data_2bru_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2bru _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 20.5 t-80 . . . . . 0 CA--C 1.488 -1.441 0 N-CA-C 108.418 -0.956 . . . . 65.739999999999995 108.418 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -72.05 86.71 0.48 Allowed Glycine 0 C--O 1.246 0.866 0 N-CA-C 108.839 -1.704 . . . . 48.659999999999997 108.839 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -118.85 131.38 56.07 Favored 'General case' 0 C--O 1.255 1.382 0 N-CA-C 105.49 -2.041 . . . . 44.560000000000002 105.49 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1003 ' ' ILE . . . . . . . . . . . . . 96.9 mt -88.74 130.32 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 103.356 -2.831 . . . . 34.859999999999999 103.356 173.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -107.22 123.26 7.2 Favored Glycine 0 C--N 1.316 -0.579 0 N-CA-C 106.398 -2.681 . . . . 30.75 106.398 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 39.5 mm -107.56 104.04 51.28 Favored Pre-proline 0 C--O 1.249 1.055 0 N-CA-C 102.832 -3.025 . . . . 32.210000000000001 102.832 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -83.01 161.31 15.74 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.973 2.449 . . . . 32.979999999999997 113.718 171.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1007 ' ' ARG . . . . . . . . . . . . . 54.0 ttp85 -69.51 149.57 48.1 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 111.094 -2.776 . . . . 47.979999999999997 106.808 161.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1008 ' ' GLU . . . . . . . . . . . . 0.297 13.9 tp10 -83.17 118.65 23.74 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 116.057 -2.257 . . . . 34.700000000000003 109.392 170.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 14.5 mtp-105 -95.19 -3.91 46.89 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 109.635 -3.439 . . . . 53.369999999999997 112.371 -173.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 65.1 tp -65.24 132.61 49.53 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 105.53 -2.026 . . . . 45.07 105.53 167.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1011 ' ' THR . . . . . . . . . . . . . 5.2 m -55.41 123.01 12.5 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 125.525 1.53 . . . . 40.359999999999999 112.179 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 66.9 m-80 58.41 28.92 17.5 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 118.259 2.689 . . . . 40.609999999999999 118.259 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -89.7 147.08 24.07 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.441 -1.688 . . . . 33.759999999999998 106.441 167.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1014 ' ' THR . . . . . . . . . . . . . 1.9 m -110.19 -4.54 15.7 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 113.574 0.954 . . . . 27.890000000000001 113.574 -170.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1015 ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -83.18 163.37 20.84 Favored 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 120.251 -1.53 . . . . 29.02 114.746 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1016 ' ' VAL . . . . . . . . . . . . . 12.5 p -121.49 162.06 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 103.782 -2.673 . . . . 28.129999999999999 103.782 159.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1017 ' ' ALA . . . . . . . . . . . . . . . -61.09 -42.45 98.54 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 115.962 1.838 . . . . 26.870000000000001 115.962 -178.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -145.45 142.48 29.31 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 122.832 1.301 . . . . 26.77 110.255 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1019 ' ' THR . . . . . . . . . . . . . 8.2 p -84.77 161.19 54.09 Favored Pre-proline 0 N--CA 1.438 -1.071 0 O-C-N 118.877 -2.39 . . . . 27.02 108.468 171.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1020 ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -40.9 -45.31 4.97 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 123.706 2.937 . . . . 30.57 117.009 175.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -57.54 -41.05 80.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 123.753 1.739 . . . . 47.810000000000002 113.213 177.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1022 ' ' THR . . . . . . . . . . . . . 1.1 p -77.73 -32.5 52.85 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 114.191 1.182 . . . . 30.77 114.191 175.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1023 ' ' VAL . . . . . . . . . . . . . 80.1 t -54.68 -44.96 72.44 Favored 'Isoleucine or valine' 0 C--N 1.345 0.385 0 O-C-N 121.257 -0.902 . . . . 33.590000000000003 110.815 170.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -48.62 -46.81 40.14 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.268 1.027 . . . . 53.289999999999999 111.184 172.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -64.66 -36.4 84.14 Favored 'General case' 0 N--CA 1.436 -1.144 0 O-C-N 123.563 0.54 . . . . 46.920000000000002 110.936 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1026 ' ' LEU . . . . . . . . . . . . . 17.4 mt -66.15 -35.38 80.32 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 117.942 -1.027 . . . . 37.170000000000002 112.591 171.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.81 -43.55 98.03 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.75 1.159 . . . . 44.439999999999998 111.575 173.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 22.9 mmmt -57.7 -36.7 72.34 Favored 'General case' 0 C--O 1.217 -0.648 0 C-N-CA 123.671 0.788 . . . . 52.579999999999998 111.674 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1029 ' ' LEU . . . . . . . . . . . . . 90.4 mt -58.48 -11.29 2.77 Favored 'General case' 0 C--O 1.249 1.03 0 N-CA-C 115.721 1.749 . . . . 45.689999999999998 115.721 173.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 88.21 22.91 39.41 Favored Glycine 0 CA--C 1.506 -0.516 0 O-C-N 118.115 -2.866 . . . . 42.090000000000003 112.345 170.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -113.76 162.47 16.26 Favored 'General case' 0 C--O 1.254 1.326 0 N-CA-C 105.905 -1.887 . . . . 40.719999999999999 105.905 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1032 ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -80.2 139.59 36.68 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 119.933 -1.73 . . . . 37.770000000000003 106.704 173.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1033 ' ' VAL . . . . . . . . . . . . . 11.0 t -121.54 127.18 75.57 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 O-C-N 117.803 -3.061 . . . . 33.539999999999999 108.187 -176.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -125.75 135.99 52.66 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 106.285 -1.746 . . . . 31.68 106.285 -176.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1035 ' ' VAL . . . . . . . . . . . . . 47.1 t -121.21 145.91 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 104.636 -2.357 . . . . 31.52 104.636 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1036 ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -58.89 154.36 15.32 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 119.52 -0.276 . . . . 41.039999999999999 111.584 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1037 ' ' SER . . . . . . . . . . . . . 4.7 m -47.27 96.09 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 113.619 0.97 . . . . 31.829999999999998 113.619 173.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 61.25 38.87 96.37 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 114.674 -1.148 . . . . 29.359999999999999 112.669 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -52.43 -26.35 12.46 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 118.023 2.601 . . . . 27.780000000000001 118.023 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -91.69 13.0 67.85 Favored Glycine 0 N--CA 1.43 -1.731 0 CA-C-O 116.237 -2.424 . . . . 28.91 113.02 -175.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -62.67 -26.95 68.91 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 123.319 3.56 . . . . 51.18 113.482 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1042 ' ' LEU . . . . . . . . . . . . . 96.0 mt -54.94 -44.22 74.12 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 122.003 0.906 . . . . 29.91 110.915 167.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1043 ' ' ALA . . . . . . . . . . . . . . . -104.1 35.84 2.55 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 114.303 -1.317 . . . . 28.539999999999999 109.491 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1044 ' ' SER . . . . . . . . . . . . . 3.0 m 65.8 0.36 1.5 Allowed 'General case' 0 C--O 1.239 0.548 0 N-CA-C 121.51 3.893 . . . . 33.060000000000002 121.51 172.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1045 ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -106.51 118.72 37.38 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 120.952 1.706 . . . . 30.289999999999999 114.15 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.9 -176.43 6.31 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 115.399 1.629 . . . . 48.619999999999997 115.399 178.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -43.55 -67.39 0.28 Allowed 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 125.642 1.838 . . . . 36.740000000000002 111.829 170.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 13.3 pttm -64.7 -24.15 67.48 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.347 0.976 . . . . 43.729999999999997 111.786 -172.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -63.48 -45.74 89.4 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.831 -1.174 . . . . 32.810000000000002 107.831 170.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1050 ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -70.95 -23.03 62.15 Favored 'General case' 0 C--O 1.211 -0.931 0 O-C-N 120.275 -1.516 . . . . 31.859999999999999 110.847 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 78.5 t -69.39 -27.95 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 O-C-N 118.495 -2.628 . . . . 33.219999999999999 109.543 170.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -62.16 -45.63 92.55 Favored 'General case' 0 CA--C 1.509 -0.622 0 O-C-N 119.461 -2.024 . . . . 50.829999999999998 110.401 174.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -65.38 -38.07 88.9 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 115.86 -0.609 . . . . 33.119999999999997 111.705 172.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 99.16 69.21 0.91 Allowed Glycine 0 C--O 1.245 0.832 0 N-CA-C 105.485 -3.046 . . . . 35.829999999999998 105.485 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -119.7 138.03 53.55 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 113.662 -1.269 . . . . 34.82 108.059 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -66.13 124.63 23.14 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.474 -1.676 . . . . 49.049999999999997 106.474 171.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1057 ' ' ILE . . . . . . . . . . . . . 30.4 mm -90.23 98.77 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.25 0 O-C-N 117.699 -3.126 . . . . 38.530000000000001 107.792 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1058 ' ' VAL . . . . . . . . . . . . . 2.5 m -79.81 123.23 36.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 125.44 2.543 . . . . 42.109999999999999 106.155 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -76.7 82.91 3.33 Favored 'General case' 0 C--N 1.31 -1.126 1 CA-C-N 107.367 -4.469 . . . . 58.0 110.01 -174.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 75.51 -133.0 13.88 Favored Glycine 0 C--O 1.223 -0.589 0 N-CA-C 109.784 -1.326 . . . . 52.119999999999997 109.784 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 3.3 t30 -56.49 -25.66 51.95 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 117.427 2.38 . . . . 54.75 117.427 -161.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1062 ' ' SER . . . . . . . . . . . . . 70.5 m -55.66 -15.66 3.28 Favored 'General case' 0 C--O 1.25 1.113 0 O-C-N 120.012 -1.68 . . . . 50.340000000000003 113.125 174.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 14.8 p -57.17 -37.22 54.71 Favored 'Isoleucine or valine' 0 C--N 1.37 1.496 0 O-C-N 120.609 -1.307 . . . . 41.460000000000001 113.536 170.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1064 ' ' TRP . . . . . . . . . . . . . 97.9 m95 -70.2 -24.38 63.11 Favored 'General case' 0 N--CA 1.435 -1.216 0 O-C-N 125.525 1.766 . . . . 39.32 114.222 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -87.95 72.04 9.34 Favored 'General case' 0 C--O 1.246 0.883 0 N-CA-C 107.83 -1.174 . . . . 55.380000000000003 107.83 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1066 ' ' SER . . . . . . . . . . . . . 11.1 m -151.74 144.61 24.42 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-O 118.552 -0.737 . . . . 41.869999999999997 109.376 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.4 -12.28 60.22 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 119.03 2.974 . . . . 53.200000000000003 119.03 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 2.4 mp -127.06 124.66 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 104.241 -2.503 . . . . 41.899999999999999 104.241 167.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1069 ' ' ILE . . . . . . . . . . . . . 46.6 mm -119.08 111.14 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.069 0 N-CA-C 104.337 -2.468 . . . . 38.729999999999997 104.337 173.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1070 ' ' LEU . . . . . . . . . . . . . 94.5 mt -90.22 85.17 6.17 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 105.665 -1.976 . . . . 32.439999999999998 105.665 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1071 ' ' LYS . . . . . 0.413 ' HZ2' ' CD ' ' A' 1079 ' ' GLU . 3.8 mmmt -81.79 145.83 30.24 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 107.049 -1.463 . . . . 34.649999999999999 107.049 -177.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1072 ' ' VAL . . . . . . . . . . . . . 2.6 t -86.89 -25.9 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-O 124.107 1.908 . . . . 31.32 111.871 -165.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -140.86 -173.82 3.82 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 105.694 -1.965 . . . . 33.939999999999998 105.694 168.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -52.0 142.7 25.72 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 116.734 2.124 . . . . 38.039999999999999 116.734 172.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1075 ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -63.77 119.21 6.18 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.652 2.902 . . . . 42.68 112.454 162.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 50.8 mt -71.31 158.45 36.32 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 113.036 -1.893 . . . . 46.740000000000002 107.098 161.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1077 ' ' ASP . . . . . 0.411 ' CG ' ' HZ1' ' A' 1104 ' ' LYS . 8.0 m-20 -57.88 -32.11 67.38 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 119.953 -1.717 . . . . 58.609999999999999 114.934 -172.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 14.2 t70 -44.85 -53.38 7.57 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 123.067 1.413 . . . . 59.200000000000003 111.858 164.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1079 ' ' GLU . . . . . 0.413 ' CD ' ' HZ2' ' A' 1071 ' ' LYS . 18.2 mt-10 -78.2 -34.81 49.21 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.96 -1.018 . . . . 50.630000000000003 109.859 -174.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1080 ' ' ILE . . . . . . . . . . . . . 66.3 mt -49.13 -48.05 17.5 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 CA-C-O 123.169 1.461 . . . . 51.479999999999997 111.175 170.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -63.47 -38.65 91.94 Favored 'General case' 0 C--O 1.25 1.106 0 CA-C-N 113.73 -1.577 . . . . 50.280000000000001 110.332 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 87.2 mt -71.52 -24.64 61.99 Favored 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 120.922 -1.112 . . . . 50.210000000000001 113.765 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1083 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.27 161.36 29.41 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 120.211 1.369 . . . . 49.060000000000002 109.467 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -123.88 140.28 34.21 Favored Pre-proline 0 C--O 1.248 0.991 0 N-CA-C 105.399 -2.074 . . . . 51.079999999999998 105.399 -176.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -56.08 155.16 24.83 Favored 'Trans proline' 0 N--CA 1.446 -1.277 1 C-N-CA 125.382 4.055 . . . . 49.729999999999997 113.64 175.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 81.58 -10.46 50.64 Favored Glycine 0 C--N 1.314 -0.65 0 O-C-N 121.158 -0.964 . . . . 47.710000000000001 112.296 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1087 ' ' THR . . . . . . . . . . . . . 92.9 m -82.52 137.91 34.46 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 119.411 1.605 . . . . 45.469999999999999 110.187 -171.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1088 ' ' THR . . . . . . . . . . . . . 2.7 m -75.94 87.53 2.9 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 107.311 -1.366 . . . . 42.039999999999999 107.311 174.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1089 ' ' LEU . . . . . . . . . . . . . 56.4 tp -82.62 97.08 8.32 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 122.733 1.254 . . . . 38.060000000000002 108.663 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 96.7 t -97.52 116.3 39.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 102.679 -3.082 . . . . 37.399999999999999 102.679 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1091 ' ' SER . . . . . . . . . . . . . 1.9 m -153.94 160.98 42.32 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 120.325 1.42 . . . . 36.159999999999997 113.179 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.79 97.51 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.757 0 O-C-N 119.434 -2.041 . . . . 38.939999999999998 111.305 154.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 25.2 mm -96.47 -36.93 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 C-N-CA 123.115 0.566 . . . . 42.170000000000002 109.98 -175.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 45.8 m95 58.16 56.6 6.63 Favored Pre-proline 0 C--O 1.256 1.418 0 O-C-N 124.867 1.354 . . . . 46.509999999999998 110.98 -172.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -50.15 -39.41 51.58 Favored 'Trans proline' 0 CA--C 1.504 -1.001 0 C-N-CA 124.414 3.409 . . . . 49.759999999999998 116.364 -173.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -72.84 -24.59 60.91 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 120.004 1.275 . . . . 52.619999999999997 113.247 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -90.32 -11.76 39.76 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 122.279 1.037 . . . . 60.740000000000002 110.032 172.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1098 ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -133.05 47.85 3.02 Favored Pre-proline 0 N--CA 1.451 -0.398 0 O-C-N 118.211 -2.806 . . . . 58.189999999999998 115.456 -174.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -55.31 -31.21 75.89 Favored 'Trans proline' 0 C--O 1.244 0.78 0 C-N-CA 124.664 3.576 . . . . 54.590000000000003 112.84 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 29.4 mp0 -61.46 -53.65 53.71 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.692 1.197 . . . . 63.280000000000001 109.971 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1101 ' ' LEU . . . . . . . . . . . . . 24.2 tp -56.54 -40.64 75.43 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 124.027 0.931 . . . . 54.75 109.831 174.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1102 ' ' MET . . . . . . . . . . . . . 81.4 mmm -55.16 -50.72 68.58 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.929 1.24 . . . . 52.649999999999999 110.087 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -57.87 -39.95 79.02 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 124.96 1.304 . . . . 66.260000000000005 109.16 176.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1104 ' ' LYS . . . . . 0.411 ' HZ1' ' CG ' ' A' 1077 ' ' ASP . 51.1 mtmt -71.72 -42.62 67.12 Favored 'General case' 0 C--N 1.313 -0.988 0 O-C-N 120.999 -1.063 . . . . 63.729999999999997 111.884 -176.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 68.3 mt -76.35 -21.28 56.32 Favored 'General case' 0 C--O 1.268 2.054 0 O-C-N 119.936 -1.728 . . . . 54.68 111.136 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -62.85 -42.54 99.79 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 120.646 -1.284 . . . . 53.640000000000001 111.759 167.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -62.47 -44.98 95.08 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 109.878 -0.415 . . . . 67.239999999999995 109.878 172.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.45 -2.79 12.07 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 117.055 -3.528 . . . . 65.760000000000005 114.347 174.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 2.1 t30 61.1 35.43 18.68 Favored 'General case' 0 C--O 1.247 0.942 0 O-C-N 118.984 -2.323 . . . . 58.710000000000001 113.717 169.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1110 ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.95 156.6 3.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 106.78 -1.563 . . . . 46.630000000000003 106.78 -171.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1111 ' ' THR . . . . . . . . . . . . . 53.9 m -81.62 97.32 7.81 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 105.878 -1.897 . . . . 44.130000000000003 105.878 165.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1112 ' ' VAL . . . . . . . . . . . . . 42.7 t -95.55 111.69 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-O 123.584 1.659 . . . . 40.439999999999998 109.11 -177.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1113 ' ' MET . . . . . . . . . . . . . 47.7 mtp -106.21 107.33 18.28 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 112.913 -1.948 . . . . 50.759999999999998 109.487 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1114 ' ' ALA . . . . . . . . . . . . . . . -87.64 105.44 17.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 126.338 2.97 . . . . 35.640000000000001 111.901 -177.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1115 ' ' MET . . . . . . . . . . . . . 74.2 mmm -60.19 -28.89 68.32 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 110.741 -2.936 . . . . 38.740000000000002 117.988 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -66.21 -44.17 84.65 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 113.293 -1.776 . . . . 40.140000000000001 109.737 167.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1117 ' ' SER . . . . . . . . . . . . . 74.5 m -80.38 48.4 1.02 Allowed 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 118.509 2.781 . . . . 44.789999999999999 118.509 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1118 ' ' VAL . . . . . . . . . . . . . 37.4 t -89.8 134.9 31.2 Favored Pre-proline 0 C--O 1.25 1.124 0 N-CA-C 107.112 -1.44 . . . . 43.75 107.112 173.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -50.22 122.96 10.18 Favored 'Trans proline' 0 N--CA 1.459 -0.546 1 C-N-CA 125.688 4.259 . . . . 48.93 112.119 170.376 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 42.3 mmm-85 -75.31 61.1 1.17 Allowed 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 123.812 0.845 . . . . 62.899999999999999 111.905 -169.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 15.6 pt -116.78 167.65 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 O-C-N 118.042 -2.911 . . . . 57.719999999999999 110.733 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1122 ' ' SER . . . . . . . . . . . . . 4.2 p -39.0 -65.86 0.33 Allowed 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 117.592 2.442 . . . . 57.259999999999998 117.592 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -57.28 -33.29 67.48 Favored 'General case' 0 C--N 1.36 1.06 0 O-C-N 121.012 -1.055 . . . . 62.899999999999999 113.381 -176.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -82.17 -15.81 51.98 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-N 113.366 -1.743 . . . . 49.829999999999998 109.682 -169.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -56.02 -30.49 61.94 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 122.826 2.557 . . . . 52.369999999999997 114.159 -172.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1126 ' ' SER . . . . . . . . . . . . . 16.9 p -66.85 -31.73 72.54 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 122.715 1.245 . . . . 42.43 113.169 172.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1127 ' ' LEU . . . . . . . . . . . . . 3.6 mp -83.65 -25.67 30.55 Favored 'General case' 0 C--N 1.346 0.436 0 O-C-N 121.197 -0.939 . . . . 43.740000000000002 111.971 172.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 62.0 t0 -69.84 89.32 0.57 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 123.736 1.731 . . . . 43.210000000000001 113.209 -172.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -67.92 -31.73 71.69 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 112.588 -2.096 . . . . 35.740000000000002 112.94 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 44.5 tp -54.18 -58.19 8.29 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 124.854 1.346 . . . . 38.090000000000003 108.702 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1131 ' ' SER . . . . . . . . . . . . . 7.0 m -69.77 -37.17 76.29 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 113.63 -1.623 . . . . 36.909999999999997 111.632 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1132 ' ' SER . . . . . . . . . . . . . 61.0 m -65.16 -38.27 90.04 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 123.048 2.658 . . . . 35.789999999999999 110.528 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1133 ' ' MET . . . . . . . . . . . . . 34.3 mmt -77.46 -40.16 44.11 Favored 'General case' 0 CA--C 1.489 -1.384 0 O-C-N 119.586 -1.946 . . . . 30.809999999999999 109.748 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1134 ' ' ALA . . . . . . . . . . . . . . . -52.33 -43.16 64.41 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.094 0.557 . . . . 28.879999999999999 111.734 168.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1135 ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -63.93 -51.43 64.46 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.232 1.015 . . . . 40.759999999999998 109.796 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1136 ' ' ILE . . . . . . . . . . . . . 94.0 mt -55.07 -42.62 65.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 114.838 -1.074 . . . . 31.539999999999999 113.343 171.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -66.54 -31.7 72.58 Favored 'General case' 0 C--O 1.219 -0.544 0 C-N-CA 124.709 1.203 . . . . 29.870000000000001 112.645 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -66.08 -50.5 51.41 Favored Glycine 0 C--O 1.216 -1.019 0 O-C-N 120.048 -1.657 . . . . 28.73 110.408 176.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 19.6 t80 -55.58 -47.11 76.97 Favored 'General case' 0 C--O 1.248 0.98 0 C-N-CA 124.187 0.995 . . . . 30.390000000000001 109.377 172.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1140 ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -68.66 -24.45 64.53 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 114.171 1.174 . . . . 26.09 114.171 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1141 ' ' ALA . . . . . . . . . . . . . . . -71.32 -40.35 70.84 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 121.572 1.987 . . . . 27.100000000000001 106.817 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 19.7 mm -63.1 -41.03 91.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.399 -0.593 . . . . 28.48 109.399 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 54.9 t -54.97 -64.85 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.607 0 C-N-CA 123.24 0.616 . . . . 23.07 111.534 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1144 ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -68.36 -19.64 64.65 Favored 'General case' 0 C--O 1.244 0.785 0 O-C-N 120.336 -1.477 . . . . 33.399999999999999 113.253 -175.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -62.65 -56.96 12.98 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 107.154 -1.425 . . . . 24.219999999999999 107.154 164.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -59.75 -20.48 56.88 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 117.477 -3.265 . . . . 24.890000000000001 112.655 175.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 29.1 t-80 -66.73 -38.43 86.65 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 117.901 -3.0 . . . . 26.73 111.06 174.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1148 ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -109.21 0.07 19.5 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 115.533 1.679 . . . . 39.960000000000001 115.533 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1149 ' ' PHE . . . . . . . . . . . . . 1.3 t80 -68.19 148.29 51.07 Favored 'General case' 0 C--O 1.246 0.888 0 O-C-N 120.988 -1.07 . . . . 25.870000000000001 108.709 -174.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1150 ' ' GLY . . . . . . . . . . . . . . . -72.81 -40.37 52.72 Favored Glycine 0 N--CA 1.438 -1.197 0 C-N-CA 118.633 -1.746 . . . . 19.280000000000001 112.044 173.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1151 ' ' ARG . . . . . . . . . . . . . 23.9 mtm-85 -108.21 -177.91 3.46 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.236 -1.155 . . . . 39.899999999999999 113.845 -166.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1152 ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -81.96 154.25 25.84 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 116.562 -2.055 . . . . 29.440000000000001 109.887 168.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1153 ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -70.47 -57.43 4.79 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 124.244 1.973 . . . . 32.600000000000001 107.177 156.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1154 ' ' THR . . . . . . . . . . . . . 3.5 m -60.16 92.24 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 110.562 -3.017 . . . . 34.640000000000001 111.425 -175.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -60.35 128.47 45.79 Favored Glycine 0 C--N 1.344 1.01 0 O-C-N 120.3 -1.5 . . . . 37.140000000000001 112.611 175.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -159.49 137.57 10.32 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 113.896 1.072 . . . . 40.57 113.896 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1157 ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.36 125.15 39.02 Favored 'Isoleucine or valine' 0 C--O 1.257 1.491 0 N-CA-C 102.891 -3.003 . . . . 44.609999999999999 102.891 169.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1158 ' ' THR . . . . . . . . . . . . . 56.0 p -98.44 -173.3 2.52 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 113.394 -1.73 . . . . 40.700000000000003 106.607 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -72.02 -19.0 61.92 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 121.48 1.945 . . . . 40.25 109.562 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -103.91 -47.81 4.09 Favored 'General case' 0 C--O 1.249 1.038 0 CA-C-N 119.972 1.26 . . . . 38.469999999999999 113.888 172.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . -148.54 162.01 28.76 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 117.723 -2.179 . . . . 37.609999999999999 114.693 -159.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 26.9 tttt -79.95 124.01 28.31 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 123.188 1.47 . . . . 48.899999999999999 113.318 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1163 ' ' VAL . . . . . . . . . . . . . 79.4 t -95.29 117.0 66.81 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 105.962 -1.866 . . . . 36.520000000000003 105.962 165.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1164 ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -71.27 140.62 37.51 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.636 2.224 . . . . 35.079999999999998 112.753 172.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1165 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -59.0 125.63 18.72 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 CA-C-N 122.258 1.842 . . . . 35.329999999999998 112.861 169.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -63.85 140.57 58.88 Favored 'General case' 0 C--O 1.244 0.814 0 N-CA-C 114.773 1.398 . . . . 34.689999999999998 114.773 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1167 ' ' LYS . . . . . . . . . . . . . 79.4 mttt -88.21 113.13 23.52 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 119.845 1.202 . . . . 45.359999999999999 113.061 170.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 64.9 t -101.99 115.5 43.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.063 -1.088 . . . . 31.710000000000001 108.063 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1169 ' ' MET . . . . . . . . . . . . . 12.4 ttt -100.03 113.75 26.57 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 121.75 2.068 . . . . 42.280000000000001 109.24 170.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 68.9 t -82.92 128.69 38.48 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 N-CA-C 105.919 -1.882 . . . . 30.510000000000002 105.919 169.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 42.3 mt -119.55 136.46 56.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 O-C-N 119.63 -1.919 . . . . 31.870000000000001 106.068 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 74.91 58.26 4.12 Favored Glycine 0 CA--C 1.539 1.587 0 N-CA-C 110.043 -1.223 . . . . 34.539999999999999 110.043 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1173 ' ' ALA . . . . . . . . . . . . . . . -72.28 85.1 1.07 Allowed 'General case' 0 C--O 1.259 1.555 0 CA-C-O 122.487 1.137 . . . . 32.509999999999998 113.867 -166.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -76.16 -175.11 38.87 Favored Glycine 0 CA--C 1.554 2.498 0 N-CA-C 108.325 -1.91 . . . . 29.899999999999999 108.325 163.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1175 ' ' VAL . . . . . . . . . . . . . 79.2 t -59.42 -37.12 68.04 Favored 'Isoleucine or valine' 0 C--O 1.25 1.125 0 CA-C-N 118.49 1.145 . . . . 33.109999999999999 110.621 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -52.52 -42.42 64.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.322 -1.308 . . . . 28.100000000000001 114.333 169.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -64.94 -40.13 96.98 Favored Glycine 0 CA--C 1.545 1.91 0 N-CA-C 110.014 -1.234 . . . . 28.539999999999999 110.014 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1178 ' ' LEU . . . . . . . . . . . . . 69.6 mt -63.31 -48.38 78.3 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.704 -0.85 . . . . 31.219999999999999 108.704 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -64.44 -34.18 77.59 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 120.259 -1.526 . . . . 28.98 114.937 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -57.95 -40.78 81.36 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 115.82 1.785 . . . . 27.829999999999998 115.82 171.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1181 ' ' ILE . . . . . . . . . . . . . 96.7 mt -56.96 -49.15 80.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.507 -0.77 . . . . 30.25 111.672 169.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -58.08 -40.63 93.8 Favored Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 111.313 -0.715 . . . . 29.59 111.313 175.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -67.43 -52.43 39.81 Favored 'General case' 0 C--O 1.243 0.728 0 O-C-N 119.51 -2.17 . . . . 30.289999999999999 112.906 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -58.6 -40.44 83.25 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-O 122.962 1.363 . . . . 30.469999999999999 111.64 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -62.48 -43.51 98.64 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 114.932 -1.031 . . . . 42.409999999999997 112.592 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1186 ' ' SER . . . . . . . . . . . . . 43.9 m -58.16 -50.8 72.26 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 123.985 0.914 . . . . 39.380000000000003 109.566 172.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 29.5 mt -60.48 -18.76 53.72 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 116.975 2.213 . . . . 36.18 116.975 171.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 97.34 33.33 5.99 Favored Glycine 0 C--N 1.356 1.664 0 CA-C-N 121.876 2.125 . . . . 33.780000000000001 112.418 174.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -99.92 155.82 17.47 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 123.249 0.62 . . . . 33.93 112.478 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 34.2 mt -79.26 103.29 6.05 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.462 0 N-CA-C 104.31 -2.478 . . . . 38.740000000000002 104.31 175.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 1.4 t -93.92 148.74 4.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 N-CA-C 106.556 -1.646 . . . . 33.090000000000003 106.556 -172.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1192 ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -141.76 158.76 43.41 Favored 'General case' 0 C--O 1.252 1.2 0 C-N-CA 124.647 1.179 . . . . 38.920000000000002 108.39 176.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -152.24 148.3 27.41 Favored 'General case' 0 C--O 1.25 1.106 0 N-CA-C 114.405 1.261 . . . . 35.32 114.405 176.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 42.3 t80 -138.23 147.64 43.94 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 113.705 -1.589 . . . . 39.350000000000001 107.648 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 10.5 t70 -170.78 167.51 7.61 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 103.109 -2.923 . . . . 40.460000000000001 103.109 170.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1196 ' ' THR . . . . . . . . . . . . . 4.0 m -69.92 -43.16 72.25 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 125.015 1.326 . . . . 45.939999999999998 110.068 175.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1197 ' ' ARG . . . . . . . . . . . . . 39.6 mtm180 -79.49 112.74 31.21 Favored Pre-proline 0 C--O 1.222 -0.357 0 N-CA-C 114.951 1.463 . . . . 56.020000000000003 114.951 -165.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1198 ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -58.39 -20.88 50.58 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.722 2.281 . . . . 51.270000000000003 117.666 178.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -55.68 -25.53 40.21 Favored 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 117.01 2.226 . . . . 59.100000000000001 117.01 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 27.7 m -87.55 -14.14 10.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 114.729 1.381 . . . . 51.060000000000002 114.729 -175.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 90.8 mttt -62.98 -38.79 92.56 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.123 -0.944 . . . . 57.380000000000003 113.443 -169.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -56.38 -48.68 76.36 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 124.638 1.211 . . . . 62.409999999999997 110.707 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.35 -44.34 87.99 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 124.918 1.386 . . . . 57.780000000000001 110.579 175.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 54.1 t -55.49 -47.02 78.99 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 CA-C-N 121.083 1.765 . . . . 46.380000000000003 111.323 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -66.11 -36.09 82.25 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-N 115.008 -0.997 . . . . 50.700000000000003 110.037 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1206 ' ' SER . . . . . . . . . . . . . 59.8 m -71.2 -51.04 26.96 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 112.724 0.639 . . . . 49.979999999999997 112.724 -176.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1207 ' ' MET . . . . . . . . . . . . . 45.7 mtp -68.35 -25.78 65.26 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 123.499 0.499 . . . . 52.990000000000002 111.008 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 131.3 68.14 0.1 OUTLIER Glycine 0 N--CA 1.475 1.289 0 O-C-N 120.018 -1.677 . . . . 47.659999999999997 113.27 156.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -155.46 161.88 40.86 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 122.683 1.23 . . . . 44.770000000000003 113.173 -174.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -89.97 113.86 25.6 Favored 'General case' 0 C--N 1.318 -0.787 0 O-C-N 118.961 -2.337 . . . . 47.640000000000001 108.313 173.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1211 ' ' PHE . . . . . . . . . . . . . 21.7 t80 -84.3 115.32 22.42 Favored 'General case' 0 N--CA 1.432 -1.375 0 C-N-CA 117.885 -1.526 . . . . 45.659999999999997 107.229 173.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 37.1 mt -71.01 116.42 11.28 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 125.955 1.702 . . . . 46.060000000000002 108.682 -176.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -69.44 144.72 53.22 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 118.444 -1.302 . . . . 60.219999999999999 112.84 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 66.6 tp -62.55 95.39 0.07 Allowed 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 113.589 -1.641 . . . . 57.25 109.72 167.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 16.3 t70 -69.45 90.67 0.54 Allowed 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 105.403 -2.073 . . . . 64.430000000000007 105.403 172.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.303 -1.428 0 O-C-N 126.325 2.265 . . . . 66.900000000000006 106.898 -172.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.429 -1.482 0 CA-C-O 122.174 0.988 . . . . 39.090000000000003 108.962 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -59.81 -38.66 94.31 Favored Glycine 0 CA--C 1.543 1.796 0 O-C-N 120.529 -1.357 . . . . 39.32 114.227 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 68.0 t80 -65.88 -46.35 78.72 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 117.336 0.568 . . . . 39.299999999999997 111.973 170.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -59.53 -49.46 77.68 Favored 'General case' 0 C--N 1.349 0.556 0 O-C-N 121.96 -0.463 . . . . 36.299999999999997 109.995 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -50.99 -56.98 9.81 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-O 117.432 -1.271 . . . . 37.380000000000003 111.973 168.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -51.91 -30.42 12.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 118.261 2.689 . . . . 39.109999999999999 118.261 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1230 ' ' MET . . . . . . . . . . . . . 38.7 mmt -79.21 -28.86 42.59 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 113.079 0.77 . . . . 49.590000000000003 113.079 174.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1231 ' ' SER . . . . . . . . . . . . . 23.1 m -58.21 140.43 53.09 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 117.142 2.275 . . . . 43.68 117.142 -169.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -58.96 -49.79 76.51 Favored 'General case' 0 C--O 1.214 -0.78 0 N-CA-C 116.251 1.945 . . . . 55.57 116.251 175.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -61.44 -25.44 67.22 Favored 'General case' 0 C--O 1.206 -1.19 0 N-CA-C 112.487 0.551 . . . . 44.939999999999998 112.487 174.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 70.7 t80 -69.22 -49.59 55.03 Favored 'General case' 0 N--CA 1.428 -1.569 0 O-C-N 124.299 0.999 . . . . 42.039999999999999 110.031 175.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 63.1 mt -62.05 -33.86 60.47 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 O-C-N 123.437 0.46 . . . . 46.280000000000001 111.982 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1236 ' ' LYS . . . . . 0.456 ' HZ1' ' CD ' ' A' 1240 ' ' GLU . 48.3 tttm -57.5 -53.12 61.72 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 118.085 -0.96 . . . . 47.869999999999997 111.049 164.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -60.43 -40.4 90.91 Favored 'General case' 0 C--O 1.259 1.558 0 N-CA-C 113.729 1.011 . . . . 41.609999999999999 113.729 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -57.13 -52.39 65.5 Favored 'General case' 0 C--O 1.254 1.321 0 O-C-N 121.557 -0.714 . . . . 50.649999999999999 109.567 173.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1239 ' ' MET . . . . . . . . . . . . . 92.9 mmm -62.43 -25.14 67.81 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 113.586 0.958 . . . . 48.869999999999997 113.586 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1240 ' ' GLU . . . . . 0.456 ' CD ' ' HZ1' ' A' 1236 ' ' LYS . 34.7 mt-10 -71.45 -42.73 67.82 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 119.952 1.251 . . . . 54.799999999999997 111.596 168.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 2.3 mm? -59.0 -45.18 91.3 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 119.495 -2.003 . . . . 43.210000000000001 108.098 172.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -62.49 -46.17 89.7 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 125.478 1.511 . . . . 38.659999999999997 111.486 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -61.49 -39.83 92.39 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 123.589 1.662 . . . . 37.920000000000002 111.588 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -65.11 -53.31 47.28 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 120.353 -1.467 . . . . 37.280000000000001 111.464 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -66.46 -31.16 71.73 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 120.825 -1.172 . . . . 43.07 112.662 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -53.37 -34.36 57.3 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 123.288 0.635 . . . . 38.299999999999997 112.099 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1247 ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -67.42 -29.0 68.37 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.139 -0.937 . . . . 47.600000000000001 113.054 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -114.9 -37.1 4.26 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 114.195 1.183 . . . . 45.420000000000002 114.195 -168.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1249 ' ' VAL . . . . . . . . . . . . . 20.7 m -68.94 166.9 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.863 0 CA-C-O 123.624 1.678 . . . . 36.259999999999998 114.967 -166.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1250 ' ' ASP . . . . . 0.406 ' CG ' ' HZ3' ' A' 1276 ' ' LYS . 9.7 m-20 -123.68 -43.24 2.15 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 110.935 -2.848 . . . . 33.039999999999999 109.439 -172.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1251 ' ' ILE . . . . . . . . . . . . . 48.4 mm -123.84 138.28 54.09 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.878 0 O-C-N 118.811 -2.43 . . . . 31.399999999999999 105.445 174.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1252 ' ' ILE . . . . . . . . . . . . . 19.8 mt -114.44 130.95 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 106.351 -1.722 . . . . 29.420000000000002 106.351 162.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 13.4 t -110.22 106.49 20.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 O-C-N 121.14 -0.975 . . . . 30.370000000000001 109.222 172.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1254 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.06 108.88 20.0 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 125.022 2.344 . . . . 35.719999999999999 110.802 -178.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1255 ' ' THR . . . . . . . . . . . . . 8.5 m -109.5 -27.25 9.54 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 111.441 -2.618 . . . . 36.0 117.437 -158.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1256 ' ' ALA . . . . . . . . . . . . . . . -70.09 77.78 0.5 Allowed 'General case' 0 C--O 1.246 0.889 0 N-CA-C 115.211 1.56 . . . . 40.93 115.211 -168.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 29.8 tp -90.8 130.27 36.79 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 124.588 1.155 . . . . 47.82 107.944 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 16.7 mm -109.57 138.61 20.64 Favored Pre-proline 0 C--O 1.246 0.91 0 N-CA-C 101.523 -3.51 . . . . 52.700000000000003 101.523 176.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -64.9 132.64 33.05 Favored 'Trans proline' 0 N--CA 1.43 -2.222 0 C-N-CA 121.589 1.526 . . . . 54.130000000000003 110.539 161.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 90.74 -69.56 2.2 Favored Glycine 0 CA--C 1.507 -0.423 0 N-CA-C 109.419 -1.472 . . . . 54.619999999999997 109.419 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 69.3 mttt -71.71 140.22 83.89 Favored Pre-proline 0 C--O 1.251 1.132 0 O-C-N 121.578 -0.954 . . . . 55.740000000000002 108.965 -176.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.36 143.95 94.39 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 123.916 3.077 . . . . 51.149999999999999 108.96 163.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -59.07 132.44 87.29 Favored Pre-proline 0 N--CA 1.446 -0.67 0 C-N-CA 126.524 1.93 . . . . 46.060000000000002 109.784 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -56.82 122.29 11.56 Favored 'Trans proline' 0 N--CA 1.445 -1.328 1 C-N-CA 125.961 4.441 . . . . 41.079999999999998 110.275 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 44.3 mttm -79.35 97.78 6.46 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 125.016 2.341 . . . . 47.420000000000002 107.721 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 48.9 mt -77.17 -63.9 1.26 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 110.931 -2.849 . . . . 39.219999999999999 109.319 -174.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 3.0 mt -87.22 111.71 22.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 CA-C-N 115.284 -0.871 . . . . 42.5 110.551 -166.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1268 ' ' THR . . . . . . . . . . . . . 63.7 m -64.39 141.95 58.59 Favored 'General case' 0 C--N 1.316 -0.85 0 O-C-N 124.728 1.267 . . . . 37.840000000000003 111.132 176.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -49.98 -47.77 52.67 Favored 'General case' 0 C--O 1.214 -0.812 0 N-CA-C 115.655 1.724 . . . . 54.799999999999997 115.655 -170.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -41.4 -50.46 3.83 Favored 'General case' 0 C--N 1.345 0.407 0 C-N-CA 126.392 1.877 . . . . 54.359999999999999 112.26 172.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1271 ' ' MET . . . . . . . . . . . . . 21.2 ttm -71.15 -25.0 62.37 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 122.661 1.219 . . . . 39.520000000000003 114.01 -173.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1272 ' ' VAL . . . . . . . . . . . . . 57.2 t -67.89 -41.9 85.27 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 O-C-N 121.003 -1.061 . . . . 38.25 111.273 174.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -59.1 -38.29 79.19 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 122.902 1.335 . . . . 40.770000000000003 111.95 172.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1274 ' ' SER . . . . . . . . . . . . . 11.8 m -67.64 -7.43 26.57 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 115.925 1.824 . . . . 36.579999999999998 115.925 174.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1275 ' ' MET . . . . . . . . . . . . . 8.7 ttt -77.34 151.38 34.95 Favored 'General case' 0 C--O 1.247 0.969 0 O-C-N 120.664 -1.273 . . . . 36.75 108.128 -174.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1276 ' ' LYS . . . . . 0.406 ' HZ3' ' CG ' ' A' 1250 ' ' ASP . 27.5 ttpt -55.22 126.67 25.86 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 114.007 -1.451 . . . . 46.109999999999999 110.698 175.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1277 ' ' ALA . . . . . . . . . . . . . . . -72.1 170.76 13.26 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 117.012 2.227 . . . . 33.520000000000003 117.012 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 68.44 30.28 73.22 Favored Glycine 0 C--O 1.25 1.102 0 C-N-CA 127.267 2.365 . . . . 31.27 111.748 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1279 ' ' SER . . . . . . . . . . . . . 64.8 m -125.79 169.17 12.87 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 125.703 1.601 . . . . 32.950000000000003 111.216 -167.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1280 ' ' VAL . . . . . . . . . . . . . 50.5 t -128.59 149.28 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 O-C-N 119.935 -1.728 . . . . 27.43 108.204 -176.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1281 ' ' ILE . . . . . . . . . . . . . 16.4 mt -120.33 103.46 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 104.686 -2.339 . . . . 30.300000000000001 104.686 161.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.34 113.64 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 118.782 -1.167 . . . . 28.629999999999999 110.681 173.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 5.6 t0 -97.79 104.93 17.0 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 122.176 0.988 . . . . 36.270000000000003 109.094 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1284 ' ' LEU . . . . . . . . . . . . . 49.1 mt -72.2 -36.31 69.16 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 112.033 -2.349 . . . . 38.57 107.602 176.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -73.38 -6.22 44.83 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 113.841 1.052 . . . . 37.560000000000002 113.841 -172.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . -43.41 -30.31 0.53 Allowed 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 127.173 2.189 . . . . 40.329999999999998 115.706 176.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -67.86 -2.31 7.09 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 116.017 1.858 . . . . 56.850000000000001 116.017 174.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -157.77 97.34 1.56 Allowed 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 102.983 -2.969 . . . . 45.859999999999999 102.983 159.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 90.93 -59.9 3.16 Favored Glycine 0 C--O 1.213 -1.168 0 O-C-N 119.222 -2.174 . . . . 40.310000000000002 111.931 169.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 80.1 134.97 1.33 Allowed Glycine 0 C--N 1.344 1.005 0 CA-C-N 120.14 1.97 . . . . 38.890000000000001 112.423 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1291 ' ' ASN . . . . . . . . . . . . . 33.1 m120 -84.53 -16.5 42.08 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.921 1.452 . . . . 37.229999999999997 114.921 -166.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1292 ' ' CYS . . . . . . . . . . . . . 37.2 t -88.75 150.27 23.04 Favored 'General case' 0 C--O 1.259 1.571 0 N-CA-C 105.595 -2.002 . . . . 36.5 105.595 171.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1293 ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -78.61 -14.15 59.47 Favored 'General case' 0 C--O 1.216 -0.697 0 N-CA-C 116.877 2.177 . . . . 43.32 116.877 170.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -75.34 -24.41 57.34 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 113.486 0.921 . . . . 41.32 113.486 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1295 ' ' THR . . . . . . . . . . . . . 24.0 m -60.96 105.35 0.46 Allowed 'General case' 0 C--O 1.249 1.036 0 C-N-CA 124.662 1.185 . . . . 35.299999999999997 113.894 -165.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 93.5 t -89.47 114.61 61.11 Favored Pre-proline 0 C--O 1.245 0.827 1 N-CA-C 99.662 -4.199 . . . . 34.840000000000003 99.662 166.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -56.85 148.89 63.98 Favored 'Trans proline' 0 CA--C 1.513 -0.546 0 C-N-CA 121.546 1.497 . . . . 33.509999999999998 111.97 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 90.35 -43.35 2.92 Favored Glycine 0 C--N 1.302 -1.343 0 CA-C-O 115.581 -2.788 . . . . 32.189999999999998 113.248 -174.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -104.91 171.39 7.34 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 121.482 2.641 . . . . 34.880000000000003 117.964 -168.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1300 ' ' ILE . . . . . . . . . . . . . 50.1 mt -96.42 112.2 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 101.157 -3.645 . . . . 32.289999999999999 101.157 167.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.8 113.73 25.59 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 101.484 -3.524 . . . . 37.25 101.484 173.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1302 ' ' THR . . . . . . . . . . . . . 60.4 m -83.18 111.59 19.06 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.528 -1.656 . . . . 35.560000000000002 106.528 174.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1303 ' ' THR . . . . . . . . . . . . . 18.0 m -61.19 137.91 58.23 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 116.656 -1.64 . . . . 36.399999999999999 106.78 172.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -57.26 -10.89 1.44 Allowed 'General case' 0 C--N 1.353 0.719 0 N-CA-C 118.047 2.61 . . . . 52.32 118.047 -172.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -79.74 -37.17 36.12 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 125.056 1.473 . . . . 40.039999999999999 108.435 172.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 123.44 31.97 0.93 Allowed Glycine 0 N--CA 1.419 -2.441 0 N-CA-C 111.161 -0.776 . . . . 36.960000000000001 111.161 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1307 ' ' VAL . . . . . . . . . . . . . 42.1 t -102.75 109.8 27.65 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 N-CA-C 103.719 -2.697 . . . . 33.399999999999999 103.719 171.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1308 ' ' LYS . . . . . . . . . . . . . 52.2 mttt -85.34 105.4 15.97 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 106.759 -1.571 . . . . 42.909999999999997 106.759 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 54.9 t -84.61 101.78 9.62 Favored 'Isoleucine or valine' 0 C--O 1.249 1.071 0 N-CA-C 106.043 -1.836 . . . . 32.289999999999999 106.043 176.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1310 ' ' ILE . . . . . . . . . . . . . 48.5 mt -96.91 96.39 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 CA-C-N 113.058 -1.883 . . . . 30.989999999999998 108.033 -173.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -89.39 61.06 3.62 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 116.423 -0.353 . . . . 28.949999999999999 112.403 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1312 ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -80.47 98.52 7.59 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 117.564 -1.654 . . . . 31.690000000000001 110.276 -171.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1313 ' ' THR . . . . . . . . . . . . . 2.8 m -59.81 -36.29 76.47 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 126.463 1.905 . . . . 34.170000000000002 108.46 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -79.54 3.9 17.42 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 114.106 1.15 . . . . 36.859999999999999 114.106 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1315 ' ' LEU . . . . . . . . . . . . . 16.6 mt -44.67 -43.83 18.87 Favored Pre-proline 0 C--O 1.22 -0.454 0 N-CA-C 119.028 2.973 . . . . 34.850000000000001 119.028 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -65.37 -21.6 60.84 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 123.653 2.902 . . . . 29.149999999999999 112.7 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -81.49 -40.29 11.27 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 110.611 -0.996 . . . . 27.289999999999999 110.611 173.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1318 ' ' ARG . . . . . . . . . . . . . 44.7 mtt-85 -50.64 -21.06 1.4 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 120.634 3.568 . . . . 41.490000000000002 120.634 -167.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1319 ' ' LEU . . . . . . . . . . . . . 14.4 tp -110.47 78.56 1.49 Allowed Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 104.557 -2.386 . . . . 27.609999999999999 104.557 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1320 ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -55.53 -61.45 0.36 Allowed 'Trans proline' 0 CA--C 1.514 -0.516 0 C-N-CA 123.793 2.995 . . . . 25.940000000000001 114.082 -157.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1321 ' ' THR . . . . . . . . . . . . . 15.8 m -64.14 -31.86 73.21 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 120.157 1.344 . . . . 25.010000000000002 112.254 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1322 ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -68.76 -52.72 27.42 Favored 'General case' 0 CA--C 1.506 -0.714 0 O-C-N 119.472 -2.017 . . . . 29.390000000000001 109.386 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1323 ' ' SER . . . . . . . . . . . . . 13.7 m -59.18 -41.14 87.76 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 125.143 1.527 . . . . 26.469999999999999 109.884 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1324 ' ' SER . . . . . . . . . . . . . 39.5 m -64.55 -42.99 95.34 Favored 'General case' 0 C--O 1.223 -0.337 0 O-C-N 123.948 0.78 . . . . 27.780000000000001 110.667 176.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -63.57 -51.31 65.91 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.047 -1.033 . . . . 37.530000000000001 108.276 -175.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1326 ' ' LEU . . . . . . . . . . . . . 96.2 mt -77.23 -35.27 55.61 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-O 116.803 -1.57 . . . . 35.710000000000001 113.309 -174.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1327 ' ' TYR . . . . . . . . . . . . . 37.1 t80 -55.94 -52.85 62.68 Favored 'General case' 0 C--N 1.362 1.139 0 CA-C-N 122.028 2.195 . . . . 31.59 108.595 168.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1328 ' ' GLY . . . . . . . . . . . . . . . -45.15 -46.37 10.29 Favored Glycine 0 N--CA 1.443 -0.838 0 O-C-N 126.037 2.086 . . . . 28.0 111.758 168.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1329 ' ' THR . . . . . . . . . . . . . 11.9 m -69.79 -36.41 75.67 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 118.775 -2.603 . . . . 32.149999999999999 110.783 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1330 ' ' ASN . . . . . . . . . . . . . 33.7 m120 -61.73 -42.73 99.34 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 120.039 1.29 . . . . 34.359999999999999 108.918 171.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1331 ' ' LEU . . . . . . . . . . . . . 22.4 mt -68.49 -39.14 81.43 Favored 'General case' 0 C--O 1.216 -0.663 0 O-C-N 121.439 -0.788 . . . . 33.369999999999997 112.515 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1332 ' ' VAL . . . . . . . . . . . . . 73.1 t -61.76 -46.38 96.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 105.403 -2.073 . . . . 35.270000000000003 105.403 175.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -55.51 -43.26 75.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 115.409 1.633 . . . . 37.659999999999997 115.409 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1334 ' ' LEU . . . . . . . . . . . . . 14.9 tp -62.92 -54.19 42.4 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 125.157 1.536 . . . . 40.270000000000003 109.831 174.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1335 ' ' LEU . . . . . . . . . . . . . 39.6 mt -65.73 -17.31 64.52 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 118.16 -0.924 . . . . 42.5 113.391 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1336 ' ' LYS . . . . . . . . . . . . . 79.0 mttt -63.07 -49.09 75.9 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.033 -1.099 . . . . 47.810000000000002 108.033 169.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1337 ' ' LEU . . . . . . . . . . . . . 77.4 mt -81.99 -20.28 38.81 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-O 124.212 1.958 . . . . 49.270000000000003 112.06 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1338 ' ' LEU . . . . . . . . . . . . . 9.2 mp -75.99 -24.96 55.37 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 113.546 -1.661 . . . . 50.539999999999999 112.503 169.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1339 ' ' CYS . . . . . . . . . . . . . 47.3 t -131.5 71.66 1.48 Allowed 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 102.57 -3.122 . . . . 53.670000000000002 102.57 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -67.77 -40.6 84.01 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 115.69 -0.686 . . . . 63.380000000000003 112.302 -177.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -72.06 -43.45 64.88 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 118.169 2.655 . . . . 70.950000000000003 118.169 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1342 ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? 55.1 77.42 0.22 Allowed 'General case' 0 C--O 1.241 0.631 0 C-N-CA 125.505 1.522 . . . . 65.25 114.771 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1343 ' ' ASP . . . . . . . . . . . . 0.34 1.9 t70 78.3 -80.88 0.03 OUTLIER 'General case' 0 C--O 1.251 1.159 2 O-C-N 113.511 -5.743 . . . . 64.530000000000001 116.93 -6.638 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A 1344 ' ' GLY . . . . . . . . . . . . . . . 76.16 65.09 2.08 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 119.005 0.82 . . . . 59.719999999999999 112.855 -170.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 11.0 t30 -144.14 140.61 29.49 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.764 -0.458 . . . . 64.090000000000003 109.764 171.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1346 ' ' ILE . . . . . . . . . . . . . 3.4 mp -79.51 90.29 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 122.961 1.363 . . . . 58.82 107.628 -171.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1347 ' ' THR . . . . . . . . . . . . . 28.6 m -89.62 89.96 8.04 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-O 124.916 2.293 . . . . 54.960000000000001 109.147 175.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1348 ' ' VAL . . . . . . . . . . . . . 92.8 t -74.2 120.34 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 112.678 -2.055 . . . . 55.640000000000001 106.524 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 1.5 t70 -94.44 148.64 22.03 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 119.544 1.065 . . . . 61.450000000000003 109.856 -176.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -109.28 -38.33 5.53 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.131 -0.941 . . . . 58.630000000000003 113.011 170.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 46.2 t0 -68.97 -29.8 68.1 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 123.463 1.601 . . . . 62.060000000000002 109.16 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 10.8 t70 -76.34 96.99 4.11 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 105.576 -2.009 . . . . 54.07 105.576 169.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 33.8 m -57.66 -29.7 35.25 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.669 0 CA-C-O 116.099 -1.905 . . . . 50.68 113.138 -174.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1354 ' ' VAL . . . . . . . . . . . . . 1.5 m -69.05 -35.56 69.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 123.218 2.735 . . . . 47.68 112.633 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1355 ' ' ILE . . . . . . . . . . . . . 75.1 mt -68.93 -45.13 80.92 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 N-CA-C 107.066 -1.457 . . . . 48.490000000000002 107.066 176.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 46.3 tpt85 -52.1 -34.99 46.52 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 119.868 -1.77 . . . . 48.270000000000003 112.997 172.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -59.69 -62.91 5.59 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 114.685 0.634 . . . . 43.530000000000001 114.685 168.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1358 ' ' VAL . . . . . . . . . . . . . 14.9 t -58.46 -37.08 62.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 O-C-N 124.848 0.97 . . . . 45.119999999999997 111.699 -177.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1359 ' ' THR . . . . . . . . . . . . . 12.7 m -72.16 78.05 0.96 Allowed 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 124.609 2.147 . . . . 42.939999999999998 109.803 175.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 29.6 m -74.56 -35.77 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 CA-C-N 113.249 -1.796 . . . . 43.259999999999998 109.719 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1361 ' ' ILE . . . . . . . . . . . . . 60.9 mt -133.08 134.19 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 103.301 -2.852 . . . . 45.659999999999997 103.301 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1362 ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -123.02 121.18 35.44 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 122.689 2.495 . . . . 61.340000000000003 111.328 169.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 46.69 44.21 13.58 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 127.354 2.909 . . . . 49.759999999999998 110.322 173.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 115.94 -60.99 0.4 Allowed Glycine 0 C--N 1.347 1.154 0 N-CA-C 117.444 1.738 . . . . 50.0 117.444 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -82.88 130.92 35.2 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 119.619 -0.832 . . . . 56.920000000000002 110.321 -175.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1366 ' ' ILE . . . . . . . . . . . . . 71.9 mt -64.64 118.74 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 N-CA-C 108.388 -0.967 . . . . 52.780000000000001 108.388 174.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1367 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.79 -0.13 43.22 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 112.613 -2.085 . . . . 49.439999999999998 115.975 173.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 7.2 t90 -63.45 150.08 90.6 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-O 115.312 -2.28 . . . . 52.380000000000003 112.412 173.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -78.21 -150.69 0.62 Allowed 'Cis proline' 0 CA--C 1.544 1.021 1 CA-C-N 129.259 4.342 . . . . 46.939999999999998 111.722 -8.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1370 ' ' ALA . . . . . . . . . . . . 0.264 . . -150.38 156.15 36.9 Favored Pre-proline 0 C--N 1.352 0.708 0 N-CA-C 108.328 -0.99 . . . . 45.909999999999997 108.328 -175.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1371 ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -43.16 117.98 1.16 Allowed 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 125.105 3.87 . . . . 46.390000000000001 114.782 169.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.39 4.35 4.5 Favored 'Trans proline' 0 N--CA 1.485 0.994 0 C-N-CA 123.973 3.115 . . . . 46.719999999999999 116.93 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.217 -5.184 0 O-C-N 120.477 -1.389 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 73.9 m80 . . . . . 0 N--CA 1.427 -1.586 0 N-CA-C 105.691 -1.966 . . . . 63.439999999999998 105.691 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -123.62 43.56 2.93 Favored 'General case' 0 C--O 1.256 1.419 0 O-C-N 117.999 -2.938 . . . . 51.740000000000002 114.885 -173.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1000 ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -69.97 144.11 52.43 Favored 'General case' 0 C--O 1.258 1.533 0 CA-C-O 123.742 1.734 . . . . 54.07 108.096 167.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 76.98 -12.18 12.49 Favored Glycine 0 CA--C 1.534 1.259 0 O-C-N 120.967 -1.083 . . . . 39.219999999999999 112.169 -168.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1002 ' ' ARG . . . . . . . . . . . . . 35.7 ttp180 -97.96 142.02 30.2 Favored 'General case' 0 CA--C 1.491 -1.299 0 CA-C-N 120.105 1.953 . . . . 38.119999999999997 109.37 174.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1003 ' ' ILE . . . . . . . . . . . . . 21.1 mt -98.74 154.77 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 N-CA-C 106.03 -1.841 . . . . 29.699999999999999 106.03 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -123.59 128.08 6.81 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 108.604 -1.799 . . . . 27.5 108.604 164.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1005 ' ' ILE . . . . . . . . . . . . . 40.8 mm -116.33 112.11 41.81 Favored Pre-proline 0 C--O 1.243 0.729 0 N-CA-C 104.161 -2.533 . . . . 24.829999999999998 104.161 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -74.88 154.2 42.94 Favored 'Trans proline' 0 N--CA 1.446 -1.314 1 C-N-CA 125.814 4.343 . . . . 27.190000000000001 111.189 176.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 63.6 ttt-85 -78.08 125.0 28.71 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 101.877 -3.379 . . . . 41.460000000000001 101.877 164.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1008 ' ' GLU . . . . . . . . . . . . 0.411 0.3 OUTLIER -78.43 126.68 31.11 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 118.899 2.925 . . . . 26.93 118.899 -175.436 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B 1009 ' ' ARG . . . . . 0.406 HH22 ' CG ' ' B' 1078 ' ' ASP . 37.2 mtm180 -98.1 11.46 37.59 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 113.466 -1.697 . . . . 34.479999999999997 113.374 -170.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B 1010 ' ' LEU . . . . . . . . . . . . . 31.9 tp -66.95 143.41 56.82 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 119.803 -1.81 . . . . 44.219999999999999 109.051 175.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1011 ' ' THR . . . . . . . . . . . . . 57.9 m -67.57 147.69 52.42 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 122.304 2.32 . . . . 40.740000000000002 110.097 165.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 60.8 m-80 58.36 58.06 3.6 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-O 124.231 1.967 . . . . 44.439999999999998 110.836 -175.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1013 ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -137.75 143.89 41.38 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.87 -1.514 . . . . 29.870000000000001 109.269 -174.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1014 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.65 3.37 2.51 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-O 124.088 1.899 . . . . 25.260000000000002 110.284 174.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 50.5 mtm180 -82.8 142.68 31.37 Favored 'General case' 0 C--O 1.24 0.586 0 O-C-N 119.66 -1.9 . . . . 29.539999999999999 112.559 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1016 ' ' VAL . . . . . . . . . . . . . 11.1 p -106.43 162.86 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 103.137 -2.912 . . . . 23.550000000000001 103.137 154.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1017 ' ' ALA . . . . . . . . . . . . . . . -68.2 -21.01 64.89 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 115.557 1.688 . . . . 23.59 115.557 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1018 ' ' ALA . . . . . . . . . . . . . . . -158.33 128.15 5.91 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 119.192 0.905 . . . . 24.93 109.254 175.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1019 ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.29 169.96 17.03 Favored Pre-proline 0 N--CA 1.477 0.895 0 CA-C-O 115.34 -2.267 . . . . 28.09 113.397 172.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -45.22 -50.93 8.38 Favored 'Trans proline' 0 CA--C 1.537 0.631 1 C-N-CA 125.371 4.047 . . . . 28.789999999999999 116.657 175.39 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 56.2 tttt -55.96 -39.45 71.77 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 113.486 0.921 . . . . 47.280000000000001 113.486 173.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1022 ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.81 -34.02 71.32 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.401 -0.592 . . . . 30.120000000000001 109.401 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B 1023 ' ' VAL . . . . . . . . . . . . . 39.7 t -61.93 -43.12 97.05 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 N-CA-C 108.921 -0.77 . . . . 32.240000000000002 108.921 176.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1024 ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -61.5 -39.54 91.33 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 123.446 0.698 . . . . 49.619999999999997 112.35 174.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -55.87 -47.86 76.6 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 122.35 1.072 . . . . 44.68 111.45 174.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 86.1 mt -64.56 -32.48 74.14 Favored 'General case' 0 C--N 1.366 1.294 0 CA-C-N 113.013 -1.903 . . . . 35.710000000000001 110.694 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1027 ' ' LEU . . . . . . . . . . . . . 86.5 mt -67.81 -41.22 83.42 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 122.314 1.055 . . . . 42.18 112.739 175.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 61.8 mttm -61.21 -32.8 72.57 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-N 112.918 -1.946 . . . . 48.340000000000003 111.645 176.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1029 ' ' LEU . . . . . . . . . . . . . 93.9 mt -70.13 -3.61 17.51 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 115.637 1.718 . . . . 38.689999999999998 115.637 174.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 96.17 6.72 58.8 Favored Glycine 0 N--CA 1.471 1.007 0 N-CA-C 110.417 -1.073 . . . . 32.280000000000001 110.417 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -97.93 170.81 8.69 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.655 -1.239 . . . . 35.939999999999998 107.655 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1032 ' ' THR . . . . . . . . . . . . . 1.4 p -113.14 148.89 34.44 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 105.906 -1.887 . . . . 33.369999999999997 105.906 170.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1033 ' ' VAL . . . . . . . . . . . . . 15.5 t -114.16 146.81 18.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 O-C-N 117.786 -3.071 . . . . 29.98 108.534 -176.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -125.1 140.84 52.52 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 107.109 -1.441 . . . . 28.18 107.109 163.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1035 ' ' VAL . . . . . . . . . . . . . 21.8 t -129.31 146.61 33.96 Favored 'Isoleucine or valine' 0 C--N 1.348 0.528 0 N-CA-C 108.234 -1.024 . . . . 25.82 108.234 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1036 ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -66.11 139.91 58.19 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 121.442 0.639 . . . . 32.439999999999998 112.545 167.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1037 ' ' SER . . . . . . . . . . . . . 48.7 m -52.81 139.52 26.61 Favored 'General case' 0 C--O 1.257 1.478 0 CA-C-N 114.207 -1.36 . . . . 29.539999999999999 114.489 165.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 89.63 0.2 79.28 Favored Glycine 0 C--O 1.252 1.274 0 C-N-CA 121.322 -0.466 . . . . 27.760000000000002 113.271 176.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1039 ' ' ALA . . . . . . . . . . . . . . . -64.83 -43.4 93.19 Favored 'General case' 0 CA--C 1.504 -0.796 0 O-C-N 124.502 0.766 . . . . 26.02 110.832 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -49.55 -47.85 36.12 Favored Glycine 0 N--CA 1.419 -2.458 0 C-N-CA 125.663 1.601 . . . . 26.469999999999999 111.118 173.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -53.21 -46.28 68.99 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-N 119.525 1.663 . . . . 50.979999999999997 112.514 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 94.7 mt -61.24 -57.62 11.64 Favored 'General case' 0 C--O 1.211 -0.964 0 N-CA-C 108.074 -1.084 . . . . 29.300000000000001 108.074 174.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1043 ' ' ALA . . . . . . . . . . . . . . . -72.62 11.85 0.57 Allowed 'General case' 0 C--O 1.248 0.982 0 N-CA-C 116.587 2.069 . . . . 26.739999999999998 116.587 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1044 ' ' SER . . . . . . . . . . . . . 17.3 m 46.89 25.24 0.44 Allowed 'General case' 0 C--O 1.248 0.987 0 C-N-CA 126.361 1.864 . . . . 31.260000000000002 113.717 -176.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1045 ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -112.86 155.93 23.82 Favored 'General case' 0 C--O 1.244 0.797 0 O-C-N 119.885 -1.76 . . . . 33.259999999999998 106.962 -177.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 11.3 t70 -67.96 126.04 28.22 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.869 -0.789 . . . . 46.740000000000002 108.869 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.8 -42.43 90.68 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 107.621 -1.251 . . . . 34.439999999999998 107.621 -173.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -53.03 -34.84 58.24 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 113.306 0.854 . . . . 48.670000000000002 113.306 172.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -62.94 -19.79 64.59 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 116.06 1.874 . . . . 35.259999999999998 116.06 176.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1050 ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -62.77 -42.72 99.82 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 123.396 1.57 . . . . 32.170000000000002 109.996 168.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 18.0 t -67.4 -50.74 59.37 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 O-C-N 119.546 -1.971 . . . . 38.369999999999997 107.061 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -52.17 -29.72 23.61 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.74 1.216 . . . . 45.770000000000003 114.174 175.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -80.55 -40.66 25.51 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 123.936 0.773 . . . . 37.829999999999998 110.584 176.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 134.81 48.73 0.08 OUTLIER Glycine 0 CA--C 1.532 1.141 0 CA-C-O 123.028 1.349 . . . . 35.82 111.657 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -128.74 140.9 51.51 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 108.206 -1.035 . . . . 33.770000000000003 108.206 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -76.38 106.79 8.21 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 104.513 -2.403 . . . . 51.020000000000003 104.513 166.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1057 ' ' ILE . . . . . . . . . . . . . 13.6 mm -82.5 102.82 8.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 N-CA-C 102.079 -3.304 . . . . 38.469999999999999 102.079 173.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 30.1 m -86.71 159.34 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-N 109.143 -3.662 . . . . 39.399999999999999 108.29 175.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -71.48 -29.24 64.6 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.258 -1.337 . . . . 57.07 114.438 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . 172.79 -97.25 0.12 Allowed Glycine 0 CA--C 1.53 0.976 0 O-C-N 120.359 -1.463 . . . . 44.829999999999998 111.541 176.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -58.6 -32.0 68.58 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 125.632 1.573 . . . . 46.270000000000003 114.057 -170.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1062 ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -44.32 -33.87 1.76 Allowed 'General case' 0 C--O 1.24 0.578 0 N-CA-C 115.215 1.561 . . . . 43.469999999999999 115.215 171.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -54.05 -38.77 38.89 Favored 'Isoleucine or valine' 0 C--N 1.355 0.828 0 C-N-CA 124.385 1.074 . . . . 36.979999999999997 111.491 176.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 96.9 m95 -67.72 -14.38 62.9 Favored 'General case' 0 C--O 1.211 -0.949 0 N-CA-C 116.877 2.177 . . . . 37.899999999999999 116.877 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -99.83 81.58 2.47 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 104.338 -2.467 . . . . 46.189999999999998 104.338 -176.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1066 ' ' SER . . . . . . . . . . . . . 68.5 m -150.65 -178.53 6.61 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 119.006 -2.309 . . . . 37.060000000000002 108.244 -174.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1067 ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -69.8 -56.12 7.98 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 120.457 -1.402 . . . . 43.950000000000003 109.473 173.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1068 ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -123.07 137.88 54.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 107.411 -1.329 . . . . 33.5 107.411 -178.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 24.1 mm -111.28 106.81 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 N-CA-C 103.561 -2.755 . . . . 30.57 103.561 170.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1070 ' ' LEU . . . . . . . . . . . . . 86.7 mt -97.23 118.46 33.73 Favored 'General case' 0 CA--C 1.505 -0.781 1 N-CA-C 98.117 -4.771 . . . . 27.66 98.117 -175.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B 1071 ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -141.33 146.77 37.13 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 104.818 -2.29 . . . . 28.399999999999999 104.818 -164.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1072 ' ' VAL . . . . . . . . . . . . . 61.8 t -79.93 -61.68 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-N 120.278 1.399 . . . . 23.18 112.462 -170.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -105.95 -161.76 0.82 Allowed 'General case' 0 C--O 1.237 0.443 0 N-CA-C 106.269 -1.752 . . . . 25.469999999999999 106.269 -173.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -61.65 148.68 86.4 Favored Pre-proline 0 C--O 1.259 1.564 0 N-CA-C 112.999 0.74 . . . . 27.899999999999999 112.999 177.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -66.56 125.49 13.95 Favored 'Trans proline' 0 CA--C 1.556 1.608 0 N-CA-C 107.939 -1.6 . . . . 31.620000000000001 107.939 162.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 57.1 mt -69.14 162.18 27.55 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 107.696 -1.224 . . . . 40.490000000000002 107.696 169.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.16 -23.63 63.97 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 118.711 2.856 . . . . 51.590000000000003 118.711 -160.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1078 ' ' ASP . . . . . 0.406 ' CG ' HH22 ' B' 1009 ' ' ARG . 17.5 p-10 -66.27 -51.36 58.28 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 112.835 -1.984 . . . . 42.359999999999999 110.553 166.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B 1079 ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -55.62 -37.35 68.04 Favored 'General case' 0 C--O 1.249 1.042 0 O-C-N 120.667 -1.271 . . . . 34.530000000000001 109.116 173.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1080 ' ' ILE . . . . . . . . . . . . . 73.1 mt -59.28 -50.43 79.86 Favored 'Isoleucine or valine' 0 C--N 1.356 0.891 0 C-N-CA 123.666 0.786 . . . . 33.25 110.355 173.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -63.45 -15.14 56.82 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 118.544 -0.741 . . . . 36.469999999999999 112.837 174.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1082 ' ' LEU . . . . . . . . . . . . . 41.3 mt -86.45 -24.31 25.68 Favored 'General case' 0 C--N 1.353 0.728 0 CA-C-N 120.466 1.485 . . . . 37.759999999999998 113.553 171.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1083 ' ' LEU . . . . . . . . . . . . . 12.7 mt -55.2 123.99 15.51 Favored 'General case' 0 C--O 1.25 1.125 0 N-CA-C 115.629 1.714 . . . . 37.43 115.629 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.09 129.35 56.37 Favored Pre-proline 0 N--CA 1.439 -0.991 0 CA-C-N 114.797 -1.092 . . . . 37.700000000000003 110.891 -172.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -58.63 123.07 12.75 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 124.55 3.5 . . . . 35.509999999999998 109.11 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 115.36 -60.49 0.4 Allowed Glycine 0 C--O 1.244 0.771 0 O-C-N 126.955 2.659 . . . . 33.869999999999997 108.097 -172.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1087 ' ' THR . . . . . . . . . . . . . 97.9 m -41.57 130.97 3.09 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 126.757 2.023 . . . . 32.5 116.059 -165.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1088 ' ' THR . . . . . . . . . . . . . 10.0 m -73.68 106.75 5.57 Favored 'General case' 0 C--O 1.216 -0.7 0 N-CA-C 107.306 -1.368 . . . . 30.219999999999999 107.306 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1089 ' ' LEU . . . . . . . . . . . . . 20.7 tp -96.91 133.05 42.05 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 103.38 -2.822 . . . . 27.239999999999998 103.38 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 15.1 t -134.48 109.93 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 106.889 -1.523 . . . . 25.390000000000001 106.889 -174.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1091 ' ' SER . . . . . . . . . . . . . 2.6 m -159.23 168.92 25.28 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.84 0.829 . . . . 28.809999999999999 112.127 -166.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1092 ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -66.1 107.41 1.91 Allowed 'General case' 0 C--O 1.247 0.973 0 CA-C-O 124.42 2.057 . . . . 30.780000000000001 110.933 161.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 45.3 mm -103.53 -37.84 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 O-C-N 120.172 -1.58 . . . . 30.280000000000001 110.552 -176.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1094 ' ' TRP . . . . . . . . . . . . . 58.8 m95 53.57 54.79 12.61 Favored Pre-proline 0 C--O 1.249 1.078 0 O-C-N 124.456 1.098 . . . . 34.07 110.342 -174.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -39.6 -60.65 0.51 Allowed 'Trans proline' 0 C--N 1.355 0.872 1 C-N-CA 126.5 4.8 . . . . 38.659999999999997 118.433 -167.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -62.94 -28.27 69.95 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 119.287 -2.133 . . . . 41.32 112.838 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -82.65 -22.11 34.77 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 122.543 1.163 . . . . 51.659999999999997 112.578 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -119.09 58.41 4.01 Favored Pre-proline 0 N--CA 1.447 -0.62 0 N-CA-C 115.511 1.671 . . . . 40.32 115.511 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -57.16 -43.15 55.78 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.561 3.507 . . . . 41.560000000000002 111.593 -173.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -76.51 -32.74 58.47 Favored 'General case' 0 C--O 1.208 -1.091 0 N-CA-C 113.139 0.792 . . . . 54.109999999999999 113.139 -174.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1101 ' ' LEU . . . . . . . . . . . . . 26.6 tp -61.59 -47.99 82.98 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 107.693 -1.225 . . . . 37.880000000000003 107.693 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1102 ' ' MET . . . . . . . . . . . . . 69.2 mmm -47.61 -55.15 9.93 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 125.601 1.813 . . . . 37.539999999999999 111.154 173.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -55.98 -45.46 78.95 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-O 118.487 -0.768 . . . . 47.009999999999998 111.527 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1104 ' ' LYS . . . . . . . . . . . . . 88.9 mttt -61.82 -36.99 82.77 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 124.544 2.116 . . . . 48.68 114.146 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1105 ' ' LEU . . . . . . . . . . . . . 43.6 mt -74.63 -32.82 62.41 Favored 'General case' 0 C--O 1.247 0.931 0 O-C-N 119.614 -1.929 . . . . 32.210000000000001 110.03 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -67.69 -43.6 79.74 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.392 0.677 . . . . 33.729999999999997 111.177 175.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -59.45 -41.28 89.3 Favored 'General case' 0 C--O 1.25 1.101 0 N-CA-C 115.128 1.529 . . . . 51.469999999999999 115.128 169.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1108 ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -71.38 -3.83 22.93 Favored 'General case' 0 C--N 1.345 0.407 0 N-CA-C 113.693 0.997 . . . . 43.899999999999999 113.693 170.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1109 ' ' ASN . . . . . . . . . . . . . 8.1 m-80 59.03 32.57 22.35 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.835 1.791 . . . . 44.82 115.835 167.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1110 ' ' VAL . . . . . . . . . . . . . 5.8 m -94.92 150.82 3.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-N 114.516 -1.22 . . . . 30.52 109.794 -174.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1111 ' ' THR . . . . . . . . . . . . . 29.9 m -83.16 86.06 7.09 Favored 'General case' 0 C--O 1.247 0.958 0 CA-C-O 122.126 0.965 . . . . 27.120000000000001 110.517 178.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1112 ' ' VAL . . . . . . . . . . . . . 6.7 t -86.21 130.72 36.12 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 CA-C-O 121.986 0.898 . . . . 26.399999999999999 109.192 -169.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1113 ' ' MET . . . . . . . . . . . . . 10.8 mtt -120.19 124.71 46.39 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 102.651 -3.092 . . . . 42.920000000000002 102.651 175.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -90.65 96.61 10.73 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 113.703 -1.59 . . . . 24.149999999999999 113.888 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1115 ' ' MET . . . . . . . . . . . . . 78.9 mmm -56.03 -25.54 45.09 Favored 'General case' 0 C--O 1.22 -0.451 0 N-CA-C 115.479 1.659 . . . . 29.949999999999999 115.479 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1116 ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -80.14 -37.14 34.12 Favored 'General case' 0 N--CA 1.439 -0.984 0 O-C-N 121.521 -0.737 . . . . 34.530000000000001 109.647 174.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1117 ' ' SER . . . . . . . . . . . . . 57.0 m -102.52 48.16 0.87 Allowed 'General case' 0 C--N 1.355 0.823 0 O-C-N 120.167 -1.583 . . . . 33.490000000000002 108.824 -168.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1118 ' ' VAL . . . . . . . . . . . . . 54.5 t -81.63 124.08 80.15 Favored Pre-proline 0 N--CA 1.48 1.048 0 N-CA-C 102.357 -3.201 . . . . 34.020000000000003 102.357 176.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -58.06 103.14 0.14 Allowed 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 124.904 3.736 . . . . 38.280000000000001 110.842 -173.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1120 ' ' ARG . . . . . . . . . . . . . 13.6 mtm-85 -72.55 71.84 0.98 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 120.338 3.459 . . . . 55.049999999999997 120.338 -159.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1121 ' ' ILE . . . . . . . . . . . . . 44.5 pt -104.48 -161.11 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.815 0 N-CA-C 104.641 -2.355 . . . . 42.090000000000003 104.641 171.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1122 ' ' SER . . . . . . . . . . . . . 31.4 m -74.56 -48.27 27.81 Favored 'General case' 0 N--CA 1.434 -1.259 0 O-C-N 118.12 -2.862 . . . . 38.020000000000003 118.226 -173.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1123 ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -74.71 -21.38 59.41 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 124.305 3.23 . . . . 34.289999999999999 114.125 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1124 ' ' ALA . . . . . . . . . . . . . . . -54.46 -48.92 71.21 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 109.182 -3.644 . . . . 32.350000000000001 109.759 170.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1125 ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -54.75 -38.12 66.78 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 114.42 1.267 . . . . 47.170000000000002 114.42 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1126 ' ' SER . . . . . . . . . . . . . 73.9 m -57.03 -36.03 69.98 Favored 'General case' 0 C--O 1.248 1.0 0 CA-C-N 121.088 1.767 . . . . 31.710000000000001 114.093 170.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1127 ' ' LEU . . . . . . . . . . . . . 8.4 mp -87.82 -23.77 23.92 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 114.946 -1.025 . . . . 37.0 112.982 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1128 ' ' ASP . . . . . . . . . . . . . 12.5 t70 -78.93 118.77 21.26 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-O 123.434 1.587 . . . . 40.399999999999999 112.549 -170.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1129 ' ' ALA . . . . . . . . . . . . . . . -62.32 -36.55 82.53 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 110.44 -3.073 . . . . 26.559999999999999 111.793 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 39.6 mt -63.09 -23.73 67.58 Favored 'General case' 0 C--O 1.248 0.976 0 CA-C-O 116.512 -1.708 . . . . 30.890000000000001 112.251 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1131 ' ' SER . . . . . . . . . . . . . 86.0 p -65.84 -57.5 7.79 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 122.611 2.46 . . . . 29.84 107.932 177.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1132 ' ' SER . . . . . . . . . . . . . 73.4 m -60.74 -43.24 98.19 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.259 -1.337 . . . . 31.91 111.223 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1133 ' ' MET . . . . . . . . . . . . . 31.2 mmt -60.56 -37.98 83.04 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 115.504 1.668 . . . . 25.899999999999999 115.504 174.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1134 ' ' ALA . . . . . . . . . . . . . . . -68.77 -41.75 78.39 Favored 'General case' 0 C--N 1.352 0.679 0 C-N-CA 119.929 -0.708 . . . . 26.620000000000001 109.182 174.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.27 -38.82 90.8 Favored 'General case' 0 C--O 1.206 -1.195 0 C-N-CA 125.076 1.35 . . . . 36.969999999999999 109.997 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B 1136 ' ' ILE . . . . . . . . . . . . . 15.0 mm -58.7 -55.4 23.21 Favored 'Isoleucine or valine' 0 C--N 1.352 0.695 0 N-CA-C 106.337 -1.727 . . . . 32.109999999999999 106.337 172.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -61.95 -25.79 67.81 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 116.019 1.859 . . . . 24.140000000000001 116.019 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -65.5 -57.83 10.58 Favored Glycine 0 N--CA 1.466 0.699 0 CA-C-N 120.982 1.719 . . . . 25.129999999999999 110.28 174.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 77.9 t80 -53.55 -43.8 68.74 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 123.663 1.697 . . . . 32.729999999999997 110.534 172.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1140 ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -70.61 -25.95 63.28 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 113.78 -1.555 . . . . 26.359999999999999 110.492 -174.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1141 ' ' ALA . . . . . . . . . . . . . . . -62.89 -49.63 74.05 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 120.661 1.573 . . . . 24.120000000000001 107.978 172.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 32.5 mm -56.94 -43.89 81.46 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 CA-C-O 118.697 -0.668 . . . . 23.370000000000001 110.801 175.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 70.4 t -68.1 -59.26 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 N-CA-C 112.573 0.582 . . . . 24.960000000000001 112.573 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -60.1 -35.83 76.08 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 119.145 -0.455 . . . . 32.07 110.306 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1145 ' ' ALA . . . . . . . . . . . . . . . -51.74 -60.32 3.3 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 119.145 0.884 . . . . 24.870000000000001 111.365 167.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1146 ' ' ALA . . . . . . . . . . . . . . . -58.53 -22.94 57.01 Favored 'General case' 0 C--N 1.348 0.506 0 N-CA-C 114.663 1.357 . . . . 24.670000000000002 114.663 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 26.8 t60 -63.15 -43.94 96.92 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 120.84 -1.163 . . . . 28.579999999999998 108.97 171.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1148 ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -107.07 3.92 26.39 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 116.996 2.221 . . . . 36.82 116.996 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1149 ' ' PHE . . . . . . . . . . . . . 1.1 t80 -71.53 140.69 49.99 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-O 124.733 2.206 . . . . 31.969999999999999 107.015 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1150 ' ' GLY . . . . . . . . . . . . . . . -71.29 -42.17 57.84 Favored Glycine 0 N--CA 1.42 -2.423 0 CA-C-N 111.079 -2.782 . . . . 25.489999999999998 110.858 170.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1151 ' ' ARG . . . . . . . . . . . . . 58.7 mtm-85 -110.58 179.36 4.09 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 123.961 3.881 . . . . 59.840000000000003 113.46 -168.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1152 ' ' PHE . . . . . . . . . . . . . 12.1 m-30 -72.9 163.52 28.03 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 120.147 -1.596 . . . . 34.450000000000003 109.383 167.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1153 ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -82.24 -51.7 7.67 Favored 'General case' 0 C--O 1.257 1.484 0 N-CA-C 107.586 -1.265 . . . . 31.170000000000002 107.586 166.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1154 ' ' THR . . . . . . . . . . . . . 45.5 m -65.55 127.98 34.06 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 113.02 -1.9 . . . . 33.890000000000001 109.724 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -78.86 72.22 2.47 Favored Glycine 0 C--O 1.251 1.217 0 N-CA-C 109.247 -1.541 . . . . 38.950000000000003 109.247 172.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -85.03 131.75 34.42 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 103.983 -2.599 . . . . 54.229999999999997 103.983 -176.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 24.7 mm -84.16 93.54 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 N-CA-C 100.719 -3.808 . . . . 51.159999999999997 100.719 173.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1158 ' ' THR . . . . . . . . . . . . . 26.0 m -81.33 166.52 20.4 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.083 -1.08 . . . . 49.609999999999999 108.083 -170.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -51.09 -58.32 6.4 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 117.403 -1.285 . . . . 49.049999999999997 112.769 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -44.3 -53.12 7.0 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 116.984 2.216 . . . . 47.649999999999999 116.984 170.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . -177.96 -177.05 46.44 Favored Glycine 0 N--CA 1.426 -1.974 0 N-CA-C 109.103 -1.599 . . . . 45.609999999999999 109.103 -174.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 87.8 mttt -75.24 138.21 41.75 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.181 -1.009 . . . . 57.460000000000001 108.538 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1163 ' ' VAL . . . . . . . . . . . . . 45.7 t -91.34 125.85 56.72 Favored Pre-proline 0 CA--C 1.511 -0.529 0 O-C-N 121.395 -0.816 . . . . 42.93 109.322 170.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1164 ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -66.22 122.06 9.49 Favored 'Trans proline' 0 C--O 1.26 1.587 0 C-N-CA 123.917 3.078 . . . . 39.289999999999999 106.029 158.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1165 ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -76.61 168.24 24.03 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.876 3.717 . . . . 34.170000000000002 114.091 -174.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -76.5 123.49 26.12 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 114.309 -1.314 . . . . 31.690000000000001 112.633 170.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1167 ' ' LYS . . . . . . . . . . . . . 70.7 mttt -92.4 107.56 19.31 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 125.228 2.442 . . . . 44.780000000000001 110.495 165.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 40.2 t -91.76 94.68 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 113.902 -1.499 . . . . 31.23 109.314 -171.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1169 ' ' MET . . . . . . . . . . . . . 40.6 ttp -88.99 96.36 10.7 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 123.415 1.579 . . . . 37.090000000000003 107.167 -177.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 38.8 t -83.75 114.78 24.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 113.242 -1.799 . . . . 30.170000000000002 107.974 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1171 ' ' ILE . . . . . . . . . . . . . 78.9 mt -104.23 114.65 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 106.943 -1.502 . . . . 33.740000000000002 106.943 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 94.74 66.09 1.0 Allowed Glycine 0 N--CA 1.421 -2.313 0 N-CA-C 108.504 -1.839 . . . . 32.590000000000003 108.504 -177.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1173 ' ' ALA . . . . . . . . . . . . . . . -59.05 -9.03 1.68 Allowed 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 116.638 2.088 . . . . 32.420000000000002 116.638 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -61.53 128.68 43.9 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 115.122 0.809 . . . . 31.739999999999998 115.122 173.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 22.4 t 56.19 -82.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 127.453 2.301 . . . . 31.48 111.407 170.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1176 ' ' ALA . . . . . . . . . . . . . . . -65.53 -42.93 91.44 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.7 -1.222 . . . . 26.120000000000001 107.7 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1177 ' ' GLY . . . . . . . . . . . . . . . -52.71 -52.79 36.24 Favored Glycine 0 N--CA 1.43 -1.763 0 CA-C-N 118.665 0.666 . . . . 25.73 113.2 172.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1178 ' ' LEU . . . . . . . . . . . . . 96.6 mt -53.3 -46.67 69.44 Favored 'General case' 0 C--O 1.241 0.65 0 O-C-N 120.79 -1.418 . . . . 32.590000000000003 113.858 173.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -61.82 -40.17 94.34 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 120.23 -0.588 . . . . 27.719999999999999 111.365 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -66.34 -38.32 87.38 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 120.686 1.585 . . . . 26.030000000000001 108.907 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1181 ' ' ILE . . . . . . . . . . . . . 70.9 mt -65.27 -47.16 88.36 Favored 'Isoleucine or valine' 0 C--N 1.36 1.033 0 O-C-N 125.347 1.654 . . . . 28.609999999999999 110.229 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -52.5 -55.24 23.47 Favored Glycine 0 N--CA 1.435 -1.374 0 C-N-CA 125.792 1.663 . . . . 25.23 111.376 174.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -61.96 -51.8 66.62 Favored 'General case' 0 C--O 1.251 1.166 0 C-N-CA 123.346 0.659 . . . . 24.09 111.425 -174.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -62.52 -41.09 98.63 Favored 'General case' 0 C--O 1.247 0.948 0 O-C-N 123.75 0.657 . . . . 26.68 111.123 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -63.31 -37.93 89.18 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 120.13 -1.606 . . . . 36.57 113.009 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1186 ' ' SER . . . . . . . . . . . . . 73.2 m -57.85 -49.83 75.37 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-O 122.804 1.287 . . . . 28.920000000000002 110.15 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1187 ' ' LEU . . . . . . . . . . . . . 12.6 mt -62.11 -21.89 65.36 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 118.192 2.664 . . . . 29.09 118.192 169.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 75.02 35.38 49.95 Favored Glycine 0 N--CA 1.433 -1.53 0 N-CA-C 109.053 -1.619 . . . . 29.260000000000002 109.053 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1189 ' ' ALA . . . . . . . . . . . . . . . -81.46 151.02 28.05 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.098 -1.816 . . . . 30.16 106.098 167.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 73.8 mt -78.74 97.49 2.35 Favored 'Isoleucine or valine' 0 C--O 1.246 0.914 0 N-CA-C 106.603 -1.629 . . . . 35.810000000000002 106.603 -174.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1191 ' ' VAL . . . . . . . . . . . . . 57.7 t -79.94 136.75 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-N 115.408 -0.815 . . . . 31.969999999999999 109.102 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1192 ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -131.9 127.27 36.1 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 104.426 -2.435 . . . . 48.159999999999997 104.426 167.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -134.64 158.21 44.63 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 124.084 1.897 . . . . 35.890000000000001 115.618 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 35.5 t80 -139.28 132.98 30.63 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 114.029 -1.441 . . . . 41.880000000000003 107.167 -171.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1195 ' ' ASP . . . . . . . . . . . . . 10.0 t70 -159.08 152.44 22.6 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 106.448 -1.686 . . . . 38.280000000000001 106.448 167.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1196 ' ' THR . . . . . . . . . . . . . 2.2 p -63.01 -44.3 96.37 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 113.997 1.11 . . . . 40.619999999999997 113.997 -177.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1197 ' ' ARG . . . . . . . . . . . . . 28.4 mtm180 -74.09 125.99 89.62 Favored Pre-proline 0 C--O 1.252 1.195 0 C-N-CA 119.67 -0.812 . . . . 53.090000000000003 111.711 -168.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -44.23 -33.79 6.32 Favored 'Trans proline' 0 C--O 1.248 0.984 1 C-N-CA 125.724 4.283 . . . . 42.560000000000002 118.219 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -54.05 -30.07 46.45 Favored 'General case' 0 C--N 1.347 0.479 0 N-CA-C 116.929 2.196 . . . . 56.310000000000002 116.929 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1200 ' ' VAL . . . . . . . . . . . . . 6.4 m -71.82 -29.47 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 O-C-N 124.554 1.159 . . . . 42.909999999999997 110.196 -177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 34.9 tttm -54.58 -48.14 72.47 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 125.714 1.884 . . . . 48.890000000000001 113.6 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.93 -48.87 77.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 117.658 -1.163 . . . . 51.700000000000003 108.869 175.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1203 ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -58.89 -46.37 88.02 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 125.225 1.578 . . . . 52.57 113.978 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1204 ' ' VAL . . . . . . . . . . . . . 48.5 t -62.52 -46.48 96.29 Favored 'Isoleucine or valine' 0 C--O 1.257 1.498 0 CA-C-N 120.429 1.468 . . . . 33.789999999999999 107.744 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -54.85 -38.77 67.86 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.563 1.145 . . . . 36.579999999999998 114.025 173.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1206 ' ' SER . . . . . . . . . . . . . 12.0 m -63.38 -37.03 85.68 Favored 'General case' 0 C--N 1.347 0.482 0 O-C-N 121.171 -0.955 . . . . 39.609999999999999 110.215 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1207 ' ' MET . . . . . . . . . . . . . 4.9 mtt -87.63 28.34 1.01 Allowed 'General case' 0 C--O 1.248 1.013 0 O-C-N 117.659 -3.151 . . . . 37.450000000000003 113.906 -175.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 55.45 30.57 55.85 Favored Glycine 0 CA--C 1.538 1.516 0 O-C-N 120.589 -1.319 . . . . 31.870000000000001 113.737 -176.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -119.04 142.01 48.22 Favored 'General case' 0 N--CA 1.428 -1.541 0 O-C-N 119.582 -2.128 . . . . 35.399999999999999 108.87 -164.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -80.61 129.08 34.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 118.694 -1.202 . . . . 47.890000000000001 108.846 -176.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 45.5 t80 -90.09 132.7 35.28 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 101.473 -3.529 . . . . 45.530000000000001 101.473 178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1212 ' ' LEU . . . . . . . . . . . . . 63.4 mt -84.73 121.58 27.89 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 103.689 -2.708 . . . . 46.329999999999998 103.689 173.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -68.81 147.94 51.02 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 115.496 1.665 . . . . 60.409999999999997 115.496 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 21.5 mt -66.6 140.64 57.96 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 112.588 -2.096 . . . . 57.380000000000003 107.002 167.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 23.4 t70 . . . . . 0 N--CA 1.433 -1.325 0 N-CA-C 107.472 -1.307 . . . . 65.069999999999993 107.472 177.538 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B 1230 ' ' MET . . . . . . . . . . . . . 5.4 mmm . . . . . 0 N--CA 1.433 -1.319 0 N-CA-C 104.705 -2.331 . . . . 80.319999999999993 104.705 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B 1231 ' ' SER . . . . . . . . . . . . . 2.6 m 78.84 -173.11 0.06 Allowed 'General case' 0 CA--C 1.539 0.542 2 O-C-N 111.99 -6.694 . . . . 79.920000000000002 118.805 -17.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -43.25 154.99 0.07 Allowed 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 119.203 3.038 . . . . 77.909999999999997 119.203 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 62.97 -59.19 0.15 Allowed 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 112.253 -2.248 . . . . 73.879999999999995 109.439 -159.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 8.3 t80 -55.76 -44.78 77.99 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 120.044 -1.66 . . . . 68.980000000000004 113.765 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 8.0 pt -44.6 -38.88 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 121.772 2.078 . . . . 64.530000000000001 112.754 175.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -75.83 -38.03 58.48 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 118.055 -0.974 . . . . 66.359999999999999 109.627 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -65.22 -26.22 68.03 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 120.91 1.687 . . . . 56.600000000000001 113.243 175.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -66.45 -47.99 71.4 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 106.786 -1.561 . . . . 56.789999999999999 106.786 175.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1239 ' ' MET . . . . . . . . . . . . . 19.6 mmm -49.84 -49.18 50.06 Favored 'General case' 0 C--O 1.25 1.087 0 O-C-N 124.528 1.143 . . . . 53.630000000000003 111.666 171.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.76 -37.06 85.3 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 121.243 0.544 . . . . 51.740000000000002 110.817 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 60.3 tp -64.78 -47.94 76.31 Favored 'General case' 0 C--N 1.342 0.25 0 O-C-N 120.555 -1.34 . . . . 44.859999999999999 107.57 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 14.8 m-30 -65.88 -34.06 77.26 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 124.546 1.138 . . . . 42.780000000000001 111.26 -174.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -67.14 -51.3 55.61 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 113.929 1.085 . . . . 40.960000000000001 113.929 172.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -69.59 -28.92 66.36 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 122.492 1.139 . . . . 43.060000000000002 108.763 -173.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 43.3 mm-40 -75.53 -37.27 60.18 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.369 -1.457 . . . . 46.450000000000003 112.608 171.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -60.67 -23.42 64.81 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 115.284 1.587 . . . . 41.780000000000001 115.284 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 26.0 tptt -62.44 -41.85 99.04 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.196 -0.911 . . . . 52.200000000000003 109.42 171.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1248 ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -91.26 -30.8 16.41 Favored 'General case' 0 C--O 1.244 0.808 0 O-C-N 121.586 -0.696 . . . . 53.549999999999997 112.705 -172.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1249 ' ' VAL . . . . . . . . . . . . . 19.1 m -84.2 169.43 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 124.684 2.183 . . . . 34.409999999999997 114.808 -173.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1250 ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -111.99 -61.89 1.65 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 111.635 -2.53 . . . . 33.380000000000003 111.573 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1251 ' ' ILE . . . . . . . . . . . . . 48.5 mm -107.24 106.69 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 123.839 0.712 . . . . 29.539999999999999 109.097 -173.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1252 ' ' ILE . . . . . . . . . . . . . 51.1 mt -92.41 118.5 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 N-CA-C 105.086 -2.19 . . . . 32.439999999999998 105.086 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1253 ' ' VAL . . . . . . . . . . . . . 72.2 t -102.32 87.29 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.254 1.339 0 N-CA-C 104.634 -2.358 . . . . 30.57 104.634 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1254 ' ' THR . . . . . . . . . . . . 0.331 1.4 t -91.3 103.53 16.18 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 127.096 3.331 . . . . 35.039999999999999 112.739 -175.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B 1255 ' ' THR . . . . . . . . . . . . . 17.1 m -99.7 -26.89 13.91 Favored 'General case' 0 C--N 1.318 -0.797 1 CA-C-N 106.0 -5.091 . . . . 34.619999999999997 109.451 -177.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . -47.79 96.65 0.01 OUTLIER 'General case' 0 C--O 1.257 1.475 0 CA-C-N 123.499 2.863 . . . . 42.719999999999999 117.74 -169.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 3.7 tt -133.9 146.0 50.14 Favored 'General case' 0 C--O 1.251 1.156 0 N-CA-C 101.845 -3.391 . . . . 52.43 101.845 -173.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 64.4 mt -119.08 122.14 29.82 Favored Pre-proline 0 C--N 1.313 -1.002 1 N-CA-C 100.102 -4.036 . . . . 59.409999999999997 100.102 177.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -56.0 126.73 23.35 Favored 'Trans proline' 0 C--O 1.247 0.955 0 C-N-CA 123.441 2.76 . . . . 62.68 115.659 -173.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 82.26 2.0 90.5 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 112.955 -1.929 . . . . 64.159999999999997 111.366 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 85.3 mttt -120.39 145.79 41.36 Favored Pre-proline 0 N--CA 1.475 0.801 0 O-C-N 118.474 -2.78 . . . . 68.530000000000001 105.181 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -56.19 136.56 75.85 Favored 'Trans proline' 0 C--N 1.362 1.273 0 C-N-CA 123.899 3.066 . . . . 61.990000000000002 112.077 164.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1263 ' ' ALA . . . . . . . . . . . . . . . -61.3 119.83 49.66 Favored Pre-proline 0 C--O 1.242 0.671 0 CA-C-N 113.024 -1.898 . . . . 57.149999999999999 112.28 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -55.08 146.49 58.53 Favored 'Trans proline' 0 CA--C 1.501 -1.157 0 C-N-CA 124.718 3.612 . . . . 51.57 112.339 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -87.91 68.31 9.25 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 122.916 1.341 . . . . 54.549999999999997 109.342 -171.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 91.0 mt -81.03 -30.15 34.92 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 111.51 -2.586 . . . . 46.859999999999999 111.798 -172.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1267 ' ' ILE . . . . . . . . . . . . . 28.3 mm -96.82 100.35 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 N-CA-C 104.665 -2.346 . . . . 41.039999999999999 104.665 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1268 ' ' THR . . . . . . . . . . . . . 1.1 p -75.03 151.42 38.73 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 125.486 1.741 . . . . 39.579999999999998 113.222 175.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1269 ' ' ARG . . . . . . . . . . . . . 78.1 mtt85 -57.65 -40.85 80.23 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-N 119.805 1.184 . . . . 53.149999999999999 111.5 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -54.61 -43.6 72.37 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 114.759 1.392 . . . . 42.960000000000001 114.759 169.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1271 ' ' MET . . . . . . . . . . . . . 39.4 ttm -60.8 -47.95 84.0 Favored 'General case' 0 C--O 1.241 0.613 0 O-C-N 120.945 -1.097 . . . . 43.890000000000001 111.846 176.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1272 ' ' VAL . . . . . . . . . . . . . 15.3 t -55.26 -52.4 45.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-N 115.091 -0.959 . . . . 38.369999999999997 110.113 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.94 2.24 7.25 Favored 'General case' 0 C--N 1.362 1.129 0 N-CA-C 115.039 1.496 . . . . 47.460000000000001 115.039 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1274 ' ' SER . . . . . . . . . . . . . 50.3 m -97.26 -14.58 21.29 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 114.79 1.404 . . . . 38.380000000000003 114.79 172.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1275 ' ' MET . . . . . . . . . . . . . 94.1 mtp -64.14 171.27 3.08 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 116.484 2.031 . . . . 37.810000000000002 116.484 -177.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -66.63 147.21 53.58 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 114.28 -1.327 . . . . 49.259999999999998 109.723 165.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -79.1 161.47 26.49 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.859 0.837 . . . . 34.460000000000001 112.931 174.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 81.3 25.22 55.32 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 112.712 -2.04 . . . . 33.530000000000001 112.926 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1279 ' ' SER . . . . . . . . . . . . . 13.0 m -126.64 165.35 19.38 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 116.439 -1.743 . . . . 31.309999999999999 111.363 -163.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1280 ' ' VAL . . . . . . . . . . . . . 73.8 t -136.7 136.89 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 124.165 3.166 . . . . 29.32 109.856 -171.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1281 ' ' ILE . . . . . . . . . . . . . 76.0 mt -113.26 113.36 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 103.735 -2.691 . . . . 31.93 103.735 171.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1282 ' ' VAL . . . . . . . . . . . . . 4.0 t -99.33 123.27 51.92 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 N-CA-C 106.408 -1.701 . . . . 29.48 106.408 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 18.2 t0 -93.69 108.76 20.46 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 114.797 -1.092 . . . . 34.5 109.013 174.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1284 ' ' LEU . . . . . . . . . . . . . 7.9 mp -84.27 -37.28 21.92 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 104.621 -2.363 . . . . 37.939999999999998 104.621 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -80.57 8.23 8.3 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 122.497 1.141 . . . . 40.920000000000002 113.277 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -43.46 -47.0 7.03 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 117.839 2.533 . . . . 44.390000000000001 117.839 175.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1287 ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -75.17 -30.09 60.61 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 112.931 0.715 . . . . 51.460000000000001 112.931 -175.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -107.52 48.1 0.86 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 122.931 1.348 . . . . 57.75 108.559 178.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B 1289 ' ' GLY . . . . . . . . . . . . . . . 129.21 -29.43 3.88 Favored Glycine 0 N--CA 1.428 -1.883 0 O-C-N 119.46 -2.025 . . . . 49.850000000000001 116.381 169.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 76.88 100.79 0.16 Allowed Glycine 0 C--O 1.245 0.804 0 CA-C-N 119.111 1.456 . . . . 45.93 109.775 -176.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1291 ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -71.48 -39.99 70.53 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 119.406 -2.232 . . . . 42.670000000000002 113.647 175.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1292 ' ' CYS . . . . . . . . . . . . . 36.1 t -83.4 150.69 25.9 Favored 'General case' 0 C--O 1.24 0.593 0 O-C-N 119.911 -1.743 . . . . 38.82 106.821 171.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1293 ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -75.39 -49.86 17.68 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 122.58 1.181 . . . . 46.710000000000001 109.251 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.13 -18.29 34.44 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 115.655 1.724 . . . . 47.229999999999997 115.655 -174.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B 1295 ' ' THR . . . . . . . . . . . . . 97.0 m -37.69 105.17 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 115.64 1.719 . . . . 36.020000000000003 115.64 168.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 71.4 t -88.34 106.18 11.69 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 105.785 -1.931 . . . . 37.259999999999998 105.785 170.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -58.89 111.42 0.89 Allowed 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 123.241 2.627 . . . . 35.090000000000003 115.811 -177.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 95.55 10.69 56.58 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 113.307 -1.77 . . . . 35.969999999999999 111.059 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -148.01 -178.03 6.06 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 124.9 2.286 . . . . 40.390000000000001 110.046 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1300 ' ' ILE . . . . . . . . . . . . . 30.3 mt -110.71 162.79 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 111.006 -2.815 . . . . 37.43 105.367 172.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 61.0 t80 -150.77 130.38 13.08 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 104.052 -2.573 . . . . 44.130000000000003 104.052 170.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1302 ' ' THR . . . . . . . . . . . . . 25.7 m -95.62 136.16 36.37 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.447 -0.945 . . . . 39.780000000000001 108.447 173.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1303 ' ' THR . . . . . . . . . . . . . 46.6 p -77.25 177.22 8.07 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.287 -1.324 . . . . 43.289999999999999 113.015 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -57.63 -59.02 5.82 Favored 'General case' 0 N--CA 1.435 -1.214 0 O-C-N 121.091 -1.006 . . . . 53.07 110.805 162.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -60.5 -22.75 63.89 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 113.759 1.022 . . . . 43.969999999999999 113.759 -174.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 108.62 47.42 0.91 Allowed Glycine 0 N--CA 1.432 -1.583 0 CA-C-O 122.57 1.094 . . . . 41.119999999999997 112.713 166.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1307 ' ' VAL . . . . . . . . . . . . . 95.1 t -122.95 128.16 75.06 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 N-CA-C 102.226 -3.25 . . . . 38.119999999999997 102.226 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1308 ' ' LYS . . . . . . . . . . . . . 43.7 mmtt -83.53 109.02 17.04 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 103.013 -2.958 . . . . 36.340000000000003 103.013 176.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1309 ' ' VAL . . . . . . . . . . . . . 44.9 t -88.1 113.44 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 O-C-N 117.288 -3.382 . . . . 30.399999999999999 103.284 168.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1310 ' ' ILE . . . . . . . . . . . . . 19.2 mt -102.41 100.16 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-N 113.617 -1.629 . . . . 30.82 107.626 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1311 ' ' GLY . . . . . . . . . . . . . . . -97.57 53.59 1.29 Allowed Glycine 0 C--N 1.352 1.426 0 C-N-CA 119.084 -1.531 . . . . 26.530000000000001 110.704 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1312 ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -74.88 94.37 2.79 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 120.759 -1.436 . . . . 38.0 108.745 -171.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B 1313 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.76 -35.33 63.65 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 121.077 -1.014 . . . . 29.800000000000001 112.24 174.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -75.1 4.28 7.08 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 126.758 2.023 . . . . 39.039999999999999 115.376 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1315 ' ' LEU . . . . . . . . . . . . . 34.6 mt -43.9 -50.99 18.52 Favored Pre-proline 0 N--CA 1.465 0.301 0 N-CA-C 118.231 2.678 . . . . 31.079999999999998 118.231 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1316 ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -56.84 -27.5 72.31 Favored 'Trans proline' 0 CA--C 1.546 1.094 0 C-N-CA 123.628 2.886 . . . . 26.100000000000001 115.315 174.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -82.06 -35.01 22.5 Favored Glycine 0 N--CA 1.435 -1.407 0 O-C-N 120.715 -1.24 . . . . 23.170000000000002 110.139 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -52.52 3.43 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.588 1 N-CA-C 123.437 4.606 . . . . 40.399999999999999 123.437 -171.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 21.3 tp -132.75 66.54 76.71 Favored Pre-proline 0 C--O 1.243 0.741 0 O-C-N 118.746 -2.471 . . . . 23.600000000000001 108.269 -175.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1320 ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -26.57 -71.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.053 1 C-N-CA 126.196 4.597 . . . . 22.350000000000001 118.72 -166.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B 1321 ' ' THR . . . . . . . . . . . . . 3.3 m -67.48 -40.62 85.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 119.952 1.251 . . . . 26.52 108.995 -169.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1322 ' ' GLN . . . . . . . . . . . . . 32.4 tp60 -79.11 -33.14 44.6 Favored 'General case' 0 CA--C 1.488 -1.41 0 O-C-N 120.66 -1.275 . . . . 24.379999999999999 110.882 -173.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1323 ' ' SER . . . . . . . . . . . . . 71.3 m -63.07 -47.5 82.66 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 109.184 -0.673 . . . . 22.800000000000001 109.184 176.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1324 ' ' SER . . . . . . . . . . . . . 22.0 m -58.32 -37.0 74.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 122.881 1.324 . . . . 21.25 114.248 175.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -65.03 -54.36 31.43 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.468 -1.242 . . . . 31.34 111.804 176.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1326 ' ' LEU . . . . . . . . . . . . . 23.8 mt -73.09 -40.4 65.03 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 117.688 -1.149 . . . . 31.559999999999999 110.944 -172.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1327 ' ' TYR . . . . . . . . . . . . . 42.5 t80 -57.94 -50.95 71.62 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 106.118 -1.808 . . . . 22.73 106.118 173.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1328 ' ' GLY . . . . . . . . . . . . . . . -52.36 -42.63 56.91 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 114.582 0.593 . . . . 21.91 114.582 174.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1329 ' ' THR . . . . . . . . . . . . . 5.5 m -71.94 -25.45 61.89 Favored 'General case' 0 C--O 1.249 1.057 0 O-C-N 120.52 -1.577 . . . . 22.149999999999999 111.936 176.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1330 ' ' ASN . . . . . . . . . . . . . 24.7 m120 -62.56 -37.45 86.21 Favored 'General case' 0 C--O 1.249 1.04 0 CA-C-N 120.893 1.679 . . . . 26.18 110.58 170.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1331 ' ' LEU . . . . . . . . . . . . . 59.1 mt -68.65 -44.0 75.07 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 113.859 -1.519 . . . . 23.68 109.977 176.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1332 ' ' VAL . . . . . . . . . . . . . 69.9 t -53.4 -55.36 13.32 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 CA-C-O 116.846 -1.55 . . . . 26.57 108.139 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -55.8 -40.29 72.52 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 115.459 1.652 . . . . 28.079999999999998 115.459 175.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1334 ' ' LEU . . . . . . . . . . . . . 12.9 tp -56.54 -48.24 77.7 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 124.722 1.209 . . . . 27.43 111.357 169.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1335 ' ' LEU . . . . . . . . . . . . . 7.2 mt -71.62 -22.32 61.72 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 119.92 -0.712 . . . . 30.5 111.648 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1336 ' ' LYS . . . . . . . . . . . . . 97.0 mttt -67.01 -47.98 69.79 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.297 -1.001 . . . . 41.649999999999999 108.297 171.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 6.6 mp -71.21 -35.08 71.39 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 119.591 -1.943 . . . . 42.079999999999998 112.053 176.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1338 ' ' LEU . . . . . . . . . . . . . 35.9 mt -69.78 -68.27 0.43 Allowed 'General case' 0 N--CA 1.438 -1.048 0 O-C-N 119.638 -1.914 . . . . 35.030000000000001 110.446 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 52.6 t -93.32 69.86 4.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.929 1.347 . . . . 37.329999999999998 108.595 -174.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 57.3 mttp -65.88 -27.81 68.49 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 114.193 1.183 . . . . 50.509999999999998 114.193 -175.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -71.44 -21.32 61.99 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 120.998 -1.064 . . . . 54.210000000000001 112.646 168.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 7.3 mptt 52.07 50.48 18.42 Favored 'General case' 0 C--O 1.252 1.199 0 CA-C-O 124.969 2.319 . . . . 50.990000000000002 111.575 -163.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -76.55 -33.24 58.54 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 111.264 -2.698 . . . . 48.82 111.274 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 108.34 14.45 16.35 Favored Glycine 0 C--O 1.244 0.77 0 CA-C-O 117.748 -1.585 . . . . 40.43 112.194 174.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -131.09 156.47 45.16 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 104.835 -2.283 . . . . 47.560000000000002 104.835 166.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1346 ' ' ILE . . . . . . . . . . . . . 26.2 mm -81.95 94.23 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 O-C-N 118.955 -2.34 . . . . 42.490000000000002 112.195 -172.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1347 ' ' THR . . . . . . . . . . . . . 88.1 m -59.21 105.31 0.32 Allowed 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 106.919 -1.511 . . . . 38.119999999999997 106.919 159.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 21.7 t -90.46 96.43 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 104.761 -2.311 . . . . 37.5 104.761 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 6.6 t70 -75.39 129.03 36.67 Favored 'General case' 0 C--O 1.265 1.891 0 CA-C-N 110.995 -2.821 . . . . 43.850000000000001 110.301 -175.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1350 ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -117.24 0.82 12.37 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.934 -1.104 . . . . 39.810000000000002 111.508 175.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 7.9 t70 -81.13 -43.86 18.77 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 119.236 0.926 . . . . 51.289999999999999 109.857 -175.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.2 145.13 51.64 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-O 122.105 0.955 . . . . 39.780000000000001 110.936 174.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 28.7 m -68.47 -36.67 75.75 Favored 'Isoleucine or valine' 0 C--O 1.25 1.131 0 CA-C-N 114.952 -1.022 . . . . 39.280000000000001 110.726 -173.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1354 ' ' VAL . . . . . . . . . . . . . 49.7 t -70.41 -47.71 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 O-C-N 121.799 -0.563 . . . . 35.700000000000003 111.19 -172.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1355 ' ' ILE . . . . . . . . . . . . . 38.7 mm -70.11 -41.52 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 O-C-N 121.398 -0.813 . . . . 35.770000000000003 109.797 176.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 47.3 tpt85 -47.63 -32.54 5.67 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 115.375 1.62 . . . . 38.549999999999997 115.375 169.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -91.94 -40.87 5.12 Favored Glycine 0 N--CA 1.442 -0.901 0 O-C-N 121.627 -0.67 . . . . 29.579999999999998 114.011 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1358 ' ' VAL . . . . . . . . . . . . . 4.0 p -66.76 -36.42 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 114.454 1.279 . . . . 32.060000000000002 114.454 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1359 ' ' THR . . . . . . . . . . . . . 4.1 m -72.35 81.16 1.03 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 123.3 1.524 . . . . 29.0 107.205 175.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1360 ' ' VAL . . . . . . . . . . . . . 14.6 m -63.24 -29.23 46.73 Favored 'Isoleucine or valine' 0 C--O 1.248 1.001 0 O-C-N 121.129 -0.982 . . . . 29.68 113.392 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 49.1 mt -138.3 108.6 4.83 Favored 'Isoleucine or valine' 0 C--O 1.249 1.058 0 N-CA-C 104.173 -2.529 . . . . 32.049999999999997 104.173 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1362 ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -91.5 105.08 17.5 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 117.99 -2.944 . . . . 32.520000000000003 107.396 169.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 45.45 58.82 3.94 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 116.91 2.189 . . . . 35.68 116.91 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 91.96 -47.27 2.7 Favored Glycine 0 CA--C 1.538 1.53 0 CA-C-O 118.017 -1.435 . . . . 34.259999999999998 112.646 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -68.32 115.31 7.62 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 123.265 1.507 . . . . 51.07 109.58 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 24.4 mt -74.76 95.8 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.981 0 CA-C-O 123.427 1.584 . . . . 39.869999999999997 112.54 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1367 ' ' THR . . . . . . . . . . . . . 11.8 p -90.43 13.63 15.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 110.445 -3.071 . . . . 38.009999999999998 113.039 -174.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1368 ' ' TRP . . . . . . . . . . . . . 32.2 t90 -77.96 135.8 62.78 Favored Pre-proline 0 C--O 1.233 0.197 0 C-N-CA 125.582 1.553 . . . . 42.140000000000001 111.024 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -91.19 -167.83 3.03 Favored 'Cis proline' 0 CA--C 1.542 0.877 0 CA-C-N 123.616 2.327 . . . . 43.259999999999998 110.21 -9.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1370 ' ' ALA . . . . . . . . . . . . . . . -72.34 167.86 28.64 Favored Pre-proline 0 C--O 1.244 0.8 0 CA-C-O 117.142 -1.408 . . . . 46.520000000000003 110.136 163.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -56.55 151.48 46.02 Favored 'Trans proline' 0 CA--C 1.548 1.191 0 CA-C-N 125.864 3.13 . . . . 51.950000000000003 109.07 164.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -64.65 100.44 0.34 Allowed 'Trans proline' 0 C--O 1.24 0.589 0 C-N-CA 122.477 2.118 . . . . 56.270000000000003 113.779 -168.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1373 ' ' ILE . . . . . . . . . . . . . 17.0 mm -100.63 101.33 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 102.22 -3.252 . . . . 60.829999999999998 102.22 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -62.55 120.23 10.74 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 122.78 1.276 . . . . 66.099999999999994 109.764 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 16.4 t -81.76 121.89 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 104.213 -2.514 . . . . 63.469999999999999 104.213 176.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.227 -4.724 0 O-C-N 121.92 -0.488 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.291 0 CA-C-O 120.375 0.131 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.35 -32.81 40.12 Favored 'General case' 0 C--O 1.214 -0.789 0 C-N-CA 124.74 1.216 . . . . 0.0 113.983 176.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -70.14 -63.33 1.1 Allowed 'General case' 0 C--O 1.245 0.865 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 170.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.36 -34.84 3.22 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 125.748 1.619 . . . . 0.0 115.061 -174.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.45 -67.0 0.29 Allowed 'General case' 0 C--O 1.256 1.419 0 N-CA-C 115.238 1.569 . . . . 0.0 115.238 166.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -55.43 -38.09 68.54 Favored 'General case' 0 C--N 1.356 0.88 0 O-C-N 119.942 -1.724 . . . . 0.0 113.457 173.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 mp -59.25 -43.4 92.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.438 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 13.6 mt -58.2 -53.46 58.01 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 125.139 1.375 . . . . 0.0 114.268 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 28' ' ' LYS . . . . . 0.426 ' HZ1' ' C ' ' C' ' 186' ' ' LEU . 11.9 pttm -58.58 -31.86 68.41 Favored 'General case' 0 C--O 1.242 0.708 0 O-C-N 120.004 -1.685 . . . . 0.0 113.726 176.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -65.62 -32.31 73.81 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 174.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 67.1 m -58.45 -34.55 70.96 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 119.609 3.188 . . . . 0.0 119.609 -158.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 59.98 -76.93 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 122.509 2.413 . . . . 0.0 107.396 -165.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 15.4 m -96.32 136.2 37.12 Favored 'General case' 0 C--O 1.243 0.724 0 O-C-N 118.087 -2.883 . . . . 0.0 110.089 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 91.3 t -129.89 122.96 55.68 Favored 'Isoleucine or valine' 0 C--O 1.247 0.962 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 26.9 mm -100.12 117.99 46.13 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 168.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 27.7 mt -94.36 118.04 39.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 119.481 1.037 . . . . 0.0 109.663 170.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 3.6 m -102.96 108.28 57.98 Favored Pre-proline 0 CA--C 1.55 0.95 0 O-C-N 120.172 -1.58 . . . . 0.0 112.424 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -74.17 37.74 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 1 C-N-CA 125.657 4.238 . . . . 0.0 118.772 -175.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -88.24 94.35 1.98 Allowed Glycine 0 C--N 1.335 0.489 0 O-C-N 119.555 -1.966 . . . . 0.0 111.987 -166.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 23.4 t80 68.66 -57.07 0.51 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 116.922 -1.513 . . . . 0.0 114.648 175.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -49.07 -46.87 33.29 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-N 120.39 1.45 . . . . 0.0 113.301 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 49.1 ttm -44.67 -52.07 8.58 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 173.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.86 -59.15 2.85 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.812 -175.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 8.2 p -57.84 -43.81 85.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 122.881 1.325 . . . . 0.0 109.179 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.44 6.66 25.79 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 119.801 -1.812 . . . . 0.0 113.496 -176.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 45' ' ' GLN . . . . . . . . . . . . 0.348 0.0 OUTLIER 49.52 25.87 1.53 Allowed 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 118.175 2.657 . . . . 0.0 118.175 -169.17 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.2 -8.33 49.08 Favored 'General case' 0 C--O 1.255 1.359 0 O-C-N 120.352 -1.467 . . . . 0.0 111.266 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 47' ' ' GLN . . . . . . . . . . . . 0.365 0.0 OUTLIER -69.54 -38.22 77.41 Favored 'General case' 0 CA--C 1.51 -0.568 0 O-C-N 118.677 -2.514 . . . . 0.0 115.532 174.836 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 48' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -58.98 -58.45 19.43 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-O 115.292 -2.29 . . . . 0.0 111.313 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 49' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -61.71 -36.57 73.89 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 124.324 3.349 . . . . 0.0 111.711 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -53.16 -39.09 32.44 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-N 122.047 2.203 . . . . 0.0 112.839 177.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.34 -38.98 69.45 Favored 'General case' 0 C--O 1.247 0.927 0 O-C-N 121.66 -0.65 . . . . 0.0 112.007 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -75.65 -48.77 20.67 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 120.746 -1.221 . . . . 0.0 108.277 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 8.1 tp -63.38 -37.4 79.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 C-N-CA 119.416 -0.914 . . . . 0.0 113.084 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 90.0 m -68.56 -41.99 78.96 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 119.961 -1.712 . . . . 0.0 109.49 -178.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -53.67 -42.39 67.86 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 124.626 1.17 . . . . 0.0 112.066 168.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -66.44 -39.44 88.89 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 120.927 -1.108 . . . . 0.0 111.378 173.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 97.9 mt -67.63 -33.52 75.14 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 119.862 1.21 . . . . 0.0 107.896 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.9 -46.51 84.49 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 121.897 0.856 . . . . 0.0 111.473 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.67 -35.97 71.28 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 124.068 1.89 . . . . 0.0 114.029 173.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -68.06 -24.07 65.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.495 -1.23 . . . . 0.0 113.53 173.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.91 79.75 1.11 Allowed Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 mt -141.94 125.97 16.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 112.89 -1.655 . . . . 0.0 107.913 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -72.41 87.91 1.18 Allowed 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 125.214 1.406 . . . . 0.0 109.601 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 9.2 p -93.17 139.98 17.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 CA-C-O 122.11 0.957 . . . . 0.0 111.591 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 84.1 mmt-85 -138.38 120.6 15.79 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 103.19 -2.892 . . . . 0.0 103.19 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -79.87 126.13 30.6 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 165.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -100.53 86.37 0.64 Allowed Glycine 0 N--CA 1.478 1.45 0 O-C-N 119.002 -2.312 . . . . 0.0 109.509 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 3.2 mp -87.09 84.93 2.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 O-C-N 118.982 -2.481 . . . . 0.0 107.857 -172.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -74.24 116.91 57.32 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-O 116.569 -1.681 . . . . 0.0 108.527 170.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 70' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -54.62 -59.29 0.89 Allowed 'Trans proline' 0 C--N 1.333 -0.247 0 C-N-CA 124.383 3.389 . . . . 0.0 117.255 -170.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 4.4 m -68.23 95.56 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 113.303 -1.771 . . . . 0.0 108.506 169.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -161.17 109.91 1.58 Allowed 'General case' 0 C--O 1.242 0.66 0 CA-C-N 109.031 -3.713 . . . . 0.0 107.16 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.48 -90.96 0.3 Allowed Glycine 0 CA--C 1.506 -0.498 0 CA-C-O 118.285 -1.286 . . . . 0.0 112.975 172.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -133.17 114.06 13.41 Favored 'General case' 0 C--O 1.256 1.419 0 CA-C-N 118.196 0.998 . . . . 0.0 111.935 -167.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 1.7 mp 63.13 142.84 0.06 OUTLIER Pre-proline 0 C--O 1.236 0.344 0 C-N-CA 128.173 2.589 . . . . 0.0 117.069 169.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -71.47 149.9 56.91 Favored 'Trans proline' 0 C--N 1.364 1.365 0 C-N-CA 123.289 2.659 . . . . 0.0 111.093 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 70.81 -96.53 0.59 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -171.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 48.55 -84.32 0.01 OUTLIER 'General case' 0 C--O 1.24 0.602 0 C-N-CA 126.089 1.756 . . . . 0.0 111.677 173.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -25.81 65.64 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.226 1.01 . . . . 0.0 113.1 177.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -58.02 -55.02 40.35 Favored 'General case' 0 C--O 1.24 0.576 0 O-C-N 121.659 -0.651 . . . . 0.0 111.497 170.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 69.8 t -73.3 -38.06 53.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 O-C-N 119.664 -1.898 . . . . 0.0 108.896 177.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 96.0 mt -48.73 -31.77 7.44 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 122.595 2.452 . . . . 0.0 114.234 169.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.82 -32.06 61.86 Favored 'General case' 0 C--O 1.221 -0.399 0 O-C-N 121.429 -0.794 . . . . 0.0 111.2 173.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.08 -32.67 74.5 Favored 'General case' 0 CA--C 1.497 -1.078 0 O-C-N 120.007 -1.683 . . . . 0.0 113.709 170.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -64.3 -50.05 69.36 Favored 'General case' 0 C--O 1.251 1.182 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 172.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.15 -18.18 60.15 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 172.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp 63.1 62.13 1.03 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-O 124.888 2.28 . . . . 0.0 109.558 -173.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 98.2 t -103.84 127.6 29.05 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 111.337 -2.665 . . . . 0.0 105.619 168.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -56.39 126.89 23.8 Favored 'Trans proline' 0 C--O 1.219 -0.469 0 C-N-CA 122.935 2.424 . . . . 0.0 117.965 175.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -59.3 -12.41 5.59 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 173.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -62.45 -47.48 83.86 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 119.96 1.254 . . . . 0.0 111.555 171.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 39.5 pt -84.09 -14.42 11.46 Favored 'Isoleucine or valine' 0 C--O 1.255 1.351 0 CA-C-O 121.984 0.897 . . . . 0.0 111.521 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 50.5 t -76.84 104.56 4.92 Favored 'Isoleucine or valine' 0 C--O 1.247 0.951 0 O-C-N 119.69 -1.881 . . . . 0.0 106.882 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 10.8 mp -104.29 103.44 13.19 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 124.831 2.253 . . . . 0.0 109.559 174.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -85.36 117.16 24.12 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 119.675 -1.891 . . . . 0.0 108.28 -176.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 12.2 ttp 42.81 29.59 0.19 Allowed 'General case' 0 C--N 1.345 0.385 0 C-N-CA 127.801 2.441 . . . . 0.0 115.162 -178.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -79.92 128.63 33.68 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 103.387 -2.819 . . . . 0.0 103.387 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -87.13 79.56 8.6 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 9.5 tp -85.21 58.97 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 112.482 -2.145 . . . . 0.0 108.265 -173.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -73.31 -38.58 65.79 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 112.837 -1.983 . . . . 0.0 111.801 -166.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.96 -39.38 79.54 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.079 -1.419 . . . . 0.0 112.437 177.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.74 -28.43 67.63 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 120.172 -1.58 . . . . 0.0 113.25 167.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 103' ' ' PHE . . . . . . . . . . . . . 6.8 m-30 -56.54 -51.19 69.49 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-O 121.575 0.703 . . . . 0.0 111.95 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.99 -45.51 82.91 Favored 'General case' 0 C--O 1.208 -1.117 0 CA-C-N 114.524 -1.217 . . . . 0.0 112.594 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -66.31 -29.18 69.33 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 106' ' ' THR . . . . . . . . . . . . . 69.6 m -64.92 135.52 55.79 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 107' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -86.94 -102.68 0.07 Allowed 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 112.373 -2.194 . . . . 0.0 109.027 166.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 53.8 m -69.83 91.77 0.66 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 124.398 3.272 . . . . 0.0 113.356 -171.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 109' ' ' VAL . . . . . . . . . . . . . 21.3 t -74.27 110.6 8.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 167.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 96.0 mt -85.6 95.44 9.34 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 50.3 t -87.1 87.68 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 -176.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 25.3 mm -72.05 79.32 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -171.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.69 -110.26 3.64 Favored Glycine 0 C--O 1.239 0.409 0 N-CA-C 107.25 -2.34 . . . . 0.0 107.25 -171.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . 47.73 9.13 0.01 OUTLIER 'General case' 0 C--N 1.352 0.686 1 N-CA-C 121.817 4.006 . . . . 0.0 121.817 163.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.29 -41.94 51.61 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 117.258 2.318 . . . . 0.0 117.258 -175.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 116' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -76.51 -28.01 56.23 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 19.4 m -72.83 -13.3 61.26 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.9 -1.125 . . . . 0.0 108.642 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 18.3 m -120.03 16.86 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 CA-C-N 119.762 1.165 . . . . 0.0 109.873 174.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -79.64 112.28 27.93 Favored Pre-proline 0 N--CA 1.451 -0.391 0 O-C-N 120.118 -1.614 . . . . 0.0 115.188 -171.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 120' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -58.91 -36.47 96.84 Favored 'Trans proline' 0 C--N 1.368 1.602 0 C-N-CA 123.557 2.838 . . . . 0.0 113.288 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.58 4.98 1.55 Allowed 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.2 -31.7 14.01 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 120.344 -1.472 . . . . 0.0 113.124 173.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -116.03 -52.37 2.61 Favored 'General case' 0 C--O 1.22 -0.49 0 C-N-CA 118.839 -1.144 . . . . 0.0 109.68 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -62.17 -51.01 69.53 Favored 'General case' 0 C--N 1.363 1.188 0 CA-C-O 122.735 1.255 . . . . 0.0 108.905 -173.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -95.54 132.07 28.27 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 102.869 -3.011 . . . . 0.0 102.869 164.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -78.05 46.58 2.11 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 122.223 1.949 . . . . 0.0 110.829 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -107.06 -33.2 7.54 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -152.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 128' ' ' SER . . . . . . . . . . . . . 36.3 m -79.57 144.36 60.94 Favored Pre-proline 0 C--O 1.24 0.559 0 O-C-N 124.735 1.272 . . . . 0.0 111.647 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 129' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -44.38 -40.0 12.85 Favored 'Trans proline' 0 CA--C 1.51 -0.677 0 C-N-CA 123.785 2.99 . . . . 0.0 114.69 176.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 35.4 pt -65.61 72.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.88 0 CA-C-O 124.4 2.048 . . . . 0.0 110.413 164.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.71 119.52 10.71 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.511 -1.222 . . . . 0.0 112.987 -172.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 61.71 50.38 66.75 Favored Glycine 0 N--CA 1.431 -1.648 0 CA-C-N 113.083 -1.871 . . . . 0.0 112.149 -175.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 133' ' ' MET . . . . . . . . . . . . . 26.5 tpp -75.98 123.79 88.27 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 119.481 1.641 . . . . 0.0 112.099 171.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.68 82.71 1.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.969 1 C-N-CA 125.833 4.355 . . . . 0.0 107.498 177.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 21.7 m -80.99 151.83 4.39 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.183 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.25 -176.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 87.5 mt -74.59 109.27 7.93 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.696 0.76 . . . . 0.0 110.214 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -72.81 80.02 1.14 Allowed 'General case' 0 N--CA 1.423 -1.789 0 CA-C-O 122.964 1.364 . . . . 0.0 112.134 -169.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 3.9 p -113.63 -1.79 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -176.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 13.1 p90 -56.56 148.71 19.0 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.131 -1.606 . . . . 0.0 111.118 174.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 140' ' ' LYS . . . . . . . . . . . . 0.378 0.0 OUTLIER 37.19 46.37 0.57 Allowed 'General case' 0 C--O 1.244 0.765 0 N-CA-C 116.55 2.056 . . . . 0.0 116.55 -160.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.5 -156.36 0.04 OUTLIER 'General case' 0 C--O 1.24 0.596 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 159.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.08 -32.81 24.59 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 119.754 -1.841 . . . . 0.0 113.787 170.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 143' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -158.55 138.2 11.9 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 121.837 2.108 . . . . 0.0 110.239 170.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 144' ' ' VAL . . . . . . . . . . . . . 21.8 t -136.46 90.43 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.598 0 O-C-N 119.051 -2.28 . . . . 0.0 105.104 -176.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 145' ' ' ILE . . . . . . . . . . . . . 10.5 tp -93.13 102.02 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 -170.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 146' ' ' VAL . . . . . . . . . . . . . 26.0 t -90.99 107.41 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 -170.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 147' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -70.3 94.09 0.9 Allowed 'General case' 0 C--N 1.35 0.618 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 -177.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 148' ' ' LYS . . . . . 0.491 ' NZ ' ' OD1' ' C' ' 152' ' ' ASN . 26.1 mtpp -140.93 117.67 11.0 Favored 'General case' 0 C--O 1.253 1.254 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 173.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -70.03 -4.47 21.12 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 1.3 m -157.72 159.87 37.33 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 124.256 1.979 . . . . 0.0 108.704 175.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.44 77.72 5.99 Favored 'General case' 0 C--O 1.252 1.194 0 O-C-N 118.901 -2.374 . . . . 0.0 105.992 169.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 152' ' ' ASN . . . . . 0.491 ' OD1' ' NZ ' ' C' ' 148' ' ' LYS . 2.1 p-10 -113.85 157.95 21.67 Favored 'General case' 0 N--CA 1.438 -1.027 0 O-C-N 125.775 1.922 . . . . 0.0 108.826 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 45.7 m -67.55 125.82 27.37 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 123.848 0.717 . . . . 0.0 111.895 174.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -84.74 -108.85 0.63 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 104.7 -3.36 . . . . 0.0 104.7 173.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -91.53 -15.34 28.86 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 164.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 156' ' ' ALA . . . . . . . . . . . . . . . -165.54 -93.55 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 159.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 74.93 41.8 32.03 Favored Glycine 0 N--CA 1.437 -1.286 0 CA-C-N 120.876 1.671 . . . . 0.0 110.372 -165.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 15.5 m -80.81 127.94 39.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 O-C-N 120.085 -1.832 . . . . 0.0 108.941 171.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . 0.3 0.0 OUTLIER 43.2 16.31 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 120.613 3.56 . . . . 0.0 120.613 173.5 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 160' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -73.9 125.98 89.83 Favored Pre-proline 0 CA--C 1.532 0.269 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -49.86 -25.63 12.33 Favored 'Trans proline' 0 C--N 1.367 1.548 1 C-N-CA 126.725 4.95 . . . . 0.0 113.367 -176.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 162' ' ' LEU . . . . . . . . . . . . . 13.2 mt -53.61 -20.14 4.8 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 173.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 163' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -82.09 -42.16 19.56 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 123.092 1.425 . . . . 0.0 112.285 175.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -103.11 -41.23 6.16 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 113.18 -1.827 . . . . 0.0 110.099 -153.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 16.0 mttm -74.34 178.92 4.86 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 -164.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -77.43 -56.81 4.22 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-N 113.965 -1.471 . . . . 0.0 108.792 -165.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 45.9 p30 -75.25 -45.84 37.53 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-O 117.383 -1.294 . . . . 0.0 110.591 168.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 168' ' ' THR . . . . . . . . . . . . . 13.6 p -87.54 94.89 9.85 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-N 121.932 2.151 . . . . 0.0 107.829 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -140.18 142.7 35.9 Favored 'General case' 0 C--N 1.353 0.743 0 O-C-N 120.419 -1.426 . . . . 0.0 110.757 -163.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 170' ' ' MET . . . . . . . . . . . . . 78.1 mtm -75.66 112.15 11.72 Favored 'General case' 0 CA--C 1.48 -1.72 0 CA-C-O 123.451 1.596 . . . . 0.0 115.232 174.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 171' ' ' LEU . . . . . . . . . . . . . 22.6 tp -71.95 109.81 6.03 Favored 'General case' 0 C--O 1.254 1.31 0 CA-C-N 114.146 -1.388 . . . . 0.0 107.847 169.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -83.26 68.24 9.56 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 126.194 2.902 . . . . 0.0 112.537 -173.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -153.03 163.42 30.51 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 110.161 -3.2 . . . . 0.0 109.735 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 174' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -74.41 155.32 38.21 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 111.868 -2.166 . . . . 0.0 109.146 173.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.47 -55.74 30.81 Favored 'General case' 0 CA--C 1.496 -1.121 0 CA-C-N 110.292 -3.14 . . . . 0.0 111.91 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.3 -54.44 24.77 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 116.845 -1.55 . . . . 0.0 107.541 176.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 177' ' ' ALA . . . . . . . . . . . . . . . -51.21 -48.98 61.88 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.192 0.997 . . . . 0.0 112.619 -170.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 38.5 m -62.61 -46.46 88.18 Favored 'General case' 0 C--O 1.246 0.877 0 O-C-N 121.004 -1.06 . . . . 0.0 110.746 178.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 179' ' ' VAL . . . . . . . . . . . . . 22.1 t -61.09 -41.81 90.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 O-C-N 119.789 -1.819 . . . . 0.0 108.14 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.97 -37.78 88.67 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.559 -174.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -70.9 -49.72 42.7 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.56 1.073 . . . . 0.0 109.769 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 182' ' ' ILE . . . . . . . . . . . . . 16.8 pt -63.06 -25.35 38.34 Favored 'Isoleucine or valine' 0 C--N 1.363 1.178 0 O-C-N 119.415 -2.053 . . . . 0.0 112.943 -174.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 183' ' ' LEU . . . . . . . . . . . . . 12.8 tp -49.9 -36.6 28.04 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 126.743 2.017 . . . . 0.0 112.97 170.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 18.7 tptt -112.95 -34.75 5.65 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -57.43 -63.99 1.04 Allowed 'General case' 0 C--O 1.257 1.478 0 N-CA-C 118.823 2.897 . . . . 0.0 118.823 172.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 186' ' ' LEU . . . . . 0.426 ' C ' ' HZ1' ' C' ' 28' ' ' LYS 0.327 1.3 pt? . . . . . 0 C--O 1.218 -0.586 0 C-N-CA 127.753 2.421 . . . . 0.0 117.349 -167.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 22.3 t-80 . . . . . 0 N--CA 1.436 -1.134 0 N-CA-C 104.856 -2.275 . . . . 65.739999999999995 104.856 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -69.94 82.09 0.33 Allowed Glycine 0 C--O 1.222 -0.638 0 O-C-N 117.868 -3.02 . . . . 48.659999999999997 112.313 169.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -113.44 109.47 18.72 Favored 'General case' 0 CA--C 1.478 -1.81 0 N-CA-C 103.633 -2.728 . . . . 44.560000000000002 103.633 170.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1003 ' ' ILE . . . . . . . . . . . . . 61.8 mt -80.18 110.51 15.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 112.179 -2.282 . . . . 34.859999999999999 109.187 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -75.83 122.11 6.53 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.122 -1.191 . . . . 30.75 110.122 163.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 16.8 mm -99.58 105.48 34.04 Favored Pre-proline 0 C--O 1.242 0.688 0 N-CA-C 102.567 -3.123 . . . . 32.210000000000001 102.567 176.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -85.8 158.35 10.38 Favored 'Trans proline' 0 N--CA 1.451 -1.007 1 C-N-CA 126.222 4.615 . . . . 32.979999999999997 110.468 175.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1007 ' ' ARG . . . . . . . . . . . . . 1.8 ttp85 -84.98 138.42 32.48 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 103.181 -2.896 . . . . 47.979999999999997 103.181 153.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1008 ' ' GLU . . . . . 0.469 ' CD ' ' HZ1' ' A' 1071 ' ' LYS . 9.6 tp10 -63.44 137.85 58.3 Favored 'General case' 0 N--CA 1.441 -0.89 0 O-C-N 124.41 1.068 . . . . 34.700000000000003 109.398 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -93.82 -27.53 16.4 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 114.725 -1.125 . . . . 53.369999999999997 113.558 -175.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 3.9 mp -52.81 129.2 29.25 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-O 123.018 1.39 . . . . 45.07 111.52 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1011 ' ' THR . . . . . . . . . . . . . 20.7 m -48.19 119.79 3.16 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 113.076 -1.874 . . . . 40.359999999999999 112.137 -171.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 12.5 m120 63.28 -4.67 0.28 Allowed 'General case' 0 C--O 1.243 0.753 0 N-CA-C 117.419 2.377 . . . . 40.609999999999999 117.419 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -88.1 71.97 9.22 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 104.424 -2.436 . . . . 33.759999999999998 104.424 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1014 ' ' THR . . . . . . . . . . . . . 47.1 m -73.29 66.7 0.93 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 125.72 2.676 . . . . 27.890000000000001 111.914 -172.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1015 ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -108.51 163.29 13.36 Favored 'General case' 0 C--O 1.224 -0.262 0 O-C-N 120.002 -1.686 . . . . 29.02 108.942 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1016 ' ' VAL . . . . . . . . . . . . . 39.4 t -137.05 151.59 27.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 101.505 -3.517 . . . . 28.129999999999999 101.505 171.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1017 ' ' ALA . . . . . . . . . . . . . . . -55.18 -54.57 41.63 Favored 'General case' 0 C--O 1.256 1.426 0 N-CA-C 119.067 2.988 . . . . 26.870000000000001 119.067 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -144.25 159.36 42.81 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 120.478 1.49 . . . . 26.77 112.566 -170.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1019 ' ' THR . . . . . . . . . . . . . 19.2 p -84.25 155.86 63.25 Favored Pre-proline 0 C--O 1.245 0.833 0 CA-C-O 117.762 -1.113 . . . . 27.02 111.423 176.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1020 ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -48.5 -40.16 36.92 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 124.059 3.172 . . . . 30.57 114.41 169.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -52.33 -48.98 65.15 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.284 1.216 . . . . 47.810000000000002 114.284 168.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1022 ' ' THR . . . . . . . . . . . . . 2.6 p -75.15 -30.87 60.88 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 124.057 1.885 . . . . 30.77 109.426 -172.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1023 ' ' VAL . . . . . . . . . . . . . 55.5 t -56.98 -52.23 58.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 C-N-CA 125.141 1.376 . . . . 33.590000000000003 108.691 168.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -46.2 -51.62 13.89 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 120.694 1.588 . . . . 53.289999999999999 110.755 172.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -54.38 -52.4 61.79 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.673 1.36 . . . . 46.920000000000002 114.673 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1026 ' ' LEU . . . . . . . . . . . . . 91.7 mt -53.94 -42.79 69.23 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 115.019 1.488 . . . . 37.170000000000002 115.019 177.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 7.1 mp -54.32 -49.9 68.62 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.711 -1.131 . . . . 44.439999999999998 113.442 168.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -62.08 -29.27 70.19 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 120.367 0.127 . . . . 52.579999999999998 111.094 175.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1029 ' ' LEU . . . . . . . . . . . . . 95.3 mt -72.26 -42.33 65.73 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 119.749 -1.844 . . . . 45.689999999999998 109.784 175.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 138.06 -8.04 3.52 Favored Glycine 0 CA--C 1.507 -0.411 0 C-N-CA 120.877 -0.678 . . . . 42.090000000000003 111.949 173.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -80.15 130.68 35.41 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 118.917 -0.563 . . . . 40.719999999999999 112.301 -173.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1032 ' ' THR . . . . . . . . . . . . . 55.8 m -74.11 127.71 33.62 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.707 -1.22 . . . . 37.770000000000003 107.707 176.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1033 ' ' VAL . . . . . . . . . . . . . 94.8 t -109.7 123.58 65.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 104.639 -2.356 . . . . 33.539999999999999 104.639 -177.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -120.1 113.12 20.01 Favored 'General case' 0 C--O 1.249 1.032 0 N-CA-C 105.966 -1.864 . . . . 31.68 105.966 175.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1035 ' ' VAL . . . . . . . . . . . . . 17.3 t -94.34 144.3 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 O-C-N 121.553 -0.717 . . . . 31.52 109.282 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1036 ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -61.44 140.63 58.02 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 123.392 1.568 . . . . 41.039999999999999 111.329 170.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1037 ' ' SER . . . . . . . . . . . . . 1.4 t -61.49 126.75 28.48 Favored 'General case' 0 N--CA 1.44 -0.951 0 O-C-N 120.187 -1.571 . . . . 31.829999999999998 114.201 171.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 83.95 9.96 81.68 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 113.976 -1.465 . . . . 29.359999999999999 112.032 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -79.04 -41.05 29.76 Favored 'General case' 0 C--N 1.347 0.462 0 O-C-N 121.058 -1.26 . . . . 27.780000000000001 110.049 -176.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -52.48 -39.21 52.48 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 122.82 1.233 . . . . 28.91 113.73 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 73.1 tp60 -46.44 -55.63 7.15 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.055 -1.072 . . . . 51.18 113.318 170.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1042 ' ' LEU . . . . . . . . . . . . . 27.0 mt -72.35 -42.28 65.49 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 120.727 -1.233 . . . . 29.91 111.213 175.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1043 ' ' ALA . . . . . . . . . . . . . . . -54.9 -22.5 15.02 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.567 0.699 . . . . 28.539999999999999 112.35 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1044 ' ' SER . . . . . . . . . . . . . 67.4 m 63.53 42.28 6.69 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 124.746 2.212 . . . . 33.060000000000002 108.628 174.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1045 ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -172.31 92.15 0.12 Allowed 'General case' 0 N--CA 1.441 -0.914 1 N-CA-C 97.761 -4.903 . . . . 30.289999999999999 97.761 178.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 1046 ' ' ASP . . . . . 0.443 ' CG ' ' HZ1' ' A' 1048 ' ' LYS . 0.0 OUTLIER -77.67 171.27 15.19 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-N 111.402 -2.635 . . . . 48.619999999999997 116.585 -147.425 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -56.77 -42.07 78.74 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 113.776 -1.556 . . . . 36.740000000000002 113.085 -176.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1048 ' ' LYS . . . . . 0.443 ' HZ1' ' CG ' ' A' 1046 ' ' ASP . 21.7 pttm -69.9 -25.73 63.83 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.543 1.519 . . . . 43.729999999999997 113.661 176.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -71.07 -37.35 72.48 Favored 'General case' 0 CA--C 1.498 -1.04 0 O-C-N 119.862 -1.774 . . . . 32.810000000000002 109.801 170.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1050 ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -57.82 -42.22 83.86 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 120.429 1.468 . . . . 31.859999999999999 112.735 167.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 21.8 t -61.28 -44.9 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 114.578 -1.192 . . . . 33.219999999999999 113.081 174.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -58.17 -37.56 74.95 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.568 0.699 . . . . 50.829999999999998 112.718 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -59.46 -46.35 89.02 Favored 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 121.62 -0.675 . . . . 33.119999999999997 110.062 173.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 128.14 9.48 3.75 Favored Glycine 0 C--N 1.349 1.26 0 C-N-CA 118.905 -1.616 . . . . 35.829999999999998 112.188 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -73.49 146.72 44.69 Favored 'General case' 0 N--CA 1.436 -1.169 0 O-C-N 121.975 -0.72 . . . . 34.82 111.151 -177.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -77.52 136.79 38.35 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 101.932 -3.359 . . . . 49.049999999999997 101.932 171.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1057 ' ' ILE . . . . . . . . . . . . . 25.7 mm -102.46 134.68 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 N-CA-C 107.063 -1.458 . . . . 38.530000000000001 107.063 172.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1058 ' ' VAL . . . . . . . . . . . . . 3.1 m -129.41 143.25 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-O 123.354 1.549 . . . . 42.109999999999999 109.444 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -106.21 128.53 54.01 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 113.452 -1.704 . . . . 58.0 108.379 -165.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 66.49 -138.93 36.56 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-O 123.379 1.544 . . . . 52.119999999999997 114.019 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 8.2 t30 -64.21 -18.94 64.99 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 113.359 -1.42 . . . . 54.75 111.976 -170.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1062 ' ' SER . . . . . . . . . . . . . 49.9 m -63.05 -8.63 7.85 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 116.743 2.127 . . . . 50.340000000000003 116.743 176.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 9.7 p -72.52 -38.13 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-O 121.921 0.867 . . . . 41.460000000000001 110.347 167.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1064 ' ' TRP . . . . . . . . . . . . . 86.1 m95 -73.07 -20.21 61.01 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.013 0.925 . . . . 39.32 110.389 174.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1065 ' ' GLN . . . . . 0.443 ' NE2' HD22 ' A' 1084 ' ' ASN . 92.3 mm-40 -77.21 64.57 2.65 Favored 'General case' 0 C--O 1.224 -0.272 0 O-C-N 120.31 -1.494 . . . . 55.380000000000003 111.36 171.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1066 ' ' SER . . . . . . . . . . . . . 47.8 m -152.17 129.06 10.95 Favored 'General case' 0 N--CA 1.444 -0.734 0 O-C-N 120.69 -1.256 . . . . 41.869999999999997 108.054 -174.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -74.54 4.49 6.01 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 120.093 3.368 . . . . 53.200000000000003 120.093 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.41 134.76 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 104.135 -2.543 . . . . 41.899999999999999 104.135 158.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1069 ' ' ILE . . . . . . . . . . . . . 34.9 mm -128.08 132.95 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 104.677 -2.342 . . . . 38.729999999999997 104.677 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1070 ' ' LEU . . . . . . . . . . . . . 19.8 mt -108.13 79.15 1.23 Allowed 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 125.385 2.517 . . . . 32.439999999999998 112.164 172.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1071 ' ' LYS . . . . . 0.5 ' HZ2' ' CD ' ' A' 1079 ' ' GLU . 8.7 mmmt -65.67 127.55 32.38 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 113.302 -1.772 . . . . 34.649999999999999 111.005 169.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1072 ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -92.23 -14.32 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 CA-C-N 114.131 -1.395 . . . . 31.32 110.623 -160.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 46.9 t30 -149.42 178.23 8.99 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 107.842 -1.17 . . . . 33.939999999999998 107.842 173.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -38.8 146.57 0.31 Allowed Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 127.547 2.339 . . . . 38.039999999999999 116.026 172.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1075 ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -80.8 157.6 21.19 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.932 3.088 . . . . 42.68 119.122 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 42.5 mt -107.77 161.27 15.04 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 105.133 -2.173 . . . . 46.740000000000002 105.133 162.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 25.5 t0 -70.27 -21.9 62.92 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.539 -0.726 . . . . 58.609999999999999 110.758 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 21.8 t0 -54.12 -56.39 18.52 Favored 'General case' 0 C--N 1.344 0.359 0 N-CA-C 108.134 -1.061 . . . . 59.200000000000003 108.134 162.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1079 ' ' GLU . . . . . 0.5 ' CD ' ' HZ2' ' A' 1071 ' ' LYS . 33.0 mt-10 -66.67 -31.22 71.75 Favored 'General case' 0 CA--C 1.501 -0.927 0 O-C-N 121.616 -0.677 . . . . 50.630000000000003 110.543 -174.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1080 ' ' ILE . . . . . . . . . . . . . 82.8 mt -68.25 -31.56 52.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 O-C-N 120.996 -1.065 . . . . 51.479999999999997 111.704 176.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -70.61 -43.24 69.74 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 118.689 -2.507 . . . . 50.280000000000001 110.707 171.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 8.0 mp -69.07 -23.94 64.1 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 114.101 1.148 . . . . 50.210000000000001 114.101 177.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1083 ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.49 116.37 8.15 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 105.41 -2.07 . . . . 49.060000000000002 105.41 175.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1084 ' ' ASN . . . . . 0.443 HD22 ' NE2' ' A' 1065 ' ' GLN . 13.1 m-80 -75.09 150.64 85.74 Favored Pre-proline 0 N--CA 1.432 -1.325 0 CA-C-O 118.561 -0.733 . . . . 51.079999999999998 110.908 171.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -55.91 165.9 3.43 Favored 'Trans proline' 0 C--O 1.249 1.053 0 C-N-CA 123.99 3.127 . . . . 49.729999999999997 113.853 167.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 81.78 -28.38 3.2 Favored Glycine 0 C--N 1.338 0.671 0 O-C-N 120.489 -1.382 . . . . 47.710000000000001 114.052 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1087 ' ' THR . . . . . . . . . . . . . 13.9 m -51.09 129.74 24.64 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 117.654 2.464 . . . . 45.469999999999999 117.654 -174.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1088 ' ' THR . . . . . . . . . . . . . 30.0 m -79.6 90.39 5.14 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 106.713 -1.588 . . . . 42.039999999999999 106.713 161.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1089 ' ' LEU . . . . . . . . . . . . . 63.5 tp -79.85 80.74 6.21 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 105.451 -2.055 . . . . 38.060000000000002 105.451 -174.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 36.2 t -81.44 104.67 10.33 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 N-CA-C 101.964 -3.347 . . . . 37.399999999999999 101.964 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1091 ' ' SER . . . . . . . . . . . . . 60.5 m -155.05 164.76 38.42 Favored 'General case' 0 C--O 1.251 1.145 0 O-C-N 119.816 -1.803 . . . . 36.159999999999997 113.769 -167.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 17.0 t80 -92.11 90.75 7.48 Favored 'General case' 0 C--O 1.246 0.915 0 O-C-N 120.111 -1.618 . . . . 38.939999999999998 107.432 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 30.9 mm -95.15 -30.37 4.1 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 N-CA-C 113.006 0.743 . . . . 42.170000000000002 113.006 -160.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 90.7 m95 56.93 74.09 0.72 Allowed Pre-proline 0 C--O 1.236 0.346 0 C-N-CA 125.635 1.574 . . . . 46.509999999999998 111.89 -171.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -62.51 -56.24 0.71 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 123.536 2.824 . . . . 49.759999999999998 115.815 -167.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -70.34 -11.79 61.14 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 118.138 -2.851 . . . . 52.619999999999997 113.514 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -86.53 -32.11 20.9 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 105.938 -1.875 . . . . 60.740000000000002 105.938 176.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1098 ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -119.83 55.96 3.77 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 117.178 2.288 . . . . 58.189999999999998 117.178 -177.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.41 -42.77 31.89 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.767 2.978 . . . . 54.590000000000003 114.647 -174.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -60.77 -46.47 90.36 Favored 'General case' 0 C--O 1.251 1.171 0 O-C-N 119.943 -1.723 . . . . 63.280000000000001 111.918 174.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1101 ' ' LEU . . . . . . . . . . . . . 20.6 mt -61.7 -33.37 73.9 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.602 -1.181 . . . . 54.75 111.24 176.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1102 ' ' MET . . . . . . . . . . . . . 46.4 mmm -61.58 -48.39 81.17 Favored 'General case' 0 C--O 1.245 0.861 0 O-C-N 121.662 -0.649 . . . . 52.649999999999999 111.657 175.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -60.3 -39.61 87.58 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.318 -0.856 . . . . 66.260000000000005 108.917 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 88.4 mttt -64.61 -32.51 74.2 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 118.865 0.757 . . . . 63.729999999999997 112.006 174.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 34.2 mt -76.15 -26.85 56.7 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 120.308 -1.495 . . . . 54.68 111.877 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -64.48 -47.65 78.16 Favored 'General case' 0 C--O 1.245 0.858 0 O-C-N 120.713 -1.242 . . . . 53.640000000000001 111.705 168.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -56.05 -33.69 65.21 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.397 -1.729 . . . . 67.239999999999995 114.163 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -60.5 -24.79 65.58 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 117.276 2.324 . . . . 65.760000000000005 117.276 170.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 3.7 t30 56.91 67.83 0.94 Allowed 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 123.445 1.593 . . . . 58.710000000000001 111.972 -165.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1110 ' ' VAL . . . . . . . . . . . . . 17.0 m -133.28 151.69 34.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 113.89 -1.505 . . . . 46.630000000000003 108.299 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1111 ' ' THR . . . . . . . . . . . . . 94.8 m -91.55 93.38 8.93 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 123.027 1.394 . . . . 44.130000000000003 110.61 171.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1112 ' ' VAL . . . . . . . . . . . . . 41.3 t -83.55 108.44 16.08 Favored 'Isoleucine or valine' 0 C--O 1.252 1.21 0 O-C-N 119.774 -1.829 . . . . 40.439999999999998 109.806 -178.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1113 ' ' MET . . . . . . . . . . . . . 22.8 mtp -100.97 93.07 5.32 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 111.59 -2.55 . . . . 50.759999999999998 109.122 173.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1114 ' ' ALA . . . . . . . . . . . . . . . -85.51 118.39 25.01 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 119.185 -1.006 . . . . 35.640000000000001 109.324 -173.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1115 ' ' MET . . . . . . . . . . . . . 79.5 mmm -66.04 -29.39 69.74 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 115.611 1.708 . . . . 38.740000000000002 115.611 -175.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.62 -44.48 69.53 Favored 'General case' 0 C--O 1.25 1.093 0 CA-C-O 121.682 0.753 . . . . 40.140000000000001 111.475 165.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1117 ' ' SER . . . . . . . . . . . . . 74.0 m -75.11 14.08 0.6 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 119.487 3.143 . . . . 44.789999999999999 119.487 -176.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1118 ' ' VAL . . . . . . . . . . . . . 13.6 t -72.77 133.67 82.12 Favored Pre-proline 0 C--O 1.215 -0.751 0 O-C-N 118.432 -2.668 . . . . 43.75 107.057 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -60.65 152.24 70.37 Favored 'Trans proline' 0 N--CA 1.443 -1.455 1 C-N-CA 125.785 4.323 . . . . 48.93 115.451 173.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -70.1 12.88 0.19 Allowed 'General case' 0 C--O 1.255 1.39 0 N-CA-C 121.027 3.714 . . . . 62.899999999999999 121.027 -173.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 10.5 pt -86.2 169.35 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 O-C-N 119.088 -2.257 . . . . 57.719999999999999 112.951 -170.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1122 ' ' SER . . . . . . . . . . . . . 69.7 m -63.37 -46.19 87.66 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 124.398 1.079 . . . . 57.259999999999998 113.721 -173.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -59.24 -36.11 74.88 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 122.922 2.601 . . . . 62.899999999999999 112.128 175.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -71.16 -23.63 62.09 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 125.012 1.445 . . . . 49.829999999999998 111.904 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -56.28 -23.69 38.16 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 118.241 2.682 . . . . 52.369999999999997 118.241 -171.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1126 ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.83 -35.12 57.77 Favored 'General case' 0 C--O 1.252 1.198 0 N-CA-C 116.463 2.023 . . . . 42.43 116.463 169.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1127 ' ' LEU . . . . . . . . . . . . . 4.5 mp -78.63 -35.82 44.93 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 113.3 -1.773 . . . . 43.740000000000002 111.504 177.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 13.3 t70 -73.64 123.04 23.27 Favored 'General case' 0 C--O 1.246 0.892 0 O-C-N 120.244 -1.535 . . . . 43.210000000000001 114.764 -165.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -75.39 -27.59 59.15 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 114.231 1.197 . . . . 35.740000000000002 114.231 175.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 69.1 mt -67.19 -11.86 58.49 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 118.679 0.672 . . . . 38.090000000000003 112.524 170.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1131 ' ' SER . . . . . . . . . . . . . 6.4 m -73.86 -77.13 0.11 Allowed 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.274 -0.639 . . . . 36.909999999999997 109.274 153.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1132 ' ' SER . . . . . . . . . . . . . 8.3 m -58.24 -55.71 31.52 Favored 'General case' 0 C--N 1.347 0.491 0 O-C-N 120.899 -1.125 . . . . 35.789999999999999 113.278 -162.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1133 ' ' MET . . . . . . . . . . . . . 18.3 mtp -62.97 -34.75 78.19 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 113.067 0.766 . . . . 30.809999999999999 113.067 -177.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1134 ' ' ALA . . . . . . . . . . . . . . . -66.75 -40.79 88.41 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.536 0.607 . . . . 28.879999999999999 109.506 174.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1135 ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -57.32 -45.04 84.64 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 117.882 -1.056 . . . . 40.759999999999998 111.204 171.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1136 ' ' ILE . . . . . . . . . . . . . 83.7 mt -56.46 -44.63 80.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-O 122.51 1.147 . . . . 31.539999999999999 110.767 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -60.62 -49.2 78.49 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 112.669 -2.06 . . . . 29.870000000000001 112.15 175.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -57.44 -46.78 91.54 Favored Glycine 0 N--CA 1.468 0.819 0 O-C-N 120.806 -1.184 . . . . 28.73 111.393 -177.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 18.4 t80 -65.01 -49.29 70.78 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 118.821 -0.609 . . . . 30.390000000000001 110.391 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1140 ' ' ARG . . . . . 0.462 HH21 ' CD ' ' A' 1144 ' ' GLU . 5.7 tpt180 -70.69 -19.26 62.79 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 117.155 -1.818 . . . . 26.09 111.951 -175.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1141 ' ' ALA . . . . . . . . . . . . . . . -69.76 -45.55 67.83 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 106.957 -1.497 . . . . 27.100000000000001 106.957 176.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 28.5 mm -50.45 -44.82 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 C-N-CA 123.588 0.755 . . . . 28.48 111.929 169.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 58.6 t -62.31 -58.94 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 112.797 0.665 . . . . 23.07 112.797 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1144 ' ' GLU . . . . . 0.462 ' CD ' HH21 ' A' 1140 ' ' ARG . 6.0 mm-40 -63.85 -31.51 72.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.839 0.828 . . . . 33.399999999999999 112.562 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -56.88 -54.5 45.85 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 115.859 -2.019 . . . . 24.219999999999999 111.554 164.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -58.4 -22.91 55.69 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 116.019 1.859 . . . . 24.890000000000001 116.019 174.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -70.0 -54.23 14.13 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 105.827 -1.916 . . . . 26.73 105.827 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1148 ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -97.49 21.6 10.0 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 116.955 2.205 . . . . 39.960000000000001 116.955 176.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1149 ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -71.92 136.49 46.89 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 106.938 -1.504 . . . . 25.870000000000001 106.938 177.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1150 ' ' GLY . . . . . . . . . . . . . . . -74.66 -52.75 6.99 Favored Glycine 0 CA--C 1.502 -0.73 0 O-C-N 127.262 2.851 . . . . 19.280000000000001 109.916 170.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1151 ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -101.17 -164.93 1.15 Allowed 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 120.8 -1.412 . . . . 39.899999999999999 113.768 -170.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1152 ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -107.23 141.21 38.9 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 120.466 -1.396 . . . . 29.440000000000001 109.129 -170.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1153 ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -65.22 -58.67 5.39 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 117.804 -3.06 . . . . 32.600000000000001 110.181 169.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1154 ' ' THR . . . . . . . . . . . . . 3.0 m -71.75 116.54 12.24 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 124.412 1.07 . . . . 34.640000000000001 111.234 -172.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -64.39 96.03 0.19 Allowed Glycine 0 CA--C 1.547 2.04 0 N-CA-C 106.253 -2.739 . . . . 37.140000000000001 106.253 165.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -136.1 -158.28 0.86 Allowed 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 118.935 -0.555 . . . . 40.57 112.191 -175.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1157 ' ' ILE . . . . . . . . . . . . . 3.3 tp -155.41 125.68 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 O-C-N 119.615 -1.928 . . . . 44.609999999999999 110.22 -159.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1158 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.74 -160.76 1.18 Allowed 'General case' 0 C--O 1.253 1.245 0 N-CA-C 105.436 -2.061 . . . . 40.700000000000003 105.436 176.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -48.29 -31.97 6.71 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 119.138 -2.226 . . . . 40.25 116.774 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -64.58 -11.65 36.94 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-O 117.929 -1.034 . . . . 38.469999999999999 113.335 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . 76.8 -117.48 4.91 Favored Glycine 0 N--CA 1.432 -1.617 0 N-CA-C 107.771 -2.132 . . . . 37.609999999999999 107.771 -171.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1162 ' ' LYS . . . . . 0.477 ' HZ3' ' CD ' ' C' ' 95' ' ' GLU . 7.1 tttp -67.89 108.2 2.93 Favored 'General case' 0 CA--C 1.482 -1.672 0 N-CA-C 107.306 -1.368 . . . . 48.899999999999999 107.306 171.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1163 ' ' VAL . . . . . . . . . . . . . 38.8 t -82.13 106.17 5.9 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 102.843 -3.021 . . . . 36.520000000000003 102.843 163.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1164 ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -65.38 122.21 9.85 Favored 'Trans proline' 0 N--CA 1.443 -1.443 0 C-N-CA 124.504 3.47 . . . . 35.079999999999998 116.688 -171.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1165 ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -68.14 156.17 66.78 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 N-CA-C 118.454 2.444 . . . . 35.329999999999998 118.454 -177.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -62.92 122.68 16.59 Favored 'General case' 0 N--CA 1.417 -2.098 0 CA-C-N 113.448 -1.705 . . . . 34.689999999999998 112.779 169.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1167 ' ' LYS . . . . . . . . . . . . . 99.0 mttt -93.84 114.35 26.58 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 104.974 -2.232 . . . . 45.359999999999999 104.974 164.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 59.8 t -99.89 134.53 39.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 103.967 -2.605 . . . . 31.710000000000001 103.967 -173.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1169 ' ' MET . . . . . . . . . . . . . 46.2 ttp -118.64 105.95 12.11 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 106.416 -1.698 . . . . 42.280000000000001 106.416 168.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 38.2 t -78.29 126.4 38.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 107.788 -1.19 . . . . 30.510000000000002 107.788 168.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 61.8 mt -112.41 126.16 69.77 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 108.787 -0.82 . . . . 31.870000000000001 108.787 171.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 79.6 79.65 0.82 Allowed Glycine 0 CA--C 1.536 1.346 0 N-CA-C 108.65 -1.78 . . . . 34.539999999999999 108.65 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1173 ' ' ALA . . . . . . . . . . . . . . . -85.87 89.43 7.77 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 125.568 2.604 . . . . 32.509999999999998 110.109 -172.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -113.35 -147.82 9.98 Favored Glycine 0 C--O 1.246 0.906 0 CA-C-N 110.788 -2.915 . . . . 29.899999999999999 108.882 174.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1175 ' ' VAL . . . . . . . . . . . . . 2.7 t -75.57 -37.35 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 119.261 1.531 . . . . 33.109999999999999 109.706 -175.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -55.77 -39.87 71.81 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 120.917 -1.115 . . . . 28.100000000000001 112.139 165.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -57.35 -49.4 73.06 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-O 118.738 -1.035 . . . . 28.539999999999999 110.572 174.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1178 ' ' LEU . . . . . . . . . . . . . 53.3 mt -56.37 -47.1 79.58 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 117.987 0.894 . . . . 31.219999999999999 110.588 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -57.28 -46.75 82.81 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 114.085 1.142 . . . . 28.98 114.085 177.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -64.02 -41.65 97.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.284 -0.871 . . . . 27.829999999999998 111.026 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1181 ' ' ILE . . . . . . . . . . . . . 92.2 mt -63.86 -46.23 94.84 Favored 'Isoleucine or valine' 0 C--N 1.361 1.085 0 CA-C-O 119.75 -0.167 . . . . 30.25 110.717 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -58.8 -54.54 37.1 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 108.64 -1.784 . . . . 29.59 108.64 -177.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -51.94 -56.1 16.25 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 118.115 0.958 . . . . 30.289999999999999 113.309 176.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -63.51 -44.49 94.15 Favored 'General case' 0 C--O 1.254 1.3 0 N-CA-C 115.274 1.583 . . . . 30.469999999999999 115.274 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -60.21 -53.25 59.93 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 124.624 1.17 . . . . 42.409999999999997 109.284 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1186 ' ' SER . . . . . . . . . . . . . 85.2 p -57.5 -40.67 79.17 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 120.557 1.526 . . . . 39.380000000000003 115.032 175.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 5.6 mt -60.6 -21.57 62.8 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 114.71 1.374 . . . . 36.18 114.71 169.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 93.96 32.75 7.35 Favored Glycine 0 C--O 1.24 0.477 0 CA-C-O 123.085 1.38 . . . . 33.780000000000001 110.905 170.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -96.35 168.94 10.26 Favored 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 121.78 -0.836 . . . . 33.93 109.393 176.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 8.4 mt -93.9 109.11 21.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 102.511 -3.144 . . . . 38.740000000000002 102.511 -176.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 5.8 t -97.74 131.81 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 118.831 -1.148 . . . . 33.090000000000003 109.769 -170.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1192 ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -123.76 151.21 43.51 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 104.054 -2.573 . . . . 38.920000000000002 104.054 175.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -143.59 147.91 35.1 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 108.382 -0.97 . . . . 35.32 108.382 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 5.9 t80 -133.18 132.63 41.8 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.006 -1.85 . . . . 39.350000000000001 106.006 -178.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 9.0 t0 -156.74 154.5 30.09 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 105.526 -2.027 . . . . 40.460000000000001 105.526 170.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1196 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.28 -40.78 81.72 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 120.138 -0.625 . . . . 45.939999999999998 109.88 175.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1197 ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -71.61 112.15 12.97 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 124.235 1.014 . . . . 56.020000000000003 113.516 -168.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1198 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -60.87 -14.78 34.32 Favored 'Trans proline' 0 C--N 1.325 -0.69 0 C-N-CA 124.775 3.65 . . . . 51.270000000000003 116.411 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -69.97 -58.96 3.23 Favored 'General case' 0 C--N 1.356 0.859 0 O-C-N 120.231 -1.543 . . . . 59.100000000000001 111.561 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 17.5 m -53.29 -25.02 9.38 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.897 0 N-CA-C 113.262 0.838 . . . . 51.060000000000002 113.262 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 86.4 tttt -41.14 -38.3 1.05 Allowed 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 126.593 1.957 . . . . 57.380000000000003 114.863 169.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -66.45 -57.93 6.33 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 115.792 -2.051 . . . . 62.409999999999997 111.915 172.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -57.18 -28.62 62.98 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 123.924 3.056 . . . . 57.780000000000001 116.309 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 49.8 t -58.5 -60.51 2.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 O-C-N 121.555 -0.716 . . . . 46.380000000000003 109.924 168.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -69.92 -49.18 54.53 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 105.958 -1.867 . . . . 50.700000000000003 105.958 -170.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1206 ' ' SER . . . . . . . . . . . . . 45.8 m -45.75 -46.83 15.36 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.689 1.737 . . . . 49.979999999999997 115.689 169.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1207 ' ' MET . . . . . . . . . . . . . 18.2 mtp -73.21 -11.22 60.44 Favored 'General case' 0 CA--C 1.504 -0.79 0 O-C-N 119.024 -2.298 . . . . 52.990000000000002 113.06 175.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 105.27 64.95 0.66 Allowed Glycine 0 N--CA 1.439 -1.136 0 N-CA-C 109.931 -1.268 . . . . 47.659999999999997 109.931 166.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -152.81 144.52 23.53 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.099 -1.05 . . . . 44.770000000000003 110.147 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -75.49 133.19 41.11 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 105.738 -1.949 . . . . 47.640000000000001 105.738 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1211 ' ' PHE . . . . . . . . . . . . . 35.1 t80 -99.22 105.93 18.02 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 117.075 -1.85 . . . . 45.659999999999997 108.974 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 55.6 mt -67.13 111.31 3.84 Favored 'General case' 0 C--O 1.252 1.229 0 CA-C-O 123.405 1.574 . . . . 46.060000000000002 109.9 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -79.18 165.37 23.37 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 113.379 -1.737 . . . . 60.219999999999999 115.318 174.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 8.4 mp -72.25 104.99 3.85 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-N 112.827 -1.988 . . . . 57.25 107.241 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 23.4 t70 -74.13 99.02 3.26 Favored 'General case' 0 CA--C 1.497 -1.071 0 O-C-N 118.416 -2.678 . . . . 64.430000000000007 106.617 166.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 14.5 t80 . . . . . 0 CA--C 1.54 0.558 0 CA-C-N 111.055 -2.793 . . . . 66.900000000000006 108.203 175.518 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 N--CA 1.425 -1.678 0 CA-C-O 121.843 0.83 . . . . 39.090000000000003 109.865 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -65.57 -29.38 75.03 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 126.927 2.203 . . . . 39.32 111.123 -169.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.7 -53.25 9.62 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 118.995 1.398 . . . . 39.299999999999997 107.546 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -55.6 -41.63 73.69 Favored 'General case' 0 C--O 1.211 -0.936 0 N-CA-C 113.358 0.873 . . . . 36.299999999999997 113.358 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -51.21 -64.77 0.7 Allowed 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 114.093 1.145 . . . . 37.380000000000003 114.093 162.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -63.62 -24.03 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 116.731 2.123 . . . . 39.109999999999999 116.731 -171.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1230 ' ' MET . . . . . . . . . . . . . 33.7 mmt -79.91 -23.57 41.7 Favored 'General case' 0 C--O 1.241 0.644 0 O-C-N 120.964 -1.085 . . . . 49.590000000000003 112.522 178.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1231 ' ' SER . . . . . . . . . . . . . 12.6 p -89.47 137.88 31.94 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 120.484 3.512 . . . . 43.68 120.484 -163.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -41.4 -45.58 3.14 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 117.457 2.392 . . . . 55.57 117.457 -174.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -73.01 -32.98 65.48 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 120.317 -1.489 . . . . 44.939999999999998 114.432 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -64.44 -53.9 41.03 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 106.804 -1.554 . . . . 42.039999999999999 106.804 172.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 35.9 mt -56.47 -27.5 24.93 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 N-CA-C 114.905 1.446 . . . . 46.280000000000001 114.905 173.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -59.08 -56.11 26.46 Favored 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 121.221 -0.924 . . . . 47.869999999999997 111.585 170.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -59.91 -52.92 63.35 Favored 'General case' 0 CA--C 1.496 -1.096 0 O-C-N 127.028 2.705 . . . . 41.609999999999999 111.339 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -48.68 -48.21 40.19 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 123.851 0.861 . . . . 50.649999999999999 112.316 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1239 ' ' MET . . . . . . . . . . . . . 28.4 ttm -55.02 -44.04 74.24 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 124.583 1.177 . . . . 48.869999999999997 109.149 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -72.07 -30.33 65.02 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.337 -0.945 . . . . 54.799999999999997 113.493 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.9 -43.54 98.36 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 118.833 -1.147 . . . . 43.210000000000001 113.824 169.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -62.15 -43.61 98.45 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.552 1.158 . . . . 38.659999999999997 109.37 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -57.15 -52.95 63.24 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.605 0.595 . . . . 37.920000000000002 112.605 171.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -54.35 -29.54 48.6 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 114.046 1.128 . . . . 37.280000000000001 114.046 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -85.31 -40.02 17.02 Favored 'General case' 0 C--N 1.315 -0.902 0 O-C-N 123.736 0.647 . . . . 43.07 110.588 174.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -66.49 -15.5 63.42 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 116.742 2.127 . . . . 38.299999999999997 116.742 -158.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1247 ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -87.05 -18.46 30.52 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 113.391 -1.731 . . . . 47.600000000000001 113.792 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -105.33 -45.53 4.45 Favored 'General case' 0 C--N 1.358 0.968 0 O-C-N 120.435 -1.415 . . . . 45.420000000000002 112.839 165.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1249 ' ' VAL . . . . . . . . . . . . . 31.4 m -64.67 148.14 12.07 Favored 'Isoleucine or valine' 0 C--N 1.345 0.382 0 CA-C-O 123.221 1.486 . . . . 36.259999999999998 114.256 -175.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1250 ' ' ASP . . . . . 0.505 ' CG ' ' HZ3' ' A' 1276 ' ' LYS . 3.8 m-20 -91.37 -71.97 0.61 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.718 1.247 . . . . 33.039999999999999 111.036 -176.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1251 ' ' ILE . . . . . . . . . . . . . 37.4 mm -97.68 101.29 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.946 0 C-N-CA 117.462 -1.695 . . . . 31.399999999999999 107.776 -171.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1252 ' ' ILE . . . . . . . . . . . . . 68.0 mt -77.09 94.15 1.25 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 106.563 -1.643 . . . . 29.420000000000002 106.563 166.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 2.0 t -81.3 98.61 4.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 104.5 -2.408 . . . . 30.370000000000001 104.5 175.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1254 ' ' THR . . . . . . . . . . . . . 22.3 m -86.76 82.16 7.94 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 124.587 2.137 . . . . 35.719999999999999 105.914 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1255 ' ' THR . . . . . . . . . . . . . 1.9 p -73.8 5.11 4.34 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 120.067 3.358 . . . . 36.0 120.067 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1256 ' ' ALA . . . . . . . . . . . . . . . -85.64 63.03 7.83 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 124.105 1.907 . . . . 40.93 112.76 -170.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 57.1 tp -70.6 91.72 0.81 Allowed 'General case' 0 C--N 1.353 0.733 0 N-CA-C 103.546 -2.761 . . . . 47.82 103.546 172.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 39.5 mm -87.08 108.15 17.63 Favored Pre-proline 0 C--O 1.22 -0.489 0 N-CA-C 104.14 -2.541 . . . . 52.700000000000003 104.14 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -56.63 109.52 0.46 Allowed 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 124.398 3.399 . . . . 54.130000000000003 116.34 -170.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 78.34 16.32 79.69 Favored Glycine 0 N--CA 1.461 0.343 0 CA-C-N 112.025 -2.352 . . . . 54.619999999999997 111.945 174.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 92.1 mttt -125.78 141.72 40.11 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 119.628 1.714 . . . . 55.740000000000002 109.022 -176.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -66.46 97.85 0.38 Allowed 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 123.299 2.666 . . . . 51.149999999999999 107.031 172.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -56.58 125.02 65.8 Favored Pre-proline 0 N--CA 1.433 -1.294 0 CA-C-O 117.375 -1.298 . . . . 46.060000000000002 112.519 176.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -50.15 128.39 22.35 Favored 'Trans proline' 0 C--O 1.25 1.09 1 C-N-CA 126.622 4.881 . . . . 41.079999999999998 112.645 -166.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -61.7 97.06 0.07 Allowed 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.933 -1.03 . . . . 47.420000000000002 110.408 172.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 83.4 mt -94.77 -54.54 3.44 Favored 'General case' 0 N--CA 1.434 -1.23 0 O-C-N 120.693 -1.254 . . . . 39.219999999999999 109.68 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 12.3 mt -78.46 104.36 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 107.937 -1.135 . . . . 42.5 107.937 -172.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1268 ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.54 148.56 48.44 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 119.078 2.992 . . . . 37.840000000000003 119.078 175.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 40.6 mtt180 -52.28 -59.45 4.38 Favored 'General case' 0 C--O 1.248 0.996 0 N-CA-C 117.159 2.281 . . . . 54.799999999999997 117.159 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.55 -27.01 68.96 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 118.819 0.736 . . . . 54.359999999999999 111.919 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1271 ' ' MET . . . . . . . . . . . . . 59.5 ttm -68.45 -36.76 79.47 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.986 1.314 . . . . 39.520000000000003 111.704 175.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1272 ' ' VAL . . . . . . . . . . . . . 92.3 t -63.25 -47.94 89.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 N-CA-C 107.503 -1.295 . . . . 38.25 107.503 171.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -57.6 -26.16 61.13 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 113.731 1.012 . . . . 40.770000000000003 113.731 175.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1274 ' ' SER . . . . . . . . . . . . . 5.1 m -85.67 -8.24 58.33 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 121.261 1.846 . . . . 36.579999999999998 114.945 173.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1275 ' ' MET . . . . . . . . . . . . . 87.1 mtp -60.76 165.19 4.11 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 116.521 2.045 . . . . 36.75 116.521 176.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1276 ' ' LYS . . . . . 0.505 ' HZ3' ' CG ' ' A' 1250 ' ' ASP . 35.9 ttpt -67.47 144.47 55.69 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 122.514 1.149 . . . . 46.109999999999999 111.585 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1277 ' ' ALA . . . . . . . . . . . . . . . -60.25 139.89 57.34 Favored 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 124.423 1.089 . . . . 33.520000000000003 109.008 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 76.43 -0.79 63.14 Favored Glycine 0 CA--C 1.538 1.479 0 O-C-N 119.943 -1.723 . . . . 31.27 113.267 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1279 ' ' SER . . . . . . . . . . . . . 47.0 m -74.56 160.53 30.76 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 118.771 -2.605 . . . . 32.950000000000003 109.37 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1280 ' ' VAL . . . . . . . . . . . . . 82.9 t -127.49 135.88 62.05 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 O-C-N 119.776 -1.828 . . . . 27.43 108.38 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1281 ' ' ILE . . . . . . . . . . . . . 83.7 mt -108.62 98.62 7.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 103.193 -2.891 . . . . 30.300000000000001 103.193 169.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -85.42 97.28 5.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.577 -1.268 . . . . 28.629999999999999 107.577 171.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 19.6 t0 -87.83 109.39 19.72 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.019 -1.474 . . . . 36.270000000000003 107.019 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1284 ' ' LEU . . . . . . . . . . . . . 25.4 mt -74.98 -28.96 60.76 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 112.909 -1.95 . . . . 38.57 115.214 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -65.99 -53.18 42.16 Favored 'General case' 0 C--O 1.218 -0.569 0 O-C-N 120.304 -1.497 . . . . 37.560000000000002 110.098 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . 38.02 -74.81 0.0 OUTLIER 'General case' 0 N--CA 1.413 -2.291 0 C-N-CA 128.511 2.724 . . . . 40.329999999999998 116.172 176.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -63.07 -47.32 83.46 Favored 'General case' 0 N--CA 1.482 1.175 0 O-C-N 120.365 -1.46 . . . . 56.850000000000001 109.634 173.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 5.5 m120 -72.83 70.1 0.97 Allowed 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 124.718 1.261 . . . . 45.859999999999999 109.43 175.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 74.26 -58.91 2.36 Favored Glycine 0 CA--C 1.538 1.524 0 N-CA-C 117.657 1.823 . . . . 40.310000000000002 117.657 -176.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 84.35 121.79 0.95 Allowed Glycine 0 C--O 1.22 -0.728 0 N-CA-C 108.835 -1.706 . . . . 38.890000000000001 108.835 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1291 ' ' ASN . . . . . . . . . . . . . 24.4 m120 -76.45 -20.6 56.87 Favored 'General case' 0 CA--C 1.492 -1.281 0 CA-C-N 121.26 2.53 . . . . 37.229999999999997 112.324 -176.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1292 ' ' CYS . . . . . . . . . . . . . 36.9 t -85.44 142.99 28.84 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 120.249 -1.532 . . . . 36.5 109.638 170.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1293 ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -74.36 -13.96 60.81 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 116.218 1.932 . . . . 43.32 116.218 169.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -90.03 -4.25 57.5 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 116.018 1.858 . . . . 41.32 116.018 169.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1295 ' ' THR . . . . . . . . . . . . . 52.5 m -65.96 119.22 10.96 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 119.375 -2.078 . . . . 35.299999999999997 110.971 -175.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 48.4 t -95.53 112.26 58.32 Favored Pre-proline 0 C--O 1.248 1.015 0 N-CA-C 101.575 -3.491 . . . . 34.840000000000003 101.575 171.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -55.86 104.54 0.13 Allowed 'Trans proline' 0 C--O 1.22 -0.408 0 C-N-CA 124.114 3.21 . . . . 33.509999999999998 111.902 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 112.23 9.77 19.22 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 113.561 -1.654 . . . . 32.189999999999998 111.048 172.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -132.89 162.34 31.85 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 121.248 2.524 . . . . 34.880000000000003 116.451 -163.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1300 ' ' ILE . . . . . . . . . . . . . 80.2 mt -90.76 105.82 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 N-CA-C 101.671 -3.455 . . . . 32.289999999999999 101.671 163.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 35.5 t80 -81.9 110.67 17.4 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 104.73 -2.322 . . . . 37.25 104.73 166.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1302 ' ' THR . . . . . . . . . . . . . 54.0 m -93.44 119.07 32.1 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.136 -1.802 . . . . 35.560000000000002 106.136 175.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1303 ' ' THR . . . . . . . . . . . . . 2.1 m -103.18 142.6 33.88 Favored 'General case' 0 C--O 1.247 0.946 0 N-CA-C 107.643 -1.243 . . . . 36.399999999999999 107.643 -173.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -52.4 -42.6 64.17 Favored 'General case' 0 C--O 1.247 0.921 0 C-N-CA 126.285 1.834 . . . . 52.32 113.445 -168.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 38.3 p-10 -61.07 -22.0 64.19 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 115.628 1.714 . . . . 40.039999999999999 115.628 175.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 120.56 0.11 12.37 Favored Glycine 0 N--CA 1.413 -2.891 0 C-N-CA 120.333 -0.937 . . . . 36.960000000000001 111.223 177.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1307 ' ' VAL . . . . . . . . . . . . . 71.0 t -82.53 131.51 33.6 Favored 'Isoleucine or valine' 0 C--N 1.347 0.493 0 O-C-N 118.452 -2.793 . . . . 33.399999999999999 110.147 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1308 ' ' LYS . . . . . . . . . . . . . 26.2 mmtp -99.15 94.91 6.76 Favored 'General case' 0 C--O 1.248 1.0 0 N-CA-C 106.226 -1.768 . . . . 42.909999999999997 106.226 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 24.0 t -76.08 85.88 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.608 0 CA-C-O 122.296 1.046 . . . . 32.289999999999999 109.803 174.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1310 ' ' ILE . . . . . . . . . . . . . 55.0 mt -89.95 95.83 5.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 124.566 2.127 . . . . 30.989999999999998 106.263 -174.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -90.55 71.26 2.06 Favored Glycine 0 N--CA 1.436 -1.364 0 O-C-N 119.515 -1.991 . . . . 28.949999999999999 110.778 171.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1312 ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.65 124.52 35.86 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 119.167 1.483 . . . . 31.690000000000001 111.187 -171.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1313 ' ' THR . . . . . . . . . . . . . 4.5 p -103.71 -21.65 13.67 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 118.862 -1.135 . . . . 34.170000000000002 113.827 -175.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -81.85 24.53 0.61 Allowed 'General case' 0 C--O 1.256 1.432 0 CA-C-O 122.06 0.933 . . . . 36.859999999999999 112.752 -173.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1315 ' ' LEU . . . . . . . . . . . . . 88.3 mt -69.84 -42.52 18.45 Favored Pre-proline 0 N--CA 1.439 -1.012 0 N-CA-C 118.075 2.62 . . . . 34.850000000000001 118.075 -168.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -59.54 -35.58 95.24 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 CA-C-N 123.672 2.347 . . . . 29.149999999999999 113.8 171.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -65.2 -35.72 91.99 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-O 122.165 0.87 . . . . 27.289999999999999 111.413 172.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1318 ' ' ARG . . . . . . . . . . . . . 79.7 mtt-85 -64.38 -3.16 2.68 Favored 'General case' 0 C--O 1.24 0.563 0 O-C-N 120.438 -1.625 . . . . 41.490000000000002 114.697 168.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1319 ' ' LEU . . . . . . . . . . . . . 8.0 tp -143.51 69.53 17.38 Favored Pre-proline 0 N--CA 1.437 -1.114 0 O-C-N 118.487 -2.633 . . . . 27.609999999999999 111.018 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1320 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -53.88 -62.72 0.28 Allowed 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 124.948 3.765 . . . . 25.940000000000001 116.451 -169.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1321 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.4 -22.95 62.17 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 121.361 1.891 . . . . 25.010000000000002 111.407 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1322 ' ' GLN . . . . . . . . . . . . . 29.7 tp60 -75.18 -37.57 61.17 Favored 'General case' 0 C--O 1.217 -0.617 0 O-C-N 120.192 -1.568 . . . . 29.390000000000001 109.088 176.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1323 ' ' SER . . . . . . . . . . . . . 73.6 m -60.4 -66.54 0.51 Allowed 'General case' 0 C--O 1.251 1.149 0 CA-C-O 118.185 -0.912 . . . . 26.469999999999999 109.897 166.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1324 ' ' SER . . . . . . . . . . . . . 14.5 m -45.29 -36.36 4.01 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 116.883 2.179 . . . . 27.780000000000001 116.883 177.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -77.88 -64.96 1.03 Allowed 'General case' 0 C--O 1.216 -0.701 0 O-C-N 119.805 -1.809 . . . . 37.530000000000001 114.723 170.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1326 ' ' LEU . . . . . . . . . . . . . 22.1 mt -70.39 -51.39 29.98 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 120.961 1.71 . . . . 35.710000000000001 113.544 -169.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1327 ' ' TYR . . . . . . . . . . . . . 64.4 t80 -66.14 -46.05 78.86 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 106.779 -1.563 . . . . 31.59 106.779 174.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1328 ' ' GLY . . . . . . . . . . . . . . . -40.42 -52.82 3.58 Favored Glycine 0 CA--C 1.541 1.664 0 CA-C-N 119.994 1.27 . . . . 28.0 113.829 166.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1329 ' ' THR . . . . . . . . . . . . . 1.1 m -79.44 -18.28 52.51 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 117.328 -3.454 . . . . 32.149999999999999 108.353 -173.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1330 ' ' ASN . . . . . . . . . . . . . 29.4 m120 -57.91 -53.96 52.26 Favored 'General case' 0 C--O 1.246 0.893 0 O-C-N 118.344 -2.722 . . . . 34.359999999999999 110.487 167.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1331 ' ' LEU . . . . . . . . . . . . . 11.7 mt -57.0 -47.5 80.69 Favored 'General case' 0 C--N 1.353 0.726 0 CA-C-N 113.63 -1.623 . . . . 33.369999999999997 110.388 175.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1332 ' ' VAL . . . . . . . . . . . . . 59.9 t -58.86 -37.53 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 124.884 1.274 . . . . 35.270000000000003 109.98 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -70.59 -41.75 71.94 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-N 121.801 2.091 . . . . 37.659999999999997 112.475 -176.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1334 ' ' LEU . . . . . . . . . . . . . 60.2 tp -58.74 -53.31 59.85 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 121.51 0.671 . . . . 40.270000000000003 109.669 170.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1335 ' ' LEU . . . . . . . . . . . . . 13.5 mt -60.92 -21.11 63.06 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 115.511 1.671 . . . . 42.5 115.511 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1336 ' ' LYS . . . . . . . . . . . . . 96.1 mttt -65.23 -46.83 79.01 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 118.626 0.648 . . . . 47.810000000000002 109.589 168.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1337 ' ' LEU . . . . . . . . . . . . . 36.7 mt -63.67 -41.22 98.21 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 124.03 1.871 . . . . 49.270000000000003 111.569 178.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1338 ' ' LEU . . . . . . . . . . . . . 10.3 mp -59.74 -41.49 91.05 Favored 'General case' 0 C--N 1.355 0.823 0 CA-C-O 122.923 1.344 . . . . 50.539999999999999 112.624 175.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1339 ' ' CYS . . . . . . . . . . . . . 18.1 t -74.93 82.01 2.18 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 123.734 1.731 . . . . 53.670000000000002 111.905 173.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -58.9 -55.23 37.76 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 112.543 -2.117 . . . . 63.380000000000003 113.229 -175.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -115.57 -0.47 13.03 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 115.351 1.611 . . . . 70.950000000000003 115.351 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1342 ' ' LYS . . . . . . . . . . . . . 31.3 mtmm 56.3 66.41 1.2 Allowed 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 118.716 2.858 . . . . 65.25 118.716 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1343 ' ' ASP . . . . . . . . . . . . 0.462 0.0 OUTLIER 87.79 -73.96 0.01 OUTLIER 'General case' 0 C--N 1.359 0.987 3 O-C-N 113.169 -5.957 . . . . 64.530000000000001 120.278 -10.645 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A 1344 ' ' GLY . . . . . . . . . . . . . . . 68.55 46.6 61.53 Favored Glycine 0 C--O 1.257 1.553 0 O-C-N 120.764 -1.21 . . . . 59.719999999999999 115.562 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -78.81 149.33 32.61 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 115.729 1.751 . . . . 64.090000000000003 115.729 176.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1346 ' ' ILE . . . . . . . . . . . . . 2.8 mp -85.04 86.69 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 N-CA-C 100.847 -3.76 . . . . 58.82 100.847 170.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1347 ' ' THR . . . . . . . . . . . . . 9.7 m -93.2 91.94 7.51 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 123.57 1.652 . . . . 54.960000000000001 113.859 172.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1348 ' ' VAL . . . . . . . . . . . . . 10.4 t -88.01 93.15 4.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 101.294 -3.595 . . . . 55.640000000000001 101.294 174.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 21.5 t70 -86.36 133.17 33.81 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-O 123.476 1.608 . . . . 61.450000000000003 107.806 169.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -99.88 -8.95 23.42 Favored 'General case' 0 N--CA 1.442 -0.838 0 O-C-N 119.991 -1.693 . . . . 58.630000000000003 113.127 176.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -73.36 -35.08 65.92 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-N 115.551 -0.75 . . . . 62.060000000000002 112.767 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 7.3 t70 -82.75 125.53 31.37 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.537 -1.283 . . . . 54.07 107.537 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 27.2 m -55.61 -30.79 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 113.53 -1.668 . . . . 50.68 114.088 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1354 ' ' VAL . . . . . . . . . . . . 0.251 6.0 m -71.03 -49.66 47.8 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 C-N-CA 118.955 -1.098 . . . . 47.68 112.374 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1355 ' ' ILE . . . . . . . . . . . . . 72.0 mt -71.36 -37.7 66.25 Favored 'Isoleucine or valine' 0 C--O 1.253 1.241 0 N-CA-C 108.623 -0.881 . . . . 48.490000000000002 108.623 -173.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 46.5 tpt85 -57.36 -33.38 67.73 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 113.56 0.948 . . . . 48.270000000000003 113.56 167.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -65.72 -52.54 37.7 Favored Glycine 0 N--CA 1.436 -1.357 0 C-N-CA 123.52 0.581 . . . . 43.530000000000001 112.486 172.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1358 ' ' VAL . . . . . . . . . . . . . 3.5 t -66.18 -37.93 80.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 107.401 -1.333 . . . . 45.119999999999997 107.401 -175.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1359 ' ' THR . . . . . . . . . . . . . 30.3 m -76.43 87.74 3.19 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 119.869 -1.77 . . . . 42.939999999999998 111.228 -174.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 33.4 m -77.93 -31.43 16.89 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 O-C-N 121.025 -1.047 . . . . 43.259999999999998 110.647 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1361 ' ' ILE . . . . . . . . . . . . . 94.8 mt -128.56 119.62 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 N-CA-C 105.844 -1.91 . . . . 45.659999999999997 105.844 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1362 ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -103.45 120.29 40.53 Favored 'General case' 0 C--N 1.364 1.209 0 CA-C-N 123.445 2.838 . . . . 61.340000000000003 106.365 174.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 36.01 48.5 0.52 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 112.14 -2.3 . . . . 49.759999999999998 115.999 -177.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 89.23 12.73 62.89 Favored Glycine 0 C--O 1.222 -0.603 0 CA-C-O 116.944 -2.031 . . . . 50.0 113.062 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -122.83 127.07 48.56 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 102.322 -3.214 . . . . 56.920000000000002 102.322 172.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1366 ' ' ILE . . . . . . . . . . . . . 43.5 mt -73.75 92.89 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 CA-C-O 123.01 1.386 . . . . 52.780000000000001 109.184 -176.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1367 ' ' THR . . . . . . . . . . . . . 6.9 p -76.55 -5.69 48.74 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 123.55 1.643 . . . . 49.439999999999998 114.609 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 20.1 t90 -60.42 143.56 89.48 Favored Pre-proline 0 N--CA 1.44 -0.931 0 CA-C-O 116.227 -1.844 . . . . 52.380000000000003 110.365 171.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -81.37 -163.88 3.55 Favored 'Cis proline' 0 C--O 1.248 1.005 0 CA-C-N 123.417 2.256 . . . . 46.939999999999998 112.571 -6.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -129.14 158.3 73.32 Favored Pre-proline 0 N--CA 1.428 -1.561 0 CA-C-O 117.188 -1.387 . . . . 45.909999999999997 108.742 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1371 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -47.28 120.83 4.69 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 124.901 3.734 . . . . 46.390000000000001 111.216 170.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -65.66 -41.26 15.17 Favored 'Trans proline' 0 CA--C 1.557 1.64 0 C-N-CA 125.076 3.851 . . . . 46.719999999999999 112.077 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.228 -4.699 0 CA-C-N 121.508 1.958 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 20.2 m80 . . . . . 0 N--CA 1.425 -1.697 0 N-CA-C 105.958 -1.867 . . . . 63.439999999999998 105.958 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -93.94 57.36 2.43 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 119.485 -2.009 . . . . 51.740000000000002 107.449 173.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1000 ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -81.46 118.45 22.72 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 106.792 -1.559 . . . . 54.07 106.792 -167.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 72.78 18.97 79.13 Favored Glycine 0 C--O 1.224 -0.529 0 CA-C-N 114.716 -1.129 . . . . 39.219999999999999 111.927 -168.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1002 ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -100.6 124.93 46.85 Favored 'General case' 0 C--O 1.256 1.419 0 CA-C-N 121.387 2.594 . . . . 38.119999999999997 109.994 169.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1003 ' ' ILE . . . . . . . . . . . . . 51.6 mt -81.41 142.61 13.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 108.942 -3.753 . . . . 29.699999999999999 105.029 171.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -112.44 128.56 8.55 Favored Glycine 0 N--CA 1.436 -1.332 0 N-CA-C 106.217 -2.753 . . . . 27.5 106.217 166.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1005 ' ' ILE . . . . . . . . . . . . . 47.6 mm -105.62 99.71 22.92 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 101.166 -3.642 . . . . 24.829999999999998 101.166 173.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -83.88 166.62 13.14 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.672 2.248 . . . . 27.190000000000001 112.148 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 30.2 ttm105 -77.17 143.61 38.95 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 103.039 -2.949 . . . . 41.460000000000001 103.039 167.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1008 ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -63.9 129.8 41.52 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 116.83 2.159 . . . . 26.93 116.83 169.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 48.5 mmm-85 -83.73 -5.7 59.26 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 110.704 -2.953 . . . . 34.479999999999997 111.339 171.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1010 ' ' LEU . . . . . . . . . . . . . 4.1 tp -60.93 126.16 26.37 Favored 'General case' 0 C--O 1.244 0.792 0 O-C-N 120.805 -1.184 . . . . 44.219999999999999 108.919 168.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1011 ' ' THR . . . . . . . . . . . . . 86.9 m -64.93 116.47 6.41 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-O 122.452 1.12 . . . . 40.740000000000002 108.95 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 21.7 t30 63.15 92.16 0.06 Allowed 'General case' 0 C--N 1.339 0.15 0 CA-C-N 112.308 -2.224 . . . . 44.439999999999998 112.546 -174.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1013 ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -137.88 138.72 39.36 Favored 'General case' 0 N--CA 1.415 -2.217 0 CA-C-N 111.147 -2.752 . . . . 29.870000000000001 104.385 176.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1014 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.38 -5.07 22.07 Favored 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 120.247 -1.533 . . . . 25.260000000000002 111.331 177.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 23.6 mtm180 -88.37 148.05 24.44 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 119.904 1.229 . . . . 29.539999999999999 113.517 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1016 ' ' VAL . . . . . . . . . . . . . 4.4 p -113.94 -173.19 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 105.643 -1.984 . . . . 23.550000000000001 105.643 151.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1017 ' ' ALA . . . . . . . . . . . . . . . -106.37 11.75 30.57 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 121.485 1.948 . . . . 23.59 115.686 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1018 ' ' ALA . . . . . . . . . . . . . . . -149.98 156.16 41.22 Favored 'General case' 0 C--O 1.211 -0.939 0 CA-C-O 123.018 1.389 . . . . 24.93 113.677 -176.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1019 ' ' THR . . . . . . . . . . . . . 26.1 p -135.12 163.48 50.81 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 110.812 -2.904 . . . . 28.09 103.308 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -49.97 -39.25 49.91 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.86 2.374 . . . . 28.789999999999999 113.541 168.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 76.4 tttt -67.9 -44.7 76.38 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 112.535 0.568 . . . . 47.280000000000001 112.535 177.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1022 ' ' THR . . . . . . . . . . . . . 13.7 p -67.99 -29.61 68.66 Favored 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 120.223 -1.548 . . . . 30.120000000000001 111.956 178.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1023 ' ' VAL . . . . . . . . . . . . . 69.1 t -56.55 -53.84 35.97 Favored 'Isoleucine or valine' 0 C--N 1.351 0.637 0 N-CA-C 107.107 -1.442 . . . . 32.240000000000002 107.107 170.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1024 ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -55.96 -39.36 71.66 Favored 'General case' 0 C--O 1.215 -0.732 0 N-CA-C 114.324 1.231 . . . . 49.619999999999997 114.324 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -65.97 -43.26 88.4 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 122.496 1.141 . . . . 44.68 109.869 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 42.6 mt -67.82 -32.17 72.52 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 119.103 -2.248 . . . . 35.710000000000001 114.641 173.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1027 ' ' LEU . . . . . . . . . . . . . 98.1 mt -62.9 -39.91 95.96 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.072 -1.017 . . . . 42.18 110.493 172.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 24.8 mttm -62.17 -47.65 83.56 Favored 'General case' 0 C--O 1.251 1.154 0 N-CA-C 109.21 -0.663 . . . . 48.340000000000003 109.21 172.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1029 ' ' LEU . . . . . . . . . . . . . 79.8 mt -64.84 -4.27 4.24 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 116.972 2.212 . . . . 38.689999999999998 116.972 172.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 88.95 20.95 44.37 Favored Glycine 0 N--CA 1.433 -1.551 0 CA-C-O 122.934 1.296 . . . . 32.280000000000001 114.355 166.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -99.05 143.95 28.75 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 123.163 1.459 . . . . 35.939999999999998 108.212 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1032 ' ' THR . . . . . . . . . . . . . 31.9 m -79.04 117.14 19.81 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 106.532 -1.655 . . . . 33.369999999999997 106.532 164.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1033 ' ' VAL . . . . . . . . . . . . . 2.9 t -91.89 108.62 20.27 Favored 'Isoleucine or valine' 0 C--O 1.262 1.741 0 O-C-N 120.599 -1.313 . . . . 29.98 107.708 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -99.84 140.17 34.44 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 107.376 -1.342 . . . . 28.18 107.376 172.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1035 ' ' VAL . . . . . . . . . . . . . 88.3 t -124.26 145.53 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 103.652 -2.721 . . . . 25.82 103.652 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1036 ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.89 129.75 40.88 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.472 -1.24 . . . . 32.439999999999998 112.585 173.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1037 ' ' SER . . . . . . . . . . . . . 12.7 m -57.16 133.9 55.43 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.239 -1.346 . . . . 29.539999999999999 108.884 172.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 88.88 -43.59 3.09 Favored Glycine 0 CA--C 1.498 -0.98 0 O-C-N 117.424 -3.297 . . . . 27.760000000000002 110.886 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1039 ' ' ALA . . . . . . . . . . . . . . . -37.52 -37.37 0.2 Allowed 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 118.304 2.705 . . . . 26.02 118.304 -175.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -62.99 -31.13 79.62 Favored Glycine 0 N--CA 1.42 -2.411 0 C-N-CA 126.029 1.776 . . . . 26.469999999999999 113.62 -175.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -56.9 -40.62 76.6 Favored 'General case' 0 CA--C 1.518 -0.26 0 O-C-N 120.137 -1.802 . . . . 50.979999999999997 114.101 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 29.9 mt -63.5 -44.19 95.04 Favored 'General case' 0 C--O 1.247 0.923 0 O-C-N 121.594 -0.691 . . . . 29.300000000000001 109.502 175.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1043 ' ' ALA . . . . . . . . . . . . . . . -87.3 17.41 4.41 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 120.732 -1.23 . . . . 26.739999999999998 113.491 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1044 ' ' SER . . . . . . . . . . . . . 10.5 m 67.83 46.24 1.29 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 123.909 1.814 . . . . 31.260000000000002 112.191 170.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1045 ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -130.86 162.86 28.68 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 104.79 -2.3 . . . . 33.259999999999998 104.79 175.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 22.9 t70 -104.19 161.3 14.15 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.011 -1.477 . . . . 46.740000000000002 107.011 158.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.55 -39.23 92.94 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 122.399 1.095 . . . . 34.439999999999998 111.094 -175.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.6 -22.01 63.29 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 115.443 1.646 . . . . 48.670000000000002 115.443 -176.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -62.73 -42.94 99.91 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 118.93 -2.356 . . . . 35.259999999999998 110.48 166.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1050 ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -69.82 -36.35 75.55 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 119.622 -1.924 . . . . 32.170000000000002 110.446 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 42.5 t -57.3 -43.34 81.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 116.08 -0.509 . . . . 38.369999999999997 110.585 171.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -71.26 -27.26 63.32 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 118.527 0.603 . . . . 45.770000000000003 111.504 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -73.02 -23.98 60.68 Favored 'General case' 0 N--CA 1.443 -0.775 0 O-C-N 120.723 -1.236 . . . . 37.829999999999998 112.407 174.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 95.15 39.33 4.57 Favored Glycine 0 C--O 1.221 -0.703 0 O-C-N 124.556 1.16 . . . . 35.82 112.85 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -102.21 139.13 38.23 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 124.082 0.953 . . . . 33.770000000000003 110.251 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -73.96 101.02 3.7 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.635 1.174 . . . . 51.020000000000003 107.955 -177.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1057 ' ' ILE . . . . . . . . . . . . . 50.2 mm -88.86 100.4 10.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 119.442 -2.036 . . . . 38.469999999999999 106.08 -172.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 3.2 m -123.87 158.89 29.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 107.267 -1.383 . . . . 39.399999999999999 107.267 -173.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -72.33 167.19 20.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 118.421 -0.799 . . . . 57.07 112.732 -175.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . -52.5 -61.37 6.77 Favored Glycine 0 C--N 1.344 1.021 0 O-C-N 124.695 1.247 . . . . 44.829999999999998 114.129 -164.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 2.3 t30 -70.82 -32.55 69.65 Favored 'General case' 0 C--O 1.223 -0.303 0 O-C-N 119.546 -2.149 . . . . 46.270000000000003 110.486 -173.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1062 ' ' SER . . . . . . . . . . . . . 5.8 m -61.4 -41.2 96.74 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 113.125 -1.852 . . . . 43.469999999999999 113.336 171.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 6.4 p -72.83 -31.11 35.03 Favored 'Isoleucine or valine' 0 C--O 1.26 1.616 0 CA-C-N 121.069 1.759 . . . . 36.979999999999997 109.788 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.53 -31.26 72.37 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-O 122.347 1.07 . . . . 37.899999999999999 112.662 174.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -79.54 80.79 5.88 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 119.594 -1.941 . . . . 46.189999999999998 111.172 174.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1066 ' ' SER . . . . . . . . . . . . . 49.3 m -138.23 168.41 19.8 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 121.645 -0.659 . . . . 37.060000000000002 110.118 176.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1067 ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -79.42 -25.86 41.97 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 124.217 1.007 . . . . 43.950000000000003 109.914 176.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1068 ' ' ILE . . . . . . . . . . . . . 3.5 mp -130.78 138.86 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 O-C-N 119.254 -2.154 . . . . 33.5 108.186 171.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 35.8 mm -124.31 120.72 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 104.036 -2.579 . . . . 30.57 104.036 176.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1070 ' ' LEU . . . . . . . . . . . . . 56.9 mt -103.77 109.48 21.22 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 101.347 -3.575 . . . . 27.66 101.347 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1071 ' ' LYS . . . . . . . . . . . . . 28.1 tttm -135.93 152.01 50.55 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 103.196 -2.89 . . . . 28.399999999999999 103.196 -167.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1072 ' ' VAL . . . . . . . . . . . . . 45.4 t -80.43 -60.92 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.566 0 N-CA-C 107.717 -1.216 . . . . 23.18 107.717 -171.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -114.86 -173.97 2.4 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 120.265 -1.522 . . . . 25.469999999999999 110.803 -166.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -46.93 133.74 8.58 Favored Pre-proline 0 C--N 1.367 1.333 0 C-N-CA 124.602 1.161 . . . . 27.899999999999999 113.62 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -65.62 139.34 57.85 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.892 2.395 . . . . 31.620000000000001 109.526 166.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 9.1 mt -80.65 164.1 23.11 Favored 'General case' 0 C--O 1.246 0.908 0 CA-C-N 113.89 -1.504 . . . . 40.490000000000002 109.672 166.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.81 -34.32 27.17 Favored 'General case' 0 C--O 1.257 1.487 0 CA-C-N 119.821 1.192 . . . . 51.590000000000003 114.144 -175.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -73.18 -42.84 62.28 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 121.254 -0.904 . . . . 42.359999999999999 109.934 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1079 ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -59.88 -35.23 74.4 Favored 'General case' 0 C--O 1.267 1.986 0 C-N-CA 123.805 0.842 . . . . 34.530000000000001 109.834 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1080 ' ' ILE . . . . . . . . . . . . . 97.7 mt -63.33 -43.78 98.76 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 CA-C-O 123.965 1.84 . . . . 33.25 110.268 173.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -65.38 -29.77 70.52 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 118.039 -2.913 . . . . 36.469999999999999 114.852 176.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1082 ' ' LEU . . . . . . . . . . . . . 41.8 mt -64.6 -40.88 96.31 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 112.836 -1.984 . . . . 37.759999999999998 113.663 168.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1083 ' ' LEU . . . . . . . . . . . . . 5.6 mt -59.68 107.34 0.58 Allowed 'General case' 0 CA--C 1.495 -1.169 0 CA-C-O 123.322 1.534 . . . . 37.43 110.209 174.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -95.47 143.06 25.47 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 111.347 -2.66 . . . . 37.700000000000003 108.58 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -52.62 113.86 1.43 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.937 3.092 . . . . 35.509999999999998 109.671 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 128.74 -32.81 3.24 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 112.357 -2.201 . . . . 33.869999999999997 112.433 -173.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1087 ' ' THR . . . . . . . . . . . . . 61.4 m -67.16 139.21 57.45 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-O 123.875 1.798 . . . . 32.5 108.682 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1088 ' ' THR . . . . . . . . . . . . . 7.8 m -98.71 110.61 23.19 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 103.498 -2.778 . . . . 30.219999999999999 103.498 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1089 ' ' LEU . . . . . . . . . . . . . 40.1 tp -95.78 118.67 32.87 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 106.715 -1.587 . . . . 27.239999999999998 106.715 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 4.2 t -118.22 107.1 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 107.44 -1.318 . . . . 25.390000000000001 107.44 176.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1091 ' ' SER . . . . . . . . . . . . . 19.7 m -161.02 163.8 31.37 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.723 -0.672 . . . . 28.809999999999999 112.712 -167.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1092 ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -69.22 105.09 2.38 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-O 123.586 1.66 . . . . 30.780000000000001 106.534 166.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 32.9 mm -95.54 -37.56 7.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 O-C-N 119.883 -1.761 . . . . 30.280000000000001 110.968 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1094 ' ' TRP . . . . . . . . . . . . . 96.4 m95 55.34 60.62 9.22 Favored Pre-proline 0 CA--C 1.55 0.955 0 O-C-N 124.868 1.355 . . . . 34.07 112.496 -173.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -51.68 -51.47 11.11 Favored 'Trans proline' 0 C--O 1.253 1.273 0 C-N-CA 125.207 3.938 . . . . 38.659999999999997 115.466 -171.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -62.98 -28.93 70.43 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-N 120.301 1.41 . . . . 41.32 112.147 176.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 18.6 mp0 -82.75 -22.74 34.25 Favored 'General case' 0 C--O 1.26 1.648 0 N-CA-C 108.066 -1.087 . . . . 51.659999999999997 108.066 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -127.82 57.71 27.66 Favored Pre-proline 0 C--O 1.223 -0.341 0 CA-C-N 120.754 1.615 . . . . 40.32 115.207 -175.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 0.7 OUTLIER -52.46 -37.02 72.16 Favored 'Trans proline' 0 C--O 1.248 0.993 0 C-N-CA 124.871 3.714 . . . . 41.560000000000002 115.116 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -59.66 -57.85 11.16 Favored 'General case' 0 C--O 1.217 -0.624 0 O-C-N 124.744 1.278 . . . . 54.109999999999999 107.69 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1101 ' ' LEU . . . . . . . . . . . . . 9.6 tp -51.27 -44.78 61.88 Favored 'General case' 0 C--O 1.211 -0.964 0 CA-C-O 116.656 -1.64 . . . . 37.880000000000003 109.452 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1102 ' ' MET . . . . . . . . . . . . . 61.1 mmm -55.75 -49.64 72.54 Favored 'General case' 0 C--O 1.252 1.209 0 CA-C-O 123.26 1.505 . . . . 37.539999999999999 113.601 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -39.97 86.73 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 114.211 -1.359 . . . . 47.009999999999998 110.73 -175.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B 1104 ' ' LYS . . . . . . . . . . . . . 43.3 mttm -55.69 -54.42 44.44 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.395 1.078 . . . . 48.68 110.453 174.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1105 ' ' LEU . . . . . . . . . . . . . 41.4 mt -61.57 -29.42 70.01 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 120.35 -1.469 . . . . 32.210000000000001 111.916 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -66.76 -39.54 87.93 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 117.278 -1.344 . . . . 33.729999999999997 111.399 173.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -64.25 -43.26 95.43 Favored 'General case' 0 C--O 1.249 1.04 0 O-C-N 124.36 1.038 . . . . 51.469999999999999 110.394 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1108 ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -67.27 -16.63 64.39 Favored 'General case' 0 C--N 1.309 -1.152 0 O-C-N 125.831 1.957 . . . . 43.899999999999999 114.031 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1109 ' ' ASN . . . . . . . . . . . . . 13.9 m120 59.07 49.76 9.01 Favored 'General case' 0 C--N 1.348 0.533 0 CA-C-O 126.397 2.999 . . . . 44.82 115.957 178.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1110 ' ' VAL . . . . . . . . . . . . . 12.8 m -107.7 163.77 5.34 Favored 'Isoleucine or valine' 0 C--O 1.248 0.992 0 O-C-N 119.517 -1.989 . . . . 30.52 111.528 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1111 ' ' THR . . . . . . . . . . . . . 18.1 m -107.04 97.5 7.27 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 123.61 1.672 . . . . 27.120000000000001 107.547 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1112 ' ' VAL . . . . . . . . . . . . . 70.6 t -97.31 115.46 37.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 112.563 -2.108 . . . . 26.399999999999999 113.457 -170.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1113 ' ' MET . . . . . . . . . . . . . 1.8 mpt? -100.13 118.45 36.5 Favored 'General case' 0 CA--C 1.504 -0.821 0 O-C-N 121.37 -0.831 . . . . 42.920000000000002 108.901 170.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -88.48 104.74 17.09 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 120.013 -0.675 . . . . 24.149999999999999 110.007 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1115 ' ' MET . . . . . . . . . . . . . 72.4 mmm -65.61 -17.84 64.88 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 116.583 2.068 . . . . 29.949999999999999 116.583 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1116 ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -84.73 -38.37 19.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 113.624 -1.625 . . . . 34.530000000000001 109.54 171.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1117 ' ' SER . . . . . . . . . . . . . 70.1 m -97.64 38.45 1.28 Allowed 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 123.44 1.59 . . . . 33.490000000000002 111.819 -176.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1118 ' ' VAL . . . . . . . . . . . . . 12.3 t -77.59 124.52 86.62 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 102.278 -3.23 . . . . 34.020000000000003 102.278 172.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -52.75 153.84 13.81 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.518 2.812 . . . . 38.280000000000001 115.964 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1120 ' ' ARG . . . . . 0.428 HH12 ' CG ' ' B' 1128 ' ' ASP . 0.0 OUTLIER -77.68 47.06 0.58 Allowed 'General case' 0 C--O 1.216 -0.679 0 O-C-N 121.757 -0.589 . . . . 55.049999999999997 110.008 178.113 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B 1121 ' ' ILE . . . . . . . . . . . . . 37.3 pt -119.94 168.86 11.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 O-C-N 119.182 -2.199 . . . . 42.090000000000003 110.146 -172.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1122 ' ' SER . . . . . . . . . . . . . 62.2 m -49.92 -80.23 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 117.618 2.451 . . . . 38.020000000000003 117.618 -161.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1123 ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -66.62 -12.77 59.58 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 124.169 3.168 . . . . 34.289999999999999 114.329 176.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1124 ' ' ALA . . . . . . . . . . . . . . . -67.16 -32.04 72.87 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 117.974 -1.012 . . . . 32.350000000000001 110.005 175.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1125 ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -58.32 -21.9 51.05 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 121.111 1.778 . . . . 47.170000000000002 114.678 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1126 ' ' SER . . . . . . . . . . . . . 10.2 m -71.6 -34.61 70.03 Favored 'General case' 0 C--O 1.246 0.885 0 O-C-N 121.119 -0.988 . . . . 31.710000000000001 111.351 173.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1127 ' ' LEU . . . . . . . . . . . . . 5.6 mp -83.9 -33.37 24.76 Favored 'General case' 0 CA--C 1.487 -1.463 0 N-CA-C 106.878 -1.527 . . . . 37.0 106.878 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1128 ' ' ASP . . . . . 0.428 ' CG ' HH12 ' B' 1120 ' ' ARG . 25.8 t70 -61.85 111.32 1.84 Allowed 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 124.303 2.001 . . . . 40.399999999999999 114.524 -168.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B 1129 ' ' ALA . . . . . . . . . . . . . . . -75.53 -20.62 58.59 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 113.22 -1.809 . . . . 26.559999999999999 109.52 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 17.1 mt -62.81 -40.34 97.07 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 122.294 2.315 . . . . 30.890000000000001 111.336 177.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1131 ' ' SER . . . . . . . . . . . . . 52.7 p -64.33 -53.78 43.47 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 118.051 -0.976 . . . . 29.84 110.782 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1132 ' ' SER . . . . . . . . . . . . . 40.2 m -50.42 -47.23 56.66 Favored 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 124.967 1.307 . . . . 31.91 114.082 172.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1133 ' ' MET . . . . . . . . . . . . . 37.3 mmt -70.43 -33.52 71.42 Favored 'General case' 0 CA--C 1.493 -1.221 0 O-C-N 124.37 1.044 . . . . 25.899999999999999 112.468 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1134 ' ' ALA . . . . . . . . . . . . . . . -67.33 -41.56 85.05 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 121.17 -0.956 . . . . 26.620000000000001 111.92 171.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -56.32 -53.45 57.14 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 108.292 -1.003 . . . . 36.969999999999999 108.292 174.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1136 ' ' ILE . . . . . . . . . . . . . 34.9 mm -52.37 -51.73 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 124.285 1.034 . . . . 32.109999999999999 109.95 174.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -57.13 -42.49 81.01 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 117.078 -1.439 . . . . 24.140000000000001 112.638 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -65.28 -45.22 91.89 Favored Glycine 0 C--O 1.253 1.328 0 CA-C-N 122.405 2.366 . . . . 25.129999999999999 111.33 -174.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 16.0 t80 -63.32 -43.27 98.28 Favored 'General case' 0 C--O 1.21 -1.011 0 CA-C-N 113.241 -1.48 . . . . 32.729999999999997 112.22 171.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1140 ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -70.89 -22.4 62.27 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 119.101 -0.476 . . . . 26.359999999999999 110.0 -176.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1141 ' ' ALA . . . . . . . . . . . . . . . -63.77 -43.98 94.75 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.242 -1.021 . . . . 24.120000000000001 108.242 167.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 16.2 mm -59.31 -47.31 90.92 Favored 'Isoleucine or valine' 0 C--N 1.359 1.004 0 CA-C-O 121.835 0.826 . . . . 23.370000000000001 111.765 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 71.1 t -53.51 -68.33 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.848 0 N-CA-C 113.477 0.917 . . . . 24.960000000000001 113.477 171.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -61.75 -31.14 71.3 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 113.72 1.008 . . . . 32.07 113.72 -172.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1145 ' ' ALA . . . . . . . . . . . . . . . -55.11 -57.42 11.81 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.687 -0.688 . . . . 24.870000000000001 110.36 168.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1146 ' ' ALA . . . . . . . . . . . . . . . -64.49 -19.33 65.51 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 115.895 1.813 . . . . 24.670000000000002 115.895 176.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 86.0 t60 -65.52 -26.66 68.0 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 116.986 -1.483 . . . . 28.579999999999998 112.278 169.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1148 ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -123.89 8.74 8.74 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 123.117 2.69 . . . . 36.82 115.955 170.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1149 ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -65.46 154.07 39.56 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-O 124.255 1.978 . . . . 31.969999999999999 111.877 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B 1150 ' ' GLY . . . . . . . . . . . . . . . -86.39 -32.09 17.39 Favored Glycine 0 N--CA 1.432 -1.613 0 CA-C-N 114.05 -1.432 . . . . 25.489999999999998 112.313 174.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1151 ' ' ARG . . . . . . . . . . . . . 64.4 mtm-85 -119.59 -174.23 2.7 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 115.981 1.845 . . . . 59.840000000000003 115.981 -166.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1152 ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -88.14 145.81 25.74 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-O 118.499 -0.762 . . . . 34.450000000000003 111.873 172.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B 1153 ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -63.16 -52.08 63.85 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 119.17 0.895 . . . . 31.170000000000002 112.294 169.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1154 ' ' THR . . . . . . . . . . . . . 7.6 m -73.88 131.08 41.12 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.896 -1.047 . . . . 33.890000000000001 110.434 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -72.34 81.84 0.58 Allowed Glycine 0 C--N 1.343 0.93 0 O-C-N 119.689 -1.882 . . . . 38.950000000000003 111.029 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -75.27 114.85 14.27 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.556 0.693 . . . . 54.229999999999997 111.794 -173.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 45.1 mm -92.53 104.78 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 1 N-CA-C 99.316 -4.327 . . . . 51.159999999999997 99.316 177.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B 1158 ' ' THR . . . . . . . . . . . . . 1.5 m -115.11 138.88 50.4 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 103.002 -2.962 . . . . 49.609999999999999 103.002 -172.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -52.61 -32.69 42.85 Favored 'General case' 0 C--O 1.248 1.016 0 CA-C-O 123.777 1.751 . . . . 49.049999999999997 115.009 175.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -59.16 -81.04 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 113.303 -1.771 . . . . 47.649999999999999 110.088 162.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . -146.68 155.2 26.42 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 121.366 1.894 . . . . 45.609999999999999 110.035 -174.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 89.0 mttt -89.39 132.12 35.13 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.648 1.213 . . . . 57.460000000000001 108.352 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1163 ' ' VAL . . . . . . . . . . . . . 90.6 t -100.3 128.56 30.16 Favored Pre-proline 0 C--O 1.247 0.925 0 CA-C-N 113.771 -1.559 . . . . 42.93 108.484 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1164 ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -67.22 133.2 29.87 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.568 3.512 . . . . 39.289999999999999 110.689 166.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1165 ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -69.0 161.64 44.99 Favored 'Trans proline' 0 N--CA 1.479 0.629 0 C-N-CA 121.255 1.303 . . . . 34.170000000000002 110.04 -172.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -70.56 111.78 6.33 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 118.04 -1.464 . . . . 31.690000000000001 108.816 172.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1167 ' ' LYS . . . . . . . . . . . . . 86.4 mttt -77.65 87.48 3.94 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.144 -1.428 . . . . 44.780000000000001 107.144 174.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 48.4 t -77.05 94.92 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 114.168 -1.378 . . . . 31.23 108.556 -174.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1169 ' ' MET . . . . . . . . . . . . . 55.5 ttp -86.19 110.37 19.54 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 122.459 1.123 . . . . 37.090000000000003 108.433 177.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 50.7 t -97.59 118.76 44.64 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 N-CA-C 107.611 -1.255 . . . . 30.170000000000002 107.611 -177.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1171 ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.94 95.97 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 103.848 -2.649 . . . . 33.740000000000002 103.848 171.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 115.4 85.18 1.23 Allowed Glycine 0 C--N 1.339 0.707 0 N-CA-C 108.657 -1.777 . . . . 32.590000000000003 108.657 170.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1173 ' ' ALA . . . . . . . . . . . . . . . -84.16 50.33 1.83 Allowed 'General case' 0 C--O 1.255 1.346 0 CA-C-O 124.302 2.001 . . . . 32.420000000000002 110.849 178.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -81.15 -165.56 34.44 Favored Glycine 0 C--N 1.342 0.884 0 O-C-N 118.59 -2.569 . . . . 31.739999999999998 107.754 163.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 19.1 t -51.36 -39.96 22.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 O-C-N 119.304 -2.292 . . . . 31.48 114.352 -176.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1176 ' ' ALA . . . . . . . . . . . . . . . -55.86 -46.82 78.15 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.934 1.087 . . . . 26.120000000000001 113.934 171.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1177 ' ' GLY . . . . . . . . . . . . . . . -68.85 -45.8 62.8 Favored Glycine 0 C--N 1.345 1.046 0 N-CA-C 109.106 -1.598 . . . . 25.73 109.106 -176.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1178 ' ' LEU . . . . . . . . . . . . . 51.4 mt -60.46 -36.36 78.07 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 118.244 -0.884 . . . . 32.590000000000003 108.9 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -68.24 -44.09 76.43 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 119.342 0.973 . . . . 27.719999999999999 110.456 176.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -58.63 -36.64 74.4 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 118.192 -0.908 . . . . 26.030000000000001 108.773 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1181 ' ' ILE . . . . . . . . . . . . . 38.2 mt -61.27 -50.0 82.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 CA-C-N 120.628 1.558 . . . . 28.609999999999999 107.783 171.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -62.67 -19.95 61.14 Favored Glycine 0 CA--C 1.543 1.808 0 CA-C-O 118.363 -1.243 . . . . 25.23 114.108 -173.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -97.96 -56.64 2.43 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 117.993 0.896 . . . . 24.09 109.895 171.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -72.01 -38.5 69.6 Favored 'General case' 0 CA--C 1.509 -0.619 0 O-C-N 119.027 -2.296 . . . . 26.68 115.861 -171.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 22.1 t30 -61.61 -39.02 89.75 Favored 'General case' 0 C--O 1.247 0.966 0 O-C-N 120.589 -1.319 . . . . 36.57 111.429 174.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1186 ' ' SER . . . . . . . . . . . . . 2.0 m -62.33 -38.73 90.62 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 112.952 -1.931 . . . . 28.920000000000002 111.559 174.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1187 ' ' LEU . . . . . . . . . . . . . 4.2 mt -61.02 -31.18 70.81 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 116.038 -0.528 . . . . 29.09 110.914 172.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 111.05 -7.55 29.15 Favored Glycine 0 CA--C 1.525 0.717 0 O-C-N 121.426 -0.796 . . . . 29.260000000000002 111.25 -176.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1189 ' ' ALA . . . . . . . . . . . . . . . -62.05 134.72 56.98 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 122.234 1.016 . . . . 30.16 109.559 175.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 18.3 mt -77.19 94.97 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 104.684 -2.339 . . . . 35.810000000000002 104.684 -174.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1191 ' ' VAL . . . . . . . . . . . . . 40.6 t -78.24 100.23 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 O-C-N 120.242 -1.536 . . . . 31.969999999999999 109.66 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1192 ' ' ARG . . . . . 0.429 HH12 ' CD ' ' B' 1248 ' ' GLU . 98.8 mtt180 -87.07 80.84 8.24 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 124.146 1.927 . . . . 48.159999999999997 108.637 174.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -84.93 144.82 28.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 111.438 -2.619 . . . . 35.890000000000001 111.335 -172.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 82.1 t80 -134.57 145.39 48.65 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.018 -1.475 . . . . 41.880000000000003 107.018 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1195 ' ' ASP . . . . . . . . . . . . . 5.5 t70 -153.03 154.59 35.22 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 103.992 -2.596 . . . . 38.280000000000001 103.992 161.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1196 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.42 -21.19 56.28 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 114.468 -1.242 . . . . 40.619999999999997 110.59 174.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B 1197 ' ' ARG . . . . . . . . . . . . . 40.2 mtm180 -78.06 126.15 84.15 Favored Pre-proline 0 N--CA 1.435 -1.183 0 C-N-CA 120.164 -0.614 . . . . 53.090000000000003 110.978 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -53.04 -46.39 34.29 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 125.273 3.982 . . . . 42.560000000000002 116.611 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 10.6 pm0 -70.24 -13.98 62.41 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 115.787 1.773 . . . . 56.310000000000002 115.787 -161.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1200 ' ' VAL . . . . . . . . . . . . . 26.7 m -74.09 -22.17 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 116.145 -0.48 . . . . 42.909999999999997 111.24 175.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 26.0 tttm -47.83 -56.45 7.45 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 114.549 1.315 . . . . 48.890000000000001 114.549 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -55.7 -42.55 75.4 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 112.716 -2.038 . . . . 51.700000000000003 112.565 174.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1203 ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -64.11 -47.84 78.45 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.308 -0.86 . . . . 52.57 109.4 -174.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1204 ' ' VAL . . . . . . . . . . . . . 55.9 t -64.02 -49.84 79.8 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-O 122.677 1.227 . . . . 33.789999999999999 108.486 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -57.39 -29.78 64.36 Favored 'General case' 0 C--N 1.359 1.007 0 N-CA-C 115.812 1.782 . . . . 36.579999999999998 115.812 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1206 ' ' SER . . . . . . . . . . . . . 43.3 p -71.86 -18.26 62.07 Favored 'General case' 0 C--O 1.248 0.978 0 CA-C-N 119.423 1.011 . . . . 39.609999999999999 110.89 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1207 ' ' MET . . . . . . . . . . . . . 26.1 mtp -87.39 -9.28 55.19 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 120.954 -1.091 . . . . 37.450000000000003 112.469 172.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 68.5 46.74 61.18 Favored Glycine 0 C--O 1.224 -0.484 0 O-C-N 119.319 -2.113 . . . . 31.870000000000001 109.548 -168.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -122.71 146.56 47.38 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 103.623 -2.732 . . . . 35.399999999999999 103.623 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -85.09 116.55 23.53 Favored 'General case' 0 N--CA 1.435 -1.225 0 O-C-N 120.418 -1.426 . . . . 47.890000000000001 109.355 -164.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 70.0 t80 -89.5 120.95 31.26 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 107.982 -1.118 . . . . 45.530000000000001 107.982 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1212 ' ' LEU . . . . . . . . . . . . . 57.8 mt -71.25 115.17 10.09 Favored 'General case' 0 N--CA 1.44 -0.964 0 O-C-N 121.323 -0.861 . . . . 46.329999999999998 109.271 174.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -98.38 141.4 31.3 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 124.7 2.19 . . . . 60.409999999999997 108.904 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 43.7 mt -66.32 161.33 22.64 Favored 'General case' 0 C--O 1.251 1.148 0 CA-C-N 112.2 -2.273 . . . . 57.380000000000003 114.597 168.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 27.0 t70 . . . . . 0 CA--C 1.518 -0.288 0 CA-C-N 114.264 -1.334 . . . . 65.069999999999993 110.19 -178.447 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B 1230 ' ' MET . . . . . 0.428 ' SD ' ' CD2' ' B' 1234 ' ' PHE . 13.8 mmt . . . . . 0 N--CA 1.448 -0.557 1 N-CA-C 98.674 -4.565 . . . . 80.319999999999993 98.674 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B 1231 ' ' SER . . . . . . . . . . . . 0.3 0.1 OUTLIER 63.05 173.77 0.15 Allowed 'General case' 0 C--N 1.356 0.879 2 CA-C-N 127.1 4.5 . . . . 79.920000000000002 119.458 0.628 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -67.01 -166.92 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 115.719 1.748 . . . . 77.909999999999997 115.719 -172.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 71.0 -80.03 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 107.447 -1.316 . . . . 73.879999999999995 107.447 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1234 ' ' PHE . . . . . 0.428 ' CD2' ' SD ' ' B' 1230 ' ' MET . 2.2 m-85 -51.51 -33.45 31.76 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 115.651 1.723 . . . . 68.980000000000004 115.651 171.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 36.1 pt -47.72 -36.5 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 120.271 1.396 . . . . 64.530000000000001 113.12 169.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -62.24 -41.62 98.58 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 120.049 -1.657 . . . . 66.359999999999999 111.011 172.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -67.34 -42.63 83.24 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 119.418 -0.913 . . . . 56.600000000000001 111.533 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -56.18 -51.74 66.94 Favored 'General case' 0 C--O 1.241 0.65 0 O-C-N 124.306 1.003 . . . . 56.789999999999999 111.966 171.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1239 ' ' MET . . . . . . . . . . . . . 10.4 tmm? -56.27 -56.74 17.27 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 118.168 -0.92 . . . . 53.630000000000003 112.976 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -55.56 -36.32 66.69 Favored 'General case' 0 C--N 1.36 1.028 0 CA-C-N 119.428 1.013 . . . . 51.740000000000002 111.111 -177.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 16.2 tp -57.44 -50.77 71.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 121.067 -1.021 . . . . 44.859999999999999 111.475 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -64.81 -39.61 93.87 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 125.99 2.056 . . . . 42.780000000000001 113.03 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -64.94 -23.72 67.31 Favored 'General case' 0 C--N 1.36 1.048 0 N-CA-C 113.574 0.953 . . . . 40.960000000000001 113.574 175.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -82.01 -53.99 5.67 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 118.72 -2.488 . . . . 43.060000000000002 108.898 172.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 61.0 mm-40 -56.32 -31.99 64.23 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 124.748 1.219 . . . . 46.450000000000003 112.861 -176.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -44.46 -34.54 2.1 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 125.435 1.494 . . . . 41.780000000000001 114.885 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 34.3 tptt -63.55 -43.78 96.06 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 124.206 1.955 . . . . 52.200000000000003 111.863 -176.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1248 ' ' GLU . . . . . 0.429 ' CD ' HH12 ' B' 1192 ' ' ARG . 39.1 mt-10 -84.5 -39.91 18.29 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 113.14 -1.846 . . . . 53.549999999999997 114.283 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B 1249 ' ' VAL . . . . . . . . . . . . 0.301 10.6 m -76.94 160.91 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 118.907 2.929 . . . . 34.409999999999997 118.907 -167.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B 1250 ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -117.9 -73.09 0.66 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 124.389 2.042 . . . . 33.380000000000003 110.454 -169.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1251 ' ' ILE . . . . . . . . . . . . . 23.5 mm -98.11 99.69 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 114.0 -1.455 . . . . 29.539999999999999 108.484 -169.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1252 ' ' ILE . . . . . . . . . . . . . 17.5 mt -89.54 96.13 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 105.607 -1.998 . . . . 32.439999999999998 105.607 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1253 ' ' VAL . . . . . . . . . . . . . 96.7 t -83.16 96.51 4.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 102.369 -3.197 . . . . 30.57 102.369 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1254 ' ' THR . . . . . . . . . . . . . 2.4 t -104.99 138.93 40.44 Favored 'General case' 0 N--CA 1.432 -1.339 0 O-C-N 119.877 -1.764 . . . . 35.039999999999999 111.89 -175.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1255 ' ' THR . . . . . . . . . . . . . 40.1 p -134.09 -83.25 0.44 Allowed 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 114.377 -1.283 . . . . 34.619999999999997 108.772 -177.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . 56.72 41.9 27.59 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.254 1.822 . . . . 42.719999999999999 114.777 -170.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 45.8 mt -89.85 93.78 9.56 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-O 123.797 1.761 . . . . 52.43 107.309 -174.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 24.7 mt -90.08 129.1 47.19 Favored Pre-proline 0 N--CA 1.438 -1.063 0 N-CA-C 107.043 -1.466 . . . . 59.409999999999997 107.043 171.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -57.03 133.31 57.08 Favored 'Trans proline' 0 N--CA 1.441 -1.577 0 C-N-CA 124.707 3.605 . . . . 62.68 114.466 -177.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 66.59 29.49 74.85 Favored Glycine 0 C--O 1.218 -0.856 0 CA-C-O 117.149 -1.917 . . . . 64.159999999999997 114.088 -174.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 59.6 mttm -138.32 148.16 58.41 Favored Pre-proline 0 CA--C 1.503 -0.827 0 CA-C-N 121.009 2.404 . . . . 68.530000000000001 111.822 172.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.63 136.96 29.27 Favored 'Trans proline' 0 C--O 1.245 0.844 0 CA-C-N 122.856 2.056 . . . . 61.990000000000002 107.486 164.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1263 ' ' ALA . . . . . . . . . . . . . . . -51.63 116.07 7.35 Favored Pre-proline 0 C--O 1.248 1.021 0 N-CA-C 113.24 0.83 . . . . 57.149999999999999 113.24 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -53.61 135.67 62.4 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 124.779 3.653 . . . . 51.57 110.5 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -78.25 84.37 4.46 Favored 'General case' 0 C--O 1.248 0.994 0 C-N-CA 123.785 0.834 . . . . 54.549999999999997 109.161 -173.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 94.9 mt -91.4 -41.31 10.95 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 113.185 0.809 . . . . 46.859999999999999 113.185 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1267 ' ' ILE . . . . . . . . . . . . . 32.1 mm -78.53 86.96 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 124.432 2.063 . . . . 41.039999999999999 111.467 171.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1268 ' ' THR . . . . . . . . . . . . . 36.2 p -84.54 151.98 24.2 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 112.316 -2.22 . . . . 39.579999999999998 112.892 -170.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1269 ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -52.22 -39.6 60.45 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 118.256 -2.778 . . . . 53.149999999999999 117.194 -176.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -58.27 -40.78 82.78 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-O 123.517 1.627 . . . . 42.960000000000001 112.392 173.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1271 ' ' MET . . . . . . . . . . . . . 54.2 ttm -65.71 -42.61 90.93 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 113.048 -1.887 . . . . 43.890000000000001 110.669 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1272 ' ' VAL . . . . . . . . . . . . . 10.4 t -54.78 -48.52 73.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 113.816 -1.538 . . . . 38.369999999999997 110.977 170.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 25.9 t70 -58.39 -40.71 83.08 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 114.251 1.204 . . . . 47.460000000000001 114.251 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1274 ' ' SER . . . . . . . . . . . . . 49.5 m -68.86 -22.99 64.17 Favored 'General case' 0 C--O 1.238 0.494 0 O-C-N 121.698 -0.626 . . . . 38.380000000000003 112.687 174.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1275 ' ' MET . . . . . . . . . . . . . 71.7 mtp -62.12 162.16 9.89 Favored 'General case' 0 C--O 1.252 1.197 0 CA-C-O 124.548 2.118 . . . . 37.810000000000002 114.014 -173.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 66.6 tttt -68.07 137.46 55.01 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 111.868 -2.423 . . . . 49.259999999999998 109.562 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -75.62 151.06 37.87 Favored 'General case' 0 C--O 1.246 0.874 0 O-C-N 124.121 0.888 . . . . 34.460000000000001 110.267 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 74.55 14.51 81.06 Favored Glycine 0 N--CA 1.47 0.922 0 C-N-CA 120.514 -0.85 . . . . 33.530000000000001 112.645 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1279 ' ' SER . . . . . . . . . . . . . 61.0 m -106.16 148.45 27.85 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 125.322 1.449 . . . . 31.309999999999999 109.67 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1280 ' ' VAL . . . . . . . . . . . . . 25.9 t -127.07 119.94 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 O-C-N 120.634 -1.291 . . . . 29.32 109.886 -163.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1281 ' ' ILE . . . . . . . . . . . . . 19.5 mt -86.8 112.26 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 102.655 -3.091 . . . . 31.93 102.655 175.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1282 ' ' VAL . . . . . . . . . . . . . 21.2 t -106.5 107.71 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 N-CA-C 101.857 -3.386 . . . . 29.48 101.857 175.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 24.3 t0 -87.93 109.08 19.52 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 110.475 -3.057 . . . . 34.5 107.653 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1284 ' ' LEU . . . . . . . . . . . . . 71.4 mt -79.58 -23.05 43.0 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-O 121.138 0.494 . . . . 37.939999999999998 110.467 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -87.52 -5.62 58.71 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 115.371 -0.831 . . . . 40.920000000000002 111.525 -175.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -18.72 -54.32 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.736 1 N-CA-C 122.173 4.138 . . . . 44.390000000000001 122.173 174.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B 1287 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.27 -43.89 69.56 Favored 'General case' 0 CA--C 1.501 -0.935 0 C-N-CA 123.431 0.692 . . . . 51.460000000000001 111.483 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 4.9 t30 -97.21 75.68 2.59 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-O 123.915 1.817 . . . . 57.75 109.378 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1289 ' ' GLY . . . . . . . . . . . . . . . 87.88 -76.72 1.95 Allowed Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 107.209 -2.356 . . . . 49.850000000000001 107.209 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 99.45 136.74 9.48 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 109.371 -1.492 . . . . 45.93 109.371 -167.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1291 ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -88.88 -35.17 16.68 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 120.15 1.975 . . . . 42.670000000000002 112.927 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1292 ' ' CYS . . . . . . . . . . . . . 40.4 t -77.87 143.91 37.39 Favored 'General case' 0 N--CA 1.441 -0.923 0 O-C-N 118.944 -2.348 . . . . 38.82 110.829 171.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1293 ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -69.08 -37.43 78.45 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.702 -1.135 . . . . 46.710000000000001 112.049 174.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -82.9 -8.13 59.6 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 115.564 1.691 . . . . 47.229999999999997 115.564 -173.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1295 ' ' THR . . . . . . . . . . . . . 49.1 m -52.35 120.4 5.49 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 116.135 1.902 . . . . 36.020000000000003 116.135 177.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 2.9 t -88.79 108.11 21.37 Favored Pre-proline 0 N--CA 1.448 -0.559 0 CA-C-O 116.007 -1.949 . . . . 37.259999999999998 106.396 172.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -64.28 88.39 0.16 Allowed 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 124.29 3.327 . . . . 35.090000000000003 113.479 -176.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 139.46 -17.46 3.09 Favored Glycine 0 C--O 1.251 1.18 0 CA-C-N 113.243 -1.798 . . . . 35.969999999999999 110.013 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -133.71 -176.69 4.25 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 121.458 2.629 . . . . 40.390000000000001 114.554 -161.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1300 ' ' ILE . . . . . . . . . . . . . 9.6 mt -99.8 155.58 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.045 0 N-CA-C 105.759 -1.941 . . . . 37.43 105.759 170.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 65.9 t80 -142.85 105.89 4.55 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 123.008 1.385 . . . . 44.130000000000003 107.63 167.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1302 ' ' THR . . . . . . . . . . . . . 96.5 m -75.46 118.58 18.49 Favored 'General case' 0 N--CA 1.438 -1.029 0 O-C-N 119.434 -2.041 . . . . 39.780000000000001 106.291 168.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1303 ' ' THR . . . . . . . . . . . . . 76.0 p -69.7 169.42 12.88 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 115.903 1.816 . . . . 43.289999999999999 115.903 172.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -48.37 -48.02 36.93 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 124.343 1.057 . . . . 53.07 113.02 167.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -85.8 23.52 1.42 Allowed 'General case' 0 C--O 1.244 0.81 0 N-CA-C 114.68 1.363 . . . . 43.969999999999999 114.68 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 69.38 23.5 76.4 Favored Glycine 0 C--N 1.358 1.761 0 O-C-N 119.332 -2.105 . . . . 41.119999999999997 114.961 170.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1307 ' ' VAL . . . . . . . . . . . . . 94.7 t -93.46 136.13 26.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 105.767 -1.938 . . . . 38.119999999999997 105.767 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1308 ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -92.77 99.54 12.19 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.757 -1.201 . . . . 36.340000000000003 107.757 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1309 ' ' VAL . . . . . . . . . . . . . 18.0 t -90.02 92.97 4.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 105.602 -1.999 . . . . 30.399999999999999 105.602 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1310 ' ' ILE . . . . . . . . . . . . . 12.1 mt -87.4 134.2 28.32 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.002 0 C-N-CA 126.02 1.728 . . . . 30.82 107.85 173.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1311 ' ' GLY . . . . . . . . . . . . . . . -149.09 86.95 0.15 Allowed Glycine 0 CA--C 1.493 -1.34 0 N-CA-C 108.396 -1.882 . . . . 26.530000000000001 108.396 171.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1312 ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -97.8 119.66 36.79 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 118.055 0.927 . . . . 38.0 108.848 -172.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1313 ' ' THR . . . . . . . . . . . . . 39.3 m -49.83 -40.37 41.83 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 124.079 1.895 . . . . 29.800000000000001 114.355 172.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -78.56 -2.96 41.35 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 112.834 -1.985 . . . . 39.039999999999999 116.201 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1315 ' ' LEU . . . . . . . . . . . . . 13.4 mt -43.29 -51.35 14.45 Favored Pre-proline 0 N--CA 1.47 0.527 0 N-CA-C 119.062 2.986 . . . . 31.079999999999998 119.062 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1316 ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -65.62 -25.06 54.86 Favored 'Trans proline' 0 C--O 1.218 -0.5 0 CA-C-N 124.606 2.681 . . . . 26.100000000000001 112.866 176.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -67.53 -49.23 52.17 Favored Glycine 0 N--CA 1.431 -1.688 0 O-C-N 120.496 -1.378 . . . . 23.170000000000002 109.964 169.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -39.69 -16.71 0.01 OUTLIER 'General case' 0 C--O 1.246 0.878 1 N-CA-C 125.201 5.26 . . . . 40.399999999999999 125.201 -161.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 15.9 tp -102.12 78.58 0.24 Allowed Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 121.301 1.864 . . . . 23.600000000000001 108.158 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1320 ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -43.53 -64.28 0.26 Allowed 'Trans proline' 0 CA--C 1.51 -0.719 1 C-N-CA 125.416 4.077 . . . . 22.350000000000001 119.138 -156.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B 1321 ' ' THR . . . . . . . . . . . . . 4.2 m -61.97 -44.79 96.01 Favored 'General case' 0 C--O 1.218 -0.578 0 O-C-N 121.17 -0.957 . . . . 26.52 112.293 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1322 ' ' GLN . . . . . . . . . . . . . 11.5 tp60 -72.48 -43.44 63.67 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 118.657 -0.687 . . . . 24.379999999999999 112.471 -173.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1323 ' ' SER . . . . . . . . . . . . . 66.6 m -48.78 -49.32 39.21 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 124.176 0.99 . . . . 22.800000000000001 110.837 164.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1324 ' ' SER . . . . . . . . . . . . . 11.4 m -61.69 -33.2 73.58 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 122.567 1.175 . . . . 21.25 113.436 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -69.43 -40.38 77.27 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 118.404 -2.685 . . . . 31.34 114.18 170.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1326 ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.89 -55.8 9.91 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.951 0.881 . . . . 31.559999999999999 112.241 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1327 ' ' TYR . . . . . . . . . . . . . 31.3 t80 -56.2 -44.57 79.61 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-N 113.992 -1.458 . . . . 22.73 110.179 175.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1328 ' ' GLY . . . . . . . . . . . . . . . -56.7 -60.45 8.98 Favored Glycine 0 C--N 1.343 0.929 0 O-C-N 124.153 0.908 . . . . 21.91 112.794 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1329 ' ' THR . . . . . . . . . . . . . 9.2 m -58.44 -23.51 57.72 Favored 'General case' 0 C--O 1.252 1.185 0 CA-C-O 116.365 -1.778 . . . . 22.149999999999999 111.893 174.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1330 ' ' ASN . . . . . . . . . . . . . 12.1 m120 -63.79 -46.72 83.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 125.4 3.727 . . . . 26.18 110.549 170.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1331 ' ' LEU . . . . . . . . . . . . . 13.9 mt -61.14 -37.28 82.27 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.079 -0.964 . . . . 23.68 109.254 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1332 ' ' VAL . . . . . . . . . . . . . 96.6 t -69.22 -45.21 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 106.847 -1.538 . . . . 26.57 106.847 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -58.69 -43.73 90.06 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 113.353 0.871 . . . . 28.079999999999998 113.353 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1334 ' ' LEU . . . . . . . . . . . . . 3.9 tt -56.95 -47.31 80.99 Favored 'General case' 0 C--O 1.247 0.929 0 C-N-CA 123.933 0.893 . . . . 27.43 109.337 170.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1335 ' ' LEU . . . . . . . . . . . . . 68.2 mt -74.42 -12.25 60.46 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 120.924 -1.11 . . . . 30.5 113.601 -177.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1336 ' ' LYS . . . . . . . . . . . . . 85.5 mttt -72.89 -49.5 29.41 Favored 'General case' 0 CA--C 1.504 -0.793 0 O-C-N 120.828 -1.17 . . . . 41.649999999999999 109.225 166.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 7.7 mp -67.51 -26.84 66.54 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 113.258 0.836 . . . . 42.079999999999998 113.258 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1338 ' ' LEU . . . . . . . . . . . . . 95.3 mt -72.34 -67.11 0.57 Allowed 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 108.373 -0.973 . . . . 35.030000000000001 108.373 168.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 43.6 t -85.34 73.69 10.51 Favored 'General case' 0 N--CA 1.436 -1.161 0 O-C-N 118.699 -2.501 . . . . 37.329999999999998 108.185 -170.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 58.0 mttp -57.44 -33.4 67.88 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 125.323 1.449 . . . . 50.509999999999998 114.353 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -80.55 -11.61 59.64 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 114.372 1.249 . . . . 54.210000000000001 114.372 178.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 60.0 mttp 60.32 34.81 20.75 Favored 'General case' 0 C--N 1.347 0.488 0 CA-C-O 122.884 1.326 . . . . 50.990000000000002 111.608 -172.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -99.6 -34.22 10.31 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 114.959 -1.018 . . . . 48.82 111.273 -176.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 125.31 9.52 5.0 Favored Glycine 0 N--CA 1.433 -1.551 0 O-C-N 124.543 1.152 . . . . 40.43 113.407 175.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -98.67 141.17 31.84 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 125.503 1.521 . . . . 47.560000000000002 113.639 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1346 ' ' ILE . . . . . . . . . . . . . 43.1 mm -82.79 76.18 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.63 0 CA-C-O 123.136 1.446 . . . . 42.490000000000002 108.728 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1347 ' ' THR . . . . . . . . . . . . . 2.4 m -73.82 78.92 1.59 Allowed 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.598 -1.183 . . . . 38.119999999999997 109.326 172.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 10.9 t -62.29 121.66 11.35 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 O-C-N 119.598 -1.939 . . . . 37.5 109.379 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 23.1 t0 -96.96 111.08 23.46 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 122.505 1.145 . . . . 43.850000000000001 108.565 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1350 ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -100.52 -0.59 37.55 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 116.385 1.994 . . . . 39.810000000000002 116.385 175.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -81.41 -43.55 18.8 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 121.728 0.775 . . . . 51.289999999999999 110.776 167.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 14.4 t0 -66.75 121.8 16.23 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 124.373 2.035 . . . . 39.780000000000001 111.995 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 3.7 m -52.25 -37.21 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 CA-C-N 110.752 -2.931 . . . . 39.280000000000001 112.686 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1354 ' ' VAL . . . . . . . . . . . . . 23.1 t -70.6 -54.01 19.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-N 114.894 -1.048 . . . . 35.700000000000003 112.355 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1355 ' ' ILE . . . . . . . . . . . . . 27.1 mm -64.68 -47.59 88.19 Favored 'Isoleucine or valine' 0 C--N 1.359 1.007 0 CA-C-O 116.95 -1.5 . . . . 35.770000000000003 112.073 176.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 42.3 tpt85 -54.1 -37.09 63.89 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 114.168 1.173 . . . . 38.549999999999997 114.168 173.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -62.63 -54.6 32.67 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 124.621 1.105 . . . . 29.579999999999998 115.437 171.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1358 ' ' VAL . . . . . . . . . . . . . 9.1 p -69.08 -38.82 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 108.668 -0.864 . . . . 32.060000000000002 108.668 -174.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1359 ' ' THR . . . . . . . . . . . . . 14.8 m -76.46 84.83 3.18 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-O 123.892 1.806 . . . . 29.0 107.944 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1360 ' ' VAL . . . . . . . . . . . . . 22.1 m -73.27 -19.55 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 111.692 -2.504 . . . . 29.68 111.252 -174.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 85.1 mt -139.16 116.28 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 105.76 -1.941 . . . . 32.049999999999997 105.76 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1362 ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -108.66 119.38 39.37 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 119.205 -2.184 . . . . 32.520000000000003 108.885 175.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 36.86 44.08 0.33 Allowed 'General case' 0 C--O 1.246 0.92 0 CA-C-O 124.454 2.073 . . . . 35.68 116.113 -172.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 93.36 -7.28 75.38 Favored Glycine 0 CA--C 1.54 1.647 0 CA-C-O 117.225 -1.875 . . . . 34.259999999999998 114.356 174.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.6 132.52 34.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 104.653 -2.351 . . . . 51.07 104.653 170.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 59.5 mt -88.75 94.05 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 N-CA-C 107.402 -1.333 . . . . 39.869999999999997 107.402 -176.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1367 ' ' THR . . . . . . . . . . . . . 3.3 p -84.77 -1.39 56.26 Favored 'General case' 0 N--CA 1.424 -1.735 0 O-C-N 126.528 2.393 . . . . 38.009999999999998 114.858 -175.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1368 ' ' TRP . . . . . . . . . . . . . 35.0 t90 -52.05 142.26 27.29 Favored Pre-proline 0 C--O 1.241 0.635 0 C-N-CA 124.255 1.022 . . . . 42.140000000000001 111.674 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -87.91 -114.77 0.0 OUTLIER 'Cis proline' 0 N--CA 1.451 -0.996 0 CA-C-N 122.575 1.955 . . . . 43.259999999999998 113.21 -7.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1370 ' ' ALA . . . . . . . . . . . . . . . -117.97 153.67 51.18 Favored Pre-proline 0 C--N 1.32 -0.696 0 O-C-N 120.104 -1.623 . . . . 46.520000000000003 107.297 166.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -59.52 133.62 53.01 Favored 'Trans proline' 0 C--N 1.33 -0.438 0 CA-C-N 122.589 1.96 . . . . 51.950000000000003 110.954 172.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -36.91 87.7 0.01 OUTLIER 'Trans proline' 0 C--O 1.25 1.091 0 C-N-CA 125.133 3.889 . . . . 56.270000000000003 118.108 -174.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B 1373 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.13 140.78 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 103.099 -2.926 . . . . 60.829999999999998 103.099 177.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -107.48 146.64 31.52 Favored 'General case' 0 C--O 1.256 1.423 0 O-C-N 120.203 -1.561 . . . . 66.099999999999994 108.184 -174.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 96.2 t -78.95 135.86 24.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 O-C-N 125.454 1.721 . . . . 63.469999999999999 111.49 -171.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.23 -4.627 0 O-C-N 120.891 -1.13 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.274 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.6 -16.23 24.29 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.071 1.348 . . . . 0.0 114.464 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 28.7 mp0 -49.54 -42.22 43.37 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.068 -1.02 . . . . 0.0 110.531 172.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 6.6 m -56.67 -46.96 80.81 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 123.593 0.757 . . . . 0.0 111.696 173.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.24 -49.81 74.23 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 123.714 0.805 . . . . 0.0 109.674 -173.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -48.82 -51.07 31.45 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 127.849 3.218 . . . . 0.0 111.409 173.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 13.5 tp -65.28 -39.41 92.53 Favored 'General case' 0 N--CA 1.44 -0.938 0 O-C-N 120.764 -1.21 . . . . 0.0 113.59 -177.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 74.1 mt -53.68 -39.62 65.26 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 118.58 2.808 . . . . 0.0 118.58 -174.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 28' ' ' LYS . . . . . 0.432 ' HZ1' ' C ' ' C' ' 186' ' ' LEU . 34.5 pttt -63.93 -28.65 69.97 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.082 -0.963 . . . . 0.0 113.015 175.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -82.87 -33.01 27.13 Favored 'General case' 0 C--O 1.246 0.88 0 O-C-N 125.349 1.656 . . . . 0.0 109.823 174.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 58.0 m -54.87 127.27 27.85 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -170.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -82.55 -58.37 2.94 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 113.956 -1.475 . . . . 0.0 109.041 -174.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 55.5 m -116.15 143.39 45.56 Favored 'General case' 0 C--O 1.251 1.135 0 O-C-N 120.801 -1.187 . . . . 0.0 110.55 166.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 96.6 t -128.44 120.2 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 38.7 mm -101.69 111.41 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 101.598 -3.482 . . . . 0.0 101.598 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 42.9 mt -83.7 122.73 38.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 169.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 13.7 m -115.97 92.94 36.65 Favored Pre-proline 0 C--O 1.246 0.919 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.129 173.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -56.3 116.66 3.34 Favored 'Trans proline' 0 N--CA 1.449 -1.107 1 C-N-CA 125.47 4.113 . . . . 0.0 112.347 168.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.29 -175.23 27.52 Favored Glycine 0 N--CA 1.433 -1.558 0 O-C-N 120.869 -1.145 . . . . 0.0 110.441 167.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -38.18 -41.59 0.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.187 1.395 . . . . 0.0 114.605 168.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -52.78 -47.96 57.73 Favored Glycine 0 C--O 1.249 1.08 0 CA-C-O 118.789 -1.006 . . . . 0.0 112.371 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 24.2 ttm -61.27 -31.48 71.3 Favored 'General case' 0 C--N 1.356 0.889 0 CA-C-N 119.801 1.801 . . . . 0.0 113.529 172.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.04 -33.33 71.82 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.548 -0.739 . . . . 0.0 110.816 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -90.31 -70.95 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 118.448 -0.787 . . . . 0.0 110.6 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.27 100.2 7.42 Favored 'General case' 0 C--O 1.252 1.206 0 CA-C-N 120.432 1.469 . . . . 0.0 107.658 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 45' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -69.49 82.73 0.4 Allowed 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -161.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.11 -4.42 55.24 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 111.164 -2.744 . . . . 0.0 114.363 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.24 -46.94 59.95 Favored 'General case' 0 C--O 1.25 1.086 0 O-C-N 119.66 -1.9 . . . . 0.0 113.659 -173.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 48' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -57.8 -44.38 99.38 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 120.333 1.424 . . . . 0.0 113.401 173.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 49' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -49.92 -49.78 15.11 Favored 'Trans proline' 0 C--O 1.255 1.352 0 C-N-CA 122.391 2.061 . . . . 0.0 115.574 163.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -68.86 -21.47 25.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 O-C-N 120.168 -1.582 . . . . 0.0 110.356 -171.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.68 -49.61 74.57 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 122.031 0.919 . . . . 0.0 111.403 172.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.12 -54.92 32.91 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.937 1.295 . . . . 0.0 112.633 176.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 6.7 tp -71.57 -33.5 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-N 119.171 0.896 . . . . 0.0 111.054 -176.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 89.2 m -67.01 -32.97 74.54 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 118.997 0.817 . . . . 0.0 109.659 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -56.14 -51.88 66.37 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 4.6 mppt? -65.11 -46.3 81.59 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 55.2 mt -58.8 -45.73 89.22 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 120.509 1.504 . . . . 0.0 111.899 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -70.04 -40.86 74.89 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.613 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.59 -45.26 73.55 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 121.478 1.945 . . . . 0.0 113.91 171.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 29.1 ttm-85 -65.38 -23.36 66.95 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.101 1.36 . . . . 0.0 112.346 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.07 21.25 9.66 Favored Glycine 0 CA--C 1.505 -0.545 0 CA-C-O 122.12 0.845 . . . . 0.0 114.053 174.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 59.0 mt -85.16 135.14 25.49 Favored 'Isoleucine or valine' 0 C--O 1.249 1.055 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -79.61 86.73 5.21 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 7.7 p -95.7 122.68 47.41 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 CA-C-O 122.456 1.122 . . . . 0.0 108.894 178.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 9.6 mmm-85 -126.27 136.71 53.11 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 122.227 1.013 . . . . 0.0 110.102 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -87.92 74.28 9.01 Favored 'General case' 0 C--O 1.243 0.715 0 O-C-N 120.082 -1.636 . . . . 0.0 109.203 177.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.65 83.14 0.91 Allowed Glycine 0 CA--C 1.529 0.965 0 N-CA-C 109.084 -1.607 . . . . 0.0 109.084 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 16.5 mt -98.08 144.67 10.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 O-C-N 124.61 0.83 . . . . 0.0 111.066 -167.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -109.84 72.37 0.61 Allowed Pre-proline 0 C--O 1.242 0.69 0 N-CA-C 103.018 -2.956 . . . . 0.0 103.018 169.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 70' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -61.47 -20.23 67.65 Favored 'Trans proline' 0 C--N 1.341 0.148 1 C-N-CA 125.335 4.024 . . . . 0.0 113.96 -167.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.84 81.32 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 122.949 1.357 . . . . 0.0 107.555 161.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.85 97.09 3.04 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 119.38 -2.075 . . . . 0.0 112.834 -172.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.92 -75.53 1.28 Allowed Glycine 0 N--CA 1.44 -1.08 0 O-C-N 120.388 -1.445 . . . . 0.0 114.632 170.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -121.63 98.9 6.17 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -174.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 75.33 132.29 0.04 OUTLIER Pre-proline 0 C--N 1.35 0.625 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 168.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.32 150.07 84.75 Favored 'Trans proline' 0 C--O 1.239 0.57 0 C-N-CA 123.287 2.658 . . . . 0.0 114.487 174.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.18 -94.16 1.46 Allowed Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 106.964 -2.454 . . . . 0.0 106.964 -169.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 2.1 t60 26.33 -80.7 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 127.83 2.452 . . . . 0.0 116.048 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -59.5 -43.62 93.3 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.698 -1.251 . . . . 0.0 111.587 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -67.98 -44.95 75.46 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 121.652 -0.655 . . . . 0.0 109.643 -176.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 90.1 t -52.1 -50.88 33.77 Favored 'Isoleucine or valine' 0 C--O 1.249 1.074 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 168.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 3.5 mp -53.55 -39.75 65.01 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 174.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 11.7 tp -59.99 -46.41 89.55 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 124.385 1.053 . . . . 0.0 112.667 170.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.37 -39.95 77.09 Favored 'General case' 0 C--O 1.246 0.911 0 C-N-CA 124.253 1.021 . . . . 0.0 111.25 173.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -60.87 -40.1 91.71 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.015 0.526 . . . . 0.0 111.01 172.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.22 0.1 3.02 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 120.645 -1.285 . . . . 0.0 113.315 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp 61.8 51.77 3.72 Favored 'General case' 0 C--O 1.266 1.921 0 C-N-CA 127.873 2.469 . . . . 0.0 111.403 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 57.8 t -100.93 130.67 24.65 Favored Pre-proline 0 N--CA 1.444 -0.739 0 CA-C-N 112.855 -1.975 . . . . 0.0 106.164 172.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -55.4 111.19 0.68 Allowed 'Trans proline' 0 CA--C 1.509 -0.744 0 C-N-CA 124.889 3.726 . . . . 0.0 116.772 177.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.16 -16.49 20.42 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 108.992 -3.731 . . . . 0.0 118.289 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -69.58 -48.76 59.1 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-O 118.081 -0.962 . . . . 0.0 111.939 174.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 22.9 pt -70.86 -15.24 18.7 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-N 120.563 1.529 . . . . 0.0 114.738 174.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 86.4 t -69.36 98.51 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-O 124.111 1.91 . . . . 0.0 106.721 167.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 19.2 mt -105.02 87.76 2.72 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 110.258 -3.155 . . . . 0.0 108.155 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 95' ' ' GLU . . . . . 0.477 ' CD ' ' HZ3' ' A' 1162 ' ' LYS . 34.8 mp0 -69.1 103.91 2.01 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 111.349 -2.66 . . . . 0.0 109.865 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 92.9 mtp 56.96 25.93 11.21 Favored 'General case' 0 C--O 1.25 1.106 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 171.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -81.88 155.46 25.31 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 113.64 -1.618 . . . . 0.0 109.751 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -82.97 56.27 3.4 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 120.095 1.316 . . . . 0.0 109.353 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 11.1 tp -74.46 41.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 O-C-N 117.28 -3.387 . . . . 0.0 111.902 173.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -76.85 -27.19 55.0 Favored 'General case' 0 C--O 1.217 -0.607 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -162.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.12 -44.82 87.46 Favored 'General case' 0 C--O 1.24 0.599 0 O-C-N 124.519 1.137 . . . . 0.0 110.274 174.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.42 -39.5 92.21 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 117.131 -1.414 . . . . 0.0 110.729 173.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 103' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -47.84 -56.5 7.33 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-N 123.042 2.655 . . . . 0.0 114.021 169.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.51 -35.89 77.04 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 123.674 0.79 . . . . 0.0 113.128 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -67.52 -39.35 85.07 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 121.221 -0.925 . . . . 0.0 111.568 175.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 106' ' ' THR . . . . . . . . . . . . . 3.8 m -52.3 133.57 34.34 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-O 126.812 3.196 . . . . 0.0 113.577 -169.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 107' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -69.26 -70.41 0.28 Allowed 'General case' 0 C--N 1.3 -1.553 1 CA-C-N 107.035 -4.62 . . . . 0.0 108.635 171.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 8.4 m -121.19 124.99 46.05 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 120.949 1.704 . . . . 0.0 110.662 -174.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 109' ' ' VAL . . . . . . . . . . . . . 32.5 t -99.33 119.26 47.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 174.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 16.2 mt -95.89 85.35 4.06 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 122.765 1.269 . . . . 0.0 109.854 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 11.8 t -81.52 103.8 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 177.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 1.8 mm -81.34 106.45 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 O-C-N 118.164 -2.835 . . . . 0.0 109.142 -171.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.22 -78.78 1.63 Allowed Glycine 0 CA--C 1.487 -1.669 0 CA-C-O 125.422 2.679 . . . . 0.0 111.863 170.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.43 127.23 40.2 Favored 'General case' 0 C--O 1.21 -0.983 0 O-C-N 120.077 -1.837 . . . . 0.0 111.613 -162.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 115' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -66.42 -53.79 31.67 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 113.611 -1.631 . . . . 0.0 114.803 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 116' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -65.75 -16.03 63.4 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 117.736 2.495 . . . . 0.0 117.736 -167.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 4.7 m -41.28 -44.85 2.79 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 127.175 2.797 . . . . 0.0 110.067 168.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.55 67.64 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.507 0 O-C-N 124.339 1.024 . . . . 0.0 108.679 169.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -87.6 119.56 70.72 Favored Pre-proline 0 C--O 1.26 1.658 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 120' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -60.88 -45.42 20.36 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.851 3.034 . . . . 0.0 110.995 -177.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.64 -14.41 62.05 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.32 -38.1 86.91 Favored 'General case' 0 CA--C 1.552 1.049 0 O-C-N 120.663 -1.273 . . . . 0.0 110.796 170.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -75.95 -50.24 15.5 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-O 122.263 1.03 . . . . 0.0 108.739 177.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -80.76 -45.08 17.6 Favored 'General case' 0 C--O 1.247 0.947 0 N-CA-C 120.196 3.406 . . . . 0.0 120.196 -173.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -103.1 123.44 41.92 Favored Pre-proline 0 CA--C 1.55 0.958 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -162.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_exo -46.26 -31.99 9.94 Favored 'Trans proline' 0 CA--C 1.503 -1.061 0 C-N-CA 124.534 3.49 . . . . 0.0 118.347 175.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -69.51 -32.8 71.88 Favored 'General case' 0 C--N 1.317 -0.829 0 O-C-N 120.904 -1.123 . . . . 0.0 110.648 -174.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 128' ' ' SER . . . . . . . . . . . . . 13.4 m -56.66 133.4 78.1 Favored Pre-proline 0 N--CA 1.467 0.42 0 C-N-CA 125.254 1.422 . . . . 0.0 107.874 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 129' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -55.14 -46.03 36.1 Favored 'Trans proline' 0 C--O 1.221 -0.368 1 C-N-CA 125.464 4.11 . . . . 0.0 114.282 175.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 4.3 pt -86.9 66.54 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.405 0 O-C-N 119.507 -1.996 . . . . 0.0 107.385 170.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -74.3 111.87 9.9 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.429 -1.26 . . . . 0.0 109.048 -174.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.73 34.87 17.82 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 122.821 1.234 . . . . 0.0 111.863 -175.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 133' ' ' MET . . . . . . . . . . . . . 39.0 tpp -70.09 123.03 88.0 Favored Pre-proline 0 C--O 1.243 0.722 0 CA-C-N 113.476 -1.362 . . . . 0.0 109.915 173.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -68.66 88.15 0.43 Allowed 'Trans proline' 0 N--CA 1.442 -1.536 0 C-N-CA 122.625 2.217 . . . . 0.0 112.198 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 28.6 m -88.31 150.09 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-N 113.424 -1.716 . . . . 0.0 106.973 168.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 27.4 mt -77.71 111.57 13.64 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 102.318 -3.215 . . . . 0.0 102.318 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -70.24 96.61 1.12 Allowed 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 123.39 1.567 . . . . 0.0 113.047 -155.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 14.8 p -85.28 110.35 19.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 125.177 2.418 . . . . 0.0 109.074 169.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 76.3 m95 -129.97 138.49 50.88 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 118.945 -2.347 . . . . 0.0 105.308 174.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 140' ' ' LYS . . . . . . . . . . . . . 24.5 pttm 38.15 20.69 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.823 1 N-CA-C 123.057 4.466 . . . . 0.0 123.057 175.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.84 150.82 36.17 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 120.369 -1.457 . . . . 0.0 107.754 163.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -62.89 -42.88 99.93 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 117.12 2.267 . . . . 0.0 117.12 -160.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 143' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -140.33 120.83 14.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 121.339 1.881 . . . . 0.0 108.443 167.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 144' ' ' VAL . . . . . . . . . . . . . 44.1 t -102.02 85.39 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 101.882 -3.377 . . . . 0.0 101.882 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 145' ' ' ILE . . . . . . . . . . . . . 26.3 mt -82.57 104.37 11.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 125.84 2.733 . . . . 0.0 110.507 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 146' ' ' VAL . . . . . . . . . . . . . 47.8 t -97.77 109.07 22.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 110.711 -2.949 . . . . 0.0 105.083 178.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 147' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -71.59 82.01 0.83 Allowed 'General case' 0 C--O 1.258 1.528 0 O-C-N 120.472 -1.393 . . . . 0.0 111.293 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 148' ' ' LYS . . . . . 0.433 ' NZ ' ' OD1' ' C' ' 152' ' ' ASN . 28.5 mtpt -103.05 133.09 48.75 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 120.297 -1.502 . . . . 0.0 107.764 177.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 -72.2 -29.3 63.84 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 123.056 1.408 . . . . 0.0 111.793 -175.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 16.0 m -142.04 151.32 42.31 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.337 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -73.23 102.87 3.76 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 103.077 -2.934 . . . . 0.0 103.077 167.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 152' ' ' ASN . . . . . 0.433 ' OD1' ' NZ ' ' C' ' 148' ' ' LYS . 13.0 p-10 -152.72 164.06 38.49 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 23.8 m -53.38 159.0 1.51 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 130.044 3.337 . . . . 0.0 113.741 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -136.21 -137.34 3.66 Favored Glycine 0 C--O 1.249 1.034 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -87.66 -63.75 1.25 Allowed 'General case' 0 C--O 1.238 0.468 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 171.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 156' ' ' ALA . . . . . . . . . . . . . . . -76.0 -53.63 8.08 Favored 'General case' 0 C--N 1.364 1.229 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 166.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 67.33 -89.16 0.17 Allowed Glycine 0 N--CA 1.461 0.327 0 N-CA-C 106.822 -2.511 . . . . 0.0 106.822 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . 0.385 35.1 m 46.3 148.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 120.84 3.644 . . . . 0.0 120.84 -176.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.9 83.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 O-C-N 121.159 -0.963 . . . . 0.0 109.477 173.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 160' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -130.77 164.27 42.93 Favored Pre-proline 0 C--O 1.242 0.673 0 CA-C-O 117.472 -1.252 . . . . 0.0 110.616 -164.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -38.33 -51.08 2.17 Favored 'Trans proline' 0 N--CA 1.445 -1.375 0 C-N-CA 124.383 3.388 . . . . 0.0 117.893 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 162' ' ' LEU . . . . . . . . . . . . . 1.4 mp -50.46 -35.41 28.76 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 176.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 163' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -73.63 -30.79 63.17 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -107.59 -51.42 2.91 Favored 'General case' 0 C--O 1.257 1.462 0 CA-C-O 123.142 1.448 . . . . 0.0 114.494 -169.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 4.9 mmtm -61.81 153.32 29.06 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 115.983 1.845 . . . . 0.0 115.983 -171.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -85.41 -45.29 12.01 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -164.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -89.12 -42.44 11.69 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.186 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 168' ' ' THR . . . . . . . . . . . . . 56.2 m -89.44 77.47 7.31 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 106.789 -1.559 . . . . 0.0 106.789 177.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -136.09 135.07 39.03 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.71 -158.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 170' ' ' MET . . . . . . . . . . . . . 67.6 mtm -63.99 94.57 0.1 Allowed 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.227 -1.806 . . . . 0.0 107.173 163.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 171' ' ' LEU . . . . . . . . . . . . . 10.4 tp -79.38 117.45 20.37 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -70.65 93.21 0.91 Allowed 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 110.716 -2.947 . . . . 0.0 114.386 -168.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -166.32 159.74 33.1 Favored Glycine 0 C--O 1.248 1.029 0 O-C-N 125.222 1.576 . . . . 0.0 109.664 176.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 174' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -69.93 151.74 45.28 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 113.582 -1.309 . . . . 0.0 108.911 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.52 -49.04 72.84 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.164 -175.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.53 -47.81 37.99 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -176.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 177' ' ' ALA . . . . . . . . . . . . . . . -56.3 -47.41 78.74 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 122.113 0.959 . . . . 0.0 113.204 -175.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 49.6 m -63.62 -36.23 83.12 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 176.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 179' ' ' VAL . . . . . . . . . . . . . 44.3 t -75.04 -39.56 44.22 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -52.71 -44.5 66.36 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.845 172.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -64.79 -52.09 58.72 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 119.131 -0.461 . . . . 0.0 111.914 174.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 182' ' ' ILE . . . . . . . . . . . . . 20.4 pt -64.79 -33.15 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 O-C-N 123.796 0.685 . . . . 0.0 111.45 -169.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 183' ' ' LEU . . . . . . . . . . . . . 4.0 pp -67.64 -36.29 80.49 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 124.138 0.975 . . . . 0.0 111.66 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -77.23 -48.04 18.6 Favored 'General case' 0 C--O 1.206 -1.215 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -69.79 -71.24 0.24 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 -171.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 186' ' ' LEU . . . . . 0.432 ' C ' ' HZ1' ' C' ' 28' ' ' LYS 0.313 0.9 OUTLIER . . . . . 0 N--CA 1.476 0.873 0 N-CA-C 116.555 2.057 . . . . 0.0 116.555 -155.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 36.6 t-80 . . . . . 0 CA--C 1.508 -0.662 0 N-CA-C 105.874 -1.898 . . . . 65.739999999999995 105.874 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -61.83 76.86 0.02 OUTLIER Glycine 0 CA--C 1.538 1.497 0 N-CA-C 116.432 1.333 . . . . 48.659999999999997 116.432 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 26.5 ttp180 -118.71 138.03 52.92 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 123.394 1.568 . . . . 44.560000000000002 108.532 175.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1003 ' ' ILE . . . . . . . . . . . . . 36.8 mt -106.65 129.75 59.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 102.253 -3.24 . . . . 34.859999999999999 102.253 -176.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -91.88 135.76 12.92 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 106.793 -2.523 . . . . 30.75 106.793 170.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 19.5 mm -113.5 97.69 44.42 Favored Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 105.954 -1.869 . . . . 32.210000000000001 105.954 172.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -81.05 166.28 18.85 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 123.171 2.581 . . . . 32.979999999999997 114.275 170.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1007 ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -85.31 140.05 31.12 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 113.066 -1.879 . . . . 47.979999999999997 106.071 167.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1008 ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -68.94 157.55 36.45 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 123.76 1.743 . . . . 34.700000000000003 113.774 -175.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -138.08 132.75 32.57 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 112.324 -2.216 . . . . 53.369999999999997 108.352 -171.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 10.8 tp 170.02 -177.24 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 102.96 -2.978 . . . . 45.07 102.96 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1011 ' ' THR . . . . . . . . . . . . . 11.0 m -72.01 114.5 10.18 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 122.745 2.521 . . . . 40.359999999999999 107.718 -174.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 4.3 m-20 64.53 43.58 4.38 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 113.712 1.004 . . . . 40.609999999999999 113.712 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -87.81 137.42 32.35 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 119.42 -0.912 . . . . 33.759999999999998 110.99 -171.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1014 ' ' THR . . . . . . . . . . . . . 19.9 p -103.24 -41.7 5.97 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 122.352 1.072 . . . . 27.890000000000001 113.038 -173.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1015 ' ' ARG . . . . . . . . . . . . . 61.9 mtm180 -48.28 167.74 0.03 OUTLIER 'General case' 0 C--N 1.356 0.88 0 N-CA-C 120.083 3.364 . . . . 29.02 120.083 -173.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1016 ' ' VAL . . . . . . . . . . . . . 7.7 p -132.12 162.52 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 113.454 -1.703 . . . . 28.129999999999999 106.712 171.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1017 ' ' ALA . . . . . . . . . . . . . . . -66.47 -36.5 82.92 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 119.087 -2.258 . . . . 26.870000000000001 115.2 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -154.47 144.76 22.05 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 106.277 -1.749 . . . . 26.77 106.277 -174.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1019 ' ' THR . . . . . . . . . . . . . 1.7 p -98.5 170.74 6.6 Favored Pre-proline 0 N--CA 1.447 -0.583 0 CA-C-O 116.797 -1.573 . . . . 27.02 113.422 169.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1020 ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -29.45 -61.66 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 125.29 3.993 . . . . 30.57 120.024 173.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -66.85 -28.48 68.37 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 123.216 2.734 . . . . 47.810000000000002 110.842 -175.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1022 ' ' THR . . . . . . . . . . . . . 22.4 m -64.38 -47.98 77.19 Favored 'General case' 0 CA--C 1.554 1.118 0 O-C-N 121.621 -0.674 . . . . 30.77 110.178 169.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1023 ' ' VAL . . . . . . . . . . . . . 24.8 t -61.89 -38.6 80.99 Favored 'Isoleucine or valine' 0 C--O 1.254 1.33 0 O-C-N 120.996 -1.065 . . . . 33.590000000000003 109.043 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -64.56 -45.12 88.43 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 118.801 -1.16 . . . . 53.289999999999999 110.797 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -57.37 -40.15 77.54 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 118.762 0.71 . . . . 46.920000000000002 112.262 174.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1026 ' ' LEU . . . . . . . . . . . . . 74.7 mt -65.34 -34.67 78.86 Favored 'General case' 0 C--O 1.249 1.043 0 O-C-N 120.189 -1.57 . . . . 37.170000000000002 112.322 176.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 81.0 mt -70.87 -38.63 73.11 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.605 -0.887 . . . . 44.439999999999998 108.605 174.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -57.85 -36.74 72.75 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.972 0.805 . . . . 52.579999999999998 111.989 175.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1029 ' ' LEU . . . . . . . . . . . . . 90.3 mt -60.97 -27.51 68.32 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 114.435 1.272 . . . . 45.689999999999998 114.435 170.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 93.2 32.27 7.94 Favored Glycine 0 C--O 1.242 0.614 0 O-C-N 121.23 -0.919 . . . . 42.090000000000003 113.111 -174.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -106.14 154.62 20.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 105.756 -1.942 . . . . 40.719999999999999 105.756 165.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1032 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.38 145.85 25.27 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 123.066 1.413 . . . . 37.770000000000003 109.42 172.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1033 ' ' VAL . . . . . . . . . . . . . 20.8 t -117.01 136.07 55.34 Favored 'Isoleucine or valine' 0 C--O 1.25 1.092 0 O-C-N 119.927 -1.733 . . . . 33.539999999999999 111.756 -172.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -119.79 140.52 50.63 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 108.156 -1.053 . . . . 31.68 108.156 170.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1035 ' ' VAL . . . . . . . . . . . . . 74.0 t -121.67 146.62 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 122.654 1.216 . . . . 31.52 109.387 178.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1036 ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -71.76 136.54 47.17 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 113.552 -1.658 . . . . 41.039999999999999 111.124 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1037 ' ' SER . . . . . . . . . . . . . 49.2 m -70.56 117.8 12.55 Favored 'General case' 0 C--O 1.246 0.883 0 N-CA-C 107.4 -1.333 . . . . 31.829999999999998 107.4 175.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 103.96 -7.24 48.48 Favored Glycine 0 C--O 1.219 -0.796 0 O-C-N 120.411 -1.431 . . . . 29.359999999999999 110.42 -174.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -68.69 -27.18 65.74 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 118.961 1.381 . . . . 27.780000000000001 112.089 -177.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -79.59 -32.57 37.2 Favored Glycine 0 N--CA 1.437 -1.27 0 CA-C-O 122.189 0.883 . . . . 28.91 112.604 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -47.59 -69.17 0.13 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.002 -1.599 . . . . 51.18 114.565 -171.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1042 ' ' LEU . . . . . . . . . . . . . 13.8 mt -77.22 -20.26 55.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.913 1.339 . . . . 29.91 111.869 -174.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1043 ' ' ALA . . . . . . . . . . . . . . . -82.22 -9.62 59.43 Favored 'General case' 0 C--O 1.243 0.759 0 O-C-N 120.419 -1.426 . . . . 28.539999999999999 113.153 171.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1044 ' ' SER . . . . . . . . . . . . . 7.9 m 56.33 63.92 1.85 Allowed 'General case' 0 C--N 1.361 1.1 0 O-C-N 126.715 2.509 . . . . 33.060000000000002 112.476 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1045 ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.78 75.15 0.62 Allowed 'General case' 0 C--N 1.315 -0.931 1 N-CA-C 98.682 -4.562 . . . . 30.289999999999999 98.682 162.332 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -62.46 150.63 39.52 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.762 -1.108 . . . . 48.619999999999997 113.621 -160.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -46.09 -29.47 1.52 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 117.612 2.449 . . . . 36.740000000000002 117.612 -156.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 21.6 pttm -53.35 -33.91 55.44 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 112.956 0.724 . . . . 43.729999999999997 112.956 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -60.49 -35.94 77.13 Favored 'General case' 0 CA--C 1.522 -0.133 0 O-C-N 120.366 -1.459 . . . . 32.810000000000002 112.917 171.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1050 ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -72.1 -24.85 61.56 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 120.187 -1.571 . . . . 31.859999999999999 111.412 175.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 61.8 t -65.41 -47.32 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 118.236 -0.888 . . . . 33.219999999999999 109.435 170.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -56.35 -34.48 66.65 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.565 1.691 . . . . 50.829999999999998 115.565 171.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -74.41 -21.78 59.46 Favored 'General case' 0 C--O 1.25 1.117 0 N-CA-C 115.093 1.516 . . . . 33.119999999999997 115.093 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 101.34 83.22 1.72 Allowed Glycine 0 CA--C 1.526 0.752 0 C-N-CA 119.453 -1.356 . . . . 35.829999999999998 110.219 -177.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -150.58 138.65 20.14 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 119.44 -2.212 . . . . 34.82 115.159 176.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -66.4 121.17 14.68 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 105.511 -2.033 . . . . 49.049999999999997 105.511 165.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1057 ' ' ILE . . . . . . . . . . . . . 43.3 mm -100.03 118.2 46.33 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 O-C-N 119.649 -1.907 . . . . 38.530000000000001 107.732 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1058 ' ' VAL . . . . . . . . . . . . . 3.2 m -133.93 172.87 15.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 125.602 1.561 . . . . 42.109999999999999 111.119 -176.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -87.84 165.36 15.35 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 122.878 2.581 . . . . 58.0 108.202 173.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . -49.53 -51.42 27.55 Favored Glycine 0 C--O 1.238 0.368 0 O-C-N 120.718 -1.239 . . . . 52.119999999999997 116.044 -172.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 7.8 t30 -49.5 -40.27 36.97 Favored 'General case' 0 C--O 1.251 1.159 0 CA-C-O 122.092 0.948 . . . . 54.75 112.817 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1062 ' ' SER . . . . . . . . . . . . . 16.5 m -78.08 -35.82 48.92 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 119.984 -1.697 . . . . 50.340000000000003 114.608 173.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 1.1 p -64.62 -28.98 46.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 119.588 -1.945 . . . . 41.460000000000001 111.027 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1064 ' ' TRP . . . . . . . . . . . . . 59.6 m95 -80.67 -13.87 58.64 Favored 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 121.064 -1.022 . . . . 39.32 112.736 175.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -77.34 67.4 3.28 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 119.302 -2.124 . . . . 55.380000000000003 105.979 173.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1066 ' ' SER . . . . . . . . . . . . . 60.1 m -148.69 142.87 26.04 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 119.709 -1.87 . . . . 41.869999999999997 111.227 -170.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.78 -36.55 79.26 Favored 'General case' 0 N--CA 1.437 -1.104 0 O-C-N 125.671 1.857 . . . . 53.200000000000003 112.438 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 3.7 mp -121.9 144.47 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 106.515 -1.661 . . . . 41.899999999999999 106.515 176.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1069 ' ' ILE . . . . . . . . . . . . . 49.0 mm -130.63 129.24 64.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 N-CA-C 107.416 -1.328 . . . . 38.729999999999997 107.416 169.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1070 ' ' LEU . . . . . . . . . . . . . 44.9 mt -97.17 143.81 27.62 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.256 -2.498 . . . . 32.439999999999998 104.256 175.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1071 ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -148.12 130.51 15.7 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.647 0.779 . . . . 34.649999999999999 111.534 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1072 ' ' VAL . . . . . . . . . . . . . 2.1 t -89.32 -13.96 9.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-N 114.86 -1.063 . . . . 31.32 113.747 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -112.89 -176.65 2.95 Favored 'General case' 0 C--O 1.248 1.018 0 N-CA-C 106.583 -1.636 . . . . 33.939999999999998 106.583 163.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -73.2 155.12 90.25 Favored Pre-proline 0 C--O 1.259 1.567 0 N-CA-C 109.043 -0.725 . . . . 38.039999999999999 109.043 161.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1075 ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -70.83 117.31 5.08 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 123.599 2.866 . . . . 42.68 114.621 168.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 86.8 mt -71.21 162.64 29.09 Favored 'General case' 0 N--CA 1.434 -1.251 0 O-C-N 125.838 1.961 . . . . 46.740000000000002 107.868 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -42.73 -46.3 5.06 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 117.743 2.498 . . . . 58.609999999999999 117.743 -177.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 38.8 t70 -64.73 -41.33 96.04 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 113.567 0.951 . . . . 59.200000000000003 113.567 174.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1079 ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -66.69 -32.96 74.61 Favored 'General case' 0 C--O 1.211 -0.956 0 N-CA-C 108.347 -0.983 . . . . 50.630000000000003 108.347 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1080 ' ' ILE . . . . . . . . . . . . . 95.7 mt -59.6 -41.53 85.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 123.648 1.69 . . . . 51.479999999999997 110.728 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -62.62 -29.35 70.55 Favored 'General case' 0 C--O 1.211 -0.969 0 O-C-N 120.876 -1.14 . . . . 50.280000000000001 111.958 175.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 8.0 mt -70.47 -27.26 64.09 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 114.815 1.413 . . . . 50.210000000000001 114.815 173.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1083 ' ' LEU . . . . . . . . . . . . . 1.3 mm? -64.16 123.95 20.41 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 122.817 1.294 . . . . 49.060000000000002 112.099 -176.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -89.81 141.24 28.15 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 104.807 -2.294 . . . . 51.079999999999998 104.807 175.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -56.81 148.26 67.51 Favored 'Trans proline' 0 CA--C 1.503 -1.031 0 C-N-CA 122.745 2.297 . . . . 49.729999999999997 116.035 -177.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 84.05 -14.11 45.76 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 113.887 -1.506 . . . . 47.710000000000001 113.658 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1087 ' ' THR . . . . . . . . . . . . . 38.6 m -59.2 127.04 30.15 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 119.868 1.834 . . . . 45.469999999999999 113.293 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1088 ' ' THR . . . . . . . . . . . . . 31.0 m -75.31 96.46 3.38 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 105.66 -1.978 . . . . 42.039999999999999 105.66 173.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1089 ' ' LEU . . . . . . . . . . . . . 42.7 tp -89.09 113.36 24.5 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 113.301 -1.772 . . . . 38.060000000000002 108.028 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 3.3 t -108.37 109.06 26.89 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 N-CA-C 102.265 -3.235 . . . . 37.399999999999999 102.265 -173.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1091 ' ' SER . . . . . . . . . . . . . 19.7 m -145.67 153.87 41.49 Favored 'General case' 0 C--O 1.224 -0.285 0 O-C-N 120.686 -1.259 . . . . 36.159999999999997 112.888 -166.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 2.8 t80 -84.67 91.03 7.83 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 105.727 -1.953 . . . . 38.939999999999998 105.727 172.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 26.5 mm -83.86 -49.57 16.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 115.37 1.619 . . . . 42.170000000000002 115.37 -172.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 96.4 m95 60.42 73.0 0.67 Allowed Pre-proline 0 C--O 1.255 1.366 0 C-N-CA 125.243 1.417 . . . . 46.509999999999998 111.021 -159.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -59.76 -38.39 80.9 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 124.754 3.636 . . . . 49.759999999999998 116.566 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -55.69 -47.44 76.78 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.618 -1.628 . . . . 52.619999999999997 110.824 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -64.77 -27.49 68.93 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 113.361 -1.745 . . . . 60.740000000000002 113.577 174.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1098 ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -123.32 56.96 10.34 Favored Pre-proline 0 N--CA 1.449 -0.478 0 N-CA-C 119.363 3.097 . . . . 58.189999999999998 119.363 -164.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -59.19 -47.67 16.6 Favored 'Trans proline' 0 N--CA 1.479 0.633 0 C-N-CA 123.399 2.732 . . . . 54.590000000000003 115.257 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.38 -44.52 97.02 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 113.18 0.807 . . . . 63.280000000000001 113.18 177.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1101 ' ' LEU . . . . . . . . . . . . . 8.2 tp -62.5 -46.26 89.26 Favored 'General case' 0 N--CA 1.441 -0.898 0 O-C-N 124.608 1.192 . . . . 54.75 107.853 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1102 ' ' MET . . . . . . . . . . . . . 49.8 mmm -53.98 -45.56 71.42 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 123.366 0.667 . . . . 52.649999999999999 112.054 175.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -62.11 -34.41 76.28 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 118.017 -0.992 . . . . 66.260000000000005 112.364 175.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 86.2 mttt -66.58 -46.62 75.38 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.891 -0.781 . . . . 63.729999999999997 108.891 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.01 -39.08 84.59 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 121.191 -0.943 . . . . 54.68 110.513 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -69.56 -38.8 77.59 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.397 -0.814 . . . . 53.640000000000001 111.308 176.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -71.85 -18.87 62.04 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 120.292 1.405 . . . . 67.239999999999995 112.186 177.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -77.55 -4.78 47.44 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 116.124 1.898 . . . . 65.760000000000005 116.124 163.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 5.2 t30 55.17 40.8 31.85 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 126.166 1.786 . . . . 58.710000000000001 111.532 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1110 ' ' VAL . . . . . . . . . . . . . 30.8 m -98.27 153.67 4.01 Favored 'Isoleucine or valine' 0 C--N 1.344 0.357 0 O-C-N 121.24 -0.913 . . . . 46.630000000000003 113.007 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1111 ' ' THR . . . . . . . . . . . . . 53.6 m -88.89 100.22 13.01 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 104.704 -2.332 . . . . 44.130000000000003 104.704 176.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1112 ' ' VAL . . . . . . . . . . . . . 62.2 t -93.82 115.16 31.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 O-C-N 121.111 -0.993 . . . . 40.439999999999998 109.743 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1113 ' ' MET . . . . . . . . . . . . . 19.3 mtp -101.24 102.42 13.3 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.033 -1.894 . . . . 50.759999999999998 108.564 173.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1114 ' ' ALA . . . . . . . . . . . . . . . -80.08 108.07 13.37 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 122.936 1.351 . . . . 35.640000000000001 108.88 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1115 ' ' MET . . . . . . . . . . . . . 69.9 mmm -71.83 -20.71 61.79 Favored 'General case' 0 C--O 1.243 0.759 0 O-C-N 119.437 -2.04 . . . . 38.740000000000002 115.308 -174.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -66.08 -32.63 74.2 Favored 'General case' 0 C--O 1.246 0.915 0 CA-C-O 122.238 1.018 . . . . 40.140000000000001 109.289 164.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1117 ' ' SER . . . . . . . . . . . . . 68.9 m -91.09 34.47 0.93 Allowed 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 117.14 2.274 . . . . 44.789999999999999 117.14 -176.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1118 ' ' VAL . . . . . . . . . . . . . 3.5 t -75.56 129.03 82.81 Favored Pre-proline 0 N--CA 1.439 -1.011 0 O-C-N 121.718 -0.614 . . . . 43.75 109.547 165.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -61.19 137.97 74.55 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.714 2.276 . . . . 48.93 111.795 172.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 25.1 mmm-85 -90.16 32.86 0.9 Allowed 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.204 -1.56 . . . . 62.899999999999999 111.546 -152.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 30.8 pt -79.89 155.63 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 O-C-N 118.492 -2.63 . . . . 57.719999999999999 112.198 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1122 ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -43.27 -58.99 2.27 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 120.653 3.575 . . . . 57.259999999999998 120.653 -177.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1123 ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.09 -16.55 32.72 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 116.565 2.061 . . . . 62.899999999999999 116.565 175.027 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -80.41 -15.05 57.74 Favored 'General case' 0 N--CA 1.424 -1.755 0 O-C-N 118.67 -2.519 . . . . 49.829999999999998 113.472 177.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 69.6 mm-40 -66.99 -22.04 65.93 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 116.996 2.221 . . . . 52.369999999999997 116.996 -163.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1126 ' ' SER . . . . . . . . . . . . . 13.7 m -73.31 -19.18 61.09 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 115.174 1.546 . . . . 42.43 115.174 169.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1127 ' ' LEU . . . . . . . . . . . . . 2.7 mp -95.84 -30.64 13.56 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.591 -0.892 . . . . 43.740000000000002 108.591 173.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 65.6 t0 -65.06 106.91 1.37 Allowed 'General case' 0 C--O 1.247 0.954 0 CA-C-O 125.833 2.73 . . . . 43.210000000000001 112.045 -173.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -85.08 -28.72 25.43 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 109.576 -3.465 . . . . 35.740000000000002 110.12 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.82 -20.26 65.9 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-N 120.866 1.666 . . . . 38.090000000000003 109.107 177.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1131 ' ' SER . . . . . . . . . . . . . 65.4 m -82.5 -64.37 1.19 Allowed 'General case' 0 CA--C 1.545 0.766 0 O-C-N 119.413 -2.054 . . . . 36.909999999999997 110.327 161.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1132 ' ' SER . . . . . . . . . . . . . 19.4 m -66.92 -44.51 80.51 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 117.678 2.473 . . . . 35.789999999999999 117.678 -168.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1133 ' ' MET . . . . . . . . . . . . . 5.2 ttt -68.37 -35.18 77.34 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 121.784 2.084 . . . . 30.809999999999999 110.624 176.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1134 ' ' ALA . . . . . . . . . . . . . . . -60.51 -40.82 92.79 Favored 'General case' 0 C--O 1.251 1.18 0 N-CA-C 109.143 -0.688 . . . . 28.879999999999999 109.143 173.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1135 ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -53.8 -48.06 70.22 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.235 1.414 . . . . 40.759999999999998 112.285 175.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1136 ' ' ILE . . . . . . . . . . . . . 69.0 mt -57.87 -47.48 86.16 Favored 'Isoleucine or valine' 0 C--O 1.247 0.934 0 CA-C-N 114.388 -1.278 . . . . 31.539999999999999 110.985 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -60.83 -34.24 74.26 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.068 -1.423 . . . . 29.870000000000001 110.495 174.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -62.59 -48.5 81.17 Favored Glycine 0 C--O 1.211 -1.327 0 CA-C-N 119.296 0.953 . . . . 28.73 112.177 176.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 28.3 t80 -59.93 -42.06 93.15 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.596 -0.802 . . . . 30.390000000000001 110.317 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1140 ' ' ARG . . . . . 0.425 ' NH1' ' O ' ' A' 1318 ' ' ARG . 1.1 tpt180 -73.34 -22.6 60.27 Favored 'General case' 0 CA--C 1.497 -1.066 0 O-C-N 124.445 1.091 . . . . 26.09 113.178 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1141 ' ' ALA . . . . . . . . . . . . . . . -66.62 -48.02 70.78 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 105.545 -2.02 . . . . 27.100000000000001 105.545 171.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 25.8 mm -53.66 -43.43 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 C-N-CA 125.442 1.497 . . . . 28.48 111.541 175.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 75.4 t -58.55 -61.68 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 O-C-N 120.653 -1.279 . . . . 23.07 110.113 173.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1144 ' ' GLU . . . . . 0.418 ' CD ' HH21 ' A' 1140 ' ' ARG . 5.7 mm-40 -62.42 -28.28 69.68 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 122.126 2.239 . . . . 33.399999999999999 114.137 -177.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -57.38 -60.47 3.59 Favored 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 124.668 1.187 . . . . 24.219999999999999 109.721 169.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -65.39 -20.49 66.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.554 0.692 . . . . 24.890000000000001 111.038 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -76.61 -33.53 58.39 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-O 115.511 -2.185 . . . . 26.73 110.725 177.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1148 ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -110.16 3.38 20.09 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 122.221 2.282 . . . . 39.960000000000001 115.785 175.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1149 ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -67.08 145.94 54.82 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 126.063 1.745 . . . . 25.870000000000001 110.448 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1150 ' ' GLY . . . . . . . . . . . . . . . -69.75 -45.18 59.59 Favored Glycine 0 N--CA 1.43 -1.732 0 O-C-N 121.308 -0.87 . . . . 19.280000000000001 113.504 171.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1151 ' ' ARG . . . . . . . . . . . . . 69.7 mtm-85 -107.42 -173.79 2.37 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 124.362 1.065 . . . . 39.899999999999999 113.347 -166.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1152 ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -84.07 149.68 26.08 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 106.218 -1.771 . . . . 29.440000000000001 106.218 172.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1153 ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -64.95 -53.31 48.39 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 124.177 1.942 . . . . 32.600000000000001 110.18 152.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1154 ' ' THR . . . . . . . . . . . . 0.255 56.3 m -65.03 110.77 2.6 Favored 'General case' 0 C--O 1.249 1.068 0 CA-C-N 111.908 -2.406 . . . . 34.640000000000001 116.427 -174.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -64.07 138.85 41.89 Favored Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 109.579 -1.409 . . . . 37.140000000000001 109.579 163.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -173.63 158.84 3.45 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 122.53 1.157 . . . . 40.57 111.507 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1157 ' ' ILE . . . . . . . . . . . . . 6.5 tp -79.03 136.81 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 O-C-N 119.995 -1.691 . . . . 44.609999999999999 109.41 163.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1158 ' ' THR . . . . . . . . . . . . . 68.7 p -111.28 -160.12 0.7 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 105.469 -2.049 . . . . 40.700000000000003 105.469 169.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -83.28 -20.29 34.72 Favored 'General case' 0 CA--C 1.541 0.634 1 O-C-N 116.284 -4.01 . . . . 40.25 108.92 165.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -96.46 43.98 1.07 Allowed 'General case' 0 C--O 1.246 0.897 0 CA-C-O 123.32 1.533 . . . . 38.469999999999999 110.238 175.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . 74.97 -171.99 53.52 Favored Glycine 0 C--O 1.244 0.762 0 O-C-N 119.943 -1.723 . . . . 37.609999999999999 116.074 170.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -72.82 135.1 45.16 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 122.812 1.292 . . . . 48.899999999999999 112.186 -174.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1163 ' ' VAL . . . . . . . . . . . . . 84.0 t -93.86 127.08 46.87 Favored Pre-proline 0 C--O 1.25 1.089 0 N-CA-C 104.398 -2.445 . . . . 36.520000000000003 104.398 162.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1164 ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.09 145.86 40.22 Favored 'Trans proline' 0 N--CA 1.444 -1.403 0 C-N-CA 124.615 3.544 . . . . 35.079999999999998 109.838 173.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1165 ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -62.01 147.13 95.75 Favored 'Trans proline' 0 C--O 1.245 0.833 0 C-N-CA 123.889 3.059 . . . . 35.329999999999998 109.713 172.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -78.64 135.41 37.21 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.736 1.014 . . . . 34.689999999999998 113.736 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1167 ' ' LYS . . . . . . . . . . . . . 44.3 mttp -84.24 100.02 10.93 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 102.263 -3.236 . . . . 45.359999999999999 102.263 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 59.9 t -91.38 88.27 2.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 114.793 -1.094 . . . . 31.710000000000001 110.241 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1169 ' ' MET . . . . . . . . . . . . . 37.2 ttp -77.2 107.04 9.3 Favored 'General case' 0 CA--C 1.498 -1.037 0 O-C-N 119.49 -2.006 . . . . 42.280000000000001 107.884 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 59.4 t -92.29 121.81 43.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 117.27 -1.348 . . . . 30.510000000000002 109.612 176.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 20.8 mt -107.36 131.37 57.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 104.609 -2.367 . . . . 31.870000000000001 104.609 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 82.22 61.77 1.97 Allowed Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 108.584 -1.807 . . . . 34.539999999999999 108.584 174.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1173 ' ' ALA . . . . . . . . . . . . . . . -77.37 76.98 3.9 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 120.373 -1.663 . . . . 32.509999999999998 115.108 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -84.81 -160.77 32.72 Favored Glycine 0 C--O 1.219 -0.796 0 CA-C-O 116.774 -2.126 . . . . 29.899999999999999 110.25 156.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1175 ' ' VAL . . . . . . . . . . . . . 48.3 t -64.63 -31.09 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 1 CA-C-N 124.977 4.389 . . . . 33.109999999999999 114.32 -176.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -53.58 -47.58 69.98 Favored 'General case' 0 C--O 1.218 -0.559 0 O-C-N 121.885 -0.509 . . . . 28.100000000000001 111.602 165.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -63.71 -42.88 98.51 Favored Glycine 0 CA--C 1.507 -0.419 0 CA-C-O 118.846 -0.974 . . . . 28.539999999999999 111.759 176.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1178 ' ' LEU . . . . . . . . . . . . . 52.4 mt -62.9 -35.19 79.25 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 117.462 -1.256 . . . . 31.219999999999999 110.698 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -64.61 -34.88 79.3 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 121.769 2.077 . . . . 28.98 112.374 172.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -67.81 -45.78 73.79 Favored 'General case' 0 C--O 1.253 1.25 0 CA-C-N 115.249 -0.887 . . . . 27.829999999999998 112.079 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1181 ' ' ILE . . . . . . . . . . . . . 54.7 mt -57.32 -53.9 37.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.496 0 CA-C-N 114.93 -1.032 . . . . 30.25 109.07 175.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -52.72 -58.0 12.6 Favored Glycine 0 N--CA 1.471 1.005 0 O-C-N 125.161 1.538 . . . . 29.59 109.71 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -60.37 -48.78 80.29 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 115.338 1.607 . . . . 30.289999999999999 115.338 -175.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -69.75 -33.22 72.14 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 120.116 1.325 . . . . 30.469999999999999 114.394 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -65.99 -43.78 86.76 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.689 -0.856 . . . . 42.409999999999997 108.689 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1186 ' ' SER . . . . . . . . . . . . . 68.1 m -59.38 -48.18 82.61 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 121.073 -1.017 . . . . 39.380000000000003 112.586 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 10.6 mt -53.43 -34.47 57.94 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 117.207 2.299 . . . . 36.18 117.207 170.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 105.36 52.38 0.82 Allowed Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 109.124 -1.591 . . . . 33.780000000000001 109.124 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -135.54 143.93 45.99 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 107.488 -1.301 . . . . 33.93 107.488 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 7.5 mt -79.57 106.85 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 103.111 -2.922 . . . . 38.740000000000002 103.111 -170.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 44.0 t -76.21 135.26 27.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 105.974 -1.861 . . . . 33.090000000000003 105.974 173.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1192 ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -126.4 87.01 2.6 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 102.741 -3.059 . . . . 38.920000000000002 102.741 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -95.59 154.56 17.15 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 120.33 -1.481 . . . . 35.32 111.794 -170.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 35.6 t80 -155.91 164.31 38.66 Favored 'General case' 0 C--O 1.25 1.115 0 O-C-N 124.557 1.161 . . . . 39.350000000000001 108.064 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 10.6 t70 -164.77 162.63 21.22 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 104.492 -2.41 . . . . 40.460000000000001 104.492 174.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1196 ' ' THR . . . . . . . . . . . . . 5.6 m -58.36 -38.63 77.62 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.836 -1.075 . . . . 45.939999999999998 111.877 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1197 ' ' ARG . . . . . . . . . . . . . 40.5 mtm180 -90.06 113.86 58.76 Favored Pre-proline 0 N--CA 1.449 -0.498 0 C-N-CA 126.191 1.796 . . . . 56.020000000000003 108.214 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1198 ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -55.1 -22.27 30.89 Favored 'Trans proline' 0 N--CA 1.435 -1.955 0 C-N-CA 125.202 3.935 . . . . 51.270000000000003 116.361 173.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -47.86 -41.0 23.03 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 116.539 2.051 . . . . 59.100000000000001 116.539 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 32.8 m -64.16 -9.29 5.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 116.095 1.887 . . . . 51.060000000000002 116.095 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1201 ' ' LYS . . . . . 0.406 ' HZ1' ' CD ' ' A' 1213 ' ' GLU . 80.6 tttt -53.74 -40.81 66.45 Favored 'General case' 0 N--CA 1.436 -1.126 0 O-C-N 123.769 0.668 . . . . 57.380000000000003 111.908 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.91 -47.51 71.11 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 115.444 1.646 . . . . 62.409999999999997 115.444 174.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -61.89 -43.41 98.91 Favored 'General case' 0 C--O 1.256 1.44 0 CA-C-O 123.37 1.557 . . . . 57.780000000000001 112.538 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 42.2 t -53.68 -57.24 5.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 112.571 -2.104 . . . . 46.380000000000003 109.0 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -70.53 -31.57 68.7 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 113.106 -1.861 . . . . 50.700000000000003 112.313 -177.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1206 ' ' SER . . . . . . . . . . . . . 66.8 m -70.7 -45.02 65.74 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 119.797 1.18 . . . . 49.979999999999997 111.328 -177.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1207 ' ' MET . . . . . . . . . . . . . 59.3 mtm -68.19 -34.18 75.8 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 122.723 1.249 . . . . 52.990000000000002 112.988 175.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 123.42 96.25 1.23 Allowed Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 107.56 -2.216 . . . . 47.659999999999997 107.56 171.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -168.12 160.19 11.62 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 120.788 -0.365 . . . . 44.770000000000003 110.188 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -85.62 145.91 27.11 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 102.894 -3.002 . . . . 47.640000000000001 102.894 170.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1211 ' ' PHE . . . . . . . . . . . . . 71.6 t80 -112.93 145.28 41.04 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 103.341 -2.837 . . . . 45.659999999999997 103.341 173.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 80.0 mt -71.14 108.54 4.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 123.369 1.557 . . . . 46.060000000000002 112.233 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1213 ' ' GLU . . . . . 0.406 ' CD ' ' HZ1' ' A' 1201 ' ' LYS . 7.2 mm-40 -87.22 123.98 32.82 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 106.238 -1.764 . . . . 60.219999999999999 106.238 174.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 8.9 mp -90.34 144.81 25.48 Favored 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 115.259 1.577 . . . . 57.25 115.259 -176.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 35.6 t70 -71.59 83.56 0.85 Allowed 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 112.976 -1.92 . . . . 64.430000000000007 109.922 165.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 83.4 t80 . . . . . 0 C--O 1.216 -0.678 0 N-CA-C 102.38 -3.193 . . . . 66.900000000000006 102.38 -177.011 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 9.2 p-10 . . . . . 0 N--CA 1.437 -1.114 0 N-CA-C 106.779 -1.563 . . . . 39.090000000000003 106.779 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -49.33 -51.11 27.51 Favored Glycine 0 N--CA 1.474 1.185 0 C-N-CA 126.956 2.217 . . . . 39.32 112.943 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 60.3 t80 -64.86 -47.56 77.46 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 119.292 1.546 . . . . 39.299999999999997 111.739 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -63.91 -43.33 96.26 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 119.625 1.102 . . . . 36.299999999999997 113.105 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -57.07 -34.52 68.35 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 124.263 0.977 . . . . 37.380000000000003 112.144 174.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -63.43 -53.99 38.36 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 CA-C-N 121.106 1.775 . . . . 39.109999999999999 111.449 166.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1230 ' ' MET . . . . . . . . . . . . . 28.9 mmt -71.13 40.57 0.06 Allowed 'General case' 0 C--O 1.242 0.709 0 N-CA-C 113.706 1.002 . . . . 49.590000000000003 113.706 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1231 ' ' SER . . . . . . . . . . . . . 61.8 p -114.12 157.02 23.15 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 118.681 -2.512 . . . . 43.68 108.131 -174.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -55.11 -46.6 75.56 Favored 'General case' 0 C--N 1.356 0.865 0 CA-C-O 123.399 1.571 . . . . 55.57 110.289 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -70.76 -35.6 72.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 117.851 -1.071 . . . . 44.939999999999998 113.579 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 31.9 t80 -72.26 -48.44 42.61 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 122.535 2.425 . . . . 42.039999999999999 109.403 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 58.9 mt -64.3 -32.17 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 CA-C-N 118.645 0.657 . . . . 46.280000000000001 111.893 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 41.1 tttm -52.88 -53.72 44.91 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.783 -1.192 . . . . 47.869999999999997 107.783 167.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -62.85 -32.2 73.38 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 114.433 1.272 . . . . 41.609999999999999 114.433 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -54.43 -50.24 68.08 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 119.054 0.843 . . . . 50.649999999999999 112.614 165.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1239 ' ' MET . . . . . . . . . . . . . 34.3 mmt -61.15 -47.52 85.84 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 123.152 1.453 . . . . 48.869999999999997 110.075 -178.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -58.83 -40.08 83.15 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 112.949 -1.932 . . . . 54.799999999999997 109.613 175.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 3.5 mm? -75.19 -33.83 61.47 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 122.376 2.353 . . . . 43.210000000000001 112.453 176.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -69.81 -40.56 75.87 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 121.788 2.086 . . . . 38.659999999999997 109.681 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -64.73 -38.65 91.7 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 125.231 1.412 . . . . 37.920000000000002 111.464 171.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -63.69 -25.15 68.08 Favored 'General case' 0 C--O 1.246 0.882 0 O-C-N 120.026 -1.671 . . . . 37.280000000000001 112.567 171.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -84.09 -32.15 24.93 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-O 118.548 -0.739 . . . . 43.07 111.83 176.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -49.92 -45.19 50.76 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 113.443 0.905 . . . . 38.299999999999997 113.443 -158.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1247 ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.38 -11.53 59.69 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 119.423 -2.048 . . . . 47.600000000000001 111.757 -172.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -106.88 -31.65 8.26 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 118.548 -0.739 . . . . 45.420000000000002 110.672 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1249 ' ' VAL . . . . . . . . . . . . 0.307 12.2 m -68.45 152.86 9.26 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 N-CA-C 117.658 2.466 . . . . 36.259999999999998 117.658 -172.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1250 ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -113.74 -54.77 2.58 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 112.636 -2.074 . . . . 33.039999999999999 109.274 -171.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1251 ' ' ILE . . . . . . . . . . . . . 25.8 mm -124.13 122.8 65.2 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.692 0 N-CA-C 101.644 -3.465 . . . . 31.399999999999999 101.644 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1252 ' ' ILE . . . . . . . . . . . . . 55.5 mt -99.72 127.47 52.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 103.579 -2.749 . . . . 29.420000000000002 103.579 161.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 11.2 t -110.87 104.73 17.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 1 N-CA-C 100.141 -4.022 . . . . 30.370000000000001 100.141 176.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1254 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.91 84.77 6.64 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-O 125.619 2.628 . . . . 35.719999999999999 111.971 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1255 ' ' THR . . . . . . . . . . . . . 14.6 p -95.09 12.68 27.76 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 110.765 -2.925 . . . . 36.0 116.748 -176.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1256 ' ' ALA . . . . . . . . . . . . . . . -83.97 67.4 9.62 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 120.909 1.686 . . . . 40.93 112.011 -176.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 37.3 tp -82.24 99.27 9.2 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 106.561 -1.644 . . . . 47.82 106.561 176.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 30.8 mm -75.87 139.65 70.02 Favored Pre-proline 0 N--CA 1.433 -1.32 0 N-CA-C 108.071 -1.085 . . . . 52.700000000000003 108.071 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -59.78 114.04 1.9 Allowed 'Trans proline' 0 CA--C 1.512 -0.597 0 C-N-CA 122.573 2.182 . . . . 54.130000000000003 112.719 169.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 80.91 -75.47 2.27 Favored Glycine 0 C--O 1.255 1.44 0 N-CA-C 107.047 -2.421 . . . . 54.619999999999997 107.047 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 89.9 mttt -51.03 140.38 21.25 Favored Pre-proline 0 C--O 1.252 1.225 0 C-N-CA 126.064 1.746 . . . . 55.740000000000002 112.072 -177.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -56.64 136.29 75.21 Favored 'Trans proline' 0 N--CA 1.44 -1.634 1 C-N-CA 125.311 4.008 . . . . 51.149999999999999 111.043 176.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -54.98 130.81 67.49 Favored Pre-proline 0 N--CA 1.47 0.538 0 CA-C-O 121.791 0.805 . . . . 46.060000000000002 110.718 170.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -56.5 129.2 33.46 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 124.565 3.51 . . . . 41.079999999999998 110.68 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -77.6 70.15 3.94 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 124.923 2.297 . . . . 47.420000000000002 111.874 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 61.0 mt -69.91 -58.53 3.75 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 109.572 -3.467 . . . . 39.219999999999999 110.75 -164.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 31.9 mt -83.78 106.26 14.07 Favored 'Isoleucine or valine' 0 C--O 1.246 0.918 0 N-CA-C 106.987 -1.486 . . . . 42.5 106.987 -174.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1268 ' ' THR . . . . . . . . . . . . . 38.5 p -67.55 156.15 37.43 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 115.83 -0.623 . . . . 37.840000000000003 111.562 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -55.32 -34.73 64.43 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.513 -0.551 . . . . 54.799999999999997 109.513 171.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -48.73 -54.65 14.09 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 113.403 0.89 . . . . 54.359999999999999 113.403 166.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1271 ' ' MET . . . . . . . . . . . . . 26.5 mtm -68.23 -35.52 78.08 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.833 0.679 . . . . 39.520000000000003 112.833 -177.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1272 ' ' VAL . . . . . . . . . . . . . 79.2 t -62.82 -51.89 66.33 Favored 'Isoleucine or valine' 0 C--O 1.25 1.13 0 N-CA-C 106.611 -1.626 . . . . 38.25 106.611 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.05 -33.48 67.28 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 117.776 2.51 . . . . 40.770000000000003 117.776 170.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1274 ' ' SER . . . . . . . . . . . . . 41.0 m -80.39 -3.06 48.23 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 113.273 0.842 . . . . 36.579999999999998 113.273 174.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1275 ' ' MET . . . . . . . . . . . . . 16.2 mtp -69.31 158.63 34.67 Favored 'General case' 0 CA--C 1.51 -0.583 0 O-C-N 118.705 -2.497 . . . . 36.75 116.706 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1276 ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -65.21 139.65 58.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 124.343 2.021 . . . . 46.109999999999999 108.006 168.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1277 ' ' ALA . . . . . . . . . . . . 0.253 . . -75.64 157.85 33.18 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 108.588 -3.915 . . . . 33.520000000000003 109.889 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 73.21 24.1 76.2 Favored Glycine 0 C--N 1.347 1.167 0 N-CA-C 110.917 -0.873 . . . . 31.27 110.917 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1279 ' ' SER . . . . . . . . . . . . . 22.7 m -122.22 169.65 10.69 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.734 -0.733 . . . . 32.950000000000003 110.971 -171.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1280 ' ' VAL . . . . . . . . . . . . . 42.5 t -132.11 141.92 44.16 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 N-CA-C 108.347 -0.983 . . . . 27.43 108.347 -171.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1281 ' ' ILE . . . . . . . . . . . . . 84.9 mt -114.44 102.32 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 1 N-CA-C 99.335 -4.32 . . . . 30.300000000000001 99.335 164.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -87.91 96.44 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 CA-C-O 123.21 1.481 . . . . 28.629999999999999 107.343 172.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 4.9 t70 -87.76 100.01 12.52 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 113.989 -1.459 . . . . 36.270000000000003 110.941 -175.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1284 ' ' LEU . . . . . . . . . . . . . 5.5 tt -74.27 -34.57 63.62 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 123.664 1.697 . . . . 38.57 108.42 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -63.42 -13.45 40.18 Favored 'General case' 0 CA--C 1.508 -0.665 0 O-C-N 120.478 -1.389 . . . . 37.560000000000002 113.84 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . -34.19 -38.39 0.06 Allowed 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 121.674 3.953 . . . . 40.329999999999998 121.674 175.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -66.63 -22.74 66.11 Favored 'General case' 0 C--N 1.345 0.4 0 C-N-CA 118.662 -1.215 . . . . 56.850000000000001 113.88 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 30.2 t30 -142.06 86.99 2.01 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.145 -1.428 . . . . 45.859999999999999 107.145 177.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 106.16 -67.84 0.24 Allowed Glycine 0 CA--C 1.492 -1.361 0 C-N-CA 120.054 -1.07 . . . . 40.310000000000002 111.494 175.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 86.08 111.27 0.8 Allowed Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 105.769 -2.933 . . . . 38.890000000000001 105.769 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1291 ' ' ASN . . . . . . . . . . . . . 27.1 m120 -70.68 -22.93 62.42 Favored 'General case' 0 C--O 1.223 -0.309 0 O-C-N 120.183 -1.775 . . . . 37.229999999999997 113.393 -171.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1292 ' ' CYS . . . . . . . . . . . . . 35.6 t -89.46 143.81 26.53 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 104.335 -2.468 . . . . 36.5 104.335 171.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1293 ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -77.14 -21.21 54.49 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 123.402 1.572 . . . . 43.32 112.425 174.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.92 10.98 12.41 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 116.958 2.207 . . . . 41.32 116.958 170.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1295 ' ' THR . . . . . . . . . . . . . 89.9 m -68.82 113.97 6.74 Favored 'General case' 0 C--O 1.25 1.092 0 O-C-N 118.282 -2.761 . . . . 35.299999999999997 110.579 -175.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 10.4 t -84.19 116.06 63.12 Favored Pre-proline 0 N--CA 1.449 -0.505 0 N-CA-C 107.28 -1.378 . . . . 34.840000000000003 107.28 169.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.87 98.66 0.71 Allowed 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 122.866 2.377 . . . . 33.509999999999998 111.944 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 115.06 13.32 9.25 Favored Glycine 0 N--CA 1.432 -1.618 0 CA-C-N 114.316 -1.311 . . . . 32.189999999999998 112.874 170.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -159.21 168.69 25.88 Favored 'General case' 0 N--CA 1.435 -1.213 0 O-C-N 120.289 -1.712 . . . . 34.880000000000003 108.958 -174.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1300 ' ' ILE . . . . . . . . . . . . . 48.4 mt -89.32 115.36 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 104.284 -2.487 . . . . 32.289999999999999 104.284 175.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 52.9 t80 -85.83 150.15 24.75 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 105.777 -1.934 . . . . 37.25 105.777 162.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1302 ' ' THR . . . . . . . . . . . . . 88.5 m -135.16 122.15 21.26 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 119.294 0.952 . . . . 35.560000000000002 109.16 174.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1303 ' ' THR . . . . . . . . . . . . . 1.2 p -74.67 160.77 30.38 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 122.289 1.043 . . . . 36.399999999999999 111.575 173.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -68.23 -22.73 64.77 Favored 'General case' 0 C--O 1.249 1.069 0 O-C-N 120.376 -1.453 . . . . 52.32 111.747 -174.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -75.41 -10.64 59.63 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 118.402 -0.809 . . . . 40.039999999999999 110.82 175.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 94.15 43.74 3.71 Favored Glycine 0 N--CA 1.432 -1.625 0 O-C-N 124.085 0.865 . . . . 36.960000000000001 111.5 175.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1307 ' ' VAL . . . . . . . . . . . . . 76.8 t -108.55 123.71 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 117.746 -1.582 . . . . 33.399999999999999 107.567 168.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1308 ' ' LYS . . . . . . . . . . . . . 32.1 mmtt -86.29 98.4 10.94 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 121.878 0.847 . . . . 42.909999999999997 109.144 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 7.7 t -84.44 86.53 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 104.73 -2.322 . . . . 32.289999999999999 104.73 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1310 ' ' ILE . . . . . . . . . . . . . 33.9 mt -81.98 92.26 2.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 113.691 -1.595 . . . . 30.989999999999998 109.582 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -85.96 53.86 4.7 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 113.452 -1.704 . . . . 28.949999999999999 113.153 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1312 ' ' TYR . . . . . . . . . . . . . 1.4 m-30 -87.67 104.61 16.69 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 125.355 2.503 . . . . 31.690000000000001 107.233 -171.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1313 ' ' THR . . . . . . . . . . . . . 33.9 p -66.26 -42.56 88.35 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 110.815 -2.902 . . . . 34.170000000000002 111.113 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -68.34 8.27 0.48 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 111.79 -2.459 . . . . 36.859999999999999 116.981 -177.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1315 ' ' LEU . . . . . . . . . . . . . 96.2 mt -45.4 -39.18 9.19 Favored Pre-proline 0 N--CA 1.478 0.945 0 O-C-N 118.345 -2.722 . . . . 34.850000000000001 116.498 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -56.14 -46.18 32.78 Favored 'Trans proline' 0 C--O 1.247 0.95 0 C-N-CA 123.064 2.509 . . . . 29.149999999999999 113.842 168.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -60.35 -43.74 98.31 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-N 114.058 -1.428 . . . . 27.289999999999999 110.951 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1318 ' ' ARG . . . . . 0.425 ' O ' ' NH1' ' A' 1140 ' ' ARG . 85.3 mtt-85 -62.37 -29.17 70.28 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 122.027 0.918 . . . . 41.490000000000002 113.233 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1319 ' ' LEU . . . . . . . . . . . . . 3.9 tp -108.05 68.61 0.3 Allowed Pre-proline 0 N--CA 1.439 -0.982 0 O-C-N 120.002 -1.686 . . . . 27.609999999999999 111.074 168.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1320 ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -62.6 -58.25 0.36 Allowed 'Trans proline' 0 CA--C 1.499 -1.233 0 C-N-CA 124.553 3.502 . . . . 25.940000000000001 111.963 -163.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1321 ' ' THR . . . . . . . . . . . . . 1.8 m -60.55 -28.88 68.78 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 120.512 1.505 . . . . 25.010000000000002 110.178 -174.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1322 ' ' GLN . . . . . . . . . . . . . 9.4 tp60 -79.79 -33.87 40.12 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 117.618 -1.182 . . . . 29.390000000000001 110.002 -176.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1323 ' ' SER . . . . . . . . . . . . . 31.6 m -57.17 -56.18 25.09 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 119.902 1.228 . . . . 26.469999999999999 108.536 165.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1324 ' ' SER . . . . . . . . . . . . . 14.9 m -65.31 -21.67 66.74 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 122.136 0.969 . . . . 27.780000000000001 113.501 -172.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -93.12 -55.41 3.34 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 115.939 -1.981 . . . . 37.530000000000001 111.138 173.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1326 ' ' LEU . . . . . . . . . . . . . 93.0 mt -71.6 -56.44 5.86 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 122.193 2.27 . . . . 35.710000000000001 112.552 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1327 ' ' TYR . . . . . . . . . . . . . 86.0 t80 -58.71 -42.45 88.68 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 119.37 0.986 . . . . 31.59 108.933 172.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1328 ' ' GLY . . . . . . . . . . . . . . . -46.21 -50.51 12.82 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-N 118.44 0.564 . . . . 28.0 112.197 169.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1329 ' ' THR . . . . . . . . . . . . . 34.6 m -71.25 -20.95 62.17 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-O 117.771 -1.109 . . . . 32.149999999999999 112.258 174.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1330 ' ' ASN . . . . . . . . . . . . . 13.7 m120 -62.18 -46.17 90.13 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 124.755 3.434 . . . . 34.359999999999999 109.73 170.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1331 ' ' LEU . . . . . . . . . . . . . 15.7 mt -57.01 -52.18 66.31 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-N 113.159 -1.837 . . . . 33.369999999999997 112.689 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1332 ' ' VAL . . . . . . . . . . . . . 45.6 t -63.5 -42.25 95.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 105.388 -2.078 . . . . 35.270000000000003 105.388 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -59.81 -37.08 78.14 Favored 'General case' 0 CA--C 1.504 -0.794 0 O-C-N 119.534 -1.979 . . . . 37.659999999999997 113.562 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1334 ' ' LEU . . . . . . . . . . . . . 43.1 tp -60.03 -52.96 63.14 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.289 -0.634 . . . . 40.270000000000003 109.289 165.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1335 ' ' LEU . . . . . . . . . . . . . 19.0 mt -63.8 -18.15 63.81 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 115.308 1.596 . . . . 42.5 115.308 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1336 ' ' LYS . . . . . . . . . . . . . 78.8 mttt -69.36 -36.38 76.79 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 120.341 -1.474 . . . . 47.810000000000002 109.198 172.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1337 ' ' LEU . . . . . . . . . . . . . 10.2 mp -70.33 -40.33 74.2 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 122.864 1.316 . . . . 49.270000000000003 111.831 170.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1338 ' ' LEU . . . . . . . . . . . . . 3.1 mp -67.83 -47.6 68.54 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 116.793 2.146 . . . . 50.539999999999999 116.793 -177.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1339 ' ' CYS . . . . . . . . . . . . . 41.1 t -83.21 100.31 10.5 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 102.639 -3.097 . . . . 53.670000000000002 102.639 175.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 28.5 mtpt -84.04 -70.37 0.57 Allowed 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 118.878 -2.389 . . . . 63.380000000000003 111.883 -177.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -72.7 -15.35 61.69 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.25 0.833 . . . . 70.950000000000003 113.25 -171.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1342 ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? 49.11 58.11 5.73 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 116.892 -1.528 . . . . 65.25 111.77 -173.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1343 ' ' ASP . . . . . . . . . . . . 0.404 0.0 OUTLIER 63.72 -78.04 0.03 OUTLIER 'General case' 0 C--N 1.356 0.874 2 O-C-N 113.242 -5.911 . . . . 64.530000000000001 114.817 21.309 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A 1344 ' ' GLY . . . . . . . . . . . . . . . 71.58 52.04 14.05 Favored Glycine 0 C--O 1.217 -0.952 0 CA-C-N 120.908 1.685 . . . . 59.719999999999999 111.607 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 44.3 t30 -146.73 155.08 42.13 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 119.799 1.799 . . . . 64.090000000000003 106.663 172.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1346 ' ' ILE . . . . . . . . . . . . . 34.4 mt -88.94 124.05 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 CA-C-O 124.48 2.086 . . . . 58.82 112.121 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1347 ' ' THR . . . . . . . . . . . . . 33.7 m -100.63 109.54 21.61 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 110.392 -3.095 . . . . 54.960000000000001 107.683 167.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1348 ' ' VAL . . . . . . . . . . . . . 34.4 t -85.19 82.39 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 N-CA-C 106.173 -1.788 . . . . 55.640000000000001 106.173 176.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 24.2 t0 -78.36 106.25 10.16 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 112.766 -2.015 . . . . 61.450000000000003 115.449 -175.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -82.66 -13.07 57.09 Favored 'General case' 0 C--O 1.246 0.921 0 CA-C-N 112.472 -2.149 . . . . 58.630000000000003 112.751 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -65.12 -47.14 78.21 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 120.904 -1.122 . . . . 62.060000000000002 109.73 172.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 10.3 t70 -65.44 108.71 2.06 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 123.271 1.51 . . . . 54.07 108.994 174.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 22.1 m -43.82 -37.24 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.765 0 N-CA-C 117.614 2.449 . . . . 50.68 117.614 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1354 ' ' VAL . . . . . . . . . . . . 0.261 5.4 m -79.72 -43.75 23.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-O 118.099 -0.953 . . . . 47.68 110.374 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1355 ' ' ILE . . . . . . . . . . . . . 80.4 mt -60.76 -45.1 98.39 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 121.58 1.991 . . . . 48.490000000000002 109.612 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 40.7 tpt85 -43.23 -50.52 6.43 Favored 'General case' 0 C--O 1.249 1.069 0 N-CA-C 115.986 1.847 . . . . 48.270000000000003 115.986 163.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -61.15 -50.71 64.29 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.86 -0.967 . . . . 43.530000000000001 112.834 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1358 ' ' VAL . . . . . . . . . . . . . 21.2 t -60.58 -49.38 84.66 Favored 'Isoleucine or valine' 0 C--O 1.249 1.059 0 N-CA-C 106.202 -1.777 . . . . 45.119999999999997 106.202 -173.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1359 ' ' THR . . . . . . . . . . . . . 6.0 m -69.01 87.84 0.38 Allowed 'General case' 0 C--N 1.313 -0.98 0 O-C-N 120.581 -1.325 . . . . 42.939999999999998 108.626 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 30.9 m -77.68 -23.74 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 CA-C-N 114.865 -1.061 . . . . 43.259999999999998 110.971 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1361 ' ' ILE . . . . . . . . . . . . . 73.4 mt -135.58 119.02 23.91 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 N-CA-C 105.567 -2.012 . . . . 45.659999999999997 105.567 172.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1362 ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -100.65 110.3 22.42 Favored 'General case' 0 C--O 1.219 -0.525 0 O-C-N 119.172 -2.205 . . . . 61.340000000000003 106.584 167.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 31.87 79.0 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 O-C-N 126.388 2.305 . . . . 49.759999999999998 112.135 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 83.25 -40.54 2.84 Favored Glycine 0 CA--C 1.521 0.457 0 CA-C-O 118.59 -1.116 . . . . 50.0 112.645 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -77.05 111.0 12.16 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 105.87 -1.9 . . . . 56.920000000000002 105.87 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1366 ' ' ILE . . . . . . . . . . . . . 66.0 mt -70.11 106.53 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 104.406 -2.442 . . . . 52.780000000000001 104.406 173.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1367 ' ' THR . . . . . . . . . . . . . 2.0 p -88.41 -4.9 58.56 Favored 'General case' 0 CA--C 1.496 -1.124 0 N-CA-C 114.901 1.445 . . . . 49.439999999999998 114.901 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 1.7 t90 -70.73 148.62 95.0 Favored Pre-proline 0 C--O 1.248 1.016 0 N-CA-C 106.701 -1.592 . . . . 52.380000000000003 106.701 166.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -65.43 156.07 77.89 Favored 'Cis proline' 0 CA--C 1.498 -1.321 0 CA-C-N 124.96 2.807 . . . . 46.939999999999998 116.32 -7.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -112.04 151.84 43.88 Favored Pre-proline 0 N--CA 1.442 -0.858 0 CA-C-N 113.342 -1.754 . . . . 45.909999999999997 110.195 -175.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1371 ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -57.25 145.02 89.21 Favored 'Trans proline' 0 C--O 1.248 1.007 0 C-N-CA 122.789 2.326 . . . . 46.390000000000001 117.643 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -67.48 -20.45 47.78 Favored 'Trans proline' 0 CA--C 1.539 0.742 1 C-N-CA 125.345 4.03 . . . . 46.719999999999999 112.435 171.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.22 -5.055 0 CA-C-N 122.539 2.427 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 35.8 m80 . . . . . 0 N--CA 1.467 0.382 0 N-CA-C 107.738 -1.208 . . . . 63.439999999999998 107.738 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -73.54 74.53 1.46 Allowed 'General case' 0 C--O 1.242 0.673 0 CA-C-O 124.37 2.033 . . . . 51.740000000000002 115.041 -177.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1000 ' ' HIS . . . . . . . . . . . . . 63.9 t60 -72.62 128.45 35.6 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 114.499 -1.228 . . . . 54.07 108.573 -174.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 68.34 15.76 68.36 Favored Glycine 0 CA--C 1.506 -0.498 0 O-C-N 120.076 -1.64 . . . . 39.219999999999999 115.328 -172.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1002 ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -89.06 129.37 35.7 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 119.833 1.816 . . . . 38.119999999999997 108.557 176.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1003 ' ' ILE . . . . . . . . . . . . . 19.6 mt -84.48 134.78 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-N 111.28 -2.691 . . . . 29.699999999999999 105.611 166.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -114.84 125.65 6.87 Favored Glycine 0 CA--C 1.503 -0.701 0 N-CA-C 106.556 -2.617 . . . . 27.5 106.556 166.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1005 ' ' ILE . . . . . . . . . . . . . 27.5 mm -99.4 105.42 33.06 Favored Pre-proline 0 N--CA 1.426 -1.646 0 N-CA-C 104.94 -2.244 . . . . 24.829999999999998 104.94 173.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -74.76 145.69 32.75 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 C-N-CA 123.905 3.07 . . . . 27.190000000000001 108.977 173.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -74.47 113.16 11.39 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 109.198 -3.637 . . . . 41.460000000000001 104.127 171.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1008 ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -40.9 145.36 0.21 Allowed 'General case' 0 C--O 1.247 0.934 0 N-CA-C 120.015 3.339 . . . . 26.93 120.015 175.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 14.3 mmm-85 -120.27 -10.13 9.4 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-N 112.636 -2.075 . . . . 34.479999999999997 111.522 -175.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1010 ' ' LEU . . . . . . . . . . . . . 4.5 tp -64.7 143.52 57.87 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 122.098 0.951 . . . . 44.219999999999999 113.002 174.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1011 ' ' THR . . . . . . . . . . . . . 3.6 m -66.7 134.33 52.01 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 108.187 -1.042 . . . . 40.740000000000002 108.187 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 49.8 t30 51.21 53.42 12.97 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 115.948 1.832 . . . . 44.439999999999998 115.948 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1013 ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -136.67 116.48 13.11 Favored 'General case' 0 C--O 1.252 1.207 0 CA-C-N 114.245 -1.343 . . . . 29.870000000000001 108.965 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1014 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.99 -0.65 15.66 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.281 -0.872 . . . . 25.260000000000002 112.186 174.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -69.07 141.32 54.79 Favored 'General case' 0 C--O 1.248 0.995 0 N-CA-C 105.857 -1.905 . . . . 29.539999999999999 105.857 173.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1016 ' ' VAL . . . . . . . . . . . . . 11.6 p -139.36 -173.62 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 104.7 -2.333 . . . . 23.550000000000001 104.7 171.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1017 ' ' ALA . . . . . . . . . . . . . . . -110.0 0.67 18.6 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 118.992 -2.318 . . . . 23.59 113.636 175.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1018 ' ' ALA . . . . . . . . . . . . . . . -88.4 128.71 35.52 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 118.671 -0.681 . . . . 24.93 111.481 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1019 ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.34 148.05 17.12 Favored Pre-proline 0 N--CA 1.442 -0.835 0 N-CA-C 105.682 -1.97 . . . . 28.09 105.682 171.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -61.96 -54.04 1.75 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 124.549 3.499 . . . . 28.789999999999999 112.981 -174.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 77.9 tttt -49.49 -48.95 47.54 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 121.289 1.859 . . . . 47.280000000000001 108.874 176.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1022 ' ' THR . . . . . . . . . . . . . 39.5 m -49.86 -54.27 20.49 Favored 'General case' 0 C--O 1.203 -1.373 0 C-N-CA 125.63 1.572 . . . . 30.120000000000001 111.842 174.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1023 ' ' VAL . . . . . . . . . . . . . 54.0 t -60.63 -37.97 77.07 Favored 'Isoleucine or valine' 0 C--N 1.352 0.691 0 CA-C-N 120.702 1.592 . . . . 32.240000000000002 108.078 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1024 ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -67.9 -44.86 75.97 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 121.205 1.821 . . . . 49.619999999999997 111.401 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -58.43 -45.99 87.41 Favored 'General case' 0 N--CA 1.44 -0.959 0 O-C-N 125.457 1.723 . . . . 44.68 108.203 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 95.4 mt -63.39 -45.38 91.35 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 118.867 -0.587 . . . . 35.710000000000001 109.727 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1027 ' ' LEU . . . . . . . . . . . . . 27.2 mt -60.71 -35.19 75.69 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 118.894 0.77 . . . . 42.18 111.302 173.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 19.3 mttm -72.46 -30.11 64.28 Favored 'General case' 0 C--O 1.239 0.526 0 O-C-N 120.219 -1.551 . . . . 48.340000000000003 109.38 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1029 ' ' LEU . . . . . . . . . . . . . 87.3 mt -74.79 -21.03 59.54 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 118.249 -2.782 . . . . 38.689999999999998 109.604 169.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 101.22 18.47 19.35 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 117.935 -2.978 . . . . 32.280000000000001 110.327 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -98.08 118.48 34.79 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 106.432 -1.692 . . . . 35.939999999999998 106.432 170.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1032 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.12 139.94 57.53 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 111.598 -2.546 . . . . 33.369999999999997 111.156 171.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B 1033 ' ' VAL . . . . . . . . . . . . . 6.7 t -114.0 130.92 67.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.704 0 CA-C-N 121.162 1.801 . . . . 29.98 106.931 -174.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -123.59 135.98 54.27 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 104.901 -2.259 . . . . 28.18 104.901 166.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1035 ' ' VAL . . . . . . . . . . . . . 46.7 t -121.72 143.43 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 103.678 -2.712 . . . . 25.82 103.678 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1036 ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -79.68 137.85 37.19 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 120.038 -1.664 . . . . 32.439999999999998 110.978 173.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1037 ' ' SER . . . . . . . . . . . . . 16.5 m -52.68 115.72 1.94 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 127.081 2.152 . . . . 29.539999999999999 109.958 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 115.12 -19.17 15.44 Favored Glycine 0 N--CA 1.423 -2.221 0 CA-C-O 119.382 -0.677 . . . . 27.760000000000002 113.381 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1039 ' ' ALA . . . . . . . . . . . . . . . -67.0 -28.87 68.6 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 120.511 -0.475 . . . . 26.02 110.266 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -56.81 -55.18 31.43 Favored Glycine 0 C--O 1.246 0.886 0 N-CA-C 110.612 -0.995 . . . . 26.469999999999999 110.612 164.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -53.24 -39.81 64.1 Favored 'General case' 0 C--O 1.25 1.095 0 O-C-N 120.463 -1.61 . . . . 50.979999999999997 114.32 177.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 31.3 mt -52.84 -54.62 31.69 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 116.86 2.17 . . . . 29.300000000000001 116.86 163.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1043 ' ' ALA . . . . . . . . . . . . . . . -71.41 17.8 0.08 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 117.856 2.539 . . . . 26.739999999999998 117.856 172.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1044 ' ' SER . . . . . . . . . . . . . 6.7 m 52.57 41.91 31.26 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 125.187 2.422 . . . . 31.260000000000002 111.396 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1045 ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -127.96 167.3 16.85 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 111.62 -2.536 . . . . 33.259999999999998 107.124 -175.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 40.6 t0 -97.15 138.53 34.52 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 117.524 -1.671 . . . . 46.740000000000002 107.359 150.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -50.07 -36.3 28.73 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 126.887 2.617 . . . . 34.439999999999998 111.892 171.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -35.38 -44.05 0.27 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 116.323 1.972 . . . . 48.670000000000002 116.323 165.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -64.24 -27.91 69.37 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 120.205 -1.56 . . . . 35.259999999999998 112.988 177.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1050 ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -75.39 -38.75 59.77 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 117.276 -1.345 . . . . 32.170000000000002 109.196 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 8.3 t -53.44 -50.77 46.91 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 N-CA-C 107.884 -1.154 . . . . 38.369999999999997 107.884 171.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -53.53 -34.9 59.88 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 124.069 0.948 . . . . 45.770000000000003 112.736 175.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -80.31 -21.7 42.31 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.17 0.895 . . . . 37.829999999999998 111.858 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 128.26 20.78 1.56 Allowed Glycine 0 CA--C 1.519 0.304 0 O-C-N 119.658 -1.901 . . . . 35.82 109.571 170.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -100.41 140.71 34.27 Favored 'General case' 0 N--CA 1.435 -1.177 0 O-C-N 119.159 -2.377 . . . . 33.770000000000003 112.026 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -76.56 130.03 37.31 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.647 1.579 . . . . 51.020000000000003 108.545 171.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1057 ' ' ILE . . . . . . . . . . . . . 35.7 mm -97.92 129.84 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 106.188 -1.782 . . . . 38.469999999999999 106.188 168.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 6.6 m -111.21 153.72 12.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 125.337 1.455 . . . . 39.399999999999999 108.048 169.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.13 -48.97 71.7 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 120.491 -1.381 . . . . 57.07 114.57 -175.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . -155.83 -110.79 0.35 Allowed Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.076 -1.059 . . . . 44.829999999999998 111.018 -176.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 2.5 m120 -58.27 -25.53 61.89 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 126.385 1.874 . . . . 46.270000000000003 115.685 -170.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1062 ' ' SER . . . . . . . . . . . . . 16.4 m -48.4 -28.19 3.08 Favored 'General case' 0 C--N 1.317 -0.81 0 O-C-N 120.731 -1.231 . . . . 43.469999999999999 112.999 165.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 1.3 p -59.04 -28.32 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 O-C-N 120.108 -1.62 . . . . 36.979999999999997 115.233 171.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 92.4 m95 -74.53 -18.65 60.57 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 122.921 0.488 . . . . 37.899999999999999 111.933 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -83.15 66.83 8.91 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 107.966 -1.124 . . . . 46.189999999999998 107.966 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1066 ' ' SER . . . . . . . . . . . . . 28.2 m -155.29 148.15 24.42 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 103.923 -2.621 . . . . 37.060000000000002 103.923 -172.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1067 ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -82.51 -15.33 52.81 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 115.844 1.794 . . . . 43.950000000000003 115.844 -172.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1068 ' ' ILE . . . . . . . . . . . . . 1.4 mp -124.54 116.28 47.04 Favored 'Isoleucine or valine' 0 C--O 1.253 1.238 0 N-CA-C 103.129 -2.915 . . . . 33.5 103.129 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 26.0 mm -106.42 115.14 47.4 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 N-CA-C 106.733 -1.58 . . . . 30.57 106.733 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1070 ' ' LEU . . . . . . . . . . . . . 85.3 mt -106.85 78.69 1.26 Allowed 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 115.224 -0.898 . . . . 27.66 111.229 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1071 ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -80.75 166.64 20.81 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.836 -0.62 . . . . 28.399999999999999 110.749 171.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1072 ' ' VAL . . . . . . . . . . . . . 8.9 t -91.51 -84.92 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 104.231 -2.507 . . . . 23.18 104.231 169.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -101.78 -170.49 1.83 Allowed 'General case' 0 C--N 1.312 -1.034 0 O-C-N 118.434 -2.666 . . . . 25.469999999999999 111.913 -170.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -33.93 125.51 0.47 Allowed Pre-proline 0 CA--C 1.554 1.109 0 N-CA-C 118.157 2.651 . . . . 27.899999999999999 118.157 -172.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.48 126.89 14.79 Favored 'Trans proline' 0 N--CA 1.434 -2.009 0 C-N-CA 123.319 2.679 . . . . 31.620000000000001 111.474 166.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 45.2 mt -76.15 160.56 29.62 Favored 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 120.437 -1.414 . . . . 40.490000000000002 107.582 168.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.76 -35.5 43.88 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 117.358 2.355 . . . . 51.590000000000003 117.358 -174.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -63.97 -42.37 97.27 Favored 'General case' 0 C--O 1.208 -1.091 0 CA-C-O 118.972 -0.537 . . . . 42.359999999999999 111.004 172.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1079 ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -66.57 -35.74 80.96 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 125.586 1.804 . . . . 34.530000000000001 108.917 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1080 ' ' ILE . . . . . . . . . . . . . 63.3 mt -61.79 -51.8 68.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 125.983 2.052 . . . . 33.25 105.766 173.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -59.03 -29.4 67.25 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 120.969 1.713 . . . . 36.469999999999999 112.005 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1082 ' ' LEU . . . . . . . . . . . . . 10.2 mt -71.74 -28.06 63.41 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.353 1.242 . . . . 37.759999999999998 114.353 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1083 ' ' LEU . . . . . . . . . . . . . 33.9 mt -64.45 112.97 3.36 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 118.594 -1.242 . . . . 37.43 109.204 -175.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -71.12 139.42 84.98 Favored Pre-proline 0 C--O 1.254 1.306 0 CA-C-N 115.149 -0.932 . . . . 37.700000000000003 109.435 167.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -55.47 151.92 35.42 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.878 2.385 . . . . 35.509999999999998 116.379 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 74.79 -8.72 13.62 Favored Glycine 0 N--CA 1.445 -0.754 0 O-C-N 120.16 -1.587 . . . . 33.869999999999997 115.981 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1087 ' ' THR . . . . . . . . . . . . . 89.2 m -71.89 139.55 48.85 Favored 'General case' 0 C--O 1.261 1.688 0 O-C-N 119.608 -2.113 . . . . 32.5 108.062 178.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1088 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.53 97.09 7.66 Favored 'General case' 0 C--O 1.255 1.387 0 N-CA-C 106.591 -1.633 . . . . 30.219999999999999 106.591 -173.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B 1089 ' ' LEU . . . . . . . . . . . . . 31.3 tp -91.77 101.21 13.81 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 122.167 0.984 . . . . 27.239999999999998 111.214 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 11.7 t -104.11 107.35 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 111.089 -2.778 . . . . 25.390000000000001 109.795 -175.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1091 ' ' SER . . . . . . . . . . . . . 13.1 m -163.48 168.14 20.58 Favored 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 117.087 -3.508 . . . . 28.809999999999999 113.308 -170.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1092 ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -65.22 91.71 0.11 Allowed 'General case' 0 C--O 1.278 2.602 0 CA-C-O 124.212 1.958 . . . . 30.780000000000001 110.183 168.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 36.8 mm -89.9 -32.25 5.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 O-C-N 120.631 -1.293 . . . . 30.280000000000001 111.178 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1094 ' ' TRP . . . . . . . . . . . . . 67.6 m95 57.92 55.83 6.77 Favored Pre-proline 0 C--O 1.247 0.965 0 CA-C-N 114.823 -1.08 . . . . 34.07 112.021 -175.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -49.97 -34.89 39.18 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 124.952 3.768 . . . . 38.659999999999997 113.409 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -56.37 -56.15 24.73 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 120.841 -1.162 . . . . 41.32 110.776 169.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -78.94 -22.68 45.39 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 113.951 1.093 . . . . 51.659999999999997 113.951 -174.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -130.22 81.1 69.34 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 119.934 1.243 . . . . 40.32 111.02 -164.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -64.17 -48.93 4.19 Favored 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 120.987 1.124 . . . . 41.560000000000002 114.561 176.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -61.93 -35.87 79.7 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.399 -0.964 . . . . 54.109999999999999 108.399 -175.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1101 ' ' LEU . . . . . . . . . . . . . 17.0 tp -60.43 -47.17 87.27 Favored 'General case' 0 CA--C 1.515 -0.386 0 O-C-N 120.703 -1.248 . . . . 37.880000000000003 110.116 175.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1102 ' ' MET . . . . . . . . . . . . . 73.2 mmm -57.82 -38.62 75.91 Favored 'General case' 0 C--O 1.238 0.45 0 O-C-N 121.116 -0.99 . . . . 37.539999999999999 113.196 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -64.21 -45.77 86.82 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.869 -1.06 . . . . 47.009999999999998 113.398 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1104 ' ' LYS . . . . . . . . . . . . . 54.1 mttm -65.98 -35.26 80.1 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.506 -0.77 . . . . 48.68 110.264 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1105 ' ' LEU . . . . . . . . . . . . . 50.2 mt -72.86 -29.5 63.25 Favored 'General case' 0 C--O 1.269 2.127 0 O-C-N 120.546 -1.346 . . . . 32.210000000000001 112.583 177.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -61.63 -49.55 76.1 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 124.648 1.179 . . . . 33.729999999999997 108.098 172.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -54.1 -40.56 67.41 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 122.753 0.421 . . . . 51.469999999999999 111.702 172.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1108 ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -72.97 -9.92 59.25 Favored 'General case' 0 C--O 1.213 -0.847 0 O-C-N 120.241 -1.537 . . . . 43.899999999999999 113.617 177.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1109 ' ' ASN . . . . . . . . . . . . . 8.9 m120 62.93 30.83 16.46 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.556 1.142 . . . . 44.82 110.637 172.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1110 ' ' VAL . . . . . . . . . . . . . 2.7 m -92.76 155.0 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 O-C-N 120.557 -1.34 . . . . 30.52 112.404 -172.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1111 ' ' THR . . . . . . . . . . . . . 1.2 m -82.75 92.26 7.18 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 105.883 -1.895 . . . . 27.120000000000001 105.883 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1112 ' ' VAL . . . . . . . . . . . . . 39.9 t -88.27 121.72 38.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 O-C-N 120.322 -1.486 . . . . 26.399999999999999 110.58 -173.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1113 ' ' MET . . . . . . . . . . . . . 21.0 mtp -115.95 116.72 28.44 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 104.904 -2.258 . . . . 42.920000000000002 104.904 177.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -96.19 107.83 20.22 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 117.34 -1.744 . . . . 24.149999999999999 110.893 -172.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1115 ' ' MET . . . . . . . . . . . . . 83.5 mmm -55.16 -26.88 41.64 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 116.543 2.053 . . . . 29.949999999999999 116.543 -176.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1116 ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -86.54 -39.84 15.82 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.117 -1.856 . . . . 34.530000000000001 110.946 177.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1117 ' ' SER . . . . . . . . . . . . . 49.9 m -99.16 31.8 2.93 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-O 123.966 1.841 . . . . 33.490000000000002 111.409 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1118 ' ' VAL . . . . . . . . . . . . . 22.0 t -64.16 119.33 54.79 Favored Pre-proline 0 C--O 1.243 0.727 0 N-CA-C 102.402 -3.185 . . . . 34.020000000000003 102.402 151.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -62.67 159.64 36.11 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 123.0 2.467 . . . . 38.280000000000001 113.047 -176.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1120 ' ' ARG . . . . . 0.406 HH12 ' CG ' ' B' 1128 ' ' ASP . 1.9 mmp_? -77.37 50.53 0.79 Allowed 'General case' 0 C--N 1.354 0.776 0 CA-C-O 122.099 0.952 . . . . 55.049999999999997 109.826 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B 1121 ' ' ILE . . . . . . . . . . . . . 39.0 pt -119.21 143.96 28.98 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.844 0 O-C-N 121.232 -0.918 . . . . 42.090000000000003 110.042 -169.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1122 ' ' SER . . . . . . . . . . . . . 53.6 p -9.08 -88.82 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 120.479 3.511 . . . . 38.020000000000003 120.479 -176.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1123 ' ' ARG . . . . . . . . . . . . 0.254 18.7 ptt180 -71.5 -30.12 65.58 Favored 'General case' 0 C--N 1.357 0.892 0 CA-C-N 121.194 1.815 . . . . 34.289999999999999 114.502 178.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B 1124 ' ' ALA . . . . . . . . . . . . . . . -58.83 -34.4 71.51 Favored 'General case' 0 C--O 1.219 -0.525 0 O-C-N 124.056 0.847 . . . . 32.350000000000001 109.851 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1125 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.2 -9.06 1.86 Allowed 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 117.473 2.397 . . . . 47.170000000000002 117.473 176.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B 1126 ' ' SER . . . . . . . . . . . . . 22.9 p -90.9 -32.95 15.81 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.863 1.211 . . . . 31.710000000000001 112.687 169.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1127 ' ' LEU . . . . . . . . . . . . . 4.1 mp -71.36 -30.06 65.71 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 111.726 -2.488 . . . . 37.0 110.71 175.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1128 ' ' ASP . . . . . 0.406 ' CG ' HH12 ' B' 1120 ' ' ARG . 9.9 t70 -62.56 127.36 30.92 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 115.694 1.738 . . . . 40.399999999999999 115.694 -176.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B 1129 ' ' ALA . . . . . . . . . . . . . . . -70.06 -38.02 75.65 Favored 'General case' 0 C--O 1.212 -0.869 0 CA-C-N 113.746 -1.57 . . . . 26.559999999999999 108.1 177.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 36.2 mt -66.79 -13.85 61.96 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 115.039 1.496 . . . . 30.890000000000001 115.039 -174.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1131 ' ' SER . . . . . . . . . . . . . 66.5 p -69.24 -56.17 8.37 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 105.507 -2.035 . . . . 29.84 105.507 167.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1132 ' ' SER . . . . . . . . . . . . . 67.5 m -55.05 -55.64 28.74 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 124.332 1.053 . . . . 31.91 113.616 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1133 ' ' MET . . . . . . . . . . . . . 32.2 mmt -54.32 -45.1 72.54 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.463 0.705 . . . . 25.899999999999999 111.757 176.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1134 ' ' ALA . . . . . . . . . . . . . . . -56.64 -52.57 64.38 Favored 'General case' 0 C--O 1.209 -1.049 0 C-N-CA 119.477 -0.889 . . . . 26.620000000000001 112.898 170.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.66 -33.41 55.18 Favored 'General case' 0 C--O 1.22 -0.491 0 O-C-N 120.807 -1.183 . . . . 36.969999999999999 113.809 174.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B 1136 ' ' ILE . . . . . . . . . . . . . 37.2 mm -68.96 -54.66 19.07 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 N-CA-C 107.255 -1.387 . . . . 32.109999999999999 107.255 175.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -59.53 -30.09 68.35 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 117.087 -1.435 . . . . 24.140000000000001 111.95 -171.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -66.49 -58.05 9.21 Favored Glycine 0 N--CA 1.47 0.912 0 CA-C-N 119.27 0.941 . . . . 25.129999999999999 111.562 174.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 21.0 t80 -58.88 -49.32 78.2 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.232 -1.025 . . . . 32.729999999999997 108.232 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1140 ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -63.49 -28.95 70.31 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-O 117.806 -1.092 . . . . 26.359999999999999 108.94 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1141 ' ' ALA . . . . . . . . . . . . . . . -62.2 -47.92 82.32 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 122.412 2.369 . . . . 24.120000000000001 108.809 173.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 45.7 mm -60.92 -39.36 81.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.281 1.432 . . . . 23.370000000000001 109.298 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 40.6 t -63.84 -57.72 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 124.728 1.211 . . . . 24.960000000000001 111.931 176.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -63.6 -37.94 89.25 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 119.819 -1.801 . . . . 32.07 110.991 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1145 ' ' ALA . . . . . . . . . . . . . . . -53.35 -51.63 61.84 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 122.432 1.111 . . . . 24.870000000000001 113.743 170.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1146 ' ' ALA . . . . . . . . . . . . . . . -59.15 -37.14 76.6 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 113.835 -1.53 . . . . 24.670000000000002 114.677 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 42.5 t60 -60.79 -22.9 64.58 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.867 1.267 . . . . 28.579999999999998 111.692 177.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1148 ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -127.81 16.24 6.89 Favored 'General case' 0 N--CA 1.442 -0.867 0 O-C-N 119.666 -1.896 . . . . 36.82 113.625 173.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1149 ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -77.65 155.93 31.08 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 122.563 1.173 . . . . 31.969999999999999 108.621 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B 1150 ' ' GLY . . . . . . . . . . . . . . . -88.72 -23.72 35.16 Favored Glycine 0 C--O 1.208 -1.507 0 O-C-N 120.146 -1.596 . . . . 25.489999999999998 111.668 176.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1151 ' ' ARG . . . . . . . . . . . . . 71.3 mtm-85 -131.62 179.98 5.73 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.614 1.166 . . . . 59.840000000000003 112.644 -162.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1152 ' ' PHE . . . . . . . . . . . . . 5.9 m-30 -83.14 163.16 21.02 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 120.941 1.7 . . . . 34.450000000000003 111.177 171.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1153 ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -85.6 -48.68 8.67 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 112.46 -2.154 . . . . 31.170000000000002 109.271 166.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1154 ' ' THR . . . . . . . . . . . . . 6.3 m -72.1 135.57 46.29 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 114.636 -1.166 . . . . 33.890000000000001 108.162 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -80.6 73.67 2.49 Favored Glycine 0 CA--C 1.543 1.843 0 N-CA-C 106.47 -2.652 . . . . 38.950000000000003 106.47 171.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -75.17 124.17 26.57 Favored 'General case' 0 C--O 1.242 0.668 0 O-C-N 120.796 -1.414 . . . . 54.229999999999997 108.065 -174.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 26.8 mm -73.5 100.54 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 105.07 -2.196 . . . . 51.159999999999997 105.07 169.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1158 ' ' THR . . . . . . . . . . . . . 5.6 m -99.72 151.43 21.24 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 103.591 -2.744 . . . . 49.609999999999999 103.591 -172.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -57.92 -37.44 74.07 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 121.398 1.908 . . . . 49.049999999999997 113.707 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -53.52 -35.21 60.42 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 115.854 1.798 . . . . 47.649999999999999 115.854 169.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . 157.88 175.45 28.82 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 108.813 -1.715 . . . . 45.609999999999999 108.813 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 82.7 mttt -83.35 145.27 29.13 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 112.932 0.715 . . . . 57.460000000000001 112.932 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1163 ' ' VAL . . . . . . . . . . . . . 94.5 t -94.25 142.84 25.44 Favored Pre-proline 0 N--CA 1.433 -1.296 0 N-CA-C 106.385 -1.709 . . . . 42.93 106.385 170.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1164 ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -81.23 133.95 8.92 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 124.989 3.793 . . . . 39.289999999999999 104.74 168.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1165 ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -62.55 148.46 93.3 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 125.293 3.995 . . . . 34.170000000000002 108.199 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -75.17 134.7 41.17 Favored 'General case' 0 C--O 1.208 -1.124 0 CA-C-N 115.213 -0.903 . . . . 31.690000000000001 111.014 172.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1167 ' ' LYS . . . . . . . . . . . . . 98.4 mttt -91.6 113.59 25.9 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 124.05 1.881 . . . . 44.780000000000001 107.189 167.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 87.6 t -98.25 99.43 8.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 113.099 -1.864 . . . . 31.23 107.212 -174.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1169 ' ' MET . . . . . . . . . . . . . 36.5 ttp -83.42 100.85 10.97 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 119.14 -1.024 . . . . 37.090000000000003 108.313 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 45.2 t -91.07 111.76 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 106.948 -1.501 . . . . 30.170000000000002 106.948 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1171 ' ' ILE . . . . . . . . . . . . . 2.7 mt -97.84 135.43 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 107.303 -1.369 . . . . 33.740000000000002 107.303 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 71.76 71.94 0.99 Allowed Glycine 0 C--O 1.247 0.911 0 N-CA-C 108.564 -1.815 . . . . 32.590000000000003 108.564 -177.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1173 ' ' ALA . . . . . . . . . . . . . . . -76.25 74.31 3.06 Favored 'General case' 0 N--CA 1.44 -0.956 0 O-C-N 121.176 -1.191 . . . . 32.420000000000002 112.693 -174.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -81.0 -155.68 12.87 Favored Glycine 0 N--CA 1.44 -1.073 0 N-CA-C 109.652 -1.379 . . . . 31.739999999999998 109.652 169.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 47.9 t -65.11 -38.94 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.416 0 O-C-N 122.016 -0.696 . . . . 31.48 109.146 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1176 ' ' ALA . . . . . . . . . . . . . . . -65.65 -39.81 91.79 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 122.66 1.219 . . . . 26.120000000000001 110.186 174.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1177 ' ' GLY . . . . . . . . . . . . . . . -52.29 -54.68 25.54 Favored Glycine 0 CA--C 1.527 0.82 0 O-C-N 120.499 -1.376 . . . . 25.73 111.05 171.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1178 ' ' LEU . . . . . . . . . . . . . 65.5 mt -57.78 -39.21 76.93 Favored 'General case' 0 C--N 1.351 0.65 0 N-CA-C 112.863 0.69 . . . . 32.590000000000003 112.863 178.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -60.67 -46.15 91.42 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 124.664 1.227 . . . . 27.719999999999999 111.777 170.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -64.71 -39.35 93.51 Favored 'General case' 0 C--O 1.249 1.075 0 O-C-N 119.884 -1.76 . . . . 26.030000000000001 111.764 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1181 ' ' ILE . . . . . . . . . . . . . 37.7 mt -56.61 -60.7 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 N-CA-C 104.137 -2.542 . . . . 28.609999999999999 104.137 171.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -43.32 -49.7 6.72 Favored Glycine 0 C--O 1.214 -1.099 0 N-CA-C 116.05 1.18 . . . . 25.23 116.05 177.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -72.59 -57.02 4.46 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 112.115 0.413 . . . . 24.09 112.115 -174.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -60.59 -41.42 94.7 Favored 'General case' 0 C--O 1.246 0.892 0 O-C-N 121.518 -0.739 . . . . 26.68 112.689 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -65.7 -32.81 74.57 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-O 118.255 -0.878 . . . . 36.57 109.946 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1186 ' ' SER . . . . . . . . . . . . . 64.8 m -57.33 -49.27 76.67 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 122.48 2.4 . . . . 28.920000000000002 108.486 167.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1187 ' ' LEU . . . . . . . . . . . . . 19.6 mt -67.88 -6.51 22.13 Favored 'General case' 0 C--N 1.365 1.267 0 N-CA-C 115.511 1.671 . . . . 29.09 115.511 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 82.39 16.11 72.22 Favored Glycine 0 N--CA 1.447 -0.584 0 O-C-N 120.285 -1.509 . . . . 29.260000000000002 113.819 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1189 ' ' ALA . . . . . . . . . . . . . . . -86.81 139.74 30.39 Favored 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 120.514 -1.58 . . . . 30.16 108.407 175.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 8.3 mt -87.08 110.33 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 105.916 -1.883 . . . . 35.810000000000002 105.916 -164.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1191 ' ' VAL . . . . . . . . . . . . . 43.8 t -81.02 123.5 37.7 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 O-C-N 121.093 -1.004 . . . . 31.969999999999999 111.351 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1192 ' ' ARG . . . . . 0.412 HH12 ' CD ' ' B' 1248 ' ' GLU . 91.2 mtt180 -105.91 105.13 15.02 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 108.202 -1.036 . . . . 48.159999999999997 108.202 170.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -103.04 155.01 18.68 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 115.823 -2.351 . . . . 35.890000000000001 110.339 -176.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 39.5 t80 -141.42 136.84 31.75 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 106.318 -1.734 . . . . 41.880000000000003 106.318 170.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1195 ' ' ASP . . . . . . . . . . . . . 9.9 t0 -149.84 159.78 44.09 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 100.948 -3.723 . . . . 38.280000000000001 100.948 165.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1196 ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.75 -9.85 59.77 Favored 'General case' 0 N--CA 1.435 -1.206 0 O-C-N 120.892 -1.13 . . . . 40.619999999999997 112.593 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B 1197 ' ' ARG . . . . . . . . . . . . . 31.9 mtm105 -90.53 134.3 31.18 Favored Pre-proline 0 C--O 1.25 1.115 0 O-C-N 119.992 -1.692 . . . . 53.090000000000003 107.815 178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -61.81 -34.39 82.66 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 123.417 2.745 . . . . 42.560000000000002 116.378 -165.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -68.57 -17.9 64.23 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 115.018 1.488 . . . . 56.310000000000002 115.018 -165.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1200 ' ' VAL . . . . . . . . . . . . . 14.1 m -58.72 -29.05 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-N 115.137 -0.938 . . . . 42.909999999999997 113.335 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 37.9 tttm -60.3 -62.31 1.96 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.685 -1.228 . . . . 48.890000000000001 107.685 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -60.16 -26.77 66.56 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 114.909 1.448 . . . . 51.700000000000003 114.909 176.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1203 ' ' GLN . . . . . . . . . . . . . 67.6 mm-40 -62.04 -47.82 83.0 Favored 'General case' 0 C--O 1.253 1.283 0 CA-C-N 121.104 1.775 . . . . 52.57 111.449 171.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1204 ' ' VAL . . . . . . . . . . . . 0.257 34.5 m -67.23 -43.97 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 O-C-N 120.619 -1.3 . . . . 33.789999999999999 113.736 175.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -56.61 -52.08 66.23 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 117.068 -1.444 . . . . 36.579999999999998 110.876 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1206 ' ' SER . . . . . . . . . . . . . 90.3 p -61.46 -40.88 96.12 Favored 'General case' 0 C--O 1.253 1.288 0 CA-C-N 120.125 1.33 . . . . 39.609999999999999 112.196 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1207 ' ' MET . . . . . . . . . . . . . 11.7 ttm -72.78 -18.78 61.45 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 119.738 -1.851 . . . . 37.450000000000003 112.808 174.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 84.83 73.36 1.27 Allowed Glycine 0 C--O 1.248 0.995 0 O-C-N 119.368 -2.083 . . . . 31.870000000000001 109.933 -176.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -163.17 155.51 18.29 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 106.742 -1.577 . . . . 35.399999999999999 106.742 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -86.56 148.48 25.48 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 112.088 -2.324 . . . . 47.890000000000001 111.59 -171.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 30.7 t80 -113.92 125.3 53.88 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 120.198 -1.564 . . . . 45.530000000000001 108.14 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1212 ' ' LEU . . . . . . . . . . . . . 44.6 mt -74.36 108.49 7.17 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 103.832 -2.655 . . . . 46.329999999999998 103.832 170.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.41 159.64 21.75 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 113.357 -1.747 . . . . 60.409999999999997 112.313 -172.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.56 145.38 54.96 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 115.19 1.552 . . . . 57.380000000000003 115.19 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 34.4 t70 . . . . . 0 C--O 1.222 -0.349 0 CA-C-N 112.911 -1.95 . . . . 65.069999999999993 107.512 173.044 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B 1230 ' ' MET . . . . . . . . . . . . . 28.2 mmt . . . . . 0 N--CA 1.445 -0.696 0 N-CA-C 107.556 -1.275 . . . . 80.319999999999993 107.556 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B 1231 ' ' SER . . . . . . . . . . . . . 18.6 m -160.25 157.63 28.49 Favored 'General case' 0 C--O 1.224 -0.286 1 O-C-N 114.94 -4.85 . . . . 79.920000000000002 104.658 -10.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.93 -175.06 3.78 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-N 121.968 2.167 . . . . 77.909999999999997 105.685 155.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 60.9 -56.48 0.09 Allowed 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 117.032 2.234 . . . . 73.879999999999995 117.032 -170.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 4.9 t80 -38.87 -33.1 0.1 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.313 1.445 . . . . 68.980000000000004 113.703 169.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 35.9 pt -36.48 -39.63 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.384 0 N-CA-C 116.967 2.21 . . . . 64.530000000000001 116.967 167.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -62.52 -51.03 69.04 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 122.903 0.481 . . . . 66.359999999999999 110.986 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -67.26 -33.72 75.91 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 125.29 1.619 . . . . 56.600000000000001 109.15 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -56.71 -52.77 63.68 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 120.637 1.562 . . . . 56.789999999999999 109.805 171.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1239 ' ' MET . . . . . . . . . . . . . 31.1 mmt -56.44 -47.2 79.6 Favored 'General case' 0 C--O 1.238 0.471 0 O-C-N 124.558 1.161 . . . . 53.630000000000003 113.38 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -63.63 -25.63 68.31 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 115.211 1.56 . . . . 51.740000000000002 115.211 175.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 13.1 tp -67.06 -46.25 74.91 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 105.483 -2.043 . . . . 44.859999999999999 105.483 174.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 8.4 m-30 -70.48 -45.13 66.3 Favored 'General case' 0 C--O 1.216 -0.701 0 O-C-N 120.268 -1.52 . . . . 42.780000000000001 106.999 -173.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -52.82 -43.08 65.71 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.343 1.238 . . . . 40.960000000000001 114.343 171.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -62.78 -29.74 70.94 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 115.813 1.782 . . . . 43.060000000000002 115.813 170.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -79.72 -24.76 41.42 Favored 'General case' 0 C--O 1.202 -1.445 0 CA-C-O 117.013 -1.47 . . . . 46.450000000000003 113.03 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -35.2 -40.45 0.13 Allowed 'General case' 0 C--O 1.241 0.636 1 N-CA-C 121.959 4.059 . . . . 41.780000000000001 121.959 -174.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 7.9 mptt -101.74 -4.9 25.65 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-N 120.379 1.445 . . . . 52.200000000000003 113.866 175.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1248 ' ' GLU . . . . . 0.412 ' CD ' HH12 ' B' 1192 ' ' ARG . 36.2 mt-10 -81.74 -63.23 1.43 Allowed 'General case' 0 C--O 1.25 1.125 0 N-CA-C 108.006 -1.109 . . . . 53.549999999999997 108.006 167.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B 1249 ' ' VAL . . . . . . . . . . . . . 21.7 m -65.69 154.41 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 123.963 1.84 . . . . 34.409999999999997 115.146 -168.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1250 ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -118.1 -56.56 2.16 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 105.271 -2.122 . . . . 33.380000000000003 105.271 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1251 ' ' ILE . . . . . . . . . . . . . 32.5 mm -110.73 109.02 26.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 O-C-N 119.782 -1.824 . . . . 29.539999999999999 106.881 -169.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1252 ' ' ILE . . . . . . . . . . . . . 47.1 mt -88.59 117.86 32.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 119.833 -1.792 . . . . 32.439999999999998 108.545 171.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1253 ' ' VAL . . . . . . . . . . . . . 74.0 t -104.28 94.34 3.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 100.286 -3.968 . . . . 30.57 100.286 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1254 ' ' THR . . . . . . . . . . . . 0.294 6.5 t -94.78 101.56 13.39 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 125.681 2.658 . . . . 35.039999999999999 109.257 -176.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B 1255 ' ' THR . . . . . . . . . . . . . 33.3 m -100.72 -21.11 15.31 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 109.192 -3.64 . . . . 34.619999999999997 113.933 -163.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . -62.17 139.25 58.48 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-O 122.877 1.323 . . . . 42.719999999999999 113.051 -162.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 5.6 tt -153.61 126.8 8.47 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 111.165 -2.743 . . . . 52.43 104.945 175.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 58.3 mt -85.69 118.21 70.19 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 101.34 -3.578 . . . . 59.409999999999997 101.34 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -51.37 92.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 124.877 3.718 . . . . 62.68 114.974 -175.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 130.46 -64.27 0.61 Allowed Glycine 0 N--CA 1.425 -2.061 0 N-CA-C 107.008 -2.437 . . . . 64.159999999999997 107.008 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 79.7 mttt -59.1 166.52 2.66 Favored Pre-proline 0 CA--C 1.51 -0.58 0 C-N-CA 125.992 1.717 . . . . 68.530000000000001 115.582 171.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -67.67 166.45 24.09 Favored 'Trans proline' 0 C--O 1.249 1.034 0 C-N-CA 122.659 2.239 . . . . 61.990000000000002 114.459 169.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1263 ' ' ALA . . . . . . . . . . . . . . . -54.71 126.92 59.02 Favored Pre-proline 0 C--O 1.25 1.091 0 CA-C-N 111.819 -2.446 . . . . 57.149999999999999 111.52 166.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -60.95 141.49 94.68 Favored 'Trans proline' 0 C--N 1.324 -0.745 0 C-N-CA 123.998 3.132 . . . . 51.57 109.57 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -77.22 73.34 3.8 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-N 114.998 -1.001 . . . . 54.549999999999997 112.724 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 43.1 mt -76.02 -40.18 54.1 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 115.217 1.562 . . . . 46.859999999999999 115.217 -170.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1267 ' ' ILE . . . . . . . . . . . . . 40.1 mm -110.72 119.75 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 106.432 -1.692 . . . . 41.039999999999999 106.432 -173.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1268 ' ' THR . . . . . . . . . . . . . 19.0 p -84.13 159.0 21.18 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 113.03 -1.895 . . . . 39.579999999999998 110.108 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1269 ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 -63.62 -33.6 75.98 Favored 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 120.689 -1.257 . . . . 53.149999999999999 111.03 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -64.4 -43.91 92.93 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 109.046 -0.724 . . . . 42.960000000000001 109.046 176.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1271 ' ' MET . . . . . . . . . . . . . 5.8 ttm -62.18 -40.45 96.06 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 114.516 1.302 . . . . 43.890000000000001 114.516 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1272 ' ' VAL . . . . . . . . . . . . . 53.7 t -56.62 -59.12 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 120.339 -0.544 . . . . 38.369999999999997 111.53 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -66.84 -25.15 66.29 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 122.779 1.275 . . . . 47.460000000000001 114.02 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1274 ' ' SER . . . . . . . . . . . . . 33.2 m -74.71 -17.13 60.71 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 118.262 -2.774 . . . . 38.380000000000003 114.131 170.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1275 ' ' MET . . . . . . . . . . . . . 34.0 mtp -69.12 163.64 24.35 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 121.388 1.904 . . . . 37.810000000000002 112.808 -174.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.04 126.32 25.41 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 113.131 -1.85 . . . . 49.259999999999998 108.778 167.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -83.47 169.85 15.07 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 120.559 1.527 . . . . 34.460000000000001 114.003 -167.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 62.32 41.64 99.74 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-O 122.995 1.331 . . . . 33.530000000000001 110.639 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1279 ' ' SER . . . . . . . . . . . . . 70.4 m -134.59 158.98 42.62 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 110.204 -2.998 . . . . 31.309999999999999 104.224 -172.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1280 ' ' VAL . . . . . . . . . . . . . 41.4 t -128.66 142.1 44.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 106.708 -1.59 . . . . 29.32 106.708 -169.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1281 ' ' ILE . . . . . . . . . . . . . 43.4 mt -113.31 113.22 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 103.002 -2.962 . . . . 31.93 103.002 167.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1282 ' ' VAL . . . . . . . . . . . . . 5.1 t -97.09 127.57 49.17 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 N-CA-C 105.873 -1.899 . . . . 29.48 105.873 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 12.8 t0 -100.12 115.37 29.65 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 104.387 -2.449 . . . . 34.5 104.387 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1284 ' ' LEU . . . . . . . . . . . . . 6.9 mp -82.01 -22.74 36.35 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.727 1.01 . . . . 37.939999999999998 113.727 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -118.45 30.72 7.05 Favored 'General case' 0 N--CA 1.428 -1.551 0 O-C-N 119.374 -2.079 . . . . 40.920000000000002 111.115 -165.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -51.72 -38.2 54.24 Favored 'General case' 0 C--O 1.248 0.987 0 N-CA-C 117.647 2.462 . . . . 44.390000000000001 117.647 -169.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1287 ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -65.31 -22.98 66.9 Favored 'General case' 0 C--O 1.268 2.049 0 N-CA-C 117.226 2.306 . . . . 51.460000000000001 117.226 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 20.7 m120 -110.31 73.31 0.83 Allowed 'General case' 0 C--N 1.35 0.604 0 N-CA-C 105.65 -1.981 . . . . 57.75 105.65 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1289 ' ' GLY . . . . . . . . . . . . . . . 87.08 -64.05 3.93 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-O 116.443 -2.31 . . . . 49.850000000000001 112.484 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 106.26 120.61 4.68 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 118.903 1.352 . . . . 45.93 112.03 -167.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1291 ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -69.6 -36.95 76.66 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.37 1.468 . . . . 42.670000000000002 112.368 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1292 ' ' CYS . . . . . . . . . . . . . 31.5 t -99.16 145.37 27.27 Favored 'General case' 0 C--O 1.253 1.257 0 CA-C-N 123.216 2.735 . . . . 38.82 108.401 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1293 ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -60.47 -29.94 69.36 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 114.93 1.456 . . . . 46.710000000000001 114.93 175.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -72.09 -16.7 62.02 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 116.396 1.998 . . . . 47.229999999999997 116.396 176.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1295 ' ' THR . . . . . . . . . . . . . 85.9 m -56.19 122.35 11.55 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 123.854 1.788 . . . . 36.020000000000003 115.756 -165.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 7.2 t -107.03 124.18 36.11 Favored Pre-proline 0 N--CA 1.438 -1.054 1 N-CA-C 100.147 -4.02 . . . . 37.259999999999998 100.147 175.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -62.67 107.74 0.64 Allowed 'Trans proline' 0 C--O 1.243 0.752 0 C-N-CA 123.906 3.07 . . . . 35.090000000000003 112.459 -172.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 83.01 50.93 4.39 Favored Glycine 0 C--O 1.252 1.265 0 N-CA-C 108.035 -2.026 . . . . 35.969999999999999 108.035 173.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -151.74 145.25 24.87 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-O 122.181 0.991 . . . . 40.390000000000001 109.706 175.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1300 ' ' ILE . . . . . . . . . . . . . 77.1 mt -80.49 130.07 36.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 103.877 -2.638 . . . . 37.43 103.877 156.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 4.5 t80 -121.94 120.79 35.47 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 104.758 -2.312 . . . . 44.130000000000003 104.758 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1302 ' ' THR . . . . . . . . . . . . . 59.6 m -83.51 133.97 34.86 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.325 -1.307 . . . . 39.780000000000001 108.264 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1303 ' ' THR . . . . . . . . . . . . . 14.0 p -97.75 179.74 4.72 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 121.105 -0.997 . . . . 43.289999999999999 112.155 175.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -60.19 -51.69 68.51 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.64 0.733 . . . . 53.07 111.457 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 43.9 p-10 -74.57 -17.18 60.77 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 116.351 1.982 . . . . 43.969999999999999 116.351 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 85.25 33.69 16.6 Favored Glycine 0 N--CA 1.468 0.799 0 CA-C-N 114.626 -1.17 . . . . 41.119999999999997 113.994 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1307 ' ' VAL . . . . . . . . . . . . . 99.8 t -92.08 94.1 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 N-CA-C 105.374 -2.084 . . . . 38.119999999999997 105.374 163.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1308 ' ' LYS . . . . . . . . . . . . . 80.7 mttt -78.59 119.72 22.27 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.649 -1.614 . . . . 36.340000000000003 109.662 -165.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1309 ' ' VAL . . . . . . . . . . . . . 59.4 t -90.01 97.18 6.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 125.084 2.373 . . . . 30.399999999999999 109.195 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1310 ' ' ILE . . . . . . . . . . . . . 14.1 mt -87.39 80.21 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.891 0 CA-C-N 112.239 -2.255 . . . . 30.82 105.314 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1311 ' ' GLY . . . . . . . . . . . . . . . -81.41 109.42 3.0 Favored Glycine 0 CA--C 1.503 -0.71 0 O-C-N 119.897 -1.752 . . . . 26.530000000000001 109.847 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1312 ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -120.23 124.99 47.03 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 119.741 3.237 . . . . 38.0 119.741 -176.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1313 ' ' THR . . . . . . . . . . . . . 4.0 m -69.65 -33.02 72.02 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.3 -1.773 . . . . 29.800000000000001 110.419 164.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -118.74 24.14 11.05 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 114.145 -1.389 . . . . 39.039999999999999 114.001 -157.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1315 ' ' LEU . . . . . . . . . . . . . 18.7 mt -52.1 -41.93 83.08 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 114.728 1.381 . . . . 31.079999999999998 114.728 176.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1316 ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -67.17 -36.84 20.19 Favored 'Trans proline' 0 CA--C 1.499 -1.252 0 CA-C-N 123.831 2.404 . . . . 26.100000000000001 113.094 168.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -60.29 -44.96 96.96 Favored Glycine 0 CA--C 1.503 -0.685 0 CA-C-N 120.512 1.506 . . . . 23.170000000000002 110.606 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 56.1 mtt-85 -66.95 -0.21 2.96 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 116.149 1.907 . . . . 40.399999999999999 116.149 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 22.6 tp -120.37 78.79 27.73 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 105.325 -2.102 . . . . 23.600000000000001 105.325 172.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1320 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -58.41 -64.78 0.1 Allowed 'Trans proline' 0 CA--C 1.552 1.397 0 C-N-CA 125.158 3.905 . . . . 22.350000000000001 113.956 -161.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1321 ' ' THR . . . . . . . . . . . . . 6.3 m -66.16 -40.96 90.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 121.149 1.795 . . . . 26.52 112.874 -175.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1322 ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -69.67 -43.57 72.27 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 120.262 1.392 . . . . 24.379999999999999 110.83 -174.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1323 ' ' SER . . . . . . . . . . . . . 21.0 m -56.13 -50.22 71.72 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 119.217 -0.993 . . . . 22.800000000000001 111.091 170.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1324 ' ' SER . . . . . . . . . . . . . 15.1 m -57.57 -34.56 69.34 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 123.242 1.496 . . . . 21.25 112.731 176.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -67.23 -55.73 12.8 Favored 'General case' 0 N--CA 1.438 -1.036 0 O-C-N 119.594 -1.941 . . . . 31.34 111.387 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1326 ' ' LEU . . . . . . . . . . . . . 45.0 mt -69.32 -40.41 77.63 Favored 'General case' 0 N--CA 1.435 -1.19 0 O-C-N 120.886 -1.134 . . . . 31.559999999999999 111.764 -173.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1327 ' ' TYR . . . . . . . . . . . . . 27.4 t80 -53.42 -53.31 53.15 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.428 -1.323 . . . . 22.73 107.428 171.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1328 ' ' GLY . . . . . . . . . . . . . . . -44.84 -56.89 5.6 Favored Glycine 0 C--O 1.254 1.381 0 C-N-CA 124.539 1.066 . . . . 21.91 114.335 172.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1329 ' ' THR . . . . . . . . . . . . . 19.3 m -69.84 -23.64 63.32 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 121.428 -1.042 . . . . 22.149999999999999 110.421 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1330 ' ' ASN . . . . . . . . . . . . . 31.6 m120 -66.3 -42.66 87.99 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.076 -1.64 . . . . 26.18 107.004 172.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1331 ' ' LEU . . . . . . . . . . . . . 41.5 mt -66.6 -39.13 88.23 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.569 -0.9 . . . . 23.68 108.569 -178.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1332 ' ' VAL . . . . . . . . . . . . . 70.3 t -58.69 -46.73 90.35 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-O 116.958 -1.496 . . . . 26.57 108.622 171.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -56.53 -43.11 79.53 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 121.018 1.736 . . . . 28.079999999999998 113.592 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1334 ' ' LEU . . . . . . . . . . . . . 46.9 tp -59.6 -50.76 72.64 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 113.82 -1.536 . . . . 27.43 107.855 175.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1335 ' ' LEU . . . . . . . . . . . . . 65.1 mt -69.77 -23.99 63.44 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 119.011 -2.306 . . . . 30.5 111.841 -177.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1336 ' ' LYS . . . . . . . . . . . . . 90.9 mttt -64.42 -40.28 95.46 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 122.81 2.55 . . . . 41.649999999999999 109.891 169.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 12.4 tp -77.75 -31.09 51.91 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 113.472 0.916 . . . . 42.079999999999998 113.472 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1338 ' ' LEU . . . . . . . . . . . . . 95.1 mt -78.64 -69.77 0.54 Allowed 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 122.281 1.039 . . . . 35.030000000000001 109.61 173.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 42.4 t -81.1 72.35 8.12 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 124.397 2.046 . . . . 37.329999999999998 107.584 -174.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 58.9 mttp -70.18 -19.25 63.2 Favored 'General case' 0 CA--C 1.5 -0.952 0 O-C-N 118.376 -2.703 . . . . 50.509999999999998 114.929 -178.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -78.14 -9.18 59.06 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 113.169 0.803 . . . . 54.210000000000001 113.169 168.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 44.9 mttt 48.11 56.23 7.61 Favored 'General case' 0 C--N 1.364 1.224 0 C-N-CA 124.96 1.304 . . . . 50.990000000000002 113.359 -173.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 26.6 p-10 -122.38 -47.87 2.1 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.857 -0.737 . . . . 48.82 111.17 -172.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 150.37 -3.71 0.56 Allowed Glycine 0 CA--C 1.54 1.623 0 CA-C-O 123.369 1.538 . . . . 40.43 111.195 172.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 22.9 t30 -79.64 116.4 19.81 Favored 'General case' 0 N--CA 1.428 -1.53 0 O-C-N 119.463 -2.198 . . . . 47.560000000000002 114.292 175.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1346 ' ' ILE . . . . . . . . . . . . . 40.4 mm -59.74 97.62 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.246 0.902 0 CA-C-O 123.204 1.478 . . . . 42.490000000000002 112.234 169.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1347 ' ' THR . . . . . . . . . . . . . 48.2 m -101.38 93.99 5.69 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 113.394 -1.73 . . . . 38.119999999999997 107.504 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 85.5 t -87.0 94.84 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 O-C-N 119.309 -2.119 . . . . 37.5 107.802 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 16.2 t70 -75.12 101.97 4.75 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 107.228 -1.397 . . . . 43.850000000000001 107.228 170.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1350 ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.98 -5.24 45.39 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 113.244 -1.798 . . . . 39.810000000000002 113.168 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 24.2 t70 -79.81 -42.65 23.95 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 120.341 -1.474 . . . . 51.289999999999999 107.706 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 20.1 t0 -57.11 113.54 1.76 Allowed 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 122.756 1.265 . . . . 39.780000000000001 109.865 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 15.1 m -46.27 -35.24 2.31 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 CA-C-N 113.502 -1.681 . . . . 39.280000000000001 114.443 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1354 ' ' VAL . . . . . . . . . . . . . 47.4 t -67.72 -50.53 59.69 Favored 'Isoleucine or valine' 0 C--O 1.263 1.794 0 O-C-N 124.72 1.262 . . . . 35.700000000000003 110.751 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1355 ' ' ILE . . . . . . . . . . . . . 34.7 mm -69.0 -40.2 80.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 CA-C-N 120.046 1.294 . . . . 35.770000000000003 108.902 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 43.8 tpt85 -52.52 -32.18 39.16 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 125.44 1.496 . . . . 38.549999999999997 111.662 168.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -74.14 -59.64 3.86 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 110.229 -1.149 . . . . 29.579999999999998 110.229 176.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1358 ' ' VAL . . . . . . . . . . . . . 11.6 p -60.32 -38.55 77.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-N 118.393 1.096 . . . . 32.060000000000002 111.634 -172.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1359 ' ' THR . . . . . . . . . . . . . 5.6 m -81.78 92.17 6.61 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 123.049 1.404 . . . . 29.0 107.695 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1360 ' ' VAL . . . . . . . . . . . . . 31.2 m -82.27 -17.88 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 110.771 -2.922 . . . . 29.68 113.903 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 48.6 mt -133.7 106.88 9.68 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 N-CA-C 101.274 -3.602 . . . . 32.049999999999997 101.274 168.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1362 ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 -87.62 78.04 8.59 Favored 'General case' 0 C--O 1.243 0.727 0 O-C-N 118.341 -2.725 . . . . 32.520000000000003 109.182 174.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 58.62 89.1 0.06 Allowed 'General case' 0 C--O 1.246 0.912 0 CA-C-N 112.488 -2.142 . . . . 35.68 114.161 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 88.56 -72.68 2.3 Favored Glycine 0 N--CA 1.477 1.43 0 CA-C-N 114.733 -1.122 . . . . 34.259999999999998 111.253 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.03 117.64 6.73 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.182 0.993 . . . . 51.07 110.46 176.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 95.9 mt -74.24 104.13 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 104.93 -2.248 . . . . 39.869999999999997 104.93 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1367 ' ' THR . . . . . . . . . . . . . 7.2 p -94.2 -1.08 54.68 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.1 -1.409 . . . . 38.009999999999998 111.985 -174.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1368 ' ' TRP . . . . . . . . . . . . . 24.5 t90 -74.23 137.67 75.34 Favored Pre-proline 0 CA--C 1.548 0.876 0 O-C-N 120.236 -1.54 . . . . 42.140000000000001 108.009 162.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -72.94 161.22 94.17 Favored 'Cis proline' 0 CA--C 1.512 -0.624 0 CA-C-N 123.171 2.168 . . . . 43.259999999999998 116.785 -11.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1370 ' ' ALA . . . . . . . . . . . . . . . -87.38 170.42 11.99 Favored Pre-proline 0 N--CA 1.469 0.505 0 CA-C-O 117.12 -1.419 . . . . 46.520000000000003 111.072 176.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -47.93 144.26 12.1 Favored 'Trans proline' 0 CA--C 1.555 1.557 0 C-N-CA 123.43 2.753 . . . . 51.950000000000003 112.671 165.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.96 75.76 2.17 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.568 2.845 . . . . 56.270000000000003 114.85 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1373 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.92 128.76 38.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 104.895 -2.261 . . . . 60.829999999999998 104.895 173.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -68.25 123.23 20.15 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 115.707 1.743 . . . . 66.099999999999994 115.707 -173.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 14.4 t -60.88 123.23 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 1 O-C-N 129.208 4.068 . . . . 63.469999999999999 110.922 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.23 -4.627 0 O-C-N 119.795 -1.816 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.702 0 CA-C-O 118.828 -0.606 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -45.33 -30.25 1.25 Allowed 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 117.454 2.39 . . . . 0.0 117.454 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -46.57 -40.19 12.34 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.991 1.716 . . . . 0.0 109.436 177.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 22.4 m -55.97 -29.23 59.9 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -178.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.55 -47.28 86.25 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.276 -1.515 . . . . 0.0 111.104 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -66.56 -34.36 77.73 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.327 1.051 . . . . 0.0 108.284 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 mp -70.06 -31.31 68.86 Favored 'General case' 0 N--CA 1.426 -1.663 0 C-N-CA 123.825 0.85 . . . . 0.0 110.827 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 63.0 mt -61.14 -48.08 83.24 Favored 'General case' 0 CA--C 1.518 -0.282 0 O-C-N 119.431 -2.043 . . . . 0.0 115.334 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 28' ' ' LYS . . . . . . . . . . . . . 10.2 pttm -63.98 -28.2 69.65 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 119.063 -1.055 . . . . 0.0 113.213 172.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -73.87 -35.3 64.72 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 118.632 -0.699 . . . . 0.0 112.053 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 39.6 m -56.42 -17.79 9.15 Favored 'General case' 0 C--O 1.239 0.531 1 N-CA-C 124.137 4.865 . . . . 0.0 124.137 -163.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 44.2 m-70 66.67 -77.31 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 125.336 1.455 . . . . 0.0 109.726 -174.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 74.2 m -97.5 160.01 14.58 Favored 'General case' 0 C--O 1.242 0.661 0 O-C-N 120.158 -1.589 . . . . 0.0 108.318 168.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 12.8 t -132.23 118.01 34.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 O-C-N 119.01 -2.306 . . . . 0.0 105.658 174.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 27.3 mm -104.29 124.12 58.56 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 N-CA-C 105.882 -1.895 . . . . 0.0 105.882 175.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 92.3 mt -107.03 125.61 63.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 82.8 m -106.86 98.79 22.51 Favored Pre-proline 0 N--CA 1.44 -0.962 0 O-C-N 119.316 -2.115 . . . . 0.0 112.249 171.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -75.95 56.32 4.75 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.421 2.747 . . . . 0.0 114.526 175.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.92 89.03 1.42 Allowed Glycine 0 N--CA 1.443 -0.894 0 O-C-N 119.78 -1.825 . . . . 0.0 111.137 -170.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 40.1 t80 65.76 -72.71 0.07 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.895 1.278 . . . . 0.0 108.916 -177.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -28.46 -64.09 0.11 Allowed Glycine 0 C--N 1.349 1.285 0 N-CA-C 117.985 1.954 . . . . 0.0 117.985 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 9.2 ttm -49.83 -39.84 40.15 Favored 'General case' 0 C--O 1.25 1.126 0 N-CA-C 118.265 2.691 . . . . 0.0 118.265 173.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -85.35 -22.92 28.25 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 9.0 p -84.13 -38.09 13.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 O-C-N 119.078 -2.264 . . . . 0.0 110.945 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.67 9.57 2.71 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 117.4 2.37 . . . . 0.0 117.4 175.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 45' ' ' GLN . . . . . . . . . . . . 0.388 1.0 OUTLIER 41.75 48.1 3.64 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 119.124 3.009 . . . . 0.0 119.124 -159.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.51 -1.31 57.05 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.887 169.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.56 -48.84 57.3 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 118.335 -0.841 . . . . 0.0 111.455 177.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 48' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -71.42 -58.01 4.09 Favored Pre-proline 0 C--O 1.247 0.964 0 CA-C-O 116.87 -1.538 . . . . 0.0 113.922 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 49' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -50.9 -15.05 1.55 Allowed 'Trans proline' 0 C--N 1.367 1.53 0 N-CA-C 120.412 3.197 . . . . 0.0 120.412 172.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 5.5 p -63.6 -29.82 48.25 Favored 'Isoleucine or valine' 0 C--O 1.246 0.87 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.294 172.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.23 93.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 117.951 -2.968 . . . . 0.0 111.148 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -47.42 -48.87 26.12 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 171.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 53' ' ' ILE . . . . . . . . . . . . 0.253 8.4 tp -72.99 -46.26 52.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.902 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 60.5 m -53.13 -36.77 61.15 Favored 'General case' 0 C--O 1.256 1.419 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -52.67 -64.22 0.89 Allowed 'General case' 0 C--O 1.238 0.485 0 C-N-CA 127.045 2.138 . . . . 0.0 111.311 173.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -66.12 -33.09 74.99 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 117.373 -1.298 . . . . 0.0 109.732 -176.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 50.4 mt -60.54 -45.89 92.2 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 122.372 2.351 . . . . 0.0 108.845 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -66.36 -43.99 84.45 Favored 'General case' 0 C--O 1.255 1.369 0 O-C-N 121.3 -0.875 . . . . 0.0 111.747 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.63 -12.56 61.09 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 121.872 0.844 . . . . 0.0 112.67 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -76.87 -31.82 57.06 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-O 123.822 1.772 . . . . 0.0 110.045 171.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.47 42.01 2.62 Favored Glycine 0 N--CA 1.431 -1.638 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.654 -173.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 95.3 mt -109.11 132.1 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 121.568 0.699 . . . . 0.0 109.68 -177.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -68.94 91.74 0.48 Allowed 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 122.684 1.23 . . . . 0.0 108.255 169.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 8.9 p -96.98 122.43 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-O 122.525 1.155 . . . . 0.0 109.687 176.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 17.8 mmt-85 -129.27 153.43 47.8 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 175.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -112.93 141.67 46.49 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -126.74 99.54 0.54 Allowed Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 107.596 -2.202 . . . . 0.0 107.596 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mt -102.92 -154.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 O-C-N 124.411 0.712 . . . . 0.0 111.384 174.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -165.2 135.2 2.9 Favored Pre-proline 0 N--CA 1.473 0.68 0 O-C-N 119.243 -2.161 . . . . 0.0 105.61 -169.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 70' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -45.4 -61.51 0.58 Allowed 'Trans proline' 0 C--N 1.352 0.716 1 C-N-CA 126.428 4.752 . . . . 0.0 117.526 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 14.5 m -94.42 133.41 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.93 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 174.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.57 9.34 8.99 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 117.786 2.513 . . . . 0.0 117.786 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.88 -52.28 0.65 Allowed Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 -169.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -147.94 177.64 9.18 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 7.0 mt 53.71 44.39 1.87 Allowed Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 119.557 3.169 . . . . 0.0 119.557 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -63.31 133.74 41.89 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.691 2.927 . . . . 0.0 113.195 -174.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.22 -70.6 1.84 Allowed Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.385 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 78' ' ' HIS . . . . . . . . . . . . 0.258 0.2 OUTLIER -36.91 -34.2 0.07 Allowed 'General case' 0 C--O 1.25 1.124 0 N-CA-C 121.648 3.944 . . . . 0.0 121.648 177.115 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -54.36 -34.13 60.54 Favored 'General case' 0 C--N 1.347 0.46 0 O-C-N 118.942 -2.348 . . . . 0.0 113.926 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -77.0 -30.38 55.89 Favored 'General case' 0 CA--C 1.501 -0.912 0 O-C-N 120.822 -1.174 . . . . 0.0 112.107 175.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 6.5 t -67.06 -39.77 84.02 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 O-C-N 120.678 -1.264 . . . . 0.0 110.689 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 95.3 mt -54.97 -36.24 65.16 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.111 0.964 . . . . 0.0 112.381 171.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 8.1 mp -71.72 -31.23 66.49 Favored 'General case' 0 C--O 1.249 1.04 0 CA-C-N 119.997 1.272 . . . . 0.0 112.077 176.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.13 -30.15 64.76 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.681 173.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.25 -48.37 78.52 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-O 122.024 0.916 . . . . 0.0 109.146 166.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.03 -1.38 2.05 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 119.171 -2.205 . . . . 0.0 115.827 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp 55.29 53.11 10.42 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -171.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 14.5 t -111.27 125.55 30.33 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 101.483 -3.525 . . . . 0.0 101.483 169.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -61.66 120.97 8.86 Favored 'Trans proline' 0 C--O 1.241 0.653 1 C-N-CA 126.49 4.793 . . . . 0.0 115.949 -171.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.58 -26.73 45.32 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 126.66 1.984 . . . . 0.0 113.008 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -58.46 -51.3 70.43 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 119.965 1.257 . . . . 0.0 112.148 174.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 45.2 pt -77.73 -23.11 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 119.655 -1.903 . . . . 0.0 110.575 -175.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 67.9 t -68.35 83.55 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 174.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 20.7 mt -89.84 151.85 21.56 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 173.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -138.53 127.96 24.59 Favored 'General case' 0 C--O 1.249 1.066 0 O-C-N 118.597 -2.565 . . . . 0.0 108.44 176.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 50.3 ttp 45.11 75.17 0.11 Allowed 'General case' 0 C--N 1.354 0.8 0 CA-C-O 124.872 2.272 . . . . 0.0 113.732 -177.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -145.5 164.01 32.93 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 109.994 -3.275 . . . . 0.0 106.809 -162.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -79.97 13.41 2.24 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 112.934 -1.939 . . . . 0.0 111.66 -178.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 4.2 tt -45.42 -16.35 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 124.614 1.166 . . . . 0.0 111.652 153.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -33.91 -35.85 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 117.108 2.262 . . . . 0.0 117.108 162.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -65.45 -62.1 1.72 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 119.336 -0.945 . . . . 0.0 111.232 172.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -51.0 -32.79 22.3 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 175.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 103' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -55.71 -47.97 75.95 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 125.705 1.602 . . . . 0.0 109.958 170.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -79.97 -18.33 50.62 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 119.01 0.823 . . . . 0.0 111.774 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -73.08 -47.13 47.11 Favored 'General case' 0 C--O 1.239 0.501 0 O-C-N 120.459 -1.401 . . . . 0.0 111.548 171.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 106' ' ' THR . . . . . . . . . . . . . 77.0 m -54.14 133.8 44.19 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 122.342 0.257 . . . . 0.0 111.599 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 107' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -67.07 -65.59 0.66 Allowed 'General case' 0 C--O 1.234 0.252 0 O-C-N 124.076 0.86 . . . . 0.0 112.292 169.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 68.0 m -103.42 105.91 16.29 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 123.978 0.911 . . . . 0.0 109.64 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 109' ' ' VAL . . . . . . . . . . . . . 16.4 t -89.54 110.97 22.35 Favored 'Isoleucine or valine' 0 C--N 1.349 0.578 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 28.5 mt -77.96 84.26 4.25 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 123.219 1.485 . . . . 0.0 110.791 -175.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 93.1 t -90.65 96.3 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 CA-C-O 123.154 1.454 . . . . 0.0 108.622 -177.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 1.3 mm -83.67 89.52 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-O 124.001 1.858 . . . . 0.0 108.586 -171.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.55 -103.91 2.47 Favored Glycine 0 CA--C 1.496 -1.116 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.669 -172.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . 56.47 -57.11 0.02 OUTLIER 'General case' 0 C--O 1.249 1.063 0 N-CA-C 120.463 3.505 . . . . 0.0 120.463 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 115' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 59.67 -93.03 0.04 OUTLIER 'General case' 0 C--O 1.241 0.644 0 CA-C-N 122.553 2.433 . . . . 0.0 112.438 173.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 116' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -82.72 -19.38 38.11 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.123 -0.986 . . . . 0.0 111.977 -176.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 117' ' ' THR . . . . . . . . . . . . 0.254 1.0 OUTLIER -67.22 -15.28 63.61 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 176.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 16.5 m -122.81 30.66 2.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 124.612 1.165 . . . . 0.0 108.327 171.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -86.78 119.62 71.31 Favored Pre-proline 0 CA--C 1.506 -0.714 0 O-C-N 119.212 -2.18 . . . . 0.0 114.146 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 120' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -53.24 -53.22 7.05 Favored 'Trans proline' 0 C--O 1.243 0.733 0 C-N-CA 124.878 3.718 . . . . 0.0 113.127 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.9 -28.09 69.27 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -174.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 122' ' ' ALA . . . . . . . . . . . . . . . -54.51 -41.05 69.19 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-O 121.609 0.719 . . . . 0.0 111.622 172.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -92.57 -16.62 25.45 Favored 'General case' 0 C--O 1.245 0.846 0 O-C-N 118.499 -2.625 . . . . 0.0 114.074 173.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -98.77 -35.52 10.12 Favored 'General case' 0 C--O 1.241 0.647 0 O-C-N 121.242 -0.911 . . . . 0.0 112.846 -165.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -117.54 126.94 26.99 Favored Pre-proline 0 C--N 1.321 -0.639 0 C-N-CA 124.516 1.126 . . . . 0.0 113.112 -157.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -62.36 -38.03 56.53 Favored 'Trans proline' 0 CA--C 1.548 1.196 0 C-N-CA 124.971 3.781 . . . . 0.0 114.57 176.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? -63.75 -29.57 70.77 Favored 'General case' 0 C--N 1.314 -0.941 0 O-C-N 119.291 -2.131 . . . . 0.0 111.267 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 128' ' ' SER . . . . . . . . . . . . . 18.4 m -58.6 127.94 82.74 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 118.074 -0.965 . . . . 0.0 111.044 172.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 129' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -56.23 -31.36 83.74 Favored 'Trans proline' 0 C--O 1.257 1.428 0 CA-C-N 122.506 1.931 . . . . 0.0 116.17 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 10.5 pt -105.78 53.53 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-O 123.246 1.498 . . . . 0.0 109.278 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.85 120.8 14.17 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 123.3 1.524 . . . . 0.0 111.811 -171.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.61 38.97 10.02 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 133' ' ' MET . . . . . . . . . . . . . 42.8 tpp -73.72 134.98 78.23 Favored Pre-proline 0 N--CA 1.45 -0.444 0 O-C-N 119.819 -1.989 . . . . 0.0 110.535 172.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -68.25 90.24 0.39 Allowed 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 124.011 3.141 . . . . 0.0 110.418 173.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 1.5 m -110.95 150.8 13.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -175.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 28.7 mt -73.9 104.51 4.79 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.934 0.873 . . . . 0.0 112.589 -165.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -64.63 110.97 2.53 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -172.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 4.9 p -151.71 61.4 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 164.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 4.5 m95 -81.63 136.67 35.53 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.909 -1.496 . . . . 0.0 112.837 -166.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 41.65 45.54 2.97 Favored 'General case' 0 C--O 1.243 0.755 0 O-C-N 126.886 2.616 . . . . 0.0 116.603 175.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -166.3 162.48 17.29 Favored 'General case' 0 C--N 1.345 0.402 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -170.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 59.91 163.29 0.05 Allowed 'General case' 0 C--O 1.242 0.681 0 N-CA-C 117.77 2.507 . . . . 0.0 117.77 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 143' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -82.3 68.91 8.91 Favored 'General case' 0 C--O 1.248 1.01 0 O-C-N 120.979 -1.076 . . . . 0.0 109.269 176.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 144' ' ' VAL . . . . . . . . . . . . . 26.0 t -74.88 96.56 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 113.598 -1.637 . . . . 0.0 108.627 -177.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 145' ' ' ILE . . . . . . . . . . . . 0.266 7.9 tp -92.1 87.31 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-O 126.416 3.008 . . . . 0.0 113.3 -170.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 146' ' ' VAL . . . . . . . . . . . . . 26.7 t -77.73 97.42 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 CA-C-N 108.761 -3.836 . . . . 0.0 111.087 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 147' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -67.1 96.24 0.44 Allowed 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 148' ' ' LYS . . . . . 0.402 ' NZ ' ' OD1' ' C' ' 152' ' ' ASN . 48.2 tptt -123.38 131.01 53.52 Favored 'General case' 0 C--O 1.211 -0.938 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -174.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 9.8 tpp85 -63.65 -49.26 73.92 Favored 'General case' 0 C--O 1.256 1.437 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -171.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 1.5 m -143.45 170.47 15.73 Favored 'General case' 0 C--O 1.249 1.073 0 O-C-N 120.86 -1.15 . . . . 0.0 108.966 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 10.5 tpt -79.17 99.11 6.84 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 176.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 152' ' ' ASN . . . . . 0.402 ' OD1' ' NZ ' ' C' ' 148' ' ' LYS . 0.6 OUTLIER -155.29 157.51 37.33 Favored 'General case' 0 N--CA 1.426 -1.671 0 C-N-CA 118.131 -1.428 . . . . 0.0 109.973 -176.428 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 4.8 m -62.75 130.29 44.26 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 125.548 1.78 . . . . 0.0 106.639 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -72.32 -120.83 0.06 OUTLIER Glycine 0 N--CA 1.415 -2.732 0 O-C-N 120.745 -1.222 . . . . 0.0 113.387 171.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -86.41 -66.83 0.86 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 170.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 156' ' ' ALA . . . . . . . . . . . . . . . -85.18 -39.65 17.6 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 170.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 54.89 33.41 56.52 Favored Glycine 0 C--N 1.352 1.423 0 C-N-CA 124.692 1.139 . . . . 0.0 114.335 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 3.3 m -76.42 144.52 11.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 O-C-N 121.441 -1.035 . . . . 0.0 111.265 -173.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.58 136.43 57.98 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 -174.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 160' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -169.72 156.54 6.19 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -171.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -54.31 -31.42 67.08 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 124.642 3.561 . . . . 0.0 115.223 177.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 162' ' ' LEU . . . . . . . . . . . . . 4.1 tt -68.04 -24.12 65.05 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 118.665 -2.522 . . . . 0.0 111.516 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 163' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -79.16 -10.78 59.91 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 172.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -127.57 -30.93 2.52 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 -169.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 35.8 mmtt -74.83 161.78 29.26 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.25 -170.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -89.84 -38.26 13.88 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.843 -173.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -74.25 -57.27 4.06 Favored 'General case' 0 C--O 1.243 0.716 0 O-C-N 117.329 -3.357 . . . . 0.0 106.93 172.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 168' ' ' THR . . . . . . . . . . . . 0.258 4.2 m -82.53 85.0 7.04 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 103.183 -2.895 . . . . 0.0 103.183 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -129.75 132.03 46.45 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-O 122.953 1.358 . . . . 0.0 113.607 -162.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 170' ' ' MET . . . . . . . . . . . . . 51.4 mtm -73.18 99.65 2.89 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 110.337 -3.119 . . . . 0.0 110.069 165.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 171' ' ' LEU . . . . . . . . . . . . . 17.4 tp -76.71 122.49 24.78 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 104.247 -2.501 . . . . 0.0 104.247 177.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -89.26 77.93 7.37 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 120.24 -1.537 . . . . 0.0 111.792 -166.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -149.99 162.78 29.27 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-N 113.46 -1.7 . . . . 0.0 112.295 -172.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 174' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -75.0 144.91 42.88 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 -177.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.06 -39.73 93.37 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 125.367 1.667 . . . . 0.0 112.795 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.92 -51.45 18.49 Favored 'General case' 0 C--N 1.359 1.005 0 C-N-CA 117.759 -1.576 . . . . 0.0 108.511 174.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 177' ' ' ALA . . . . . . . . . . . . . . . -53.7 -55.94 21.73 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 125.939 1.696 . . . . 0.0 114.379 -168.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 4.5 m -57.99 -38.3 75.85 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-N 114.678 -1.146 . . . . 0.0 113.83 175.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 179' ' ' VAL . . . . . . . . . . . . . 40.0 t -72.24 -38.38 61.83 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -57.6 -40.71 79.68 Favored 'General case' 0 C--N 1.351 0.66 0 O-C-N 118.45 -2.656 . . . . 0.0 112.461 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -58.97 -53.37 59.15 Favored 'General case' 0 CA--C 1.552 1.022 0 O-C-N 121.506 -0.746 . . . . 0.0 111.812 170.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 182' ' ' ILE . . . . . . . . . . . . . 30.9 pt -78.15 -24.41 13.87 Favored 'Isoleucine or valine' 0 C--O 1.249 1.077 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -168.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 183' ' ' LEU . . . . . . . . . . . . . 4.7 pp -59.0 -24.78 63.08 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 118.831 -2.418 . . . . 0.0 114.815 171.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 28.6 tptt -96.71 -60.18 1.65 Allowed 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 175.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -88.88 107.25 18.89 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 123.172 1.463 . . . . 0.0 108.265 -171.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 186' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--O 1.218 -0.567 0 CA-C-N 114.519 -1.219 . . . . 0.0 112.352 160.851 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 48.6 t-80 . . . . . 0 CA--C 1.506 -0.723 0 N-CA-C 108.811 -0.811 . . . . 65.739999999999995 108.811 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -67.47 81.28 0.15 Allowed Glycine 0 N--CA 1.424 -2.122 0 CA-C-O 125.576 2.764 . . . . 48.659999999999997 114.539 176.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -100.85 118.7 37.43 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 111.07 -2.565 . . . . 44.560000000000002 104.154 172.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1003 ' ' ILE . . . . . . . . . . . . . 54.9 mt -101.46 101.91 12.76 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 103.332 -2.84 . . . . 34.859999999999999 103.332 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -76.41 122.25 6.37 Favored Glycine 0 C--O 1.256 1.477 0 CA-C-N 109.644 -3.434 . . . . 30.75 110.41 174.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 49.0 mm -105.01 98.02 14.55 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 105.912 -1.884 . . . . 32.210000000000001 105.912 177.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -73.81 155.16 48.92 Favored 'Trans proline' 0 CA--C 1.508 -0.8 0 C-N-CA 123.305 2.67 . . . . 32.979999999999997 112.133 167.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1007 ' ' ARG . . . . . . . . . . . . . 33.9 ttp85 -71.85 146.14 48.14 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 110.564 -3.016 . . . . 47.979999999999997 105.316 162.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1008 ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -75.31 119.49 19.49 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 123.603 1.668 . . . . 34.700000000000003 108.254 172.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 25.7 mtp-105 -104.43 7.65 35.54 Favored 'General case' 0 N--CA 1.423 -1.778 0 CA-C-N 109.734 -3.394 . . . . 53.369999999999997 108.052 -172.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 19.9 tp -62.88 127.11 29.7 Favored 'General case' 0 CA--C 1.505 -0.774 0 O-C-N 118.376 -2.702 . . . . 45.07 108.171 152.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1011 ' ' THR . . . . . . . . . . . . . 7.9 m -52.95 144.42 14.89 Favored 'General case' 0 C--O 1.255 1.365 0 C-N-CA 125.06 1.344 . . . . 40.359999999999999 112.067 -173.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 57.8 t30 70.19 -35.37 0.32 Allowed 'General case' 0 C--O 1.269 2.1 0 N-CA-C 114.728 1.381 . . . . 40.609999999999999 114.728 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -74.25 99.59 3.48 Favored 'General case' 0 C--O 1.254 1.331 0 CA-C-N 120.95 1.705 . . . . 33.759999999999998 110.647 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1014 ' ' THR . . . . . . . . . . . . . 5.3 p -75.81 94.83 3.37 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 112.186 -2.279 . . . . 27.890000000000001 106.314 174.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1015 ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -145.63 147.19 31.75 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 104.472 -2.418 . . . . 29.02 104.472 173.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1016 ' ' VAL . . . . . . . . . . . . . 11.7 p -110.85 160.83 9.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 O-C-N 118.791 -2.443 . . . . 28.129999999999999 106.245 168.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1017 ' ' ALA . . . . . . . . . . . . . . . -69.77 -23.34 63.34 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 118.583 -2.573 . . . . 26.870000000000001 114.673 -176.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -156.72 136.29 12.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.454 -0.943 . . . . 26.77 108.454 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1019 ' ' THR . . . . . . . . . . . . . 41.6 p -72.58 172.7 7.03 Favored Pre-proline 0 C--O 1.249 1.045 0 CA-C-N 119.822 1.192 . . . . 27.02 114.207 174.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1020 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -49.96 -38.98 49.9 Favored 'Trans proline' 0 C--O 1.245 0.832 0 C-N-CA 123.216 2.611 . . . . 30.57 113.813 166.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -63.78 -39.41 94.2 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 113.029 0.752 . . . . 47.810000000000002 113.029 173.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1022 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.66 -29.48 64.67 Favored 'General case' 0 C--N 1.312 -1.039 0 O-C-N 121.124 -0.985 . . . . 30.77 113.245 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1023 ' ' VAL . . . . . . . . . . . . . 48.7 t -61.52 -48.49 88.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.862 0 C-N-CA 125.909 1.684 . . . . 33.590000000000003 107.416 171.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -55.94 -34.37 65.6 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 120.327 -1.483 . . . . 53.289999999999999 112.616 175.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -64.7 -47.76 77.15 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 119.792 1.178 . . . . 46.920000000000002 110.596 174.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1026 ' ' LEU . . . . . . . . . . . . . 60.3 mt -59.14 -32.57 69.98 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.574 1.324 . . . . 37.170000000000002 114.574 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 1.9 tp -65.19 -34.86 79.39 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.874 -1.057 . . . . 44.439999999999998 111.689 168.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -67.49 -32.78 73.83 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 122.402 1.096 . . . . 52.579999999999998 112.22 175.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1029 ' ' LEU . . . . . . . . . . . . . 45.2 mt -76.23 -26.11 55.72 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.446 -1.252 . . . . 45.689999999999998 110.269 171.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 84.62 43.51 6.84 Favored Glycine 0 N--CA 1.431 -1.698 0 CA-C-O 124.117 1.954 . . . . 42.090000000000003 112.679 175.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -118.53 137.71 53.03 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 104.688 -2.338 . . . . 40.719999999999999 104.688 -176.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1032 ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.5 113.06 16.18 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.187 -1.412 . . . . 37.770000000000003 107.187 -172.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1033 ' ' VAL . . . . . . . . . . . . . 3.1 t -85.15 134.37 27.23 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 N-CA-C 107.318 -1.364 . . . . 33.539999999999999 107.318 -174.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -124.86 129.57 50.67 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 116.753 -1.594 . . . . 31.68 106.742 174.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1035 ' ' VAL . . . . . . . . . . . . . 90.5 t -122.16 145.84 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 123.589 2.904 . . . . 31.52 108.331 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1036 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.66 134.66 54.72 Favored 'General case' 0 N--CA 1.436 -1.158 0 O-C-N 125.249 1.593 . . . . 41.039999999999999 108.373 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1037 ' ' SER . . . . . . . . . . . . . 25.5 m -75.22 122.51 23.78 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-N 115.093 -0.958 . . . . 31.829999999999998 110.422 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 91.36 21.76 33.99 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 114.764 -1.107 . . . . 29.359999999999999 112.236 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -87.06 -46.01 10.19 Favored 'General case' 0 CA--C 1.495 -1.172 0 O-C-N 119.952 -1.911 . . . . 27.780000000000001 109.847 -178.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -70.44 -24.73 76.55 Favored Glycine 0 C--O 1.242 0.596 0 C-N-CA 120.182 -1.008 . . . . 28.91 113.047 -170.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -61.59 -38.11 86.35 Favored 'General case' 0 CA--C 1.505 -0.756 0 O-C-N 124.314 0.655 . . . . 51.18 111.401 175.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1042 ' ' LEU . . . . . . . . . . . . . 16.8 mt -70.59 -58.2 3.93 Favored 'General case' 0 CA--C 1.513 -0.459 0 O-C-N 121.468 -0.77 . . . . 29.91 110.118 169.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1043 ' ' ALA . . . . . . . . . . . . . . . -65.5 3.8 0.65 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.375 1.62 . . . . 28.539999999999999 115.375 -173.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1044 ' ' SER . . . . . . . . . . . . . 49.5 m 65.73 28.77 10.96 Favored 'General case' 0 C--O 1.244 0.791 0 O-C-N 120.259 -1.526 . . . . 33.060000000000002 114.95 172.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1045 ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -155.81 101.33 2.12 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 101.86 -3.385 . . . . 30.289999999999999 101.86 174.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 4.2 p30 -73.36 161.31 30.61 Favored 'General case' 0 C--O 1.248 0.984 0 N-CA-C 117.676 2.472 . . . . 48.619999999999997 117.676 -153.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -57.54 -23.4 50.19 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-N 112.493 -2.139 . . . . 36.740000000000002 114.993 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.9 -32.12 40.25 Favored 'General case' 0 C--O 1.24 0.605 0 O-C-N 121.156 -0.965 . . . . 43.729999999999997 111.298 174.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -72.09 -29.79 64.45 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.967 -0.753 . . . . 32.810000000000002 108.967 172.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1050 ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -58.42 -49.07 78.59 Favored 'General case' 0 C--N 1.346 0.442 0 N-CA-C 114.45 1.278 . . . . 31.859999999999999 114.45 165.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 6.9 t -59.16 -39.55 78.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 O-C-N 119.881 -1.762 . . . . 33.219999999999999 111.891 174.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -61.15 -40.65 94.64 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 123.244 0.617 . . . . 50.829999999999998 111.99 172.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -72.06 -23.8 61.42 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 118.98 -2.325 . . . . 33.119999999999997 110.822 173.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 101.8 49.31 1.28 Allowed Glycine 0 N--CA 1.439 -1.118 0 C-N-CA 118.247 -1.93 . . . . 35.829999999999998 112.443 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -101.98 135.89 42.76 Favored 'General case' 0 N--CA 1.423 -1.775 0 O-C-N 125.0 1.059 . . . . 34.82 111.369 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -77.65 99.04 5.65 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 104.968 -2.234 . . . . 49.049999999999997 104.968 -177.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1057 ' ' ILE . . . . . . . . . . . . . 32.0 mm -75.18 102.96 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 N-CA-C 108.535 -0.913 . . . . 38.530000000000001 108.535 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1058 ' ' VAL . . . . . . . . . . . . . 2.8 m -127.08 166.5 23.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 122.512 1.149 . . . . 42.109999999999999 108.287 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -114.47 141.34 47.81 Favored 'General case' 0 C--O 1.258 1.513 0 O-C-N 120.602 -1.311 . . . . 58.0 109.832 -161.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 44.25 -116.49 1.62 Allowed Glycine 0 N--CA 1.477 1.411 0 N-CA-C 115.736 1.055 . . . . 52.119999999999997 115.736 163.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 6.8 m120 -60.28 -38.44 83.59 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 120.153 -0.619 . . . . 54.75 110.046 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1062 ' ' SER . . . . . . . . . . . . . 14.6 m -74.66 -11.67 60.24 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 120.037 -1.664 . . . . 50.340000000000003 110.267 -173.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 11.6 p -88.79 -41.14 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 O-C-N 119.107 -2.246 . . . . 41.460000000000001 106.291 166.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1064 ' ' TRP . . . . . . . . . . . . . 24.9 m95 -64.44 -24.61 67.69 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 115.283 1.586 . . . . 39.32 115.283 -174.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -87.04 79.58 8.65 Favored 'General case' 0 C--O 1.247 0.94 0 O-C-N 120.943 -1.098 . . . . 55.380000000000003 109.729 174.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1066 ' ' SER . . . . . . . . . . . . . 69.2 m -135.41 166.06 24.03 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 120.264 -0.575 . . . . 41.869999999999997 111.032 175.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -68.24 -35.67 78.28 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-O 121.593 0.711 . . . . 53.200000000000003 110.241 -177.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 4.9 mp -124.55 141.24 45.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 O-C-N 119.193 -2.192 . . . . 41.899999999999999 107.825 173.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1069 ' ' ILE . . . . . . . . . . . . . 19.5 mm -126.34 118.76 52.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 104.139 -2.541 . . . . 38.729999999999997 104.139 171.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1070 ' ' LEU . . . . . . . . . . . . . 64.3 mt -93.02 135.74 33.92 Favored 'General case' 0 C--N 1.316 -0.859 0 O-C-N 124.419 1.075 . . . . 32.439999999999998 108.553 172.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1071 ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -137.21 147.16 45.65 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-O 123.528 1.632 . . . . 34.649999999999999 112.714 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1072 ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -86.75 -35.43 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 CA-C-N 110.088 -3.233 . . . . 31.32 111.094 -163.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -127.32 -175.96 3.59 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 106.83 -1.545 . . . . 33.939999999999998 106.83 165.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -53.97 132.68 58.46 Favored Pre-proline 0 N--CA 1.465 0.31 0 CA-C-N 113.984 -1.462 . . . . 38.039999999999999 108.247 166.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1075 ' ' PRO . . . . . . . . . . . . . 92.6 Cg_exo -65.88 145.88 81.49 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 123.677 2.918 . . . . 42.68 111.551 175.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 15.3 mt -71.65 159.63 34.06 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 106.49 -1.67 . . . . 46.740000000000002 106.49 173.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -50.45 -32.45 17.95 Favored 'General case' 0 C--O 1.242 0.687 0 O-C-N 119.744 -1.848 . . . . 58.609999999999999 113.683 171.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 12.4 t0 -51.98 -60.89 2.67 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 124.294 1.038 . . . . 59.200000000000003 109.887 167.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1079 ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -65.04 -36.83 85.62 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.047 -1.433 . . . . 50.630000000000003 114.016 -173.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1080 ' ' ILE . . . . . . . . . . . . . 66.3 mt -48.0 -52.46 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.125 1.77 . . . . 51.479999999999997 109.275 171.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -66.44 -25.85 66.94 Favored 'General case' 0 CA--C 1.512 -0.518 0 O-C-N 119.323 -2.111 . . . . 50.280000000000001 113.743 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 25.8 mt -77.81 -17.76 57.1 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 115.649 -0.705 . . . . 50.210000000000001 112.207 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1083 ' ' LEU . . . . . . . . . . . . . 1.2 mm? -58.84 134.1 56.59 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 119.305 -2.122 . . . . 49.060000000000002 111.329 168.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.72 152.02 42.03 Favored Pre-proline 0 N--CA 1.473 0.705 0 CA-C-O 117.832 -1.08 . . . . 51.079999999999998 109.874 -175.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -54.34 116.39 3.03 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 124.707 3.605 . . . . 49.729999999999997 110.052 172.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 110.45 -5.8 29.92 Favored Glycine 0 CA--C 1.489 -1.587 0 N-CA-C 112.3 -0.32 . . . . 47.710000000000001 112.3 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1087 ' ' THR . . . . . . . . . . . . . 84.0 m -83.54 132.84 34.9 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 118.097 -3.002 . . . . 45.469999999999999 109.905 -174.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1088 ' ' THR . . . . . . . . . . . . . 1.6 m -89.09 94.65 10.01 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.333 -1.729 . . . . 42.039999999999999 106.333 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1089 ' ' LEU . . . . . . . . . . . . . 54.2 tp -81.36 102.35 10.4 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.182 -0.949 . . . . 38.060000000000002 109.376 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 3.2 t -99.75 123.05 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 104.822 -2.288 . . . . 37.399999999999999 104.822 174.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1091 ' ' SER . . . . . . . . . . . . . 4.9 m -153.8 165.48 35.91 Favored 'General case' 0 CA--C 1.549 0.915 0 O-C-N 120.103 -1.623 . . . . 36.159999999999997 111.319 -175.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 15.2 t80 -86.66 101.97 13.76 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 106.048 -1.834 . . . . 38.939999999999998 106.048 166.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 40.3 mm -91.56 -65.34 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 123.046 1.403 . . . . 42.170000000000002 113.256 -170.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 29.7 m95 69.69 74.63 0.27 Allowed Pre-proline 0 C--N 1.354 0.773 0 CA-C-N 112.185 -2.28 . . . . 46.509999999999998 113.947 -159.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -59.03 -32.6 97.8 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 122.803 2.336 . . . . 49.759999999999998 115.301 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -63.23 -43.63 97.53 Favored 'General case' 0 C--N 1.356 0.889 0 CA-C-N 120.846 1.657 . . . . 52.619999999999997 110.834 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -66.33 -52.72 44.27 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-N 114.257 -1.338 . . . . 60.740000000000002 112.621 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1098 ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -120.48 80.43 30.2 Favored Pre-proline 0 C--O 1.239 0.528 0 O-C-N 118.111 -2.868 . . . . 58.189999999999998 115.525 -174.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.95 -28.37 58.12 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 124.667 3.578 . . . . 54.590000000000003 111.404 175.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -54.97 -48.39 73.3 Favored 'General case' 0 CA--C 1.504 -0.813 0 O-C-N 120.171 -1.58 . . . . 63.280000000000001 109.321 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1101 ' ' LEU . . . . . . . . . . . . . 1.3 mp -46.98 -52.62 14.24 Favored 'General case' 0 CA--C 1.513 -0.463 0 O-C-N 125.62 1.825 . . . . 54.75 113.685 172.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1102 ' ' MET . . . . . . . . . . . . . 72.8 mmm -57.8 -49.24 77.3 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 113.497 -1.683 . . . . 52.649999999999999 109.864 -176.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -58.66 -51.62 69.15 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 123.192 1.472 . . . . 66.260000000000005 109.025 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.47 -40.75 96.29 Favored 'General case' 0 C--O 1.239 0.539 0 O-C-N 118.599 -2.563 . . . . 63.729999999999997 110.884 -176.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 63.3 mt -69.16 -34.46 75.01 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.095 0.558 . . . . 54.68 111.117 176.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -65.3 -42.65 92.86 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 106.766 -1.568 . . . . 53.640000000000001 106.766 177.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -55.85 -40.84 73.45 Favored 'General case' 0 CA--C 1.501 -0.919 0 O-C-N 125.296 1.623 . . . . 67.239999999999995 112.826 170.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -65.86 -23.02 66.58 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 116.945 -1.503 . . . . 65.760000000000005 112.685 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 30.8 t30 61.43 60.81 1.62 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 126.895 3.236 . . . . 58.710000000000001 113.446 -175.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1110 ' ' VAL . . . . . . . . . . . . . 19.3 m -122.1 157.9 26.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 111.543 -2.572 . . . . 46.630000000000003 108.558 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1111 ' ' THR . . . . . . . . . . . . . 51.6 m -94.81 109.32 21.3 Favored 'General case' 0 N--CA 1.44 -0.961 0 O-C-N 120.999 -1.063 . . . . 44.130000000000003 111.426 171.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1112 ' ' VAL . . . . . . . . . . . . . 49.8 t -99.83 119.52 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-O 122.902 1.334 . . . . 40.439999999999998 109.366 -175.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1113 ' ' MET . . . . . . . . . . . . . 10.7 mtp -108.17 120.52 42.57 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 104.793 -2.299 . . . . 50.759999999999998 104.793 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1114 ' ' ALA . . . . . . . . . . . . . . . -107.89 108.84 20.18 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 118.204 -2.81 . . . . 35.640000000000001 108.363 -175.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1115 ' ' MET . . . . . . . . . . . . . 62.1 mmm -65.92 -19.12 65.76 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 117.947 2.573 . . . . 38.740000000000002 117.947 -173.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -71.88 -36.73 70.15 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 122.553 1.168 . . . . 40.140000000000001 108.582 166.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1117 ' ' SER . . . . . . . . . . . . . 58.3 m -86.35 28.63 0.82 Allowed 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 115.085 1.513 . . . . 44.789999999999999 115.085 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1118 ' ' VAL . . . . . . . . . . . . . 88.0 t -74.05 132.95 79.09 Favored Pre-proline 0 N--CA 1.471 0.611 0 N-CA-C 106.296 -1.742 . . . . 43.75 106.296 171.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -65.95 132.22 29.58 Favored 'Trans proline' 0 C--N 1.323 -0.777 0 C-N-CA 123.752 2.968 . . . . 48.93 108.211 175.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 30.9 mmm-85 -77.26 32.11 0.15 Allowed 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 116.667 2.099 . . . . 62.899999999999999 116.667 -164.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 31.8 pt -89.2 170.78 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 120.599 -1.313 . . . . 57.719999999999999 111.754 -169.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1122 ' ' SER . . . . . . . . . . . . . 11.4 p -57.2 -58.65 7.28 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 120.04 1.291 . . . . 57.259999999999998 114.286 -172.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 31.5 ptt85 -62.03 -19.1 62.52 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 116.576 2.065 . . . . 62.899999999999999 116.576 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -77.92 -15.99 58.56 Favored 'General case' 0 C--O 1.214 -0.77 0 O-C-N 120.254 -1.529 . . . . 49.829999999999998 113.965 172.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -56.78 -35.9 69.22 Favored 'General case' 0 C--O 1.258 1.521 0 CA-C-N 121.068 1.758 . . . . 52.369999999999997 115.019 -171.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1126 ' ' SER . . . . . . . . . . . . . 38.3 m -67.38 -23.55 65.6 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 119.51 -1.994 . . . . 42.43 111.226 176.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1127 ' ' LEU . . . . . . . . . . . . . 6.8 mp -89.79 -29.3 18.75 Favored 'General case' 0 C--O 1.221 -0.423 0 O-C-N 119.297 -2.127 . . . . 43.740000000000002 111.645 172.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 51.2 t0 -61.57 107.78 0.86 Allowed 'General case' 0 C--O 1.247 0.942 0 C-N-CA 125.358 1.463 . . . . 43.210000000000001 111.994 -170.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -71.62 -37.49 70.9 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 115.277 -0.874 . . . . 35.740000000000002 111.336 174.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 45.7 mt -66.47 -16.19 63.93 Favored 'General case' 0 C--O 1.244 0.799 0 O-C-N 119.97 -1.706 . . . . 38.090000000000003 112.047 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1131 ' ' SER . . . . . . . . . . . . . 70.6 m -86.63 -64.25 1.18 Allowed 'General case' 0 CA--C 1.55 0.959 0 O-C-N 120.656 -1.278 . . . . 36.909999999999997 109.194 163.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1132 ' ' SER . . . . . . . . . . . . . 1.6 m -76.6 -45.27 30.92 Favored 'General case' 0 C--O 1.244 0.802 0 O-C-N 117.789 -3.069 . . . . 35.789999999999999 114.594 -166.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1133 ' ' MET . . . . . . . . . . . . . 5.0 ttp -66.38 -42.81 87.39 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 122.08 2.218 . . . . 30.809999999999999 108.996 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1134 ' ' ALA . . . . . . . . . . . . . . . -50.71 -46.57 59.02 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.627 0.973 . . . . 28.879999999999999 113.627 166.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1135 ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -62.47 -36.62 83.04 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 119.762 1.164 . . . . 40.759999999999998 111.354 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1136 ' ' ILE . . . . . . . . . . . . . 57.3 mt -53.02 -57.1 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 O-C-N 121.597 -0.689 . . . . 31.539999999999999 110.274 170.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -60.07 -29.71 68.74 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.57 -0.741 . . . . 29.870000000000001 112.486 175.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -64.52 -44.53 95.03 Favored Glycine 0 CA--C 1.533 1.174 0 O-C-N 120.649 -1.282 . . . . 28.73 113.757 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 43.2 t80 -60.64 -50.53 73.14 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 123.587 1.66 . . . . 30.390000000000001 107.677 173.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1140 ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -61.68 -24.61 66.87 Favored 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 111.81 -2.45 . . . . 26.09 113.107 -178.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1141 ' ' ALA . . . . . . . . . . . . . . . -60.1 -38.83 84.13 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 122.136 0.97 . . . . 27.100000000000001 113.584 171.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 40.9 mm -66.43 -46.15 87.4 Favored 'Isoleucine or valine' 0 C--O 1.246 0.894 0 O-C-N 121.222 -0.924 . . . . 28.48 109.777 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 94.4 t -57.38 -60.12 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 114.394 -1.275 . . . . 23.07 110.207 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1144 ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -72.93 -21.28 60.91 Favored 'General case' 0 CA--C 1.502 -0.879 0 O-C-N 124.262 0.976 . . . . 33.399999999999999 113.322 -175.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -55.48 -57.65 11.03 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 124.013 0.821 . . . . 24.219999999999999 108.96 163.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -67.43 -16.18 64.08 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 124.522 1.139 . . . . 24.890000000000001 111.96 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 66.2 t-80 -72.34 -49.3 35.32 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 117.911 -1.042 . . . . 26.73 108.397 175.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1148 ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -81.63 -15.05 55.84 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 121.493 1.951 . . . . 39.960000000000001 115.139 175.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1149 ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -59.18 140.03 56.32 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 125.226 2.441 . . . . 25.870000000000001 109.767 -170.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1150 ' ' GLY . . . . . . . . . . . . . . . -79.99 -35.51 27.41 Favored Glycine 0 N--CA 1.426 -2.019 0 CA-C-N 109.823 -3.353 . . . . 19.280000000000001 109.248 170.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1151 ' ' ARG . . . . . . . . . . . . . 10.9 mtt-85 -108.48 -169.94 1.59 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.789 0.804 . . . . 39.899999999999999 112.756 -159.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1152 ' ' PHE . . . . . . . . . . . . . 1.7 t80 -110.98 145.92 37.57 Favored 'General case' 0 C--O 1.248 0.978 0 CA-C-O 118.178 -0.915 . . . . 29.440000000000001 109.078 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1153 ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -66.94 -50.74 61.41 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 120.924 1.693 . . . . 32.600000000000001 114.269 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1154 ' ' THR . . . . . . . . . . . . . 51.6 m -93.59 134.84 35.47 Favored 'General case' 0 CA--C 1.549 0.923 0 O-C-N 120.665 -1.272 . . . . 34.640000000000001 110.653 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -76.67 69.77 2.32 Favored Glycine 0 C--N 1.338 0.651 0 O-C-N 121.53 -0.731 . . . . 37.140000000000001 112.023 176.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -81.28 151.73 27.94 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 116.107 1.891 . . . . 40.57 116.107 -175.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1157 ' ' ILE . . . . . . . . . . . . . 6.9 tp -79.25 119.21 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 123.068 1.413 . . . . 44.609999999999999 110.58 165.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1158 ' ' THR . . . . . . . . . . . . . 37.7 p -92.15 -168.27 1.96 Allowed 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.489 -1.232 . . . . 40.700000000000003 109.59 174.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -76.13 -23.18 54.84 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 124.091 3.132 . . . . 40.25 108.596 173.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -85.37 -60.8 1.92 Allowed 'General case' 0 C--O 1.251 1.175 0 CA-C-N 115.804 -0.635 . . . . 38.469999999999999 110.012 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . 175.66 -157.55 23.98 Favored Glycine 0 CA--C 1.505 -0.575 0 O-C-N 118.625 -2.547 . . . . 37.609999999999999 110.471 -174.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 32.3 tttt -92.84 138.99 31.0 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 125.332 2.491 . . . . 48.899999999999999 113.335 -163.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1163 ' ' VAL . . . . . . . . . . . . . 24.9 t -83.9 147.11 50.61 Favored Pre-proline 0 C--N 1.305 -1.338 0 CA-C-N 109.202 -3.636 . . . . 36.520000000000003 109.241 167.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1164 ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.58 119.75 6.66 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 124.756 3.637 . . . . 35.079999999999998 116.106 162.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1165 ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -66.16 142.96 69.5 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.612 2.208 . . . . 35.329999999999998 115.17 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -82.36 126.63 32.39 Favored 'General case' 0 C--N 1.343 0.295 0 O-C-N 120.389 -1.444 . . . . 34.689999999999998 112.955 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1167 ' ' LYS . . . . . . . . . . . . . 61.7 mttp -86.52 102.07 13.77 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 106.293 -1.743 . . . . 45.359999999999999 106.293 168.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 16.2 t -88.58 86.36 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 112.567 -2.106 . . . . 31.710000000000001 110.006 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1169 ' ' MET . . . . . . . . . . . . . 62.4 ttp -79.34 103.53 9.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 123.933 1.825 . . . . 42.280000000000001 110.73 176.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 21.6 t -92.26 119.27 39.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 106.699 -1.593 . . . . 30.510000000000002 106.699 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 63.9 mt -108.92 126.84 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 104.898 -2.26 . . . . 31.870000000000001 104.898 -173.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 70.83 71.64 1.0 Allowed Glycine 0 C--N 1.352 1.449 0 C-N-CA 119.719 -1.229 . . . . 34.539999999999999 110.3 -175.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1173 ' ' ALA . . . . . . . . . . . . . . . -76.97 68.66 3.16 Favored 'General case' 0 C--O 1.243 0.752 0 O-C-N 121.188 -1.183 . . . . 32.509999999999998 111.854 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -78.7 -173.03 42.35 Favored Glycine 0 C--N 1.342 0.871 0 N-CA-C 107.667 -2.173 . . . . 29.899999999999999 107.667 164.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1175 ' ' VAL . . . . . . . . . . . . . 48.8 t -62.83 -31.22 51.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 121.58 2.69 . . . . 33.109999999999999 113.995 -172.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -58.7 -52.44 65.67 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 118.102 0.41 . . . . 28.100000000000001 110.621 168.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -56.72 -36.13 70.64 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.27 0.938 . . . . 28.539999999999999 112.653 173.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1178 ' ' LEU . . . . . . . . . . . . . 56.6 mt -65.64 -37.85 87.73 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 118.244 1.022 . . . . 31.219999999999999 110.702 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -64.11 -42.7 96.79 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 112.406 0.521 . . . . 28.98 112.406 173.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -58.98 -44.91 91.66 Favored 'General case' 0 C--N 1.352 0.683 0 O-C-N 125.012 1.445 . . . . 27.829999999999998 113.995 173.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1181 ' ' ILE . . . . . . . . . . . . . 47.1 mt -60.61 -51.08 77.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 O-C-N 122.045 -0.409 . . . . 30.25 111.232 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -60.67 -57.42 19.02 Favored Glycine 0 CA--C 1.525 0.665 0 O-C-N 126.523 2.389 . . . . 29.59 111.56 -174.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -55.09 -50.1 70.03 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 119.057 1.428 . . . . 30.289999999999999 111.534 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -70.31 -27.14 64.15 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 114.988 1.477 . . . . 30.469999999999999 114.988 -175.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -71.86 -40.31 69.06 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-O 116.144 -1.884 . . . . 42.409999999999997 110.181 172.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1186 ' ' SER . . . . . . . . . . . . . 1.5 m -64.52 -31.05 72.1 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-N 119.752 1.16 . . . . 39.380000000000003 110.617 172.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 58.9 mt -65.75 -33.36 75.7 Favored 'General case' 0 C--N 1.345 0.393 0 O-C-N 119.187 -2.196 . . . . 36.18 111.404 168.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 84.8 60.35 1.88 Allowed Glycine 0 N--CA 1.433 -1.542 0 CA-C-O 123.366 1.537 . . . . 33.780000000000001 110.076 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -119.11 160.22 22.48 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 113.751 -1.224 . . . . 33.93 108.722 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 79.0 mt -79.33 81.57 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.825 0 C-N-CA 118.841 -1.144 . . . . 38.740000000000002 108.915 -173.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 12.1 t -81.56 131.86 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.792 -1.188 . . . . 33.090000000000003 107.792 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1192 ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -139.58 103.29 4.66 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 104.926 -2.25 . . . . 38.920000000000002 104.926 177.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -95.46 131.96 41.05 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 110.883 -2.871 . . . . 35.32 110.983 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 71.5 t80 -111.93 140.12 46.86 Favored 'General case' 0 C--O 1.248 1.002 0 O-C-N 119.236 -2.165 . . . . 39.350000000000001 106.537 168.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 8.9 t0 -141.51 150.12 41.76 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 105.197 -2.149 . . . . 40.460000000000001 105.197 163.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1196 ' ' THR . . . . . . . . . . . . . 1.3 m -60.19 -32.33 70.97 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 111.816 -2.447 . . . . 45.939999999999998 110.064 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1197 ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -83.13 117.81 69.74 Favored Pre-proline 0 N--CA 1.447 -0.624 0 C-N-CA 124.99 1.316 . . . . 56.020000000000003 108.739 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1198 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.45 -19.06 49.53 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.891 2.394 . . . . 51.270000000000003 110.058 176.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -58.17 -37.97 75.74 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 124.248 1.019 . . . . 59.100000000000001 113.146 -174.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 16.1 m -83.96 5.2 2.36 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.583 0 N-CA-C 116.949 2.204 . . . . 51.060000000000002 116.949 -172.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 81.2 tttt -62.61 -55.47 26.83 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 126.194 1.798 . . . . 57.380000000000003 111.736 -172.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -54.9 -44.36 74.08 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 113.034 -1.894 . . . . 62.409999999999997 112.698 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -61.83 -47.87 83.12 Favored 'General case' 0 C--N 1.344 0.349 0 O-C-N 124.166 0.916 . . . . 57.780000000000001 112.794 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 82.6 t -49.39 -46.76 19.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 122.29 1.043 . . . . 46.380000000000003 113.428 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -69.61 -30.21 67.91 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 113.432 -1.713 . . . . 50.700000000000003 111.592 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1206 ' ' SER . . . . . . . . . . . . . 24.6 m -70.93 -22.1 62.27 Favored 'General case' 0 N--CA 1.435 -1.225 0 O-C-N 120.345 -1.472 . . . . 49.979999999999997 113.375 172.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1207 ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -76.58 -49.91 15.18 Favored 'General case' 0 C--N 1.362 1.131 0 O-C-N 118.974 -2.329 . . . . 52.990000000000002 108.341 164.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 126.67 58.1 0.14 Allowed Glycine 0 C--N 1.304 -1.233 0 N-CA-C 109.292 -1.523 . . . . 47.659999999999997 109.292 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -144.73 150.84 37.95 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 106.407 -1.701 . . . . 44.770000000000003 106.407 -177.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -65.98 137.99 57.51 Favored 'General case' 0 C--O 1.252 1.232 0 O-C-N 125.936 2.023 . . . . 47.640000000000001 106.587 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1211 ' ' PHE . . . . . . . . . . . . . 44.6 t80 -104.13 116.92 33.08 Favored 'General case' 0 C--N 1.31 -1.109 1 N-CA-C 99.786 -4.153 . . . . 45.659999999999997 99.786 166.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 97.1 mt -71.2 119.63 15.62 Favored 'General case' 0 C--O 1.201 -1.486 0 N-CA-C 106.627 -1.62 . . . . 46.060000000000002 106.627 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -82.62 140.47 33.17 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 127.45 2.969 . . . . 60.219999999999999 110.107 171.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 29.4 tp -81.21 125.81 30.75 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 127.328 3.442 . . . . 57.25 107.886 -166.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 24.6 t70 -74.59 87.66 2.14 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 111.729 -2.487 . . . . 64.430000000000007 109.613 165.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 47.8 t80 . . . . . 0 N--CA 1.432 -1.366 0 CA-C-N 113.178 -1.828 . . . . 66.900000000000006 107.394 -178.475 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 3.6 p-10 . . . . . 0 N--CA 1.442 -0.867 0 N-CA-C 107.655 -1.239 . . . . 39.090000000000003 107.655 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -54.33 -57.14 18.31 Favored Glycine 0 C--O 1.224 -0.474 0 O-C-N 127.301 2.876 . . . . 39.32 115.346 -174.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 24.7 t80 -72.76 -39.82 66.51 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-N 118.294 1.047 . . . . 39.299999999999997 111.277 -169.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -68.35 -42.38 79.31 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.675 -1.602 . . . . 36.299999999999997 106.675 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -58.9 -44.43 91.21 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 116.211 -1.852 . . . . 37.380000000000003 111.293 175.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -59.3 -51.79 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 125.036 1.46 . . . . 39.109999999999999 112.665 174.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1230 ' ' MET . . . . . . . . . . . . . 26.8 mmt -84.27 70.46 10.6 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 123.135 1.445 . . . . 49.590000000000003 110.211 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1231 ' ' SER . . . . . . . . . . . . . 61.5 m -138.93 154.62 48.36 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.556 -1.202 . . . . 43.68 109.152 176.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -58.63 -66.8 0.44 Allowed 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.311 1.045 . . . . 55.57 111.672 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -62.41 -23.83 67.06 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.092 -0.958 . . . . 44.939999999999998 113.006 -174.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 15.1 t80 -66.75 -51.89 50.59 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-O 117.522 -1.227 . . . . 42.039999999999999 109.383 171.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 13.3 mt -68.57 -26.0 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 123.554 2.888 . . . . 46.280000000000001 109.054 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 33.3 tttm -61.75 -46.14 90.9 Favored 'General case' 0 C--O 1.237 0.43 0 O-C-N 119.705 -1.872 . . . . 47.869999999999997 109.308 169.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -67.52 -36.52 81.18 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-N 115.816 -0.629 . . . . 41.609999999999999 111.81 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -58.5 -56.36 23.11 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.076 0.55 . . . . 50.649999999999999 110.142 173.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1239 ' ' MET . . . . . . . . . . . . . 3.2 mtm -52.66 -45.71 66.85 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 114.044 1.127 . . . . 48.869999999999997 114.044 173.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -68.91 -33.43 73.74 Favored 'General case' 0 C--N 1.315 -0.907 0 O-C-N 121.618 -0.676 . . . . 54.799999999999997 110.998 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.42 -45.12 85.14 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 105.334 -2.099 . . . . 43.210000000000001 105.334 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -67.17 -36.92 82.81 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.08 1.352 . . . . 38.659999999999997 113.202 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -62.26 -45.76 91.88 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 123.015 0.526 . . . . 37.920000000000002 112.289 175.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -67.16 -36.93 82.87 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 121.445 -0.784 . . . . 37.280000000000001 110.99 176.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -65.75 -30.38 71.03 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 112.971 0.73 . . . . 43.07 112.971 172.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -59.09 -34.18 71.69 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 112.565 0.58 . . . . 38.299999999999997 112.565 -175.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1247 ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.1 -15.55 63.46 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 119.521 -0.872 . . . . 47.600000000000001 112.869 178.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -114.2 -25.39 8.5 Favored 'General case' 0 N--CA 1.441 -0.924 0 O-C-N 119.077 -2.264 . . . . 45.420000000000002 115.988 176.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1249 ' ' VAL . . . . . . . . . . . . . 34.7 m -74.93 163.68 3.92 Favored 'Isoleucine or valine' 0 C--O 1.247 0.944 0 CA-C-N 121.74 2.064 . . . . 36.259999999999998 116.541 -173.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1250 ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -124.81 -57.45 1.53 Allowed 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 113.448 -1.705 . . . . 33.039999999999999 108.432 -170.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1251 ' ' ILE . . . . . . . . . . . . . 34.6 mm -110.91 131.67 61.49 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.977 0 N-CA-C 106.613 -1.625 . . . . 31.399999999999999 106.613 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1252 ' ' ILE . . . . . . . . . . . . . 52.3 mt -122.43 134.97 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 N-CA-C 103.912 -2.625 . . . . 29.420000000000002 103.912 170.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 9.2 t -117.45 92.31 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 103.102 -2.925 . . . . 30.370000000000001 103.102 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1254 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.35 98.02 6.55 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 123.189 1.471 . . . . 35.719999999999999 113.213 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1255 ' ' THR . . . . . . . . . . . . . 4.0 m -111.5 0.16 16.4 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.09 -1.414 . . . . 36.0 114.466 -168.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1256 ' ' ALA . . . . . . . . . . . . . . . -84.3 79.32 9.58 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 125.607 2.622 . . . . 40.93 113.553 -170.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 41.7 tp -94.36 109.53 21.37 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 112.024 -2.353 . . . . 47.82 106.777 172.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 28.1 mm -66.37 119.05 59.37 Favored Pre-proline 0 CA--C 1.554 1.116 0 N-CA-C 103.651 -2.722 . . . . 52.700000000000003 103.651 168.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -53.25 125.32 18.02 Favored 'Trans proline' 0 C--N 1.35 0.637 1 C-N-CA 126.002 4.468 . . . . 54.130000000000003 112.313 -173.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 76.2 6.12 82.55 Favored Glycine 0 CA--C 1.489 -1.576 0 CA-C-O 119.907 -0.385 . . . . 54.619999999999997 112.947 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 89.2 mttt -128.78 155.84 78.64 Favored Pre-proline 0 C--O 1.252 1.198 0 O-C-N 119.492 -2.181 . . . . 55.740000000000002 109.337 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -61.36 117.8 4.63 Favored 'Trans proline' 0 N--CA 1.44 -1.63 0 C-N-CA 121.905 1.737 . . . . 51.149999999999999 113.083 168.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -51.26 132.47 32.61 Favored Pre-proline 0 N--CA 1.473 0.695 0 CA-C-N 113.094 -1.866 . . . . 46.060000000000002 111.953 176.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -55.62 138.86 82.09 Favored 'Trans proline' 0 C--O 1.249 1.051 0 C-N-CA 124.974 3.782 . . . . 41.079999999999998 112.283 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -78.13 99.59 6.23 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 104.22 -2.511 . . . . 47.420000000000002 104.22 171.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 94.6 mt -98.89 -21.09 16.47 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 113.189 -1.823 . . . . 39.219999999999999 111.299 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 86.4 mt -117.55 114.23 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 O-C-N 118.298 -2.751 . . . . 42.5 106.718 172.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1268 ' ' THR . . . . . . . . . . . . . 5.0 p -80.31 162.49 24.54 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 115.665 1.728 . . . . 37.840000000000003 115.665 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -60.6 -41.87 95.61 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-O 116.381 -1.771 . . . . 54.799999999999997 112.764 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -53.06 -51.07 62.97 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 125.243 1.417 . . . . 54.359999999999999 110.825 171.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1271 ' ' MET . . . . . . . . . . . . . 43.0 ttm -55.49 -44.11 76.21 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 125.483 1.739 . . . . 39.520000000000003 112.485 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1272 ' ' VAL . . . . . . . . . . . . . 2.4 t -68.05 -45.57 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 120.781 1.628 . . . . 38.25 110.588 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -59.77 -28.27 67.25 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 114.64 1.348 . . . . 40.770000000000003 114.64 173.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1274 ' ' SER . . . . . . . . . . . . . 20.4 m -89.02 13.37 13.08 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 113.591 0.96 . . . . 36.579999999999998 113.591 172.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1275 ' ' MET . . . . . . . . . . . . . 36.0 ttm -85.69 164.53 17.6 Favored 'General case' 0 C--O 1.246 0.87 0 O-C-N 120.899 -1.125 . . . . 36.75 109.573 -175.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1276 ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -76.8 130.62 37.92 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 105.527 -2.027 . . . . 46.109999999999999 105.527 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1277 ' ' ALA . . . . . . . . . . . . . . . -86.01 172.17 10.85 Favored 'General case' 0 CA--C 1.504 -0.796 0 O-C-N 120.181 -1.574 . . . . 33.520000000000003 115.14 -168.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 86.26 14.99 65.32 Favored Glycine 0 C--O 1.217 -0.939 0 O-C-N 120.648 -1.283 . . . . 31.27 111.799 -171.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1279 ' ' SER . . . . . . . . . . . . . 36.9 m -130.45 163.88 26.01 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 124.108 0.963 . . . . 32.950000000000003 111.006 -156.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1280 ' ' VAL . . . . . . . . . . . . . 65.4 t -134.93 131.65 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 O-C-N 119.959 -1.713 . . . . 27.43 111.466 -170.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1281 ' ' ILE . . . . . . . . . . . . . 46.3 mt -106.36 104.35 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 106.213 -1.773 . . . . 30.300000000000001 106.213 171.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 43.9 t -88.9 109.74 20.52 Favored 'Isoleucine or valine' 0 C--O 1.252 1.215 0 O-C-N 119.189 -2.195 . . . . 28.629999999999999 106.773 175.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 5.0 t70 -86.15 96.64 9.97 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 123.277 1.513 . . . . 36.270000000000003 108.14 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1284 ' ' LEU . . . . . . . . . . . . . 21.1 mt -73.69 -12.73 60.82 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 112.604 -2.089 . . . . 38.57 112.889 172.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -77.24 -34.58 55.84 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 120.922 1.692 . . . . 37.560000000000002 110.179 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . 33.54 -74.33 0.0 OUTLIER 'General case' 0 C--O 1.246 0.883 1 N-CA-C 123.423 4.601 . . . . 40.329999999999998 123.423 171.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -55.15 -40.54 70.73 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 116.966 2.21 . . . . 56.850000000000001 116.966 -166.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 18.0 m120 -125.59 116.89 22.44 Favored 'General case' 0 CA--C 1.491 -1.317 0 O-C-N 119.688 -1.883 . . . . 45.859999999999999 107.211 177.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 73.82 -74.6 1.14 Allowed Glycine 0 C--N 1.345 1.033 0 N-CA-C 110.859 -0.896 . . . . 40.310000000000002 110.859 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 86.03 134.26 3.52 Favored Glycine 0 C--O 1.237 0.335 0 N-CA-C 109.493 -1.443 . . . . 38.890000000000001 109.493 -173.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1291 ' ' ASN . . . . . . . . . . . . . 25.6 m120 -70.93 -24.91 62.54 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-N 118.009 0.905 . . . . 37.229999999999997 112.391 -167.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1292 ' ' CYS . . . . . . . . . . . . . 53.7 t -91.58 155.65 18.21 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 120.835 -1.166 . . . . 36.5 111.853 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1293 ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -83.46 6.51 19.98 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 119.729 -1.857 . . . . 43.32 115.343 173.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -113.47 8.5 17.84 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-O 123.053 1.406 . . . . 41.32 111.99 171.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1295 ' ' THR . . . . . . . . . . . . . 33.5 m -75.84 95.14 3.43 Favored 'General case' 0 CA--C 1.501 -0.938 0 O-C-N 118.744 -2.472 . . . . 35.299999999999997 112.098 -176.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 60.1 t -92.07 115.94 65.57 Favored Pre-proline 0 N--CA 1.437 -1.124 0 CA-C-N 109.583 -3.462 . . . . 34.840000000000003 105.562 169.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -54.51 107.78 0.25 Allowed 'Trans proline' 0 C--O 1.247 0.975 0 C-N-CA 124.969 3.779 . . . . 33.509999999999998 115.202 174.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 85.65 28.12 30.39 Favored Glycine 0 N--CA 1.442 -0.9 0 CA-C-N 111.761 -2.472 . . . . 32.189999999999998 113.793 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -140.36 158.0 44.68 Favored 'General case' 0 C--O 1.242 0.685 0 O-C-N 118.935 -2.509 . . . . 34.880000000000003 111.475 177.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1300 ' ' ILE . . . . . . . . . . . . . 31.4 mt -94.88 124.46 47.39 Favored 'Isoleucine or valine' 0 C--O 1.254 1.315 0 N-CA-C 105.152 -2.166 . . . . 32.289999999999999 105.152 169.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -128.4 108.03 10.23 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 105.385 -2.08 . . . . 37.25 105.385 175.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1302 ' ' THR . . . . . . . . . . . . . 55.9 m -75.53 135.26 40.62 Favored 'General case' 0 C--O 1.243 0.736 0 O-C-N 120.847 -1.158 . . . . 35.560000000000002 108.529 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1303 ' ' THR . . . . . . . . . . . . . 35.8 p -85.07 172.36 11.32 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 119.581 -1.95 . . . . 36.399999999999999 109.981 176.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -61.97 -42.67 99.38 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 118.647 0.658 . . . . 52.32 111.914 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -64.56 -35.77 82.06 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.628 0.728 . . . . 40.039999999999999 112.644 176.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 117.17 44.79 0.55 Allowed Glycine 0 C--O 1.217 -0.912 0 O-C-N 120.063 -1.648 . . . . 36.960000000000001 110.157 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1307 ' ' VAL . . . . . . . . . . . . . 74.3 t -113.51 124.5 70.21 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.233 0 N-CA-C 104.273 -2.491 . . . . 33.399999999999999 104.273 171.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1308 ' ' LYS . . . . . . . . . . . . . 88.3 mttt -84.6 119.26 25.01 Favored 'General case' 0 CA--C 1.496 -1.127 0 C-N-CA 119.411 -0.916 . . . . 42.909999999999997 109.465 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 57.3 t -96.52 130.73 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.082 0 N-CA-C 106.919 -1.511 . . . . 32.289999999999999 106.919 172.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1310 ' ' ILE . . . . . . . . . . . . . 1.5 mt -125.06 111.27 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.369 0 O-C-N 120.512 -1.367 . . . . 30.989999999999998 108.125 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -83.31 59.3 4.99 Favored Glycine 0 N--CA 1.466 0.686 0 O-C-N 120.448 -1.408 . . . . 28.949999999999999 109.885 174.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1312 ' ' TYR . . . . . . . . . . . . 0.252 0.5 OUTLIER -73.98 85.77 1.79 Allowed 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 121.189 2.495 . . . . 31.690000000000001 116.952 -172.301 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 1313 ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -54.57 -53.44 54.58 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 113.906 -1.497 . . . . 34.170000000000002 112.823 168.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -65.42 5.9 0.36 Allowed 'General case' 0 C--O 1.248 1.021 0 N-CA-C 116.849 2.166 . . . . 36.859999999999999 116.849 -172.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1315 ' ' LEU . . . . . . . . . . . . . 58.5 mt -47.09 -39.92 20.48 Favored Pre-proline 0 CA--C 1.547 0.86 0 CA-C-N 121.544 1.975 . . . . 34.850000000000001 116.123 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -57.19 -43.12 55.94 Favored 'Trans proline' 0 CA--C 1.505 -0.953 0 CA-C-N 123.311 2.218 . . . . 29.149999999999999 116.542 168.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -66.04 -39.19 94.66 Favored Glycine 0 C--N 1.313 -0.709 0 O-C-N 119.918 -1.738 . . . . 27.289999999999999 111.859 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1318 ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -62.97 -25.03 68.18 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 124.747 1.219 . . . . 41.490000000000002 113.796 174.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1319 ' ' LEU . . . . . . . . . . . . . 12.7 tp -115.91 70.26 3.68 Favored Pre-proline 0 C--O 1.251 1.132 0 N-CA-C 107.748 -1.205 . . . . 27.609999999999999 107.748 172.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1320 ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -59.5 -59.68 0.4 Allowed 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 122.722 2.281 . . . . 25.940000000000001 115.057 -163.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1321 ' ' THR . . . . . . . . . . . . . 7.6 m -65.0 -36.45 84.45 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 108.735 -0.839 . . . . 25.010000000000002 108.735 -171.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1322 ' ' GLN . . . . . . . . . . . . . 31.6 tp60 -72.97 -32.31 65.13 Favored 'General case' 0 CA--C 1.502 -0.866 0 O-C-N 120.988 -1.07 . . . . 29.390000000000001 112.18 -172.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1323 ' ' SER . . . . . . . . . . . . . 40.2 m -65.68 -50.66 64.12 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 107.098 -1.445 . . . . 26.469999999999999 107.098 172.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1324 ' ' SER . . . . . . . . . . . . . 3.4 m -60.8 -23.62 65.18 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.962 0.905 . . . . 27.780000000000001 112.22 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 19.4 tm0? -86.43 -76.29 0.35 Allowed 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.782 -1.562 . . . . 37.530000000000001 106.782 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1326 ' ' LEU . . . . . . . . . . . . . 92.8 mt -54.76 -62.27 1.77 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 115.446 1.647 . . . . 35.710000000000001 115.446 -175.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1327 ' ' TYR . . . . . . . . . . . . . 30.3 t80 -63.85 -35.49 80.81 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 107.613 -1.254 . . . . 31.59 107.613 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1328 ' ' GLY . . . . . . . . . . . . . . . -54.06 -46.18 70.5 Favored Glycine 0 C--N 1.359 1.818 0 O-C-N 124.156 0.91 . . . . 28.0 111.699 171.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1329 ' ' THR . . . . . . . . . . . . . 28.5 m -71.29 -24.46 62.15 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 123.241 0.616 . . . . 32.149999999999999 110.922 175.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1330 ' ' ASN . . . . . . . . . . . . . 3.1 m120 -61.78 -54.07 47.41 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 116.911 -3.618 . . . . 34.359999999999999 107.246 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1331 ' ' LEU . . . . . . . . . . . . . 12.9 mt -47.01 -54.51 10.04 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 126.548 1.939 . . . . 33.369999999999997 111.155 170.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1332 ' ' VAL . . . . . . . . . . . . . 70.0 t -63.98 -32.71 58.27 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.729 0 CA-C-O 117.179 -1.391 . . . . 35.270000000000003 114.073 177.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -73.67 -31.19 63.34 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 124.191 3.178 . . . . 37.659999999999997 110.737 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1334 ' ' LEU . . . . . . . . . . . . . 43.3 tp -60.71 -51.11 70.74 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-N 118.687 0.676 . . . . 40.270000000000003 110.592 164.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1335 ' ' LEU . . . . . . . . . . . . . 55.2 mt -54.5 -34.96 62.58 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 114.793 1.405 . . . . 42.5 114.793 168.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1336 ' ' LYS . . . . . . . . . . . . . 90.0 mttt -60.69 -46.17 91.38 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 123.18 2.718 . . . . 47.810000000000002 112.977 174.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1337 ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.85 -36.99 78.0 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 124.365 1.041 . . . . 49.270000000000003 113.251 173.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1338 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.8 -32.51 70.99 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 124.628 1.171 . . . . 50.539999999999999 111.16 172.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1339 ' ' CYS . . . . . . . . . . . . . 64.8 m -79.48 88.78 5.04 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 124.052 1.882 . . . . 53.670000000000002 107.958 172.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -76.01 -66.26 0.81 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 113.67 -1.605 . . . . 63.380000000000003 106.734 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -85.69 -18.88 31.87 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.384 -0.826 . . . . 70.950000000000003 110.626 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1342 ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? 68.41 56.91 0.47 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.129 -1.396 . . . . 65.25 114.437 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1343 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 172.84 -38.49 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.389 2 O-C-N 112.345 -6.472 . . . . 64.530000000000001 107.714 -17.335 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 1344 ' ' GLY . . . . . . . . . . . . . . . 84.34 -62.45 4.57 Favored Glycine 0 C--N 1.346 1.118 0 O-C-N 117.491 -3.255 . . . . 59.719999999999999 111.129 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 4.6 t30 -116.62 132.23 56.74 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 103.666 -2.716 . . . . 64.090000000000003 103.666 169.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1346 ' ' ILE . . . . . . . . . . . . . 20.8 pt -62.92 164.47 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.256 1.409 0 O-C-N 123.891 0.744 . . . . 58.82 112.785 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1347 ' ' THR . . . . . . . . . . . . . 1.8 m -124.97 92.98 3.76 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 104.834 -2.284 . . . . 54.960000000000001 104.834 -176.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1348 ' ' VAL . . . . . . . . . . . . . 60.2 t -77.29 84.78 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 N-CA-C 105.201 -2.148 . . . . 55.640000000000001 105.201 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.67 126.63 30.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 124.113 1.911 . . . . 61.450000000000003 112.752 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -96.32 -5.48 39.95 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 118.182 2.66 . . . . 58.630000000000003 118.182 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -73.72 -39.89 63.98 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 118.351 -1.34 . . . . 62.060000000000002 110.095 172.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 17.3 t70 -70.57 112.5 6.87 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.038 -0.983 . . . . 54.07 112.144 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 15.8 m -59.51 -20.43 18.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 N-CA-C 116.33 1.974 . . . . 50.68 116.33 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1354 ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -79.77 -47.39 21.83 Favored 'Isoleucine or valine' 0 C--N 1.343 0.317 0 CA-C-N 121.485 1.948 . . . . 47.68 105.778 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1355 ' ' ILE . . . . . . . . . . . . . 89.9 mt -64.65 -55.14 22.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 108.476 -0.935 . . . . 48.490000000000002 108.476 -177.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 34.0 tpt85 -45.36 -46.77 13.28 Favored 'General case' 0 C--O 1.255 1.379 0 O-C-N 124.123 0.889 . . . . 48.270000000000003 113.362 167.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -59.39 -51.03 61.57 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-O 117.563 -1.687 . . . . 43.530000000000001 111.882 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1358 ' ' VAL . . . . . . . . . . . . . 17.5 t -63.37 -35.08 70.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 CA-C-N 118.808 1.304 . . . . 45.119999999999997 108.544 -175.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1359 ' ' THR . . . . . . . . . . . . . 18.1 m -75.84 93.84 3.24 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 123.959 1.838 . . . . 42.939999999999998 109.889 -176.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 16.6 m -80.02 -22.84 11.75 Favored 'Isoleucine or valine' 0 C--O 1.248 1.011 0 CA-C-N 110.998 -2.819 . . . . 43.259999999999998 113.858 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1361 ' ' ILE . . . . . . . . . . . . . 43.7 mt -137.11 119.39 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 N-CA-C 104.055 -2.572 . . . . 45.659999999999997 104.055 175.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1362 ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -106.92 113.28 26.67 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 104.311 -2.477 . . . . 61.340000000000003 104.311 170.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 32.95 77.38 0.03 OUTLIER 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 117.204 2.298 . . . . 49.759999999999998 117.204 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 86.52 -50.26 4.19 Favored Glycine 0 N--CA 1.481 1.685 0 CA-C-N 113.645 -1.616 . . . . 50.0 111.628 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -70.37 116.43 10.7 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 106.953 -1.499 . . . . 56.920000000000002 106.953 -176.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1366 ' ' ILE . . . . . . . . . . . . . 67.5 mt -72.83 101.57 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.066 0 CA-C-O 123.408 1.575 . . . . 52.780000000000001 109.006 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1367 ' ' THR . . . . . . . . . . . . . 10.9 p -92.94 10.49 31.02 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 112.857 -1.974 . . . . 49.439999999999998 116.16 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 1.9 t90 -58.82 145.77 77.66 Favored Pre-proline 0 C--O 1.254 1.333 0 O-C-N 117.972 -2.955 . . . . 52.380000000000003 105.683 163.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -85.76 -175.0 11.55 Favored 'Cis proline' 0 C--O 1.211 -0.829 0 CA-C-N 123.983 2.458 . . . . 46.939999999999998 113.553 4.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -83.19 138.66 42.21 Favored Pre-proline 0 CA--C 1.545 0.756 0 O-C-N 124.065 0.853 . . . . 45.909999999999997 108.84 164.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1371 ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -58.3 135.29 67.1 Favored 'Trans proline' 0 C--N 1.351 0.678 1 C-N-CA 125.777 4.318 . . . . 46.390000000000001 111.509 177.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -59.03 -35.35 98.57 Favored 'Trans proline' 0 CA--C 1.549 1.241 1 C-N-CA 125.36 4.04 . . . . 46.719999999999999 116.653 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.233 -4.489 0 O-C-N 118.331 -2.731 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 15.9 m80 . . . . . 0 N--CA 1.432 -1.347 0 N-CA-C 108.174 -1.047 . . . . 63.439999999999998 108.174 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -77.44 76.65 3.98 Favored 'General case' 0 C--O 1.254 1.304 0 O-C-N 121.093 -1.005 . . . . 51.740000000000002 112.402 -177.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1000 ' ' HIS . . . . . . . . . . . . . 12.0 t60 -72.55 118.38 15.38 Favored 'General case' 0 C--O 1.247 0.964 0 CA-C-O 122.694 1.235 . . . . 54.07 111.618 -166.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 64.27 27.11 71.11 Favored Glycine 0 C--O 1.209 -1.434 0 CA-C-O 123.46 1.589 . . . . 39.219999999999999 111.889 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1002 ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -97.21 134.52 40.42 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 105.515 -2.031 . . . . 38.119999999999997 105.515 173.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1003 ' ' ILE . . . . . . . . . . . . . 57.1 mt -84.92 149.97 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 CA-C-N 112.023 -2.353 . . . . 29.699999999999999 105.89 170.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -118.71 131.39 9.12 Favored Glycine 0 CA--C 1.492 -1.404 0 N-CA-C 108.351 -1.9 . . . . 27.5 108.351 164.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1005 ' ' ILE . . . . . . . . . . . . . 45.4 mm -102.69 110.08 62.4 Favored Pre-proline 0 C--N 1.313 -1.002 0 N-CA-C 104.852 -2.277 . . . . 24.829999999999998 104.852 172.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -83.83 155.0 13.4 Favored 'Trans proline' 0 C--O 1.238 0.514 0 C-N-CA 121.743 1.629 . . . . 27.190000000000001 111.966 173.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -77.39 114.97 16.77 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 112.031 -2.349 . . . . 41.460000000000001 106.013 169.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1008 ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -51.43 164.77 0.18 Allowed 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 116.463 2.023 . . . . 26.93 116.463 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -146.15 59.06 1.23 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 123.314 1.531 . . . . 34.479999999999997 108.566 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1010 ' ' LEU . . . . . . . . . . . . . 17.9 tp -104.37 152.94 21.67 Favored 'General case' 0 N--CA 1.469 0.511 1 O-C-N 116.287 -4.008 . . . . 44.219999999999999 107.743 174.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B 1011 ' ' THR . . . . . . . . . . . . . 24.3 m -58.99 114.42 2.57 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 123.779 0.832 . . . . 40.740000000000002 109.107 167.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 47.6 t30 54.62 80.08 0.13 Allowed 'General case' 0 C--N 1.35 0.624 0 C-N-CA 125.271 1.428 . . . . 44.439999999999998 111.861 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1013 ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -147.29 141.54 26.21 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 123.817 1.77 . . . . 29.870000000000001 109.857 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1014 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.43 2.96 5.64 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 113.173 -1.83 . . . . 25.260000000000002 111.535 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 65.4 mtm180 -76.95 145.29 38.23 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 123.925 1.821 . . . . 29.539999999999999 110.631 174.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1016 ' ' VAL . . . . . . . . . . . . . 2.2 p -126.64 -175.96 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-N 114.45 -1.25 . . . . 23.550000000000001 109.161 161.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1017 ' ' ALA . . . . . . . . . . . . . . . -93.64 7.95 42.76 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 115.339 1.607 . . . . 23.59 115.339 -176.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1018 ' ' ALA . . . . . . . . . . . . . . . -164.75 147.55 8.58 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 114.608 1.336 . . . . 24.93 114.608 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1019 ' ' THR . . . . . . . . . . . . . 68.7 p -98.91 172.77 4.4 Favored Pre-proline 0 C--O 1.242 0.688 0 N-CA-C 106.839 -1.541 . . . . 28.09 106.839 159.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -49.56 -51.28 11.05 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.404 3.402 . . . . 28.789999999999999 110.959 166.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 37.9 tttp -46.88 -48.29 21.19 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 123.533 2.879 . . . . 47.280000000000001 112.728 170.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1022 ' ' THR . . . . . . . . . . . . . 3.4 m -62.45 -32.39 73.26 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 117.715 0.234 . . . . 30.120000000000001 111.071 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1023 ' ' VAL . . . . . . . . . . . . . 91.6 t -64.21 -48.82 83.96 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 O-C-N 120.514 -1.367 . . . . 32.240000000000002 108.109 176.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1024 ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -60.36 -29.15 68.73 Favored 'General case' 0 C--O 1.246 0.921 0 O-C-N 121.937 -0.477 . . . . 49.619999999999997 111.305 176.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -66.44 -42.06 88.24 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-O 123.805 1.764 . . . . 44.68 113.034 176.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 34.2 mt -70.38 -37.8 74.62 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 113.71 -1.586 . . . . 35.710000000000001 109.392 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1027 ' ' LEU . . . . . . . . . . . . . 63.4 mt -67.47 -26.8 66.55 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 115.599 -0.728 . . . . 42.18 111.179 174.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 65.1 mttm -61.01 -33.82 73.86 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.273 0.942 . . . . 48.340000000000003 111.99 169.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1029 ' ' LEU . . . . . . . . . . . . . 7.8 mt -88.61 10.39 20.69 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 120.984 -1.072 . . . . 38.689999999999998 111.326 176.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 85.09 -10.45 63.24 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 116.169 1.228 . . . . 32.280000000000001 116.169 -175.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -78.19 120.21 22.67 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 119.447 1.624 . . . . 35.939999999999998 112.659 -170.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1032 ' ' THR . . . . . . . . . . . . . 34.8 m -73.74 132.51 42.72 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 106.596 -1.631 . . . . 33.369999999999997 106.596 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1033 ' ' VAL . . . . . . . . . . . . . 16.9 t -117.63 128.93 74.76 Favored 'Isoleucine or valine' 0 C--O 1.249 1.028 0 O-C-N 119.489 -2.007 . . . . 29.98 108.662 -171.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -108.56 143.61 37.36 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.31 -0.859 . . . . 28.18 110.228 166.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1035 ' ' VAL . . . . . . . . . . . . . 57.6 t -125.57 131.35 72.2 Favored 'Isoleucine or valine' 0 C--N 1.372 1.552 0 N-CA-C 108.107 -1.071 . . . . 25.82 108.107 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1036 ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -73.3 143.16 47.08 Favored 'General case' 0 C--O 1.252 1.223 0 O-C-N 120.455 -1.403 . . . . 32.439999999999998 108.996 177.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1037 ' ' SER . . . . . . . . . . . . . 1.2 m -65.95 137.98 57.51 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 119.612 -1.93 . . . . 29.539999999999999 111.64 174.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 103.09 -22.08 37.85 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 124.844 1.34 . . . . 27.760000000000002 111.165 -175.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1039 ' ' ALA . . . . . . . . . . . . . . . -65.46 -40.14 92.84 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 123.089 0.555 . . . . 26.02 110.428 174.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -55.05 -51.71 51.96 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 124.445 1.091 . . . . 26.469999999999999 112.093 169.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.19 -28.71 68.18 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 113.745 1.017 . . . . 50.979999999999997 113.745 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 76.9 mt -67.63 -52.68 35.38 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 119.951 1.251 . . . . 29.300000000000001 109.092 168.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1043 ' ' ALA . . . . . . . . . . . . . . . -72.26 29.81 0.05 Allowed 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 118.014 2.598 . . . . 26.739999999999998 118.014 174.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1044 ' ' SER . . . . . . . . . . . . . 28.4 m 47.66 36.51 5.6 Favored 'General case' 0 C--N 1.358 0.951 0 N-CA-C 117.713 2.486 . . . . 31.260000000000002 117.713 -173.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1045 ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -130.06 163.5 26.39 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 124.112 1.91 . . . . 33.259999999999998 112.626 -173.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 3.3 t70 -67.84 139.84 56.56 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 114.548 -1.205 . . . . 46.740000000000002 109.525 158.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -68.42 -36.59 79.3 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 121.057 1.753 . . . . 34.439999999999998 111.259 174.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.97 -15.08 62.56 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.463 0.649 . . . . 48.670000000000002 112.652 -175.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -58.56 -37.04 74.9 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 119.234 -2.166 . . . . 35.259999999999998 111.122 165.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1050 ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -65.29 -33.57 76.28 Favored 'General case' 0 CA--C 1.563 1.451 0 CA-C-O 117.843 -1.075 . . . . 32.170000000000002 111.725 170.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.1 -30.28 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 121.404 1.911 . . . . 38.369999999999997 108.702 176.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -63.59 -38.46 91.22 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.222 0.919 . . . . 45.770000000000003 109.883 173.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -76.97 -21.66 54.39 Favored 'General case' 0 C--N 1.36 1.065 0 CA-C-O 121.557 0.694 . . . . 37.829999999999998 112.685 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 118.73 31.12 1.52 Allowed Glycine 0 C--O 1.215 -1.07 0 O-C-N 120.515 -1.366 . . . . 35.82 113.346 176.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -102.05 135.73 43.12 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 123.175 1.464 . . . . 33.770000000000003 109.558 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -75.4 105.5 6.46 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 106.374 -1.713 . . . . 51.020000000000003 106.374 174.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1057 ' ' ILE . . . . . . . . . . . . . 37.5 mm -77.64 85.62 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 O-C-N 120.476 -1.39 . . . . 38.469999999999999 107.597 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 3.5 m -117.98 123.7 72.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 125.038 1.461 . . . . 39.399999999999999 110.712 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -90.58 155.77 18.63 Favored 'General case' 0 C--O 1.248 1.01 0 O-C-N 120.758 -1.214 . . . . 57.07 110.274 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . 65.23 -145.61 49.2 Favored Glycine 0 C--O 1.21 -1.375 0 CA-C-N 113.405 -1.725 . . . . 44.829999999999998 114.23 169.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 5.4 m120 -55.31 -20.26 10.93 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 115.586 1.699 . . . . 46.270000000000003 115.586 -177.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1062 ' ' SER . . . . . . . . . . . . . 28.9 m -59.54 -50.73 72.78 Favored 'General case' 0 CA--C 1.489 -1.395 0 O-C-N 120.166 -1.584 . . . . 43.469999999999999 111.9 164.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.41 -38.42 82.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 120.61 1.55 . . . . 36.979999999999997 109.91 177.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 98.9 m95 -66.48 -21.47 66.19 Favored 'General case' 0 C--O 1.269 2.108 0 N-CA-C 114.936 1.458 . . . . 37.899999999999999 114.936 178.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -83.74 90.25 7.29 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 104.687 -2.338 . . . . 46.189999999999998 104.687 169.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B 1066 ' ' SER . . . . . . . . . . . . . 73.4 m -154.36 150.88 28.41 Favored 'General case' 0 CA--C 1.49 -1.335 0 CA-C-N 113.213 -1.812 . . . . 37.060000000000002 108.512 176.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1067 ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -79.3 -17.87 53.78 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 120.799 -1.188 . . . . 43.950000000000003 113.783 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1068 ' ' ILE . . . . . . . . . . . . . 3.1 mp -126.67 143.99 38.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 103.233 -2.877 . . . . 33.5 103.233 173.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 16.5 mm -122.9 105.59 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 102.245 -3.243 . . . . 30.57 102.245 165.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1070 ' ' LEU . . . . . . . . . . . . . 81.5 mt -86.7 122.27 30.37 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 101.975 -3.343 . . . . 27.66 101.975 176.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1071 ' ' LYS . . . . . . . . . . . . . 34.0 tttm -146.58 158.21 43.86 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 108.255 -1.017 . . . . 28.399999999999999 108.255 -169.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1072 ' ' VAL . . . . . . . . . . . . . 58.7 t -90.82 -77.0 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 108.481 -0.933 . . . . 23.18 108.481 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -93.89 146.07 24.17 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 108.178 -1.045 . . . . 25.469999999999999 108.178 -165.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -50.11 115.38 5.28 Favored Pre-proline 0 C--O 1.249 1.028 0 N-CA-C 114.386 1.254 . . . . 27.899999999999999 114.386 -174.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -43.57 136.67 6.32 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.26 3.307 . . . . 31.620000000000001 115.587 -173.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 13.3 mt -69.75 166.79 18.51 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 112.047 -2.342 . . . . 40.490000000000002 107.905 173.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 27.7 t70 -58.76 -35.83 73.4 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 119.315 -0.954 . . . . 51.590000000000003 110.065 -174.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.39 -39.47 81.69 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 122.307 1.051 . . . . 42.359999999999999 109.549 -178.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B 1079 ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -68.11 -27.25 66.3 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 113.678 -1.601 . . . . 34.530000000000001 109.636 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1080 ' ' ILE . . . . . . . . . . . . . 88.3 mt -70.84 -37.75 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 120.461 1.482 . . . . 33.25 108.071 177.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -64.84 -46.99 79.58 Favored 'General case' 0 C--O 1.247 0.959 0 N-CA-C 109.822 -0.436 . . . . 36.469999999999999 109.822 174.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1082 ' ' LEU . . . . . . . . . . . . . 33.0 mt -53.96 -44.96 71.18 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 125.119 1.368 . . . . 37.759999999999998 113.314 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1083 ' ' LEU . . . . . . . . . . . . . 9.6 mt -57.89 125.09 21.55 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 122.396 1.093 . . . . 37.43 109.9 175.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -96.17 147.09 32.43 Favored Pre-proline 0 N--CA 1.438 -1.073 0 CA-C-N 114.279 -1.328 . . . . 37.700000000000003 108.522 -172.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -51.93 122.6 10.77 Favored 'Trans proline' 0 N--CA 1.451 -0.996 1 C-N-CA 126.114 4.543 . . . . 35.509999999999998 114.319 -178.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 98.22 -15.16 61.74 Favored Glycine 0 N--CA 1.466 0.678 0 CA-C-N 113.123 -1.853 . . . . 33.869999999999997 113.003 176.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1087 ' ' THR . . . . . . . . . . . . . 29.3 m -63.02 133.14 54.1 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 124.515 2.103 . . . . 32.5 111.299 174.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1088 ' ' THR . . . . . . . . . . . . . 4.8 m -74.42 92.53 2.33 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 113.233 -1.803 . . . . 30.219999999999999 111.059 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1089 ' ' LEU . . . . . . . . . . . . . 14.2 tp -76.89 119.69 20.99 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 122.374 1.083 . . . . 27.239999999999998 108.721 171.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 24.8 t -112.95 122.61 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 107.304 -1.369 . . . . 25.390000000000001 107.304 171.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1091 ' ' SER . . . . . . . . . . . . . 69.0 m -157.58 165.38 35.69 Favored 'General case' 0 CA--C 1.504 -0.799 0 O-C-N 120.122 -1.611 . . . . 28.809999999999999 109.995 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1092 ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -62.53 96.35 0.08 Allowed 'General case' 0 N--CA 1.466 0.351 0 O-C-N 119.374 -2.078 . . . . 30.780000000000001 107.978 159.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 44.0 mm -88.63 -27.7 5.4 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.184 0 O-C-N 121.087 -1.008 . . . . 30.280000000000001 112.683 -174.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1094 ' ' TRP . . . . . . . . . . . . . 76.1 m95 50.37 54.7 15.98 Favored Pre-proline 0 C--N 1.321 -0.654 0 O-C-N 124.486 1.116 . . . . 34.07 113.957 -177.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -41.5 -56.26 1.9 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 1 C-N-CA 125.776 4.317 . . . . 38.659999999999997 117.607 -164.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -66.99 -38.56 86.26 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 121.015 1.734 . . . . 41.32 111.826 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -68.61 -22.46 64.43 Favored 'General case' 0 C--O 1.209 -1.051 0 CA-C-N 113.644 -1.616 . . . . 51.659999999999997 111.199 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -126.25 68.84 66.69 Favored Pre-proline 0 N--CA 1.439 -0.987 0 O-C-N 120.364 -1.46 . . . . 40.32 109.94 -174.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -64.94 -62.18 0.09 OUTLIER 'Trans proline' 0 CA--C 1.559 1.756 0 C-N-CA 124.112 3.208 . . . . 41.560000000000002 109.85 -174.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -51.87 -44.0 63.5 Favored 'General case' 0 C--N 1.374 1.664 0 N-CA-C 114.101 1.149 . . . . 54.109999999999999 114.101 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1101 ' ' LEU . . . . . . . . . . . . . 9.1 mp -58.36 -48.16 81.46 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.472 -0.767 . . . . 37.880000000000003 110.034 175.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1102 ' ' MET . . . . . . . . . . . . . 39.6 mmm -57.19 -43.1 82.39 Favored 'General case' 0 C--O 1.241 0.607 0 O-C-N 121.459 -0.775 . . . . 37.539999999999999 112.446 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -71.62 -41.8 68.45 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 107.798 -1.186 . . . . 47.009999999999998 107.798 -171.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1104 ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -61.94 -40.73 96.51 Favored 'General case' 0 C--O 1.262 1.759 0 N-CA-C 114.849 1.425 . . . . 48.68 114.849 175.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1105 ' ' LEU . . . . . . . . . . . . . 61.6 mt -64.98 -37.79 88.83 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.779 1.231 . . . . 32.210000000000001 111.16 173.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -60.72 -45.78 92.91 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 117.524 -1.226 . . . . 33.729999999999997 113.138 172.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -55.98 -44.6 78.71 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 122.379 1.085 . . . . 51.469999999999999 112.296 171.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1108 ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -69.51 -6.49 30.99 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 120.747 -1.221 . . . . 43.899999999999999 113.205 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1109 ' ' ASN . . . . . . . . . . . . . 13.7 m-80 62.15 27.6 16.61 Favored 'General case' 0 CA--C 1.486 -1.493 0 N-CA-C 114.084 1.142 . . . . 44.82 114.084 170.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1110 ' ' VAL . . . . . . . . . . . . . 11.1 m -84.06 154.18 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 113.516 0.932 . . . . 30.52 113.516 174.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1111 ' ' THR . . . . . . . . . . . . . 4.1 m -86.59 90.85 8.38 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 120.749 -1.219 . . . . 27.120000000000001 109.22 178.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1112 ' ' VAL . . . . . . . . . . . . . 41.0 t -91.51 125.02 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 124.738 1.274 . . . . 26.399999999999999 112.644 -168.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1113 ' ' MET . . . . . . . . . . . . . 59.2 mtp -123.18 127.62 48.91 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 104.301 -2.481 . . . . 42.920000000000002 104.301 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -101.56 113.1 25.93 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 122.918 1.342 . . . . 24.149999999999999 112.2 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1115 ' ' MET . . . . . . . . . . . . . 24.0 mmm -66.81 -21.16 66.05 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 113.395 -1.729 . . . . 29.949999999999999 115.318 -173.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1116 ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -81.02 -52.65 7.19 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 111.253 -2.703 . . . . 34.530000000000001 112.793 172.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1117 ' ' SER . . . . . . . . . . . . . 57.8 m -90.11 68.22 7.09 Favored 'General case' 0 C--O 1.242 0.684 0 O-C-N 118.826 -2.421 . . . . 33.490000000000002 112.021 -171.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1118 ' ' VAL . . . . . . . . . . . . . 1.8 t -94.87 131.18 30.94 Favored Pre-proline 0 N--CA 1.467 0.376 0 CA-C-N 112.967 -1.924 . . . . 34.020000000000003 106.3 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -62.34 115.41 2.85 Favored 'Trans proline' 0 C--O 1.249 1.038 1 C-N-CA 125.711 4.274 . . . . 38.280000000000001 112.321 175.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B 1120 ' ' ARG . . . . . 0.427 HH12 ' CG ' ' B' 1128 ' ' ASP . 7.8 mmt180 -82.19 86.81 6.58 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 122.367 1.079 . . . . 55.049999999999997 112.74 -166.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B 1121 ' ' ILE . . . . . . . . . . . . . 11.1 pt -123.16 142.73 38.71 Favored 'Isoleucine or valine' 0 C--O 1.256 1.41 0 N-CA-C 101.351 -3.574 . . . . 42.090000000000003 101.351 151.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1122 ' ' SER . . . . . . . . . . . . . 2.5 m -37.05 -43.55 0.48 Allowed 'General case' 0 C--O 1.243 0.761 0 N-CA-C 121.466 3.876 . . . . 38.020000000000003 121.466 -161.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1123 ' ' ARG . . . . . . . . . . . . . 20.8 ptt-85 -47.9 -31.26 4.93 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 121.364 1.893 . . . . 34.289999999999999 115.549 175.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1124 ' ' ALA . . . . . . . . . . . . . . . -43.13 -47.53 6.15 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 114.623 1.342 . . . . 32.350000000000001 114.623 169.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1125 ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -52.5 -26.56 13.35 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 116.511 2.041 . . . . 47.170000000000002 116.511 -178.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1126 ' ' SER . . . . . . . . . . . . . 47.3 p -71.27 -32.25 68.48 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 124.135 1.922 . . . . 31.710000000000001 110.968 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1127 ' ' LEU . . . . . . . . . . . . . 4.3 mp -88.12 -32.02 18.89 Favored 'General case' 0 C--N 1.356 0.888 0 CA-C-N 113.949 -1.478 . . . . 37.0 110.268 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1128 ' ' ASP . . . . . 0.427 ' CG ' HH12 ' B' 1120 ' ' ARG . 14.7 t0 -58.73 103.87 0.19 Allowed 'General case' 0 CA--C 1.505 -0.773 0 O-C-N 120.291 -1.506 . . . . 40.399999999999999 113.114 -173.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B 1129 ' ' ALA . . . . . . . . . . . . . . . -63.86 -29.13 70.35 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 111.911 -2.404 . . . . 26.559999999999999 113.862 175.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 53.8 mt -67.95 -31.47 71.24 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-O 117.295 -1.336 . . . . 30.890000000000001 110.66 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1131 ' ' SER . . . . . . . . . . . . . 84.0 p -60.16 -53.14 61.21 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 122.301 2.319 . . . . 29.84 110.608 175.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1132 ' ' SER . . . . . . . . . . . . . 51.7 m -57.93 -49.46 76.68 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 113.451 0.908 . . . . 31.91 113.451 176.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1133 ' ' MET . . . . . . . . . . . . . 32.7 mmt -63.84 -37.63 88.09 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 122.678 1.227 . . . . 25.899999999999999 110.667 -175.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1134 ' ' ALA . . . . . . . . . . . . . . . -62.98 -48.12 80.24 Favored 'General case' 0 N--CA 1.426 -1.64 0 O-C-N 121.139 -0.976 . . . . 26.620000000000001 110.097 171.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -51.23 -51.28 55.46 Favored 'General case' 0 C--N 1.35 0.607 0 C-N-CA 125.287 1.435 . . . . 36.969999999999999 112.247 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1136 ' ' ILE . . . . . . . . . . . . . 29.7 mm -50.25 -58.62 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 C-N-CA 124.938 1.295 . . . . 32.109999999999999 108.893 169.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -58.92 -30.14 67.61 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 119.077 -0.487 . . . . 24.140000000000001 110.053 -175.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -66.3 -57.38 10.51 Favored Glycine 0 N--CA 1.479 1.555 0 N-CA-C 109.777 -1.329 . . . . 25.129999999999999 109.777 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 53.4 t80 -55.65 -47.21 77.06 Favored 'General case' 0 C--O 1.204 -1.32 0 CA-C-N 117.9 0.85 . . . . 32.729999999999997 111.706 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1140 ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -67.65 -23.43 65.34 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 116.975 -1.488 . . . . 26.359999999999999 110.848 -178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1141 ' ' ALA . . . . . . . . . . . . . . . -64.22 -45.33 88.74 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 122.126 2.239 . . . . 24.120000000000001 111.152 171.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 49.4 mm -60.49 -44.76 97.1 Favored 'Isoleucine or valine' 0 C--O 1.247 0.937 0 CA-C-N 115.718 -0.674 . . . . 23.370000000000001 110.323 176.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 98.0 t -53.83 -69.99 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 114.607 1.336 . . . . 24.960000000000001 114.607 171.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -59.12 -27.78 65.92 Favored 'General case' 0 C--O 1.243 0.736 0 O-C-N 121.724 -0.61 . . . . 32.07 111.922 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1145 ' ' ALA . . . . . . . . . . . . . . . -58.95 -63.89 1.14 Allowed 'General case' 0 C--O 1.246 0.883 0 CA-C-O 117.459 -1.258 . . . . 24.870000000000001 108.202 169.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1146 ' ' ALA . . . . . . . . . . . . . . . -58.68 -20.33 47.53 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 121.474 1.943 . . . . 24.670000000000002 115.326 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 74.9 t60 -62.39 -63.72 1.15 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.254 1.421 . . . . 28.579999999999998 107.674 170.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1148 ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -87.83 -1.65 58.11 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 118.663 2.838 . . . . 36.82 118.663 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1149 ' ' PHE . . . . . . . . . . . . . 2.7 t80 -69.22 141.65 54.43 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 122.801 1.286 . . . . 31.969999999999999 110.77 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1150 ' ' GLY . . . . . . . . . . . . . . . -66.79 -34.72 88.15 Favored Glycine 0 CA--C 1.536 1.36 0 CA-C-O 118.599 -1.111 . . . . 25.489999999999998 112.461 175.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1151 ' ' ARG . . . . . . . . . . . . . 71.6 mtm-85 -122.77 177.46 5.46 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 120.773 2.287 . . . . 59.840000000000003 109.6 -157.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1152 ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -78.67 156.8 28.82 Favored 'General case' 0 C--O 1.25 1.111 0 CA-C-N 119.79 1.177 . . . . 34.450000000000003 108.69 167.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1153 ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -68.03 -50.8 53.16 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.441 1.591 . . . . 31.170000000000002 108.865 163.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1154 ' ' THR . . . . . . . . . . . . . 2.8 m -61.74 124.32 20.41 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 113.264 -1.789 . . . . 33.890000000000001 115.618 -175.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -74.08 69.78 1.58 Allowed Glycine 0 N--CA 1.442 -0.948 0 O-C-N 120.942 -1.098 . . . . 38.950000000000003 110.738 175.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -99.57 133.02 44.5 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-O 123.436 1.589 . . . . 54.229999999999997 112.291 -168.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 20.6 mm -85.77 99.92 8.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 101.191 -3.633 . . . . 51.159999999999997 101.191 173.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1158 ' ' THR . . . . . . . . . . . . . 6.4 m -110.63 101.58 10.22 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.592 -1.186 . . . . 49.609999999999999 108.809 -171.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . 27.31 -71.41 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 120.28 3.437 . . . . 49.049999999999997 120.28 -175.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -69.13 -48.87 61.26 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 125.272 1.429 . . . . 47.649999999999999 112.926 175.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . -137.05 -171.56 12.23 Favored Glycine 0 C--O 1.243 0.663 0 CA-C-N 121.856 2.116 . . . . 45.609999999999999 111.283 -170.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 92.0 mttt -111.58 139.22 47.2 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 111.595 -2.303 . . . . 57.460000000000001 109.052 175.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1163 ' ' VAL . . . . . . . . . . . . . 74.4 t -98.96 130.91 26.48 Favored Pre-proline 0 N--CA 1.426 -1.662 0 CA-C-O 116.691 -1.623 . . . . 42.93 108.05 170.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1164 ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.78 140.2 42.02 Favored 'Trans proline' 0 N--CA 1.441 -1.609 0 C-N-CA 123.715 2.943 . . . . 39.289999999999999 110.432 171.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1165 ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -66.78 115.51 3.62 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 123.185 2.59 . . . . 34.170000000000002 111.72 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -64.49 125.59 25.16 Favored 'General case' 0 C--N 1.355 0.837 0 CA-C-N 119.496 1.044 . . . . 31.690000000000001 112.875 -177.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1167 ' ' LYS . . . . . . . . . . . . . 77.4 mttt -90.94 115.12 27.72 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 104.205 -2.517 . . . . 44.780000000000001 104.205 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 85.4 t -104.41 96.25 4.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 O-C-N 120.507 -1.371 . . . . 31.23 108.627 -174.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1169 ' ' MET . . . . . . . . . . . . . 57.1 ttp -77.36 94.85 4.28 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 122.63 1.205 . . . . 37.090000000000003 110.697 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 92.8 t -81.26 115.88 24.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 N-CA-C 107.075 -1.454 . . . . 30.170000000000002 107.075 175.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1171 ' ' ILE . . . . . . . . . . . . . 84.0 mt -98.85 112.76 31.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 104.456 -2.424 . . . . 33.740000000000002 104.456 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 98.19 91.39 1.95 Allowed Glycine 0 CA--C 1.486 -1.78 0 CA-C-N 113.547 -1.66 . . . . 32.590000000000003 109.166 175.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1173 ' ' ALA . . . . . . . . . . . . . . . -75.68 61.28 1.35 Allowed 'General case' 0 C--O 1.253 1.251 0 CA-C-O 123.46 1.6 . . . . 32.420000000000002 112.095 174.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -78.48 -170.06 36.54 Favored Glycine 0 C--O 1.224 -0.502 0 O-C-N 120.745 -1.222 . . . . 31.739999999999998 110.063 170.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 36.5 t -56.44 -44.98 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-N 119.224 1.512 . . . . 31.48 111.031 174.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1176 ' ' ALA . . . . . . . . . . . . . . . -55.19 -50.25 69.85 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 123.856 0.862 . . . . 26.120000000000001 112.136 172.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1177 ' ' GLY . . . . . . . . . . . . . . . -54.56 -47.39 70.3 Favored Glycine 0 C--N 1.344 1.01 0 O-C-N 125.008 1.442 . . . . 25.73 109.574 178.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1178 ' ' LEU . . . . . . . . . . . . . 81.3 mt -66.57 -34.94 79.01 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.778 -1.424 . . . . 32.590000000000003 112.684 -173.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -71.73 -33.93 69.13 Favored 'General case' 0 C--N 1.351 0.674 0 O-C-N 120.452 -1.405 . . . . 27.719999999999999 112.26 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -67.16 -42.58 84.08 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 123.044 1.402 . . . . 26.030000000000001 110.348 172.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1181 ' ' ILE . . . . . . . . . . . . . 60.0 mt -58.71 -45.82 90.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 O-C-N 119.6 -1.937 . . . . 28.609999999999999 112.314 174.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -53.94 -55.08 27.62 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-N 115.105 -0.952 . . . . 25.23 111.942 172.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -60.31 -50.05 75.18 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.985 1.393 . . . . 24.09 113.265 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -69.58 -33.78 73.2 Favored 'General case' 0 C--O 1.241 0.636 0 O-C-N 121.401 -0.812 . . . . 26.68 110.404 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -68.71 -41.11 79.55 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 120.379 -1.45 . . . . 36.57 111.027 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1186 ' ' SER . . . . . . . . . . . . . 70.7 m -51.62 -44.36 62.87 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 122.211 1.005 . . . . 28.920000000000002 113.497 163.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1187 ' ' LEU . . . . . . . . . . . . . 74.7 mt -78.92 -1.76 36.71 Favored 'General case' 0 N--CA 1.433 -1.298 0 O-C-N 119.893 -1.754 . . . . 29.09 113.92 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 71.17 42.19 58.63 Favored Glycine 0 C--O 1.219 -0.817 0 O-C-N 120.746 -1.221 . . . . 29.260000000000002 111.961 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1189 ' ' ALA . . . . . . . . . . . . 0.251 . . -104.59 154.06 20.41 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.491 -0.559 . . . . 30.16 109.491 172.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 65.1 mt -81.11 93.37 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 O-C-N 119.726 -1.859 . . . . 35.810000000000002 108.389 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1191 ' ' VAL . . . . . . . . . . . . . 4.4 t -78.4 125.57 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.289 -1.004 . . . . 31.969999999999999 108.289 -178.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1192 ' ' ARG . . . . . 0.479 HH12 ' CD ' ' B' 1248 ' ' GLU . 27.0 mmt85 -112.33 94.44 4.93 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 106.081 -1.822 . . . . 48.159999999999997 106.081 177.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -103.78 133.34 48.93 Favored 'General case' 0 C--N 1.355 0.845 0 O-C-N 119.223 -2.173 . . . . 35.890000000000001 115.044 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 38.4 t80 -108.16 156.46 19.29 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 105.02 -2.215 . . . . 41.880000000000003 105.02 176.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1195 ' ' ASP . . . . . . . . . . . . . 7.5 t70 -167.23 146.69 5.22 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 113.371 -1.741 . . . . 38.280000000000001 107.949 163.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1196 ' ' THR . . . . . . . . . . . . . 2.7 p -68.27 -31.49 70.98 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 115.474 1.657 . . . . 40.619999999999997 115.474 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1197 ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -79.02 139.85 57.29 Favored Pre-proline 0 C--N 1.304 -1.391 0 CA-C-O 122.341 1.067 . . . . 53.090000000000003 110.928 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -69.09 -37.33 10.94 Favored 'Trans proline' 0 C--O 1.236 0.414 0 N-CA-C 117.991 2.266 . . . . 42.560000000000002 117.991 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -30.28 71.47 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 122.286 2.312 . . . . 56.310000000000002 116.514 -170.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B 1200 ' ' VAL . . . . . . . . . . . . . 2.1 m -63.99 -29.07 46.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 114.654 -1.157 . . . . 42.909999999999997 113.201 174.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 41.6 tttm -43.03 -56.57 3.27 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 115.711 1.745 . . . . 48.890000000000001 115.711 175.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -56.75 -37.99 71.8 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.604 -1.18 . . . . 51.700000000000003 112.824 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1203 ' ' GLN . . . . . . . . . . . . . 47.3 mm-40 -60.19 -52.07 66.88 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 109.187 -0.671 . . . . 52.57 109.187 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1204 ' ' VAL . . . . . . . . . . . . . 99.7 t -61.79 -47.57 92.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 O-C-N 125.561 1.788 . . . . 33.789999999999999 110.671 -174.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -53.41 -49.34 67.5 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 125.366 1.466 . . . . 36.579999999999998 111.025 175.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1206 ' ' SER . . . . . . . . . . . . . 18.8 m -80.01 -3.38 48.2 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 114.149 1.166 . . . . 39.609999999999999 114.149 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1207 ' ' MET . . . . . . . . . . . . . 9.1 tpt -79.21 -22.38 44.95 Favored 'General case' 0 CA--C 1.511 -0.523 0 O-C-N 120.911 -1.118 . . . . 37.450000000000003 111.019 163.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 96.23 41.59 3.69 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 119.777 -1.827 . . . . 31.870000000000001 109.522 -173.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -144.95 142.79 30.13 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 123.759 0.824 . . . . 35.399999999999999 111.831 -171.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -80.74 130.69 35.22 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.981 -0.748 . . . . 47.890000000000001 108.981 -173.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 53.2 t80 -96.77 110.84 23.23 Favored 'General case' 0 C--O 1.247 0.925 0 N-CA-C 105.967 -1.864 . . . . 45.530000000000001 105.967 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1212 ' ' LEU . . . . . . . . . . . . . 78.6 mt -70.66 129.68 39.8 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 105.107 -2.182 . . . . 46.329999999999998 105.107 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -115.28 164.55 14.07 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 114.603 -1.18 . . . . 60.409999999999997 111.246 -170.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 4.9 mp -70.57 137.69 50.29 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-O 121.228 0.537 . . . . 57.380000000000003 109.875 -167.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 19.5 t70 . . . . . 0 N--CA 1.476 0.84 0 O-C-N 120.697 -1.252 . . . . 65.069999999999993 111.066 -169.699 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B 1230 ' ' MET . . . . . . . . . . . . . 28.5 mmt . . . . . 0 N--CA 1.422 -1.865 0 N-CA-C 109.654 -0.499 . . . . 80.319999999999993 109.654 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B 1231 ' ' SER . . . . . . . . . . . . . 40.0 m 70.05 174.51 0.29 Allowed 'General case' 0 N--CA 1.476 0.853 2 O-C-N 112.163 -6.586 . . . . 79.920000000000002 117.433 -1.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -114.3 -117.37 0.32 Allowed 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 105.254 -2.128 . . . . 77.909999999999997 105.254 175.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 57.99 -60.51 0.03 OUTLIER 'General case' 0 C--O 1.241 0.649 0 CA-C-N 123.073 2.669 . . . . 73.879999999999995 116.132 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.41 -26.3 66.59 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 120.218 1.372 . . . . 68.980000000000004 112.0 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 37.3 pt -31.27 -44.91 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.247 0.931 0 N-CA-C 116.056 1.873 . . . . 64.530000000000001 116.056 164.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -63.69 -39.17 93.65 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-O 121.336 0.589 . . . . 66.359999999999999 109.656 -177.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -68.02 -52.3 37.21 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.507 -0.77 . . . . 56.600000000000001 111.888 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -50.39 -66.2 0.43 Allowed 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 125.06 1.344 . . . . 56.789999999999999 110.405 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1239 ' ' MET . . . . . . . . . . . . . 82.7 mtp -50.49 -40.57 51.54 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 115.929 1.826 . . . . 53.630000000000003 115.929 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -57.27 -49.78 75.0 Favored 'General case' 0 C--O 1.259 1.601 0 O-C-N 124.511 1.132 . . . . 51.740000000000002 110.742 173.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 4.2 tt -66.34 -37.36 85.16 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 116.214 -0.448 . . . . 44.859999999999999 110.525 -174.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -67.17 -42.49 84.21 Favored 'General case' 0 N--CA 1.438 -1.041 0 O-C-N 126.257 2.223 . . . . 42.780000000000001 109.597 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -63.65 -40.84 97.86 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 120.294 -1.504 . . . . 40.960000000000001 108.607 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -67.41 -34.43 77.23 Favored 'General case' 0 C--O 1.246 0.907 0 O-C-N 120.58 -1.325 . . . . 43.060000000000002 110.798 175.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -70.03 -27.58 64.78 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.378 0.881 . . . . 46.450000000000003 113.378 168.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -57.43 -45.38 84.72 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 119.953 -1.717 . . . . 41.780000000000001 111.598 -176.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 21.1 tptt -62.26 -31.69 72.3 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.33 0.863 . . . . 52.200000000000003 113.33 173.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1248 ' ' GLU . . . . . 0.479 ' CD ' HH12 ' B' 1192 ' ' ARG . 0.5 OUTLIER -77.35 -43.64 32.23 Favored 'General case' 0 C--O 1.248 0.986 0 O-C-N 121.394 -0.816 . . . . 53.549999999999997 113.019 177.646 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B 1249 ' ' VAL . . . . . . . . . . . . . 30.0 m -81.49 -179.26 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.031 0 O-C-N 120.575 -1.328 . . . . 34.409999999999997 114.457 -160.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1250 ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -132.94 -37.94 0.99 Allowed 'General case' 0 C--O 1.247 0.948 0 CA-C-N 113.087 -1.869 . . . . 33.380000000000003 109.616 -172.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1251 ' ' ILE . . . . . . . . . . . . . 41.1 mm -129.8 138.11 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 N-CA-C 104.469 -2.419 . . . . 29.539999999999999 104.469 175.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1252 ' ' ILE . . . . . . . . . . . . . 78.7 mt -112.84 116.36 52.4 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 N-CA-C 103.641 -2.726 . . . . 32.439999999999998 103.641 166.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1253 ' ' VAL . . . . . . . . . . . . . 42.8 t -97.57 87.56 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.258 1.52 0 N-CA-C 102.139 -3.282 . . . . 30.57 102.139 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1254 ' ' THR . . . . . . . . . . . . 0.286 1.3 t -89.7 104.63 17.17 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 126.245 2.926 . . . . 35.039999999999999 109.141 -174.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B 1255 ' ' THR . . . . . . . . . . . . . 21.9 m -110.99 -5.26 14.86 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 109.021 -3.718 . . . . 34.619999999999997 113.099 -169.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . -71.08 79.7 0.68 Allowed 'General case' 0 C--O 1.247 0.921 0 CA-C-O 124.026 1.869 . . . . 42.719999999999999 112.45 -162.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 29.2 mt -92.56 120.9 33.47 Favored 'General case' 0 C--O 1.249 1.077 0 N-CA-C 106.912 -1.514 . . . . 52.43 106.912 169.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 70.1 mt -81.68 113.6 43.65 Favored Pre-proline 0 N--CA 1.449 -0.486 0 N-CA-C 102.055 -3.313 . . . . 59.409999999999997 102.055 176.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -57.02 94.44 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 124.077 3.185 . . . . 62.68 115.746 -171.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 135.56 -44.91 1.13 Allowed Glycine 0 CA--C 1.493 -1.285 0 CA-C-N 112.065 -2.334 . . . . 64.159999999999997 108.479 174.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 82.5 mttt -68.98 161.78 69.85 Favored Pre-proline 0 N--CA 1.446 -0.626 0 O-C-N 120.215 -1.756 . . . . 68.530000000000001 114.335 172.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -61.07 157.48 39.07 Favored 'Trans proline' 0 N--CA 1.44 -1.64 0 C-N-CA 122.235 1.957 . . . . 61.990000000000002 111.504 157.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1263 ' ' ALA . . . . . . . . . . . . . . . -66.14 128.23 93.7 Favored Pre-proline 0 N--CA 1.416 -2.142 0 O-C-N 120.761 -1.212 . . . . 57.149999999999999 112.811 174.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.15 137.94 42.04 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 123.787 2.991 . . . . 51.57 110.24 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -76.9 71.15 3.4 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 123.358 1.552 . . . . 54.549999999999997 111.248 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 63.4 mt -70.1 -42.58 72.51 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 124.086 1.898 . . . . 46.859999999999999 110.7 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1267 ' ' ILE . . . . . . . . . . . . . 44.4 mm -80.07 93.44 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 O-C-N 119.207 -2.183 . . . . 41.039999999999999 107.129 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1268 ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.81 152.63 31.0 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 113.429 -1.714 . . . . 39.579999999999998 112.8 170.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B 1269 ' ' ARG . . . . . . . . . . . . . 73.1 mtt85 -56.4 -37.97 70.86 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 120.782 -1.199 . . . . 53.149999999999999 111.675 172.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -43.85 -54.54 5.17 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 125.888 1.675 . . . . 42.960000000000001 114.376 168.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B 1271 ' ' MET . . . . . . . . . . . . . 48.7 ttm -64.37 -33.91 76.95 Favored 'General case' 0 C--N 1.353 0.758 0 CA-C-N 114.648 -1.16 . . . . 43.890000000000001 109.551 -174.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1272 ' ' VAL . . . . . . . . . . . . . 21.5 t -65.89 -48.58 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 123.315 1.531 . . . . 38.369999999999997 108.087 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -67.47 -14.63 63.1 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 120.802 -1.187 . . . . 47.460000000000001 114.155 173.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1274 ' ' SER . . . . . . . . . . . . . 48.6 m -86.73 0.2 55.14 Favored 'General case' 0 N--CA 1.44 -0.926 0 O-C-N 119.2 -2.187 . . . . 38.380000000000003 114.367 168.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1275 ' ' MET . . . . . . . . . . . . . 55.6 mtp -82.24 156.98 24.08 Favored 'General case' 0 CA--C 1.486 -1.499 0 O-C-N 118.502 -2.624 . . . . 37.810000000000002 112.946 173.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1276 ' ' LYS . . . . . 0.473 ' NZ ' ' O ' ' B' 1248 ' ' GLU . 8.0 ttmt -62.39 146.59 50.9 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 112.743 -2.026 . . . . 49.259999999999998 107.25 167.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -73.62 150.43 41.37 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 114.319 1.229 . . . . 34.460000000000001 114.319 -176.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 62.18 51.6 55.57 Favored Glycine 0 N--CA 1.479 1.521 0 CA-C-O 124.859 2.366 . . . . 33.530000000000001 111.698 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1279 ' ' SER . . . . . . . . . . . . . 45.4 m -134.49 154.27 51.51 Favored 'General case' 0 C--O 1.26 1.607 0 CA-C-N 111.543 -2.328 . . . . 31.309999999999999 105.348 -173.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1280 ' ' VAL . . . . . . . . . . . . . 63.3 t -120.65 138.99 49.33 Favored 'Isoleucine or valine' 0 C--O 1.247 0.961 0 O-C-N 119.459 -2.026 . . . . 29.32 109.108 -170.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1281 ' ' ILE . . . . . . . . . . . . . 40.7 mt -106.81 101.48 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 105.874 -1.899 . . . . 31.93 105.874 168.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1282 ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.81 114.65 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.179 0 CA-C-O 124.414 2.054 . . . . 29.48 107.498 176.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 22.5 t0 -94.51 108.48 20.42 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 113.192 -1.822 . . . . 34.5 106.439 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1284 ' ' LEU . . . . . . . . . . . . . 5.9 mp -84.78 -33.43 22.99 Favored 'General case' 0 C--O 1.255 1.354 0 CA-C-N 112.448 -2.16 . . . . 37.939999999999998 108.779 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -75.23 -9.67 58.76 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 113.298 -1.774 . . . . 40.920000000000002 110.881 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -42.65 -30.02 0.34 Allowed 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 118.709 2.855 . . . . 44.390000000000001 118.709 169.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1287 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.96 -36.56 83.68 Favored 'General case' 0 C--N 1.363 1.157 0 CA-C-N 121.385 1.902 . . . . 51.460000000000001 110.566 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 20.9 t30 -122.92 100.09 6.71 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 122.996 1.379 . . . . 57.75 109.328 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1289 ' ' GLY . . . . . . . . . . . . . . . 82.9 -60.85 4.85 Favored Glycine 0 C--O 1.259 1.693 0 O-C-N 119.858 -1.776 . . . . 49.850000000000001 114.274 177.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 90.61 128.35 3.84 Favored Glycine 0 C--O 1.252 1.234 0 O-C-N 120.674 -1.486 . . . . 45.93 111.535 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1291 ' ' ASN . . . . . . . . . . . . . 7.7 m120 -80.83 -31.57 35.46 Favored 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 124.298 0.646 . . . . 42.670000000000002 110.667 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1292 ' ' CYS . . . . . . . . . . . . . 52.5 t -92.1 140.49 29.59 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.285 -1.005 . . . . 38.82 108.285 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1293 ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -65.57 -45.28 83.89 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 113.376 0.88 . . . . 46.710000000000001 113.376 171.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -63.78 -15.57 59.03 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 117.458 2.392 . . . . 47.229999999999997 117.458 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1295 ' ' THR . . . . . . . . . . . . . 33.2 m -59.98 119.02 6.98 Favored 'General case' 0 C--O 1.262 1.755 0 O-C-N 120.986 -1.071 . . . . 36.020000000000003 111.41 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 60.8 t -79.49 121.42 82.69 Favored Pre-proline 0 N--CA 1.473 0.694 0 N-CA-C 102.767 -3.049 . . . . 37.259999999999998 102.767 163.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -62.45 92.63 0.13 Allowed 'Trans proline' 0 C--O 1.249 1.036 0 C-N-CA 124.592 3.528 . . . . 35.090000000000003 110.542 -177.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 114.66 27.02 3.43 Favored Glycine 0 N--CA 1.443 -0.886 0 O-C-N 120.861 -1.15 . . . . 35.969999999999999 112.237 175.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -153.04 171.4 18.44 Favored 'General case' 0 C--N 1.356 0.861 0 CA-C-N 121.001 2.401 . . . . 40.390000000000001 116.079 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1300 ' ' ILE . . . . . . . . . . . . . 18.9 mt -87.82 160.08 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 O-C-N 122.103 -0.373 . . . . 37.43 110.086 165.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 51.6 t80 -150.44 161.71 41.98 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 106.116 -1.809 . . . . 44.130000000000003 106.116 169.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1302 ' ' THR . . . . . . . . . . . . . 9.2 m -136.16 138.39 41.9 Favored 'General case' 0 C--O 1.253 1.249 0 O-C-N 120.519 -1.363 . . . . 39.780000000000001 109.483 173.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1303 ' ' THR . . . . . . . . . . . . . 41.4 p -98.37 168.49 10.18 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 126.004 2.065 . . . . 43.289999999999999 114.095 -167.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -47.74 -49.4 28.38 Favored 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 124.721 1.208 . . . . 53.07 113.161 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 32.9 p-10 -67.69 -39.95 84.39 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 115.226 1.565 . . . . 43.969999999999999 115.226 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 127.62 29.03 0.85 Allowed Glycine 0 CA--C 1.527 0.783 0 N-CA-C 109.547 -1.421 . . . . 41.119999999999997 109.547 177.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1307 ' ' VAL . . . . . . . . . . . . . 47.3 t -98.61 148.25 6.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 107.409 -1.33 . . . . 38.119999999999997 107.409 173.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1308 ' ' LYS . . . . . . . . . . . . . 90.6 mttt -113.27 128.51 56.49 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 118.718 -2.489 . . . . 36.340000000000003 105.482 -175.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1309 ' ' VAL . . . . . . . . . . . . . 42.7 t -110.06 130.41 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 103.294 -2.854 . . . . 30.399999999999999 103.294 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1310 ' ' ILE . . . . . . . . . . . . . 52.9 mt -127.14 113.01 30.48 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.411 0 N-CA-C 105.108 -2.182 . . . . 30.82 105.108 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1311 ' ' GLY . . . . . . . . . . . . . . . -132.98 117.54 1.97 Allowed Glycine 0 C--O 1.214 -1.134 0 N-CA-C 104.789 -3.324 . . . . 26.530000000000001 104.789 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1312 ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -117.59 128.03 54.55 Favored 'General case' 0 CA--C 1.493 -1.235 0 CA-C-N 118.345 1.073 . . . . 38.0 110.667 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1313 ' ' THR . . . . . . . . . . . . . 26.3 m -68.11 -28.42 67.31 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.511 -1.677 . . . . 29.800000000000001 107.601 167.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -89.4 18.61 5.09 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 124.835 1.254 . . . . 39.039999999999999 113.592 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1315 ' ' LEU . . . . . . . . . . . . . 6.9 mt -48.24 -40.21 34.34 Favored Pre-proline 0 CA--C 1.509 -0.633 0 N-CA-C 117.25 2.315 . . . . 31.079999999999998 117.25 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1316 ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -64.19 -44.56 11.92 Favored 'Trans proline' 0 CA--C 1.513 -0.548 0 C-N-CA 123.911 3.074 . . . . 26.100000000000001 111.968 169.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -56.02 -33.05 60.15 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 115.524 0.969 . . . . 23.170000000000002 115.524 172.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -54.9 -23.92 21.03 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 113.623 0.971 . . . . 40.399999999999999 113.623 171.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 12.6 tp -126.76 79.73 71.59 Favored Pre-proline 0 N--CA 1.442 -0.874 0 O-C-N 119.08 -2.263 . . . . 23.600000000000001 107.194 176.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1320 ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -58.65 -63.04 0.15 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.801 3.001 . . . . 22.350000000000001 119.246 -171.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1321 ' ' THR . . . . . . . . . . . . . 2.3 m -57.02 -43.82 82.23 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 119.666 1.121 . . . . 26.52 109.779 -175.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1322 ' ' GLN . . . . . . . . . . . . . 34.4 tp60 -74.13 -35.79 64.14 Favored 'General case' 0 CA--C 1.493 -1.218 0 O-C-N 121.626 -0.671 . . . . 24.379999999999999 112.442 -172.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1323 ' ' SER . . . . . . . . . . . . . 68.6 m -61.01 -45.28 95.46 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 113.905 1.076 . . . . 22.800000000000001 113.905 168.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1324 ' ' SER . . . . . . . . . . . . . 14.5 m -59.01 -37.94 78.07 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.89 0.476 . . . . 21.25 111.015 175.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 43.6 tp60 -63.05 -49.18 75.59 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 113.12 0.785 . . . . 31.34 113.12 171.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1326 ' ' LEU . . . . . . . . . . . . . 35.7 mt -78.57 -48.1 15.87 Favored 'General case' 0 CA--C 1.488 -1.439 0 O-C-N 120.092 -1.63 . . . . 31.559999999999999 113.02 -170.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1327 ' ' TYR . . . . . . . . . . . . . 38.7 t80 -57.26 -42.81 82.27 Favored 'General case' 0 C--N 1.359 1.003 0 N-CA-C 107.536 -1.283 . . . . 22.73 107.536 170.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1328 ' ' GLY . . . . . . . . . . . . . . . -52.37 -50.87 45.52 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 123.472 0.558 . . . . 21.91 112.438 171.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1329 ' ' THR . . . . . . . . . . . . . 34.6 m -65.39 -29.46 70.16 Favored 'General case' 0 C--O 1.245 0.84 0 O-C-N 119.004 -2.468 . . . . 22.149999999999999 111.265 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1330 ' ' ASN . . . . . . . . . . . . . 20.3 m120 -60.59 -49.19 78.53 Favored 'General case' 0 C--O 1.25 1.12 0 CA-C-O 122.446 1.117 . . . . 26.18 110.889 173.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1331 ' ' LEU . . . . . . . . . . . . . 36.4 mt -53.21 -46.16 68.95 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 113.278 -1.783 . . . . 23.68 113.16 171.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1332 ' ' VAL . . . . . . . . . . . . . 39.0 t -53.79 -50.0 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 115.754 -0.657 . . . . 26.57 110.643 171.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -69.55 -27.37 65.09 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 119.875 -1.766 . . . . 28.079999999999998 113.303 -177.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1334 ' ' LEU . . . . . . . . . . . . . 1.2 tt -66.96 -51.62 52.88 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 106.206 -1.775 . . . . 27.43 106.206 175.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1335 ' ' LEU . . . . . . . . . . . . . 86.3 mt -62.4 -29.75 70.71 Favored 'General case' 0 C--N 1.355 0.844 0 CA-C-N 115.162 -0.926 . . . . 30.5 111.255 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1336 ' ' LYS . . . . . . . . . . . . . 95.0 mttt -64.8 -45.73 85.05 Favored 'General case' 0 C--O 1.245 0.843 0 O-C-N 120.418 -1.426 . . . . 41.649999999999999 110.052 169.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 29.5 tp -76.04 -18.27 59.3 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 119.454 1.024 . . . . 42.079999999999998 112.227 -174.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1338 ' ' LEU . . . . . . . . . . . . . 26.8 mt -79.09 -67.92 0.71 Allowed 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 119.637 -1.914 . . . . 35.030000000000001 108.194 167.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 43.0 t -76.45 80.46 3.16 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 124.283 1.992 . . . . 37.329999999999998 108.282 -173.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -62.22 -27.64 69.13 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.531 -1.356 . . . . 50.509999999999998 111.984 174.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -84.63 -6.24 59.35 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 114.245 1.202 . . . . 54.210000000000001 114.245 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 90.7 mttt 39.07 39.8 0.42 Allowed 'General case' 0 C--O 1.257 1.477 0 N-CA-C 116.717 2.117 . . . . 50.990000000000002 116.717 -172.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -89.69 -14.52 34.6 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 113.885 -1.507 . . . . 48.82 107.542 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 89.98 27.99 19.58 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.052 -1.071 . . . . 40.43 112.351 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -136.68 160.84 37.62 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 120.289 2.044 . . . . 47.560000000000002 109.012 164.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1346 ' ' ILE . . . . . . . . . . . . . 45.0 mm -68.1 101.13 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 C-N-CA 119.612 -0.835 . . . . 42.490000000000002 108.898 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1347 ' ' THR . . . . . . . . . . . . . 17.6 m -71.91 105.56 3.88 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 103.412 -2.81 . . . . 38.119999999999997 103.412 163.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 47.3 t -69.03 84.97 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.144 -1.389 . . . . 37.5 109.292 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 24.5 t70 -81.29 164.13 22.44 Favored 'General case' 0 C--O 1.243 0.761 0 O-C-N 121.298 -0.876 . . . . 43.850000000000001 110.701 171.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1350 ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -155.0 3.09 0.2 Allowed 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 126.925 2.09 . . . . 39.810000000000002 111.17 158.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 10.6 t70 -72.94 -32.68 65.43 Favored 'General case' 0 C--O 1.247 0.939 0 CA-C-O 121.761 0.791 . . . . 51.289999999999999 112.234 -163.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.39 142.34 31.07 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.31 -0.859 . . . . 39.780000000000001 111.904 170.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 22.5 m -62.84 -26.47 40.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 114.956 1.465 . . . . 39.280000000000001 114.956 -178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1354 ' ' VAL . . . . . . . . . . . . . 81.1 t -71.06 -49.94 45.73 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.195 0 N-CA-C 106.389 -1.708 . . . . 35.700000000000003 106.389 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1355 ' ' ILE . . . . . . . . . . . . . 25.6 mm -62.49 -46.63 95.95 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 119.458 1.026 . . . . 35.770000000000003 111.766 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 45.1 tpt85 -46.15 -32.2 2.82 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 124.331 1.019 . . . . 38.549999999999997 113.091 172.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -97.28 -46.37 2.39 Favored Glycine 0 CA--C 1.497 -1.061 0 O-C-N 120.682 -1.261 . . . . 29.579999999999998 114.125 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1358 ' ' VAL . . . . . . . . . . . . . 10.9 p -65.52 -35.73 75.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 117.035 0.417 . . . . 32.060000000000002 111.848 -176.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1359 ' ' THR . . . . . . . . . . . . . 2.8 m -75.6 80.93 2.59 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.519 -1.66 . . . . 29.0 106.519 172.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1360 ' ' VAL . . . . . . . . . . . . . 15.6 m -68.39 -24.35 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 O-C-N 121.123 -0.986 . . . . 29.68 113.161 -172.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 74.7 mt -132.88 97.39 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 103.842 -2.651 . . . . 32.049999999999997 103.842 176.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1362 ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -79.71 92.63 5.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 124.442 3.292 . . . . 32.520000000000003 109.81 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 57.09 30.68 18.67 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 115.922 1.823 . . . . 35.68 115.922 168.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 147.97 -73.39 0.29 Allowed Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.26 -0.972 . . . . 34.259999999999998 110.887 177.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -69.28 141.45 54.34 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 113.565 0.95 . . . . 51.07 113.565 173.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 88.8 mt -86.66 113.33 24.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 125.198 2.428 . . . . 39.869999999999997 111.436 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1367 ' ' THR . . . . . . . . . . . . . 1.1 p -98.45 3.14 48.31 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 111.344 -2.662 . . . . 38.009999999999998 112.698 -172.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1368 ' ' TRP . . . . . . . . . . . . . 57.7 t90 -73.07 137.45 79.13 Favored Pre-proline 0 N--CA 1.447 -0.599 0 N-CA-C 107.757 -1.201 . . . . 42.140000000000001 107.757 167.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -94.49 -178.84 8.06 Favored 'Cis proline' 0 N--CA 1.452 -0.939 0 C-N-CA 124.695 -0.96 . . . . 43.259999999999998 111.464 -5.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1370 ' ' ALA . . . . . . . . . . . . . . . -76.08 163.54 65.95 Favored Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 124.718 1.207 . . . . 46.520000000000003 108.19 169.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -54.04 126.89 23.55 Favored 'Trans proline' 0 CA--C 1.553 1.46 0 C-N-CA 125.149 3.899 . . . . 51.950000000000003 111.003 166.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -37.88 109.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.365 1.442 1 C-N-CA 126.99 5.127 . . . . 56.270000000000003 113.375 -173.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B 1373 ' ' ILE . . . . . . . . . . . . . 8.3 tp -82.44 137.33 21.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 C-N-CA 126.655 1.982 . . . . 60.829999999999998 113.094 -174.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 16.1 mp0 -87.49 101.09 13.26 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-O 122.979 1.371 . . . . 66.099999999999994 110.188 175.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 43.1 t -73.97 118.34 19.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 112.396 -2.184 . . . . 63.469999999999999 108.12 176.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.217 -5.174 0 O-C-N 118.206 -2.809 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.541 0 CA-C-O 116.792 -1.575 . . . . 0.0 111.416 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -58.11 -23.24 54.17 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 122.655 2.479 . . . . 0.0 115.676 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 52.9 mp0 -52.49 -53.07 50.71 Favored 'General case' 0 C--O 1.215 -0.715 0 CA-C-O 122.027 0.918 . . . . 0.0 109.25 171.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 16.8 m -67.3 -43.53 81.48 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 114.561 -1.199 . . . . 0.0 109.791 -176.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.87 -36.38 67.52 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 123.993 0.917 . . . . 0.0 111.26 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.12 -57.87 3.62 Favored 'General case' 0 C--O 1.24 0.605 0 O-C-N 120.082 -1.636 . . . . 0.0 112.706 171.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 mp -46.82 -44.94 19.76 Favored 'General case' 0 C--O 1.21 -1.025 0 C-N-CA 125.664 1.585 . . . . 0.0 114.284 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 27.6 mt -62.77 -49.52 74.68 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 28' ' ' LYS . . . . . 0.538 ' HZ3' ' C ' ' C' ' 186' ' ' LEU . 20.0 pttm -67.6 -30.33 69.89 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 119.241 -0.983 . . . . 0.0 111.795 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -62.52 -43.2 99.4 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 124.06 0.944 . . . . 0.0 111.937 168.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 51.7 m -44.87 -31.7 1.34 Allowed 'General case' 0 CA--C 1.498 -1.028 1 N-CA-C 122.175 4.139 . . . . 0.0 122.175 -164.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 70.85 -62.67 0.44 Allowed 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.499 1.12 . . . . 0.0 111.607 -175.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 71.7 m -108.52 139.67 42.95 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 162.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 92.2 t -124.05 134.98 65.08 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 103.738 -2.69 . . . . 0.0 103.738 174.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 42.5 mm -109.95 123.73 66.09 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.305 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 165.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 66.9 mt -108.51 124.8 65.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 172.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 89.2 m -108.1 100.22 35.39 Favored Pre-proline 0 C--O 1.245 0.825 0 CA-C-N 113.359 -1.746 . . . . 0.0 109.147 173.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -61.76 82.47 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.482 3.455 . . . . 0.0 110.391 174.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.18 -132.91 3.65 Favored Glycine 0 N--CA 1.432 -1.61 0 CA-C-O 123.3 1.5 . . . . 0.0 110.503 169.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -59.28 -57.4 13.19 Favored 'General case' 0 CA--C 1.5 -0.966 0 O-C-N 121.306 -1.114 . . . . 0.0 110.834 -157.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -55.24 -34.92 59.41 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-O 118.392 -1.227 . . . . 0.0 112.328 -173.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 31.3 ttm -88.15 -37.55 16.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 118.539 1.169 . . . . 0.0 110.421 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.36 -2.37 37.86 Favored 'General case' 0 C--O 1.246 0.887 0 C-N-CA 122.416 0.287 . . . . 0.0 111.525 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 p -111.39 -43.53 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 166.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -135.9 179.03 6.59 Favored 'General case' 0 CA--C 1.507 -0.709 0 O-C-N 119.412 -2.055 . . . . 0.0 110.255 -167.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 45' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -63.64 16.02 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 120.583 3.549 . . . . 0.0 120.583 -169.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.9 -17.01 33.98 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 123.68 2.945 . . . . 0.0 115.048 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -44.22 96.92 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.157 0.983 . . . . 0.0 111.106 174.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 48' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -62.74 -47.26 88.01 Favored Pre-proline 0 C--O 1.253 1.265 0 CA-C-N 121.99 2.177 . . . . 0.0 110.011 177.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 49' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -53.95 -42.64 65.04 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 124.642 3.561 . . . . 0.0 114.884 169.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 p -65.95 -34.98 73.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 119.203 0.91 . . . . 0.0 111.09 -174.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.3 -50.07 70.53 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.175 0.99 . . . . 0.0 112.419 169.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -68.82 -29.41 67.74 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -178.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 9.4 tp -76.53 -46.05 32.35 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 N-CA-C 115.597 1.702 . . . . 0.0 115.597 166.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 96.9 m -57.63 -27.93 63.23 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 113.421 0.896 . . . . 0.0 113.421 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -47.43 -57.45 5.32 Favored 'General case' 0 N--CA 1.427 -1.618 0 C-N-CA 125.608 1.563 . . . . 0.0 114.017 167.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -81.17 -25.31 36.92 Favored 'General case' 0 N--CA 1.434 -1.244 0 O-C-N 120.76 -1.213 . . . . 0.0 112.271 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.77 -38.35 90.26 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 123.083 1.421 . . . . 0.0 111.488 171.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -73.42 -32.9 64.66 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.536 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.18 -23.08 66.39 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 167.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -81.71 -6.29 58.89 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 119.157 0.89 . . . . 0.0 110.97 168.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.01 41.74 80.43 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 120.52 -1.363 . . . . 0.0 114.465 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 25.2 mt -96.04 134.54 33.22 Favored 'Isoleucine or valine' 0 C--O 1.253 1.253 0 CA-C-O 123.756 1.741 . . . . 0.0 111.081 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -68.99 83.07 0.32 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 124.629 2.156 . . . . 0.0 110.182 168.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 p -100.39 92.0 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 113.748 -1.569 . . . . 0.0 107.749 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -91.62 128.08 37.32 Favored 'General case' 0 N--CA 1.442 -0.836 0 O-C-N 120.117 -1.614 . . . . 0.0 111.929 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -83.1 78.69 9.56 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 122.639 1.209 . . . . 0.0 109.047 176.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.48 89.06 0.35 Allowed Glycine 0 C--O 1.219 -0.804 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 20.6 mt -88.72 132.62 33.13 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.902 0 CA-C-O 120.953 0.406 . . . . 0.0 111.845 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -83.39 128.99 62.15 Favored Pre-proline 0 N--CA 1.472 0.654 0 CA-C-O 117.583 -1.199 . . . . 0.0 109.45 169.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 70' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -61.11 -66.36 0.06 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.526 0 C-N-CA 124.582 3.521 . . . . 0.0 117.934 -175.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 45.8 t -76.16 107.54 7.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 170.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -168.15 142.71 3.48 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-N 121.315 1.871 . . . . 0.0 111.901 -171.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 61.77 -113.75 6.05 Favored Glycine 0 C--N 1.346 1.103 0 O-C-N 121.208 -0.932 . . . . 0.0 111.493 171.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -128.72 105.88 8.56 Favored 'General case' 0 C--O 1.242 0.681 0 O-C-N 121.163 -1.199 . . . . 0.0 109.914 177.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . 0.25 2.0 mp 68.63 132.35 0.04 OUTLIER Pre-proline 0 CA--C 1.553 1.058 0 O-C-N 127.605 3.065 . . . . 0.0 116.269 -177.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.42 158.29 57.77 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 124.346 3.364 . . . . 0.0 107.784 167.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.04 -63.92 1.62 Allowed Glycine 0 C--O 1.212 -1.244 0 CA-C-O 116.802 -2.11 . . . . 0.0 111.856 -168.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -33.23 -50.25 0.29 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -172.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.37 -45.03 85.7 Favored 'General case' 0 C--O 1.245 0.819 0 O-C-N 124.294 0.996 . . . . 0.0 113.207 -178.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.16 -26.07 42.77 Favored 'General case' 0 C--O 1.246 0.908 0 O-C-N 120.266 -1.521 . . . . 0.0 109.409 -175.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 46.5 t -58.48 -52.87 54.24 Favored 'Isoleucine or valine' 0 C--N 1.347 0.477 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 166.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 63.0 mt -56.95 -29.5 63.21 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 11.1 mp -63.96 -44.98 91.14 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 121.756 -0.59 . . . . 0.0 111.12 167.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.53 -38.08 86.39 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 120.223 -1.548 . . . . 0.0 112.334 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -50.39 -53.79 26.59 Favored 'General case' 0 C--N 1.349 0.572 0 O-C-N 124.654 1.221 . . . . 0.0 113.167 163.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.51 10.31 3.27 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp 58.68 30.29 19.73 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.867 2.067 . . . . 0.0 112.243 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 65.9 t -70.16 127.36 92.33 Favored Pre-proline 0 C--O 1.242 0.697 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 -174.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -50.56 107.41 0.16 Allowed 'Trans proline' 0 C--O 1.243 0.758 1 C-N-CA 125.313 4.009 . . . . 0.0 112.513 -176.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.75 -26.67 64.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.107 -1.406 . . . . 0.0 112.462 -165.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -40.15 -44.11 1.76 Allowed 'General case' 0 C--O 1.245 0.844 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 174.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -90.87 -1.42 9.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 -173.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 10.6 t -83.36 121.73 36.59 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 O-C-N 120.686 -1.258 . . . . 0.0 114.38 -174.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 45.0 mt -125.59 81.78 2.01 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -170.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 27.7 mp0 -75.76 104.38 6.28 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 121.677 -0.64 . . . . 0.0 110.433 -174.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 41.5 ttp 49.31 59.65 4.33 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.35 -171.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -103.84 135.74 44.82 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 167.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -85.73 75.64 10.05 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 -172.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 8.3 tp -92.97 62.27 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-O 124.777 2.227 . . . . 0.0 110.585 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -60.04 -32.97 71.42 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 112.397 -2.183 . . . . 0.0 109.354 -170.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.83 -59.65 4.57 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 118.155 -0.926 . . . . 0.0 112.23 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.01 -28.66 69.73 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 128.266 3.479 . . . . 0.0 113.239 176.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 103' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -64.52 -39.92 94.67 Favored 'General case' 0 C--O 1.224 -0.269 0 O-C-N 120.415 -1.428 . . . . 0.0 111.231 174.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -103.32 60.76 0.77 Allowed 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 123.263 1.506 . . . . 0.0 109.453 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -168.79 -37.02 0.02 OUTLIER 'General case' 0 C--O 1.241 0.655 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 106' ' ' THR . . . . . . . . . . . . . 2.7 m -51.12 132.46 28.0 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 121.256 -0.902 . . . . 0.0 113.282 170.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 107' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -85.84 -60.49 2.0 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 34.6 m -109.22 130.67 55.49 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 118.572 -1.251 . . . . 0.0 112.563 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 109' ' ' VAL . . . . . . . . . . . . . 47.9 t -102.17 132.73 47.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 O-C-N 124.647 1.217 . . . . 0.0 108.225 173.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 15.3 mt -98.58 84.24 3.13 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 124.57 1.169 . . . . 0.0 109.679 176.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 61.8 t -78.55 104.74 6.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 124.461 2.077 . . . . 0.0 107.494 170.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 36.3 mm -72.62 76.47 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.185 0 CA-C-O 124.424 2.059 . . . . 0.0 113.779 -175.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.11 -58.21 3.57 Favored Glycine 0 C--N 1.346 1.128 0 O-C-N 118.18 -2.825 . . . . 0.0 114.568 171.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -82.75 95.05 7.75 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 123.153 1.454 . . . . 0.0 111.557 -171.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 115' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -52.25 -57.56 9.33 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 111.098 -2.774 . . . . 0.0 112.127 165.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 116' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -56.95 -34.03 67.63 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -169.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 20.7 m -43.46 -38.36 2.8 Favored 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 169.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 16.8 m -127.22 26.15 2.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 125.22 1.408 . . . . 0.0 110.826 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -75.54 120.71 82.93 Favored Pre-proline 0 CA--C 1.505 -0.775 0 CA-C-O 117.524 -1.227 . . . . 0.0 109.513 -177.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 120' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.25 -45.25 42.44 Favored 'Trans proline' 0 CA--C 1.51 -0.696 0 C-N-CA 124.639 3.559 . . . . 0.0 115.419 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -55.4 -32.88 63.02 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 120.675 1.579 . . . . 0.0 112.897 -176.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 122' ' ' ALA . . . . . . . . . . . . . . . -56.06 -20.15 15.81 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 120.774 -1.203 . . . . 0.0 113.121 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -119.11 -27.42 5.7 Favored 'General case' 0 C--O 1.221 -0.432 0 O-C-N 119.982 -1.699 . . . . 0.0 111.612 166.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -84.07 -11.08 57.26 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.26 -169.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -128.49 99.42 23.77 Favored Pre-proline 0 C--O 1.247 0.967 0 C-N-CA 119.314 -0.954 . . . . 0.0 111.096 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -64.19 69.25 0.21 Allowed 'Trans proline' 0 N--CA 1.441 -1.582 1 C-N-CA 125.62 4.213 . . . . 0.0 114.642 170.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -177.66 -28.11 0.01 OUTLIER 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 -174.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 128' ' ' SER . . . . . . . . . . . . . 66.2 m -59.46 129.39 86.94 Favored Pre-proline 0 C--O 1.222 -0.355 0 O-C-N 117.532 -3.23 . . . . 0.0 110.6 168.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 129' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -57.29 -46.82 25.54 Favored 'Trans proline' 0 N--CA 1.459 -0.522 1 C-N-CA 126.189 4.592 . . . . 0.0 115.738 -173.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 9.1 pt -84.11 63.7 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.842 0 CA-C-N 121.721 2.055 . . . . 0.0 111.038 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.75 153.44 43.36 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 118.111 2.634 . . . . 0.0 118.111 -168.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.15 22.83 77.46 Favored Glycine 0 C--O 1.213 -1.193 0 CA-C-N 110.232 -3.167 . . . . 0.0 111.553 177.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 133' ' ' MET . . . . . . . . . . . . . 34.0 tpp -74.15 119.32 75.76 Favored Pre-proline 0 C--O 1.238 0.481 0 CA-C-N 120.444 2.122 . . . . 0.0 107.956 -175.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.89 105.17 1.1 Allowed 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 121.112 1.208 . . . . 0.0 108.99 -175.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 4.5 m -117.93 103.71 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 103.503 -2.777 . . . . 0.0 103.503 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 42.2 mt -73.81 90.73 1.9 Allowed 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 110.777 -2.92 . . . . 0.0 113.123 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 51.68 -12.48 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 120.96 3.689 . . . . 0.0 120.96 163.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 8.4 p -80.8 82.88 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-N 125.177 3.626 . . . . 0.0 113.182 -171.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 44.6 p90 -163.71 173.12 13.27 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 111.799 -2.455 . . . . 0.0 106.754 173.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 140' ' ' LYS . . . . . . . . . . . . 0.398 25.2 pttm 68.31 -62.81 0.36 Allowed 'General case' 0 C--O 1.242 0.667 0 C-N-CA 128.233 2.613 . . . . 0.0 116.078 171.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.25 110.45 4.05 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-O 121.661 0.743 . . . . 0.0 111.961 169.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 142' ' ' GLN . . . . . . . . . . . . 0.261 18.3 mm100 74.75 -163.27 0.08 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 172.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 143' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -91.03 69.37 6.26 Favored 'General case' 0 C--O 1.248 1.018 0 CA-C-O 124.605 2.145 . . . . 0.0 107.288 -159.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 144' ' ' VAL . . . . . . . . . . . . . 20.5 t -75.24 82.69 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 114.145 -1.389 . . . . 0.0 107.384 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 145' ' ' ILE . . . . . . . . . . . . . 1.3 mp -80.17 120.71 32.16 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -176.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 146' ' ' VAL . . . . . . . . . . . . . 92.9 t -98.6 115.53 39.19 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 N-CA-C 102.919 -2.993 . . . . 0.0 102.919 172.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 147' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -64.82 123.96 20.73 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.611 0.719 . . . . 0.0 111.739 173.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 148' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -126.54 146.41 50.14 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 2.1 tpp85 -89.02 -55.21 3.78 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 100.513 -3.884 . . . . 0.0 100.513 162.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 3.4 m -152.82 -179.82 7.98 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 167.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 10.6 tpt -115.61 111.83 21.23 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 171.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -84.13 -144.1 0.08 Allowed 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 111.802 -2.453 . . . . 0.0 107.371 167.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 91.8 m -97.01 133.9 41.08 Favored 'General case' 0 C--O 1.24 0.577 0 O-C-N 117.243 -3.411 . . . . 0.0 107.43 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -84.57 151.91 27.07 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 113.256 -1.793 . . . . 0.0 110.292 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 16.1 m-30 -59.93 -39.03 84.11 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 117.917 -3.107 . . . . 0.0 114.523 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 156' ' ' ALA . . . . . . . . . . . . . . . -85.17 -54.6 4.51 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 119.199 -2.188 . . . . 0.0 107.548 166.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 80.84 -77.25 2.03 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.302 -0.863 . . . . 0.0 114.56 171.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 20.2 m -63.57 159.93 3.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 117.73 2.493 . . . . 0.0 117.73 -162.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . 0.258 0.0 OUTLIER -2.48 104.56 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.527 1 N-CA-C 122.043 4.09 . . . . 0.0 122.043 -176.071 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' C' C ' 160' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -165.89 140.25 3.77 Favored Pre-proline 0 N--CA 1.434 -1.257 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.598 -173.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -45.56 -33.78 10.13 Favored 'Trans proline' 0 CA--C 1.512 -0.599 0 C-N-CA 123.521 2.814 . . . . 0.0 118.638 170.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 162' ' ' LEU . . . . . . . . . . . . . 6.6 tp -68.28 -25.75 65.31 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 121.575 -0.703 . . . . 0.0 111.608 -173.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 163' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -87.66 -39.15 15.26 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 120.483 -1.385 . . . . 0.0 113.553 165.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -74.78 -53.26 9.5 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 115.802 1.778 . . . . 0.0 115.802 -169.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 5.4 mtpt -69.8 165.49 21.35 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 117.876 2.547 . . . . 0.0 117.876 -160.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -39.84 65.49 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 127.106 2.162 . . . . 0.0 113.109 174.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -102.86 -46.19 4.76 Favored 'General case' 0 CA--C 1.498 -1.047 0 O-C-N 120.25 -1.531 . . . . 0.0 109.887 -174.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 168' ' ' THR . . . . . . . . . . . . . 54.4 m -74.27 91.84 2.2 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 102.92 -2.993 . . . . 0.0 102.92 161.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -132.08 135.38 46.41 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 -164.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 170' ' ' MET . . . . . . . . . . . . . 75.7 mtm -74.1 102.28 4.18 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 113.397 -1.729 . . . . 0.0 108.399 169.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 171' ' ' LEU . . . . . . . . . . . . . 54.6 tp -100.01 129.29 46.05 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 -173.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -76.4 96.29 3.99 Favored 'General case' 0 C--O 1.248 0.976 0 CA-C-O 123.969 1.842 . . . . 0.0 112.839 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -156.88 134.65 4.1 Favored Glycine 0 CA--C 1.503 -0.671 0 N-CA-C 106.323 -2.711 . . . . 0.0 106.323 168.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 174' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -60.17 143.12 53.17 Favored 'General case' 0 C--O 1.217 -0.631 0 O-C-N 121.734 -0.863 . . . . 0.0 111.296 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.48 -31.16 72.09 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -173.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.42 -61.53 1.7 Allowed 'General case' 0 C--O 1.236 0.357 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 168.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 177' ' ' ALA . . . . . . . . . . . . . . . -49.35 -44.76 44.88 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 -164.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 3.3 m -65.2 -42.59 93.38 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.58 177.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 179' ' ' VAL . . . . . . . . . . . . . 45.8 t -68.19 -40.95 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 119.451 1.023 . . . . 0.0 108.705 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -61.04 -28.98 69.45 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 114.996 -1.002 . . . . 0.0 113.184 174.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -77.69 -51.55 10.41 Favored 'General case' 0 N--CA 1.445 -0.688 0 O-C-N 117.366 -3.334 . . . . 0.0 112.323 171.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 182' ' ' ILE . . . . . . . . . . . . . 29.1 pt -62.68 -27.01 42.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 117.791 -1.1 . . . . 0.0 110.748 -174.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 183' ' ' LEU . . . . . . . . . . . . . 3.5 pp -58.42 -27.8 64.66 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 120.555 1.525 . . . . 0.0 114.315 174.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -94.38 -51.05 4.96 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -68.13 -72.57 0.17 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -175.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 186' ' ' LEU . . . . . 0.538 ' C ' ' HZ3' ' C' ' 28' ' ' LYS 0.293 0.5 OUTLIER . . . . . 0 CA--C 1.538 0.517 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -158.68 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 57.9 t-80 . . . . . 0 N--CA 1.44 -0.946 0 N-CA-C 106.322 -1.733 . . . . 65.739999999999995 106.322 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -52.48 88.01 0.01 OUTLIER Glycine 0 CA--C 1.526 0.753 0 O-C-N 119.562 -1.961 . . . . 48.659999999999997 110.462 160.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -130.1 131.39 45.71 Favored 'General case' 0 N--CA 1.431 -1.403 1 N-CA-C 97.445 -5.02 . . . . 44.560000000000002 97.445 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1003 ' ' ILE . . . . . . . . . . . . . 42.2 mt -100.46 112.18 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 N-CA-C 105.266 -2.124 . . . . 34.859999999999999 105.266 176.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -77.73 132.06 11.6 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 112.646 -2.07 . . . . 30.75 110.259 169.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 28.0 mm -119.18 91.05 43.07 Favored Pre-proline 0 CA--C 1.508 -0.642 0 N-CA-C 103.857 -2.645 . . . . 32.210000000000001 103.857 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -71.82 164.21 36.4 Favored 'Trans proline' 0 C--O 1.245 0.862 0 C-N-CA 123.421 2.747 . . . . 32.979999999999997 111.856 172.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1007 ' ' ARG . . . . . . . . . . . . . 40.0 ttp85 -87.22 141.83 28.36 Favored 'General case' 0 C--O 1.267 1.998 0 N-CA-C 103.401 -2.814 . . . . 47.979999999999997 103.401 161.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1008 ' ' GLU . . . . . 0.464 ' CD ' ' HZ1' ' A' 1071 ' ' LYS 0.267 22.3 mm-40 -63.95 150.26 45.49 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 114.298 1.222 . . . . 34.700000000000003 114.298 177.342 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 24.4 mtp-105 -121.01 37.81 4.23 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 115.356 1.613 . . . . 53.369999999999997 115.356 -175.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 11.1 tp -96.63 179.18 5.08 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.144 -1.058 . . . . 45.07 108.144 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1011 ' ' THR . . . . . . . . . . . . . 10.3 m -63.2 140.1 58.84 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 107.419 -1.326 . . . . 40.359999999999999 107.419 171.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 60.4 m-80 63.17 33.89 13.98 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 122.924 1.345 . . . . 40.609999999999999 114.501 169.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -98.4 151.02 21.01 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 116.898 2.185 . . . . 33.759999999999998 116.898 -158.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1014 ' ' THR . . . . . . . . . . . . . 5.0 m -136.13 -16.2 1.67 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 118.301 -0.857 . . . . 27.890000000000001 112.541 -177.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1015 ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -70.01 150.68 46.39 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 117.081 2.252 . . . . 29.02 117.081 -173.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1016 ' ' VAL . . . . . . . . . . . . . 4.3 p -113.96 166.76 7.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 103.976 -2.602 . . . . 28.129999999999999 103.976 159.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1017 ' ' ALA . . . . . . . . . . . . . . . -67.51 -47.88 68.67 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.099 -1.041 . . . . 26.870000000000001 113.205 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -146.68 133.44 20.03 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 118.635 -2.54 . . . . 26.77 109.071 -176.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1019 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.51 172.87 6.29 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-O 117.3 -1.333 . . . . 27.02 110.652 -177.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1020 ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -25.45 -71.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.006 1 C-N-CA 127.496 5.464 . . . . 30.57 119.573 178.41 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 14.3 mptt -54.58 -44.0 72.62 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 120.371 1.441 . . . . 47.810000000000002 114.082 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1022 ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.8 -37.33 85.97 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 120.017 1.281 . . . . 30.77 112.217 175.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1023 ' ' VAL . . . . . . . . . . . . . 25.5 t -59.52 -46.5 92.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 119.015 0.825 . . . . 33.590000000000003 110.3 170.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -59.95 -34.22 72.96 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 113.562 0.949 . . . . 53.289999999999999 113.562 172.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -64.36 -38.47 91.16 Favored 'General case' 0 N--CA 1.441 -0.883 0 O-C-N 120.73 -1.231 . . . . 46.920000000000002 112.122 171.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1026 ' ' LEU . . . . . . . . . . . . . 14.5 mt -68.37 -34.84 76.79 Favored 'General case' 0 C--O 1.249 1.078 0 O-C-N 121.082 -1.011 . . . . 37.170000000000002 110.195 175.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 10.8 mp -59.29 -42.58 91.61 Favored 'General case' 0 C--O 1.246 0.876 0 O-C-N 121.062 -1.024 . . . . 44.439999999999998 111.349 169.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -49.61 -51.21 39.03 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 124.361 1.038 . . . . 52.579999999999998 111.811 169.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1029 ' ' LEU . . . . . . . . . . . . . 59.7 mt -65.9 -11.64 48.55 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 114.279 1.214 . . . . 45.689999999999998 114.279 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 90.12 28.24 18.41 Favored Glycine 0 C--O 1.25 1.148 0 O-C-N 121.223 -0.923 . . . . 42.090000000000003 112.646 174.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -119.34 127.63 53.35 Favored 'General case' 0 CA--C 1.488 -1.413 0 CA-C-O 117.854 -1.069 . . . . 40.719999999999999 108.255 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1032 ' ' THR . . . . . . . . . . . . . 97.4 m -67.27 135.53 53.51 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 108.683 -0.858 . . . . 37.770000000000003 108.683 176.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1033 ' ' VAL . . . . . . . . . . . . . 57.9 t -103.53 134.41 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 O-C-N 119.365 -2.084 . . . . 33.539999999999999 108.353 -172.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -121.68 105.26 10.25 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 105.907 -1.886 . . . . 31.68 105.907 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1035 ' ' VAL . . . . . . . . . . . . . 21.9 t -99.16 138.69 22.84 Favored 'Isoleucine or valine' 0 C--O 1.246 0.917 0 CA-C-N 114.944 -1.026 . . . . 31.52 108.737 -173.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1036 ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -57.76 130.88 48.43 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 123.867 1.794 . . . . 41.039999999999999 113.277 173.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1037 ' ' SER . . . . . . . . . . . . . 7.1 t -60.89 132.67 54.59 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 113.176 -1.829 . . . . 31.829999999999998 112.746 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 77.02 -4.92 52.43 Favored Glycine 0 CA--C 1.525 0.696 0 O-C-N 119.876 -1.765 . . . . 29.359999999999999 111.54 173.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -62.61 -40.14 96.03 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 119.04 -2.447 . . . . 27.780000000000001 113.667 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -62.52 -18.73 59.21 Favored Glycine 0 C--O 1.25 1.121 0 N-CA-C 114.652 0.621 . . . . 28.91 114.652 -177.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -62.38 -47.53 83.74 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.099 -1.236 . . . . 51.18 110.957 173.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1042 ' ' LEU . . . . . . . . . . . . . 36.2 mt -64.39 -57.59 8.89 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.969 0.89 . . . . 29.91 112.528 167.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1043 ' ' ALA . . . . . . . . . . . . . . . -60.38 -7.57 2.12 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 115.241 1.571 . . . . 28.539999999999999 115.241 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1044 ' ' SER . . . . . . . . . . . . . 62.9 m 69.81 31.47 3.48 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 125.393 1.477 . . . . 33.060000000000002 111.2 169.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1045 ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -157.95 107.06 2.06 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 102.44 -3.17 . . . . 30.289999999999999 102.44 169.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1046 ' ' ASP . . . . . 0.449 ' CG ' ' HZ1' ' A' 1048 ' ' LYS . 0.3 OUTLIER -79.74 174.22 11.81 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 117.372 2.36 . . . . 48.619999999999997 117.372 -148.094 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 28.9 t70 -47.7 -49.64 27.26 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 112.659 -2.064 . . . . 36.740000000000002 113.355 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1048 ' ' LYS . . . . . 0.449 ' HZ1' ' CG ' ' A' 1046 ' ' ASP . 24.8 pttm -75.27 -26.72 59.01 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 120.947 -1.096 . . . . 43.729999999999997 110.206 176.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -62.35 -29.98 70.84 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 118.162 -2.837 . . . . 32.810000000000002 110.874 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1050 ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -62.46 -41.13 98.54 Favored 'General case' 0 C--O 1.219 -0.536 0 O-C-N 121.72 -0.613 . . . . 31.859999999999999 111.345 171.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 25.6 t -66.26 -40.81 87.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 119.889 -0.724 . . . . 33.219999999999999 111.771 172.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -56.68 -40.85 76.27 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 122.243 1.021 . . . . 50.829999999999998 111.163 176.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -61.98 -50.38 72.33 Favored 'General case' 0 C--O 1.263 1.815 0 N-CA-C 113.596 0.961 . . . . 33.119999999999997 113.596 168.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 131.65 47.63 0.12 Allowed Glycine 0 N--CA 1.443 -0.886 0 CA-C-O 119.337 -0.702 . . . . 35.829999999999998 113.617 175.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -126.82 150.53 49.14 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 114.698 1.37 . . . . 34.82 114.698 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -73.51 125.64 28.4 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 105.732 -1.951 . . . . 49.049999999999997 105.732 174.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1057 ' ' ILE . . . . . . . . . . . . . 6.9 mm -89.52 125.46 42.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 106.203 -1.777 . . . . 38.530000000000001 106.203 173.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1058 ' ' VAL . . . . . . . . . . . . . 29.8 m -115.99 135.15 57.06 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 107.609 -1.256 . . . . 42.109999999999999 107.609 -177.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -75.74 79.13 2.69 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-O 122.696 1.236 . . . . 58.0 114.169 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 76.2 -123.77 7.01 Favored Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 107.739 -2.145 . . . . 52.119999999999997 107.739 171.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 39.7 t30 -47.92 -23.65 0.83 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 118.476 2.769 . . . . 54.75 118.476 -172.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1062 ' ' SER . . . . . . . . . . . . . 1.3 m -53.26 -24.38 11.29 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 116.212 1.93 . . . . 50.340000000000003 116.212 171.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 6.1 p -44.71 -35.24 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 116.423 2.008 . . . . 41.460000000000001 116.423 172.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1064 ' ' TRP . . . . . . . . . . . . . 46.0 m95 -73.25 -22.41 60.41 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-N 119.64 1.109 . . . . 39.32 111.941 -169.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -69.22 70.39 0.24 Allowed 'General case' 0 CA--C 1.547 0.859 0 O-C-N 119.414 -2.054 . . . . 55.380000000000003 110.676 172.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1066 ' ' SER . . . . . . . . . . . . . 72.3 m -160.17 123.17 3.44 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 101.457 -3.535 . . . . 41.869999999999997 101.457 -171.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -74.56 2.08 10.54 Favored 'General case' 0 CA--C 1.508 -0.646 0 O-C-N 120.924 -1.11 . . . . 53.200000000000003 112.285 -178.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 4.9 mp -130.19 129.11 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 104.05 -2.574 . . . . 41.899999999999999 104.05 167.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1069 ' ' ILE . . . . . . . . . . . . . 25.7 mm -125.58 120.57 58.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 104.972 -2.233 . . . . 38.729999999999997 104.972 171.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1070 ' ' LEU . . . . . . . . . . . . . 80.1 mt -101.75 133.95 45.68 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.061 -2.2 . . . . 32.439999999999998 105.061 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1071 ' ' LYS . . . . . 0.464 ' HZ1' ' CD ' ' A' 1008 ' ' GLU . 2.5 mmmp? -133.68 141.78 47.73 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.134 -1.432 . . . . 34.649999999999999 107.134 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1072 ' ' VAL . . . . . . . . . . . . . 2.4 t -92.16 -4.1 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.016 0 O-C-N 119.87 -1.769 . . . . 31.32 111.031 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -142.09 159.41 42.28 Favored 'General case' 0 C--O 1.256 1.396 0 N-CA-C 102.393 -3.188 . . . . 33.939999999999998 102.393 173.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -42.1 140.89 1.47 Allowed Pre-proline 0 C--O 1.239 0.515 0 C-N-CA 124.872 1.269 . . . . 38.039999999999999 113.25 171.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1075 ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -67.36 99.67 0.52 Allowed 'Trans proline' 0 CA--C 1.492 -1.589 0 C-N-CA 122.18 1.92 . . . . 42.68 107.595 165.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 38.9 mt -73.02 167.35 21.28 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 112.219 -2.264 . . . . 46.740000000000002 108.61 -173.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -43.15 -32.94 0.8 Allowed 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 120.46 3.504 . . . . 58.609999999999999 120.46 -175.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 16.0 t70 -75.09 -44.08 49.44 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 118.412 -0.804 . . . . 59.200000000000003 109.772 176.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1079 ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -59.73 -40.63 88.65 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 119.525 -0.87 . . . . 50.630000000000003 112.378 173.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1080 ' ' ILE . . . . . . . . . . . . . 74.5 mt -54.15 -49.56 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 O-C-N 124.443 1.09 . . . . 51.479999999999997 108.36 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -57.15 -33.82 67.79 Favored 'General case' 0 C--O 1.249 1.075 0 N-CA-C 112.864 0.69 . . . . 50.280000000000001 112.864 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 42.0 mt -87.4 -16.75 34.03 Favored 'General case' 0 C--N 1.334 -0.078 0 O-C-N 120.29 -1.506 . . . . 50.210000000000001 114.239 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1083 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.81 132.88 48.23 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 118.841 -2.412 . . . . 49.060000000000002 116.476 -162.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 31.7 t30 -76.86 123.77 87.48 Favored Pre-proline 0 N--CA 1.452 -0.339 0 CA-C-N 114.293 -1.321 . . . . 51.079999999999998 113.651 174.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -61.27 155.59 50.74 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 124.249 3.3 . . . . 49.729999999999997 115.939 173.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 68.45 66.16 2.4 Favored Glycine 0 C--O 1.215 -1.058 0 CA-C-O 124.63 2.239 . . . . 47.710000000000001 109.539 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1087 ' ' THR . . . . . . . . . . . . . 33.0 m -146.22 137.75 24.74 Favored 'General case' 0 C--O 1.252 1.23 0 O-C-N 119.631 -2.1 . . . . 45.469999999999999 107.519 -171.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1088 ' ' THR . . . . . . . . . . . . . 3.0 m -80.21 94.98 6.15 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 104.169 -2.53 . . . . 42.039999999999999 104.169 165.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1089 ' ' LEU . . . . . . . . . . . . . 27.7 tp -94.35 87.71 5.29 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 106.469 -1.678 . . . . 38.060000000000002 106.469 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 33.8 t -92.95 121.1 43.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 104.544 -2.391 . . . . 37.399999999999999 104.544 -176.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1091 ' ' SER . . . . . . . . . . . . . 26.7 m -153.37 151.83 30.38 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.857 -1.152 . . . . 36.159999999999997 112.673 -169.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 5.2 t80 -77.92 109.73 12.21 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 118.748 -2.47 . . . . 38.939999999999998 105.561 169.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 29.9 mm -90.56 -45.46 14.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 113.295 0.85 . . . . 42.170000000000002 113.295 -168.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 86.3 m95 54.61 66.36 4.21 Favored Pre-proline 0 C--O 1.245 0.827 0 O-C-N 124.485 1.115 . . . . 46.509999999999998 111.423 -157.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -52.0 -36.08 63.51 Favored 'Trans proline' 0 N--CA 1.449 -1.124 1 C-N-CA 125.801 4.334 . . . . 49.759999999999998 116.268 -175.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -72.35 -31.88 66.0 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-N 119.334 0.97 . . . . 52.619999999999997 108.84 -177.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 10.2 mp0 -77.95 -20.65 52.33 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 118.858 0.754 . . . . 60.740000000000002 112.243 172.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1098 ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -118.99 38.85 0.29 Allowed Pre-proline 0 N--CA 1.44 -0.958 0 N-CA-C 117.945 2.572 . . . . 58.189999999999998 117.945 -172.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -66.87 -24.59 46.24 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 124.569 3.513 . . . . 54.590000000000003 113.04 -168.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.99 -39.0 18.58 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 113.05 0.759 . . . . 63.280000000000001 113.05 175.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1101 ' ' LEU . . . . . . . . . . . . . 10.2 tt -54.97 -39.78 69.32 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 109.765 -0.458 . . . . 54.75 109.765 166.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1102 ' ' MET . . . . . . . . . . . . . 49.2 mmm -57.74 -45.05 86.36 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.677 -1.264 . . . . 52.649999999999999 114.156 175.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -54.78 -43.35 72.75 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 112.536 0.569 . . . . 66.260000000000005 112.536 174.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 82.5 mttt -71.09 -41.67 70.32 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.435 0.636 . . . . 63.729999999999997 112.102 -175.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 71.8 mt -68.53 -32.38 72.29 Favored 'General case' 0 C--O 1.241 0.618 0 O-C-N 120.572 -1.33 . . . . 54.68 112.874 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -57.72 -51.52 69.2 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 120.455 1.479 . . . . 53.640000000000001 108.203 167.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -57.08 -25.68 59.14 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 122.14 2.246 . . . . 67.239999999999995 115.001 169.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -80.01 -3.85 50.15 Favored 'General case' 0 C--N 1.361 1.085 0 CA-C-N 121.177 1.808 . . . . 65.760000000000005 111.191 171.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 24.9 t-20 62.7 47.67 4.62 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 122.744 1.259 . . . . 58.710000000000001 109.578 168.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1110 ' ' VAL . . . . . . . . . . . . . 17.3 m -118.06 145.71 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 O-C-N 121.558 -0.714 . . . . 46.630000000000003 111.607 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1111 ' ' THR . . . . . . . . . . . . . 49.2 m -83.62 94.63 8.14 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-O 123.156 1.455 . . . . 44.130000000000003 107.681 174.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1112 ' ' VAL . . . . . . . . . . . . . 82.8 t -89.94 118.93 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.008 0 CA-C-N 113.624 -1.625 . . . . 40.439999999999998 109.414 -174.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1113 ' ' MET . . . . . . . . . . . . . 63.6 mtp -109.75 108.59 19.0 Favored 'General case' 0 C--O 1.252 1.229 0 N-CA-C 107.547 -1.279 . . . . 50.759999999999998 107.547 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1114 ' ' ALA . . . . . . . . . . . . . . . -85.12 108.42 17.67 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-O 123.736 1.731 . . . . 35.640000000000001 110.653 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1115 ' ' MET . . . . . . . . . . . . . 61.8 mmm -69.39 -14.35 62.86 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 112.049 -2.342 . . . . 38.740000000000002 115.467 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 3.6 p30 -71.14 -36.25 72.01 Favored 'General case' 0 C--N 1.352 0.674 0 CA-C-N 120.189 1.359 . . . . 40.140000000000001 111.122 162.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1117 ' ' SER . . . . . . . . . . . . . 49.2 m -80.97 23.33 0.56 Allowed 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 125.121 1.513 . . . . 44.789999999999999 114.551 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1118 ' ' VAL . . . . . . . . . . . . . 16.5 t -70.3 131.41 88.55 Favored Pre-proline 0 N--CA 1.445 -0.681 0 N-CA-C 104.576 -2.379 . . . . 43.75 104.576 166.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -58.36 146.25 90.48 Favored 'Trans proline' 0 C--O 1.252 1.216 0 C-N-CA 122.63 2.22 . . . . 48.93 113.556 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -66.6 -10.31 44.41 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 120.691 -1.255 . . . . 62.899999999999999 113.0 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 50.0 pt -62.19 152.19 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 N-CA-C 114.003 1.112 . . . . 57.719999999999999 114.003 -177.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1122 ' ' SER . . . . . . . . . . . . . 6.5 m -48.52 -52.63 21.61 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 118.304 2.705 . . . . 57.259999999999998 118.304 -177.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -56.64 -22.62 35.69 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 118.386 -2.696 . . . . 62.899999999999999 113.423 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -90.04 -21.52 22.31 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 117.025 -1.464 . . . . 49.829999999999998 111.773 -172.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -61.67 -26.73 68.2 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 116.444 2.016 . . . . 52.369999999999997 116.444 -163.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1126 ' ' SER . . . . . . . . . . . . . 5.8 p -66.83 -37.77 85.13 Favored 'General case' 0 C--O 1.245 0.821 0 O-C-N 119.058 -2.276 . . . . 42.43 111.999 170.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1127 ' ' LEU . . . . . . . . . . . . . 3.5 mp -77.23 -31.16 54.94 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 122.95 1.357 . . . . 43.740000000000002 110.739 176.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 6.1 t70 -53.82 109.78 0.5 Allowed 'General case' 0 C--O 1.252 1.227 0 CA-C-O 123.965 1.84 . . . . 43.210000000000001 113.649 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -80.06 -31.65 39.39 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 111.62 -2.536 . . . . 35.740000000000002 112.687 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 36.0 tp -54.45 -51.64 64.35 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.775 0.716 . . . . 38.090000000000003 110.538 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1131 ' ' SER . . . . . . . . . . . . . 7.3 m -50.47 -49.26 55.69 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.715 1.206 . . . . 36.909999999999997 111.347 174.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1132 ' ' SER . . . . . . . . . . . . . 1.4 m -73.28 -42.29 62.61 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 115.676 -0.693 . . . . 35.789999999999999 111.123 -171.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1133 ' ' MET . . . . . . . . . . . . . 28.6 mtp -63.2 -43.09 99.15 Favored 'General case' 0 N--CA 1.433 -1.308 0 O-C-N 120.479 -1.388 . . . . 30.809999999999999 110.564 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1134 ' ' ALA . . . . . . . . . . . . . . . -52.09 -47.17 65.38 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 122.99 1.376 . . . . 28.879999999999999 112.903 168.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1135 ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -59.01 -48.21 82.4 Favored 'General case' 0 C--N 1.347 0.463 0 O-C-N 120.832 -1.168 . . . . 40.759999999999998 112.18 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1136 ' ' ILE . . . . . . . . . . . . . 61.3 mt -59.18 -46.48 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 108.782 -0.821 . . . . 31.539999999999999 108.782 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -61.39 -30.46 70.56 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 115.905 -1.998 . . . . 29.870000000000001 112.771 175.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -75.14 -39.8 36.18 Favored Glycine 0 CA--C 1.499 -0.932 0 CA-C-N 121.472 1.942 . . . . 28.73 109.814 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 25.5 t80 -65.62 -45.68 82.18 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.21 -1.033 . . . . 30.390000000000001 108.21 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1140 ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -69.19 -24.82 64.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.906 0.86 . . . . 26.09 112.536 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1141 ' ' ALA . . . . . . . . . . . . . . . -62.13 -45.14 94.77 Favored 'General case' 0 C--O 1.245 0.858 0 O-C-N 120.353 -1.467 . . . . 27.100000000000001 109.409 168.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 46.7 mm -58.52 -44.48 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 120.444 1.475 . . . . 28.48 114.538 172.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 28.8 t -53.1 -59.62 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 114.72 -1.127 . . . . 23.07 111.266 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1144 ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -75.27 -23.9 57.51 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.982 -0.377 . . . . 33.399999999999999 109.982 -171.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -62.12 -51.55 67.44 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.334 -0.987 . . . . 24.219999999999999 108.334 171.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -64.07 -28.06 69.53 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 123.8 0.84 . . . . 24.890000000000001 112.348 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -65.51 -40.28 92.82 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 118.763 -0.637 . . . . 26.73 110.832 171.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1148 ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -101.68 5.78 41.6 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 119.009 -2.307 . . . . 39.960000000000001 113.043 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1149 ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -76.15 144.9 40.29 Favored 'General case' 0 CA--C 1.514 -0.427 0 O-C-N 120.067 -1.645 . . . . 25.870000000000001 112.816 -169.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1150 ' ' GLY . . . . . . . . . . . . . . . -71.21 -48.97 28.8 Favored Glycine 0 C--O 1.218 -0.9 0 N-CA-C 109.799 -1.32 . . . . 19.280000000000001 109.799 172.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1151 ' ' ARG . . . . . . . . . . . . . 74.2 mtm-85 -99.57 -172.17 2.2 Favored 'General case' 0 C--N 1.318 -0.795 0 O-C-N 120.906 -1.35 . . . . 39.899999999999999 114.071 -172.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1152 ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -96.51 144.69 26.36 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 103.856 -2.646 . . . . 29.440000000000001 103.856 177.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1153 ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -64.21 -57.19 10.2 Favored 'General case' 0 C--N 1.341 0.224 0 O-C-N 121.211 -0.931 . . . . 32.600000000000001 110.039 168.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1154 ' ' THR . . . . . . . . . . . . . 90.8 m -61.8 123.95 19.41 Favored 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 126.431 1.893 . . . . 34.640000000000001 116.015 -177.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -71.78 73.43 0.81 Allowed Glycine 0 N--CA 1.439 -1.158 0 CA-C-O 126.052 3.029 . . . . 37.140000000000001 111.259 175.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -108.93 136.2 48.86 Favored 'General case' 0 N--CA 1.434 -1.232 0 O-C-N 118.588 -2.713 . . . . 40.57 115.876 -177.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1157 ' ' ILE . . . . . . . . . . . . . 4.5 tp -90.87 110.2 21.97 Favored 'Isoleucine or valine' 0 C--O 1.256 1.431 0 CA-C-N 113.361 -1.745 . . . . 44.609999999999999 106.673 171.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1158 ' ' THR . . . . . . . . . . . . . 17.5 m -78.15 177.11 8.62 Favored 'General case' 0 C--O 1.252 1.202 0 O-C-N 120.87 -1.144 . . . . 40.700000000000003 110.563 169.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -65.09 -23.24 67.1 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 116.97 -3.581 . . . . 40.25 111.171 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -134.35 131.01 37.8 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 104.828 -2.286 . . . . 38.469999999999999 104.828 159.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . 111.93 115.05 3.42 Favored Glycine 0 C--O 1.247 0.93 0 C-N-CA 119.572 -1.299 . . . . 37.609999999999999 112.095 170.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 15.8 tttp -85.7 130.87 34.45 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 104.456 -2.424 . . . . 48.899999999999999 104.456 169.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1163 ' ' VAL . . . . . . . . . . . . . 69.7 t -85.98 128.19 59.09 Favored Pre-proline 0 N--CA 1.42 -1.933 0 O-C-N 120.01 -1.681 . . . . 36.520000000000003 107.896 164.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1164 ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -72.26 108.23 2.44 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.516 2.144 . . . . 35.079999999999998 108.904 155.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1165 ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -56.34 148.25 62.67 Favored 'Trans proline' 0 N--CA 1.444 -1.394 1 C-N-CA 126.314 4.676 . . . . 35.329999999999998 115.289 -176.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -66.12 129.02 38.39 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 125.159 1.537 . . . . 34.689999999999998 110.962 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1167 ' ' LYS . . . . . . . . . . . . . 64.4 mttp -92.41 106.99 18.88 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 105.17 -2.159 . . . . 45.359999999999999 105.17 172.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 60.6 t -91.58 91.57 3.57 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 106.967 -1.494 . . . . 31.710000000000001 106.967 -175.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1169 ' ' MET . . . . . . . . . . . . . 25.1 ttp -79.29 92.11 5.1 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 124.593 2.14 . . . . 42.280000000000001 108.717 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 13.8 t -75.29 115.14 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 112.128 -2.305 . . . . 30.510000000000002 106.629 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 64.5 mt -104.07 123.59 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 104.528 -2.397 . . . . 31.870000000000001 104.528 176.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 79.32 79.25 0.83 Allowed Glycine 0 CA--C 1.493 -1.332 0 CA-C-O 123.796 1.776 . . . . 34.539999999999999 109.81 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1173 ' ' ALA . . . . . . . . . . . . . . . -75.7 179.86 5.15 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 123.417 1.58 . . . . 32.509999999999998 109.669 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . 138.92 -157.69 24.89 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 106.182 -2.767 . . . . 29.899999999999999 106.182 -175.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1175 ' ' VAL . . . . . . . . . . . . . 34.3 t -70.49 -30.06 41.19 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 CA-C-N 122.188 2.994 . . . . 33.109999999999999 110.66 -170.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -65.35 -41.73 93.57 Favored 'General case' 0 C--N 1.348 0.517 0 CA-C-O 122.343 1.068 . . . . 28.100000000000001 108.832 171.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -60.67 -42.45 99.32 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 124.478 2.154 . . . . 28.539999999999999 109.997 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1178 ' ' LEU . . . . . . . . . . . . . 72.8 mt -67.83 -35.69 79.05 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 113.403 -1.399 . . . . 31.219999999999999 111.052 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -64.99 -44.59 88.79 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-N 122.832 2.56 . . . . 28.98 108.822 175.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -55.25 -45.46 76.08 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 126.317 2.26 . . . . 27.829999999999998 113.085 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1181 ' ' ILE . . . . . . . . . . . . . 33.5 mt -63.62 -54.28 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 O-C-N 120.237 -1.54 . . . . 30.25 108.819 175.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -52.29 -26.02 20.52 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 112.668 -2.06 . . . . 29.59 112.761 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -85.24 -60.25 2.09 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 115.323 1.601 . . . . 30.289999999999999 115.323 165.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -74.8 -39.73 61.52 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 115.386 1.624 . . . . 30.469999999999999 115.386 -167.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -60.22 -43.49 95.96 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 119.759 -1.838 . . . . 42.409999999999997 109.685 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1186 ' ' SER . . . . . . . . . . . . . 21.4 m -58.39 -46.11 87.03 Favored 'General case' 0 C--O 1.213 -0.827 0 CA-C-O 121.957 0.885 . . . . 39.380000000000003 111.078 175.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 44.0 mt -62.47 -30.44 71.26 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 114.909 1.448 . . . . 36.18 114.909 174.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 103.36 42.38 2.04 Favored Glycine 0 N--CA 1.428 -1.879 0 CA-C-N 114.839 -1.073 . . . . 33.780000000000001 111.015 176.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -115.9 144.2 44.38 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 106.915 -1.513 . . . . 33.93 106.915 174.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 45.7 mt -72.07 102.63 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 O-C-N 120.226 -1.546 . . . . 38.740000000000002 110.375 -174.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 17.0 t -86.84 121.27 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 O-C-N 119.817 -1.802 . . . . 33.090000000000003 106.854 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1192 ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -115.68 105.33 12.63 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 105.321 -2.103 . . . . 38.920000000000002 105.321 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -102.73 124.67 48.69 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 118.928 -1.109 . . . . 35.32 110.482 -176.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 69.7 t80 -110.59 140.74 44.63 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 122.133 0.968 . . . . 39.350000000000001 109.419 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 7.1 t0 -157.52 150.12 22.95 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.182 -1.044 . . . . 40.460000000000001 108.182 174.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1196 ' ' THR . . . . . . . . . . . . . 8.7 m -58.31 -38.98 78.16 Favored 'General case' 0 N--CA 1.445 -0.698 0 O-C-N 128.391 3.557 . . . . 45.939999999999998 109.493 171.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1197 ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -87.73 110.92 38.6 Favored Pre-proline 0 C--N 1.318 -0.776 0 C-N-CA 126.67 1.988 . . . . 56.020000000000003 109.777 -172.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1198 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -66.32 -13.32 39.38 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 121.457 1.438 . . . . 51.270000000000003 112.072 166.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -52.8 -30.49 33.54 Favored 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 118.66 -2.525 . . . . 59.100000000000001 115.1 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 35.6 m -93.92 -9.84 9.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 114.235 1.198 . . . . 51.060000000000002 114.235 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 86.4 tttt -52.17 -61.52 2.21 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 114.991 1.478 . . . . 57.380000000000003 114.991 -174.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 23.7 mp0 -69.37 -22.27 63.74 Favored 'General case' 0 C--O 1.211 -0.955 0 CA-C-N 119.934 1.243 . . . . 62.409999999999997 112.567 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -63.84 -50.79 67.51 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 113.174 0.805 . . . . 57.780000000000001 113.174 170.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 47.4 t -58.98 -41.01 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 113.751 -1.568 . . . . 46.380000000000003 110.634 173.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -68.19 -29.37 68.21 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 115.401 1.63 . . . . 50.700000000000003 115.401 173.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1206 ' ' SER . . . . . . . . . . . . . 64.0 m -74.59 -31.37 62.01 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 121.062 -1.024 . . . . 49.979999999999997 110.872 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1207 ' ' MET . . . . . . . . . . . . . 36.8 mtp -79.68 -15.2 58.0 Favored 'General case' 0 C--O 1.249 1.045 0 O-C-N 120.745 -1.222 . . . . 52.990000000000002 113.469 170.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 97.53 83.83 1.72 Allowed Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 109.009 -1.636 . . . . 47.659999999999997 109.009 173.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -161.27 145.82 13.49 Favored 'General case' 0 C--N 1.289 -2.03 0 O-C-N 119.093 -2.416 . . . . 44.770000000000003 107.311 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -76.76 123.04 25.59 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 103.74 -2.689 . . . . 47.640000000000001 103.74 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1211 ' ' PHE . . . . . . . . . . . . . 11.9 t80 -89.01 136.52 32.97 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 106.606 -1.627 . . . . 45.659999999999997 106.606 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 68.4 mt -94.51 119.22 32.87 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 107.521 -1.288 . . . . 46.060000000000002 107.521 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -71.76 144.25 49.28 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 112.79 -2.004 . . . . 60.219999999999999 111.875 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 17.2 tp -73.66 89.13 1.74 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 109.504 -3.498 . . . . 57.25 112.421 -171.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 23.6 t0 -71.53 87.09 0.89 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 114.086 1.143 . . . . 64.430000000000007 114.086 -174.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 85.4 t80 . . . . . 0 C--O 1.202 -1.413 0 O-C-N 124.794 1.309 . . . . 66.900000000000006 107.814 -170.507 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 30.9 t70 . . . . . 0 N--CA 1.447 -0.578 0 N-CA-C 107.071 -1.455 . . . . 39.090000000000003 107.071 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -67.34 -41.87 90.75 Favored Glycine 0 C--N 1.347 1.17 0 CA-C-N 114.484 -1.235 . . . . 39.32 111.598 -173.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 51.0 t80 -73.4 -42.09 62.53 Favored 'General case' 0 CA--C 1.504 -0.788 0 CA-C-O 118.151 -0.928 . . . . 39.299999999999997 108.696 -177.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -62.04 -38.51 89.01 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-N 119.539 1.063 . . . . 36.299999999999997 109.226 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -57.11 -45.94 83.02 Favored 'General case' 0 C--O 1.207 -1.159 0 CA-C-O 117.903 -1.046 . . . . 37.380000000000003 111.241 172.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -53.79 -31.12 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 113.15 0.796 . . . . 39.109999999999999 113.15 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1230 ' ' MET . . . . . . . . . . . . . 38.1 mmt -81.36 -23.97 37.37 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 116.394 1.998 . . . . 49.590000000000003 116.394 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1231 ' ' SER . . . . . . . . . . . . . 54.0 p -67.77 133.69 49.68 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.194 0.812 . . . . 43.68 113.194 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -50.23 -40.52 47.82 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 116.282 1.956 . . . . 55.57 116.282 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -64.72 -33.12 75.21 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 122.16 0.981 . . . . 44.939999999999998 110.271 178.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 26.0 t80 -76.16 -46.48 28.37 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.365 -0.834 . . . . 42.039999999999999 109.041 -178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 12.2 mt -59.26 -31.43 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 122.344 -0.222 . . . . 46.280000000000001 111.377 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 53.3 tttm -62.48 -48.46 79.51 Favored 'General case' 0 C--O 1.245 0.867 0 O-C-N 119.531 -1.981 . . . . 47.869999999999997 109.0 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -58.83 -51.68 68.98 Favored 'General case' 0 C--O 1.247 0.931 0 N-CA-C 113.859 1.059 . . . . 41.609999999999999 113.859 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -54.79 -53.67 52.16 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 114.615 -1.175 . . . . 50.649999999999999 109.629 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1239 ' ' MET . . . . . . . . . . . . . 43.1 ttm -57.95 -41.36 82.66 Favored 'General case' 0 C--O 1.22 -0.484 0 O-C-N 123.694 0.621 . . . . 48.869999999999997 110.582 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -76.48 -22.5 54.44 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 120.119 -1.613 . . . . 54.799999999999997 111.725 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 1.3 tm? -66.9 -47.35 72.08 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.512 -1.662 . . . . 43.210000000000001 106.512 169.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -60.05 -36.51 77.47 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-O 118.701 -0.666 . . . . 38.659999999999997 110.283 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -67.19 -47.96 69.37 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 121.003 1.729 . . . . 37.920000000000002 111.353 -177.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -56.97 -55.19 37.88 Favored 'General case' 0 C--O 1.249 1.047 0 O-C-N 121.357 -0.839 . . . . 37.280000000000001 110.769 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -55.95 -36.33 67.66 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.743 1.217 . . . . 43.07 113.943 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -56.46 -30.4 62.85 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.996 1.11 . . . . 38.299999999999997 113.996 -176.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1247 ' ' LYS . . . . . . . . . . . . . 16.4 mtmt -78.89 -10.63 59.87 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 114.94 1.459 . . . . 47.600000000000001 114.94 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -121.18 -16.53 7.95 Favored 'General case' 0 C--O 1.246 0.899 0 O-C-N 119.0 -2.313 . . . . 45.420000000000002 114.858 173.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1249 ' ' VAL . . . . . . . . . . . . . 27.7 m -85.33 175.21 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 O-C-N 119.199 -2.188 . . . . 36.259999999999998 111.193 -175.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1250 ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -134.27 -61.83 0.77 Allowed 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 112.818 -1.992 . . . . 33.039999999999999 109.371 -169.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1251 ' ' ILE . . . . . . . . . . . . . 39.3 mm -108.61 94.99 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 107.002 -1.481 . . . . 31.399999999999999 107.002 -173.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1252 ' ' ILE . . . . . . . . . . . . . 44.2 mt -77.7 107.65 9.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 106.13 -1.804 . . . . 29.420000000000002 106.13 171.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 5.5 t -99.28 105.19 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 104.635 -2.357 . . . . 30.370000000000001 104.635 173.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1254 ' ' THR . . . . . . . . . . . . . 29.1 m -74.37 84.58 1.95 Allowed 'General case' 0 C--O 1.248 1.004 0 CA-C-O 122.732 1.253 . . . . 35.719999999999999 109.561 171.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1255 ' ' THR . . . . . . . . . . . . . 1.1 p -75.89 -4.28 39.98 Favored 'General case' 0 C--O 1.25 1.093 0 N-CA-C 115.067 1.506 . . . . 36.0 115.067 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1256 ' ' ALA . . . . . . . . . . . . . . . -69.34 86.94 0.43 Allowed 'General case' 0 C--O 1.246 0.878 0 CA-C-O 121.65 0.738 . . . . 40.93 109.41 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 8.8 tp -73.13 91.96 1.67 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 105.653 -1.98 . . . . 47.82 105.653 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 41.8 mm -69.49 131.46 89.96 Favored Pre-proline 0 C--O 1.213 -0.865 0 CA-C-N 112.838 -1.983 . . . . 52.700000000000003 109.048 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -99.41 124.74 0.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.816 2.344 . . . . 54.130000000000003 114.387 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 78.2 -83.63 1.19 Allowed Glycine 0 C--N 1.343 0.962 0 CA-C-O 124.698 2.277 . . . . 54.619999999999997 114.786 173.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 55.2 pttt -42.84 146.91 0.7 Allowed Pre-proline 0 C--O 1.257 1.474 0 N-CA-C 117.711 2.486 . . . . 55.740000000000002 117.711 171.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -57.22 142.65 94.63 Favored 'Trans proline' 0 N--CA 1.451 -0.999 1 C-N-CA 125.336 4.024 . . . . 51.149999999999999 112.579 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -66.93 123.51 86.32 Favored Pre-proline 0 C--N 1.343 0.307 0 CA-C-N 113.446 -1.706 . . . . 46.060000000000002 111.169 174.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -58.43 115.58 2.64 Favored 'Trans proline' 0 CA--C 1.509 -0.743 0 C-N-CA 123.792 2.995 . . . . 41.079999999999998 115.769 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -75.6 89.58 2.76 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 122.495 1.141 . . . . 47.420000000000002 108.83 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 37.7 mt -97.67 -45.87 6.21 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.243 -1.391 . . . . 39.219999999999999 107.243 -177.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 7.9 mt -87.37 93.99 4.35 Favored 'Isoleucine or valine' 0 C--O 1.252 1.224 0 CA-C-O 126.19 2.9 . . . . 42.5 107.739 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1268 ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.75 143.68 30.01 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 111.97 -2.377 . . . . 37.840000000000003 112.383 175.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 56.3 mtt-85 -47.51 -39.18 15.54 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.072 0.949 . . . . 54.799999999999997 112.199 175.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -56.72 -50.09 73.24 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.388 -1.445 . . . . 54.359999999999999 109.154 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1271 ' ' MET . . . . . . . . . . . . . 10.0 mtt -68.78 -25.36 64.67 Favored 'General case' 0 CA--C 1.497 -1.09 0 O-C-N 123.789 0.68 . . . . 39.520000000000003 111.189 -170.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1272 ' ' VAL . . . . . . . . . . . . . 59.1 t -66.56 -49.62 73.5 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 O-C-N 126.179 2.174 . . . . 38.25 110.473 175.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -68.58 -26.43 65.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 119.985 -1.697 . . . . 40.770000000000003 112.445 174.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1274 ' ' SER . . . . . . . . . . . . . 7.2 m -68.76 -11.84 60.79 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 120.527 1.512 . . . . 36.579999999999998 114.442 169.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1275 ' ' MET . . . . . . . . . . . . . 62.7 mtp -62.52 145.69 53.63 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-O 124.478 2.085 . . . . 36.75 111.005 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1276 ' ' LYS . . . . . . . . . . . . . 74.1 tttt -50.64 137.38 19.88 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 110.967 -2.833 . . . . 46.109999999999999 106.468 165.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1277 ' ' ALA . . . . . . . . . . . . . . . -90.94 176.85 6.46 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 117.9 -1.52 . . . . 33.520000000000003 110.472 -169.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 63.42 31.01 79.31 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 111.404 -0.679 . . . . 31.27 111.404 -170.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1279 ' ' SER . . . . . . . . . . . . . 15.2 m -122.32 171.93 8.68 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 120.587 -1.537 . . . . 32.950000000000003 110.528 -171.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1280 ' ' VAL . . . . . . . . . . . . . 41.7 t -134.45 136.27 53.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 O-C-N 120.822 -1.174 . . . . 27.43 110.425 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1281 ' ' ILE . . . . . . . . . . . . . 66.0 mt -113.37 109.02 27.01 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 N-CA-C 103.122 -2.918 . . . . 30.300000000000001 103.122 170.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 2.4 t -101.15 97.86 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 105.104 -2.184 . . . . 28.629999999999999 105.104 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 9.4 t70 -95.63 101.18 12.86 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 113.568 -1.651 . . . . 36.270000000000003 107.155 -171.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1284 ' ' LEU . . . . . . . . . . . . . 31.2 mt -64.38 -37.69 88.41 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 119.608 -0.837 . . . . 38.57 110.688 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -59.23 -1.86 0.23 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 116.523 2.046 . . . . 37.560000000000002 116.523 173.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . -36.7 -42.52 0.37 Allowed 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 116.687 2.106 . . . . 40.329999999999998 116.687 161.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -51.33 -28.19 11.61 Favored 'General case' 0 C--N 1.348 0.534 0 N-CA-C 115.714 1.746 . . . . 56.850000000000001 115.714 174.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 11.4 m120 -113.97 22.88 13.49 Favored 'General case' 0 N--CA 1.433 -1.281 0 O-C-N 121.4 -0.813 . . . . 45.859999999999999 108.866 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 109.68 -23.11 22.75 Favored Glycine 0 N--CA 1.43 -1.731 0 O-C-N 118.196 -2.815 . . . . 40.310000000000002 114.338 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 87.62 127.92 2.63 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 120.853 2.327 . . . . 38.890000000000001 112.2 -177.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1291 ' ' ASN . . . . . . . . . . . . . 2.8 m120 -71.27 -26.22 62.79 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 113.345 -1.427 . . . . 37.229999999999997 113.804 175.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1292 ' ' CYS . . . . . . . . . . . . . 1.6 t -82.51 138.86 34.19 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.757 -1.11 . . . . 36.5 108.951 165.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1293 ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -68.8 -6.56 27.52 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 115.371 1.619 . . . . 43.32 115.371 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -102.81 -2.09 28.59 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 119.688 -1.883 . . . . 41.32 112.706 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1295 ' ' THR . . . . . . . . . . . . . 31.5 m -78.04 103.13 7.79 Favored 'General case' 0 C--N 1.355 0.832 0 O-C-N 120.845 -1.16 . . . . 35.299999999999997 112.827 -168.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 47.8 t -82.6 121.59 78.1 Favored Pre-proline 0 C--N 1.31 -1.131 0 O-C-N 125.292 1.62 . . . . 34.840000000000003 107.4 174.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -63.51 143.46 88.0 Favored 'Trans proline' 0 C--O 1.25 1.118 0 C-N-CA 122.984 2.456 . . . . 33.509999999999998 108.884 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 69.69 13.56 68.87 Favored Glycine 0 CA--C 1.544 1.9 0 CA-C-O 116.682 -2.177 . . . . 32.189999999999998 115.425 -175.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -147.37 169.98 18.32 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-N 123.988 3.894 . . . . 34.880000000000003 112.823 -172.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1300 ' ' ILE . . . . . . . . . . . . . 74.3 mt -107.92 141.44 23.16 Favored 'Isoleucine or valine' 0 C--O 1.248 0.992 0 N-CA-C 106.555 -1.646 . . . . 32.289999999999999 106.555 166.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 78.8 t80 -119.74 114.28 21.92 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 104.194 -2.521 . . . . 37.25 104.194 164.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1302 ' ' THR . . . . . . . . . . . . . 46.0 m -93.66 118.9 31.99 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 103.614 -2.735 . . . . 35.560000000000002 103.614 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1303 ' ' THR . . . . . . . . . . . . . 8.5 p -70.74 170.92 11.41 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 113.525 -1.671 . . . . 36.399999999999999 114.284 -171.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -75.23 -9.65 58.75 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 113.963 1.097 . . . . 52.32 113.963 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 37.3 p-10 -83.84 -46.14 12.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.363 0.601 . . . . 40.039999999999999 111.356 166.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 127.45 52.0 0.14 Allowed Glycine 0 N--CA 1.427 -1.903 0 CA-C-N 114.466 -1.243 . . . . 36.960000000000001 112.808 -177.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1307 ' ' VAL . . . . . . . . . . . . . 82.0 t -118.77 124.02 72.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 N-CA-C 104.943 -2.243 . . . . 33.399999999999999 104.943 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1308 ' ' LYS . . . . . . . . . . . . . 53.7 mmtt -80.21 95.11 6.18 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 106.116 -1.809 . . . . 42.909999999999997 106.116 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 38.4 t -84.22 92.68 3.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 106.357 -1.72 . . . . 32.289999999999999 106.357 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1310 ' ' ILE . . . . . . . . . . . . . 82.6 mt -82.44 103.41 9.62 Favored 'Isoleucine or valine' 0 C--N 1.351 0.642 0 CA-C-N 112.782 -2.008 . . . . 30.989999999999998 109.166 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -103.21 60.69 0.48 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 108.936 -1.666 . . . . 28.949999999999999 108.936 168.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1312 ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -83.25 95.73 8.24 Favored 'General case' 0 C--O 1.252 1.189 0 CA-C-O 125.278 2.466 . . . . 31.690000000000001 111.483 177.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1313 ' ' THR . . . . . . . . . . . . . 2.8 m -51.91 -37.92 54.35 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 112.46 -2.155 . . . . 34.170000000000002 111.567 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -84.77 10.38 11.58 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 113.381 -1.736 . . . . 36.859999999999999 111.679 -169.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1315 ' ' LEU . . . . . . . . . . . . . 96.9 mt -44.05 -44.36 17.0 Favored Pre-proline 0 N--CA 1.474 0.743 0 N-CA-C 119.356 3.095 . . . . 34.850000000000001 119.356 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -53.6 -33.46 68.88 Favored 'Trans proline' 0 C--O 1.258 1.518 0 C-N-CA 124.53 3.486 . . . . 29.149999999999999 115.025 170.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -76.32 -40.66 28.02 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 109.496 -1.442 . . . . 27.289999999999999 109.496 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1318 ' ' ARG . . . . . . . . . . . . . 58.1 mtt-85 -58.05 -26.62 62.73 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 115.641 1.719 . . . . 41.490000000000002 115.641 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1319 ' ' LEU . . . . . . . . . . . . . 13.1 tp -103.97 71.88 0.17 Allowed Pre-proline 0 C--O 1.238 0.486 0 O-C-N 119.587 -1.946 . . . . 27.609999999999999 109.141 168.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1320 ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -58.12 -54.87 2.67 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.854 3.036 . . . . 25.940000000000001 113.985 -166.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1321 ' ' THR . . . . . . . . . . . . . 4.3 m -63.7 -43.53 96.35 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.937 0.895 . . . . 25.010000000000002 109.621 -171.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1322 ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -67.56 -26.76 66.46 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 117.451 -1.261 . . . . 29.390000000000001 112.803 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1323 ' ' SER . . . . . . . . . . . . . 36.9 m -66.81 -51.29 57.34 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 120.346 1.43 . . . . 26.469999999999999 111.131 162.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1324 ' ' SER . . . . . . . . . . . . . 4.3 m -63.39 -17.83 63.04 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 116.296 1.962 . . . . 27.780000000000001 116.296 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -104.44 -54.87 2.45 Favored 'General case' 0 C--O 1.247 0.937 0 CA-C-N 114.787 -1.097 . . . . 37.530000000000001 110.811 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1326 ' ' LEU . . . . . . . . . . . . . 33.6 mt -69.3 -59.5 2.96 Favored 'General case' 0 CA--C 1.505 -0.761 0 O-C-N 118.015 -2.928 . . . . 35.710000000000001 112.274 175.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1327 ' ' TYR . . . . . . . . . . . . . 31.3 t80 -57.16 -37.5 72.18 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-O 122.31 1.052 . . . . 31.59 108.218 177.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1328 ' ' GLY . . . . . . . . . . . . . . . -46.77 -58.4 6.13 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.95 1.262 . . . . 28.0 113.226 168.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1329 ' ' THR . . . . . . . . . . . . . 17.3 m -70.14 -25.45 63.47 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.371 1.586 . . . . 32.149999999999999 110.619 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1330 ' ' ASN . . . . . . . . . . . . . 26.4 m120 -59.3 -49.97 75.79 Favored 'General case' 0 C--O 1.244 0.792 0 O-C-N 119.807 -1.808 . . . . 34.359999999999999 111.361 168.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1331 ' ' LEU . . . . . . . . . . . . . 13.2 mt -55.55 -48.96 73.91 Favored 'General case' 0 C--N 1.357 0.907 0 O-C-N 127.226 2.829 . . . . 33.369999999999997 108.747 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1332 ' ' VAL . . . . . . . . . . . . . 44.1 t -56.9 -42.66 78.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 O-C-N 124.782 1.301 . . . . 35.270000000000003 110.783 175.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -57.55 -49.33 76.71 Favored 'General case' 0 C--O 1.242 0.706 0 O-C-N 119.844 -1.785 . . . . 37.659999999999997 112.677 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1334 ' ' LEU . . . . . . . . . . . . . 53.6 tp -57.06 -54.02 51.52 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 124.736 1.273 . . . . 40.270000000000003 108.43 176.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1335 ' ' LEU . . . . . . . . . . . . . 46.6 mt -62.98 -23.81 67.61 Favored 'General case' 0 N--CA 1.436 -1.154 0 O-C-N 126.369 2.293 . . . . 42.5 111.146 -176.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1336 ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -69.02 -35.19 76.37 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 123.284 2.766 . . . . 47.810000000000002 111.944 173.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1337 ' ' LEU . . . . . . . . . . . . . 58.5 mt -67.84 -43.94 78.32 Favored 'General case' 0 CA--C 1.507 -0.709 0 O-C-N 120.84 -1.163 . . . . 49.270000000000003 108.297 172.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1338 ' ' LEU . . . . . . . . . . . . . 6.9 mp -66.91 -38.93 87.15 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 116.724 2.12 . . . . 50.539999999999999 116.724 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1339 ' ' CYS . . . . . . . . . . . . . 49.1 t -104.82 81.32 1.74 Allowed 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 104.761 -2.311 . . . . 53.670000000000002 104.761 -175.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 75.3 mttt -74.31 -52.13 13.16 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 124.312 2.006 . . . . 63.380000000000003 113.096 -165.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -76.48 -44.16 36.61 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 110.077 -3.238 . . . . 70.950000000000003 111.85 -166.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1342 ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? 59.84 67.5 0.87 Allowed 'General case' 0 C--N 1.356 0.881 0 C-N-CA 127.043 2.137 . . . . 65.25 113.216 176.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1343 ' ' ASP . . . . . . . . . . . . 0.468 0.0 OUTLIER 68.38 -72.14 0.1 Allowed 'General case' 0 C--N 1.375 1.712 1 O-C-N 115.001 -4.812 . . . . 64.530000000000001 118.904 8.507 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A 1344 ' ' GLY . . . . . . . . . . . . . . . 79.71 46.69 7.71 Favored Glycine 0 C--O 1.244 0.755 0 CA-C-N 121.238 1.835 . . . . 59.719999999999999 110.462 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 28.8 t30 -130.03 122.8 29.1 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 121.792 0.806 . . . . 64.090000000000003 111.081 166.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1346 ' ' ILE . . . . . . . . . . . . . 13.4 mt -79.99 109.9 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 CA-C-O 123.513 1.625 . . . . 58.82 109.382 170.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1347 ' ' THR . . . . . . . . . . . . . 28.6 m -96.84 107.2 19.65 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 110.275 -3.148 . . . . 54.960000000000001 104.533 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1348 ' ' VAL . . . . . . . . . . . . . 42.2 t -84.16 87.78 2.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 103.608 -2.738 . . . . 55.640000000000001 103.608 -178.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 29.8 t70 -73.16 111.54 8.37 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.539 -1.21 . . . . 61.450000000000003 112.605 178.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -79.79 4.51 16.21 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 114.946 1.461 . . . . 58.630000000000003 114.946 171.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -78.45 -33.04 48.71 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 117.12 -1.832 . . . . 62.060000000000002 112.377 173.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 5.1 t70 -84.31 123.96 30.73 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 124.703 2.192 . . . . 54.07 108.8 171.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 32.2 m -61.46 -29.83 46.83 Favored 'Isoleucine or valine' 0 C--O 1.247 0.973 0 CA-C-N 109.902 -3.317 . . . . 50.68 113.089 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1354 ' ' VAL . . . . . . . . . . . . . 5.8 m -69.45 -40.92 80.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 119.908 1.231 . . . . 47.68 109.7 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1355 ' ' ILE . . . . . . . . . . . . . 54.7 mt -68.11 -48.4 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.872 -1.159 . . . . 48.490000000000002 107.872 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 22.5 tpt85 -52.08 -40.52 61.34 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.687 1.195 . . . . 48.270000000000003 113.145 168.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -58.65 -53.43 46.17 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 125.67 1.605 . . . . 43.530000000000001 112.623 174.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1358 ' ' VAL . . . . . . . . . . . . . 10.9 t -62.92 -39.9 86.86 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.5 0 O-C-N 124.982 1.048 . . . . 45.119999999999997 109.079 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1359 ' ' THR . . . . . . . . . . . . . 21.4 m -74.16 88.68 1.97 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 123.278 1.513 . . . . 42.939999999999998 109.835 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 29.7 m -78.62 -23.0 13.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 113.874 1.065 . . . . 43.259999999999998 113.874 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1361 ' ' ILE . . . . . . . . . . . . . 57.7 mt -133.36 120.5 39.11 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.003 0 O-C-N 118.119 -2.863 . . . . 45.659999999999997 106.604 170.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1362 ' ' ARG . . . . . . . . . . . . . 12.9 ttt180 -102.09 109.78 21.57 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 118.474 -2.641 . . . . 61.340000000000003 106.358 170.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 43.16 39.92 2.16 Favored 'General case' 0 C--O 1.249 1.044 0 N-CA-C 117.278 2.325 . . . . 49.759999999999998 117.278 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 119.6 -34.75 4.12 Favored Glycine 0 C--N 1.349 1.283 0 C-N-CA 119.392 -1.385 . . . . 50.0 111.758 177.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -82.4 123.12 28.83 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.002 -1.481 . . . . 56.920000000000002 107.002 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1366 ' ' ILE . . . . . . . . . . . . . 93.4 mt -84.85 87.31 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 107.851 -1.166 . . . . 52.780000000000001 107.851 -177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1367 ' ' THR . . . . . . . . . . . . . 1.3 p -66.25 -6.76 14.92 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 116.031 1.863 . . . . 49.439999999999998 116.031 175.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 20.7 t90 -59.45 141.14 88.16 Favored Pre-proline 0 N--CA 1.442 -0.872 0 CA-C-O 116.13 -1.89 . . . . 52.380000000000003 108.128 164.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -67.06 160.32 78.85 Favored 'Cis proline' 0 C--N 1.362 1.258 0 N-CA-C 119.733 2.936 . . . . 46.939999999999998 119.733 -0.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -89.68 142.53 29.35 Favored Pre-proline 0 C--O 1.24 0.6 0 CA-C-N 114.862 -1.063 . . . . 45.909999999999997 113.208 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1371 ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -51.59 124.1 13.63 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 124.366 3.377 . . . . 46.390000000000001 114.77 169.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -72.29 -59.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.357 1.005 1 C-N-CA 126.839 5.026 . . . . 46.719999999999999 109.225 173.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.223 -4.904 0 CA-C-N 119.741 1.155 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 79.4 m80 . . . . . 0 CA--C 1.548 0.884 0 N-CA-C 102.436 -3.172 . . . . 63.439999999999998 102.436 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -124.02 50.72 1.62 Allowed 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 121.875 2.125 . . . . 51.740000000000002 111.849 170.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1000 ' ' HIS . . . . . . . . . . . . . 33.2 t60 -71.53 119.45 15.7 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 111.868 -2.424 . . . . 54.07 107.552 174.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 82.13 15.19 75.22 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 123.773 0.701 . . . . 39.219999999999999 111.442 -174.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1002 ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -107.59 128.05 54.19 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 124.534 2.112 . . . . 38.119999999999997 108.765 167.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1003 ' ' ILE . . . . . . . . . . . . . 14.9 mt -81.79 150.52 4.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 110.191 -3.186 . . . . 29.699999999999999 107.229 174.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -129.34 120.42 3.2 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 105.167 -3.173 . . . . 27.5 105.167 171.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1005 ' ' ILE . . . . . . . . . . . . . 45.8 mm -100.06 110.4 59.39 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 116.514 -1.708 . . . . 24.829999999999998 107.505 173.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -78.77 152.44 25.41 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 124.117 3.211 . . . . 27.190000000000001 110.757 175.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -79.97 110.27 15.19 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 102.938 -2.986 . . . . 41.460000000000001 102.938 160.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1008 ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -55.36 131.26 45.29 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 124.176 1.941 . . . . 26.93 115.757 -165.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 36.7 mmm-85 -84.95 -12.28 53.67 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 111.71 -2.496 . . . . 34.479999999999997 111.033 -169.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1010 ' ' LEU . . . . . . . . . . . . . 13.1 tp -55.74 133.67 51.02 Favored 'General case' 0 C--O 1.243 0.728 0 O-C-N 120.776 -1.203 . . . . 44.219999999999999 109.609 172.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1011 ' ' THR . . . . . . . . . . . . . 28.7 m -60.46 111.65 1.66 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 114.365 1.246 . . . . 40.740000000000002 114.365 -168.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 42.3 t30 54.69 55.73 7.56 Favored 'General case' 0 C--O 1.222 -0.368 0 O-C-N 124.51 1.131 . . . . 44.439999999999998 114.047 -170.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1013 ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -88.49 136.75 32.84 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 115.054 -0.976 . . . . 29.870000000000001 108.988 166.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1014 ' ' THR . . . . . . . . . . . . . 96.2 m -96.97 -26.18 15.13 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 111.422 -2.626 . . . . 25.260000000000002 109.906 -173.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -70.96 141.81 51.05 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 123.985 1.85 . . . . 29.539999999999999 112.218 175.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1016 ' ' VAL . . . . . . . . . . . . . 9.9 p -102.47 169.5 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 N-CA-C 105.586 -2.005 . . . . 23.550000000000001 105.586 151.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1017 ' ' ALA . . . . . . . . . . . . . . . -72.24 -35.93 68.97 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.294 1.22 . . . . 23.59 114.294 -174.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1018 ' ' ALA . . . . . . . . . . . . . . . -147.16 153.08 39.45 Favored 'General case' 0 CA--C 1.509 -0.612 0 O-C-N 124.001 0.813 . . . . 24.93 111.71 -172.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1019 ' ' THR . . . . . . . . . . . . . 12.7 p -91.57 163.75 27.09 Favored Pre-proline 0 C--O 1.25 1.11 0 CA-C-O 117.742 -1.123 . . . . 28.09 110.343 171.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -48.27 -41.76 34.54 Favored 'Trans proline' 0 CA--C 1.501 -1.166 1 C-N-CA 125.664 4.242 . . . . 28.789999999999999 111.966 173.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.4 -47.57 62.9 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 122.638 1.209 . . . . 47.280000000000001 112.182 174.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B 1022 ' ' THR . . . . . . . . . . . . . 9.6 p -78.41 -22.34 47.93 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 118.835 -1.146 . . . . 30.120000000000001 112.038 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1023 ' ' VAL . . . . . . . . . . . . . 51.6 t -66.24 -42.3 90.72 Favored 'Isoleucine or valine' 0 C--N 1.349 0.548 0 O-C-N 120.84 -1.162 . . . . 32.240000000000002 110.421 169.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1024 ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -54.57 -48.59 71.88 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 120.451 -1.405 . . . . 49.619999999999997 112.42 171.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -49.49 -48.36 47.93 Favored 'General case' 0 C--O 1.21 -0.975 0 N-CA-C 114.31 1.226 . . . . 44.68 114.31 169.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 70.8 mt -58.07 -41.09 82.63 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 120.063 -1.648 . . . . 35.710000000000001 111.432 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1027 ' ' LEU . . . . . . . . . . . . . 12.3 mt -70.05 -27.64 64.81 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.894 1.278 . . . . 42.18 114.247 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 51.5 mttm -66.11 -47.21 74.91 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 105.877 -1.898 . . . . 48.340000000000003 105.877 169.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1029 ' ' LEU . . . . . . . . . . . . . 74.1 mt -69.42 -10.99 60.4 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 120.426 -1.421 . . . . 38.689999999999998 113.714 175.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 97.05 10.52 54.79 Favored Glycine 0 C--N 1.353 1.522 0 C-N-CA 125.722 1.63 . . . . 32.280000000000001 113.015 166.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -77.12 140.59 40.28 Favored 'General case' 0 N--CA 1.44 -0.974 0 O-C-N 120.735 -1.45 . . . . 35.939999999999998 110.913 173.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1032 ' ' THR . . . . . . . . . . . . . 5.9 m -83.95 138.95 32.88 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 104.788 -2.301 . . . . 33.369999999999997 104.788 174.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1033 ' ' VAL . . . . . . . . . . . . . 10.0 t -122.34 144.39 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 124.045 3.111 . . . . 29.98 111.769 -172.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -129.57 144.93 51.49 Favored 'General case' 0 C--O 1.249 1.036 0 C-N-CA 125.791 1.636 . . . . 28.18 108.537 169.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1035 ' ' VAL . . . . . . . . . . . . . 47.0 t -136.84 142.47 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 105.831 -1.914 . . . . 25.82 105.831 -174.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1036 ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -76.95 141.33 40.5 Favored 'General case' 0 C--O 1.258 1.535 0 C-N-CA 118.886 -1.126 . . . . 32.439999999999998 113.968 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1037 ' ' SER . . . . . . . . . . . . . 49.6 m -52.24 128.06 23.92 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.117 0.961 . . . . 29.539999999999999 113.178 171.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 92.34 -13.2 67.81 Favored Glycine 0 CA--C 1.542 1.779 0 CA-C-N 115.292 -0.867 . . . . 27.760000000000002 113.475 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1039 ' ' ALA . . . . . . . . . . . . . . . -62.71 -39.37 93.81 Favored 'General case' 0 N--CA 1.438 -1.062 0 O-C-N 120.553 -1.557 . . . . 26.02 112.062 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -61.08 -45.81 95.83 Favored Glycine 0 C--N 1.304 -1.232 0 C-N-CA 119.315 -1.422 . . . . 26.469999999999999 110.962 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -68.17 -28.18 67.06 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 118.421 -2.811 . . . . 50.979999999999997 111.972 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 15.3 mt -58.91 -51.23 70.95 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 117.955 -2.965 . . . . 29.300000000000001 109.97 166.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1043 ' ' ALA . . . . . . . . . . . . . . . -68.2 17.13 0.04 OUTLIER 'General case' 0 C--O 1.213 -0.823 0 O-C-N 119.0 -2.313 . . . . 26.739999999999998 116.564 167.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1044 ' ' SER . . . . . . . . . . . . . 15.1 m 54.12 34.47 20.13 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 123.707 1.717 . . . . 31.260000000000002 114.792 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1045 ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -127.94 158.59 37.41 Favored 'General case' 0 C--O 1.241 0.65 0 O-C-N 121.172 -0.955 . . . . 33.259999999999998 108.712 -177.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 29.1 t0 -72.71 139.05 46.97 Favored 'General case' 0 C--O 1.245 0.835 0 O-C-N 120.755 -1.215 . . . . 46.740000000000002 108.824 170.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.54 -40.57 72.03 Favored 'General case' 0 C--O 1.214 -0.816 0 CA-C-O 122.572 1.177 . . . . 34.439999999999998 110.858 175.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.65 -2.41 17.14 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 120.635 -1.291 . . . . 48.670000000000002 113.134 -174.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -72.08 -35.68 69.3 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 118.302 -2.749 . . . . 35.259999999999998 108.365 167.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1050 ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -65.32 -41.63 93.81 Favored 'General case' 0 C--O 1.219 -0.524 0 O-C-N 120.335 -1.478 . . . . 32.170000000000002 108.438 176.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 17.5 t -50.8 -57.98 2.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 123.757 0.66 . . . . 38.369999999999997 111.98 168.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -42.77 -54.28 4.17 Favored 'General case' 0 C--O 1.213 -0.845 0 N-CA-C 113.511 0.93 . . . . 45.770000000000003 113.511 172.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -54.25 -38.4 65.75 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.376 1.251 . . . . 37.829999999999998 114.376 173.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 126.89 34.53 0.59 Allowed Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.845 -0.902 . . . . 35.82 110.845 174.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -112.23 147.21 36.71 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 107.985 -1.117 . . . . 33.770000000000003 107.985 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -76.85 132.82 39.37 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 107.19 -1.411 . . . . 51.020000000000003 107.19 168.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1057 ' ' ILE . . . . . . . . . . . . . 27.8 mm -100.96 124.68 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-O 122.92 1.343 . . . . 38.469999999999999 108.06 169.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.52 142.34 25.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 C-N-CA 124.942 1.297 . . . . 39.399999999999999 113.235 -171.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -82.17 123.13 28.72 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.998 -1.112 . . . . 57.07 107.998 -171.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . 57.0 -133.82 52.53 Favored Glycine 0 N--CA 1.432 -1.596 0 CA-C-O 122.605 1.114 . . . . 44.829999999999998 114.404 165.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -38.92 -40.52 0.65 Allowed 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 111.084 -2.558 . . . . 46.270000000000003 115.403 -172.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B 1062 ' ' SER . . . . . . . . . . . . . 5.5 m -45.71 -51.31 12.67 Favored 'General case' 0 C--N 1.349 0.586 0 N-CA-C 113.98 1.104 . . . . 43.469999999999999 113.98 173.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 3.6 p -69.3 -35.32 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 C-N-CA 123.371 0.668 . . . . 36.979999999999997 110.15 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -64.22 -28.57 69.83 Favored 'General case' 0 N--CA 1.422 -1.844 0 O-C-N 123.813 0.696 . . . . 37.899999999999999 111.908 175.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -82.29 82.91 7.61 Favored 'General case' 0 C--O 1.243 0.748 0 O-C-N 118.798 -2.439 . . . . 46.189999999999998 110.802 171.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1066 ' ' SER . . . . . . . . . . . . . 44.7 m -150.35 162.36 40.69 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.412 -1.267 . . . . 37.060000000000002 108.299 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1067 ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -72.02 -58.3 3.55 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 117.821 -1.551 . . . . 43.950000000000003 111.951 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1068 ' ' ILE . . . . . . . . . . . . . 4.4 mp -96.22 107.15 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 103.165 -2.902 . . . . 33.5 103.165 -169.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 48.9 mm -97.54 109.22 23.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 107.208 -1.404 . . . . 30.57 107.208 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1070 ' ' LEU . . . . . . . . . . . . . 83.6 mt -95.74 91.86 6.29 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 124.377 2.037 . . . . 27.66 107.174 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1071 ' ' LYS . . . . . . . . . . . . . 10.9 mtpt -90.69 161.27 15.44 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-N 112.59 -2.095 . . . . 28.399999999999999 109.491 176.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1072 ' ' VAL . . . . . . . . . . . . . 2.7 t -83.91 -56.91 4.97 Favored 'Isoleucine or valine' 0 C--N 1.351 0.637 0 N-CA-C 104.733 -2.321 . . . . 23.18 104.733 -177.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -113.46 173.88 6.19 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 113.808 -1.542 . . . . 25.469999999999999 107.448 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -49.41 146.93 6.08 Favored Pre-proline 0 C--O 1.264 1.832 0 C-N-CA 124.899 1.28 . . . . 27.899999999999999 113.66 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -60.52 151.89 72.06 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.455 2.77 . . . . 31.620000000000001 110.574 166.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 7.4 mp -89.7 165.74 14.01 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 113.828 -1.533 . . . . 40.490000000000002 107.171 166.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 10.1 t70 -58.71 -40.63 84.24 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 116.448 2.018 . . . . 51.590000000000003 116.448 -173.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -57.3 -43.43 83.22 Favored 'General case' 0 C--O 1.244 0.773 0 O-C-N 121.489 -0.757 . . . . 42.359999999999999 111.202 169.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1079 ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -64.8 -28.65 69.71 Favored 'General case' 0 C--O 1.221 -0.426 0 O-C-N 121.404 -0.81 . . . . 34.530000000000001 109.868 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1080 ' ' ILE . . . . . . . . . . . . . 69.5 mt -64.13 -41.21 91.73 Favored 'Isoleucine or valine' 0 C--N 1.36 1.053 0 O-C-N 119.926 -1.734 . . . . 33.25 110.231 171.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -62.73 -30.01 71.1 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.442 -1.411 . . . . 36.469999999999999 114.365 172.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1082 ' ' LEU . . . . . . . . . . . . . 65.4 mt -75.16 -28.34 60.05 Favored 'General case' 0 C--N 1.348 0.532 0 O-C-N 121.584 -0.698 . . . . 37.759999999999998 110.852 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1083 ' ' LEU . . . . . . . . . . . . . 34.1 mt -52.78 114.8 1.53 Allowed 'General case' 0 C--O 1.247 0.953 0 N-CA-C 114.928 1.455 . . . . 37.43 114.928 174.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.34 143.83 52.65 Favored Pre-proline 0 N--CA 1.453 -0.314 0 CA-C-N 111.289 -2.687 . . . . 37.700000000000003 107.587 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -54.67 123.69 14.33 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.176 3.251 . . . . 35.509999999999998 109.434 175.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 83.61 17.16 66.66 Favored Glycine 0 C--N 1.316 -0.565 0 CA-C-O 119.608 -0.551 . . . . 33.869999999999997 112.076 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1087 ' ' THR . . . . . . . . . . . . . 52.5 m -69.76 134.44 48.58 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 121.707 2.753 . . . . 32.5 108.72 163.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1088 ' ' THR . . . . . . . . . . . . . 38.9 m -92.93 97.94 11.05 Favored 'General case' 0 C--O 1.254 1.321 0 N-CA-C 105.528 -2.027 . . . . 30.219999999999999 105.528 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1089 ' ' LEU . . . . . . . . . . . . . 22.1 tp -96.17 130.19 43.29 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 120.829 -1.169 . . . . 27.239999999999998 108.639 -176.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 95.8 t -125.6 128.01 72.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 102.247 -3.242 . . . . 25.390000000000001 102.247 -175.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1091 ' ' SER . . . . . . . . . . . . . 3.9 m -160.23 168.38 25.51 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 121.893 2.133 . . . . 28.809999999999999 111.925 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1092 ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -66.71 108.25 2.42 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.549 -1.278 . . . . 30.780000000000001 107.549 155.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 26.2 mm -104.31 -36.67 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 O-C-N 118.837 -2.414 . . . . 30.280000000000001 114.267 -176.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1094 ' ' TRP . . . . . . . . . . . . . 61.9 m95 54.53 65.49 5.06 Favored Pre-proline 0 CA--C 1.548 0.886 0 O-C-N 124.319 1.012 . . . . 34.07 110.582 -175.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -47.99 -58.39 1.78 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 1 C-N-CA 127.375 5.383 . . . . 38.659999999999997 118.91 -166.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -82.29 -14.89 54.7 Favored 'General case' 0 N--CA 1.436 -1.163 0 O-C-N 119.734 -1.854 . . . . 41.32 110.437 -177.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -76.58 -21.96 54.91 Favored 'General case' 0 C--O 1.246 0.895 0 N-CA-C 108.579 -0.897 . . . . 51.659999999999997 108.579 166.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -121.36 42.39 0.56 Allowed Pre-proline 0 C--N 1.309 -1.168 0 N-CA-C 117.391 2.367 . . . . 40.32 117.391 -172.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -56.49 -42.54 64.47 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 123.633 2.889 . . . . 41.560000000000002 117.188 -167.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -61.25 -39.84 91.83 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.714 1.143 . . . . 54.109999999999999 113.316 175.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1101 ' ' LEU . . . . . . . . . . . . . 6.2 tp -62.78 -49.44 74.97 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 108.521 -0.918 . . . . 37.880000000000003 108.521 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1102 ' ' MET . . . . . . . . . . . . . 91.6 mmm -51.25 -55.73 16.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.712 -0.676 . . . . 37.539999999999999 110.381 177.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -49.34 -49.74 42.86 Favored 'General case' 0 C--O 1.244 0.775 0 O-C-N 121.694 -0.629 . . . . 47.009999999999998 112.483 176.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1104 ' ' LYS . . . . . . . . . . . . . 83.4 mttt -60.46 -38.25 83.6 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 114.991 1.478 . . . . 48.68 114.991 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1105 ' ' LEU . . . . . . . . . . . . . 31.3 mt -66.96 -36.82 83.07 Favored 'General case' 0 C--O 1.245 0.837 0 O-C-N 121.009 -1.057 . . . . 32.210000000000001 109.198 177.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -67.87 -28.24 67.36 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 108.871 -0.788 . . . . 33.729999999999997 108.871 177.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -68.44 -39.62 81.45 Favored 'General case' 0 CA--C 1.494 -1.197 0 O-C-N 119.412 -2.055 . . . . 51.469999999999999 110.207 175.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1108 ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -72.85 -4.05 29.38 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 115.026 1.491 . . . . 43.899999999999999 115.026 -178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1109 ' ' ASN . . . . . . . . . . . . . 9.9 m120 58.6 32.81 22.55 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 124.027 1.87 . . . . 44.82 113.436 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1110 ' ' VAL . . . . . . . . . . . . . 33.6 m -93.14 166.27 1.8 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.662 0 CA-C-N 114.351 -1.295 . . . . 30.52 111.454 177.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1111 ' ' THR . . . . . . . . . . . . . 87.2 m -109.65 103.26 12.09 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 105.532 -2.025 . . . . 27.120000000000001 105.532 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1112 ' ' VAL . . . . . . . . . . . . . 40.7 t -99.36 129.11 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-O 122.418 1.104 . . . . 26.399999999999999 109.496 -174.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1113 ' ' MET . . . . . . . . . . . . . 31.2 mtp -109.65 124.33 50.99 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.921 0.889 . . . . 42.920000000000002 110.128 171.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -102.51 106.18 16.85 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 119.716 1.144 . . . . 24.149999999999999 109.17 -174.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1115 ' ' MET . . . . . . . . . . . . . 80.2 mmm -71.29 -2.33 15.83 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 113.072 -1.876 . . . . 29.949999999999999 112.168 -169.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1116 ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -93.44 -52.07 4.68 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.745 1.218 . . . . 34.530000000000001 112.428 169.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1117 ' ' SER . . . . . . . . . . . . . 51.1 m -86.71 60.94 6.52 Favored 'General case' 0 C--N 1.343 0.298 0 O-C-N 120.401 -1.437 . . . . 33.490000000000002 111.118 -175.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1118 ' ' VAL . . . . . . . . . . . . . 17.9 t -95.62 146.56 31.54 Favored Pre-proline 0 C--O 1.245 0.868 0 N-CA-C 105.171 -2.159 . . . . 34.020000000000003 105.171 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -60.97 146.02 98.3 Favored 'Trans proline' 0 C--N 1.354 0.82 0 CA-C-N 124.661 2.7 . . . . 38.280000000000001 113.308 174.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1120 ' ' ARG . . . . . 0.54 HH12 ' CG ' ' B' 1128 ' ' ASP . 5.3 mmt180 -85.82 56.82 4.14 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 120.685 -1.259 . . . . 55.049999999999997 111.481 -167.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B 1121 ' ' ILE . . . . . . . . . . . . . 6.7 pt -132.26 164.28 35.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 CA-C-N 114.53 -1.213 . . . . 42.090000000000003 112.585 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1122 ' ' SER . . . . . . . . . . . . . 8.9 m -48.75 -63.94 0.95 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 119.12 3.008 . . . . 38.020000000000003 119.12 -162.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1123 ' ' ARG . . . . . . . . . . . . . 21.4 ptt-85 -70.53 -29.06 65.44 Favored 'General case' 0 C--N 1.354 0.804 1 O-C-N 116.114 -4.116 . . . . 34.289999999999999 110.924 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B 1124 ' ' ALA . . . . . . . . . . . . . . . -60.51 -40.62 92.08 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 113.282 -1.781 . . . . 32.350000000000001 108.151 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1125 ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -60.75 -24.67 65.91 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 115.744 1.757 . . . . 47.170000000000002 115.744 173.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1126 ' ' SER . . . . . . . . . . . . . 57.1 m -68.59 -36.66 79.01 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 119.05 -2.281 . . . . 31.710000000000001 114.667 165.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1127 ' ' LEU . . . . . . . . . . . . . 6.9 mp -72.84 -30.15 63.79 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.181 -0.949 . . . . 37.0 111.472 172.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1128 ' ' ASP . . . . . 0.54 ' CG ' HH12 ' B' 1120 ' ' ARG . 37.9 t70 -64.54 101.02 0.41 Allowed 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 115.59 -0.732 . . . . 40.399999999999999 110.977 -169.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B 1129 ' ' ALA . . . . . . . . . . . . . . . -72.52 -21.42 61.18 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 118.411 -1.316 . . . . 26.559999999999999 110.506 174.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 7.8 tt -55.13 -26.37 37.98 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.378 1.251 . . . . 30.890000000000001 114.378 168.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1131 ' ' SER . . . . . . . . . . . . . 13.6 p -77.59 -51.91 9.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 122.68 1.228 . . . . 29.84 113.118 172.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1132 ' ' SER . . . . . . . . . . . . . 16.6 m -58.23 -49.51 76.83 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.279 -1.513 . . . . 31.91 114.663 177.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1133 ' ' MET . . . . . . . . . . . . . 38.1 mmt -68.74 -36.58 78.56 Favored 'General case' 0 CA--C 1.509 -0.598 0 O-C-N 120.776 -1.202 . . . . 25.899999999999999 110.765 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1134 ' ' ALA . . . . . . . . . . . . . . . -55.62 -44.55 77.18 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 119.137 0.881 . . . . 26.620000000000001 113.289 164.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -58.03 -48.08 81.15 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 122.272 1.034 . . . . 36.969999999999999 112.096 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1136 ' ' ILE . . . . . . . . . . . . . 42.9 mm -52.3 -58.07 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-N 113.294 -1.775 . . . . 32.109999999999999 111.48 173.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -57.27 -30.36 64.62 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.888 1.069 . . . . 24.140000000000001 113.888 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -68.58 -49.28 44.96 Favored Glycine 0 N--CA 1.484 1.9 0 N-CA-C 110.202 -1.159 . . . . 25.129999999999999 110.202 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 55.3 t80 -63.72 -44.47 93.46 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 123.417 1.579 . . . . 32.729999999999997 112.748 173.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1140 ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -62.57 -33.94 75.96 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 114.041 -1.436 . . . . 26.359999999999999 110.914 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1141 ' ' ALA . . . . . . . . . . . . . . . -55.71 -49.38 73.16 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 123.232 0.613 . . . . 24.120000000000001 112.42 168.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 50.1 mm -58.78 -35.97 58.54 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 O-C-N 120.873 -1.142 . . . . 23.370000000000001 109.927 174.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 14.3 t -71.24 -46.19 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 O-C-N 119.555 -1.966 . . . . 24.960000000000001 111.837 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -72.0 -41.82 67.15 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 106.661 -1.607 . . . . 32.07 106.661 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1145 ' ' ALA . . . . . . . . . . . . . . . -53.38 -45.86 69.42 Favored 'General case' 0 C--O 1.206 -1.209 0 O-C-N 121.318 -0.864 . . . . 24.870000000000001 111.655 170.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1146 ' ' ALA . . . . . . . . . . . . . . . -63.99 -39.08 93.32 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 123.016 0.527 . . . . 24.670000000000002 109.658 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 16.5 t60 -59.06 -34.33 71.82 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 119.746 -1.846 . . . . 28.579999999999998 109.177 172.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1148 ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -93.93 -10.38 33.96 Favored 'General case' 0 C--O 1.25 1.088 0 O-C-N 120.118 -1.614 . . . . 36.82 113.8 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1149 ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -78.9 144.09 35.24 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-O 123.488 1.613 . . . . 31.969999999999999 109.257 -171.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B 1150 ' ' GLY . . . . . . . . . . . . . . . -93.93 -19.64 33.38 Favored Glycine 0 C--O 1.242 0.644 0 CA-C-N 114.313 -1.312 . . . . 25.489999999999998 113.239 174.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1151 ' ' ARG . . . . . . . . . . . . . 81.1 mtm-85 -112.65 166.75 11.06 Favored 'General case' 0 C--O 1.242 0.709 0 O-C-N 121.537 -0.978 . . . . 59.840000000000003 111.067 -169.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1152 ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -78.85 156.81 28.52 Favored 'General case' 0 C--O 1.239 0.543 0 O-C-N 119.803 -1.811 . . . . 34.450000000000003 108.647 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1153 ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -84.59 -43.74 14.17 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 123.837 1.78 . . . . 31.170000000000002 108.655 166.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1154 ' ' THR . . . . . . . . . . . . . 48.2 m -68.01 128.17 35.56 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 112.934 -1.939 . . . . 33.890000000000001 111.367 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -75.94 65.47 2.58 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 109.161 -1.576 . . . . 38.950000000000003 109.161 174.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -85.17 121.37 27.83 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 119.461 1.631 . . . . 54.229999999999997 109.476 -160.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 29.8 mm -70.82 95.09 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.883 0 O-C-N 119.906 -1.746 . . . . 51.159999999999997 106.406 173.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1158 ' ' THR . . . . . . . . . . . . . 1.7 m -109.22 138.8 45.02 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 107.783 -1.191 . . . . 49.609999999999999 107.783 -175.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -56.62 -30.57 63.42 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 121.034 1.743 . . . . 49.049999999999997 115.51 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -52.34 -53.09 48.94 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.245 0.545 . . . . 47.649999999999999 111.127 167.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . -179.02 156.14 17.86 Favored Glycine 0 C--O 1.215 -1.062 0 N-CA-C 108.071 -2.012 . . . . 45.609999999999999 108.071 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 79.9 mttt -76.91 128.15 34.03 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 120.197 1.998 . . . . 57.460000000000001 111.966 177.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1163 ' ' VAL . . . . . . . . . . . . . 23.3 t -80.18 129.6 69.18 Favored Pre-proline 0 CA--C 1.514 -0.425 0 CA-C-N 118.923 0.783 . . . . 42.93 110.08 177.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1164 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.74 142.67 64.51 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.618 2.212 . . . . 39.289999999999999 110.667 164.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1165 ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -59.85 153.77 54.56 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 C-N-CA 122.898 2.399 . . . . 34.170000000000002 114.943 170.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -83.25 159.85 21.87 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 113.088 -1.869 . . . . 31.690000000000001 108.383 168.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1167 ' ' LYS . . . . . . . . . . . . . 67.2 mttt -123.56 118.04 26.45 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 105.466 -2.05 . . . . 44.780000000000001 105.466 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 60.3 t -104.31 104.83 17.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 O-C-N 121.827 -0.546 . . . . 31.23 111.122 -174.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1169 ' ' MET . . . . . . . . . . . . . 42.7 ttp -82.82 98.11 8.97 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.088 -0.708 . . . . 37.090000000000003 109.088 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 53.1 t -89.74 119.35 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 N-CA-C 109.029 -0.73 . . . . 30.170000000000002 109.029 -177.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1171 ' ' ILE . . . . . . . . . . . . . 9.7 mt -113.52 132.76 61.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 CA-C-N 120.307 1.412 . . . . 33.740000000000002 107.578 -175.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 69.56 63.86 3.2 Favored Glycine 0 CA--C 1.502 -0.72 0 N-CA-C 110.046 -1.221 . . . . 32.590000000000003 110.046 -176.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1173 ' ' ALA . . . . . . . . . . . . . . . -79.89 75.6 6.6 Favored 'General case' 0 C--O 1.252 1.233 0 CA-C-O 124.17 1.938 . . . . 32.420000000000002 114.018 -174.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -86.52 -165.3 40.86 Favored Glycine 0 C--O 1.216 -0.982 0 N-CA-C 107.367 -2.293 . . . . 31.739999999999998 107.367 166.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 46.1 t -48.54 -38.14 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 122.11 2.955 . . . . 31.48 114.279 -176.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1176 ' ' ALA . . . . . . . . . . . . . . . -58.06 -51.67 68.73 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 113.462 -1.699 . . . . 26.120000000000001 114.063 171.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1177 ' ' GLY . . . . . . . . . . . . . . . -60.46 -48.61 85.35 Favored Glycine 0 CA--C 1.49 -1.473 0 N-CA-C 111.321 -0.712 . . . . 25.73 111.321 176.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1178 ' ' LEU . . . . . . . . . . . . . 91.5 mt -53.75 -38.26 64.2 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 114.899 1.444 . . . . 32.590000000000003 114.899 174.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -70.67 -38.68 73.8 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 119.298 0.953 . . . . 27.719999999999999 111.734 175.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -60.9 -46.7 89.59 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 114.602 1.334 . . . . 26.030000000000001 114.602 175.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1181 ' ' ILE . . . . . . . . . . . . . 79.0 mt -58.32 -48.04 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 123.707 0.803 . . . . 28.609999999999999 109.095 173.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -51.09 -53.11 28.61 Favored Glycine 0 C--N 1.373 2.611 0 CA-C-N 114.827 -1.079 . . . . 25.23 110.721 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -63.26 -50.78 68.83 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 114.419 1.266 . . . . 24.09 114.419 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -69.42 -42.81 74.52 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 121.195 -0.94 . . . . 26.68 112.579 -172.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -57.49 -47.11 82.78 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 115.713 -0.676 . . . . 36.57 111.271 174.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1186 ' ' SER . . . . . . . . . . . . . 75.4 m -58.81 -39.87 82.44 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-O 121.81 0.814 . . . . 28.920000000000002 112.338 177.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1187 ' ' LEU . . . . . . . . . . . . . 66.1 mt -61.78 -35.13 77.26 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 121.041 -1.037 . . . . 29.09 112.997 172.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 120.3 -7.07 11.65 Favored Glycine 0 CA--C 1.539 1.591 0 N-CA-C 111.113 -0.795 . . . . 29.260000000000002 111.113 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1189 ' ' ALA . . . . . . . . . . . . . . . -68.46 121.7 16.89 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 121.666 0.746 . . . . 30.16 112.272 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 37.2 mt -67.31 112.07 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-O 123.594 1.664 . . . . 35.810000000000002 109.718 -172.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1191 ' ' VAL . . . . . . . . . . . . . 93.2 t -82.46 128.75 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 107.706 -1.22 . . . . 31.969999999999999 107.706 -177.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1192 ' ' ARG . . . . . 0.414 HH12 ' CD ' ' B' 1248 ' ' GLU . 22.9 mmt85 -118.89 90.39 3.32 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 102.903 -2.999 . . . . 48.159999999999997 102.903 174.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -103.07 159.69 15.3 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 120.712 -1.242 . . . . 35.890000000000001 114.281 -172.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 35.2 t80 -150.13 152.41 34.68 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 123.041 1.4 . . . . 41.880000000000003 107.224 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1195 ' ' ASP . . . . . . . . . . . . . 10.0 t0 -158.55 155.61 28.68 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 103.666 -2.716 . . . . 38.280000000000001 103.666 168.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1196 ' ' THR . . . . . . . . . . . . . 43.0 m -59.23 -24.15 62.92 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 124.956 1.302 . . . . 40.619999999999997 110.53 172.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1197 ' ' ARG . . . . . . . . . . . . . 33.1 mtm105 -91.97 144.33 29.06 Favored Pre-proline 0 C--O 1.249 1.066 0 O-C-N 119.925 -1.735 . . . . 53.090000000000003 111.026 -174.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -71.95 -42.58 1.53 Allowed 'Trans proline' 0 CA--C 1.548 1.188 1 C-N-CA 125.637 4.225 . . . . 42.560000000000002 117.418 -174.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -29.4 70.55 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 121.269 1.85 . . . . 56.310000000000002 114.462 -168.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B 1200 ' ' VAL . . . . . . . . . . . . . 10.8 p -58.56 -28.65 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 115.133 -0.94 . . . . 42.909999999999997 112.596 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 35.1 tttm -45.05 -58.66 3.04 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 124.581 1.153 . . . . 48.890000000000001 113.535 168.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 16.0 mp0 -63.39 -28.37 69.94 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 114.265 1.209 . . . . 51.700000000000003 114.265 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1203 ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -66.13 -46.63 76.83 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.586 -0.734 . . . . 52.57 109.442 176.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1204 ' ' VAL . . . . . . . . . . . . . 40.0 t -72.69 -40.67 62.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.255 -1.017 . . . . 33.789999999999999 108.255 -173.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -60.98 -29.36 69.62 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 113.57 0.952 . . . . 36.579999999999998 113.57 176.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1206 ' ' SER . . . . . . . . . . . . . 44.7 m -68.67 -10.85 58.71 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 120.254 -1.529 . . . . 39.609999999999999 114.246 174.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1207 ' ' MET . . . . . . . . . . . . . 46.1 mmm -97.22 5.21 50.47 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.587 0.708 . . . . 37.450000000000003 109.579 174.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 60.5 32.28 77.34 Favored Glycine 0 N--CA 1.471 0.984 0 O-C-N 120.133 -1.604 . . . . 31.870000000000001 111.829 -165.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -119.6 163.23 17.66 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 105.328 -2.101 . . . . 35.399999999999999 105.328 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -108.62 137.23 46.9 Favored 'General case' 0 C--N 1.313 -1.014 0 O-C-N 119.859 -1.776 . . . . 47.890000000000001 111.999 -166.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 75.7 t80 -84.97 141.39 30.38 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 106.416 -1.698 . . . . 45.530000000000001 106.416 172.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1212 ' ' LEU . . . . . . . . . . . . . 73.8 mt -73.74 99.64 3.2 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 125.11 2.386 . . . . 46.329999999999998 116.641 -176.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -77.08 122.75 25.4 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 112.101 -2.318 . . . . 60.409999999999997 108.147 172.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.03 176.38 5.59 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 104.5 -2.407 . . . . 57.380000000000003 104.5 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 14.0 t70 . . . . . 0 CA--C 1.499 -0.994 0 CA-C-O 117.665 -1.159 . . . . 65.069999999999993 108.613 177.149 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B 1230 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.429 -1.48 0 N-CA-C 104.147 -2.538 . . . . 80.319999999999993 104.147 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1231 ' ' SER . . . . . . . . . . . . . 1.6 m 78.26 156.71 0.17 Allowed 'General case' 0 C--O 1.251 1.174 2 CA-C-N 127.914 4.87 . . . . 79.920000000000002 119.591 -8.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -88.7 -157.62 0.44 Allowed 'General case' 0 C--O 1.248 0.991 0 CA-C-N 112.584 -2.098 . . . . 77.909999999999997 111.872 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 66.38 -68.2 0.14 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 121.383 1.902 . . . . 73.879999999999995 111.036 -170.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 11.4 t80 -55.81 -33.18 64.2 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.75 1.22 . . . . 68.980000000000004 110.802 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 32.6 pt -42.94 -39.24 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 114.858 1.429 . . . . 64.530000000000001 114.858 170.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -58.95 -45.81 89.54 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 121.306 1.866 . . . . 66.359999999999999 111.306 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -67.01 -30.54 70.67 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 114.609 1.337 . . . . 56.600000000000001 114.609 170.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.9 -46.4 85.02 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 120.302 1.41 . . . . 56.789999999999999 108.643 171.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1239 ' ' MET . . . . . . . . . . . . . 31.0 mmt -67.79 -36.53 80.6 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 120.848 -1.157 . . . . 53.630000000000003 108.711 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -70.11 -39.63 75.37 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 119.52 -0.872 . . . . 51.740000000000002 109.347 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 17.4 tp -53.14 -53.59 48.25 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-O 118.17 -0.919 . . . . 44.859999999999999 110.116 170.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -64.27 -40.57 96.24 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 112.509 0.559 . . . . 42.780000000000001 112.509 -177.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -61.02 -49.41 77.54 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 124.522 1.129 . . . . 40.960000000000001 108.138 -178.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -59.35 -43.84 92.76 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.608 1.549 . . . . 43.060000000000002 112.215 175.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 46.5 mm-40 -62.01 -28.39 69.54 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.127 -1.397 . . . . 46.450000000000003 114.392 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -57.27 -27.44 62.11 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 123.263 1.506 . . . . 41.780000000000001 112.171 -174.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 10.5 tptt -77.98 -41.93 34.4 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 114.094 -1.412 . . . . 52.200000000000003 110.901 175.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1248 ' ' GLU . . . . . 0.414 ' CD ' HH12 ' B' 1192 ' ' ARG . 26.0 mt-10 -70.26 -41.45 73.46 Favored 'General case' 0 C--O 1.244 0.813 0 O-C-N 120.604 -1.31 . . . . 53.549999999999997 111.952 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B 1249 ' ' VAL . . . . . . . . . . . . 0.259 32.8 m -84.88 164.3 2.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 124.336 2.017 . . . . 34.409999999999997 113.504 -166.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B 1250 ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -122.63 -50.07 1.98 Allowed 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 113.663 -1.608 . . . . 33.380000000000003 107.602 -176.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1251 ' ' ILE . . . . . . . . . . . . . 24.5 mm -119.94 114.98 45.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 108.035 -1.098 . . . . 29.539999999999999 108.035 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1252 ' ' ILE . . . . . . . . . . . . . 82.3 mt -91.62 119.79 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 N-CA-C 104.477 -2.416 . . . . 32.439999999999998 104.477 169.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1253 ' ' VAL . . . . . . . . . . . . . 55.9 t -112.81 100.91 11.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 104.665 -2.346 . . . . 30.57 104.665 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1254 ' ' THR . . . . . . . . . . . . . 7.4 t -103.08 98.6 8.51 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 125.982 2.801 . . . . 35.039999999999999 108.894 -175.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1255 ' ' THR . . . . . . . . . . . . . 3.2 p -84.74 8.7 16.2 Favored 'General case' 0 N--CA 1.421 -1.888 1 CA-C-N 107.26 -4.518 . . . . 34.619999999999997 117.662 -176.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . -72.98 92.06 1.61 Allowed 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 114.115 1.154 . . . . 42.719999999999999 114.115 -174.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 13.7 mt -109.0 101.34 10.43 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 102.936 -2.987 . . . . 52.43 102.936 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 2.3 mp -93.99 128.87 39.58 Favored Pre-proline 0 N--CA 1.481 1.123 0 C-N-CA 118.962 -1.095 . . . . 59.409999999999997 110.014 -177.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -58.68 126.43 21.23 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.779 2.32 . . . . 62.68 107.831 170.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 81.8 -75.24 2.35 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 117.033 -1.982 . . . . 64.159999999999997 108.46 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 91.5 mttt -58.13 149.73 55.44 Favored Pre-proline 0 C--O 1.242 0.676 0 CA-C-N 121.838 2.819 . . . . 68.530000000000001 115.715 -174.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.76 118.49 3.47 Favored 'Trans proline' 0 C--O 1.246 0.9 0 C-N-CA 123.544 2.829 . . . . 61.990000000000002 113.178 167.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1263 ' ' ALA . . . . . . . . . . . . . . . -35.78 122.95 0.68 Allowed Pre-proline 0 C--O 1.245 0.831 0 C-N-CA 124.858 1.263 . . . . 57.149999999999999 111.052 164.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.13 158.6 33.85 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.292 1.995 . . . . 51.57 111.633 -172.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1265 ' ' LYS . . . . . 0.438 ' NZ ' ' O ' ' B' 1289 ' ' GLY . 46.6 mmtm -78.76 76.09 5.26 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 125.566 2.603 . . . . 54.549999999999997 110.751 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 40.3 mt -67.27 -52.99 34.03 Favored 'General case' 0 N--CA 1.438 -1.069 0 O-C-N 118.317 -2.739 . . . . 46.859999999999999 111.615 -177.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1267 ' ' ILE . . . . . . . . . . . . . 38.0 mm -89.15 99.19 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 107.13 -1.433 . . . . 41.039999999999999 107.13 -176.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1268 ' ' THR . . . . . . . . . . . . . 7.8 p -73.64 156.82 37.61 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 111.057 -2.792 . . . . 39.579999999999998 113.301 -175.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1269 ' ' ARG . . . . . . . . . . . . . 78.3 mtt85 -55.81 -41.08 73.65 Favored 'General case' 0 C--O 1.206 -1.21 0 N-CA-C 113.371 0.878 . . . . 53.149999999999999 113.371 -175.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -59.38 -46.52 88.46 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 124.64 1.212 . . . . 42.960000000000001 110.481 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1271 ' ' MET . . . . . . . . . . . . . 48.6 ttm -58.48 -48.08 81.96 Favored 'General case' 0 C--O 1.242 0.66 0 O-C-N 124.096 0.873 . . . . 43.890000000000001 110.252 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1272 ' ' VAL . . . . . . . . . . . . . 33.2 t -57.2 -50.26 77.16 Favored 'Isoleucine or valine' 0 C--O 1.257 1.45 0 O-C-N 125.637 1.836 . . . . 38.369999999999997 111.521 176.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.83 -29.59 67.03 Favored 'General case' 0 C--N 1.357 0.919 0 N-CA-C 115.364 1.616 . . . . 47.460000000000001 115.364 176.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B 1274 ' ' SER . . . . . . . . . . . . . 50.4 m -84.49 -7.35 59.3 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 126.022 1.729 . . . . 38.380000000000003 114.5 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1275 ' ' MET . . . . . . . . . . . . . 49.5 mtp -66.5 164.77 15.79 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 113.576 0.954 . . . . 37.810000000000002 113.576 -175.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -55.85 137.1 50.87 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 124.645 1.178 . . . . 49.259999999999998 108.506 169.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -67.96 140.99 56.43 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 121.55 -0.719 . . . . 34.460000000000001 111.136 -177.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 72.93 55.15 6.58 Favored Glycine 0 N--CA 1.434 -1.495 0 CA-C-O 122.669 1.149 . . . . 33.530000000000001 113.824 175.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1279 ' ' SER . . . . . . . . . . . . . 70.9 m -141.37 160.87 39.23 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 107.7 -1.222 . . . . 31.309999999999999 107.7 -167.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1280 ' ' VAL . . . . . . . . . . . . . 69.0 t -123.53 141.57 43.32 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 CA-C-N 120.039 1.29 . . . . 29.32 109.547 -169.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1281 ' ' ILE . . . . . . . . . . . . . 74.8 mt -118.2 98.95 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 105.367 -2.086 . . . . 31.93 105.367 170.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1282 ' ' VAL . . . . . . . . . . . . . 5.3 t -86.85 109.84 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 106.77 -1.567 . . . . 29.48 106.77 174.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 58.4 t0 -93.64 111.76 23.5 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 103.236 -2.876 . . . . 34.5 103.236 171.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1284 ' ' LEU . . . . . . . . . . . . . 7.2 mp -74.15 -40.44 62.59 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 113.686 -1.597 . . . . 37.939999999999998 106.718 172.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -76.03 11.52 1.43 Allowed 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 120.285 -1.509 . . . . 40.920000000000002 114.898 -160.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -47.73 -45.05 28.42 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 118.486 2.773 . . . . 44.390000000000001 118.486 176.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1287 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -28.94 68.74 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 122.588 1.185 . . . . 51.460000000000001 112.196 172.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -82.57 -33.9 27.91 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 114.671 1.36 . . . . 57.75 114.671 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1289 ' ' GLY . . . . . 0.438 ' O ' ' NZ ' ' B' 1265 ' ' LYS . . . 164.65 -21.95 0.14 Allowed Glycine 0 CA--C 1.536 1.4 0 C-N-CA 120.138 -1.029 . . . . 49.850000000000001 113.258 -172.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 80.48 112.01 0.29 Allowed Glycine 0 N--CA 1.464 0.535 0 CA-C-O 118.25 -1.305 . . . . 45.93 112.844 175.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1291 ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -89.93 -15.28 32.37 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 119.152 1.476 . . . . 42.670000000000002 114.711 178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1292 ' ' CYS . . . . . . . . . . . . . 48.5 t -105.88 144.06 33.13 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.287 0.847 . . . . 38.82 113.287 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1293 ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -69.5 -16.38 63.44 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 119.189 3.033 . . . . 46.710000000000001 119.189 -176.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -107.39 0.36 22.91 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 120.211 -1.555 . . . . 47.229999999999997 113.023 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1295 ' ' THR . . . . . . . . . . . . . 91.2 m -53.79 115.58 2.07 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 116.148 1.907 . . . . 36.020000000000003 116.148 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 46.5 t -97.13 121.03 60.08 Favored Pre-proline 0 N--CA 1.435 -1.199 0 N-CA-C 102.551 -3.129 . . . . 37.259999999999998 102.551 169.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -51.59 114.29 1.51 Allowed 'Trans proline' 0 C--O 1.238 0.475 0 C-N-CA 124.827 3.684 . . . . 35.090000000000003 116.612 -177.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 66.18 42.56 94.25 Favored Glycine 0 C--O 1.245 0.793 0 CA-C-O 116.342 -2.365 . . . . 35.969999999999999 114.016 -173.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -151.87 175.48 12.43 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 118.484 1.142 . . . . 40.390000000000001 111.17 175.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1300 ' ' ILE . . . . . . . . . . . . . 58.6 mt -110.19 133.49 55.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 107.536 -1.283 . . . . 37.43 107.536 170.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 69.3 t80 -107.8 124.78 50.57 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.509 -0.876 . . . . 44.130000000000003 110.347 163.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1302 ' ' THR . . . . . . . . . . . . . 96.0 m -92.84 126.79 38.09 Favored 'General case' 0 C--O 1.248 0.985 0 O-C-N 120.238 -1.539 . . . . 39.780000000000001 107.95 176.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1303 ' ' THR . . . . . . . . . . . . . 67.5 p -82.56 175.08 10.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 120.851 1.66 . . . . 43.289999999999999 113.249 166.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -69.81 -30.6 68.16 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 122.222 1.01 . . . . 53.07 109.882 -174.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -82.98 14.45 3.31 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 114.5 1.296 . . . . 43.969999999999999 114.5 173.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 70.31 32.23 68.59 Favored Glycine 0 C--O 1.211 -1.339 0 O-C-N 120.569 -1.332 . . . . 41.119999999999997 110.909 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1307 ' ' VAL . . . . . . . . . . . . . 73.6 t -98.67 109.45 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 105.075 -2.194 . . . . 38.119999999999997 105.075 173.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1308 ' ' LYS . . . . . . . . . . . . . 78.5 mttt -86.44 98.04 10.8 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 113.321 -1.763 . . . . 36.340000000000003 107.562 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1309 ' ' VAL . . . . . . . . . . . . . 44.4 t -71.34 90.96 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 CA-C-N 114.608 -1.178 . . . . 30.399999999999999 108.93 172.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1310 ' ' ILE . . . . . . . . . . . . . 37.0 mt -83.46 101.96 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 O-C-N 120.564 -1.335 . . . . 30.82 110.225 176.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1311 ' ' GLY . . . . . . . . . . . . . . . -99.5 63.38 0.7 Allowed Glycine 0 CA--C 1.499 -0.936 0 CA-C-N 114.137 -1.392 . . . . 26.530000000000001 111.317 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1312 ' ' TYR . . . . . . . . . . . . . 8.4 m-30 -82.08 100.44 9.77 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 119.635 -2.097 . . . . 38.0 113.995 -175.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1313 ' ' THR . . . . . . . . . . . . . 98.3 m -51.42 -38.0 51.39 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 114.082 -1.417 . . . . 29.800000000000001 109.733 168.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -95.59 14.86 21.52 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.965 2.106 . . . . 39.039999999999999 112.576 -166.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1315 ' ' LEU . . . . . . . . . . . . . 41.9 mt -50.58 -50.36 72.84 Favored Pre-proline 0 C--O 1.21 -1.019 0 CA-C-O 113.274 -3.25 . . . . 31.079999999999998 116.425 176.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1316 ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -51.73 -34.69 55.14 Favored 'Trans proline' 0 CA--C 1.536 0.581 1 C-N-CA 125.955 4.437 . . . . 26.100000000000001 113.646 174.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -66.16 -48.47 64.57 Favored Glycine 0 C--N 1.344 0.98 0 O-C-N 120.378 -1.451 . . . . 23.170000000000002 113.228 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 75.6 mtt-85 -50.34 -0.55 0.01 OUTLIER 'General case' 0 C--O 1.237 0.405 1 N-CA-C 124.683 5.068 . . . . 40.399999999999999 124.683 -169.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 13.5 tp -126.92 72.67 75.95 Favored Pre-proline 0 C--O 1.245 0.843 0 N-CA-C 104.872 -2.27 . . . . 23.600000000000001 104.872 176.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1320 ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -43.49 -72.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 124.882 3.721 . . . . 22.350000000000001 119.847 -160.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1321 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.9 -37.66 66.61 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 113.349 0.87 . . . . 26.52 113.349 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B 1322 ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -74.23 -41.96 60.5 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 118.653 -1.219 . . . . 24.379999999999999 110.066 -173.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1323 ' ' SER . . . . . . . . . . . . . 14.8 m -59.43 -40.81 87.93 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.601 -0.84 . . . . 22.800000000000001 112.284 170.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1324 ' ' SER . . . . . . . . . . . . . 13.7 m -64.22 -25.04 67.89 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 115.481 1.66 . . . . 21.25 115.481 170.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -74.05 -50.17 20.88 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.767 -0.583 . . . . 31.34 109.551 175.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1326 ' ' LEU . . . . . . . . . . . . . 13.7 mt -72.33 -51.84 18.85 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 108.125 -1.065 . . . . 31.559999999999999 108.125 -174.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1327 ' ' TYR . . . . . . . . . . . . . 18.7 t80 -51.19 -46.63 62.22 Favored 'General case' 0 C--N 1.377 1.774 0 O-C-N 118.984 -2.322 . . . . 22.73 111.613 172.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1328 ' ' GLY . . . . . . . . . . . . . . . -51.16 -52.91 29.69 Favored Glycine 0 C--O 1.244 0.763 0 CA-C-O 123.654 1.697 . . . . 21.91 112.115 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1329 ' ' THR . . . . . . . . . . . . . 20.1 m -65.69 -36.41 83.56 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.099 -1.074 . . . . 22.149999999999999 108.099 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1330 ' ' ASN . . . . . . . . . . . . . 23.7 m120 -60.56 -47.72 84.92 Favored 'General case' 0 N--CA 1.437 -1.082 0 O-C-N 118.673 -2.517 . . . . 26.18 110.275 178.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1331 ' ' LEU . . . . . . . . . . . . . 20.1 mt -57.61 -42.57 83.52 Favored 'General case' 0 N--CA 1.435 -1.179 0 O-C-N 125.853 1.97 . . . . 23.68 111.842 172.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1332 ' ' VAL . . . . . . . . . . . . . 97.9 t -59.56 -44.91 94.2 Favored 'Isoleucine or valine' 0 C--N 1.349 0.552 0 CA-C-O 121.436 0.636 . . . . 26.57 110.581 178.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -62.67 -45.72 91.5 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.953 0.901 . . . . 28.079999999999998 110.109 -177.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1334 ' ' LEU . . . . . . . . . . . . . 4.3 tp -52.0 -52.17 52.43 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 124.733 1.27 . . . . 27.43 109.616 174.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1335 ' ' LEU . . . . . . . . . . . . . 75.3 mt -72.7 -19.29 61.43 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 114.234 -1.348 . . . . 30.5 113.356 -178.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1336 ' ' LYS . . . . . . . . . . . . . 88.5 mttt -65.63 -48.17 73.11 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-N 122.9 2.591 . . . . 41.649999999999999 107.526 169.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 10.6 mp -75.1 -30.55 60.93 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.362 0.665 . . . . 42.079999999999998 110.663 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1338 ' ' LEU . . . . . . . . . . . . . 79.0 mt -71.11 -51.53 24.55 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 119.697 -1.877 . . . . 35.030000000000001 111.052 172.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 49.8 t -96.5 71.67 2.7 Favored 'General case' 0 C--O 1.254 1.298 0 CA-C-O 124.849 2.261 . . . . 37.329999999999998 107.462 -173.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 12.8 mttp -54.35 -39.08 66.78 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 111.827 -2.442 . . . . 50.509999999999998 112.472 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -98.93 20.06 13.9 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 112.998 0.74 . . . . 54.210000000000001 112.998 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 97.1 mttt 42.6 38.35 1.26 Allowed 'General case' 0 C--O 1.248 0.974 0 C-N-CA 127.758 2.423 . . . . 50.990000000000002 117.081 159.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -111.76 -2.95 15.12 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 112.456 -2.156 . . . . 48.82 109.808 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 89.08 26.1 27.19 Favored Glycine 0 C--O 1.214 -1.1 0 CA-C-O 116.849 -2.084 . . . . 40.43 111.711 -171.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -116.78 122.76 45.37 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-N 122.277 3.038 . . . . 47.560000000000002 113.013 174.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1346 ' ' ILE . . . . . . . . . . . . . 37.6 mm -68.28 113.18 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 124.265 1.026 . . . . 42.490000000000002 111.343 -174.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1347 ' ' THR . . . . . . . . . . . . . 11.2 m -106.13 106.28 16.72 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 104.84 -2.281 . . . . 38.119999999999997 104.84 170.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 98.9 t -81.04 100.97 5.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 106.573 -1.64 . . . . 37.5 106.573 -174.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 61.0 t0 -72.91 113.2 9.67 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.712 -1.131 . . . . 43.850000000000001 111.544 -174.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1350 ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.32 -6.54 25.7 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.567 -1.333 . . . . 39.810000000000002 110.909 176.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -76.51 -29.31 56.75 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.809 -0.632 . . . . 51.289999999999999 110.827 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 42.6 t0 -88.04 127.47 35.4 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 104.147 -2.538 . . . . 39.780000000000001 104.147 -176.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 15.5 m -63.44 -27.26 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 123.766 0.826 . . . . 39.280000000000001 111.519 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1354 ' ' VAL . . . . . . . . . . . . . 50.6 t -65.16 -56.01 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.796 0.838 . . . . 35.700000000000003 112.931 175.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1355 ' ' ILE . . . . . . . . . . . . . 27.5 mm -68.86 -45.62 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-O 117.284 -1.341 . . . . 35.770000000000003 109.263 178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 52.3 tpt85 -49.1 -32.1 9.23 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 120.158 1.344 . . . . 38.549999999999997 114.577 172.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -76.14 -61.33 2.86 Favored Glycine 0 CA--C 1.492 -1.402 0 CA-C-N 116.027 -0.533 . . . . 29.579999999999998 113.101 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1358 ' ' VAL . . . . . . . . . . . . . 13.1 p -64.97 -32.65 59.19 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 O-C-N 122.079 -0.659 . . . . 32.060000000000002 111.053 -172.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1359 ' ' THR . . . . . . . . . . . . . 4.2 m -71.92 81.78 0.92 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 122.85 1.309 . . . . 29.0 108.274 175.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1360 ' ' VAL . . . . . . . . . . . . . 34.8 m -71.13 -26.03 26.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 113.004 -1.907 . . . . 29.68 111.34 -175.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 83.9 mt -132.25 119.22 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 107.118 -1.438 . . . . 32.049999999999997 107.118 170.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1362 ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -106.8 125.34 50.87 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 105.571 -2.011 . . . . 32.520000000000003 105.571 172.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 45.62 37.3 3.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 117.542 2.423 . . . . 35.68 117.542 176.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 85.84 14.88 66.51 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 113.926 -1.488 . . . . 34.259999999999998 116.057 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -108.41 135.48 49.64 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.465 -0.939 . . . . 51.07 108.465 164.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 61.4 mt -69.6 90.71 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 106.57 -1.641 . . . . 39.869999999999997 106.57 173.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1367 ' ' THR . . . . . . . . . . . . 0.252 23.8 p -85.7 10.88 12.21 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 116.698 2.11 . . . . 38.009999999999998 116.698 176.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B 1368 ' ' TRP . . . . . . . . . . . . . 1.7 t90 -78.07 138.8 60.78 Favored Pre-proline 0 C--O 1.252 1.232 0 N-CA-C 107.586 -1.264 . . . . 42.140000000000001 107.586 166.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -94.3 179.77 9.28 Favored 'Cis proline' 0 C--N 1.35 0.627 0 N-CA-C 115.958 1.484 . . . . 43.259999999999998 115.958 -3.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1370 ' ' ALA . . . . . . . . . . . . . . . -81.97 149.99 64.28 Favored Pre-proline 0 C--O 1.242 0.686 0 CA-C-O 116.77 -1.586 . . . . 46.520000000000003 108.486 163.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -49.01 120.24 5.26 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 124.44 3.427 . . . . 51.950000000000003 110.734 175.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -48.83 100.95 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 125.121 3.88 . . . . 56.270000000000003 117.503 -172.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1373 ' ' ILE . . . . . . . . . . . . . 19.1 tt -76.37 126.16 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 106.34 -1.726 . . . . 60.829999999999998 106.34 172.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -72.02 106.57 4.34 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-O 125.566 2.603 . . . . 66.099999999999994 109.634 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 71.2 t -98.24 121.56 48.92 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 CA-C-N 111.45 -2.614 . . . . 63.469999999999999 106.279 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.218 -5.11 0 O-C-N 120.004 -1.685 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.414 -2.236 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.26 -31.82 71.63 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 124.789 1.235 . . . . 0.0 110.026 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -36.15 83.42 Favored 'General case' 0 C--O 1.252 1.19 0 CA-C-N 119.398 0.999 . . . . 0.0 109.787 175.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 84.8 m -67.04 -33.03 74.65 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 118.622 0.646 . . . . 0.0 109.91 171.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.65 -50.35 51.91 Favored 'General case' 0 C--O 1.246 0.87 0 O-C-N 119.41 -2.056 . . . . 0.0 110.973 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -41.72 -57.28 2.37 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.728 -1.233 . . . . 0.0 113.557 162.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 84.7 mt -60.96 -25.42 66.81 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 175.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 44.4 mt -58.37 -56.46 21.81 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 116.613 -1.66 . . . . 0.0 110.868 172.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 28' ' ' LYS . . . . . . . . . . . . . 12.3 pttt -67.9 -31.33 71.04 Favored 'General case' 0 C--O 1.257 1.459 0 CA-C-O 123.556 1.646 . . . . 0.0 110.272 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -64.46 -27.33 68.91 Favored 'General case' 0 C--O 1.212 -0.886 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 169.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 35.4 m -65.69 -31.85 73.08 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 116.582 2.068 . . . . 0.0 116.582 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 61.08 -60.79 0.08 Allowed 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.289 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 42.0 m -85.74 137.04 33.09 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 117.072 -3.518 . . . . 0.0 106.948 156.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 60.7 t -127.99 94.33 2.48 Favored 'Isoleucine or valine' 0 C--O 1.246 0.892 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 174.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 23.6 mm -74.11 110.25 7.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 O-C-N 118.607 -2.558 . . . . 0.0 107.666 168.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 33.6 mt -85.88 114.59 25.85 Favored 'Isoleucine or valine' 0 C--O 1.254 1.303 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 169.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 36.2 m -93.67 107.88 30.3 Favored Pre-proline 0 C--O 1.246 0.914 0 O-C-N 121.08 -1.013 . . . . 0.0 110.382 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -61.18 91.35 0.1 OUTLIER 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 123.294 2.663 . . . . 0.0 113.382 177.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.56 168.92 40.5 Favored Glycine 0 N--CA 1.432 -1.569 0 CA-C-N 113.086 -1.87 . . . . 0.0 108.624 169.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -57.43 -28.04 62.96 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -177.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.45 -32.71 69.06 Favored Glycine 0 C--O 1.244 0.758 0 O-C-N 120.83 -1.169 . . . . 0.0 112.536 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 16.1 ttm -55.64 -44.54 77.26 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.557 -0.822 . . . . 0.0 111.454 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.89 -51.97 10.29 Favored 'General case' 0 C--O 1.214 -0.777 0 O-C-N 124.967 1.417 . . . . 0.0 111.627 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 11.3 p -67.43 -41.47 86.17 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 C-N-CA 119.333 -0.947 . . . . 0.0 113.358 -168.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.47 19.71 6.97 Favored 'General case' 0 N--CA 1.424 -1.731 0 O-C-N 120.899 -1.125 . . . . 0.0 110.597 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 45' ' ' GLN . . . . . . . . . . . . 0.353 0.0 OUTLIER 30.31 56.65 0.19 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 117.819 2.525 . . . . 0.0 117.819 -167.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.26 -14.19 59.54 Favored 'General case' 0 C--O 1.202 -1.44 0 CA-C-N 111.891 -2.413 . . . . 0.0 114.094 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.89 -26.38 66.85 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 48' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -62.58 -52.2 66.95 Favored Pre-proline 0 N--CA 1.443 -0.787 0 CA-C-O 117.636 -1.174 . . . . 0.0 111.767 170.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 49' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -63.58 -39.34 36.12 Favored 'Trans proline' 0 CA--C 1.551 1.359 0 C-N-CA 122.846 2.364 . . . . 0.0 114.231 170.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 54.2 t -59.81 -37.4 71.39 Favored 'Isoleucine or valine' 0 C--N 1.346 0.442 0 CA-C-O 116.126 -1.892 . . . . 0.0 111.191 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.02 -46.8 89.26 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 122.971 2.623 . . . . 0.0 108.993 -176.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -69.57 -41.18 76.19 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.332 -1.304 . . . . 0.0 113.721 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 10.2 tp -60.45 -39.72 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 120.309 1.413 . . . . 0.0 113.002 172.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 95.0 m -60.68 -46.82 88.91 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.166 173.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -55.15 -50.82 68.33 Favored 'General case' 0 C--O 1.252 1.184 0 C-N-CA 127.178 2.191 . . . . 0.0 110.231 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -57.57 -50.73 72.14 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 116.59 2.071 . . . . 0.0 116.59 175.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 29.6 mt -63.06 -40.33 97.38 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.803 -0.561 . . . . 0.0 111.787 175.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -67.7 -46.04 73.41 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 118.787 -0.625 . . . . 0.0 109.882 -175.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.74 -31.72 72.98 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 120.231 1.378 . . . . 0.0 112.502 175.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -61.36 -28.52 69.29 Favored 'General case' 0 C--N 1.346 0.45 0 O-C-N 119.913 -1.742 . . . . 0.0 110.89 171.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.4 1.84 40.91 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -177.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 64.5 mt -73.28 137.18 23.88 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 CA-C-O 126.096 2.855 . . . . 0.0 107.131 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -81.52 67.01 7.31 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 112.275 -2.239 . . . . 0.0 111.754 -177.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 2.8 p -78.51 128.64 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 173.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 30.2 mmm-85 -137.42 148.78 46.42 Favored 'General case' 0 C--N 1.349 0.546 0 N-CA-C 103.468 -2.79 . . . . 0.0 103.468 -174.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -106.09 118.89 37.8 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 122.798 1.285 . . . . 0.0 111.048 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -97.29 83.05 0.72 Allowed Glycine 0 C--O 1.25 1.107 0 N-CA-C 107.919 -2.072 . . . . 0.0 107.919 -177.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 mp -73.03 126.38 33.59 Favored 'Isoleucine or valine' 0 C--N 1.348 0.518 0 CA-C-N 119.918 1.859 . . . . 0.0 110.191 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -118.16 91.98 41.59 Favored Pre-proline 0 CA--C 1.5 -0.945 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.911 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 70' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -54.39 -39.29 88.07 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 124.733 3.622 . . . . 0.0 118.307 -168.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 42.2 t -71.03 95.57 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 171.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -161.49 106.58 1.31 Allowed 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.445 1.117 . . . . 0.0 110.762 -172.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.31 -90.95 0.53 Allowed Glycine 0 N--CA 1.467 0.719 0 O-C-N 118.34 -2.725 . . . . 0.0 113.984 156.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -145.91 114.09 6.61 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -169.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 4.0 mp 60.36 119.89 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.416 0 O-C-N 127.079 2.737 . . . . 0.0 116.808 175.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -66.69 165.14 26.54 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 124.244 3.296 . . . . 0.0 109.423 167.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.39 -115.94 5.01 Favored Glycine 0 CA--C 1.505 -0.535 0 O-C-N 120.21 -1.556 . . . . 0.0 110.338 -169.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 49.56 -79.95 0.01 OUTLIER 'General case' 0 C--O 1.248 0.979 0 C-N-CA 124.819 1.248 . . . . 0.0 114.166 155.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -67.65 -35.43 78.87 Favored 'General case' 0 C--O 1.241 0.652 0 O-C-N 118.962 -2.336 . . . . 0.0 110.209 -177.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -64.13 -34.1 77.29 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 74.8 t -65.71 -41.03 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 122.139 -0.351 . . . . 0.0 111.351 176.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 45.9 mt -66.63 -30.27 70.5 Favored 'General case' 0 C--O 1.252 1.194 0 CA-C-O 123.361 1.553 . . . . 0.0 109.904 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 6.0 mp -66.89 -48.34 69.05 Favored 'General case' 0 C--O 1.24 0.568 0 O-C-N 120.869 -1.144 . . . . 0.0 110.162 172.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.18 -49.42 77.1 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 177.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -58.59 -55.04 40.18 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-O 117.873 -1.061 . . . . 0.0 109.075 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.77 9.08 0.3 Allowed 'General case' 0 C--O 1.246 0.874 0 CA-C-N 121.158 1.799 . . . . 0.0 114.05 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp 64.14 30.87 13.64 Favored 'General case' 0 C--O 1.257 1.5 0 CA-C-N 122.017 2.19 . . . . 0.0 115.012 172.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 60.7 t -72.34 120.24 79.33 Favored Pre-proline 0 C--O 1.262 1.722 0 N-CA-C 104.462 -2.421 . . . . 0.0 104.462 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -56.71 115.94 2.84 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.854 3.036 . . . . 0.0 116.37 -171.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -60.69 -22.37 63.85 Favored 'General case' 0 C--O 1.246 0.885 0 CA-C-O 123.381 1.562 . . . . 0.0 114.125 173.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -43.19 -56.75 3.28 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 124.87 1.268 . . . . 0.0 112.758 164.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 1.9 pt -96.43 -10.38 8.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.577 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 41.5 t -74.13 108.43 5.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-O 123.749 1.738 . . . . 0.0 110.656 175.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 6.0 mt -106.25 95.61 5.89 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 120.624 -1.297 . . . . 0.0 110.975 176.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -71.19 91.53 0.95 Allowed 'General case' 0 C--O 1.255 1.352 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.056 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 39.3 ttp 50.52 97.8 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 124.503 2.097 . . . . 0.0 116.445 -175.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -157.94 163.51 37.77 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 113.396 -1.729 . . . . 0.0 107.53 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -84.8 94.92 8.82 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 124.975 2.322 . . . . 0.0 111.471 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 10.3 tp -100.03 41.02 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 CA-C-N 109.079 -3.691 . . . . 0.0 107.386 164.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -76.91 -31.12 56.47 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 119.984 -1.698 . . . . 0.0 108.153 -161.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -63.45 -61.22 2.48 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 124.576 1.15 . . . . 0.0 113.93 170.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.83 -21.08 66.45 Favored 'General case' 0 C--N 1.355 0.818 0 O-C-N 123.852 0.72 . . . . 0.0 111.626 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.62 -60.17 3.94 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 123.304 0.642 . . . . 0.0 110.768 170.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.25 -31.35 72.48 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 173.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -66.24 -26.45 67.37 Favored 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 120.509 -1.369 . . . . 0.0 111.837 175.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 106' ' ' THR . . . . . . . . . . . . . 53.6 m -73.02 125.75 28.35 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 121.842 2.11 . . . . 0.0 108.946 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 107' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -72.36 -43.37 64.13 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 113.006 -1.906 . . . . 0.0 110.621 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 80.0 m -125.62 104.53 8.44 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 119.015 0.825 . . . . 0.0 111.622 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 109' ' ' VAL . . . . . . . . . . . . . 8.1 t -87.0 120.95 37.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -171.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 20.8 mt -90.32 93.77 9.47 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -171.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 19.1 t -84.81 109.31 17.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.037 170.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 6.5 mm -78.06 90.02 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.919 0 CA-C-O 121.888 0.851 . . . . 0.0 110.652 -174.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.79 -72.95 2.54 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-O 124.106 1.948 . . . . 0.0 113.969 168.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.77 108.29 8.52 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 120.773 -1.428 . . . . 0.0 112.819 -168.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 115' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -65.75 -58.46 5.62 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 113.106 -1.861 . . . . 0.0 115.213 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 116' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -57.62 -19.38 25.77 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 116.713 2.116 . . . . 0.0 116.713 -168.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 3.1 m -44.54 -43.47 8.03 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.658 1.983 . . . . 0.0 110.624 173.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 13.7 m -125.07 37.75 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.624 0 CA-C-O 122.952 1.358 . . . . 0.0 110.83 -177.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -77.82 114.22 39.55 Favored Pre-proline 0 C--O 1.243 0.73 0 O-C-N 120.463 -1.398 . . . . 0.0 110.832 -176.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 120' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -64.6 -34.0 53.69 Favored 'Trans proline' 0 CA--C 1.495 -1.471 0 C-N-CA 125.045 3.83 . . . . 0.0 114.183 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.23 -30.27 71.33 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 118.614 -1.235 . . . . 0.0 110.429 174.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.72 -19.83 64.37 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -86.7 -59.78 2.17 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 118.039 -2.913 . . . . 0.0 114.621 161.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -65.44 -45.05 85.33 Favored 'General case' 0 N--CA 1.438 -1.067 0 O-C-N 127.431 2.957 . . . . 0.0 115.042 -168.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.59 119.98 77.84 Favored Pre-proline 0 C--O 1.243 0.735 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -170.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -75.49 76.01 3.73 Favored 'Trans proline' 0 N--CA 1.436 -1.878 1 C-N-CA 125.843 4.362 . . . . 0.0 109.413 175.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? 174.98 -25.5 0.0 OUTLIER 'General case' 0 C--O 1.248 0.981 0 C-N-CA 125.98 1.712 . . . . 0.0 108.378 -173.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 128' ' ' SER . . . . . . . . . . . . . 73.8 m -68.17 126.62 92.87 Favored Pre-proline 0 N--CA 1.446 -0.658 0 CA-C-N 120.961 1.709 . . . . 0.0 112.024 175.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 129' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -56.72 -58.39 0.98 Allowed 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 123.836 3.024 . . . . 0.0 114.091 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 13.3 pt -73.21 66.32 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 C-N-CA 123.977 0.911 . . . . 0.0 112.308 171.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -72.93 150.9 42.15 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 122.695 1.236 . . . . 0.0 113.409 -170.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.03 53.36 27.0 Favored Glycine 0 CA--C 1.497 -1.045 0 CA-C-N 111.846 -2.434 . . . . 0.0 107.679 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 133' ' ' MET . . . . . . . . . . . . . 24.5 tpp -76.62 129.45 79.4 Favored Pre-proline 0 C--O 1.252 1.185 0 CA-C-N 118.69 1.245 . . . . 0.0 110.715 175.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -62.78 101.93 0.28 Allowed 'Trans proline' 0 CA--C 1.517 -0.341 0 C-N-CA 125.22 3.947 . . . . 0.0 110.981 171.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 15.7 t -120.45 93.88 2.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 1 N-CA-C 99.743 -4.169 . . . . 0.0 99.743 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 5.1 mt -73.5 78.84 1.43 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.451 0.643 . . . . 0.0 112.196 -170.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 48.68 5.05 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 120.243 3.423 . . . . 0.0 120.243 -167.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 138' ' ' VAL . . . . . . . . . . . . 0.291 13.0 p -76.22 61.9 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 117.457 2.391 . . . . 0.0 117.457 -173.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 17.7 p90 -158.2 178.18 10.47 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 123.302 0.641 . . . . 0.0 109.618 171.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 140' ' ' LYS . . . . . . . . . . . . . 15.4 pttm 63.58 -58.16 0.19 Allowed 'General case' 0 C--O 1.247 0.933 0 C-N-CA 126.998 2.119 . . . . 0.0 115.681 174.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -90.76 174.28 7.56 Favored 'General case' 0 C--N 1.319 -0.746 0 O-C-N 120.122 -1.611 . . . . 0.0 107.346 170.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 63.97 157.51 0.08 Allowed 'General case' 0 C--N 1.345 0.383 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 172.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 143' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -80.14 79.26 6.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 125.167 2.413 . . . . 0.0 107.075 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 144' ' ' VAL . . . . . . . . . . . . . 58.0 t -85.94 83.97 2.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 O-C-N 118.598 -2.564 . . . . 0.0 106.001 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 145' ' ' ILE . . . . . . . . . . . . . 35.7 mt -88.91 109.18 19.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 125.501 2.572 . . . . 0.0 114.823 -170.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 146' ' ' VAL . . . . . . . . . . . . . 27.1 t -96.05 108.58 21.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 109.444 -3.525 . . . . 0.0 107.142 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 147' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -70.75 102.58 2.35 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 148' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -131.28 133.77 45.73 Favored 'General case' 0 C--O 1.244 0.797 0 O-C-N 118.973 -2.329 . . . . 0.0 109.512 -175.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 19.6 ttm105 -83.37 -92.27 0.07 Allowed 'General case' 0 C--O 1.24 0.565 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 176.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 1.1 m -70.52 131.46 44.05 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 121.475 1.943 . . . . 0.0 111.056 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 5.7 tpt -75.58 92.86 2.96 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-O 125.823 2.725 . . . . 0.0 107.713 163.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -133.85 152.02 51.73 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-N 110.698 -2.956 . . . . 0.0 109.523 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 73.2 m -63.46 150.63 43.27 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.396 172.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -111.2 -81.32 1.17 Allowed Glycine 0 C--N 1.353 1.527 0 N-CA-C 107.27 -2.332 . . . . 0.0 107.27 165.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -112.0 -46.94 3.17 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 117.51 -1.233 . . . . 0.0 110.876 174.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 156' ' ' ALA . . . . . . . . . . . . . . . -87.4 -69.18 0.7 Allowed 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 119.614 1.097 . . . . 0.0 110.403 166.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 50.15 32.08 20.17 Favored Glycine 0 C--N 1.34 0.802 0 N-CA-C 115.218 0.847 . . . . 0.0 115.218 -170.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 14.6 m -92.26 153.69 3.26 Favored 'Isoleucine or valine' 0 C--O 1.253 1.27 0 C-N-CA 123.41 0.684 . . . . 0.0 110.007 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -41.76 112.05 0.29 Allowed 'General case' 0 C--N 1.345 0.394 0 N-CA-C 119.75 3.241 . . . . 0.0 119.75 176.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 160' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -157.54 159.09 30.9 Favored Pre-proline 0 N--CA 1.436 -1.147 0 O-C-N 120.486 -1.384 . . . . 0.0 110.511 -173.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -38.38 -57.7 0.82 Allowed 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 124.43 3.42 . . . . 0.0 112.313 176.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 162' ' ' LEU . . . . . . . . . . . . . 9.6 mp -43.21 -31.34 0.59 Allowed 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 -175.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 163' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -88.11 -59.57 2.2 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.729 -1.578 . . . . 0.0 107.382 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -91.44 -10.16 42.0 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 116.579 2.066 . . . . 0.0 116.579 -161.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -84.58 152.62 23.74 Favored 'General case' 0 C--O 1.243 0.713 0 O-C-N 120.614 -1.304 . . . . 0.0 110.639 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -78.87 -34.08 45.25 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-N 112.936 -1.938 . . . . 0.0 110.546 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 40.3 p-10 -91.78 -63.16 1.28 Allowed 'General case' 0 C--O 1.245 0.848 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 168' ' ' THR . . . . . . . . . . . . . 25.1 m -72.02 102.71 3.03 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 117.091 -3.505 . . . . 0.0 103.328 172.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -143.72 136.57 27.42 Favored 'General case' 0 CA--C 1.5 -0.962 0 O-C-N 119.254 -2.154 . . . . 0.0 112.692 -153.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 170' ' ' MET . . . . . . . . . . . . . 76.9 mtm -67.12 119.97 12.93 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 120.526 -1.359 . . . . 0.0 109.057 163.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 171' ' ' LEU . . . . . . . . . . . . . 13.1 tp -83.92 144.65 29.06 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 168.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -89.22 99.27 12.3 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 -167.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . 154.79 166.4 15.18 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-O 124.466 2.148 . . . . 0.0 109.992 167.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 174' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -50.68 153.13 1.78 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.339 1.856 . . . . 0.0 112.648 169.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.9 -56.0 27.16 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.886 1.274 . . . . 0.0 110.842 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.81 -39.88 76.25 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 121.272 -0.892 . . . . 0.0 112.61 -177.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 177' ' ' ALA . . . . . . . . . . . . . . . -53.73 -44.1 69.62 Favored 'General case' 0 C--O 1.256 1.395 0 C-N-CA 125.249 1.42 . . . . 0.0 110.642 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 20.0 m -74.81 -42.5 57.93 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.0 -1.454 . . . . 0.0 111.456 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 179' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.17 -55.01 26.82 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-N 120.223 1.374 . . . . 0.0 112.335 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -55.87 -39.12 71.05 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 119.001 -2.312 . . . . 0.0 112.672 178.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -54.46 -56.59 17.23 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 117.479 -1.248 . . . . 0.0 111.172 169.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 182' ' ' ILE . . . . . . . . . . . . . 19.0 pt -66.59 -32.32 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 121.058 1.754 . . . . 0.0 114.583 -175.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 183' ' ' LEU . . . . . . . . . . . . . 59.3 tp -48.27 -57.14 6.38 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 127.002 2.121 . . . . 0.0 112.581 170.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 24.6 tptt -75.15 -33.48 61.52 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 124.83 1.332 . . . . 0.0 112.648 -178.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -67.78 -91.61 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.17 0 O-C-N 126.502 2.376 . . . . 0.0 110.972 177.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 186' ' ' LEU . . . . . . . . . . . . 0.25 8.8 mt . . . . . 0 C--O 1.205 -1.255 0 O-C-N 120.237 -1.54 . . . . 0.0 112.505 -152.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 42.2 t-80 . . . . . 0 N--CA 1.419 -1.999 0 N-CA-C 105.757 -1.942 . . . . 65.739999999999995 105.757 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -69.1 66.88 0.5 Allowed Glycine 0 C--N 1.348 1.236 0 C-N-CA 123.937 0.779 . . . . 48.659999999999997 111.622 172.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -80.18 124.86 29.16 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 120.002 -0.679 . . . . 44.560000000000002 109.388 173.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1003 ' ' ILE . . . . . . . . . . . . . 34.8 mt -95.65 132.71 39.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 120.554 -1.341 . . . . 34.859999999999999 107.668 171.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -105.11 127.76 9.17 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 108.438 -1.865 . . . . 30.75 108.438 172.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 23.0 mm -103.01 108.63 59.29 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 102.903 -2.999 . . . . 32.210000000000001 102.903 172.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -74.09 167.09 28.03 Favored 'Trans proline' 0 N--CA 1.439 -1.68 0 C-N-CA 122.474 2.116 . . . . 32.979999999999997 111.104 171.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1007 ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -84.77 131.78 34.51 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 102.438 -3.171 . . . . 47.979999999999997 102.438 157.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1008 ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -55.81 134.19 51.58 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 117.157 2.28 . . . . 34.700000000000003 117.157 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 21.7 mtp-105 -101.18 0.44 37.61 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 113.658 -1.61 . . . . 53.369999999999997 110.796 -171.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 52.7 tp -70.57 136.78 49.53 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 106.314 -1.735 . . . . 45.07 106.314 169.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1011 ' ' THR . . . . . . . . . . . . . 45.8 m -57.27 135.39 56.46 Favored 'General case' 0 C--O 1.243 0.76 0 O-C-N 120.461 -1.4 . . . . 40.359999999999999 109.81 -174.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 84.3 m-20 60.34 27.92 17.51 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 116.412 2.004 . . . . 40.609999999999999 116.412 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -87.74 147.93 24.97 Favored 'General case' 0 CA--C 1.504 -0.811 0 C-N-CA 118.616 -1.234 . . . . 33.759999999999998 109.797 -174.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1014 ' ' THR . . . . . . . . . . . . . 1.9 m -117.06 -14.41 10.58 Favored 'General case' 0 C--O 1.257 1.483 0 CA-C-O 124.199 1.952 . . . . 27.890000000000001 110.81 176.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1015 ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -66.12 125.76 26.52 Favored 'General case' 0 C--O 1.214 -0.775 0 O-C-N 119.468 -2.02 . . . . 29.02 114.054 173.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1016 ' ' VAL . . . . . . . . . . . . . 3.4 t -120.52 150.81 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 106.721 -1.585 . . . . 28.129999999999999 106.721 165.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1017 ' ' ALA . . . . . . . . . . . . . . . -59.19 -53.24 60.6 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 117.311 2.337 . . . . 26.870000000000001 117.311 -177.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -129.52 143.05 50.67 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 112.22 0.452 . . . . 26.77 112.22 -167.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1019 ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.5 174.06 6.74 Favored Pre-proline 0 C--N 1.347 0.475 0 C-N-CA 124.176 0.99 . . . . 27.02 110.887 168.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1020 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -54.18 -34.96 81.03 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.33 2.687 . . . . 30.57 111.455 168.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -55.24 -58.02 9.4 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 114.055 -1.43 . . . . 47.810000000000002 112.461 173.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1022 ' ' THR . . . . . . . . . . . . 0.281 3.2 p -77.13 -21.75 53.67 Favored 'General case' 0 C--N 1.309 -1.17 0 O-C-N 120.312 -1.492 . . . . 30.77 112.892 -174.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1023 ' ' VAL . . . . . . . . . . . . . 8.9 t -56.89 -51.29 69.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 N-CA-C 108.594 -0.891 . . . . 33.590000000000003 108.594 164.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -65.8 -32.73 74.42 Favored 'General case' 0 C--N 1.35 0.617 0 N-CA-C 114.284 1.216 . . . . 53.289999999999999 114.284 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -58.2 -49.71 76.09 Favored 'General case' 0 C--O 1.254 1.336 0 CA-C-N 119.286 0.948 . . . . 46.920000000000002 112.125 170.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1026 ' ' LEU . . . . . . . . . . . . . 14.9 mt -59.75 -38.56 82.1 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 118.527 -2.608 . . . . 37.170000000000002 114.006 176.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 29.3 tp -59.11 -40.59 85.83 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 113.848 -1.523 . . . . 44.439999999999998 112.404 171.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -70.06 -26.29 63.94 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 119.526 -1.983 . . . . 52.579999999999998 113.71 173.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1029 ' ' LEU . . . . . . . . . . . . . 25.5 mt -65.51 -39.88 92.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.609 0.719 . . . . 45.689999999999998 111.019 162.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 115.55 15.57 7.47 Favored Glycine 0 CA--C 1.503 -0.715 0 O-C-N 118.708 -2.495 . . . . 42.090000000000003 110.97 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -92.82 147.54 22.77 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 107.299 -1.371 . . . . 40.719999999999999 107.299 168.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1032 ' ' THR . . . . . . . . . . . . . 10.7 m -99.17 118.68 36.44 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.056 -1.091 . . . . 37.770000000000003 108.056 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1033 ' ' VAL . . . . . . . . . . . . . 3.5 t -89.49 141.96 13.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.134 -0.939 . . . . 33.539999999999999 111.761 -171.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -128.58 135.01 48.77 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 104.445 -2.428 . . . . 31.68 104.445 176.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1035 ' ' VAL . . . . . . . . . . . . . 69.2 t -119.71 144.5 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 O-C-N 120.697 -1.252 . . . . 31.52 110.718 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1036 ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -72.7 130.2 39.99 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 124.155 0.91 . . . . 41.039999999999999 110.778 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1037 ' ' SER . . . . . . . . . . . . . 65.9 m -60.1 111.2 1.42 Allowed 'General case' 0 C--O 1.262 1.714 0 N-CA-C 107.293 -1.373 . . . . 31.829999999999998 107.293 165.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 130.01 -32.41 3.14 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.573 -0.822 . . . . 29.359999999999999 111.127 -172.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -64.08 -39.89 95.06 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 117.594 -1.193 . . . . 27.780000000000001 108.842 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -52.08 -47.32 55.03 Favored Glycine 0 C--N 1.359 1.809 0 CA-C-O 121.817 0.676 . . . . 28.91 112.325 169.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -66.24 -32.37 73.75 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.771 -0.841 . . . . 51.18 110.894 -175.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1042 ' ' LEU . . . . . . . . . . . . . 14.0 mt -69.93 -56.3 7.39 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 121.16 1.8 . . . . 29.91 111.528 165.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1043 ' ' ALA . . . . . . . . . . . . . . . -69.9 12.31 0.22 Allowed 'General case' 0 CA--C 1.556 1.2 0 O-C-N 119.334 -2.104 . . . . 28.539999999999999 112.636 -174.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1044 ' ' SER . . . . . . . . . . . . . 13.8 m 63.27 59.54 1.26 Allowed 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 124.454 2.073 . . . . 33.060000000000002 113.863 174.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1045 ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -150.58 167.15 28.1 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 111.088 -2.778 . . . . 30.289999999999999 106.52 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1046 ' ' ASP . . . . . 0.428 ' CG ' ' HZ1' ' A' 1048 ' ' LYS . 24.4 p-10 -97.25 151.34 19.95 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 106.624 -1.621 . . . . 48.619999999999997 106.624 151.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -59.84 -16.99 32.97 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 114.199 1.185 . . . . 36.740000000000002 114.199 -166.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1048 ' ' LYS . . . . . 0.428 ' HZ1' ' CG ' ' A' 1046 ' ' ASP . 20.5 pttm -55.05 -26.36 36.99 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 121.987 2.176 . . . . 43.729999999999997 110.91 174.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -52.73 -53.63 45.17 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 120.661 -1.274 . . . . 32.810000000000002 112.576 171.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1050 ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -63.09 -33.38 75.32 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.909 -1.041 . . . . 31.859999999999999 113.657 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 25.5 t -63.98 -41.27 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 O-C-N 121.157 -0.964 . . . . 33.219999999999999 109.313 173.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -64.41 -41.99 96.31 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 122.468 1.128 . . . . 50.829999999999998 111.586 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -60.48 -52.76 63.82 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 114.333 -1.303 . . . . 33.119999999999997 110.64 170.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 122.34 75.03 0.33 Allowed Glycine 0 CA--C 1.489 -1.555 0 CA-C-O 123.523 1.624 . . . . 35.829999999999998 110.057 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -143.26 127.22 17.34 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 105.809 -1.923 . . . . 34.82 105.809 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -62.28 118.57 7.61 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.283 -0.871 . . . . 49.049999999999997 111.718 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1057 ' ' ILE . . . . . . . . . . . . . 17.3 mm -89.04 124.62 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 124.538 2.113 . . . . 38.530000000000001 110.953 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1058 ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.11 158.55 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 110.877 -2.874 . . . . 42.109999999999999 107.133 -175.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -88.22 167.8 13.28 Favored 'General case' 0 C--O 1.259 1.592 0 N-CA-C 113.925 1.083 . . . . 58.0 113.925 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . -31.05 -69.66 0.09 OUTLIER Glycine 0 C--N 1.348 1.235 0 N-CA-C 117.881 1.912 . . . . 52.119999999999997 117.881 -172.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 5.4 m120 -64.37 -33.59 76.2 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 119.912 1.856 . . . . 54.75 112.215 -169.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1062 ' ' SER . . . . . . . . . . . . . 16.8 m -73.91 -40.33 63.22 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 125.972 2.045 . . . . 50.340000000000003 108.009 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 4.1 p -68.88 -25.95 31.46 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 CA-C-N 122.473 2.397 . . . . 41.460000000000001 111.415 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1064 ' ' TRP . . . . . . . . . . . . . 11.4 m95 -66.21 -29.56 69.84 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-N 115.303 -0.862 . . . . 39.32 112.837 173.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -81.31 79.44 7.94 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 123.423 1.582 . . . . 55.380000000000003 107.847 -174.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1066 ' ' SER . . . . . . . . . . . . . 58.7 m -147.63 161.4 41.23 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 120.553 -1.342 . . . . 41.869999999999997 108.771 -171.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -69.62 -44.78 69.98 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 107.009 -1.478 . . . . 53.200000000000003 107.009 -176.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 5.2 mp -120.12 139.44 47.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 103.605 -2.739 . . . . 41.899999999999999 103.605 -178.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1069 ' ' ILE . . . . . . . . . . . . . 9.7 mm -119.23 126.9 75.76 Favored 'Isoleucine or valine' 0 C--O 1.248 0.989 0 N-CA-C 105.292 -2.114 . . . . 38.729999999999997 105.292 170.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1070 ' ' LEU . . . . . . . . . . . . . 71.4 mt -107.47 87.6 2.54 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-O 122.618 1.199 . . . . 32.439999999999998 108.233 173.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1071 ' ' LYS . . . . . . . . . . . . . 3.5 mmmt -87.32 171.67 10.43 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 107.429 -1.322 . . . . 34.649999999999999 107.429 166.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1072 ' ' VAL . . . . . . . . . . . . . 8.0 t -100.37 -78.05 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 107.043 -1.465 . . . . 31.32 107.043 171.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -101.26 140.25 35.82 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 108.038 -1.097 . . . . 33.939999999999998 108.038 -161.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . 27.58 103.03 0.01 OUTLIER Pre-proline 0 C--O 1.247 0.933 0 N-CA-C 119.642 3.201 . . . . 38.039999999999999 119.642 171.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1075 ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -76.39 91.04 1.15 Allowed 'Trans proline' 0 CA--C 1.509 -0.77 0 C-N-CA 123.678 2.918 . . . . 42.68 109.541 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 65.3 mt -71.36 -179.75 2.59 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 114.425 -1.262 . . . . 46.740000000000002 114.043 -171.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.38 -35.6 67.9 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 116.907 2.188 . . . . 58.609999999999999 116.907 -173.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 16.4 t70 -67.2 -47.86 69.63 Favored 'General case' 0 C--O 1.26 1.641 0 C-N-CA 124.094 0.957 . . . . 59.200000000000003 110.388 173.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1079 ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -53.78 -37.35 63.36 Favored 'General case' 0 C--N 1.363 1.173 0 CA-C-O 117.108 -1.425 . . . . 50.630000000000003 110.753 174.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1080 ' ' ILE . . . . . . . . . . . . . 55.6 mt -54.4 -47.3 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-N 119.433 1.015 . . . . 51.479999999999997 111.05 175.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -64.19 -33.77 76.56 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.54 1.518 . . . . 50.280000000000001 109.843 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 34.6 mt -71.82 -27.04 62.64 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 114.044 1.127 . . . . 50.210000000000001 114.044 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1083 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.44 133.15 49.79 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-O 122.656 1.217 . . . . 49.060000000000002 112.205 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.02 125.96 62.65 Favored Pre-proline 0 N--CA 1.472 0.627 0 N-CA-C 101.431 -3.544 . . . . 51.079999999999998 101.431 177.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.87 63.92 0.03 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 124.165 3.243 . . . . 49.729999999999997 119.729 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 173.44 -33.68 0.11 Allowed Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.111 -1.195 . . . . 47.710000000000001 110.111 -168.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1087 ' ' THR . . . . . . . . . . . . . 98.0 m -44.78 130.13 7.12 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 117.42 2.378 . . . . 45.469999999999999 117.42 -175.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1088 ' ' THR . . . . . . . . . . . . . 1.4 m -75.53 93.82 3.06 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 113.427 -1.715 . . . . 42.039999999999999 108.956 170.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1089 ' ' LEU . . . . . . . . . . . . . 54.8 tp -90.67 92.83 9.0 Favored 'General case' 0 C--N 1.348 0.535 0 O-C-N 121.074 -1.016 . . . . 38.060000000000002 108.398 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 89.1 t -99.65 99.03 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 102.559 -3.126 . . . . 37.399999999999999 102.559 -172.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1091 ' ' SER . . . . . . . . . . . . . 49.5 m -152.55 166.31 32.44 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 115.51 1.67 . . . . 36.159999999999997 115.51 -174.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -66.42 88.28 0.13 Allowed 'General case' 0 C--O 1.253 1.274 0 O-C-N 118.118 -2.864 . . . . 38.939999999999998 109.822 161.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 26.2 mm -81.22 -32.43 12.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 122.935 1.35 . . . . 42.170000000000002 110.981 -173.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 77.8 m95 60.5 48.53 1.71 Allowed Pre-proline 0 C--O 1.243 0.717 0 C-N-CA 125.306 1.442 . . . . 46.509999999999998 111.108 -170.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -54.68 -44.62 47.91 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 124.691 3.594 . . . . 49.759999999999998 116.468 -169.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -67.41 -33.98 76.29 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 122.529 1.157 . . . . 52.619999999999997 110.724 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -85.2 -5.39 59.33 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 114.67 -1.15 . . . . 60.740000000000002 110.657 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1098 ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -130.94 64.17 72.83 Favored Pre-proline 0 N--CA 1.439 -0.975 0 N-CA-C 114.082 1.141 . . . . 58.189999999999998 114.082 -178.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -61.11 -42.97 32.28 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.759 2.973 . . . . 54.590000000000003 114.8 -174.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 52.2 mp0 -70.5 -42.73 70.96 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.541 -0.911 . . . . 63.280000000000001 108.541 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1101 ' ' LEU . . . . . . . . . . . . . 5.7 tp -57.39 -41.14 79.67 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.859 0.864 . . . . 54.75 109.309 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1102 ' ' MET . . . . . . . . . . . . . 43.1 mmm -54.93 -48.37 73.22 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 120.599 -1.313 . . . . 52.649999999999999 112.46 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -61.25 -41.11 96.35 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 124.305 1.042 . . . . 66.260000000000005 110.479 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -74.23 -34.1 63.57 Favored 'General case' 0 C--O 1.247 0.946 0 O-C-N 121.373 -0.829 . . . . 63.729999999999997 110.947 -177.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 79.3 mt -68.51 -35.13 77.06 Favored 'General case' 0 C--O 1.253 1.281 0 CA-C-O 121.218 0.532 . . . . 54.68 109.826 174.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -66.83 -40.37 87.97 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.59 0.709 . . . . 53.640000000000001 112.089 172.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -54.91 -33.13 61.76 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.607 2.363 . . . . 67.239999999999995 113.981 168.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.43 10.49 3.08 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 116.121 -1.895 . . . . 65.760000000000005 115.343 172.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 20.1 t30 53.65 21.17 2.47 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 123.136 2.698 . . . . 58.710000000000001 114.602 173.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1110 ' ' VAL . . . . . . . . . . . . . 17.9 m -90.67 175.08 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 O-C-N 118.412 -2.68 . . . . 46.630000000000003 114.422 -173.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1111 ' ' THR . . . . . . . . . . . . . 22.0 m -112.91 90.84 3.45 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 106.788 -1.56 . . . . 44.130000000000003 106.788 174.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1112 ' ' VAL . . . . . . . . . . . . . 53.0 t -92.14 109.98 22.15 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 CA-C-N 114.653 -1.158 . . . . 40.439999999999998 110.446 -173.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1113 ' ' MET . . . . . . . . . . . . . 64.6 mtp -102.93 115.52 30.76 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 112.326 -2.216 . . . . 50.759999999999998 110.489 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1114 ' ' ALA . . . . . . . . . . . . . . . -94.44 94.08 8.03 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-N 114.435 -1.257 . . . . 35.640000000000001 109.511 -169.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1115 ' ' MET . . . . . . . . . . . . . 83.8 mmm -57.7 -34.49 69.5 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 114.951 1.463 . . . . 38.740000000000002 114.951 -178.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -61.04 -38.69 87.04 Favored 'General case' 0 C--O 1.219 -0.525 0 O-C-N 121.694 -0.629 . . . . 40.140000000000001 110.533 174.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1117 ' ' SER . . . . . . . . . . . . . 47.9 m -94.68 27.88 2.87 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 115.058 1.503 . . . . 44.789999999999999 115.058 -176.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1118 ' ' VAL . . . . . . . . . . . . . 10.3 m -53.96 140.93 50.25 Favored Pre-proline 0 N--CA 1.436 -1.166 0 CA-C-O 117.49 -1.243 . . . . 43.75 112.072 168.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -66.2 125.71 14.51 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.373 2.716 . . . . 48.93 109.684 168.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 34.1 mmm-85 -78.81 20.31 0.47 Allowed 'General case' 0 C--O 1.249 1.041 0 N-CA-C 117.082 2.253 . . . . 62.899999999999999 117.082 -160.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 38.9 pt -72.86 167.99 2.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 114.538 1.31 . . . . 57.719999999999999 114.538 -167.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1122 ' ' SER . . . . . . . . . . . . . 6.7 m -59.73 -40.35 87.76 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-O 118.066 -0.968 . . . . 57.259999999999998 111.435 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -56.45 -36.23 68.79 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 121.443 1.929 . . . . 62.899999999999999 108.762 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -73.75 -24.34 59.86 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-O 116.114 -1.898 . . . . 49.829999999999998 115.68 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1125 ' ' GLN . . . . . . . . . . . . 0.28 73.4 mm-40 -46.8 -21.96 0.26 Allowed 'General case' 0 N--CA 1.474 0.754 1 N-CA-C 122.352 4.205 . . . . 52.369999999999997 122.352 -169.238 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A 1126 ' ' SER . . . . . . . . . . . . . 11.9 p -85.07 -35.66 21.7 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 119.199 -2.188 . . . . 42.43 109.971 172.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1127 ' ' LEU . . . . . . . . . . . . . 4.6 mp -84.78 -18.79 33.92 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.354 1.862 . . . . 43.740000000000002 112.394 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 53.8 t0 -70.97 92.92 0.95 Allowed 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 125.423 2.535 . . . . 43.210000000000001 110.645 -173.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -61.02 -40.98 95.67 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 110.024 -3.262 . . . . 35.740000000000002 111.273 177.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.95 -28.63 68.44 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 119.043 -2.286 . . . . 38.090000000000003 108.737 -176.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1131 ' ' SER . . . . . . . . . . . . . 75.0 m -67.71 -55.47 13.05 Favored 'General case' 0 CA--C 1.501 -0.935 0 O-C-N 119.487 -2.008 . . . . 36.909999999999997 113.634 172.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1132 ' ' SER . . . . . . . . . . . . . 4.1 m -61.99 -43.85 97.97 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 119.159 0.89 . . . . 35.789999999999999 113.203 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1133 ' ' MET . . . . . . . . . . . . . 13.9 mmm -59.58 -41.56 90.5 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 121.005 1.73 . . . . 30.809999999999999 109.897 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1134 ' ' ALA . . . . . . . . . . . . . . . -63.45 -45.03 92.74 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 123.636 0.775 . . . . 28.879999999999999 109.157 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1135 ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -59.5 -46.25 89.37 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.532 0.682 . . . . 40.759999999999998 112.237 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1136 ' ' ILE . . . . . . . . . . . . . 68.6 mt -55.9 -50.3 69.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 125.038 1.335 . . . . 31.539999999999999 109.4 173.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -62.55 -32.1 73.01 Favored 'General case' 0 C--N 1.344 0.352 0 N-CA-C 114.193 1.183 . . . . 29.870000000000001 114.193 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -70.53 -44.02 59.33 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 118.914 0.779 . . . . 28.73 112.412 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 20.1 t80 -66.76 -48.5 68.89 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 107.321 -1.363 . . . . 30.390000000000001 107.321 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1140 ' ' ARG . . . . . 0.44 ' NH1' ' O ' ' A' 1318 ' ' ARG . 6.0 tpt180 -65.19 -26.22 68.05 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 113.577 0.954 . . . . 26.09 113.577 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1141 ' ' ALA . . . . . . . . . . . . . . . -58.84 -53.5 57.68 Favored 'General case' 0 C--N 1.359 1.0 0 CA-C-O 118.521 -0.752 . . . . 27.100000000000001 109.914 167.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 32.8 mm -51.8 -43.58 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 O-C-N 124.238 0.961 . . . . 28.48 112.219 172.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 76.2 t -58.98 -62.02 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-N 119.655 1.116 . . . . 23.07 112.687 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1144 ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -64.73 -29.1 70.07 Favored 'General case' 0 C--N 1.343 0.296 0 O-C-N 120.703 -1.248 . . . . 33.399999999999999 111.551 -177.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -54.61 -63.95 0.99 Allowed 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 117.784 -1.103 . . . . 24.219999999999999 112.601 165.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -54.35 -23.17 14.35 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 122.881 1.324 . . . . 24.890000000000001 113.908 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -66.63 -69.03 0.33 Allowed 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 120.272 -1.518 . . . . 26.73 110.13 169.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1148 ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -73.72 -9.46 58.68 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 116.684 2.105 . . . . 39.960000000000001 116.684 -176.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1149 ' ' PHE . . . . . . . . . . . . . 1.2 t80 -59.99 146.18 43.53 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 123.272 1.511 . . . . 25.870000000000001 111.678 176.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1150 ' ' GLY . . . . . . . . . . . . . . . -80.63 -38.92 15.42 Favored Glycine 0 N--CA 1.429 -1.816 0 CA-C-N 113.374 -1.739 . . . . 19.280000000000001 109.617 173.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1151 ' ' ARG . . . . . . . . . . . . . 66.6 mtm-85 -113.84 -170.83 1.78 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 121.157 2.479 . . . . 39.899999999999999 114.774 -163.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1152 ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -83.49 152.97 24.67 Favored 'General case' 0 C--O 1.218 -0.557 0 O-C-N 119.369 -2.082 . . . . 29.440000000000001 113.637 165.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1153 ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -70.64 -49.75 44.2 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 113.232 -1.804 . . . . 32.600000000000001 107.509 157.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1154 ' ' THR . . . . . . . . . . . . . 1.8 m -76.47 115.57 16.34 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 125.236 1.414 . . . . 34.640000000000001 113.955 -165.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -69.47 109.06 2.71 Favored Glycine 0 C--O 1.251 1.176 0 N-CA-C 105.838 -2.905 . . . . 37.140000000000001 105.838 170.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -158.9 -169.3 2.64 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-N 117.918 0.859 . . . . 40.57 111.99 -174.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1157 ' ' ILE . . . . . . . . . . . . . 1.5 tp -137.02 142.51 37.43 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.201 0 C-N-CA 125.426 1.49 . . . . 44.609999999999999 111.298 -171.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1158 ' ' THR . . . . . . . . . . . . . 1.1 p -93.33 -143.07 0.22 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.592 -1.64 . . . . 40.700000000000003 109.03 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -103.09 -14.3 16.47 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.423 -1.695 . . . . 40.25 106.423 157.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -76.09 -58.19 3.43 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 117.198 2.296 . . . . 38.469999999999999 117.198 173.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . 175.92 -165.27 35.81 Favored Glycine 0 CA--C 1.505 -0.556 0 CA-C-O 124.58 2.211 . . . . 37.609999999999999 111.128 -170.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1162 ' ' LYS . . . . . 0.437 ' HZ3' ' CD ' ' C' ' 95' ' ' GLU . 8.8 tttp -64.29 130.55 44.29 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 111.823 -2.188 . . . . 48.899999999999999 111.327 -171.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1163 ' ' VAL . . . . . . . . . . . . . 10.1 t -100.93 114.69 65.82 Favored Pre-proline 0 N--CA 1.426 -1.661 0 CA-C-N 110.589 -3.005 . . . . 36.520000000000003 104.401 165.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1164 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -73.05 137.05 25.81 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 124.938 3.759 . . . . 35.079999999999998 116.827 -176.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1165 ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.01 138.69 28.71 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 124.003 3.135 . . . . 35.329999999999998 116.312 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -79.63 141.96 36.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.212 -1.358 . . . . 34.689999999999998 112.415 174.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1167 ' ' LYS . . . . . . . . . . . . . 44.1 mttp -100.69 115.14 29.55 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 113.099 -1.864 . . . . 45.359999999999999 107.298 172.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 49.9 t -100.38 91.38 2.15 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 CA-C-N 113.745 -1.571 . . . . 31.710000000000001 108.825 -174.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1169 ' ' MET . . . . . . . . . . . . . 35.3 ttp -76.85 92.67 3.64 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 123.749 1.737 . . . . 42.280000000000001 111.981 175.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 42.9 t -81.0 110.58 16.64 Favored 'Isoleucine or valine' 0 C--O 1.246 0.919 0 O-C-N 121.104 -0.997 . . . . 30.510000000000002 110.067 174.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 66.7 mt -88.84 119.63 36.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.194 -1.039 . . . . 31.870000000000001 108.194 176.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 87.13 87.23 1.09 Allowed Glycine 0 CA--C 1.537 1.428 0 N-CA-C 106.74 -2.544 . . . . 34.539999999999999 106.74 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1173 ' ' ALA . . . . . . . . . . . . . . . -85.05 57.3 4.37 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 120.45 2.125 . . . . 32.509999999999998 111.612 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -73.85 -163.73 9.27 Favored Glycine 0 N--CA 1.448 -0.566 0 O-C-N 120.224 -1.548 . . . . 29.899999999999999 109.439 160.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1175 ' ' VAL . . . . . . . . . . . . . 3.5 t -62.25 -36.6 75.34 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 O-C-N 121.342 -1.093 . . . . 33.109999999999999 111.651 -174.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -61.48 -43.12 99.42 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 113.626 -1.625 . . . . 28.100000000000001 114.363 170.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -63.32 -49.94 66.59 Favored Glycine 0 C--N 1.312 -0.752 0 N-CA-C 110.322 -1.111 . . . . 28.539999999999999 110.322 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1178 ' ' LEU . . . . . . . . . . . . . 70.3 mt -53.56 -51.6 62.4 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 117.693 0.747 . . . . 31.219999999999999 112.387 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -51.21 -46.34 62.19 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.624 0.972 . . . . 28.98 113.624 175.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -60.13 -41.1 91.96 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 116.664 2.098 . . . . 27.829999999999998 116.664 174.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1181 ' ' ILE . . . . . . . . . . . . . 55.8 mt -64.8 -50.47 75.19 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 O-C-N 121.252 -0.905 . . . . 30.25 109.678 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -50.36 -54.77 18.79 Favored Glycine 0 C--O 1.241 0.579 0 O-C-N 120.54 -1.35 . . . . 29.59 110.289 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -59.88 -48.0 83.46 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 116.243 1.942 . . . . 30.289999999999999 116.243 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -68.77 -43.94 74.73 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.478 -1.389 . . . . 30.469999999999999 112.537 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -60.18 -43.68 95.67 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 118.482 0.583 . . . . 42.409999999999997 110.906 176.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1186 ' ' SER . . . . . . . . . . . . . 72.4 m -48.65 -40.44 27.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.719 1.007 . . . . 39.380000000000003 113.719 164.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 27.2 mt -91.02 24.83 2.65 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 115.154 1.538 . . . . 36.18 115.154 173.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 69.38 8.9 60.19 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 115.535 0.974 . . . . 33.780000000000001 115.535 171.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -79.24 145.14 33.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 118.464 1.132 . . . . 33.93 111.63 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 9.5 mt -77.26 88.48 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 105.459 -2.052 . . . . 38.740000000000002 105.459 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 14.0 t -76.21 125.59 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 106.828 -1.545 . . . . 33.090000000000003 106.828 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1192 ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -114.39 99.75 7.81 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 105.045 -2.206 . . . . 38.920000000000002 105.045 170.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -92.91 144.35 25.35 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 119.58 -1.95 . . . . 35.32 111.126 177.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 37.6 t80 -128.76 157.05 42.5 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 106.904 -1.517 . . . . 39.350000000000001 106.904 171.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 8.0 t0 -163.1 148.09 11.49 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 105.983 -1.858 . . . . 40.460000000000001 105.983 168.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1196 ' ' THR . . . . . . . . . . . . . 1.1 p -77.38 -12.52 59.96 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 114.837 -1.074 . . . . 45.939999999999998 112.359 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1197 ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -94.06 115.74 65.56 Favored Pre-proline 0 N--CA 1.471 0.619 0 N-CA-C 106.146 -1.798 . . . . 56.020000000000003 106.146 172.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1198 ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -66.3 -14.71 45.38 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.305 2.003 . . . . 51.270000000000003 114.473 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -51.72 -54.41 28.7 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 122.328 1.061 . . . . 59.100000000000001 112.342 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 26.8 m -71.95 -2.91 3.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 115.402 1.63 . . . . 51.060000000000002 115.402 -169.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 83.5 tttt -55.36 -36.08 65.94 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 119.758 -1.839 . . . . 57.380000000000003 113.074 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -71.38 -37.73 71.58 Favored 'General case' 0 C--O 1.247 0.922 0 CA-C-N 118.552 0.614 . . . . 62.409999999999997 110.657 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -62.84 -37.79 88.2 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 120.739 -1.226 . . . . 57.780000000000001 112.719 171.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 25.4 t -58.49 -47.48 88.15 Favored 'Isoleucine or valine' 0 C--N 1.343 0.297 0 O-C-N 124.006 0.816 . . . . 46.380000000000003 111.432 173.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -54.09 -54.08 44.36 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.261 1.024 . . . . 50.700000000000003 113.349 171.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1206 ' ' SER . . . . . . . . . . . . . 6.4 m -62.32 -42.85 99.72 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 113.323 0.86 . . . . 49.979999999999997 113.323 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1207 ' ' MET . . . . . . . . . . . . . 29.0 mtp -77.49 -13.31 59.95 Favored 'General case' 0 C--O 1.242 0.692 0 O-C-N 117.635 -3.166 . . . . 52.990000000000002 114.107 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 97.7 59.64 0.96 Allowed Glycine 0 N--CA 1.429 -1.802 0 O-C-N 121.427 -0.795 . . . . 47.659999999999997 111.151 166.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -134.26 151.22 51.17 Favored 'General case' 0 N--CA 1.457 -0.087 0 O-C-N 120.126 -1.808 . . . . 44.770000000000003 110.709 167.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -76.15 145.73 39.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.805 -1.089 . . . . 47.640000000000001 108.763 165.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1211 ' ' PHE . . . . . . . . . . . . . 9.9 t80 -93.97 160.06 14.89 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 106.947 -1.501 . . . . 45.659999999999997 106.947 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 77.7 mt -85.39 106.4 16.73 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 104.613 -2.366 . . . . 46.060000000000002 104.613 171.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -73.86 97.59 2.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.314 -0.857 . . . . 60.219999999999999 108.793 168.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 5.8 tp -65.68 101.54 0.64 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.472 -0.785 . . . . 57.25 109.653 -174.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 19.7 t0 -61.08 100.27 0.11 Allowed 'General case' 0 C--O 1.247 0.925 0 O-C-N 124.73 1.268 . . . . 64.430000000000007 108.483 175.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 3.8 t80 . . . . . 0 C--O 1.212 -0.91 0 N-CA-C 102.556 -3.127 . . . . 66.900000000000006 102.556 179.27 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 2.8 p30 . . . . . 0 N--CA 1.426 -1.659 0 CA-C-O 118.765 -0.636 . . . . 39.090000000000003 109.569 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -57.35 -36.88 78.5 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 118.66 0.663 . . . . 39.32 113.565 -170.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 76.8 t80 -74.96 -43.67 52.74 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-O 116.901 -1.523 . . . . 39.299999999999997 110.287 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -58.14 -46.35 85.79 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.617 1.099 . . . . 36.299999999999997 111.057 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -62.54 -72.09 0.14 Allowed 'General case' 0 C--N 1.346 0.415 0 CA-C-O 117.332 -1.318 . . . . 37.380000000000003 110.326 173.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -50.18 -42.04 19.47 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 N-CA-C 117.468 2.396 . . . . 39.109999999999999 117.468 -172.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1230 ' ' MET . . . . . . . . . . . . . 21.0 mmt -86.23 1.67 49.94 Favored 'General case' 0 C--O 1.25 1.13 0 O-C-N 119.532 -1.98 . . . . 49.590000000000003 113.576 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1231 ' ' SER . . . . . . . . . . . . . 22.1 p -76.89 143.38 39.66 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 122.304 2.32 . . . . 43.68 110.52 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -49.08 -47.57 44.92 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.727 1.211 . . . . 55.57 112.961 -174.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -60.18 -34.04 73.05 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 113.333 0.864 . . . . 44.939999999999998 113.333 172.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 13.3 t80 -69.27 -49.82 52.57 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 120.46 1.482 . . . . 42.039999999999999 108.363 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 63.4 mt -58.53 -34.6 51.52 Favored 'Isoleucine or valine' 0 C--O 1.249 1.048 0 CA-C-O 118.325 -0.845 . . . . 46.280000000000001 110.026 175.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 25.8 tttm -62.43 -44.75 95.69 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 119.743 1.156 . . . . 47.869999999999997 108.844 171.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -60.71 -33.77 73.38 Favored 'General case' 0 C--O 1.25 1.104 0 O-C-N 119.406 -2.059 . . . . 41.609999999999999 112.755 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -56.22 -51.65 67.29 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 113.723 1.008 . . . . 50.649999999999999 113.723 168.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1239 ' ' MET . . . . . . . . . . . . . 8.3 mmm -57.55 -47.94 80.66 Favored 'General case' 0 C--O 1.247 0.972 0 C-N-CA 124.745 1.218 . . . . 48.869999999999997 112.018 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -58.65 -45.31 89.6 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 118.864 -0.588 . . . . 54.799999999999997 112.239 177.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 1.8 mm? -63.07 -39.09 93.68 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 123.672 0.608 . . . . 43.210000000000001 112.453 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -70.64 -39.34 73.73 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 125.492 1.745 . . . . 38.659999999999997 111.214 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -63.68 -29.49 70.71 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.131 1.772 . . . . 37.920000000000002 114.743 174.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -74.22 -66.23 0.75 Allowed 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 113.593 -1.64 . . . . 37.280000000000001 110.236 173.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -52.79 -31.48 38.82 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 124.699 1.2 . . . . 43.07 113.619 -177.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -45.17 -46.2 11.97 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.814 1.246 . . . . 38.299999999999997 111.857 175.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1247 ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -68.77 -18.21 64.16 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 116.682 -1.628 . . . . 47.600000000000001 113.736 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -113.29 -30.45 6.92 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 121.322 1.874 . . . . 45.420000000000002 114.896 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1249 ' ' VAL . . . . . . . . . . . . . 29.6 m -78.41 172.35 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 O-C-N 119.954 -1.716 . . . . 36.259999999999998 113.607 -171.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1250 ' ' ASP . . . . . 0.43 ' CG ' ' HZ3' ' A' 1276 ' ' LYS . 4.5 m-20 -121.71 -64.48 1.21 Allowed 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 124.018 0.824 . . . . 33.039999999999999 111.245 -173.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1251 ' ' ILE . . . . . . . . . . . . . 32.3 mm -102.73 123.21 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 N-CA-C 105.629 -1.989 . . . . 31.399999999999999 105.629 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1252 ' ' ILE . . . . . . . . . . . . . 68.3 mt -105.85 136.41 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 O-C-N 124.764 1.29 . . . . 29.420000000000002 107.83 165.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 65.3 t -119.23 108.69 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.008 0 N-CA-C 104.265 -2.495 . . . . 30.370000000000001 104.265 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1254 ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.53 95.82 7.56 Favored 'General case' 0 C--O 1.246 0.89 0 CA-C-N 121.828 2.103 . . . . 35.719999999999999 113.188 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1255 ' ' THR . . . . . . . . . . . . . 36.6 p -72.23 -24.99 61.47 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 119.068 2.988 . . . . 36.0 119.068 -166.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1256 ' ' ALA . . . . . . . . . . . . . . . -70.89 74.81 0.62 Allowed 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 117.571 2.434 . . . . 40.93 117.571 -151.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 14.0 tp -71.0 81.34 0.66 Allowed 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.174 -1.417 . . . . 47.82 107.174 167.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 42.6 mm -75.44 134.95 72.71 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 104.503 -2.406 . . . . 52.700000000000003 104.503 173.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -64.86 92.93 0.21 Allowed 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 122.131 1.887 . . . . 54.130000000000003 114.545 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 93.99 -57.51 2.14 Favored Glycine 0 CA--C 1.489 -1.57 0 O-C-N 121.019 -1.051 . . . . 54.619999999999997 112.754 166.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 25.1 mtmt -63.86 119.93 59.1 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-O 116.567 -1.682 . . . . 55.740000000000002 107.652 174.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -56.98 134.44 64.53 Favored 'Trans proline' 0 CA--C 1.5 -1.201 0 C-N-CA 124.131 3.221 . . . . 51.149999999999999 114.808 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -62.15 122.96 76.04 Favored Pre-proline 0 C--O 1.247 0.943 0 O-C-N 124.089 0.868 . . . . 46.060000000000002 110.114 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -49.59 133.26 31.87 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 125.282 3.988 . . . . 41.079999999999998 117.494 -175.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -68.07 83.36 0.22 Allowed 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.528 -0.916 . . . . 47.420000000000002 108.528 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 98.0 mt -79.42 -41.55 27.4 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 122.476 1.131 . . . . 39.219999999999999 108.473 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 21.7 mt -97.65 91.41 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 N-CA-C 105.013 -2.217 . . . . 42.5 105.013 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1268 ' ' THR . . . . . . . . . . . . . 39.6 p -71.16 153.84 42.18 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.589 -1.187 . . . . 37.840000000000003 111.233 176.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -47.0 -50.67 18.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.354 1.462 . . . . 54.799999999999997 111.136 -177.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -42.89 -46.6 5.39 Favored 'General case' 0 C--O 1.249 1.072 0 C-N-CA 124.123 0.969 . . . . 54.359999999999999 113.426 172.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1271 ' ' MET . . . . . . . . . . . . . 26.6 mtt -68.83 -41.57 78.38 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 118.522 -0.752 . . . . 39.520000000000003 112.213 177.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1272 ' ' VAL . . . . . . . . . . . . . 14.0 t -65.95 -44.53 92.37 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 CA-C-O 121.811 0.815 . . . . 38.25 109.648 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -54.66 -44.02 72.91 Favored 'General case' 0 C--O 1.249 1.048 0 C-N-CA 124.466 1.107 . . . . 40.770000000000003 111.793 171.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1274 ' ' SER . . . . . . . . . . . . . 76.5 p -86.05 12.3 9.83 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 119.579 -1.951 . . . . 36.579999999999998 115.072 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1275 ' ' MET . . . . . . . . . . . . . 52.5 mtp -70.89 160.92 31.93 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 123.521 1.629 . . . . 36.75 110.751 173.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1276 ' ' LYS . . . . . 0.43 ' HZ3' ' CG ' ' A' 1250 ' ' ASP . 36.4 ttpt -68.61 134.84 50.53 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 112.999 -1.909 . . . . 46.109999999999999 106.007 166.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1277 ' ' ALA . . . . . . . . . . . . . . . -85.69 -179.73 6.92 Favored 'General case' 0 C--O 1.261 1.677 0 N-CA-C 115.365 1.617 . . . . 33.520000000000003 115.365 -176.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 67.99 29.05 73.3 Favored Glycine 0 CA--C 1.538 1.515 0 O-C-N 120.315 -1.491 . . . . 31.27 109.697 -171.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1279 ' ' SER . . . . . . . . . . . . . 16.7 m -131.33 173.21 11.29 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.692 1.746 . . . . 32.950000000000003 110.833 -165.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1280 ' ' VAL . . . . . . . . . . . . . 98.5 t -140.77 144.63 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 O-C-N 118.623 -2.548 . . . . 27.43 104.783 -169.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1281 ' ' ILE . . . . . . . . . . . . . 59.9 mt -119.08 107.18 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.646 0 N-CA-C 101.813 -3.402 . . . . 30.300000000000001 101.813 164.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -92.36 104.2 15.39 Favored 'Isoleucine or valine' 0 C--O 1.25 1.102 0 N-CA-C 107.019 -1.474 . . . . 28.629999999999999 107.019 171.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 7.1 t70 -96.03 115.38 27.34 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 111.472 -2.604 . . . . 36.270000000000003 109.396 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1284 ' ' LEU . . . . . . . . . . . . . 90.9 mt -87.2 -29.19 21.91 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 112.237 -2.256 . . . . 38.57 111.194 -173.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -62.51 -41.67 98.99 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 114.711 -1.132 . . . . 37.560000000000002 111.293 176.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . 22.84 -75.97 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 120.158 3.392 . . . . 40.329999999999998 120.158 174.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -59.92 -42.73 94.57 Favored 'General case' 0 C--O 1.212 -0.875 0 CA-C-O 121.538 0.685 . . . . 56.850000000000001 111.44 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 29.9 t30 -85.34 65.29 9.12 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.094 -1.412 . . . . 45.859999999999999 108.633 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 84.34 -57.61 5.02 Favored Glycine 0 C--O 1.246 0.858 0 O-C-N 120.63 -1.294 . . . . 40.310000000000002 113.682 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 84.51 128.62 1.75 Allowed Glycine 0 CA--C 1.538 1.515 0 N-CA-C 108.531 -1.828 . . . . 38.890000000000001 108.531 -171.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1291 ' ' ASN . . . . . . . . . . . . . 33.8 m120 -74.9 -21.6 59.12 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.743 1.771 . . . . 37.229999999999997 111.545 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1292 ' ' CYS . . . . . . . . . . . . . 18.0 t -96.79 148.24 23.11 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.417 -1.427 . . . . 36.5 107.851 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1293 ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -75.13 -39.98 60.12 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 120.556 -1.34 . . . . 43.32 111.94 177.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -65.11 -5.88 7.69 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 115.291 1.589 . . . . 41.32 115.291 174.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1295 ' ' THR . . . . . . . . . . . . . 86.5 m -58.48 115.18 2.84 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 119.262 0.937 . . . . 35.299999999999997 110.514 174.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 35.4 t -96.77 114.28 64.27 Favored Pre-proline 0 C--N 1.313 -1.004 0 N-CA-C 102.126 -3.287 . . . . 34.840000000000003 102.126 169.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -54.34 118.01 4.56 Favored 'Trans proline' 0 CA--C 1.537 0.669 1 C-N-CA 125.787 4.324 . . . . 33.509999999999998 111.757 176.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 99.19 -16.06 59.65 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 113.144 -1.844 . . . . 32.189999999999998 113.063 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -135.61 162.91 31.38 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 125.009 2.338 . . . . 34.880000000000003 115.541 -167.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1300 ' ' ILE . . . . . . . . . . . . . 50.1 mt -75.58 140.59 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 CA-C-N 112.635 -2.075 . . . . 32.289999999999999 110.539 167.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 54.5 t80 -129.38 120.02 24.86 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 120.113 1.324 . . . . 37.25 108.194 159.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1302 ' ' THR . . . . . . . . . . . . . 34.8 m -79.14 125.05 28.92 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 104.198 -2.519 . . . . 35.560000000000002 104.198 172.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1303 ' ' THR . . . . . . . . . . . . . 76.3 p -85.45 -179.63 6.97 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 113.991 1.108 . . . . 36.399999999999999 113.991 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -67.84 -34.36 76.56 Favored 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 120.131 -1.606 . . . . 52.32 112.33 -170.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -74.99 -41.85 58.69 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.09 -1.414 . . . . 40.039999999999999 111.001 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 118.38 57.72 0.28 Allowed Glycine 0 N--CA 1.448 -0.512 0 O-C-N 119.901 -1.749 . . . . 36.960000000000001 109.207 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1307 ' ' VAL . . . . . . . . . . . . . 73.5 t -124.32 121.12 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.898 0 N-CA-C 101.336 -3.579 . . . . 33.399999999999999 101.336 174.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1308 ' ' LYS . . . . . . . . . . . . . 20.8 mmtp -81.81 95.68 7.37 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 113.4 -1.727 . . . . 42.909999999999997 108.507 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 44.0 t -85.83 93.44 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 O-C-N 121.125 -0.984 . . . . 32.289999999999999 108.618 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1310 ' ' ILE . . . . . . . . . . . . . 61.0 mt -89.52 95.33 5.36 Favored 'Isoleucine or valine' 0 C--O 1.256 1.419 0 N-CA-C 105.378 -2.082 . . . . 30.989999999999998 105.378 -174.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -91.37 56.75 3.15 Favored Glycine 0 N--CA 1.431 -1.641 0 N-CA-C 110.877 -0.889 . . . . 28.949999999999999 110.877 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1312 ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -78.66 113.54 16.81 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 120.602 2.201 . . . . 31.690000000000001 116.808 -170.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1313 ' ' THR . . . . . . . . . . . . . 4.6 p -71.8 -40.38 69.23 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 125.889 2.757 . . . . 34.170000000000002 109.841 -177.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -69.81 -0.88 7.91 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 110.072 -3.24 . . . . 36.859999999999999 115.802 176.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1315 ' ' LEU . . . . . . . . . . . . 0.342 42.0 mt -40.65 -45.9 5.9 Favored Pre-proline 0 N--CA 1.487 1.404 0 N-CA-C 121.241 3.793 . . . . 34.850000000000001 121.241 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -56.55 -47.26 24.71 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.916 2.411 . . . . 29.149999999999999 110.529 168.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -61.18 -44.81 97.65 Favored Glycine 0 CA--C 1.483 -1.936 0 CA-C-O 118.545 -1.142 . . . . 27.289999999999999 111.578 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1318 ' ' ARG . . . . . 0.44 ' O ' ' NH1' ' A' 1140 ' ' ARG . 59.2 mtt-85 -60.21 -15.72 26.96 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 114.204 1.187 . . . . 41.490000000000002 114.204 174.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1319 ' ' LEU . . . . . . . . . . . . . 14.0 tp -110.95 73.2 0.86 Allowed Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-N 123.258 2.754 . . . . 27.609999999999999 103.779 166.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1320 ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -59.06 -58.93 0.53 Allowed 'Trans proline' 0 C--O 1.213 -0.769 0 C-N-CA 122.85 2.367 . . . . 25.940000000000001 112.567 -159.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1321 ' ' THR . . . . . . . . . . . . . 3.1 m -58.37 -30.37 66.73 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 112.797 -2.001 . . . . 25.010000000000002 113.704 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1322 ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -74.23 -39.87 62.79 Favored 'General case' 0 N--CA 1.436 -1.166 0 O-C-N 120.589 -1.32 . . . . 29.390000000000001 110.852 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1323 ' ' SER . . . . . . . . . . . . . 75.0 m -52.7 -53.18 51.1 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 118.912 0.778 . . . . 26.469999999999999 109.449 168.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1324 ' ' SER . . . . . . . . . . . . . 2.3 m -61.0 -26.12 67.37 Favored 'General case' 0 C--O 1.25 1.121 0 N-CA-C 114.335 1.235 . . . . 27.780000000000001 114.335 175.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -75.37 -63.15 1.34 Allowed 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 117.739 -3.1 . . . . 37.530000000000001 110.228 172.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1326 ' ' LEU . . . . . . . . . . . . . 18.2 mt -77.98 -47.86 17.56 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 116.973 -1.489 . . . . 35.710000000000001 114.357 -170.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1327 ' ' TYR . . . . . . . . . . . . . 32.1 t80 -59.29 -47.29 85.92 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 105.877 -1.897 . . . . 31.59 105.877 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1328 ' ' GLY . . . . . . . . . . . . . . . -40.78 -54.47 3.51 Favored Glycine 0 CA--C 1.544 1.847 0 C-N-CA 124.668 1.127 . . . . 28.0 114.778 167.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1329 ' ' THR . . . . . . . . . . . . . 28.7 m -67.57 -35.09 78.36 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-O 118.106 -0.95 . . . . 32.149999999999999 109.449 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1330 ' ' ASN . . . . . . . . . . . . . 29.2 m120 -62.47 -43.86 97.79 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.579 -0.897 . . . . 34.359999999999999 108.579 174.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1331 ' ' LEU . . . . . . . . . . . . . 13.9 mt -59.96 -50.16 74.84 Favored 'General case' 0 C--O 1.213 -0.85 0 N-CA-C 109.367 -0.605 . . . . 33.369999999999997 109.367 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1332 ' ' VAL . . . . . . . . . . . . . 44.2 t -57.04 -40.17 71.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 118.787 -0.625 . . . . 35.270000000000003 111.181 174.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -68.02 -38.45 82.6 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 114.602 1.334 . . . . 37.659999999999997 114.602 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1334 ' ' LEU . . . . . . . . . . . . . 28.9 tp -60.97 -48.61 81.03 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 106.916 -1.513 . . . . 40.270000000000003 106.916 172.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1335 ' ' LEU . . . . . . . . . . . . . 20.5 mt -71.66 -4.4 27.11 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 114.625 1.343 . . . . 42.5 114.625 175.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1336 ' ' LYS . . . . . . . . . . . . . 82.6 mttt -74.76 -44.91 47.22 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 121.81 2.095 . . . . 47.810000000000002 111.774 161.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1337 ' ' LEU . . . . . . . . . . . . . 10.4 mp -62.34 -41.02 98.24 Favored 'General case' 0 C--O 1.216 -0.672 0 C-N-CA 118.555 -1.258 . . . . 49.270000000000003 113.8 172.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1338 ' ' LEU . . . . . . . . . . . . . 10.2 mp -70.8 -69.38 0.37 Allowed 'General case' 0 CA--C 1.51 -0.577 0 O-C-N 124.695 1.247 . . . . 50.539999999999999 113.054 172.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1339 ' ' CYS . . . . . . . . . . . . . 51.5 t -69.71 91.95 0.64 Allowed 'General case' 0 CA--C 1.503 -0.835 0 O-C-N 118.396 -2.69 . . . . 53.670000000000002 107.571 172.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 72.3 tttt -83.73 -62.56 1.54 Allowed 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.121 -1.4 . . . . 63.380000000000003 108.052 -165.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -74.88 -35.89 62.3 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 124.82 1.248 . . . . 70.950000000000003 114.057 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1342 ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? 62.22 83.88 0.15 Allowed 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 125.537 1.535 . . . . 65.25 113.484 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1343 ' ' ASP . . . . . . . . . . . . 0.38 0.0 OUTLIER 79.21 -78.81 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.775 2 O-C-N 112.593 -6.317 . . . . 64.530000000000001 120.076 -19.347 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A 1344 ' ' GLY . . . . . . . . . . . . . . . 104.39 10.73 33.02 Favored Glycine 0 CA--C 1.545 1.94 0 O-C-N 117.536 -3.227 . . . . 59.719999999999999 111.379 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 19.0 t30 -72.05 131.24 42.61 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 121.932 2.866 . . . . 64.090000000000003 112.929 174.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1346 ' ' ILE . . . . . . . . . . . . . 24.7 mt -80.31 79.37 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.83 0 O-C-N 120.018 -1.676 . . . . 58.82 109.063 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1347 ' ' THR . . . . . . . . . . . . . 5.3 m -66.43 85.14 0.1 Allowed 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 119.867 -1.771 . . . . 54.960000000000001 112.711 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1348 ' ' VAL . . . . . . . . . . . . . 40.0 t -76.46 98.45 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.803 0 N-CA-C 102.915 -2.994 . . . . 55.640000000000001 102.915 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 8.8 t70 -87.79 138.14 31.72 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 111.735 -2.484 . . . . 61.450000000000003 110.906 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -107.22 -12.39 15.38 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 117.443 2.386 . . . . 58.630000000000003 117.443 176.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -76.69 -48.47 18.83 Favored 'General case' 0 C--O 1.246 0.904 0 O-C-N 124.028 0.83 . . . . 62.060000000000002 109.073 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 28.0 t70 -65.76 118.82 10.17 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.651 0.738 . . . . 54.07 112.621 -177.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 13.7 m -40.23 -46.87 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 116.545 2.054 . . . . 50.68 116.545 173.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1354 ' ' VAL . . . . . . . . . . . . . 3.2 m -77.52 -41.85 29.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 122.426 2.375 . . . . 47.68 109.466 -174.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1355 ' ' ILE . . . . . . . . . . . . . 53.6 mt -64.88 -49.26 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.718 1.207 . . . . 48.490000000000002 107.791 -177.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1356 ' ' ARG . . . . . 0.41 ' NH1' ' O ' ' A' 1367 ' ' THR . 31.4 tpt85 -57.17 -40.71 77.86 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.592 0.96 . . . . 48.270000000000003 113.592 172.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -67.21 -39.9 92.37 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-O 119.018 -0.879 . . . . 43.530000000000001 111.911 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1358 ' ' VAL . . . . . . . . . . . . . 5.7 t -72.06 -36.35 56.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 CA-C-O 118.554 -0.736 . . . . 45.119999999999997 112.045 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1359 ' ' THR . . . . . . . . . . . . . 10.6 m -72.21 88.11 1.13 Allowed 'General case' 0 C--O 1.239 0.517 0 CA-C-N 119.346 0.975 . . . . 42.939999999999998 110.492 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 27.6 m -85.77 -25.51 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 CA-C-O 121.794 0.807 . . . . 43.259999999999998 110.805 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1361 ' ' ILE . . . . . . . . . . . . . 23.6 mm -126.55 114.71 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 117.705 -3.122 . . . . 45.659999999999997 102.994 171.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1362 ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -100.93 104.13 15.31 Favored 'General case' 0 CA--C 1.511 -0.548 0 O-C-N 119.128 -2.232 . . . . 61.340000000000003 109.687 172.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 54.54 51.34 14.21 Favored 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 114.367 1.247 . . . . 49.759999999999998 114.367 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 86.68 -27.38 5.89 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 117.997 1.959 . . . . 50.0 117.997 -175.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -81.71 138.19 35.28 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 120.476 2.138 . . . . 56.920000000000002 106.951 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1366 ' ' ILE . . . . . . . . . . . . . 70.1 mt -83.18 100.56 6.89 Favored 'Isoleucine or valine' 0 C--O 1.263 1.811 0 N-CA-C 105.629 -1.989 . . . . 52.780000000000001 105.629 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1367 ' ' THR . . . . . 0.41 ' O ' ' NH1' ' A' 1356 ' ' ARG . 10.8 p -94.22 10.92 32.05 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 112.916 -1.947 . . . . 49.439999999999998 110.199 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 6.7 t90 -73.32 150.39 89.5 Favored Pre-proline 0 C--O 1.251 1.141 0 N-CA-C 106.479 -1.674 . . . . 52.380000000000003 106.479 162.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -68.48 169.58 56.62 Favored 'Cis proline' 0 C--O 1.249 1.057 0 N-CA-C 121.017 3.43 . . . . 46.939999999999998 121.017 -0.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -86.99 124.89 68.08 Favored Pre-proline 0 CA--C 1.506 -0.728 0 CA-C-O 122.366 1.079 . . . . 45.909999999999997 109.404 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1371 ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -70.81 126.84 13.03 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 122.849 2.366 . . . . 46.390000000000001 111.974 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -77.31 -57.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 123.538 2.825 . . . . 46.719999999999999 108.332 169.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.221 -5.008 0 O-C-N 119.552 -1.968 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 15.4 m80 . . . . . 0 N--CA 1.432 -1.353 0 N-CA-C 104.361 -2.459 . . . . 63.439999999999998 104.361 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -126.03 56.03 1.44 Allowed 'General case' 0 C--N 1.352 0.698 0 CA-C-N 121.292 1.86 . . . . 51.740000000000002 109.792 175.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1000 ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -71.87 145.71 48.38 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 114.162 -1.381 . . . . 54.07 110.936 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 64.56 5.87 19.58 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 122.435 1.02 . . . . 39.219999999999999 112.675 -173.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1002 ' ' ARG . . . . . 0.402 ' NH2' ' O ' ' B' 1065 ' ' GLN . 28.0 ttp180 -104.62 141.41 36.48 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 119.523 -2.163 . . . . 38.119999999999997 106.8 -173.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B 1003 ' ' ILE . . . . . . . . . . . . . 87.4 mt -100.79 134.47 40.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 105.827 -1.916 . . . . 29.699999999999999 105.827 174.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -94.56 135.13 12.31 Favored Glycine 0 N--CA 1.419 -2.448 0 C-N-CA 119.914 -1.136 . . . . 27.5 111.136 156.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1005 ' ' ILE . . . . . . . . . . . . . 40.6 mm -104.61 104.86 47.76 Favored Pre-proline 0 CA--C 1.553 1.064 0 N-CA-C 102.244 -3.243 . . . . 24.829999999999998 102.244 171.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -66.25 157.47 59.84 Favored 'Trans proline' 0 C--N 1.361 1.214 1 C-N-CA 125.818 4.345 . . . . 27.190000000000001 114.811 172.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 44.1 ttt180 -86.26 101.78 13.36 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 113.765 -1.561 . . . . 41.460000000000001 107.874 173.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1008 ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -49.35 134.23 18.89 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 117.342 2.349 . . . . 26.93 117.342 -175.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 32.3 mmm-85 -107.52 -11.32 15.51 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 111.935 -2.393 . . . . 34.479999999999997 114.129 -163.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1010 ' ' LEU . . . . . . . . . . . . . 13.0 tp -63.31 145.5 55.43 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-N 119.796 1.18 . . . . 44.219999999999999 112.514 -174.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1011 ' ' THR . . . . . . . . . . . . . 33.1 m -32.95 106.65 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 115.75 1.759 . . . . 40.740000000000002 115.75 172.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 53.9 t30 46.25 49.69 12.6 Favored 'General case' 0 C--O 1.254 1.302 0 C-N-CA 125.552 1.541 . . . . 44.439999999999998 112.737 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1013 ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -79.97 133.57 36.19 Favored 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 118.292 -1.363 . . . . 29.870000000000001 108.102 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1014 ' ' THR . . . . . . . . . . . . . 3.4 m -112.76 -9.01 13.73 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 107.353 -1.351 . . . . 25.260000000000002 107.353 -178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -77.92 129.42 35.33 Favored 'General case' 0 CA--C 1.503 -0.854 0 O-C-N 120.359 -1.463 . . . . 29.539999999999999 110.694 174.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1016 ' ' VAL . . . . . . . . . . . . . 5.0 p -97.65 177.64 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 120.388 -1.445 . . . . 23.550000000000001 107.452 155.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1017 ' ' ALA . . . . . . . . . . . . . . . -79.89 -19.37 48.35 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.154 -1.591 . . . . 23.59 113.604 -177.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1018 ' ' ALA . . . . . . . . . . . . . . . -153.43 146.87 24.9 Favored 'General case' 0 N--CA 1.442 -0.825 0 O-C-N 119.908 -1.745 . . . . 24.93 114.143 -167.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1019 ' ' THR . . . . . . . . . . . . . 76.7 p -88.75 172.29 7.79 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 118.594 0.634 . . . . 28.09 112.509 169.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -55.25 -36.1 92.67 Favored 'Trans proline' 0 C--O 1.249 1.046 0 C-N-CA 122.448 2.098 . . . . 28.789999999999999 116.631 165.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 51.4 tttt -54.13 -51.12 65.25 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 119.013 -2.304 . . . . 47.280000000000001 113.325 161.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1022 ' ' THR . . . . . . . . . . . . . 22.8 m -52.77 -38.68 61.38 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 118.471 0.578 . . . . 30.120000000000001 109.873 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1023 ' ' VAL . . . . . . . . . . . . . 73.5 t -53.41 -53.37 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 O-C-N 121.254 -0.904 . . . . 32.240000000000002 109.156 174.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1024 ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -57.42 -41.94 81.38 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.906 0.86 . . . . 49.619999999999997 113.193 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -58.39 -47.77 82.79 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 123.044 1.402 . . . . 44.68 111.735 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 41.5 mt -72.13 -34.37 68.52 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.528 -1.215 . . . . 35.710000000000001 110.487 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1027 ' ' LEU . . . . . . . . . . . . . 50.5 mt -57.64 -40.52 79.41 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 122.927 1.346 . . . . 42.18 110.636 175.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 58.2 mttm -58.34 -36.45 73.43 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 115.211 -0.904 . . . . 48.340000000000003 111.425 173.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1029 ' ' LEU . . . . . . . . . . . . . 20.7 mt -77.33 -1.87 32.07 Favored 'General case' 0 C--O 1.259 1.56 0 N-CA-C 116.414 2.005 . . . . 38.689999999999998 116.414 175.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 90.03 25.0 28.04 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 125.877 1.703 . . . . 32.280000000000001 111.189 176.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -103.89 127.96 51.39 Favored 'General case' 0 C--O 1.252 1.236 0 N-CA-C 107.78 -1.193 . . . . 35.939999999999998 107.78 -177.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1032 ' ' THR . . . . . . . . . . . . . 11.9 m -72.22 122.2 20.65 Favored 'General case' 0 C--O 1.251 1.166 0 N-CA-C 103.165 -2.902 . . . . 33.369999999999997 103.165 167.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1033 ' ' VAL . . . . . . . . . . . . . 48.8 t -93.32 134.92 29.48 Favored 'Isoleucine or valine' 0 C--O 1.258 1.508 0 N-CA-C 104.681 -2.34 . . . . 29.98 104.681 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -123.0 140.11 53.38 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 104.063 -2.569 . . . . 28.18 104.063 172.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1035 ' ' VAL . . . . . . . . . . . . . 89.3 t -131.5 135.14 59.79 Favored 'Isoleucine or valine' 0 C--O 1.255 1.373 0 N-CA-C 104.29 -2.485 . . . . 25.82 104.29 -170.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1036 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.91 151.23 43.49 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-O 123.123 1.44 . . . . 32.439999999999998 109.755 177.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B 1037 ' ' SER . . . . . . . . . . . . . 47.1 p -65.99 130.09 42.06 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 111.839 -2.437 . . . . 29.539999999999999 112.413 177.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 92.96 -15.57 62.5 Favored Glycine 0 CA--C 1.504 -0.645 0 O-C-N 118.366 -2.709 . . . . 27.760000000000002 111.62 -177.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1039 ' ' ALA . . . . . . . . . . . . . . . -73.52 -33.93 64.99 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-O 122.29 1.043 . . . . 26.02 112.874 -171.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -59.86 -53.78 43.06 Favored Glycine 0 C--O 1.249 1.076 0 N-CA-C 110.477 -1.049 . . . . 26.469999999999999 110.477 167.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.07 -26.79 64.93 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 117.154 -1.403 . . . . 50.979999999999997 112.154 -177.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 58.3 mt -54.47 -48.84 71.31 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 120.944 1.702 . . . . 29.300000000000001 112.091 167.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1043 ' ' ALA . . . . . . . . . . . . . . . -88.27 36.37 0.78 Allowed 'General case' 0 C--O 1.238 0.486 0 CA-C-O 116.166 -1.873 . . . . 26.739999999999998 111.341 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1044 ' ' SER . . . . . . . . . . . . . 18.9 m 47.72 31.3 2.12 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 116.038 1.866 . . . . 31.260000000000002 116.038 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1045 ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.77 147.93 48.4 Favored 'General case' 0 C--N 1.36 1.051 0 CA-C-O 122.585 1.183 . . . . 33.259999999999998 109.366 177.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 11.3 t0 -71.2 123.75 22.92 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.153 -1.054 . . . . 46.740000000000002 108.153 173.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.75 -29.3 64.68 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 124.993 1.317 . . . . 34.439999999999998 112.1 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.32 -22.45 66.95 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 119.624 -1.923 . . . . 48.670000000000002 113.12 172.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -64.69 -26.5 68.4 Favored 'General case' 0 C--N 1.365 1.262 0 O-C-N 119.311 -2.118 . . . . 35.259999999999998 112.692 169.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1050 ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -69.1 -40.38 78.42 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 118.474 -0.774 . . . . 32.170000000000002 111.952 168.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 20.6 m -70.93 -29.25 36.47 Favored 'Isoleucine or valine' 0 C--N 1.347 0.477 0 CA-C-N 120.668 1.576 . . . . 38.369999999999997 111.155 175.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -60.18 -48.05 83.36 Favored 'General case' 0 C--O 1.205 -1.257 0 O-C-N 119.013 -2.304 . . . . 45.770000000000003 111.405 167.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -64.62 -16.56 62.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 115.29 1.589 . . . . 37.829999999999998 115.29 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 99.39 31.53 6.1 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.632 -0.987 . . . . 35.82 110.632 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -110.77 143.45 41.29 Favored 'General case' 0 C--N 1.356 0.858 0 O-C-N 120.859 -1.377 . . . . 33.770000000000003 108.448 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -90.81 115.88 28.22 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 120.113 -1.617 . . . . 51.020000000000003 109.46 -172.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1057 ' ' ILE . . . . . . . . . . . . . 11.8 mm -76.15 109.59 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 106.494 -1.669 . . . . 38.469999999999999 106.494 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 6.5 m -126.03 126.26 69.39 Favored 'Isoleucine or valine' 0 C--O 1.247 0.969 0 CA-C-O 123.613 1.673 . . . . 39.399999999999999 111.576 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -86.52 125.49 33.8 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.977 -1.011 . . . . 57.07 111.195 -162.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . 71.31 -124.66 11.24 Favored Glycine 0 CA--C 1.517 0.206 0 O-C-N 125.785 1.928 . . . . 44.829999999999998 112.795 167.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 5.8 m120 -57.84 -31.36 66.58 Favored 'General case' 0 CA--C 1.481 -1.709 0 CA-C-N 118.566 1.183 . . . . 46.270000000000003 113.946 -175.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1062 ' ' SER . . . . . . . . . . . . . 4.8 m -52.47 -51.17 60.68 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 116.727 -1.606 . . . . 43.469999999999999 107.407 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.21 -39.81 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 121.313 1.87 . . . . 36.979999999999997 110.59 -177.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 93.2 m95 -60.41 -38.46 84.11 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 117.072 2.249 . . . . 37.899999999999999 117.072 174.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1065 ' ' GLN . . . . . 0.402 ' O ' ' NH2' ' B' 1002 ' ' ARG . 6.0 mm-40 -74.0 106.92 5.91 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 122.875 2.58 . . . . 46.189999999999998 104.952 172.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B 1066 ' ' SER . . . . . . . . . . . . . 51.1 m -164.76 166.49 19.81 Favored 'General case' 0 C--O 1.25 1.121 0 N-CA-C 109.304 -0.628 . . . . 37.060000000000002 109.304 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1067 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.55 -53.36 43.08 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 125.662 1.851 . . . . 43.950000000000003 111.993 169.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B 1068 ' ' ILE . . . . . . . . . . . . . 4.5 mp -120.33 145.47 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 102.907 -2.997 . . . . 33.5 102.907 -173.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 16.8 mm -127.52 117.77 47.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 103.452 -2.796 . . . . 30.57 103.452 170.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1070 ' ' LEU . . . . . . . . . . . . . 96.8 mt -106.42 114.46 28.59 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 103.934 -2.617 . . . . 27.66 103.934 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1071 ' ' LYS . . . . . . . . . . . . . 43.6 tttm -133.99 153.71 51.6 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 106.848 -1.538 . . . . 28.399999999999999 106.848 -168.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1072 ' ' VAL . . . . . . . . . . . . . 61.5 t -85.03 -65.62 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 CA-C-N 119.517 1.053 . . . . 23.18 108.507 -174.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -107.02 165.34 11.42 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 105.865 -1.902 . . . . 25.469999999999999 105.865 -168.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -51.58 135.91 33.87 Favored Pre-proline 0 C--O 1.206 -1.22 0 CA-C-N 111.841 -2.436 . . . . 27.899999999999999 113.468 -171.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -60.22 123.49 13.26 Favored 'Trans proline' 0 N--CA 1.429 -2.279 0 C-N-CA 123.491 2.794 . . . . 31.620000000000001 113.425 171.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 91.6 mt -70.78 161.96 29.98 Favored 'General case' 0 C--O 1.244 0.802 0 O-C-N 125.61 1.818 . . . . 40.490000000000002 107.453 174.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 33.6 t70 -44.79 -42.28 7.68 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 120.072 3.36 . . . . 51.590000000000003 120.072 -173.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -68.09 -44.38 76.38 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 113.535 -1.666 . . . . 42.359999999999999 112.059 173.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1079 ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -61.63 -35.7 78.66 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.109 -1.071 . . . . 34.530000000000001 108.109 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1080 ' ' ILE . . . . . . . . . . . . . 76.5 mt -56.42 -50.91 70.15 Favored 'Isoleucine or valine' 0 C--O 1.25 1.082 0 O-C-N 119.936 -1.728 . . . . 33.25 108.524 172.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -63.59 -33.85 76.51 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 119.579 -1.95 . . . . 36.469999999999999 112.74 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1082 ' ' LEU . . . . . . . . . . . . . 67.5 mt -61.05 -38.43 86.13 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.873 -0.603 . . . . 37.759999999999998 112.119 174.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1083 ' ' LEU . . . . . . . . . . . . . 14.2 mt -58.66 154.31 14.74 Favored 'General case' 0 C--O 1.261 1.667 0 CA-C-O 123.594 1.664 . . . . 37.43 110.851 172.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -124.1 154.73 68.31 Favored Pre-proline 0 C--O 1.237 0.429 0 N-CA-C 106.747 -1.575 . . . . 37.700000000000003 106.747 -158.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -50.42 129.87 27.52 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 124.515 3.477 . . . . 35.509999999999998 110.667 171.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 93.58 -46.37 2.34 Favored Glycine 0 CA--C 1.542 1.738 0 CA-C-O 117.041 -1.977 . . . . 33.869999999999997 113.306 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1087 ' ' THR . . . . . . . . . . . . . 59.1 m -46.28 118.13 1.82 Allowed 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 114.906 1.446 . . . . 32.5 114.906 -164.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1088 ' ' THR . . . . . . . . . . . . . 54.6 m -69.17 101.27 1.42 Allowed 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 106.782 -1.562 . . . . 30.219999999999999 106.782 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1089 ' ' LEU . . . . . . . . . . . . . 13.2 tp -95.6 128.74 42.72 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-O 123.691 1.71 . . . . 27.239999999999998 110.245 174.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 19.2 t -123.53 115.59 45.8 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 N-CA-C 105.677 -1.972 . . . . 25.390000000000001 105.677 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1091 ' ' SER . . . . . . . . . . . . . 14.8 m -155.76 165.39 36.65 Favored 'General case' 0 C--N 1.352 0.685 0 O-C-N 120.654 -1.278 . . . . 28.809999999999999 110.123 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1092 ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -64.53 103.86 0.72 Allowed 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 107.119 -1.437 . . . . 30.780000000000001 107.119 158.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 26.9 mm -94.79 -37.92 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.221 0 CA-C-N 114.561 -1.2 . . . . 30.280000000000001 111.632 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1094 ' ' TRP . . . . . . . . . . . . . 82.6 m95 60.25 71.83 0.82 Allowed Pre-proline 0 C--O 1.242 0.659 0 N-CA-C 107.057 -1.461 . . . . 34.07 107.057 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -55.95 -58.06 1.24 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 125.24 3.96 . . . . 38.659999999999997 115.416 -170.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -66.22 -21.34 66.3 Favored 'General case' 0 CA--C 1.505 -0.762 0 O-C-N 120.627 -1.296 . . . . 41.32 112.321 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 12.6 mp0 -89.07 -20.89 23.77 Favored 'General case' 0 C--O 1.25 1.118 0 N-CA-C 107.23 -1.396 . . . . 51.659999999999997 107.23 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -135.57 54.92 11.36 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-N 120.7 1.591 . . . . 40.32 110.387 -176.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -55.51 -49.01 17.45 Favored 'Trans proline' 0 CA--C 1.54 0.819 1 C-N-CA 125.314 4.009 . . . . 41.560000000000002 119.478 -175.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.85 -40.38 88.4 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.538 0.94 . . . . 54.109999999999999 113.538 173.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B 1101 ' ' LEU . . . . . . . . . . . . . 9.3 tt -58.51 -49.51 77.13 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 125.194 1.398 . . . . 37.880000000000003 107.374 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1102 ' ' MET . . . . . . . . . . . . . 69.7 mmm -49.74 -45.64 49.59 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 113.934 1.087 . . . . 37.539999999999999 113.934 165.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -65.26 -44.14 89.08 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 121.288 1.858 . . . . 47.009999999999998 110.367 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1104 ' ' LYS . . . . . . . . . . . . . 74.1 mttt -60.36 -38.49 84.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 119.423 -2.048 . . . . 48.68 110.652 -178.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1105 ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.04 -41.44 99.5 Favored 'General case' 0 C--O 1.25 1.081 0 CA-C-O 122.888 1.327 . . . . 32.210000000000001 113.977 171.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -63.91 -44.59 92.48 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.26 1.824 . . . . 33.729999999999997 108.93 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -54.11 -49.33 69.4 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 121.406 -0.809 . . . . 51.469999999999999 110.056 170.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1108 ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -67.86 -16.46 64.1 Favored 'General case' 0 C--O 1.207 -1.179 0 CA-C-N 120.221 1.373 . . . . 43.899999999999999 110.92 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1109 ' ' ASN . . . . . . . . . . . . . 4.6 m-80 69.41 28.84 4.62 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 123.73 1.728 . . . . 44.82 113.158 174.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1110 ' ' VAL . . . . . . . . . . . . . 17.4 m -72.87 151.19 7.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 CA-C-N 114.179 -1.373 . . . . 30.52 109.45 174.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1111 ' ' THR . . . . . . . . . . . . . 6.4 m -94.77 107.3 19.31 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 106.524 -1.658 . . . . 27.120000000000001 106.524 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1112 ' ' VAL . . . . . . . . . . . . . 4.0 t -101.29 126.14 55.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 115.237 1.569 . . . . 26.399999999999999 115.237 -169.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1113 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.43 127.57 53.71 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 106.08 -1.822 . . . . 42.920000000000002 106.08 165.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -100.74 105.74 17.09 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 113.362 -1.745 . . . . 24.149999999999999 108.044 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1115 ' ' MET . . . . . . . . . . . . . 56.8 mmm -60.51 -23.33 64.45 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 112.896 -1.956 . . . . 29.949999999999999 116.24 -173.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1116 ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -78.46 -33.3 48.45 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 113.249 -1.796 . . . . 34.530000000000001 112.076 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1117 ' ' SER . . . . . . . . . . . . . 51.2 m -111.36 48.77 0.92 Allowed 'General case' 0 N--CA 1.435 -1.207 0 O-C-N 120.483 -1.386 . . . . 33.490000000000002 109.691 -178.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1118 ' ' VAL . . . . . . . . . . . . . 55.3 t -76.73 139.91 67.08 Favored Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 104.81 -2.293 . . . . 34.020000000000003 104.81 167.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -50.35 141.06 33.22 Favored 'Trans proline' 0 C--O 1.245 0.871 0 C-N-CA 123.021 2.481 . . . . 38.280000000000001 117.395 175.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1120 ' ' ARG . . . . . 0.43 HH12 ' CG ' ' B' 1128 ' ' ASP . 9.7 mmt-85 -74.69 36.35 0.11 Allowed 'General case' 0 C--O 1.242 0.694 0 N-CA-C 116.714 2.116 . . . . 55.049999999999997 116.714 177.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B 1121 ' ' ILE . . . . . . . . . . . . . 17.3 pt -118.8 142.75 32.29 Favored 'Isoleucine or valine' 0 C--N 1.347 0.466 0 O-C-N 117.702 -3.124 . . . . 42.090000000000003 106.695 -176.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1122 ' ' SER . . . . . . . . . . . . . 62.0 m -35.88 -47.96 0.54 Allowed 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 117.91 2.559 . . . . 38.020000000000003 117.91 -175.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1123 ' ' ARG . . . . . . . . . . . . . 37.9 ptt85 -74.86 -35.92 62.34 Favored 'General case' 0 C--O 1.208 -1.122 0 CA-C-N 123.581 2.9 . . . . 34.289999999999999 113.416 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1124 ' ' ALA . . . . . . . . . . . . . . . -68.51 -26.54 65.5 Favored 'General case' 0 C--O 1.218 -0.57 0 O-C-N 120.314 -1.491 . . . . 32.350000000000001 109.823 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1125 ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -60.01 -15.07 19.52 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 115.42 1.637 . . . . 47.170000000000002 115.42 171.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1126 ' ' SER . . . . . . . . . . . . . 97.1 p -77.47 -30.54 53.2 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 114.568 1.321 . . . . 31.710000000000001 114.568 170.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1127 ' ' LEU . . . . . . . . . . . . . 3.4 mp -83.58 -25.22 31.11 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 112.395 -2.184 . . . . 37.0 109.212 175.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1128 ' ' ASP . . . . . 0.43 ' CG ' HH12 ' B' 1120 ' ' ARG . 33.9 t70 -69.76 118.86 13.14 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 115.421 1.637 . . . . 40.399999999999999 115.421 -174.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B 1129 ' ' ALA . . . . . . . . . . . . . . . -62.93 -46.09 89.43 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 109.851 -3.34 . . . . 26.559999999999999 111.095 177.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 35.2 mt -53.95 -41.83 68.2 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 117.071 -1.442 . . . . 30.890000000000001 114.452 -173.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1131 ' ' SER . . . . . . . . . . . . . 16.3 p -62.09 -46.97 86.73 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 124.473 1.108 . . . . 29.84 113.271 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1132 ' ' SER . . . . . . . . . . . . . 14.6 m -65.13 -46.64 80.11 Favored 'General case' 0 N--CA 1.421 -1.881 0 O-C-N 119.421 -2.049 . . . . 31.91 111.17 174.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1133 ' ' MET . . . . . . . . . . . . . 38.8 mmt -59.32 -32.17 69.83 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 120.555 -1.341 . . . . 25.899999999999999 114.182 175.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1134 ' ' ALA . . . . . . . . . . . . . . . -75.07 -35.66 61.82 Favored 'General case' 0 C--O 1.203 -1.369 0 O-C-N 120.393 -1.442 . . . . 26.620000000000001 108.542 173.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -61.23 -41.71 97.34 Favored 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 119.092 -2.255 . . . . 36.969999999999999 110.527 176.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1136 ' ' ILE . . . . . . . . . . . . . 48.5 mm -59.33 -56.7 15.38 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 O-C-N 125.406 1.691 . . . . 32.109999999999999 108.47 171.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -55.69 -42.25 74.91 Favored 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 126.128 1.771 . . . . 24.140000000000001 114.682 -174.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -64.75 -45.47 92.64 Favored Glycine 0 C--N 1.316 -0.549 0 CA-C-N 122.031 2.196 . . . . 25.129999999999999 111.577 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 16.1 t80 -67.14 -43.21 82.94 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 122.683 1.23 . . . . 32.729999999999997 108.917 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1140 ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -68.0 -32.54 73.01 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.709 -0.849 . . . . 26.359999999999999 108.709 -175.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1141 ' ' ALA . . . . . . . . . . . . . . . -55.98 -53.9 51.34 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 113.015 0.746 . . . . 24.120000000000001 113.015 170.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 36.5 mm -52.38 -45.51 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 124.052 0.941 . . . . 23.370000000000001 110.163 174.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 75.5 t -60.05 -62.8 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 117.537 -1.22 . . . . 24.960000000000001 114.274 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -61.87 -36.13 80.35 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-N 120.764 1.62 . . . . 32.07 111.138 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1145 ' ' ALA . . . . . . . . . . . . . . . -54.28 -49.66 69.07 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 117.476 -1.25 . . . . 24.870000000000001 109.987 169.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1146 ' ' ALA . . . . . . . . . . . . . . . -67.26 -27.13 66.95 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 119.105 0.866 . . . . 24.670000000000002 110.792 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 51.9 t60 -57.85 -47.04 83.85 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 119.056 -0.497 . . . . 28.579999999999998 111.053 169.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1148 ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -94.53 -5.09 46.78 Favored 'General case' 0 CA--C 1.501 -0.912 0 O-C-N 120.102 -1.624 . . . . 36.82 113.462 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1149 ' ' PHE . . . . . . . . . . . . . 3.3 t80 -67.73 137.52 55.54 Favored 'General case' 0 C--O 1.254 1.313 0 C-N-CA 124.827 1.251 . . . . 31.969999999999999 108.945 -177.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1150 ' ' GLY . . . . . . . . . . . . . . . -75.31 -19.07 79.81 Favored Glycine 0 N--CA 1.44 -1.081 0 CA-C-O 118.135 -1.37 . . . . 25.489999999999998 114.083 174.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1151 ' ' ARG . . . . . . . . . . . . . 71.1 mtm-85 -130.34 177.59 7.22 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 122.811 3.305 . . . . 59.840000000000003 114.306 -158.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1152 ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -81.36 162.21 23.49 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 123.111 1.434 . . . . 34.450000000000003 109.238 170.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1153 ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -82.14 -50.15 9.36 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 112.949 -1.932 . . . . 31.170000000000002 108.834 165.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1154 ' ' THR . . . . . . . . . . . . . 3.5 m -77.19 126.68 31.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 112.273 -2.239 . . . . 33.890000000000001 108.666 -168.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -81.37 65.91 3.91 Favored Glycine 0 N--CA 1.433 -1.535 0 N-CA-C 110.132 -1.187 . . . . 38.950000000000003 110.132 -176.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -67.05 146.99 53.74 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.587 1.955 . . . . 54.229999999999997 115.786 -170.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 12.7 mm -90.87 125.89 43.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 102.012 -3.329 . . . . 51.159999999999997 102.012 173.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1158 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.75 138.08 51.91 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 102.327 -3.212 . . . . 49.609999999999999 102.327 172.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -58.65 -29.2 66.38 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.744 1.156 . . . . 49.049999999999997 110.817 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -55.0 -58.92 5.67 Favored 'General case' 0 C--N 1.363 1.171 0 N-CA-C 112.993 0.738 . . . . 47.649999999999999 112.993 165.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . -171.52 143.27 7.47 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 107.766 -2.133 . . . . 45.609999999999999 107.766 -165.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 92.7 mttt -78.25 138.56 38.69 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 118.584 1.192 . . . . 57.460000000000001 109.55 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1163 ' ' VAL . . . . . . . . . . . . . 48.0 t -88.01 133.34 37.49 Favored Pre-proline 0 C--O 1.251 1.144 0 N-CA-C 105.533 -2.025 . . . . 42.93 105.533 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1164 ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -67.48 145.06 69.56 Favored 'Trans proline' 0 C--N 1.323 -0.815 0 C-N-CA 123.265 2.643 . . . . 39.289999999999999 113.655 170.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1165 ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -65.54 152.77 80.84 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 CA-C-N 124.016 2.47 . . . . 34.170000000000002 113.836 176.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -88.42 143.65 26.86 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.57 -1.27 . . . . 31.690000000000001 107.57 167.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1167 ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -107.7 117.35 33.89 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 106.945 -1.502 . . . . 44.780000000000001 106.945 173.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 61.8 t -102.59 113.83 40.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 106.418 -1.697 . . . . 31.23 106.418 -174.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1169 ' ' MET . . . . . . . . . . . . . 43.0 ttp -95.94 97.52 9.68 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 120.892 0.377 . . . . 37.090000000000003 110.967 178.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 61.4 t -88.78 122.0 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.851 -1.166 . . . . 30.170000000000002 107.851 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1171 ' ' ILE . . . . . . . . . . . . . 44.4 mt -112.07 131.94 62.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 104.097 -2.557 . . . . 33.740000000000002 104.097 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 81.29 64.6 1.76 Allowed Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 108.11 -1.996 . . . . 32.590000000000003 108.11 -174.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1173 ' ' ALA . . . . . . . . . . . . . . . -62.93 -7.01 4.37 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 120.842 -1.387 . . . . 32.420000000000002 114.683 -177.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -58.11 129.19 49.2 Favored Glycine 0 C--O 1.245 0.799 0 CA-C-O 122.8 1.222 . . . . 31.739999999999998 112.23 175.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 1.5 t 48.81 -82.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 112.612 -1.794 . . . . 31.48 114.441 173.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1176 ' ' ALA . . . . . . . . . . . . . . . -65.34 -42.38 92.95 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.548 0.69 . . . . 26.120000000000001 112.609 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1177 ' ' GLY . . . . . . . . . . . . . . . -56.72 -45.22 91.11 Favored Glycine 0 N--CA 1.464 0.563 0 CA-C-N 113.123 -1.853 . . . . 25.73 108.781 174.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1178 ' ' LEU . . . . . . . . . . . . . 5.5 tp -58.62 -48.89 79.48 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 126.288 1.835 . . . . 32.590000000000003 108.336 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -58.74 -38.81 79.22 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 114.347 1.24 . . . . 27.719999999999999 114.347 175.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -65.82 -43.21 89.28 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.884 0.874 . . . . 26.030000000000001 112.034 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1181 ' ' ILE . . . . . . . . . . . . . 9.5 mt -56.12 -48.29 79.33 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 O-C-N 120.299 -1.5 . . . . 28.609999999999999 108.633 170.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -57.68 -49.88 70.17 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 117.749 -1.584 . . . . 25.23 112.986 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -63.48 -49.57 73.1 Favored 'General case' 0 C--O 1.249 1.063 0 CA-C-N 120.78 2.29 . . . . 24.09 113.253 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -68.02 -38.44 82.58 Favored 'General case' 0 C--O 1.24 0.605 0 O-C-N 121.497 -0.752 . . . . 26.68 109.323 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 45.5 t30 -62.32 -33.65 75.09 Favored 'General case' 0 C--O 1.249 1.042 0 O-C-N 118.075 -2.891 . . . . 36.57 111.004 174.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1186 ' ' SER . . . . . . . . . . . . . 61.4 m -67.42 -45.85 74.9 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 111.941 0.348 . . . . 28.920000000000002 111.941 174.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1187 ' ' LEU . . . . . . . . . . . . . 5.6 mt -60.49 -24.64 65.45 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.093 0.957 . . . . 29.09 111.477 169.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 93.75 34.74 6.42 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 121.559 1.981 . . . . 29.260000000000002 112.224 175.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1189 ' ' ALA . . . . . . . . . . . . . . . -104.3 146.02 29.4 Favored 'General case' 0 C--O 1.252 1.192 0 N-CA-C 107.772 -1.196 . . . . 30.16 107.772 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 69.9 mt -77.18 110.76 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 102.776 -3.046 . . . . 35.810000000000002 102.776 -173.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1191 ' ' VAL . . . . . . . . . . . . . 17.4 t -91.93 128.28 43.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 C-N-CA 118.485 -1.286 . . . . 31.969999999999999 108.024 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1192 ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -113.83 107.76 16.16 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 106.868 -1.53 . . . . 48.159999999999997 106.868 168.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -114.92 147.39 40.03 Favored 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 120.381 -1.449 . . . . 35.890000000000001 110.74 -173.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 42.0 t80 -135.9 146.96 47.92 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.304 -1.369 . . . . 41.880000000000003 107.304 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1195 ' ' ASP . . . . . . . . . . . . . 23.7 t0 -154.46 154.06 32.57 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 102.051 -3.314 . . . . 38.280000000000001 102.051 172.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1196 ' ' THR . . . . . . . . . . . . . 1.8 p -85.76 37.92 0.72 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 117.695 -1.145 . . . . 40.619999999999997 110.811 -170.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1197 ' ' ARG . . . . . . . . . . . . . 75.4 mtm180 -140.24 166.2 25.13 Favored Pre-proline 0 C--O 1.246 0.878 0 CA-C-N 121.955 2.161 . . . . 53.090000000000003 112.386 -166.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -72.35 -64.33 0.03 OUTLIER 'Trans proline' 0 C--O 1.254 1.299 0 N-CA-C 119.149 2.711 . . . . 42.560000000000002 119.149 168.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.02 -34.26 63.33 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 115.574 1.694 . . . . 56.310000000000002 115.574 -167.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B 1200 ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -43.96 -42.18 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 N-CA-C 116.102 1.89 . . . . 42.909999999999997 116.102 172.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 43.5 tttm -58.2 -51.79 68.27 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 120.038 -1.664 . . . . 48.890000000000001 110.216 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -61.34 -28.05 68.94 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 122.36 1.076 . . . . 51.700000000000003 112.847 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1203 ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -68.16 -46.55 70.45 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 107.641 -1.244 . . . . 52.57 107.641 173.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1204 ' ' VAL . . . . . . . . . . . . . 25.5 t -63.99 -34.34 67.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 120.383 1.447 . . . . 33.789999999999999 111.292 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -61.97 -34.92 77.03 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.806 0.843 . . . . 36.579999999999998 109.972 171.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1206 ' ' SER . . . . . . . . . . . . . 14.9 m -72.78 -1.64 17.35 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 115.359 1.615 . . . . 39.609999999999999 115.359 173.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1207 ' ' MET . . . . . . . . . . . . . 2.8 mpp? -98.42 -18.68 18.13 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 113.258 0.836 . . . . 37.450000000000003 113.258 165.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 72.04 43.97 46.98 Favored Glycine 0 N--CA 1.484 1.843 0 O-C-N 119.624 -1.923 . . . . 31.870000000000001 110.868 -167.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -126.38 166.96 16.21 Favored 'General case' 0 CA--C 1.505 -0.772 0 O-C-N 120.471 -1.605 . . . . 35.399999999999999 111.899 -176.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -81.0 125.56 30.32 Favored 'General case' 0 C--O 1.216 -0.663 0 O-C-N 120.529 -1.357 . . . . 47.890000000000001 108.989 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 70.9 t80 -92.1 130.7 37.77 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 104.33 -2.47 . . . . 45.530000000000001 104.33 165.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1212 ' ' LEU . . . . . . . . . . . . . 53.0 mt -76.25 106.89 8.12 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 105.2 -2.148 . . . . 46.329999999999998 105.2 167.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.17 150.79 37.09 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 124.07 1.89 . . . . 60.409999999999997 111.577 -173.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 8.0 mp -60.97 127.41 31.45 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 111.847 -2.433 . . . . 57.380000000000003 112.895 176.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 30.9 t0 . . . . . 0 N--CA 1.45 -0.465 0 C-N-CA 127.154 2.182 . . . . 65.069999999999993 110.46 -169.088 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B 1230 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.417 -2.123 0 N-CA-C 102.489 -3.152 . . . . 80.319999999999993 102.489 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1231 ' ' SER . . . . . . . . . . . . 0.298 2.6 p 58.75 169.15 0.06 Allowed 'General case' 0 N--CA 1.444 -0.762 2 CA-C-N 130.094 5.861 . . . . 79.920000000000002 116.365 2.152 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -61.04 -49.76 76.06 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.274 -1.517 . . . . 77.909999999999997 108.304 175.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 34.22 -77.56 0.0 OUTLIER 'General case' 0 C--O 1.248 1.012 0 N-CA-C 119.657 3.206 . . . . 73.879999999999995 119.657 175.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 8.3 m-30 -93.59 -0.25 56.29 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 120.98 1.718 . . . . 68.980000000000004 110.365 -168.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 13.5 pt -33.16 -33.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 119.213 3.042 . . . . 64.530000000000001 119.213 -174.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -80.27 -38.57 30.63 Favored 'General case' 0 C--O 1.245 0.859 0 O-C-N 120.74 -1.225 . . . . 66.359999999999999 113.79 173.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -63.89 -47.65 79.78 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-O 117.45 -1.262 . . . . 56.600000000000001 109.154 170.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -47.96 -61.14 2.11 Favored 'General case' 0 C--N 1.36 1.06 0 O-C-N 124.347 1.029 . . . . 56.789999999999999 112.284 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1239 ' ' MET . . . . . . . . . . . . . 14.1 ttm -54.28 -50.15 67.92 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 124.853 1.261 . . . . 53.630000000000003 111.029 -175.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -72.41 -27.9 62.64 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 117.432 2.382 . . . . 51.740000000000002 117.432 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 28.2 tp -63.48 -50.46 69.6 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 106.498 -1.667 . . . . 44.859999999999999 106.498 169.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -58.62 -41.91 86.99 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.998 1.436 . . . . 42.780000000000001 111.375 176.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -59.46 -44.77 92.91 Favored 'General case' 0 C--O 1.25 1.088 0 CA-C-N 120.577 1.535 . . . . 40.960000000000001 114.876 173.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -61.43 -51.84 67.07 Favored 'General case' 0 C--O 1.25 1.085 0 C-N-CA 120.169 -0.612 . . . . 43.060000000000002 110.063 174.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 -58.84 -28.64 66.26 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 116.203 1.927 . . . . 46.450000000000003 116.203 173.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -52.34 -33.09 41.21 Favored 'General case' 0 C--O 1.254 1.323 0 CA-C-N 119.291 0.95 . . . . 41.780000000000001 113.143 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 22.0 tptt -76.61 -31.56 57.52 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 120.932 -1.105 . . . . 52.200000000000003 112.322 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1248 ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -84.49 -42.12 15.87 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 120.818 -1.176 . . . . 53.549999999999997 112.697 178.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1249 ' ' VAL . . . . . . . . . . . . . 36.0 m -82.03 160.11 3.82 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.788 0 CA-C-O 123.154 1.454 . . . . 34.409999999999997 113.713 -162.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1250 ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -107.48 -69.72 0.83 Allowed 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 111.832 -2.44 . . . . 33.380000000000003 113.748 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1251 ' ' ILE . . . . . . . . . . . . . 44.2 mm -101.6 102.5 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 N-CA-C 108.04 -1.096 . . . . 29.539999999999999 108.04 -175.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1252 ' ' ILE . . . . . . . . . . . . . 75.0 mt -83.29 116.41 27.34 Favored 'Isoleucine or valine' 0 C--O 1.25 1.127 0 N-CA-C 107.082 -1.451 . . . . 32.439999999999998 107.082 168.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1253 ' ' VAL . . . . . . . . . . . . . 39.0 t -101.16 87.9 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 105.644 -1.984 . . . . 30.57 105.644 174.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1254 ' ' THR . . . . . . . . . . . . . 1.2 t -92.85 115.02 27.73 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-O 125.462 2.553 . . . . 35.039999999999999 111.331 -174.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1255 ' ' THR . . . . . . . . . . . . . 7.1 m -135.83 10.16 3.35 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 110.606 -2.997 . . . . 34.619999999999997 108.987 -161.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . -70.37 84.86 0.58 Allowed 'General case' 0 C--N 1.35 0.628 0 O-C-N 121.086 -1.009 . . . . 42.719999999999999 113.552 -172.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 41.1 mt -105.89 126.63 52.41 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 125.387 1.475 . . . . 52.43 110.103 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 2.6 mp -77.14 132.1 71.2 Favored Pre-proline 0 N--CA 1.438 -1.057 0 N-CA-C 103.151 -2.907 . . . . 59.409999999999997 103.151 168.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -65.22 69.87 0.29 Allowed 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 124.217 3.278 . . . . 62.68 111.967 169.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 153.19 -81.12 0.18 Allowed Glycine 0 CA--C 1.534 1.266 0 O-C-N 118.653 -2.53 . . . . 64.159999999999997 108.43 -171.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 38.3 tttt -64.69 138.45 97.46 Favored Pre-proline 0 N--CA 1.44 -0.968 0 N-CA-C 114.755 1.391 . . . . 68.530000000000001 114.755 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -55.31 132.08 50.07 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 124.703 3.602 . . . . 61.990000000000002 111.392 166.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1263 ' ' ALA . . . . . . . . . . . . . . . -59.53 128.18 85.73 Favored Pre-proline 0 C--O 1.239 0.544 0 CA-C-N 111.675 -2.511 . . . . 57.149999999999999 111.407 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -64.19 146.08 89.95 Favored 'Trans proline' 0 C--O 1.25 1.077 0 C-N-CA 124.69 3.594 . . . . 51.57 113.815 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1265 ' ' LYS . . . . . 0.463 ' NZ ' ' O ' ' B' 1289 ' ' GLY . 38.5 mmtm -71.7 97.44 1.75 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 123.56 1.647 . . . . 54.549999999999997 108.309 167.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 91.3 mt -94.14 -47.85 6.47 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 123.223 1.487 . . . . 46.859999999999999 112.134 172.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1267 ' ' ILE . . . . . . . . . . . . . 20.7 mm -84.06 82.36 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 104.651 -2.351 . . . . 41.039999999999999 104.651 -175.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1268 ' ' THR . . . . . . . . . . . . . 23.2 p -82.36 175.45 10.24 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 111.068 -2.787 . . . . 39.579999999999998 108.729 -175.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1269 ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 -52.56 -41.28 63.42 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.019 0.927 . . . . 53.149999999999999 111.765 175.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -60.57 -21.06 62.18 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 115.727 1.751 . . . . 42.960000000000001 115.727 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1271 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.42 -51.51 6.89 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 120.338 1.426 . . . . 43.890000000000001 110.725 162.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B 1272 ' ' VAL . . . . . . . . . . . . . 96.4 t -57.72 -60.68 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 CA-C-N 115.187 -0.915 . . . . 38.369999999999997 112.203 -168.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.26 -34.93 77.49 Favored 'General case' 0 C--O 1.247 0.97 0 O-C-N 119.541 -1.974 . . . . 47.460000000000001 112.708 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1274 ' ' SER . . . . . . . . . . . . . 5.2 m -74.32 -17.03 60.9 Favored 'General case' 0 C--O 1.244 0.786 0 O-C-N 120.044 -1.66 . . . . 38.380000000000003 111.16 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1275 ' ' MET . . . . . . . . . . . . . 38.3 mtp -53.75 145.07 16.53 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 118.747 2.869 . . . . 37.810000000000002 118.747 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -61.39 130.76 47.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.547 -1.206 . . . . 49.259999999999998 109.101 171.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -64.03 165.35 9.12 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 118.5 2.778 . . . . 34.460000000000001 118.5 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 67.34 26.47 73.52 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-O 124.711 2.284 . . . . 33.530000000000001 115.363 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1279 ' ' SER . . . . . . . . . . . . . 36.6 m -127.89 159.75 33.95 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 111.243 -2.478 . . . . 31.309999999999999 106.139 -168.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1280 ' ' VAL . . . . . . . . . . . . . 94.8 t -128.28 129.31 69.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.537 -0.912 . . . . 29.32 108.537 -165.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1281 ' ' ILE . . . . . . . . . . . . . 58.5 mt -99.49 96.28 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 N-CA-C 107.304 -1.369 . . . . 31.93 107.304 170.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1282 ' ' VAL . . . . . . . . . . . . . 14.2 t -80.63 110.99 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 O-C-N 120.383 -1.448 . . . . 29.48 110.793 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 33.6 t0 -90.57 95.81 10.34 Favored 'General case' 0 N--CA 1.417 -2.115 0 O-C-N 120.289 -1.507 . . . . 34.5 107.189 173.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1284 ' ' LEU . . . . . . . . . . . . . 5.0 mp -76.65 -21.97 54.72 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-N 113.18 -1.827 . . . . 37.939999999999998 111.207 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -87.0 8.01 25.2 Favored 'General case' 0 C--N 1.35 0.589 0 N-CA-C 115.656 1.724 . . . . 40.920000000000002 115.656 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -50.29 -42.66 52.79 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 119.524 3.157 . . . . 44.390000000000001 119.524 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1287 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.03 -28.86 70.09 Favored 'General case' 0 C--O 1.257 1.495 0 O-C-N 119.322 -2.111 . . . . 51.460000000000001 114.137 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 38.9 t30 -121.91 76.78 1.31 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.243 -1.021 . . . . 57.75 108.243 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1289 ' ' GLY . . . . . 0.463 ' O ' ' NZ ' ' B' 1265 ' ' LYS . . . 98.45 -60.68 0.9 Allowed Glycine 0 C--N 1.336 0.531 0 O-C-N 120.102 -1.624 . . . . 49.850000000000001 114.902 176.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 80.99 119.48 0.44 Allowed Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 121.247 2.523 . . . . 45.93 112.128 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1291 ' ' ASN . . . . . . . . . . . . . 27.0 m120 -81.5 -25.84 35.66 Favored 'General case' 0 C--N 1.346 0.429 0 N-CA-C 114.457 1.28 . . . . 42.670000000000002 114.457 -175.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1292 ' ' CYS . . . . . . . . . . . . . 48.2 t -95.14 144.44 25.77 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 120.399 -1.438 . . . . 38.82 111.754 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1293 ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -68.82 -34.25 75.2 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 113.784 1.031 . . . . 46.710000000000001 113.784 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -80.91 7.76 9.86 Favored 'General case' 0 C--O 1.248 0.982 0 N-CA-C 116.766 2.135 . . . . 47.229999999999997 116.766 -176.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1295 ' ' THR . . . . . . . . . . . . . 26.4 m -71.79 107.73 4.74 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 114.007 1.114 . . . . 36.020000000000003 114.007 -173.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 36.7 t -93.57 123.42 60.14 Favored Pre-proline 0 C--N 1.304 -1.394 0 N-CA-C 103.448 -2.797 . . . . 37.259999999999998 103.448 155.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -61.16 136.8 67.14 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.649 2.233 . . . . 35.090000000000003 114.268 177.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 71.69 40.73 58.16 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 113.699 -1.591 . . . . 35.969999999999999 112.691 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -148.91 152.75 36.94 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-O 124.882 2.277 . . . . 40.390000000000001 114.671 -172.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1300 ' ' ILE . . . . . . . . . . . . . 55.3 mt -99.84 107.61 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 101.422 -3.547 . . . . 37.43 101.422 166.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 15.2 t80 -104.78 103.12 12.68 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.07 -1.085 . . . . 44.130000000000003 108.07 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1302 ' ' THR . . . . . . . . . . . . . 17.7 m -82.98 120.42 25.69 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-O 123.337 1.541 . . . . 39.780000000000001 111.012 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1303 ' ' THR . . . . . . . . . . . . . 3.2 p -79.84 139.35 37.22 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 112.929 -1.941 . . . . 43.289999999999999 109.398 175.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -48.25 -31.22 5.59 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 117.352 2.352 . . . . 53.07 117.352 -175.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -59.88 -21.93 61.68 Favored 'General case' 0 C--O 1.262 1.713 0 C-N-CA 126.496 1.918 . . . . 43.969999999999999 116.062 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 113.35 1.09 24.94 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 110.987 -0.845 . . . . 41.119999999999997 110.987 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1307 ' ' VAL . . . . . . . . . . . . . 45.6 t -88.95 148.28 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-N 118.653 1.227 . . . . 38.119999999999997 109.437 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1308 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.09 114.87 27.97 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 107.726 -1.212 . . . . 36.340000000000003 107.726 177.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B 1309 ' ' VAL . . . . . . . . . . . . . 85.2 t -84.05 97.04 4.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 107.108 -1.441 . . . . 30.399999999999999 107.108 172.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1310 ' ' ILE . . . . . . . . . . . . . 19.0 mt -88.32 91.58 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 CA-C-O 122.912 1.339 . . . . 30.82 108.228 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1311 ' ' GLY . . . . . . . . . . . . . . . -88.97 93.32 1.88 Allowed Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 109.65 -1.38 . . . . 26.530000000000001 109.65 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1312 ' ' TYR . . . . . . . . . . . . . 13.9 m-30 -116.56 128.18 55.19 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 117.755 2.502 . . . . 38.0 117.755 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1313 ' ' THR . . . . . . . . . . . . . 24.0 p -81.83 -56.25 4.1 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 112.668 -2.06 . . . . 29.800000000000001 108.64 173.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -70.05 21.26 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 117.991 2.589 . . . . 39.039999999999999 117.991 -173.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1315 ' ' LEU . . . . . . . . . . . . . 63.8 mt -50.78 -34.29 11.57 Favored Pre-proline 0 CA--C 1.545 0.777 0 O-C-N 118.013 -2.93 . . . . 31.079999999999998 117.128 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1316 ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -61.87 -54.23 1.67 Allowed 'Trans proline' 0 C--O 1.24 0.589 0 C-N-CA 123.213 2.608 . . . . 26.100000000000001 112.173 166.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -58.1 -32.99 68.07 Favored Glycine 0 C--O 1.213 -1.168 0 O-C-N 121.548 -0.72 . . . . 23.170000000000002 113.004 -177.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 74.7 mtt-85 -60.24 -27.44 67.21 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 113.584 0.957 . . . . 40.399999999999999 113.584 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 14.1 tp -111.86 77.98 2.1 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 105.397 -2.075 . . . . 23.600000000000001 105.397 171.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1320 ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -59.71 -64.66 0.1 OUTLIER 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.309 2.673 . . . . 22.350000000000001 115.414 -163.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1321 ' ' THR . . . . . . . . . . . . . 1.5 m -60.6 -38.07 83.48 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 120.552 -1.342 . . . . 26.52 111.404 -172.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1322 ' ' GLN . . . . . . . . . . . . . 43.1 tp60 -72.34 -35.37 68.54 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 120.288 -1.508 . . . . 24.379999999999999 109.342 -175.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1323 ' ' SER . . . . . . . . . . . . . 68.8 m -61.56 -47.6 84.77 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 124.633 1.208 . . . . 22.800000000000001 111.433 171.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1324 ' ' SER . . . . . . . . . . . . . 7.6 m -60.71 -28.86 68.97 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 119.612 -1.93 . . . . 21.25 112.915 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -74.61 -47.27 33.25 Favored 'General case' 0 C--O 1.252 1.211 0 O-C-N 119.82 -1.8 . . . . 31.34 109.973 176.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1326 ' ' LEU . . . . . . . . . . . . . 86.1 mt -74.85 -47.35 30.76 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 120.343 1.429 . . . . 31.559999999999999 109.527 -173.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1327 ' ' TYR . . . . . . . . . . . . . 55.9 t80 -58.35 -45.1 88.81 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 109.547 -0.538 . . . . 22.73 109.547 174.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1328 ' ' GLY . . . . . . . . . . . . . . . -55.4 -46.49 80.15 Favored Glycine 0 C--N 1.357 1.719 0 N-CA-C 111.253 -0.739 . . . . 21.91 111.253 173.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1329 ' ' THR . . . . . . . . . . . . . 48.2 m -67.98 -25.24 65.32 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 120.323 -1.692 . . . . 22.149999999999999 111.217 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1330 ' ' ASN . . . . . . . . . . . . . 31.7 m120 -69.25 -48.47 61.75 Favored 'General case' 0 C--N 1.314 -0.941 0 O-C-N 119.637 -1.914 . . . . 26.18 107.252 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1331 ' ' LEU . . . . . . . . . . . . . 33.8 mt -56.7 -38.9 72.93 Favored 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 123.003 0.521 . . . . 23.68 110.663 176.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1332 ' ' VAL . . . . . . . . . . . . . 71.0 t -54.3 -53.76 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 CA-C-N 120.157 1.344 . . . . 26.57 111.897 171.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -61.9 -44.24 97.2 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 122.37 1.081 . . . . 28.079999999999998 111.387 -177.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1334 ' ' LEU . . . . . . . . . . . . . 5.0 tt -53.92 -47.84 70.78 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 123.745 1.735 . . . . 27.43 113.016 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1335 ' ' LEU . . . . . . . . . . . . . 39.1 mt -78.9 -15.29 58.52 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 119.844 -1.785 . . . . 30.5 109.606 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1336 ' ' LYS . . . . . . . . . . . . . 89.7 mttt -72.08 -36.68 69.6 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-N 119.583 1.083 . . . . 41.649999999999999 109.771 167.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 10.4 mp -67.33 -34.12 76.68 Favored 'General case' 0 N--CA 1.434 -1.251 0 O-C-N 120.086 -1.634 . . . . 42.079999999999998 113.749 169.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1338 ' ' LEU . . . . . . . . . . . . . 85.6 mt -81.78 -43.71 17.98 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 118.878 -2.389 . . . . 35.030000000000001 113.774 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 41.5 t -105.23 60.3 0.68 Allowed 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 105.462 -2.051 . . . . 37.329999999999998 105.462 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 56.7 mttp -57.83 -21.15 40.88 Favored 'General case' 0 N--CA 1.432 -1.339 0 O-C-N 118.964 -2.335 . . . . 50.509999999999998 115.906 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -85.52 -5.42 59.29 Favored 'General case' 0 C--O 1.249 1.053 0 N-CA-C 114.856 1.428 . . . . 54.210000000000001 114.856 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 45.7 mttp 56.85 56.57 5.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 123.826 1.774 . . . . 50.990000000000002 111.16 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -133.04 -1.97 3.25 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 113.344 -1.753 . . . . 48.82 113.809 -168.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 88.95 -30.72 5.32 Favored Glycine 0 CA--C 1.541 1.657 0 N-CA-C 117.509 1.764 . . . . 40.43 117.509 -170.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -86.4 124.22 32.5 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 117.839 -1.545 . . . . 47.560000000000002 110.369 -171.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1346 ' ' ILE . . . . . . . . . . . . . 39.4 mm -80.51 117.11 25.86 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.416 0 N-CA-C 107.12 -1.437 . . . . 42.490000000000002 107.12 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1347 ' ' THR . . . . . . . . . . . . . 35.6 m -82.73 106.44 14.58 Favored 'General case' 0 C--N 1.352 0.708 0 CA-C-O 123.748 1.737 . . . . 38.119999999999997 108.935 164.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 18.8 t -84.0 93.14 3.14 Favored 'Isoleucine or valine' 0 C--O 1.257 1.457 0 N-CA-C 107.259 -1.386 . . . . 37.5 107.259 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 4.4 t70 -68.86 167.09 16.33 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.179 -1.373 . . . . 43.850000000000001 109.296 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1350 ' ' PHE . . . . . . . . . . . . . 13.5 t80 -131.61 -42.32 1.04 Allowed 'General case' 0 C--N 1.314 -0.945 0 O-C-N 121.023 -1.048 . . . . 39.810000000000002 110.391 169.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -64.51 -39.86 94.57 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 114.607 1.336 . . . . 51.289999999999999 114.607 -174.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 34.4 t70 -62.42 112.95 2.66 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 121.523 -0.736 . . . . 39.780000000000001 111.991 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 27.0 m -47.99 -37.88 6.97 Favored 'Isoleucine or valine' 0 C--N 1.35 0.628 0 N-CA-C 114.101 1.149 . . . . 39.280000000000001 114.101 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1354 ' ' VAL . . . . . . . . . . . . . 99.5 t -67.79 -53.96 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 O-C-N 120.311 -1.493 . . . . 35.700000000000003 111.392 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1355 ' ' ILE . . . . . . . . . . . . . 25.0 mm -56.11 -51.79 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 114.153 1.168 . . . . 35.770000000000003 114.153 174.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 43.0 tpt85 -55.43 -31.47 61.92 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 115.725 1.75 . . . . 38.549999999999997 115.725 176.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -68.96 -58.84 6.39 Favored Glycine 0 C--N 1.341 0.857 0 C-N-CA 125.855 1.693 . . . . 29.579999999999998 109.934 172.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1358 ' ' VAL . . . . . . . . . . . . . 13.0 p -71.65 -36.67 60.32 Favored 'Isoleucine or valine' 0 C--O 1.249 1.072 0 O-C-N 120.763 -1.433 . . . . 32.060000000000002 112.152 -171.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1359 ' ' THR . . . . . . . . . . . . . 54.1 m -78.29 93.22 4.61 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 103.575 -2.75 . . . . 29.0 103.575 -176.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1360 ' ' VAL . . . . . . . . . . . . . 18.6 m -80.17 -27.88 12.08 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 CA-C-N 111.467 -2.606 . . . . 29.68 110.394 -175.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 97.7 mt -128.31 106.64 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.644 -1.243 . . . . 32.049999999999997 107.644 172.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1362 ' ' ARG . . . . . . . . . . . . . 46.1 ttt85 -83.08 90.45 7.05 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 105.643 -1.984 . . . . 32.520000000000003 105.643 172.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 47.35 71.66 0.31 Allowed 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 123.809 1.766 . . . . 35.68 112.786 170.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 85.85 -41.41 3.07 Favored Glycine 0 C--N 1.344 1.026 0 N-CA-C 116.311 1.284 . . . . 34.259999999999998 116.311 -173.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -78.87 112.24 15.84 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 106.508 -1.664 . . . . 51.07 106.508 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 65.5 mt -67.98 93.71 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 O-C-N 120.152 -1.593 . . . . 39.869999999999997 108.167 176.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1367 ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.02 -4.13 54.12 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 126.063 1.745 . . . . 38.009999999999998 113.247 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B 1368 ' ' TRP . . . . . . . . . . . . . 49.3 t90 -86.52 134.3 38.24 Favored Pre-proline 0 C--O 1.242 0.671 0 N-CA-C 103.248 -2.871 . . . . 42.140000000000001 103.248 168.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -64.6 140.89 43.49 Favored 'Cis proline' 0 N--CA 1.489 1.243 0 N-CA-C 121.457 3.599 . . . . 43.259999999999998 121.457 9.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1370 ' ' ALA . . . . . . . . . . . . . . . -87.57 160.97 46.57 Favored Pre-proline 0 C--N 1.307 -1.261 0 CA-C-N 113.527 -1.67 . . . . 46.520000000000003 107.243 -174.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -56.25 153.28 34.26 Favored 'Trans proline' 0 C--O 1.245 0.866 0 C-N-CA 125.212 3.941 . . . . 51.950000000000003 111.838 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -63.9 114.13 2.47 Favored 'Trans proline' 0 C--O 1.251 1.146 0 C-N-CA 122.804 2.336 . . . . 56.270000000000003 114.544 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1373 ' ' ILE . . . . . . . . . . . . . 37.2 mm -93.81 129.85 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 114.588 -1.187 . . . . 60.829999999999998 108.558 -171.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -70.03 121.57 17.69 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-O 123.642 1.687 . . . . 66.099999999999994 109.035 166.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 59.7 t -109.96 127.25 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 113.827 -1.533 . . . . 63.469999999999999 108.545 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.226 -4.764 0 CA-C-N 120.254 1.388 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.209 -1.044 0 CA-C-O 118.445 -0.788 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -47.53 -36.86 11.05 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 123.769 1.747 . . . . 0.0 113.915 168.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 35.4 mp0 -56.14 -42.0 76.27 Favored 'General case' 0 C--O 1.249 1.075 0 C-N-CA 126.308 1.843 . . . . 0.0 108.904 176.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 14.6 m -66.05 -32.62 74.2 Favored 'General case' 0 C--O 1.24 0.583 0 O-C-N 120.026 -1.671 . . . . 0.0 111.122 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.31 -46.81 81.92 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 121.438 1.926 . . . . 0.0 111.249 175.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -57.38 -35.17 69.65 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 126.356 2.285 . . . . 0.0 113.62 174.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 14.6 tp -68.12 -60.81 2.2 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.31 -1.314 . . . . 0.0 111.219 177.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 7.9 mt -48.4 -43.46 33.98 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 115.931 -1.985 . . . . 0.0 113.746 -169.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 28' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -58.05 -30.48 66.21 Favored 'General case' 0 C--O 1.244 0.783 0 O-C-N 125.076 1.485 . . . . 0.0 114.813 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -93.12 -23.76 18.5 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 174.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 53.2 m -57.85 -16.91 13.26 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 120.201 3.408 . . . . 0.0 120.201 -168.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 31' ' ' HIS . . . . . . . . . . . . 0.45 1.3 p-80 53.9 -55.4 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 117.373 2.36 . . . . 0.0 117.373 -174.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 68.0 m -108.53 133.88 52.06 Favored 'General case' 0 CA--C 1.476 -1.902 0 O-C-N 118.419 -2.676 . . . . 0.0 110.426 167.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 42.6 t -134.38 115.01 19.46 Favored 'Isoleucine or valine' 0 C--N 1.355 0.833 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 174.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 42.5 mt -106.22 100.76 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 84.4 mt -81.59 108.36 14.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 103.719 -2.697 . . . . 0.0 103.719 -177.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 89.2 m -103.56 95.31 7.1 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -171.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -63.29 114.1 2.35 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.091 2.528 . . . . 0.0 113.21 176.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.85 -166.44 33.16 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 158.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -50.08 -21.18 1.17 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 175.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.24 -38.46 94.57 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-N 121.154 1.797 . . . . 0.0 111.365 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 26.4 ttm -74.98 -6.73 50.89 Favored 'General case' 0 C--O 1.248 1.018 0 O-C-N 121.271 -1.135 . . . . 0.0 113.887 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.78 -52.26 3.5 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 121.147 1.794 . . . . 0.0 109.16 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.09 -45.57 90.14 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.557 0 O-C-N 123.734 0.646 . . . . 0.0 110.691 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.23 144.62 25.67 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 174.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.7 55.58 0.52 Allowed 'General case' 0 CA--C 1.552 1.022 0 CA-C-O 123.118 1.437 . . . . 0.0 112.475 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.26 -16.13 60.47 Favored 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 120.617 -1.302 . . . . 0.0 111.047 -171.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.97 -38.04 75.95 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 117.68 2.474 . . . . 0.0 117.68 177.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 48' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -62.22 -36.66 30.33 Favored Pre-proline 0 CA--C 1.517 -0.308 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -175.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 49' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.19 -28.98 8.4 Favored 'Trans proline' 0 C--N 1.318 -1.026 0 C-N-CA 122.34 2.026 . . . . 0.0 115.223 164.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.93 -35.54 61.4 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 O-C-N 118.38 -2.7 . . . . 0.0 115.318 -170.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.17 -27.12 67.76 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.45 -30.49 66.09 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.2 176.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 10.9 tp -76.76 -41.5 33.19 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 O-C-N 120.056 -1.653 . . . . 0.0 107.664 170.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 27.5 m -53.77 -27.26 27.79 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 121.256 1.844 . . . . 0.0 113.662 172.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -57.32 -57.18 13.74 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 121.014 -1.053 . . . . 0.0 108.963 172.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -74.89 -27.87 60.41 Favored 'General case' 0 C--O 1.253 1.266 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 95.9 mt -66.16 -47.68 73.23 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -66.5 -44.22 83.16 Favored 'General case' 0 C--N 1.359 0.988 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.583 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.72 -30.18 55.39 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 171.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -89.83 8.14 33.51 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.97 36.75 91.46 Favored Glycine 0 N--CA 1.432 -1.589 0 O-C-N 119.896 -1.753 . . . . 0.0 110.418 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 64.1 mt -94.66 126.61 47.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -62.99 91.5 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.326 171.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 7.1 p -107.71 129.68 61.32 Favored 'Isoleucine or valine' 0 C--O 1.258 1.522 0 C-N-CA 119.629 -0.828 . . . . 0.0 108.811 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 23.1 mmm-85 -127.01 156.35 41.77 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 175.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -117.71 105.4 11.97 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-O 122.65 1.215 . . . . 0.0 108.434 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.92 80.14 1.85 Allowed Glycine 0 C--O 1.24 0.477 0 CA-C-O 117.347 -1.807 . . . . 0.0 109.593 -174.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.06 126.25 32.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 121.447 2.624 . . . . 0.0 109.639 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -94.67 126.43 47.54 Favored Pre-proline 0 N--CA 1.437 -1.082 0 C-N-CA 117.626 -1.63 . . . . 0.0 108.728 -177.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 70' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -57.92 -62.74 0.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.967 2.444 . . . . 0.0 112.806 175.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 42.4 t -64.01 92.33 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.211 -0.927 0 CA-C-O 123.252 1.501 . . . . 0.0 107.096 166.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.19 -32.79 24.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 113.451 -1.704 . . . . 0.0 114.134 -174.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 129.97 -51.23 0.86 Allowed Glycine 0 CA--C 1.504 -0.63 0 CA-C-N 113.302 -1.772 . . . . 0.0 109.26 -171.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -130.86 129.2 42.0 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 101.625 -3.472 . . . . 0.0 101.625 163.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 1.9 mp 68.59 153.38 0.14 Allowed Pre-proline 0 N--CA 1.441 -0.892 0 C-N-CA 127.034 2.133 . . . . 0.0 115.8 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -57.46 88.31 0.05 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 123.689 2.926 . . . . 0.0 110.659 158.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 46.17 48.47 15.11 Favored Glycine 0 C--O 1.216 -1.001 0 N-CA-C 118.139 2.016 . . . . 0.0 118.139 175.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -49.91 -24.19 2.37 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 122.032 2.916 . . . . 0.0 116.346 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -63.81 -25.89 68.38 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -69.14 -22.52 63.94 Favored 'General case' 0 CA--C 1.561 1.369 0 O-C-N 124.102 0.876 . . . . 0.0 111.751 -176.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 40.7 t -66.13 -52.97 42.09 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 169.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 6.9 mp -57.64 -30.32 65.29 Favored 'General case' 0 CA--C 1.512 -0.499 0 O-C-N 119.944 -1.723 . . . . 0.0 114.319 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 5.3 mp -64.46 -22.22 66.9 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 117.836 -1.078 . . . . 0.0 113.063 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.99 -34.89 76.02 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 120.338 1.426 . . . . 0.0 113.178 173.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -69.07 -42.3 76.4 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 172.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.37 -21.69 66.24 Favored 'General case' 0 C--O 1.213 -0.833 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 177.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp 70.73 45.49 0.57 Allowed 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 128.165 2.586 . . . . 0.0 108.436 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 45.6 t -81.58 130.8 60.1 Favored Pre-proline 0 C--N 1.351 0.672 0 CA-C-O 117.664 -1.16 . . . . 0.0 108.259 174.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -61.81 115.4 2.78 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 124.025 3.15 . . . . 0.0 114.143 176.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -60.76 -13.09 12.92 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-N 114.765 -1.107 . . . . 0.0 113.481 -177.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -59.16 -51.73 68.76 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 166.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 26.3 pt -82.64 -15.71 11.77 Favored 'Isoleucine or valine' 0 C--O 1.249 1.047 0 CA-C-N 119.169 0.895 . . . . 0.0 110.447 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 73.5 t -75.59 99.99 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 123.026 1.394 . . . . 0.0 109.453 175.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 53.0 mt -103.7 100.44 10.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 113.707 -1.588 . . . . 0.0 112.621 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 95' ' ' GLU . . . . . 0.437 ' CD ' ' HZ3' ' A' 1162 ' ' LYS . 40.9 mp0 -81.06 91.8 6.15 Favored 'General case' 0 C--O 1.267 1.989 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 -178.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 31.8 ttp 47.94 73.47 0.21 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 123.892 1.806 . . . . 0.0 115.606 -171.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -91.74 144.42 25.52 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 168.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -92.82 51.9 1.77 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 123.844 1.783 . . . . 0.0 112.247 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 99' ' ' ILE . . . . . . . . . . . . 0.286 10.2 tt -87.22 70.0 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-O 126.978 3.275 . . . . 0.0 108.852 -166.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -54.73 -52.49 62.33 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 108.834 -3.803 . . . . 0.0 114.935 -174.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -62.49 -42.98 99.86 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 118.368 -0.825 . . . . 0.0 112.861 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.54 -39.32 81.18 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-N 119.974 1.261 . . . . 0.0 108.785 -174.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 103' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -55.34 -52.5 63.29 Favored 'General case' 0 C--O 1.251 1.173 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 168.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.85 -26.02 67.06 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -75.62 -39.53 57.73 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 106' ' ' THR . . . . . . . . . . . . . 96.0 m -61.34 141.52 57.53 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 -162.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 107' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -71.53 -87.8 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 124.019 0.928 . . . . 0.0 108.714 161.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.09 112.35 23.31 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 122.448 1.118 . . . . 0.0 112.395 -165.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 109' ' ' VAL . . . . . . . . . . . . . 4.4 t -102.92 104.2 16.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 174.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 95.9 mt -88.3 90.6 8.46 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.521 -172.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 28.2 t -81.19 104.84 10.33 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 CA-C-O 124.338 2.018 . . . . 0.0 107.771 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 45.1 mm -78.24 97.79 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 CA-C-O 122.635 1.207 . . . . 0.0 108.45 -171.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.21 -70.45 3.1 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-N 111.275 -2.693 . . . . 0.0 113.738 165.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -87.57 121.84 30.51 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 120.775 -1.427 . . . . 0.0 112.441 -163.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 115' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -85.09 -55.1 4.22 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 118.156 -0.926 . . . . 0.0 113.192 -173.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.19 -38.89 66.12 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 121.298 1.863 . . . . 0.0 109.915 -175.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 67.6 m -33.61 -36.31 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 118.751 2.871 . . . . 0.0 118.751 166.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 26.7 m -119.58 2.53 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-O 117.646 -1.168 . . . . 0.0 110.459 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -52.09 117.77 10.81 Favored Pre-proline 0 C--O 1.257 1.454 0 CA-C-N 122.472 2.396 . . . . 0.0 115.708 -164.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 120' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -45.1 -59.92 1.0 Allowed 'Trans proline' 0 C--N 1.363 1.339 1 C-N-CA 127.954 5.77 . . . . 0.0 110.706 174.293 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -48.28 -38.75 19.56 Favored 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.92 -16.54 63.42 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 118.618 -1.233 . . . . 0.0 114.256 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.25 -41.68 6.61 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 117.359 -1.736 . . . . 0.0 110.892 165.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.68 -60.95 2.98 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 126.297 1.839 . . . . 0.0 114.27 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 125' ' ' ASP . . . . . 0.416 ' CG ' ' HZ2' ' C' ' 127' ' ' LYS . 16.4 t70 -82.09 117.04 66.92 Favored Pre-proline 0 C--O 1.246 0.918 0 O-C-N 124.851 1.345 . . . . 0.0 111.222 173.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -67.52 -26.53 40.19 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.732 3.621 . . . . 0.0 112.157 176.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 127' ' ' LYS . . . . . 0.416 ' HZ2' ' CG ' ' C' ' 125' ' ' ASP . 6.0 ttpm? -64.96 -28.34 69.45 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 122.445 1.117 . . . . 0.0 113.934 -175.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 128' ' ' SER . . . . . . . . . . . . . 70.3 m -32.9 116.66 0.42 Allowed Pre-proline 0 C--N 1.357 0.92 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 166.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 129' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -50.03 -48.84 18.03 Favored 'Trans proline' 0 C--O 1.241 0.67 0 C-N-CA 124.042 3.162 . . . . 0.0 111.58 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 13.1 pt -73.97 84.07 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 O-C-N 119.732 -1.855 . . . . 0.0 108.669 168.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.93 119.17 19.54 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -172.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 73.76 78.36 0.57 Allowed Glycine 0 N--CA 1.48 1.57 0 CA-C-N 114.715 -1.13 . . . . 0.0 113.113 177.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 133' ' ' MET . . . . . . . . . . . . . 41.6 tpp -76.01 124.06 88.32 Favored Pre-proline 0 C--N 1.313 -0.999 0 O-C-N 118.965 -2.491 . . . . 0.0 109.638 171.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -70.62 85.52 0.74 Allowed 'Trans proline' 0 CA--C 1.5 -1.188 0 C-N-CA 123.562 2.841 . . . . 0.0 113.734 176.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.93 137.54 50.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 124.889 2.28 . . . . 0.0 111.233 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -105.17 137.59 42.7 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 111.839 -2.437 . . . . 0.0 107.134 167.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . 0.258 6.3 mm-40 23.23 40.68 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.964 1 N-CA-C 122.531 4.271 . . . . 0.0 122.531 166.429 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 13.7 p -88.01 48.35 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 126.228 2.918 . . . . 0.0 109.386 174.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -159.0 148.54 18.92 Favored 'General case' 0 C--O 1.256 1.434 0 CA-C-N 111.185 -2.734 . . . . 0.0 104.597 -172.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 140' ' ' LYS . . . . . . . . . . . . 0.356 23.6 pttm 65.63 -26.57 0.1 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 118.017 2.599 . . . . 0.0 118.017 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -45.4 146.71 0.93 Allowed 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 125.665 1.586 . . . . 0.0 113.614 161.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -58.62 -28.88 66.05 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 120.136 3.384 . . . . 0.0 120.136 -151.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 143' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -153.57 87.51 1.24 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 172.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 144' ' ' VAL . . . . . . . . . . . . . 37.4 t -81.24 89.76 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.146 0 O-C-N 119.803 -1.811 . . . . 0.0 107.358 177.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 145' ' ' ILE . . . . . . . . . . . . . 21.7 mt -92.28 104.63 15.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 125.545 2.593 . . . . 0.0 107.977 -173.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 146' ' ' VAL . . . . . . . . . . . . . 10.0 t -86.25 102.7 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 CA-C-N 111.38 -2.645 . . . . 0.0 107.552 176.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 147' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -64.34 94.48 0.11 Allowed 'General case' 0 C--O 1.242 0.7 0 CA-C-O 122.372 1.082 . . . . 0.0 112.105 177.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 148' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -128.22 111.59 13.59 Favored 'General case' 0 CA--C 1.485 -1.541 0 C-N-CA 123.98 0.912 . . . . 0.0 109.352 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 10.7 ptp85 -54.0 -31.96 52.59 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 174.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 19.4 m -153.0 155.47 36.98 Favored 'General case' 0 C--O 1.249 1.067 0 O-C-N 118.682 -2.511 . . . . 0.0 106.185 -170.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 151' ' ' MET . . . . . 0.608 ' SD ' ' SD ' ' C' ' 170' ' ' MET . 6.8 tpt -88.03 67.17 8.87 Favored 'General case' 0 C--O 1.254 1.329 0 CA-C-O 125.865 2.745 . . . . 0.0 108.074 177.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -94.93 117.32 29.93 Favored 'General case' 0 N--CA 1.44 -0.958 0 O-C-N 119.636 -1.915 . . . . 0.0 106.109 170.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 7.4 m -64.18 138.99 58.72 Favored 'General case' 0 C--O 1.249 1.074 0 CA-C-N 113.286 -1.779 . . . . 0.0 107.696 171.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -86.85 -53.42 2.87 Favored Glycine 0 C--O 1.214 -1.105 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -132.17 -78.3 0.5 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 118.002 0.901 . . . . 0.0 108.901 164.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 156' ' ' ALA . . . . . . . . . . . . . . . -86.71 -61.44 1.73 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -170.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.81 28.85 5.69 Favored Glycine 0 C--N 1.353 1.475 0 C-N-CA 127.387 2.422 . . . . 0.0 114.654 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 6.1 m -54.76 138.97 14.26 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 N-CA-C 119.414 3.116 . . . . 0.0 119.414 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . 0.263 0.0 OUTLIER 6.76 92.53 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.974 1 N-CA-C 122.811 4.375 . . . . 0.0 122.811 173.663 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' C' C ' 160' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -150.1 152.16 33.25 Favored Pre-proline 0 N--CA 1.469 0.493 0 CA-C-O 117.602 -1.19 . . . . 0.0 112.952 -174.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.76 -27.85 37.41 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 124.551 3.501 . . . . 0.0 114.025 167.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 162' ' ' LEU . . . . . . . . . . . . . 16.3 tp -43.8 -31.5 0.84 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 119.415 3.117 . . . . 0.0 119.415 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 163' ' ' PHE . . . . . . . . . . . . . 14.0 m-30 -85.7 -60.62 1.97 Allowed 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 124.611 2.148 . . . . 0.0 109.749 171.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -82.8 -7.43 59.66 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-N 111.752 -2.476 . . . . 0.0 113.97 -158.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -91.71 177.16 6.28 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 122.0 0.905 . . . . 0.0 110.611 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.77 -51.98 4.66 Favored 'General case' 0 C--O 1.254 1.316 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -174.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -78.88 -45.55 20.44 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 120.552 -1.342 . . . . 0.0 111.344 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 168' ' ' THR . . . . . . . . . . . . . 3.0 m -89.75 95.15 10.12 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 101.495 -3.52 . . . . 0.0 101.495 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -150.26 132.3 15.27 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 123.662 1.696 . . . . 0.0 112.302 -162.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 170' ' ' MET . . . . . 0.608 ' SD ' ' SD ' ' C' ' 151' ' ' MET . 33.7 mtm -64.88 110.78 2.55 Favored 'General case' 0 C--O 1.253 1.288 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 165.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 171' ' ' LEU . . . . . . . . . . . . . 15.2 tp -91.16 124.01 35.05 Favored 'General case' 0 C--O 1.256 1.401 0 N-CA-C 103.545 -2.761 . . . . 0.0 103.545 172.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -70.76 82.74 0.63 Allowed 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 111.774 -2.466 . . . . 0.0 115.317 -175.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -157.97 147.5 15.52 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 106.611 -2.595 . . . . 0.0 106.611 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 174' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -63.69 147.69 50.99 Favored 'General case' 0 N--CA 1.431 -1.378 0 O-C-N 121.706 -0.879 . . . . 0.0 112.609 172.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -52.24 -60.22 3.47 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -48.8 62.14 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 -171.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 177' ' ' ALA . . . . . . . . . . . . . . . -55.25 -50.55 69.18 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 127.03 2.706 . . . . 0.0 109.978 -176.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 44.2 m -68.26 -32.87 73.35 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.941 -1.1 . . . . 0.0 110.697 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 179' ' ' VAL . . . . . . . . . . . . . 86.9 t -62.87 -45.51 98.68 Favored 'Isoleucine or valine' 0 C--N 1.343 0.287 0 CA-C-N 119.642 1.11 . . . . 0.0 108.421 176.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -68.06 -28.9 67.77 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 119.966 -1.709 . . . . 0.0 111.471 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -64.99 -56.27 14.12 Favored 'General case' 0 C--N 1.348 0.536 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 182' ' ' ILE . . . . . . . . . . . . . 23.8 pt -64.29 -33.47 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 183' ' ' LEU . . . . . . . . . . . . . 5.9 tp -32.02 -50.62 0.22 Allowed 'General case' 0 C--O 1.248 1.012 0 C-N-CA 128.934 2.894 . . . . 0.0 118.565 -171.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -123.79 -7.11 7.92 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.633 169.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -62.39 -44.12 97.2 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -170.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 186' ' ' LEU . . . . . . . . . . . . 0.331 88.1 mt . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 121.588 3.922 . . . . 0.0 121.588 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 9.8 t-80 . . . . . 0 N--CA 1.444 -0.738 0 N-CA-C 103.958 -2.608 . . . . 65.739999999999995 103.958 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -75.04 78.28 1.09 Allowed Glycine 0 C--O 1.256 1.487 0 CA-C-O 119.067 -0.852 . . . . 48.659999999999997 112.326 -174.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 24.2 ttp180 -86.81 131.98 33.97 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 120.045 1.922 . . . . 44.560000000000002 106.289 153.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1003 ' ' ILE . . . . . . . . . . . . . 39.9 mt -101.4 124.74 55.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 102.471 -3.159 . . . . 34.859999999999999 102.471 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -88.1 129.25 9.47 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 107.486 -2.245 . . . . 30.75 107.486 165.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 48.2 mm -98.63 99.55 7.77 Favored Pre-proline 0 C--O 1.249 1.027 0 N-CA-C 105.647 -1.982 . . . . 32.210000000000001 105.647 174.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -71.51 131.03 18.1 Favored 'Trans proline' 0 CA--C 1.499 -1.24 0 C-N-CA 123.779 2.986 . . . . 32.979999999999997 109.317 174.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1007 ' ' ARG . . . . . . . . . . . . . 7.1 ttp85 -73.86 121.34 20.75 Favored 'General case' 0 C--O 1.255 1.347 0 CA-C-N 110.284 -3.144 . . . . 47.979999999999997 106.734 155.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1008 ' ' GLU . . . . . 0.423 ' CD ' ' HZ1' ' A' 1071 ' ' LYS . 6.4 tp10 -73.33 133.33 43.81 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 123.306 1.527 . . . . 34.700000000000003 112.956 -165.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -97.86 9.43 42.7 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 112.805 -1.998 . . . . 53.369999999999997 111.456 -174.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 17.7 tp -70.28 146.54 50.53 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 117.211 -1.796 . . . . 45.07 106.396 168.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1011 ' ' THR . . . . . . . . . . . . . 5.7 m -54.58 146.42 16.51 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-O 117.7 -1.143 . . . . 40.359999999999999 110.698 174.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 76.8 m-20 61.81 -10.67 0.07 Allowed 'General case' 0 C--O 1.258 1.508 0 N-CA-C 119.089 2.996 . . . . 40.609999999999999 119.089 -175.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -68.99 114.93 7.73 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 124.35 2.024 . . . . 33.759999999999998 113.838 -160.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1014 ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.56 -26.95 68.93 Favored 'General case' 0 N--CA 1.427 -1.597 1 CA-C-N 108.27 -4.059 . . . . 27.890000000000001 114.86 174.518 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 1015 ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -79.81 151.32 30.35 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 126.65 3.119 . . . . 29.02 116.621 -171.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1016 ' ' VAL . . . . . . . . . . . . . 2.6 p -115.8 169.02 6.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 1 CA-C-N 107.745 -4.298 . . . . 28.129999999999999 106.655 160.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1017 ' ' ALA . . . . . . . . . . . . . . . -60.98 -46.92 88.81 Favored 'General case' 0 C--O 1.217 -0.617 0 O-C-N 119.296 -2.128 . . . . 26.870000000000001 113.45 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -155.82 133.55 11.15 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 120.838 -1.164 . . . . 26.77 108.516 -175.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1019 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.41 167.39 25.6 Favored Pre-proline 0 C--O 1.239 0.517 0 O-C-N 120.36 -1.462 . . . . 27.02 114.539 177.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1020 ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -42.87 -53.57 3.87 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 124.667 3.578 . . . . 30.57 119.546 -174.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 9.5 tttp -58.28 -39.26 78.81 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 124.111 1.91 . . . . 47.810000000000002 112.853 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1022 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.57 -40.38 92.71 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 113.188 -1.824 . . . . 30.77 109.833 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1023 ' ' VAL . . . . . . . . . . . . . 8.9 t -59.75 -42.61 89.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 118.953 -0.546 . . . . 33.590000000000003 110.475 176.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -49.32 -46.44 46.68 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 124.165 0.915 . . . . 53.289999999999999 112.05 172.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -68.04 -32.74 73.32 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.97 0.89 . . . . 46.920000000000002 111.383 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1026 ' ' LEU . . . . . . . . . . . . . 99.0 mt -68.61 -41.53 79.41 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.166 -1.584 . . . . 37.170000000000002 112.434 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 36.0 tp -61.67 -50.69 71.47 Favored 'General case' 0 C--O 1.254 1.294 0 CA-C-N 111.928 -2.396 . . . . 44.439999999999998 107.039 173.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -48.79 -41.62 33.15 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 116.762 2.134 . . . . 52.579999999999998 116.762 171.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1029 ' ' LEU . . . . . . . . . . . . . 77.0 mt -71.78 -11.32 60.76 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 121.467 1.939 . . . . 45.689999999999998 110.21 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 110.84 33.28 2.45 Favored Glycine 0 C--O 1.244 0.756 0 CA-C-O 122.971 1.317 . . . . 42.090000000000003 111.641 166.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1031 ' ' PHE . . . . . 0.438 ' CZ ' ' SG ' ' A' 1339 ' ' CYS . 50.1 m-85 -117.19 155.14 29.9 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 118.584 -2.715 . . . . 40.719999999999999 109.785 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1032 ' ' THR . . . . . . . . . . . . . 40.1 m -86.62 114.93 23.74 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 104.225 -2.509 . . . . 37.770000000000003 104.225 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1033 ' ' VAL . . . . . . . . . . . . . 19.3 t -88.77 125.78 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 105.837 -1.912 . . . . 33.539999999999999 105.837 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -117.26 126.37 52.63 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 104.446 -2.428 . . . . 31.68 104.446 173.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1035 ' ' VAL . . . . . . . . . . . . . 59.4 t -116.01 145.69 21.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 105.1 -2.185 . . . . 31.52 105.1 -177.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1036 ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -69.38 133.47 47.84 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 122.971 0.509 . . . . 41.039999999999999 111.915 174.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1037 ' ' SER . . . . . . . . . . . . . 54.4 m -54.89 123.33 13.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 123.926 1.822 . . . . 31.829999999999998 114.414 168.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 99.83 -8.14 59.5 Favored Glycine 0 N--CA 1.444 -0.806 0 O-C-N 119.035 -2.29 . . . . 29.359999999999999 112.159 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -64.53 -34.19 77.67 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 113.898 1.073 . . . . 27.780000000000001 113.898 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -59.76 -19.48 49.49 Favored Glycine 0 N--CA 1.427 -1.963 0 CA-C-N 112.14 -2.3 . . . . 28.91 114.648 175.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -76.24 -44.94 35.26 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 120.076 1.938 . . . . 51.18 110.646 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1042 ' ' LEU . . . . . . . . . . . . . 20.6 mt -64.32 -50.01 69.5 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.949 0.881 . . . . 29.91 111.39 173.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1043 ' ' ALA . . . . . . . . . . . . 0.267 . . -53.5 -22.65 8.46 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 112.807 -1.997 . . . . 28.539999999999999 114.477 172.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1044 ' ' SER . . . . . . . . . . . . . 15.5 m 53.98 44.93 28.65 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 124.688 2.185 . . . . 33.060000000000002 110.281 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1045 ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -167.59 102.82 0.5 Allowed 'General case' 0 C--O 1.249 1.066 0 N-CA-C 100.292 -3.966 . . . . 30.289999999999999 100.292 178.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -84.51 168.85 15.05 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 123.479 1.609 . . . . 48.619999999999997 114.464 -151.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -46.01 -45.85 16.16 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 112.499 -2.137 . . . . 36.740000000000002 115.609 -172.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 22.5 pttm -54.21 -40.71 67.88 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 115.191 1.552 . . . . 43.729999999999997 115.191 169.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -65.02 -31.52 72.8 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 119.752 1.16 . . . . 32.810000000000002 112.275 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1050 ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -64.01 -42.37 97.16 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 111.612 0.227 . . . . 31.859999999999999 111.612 169.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 41.3 t -61.68 -46.61 96.18 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 N-CA-C 106.774 -1.565 . . . . 33.219999999999999 106.774 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -55.15 -37.06 66.47 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 123.914 0.885 . . . . 50.829999999999998 112.521 174.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -62.56 -41.45 98.93 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 120.065 1.302 . . . . 33.119999999999997 112.578 172.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 120.31 81.36 0.67 Allowed Glycine 0 C--O 1.21 -1.399 0 N-CA-C 106.039 -2.824 . . . . 35.829999999999998 106.039 -177.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -161.06 132.22 5.45 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 125.162 1.154 . . . . 34.82 109.204 -173.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -71.19 135.3 47.48 Favored 'General case' 0 N--CA 1.44 -0.945 0 O-C-N 126.727 2.517 . . . . 49.049999999999997 107.201 166.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1057 ' ' ILE . . . . . . . . . . . . . 36.1 mm -104.43 125.95 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 101.951 -3.351 . . . . 38.530000000000001 101.951 169.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1058 ' ' VAL . . . . . . . . . . . . . 44.1 t -102.29 135.72 37.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 103.566 -2.753 . . . . 42.109999999999999 103.566 174.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -69.38 76.08 0.38 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 114.13 1.159 . . . . 58.0 114.13 178.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 80.08 -129.83 9.38 Favored Glycine 0 N--CA 1.422 -2.253 0 C-N-CA 121.092 -0.575 . . . . 52.119999999999997 113.187 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 29.4 t30 -46.79 -40.14 13.13 Favored 'General case' 0 C--O 1.217 -0.612 0 N-CA-C 117.963 2.579 . . . . 54.75 117.963 -156.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1062 ' ' SER . . . . . . . . . . . . . 15.3 m -67.79 -9.36 43.58 Favored 'General case' 0 C--O 1.247 0.932 0 O-C-N 118.23 -2.794 . . . . 50.340000000000003 116.468 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 8.3 p -64.08 -26.57 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 O-C-N 120.763 -1.211 . . . . 41.460000000000001 111.444 169.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1064 ' ' TRP . . . . . . . . . . . . . 76.8 m95 -72.42 -23.01 61.02 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.941 1.296 . . . . 39.32 112.312 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -83.49 73.58 10.18 Favored 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 120.743 -1.223 . . . . 55.380000000000003 109.058 175.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1066 ' ' SER . . . . . . . . . . . . . 70.5 m -146.34 164.7 31.56 Favored 'General case' 0 C--O 1.257 1.468 0 CA-C-O 121.661 0.743 . . . . 41.869999999999997 109.983 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.11 -66.84 0.63 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.04 -0.982 . . . . 53.200000000000003 109.571 -176.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 31.4 mt -88.63 110.48 21.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 O-C-N 118.236 -2.79 . . . . 41.899999999999999 104.97 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1069 ' ' ILE . . . . . . . . . . . . . 28.1 mm -102.12 119.42 50.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 107.046 -1.465 . . . . 38.729999999999997 107.046 168.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1070 ' ' LEU . . . . . . . . . . . . . 81.6 mt -88.02 74.83 8.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.736 -1.12 . . . . 32.439999999999998 110.126 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1071 ' ' LYS . . . . . 0.423 ' HZ1' ' CD ' ' A' 1008 ' ' GLU . 5.1 mmmt -71.54 128.65 36.53 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 121.98 0.895 . . . . 34.649999999999999 111.111 -176.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1072 ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -82.04 -30.7 10.08 Favored 'Isoleucine or valine' 0 C--O 1.251 1.17 0 N-CA-C 109.167 -0.679 . . . . 31.32 109.167 -163.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -128.61 -171.1 2.38 Favored 'General case' 0 C--O 1.246 0.902 0 N-CA-C 108.305 -0.998 . . . . 33.939999999999998 108.305 171.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -54.5 141.89 52.85 Favored Pre-proline 0 N--CA 1.47 0.556 0 CA-C-N 119.783 1.174 . . . . 38.039999999999999 112.069 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1075 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -72.76 130.56 15.93 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.37 2.047 . . . . 42.68 112.892 173.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 17.8 mt -105.98 165.13 11.43 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 103.969 -2.604 . . . . 46.740000000000002 103.969 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -31.01 -58.7 0.22 Allowed 'General case' 0 C--N 1.357 0.909 0 N-CA-C 117.057 2.243 . . . . 58.609999999999999 117.057 -173.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 13.8 t70 -62.79 -43.63 98.28 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 113.496 0.924 . . . . 59.200000000000003 113.496 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1079 ' ' GLU . . . . . 0.418 ' CD ' ' HZ2' ' A' 1071 ' ' LYS . 33.4 mt-10 -64.93 -37.88 89.1 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 113.581 0.956 . . . . 50.630000000000003 113.581 176.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1080 ' ' ILE . . . . . . . . . . . . . 25.0 mt -54.01 -54.03 23.48 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.88 0 CA-C-N 112.906 -1.952 . . . . 51.479999999999997 108.882 175.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -59.34 -25.69 64.41 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 123.812 1.768 . . . . 50.280000000000001 114.315 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 61.5 mt -77.92 -41.88 34.98 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 120.48 -1.387 . . . . 50.210000000000001 111.424 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1083 ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.27 139.92 40.88 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 123.93 1.824 . . . . 49.060000000000002 112.936 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -101.8 152.69 38.17 Favored Pre-proline 0 N--CA 1.435 -1.185 0 CA-C-N 112.197 -2.274 . . . . 51.079999999999998 108.543 -156.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -64.07 109.67 1.18 Allowed 'Trans proline' 0 C--N 1.322 -0.824 0 CA-C-N 121.446 1.552 . . . . 49.729999999999997 114.006 170.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 110.94 -7.04 29.3 Favored Glycine 0 C--N 1.316 -0.539 0 C-N-CA 119.103 -1.522 . . . . 47.710000000000001 113.424 -171.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1087 ' ' THR . . . . . . . . . . . . . 2.8 m -64.18 118.35 8.46 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 117.487 0.643 . . . . 45.469999999999999 110.921 176.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1088 ' ' THR . . . . . . . . . . . . . 99.2 m -83.86 93.51 8.02 Favored 'General case' 0 N--CA 1.411 -2.4 0 N-CA-C 104.491 -2.411 . . . . 42.039999999999999 104.491 172.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1089 ' ' LEU . . . . . . . . . . . . . 55.0 tp -84.88 87.31 7.33 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 110.321 -3.127 . . . . 38.060000000000002 108.796 -174.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 15.8 t -83.11 120.16 33.91 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.813 0 N-CA-C 105.2 -2.148 . . . . 37.399999999999999 105.2 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1091 ' ' SER . . . . . . . . . . . . . 13.7 p -154.46 143.38 20.99 Favored 'General case' 0 C--O 1.247 0.974 0 O-C-N 119.454 -2.029 . . . . 36.159999999999997 114.897 -168.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 45.5 t80 -84.26 82.48 8.36 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-O 124.138 1.923 . . . . 38.939999999999998 109.694 168.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.28 -31.39 3.7 Favored 'Isoleucine or valine' 0 C--O 1.254 1.294 0 N-CA-C 116.865 2.172 . . . . 42.170000000000002 116.865 -169.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 99.0 m95 58.5 75.08 0.55 Allowed Pre-proline 0 C--O 1.247 0.932 0 CA-C-O 122.782 1.277 . . . . 46.509999999999998 113.039 -168.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -60.04 -40.81 58.05 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 124.613 3.542 . . . . 49.759999999999998 115.687 -172.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -61.15 -29.31 69.71 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.633 1.206 . . . . 52.619999999999997 113.84 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 28.0 mp0 -83.84 -24.27 30.99 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 106.276 -1.75 . . . . 60.740000000000002 106.276 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1098 ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -122.15 55.05 5.9 Favored Pre-proline 0 C--O 1.239 0.514 0 O-C-N 119.817 -1.802 . . . . 58.189999999999998 115.426 -168.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.01 -41.57 73.64 Favored 'Trans proline' 0 N--CA 1.476 0.478 1 C-N-CA 125.891 4.394 . . . . 54.590000000000003 114.218 -176.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -47.69 77.2 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.027 -0.988 . . . . 63.280000000000001 111.845 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1101 ' ' LEU . . . . . . . . . . . . . 7.6 tp -56.89 -41.43 78.07 Favored 'General case' 0 C--O 1.254 1.307 0 CA-C-N 113.304 -1.771 . . . . 54.75 112.288 178.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1102 ' ' MET . . . . . . . . . . . . . 75.0 mmm -57.09 -49.0 77.22 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 126.204 2.19 . . . . 52.649999999999999 109.598 174.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -65.01 -35.34 80.89 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.41 1.005 . . . . 66.260000000000005 111.116 -175.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -64.87 -43.88 91.53 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 109.136 -0.69 . . . . 63.729999999999997 109.136 177.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 49.0 mt -69.51 -30.57 68.45 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.926 0.869 . . . . 54.68 112.593 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -55.63 -48.92 74.13 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.482 0.919 . . . . 53.640000000000001 113.482 165.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -52.57 -46.58 66.92 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 114.479 1.289 . . . . 67.239999999999995 114.479 173.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -58.39 -22.16 52.87 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.702 -0.681 . . . . 65.760000000000005 111.95 174.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 45.2 t30 68.58 44.33 1.23 Allowed 'General case' 0 C--O 1.239 0.552 0 CA-C-O 124.322 2.011 . . . . 58.710000000000001 112.075 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1110 ' ' VAL . . . . . . . . . . . . . 28.3 m -93.11 165.7 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 O-C-N 119.288 -2.132 . . . . 46.630000000000003 112.109 175.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1111 ' ' THR . . . . . . . . . . . . . 58.7 m -102.32 101.4 11.65 Favored 'General case' 0 C--O 1.214 -0.794 0 O-C-N 119.281 -2.137 . . . . 44.130000000000003 110.078 165.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1112 ' ' VAL . . . . . . . . . . . . . 48.6 t -90.96 117.58 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 109.513 -0.551 . . . . 40.439999999999998 109.513 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1113 ' ' MET . . . . . . . . . . . . . 58.3 mtp -112.61 108.16 17.13 Favored 'General case' 0 N--CA 1.422 -1.842 0 C-N-CA 124.105 0.962 . . . . 50.759999999999998 108.788 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1114 ' ' ALA . . . . . . . . . . . . . . . -81.37 115.42 20.71 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 116.065 -0.516 . . . . 35.640000000000001 111.575 -172.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1115 ' ' MET . . . . . . . . . . . . . 93.5 mmm -76.0 -21.0 57.37 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 123.616 1.674 . . . . 38.740000000000002 114.877 -176.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -62.73 -50.38 71.33 Favored 'General case' 0 CA--C 1.482 -1.643 0 CA-C-N 112.767 -2.015 . . . . 40.140000000000001 111.692 163.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1117 ' ' SER . . . . . . . . . . . . . 75.8 m -76.12 22.22 0.16 Allowed 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 118.866 2.913 . . . . 44.789999999999999 118.866 -175.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1118 ' ' VAL . . . . . . . . . . . . . 59.9 t -66.12 130.75 94.36 Favored Pre-proline 0 C--O 1.249 1.063 0 N-CA-C 107.322 -1.362 . . . . 43.75 107.322 175.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -61.63 133.64 46.53 Favored 'Trans proline' 0 N--CA 1.428 -2.33 0 N-CA-C 107.903 -1.614 . . . . 48.93 107.903 175.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 23.4 mmm-85 -79.5 41.02 0.46 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 113.861 -1.518 . . . . 62.899999999999999 114.665 -161.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 18.1 pt -116.56 155.15 18.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 O-C-N 119.978 -1.701 . . . . 57.719999999999999 113.132 -167.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1122 ' ' SER . . . . . . . . . . . . . 2.8 m -27.23 -64.73 0.08 Allowed 'General case' 0 C--N 1.312 -1.024 0 O-C-N 127.07 2.731 . . . . 57.259999999999998 116.637 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 39.9 ptt85 -68.53 -22.36 64.52 Favored 'General case' 0 C--N 1.353 0.726 0 O-C-N 119.655 -1.903 . . . . 62.899999999999999 112.428 -172.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -77.68 -13.66 59.84 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 115.108 1.521 . . . . 49.829999999999998 115.108 174.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 42.0 mm-40 -59.85 -29.22 68.14 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 119.04 2.978 . . . . 52.369999999999997 119.04 -165.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1126 ' ' SER . . . . . . . . . . . . . 15.8 m -69.96 -22.28 63.17 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 115.43 1.641 . . . . 42.43 115.43 168.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1127 ' ' LEU . . . . . . . . . . . . . 3.3 mp -88.22 -45.48 10.05 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.179 -2.156 . . . . 43.740000000000002 105.179 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 30.3 t0 -50.45 109.23 0.29 Allowed 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 116.238 1.94 . . . . 43.210000000000001 116.238 -176.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -79.04 -30.06 43.9 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.68 -1.6 . . . . 35.740000000000002 113.134 176.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 80.8 mt -72.7 -6.52 45.01 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 119.545 -1.972 . . . . 38.090000000000003 111.945 175.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1131 ' ' SER . . . . . . . . . . . . . 32.9 m -94.73 -57.66 2.4 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 107.801 -1.185 . . . . 36.909999999999997 107.801 161.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1132 ' ' SER . . . . . . . . . . . . . 22.2 m -77.28 -51.9 10.1 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 117.094 -1.431 . . . . 35.789999999999999 113.848 -169.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1133 ' ' MET . . . . . . . . . . . . . 81.6 mtp -58.25 -37.81 75.67 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 124.274 3.215 . . . . 30.809999999999999 110.045 173.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1134 ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.19 77.53 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 120.538 -0.465 . . . . 28.879999999999999 110.333 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1135 ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -60.79 -46.21 91.4 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 120.704 -1.248 . . . . 40.759999999999998 108.938 173.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1136 ' ' ILE . . . . . . . . . . . . . 16.8 mt -56.78 -50.65 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 117.631 -1.176 . . . . 31.539999999999999 111.745 172.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -53.56 -38.41 63.85 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 114.672 1.36 . . . . 29.870000000000001 114.672 169.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -63.9 -41.41 98.73 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-O 123.41 1.561 . . . . 28.73 111.652 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 17.0 t80 -71.68 -46.37 59.03 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-N 114.16 -1.02 . . . . 30.390000000000001 110.428 176.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1140 ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -67.94 -19.97 65.03 Favored 'General case' 0 C--N 1.356 0.884 0 N-CA-C 107.949 -1.13 . . . . 26.09 107.949 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1141 ' ' ALA . . . . . . . . . . . . . . . -62.89 -48.66 78.04 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 106.833 -1.543 . . . . 27.100000000000001 106.833 172.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 36.3 mm -64.53 -42.68 95.9 Favored 'Isoleucine or valine' 0 C--N 1.346 0.44 0 CA-C-N 119.343 0.974 . . . . 28.48 109.792 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 21.8 t -54.86 -60.04 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 113.533 0.938 . . . . 23.07 113.533 175.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1144 ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -71.7 -27.98 63.4 Favored 'General case' 0 C--O 1.248 0.989 0 O-C-N 119.561 -1.962 . . . . 33.399999999999999 112.456 -174.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -62.18 -49.04 77.38 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 106.54 -1.652 . . . . 24.219999999999999 106.54 175.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -58.76 -33.74 70.62 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 115.375 1.62 . . . . 24.890000000000001 115.375 171.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -61.96 -31.62 71.98 Favored 'General case' 0 C--N 1.372 1.569 0 CA-C-O 117.925 -1.036 . . . . 26.73 111.628 175.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1148 ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -109.77 1.63 19.5 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 115.706 1.743 . . . . 39.960000000000001 115.706 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1149 ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -64.47 138.38 58.38 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 126.06 1.744 . . . . 25.870000000000001 110.516 -170.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1150 ' ' GLY . . . . . . . . . . . . . . . -73.01 -55.46 6.34 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 110.259 -1.136 . . . . 19.280000000000001 110.259 171.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1151 ' ' ARG . . . . . 0.403 ' NH2' ' OG ' ' A' 1279 ' ' SER . 33.4 mtm-85 -94.37 -178.8 4.7 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 113.025 0.75 . . . . 39.899999999999999 113.025 -174.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1152 ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -85.68 160.6 19.52 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 116.578 -2.049 . . . . 29.440000000000001 111.716 171.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1153 ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -73.27 -58.45 3.31 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 122.45 1.119 . . . . 32.600000000000001 108.523 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1154 ' ' THR . . . . . . . . . . . . . 20.9 m -62.86 123.93 19.74 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 125.536 1.534 . . . . 34.640000000000001 110.379 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -80.48 71.26 2.85 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 109.957 -1.257 . . . . 37.140000000000001 109.957 174.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -90.75 139.36 30.8 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 120.848 -0.341 . . . . 40.57 111.113 -166.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1157 ' ' ILE . . . . . . . . . . . . . 2.6 tp -73.77 112.28 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 107.86 -1.163 . . . . 44.609999999999999 107.86 168.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1158 ' ' THR . . . . . . . . . . . . . 42.6 p -91.21 174.53 7.35 Favored 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 109.013 -0.736 . . . . 40.700000000000003 109.013 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -49.06 -39.97 29.64 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 115.469 1.655 . . . . 40.25 115.469 167.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -86.55 -46.69 9.91 Favored 'General case' 0 C--O 1.253 1.255 0 N-CA-C 116.194 1.924 . . . . 38.469999999999999 116.194 178.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . -172.24 179.07 44.08 Favored Glycine 0 N--CA 1.475 1.259 0 CA-C-O 124.456 2.142 . . . . 37.609999999999999 116.493 -170.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 17.1 tttt -76.27 115.06 15.65 Favored 'General case' 0 C--O 1.251 1.168 0 CA-C-N 111.995 -2.103 . . . . 48.899999999999999 108.788 -178.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1163 ' ' VAL . . . . . . . . . . . . . 38.8 t -69.36 128.97 92.11 Favored Pre-proline 0 C--O 1.243 0.747 0 CA-C-O 116.662 -1.637 . . . . 36.520000000000003 108.977 171.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1164 ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -77.29 103.79 1.79 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 124.047 3.165 . . . . 35.079999999999998 112.151 177.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1165 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -46.86 151.37 2.18 Favored 'Trans proline' 0 N--CA 1.455 -0.762 1 C-N-CA 125.46 4.107 . . . . 35.329999999999998 117.67 -173.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -79.27 137.47 37.39 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.948 1.356 . . . . 34.689999999999998 109.284 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1167 ' ' LYS . . . . . . . . . . . . . 6.7 mptt -99.91 105.86 17.62 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 103.972 -2.603 . . . . 45.359999999999999 103.972 171.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 58.8 t -90.57 90.2 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 N-CA-C 105.039 -2.208 . . . . 31.710000000000001 105.039 -176.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1169 ' ' MET . . . . . . . . . . . . . 6.2 ttp -80.5 116.81 20.74 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.449 -1.315 . . . . 42.280000000000001 107.449 172.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 86.0 t -91.08 136.06 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 105.574 -2.01 . . . . 30.510000000000002 105.574 176.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 15.8 mt -109.92 120.5 61.12 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 N-CA-C 104.46 -2.422 . . . . 31.870000000000001 104.46 170.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 87.3 80.73 1.22 Allowed Glycine 0 C--O 1.256 1.489 0 N-CA-C 109.63 -1.388 . . . . 34.539999999999999 109.63 175.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1173 ' ' ALA . . . . . . . . . . . . . . . -87.34 118.83 27.04 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 122.726 1.25 . . . . 32.509999999999998 109.819 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -148.34 -149.8 5.06 Favored Glycine 0 N--CA 1.437 -1.249 0 N-CA-C 106.513 -2.635 . . . . 29.899999999999999 106.513 164.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1175 ' ' VAL . . . . . . . . . . . . . 54.1 t -57.21 -41.67 78.45 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 CA-C-N 121.101 2.45 . . . . 33.109999999999999 111.382 -175.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -60.02 -49.5 77.42 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-N 114.301 -1.318 . . . . 28.100000000000001 111.659 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -59.52 -46.96 93.1 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 108.458 -1.857 . . . . 28.539999999999999 108.458 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1178 ' ' LEU . . . . . . . . . . . . . 47.9 mt -58.77 -29.72 67.0 Favored 'General case' 0 C--O 1.241 0.62 0 O-C-N 119.129 -2.395 . . . . 31.219999999999999 113.447 175.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -58.68 -55.74 31.24 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-O 122.356 1.074 . . . . 28.98 110.88 168.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -55.85 -43.43 77.06 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 113.886 -1.507 . . . . 27.829999999999998 114.446 177.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1181 ' ' ILE . . . . . . . . . . . . . 74.8 mt -62.05 -49.52 83.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 107.89 -1.152 . . . . 30.25 107.89 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -54.47 -34.54 55.08 Favored Glycine 0 C--N 1.343 0.928 0 O-C-N 126.744 2.527 . . . . 29.59 113.512 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -74.92 -61.77 1.77 Allowed 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 117.503 0.652 . . . . 30.289999999999999 112.52 170.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -59.69 -32.21 70.29 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-O 121.752 0.787 . . . . 30.469999999999999 113.088 -166.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -56.49 -53.3 59.04 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.622 1.169 . . . . 42.409999999999997 112.206 173.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1186 ' ' SER . . . . . . . . . . . . . 3.6 m -64.41 -39.66 94.28 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.765 -1.107 . . . . 39.380000000000003 109.295 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 25.8 mt -55.87 -34.71 65.73 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 115.826 1.787 . . . . 36.18 115.826 173.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 93.27 48.37 2.84 Favored Glycine 0 CA--C 1.534 1.259 0 O-C-N 124.108 0.88 . . . . 33.780000000000001 112.317 -177.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -113.98 162.02 16.94 Favored 'General case' 0 C--O 1.247 0.958 0 O-C-N 126.114 1.714 . . . . 33.93 108.756 172.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 66.1 mt -84.8 103.02 11.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 104.55 -2.389 . . . . 38.740000000000002 104.55 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 3.5 t -94.48 142.5 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 O-C-N 120.958 -1.089 . . . . 33.090000000000003 108.847 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1192 ' ' ARG . . . . . 0.43 HH12 ' CD ' ' A' 1248 ' ' GLU . 98.6 mtt180 -143.76 108.78 4.97 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.06 -1.089 . . . . 38.920000000000002 108.06 177.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -96.42 120.16 36.22 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 120.335 -1.478 . . . . 35.32 113.988 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 87.4 t80 -80.34 131.13 35.59 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 114.984 -1.007 . . . . 39.350000000000001 109.501 166.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 8.0 t70 -150.74 178.56 9.0 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 105.397 -2.075 . . . . 40.460000000000001 105.397 153.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1196 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.08 -31.98 9.91 Favored 'General case' 0 N--CA 1.428 -1.556 0 O-C-N 119.569 -1.957 . . . . 45.939999999999998 108.875 175.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1197 ' ' ARG . . . . . . . . . . . . . 53.0 mtm180 -69.63 133.44 88.73 Favored Pre-proline 0 N--CA 1.445 -0.684 0 O-C-N 120.832 -1.167 . . . . 56.020000000000003 109.916 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1198 ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -67.08 -28.29 41.31 Favored 'Trans proline' 0 C--O 1.242 0.719 0 C-N-CA 124.537 3.491 . . . . 51.270000000000003 118.276 173.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -55.71 -55.14 35.8 Favored 'General case' 0 C--O 1.254 1.334 0 O-C-N 119.925 -1.734 . . . . 59.100000000000001 114.037 -168.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 18.5 m -53.8 -25.35 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 116.749 2.129 . . . . 51.060000000000002 116.749 176.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 98.9 mttt -47.36 -43.45 23.13 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 115.774 1.768 . . . . 57.380000000000003 115.774 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -54.17 -51.29 64.8 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 122.942 1.353 . . . . 62.409999999999997 113.542 -175.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -70.87 -41.72 71.02 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 111.31 -2.677 . . . . 57.780000000000001 112.97 177.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 4.8 t -45.29 -49.88 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.448 1.499 . . . . 46.380000000000003 112.429 174.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -68.22 -52.82 29.85 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 113.639 -1.618 . . . . 50.700000000000003 112.435 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1206 ' ' SER . . . . . . . . . . . . . 41.0 p -66.87 -28.39 68.3 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.65 -0.705 . . . . 49.979999999999997 112.37 -172.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1207 ' ' MET . . . . . . . . . . . . . 12.3 mtt -66.55 -67.79 0.42 Allowed 'General case' 0 C--O 1.249 1.055 0 N-CA-C 106.562 -1.644 . . . . 52.990000000000002 106.562 166.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 154.9 60.25 0.01 OUTLIER Glycine 0 CA--C 1.522 0.522 0 CA-C-O 123.217 1.454 . . . . 47.659999999999997 112.955 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -141.44 145.5 35.36 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 112.347 -1.926 . . . . 44.770000000000003 111.32 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -74.01 155.51 38.51 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 104.068 -2.568 . . . . 47.640000000000001 104.068 163.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1211 ' ' PHE . . . . . . . . . . . . . 44.0 t80 -94.61 131.58 40.24 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 105.772 -1.936 . . . . 45.659999999999997 105.772 163.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 72.7 mt -88.33 108.42 19.33 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 106.993 -1.484 . . . . 46.060000000000002 106.993 174.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -82.19 133.26 35.25 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 111.801 -2.454 . . . . 60.219999999999999 109.012 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 4.9 tp -41.72 133.51 2.72 Favored 'General case' 0 C--O 1.241 0.609 0 O-C-N 127.858 3.224 . . . . 57.25 110.69 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 27.8 t0 -76.58 75.16 3.29 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 123.509 1.623 . . . . 64.430000000000007 114.013 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 3.2 t80 . . . . . 0 C--O 1.213 -0.853 0 N-CA-C 102.801 -3.037 . . . . 66.900000000000006 102.801 -171.806 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 N--CA 1.421 -1.886 0 N-CA-C 107.917 -1.142 . . . . 39.090000000000003 107.917 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -61.62 -45.26 96.68 Favored Glycine 0 CA--C 1.535 1.285 0 N-CA-C 115.988 1.155 . . . . 39.32 115.988 -174.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 91.5 t80 -72.98 -43.53 62.11 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 120.455 2.128 . . . . 39.299999999999997 112.639 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -69.31 -27.17 65.15 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 118.311 -2.743 . . . . 36.299999999999997 112.4 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -61.89 -60.44 3.64 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 120.089 -1.632 . . . . 37.380000000000003 106.988 163.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -52.42 -61.13 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.581 0 N-CA-C 116.769 2.137 . . . . 39.109999999999999 116.769 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1230 ' ' MET . . . . . . . . . . . . . 34.7 mmt -89.94 49.38 1.71 Allowed 'General case' 0 C--O 1.251 1.166 0 O-C-N 118.197 -2.814 . . . . 49.590000000000003 116.202 -174.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1231 ' ' SER . . . . . . . . . . . . . 67.7 p -98.57 163.85 12.5 Favored 'General case' 0 C--O 1.253 1.286 0 CA-C-N 113.972 -1.467 . . . . 43.68 108.999 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.43 -36.85 83.84 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 116.172 -0.467 . . . . 55.57 110.928 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -60.31 -54.79 41.53 Favored 'General case' 0 C--O 1.215 -0.748 0 C-N-CA 125.403 1.481 . . . . 44.939999999999998 112.157 173.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -60.63 -52.49 64.91 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 115.23 1.566 . . . . 42.039999999999999 115.23 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 94.8 mt -57.28 -32.26 40.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-O 123.491 1.615 . . . . 46.280000000000001 113.65 173.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 47.9 tttm -58.12 -57.67 11.81 Favored 'General case' 0 C--O 1.252 1.21 0 CA-C-O 124.525 2.107 . . . . 47.869999999999997 111.323 170.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -70.92 -11.89 61.23 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 115.731 1.752 . . . . 41.609999999999999 115.731 -175.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -67.73 -62.94 1.17 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.714 -1.587 . . . . 50.649999999999999 106.714 170.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1239 ' ' MET . . . . . . . . . . . . . 2.4 mtm -58.44 -35.42 72.1 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 121.158 -0.964 . . . . 48.869999999999997 113.249 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -68.73 -26.64 65.36 Favored 'General case' 0 C--O 1.25 1.11 0 C-N-CA 120.79 -0.364 . . . . 54.799999999999997 111.379 176.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 2.3 tm? -69.83 -56.99 5.64 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.962 -0.755 . . . . 43.210000000000001 108.962 166.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 22.9 m-30 -57.95 -41.79 83.58 Favored 'General case' 0 C--O 1.221 -0.409 0 O-C-N 124.76 1.287 . . . . 38.659999999999997 111.749 -166.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -68.84 -38.07 79.55 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.402 1.001 . . . . 37.920000000000002 111.764 -175.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -63.38 -51.0 67.69 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 120.266 -1.521 . . . . 37.280000000000001 109.994 174.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 -59.2 -34.36 72.06 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.232 1.413 . . . . 43.07 109.897 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -62.77 -17.95 61.86 Favored 'General case' 0 N--CA 1.439 -1.021 0 O-C-N 119.314 -2.116 . . . . 38.299999999999997 116.272 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1247 ' ' LYS . . . . . . . . . . . . . 16.5 mtmm -81.83 -1.93 49.18 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 122.532 1.158 . . . . 47.600000000000001 112.929 174.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1248 ' ' GLU . . . . . 0.43 ' CD ' HH12 ' A' 1192 ' ' ARG . 14.6 pt-20 -129.35 -35.69 1.75 Allowed 'General case' 0 C--O 1.239 0.537 0 CA-C-O 116.117 -1.897 . . . . 45.420000000000002 113.6 177.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1249 ' ' VAL . . . . . . . . . . . . . 33.0 m -75.71 161.77 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 121.635 2.016 . . . . 36.259999999999998 114.614 -168.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1250 ' ' ASP . . . . . 0.414 ' CG ' ' HZ2' ' A' 1276 ' ' LYS . 4.7 m-20 -108.84 -60.32 1.76 Allowed 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.129 -1.396 . . . . 33.039999999999999 109.647 -175.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1251 ' ' ILE . . . . . . . . . . . . . 51.5 mm -110.91 112.89 42.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 107.436 -1.32 . . . . 31.399999999999999 107.436 -168.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1252 ' ' ILE . . . . . . . . . . . . . 64.2 mt -100.6 102.8 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 104.249 -2.5 . . . . 29.420000000000002 104.249 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 89.9 t -84.78 97.74 5.56 Favored 'Isoleucine or valine' 0 C--O 1.251 1.173 0 N-CA-C 104.296 -2.483 . . . . 30.370000000000001 104.296 175.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1254 ' ' THR . . . . . . . . . . . . . 3.8 m -93.58 70.48 4.22 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 104.449 -2.426 . . . . 35.719999999999999 104.449 -167.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1255 ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.48 0.88 24.23 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 119.443 -2.036 . . . . 36.0 115.844 -175.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1256 ' ' ALA . . . . . . . . . . . . . . . -64.77 68.83 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 118.297 2.702 . . . . 40.93 118.297 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 60.4 tp -77.8 91.81 4.15 Favored 'General case' 0 C--O 1.246 0.909 0 N-CA-C 106.456 -1.683 . . . . 47.82 106.456 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 39.3 mm -64.53 128.85 93.86 Favored Pre-proline 0 C--O 1.241 0.608 0 N-CA-C 108.275 -1.009 . . . . 52.700000000000003 108.275 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -62.05 108.49 0.67 Allowed 'Trans proline' 0 N--CA 1.439 -1.701 0 C-N-CA 123.933 3.089 . . . . 54.130000000000003 109.786 -175.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 82.44 -64.95 4.19 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-O 118.186 -1.341 . . . . 54.619999999999997 113.589 168.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 13.5 mttp -65.9 137.03 95.87 Favored Pre-proline 0 C--O 1.216 -0.677 0 C-N-CA 125.468 1.507 . . . . 55.740000000000002 110.728 173.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -52.81 144.79 42.56 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.636 2.891 . . . . 51.149999999999999 116.371 176.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -67.28 133.72 93.31 Favored Pre-proline 0 CA--C 1.529 0.157 0 O-C-N 121.996 -0.44 . . . . 46.060000000000002 110.933 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -63.51 145.38 91.95 Favored 'Trans proline' 0 C--N 1.344 0.308 1 C-N-CA 125.914 4.409 . . . . 41.079999999999998 111.596 -178.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -78.14 78.92 4.61 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 122.147 0.975 . . . . 47.420000000000002 109.785 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 62.4 mt -83.82 -37.08 22.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.034 -1.439 . . . . 39.219999999999999 110.109 -171.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 15.4 mt -94.5 97.41 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 103.783 -2.673 . . . . 42.5 103.783 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1268 ' ' THR . . . . . . . . . . . . . 16.5 p -70.51 157.01 38.63 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 114.631 -1.168 . . . . 37.840000000000003 111.309 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -52.09 -41.4 62.38 Favored 'General case' 0 CA--C 1.512 -0.499 0 O-C-N 120.994 -1.066 . . . . 54.799999999999997 111.833 168.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -44.37 -62.57 1.12 Allowed 'General case' 0 N--CA 1.476 0.836 0 O-C-N 125.362 1.664 . . . . 54.359999999999999 111.547 164.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1271 ' ' MET . . . . . . . . . . . . . 34.0 ttm -58.52 -44.36 89.48 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 120.726 1.603 . . . . 39.520000000000003 111.36 -173.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1272 ' ' VAL . . . . . . . . . . . . . 20.0 t -66.77 -46.58 85.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 115.793 -0.64 . . . . 38.25 111.553 -175.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.44 -3.84 26.65 Favored 'General case' 0 CA--C 1.506 -0.713 0 O-C-N 119.943 -1.723 . . . . 40.770000000000003 115.583 172.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1274 ' ' SER . . . . . . . . . . . . . 8.6 m -113.03 14.75 19.67 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 116.085 1.883 . . . . 36.579999999999998 116.085 164.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1275 ' ' MET . . . . . . . . . . . . . 4.8 ttt -85.35 162.44 19.06 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.362 -0.977 . . . . 36.75 108.362 -178.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1276 ' ' LYS . . . . . 0.414 ' HZ2' ' CG ' ' A' 1250 ' ' ASP . 31.6 ttpt -63.07 132.48 52.05 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 124.198 1.951 . . . . 46.109999999999999 109.536 174.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1277 ' ' ALA . . . . . . . . . . . . . . . -70.56 162.22 29.26 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 111.736 -2.484 . . . . 33.520000000000003 113.713 -172.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 67.28 27.54 73.52 Favored Glycine 0 N--CA 1.479 1.535 0 O-C-N 119.485 -2.01 . . . . 31.27 113.449 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1279 ' ' SER . . . . . 0.403 ' OG ' ' NH2' ' A' 1151 ' ' ARG . 14.0 m -132.0 154.21 49.57 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 113.671 -1.265 . . . . 32.950000000000003 107.912 -168.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1280 ' ' VAL . . . . . . . . . . . . . 18.5 t -126.52 123.88 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 122.082 0.944 . . . . 27.43 112.988 -171.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1281 ' ' ILE . . . . . . . . . . . . . 52.1 mt -91.66 108.37 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 105.973 -1.862 . . . . 30.300000000000001 105.973 166.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -89.13 124.0 41.66 Favored 'Isoleucine or valine' 0 C--O 1.25 1.108 0 O-C-N 120.813 -1.179 . . . . 28.629999999999999 108.729 170.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 14.5 t0 -96.42 121.72 38.54 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 120.595 1.543 . . . . 36.270000000000003 110.482 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1284 ' ' LEU . . . . . . . . . . . . . 2.1 mm? -107.01 -9.08 16.33 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-O 122.968 1.366 . . . . 38.57 112.149 -176.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -76.99 -29.85 55.68 Favored 'General case' 0 C--O 1.243 0.736 0 O-C-N 120.691 -1.256 . . . . 37.560000000000002 108.092 164.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . 28.06 -82.79 0.0 OUTLIER 'General case' 0 C--N 1.361 1.094 0 N-CA-C 118.545 2.795 . . . . 40.329999999999998 118.545 173.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -66.33 -41.93 88.92 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 113.905 1.076 . . . . 56.850000000000001 113.905 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 46.9 t30 -85.7 82.32 8.26 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 122.65 1.214 . . . . 45.859999999999999 111.824 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 73.52 -67.14 1.59 Allowed Glycine 0 CA--C 1.538 1.524 0 O-C-N 119.498 -2.001 . . . . 40.310000000000002 111.724 -175.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 89.26 129.49 3.62 Favored Glycine 0 CA--C 1.536 1.356 0 N-CA-C 110.357 -1.097 . . . . 38.890000000000001 110.357 -177.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1291 ' ' ASN . . . . . . . . . . . . . 32.2 m120 -73.47 -17.06 61.28 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.469 1.634 . . . . 37.229999999999997 115.3 -172.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1292 ' ' CYS . . . . . . . . . . . . . 49.1 t -91.75 146.33 23.85 Favored 'General case' 0 C--O 1.248 1.016 0 CA-C-O 125.36 2.505 . . . . 36.5 110.359 173.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1293 ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -75.67 -7.99 55.7 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 119.259 -2.151 . . . . 43.32 115.782 172.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -109.05 26.56 10.48 Favored 'General case' 0 C--O 1.215 -0.735 0 O-C-N 120.124 -1.61 . . . . 41.32 113.629 175.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1295 ' ' THR . . . . . . . . . . . . . 54.6 m -81.3 81.15 7.55 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 125.868 2.747 . . . . 35.299999999999997 108.925 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 72.5 t -76.58 124.11 87.79 Favored Pre-proline 0 N--CA 1.424 -1.733 0 O-C-N 119.794 -1.817 . . . . 34.840000000000003 108.389 -176.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.47 99.21 0.08 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.684 0 C-N-CA 124.362 3.375 . . . . 33.509999999999998 115.291 -167.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 81.83 37.8 15.43 Favored Glycine 0 N--CA 1.437 -1.266 0 CA-C-N 112.565 -2.107 . . . . 32.189999999999998 111.575 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -145.3 153.6 41.45 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 124.234 1.969 . . . . 34.880000000000003 110.151 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1300 ' ' ILE . . . . . . . . . . . . . 77.2 mt -83.75 157.6 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 CA-C-N 111.203 -2.726 . . . . 32.289999999999999 105.328 161.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 58.3 t80 -137.47 147.31 45.21 Favored 'General case' 0 C--O 1.253 1.262 0 N-CA-C 104.948 -2.241 . . . . 37.25 104.948 176.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1302 ' ' THR . . . . . . . . . . . . . 8.3 m -126.65 134.68 50.69 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 106.098 -1.816 . . . . 35.560000000000002 106.098 170.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1303 ' ' THR . . . . . . . . . . . . . 24.9 p -79.78 174.71 11.31 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 112.705 0.631 . . . . 36.399999999999999 112.705 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -53.32 -56.34 17.46 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 121.335 -0.853 . . . . 52.32 111.218 171.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -68.46 10.01 0.29 Allowed 'General case' 0 C--N 1.352 0.684 0 N-CA-C 117.189 2.292 . . . . 40.039999999999999 117.189 176.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 70.67 38.12 67.4 Favored Glycine 0 C--O 1.244 0.753 0 O-C-N 121.909 -0.494 . . . . 36.960000000000001 112.9 169.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1307 ' ' VAL . . . . . . . . . . . . . 87.5 t -99.83 133.9 41.13 Favored 'Isoleucine or valine' 0 C--O 1.262 1.715 0 N-CA-C 101.412 -3.551 . . . . 33.399999999999999 101.412 170.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1308 ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -94.93 136.41 35.27 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 111.659 -2.519 . . . . 42.909999999999997 108.809 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 21.8 t -118.13 116.75 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 N-CA-C 106.581 -1.637 . . . . 32.289999999999999 106.581 171.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1310 ' ' ILE . . . . . . . . . . . . . 27.3 mt -102.61 98.09 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 105.423 -2.066 . . . . 30.989999999999998 105.423 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -103.68 51.29 0.83 Allowed Glycine 0 CA--C 1.529 0.962 0 N-CA-C 106.353 -2.699 . . . . 28.949999999999999 106.353 175.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1312 ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -72.64 101.82 3.14 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 105.037 -2.209 . . . . 31.690000000000001 105.037 171.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1313 ' ' THR . . . . . . . . . . . . . 1.6 p -53.3 -31.79 45.67 Favored 'General case' 0 C--O 1.243 0.719 0 O-C-N 121.022 -1.049 . . . . 34.170000000000002 111.426 177.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -81.46 7.74 11.12 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 118.695 2.85 . . . . 36.859999999999999 118.695 174.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1315 ' ' LEU . . . . . . . . . . . . . 26.7 mt -47.69 -39.35 22.47 Favored Pre-proline 0 C--O 1.252 1.223 0 CA-C-N 123.798 2.999 . . . . 34.850000000000001 118.511 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -59.15 -35.83 96.98 Favored 'Trans proline' 0 C--O 1.205 -1.17 0 C-N-CA 123.143 2.562 . . . . 29.149999999999999 112.961 173.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -94.74 -12.87 55.09 Favored Glycine 0 CA--C 1.495 -1.209 0 O-C-N 120.5 -1.375 . . . . 27.289999999999999 116.173 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1318 ' ' ARG . . . . . . . . . . . . . 8.2 ttt-85 -64.76 6.1 0.25 Allowed 'General case' 0 C--O 1.244 0.777 0 N-CA-C 117.057 2.243 . . . . 41.490000000000002 117.057 -175.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1319 ' ' LEU . . . . . . . . . . . . . 15.4 tp -116.6 78.96 9.11 Favored Pre-proline 0 N--CA 1.439 -1.008 0 CA-C-N 123.23 2.741 . . . . 27.609999999999999 107.011 173.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1320 ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -40.89 -57.87 1.19 Allowed 'Trans proline' 0 CA--C 1.504 -0.988 0 C-N-CA 124.476 3.45 . . . . 25.940000000000001 118.126 -155.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1321 ' ' THR . . . . . . . . . . . . . 3.0 m -72.04 -33.65 68.16 Favored 'General case' 0 N--CA 1.437 -1.125 0 O-C-N 118.597 -2.564 . . . . 25.010000000000002 109.678 -174.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1322 ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -84.88 -39.08 18.66 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 120.26 1.391 . . . . 29.390000000000001 110.575 -171.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1323 ' ' SER . . . . . . . . . . . . . 17.6 m -47.5 -56.69 6.54 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.963 1.098 . . . . 26.469999999999999 113.963 158.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1324 ' ' SER . . . . . . . . . . . . . 14.4 m -68.93 -17.28 63.93 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.274 0.842 . . . . 27.780000000000001 113.274 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -75.62 -67.91 0.62 Allowed 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 103.856 -2.646 . . . . 37.530000000000001 103.856 174.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1326 ' ' LEU . . . . . . . . . . . . . 89.8 mt -72.42 -43.83 63.3 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 115.042 -2.409 . . . . 35.710000000000001 112.921 -168.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1327 ' ' TYR . . . . . . . . . . . . . 73.8 t80 -58.02 -43.63 86.84 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-N 122.501 2.41 . . . . 31.59 107.703 169.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1328 ' ' GLY . . . . . . . . . . . . . . . -58.17 -37.28 85.92 Favored Glycine 0 C--N 1.345 1.058 0 N-CA-C 110.884 -0.886 . . . . 28.0 110.884 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1329 ' ' THR . . . . . . . . . . . . . 36.5 m -77.8 -28.7 50.49 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 118.938 1.369 . . . . 32.149999999999999 111.415 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1330 ' ' ASN . . . . . . . . . . . . . 16.2 m120 -55.31 -48.31 74.31 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 120.693 1.588 . . . . 34.359999999999999 111.611 164.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1331 ' ' LEU . . . . . . . . . . . . . 19.6 mt -56.1 -53.35 58.08 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 124.507 1.123 . . . . 33.369999999999997 111.241 175.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1332 ' ' VAL . . . . . . . . . . . . . 59.8 t -49.13 -47.45 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 C-N-CA 125.898 1.679 . . . . 35.270000000000003 111.125 175.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -70.19 -30.35 67.45 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-O 117.243 -1.361 . . . . 37.659999999999997 113.85 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1334 ' ' LEU . . . . . . . . . . . . . 18.3 tp -62.76 -48.67 78.15 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 122.887 1.327 . . . . 40.270000000000003 108.451 169.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1335 ' ' LEU . . . . . . . . . . . . . 82.0 mt -66.12 -23.65 66.53 Favored 'General case' 0 C--O 1.246 0.899 0 O-C-N 120.252 -1.53 . . . . 42.5 110.096 -175.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1336 ' ' LYS . . . . . . . . . . . . . 96.9 mttt -60.24 -45.31 93.67 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.445 -1.41 . . . . 47.810000000000002 112.836 168.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1337 ' ' LEU . . . . . . . . . . . . . 8.1 mp -75.03 -38.97 61.33 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 113.218 -1.81 . . . . 49.270000000000003 113.049 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1338 ' ' LEU . . . . . . . . . . . . . 6.3 mp -72.56 -58.37 3.43 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 125.818 1.647 . . . . 50.539999999999999 111.204 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1339 ' ' CYS . . . . . 0.438 ' SG ' ' CZ ' ' A' 1031 ' ' PHE . 58.7 m -92.38 68.45 4.95 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-O 124.408 2.051 . . . . 53.670000000000002 106.35 -177.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 75.3 tttt -76.02 -47.93 22.95 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 111.526 -2.579 . . . . 63.380000000000003 109.016 -158.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -70.08 -25.64 63.62 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 113.425 0.898 . . . . 70.950000000000003 113.425 -175.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1342 ' ' LYS . . . . . . . . . . . . . 46.5 mtpt 52.12 68.27 0.84 Allowed 'General case' 0 C--O 1.253 1.26 0 N-CA-C 118.106 2.632 . . . . 65.25 118.106 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1343 ' ' ASP . . . . . . . . . . . . 0.278 10.9 t70 67.04 -88.14 0.03 OUTLIER 'General case' 0 C--O 1.236 0.387 2 O-C-N 110.921 -7.362 . . . . 64.530000000000001 119.784 -0.177 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A 1344 ' ' GLY . . . . . . . . . . . . . . . 86.29 17.85 60.02 Favored Glycine 0 N--CA 1.425 -2.036 0 O-C-N 119.98 -1.7 . . . . 59.719999999999999 115.963 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 19.5 t30 -80.4 143.24 33.63 Favored 'General case' 0 N--CA 1.434 -1.226 0 O-C-N 120.469 -1.607 . . . . 64.090000000000003 108.767 160.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1346 ' ' ILE . . . . . . . . . . . . . 14.7 mt -91.6 100.18 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 104.49 -2.411 . . . . 58.82 104.49 -167.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1347 ' ' THR . . . . . . . . . . . . . 6.9 m -84.08 98.8 10.07 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 104.339 -2.467 . . . . 54.960000000000001 104.339 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1348 ' ' VAL . . . . . . . . . . . . . 19.5 t -93.4 80.02 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.257 1.475 0 N-CA-C 105.448 -2.056 . . . . 55.640000000000001 105.448 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 12.9 t70 -76.68 135.17 39.09 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 115.238 1.57 . . . . 61.450000000000003 115.238 -167.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -80.89 -28.28 35.99 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-N 114.864 -1.062 . . . . 58.630000000000003 111.882 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -85.82 -31.82 22.08 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 119.977 -1.702 . . . . 62.060000000000002 114.747 -170.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 9.9 t70 -64.07 123.08 18.11 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 125.046 1.466 . . . . 54.07 109.238 169.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 18.6 m -57.44 -45.66 85.66 Favored 'Isoleucine or valine' 0 C--O 1.253 1.268 0 N-CA-C 113.508 0.929 . . . . 50.68 113.508 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1354 ' ' VAL . . . . . . . . . . . . . 12.9 m -77.45 -38.53 26.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 119.971 -0.692 . . . . 47.68 110.188 -172.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1355 ' ' ILE . . . . . . . . . . . . . 90.3 mt -62.39 -54.05 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-N 121.141 1.791 . . . . 48.490000000000002 108.589 174.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 45.3 tpt85 -55.92 -37.92 69.58 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 112.107 0.41 . . . . 48.270000000000003 112.107 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -59.72 -46.92 93.22 Favored Glycine 0 N--CA 1.469 0.846 0 O-C-N 125.41 1.694 . . . . 43.530000000000001 112.466 174.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1358 ' ' VAL . . . . . . . . . . . . . 30.2 t -75.08 -28.69 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 O-C-N 118.428 -2.807 . . . . 45.119999999999997 109.726 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1359 ' ' THR . . . . . . . . . . . . . 26.2 m -64.71 96.16 0.17 Allowed 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 118.082 -2.886 . . . . 42.939999999999998 114.706 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 17.5 m -96.55 -30.62 3.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 112.214 0.449 . . . . 43.259999999999998 112.214 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1361 ' ' ILE . . . . . . . . . . . . . 95.7 mt -131.49 136.22 57.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 101.919 -3.363 . . . . 45.659999999999997 101.919 163.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1362 ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -124.62 125.77 44.67 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 104.428 -2.434 . . . . 61.340000000000003 104.428 165.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 48.89 55.7 8.83 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 125.507 1.754 . . . . 49.759999999999998 113.996 172.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 82.08 -42.33 2.85 Favored Glycine 0 C--O 1.218 -0.871 0 CA-C-N 113.021 -1.899 . . . . 50.0 112.569 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -69.9 126.47 29.81 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 119.953 1.876 . . . . 56.920000000000002 107.071 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1366 ' ' ILE . . . . . . . . . . . . . 96.5 mt -74.59 96.18 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.391 0 N-CA-C 107.19 -1.411 . . . . 52.780000000000001 107.19 178.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1367 ' ' THR . . . . . . . . . . . . . 17.6 p -82.75 1.52 38.39 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 115.932 1.827 . . . . 49.439999999999998 115.932 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 29.6 t90 -78.66 133.71 62.35 Favored Pre-proline 0 N--CA 1.442 -0.872 0 N-CA-C 105.313 -2.106 . . . . 52.380000000000003 105.313 161.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -58.28 130.09 4.53 Favored 'Cis proline' 0 C--N 1.329 -0.47 0 N-CA-C 119.687 2.918 . . . . 46.939999999999998 119.687 5.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -72.84 112.53 15.65 Favored Pre-proline 0 C--O 1.245 0.838 0 C-N-CA 124.567 1.147 . . . . 45.909999999999997 110.837 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1371 ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -67.61 120.65 7.68 Favored 'Trans proline' 0 N--CA 1.433 -2.082 0 C-N-CA 124.636 3.558 . . . . 46.390000000000001 118.104 -173.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -71.89 -62.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 123.179 2.586 . . . . 46.719999999999999 109.968 164.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.239 -4.238 0 CA-C-N 120.642 1.564 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 23.1 m80 . . . . . 0 C--O 1.245 0.826 0 N-CA-C 107.24 -1.393 . . . . 63.439999999999998 107.24 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -120.75 59.74 0.91 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.857 -0.794 . . . . 51.740000000000002 108.857 164.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1000 ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -77.18 139.53 39.93 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 102.795 -3.039 . . . . 54.07 102.795 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 81.88 -0.46 88.37 Favored Glycine 0 C--O 1.26 1.721 0 CA-C-N 113.728 -1.578 . . . . 39.219999999999999 111.814 -171.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1002 ' ' ARG . . . . . . . . . . . . . 34.1 ttp180 -108.52 148.36 30.38 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 119.59 1.695 . . . . 38.119999999999997 106.677 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1003 ' ' ILE . . . . . . . . . . . . . 24.3 mt -102.61 147.27 9.38 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 N-CA-C 105.724 -1.954 . . . . 29.699999999999999 105.724 172.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -107.38 121.72 6.58 Favored Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 108.492 -1.843 . . . . 27.5 108.492 167.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1005 ' ' ILE . . . . . . . . . . . . . 40.7 mm -105.77 106.51 56.8 Favored Pre-proline 0 N--CA 1.439 -1.006 0 N-CA-C 106.689 -1.597 . . . . 24.829999999999998 106.689 171.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -80.12 176.82 8.93 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 124.687 3.591 . . . . 27.190000000000001 108.35 -175.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 22.9 ttm105 -84.82 131.51 34.52 Favored 'General case' 0 C--N 1.318 -0.773 0 O-C-N 120.128 -1.608 . . . . 41.460000000000001 108.124 165.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1008 ' ' GLU . . . . . . . . . . . . 0.311 25.2 mm-40 -68.93 136.18 52.16 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 119.612 3.19 . . . . 26.93 119.612 173.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 47.6 mmm-85 -99.08 -3.76 33.95 Favored 'General case' 0 C--O 1.253 1.285 0 CA-C-N 111.512 -2.585 . . . . 34.479999999999997 116.068 -165.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1010 ' ' LEU . . . . . . . . . . . . . 65.6 tp -58.21 138.6 56.14 Favored 'General case' 0 N--CA 1.441 -0.875 0 O-C-N 121.177 -0.952 . . . . 44.219999999999999 112.108 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1011 ' ' THR . . . . . . . . . . . . . 1.3 m -59.72 111.93 1.63 Allowed 'General case' 0 C--N 1.319 -0.759 0 O-C-N 124.573 1.171 . . . . 40.740000000000002 108.187 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 38.8 t30 60.63 92.75 0.05 OUTLIER 'General case' 0 C--O 1.252 1.199 0 O-C-N 126.657 2.473 . . . . 44.439999999999998 107.894 -171.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1013 ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -130.99 132.72 45.2 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 124.88 2.276 . . . . 29.870000000000001 109.609 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1014 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.16 -32.49 50.27 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-N 108.816 -3.811 . . . . 25.260000000000002 117.642 176.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 43.5 mtm180 -95.64 159.86 14.78 Favored 'General case' 0 C--O 1.252 1.201 0 CA-C-O 124.021 1.867 . . . . 29.539999999999999 115.179 -161.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1016 ' ' VAL . . . . . . . . . . . . . 4.7 p -128.86 -176.5 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 102.936 -2.987 . . . . 23.550000000000001 102.936 159.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1017 ' ' ALA . . . . . . . . . . . . . . . -90.34 -8.81 49.84 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 116.854 2.168 . . . . 23.59 116.854 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1018 ' ' ALA . . . . . . . . . . . . . . . -159.75 145.72 15.86 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-O 121.528 0.68 . . . . 24.93 110.313 -177.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1019 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.8 165.45 12.64 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-O 116.682 -1.628 . . . . 28.09 111.924 172.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -47.88 -43.2 30.15 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 124.331 3.354 . . . . 28.789999999999999 116.652 175.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 47.7 tptt -50.71 -41.53 56.16 Favored 'General case' 0 C--O 1.256 1.446 0 N-CA-C 113.358 0.873 . . . . 47.280000000000001 113.358 168.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1022 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.63 -38.49 67.73 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 118.83 -0.605 . . . . 30.120000000000001 111.63 177.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B 1023 ' ' VAL . . . . . . . . . . . . . 79.8 t -49.23 -48.63 17.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-O 122.61 1.195 . . . . 32.240000000000002 113.156 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1024 ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -53.25 -48.16 68.45 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 112.684 -2.053 . . . . 49.619999999999997 110.492 174.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -61.71 -43.24 99.24 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 120.831 -1.168 . . . . 44.68 110.316 -174.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 51.1 mt -64.93 -39.03 92.89 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 115.069 1.507 . . . . 35.710000000000001 115.069 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1027 ' ' LEU . . . . . . . . . . . . . 58.1 mt -64.78 -41.58 95.74 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 125.581 1.552 . . . . 42.18 109.006 174.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 31.4 mttm -63.5 -35.9 81.97 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 123.731 0.644 . . . . 48.340000000000003 110.652 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1029 ' ' LEU . . . . . . . . . . . . . 82.0 mt -59.47 -62.36 1.93 Allowed 'General case' 0 CA--C 1.504 -0.808 0 C-N-CA 123.618 0.767 . . . . 38.689999999999998 109.212 170.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 143.35 45.02 0.05 OUTLIER Glycine 0 C--N 1.312 -0.758 0 N-CA-C 110.309 -1.116 . . . . 32.280000000000001 110.309 168.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -133.17 122.7 24.39 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 123.038 1.399 . . . . 35.939999999999998 108.733 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1032 ' ' THR . . . . . . . . . . . . . 28.0 m -66.3 133.2 50.06 Favored 'General case' 0 C--O 1.25 1.098 0 CA-C-N 114.121 -1.399 . . . . 33.369999999999997 108.414 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1033 ' ' VAL . . . . . . . . . . . . . 22.2 t -107.38 126.88 63.57 Favored 'Isoleucine or valine' 0 C--O 1.251 1.169 0 O-C-N 120.068 -1.645 . . . . 29.98 107.271 -169.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -122.45 139.15 54.2 Favored 'General case' 0 C--O 1.243 0.714 0 O-C-N 124.134 0.896 . . . . 28.18 111.553 168.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1035 ' ' VAL . . . . . . . . . . . . . 21.2 t -127.35 149.33 32.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 105.866 -1.901 . . . . 25.82 105.866 -175.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1036 ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -62.67 145.61 54.22 Favored 'General case' 0 C--O 1.257 1.473 0 N-CA-C 113.7 1.0 . . . . 32.439999999999998 113.7 171.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1037 ' ' SER . . . . . . . . . . . . . 13.0 m -70.54 148.13 48.54 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 106.038 -1.838 . . . . 29.539999999999999 106.038 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 82.11 -53.2 4.73 Favored Glycine 0 CA--C 1.534 1.27 0 O-C-N 119.205 -2.184 . . . . 27.760000000000002 110.401 -172.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1039 ' ' ALA . . . . . . . . . . . . . . . -51.61 -40.99 60.91 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-N 119.434 1.617 . . . . 26.02 112.547 172.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -57.59 -49.08 76.68 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 120.465 -0.874 . . . . 26.469999999999999 112.288 171.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -59.12 -40.62 85.98 Favored 'General case' 0 C--O 1.246 0.877 0 C-N-CA 123.233 0.613 . . . . 50.979999999999997 110.429 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 46.2 mt -66.5 -26.51 67.2 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.771 1.026 . . . . 29.300000000000001 113.771 -171.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1043 ' ' ALA . . . . . . . . . . . . . . . -83.88 40.48 0.75 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 119.521 1.055 . . . . 26.739999999999998 111.926 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1044 ' ' SER . . . . . . . . . . . . . 38.6 m 44.3 54.62 6.07 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 126.284 1.833 . . . . 31.260000000000002 110.899 -166.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1045 ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.68 -167.39 2.64 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.439 -1.255 . . . . 33.259999999999998 109.775 -174.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 22.3 t70 -131.06 140.22 50.02 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 105.805 -1.924 . . . . 46.740000000000002 105.805 174.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -68.06 -37.47 81.31 Favored 'General case' 0 CA--C 1.502 -0.866 0 O-C-N 125.954 2.034 . . . . 34.439999999999998 111.407 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -77.85 -23.95 48.75 Favored 'General case' 0 N--CA 1.435 -1.2 0 O-C-N 119.279 -2.138 . . . . 48.670000000000002 109.955 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -58.45 -43.42 88.8 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 118.762 -0.637 . . . . 35.259999999999998 111.896 163.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1050 ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -60.87 -37.85 83.57 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 120.889 1.677 . . . . 32.170000000000002 112.167 170.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 98.0 t -59.67 -45.74 94.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 O-C-N 119.585 -1.947 . . . . 38.369999999999997 108.503 174.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -63.76 -23.36 67.33 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 116.261 1.949 . . . . 45.770000000000003 116.261 174.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -78.35 -4.67 49.26 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 124.91 1.284 . . . . 37.829999999999998 112.269 170.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 87.75 34.57 9.99 Favored Glycine 0 CA--C 1.5 -0.866 0 CA-C-N 120.29 1.404 . . . . 35.82 110.681 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -114.62 138.1 51.09 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-O 124.151 1.929 . . . . 33.770000000000003 107.401 174.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -77.45 134.77 38.29 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 104.487 -2.412 . . . . 51.020000000000003 104.487 173.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1057 ' ' ILE . . . . . . . . . . . . . 19.5 mm -108.46 107.16 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 106.259 -1.756 . . . . 38.469999999999999 106.259 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 88.1 t -86.29 132.77 31.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 CA-C-N 113.163 -1.835 . . . . 39.399999999999999 108.045 -173.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -72.5 95.82 1.85 Allowed 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 123.291 1.519 . . . . 57.07 110.576 168.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . 82.27 -151.16 29.54 Favored Glycine 0 C--O 1.248 1.026 0 CA-C-O 125.093 2.496 . . . . 44.829999999999998 116.191 166.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 5.0 m120 -58.64 -21.28 53.44 Favored 'General case' 0 C--O 1.212 -0.869 0 N-CA-C 118.91 2.93 . . . . 46.270000000000003 118.91 -167.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1062 ' ' SER . . . . . . . . . . . . . 4.2 m -53.65 -22.12 8.2 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.188 -1.57 . . . . 43.469999999999999 112.677 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 1.5 p -53.28 -35.31 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 O-C-N 120.983 -1.073 . . . . 36.979999999999997 111.181 176.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 55.2 m95 -63.16 -23.35 67.39 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 116.155 1.909 . . . . 37.899999999999999 116.155 177.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -83.44 93.58 7.82 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 124.475 2.083 . . . . 46.189999999999998 108.923 173.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1066 ' ' SER . . . . . . . . . . . . . 71.4 m -149.77 179.7 7.81 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 111.206 -2.725 . . . . 37.060000000000002 107.211 -174.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1067 ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -83.37 -51.3 7.52 Favored 'General case' 0 N--CA 1.437 -1.103 0 O-C-N 123.792 0.683 . . . . 43.950000000000003 109.952 166.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1068 ' ' ILE . . . . . . . . . . . . . 1.3 mt -108.99 145.15 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 N-CA-C 107.061 -1.459 . . . . 33.5 107.061 178.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 46.0 mm -109.0 118.26 56.15 Favored 'Isoleucine or valine' 0 C--O 1.254 1.299 0 N-CA-C 104.33 -2.47 . . . . 30.57 104.33 158.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1070 ' ' LEU . . . . . . . . . . . . . 94.5 mt -101.8 117.75 35.51 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 106.674 -1.602 . . . . 27.66 106.674 170.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1071 ' ' LYS . . . . . . . . . . . . 0.279 13.6 tttm -140.83 160.16 40.64 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 125.994 2.059 . . . . 28.399999999999999 111.042 -170.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B 1072 ' ' VAL . . . . . . . . . . . . . 99.7 t -94.63 -70.76 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.429 0 O-C-N 120.629 -1.294 . . . . 23.18 108.155 -173.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -97.4 152.68 18.69 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.893 -1.129 . . . . 25.469999999999999 108.011 -170.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -53.3 133.05 52.35 Favored Pre-proline 0 C--O 1.243 0.725 0 C-N-CA 126.29 1.836 . . . . 27.899999999999999 111.907 -173.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -60.32 129.75 31.13 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 122.752 2.301 . . . . 31.620000000000001 114.949 -173.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 49.2 mt -72.65 158.56 35.41 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.202 -1.036 . . . . 40.490000000000002 108.202 173.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.23 -29.7 10.04 Favored 'General case' 0 C--O 1.214 -0.768 0 O-C-N 118.937 -2.352 . . . . 51.590000000000003 117.014 -171.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -67.28 -46.21 74.3 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-N 114.986 -1.006 . . . . 42.359999999999999 110.017 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1079 ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -63.07 -40.49 97.83 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 123.162 1.458 . . . . 34.530000000000001 109.029 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1080 ' ' ILE . . . . . . . . . . . . . 84.3 mt -59.1 -48.81 85.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 108.333 -0.988 . . . . 33.25 108.333 175.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -56.84 -39.7 74.73 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 119.143 0.883 . . . . 36.469999999999999 112.874 175.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1082 ' ' LEU . . . . . . . . . . . . . 28.6 mt -61.12 -38.51 86.61 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 125.762 1.625 . . . . 37.759999999999998 111.08 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1083 ' ' LEU . . . . . . . . . . . . . 21.8 mt -56.73 121.11 9.02 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 123.17 0.588 . . . . 37.43 110.679 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -78.07 148.7 75.45 Favored Pre-proline 0 CA--C 1.558 1.271 0 N-CA-C 106.953 -1.499 . . . . 37.700000000000003 106.953 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -40.3 102.37 0.04 OUTLIER 'Trans proline' 0 C--O 1.239 0.562 0 C-N-CA 122.826 2.35 . . . . 35.509999999999998 115.564 169.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 84.49 26.38 39.46 Favored Glycine 0 C--N 1.345 1.04 0 CA-C-N 112.652 -2.067 . . . . 33.869999999999997 114.532 177.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1087 ' ' THR . . . . . . . . . . . . . 16.8 m -66.67 155.79 37.03 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 120.956 2.378 . . . . 32.5 108.491 166.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1088 ' ' THR . . . . . . . . . . . . . 4.1 m -87.49 131.37 34.38 Favored 'General case' 0 C--O 1.205 -1.245 0 N-CA-C 105.088 -2.189 . . . . 30.219999999999999 105.088 174.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1089 ' ' LEU . . . . . . . . . . . . . 39.3 tp -122.87 127.65 49.28 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 107.926 -1.139 . . . . 27.239999999999998 107.926 173.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 44.2 t -120.2 120.1 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 N-CA-C 103.326 -2.842 . . . . 25.390000000000001 103.326 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1091 ' ' SER . . . . . . . . . . . . . 2.6 m -164.53 160.31 20.2 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.528 1.513 . . . . 28.809999999999999 108.857 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1092 ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -59.48 99.43 0.06 Allowed 'General case' 0 C--O 1.247 0.971 0 O-C-N 121.088 -1.008 . . . . 30.780000000000001 111.204 158.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 32.2 mm -95.73 -28.53 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 109.199 -0.667 . . . . 30.280000000000001 109.199 -171.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1094 ' ' TRP . . . . . . . . . . . . . 68.5 m95 52.06 56.08 15.48 Favored Pre-proline 0 N--CA 1.472 0.659 0 O-C-N 121.129 -0.982 . . . . 34.07 112.551 -175.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -53.43 -51.05 11.82 Favored 'Trans proline' 0 CA--C 1.505 -0.952 1 C-N-CA 126.541 4.828 . . . . 38.659999999999997 115.999 -162.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -69.17 -28.77 66.71 Favored 'General case' 0 C--O 1.247 0.929 0 O-C-N 120.714 -1.241 . . . . 41.32 110.684 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.04 -17.82 48.87 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 120.71 -1.244 . . . . 51.659999999999997 111.197 172.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -125.73 61.19 36.82 Favored Pre-proline 0 C--O 1.243 0.728 0 N-CA-C 114.719 1.377 . . . . 40.32 114.719 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -60.45 -38.68 72.18 Favored 'Trans proline' 0 CA--C 1.506 -0.887 0 C-N-CA 123.743 2.962 . . . . 41.560000000000002 113.13 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -69.52 -45.24 69.32 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 106.863 -1.532 . . . . 54.109999999999999 106.863 -174.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1101 ' ' LEU . . . . . . . . . . . . . 7.0 tt -60.64 -48.77 80.29 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.645 -1.243 . . . . 37.880000000000003 107.645 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1102 ' ' MET . . . . . . . . . . . . . 43.2 mmm -50.86 -46.76 60.37 Favored 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 120.616 -1.302 . . . . 37.539999999999999 114.341 173.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -64.55 -39.0 92.96 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 123.173 1.463 . . . . 47.009999999999998 112.794 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1104 ' ' LYS . . . . . . . . . . . . . 52.5 mttm -60.98 -45.47 94.68 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 118.928 -2.358 . . . . 48.68 111.77 175.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1105 ' ' LEU . . . . . . . . . . . . . 52.2 mt -62.05 -39.25 91.74 Favored 'General case' 0 C--O 1.252 1.235 0 O-C-N 120.668 -1.27 . . . . 32.210000000000001 109.604 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -57.36 -37.05 71.99 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 112.968 0.729 . . . . 33.729999999999997 112.968 171.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -67.63 -45.92 73.97 Favored 'General case' 0 CA--C 1.504 -0.824 0 O-C-N 118.888 -2.383 . . . . 51.469999999999999 112.105 172.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1108 ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -61.42 -11.64 11.24 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 120.577 -1.327 . . . . 43.899999999999999 112.013 169.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1109 ' ' ASN . . . . . . . . . . . . . 27.0 m-80 63.04 24.86 14.73 Favored 'General case' 0 C--N 1.358 0.96 0 O-C-N 120.024 -1.673 . . . . 44.82 114.253 172.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1110 ' ' VAL . . . . . . . . . . . . . 18.4 m -83.59 167.87 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 N-CA-C 112.563 0.579 . . . . 30.52 112.563 -171.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1111 ' ' THR . . . . . . . . . . . . . 95.9 m -109.74 111.14 22.41 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.439 -1.689 . . . . 27.120000000000001 106.439 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1112 ' ' VAL . . . . . . . . . . . . . 63.6 t -113.27 120.3 62.86 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.621 0 N-CA-C 108.178 -1.045 . . . . 26.399999999999999 108.178 -165.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1113 ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -94.79 105.92 17.88 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-O 123.596 1.665 . . . . 42.920000000000002 109.376 164.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -86.4 108.55 18.52 Favored 'General case' 0 CA--C 1.5 -0.958 0 O-C-N 119.302 -2.124 . . . . 24.149999999999999 108.444 177.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1115 ' ' MET . . . . . . . . . . . . . 82.1 mmm -67.98 -16.93 64.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 111.971 -2.377 . . . . 29.949999999999999 113.32 -173.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1116 ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -79.6 -35.01 40.25 Favored 'General case' 0 C--O 1.253 1.244 0 O-C-N 120.018 -1.676 . . . . 34.530000000000001 109.481 171.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1117 ' ' SER . . . . . . . . . . . . . 69.1 m -87.62 31.13 0.77 Allowed 'General case' 0 C--O 1.247 0.97 0 C-N-CA 126.293 1.837 . . . . 33.490000000000002 114.451 -166.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1118 ' ' VAL . . . . . . . . . . . . . 15.1 t -77.98 136.96 61.7 Favored Pre-proline 0 C--O 1.259 1.555 0 N-CA-C 107.887 -1.153 . . . . 34.020000000000003 107.887 -177.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -62.06 132.31 38.7 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 124.226 3.284 . . . . 38.280000000000001 108.232 174.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1120 ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -73.27 29.36 0.07 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 119.158 3.022 . . . . 55.049999999999997 119.158 -160.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1121 ' ' ILE . . . . . . . . . . . . . 23.8 pt -90.51 162.74 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 CA-C-N 119.176 0.898 . . . . 42.090000000000003 110.582 -169.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1122 ' ' SER . . . . . . . . . . . . . 1.1 m -51.29 -40.91 59.98 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 112.954 -1.93 . . . . 38.020000000000003 115.576 -175.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1123 ' ' ARG . . . . . . . . . . . . . 24.1 ptt-85 -72.37 -41.48 66.32 Favored 'General case' 0 C--N 1.361 1.084 0 O-C-N 119.921 -1.737 . . . . 34.289999999999999 112.632 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1124 ' ' ALA . . . . . . . . . . . . . . . -53.49 -35.3 60.46 Favored 'General case' 0 N--CA 1.434 -1.232 0 O-C-N 124.957 1.411 . . . . 32.350000000000001 114.766 175.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1125 ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -58.71 -20.77 51.77 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 117.964 2.579 . . . . 47.170000000000002 117.964 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1126 ' ' SER . . . . . . . . . . . . . 73.3 p -70.72 -35.89 72.93 Favored 'General case' 0 C--O 1.251 1.178 0 O-C-N 120.05 -1.656 . . . . 31.710000000000001 112.099 170.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1127 ' ' LEU . . . . . . . . . . . . . 4.5 mp -86.56 -16.85 35.57 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.884 -1.053 . . . . 37.0 112.35 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1128 ' ' ASP . . . . . . . . . . . . . 24.3 t70 -75.09 117.38 16.87 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 126.49 3.043 . . . . 40.399999999999999 117.06 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1129 ' ' ALA . . . . . . . . . . . . . . . -70.13 -33.83 72.31 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-N 109.924 -3.307 . . . . 26.559999999999999 107.419 -176.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 32.0 mt -61.98 -35.34 78.19 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 124.045 0.938 . . . . 30.890000000000001 110.664 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1131 ' ' SER . . . . . . . . . . . . . 61.4 m -71.39 -51.43 24.06 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 120.937 1.699 . . . . 29.84 109.164 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1132 ' ' SER . . . . . . . . . . . . . 55.5 m -55.85 -44.45 78.02 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.51 1.505 . . . . 31.91 112.47 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1133 ' ' MET . . . . . . . . . . . . . 36.7 mmt -71.56 -33.66 69.3 Favored 'General case' 0 CA--C 1.51 -0.57 0 O-C-N 121.175 -0.953 . . . . 25.899999999999999 111.101 -178.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1134 ' ' ALA . . . . . . . . . . . . . . . -66.72 -38.15 86.12 Favored 'General case' 0 C--O 1.201 -1.483 0 O-C-N 119.767 -1.833 . . . . 26.620000000000001 110.558 170.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.45 -30.75 71.17 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 120.126 1.33 . . . . 36.969999999999999 113.064 176.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B 1136 ' ' ILE . . . . . . . . . . . . . 39.3 mm -58.37 -56.96 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 CA-C-O 117.492 -1.242 . . . . 32.109999999999999 110.231 164.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -53.76 -37.96 63.92 Favored 'General case' 0 CA--C 1.508 -0.64 0 O-C-N 124.901 1.376 . . . . 24.140000000000001 112.985 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -71.74 -40.71 57.91 Favored Glycine 0 N--CA 1.441 -1.033 0 CA-C-O 122.22 0.9 . . . . 25.129999999999999 111.492 -176.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 4.5 t80 -68.25 -41.86 80.52 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 120.847 -1.384 . . . . 32.729999999999997 108.405 174.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1140 ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -71.2 -19.68 62.36 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 118.51 -0.757 . . . . 26.359999999999999 110.901 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1141 ' ' ALA . . . . . . . . . . . . . . . -60.34 -52.72 64.07 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 119.721 1.146 . . . . 24.120000000000001 108.682 171.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 42.6 mm -64.98 -36.08 76.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 O-C-N 124.219 0.949 . . . . 23.370000000000001 111.623 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 57.2 t -65.58 -67.39 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 C-N-CA 124.018 0.927 . . . . 24.960000000000001 112.112 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -55.56 -31.95 62.59 Favored 'General case' 0 C--N 1.354 0.783 0 O-C-N 120.103 -1.623 . . . . 32.07 114.116 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1145 ' ' ALA . . . . . . . . . . . . . . . -58.21 -57.2 13.92 Favored 'General case' 0 C--O 1.203 -1.388 0 CA-C-N 115.817 -0.629 . . . . 24.870000000000001 109.589 170.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1146 ' ' ALA . . . . . . . . . . . . . . . -58.04 -38.95 77.21 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.831 0.824 . . . . 24.670000000000002 113.051 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 83.4 t60 -51.7 -56.96 10.68 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.699 -1.137 . . . . 28.579999999999998 111.152 170.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1148 ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -90.13 1.76 56.04 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 115.557 1.688 . . . . 36.82 115.557 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1149 ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -72.23 153.06 41.79 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.886 1.674 . . . . 31.969999999999999 109.277 -174.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B 1150 ' ' GLY . . . . . . . . . . . . . . . -86.24 -36.06 10.25 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 117.211 -1.883 . . . . 25.489999999999998 112.685 169.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1151 ' ' ARG . . . . . . . . . . . . . 25.8 mtm-85 -119.05 -177.95 3.45 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 122.717 3.258 . . . . 59.840000000000003 115.893 -168.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1152 ' ' PHE . . . . . . . . . . . . . 18.2 m-30 -81.75 165.66 20.74 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 124.124 1.916 . . . . 34.450000000000003 110.092 175.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1153 ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -82.31 -49.89 9.55 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.415 -1.266 . . . . 31.170000000000002 111.605 166.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1154 ' ' THR . . . . . . . . . . . . . 3.1 m -65.31 142.42 58.26 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.684 1.193 . . . . 33.890000000000001 111.31 -176.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -80.52 72.35 2.68 Favored Glycine 0 C--N 1.34 0.786 0 O-C-N 117.871 -3.018 . . . . 38.950000000000003 108.754 169.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -89.82 114.53 26.27 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 123.169 1.461 . . . . 54.229999999999997 110.77 -163.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 6.9 mm -67.87 95.07 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 113.441 -1.709 . . . . 51.159999999999997 106.426 166.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1158 ' ' THR . . . . . . . . . . . . . 10.3 m -95.9 157.24 15.99 Favored 'General case' 0 C--O 1.249 1.069 0 N-CA-C 108.03 -1.1 . . . . 49.609999999999999 108.03 -172.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -46.92 -51.56 16.56 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.024 0.75 . . . . 49.049999999999997 113.024 174.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -63.65 -58.27 7.44 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 114.659 1.355 . . . . 47.649999999999999 114.659 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . -159.87 179.18 35.6 Favored Glycine 0 C--O 1.25 1.119 0 CA-C-O 118.079 -1.401 . . . . 45.609999999999999 110.864 -168.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 95.6 mttt -94.46 140.14 30.21 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.169 -1.048 . . . . 57.460000000000001 108.169 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1163 ' ' VAL . . . . . . . . . . . . . 59.2 t -97.41 128.57 34.32 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-N 114.59 -1.186 . . . . 42.93 112.573 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1164 ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.21 130.42 17.54 Favored 'Trans proline' 0 N--CA 1.483 0.911 0 C-N-CA 122.84 2.36 . . . . 39.289999999999999 108.322 174.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1165 ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -68.27 146.1 68.25 Favored 'Trans proline' 0 C--O 1.245 0.829 0 C-N-CA 123.251 2.634 . . . . 34.170000000000002 111.02 -172.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -68.98 119.41 13.23 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-O 123.731 1.729 . . . . 31.690000000000001 111.438 170.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1167 ' ' LYS . . . . . . . . . . . . . 87.9 mttt -89.41 98.04 11.54 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 125.42 2.533 . . . . 44.780000000000001 107.566 171.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 60.5 t -89.03 100.48 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 109.739 -3.391 . . . . 31.23 108.867 -178.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1169 ' ' MET . . . . . . . . . . . . . 42.6 ttp -85.02 89.93 7.72 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.29 -0.868 . . . . 37.090000000000003 108.908 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 62.8 t -83.22 105.45 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-O 122.728 1.252 . . . . 30.170000000000002 108.415 177.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1171 ' ' ILE . . . . . . . . . . . . . 97.3 mt -88.93 87.86 2.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 105.285 -2.117 . . . . 33.740000000000002 105.285 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 134.37 95.85 0.54 Allowed Glycine 0 N--CA 1.437 -1.298 0 CA-C-N 113.499 -1.682 . . . . 32.590000000000003 109.962 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1173 ' ' ALA . . . . . . . . . . . . . . . -92.99 46.09 1.21 Allowed 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 119.911 1.856 . . . . 32.420000000000002 112.978 -175.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -134.22 151.94 20.44 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 108.241 -1.944 . . . . 31.739999999999998 108.241 -174.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 23.4 t 24.97 -84.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 127.324 2.249 . . . . 31.48 115.242 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1176 ' ' ALA . . . . . . . . . . . . . . . -62.61 -41.36 98.95 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 123.418 1.58 . . . . 26.120000000000001 111.137 -175.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1177 ' ' GLY . . . . . . . . . . . . . . . -68.95 -31.37 72.52 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 113.093 -1.867 . . . . 25.73 111.284 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1178 ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.0 -48.41 81.67 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 121.445 2.622 . . . . 32.590000000000003 108.126 175.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -61.43 -46.78 88.69 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 112.764 0.653 . . . . 27.719999999999999 112.764 176.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -56.86 -46.52 81.72 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 121.993 0.902 . . . . 26.030000000000001 112.875 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1181 ' ' ILE . . . . . . . . . . . . . 72.5 mt -60.11 -50.55 79.74 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.435 0 C-N-CA 126.559 1.944 . . . . 28.609999999999999 107.784 174.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -48.07 -55.78 9.78 Favored Glycine 0 N--CA 1.44 -1.042 0 O-C-N 124.228 0.955 . . . . 25.23 113.151 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -63.9 -51.09 66.12 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 117.754 -1.117 . . . . 24.09 110.882 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -62.23 -43.77 98.08 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-O 123.549 1.642 . . . . 26.68 113.963 -175.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -67.24 -40.35 86.29 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 119.346 -2.096 . . . . 36.57 109.02 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1186 ' ' SER . . . . . . . . . . . . . 61.0 m -66.44 -23.63 66.32 Favored 'General case' 0 C--O 1.25 1.088 0 CA-C-N 119.914 1.234 . . . . 28.920000000000002 113.226 173.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1187 ' ' LEU . . . . . . . . . . . . . 19.5 mt -84.32 6.8 21.61 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 119.871 -1.768 . . . . 29.09 112.997 165.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 83.62 14.05 74.27 Favored Glycine 0 CA--C 1.538 1.524 0 O-C-N 118.546 -2.596 . . . . 29.260000000000002 114.33 172.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1189 ' ' ALA . . . . . . . . . . . . . . . -88.98 143.76 26.63 Favored 'General case' 0 N--CA 1.433 -1.276 0 O-C-N 120.843 -1.386 . . . . 30.16 112.396 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 97.0 mt -76.77 97.43 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 105.13 -2.174 . . . . 35.810000000000002 105.13 174.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1191 ' ' VAL . . . . . . . . . . . . . 47.7 t -74.35 115.95 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 104.955 -2.239 . . . . 31.969999999999999 104.955 176.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1192 ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -103.3 77.91 1.57 Allowed 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 106.438 -1.69 . . . . 48.159999999999997 106.438 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -87.07 155.64 20.06 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 114.719 1.377 . . . . 35.890000000000001 114.719 -172.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 44.7 t80 -138.87 139.25 38.05 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 104.872 -2.27 . . . . 41.880000000000003 104.872 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1195 ' ' ASP . . . . . . . . . . . . . 8.8 t0 -146.1 150.07 35.23 Favored 'General case' 0 C--O 1.245 0.857 0 N-CA-C 102.289 -3.226 . . . . 38.280000000000001 102.289 165.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1196 ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -72.15 -27.47 62.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 120.383 -1.448 . . . . 40.619999999999997 111.605 176.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B 1197 ' ' ARG . . . . . . . . . . . . . 36.5 mtm180 -84.4 132.09 48.34 Favored Pre-proline 0 N--CA 1.444 -0.759 0 N-CA-C 115.876 1.806 . . . . 53.090000000000003 115.876 -171.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -69.31 -30.32 24.58 Favored 'Trans proline' 0 CA--C 1.498 -1.291 0 C-N-CA 122.906 2.404 . . . . 42.560000000000002 117.35 -176.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -54.89 -26.74 37.83 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 113.199 0.814 . . . . 56.310000000000002 113.199 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1200 ' ' VAL . . . . . . . . . . . . . 3.5 m -114.5 20.34 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 CA-C-O 123.59 1.662 . . . . 42.909999999999997 114.717 -173.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 58.0 tttm -69.94 -56.12 7.86 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 122.53 1.157 . . . . 48.890000000000001 110.931 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -55.66 -43.51 76.36 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 115.957 1.836 . . . . 51.700000000000003 115.957 -165.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1203 ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -43.37 -38.51 2.76 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 119.307 3.077 . . . . 52.57 119.307 -175.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1204 ' ' VAL . . . . . . . . . . . . . 43.7 t -71.91 -47.05 57.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 106.058 -1.83 . . . . 33.789999999999999 106.058 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -62.65 -44.58 95.9 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.773 -0.455 . . . . 36.579999999999998 109.773 175.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1206 ' ' SER . . . . . . . . . . . . . 16.8 m -60.87 -22.24 64.06 Favored 'General case' 0 CA--C 1.504 -0.808 0 C-N-CA 127.186 2.194 . . . . 39.609999999999999 115.333 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1207 ' ' MET . . . . . . . . . . . . . 27.0 mtp -87.59 -23.59 24.25 Favored 'General case' 0 C--O 1.253 1.249 0 CA-C-O 123.98 1.848 . . . . 37.450000000000003 111.523 175.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 95.32 73.58 1.19 Allowed Glycine 0 CA--C 1.5 -0.858 0 O-C-N 118.274 -2.766 . . . . 31.870000000000001 107.158 -175.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -169.67 -170.96 1.12 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 109.842 -3.179 . . . . 35.399999999999999 106.448 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -125.45 147.55 49.16 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 121.581 1.992 . . . . 47.890000000000001 111.885 -172.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 14.9 t80 -105.92 138.95 41.22 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 105.673 -1.973 . . . . 45.530000000000001 105.673 173.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1212 ' ' LEU . . . . . . . . . . . . . 78.9 mt -86.86 128.06 35.04 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 122.449 1.119 . . . . 46.329999999999998 111.344 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -94.44 145.2 24.94 Favored 'General case' 0 C--O 1.254 1.317 0 CA-C-N 112.299 -2.228 . . . . 60.409999999999997 111.72 177.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.62 153.51 17.68 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 114.184 -1.371 . . . . 57.380000000000003 108.775 -175.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 18.2 t70 . . . . . 0 CA--C 1.506 -0.738 0 N-CA-C 112.72 0.637 . . . . 65.069999999999993 112.72 -178.329 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B 1230 ' ' MET . . . . . . . . . . . . . 16.3 mmt . . . . . 0 N--CA 1.432 -1.372 1 N-CA-C 99.374 -4.306 . . . . 80.319999999999993 99.374 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1231 ' ' SER . . . . . . . . . . . . . 67.1 m 127.5 147.28 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.348 3 O-C-N 110.924 -7.36 . . . . 79.920000000000002 107.109 -10.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -63.79 150.54 44.43 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 120.618 1.554 . . . . 77.909999999999997 110.338 -172.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 65.92 -43.11 0.38 Allowed 'General case' 0 C--N 1.356 0.888 0 C-N-CA 125.065 1.346 . . . . 73.879999999999995 114.08 -170.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 12.0 t80 -56.35 -50.91 70.14 Favored 'General case' 0 CA--C 1.507 -0.707 0 O-C-N 118.935 -2.353 . . . . 68.980000000000004 109.996 172.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 30.3 pt -54.77 -31.87 24.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 112.57 -2.104 . . . . 64.530000000000001 113.048 172.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -74.43 -30.45 61.91 Favored 'General case' 0 C--O 1.218 -0.598 0 O-C-N 117.947 -2.971 . . . . 66.359999999999999 111.632 172.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -64.61 -41.75 96.01 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-N 119.629 1.104 . . . . 56.600000000000001 110.645 170.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -55.85 -52.66 63.27 Favored 'General case' 0 C--O 1.249 1.065 0 O-C-N 121.606 -0.684 . . . . 56.789999999999999 111.368 169.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1239 ' ' MET . . . . . . . . . . . . . 14.2 mtm -49.05 -45.05 42.34 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 114.589 1.329 . . . . 53.630000000000003 114.589 174.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -65.59 -37.1 85.67 Favored 'General case' 0 C--O 1.247 0.971 0 CA-C-O 123.042 1.401 . . . . 51.740000000000002 109.995 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 31.4 tp -63.17 -44.75 94.55 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 118.319 -2.738 . . . . 44.859999999999999 107.474 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 11.4 m-30 -68.85 -37.57 79.22 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.362 -1.29 . . . . 42.780000000000001 109.772 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -62.48 -33.73 75.45 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 121.123 1.783 . . . . 40.960000000000001 109.58 175.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -66.23 -47.52 73.53 Favored 'General case' 0 C--N 1.345 0.413 0 CA-C-O 122.253 1.025 . . . . 43.060000000000002 110.278 173.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -63.97 -25.54 68.18 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.588 -1.642 . . . . 46.450000000000003 113.241 176.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -31.85 -51.16 0.22 Allowed 'General case' 0 N--CA 1.472 0.671 1 N-CA-C 122.109 4.114 . . . . 41.780000000000001 122.109 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 6.2 tptt -86.08 -18.28 32.84 Favored 'General case' 0 C--N 1.347 0.49 0 O-C-N 120.438 -1.414 . . . . 52.200000000000003 111.874 176.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1248 ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -80.96 -48.15 12.68 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 118.745 -2.472 . . . . 53.549999999999997 112.618 172.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1249 ' ' VAL . . . . . . . . . . . . 0.255 26.8 m -71.02 137.38 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 CA-C-O 126.54 3.067 . . . . 34.409999999999997 114.933 -168.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B 1250 ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -98.29 -51.43 3.99 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 108.62 -3.9 . . . . 33.380000000000003 111.225 -176.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1251 ' ' ILE . . . . . . . . . . . . . 40.4 mm -126.39 111.7 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 O-C-N 118.439 -2.663 . . . . 29.539999999999999 106.543 -174.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1252 ' ' ILE . . . . . . . . . . . . . 61.8 mt -98.28 108.62 22.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 105.947 -1.871 . . . . 32.439999999999998 105.947 176.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1253 ' ' VAL . . . . . . . . . . . . . 39.9 t -90.71 87.13 2.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 N-CA-C 102.342 -3.207 . . . . 30.57 102.342 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1254 ' ' THR . . . . . . . . . . . . 0.275 2.0 t -88.33 96.17 10.47 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 103.452 -2.795 . . . . 35.039999999999999 103.452 -176.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B 1255 ' ' THR . . . . . . . . . . . . . 21.6 m -90.11 -73.56 0.52 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 109.795 -3.366 . . . . 34.619999999999997 108.515 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . 45.3 1.51 0.0 OUTLIER 'General case' 0 C--O 1.242 0.671 1 N-CA-C 123.175 4.509 . . . . 42.719999999999999 123.175 -178.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 2.6 mp -65.64 92.79 0.15 Allowed 'General case' 0 C--O 1.242 0.68 0 CA-C-N 123.173 2.715 . . . . 52.43 113.863 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -76.0 137.59 69.21 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 112.319 -2.218 . . . . 59.409999999999997 108.7 171.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -55.22 113.3 1.35 Allowed 'Trans proline' 0 N--CA 1.444 -1.411 0 C-N-CA 124.499 3.466 . . . . 62.68 116.391 -165.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 89.77 -36.4 3.54 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 109.772 -1.331 . . . . 64.159999999999997 109.772 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 70.6 mttt -75.16 135.69 73.12 Favored Pre-proline 0 C--O 1.247 0.95 0 CA-C-N 120.886 2.343 . . . . 68.530000000000001 107.63 -175.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.58 145.49 98.72 Favored 'Trans proline' 0 CA--C 1.5 -1.205 0 C-N-CA 123.895 3.064 . . . . 61.990000000000002 113.097 161.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1263 ' ' ALA . . . . . . . . . . . . . . . -81.92 128.81 67.14 Favored Pre-proline 0 C--O 1.24 0.561 0 O-C-N 120.618 -1.301 . . . . 57.149999999999999 112.833 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -64.32 153.03 78.93 Favored 'Trans proline' 0 C--O 1.247 0.969 0 C-N-CA 122.416 2.077 . . . . 51.57 116.101 169.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1265 ' ' LYS . . . . . 0.427 ' NZ ' ' O ' ' B' 1289 ' ' GLY . 41.9 mmtm -77.22 88.59 3.67 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 122.603 1.192 . . . . 54.549999999999997 110.065 -174.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 68.6 mt -80.35 -43.49 21.06 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 115.102 1.519 . . . . 46.859999999999999 115.102 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1267 ' ' ILE . . . . . . . . . . . . . 35.1 mm -87.7 101.94 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 105.809 -1.923 . . . . 41.039999999999999 105.809 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1268 ' ' THR . . . . . . . . . . . . . 24.4 p -73.96 159.16 33.15 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-N 113.858 -1.519 . . . . 39.579999999999998 112.484 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1269 ' ' ARG . . . . . . . . . . . . . 79.1 mtt85 -55.45 -43.42 75.42 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 115.997 -0.547 . . . . 53.149999999999999 110.471 172.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -56.37 -41.33 76.01 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 113.816 1.043 . . . . 42.960000000000001 113.816 175.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1271 ' ' MET . . . . . . . . . . . . . 43.4 ttm -65.94 -47.79 73.48 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.704 -0.68 . . . . 43.890000000000001 110.189 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1272 ' ' VAL . . . . . . . . . . . . . 38.5 t -65.68 -41.97 91.67 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.671 0 CA-C-O 121.467 0.651 . . . . 38.369999999999997 110.922 -177.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -63.13 -35.78 81.43 Favored 'General case' 0 C--O 1.239 0.541 0 O-C-N 118.53 -2.606 . . . . 47.460000000000001 112.664 173.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1274 ' ' SER . . . . . . . . . . . . . 72.8 m -70.14 -25.34 63.43 Favored 'General case' 0 N--CA 1.441 -0.917 0 O-C-N 120.845 -1.16 . . . . 38.380000000000003 113.868 173.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1275 ' ' MET . . . . . . . . . . . . . 40.2 mtp -60.79 163.53 5.57 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 117.95 2.574 . . . . 37.810000000000002 117.95 -174.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 81.8 tttt -62.95 131.79 49.88 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 110.242 -3.163 . . . . 49.259999999999998 108.97 166.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -84.24 166.37 17.58 Favored 'General case' 0 CA--C 1.51 -0.594 0 O-C-N 124.83 1.331 . . . . 34.460000000000001 110.023 -177.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 63.2 30.53 77.81 Favored Glycine 0 C--N 1.334 0.467 0 O-C-N 120.886 -1.134 . . . . 33.530000000000001 111.861 -172.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1279 ' ' SER . . . . . . . . . . . . . 42.3 m -126.5 146.81 49.97 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 106.062 -1.829 . . . . 31.309999999999999 106.062 -176.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1280 ' ' VAL . . . . . . . . . . . . . 58.1 t -117.66 135.36 58.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 122.592 1.187 . . . . 29.32 109.278 -171.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1281 ' ' ILE . . . . . . . . . . . . . 67.4 mt -110.62 104.09 16.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 103.601 -2.74 . . . . 31.93 103.601 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1282 ' ' VAL . . . . . . . . . . . . . 31.7 t -95.78 111.72 26.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 N-CA-C 101.681 -3.451 . . . . 29.48 101.681 -175.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 36.8 t0 -87.67 107.01 18.42 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.231 -1.349 . . . . 34.5 108.544 175.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1284 ' ' LEU . . . . . . . . . . . . . 19.6 mt -79.02 -17.21 55.72 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 118.609 -1.236 . . . . 37.939999999999998 111.045 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -102.12 29.23 5.22 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.664 0.745 . . . . 40.920000000000002 111.868 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -51.83 -36.59 48.63 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.64 1.976 . . . . 44.390000000000001 115.797 177.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1287 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.19 -38.86 21.74 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.497 1.119 . . . . 51.460000000000001 110.347 171.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 11.3 t30 -98.37 71.95 2.07 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-O 121.482 0.658 . . . . 57.75 111.574 -171.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1289 ' ' GLY . . . . . 0.427 ' O ' ' NZ ' ' B' 1265 ' ' LYS . . . 86.61 -40.74 3.07 Favored Glycine 0 N--CA 1.47 0.948 0 CA-C-O 117.949 -1.473 . . . . 49.850000000000001 113.614 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 72.57 119.73 0.06 OUTLIER Glycine 0 CA--C 1.541 1.672 0 CA-C-N 121.42 2.61 . . . . 45.93 112.195 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1291 ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -85.52 -21.75 28.46 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.625 1.17 . . . . 42.670000000000002 110.034 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1292 ' ' CYS . . . . . . . . . . . . . 27.1 t -110.83 132.19 54.41 Favored 'General case' 0 CA--C 1.51 -0.582 0 O-C-N 118.503 -2.623 . . . . 38.82 111.608 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1293 ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -58.17 -41.79 84.62 Favored 'General case' 0 C--O 1.245 0.856 0 CA-C-O 121.399 0.619 . . . . 46.710000000000001 111.928 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -75.56 -7.71 54.91 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 115.37 1.618 . . . . 47.229999999999997 115.37 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1295 ' ' THR . . . . . . . . . . . . . 38.6 m -53.89 122.3 9.75 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.239 0.616 . . . . 36.020000000000003 112.551 172.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 26.3 t -89.0 106.31 12.84 Favored Pre-proline 0 N--CA 1.488 1.452 0 N-CA-C 101.993 -3.336 . . . . 37.259999999999998 101.993 161.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -59.97 76.15 0.06 OUTLIER 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 125.227 3.951 . . . . 35.090000000000003 115.536 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 149.24 -14.92 1.12 Allowed Glycine 0 CA--C 1.528 0.887 0 CA-C-N 113.218 -1.81 . . . . 35.969999999999999 111.679 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -139.48 -174.31 3.85 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 123.487 3.643 . . . . 40.390000000000001 112.262 -174.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1300 ' ' ILE . . . . . . . . . . . . . 30.7 mt -88.44 133.91 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-N 113.917 -1.492 . . . . 37.43 109.374 166.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 61.8 t80 -108.66 116.84 32.74 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 107.223 -1.399 . . . . 44.130000000000003 107.223 159.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1302 ' ' THR . . . . . . . . . . . . . 13.9 m -84.82 112.38 20.48 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.632 -1.618 . . . . 39.780000000000001 106.632 172.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1303 ' ' THR . . . . . . . . . . . . . 34.5 p -74.36 162.32 28.99 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 120.879 -1.138 . . . . 43.289999999999999 111.628 175.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -49.96 -47.72 52.49 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 125.192 1.397 . . . . 53.07 114.313 -168.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 47.7 p30 -70.51 -23.96 62.74 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 115.531 1.678 . . . . 43.969999999999999 115.531 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 114.38 21.13 5.62 Favored Glycine 0 CA--C 1.529 0.932 0 O-C-N 121.177 -0.952 . . . . 41.119999999999997 111.885 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1307 ' ' VAL . . . . . . . . . . . . . 47.6 t -80.08 128.56 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 O-C-N 119.6 -2.118 . . . . 38.119999999999997 106.439 163.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1308 ' ' LYS . . . . . . . . . . . . . 92.6 mttt -109.76 114.67 28.43 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-N 120.58 1.536 . . . . 36.340000000000003 109.285 -176.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1309 ' ' VAL . . . . . . . . . . . . . 44.0 t -89.88 103.26 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 O-C-N 120.589 -1.32 . . . . 30.399999999999999 110.059 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1310 ' ' ILE . . . . . . . . . . . . . 40.4 mt -92.93 104.4 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.98 0 N-CA-C 104.921 -2.252 . . . . 30.82 104.921 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1311 ' ' GLY . . . . . . . . . . . . . . . -124.09 81.59 0.35 Allowed Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 104.246 -3.542 . . . . 26.530000000000001 104.246 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1312 ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -92.4 137.82 32.04 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 120.452 -1.617 . . . . 38.0 111.849 176.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1313 ' ' THR . . . . . . . . . . . . . 3.4 p -61.72 -36.37 80.76 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.79 -1.189 . . . . 29.800000000000001 107.79 168.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -83.49 12.13 6.04 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 118.143 2.645 . . . . 39.039999999999999 118.143 -175.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1315 ' ' LEU . . . . . . . . . . . . . 12.2 mt -58.37 -42.76 96.45 Favored Pre-proline 0 C--O 1.245 0.831 0 O-C-N 118.671 -2.518 . . . . 31.079999999999998 114.992 170.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1316 ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -67.22 -3.45 9.9 Favored 'Trans proline' 0 C--O 1.24 0.602 0 C-N-CA 122.509 2.139 . . . . 26.100000000000001 113.361 169.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -89.12 -57.26 1.81 Allowed Glycine 0 CA--C 1.536 1.373 0 O-C-N 119.243 -2.16 . . . . 23.170000000000002 110.409 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -68.89 52.65 0.09 Allowed 'General case' 0 CA--C 1.529 0.139 1 N-CA-C 122.582 4.29 . . . . 40.399999999999999 122.582 -158.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -133.66 76.47 66.33 Favored Pre-proline 0 C--O 1.236 0.394 0 O-C-N 118.579 -2.576 . . . . 23.600000000000001 104.94 151.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1320 ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -35.32 -70.78 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.199 3.266 . . . . 22.350000000000001 120.553 -166.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1321 ' ' THR . . . . . . . . . . . . . 2.8 m -55.69 -43.45 76.43 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 114.858 1.429 . . . . 26.52 114.858 173.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1322 ' ' GLN . . . . . . . . . . . . . 42.3 tp60 -72.94 -37.59 67.1 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 118.144 -2.847 . . . . 24.379999999999999 109.296 -173.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1323 ' ' SER . . . . . . . . . . . . . 49.7 m -61.13 -54.37 45.4 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 116.925 -1.512 . . . . 22.800000000000001 107.653 174.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1324 ' ' SER . . . . . . . . . . . . . 15.2 m -54.16 -35.88 62.75 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 114.417 1.266 . . . . 21.25 114.417 173.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -67.44 -57.41 6.61 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 120.921 -1.112 . . . . 31.34 110.783 173.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1326 ' ' LEU . . . . . . . . . . . . . 97.3 mt -73.3 -32.6 64.71 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-N 121.765 2.075 . . . . 31.559999999999999 108.349 -166.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1327 ' ' TYR . . . . . . . . . . . . . 24.7 t80 -60.94 -56.97 14.83 Favored 'General case' 0 C--O 1.257 1.471 0 N-CA-C 105.421 -2.066 . . . . 22.73 105.421 169.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1328 ' ' GLY . . . . . . . . . . . . . . . -48.24 -41.55 23.58 Favored Glycine 0 N--CA 1.467 0.725 0 CA-C-O 119.786 -0.452 . . . . 21.91 114.162 173.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1329 ' ' THR . . . . . . . . . . . . . 16.5 m -72.0 -31.17 65.97 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 118.709 1.255 . . . . 22.149999999999999 110.598 -175.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1330 ' ' ASN . . . . . . . . . . . . . 33.0 m120 -63.6 -46.46 85.69 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.291 -0.881 . . . . 26.18 109.885 170.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1331 ' ' LEU . . . . . . . . . . . . . 73.1 mt -53.72 -48.13 69.9 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.77 0.828 . . . . 23.68 112.224 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1332 ' ' VAL . . . . . . . . . . . . . 90.8 t -51.92 -57.49 3.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 O-C-N 124.638 1.212 . . . . 26.57 110.804 169.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -55.06 -37.49 66.81 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.79 1.177 . . . . 28.079999999999998 112.165 -177.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1334 ' ' LEU . . . . . . . . . . . . . 32.4 tp -64.78 -49.29 71.28 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 124.779 1.3 . . . . 27.43 111.39 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1335 ' ' LEU . . . . . . . . . . . . . 64.4 mt -62.13 -35.43 78.72 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 114.68 -1.146 . . . . 30.5 109.616 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1336 ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.87 -42.04 83.71 Favored 'General case' 0 CA--C 1.512 -0.498 0 O-C-N 121.486 -0.758 . . . . 41.649999999999999 112.555 171.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 8.2 mp -72.74 -34.85 67.31 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 113.164 0.801 . . . . 42.079999999999998 113.164 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1338 ' ' LEU . . . . . . . . . . . . . 47.0 mt -74.59 -72.81 0.27 Allowed 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 122.804 1.288 . . . . 35.030000000000001 107.967 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 50.0 m -81.02 69.93 7.73 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-O 123.442 1.591 . . . . 37.329999999999998 113.982 -175.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 55.4 mttp -67.69 -6.28 19.91 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 113.65 -1.613 . . . . 50.509999999999998 115.262 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -95.07 -24.62 16.8 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.508 0.723 . . . . 54.210000000000001 110.753 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.23 34.85 21.25 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.957 1.703 . . . . 50.990000000000002 111.501 -174.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -82.7 -30.11 29.4 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 114.177 -1.374 . . . . 48.82 111.658 -172.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 116.16 22.61 4.47 Favored Glycine 0 N--CA 1.473 1.141 0 CA-C-O 118.335 -1.258 . . . . 40.43 110.319 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -134.32 140.14 46.17 Favored 'General case' 0 C--O 1.25 1.102 0 CA-C-N 120.955 2.378 . . . . 47.560000000000002 108.149 173.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1346 ' ' ILE . . . . . . . . . . . . . 22.6 mm -63.9 92.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 CA-C-O 126.284 2.945 . . . . 42.490000000000002 108.807 171.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1347 ' ' THR . . . . . . . . . . . . . 61.1 m -80.19 99.36 7.75 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 100.778 -3.786 . . . . 38.119999999999997 100.778 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 6.7 t -82.32 102.42 8.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 106.515 -1.661 . . . . 37.5 106.515 -176.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 29.0 t70 -67.14 164.61 17.68 Favored 'General case' 0 C--O 1.214 -0.767 0 O-C-N 125.645 1.841 . . . . 43.850000000000001 110.264 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1350 ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.7 5.42 0.69 Allowed 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.769 -0.826 . . . . 39.810000000000002 108.769 177.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 32.4 t70 -92.18 -56.59 3.0 Favored 'General case' 0 C--O 1.247 0.946 0 N-CA-C 114.26 1.207 . . . . 51.289999999999999 114.26 -174.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 7.7 t0 -65.06 134.68 54.35 Favored 'General case' 0 C--O 1.258 1.513 0 CA-C-O 121.703 0.764 . . . . 39.780000000000001 110.381 -174.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 30.6 m -48.71 -38.52 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 116.813 2.153 . . . . 39.280000000000001 116.813 175.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1354 ' ' VAL . . . . . . . . . . . . . 95.0 t -58.84 -59.34 3.87 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 CA-C-N 114.805 -1.089 . . . . 35.700000000000003 109.306 173.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1355 ' ' ILE . . . . . . . . . . . . . 43.6 mm -61.06 -42.95 95.11 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.93 0 O-C-N 124.319 1.012 . . . . 35.770000000000003 109.557 -173.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 39.9 tpt85 -58.98 -25.01 63.22 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 120.002 -1.686 . . . . 38.549999999999997 113.865 175.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -82.33 -67.03 1.52 Allowed Glycine 0 CA--C 1.535 1.316 0 N-CA-C 110.1 -1.2 . . . . 29.579999999999998 110.1 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1358 ' ' VAL . . . . . . . . . . . . . 10.0 p -54.42 -35.34 30.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 116.025 1.861 . . . . 32.060000000000002 116.025 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1359 ' ' THR . . . . . . . . . . . . . 8.0 m -85.09 83.21 8.11 Favored 'General case' 0 CA--C 1.513 -0.464 0 O-C-N 118.413 -2.679 . . . . 29.0 108.173 178.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1360 ' ' VAL . . . . . . . . . . . . . 36.0 m -76.06 -21.99 15.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 109.905 -3.316 . . . . 29.68 112.478 -168.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 60.6 mt -133.17 129.45 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 101.832 -3.396 . . . . 32.049999999999997 101.832 172.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1362 ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -112.45 104.83 12.97 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 123.484 1.611 . . . . 32.520000000000003 108.327 168.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 50.9 60.03 4.18 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 122.711 1.243 . . . . 35.68 111.706 171.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 94.46 -43.69 2.33 Favored Glycine 0 CA--C 1.529 0.911 0 O-C-N 119.019 -2.301 . . . . 34.259999999999998 110.743 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -72.45 117.59 14.3 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-O 117.711 -1.138 . . . . 51.07 109.769 -174.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 54.1 mt -73.92 94.87 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.34 0 CA-C-O 123.39 1.567 . . . . 39.869999999999997 108.368 174.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1367 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.14 -14.08 59.33 Favored 'General case' 0 C--O 1.25 1.092 0 CA-C-N 111.903 -2.408 . . . . 38.009999999999998 114.701 -173.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B 1368 ' ' TRP . . . . . . . . . . . . . 73.8 t90 -59.81 140.05 89.93 Favored Pre-proline 0 N--CA 1.47 0.529 0 CA-C-N 110.941 -2.845 . . . . 42.140000000000001 106.362 170.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -78.77 178.07 35.85 Favored 'Cis proline' 0 N--CA 1.446 -1.31 0 CA-C-N 124.811 2.754 . . . . 43.259999999999998 118.12 4.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1370 ' ' ALA . . . . . . . . . . . . . . . -76.84 149.03 80.0 Favored Pre-proline 0 C--O 1.248 1.021 0 CA-C-N 110.897 -2.865 . . . . 46.520000000000003 110.718 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -62.71 142.63 90.03 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.573 2.182 . . . . 51.950000000000003 113.702 170.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.0 72.57 1.55 Allowed 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 124.853 3.702 . . . . 56.270000000000003 113.648 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1373 ' ' ILE . . . . . . . . . . . . 0.26 0.1 OUTLIER -79.71 135.12 26.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 O-C-N 119.627 -1.921 . . . . 60.829999999999998 106.929 173.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -75.31 116.62 16.23 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.032 -1.47 . . . . 66.099999999999994 107.032 -176.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 49.1 t -104.06 109.1 26.25 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 CA-C-N 113.061 -1.882 . . . . 63.469999999999999 106.712 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.223 -4.929 0 O-C-N 118.967 -2.333 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.818 0 CA-C-O 121.723 0.773 . . . . 0.0 111.997 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.66 -42.86 65.08 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 175.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.93 -43.73 77.67 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 122.572 2.442 . . . . 0.0 108.456 177.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 85.6 m -64.11 -37.91 89.15 Favored 'General case' 0 C--O 1.249 1.077 0 CA-C-O 117.924 -1.036 . . . . 0.0 111.846 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.2 -51.58 69.37 Favored 'General case' 0 CA--C 1.559 1.326 0 CA-C-N 120.016 1.28 . . . . 0.0 110.625 173.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.99 -33.09 62.22 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.515 1.126 . . . . 0.0 110.897 174.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.7 -54.33 33.31 Favored 'General case' 0 C--O 1.214 -0.78 0 O-C-N 119.608 -1.933 . . . . 0.0 111.556 171.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -47.81 -59.02 3.62 Favored 'General case' 0 C--O 1.247 0.949 0 C-N-CA 127.187 2.195 . . . . 0.0 113.382 -175.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 28' ' ' LYS . . . . . . . . . . . . . 27.2 pttt -59.32 -35.91 74.68 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.328 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -79.05 -30.37 44.01 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 69.7 m -43.25 -35.99 1.64 Allowed 'General case' 0 CA--C 1.508 -0.659 1 N-CA-C 122.869 4.396 . . . . 0.0 122.869 -167.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 67.73 -41.62 0.43 Allowed 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.887 1.675 . . . . 0.0 112.309 -171.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 12.0 m -121.15 139.42 53.37 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 120.028 1.285 . . . . 0.0 109.533 162.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 89.0 t -130.08 125.88 60.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 175.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 41.5 mm -104.74 123.56 58.82 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 O-C-N 118.93 -2.356 . . . . 0.0 106.071 169.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 29.7 mt -100.97 128.22 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 172.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 52.7 m -113.91 107.85 51.83 Favored Pre-proline 0 N--CA 1.426 -1.643 0 C-N-CA 125.565 1.546 . . . . 0.0 108.721 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -64.69 117.59 4.65 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.311 3.341 . . . . 0.0 110.16 170.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.39 -155.63 10.87 Favored Glycine 0 N--CA 1.416 -2.634 0 CA-C-N 111.906 -2.406 . . . . 0.0 110.465 164.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -66.82 -42.57 85.62 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.512 -0.993 . . . . 0.0 111.202 -173.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.52 -39.84 96.95 Favored Glycine 0 N--CA 1.437 -1.247 0 CA-C-O 117.483 -1.732 . . . . 0.0 110.781 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 9.1 ttm -56.66 -43.47 80.41 Favored 'General case' 0 C--N 1.36 1.036 0 CA-C-N 122.221 3.01 . . . . 0.0 111.284 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.36 -36.72 26.55 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 121.617 -0.677 . . . . 0.0 112.47 -171.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 85.6 t -77.79 -64.09 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.965 1.306 . . . . 0.0 110.533 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.95 65.81 2.97 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.535 1.159 . . . . 0.0 109.626 -172.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 45' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 17.71 36.18 0.0 OUTLIER 'General case' 0 C--O 1.245 0.863 1 N-CA-C 123.805 4.743 . . . . 0.0 123.805 175.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.81 -14.94 61.18 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 119.033 2.975 . . . . 0.0 119.033 -176.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 47' ' ' GLN . . . . . . . . . . . . 0.251 0.0 OUTLIER -65.83 -46.85 77.03 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 114.721 -2.561 . . . . 0.0 114.762 -178.358 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 48' ' ' TYR . . . . . . . . . . . . 0.37 2.8 p90 -65.88 -32.59 6.0 Favored Pre-proline 0 N--CA 1.474 0.771 0 CA-C-N 125.389 3.722 . . . . 0.0 115.294 174.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 49' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -58.96 -44.85 32.04 Favored 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 123.042 2.494 . . . . 0.0 111.293 164.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 23.2 t -55.55 -40.64 60.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 119.59 1.086 . . . . 0.0 109.655 173.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.33 -42.04 77.03 Favored 'General case' 0 C--N 1.367 1.334 0 CA-C-N 121.004 1.729 . . . . 0.0 112.763 175.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -60.81 -40.03 91.18 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 173.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 8.2 tp -75.93 -31.53 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 120.368 1.44 . . . . 0.0 109.659 177.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 89.6 m -68.89 -29.34 67.6 Favored 'General case' 0 CA--C 1.498 -1.028 0 O-C-N 119.833 -1.792 . . . . 0.0 112.458 -174.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -48.93 -67.82 0.23 Allowed 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 163.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -57.59 -41.4 81.08 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -172.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 58.0 mt -61.91 -52.25 64.84 Favored 'General case' 0 N--CA 1.434 -1.249 0 O-C-N 124.779 1.3 . . . . 0.0 109.443 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -70.07 -36.1 74.71 Favored 'General case' 0 C--O 1.245 0.865 0 O-C-N 120.27 -1.519 . . . . 0.0 108.74 -174.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.54 -27.55 64.65 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 173.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 30.3 ttm-85 -87.8 2.34 51.58 Favored 'General case' 0 CA--C 1.543 0.712 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 175.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.22 3.36 84.89 Favored Glycine 0 C--N 1.343 0.962 0 O-C-N 118.557 -2.589 . . . . 0.0 111.782 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 88.2 mt -66.87 130.05 31.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 CA-C-N 118.732 1.266 . . . . 0.0 109.676 -177.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -70.11 75.67 0.5 Allowed 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 122.844 1.307 . . . . 0.0 109.111 169.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 2.9 p -86.64 103.28 12.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-O 123.096 1.427 . . . . 0.0 107.76 173.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 50.0 mmm-85 -108.74 151.4 26.25 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 124.833 2.254 . . . . 0.0 109.573 173.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -106.94 114.5 28.62 Favored 'General case' 0 C--O 1.251 1.142 0 C-N-CA 117.664 -1.614 . . . . 0.0 108.049 -176.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -98.99 98.57 2.01 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 106.79 -2.524 . . . . 0.0 106.79 176.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 3.2 mp -89.93 140.25 16.2 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -114.21 121.74 35.84 Favored Pre-proline 0 CA--C 1.506 -0.747 0 CA-C-O 116.034 -1.936 . . . . 0.0 106.029 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 70' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -61.56 -50.52 5.42 Favored 'Trans proline' 0 N--CA 1.482 0.823 0 C-N-CA 124.237 3.291 . . . . 0.0 112.214 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 73.0 t -72.86 96.71 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.256 1.397 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 168.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -158.54 128.58 5.92 Favored 'General case' 0 C--O 1.259 1.585 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 176.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.23 -102.79 0.83 Allowed Glycine 0 C--N 1.319 -0.397 0 O-C-N 121.535 -0.728 . . . . 0.0 111.454 167.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.14 122.34 5.05 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -172.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 67.09 115.76 0.03 OUTLIER Pre-proline 0 N--CA 1.444 -0.734 0 C-N-CA 125.73 1.612 . . . . 0.0 111.598 -177.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.09 172.48 11.91 Favored 'Trans proline' 0 C--O 1.26 1.614 0 C-N-CA 123.508 2.805 . . . . 0.0 114.386 169.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.63 -104.69 1.35 Allowed Glycine 0 N--CA 1.441 -0.971 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 -166.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 34.02 -78.07 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 127.256 2.222 . . . . 0.0 116.018 160.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -61.86 -41.44 97.84 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 119.404 1.002 . . . . 0.0 113.078 -175.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -85.82 -23.46 27.15 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 113.944 -1.48 . . . . 0.0 112.249 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 98.7 t -62.37 -51.78 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 171.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 11.1 mt -57.95 -29.78 65.44 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 170.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 11.8 tp -62.0 -37.26 84.18 Favored 'General case' 0 C--O 1.239 0.517 0 O-C-N 119.673 -1.892 . . . . 0.0 111.498 167.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.4 -43.16 74.03 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 120.542 -1.349 . . . . 0.0 109.704 173.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -60.05 -31.05 69.62 Favored 'General case' 0 C--N 1.348 0.5 0 O-C-N 120.089 -1.632 . . . . 0.0 113.391 173.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . 0.261 . . -73.24 -5.93 42.65 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 120.245 -1.534 . . . . 0.0 112.236 171.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 65.49 29.44 11.19 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 118.515 -2.616 . . . . 0.0 116.735 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 78.0 t -82.83 123.0 78.45 Favored Pre-proline 0 N--CA 1.438 -1.031 0 CA-C-N 112.711 -2.041 . . . . 0.0 106.281 172.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -60.12 103.59 0.21 Allowed 'Trans proline' 0 CA--C 1.545 1.037 1 C-N-CA 125.69 4.26 . . . . 0.0 116.681 -176.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 1.4 m-30 -50.41 -16.99 0.4 Allowed 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 177.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -61.62 -59.82 4.62 Favored 'General case' 0 C--N 1.344 0.349 0 O-C-N 121.383 -0.823 . . . . 0.0 110.554 165.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 5.6 pt -74.94 -18.13 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 118.392 -2.693 . . . . 0.0 111.736 -175.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 51.7 t -70.05 135.56 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 127.186 2.195 . . . . 0.0 106.574 170.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 16.4 tp -138.2 101.72 4.47 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 124.361 2.029 . . . . 0.0 108.353 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -74.91 84.08 2.21 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 112.004 -2.362 . . . . 0.0 111.06 -177.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 24.8 ttp 43.73 60.58 2.61 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 119.548 3.166 . . . . 0.0 119.548 176.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -119.13 -152.02 0.5 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 111.275 -2.693 . . . . 0.0 105.824 -175.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -77.1 54.34 1.05 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 125.098 3.59 . . . . 0.0 113.512 -177.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 9.6 tp -79.11 3.01 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 O-C-N 120.753 -1.217 . . . . 0.0 111.334 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -44.48 -52.49 7.86 Favored 'General case' 0 C--N 1.362 1.121 0 C-N-CA 125.58 1.552 . . . . 0.0 114.144 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -57.05 -55.09 39.27 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 124.778 1.299 . . . . 0.0 110.681 -174.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.0 -41.78 77.33 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 113.724 -1.58 . . . . 0.0 107.832 -174.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.53 -57.41 13.08 Favored 'General case' 0 C--N 1.358 0.962 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -172.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.44 -15.42 63.28 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 118.979 0.809 . . . . 0.0 112.465 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -73.33 -39.2 65.42 Favored 'General case' 0 CA--C 1.568 1.66 0 O-C-N 119.755 -1.84 . . . . 0.0 110.499 174.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 106' ' ' THR . . . . . . . . . . . . . 19.9 m -52.28 146.16 9.76 Favored 'General case' 0 C--O 1.247 0.948 0 O-C-N 126.984 2.678 . . . . 0.0 116.087 -165.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 107' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -81.06 -83.06 0.11 Allowed 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 111.907 -2.406 . . . . 0.0 108.386 165.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 31.4 m -89.82 118.35 29.35 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 120.565 1.529 . . . . 0.0 112.866 -174.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 109' ' ' VAL . . . . . . . . . . . . . 84.2 t -101.49 100.05 9.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 C-N-CA 124.266 1.026 . . . . 0.0 109.76 169.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 29.2 mt -72.12 93.29 1.41 Allowed 'General case' 0 C--O 1.236 0.356 0 O-C-N 124.286 0.992 . . . . 0.0 108.776 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 38.3 t -85.51 94.14 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 8.5 mm -81.13 92.52 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-O 122.697 1.236 . . . . 0.0 111.096 -171.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.69 65.81 1.99 Allowed Glycine 0 C--N 1.315 -0.598 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 168.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -170.98 -166.71 0.5 Allowed 'General case' 0 CA--C 1.504 -0.803 0 O-C-N 122.048 -0.677 . . . . 0.0 110.895 -174.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 115' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -174.01 -53.74 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 166.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 116' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -61.26 -25.32 67.01 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 123.58 1.657 . . . . 0.0 112.575 -172.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.6 -43.49 62.52 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 176.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 3.6 m -124.49 13.32 4.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 112.276 -2.238 . . . . 0.0 112.26 -176.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -68.26 112.49 11.07 Favored Pre-proline 0 C--N 1.364 1.201 0 O-C-N 118.372 -2.705 . . . . 0.0 111.814 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 120' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -45.17 -45.38 14.79 Favored 'Trans proline' 0 N--CA 1.444 -1.394 1 C-N-CA 125.353 4.035 . . . . 0.0 115.584 -176.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.06 -31.72 65.49 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 124.93 1.292 . . . . 0.0 111.864 -177.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.69 -12.77 61.22 Favored 'General case' 0 N--CA 1.438 -1.035 0 O-C-N 120.325 -1.484 . . . . 0.0 112.883 -174.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -106.97 -35.19 6.97 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 120.662 -1.274 . . . . 0.0 110.341 159.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -65.32 -65.2 0.7 Allowed 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 123.251 1.5 . . . . 0.0 111.253 -172.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 125' ' ' ASP . . . . . 0.414 ' CG ' ' HZ2' ' C' ' 127' ' ' LYS . 14.6 t70 -84.07 119.16 72.96 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-N 112.783 -2.008 . . . . 0.0 112.469 -173.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -70.83 -11.54 29.59 Favored 'Trans proline' 0 N--CA 1.449 -1.145 1 C-N-CA 125.534 4.156 . . . . 0.0 111.984 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 127' ' ' LYS . . . . . 0.414 ' HZ2' ' CG ' ' C' ' 125' ' ' ASP . 6.4 ttpm? -77.09 -0.63 25.46 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 119.337 0.971 . . . . 0.0 112.646 176.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 128' ' ' SER . . . . . . . . . . . . . 70.0 m -59.07 121.19 53.52 Favored Pre-proline 0 C--N 1.355 0.824 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 172.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 129' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -58.82 -45.36 29.39 Favored 'Trans proline' 0 C--N 1.353 0.774 1 C-N-CA 126.181 4.587 . . . . 0.0 116.816 173.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 15.0 pt -69.54 92.62 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.716 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 165.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.91 110.2 1.27 Allowed 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 125.801 2.715 . . . . 0.0 112.151 -169.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.89 72.57 0.48 Allowed Glycine 0 N--CA 1.462 0.428 0 CA-C-N 109.11 -3.677 . . . . 0.0 113.411 -176.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 133' ' ' MET . . . . . . . . . . . . . 62.0 tpp -82.69 127.6 69.56 Favored Pre-proline 0 C--O 1.249 1.053 0 CA-C-N 118.207 1.004 . . . . 0.0 110.291 -177.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -78.95 67.37 8.58 Favored 'Trans proline' 0 C--O 1.243 0.746 0 C-N-CA 124.777 3.651 . . . . 0.0 113.275 -174.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 27.7 m -68.96 136.5 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-N 113.414 -1.721 . . . . 0.0 112.464 -177.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 97.4 mt -77.54 153.23 33.57 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.288 -1.778 . . . . 0.0 108.68 -174.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -67.63 59.5 0.06 Allowed 'General case' 0 C--O 1.211 -0.967 0 N-CA-C 118.218 2.673 . . . . 0.0 118.218 -162.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 4.5 p -82.25 20.16 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.254 1.331 0 CA-C-O 123.864 1.792 . . . . 0.0 112.826 -173.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -70.73 133.12 46.32 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.831 -162.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 140' ' ' LYS . . . . . . . . . . . . . 20.3 pttm 36.62 42.32 0.2 Allowed 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 -169.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.13 152.02 41.34 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 120.574 -1.329 . . . . 0.0 112.154 174.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -77.23 -9.21 58.65 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -159.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 143' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -164.49 95.29 0.73 Allowed 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.636 1.574 . . . . 0.0 108.672 169.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 144' ' ' VAL . . . . . . . . . . . . . 21.9 t -89.8 101.0 11.74 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 145' ' ' ILE . . . . . . . . . . . . . 10.1 tp -110.8 102.34 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.352 0 CA-C-O 125.333 2.492 . . . . 0.0 107.359 -166.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 146' ' ' VAL . . . . . . . . . . . . . 28.8 t -95.82 100.67 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 111.728 -2.487 . . . . 0.0 110.998 -168.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 147' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -60.61 115.07 3.35 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 119.752 -1.842 . . . . 0.0 109.845 178.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 148' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -141.1 138.57 33.62 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 166.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 8.4 tpp85 -59.37 -38.98 81.84 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 117.528 -1.225 . . . . 0.0 111.513 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 20.2 m -148.16 164.49 33.76 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 120.936 1.698 . . . . 0.0 108.816 173.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 8.0 tpt -54.88 108.87 0.44 Allowed 'General case' 0 CA--C 1.502 -0.876 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.239 171.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -155.42 124.18 6.07 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.567 -173.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 46.2 m -62.16 136.52 57.98 Favored 'General case' 0 N--CA 1.434 -1.232 0 O-C-N 125.767 1.917 . . . . 0.0 107.889 175.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -76.08 -146.3 1.79 Allowed Glycine 0 N--CA 1.443 -0.855 0 O-C-N 119.641 -1.912 . . . . 0.0 110.371 172.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -60.97 -63.25 1.36 Allowed 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 120.955 -1.321 . . . . 0.0 109.438 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 156' ' ' ALA . . . . . . . . . . . . . . . -83.24 -52.36 6.65 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.899 -176.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 65.31 -85.31 0.08 OUTLIER Glycine 0 CA--C 1.531 1.038 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -165.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . 0.293 17.3 m 30.91 104.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 50.45 12.67 0.1 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -171.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 160' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -53.05 94.73 0.06 OUTLIER Pre-proline 0 C--N 1.35 0.629 0 N-CA-C 117.338 2.348 . . . . 0.0 117.338 -159.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -57.81 -34.42 98.23 Favored 'Trans proline' 0 N--CA 1.482 0.795 0 C-N-CA 123.361 2.708 . . . . 0.0 109.974 -169.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 162' ' ' LEU . . . . . . . . . . . . . 13.3 mt -54.29 -17.99 3.52 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 116.966 2.21 . . . . 0.0 116.966 -176.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 163' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -91.74 -45.14 8.59 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 123.022 1.392 . . . . 0.0 107.756 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -86.47 -51.8 5.97 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 111.446 -2.615 . . . . 0.0 112.732 -158.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 17.1 mmmt -73.2 -176.16 2.08 Favored 'General case' 0 C--O 1.246 0.871 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -157.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -69.5 -70.0 0.31 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.362 1.065 . . . . 0.0 108.168 -165.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -86.45 -19.04 30.21 Favored 'General case' 0 C--N 1.347 0.478 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 175.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 168' ' ' THR . . . . . . . . . . . . 0.275 37.6 m -93.67 86.33 5.13 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -150.47 155.74 40.1 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 123.075 1.417 . . . . 0.0 107.877 -164.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 170' ' ' MET . . . . . . . . . . . . . 76.7 mtm -73.33 140.38 46.68 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 171' ' ' LEU . . . . . . . . . . . . . 40.8 tp -92.18 107.51 19.27 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 103.448 -2.797 . . . . 0.0 103.448 167.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -78.4 102.79 7.95 Favored 'General case' 0 C--O 1.253 1.253 0 CA-C-N 111.902 -2.408 . . . . 0.0 111.279 -174.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . 167.97 175.36 37.65 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.203 175.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 174' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -62.67 149.13 44.39 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 114.422 -0.889 . . . . 0.0 111.4 173.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.57 -59.78 4.84 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 120.088 -1.632 . . . . 0.0 113.651 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.59 -66.47 0.39 Allowed 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 124.579 1.175 . . . . 0.0 108.133 176.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 177' ' ' ALA . . . . . . . . . . . . . . . -48.16 -39.23 20.1 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 117.781 2.511 . . . . 0.0 117.781 -177.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 56.2 m -67.82 -43.34 79.81 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 120.545 1.52 . . . . 0.0 111.301 173.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 179' ' ' VAL . . . . . . . . . . . . . 3.1 t -64.5 -39.68 86.44 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 CA-C-N 121.028 1.74 . . . . 0.0 108.175 175.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -56.78 -45.75 81.94 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 122.786 1.279 . . . . 0.0 112.55 176.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -56.58 -31.22 64.03 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 182' ' ' ILE . . . . . . . . . . . . . 42.9 pt -98.21 -25.81 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 183' ' ' LEU . . . . . . . . . . . . . 2.9 pp -59.44 -20.16 52.93 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 120.287 3.44 . . . . 0.0 120.287 -164.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -126.65 -34.75 2.4 Favored 'General case' 0 CA--C 1.492 -1.28 0 O-C-N 125.371 1.669 . . . . 0.0 107.118 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -73.06 -14.94 61.5 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 120.299 -1.5 . . . . 0.0 114.151 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 186' ' ' LEU . . . . . . . . . . . . . 2.6 pt? . . . . . 0 C--O 1.219 -0.547 0 N-CA-C 119.796 3.258 . . . . 0.0 119.796 -167.96 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 19.6 t-80 . . . . . 0 C--O 1.236 0.346 0 N-CA-C 102.441 -3.17 . . . . 65.739999999999995 102.441 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -67.64 81.47 0.16 Allowed Glycine 0 CA--C 1.544 1.864 0 CA-C-O 123.33 1.516 . . . . 48.659999999999997 111.332 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -116.06 122.92 46.6 Favored 'General case' 0 N--CA 1.419 -1.982 1 N-CA-C 100.1 -4.037 . . . . 44.560000000000002 100.1 175.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1003 ' ' ILE . . . . . . . . . . . . . 30.4 mt -99.13 121.51 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.163 0 N-CA-C 106.024 -1.843 . . . . 34.859999999999999 106.024 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -79.47 135.15 14.76 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 108.35 -1.9 . . . . 30.75 108.35 165.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 32.8 mm -110.82 96.25 27.94 Favored Pre-proline 0 C--O 1.242 0.696 0 N-CA-C 101.564 -3.495 . . . . 32.210000000000001 101.564 170.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -71.6 171.59 16.03 Favored 'Trans proline' 0 CA--C 1.504 -0.992 0 C-N-CA 122.529 2.153 . . . . 32.979999999999997 111.312 170.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1007 ' ' ARG . . . . . . . . . . . . . 19.0 ttp85 -104.32 141.36 36.44 Favored 'General case' 0 C--O 1.258 1.549 0 CA-C-N 110.976 -2.829 . . . . 47.979999999999997 106.726 169.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1008 ' ' GLU . . . . . 0.462 ' CD ' ' HZ1' ' A' 1071 ' ' LYS . 57.1 mm-40 -65.25 143.32 57.88 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 123.456 1.598 . . . . 34.700000000000003 112.699 -178.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 37.7 mtp180 -108.74 22.29 16.12 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-O 123.473 1.606 . . . . 53.369999999999997 113.553 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 30.0 tp -77.96 149.65 34.11 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.588 -1.264 . . . . 45.07 107.588 170.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1011 ' ' THR . . . . . . . . . . . . . 23.5 m -74.77 143.99 43.78 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 122.378 2.354 . . . . 40.359999999999999 110.023 -174.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 32.4 t30 41.64 64.4 1.06 Allowed 'General case' 0 N--CA 1.439 -0.997 0 CA-C-O 125.178 2.418 . . . . 40.609999999999999 113.283 -176.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -134.04 147.61 50.96 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 109.932 -3.304 . . . . 33.759999999999998 104.424 -169.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1014 ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.15 1.1 8.51 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 112.935 0.717 . . . . 27.890000000000001 112.935 177.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1015 ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -68.13 130.57 43.34 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 119.884 -1.76 . . . . 29.02 112.161 -176.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1016 ' ' VAL . . . . . . . . . . . . . 83.9 t -132.17 141.73 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 110.644 -2.98 . . . . 28.129999999999999 103.862 168.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1017 ' ' ALA . . . . . . . . . . . . . . . -56.54 -37.23 70.22 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 118.024 2.601 . . . . 26.870000000000001 118.024 -171.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -136.08 143.01 44.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 120.077 1.308 . . . . 26.77 110.64 -165.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1019 ' ' THR . . . . . . . . . . . . . 75.5 p -77.67 173.4 7.64 Favored Pre-proline 0 C--N 1.346 0.444 0 O-C-N 120.104 -1.622 . . . . 27.02 108.25 163.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1020 ' ' PRO . . . . . . . . . . . . . 2.5 Cg_exo -55.39 -35.3 91.53 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 123.837 3.025 . . . . 30.57 111.741 164.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -62.49 -49.55 74.94 Favored 'General case' 0 C--N 1.358 0.957 0 CA-C-N 118.98 0.809 . . . . 47.810000000000002 110.826 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1022 ' ' THR . . . . . . . . . . . . . 6.7 p -65.74 -29.16 69.63 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.573 0.953 . . . . 30.77 113.573 176.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1023 ' ' VAL . . . . . . . . . . . . . 3.4 t -62.74 -44.83 99.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 107.65 -1.241 . . . . 33.590000000000003 107.65 175.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -59.75 -44.22 93.91 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 117.609 -1.186 . . . . 53.289999999999999 111.847 173.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -54.71 -38.69 67.36 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-N 119.998 1.272 . . . . 46.920000000000002 114.333 170.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1026 ' ' LEU . . . . . . . . . . . . . 91.2 mt -68.75 -38.63 80.27 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 119.141 0.882 . . . . 37.170000000000002 109.278 177.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 12.7 tp -63.83 -43.29 96.62 Favored 'General case' 0 CA--C 1.556 1.183 0 O-C-N 124.074 0.859 . . . . 44.439999999999998 109.064 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -59.67 -41.21 90.13 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 123.292 0.637 . . . . 52.579999999999998 109.698 175.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1029 ' ' LEU . . . . . . . . . . . . . 61.9 mt -72.44 7.23 1.9 Allowed 'General case' 0 C--O 1.253 1.247 0 N-CA-C 116.654 2.094 . . . . 45.689999999999998 116.654 174.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 94.74 -5.19 69.45 Favored Glycine 0 CA--C 1.494 -1.272 0 O-C-N 121.004 -1.06 . . . . 42.090000000000003 112.303 171.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -86.66 137.07 32.76 Favored 'General case' 0 N--CA 1.443 -0.803 0 O-C-N 119.352 -2.264 . . . . 40.719999999999999 106.86 -171.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1032 ' ' THR . . . . . . . . . . . . . 37.8 m -76.69 127.38 32.67 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 104.915 -2.254 . . . . 37.770000000000003 104.915 162.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1033 ' ' VAL . . . . . . . . . . . . . 4.1 t -94.06 133.71 34.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 103.225 -2.88 . . . . 33.539999999999999 103.225 177.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -126.84 116.61 21.12 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 104.803 -2.295 . . . . 31.68 104.803 172.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1035 ' ' VAL . . . . . . . . . . . . . 21.2 t -109.29 142.34 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 O-C-N 120.91 -1.119 . . . . 31.52 109.765 -174.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1036 ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -65.17 139.14 58.64 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.32 -1.363 . . . . 41.039999999999999 107.32 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1037 ' ' SER . . . . . . . . . . . . . 8.6 t -73.56 132.7 43.12 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 106.176 -1.787 . . . . 31.829999999999998 106.176 176.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 100.04 -20.91 47.01 Favored Glycine 0 C--O 1.22 -0.773 0 N-CA-C 109.278 -1.529 . . . . 29.359999999999999 109.278 -175.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -67.73 -34.91 77.79 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 121.484 -1.009 . . . . 27.780000000000001 110.649 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -59.98 -43.18 98.4 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-O 123.429 1.571 . . . . 28.91 110.622 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -52.15 -49.12 64.36 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 112.218 -1.991 . . . . 51.18 113.652 172.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1042 ' ' LEU . . . . . . . . . . . . . 10.7 mt -78.54 -38.47 40.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.541 -1.974 . . . . 29.91 114.119 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1043 ' ' ALA . . . . . . . . . . . . . . . -61.26 -14.95 30.06 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 113.719 1.007 . . . . 28.539999999999999 113.719 169.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1044 ' ' SER . . . . . . . . . . . . . 51.1 m 68.27 34.56 3.81 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 120.246 -1.534 . . . . 33.060000000000002 108.596 173.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1045 ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -161.58 97.74 1.09 Allowed 'General case' 0 C--O 1.247 0.96 0 N-CA-C 101.092 -3.669 . . . . 30.289999999999999 101.092 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -71.92 165.77 23.49 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 120.854 3.65 . . . . 48.619999999999997 120.854 -149.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.42 -53.97 12.58 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 112.35 -2.205 . . . . 36.740000000000002 111.438 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 3.4 pttm -65.02 -39.02 92.79 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-N 121.76 2.073 . . . . 43.729999999999997 111.132 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -62.25 -29.86 70.7 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.398 -1.439 . . . . 32.810000000000002 112.198 175.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1050 ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -62.52 -50.01 73.08 Favored 'General case' 0 C--O 1.255 1.352 0 C-N-CA 120.246 -0.581 . . . . 31.859999999999999 112.494 169.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 11.0 t -62.95 -42.45 96.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 O-C-N 121.101 -0.999 . . . . 33.219999999999999 109.289 -176.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -51.01 -44.87 61.04 Favored 'General case' 0 C--O 1.256 1.434 0 C-N-CA 125.212 1.405 . . . . 50.829999999999998 110.599 172.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -65.87 -44.82 84.27 Favored 'General case' 0 C--O 1.246 0.91 0 CA-C-O 124.819 2.247 . . . . 33.119999999999997 113.016 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 147.56 33.88 0.06 OUTLIER Glycine 0 N--CA 1.464 0.511 0 CA-C-N 113.141 -1.845 . . . . 35.829999999999998 114.553 -177.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -111.04 139.37 46.46 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-N 118.66 1.23 . . . . 34.82 110.138 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -84.09 121.56 27.59 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 103.297 -2.853 . . . . 49.049999999999997 103.297 167.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1057 ' ' ILE . . . . . . . . . . . . . 26.2 mm -85.32 122.49 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 O-C-N 118.105 -2.872 . . . . 38.530000000000001 108.807 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1058 ' ' VAL . . . . . . . . . . . . . 12.0 m -122.31 147.05 26.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 105.4 -2.074 . . . . 42.109999999999999 105.4 -173.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -121.4 135.01 55.11 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 126.026 2.822 . . . . 58.0 111.632 -171.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 57.3 -141.9 43.32 Favored Glycine 0 N--CA 1.465 0.616 0 CA-C-N 110.451 -3.068 . . . . 52.119999999999997 113.444 -176.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 1.4 t30 -48.12 -25.34 1.42 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 116.527 2.047 . . . . 54.75 116.527 -176.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1062 ' ' SER . . . . . . . . . . . . . 15.2 m -60.22 -20.73 60.09 Favored 'General case' 0 CA--C 1.552 1.048 0 N-CA-C 114.028 1.122 . . . . 50.340000000000003 114.028 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 14.9 p -70.03 -48.36 63.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 107.309 -1.367 . . . . 41.460000000000001 107.309 169.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1064 ' ' TRP . . . . . . . . . . . . . 75.4 m95 -65.34 -30.73 71.6 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 124.397 1.079 . . . . 39.32 110.907 -172.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.43 81.05 4.79 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 113.489 -1.687 . . . . 55.380000000000003 109.427 172.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1066 ' ' SER . . . . . . . . . . . . . 68.5 m -145.72 -178.91 6.34 Favored 'General case' 0 C--O 1.242 0.67 0 O-C-N 120.431 -1.418 . . . . 41.869999999999997 111.128 172.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -69.77 -62.81 1.23 Allowed 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.183 -1.414 . . . . 53.200000000000003 107.183 174.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 5.3 mp -107.56 142.17 20.94 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 N-CA-C 105.482 -2.044 . . . . 41.899999999999999 105.482 -178.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1069 ' ' ILE . . . . . . . . . . . . . 5.4 mm -124.38 121.28 61.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 104.177 -2.527 . . . . 38.729999999999997 104.177 168.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1070 ' ' LEU . . . . . . . . . . . . . 77.2 mt -98.74 87.05 3.67 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 104.302 -2.481 . . . . 32.439999999999998 104.302 172.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1071 ' ' LYS . . . . . 0.462 ' HZ1' ' CD ' ' A' 1008 ' ' GLU . 1.1 mmmt -83.59 162.09 20.94 Favored 'General case' 0 C--O 1.257 1.48 0 N-CA-C 105.403 -2.073 . . . . 34.649999999999999 105.403 167.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1072 ' ' VAL . . . . . . . . . . . . . 18.8 t -88.18 -86.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.705 0 C-N-CA 119.588 -0.845 . . . . 31.32 110.844 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -84.4 151.89 24.39 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.133 -1.432 . . . . 33.939999999999998 107.133 -170.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -33.92 120.29 0.5 Allowed Pre-proline 0 C--O 1.253 1.271 0 C-N-CA 125.084 1.353 . . . . 38.039999999999999 114.646 170.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1075 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -56.81 128.2 28.97 Favored 'Trans proline' 0 N--CA 1.441 -1.579 0 C-N-CA 125.074 3.85 . . . . 42.68 114.887 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 33.0 mt -72.88 158.25 35.87 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 120.712 -1.242 . . . . 46.740000000000002 108.295 170.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -45.98 -39.63 9.25 Favored 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 118.515 2.783 . . . . 58.609999999999999 118.515 -176.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 15.7 t70 -61.98 -48.71 79.12 Favored 'General case' 0 C--N 1.352 0.686 0 CA-C-N 119.144 0.884 . . . . 59.200000000000003 109.706 173.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1079 ' ' GLU . . . . . 0.433 ' CD ' ' HZ2' ' A' 1071 ' ' LYS . 35.5 mt-10 -62.88 -32.42 73.66 Favored 'General case' 0 C--O 1.259 1.559 0 CA-C-N 114.024 -1.444 . . . . 50.630000000000003 109.109 -178.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1080 ' ' ILE . . . . . . . . . . . . . 73.7 mt -62.88 -44.51 99.64 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-N 118.899 0.772 . . . . 51.479999999999997 109.59 173.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -62.53 -26.22 68.44 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 119.789 -1.82 . . . . 50.280000000000001 112.321 175.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 15.7 mt -80.96 -24.33 38.16 Favored 'General case' 0 C--O 1.25 1.102 0 O-C-N 119.339 -2.1 . . . . 50.210000000000001 112.206 174.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1083 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.22 120.26 10.01 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 124.477 2.084 . . . . 49.060000000000002 111.501 176.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -82.99 134.81 45.82 Favored Pre-proline 0 CA--C 1.515 -0.385 0 CA-C-N 112.483 -2.144 . . . . 51.079999999999998 111.756 -167.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -48.96 113.18 0.81 Allowed 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 125.106 3.871 . . . . 49.729999999999997 119.159 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 104.31 -27.16 20.41 Favored Glycine 0 N--CA 1.436 -1.309 0 O-C-N 124.9 1.375 . . . . 47.710000000000001 114.021 177.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1087 ' ' THR . . . . . . . . . . . . . 39.4 m -49.92 128.87 19.45 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 118.316 2.71 . . . . 45.469999999999999 118.316 -174.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1088 ' ' THR . . . . . . . . . . . . . 41.2 m -68.77 88.86 0.38 Allowed 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 123.354 1.549 . . . . 42.039999999999999 113.047 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1089 ' ' LEU . . . . . . . . . . . . . 57.2 tp -83.43 98.32 9.44 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 104.291 -2.485 . . . . 38.060000000000002 104.291 -176.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 45.5 t -96.49 109.37 22.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 104.719 -2.326 . . . . 37.399999999999999 104.719 175.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1091 ' ' SER . . . . . . . . . . . . . 13.4 m -152.26 162.91 40.45 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 116.537 2.051 . . . . 36.159999999999997 116.537 -175.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 51.4 t80 -74.33 79.42 1.85 Allowed 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 123.133 1.444 . . . . 38.939999999999998 107.652 170.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 21.8 mm -82.27 -42.72 18.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 126.571 1.948 . . . . 42.170000000000002 114.966 -168.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 2.9 m95 66.67 60.57 0.94 Allowed Pre-proline 0 N--CA 1.436 -1.175 0 C-N-CA 125.113 1.365 . . . . 46.509999999999998 114.625 -174.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.43 -33.44 92.1 Favored 'Trans proline' 0 C--O 1.253 1.269 0 C-N-CA 124.87 3.713 . . . . 49.759999999999998 114.319 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -60.65 -51.8 67.86 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.118 -1.401 . . . . 52.619999999999997 111.61 174.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -78.96 -14.4 59.23 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 115.32 1.6 . . . . 60.740000000000002 115.32 177.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1098 ' ' ASN . . . . . . . . . . . . . 43.6 m-20 -125.36 65.91 51.85 Favored Pre-proline 0 N--CA 1.441 -0.901 0 N-CA-C 115.765 1.765 . . . . 58.189999999999998 115.765 -173.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -66.24 -41.6 12.28 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.715 2.944 . . . . 54.590000000000003 113.308 -175.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.23 -42.09 85.54 Favored 'General case' 0 C--O 1.253 1.237 0 CA-C-O 123.335 1.54 . . . . 63.280000000000001 112.696 176.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1101 ' ' LEU . . . . . . . . . . . . . 21.3 tp -55.78 -37.03 68.03 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 113.162 -1.835 . . . . 54.75 109.928 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1102 ' ' MET . . . . . . . . . . . . . 82.3 mmm -61.06 -45.3 95.34 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 108.667 -0.864 . . . . 52.649999999999999 108.667 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -64.8 -45.0 88.11 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-N 114.642 -1.163 . . . . 66.260000000000005 112.197 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 95.0 mttt -61.62 -41.84 98.04 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 123.132 1.444 . . . . 63.729999999999997 110.352 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 95.8 mt -74.83 -35.5 62.41 Favored 'General case' 0 C--O 1.246 0.884 0 O-C-N 118.485 -2.635 . . . . 54.68 109.227 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -62.84 -38.87 92.51 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 117.427 -1.273 . . . . 53.640000000000001 109.953 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -60.67 -41.19 94.57 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 124.277 0.985 . . . . 67.239999999999995 110.671 169.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 12.0 mmt85 -76.28 -0.05 21.02 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 114.281 1.215 . . . . 65.760000000000005 114.281 173.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 35.7 t30 61.22 15.22 6.2 Favored 'General case' 0 C--N 1.346 0.422 0 N-CA-C 114.431 1.271 . . . . 58.710000000000001 114.431 175.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1110 ' ' VAL . . . . . . . . . . . . . 29.8 m -79.39 132.97 30.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 O-C-N 120.111 -1.618 . . . . 46.630000000000003 108.623 -169.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1111 ' ' THR . . . . . . . . . . . . . 56.5 m -74.72 93.91 2.64 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.509 0.671 . . . . 44.130000000000003 110.02 -176.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1112 ' ' VAL . . . . . . . . . . . . . 38.9 t -92.84 115.97 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 123.874 1.797 . . . . 40.439999999999998 111.376 -170.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1113 ' ' MET . . . . . . . . . . . . . 73.9 mtp -107.86 105.93 15.97 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 104.525 -2.398 . . . . 50.759999999999998 104.525 173.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1114 ' ' ALA . . . . . . . . . . . . . . . -86.63 109.07 18.91 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.399 -0.819 . . . . 35.640000000000001 111.608 -177.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1115 ' ' MET . . . . . . . . . . . . . 90.9 mmm -66.19 -21.59 66.32 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 115.929 1.826 . . . . 38.740000000000002 115.929 -175.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -73.09 -32.84 65.23 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 114.234 -1.348 . . . . 40.140000000000001 109.948 169.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1117 ' ' SER . . . . . . . . . . . . . 29.5 m -82.97 13.19 4.13 Favored 'General case' 0 C--O 1.244 0.772 0 O-C-N 119.777 -1.827 . . . . 44.789999999999999 114.937 -175.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1118 ' ' VAL . . . . . . . . . . . . . 12.0 t -64.14 124.3 85.0 Favored Pre-proline 0 N--CA 1.484 1.26 0 CA-C-O 117.246 -1.359 . . . . 43.75 107.426 169.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -55.88 134.64 65.31 Favored 'Trans proline' 0 C--O 1.242 0.698 0 C-N-CA 124.93 3.753 . . . . 48.93 110.745 173.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 41.8 mmm-85 -69.12 17.56 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 120.018 3.34 . . . . 62.899999999999999 120.018 -163.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 26.9 pt -85.67 171.46 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 C-N-CA 123.344 0.658 . . . . 57.719999999999999 112.562 -165.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1122 ' ' SER . . . . . . . . . . . . . 1.1 p -51.48 -53.79 33.68 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 118.822 -2.424 . . . . 57.259999999999998 114.743 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -64.58 -2.19 2.24 Favored 'General case' 0 C--O 1.248 0.997 0 CA-C-N 121.359 1.89 . . . . 62.899999999999999 115.875 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -106.41 -11.68 15.88 Favored 'General case' 0 C--O 1.2 -1.521 0 CA-C-O 116.381 -1.771 . . . . 49.829999999999998 114.198 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -57.99 -29.36 65.19 Favored 'General case' 0 CA--C 1.488 -1.415 0 N-CA-C 115.628 1.714 . . . . 52.369999999999997 115.628 -170.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1126 ' ' SER . . . . . . . . . . . . . 64.0 p -65.16 -41.14 94.98 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 115.102 1.519 . . . . 42.43 115.102 169.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1127 ' ' LEU . . . . . . . . . . . . . 1.6 mp -81.43 -28.44 34.24 Favored 'General case' 0 C--O 1.208 -1.096 0 CA-C-N 115.492 -0.777 . . . . 43.740000000000002 111.013 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 61.3 t0 -67.88 101.11 1.03 Allowed 'General case' 0 N--CA 1.439 -0.985 0 O-C-N 119.699 -1.876 . . . . 43.210000000000001 110.063 -164.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -74.2 -34.23 63.66 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.963 -0.562 . . . . 35.740000000000002 109.977 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.16 -26.81 66.6 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 119.029 -2.294 . . . . 38.090000000000003 108.627 177.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1131 ' ' SER . . . . . . . . . . . . . 61.9 m -84.92 -56.34 3.62 Favored 'General case' 0 C--O 1.216 -0.677 0 O-C-N 120.928 -1.107 . . . . 36.909999999999997 110.441 168.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1132 ' ' SER . . . . . . . . . . . . . 13.8 m -73.17 -43.72 61.04 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 116.854 2.168 . . . . 35.789999999999999 116.854 -168.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1133 ' ' MET . . . . . . . . . . . . . 53.1 mtp -57.55 -45.45 85.08 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 122.463 1.125 . . . . 30.809999999999999 113.103 169.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1134 ' ' ALA . . . . . . . . . . . . . . . -57.03 -39.17 74.27 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 112.91 -1.95 . . . . 28.879999999999999 111.144 170.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1135 ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -58.54 -51.59 69.25 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 120.389 -1.444 . . . . 40.759999999999998 113.743 175.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1136 ' ' ILE . . . . . . . . . . . . . 14.6 mt -52.34 -46.68 46.35 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 CA-C-O 118.163 -0.923 . . . . 31.539999999999999 108.977 172.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -67.02 -27.11 67.14 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 124.925 1.29 . . . . 29.870000000000001 113.6 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -74.61 -44.2 27.11 Favored Glycine 0 C--N 1.313 -0.713 0 O-C-N 120.865 -1.147 . . . . 28.73 110.812 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 16.1 t80 -61.85 -46.34 89.88 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.206 -1.173 . . . . 30.390000000000001 108.506 171.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1140 ' ' ARG . . . . . 0.413 ' NH2' ' O ' ' B' 1147 ' ' HIS . 5.6 tpt180 -63.33 -29.75 71.0 Favored 'General case' 0 CA--C 1.493 -1.229 0 O-C-N 121.339 -0.851 . . . . 26.09 112.427 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1141 ' ' ALA . . . . . . . . . . . . . . . -63.29 -43.68 97.19 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 119.905 -1.747 . . . . 27.100000000000001 110.674 173.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 47.1 mm -54.3 -45.64 68.3 Favored 'Isoleucine or valine' 0 C--N 1.347 0.488 0 O-C-N 120.693 -1.255 . . . . 28.48 111.77 168.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 25.1 t -62.38 -55.26 25.1 Favored 'Isoleucine or valine' 0 C--O 1.252 1.223 0 CA-C-O 115.88 -2.01 . . . . 23.07 114.243 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1144 ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -70.19 -22.36 62.95 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 123.563 2.892 . . . . 33.399999999999999 110.159 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -63.61 -56.33 16.71 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 119.458 -0.897 . . . . 24.219999999999999 109.708 167.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -59.28 -21.33 59.49 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-O 117.871 -1.061 . . . . 24.890000000000001 112.496 174.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -66.35 -41.51 89.44 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 120.59 1.541 . . . . 26.73 111.691 169.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1148 ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -105.98 -2.62 22.63 Favored 'General case' 0 C--O 1.252 1.207 0 N-CA-C 114.991 1.478 . . . . 39.960000000000001 114.991 -176.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1149 ' ' PHE . . . . . . . . . . . . . 1.3 t80 -70.18 149.03 47.95 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 116.167 -0.469 . . . . 25.870000000000001 111.546 -178.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1150 ' ' GLY . . . . . . . . . . . . . . . -75.71 -49.9 8.51 Favored Glycine 0 N--CA 1.43 -1.702 0 CA-C-N 114.479 -1.237 . . . . 19.280000000000001 113.616 172.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1151 ' ' ARG . . . . . . . . . . . . . 29.1 mtm-85 -97.94 170.68 8.78 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-O 123.308 1.527 . . . . 39.899999999999999 113.865 -168.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1152 ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -72.97 142.63 47.79 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.46 -0.941 . . . . 29.440000000000001 108.46 166.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1153 ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -58.03 -46.87 84.63 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 114.528 1.307 . . . . 32.600000000000001 114.528 168.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1154 ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -72.29 145.92 47.53 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 125.068 1.347 . . . . 34.640000000000001 109.215 -178.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -77.88 65.99 3.15 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 119.214 -2.179 . . . . 37.140000000000001 108.272 169.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -92.1 136.38 33.22 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 107.772 -1.196 . . . . 40.57 107.772 -167.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1157 ' ' ILE . . . . . . . . . . . . . 3.8 tp -96.16 135.58 29.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 105.075 -2.194 . . . . 44.609999999999999 105.075 163.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1158 ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.65 -123.72 0.1 Allowed 'General case' 0 C--O 1.242 0.696 0 CA-C-O 117.171 -1.395 . . . . 40.700000000000003 112.435 173.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -84.18 -45.71 12.65 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 122.034 2.197 . . . . 40.25 106.94 160.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -126.13 153.53 44.42 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 113.261 -1.791 . . . . 38.469999999999999 107.704 170.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . 87.26 103.95 0.85 Allowed Glycine 0 CA--C 1.496 -1.099 0 C-N-CA 119.632 -1.27 . . . . 37.609999999999999 113.559 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1162 ' ' LYS . . . . . 0.488 ' HZ3' ' CD ' ' C' ' 95' ' ' GLU . 1.5 tmtp? -102.53 122.05 43.58 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 126.642 2.025 . . . . 48.899999999999999 106.026 171.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1163 ' ' VAL . . . . . . . . . . . . . 45.8 t -82.0 133.67 51.0 Favored Pre-proline 0 C--O 1.247 0.943 0 CA-C-O 117.451 -1.262 . . . . 36.520000000000003 109.438 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1164 ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -73.3 109.49 2.85 Favored 'Trans proline' 0 N--CA 1.43 -2.248 0 CA-C-N 124.326 2.581 . . . . 35.079999999999998 109.739 160.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1165 ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -50.96 161.74 1.34 Allowed 'Trans proline' 0 N--CA 1.483 0.865 1 C-N-CA 125.957 4.438 . . . . 35.329999999999998 118.696 -169.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -74.54 122.04 22.48 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.863 -1.162 . . . . 34.689999999999998 107.863 -176.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1167 ' ' LYS . . . . . . . . . . . . . 76.6 mttt -88.2 104.99 17.23 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-O 124.007 1.86 . . . . 45.359999999999999 106.628 166.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 58.7 t -94.58 89.99 2.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 113.681 -1.6 . . . . 31.710000000000001 108.259 -175.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1169 ' ' MET . . . . . . . . . . . . . 5.6 ttp -77.9 92.1 4.24 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 113.407 -1.724 . . . . 42.280000000000001 111.828 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 81.0 t -88.79 112.5 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 106.146 -1.798 . . . . 30.510000000000002 106.146 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 57.7 mt -98.24 123.1 50.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 109.631 -0.507 . . . . 31.870000000000001 109.631 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 77.13 81.58 0.6 Allowed Glycine 0 N--CA 1.436 -1.346 0 CA-C-O 122.77 1.206 . . . . 34.539999999999999 113.716 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1173 ' ' ALA . . . . . . . . . . . . . . . -82.07 80.05 8.42 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 111.773 -2.214 . . . . 32.509999999999998 109.212 -172.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -85.09 -157.0 27.14 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 108.056 -2.018 . . . . 29.899999999999999 108.056 163.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1175 ' ' VAL . . . . . . . . . . . . . 67.2 t -74.02 -26.9 21.54 Favored 'Isoleucine or valine' 0 C--O 1.259 1.598 0 CA-C-N 120.378 2.089 . . . . 33.109999999999999 108.765 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -50.22 -47.27 54.95 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.596 0.712 . . . . 28.100000000000001 112.623 162.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -61.25 -52.21 53.18 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 113.475 -1.693 . . . . 28.539999999999999 110.115 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1178 ' ' LEU . . . . . . . . . . . . . 94.3 mt -53.14 -43.89 67.33 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 118.923 1.361 . . . . 31.219999999999999 113.177 178.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -66.47 -34.75 78.62 Favored 'General case' 0 C--O 1.245 0.822 0 O-C-N 118.088 -2.883 . . . . 28.98 114.115 174.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -65.62 -45.74 81.96 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.069 0.85 . . . . 27.829999999999998 109.498 176.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1181 ' ' ILE . . . . . . . . . . . . . 55.6 mt -59.33 -52.68 58.04 Favored 'Isoleucine or valine' 0 C--N 1.349 0.561 0 C-N-CA 124.571 1.148 . . . . 30.25 109.89 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -51.67 -54.88 22.85 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 125.735 1.636 . . . . 29.59 110.53 176.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -65.26 -43.23 91.94 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 114.176 1.176 . . . . 30.289999999999999 114.176 -175.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -68.96 -43.56 74.76 Favored 'General case' 0 N--CA 1.425 -1.699 0 C-N-CA 123.771 0.828 . . . . 30.469999999999999 109.404 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -64.76 -35.61 81.63 Favored 'General case' 0 C--O 1.243 0.755 0 O-C-N 120.693 -1.254 . . . . 42.409999999999997 109.376 173.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1186 ' ' SER . . . . . . . . . . . . . 72.9 m -60.25 -36.95 78.95 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 121.509 1.959 . . . . 39.380000000000003 112.354 169.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 89.4 mt -82.18 18.68 1.33 Allowed 'General case' 0 C--O 1.244 0.791 0 CA-C-N 120.361 1.437 . . . . 36.18 114.001 169.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 78.93 2.35 86.46 Favored Glycine 0 N--CA 1.47 0.952 0 CA-C-N 119.876 1.217 . . . . 33.780000000000001 115.003 170.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -73.34 151.14 41.38 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 124.106 0.962 . . . . 33.93 113.009 -175.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 18.5 mt -86.36 101.67 10.89 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 N-CA-C 103.153 -2.906 . . . . 38.740000000000002 103.153 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 3.0 t -86.99 127.78 40.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 112.921 -1.945 . . . . 33.090000000000003 107.231 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1192 ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -119.85 107.33 13.02 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 106.761 -1.57 . . . . 38.920000000000002 106.761 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -108.39 121.75 45.57 Favored 'General case' 0 C--O 1.248 0.982 0 O-C-N 120.626 -1.297 . . . . 35.32 109.571 -174.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 75.5 t80 -93.85 147.73 22.8 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 105.517 -2.031 . . . . 39.350000000000001 105.517 169.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 7.2 t70 -149.29 157.41 43.32 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 105.874 -1.899 . . . . 40.460000000000001 105.874 154.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1196 ' ' THR . . . . . . . . . . . . . 2.7 m -67.08 -43.39 82.71 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 104.962 -2.236 . . . . 45.939999999999998 104.962 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1197 ' ' ARG . . . . . . . . . . . . . 72.4 mtm180 -72.48 116.69 52.06 Favored Pre-proline 0 N--CA 1.453 -0.322 0 O-C-N 120.966 -1.084 . . . . 56.020000000000003 111.721 -175.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1198 ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -62.05 -26.94 78.78 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 125.244 3.963 . . . . 51.270000000000003 116.826 175.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -54.23 -34.65 61.18 Favored 'General case' 0 C--O 1.248 1.023 0 CA-C-N 114.557 -1.201 . . . . 59.100000000000001 112.598 -176.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 34.6 m -75.35 -10.7 13.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 117.23 2.307 . . . . 51.060000000000002 117.23 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1201 ' ' LYS . . . . . 0.516 ' HZ1' ' CD ' ' A' 1213 ' ' GLU . 83.3 tttt -51.2 -46.21 62.1 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 124.709 1.204 . . . . 57.380000000000003 111.852 -176.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -72.99 -29.79 63.31 Favored 'General case' 0 CA--C 1.512 -0.482 0 O-C-N 120.472 -1.393 . . . . 62.409999999999997 109.845 -173.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -66.3 -42.46 88.27 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.294 -1.373 . . . . 57.780000000000001 107.294 173.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 5.3 t -60.93 -50.23 81.41 Favored 'Isoleucine or valine' 0 C--N 1.344 0.357 0 C-N-CA 124.928 1.291 . . . . 46.380000000000003 109.141 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -56.54 -44.59 81.02 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 114.421 1.267 . . . . 50.700000000000003 114.421 173.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1206 ' ' SER . . . . . . . . . . . . . 48.7 m -58.44 -34.91 71.34 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.028 1.492 . . . . 49.979999999999997 115.028 174.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1207 ' ' MET . . . . . . . . . . . . . 61.4 mtp -92.54 11.02 27.83 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 119.759 -1.838 . . . . 52.990000000000002 111.08 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 78.28 51.19 5.81 Favored Glycine 0 CA--C 1.549 2.218 0 CA-C-O 124.39 2.106 . . . . 47.659999999999997 111.481 168.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -129.67 143.3 50.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 113.059 -1.57 . . . . 44.770000000000003 114.19 171.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -69.84 132.5 46.12 Favored 'General case' 0 C--N 1.347 0.468 0 N-CA-C 105.957 -1.868 . . . . 47.640000000000001 105.957 167.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1211 ' ' PHE . . . . . . . . . . . . . 26.5 t80 -86.76 134.32 33.58 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 104.739 -2.319 . . . . 45.659999999999997 104.739 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 51.7 mt -84.93 109.09 17.9 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 123.719 1.724 . . . . 46.060000000000002 108.41 165.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1213 ' ' GLU . . . . . 0.516 ' CD ' ' HZ1' ' A' 1201 ' ' LYS . 1.9 mm-40 -79.32 145.23 33.57 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 113.703 -1.589 . . . . 60.219999999999999 109.414 -175.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 9.2 tp -79.94 85.36 5.57 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 124.369 2.033 . . . . 57.25 108.953 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 12.3 t70 -76.71 111.89 12.71 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 110.978 -2.828 . . . . 64.430000000000007 104.696 -176.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 33.4 t80 . . . . . 0 CA--C 1.516 -0.362 0 N-CA-C 107.765 -1.198 . . . . 66.900000000000006 107.765 -175.257 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 2.2 p-10 . . . . . 0 N--CA 1.446 -0.663 0 CA-C-O 120.954 0.407 . . . . 39.090000000000003 110.978 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -42.26 -57.07 3.81 Favored Glycine 0 C--O 1.208 -1.492 0 O-C-N 126.427 2.329 . . . . 39.32 113.912 175.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 79.0 t80 -60.9 -47.89 84.34 Favored 'General case' 0 N--CA 1.44 -0.955 0 O-C-N 120.98 -1.306 . . . . 39.299999999999997 110.739 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -63.07 -35.98 82.05 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 120.645 -1.284 . . . . 36.299999999999997 114.42 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -65.4 -59.83 3.61 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 117.695 -1.145 . . . . 37.380000000000003 110.476 176.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -54.23 -47.78 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 121.065 1.757 . . . . 39.109999999999999 114.047 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1230 ' ' MET . . . . . . . . . . . . . 20.3 mmt -90.21 68.61 7.06 Favored 'General case' 0 C--O 1.247 0.933 0 CA-C-O 123.094 1.426 . . . . 49.590000000000003 112.708 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1231 ' ' SER . . . . . . . . . . . . . 1.9 p -142.43 132.69 24.79 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.222 -1.399 . . . . 43.68 107.222 165.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -49.08 -42.37 38.6 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 116.426 2.01 . . . . 55.57 116.426 -172.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -59.57 -39.02 82.72 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 119.109 0.868 . . . . 44.939999999999998 113.158 174.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -55.0 -60.59 3.16 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 114.435 1.272 . . . . 42.039999999999999 114.435 170.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 59.3 mt -57.89 -42.41 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 124.425 2.059 . . . . 46.280000000000001 109.854 -176.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 45.2 tttm -50.86 -53.12 35.07 Favored 'General case' 0 C--O 1.25 1.095 0 CA-C-N 113.289 -1.778 . . . . 47.869999999999997 114.15 166.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -63.47 -33.41 75.51 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 120.419 1.463 . . . . 41.609999999999999 110.703 -176.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -55.13 -59.66 4.46 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 124.883 1.273 . . . . 50.649999999999999 107.708 169.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1239 ' ' MET . . . . . . . . . . . . . 32.7 mtm -56.31 -31.69 63.93 Favored 'General case' 0 C--O 1.238 0.498 0 O-C-N 120.135 -1.603 . . . . 48.869999999999997 113.368 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -64.54 -39.72 94.28 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 112.166 0.432 . . . . 54.799999999999997 112.166 175.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 1.6 mm? -65.6 -46.24 80.12 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 120.598 -1.314 . . . . 43.210000000000001 108.738 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -64.0 -34.38 77.86 Favored 'General case' 0 CA--C 1.508 -0.666 0 O-C-N 126.922 2.639 . . . . 38.659999999999997 112.635 -168.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -59.19 -54.12 50.54 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 120.403 1.456 . . . . 37.920000000000002 113.394 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -67.23 -42.94 83.18 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 119.803 1.183 . . . . 37.280000000000001 110.242 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -54.19 -40.97 68.07 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 121.383 -0.823 . . . . 43.07 112.297 177.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -55.49 -37.08 67.37 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.076 0.95 . . . . 38.299999999999997 112.172 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1247 ' ' LYS . . . . . . . . . . . . . 12.8 ttmm -54.9 -35.93 64.64 Favored 'General case' 0 C--O 1.258 1.517 0 C-N-CA 125.115 1.366 . . . . 47.600000000000001 110.905 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -111.24 -20.29 12.37 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.477 1.288 . . . . 45.420000000000002 114.477 -175.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1249 ' ' VAL . . . . . . . . . . . . . 31.2 m -78.27 162.63 4.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 115.303 1.594 . . . . 36.259999999999998 115.303 -173.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1250 ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -109.42 -60.47 1.77 Allowed 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 115.076 -0.965 . . . . 33.039999999999999 111.381 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1251 ' ' ILE . . . . . . . . . . . . . 36.1 mm -112.76 102.08 13.43 Favored 'Isoleucine or valine' 0 C--O 1.247 0.934 0 N-CA-C 105.709 -1.96 . . . . 31.399999999999999 105.709 -170.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1252 ' ' ILE . . . . . . . . . . . . . 64.9 mt -80.63 117.15 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 104.354 -2.462 . . . . 29.420000000000002 104.354 167.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 18.2 t -103.92 109.75 28.14 Favored 'Isoleucine or valine' 0 C--O 1.248 0.985 0 N-CA-C 100.694 -3.817 . . . . 30.370000000000001 100.694 175.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1254 ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.53 82.4 5.34 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 124.904 2.287 . . . . 35.719999999999999 110.65 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1255 ' ' THR . . . . . . . . . . . . . 1.1 p -86.29 -16.95 35.93 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 112.09 -2.323 . . . . 36.0 115.112 -174.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1256 ' ' ALA . . . . . . . . . . . . . . . -57.81 64.45 0.0 OUTLIER 'General case' 0 C--O 1.261 1.675 0 N-CA-C 116.927 2.195 . . . . 40.93 116.927 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 44.4 tp -83.67 101.14 11.32 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 124.356 2.027 . . . . 47.82 110.369 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 32.8 mm -82.51 120.99 77.87 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-N 111.883 -2.417 . . . . 52.700000000000003 108.24 173.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -72.79 148.7 46.81 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 124.887 3.724 . . . . 54.130000000000003 111.366 175.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 74.69 -88.8 0.74 Allowed Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.699 -0.96 . . . . 54.619999999999997 110.699 176.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 41.1 mttt -56.78 124.93 66.63 Favored Pre-proline 0 CA--C 1.55 0.946 0 O-C-N 121.288 -1.125 . . . . 55.740000000000002 108.194 173.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -57.76 135.31 68.4 Favored 'Trans proline' 0 CA--C 1.521 -0.142 0 C-N-CA 123.306 2.671 . . . . 51.149999999999999 109.483 177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -57.53 130.59 81.44 Favored Pre-proline 0 N--CA 1.482 1.14 0 O-C-N 124.049 0.843 . . . . 46.060000000000002 110.042 -178.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -60.01 143.74 99.54 Favored 'Trans proline' 0 C--O 1.242 0.679 0 C-N-CA 124.187 3.258 . . . . 41.079999999999998 117.17 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -79.65 85.54 5.36 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-O 124.423 2.058 . . . . 47.420000000000002 106.684 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 74.0 mt -84.43 -42.17 15.9 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 109.378 -3.555 . . . . 39.219999999999999 108.848 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 4.0 mp -99.07 108.76 22.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.842 0 N-CA-C 102.242 -3.244 . . . . 42.5 102.242 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1268 ' ' THR . . . . . . . . . . . . . 27.1 p -80.2 163.23 24.2 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 113.931 -1.486 . . . . 37.840000000000003 114.31 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 59.2 mtt-85 -58.27 -39.72 79.98 Favored 'General case' 0 C--O 1.212 -0.921 0 CA-C-N 115.883 -0.599 . . . . 54.799999999999997 110.487 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -60.15 -53.72 54.33 Favored 'General case' 0 N--CA 1.426 -1.654 0 O-C-N 124.851 1.344 . . . . 54.359999999999999 109.443 174.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1271 ' ' MET . . . . . . . . . . . . . 42.1 ttm -58.04 -37.46 74.4 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.087 0.955 . . . . 39.520000000000003 113.423 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1272 ' ' VAL . . . . . . . . . . . . . 13.5 t -67.45 -48.48 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 108.72 -0.844 . . . . 38.25 108.72 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.89 -29.18 70.03 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.491 0.922 . . . . 40.770000000000003 113.491 175.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1274 ' ' SER . . . . . . . . . . . . . 28.6 m -73.94 -12.43 60.65 Favored 'General case' 0 C--O 1.256 1.395 0 O-C-N 120.863 -1.148 . . . . 36.579999999999998 113.81 173.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1275 ' ' MET . . . . . . . . . . . . . 70.3 mtp -63.16 155.77 27.11 Favored 'General case' 0 C--O 1.245 0.854 0 O-C-N 119.084 -2.26 . . . . 36.75 113.601 -177.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1276 ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -61.21 133.52 56.03 Favored 'General case' 0 C--N 1.347 0.471 0 N-CA-C 106.596 -1.631 . . . . 46.109999999999999 106.596 171.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1277 ' ' ALA . . . . . . . . . . . . . . . -71.29 175.15 5.6 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 122.441 1.115 . . . . 33.520000000000003 112.978 -172.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 67.34 28.16 73.62 Favored Glycine 0 C--O 1.22 -0.76 0 O-C-N 120.907 -1.12 . . . . 31.27 111.932 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1279 ' ' SER . . . . . . . . . . . . . 50.4 m -125.75 170.2 11.81 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.389 -1.065 . . . . 32.950000000000003 112.097 -165.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1280 ' ' VAL . . . . . . . . . . . . . 65.2 t -130.82 133.45 63.16 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 O-C-N 119.472 -2.017 . . . . 27.43 108.66 -167.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1281 ' ' ILE . . . . . . . . . . . . . 48.4 mt -110.98 100.75 11.41 Favored 'Isoleucine or valine' 0 C--O 1.251 1.179 0 N-CA-C 103.624 -2.732 . . . . 30.300000000000001 103.624 166.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.64 97.82 7.67 Favored 'Isoleucine or valine' 0 C--O 1.249 1.065 0 N-CA-C 107.108 -1.441 . . . . 28.629999999999999 107.108 176.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 4.4 t70 -86.95 108.72 18.94 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 106.819 -1.549 . . . . 36.270000000000003 106.819 -173.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1284 ' ' LEU . . . . . . . . . . . . . 9.6 tt -80.14 -35.62 36.4 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.88 0.847 . . . . 38.57 109.207 171.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -63.57 -12.71 35.02 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.497 -0.774 . . . . 37.560000000000002 112.765 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . -41.04 -29.51 0.11 Allowed 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 117.011 2.226 . . . . 40.329999999999998 117.011 162.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -51.19 -40.55 58.91 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-O 117.978 -1.01 . . . . 56.850000000000001 110.8 171.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 48.4 t30 -141.45 96.25 2.95 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 118.976 0.807 . . . . 45.859999999999999 110.1 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 92.28 -59.8 2.64 Favored Glycine 0 C--N 1.348 1.196 0 O-C-N 120.305 -1.497 . . . . 40.310000000000002 112.607 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 81.63 128.93 1.03 Allowed Glycine 0 N--CA 1.471 0.975 0 CA-C-N 120.485 2.143 . . . . 38.890000000000001 114.053 -171.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1291 ' ' ASN . . . . . . . . . . . . . 20.3 m120 -82.02 -22.51 36.43 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 116.311 1.967 . . . . 37.229999999999997 116.311 -170.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1292 ' ' CYS . . . . . . . . . . . . . 29.6 t -94.29 144.36 25.59 Favored 'General case' 0 C--O 1.252 1.228 0 N-CA-C 102.461 -3.163 . . . . 36.5 102.461 174.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1293 ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -64.96 -51.46 61.69 Favored 'General case' 0 CA--C 1.56 1.336 0 CA-C-O 122.811 1.291 . . . . 43.32 107.868 172.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -54.78 -18.68 5.06 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 119.916 3.302 . . . . 41.32 119.916 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1295 ' ' THR . . . . . . . . . . . . . 58.4 m -49.75 103.97 0.06 Allowed 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 122.423 1.106 . . . . 35.299999999999997 112.77 167.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 94.6 t -86.1 121.29 72.8 Favored Pre-proline 0 C--O 1.246 0.887 0 N-CA-C 100.913 -3.736 . . . . 34.840000000000003 100.913 164.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -65.49 125.09 13.82 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.855 2.37 . . . . 33.509999999999998 107.597 -176.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 93.42 -3.23 71.84 Favored Glycine 0 N--CA 1.433 -1.556 0 CA-C-O 117.777 -1.568 . . . . 32.189999999999998 113.699 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -130.46 172.28 12.06 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 123.656 3.728 . . . . 34.880000000000003 117.206 -177.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1300 ' ' ILE . . . . . . . . . . . . . 59.3 mt -98.72 98.17 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 101.744 -3.428 . . . . 32.289999999999999 101.744 170.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 61.9 t80 -71.99 148.56 45.82 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 103.905 -2.628 . . . . 37.25 103.905 161.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1302 ' ' THR . . . . . . . . . . . . . 86.4 m -132.46 141.67 48.92 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 105.644 -1.984 . . . . 35.560000000000002 105.644 169.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1303 ' ' THR . . . . . . . . . . . . . 16.8 p -81.23 163.71 22.81 Favored 'General case' 0 N--CA 1.425 -1.693 0 C-N-CA 125.333 1.453 . . . . 36.399999999999999 109.795 168.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -55.84 -49.66 72.7 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 124.924 1.29 . . . . 52.32 109.568 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 39.4 p-10 -66.44 -19.56 65.83 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.854 1.057 . . . . 40.039999999999999 113.854 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 97.94 63.12 0.88 Allowed Glycine 0 N--CA 1.426 -2.025 0 CA-C-N 113.865 -1.516 . . . . 36.960000000000001 112.036 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1307 ' ' VAL . . . . . . . . . . . . . 45.6 t -118.18 114.5 45.38 Favored 'Isoleucine or valine' 0 C--O 1.251 1.158 0 N-CA-C 108.221 -1.029 . . . . 33.399999999999999 108.221 163.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1308 ' ' LYS . . . . . . . . . . . . . 78.2 mttt -92.75 108.19 19.8 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.943 0.878 . . . . 42.909999999999997 112.686 -171.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 14.0 t -94.62 83.43 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 106.025 -1.842 . . . . 32.289999999999999 106.025 -174.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1310 ' ' ILE . . . . . . . . . . . . . 47.8 mt -80.83 91.33 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.35 0 CA-C-N 110.737 -2.938 . . . . 30.989999999999998 108.648 -173.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -87.47 71.17 2.7 Favored Glycine 0 CA--C 1.537 1.442 0 O-C-N 118.284 -2.76 . . . . 28.949999999999999 112.318 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1312 ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -90.63 93.9 9.46 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 118.815 -1.154 . . . . 31.690000000000001 112.529 -172.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1313 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.53 -36.81 62.18 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 112.985 -1.916 . . . . 34.170000000000002 109.756 172.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 29.1 p-10 -84.74 3.87 35.41 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 118.192 2.664 . . . . 36.859999999999999 118.192 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1315 ' ' LEU . . . . . . . . . . . . . 28.7 mt -37.11 -50.85 2.26 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 118.322 2.712 . . . . 34.850000000000001 118.322 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -53.35 -46.82 31.1 Favored 'Trans proline' 0 C--N 1.355 0.9 0 CA-C-N 125.655 3.056 . . . . 29.149999999999999 112.791 171.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -63.41 -29.89 75.93 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 115.097 0.799 . . . . 27.289999999999999 115.097 -175.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1318 ' ' ARG . . . . . . . . . . . . . 52.3 mtt-85 -65.88 -19.94 66.05 Favored 'General case' 0 C--O 1.255 1.376 0 O-C-N 126.348 1.852 . . . . 41.490000000000002 115.345 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1319 ' ' LEU . . . . . . . . . . . . . 13.3 tp -118.2 72.09 9.23 Favored Pre-proline 0 N--CA 1.438 -1.031 0 N-CA-C 105.232 -2.136 . . . . 27.609999999999999 105.232 178.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1320 ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -56.04 -53.82 4.91 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.571 2.847 . . . . 25.940000000000001 114.698 -164.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1321 ' ' THR . . . . . . . . . . . . . 1.8 m -67.64 -39.52 84.63 Favored 'General case' 0 CA--C 1.499 -0.995 0 O-C-N 119.485 -2.009 . . . . 25.010000000000002 110.41 -168.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1322 ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -68.77 -26.57 65.29 Favored 'General case' 0 CA--C 1.511 -0.519 0 O-C-N 118.19 -2.819 . . . . 29.390000000000001 110.838 176.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1323 ' ' SER . . . . . . . . . . . . . 70.6 m -64.59 -53.11 52.9 Favored 'General case' 0 CA--C 1.501 -0.913 0 O-C-N 119.569 -1.957 . . . . 26.469999999999999 109.91 167.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1324 ' ' SER . . . . . . . . . . . . . 4.6 m -55.66 -27.5 50.28 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.96 0.886 . . . . 27.780000000000001 113.001 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -86.54 -51.68 6.03 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 118.319 -1.352 . . . . 37.530000000000001 110.81 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1326 ' ' LEU . . . . . . . . . . . . . 92.9 mt -79.94 -52.2 8.15 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 118.182 -0.913 . . . . 35.710000000000001 111.261 -172.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1327 ' ' TYR . . . . . . . . . . . . . 66.8 t80 -57.47 -43.39 84.02 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.799 0.809 . . . . 31.59 110.99 170.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1328 ' ' GLY . . . . . . . . . . . . . . . -49.72 -50.11 32.4 Favored Glycine 0 N--CA 1.468 0.798 0 CA-C-O 118.149 -1.362 . . . . 28.0 110.816 171.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1329 ' ' THR . . . . . . . . . . . . . 52.4 m -72.5 -27.7 62.43 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 118.76 -1.176 . . . . 32.149999999999999 112.484 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1330 ' ' ASN . . . . . . . . . . . . . 28.5 m120 -60.1 -43.73 95.34 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 118.007 -2.933 . . . . 34.359999999999999 108.957 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1331 ' ' LEU . . . . . . . . . . . . . 27.7 mt -59.79 -48.8 80.21 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 112.774 -2.012 . . . . 33.369999999999997 108.027 177.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1332 ' ' VAL . . . . . . . . . . . . . 77.5 t -54.0 -47.75 64.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 C-N-CA 124.712 1.205 . . . . 35.270000000000003 111.682 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -61.3 -34.09 74.65 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 115.343 1.608 . . . . 37.659999999999997 115.343 -177.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1334 ' ' LEU . . . . . . . . . . . . . 44.2 tp -72.09 -47.3 52.39 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 106.35 -1.722 . . . . 40.270000000000003 106.35 173.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1335 ' ' LEU . . . . . . . . . . . . . 20.2 mt -64.94 -21.05 66.76 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 115.512 1.671 . . . . 42.5 115.512 -176.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1336 ' ' LYS . . . . . . . . . . . . . 94.4 mttt -56.33 -42.93 78.46 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 119.617 -1.927 . . . . 47.810000000000002 112.145 164.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1337 ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.01 -33.69 44.68 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.044 -0.98 . . . . 49.270000000000003 111.318 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1338 ' ' LEU . . . . . . . . . . . . . 8.3 mp -65.86 -37.52 86.39 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 114.075 1.139 . . . . 50.539999999999999 114.075 174.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1339 ' ' CYS . . . . . . . . . . . . . 27.0 m -116.73 87.19 2.64 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 124.301 2.001 . . . . 53.670000000000002 112.538 169.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 96.7 mttt -76.46 -52.8 9.13 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 112.2 -2.273 . . . . 63.380000000000003 108.954 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -74.61 -44.87 48.56 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-O 122.707 1.241 . . . . 70.950000000000003 110.837 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1342 ' ' LYS . . . . . . . . . . . . . 2.8 mtpt 61.41 90.44 0.07 Allowed 'General case' 0 C--O 1.214 -0.766 0 C-N-CA 126.122 1.769 . . . . 65.25 113.336 -173.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1343 ' ' ASP . . . . . . . . . . . . . 24.8 t70 70.27 160.75 0.21 Allowed 'General case' 0 C--O 1.247 0.928 2 O-C-N 111.146 -7.221 . . . . 64.530000000000001 115.526 -6.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1344 ' ' GLY . . . . . . . . . . . . . . . -140.61 2.18 2.18 Favored Glycine 0 N--CA 1.433 -1.501 0 CA-C-O 122.267 0.926 . . . . 59.719999999999999 112.013 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 10.2 t30 -80.03 85.59 5.61 Favored 'General case' 0 C--O 1.247 0.933 0 O-C-N 119.218 -2.342 . . . . 64.090000000000003 106.88 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1346 ' ' ILE . . . . . . . . . . . . . 1.2 pp -54.26 117.18 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 109.877 -3.329 . . . . 58.82 111.176 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1347 ' ' THR . . . . . . . . . . . . . 4.0 m -78.47 96.04 5.29 Favored 'General case' 0 C--N 1.348 0.52 0 N-CA-C 103.779 -2.674 . . . . 54.960000000000001 103.779 -177.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1348 ' ' VAL . . . . . . . . . . . . . 3.5 t -75.96 85.27 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 N-CA-C 104.511 -2.403 . . . . 55.640000000000001 104.511 170.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 33.4 t70 -73.39 150.6 41.63 Favored 'General case' 0 C--O 1.254 1.296 0 CA-C-N 112.065 -2.334 . . . . 61.450000000000003 112.805 -169.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -111.79 -30.16 7.41 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 113.12 -1.855 . . . . 58.630000000000003 108.527 171.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -69.58 -23.47 63.55 Favored 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 120.381 -1.449 . . . . 62.060000000000002 114.21 -159.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 10.1 t70 -91.53 136.66 32.96 Favored 'General case' 0 C--O 1.253 1.254 0 N-CA-C 106.429 -1.693 . . . . 54.07 106.429 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 4.6 m -50.42 -41.47 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 123.671 0.788 . . . . 50.68 112.151 177.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1354 ' ' VAL . . . . . . . . . . . . . 15.2 m -71.83 -41.74 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 C-N-CA 117.137 -1.825 . . . . 47.68 109.143 -175.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1355 ' ' ILE . . . . . . . . . . . . . 26.6 mt -74.13 -29.05 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 120.167 -0.613 . . . . 48.490000000000002 111.697 -176.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 32.6 tpt85 -60.96 -24.75 66.32 Favored 'General case' 0 C--O 1.248 0.983 0 O-C-N 120.047 -1.658 . . . . 48.270000000000003 112.352 170.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -82.97 -32.58 26.05 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-O 123.839 1.8 . . . . 43.530000000000001 110.945 175.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1358 ' ' VAL . . . . . . . . . . . . . 21.7 t -76.1 -46.04 34.87 Favored 'Isoleucine or valine' 0 C--O 1.256 1.433 0 O-C-N 121.636 -0.92 . . . . 45.119999999999997 108.701 -176.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1359 ' ' THR . . . . . . . . . . . . . 22.1 m -64.82 84.83 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 123.788 1.756 . . . . 42.939999999999998 110.474 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 27.2 m -92.22 -34.95 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 114.828 -1.078 . . . . 43.259999999999998 111.883 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1361 ' ' ILE . . . . . . . . . . . . . 79.6 mt -130.86 109.54 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 106.308 -1.738 . . . . 45.659999999999997 106.308 171.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1362 ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -94.82 121.58 36.57 Favored 'General case' 0 C--O 1.207 -1.134 0 O-C-N 118.258 -2.776 . . . . 61.340000000000003 107.826 169.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 45.25 61.15 2.68 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.184 1.179 . . . . 49.759999999999998 114.184 166.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 88.3 -47.52 3.5 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 114.016 -1.447 . . . . 50.0 112.042 -178.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -77.83 130.8 37.12 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 118.12 0.96 . . . . 56.920000000000002 109.293 -173.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1366 ' ' ILE . . . . . . . . . . . . . 31.2 mt -81.34 93.88 2.4 Favored 'Isoleucine or valine' 0 C--O 1.249 1.053 0 N-CA-C 105.02 -2.215 . . . . 52.780000000000001 105.02 177.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1367 ' ' THR . . . . . . . . . . . . . 26.0 p -72.12 -9.91 59.07 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 112.832 -1.985 . . . . 49.439999999999998 113.836 176.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 1.4 t90 -65.28 143.96 98.89 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 106.615 -1.624 . . . . 52.380000000000003 106.615 164.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -67.93 167.7 61.82 Favored 'Cis proline' 0 C--O 1.244 0.82 0 CA-C-N 124.811 2.754 . . . . 46.939999999999998 118.616 2.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -111.3 121.71 39.63 Favored Pre-proline 0 N--CA 1.437 -1.086 0 N-CA-C 106.076 -1.824 . . . . 45.909999999999997 106.076 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1371 ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -51.05 139.52 42.02 Favored 'Trans proline' 0 C--O 1.247 0.959 0 C-N-CA 123.67 2.913 . . . . 46.390000000000001 110.379 174.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -57.44 -31.09 90.33 Favored 'Trans proline' 0 N--CA 1.44 -1.621 0 C-N-CA 124.761 3.641 . . . . 46.719999999999999 112.719 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.231 -4.556 0 O-C-N 119.731 -1.856 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.441 -0.893 0 CA-C-O 117.6 -1.191 . . . . 63.439999999999998 110.644 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -79.68 55.6 2.05 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 123.652 2.933 . . . . 51.740000000000002 111.034 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1000 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.84 125.34 28.61 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 124.488 1.115 . . . . 54.07 111.407 -172.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 65.76 17.77 65.37 Favored Glycine 0 CA--C 1.531 1.079 0 O-C-N 121.688 -0.633 . . . . 39.219999999999999 112.7 -169.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1002 ' ' ARG . . . . . . . . . . . . . 13.7 ttp180 -90.19 118.66 29.88 Favored 'General case' 0 C--O 1.211 -0.939 0 CA-C-N 120.327 2.063 . . . . 38.119999999999997 111.381 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1003 ' ' ILE . . . . . . . . . . . . . 21.8 mt -75.63 150.04 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 112.25 -2.25 . . . . 29.699999999999999 110.36 169.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -123.36 118.39 3.51 Favored Glycine 0 C--O 1.241 0.582 0 N-CA-C 110.472 -1.051 . . . . 27.5 110.472 165.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1005 ' ' ILE . . . . . . . . . . . . . 23.3 mm -97.55 116.81 65.86 Favored Pre-proline 0 CA--C 1.558 1.278 0 N-CA-C 105.915 -1.883 . . . . 24.829999999999998 105.915 173.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -86.81 162.7 9.1 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.709 2.94 . . . . 27.190000000000001 112.446 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -77.59 101.3 6.48 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 102.028 -3.323 . . . . 41.460000000000001 102.028 163.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1008 ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -58.71 140.62 54.5 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-O 122.369 1.081 . . . . 26.93 113.663 -178.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 43.0 mmm-85 -86.89 -25.46 24.43 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.226 -1.352 . . . . 34.479999999999997 109.787 -162.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1010 ' ' LEU . . . . . . . . . . . . . 4.8 tp -59.42 155.64 14.52 Favored 'General case' 0 C--O 1.25 1.093 0 N-CA-C 115.175 1.546 . . . . 44.219999999999999 115.175 -157.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1011 ' ' THR . . . . . . . . . . . . . 28.7 m -61.17 120.06 9.6 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.885 -0.598 . . . . 40.740000000000002 111.155 174.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 67.37 41.53 2.42 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 123.523 1.63 . . . . 44.439999999999998 112.151 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B 1013 ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -102.16 128.4 48.68 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.596 -1.184 . . . . 29.870000000000001 111.687 -175.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1014 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.01 -11.35 7.09 Favored 'General case' 0 C--O 1.247 0.934 0 O-C-N 125.456 1.723 . . . . 25.260000000000002 110.286 176.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -76.97 98.32 4.9 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 120.174 -1.579 . . . . 29.539999999999999 112.633 -175.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1016 ' ' VAL . . . . . . . . . . . . . 44.0 t -96.56 141.95 14.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 105.02 -2.215 . . . . 23.550000000000001 105.02 168.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1017 ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.32 92.93 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 118.307 2.706 . . . . 23.59 118.307 -155.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1018 ' ' ALA . . . . . . . . . . . . . . . -128.12 149.95 50.19 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 119.255 -2.153 . . . . 24.93 111.76 -168.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1019 ' ' THR . . . . . . . . . . . . . 13.2 p -84.9 166.16 33.33 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-O 117.361 -1.304 . . . . 28.09 111.101 165.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -55.02 -39.75 89.35 Favored 'Trans proline' 0 CA--C 1.549 1.241 0 C-N-CA 123.163 2.576 . . . . 28.789999999999999 112.838 165.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 70.7 tttt -57.49 -49.1 77.38 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 120.17 -1.581 . . . . 47.280000000000001 111.144 175.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1022 ' ' THR . . . . . . . . . . . . . 11.8 p -73.64 -27.33 61.2 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 117.068 -1.444 . . . . 30.120000000000001 110.275 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1023 ' ' VAL . . . . . . . . . . . . . 46.0 t -53.2 -50.32 47.1 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 CA-C-N 120.624 1.556 . . . . 32.240000000000002 108.638 165.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1024 ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.4 -35.61 80.99 Favored 'General case' 0 CA--C 1.511 -0.553 0 O-C-N 120.42 -1.425 . . . . 49.619999999999997 113.038 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -63.74 -43.23 97.08 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.438 -0.789 . . . . 44.68 109.849 172.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 19.2 mt -63.79 -35.41 80.49 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 115.651 1.722 . . . . 35.710000000000001 115.651 176.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1027 ' ' LEU . . . . . . . . . . . . . 68.1 mt -62.4 -45.2 94.19 Favored 'General case' 0 C--O 1.237 0.445 0 O-C-N 124.254 0.971 . . . . 42.18 109.937 170.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 62.9 mttm -61.12 -30.06 70.15 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.205 1.187 . . . . 48.340000000000003 114.205 172.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1029 ' ' LEU . . . . . . . . . . . . . 85.6 mt -69.27 -30.98 69.21 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-O 122.978 1.37 . . . . 38.689999999999998 112.832 165.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 113.34 31.6 2.36 Favored Glycine 0 N--CA 1.465 0.576 0 O-C-N 118.518 -2.614 . . . . 32.280000000000001 108.749 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -126.64 112.7 15.78 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 120.551 -1.558 . . . . 35.939999999999998 109.158 -177.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1032 ' ' THR . . . . . . . . . . . . . 15.0 m -71.5 137.55 48.25 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 106.942 -1.503 . . . . 33.369999999999997 106.942 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1033 ' ' VAL . . . . . . . . . . . . . 61.0 t -106.17 119.47 55.6 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 CA-C-N 120.272 1.396 . . . . 29.98 112.774 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -96.07 140.31 30.98 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 106.802 -1.555 . . . . 28.18 106.802 169.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1035 ' ' VAL . . . . . . . . . . . . . 39.8 t -133.36 140.56 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 119.02 -2.3 . . . . 25.82 105.923 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1036 ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -65.63 142.51 58.03 Favored 'General case' 0 C--O 1.247 0.971 0 O-C-N 121.004 -1.06 . . . . 32.439999999999998 112.956 175.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1037 ' ' SER . . . . . . . . . . . . . 24.0 m -59.15 124.35 19.68 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 121.587 -0.695 . . . . 29.539999999999999 111.268 170.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 93.65 -18.08 57.24 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.04 -0.824 . . . . 27.760000000000002 111.04 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1039 ' ' ALA . . . . . . . . . . . . . . . -66.48 -40.4 89.3 Favored 'General case' 0 C--O 1.243 0.759 0 O-C-N 120.778 -1.425 . . . . 26.02 111.495 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -56.09 -51.36 56.22 Favored Glycine 0 CA--C 1.5 -0.891 0 N-CA-C 110.077 -1.209 . . . . 26.469999999999999 110.077 171.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -58.42 -29.49 66.15 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 120.661 -1.494 . . . . 50.979999999999997 113.033 173.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 65.0 mt -70.55 -48.27 56.26 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 123.045 2.657 . . . . 29.300000000000001 110.631 176.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1043 ' ' ALA . . . . . . . . . . . . . . . -63.68 -17.96 63.49 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 114.928 -1.033 . . . . 26.739999999999998 111.834 174.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1044 ' ' SER . . . . . . . . . . . . . 29.0 m 69.11 47.47 0.74 Allowed 'General case' 0 C--N 1.352 0.694 0 CA-C-O 127.408 3.48 . . . . 31.260000000000002 109.813 175.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1045 ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -146.9 105.25 3.78 Favored 'General case' 0 N--CA 1.442 -0.866 1 N-CA-C 97.413 -5.032 . . . . 33.259999999999998 97.413 171.464 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 26.7 t0 -57.46 146.86 28.19 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 123.614 1.673 . . . . 46.740000000000002 115.465 -164.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -49.4 -43.17 44.12 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 110.803 -2.908 . . . . 34.439999999999998 110.091 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -66.14 -28.52 68.86 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.228 -0.92 . . . . 48.670000000000002 113.218 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -66.4 -32.29 73.58 Favored 'General case' 0 C--O 1.246 0.889 0 O-C-N 120.618 -1.301 . . . . 35.259999999999998 111.272 167.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1050 ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -70.98 -33.46 70.45 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 119.334 0.97 . . . . 32.170000000000002 109.005 170.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 76.7 t -58.98 -40.19 79.98 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 O-C-N 119.706 -1.871 . . . . 38.369999999999997 112.726 170.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -61.16 -38.94 88.26 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-O 118.427 -0.797 . . . . 45.770000000000003 112.19 171.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -68.15 -22.92 64.83 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 124.281 0.988 . . . . 37.829999999999998 113.064 172.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 76.34 59.04 3.44 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 109.782 -1.327 . . . . 35.82 109.782 -175.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -109.99 140.63 43.78 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 122.186 0.993 . . . . 33.770000000000003 108.49 166.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -78.34 96.51 5.33 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 118.207 -2.808 . . . . 51.020000000000003 108.887 -175.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1057 ' ' ILE . . . . . . . . . . . . . 34.4 mm -72.97 110.13 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 106.712 -1.588 . . . . 38.469999999999999 106.712 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 2.9 m -127.1 143.78 39.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 112.195 -2.275 . . . . 39.399999999999999 110.988 -174.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -77.44 124.16 27.52 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 122.181 0.991 . . . . 57.07 110.454 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . 50.3 -107.78 0.4 Allowed Glycine 0 CA--C 1.497 -1.074 0 N-CA-C 117.423 1.729 . . . . 44.829999999999998 117.423 164.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 25.9 m120 -63.73 -27.85 69.48 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.911 0.862 . . . . 46.270000000000003 111.934 -164.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1062 ' ' SER . . . . . . . . . . . . . 3.1 m -55.48 -39.96 71.07 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 113.848 -1.524 . . . . 43.469999999999999 111.822 175.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.71 -27.13 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 O-C-N 119.992 -1.692 . . . . 36.979999999999997 113.645 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 96.5 m95 -71.42 -27.49 63.33 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 124.042 1.877 . . . . 37.899999999999999 111.993 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -79.12 80.24 5.48 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 118.744 -2.473 . . . . 46.189999999999998 108.869 176.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1066 ' ' SER . . . . . . . . . . . . . 72.9 m -156.39 165.05 37.46 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.093 -0.958 . . . . 37.060000000000002 109.786 -172.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1067 ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.31 -39.15 25.62 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 114.504 -1.225 . . . . 43.950000000000003 109.236 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B 1068 ' ' ILE . . . . . . . . . . . . . 4.1 mp -123.93 140.45 47.34 Favored 'Isoleucine or valine' 0 C--O 1.251 1.142 0 N-CA-C 104.034 -2.58 . . . . 33.5 104.034 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 43.8 mm -112.31 135.65 51.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 N-CA-C 103.599 -2.741 . . . . 30.57 103.599 165.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1070 ' ' LEU . . . . . . . . . . . . . 84.9 mt -114.27 75.67 0.94 Allowed 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 121.391 1.905 . . . . 27.66 105.913 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1071 ' ' LYS . . . . . . . . . . . . . 4.6 mttm -73.34 152.93 40.72 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 124.371 1.068 . . . . 28.399999999999999 111.656 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1072 ' ' VAL . . . . . . . . . . . . . 15.6 t -94.01 -31.93 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-O 118.967 -0.539 . . . . 23.18 110.729 176.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -111.85 -167.84 1.23 Allowed 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 124.242 1.017 . . . . 25.469999999999999 111.303 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -71.38 162.36 73.21 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 119.166 0.894 . . . . 27.899999999999999 111.902 165.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -76.8 143.77 23.89 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.605 2.203 . . . . 31.620000000000001 113.727 164.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 31.9 mt -88.86 178.14 6.51 Favored 'General case' 0 CA--C 1.555 1.166 0 O-C-N 120.916 -1.115 . . . . 40.490000000000002 109.305 170.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 28.3 t70 -62.16 -31.68 72.2 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 122.418 2.372 . . . . 51.590000000000003 114.691 -172.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -68.7 -39.58 80.43 Favored 'General case' 0 N--CA 1.439 -0.991 0 O-C-N 120.844 -1.16 . . . . 42.359999999999999 112.112 175.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1079 ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -69.58 -35.95 75.83 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.985 -1.007 . . . . 34.530000000000001 109.049 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1080 ' ' ILE . . . . . . . . . . . . . 86.5 mt -59.49 -45.28 93.92 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 C-N-CA 124.447 1.099 . . . . 33.25 110.78 171.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -61.23 -39.6 90.9 Favored 'General case' 0 C--O 1.251 1.166 0 N-CA-C 113.095 0.776 . . . . 36.469999999999999 113.095 173.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1082 ' ' LEU . . . . . . . . . . . . . 51.7 mt -67.25 -34.04 76.6 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 115.365 1.616 . . . . 37.759999999999998 115.365 173.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1083 ' ' LEU . . . . . . . . . . . . . 16.6 mt -56.74 112.01 1.18 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 123.467 1.603 . . . . 37.43 111.045 175.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -69.67 136.07 88.07 Favored Pre-proline 0 C--O 1.219 -0.509 0 CA-C-N 111.754 -2.476 . . . . 37.700000000000003 113.267 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -51.69 109.92 0.37 Allowed 'Trans proline' 0 C--O 1.246 0.896 0 C-N-CA 124.383 3.389 . . . . 35.509999999999998 116.982 171.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 101.72 3.83 52.36 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 113.726 -1.579 . . . . 33.869999999999997 115.253 -172.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1087 ' ' THR . . . . . . . . . . . . . 52.0 m -74.23 127.72 33.69 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-N 119.523 1.661 . . . . 32.5 109.266 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1088 ' ' THR . . . . . . . . . . . . . 1.2 m -62.87 101.23 0.25 Allowed 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 105.312 -2.107 . . . . 30.219999999999999 105.312 170.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1089 ' ' LEU . . . . . . . . . . . . . 43.3 tp -96.85 109.69 22.34 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 104.719 -2.326 . . . . 27.239999999999998 104.719 -176.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 70.3 t -94.05 123.51 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 105.835 -1.913 . . . . 25.390000000000001 105.835 169.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1091 ' ' SER . . . . . . . . . . . . . 58.0 m -156.15 164.62 38.16 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 123.613 1.673 . . . . 28.809999999999999 110.544 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1092 ' ' PHE . . . . . . . . . . . . . 10.8 t80 -93.12 95.85 9.68 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 101.557 -3.498 . . . . 30.780000000000001 101.557 174.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 37.3 mm -83.43 -52.77 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-O 117.349 -1.31 . . . . 30.280000000000001 113.036 -172.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1094 ' ' TRP . . . . . . . . . . . . . 20.9 m95 52.96 75.9 0.59 Allowed Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 118.631 0.65 . . . . 34.07 109.657 -154.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -57.15 -49.51 13.92 Favored 'Trans proline' 0 CA--C 1.511 -0.638 1 C-N-CA 125.707 4.271 . . . . 38.659999999999997 113.502 -171.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -71.52 -14.38 62.09 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 118.643 0.656 . . . . 41.32 111.302 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -103.86 -4.89 22.92 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.794 1.238 . . . . 51.659999999999997 109.59 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -137.53 62.65 37.34 Favored Pre-proline 0 C--O 1.24 0.573 0 O-C-N 120.456 -1.402 . . . . 40.32 109.087 167.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -63.07 -45.94 11.46 Favored 'Trans proline' 0 CA--C 1.536 0.604 1 C-N-CA 128.191 5.927 . . . . 41.560000000000002 113.92 -171.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.14 -38.86 89.17 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 123.945 0.898 . . . . 54.109999999999999 108.84 176.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B 1101 ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.31 -48.76 80.35 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.727 0.775 . . . . 37.880000000000003 109.006 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1102 ' ' MET . . . . . . . . . . . . . 62.1 mmm -53.44 -45.14 69.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.086 -0.961 . . . . 37.539999999999999 112.994 171.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -62.6 -33.1 74.31 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.92 1.082 . . . . 47.009999999999998 113.92 175.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1104 ' ' LYS . . . . . . . . . . . . . 82.0 mttt -73.02 -32.07 64.88 Favored 'General case' 0 C--O 1.213 -0.827 0 O-C-N 119.994 -1.691 . . . . 48.68 111.539 173.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1105 ' ' LEU . . . . . . . . . . . . . 66.6 mt -66.11 -34.51 78.23 Favored 'General case' 0 C--O 1.256 1.447 0 O-C-N 121.609 -0.682 . . . . 32.210000000000001 110.244 174.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -61.18 -46.89 88.64 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 123.209 0.604 . . . . 33.729999999999997 111.541 168.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -58.22 -47.75 82.53 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 125.783 2.706 . . . . 51.469999999999999 117.016 174.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1108 ' ' ARG . . . . . . . . . . . . . 31.6 mmm180 -69.17 -10.54 58.2 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 112.728 -2.033 . . . . 43.899999999999999 111.218 171.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1109 ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.19 42.82 18.02 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 123.504 1.621 . . . . 44.82 111.586 170.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B 1110 ' ' VAL . . . . . . . . . . . . . 12.4 m -93.32 149.89 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 115.032 -0.986 . . . . 30.52 109.124 -177.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1111 ' ' THR . . . . . . . . . . . . . 88.5 m -86.33 92.39 8.79 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.963 -0.754 . . . . 27.120000000000001 108.963 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1112 ' ' VAL . . . . . . . . . . . . . 4.1 t -94.99 124.88 47.68 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 120.297 1.408 . . . . 26.399999999999999 110.781 -168.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1113 ' ' MET . . . . . . . . . . . . . 1.3 mpt? -102.33 115.7 31.11 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 124.388 2.042 . . . . 42.920000000000002 107.932 163.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -93.75 106.93 18.87 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 120.55 -1.344 . . . . 24.149999999999999 110.216 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1115 ' ' MET . . . . . . . . . . . . . 14.2 mmm -63.94 -11.14 25.64 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 117.303 2.334 . . . . 29.949999999999999 117.303 -176.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1116 ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -84.81 -41.86 15.69 Favored 'General case' 0 C--O 1.218 -0.58 0 C-N-CA 123.721 0.809 . . . . 34.530000000000001 109.323 169.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1117 ' ' SER . . . . . . . . . . . . . 25.0 m -91.45 37.49 0.95 Allowed 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 120.066 -1.646 . . . . 33.490000000000002 109.666 -173.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1118 ' ' VAL . . . . . . . . . . . . . 1.8 t -78.38 147.67 72.59 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 103.988 -2.597 . . . . 34.020000000000003 103.988 166.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 1.6 Cg_exo -58.13 165.56 6.87 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.971 2.447 . . . . 38.280000000000001 114.192 169.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1120 ' ' ARG . . . . . 0.466 HH12 ' CG ' ' B' 1128 ' ' ASP . 5.0 mmp_? -92.27 -0.07 57.42 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 120.924 -1.11 . . . . 55.049999999999997 112.186 -178.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B 1121 ' ' ILE . . . . . . . . . . . . . 30.3 pt -68.76 141.82 16.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 119.964 1.256 . . . . 42.090000000000003 108.65 175.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1122 ' ' SER . . . . . . . . . . . . . 5.0 m -58.73 -28.45 65.86 Favored 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 116.982 2.216 . . . . 38.020000000000003 116.982 -158.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1123 ' ' ARG . . . . . . . . . . . . . 19.4 ptt-85 -66.45 -39.59 88.94 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 121.359 1.891 . . . . 34.289999999999999 107.849 174.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1124 ' ' ALA . . . . . . . . . . . . . . . -68.03 -38.44 82.53 Favored 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 106.764 -1.569 . . . . 32.350000000000001 106.764 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1125 ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -51.15 -38.97 55.15 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 118.197 2.666 . . . . 47.170000000000002 118.197 170.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1126 ' ' SER . . . . . . . . . . . . . 3.9 p -69.18 -19.68 63.99 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 122.107 0.956 . . . . 31.710000000000001 113.549 175.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1127 ' ' LEU . . . . . . . . . . . . . 5.2 mp -90.26 -36.06 14.94 Favored 'General case' 0 C--N 1.347 0.48 0 N-CA-C 107.911 -1.144 . . . . 37.0 107.911 173.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1128 ' ' ASP . . . . . 0.466 ' CG ' HH12 ' B' 1120 ' ' ARG . 4.6 t70 -62.88 130.08 43.27 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 125.958 1.703 . . . . 40.399999999999999 115.107 -164.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B 1129 ' ' ALA . . . . . . . . . . . . . . . -72.14 -36.93 69.49 Favored 'General case' 0 C--O 1.255 1.393 0 N-CA-C 106.713 -1.588 . . . . 26.559999999999999 106.713 -176.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 56.9 mt -59.83 -24.63 64.35 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 121.191 1.814 . . . . 30.890000000000001 112.494 -172.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1131 ' ' SER . . . . . . . . . . . . . 93.9 p -69.23 -60.48 2.32 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 106.035 -1.839 . . . . 29.84 106.035 176.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1132 ' ' SER . . . . . . . . . . . . . 16.0 m -62.64 -34.86 77.91 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 115.438 1.644 . . . . 31.91 115.438 -178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1133 ' ' MET . . . . . . . . . . . . . 35.3 mmt -72.68 -36.53 67.91 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.872 0.844 . . . . 25.899999999999999 111.596 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1134 ' ' ALA . . . . . . . . . . . . . . . -60.84 -39.44 89.08 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 115.259 -0.882 . . . . 26.620000000000001 109.959 167.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -60.37 -50.09 74.98 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 117.782 -1.104 . . . . 36.969999999999999 113.738 173.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1136 ' ' ILE . . . . . . . . . . . . . 16.4 mm -53.48 -52.02 36.49 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 O-C-N 124.686 1.241 . . . . 32.109999999999999 108.416 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -61.87 -35.88 79.6 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 114.132 1.16 . . . . 24.140000000000001 114.132 176.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -71.53 -41.55 57.47 Favored Glycine 0 CA--C 1.503 -0.713 0 N-CA-C 109.262 -1.535 . . . . 25.129999999999999 109.262 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 17.8 t80 -61.74 -55.6 28.54 Favored 'General case' 0 C--O 1.211 -0.958 0 O-C-N 120.928 -1.337 . . . . 32.729999999999997 109.689 169.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1140 ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -59.36 -25.18 64.01 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 119.15 0.886 . . . . 26.359999999999999 111.75 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1141 ' ' ALA . . . . . . . . . . . . . . . -62.91 -55.65 24.2 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.466 1.106 . . . . 24.120000000000001 109.971 170.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 21.4 mm -57.94 -40.7 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 107.839 -1.171 . . . . 23.370000000000001 107.839 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 19.4 t -59.29 -66.49 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.662 0 CA-C-O 117.8 -1.095 . . . . 24.960000000000001 112.356 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -61.1 -33.2 72.97 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.518 1.127 . . . . 32.07 112.09 -175.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1145 ' ' ALA . . . . . . . . . . . . . . . -60.54 -59.37 5.5 Favored 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 106.386 -1.709 . . . . 24.870000000000001 106.386 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1146 ' ' ALA . . . . . . . . . . . . . . . -58.27 -33.64 69.62 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 120.577 1.535 . . . . 24.670000000000002 111.727 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1147 ' ' HIS . . . . . 0.413 ' O ' ' NH2' ' A' 1140 ' ' ARG . 73.8 t60 -59.72 -44.63 93.65 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.052 1.341 . . . . 28.579999999999998 111.282 174.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B 1148 ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -96.8 -6.81 35.22 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 122.614 1.197 . . . . 36.82 113.933 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1149 ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -76.26 148.84 37.32 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 113.235 -1.802 . . . . 31.969999999999999 110.263 -176.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B 1150 ' ' GLY . . . . . . . . . . . . . . . -92.73 -19.34 37.72 Favored Glycine 0 N--CA 1.427 -1.964 0 CA-C-N 113.474 -1.694 . . . . 25.489999999999998 115.42 173.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1151 ' ' ARG . . . . . . . . . . . . . 86.5 mtm-85 -121.17 177.22 5.23 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 119.738 1.769 . . . . 59.840000000000003 110.97 -169.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1152 ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -84.99 155.04 21.75 Favored 'General case' 0 C--N 1.352 0.691 0 CA-C-N 121.544 1.975 . . . . 34.450000000000003 108.857 175.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1153 ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -74.93 -46.82 33.22 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.529 -1.214 . . . . 31.170000000000002 109.794 164.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1154 ' ' THR . . . . . . . . . . . . . 22.4 m -71.58 122.64 20.87 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 113.379 -1.737 . . . . 33.890000000000001 109.362 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -75.18 103.47 1.59 Allowed Glycine 0 C--O 1.269 2.287 0 N-CA-C 106.837 -2.505 . . . . 38.950000000000003 106.837 172.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -112.09 112.39 23.97 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 105.638 -1.986 . . . . 54.229999999999997 105.638 -169.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 29.6 mm -81.53 96.88 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 102.954 -2.98 . . . . 51.159999999999997 102.954 172.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1158 ' ' THR . . . . . . . . . . . . . 34.9 m -95.13 153.93 17.42 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 112.841 -1.981 . . . . 49.609999999999999 107.382 -163.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -36.95 -51.35 0.91 Allowed 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 116.64 2.089 . . . . 49.049999999999997 116.64 175.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -55.74 -56.15 23.83 Favored 'General case' 0 C--N 1.349 0.577 0 N-CA-C 114.833 1.42 . . . . 47.649999999999999 114.833 169.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . 177.53 -165.79 35.77 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 108.773 -1.731 . . . . 45.609999999999999 108.773 -175.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 89.3 mttt -95.49 149.46 21.38 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 122.38 1.086 . . . . 57.460000000000001 112.968 -166.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1163 ' ' VAL . . . . . . . . . . . . . 99.1 t -116.69 121.59 32.79 Favored Pre-proline 0 CA--C 1.499 -0.994 0 CA-C-N 113.067 -1.878 . . . . 42.93 106.279 166.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1164 ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.82 137.55 38.61 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.478 2.118 . . . . 39.289999999999999 109.66 168.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1165 ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -62.93 149.08 92.59 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.548 2.832 . . . . 34.170000000000002 113.193 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -73.47 122.1 21.6 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 124.837 1.336 . . . . 31.690000000000001 109.11 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1167 ' ' LYS . . . . . . . . . . . . . 80.4 mttt -79.59 104.05 9.92 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 105.63 -1.989 . . . . 44.780000000000001 105.63 171.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 62.0 t -102.02 99.59 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 N-CA-C 106.69 -1.596 . . . . 31.23 106.69 -170.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1169 ' ' MET . . . . . . . . . . . . . 30.2 ttp -82.29 112.2 19.06 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 119.419 -0.913 . . . . 37.090000000000003 109.132 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 60.0 t -104.03 107.21 21.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 N-CA-C 105.511 -2.033 . . . . 30.170000000000002 105.511 -177.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1171 ' ' ILE . . . . . . . . . . . . . 70.4 mt -97.49 127.17 50.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 108.222 -1.029 . . . . 33.740000000000002 108.222 -177.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 88.72 67.21 1.27 Allowed Glycine 0 C--N 1.318 -0.44 0 CA-C-O 124.502 2.168 . . . . 32.590000000000003 108.458 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1173 ' ' ALA . . . . . . . . . . . . . . . -74.42 42.25 0.16 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 117.975 2.583 . . . . 32.420000000000002 117.975 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -79.78 -155.26 10.03 Favored Glycine 0 CA--C 1.524 0.601 0 O-C-N 117.573 -3.204 . . . . 31.739999999999998 110.397 164.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 86.7 t -48.58 -50.8 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-N 120.762 2.281 . . . . 31.48 115.289 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1176 ' ' ALA . . . . . . . . . . . . . . . -49.46 -50.83 39.42 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 123.591 1.663 . . . . 26.120000000000001 113.324 172.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1177 ' ' GLY . . . . . . . . . . . . . . . -63.73 -49.79 66.16 Favored Glycine 0 C--O 1.211 -1.3 0 CA-C-N 112.748 -2.024 . . . . 25.73 110.765 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1178 ' ' LEU . . . . . . . . . . . . . 46.3 mt -56.59 -33.38 66.14 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 123.94 0.896 . . . . 32.590000000000003 112.718 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -62.34 -57.96 9.42 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.893 -1.049 . . . . 27.719999999999999 110.602 172.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -57.78 -39.78 78.29 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 114.137 1.162 . . . . 26.030000000000001 114.137 177.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1181 ' ' ILE . . . . . . . . . . . . . 96.4 mt -57.06 -45.84 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 108.413 -0.958 . . . . 28.609999999999999 108.413 172.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -55.25 -54.39 34.46 Favored Glycine 0 N--CA 1.465 0.583 0 N-CA-C 110.4 -1.08 . . . . 25.23 110.4 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -56.93 -61.42 2.45 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.276 1.213 . . . . 24.09 114.276 174.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -67.3 -35.73 80.06 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-O 119.178 -0.439 . . . . 26.68 111.504 -169.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -66.91 -45.32 78.28 Favored 'General case' 0 CA--C 1.502 -0.873 0 O-C-N 120.554 -1.341 . . . . 36.57 110.071 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1186 ' ' SER . . . . . . . . . . . . . 61.3 m -66.04 -32.31 73.71 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 119.923 -0.711 . . . . 28.920000000000002 112.823 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1187 ' ' LEU . . . . . . . . . . . . . 25.8 mt -57.87 -23.68 54.13 Favored 'General case' 0 C--O 1.247 0.941 0 N-CA-C 113.4 0.889 . . . . 29.09 113.4 165.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 89.68 20.91 42.04 Favored Glycine 0 CA--C 1.534 1.247 0 N-CA-C 108.593 -1.803 . . . . 29.260000000000002 108.593 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1189 ' ' ALA . . . . . . . . . . . . . . . -82.29 149.64 27.69 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 118.385 -0.817 . . . . 30.16 109.461 174.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 74.8 mt -80.51 90.93 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 120.094 1.315 . . . . 35.810000000000002 108.32 -176.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1191 ' ' VAL . . . . . . . . . . . . . 67.1 t -77.3 109.24 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 105.421 -2.066 . . . . 31.969999999999999 105.421 -172.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1192 ' ' ARG . . . . . 0.442 HH12 ' CD ' ' B' 1248 ' ' GLU . 47.5 mtt180 -101.21 85.58 2.84 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-O 123.776 1.75 . . . . 48.159999999999997 106.911 172.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -93.62 152.91 18.69 Favored 'General case' 0 C--O 1.259 1.598 0 CA-C-N 112.223 -2.262 . . . . 35.890000000000001 112.227 -171.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 87.7 t80 -144.75 148.72 34.45 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 124.567 2.127 . . . . 41.880000000000003 105.592 -176.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1195 ' ' ASP . . . . . . . . . . . . . 22.4 t0 -159.77 154.04 23.65 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 101.513 -3.514 . . . . 38.280000000000001 101.513 163.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1196 ' ' THR . . . . . . . . . . . . . 1.1 m -73.53 -27.16 61.2 Favored 'General case' 0 C--O 1.247 0.942 0 C-N-CA 119.654 -0.818 . . . . 40.619999999999997 111.469 -176.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1197 ' ' ARG . . . . . . . . . . . . . 22.9 mtm105 -73.41 103.37 0.79 Allowed Pre-proline 0 CA--C 1.565 1.542 0 O-C-N 121.079 -1.013 . . . . 53.090000000000003 108.832 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -56.34 -26.2 60.93 Favored 'Trans proline' 0 C--N 1.347 0.481 1 C-N-CA 125.775 4.316 . . . . 42.560000000000002 119.25 -162.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.91 -12.74 19.53 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 119.726 -1.859 . . . . 56.310000000000002 113.828 -177.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B 1200 ' ' VAL . . . . . . . . . . . . . 23.3 m -57.98 -20.88 15.79 Favored 'Isoleucine or valine' 0 C--O 1.25 1.106 0 O-C-N 119.873 -1.767 . . . . 42.909999999999997 112.298 172.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 46.2 tttm -50.55 -55.9 14.1 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 122.901 0.48 . . . . 48.890000000000001 111.712 166.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -70.07 -34.0 72.62 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 120.727 -1.233 . . . . 51.700000000000003 110.488 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1203 ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -50.47 -52.09 41.24 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 120.999 -1.063 . . . . 52.57 111.815 176.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1204 ' ' VAL . . . . . . . . . . . . . 18.6 m -73.42 -36.95 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 O-C-N 121.247 -0.908 . . . . 33.789999999999999 112.16 175.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -53.6 -39.63 65.03 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 114.957 1.465 . . . . 36.579999999999998 114.957 174.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1206 ' ' SER . . . . . . . . . . . . . 84.4 p -60.62 -45.84 92.51 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.45 -1.406 . . . . 39.609999999999999 109.096 175.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1207 ' ' MET . . . . . . . . . . . . . 5.0 mtp -68.6 -18.14 64.26 Favored 'General case' 0 N--CA 1.44 -0.959 0 O-C-N 119.519 -1.988 . . . . 37.450000000000003 113.632 177.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 77.62 56.6 3.82 Favored Glycine 0 N--CA 1.475 1.238 0 N-CA-C 108.686 -1.766 . . . . 31.870000000000001 108.686 -172.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -139.87 159.52 41.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.886 1.274 . . . . 35.399999999999999 111.131 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -90.46 136.21 33.2 Favored 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 120.559 -1.338 . . . . 47.890000000000001 110.038 -165.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 29.1 t80 -86.94 141.7 28.53 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.743 -1.206 . . . . 45.530000000000001 107.743 167.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1212 ' ' LEU . . . . . . . . . . . . . 32.2 mt -81.85 102.92 11.15 Favored 'General case' 0 N--CA 1.433 -1.32 0 O-C-N 121.396 -0.815 . . . . 46.329999999999998 111.02 167.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -83.51 124.48 30.78 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 103.864 -2.643 . . . . 60.409999999999997 103.864 -176.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 4.6 mp -68.32 164.52 20.59 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 114.075 -1.42 . . . . 57.380000000000003 110.108 -177.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 28.0 t70 . . . . . 0 N--CA 1.444 -0.752 0 CA-C-O 116.326 -1.797 . . . . 65.069999999999993 107.083 168.932 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B 1230 ' ' MET . . . . . . . . . . . . . 3.7 mmt . . . . . 0 N--CA 1.435 -1.217 0 N-CA-C 101.725 -3.435 . . . . 80.319999999999993 101.725 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B 1231 ' ' SER . . . . . . . . . . . . 0.275 19.4 m 112.66 155.47 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 3 CA-C-N 130.408 6.003 . . . . 79.920000000000002 115.221 -9.924 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 28.6 t70 -43.12 140.24 1.55 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 116.203 1.927 . . . . 77.909999999999997 116.203 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 67.46 -54.38 0.48 Allowed 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 115.846 1.795 . . . . 73.879999999999995 115.846 -166.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 1.5 t80 -61.23 -21.68 64.09 Favored 'General case' 0 C--O 1.254 1.293 0 CA-C-N 120.096 1.316 . . . . 68.980000000000004 112.92 176.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 1.9 pp -42.05 -38.71 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 O-C-N 120.795 -1.191 . . . . 64.530000000000001 113.361 159.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -69.29 -29.26 67.09 Favored 'General case' 0 CA--C 1.501 -0.919 0 O-C-N 120.124 -1.61 . . . . 66.359999999999999 112.89 174.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -62.4 -31.11 71.74 Favored 'General case' 0 N--CA 1.438 -1.061 0 O-C-N 117.575 -3.203 . . . . 56.600000000000001 111.333 171.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -68.97 -61.41 1.81 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.86 0.864 . . . . 56.789999999999999 111.289 170.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1239 ' ' MET . . . . . . . . . . . . . 14.4 mtt -59.01 -44.79 91.75 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 114.842 1.423 . . . . 53.630000000000003 114.842 -177.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -68.53 -35.38 77.37 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 120.497 1.499 . . . . 51.740000000000002 112.828 -176.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 46.3 tp -54.27 -49.18 70.14 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.983 -1.008 . . . . 44.859999999999999 110.856 166.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 13.0 m-30 -62.68 -38.59 90.99 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 114.096 1.147 . . . . 42.780000000000001 114.096 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -59.3 -41.47 89.08 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 114.685 -1.143 . . . . 40.960000000000001 110.935 170.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -77.55 -8.66 58.15 Favored 'General case' 0 C--O 1.249 1.049 0 O-C-N 120.385 -1.447 . . . . 43.060000000000002 112.361 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -82.23 -26.4 33.28 Favored 'General case' 0 C--O 1.207 -1.14 0 N-CA-C 114.407 1.262 . . . . 46.450000000000003 114.407 164.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -54.69 -38.18 66.7 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 118.941 2.941 . . . . 41.780000000000001 118.941 -167.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 11.9 mptt -68.97 -30.22 68.61 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 115.011 1.485 . . . . 52.200000000000003 115.011 174.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1248 ' ' GLU . . . . . 0.442 ' CD ' HH12 ' B' 1192 ' ' ARG . 33.5 mt-10 -85.09 -39.91 17.4 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 115.055 1.502 . . . . 53.549999999999997 115.055 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B 1249 ' ' VAL . . . . . . . . . . . . 0.266 18.4 m -68.94 135.4 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 124.165 1.936 . . . . 34.409999999999997 115.575 -163.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B 1250 ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -97.57 -48.91 5.07 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 111.969 -2.378 . . . . 33.380000000000003 110.387 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1251 ' ' ILE . . . . . . . . . . . . . 30.1 mm -128.23 126.3 65.77 Favored 'Isoleucine or valine' 0 C--O 1.248 0.988 0 N-CA-C 103.434 -2.802 . . . . 29.539999999999999 103.434 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1252 ' ' ILE . . . . . . . . . . . . . 53.6 mt -90.49 97.91 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 107.013 -1.477 . . . . 32.439999999999998 107.013 159.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1253 ' ' VAL . . . . . . . . . . . . . 4.0 t -83.99 93.05 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 103.181 -2.896 . . . . 30.57 103.181 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1254 ' ' THR . . . . . . . . . . . . 0.353 8.8 t -90.42 84.63 6.01 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 124.207 1.956 . . . . 35.039999999999999 107.158 -178.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B 1255 ' ' THR . . . . . . . . . . . . . 2.7 p -69.73 -16.5 63.33 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 110.927 -2.851 . . . . 34.619999999999997 114.305 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . -57.46 82.84 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 124.172 0.989 . . . . 42.719999999999999 112.773 176.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 3.4 tt -90.82 85.5 6.04 Favored 'General case' 0 CA--C 1.54 0.562 1 N-CA-C 99.175 -4.379 . . . . 52.43 99.175 173.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 2.6 mp -55.5 125.54 60.26 Favored Pre-proline 0 C--N 1.353 0.759 0 O-C-N 120.996 -1.065 . . . . 59.409999999999997 111.144 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -57.31 110.45 0.61 Allowed 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 125.119 3.879 . . . . 62.68 111.928 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 77.73 -79.01 1.45 Allowed Glycine 0 CA--C 1.55 2.238 0 O-C-N 119.846 -1.784 . . . . 64.159999999999997 113.229 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 37.2 mttm -46.44 125.79 7.68 Favored Pre-proline 0 C--O 1.239 0.549 0 CA-C-O 116.535 -1.698 . . . . 68.530000000000001 113.667 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -55.16 120.93 9.0 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 124.027 3.151 . . . . 61.990000000000002 111.068 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1263 ' ' ALA . . . . . . . . . . . . . . . -48.73 122.78 11.19 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 117.402 2.371 . . . . 57.149999999999999 117.402 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -58.26 141.67 96.91 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 124.477 3.451 . . . . 51.57 111.903 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -75.89 82.37 2.8 Favored 'General case' 0 C--O 1.21 -1.026 0 O-C-N 121.13 -0.981 . . . . 54.549999999999997 110.977 -178.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 49.7 mt -74.96 -56.34 4.84 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.352 -1.295 . . . . 46.859999999999999 109.567 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1267 ' ' ILE . . . . . . . . . . . . . 32.1 mm -84.43 89.35 2.56 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 N-CA-C 103.655 -2.72 . . . . 41.039999999999999 103.655 -175.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1268 ' ' THR . . . . . . . . . . . . . 1.1 p -80.63 160.09 25.17 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 113.001 -1.909 . . . . 39.579999999999998 112.286 -176.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1269 ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -53.31 -54.87 30.11 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 117.467 2.395 . . . . 53.149999999999999 117.467 -168.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -55.46 -40.35 71.51 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 125.1 1.5 . . . . 42.960000000000001 113.892 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1271 ' ' MET . . . . . . . . . . . . . 41.6 ttm -56.89 -58.27 8.87 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 117.673 -1.156 . . . . 43.890000000000001 108.394 168.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1272 ' ' VAL . . . . . . . . . . . . . 24.6 t -52.7 -59.83 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.808 0 CA-C-N 120.001 1.273 . . . . 38.369999999999997 111.877 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1273 ' ' ASP . . . . . . . . . . . . 0.265 1.2 m-20 -68.28 14.31 0.07 Allowed 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 120.358 3.466 . . . . 47.460000000000001 120.358 176.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B 1274 ' ' SER . . . . . . . . . . . . . 54.7 p -124.36 -2.28 8.04 Favored 'General case' 0 C--O 1.247 0.93 0 O-C-N 119.956 -1.715 . . . . 38.380000000000003 110.432 170.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1275 ' ' MET . . . . . . . . . . . . . 40.6 mtp -63.88 162.99 12.69 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 114.093 1.145 . . . . 37.810000000000002 114.093 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.06 134.67 52.76 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.182 -0.949 . . . . 49.259999999999998 112.721 175.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -64.84 141.43 58.78 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 123.311 1.529 . . . . 34.460000000000001 113.332 -173.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 70.38 24.23 76.88 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 114.922 -1.035 . . . . 33.530000000000001 112.165 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1279 ' ' SER . . . . . . . . . . . . . 59.0 m -95.7 153.72 17.59 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 122.91 0.484 . . . . 31.309999999999999 109.736 176.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1280 ' ' VAL . . . . . . . . . . . . . 84.4 t -118.01 144.29 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 O-C-N 119.307 -2.12 . . . . 29.32 106.815 -170.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1281 ' ' ILE . . . . . . . . . . . . . 75.8 mt -121.5 120.22 61.21 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 N-CA-C 101.054 -3.684 . . . . 31.93 101.054 170.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1282 ' ' VAL . . . . . . . . . . . . . 12.3 t -108.22 113.58 44.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 105.983 -1.858 . . . . 29.48 105.983 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 5.6 t0 -87.33 102.73 14.79 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-N 113.826 -1.534 . . . . 34.5 110.885 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1284 ' ' LEU . . . . . . . . . . . . . 8.5 mp -69.46 -23.72 63.7 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 113.977 1.103 . . . . 37.939999999999998 113.977 172.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -88.38 16.09 6.89 Favored 'General case' 0 C--N 1.364 1.216 0 O-C-N 121.548 -0.72 . . . . 40.920000000000002 111.454 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -45.42 -37.5 5.16 Favored 'General case' 0 C--O 1.214 -0.786 0 N-CA-C 115.986 1.847 . . . . 44.390000000000001 115.986 174.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1287 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.43 -24.54 39.53 Favored 'General case' 0 C--N 1.313 -1.014 0 O-C-N 119.527 -1.983 . . . . 51.460000000000001 112.047 176.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 1.5 t30 -114.06 64.7 0.66 Allowed 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 125.101 1.361 . . . . 57.75 109.13 -170.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1289 ' ' GLY . . . . . . . . . . . . . . . 92.34 -39.62 2.98 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-O 117.056 -1.969 . . . . 49.850000000000001 114.663 170.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 87.02 117.2 1.1 Allowed Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 120.531 2.166 . . . . 45.93 112.292 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1291 ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -77.25 -29.63 54.08 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 119.761 1.78 . . . . 42.670000000000002 111.03 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1292 ' ' CYS . . . . . . . . . . . . . 40.9 t -95.84 146.03 24.88 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 118.704 -2.497 . . . . 38.82 108.442 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1293 ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -69.74 -38.64 76.9 Favored 'General case' 0 CA--C 1.502 -0.882 0 O-C-N 119.927 -1.733 . . . . 46.710000000000001 114.564 172.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -74.33 -3.84 32.68 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.273 0.842 . . . . 47.229999999999997 113.273 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1295 ' ' THR . . . . . . . . . . . . . 88.2 m -59.6 110.77 1.2 Allowed 'General case' 0 C--O 1.243 0.759 0 CA-C-N 120.077 1.308 . . . . 36.020000000000003 111.238 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 51.2 t -78.34 100.25 0.5 Allowed Pre-proline 0 N--CA 1.44 -0.933 0 CA-C-N 112.604 -2.089 . . . . 37.259999999999998 105.437 163.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -65.46 78.22 0.25 Allowed 'Trans proline' 0 N--CA 1.44 -1.672 0 C-N-CA 125.024 3.816 . . . . 35.090000000000003 112.464 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 169.09 -43.52 0.22 Allowed Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 109.045 -1.622 . . . . 35.969999999999999 109.045 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -134.35 -179.27 5.47 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 115.406 1.632 . . . . 40.390000000000001 115.406 -165.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1300 ' ' ILE . . . . . . . . . . . . . 21.2 mt -82.63 140.6 16.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 107.563 -1.273 . . . . 37.43 107.563 172.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 58.6 t80 -119.96 112.66 19.45 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 104.706 -2.331 . . . . 44.130000000000003 104.706 163.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1302 ' ' THR . . . . . . . . . . . . . 29.4 m -79.72 137.03 36.92 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 119.92 -1.737 . . . . 39.780000000000001 109.623 167.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1303 ' ' THR . . . . . . . . . . . . . 35.7 p -93.32 -179.72 5.15 Favored 'General case' 0 C--O 1.251 1.184 0 N-CA-C 114.54 1.311 . . . . 43.289999999999999 114.54 177.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -75.97 -27.34 57.45 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 120.323 -1.486 . . . . 53.07 109.692 -169.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -84.55 2.55 40.7 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 124.519 2.104 . . . . 43.969999999999999 110.008 173.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 78.63 38.99 22.83 Favored Glycine 0 CA--C 1.539 1.533 0 O-C-N 118.217 -2.802 . . . . 41.119999999999997 113.495 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1307 ' ' VAL . . . . . . . . . . . . . 18.0 t -100.72 127.4 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-O 122.252 1.025 . . . . 38.119999999999997 109.705 172.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1308 ' ' LYS . . . . . . . . . . . . . 98.1 mttt -97.59 99.86 11.26 Favored 'General case' 0 N--CA 1.437 -1.093 0 O-C-N 119.01 -2.306 . . . . 36.340000000000003 109.782 -171.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1309 ' ' VAL . . . . . . . . . . . . . 23.9 t -82.53 99.67 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 106.941 -1.503 . . . . 30.399999999999999 106.941 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1310 ' ' ILE . . . . . . . . . . . . . 72.4 mt -82.82 107.64 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 N-CA-C 106.425 -1.695 . . . . 30.82 106.425 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1311 ' ' GLY . . . . . . . . . . . . . . . -116.0 61.52 0.39 Allowed Glycine 0 C--N 1.354 1.535 0 C-N-CA 118.567 -1.778 . . . . 26.530000000000001 111.6 176.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1312 ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -81.52 123.3 28.52 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 118.526 1.163 . . . . 38.0 108.984 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1313 ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.1 -48.87 70.25 Favored 'General case' 0 C--O 1.256 1.428 0 CA-C-O 123.839 1.78 . . . . 29.800000000000001 108.56 167.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -72.41 16.66 0.13 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 116.453 2.02 . . . . 39.039999999999999 116.453 -176.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1315 ' ' LEU . . . . . . . . . . . . . 25.4 mt -53.72 -43.63 96.48 Favored Pre-proline 0 C--O 1.224 -0.272 0 O-C-N 119.549 -1.969 . . . . 31.079999999999998 113.995 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1316 ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -63.97 -50.97 2.53 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.909 3.073 . . . . 26.100000000000001 112.475 168.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -50.76 -35.39 30.85 Favored Glycine 0 C--N 1.343 0.962 0 C-N-CA 125.867 1.698 . . . . 23.170000000000002 115.015 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 53.3 mtt180 -66.52 -7.22 18.39 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 117.492 2.404 . . . . 40.399999999999999 117.492 177.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 38.4 tp -127.48 117.64 21.39 Favored Pre-proline 0 C--N 1.347 0.488 0 O-C-N 119.395 -2.065 . . . . 23.600000000000001 110.24 -173.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1320 ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.62 -95.48 0.01 OUTLIER 'Trans proline' 0 N--CA 1.481 0.774 0 N-CA-C 121.428 3.588 . . . . 22.350000000000001 121.428 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1321 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.49 -31.25 61.86 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 116.125 1.898 . . . . 26.52 116.125 -162.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B 1322 ' ' GLN . . . . . . . . . . . . . 35.8 tp60 -52.86 -51.3 61.54 Favored 'General case' 0 C--O 1.248 1.018 0 CA-C-N 113.13 -1.85 . . . . 24.379999999999999 109.67 173.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1323 ' ' SER . . . . . . . . . . . . . 8.1 m -62.77 -48.35 79.56 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 118.121 -0.942 . . . . 22.800000000000001 112.578 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1324 ' ' SER . . . . . . . . . . . . . 3.0 m -49.49 -35.7 20.67 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 123.797 1.761 . . . . 21.25 115.263 174.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 45.8 tp60 -78.15 -60.82 2.21 Favored 'General case' 0 CA--C 1.505 -0.788 0 O-C-N 119.587 -1.946 . . . . 31.34 110.571 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1326 ' ' LEU . . . . . . . . . . . . . 12.5 mt -62.7 -59.07 5.41 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 117.182 -1.39 . . . . 31.559999999999999 110.372 -174.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1327 ' ' TYR . . . . . . . . . . . . . 57.9 t80 -63.06 -40.32 97.35 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 119.033 0.833 . . . . 22.73 109.798 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1328 ' ' GLY . . . . . . . . . . . . . . . -42.8 -49.01 6.14 Favored Glycine 0 C--N 1.308 -1.006 0 O-C-N 124.716 1.26 . . . . 21.91 115.122 165.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1329 ' ' THR . . . . . . . . . . . . . 8.7 m -72.56 -35.28 67.95 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 117.669 0.734 . . . . 22.149999999999999 109.631 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1330 ' ' ASN . . . . . . . . . . . . . 9.5 m120 -55.1 -46.07 75.5 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 123.765 0.666 . . . . 26.18 110.362 172.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1331 ' ' LEU . . . . . . . . . . . . . 14.6 mt -66.54 -41.22 89.04 Favored 'General case' 0 C--O 1.253 1.246 0 O-C-N 119.729 -1.857 . . . . 23.68 110.339 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1332 ' ' VAL . . . . . . . . . . . . . 69.7 t -55.09 -48.77 75.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 O-C-N 123.493 0.495 . . . . 26.57 109.807 174.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -62.09 -35.18 77.91 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 124.327 1.051 . . . . 28.079999999999998 112.13 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1334 ' ' LEU . . . . . . . . . . . . . 32.3 tp -64.85 -58.9 4.96 Favored 'General case' 0 CA--C 1.492 -1.256 0 C-N-CA 124.446 1.099 . . . . 27.43 109.818 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1335 ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.11 -39.46 86.26 Favored 'General case' 0 C--O 1.242 0.694 0 O-C-N 124.708 1.255 . . . . 30.5 112.977 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1336 ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -54.64 -44.98 73.68 Favored 'General case' 0 CA--C 1.495 -1.17 0 C-N-CA 124.483 1.113 . . . . 41.649999999999999 113.16 171.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 13.5 tp -85.75 -25.39 26.45 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.26 -0.9 . . . . 42.079999999999998 113.267 -174.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1338 ' ' LEU . . . . . . . . . . . . . 7.3 mt -73.08 -67.97 0.53 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.45 -1.315 . . . . 35.030000000000001 107.45 170.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 43.8 t -85.43 73.23 10.55 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 107.187 -1.412 . . . . 37.329999999999998 107.187 -174.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 61.7 mttp -68.18 -22.28 64.83 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 119.471 -2.018 . . . . 50.509999999999998 111.743 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -78.11 -10.51 59.66 Favored 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 120.271 -1.518 . . . . 54.210000000000001 113.021 174.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 91.3 mttt 52.31 41.99 30.74 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-O 125.793 2.711 . . . . 50.990000000000002 111.787 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -105.73 -43.98 4.77 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 126.196 1.798 . . . . 48.82 109.548 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 132.69 -9.29 5.24 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 109.069 -1.612 . . . . 40.43 109.069 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -82.49 120.8 25.95 Favored 'General case' 0 C--O 1.242 0.665 0 O-C-N 119.256 -2.32 . . . . 47.560000000000002 109.453 175.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1346 ' ' ILE . . . . . . . . . . . . . 31.4 mm -68.11 90.5 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-N 114.171 -1.377 . . . . 42.490000000000002 110.413 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1347 ' ' THR . . . . . . . . . . . . . 92.5 m -74.47 90.88 2.22 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 123.869 1.795 . . . . 38.119999999999997 109.555 -177.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 39.4 t -84.17 90.53 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 106.697 -1.594 . . . . 37.5 106.697 171.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 10.5 t70 -77.7 147.21 35.56 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 109.067 -3.697 . . . . 43.850000000000001 108.409 175.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1350 ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -109.5 -16.83 13.9 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 118.599 -1.24 . . . . 39.810000000000002 113.689 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -91.35 -16.23 27.77 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 114.094 1.146 . . . . 51.289999999999999 114.094 -175.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 54.6 t0 -83.92 116.32 22.73 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 105.027 -2.212 . . . . 39.780000000000001 105.027 158.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 11.1 m -55.5 -25.33 17.51 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 C-N-CA 125.186 1.394 . . . . 39.280000000000001 109.822 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1354 ' ' VAL . . . . . . . . . . . . . 73.9 t -64.48 -50.75 74.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 117.68 -1.152 . . . . 35.700000000000003 110.907 175.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1355 ' ' ILE . . . . . . . . . . . . . 23.1 mm -70.95 -42.39 77.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 119.634 -0.826 . . . . 35.770000000000003 110.563 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 48.5 tpt85 -52.37 -36.91 54.99 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 112.849 -1.978 . . . . 38.549999999999997 113.059 169.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -80.8 -51.05 4.97 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 121.88 2.127 . . . . 29.579999999999998 112.525 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1358 ' ' VAL . . . . . . . . . . . . . 10.6 p -63.27 -35.68 73.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 118.917 1.358 . . . . 32.060000000000002 112.132 -171.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1359 ' ' THR . . . . . . . . . . . . . 14.0 m -84.21 88.22 7.21 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 103.268 -2.864 . . . . 29.0 103.268 -178.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1360 ' ' VAL . . . . . . . . . . . . . 35.7 m -70.83 -25.42 26.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 114.816 -1.083 . . . . 29.68 112.428 -176.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 75.7 mt -139.79 136.92 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 103.121 -2.918 . . . . 32.049999999999997 103.121 175.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1362 ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -120.66 108.82 14.47 Favored 'General case' 0 C--O 1.254 1.318 0 N-CA-C 105.392 -2.077 . . . . 32.520000000000003 105.392 171.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 35.87 77.36 0.04 OUTLIER 'General case' 0 C--O 1.241 0.617 0 N-CA-C 116.335 1.976 . . . . 35.68 116.335 -170.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 80.65 -43.74 2.83 Favored Glycine 0 C--N 1.308 -1.013 0 CA-C-N 114.005 -1.452 . . . . 34.259999999999998 115.005 176.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -68.01 116.05 8.21 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 119.609 1.704 . . . . 51.07 112.04 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 83.5 mt -68.91 110.55 2.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 121.166 -0.959 . . . . 39.869999999999997 109.299 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1367 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.55 -20.14 25.44 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 115.474 1.657 . . . . 38.009999999999998 115.474 168.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B 1368 ' ' TRP . . . . . . . . . . . . . 15.2 t90 -57.71 146.07 67.65 Favored Pre-proline 0 C--O 1.244 0.774 0 C-N-CA 123.281 0.632 . . . . 42.140000000000001 110.767 176.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -78.1 -172.21 10.94 Favored 'Cis proline' 0 C--N 1.369 1.644 0 CA-C-N 121.362 1.522 . . . . 43.259999999999998 115.046 -5.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1370 ' ' ALA . . . . . . . . . . . . . . . -78.8 162.01 66.77 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 114.624 -1.171 . . . . 46.520000000000003 108.72 166.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -59.59 153.01 58.15 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 123.918 3.078 . . . . 51.950000000000003 108.995 162.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -57.53 113.61 1.58 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 1 C-N-CA 126.662 4.908 . . . . 56.270000000000003 115.056 -177.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B 1373 ' ' ILE . . . . . . . . . . . . . 50.7 mm -92.49 120.28 41.5 Favored 'Isoleucine or valine' 0 C--O 1.255 1.377 0 O-C-N 120.715 -1.24 . . . . 60.829999999999998 110.927 -174.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -92.46 127.88 38.11 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.961 -1.126 . . . . 66.099999999999994 107.961 174.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 19.9 t -124.72 118.57 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 113.401 -1.727 . . . . 63.469999999999999 107.693 -170.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.223 -4.906 0 O-C-N 117.774 -3.079 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.582 0 CA-C-O 118.926 -0.559 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -23.76 67.37 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 121.18 1.809 . . . . 0.0 113.323 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 32.7 mp0 -53.91 -50.68 65.84 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 123.107 1.432 . . . . 0.0 110.734 165.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 3.3 m -65.0 -38.21 90.19 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 113.579 -1.646 . . . . 0.0 109.362 -171.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.95 76.13 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-O 124.193 1.949 . . . . 0.0 114.682 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -70.25 -52.22 24.71 Favored 'General case' 0 C--O 1.249 1.076 0 CA-C-N 114.044 -1.434 . . . . 0.0 112.343 172.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 74.8 mt -62.58 -43.08 99.7 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-O 116.965 -1.493 . . . . 0.0 113.368 -175.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 43.7 mt -52.39 -51.32 59.61 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 28' ' ' LYS . . . . . . . . . . . . . 13.3 pttm -65.93 -26.49 67.62 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -72.32 -35.67 68.68 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.304 1.041 . . . . 0.0 110.178 170.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 58.2 m -54.28 -43.99 71.5 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 120.941 3.682 . . . . 0.0 120.941 -167.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 31' ' ' HIS . . . . . . . . . . . . 0.27 56.3 p-80 43.58 -18.22 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 123.418 2.827 . . . . 0.0 117.288 -160.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 19.3 m -136.17 127.32 28.04 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.652 -3.78 . . . . 0.0 104.936 169.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 77.3 t -137.03 126.88 38.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 104.104 -2.554 . . . . 0.0 104.104 -174.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 21.8 mm -109.26 132.91 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 172.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 55.5 mt -98.64 117.06 43.06 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 170.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 89.8 m -113.47 99.78 50.29 Favored Pre-proline 0 N--CA 1.44 -0.971 0 CA-C-O 122.597 1.189 . . . . 0.0 110.779 175.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -81.84 147.26 15.12 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 124.573 3.516 . . . . 0.0 114.973 178.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -159.95 120.29 0.95 Allowed Glycine 0 N--CA 1.415 -2.718 0 N-CA-C 108.014 -2.035 . . . . 0.0 108.014 166.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 4.3 t80 61.45 -67.35 0.06 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.212 1.405 . . . . 0.0 113.839 -175.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -47.85 -43.3 23.12 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-N 121.394 1.906 . . . . 0.0 116.117 -170.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 5.6 ttm -47.24 -46.98 24.79 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 123.097 1.427 . . . . 0.0 113.49 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.16 -56.27 4.34 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.68 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 p -62.81 -30.46 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 N-CA-C 117.392 2.367 . . . . 0.0 117.392 -168.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.18 18.75 17.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.366 -0.833 . . . . 0.0 108.857 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 45' ' ' GLN . . . . . . . . . . . . 0.255 0.1 OUTLIER 35.31 46.73 0.27 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 124.95 2.31 . . . . 0.0 112.899 -158.347 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.81 -20.16 63.46 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 114.203 -1.362 . . . . 0.0 113.523 -175.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.95 -39.13 77.34 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 176.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 48' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -59.2 -41.2 86.45 Favored Pre-proline 0 CA--C 1.553 1.07 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 49' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -67.32 -39.76 12.3 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 123.267 2.645 . . . . 0.0 111.671 164.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 64.2 t -58.93 -33.67 50.48 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 O-C-N 121.57 -0.706 . . . . 0.0 110.304 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.35 -54.07 50.97 Favored 'General case' 0 C--O 1.243 0.739 0 O-C-N 120.308 -1.495 . . . . 0.0 107.386 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -54.94 -37.64 66.7 Favored 'General case' 0 C--O 1.249 1.037 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 9.0 tp -78.05 -44.47 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 O-C-N 121.466 -0.771 . . . . 0.0 111.493 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 88.3 m -59.87 -34.67 73.45 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -58.98 -52.95 63.57 Favored 'General case' 0 C--O 1.266 1.944 0 C-N-CA 124.658 1.183 . . . . 0.0 107.936 -175.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -74.85 -32.96 62.05 Favored 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 120.753 -1.217 . . . . 0.0 112.597 -177.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 93.6 mt -60.87 -42.08 97.21 Favored 'General case' 0 C--O 1.211 -0.93 0 O-C-N 120.659 -1.275 . . . . 0.0 110.566 174.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -78.01 -27.78 49.01 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 119.743 -1.848 . . . . 0.0 110.934 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.05 -34.27 77.69 Favored 'General case' 0 C--N 1.349 0.548 0 O-C-N 121.587 -0.696 . . . . 0.0 109.89 173.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 9.2 ttm-85 -79.61 3.34 19.27 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 118.877 0.762 . . . . 0.0 111.182 174.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.44 36.92 78.46 Favored Glycine 0 C--O 1.251 1.185 0 O-C-N 120.395 -1.441 . . . . 0.0 111.067 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 7.0 mt -85.31 140.15 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -68.3 75.87 0.25 Allowed 'General case' 0 C--O 1.239 0.53 0 O-C-N 121.149 -0.969 . . . . 0.0 109.069 166.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 8.1 p -97.06 118.72 44.03 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 175.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 31.7 mmm-85 -126.2 144.35 50.8 Favored 'General case' 0 C--N 1.312 -1.036 0 O-C-N 124.842 1.339 . . . . 0.0 109.004 -173.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -100.08 98.11 8.87 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 123.666 1.698 . . . . 0.0 112.618 -176.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.88 83.11 1.63 Allowed Glycine 0 C--N 1.34 0.786 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 68' ' ' ILE . . . . . . . . . . . . 0.273 1.7 mp -77.89 112.89 16.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 122.006 0.908 . . . . 0.0 110.989 178.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -86.13 86.54 0.09 OUTLIER Pre-proline 0 N--CA 1.449 -0.477 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 165.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 70' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -48.25 -52.87 7.61 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 125.211 3.94 . . . . 0.0 118.055 -165.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.6 92.07 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 N-CA-C 102.13 -3.285 . . . . 0.0 102.13 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -153.68 104.84 2.74 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 123.224 1.487 . . . . 0.0 113.387 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.94 -98.32 2.35 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 111.723 -2.489 . . . . 0.0 108.149 177.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -128.15 111.89 13.96 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 125.184 1.167 . . . . 0.0 112.549 -170.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 6.7 mp 71.62 134.04 0.04 OUTLIER Pre-proline 0 C--O 1.254 1.322 0 O-C-N 125.766 1.916 . . . . 0.0 112.481 -170.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.35 124.64 12.78 Favored 'Trans proline' 0 N--CA 1.432 -2.091 0 C-N-CA 121.951 1.767 . . . . 0.0 107.708 167.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 78.26 3.94 86.12 Favored Glycine 0 CA--C 1.54 1.626 0 CA-C-N 114.053 -1.431 . . . . 0.0 114.051 169.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 21.3 t-160 -54.49 -31.46 55.93 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -44.15 97.24 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 172.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -65.81 -36.49 83.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 122.413 1.102 . . . . 0.0 109.638 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 51.1 t -61.08 -43.65 96.67 Favored 'Isoleucine or valine' 0 C--N 1.357 0.903 0 CA-C-O 116.815 -1.564 . . . . 0.0 108.594 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 10.9 mp -82.61 -16.97 46.39 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 120.658 1.572 . . . . 0.0 112.104 174.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 15.0 tp -63.42 -32.15 73.51 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 117.492 -3.255 . . . . 0.0 110.576 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.75 -33.73 64.57 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 169.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -67.27 -45.21 77.31 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 120.274 -1.516 . . . . 0.0 113.598 166.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.52 -11.22 41.66 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt 64.78 22.8 12.61 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 169.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 74.9 t -84.55 121.75 74.93 Favored Pre-proline 0 C--O 1.249 1.034 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 173.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -50.39 124.81 13.84 Favored 'Trans proline' 0 N--CA 1.442 -1.541 1 C-N-CA 126.392 4.728 . . . . 0.0 114.339 177.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -63.18 -16.34 59.82 Favored 'General case' 0 C--N 1.363 1.168 0 O-C-N 120.144 -1.598 . . . . 0.0 115.052 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -61.75 -40.04 93.74 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 123.345 0.658 . . . . 0.0 111.485 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 22.5 pt -75.44 -8.29 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 O-C-N 118.023 -2.923 . . . . 0.0 117.387 173.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 16.8 t -88.06 121.47 38.5 Favored 'Isoleucine or valine' 0 C--O 1.248 1.02 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 6.2 mp -104.27 97.26 7.23 Favored 'General case' 0 C--O 1.25 1.107 0 CA-C-N 113.335 -1.757 . . . . 0.0 108.564 168.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 95' ' ' GLU . . . . . 0.488 ' CD ' ' HZ3' ' A' 1162 ' ' LYS . 53.7 mp0 -81.84 93.45 6.87 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 4.0 tpp 56.55 29.57 15.74 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.451 1.9 . . . . 0.0 112.271 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -92.11 172.7 8.25 Favored 'General case' 0 C--O 1.251 1.163 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 173.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -67.7 87.67 0.23 Allowed 'General case' 0 C--N 1.347 0.491 0 CA-C-O 123.724 1.726 . . . . 0.0 113.464 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 6.5 tp -101.29 7.31 9.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-N 110.712 -2.949 . . . . 0.0 110.543 174.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -58.94 -49.11 79.08 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 119.765 -1.834 . . . . 0.0 112.168 -171.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -79.42 -29.54 41.95 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.839 0.828 . . . . 0.0 110.833 -174.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.73 -32.12 73.51 Favored 'General case' 0 N--CA 1.433 -1.319 0 O-C-N 121.051 -1.031 . . . . 0.0 112.826 169.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 103' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -63.22 -48.54 77.86 Favored 'General case' 0 N--CA 1.426 -1.657 0 O-C-N 119.606 -1.934 . . . . 0.0 111.617 169.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.15 -27.67 69.11 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 124.319 1.012 . . . . 0.0 112.959 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -72.16 -40.57 67.89 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.799 1.285 . . . . 0.0 112.179 174.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 106' ' ' THR . . . . . . . . . . . . . 3.1 m -60.6 143.58 53.6 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 112.901 -1.954 . . . . 0.0 114.856 -174.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 107' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -92.56 -62.87 1.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 112.337 -2.21 . . . . 0.0 107.948 175.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 97.0 m -108.44 126.19 52.61 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-O 123.789 1.757 . . . . 0.0 111.134 -178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 109' ' ' VAL . . . . . . . . . . . . . 3.2 t -108.96 119.93 59.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.985 0 CA-C-N 113.191 -1.822 . . . . 0.0 106.73 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 34.7 mt -91.14 91.54 8.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 123.745 1.736 . . . . 0.0 110.019 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 12.0 t -90.87 99.87 10.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 -175.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 26.4 mm -78.86 97.9 2.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 CA-C-N 112.314 -2.221 . . . . 0.0 110.394 -171.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.04 -100.76 1.16 Allowed Glycine 0 C--N 1.334 0.467 0 N-CA-C 107.233 -2.347 . . . . 0.0 107.233 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . 57.41 -56.55 0.03 OUTLIER 'General case' 0 C--O 1.25 1.113 1 N-CA-C 126.336 5.68 . . . . 0.0 126.336 162.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 115' ' ' ASN . . . . . . . . . . . . 0.344 2.7 p-10 24.48 -80.44 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 120.391 3.478 . . . . 0.0 120.391 -169.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 116' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -64.35 -18.38 64.6 Favored 'General case' 0 C--O 1.241 0.648 0 O-C-N 118.067 -2.896 . . . . 0.0 114.36 -177.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 30.8 m -45.66 -35.96 4.52 Favored 'General case' 0 C--O 1.248 0.993 0 C-N-CA 125.627 1.571 . . . . 0.0 111.792 169.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 4.3 m -127.44 20.45 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 O-C-N 120.28 -1.512 . . . . 0.0 113.184 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -73.12 108.36 4.47 Favored Pre-proline 0 C--N 1.32 -0.688 0 O-C-N 119.656 -1.902 . . . . 0.0 111.025 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 120' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -56.3 -27.19 65.65 Favored 'Trans proline' 0 N--CA 1.441 -1.601 0 C-N-CA 125.041 3.827 . . . . 0.0 115.868 -172.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -55.88 -39.16 71.15 Favored 'General case' 0 C--O 1.204 -1.324 0 O-C-N 125.719 1.887 . . . . 0.0 111.874 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 122' ' ' ALA . . . . . . . . . . . . . . . -57.35 -21.86 38.5 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 117.998 2.592 . . . . 0.0 117.998 177.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -102.45 -43.92 5.51 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 117.859 -1.536 . . . . 0.0 112.591 169.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.37 -30.13 47.78 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 122.98 1.372 . . . . 0.0 111.66 -171.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -107.94 101.7 42.18 Favored Pre-proline 0 N--CA 1.429 -1.477 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 -169.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -55.13 -39.06 92.92 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 124.009 3.139 . . . . 0.0 114.26 171.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -53.4 -21.09 5.35 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 128' ' ' SER . . . . . . . . . . . . . 22.3 m -48.1 134.49 11.95 Favored Pre-proline 0 N--CA 1.434 -1.227 0 O-C-N 120.685 -1.26 . . . . 0.0 113.822 172.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 129' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -55.39 -38.0 94.26 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 124.912 3.742 . . . . 0.0 117.777 172.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 130' ' ' ILE . . . . . . . . . . . . 0.291 39.3 pt -77.19 104.64 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.367 168.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.7 115.02 4.37 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 113.125 -1.852 . . . . 0.0 111.363 -168.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 29.56 69.18 0.08 OUTLIER Glycine 0 N--CA 1.473 1.108 0 CA-C-O 116.525 -2.264 . . . . 0.0 114.192 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 133' ' ' MET . . . . . . . . . . . . . 5.9 tpp -96.2 126.22 45.0 Favored Pre-proline 0 N--CA 1.434 -1.247 0 CA-C-N 119.638 1.719 . . . . 0.0 113.344 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -66.54 81.05 0.32 Allowed 'Trans proline' 0 C--O 1.262 1.707 1 C-N-CA 125.696 4.264 . . . . 0.0 107.247 168.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 6.3 m -69.38 137.0 25.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.363 171.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 7.8 tp -78.53 83.42 4.73 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.301 -1.318 . . . . 0.0 113.564 -166.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . 0.28 34.2 mm-40 42.04 -26.44 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.329 1 N-CA-C 128.213 6.375 . . . . 0.0 128.213 160.092 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 4.4 p -73.96 14.78 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.491 0 O-C-N 117.144 -3.472 . . . . 0.0 117.152 -160.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 5.3 p90 -69.19 142.67 54.22 Favored 'General case' 0 C--O 1.244 0.772 0 O-C-N 119.45 -2.031 . . . . 0.0 109.006 176.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.77 24.46 0.34 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 127.055 2.142 . . . . 0.0 116.588 -166.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -101.12 70.47 1.34 Allowed 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 123.154 1.454 . . . . 0.0 110.112 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 64.75 -135.66 0.26 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 112.271 -2.241 . . . . 0.0 114.487 171.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 143' ' ' ASN . . . . . . . . . . . . . 53.8 m-20 -85.57 84.87 7.48 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 118.986 -1.086 . . . . 0.0 109.102 -168.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 144' ' ' VAL . . . . . . . . . . . . . 58.2 t -88.51 88.25 2.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 102.617 -3.105 . . . . 0.0 102.617 -173.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 145' ' ' ILE . . . . . . . . . . . . . 97.4 mt -88.92 97.79 7.31 Favored 'Isoleucine or valine' 0 C--O 1.251 1.171 0 CA-C-O 123.308 1.528 . . . . 0.0 107.802 -173.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 146' ' ' VAL . . . . . . . . . . . . . 48.7 t -85.44 104.22 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 113.298 -1.774 . . . . 0.0 106.967 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 147' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -67.55 91.64 0.29 Allowed 'General case' 0 C--O 1.242 0.661 0 O-C-N 120.625 -1.297 . . . . 0.0 109.646 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 148' ' ' LYS . . . . . 0.428 ' NZ ' ' OD1' ' C' ' 152' ' ' ASN . 15.7 mmmt -118.62 110.45 17.34 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.171 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -64.35 -36.0 82.7 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.046 1.338 . . . . 0.0 109.683 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 10.7 m -139.5 137.41 35.48 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 5.2 tpt -77.35 98.31 5.19 Favored 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 118.791 -2.443 . . . . 0.0 109.007 170.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 152' ' ' ASN . . . . . 0.428 ' OD1' ' NZ ' ' C' ' 148' ' ' LYS . 38.5 p30 -140.68 152.17 45.15 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 110.837 -2.892 . . . . 0.0 108.952 177.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 98.6 m -65.17 120.39 12.62 Favored 'General case' 0 C--N 1.358 0.977 0 O-C-N 125.073 1.483 . . . . 0.0 107.797 176.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -78.58 -115.76 0.21 Allowed Glycine 0 N--CA 1.424 -2.118 0 CA-C-N 112.358 -2.201 . . . . 0.0 108.272 167.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -79.7 -53.65 6.61 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 156' ' ' ALA . . . . . . . . . . . . . . . -92.57 -60.32 1.86 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.362 0.983 . . . . 0.0 108.37 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.46 44.5 93.66 Favored Glycine 0 CA--C 1.492 -1.368 0 CA-C-N 113.544 -1.662 . . . . 0.0 112.257 -176.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 28.4 m -123.37 157.56 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-O 122.309 1.052 . . . . 0.0 112.503 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -30.59 123.67 0.19 Allowed 'General case' 0 C--O 1.242 0.679 1 N-CA-C 122.008 4.077 . . . . 0.0 122.008 178.491 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 160' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -168.22 163.59 8.66 Favored Pre-proline 0 C--O 1.268 2.052 0 C-N-CA 126.088 1.755 . . . . 0.0 109.99 -176.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.74 -36.23 1.66 Allowed 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 124.106 3.204 . . . . 0.0 115.212 169.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 162' ' ' LEU . . . . . . . . . . . . . 8.1 tt -58.07 -35.66 71.7 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -166.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 163' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -70.39 -29.0 65.52 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 118.298 -2.751 . . . . 0.0 113.361 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -102.94 -17.9 15.27 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.169 -1.378 . . . . 0.0 114.206 -162.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -73.64 -177.26 2.65 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.698 1.237 . . . . 0.0 111.986 -170.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -88.63 -63.17 1.34 Allowed 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 120.361 -1.462 . . . . 0.0 109.616 -164.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -86.94 -26.15 24.01 Favored 'General case' 0 C--O 1.243 0.753 0 O-C-N 120.329 -1.482 . . . . 0.0 112.442 170.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 168' ' ' THR . . . . . . . . . . . . . 96.3 m -88.81 91.11 8.69 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 124.45 2.072 . . . . 0.0 105.467 165.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -146.89 137.79 23.91 Favored 'General case' 0 N--CA 1.432 -1.34 0 O-C-N 118.682 -2.511 . . . . 0.0 111.585 -160.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 170' ' ' MET . . . . . . . . . . . . . 54.3 mtm -69.97 107.58 3.66 Favored 'General case' 0 N--CA 1.418 -2.044 0 O-C-N 121.507 -0.746 . . . . 0.0 110.077 162.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 171' ' ' LEU . . . . . . . . . . . . . 7.5 mp -79.22 130.56 35.6 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 172.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -82.5 85.73 6.89 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 125.675 1.86 . . . . 0.0 110.853 -167.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -162.68 150.14 18.86 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 124.561 1.077 . . . . 0.0 111.388 -173.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 174' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -68.07 149.42 49.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.607 -0.796 . . . . 0.0 112.01 176.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.82 -51.67 45.96 Favored 'General case' 0 C--O 1.241 0.653 0 O-C-N 121.329 -0.857 . . . . 0.0 108.879 -175.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.66 -54.5 19.08 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 116.39 -1.767 . . . . 0.0 106.277 178.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 177' ' ' ALA . . . . . . . . . . . . . . . -53.47 -55.99 20.69 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 -174.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 6.4 m -60.71 -37.52 81.98 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 121.622 -0.674 . . . . 0.0 110.869 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 179' ' ' VAL . . . . . . . . . . . . . 50.9 t -67.56 -36.99 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 120.617 -1.302 . . . . 0.0 110.366 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -59.39 -39.17 82.5 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 125.934 1.694 . . . . 0.0 109.661 174.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.34 -52.98 62.41 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 120.926 0.393 . . . . 0.0 110.075 173.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 182' ' ' ILE . . . . . . . . . . . . . 20.8 pt -75.53 -19.77 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 O-C-N 119.592 -1.943 . . . . 0.0 114.106 -175.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 183' ' ' LEU . . . . . . . . . . . . . 4.2 pp -58.57 -44.85 89.87 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 122.106 2.23 . . . . 0.0 115.271 -167.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -96.12 -14.4 22.87 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.575 168.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -80.19 -74.47 0.31 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 119.251 -0.98 . . . . 0.0 111.607 -176.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 186' ' ' LEU . . . . . . . . . . . . 0.301 1.9 pt? . . . . . 0 C--N 1.363 1.158 0 N-CA-C 117.582 2.438 . . . . 0.0 117.582 -171.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 26.4 t-80 . . . . . 0 CA--C 1.512 -0.505 0 N-CA-C 102.757 -3.053 . . . . 65.739999999999995 102.757 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -69.17 78.13 0.3 Allowed Glycine 0 CA--C 1.533 1.176 0 CA-C-O 122.337 0.965 . . . . 48.659999999999997 112.565 -167.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 21.1 ttp180 -125.55 141.06 52.24 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 103.323 -2.843 . . . . 44.560000000000002 103.323 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1003 ' ' ILE . . . . . . . . . . . . . 96.0 mt -105.88 127.07 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 O-C-N 117.995 -2.941 . . . . 34.859999999999999 104.787 169.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -92.89 136.71 13.3 Favored Glycine 0 N--CA 1.434 -1.487 0 CA-C-N 115.463 -0.79 . . . . 30.75 111.419 170.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 37.5 mm -109.87 99.31 38.05 Favored Pre-proline 0 C--O 1.248 0.99 0 N-CA-C 103.75 -2.685 . . . . 32.210000000000001 103.75 173.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -80.57 144.68 15.95 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 124.536 3.491 . . . . 32.979999999999997 112.636 174.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1007 ' ' ARG . . . . . . . . . . . . . 10.0 ttp85 -75.42 155.11 36.68 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 113.25 -1.795 . . . . 47.979999999999997 107.878 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1008 ' ' GLU . . . . . 0.473 ' CD ' ' HZ1' ' A' 1071 ' ' LYS . 4.7 mm-40 -83.9 146.23 28.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 118.409 2.744 . . . . 34.700000000000003 118.409 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -83.45 -30.28 27.37 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 111.704 -2.498 . . . . 53.369999999999997 110.792 166.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 2.5 mp -49.32 135.64 16.96 Favored 'General case' 0 C--O 1.251 1.175 0 C-N-CA 125.024 1.33 . . . . 45.07 113.389 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1011 ' ' THR . . . . . . . . . . . . . 2.3 m -68.95 147.17 52.03 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 123.289 1.518 . . . . 40.359999999999999 107.205 -177.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 10.7 t30 65.06 -17.01 0.09 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 112.795 -2.002 . . . . 40.609999999999999 114.354 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -69.53 112.92 6.37 Favored 'General case' 0 C--O 1.243 0.713 0 O-C-N 119.398 -2.064 . . . . 33.759999999999998 111.049 -165.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1014 ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.36 -13.19 23.43 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 112.727 0.64 . . . . 27.890000000000001 112.727 173.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1015 ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.02 136.88 39.96 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 118.988 -2.32 . . . . 29.02 106.555 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1016 ' ' VAL . . . . . . . . . . . . . 4.2 p -109.72 -178.51 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.101 0 N-CA-C 106.42 -1.696 . . . . 28.129999999999999 106.42 168.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1017 ' ' ALA . . . . . . . . . . . . . . . -68.99 -53.65 19.45 Favored 'General case' 0 C--N 1.309 -1.18 0 O-C-N 120.538 -1.351 . . . . 26.870000000000001 111.817 -176.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -136.03 140.76 44.1 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.675 0.75 . . . . 26.77 112.404 -173.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1019 ' ' THR . . . . . . . . . . . . . 3.4 p -79.6 166.66 39.69 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 124.311 1.044 . . . . 27.02 111.494 172.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1020 ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -51.07 -38.94 60.81 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.614 2.876 . . . . 30.57 114.585 171.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 52.2 mttp -56.1 -48.89 75.29 Favored 'General case' 0 C--O 1.219 -0.541 0 O-C-N 123.965 0.791 . . . . 47.810000000000002 111.802 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1022 ' ' THR . . . . . . . . . . . . . 1.9 p -74.44 -40.08 62.16 Favored 'General case' 0 C--N 1.348 0.505 0 C-N-CA 119.354 -0.938 . . . . 30.77 111.11 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1023 ' ' VAL . . . . . . . . . . . . . 3.3 t -51.65 -42.46 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 113.091 0.775 . . . . 33.590000000000003 113.091 170.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -59.4 -43.77 92.94 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 124.278 1.031 . . . . 53.289999999999999 109.545 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -69.06 -40.38 78.56 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 125.294 1.438 . . . . 46.920000000000002 110.014 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1026 ' ' LEU . . . . . . . . . . . . . 91.0 mt -54.51 -46.49 73.51 Favored 'General case' 0 C--O 1.248 0.974 0 C-N-CA 124.036 0.934 . . . . 37.170000000000002 112.364 171.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 14.3 mt -57.85 -43.0 85.6 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-O 118.177 -0.916 . . . . 44.439999999999998 111.922 170.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 55.7 mmtt -60.38 -20.29 58.98 Favored 'General case' 0 C--O 1.257 1.493 0 C-N-CA 124.296 1.039 . . . . 52.579999999999998 113.714 174.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1029 ' ' LEU . . . . . . . . . . . . . 32.3 mt -78.35 24.31 0.27 Allowed 'General case' 0 N--CA 1.472 0.67 0 O-C-N 119.617 -1.927 . . . . 45.689999999999998 114.791 164.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 68.94 13.75 66.99 Favored Glycine 0 C--N 1.343 0.933 0 O-C-N 119.899 -1.75 . . . . 42.090000000000003 113.546 -176.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -93.29 159.44 15.27 Favored 'General case' 0 C--O 1.251 1.176 0 CA-C-N 121.91 2.855 . . . . 40.719999999999999 110.928 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1032 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.95 155.2 19.96 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 103.707 -2.701 . . . . 37.770000000000003 103.707 158.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1033 ' ' VAL . . . . . . . . . . . . . 87.2 t -135.51 131.3 51.11 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 O-C-N 120.037 -1.665 . . . . 33.539999999999999 108.511 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -116.07 143.59 45.26 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 119.217 0.917 . . . . 31.68 109.46 171.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1035 ' ' VAL . . . . . . . . . . . . . 80.0 t -128.77 137.0 58.46 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.52 0 O-C-N 119.452 -2.03 . . . . 31.52 108.273 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1036 ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -73.3 119.43 17.52 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 119.542 -1.974 . . . . 41.039999999999999 108.419 174.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1037 ' ' SER . . . . . . . . . . . . . 19.7 t -63.49 144.18 57.2 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.853 0.835 . . . . 31.829999999999998 110.072 -171.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 110.27 -31.61 7.29 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 107.378 -2.289 . . . . 29.359999999999999 107.378 -169.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -52.44 -34.03 46.77 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.456 1.28 . . . . 27.780000000000001 114.456 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -60.6 -48.85 84.14 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 120.306 1.412 . . . . 28.91 112.25 172.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -65.05 -31.72 73.09 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 114.507 -0.847 . . . . 51.18 112.518 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1042 ' ' LEU . . . . . . . . . . . . . 8.9 mp -67.91 -66.9 0.51 Allowed 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.587 0.708 . . . . 29.91 109.407 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1043 ' ' ALA . . . . . . . . . . . . . . . -66.36 -5.54 11.11 Favored 'General case' 0 N--CA 1.439 -1.0 0 O-C-N 121.239 -0.913 . . . . 28.539999999999999 111.496 -171.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1044 ' ' SER . . . . . . . . . . . . . 16.6 m 62.45 72.59 0.49 Allowed 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 126.967 3.27 . . . . 33.060000000000002 110.077 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1045 ' ' PHE . . . . . . . . . . . . . 1.9 t80 -157.57 155.03 29.49 Favored 'General case' 0 N--CA 1.423 -1.784 1 CA-C-N 108.063 -4.153 . . . . 30.289999999999999 101.896 -172.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 10.7 t0 -68.18 123.83 21.77 Favored 'General case' 0 N--CA 1.439 -0.999 0 O-C-N 120.394 -1.441 . . . . 48.619999999999997 109.688 171.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.65 -49.34 77.93 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 122.811 1.291 . . . . 36.740000000000002 111.69 176.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.01 -13.71 62.35 Favored 'General case' 0 N--CA 1.434 -1.273 0 O-C-N 119.031 -2.293 . . . . 43.729999999999997 112.081 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -65.19 -15.63 62.65 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 116.957 -1.497 . . . . 32.810000000000002 113.904 168.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1050 ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -65.82 -47.0 76.51 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 106.464 -1.68 . . . . 31.859999999999999 106.464 167.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 76.6 t -60.71 -38.55 78.99 Favored 'Isoleucine or valine' 0 C--O 1.254 1.318 0 CA-C-O 118.266 -0.873 . . . . 33.219999999999999 111.242 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -52.91 -50.58 63.66 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 119.398 0.999 . . . . 50.829999999999998 113.009 171.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -61.37 -33.89 74.39 Favored 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 124.339 1.056 . . . . 33.119999999999997 112.213 173.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 114.24 15.96 8.05 Favored Glycine 0 C--O 1.257 1.552 0 O-C-N 120.436 -1.415 . . . . 35.829999999999998 111.326 175.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -84.42 140.15 31.73 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 107.374 -1.343 . . . . 34.82 107.374 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -70.09 121.3 17.21 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 117.534 -1.222 . . . . 49.049999999999997 111.101 172.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1057 ' ' ILE . . . . . . . . . . . . . 3.6 mm -90.11 103.16 13.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 104.9 -2.259 . . . . 38.530000000000001 104.9 177.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1058 ' ' VAL . . . . . . . . . . . . . 34.6 m -110.98 172.15 2.78 Favored 'Isoleucine or valine' 0 C--O 1.252 1.236 0 CA-C-N 113.309 -1.769 . . . . 42.109999999999999 108.432 -170.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -119.35 131.99 55.79 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 106.666 -1.605 . . . . 58.0 106.666 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 54.86 -129.14 44.7 Favored Glycine 0 CA--C 1.526 0.736 0 O-C-N 125.375 1.672 . . . . 52.119999999999997 112.918 169.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 1.4 t30 -57.0 -26.43 60.22 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 112.807 -1.697 . . . . 54.75 112.643 -168.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1062 ' ' SER . . . . . . . . . . . . . 3.0 m -55.83 -37.31 68.53 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-O 122.56 1.172 . . . . 50.340000000000003 111.863 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 9.3 p -62.26 -33.43 58.83 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.186 0 O-C-N 119.19 -2.194 . . . . 41.460000000000001 116.183 176.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1064 ' ' TRP . . . . . . . . . . . . . 93.2 m95 -74.0 -15.86 61.08 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 113.551 0.945 . . . . 39.32 113.551 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -82.63 83.02 7.77 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.408 1.099 . . . . 55.380000000000003 108.427 170.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1066 ' ' SER . . . . . . . . . . . . . 66.1 m -153.65 173.9 15.19 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 113.769 -1.56 . . . . 41.869999999999997 110.549 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.74 -57.16 3.96 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 106.976 -1.49 . . . . 53.200000000000003 106.976 173.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 5.4 mp -109.68 149.22 12.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 105.45 -2.056 . . . . 41.899999999999999 105.45 -176.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1069 ' ' ILE . . . . . . . . . . . . . 20.6 mm -128.78 120.16 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 N-CA-C 104.39 -2.448 . . . . 38.729999999999997 104.39 172.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1070 ' ' LEU . . . . . . . . . . . . . 33.9 mt -97.69 97.93 9.44 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 104.908 -2.256 . . . . 32.439999999999998 104.908 175.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1071 ' ' LYS . . . . . 0.473 ' HZ1' ' CD ' ' A' 1008 ' ' GLU . 7.5 tmtt? -90.36 141.51 28.66 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 125.608 2.623 . . . . 34.649999999999999 109.074 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1072 ' ' VAL . . . . . . . . . . . . . 15.1 t -62.86 -46.34 96.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 111.531 -2.577 . . . . 31.32 109.888 -168.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -127.42 -160.11 0.98 Allowed 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.082 -1.081 . . . . 33.939999999999998 108.082 172.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -67.96 147.56 98.46 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 121.869 2.122 . . . . 38.039999999999999 111.481 173.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1075 ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -63.38 132.46 36.02 Favored 'Trans proline' 0 C--O 1.266 1.89 0 C-N-CA 123.332 2.688 . . . . 42.68 111.065 163.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 11.8 mt -90.81 175.98 6.8 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 105.51 -2.033 . . . . 46.740000000000002 105.51 170.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.71 -31.82 49.56 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.655 1.724 . . . . 58.609999999999999 115.655 -171.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 13.1 t70 -65.9 -52.06 53.35 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.037 -0.727 . . . . 59.200000000000003 109.037 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1079 ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -62.92 -31.03 72.02 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 114.294 1.22 . . . . 50.630000000000003 114.294 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1080 ' ' ILE . . . . . . . . . . . . . 57.5 mt -61.97 -44.88 99.52 Favored 'Isoleucine or valine' 0 C--N 1.346 0.418 0 CA-C-N 115.948 -0.569 . . . . 51.479999999999997 111.109 170.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -59.49 -33.23 71.07 Favored 'General case' 0 C--O 1.25 1.112 0 CA-C-O 122.755 1.264 . . . . 50.280000000000001 113.646 170.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 66.2 mt -72.33 -26.77 62.06 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.228 -1.351 . . . . 50.210000000000001 112.49 173.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1083 ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.81 149.73 34.97 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 125.73 2.681 . . . . 49.060000000000002 113.574 172.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -113.3 136.84 21.86 Favored Pre-proline 0 N--CA 1.437 -1.106 0 CA-C-N 111.361 -2.654 . . . . 51.079999999999998 107.097 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -60.2 124.59 15.53 Favored 'Trans proline' 0 N--CA 1.435 -1.914 0 C-N-CA 121.4 1.4 . . . . 49.729999999999997 115.014 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 91.7 8.43 63.77 Favored Glycine 0 C--O 1.259 1.709 0 N-CA-C 111.158 -0.777 . . . . 47.710000000000001 111.158 -177.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1087 ' ' THR . . . . . . . . . . . . . 72.7 m -84.66 145.64 27.87 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 123.208 1.48 . . . . 45.469999999999999 110.652 167.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1088 ' ' THR . . . . . . . . . . . . . 52.3 m -91.98 121.53 33.65 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 118.19 -2.819 . . . . 42.039999999999999 104.295 173.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1089 ' ' LEU . . . . . . . . . . . . . 55.6 tp -106.84 116.66 32.3 Favored 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 123.961 0.904 . . . . 38.060000000000002 109.029 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 38.5 t -114.62 124.49 71.32 Favored 'Isoleucine or valine' 0 C--O 1.25 1.081 0 N-CA-C 105.184 -2.154 . . . . 37.399999999999999 105.184 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1091 ' ' SER . . . . . . . . . . . . . 3.5 m -158.46 168.56 26.62 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 122.424 1.107 . . . . 36.159999999999997 113.049 -174.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -82.23 94.85 7.38 Favored 'General case' 0 C--O 1.25 1.087 0 O-C-N 119.579 -1.951 . . . . 38.939999999999998 108.486 165.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 26.6 mm -84.76 -34.63 9.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 113.864 1.061 . . . . 42.170000000000002 113.864 -172.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 84.0 m95 57.99 60.06 6.29 Favored Pre-proline 0 C--N 1.357 0.921 0 C-N-CA 123.086 0.554 . . . . 46.509999999999998 111.56 -169.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -62.78 -34.22 73.59 Favored 'Trans proline' 0 C--O 1.241 0.646 0 C-N-CA 124.185 3.257 . . . . 49.759999999999998 117.013 -165.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -69.2 -35.99 76.82 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 124.643 1.215 . . . . 52.619999999999997 108.784 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -76.78 -30.28 56.42 Favored 'General case' 0 C--O 1.216 -0.669 0 CA-C-N 115.151 -0.931 . . . . 60.740000000000002 109.34 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1098 ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -109.84 36.03 0.11 Allowed Pre-proline 0 CA--C 1.557 1.215 1 N-CA-C 124.96 5.17 . . . . 58.189999999999998 124.96 -169.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -52.09 -24.08 18.96 Favored 'Trans proline' 0 C--N 1.366 1.493 0 C-N-CA 124.655 3.57 . . . . 54.590000000000003 113.961 175.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -57.84 -59.53 5.09 Favored 'General case' 0 C--O 1.253 1.287 0 CA-C-O 124.396 2.046 . . . . 63.280000000000001 110.019 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1101 ' ' LEU . . . . . . . . . . . . . 5.4 mp -70.55 -42.07 71.66 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 111.526 -2.579 . . . . 54.75 107.587 -175.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1102 ' ' MET . . . . . . . . . . . . . 72.0 mtm -56.74 -39.22 73.56 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 114.757 1.391 . . . . 52.649999999999999 114.757 174.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -62.78 -38.33 90.2 Favored 'General case' 0 C--N 1.35 0.608 0 O-C-N 119.968 -1.707 . . . . 66.260000000000005 110.329 -178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 87.7 mttt -74.18 -36.76 64.07 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 114.262 -1.335 . . . . 63.729999999999997 110.49 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 22.6 mt -63.64 -35.1 79.41 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 120.652 -1.28 . . . . 54.68 112.699 169.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -65.97 -41.45 91.17 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 106.907 -1.516 . . . . 53.640000000000001 106.907 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -51.46 -46.01 62.91 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 113.94 1.089 . . . . 67.239999999999995 113.94 168.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -67.18 1.12 2.24 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 115.848 1.796 . . . . 65.760000000000005 115.848 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 10.0 t30 49.81 44.55 25.03 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 125.088 2.375 . . . . 58.710000000000001 113.925 177.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1110 ' ' VAL . . . . . . . . . . . . . 3.7 m -110.75 152.6 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 113.944 -1.48 . . . . 46.630000000000003 109.421 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1111 ' ' THR . . . . . . . . . . . . . 89.4 m -89.14 99.85 12.75 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 106.881 -1.526 . . . . 44.130000000000003 106.881 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1112 ' ' VAL . . . . . . . . . . . . . 91.6 t -91.56 128.01 43.55 Favored 'Isoleucine or valine' 0 C--O 1.253 1.25 0 CA-C-O 123.829 1.776 . . . . 40.439999999999998 110.366 -176.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1113 ' ' MET . . . . . . . . . . . . . 35.2 mtp -119.27 123.18 43.63 Favored 'General case' 0 C--O 1.255 1.367 0 N-CA-C 105.79 -1.93 . . . . 50.759999999999998 105.79 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1114 ' ' ALA . . . . . . . . . . . . . . . -99.42 96.62 7.82 Favored 'General case' 0 N--CA 1.428 -1.575 0 O-C-N 124.106 0.879 . . . . 35.640000000000001 111.896 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1115 ' ' MET . . . . . . . . . . . . . 36.0 mmm -65.33 -17.77 64.78 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 116.765 2.135 . . . . 38.740000000000002 116.765 -173.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -73.67 -36.52 65.35 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 118.179 -0.915 . . . . 40.140000000000001 108.561 168.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1117 ' ' SER . . . . . . . . . . . . . 63.6 m -102.37 62.3 0.86 Allowed 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 125.05 2.357 . . . . 44.789999999999999 109.801 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1118 ' ' VAL . . . . . . . . . . . . . 87.4 t -90.94 134.31 30.5 Favored Pre-proline 0 C--O 1.243 0.739 0 N-CA-C 106.55 -1.648 . . . . 43.75 106.55 174.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -46.13 120.9 3.96 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.732 3.622 . . . . 48.93 111.299 171.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -63.3 -4.56 2.66 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 117.502 2.408 . . . . 62.899999999999999 117.502 -169.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 45.1 pt -66.77 158.14 5.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 115.172 1.545 . . . . 57.719999999999999 115.172 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1122 ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.66 -49.19 68.48 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 125.499 1.75 . . . . 57.259999999999998 114.242 -173.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 21.4 ptt85 -63.21 -13.34 36.43 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 118.36 -2.712 . . . . 62.899999999999999 115.286 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -89.65 -21.37 22.81 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 120.394 -1.441 . . . . 49.829999999999998 108.573 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -61.27 -20.51 62.96 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 115.532 1.679 . . . . 52.369999999999997 115.532 -163.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1126 ' ' SER . . . . . . . . . . . . . 6.0 p -68.52 -39.0 81.36 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.184 0.902 . . . . 42.43 112.341 168.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1127 ' ' LEU . . . . . . . . . . . . . 5.1 mp -82.56 -23.68 34.36 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.277 -0.874 . . . . 43.740000000000002 110.977 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 10.1 t0 -68.04 105.03 1.91 Allowed 'General case' 0 C--O 1.246 0.908 0 CA-C-O 124.658 2.17 . . . . 43.210000000000001 112.361 -167.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -72.37 -41.22 66.63 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 111.159 -2.746 . . . . 35.740000000000002 111.502 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 9.0 tp -54.94 -40.94 70.47 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 118.889 0.768 . . . . 38.090000000000003 112.009 175.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1131 ' ' SER . . . . . . . . . . . . . 68.1 m -54.8 -53.01 60.82 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-N 119.979 1.263 . . . . 36.909999999999997 112.732 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1132 ' ' SER . . . . . . . . . . . . . 4.6 m -65.2 -37.49 87.48 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 119.312 0.96 . . . . 35.789999999999999 113.303 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1133 ' ' MET . . . . . . . . . . . . . 24.8 mmt -59.46 -45.46 91.56 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 121.893 2.133 . . . . 30.809999999999999 115.69 171.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1134 ' ' ALA . . . . . . . . . . . . . . . -69.29 -39.75 78.13 Favored 'General case' 0 CA--C 1.504 -0.803 0 O-C-N 124.275 0.984 . . . . 28.879999999999999 109.936 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1135 ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -53.27 -47.76 68.86 Favored 'General case' 0 C--O 1.245 0.86 0 O-C-N 123.972 0.795 . . . . 40.759999999999998 112.518 169.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1136 ' ' ILE . . . . . . . . . . . . . 71.4 mt -59.95 -44.71 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 107.951 -1.129 . . . . 31.539999999999999 107.951 177.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -60.06 -44.01 95.02 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-O 117.251 -1.357 . . . . 29.870000000000001 111.109 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -62.3 -46.79 93.17 Favored Glycine 0 N--CA 1.439 -1.155 0 CA-C-N 123.074 2.67 . . . . 28.73 112.478 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 36.5 t80 -59.87 -48.97 79.52 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 122.353 1.073 . . . . 30.390000000000001 109.226 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1140 ' ' ARG . . . . . 0.403 HH21 ' CD ' ' A' 1144 ' ' GLU . 3.7 tpt180 -65.58 -24.46 67.08 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 112.895 0.702 . . . . 26.09 112.895 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1141 ' ' ALA . . . . . . . . . . . . . . . -65.73 -44.83 84.82 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 109.655 -0.498 . . . . 27.100000000000001 109.655 173.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 42.2 mm -57.36 -38.67 63.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 123.984 0.914 . . . . 28.48 109.664 175.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 97.7 t -68.05 -59.89 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-O 121.242 0.544 . . . . 23.07 111.804 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1144 ' ' GLU . . . . . 0.403 ' CD ' HH21 ' A' 1140 ' ' ARG . 4.4 mm-40 -61.05 -28.56 69.16 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 120.637 -1.289 . . . . 33.399999999999999 111.642 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -65.73 -60.71 2.62 Favored 'General case' 0 C--O 1.206 -1.209 0 CA-C-O 115.256 -2.307 . . . . 24.219999999999999 107.227 171.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -55.17 -18.62 6.11 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 121.922 2.146 . . . . 24.890000000000001 115.881 176.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -68.21 -56.36 8.97 Favored 'General case' 0 N--CA 1.439 -1.011 0 O-C-N 120.438 -1.413 . . . . 26.73 111.267 169.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1148 ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -90.35 -12.67 36.96 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 118.025 2.602 . . . . 39.960000000000001 118.025 -174.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1149 ' ' PHE . . . . . . . . . . . . . 2.9 t80 -67.92 152.24 45.86 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 124.086 1.898 . . . . 25.870000000000001 108.186 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1150 ' ' GLY . . . . . . . . . . . . . . . -74.01 -48.62 15.31 Favored Glycine 0 N--CA 1.41 -3.058 0 CA-C-N 111.554 -2.566 . . . . 19.280000000000001 113.075 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1151 ' ' ARG . . . . . . . . . . . . . 61.8 mtm-85 -103.56 176.25 5.21 Favored 'General case' 0 C--O 1.25 1.1 0 N-CA-C 109.241 -0.652 . . . . 39.899999999999999 109.241 -164.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1152 ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -76.24 161.11 29.04 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 120.87 -1.144 . . . . 29.440000000000001 108.122 169.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1153 ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -78.78 -48.61 14.51 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 122.891 1.329 . . . . 32.600000000000001 108.662 168.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1154 ' ' THR . . . . . . . . . . . . . 9.7 m -64.45 116.62 6.3 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 115.252 1.575 . . . . 34.640000000000001 115.252 -170.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -66.49 88.67 0.13 Allowed Glycine 0 C--O 1.24 0.486 0 N-CA-C 110.666 -0.973 . . . . 37.140000000000001 110.666 173.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -139.45 178.89 6.88 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 124.883 2.278 . . . . 40.57 111.137 -173.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1157 ' ' ILE . . . . . . . . . . . . . 3.1 tp -107.53 153.44 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 112.928 -1.942 . . . . 44.609999999999999 107.548 167.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1158 ' ' THR . . . . . . . . . . . . . 24.5 p -103.76 -143.63 0.36 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.539 -1.282 . . . . 40.700000000000003 107.539 169.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -94.45 -25.15 17.02 Favored 'General case' 0 C--O 1.246 0.869 0 O-C-N 119.301 -2.124 . . . . 40.25 110.233 167.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -82.78 -56.53 3.78 Favored 'General case' 0 C--O 1.249 1.059 0 O-C-N 121.914 -0.491 . . . . 38.469999999999999 111.952 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . -169.02 -173.42 36.71 Favored Glycine 0 N--CA 1.476 1.333 0 N-CA-C 111.894 -0.483 . . . . 37.609999999999999 111.894 -164.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 15.6 tttp -78.35 151.8 32.68 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 126.057 1.743 . . . . 48.899999999999999 111.772 -170.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1163 ' ' VAL . . . . . . . . . . . . . 92.5 t -102.07 123.86 42.04 Favored Pre-proline 0 N--CA 1.44 -0.942 0 CA-C-N 113.197 -1.82 . . . . 36.520000000000003 108.019 161.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1164 ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -62.82 114.47 2.43 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 123.897 3.064 . . . . 35.079999999999998 115.046 162.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1165 ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -61.91 130.8 32.34 Favored 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 124.142 3.228 . . . . 35.329999999999998 113.42 -171.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -66.8 123.39 20.01 Favored 'General case' 0 CA--C 1.501 -0.925 0 O-C-N 125.043 1.464 . . . . 34.689999999999998 112.055 172.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1167 ' ' LYS . . . . . . . . . . . . . 7.1 mttp -96.89 94.32 7.16 Favored 'General case' 0 CA--C 1.486 -1.494 0 N-CA-C 105.227 -2.138 . . . . 45.359999999999999 105.227 176.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 20.2 t -82.19 97.83 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 C-N-CA 124.479 1.111 . . . . 31.710000000000001 108.215 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1169 ' ' MET . . . . . . . . . . . . . 59.2 ttp -77.96 125.78 29.85 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.037 -1.468 . . . . 42.280000000000001 107.037 166.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 94.6 t -111.86 112.04 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 106.828 -1.545 . . . . 30.510000000000002 106.828 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 75.8 mt -88.69 116.29 30.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 119.979 -1.701 . . . . 31.870000000000001 109.412 173.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 93.61 89.51 1.61 Allowed Glycine 0 C--O 1.215 -1.043 0 N-CA-C 109.215 -1.554 . . . . 34.539999999999999 109.215 171.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1173 ' ' ALA . . . . . . . . . . . . . . . -80.95 67.73 6.96 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 123.05 1.405 . . . . 32.509999999999998 110.19 176.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -100.98 -153.73 26.5 Favored Glycine 0 C--O 1.217 -0.95 0 CA-C-O 117.101 -1.944 . . . . 29.899999999999999 108.369 167.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1175 ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -58.45 -49.03 83.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 CA-C-N 121.438 2.619 . . . . 33.109999999999999 111.931 -178.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1176 ' ' ALA . . . . . . . . . . . . 0.26 . . -59.89 -36.98 78.11 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 121.984 0.897 . . . . 28.100000000000001 110.538 174.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -63.96 -55.05 26.57 Favored Glycine 0 C--O 1.215 -1.057 0 N-CA-C 109.63 -1.388 . . . . 28.539999999999999 109.63 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1178 ' ' LEU . . . . . . . . . . . . . 29.5 mt -65.7 -30.76 71.49 Favored 'General case' 0 C--O 1.254 1.303 0 CA-C-N 114.231 -0.984 . . . . 31.219999999999999 110.869 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -66.28 -40.34 90.03 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.022 -1.674 . . . . 28.98 112.391 173.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -65.03 -42.18 94.59 Favored 'General case' 0 C--O 1.221 -0.433 0 O-C-N 119.23 -2.169 . . . . 27.829999999999998 112.261 173.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1181 ' ' ILE . . . . . . . . . . . . . 71.1 mt -54.07 -55.09 15.94 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 CA-C-O 118.46 -0.781 . . . . 30.25 110.055 172.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -59.3 -53.27 47.64 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-O 122.957 1.309 . . . . 29.59 111.633 -175.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -50.39 -64.22 0.88 Allowed 'General case' 0 C--N 1.348 0.535 0 O-C-N 120.022 -1.869 . . . . 30.289999999999999 113.535 173.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -60.8 -37.86 83.4 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 115.86 1.8 . . . . 30.469999999999999 115.86 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -60.11 -45.91 91.4 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 107.923 -1.14 . . . . 42.409999999999997 107.923 174.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1186 ' ' SER . . . . . . . . . . . . . 67.4 m -62.77 -44.33 96.47 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 123.458 1.599 . . . . 39.380000000000003 113.026 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 25.2 tp -63.87 -30.94 71.98 Favored 'General case' 0 C--O 1.244 0.796 0 O-C-N 119.765 -1.834 . . . . 36.18 110.36 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 108.89 40.14 1.61 Allowed Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 125.722 1.629 . . . . 33.780000000000001 114.114 170.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -108.75 161.18 15.34 Favored 'General case' 0 CA--C 1.49 -1.332 0 O-C-N 121.164 -1.198 . . . . 33.93 110.745 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 67.8 mt -72.56 120.29 20.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 104.996 -2.224 . . . . 38.740000000000002 104.996 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 10.1 t -110.65 129.2 66.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.15 -1.426 . . . . 33.090000000000003 107.15 175.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1192 ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -127.59 101.89 6.6 Favored 'General case' 0 N--CA 1.438 -1.027 0 O-C-N 125.399 1.687 . . . . 38.920000000000002 108.022 173.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -100.47 152.3 20.54 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.619 0.723 . . . . 35.32 112.536 -175.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 79.1 t80 -128.67 148.35 50.81 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 127.751 2.42 . . . . 39.350000000000001 105.231 -172.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 7.9 t70 -166.59 161.89 16.22 Favored 'General case' 0 C--O 1.243 0.714 0 O-C-N 124.483 1.114 . . . . 40.460000000000001 109.966 170.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1196 ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.86 -42.41 81.36 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 113.625 -1.625 . . . . 45.939999999999998 107.734 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1197 ' ' ARG . . . . . . . . . . . . . 47.7 mtm180 -94.26 117.67 67.08 Favored Pre-proline 0 C--O 1.212 -0.892 0 C-N-CA 123.97 0.908 . . . . 56.020000000000003 109.65 -162.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1198 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.12 -8.82 23.89 Favored 'Trans proline' 0 C--N 1.36 1.142 0 C-N-CA 124.125 3.217 . . . . 51.270000000000003 114.555 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.44 -35.63 34.73 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 120.299 -1.501 . . . . 59.100000000000001 108.485 -177.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 15.0 m -71.36 -26.39 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 113.662 0.986 . . . . 51.060000000000002 113.662 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 74.9 tttt -39.39 -42.41 1.07 Allowed 'General case' 0 C--O 1.239 0.512 0 N-CA-C 115.878 1.807 . . . . 57.380000000000003 115.878 166.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -57.37 -47.85 80.59 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 114.814 -1.085 . . . . 62.409999999999997 111.114 177.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -69.46 -41.61 75.97 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 118.752 -0.642 . . . . 57.780000000000001 109.634 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 99.9 t -51.95 -54.65 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 120.276 1.398 . . . . 46.380000000000003 114.529 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -53.42 -51.22 63.29 Favored 'General case' 0 N--CA 1.427 -1.585 0 C-N-CA 125.208 1.403 . . . . 50.700000000000003 112.452 169.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1206 ' ' SER . . . . . . . . . . . . . 7.1 m -78.41 4.15 13.86 Favored 'General case' 0 C--O 1.261 1.663 0 O-C-N 119.429 -2.044 . . . . 49.979999999999997 115.531 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1207 ' ' MET . . . . . . . . . . . . . 75.6 mtp -99.69 -1.86 36.83 Favored 'General case' 0 C--O 1.244 0.784 0 O-C-N 119.87 -1.769 . . . . 52.990000000000002 111.828 169.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 86.79 48.93 4.26 Favored Glycine 0 C--N 1.346 1.13 0 C-N-CA 120.304 -0.95 . . . . 47.659999999999997 111.112 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -137.62 153.67 49.86 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 124.532 2.11 . . . . 44.770000000000003 108.353 170.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -85.44 134.17 34.07 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 113.094 -1.866 . . . . 47.640000000000001 106.351 172.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1211 ' ' PHE . . . . . . . . . . . . . 39.2 t80 -86.09 128.06 34.8 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 120.42 -1.425 . . . . 45.659999999999997 109.174 175.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 32.5 mt -99.44 115.02 28.32 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 106.072 -1.825 . . . . 46.060000000000002 106.072 171.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -88.02 167.88 13.31 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-O 122.708 1.242 . . . . 60.219999999999999 109.876 167.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 4.9 mp -74.22 136.41 42.76 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 106.471 -1.677 . . . . 57.25 106.471 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.75 92.46 1.57 Allowed 'General case' 0 C--O 1.243 0.734 0 N-CA-C 107.411 -1.329 . . . . 64.430000000000007 107.411 166.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 5.1 t80 . . . . . 0 CA--C 1.506 -0.734 0 CA-C-N 114.326 -1.306 . . . . 66.900000000000006 111.277 -167.368 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 6.1 p-10 . . . . . 0 N--CA 1.443 -0.816 0 N-CA-C 103.313 -2.847 . . . . 39.090000000000003 103.313 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -55.09 -37.36 63.28 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.61 -0.723 . . . . 39.32 113.089 -175.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 84.2 t80 -69.3 -54.26 15.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 117.759 0.78 . . . . 39.299999999999997 111.11 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -67.05 -34.01 76.75 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 119.277 0.944 . . . . 36.299999999999997 112.917 -177.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -62.01 -37.41 84.75 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 113.122 0.786 . . . . 37.380000000000003 113.122 168.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -70.87 -36.1 62.8 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 CA-C-N 121.429 1.922 . . . . 39.109999999999999 110.579 169.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1230 ' ' MET . . . . . . . . . . . . . 33.2 mmt -90.22 63.5 5.78 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 124.101 1.905 . . . . 49.590000000000003 110.97 -177.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1231 ' ' SER . . . . . . . . . . . . . 67.0 m -151.68 126.64 9.73 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 110.847 -2.888 . . . . 43.68 107.141 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -56.78 -18.27 12.1 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 114.136 1.162 . . . . 55.57 114.136 -176.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -56.75 -49.02 76.49 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 114.238 1.199 . . . . 44.939999999999998 114.238 167.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 19.5 t80 -63.07 -56.6 15.49 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 124.835 1.254 . . . . 42.039999999999999 108.151 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 93.0 mt -51.72 -45.32 37.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 114.532 -1.213 . . . . 46.280000000000001 110.173 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 26.7 tttm -66.16 -39.9 90.12 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 115.69 -2.1 . . . . 47.869999999999997 111.791 175.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -64.08 -37.5 87.68 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-N 121.98 2.173 . . . . 41.609999999999999 112.629 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -55.59 -56.87 15.24 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 106.524 -1.658 . . . . 50.649999999999999 106.524 170.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1239 ' ' MET . . . . . 0.415 ' SD ' ' O ' ' A' 1266 ' ' LEU . 97.7 mmm -50.0 -48.91 52.17 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.713 1.005 . . . . 48.869999999999997 113.713 178.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -62.72 -40.17 96.36 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 119.462 -2.024 . . . . 54.799999999999997 110.749 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.32 -46.56 79.81 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.455 0.702 . . . . 43.210000000000001 111.855 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -64.33 -47.34 79.77 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 106.659 -1.608 . . . . 38.659999999999997 106.659 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -62.63 -32.9 74.02 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 122.761 1.267 . . . . 37.920000000000002 114.14 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -70.02 -51.94 28.13 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.634 -0.876 . . . . 37.280000000000001 108.634 174.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -61.31 -29.05 69.64 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 113.593 0.96 . . . . 43.07 113.593 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -51.1 -34.24 29.64 Favored 'General case' 0 C--O 1.248 1.01 0 C-N-CA 126.249 1.82 . . . . 38.299999999999997 112.612 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1247 ' ' LYS . . . . . . . . . . . . . 11.3 mtmm -57.7 -22.3 45.49 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 118.505 2.78 . . . . 47.600000000000001 118.505 174.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.78 -30.73 0.81 Allowed 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 117.383 2.364 . . . . 45.420000000000002 117.383 -171.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1249 ' ' VAL . . . . . . . . . . . . . 34.6 m -70.06 158.6 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 123.661 1.696 . . . . 36.259999999999998 111.386 -173.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1250 ' ' ASP . . . . . 0.467 ' CG ' ' HZ3' ' A' 1276 ' ' LYS . 7.4 m-20 -103.04 -50.78 3.41 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 113.884 -1.507 . . . . 33.039999999999999 111.641 -172.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1251 ' ' ILE . . . . . . . . . . . . . 51.7 mm -121.05 138.33 51.82 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 N-CA-C 103.938 -2.616 . . . . 31.399999999999999 103.938 -177.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1252 ' ' ILE . . . . . . . . . . . . . 39.5 mt -120.87 113.68 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 105.798 -1.927 . . . . 29.420000000000002 105.798 166.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 27.7 t -97.0 111.46 26.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 104.504 -2.406 . . . . 30.370000000000001 104.504 176.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1254 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.58 112.01 24.13 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 102.468 -3.16 . . . . 35.719999999999999 102.468 -173.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1255 ' ' THR . . . . . . . . . . . . . 66.1 p -98.89 -27.55 13.85 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 120.004 3.335 . . . . 36.0 120.004 -159.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1256 ' ' ALA . . . . . . . . . . . . . . . -71.19 82.31 0.72 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 118.579 2.807 . . . . 40.93 118.579 -140.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 52.9 tp -84.39 84.18 7.73 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 104.897 -2.26 . . . . 47.82 104.897 175.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 26.0 mm -70.26 131.14 88.77 Favored Pre-proline 0 N--CA 1.431 -1.417 0 CA-C-N 112.701 -2.045 . . . . 52.700000000000003 107.83 172.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -59.78 133.75 52.99 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.3 2.667 . . . . 54.130000000000003 111.144 176.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 76.64 -67.44 2.6 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 122.581 1.101 . . . . 54.619999999999997 115.418 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 85.3 mttt -80.8 129.05 69.58 Favored Pre-proline 0 C--O 1.24 0.575 0 N-CA-C 114.839 1.422 . . . . 55.740000000000002 114.839 -173.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -46.0 134.02 14.58 Favored 'Trans proline' 0 N--CA 1.451 -0.976 1 C-N-CA 127.395 5.397 . . . . 51.149999999999999 112.14 167.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -64.94 131.88 95.32 Favored Pre-proline 0 C--O 1.246 0.881 0 CA-C-O 117.194 -1.384 . . . . 46.060000000000002 111.95 171.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -66.66 148.56 83.3 Favored 'Trans proline' 0 C--O 1.255 1.352 0 C-N-CA 123.379 2.719 . . . . 41.079999999999998 111.581 -177.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 61.8 mttm -85.75 79.09 9.42 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 124.356 2.026 . . . . 47.420000000000002 112.347 -175.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1266 ' ' LEU . . . . . 0.415 ' O ' ' SD ' ' A' 1239 ' ' MET . 93.5 mt -74.19 -59.01 2.92 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 110.737 -2.938 . . . . 39.219999999999999 113.125 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 63.8 mt -75.29 112.43 12.83 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 CA-C-N 120.884 1.675 . . . . 42.5 107.801 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1268 ' ' THR . . . . . . . . . . . . . 1.1 p -76.92 163.04 27.11 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.005 -1.452 . . . . 37.840000000000003 113.202 -176.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 58.7 mtt-85 -62.5 -40.46 96.78 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-O 121.793 0.806 . . . . 54.799999999999997 112.836 172.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -50.38 -51.86 42.36 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 124.874 1.27 . . . . 54.359999999999999 113.1 167.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1271 ' ' MET . . . . . . . . . . . . . 30.0 ttm -60.43 -48.04 83.47 Favored 'General case' 0 C--O 1.253 1.249 0 C-N-CA 124.831 1.252 . . . . 39.520000000000003 112.136 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1272 ' ' VAL . . . . . . . . . . . . . 60.0 t -57.33 -50.02 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 C-N-CA 123.69 0.796 . . . . 38.25 111.895 176.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -54.05 -43.89 70.61 Favored 'General case' 0 C--O 1.262 1.761 0 O-C-N 119.666 -1.896 . . . . 40.770000000000003 114.432 171.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1274 ' ' SER . . . . . . . . . . . . . 10.5 p -73.02 3.18 5.69 Favored 'General case' 0 CA--C 1.556 1.203 0 O-C-N 120.219 -1.55 . . . . 36.579999999999998 113.646 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1275 ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -78.63 151.65 32.19 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 118.641 -2.537 . . . . 36.75 108.245 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1276 ' ' LYS . . . . . 0.467 ' HZ3' ' CG ' ' A' 1250 ' ' ASP . 31.4 ttpt -66.4 142.0 57.75 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.056 1.742 . . . . 46.109999999999999 113.007 177.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1277 ' ' ALA . . . . . . . . . . . . . . . -72.69 153.06 41.37 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 115.327 1.603 . . . . 33.520000000000003 115.327 -169.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 80.02 37.66 21.41 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 108.694 -1.762 . . . . 31.27 108.694 174.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1279 ' ' SER . . . . . . . . . . . . . 19.7 m -139.56 163.27 32.99 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 119.27 1.535 . . . . 32.950000000000003 111.065 -160.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1280 ' ' VAL . . . . . . . . . . . . . 92.7 t -123.78 148.78 27.76 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 O-C-N 118.496 -2.628 . . . . 27.43 111.175 -173.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1281 ' ' ILE . . . . . . . . . . . . . 60.9 mt -121.83 112.18 33.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 103.872 -2.64 . . . . 30.300000000000001 103.872 164.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 4.1 t -98.5 134.59 36.55 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 104.984 -2.228 . . . . 28.629999999999999 104.984 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 6.1 t0 -111.55 121.32 44.86 Favored 'General case' 0 C--O 1.254 1.32 0 CA-C-N 114.692 -1.14 . . . . 36.270000000000003 108.956 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1284 ' ' LEU . . . . . . . . . . . . . 72.4 mt -105.96 14.5 27.86 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.678 -0.692 . . . . 38.57 109.814 -175.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -104.95 -40.3 5.97 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 122.862 1.315 . . . . 37.560000000000002 109.015 169.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . 49.32 -81.0 0.01 OUTLIER 'General case' 0 C--O 1.263 1.809 0 N-CA-C 117.992 2.59 . . . . 40.329999999999998 117.992 173.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -76.61 -36.13 57.66 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 123.938 0.895 . . . . 56.850000000000001 111.865 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 52.4 t30 -80.13 77.98 6.81 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 104.802 -2.296 . . . . 45.859999999999999 104.802 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 72.16 -72.51 0.93 Allowed Glycine 0 CA--C 1.5 -0.854 0 N-CA-C 109.444 -1.462 . . . . 40.310000000000002 109.444 -176.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 87.16 117.32 1.13 Allowed Glycine 0 C--O 1.22 -0.722 0 N-CA-C 106.755 -2.538 . . . . 38.890000000000001 106.755 -175.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1291 ' ' ASN . . . . . . . . . . . . . 12.4 m120 -65.46 -16.78 63.99 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 115.633 1.716 . . . . 37.229999999999997 115.633 -172.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1292 ' ' CYS . . . . . . . . . . . . . 36.0 t -103.34 157.08 17.27 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 119.45 1.023 . . . . 36.5 109.497 173.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1293 ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -82.53 -9.17 59.52 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 115.331 1.604 . . . . 43.32 115.331 173.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -96.38 9.02 42.54 Favored 'General case' 0 C--O 1.244 0.778 0 O-C-N 117.55 -3.219 . . . . 41.32 111.699 172.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1295 ' ' THR . . . . . . . . . . . . . 85.3 m -75.61 98.8 4.12 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.871 0.843 . . . . 35.299999999999997 111.072 -173.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 2.3 t -81.94 128.25 69.12 Favored Pre-proline 0 C--O 1.251 1.166 0 N-CA-C 102.622 -3.103 . . . . 34.840000000000003 102.622 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -51.42 105.34 0.11 Allowed 'Trans proline' 0 C--O 1.251 1.137 0 C-N-CA 124.773 3.649 . . . . 33.509999999999998 113.04 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 76.98 23.43 69.12 Favored Glycine 0 CA--C 1.504 -0.635 0 CA-C-N 113.328 -1.76 . . . . 32.189999999999998 113.937 175.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -131.6 170.58 14.56 Favored 'General case' 0 C--O 1.246 0.916 0 CA-C-N 118.86 1.33 . . . . 34.880000000000003 112.905 -175.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1300 ' ' ILE . . . . . . . . . . . . . 43.3 mt -108.58 121.84 62.23 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.198 0 N-CA-C 106.044 -1.835 . . . . 32.289999999999999 106.044 169.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 16.0 t80 -97.96 126.5 43.4 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 103.624 -2.732 . . . . 37.25 103.624 169.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1302 ' ' THR . . . . . . . . . . . . . 8.2 m -106.41 123.91 48.8 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 119.735 1.152 . . . . 35.560000000000002 108.628 174.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1303 ' ' THR . . . . . . . . . . . . . 2.6 p -86.7 165.17 16.3 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 118.37 -0.824 . . . . 36.399999999999999 113.191 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -53.96 -41.1 67.44 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 121.254 1.843 . . . . 52.32 115.704 -176.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -62.18 -24.05 66.97 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.369 -1.287 . . . . 40.039999999999999 111.741 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 98.23 44.51 2.56 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.294 -1.122 . . . . 36.960000000000001 110.294 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1307 ' ' VAL . . . . . . . . . . . . . 59.7 t -107.08 120.11 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 123.617 1.675 . . . . 33.399999999999999 108.584 168.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1308 ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -87.3 102.78 14.83 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 110.541 -3.027 . . . . 42.909999999999997 106.986 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 39.3 t -88.98 95.22 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.676 0 O-C-N 119.469 -2.019 . . . . 32.289999999999999 108.212 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1310 ' ' ILE . . . . . . . . . . . . . 91.1 mt -89.54 95.17 5.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 O-C-N 120.76 -1.212 . . . . 30.989999999999998 110.093 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -97.33 57.9 1.17 Allowed Glycine 0 N--CA 1.441 -1.012 0 O-C-N 120.483 -1.386 . . . . 28.949999999999999 113.798 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1312 ' ' TYR . . . . . . . . . . . . . 7.0 m-30 -77.36 131.82 38.26 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 122.914 1.34 . . . . 31.690000000000001 113.374 -169.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1313 ' ' THR . . . . . . . . . . . . . 8.8 p -86.6 -49.79 7.28 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 120.965 -1.084 . . . . 34.170000000000002 110.596 174.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -72.29 14.27 0.25 Allowed 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 117.367 2.358 . . . . 36.859999999999999 117.367 -167.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1315 ' ' LEU . . . . . . . . . . . . . 28.5 mt -51.04 -39.45 56.12 Favored Pre-proline 0 C--N 1.347 0.495 0 O-C-N 119.827 -1.796 . . . . 34.850000000000001 114.256 -173.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.74 -43.98 40.02 Favored 'Trans proline' 0 C--O 1.257 1.431 0 CA-C-N 124.408 2.61 . . . . 29.149999999999999 113.207 170.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -58.25 -45.12 94.55 Favored Glycine 0 CA--C 1.543 1.807 0 N-CA-C 109.124 -1.59 . . . . 27.289999999999999 109.124 174.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1318 ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -58.35 -23.38 56.6 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 116.47 2.026 . . . . 41.490000000000002 116.47 177.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1319 ' ' LEU . . . . . . . . . . . . . 12.3 tp -123.07 67.27 32.9 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 104.018 -2.586 . . . . 27.609999999999999 104.018 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1320 ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -58.14 -53.05 4.67 Favored 'Trans proline' 0 C--O 1.257 1.456 1 C-N-CA 125.396 4.064 . . . . 25.940000000000001 114.67 -163.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1321 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.86 -39.79 91.05 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 109.868 -0.419 . . . . 25.010000000000002 109.868 -173.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1322 ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -64.83 -43.82 91.84 Favored 'General case' 0 CA--C 1.51 -0.563 0 O-C-N 123.968 0.792 . . . . 29.390000000000001 109.78 -175.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1323 ' ' SER . . . . . . . . . . . . . 49.6 m -58.47 -53.52 57.41 Favored 'General case' 0 CA--C 1.486 -1.514 0 CA-C-N 114.16 -1.382 . . . . 26.469999999999999 113.166 173.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1324 ' ' SER . . . . . . . . . . . . . 5.0 m -65.01 -29.37 70.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.324 -0.86 . . . . 27.780000000000001 110.002 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -68.81 -59.66 2.93 Favored 'General case' 0 C--N 1.348 0.519 0 O-C-N 121.653 -0.654 . . . . 37.530000000000001 110.783 172.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1326 ' ' LEU . . . . . . . . . . . . . 59.5 mt -72.29 -51.79 19.23 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 115.838 -2.03 . . . . 35.710000000000001 111.102 -170.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1327 ' ' TYR . . . . . . . . . . . . . 7.3 t80 -48.83 -48.26 41.84 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 121.364 1.893 . . . . 31.59 110.96 170.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1328 ' ' GLY . . . . . . . . . . . . . . . -47.46 -52.52 14.06 Favored Glycine 0 N--CA 1.465 0.61 0 C-N-CA 124.229 0.918 . . . . 28.0 112.49 170.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1329 ' ' THR . . . . . . . . . . . . . 77.2 m -70.4 -34.81 72.97 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 120.344 -1.68 . . . . 32.149999999999999 110.188 -173.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1330 ' ' ASN . . . . . . . . . . . . . 29.4 m120 -64.65 -43.6 93.13 Favored 'General case' 0 C--O 1.21 -0.997 0 C-N-CA 119.521 -0.871 . . . . 34.359999999999999 111.28 173.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1331 ' ' LEU . . . . . . . . . . . . . 80.6 mt -53.09 -44.83 67.88 Favored 'General case' 0 C--O 1.219 -0.534 0 O-C-N 124.71 1.256 . . . . 33.369999999999997 111.527 173.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1332 ' ' VAL . . . . . . . . . . . . . 6.8 t -70.62 -37.12 68.37 Favored 'Isoleucine or valine' 0 C--O 1.245 0.842 0 CA-C-N 114.849 -1.069 . . . . 35.270000000000003 110.125 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -69.89 -28.69 65.84 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 121.414 0.626 . . . . 37.659999999999997 111.227 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1334 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.52 -51.99 20.62 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 108.805 -0.813 . . . . 40.270000000000003 108.805 171.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1335 ' ' LEU . . . . . . . . . . . . . 37.1 mt -68.41 -5.91 21.7 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 115.564 1.69 . . . . 42.5 115.564 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1336 ' ' LYS . . . . . . . . . . . . . 74.8 mttt -66.96 -35.75 80.68 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 119.85 -1.781 . . . . 47.810000000000002 111.823 162.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1337 ' ' LEU . . . . . . . . . . . . . 4.8 mp -78.08 -46.74 19.99 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 120.9 -1.125 . . . . 49.270000000000003 109.995 169.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1338 ' ' LEU . . . . . . . . . . . . . 6.0 mp -76.81 16.96 0.46 Allowed 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 115.786 1.773 . . . . 50.539999999999999 115.786 176.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1339 ' ' CYS . . . . . . . . . . . . . 36.5 t -156.98 80.34 0.92 Allowed 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 126.042 2.829 . . . . 53.670000000000002 104.768 164.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 82.6 mttt -79.08 -40.66 30.61 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 113.431 -1.713 . . . . 63.380000000000003 111.139 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -69.69 -51.26 36.1 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 113.706 1.002 . . . . 70.950000000000003 113.706 -166.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1342 ' ' LYS . . . . . . . . . . . . . 36.3 mtpt 52.77 67.08 1.05 Allowed 'General case' 0 C--O 1.239 0.535 0 N-CA-C 117.499 2.407 . . . . 65.25 117.499 171.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1343 ' ' ASP . . . . . . . . . . . . 0.262 7.8 t70 59.82 -94.19 0.05 OUTLIER 'General case' 0 CA--C 1.502 -0.869 2 O-C-N 110.915 -7.365 . . . . 64.530000000000001 117.847 4.486 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A 1344 ' ' GLY . . . . . . . . . . . . . . . 117.86 70.15 0.38 Allowed Glycine 0 C--N 1.348 1.212 0 N-CA-C 107.764 -2.134 . . . . 59.719999999999999 107.764 172.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -167.78 149.56 5.52 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 113.683 -1.259 . . . . 64.090000000000003 108.12 -177.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1346 ' ' ILE . . . . . . . . . . . . . 8.4 pt -55.38 125.22 10.03 Favored 'Isoleucine or valine' 0 C--O 1.247 0.95 0 N-CA-C 115.211 1.56 . . . . 58.82 115.211 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1347 ' ' THR . . . . . . . . . . . . . 7.8 m -97.91 100.12 11.45 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 103.309 -2.848 . . . . 54.960000000000001 103.309 163.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1348 ' ' VAL . . . . . . . . . . . . . 15.1 t -90.87 113.08 26.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 106.663 -1.606 . . . . 55.640000000000001 106.663 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 27.9 t70 -112.55 145.22 40.69 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 122.194 0.997 . . . . 61.450000000000003 110.094 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 60.2 t80 -116.23 4.19 13.51 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.509 1.124 . . . . 58.630000000000003 109.238 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.77 -62.71 1.25 Allowed 'General case' 0 N--CA 1.477 0.893 0 O-C-N 119.723 -1.861 . . . . 62.060000000000002 110.469 -169.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 7.3 t70 -69.83 143.95 52.73 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 114.571 1.322 . . . . 54.07 114.571 -170.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 20.3 m -65.49 -29.73 48.01 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 CA-C-N 119.541 1.064 . . . . 50.68 111.114 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1354 ' ' VAL . . . . . . . . . . . . . 4.3 m -76.53 -17.26 14.97 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 O-C-N 120.284 -1.51 . . . . 47.68 110.404 -176.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1355 ' ' ILE . . . . . . . . . . . . . 74.8 mt -100.34 -69.79 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.867 0 N-CA-C 106.636 -1.616 . . . . 48.490000000000002 106.636 171.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 40.4 tpt85 -55.73 -31.99 62.98 Favored 'General case' 0 C--N 1.349 0.548 0 O-C-N 120.653 -1.28 . . . . 48.270000000000003 114.286 -175.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -62.27 -46.18 94.45 Favored Glycine 0 CA--C 1.525 0.662 0 O-C-N 120.025 -1.672 . . . . 43.530000000000001 111.749 171.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1358 ' ' VAL . . . . . . . . . . . . . 42.4 t -72.18 -35.27 52.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 122.042 0.925 . . . . 45.119999999999997 111.025 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1359 ' ' THR . . . . . . . . . . . . . 25.6 m -69.07 88.43 0.41 Allowed 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 122.817 1.294 . . . . 42.939999999999998 109.162 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 16.1 m -76.83 -22.82 14.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-O 122.317 1.056 . . . . 43.259999999999998 113.122 176.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1361 ' ' ILE . . . . . . . . . . . . . 30.5 mt -133.29 135.52 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 103.563 -2.754 . . . . 45.659999999999997 103.563 169.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1362 ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -117.68 113.11 21.4 Favored 'General case' 0 C--O 1.252 1.228 0 N-CA-C 104.879 -2.267 . . . . 61.340000000000003 104.879 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 26.53 73.6 0.03 OUTLIER 'General case' 0 C--O 1.231 0.115 0 C-N-CA 127.047 2.139 . . . . 49.759999999999998 113.186 -166.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 88.9 -38.1 3.24 Favored Glycine 0 CA--C 1.529 0.911 0 O-C-N 119.902 -1.749 . . . . 50.0 112.443 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -74.46 124.0 25.75 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 119.416 1.608 . . . . 56.920000000000002 109.168 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1366 ' ' ILE . . . . . . . . . . . . . 10.2 mt -77.13 86.3 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.256 1.401 0 CA-C-O 123.07 1.414 . . . . 52.780000000000001 111.748 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1367 ' ' THR . . . . . . . . . . . . . 16.6 p -70.95 -11.88 61.22 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 111.728 -2.487 . . . . 49.439999999999998 114.624 -174.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 26.3 t90 -47.44 133.81 10.05 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 127.362 2.265 . . . . 52.380000000000003 110.157 170.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -81.79 -166.61 5.19 Favored 'Cis proline' 0 C--O 1.238 0.497 0 N-CA-C 117.443 2.055 . . . . 46.939999999999998 117.443 4.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -73.63 140.69 78.65 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 117.113 -1.422 . . . . 45.909999999999997 110.925 164.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1371 ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -70.43 139.74 38.58 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.691 2.927 . . . . 46.390000000000001 107.052 164.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -65.64 -35.86 35.69 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.778 2.319 . . . . 46.719999999999999 117.073 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.235 -4.412 0 CA-C-N 120.726 1.603 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 7.1 m80 . . . . . 0 N--CA 1.438 -1.043 0 N-CA-C 104.143 -2.54 . . . . 63.439999999999998 104.143 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -106.14 65.49 0.69 Allowed 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 102.939 -2.985 . . . . 51.740000000000002 102.939 159.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1000 ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -76.1 128.03 34.16 Favored 'General case' 0 C--N 1.36 1.054 0 O-C-N 120.584 -1.322 . . . . 54.07 109.986 -173.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 86.23 -6.47 81.6 Favored Glycine 0 C--O 1.218 -0.885 0 CA-C-O 121.656 0.587 . . . . 39.219999999999999 113.696 -169.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1002 ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -93.12 138.85 31.18 Favored 'General case' 0 C--O 1.252 1.185 0 CA-C-O 124.854 2.264 . . . . 38.119999999999997 109.482 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1003 ' ' ILE . . . . . . . . . . . . . 49.0 mt -98.25 141.63 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 110.835 -2.893 . . . . 29.699999999999999 105.201 169.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -111.0 123.79 6.67 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 108.659 -1.776 . . . . 27.5 108.659 172.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1005 ' ' ILE . . . . . . . . . . . . . 41.1 mm -109.8 111.77 58.64 Favored Pre-proline 0 N--CA 1.447 -0.582 0 N-CA-C 106.515 -1.661 . . . . 24.829999999999998 106.515 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -74.7 156.36 44.36 Favored 'Trans proline' 0 N--CA 1.44 -1.626 0 C-N-CA 123.473 2.782 . . . . 27.190000000000001 115.944 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -79.0 96.65 5.82 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 118.782 -2.449 . . . . 41.460000000000001 106.468 162.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1008 ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -51.94 151.5 3.55 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 118.734 2.864 . . . . 26.93 118.734 -170.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 45.1 mmm-85 -92.97 -20.72 20.32 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 112.528 -2.124 . . . . 34.479999999999997 115.535 -164.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1010 ' ' LEU . . . . . . . . . . . . . 4.7 tp -67.74 160.21 28.59 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 119.386 0.994 . . . . 44.219999999999999 113.678 -173.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1011 ' ' THR . . . . . . . . . . . . . 63.3 m -68.25 132.61 47.44 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 106.018 -1.845 . . . . 40.740000000000002 106.018 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 27.0 m-80 62.22 22.22 13.01 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 113.984 -1.462 . . . . 44.439999999999998 112.119 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1013 ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -78.1 118.7 20.6 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 117.748 -1.581 . . . . 29.870000000000001 111.85 -173.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1014 ' ' THR . . . . . . . . . . . . . 1.6 p -105.17 -9.62 17.63 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 111.514 -2.585 . . . . 25.260000000000002 112.413 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1015 ' ' ARG . . . . . 0.481 ' NH1' ' SD ' ' B' 1133 ' ' MET . 77.4 mtm180 -77.01 110.3 11.53 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 123.546 1.641 . . . . 29.539999999999999 113.188 -176.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B 1016 ' ' VAL . . . . . . . . . . . . . 7.2 p -87.69 120.54 36.98 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 N-CA-C 104.153 -2.536 . . . . 23.550000000000001 104.153 164.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1017 ' ' ALA . . . . . . . . . . . . . . . -62.71 -5.96 3.18 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 116.29 1.959 . . . . 23.59 116.29 -177.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1018 ' ' ALA . . . . . . . . . . . . . . . -150.34 111.95 4.48 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 123.996 1.855 . . . . 24.93 107.059 170.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1019 ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.43 164.38 40.81 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 115.14 -2.362 . . . . 28.09 111.696 172.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 0.7 OUTLIER -38.93 -46.35 2.74 Favored 'Trans proline' 0 C--N 1.362 1.245 1 C-N-CA 125.669 4.246 . . . . 28.789999999999999 117.717 -176.528 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 77.3 tttt -63.67 -49.21 74.09 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 120.086 1.312 . . . . 47.280000000000001 107.743 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1022 ' ' THR . . . . . . . . . . . . . 39.0 m -61.39 -34.98 76.26 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 114.001 1.111 . . . . 30.120000000000001 114.001 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1023 ' ' VAL . . . . . . . . . . . . . 75.4 t -51.11 -52.96 16.44 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 CA-C-N 121.239 1.836 . . . . 32.240000000000002 110.381 167.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1024 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.04 -37.1 86.2 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 113.973 1.101 . . . . 49.619999999999997 113.973 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -56.5 -46.4 80.55 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 114.373 -1.285 . . . . 44.68 109.871 177.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 14.4 mt -72.49 -35.86 68.26 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 114.341 1.238 . . . . 35.710000000000001 114.341 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1027 ' ' LEU . . . . . . . . . . . . . 75.8 mt -63.51 -41.51 98.51 Favored 'General case' 0 C--N 1.346 0.436 0 N-CA-C 109.896 -0.409 . . . . 42.18 109.896 176.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 55.1 mttm -57.96 -40.87 81.66 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 115.897 1.814 . . . . 48.340000000000003 115.897 169.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1029 ' ' LEU . . . . . . . . . . . . . 65.4 mt -69.67 -10.51 58.57 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 121.442 -0.787 . . . . 38.689999999999998 110.719 173.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 106.12 3.51 38.81 Favored Glycine 0 C--N 1.321 -0.294 0 O-C-N 119.861 -1.774 . . . . 32.280000000000001 112.407 166.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -90.77 158.61 16.76 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 119.957 -1.908 . . . . 35.939999999999998 108.879 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1032 ' ' THR . . . . . . . . . . . . . 5.9 m -101.06 137.33 39.56 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 103.834 -2.654 . . . . 33.369999999999997 103.834 172.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1033 ' ' VAL . . . . . . . . . . . . . 5.1 t -107.88 137.65 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 0 O-C-N 118.222 -2.799 . . . . 29.98 106.701 -172.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -128.21 131.62 48.84 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.243 -1.391 . . . . 28.18 107.243 168.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1035 ' ' VAL . . . . . . . . . . . . . 87.5 t -115.79 137.34 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.286 0 CA-C-N 113.225 -1.807 . . . . 25.82 110.216 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1036 ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -74.13 125.98 29.55 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 107.425 -1.324 . . . . 32.439999999999998 107.425 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1037 ' ' SER . . . . . . . . . . . . . 2.8 t -58.08 121.89 11.73 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 124.313 2.006 . . . . 29.539999999999999 113.309 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 119.45 -26.72 7.22 Favored Glycine 0 C--O 1.259 1.678 0 CA-C-N 113.187 -1.824 . . . . 27.760000000000002 109.413 -175.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1039 ' ' ALA . . . . . . . . . . . . . . . -59.43 -32.21 69.99 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.243 1.02 . . . . 26.02 113.057 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -57.99 -51.63 57.15 Favored Glycine 0 N--CA 1.466 0.686 0 CA-C-N 113.148 -1.842 . . . . 26.469999999999999 111.918 165.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -59.46 -30.19 68.34 Favored 'General case' 0 C--O 1.251 1.149 0 CA-C-N 118.254 1.027 . . . . 50.979999999999997 112.272 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 75.2 mt -64.65 -58.01 7.47 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-N 115.784 -0.644 . . . . 29.300000000000001 110.598 167.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1043 ' ' ALA . . . . . . . . . . . . . . . -74.66 14.73 0.44 Allowed 'General case' 0 C--O 1.215 -0.737 0 O-C-N 119.776 -1.828 . . . . 26.739999999999998 112.611 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1044 ' ' SER . . . . . . . . . . . . . 72.7 m 63.61 49.3 3.08 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 127.321 3.439 . . . . 31.260000000000002 112.646 174.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1045 ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.59 155.25 44.22 Favored 'General case' 0 N--CA 1.432 -1.352 0 O-C-N 119.314 -2.116 . . . . 33.259999999999998 107.056 -168.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 14.2 t70 -82.88 127.32 33.39 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 107.385 -1.339 . . . . 46.740000000000002 107.385 168.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -57.45 -32.32 66.81 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 124.439 1.096 . . . . 34.439999999999998 112.47 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -14.28 62.92 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 121.024 -1.048 . . . . 48.670000000000002 111.316 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -68.32 -28.9 67.56 Favored 'General case' 0 C--O 1.216 -0.662 0 O-C-N 120.241 -1.537 . . . . 35.259999999999998 110.851 169.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1050 ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -69.47 -31.14 69.25 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 108.142 -1.059 . . . . 32.170000000000002 108.142 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 83.9 t -70.16 -41.55 78.95 Favored 'Isoleucine or valine' 0 C--O 1.25 1.123 0 N-CA-C 106.305 -1.739 . . . . 38.369999999999997 106.305 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -60.49 -29.59 69.17 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 123.133 1.444 . . . . 45.770000000000003 110.118 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -77.48 -40.17 43.92 Favored 'General case' 0 CA--C 1.5 -0.957 0 O-C-N 120.421 -1.425 . . . . 37.829999999999998 112.905 168.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 137.03 18.89 0.64 Allowed Glycine 0 C--N 1.334 0.468 0 O-C-N 120.178 -1.576 . . . . 35.82 113.834 172.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -88.93 144.32 26.26 Favored 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 120.512 2.156 . . . . 33.770000000000003 112.724 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -73.83 124.6 26.4 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 103.844 -2.65 . . . . 51.020000000000003 103.844 168.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1057 ' ' ILE . . . . . . . . . . . . . 39.0 mm -89.42 116.75 31.45 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 O-C-N 120.155 -1.591 . . . . 38.469999999999999 107.752 168.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 2.8 m -112.56 139.37 37.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 O-C-N 125.785 1.928 . . . . 39.399999999999999 106.345 174.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -100.65 100.54 11.26 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 123.729 0.812 . . . . 57.07 110.012 -172.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . 102.78 -178.95 26.27 Favored Glycine 0 C--O 1.248 0.983 0 CA-C-O 123.005 1.336 . . . . 44.829999999999998 112.353 -175.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 30.2 m120 -64.47 2.59 0.6 Allowed 'General case' 0 C--O 1.239 0.523 0 N-CA-C 118.229 2.677 . . . . 46.270000000000003 118.229 -168.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1062 ' ' SER . . . . . . . . . . . . . 13.3 m -41.07 -40.77 1.55 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 127.75 2.42 . . . . 43.469999999999999 107.325 156.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -52.62 -30.34 14.77 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 O-C-N 119.125 -2.235 . . . . 36.979999999999997 114.566 176.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 52.1 m95 -76.41 -22.08 55.19 Favored 'General case' 0 N--CA 1.439 -0.99 0 O-C-N 120.867 -1.145 . . . . 37.899999999999999 110.68 -174.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -85.65 84.46 7.58 Favored 'General case' 0 C--O 1.205 -1.283 0 N-CA-C 103.482 -2.785 . . . . 46.189999999999998 103.482 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1066 ' ' SER . . . . . . . . . . . . . 56.6 m -151.08 173.41 14.39 Favored 'General case' 0 C--O 1.261 1.685 0 C-N-CA 126.117 1.767 . . . . 37.060000000000002 107.523 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1067 ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -82.61 -40.55 20.65 Favored 'General case' 0 N--CA 1.433 -1.298 0 O-C-N 120.428 -1.42 . . . . 43.950000000000003 111.512 174.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1068 ' ' ILE . . . . . . . . . . . . . 1.2 mp -120.8 135.09 62.13 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 N-CA-C 103.777 -2.675 . . . . 33.5 103.777 -175.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 37.1 mm -120.21 116.06 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 101.208 -3.627 . . . . 30.57 101.208 172.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1070 ' ' LEU . . . . . . . . . . . . . 30.1 mt -102.8 105.62 16.06 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 102.845 -3.02 . . . . 27.66 102.845 172.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1071 ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -127.77 147.17 50.41 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 103.873 -2.64 . . . . 28.399999999999999 103.873 -168.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1072 ' ' VAL . . . . . . . . . . . . . 25.5 t -81.4 -65.07 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.85 0 CA-C-O 117.723 -1.132 . . . . 23.18 112.201 -171.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -106.45 -159.42 0.7 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 120.843 1.656 . . . . 25.469999999999999 111.817 -161.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -64.28 142.28 98.29 Favored Pre-proline 0 CA--C 1.517 -0.317 0 CA-C-N 120.691 1.587 . . . . 27.899999999999999 111.222 -177.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -70.94 118.71 5.84 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.024 3.149 . . . . 31.620000000000001 117.116 164.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 5.3 mp -74.48 170.75 15.07 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 124.652 2.168 . . . . 40.490000000000002 107.47 166.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 36.6 t70 -56.22 -39.26 72.22 Favored 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 125.222 1.409 . . . . 51.590000000000003 113.707 -175.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -67.89 -39.12 83.69 Favored 'General case' 0 C--N 1.348 0.5 0 O-C-N 120.626 -1.296 . . . . 42.359999999999999 108.19 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1079 ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -63.5 -45.54 90.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 123.501 1.619 . . . . 34.530000000000001 108.94 -178.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1080 ' ' ILE . . . . . . . . . . . . . 61.3 mt -60.67 -37.07 74.67 Favored 'Isoleucine or valine' 0 C--O 1.261 1.694 0 CA-C-N 113.354 -1.748 . . . . 33.25 110.959 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -74.13 -28.92 61.56 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 115.614 1.709 . . . . 36.469999999999999 115.614 172.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1082 ' ' LEU . . . . . . . . . . . . . 23.3 mt -71.36 -28.26 63.93 Favored 'General case' 0 C--N 1.317 -0.821 0 O-C-N 119.933 -1.729 . . . . 37.759999999999998 110.644 173.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1083 ' ' LEU . . . . . . . . . . . . . 28.7 mt -58.77 127.79 33.96 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 123.037 1.398 . . . . 37.43 111.997 171.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.38 133.55 42.17 Favored Pre-proline 0 C--O 1.243 0.759 0 CA-C-N 112.892 -1.958 . . . . 37.700000000000003 107.572 177.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -44.42 111.42 0.27 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 123.996 3.131 . . . . 35.509999999999998 113.68 169.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 130.2 -48.96 0.94 Allowed Glycine 0 C--N 1.31 -0.911 0 CA-C-N 110.954 -2.839 . . . . 33.869999999999997 109.645 175.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1087 ' ' THR . . . . . . . . . . . . . 72.5 m -43.74 126.84 4.82 Favored 'General case' 0 C--O 1.252 1.21 0 C-N-CA 126.051 1.74 . . . . 32.5 114.504 -165.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1088 ' ' THR . . . . . . . . . . . . . 50.1 m -78.97 91.71 4.86 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-O 124.037 1.875 . . . . 30.219999999999999 109.843 -176.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1089 ' ' LEU . . . . . . . . . . . . . 36.0 tp -76.15 137.39 40.04 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 113.112 -1.858 . . . . 27.239999999999998 111.084 170.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 56.7 t -133.95 112.12 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 103.589 -2.745 . . . . 25.390000000000001 103.589 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1091 ' ' SER . . . . . . . . . . . . . 48.7 m -160.45 163.84 32.71 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 120.43 -1.419 . . . . 28.809999999999999 111.201 -171.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1092 ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -71.18 102.88 2.62 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.005 -1.059 . . . . 30.780000000000001 110.606 165.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 29.7 mm -85.29 -45.21 17.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 120.261 1.391 . . . . 30.280000000000001 111.807 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1094 ' ' TRP . . . . . . . . . . . . . 93.1 m95 56.21 73.52 0.82 Allowed Pre-proline 0 C--O 1.244 0.809 0 O-C-N 125.091 1.495 . . . . 34.07 110.403 -157.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -55.28 -50.16 13.88 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 123.819 3.013 . . . . 38.659999999999997 115.951 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -64.67 -33.05 75.03 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-O 123.057 1.408 . . . . 41.32 110.096 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 8.4 mp0 -80.25 -17.58 51.8 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 116.711 -1.614 . . . . 51.659999999999997 110.378 175.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -142.46 59.89 9.33 Favored Pre-proline 0 N--CA 1.481 1.092 0 CA-C-N 122.588 2.449 . . . . 40.32 111.591 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -59.55 -32.72 96.59 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 123.621 2.881 . . . . 41.560000000000002 112.955 177.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -63.46 -47.71 80.72 Favored 'General case' 0 C--O 1.206 -1.196 0 CA-C-O 123.001 1.381 . . . . 54.109999999999999 109.217 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1101 ' ' LEU . . . . . . . . . . . . . 5.1 tp -62.95 -45.71 91.18 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 113.313 -1.767 . . . . 37.880000000000003 108.547 -176.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1102 ' ' MET . . . . . . . . . . . . . 67.9 mmm -49.77 -51.31 40.2 Favored 'General case' 0 CA--C 1.498 -1.03 0 C-N-CA 124.122 0.969 . . . . 37.539999999999999 109.994 169.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 42.3 tp60 -62.83 -36.13 82.22 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 118.772 -1.171 . . . . 47.009999999999998 113.922 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1104 ' ' LYS . . . . . . . . . . . . . 93.2 mttt -60.95 -45.8 93.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 120.139 -0.624 . . . . 48.68 112.352 173.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1105 ' ' LEU . . . . . . . . . . . . . 73.9 mt -57.89 -43.35 86.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 124.839 2.257 . . . . 32.210000000000001 114.95 175.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -56.24 -55.59 31.45 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 112.089 -2.323 . . . . 33.729999999999997 111.717 172.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.51 -20.69 66.45 Favored 'General case' 0 C--N 1.359 1.01 0 O-C-N 118.811 -2.431 . . . . 51.469999999999999 114.159 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1108 ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -82.96 -1.51 52.65 Favored 'General case' 0 C--N 1.348 0.543 0 N-CA-C 114.249 1.204 . . . . 43.899999999999999 114.249 170.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1109 ' ' ASN . . . . . . . . . . . . . 12.1 m-80 61.93 28.87 17.6 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 118.813 2.894 . . . . 44.82 118.813 171.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1110 ' ' VAL . . . . . . . . . . . . . 30.0 m -89.77 170.04 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.28 0 CA-C-N 113.486 -1.688 . . . . 30.52 111.921 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1111 ' ' THR . . . . . . . . . . . . . 59.1 m -111.21 119.02 37.55 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 104.417 -2.438 . . . . 27.120000000000001 104.417 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1112 ' ' VAL . . . . . . . . . . . . . 34.3 t -119.15 126.5 75.41 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 CA-C-O 118.726 -0.654 . . . . 26.399999999999999 110.129 -171.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1113 ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -101.01 115.41 30.43 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 106.011 -1.848 . . . . 42.920000000000002 106.011 168.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -85.91 104.11 15.26 Favored 'General case' 0 N--CA 1.426 -1.631 0 C-N-CA 119.118 -1.033 . . . . 24.149999999999999 109.909 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1115 ' ' MET . . . . . . . . . . . . . 44.2 mmm -59.35 -14.86 13.24 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 116.326 1.972 . . . . 29.949999999999999 116.326 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1116 ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -86.42 -37.95 17.85 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 108.246 -1.02 . . . . 34.530000000000001 108.246 172.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1117 ' ' SER . . . . . . . . . . . . . 68.4 m -95.05 38.51 1.13 Allowed 'General case' 0 C--N 1.316 -0.863 0 O-C-N 118.605 -2.56 . . . . 33.490000000000002 110.066 -173.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1118 ' ' VAL . . . . . . . . . . . . . 2.2 t -78.47 133.22 63.78 Favored Pre-proline 0 N--CA 1.468 0.453 0 N-CA-C 105.8 -1.926 . . . . 34.020000000000003 105.8 169.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -47.21 142.16 12.34 Favored 'Trans proline' 0 C--N 1.328 -0.507 1 C-N-CA 126.321 4.681 . . . . 38.280000000000001 115.224 -176.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B 1120 ' ' ARG . . . . . 0.459 HH12 ' CG ' ' B' 1128 ' ' ASP . 0.4 OUTLIER -81.58 56.62 3.04 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 114.226 1.195 . . . . 55.049999999999997 114.226 -175.528 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B 1121 ' ' ILE . . . . . . . . . . . . . 13.1 pt -129.4 149.22 33.45 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 107.969 -1.123 . . . . 42.090000000000003 107.969 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1122 ' ' SER . . . . . . . . . . . . . 48.6 m -51.14 -32.48 23.16 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 116.894 2.183 . . . . 38.020000000000003 116.894 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1123 ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -58.02 -39.05 77.37 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.642 1.577 . . . . 34.289999999999999 109.219 174.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1124 ' ' ALA . . . . . . . . . . . . . . . -84.19 -30.82 25.48 Favored 'General case' 0 C--O 1.206 -1.191 0 O-C-N 121.241 -0.912 . . . . 32.350000000000001 111.419 175.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1125 ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -58.85 -26.84 64.57 Favored 'General case' 0 C--N 1.348 0.534 0 N-CA-C 118.304 2.705 . . . . 47.170000000000002 118.304 -165.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1126 ' ' SER . . . . . . . . . . . . . 1.4 p -72.04 -34.49 68.81 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 124.183 1.944 . . . . 31.710000000000001 110.805 173.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1127 ' ' LEU . . . . . . . . . . . . . 2.5 mp -80.64 -30.84 36.6 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 113.304 -1.771 . . . . 37.0 110.363 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1128 ' ' ASP . . . . . 0.459 ' CG ' HH12 ' B' 1120 ' ' ARG . 10.1 t70 -62.74 123.43 18.42 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 114.554 1.316 . . . . 40.399999999999999 114.554 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B 1129 ' ' ALA . . . . . . . . . . . . . . . -70.12 -35.17 73.91 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 115.671 -0.695 . . . . 26.559999999999999 112.359 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 46.7 mt -57.48 -33.53 68.09 Favored 'General case' 0 CA--C 1.557 1.248 0 CA-C-O 115.635 -2.126 . . . . 30.890000000000001 111.751 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1131 ' ' SER . . . . . . . . . . . . . 59.7 p -57.15 -56.99 14.58 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 119.825 1.193 . . . . 29.84 113.047 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1132 ' ' SER . . . . . . . . . . . . . 24.9 m -64.93 -39.29 93.28 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 126.121 2.138 . . . . 31.91 111.862 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1133 ' ' MET . . . . . 0.481 ' SD ' ' NH1' ' B' 1015 ' ' ARG . 36.4 mmt -69.73 -30.61 68.26 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 113.102 0.779 . . . . 25.899999999999999 113.102 178.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B 1134 ' ' ALA . . . . . . . . . . . . . . . -72.52 -39.04 67.89 Favored 'General case' 0 N--CA 1.415 -2.222 0 CA-C-N 114.447 -1.251 . . . . 26.620000000000001 107.95 174.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.85 -35.22 79.54 Favored 'General case' 0 C--O 1.215 -0.763 0 CA-C-N 119.506 1.048 . . . . 36.969999999999999 110.902 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B 1136 ' ' ILE . . . . . . . . . . . . . 39.5 mm -64.09 -53.67 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 102.457 -3.164 . . . . 32.109999999999999 102.457 174.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -55.25 -37.16 66.86 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 114.23 1.196 . . . . 24.140000000000001 114.23 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -71.64 -43.28 52.53 Favored Glycine 0 C--N 1.308 -1.018 0 CA-C-N 118.273 0.488 . . . . 25.129999999999999 114.291 178.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 34.6 t80 -71.01 -41.59 70.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 123.316 1.531 . . . . 32.729999999999997 112.535 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1140 ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -67.98 -28.59 67.58 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 113.463 -1.699 . . . . 26.359999999999999 110.552 175.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1141 ' ' ALA . . . . . . . . . . . . . . . -58.95 -51.46 69.96 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 105.931 -1.877 . . . . 24.120000000000001 105.931 174.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 20.6 mm -59.03 -42.29 85.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-O 117.84 -1.076 . . . . 23.370000000000001 109.686 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 76.4 t -58.97 -62.41 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 119.528 1.058 . . . . 24.960000000000001 113.454 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -62.85 -35.58 80.43 Favored 'General case' 0 C--O 1.267 1.983 0 O-C-N 124.384 1.053 . . . . 32.07 110.258 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1145 ' ' ALA . . . . . . . . . . . . . . . -54.65 -61.58 2.22 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.124 0.57 . . . . 24.870000000000001 112.085 167.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1146 ' ' ALA . . . . . . . . . . . . . . . -58.85 -27.5 65.2 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 118.965 -2.334 . . . . 24.670000000000002 114.893 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 62.1 t60 -63.57 -45.87 88.51 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 114.374 -1.285 . . . . 28.579999999999998 109.973 170.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1148 ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -100.59 4.89 43.76 Favored 'General case' 0 C--O 1.255 1.343 0 N-CA-C 114.628 1.344 . . . . 36.82 114.628 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1149 ' ' PHE . . . . . . . . . . . . . 1.4 t80 -76.45 146.09 38.83 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 123.719 1.723 . . . . 31.969999999999999 108.099 -174.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1150 ' ' GLY . . . . . . . . . . . . . . . -66.29 -43.82 92.05 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 113.355 -1.748 . . . . 25.489999999999998 109.682 170.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1151 ' ' ARG . . . . . . . . . . . . . 75.2 mtm-85 -119.89 -171.58 2.17 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 117.983 0.892 . . . . 59.840000000000003 113.374 -163.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1152 ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -88.65 159.11 18.0 Favored 'General case' 0 C--O 1.238 0.486 0 O-C-N 120.264 -1.522 . . . . 34.450000000000003 111.759 169.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1153 ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -77.02 -56.59 4.45 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 114.205 -1.361 . . . . 31.170000000000002 112.809 171.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1154 ' ' THR . . . . . . . . . . . . . 12.1 m -65.05 142.07 58.53 Favored 'General case' 0 C--O 1.25 1.131 0 CA-C-O 121.899 0.857 . . . . 33.890000000000001 109.956 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -73.06 59.0 1.83 Allowed Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 110.515 -1.034 . . . . 38.950000000000003 110.515 170.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -77.24 134.6 38.54 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 124.938 1.295 . . . . 54.229999999999997 110.646 -160.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 15.0 mm -80.68 116.58 25.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 101.454 -3.535 . . . . 51.159999999999997 101.454 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1158 ' ' THR . . . . . . . . . . . . . 31.5 m -122.22 155.07 36.6 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.305 1.05 . . . . 49.609999999999999 108.396 -175.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -26.36 -61.2 0.08 Allowed 'General case' 0 C--O 1.212 -0.907 0 N-CA-C 119.422 3.119 . . . . 49.049999999999997 119.422 172.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -57.94 -51.03 71.32 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 114.299 1.222 . . . . 47.649999999999999 114.299 170.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . 179.6 178.59 48.5 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-O 122.225 0.903 . . . . 45.609999999999999 113.717 -165.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 84.4 mttt -79.3 140.61 37.52 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 123.083 1.42 . . . . 57.460000000000001 109.764 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1163 ' ' VAL . . . . . . . . . . . . . 48.6 t -90.99 130.11 41.62 Favored Pre-proline 0 C--N 1.299 -1.624 0 CA-C-O 116.5 -1.714 . . . . 42.93 107.603 173.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1164 ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -59.33 135.83 68.0 Favored 'Trans proline' 0 N--CA 1.479 0.667 0 C-N-CA 123.906 3.071 . . . . 39.289999999999999 111.865 167.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1165 ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -67.31 141.46 56.68 Favored 'Trans proline' 0 C--O 1.255 1.327 0 C-N-CA 123.287 2.658 . . . . 34.170000000000002 114.254 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -73.09 127.68 33.29 Favored 'General case' 0 C--O 1.253 1.266 0 N-CA-C 105.826 -1.916 . . . . 31.690000000000001 105.826 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1167 ' ' LYS . . . . . . . . . . . . . 93.6 mttt -93.81 108.27 20.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 123.201 1.477 . . . . 44.780000000000001 107.949 168.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 87.7 t -94.24 95.44 5.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 113.766 -1.561 . . . . 31.23 108.153 -172.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1169 ' ' MET . . . . . . . . . . . . . 54.8 ttp -79.83 95.69 6.11 Favored 'General case' 0 C--O 1.245 0.831 0 O-C-N 120.534 -1.354 . . . . 37.090000000000003 108.759 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 24.3 t -93.22 99.2 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 N-CA-C 106.435 -1.691 . . . . 30.170000000000002 106.435 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1171 ' ' ILE . . . . . . . . . . . . . 35.4 mt -93.38 119.75 41.66 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 N-CA-C 105.677 -1.972 . . . . 33.740000000000002 105.677 -175.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 98.68 62.52 0.86 Allowed Glycine 0 C--N 1.346 1.131 0 N-CA-C 108.44 -1.864 . . . . 32.590000000000003 108.44 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1173 ' ' ALA . . . . . . . . . . . . . . . -74.44 60.34 0.86 Allowed 'General case' 0 C--O 1.247 0.944 0 N-CA-C 114.89 1.441 . . . . 32.420000000000002 114.89 176.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -87.95 -158.76 33.64 Favored Glycine 0 C--O 1.213 -1.203 0 N-CA-C 105.642 -2.983 . . . . 31.739999999999998 105.642 160.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 3.7 t -54.42 -39.1 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-N 120.432 2.116 . . . . 31.48 112.439 -172.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1176 ' ' ALA . . . . . . . . . . . . . . . -67.14 -38.24 85.17 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 120.689 -1.257 . . . . 26.120000000000001 110.977 178.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1177 ' ' GLY . . . . . . . . . . . . . . . -55.29 -54.12 36.34 Favored Glycine 0 C--O 1.208 -1.519 0 C-N-CA 124.534 1.064 . . . . 25.73 110.759 174.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1178 ' ' LEU . . . . . . . . . . . . . 15.6 mt -65.39 -30.03 70.8 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 113.285 -1.457 . . . . 32.590000000000003 110.846 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -68.82 -42.19 77.58 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.765 -0.584 . . . . 27.719999999999999 109.782 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -70.25 -37.57 74.96 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 107.498 -1.297 . . . . 26.030000000000001 107.498 -174.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1181 ' ' ILE . . . . . . . . . . . . . 13.3 mt -63.06 -48.8 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 107.342 -1.355 . . . . 28.609999999999999 107.342 171.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -58.38 -26.7 59.66 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-O 118.724 -1.042 . . . . 25.23 115.203 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -90.11 -60.78 1.84 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 118.683 1.241 . . . . 24.09 111.308 174.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -61.05 -44.92 96.67 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 116.097 1.888 . . . . 26.68 116.097 -175.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 5.0 t30 -66.14 -45.91 79.37 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 118.099 -0.953 . . . . 36.57 109.344 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1186 ' ' SER . . . . . . . . . . . . . 16.1 m -56.21 -45.61 79.8 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 120.577 1.535 . . . . 28.920000000000002 112.876 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1187 ' ' LEU . . . . . . . . . . . . . 58.6 mt -45.1 -52.35 9.23 Favored 'General case' 0 C--O 1.246 0.879 0 O-C-N 123.934 0.771 . . . . 29.09 112.788 165.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 128.41 27.24 0.91 Allowed Glycine 0 N--CA 1.438 -1.175 0 O-C-N 121.26 -0.9 . . . . 29.260000000000002 112.969 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1189 ' ' ALA . . . . . . . . . . . . 0.259 . . -102.48 146.11 28.59 Favored 'General case' 0 C--O 1.251 1.176 0 N-CA-C 107.747 -1.205 . . . . 30.16 107.747 -179.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 74.0 mt -83.82 103.94 11.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 103.178 -2.897 . . . . 35.810000000000002 103.178 -171.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1191 ' ' VAL . . . . . . . . . . . . . 53.0 t -81.26 131.85 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.646 0 N-CA-C 104.903 -2.258 . . . . 31.969999999999999 104.903 176.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1192 ' ' ARG . . . . . . . . . . . . . 33.2 mtt180 -120.57 89.85 3.21 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 109.827 -3.351 . . . . 48.159999999999997 104.946 171.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -90.31 130.29 36.43 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.401 -1.272 . . . . 35.890000000000001 113.151 -176.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 35.2 t80 -106.31 144.12 33.45 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.72 -1.215 . . . . 41.880000000000003 107.72 175.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1195 ' ' ASP . . . . . . . . . . . . . 8.9 t70 -157.98 153.26 25.82 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 104.417 -2.438 . . . . 38.280000000000001 104.417 160.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1196 ' ' THR . . . . . . . . . . . . . 13.4 p -84.25 -10.04 58.0 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.114 0.783 . . . . 40.619999999999997 113.114 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1197 ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -91.43 126.6 53.93 Favored Pre-proline 0 C--O 1.247 0.969 0 C-N-CA 124.294 1.038 . . . . 53.090000000000003 108.353 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -52.6 -45.7 38.37 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 N-CA-C 121.264 3.525 . . . . 42.560000000000002 121.264 177.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.66 -8.42 55.21 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 118.351 -2.718 . . . . 56.310000000000002 114.094 -157.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B 1200 ' ' VAL . . . . . . . . . . . . . 34.5 m -85.06 -17.46 9.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 120.799 -1.188 . . . . 42.909999999999997 111.257 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 49.1 tttm -50.39 -54.26 23.12 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 121.428 1.922 . . . . 48.890000000000001 112.252 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 20.6 mp0 -64.64 -21.96 66.85 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 116.715 2.117 . . . . 51.700000000000003 116.715 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1203 ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -64.98 -48.16 74.98 Favored 'General case' 0 C--O 1.248 1.0 0 O-C-N 118.647 -2.533 . . . . 52.57 110.197 172.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1204 ' ' VAL . . . . . . . . . . . . . 12.1 t -59.97 -54.2 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 112.144 -2.298 . . . . 33.789999999999999 108.504 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -51.08 -51.73 50.4 Favored 'General case' 0 C--O 1.203 -1.362 0 C-N-CA 124.579 1.152 . . . . 36.579999999999998 112.88 177.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1206 ' ' SER . . . . . . . . . . . . . 16.5 m -71.41 -7.58 48.23 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 115.634 1.716 . . . . 39.609999999999999 115.634 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1207 ' ' MET . . . . . . . . . . . . . 27.5 mtp -80.21 -38.71 30.58 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 123.118 1.437 . . . . 37.450000000000003 112.012 167.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 121.58 46.87 0.31 Allowed Glycine 0 CA--C 1.519 0.297 0 CA-C-N 112.035 -2.348 . . . . 31.870000000000001 108.031 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -142.36 150.28 40.51 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 114.033 -1.083 . . . . 35.399999999999999 110.233 -168.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -81.58 139.51 35.02 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 125.677 1.861 . . . . 47.890000000000001 107.421 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 87.7 t80 -107.21 114.24 28.16 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 106.244 -1.761 . . . . 45.530000000000001 106.244 170.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1212 ' ' LEU . . . . . . . . . . . . . 62.7 mt -65.94 116.65 7.31 Favored 'General case' 0 N--CA 1.441 -0.913 0 O-C-N 120.616 -1.303 . . . . 46.329999999999998 108.075 170.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -80.99 175.81 10.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 122.964 1.364 . . . . 60.409999999999997 111.932 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 25.4 mt -56.92 132.0 51.33 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 112.705 -2.043 . . . . 57.380000000000003 108.998 168.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 15.1 t70 . . . . . 0 N--CA 1.443 -0.777 0 C-N-CA 124.354 1.062 . . . . 65.069999999999993 108.848 -177.102 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B 1230 ' ' MET . . . . . . . . . . . . . 3.0 mmt . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 105.121 -2.178 . . . . 80.319999999999993 105.121 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B 1231 ' ' SER . . . . . . . . . . . . . 4.8 m 103.83 159.49 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.085 2 O-C-N 114.398 -5.189 . . . . 79.920000000000002 114.175 -18.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -56.06 154.0 8.22 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 116.579 2.066 . . . . 77.909999999999997 116.579 -172.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 66.39 -53.79 0.41 Allowed 'General case' 0 C--N 1.356 0.873 0 C-N-CA 126.273 1.829 . . . . 73.879999999999995 112.688 -172.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 32.2 t80 -60.5 -35.7 76.59 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-N 121.025 1.739 . . . . 68.980000000000004 109.227 171.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 15.4 pt -47.46 -32.69 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 120.22 1.373 . . . . 64.530000000000001 114.175 169.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -60.17 -46.02 91.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 117.994 -2.941 . . . . 66.359999999999999 111.75 169.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -69.5 -29.94 67.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 123.229 1.49 . . . . 56.600000000000001 111.527 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -63.79 -48.38 77.13 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 114.16 -1.382 . . . . 56.789999999999999 109.196 175.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1239 ' ' MET . . . . . . . . . . . . . 29.6 mmt -57.47 -55.98 27.73 Favored 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 125.359 1.464 . . . . 53.630000000000003 107.343 177.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -53.9 -29.44 41.91 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 114.643 1.349 . . . . 51.740000000000002 114.643 176.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 58.3 tp -70.02 -43.46 71.29 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 108.978 -0.749 . . . . 44.859999999999999 108.978 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -74.08 -39.94 63.1 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 124.722 1.264 . . . . 42.780000000000001 111.408 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.97 93.77 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.373 -0.831 . . . . 40.960000000000001 109.86 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -60.25 -49.13 78.81 Favored 'General case' 0 C--N 1.316 -0.879 0 O-C-N 121.195 -0.941 . . . . 43.060000000000002 110.368 172.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -65.38 -24.19 67.16 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 113.052 -1.885 . . . . 46.450000000000003 110.842 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -48.84 -39.75 26.8 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 119.589 3.181 . . . . 41.780000000000001 119.589 -174.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 12.3 mptt -67.91 -31.7 71.65 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.224 -1.548 . . . . 52.200000000000003 112.324 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1248 ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -80.97 -44.17 18.57 Favored 'General case' 0 C--O 1.251 1.158 0 CA-C-N 114.168 -1.378 . . . . 53.549999999999997 111.885 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1249 ' ' VAL . . . . . . . . . . . . . 35.2 m -85.72 150.36 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 124.454 2.073 . . . . 34.409999999999997 111.135 -165.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1250 ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -108.08 -47.59 3.53 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 110.749 -2.932 . . . . 33.380000000000003 111.328 -176.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1251 ' ' ILE . . . . . . . . . . . . . 33.0 mm -119.21 125.15 74.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 105.978 -1.86 . . . . 29.539999999999999 105.978 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1252 ' ' ILE . . . . . . . . . . . . . 79.8 mt -103.68 118.56 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 104.583 -2.377 . . . . 32.439999999999998 104.583 172.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1253 ' ' VAL . . . . . . . . . . . . . 52.9 t -111.39 89.99 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.072 0 N-CA-C 104.433 -2.432 . . . . 30.57 104.433 177.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1254 ' ' THR . . . . . . . . . . . . . 14.1 t -101.44 131.94 47.3 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 113.736 -1.575 . . . . 35.039999999999999 109.027 -169.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1255 ' ' THR . . . . . . . . . . . . . 2.6 m -146.93 31.43 0.94 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.875 -1.057 . . . . 34.619999999999997 113.14 -157.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . -73.7 75.62 1.55 Allowed 'General case' 0 C--O 1.244 0.804 0 O-C-N 117.842 -3.036 . . . . 42.719999999999999 111.483 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 32.7 mt -83.83 79.18 9.56 Favored 'General case' 0 C--O 1.248 0.976 0 CA-C-O 123.677 1.703 . . . . 52.43 108.084 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 27.2 pt -81.86 132.91 52.88 Favored Pre-proline 0 N--CA 1.448 -0.568 0 CA-C-N 113.357 -1.747 . . . . 59.409999999999997 109.985 -173.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -49.59 99.33 0.04 OUTLIER 'Trans proline' 0 CA--C 1.495 -1.451 0 N-CA-C 120.113 3.082 . . . . 62.68 120.113 -166.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 74.09 3.81 65.93 Favored Glycine 0 N--CA 1.432 -1.574 0 CA-C-N 112.604 -2.089 . . . . 64.159999999999997 112.698 173.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 95.0 mttt -105.53 164.7 14.51 Favored Pre-proline 0 C--O 1.211 -0.946 0 CA-C-O 115.919 -1.991 . . . . 68.530000000000001 110.991 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -70.92 142.24 42.36 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 CA-C-N 126.654 3.412 . . . . 61.990000000000002 111.957 167.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1263 ' ' ALA . . . . . . . . . . . . . . . -62.68 135.91 95.96 Favored Pre-proline 0 C--O 1.249 1.073 0 N-CA-C 113.851 1.056 . . . . 57.149999999999999 113.851 173.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -64.91 154.26 73.98 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 121.991 1.794 . . . . 51.57 114.647 173.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -81.96 82.69 7.49 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 118.649 -1.221 . . . . 54.549999999999997 109.019 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 62.5 mt -64.98 -48.19 74.87 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-O 123.125 1.441 . . . . 46.859999999999999 113.399 175.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1267 ' ' ILE . . . . . . . . . . . . . 22.9 mm -96.0 97.56 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 122.088 0.947 . . . . 41.039999999999999 108.896 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1268 ' ' THR . . . . . . . . . . . . . 18.1 p -76.5 162.04 28.14 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 113.732 -1.576 . . . . 39.579999999999998 113.197 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1269 ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -59.24 -36.05 74.78 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 124.376 1.07 . . . . 53.149999999999999 111.296 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -50.65 -58.65 5.34 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 114.57 -1.196 . . . . 42.960000000000001 111.638 167.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1271 ' ' MET . . . . . . . . . . . . . 28.6 ttm -60.08 -33.55 72.22 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.637 1.347 . . . . 43.890000000000001 114.637 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1272 ' ' VAL . . . . . . . . . . . . . 58.1 t -66.27 -48.05 82.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 109.048 -0.723 . . . . 38.369999999999997 109.048 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 4.7 t70 -77.25 -27.43 53.28 Favored 'General case' 0 C--O 1.244 0.776 0 O-C-N 121.617 -0.677 . . . . 47.460000000000001 110.059 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1274 ' ' SER . . . . . . . . . . . . . 67.3 m -74.13 -24.27 59.4 Favored 'General case' 0 C--O 1.246 0.878 0 CA-C-N 115.962 -0.563 . . . . 38.380000000000003 111.814 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1275 ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -60.51 163.19 5.53 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 115.553 1.686 . . . . 37.810000000000002 115.553 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -56.12 130.04 42.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 113.742 -1.572 . . . . 49.259999999999998 110.219 169.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -60.59 159.63 10.34 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.732 -1.576 . . . . 34.460000000000001 111.141 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 64.78 33.54 87.51 Favored Glycine 0 CA--C 1.521 0.421 0 O-C-N 121.427 -0.795 . . . . 33.530000000000001 113.526 172.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1279 ' ' SER . . . . . . . . . . . . . 15.2 m -133.94 167.28 20.89 Favored 'General case' 0 C--O 1.262 1.763 0 C-N-CA 123.481 0.712 . . . . 31.309999999999999 111.598 -164.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1280 ' ' VAL . . . . . . . . . . . . . 66.9 t -127.01 131.06 71.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 O-C-N 119.868 -1.77 . . . . 29.32 111.118 -173.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1281 ' ' ILE . . . . . . . . . . . . . 91.3 mt -103.25 99.37 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 102.505 -3.146 . . . . 31.93 102.505 169.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1282 ' ' VAL . . . . . . . . . . . . . 17.4 t -82.52 115.04 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 105.121 -2.177 . . . . 29.48 105.121 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 42.8 t0 -97.99 112.64 24.5 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 123.819 1.771 . . . . 34.5 106.76 174.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1284 ' ' LEU . . . . . . . . . . . . . 7.3 mp -90.6 -21.28 21.8 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 113.64 -1.618 . . . . 37.939999999999998 110.215 -176.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -96.87 16.68 18.64 Favored 'General case' 0 C--O 1.25 1.115 0 CA-C-O 121.503 0.668 . . . . 40.920000000000002 111.784 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -63.5 -34.89 78.76 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 122.756 1.265 . . . . 44.390000000000001 112.399 -167.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1287 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -45.99 74.36 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 115.237 -0.892 . . . . 51.460000000000001 109.656 174.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.4 37.75 1.62 Allowed 'General case' 0 C--O 1.245 0.843 0 CA-C-O 125.214 2.435 . . . . 57.75 108.856 -167.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B 1289 ' ' GLY . . . . . . . . . . . . . . . 139.57 -61.75 0.56 Allowed Glycine 0 N--CA 1.433 -1.532 0 O-C-N 119.147 -2.221 . . . . 49.850000000000001 111.869 175.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 96.19 114.39 2.98 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 107.519 -2.232 . . . . 45.93 107.519 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1291 ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -72.86 -16.26 61.59 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.314 -0.995 . . . . 42.670000000000002 108.314 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1292 ' ' CYS . . . . . . . . . . . . . 25.3 t -118.93 139.09 52.24 Favored 'General case' 0 N--CA 1.432 -1.33 0 O-C-N 118.748 -2.47 . . . . 38.82 113.265 -175.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1293 ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -66.81 -40.84 88.21 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 118.745 -0.645 . . . . 46.710000000000001 112.441 177.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.08 -6.41 50.99 Favored 'General case' 0 C--O 1.239 0.531 0 O-C-N 125.866 1.979 . . . . 47.229999999999997 113.124 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B 1295 ' ' THR . . . . . . . . . . . . . 74.1 m -52.67 137.76 30.24 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 124.955 2.312 . . . . 36.020000000000003 112.025 172.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 3.7 t -117.42 105.14 48.94 Favored Pre-proline 0 C--N 1.321 -0.643 1 N-CA-C 96.65 -5.315 . . . . 37.259999999999998 96.65 168.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -56.7 128.42 29.93 Favored 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 124.968 3.779 . . . . 35.090000000000003 111.311 177.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 96.12 -17.46 59.24 Favored Glycine 0 C--N 1.315 -0.615 0 CA-C-O 122.288 0.938 . . . . 35.969999999999999 112.296 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -123.44 173.64 7.88 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 123.822 1.772 . . . . 40.390000000000001 110.751 -171.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1300 ' ' ILE . . . . . . . . . . . . . 96.4 mt -113.55 105.96 19.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 110.744 -2.935 . . . . 37.43 103.088 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 76.6 t80 -73.1 148.5 43.92 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.347 -1.353 . . . . 44.130000000000003 107.347 171.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1302 ' ' THR . . . . . . . . . . . . . 40.7 m -140.46 119.41 12.65 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 122.773 2.533 . . . . 39.780000000000001 106.538 175.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1303 ' ' THR . . . . . . . . . . . . . 2.7 p -74.21 175.15 7.82 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.854 0.835 . . . . 43.289999999999999 109.801 171.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -74.66 -25.39 59.15 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-O 121.849 0.833 . . . . 53.07 109.801 -174.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -80.47 -7.99 59.38 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.342 -0.984 . . . . 43.969999999999999 108.342 173.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 90.3 37.46 6.64 Favored Glycine 0 N--CA 1.462 0.382 0 O-C-N 119.752 -1.842 . . . . 41.119999999999997 111.382 174.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1307 ' ' VAL . . . . . . . . . . . . . 43.2 t -97.69 108.79 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-O 125.837 2.732 . . . . 38.119999999999997 104.019 170.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1308 ' ' LYS . . . . . . . . . . . . . 83.9 mttt -84.67 102.56 13.05 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 108.783 -3.826 . . . . 36.340000000000003 109.498 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1309 ' ' VAL . . . . . . . . . . . . . 22.0 t -85.02 100.17 7.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 105.483 -2.043 . . . . 30.399999999999999 105.483 177.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1310 ' ' ILE . . . . . . . . . . . . . 27.1 mt -81.8 90.53 2.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 107.032 -1.47 . . . . 30.82 107.032 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1311 ' ' GLY . . . . . . . . . . . . . . . -89.57 83.02 1.41 Allowed Glycine 0 C--N 1.301 -1.411 0 N-CA-C 108.751 -1.739 . . . . 26.530000000000001 108.751 -172.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1312 ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -98.57 133.05 43.47 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 119.306 3.076 . . . . 38.0 119.306 -170.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1313 ' ' THR . . . . . . . . . . . . . 2.6 p -76.87 -63.86 1.26 Allowed 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 109.222 -3.626 . . . . 29.800000000000001 108.509 166.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 4.3 p30 -69.62 6.85 0.98 Allowed 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 120.405 3.483 . . . . 39.039999999999999 120.405 -171.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1315 ' ' LEU . . . . . . . . . . . . . 28.4 mt -46.6 -50.42 41.87 Favored Pre-proline 0 C--N 1.352 0.703 0 N-CA-C 118.952 2.945 . . . . 31.079999999999998 118.952 175.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1316 ' ' PRO . . . . . . . . . . . . . 92.6 Cg_exo -55.45 -33.39 85.81 Favored 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 123.956 3.104 . . . . 26.100000000000001 112.072 174.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -82.56 -53.73 3.5 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 120.424 -1.423 . . . . 23.170000000000002 111.247 -175.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 71.3 mtt-85 -36.95 -16.5 0.0 OUTLIER 'General case' 0 C--O 1.235 0.318 1 N-CA-C 124.077 4.843 . . . . 40.399999999999999 124.077 -170.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 1.3 tp -105.52 77.35 0.38 Allowed Pre-proline 0 C--O 1.252 1.232 0 CA-C-N 124.031 3.105 . . . . 23.600000000000001 106.684 -176.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1320 ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -39.79 -72.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 124.79 3.66 . . . . 22.350000000000001 117.926 -151.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1321 ' ' THR . . . . . . . . . . . . . 2.0 m -66.64 -31.83 72.77 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 112.904 0.705 . . . . 26.52 112.904 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1322 ' ' GLN . . . . . . . . . . . . . 45.8 tp60 -75.81 -44.66 40.07 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 119.097 -2.252 . . . . 24.379999999999999 110.267 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1323 ' ' SER . . . . . . . . . . . . . 50.6 m -46.97 -52.1 15.47 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 120.272 -1.517 . . . . 22.800000000000001 110.394 169.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1324 ' ' SER . . . . . . . . . . . . . 29.0 m -57.1 -59.58 4.88 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 113.495 -1.684 . . . . 21.25 113.457 173.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 66.3 tp60 -52.84 -40.58 63.46 Favored 'General case' 0 C--N 1.344 0.346 0 O-C-N 120.303 -1.498 . . . . 31.34 113.957 -177.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1326 ' ' LEU . . . . . . . . . . . . . 63.4 mt -73.54 -46.94 44.55 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 113.665 0.987 . . . . 31.559999999999999 113.665 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1327 ' ' TYR . . . . . . . . . . . . . 47.2 t80 -54.22 -51.68 63.66 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-O 122.947 1.356 . . . . 22.73 108.6 173.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1328 ' ' GLY . . . . . . . . . . . . . . . -41.06 -57.22 3.04 Favored Glycine 0 CA--C 1.496 -1.151 0 CA-C-N 112.614 -2.085 . . . . 21.91 115.793 168.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1329 ' ' THR . . . . . . . . . . . . . 62.4 m -66.92 -28.96 68.73 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 114.605 1.335 . . . . 22.149999999999999 114.605 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1330 ' ' ASN . . . . . . . . . . . . . 30.5 m120 -53.45 -51.42 62.72 Favored 'General case' 0 C--O 1.24 0.573 0 O-C-N 121.365 -0.834 . . . . 26.18 109.952 167.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1331 ' ' LEU . . . . . . . . . . . . . 20.2 mt -65.95 -39.0 90.07 Favored 'General case' 0 CA--C 1.508 -0.653 0 O-C-N 125.413 1.696 . . . . 23.68 110.404 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1332 ' ' VAL . . . . . . . . . . . . . 59.6 t -55.49 -51.31 58.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 120.073 1.306 . . . . 26.57 109.545 171.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -61.33 -39.86 92.1 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 114.371 -1.286 . . . . 28.079999999999998 109.771 -173.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1334 ' ' LEU . . . . . . . . . . . . . 15.2 tp -70.95 -42.78 69.33 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 126.315 1.846 . . . . 27.43 107.482 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1335 ' ' LEU . . . . . . . . . . . . . 79.7 mt -69.6 -24.19 63.63 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 121.195 1.816 . . . . 30.5 111.495 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1336 ' ' LYS . . . . . . . . . . . . . 76.1 mttt -67.94 -40.57 83.25 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 120.166 1.348 . . . . 41.649999999999999 109.649 169.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 11.5 tp -81.31 -25.88 36.1 Favored 'General case' 0 C--O 1.244 0.802 0 O-C-N 119.266 -2.146 . . . . 42.079999999999998 110.985 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1338 ' ' LEU . . . . . . . . . . . . . 12.8 mt -68.81 -78.94 0.06 Allowed 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 122.753 1.263 . . . . 35.030000000000001 109.946 164.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 18.0 t -78.75 76.5 5.24 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.278 -1.379 . . . . 37.329999999999998 107.278 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 58.2 mttp -65.47 -24.76 67.24 Favored 'General case' 0 C--N 1.35 0.595 0 N-CA-C 113.901 1.074 . . . . 50.509999999999998 113.901 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -73.83 -3.3 27.86 Favored 'General case' 0 C--O 1.25 1.097 0 N-CA-C 115.41 1.633 . . . . 54.210000000000001 115.41 169.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? 33.43 66.58 0.22 Allowed 'General case' 0 C--N 1.357 0.923 0 CA-C-O 125.141 2.4 . . . . 50.990000000000002 116.891 -173.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -134.76 -37.01 0.83 Allowed 'General case' 0 C--O 1.248 0.981 0 CA-C-N 112.975 -1.92 . . . . 48.82 111.315 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 148.23 -31.37 1.3 Allowed Glycine 0 N--CA 1.434 -1.483 0 CA-C-N 122.64 2.473 . . . . 40.43 109.583 -178.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -75.82 113.96 13.88 Favored 'General case' 0 C--N 1.361 1.087 0 CA-C-N 119.442 1.621 . . . . 47.560000000000002 109.758 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1346 ' ' ILE . . . . . . . . . . . . . 46.1 mm -69.4 107.05 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 CA-C-O 125.715 2.674 . . . . 42.490000000000002 107.589 177.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1347 ' ' THR . . . . . . . . . . . . . 9.2 m -83.11 108.24 16.24 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 103.154 -2.906 . . . . 38.119999999999997 103.154 176.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 11.7 t -84.16 84.78 2.01 Favored 'Isoleucine or valine' 0 C--O 1.257 1.478 0 N-CA-C 108.049 -1.093 . . . . 37.5 108.049 -175.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 50.5 t0 -80.86 129.78 34.71 Favored 'General case' 0 CA--C 1.5 -0.951 0 O-C-N 124.053 0.846 . . . . 43.850000000000001 111.244 -169.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1350 ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -114.67 -8.89 12.65 Favored 'General case' 0 C--O 1.251 1.147 0 O-C-N 118.668 -2.52 . . . . 39.810000000000002 110.3 175.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 34.3 t70 -72.78 -49.07 32.98 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 120.306 -1.496 . . . . 51.289999999999999 110.075 177.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 2.6 t70 -64.1 135.63 56.54 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 122.098 2.226 . . . . 39.780000000000001 109.787 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 7.4 m -57.48 -34.32 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 114.507 -1.224 . . . . 39.280000000000001 113.266 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1354 ' ' VAL . . . . . . . . . . . . . 35.8 t -76.02 -48.37 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.408 0 CA-C-N 120.124 1.329 . . . . 35.700000000000003 109.353 -174.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1355 ' ' ILE . . . . . . . . . . . . 0.257 24.1 mm -69.58 -32.86 54.26 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 CA-C-O 116.825 -1.56 . . . . 35.770000000000003 112.917 176.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 39.5 tpt85 -54.79 -49.16 71.63 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 120.488 1.495 . . . . 38.549999999999997 109.287 166.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -64.39 -55.96 20.3 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 119.62 1.1 . . . . 29.579999999999998 112.91 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1358 ' ' VAL . . . . . . . . . . . . . 5.0 p -67.85 -34.19 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 124.334 1.054 . . . . 32.060000000000002 112.704 -174.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1359 ' ' THR . . . . . . . . . . . . . 6.2 m -78.34 92.16 4.52 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-O 125.264 2.459 . . . . 29.0 108.733 177.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1360 ' ' VAL . . . . . . . . . . . . . 18.9 m -78.51 -31.68 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.978 0 CA-C-N 108.898 -3.774 . . . . 29.68 108.257 -175.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 70.0 mt -128.97 119.95 50.7 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 N-CA-C 107.027 -1.471 . . . . 32.049999999999997 107.027 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1362 ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -97.67 113.13 24.82 Favored 'General case' 0 C--O 1.249 1.035 0 O-C-N 119.171 -2.205 . . . . 32.520000000000003 105.187 171.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 26.04 70.75 0.04 OUTLIER 'General case' 0 C--O 1.256 1.432 0 N-CA-C 118.028 2.603 . . . . 35.68 118.028 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 95.06 -50.1 1.94 Allowed Glycine 0 N--CA 1.428 -1.886 0 O-C-N 120.437 -1.414 . . . . 34.259999999999998 114.126 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -66.18 126.41 28.58 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.231 -0.655 . . . . 51.07 109.231 -175.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 49.7 mt -76.44 103.38 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.819 0 O-C-N 119.046 -2.284 . . . . 39.869999999999997 107.885 169.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1367 ' ' THR . . . . . . . . . . . . . 7.3 p -90.79 1.0 57.28 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 116.167 1.914 . . . . 38.009999999999998 116.167 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1368 ' ' TRP . . . . . . . . . . . . . 62.2 t90 -65.26 140.92 98.01 Favored Pre-proline 0 N--CA 1.432 -1.359 0 N-CA-C 105.017 -2.216 . . . . 42.140000000000001 105.017 160.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -70.22 157.69 93.1 Favored 'Cis proline' 0 C--O 1.252 1.184 0 N-CA-C 119.223 2.74 . . . . 43.259999999999998 119.223 10.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1370 ' ' ALA . . . . . . . . . . . . . . . -82.86 113.0 42.35 Favored Pre-proline 0 C--O 1.247 0.95 0 N-CA-C 104.427 -2.435 . . . . 46.520000000000003 104.427 168.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -49.46 132.91 30.67 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.796 2.997 . . . . 51.950000000000003 116.411 -173.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -55.83 83.48 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.838 1 C-N-CA 126.144 4.563 . . . . 56.270000000000003 113.604 176.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B 1373 ' ' ILE . . . . . . . . . . . . . 12.8 tt -75.46 140.78 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-N 114.335 -1.302 . . . . 60.829999999999998 110.552 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -67.4 108.47 2.8 Favored 'General case' 0 C--O 1.249 1.064 0 N-CA-C 107.27 -1.381 . . . . 66.099999999999994 107.27 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 60.8 t -102.97 113.64 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 106.437 -1.69 . . . . 63.469999999999999 106.437 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.206 -5.637 0 O-C-N 120.889 -1.132 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.422 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -52.96 -36.65 60.27 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 116.739 2.126 . . . . 0.0 116.739 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -37.96 -43.68 0.73 Allowed 'General case' 0 C--O 1.242 0.676 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 174.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 22.0 m -42.47 -30.04 0.32 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.678 1.591 . . . . 0.0 114.056 176.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.1 -46.93 86.88 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 123.919 1.819 . . . . 0.0 114.508 171.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -67.23 -46.11 74.79 Favored 'General case' 0 C--O 1.252 1.202 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.105 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 10.9 mp -52.68 -48.66 66.37 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.638 173.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -60.85 -40.36 92.57 Favored 'General case' 0 C--O 1.223 -0.297 0 O-C-N 119.654 -1.904 . . . . 0.0 115.187 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 28' ' ' LYS . . . . . . . . . . . . . 3.0 pttm -67.09 -29.29 69.01 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 118.496 -1.282 . . . . 0.0 113.729 168.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -79.28 -20.12 48.85 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -53.38 -21.34 5.71 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 118.467 2.766 . . . . 0.0 118.467 -160.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 48.4 m-70 71.63 -69.3 0.19 Allowed 'General case' 0 C--N 1.352 0.682 0 CA-C-N 122.925 2.602 . . . . 0.0 109.137 -176.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 48.7 m -120.12 158.62 26.51 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 159.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 32.7 t -123.06 114.56 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.155 0 N-CA-C 101.946 -3.353 . . . . 0.0 101.946 -178.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 18.5 mm -99.32 113.69 35.12 Favored 'Isoleucine or valine' 0 C--O 1.249 1.055 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 175.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 75.9 mt -97.03 116.34 39.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 174.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 93.2 m -99.68 100.74 11.59 Favored Pre-proline 0 C--O 1.239 0.552 0 CA-C-N 114.867 -1.06 . . . . 0.0 113.22 174.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -62.48 149.1 92.11 Favored 'Trans proline' 0 C--O 1.238 0.519 1 C-N-CA 125.879 4.386 . . . . 0.0 109.615 176.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.18 -153.8 7.92 Favored Glycine 0 C--O 1.217 -0.959 0 CA-C-N 109.694 -3.412 . . . . 0.0 108.62 174.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -65.59 -41.35 92.92 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 110.127 -3.037 . . . . 0.0 108.165 -170.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -51.74 -54.76 23.6 Favored Glycine 0 C--N 1.347 1.19 0 O-C-N 120.543 -1.348 . . . . 0.0 113.972 174.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 30.4 ttm -58.97 -35.47 73.24 Favored 'General case' 0 C--O 1.215 -0.722 0 C-N-CA 124.484 1.114 . . . . 0.0 110.307 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.94 -60.59 2.15 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 2.9 p -75.03 -35.49 35.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 CA-C-N 118.422 0.555 . . . . 0.0 111.1 -168.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -112.5 100.16 8.53 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 103.933 -2.617 . . . . 0.0 103.933 166.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 45' ' ' GLN . . . . . . . . . . . . . 16.3 pm0 -46.97 72.64 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 117.955 2.576 . . . . 0.0 117.955 -175.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.21 -22.69 54.97 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.914 -1.741 . . . . 0.0 111.507 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.24 -33.38 65.35 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 -176.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 48' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -65.3 -57.78 14.11 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 120.803 1.638 . . . . 0.0 110.59 172.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 49' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -58.47 -29.09 87.55 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 CA-C-N 125.526 3.009 . . . . 0.0 116.619 171.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 20.3 t -58.16 -51.44 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 120.478 -1.389 . . . . 0.0 108.016 168.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.18 -36.39 79.72 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.324 0.965 . . . . 0.0 112.656 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.28 -53.98 40.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 117.424 -1.274 . . . . 0.0 112.758 173.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 9.6 tp -62.83 -36.48 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 121.991 2.178 . . . . 0.0 110.398 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 74.2 m -47.89 -39.29 18.4 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 176.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -59.9 -42.54 94.08 Favored 'General case' 0 N--CA 1.437 -1.12 0 O-C-N 121.874 -0.517 . . . . 0.0 111.7 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.41 -39.27 59.21 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -176.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 72.9 mt -65.59 -33.23 75.42 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.658 1.183 . . . . 0.0 108.72 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.58 -32.49 53.76 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 120.231 -1.543 . . . . 0.0 108.882 177.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.89 -46.93 61.71 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-N 121.005 1.73 . . . . 0.0 109.388 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -42.93 -42.42 3.72 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.329 1.452 . . . . 0.0 112.844 162.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.44 54.72 2.61 Favored Glycine 0 N--CA 1.437 -1.271 0 O-C-N 126.016 2.072 . . . . 0.0 112.154 176.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 93.8 mt -103.35 142.7 16.67 Favored 'Isoleucine or valine' 0 C--O 1.248 1.006 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -71.41 74.52 0.75 Allowed 'General case' 0 C--O 1.257 1.466 0 CA-C-O 123.418 1.58 . . . . 0.0 109.418 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.14 115.34 28.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 117.551 -1.659 . . . . 0.0 108.211 -176.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 14.3 mmm-85 -114.84 134.25 55.29 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.273 -177.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -93.5 79.48 4.35 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 123.01 1.386 . . . . 0.0 109.857 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.95 78.04 0.4 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-N 110.316 -3.129 . . . . 0.0 111.809 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 12.9 mt -77.72 148.62 6.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 -103.15 134.39 19.81 Favored Pre-proline 0 C--O 1.242 0.699 0 N-CA-C 104.152 -2.536 . . . . 0.0 104.152 168.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 70' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -59.6 -72.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.123 0 C-N-CA 123.862 3.041 . . . . 0.0 114.887 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 23.0 t -70.87 95.53 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 170.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -165.26 161.34 19.16 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 123.252 1.501 . . . . 0.0 108.608 175.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 54.15 -110.55 1.58 Allowed Glycine 0 CA--C 1.535 1.296 0 CA-C-N 112.934 -1.939 . . . . 0.0 109.824 171.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -130.85 108.28 9.73 Favored 'General case' 0 C--O 1.259 1.605 0 O-C-N 121.959 -0.73 . . . . 0.0 111.234 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 4.5 tt 63.83 114.67 0.02 OUTLIER Pre-proline 0 N--CA 1.445 -0.682 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 174.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -56.89 104.28 0.14 Allowed 'Trans proline' 0 C--N 1.32 -0.925 1 C-N-CA 126.037 4.491 . . . . 0.0 107.805 175.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 132.01 -68.34 0.55 Allowed Glycine 0 N--CA 1.435 -1.395 0 N-CA-C 106.818 -2.513 . . . . 0.0 106.818 -171.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -63.37 -29.19 70.53 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -159.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -42.43 94.67 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 119.406 1.003 . . . . 0.0 110.493 175.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -72.83 -32.16 65.3 Favored 'General case' 0 C--N 1.368 1.377 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.562 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 48.7 t -73.01 -26.22 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 123.893 1.806 . . . . 0.0 110.303 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.9 tp -75.11 -31.92 61.26 Favored 'General case' 0 C--N 1.312 -1.03 0 O-C-N 120.55 -1.343 . . . . 0.0 108.397 166.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 9.0 mp -63.86 -30.52 71.6 Favored 'General case' 0 C--O 1.241 0.653 0 O-C-N 116.976 -3.577 . . . . 0.0 112.872 166.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.21 -49.24 76.54 Favored 'General case' 0 N--CA 1.442 -0.849 0 O-C-N 124.57 1.169 . . . . 0.0 111.877 168.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -55.55 -40.02 71.36 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.225 1.01 . . . . 0.0 111.845 171.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.43 -21.27 53.27 Favored 'General case' 0 C--O 1.254 1.324 0 O-C-N 121.069 -1.019 . . . . 0.0 112.274 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp 77.36 50.82 0.04 OUTLIER 'General case' 0 C--O 1.242 0.682 0 CA-C-O 125.627 2.632 . . . . 0.0 112.95 -177.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 66.5 t -91.56 131.58 35.69 Favored Pre-proline 0 C--N 1.319 -0.751 0 O-C-N 118.885 -2.385 . . . . 0.0 112.146 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -61.28 99.57 0.16 Allowed 'Trans proline' 0 C--O 1.242 0.703 0 C-N-CA 124.471 3.447 . . . . 0.0 116.264 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -54.49 -26.07 29.15 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -174.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.97 -47.78 77.04 Favored 'General case' 0 C--O 1.248 1.004 0 O-C-N 120.116 -1.615 . . . . 0.0 112.024 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 5.0 pt -88.47 -8.54 10.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 84.8 t -71.19 119.77 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 165.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 65.0 mt -123.77 99.72 6.42 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.711 -1.132 . . . . 0.0 109.129 -175.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -91.79 74.47 5.74 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 -171.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 6.2 ttp 62.83 124.5 0.01 OUTLIER 'General case' 0 CA--C 1.497 -1.089 0 CA-C-N 111.322 -2.672 . . . . 0.0 111.602 -167.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -159.34 -172.35 3.7 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-N 112.657 -2.065 . . . . 0.0 106.973 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -76.49 61.19 1.71 Allowed 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 121.082 -1.012 . . . . 0.0 111.223 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 6.2 tp -92.64 27.66 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.778 0 CA-C-O 124.851 2.262 . . . . 0.0 109.92 -168.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -71.64 -60.82 2.03 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.602 -1.311 . . . . 0.0 114.115 -166.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -70.3 -32.49 70.28 Favored 'General case' 0 C--O 1.215 -0.753 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -56.97 -41.44 78.36 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 117.11 -1.424 . . . . 0.0 110.697 173.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 103' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -54.98 -45.08 74.98 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 120.185 1.357 . . . . 0.0 113.153 169.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.21 -33.19 73.96 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 122.411 1.101 . . . . 0.0 108.722 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -68.03 -33.13 74.01 Favored 'General case' 0 C--O 1.243 0.711 0 O-C-N 118.87 -2.394 . . . . 0.0 111.367 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 106' ' ' THR . . . . . . . . . . . . . 51.7 m -76.11 122.42 24.26 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.745 1.26 . . . . 0.0 109.183 -175.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.26 -57.97 3.98 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.594 169.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 4.3 m -104.05 104.99 15.02 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -169.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 109' ' ' VAL . . . . . . . . . . . . . 24.4 t -94.95 107.95 20.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 172.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 80.2 mt -78.23 86.37 4.35 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.901 -0.499 . . . . 0.0 111.827 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 98.8 t -79.93 83.1 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-O 124.315 2.007 . . . . 0.0 108.237 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 7.4 mt -78.05 77.22 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.747 0 CA-C-O 123.321 1.534 . . . . 0.0 113.03 -172.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 113' ' ' GLY . . . . . . . . . . . . . . . 71.19 42.07 58.71 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.054 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -107.83 -24.8 11.52 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 120.84 -1.388 . . . . 0.0 110.321 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 115' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.94 -85.79 0.02 OUTLIER 'General case' 0 C--N 1.352 0.709 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 162.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 116' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -83.61 -22.74 32.16 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -174.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 2.7 p -80.01 9.99 4.82 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 117.303 2.335 . . . . 0.0 117.303 -175.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.66 13.06 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 112.947 -1.933 . . . . 0.0 109.645 169.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -90.08 121.02 69.19 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-O 118.475 -0.774 . . . . 0.0 111.17 -169.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 120' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -52.75 -28.33 37.66 Favored 'Trans proline' 0 C--O 1.251 1.153 0 C-N-CA 123.401 2.734 . . . . 0.0 113.701 175.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.97 12.48 0.04 OUTLIER 'General case' 0 C--N 1.354 0.784 0 N-CA-C 116.644 2.091 . . . . 0.0 116.644 174.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 122' ' ' ALA . . . . . . . . . . . . . . . -109.61 -2.34 17.58 Favored 'General case' 0 N--CA 1.426 -1.653 0 O-C-N 120.628 -1.295 . . . . 0.0 113.993 171.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.9 -39.85 0.09 Allowed 'General case' 0 C--N 1.351 0.671 0 CA-C-O 125.021 2.344 . . . . 0.0 115.969 169.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -66.12 -38.6 88.6 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 119.351 -2.093 . . . . 0.0 111.818 173.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -102.63 121.08 50.91 Favored Pre-proline 0 C--N 1.347 0.457 0 O-C-N 124.19 0.931 . . . . 0.0 110.707 171.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -77.6 -18.28 13.73 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 124.461 3.441 . . . . 0.0 115.677 174.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -62.95 -58.93 5.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 122.061 0.934 . . . . 0.0 112.47 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 128' ' ' SER . . . . . . . . . . . . . 66.6 m -57.36 149.52 48.3 Favored Pre-proline 0 C--O 1.24 0.595 0 N-CA-C 116.496 2.036 . . . . 0.0 116.496 -163.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 129' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -55.18 -17.73 15.98 Favored 'Trans proline' 0 CA--C 1.564 2.012 1 C-N-CA 126.003 4.469 . . . . 0.0 115.296 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 8.8 pt -101.67 12.8 6.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 120.004 1.275 . . . . 0.0 114.283 173.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -71.77 86.04 0.94 Allowed 'General case' 0 C--O 1.239 0.549 0 CA-C-O 124.353 2.025 . . . . 0.0 109.147 -172.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 149.5 53.83 0.02 OUTLIER Glycine 0 N--CA 1.423 -2.17 0 CA-C-N 111.963 -2.381 . . . . 0.0 108.777 -175.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 133' ' ' MET . . . . . . . . . . . . . 6.6 tpp -147.54 125.3 5.88 Favored Pre-proline 0 CA--C 1.548 0.865 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -78.1 83.6 2.17 Favored 'Trans proline' 0 C--O 1.238 0.492 1 C-N-CA 125.612 4.208 . . . . 0.0 107.479 -175.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 8.3 m -64.7 154.02 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 CA-C-N 113.681 -1.6 . . . . 0.0 113.288 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 88.3 mt -74.87 120.51 20.52 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -21.29 -28.02 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.159 1 N-CA-C 123.738 4.718 . . . . 0.0 123.738 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 8.3 p -79.6 83.35 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -175.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 34.7 p90 -125.91 171.01 11.09 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-N 112.206 -2.27 . . . . 0.0 109.008 165.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 140' ' ' LYS . . . . . . . . . . . . . 21.0 pttm 56.55 -0.55 0.06 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 117.598 2.444 . . . . 0.0 117.598 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -141.76 165.62 26.97 Favored 'General case' 0 C--O 1.256 1.423 0 CA-C-O 116.015 -1.945 . . . . 0.0 109.731 -175.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 64.35 168.1 0.17 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 161.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 143' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -84.24 73.49 10.43 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 124.52 2.105 . . . . 0.0 109.667 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 144' ' ' VAL . . . . . . . . . . . . . 3.2 t -81.34 100.58 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 103.393 -2.818 . . . . 0.0 103.393 175.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 145' ' ' ILE . . . . . . . . . . . . 0.287 13.0 tt -98.87 99.27 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 112.31 -2.223 . . . . 0.0 112.062 -173.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 146' ' ' VAL . . . . . . . . . . . . . 39.5 t -84.11 113.38 22.85 Favored 'Isoleucine or valine' 0 C--N 1.343 0.298 0 CA-C-N 112.702 -2.044 . . . . 0.0 107.013 -171.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 147' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -66.41 112.73 4.2 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 122.647 1.213 . . . . 0.0 110.427 177.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 148' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -146.26 108.76 4.48 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 105.909 -1.885 . . . . 0.0 105.909 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -64.97 -40.7 95.38 Favored 'General case' 0 C--N 1.344 0.333 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.78 145.13 51.88 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 103.988 -2.597 . . . . 0.0 103.988 -174.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -84.02 68.94 10.24 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 170.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -87.16 168.06 13.59 Favored 'General case' 0 C--O 1.258 1.536 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.294 173.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 13.3 m -71.43 119.52 15.7 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -72.94 -133.16 0.18 Allowed Glycine 0 N--CA 1.478 1.441 0 O-C-N 118.797 -2.439 . . . . 0.0 108.75 172.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -77.03 -50.86 12.15 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 117.135 -1.826 . . . . 0.0 109.881 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 156' ' ' ALA . . . . . . . . . . . . . . . -94.83 -53.32 3.89 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 161.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 65.96 14.68 61.48 Favored Glycine 0 C--O 1.254 1.349 0 CA-C-O 122.504 1.058 . . . . 0.0 114.253 -173.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 13.5 m -89.6 124.84 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -162.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . 0.301 0.0 OUTLIER 37.0 24.61 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 118.266 2.691 . . . . 0.0 118.266 172.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 160' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -62.57 111.63 5.1 Favored Pre-proline 0 C--O 1.239 0.535 0 O-C-N 120.461 -1.399 . . . . 0.0 110.22 -171.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -56.18 -41.94 71.46 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.885 2.39 . . . . 0.0 112.48 -177.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 162' ' ' LEU . . . . . . . . . . . . . 16.0 mt -17.48 -40.91 0.0 OUTLIER 'General case' 0 C--O 1.244 0.794 0 N-CA-C 120.62 3.563 . . . . 0.0 120.62 155.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 163' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -82.02 -48.33 11.55 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-O 124.385 2.041 . . . . 0.0 111.777 176.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -91.06 -17.04 26.88 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 111.963 -2.38 . . . . 0.0 113.611 -158.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -87.88 172.43 9.62 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 121.818 2.099 . . . . 0.0 110.863 -168.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -55.75 10.62 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 120.406 -1.434 . . . . 0.0 114.479 177.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -82.53 -49.97 9.31 Favored 'General case' 0 C--O 1.239 0.538 0 O-C-N 124.848 1.342 . . . . 0.0 108.115 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 168' ' ' THR . . . . . . . . . . . . . 4.8 m -82.84 91.9 7.17 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 123.328 1.537 . . . . 0.0 107.443 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -142.41 142.82 32.44 Favored 'General case' 0 N--CA 1.439 -1.013 0 O-C-N 120.88 -1.137 . . . . 0.0 111.686 -154.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 170' ' ' MET . . . . . . . . . . . . . 54.1 mtm -58.41 126.83 29.21 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 121.169 -0.957 . . . . 0.0 108.878 166.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 171' ' ' LEU . . . . . . . . . . . . . 39.4 tp -89.06 108.78 19.78 Favored 'General case' 0 C--O 1.254 1.329 0 N-CA-C 104.103 -2.554 . . . . 0.0 104.103 166.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -82.22 91.51 6.74 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -174.69 168.19 40.74 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 106.139 -2.784 . . . . 0.0 106.139 175.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 174' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -72.57 151.7 42.23 Favored 'General case' 0 C--O 1.252 1.225 0 O-C-N 119.026 -2.455 . . . . 0.0 111.528 170.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.85 -50.79 72.42 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 126.251 1.82 . . . . 0.0 111.676 -170.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.67 -55.9 6.84 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 177' ' ' ALA . . . . . . . . . . . . . . . -41.35 -44.83 2.88 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 117.851 2.537 . . . . 0.0 117.851 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 9.3 m -64.48 -41.34 96.53 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 175.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 179' ' ' VAL . . . . . . . . . . . . . 5.2 t -72.45 -32.05 40.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 119.278 -2.138 . . . . 0.0 107.615 177.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -67.67 -33.17 74.39 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 117.912 -2.992 . . . . 0.0 111.321 176.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.69 -30.61 70.86 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.202 173.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 182' ' ' ILE . . . . . . . . . . . . . 31.0 pt -87.22 -39.14 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 CA-C-O 122.668 1.223 . . . . 0.0 113.672 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 183' ' ' LEU . . . . . . . . . . . . . 12.9 tp -11.42 -66.9 0.01 OUTLIER 'General case' 0 C--N 1.355 0.838 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -107.7 -19.76 13.44 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 118.365 -1.334 . . . . 0.0 114.486 176.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -70.07 -65.28 0.74 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.941 -1.027 . . . . 0.0 113.743 -172.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 186' ' ' LEU . . . . . . . . . . . . 0.345 2.2 pt? . . . . . 0 N--CA 1.43 -1.433 0 N-CA-C 118.969 2.951 . . . . 0.0 118.969 -165.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 11.9 t-80 . . . . . 0 N--CA 1.418 -2.064 0 N-CA-C 106.906 -1.516 . . . . 65.739999999999995 106.906 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -54.63 77.17 0.01 OUTLIER Glycine 0 C--O 1.223 -0.574 0 C-N-CA 125.581 1.562 . . . . 48.659999999999997 114.438 164.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 26.1 ttp180 -110.0 134.79 51.75 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.128 -1.536 . . . . 44.560000000000002 107.299 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1003 ' ' ILE . . . . . . . . . . . . . 30.2 mt -99.75 139.22 21.86 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.757 0 O-C-N 124.482 1.114 . . . . 34.859999999999999 110.0 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -109.7 135.17 12.68 Favored Glycine 0 C--O 1.25 1.146 0 N-CA-C 107.376 -2.29 . . . . 30.75 107.376 172.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 43.6 mm -106.76 112.05 63.63 Favored Pre-proline 0 N--CA 1.427 -1.578 0 N-CA-C 102.008 -3.33 . . . . 32.210000000000001 102.008 175.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -71.45 143.86 43.96 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 123.137 2.558 . . . . 32.979999999999997 111.438 168.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1007 ' ' ARG . . . . . . . . . . . . . 25.3 ttp85 -67.8 126.61 29.95 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 104.248 -2.501 . . . . 47.979999999999997 104.248 162.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1008 ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -62.81 130.96 47.18 Favored 'General case' 0 CA--C 1.513 -0.478 0 O-C-N 120.247 -1.533 . . . . 34.700000000000003 113.219 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -86.68 -11.48 51.13 Favored 'General case' 0 C--O 1.252 1.191 0 O-C-N 121.125 -0.984 . . . . 53.369999999999997 113.579 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 5.9 mp -63.17 148.45 47.99 Favored 'General case' 0 C--O 1.214 -0.786 0 CA-C-O 123.034 1.397 . . . . 45.07 112.529 -176.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1011 ' ' THR . . . . . . . . . . . . . 7.3 m -64.23 107.59 1.35 Allowed 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 114.048 -1.433 . . . . 40.359999999999999 111.89 -167.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 33.8 t30 68.31 69.07 0.32 Allowed 'General case' 0 C--O 1.215 -0.73 0 CA-C-N 113.173 -1.831 . . . . 40.609999999999999 110.264 176.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -104.08 146.1 29.21 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 120.034 -0.666 . . . . 33.759999999999998 112.207 -168.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1014 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.93 -6.23 21.5 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 122.758 1.266 . . . . 27.890000000000001 112.664 178.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1015 ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -106.19 147.3 29.21 Favored 'General case' 0 N--CA 1.44 -0.932 0 O-C-N 120.691 -1.255 . . . . 29.02 113.413 -172.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1016 ' ' VAL . . . . . . . . . . . . . 8.6 p -148.48 138.93 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 N-CA-C 104.033 -2.58 . . . . 28.129999999999999 104.033 159.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1017 ' ' ALA . . . . . . . . . . . . . . . -63.44 -12.94 35.24 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 117.742 -3.098 . . . . 26.870000000000001 116.749 -176.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -84.11 112.1 19.93 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 123.734 1.73 . . . . 26.77 111.204 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1019 ' ' THR . . . . . . . . . . . . . 67.8 p -118.26 167.74 10.85 Favored Pre-proline 0 N--CA 1.416 -2.138 0 N-CA-C 106.297 -1.742 . . . . 27.02 106.297 158.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1020 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -48.0 -57.48 2.31 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 124.767 3.645 . . . . 30.57 109.782 163.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 21.0 mttp -53.7 -31.12 46.73 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.856 1.662 . . . . 47.810000000000002 113.966 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1022 ' ' THR . . . . . . . . . . . . . 5.0 m -62.67 -65.57 0.67 Allowed 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 120.435 1.47 . . . . 30.77 108.758 169.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1023 ' ' VAL . . . . . . . . . . . . . 59.0 t -56.75 -55.91 17.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 O-C-N 126.611 2.444 . . . . 33.590000000000003 113.11 -171.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -49.66 -52.24 32.3 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.036 1.334 . . . . 53.289999999999999 114.568 -176.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -75.44 -34.46 60.98 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 114.389 -1.278 . . . . 46.920000000000002 113.122 -173.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1026 ' ' LEU . . . . . . . . . . . . . 95.9 mt -66.87 -39.38 87.51 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.219 -0.901 . . . . 37.170000000000002 110.025 177.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 96.5 mt -54.53 -50.03 68.84 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 118.241 -0.885 . . . . 44.439999999999998 110.673 172.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 42.5 mttm -57.61 -37.86 73.97 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.94 1.296 . . . . 52.579999999999998 112.051 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1029 ' ' LEU . . . . . . . . . . . . . 98.6 mt -66.97 -40.23 87.4 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 119.015 0.825 . . . . 45.689999999999998 110.625 173.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 148.88 -30.31 1.24 Allowed Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.832 -0.699 . . . . 42.090000000000003 111.46 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -74.85 109.36 8.25 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 124.72 2.2 . . . . 40.719999999999999 108.884 -172.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1032 ' ' THR . . . . . . . . . . . . . 18.6 m -74.51 131.14 40.76 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 105.611 -1.996 . . . . 37.770000000000003 105.611 176.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1033 ' ' VAL . . . . . . . . . . . . . 61.1 t -109.83 136.78 44.73 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.784 0 CA-C-O 121.536 0.684 . . . . 33.539999999999999 109.66 -171.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -119.37 130.94 55.58 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 126.789 2.556 . . . . 31.68 109.456 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1035 ' ' VAL . . . . . . . . . . . . . 77.6 t -115.34 135.87 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 105.765 -1.939 . . . . 31.52 105.765 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1036 ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -62.31 141.67 58.15 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 123.703 1.716 . . . . 41.039999999999999 110.626 169.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1037 ' ' SER . . . . . . . . . . . . . 19.5 m -70.05 151.16 45.83 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.46 -1.245 . . . . 31.829999999999998 108.736 174.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 91.71 -29.27 7.49 Favored Glycine 0 C--O 1.213 -1.192 0 C-N-CA 120.057 -1.068 . . . . 29.359999999999999 110.561 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -62.37 -21.11 65.07 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 116.825 2.158 . . . . 27.780000000000001 116.825 -169.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -61.78 -43.2 99.55 Favored Glycine 0 CA--C 1.538 1.492 0 O-C-N 119.795 -1.816 . . . . 28.91 114.342 -175.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.79 -28.31 68.91 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 116.35 1.982 . . . . 51.18 116.35 -174.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1042 ' ' LEU . . . . . . . . . . . . . 19.5 mt -52.82 -60.79 2.83 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 123.615 1.674 . . . . 29.91 107.898 171.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1043 ' ' ALA . . . . . . . . . . . . . . . -84.88 17.8 2.7 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.854 -1.066 . . . . 28.539999999999999 112.792 -173.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1044 ' ' SER . . . . . . . . . . . . . 60.8 m 52.56 63.79 2.1 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-O 124.13 1.919 . . . . 33.060000000000002 112.959 -174.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1045 ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -128.66 157.08 42.34 Favored 'General case' 0 C--O 1.245 0.842 0 O-C-N 120.849 -1.157 . . . . 30.289999999999999 110.675 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 2.4 t70 -85.26 127.65 34.39 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 111.125 -2.762 . . . . 48.619999999999997 104.506 164.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -65.17 -39.34 92.8 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 123.068 1.413 . . . . 36.740000000000002 112.342 -174.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 25.5 pttm -66.84 -12.53 59.45 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 120.059 -1.651 . . . . 43.729999999999997 113.918 173.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -71.64 -21.65 61.8 Favored 'General case' 0 C--O 1.247 0.964 0 CA-C-O 122.776 1.274 . . . . 32.810000000000002 110.819 168.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1050 ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -78.84 -32.21 46.05 Favored 'General case' 0 CA--C 1.505 -0.773 0 O-C-N 119.492 -2.005 . . . . 31.859999999999999 110.056 169.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 62.2 t -62.87 -50.66 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-O 122.452 1.12 . . . . 33.219999999999999 109.095 173.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -43.65 -53.38 5.78 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.038 1.735 . . . . 50.829999999999998 112.676 165.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -56.75 -29.99 63.13 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-O 118.298 -0.858 . . . . 33.119999999999997 111.389 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 104.32 31.28 4.7 Favored Glycine 0 C--N 1.343 0.96 0 N-CA-C 111.896 -0.482 . . . . 35.829999999999998 111.896 176.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -90.59 149.51 22.1 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 121.783 -0.834 . . . . 34.82 109.92 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -83.04 122.21 28.02 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 106.295 -1.743 . . . . 49.049999999999997 106.295 167.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1057 ' ' ILE . . . . . . . . . . . . . 27.3 mm -98.41 83.71 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.879 0 N-CA-C 106.389 -1.708 . . . . 38.530000000000001 106.389 -165.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1058 ' ' VAL . . . . . . . . . . . . . 48.7 t -80.11 130.11 36.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 O-C-N 124.312 1.008 . . . . 42.109999999999999 111.976 -173.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -79.62 78.55 6.17 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 123.994 1.854 . . . . 58.0 111.537 177.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 101.84 -142.49 15.68 Favored Glycine 0 CA--C 1.49 -1.531 0 CA-C-N 113.599 -1.637 . . . . 52.119999999999997 110.631 167.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 2.1 t30 -58.19 -26.4 62.74 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 111.33 -2.435 . . . . 54.75 114.12 -156.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1062 ' ' SER . . . . . . . . . . . . . 49.0 m -63.18 -14.3 47.36 Favored 'General case' 0 N--CA 1.427 -1.617 0 O-C-N 119.4 -2.062 . . . . 50.340000000000003 111.194 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -61.47 -29.29 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 O-C-N 119.839 -1.788 . . . . 41.460000000000001 109.634 172.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1064 ' ' TRP . . . . . . . . . . . . . 87.7 m95 -65.28 -26.31 68.03 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 114.791 1.404 . . . . 39.32 114.791 171.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -79.49 75.34 6.11 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 122.508 1.147 . . . . 55.380000000000003 109.125 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1066 ' ' SER . . . . . . . . . . . . . 69.6 m -152.32 151.4 30.84 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 107.118 -1.438 . . . . 41.869999999999997 107.118 -172.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -66.74 -29.55 69.55 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-O 123.519 1.628 . . . . 53.200000000000003 112.324 -174.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 60.4 mt -131.04 143.21 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 102.868 -3.012 . . . . 41.899999999999999 102.868 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1069 ' ' ILE . . . . . . . . . . . . . 23.2 mm -123.97 114.29 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 N-CA-C 103.221 -2.881 . . . . 38.729999999999997 103.221 175.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1070 ' ' LEU . . . . . . . . . . . . . 95.9 mt -90.05 94.27 9.72 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-N 116.144 -0.48 . . . . 32.439999999999998 112.07 172.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1071 ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -91.81 154.3 19.0 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 106.675 -1.602 . . . . 34.649999999999999 106.675 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1072 ' ' VAL . . . . . . . . . . . . . 12.2 t -90.73 -67.32 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.964 0 N-CA-C 105.038 -2.208 . . . . 31.32 105.038 172.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -88.04 179.24 6.45 Favored 'General case' 0 CA--C 1.508 -0.658 0 O-C-N 120.39 -1.444 . . . . 33.939999999999998 110.571 -170.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -52.61 128.89 44.36 Favored Pre-proline 0 N--CA 1.441 -0.894 0 N-CA-C 114.079 1.141 . . . . 38.039999999999999 114.079 165.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1075 ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -67.13 128.39 18.48 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.089 2.526 . . . . 42.68 109.048 174.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 53.4 mt -78.16 158.06 29.19 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 112.557 -2.111 . . . . 46.740000000000002 106.068 175.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -45.39 -35.82 3.88 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 118.054 2.613 . . . . 58.609999999999999 118.054 -169.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -68.6 -47.47 66.63 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 125.027 1.454 . . . . 59.200000000000003 110.729 173.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1079 ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -60.44 -37.77 82.0 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 109.361 -0.607 . . . . 50.630000000000003 109.361 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1080 ' ' ILE . . . . . . . . . . . . . 96.6 mt -56.5 -56.79 11.86 Favored 'Isoleucine or valine' 0 C--N 1.355 0.836 0 O-C-N 120.942 -1.099 . . . . 51.479999999999997 108.077 176.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -62.59 -20.91 65.2 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.712 -1.243 . . . . 50.280000000000001 113.028 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 75.2 mt -79.17 -16.22 56.92 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 114.954 1.465 . . . . 50.210000000000001 114.954 175.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1083 ' ' LEU . . . . . . . . . . . . . 2.3 mm? -59.68 141.04 55.91 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.02 1.282 . . . . 49.060000000000002 109.549 172.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -86.61 142.61 35.0 Favored Pre-proline 0 C--O 1.217 -0.626 0 N-CA-C 103.413 -2.81 . . . . 51.079999999999998 103.413 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -54.39 120.96 8.88 Favored 'Trans proline' 0 N--CA 1.42 -2.829 0 C-N-CA 124.306 3.337 . . . . 49.729999999999997 109.83 168.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 98.67 -3.68 59.27 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-O 117.925 -1.486 . . . . 47.710000000000001 112.757 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1087 ' ' THR . . . . . . . . . . . . . 87.1 m -68.09 129.43 39.89 Favored 'General case' 0 C--O 1.251 1.134 0 CA-C-N 119.139 1.47 . . . . 45.469999999999999 111.819 173.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1088 ' ' THR . . . . . . . . . . . . . 2.8 m -68.75 110.51 4.35 Favored 'General case' 0 C--O 1.244 0.803 0 O-C-N 119.324 -2.11 . . . . 42.039999999999999 108.739 165.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1089 ' ' LEU . . . . . . . . . . . . . 33.1 tp -98.89 118.88 36.66 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 105.741 -1.948 . . . . 38.060000000000002 105.741 173.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 24.4 t -113.26 126.43 70.68 Favored 'Isoleucine or valine' 0 C--O 1.256 1.433 0 N-CA-C 104.642 -2.355 . . . . 37.399999999999999 104.642 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1091 ' ' SER . . . . . . . . . . . . . 5.1 m -162.17 168.98 21.61 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 121.172 1.805 . . . . 36.159999999999997 111.05 -176.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -69.46 99.82 1.3 Allowed 'General case' 0 C--N 1.349 0.562 0 O-C-N 120.962 -1.086 . . . . 38.939999999999998 109.672 159.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 40.7 mm -90.21 -46.93 14.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 113.316 0.858 . . . . 42.170000000000002 113.316 175.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 23.8 m95 61.52 63.35 2.32 Favored Pre-proline 0 N--CA 1.469 0.499 0 C-N-CA 124.02 0.928 . . . . 46.509999999999998 112.037 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -55.96 -27.85 65.81 Favored 'Trans proline' 0 C--N 1.346 0.423 0 N-CA-C 120.494 3.229 . . . . 49.759999999999998 120.494 -166.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -77.2 -29.57 54.35 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 121.546 1.975 . . . . 52.619999999999997 112.538 175.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -86.75 -24.16 25.22 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 124.456 2.074 . . . . 60.740000000000002 111.233 173.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1098 ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -127.33 74.24 77.48 Favored Pre-proline 0 N--CA 1.431 -1.422 0 O-C-N 120.024 -1.672 . . . . 58.189999999999998 112.81 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -70.96 -29.42 18.17 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.947 2.431 . . . . 54.590000000000003 113.508 177.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -80.89 -28.02 36.09 Favored 'General case' 0 N--CA 1.434 -1.225 0 O-C-N 119.424 -2.047 . . . . 63.280000000000001 106.067 -163.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1101 ' ' LEU . . . . . . . . . . . . . 15.1 mt -50.72 -41.97 56.73 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 124.917 1.287 . . . . 54.75 110.31 171.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1102 ' ' MET . . . . . . . . . . . . . 18.6 mmm -66.77 -47.44 72.17 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 118.676 0.671 . . . . 52.649999999999999 111.533 -168.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -64.16 -38.02 89.57 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 120.735 -1.228 . . . . 66.260000000000005 112.673 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 86.1 mttt -67.42 -42.33 83.41 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 123.037 1.399 . . . . 63.729999999999997 112.926 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 47.8 mt -71.83 -28.41 63.56 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.834 -1.075 . . . . 54.68 112.63 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -65.12 -41.95 94.39 Favored 'General case' 0 C--O 1.243 0.751 0 O-C-N 120.694 -1.254 . . . . 53.640000000000001 110.473 170.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -56.28 -39.25 72.36 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.074 0.95 . . . . 67.239999999999995 109.696 169.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -69.82 -20.93 63.43 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 115.446 1.647 . . . . 65.760000000000005 115.446 173.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 53.7 t30 68.83 38.69 2.06 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 124.594 2.14 . . . . 58.710000000000001 109.106 177.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1110 ' ' VAL . . . . . . . . . . . . . 27.1 m -97.92 161.05 2.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 N-CA-C 115.41 1.633 . . . . 46.630000000000003 115.41 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1111 ' ' THR . . . . . . . . . . . . . 95.0 m -97.68 95.22 7.43 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 106.446 -1.687 . . . . 44.130000000000003 106.446 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1112 ' ' VAL . . . . . . . . . . . . . 49.1 t -86.57 110.7 20.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 O-C-N 121.147 -0.971 . . . . 40.439999999999998 112.306 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1113 ' ' MET . . . . . . . . . . . . . 46.8 mtp -101.74 110.65 22.68 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 106.344 -1.724 . . . . 50.759999999999998 106.344 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1114 ' ' ALA . . . . . . . . . . . . . . . -83.99 116.52 22.86 Favored 'General case' 0 C--O 1.253 1.244 0 O-C-N 121.369 -0.832 . . . . 35.640000000000001 108.989 -176.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1115 ' ' MET . . . . . . . . . . . . . 32.7 mmm -70.62 -30.65 67.36 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 113.369 0.877 . . . . 38.740000000000002 113.369 -176.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -60.33 -35.19 75.07 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 124.486 1.114 . . . . 40.140000000000001 112.141 164.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1117 ' ' SER . . . . . . . . . . . . . 48.5 m -87.58 11.88 13.88 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 118.466 2.765 . . . . 44.789999999999999 118.466 177.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1118 ' ' VAL . . . . . . . . . . . . . 40.8 t -60.96 128.39 89.06 Favored Pre-proline 0 N--CA 1.473 0.685 0 N-CA-C 103.755 -2.683 . . . . 43.75 103.755 168.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -46.6 140.78 11.8 Favored 'Trans proline' 0 CA--C 1.543 0.928 1 C-N-CA 127.7 5.6 . . . . 48.93 117.762 179.279 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -64.32 -0.3 1.23 Allowed 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 116.798 2.147 . . . . 62.899999999999999 116.798 -174.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 14.5 pt -83.26 148.98 4.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 114.281 1.215 . . . . 57.719999999999999 114.281 -170.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1122 ' ' SER . . . . . . . . . . . . . 8.5 m -45.54 -51.56 11.67 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 126.512 1.925 . . . . 57.259999999999998 114.432 -176.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.62 -24.19 66.53 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 120.676 -1.265 . . . . 62.899999999999999 112.258 -178.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -87.41 -19.0 28.69 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-O 116.642 -1.647 . . . . 49.829999999999998 111.097 -176.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -61.31 -21.34 63.88 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 115.941 1.83 . . . . 52.369999999999997 115.941 -167.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1126 ' ' SER . . . . . . . . . . . . . 31.9 m -68.47 -38.77 81.35 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 122.587 1.184 . . . . 42.43 111.117 172.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1127 ' ' LEU . . . . . . . . . . . . . 4.6 mp -77.64 -35.81 52.18 Favored 'General case' 0 C--N 1.35 0.609 0 CA-C-N 115.009 -0.996 . . . . 43.740000000000002 110.986 172.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 37.0 t70 -59.71 108.15 0.7 Allowed 'General case' 0 C--N 1.352 0.709 0 CA-C-O 125.892 2.758 . . . . 43.210000000000001 115.953 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -68.09 -29.06 67.9 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 110.459 -3.064 . . . . 35.740000000000002 112.293 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 43.3 mt -60.36 -37.09 79.62 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 114.934 -1.03 . . . . 38.090000000000003 112.854 172.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1131 ' ' SER . . . . . . . . . . . . . 16.5 m -58.95 -48.32 81.92 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 119.255 0.934 . . . . 36.909999999999997 111.367 173.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1132 ' ' SER . . . . . . . . . . . . . 73.9 m -59.82 -58.3 9.18 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 119.098 0.863 . . . . 35.789999999999999 111.757 175.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1133 ' ' MET . . . . . . . . . . . . . 27.1 mmt -61.24 -31.17 70.97 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 117.635 2.457 . . . . 30.809999999999999 117.635 -176.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1134 ' ' ALA . . . . . . . . . . . . . . . -68.81 -57.06 6.12 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.029 -0.987 . . . . 28.879999999999999 112.467 169.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1135 ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -54.8 -48.87 72.22 Favored 'General case' 0 C--O 1.245 0.864 0 C-N-CA 124.379 1.071 . . . . 40.759999999999998 110.604 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1136 ' ' ILE . . . . . . . . . . . . . 42.4 mt -56.31 -50.63 70.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 113.02 0.748 . . . . 31.539999999999999 113.02 174.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -57.83 -31.55 66.74 Favored 'General case' 0 C--O 1.213 -0.867 0 N-CA-C 114.208 1.188 . . . . 29.870000000000001 114.208 174.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -68.07 -51.09 35.74 Favored Glycine 0 N--CA 1.443 -0.863 0 O-C-N 120.54 -1.35 . . . . 28.73 111.287 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 15.7 t80 -62.21 -38.76 90.4 Favored 'General case' 0 C--O 1.217 -0.607 0 O-C-N 122.208 -0.583 . . . . 30.390000000000001 110.634 175.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1140 ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -74.54 -24.43 58.95 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.864 1.266 . . . . 26.09 112.521 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1141 ' ' ALA . . . . . . . . . . . . . . . -68.15 -40.14 82.44 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.16 -1.422 . . . . 27.100000000000001 107.16 170.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 35.3 mm -64.03 -39.74 86.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 108.259 -1.015 . . . . 28.48 108.259 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 54.4 t -59.97 -64.54 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-O 118.694 -0.67 . . . . 23.07 110.792 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1144 ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -71.88 -23.72 61.55 Favored 'General case' 0 C--O 1.247 0.959 0 CA-C-N 121.257 1.844 . . . . 33.399999999999999 114.015 -168.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -58.36 -59.06 5.93 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 115.951 -1.976 . . . . 24.219999999999999 108.657 164.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -60.87 -28.21 68.7 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.285 0.991 . . . . 24.890000000000001 110.528 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -64.5 -37.23 86.82 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 112.865 0.691 . . . . 26.73 112.865 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1148 ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -107.74 -3.63 18.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 117.981 -1.488 . . . . 39.960000000000001 112.41 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1149 ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -64.67 134.72 54.85 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 107.976 -1.12 . . . . 25.870000000000001 107.976 178.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1150 ' ' GLY . . . . . . . . . . . . . . . -74.12 -38.74 46.76 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 110.638 -0.985 . . . . 19.280000000000001 110.638 173.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1151 ' ' ARG . . . . . . . . . . . . . 46.1 mtm-85 -94.97 177.09 6.0 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 120.67 -1.488 . . . . 39.899999999999999 111.48 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1152 ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -79.48 157.46 27.47 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 120.021 1.282 . . . . 29.440000000000001 109.288 169.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1153 ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -66.46 -56.05 12.77 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 105.819 -1.919 . . . . 32.600000000000001 105.819 155.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1154 ' ' THR . . . . . . . . . . . . . 25.9 m -51.57 89.24 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 128.352 2.661 . . . . 34.640000000000001 116.433 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -69.05 83.95 0.23 Allowed Glycine 0 C--O 1.215 -1.05 0 CA-C-O 122.291 0.939 . . . . 37.140000000000001 111.328 174.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -117.23 -170.68 1.89 Allowed 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 112.365 -1.917 . . . . 40.57 108.931 168.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1157 ' ' ILE . . . . . . . . . . . . . 1.1 tp -141.83 148.7 20.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 103.404 -2.813 . . . . 44.609999999999999 103.404 -175.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1158 ' ' THR . . . . . . . . . . . . . 16.7 p -98.8 -144.23 0.32 Allowed 'General case' 0 C--O 1.249 1.075 0 CA-C-O 116.628 -1.653 . . . . 40.700000000000003 110.349 175.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -95.39 -29.47 14.42 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 121.866 2.121 . . . . 40.25 106.932 163.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -76.27 -83.5 0.07 Allowed 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 109.713 -0.477 . . . . 38.469999999999999 109.713 173.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . -122.3 169.43 14.93 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-O 123.85 1.806 . . . . 37.609999999999999 113.574 -160.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 23.2 tttp -102.01 140.98 35.56 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-N 109.908 -3.146 . . . . 48.899999999999999 108.667 -172.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1163 ' ' VAL . . . . . . . . . . . . . 47.0 t -98.27 114.98 65.84 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-N 113.658 -1.61 . . . . 36.520000000000003 106.8 167.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1164 ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -54.92 123.53 14.0 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.97 2.447 . . . . 35.079999999999998 112.103 165.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1165 ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -60.39 119.9 7.35 Favored 'Trans proline' 0 N--CA 1.432 -2.138 0 C-N-CA 125.091 3.86 . . . . 35.329999999999998 109.532 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -67.87 126.11 28.4 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 113.838 -1.528 . . . . 34.689999999999998 114.615 -167.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1167 ' ' LYS . . . . . . . . . . . . . 9.4 mptt -73.53 90.67 1.76 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 124.662 1.226 . . . . 45.359999999999999 109.535 172.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 34.3 t -83.7 89.85 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-O 124.439 2.066 . . . . 31.710000000000001 105.823 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1169 ' ' MET . . . . . . . . . . . . . 25.7 ttp -74.98 134.09 41.56 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 113.917 -1.492 . . . . 42.280000000000001 108.888 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 99.1 t -125.26 136.99 59.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 104.442 -2.429 . . . . 30.510000000000002 104.442 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 61.3 mt -121.69 127.57 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 103.979 -2.6 . . . . 31.870000000000001 103.979 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 73.82 70.51 1.23 Allowed Glycine 0 CA--C 1.535 1.304 0 N-CA-C 107.557 -2.217 . . . . 34.539999999999999 107.557 -170.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1173 ' ' ALA . . . . . . . . . . . . . . . -72.95 59.96 0.52 Allowed 'General case' 0 N--CA 1.445 -0.725 0 O-C-N 120.311 -1.699 . . . . 32.509999999999998 109.577 173.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -86.95 -148.98 13.78 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 107.987 -2.045 . . . . 29.899999999999999 107.987 -177.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1175 ' ' VAL . . . . . . . . . . . . . 57.7 t -60.03 -40.43 83.15 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 O-C-N 119.329 -2.277 . . . . 33.109999999999999 108.832 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -69.62 -52.75 23.13 Favored 'General case' 0 C--O 1.224 -0.277 0 O-C-N 121.858 -0.526 . . . . 28.100000000000001 110.712 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -56.27 -48.02 77.94 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 110.892 -0.883 . . . . 28.539999999999999 110.892 -176.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1178 ' ' LEU . . . . . . . . . . . . . 51.4 mt -58.57 -39.4 80.17 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.939 1.459 . . . . 31.219999999999999 114.939 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -68.84 -36.49 78.23 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.708 -0.62 . . . . 28.98 112.355 173.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -63.92 -37.31 86.93 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.399 0.518 . . . . 27.829999999999998 112.399 171.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1181 ' ' ILE . . . . . . . . . . . . . 90.0 mt -62.46 -53.28 49.33 Favored 'Isoleucine or valine' 0 C--O 1.246 0.904 0 C-N-CA 125.622 1.569 . . . . 30.25 108.775 175.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -50.25 -52.3 28.02 Favored Glycine 0 N--CA 1.435 -1.399 0 O-C-N 125.481 1.738 . . . . 29.59 114.134 175.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -61.42 -45.24 95.13 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.982 0.734 . . . . 30.289999999999999 112.982 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -74.15 -36.82 64.14 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 113.457 0.91 . . . . 30.469999999999999 113.457 -173.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -57.73 -48.77 78.67 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 108.369 -0.974 . . . . 42.409999999999997 108.369 167.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1186 ' ' SER . . . . . . . . . . . . . 74.1 m -56.68 -37.23 70.56 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 123.153 1.454 . . . . 39.380000000000003 112.546 176.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 13.5 mt -69.39 -34.84 75.12 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 118.141 -2.849 . . . . 36.18 114.548 173.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 105.11 76.08 1.05 Allowed Glycine 0 C--N 1.308 -0.995 0 O-C-N 119.929 -1.732 . . . . 33.780000000000001 112.057 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -151.64 168.41 25.06 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 113.635 -1.282 . . . . 33.93 109.362 -168.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 86.3 mt -90.67 95.38 5.48 Favored 'Isoleucine or valine' 0 C--O 1.253 1.288 0 N-CA-C 107.122 -1.436 . . . . 38.740000000000002 107.122 177.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 10.8 t -86.93 133.47 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 106.806 -1.553 . . . . 33.090000000000003 106.806 -178.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1192 ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -133.02 121.52 22.85 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 105.295 -2.113 . . . . 38.920000000000002 105.295 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -127.39 149.41 50.09 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 115.089 1.514 . . . . 35.32 115.089 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 47.5 t80 -137.39 154.0 50.08 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.425 -2.065 . . . . 39.350000000000001 105.425 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 13.4 t0 -146.91 159.16 43.88 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 103.352 -2.833 . . . . 40.460000000000001 103.352 173.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1196 ' ' THR . . . . . . . . . . . . . 53.5 m -63.7 -30.7 71.77 Favored 'General case' 0 C--O 1.254 1.32 0 CA-C-N 111.574 -2.557 . . . . 45.939999999999998 108.692 171.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1197 ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -101.47 100.69 14.56 Favored Pre-proline 0 CA--C 1.509 -0.629 0 N-CA-C 105.391 -2.078 . . . . 56.020000000000003 105.391 176.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1198 ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -59.59 -12.57 17.99 Favored 'Trans proline' 0 C--O 1.257 1.44 0 C-N-CA 122.621 2.214 . . . . 51.270000000000003 114.914 175.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -48.37 -16.61 0.11 Allowed 'General case' 0 C--O 1.234 0.257 0 N-CA-C 121.219 3.785 . . . . 59.100000000000001 121.219 167.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 33.8 m -80.65 -10.26 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 116.273 1.953 . . . . 51.060000000000002 116.273 169.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 75.0 tttt -50.59 -54.4 22.97 Favored 'General case' 0 C--N 1.348 0.516 0 N-CA-C 117.431 2.382 . . . . 57.380000000000003 117.431 -167.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.65 -30.78 63.14 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 115.368 -0.833 . . . . 62.409999999999997 108.776 -176.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -66.82 -33.2 75.09 Favored 'General case' 0 CA--C 1.501 -0.914 0 O-C-N 119.795 -1.815 . . . . 57.780000000000001 111.976 173.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 25.1 t -64.41 -47.9 87.5 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 C-N-CA 124.571 1.148 . . . . 46.380000000000003 109.3 172.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 21.6 mm100 -60.3 -45.62 92.74 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 122.006 -0.434 . . . . 50.700000000000003 111.403 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1206 ' ' SER . . . . . . . . . . . . . 47.5 m -69.54 -24.38 63.71 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 113.098 0.777 . . . . 49.979999999999997 113.098 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1207 ' ' MET . . . . . . . . . . . . . 36.6 mtp -86.67 9.77 17.73 Favored 'General case' 0 N--CA 1.443 -0.824 0 O-C-N 120.9 -1.125 . . . . 52.990000000000002 113.834 173.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 89.18 49.31 3.54 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 118.565 0.621 . . . . 47.659999999999997 112.648 170.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -158.28 160.88 37.55 Favored 'General case' 0 C--O 1.246 0.91 0 C-N-CA 124.116 0.966 . . . . 44.770000000000003 112.814 -174.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -96.4 147.52 23.73 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 105.476 -2.046 . . . . 47.640000000000001 105.476 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1211 ' ' PHE . . . . . . . . . . . . . 44.8 t80 -95.48 130.78 42.19 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.792 -1.188 . . . . 45.659999999999997 107.792 166.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 84.6 mt -65.43 105.6 1.2 Allowed 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 113.508 0.929 . . . . 46.060000000000002 113.508 -177.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -79.11 124.33 28.21 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 122.58 1.181 . . . . 60.219999999999999 110.024 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 9.6 mp -76.5 133.8 39.67 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 112.736 -2.029 . . . . 57.25 108.321 174.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 28.6 t70 -85.56 81.01 8.85 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 104.801 -2.296 . . . . 64.430000000000007 104.801 177.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 14.8 t80 . . . . . 0 CA--C 1.503 -0.836 0 CA-C-N 113.483 -1.69 . . . . 66.900000000000006 112.66 -167.278 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 CA--C 1.561 1.394 0 CA-C-O 116.809 -1.567 . . . . 39.090000000000003 108.576 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -52.12 -49.67 48.79 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 120.689 1.586 . . . . 39.32 114.242 173.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 74.3 t80 -64.25 -41.47 96.94 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.878 0.847 . . . . 39.299999999999997 109.738 -175.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -62.05 -41.89 98.61 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 114.479 -1.237 . . . . 36.299999999999997 111.466 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -58.14 -49.8 75.72 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 124.078 0.861 . . . . 37.380000000000003 109.364 170.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -65.99 -11.17 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 114.77 1.396 . . . . 39.109999999999999 114.77 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1230 ' ' MET . . . . . . . . . . . . . 26.4 mmt -107.93 -7.39 16.23 Favored 'General case' 0 C--O 1.244 0.789 0 O-C-N 121.103 -0.998 . . . . 49.590000000000003 110.235 175.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1231 ' ' SER . . . . . . . . . . . . . 69.4 m -87.12 132.74 33.75 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 118.919 0.781 . . . . 43.68 109.06 176.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -49.46 -58.34 5.34 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 114.462 1.282 . . . . 55.57 114.462 -167.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -64.94 -30.13 71.1 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 113.86 1.059 . . . . 44.939999999999998 113.86 -173.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 32.5 t80 -66.29 -48.74 69.43 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 115.483 -2.199 . . . . 42.039999999999999 107.994 172.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 2.9 mt -59.2 -30.92 44.94 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 CA-C-O 123.627 1.679 . . . . 46.280000000000001 112.8 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 33.3 tttm -74.49 -42.15 59.49 Favored 'General case' 0 C--O 1.215 -0.761 0 O-C-N 119.156 -2.215 . . . . 47.869999999999997 105.585 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -61.18 -31.03 70.78 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 119.551 1.069 . . . . 41.609999999999999 112.012 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -62.14 -59.1 5.54 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.741 -1.207 . . . . 50.649999999999999 107.741 168.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1239 ' ' MET . . . . . . . . . . . . . 38.6 mtt -55.33 -40.15 70.84 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 121.688 0.756 . . . . 48.869999999999997 112.667 -178.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -61.43 -51.46 68.65 Favored 'General case' 0 C--O 1.254 1.291 0 O-C-N 120.267 -1.521 . . . . 54.799999999999997 108.984 176.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 1.5 tm? -65.43 -37.39 86.77 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.703 -0.851 . . . . 43.210000000000001 108.703 -172.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -66.94 -43.06 84.2 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.685 -1.143 . . . . 38.659999999999997 112.256 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -58.41 -45.09 89.08 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 120.799 1.636 . . . . 37.920000000000002 111.288 175.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -60.8 -48.57 81.18 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 114.337 -1.301 . . . . 37.280000000000001 110.28 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -63.93 -43.45 95.82 Favored 'General case' 0 C--O 1.214 -0.783 0 CA-C-O 115.413 -2.232 . . . . 43.07 112.496 170.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -57.59 -38.75 75.4 Favored 'General case' 0 C--O 1.212 -0.892 0 CA-C-N 122.471 2.396 . . . . 38.299999999999997 110.186 -170.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1247 ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -62.71 -22.1 66.26 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 115.658 1.725 . . . . 47.600000000000001 115.658 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -118.56 -14.36 9.65 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-O 117.914 -1.041 . . . . 45.420000000000002 112.444 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1249 ' ' VAL . . . . . . . . . . . . 0.277 34.7 m -78.79 175.66 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 120.801 1.637 . . . . 36.259999999999998 113.304 -178.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1250 ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -124.28 -47.4 1.88 Allowed 'General case' 0 N--CA 1.432 -1.339 0 O-C-N 124.586 1.179 . . . . 33.039999999999999 112.823 -171.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1251 ' ' ILE . . . . . . . . . . . . . 38.0 mm -127.04 137.61 57.34 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 N-CA-C 105.147 -2.168 . . . . 31.399999999999999 105.147 -178.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1252 ' ' ILE . . . . . . . . . . . . . 33.0 mt -125.14 113.14 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 C-N-CA 119.282 -0.967 . . . . 29.420000000000002 108.526 167.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 48.5 t -90.65 102.93 13.87 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 CA-C-O 124.394 2.045 . . . . 30.370000000000001 106.728 176.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1254 ' ' THR . . . . . . . . . . . . . 21.8 m -100.36 99.17 9.77 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 110.473 -3.058 . . . . 35.719999999999999 104.04 -158.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1255 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.4 22.75 2.96 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.758 -1.565 . . . . 36.0 113.845 -168.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1256 ' ' ALA . . . . . . . . . . . . . . . -78.48 85.84 4.54 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 118.166 -2.834 . . . . 40.93 110.223 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 10.2 tp -142.55 124.2 14.99 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 111.514 -2.585 . . . . 47.82 109.311 -168.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 8.4 mm -78.13 120.71 82.24 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 100.916 -3.735 . . . . 52.700000000000003 100.916 160.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 1.3 Cg_exo -44.18 113.33 0.42 Allowed 'Trans proline' 0 C--N 1.319 -0.982 1 C-N-CA 125.551 4.167 . . . . 54.130000000000003 116.373 -167.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 78.71 3.96 87.55 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 112.243 -2.253 . . . . 54.619999999999997 115.727 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -111.22 145.16 31.92 Favored Pre-proline 0 C--O 1.219 -0.539 0 CA-C-N 121.561 2.68 . . . . 55.740000000000002 105.581 -174.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -48.16 108.27 0.17 Allowed 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 125.08 3.853 . . . . 51.149999999999999 116.055 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -65.12 154.85 85.99 Favored Pre-proline 0 C--O 1.222 -0.358 0 CA-C-N 112.579 -2.1 . . . . 46.060000000000002 112.725 -176.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.44 126.26 15.27 Favored 'Trans proline' 0 C--O 1.248 0.983 0 C-N-CA 123.737 2.958 . . . . 41.079999999999998 109.826 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 50.1 mmtt -77.56 105.63 8.83 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 106.385 -1.709 . . . . 47.420000000000002 106.385 176.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 52.4 mt -107.59 -52.35 2.78 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 113.112 -1.858 . . . . 39.219999999999999 110.246 -174.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 61.1 mt -88.03 100.46 10.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 104.882 -2.266 . . . . 42.5 104.882 -169.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1268 ' ' THR . . . . . . . . . . . . . 12.3 p -68.05 157.6 34.81 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 126.146 1.778 . . . . 37.840000000000003 113.934 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -57.49 -34.15 68.76 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 115.223 1.564 . . . . 54.799999999999997 115.223 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -67.37 -47.24 70.97 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 114.355 -1.293 . . . . 54.359999999999999 110.889 172.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1271 ' ' MET . . . . . . . . . . . . . 54.6 ttm -58.33 -45.41 88.15 Favored 'General case' 0 C--O 1.251 1.18 0 C-N-CA 124.297 1.039 . . . . 39.520000000000003 109.862 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1272 ' ' VAL . . . . . . . . . . . . . 21.2 t -57.4 -54.44 30.88 Favored 'Isoleucine or valine' 0 C--O 1.249 1.069 0 CA-C-N 115.843 -0.617 . . . . 38.25 110.379 178.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.41 -11.91 60.14 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 114.096 1.147 . . . . 40.770000000000003 114.096 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1274 ' ' SER . . . . . . . . . . . . . 70.7 m -78.28 -18.96 54.58 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 116.631 -1.652 . . . . 36.579999999999998 112.875 172.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1275 ' ' MET . . . . . . . . . . . . . 85.0 mtp -53.4 155.03 3.05 Favored 'General case' 0 CA--C 1.51 -0.571 0 O-C-N 125.222 1.576 . . . . 36.75 115.156 -176.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1276 ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -60.93 139.99 57.87 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 105.532 -2.025 . . . . 46.109999999999999 105.532 166.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1277 ' ' ALA . . . . . . . . . . . . . . . -85.57 165.37 17.12 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 123.182 1.468 . . . . 33.520000000000003 110.304 -171.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 74.02 36.5 51.64 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.697 1.141 . . . . 31.27 111.977 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1279 ' ' SER . . . . . . . . . . . . . 37.3 m -134.42 166.27 23.24 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 114.2 -1.0 . . . . 32.950000000000003 108.539 -165.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1280 ' ' VAL . . . . . . . . . . . . . 48.4 t -133.65 142.94 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 O-C-N 118.939 -2.35 . . . . 27.43 111.474 -176.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1281 ' ' ILE . . . . . . . . . . . . . 74.7 mt -110.49 103.23 15.15 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 N-CA-C 102.167 -3.272 . . . . 30.300000000000001 102.167 164.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -86.85 95.86 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 N-CA-C 107.291 -1.374 . . . . 28.629999999999999 107.291 174.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 19.7 t0 -85.96 106.92 17.48 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 105.547 -2.019 . . . . 36.270000000000003 105.547 -173.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1284 ' ' LEU . . . . . . . . . . . . . 91.0 mt -89.59 -31.9 17.36 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 114.924 -1.035 . . . . 38.57 108.584 175.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -66.43 -11.25 50.86 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 122.449 1.119 . . . . 37.560000000000002 110.861 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . -42.48 -20.36 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 126.509 1.924 . . . . 40.329999999999998 115.304 163.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -47.92 -41.25 24.22 Favored 'General case' 0 CA--C 1.553 1.071 0 O-C-N 121.378 -0.826 . . . . 56.850000000000001 110.675 173.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 1.4 t30 -137.07 99.26 3.95 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 119.787 -0.765 . . . . 45.859999999999999 109.509 170.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 82.18 -50.34 4.29 Favored Glycine 0 N--CA 1.476 1.317 0 O-C-N 119.693 -1.879 . . . . 40.310000000000002 113.863 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 101.39 164.47 27.41 Favored Glycine 0 N--CA 1.477 1.373 0 CA-C-N 119.749 1.775 . . . . 38.890000000000001 113.241 -176.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1291 ' ' ASN . . . . . . . . . . . . . 33.5 m120 -93.14 -35.84 12.96 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 117.954 0.877 . . . . 37.229999999999997 109.1 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1292 ' ' CYS . . . . . . . . . . . . . 20.5 t -78.49 153.67 31.16 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 122.885 1.326 . . . . 36.5 109.265 173.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1293 ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -82.89 -50.5 8.55 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 113.104 -1.862 . . . . 43.32 109.666 174.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.64 -24.94 59.19 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 117.454 2.39 . . . . 41.32 117.454 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1295 ' ' THR . . . . . . . . . . . . . 98.0 m -38.48 112.52 0.23 Allowed 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 124.915 1.286 . . . . 35.299999999999997 113.585 167.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 29.6 t -87.65 111.65 43.34 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 102.921 -2.992 . . . . 34.840000000000003 102.921 163.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -64.92 86.44 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.697 1 C-N-CA 125.327 4.018 . . . . 33.509999999999998 107.056 174.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 154.77 -27.94 0.66 Allowed Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 107.722 -2.151 . . . . 32.189999999999998 107.722 178.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -130.94 164.63 24.9 Favored 'General case' 0 C--O 1.251 1.135 0 CA-C-N 122.067 2.934 . . . . 34.880000000000003 113.975 -168.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1300 ' ' ILE . . . . . . . . . . . . . 84.1 mt -77.13 124.45 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 104.563 -2.384 . . . . 32.289999999999999 104.563 156.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 50.9 t80 -108.0 113.14 26.11 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 102.387 -3.19 . . . . 37.25 102.387 170.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1302 ' ' THR . . . . . . . . . . . . . 5.5 m -94.08 108.42 20.25 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 120.067 -1.646 . . . . 35.560000000000002 107.066 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1303 ' ' THR . . . . . . . . . . . . . 8.8 p -74.96 166.32 23.85 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 115.517 1.673 . . . . 36.399999999999999 115.517 -174.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.41 -26.53 65.58 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 120.561 -1.337 . . . . 52.32 112.039 -164.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 49.1 p-10 -66.75 -42.99 85.29 Favored 'General case' 0 C--O 1.239 0.552 0 O-C-N 121.116 -0.99 . . . . 40.039999999999999 112.116 171.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 123.61 43.15 0.35 Allowed Glycine 0 N--CA 1.414 -2.785 0 CA-C-O 123.244 1.469 . . . . 36.960000000000001 111.663 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1307 ' ' VAL . . . . . . . . . . . . . 41.5 t -113.52 140.89 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-N 113.728 -1.236 . . . . 33.399999999999999 109.253 176.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1308 ' ' LYS . . . . . . . . . . . . . 34.6 mmtt -97.81 110.73 23.24 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 112.658 -2.064 . . . . 42.909999999999997 107.902 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 5.3 t -99.62 87.42 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.817 0 N-CA-C 104.73 -2.322 . . . . 32.289999999999999 104.73 -176.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1310 ' ' ILE . . . . . . . . . . . . . 75.2 mt -88.57 83.09 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 113.979 -1.464 . . . . 30.989999999999998 109.232 -171.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -82.11 54.83 4.9 Favored Glycine 0 N--CA 1.437 -1.282 0 CA-C-O 123.415 1.564 . . . . 28.949999999999999 112.249 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1312 ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -82.58 98.73 9.13 Favored 'General case' 0 CA--C 1.502 -0.881 0 O-C-N 118.242 -2.916 . . . . 31.690000000000001 114.314 -173.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1313 ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -52.05 -44.26 64.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 112.041 -2.345 . . . . 34.170000000000002 111.806 170.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -64.9 -10.12 26.3 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 117.827 2.529 . . . . 36.859999999999999 117.827 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1315 ' ' LEU . . . . . . . . . . . . . 45.9 mt -62.55 -29.24 4.45 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 118.713 2.857 . . . . 34.850000000000001 118.713 -175.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 0.7 OUTLIER -59.92 -27.61 85.3 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.446 2.764 . . . . 29.149999999999999 114.267 165.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -79.98 -48.97 6.23 Favored Glycine 0 CA--C 1.502 -0.764 0 N-CA-C 107.55 -2.22 . . . . 27.289999999999999 107.55 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1318 ' ' ARG . . . . . . . . . . . . . 4.7 ttm180 -87.05 57.1 4.31 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 113.627 0.973 . . . . 41.490000000000002 113.627 -159.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1319 ' ' LEU . . . . . . . . . . . . . 15.1 tp -135.89 73.31 60.11 Favored Pre-proline 0 C--N 1.32 -0.715 1 N-CA-C 99.327 -4.323 . . . . 27.609999999999999 99.327 156.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1320 ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -42.25 -64.18 0.27 Allowed 'Trans proline' 0 N--CA 1.442 -1.531 1 C-N-CA 126.171 4.581 . . . . 25.940000000000001 117.999 -158.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1321 ' ' THR . . . . . . . . . . . . . 6.7 m -58.07 -45.58 86.89 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 119.803 -0.759 . . . . 25.010000000000002 111.016 176.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1322 ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -67.38 -48.07 68.48 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 123.767 0.667 . . . . 29.390000000000001 109.76 -169.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1323 ' ' SER . . . . . . . . . . . . . 20.4 m -56.08 -48.67 75.66 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 118.391 -0.814 . . . . 26.469999999999999 112.946 174.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1324 ' ' SER . . . . . . . . . . . . . 36.0 m -65.03 -29.76 70.69 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 123.069 1.414 . . . . 27.780000000000001 112.581 175.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -72.6 -58.84 3.06 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 106.641 -1.614 . . . . 37.530000000000001 106.641 -174.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1326 ' ' LEU . . . . . . . . . . . . . 37.9 mt -71.21 -42.01 69.51 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 118.385 -0.817 . . . . 35.710000000000001 109.151 -172.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1327 ' ' TYR . . . . . . . . . . . . . 53.0 t80 -60.55 -41.32 94.29 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 119.636 1.107 . . . . 31.59 110.857 173.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1328 ' ' GLY . . . . . . . . . . . . . . . -61.71 -47.01 93.0 Favored Glycine 0 C--O 1.256 1.487 0 O-C-N 121.336 -0.852 . . . . 28.0 111.653 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1329 ' ' THR . . . . . . . . . . . . . 6.5 m -71.99 -24.05 61.52 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 113.964 -1.118 . . . . 32.149999999999999 109.251 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1330 ' ' ASN . . . . . . . . . . . . . 17.6 m120 -60.74 -49.28 78.15 Favored 'General case' 0 C--O 1.24 0.595 0 O-C-N 119.067 -2.27 . . . . 34.359999999999999 111.851 168.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1331 ' ' LEU . . . . . . . . . . . . . 16.4 mt -62.41 -37.81 87.22 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 114.758 -1.11 . . . . 33.369999999999997 111.136 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1332 ' ' VAL . . . . . . . . . . . . . 64.1 t -63.76 -45.64 96.69 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 N-CA-C 108.634 -0.876 . . . . 35.270000000000003 108.634 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -57.8 -44.82 86.58 Favored 'General case' 0 C--O 1.241 0.613 0 O-C-N 118.979 -2.325 . . . . 37.659999999999997 112.679 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1334 ' ' LEU . . . . . . . . . . . . . 41.3 tp -53.64 -59.22 4.88 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.886 -1.052 . . . . 40.270000000000003 110.443 169.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1335 ' ' LEU . . . . . . . . . . . . . 32.0 mt -62.9 -14.23 44.05 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 117.472 2.397 . . . . 42.5 117.472 174.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1336 ' ' LYS . . . . . . . . . . . . . 94.5 mttt -66.52 -46.21 76.93 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 121.749 2.068 . . . . 47.810000000000002 107.123 169.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1337 ' ' LEU . . . . . . . . . . . . . 10.9 mp -72.51 -39.68 67.41 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 114.657 -1.156 . . . . 49.270000000000003 112.792 177.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1338 ' ' LEU . . . . . . . . . . . . . 9.4 mp -66.85 -32.73 74.19 Favored 'General case' 0 C--O 1.246 0.877 0 O-C-N 120.457 -1.402 . . . . 50.539999999999999 112.821 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1339 ' ' CYS . . . . . . . . . . . . . 50.2 t -116.38 68.47 0.73 Allowed 'General case' 0 C--O 1.25 1.079 0 O-C-N 118.711 -2.493 . . . . 53.670000000000002 105.532 175.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -75.02 -42.71 56.74 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.354 1.073 . . . . 63.380000000000003 111.132 174.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -68.44 -44.94 73.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 123.63 1.681 . . . . 70.950000000000003 114.069 -177.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1342 ' ' LYS . . . . . . . . . . . . . 18.3 mtpt 59.77 67.61 0.86 Allowed 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 128.072 2.549 . . . . 65.25 112.859 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1343 ' ' ASP . . . . . . . . . . . . 0.269 37.5 t70 60.42 -122.11 0.96 Allowed 'General case' 0 N--CA 1.426 -1.66 2 O-C-N 111.602 -6.936 . . . . 64.530000000000001 111.795 9.594 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A 1344 ' ' GLY . . . . . . . . . . . . . . . 109.97 31.25 3.18 Favored Glycine 0 C--O 1.252 1.225 0 O-C-N 117.289 -3.382 . . . . 59.719999999999999 111.461 -174.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 28.5 t30 -84.21 149.0 26.42 Favored 'General case' 0 N--CA 1.436 -1.156 0 O-C-N 120.492 -1.593 . . . . 64.090000000000003 107.105 164.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1346 ' ' ILE . . . . . . . . . . . . . 2.6 mp -81.36 83.56 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 103.198 -2.89 . . . . 58.82 103.198 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1347 ' ' THR . . . . . . . . . . . . . 3.3 m -76.91 83.43 3.46 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 105.798 -1.926 . . . . 54.960000000000001 105.798 -177.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1348 ' ' VAL . . . . . . . . . . . . . 21.8 t -78.33 76.13 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 124.406 2.051 . . . . 55.640000000000001 106.508 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 27.0 t70 -75.13 138.38 42.0 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 112.113 -2.312 . . . . 61.450000000000003 112.518 -165.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 11.4 m-30 -103.49 -6.35 21.89 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 112.082 -2.326 . . . . 58.630000000000003 112.898 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 15.1 t70 -71.71 -48.24 48.49 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 118.797 0.726 . . . . 62.060000000000002 110.072 177.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 18.2 t0 -66.25 130.57 43.67 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.538 -0.756 . . . . 54.07 109.397 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 31.8 m -67.95 -28.31 40.81 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 N-CA-C 113.077 0.769 . . . . 50.68 113.077 -176.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1354 ' ' VAL . . . . . . . . . . . . . 3.1 m -80.23 -43.65 22.14 Favored 'Isoleucine or valine' 0 C--O 1.246 0.876 0 N-CA-C 105.471 -2.048 . . . . 47.68 105.471 -174.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1355 ' ' ILE . . . . . . . . . . . . . 62.2 mt -65.77 -44.08 93.2 Favored 'Isoleucine or valine' 0 C--O 1.25 1.115 0 C-N-CA 119.423 -0.911 . . . . 48.490000000000002 109.731 -177.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 35.2 tpt85 -53.61 -48.04 69.67 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 115.269 -2.3 . . . . 48.270000000000003 113.329 168.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -57.9 -45.58 93.47 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 122.124 2.238 . . . . 43.530000000000001 114.995 174.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1358 ' ' VAL . . . . . . . . . . . . . 11.6 t -59.44 -49.82 82.18 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 C-N-CA 125.041 1.337 . . . . 45.119999999999997 110.913 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1359 ' ' THR . . . . . . . . . . . . . 18.5 m -70.74 87.73 0.7 Allowed 'General case' 0 C--O 1.244 0.774 0 CA-C-O 125.011 2.338 . . . . 42.939999999999998 112.479 -177.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 16.5 m -78.13 -28.83 15.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 112.642 -2.072 . . . . 43.259999999999998 111.461 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1361 ' ' ILE . . . . . . . . . . . . . 96.5 mt -131.98 119.83 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 102.972 -2.973 . . . . 45.659999999999997 102.972 175.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1362 ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -106.41 124.42 49.57 Favored 'General case' 0 C--O 1.253 1.241 1 CA-C-N 126.254 4.116 . . . . 61.340000000000003 106.762 168.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 43.81 54.6 5.58 Favored 'General case' 0 C--O 1.241 0.627 0 O-C-N 126.447 2.342 . . . . 49.759999999999998 115.192 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 86.04 -24.08 8.49 Favored Glycine 0 CA--C 1.526 0.74 0 O-C-N 120.014 -1.678 . . . . 50.0 114.301 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -88.78 124.93 34.62 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 103.692 -2.707 . . . . 56.920000000000002 103.692 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1366 ' ' ILE . . . . . . . . . . . . . 92.4 mt -75.18 89.32 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.753 0 CA-C-O 123.073 1.416 . . . . 52.780000000000001 108.065 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1367 ' ' THR . . . . . . . . . . . . . 17.1 p -75.76 53.05 0.71 Allowed 'General case' 0 C--O 1.252 1.211 0 CA-C-O 125.951 2.786 . . . . 49.439999999999998 113.767 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 57.1 t90 -132.37 144.07 51.49 Favored Pre-proline 0 CA--C 1.545 0.787 0 O-C-N 119.525 -1.984 . . . . 52.380000000000003 108.491 -170.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.39 170.81 70.84 Favored 'Cis proline' 0 C--O 1.25 1.11 0 CA-C-N 123.101 2.143 . . . . 46.939999999999998 114.164 -4.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -128.75 117.98 19.7 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 108.5 -0.926 . . . . 45.909999999999997 108.5 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1371 ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -61.22 137.62 72.12 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 125.198 3.932 . . . . 46.390000000000001 112.823 -174.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.35 8.61 3.51 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 121.105 1.204 . . . . 46.719999999999999 113.797 160.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.214 -5.31 0 O-C-N 119.541 -1.974 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 60.3 m80 . . . . . 0 N--CA 1.436 -1.16 0 N-CA-C 102.989 -2.967 . . . . 63.439999999999998 102.989 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -111.05 43.53 1.44 Allowed 'General case' 0 C--O 1.243 0.739 0 CA-C-O 123.21 1.481 . . . . 51.740000000000002 109.045 148.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1000 ' ' HIS . . . . . . . . . . . . . 18.7 t60 -84.61 135.61 34.11 Favored 'General case' 0 C--O 1.247 0.96 0 N-CA-C 104.924 -2.25 . . . . 54.07 104.924 -166.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 67.01 13.22 61.49 Favored Glycine 0 N--CA 1.451 -0.341 0 O-C-N 119.304 -2.122 . . . . 39.219999999999999 111.806 -172.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1002 ' ' ARG . . . . . 0.424 ' NH2' ' O ' ' B' 1065 ' ' GLN . 16.6 ttp180 -97.74 121.93 40.24 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.049 -1.463 . . . . 38.119999999999997 107.049 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B 1003 ' ' ILE . . . . . . . . . . . . 0.279 46.6 mt -78.79 149.94 5.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 106.378 -1.712 . . . . 29.699999999999999 106.378 172.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -121.18 130.09 8.05 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 108.568 -1.813 . . . . 27.5 108.568 162.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1005 ' ' ILE . . . . . . . . . . . . . 38.4 mm -104.91 103.14 39.63 Favored Pre-proline 0 C--O 1.243 0.748 0 N-CA-C 105.371 -2.085 . . . . 24.829999999999998 105.371 170.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -74.15 162.47 38.71 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 124.399 3.399 . . . . 27.190000000000001 108.993 171.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -80.52 137.33 36.42 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 104.449 -2.426 . . . . 41.460000000000001 104.449 157.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1008 ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -68.82 158.84 33.6 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-N 115.076 -0.965 . . . . 26.93 110.779 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 35.0 mmm-85 -113.91 -35.16 5.2 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 111.975 -2.375 . . . . 34.479999999999997 112.848 -171.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1010 ' ' LEU . . . . . . . . . . . . . 7.3 mp -61.04 153.31 25.72 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 115.713 1.746 . . . . 44.219999999999999 115.713 -169.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1011 ' ' THR . . . . . . . . . . . . . 20.1 m -62.82 131.82 50.09 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 113.74 -1.573 . . . . 40.740000000000002 110.781 -173.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 5.2 t30 38.64 47.65 1.17 Allowed 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 129.492 3.117 . . . . 44.439999999999998 116.042 -166.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1013 ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -105.19 118.58 36.9 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 112.217 -2.265 . . . . 29.870000000000001 106.809 175.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1014 ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.0 0.51 25.73 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 115.14 1.533 . . . . 25.260000000000002 115.14 176.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -80.6 144.42 32.4 Favored 'General case' 0 C--O 1.241 0.62 0 O-C-N 119.53 -1.981 . . . . 29.539999999999999 112.957 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1016 ' ' VAL . . . . . . . . . . . . . 4.7 p -111.42 175.63 1.8 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 103.992 -2.596 . . . . 23.550000000000001 103.992 165.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1017 ' ' ALA . . . . . . . . . . . . . . . -75.91 -40.33 54.49 Favored 'General case' 0 C--N 1.344 0.356 0 O-C-N 117.939 -2.976 . . . . 23.59 115.042 -176.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1018 ' ' ALA . . . . . . . . . . . . . . . -152.19 145.47 24.71 Favored 'General case' 0 C--O 1.247 0.935 0 N-CA-C 105.28 -2.118 . . . . 24.93 105.28 -176.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1019 ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.14 172.6 5.02 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 115.725 -2.083 . . . . 28.09 111.521 -178.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -51.61 -42.65 55.14 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 CA-C-N 127.155 3.591 . . . . 28.789999999999999 118.161 -172.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 83.6 tttt -54.96 -48.76 72.79 Favored 'General case' 0 CA--C 1.502 -0.89 0 O-C-N 121.236 -0.915 . . . . 47.280000000000001 112.617 169.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1022 ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.77 -24.22 65.3 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 120.755 -1.215 . . . . 30.120000000000001 113.253 177.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B 1023 ' ' VAL . . . . . . . . . . . . . 43.0 t -67.41 -47.57 80.42 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.711 0 O-C-N 120.244 -1.535 . . . . 32.240000000000002 107.713 171.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1024 ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -62.73 -36.09 81.87 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 118.776 -0.63 . . . . 49.619999999999997 112.684 176.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -58.68 -43.78 90.06 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 124.305 1.003 . . . . 44.68 113.271 169.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 35.1 mt -62.14 -43.45 98.8 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 119.895 -1.753 . . . . 35.710000000000001 113.217 171.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1027 ' ' LEU . . . . . . . . . . . . . 24.7 mt -58.24 -27.16 63.71 Favored 'General case' 0 C--N 1.348 0.542 0 O-C-N 119.808 -1.807 . . . . 42.18 112.332 174.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 62.7 mttm -61.75 -21.48 64.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 121.097 1.772 . . . . 48.340000000000003 112.38 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1029 ' ' LEU . . . . . . . . . . . . . 49.6 mt -86.45 -4.16 59.13 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 114.233 1.197 . . . . 38.689999999999998 114.233 175.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 78.58 21.98 68.08 Favored Glycine 0 N--CA 1.446 -0.693 0 O-C-N 120.314 -1.491 . . . . 32.280000000000001 113.301 -174.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -99.35 132.44 44.67 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 105.419 -2.067 . . . . 35.939999999999998 105.419 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1032 ' ' THR . . . . . . . . . . . . . 3.6 m -89.35 123.97 34.01 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 107.971 -1.122 . . . . 33.369999999999997 107.971 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1033 ' ' VAL . . . . . . . . . . . . . 22.8 t -95.34 134.12 33.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.637 -1.616 . . . . 29.98 106.637 -171.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -111.77 145.83 38.68 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.911 -1.144 . . . . 28.18 107.911 159.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1035 ' ' VAL . . . . . . . . . . . . . 97.1 t -122.5 149.73 26.06 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 N-CA-C 103.713 -2.699 . . . . 25.82 103.713 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1036 ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -73.3 147.27 44.65 Favored 'General case' 0 C--O 1.213 -0.835 0 C-N-CA 123.252 0.621 . . . . 32.439999999999998 111.293 176.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1037 ' ' SER . . . . . . . . . . . . . 44.0 m -60.25 112.72 2.03 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.347 -1.297 . . . . 29.539999999999999 111.015 172.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 77.92 20.4 73.39 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 111.695 -2.502 . . . . 27.760000000000002 113.941 -175.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1039 ' ' ALA . . . . . . . . . . . . . . . -64.81 -57.8 7.93 Favored 'General case' 0 C--O 1.25 1.12 0 N-CA-C 115.69 1.737 . . . . 26.02 115.69 -176.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -67.58 -15.1 65.83 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 114.201 -1.363 . . . . 26.469999999999999 113.543 -173.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -53.36 -35.72 60.59 Favored 'General case' 0 C--O 1.255 1.347 0 O-C-N 119.615 -2.109 . . . . 50.979999999999997 113.133 172.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 60.8 mt -53.03 -54.47 34.79 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 123.028 2.649 . . . . 29.300000000000001 110.03 167.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1043 ' ' ALA . . . . . . . . . . . . . . . -66.67 2.81 1.19 Allowed 'General case' 0 C--O 1.241 0.641 0 N-CA-C 115.706 1.743 . . . . 26.739999999999998 115.706 174.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1044 ' ' SER . . . . . . . . . . . . . 24.3 m 62.28 35.67 15.12 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 123.702 1.715 . . . . 31.260000000000002 114.668 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1045 ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.5 108.81 9.36 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 105.005 -2.221 . . . . 33.259999999999998 105.005 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 8.5 t70 -61.52 144.31 54.5 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 114.975 1.472 . . . . 46.740000000000002 114.975 -177.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 43.0 p-10 -65.13 -20.4 66.44 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 114.146 1.165 . . . . 34.439999999999998 114.146 -175.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -56.72 -23.47 42.62 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 117.371 2.36 . . . . 48.670000000000002 117.371 165.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -83.81 -24.21 31.08 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 123.672 0.789 . . . . 35.259999999999998 110.371 172.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1050 ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -74.22 -28.33 61.2 Favored 'General case' 0 C--O 1.251 1.184 0 O-C-N 119.156 -2.215 . . . . 32.170000000000002 110.262 171.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 91.6 t -62.43 -50.29 80.46 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 N-CA-C 105.918 -1.882 . . . . 38.369999999999997 105.918 167.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -51.6 -41.52 61.29 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.135 1.531 . . . . 45.770000000000003 115.135 172.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -65.42 -41.69 93.3 Favored 'General case' 0 C--O 1.218 -0.558 0 O-C-N 123.618 0.574 . . . . 37.829999999999998 111.78 173.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 111.61 53.21 0.53 Allowed Glycine 0 C--N 1.35 1.317 0 N-CA-C 110.704 -0.959 . . . . 35.82 110.704 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -120.69 150.26 41.22 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-O 123.854 1.788 . . . . 33.770000000000003 109.365 171.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -63.76 142.83 58.26 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 112.227 -2.261 . . . . 51.020000000000003 108.493 167.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1057 ' ' ILE . . . . . . . . . . . . . 46.2 mm -120.17 112.74 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 N-CA-C 106.17 -1.789 . . . . 38.469999999999999 106.17 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 1.8 m -133.74 142.23 42.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 115.445 1.646 . . . . 39.399999999999999 115.445 -171.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -72.82 105.01 4.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 113.479 -1.691 . . . . 57.07 114.762 -169.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . 59.96 -113.7 5.61 Favored Glycine 0 N--CA 1.433 -1.558 0 CA-C-N 114.425 -1.261 . . . . 44.829999999999998 112.554 165.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -61.96 -25.1 67.41 Favored 'General case' 0 C--O 1.241 0.632 0 O-C-N 120.459 -1.613 . . . . 46.270000000000003 111.922 -171.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1062 ' ' SER . . . . . . . . . . . . . 66.5 m -59.08 -41.89 89.1 Favored 'General case' 0 N--CA 1.426 -1.642 0 C-N-CA 124.349 1.06 . . . . 43.469999999999999 111.21 173.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 2.0 p -66.91 -31.53 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 O-C-N 118.593 -2.567 . . . . 36.979999999999997 109.347 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 38.8 m95 -68.87 -30.55 69.09 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 113.994 1.109 . . . . 37.899999999999999 113.994 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1065 ' ' GLN . . . . . 0.424 ' O ' ' NH2' ' B' 1002 ' ' ARG . 47.1 mm-40 -77.47 92.88 4.04 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.03 -1.1 . . . . 46.189999999999998 108.03 175.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B 1066 ' ' SER . . . . . . . . . . . . . 53.5 m -159.94 165.79 31.39 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 119.929 -1.732 . . . . 37.060000000000002 110.906 -169.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1067 ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -65.47 -52.52 52.35 Favored 'General case' 0 C--O 1.22 -0.468 0 O-C-N 124.643 1.214 . . . . 43.950000000000003 111.277 170.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1068 ' ' ILE . . . . . . . . . . . . . 23.9 mt -123.74 131.81 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 104.888 -2.264 . . . . 33.5 104.888 -173.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 26.4 mm -111.4 116.92 53.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 104.779 -2.304 . . . . 30.57 104.779 171.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1070 ' ' LEU . . . . . . . . . . . . . 73.7 mt -102.27 114.96 29.57 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 101.72 -3.437 . . . . 27.66 101.72 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1071 ' ' LYS . . . . . . . . . . . . . 18.9 tttm -140.14 157.73 45.16 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 106.182 -1.784 . . . . 28.399999999999999 106.182 -169.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1072 ' ' VAL . . . . . . . . . . . . . 67.6 t -83.27 -81.14 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.828 0 C-N-CA 117.547 -1.661 . . . . 23.18 110.188 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -87.04 156.89 19.56 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 114.174 1.176 . . . . 25.469999999999999 114.174 -167.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -46.65 117.14 4.21 Favored Pre-proline 0 C--O 1.249 1.075 0 C-N-CA 124.129 0.972 . . . . 27.899999999999999 113.049 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -54.48 136.14 68.69 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.903 2.402 . . . . 31.620000000000001 114.074 -173.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 38.3 mt -71.33 160.28 33.07 Favored 'General case' 0 CA--C 1.506 -0.74 0 O-C-N 126.51 2.381 . . . . 40.490000000000002 106.776 173.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.49 -38.68 63.91 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 115.923 1.823 . . . . 51.590000000000003 115.923 -168.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -68.69 -36.13 78.1 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-O 120.84 0.352 . . . . 42.359999999999999 111.751 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1079 ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -64.07 -36.02 82.64 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-O 123.551 1.643 . . . . 34.530000000000001 111.37 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1080 ' ' ILE . . . . . . . . . . . . . 57.6 mt -60.45 -50.78 78.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 113.119 -1.855 . . . . 33.25 109.64 174.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -57.15 -34.01 67.99 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 115.486 1.661 . . . . 36.469999999999999 115.486 173.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1082 ' ' LEU . . . . . . . . . . . . . 86.0 mt -62.94 -26.88 69.03 Favored 'General case' 0 CA--C 1.491 -1.31 0 O-C-N 125.391 1.682 . . . . 37.759999999999998 114.303 173.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1083 ' ' LEU . . . . . . . . . . . . . 68.8 mt -55.28 156.63 4.11 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 113.865 1.061 . . . . 37.43 113.865 167.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1084 ' ' ASN . . . . . . . . . . . . 0.252 1.5 m-80 -130.56 148.53 70.36 Favored Pre-proline 0 C--N 1.319 -0.753 0 N-CA-C 103.673 -2.714 . . . . 37.700000000000003 103.673 -167.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -55.82 114.0 1.69 Allowed 'Trans proline' 0 C--O 1.25 1.11 0 C-N-CA 125.004 3.803 . . . . 35.509999999999998 109.673 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 120.71 -37.65 2.96 Favored Glycine 0 N--CA 1.437 -1.246 0 CA-C-N 111.624 -2.535 . . . . 33.869999999999997 114.332 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1087 ' ' THR . . . . . . . . . . . . . 26.4 m -56.2 122.24 11.3 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 114.513 1.301 . . . . 32.5 114.513 -164.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1088 ' ' THR . . . . . . . . . . . . . 13.5 m -70.49 94.72 0.99 Allowed 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 113.633 -1.621 . . . . 30.219999999999999 107.268 174.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1089 ' ' LEU . . . . . . . . . . . . . 42.4 tp -85.77 111.36 20.08 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 118.951 0.796 . . . . 27.239999999999998 110.05 174.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 6.0 t -112.76 104.53 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 104.037 -2.579 . . . . 25.390000000000001 104.037 -175.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1091 ' ' SER . . . . . . . . . . . . . 45.5 m -154.86 163.4 40.34 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.043 -1.435 . . . . 28.809999999999999 113.282 -171.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1092 ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -73.64 99.77 3.18 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 104.233 -2.506 . . . . 30.780000000000001 104.233 171.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 37.6 mm -85.38 -33.71 8.04 Favored 'Isoleucine or valine' 0 C--N 1.355 0.843 0 CA-C-O 118.254 -0.879 . . . . 30.280000000000001 111.909 -175.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1094 ' ' TRP . . . . . . . . . . . . . 70.6 m95 53.59 62.23 9.57 Favored Pre-proline 0 C--O 1.248 0.994 0 C-N-CA 124.811 1.245 . . . . 34.07 113.274 -167.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -50.1 -49.2 16.89 Favored 'Trans proline' 0 C--O 1.248 0.992 0 C-N-CA 125.104 3.87 . . . . 38.659999999999997 114.089 -170.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -75.18 -19.7 59.7 Favored 'General case' 0 C--O 1.241 0.621 0 O-C-N 120.617 -1.302 . . . . 41.32 110.142 -175.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -85.43 -22.9 28.11 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 122.272 1.034 . . . . 51.659999999999997 111.279 173.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -127.84 48.87 3.74 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 113.869 1.063 . . . . 40.32 113.869 -170.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -60.98 -40.26 53.79 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 124.044 3.163 . . . . 41.560000000000002 118.051 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -64.11 -39.13 93.37 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 109.206 -0.664 . . . . 54.109999999999999 109.206 175.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1101 ' ' LEU . . . . . . . . . . . . . 9.9 mp -61.89 -45.21 94.75 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 118.17 0.441 . . . . 37.880000000000003 111.873 172.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1102 ' ' MET . . . . . . . . . . . . . 75.1 mmm -55.42 -42.63 74.42 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 123.214 0.605 . . . . 37.539999999999999 112.432 173.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -66.55 -40.77 89.23 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-O 122.407 1.098 . . . . 47.009999999999998 108.434 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1104 ' ' LYS . . . . . . . . . . . . . 37.8 mtmt -65.65 -27.72 68.57 Favored 'General case' 0 CA--C 1.481 -1.681 0 O-C-N 118.101 -2.875 . . . . 48.68 116.043 170.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1105 ' ' LEU . . . . . . . . . . . . . 31.3 mt -70.82 -38.81 73.29 Favored 'General case' 0 C--O 1.265 1.869 0 O-C-N 120.385 -1.447 . . . . 32.210000000000001 110.374 173.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -61.77 -42.21 98.7 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 109.019 -0.734 . . . . 33.729999999999997 109.019 175.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -60.14 -44.92 94.58 Favored 'General case' 0 CA--C 1.497 -1.075 0 O-C-N 121.039 -1.038 . . . . 51.469999999999999 113.773 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1108 ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -62.2 -24.5 67.25 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.649 -1.282 . . . . 43.899999999999999 114.332 173.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1109 ' ' ASN . . . . . . . . . . . . . 14.9 m-80 72.01 47.12 0.32 Allowed 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 125.12 2.391 . . . . 44.82 110.94 173.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1110 ' ' VAL . . . . . . . . . . . . . 16.5 m -96.46 169.38 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-N 110.081 -3.236 . . . . 30.52 113.826 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1111 ' ' THR . . . . . . . . . . . . . 8.1 m -104.65 97.87 7.7 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 107.548 -1.278 . . . . 27.120000000000001 107.548 171.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1112 ' ' VAL . . . . . . . . . . . . . 93.4 t -92.8 123.85 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 O-C-N 119.556 -1.965 . . . . 26.399999999999999 108.736 -173.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1113 ' ' MET . . . . . . . . . . . . . 21.0 mtp -116.87 103.12 9.98 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.986 -1.487 . . . . 42.920000000000002 106.986 174.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -79.75 88.04 5.23 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 113.457 -1.701 . . . . 24.149999999999999 113.782 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1115 ' ' MET . . . . . . . . . . . . . 95.0 mmm -54.71 -19.23 5.79 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 117.073 2.249 . . . . 29.949999999999999 117.073 -173.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1116 ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -72.7 -46.23 54.79 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.115 -1.402 . . . . 34.530000000000001 114.503 168.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1117 ' ' SER . . . . . . . . . . . . . 66.1 m -93.8 52.87 1.73 Allowed 'General case' 0 C--O 1.255 1.347 0 O-C-N 119.181 -2.199 . . . . 33.490000000000002 112.028 -167.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1118 ' ' VAL . . . . . . . . . . . . . 40.5 t -89.53 137.38 28.86 Favored Pre-proline 0 N--CA 1.445 -0.718 0 N-CA-C 106.565 -1.643 . . . . 34.020000000000003 106.565 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -63.63 131.07 30.04 Favored 'Trans proline' 0 CA--C 1.512 -0.602 0 C-N-CA 123.765 2.976 . . . . 38.280000000000001 108.336 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1120 ' ' ARG . . . . . 0.503 HH12 ' CG ' ' B' 1128 ' ' ASP . 1.8 mmt180 -74.77 50.2 0.44 Allowed 'General case' 0 C--O 1.247 0.97 0 N-CA-C 115.09 1.515 . . . . 55.049999999999997 115.09 -163.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B 1121 ' ' ILE . . . . . . . . . . . . . 36.1 pt -102.08 172.51 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.912 0 O-C-N 117.082 -3.511 . . . . 42.090000000000003 115.969 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1122 ' ' SER . . . . . . . . . . . . . 2.9 m -62.29 -32.73 73.5 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 117.718 2.488 . . . . 38.020000000000003 117.718 -172.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1123 ' ' ARG . . . . . . . . . . . . . 11.3 ptt-85 -67.25 -35.76 80.21 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 119.378 -0.929 . . . . 34.289999999999999 113.407 162.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1124 ' ' ALA . . . . . . . . . . . . . . . -62.22 -36.08 80.88 Favored 'General case' 0 C--N 1.359 0.98 0 N-CA-C 116.877 2.177 . . . . 32.350000000000001 116.877 -158.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1125 ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -64.94 -8.73 16.88 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 115.415 1.635 . . . . 47.170000000000002 115.415 -172.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1126 ' ' SER . . . . . . . . . . . . . 21.1 p -75.05 -41.82 58.29 Favored 'General case' 0 C--O 1.24 0.585 0 O-C-N 120.414 -1.429 . . . . 31.710000000000001 109.074 173.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1127 ' ' LEU . . . . . . . . . . . . . 3.5 mp -80.13 -40.85 26.58 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-N 113.248 -1.796 . . . . 37.0 111.159 174.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1128 ' ' ASP . . . . . 0.503 ' CG ' HH12 ' B' 1120 ' ' ARG . 9.3 t70 -61.6 119.89 9.52 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 123.743 1.735 . . . . 40.399999999999999 115.001 -173.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B 1129 ' ' ALA . . . . . . . . . . . . . . . -68.63 -34.98 76.68 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 111.629 -2.532 . . . . 26.559999999999999 109.277 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 58.8 mt -67.8 -28.93 68.01 Favored 'General case' 0 C--N 1.31 -1.111 0 O-C-N 118.957 -2.339 . . . . 30.890000000000001 112.451 -169.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1131 ' ' SER . . . . . . . . . . . . . 57.9 p -65.5 -56.11 14.15 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 107.685 -1.228 . . . . 29.84 107.685 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1132 ' ' SER . . . . . . . . . . . . . 5.8 m -55.54 -47.69 75.92 Favored 'General case' 0 CA--C 1.507 -0.675 0 O-C-N 125.727 1.892 . . . . 31.91 110.174 178.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1133 ' ' MET . . . . . . . . . . . . . 33.2 mmt -65.87 -31.35 72.24 Favored 'General case' 0 C--N 1.361 1.073 0 N-CA-C 115.72 1.748 . . . . 25.899999999999999 115.72 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1134 ' ' ALA . . . . . . . . . . . . . . . -67.06 -43.62 82.18 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 107.602 -1.258 . . . . 26.620000000000001 107.602 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.97 -35.59 78.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 121.501 1.955 . . . . 36.969999999999999 110.466 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B 1136 ' ' ILE . . . . . . . . . . . . . 23.5 mm -52.02 -56.81 4.97 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 O-C-N 121.393 -0.817 . . . . 32.109999999999999 110.313 167.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -69.75 -20.32 63.51 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 116.968 -1.491 . . . . 24.140000000000001 110.551 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -69.15 -48.16 48.46 Favored Glycine 0 N--CA 1.471 1.002 0 CA-C-N 120.909 1.686 . . . . 25.129999999999999 110.545 173.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 81.9 t80 -66.33 -51.85 53.03 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 105.595 -2.002 . . . . 32.729999999999997 105.595 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1140 ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -54.63 -25.78 28.81 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-O 115.538 -2.172 . . . . 26.359999999999999 113.4 173.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1141 ' ' ALA . . . . . . . . . . . . . . . -62.17 -54.28 43.26 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 121.381 1.901 . . . . 24.120000000000001 109.055 173.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 45.7 mm -57.69 -43.37 83.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 CA-C-O 122.734 1.254 . . . . 23.370000000000001 110.96 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 75.3 t -63.46 -56.76 15.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 114.523 1.305 . . . . 24.960000000000001 114.523 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -70.16 -29.74 66.72 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 120.47 -1.394 . . . . 32.07 111.639 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1145 ' ' ALA . . . . . . . . . . . . . . . -55.99 -60.3 3.67 Favored 'General case' 0 C--N 1.346 0.418 0 N-CA-C 107.68 -1.23 . . . . 24.870000000000001 107.68 168.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1146 ' ' ALA . . . . . . . . . . . . . . . -48.4 -32.48 7.68 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.248 1.573 . . . . 24.670000000000002 115.248 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 80.7 t60 -53.59 -50.53 65.41 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 119.76 1.164 . . . . 28.579999999999998 111.988 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1148 ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -108.14 -5.38 16.97 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 119.561 -1.962 . . . . 36.82 114.377 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1149 ' ' PHE . . . . . . . . . . . . . 2.8 t80 -54.09 138.94 36.55 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 126.029 2.823 . . . . 31.969999999999999 109.141 177.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1150 ' ' GLY . . . . . . . . . . . . . . . -68.6 -35.35 80.71 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 109.784 -3.371 . . . . 25.489999999999998 113.816 175.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1151 ' ' ARG . . . . . . . . . . . . . 55.3 mtm-85 -128.37 -170.56 2.27 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 123.048 3.424 . . . . 59.840000000000003 110.022 -162.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1152 ' ' PHE . . . . . . . . . . . . . 19.0 m-30 -81.7 161.29 23.43 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 107.734 -1.21 . . . . 34.450000000000003 107.734 168.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1153 ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -79.91 -47.91 14.3 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.102 -1.814 . . . . 31.170000000000002 106.102 166.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1154 ' ' THR . . . . . . . . . . . . . 57.5 m -54.77 134.82 47.82 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 112.28 -2.237 . . . . 33.890000000000001 112.411 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -78.02 62.64 3.63 Favored Glycine 0 N--CA 1.44 -1.094 0 O-C-N 123.881 0.738 . . . . 38.950000000000003 112.86 169.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -83.79 125.04 31.53 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 122.984 1.373 . . . . 54.229999999999997 111.767 -166.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 18.8 mm -78.09 89.39 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 105.375 -2.083 . . . . 51.159999999999997 105.375 172.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1158 ' ' THR . . . . . . . . . . . . . 6.2 m -97.79 146.46 25.37 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 107.157 -1.423 . . . . 49.609999999999999 107.157 -177.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -44.15 -57.3 3.49 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 115.09 1.515 . . . . 49.049999999999997 115.09 -171.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -60.43 -37.27 80.38 Favored 'General case' 0 C--O 1.207 -1.144 0 C-N-CA 125.175 1.39 . . . . 47.649999999999999 112.011 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . 179.87 157.52 20.23 Favored Glycine 0 CA--C 1.498 -1.026 0 N-CA-C 109.421 -1.472 . . . . 45.609999999999999 109.421 -177.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 85.6 mttt -75.1 125.63 29.34 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.044 -1.078 . . . . 57.460000000000001 110.605 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1163 ' ' VAL . . . . . . . . . . . . . 57.1 t -75.81 128.0 84.41 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-O 118.332 -0.842 . . . . 42.93 108.864 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1164 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.92 122.46 9.81 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 124.826 3.684 . . . . 39.289999999999999 108.442 172.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1165 ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -64.88 142.48 75.8 Favored 'Trans proline' 0 C--O 1.248 1.013 0 O-C-N 124.289 1.678 . . . . 34.170000000000002 109.452 -171.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -76.89 120.77 22.49 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 123.833 1.778 . . . . 31.690000000000001 108.898 -173.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1167 ' ' LYS . . . . . . . . . . . . . 87.4 mttt -86.54 101.86 13.59 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 103.085 -2.931 . . . . 44.780000000000001 103.085 174.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 35.7 t -97.31 91.59 2.65 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 CA-C-N 112.805 -1.998 . . . . 31.23 109.46 -175.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1169 ' ' MET . . . . . . . . . . . . . 48.3 ttp -77.48 99.68 5.75 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 105.442 -2.058 . . . . 37.090000000000003 105.442 -177.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 93.3 t -87.6 96.42 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 106.668 -1.605 . . . . 30.170000000000002 106.668 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1171 ' ' ILE . . . . . . . . . . . . . 61.3 mt -90.03 113.08 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 N-CA-C 107.132 -1.433 . . . . 33.740000000000002 107.132 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 94.91 73.85 1.21 Allowed Glycine 0 CA--C 1.5 -0.895 0 C-N-CA 119.561 -1.304 . . . . 32.590000000000003 110.455 170.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1173 ' ' ALA . . . . . . . . . . . . . . . -78.47 57.16 1.9 Allowed 'General case' 0 C--N 1.329 -0.295 0 O-C-N 126.465 1.921 . . . . 32.420000000000002 113.79 -175.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -86.83 -162.52 37.54 Favored Glycine 0 C--O 1.211 -1.3 0 N-CA-C 108.185 -1.966 . . . . 31.739999999999998 108.185 164.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 41.4 t -47.37 -46.9 10.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 CA-C-N 121.538 2.669 . . . . 31.48 116.521 -171.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1176 ' ' ALA . . . . . . . . . . . . . . . -53.97 -56.15 20.5 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 115.665 1.728 . . . . 26.120000000000001 115.665 169.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1177 ' ' GLY . . . . . . . . . . . . . . . -51.3 -52.19 33.31 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-N 113.474 -1.694 . . . . 25.73 111.185 176.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1178 ' ' LEU . . . . . . . . . . . . . 37.8 mt -62.13 -44.34 96.84 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 126.02 1.728 . . . . 32.590000000000003 113.158 -174.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -59.9 -39.36 85.13 Favored 'General case' 0 C--N 1.348 0.517 0 N-CA-C 113.762 1.023 . . . . 27.719999999999999 113.762 171.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -66.53 -39.53 88.66 Favored 'General case' 0 C--O 1.244 0.767 0 O-C-N 124.0 0.813 . . . . 26.030000000000001 111.784 178.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1181 ' ' ILE . . . . . . . . . . . . . 62.9 mt -57.03 -52.85 50.74 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 118.375 -0.821 . . . . 28.609999999999999 111.3 171.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -46.8 -61.85 4.07 Favored Glycine 0 C--N 1.346 1.106 0 O-C-N 126.148 2.155 . . . . 25.23 109.495 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -64.45 -47.27 79.67 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 121.799 0.809 . . . . 24.09 112.921 -171.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -64.67 -37.78 88.77 Favored 'General case' 0 CA--C 1.509 -0.632 0 O-C-N 121.04 -1.038 . . . . 26.68 112.483 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -66.38 -45.52 79.8 Favored 'General case' 0 C--O 1.252 1.208 0 C-N-CA 124.155 0.982 . . . . 36.57 110.009 176.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1186 ' ' SER . . . . . . . . . . . . . 69.1 m -58.29 -37.3 74.76 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 113.138 0.792 . . . . 28.920000000000002 113.138 173.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1187 ' ' LEU . . . . . . . . . . . . . 19.1 mt -69.49 -16.54 63.48 Favored 'General case' 0 C--O 1.249 1.03 0 N-CA-C 114.853 1.427 . . . . 29.09 114.853 173.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 80.42 52.38 4.52 Favored Glycine 0 C--O 1.251 1.187 0 O-C-N 119.151 -2.218 . . . . 29.260000000000002 109.168 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1189 ' ' ALA . . . . . . . . . . . . . . . -115.52 155.34 27.72 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 113.325 -1.438 . . . . 30.16 108.597 170.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 80.2 mt -81.48 94.89 2.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 103.413 -2.81 . . . . 35.810000000000002 103.413 -175.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1191 ' ' VAL . . . . . . . . . . . . . 23.8 t -71.0 121.8 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 C-N-CA 118.228 -1.389 . . . . 31.969999999999999 108.223 170.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1192 ' ' ARG . . . . . 0.401 HH12 ' CD ' ' B' 1248 ' ' GLU . 26.6 mmt85 -104.85 85.12 2.24 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 113.279 -1.782 . . . . 48.159999999999997 106.197 173.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -96.3 149.94 21.12 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 118.368 -2.708 . . . . 35.890000000000001 114.257 -165.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 20.2 t80 -147.54 153.4 39.43 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 120.397 -1.439 . . . . 41.880000000000003 108.615 -177.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1195 ' ' ASP . . . . . . . . . . . . . 8.9 t0 -162.97 159.9 24.06 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 103.409 -2.812 . . . . 38.280000000000001 103.409 167.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1196 ' ' THR . . . . . . . . . . . . . 4.7 m -65.48 -47.17 76.97 Favored 'General case' 0 N--CA 1.427 -1.611 0 C-N-CA 125.38 1.472 . . . . 40.619999999999997 108.203 171.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1197 ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -75.43 130.56 79.45 Favored Pre-proline 0 C--N 1.345 0.387 0 C-N-CA 124.14 0.976 . . . . 53.090000000000003 109.929 -171.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -58.01 -34.58 98.57 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.892 2.395 . . . . 42.560000000000002 117.522 -172.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -35.83 81.48 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.539 -1.351 . . . . 56.310000000000002 113.252 -150.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B 1200 ' ' VAL . . . . . . . . . . . . . 17.0 m -59.48 -22.36 22.81 Favored 'Isoleucine or valine' 0 C--O 1.249 1.076 0 CA-C-N 112.699 -2.046 . . . . 42.909999999999997 113.44 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 51.8 tttm -52.66 -45.94 66.95 Favored 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 124.665 1.186 . . . . 48.890000000000001 113.744 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -65.94 -31.17 71.93 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.823 0.82 . . . . 51.700000000000003 112.815 -176.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1203 ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -61.37 -48.76 79.8 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.945 -1.131 . . . . 52.57 107.945 172.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1204 ' ' VAL . . . . . . . . . . . . . 18.9 t -72.87 -33.91 44.96 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.222 0 CA-C-O 125.358 2.504 . . . . 33.789999999999999 110.606 -167.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -57.38 -52.25 66.11 Favored 'General case' 0 C--O 1.256 1.435 0 CA-C-N 112.997 -1.911 . . . . 36.579999999999998 110.47 168.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1206 ' ' SER . . . . . . . . . . . . . 17.7 m -62.62 -25.39 68.08 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 121.864 2.12 . . . . 39.609999999999999 112.135 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1207 ' ' MET . . . . . . . . . . . . . 20.4 mtp -75.04 -21.21 59.2 Favored 'General case' 0 C--N 1.359 0.988 0 N-CA-C 116.348 1.981 . . . . 37.450000000000003 116.348 172.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 74.7 52.76 6.94 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-O 125.354 2.641 . . . . 31.870000000000001 110.54 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -148.22 151.74 36.01 Favored 'General case' 0 C--O 1.25 1.118 0 N-CA-C 103.382 -2.821 . . . . 35.399999999999999 103.382 -173.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -89.61 126.71 35.72 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 119.602 1.092 . . . . 47.890000000000001 113.548 -169.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 59.4 t80 -85.52 115.96 23.54 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 103.501 -2.777 . . . . 45.530000000000001 103.501 169.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1212 ' ' LEU . . . . . . . . . . . . . 97.3 mt -70.27 93.31 0.83 Allowed 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 114.57 -1.196 . . . . 46.329999999999998 108.163 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -76.31 150.85 36.87 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 122.61 1.195 . . . . 60.409999999999997 111.23 172.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 97.2 mt -70.7 144.64 50.94 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 110.53 -3.032 . . . . 57.380000000000003 112.548 174.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 36.3 t0 . . . . . 0 N--CA 1.425 -1.68 0 O-C-N 125.445 1.716 . . . . 65.069999999999993 107.678 173.934 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B 1230 ' ' MET . . . . . . . . . . . . . 15.2 mmt . . . . . 0 N--CA 1.442 -0.836 0 N-CA-C 103.197 -2.89 . . . . 80.319999999999993 103.197 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B 1231 ' ' SER . . . . . . . . . . . . 0.324 66.8 m 75.53 132.8 0.05 OUTLIER 'General case' 0 C--O 1.212 -0.912 2 CA-C-N 129.98 5.809 . . . . 79.920000000000002 121.428 -0.032 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -70.29 -158.81 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.188 0 O-C-N 125.307 1.63 . . . . 77.909999999999997 111.096 -176.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 68.71 -52.9 0.56 Allowed 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 126.043 1.737 . . . . 73.879999999999995 110.969 -160.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 10.9 t80 -39.77 -51.57 2.36 Favored 'General case' 0 CA--C 1.5 -0.965 0 C-N-CA 127.96 2.504 . . . . 68.980000000000004 110.937 162.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 46.9 pt -52.4 -25.8 8.16 Favored 'Isoleucine or valine' 0 C--O 1.248 1.01 0 N-CA-C 115.84 1.793 . . . . 64.530000000000001 115.84 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -77.97 -48.31 16.54 Favored 'General case' 0 CA--C 1.511 -0.529 0 O-C-N 119.883 -1.761 . . . . 66.359999999999999 110.064 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -60.09 -36.15 76.76 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 123.978 0.911 . . . . 56.600000000000001 109.832 177.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -59.08 -62.11 2.13 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.259 -1.015 . . . . 56.789999999999999 108.259 171.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1239 ' ' MET . . . . . . . . . . . . . 20.3 mmt -59.26 -34.3 72.07 Favored 'General case' 0 C--O 1.222 -0.392 0 O-C-N 119.41 -2.056 . . . . 53.630000000000003 114.356 -173.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -46.33 -54.34 9.16 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 113.871 1.063 . . . . 51.740000000000002 113.871 168.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 48.8 tp -68.24 -49.16 62.56 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 112.488 -2.142 . . . . 44.859999999999999 106.38 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -64.95 -44.22 90.12 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 119.494 -2.004 . . . . 42.780000000000001 111.644 -172.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -65.73 -24.05 66.88 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 114.688 1.366 . . . . 40.960000000000001 114.688 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -76.63 -58.04 3.51 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 104.834 -2.284 . . . . 43.060000000000002 104.834 171.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 75.7 mm-40 -53.45 -30.32 40.05 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.901 1.281 . . . . 46.450000000000003 112.195 -173.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -57.67 -35.98 71.29 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.946 1.248 . . . . 41.780000000000001 113.003 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 31.4 tptt -67.04 -23.76 65.92 Favored 'General case' 0 C--O 1.241 0.637 0 O-C-N 119.369 -2.082 . . . . 52.200000000000003 113.6 176.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1248 ' ' GLU . . . . . 0.401 ' CD ' HH12 ' B' 1192 ' ' ARG . 20.8 mt-10 -95.12 -44.84 7.47 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 114.179 -1.373 . . . . 53.549999999999997 113.76 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B 1249 ' ' VAL . . . . . . . . . . . . . 29.0 m -77.99 143.13 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-O 126.352 2.977 . . . . 34.409999999999997 114.21 -162.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1250 ' ' ASP . . . . . 0.41 ' CG ' ' HZ2' ' B' 1276 ' ' LYS . 8.3 m-20 -100.05 -37.35 9.02 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 109.066 -3.697 . . . . 33.380000000000003 107.247 -177.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B 1251 ' ' ILE . . . . . . . . . . . . . 37.0 mm -128.98 125.64 63.2 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.755 0 O-C-N 119.789 -1.82 . . . . 29.539999999999999 107.083 176.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1252 ' ' ILE . . . . . . . . . . . . . 64.8 mt -103.34 109.2 26.27 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.734 0 N-CA-C 103.927 -2.62 . . . . 32.439999999999998 103.927 166.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1253 ' ' VAL . . . . . . . . . . . . . 95.4 t -84.76 82.31 1.86 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.976 0 N-CA-C 103.924 -2.621 . . . . 30.57 103.924 169.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1254 ' ' THR . . . . . . . . . . . . 0.283 2.8 t -84.13 91.16 7.62 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-O 127.243 3.402 . . . . 35.039999999999999 110.037 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B 1255 ' ' THR . . . . . . . . . . . . . 27.1 m -85.45 -71.24 0.54 Allowed 'General case' 0 C--O 1.242 0.703 0 CA-C-N 110.001 -3.272 . . . . 34.619999999999997 108.136 -175.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . 44.1 24.74 0.09 Allowed 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 120.973 3.694 . . . . 42.719999999999999 120.973 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 39.3 mt -66.2 112.25 3.85 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-O 123.255 1.502 . . . . 52.43 110.576 -172.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 55.6 mt -91.92 109.01 34.28 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 105.066 -2.198 . . . . 59.409999999999997 105.066 175.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -56.3 97.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 123.441 2.761 . . . . 62.68 114.864 -175.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 68.61 47.92 53.46 Favored Glycine 0 N--CA 1.466 0.652 0 N-CA-C 109.353 -1.499 . . . . 64.159999999999997 109.353 174.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 55.5 tttt -155.76 149.1 18.56 Favored Pre-proline 0 C--O 1.248 1.019 0 N-CA-C 102.258 -3.238 . . . . 68.530000000000001 102.258 168.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.53 132.22 37.09 Favored 'Trans proline' 0 C--N 1.364 1.376 0 C-N-CA 124.746 3.631 . . . . 61.990000000000002 112.765 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1263 ' ' ALA . . . . . . . . . . . . . . . -71.69 143.08 86.72 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-N 112.933 -1.94 . . . . 57.149999999999999 112.201 175.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -73.08 147.87 43.71 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 124.156 3.237 . . . . 51.57 116.003 -176.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -71.46 82.63 0.8 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 118.567 -2.583 . . . . 54.549999999999997 109.58 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 84.9 mt -71.3 -64.4 0.92 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.103 -1.408 . . . . 46.859999999999999 113.946 178.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1267 ' ' ILE . . . . . . . . . . . . . 26.5 mm -87.66 89.66 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 107.389 -1.337 . . . . 41.039999999999999 107.389 -170.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1268 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.86 150.64 47.56 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 111.504 -2.589 . . . . 39.579999999999998 116.51 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B 1269 ' ' ARG . . . . . . . . . . . . . 44.3 mtt85 -54.28 -44.27 71.76 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 114.516 1.302 . . . . 53.149999999999999 114.516 -169.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -57.53 -44.6 85.23 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.261 0.624 . . . . 42.960000000000001 112.551 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1271 ' ' MET . . . . . . . . . . . . . 30.1 ttm -58.91 -52.2 66.78 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 125.687 1.867 . . . . 43.890000000000001 109.966 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1272 ' ' VAL . . . . . . . . . . . . . 40.2 t -54.95 -47.09 76.67 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 C-N-CA 124.176 0.99 . . . . 38.369999999999997 108.618 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.99 -26.7 67.78 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 115.634 1.716 . . . . 47.460000000000001 115.634 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B 1274 ' ' SER . . . . . . . . . . . . . 3.2 p -92.42 -6.39 50.08 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 114.53 1.307 . . . . 38.380000000000003 114.53 174.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1275 ' ' MET . . . . . . . . . . . . . 11.2 ttt -67.02 159.72 28.06 Favored 'General case' 0 C--O 1.24 0.586 0 O-C-N 121.22 -0.925 . . . . 37.810000000000002 112.56 -176.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1276 ' ' LYS . . . . . 0.41 ' HZ2' ' CG ' ' B' 1250 ' ' ASP . 83.1 tttt -55.62 147.98 17.01 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 124.627 1.171 . . . . 49.259999999999998 113.059 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -76.35 150.15 36.89 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 108.195 -1.039 . . . . 34.460000000000001 108.195 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 68.28 26.59 74.12 Favored Glycine 0 N--CA 1.466 0.657 0 C-N-CA 125.006 1.289 . . . . 33.530000000000001 112.118 173.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1279 ' ' SER . . . . . . . . . . . . . 36.6 m -113.17 156.49 23.14 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 106.198 -1.779 . . . . 31.309999999999999 106.198 -171.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1280 ' ' VAL . . . . . . . . . . . . . 52.9 t -115.62 140.04 39.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 O-C-N 119.535 -1.978 . . . . 29.32 109.314 -171.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1281 ' ' ILE . . . . . . . . . . . . . 19.5 mt -109.27 105.18 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 104.953 -2.24 . . . . 31.93 104.953 165.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1282 ' ' VAL . . . . . . . . . . . . . 15.8 t -84.35 114.92 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 N-CA-C 101.078 -3.675 . . . . 29.48 101.078 176.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 45.7 t0 -97.98 96.62 8.29 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.208 -1.405 . . . . 34.5 107.208 175.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1284 ' ' LEU . . . . . . . . . . . . . 6.6 mp -68.48 -32.84 73.12 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 113.548 -1.66 . . . . 37.939999999999998 110.727 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -89.03 20.23 3.74 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 125.54 1.775 . . . . 40.920000000000002 112.35 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -48.48 -34.23 10.8 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 120.917 1.69 . . . . 44.390000000000001 115.062 177.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1287 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.56 -20.51 22.54 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 113.165 0.802 . . . . 51.460000000000001 113.165 175.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -91.21 -17.16 26.49 Favored 'General case' 0 C--O 1.215 -0.727 0 O-C-N 120.515 -1.366 . . . . 57.75 113.575 -177.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1289 ' ' GLY . . . . . . . . . . . . . . . 173.17 -19.55 0.06 OUTLIER Glycine 0 C--O 1.243 0.699 0 CA-C-O 116.82 -2.1 . . . . 49.850000000000001 112.97 177.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 74.89 88.3 0.23 Allowed Glycine 0 CA--C 1.524 0.65 0 CA-C-N 122.12 2.96 . . . . 45.93 108.806 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1291 ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -71.41 -30.58 66.27 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 123.015 1.388 . . . . 42.670000000000002 113.616 -173.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1292 ' ' CYS . . . . . . . . . . . . . 33.2 t -98.57 145.83 26.43 Favored 'General case' 0 C--O 1.241 0.619 0 O-C-N 121.445 -0.785 . . . . 38.82 109.134 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1293 ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -73.57 -35.85 65.52 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.463 -0.495 . . . . 46.710000000000001 111.07 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -72.94 -13.64 61.29 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.188 0.81 . . . . 47.229999999999997 113.188 -178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1295 ' ' THR . . . . . . . . . . . . . 98.1 m -53.39 102.39 0.06 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.992 0.738 . . . . 36.020000000000003 112.992 173.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 82.8 t -73.24 113.97 26.99 Favored Pre-proline 0 N--CA 1.429 -1.503 0 N-CA-C 104.298 -2.482 . . . . 37.259999999999998 104.298 158.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -62.01 131.06 33.13 Favored 'Trans proline' 0 CA--C 1.507 -0.868 0 C-N-CA 122.773 2.315 . . . . 35.090000000000003 114.125 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 81.07 8.78 86.99 Favored Glycine 0 CA--C 1.543 1.826 0 CA-C-O 118.174 -1.348 . . . . 35.969999999999999 110.692 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -143.61 172.5 12.72 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 120.82 2.31 . . . . 40.390000000000001 112.075 -173.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1300 ' ' ILE . . . . . . . . . . . . . 67.4 mt -101.11 148.1 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 103.848 -2.649 . . . . 37.43 103.848 170.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 65.3 t80 -123.7 125.21 44.36 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 101.561 -3.496 . . . . 44.130000000000003 101.561 164.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1302 ' ' THR . . . . . . . . . . . . . 90.8 m -98.03 110.72 23.24 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.476 -1.305 . . . . 39.780000000000001 107.476 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1303 ' ' THR . . . . . . . . . . . . . 40.5 p -72.62 162.48 29.43 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 113.515 0.932 . . . . 43.289999999999999 113.515 -174.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -53.7 -37.1 62.91 Favored 'General case' 0 C--N 1.354 0.789 0 O-C-N 120.338 -1.476 . . . . 53.07 112.085 173.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -77.81 12.71 1.6 Allowed 'General case' 0 C--N 1.349 0.555 0 O-C-N 120.192 -1.567 . . . . 43.969999999999999 114.437 174.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 72.13 34.89 61.14 Favored Glycine 0 CA--C 1.546 1.997 0 C-N-CA 119.078 -1.534 . . . . 41.119999999999997 111.879 173.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1307 ' ' VAL . . . . . . . . . . . . . 68.0 t -104.87 133.68 48.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 116.723 -3.81 . . . . 38.119999999999997 102.381 175.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1308 ' ' LYS . . . . . . . . . . . . . 41.7 mmtt -97.68 97.71 9.25 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 105.938 -1.875 . . . . 36.340000000000003 105.938 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1309 ' ' VAL . . . . . . . . . . . . . 21.8 t -85.62 92.22 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 N-CA-C 106.68 -1.6 . . . . 30.399999999999999 106.68 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1310 ' ' ILE . . . . . . . . . . . . . 56.8 mt -89.45 87.51 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 C-N-CA 124.615 1.166 . . . . 30.82 111.378 -177.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1311 ' ' GLY . . . . . . . . . . . . . . . -94.48 62.44 1.71 Allowed Glycine 0 C--O 1.245 0.839 0 N-CA-C 110.825 -0.91 . . . . 26.530000000000001 110.825 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1312 ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -83.0 99.27 9.73 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 124.02 1.866 . . . . 38.0 111.732 -176.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1313 ' ' THR . . . . . . . . . . . . . 26.9 m -51.76 -37.87 53.1 Favored 'General case' 0 C--O 1.255 1.365 0 C-N-CA 126.006 1.722 . . . . 29.800000000000001 113.226 170.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -81.09 17.57 1.22 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 116.292 1.96 . . . . 39.039999999999999 116.292 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1315 ' ' LEU . . . . . . . . . . . . . 42.9 mt -45.51 -46.76 36.27 Favored Pre-proline 0 C--O 1.254 1.323 0 N-CA-C 117.214 2.301 . . . . 31.079999999999998 117.214 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1316 ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -61.5 -33.03 88.55 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.244 2.629 . . . . 26.100000000000001 115.19 167.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -70.51 -40.69 67.49 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 118.447 -1.835 . . . . 23.170000000000002 112.608 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -60.84 -2.74 0.6 Allowed 'General case' 0 C--O 1.246 0.894 0 N-CA-C 118.384 2.735 . . . . 40.399999999999999 118.384 -174.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 3.3 tp -120.52 58.41 6.26 Favored Pre-proline 0 C--N 1.327 -0.38 0 O-C-N 118.843 -2.411 . . . . 23.600000000000001 107.003 -176.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1320 ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -54.19 -60.93 0.49 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 124.429 3.419 . . . . 22.350000000000001 117.588 -152.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1321 ' ' THR . . . . . . . . . . . . . 1.3 m -57.03 -49.81 74.67 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.504 1.502 . . . . 26.52 111.375 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1322 ' ' GLN . . . . . . . . . . . . . 39.1 tp60 -73.26 -33.81 65.47 Favored 'General case' 0 N--CA 1.435 -1.223 0 O-C-N 122.15 -0.344 . . . . 24.379999999999999 110.903 -172.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1323 ' ' SER . . . . . . . . . . . . . 68.3 m -57.84 -46.57 84.56 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 123.702 0.801 . . . . 22.800000000000001 112.488 165.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1324 ' ' SER . . . . . . . . . . . . . 15.7 m -69.48 -30.74 68.69 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 120.24 -1.538 . . . . 21.25 110.416 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -73.64 -36.54 65.43 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 121.093 1.77 . . . . 31.34 108.692 176.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1326 ' ' LEU . . . . . . . . . . . . . 11.3 mt -70.92 -58.21 3.81 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.871 1.669 . . . . 31.559999999999999 108.346 -175.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1327 ' ' TYR . . . . . . . . . . . . . 12.4 t80 -52.63 -45.25 66.55 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 125.44 1.496 . . . . 22.73 110.747 173.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1328 ' ' GLY . . . . . . . . . . . . . . . -51.87 -50.98 41.97 Favored Glycine 0 C--O 1.249 1.08 0 CA-C-O 118.951 -0.916 . . . . 21.91 111.552 170.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1329 ' ' THR . . . . . . . . . . . . . 8.5 m -66.87 -28.62 68.48 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 121.4 2.6 . . . . 22.149999999999999 109.377 -177.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1330 ' ' ASN . . . . . . . . . . . . . 10.1 m120 -60.86 -50.17 74.5 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.312 -0.868 . . . . 26.18 110.649 174.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1331 ' ' LEU . . . . . . . . . . . . . 18.7 mt -60.22 -36.76 78.42 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 126.904 2.081 . . . . 23.68 112.123 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1332 ' ' VAL . . . . . . . . . . . . . 20.9 t -65.15 -48.7 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 N-CA-C 107.301 -1.37 . . . . 26.57 107.301 175.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -59.63 -47.75 84.38 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 109.641 -0.503 . . . . 28.079999999999998 109.641 -174.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1334 ' ' LEU . . . . . . . . . . . . . 6.1 tt -56.25 -50.82 70.24 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 113.486 0.921 . . . . 27.43 113.486 170.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1335 ' ' LEU . . . . . . . . . . . . . 93.0 mt -64.88 -16.89 63.78 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 114.96 1.466 . . . . 30.5 114.96 177.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1336 ' ' LYS . . . . . . . . . . . . . 86.8 mttt -72.6 -46.28 55.01 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 120.256 1.389 . . . . 41.649999999999999 107.292 170.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 11.6 tp -64.63 -32.88 74.74 Favored 'General case' 0 N--CA 1.441 -0.91 0 O-C-N 120.329 -1.482 . . . . 42.079999999999998 110.731 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1338 ' ' LEU . . . . . . . . . . . . . 24.2 mt -73.2 -47.01 47.07 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 118.896 -0.573 . . . . 35.030000000000001 110.289 168.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1339 ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' B' 1344 ' ' GLY . 0.5 OUTLIER -88.3 81.95 7.17 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 121.522 1.964 . . . . 37.329999999999998 109.328 -175.171 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -27.56 66.85 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.7 -1.136 . . . . 50.509999999999998 112.207 -160.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -117.14 18.18 14.62 Favored 'General case' 0 C--O 1.242 0.703 0 O-C-N 123.949 0.781 . . . . 54.210000000000001 110.831 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1342 ' ' LYS . . . . . 0.431 ' HZ2' ' CD ' ' C' ' 98' ' ' GLU . 49.0 mttp 49.09 59.42 4.47 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 124.572 2.129 . . . . 50.990000000000002 109.303 -166.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -127.67 31.58 5.13 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 111.683 -2.508 . . . . 48.82 111.083 -165.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1344 ' ' GLY . . . . . 0.528 ' N ' ' SG ' ' B' 1339 ' ' CYS . . . 47.3 24.07 2.19 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 116.912 1.525 . . . . 40.43 116.912 175.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 40.0 t30 -127.28 151.12 49.15 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.775 -1.194 . . . . 47.560000000000002 107.775 -169.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1346 ' ' ILE . . . . . . . . . . . . . 32.9 mm -100.24 86.65 1.26 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 105.012 -2.218 . . . . 42.490000000000002 105.012 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1347 ' ' THR . . . . . . . . . . . . . 33.2 p -87.34 102.48 14.56 Favored 'General case' 0 C--O 1.241 0.632 0 O-C-N 118.157 -2.839 . . . . 38.119999999999997 109.839 164.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 61.0 t -90.84 111.89 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 107.094 -1.447 . . . . 37.5 107.094 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 23.6 t70 -97.69 127.92 44.0 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 106.051 -1.833 . . . . 43.850000000000001 106.051 172.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1350 ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.62 -0.12 46.27 Favored 'General case' 0 C--O 1.257 1.476 0 O-C-N 119.92 -1.737 . . . . 39.810000000000002 114.016 175.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -73.17 -37.21 66.63 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 121.441 1.928 . . . . 51.289999999999999 109.122 176.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 22.1 t0 -54.66 118.3 4.09 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 119.754 -0.779 . . . . 39.780000000000001 110.754 167.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 33.9 m -55.93 -31.18 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 O-C-N 123.868 0.73 . . . . 39.280000000000001 112.843 176.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1354 ' ' VAL . . . . . . . . . . . . . 83.7 t -70.37 -51.73 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 N-CA-C 106.637 -1.616 . . . . 35.700000000000003 106.637 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1355 ' ' ILE . . . . . . . . . . . . . 50.4 mm -62.27 -46.02 97.4 Favored 'Isoleucine or valine' 0 C--N 1.359 0.99 0 CA-C-N 121.82 2.1 . . . . 35.770000000000003 113.464 173.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 49.5 tpt85 -49.73 -33.63 16.7 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 114.505 1.298 . . . . 38.549999999999997 114.505 171.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -83.71 -54.16 3.17 Favored Glycine 0 C--N 1.343 0.963 0 N-CA-C 109.454 -1.458 . . . . 29.579999999999998 109.454 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1358 ' ' VAL . . . . . . . . . . . . . 14.8 p -62.95 -42.54 96.98 Favored 'Isoleucine or valine' 0 C--O 1.256 1.413 0 CA-C-O 121.916 0.865 . . . . 32.060000000000002 112.531 -173.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1359 ' ' THR . . . . . . . . . . . . . 3.6 m -83.83 81.96 8.54 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 124.13 1.919 . . . . 29.0 109.42 -174.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1360 ' ' VAL . . . . . . . . . . . . . 10.0 m -71.23 -16.98 19.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 113.022 -1.899 . . . . 29.68 113.907 -173.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 57.7 mt -134.98 110.22 12.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 N-CA-C 107.041 -1.466 . . . . 32.049999999999997 107.041 170.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1362 ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -98.74 110.43 23.03 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 104.99 -2.226 . . . . 32.520000000000003 104.99 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 48.26 60.77 3.39 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 112.922 -1.944 . . . . 35.68 113.528 172.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 83.58 -46.24 3.61 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 115.495 0.958 . . . . 34.259999999999998 115.495 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -64.62 124.56 22.21 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 119.277 -0.969 . . . . 51.07 111.802 172.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 69.7 mt -78.47 118.08 25.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 N-CA-C 103.265 -2.865 . . . . 39.869999999999997 103.265 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1367 ' ' THR . . . . . . . . . . . . . 1.4 p -107.03 11.57 29.56 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 113.883 -1.508 . . . . 38.009999999999998 112.039 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1368 ' ' TRP . . . . . . . . . . . . . 20.7 t90 -82.74 131.96 53.08 Favored Pre-proline 0 C--O 1.241 0.657 0 N-CA-C 103.531 -2.766 . . . . 42.140000000000001 103.531 164.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -82.23 171.89 53.15 Favored 'Cis proline' 0 C--N 1.353 0.812 0 N-CA-C 116.805 1.81 . . . . 43.259999999999998 116.805 -2.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1370 ' ' ALA . . . . . . . . . . . . . . . -113.74 130.14 24.07 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 105.712 -1.958 . . . . 46.520000000000003 105.712 173.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -62.73 106.36 0.51 Allowed 'Trans proline' 0 CA--C 1.552 1.419 0 C-N-CA 123.384 2.723 . . . . 51.950000000000003 108.671 173.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -65.66 140.56 62.68 Favored 'Trans proline' 0 N--CA 1.441 -1.579 0 C-N-CA 123.584 2.856 . . . . 56.270000000000003 119.118 -170.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1373 ' ' ILE . . . . . . . . . . . . . 14.9 tt -74.61 145.67 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 113.902 -1.499 . . . . 60.829999999999998 108.02 170.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -65.83 108.9 2.29 Favored 'General case' 0 C--N 1.317 -0.845 0 O-C-N 120.91 -1.119 . . . . 66.099999999999994 110.054 176.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 76.9 t -102.01 108.86 24.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 106.082 -1.822 . . . . 63.469999999999999 106.082 -169.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.23 -4.619 0 O-C-N 120.601 -1.312 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.274 0 CA-C-O 121.637 0.732 . . . . 0.0 112.4 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -58.09 -28.01 64.21 Favored 'General case' 0 C--O 1.251 1.162 0 O-C-N 119.141 -2.225 . . . . 0.0 114.1 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -66.08 -53.25 40.47 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 176.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 29.2 m -56.33 -34.11 66.27 Favored 'General case' 0 C--O 1.209 -1.064 0 C-N-CA 126.043 1.737 . . . . 0.0 112.516 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.32 -36.82 83.35 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.59 0.756 . . . . 0.0 112.089 174.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.78 -50.12 16.15 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.917 171.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.3 -43.62 64.58 Favored 'General case' 0 C--O 1.213 -0.867 0 C-N-CA 126.239 1.816 . . . . 0.0 113.175 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 81.1 mt -60.16 -51.23 70.49 Favored 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 118.63 -2.544 . . . . 0.0 115.315 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 28' ' ' LYS . . . . . 0.432 ' HZ3' ' C ' ' C' ' 186' ' ' LEU . 18.5 pttm -67.66 -17.41 64.58 Favored 'General case' 0 CA--C 1.555 1.169 0 O-C-N 121.113 -0.992 . . . . 0.0 110.022 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -75.21 -46.85 31.31 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 119.746 1.157 . . . . 0.0 111.048 164.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 38.9 m -50.28 -35.52 27.53 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 121.229 3.788 . . . . 0.0 121.229 -163.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 31' ' ' HIS . . . . . . . . . . . . 0.4 3.7 p-80 54.32 -38.86 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 119.121 3.008 . . . . 0.0 119.121 -170.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 17.7 m -123.99 133.61 53.65 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 103.019 -2.956 . . . . 0.0 103.019 169.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 64.3 t -131.7 125.17 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 -174.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 34.4 mm -102.97 128.94 55.43 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 N-CA-C 103.467 -2.79 . . . . 0.0 103.467 172.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 31.8 mt -103.59 117.5 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 172.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 93.2 m -111.24 92.42 15.71 Favored Pre-proline 0 C--N 1.347 0.485 0 C-N-CA 124.255 1.022 . . . . 0.0 109.294 176.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -78.7 154.88 27.09 Favored 'Trans proline' 0 C--O 1.246 0.911 0 C-N-CA 123.614 2.876 . . . . 0.0 112.856 169.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.77 -143.78 3.79 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 109.766 -3.379 . . . . 0.0 105.096 174.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -61.34 -34.49 75.36 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 117.393 -1.289 . . . . 0.0 113.449 -168.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.08 -32.55 63.01 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-O 116.528 -2.262 . . . . 0.0 112.474 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 32.8 ttm -75.82 -26.13 56.94 Favored 'General case' 0 C--O 1.253 1.266 0 CA-C-N 119.556 1.678 . . . . 0.0 111.294 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.68 -38.82 58.39 Favored 'General case' 0 C--O 1.221 -0.443 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.274 175.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 59.9 t -74.95 -66.08 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 O-C-N 121.215 -0.928 . . . . 0.0 110.495 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -91.04 113.51 25.79 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 45' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -72.0 79.5 0.92 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 124.514 2.102 . . . . 0.0 110.265 -169.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.41 -6.13 22.92 Favored 'General case' 0 C--O 1.239 0.534 0 O-C-N 120.332 -1.48 . . . . 0.0 112.974 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.21 -41.81 48.19 Favored 'General case' 0 C--O 1.249 1.05 0 O-C-N 120.155 -1.591 . . . . 0.0 114.235 -159.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 48' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -61.34 -43.74 90.63 Favored Pre-proline 0 CA--C 1.55 0.971 0 O-C-N 119.964 -1.71 . . . . 0.0 113.352 168.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 49' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -54.34 -41.44 76.44 Favored 'Trans proline' 0 C--N 1.351 0.696 0 CA-C-N 124.069 2.489 . . . . 0.0 116.536 165.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 48.6 t -60.87 -41.58 89.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 O-C-N 119.971 -1.706 . . . . 0.0 112.509 175.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.08 -33.72 76.05 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 171.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -67.09 -39.41 86.76 Favored 'General case' 0 C--N 1.351 0.638 0 CA-C-O 118.284 -0.865 . . . . 0.0 113.277 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 10.2 tp -76.04 -37.27 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.718 0 CA-C-N 119.775 1.171 . . . . 0.0 110.429 175.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 26.1 m -64.78 -37.53 87.91 Favored 'General case' 0 C--O 1.244 0.814 0 O-C-N 120.219 -1.55 . . . . 0.0 112.889 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -34.12 -43.36 0.15 Allowed 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 126.808 2.043 . . . . 0.0 112.858 159.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -87.95 -44.57 10.93 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 120.254 1.388 . . . . 0.0 109.92 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 74.8 mt -62.91 -48.74 77.65 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 121.017 -1.052 . . . . 0.0 111.309 -167.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -72.38 -34.51 68.0 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 121.334 1.879 . . . . 0.0 108.901 -171.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.28 -19.42 54.87 Favored 'General case' 0 C--N 1.345 0.384 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 166.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 28.8 ttm-85 -94.35 14.14 21.4 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-O 120.96 0.409 . . . . 0.0 110.557 173.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.48 22.89 66.2 Favored Glycine 0 C--O 1.24 0.52 0 O-C-N 120.647 -1.283 . . . . 0.0 114.425 -177.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 15.0 mt -76.66 119.93 25.9 Favored 'Isoleucine or valine' 0 C--O 1.254 1.298 0 CA-C-O 122.062 0.934 . . . . 0.0 113.191 177.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -63.23 84.66 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.561 0 CA-C-O 123.935 1.826 . . . . 0.0 106.285 171.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 9.2 p -100.51 135.08 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 5.1 mmm-85 -137.84 140.06 40.26 Favored 'General case' 0 C--O 1.253 1.281 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -101.44 84.05 2.54 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -176.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.95 69.42 2.68 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.399 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 10.1 mt -70.07 142.3 16.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 120.763 -1.433 . . . . 0.0 112.772 -174.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -114.66 89.59 19.17 Favored Pre-proline 0 N--CA 1.475 0.794 0 O-C-N 120.277 -1.514 . . . . 0.0 107.054 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 70' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.84 -53.09 2.36 Favored 'Trans proline' 0 CA--C 1.513 -0.575 1 C-N-CA 125.504 4.136 . . . . 0.0 117.919 -163.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 51.8 t -67.26 104.79 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 168.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -171.89 119.26 0.43 Allowed 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 113.121 -1.854 . . . . 0.0 106.374 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.87 -97.82 2.08 Favored Glycine 0 C--O 1.213 -1.161 0 O-C-N 120.209 -1.557 . . . . 0.0 112.115 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -149.17 171.22 16.8 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 103.384 -2.821 . . . . 0.0 103.384 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . 0.268 33.0 mt 60.43 103.59 0.03 OUTLIER Pre-proline 0 C--O 1.236 0.385 0 N-CA-C 117.21 2.3 . . . . 0.0 117.21 -175.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -63.53 90.16 0.15 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.891 2.394 . . . . 0.0 112.137 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.08 -7.64 62.87 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-O 116.125 -2.486 . . . . 0.0 115.507 175.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -51.29 -28.01 10.88 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 123.733 3.766 . . . . 0.0 119.592 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -58.52 -32.27 68.69 Favored 'General case' 0 C--O 1.243 0.757 0 O-C-N 118.925 -2.359 . . . . 0.0 113.748 169.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -66.88 -37.79 85.07 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 122.586 0.354 . . . . 0.0 111.054 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 92.9 t -68.74 -42.76 83.12 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.718 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.383 -175.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 34.9 mt -53.56 -41.55 66.59 Favored 'General case' 0 C--N 1.35 0.619 0 C-N-CA 125.319 1.448 . . . . 0.0 113.144 170.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 21.4 tp -65.24 -46.4 80.74 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.181 0.991 . . . . 0.0 110.379 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.44 -35.26 77.08 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-O 118.107 -0.949 . . . . 0.0 112.38 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -64.51 -43.88 92.67 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.597 0.561 . . . . 0.0 112.283 173.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.35 -3.31 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 119.131 3.011 . . . . 0.0 119.131 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp 60.3 65.9 1.02 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 125.278 2.466 . . . . 0.0 112.184 -175.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 87.0 t -115.29 149.96 43.65 Favored Pre-proline 0 N--CA 1.481 1.1 0 CA-C-N 108.748 -3.842 . . . . 0.0 104.208 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -55.94 76.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.476 0.47 1 C-N-CA 127.178 5.252 . . . . 0.0 113.823 164.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -60.4 -30.24 69.47 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 113.062 -1.881 . . . . 0.0 107.004 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -39.02 -39.76 0.59 Allowed 'General case' 0 C--N 1.354 0.763 0 CA-C-O 116.359 -1.781 . . . . 0.0 115.436 168.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 2.3 pt -107.52 24.92 2.59 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 CA-C-O 124.034 1.873 . . . . 0.0 111.881 -176.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 53.4 t -87.52 128.68 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 O-C-N 120.623 -1.298 . . . . 0.0 109.304 174.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 4.7 mp -117.36 83.45 1.99 Allowed 'General case' 0 C--O 1.259 1.58 0 CA-C-O 123.644 1.688 . . . . 0.0 110.495 172.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -75.94 111.8 11.7 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 119.876 -1.765 . . . . 0.0 106.729 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 68.35 -9.08 0.54 Allowed 'General case' 0 C--O 1.251 1.182 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 173.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -68.09 -177.01 0.78 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 118.109 -0.948 . . . . 0.0 113.089 175.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . 0.431 ' CD ' ' HZ2' ' B' 1342 ' ' LYS . 83.9 mt-10 -77.22 57.84 1.51 Allowed 'General case' 0 C--O 1.24 0.603 0 CA-C-O 125.627 2.632 . . . . 0.0 117.168 -171.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 8.6 tp -77.75 -2.52 4.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 O-C-N 119.174 -2.204 . . . . 0.0 111.334 173.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -57.79 -45.33 86.18 Favored 'General case' 0 C--N 1.354 0.768 0 O-C-N 121.292 -0.88 . . . . 0.0 113.226 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -57.05 -43.19 81.74 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 122.936 1.35 . . . . 0.0 113.87 174.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -68.42 -24.32 64.73 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.853 -175.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 103' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -53.67 -43.48 68.89 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 116.078 -1.915 . . . . 0.0 111.23 167.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.7 -45.73 88.69 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 121.128 1.785 . . . . 0.0 111.066 173.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -57.26 -31.41 65.55 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 106' ' ' THR . . . . . . . . . . . . . 10.2 m -79.11 159.34 27.52 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-N 113.414 -1.721 . . . . 0.0 113.143 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 107' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -99.98 -84.76 0.41 Allowed 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 165.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 57.2 m -79.01 111.44 15.21 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 125.307 2.48 . . . . 0.0 116.535 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 109' ' ' VAL . . . . . . . . . . . . . 21.0 t -90.3 105.61 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 112.208 -2.269 . . . . 0.0 107.857 174.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 15.4 mt -71.55 87.79 0.91 Allowed 'General case' 0 C--O 1.25 1.125 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 173.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 89.9 t -82.29 83.07 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 O-C-N 120.277 -1.514 . . . . 0.0 109.862 178.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 56.0 mt -82.53 92.54 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 123.31 1.528 . . . . 0.0 110.185 -175.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 113' ' ' GLY . . . . . . . . . . . . . . . 57.95 29.61 62.32 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 110.513 -3.04 . . . . 0.0 113.681 175.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -82.66 -28.84 30.41 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 118.485 -1.286 . . . . 0.0 112.322 173.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 115' ' ' ASN . . . . . 0.517 ' ND2' ' H ' ' C' ' 116' ' ' ASP . 6.2 t30 64.93 -163.26 0.26 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 116.377 -1.773 . . . . 0.0 112.564 161.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 116' ' ' ASP . . . . . 0.517 ' H ' ' ND2' ' C' ' 115' ' ' ASN . 1.9 p30 -51.99 -14.48 0.4 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 125.31 3.687 . . . . 0.0 116.881 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 1.3 m -63.64 -14.07 48.37 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 169.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 21.3 m -106.55 12.96 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 117.242 -3.411 . . . . 0.0 112.871 167.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -102.15 131.81 22.22 Favored Pre-proline 0 N--CA 1.478 0.961 0 O-C-N 118.904 -2.372 . . . . 0.0 114.392 -166.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 120' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -50.89 -40.01 58.22 Favored 'Trans proline' 0 C--O 1.242 0.707 0 C-N-CA 123.939 3.093 . . . . 0.0 113.869 -178.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.87 -14.28 8.58 Favored 'General case' 0 C--O 1.208 -1.092 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 -167.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.98 -37.97 78.04 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 119.241 -2.162 . . . . 0.0 112.365 170.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -95.02 -41.38 9.17 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.369 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -67.77 -46.88 70.77 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 124.305 1.042 . . . . 0.0 111.129 -170.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -108.55 94.85 14.74 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 120.272 1.396 . . . . 0.0 109.264 172.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -49.58 -15.43 0.96 Allowed 'Trans proline' 0 C--O 1.257 1.451 1 C-N-CA 125.677 4.251 . . . . 0.0 112.362 172.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -68.06 -32.62 73.09 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 118.654 -2.528 . . . . 0.0 109.177 176.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 128' ' ' SER . . . . . . . . . . . . . 44.6 m -53.44 123.01 34.59 Favored Pre-proline 0 N--CA 1.449 -0.501 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 129' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -52.18 -39.72 70.78 Favored 'Trans proline' 0 N--CA 1.435 -1.93 1 C-N-CA 125.701 4.267 . . . . 0.0 115.076 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 28.4 pt -78.11 130.6 36.0 Favored 'Isoleucine or valine' 0 C--O 1.252 1.205 0 CA-C-N 120.615 1.552 . . . . 0.0 110.931 170.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -108.8 124.95 51.41 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-O 122.698 1.237 . . . . 0.0 113.396 -174.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.03 134.14 2.59 Favored Glycine 0 N--CA 1.474 1.225 0 CA-C-N 113.482 -1.69 . . . . 0.0 112.353 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 133' ' ' MET . . . . . . . . . . . . . 34.0 tpp -129.25 131.73 23.85 Favored Pre-proline 0 CA--C 1.506 -0.717 0 N-CA-C 104.932 -2.247 . . . . 0.0 104.932 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -57.54 149.93 63.7 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.748 2.299 . . . . 0.0 113.178 165.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 3.2 m -64.08 5.96 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.052 0 N-CA-C 119.054 2.983 . . . . 0.0 119.054 -168.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 27.6 mt -80.77 52.49 1.72 Allowed 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 120.193 -1.567 . . . . 0.0 110.199 171.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -82.22 96.37 7.84 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 -177.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 13.4 p -94.12 77.89 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 113.475 -1.693 . . . . 0.0 109.294 -171.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -131.79 165.76 23.07 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 173.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 140' ' ' LYS . . . . . . . . . . . . 0.29 0.8 OUTLIER 61.9 -24.01 0.05 OUTLIER 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 126.708 2.003 . . . . 0.0 113.777 173.79 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -52.51 153.91 2.83 Favored 'General case' 0 C--O 1.252 1.234 0 CA-C-N 123.017 2.644 . . . . 0.0 116.409 163.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -35.67 -44.69 0.33 Allowed 'General case' 0 C--N 1.354 0.8 0 N-CA-C 120.147 3.388 . . . . 0.0 120.147 -160.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 143' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -157.56 93.79 1.32 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 122.643 1.211 . . . . 0.0 112.967 162.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 144' ' ' VAL . . . . . . . . . . . . . 90.2 t -87.67 104.27 14.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 103.923 -2.621 . . . . 0.0 103.923 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 145' ' ' ILE . . . . . . . . . . . . . 3.7 tp -101.73 104.81 16.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 123.696 1.712 . . . . 0.0 111.748 -177.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 146' ' ' VAL . . . . . . . . . . . . . 27.2 t -91.51 98.83 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 O-C-N 119.658 -1.901 . . . . 0.0 109.453 -169.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 147' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -67.95 115.3 7.31 Favored 'General case' 0 C--O 1.249 1.079 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 148' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -155.5 137.09 14.2 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 7.3 tpp85 -48.41 -60.65 2.51 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 110.633 -2.985 . . . . 0.0 113.924 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 8.0 m -133.7 159.75 39.6 Favored 'General case' 0 CA--C 1.552 1.022 0 O-C-N 119.977 -1.702 . . . . 0.0 112.865 -171.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 10.7 tpt -67.51 93.81 0.37 Allowed 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 168.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -155.99 160.38 40.01 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.178 0.991 . . . . 0.0 109.259 -176.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 8.9 m -62.86 161.33 12.93 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.94 0.896 . . . . 0.0 112.997 175.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -106.8 -92.35 2.26 Favored Glycine 0 CA--C 1.508 -0.382 0 N-CA-C 105.49 -3.044 . . . . 0.0 105.49 153.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -114.92 -20.11 10.68 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 172.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 156' ' ' ALA . . . . . . . . . . . . . . . -103.32 -81.05 0.51 Allowed 'General case' 0 C--N 1.322 -0.614 0 O-C-N 119.121 -2.237 . . . . 0.0 110.703 168.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 88.71 -61.25 3.83 Favored Glycine 0 C--N 1.347 1.139 0 CA-C-N 121.594 1.997 . . . . 0.0 112.064 168.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 34.0 m -37.34 98.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-O 123.951 1.834 . . . . 0.0 115.465 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 35.72 34.62 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 120.515 3.524 . . . . 0.0 120.515 -174.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 160' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -70.75 118.65 67.03 Favored Pre-proline 0 C--N 1.347 0.491 0 CA-C-N 113.193 -1.822 . . . . 0.0 111.075 -170.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -46.64 -25.95 3.99 Favored 'Trans proline' 0 CA--C 1.509 -0.725 1 C-N-CA 126.007 4.471 . . . . 0.0 117.102 -172.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 162' ' ' LEU . . . . . . . . . . . . . 13.6 tp -50.71 -39.64 52.16 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 125.338 1.455 . . . . 0.0 113.529 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 163' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -84.6 -23.1 29.75 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 118.887 -1.125 . . . . 0.0 108.688 -172.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -102.67 -34.21 9.14 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 118.246 2.684 . . . . 0.0 118.246 -160.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -57.16 157.57 5.99 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 -175.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.5 -40.14 96.29 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -99.21 -22.98 15.38 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 119.292 0.951 . . . . 0.0 111.894 173.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 168' ' ' THR . . . . . . . . . . . . . 89.5 m -101.24 93.91 5.68 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.91 146.87 36.21 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.07 -1.052 . . . . 0.0 108.73 -171.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 170' ' ' MET . . . . . . . . . . . . . 30.8 mtm -62.16 130.49 45.69 Favored 'General case' 0 C--N 1.36 1.056 0 CA-C-O 123.94 1.829 . . . . 0.0 115.123 167.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 171' ' ' LEU . . . . . . . . . . . . . 20.8 tp -92.96 104.25 16.49 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 101.338 -3.578 . . . . 0.0 101.338 167.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -72.44 136.32 45.98 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 113.059 -1.882 . . . . 0.0 110.04 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . 128.66 166.64 12.02 Favored Glycine 0 N--CA 1.432 -1.589 0 CA-C-O 124.525 2.18 . . . . 0.0 110.113 -177.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 174' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -62.75 149.2 44.54 Favored 'General case' 0 C--O 1.252 1.198 0 CA-C-N 112.197 -2.001 . . . . 0.0 112.902 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.93 -53.44 57.27 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 121.421 -0.799 . . . . 0.0 113.02 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -62.49 -62.94 1.4 Allowed 'General case' 0 C--O 1.217 -0.623 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 177' ' ' ALA . . . . . . . . . . . . . . . -51.42 -36.38 43.53 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -176.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 14.7 m -68.6 -39.16 81.0 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 173.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 179' ' ' VAL . . . . . . . . . . . . . 5.7 t -74.47 -37.23 43.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 124.041 1.877 . . . . 0.0 109.239 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -58.89 -40.77 85.46 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-N 114.299 -1.318 . . . . 0.0 110.67 176.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.04 -29.34 69.67 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.611 175.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 182' ' ' ILE . . . . . . . . . . . . . 19.9 pt -101.07 -16.2 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 183' ' ' LEU . . . . . . . . . . . . 0.265 2.0 pp -48.29 -35.22 11.8 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 118.981 2.956 . . . . 0.0 118.981 -170.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -131.85 -21.21 2.46 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.909 171.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -88.23 60.24 5.65 Favored 'General case' 0 C--O 1.243 0.747 0 O-C-N 119.869 -1.77 . . . . 0.0 109.546 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 186' ' ' LEU . . . . . 0.432 ' C ' ' HZ3' ' C' ' 28' ' ' LYS . 1.7 pt? . . . . . 0 N--CA 1.436 -1.16 0 CA-C-O 114.698 -2.573 . . . . 0.0 113.962 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 20.5 t-80 . . . . . 0 CA--C 1.488 -1.441 0 N-CA-C 108.418 -0.956 . . . . 65.739999999999995 108.418 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -72.05 86.71 0.48 Allowed Glycine 0 C--O 1.246 0.866 0 N-CA-C 108.839 -1.704 . . . . 48.659999999999997 108.839 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -118.85 131.38 56.07 Favored 'General case' 0 C--O 1.255 1.382 0 N-CA-C 105.49 -2.041 . . . . 44.560000000000002 105.49 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1003 ' ' ILE . . . . . . . . . . . . . 96.9 mt -88.74 130.32 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 103.356 -2.831 . . . . 34.859999999999999 103.356 173.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -107.22 123.26 7.2 Favored Glycine 0 C--N 1.316 -0.579 0 N-CA-C 106.398 -2.681 . . . . 30.75 106.398 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 39.5 mm -107.56 104.04 51.28 Favored Pre-proline 0 C--O 1.249 1.055 0 N-CA-C 102.832 -3.025 . . . . 32.210000000000001 102.832 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -83.01 161.31 15.74 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.973 2.449 . . . . 32.979999999999997 113.718 171.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1007 ' ' ARG . . . . . . . . . . . . . 54.0 ttp85 -69.51 149.57 48.1 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 111.094 -2.776 . . . . 47.979999999999997 106.808 161.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1008 ' ' GLU . . . . . . . . . . . . 0.297 13.9 tp10 -83.17 118.65 23.74 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 116.057 -2.257 . . . . 34.700000000000003 109.392 170.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 14.5 mtp-105 -95.19 -3.91 46.89 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 109.635 -3.439 . . . . 53.369999999999997 112.371 -173.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 65.1 tp -65.24 132.61 49.53 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 105.53 -2.026 . . . . 45.07 105.53 167.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1011 ' ' THR . . . . . . . . . . . . . 5.2 m -55.41 123.01 12.5 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 125.525 1.53 . . . . 40.359999999999999 112.179 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 66.9 m-80 58.41 28.92 17.5 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 118.259 2.689 . . . . 40.609999999999999 118.259 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -89.7 147.08 24.07 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.441 -1.688 . . . . 33.759999999999998 106.441 167.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1014 ' ' THR . . . . . . . . . . . . . 1.9 m -110.19 -4.54 15.7 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 113.574 0.954 . . . . 27.890000000000001 113.574 -170.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1015 ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -83.18 163.37 20.84 Favored 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 120.251 -1.53 . . . . 29.02 114.746 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1016 ' ' VAL . . . . . . . . . . . . . 12.5 p -121.49 162.06 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 103.782 -2.673 . . . . 28.129999999999999 103.782 159.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1017 ' ' ALA . . . . . . . . . . . . . . . -61.09 -42.45 98.54 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 115.962 1.838 . . . . 26.870000000000001 115.962 -178.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -145.45 142.48 29.31 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 122.832 1.301 . . . . 26.77 110.255 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1019 ' ' THR . . . . . . . . . . . . . 8.2 p -84.77 161.19 54.09 Favored Pre-proline 0 N--CA 1.438 -1.071 0 O-C-N 118.877 -2.39 . . . . 27.02 108.468 171.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1020 ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -40.9 -45.31 4.97 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 123.706 2.937 . . . . 30.57 117.009 175.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -57.54 -41.05 80.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 123.753 1.739 . . . . 47.810000000000002 113.213 177.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1022 ' ' THR . . . . . . . . . . . . . 1.1 p -77.73 -32.5 52.85 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 114.191 1.182 . . . . 30.77 114.191 175.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1023 ' ' VAL . . . . . . . . . . . . . 80.1 t -54.68 -44.96 72.44 Favored 'Isoleucine or valine' 0 C--N 1.345 0.385 0 O-C-N 121.257 -0.902 . . . . 33.590000000000003 110.815 170.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -48.62 -46.81 40.14 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.268 1.027 . . . . 53.289999999999999 111.184 172.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -64.66 -36.4 84.14 Favored 'General case' 0 N--CA 1.436 -1.144 0 O-C-N 123.563 0.54 . . . . 46.920000000000002 110.936 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1026 ' ' LEU . . . . . . . . . . . . . 17.4 mt -66.15 -35.38 80.32 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 117.942 -1.027 . . . . 37.170000000000002 112.591 171.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.81 -43.55 98.03 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.75 1.159 . . . . 44.439999999999998 111.575 173.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 22.9 mmmt -57.7 -36.7 72.34 Favored 'General case' 0 C--O 1.217 -0.648 0 C-N-CA 123.671 0.788 . . . . 52.579999999999998 111.674 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1029 ' ' LEU . . . . . . . . . . . . . 90.4 mt -58.48 -11.29 2.77 Favored 'General case' 0 C--O 1.249 1.03 0 N-CA-C 115.721 1.749 . . . . 45.689999999999998 115.721 173.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 88.21 22.91 39.41 Favored Glycine 0 CA--C 1.506 -0.516 0 O-C-N 118.115 -2.866 . . . . 42.090000000000003 112.345 170.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -113.76 162.47 16.26 Favored 'General case' 0 C--O 1.254 1.326 0 N-CA-C 105.905 -1.887 . . . . 40.719999999999999 105.905 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1032 ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -80.2 139.59 36.68 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 119.933 -1.73 . . . . 37.770000000000003 106.704 173.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1033 ' ' VAL . . . . . . . . . . . . . 11.0 t -121.54 127.18 75.57 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 O-C-N 117.803 -3.061 . . . . 33.539999999999999 108.187 -176.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -125.75 135.99 52.66 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 106.285 -1.746 . . . . 31.68 106.285 -176.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1035 ' ' VAL . . . . . . . . . . . . . 47.1 t -121.21 145.91 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 104.636 -2.357 . . . . 31.52 104.636 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1036 ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -58.89 154.36 15.32 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 119.52 -0.276 . . . . 41.039999999999999 111.584 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1037 ' ' SER . . . . . . . . . . . . . 4.7 m -47.27 96.09 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 113.619 0.97 . . . . 31.829999999999998 113.619 173.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 61.25 38.87 96.37 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 114.674 -1.148 . . . . 29.359999999999999 112.669 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -52.43 -26.35 12.46 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 118.023 2.601 . . . . 27.780000000000001 118.023 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -91.69 13.0 67.85 Favored Glycine 0 N--CA 1.43 -1.731 0 CA-C-O 116.237 -2.424 . . . . 28.91 113.02 -175.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -62.67 -26.95 68.91 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 123.319 3.56 . . . . 51.18 113.482 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1042 ' ' LEU . . . . . . . . . . . . . 96.0 mt -54.94 -44.22 74.12 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 122.003 0.906 . . . . 29.91 110.915 167.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1043 ' ' ALA . . . . . . . . . . . . . . . -104.1 35.84 2.55 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 114.303 -1.317 . . . . 28.539999999999999 109.491 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1044 ' ' SER . . . . . . . . . . . . . 3.0 m 65.8 0.36 1.5 Allowed 'General case' 0 C--O 1.239 0.548 0 N-CA-C 121.51 3.893 . . . . 33.060000000000002 121.51 172.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1045 ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -106.51 118.72 37.38 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 120.952 1.706 . . . . 30.289999999999999 114.15 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.9 -176.43 6.31 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 115.399 1.629 . . . . 48.619999999999997 115.399 178.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -43.55 -67.39 0.28 Allowed 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 125.642 1.838 . . . . 36.740000000000002 111.829 170.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 13.3 pttm -64.7 -24.15 67.48 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.347 0.976 . . . . 43.729999999999997 111.786 -172.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -63.48 -45.74 89.4 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.831 -1.174 . . . . 32.810000000000002 107.831 170.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1050 ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -70.95 -23.03 62.15 Favored 'General case' 0 C--O 1.211 -0.931 0 O-C-N 120.275 -1.516 . . . . 31.859999999999999 110.847 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 78.5 t -69.39 -27.95 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 O-C-N 118.495 -2.628 . . . . 33.219999999999999 109.543 170.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -62.16 -45.63 92.55 Favored 'General case' 0 CA--C 1.509 -0.622 0 O-C-N 119.461 -2.024 . . . . 50.829999999999998 110.401 174.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -65.38 -38.07 88.9 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 115.86 -0.609 . . . . 33.119999999999997 111.705 172.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 99.16 69.21 0.91 Allowed Glycine 0 C--O 1.245 0.832 0 N-CA-C 105.485 -3.046 . . . . 35.829999999999998 105.485 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -119.7 138.03 53.55 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 113.662 -1.269 . . . . 34.82 108.059 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -66.13 124.63 23.14 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.474 -1.676 . . . . 49.049999999999997 106.474 171.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1057 ' ' ILE . . . . . . . . . . . . . 30.4 mm -90.23 98.77 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.25 0 O-C-N 117.699 -3.126 . . . . 38.530000000000001 107.792 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1058 ' ' VAL . . . . . . . . . . . . . 2.5 m -79.81 123.23 36.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 125.44 2.543 . . . . 42.109999999999999 106.155 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -76.7 82.91 3.33 Favored 'General case' 0 C--N 1.31 -1.126 1 CA-C-N 107.367 -4.469 . . . . 58.0 110.01 -174.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 75.51 -133.0 13.88 Favored Glycine 0 C--O 1.223 -0.589 0 N-CA-C 109.784 -1.326 . . . . 52.119999999999997 109.784 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 3.3 t30 -56.49 -25.66 51.95 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 117.427 2.38 . . . . 54.75 117.427 -161.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1062 ' ' SER . . . . . . . . . . . . . 70.5 m -55.66 -15.66 3.28 Favored 'General case' 0 C--O 1.25 1.113 0 O-C-N 120.012 -1.68 . . . . 50.340000000000003 113.125 174.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 14.8 p -57.17 -37.22 54.71 Favored 'Isoleucine or valine' 0 C--N 1.37 1.496 0 O-C-N 120.609 -1.307 . . . . 41.460000000000001 113.536 170.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1064 ' ' TRP . . . . . . . . . . . . . 97.9 m95 -70.2 -24.38 63.11 Favored 'General case' 0 N--CA 1.435 -1.216 0 O-C-N 125.525 1.766 . . . . 39.32 114.222 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -87.95 72.04 9.34 Favored 'General case' 0 C--O 1.246 0.883 0 N-CA-C 107.83 -1.174 . . . . 55.380000000000003 107.83 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1066 ' ' SER . . . . . . . . . . . . . 11.1 m -151.74 144.61 24.42 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-O 118.552 -0.737 . . . . 41.869999999999997 109.376 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.4 -12.28 60.22 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 119.03 2.974 . . . . 53.200000000000003 119.03 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 2.4 mp -127.06 124.66 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 104.241 -2.503 . . . . 41.899999999999999 104.241 167.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1069 ' ' ILE . . . . . . . . . . . . . 46.6 mm -119.08 111.14 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.069 0 N-CA-C 104.337 -2.468 . . . . 38.729999999999997 104.337 173.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1070 ' ' LEU . . . . . . . . . . . . . 94.5 mt -90.22 85.17 6.17 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 105.665 -1.976 . . . . 32.439999999999998 105.665 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1071 ' ' LYS . . . . . 0.413 ' HZ2' ' CD ' ' A' 1079 ' ' GLU . 3.8 mmmt -81.79 145.83 30.24 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 107.049 -1.463 . . . . 34.649999999999999 107.049 -177.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1072 ' ' VAL . . . . . . . . . . . . . 2.6 t -86.89 -25.9 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-O 124.107 1.908 . . . . 31.32 111.871 -165.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -140.86 -173.82 3.82 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 105.694 -1.965 . . . . 33.939999999999998 105.694 168.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -52.0 142.7 25.72 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 116.734 2.124 . . . . 38.039999999999999 116.734 172.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1075 ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -63.77 119.21 6.18 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.652 2.902 . . . . 42.68 112.454 162.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 50.8 mt -71.31 158.45 36.32 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 113.036 -1.893 . . . . 46.740000000000002 107.098 161.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1077 ' ' ASP . . . . . 0.411 ' CG ' ' HZ1' ' A' 1104 ' ' LYS . 8.0 m-20 -57.88 -32.11 67.38 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 119.953 -1.717 . . . . 58.609999999999999 114.934 -172.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 14.2 t70 -44.85 -53.38 7.57 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 123.067 1.413 . . . . 59.200000000000003 111.858 164.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1079 ' ' GLU . . . . . 0.413 ' CD ' ' HZ2' ' A' 1071 ' ' LYS . 18.2 mt-10 -78.2 -34.81 49.21 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.96 -1.018 . . . . 50.630000000000003 109.859 -174.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1080 ' ' ILE . . . . . . . . . . . . . 66.3 mt -49.13 -48.05 17.5 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 CA-C-O 123.169 1.461 . . . . 51.479999999999997 111.175 170.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -63.47 -38.65 91.94 Favored 'General case' 0 C--O 1.25 1.106 0 CA-C-N 113.73 -1.577 . . . . 50.280000000000001 110.332 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 87.2 mt -71.52 -24.64 61.99 Favored 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 120.922 -1.112 . . . . 50.210000000000001 113.765 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1083 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.27 161.36 29.41 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 120.211 1.369 . . . . 49.060000000000002 109.467 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -123.88 140.28 34.21 Favored Pre-proline 0 C--O 1.248 0.991 0 N-CA-C 105.399 -2.074 . . . . 51.079999999999998 105.399 -176.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -56.08 155.16 24.83 Favored 'Trans proline' 0 N--CA 1.446 -1.277 1 C-N-CA 125.382 4.055 . . . . 49.729999999999997 113.64 175.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 81.58 -10.46 50.64 Favored Glycine 0 C--N 1.314 -0.65 0 O-C-N 121.158 -0.964 . . . . 47.710000000000001 112.296 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1087 ' ' THR . . . . . . . . . . . . . 92.9 m -82.52 137.91 34.46 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 119.411 1.605 . . . . 45.469999999999999 110.187 -171.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1088 ' ' THR . . . . . . . . . . . . . 2.7 m -75.94 87.53 2.9 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 107.311 -1.366 . . . . 42.039999999999999 107.311 174.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1089 ' ' LEU . . . . . . . . . . . . . 56.4 tp -82.62 97.08 8.32 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 122.733 1.254 . . . . 38.060000000000002 108.663 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 96.7 t -97.52 116.3 39.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 102.679 -3.082 . . . . 37.399999999999999 102.679 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1091 ' ' SER . . . . . . . . . . . . . 1.9 m -153.94 160.98 42.32 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 120.325 1.42 . . . . 36.159999999999997 113.179 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.79 97.51 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.757 0 O-C-N 119.434 -2.041 . . . . 38.939999999999998 111.305 154.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 25.2 mm -96.47 -36.93 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 C-N-CA 123.115 0.566 . . . . 42.170000000000002 109.98 -175.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 45.8 m95 58.16 56.6 6.63 Favored Pre-proline 0 C--O 1.256 1.418 0 O-C-N 124.867 1.354 . . . . 46.509999999999998 110.98 -172.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -50.15 -39.41 51.58 Favored 'Trans proline' 0 CA--C 1.504 -1.001 0 C-N-CA 124.414 3.409 . . . . 49.759999999999998 116.364 -173.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -72.84 -24.59 60.91 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 120.004 1.275 . . . . 52.619999999999997 113.247 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -90.32 -11.76 39.76 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 122.279 1.037 . . . . 60.740000000000002 110.032 172.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1098 ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -133.05 47.85 3.02 Favored Pre-proline 0 N--CA 1.451 -0.398 0 O-C-N 118.211 -2.806 . . . . 58.189999999999998 115.456 -174.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -55.31 -31.21 75.89 Favored 'Trans proline' 0 C--O 1.244 0.78 0 C-N-CA 124.664 3.576 . . . . 54.590000000000003 112.84 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 29.4 mp0 -61.46 -53.65 53.71 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.692 1.197 . . . . 63.280000000000001 109.971 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1101 ' ' LEU . . . . . . . . . . . . . 24.2 tp -56.54 -40.64 75.43 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 124.027 0.931 . . . . 54.75 109.831 174.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1102 ' ' MET . . . . . . . . . . . . . 81.4 mmm -55.16 -50.72 68.58 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.929 1.24 . . . . 52.649999999999999 110.087 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -57.87 -39.95 79.02 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 124.96 1.304 . . . . 66.260000000000005 109.16 176.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1104 ' ' LYS . . . . . 0.411 ' HZ1' ' CG ' ' A' 1077 ' ' ASP . 51.1 mtmt -71.72 -42.62 67.12 Favored 'General case' 0 C--N 1.313 -0.988 0 O-C-N 120.999 -1.063 . . . . 63.729999999999997 111.884 -176.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 68.3 mt -76.35 -21.28 56.32 Favored 'General case' 0 C--O 1.268 2.054 0 O-C-N 119.936 -1.728 . . . . 54.68 111.136 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -62.85 -42.54 99.79 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 120.646 -1.284 . . . . 53.640000000000001 111.759 167.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -62.47 -44.98 95.08 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 109.878 -0.415 . . . . 67.239999999999995 109.878 172.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.45 -2.79 12.07 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 117.055 -3.528 . . . . 65.760000000000005 114.347 174.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 2.1 t30 61.1 35.43 18.68 Favored 'General case' 0 C--O 1.247 0.942 0 O-C-N 118.984 -2.323 . . . . 58.710000000000001 113.717 169.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1110 ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.95 156.6 3.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 106.78 -1.563 . . . . 46.630000000000003 106.78 -171.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1111 ' ' THR . . . . . . . . . . . . . 53.9 m -81.62 97.32 7.81 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 105.878 -1.897 . . . . 44.130000000000003 105.878 165.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1112 ' ' VAL . . . . . . . . . . . . . 42.7 t -95.55 111.69 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-O 123.584 1.659 . . . . 40.439999999999998 109.11 -177.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1113 ' ' MET . . . . . . . . . . . . . 47.7 mtp -106.21 107.33 18.28 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 112.913 -1.948 . . . . 50.759999999999998 109.487 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1114 ' ' ALA . . . . . . . . . . . . . . . -87.64 105.44 17.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 126.338 2.97 . . . . 35.640000000000001 111.901 -177.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1115 ' ' MET . . . . . . . . . . . . . 74.2 mmm -60.19 -28.89 68.32 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 110.741 -2.936 . . . . 38.740000000000002 117.988 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -66.21 -44.17 84.65 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 113.293 -1.776 . . . . 40.140000000000001 109.737 167.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1117 ' ' SER . . . . . . . . . . . . . 74.5 m -80.38 48.4 1.02 Allowed 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 118.509 2.781 . . . . 44.789999999999999 118.509 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1118 ' ' VAL . . . . . . . . . . . . . 37.4 t -89.8 134.9 31.2 Favored Pre-proline 0 C--O 1.25 1.124 0 N-CA-C 107.112 -1.44 . . . . 43.75 107.112 173.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -50.22 122.96 10.18 Favored 'Trans proline' 0 N--CA 1.459 -0.546 1 C-N-CA 125.688 4.259 . . . . 48.93 112.119 170.376 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 42.3 mmm-85 -75.31 61.1 1.17 Allowed 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 123.812 0.845 . . . . 62.899999999999999 111.905 -169.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 15.6 pt -116.78 167.65 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 O-C-N 118.042 -2.911 . . . . 57.719999999999999 110.733 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1122 ' ' SER . . . . . . . . . . . . . 4.2 p -39.0 -65.86 0.33 Allowed 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 117.592 2.442 . . . . 57.259999999999998 117.592 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -57.28 -33.29 67.48 Favored 'General case' 0 C--N 1.36 1.06 0 O-C-N 121.012 -1.055 . . . . 62.899999999999999 113.381 -176.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -82.17 -15.81 51.98 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-N 113.366 -1.743 . . . . 49.829999999999998 109.682 -169.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -56.02 -30.49 61.94 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 122.826 2.557 . . . . 52.369999999999997 114.159 -172.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1126 ' ' SER . . . . . . . . . . . . . 16.9 p -66.85 -31.73 72.54 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 122.715 1.245 . . . . 42.43 113.169 172.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1127 ' ' LEU . . . . . . . . . . . . . 3.6 mp -83.65 -25.67 30.55 Favored 'General case' 0 C--N 1.346 0.436 0 O-C-N 121.197 -0.939 . . . . 43.740000000000002 111.971 172.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 62.0 t0 -69.84 89.32 0.57 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 123.736 1.731 . . . . 43.210000000000001 113.209 -172.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -67.92 -31.73 71.69 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 112.588 -2.096 . . . . 35.740000000000002 112.94 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 44.5 tp -54.18 -58.19 8.29 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 124.854 1.346 . . . . 38.090000000000003 108.702 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1131 ' ' SER . . . . . . . . . . . . . 7.0 m -69.77 -37.17 76.29 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 113.63 -1.623 . . . . 36.909999999999997 111.632 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1132 ' ' SER . . . . . . . . . . . . . 61.0 m -65.16 -38.27 90.04 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 123.048 2.658 . . . . 35.789999999999999 110.528 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1133 ' ' MET . . . . . . . . . . . . . 34.3 mmt -77.46 -40.16 44.11 Favored 'General case' 0 CA--C 1.489 -1.384 0 O-C-N 119.586 -1.946 . . . . 30.809999999999999 109.748 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1134 ' ' ALA . . . . . . . . . . . . . . . -52.33 -43.16 64.41 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.094 0.557 . . . . 28.879999999999999 111.734 168.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1135 ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -63.93 -51.43 64.46 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.232 1.015 . . . . 40.759999999999998 109.796 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1136 ' ' ILE . . . . . . . . . . . . . 94.0 mt -55.07 -42.62 65.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 114.838 -1.074 . . . . 31.539999999999999 113.343 171.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -66.54 -31.7 72.58 Favored 'General case' 0 C--O 1.219 -0.544 0 C-N-CA 124.709 1.203 . . . . 29.870000000000001 112.645 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -66.08 -50.5 51.41 Favored Glycine 0 C--O 1.216 -1.019 0 O-C-N 120.048 -1.657 . . . . 28.73 110.408 176.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 19.6 t80 -55.58 -47.11 76.97 Favored 'General case' 0 C--O 1.248 0.98 0 C-N-CA 124.187 0.995 . . . . 30.390000000000001 109.377 172.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1140 ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -68.66 -24.45 64.53 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 114.171 1.174 . . . . 26.09 114.171 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1141 ' ' ALA . . . . . . . . . . . . . . . -71.32 -40.35 70.84 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 121.572 1.987 . . . . 27.100000000000001 106.817 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 19.7 mm -63.1 -41.03 91.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.399 -0.593 . . . . 28.48 109.399 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 54.9 t -54.97 -64.85 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.607 0 C-N-CA 123.24 0.616 . . . . 23.07 111.534 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1144 ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -68.36 -19.64 64.65 Favored 'General case' 0 C--O 1.244 0.785 0 O-C-N 120.336 -1.477 . . . . 33.399999999999999 113.253 -175.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -62.65 -56.96 12.98 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 107.154 -1.425 . . . . 24.219999999999999 107.154 164.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -59.75 -20.48 56.88 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 117.477 -3.265 . . . . 24.890000000000001 112.655 175.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 29.1 t-80 -66.73 -38.43 86.65 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 117.901 -3.0 . . . . 26.73 111.06 174.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1148 ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -109.21 0.07 19.5 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 115.533 1.679 . . . . 39.960000000000001 115.533 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1149 ' ' PHE . . . . . . . . . . . . . 1.3 t80 -68.19 148.29 51.07 Favored 'General case' 0 C--O 1.246 0.888 0 O-C-N 120.988 -1.07 . . . . 25.870000000000001 108.709 -174.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1150 ' ' GLY . . . . . . . . . . . . . . . -72.81 -40.37 52.72 Favored Glycine 0 N--CA 1.438 -1.197 0 C-N-CA 118.633 -1.746 . . . . 19.280000000000001 112.044 173.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1151 ' ' ARG . . . . . . . . . . . . . 23.9 mtm-85 -108.21 -177.91 3.46 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.236 -1.155 . . . . 39.899999999999999 113.845 -166.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1152 ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -81.96 154.25 25.84 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 116.562 -2.055 . . . . 29.440000000000001 109.887 168.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1153 ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -70.47 -57.43 4.79 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 124.244 1.973 . . . . 32.600000000000001 107.177 156.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1154 ' ' THR . . . . . . . . . . . . . 3.5 m -60.16 92.24 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 110.562 -3.017 . . . . 34.640000000000001 111.425 -175.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -60.35 128.47 45.79 Favored Glycine 0 C--N 1.344 1.01 0 O-C-N 120.3 -1.5 . . . . 37.140000000000001 112.611 175.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -159.49 137.57 10.32 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 113.896 1.072 . . . . 40.57 113.896 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1157 ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.36 125.15 39.02 Favored 'Isoleucine or valine' 0 C--O 1.257 1.491 0 N-CA-C 102.891 -3.003 . . . . 44.609999999999999 102.891 169.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1158 ' ' THR . . . . . . . . . . . . . 56.0 p -98.44 -173.3 2.52 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 113.394 -1.73 . . . . 40.700000000000003 106.607 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -72.02 -19.0 61.92 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 121.48 1.945 . . . . 40.25 109.562 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -103.91 -47.81 4.09 Favored 'General case' 0 C--O 1.249 1.038 0 CA-C-N 119.972 1.26 . . . . 38.469999999999999 113.888 172.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . -148.54 162.01 28.76 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 117.723 -2.179 . . . . 37.609999999999999 114.693 -159.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 26.9 tttt -79.95 124.01 28.31 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 123.188 1.47 . . . . 48.899999999999999 113.318 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1163 ' ' VAL . . . . . . . . . . . . . 79.4 t -95.29 117.0 66.81 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 105.962 -1.866 . . . . 36.520000000000003 105.962 165.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1164 ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -71.27 140.62 37.51 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.636 2.224 . . . . 35.079999999999998 112.753 172.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1165 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -59.0 125.63 18.72 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 CA-C-N 122.258 1.842 . . . . 35.329999999999998 112.861 169.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -63.85 140.57 58.88 Favored 'General case' 0 C--O 1.244 0.814 0 N-CA-C 114.773 1.398 . . . . 34.689999999999998 114.773 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1167 ' ' LYS . . . . . . . . . . . . . 79.4 mttt -88.21 113.13 23.52 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 119.845 1.202 . . . . 45.359999999999999 113.061 170.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 64.9 t -101.99 115.5 43.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.063 -1.088 . . . . 31.710000000000001 108.063 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1169 ' ' MET . . . . . . . . . . . . . 12.4 ttt -100.03 113.75 26.57 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 121.75 2.068 . . . . 42.280000000000001 109.24 170.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 68.9 t -82.92 128.69 38.48 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 N-CA-C 105.919 -1.882 . . . . 30.510000000000002 105.919 169.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 42.3 mt -119.55 136.46 56.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 O-C-N 119.63 -1.919 . . . . 31.870000000000001 106.068 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 74.91 58.26 4.12 Favored Glycine 0 CA--C 1.539 1.587 0 N-CA-C 110.043 -1.223 . . . . 34.539999999999999 110.043 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1173 ' ' ALA . . . . . . . . . . . . . . . -72.28 85.1 1.07 Allowed 'General case' 0 C--O 1.259 1.555 0 CA-C-O 122.487 1.137 . . . . 32.509999999999998 113.867 -166.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -76.16 -175.11 38.87 Favored Glycine 0 CA--C 1.554 2.498 0 N-CA-C 108.325 -1.91 . . . . 29.899999999999999 108.325 163.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1175 ' ' VAL . . . . . . . . . . . . . 79.2 t -59.42 -37.12 68.04 Favored 'Isoleucine or valine' 0 C--O 1.25 1.125 0 CA-C-N 118.49 1.145 . . . . 33.109999999999999 110.621 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -52.52 -42.42 64.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.322 -1.308 . . . . 28.100000000000001 114.333 169.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -64.94 -40.13 96.98 Favored Glycine 0 CA--C 1.545 1.91 0 N-CA-C 110.014 -1.234 . . . . 28.539999999999999 110.014 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1178 ' ' LEU . . . . . . . . . . . . . 69.6 mt -63.31 -48.38 78.3 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.704 -0.85 . . . . 31.219999999999999 108.704 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -64.44 -34.18 77.59 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 120.259 -1.526 . . . . 28.98 114.937 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -57.95 -40.78 81.36 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 115.82 1.785 . . . . 27.829999999999998 115.82 171.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1181 ' ' ILE . . . . . . . . . . . . . 96.7 mt -56.96 -49.15 80.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.507 -0.77 . . . . 30.25 111.672 169.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -58.08 -40.63 93.8 Favored Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 111.313 -0.715 . . . . 29.59 111.313 175.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -67.43 -52.43 39.81 Favored 'General case' 0 C--O 1.243 0.728 0 O-C-N 119.51 -2.17 . . . . 30.289999999999999 112.906 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -58.6 -40.44 83.25 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-O 122.962 1.363 . . . . 30.469999999999999 111.64 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -62.48 -43.51 98.64 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 114.932 -1.031 . . . . 42.409999999999997 112.592 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1186 ' ' SER . . . . . . . . . . . . . 43.9 m -58.16 -50.8 72.26 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 123.985 0.914 . . . . 39.380000000000003 109.566 172.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 29.5 mt -60.48 -18.76 53.72 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 116.975 2.213 . . . . 36.18 116.975 171.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 97.34 33.33 5.99 Favored Glycine 0 C--N 1.356 1.664 0 CA-C-N 121.876 2.125 . . . . 33.780000000000001 112.418 174.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -99.92 155.82 17.47 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 123.249 0.62 . . . . 33.93 112.478 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 34.2 mt -79.26 103.29 6.05 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.462 0 N-CA-C 104.31 -2.478 . . . . 38.740000000000002 104.31 175.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 1.4 t -93.92 148.74 4.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 N-CA-C 106.556 -1.646 . . . . 33.090000000000003 106.556 -172.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1192 ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -141.76 158.76 43.41 Favored 'General case' 0 C--O 1.252 1.2 0 C-N-CA 124.647 1.179 . . . . 38.920000000000002 108.39 176.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -152.24 148.3 27.41 Favored 'General case' 0 C--O 1.25 1.106 0 N-CA-C 114.405 1.261 . . . . 35.32 114.405 176.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 42.3 t80 -138.23 147.64 43.94 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 113.705 -1.589 . . . . 39.350000000000001 107.648 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 10.5 t70 -170.78 167.51 7.61 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 103.109 -2.923 . . . . 40.460000000000001 103.109 170.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1196 ' ' THR . . . . . . . . . . . . . 4.0 m -69.92 -43.16 72.25 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 125.015 1.326 . . . . 45.939999999999998 110.068 175.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1197 ' ' ARG . . . . . . . . . . . . . 39.6 mtm180 -79.49 112.74 31.21 Favored Pre-proline 0 C--O 1.222 -0.357 0 N-CA-C 114.951 1.463 . . . . 56.020000000000003 114.951 -165.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1198 ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -58.39 -20.88 50.58 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.722 2.281 . . . . 51.270000000000003 117.666 178.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -55.68 -25.53 40.21 Favored 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 117.01 2.226 . . . . 59.100000000000001 117.01 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 27.7 m -87.55 -14.14 10.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 114.729 1.381 . . . . 51.060000000000002 114.729 -175.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 90.8 mttt -62.98 -38.79 92.56 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.123 -0.944 . . . . 57.380000000000003 113.443 -169.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -56.38 -48.68 76.36 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 124.638 1.211 . . . . 62.409999999999997 110.707 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.35 -44.34 87.99 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 124.918 1.386 . . . . 57.780000000000001 110.579 175.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 54.1 t -55.49 -47.02 78.99 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 CA-C-N 121.083 1.765 . . . . 46.380000000000003 111.323 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -66.11 -36.09 82.25 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-N 115.008 -0.997 . . . . 50.700000000000003 110.037 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1206 ' ' SER . . . . . . . . . . . . . 59.8 m -71.2 -51.04 26.96 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 112.724 0.639 . . . . 49.979999999999997 112.724 -176.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1207 ' ' MET . . . . . . . . . . . . . 45.7 mtp -68.35 -25.78 65.26 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 123.499 0.499 . . . . 52.990000000000002 111.008 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 131.3 68.14 0.1 OUTLIER Glycine 0 N--CA 1.475 1.289 0 O-C-N 120.018 -1.677 . . . . 47.659999999999997 113.27 156.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -155.46 161.88 40.86 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 122.683 1.23 . . . . 44.770000000000003 113.173 -174.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -89.97 113.86 25.6 Favored 'General case' 0 C--N 1.318 -0.787 0 O-C-N 118.961 -2.337 . . . . 47.640000000000001 108.313 173.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1211 ' ' PHE . . . . . . . . . . . . . 21.7 t80 -84.3 115.32 22.42 Favored 'General case' 0 N--CA 1.432 -1.375 0 C-N-CA 117.885 -1.526 . . . . 45.659999999999997 107.229 173.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 37.1 mt -71.01 116.42 11.28 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 125.955 1.702 . . . . 46.060000000000002 108.682 -176.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -69.44 144.72 53.22 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 118.444 -1.302 . . . . 60.219999999999999 112.84 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 66.6 tp -62.55 95.39 0.07 Allowed 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 113.589 -1.641 . . . . 57.25 109.72 167.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 16.3 t70 -69.45 90.67 0.54 Allowed 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 105.403 -2.073 . . . . 64.430000000000007 105.403 172.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.303 -1.428 0 O-C-N 126.325 2.265 . . . . 66.900000000000006 106.898 -172.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.429 -1.482 0 CA-C-O 122.174 0.988 . . . . 39.090000000000003 108.962 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -59.81 -38.66 94.31 Favored Glycine 0 CA--C 1.543 1.796 0 O-C-N 120.529 -1.357 . . . . 39.32 114.227 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 68.0 t80 -65.88 -46.35 78.72 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 117.336 0.568 . . . . 39.299999999999997 111.973 170.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -59.53 -49.46 77.68 Favored 'General case' 0 C--N 1.349 0.556 0 O-C-N 121.96 -0.463 . . . . 36.299999999999997 109.995 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -50.99 -56.98 9.81 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-O 117.432 -1.271 . . . . 37.380000000000003 111.973 168.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -51.91 -30.42 12.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 118.261 2.689 . . . . 39.109999999999999 118.261 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1230 ' ' MET . . . . . . . . . . . . . 38.7 mmt -79.21 -28.86 42.59 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 113.079 0.77 . . . . 49.590000000000003 113.079 174.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1231 ' ' SER . . . . . . . . . . . . . 23.1 m -58.21 140.43 53.09 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 117.142 2.275 . . . . 43.68 117.142 -169.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -58.96 -49.79 76.51 Favored 'General case' 0 C--O 1.214 -0.78 0 N-CA-C 116.251 1.945 . . . . 55.57 116.251 175.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -61.44 -25.44 67.22 Favored 'General case' 0 C--O 1.206 -1.19 0 N-CA-C 112.487 0.551 . . . . 44.939999999999998 112.487 174.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 70.7 t80 -69.22 -49.59 55.03 Favored 'General case' 0 N--CA 1.428 -1.569 0 O-C-N 124.299 0.999 . . . . 42.039999999999999 110.031 175.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 63.1 mt -62.05 -33.86 60.47 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 O-C-N 123.437 0.46 . . . . 46.280000000000001 111.982 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1236 ' ' LYS . . . . . 0.456 ' HZ1' ' CD ' ' A' 1240 ' ' GLU . 48.3 tttm -57.5 -53.12 61.72 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 118.085 -0.96 . . . . 47.869999999999997 111.049 164.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -60.43 -40.4 90.91 Favored 'General case' 0 C--O 1.259 1.558 0 N-CA-C 113.729 1.011 . . . . 41.609999999999999 113.729 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -57.13 -52.39 65.5 Favored 'General case' 0 C--O 1.254 1.321 0 O-C-N 121.557 -0.714 . . . . 50.649999999999999 109.567 173.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1239 ' ' MET . . . . . . . . . . . . . 92.9 mmm -62.43 -25.14 67.81 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 113.586 0.958 . . . . 48.869999999999997 113.586 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1240 ' ' GLU . . . . . 0.456 ' CD ' ' HZ1' ' A' 1236 ' ' LYS . 34.7 mt-10 -71.45 -42.73 67.82 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 119.952 1.251 . . . . 54.799999999999997 111.596 168.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 2.3 mm? -59.0 -45.18 91.3 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 119.495 -2.003 . . . . 43.210000000000001 108.098 172.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -62.49 -46.17 89.7 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 125.478 1.511 . . . . 38.659999999999997 111.486 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -61.49 -39.83 92.39 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 123.589 1.662 . . . . 37.920000000000002 111.588 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -65.11 -53.31 47.28 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 120.353 -1.467 . . . . 37.280000000000001 111.464 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -66.46 -31.16 71.73 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 120.825 -1.172 . . . . 43.07 112.662 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -53.37 -34.36 57.3 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 123.288 0.635 . . . . 38.299999999999997 112.099 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1247 ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -67.42 -29.0 68.37 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.139 -0.937 . . . . 47.600000000000001 113.054 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -114.9 -37.1 4.26 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 114.195 1.183 . . . . 45.420000000000002 114.195 -168.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1249 ' ' VAL . . . . . . . . . . . . . 20.7 m -68.94 166.9 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.863 0 CA-C-O 123.624 1.678 . . . . 36.259999999999998 114.967 -166.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1250 ' ' ASP . . . . . 0.406 ' CG ' ' HZ3' ' A' 1276 ' ' LYS . 9.7 m-20 -123.68 -43.24 2.15 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 110.935 -2.848 . . . . 33.039999999999999 109.439 -172.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1251 ' ' ILE . . . . . . . . . . . . . 48.4 mm -123.84 138.28 54.09 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.878 0 O-C-N 118.811 -2.43 . . . . 31.399999999999999 105.445 174.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1252 ' ' ILE . . . . . . . . . . . . . 19.8 mt -114.44 130.95 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 106.351 -1.722 . . . . 29.420000000000002 106.351 162.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 13.4 t -110.22 106.49 20.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 O-C-N 121.14 -0.975 . . . . 30.370000000000001 109.222 172.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1254 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.06 108.88 20.0 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 125.022 2.344 . . . . 35.719999999999999 110.802 -178.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1255 ' ' THR . . . . . . . . . . . . . 8.5 m -109.5 -27.25 9.54 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 111.441 -2.618 . . . . 36.0 117.437 -158.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1256 ' ' ALA . . . . . . . . . . . . . . . -70.09 77.78 0.5 Allowed 'General case' 0 C--O 1.246 0.889 0 N-CA-C 115.211 1.56 . . . . 40.93 115.211 -168.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 29.8 tp -90.8 130.27 36.79 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 124.588 1.155 . . . . 47.82 107.944 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 16.7 mm -109.57 138.61 20.64 Favored Pre-proline 0 C--O 1.246 0.91 0 N-CA-C 101.523 -3.51 . . . . 52.700000000000003 101.523 176.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -64.9 132.64 33.05 Favored 'Trans proline' 0 N--CA 1.43 -2.222 0 C-N-CA 121.589 1.526 . . . . 54.130000000000003 110.539 161.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 90.74 -69.56 2.2 Favored Glycine 0 CA--C 1.507 -0.423 0 N-CA-C 109.419 -1.472 . . . . 54.619999999999997 109.419 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 69.3 mttt -71.71 140.22 83.89 Favored Pre-proline 0 C--O 1.251 1.132 0 O-C-N 121.578 -0.954 . . . . 55.740000000000002 108.965 -176.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.36 143.95 94.39 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 123.916 3.077 . . . . 51.149999999999999 108.96 163.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -59.07 132.44 87.29 Favored Pre-proline 0 N--CA 1.446 -0.67 0 C-N-CA 126.524 1.93 . . . . 46.060000000000002 109.784 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -56.82 122.29 11.56 Favored 'Trans proline' 0 N--CA 1.445 -1.328 1 C-N-CA 125.961 4.441 . . . . 41.079999999999998 110.275 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 44.3 mttm -79.35 97.78 6.46 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 125.016 2.341 . . . . 47.420000000000002 107.721 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 48.9 mt -77.17 -63.9 1.26 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 110.931 -2.849 . . . . 39.219999999999999 109.319 -174.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 3.0 mt -87.22 111.71 22.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 CA-C-N 115.284 -0.871 . . . . 42.5 110.551 -166.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1268 ' ' THR . . . . . . . . . . . . . 63.7 m -64.39 141.95 58.59 Favored 'General case' 0 C--N 1.316 -0.85 0 O-C-N 124.728 1.267 . . . . 37.840000000000003 111.132 176.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -49.98 -47.77 52.67 Favored 'General case' 0 C--O 1.214 -0.812 0 N-CA-C 115.655 1.724 . . . . 54.799999999999997 115.655 -170.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -41.4 -50.46 3.83 Favored 'General case' 0 C--N 1.345 0.407 0 C-N-CA 126.392 1.877 . . . . 54.359999999999999 112.26 172.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1271 ' ' MET . . . . . . . . . . . . . 21.2 ttm -71.15 -25.0 62.37 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 122.661 1.219 . . . . 39.520000000000003 114.01 -173.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1272 ' ' VAL . . . . . . . . . . . . . 57.2 t -67.89 -41.9 85.27 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 O-C-N 121.003 -1.061 . . . . 38.25 111.273 174.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -59.1 -38.29 79.19 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 122.902 1.335 . . . . 40.770000000000003 111.95 172.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1274 ' ' SER . . . . . . . . . . . . . 11.8 m -67.64 -7.43 26.57 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 115.925 1.824 . . . . 36.579999999999998 115.925 174.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1275 ' ' MET . . . . . . . . . . . . . 8.7 ttt -77.34 151.38 34.95 Favored 'General case' 0 C--O 1.247 0.969 0 O-C-N 120.664 -1.273 . . . . 36.75 108.128 -174.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1276 ' ' LYS . . . . . 0.406 ' HZ3' ' CG ' ' A' 1250 ' ' ASP . 27.5 ttpt -55.22 126.67 25.86 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 114.007 -1.451 . . . . 46.109999999999999 110.698 175.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1277 ' ' ALA . . . . . . . . . . . . . . . -72.1 170.76 13.26 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 117.012 2.227 . . . . 33.520000000000003 117.012 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 68.44 30.28 73.22 Favored Glycine 0 C--O 1.25 1.102 0 C-N-CA 127.267 2.365 . . . . 31.27 111.748 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1279 ' ' SER . . . . . . . . . . . . . 64.8 m -125.79 169.17 12.87 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 125.703 1.601 . . . . 32.950000000000003 111.216 -167.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1280 ' ' VAL . . . . . . . . . . . . . 50.5 t -128.59 149.28 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 O-C-N 119.935 -1.728 . . . . 27.43 108.204 -176.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1281 ' ' ILE . . . . . . . . . . . . . 16.4 mt -120.33 103.46 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 104.686 -2.339 . . . . 30.300000000000001 104.686 161.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.34 113.64 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 118.782 -1.167 . . . . 28.629999999999999 110.681 173.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 5.6 t0 -97.79 104.93 17.0 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 122.176 0.988 . . . . 36.270000000000003 109.094 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1284 ' ' LEU . . . . . . . . . . . . . 49.1 mt -72.2 -36.31 69.16 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 112.033 -2.349 . . . . 38.57 107.602 176.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -73.38 -6.22 44.83 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 113.841 1.052 . . . . 37.560000000000002 113.841 -172.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . -43.41 -30.31 0.53 Allowed 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 127.173 2.189 . . . . 40.329999999999998 115.706 176.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -67.86 -2.31 7.09 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 116.017 1.858 . . . . 56.850000000000001 116.017 174.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -157.77 97.34 1.56 Allowed 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 102.983 -2.969 . . . . 45.859999999999999 102.983 159.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 90.93 -59.9 3.16 Favored Glycine 0 C--O 1.213 -1.168 0 O-C-N 119.222 -2.174 . . . . 40.310000000000002 111.931 169.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 80.1 134.97 1.33 Allowed Glycine 0 C--N 1.344 1.005 0 CA-C-N 120.14 1.97 . . . . 38.890000000000001 112.423 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1291 ' ' ASN . . . . . . . . . . . . . 33.1 m120 -84.53 -16.5 42.08 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.921 1.452 . . . . 37.229999999999997 114.921 -166.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1292 ' ' CYS . . . . . . . . . . . . . 37.2 t -88.75 150.27 23.04 Favored 'General case' 0 C--O 1.259 1.571 0 N-CA-C 105.595 -2.002 . . . . 36.5 105.595 171.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1293 ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -78.61 -14.15 59.47 Favored 'General case' 0 C--O 1.216 -0.697 0 N-CA-C 116.877 2.177 . . . . 43.32 116.877 170.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -75.34 -24.41 57.34 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 113.486 0.921 . . . . 41.32 113.486 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1295 ' ' THR . . . . . . . . . . . . . 24.0 m -60.96 105.35 0.46 Allowed 'General case' 0 C--O 1.249 1.036 0 C-N-CA 124.662 1.185 . . . . 35.299999999999997 113.894 -165.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 93.5 t -89.47 114.61 61.11 Favored Pre-proline 0 C--O 1.245 0.827 1 N-CA-C 99.662 -4.199 . . . . 34.840000000000003 99.662 166.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -56.85 148.89 63.98 Favored 'Trans proline' 0 CA--C 1.513 -0.546 0 C-N-CA 121.546 1.497 . . . . 33.509999999999998 111.97 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 90.35 -43.35 2.92 Favored Glycine 0 C--N 1.302 -1.343 0 CA-C-O 115.581 -2.788 . . . . 32.189999999999998 113.248 -174.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -104.91 171.39 7.34 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 121.482 2.641 . . . . 34.880000000000003 117.964 -168.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1300 ' ' ILE . . . . . . . . . . . . . 50.1 mt -96.42 112.2 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 101.157 -3.645 . . . . 32.289999999999999 101.157 167.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.8 113.73 25.59 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 101.484 -3.524 . . . . 37.25 101.484 173.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1302 ' ' THR . . . . . . . . . . . . . 60.4 m -83.18 111.59 19.06 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.528 -1.656 . . . . 35.560000000000002 106.528 174.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1303 ' ' THR . . . . . . . . . . . . . 18.0 m -61.19 137.91 58.23 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 116.656 -1.64 . . . . 36.399999999999999 106.78 172.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -57.26 -10.89 1.44 Allowed 'General case' 0 C--N 1.353 0.719 0 N-CA-C 118.047 2.61 . . . . 52.32 118.047 -172.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -79.74 -37.17 36.12 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 125.056 1.473 . . . . 40.039999999999999 108.435 172.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 123.44 31.97 0.93 Allowed Glycine 0 N--CA 1.419 -2.441 0 N-CA-C 111.161 -0.776 . . . . 36.960000000000001 111.161 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1307 ' ' VAL . . . . . . . . . . . . . 42.1 t -102.75 109.8 27.65 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 N-CA-C 103.719 -2.697 . . . . 33.399999999999999 103.719 171.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1308 ' ' LYS . . . . . . . . . . . . . 52.2 mttt -85.34 105.4 15.97 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 106.759 -1.571 . . . . 42.909999999999997 106.759 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 54.9 t -84.61 101.78 9.62 Favored 'Isoleucine or valine' 0 C--O 1.249 1.071 0 N-CA-C 106.043 -1.836 . . . . 32.289999999999999 106.043 176.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1310 ' ' ILE . . . . . . . . . . . . . 48.5 mt -96.91 96.39 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 CA-C-N 113.058 -1.883 . . . . 30.989999999999998 108.033 -173.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -89.39 61.06 3.62 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 116.423 -0.353 . . . . 28.949999999999999 112.403 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1312 ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -80.47 98.52 7.59 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 117.564 -1.654 . . . . 31.690000000000001 110.276 -171.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1313 ' ' THR . . . . . . . . . . . . . 2.8 m -59.81 -36.29 76.47 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 126.463 1.905 . . . . 34.170000000000002 108.46 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -79.54 3.9 17.42 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 114.106 1.15 . . . . 36.859999999999999 114.106 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1315 ' ' LEU . . . . . . . . . . . . . 16.6 mt -44.67 -43.83 18.87 Favored Pre-proline 0 C--O 1.22 -0.454 0 N-CA-C 119.028 2.973 . . . . 34.850000000000001 119.028 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -65.37 -21.6 60.84 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 123.653 2.902 . . . . 29.149999999999999 112.7 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -81.49 -40.29 11.27 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 110.611 -0.996 . . . . 27.289999999999999 110.611 173.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1318 ' ' ARG . . . . . . . . . . . . . 44.7 mtt-85 -50.64 -21.06 1.4 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 120.634 3.568 . . . . 41.490000000000002 120.634 -167.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1319 ' ' LEU . . . . . . . . . . . . . 14.4 tp -110.47 78.56 1.49 Allowed Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 104.557 -2.386 . . . . 27.609999999999999 104.557 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1320 ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -55.53 -61.45 0.36 Allowed 'Trans proline' 0 CA--C 1.514 -0.516 0 C-N-CA 123.793 2.995 . . . . 25.940000000000001 114.082 -157.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1321 ' ' THR . . . . . . . . . . . . . 15.8 m -64.14 -31.86 73.21 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 120.157 1.344 . . . . 25.010000000000002 112.254 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1322 ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -68.76 -52.72 27.42 Favored 'General case' 0 CA--C 1.506 -0.714 0 O-C-N 119.472 -2.017 . . . . 29.390000000000001 109.386 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1323 ' ' SER . . . . . . . . . . . . . 13.7 m -59.18 -41.14 87.76 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 125.143 1.527 . . . . 26.469999999999999 109.884 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1324 ' ' SER . . . . . . . . . . . . . 39.5 m -64.55 -42.99 95.34 Favored 'General case' 0 C--O 1.223 -0.337 0 O-C-N 123.948 0.78 . . . . 27.780000000000001 110.667 176.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -63.57 -51.31 65.91 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.047 -1.033 . . . . 37.530000000000001 108.276 -175.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1326 ' ' LEU . . . . . . . . . . . . . 96.2 mt -77.23 -35.27 55.61 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-O 116.803 -1.57 . . . . 35.710000000000001 113.309 -174.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1327 ' ' TYR . . . . . . . . . . . . . 37.1 t80 -55.94 -52.85 62.68 Favored 'General case' 0 C--N 1.362 1.139 0 CA-C-N 122.028 2.195 . . . . 31.59 108.595 168.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1328 ' ' GLY . . . . . . . . . . . . . . . -45.15 -46.37 10.29 Favored Glycine 0 N--CA 1.443 -0.838 0 O-C-N 126.037 2.086 . . . . 28.0 111.758 168.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1329 ' ' THR . . . . . . . . . . . . . 11.9 m -69.79 -36.41 75.67 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 118.775 -2.603 . . . . 32.149999999999999 110.783 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1330 ' ' ASN . . . . . . . . . . . . . 33.7 m120 -61.73 -42.73 99.34 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 120.039 1.29 . . . . 34.359999999999999 108.918 171.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1331 ' ' LEU . . . . . . . . . . . . . 22.4 mt -68.49 -39.14 81.43 Favored 'General case' 0 C--O 1.216 -0.663 0 O-C-N 121.439 -0.788 . . . . 33.369999999999997 112.515 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1332 ' ' VAL . . . . . . . . . . . . . 73.1 t -61.76 -46.38 96.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 105.403 -2.073 . . . . 35.270000000000003 105.403 175.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -55.51 -43.26 75.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 115.409 1.633 . . . . 37.659999999999997 115.409 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1334 ' ' LEU . . . . . . . . . . . . . 14.9 tp -62.92 -54.19 42.4 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 125.157 1.536 . . . . 40.270000000000003 109.831 174.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1335 ' ' LEU . . . . . . . . . . . . . 39.6 mt -65.73 -17.31 64.52 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 118.16 -0.924 . . . . 42.5 113.391 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1336 ' ' LYS . . . . . . . . . . . . . 79.0 mttt -63.07 -49.09 75.9 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.033 -1.099 . . . . 47.810000000000002 108.033 169.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1337 ' ' LEU . . . . . . . . . . . . . 77.4 mt -81.99 -20.28 38.81 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-O 124.212 1.958 . . . . 49.270000000000003 112.06 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1338 ' ' LEU . . . . . . . . . . . . . 9.2 mp -75.99 -24.96 55.37 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 113.546 -1.661 . . . . 50.539999999999999 112.503 169.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1339 ' ' CYS . . . . . . . . . . . . . 47.3 t -131.5 71.66 1.48 Allowed 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 102.57 -3.122 . . . . 53.670000000000002 102.57 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -67.77 -40.6 84.01 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 115.69 -0.686 . . . . 63.380000000000003 112.302 -177.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -72.06 -43.45 64.88 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 118.169 2.655 . . . . 70.950000000000003 118.169 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1342 ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? 55.1 77.42 0.22 Allowed 'General case' 0 C--O 1.241 0.631 0 C-N-CA 125.505 1.522 . . . . 65.25 114.771 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1343 ' ' ASP . . . . . . . . . . . . 0.34 1.9 t70 78.3 -80.88 0.03 OUTLIER 'General case' 0 C--O 1.251 1.159 2 O-C-N 113.511 -5.743 . . . . 64.530000000000001 116.93 -6.638 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A 1344 ' ' GLY . . . . . . . . . . . . . . . 76.16 65.09 2.08 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 119.005 0.82 . . . . 59.719999999999999 112.855 -170.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 11.0 t30 -144.14 140.61 29.49 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.764 -0.458 . . . . 64.090000000000003 109.764 171.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1346 ' ' ILE . . . . . . . . . . . . . 3.4 mp -79.51 90.29 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 122.961 1.363 . . . . 58.82 107.628 -171.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1347 ' ' THR . . . . . . . . . . . . . 28.6 m -89.62 89.96 8.04 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-O 124.916 2.293 . . . . 54.960000000000001 109.147 175.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1348 ' ' VAL . . . . . . . . . . . . . 92.8 t -74.2 120.34 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 112.678 -2.055 . . . . 55.640000000000001 106.524 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 1.5 t70 -94.44 148.64 22.03 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 119.544 1.065 . . . . 61.450000000000003 109.856 -176.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -109.28 -38.33 5.53 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.131 -0.941 . . . . 58.630000000000003 113.011 170.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 46.2 t0 -68.97 -29.8 68.1 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 123.463 1.601 . . . . 62.060000000000002 109.16 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 10.8 t70 -76.34 96.99 4.11 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 105.576 -2.009 . . . . 54.07 105.576 169.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 33.8 m -57.66 -29.7 35.25 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.669 0 CA-C-O 116.099 -1.905 . . . . 50.68 113.138 -174.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1354 ' ' VAL . . . . . . . . . . . . . 1.5 m -69.05 -35.56 69.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 123.218 2.735 . . . . 47.68 112.633 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1355 ' ' ILE . . . . . . . . . . . . . 75.1 mt -68.93 -45.13 80.92 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 N-CA-C 107.066 -1.457 . . . . 48.490000000000002 107.066 176.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 46.3 tpt85 -52.1 -34.99 46.52 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 119.868 -1.77 . . . . 48.270000000000003 112.997 172.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -59.69 -62.91 5.59 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 114.685 0.634 . . . . 43.530000000000001 114.685 168.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1358 ' ' VAL . . . . . . . . . . . . . 14.9 t -58.46 -37.08 62.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 O-C-N 124.848 0.97 . . . . 45.119999999999997 111.699 -177.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1359 ' ' THR . . . . . . . . . . . . . 12.7 m -72.16 78.05 0.96 Allowed 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 124.609 2.147 . . . . 42.939999999999998 109.803 175.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 29.6 m -74.56 -35.77 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 CA-C-N 113.249 -1.796 . . . . 43.259999999999998 109.719 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1361 ' ' ILE . . . . . . . . . . . . . 60.9 mt -133.08 134.19 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 103.301 -2.852 . . . . 45.659999999999997 103.301 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1362 ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -123.02 121.18 35.44 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 122.689 2.495 . . . . 61.340000000000003 111.328 169.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 46.69 44.21 13.58 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 127.354 2.909 . . . . 49.759999999999998 110.322 173.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 115.94 -60.99 0.4 Allowed Glycine 0 C--N 1.347 1.154 0 N-CA-C 117.444 1.738 . . . . 50.0 117.444 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -82.88 130.92 35.2 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 119.619 -0.832 . . . . 56.920000000000002 110.321 -175.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1366 ' ' ILE . . . . . . . . . . . . . 71.9 mt -64.64 118.74 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 N-CA-C 108.388 -0.967 . . . . 52.780000000000001 108.388 174.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1367 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.79 -0.13 43.22 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 112.613 -2.085 . . . . 49.439999999999998 115.975 173.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 7.2 t90 -63.45 150.08 90.6 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-O 115.312 -2.28 . . . . 52.380000000000003 112.412 173.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -78.21 -150.69 0.62 Allowed 'Cis proline' 0 CA--C 1.544 1.021 1 CA-C-N 129.259 4.342 . . . . 46.939999999999998 111.722 -8.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1370 ' ' ALA . . . . . . . . . . . . 0.264 . . -150.38 156.15 36.9 Favored Pre-proline 0 C--N 1.352 0.708 0 N-CA-C 108.328 -0.99 . . . . 45.909999999999997 108.328 -175.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1371 ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -43.16 117.98 1.16 Allowed 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 125.105 3.87 . . . . 46.390000000000001 114.782 169.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.39 4.35 4.5 Favored 'Trans proline' 0 N--CA 1.485 0.994 0 C-N-CA 123.973 3.115 . . . . 46.719999999999999 116.93 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.217 -5.184 0 O-C-N 120.477 -1.389 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 73.9 m80 . . . . . 0 N--CA 1.427 -1.586 0 N-CA-C 105.691 -1.966 . . . . 63.439999999999998 105.691 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -123.62 43.56 2.93 Favored 'General case' 0 C--O 1.256 1.419 0 O-C-N 117.999 -2.938 . . . . 51.740000000000002 114.885 -173.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1000 ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -69.97 144.11 52.43 Favored 'General case' 0 C--O 1.258 1.533 0 CA-C-O 123.742 1.734 . . . . 54.07 108.096 167.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 76.98 -12.18 12.49 Favored Glycine 0 CA--C 1.534 1.259 0 O-C-N 120.967 -1.083 . . . . 39.219999999999999 112.169 -168.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1002 ' ' ARG . . . . . . . . . . . . . 35.7 ttp180 -97.96 142.02 30.2 Favored 'General case' 0 CA--C 1.491 -1.299 0 CA-C-N 120.105 1.953 . . . . 38.119999999999997 109.37 174.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1003 ' ' ILE . . . . . . . . . . . . . 21.1 mt -98.74 154.77 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 N-CA-C 106.03 -1.841 . . . . 29.699999999999999 106.03 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -123.59 128.08 6.81 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 108.604 -1.799 . . . . 27.5 108.604 164.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1005 ' ' ILE . . . . . . . . . . . . . 40.8 mm -116.33 112.11 41.81 Favored Pre-proline 0 C--O 1.243 0.729 0 N-CA-C 104.161 -2.533 . . . . 24.829999999999998 104.161 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -74.88 154.2 42.94 Favored 'Trans proline' 0 N--CA 1.446 -1.314 1 C-N-CA 125.814 4.343 . . . . 27.190000000000001 111.189 176.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 63.6 ttt-85 -78.08 125.0 28.71 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 101.877 -3.379 . . . . 41.460000000000001 101.877 164.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1008 ' ' GLU . . . . . . . . . . . . 0.411 0.3 OUTLIER -78.43 126.68 31.11 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 118.899 2.925 . . . . 26.93 118.899 -175.436 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B 1009 ' ' ARG . . . . . 0.406 HH22 ' CG ' ' B' 1078 ' ' ASP . 37.2 mtm180 -98.1 11.46 37.59 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 113.466 -1.697 . . . . 34.479999999999997 113.374 -170.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B 1010 ' ' LEU . . . . . . . . . . . . . 31.9 tp -66.95 143.41 56.82 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 119.803 -1.81 . . . . 44.219999999999999 109.051 175.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1011 ' ' THR . . . . . . . . . . . . . 57.9 m -67.57 147.69 52.42 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 122.304 2.32 . . . . 40.740000000000002 110.097 165.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 60.8 m-80 58.36 58.06 3.6 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-O 124.231 1.967 . . . . 44.439999999999998 110.836 -175.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1013 ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -137.75 143.89 41.38 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.87 -1.514 . . . . 29.870000000000001 109.269 -174.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1014 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.65 3.37 2.51 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-O 124.088 1.899 . . . . 25.260000000000002 110.284 174.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 50.5 mtm180 -82.8 142.68 31.37 Favored 'General case' 0 C--O 1.24 0.586 0 O-C-N 119.66 -1.9 . . . . 29.539999999999999 112.559 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1016 ' ' VAL . . . . . . . . . . . . . 11.1 p -106.43 162.86 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 103.137 -2.912 . . . . 23.550000000000001 103.137 154.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1017 ' ' ALA . . . . . . . . . . . . . . . -68.2 -21.01 64.89 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 115.557 1.688 . . . . 23.59 115.557 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1018 ' ' ALA . . . . . . . . . . . . . . . -158.33 128.15 5.91 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 119.192 0.905 . . . . 24.93 109.254 175.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1019 ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.29 169.96 17.03 Favored Pre-proline 0 N--CA 1.477 0.895 0 CA-C-O 115.34 -2.267 . . . . 28.09 113.397 172.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -45.22 -50.93 8.38 Favored 'Trans proline' 0 CA--C 1.537 0.631 1 C-N-CA 125.371 4.047 . . . . 28.789999999999999 116.657 175.39 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 56.2 tttt -55.96 -39.45 71.77 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 113.486 0.921 . . . . 47.280000000000001 113.486 173.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1022 ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.81 -34.02 71.32 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.401 -0.592 . . . . 30.120000000000001 109.401 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B 1023 ' ' VAL . . . . . . . . . . . . . 39.7 t -61.93 -43.12 97.05 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 N-CA-C 108.921 -0.77 . . . . 32.240000000000002 108.921 176.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1024 ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -61.5 -39.54 91.33 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 123.446 0.698 . . . . 49.619999999999997 112.35 174.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -55.87 -47.86 76.6 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 122.35 1.072 . . . . 44.68 111.45 174.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 86.1 mt -64.56 -32.48 74.14 Favored 'General case' 0 C--N 1.366 1.294 0 CA-C-N 113.013 -1.903 . . . . 35.710000000000001 110.694 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1027 ' ' LEU . . . . . . . . . . . . . 86.5 mt -67.81 -41.22 83.42 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 122.314 1.055 . . . . 42.18 112.739 175.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 61.8 mttm -61.21 -32.8 72.57 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-N 112.918 -1.946 . . . . 48.340000000000003 111.645 176.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1029 ' ' LEU . . . . . . . . . . . . . 93.9 mt -70.13 -3.61 17.51 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 115.637 1.718 . . . . 38.689999999999998 115.637 174.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 96.17 6.72 58.8 Favored Glycine 0 N--CA 1.471 1.007 0 N-CA-C 110.417 -1.073 . . . . 32.280000000000001 110.417 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -97.93 170.81 8.69 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.655 -1.239 . . . . 35.939999999999998 107.655 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1032 ' ' THR . . . . . . . . . . . . . 1.4 p -113.14 148.89 34.44 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 105.906 -1.887 . . . . 33.369999999999997 105.906 170.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1033 ' ' VAL . . . . . . . . . . . . . 15.5 t -114.16 146.81 18.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 O-C-N 117.786 -3.071 . . . . 29.98 108.534 -176.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -125.1 140.84 52.52 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 107.109 -1.441 . . . . 28.18 107.109 163.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1035 ' ' VAL . . . . . . . . . . . . . 21.8 t -129.31 146.61 33.96 Favored 'Isoleucine or valine' 0 C--N 1.348 0.528 0 N-CA-C 108.234 -1.024 . . . . 25.82 108.234 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1036 ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -66.11 139.91 58.19 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 121.442 0.639 . . . . 32.439999999999998 112.545 167.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1037 ' ' SER . . . . . . . . . . . . . 48.7 m -52.81 139.52 26.61 Favored 'General case' 0 C--O 1.257 1.478 0 CA-C-N 114.207 -1.36 . . . . 29.539999999999999 114.489 165.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 89.63 0.2 79.28 Favored Glycine 0 C--O 1.252 1.274 0 C-N-CA 121.322 -0.466 . . . . 27.760000000000002 113.271 176.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1039 ' ' ALA . . . . . . . . . . . . . . . -64.83 -43.4 93.19 Favored 'General case' 0 CA--C 1.504 -0.796 0 O-C-N 124.502 0.766 . . . . 26.02 110.832 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -49.55 -47.85 36.12 Favored Glycine 0 N--CA 1.419 -2.458 0 C-N-CA 125.663 1.601 . . . . 26.469999999999999 111.118 173.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -53.21 -46.28 68.99 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-N 119.525 1.663 . . . . 50.979999999999997 112.514 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 94.7 mt -61.24 -57.62 11.64 Favored 'General case' 0 C--O 1.211 -0.964 0 N-CA-C 108.074 -1.084 . . . . 29.300000000000001 108.074 174.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1043 ' ' ALA . . . . . . . . . . . . . . . -72.62 11.85 0.57 Allowed 'General case' 0 C--O 1.248 0.982 0 N-CA-C 116.587 2.069 . . . . 26.739999999999998 116.587 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1044 ' ' SER . . . . . . . . . . . . . 17.3 m 46.89 25.24 0.44 Allowed 'General case' 0 C--O 1.248 0.987 0 C-N-CA 126.361 1.864 . . . . 31.260000000000002 113.717 -176.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1045 ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -112.86 155.93 23.82 Favored 'General case' 0 C--O 1.244 0.797 0 O-C-N 119.885 -1.76 . . . . 33.259999999999998 106.962 -177.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 11.3 t70 -67.96 126.04 28.22 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.869 -0.789 . . . . 46.740000000000002 108.869 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.8 -42.43 90.68 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 107.621 -1.251 . . . . 34.439999999999998 107.621 -173.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -53.03 -34.84 58.24 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 113.306 0.854 . . . . 48.670000000000002 113.306 172.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -62.94 -19.79 64.59 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 116.06 1.874 . . . . 35.259999999999998 116.06 176.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1050 ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -62.77 -42.72 99.82 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 123.396 1.57 . . . . 32.170000000000002 109.996 168.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 18.0 t -67.4 -50.74 59.37 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 O-C-N 119.546 -1.971 . . . . 38.369999999999997 107.061 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -52.17 -29.72 23.61 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.74 1.216 . . . . 45.770000000000003 114.174 175.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -80.55 -40.66 25.51 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 123.936 0.773 . . . . 37.829999999999998 110.584 176.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 134.81 48.73 0.08 OUTLIER Glycine 0 CA--C 1.532 1.141 0 CA-C-O 123.028 1.349 . . . . 35.82 111.657 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -128.74 140.9 51.51 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 108.206 -1.035 . . . . 33.770000000000003 108.206 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -76.38 106.79 8.21 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 104.513 -2.403 . . . . 51.020000000000003 104.513 166.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1057 ' ' ILE . . . . . . . . . . . . . 13.6 mm -82.5 102.82 8.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 N-CA-C 102.079 -3.304 . . . . 38.469999999999999 102.079 173.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 30.1 m -86.71 159.34 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-N 109.143 -3.662 . . . . 39.399999999999999 108.29 175.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -71.48 -29.24 64.6 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.258 -1.337 . . . . 57.07 114.438 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . 172.79 -97.25 0.12 Allowed Glycine 0 CA--C 1.53 0.976 0 O-C-N 120.359 -1.463 . . . . 44.829999999999998 111.541 176.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -58.6 -32.0 68.58 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 125.632 1.573 . . . . 46.270000000000003 114.057 -170.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1062 ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -44.32 -33.87 1.76 Allowed 'General case' 0 C--O 1.24 0.578 0 N-CA-C 115.215 1.561 . . . . 43.469999999999999 115.215 171.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -54.05 -38.77 38.89 Favored 'Isoleucine or valine' 0 C--N 1.355 0.828 0 C-N-CA 124.385 1.074 . . . . 36.979999999999997 111.491 176.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 96.9 m95 -67.72 -14.38 62.9 Favored 'General case' 0 C--O 1.211 -0.949 0 N-CA-C 116.877 2.177 . . . . 37.899999999999999 116.877 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -99.83 81.58 2.47 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 104.338 -2.467 . . . . 46.189999999999998 104.338 -176.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1066 ' ' SER . . . . . . . . . . . . . 68.5 m -150.65 -178.53 6.61 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 119.006 -2.309 . . . . 37.060000000000002 108.244 -174.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1067 ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -69.8 -56.12 7.98 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 120.457 -1.402 . . . . 43.950000000000003 109.473 173.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1068 ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -123.07 137.88 54.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 107.411 -1.329 . . . . 33.5 107.411 -178.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 24.1 mm -111.28 106.81 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 N-CA-C 103.561 -2.755 . . . . 30.57 103.561 170.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1070 ' ' LEU . . . . . . . . . . . . . 86.7 mt -97.23 118.46 33.73 Favored 'General case' 0 CA--C 1.505 -0.781 1 N-CA-C 98.117 -4.771 . . . . 27.66 98.117 -175.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B 1071 ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -141.33 146.77 37.13 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 104.818 -2.29 . . . . 28.399999999999999 104.818 -164.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1072 ' ' VAL . . . . . . . . . . . . . 61.8 t -79.93 -61.68 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-N 120.278 1.399 . . . . 23.18 112.462 -170.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -105.95 -161.76 0.82 Allowed 'General case' 0 C--O 1.237 0.443 0 N-CA-C 106.269 -1.752 . . . . 25.469999999999999 106.269 -173.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -61.65 148.68 86.4 Favored Pre-proline 0 C--O 1.259 1.564 0 N-CA-C 112.999 0.74 . . . . 27.899999999999999 112.999 177.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -66.56 125.49 13.95 Favored 'Trans proline' 0 CA--C 1.556 1.608 0 N-CA-C 107.939 -1.6 . . . . 31.620000000000001 107.939 162.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 57.1 mt -69.14 162.18 27.55 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 107.696 -1.224 . . . . 40.490000000000002 107.696 169.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.16 -23.63 63.97 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 118.711 2.856 . . . . 51.590000000000003 118.711 -160.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1078 ' ' ASP . . . . . 0.406 ' CG ' HH22 ' B' 1009 ' ' ARG . 17.5 p-10 -66.27 -51.36 58.28 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 112.835 -1.984 . . . . 42.359999999999999 110.553 166.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B 1079 ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -55.62 -37.35 68.04 Favored 'General case' 0 C--O 1.249 1.042 0 O-C-N 120.667 -1.271 . . . . 34.530000000000001 109.116 173.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1080 ' ' ILE . . . . . . . . . . . . . 73.1 mt -59.28 -50.43 79.86 Favored 'Isoleucine or valine' 0 C--N 1.356 0.891 0 C-N-CA 123.666 0.786 . . . . 33.25 110.355 173.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -63.45 -15.14 56.82 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 118.544 -0.741 . . . . 36.469999999999999 112.837 174.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1082 ' ' LEU . . . . . . . . . . . . . 41.3 mt -86.45 -24.31 25.68 Favored 'General case' 0 C--N 1.353 0.728 0 CA-C-N 120.466 1.485 . . . . 37.759999999999998 113.553 171.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1083 ' ' LEU . . . . . . . . . . . . . 12.7 mt -55.2 123.99 15.51 Favored 'General case' 0 C--O 1.25 1.125 0 N-CA-C 115.629 1.714 . . . . 37.43 115.629 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.09 129.35 56.37 Favored Pre-proline 0 N--CA 1.439 -0.991 0 CA-C-N 114.797 -1.092 . . . . 37.700000000000003 110.891 -172.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -58.63 123.07 12.75 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 124.55 3.5 . . . . 35.509999999999998 109.11 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 115.36 -60.49 0.4 Allowed Glycine 0 C--O 1.244 0.771 0 O-C-N 126.955 2.659 . . . . 33.869999999999997 108.097 -172.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1087 ' ' THR . . . . . . . . . . . . . 97.9 m -41.57 130.97 3.09 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 126.757 2.023 . . . . 32.5 116.059 -165.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1088 ' ' THR . . . . . . . . . . . . . 10.0 m -73.68 106.75 5.57 Favored 'General case' 0 C--O 1.216 -0.7 0 N-CA-C 107.306 -1.368 . . . . 30.219999999999999 107.306 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1089 ' ' LEU . . . . . . . . . . . . . 20.7 tp -96.91 133.05 42.05 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 103.38 -2.822 . . . . 27.239999999999998 103.38 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 15.1 t -134.48 109.93 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 106.889 -1.523 . . . . 25.390000000000001 106.889 -174.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1091 ' ' SER . . . . . . . . . . . . . 2.6 m -159.23 168.92 25.28 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.84 0.829 . . . . 28.809999999999999 112.127 -166.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1092 ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -66.1 107.41 1.91 Allowed 'General case' 0 C--O 1.247 0.973 0 CA-C-O 124.42 2.057 . . . . 30.780000000000001 110.933 161.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 45.3 mm -103.53 -37.84 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 O-C-N 120.172 -1.58 . . . . 30.280000000000001 110.552 -176.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1094 ' ' TRP . . . . . . . . . . . . . 58.8 m95 53.57 54.79 12.61 Favored Pre-proline 0 C--O 1.249 1.078 0 O-C-N 124.456 1.098 . . . . 34.07 110.342 -174.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -39.6 -60.65 0.51 Allowed 'Trans proline' 0 C--N 1.355 0.872 1 C-N-CA 126.5 4.8 . . . . 38.659999999999997 118.433 -167.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -62.94 -28.27 69.95 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 119.287 -2.133 . . . . 41.32 112.838 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -82.65 -22.11 34.77 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 122.543 1.163 . . . . 51.659999999999997 112.578 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -119.09 58.41 4.01 Favored Pre-proline 0 N--CA 1.447 -0.62 0 N-CA-C 115.511 1.671 . . . . 40.32 115.511 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -57.16 -43.15 55.78 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.561 3.507 . . . . 41.560000000000002 111.593 -173.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -76.51 -32.74 58.47 Favored 'General case' 0 C--O 1.208 -1.091 0 N-CA-C 113.139 0.792 . . . . 54.109999999999999 113.139 -174.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1101 ' ' LEU . . . . . . . . . . . . . 26.6 tp -61.59 -47.99 82.98 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 107.693 -1.225 . . . . 37.880000000000003 107.693 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1102 ' ' MET . . . . . . . . . . . . . 69.2 mmm -47.61 -55.15 9.93 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 125.601 1.813 . . . . 37.539999999999999 111.154 173.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -55.98 -45.46 78.95 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-O 118.487 -0.768 . . . . 47.009999999999998 111.527 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1104 ' ' LYS . . . . . . . . . . . . . 88.9 mttt -61.82 -36.99 82.77 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 124.544 2.116 . . . . 48.68 114.146 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1105 ' ' LEU . . . . . . . . . . . . . 43.6 mt -74.63 -32.82 62.41 Favored 'General case' 0 C--O 1.247 0.931 0 O-C-N 119.614 -1.929 . . . . 32.210000000000001 110.03 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -67.69 -43.6 79.74 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.392 0.677 . . . . 33.729999999999997 111.177 175.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -59.45 -41.28 89.3 Favored 'General case' 0 C--O 1.25 1.101 0 N-CA-C 115.128 1.529 . . . . 51.469999999999999 115.128 169.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1108 ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -71.38 -3.83 22.93 Favored 'General case' 0 C--N 1.345 0.407 0 N-CA-C 113.693 0.997 . . . . 43.899999999999999 113.693 170.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1109 ' ' ASN . . . . . . . . . . . . . 8.1 m-80 59.03 32.57 22.35 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.835 1.791 . . . . 44.82 115.835 167.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1110 ' ' VAL . . . . . . . . . . . . . 5.8 m -94.92 150.82 3.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-N 114.516 -1.22 . . . . 30.52 109.794 -174.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1111 ' ' THR . . . . . . . . . . . . . 29.9 m -83.16 86.06 7.09 Favored 'General case' 0 C--O 1.247 0.958 0 CA-C-O 122.126 0.965 . . . . 27.120000000000001 110.517 178.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1112 ' ' VAL . . . . . . . . . . . . . 6.7 t -86.21 130.72 36.12 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 CA-C-O 121.986 0.898 . . . . 26.399999999999999 109.192 -169.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1113 ' ' MET . . . . . . . . . . . . . 10.8 mtt -120.19 124.71 46.39 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 102.651 -3.092 . . . . 42.920000000000002 102.651 175.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -90.65 96.61 10.73 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 113.703 -1.59 . . . . 24.149999999999999 113.888 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1115 ' ' MET . . . . . . . . . . . . . 78.9 mmm -56.03 -25.54 45.09 Favored 'General case' 0 C--O 1.22 -0.451 0 N-CA-C 115.479 1.659 . . . . 29.949999999999999 115.479 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1116 ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -80.14 -37.14 34.12 Favored 'General case' 0 N--CA 1.439 -0.984 0 O-C-N 121.521 -0.737 . . . . 34.530000000000001 109.647 174.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1117 ' ' SER . . . . . . . . . . . . . 57.0 m -102.52 48.16 0.87 Allowed 'General case' 0 C--N 1.355 0.823 0 O-C-N 120.167 -1.583 . . . . 33.490000000000002 108.824 -168.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1118 ' ' VAL . . . . . . . . . . . . . 54.5 t -81.63 124.08 80.15 Favored Pre-proline 0 N--CA 1.48 1.048 0 N-CA-C 102.357 -3.201 . . . . 34.020000000000003 102.357 176.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -58.06 103.14 0.14 Allowed 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 124.904 3.736 . . . . 38.280000000000001 110.842 -173.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1120 ' ' ARG . . . . . . . . . . . . . 13.6 mtm-85 -72.55 71.84 0.98 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 120.338 3.459 . . . . 55.049999999999997 120.338 -159.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1121 ' ' ILE . . . . . . . . . . . . . 44.5 pt -104.48 -161.11 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.815 0 N-CA-C 104.641 -2.355 . . . . 42.090000000000003 104.641 171.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1122 ' ' SER . . . . . . . . . . . . . 31.4 m -74.56 -48.27 27.81 Favored 'General case' 0 N--CA 1.434 -1.259 0 O-C-N 118.12 -2.862 . . . . 38.020000000000003 118.226 -173.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1123 ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -74.71 -21.38 59.41 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 124.305 3.23 . . . . 34.289999999999999 114.125 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1124 ' ' ALA . . . . . . . . . . . . . . . -54.46 -48.92 71.21 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 109.182 -3.644 . . . . 32.350000000000001 109.759 170.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1125 ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -54.75 -38.12 66.78 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 114.42 1.267 . . . . 47.170000000000002 114.42 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1126 ' ' SER . . . . . . . . . . . . . 73.9 m -57.03 -36.03 69.98 Favored 'General case' 0 C--O 1.248 1.0 0 CA-C-N 121.088 1.767 . . . . 31.710000000000001 114.093 170.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1127 ' ' LEU . . . . . . . . . . . . . 8.4 mp -87.82 -23.77 23.92 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 114.946 -1.025 . . . . 37.0 112.982 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1128 ' ' ASP . . . . . . . . . . . . . 12.5 t70 -78.93 118.77 21.26 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-O 123.434 1.587 . . . . 40.399999999999999 112.549 -170.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1129 ' ' ALA . . . . . . . . . . . . . . . -62.32 -36.55 82.53 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 110.44 -3.073 . . . . 26.559999999999999 111.793 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 39.6 mt -63.09 -23.73 67.58 Favored 'General case' 0 C--O 1.248 0.976 0 CA-C-O 116.512 -1.708 . . . . 30.890000000000001 112.251 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1131 ' ' SER . . . . . . . . . . . . . 86.0 p -65.84 -57.5 7.79 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 122.611 2.46 . . . . 29.84 107.932 177.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1132 ' ' SER . . . . . . . . . . . . . 73.4 m -60.74 -43.24 98.19 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.259 -1.337 . . . . 31.91 111.223 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1133 ' ' MET . . . . . . . . . . . . . 31.2 mmt -60.56 -37.98 83.04 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 115.504 1.668 . . . . 25.899999999999999 115.504 174.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1134 ' ' ALA . . . . . . . . . . . . . . . -68.77 -41.75 78.39 Favored 'General case' 0 C--N 1.352 0.679 0 C-N-CA 119.929 -0.708 . . . . 26.620000000000001 109.182 174.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.27 -38.82 90.8 Favored 'General case' 0 C--O 1.206 -1.195 0 C-N-CA 125.076 1.35 . . . . 36.969999999999999 109.997 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B 1136 ' ' ILE . . . . . . . . . . . . . 15.0 mm -58.7 -55.4 23.21 Favored 'Isoleucine or valine' 0 C--N 1.352 0.695 0 N-CA-C 106.337 -1.727 . . . . 32.109999999999999 106.337 172.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -61.95 -25.79 67.81 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 116.019 1.859 . . . . 24.140000000000001 116.019 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -65.5 -57.83 10.58 Favored Glycine 0 N--CA 1.466 0.699 0 CA-C-N 120.982 1.719 . . . . 25.129999999999999 110.28 174.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 77.9 t80 -53.55 -43.8 68.74 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 123.663 1.697 . . . . 32.729999999999997 110.534 172.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1140 ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -70.61 -25.95 63.28 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 113.78 -1.555 . . . . 26.359999999999999 110.492 -174.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1141 ' ' ALA . . . . . . . . . . . . . . . -62.89 -49.63 74.05 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 120.661 1.573 . . . . 24.120000000000001 107.978 172.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 32.5 mm -56.94 -43.89 81.46 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 CA-C-O 118.697 -0.668 . . . . 23.370000000000001 110.801 175.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 70.4 t -68.1 -59.26 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 N-CA-C 112.573 0.582 . . . . 24.960000000000001 112.573 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -60.1 -35.83 76.08 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 119.145 -0.455 . . . . 32.07 110.306 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1145 ' ' ALA . . . . . . . . . . . . . . . -51.74 -60.32 3.3 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 119.145 0.884 . . . . 24.870000000000001 111.365 167.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1146 ' ' ALA . . . . . . . . . . . . . . . -58.53 -22.94 57.01 Favored 'General case' 0 C--N 1.348 0.506 0 N-CA-C 114.663 1.357 . . . . 24.670000000000002 114.663 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 26.8 t60 -63.15 -43.94 96.92 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 120.84 -1.163 . . . . 28.579999999999998 108.97 171.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1148 ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -107.07 3.92 26.39 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 116.996 2.221 . . . . 36.82 116.996 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1149 ' ' PHE . . . . . . . . . . . . . 1.1 t80 -71.53 140.69 49.99 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-O 124.733 2.206 . . . . 31.969999999999999 107.015 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1150 ' ' GLY . . . . . . . . . . . . . . . -71.29 -42.17 57.84 Favored Glycine 0 N--CA 1.42 -2.423 0 CA-C-N 111.079 -2.782 . . . . 25.489999999999998 110.858 170.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1151 ' ' ARG . . . . . . . . . . . . . 58.7 mtm-85 -110.58 179.36 4.09 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 123.961 3.881 . . . . 59.840000000000003 113.46 -168.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1152 ' ' PHE . . . . . . . . . . . . . 12.1 m-30 -72.9 163.52 28.03 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 120.147 -1.596 . . . . 34.450000000000003 109.383 167.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1153 ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -82.24 -51.7 7.67 Favored 'General case' 0 C--O 1.257 1.484 0 N-CA-C 107.586 -1.265 . . . . 31.170000000000002 107.586 166.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1154 ' ' THR . . . . . . . . . . . . . 45.5 m -65.55 127.98 34.06 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 113.02 -1.9 . . . . 33.890000000000001 109.724 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -78.86 72.22 2.47 Favored Glycine 0 C--O 1.251 1.217 0 N-CA-C 109.247 -1.541 . . . . 38.950000000000003 109.247 172.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -85.03 131.75 34.42 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 103.983 -2.599 . . . . 54.229999999999997 103.983 -176.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 24.7 mm -84.16 93.54 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 N-CA-C 100.719 -3.808 . . . . 51.159999999999997 100.719 173.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1158 ' ' THR . . . . . . . . . . . . . 26.0 m -81.33 166.52 20.4 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.083 -1.08 . . . . 49.609999999999999 108.083 -170.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -51.09 -58.32 6.4 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 117.403 -1.285 . . . . 49.049999999999997 112.769 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -44.3 -53.12 7.0 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 116.984 2.216 . . . . 47.649999999999999 116.984 170.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . -177.96 -177.05 46.44 Favored Glycine 0 N--CA 1.426 -1.974 0 N-CA-C 109.103 -1.599 . . . . 45.609999999999999 109.103 -174.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 87.8 mttt -75.24 138.21 41.75 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.181 -1.009 . . . . 57.460000000000001 108.538 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1163 ' ' VAL . . . . . . . . . . . . . 45.7 t -91.34 125.85 56.72 Favored Pre-proline 0 CA--C 1.511 -0.529 0 O-C-N 121.395 -0.816 . . . . 42.93 109.322 170.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1164 ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -66.22 122.06 9.49 Favored 'Trans proline' 0 C--O 1.26 1.587 0 C-N-CA 123.917 3.078 . . . . 39.289999999999999 106.029 158.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1165 ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -76.61 168.24 24.03 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.876 3.717 . . . . 34.170000000000002 114.091 -174.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -76.5 123.49 26.12 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 114.309 -1.314 . . . . 31.690000000000001 112.633 170.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1167 ' ' LYS . . . . . . . . . . . . . 70.7 mttt -92.4 107.56 19.31 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 125.228 2.442 . . . . 44.780000000000001 110.495 165.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 40.2 t -91.76 94.68 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 113.902 -1.499 . . . . 31.23 109.314 -171.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1169 ' ' MET . . . . . . . . . . . . . 40.6 ttp -88.99 96.36 10.7 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 123.415 1.579 . . . . 37.090000000000003 107.167 -177.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 38.8 t -83.75 114.78 24.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 113.242 -1.799 . . . . 30.170000000000002 107.974 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1171 ' ' ILE . . . . . . . . . . . . . 78.9 mt -104.23 114.65 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 106.943 -1.502 . . . . 33.740000000000002 106.943 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 94.74 66.09 1.0 Allowed Glycine 0 N--CA 1.421 -2.313 0 N-CA-C 108.504 -1.839 . . . . 32.590000000000003 108.504 -177.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1173 ' ' ALA . . . . . . . . . . . . . . . -59.05 -9.03 1.68 Allowed 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 116.638 2.088 . . . . 32.420000000000002 116.638 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -61.53 128.68 43.9 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 115.122 0.809 . . . . 31.739999999999998 115.122 173.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 22.4 t 56.19 -82.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 127.453 2.301 . . . . 31.48 111.407 170.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1176 ' ' ALA . . . . . . . . . . . . . . . -65.53 -42.93 91.44 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.7 -1.222 . . . . 26.120000000000001 107.7 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1177 ' ' GLY . . . . . . . . . . . . . . . -52.71 -52.79 36.24 Favored Glycine 0 N--CA 1.43 -1.763 0 CA-C-N 118.665 0.666 . . . . 25.73 113.2 172.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1178 ' ' LEU . . . . . . . . . . . . . 96.6 mt -53.3 -46.67 69.44 Favored 'General case' 0 C--O 1.241 0.65 0 O-C-N 120.79 -1.418 . . . . 32.590000000000003 113.858 173.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -61.82 -40.17 94.34 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 120.23 -0.588 . . . . 27.719999999999999 111.365 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -66.34 -38.32 87.38 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 120.686 1.585 . . . . 26.030000000000001 108.907 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1181 ' ' ILE . . . . . . . . . . . . . 70.9 mt -65.27 -47.16 88.36 Favored 'Isoleucine or valine' 0 C--N 1.36 1.033 0 O-C-N 125.347 1.654 . . . . 28.609999999999999 110.229 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -52.5 -55.24 23.47 Favored Glycine 0 N--CA 1.435 -1.374 0 C-N-CA 125.792 1.663 . . . . 25.23 111.376 174.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -61.96 -51.8 66.62 Favored 'General case' 0 C--O 1.251 1.166 0 C-N-CA 123.346 0.659 . . . . 24.09 111.425 -174.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -62.52 -41.09 98.63 Favored 'General case' 0 C--O 1.247 0.948 0 O-C-N 123.75 0.657 . . . . 26.68 111.123 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -63.31 -37.93 89.18 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 120.13 -1.606 . . . . 36.57 113.009 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1186 ' ' SER . . . . . . . . . . . . . 73.2 m -57.85 -49.83 75.37 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-O 122.804 1.287 . . . . 28.920000000000002 110.15 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1187 ' ' LEU . . . . . . . . . . . . . 12.6 mt -62.11 -21.89 65.36 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 118.192 2.664 . . . . 29.09 118.192 169.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 75.02 35.38 49.95 Favored Glycine 0 N--CA 1.433 -1.53 0 N-CA-C 109.053 -1.619 . . . . 29.260000000000002 109.053 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1189 ' ' ALA . . . . . . . . . . . . . . . -81.46 151.02 28.05 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.098 -1.816 . . . . 30.16 106.098 167.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 73.8 mt -78.74 97.49 2.35 Favored 'Isoleucine or valine' 0 C--O 1.246 0.914 0 N-CA-C 106.603 -1.629 . . . . 35.810000000000002 106.603 -174.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1191 ' ' VAL . . . . . . . . . . . . . 57.7 t -79.94 136.75 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-N 115.408 -0.815 . . . . 31.969999999999999 109.102 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1192 ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -131.9 127.27 36.1 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 104.426 -2.435 . . . . 48.159999999999997 104.426 167.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -134.64 158.21 44.63 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 124.084 1.897 . . . . 35.890000000000001 115.618 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 35.5 t80 -139.28 132.98 30.63 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 114.029 -1.441 . . . . 41.880000000000003 107.167 -171.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1195 ' ' ASP . . . . . . . . . . . . . 10.0 t70 -159.08 152.44 22.6 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 106.448 -1.686 . . . . 38.280000000000001 106.448 167.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1196 ' ' THR . . . . . . . . . . . . . 2.2 p -63.01 -44.3 96.37 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 113.997 1.11 . . . . 40.619999999999997 113.997 -177.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1197 ' ' ARG . . . . . . . . . . . . . 28.4 mtm180 -74.09 125.99 89.62 Favored Pre-proline 0 C--O 1.252 1.195 0 C-N-CA 119.67 -0.812 . . . . 53.090000000000003 111.711 -168.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -44.23 -33.79 6.32 Favored 'Trans proline' 0 C--O 1.248 0.984 1 C-N-CA 125.724 4.283 . . . . 42.560000000000002 118.219 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -54.05 -30.07 46.45 Favored 'General case' 0 C--N 1.347 0.479 0 N-CA-C 116.929 2.196 . . . . 56.310000000000002 116.929 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1200 ' ' VAL . . . . . . . . . . . . . 6.4 m -71.82 -29.47 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 O-C-N 124.554 1.159 . . . . 42.909999999999997 110.196 -177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 34.9 tttm -54.58 -48.14 72.47 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 125.714 1.884 . . . . 48.890000000000001 113.6 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.93 -48.87 77.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 117.658 -1.163 . . . . 51.700000000000003 108.869 175.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1203 ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -58.89 -46.37 88.02 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 125.225 1.578 . . . . 52.57 113.978 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1204 ' ' VAL . . . . . . . . . . . . . 48.5 t -62.52 -46.48 96.29 Favored 'Isoleucine or valine' 0 C--O 1.257 1.498 0 CA-C-N 120.429 1.468 . . . . 33.789999999999999 107.744 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -54.85 -38.77 67.86 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.563 1.145 . . . . 36.579999999999998 114.025 173.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1206 ' ' SER . . . . . . . . . . . . . 12.0 m -63.38 -37.03 85.68 Favored 'General case' 0 C--N 1.347 0.482 0 O-C-N 121.171 -0.955 . . . . 39.609999999999999 110.215 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1207 ' ' MET . . . . . . . . . . . . . 4.9 mtt -87.63 28.34 1.01 Allowed 'General case' 0 C--O 1.248 1.013 0 O-C-N 117.659 -3.151 . . . . 37.450000000000003 113.906 -175.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 55.45 30.57 55.85 Favored Glycine 0 CA--C 1.538 1.516 0 O-C-N 120.589 -1.319 . . . . 31.870000000000001 113.737 -176.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -119.04 142.01 48.22 Favored 'General case' 0 N--CA 1.428 -1.541 0 O-C-N 119.582 -2.128 . . . . 35.399999999999999 108.87 -164.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -80.61 129.08 34.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 118.694 -1.202 . . . . 47.890000000000001 108.846 -176.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 45.5 t80 -90.09 132.7 35.28 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 101.473 -3.529 . . . . 45.530000000000001 101.473 178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1212 ' ' LEU . . . . . . . . . . . . . 63.4 mt -84.73 121.58 27.89 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 103.689 -2.708 . . . . 46.329999999999998 103.689 173.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -68.81 147.94 51.02 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 115.496 1.665 . . . . 60.409999999999997 115.496 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 21.5 mt -66.6 140.64 57.96 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 112.588 -2.096 . . . . 57.380000000000003 107.002 167.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 23.4 t70 . . . . . 0 N--CA 1.433 -1.325 0 N-CA-C 107.472 -1.307 . . . . 65.069999999999993 107.472 177.538 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B 1230 ' ' MET . . . . . . . . . . . . . 5.4 mmm . . . . . 0 N--CA 1.433 -1.319 0 N-CA-C 104.705 -2.331 . . . . 80.319999999999993 104.705 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B 1231 ' ' SER . . . . . . . . . . . . . 2.6 m 78.84 -173.11 0.06 Allowed 'General case' 0 CA--C 1.539 0.542 2 O-C-N 111.99 -6.694 . . . . 79.920000000000002 118.805 -17.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -43.25 154.99 0.07 Allowed 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 119.203 3.038 . . . . 77.909999999999997 119.203 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 62.97 -59.19 0.15 Allowed 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 112.253 -2.248 . . . . 73.879999999999995 109.439 -159.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 8.3 t80 -55.76 -44.78 77.99 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 120.044 -1.66 . . . . 68.980000000000004 113.765 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 8.0 pt -44.6 -38.88 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 121.772 2.078 . . . . 64.530000000000001 112.754 175.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -75.83 -38.03 58.48 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 118.055 -0.974 . . . . 66.359999999999999 109.627 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -65.22 -26.22 68.03 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 120.91 1.687 . . . . 56.600000000000001 113.243 175.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -66.45 -47.99 71.4 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 106.786 -1.561 . . . . 56.789999999999999 106.786 175.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1239 ' ' MET . . . . . . . . . . . . . 19.6 mmm -49.84 -49.18 50.06 Favored 'General case' 0 C--O 1.25 1.087 0 O-C-N 124.528 1.143 . . . . 53.630000000000003 111.666 171.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.76 -37.06 85.3 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 121.243 0.544 . . . . 51.740000000000002 110.817 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 60.3 tp -64.78 -47.94 76.31 Favored 'General case' 0 C--N 1.342 0.25 0 O-C-N 120.555 -1.34 . . . . 44.859999999999999 107.57 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 14.8 m-30 -65.88 -34.06 77.26 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 124.546 1.138 . . . . 42.780000000000001 111.26 -174.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -67.14 -51.3 55.61 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 113.929 1.085 . . . . 40.960000000000001 113.929 172.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -69.59 -28.92 66.36 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 122.492 1.139 . . . . 43.060000000000002 108.763 -173.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 43.3 mm-40 -75.53 -37.27 60.18 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.369 -1.457 . . . . 46.450000000000003 112.608 171.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -60.67 -23.42 64.81 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 115.284 1.587 . . . . 41.780000000000001 115.284 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 26.0 tptt -62.44 -41.85 99.04 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.196 -0.911 . . . . 52.200000000000003 109.42 171.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1248 ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -91.26 -30.8 16.41 Favored 'General case' 0 C--O 1.244 0.808 0 O-C-N 121.586 -0.696 . . . . 53.549999999999997 112.705 -172.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1249 ' ' VAL . . . . . . . . . . . . . 19.1 m -84.2 169.43 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 124.684 2.183 . . . . 34.409999999999997 114.808 -173.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1250 ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -111.99 -61.89 1.65 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 111.635 -2.53 . . . . 33.380000000000003 111.573 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1251 ' ' ILE . . . . . . . . . . . . . 48.5 mm -107.24 106.69 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 123.839 0.712 . . . . 29.539999999999999 109.097 -173.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1252 ' ' ILE . . . . . . . . . . . . . 51.1 mt -92.41 118.5 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 N-CA-C 105.086 -2.19 . . . . 32.439999999999998 105.086 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1253 ' ' VAL . . . . . . . . . . . . . 72.2 t -102.32 87.29 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.254 1.339 0 N-CA-C 104.634 -2.358 . . . . 30.57 104.634 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1254 ' ' THR . . . . . . . . . . . . 0.331 1.4 t -91.3 103.53 16.18 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 127.096 3.331 . . . . 35.039999999999999 112.739 -175.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B 1255 ' ' THR . . . . . . . . . . . . . 17.1 m -99.7 -26.89 13.91 Favored 'General case' 0 C--N 1.318 -0.797 1 CA-C-N 106.0 -5.091 . . . . 34.619999999999997 109.451 -177.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . -47.79 96.65 0.01 OUTLIER 'General case' 0 C--O 1.257 1.475 0 CA-C-N 123.499 2.863 . . . . 42.719999999999999 117.74 -169.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 3.7 tt -133.9 146.0 50.14 Favored 'General case' 0 C--O 1.251 1.156 0 N-CA-C 101.845 -3.391 . . . . 52.43 101.845 -173.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 64.4 mt -119.08 122.14 29.82 Favored Pre-proline 0 C--N 1.313 -1.002 1 N-CA-C 100.102 -4.036 . . . . 59.409999999999997 100.102 177.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -56.0 126.73 23.35 Favored 'Trans proline' 0 C--O 1.247 0.955 0 C-N-CA 123.441 2.76 . . . . 62.68 115.659 -173.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 82.26 2.0 90.5 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 112.955 -1.929 . . . . 64.159999999999997 111.366 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 85.3 mttt -120.39 145.79 41.36 Favored Pre-proline 0 N--CA 1.475 0.801 0 O-C-N 118.474 -2.78 . . . . 68.530000000000001 105.181 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -56.19 136.56 75.85 Favored 'Trans proline' 0 C--N 1.362 1.273 0 C-N-CA 123.899 3.066 . . . . 61.990000000000002 112.077 164.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1263 ' ' ALA . . . . . . . . . . . . . . . -61.3 119.83 49.66 Favored Pre-proline 0 C--O 1.242 0.671 0 CA-C-N 113.024 -1.898 . . . . 57.149999999999999 112.28 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -55.08 146.49 58.53 Favored 'Trans proline' 0 CA--C 1.501 -1.157 0 C-N-CA 124.718 3.612 . . . . 51.57 112.339 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -87.91 68.31 9.25 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 122.916 1.341 . . . . 54.549999999999997 109.342 -171.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 91.0 mt -81.03 -30.15 34.92 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 111.51 -2.586 . . . . 46.859999999999999 111.798 -172.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1267 ' ' ILE . . . . . . . . . . . . . 28.3 mm -96.82 100.35 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 N-CA-C 104.665 -2.346 . . . . 41.039999999999999 104.665 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1268 ' ' THR . . . . . . . . . . . . . 1.1 p -75.03 151.42 38.73 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 125.486 1.741 . . . . 39.579999999999998 113.222 175.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1269 ' ' ARG . . . . . . . . . . . . . 78.1 mtt85 -57.65 -40.85 80.23 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-N 119.805 1.184 . . . . 53.149999999999999 111.5 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -54.61 -43.6 72.37 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 114.759 1.392 . . . . 42.960000000000001 114.759 169.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1271 ' ' MET . . . . . . . . . . . . . 39.4 ttm -60.8 -47.95 84.0 Favored 'General case' 0 C--O 1.241 0.613 0 O-C-N 120.945 -1.097 . . . . 43.890000000000001 111.846 176.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1272 ' ' VAL . . . . . . . . . . . . . 15.3 t -55.26 -52.4 45.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-N 115.091 -0.959 . . . . 38.369999999999997 110.113 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.94 2.24 7.25 Favored 'General case' 0 C--N 1.362 1.129 0 N-CA-C 115.039 1.496 . . . . 47.460000000000001 115.039 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1274 ' ' SER . . . . . . . . . . . . . 50.3 m -97.26 -14.58 21.29 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 114.79 1.404 . . . . 38.380000000000003 114.79 172.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1275 ' ' MET . . . . . . . . . . . . . 94.1 mtp -64.14 171.27 3.08 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 116.484 2.031 . . . . 37.810000000000002 116.484 -177.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -66.63 147.21 53.58 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 114.28 -1.327 . . . . 49.259999999999998 109.723 165.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -79.1 161.47 26.49 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.859 0.837 . . . . 34.460000000000001 112.931 174.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 81.3 25.22 55.32 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 112.712 -2.04 . . . . 33.530000000000001 112.926 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1279 ' ' SER . . . . . . . . . . . . . 13.0 m -126.64 165.35 19.38 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 116.439 -1.743 . . . . 31.309999999999999 111.363 -163.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1280 ' ' VAL . . . . . . . . . . . . . 73.8 t -136.7 136.89 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 124.165 3.166 . . . . 29.32 109.856 -171.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1281 ' ' ILE . . . . . . . . . . . . . 76.0 mt -113.26 113.36 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 103.735 -2.691 . . . . 31.93 103.735 171.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1282 ' ' VAL . . . . . . . . . . . . . 4.0 t -99.33 123.27 51.92 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 N-CA-C 106.408 -1.701 . . . . 29.48 106.408 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 18.2 t0 -93.69 108.76 20.46 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 114.797 -1.092 . . . . 34.5 109.013 174.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1284 ' ' LEU . . . . . . . . . . . . . 7.9 mp -84.27 -37.28 21.92 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 104.621 -2.363 . . . . 37.939999999999998 104.621 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -80.57 8.23 8.3 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 122.497 1.141 . . . . 40.920000000000002 113.277 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -43.46 -47.0 7.03 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 117.839 2.533 . . . . 44.390000000000001 117.839 175.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1287 ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -75.17 -30.09 60.61 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 112.931 0.715 . . . . 51.460000000000001 112.931 -175.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -107.52 48.1 0.86 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 122.931 1.348 . . . . 57.75 108.559 178.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B 1289 ' ' GLY . . . . . . . . . . . . . . . 129.21 -29.43 3.88 Favored Glycine 0 N--CA 1.428 -1.883 0 O-C-N 119.46 -2.025 . . . . 49.850000000000001 116.381 169.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 76.88 100.79 0.16 Allowed Glycine 0 C--O 1.245 0.804 0 CA-C-N 119.111 1.456 . . . . 45.93 109.775 -176.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1291 ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -71.48 -39.99 70.53 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 119.406 -2.232 . . . . 42.670000000000002 113.647 175.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1292 ' ' CYS . . . . . . . . . . . . . 36.1 t -83.4 150.69 25.9 Favored 'General case' 0 C--O 1.24 0.593 0 O-C-N 119.911 -1.743 . . . . 38.82 106.821 171.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1293 ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -75.39 -49.86 17.68 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 122.58 1.181 . . . . 46.710000000000001 109.251 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.13 -18.29 34.44 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 115.655 1.724 . . . . 47.229999999999997 115.655 -174.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B 1295 ' ' THR . . . . . . . . . . . . . 97.0 m -37.69 105.17 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 115.64 1.719 . . . . 36.020000000000003 115.64 168.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 71.4 t -88.34 106.18 11.69 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 105.785 -1.931 . . . . 37.259999999999998 105.785 170.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -58.89 111.42 0.89 Allowed 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 123.241 2.627 . . . . 35.090000000000003 115.811 -177.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 95.55 10.69 56.58 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 113.307 -1.77 . . . . 35.969999999999999 111.059 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -148.01 -178.03 6.06 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 124.9 2.286 . . . . 40.390000000000001 110.046 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1300 ' ' ILE . . . . . . . . . . . . . 30.3 mt -110.71 162.79 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 111.006 -2.815 . . . . 37.43 105.367 172.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 61.0 t80 -150.77 130.38 13.08 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 104.052 -2.573 . . . . 44.130000000000003 104.052 170.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1302 ' ' THR . . . . . . . . . . . . . 25.7 m -95.62 136.16 36.37 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.447 -0.945 . . . . 39.780000000000001 108.447 173.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1303 ' ' THR . . . . . . . . . . . . . 46.6 p -77.25 177.22 8.07 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.287 -1.324 . . . . 43.289999999999999 113.015 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -57.63 -59.02 5.82 Favored 'General case' 0 N--CA 1.435 -1.214 0 O-C-N 121.091 -1.006 . . . . 53.07 110.805 162.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -60.5 -22.75 63.89 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 113.759 1.022 . . . . 43.969999999999999 113.759 -174.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 108.62 47.42 0.91 Allowed Glycine 0 N--CA 1.432 -1.583 0 CA-C-O 122.57 1.094 . . . . 41.119999999999997 112.713 166.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1307 ' ' VAL . . . . . . . . . . . . . 95.1 t -122.95 128.16 75.06 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 N-CA-C 102.226 -3.25 . . . . 38.119999999999997 102.226 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1308 ' ' LYS . . . . . . . . . . . . . 43.7 mmtt -83.53 109.02 17.04 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 103.013 -2.958 . . . . 36.340000000000003 103.013 176.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1309 ' ' VAL . . . . . . . . . . . . . 44.9 t -88.1 113.44 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 O-C-N 117.288 -3.382 . . . . 30.399999999999999 103.284 168.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1310 ' ' ILE . . . . . . . . . . . . . 19.2 mt -102.41 100.16 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-N 113.617 -1.629 . . . . 30.82 107.626 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1311 ' ' GLY . . . . . . . . . . . . . . . -97.57 53.59 1.29 Allowed Glycine 0 C--N 1.352 1.426 0 C-N-CA 119.084 -1.531 . . . . 26.530000000000001 110.704 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1312 ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -74.88 94.37 2.79 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 120.759 -1.436 . . . . 38.0 108.745 -171.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B 1313 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.76 -35.33 63.65 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 121.077 -1.014 . . . . 29.800000000000001 112.24 174.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -75.1 4.28 7.08 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 126.758 2.023 . . . . 39.039999999999999 115.376 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1315 ' ' LEU . . . . . . . . . . . . . 34.6 mt -43.9 -50.99 18.52 Favored Pre-proline 0 N--CA 1.465 0.301 0 N-CA-C 118.231 2.678 . . . . 31.079999999999998 118.231 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1316 ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -56.84 -27.5 72.31 Favored 'Trans proline' 0 CA--C 1.546 1.094 0 C-N-CA 123.628 2.886 . . . . 26.100000000000001 115.315 174.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -82.06 -35.01 22.5 Favored Glycine 0 N--CA 1.435 -1.407 0 O-C-N 120.715 -1.24 . . . . 23.170000000000002 110.139 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -52.52 3.43 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.588 1 N-CA-C 123.437 4.606 . . . . 40.399999999999999 123.437 -171.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 21.3 tp -132.75 66.54 76.71 Favored Pre-proline 0 C--O 1.243 0.741 0 O-C-N 118.746 -2.471 . . . . 23.600000000000001 108.269 -175.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1320 ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -26.57 -71.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.053 1 C-N-CA 126.196 4.597 . . . . 22.350000000000001 118.72 -166.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B 1321 ' ' THR . . . . . . . . . . . . . 3.3 m -67.48 -40.62 85.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 119.952 1.251 . . . . 26.52 108.995 -169.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1322 ' ' GLN . . . . . . . . . . . . . 32.4 tp60 -79.11 -33.14 44.6 Favored 'General case' 0 CA--C 1.488 -1.41 0 O-C-N 120.66 -1.275 . . . . 24.379999999999999 110.882 -173.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1323 ' ' SER . . . . . . . . . . . . . 71.3 m -63.07 -47.5 82.66 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 109.184 -0.673 . . . . 22.800000000000001 109.184 176.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1324 ' ' SER . . . . . . . . . . . . . 22.0 m -58.32 -37.0 74.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 122.881 1.324 . . . . 21.25 114.248 175.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -65.03 -54.36 31.43 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.468 -1.242 . . . . 31.34 111.804 176.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1326 ' ' LEU . . . . . . . . . . . . . 23.8 mt -73.09 -40.4 65.03 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 117.688 -1.149 . . . . 31.559999999999999 110.944 -172.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1327 ' ' TYR . . . . . . . . . . . . . 42.5 t80 -57.94 -50.95 71.62 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 106.118 -1.808 . . . . 22.73 106.118 173.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1328 ' ' GLY . . . . . . . . . . . . . . . -52.36 -42.63 56.91 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 114.582 0.593 . . . . 21.91 114.582 174.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1329 ' ' THR . . . . . . . . . . . . . 5.5 m -71.94 -25.45 61.89 Favored 'General case' 0 C--O 1.249 1.057 0 O-C-N 120.52 -1.577 . . . . 22.149999999999999 111.936 176.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1330 ' ' ASN . . . . . . . . . . . . . 24.7 m120 -62.56 -37.45 86.21 Favored 'General case' 0 C--O 1.249 1.04 0 CA-C-N 120.893 1.679 . . . . 26.18 110.58 170.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1331 ' ' LEU . . . . . . . . . . . . . 59.1 mt -68.65 -44.0 75.07 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 113.859 -1.519 . . . . 23.68 109.977 176.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1332 ' ' VAL . . . . . . . . . . . . . 69.9 t -53.4 -55.36 13.32 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 CA-C-O 116.846 -1.55 . . . . 26.57 108.139 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -55.8 -40.29 72.52 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 115.459 1.652 . . . . 28.079999999999998 115.459 175.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1334 ' ' LEU . . . . . . . . . . . . . 12.9 tp -56.54 -48.24 77.7 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 124.722 1.209 . . . . 27.43 111.357 169.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1335 ' ' LEU . . . . . . . . . . . . . 7.2 mt -71.62 -22.32 61.72 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 119.92 -0.712 . . . . 30.5 111.648 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1336 ' ' LYS . . . . . . . . . . . . . 97.0 mttt -67.01 -47.98 69.79 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.297 -1.001 . . . . 41.649999999999999 108.297 171.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 6.6 mp -71.21 -35.08 71.39 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 119.591 -1.943 . . . . 42.079999999999998 112.053 176.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1338 ' ' LEU . . . . . . . . . . . . . 35.9 mt -69.78 -68.27 0.43 Allowed 'General case' 0 N--CA 1.438 -1.048 0 O-C-N 119.638 -1.914 . . . . 35.030000000000001 110.446 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 52.6 t -93.32 69.86 4.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.929 1.347 . . . . 37.329999999999998 108.595 -174.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 57.3 mttp -65.88 -27.81 68.49 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 114.193 1.183 . . . . 50.509999999999998 114.193 -175.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -71.44 -21.32 61.99 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 120.998 -1.064 . . . . 54.210000000000001 112.646 168.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 7.3 mptt 52.07 50.48 18.42 Favored 'General case' 0 C--O 1.252 1.199 0 CA-C-O 124.969 2.319 . . . . 50.990000000000002 111.575 -163.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -76.55 -33.24 58.54 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 111.264 -2.698 . . . . 48.82 111.274 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 108.34 14.45 16.35 Favored Glycine 0 C--O 1.244 0.77 0 CA-C-O 117.748 -1.585 . . . . 40.43 112.194 174.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -131.09 156.47 45.16 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 104.835 -2.283 . . . . 47.560000000000002 104.835 166.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1346 ' ' ILE . . . . . . . . . . . . . 26.2 mm -81.95 94.23 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 O-C-N 118.955 -2.34 . . . . 42.490000000000002 112.195 -172.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1347 ' ' THR . . . . . . . . . . . . . 88.1 m -59.21 105.31 0.32 Allowed 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 106.919 -1.511 . . . . 38.119999999999997 106.919 159.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 21.7 t -90.46 96.43 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 104.761 -2.311 . . . . 37.5 104.761 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 6.6 t70 -75.39 129.03 36.67 Favored 'General case' 0 C--O 1.265 1.891 0 CA-C-N 110.995 -2.821 . . . . 43.850000000000001 110.301 -175.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1350 ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -117.24 0.82 12.37 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.934 -1.104 . . . . 39.810000000000002 111.508 175.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 7.9 t70 -81.13 -43.86 18.77 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 119.236 0.926 . . . . 51.289999999999999 109.857 -175.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.2 145.13 51.64 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-O 122.105 0.955 . . . . 39.780000000000001 110.936 174.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 28.7 m -68.47 -36.67 75.75 Favored 'Isoleucine or valine' 0 C--O 1.25 1.131 0 CA-C-N 114.952 -1.022 . . . . 39.280000000000001 110.726 -173.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1354 ' ' VAL . . . . . . . . . . . . . 49.7 t -70.41 -47.71 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 O-C-N 121.799 -0.563 . . . . 35.700000000000003 111.19 -172.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1355 ' ' ILE . . . . . . . . . . . . . 38.7 mm -70.11 -41.52 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 O-C-N 121.398 -0.813 . . . . 35.770000000000003 109.797 176.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 47.3 tpt85 -47.63 -32.54 5.67 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 115.375 1.62 . . . . 38.549999999999997 115.375 169.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -91.94 -40.87 5.12 Favored Glycine 0 N--CA 1.442 -0.901 0 O-C-N 121.627 -0.67 . . . . 29.579999999999998 114.011 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1358 ' ' VAL . . . . . . . . . . . . . 4.0 p -66.76 -36.42 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 114.454 1.279 . . . . 32.060000000000002 114.454 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1359 ' ' THR . . . . . . . . . . . . . 4.1 m -72.35 81.16 1.03 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 123.3 1.524 . . . . 29.0 107.205 175.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1360 ' ' VAL . . . . . . . . . . . . . 14.6 m -63.24 -29.23 46.73 Favored 'Isoleucine or valine' 0 C--O 1.248 1.001 0 O-C-N 121.129 -0.982 . . . . 29.68 113.392 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 49.1 mt -138.3 108.6 4.83 Favored 'Isoleucine or valine' 0 C--O 1.249 1.058 0 N-CA-C 104.173 -2.529 . . . . 32.049999999999997 104.173 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1362 ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -91.5 105.08 17.5 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 117.99 -2.944 . . . . 32.520000000000003 107.396 169.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 45.45 58.82 3.94 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 116.91 2.189 . . . . 35.68 116.91 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 91.96 -47.27 2.7 Favored Glycine 0 CA--C 1.538 1.53 0 CA-C-O 118.017 -1.435 . . . . 34.259999999999998 112.646 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -68.32 115.31 7.62 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 123.265 1.507 . . . . 51.07 109.58 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 24.4 mt -74.76 95.8 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.981 0 CA-C-O 123.427 1.584 . . . . 39.869999999999997 112.54 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1367 ' ' THR . . . . . . . . . . . . . 11.8 p -90.43 13.63 15.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 110.445 -3.071 . . . . 38.009999999999998 113.039 -174.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1368 ' ' TRP . . . . . . . . . . . . . 32.2 t90 -77.96 135.8 62.78 Favored Pre-proline 0 C--O 1.233 0.197 0 C-N-CA 125.582 1.553 . . . . 42.140000000000001 111.024 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -91.19 -167.83 3.03 Favored 'Cis proline' 0 CA--C 1.542 0.877 0 CA-C-N 123.616 2.327 . . . . 43.259999999999998 110.21 -9.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1370 ' ' ALA . . . . . . . . . . . . . . . -72.34 167.86 28.64 Favored Pre-proline 0 C--O 1.244 0.8 0 CA-C-O 117.142 -1.408 . . . . 46.520000000000003 110.136 163.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -56.55 151.48 46.02 Favored 'Trans proline' 0 CA--C 1.548 1.191 0 CA-C-N 125.864 3.13 . . . . 51.950000000000003 109.07 164.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -64.65 100.44 0.34 Allowed 'Trans proline' 0 C--O 1.24 0.589 0 C-N-CA 122.477 2.118 . . . . 56.270000000000003 113.779 -168.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1373 ' ' ILE . . . . . . . . . . . . . 17.0 mm -100.63 101.33 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 102.22 -3.252 . . . . 60.829999999999998 102.22 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -62.55 120.23 10.74 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 122.78 1.276 . . . . 66.099999999999994 109.764 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 16.4 t -81.76 121.89 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 104.213 -2.514 . . . . 63.469999999999999 104.213 176.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.227 -4.724 0 O-C-N 121.92 -0.488 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.291 0 CA-C-O 120.375 0.131 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.35 -32.81 40.12 Favored 'General case' 0 C--O 1.214 -0.789 0 C-N-CA 124.74 1.216 . . . . 0.0 113.983 176.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -70.14 -63.33 1.1 Allowed 'General case' 0 C--O 1.245 0.865 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 170.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.36 -34.84 3.22 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 125.748 1.619 . . . . 0.0 115.061 -174.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.45 -67.0 0.29 Allowed 'General case' 0 C--O 1.256 1.419 0 N-CA-C 115.238 1.569 . . . . 0.0 115.238 166.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -55.43 -38.09 68.54 Favored 'General case' 0 C--N 1.356 0.88 0 O-C-N 119.942 -1.724 . . . . 0.0 113.457 173.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 mp -59.25 -43.4 92.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.438 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 13.6 mt -58.2 -53.46 58.01 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 125.139 1.375 . . . . 0.0 114.268 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' LYS . . . . . 0.426 ' HZ1' ' C ' ' C' ' 186' ' ' LEU . 11.9 pttm -58.58 -31.86 68.41 Favored 'General case' 0 C--O 1.242 0.708 0 O-C-N 120.004 -1.685 . . . . 0.0 113.726 176.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -65.62 -32.31 73.81 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 174.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 67.1 m -58.45 -34.55 70.96 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 119.609 3.188 . . . . 0.0 119.609 -158.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 59.98 -76.93 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 122.509 2.413 . . . . 0.0 107.396 -165.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 15.4 m -96.32 136.2 37.12 Favored 'General case' 0 C--O 1.243 0.724 0 O-C-N 118.087 -2.883 . . . . 0.0 110.089 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 91.3 t -129.89 122.96 55.68 Favored 'Isoleucine or valine' 0 C--O 1.247 0.962 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 26.9 mm -100.12 117.99 46.13 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 168.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 27.7 mt -94.36 118.04 39.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 119.481 1.037 . . . . 0.0 109.663 170.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 3.6 m -102.96 108.28 57.98 Favored Pre-proline 0 CA--C 1.55 0.95 0 O-C-N 120.172 -1.58 . . . . 0.0 112.424 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -74.17 37.74 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 1 C-N-CA 125.657 4.238 . . . . 0.0 118.772 -175.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -88.24 94.35 1.98 Allowed Glycine 0 C--N 1.335 0.489 0 O-C-N 119.555 -1.966 . . . . 0.0 111.987 -166.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 23.4 t80 68.66 -57.07 0.51 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 116.922 -1.513 . . . . 0.0 114.648 175.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -49.07 -46.87 33.29 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-N 120.39 1.45 . . . . 0.0 113.301 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 49.1 ttm -44.67 -52.07 8.58 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 173.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.86 -59.15 2.85 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.812 -175.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 8.2 p -57.84 -43.81 85.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 122.881 1.325 . . . . 0.0 109.179 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.44 6.66 25.79 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 119.801 -1.812 . . . . 0.0 113.496 -176.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' GLN . . . . . . . . . . . . 0.348 0.0 OUTLIER 49.52 25.87 1.53 Allowed 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 118.175 2.657 . . . . 0.0 118.175 -169.17 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.2 -8.33 49.08 Favored 'General case' 0 C--O 1.255 1.359 0 O-C-N 120.352 -1.467 . . . . 0.0 111.266 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . 0.365 0.0 OUTLIER -69.54 -38.22 77.41 Favored 'General case' 0 CA--C 1.51 -0.568 0 O-C-N 118.677 -2.514 . . . . 0.0 115.532 174.836 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -58.98 -58.45 19.43 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-O 115.292 -2.29 . . . . 0.0 111.313 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -61.71 -36.57 73.89 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 124.324 3.349 . . . . 0.0 111.711 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -53.16 -39.09 32.44 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-N 122.047 2.203 . . . . 0.0 112.839 177.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.34 -38.98 69.45 Favored 'General case' 0 C--O 1.247 0.927 0 O-C-N 121.66 -0.65 . . . . 0.0 112.007 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -75.65 -48.77 20.67 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 120.746 -1.221 . . . . 0.0 108.277 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 8.1 tp -63.38 -37.4 79.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 C-N-CA 119.416 -0.914 . . . . 0.0 113.084 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 90.0 m -68.56 -41.99 78.96 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 119.961 -1.712 . . . . 0.0 109.49 -178.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -53.67 -42.39 67.86 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 124.626 1.17 . . . . 0.0 112.066 168.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -66.44 -39.44 88.89 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 120.927 -1.108 . . . . 0.0 111.378 173.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 97.9 mt -67.63 -33.52 75.14 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 119.862 1.21 . . . . 0.0 107.896 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.9 -46.51 84.49 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 121.897 0.856 . . . . 0.0 111.473 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.67 -35.97 71.28 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 124.068 1.89 . . . . 0.0 114.029 173.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -68.06 -24.07 65.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.495 -1.23 . . . . 0.0 113.53 173.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.91 79.75 1.11 Allowed Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 mt -141.94 125.97 16.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 112.89 -1.655 . . . . 0.0 107.913 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -72.41 87.91 1.18 Allowed 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 125.214 1.406 . . . . 0.0 109.601 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 9.2 p -93.17 139.98 17.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 CA-C-O 122.11 0.957 . . . . 0.0 111.591 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 84.1 mmt-85 -138.38 120.6 15.79 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 103.19 -2.892 . . . . 0.0 103.19 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -79.87 126.13 30.6 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 165.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -100.53 86.37 0.64 Allowed Glycine 0 N--CA 1.478 1.45 0 O-C-N 119.002 -2.312 . . . . 0.0 109.509 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 3.2 mp -87.09 84.93 2.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 O-C-N 118.982 -2.481 . . . . 0.0 107.857 -172.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -74.24 116.91 57.32 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-O 116.569 -1.681 . . . . 0.0 108.527 170.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 70' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -54.62 -59.29 0.89 Allowed 'Trans proline' 0 C--N 1.333 -0.247 0 C-N-CA 124.383 3.389 . . . . 0.0 117.255 -170.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 4.4 m -68.23 95.56 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 113.303 -1.771 . . . . 0.0 108.506 169.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -161.17 109.91 1.58 Allowed 'General case' 0 C--O 1.242 0.66 0 CA-C-N 109.031 -3.713 . . . . 0.0 107.16 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.48 -90.96 0.3 Allowed Glycine 0 CA--C 1.506 -0.498 0 CA-C-O 118.285 -1.286 . . . . 0.0 112.975 172.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -133.17 114.06 13.41 Favored 'General case' 0 C--O 1.256 1.419 0 CA-C-N 118.196 0.998 . . . . 0.0 111.935 -167.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 1.7 mp 63.13 142.84 0.06 OUTLIER Pre-proline 0 C--O 1.236 0.344 0 C-N-CA 128.173 2.589 . . . . 0.0 117.069 169.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -71.47 149.9 56.91 Favored 'Trans proline' 0 C--N 1.364 1.365 0 C-N-CA 123.289 2.659 . . . . 0.0 111.093 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 70.81 -96.53 0.59 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -171.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 48.55 -84.32 0.01 OUTLIER 'General case' 0 C--O 1.24 0.602 0 C-N-CA 126.089 1.756 . . . . 0.0 111.677 173.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -25.81 65.64 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.226 1.01 . . . . 0.0 113.1 177.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -58.02 -55.02 40.35 Favored 'General case' 0 C--O 1.24 0.576 0 O-C-N 121.659 -0.651 . . . . 0.0 111.497 170.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 69.8 t -73.3 -38.06 53.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 O-C-N 119.664 -1.898 . . . . 0.0 108.896 177.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 96.0 mt -48.73 -31.77 7.44 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 122.595 2.452 . . . . 0.0 114.234 169.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.82 -32.06 61.86 Favored 'General case' 0 C--O 1.221 -0.399 0 O-C-N 121.429 -0.794 . . . . 0.0 111.2 173.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.08 -32.67 74.5 Favored 'General case' 0 CA--C 1.497 -1.078 0 O-C-N 120.007 -1.683 . . . . 0.0 113.709 170.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -64.3 -50.05 69.36 Favored 'General case' 0 C--O 1.251 1.182 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 172.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.15 -18.18 60.15 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 172.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp 63.1 62.13 1.03 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-O 124.888 2.28 . . . . 0.0 109.558 -173.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 98.2 t -103.84 127.6 29.05 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 111.337 -2.665 . . . . 0.0 105.619 168.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -56.39 126.89 23.8 Favored 'Trans proline' 0 C--O 1.219 -0.469 0 C-N-CA 122.935 2.424 . . . . 0.0 117.965 175.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -59.3 -12.41 5.59 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 173.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -62.45 -47.48 83.86 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 119.96 1.254 . . . . 0.0 111.555 171.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 39.5 pt -84.09 -14.42 11.46 Favored 'Isoleucine or valine' 0 C--O 1.255 1.351 0 CA-C-O 121.984 0.897 . . . . 0.0 111.521 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 50.5 t -76.84 104.56 4.92 Favored 'Isoleucine or valine' 0 C--O 1.247 0.951 0 O-C-N 119.69 -1.881 . . . . 0.0 106.882 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 10.8 mp -104.29 103.44 13.19 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 124.831 2.253 . . . . 0.0 109.559 174.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -85.36 117.16 24.12 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 119.675 -1.891 . . . . 0.0 108.28 -176.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 12.2 ttp 42.81 29.59 0.19 Allowed 'General case' 0 C--N 1.345 0.385 0 C-N-CA 127.801 2.441 . . . . 0.0 115.162 -178.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -79.92 128.63 33.68 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 103.387 -2.819 . . . . 0.0 103.387 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -87.13 79.56 8.6 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 9.5 tp -85.21 58.97 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 112.482 -2.145 . . . . 0.0 108.265 -173.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -73.31 -38.58 65.79 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 112.837 -1.983 . . . . 0.0 111.801 -166.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.96 -39.38 79.54 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.079 -1.419 . . . . 0.0 112.437 177.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.74 -28.43 67.63 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 120.172 -1.58 . . . . 0.0 113.25 167.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 103' ' ' PHE . . . . . . . . . . . . . 6.8 m-30 -56.54 -51.19 69.49 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-O 121.575 0.703 . . . . 0.0 111.95 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.99 -45.51 82.91 Favored 'General case' 0 C--O 1.208 -1.117 0 CA-C-N 114.524 -1.217 . . . . 0.0 112.594 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -66.31 -29.18 69.33 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 106' ' ' THR . . . . . . . . . . . . . 69.6 m -64.92 135.52 55.79 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 107' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -86.94 -102.68 0.07 Allowed 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 112.373 -2.194 . . . . 0.0 109.027 166.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 53.8 m -69.83 91.77 0.66 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 124.398 3.272 . . . . 0.0 113.356 -171.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 109' ' ' VAL . . . . . . . . . . . . . 21.3 t -74.27 110.6 8.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 167.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 96.0 mt -85.6 95.44 9.34 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 50.3 t -87.1 87.68 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 -176.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 25.3 mm -72.05 79.32 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -171.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.69 -110.26 3.64 Favored Glycine 0 C--O 1.239 0.409 0 N-CA-C 107.25 -2.34 . . . . 0.0 107.25 -171.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . 47.73 9.13 0.01 OUTLIER 'General case' 0 C--N 1.352 0.686 1 N-CA-C 121.817 4.006 . . . . 0.0 121.817 163.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.29 -41.94 51.61 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 117.258 2.318 . . . . 0.0 117.258 -175.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 116' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -76.51 -28.01 56.23 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 19.4 m -72.83 -13.3 61.26 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.9 -1.125 . . . . 0.0 108.642 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 18.3 m -120.03 16.86 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 CA-C-N 119.762 1.165 . . . . 0.0 109.873 174.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -79.64 112.28 27.93 Favored Pre-proline 0 N--CA 1.451 -0.391 0 O-C-N 120.118 -1.614 . . . . 0.0 115.188 -171.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 120' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -58.91 -36.47 96.84 Favored 'Trans proline' 0 C--N 1.368 1.602 0 C-N-CA 123.557 2.838 . . . . 0.0 113.288 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.58 4.98 1.55 Allowed 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.2 -31.7 14.01 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 120.344 -1.472 . . . . 0.0 113.124 173.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -116.03 -52.37 2.61 Favored 'General case' 0 C--O 1.22 -0.49 0 C-N-CA 118.839 -1.144 . . . . 0.0 109.68 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -62.17 -51.01 69.53 Favored 'General case' 0 C--N 1.363 1.188 0 CA-C-O 122.735 1.255 . . . . 0.0 108.905 -173.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -95.54 132.07 28.27 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 102.869 -3.011 . . . . 0.0 102.869 164.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -78.05 46.58 2.11 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 122.223 1.949 . . . . 0.0 110.829 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -107.06 -33.2 7.54 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -152.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 128' ' ' SER . . . . . . . . . . . . . 36.3 m -79.57 144.36 60.94 Favored Pre-proline 0 C--O 1.24 0.559 0 O-C-N 124.735 1.272 . . . . 0.0 111.647 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 129' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -44.38 -40.0 12.85 Favored 'Trans proline' 0 CA--C 1.51 -0.677 0 C-N-CA 123.785 2.99 . . . . 0.0 114.69 176.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 35.4 pt -65.61 72.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.88 0 CA-C-O 124.4 2.048 . . . . 0.0 110.413 164.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.71 119.52 10.71 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.511 -1.222 . . . . 0.0 112.987 -172.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 61.71 50.38 66.75 Favored Glycine 0 N--CA 1.431 -1.648 0 CA-C-N 113.083 -1.871 . . . . 0.0 112.149 -175.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 133' ' ' MET . . . . . . . . . . . . . 26.5 tpp -75.98 123.79 88.27 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 119.481 1.641 . . . . 0.0 112.099 171.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.68 82.71 1.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.969 1 C-N-CA 125.833 4.355 . . . . 0.0 107.498 177.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 21.7 m -80.99 151.83 4.39 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.183 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.25 -176.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 87.5 mt -74.59 109.27 7.93 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.696 0.76 . . . . 0.0 110.214 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -72.81 80.02 1.14 Allowed 'General case' 0 N--CA 1.423 -1.789 0 CA-C-O 122.964 1.364 . . . . 0.0 112.134 -169.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 3.9 p -113.63 -1.79 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -176.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 13.1 p90 -56.56 148.71 19.0 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.131 -1.606 . . . . 0.0 111.118 174.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 140' ' ' LYS . . . . . . . . . . . . 0.378 0.0 OUTLIER 37.19 46.37 0.57 Allowed 'General case' 0 C--O 1.244 0.765 0 N-CA-C 116.55 2.056 . . . . 0.0 116.55 -160.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.5 -156.36 0.04 OUTLIER 'General case' 0 C--O 1.24 0.596 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 159.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.08 -32.81 24.59 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 119.754 -1.841 . . . . 0.0 113.787 170.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 143' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -158.55 138.2 11.9 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 121.837 2.108 . . . . 0.0 110.239 170.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 144' ' ' VAL . . . . . . . . . . . . . 21.8 t -136.46 90.43 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.598 0 O-C-N 119.051 -2.28 . . . . 0.0 105.104 -176.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 145' ' ' ILE . . . . . . . . . . . . . 10.5 tp -93.13 102.02 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 -170.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 146' ' ' VAL . . . . . . . . . . . . . 26.0 t -90.99 107.41 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 -170.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 147' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -70.3 94.09 0.9 Allowed 'General case' 0 C--N 1.35 0.618 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 -177.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 148' ' ' LYS . . . . . 0.491 ' NZ ' ' OD1' ' C' ' 152' ' ' ASN . 26.1 mtpp -140.93 117.67 11.0 Favored 'General case' 0 C--O 1.253 1.254 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 173.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -70.03 -4.47 21.12 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 1.3 m -157.72 159.87 37.33 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 124.256 1.979 . . . . 0.0 108.704 175.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.44 77.72 5.99 Favored 'General case' 0 C--O 1.252 1.194 0 O-C-N 118.901 -2.374 . . . . 0.0 105.992 169.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 152' ' ' ASN . . . . . 0.491 ' OD1' ' NZ ' ' C' ' 148' ' ' LYS . 2.1 p-10 -113.85 157.95 21.67 Favored 'General case' 0 N--CA 1.438 -1.027 0 O-C-N 125.775 1.922 . . . . 0.0 108.826 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 45.7 m -67.55 125.82 27.37 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 123.848 0.717 . . . . 0.0 111.895 174.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -84.74 -108.85 0.63 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 104.7 -3.36 . . . . 0.0 104.7 173.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -91.53 -15.34 28.86 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 164.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 156' ' ' ALA . . . . . . . . . . . . . . . -165.54 -93.55 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 159.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 74.93 41.8 32.03 Favored Glycine 0 N--CA 1.437 -1.286 0 CA-C-N 120.876 1.671 . . . . 0.0 110.372 -165.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 15.5 m -80.81 127.94 39.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 O-C-N 120.085 -1.832 . . . . 0.0 108.941 171.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . 0.3 0.0 OUTLIER 43.2 16.31 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 120.613 3.56 . . . . 0.0 120.613 173.5 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 160' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -73.9 125.98 89.83 Favored Pre-proline 0 CA--C 1.532 0.269 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -49.86 -25.63 12.33 Favored 'Trans proline' 0 C--N 1.367 1.548 1 C-N-CA 126.725 4.95 . . . . 0.0 113.367 -176.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 162' ' ' LEU . . . . . . . . . . . . . 13.2 mt -53.61 -20.14 4.8 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 173.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 163' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -82.09 -42.16 19.56 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 123.092 1.425 . . . . 0.0 112.285 175.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -103.11 -41.23 6.16 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 113.18 -1.827 . . . . 0.0 110.099 -153.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 16.0 mttm -74.34 178.92 4.86 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 -164.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -77.43 -56.81 4.22 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-N 113.965 -1.471 . . . . 0.0 108.792 -165.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 45.9 p30 -75.25 -45.84 37.53 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-O 117.383 -1.294 . . . . 0.0 110.591 168.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 168' ' ' THR . . . . . . . . . . . . . 13.6 p -87.54 94.89 9.85 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-N 121.932 2.151 . . . . 0.0 107.829 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -140.18 142.7 35.9 Favored 'General case' 0 C--N 1.353 0.743 0 O-C-N 120.419 -1.426 . . . . 0.0 110.757 -163.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 170' ' ' MET . . . . . . . . . . . . . 78.1 mtm -75.66 112.15 11.72 Favored 'General case' 0 CA--C 1.48 -1.72 0 CA-C-O 123.451 1.596 . . . . 0.0 115.232 174.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 171' ' ' LEU . . . . . . . . . . . . . 22.6 tp -71.95 109.81 6.03 Favored 'General case' 0 C--O 1.254 1.31 0 CA-C-N 114.146 -1.388 . . . . 0.0 107.847 169.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -83.26 68.24 9.56 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 126.194 2.902 . . . . 0.0 112.537 -173.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -153.03 163.42 30.51 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 110.161 -3.2 . . . . 0.0 109.735 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 174' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -74.41 155.32 38.21 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 111.868 -2.166 . . . . 0.0 109.146 173.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.47 -55.74 30.81 Favored 'General case' 0 CA--C 1.496 -1.121 0 CA-C-N 110.292 -3.14 . . . . 0.0 111.91 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.3 -54.44 24.77 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 116.845 -1.55 . . . . 0.0 107.541 176.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 177' ' ' ALA . . . . . . . . . . . . . . . -51.21 -48.98 61.88 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.192 0.997 . . . . 0.0 112.619 -170.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 38.5 m -62.61 -46.46 88.18 Favored 'General case' 0 C--O 1.246 0.877 0 O-C-N 121.004 -1.06 . . . . 0.0 110.746 178.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 179' ' ' VAL . . . . . . . . . . . . . 22.1 t -61.09 -41.81 90.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 O-C-N 119.789 -1.819 . . . . 0.0 108.14 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.97 -37.78 88.67 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.559 -174.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -70.9 -49.72 42.7 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.56 1.073 . . . . 0.0 109.769 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 182' ' ' ILE . . . . . . . . . . . . . 16.8 pt -63.06 -25.35 38.34 Favored 'Isoleucine or valine' 0 C--N 1.363 1.178 0 O-C-N 119.415 -2.053 . . . . 0.0 112.943 -174.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 183' ' ' LEU . . . . . . . . . . . . . 12.8 tp -49.9 -36.6 28.04 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 126.743 2.017 . . . . 0.0 112.97 170.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 18.7 tptt -112.95 -34.75 5.65 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -57.43 -63.99 1.04 Allowed 'General case' 0 C--O 1.257 1.478 0 N-CA-C 118.823 2.897 . . . . 0.0 118.823 172.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 186' ' ' LEU . . . . . 0.426 ' C ' ' HZ1' ' C' ' 28' ' ' LYS 0.327 1.3 pt? . . . . . 0 C--O 1.218 -0.586 0 C-N-CA 127.753 2.421 . . . . 0.0 117.349 -167.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' NAD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C 1001 ' ' NAP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 22.3 t-80 . . . . . 0 N--CA 1.436 -1.134 0 N-CA-C 104.856 -2.275 . . . . 65.739999999999995 104.856 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -69.94 82.09 0.33 Allowed Glycine 0 C--O 1.222 -0.638 0 O-C-N 117.868 -3.02 . . . . 48.659999999999997 112.313 169.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -113.44 109.47 18.72 Favored 'General case' 0 CA--C 1.478 -1.81 0 N-CA-C 103.633 -2.728 . . . . 44.560000000000002 103.633 170.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1003 ' ' ILE . . . . . . . . . . . . . 61.8 mt -80.18 110.51 15.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 112.179 -2.282 . . . . 34.859999999999999 109.187 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -75.83 122.11 6.53 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.122 -1.191 . . . . 30.75 110.122 163.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 16.8 mm -99.58 105.48 34.04 Favored Pre-proline 0 C--O 1.242 0.688 0 N-CA-C 102.567 -3.123 . . . . 32.210000000000001 102.567 176.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -85.8 158.35 10.38 Favored 'Trans proline' 0 N--CA 1.451 -1.007 1 C-N-CA 126.222 4.615 . . . . 32.979999999999997 110.468 175.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1007 ' ' ARG . . . . . . . . . . . . . 1.8 ttp85 -84.98 138.42 32.48 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 103.181 -2.896 . . . . 47.979999999999997 103.181 153.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1008 ' ' GLU . . . . . 0.469 ' CD ' ' HZ1' ' A' 1071 ' ' LYS . 9.6 tp10 -63.44 137.85 58.3 Favored 'General case' 0 N--CA 1.441 -0.89 0 O-C-N 124.41 1.068 . . . . 34.700000000000003 109.398 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -93.82 -27.53 16.4 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 114.725 -1.125 . . . . 53.369999999999997 113.558 -175.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 3.9 mp -52.81 129.2 29.25 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-O 123.018 1.39 . . . . 45.07 111.52 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1011 ' ' THR . . . . . . . . . . . . . 20.7 m -48.19 119.79 3.16 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 113.076 -1.874 . . . . 40.359999999999999 112.137 -171.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 12.5 m120 63.28 -4.67 0.28 Allowed 'General case' 0 C--O 1.243 0.753 0 N-CA-C 117.419 2.377 . . . . 40.609999999999999 117.419 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -88.1 71.97 9.22 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 104.424 -2.436 . . . . 33.759999999999998 104.424 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1014 ' ' THR . . . . . . . . . . . . . 47.1 m -73.29 66.7 0.93 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 125.72 2.676 . . . . 27.890000000000001 111.914 -172.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1015 ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -108.51 163.29 13.36 Favored 'General case' 0 C--O 1.224 -0.262 0 O-C-N 120.002 -1.686 . . . . 29.02 108.942 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1016 ' ' VAL . . . . . . . . . . . . . 39.4 t -137.05 151.59 27.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 101.505 -3.517 . . . . 28.129999999999999 101.505 171.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1017 ' ' ALA . . . . . . . . . . . . . . . -55.18 -54.57 41.63 Favored 'General case' 0 C--O 1.256 1.426 0 N-CA-C 119.067 2.988 . . . . 26.870000000000001 119.067 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -144.25 159.36 42.81 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 120.478 1.49 . . . . 26.77 112.566 -170.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1019 ' ' THR . . . . . . . . . . . . . 19.2 p -84.25 155.86 63.25 Favored Pre-proline 0 C--O 1.245 0.833 0 CA-C-O 117.762 -1.113 . . . . 27.02 111.423 176.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1020 ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -48.5 -40.16 36.92 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 124.059 3.172 . . . . 30.57 114.41 169.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -52.33 -48.98 65.15 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.284 1.216 . . . . 47.810000000000002 114.284 168.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1022 ' ' THR . . . . . . . . . . . . . 2.6 p -75.15 -30.87 60.88 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 124.057 1.885 . . . . 30.77 109.426 -172.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1023 ' ' VAL . . . . . . . . . . . . . 55.5 t -56.98 -52.23 58.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 C-N-CA 125.141 1.376 . . . . 33.590000000000003 108.691 168.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -46.2 -51.62 13.89 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 120.694 1.588 . . . . 53.289999999999999 110.755 172.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -54.38 -52.4 61.79 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.673 1.36 . . . . 46.920000000000002 114.673 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1026 ' ' LEU . . . . . . . . . . . . . 91.7 mt -53.94 -42.79 69.23 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 115.019 1.488 . . . . 37.170000000000002 115.019 177.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 7.1 mp -54.32 -49.9 68.62 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.711 -1.131 . . . . 44.439999999999998 113.442 168.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -62.08 -29.27 70.19 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 120.367 0.127 . . . . 52.579999999999998 111.094 175.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1029 ' ' LEU . . . . . . . . . . . . . 95.3 mt -72.26 -42.33 65.73 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 119.749 -1.844 . . . . 45.689999999999998 109.784 175.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 138.06 -8.04 3.52 Favored Glycine 0 CA--C 1.507 -0.411 0 C-N-CA 120.877 -0.678 . . . . 42.090000000000003 111.949 173.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -80.15 130.68 35.41 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 118.917 -0.563 . . . . 40.719999999999999 112.301 -173.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1032 ' ' THR . . . . . . . . . . . . . 55.8 m -74.11 127.71 33.62 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.707 -1.22 . . . . 37.770000000000003 107.707 176.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1033 ' ' VAL . . . . . . . . . . . . . 94.8 t -109.7 123.58 65.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 104.639 -2.356 . . . . 33.539999999999999 104.639 -177.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -120.1 113.12 20.01 Favored 'General case' 0 C--O 1.249 1.032 0 N-CA-C 105.966 -1.864 . . . . 31.68 105.966 175.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1035 ' ' VAL . . . . . . . . . . . . . 17.3 t -94.34 144.3 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 O-C-N 121.553 -0.717 . . . . 31.52 109.282 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1036 ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -61.44 140.63 58.02 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 123.392 1.568 . . . . 41.039999999999999 111.329 170.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1037 ' ' SER . . . . . . . . . . . . . 1.4 t -61.49 126.75 28.48 Favored 'General case' 0 N--CA 1.44 -0.951 0 O-C-N 120.187 -1.571 . . . . 31.829999999999998 114.201 171.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 83.95 9.96 81.68 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 113.976 -1.465 . . . . 29.359999999999999 112.032 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -79.04 -41.05 29.76 Favored 'General case' 0 C--N 1.347 0.462 0 O-C-N 121.058 -1.26 . . . . 27.780000000000001 110.049 -176.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -52.48 -39.21 52.48 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 122.82 1.233 . . . . 28.91 113.73 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 73.1 tp60 -46.44 -55.63 7.15 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.055 -1.072 . . . . 51.18 113.318 170.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1042 ' ' LEU . . . . . . . . . . . . . 27.0 mt -72.35 -42.28 65.49 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 120.727 -1.233 . . . . 29.91 111.213 175.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1043 ' ' ALA . . . . . . . . . . . . . . . -54.9 -22.5 15.02 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.567 0.699 . . . . 28.539999999999999 112.35 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1044 ' ' SER . . . . . . . . . . . . . 67.4 m 63.53 42.28 6.69 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 124.746 2.212 . . . . 33.060000000000002 108.628 174.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1045 ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -172.31 92.15 0.12 Allowed 'General case' 0 N--CA 1.441 -0.914 1 N-CA-C 97.761 -4.903 . . . . 30.289999999999999 97.761 178.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 1046 ' ' ASP . . . . . 0.443 ' CG ' ' HZ1' ' A' 1048 ' ' LYS . 0.0 OUTLIER -77.67 171.27 15.19 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-N 111.402 -2.635 . . . . 48.619999999999997 116.585 -147.425 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -56.77 -42.07 78.74 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 113.776 -1.556 . . . . 36.740000000000002 113.085 -176.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1048 ' ' LYS . . . . . 0.443 ' HZ1' ' CG ' ' A' 1046 ' ' ASP . 21.7 pttm -69.9 -25.73 63.83 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.543 1.519 . . . . 43.729999999999997 113.661 176.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -71.07 -37.35 72.48 Favored 'General case' 0 CA--C 1.498 -1.04 0 O-C-N 119.862 -1.774 . . . . 32.810000000000002 109.801 170.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1050 ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -57.82 -42.22 83.86 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 120.429 1.468 . . . . 31.859999999999999 112.735 167.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 21.8 t -61.28 -44.9 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 114.578 -1.192 . . . . 33.219999999999999 113.081 174.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -58.17 -37.56 74.95 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.568 0.699 . . . . 50.829999999999998 112.718 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -59.46 -46.35 89.02 Favored 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 121.62 -0.675 . . . . 33.119999999999997 110.062 173.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 128.14 9.48 3.75 Favored Glycine 0 C--N 1.349 1.26 0 C-N-CA 118.905 -1.616 . . . . 35.829999999999998 112.188 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -73.49 146.72 44.69 Favored 'General case' 0 N--CA 1.436 -1.169 0 O-C-N 121.975 -0.72 . . . . 34.82 111.151 -177.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -77.52 136.79 38.35 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 101.932 -3.359 . . . . 49.049999999999997 101.932 171.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1057 ' ' ILE . . . . . . . . . . . . . 25.7 mm -102.46 134.68 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 N-CA-C 107.063 -1.458 . . . . 38.530000000000001 107.063 172.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1058 ' ' VAL . . . . . . . . . . . . . 3.1 m -129.41 143.25 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-O 123.354 1.549 . . . . 42.109999999999999 109.444 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -106.21 128.53 54.01 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 113.452 -1.704 . . . . 58.0 108.379 -165.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 66.49 -138.93 36.56 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-O 123.379 1.544 . . . . 52.119999999999997 114.019 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 8.2 t30 -64.21 -18.94 64.99 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 113.359 -1.42 . . . . 54.75 111.976 -170.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1062 ' ' SER . . . . . . . . . . . . . 49.9 m -63.05 -8.63 7.85 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 116.743 2.127 . . . . 50.340000000000003 116.743 176.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 9.7 p -72.52 -38.13 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-O 121.921 0.867 . . . . 41.460000000000001 110.347 167.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1064 ' ' TRP . . . . . . . . . . . . . 86.1 m95 -73.07 -20.21 61.01 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.013 0.925 . . . . 39.32 110.389 174.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1065 ' ' GLN . . . . . 0.443 ' NE2' HD22 ' A' 1084 ' ' ASN . 92.3 mm-40 -77.21 64.57 2.65 Favored 'General case' 0 C--O 1.224 -0.272 0 O-C-N 120.31 -1.494 . . . . 55.380000000000003 111.36 171.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1066 ' ' SER . . . . . . . . . . . . . 47.8 m -152.17 129.06 10.95 Favored 'General case' 0 N--CA 1.444 -0.734 0 O-C-N 120.69 -1.256 . . . . 41.869999999999997 108.054 -174.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -74.54 4.49 6.01 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 120.093 3.368 . . . . 53.200000000000003 120.093 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.41 134.76 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 104.135 -2.543 . . . . 41.899999999999999 104.135 158.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1069 ' ' ILE . . . . . . . . . . . . . 34.9 mm -128.08 132.95 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 104.677 -2.342 . . . . 38.729999999999997 104.677 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1070 ' ' LEU . . . . . . . . . . . . . 19.8 mt -108.13 79.15 1.23 Allowed 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 125.385 2.517 . . . . 32.439999999999998 112.164 172.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1071 ' ' LYS . . . . . 0.5 ' HZ2' ' CD ' ' A' 1079 ' ' GLU . 8.7 mmmt -65.67 127.55 32.38 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 113.302 -1.772 . . . . 34.649999999999999 111.005 169.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1072 ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -92.23 -14.32 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 CA-C-N 114.131 -1.395 . . . . 31.32 110.623 -160.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 46.9 t30 -149.42 178.23 8.99 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 107.842 -1.17 . . . . 33.939999999999998 107.842 173.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -38.8 146.57 0.31 Allowed Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 127.547 2.339 . . . . 38.039999999999999 116.026 172.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1075 ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -80.8 157.6 21.19 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.932 3.088 . . . . 42.68 119.122 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 42.5 mt -107.77 161.27 15.04 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 105.133 -2.173 . . . . 46.740000000000002 105.133 162.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 25.5 t0 -70.27 -21.9 62.92 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.539 -0.726 . . . . 58.609999999999999 110.758 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 21.8 t0 -54.12 -56.39 18.52 Favored 'General case' 0 C--N 1.344 0.359 0 N-CA-C 108.134 -1.061 . . . . 59.200000000000003 108.134 162.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1079 ' ' GLU . . . . . 0.5 ' CD ' ' HZ2' ' A' 1071 ' ' LYS . 33.0 mt-10 -66.67 -31.22 71.75 Favored 'General case' 0 CA--C 1.501 -0.927 0 O-C-N 121.616 -0.677 . . . . 50.630000000000003 110.543 -174.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1080 ' ' ILE . . . . . . . . . . . . . 82.8 mt -68.25 -31.56 52.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 O-C-N 120.996 -1.065 . . . . 51.479999999999997 111.704 176.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -70.61 -43.24 69.74 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 118.689 -2.507 . . . . 50.280000000000001 110.707 171.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 8.0 mp -69.07 -23.94 64.1 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 114.101 1.148 . . . . 50.210000000000001 114.101 177.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1083 ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.49 116.37 8.15 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 105.41 -2.07 . . . . 49.060000000000002 105.41 175.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1084 ' ' ASN . . . . . 0.443 HD22 ' NE2' ' A' 1065 ' ' GLN . 13.1 m-80 -75.09 150.64 85.74 Favored Pre-proline 0 N--CA 1.432 -1.325 0 CA-C-O 118.561 -0.733 . . . . 51.079999999999998 110.908 171.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -55.91 165.9 3.43 Favored 'Trans proline' 0 C--O 1.249 1.053 0 C-N-CA 123.99 3.127 . . . . 49.729999999999997 113.853 167.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 81.78 -28.38 3.2 Favored Glycine 0 C--N 1.338 0.671 0 O-C-N 120.489 -1.382 . . . . 47.710000000000001 114.052 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1087 ' ' THR . . . . . . . . . . . . . 13.9 m -51.09 129.74 24.64 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 117.654 2.464 . . . . 45.469999999999999 117.654 -174.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1088 ' ' THR . . . . . . . . . . . . . 30.0 m -79.6 90.39 5.14 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 106.713 -1.588 . . . . 42.039999999999999 106.713 161.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1089 ' ' LEU . . . . . . . . . . . . . 63.5 tp -79.85 80.74 6.21 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 105.451 -2.055 . . . . 38.060000000000002 105.451 -174.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 36.2 t -81.44 104.67 10.33 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 N-CA-C 101.964 -3.347 . . . . 37.399999999999999 101.964 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1091 ' ' SER . . . . . . . . . . . . . 60.5 m -155.05 164.76 38.42 Favored 'General case' 0 C--O 1.251 1.145 0 O-C-N 119.816 -1.803 . . . . 36.159999999999997 113.769 -167.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 17.0 t80 -92.11 90.75 7.48 Favored 'General case' 0 C--O 1.246 0.915 0 O-C-N 120.111 -1.618 . . . . 38.939999999999998 107.432 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 30.9 mm -95.15 -30.37 4.1 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 N-CA-C 113.006 0.743 . . . . 42.170000000000002 113.006 -160.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 90.7 m95 56.93 74.09 0.72 Allowed Pre-proline 0 C--O 1.236 0.346 0 C-N-CA 125.635 1.574 . . . . 46.509999999999998 111.89 -171.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -62.51 -56.24 0.71 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 123.536 2.824 . . . . 49.759999999999998 115.815 -167.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -70.34 -11.79 61.14 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 118.138 -2.851 . . . . 52.619999999999997 113.514 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -86.53 -32.11 20.9 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 105.938 -1.875 . . . . 60.740000000000002 105.938 176.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1098 ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -119.83 55.96 3.77 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 117.178 2.288 . . . . 58.189999999999998 117.178 -177.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.41 -42.77 31.89 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.767 2.978 . . . . 54.590000000000003 114.647 -174.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -60.77 -46.47 90.36 Favored 'General case' 0 C--O 1.251 1.171 0 O-C-N 119.943 -1.723 . . . . 63.280000000000001 111.918 174.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1101 ' ' LEU . . . . . . . . . . . . . 20.6 mt -61.7 -33.37 73.9 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.602 -1.181 . . . . 54.75 111.24 176.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1102 ' ' MET . . . . . . . . . . . . . 46.4 mmm -61.58 -48.39 81.17 Favored 'General case' 0 C--O 1.245 0.861 0 O-C-N 121.662 -0.649 . . . . 52.649999999999999 111.657 175.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -60.3 -39.61 87.58 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.318 -0.856 . . . . 66.260000000000005 108.917 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 88.4 mttt -64.61 -32.51 74.2 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 118.865 0.757 . . . . 63.729999999999997 112.006 174.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 34.2 mt -76.15 -26.85 56.7 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 120.308 -1.495 . . . . 54.68 111.877 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -64.48 -47.65 78.16 Favored 'General case' 0 C--O 1.245 0.858 0 O-C-N 120.713 -1.242 . . . . 53.640000000000001 111.705 168.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -56.05 -33.69 65.21 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.397 -1.729 . . . . 67.239999999999995 114.163 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -60.5 -24.79 65.58 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 117.276 2.324 . . . . 65.760000000000005 117.276 170.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 3.7 t30 56.91 67.83 0.94 Allowed 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 123.445 1.593 . . . . 58.710000000000001 111.972 -165.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1110 ' ' VAL . . . . . . . . . . . . . 17.0 m -133.28 151.69 34.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 113.89 -1.505 . . . . 46.630000000000003 108.299 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1111 ' ' THR . . . . . . . . . . . . . 94.8 m -91.55 93.38 8.93 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 123.027 1.394 . . . . 44.130000000000003 110.61 171.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1112 ' ' VAL . . . . . . . . . . . . . 41.3 t -83.55 108.44 16.08 Favored 'Isoleucine or valine' 0 C--O 1.252 1.21 0 O-C-N 119.774 -1.829 . . . . 40.439999999999998 109.806 -178.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1113 ' ' MET . . . . . . . . . . . . . 22.8 mtp -100.97 93.07 5.32 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 111.59 -2.55 . . . . 50.759999999999998 109.122 173.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1114 ' ' ALA . . . . . . . . . . . . . . . -85.51 118.39 25.01 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 119.185 -1.006 . . . . 35.640000000000001 109.324 -173.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1115 ' ' MET . . . . . . . . . . . . . 79.5 mmm -66.04 -29.39 69.74 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 115.611 1.708 . . . . 38.740000000000002 115.611 -175.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.62 -44.48 69.53 Favored 'General case' 0 C--O 1.25 1.093 0 CA-C-O 121.682 0.753 . . . . 40.140000000000001 111.475 165.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1117 ' ' SER . . . . . . . . . . . . . 74.0 m -75.11 14.08 0.6 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 119.487 3.143 . . . . 44.789999999999999 119.487 -176.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1118 ' ' VAL . . . . . . . . . . . . . 13.6 t -72.77 133.67 82.12 Favored Pre-proline 0 C--O 1.215 -0.751 0 O-C-N 118.432 -2.668 . . . . 43.75 107.057 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -60.65 152.24 70.37 Favored 'Trans proline' 0 N--CA 1.443 -1.455 1 C-N-CA 125.785 4.323 . . . . 48.93 115.451 173.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -70.1 12.88 0.19 Allowed 'General case' 0 C--O 1.255 1.39 0 N-CA-C 121.027 3.714 . . . . 62.899999999999999 121.027 -173.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 10.5 pt -86.2 169.35 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 O-C-N 119.088 -2.257 . . . . 57.719999999999999 112.951 -170.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1122 ' ' SER . . . . . . . . . . . . . 69.7 m -63.37 -46.19 87.66 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 124.398 1.079 . . . . 57.259999999999998 113.721 -173.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -59.24 -36.11 74.88 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 122.922 2.601 . . . . 62.899999999999999 112.128 175.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -71.16 -23.63 62.09 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 125.012 1.445 . . . . 49.829999999999998 111.904 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -56.28 -23.69 38.16 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 118.241 2.682 . . . . 52.369999999999997 118.241 -171.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1126 ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.83 -35.12 57.77 Favored 'General case' 0 C--O 1.252 1.198 0 N-CA-C 116.463 2.023 . . . . 42.43 116.463 169.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1127 ' ' LEU . . . . . . . . . . . . . 4.5 mp -78.63 -35.82 44.93 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 113.3 -1.773 . . . . 43.740000000000002 111.504 177.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 13.3 t70 -73.64 123.04 23.27 Favored 'General case' 0 C--O 1.246 0.892 0 O-C-N 120.244 -1.535 . . . . 43.210000000000001 114.764 -165.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -75.39 -27.59 59.15 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 114.231 1.197 . . . . 35.740000000000002 114.231 175.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 69.1 mt -67.19 -11.86 58.49 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 118.679 0.672 . . . . 38.090000000000003 112.524 170.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1131 ' ' SER . . . . . . . . . . . . . 6.4 m -73.86 -77.13 0.11 Allowed 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.274 -0.639 . . . . 36.909999999999997 109.274 153.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1132 ' ' SER . . . . . . . . . . . . . 8.3 m -58.24 -55.71 31.52 Favored 'General case' 0 C--N 1.347 0.491 0 O-C-N 120.899 -1.125 . . . . 35.789999999999999 113.278 -162.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1133 ' ' MET . . . . . . . . . . . . . 18.3 mtp -62.97 -34.75 78.19 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 113.067 0.766 . . . . 30.809999999999999 113.067 -177.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1134 ' ' ALA . . . . . . . . . . . . . . . -66.75 -40.79 88.41 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.536 0.607 . . . . 28.879999999999999 109.506 174.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1135 ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -57.32 -45.04 84.64 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 117.882 -1.056 . . . . 40.759999999999998 111.204 171.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1136 ' ' ILE . . . . . . . . . . . . . 83.7 mt -56.46 -44.63 80.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-O 122.51 1.147 . . . . 31.539999999999999 110.767 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -60.62 -49.2 78.49 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 112.669 -2.06 . . . . 29.870000000000001 112.15 175.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -57.44 -46.78 91.54 Favored Glycine 0 N--CA 1.468 0.819 0 O-C-N 120.806 -1.184 . . . . 28.73 111.393 -177.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 18.4 t80 -65.01 -49.29 70.78 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 118.821 -0.609 . . . . 30.390000000000001 110.391 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1140 ' ' ARG . . . . . 0.462 HH21 ' CD ' ' A' 1144 ' ' GLU . 5.7 tpt180 -70.69 -19.26 62.79 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 117.155 -1.818 . . . . 26.09 111.951 -175.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1141 ' ' ALA . . . . . . . . . . . . . . . -69.76 -45.55 67.83 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 106.957 -1.497 . . . . 27.100000000000001 106.957 176.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 28.5 mm -50.45 -44.82 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 C-N-CA 123.588 0.755 . . . . 28.48 111.929 169.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 58.6 t -62.31 -58.94 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 112.797 0.665 . . . . 23.07 112.797 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1144 ' ' GLU . . . . . 0.462 ' CD ' HH21 ' A' 1140 ' ' ARG . 6.0 mm-40 -63.85 -31.51 72.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.839 0.828 . . . . 33.399999999999999 112.562 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -56.88 -54.5 45.85 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 115.859 -2.019 . . . . 24.219999999999999 111.554 164.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -58.4 -22.91 55.69 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 116.019 1.859 . . . . 24.890000000000001 116.019 174.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -70.0 -54.23 14.13 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 105.827 -1.916 . . . . 26.73 105.827 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1148 ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -97.49 21.6 10.0 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 116.955 2.205 . . . . 39.960000000000001 116.955 176.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1149 ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -71.92 136.49 46.89 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 106.938 -1.504 . . . . 25.870000000000001 106.938 177.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1150 ' ' GLY . . . . . . . . . . . . . . . -74.66 -52.75 6.99 Favored Glycine 0 CA--C 1.502 -0.73 0 O-C-N 127.262 2.851 . . . . 19.280000000000001 109.916 170.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1151 ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -101.17 -164.93 1.15 Allowed 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 120.8 -1.412 . . . . 39.899999999999999 113.768 -170.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1152 ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -107.23 141.21 38.9 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 120.466 -1.396 . . . . 29.440000000000001 109.129 -170.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1153 ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -65.22 -58.67 5.39 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 117.804 -3.06 . . . . 32.600000000000001 110.181 169.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1154 ' ' THR . . . . . . . . . . . . . 3.0 m -71.75 116.54 12.24 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 124.412 1.07 . . . . 34.640000000000001 111.234 -172.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -64.39 96.03 0.19 Allowed Glycine 0 CA--C 1.547 2.04 0 N-CA-C 106.253 -2.739 . . . . 37.140000000000001 106.253 165.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -136.1 -158.28 0.86 Allowed 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 118.935 -0.555 . . . . 40.57 112.191 -175.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1157 ' ' ILE . . . . . . . . . . . . . 3.3 tp -155.41 125.68 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 O-C-N 119.615 -1.928 . . . . 44.609999999999999 110.22 -159.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1158 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.74 -160.76 1.18 Allowed 'General case' 0 C--O 1.253 1.245 0 N-CA-C 105.436 -2.061 . . . . 40.700000000000003 105.436 176.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -48.29 -31.97 6.71 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 119.138 -2.226 . . . . 40.25 116.774 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -64.58 -11.65 36.94 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-O 117.929 -1.034 . . . . 38.469999999999999 113.335 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . 76.8 -117.48 4.91 Favored Glycine 0 N--CA 1.432 -1.617 0 N-CA-C 107.771 -2.132 . . . . 37.609999999999999 107.771 -171.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1162 ' ' LYS . . . . . 0.477 ' HZ3' ' CD ' ' C' ' 95' ' ' GLU . 7.1 tttp -67.89 108.2 2.93 Favored 'General case' 0 CA--C 1.482 -1.672 0 N-CA-C 107.306 -1.368 . . . . 48.899999999999999 107.306 171.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1163 ' ' VAL . . . . . . . . . . . . . 38.8 t -82.13 106.17 5.9 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 102.843 -3.021 . . . . 36.520000000000003 102.843 163.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1164 ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -65.38 122.21 9.85 Favored 'Trans proline' 0 N--CA 1.443 -1.443 0 C-N-CA 124.504 3.47 . . . . 35.079999999999998 116.688 -171.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1165 ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -68.14 156.17 66.78 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 N-CA-C 118.454 2.444 . . . . 35.329999999999998 118.454 -177.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -62.92 122.68 16.59 Favored 'General case' 0 N--CA 1.417 -2.098 0 CA-C-N 113.448 -1.705 . . . . 34.689999999999998 112.779 169.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1167 ' ' LYS . . . . . . . . . . . . . 99.0 mttt -93.84 114.35 26.58 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 104.974 -2.232 . . . . 45.359999999999999 104.974 164.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 59.8 t -99.89 134.53 39.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 103.967 -2.605 . . . . 31.710000000000001 103.967 -173.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1169 ' ' MET . . . . . . . . . . . . . 46.2 ttp -118.64 105.95 12.11 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 106.416 -1.698 . . . . 42.280000000000001 106.416 168.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 38.2 t -78.29 126.4 38.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 107.788 -1.19 . . . . 30.510000000000002 107.788 168.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 61.8 mt -112.41 126.16 69.77 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 108.787 -0.82 . . . . 31.870000000000001 108.787 171.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 79.6 79.65 0.82 Allowed Glycine 0 CA--C 1.536 1.346 0 N-CA-C 108.65 -1.78 . . . . 34.539999999999999 108.65 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1173 ' ' ALA . . . . . . . . . . . . . . . -85.87 89.43 7.77 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 125.568 2.604 . . . . 32.509999999999998 110.109 -172.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -113.35 -147.82 9.98 Favored Glycine 0 C--O 1.246 0.906 0 CA-C-N 110.788 -2.915 . . . . 29.899999999999999 108.882 174.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1175 ' ' VAL . . . . . . . . . . . . . 2.7 t -75.57 -37.35 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 119.261 1.531 . . . . 33.109999999999999 109.706 -175.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -55.77 -39.87 71.81 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 120.917 -1.115 . . . . 28.100000000000001 112.139 165.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -57.35 -49.4 73.06 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-O 118.738 -1.035 . . . . 28.539999999999999 110.572 174.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1178 ' ' LEU . . . . . . . . . . . . . 53.3 mt -56.37 -47.1 79.58 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 117.987 0.894 . . . . 31.219999999999999 110.588 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -57.28 -46.75 82.81 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 114.085 1.142 . . . . 28.98 114.085 177.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -64.02 -41.65 97.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.284 -0.871 . . . . 27.829999999999998 111.026 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1181 ' ' ILE . . . . . . . . . . . . . 92.2 mt -63.86 -46.23 94.84 Favored 'Isoleucine or valine' 0 C--N 1.361 1.085 0 CA-C-O 119.75 -0.167 . . . . 30.25 110.717 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -58.8 -54.54 37.1 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 108.64 -1.784 . . . . 29.59 108.64 -177.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -51.94 -56.1 16.25 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 118.115 0.958 . . . . 30.289999999999999 113.309 176.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -63.51 -44.49 94.15 Favored 'General case' 0 C--O 1.254 1.3 0 N-CA-C 115.274 1.583 . . . . 30.469999999999999 115.274 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -60.21 -53.25 59.93 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 124.624 1.17 . . . . 42.409999999999997 109.284 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1186 ' ' SER . . . . . . . . . . . . . 85.2 p -57.5 -40.67 79.17 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 120.557 1.526 . . . . 39.380000000000003 115.032 175.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 5.6 mt -60.6 -21.57 62.8 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 114.71 1.374 . . . . 36.18 114.71 169.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 93.96 32.75 7.35 Favored Glycine 0 C--O 1.24 0.477 0 CA-C-O 123.085 1.38 . . . . 33.780000000000001 110.905 170.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -96.35 168.94 10.26 Favored 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 121.78 -0.836 . . . . 33.93 109.393 176.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 8.4 mt -93.9 109.11 21.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 102.511 -3.144 . . . . 38.740000000000002 102.511 -176.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 5.8 t -97.74 131.81 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 118.831 -1.148 . . . . 33.090000000000003 109.769 -170.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1192 ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -123.76 151.21 43.51 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 104.054 -2.573 . . . . 38.920000000000002 104.054 175.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -143.59 147.91 35.1 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 108.382 -0.97 . . . . 35.32 108.382 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 5.9 t80 -133.18 132.63 41.8 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.006 -1.85 . . . . 39.350000000000001 106.006 -178.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 9.0 t0 -156.74 154.5 30.09 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 105.526 -2.027 . . . . 40.460000000000001 105.526 170.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1196 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.28 -40.78 81.72 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 120.138 -0.625 . . . . 45.939999999999998 109.88 175.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1197 ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -71.61 112.15 12.97 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 124.235 1.014 . . . . 56.020000000000003 113.516 -168.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1198 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -60.87 -14.78 34.32 Favored 'Trans proline' 0 C--N 1.325 -0.69 0 C-N-CA 124.775 3.65 . . . . 51.270000000000003 116.411 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -69.97 -58.96 3.23 Favored 'General case' 0 C--N 1.356 0.859 0 O-C-N 120.231 -1.543 . . . . 59.100000000000001 111.561 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 17.5 m -53.29 -25.02 9.38 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.897 0 N-CA-C 113.262 0.838 . . . . 51.060000000000002 113.262 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 86.4 tttt -41.14 -38.3 1.05 Allowed 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 126.593 1.957 . . . . 57.380000000000003 114.863 169.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -66.45 -57.93 6.33 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 115.792 -2.051 . . . . 62.409999999999997 111.915 172.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -57.18 -28.62 62.98 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 123.924 3.056 . . . . 57.780000000000001 116.309 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 49.8 t -58.5 -60.51 2.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 O-C-N 121.555 -0.716 . . . . 46.380000000000003 109.924 168.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -69.92 -49.18 54.53 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 105.958 -1.867 . . . . 50.700000000000003 105.958 -170.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1206 ' ' SER . . . . . . . . . . . . . 45.8 m -45.75 -46.83 15.36 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.689 1.737 . . . . 49.979999999999997 115.689 169.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1207 ' ' MET . . . . . . . . . . . . . 18.2 mtp -73.21 -11.22 60.44 Favored 'General case' 0 CA--C 1.504 -0.79 0 O-C-N 119.024 -2.298 . . . . 52.990000000000002 113.06 175.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 105.27 64.95 0.66 Allowed Glycine 0 N--CA 1.439 -1.136 0 N-CA-C 109.931 -1.268 . . . . 47.659999999999997 109.931 166.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -152.81 144.52 23.53 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.099 -1.05 . . . . 44.770000000000003 110.147 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -75.49 133.19 41.11 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 105.738 -1.949 . . . . 47.640000000000001 105.738 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1211 ' ' PHE . . . . . . . . . . . . . 35.1 t80 -99.22 105.93 18.02 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 117.075 -1.85 . . . . 45.659999999999997 108.974 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 55.6 mt -67.13 111.31 3.84 Favored 'General case' 0 C--O 1.252 1.229 0 CA-C-O 123.405 1.574 . . . . 46.060000000000002 109.9 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -79.18 165.37 23.37 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 113.379 -1.737 . . . . 60.219999999999999 115.318 174.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 8.4 mp -72.25 104.99 3.85 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-N 112.827 -1.988 . . . . 57.25 107.241 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 23.4 t70 -74.13 99.02 3.26 Favored 'General case' 0 CA--C 1.497 -1.071 0 O-C-N 118.416 -2.678 . . . . 64.430000000000007 106.617 166.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 14.5 t80 . . . . . 0 CA--C 1.54 0.558 0 CA-C-N 111.055 -2.793 . . . . 66.900000000000006 108.203 175.518 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 N--CA 1.425 -1.678 0 CA-C-O 121.843 0.83 . . . . 39.090000000000003 109.865 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -65.57 -29.38 75.03 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 126.927 2.203 . . . . 39.32 111.123 -169.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.7 -53.25 9.62 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 118.995 1.398 . . . . 39.299999999999997 107.546 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -55.6 -41.63 73.69 Favored 'General case' 0 C--O 1.211 -0.936 0 N-CA-C 113.358 0.873 . . . . 36.299999999999997 113.358 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -51.21 -64.77 0.7 Allowed 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 114.093 1.145 . . . . 37.380000000000003 114.093 162.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -63.62 -24.03 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 116.731 2.123 . . . . 39.109999999999999 116.731 -171.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1230 ' ' MET . . . . . . . . . . . . . 33.7 mmt -79.91 -23.57 41.7 Favored 'General case' 0 C--O 1.241 0.644 0 O-C-N 120.964 -1.085 . . . . 49.590000000000003 112.522 178.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1231 ' ' SER . . . . . . . . . . . . . 12.6 p -89.47 137.88 31.94 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 120.484 3.512 . . . . 43.68 120.484 -163.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -41.4 -45.58 3.14 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 117.457 2.392 . . . . 55.57 117.457 -174.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -73.01 -32.98 65.48 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 120.317 -1.489 . . . . 44.939999999999998 114.432 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -64.44 -53.9 41.03 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 106.804 -1.554 . . . . 42.039999999999999 106.804 172.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 35.9 mt -56.47 -27.5 24.93 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 N-CA-C 114.905 1.446 . . . . 46.280000000000001 114.905 173.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -59.08 -56.11 26.46 Favored 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 121.221 -0.924 . . . . 47.869999999999997 111.585 170.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -59.91 -52.92 63.35 Favored 'General case' 0 CA--C 1.496 -1.096 0 O-C-N 127.028 2.705 . . . . 41.609999999999999 111.339 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -48.68 -48.21 40.19 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 123.851 0.861 . . . . 50.649999999999999 112.316 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1239 ' ' MET . . . . . . . . . . . . . 28.4 ttm -55.02 -44.04 74.24 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 124.583 1.177 . . . . 48.869999999999997 109.149 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -72.07 -30.33 65.02 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.337 -0.945 . . . . 54.799999999999997 113.493 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.9 -43.54 98.36 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 118.833 -1.147 . . . . 43.210000000000001 113.824 169.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -62.15 -43.61 98.45 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.552 1.158 . . . . 38.659999999999997 109.37 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -57.15 -52.95 63.24 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.605 0.595 . . . . 37.920000000000002 112.605 171.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -54.35 -29.54 48.6 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 114.046 1.128 . . . . 37.280000000000001 114.046 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -85.31 -40.02 17.02 Favored 'General case' 0 C--N 1.315 -0.902 0 O-C-N 123.736 0.647 . . . . 43.07 110.588 174.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -66.49 -15.5 63.42 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 116.742 2.127 . . . . 38.299999999999997 116.742 -158.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1247 ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -87.05 -18.46 30.52 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 113.391 -1.731 . . . . 47.600000000000001 113.792 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -105.33 -45.53 4.45 Favored 'General case' 0 C--N 1.358 0.968 0 O-C-N 120.435 -1.415 . . . . 45.420000000000002 112.839 165.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1249 ' ' VAL . . . . . . . . . . . . . 31.4 m -64.67 148.14 12.07 Favored 'Isoleucine or valine' 0 C--N 1.345 0.382 0 CA-C-O 123.221 1.486 . . . . 36.259999999999998 114.256 -175.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1250 ' ' ASP . . . . . 0.505 ' CG ' ' HZ3' ' A' 1276 ' ' LYS . 3.8 m-20 -91.37 -71.97 0.61 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.718 1.247 . . . . 33.039999999999999 111.036 -176.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1251 ' ' ILE . . . . . . . . . . . . . 37.4 mm -97.68 101.29 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.946 0 C-N-CA 117.462 -1.695 . . . . 31.399999999999999 107.776 -171.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1252 ' ' ILE . . . . . . . . . . . . . 68.0 mt -77.09 94.15 1.25 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 106.563 -1.643 . . . . 29.420000000000002 106.563 166.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 2.0 t -81.3 98.61 4.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 104.5 -2.408 . . . . 30.370000000000001 104.5 175.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1254 ' ' THR . . . . . . . . . . . . . 22.3 m -86.76 82.16 7.94 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 124.587 2.137 . . . . 35.719999999999999 105.914 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1255 ' ' THR . . . . . . . . . . . . . 1.9 p -73.8 5.11 4.34 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 120.067 3.358 . . . . 36.0 120.067 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1256 ' ' ALA . . . . . . . . . . . . . . . -85.64 63.03 7.83 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 124.105 1.907 . . . . 40.93 112.76 -170.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 57.1 tp -70.6 91.72 0.81 Allowed 'General case' 0 C--N 1.353 0.733 0 N-CA-C 103.546 -2.761 . . . . 47.82 103.546 172.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 39.5 mm -87.08 108.15 17.63 Favored Pre-proline 0 C--O 1.22 -0.489 0 N-CA-C 104.14 -2.541 . . . . 52.700000000000003 104.14 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -56.63 109.52 0.46 Allowed 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 124.398 3.399 . . . . 54.130000000000003 116.34 -170.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 78.34 16.32 79.69 Favored Glycine 0 N--CA 1.461 0.343 0 CA-C-N 112.025 -2.352 . . . . 54.619999999999997 111.945 174.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 92.1 mttt -125.78 141.72 40.11 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 119.628 1.714 . . . . 55.740000000000002 109.022 -176.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -66.46 97.85 0.38 Allowed 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 123.299 2.666 . . . . 51.149999999999999 107.031 172.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -56.58 125.02 65.8 Favored Pre-proline 0 N--CA 1.433 -1.294 0 CA-C-O 117.375 -1.298 . . . . 46.060000000000002 112.519 176.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -50.15 128.39 22.35 Favored 'Trans proline' 0 C--O 1.25 1.09 1 C-N-CA 126.622 4.881 . . . . 41.079999999999998 112.645 -166.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -61.7 97.06 0.07 Allowed 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.933 -1.03 . . . . 47.420000000000002 110.408 172.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 83.4 mt -94.77 -54.54 3.44 Favored 'General case' 0 N--CA 1.434 -1.23 0 O-C-N 120.693 -1.254 . . . . 39.219999999999999 109.68 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 12.3 mt -78.46 104.36 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 107.937 -1.135 . . . . 42.5 107.937 -172.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1268 ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.54 148.56 48.44 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 119.078 2.992 . . . . 37.840000000000003 119.078 175.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 40.6 mtt180 -52.28 -59.45 4.38 Favored 'General case' 0 C--O 1.248 0.996 0 N-CA-C 117.159 2.281 . . . . 54.799999999999997 117.159 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.55 -27.01 68.96 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 118.819 0.736 . . . . 54.359999999999999 111.919 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1271 ' ' MET . . . . . . . . . . . . . 59.5 ttm -68.45 -36.76 79.47 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.986 1.314 . . . . 39.520000000000003 111.704 175.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1272 ' ' VAL . . . . . . . . . . . . . 92.3 t -63.25 -47.94 89.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 N-CA-C 107.503 -1.295 . . . . 38.25 107.503 171.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -57.6 -26.16 61.13 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 113.731 1.012 . . . . 40.770000000000003 113.731 175.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1274 ' ' SER . . . . . . . . . . . . . 5.1 m -85.67 -8.24 58.33 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 121.261 1.846 . . . . 36.579999999999998 114.945 173.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1275 ' ' MET . . . . . . . . . . . . . 87.1 mtp -60.76 165.19 4.11 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 116.521 2.045 . . . . 36.75 116.521 176.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1276 ' ' LYS . . . . . 0.505 ' HZ3' ' CG ' ' A' 1250 ' ' ASP . 35.9 ttpt -67.47 144.47 55.69 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 122.514 1.149 . . . . 46.109999999999999 111.585 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1277 ' ' ALA . . . . . . . . . . . . . . . -60.25 139.89 57.34 Favored 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 124.423 1.089 . . . . 33.520000000000003 109.008 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 76.43 -0.79 63.14 Favored Glycine 0 CA--C 1.538 1.479 0 O-C-N 119.943 -1.723 . . . . 31.27 113.267 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1279 ' ' SER . . . . . . . . . . . . . 47.0 m -74.56 160.53 30.76 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 118.771 -2.605 . . . . 32.950000000000003 109.37 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1280 ' ' VAL . . . . . . . . . . . . . 82.9 t -127.49 135.88 62.05 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 O-C-N 119.776 -1.828 . . . . 27.43 108.38 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1281 ' ' ILE . . . . . . . . . . . . . 83.7 mt -108.62 98.62 7.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 103.193 -2.891 . . . . 30.300000000000001 103.193 169.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -85.42 97.28 5.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.577 -1.268 . . . . 28.629999999999999 107.577 171.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 19.6 t0 -87.83 109.39 19.72 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.019 -1.474 . . . . 36.270000000000003 107.019 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1284 ' ' LEU . . . . . . . . . . . . . 25.4 mt -74.98 -28.96 60.76 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 112.909 -1.95 . . . . 38.57 115.214 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -65.99 -53.18 42.16 Favored 'General case' 0 C--O 1.218 -0.569 0 O-C-N 120.304 -1.497 . . . . 37.560000000000002 110.098 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . 38.02 -74.81 0.0 OUTLIER 'General case' 0 N--CA 1.413 -2.291 0 C-N-CA 128.511 2.724 . . . . 40.329999999999998 116.172 176.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -63.07 -47.32 83.46 Favored 'General case' 0 N--CA 1.482 1.175 0 O-C-N 120.365 -1.46 . . . . 56.850000000000001 109.634 173.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 5.5 m120 -72.83 70.1 0.97 Allowed 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 124.718 1.261 . . . . 45.859999999999999 109.43 175.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 74.26 -58.91 2.36 Favored Glycine 0 CA--C 1.538 1.524 0 N-CA-C 117.657 1.823 . . . . 40.310000000000002 117.657 -176.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 84.35 121.79 0.95 Allowed Glycine 0 C--O 1.22 -0.728 0 N-CA-C 108.835 -1.706 . . . . 38.890000000000001 108.835 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1291 ' ' ASN . . . . . . . . . . . . . 24.4 m120 -76.45 -20.6 56.87 Favored 'General case' 0 CA--C 1.492 -1.281 0 CA-C-N 121.26 2.53 . . . . 37.229999999999997 112.324 -176.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1292 ' ' CYS . . . . . . . . . . . . . 36.9 t -85.44 142.99 28.84 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 120.249 -1.532 . . . . 36.5 109.638 170.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1293 ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -74.36 -13.96 60.81 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 116.218 1.932 . . . . 43.32 116.218 169.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -90.03 -4.25 57.5 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 116.018 1.858 . . . . 41.32 116.018 169.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1295 ' ' THR . . . . . . . . . . . . . 52.5 m -65.96 119.22 10.96 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 119.375 -2.078 . . . . 35.299999999999997 110.971 -175.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 48.4 t -95.53 112.26 58.32 Favored Pre-proline 0 C--O 1.248 1.015 0 N-CA-C 101.575 -3.491 . . . . 34.840000000000003 101.575 171.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -55.86 104.54 0.13 Allowed 'Trans proline' 0 C--O 1.22 -0.408 0 C-N-CA 124.114 3.21 . . . . 33.509999999999998 111.902 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 112.23 9.77 19.22 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 113.561 -1.654 . . . . 32.189999999999998 111.048 172.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -132.89 162.34 31.85 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 121.248 2.524 . . . . 34.880000000000003 116.451 -163.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1300 ' ' ILE . . . . . . . . . . . . . 80.2 mt -90.76 105.82 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 N-CA-C 101.671 -3.455 . . . . 32.289999999999999 101.671 163.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 35.5 t80 -81.9 110.67 17.4 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 104.73 -2.322 . . . . 37.25 104.73 166.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1302 ' ' THR . . . . . . . . . . . . . 54.0 m -93.44 119.07 32.1 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.136 -1.802 . . . . 35.560000000000002 106.136 175.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1303 ' ' THR . . . . . . . . . . . . . 2.1 m -103.18 142.6 33.88 Favored 'General case' 0 C--O 1.247 0.946 0 N-CA-C 107.643 -1.243 . . . . 36.399999999999999 107.643 -173.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -52.4 -42.6 64.17 Favored 'General case' 0 C--O 1.247 0.921 0 C-N-CA 126.285 1.834 . . . . 52.32 113.445 -168.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 38.3 p-10 -61.07 -22.0 64.19 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 115.628 1.714 . . . . 40.039999999999999 115.628 175.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 120.56 0.11 12.37 Favored Glycine 0 N--CA 1.413 -2.891 0 C-N-CA 120.333 -0.937 . . . . 36.960000000000001 111.223 177.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1307 ' ' VAL . . . . . . . . . . . . . 71.0 t -82.53 131.51 33.6 Favored 'Isoleucine or valine' 0 C--N 1.347 0.493 0 O-C-N 118.452 -2.793 . . . . 33.399999999999999 110.147 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1308 ' ' LYS . . . . . . . . . . . . . 26.2 mmtp -99.15 94.91 6.76 Favored 'General case' 0 C--O 1.248 1.0 0 N-CA-C 106.226 -1.768 . . . . 42.909999999999997 106.226 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 24.0 t -76.08 85.88 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.608 0 CA-C-O 122.296 1.046 . . . . 32.289999999999999 109.803 174.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1310 ' ' ILE . . . . . . . . . . . . . 55.0 mt -89.95 95.83 5.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 124.566 2.127 . . . . 30.989999999999998 106.263 -174.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -90.55 71.26 2.06 Favored Glycine 0 N--CA 1.436 -1.364 0 O-C-N 119.515 -1.991 . . . . 28.949999999999999 110.778 171.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1312 ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.65 124.52 35.86 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 119.167 1.483 . . . . 31.690000000000001 111.187 -171.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1313 ' ' THR . . . . . . . . . . . . . 4.5 p -103.71 -21.65 13.67 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 118.862 -1.135 . . . . 34.170000000000002 113.827 -175.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -81.85 24.53 0.61 Allowed 'General case' 0 C--O 1.256 1.432 0 CA-C-O 122.06 0.933 . . . . 36.859999999999999 112.752 -173.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1315 ' ' LEU . . . . . . . . . . . . . 88.3 mt -69.84 -42.52 18.45 Favored Pre-proline 0 N--CA 1.439 -1.012 0 N-CA-C 118.075 2.62 . . . . 34.850000000000001 118.075 -168.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -59.54 -35.58 95.24 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 CA-C-N 123.672 2.347 . . . . 29.149999999999999 113.8 171.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -65.2 -35.72 91.99 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-O 122.165 0.87 . . . . 27.289999999999999 111.413 172.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1318 ' ' ARG . . . . . . . . . . . . . 79.7 mtt-85 -64.38 -3.16 2.68 Favored 'General case' 0 C--O 1.24 0.563 0 O-C-N 120.438 -1.625 . . . . 41.490000000000002 114.697 168.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1319 ' ' LEU . . . . . . . . . . . . . 8.0 tp -143.51 69.53 17.38 Favored Pre-proline 0 N--CA 1.437 -1.114 0 O-C-N 118.487 -2.633 . . . . 27.609999999999999 111.018 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1320 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -53.88 -62.72 0.28 Allowed 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 124.948 3.765 . . . . 25.940000000000001 116.451 -169.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1321 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.4 -22.95 62.17 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 121.361 1.891 . . . . 25.010000000000002 111.407 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1322 ' ' GLN . . . . . . . . . . . . . 29.7 tp60 -75.18 -37.57 61.17 Favored 'General case' 0 C--O 1.217 -0.617 0 O-C-N 120.192 -1.568 . . . . 29.390000000000001 109.088 176.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1323 ' ' SER . . . . . . . . . . . . . 73.6 m -60.4 -66.54 0.51 Allowed 'General case' 0 C--O 1.251 1.149 0 CA-C-O 118.185 -0.912 . . . . 26.469999999999999 109.897 166.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1324 ' ' SER . . . . . . . . . . . . . 14.5 m -45.29 -36.36 4.01 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 116.883 2.179 . . . . 27.780000000000001 116.883 177.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -77.88 -64.96 1.03 Allowed 'General case' 0 C--O 1.216 -0.701 0 O-C-N 119.805 -1.809 . . . . 37.530000000000001 114.723 170.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1326 ' ' LEU . . . . . . . . . . . . . 22.1 mt -70.39 -51.39 29.98 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 120.961 1.71 . . . . 35.710000000000001 113.544 -169.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1327 ' ' TYR . . . . . . . . . . . . . 64.4 t80 -66.14 -46.05 78.86 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 106.779 -1.563 . . . . 31.59 106.779 174.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1328 ' ' GLY . . . . . . . . . . . . . . . -40.42 -52.82 3.58 Favored Glycine 0 CA--C 1.541 1.664 0 CA-C-N 119.994 1.27 . . . . 28.0 113.829 166.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1329 ' ' THR . . . . . . . . . . . . . 1.1 m -79.44 -18.28 52.51 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 117.328 -3.454 . . . . 32.149999999999999 108.353 -173.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1330 ' ' ASN . . . . . . . . . . . . . 29.4 m120 -57.91 -53.96 52.26 Favored 'General case' 0 C--O 1.246 0.893 0 O-C-N 118.344 -2.722 . . . . 34.359999999999999 110.487 167.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1331 ' ' LEU . . . . . . . . . . . . . 11.7 mt -57.0 -47.5 80.69 Favored 'General case' 0 C--N 1.353 0.726 0 CA-C-N 113.63 -1.623 . . . . 33.369999999999997 110.388 175.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1332 ' ' VAL . . . . . . . . . . . . . 59.9 t -58.86 -37.53 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 124.884 1.274 . . . . 35.270000000000003 109.98 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -70.59 -41.75 71.94 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-N 121.801 2.091 . . . . 37.659999999999997 112.475 -176.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1334 ' ' LEU . . . . . . . . . . . . . 60.2 tp -58.74 -53.31 59.85 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 121.51 0.671 . . . . 40.270000000000003 109.669 170.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1335 ' ' LEU . . . . . . . . . . . . . 13.5 mt -60.92 -21.11 63.06 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 115.511 1.671 . . . . 42.5 115.511 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1336 ' ' LYS . . . . . . . . . . . . . 96.1 mttt -65.23 -46.83 79.01 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 118.626 0.648 . . . . 47.810000000000002 109.589 168.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1337 ' ' LEU . . . . . . . . . . . . . 36.7 mt -63.67 -41.22 98.21 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 124.03 1.871 . . . . 49.270000000000003 111.569 178.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1338 ' ' LEU . . . . . . . . . . . . . 10.3 mp -59.74 -41.49 91.05 Favored 'General case' 0 C--N 1.355 0.823 0 CA-C-O 122.923 1.344 . . . . 50.539999999999999 112.624 175.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1339 ' ' CYS . . . . . . . . . . . . . 18.1 t -74.93 82.01 2.18 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 123.734 1.731 . . . . 53.670000000000002 111.905 173.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -58.9 -55.23 37.76 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 112.543 -2.117 . . . . 63.380000000000003 113.229 -175.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -115.57 -0.47 13.03 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 115.351 1.611 . . . . 70.950000000000003 115.351 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1342 ' ' LYS . . . . . . . . . . . . . 31.3 mtmm 56.3 66.41 1.2 Allowed 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 118.716 2.858 . . . . 65.25 118.716 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1343 ' ' ASP . . . . . . . . . . . . 0.462 0.0 OUTLIER 87.79 -73.96 0.01 OUTLIER 'General case' 0 C--N 1.359 0.987 3 O-C-N 113.169 -5.957 . . . . 64.530000000000001 120.278 -10.645 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A 1344 ' ' GLY . . . . . . . . . . . . . . . 68.55 46.6 61.53 Favored Glycine 0 C--O 1.257 1.553 0 O-C-N 120.764 -1.21 . . . . 59.719999999999999 115.562 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -78.81 149.33 32.61 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 115.729 1.751 . . . . 64.090000000000003 115.729 176.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1346 ' ' ILE . . . . . . . . . . . . . 2.8 mp -85.04 86.69 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 N-CA-C 100.847 -3.76 . . . . 58.82 100.847 170.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1347 ' ' THR . . . . . . . . . . . . . 9.7 m -93.2 91.94 7.51 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 123.57 1.652 . . . . 54.960000000000001 113.859 172.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1348 ' ' VAL . . . . . . . . . . . . . 10.4 t -88.01 93.15 4.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 101.294 -3.595 . . . . 55.640000000000001 101.294 174.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 21.5 t70 -86.36 133.17 33.81 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-O 123.476 1.608 . . . . 61.450000000000003 107.806 169.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -99.88 -8.95 23.42 Favored 'General case' 0 N--CA 1.442 -0.838 0 O-C-N 119.991 -1.693 . . . . 58.630000000000003 113.127 176.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -73.36 -35.08 65.92 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-N 115.551 -0.75 . . . . 62.060000000000002 112.767 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 7.3 t70 -82.75 125.53 31.37 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.537 -1.283 . . . . 54.07 107.537 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 27.2 m -55.61 -30.79 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 113.53 -1.668 . . . . 50.68 114.088 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1354 ' ' VAL . . . . . . . . . . . . 0.251 6.0 m -71.03 -49.66 47.8 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 C-N-CA 118.955 -1.098 . . . . 47.68 112.374 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1355 ' ' ILE . . . . . . . . . . . . . 72.0 mt -71.36 -37.7 66.25 Favored 'Isoleucine or valine' 0 C--O 1.253 1.241 0 N-CA-C 108.623 -0.881 . . . . 48.490000000000002 108.623 -173.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 46.5 tpt85 -57.36 -33.38 67.73 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 113.56 0.948 . . . . 48.270000000000003 113.56 167.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -65.72 -52.54 37.7 Favored Glycine 0 N--CA 1.436 -1.357 0 C-N-CA 123.52 0.581 . . . . 43.530000000000001 112.486 172.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1358 ' ' VAL . . . . . . . . . . . . . 3.5 t -66.18 -37.93 80.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 107.401 -1.333 . . . . 45.119999999999997 107.401 -175.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1359 ' ' THR . . . . . . . . . . . . . 30.3 m -76.43 87.74 3.19 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 119.869 -1.77 . . . . 42.939999999999998 111.228 -174.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 33.4 m -77.93 -31.43 16.89 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 O-C-N 121.025 -1.047 . . . . 43.259999999999998 110.647 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1361 ' ' ILE . . . . . . . . . . . . . 94.8 mt -128.56 119.62 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 N-CA-C 105.844 -1.91 . . . . 45.659999999999997 105.844 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1362 ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -103.45 120.29 40.53 Favored 'General case' 0 C--N 1.364 1.209 0 CA-C-N 123.445 2.838 . . . . 61.340000000000003 106.365 174.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 36.01 48.5 0.52 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 112.14 -2.3 . . . . 49.759999999999998 115.999 -177.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 89.23 12.73 62.89 Favored Glycine 0 C--O 1.222 -0.603 0 CA-C-O 116.944 -2.031 . . . . 50.0 113.062 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -122.83 127.07 48.56 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 102.322 -3.214 . . . . 56.920000000000002 102.322 172.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1366 ' ' ILE . . . . . . . . . . . . . 43.5 mt -73.75 92.89 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 CA-C-O 123.01 1.386 . . . . 52.780000000000001 109.184 -176.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1367 ' ' THR . . . . . . . . . . . . . 6.9 p -76.55 -5.69 48.74 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 123.55 1.643 . . . . 49.439999999999998 114.609 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 20.1 t90 -60.42 143.56 89.48 Favored Pre-proline 0 N--CA 1.44 -0.931 0 CA-C-O 116.227 -1.844 . . . . 52.380000000000003 110.365 171.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -81.37 -163.88 3.55 Favored 'Cis proline' 0 C--O 1.248 1.005 0 CA-C-N 123.417 2.256 . . . . 46.939999999999998 112.571 -6.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -129.14 158.3 73.32 Favored Pre-proline 0 N--CA 1.428 -1.561 0 CA-C-O 117.188 -1.387 . . . . 45.909999999999997 108.742 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1371 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -47.28 120.83 4.69 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 124.901 3.734 . . . . 46.390000000000001 111.216 170.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -65.66 -41.26 15.17 Favored 'Trans proline' 0 CA--C 1.557 1.64 0 C-N-CA 125.076 3.851 . . . . 46.719999999999999 112.077 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.228 -4.699 0 CA-C-N 121.508 1.958 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 20.2 m80 . . . . . 0 N--CA 1.425 -1.697 0 N-CA-C 105.958 -1.867 . . . . 63.439999999999998 105.958 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -93.94 57.36 2.43 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 119.485 -2.009 . . . . 51.740000000000002 107.449 173.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1000 ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -81.46 118.45 22.72 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 106.792 -1.559 . . . . 54.07 106.792 -167.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 72.78 18.97 79.13 Favored Glycine 0 C--O 1.224 -0.529 0 CA-C-N 114.716 -1.129 . . . . 39.219999999999999 111.927 -168.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1002 ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -100.6 124.93 46.85 Favored 'General case' 0 C--O 1.256 1.419 0 CA-C-N 121.387 2.594 . . . . 38.119999999999997 109.994 169.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1003 ' ' ILE . . . . . . . . . . . . . 51.6 mt -81.41 142.61 13.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 108.942 -3.753 . . . . 29.699999999999999 105.029 171.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -112.44 128.56 8.55 Favored Glycine 0 N--CA 1.436 -1.332 0 N-CA-C 106.217 -2.753 . . . . 27.5 106.217 166.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1005 ' ' ILE . . . . . . . . . . . . . 47.6 mm -105.62 99.71 22.92 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 101.166 -3.642 . . . . 24.829999999999998 101.166 173.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -83.88 166.62 13.14 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.672 2.248 . . . . 27.190000000000001 112.148 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 30.2 ttm105 -77.17 143.61 38.95 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 103.039 -2.949 . . . . 41.460000000000001 103.039 167.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1008 ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -63.9 129.8 41.52 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 116.83 2.159 . . . . 26.93 116.83 169.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 48.5 mmm-85 -83.73 -5.7 59.26 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 110.704 -2.953 . . . . 34.479999999999997 111.339 171.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1010 ' ' LEU . . . . . . . . . . . . . 4.1 tp -60.93 126.16 26.37 Favored 'General case' 0 C--O 1.244 0.792 0 O-C-N 120.805 -1.184 . . . . 44.219999999999999 108.919 168.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1011 ' ' THR . . . . . . . . . . . . . 86.9 m -64.93 116.47 6.41 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-O 122.452 1.12 . . . . 40.740000000000002 108.95 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 21.7 t30 63.15 92.16 0.06 Allowed 'General case' 0 C--N 1.339 0.15 0 CA-C-N 112.308 -2.224 . . . . 44.439999999999998 112.546 -174.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1013 ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -137.88 138.72 39.36 Favored 'General case' 0 N--CA 1.415 -2.217 0 CA-C-N 111.147 -2.752 . . . . 29.870000000000001 104.385 176.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1014 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.38 -5.07 22.07 Favored 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 120.247 -1.533 . . . . 25.260000000000002 111.331 177.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 23.6 mtm180 -88.37 148.05 24.44 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 119.904 1.229 . . . . 29.539999999999999 113.517 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1016 ' ' VAL . . . . . . . . . . . . . 4.4 p -113.94 -173.19 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 105.643 -1.984 . . . . 23.550000000000001 105.643 151.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1017 ' ' ALA . . . . . . . . . . . . . . . -106.37 11.75 30.57 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 121.485 1.948 . . . . 23.59 115.686 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1018 ' ' ALA . . . . . . . . . . . . . . . -149.98 156.16 41.22 Favored 'General case' 0 C--O 1.211 -0.939 0 CA-C-O 123.018 1.389 . . . . 24.93 113.677 -176.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1019 ' ' THR . . . . . . . . . . . . . 26.1 p -135.12 163.48 50.81 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 110.812 -2.904 . . . . 28.09 103.308 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -49.97 -39.25 49.91 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.86 2.374 . . . . 28.789999999999999 113.541 168.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 76.4 tttt -67.9 -44.7 76.38 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 112.535 0.568 . . . . 47.280000000000001 112.535 177.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1022 ' ' THR . . . . . . . . . . . . . 13.7 p -67.99 -29.61 68.66 Favored 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 120.223 -1.548 . . . . 30.120000000000001 111.956 178.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1023 ' ' VAL . . . . . . . . . . . . . 69.1 t -56.55 -53.84 35.97 Favored 'Isoleucine or valine' 0 C--N 1.351 0.637 0 N-CA-C 107.107 -1.442 . . . . 32.240000000000002 107.107 170.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1024 ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -55.96 -39.36 71.66 Favored 'General case' 0 C--O 1.215 -0.732 0 N-CA-C 114.324 1.231 . . . . 49.619999999999997 114.324 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -65.97 -43.26 88.4 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 122.496 1.141 . . . . 44.68 109.869 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 42.6 mt -67.82 -32.17 72.52 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 119.103 -2.248 . . . . 35.710000000000001 114.641 173.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1027 ' ' LEU . . . . . . . . . . . . . 98.1 mt -62.9 -39.91 95.96 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.072 -1.017 . . . . 42.18 110.493 172.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 24.8 mttm -62.17 -47.65 83.56 Favored 'General case' 0 C--O 1.251 1.154 0 N-CA-C 109.21 -0.663 . . . . 48.340000000000003 109.21 172.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1029 ' ' LEU . . . . . . . . . . . . . 79.8 mt -64.84 -4.27 4.24 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 116.972 2.212 . . . . 38.689999999999998 116.972 172.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 88.95 20.95 44.37 Favored Glycine 0 N--CA 1.433 -1.551 0 CA-C-O 122.934 1.296 . . . . 32.280000000000001 114.355 166.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -99.05 143.95 28.75 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 123.163 1.459 . . . . 35.939999999999998 108.212 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1032 ' ' THR . . . . . . . . . . . . . 31.9 m -79.04 117.14 19.81 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 106.532 -1.655 . . . . 33.369999999999997 106.532 164.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1033 ' ' VAL . . . . . . . . . . . . . 2.9 t -91.89 108.62 20.27 Favored 'Isoleucine or valine' 0 C--O 1.262 1.741 0 O-C-N 120.599 -1.313 . . . . 29.98 107.708 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -99.84 140.17 34.44 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 107.376 -1.342 . . . . 28.18 107.376 172.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1035 ' ' VAL . . . . . . . . . . . . . 88.3 t -124.26 145.53 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 103.652 -2.721 . . . . 25.82 103.652 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1036 ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.89 129.75 40.88 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.472 -1.24 . . . . 32.439999999999998 112.585 173.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1037 ' ' SER . . . . . . . . . . . . . 12.7 m -57.16 133.9 55.43 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.239 -1.346 . . . . 29.539999999999999 108.884 172.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 88.88 -43.59 3.09 Favored Glycine 0 CA--C 1.498 -0.98 0 O-C-N 117.424 -3.297 . . . . 27.760000000000002 110.886 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1039 ' ' ALA . . . . . . . . . . . . . . . -37.52 -37.37 0.2 Allowed 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 118.304 2.705 . . . . 26.02 118.304 -175.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -62.99 -31.13 79.62 Favored Glycine 0 N--CA 1.42 -2.411 0 C-N-CA 126.029 1.776 . . . . 26.469999999999999 113.62 -175.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -56.9 -40.62 76.6 Favored 'General case' 0 CA--C 1.518 -0.26 0 O-C-N 120.137 -1.802 . . . . 50.979999999999997 114.101 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 29.9 mt -63.5 -44.19 95.04 Favored 'General case' 0 C--O 1.247 0.923 0 O-C-N 121.594 -0.691 . . . . 29.300000000000001 109.502 175.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1043 ' ' ALA . . . . . . . . . . . . . . . -87.3 17.41 4.41 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 120.732 -1.23 . . . . 26.739999999999998 113.491 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1044 ' ' SER . . . . . . . . . . . . . 10.5 m 67.83 46.24 1.29 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 123.909 1.814 . . . . 31.260000000000002 112.191 170.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1045 ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -130.86 162.86 28.68 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 104.79 -2.3 . . . . 33.259999999999998 104.79 175.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 22.9 t70 -104.19 161.3 14.15 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.011 -1.477 . . . . 46.740000000000002 107.011 158.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.55 -39.23 92.94 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 122.399 1.095 . . . . 34.439999999999998 111.094 -175.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.6 -22.01 63.29 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 115.443 1.646 . . . . 48.670000000000002 115.443 -176.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -62.73 -42.94 99.91 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 118.93 -2.356 . . . . 35.259999999999998 110.48 166.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1050 ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -69.82 -36.35 75.55 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 119.622 -1.924 . . . . 32.170000000000002 110.446 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 42.5 t -57.3 -43.34 81.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 116.08 -0.509 . . . . 38.369999999999997 110.585 171.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -71.26 -27.26 63.32 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 118.527 0.603 . . . . 45.770000000000003 111.504 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -73.02 -23.98 60.68 Favored 'General case' 0 N--CA 1.443 -0.775 0 O-C-N 120.723 -1.236 . . . . 37.829999999999998 112.407 174.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 95.15 39.33 4.57 Favored Glycine 0 C--O 1.221 -0.703 0 O-C-N 124.556 1.16 . . . . 35.82 112.85 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -102.21 139.13 38.23 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 124.082 0.953 . . . . 33.770000000000003 110.251 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -73.96 101.02 3.7 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.635 1.174 . . . . 51.020000000000003 107.955 -177.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1057 ' ' ILE . . . . . . . . . . . . . 50.2 mm -88.86 100.4 10.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 119.442 -2.036 . . . . 38.469999999999999 106.08 -172.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 3.2 m -123.87 158.89 29.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 107.267 -1.383 . . . . 39.399999999999999 107.267 -173.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -72.33 167.19 20.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 118.421 -0.799 . . . . 57.07 112.732 -175.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . -52.5 -61.37 6.77 Favored Glycine 0 C--N 1.344 1.021 0 O-C-N 124.695 1.247 . . . . 44.829999999999998 114.129 -164.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 2.3 t30 -70.82 -32.55 69.65 Favored 'General case' 0 C--O 1.223 -0.303 0 O-C-N 119.546 -2.149 . . . . 46.270000000000003 110.486 -173.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1062 ' ' SER . . . . . . . . . . . . . 5.8 m -61.4 -41.2 96.74 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 113.125 -1.852 . . . . 43.469999999999999 113.336 171.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 6.4 p -72.83 -31.11 35.03 Favored 'Isoleucine or valine' 0 C--O 1.26 1.616 0 CA-C-N 121.069 1.759 . . . . 36.979999999999997 109.788 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.53 -31.26 72.37 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-O 122.347 1.07 . . . . 37.899999999999999 112.662 174.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -79.54 80.79 5.88 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 119.594 -1.941 . . . . 46.189999999999998 111.172 174.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1066 ' ' SER . . . . . . . . . . . . . 49.3 m -138.23 168.41 19.8 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 121.645 -0.659 . . . . 37.060000000000002 110.118 176.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1067 ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -79.42 -25.86 41.97 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 124.217 1.007 . . . . 43.950000000000003 109.914 176.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1068 ' ' ILE . . . . . . . . . . . . . 3.5 mp -130.78 138.86 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 O-C-N 119.254 -2.154 . . . . 33.5 108.186 171.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 35.8 mm -124.31 120.72 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 104.036 -2.579 . . . . 30.57 104.036 176.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1070 ' ' LEU . . . . . . . . . . . . . 56.9 mt -103.77 109.48 21.22 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 101.347 -3.575 . . . . 27.66 101.347 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1071 ' ' LYS . . . . . . . . . . . . . 28.1 tttm -135.93 152.01 50.55 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 103.196 -2.89 . . . . 28.399999999999999 103.196 -167.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1072 ' ' VAL . . . . . . . . . . . . . 45.4 t -80.43 -60.92 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.566 0 N-CA-C 107.717 -1.216 . . . . 23.18 107.717 -171.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -114.86 -173.97 2.4 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 120.265 -1.522 . . . . 25.469999999999999 110.803 -166.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -46.93 133.74 8.58 Favored Pre-proline 0 C--N 1.367 1.333 0 C-N-CA 124.602 1.161 . . . . 27.899999999999999 113.62 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -65.62 139.34 57.85 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.892 2.395 . . . . 31.620000000000001 109.526 166.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 9.1 mt -80.65 164.1 23.11 Favored 'General case' 0 C--O 1.246 0.908 0 CA-C-N 113.89 -1.504 . . . . 40.490000000000002 109.672 166.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.81 -34.32 27.17 Favored 'General case' 0 C--O 1.257 1.487 0 CA-C-N 119.821 1.192 . . . . 51.590000000000003 114.144 -175.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -73.18 -42.84 62.28 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 121.254 -0.904 . . . . 42.359999999999999 109.934 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1079 ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -59.88 -35.23 74.4 Favored 'General case' 0 C--O 1.267 1.986 0 C-N-CA 123.805 0.842 . . . . 34.530000000000001 109.834 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1080 ' ' ILE . . . . . . . . . . . . . 97.7 mt -63.33 -43.78 98.76 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 CA-C-O 123.965 1.84 . . . . 33.25 110.268 173.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -65.38 -29.77 70.52 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 118.039 -2.913 . . . . 36.469999999999999 114.852 176.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1082 ' ' LEU . . . . . . . . . . . . . 41.8 mt -64.6 -40.88 96.31 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 112.836 -1.984 . . . . 37.759999999999998 113.663 168.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1083 ' ' LEU . . . . . . . . . . . . . 5.6 mt -59.68 107.34 0.58 Allowed 'General case' 0 CA--C 1.495 -1.169 0 CA-C-O 123.322 1.534 . . . . 37.43 110.209 174.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -95.47 143.06 25.47 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 111.347 -2.66 . . . . 37.700000000000003 108.58 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -52.62 113.86 1.43 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.937 3.092 . . . . 35.509999999999998 109.671 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 128.74 -32.81 3.24 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 112.357 -2.201 . . . . 33.869999999999997 112.433 -173.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1087 ' ' THR . . . . . . . . . . . . . 61.4 m -67.16 139.21 57.45 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-O 123.875 1.798 . . . . 32.5 108.682 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1088 ' ' THR . . . . . . . . . . . . . 7.8 m -98.71 110.61 23.19 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 103.498 -2.778 . . . . 30.219999999999999 103.498 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1089 ' ' LEU . . . . . . . . . . . . . 40.1 tp -95.78 118.67 32.87 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 106.715 -1.587 . . . . 27.239999999999998 106.715 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 4.2 t -118.22 107.1 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 107.44 -1.318 . . . . 25.390000000000001 107.44 176.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1091 ' ' SER . . . . . . . . . . . . . 19.7 m -161.02 163.8 31.37 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.723 -0.672 . . . . 28.809999999999999 112.712 -167.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1092 ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -69.22 105.09 2.38 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-O 123.586 1.66 . . . . 30.780000000000001 106.534 166.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 32.9 mm -95.54 -37.56 7.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 O-C-N 119.883 -1.761 . . . . 30.280000000000001 110.968 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1094 ' ' TRP . . . . . . . . . . . . . 96.4 m95 55.34 60.62 9.22 Favored Pre-proline 0 CA--C 1.55 0.955 0 O-C-N 124.868 1.355 . . . . 34.07 112.496 -173.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -51.68 -51.47 11.11 Favored 'Trans proline' 0 C--O 1.253 1.273 0 C-N-CA 125.207 3.938 . . . . 38.659999999999997 115.466 -171.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -62.98 -28.93 70.43 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-N 120.301 1.41 . . . . 41.32 112.147 176.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 18.6 mp0 -82.75 -22.74 34.25 Favored 'General case' 0 C--O 1.26 1.648 0 N-CA-C 108.066 -1.087 . . . . 51.659999999999997 108.066 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -127.82 57.71 27.66 Favored Pre-proline 0 C--O 1.223 -0.341 0 CA-C-N 120.754 1.615 . . . . 40.32 115.207 -175.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 0.7 OUTLIER -52.46 -37.02 72.16 Favored 'Trans proline' 0 C--O 1.248 0.993 0 C-N-CA 124.871 3.714 . . . . 41.560000000000002 115.116 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -59.66 -57.85 11.16 Favored 'General case' 0 C--O 1.217 -0.624 0 O-C-N 124.744 1.278 . . . . 54.109999999999999 107.69 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1101 ' ' LEU . . . . . . . . . . . . . 9.6 tp -51.27 -44.78 61.88 Favored 'General case' 0 C--O 1.211 -0.964 0 CA-C-O 116.656 -1.64 . . . . 37.880000000000003 109.452 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1102 ' ' MET . . . . . . . . . . . . . 61.1 mmm -55.75 -49.64 72.54 Favored 'General case' 0 C--O 1.252 1.209 0 CA-C-O 123.26 1.505 . . . . 37.539999999999999 113.601 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -39.97 86.73 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 114.211 -1.359 . . . . 47.009999999999998 110.73 -175.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B 1104 ' ' LYS . . . . . . . . . . . . . 43.3 mttm -55.69 -54.42 44.44 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.395 1.078 . . . . 48.68 110.453 174.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1105 ' ' LEU . . . . . . . . . . . . . 41.4 mt -61.57 -29.42 70.01 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 120.35 -1.469 . . . . 32.210000000000001 111.916 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -66.76 -39.54 87.93 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 117.278 -1.344 . . . . 33.729999999999997 111.399 173.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -64.25 -43.26 95.43 Favored 'General case' 0 C--O 1.249 1.04 0 O-C-N 124.36 1.038 . . . . 51.469999999999999 110.394 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1108 ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -67.27 -16.63 64.39 Favored 'General case' 0 C--N 1.309 -1.152 0 O-C-N 125.831 1.957 . . . . 43.899999999999999 114.031 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1109 ' ' ASN . . . . . . . . . . . . . 13.9 m120 59.07 49.76 9.01 Favored 'General case' 0 C--N 1.348 0.533 0 CA-C-O 126.397 2.999 . . . . 44.82 115.957 178.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1110 ' ' VAL . . . . . . . . . . . . . 12.8 m -107.7 163.77 5.34 Favored 'Isoleucine or valine' 0 C--O 1.248 0.992 0 O-C-N 119.517 -1.989 . . . . 30.52 111.528 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1111 ' ' THR . . . . . . . . . . . . . 18.1 m -107.04 97.5 7.27 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 123.61 1.672 . . . . 27.120000000000001 107.547 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1112 ' ' VAL . . . . . . . . . . . . . 70.6 t -97.31 115.46 37.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 112.563 -2.108 . . . . 26.399999999999999 113.457 -170.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1113 ' ' MET . . . . . . . . . . . . . 1.8 mpt? -100.13 118.45 36.5 Favored 'General case' 0 CA--C 1.504 -0.821 0 O-C-N 121.37 -0.831 . . . . 42.920000000000002 108.901 170.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -88.48 104.74 17.09 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 120.013 -0.675 . . . . 24.149999999999999 110.007 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1115 ' ' MET . . . . . . . . . . . . . 72.4 mmm -65.61 -17.84 64.88 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 116.583 2.068 . . . . 29.949999999999999 116.583 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1116 ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -84.73 -38.37 19.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 113.624 -1.625 . . . . 34.530000000000001 109.54 171.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1117 ' ' SER . . . . . . . . . . . . . 70.1 m -97.64 38.45 1.28 Allowed 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 123.44 1.59 . . . . 33.490000000000002 111.819 -176.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1118 ' ' VAL . . . . . . . . . . . . . 12.3 t -77.59 124.52 86.62 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 102.278 -3.23 . . . . 34.020000000000003 102.278 172.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -52.75 153.84 13.81 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.518 2.812 . . . . 38.280000000000001 115.964 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1120 ' ' ARG . . . . . 0.428 HH12 ' CG ' ' B' 1128 ' ' ASP . 0.0 OUTLIER -77.68 47.06 0.58 Allowed 'General case' 0 C--O 1.216 -0.679 0 O-C-N 121.757 -0.589 . . . . 55.049999999999997 110.008 178.113 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B 1121 ' ' ILE . . . . . . . . . . . . . 37.3 pt -119.94 168.86 11.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 O-C-N 119.182 -2.199 . . . . 42.090000000000003 110.146 -172.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1122 ' ' SER . . . . . . . . . . . . . 62.2 m -49.92 -80.23 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 117.618 2.451 . . . . 38.020000000000003 117.618 -161.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1123 ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -66.62 -12.77 59.58 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 124.169 3.168 . . . . 34.289999999999999 114.329 176.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1124 ' ' ALA . . . . . . . . . . . . . . . -67.16 -32.04 72.87 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 117.974 -1.012 . . . . 32.350000000000001 110.005 175.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1125 ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -58.32 -21.9 51.05 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 121.111 1.778 . . . . 47.170000000000002 114.678 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1126 ' ' SER . . . . . . . . . . . . . 10.2 m -71.6 -34.61 70.03 Favored 'General case' 0 C--O 1.246 0.885 0 O-C-N 121.119 -0.988 . . . . 31.710000000000001 111.351 173.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1127 ' ' LEU . . . . . . . . . . . . . 5.6 mp -83.9 -33.37 24.76 Favored 'General case' 0 CA--C 1.487 -1.463 0 N-CA-C 106.878 -1.527 . . . . 37.0 106.878 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1128 ' ' ASP . . . . . 0.428 ' CG ' HH12 ' B' 1120 ' ' ARG . 25.8 t70 -61.85 111.32 1.84 Allowed 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 124.303 2.001 . . . . 40.399999999999999 114.524 -168.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B 1129 ' ' ALA . . . . . . . . . . . . . . . -75.53 -20.62 58.59 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 113.22 -1.809 . . . . 26.559999999999999 109.52 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 17.1 mt -62.81 -40.34 97.07 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 122.294 2.315 . . . . 30.890000000000001 111.336 177.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1131 ' ' SER . . . . . . . . . . . . . 52.7 p -64.33 -53.78 43.47 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 118.051 -0.976 . . . . 29.84 110.782 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1132 ' ' SER . . . . . . . . . . . . . 40.2 m -50.42 -47.23 56.66 Favored 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 124.967 1.307 . . . . 31.91 114.082 172.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1133 ' ' MET . . . . . . . . . . . . . 37.3 mmt -70.43 -33.52 71.42 Favored 'General case' 0 CA--C 1.493 -1.221 0 O-C-N 124.37 1.044 . . . . 25.899999999999999 112.468 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1134 ' ' ALA . . . . . . . . . . . . . . . -67.33 -41.56 85.05 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 121.17 -0.956 . . . . 26.620000000000001 111.92 171.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -56.32 -53.45 57.14 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 108.292 -1.003 . . . . 36.969999999999999 108.292 174.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1136 ' ' ILE . . . . . . . . . . . . . 34.9 mm -52.37 -51.73 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 124.285 1.034 . . . . 32.109999999999999 109.95 174.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -57.13 -42.49 81.01 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 117.078 -1.439 . . . . 24.140000000000001 112.638 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -65.28 -45.22 91.89 Favored Glycine 0 C--O 1.253 1.328 0 CA-C-N 122.405 2.366 . . . . 25.129999999999999 111.33 -174.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 16.0 t80 -63.32 -43.27 98.28 Favored 'General case' 0 C--O 1.21 -1.011 0 CA-C-N 113.241 -1.48 . . . . 32.729999999999997 112.22 171.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1140 ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -70.89 -22.4 62.27 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 119.101 -0.476 . . . . 26.359999999999999 110.0 -176.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1141 ' ' ALA . . . . . . . . . . . . . . . -63.77 -43.98 94.75 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.242 -1.021 . . . . 24.120000000000001 108.242 167.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 16.2 mm -59.31 -47.31 90.92 Favored 'Isoleucine or valine' 0 C--N 1.359 1.004 0 CA-C-O 121.835 0.826 . . . . 23.370000000000001 111.765 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 71.1 t -53.51 -68.33 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.848 0 N-CA-C 113.477 0.917 . . . . 24.960000000000001 113.477 171.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -61.75 -31.14 71.3 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 113.72 1.008 . . . . 32.07 113.72 -172.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1145 ' ' ALA . . . . . . . . . . . . . . . -55.11 -57.42 11.81 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.687 -0.688 . . . . 24.870000000000001 110.36 168.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1146 ' ' ALA . . . . . . . . . . . . . . . -64.49 -19.33 65.51 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 115.895 1.813 . . . . 24.670000000000002 115.895 176.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 86.0 t60 -65.52 -26.66 68.0 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 116.986 -1.483 . . . . 28.579999999999998 112.278 169.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1148 ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -123.89 8.74 8.74 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 123.117 2.69 . . . . 36.82 115.955 170.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1149 ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -65.46 154.07 39.56 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-O 124.255 1.978 . . . . 31.969999999999999 111.877 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B 1150 ' ' GLY . . . . . . . . . . . . . . . -86.39 -32.09 17.39 Favored Glycine 0 N--CA 1.432 -1.613 0 CA-C-N 114.05 -1.432 . . . . 25.489999999999998 112.313 174.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1151 ' ' ARG . . . . . . . . . . . . . 64.4 mtm-85 -119.59 -174.23 2.7 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 115.981 1.845 . . . . 59.840000000000003 115.981 -166.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1152 ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -88.14 145.81 25.74 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-O 118.499 -0.762 . . . . 34.450000000000003 111.873 172.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B 1153 ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -63.16 -52.08 63.85 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 119.17 0.895 . . . . 31.170000000000002 112.294 169.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1154 ' ' THR . . . . . . . . . . . . . 7.6 m -73.88 131.08 41.12 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.896 -1.047 . . . . 33.890000000000001 110.434 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -72.34 81.84 0.58 Allowed Glycine 0 C--N 1.343 0.93 0 O-C-N 119.689 -1.882 . . . . 38.950000000000003 111.029 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -75.27 114.85 14.27 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.556 0.693 . . . . 54.229999999999997 111.794 -173.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 45.1 mm -92.53 104.78 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 1 N-CA-C 99.316 -4.327 . . . . 51.159999999999997 99.316 177.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B 1158 ' ' THR . . . . . . . . . . . . . 1.5 m -115.11 138.88 50.4 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 103.002 -2.962 . . . . 49.609999999999999 103.002 -172.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -52.61 -32.69 42.85 Favored 'General case' 0 C--O 1.248 1.016 0 CA-C-O 123.777 1.751 . . . . 49.049999999999997 115.009 175.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -59.16 -81.04 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 113.303 -1.771 . . . . 47.649999999999999 110.088 162.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . -146.68 155.2 26.42 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 121.366 1.894 . . . . 45.609999999999999 110.035 -174.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 89.0 mttt -89.39 132.12 35.13 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.648 1.213 . . . . 57.460000000000001 108.352 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1163 ' ' VAL . . . . . . . . . . . . . 90.6 t -100.3 128.56 30.16 Favored Pre-proline 0 C--O 1.247 0.925 0 CA-C-N 113.771 -1.559 . . . . 42.93 108.484 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1164 ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -67.22 133.2 29.87 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.568 3.512 . . . . 39.289999999999999 110.689 166.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1165 ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -69.0 161.64 44.99 Favored 'Trans proline' 0 N--CA 1.479 0.629 0 C-N-CA 121.255 1.303 . . . . 34.170000000000002 110.04 -172.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -70.56 111.78 6.33 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 118.04 -1.464 . . . . 31.690000000000001 108.816 172.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1167 ' ' LYS . . . . . . . . . . . . . 86.4 mttt -77.65 87.48 3.94 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.144 -1.428 . . . . 44.780000000000001 107.144 174.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 48.4 t -77.05 94.92 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 114.168 -1.378 . . . . 31.23 108.556 -174.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1169 ' ' MET . . . . . . . . . . . . . 55.5 ttp -86.19 110.37 19.54 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 122.459 1.123 . . . . 37.090000000000003 108.433 177.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 50.7 t -97.59 118.76 44.64 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 N-CA-C 107.611 -1.255 . . . . 30.170000000000002 107.611 -177.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1171 ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.94 95.97 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 103.848 -2.649 . . . . 33.740000000000002 103.848 171.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 115.4 85.18 1.23 Allowed Glycine 0 C--N 1.339 0.707 0 N-CA-C 108.657 -1.777 . . . . 32.590000000000003 108.657 170.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1173 ' ' ALA . . . . . . . . . . . . . . . -84.16 50.33 1.83 Allowed 'General case' 0 C--O 1.255 1.346 0 CA-C-O 124.302 2.001 . . . . 32.420000000000002 110.849 178.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -81.15 -165.56 34.44 Favored Glycine 0 C--N 1.342 0.884 0 O-C-N 118.59 -2.569 . . . . 31.739999999999998 107.754 163.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 19.1 t -51.36 -39.96 22.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 O-C-N 119.304 -2.292 . . . . 31.48 114.352 -176.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1176 ' ' ALA . . . . . . . . . . . . . . . -55.86 -46.82 78.15 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.934 1.087 . . . . 26.120000000000001 113.934 171.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1177 ' ' GLY . . . . . . . . . . . . . . . -68.85 -45.8 62.8 Favored Glycine 0 C--N 1.345 1.046 0 N-CA-C 109.106 -1.598 . . . . 25.73 109.106 -176.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1178 ' ' LEU . . . . . . . . . . . . . 51.4 mt -60.46 -36.36 78.07 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 118.244 -0.884 . . . . 32.590000000000003 108.9 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -68.24 -44.09 76.43 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 119.342 0.973 . . . . 27.719999999999999 110.456 176.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -58.63 -36.64 74.4 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 118.192 -0.908 . . . . 26.030000000000001 108.773 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1181 ' ' ILE . . . . . . . . . . . . . 38.2 mt -61.27 -50.0 82.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 CA-C-N 120.628 1.558 . . . . 28.609999999999999 107.783 171.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -62.67 -19.95 61.14 Favored Glycine 0 CA--C 1.543 1.808 0 CA-C-O 118.363 -1.243 . . . . 25.23 114.108 -173.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -97.96 -56.64 2.43 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 117.993 0.896 . . . . 24.09 109.895 171.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -72.01 -38.5 69.6 Favored 'General case' 0 CA--C 1.509 -0.619 0 O-C-N 119.027 -2.296 . . . . 26.68 115.861 -171.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 22.1 t30 -61.61 -39.02 89.75 Favored 'General case' 0 C--O 1.247 0.966 0 O-C-N 120.589 -1.319 . . . . 36.57 111.429 174.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1186 ' ' SER . . . . . . . . . . . . . 2.0 m -62.33 -38.73 90.62 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 112.952 -1.931 . . . . 28.920000000000002 111.559 174.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1187 ' ' LEU . . . . . . . . . . . . . 4.2 mt -61.02 -31.18 70.81 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 116.038 -0.528 . . . . 29.09 110.914 172.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 111.05 -7.55 29.15 Favored Glycine 0 CA--C 1.525 0.717 0 O-C-N 121.426 -0.796 . . . . 29.260000000000002 111.25 -176.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1189 ' ' ALA . . . . . . . . . . . . . . . -62.05 134.72 56.98 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 122.234 1.016 . . . . 30.16 109.559 175.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 18.3 mt -77.19 94.97 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 104.684 -2.339 . . . . 35.810000000000002 104.684 -174.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1191 ' ' VAL . . . . . . . . . . . . . 40.6 t -78.24 100.23 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 O-C-N 120.242 -1.536 . . . . 31.969999999999999 109.66 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1192 ' ' ARG . . . . . 0.429 HH12 ' CD ' ' B' 1248 ' ' GLU . 98.8 mtt180 -87.07 80.84 8.24 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 124.146 1.927 . . . . 48.159999999999997 108.637 174.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -84.93 144.82 28.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 111.438 -2.619 . . . . 35.890000000000001 111.335 -172.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 82.1 t80 -134.57 145.39 48.65 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.018 -1.475 . . . . 41.880000000000003 107.018 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1195 ' ' ASP . . . . . . . . . . . . . 5.5 t70 -153.03 154.59 35.22 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 103.992 -2.596 . . . . 38.280000000000001 103.992 161.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1196 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.42 -21.19 56.28 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 114.468 -1.242 . . . . 40.619999999999997 110.59 174.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B 1197 ' ' ARG . . . . . . . . . . . . . 40.2 mtm180 -78.06 126.15 84.15 Favored Pre-proline 0 N--CA 1.435 -1.183 0 C-N-CA 120.164 -0.614 . . . . 53.090000000000003 110.978 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -53.04 -46.39 34.29 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 125.273 3.982 . . . . 42.560000000000002 116.611 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 10.6 pm0 -70.24 -13.98 62.41 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 115.787 1.773 . . . . 56.310000000000002 115.787 -161.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1200 ' ' VAL . . . . . . . . . . . . . 26.7 m -74.09 -22.17 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 116.145 -0.48 . . . . 42.909999999999997 111.24 175.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 26.0 tttm -47.83 -56.45 7.45 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 114.549 1.315 . . . . 48.890000000000001 114.549 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -55.7 -42.55 75.4 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 112.716 -2.038 . . . . 51.700000000000003 112.565 174.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1203 ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -64.11 -47.84 78.45 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.308 -0.86 . . . . 52.57 109.4 -174.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1204 ' ' VAL . . . . . . . . . . . . . 55.9 t -64.02 -49.84 79.8 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-O 122.677 1.227 . . . . 33.789999999999999 108.486 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -57.39 -29.78 64.36 Favored 'General case' 0 C--N 1.359 1.007 0 N-CA-C 115.812 1.782 . . . . 36.579999999999998 115.812 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1206 ' ' SER . . . . . . . . . . . . . 43.3 p -71.86 -18.26 62.07 Favored 'General case' 0 C--O 1.248 0.978 0 CA-C-N 119.423 1.011 . . . . 39.609999999999999 110.89 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1207 ' ' MET . . . . . . . . . . . . . 26.1 mtp -87.39 -9.28 55.19 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 120.954 -1.091 . . . . 37.450000000000003 112.469 172.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 68.5 46.74 61.18 Favored Glycine 0 C--O 1.224 -0.484 0 O-C-N 119.319 -2.113 . . . . 31.870000000000001 109.548 -168.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -122.71 146.56 47.38 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 103.623 -2.732 . . . . 35.399999999999999 103.623 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -85.09 116.55 23.53 Favored 'General case' 0 N--CA 1.435 -1.225 0 O-C-N 120.418 -1.426 . . . . 47.890000000000001 109.355 -164.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 70.0 t80 -89.5 120.95 31.26 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 107.982 -1.118 . . . . 45.530000000000001 107.982 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1212 ' ' LEU . . . . . . . . . . . . . 57.8 mt -71.25 115.17 10.09 Favored 'General case' 0 N--CA 1.44 -0.964 0 O-C-N 121.323 -0.861 . . . . 46.329999999999998 109.271 174.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -98.38 141.4 31.3 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 124.7 2.19 . . . . 60.409999999999997 108.904 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 43.7 mt -66.32 161.33 22.64 Favored 'General case' 0 C--O 1.251 1.148 0 CA-C-N 112.2 -2.273 . . . . 57.380000000000003 114.597 168.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 27.0 t70 . . . . . 0 CA--C 1.518 -0.288 0 CA-C-N 114.264 -1.334 . . . . 65.069999999999993 110.19 -178.447 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B 1230 ' ' MET . . . . . 0.428 ' SD ' ' CD2' ' B' 1234 ' ' PHE . 13.8 mmt . . . . . 0 N--CA 1.448 -0.557 1 N-CA-C 98.674 -4.565 . . . . 80.319999999999993 98.674 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B 1231 ' ' SER . . . . . . . . . . . . 0.3 0.1 OUTLIER 63.05 173.77 0.15 Allowed 'General case' 0 C--N 1.356 0.879 2 CA-C-N 127.1 4.5 . . . . 79.920000000000002 119.458 0.628 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -67.01 -166.92 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 115.719 1.748 . . . . 77.909999999999997 115.719 -172.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 71.0 -80.03 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 107.447 -1.316 . . . . 73.879999999999995 107.447 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1234 ' ' PHE . . . . . 0.428 ' CD2' ' SD ' ' B' 1230 ' ' MET . 2.2 m-85 -51.51 -33.45 31.76 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 115.651 1.723 . . . . 68.980000000000004 115.651 171.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 36.1 pt -47.72 -36.5 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 120.271 1.396 . . . . 64.530000000000001 113.12 169.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -62.24 -41.62 98.58 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 120.049 -1.657 . . . . 66.359999999999999 111.011 172.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -67.34 -42.63 83.24 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 119.418 -0.913 . . . . 56.600000000000001 111.533 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -56.18 -51.74 66.94 Favored 'General case' 0 C--O 1.241 0.65 0 O-C-N 124.306 1.003 . . . . 56.789999999999999 111.966 171.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1239 ' ' MET . . . . . . . . . . . . . 10.4 tmm? -56.27 -56.74 17.27 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 118.168 -0.92 . . . . 53.630000000000003 112.976 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -55.56 -36.32 66.69 Favored 'General case' 0 C--N 1.36 1.028 0 CA-C-N 119.428 1.013 . . . . 51.740000000000002 111.111 -177.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 16.2 tp -57.44 -50.77 71.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 121.067 -1.021 . . . . 44.859999999999999 111.475 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -64.81 -39.61 93.87 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 125.99 2.056 . . . . 42.780000000000001 113.03 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -64.94 -23.72 67.31 Favored 'General case' 0 C--N 1.36 1.048 0 N-CA-C 113.574 0.953 . . . . 40.960000000000001 113.574 175.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -82.01 -53.99 5.67 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 118.72 -2.488 . . . . 43.060000000000002 108.898 172.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 61.0 mm-40 -56.32 -31.99 64.23 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 124.748 1.219 . . . . 46.450000000000003 112.861 -176.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -44.46 -34.54 2.1 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 125.435 1.494 . . . . 41.780000000000001 114.885 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 34.3 tptt -63.55 -43.78 96.06 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 124.206 1.955 . . . . 52.200000000000003 111.863 -176.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1248 ' ' GLU . . . . . 0.429 ' CD ' HH12 ' B' 1192 ' ' ARG . 39.1 mt-10 -84.5 -39.91 18.29 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 113.14 -1.846 . . . . 53.549999999999997 114.283 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B 1249 ' ' VAL . . . . . . . . . . . . 0.301 10.6 m -76.94 160.91 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 118.907 2.929 . . . . 34.409999999999997 118.907 -167.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B 1250 ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -117.9 -73.09 0.66 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 124.389 2.042 . . . . 33.380000000000003 110.454 -169.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1251 ' ' ILE . . . . . . . . . . . . . 23.5 mm -98.11 99.69 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 114.0 -1.455 . . . . 29.539999999999999 108.484 -169.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1252 ' ' ILE . . . . . . . . . . . . . 17.5 mt -89.54 96.13 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 105.607 -1.998 . . . . 32.439999999999998 105.607 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1253 ' ' VAL . . . . . . . . . . . . . 96.7 t -83.16 96.51 4.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 102.369 -3.197 . . . . 30.57 102.369 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1254 ' ' THR . . . . . . . . . . . . . 2.4 t -104.99 138.93 40.44 Favored 'General case' 0 N--CA 1.432 -1.339 0 O-C-N 119.877 -1.764 . . . . 35.039999999999999 111.89 -175.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1255 ' ' THR . . . . . . . . . . . . . 40.1 p -134.09 -83.25 0.44 Allowed 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 114.377 -1.283 . . . . 34.619999999999997 108.772 -177.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . 56.72 41.9 27.59 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.254 1.822 . . . . 42.719999999999999 114.777 -170.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 45.8 mt -89.85 93.78 9.56 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-O 123.797 1.761 . . . . 52.43 107.309 -174.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 24.7 mt -90.08 129.1 47.19 Favored Pre-proline 0 N--CA 1.438 -1.063 0 N-CA-C 107.043 -1.466 . . . . 59.409999999999997 107.043 171.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -57.03 133.31 57.08 Favored 'Trans proline' 0 N--CA 1.441 -1.577 0 C-N-CA 124.707 3.605 . . . . 62.68 114.466 -177.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 66.59 29.49 74.85 Favored Glycine 0 C--O 1.218 -0.856 0 CA-C-O 117.149 -1.917 . . . . 64.159999999999997 114.088 -174.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 59.6 mttm -138.32 148.16 58.41 Favored Pre-proline 0 CA--C 1.503 -0.827 0 CA-C-N 121.009 2.404 . . . . 68.530000000000001 111.822 172.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.63 136.96 29.27 Favored 'Trans proline' 0 C--O 1.245 0.844 0 CA-C-N 122.856 2.056 . . . . 61.990000000000002 107.486 164.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1263 ' ' ALA . . . . . . . . . . . . . . . -51.63 116.07 7.35 Favored Pre-proline 0 C--O 1.248 1.021 0 N-CA-C 113.24 0.83 . . . . 57.149999999999999 113.24 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -53.61 135.67 62.4 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 124.779 3.653 . . . . 51.57 110.5 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -78.25 84.37 4.46 Favored 'General case' 0 C--O 1.248 0.994 0 C-N-CA 123.785 0.834 . . . . 54.549999999999997 109.161 -173.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 94.9 mt -91.4 -41.31 10.95 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 113.185 0.809 . . . . 46.859999999999999 113.185 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1267 ' ' ILE . . . . . . . . . . . . . 32.1 mm -78.53 86.96 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 124.432 2.063 . . . . 41.039999999999999 111.467 171.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1268 ' ' THR . . . . . . . . . . . . . 36.2 p -84.54 151.98 24.2 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 112.316 -2.22 . . . . 39.579999999999998 112.892 -170.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1269 ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -52.22 -39.6 60.45 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 118.256 -2.778 . . . . 53.149999999999999 117.194 -176.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -58.27 -40.78 82.78 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-O 123.517 1.627 . . . . 42.960000000000001 112.392 173.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1271 ' ' MET . . . . . . . . . . . . . 54.2 ttm -65.71 -42.61 90.93 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 113.048 -1.887 . . . . 43.890000000000001 110.669 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1272 ' ' VAL . . . . . . . . . . . . . 10.4 t -54.78 -48.52 73.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 113.816 -1.538 . . . . 38.369999999999997 110.977 170.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 25.9 t70 -58.39 -40.71 83.08 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 114.251 1.204 . . . . 47.460000000000001 114.251 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1274 ' ' SER . . . . . . . . . . . . . 49.5 m -68.86 -22.99 64.17 Favored 'General case' 0 C--O 1.238 0.494 0 O-C-N 121.698 -0.626 . . . . 38.380000000000003 112.687 174.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1275 ' ' MET . . . . . . . . . . . . . 71.7 mtp -62.12 162.16 9.89 Favored 'General case' 0 C--O 1.252 1.197 0 CA-C-O 124.548 2.118 . . . . 37.810000000000002 114.014 -173.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 66.6 tttt -68.07 137.46 55.01 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 111.868 -2.423 . . . . 49.259999999999998 109.562 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -75.62 151.06 37.87 Favored 'General case' 0 C--O 1.246 0.874 0 O-C-N 124.121 0.888 . . . . 34.460000000000001 110.267 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 74.55 14.51 81.06 Favored Glycine 0 N--CA 1.47 0.922 0 C-N-CA 120.514 -0.85 . . . . 33.530000000000001 112.645 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1279 ' ' SER . . . . . . . . . . . . . 61.0 m -106.16 148.45 27.85 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 125.322 1.449 . . . . 31.309999999999999 109.67 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1280 ' ' VAL . . . . . . . . . . . . . 25.9 t -127.07 119.94 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 O-C-N 120.634 -1.291 . . . . 29.32 109.886 -163.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1281 ' ' ILE . . . . . . . . . . . . . 19.5 mt -86.8 112.26 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 102.655 -3.091 . . . . 31.93 102.655 175.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1282 ' ' VAL . . . . . . . . . . . . . 21.2 t -106.5 107.71 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 N-CA-C 101.857 -3.386 . . . . 29.48 101.857 175.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 24.3 t0 -87.93 109.08 19.52 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 110.475 -3.057 . . . . 34.5 107.653 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1284 ' ' LEU . . . . . . . . . . . . . 71.4 mt -79.58 -23.05 43.0 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-O 121.138 0.494 . . . . 37.939999999999998 110.467 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -87.52 -5.62 58.71 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 115.371 -0.831 . . . . 40.920000000000002 111.525 -175.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -18.72 -54.32 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.736 1 N-CA-C 122.173 4.138 . . . . 44.390000000000001 122.173 174.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B 1287 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.27 -43.89 69.56 Favored 'General case' 0 CA--C 1.501 -0.935 0 C-N-CA 123.431 0.692 . . . . 51.460000000000001 111.483 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 4.9 t30 -97.21 75.68 2.59 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-O 123.915 1.817 . . . . 57.75 109.378 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1289 ' ' GLY . . . . . . . . . . . . . . . 87.88 -76.72 1.95 Allowed Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 107.209 -2.356 . . . . 49.850000000000001 107.209 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 99.45 136.74 9.48 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 109.371 -1.492 . . . . 45.93 109.371 -167.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1291 ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -88.88 -35.17 16.68 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 120.15 1.975 . . . . 42.670000000000002 112.927 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1292 ' ' CYS . . . . . . . . . . . . . 40.4 t -77.87 143.91 37.39 Favored 'General case' 0 N--CA 1.441 -0.923 0 O-C-N 118.944 -2.348 . . . . 38.82 110.829 171.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1293 ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -69.08 -37.43 78.45 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.702 -1.135 . . . . 46.710000000000001 112.049 174.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -82.9 -8.13 59.6 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 115.564 1.691 . . . . 47.229999999999997 115.564 -173.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1295 ' ' THR . . . . . . . . . . . . . 49.1 m -52.35 120.4 5.49 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 116.135 1.902 . . . . 36.020000000000003 116.135 177.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 2.9 t -88.79 108.11 21.37 Favored Pre-proline 0 N--CA 1.448 -0.559 0 CA-C-O 116.007 -1.949 . . . . 37.259999999999998 106.396 172.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -64.28 88.39 0.16 Allowed 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 124.29 3.327 . . . . 35.090000000000003 113.479 -176.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 139.46 -17.46 3.09 Favored Glycine 0 C--O 1.251 1.18 0 CA-C-N 113.243 -1.798 . . . . 35.969999999999999 110.013 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -133.71 -176.69 4.25 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 121.458 2.629 . . . . 40.390000000000001 114.554 -161.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1300 ' ' ILE . . . . . . . . . . . . . 9.6 mt -99.8 155.58 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.045 0 N-CA-C 105.759 -1.941 . . . . 37.43 105.759 170.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 65.9 t80 -142.85 105.89 4.55 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 123.008 1.385 . . . . 44.130000000000003 107.63 167.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1302 ' ' THR . . . . . . . . . . . . . 96.5 m -75.46 118.58 18.49 Favored 'General case' 0 N--CA 1.438 -1.029 0 O-C-N 119.434 -2.041 . . . . 39.780000000000001 106.291 168.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1303 ' ' THR . . . . . . . . . . . . . 76.0 p -69.7 169.42 12.88 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 115.903 1.816 . . . . 43.289999999999999 115.903 172.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -48.37 -48.02 36.93 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 124.343 1.057 . . . . 53.07 113.02 167.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -85.8 23.52 1.42 Allowed 'General case' 0 C--O 1.244 0.81 0 N-CA-C 114.68 1.363 . . . . 43.969999999999999 114.68 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 69.38 23.5 76.4 Favored Glycine 0 C--N 1.358 1.761 0 O-C-N 119.332 -2.105 . . . . 41.119999999999997 114.961 170.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1307 ' ' VAL . . . . . . . . . . . . . 94.7 t -93.46 136.13 26.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 105.767 -1.938 . . . . 38.119999999999997 105.767 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1308 ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -92.77 99.54 12.19 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.757 -1.201 . . . . 36.340000000000003 107.757 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1309 ' ' VAL . . . . . . . . . . . . . 18.0 t -90.02 92.97 4.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 105.602 -1.999 . . . . 30.399999999999999 105.602 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1310 ' ' ILE . . . . . . . . . . . . . 12.1 mt -87.4 134.2 28.32 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.002 0 C-N-CA 126.02 1.728 . . . . 30.82 107.85 173.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1311 ' ' GLY . . . . . . . . . . . . . . . -149.09 86.95 0.15 Allowed Glycine 0 CA--C 1.493 -1.34 0 N-CA-C 108.396 -1.882 . . . . 26.530000000000001 108.396 171.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1312 ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -97.8 119.66 36.79 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 118.055 0.927 . . . . 38.0 108.848 -172.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1313 ' ' THR . . . . . . . . . . . . . 39.3 m -49.83 -40.37 41.83 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 124.079 1.895 . . . . 29.800000000000001 114.355 172.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -78.56 -2.96 41.35 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 112.834 -1.985 . . . . 39.039999999999999 116.201 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1315 ' ' LEU . . . . . . . . . . . . . 13.4 mt -43.29 -51.35 14.45 Favored Pre-proline 0 N--CA 1.47 0.527 0 N-CA-C 119.062 2.986 . . . . 31.079999999999998 119.062 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1316 ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -65.62 -25.06 54.86 Favored 'Trans proline' 0 C--O 1.218 -0.5 0 CA-C-N 124.606 2.681 . . . . 26.100000000000001 112.866 176.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -67.53 -49.23 52.17 Favored Glycine 0 N--CA 1.431 -1.688 0 O-C-N 120.496 -1.378 . . . . 23.170000000000002 109.964 169.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -39.69 -16.71 0.01 OUTLIER 'General case' 0 C--O 1.246 0.878 1 N-CA-C 125.201 5.26 . . . . 40.399999999999999 125.201 -161.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 15.9 tp -102.12 78.58 0.24 Allowed Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 121.301 1.864 . . . . 23.600000000000001 108.158 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1320 ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -43.53 -64.28 0.26 Allowed 'Trans proline' 0 CA--C 1.51 -0.719 1 C-N-CA 125.416 4.077 . . . . 22.350000000000001 119.138 -156.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B 1321 ' ' THR . . . . . . . . . . . . . 4.2 m -61.97 -44.79 96.01 Favored 'General case' 0 C--O 1.218 -0.578 0 O-C-N 121.17 -0.957 . . . . 26.52 112.293 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1322 ' ' GLN . . . . . . . . . . . . . 11.5 tp60 -72.48 -43.44 63.67 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 118.657 -0.687 . . . . 24.379999999999999 112.471 -173.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1323 ' ' SER . . . . . . . . . . . . . 66.6 m -48.78 -49.32 39.21 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 124.176 0.99 . . . . 22.800000000000001 110.837 164.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1324 ' ' SER . . . . . . . . . . . . . 11.4 m -61.69 -33.2 73.58 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 122.567 1.175 . . . . 21.25 113.436 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -69.43 -40.38 77.27 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 118.404 -2.685 . . . . 31.34 114.18 170.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1326 ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.89 -55.8 9.91 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.951 0.881 . . . . 31.559999999999999 112.241 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1327 ' ' TYR . . . . . . . . . . . . . 31.3 t80 -56.2 -44.57 79.61 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-N 113.992 -1.458 . . . . 22.73 110.179 175.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1328 ' ' GLY . . . . . . . . . . . . . . . -56.7 -60.45 8.98 Favored Glycine 0 C--N 1.343 0.929 0 O-C-N 124.153 0.908 . . . . 21.91 112.794 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1329 ' ' THR . . . . . . . . . . . . . 9.2 m -58.44 -23.51 57.72 Favored 'General case' 0 C--O 1.252 1.185 0 CA-C-O 116.365 -1.778 . . . . 22.149999999999999 111.893 174.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1330 ' ' ASN . . . . . . . . . . . . . 12.1 m120 -63.79 -46.72 83.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 125.4 3.727 . . . . 26.18 110.549 170.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1331 ' ' LEU . . . . . . . . . . . . . 13.9 mt -61.14 -37.28 82.27 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.079 -0.964 . . . . 23.68 109.254 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1332 ' ' VAL . . . . . . . . . . . . . 96.6 t -69.22 -45.21 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 106.847 -1.538 . . . . 26.57 106.847 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -58.69 -43.73 90.06 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 113.353 0.871 . . . . 28.079999999999998 113.353 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1334 ' ' LEU . . . . . . . . . . . . . 3.9 tt -56.95 -47.31 80.99 Favored 'General case' 0 C--O 1.247 0.929 0 C-N-CA 123.933 0.893 . . . . 27.43 109.337 170.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1335 ' ' LEU . . . . . . . . . . . . . 68.2 mt -74.42 -12.25 60.46 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 120.924 -1.11 . . . . 30.5 113.601 -177.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1336 ' ' LYS . . . . . . . . . . . . . 85.5 mttt -72.89 -49.5 29.41 Favored 'General case' 0 CA--C 1.504 -0.793 0 O-C-N 120.828 -1.17 . . . . 41.649999999999999 109.225 166.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 7.7 mp -67.51 -26.84 66.54 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 113.258 0.836 . . . . 42.079999999999998 113.258 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1338 ' ' LEU . . . . . . . . . . . . . 95.3 mt -72.34 -67.11 0.57 Allowed 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 108.373 -0.973 . . . . 35.030000000000001 108.373 168.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 43.6 t -85.34 73.69 10.51 Favored 'General case' 0 N--CA 1.436 -1.161 0 O-C-N 118.699 -2.501 . . . . 37.329999999999998 108.185 -170.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 58.0 mttp -57.44 -33.4 67.88 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 125.323 1.449 . . . . 50.509999999999998 114.353 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -80.55 -11.61 59.64 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 114.372 1.249 . . . . 54.210000000000001 114.372 178.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 60.0 mttp 60.32 34.81 20.75 Favored 'General case' 0 C--N 1.347 0.488 0 CA-C-O 122.884 1.326 . . . . 50.990000000000002 111.608 -172.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -99.6 -34.22 10.31 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 114.959 -1.018 . . . . 48.82 111.273 -176.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 125.31 9.52 5.0 Favored Glycine 0 N--CA 1.433 -1.551 0 O-C-N 124.543 1.152 . . . . 40.43 113.407 175.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -98.67 141.17 31.84 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 125.503 1.521 . . . . 47.560000000000002 113.639 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1346 ' ' ILE . . . . . . . . . . . . . 43.1 mm -82.79 76.18 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.63 0 CA-C-O 123.136 1.446 . . . . 42.490000000000002 108.728 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1347 ' ' THR . . . . . . . . . . . . . 2.4 m -73.82 78.92 1.59 Allowed 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.598 -1.183 . . . . 38.119999999999997 109.326 172.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 10.9 t -62.29 121.66 11.35 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 O-C-N 119.598 -1.939 . . . . 37.5 109.379 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 23.1 t0 -96.96 111.08 23.46 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 122.505 1.145 . . . . 43.850000000000001 108.565 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1350 ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -100.52 -0.59 37.55 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 116.385 1.994 . . . . 39.810000000000002 116.385 175.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -81.41 -43.55 18.8 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 121.728 0.775 . . . . 51.289999999999999 110.776 167.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 14.4 t0 -66.75 121.8 16.23 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 124.373 2.035 . . . . 39.780000000000001 111.995 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 3.7 m -52.25 -37.21 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 CA-C-N 110.752 -2.931 . . . . 39.280000000000001 112.686 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1354 ' ' VAL . . . . . . . . . . . . . 23.1 t -70.6 -54.01 19.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-N 114.894 -1.048 . . . . 35.700000000000003 112.355 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1355 ' ' ILE . . . . . . . . . . . . . 27.1 mm -64.68 -47.59 88.19 Favored 'Isoleucine or valine' 0 C--N 1.359 1.007 0 CA-C-O 116.95 -1.5 . . . . 35.770000000000003 112.073 176.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 42.3 tpt85 -54.1 -37.09 63.89 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 114.168 1.173 . . . . 38.549999999999997 114.168 173.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -62.63 -54.6 32.67 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 124.621 1.105 . . . . 29.579999999999998 115.437 171.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1358 ' ' VAL . . . . . . . . . . . . . 9.1 p -69.08 -38.82 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 108.668 -0.864 . . . . 32.060000000000002 108.668 -174.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1359 ' ' THR . . . . . . . . . . . . . 14.8 m -76.46 84.83 3.18 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-O 123.892 1.806 . . . . 29.0 107.944 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1360 ' ' VAL . . . . . . . . . . . . . 22.1 m -73.27 -19.55 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 111.692 -2.504 . . . . 29.68 111.252 -174.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 85.1 mt -139.16 116.28 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 105.76 -1.941 . . . . 32.049999999999997 105.76 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1362 ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -108.66 119.38 39.37 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 119.205 -2.184 . . . . 32.520000000000003 108.885 175.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 36.86 44.08 0.33 Allowed 'General case' 0 C--O 1.246 0.92 0 CA-C-O 124.454 2.073 . . . . 35.68 116.113 -172.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 93.36 -7.28 75.38 Favored Glycine 0 CA--C 1.54 1.647 0 CA-C-O 117.225 -1.875 . . . . 34.259999999999998 114.356 174.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.6 132.52 34.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 104.653 -2.351 . . . . 51.07 104.653 170.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 59.5 mt -88.75 94.05 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 N-CA-C 107.402 -1.333 . . . . 39.869999999999997 107.402 -176.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1367 ' ' THR . . . . . . . . . . . . . 3.3 p -84.77 -1.39 56.26 Favored 'General case' 0 N--CA 1.424 -1.735 0 O-C-N 126.528 2.393 . . . . 38.009999999999998 114.858 -175.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1368 ' ' TRP . . . . . . . . . . . . . 35.0 t90 -52.05 142.26 27.29 Favored Pre-proline 0 C--O 1.241 0.635 0 C-N-CA 124.255 1.022 . . . . 42.140000000000001 111.674 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -87.91 -114.77 0.0 OUTLIER 'Cis proline' 0 N--CA 1.451 -0.996 0 CA-C-N 122.575 1.955 . . . . 43.259999999999998 113.21 -7.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1370 ' ' ALA . . . . . . . . . . . . . . . -117.97 153.67 51.18 Favored Pre-proline 0 C--N 1.32 -0.696 0 O-C-N 120.104 -1.623 . . . . 46.520000000000003 107.297 166.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -59.52 133.62 53.01 Favored 'Trans proline' 0 C--N 1.33 -0.438 0 CA-C-N 122.589 1.96 . . . . 51.950000000000003 110.954 172.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -36.91 87.7 0.01 OUTLIER 'Trans proline' 0 C--O 1.25 1.091 0 C-N-CA 125.133 3.889 . . . . 56.270000000000003 118.108 -174.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B 1373 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.13 140.78 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 103.099 -2.926 . . . . 60.829999999999998 103.099 177.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -107.48 146.64 31.52 Favored 'General case' 0 C--O 1.256 1.423 0 O-C-N 120.203 -1.561 . . . . 66.099999999999994 108.184 -174.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 96.2 t -78.95 135.86 24.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 O-C-N 125.454 1.721 . . . . 63.469999999999999 111.49 -171.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.23 -4.627 0 O-C-N 120.891 -1.13 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.274 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.6 -16.23 24.29 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.071 1.348 . . . . 0.0 114.464 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 28.7 mp0 -49.54 -42.22 43.37 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.068 -1.02 . . . . 0.0 110.531 172.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 6.6 m -56.67 -46.96 80.81 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 123.593 0.757 . . . . 0.0 111.696 173.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.24 -49.81 74.23 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 123.714 0.805 . . . . 0.0 109.674 -173.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -48.82 -51.07 31.45 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 127.849 3.218 . . . . 0.0 111.409 173.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 13.5 tp -65.28 -39.41 92.53 Favored 'General case' 0 N--CA 1.44 -0.938 0 O-C-N 120.764 -1.21 . . . . 0.0 113.59 -177.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 74.1 mt -53.68 -39.62 65.26 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 118.58 2.808 . . . . 0.0 118.58 -174.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 28' ' ' LYS . . . . . 0.432 ' HZ1' ' C ' ' C' ' 186' ' ' LEU . 34.5 pttt -63.93 -28.65 69.97 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.082 -0.963 . . . . 0.0 113.015 175.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -82.87 -33.01 27.13 Favored 'General case' 0 C--O 1.246 0.88 0 O-C-N 125.349 1.656 . . . . 0.0 109.823 174.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 58.0 m -54.87 127.27 27.85 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -170.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -82.55 -58.37 2.94 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 113.956 -1.475 . . . . 0.0 109.041 -174.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 55.5 m -116.15 143.39 45.56 Favored 'General case' 0 C--O 1.251 1.135 0 O-C-N 120.801 -1.187 . . . . 0.0 110.55 166.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 96.6 t -128.44 120.2 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 38.7 mm -101.69 111.41 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 101.598 -3.482 . . . . 0.0 101.598 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 42.9 mt -83.7 122.73 38.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 169.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 13.7 m -115.97 92.94 36.65 Favored Pre-proline 0 C--O 1.246 0.919 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.129 173.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -56.3 116.66 3.34 Favored 'Trans proline' 0 N--CA 1.449 -1.107 1 C-N-CA 125.47 4.113 . . . . 0.0 112.347 168.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.29 -175.23 27.52 Favored Glycine 0 N--CA 1.433 -1.558 0 O-C-N 120.869 -1.145 . . . . 0.0 110.441 167.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -38.18 -41.59 0.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.187 1.395 . . . . 0.0 114.605 168.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -52.78 -47.96 57.73 Favored Glycine 0 C--O 1.249 1.08 0 CA-C-O 118.789 -1.006 . . . . 0.0 112.371 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 24.2 ttm -61.27 -31.48 71.3 Favored 'General case' 0 C--N 1.356 0.889 0 CA-C-N 119.801 1.801 . . . . 0.0 113.529 172.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.04 -33.33 71.82 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.548 -0.739 . . . . 0.0 110.816 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -90.31 -70.95 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 118.448 -0.787 . . . . 0.0 110.6 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.27 100.2 7.42 Favored 'General case' 0 C--O 1.252 1.206 0 CA-C-N 120.432 1.469 . . . . 0.0 107.658 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 45' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -69.49 82.73 0.4 Allowed 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -161.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.11 -4.42 55.24 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 111.164 -2.744 . . . . 0.0 114.363 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.24 -46.94 59.95 Favored 'General case' 0 C--O 1.25 1.086 0 O-C-N 119.66 -1.9 . . . . 0.0 113.659 -173.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 48' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -57.8 -44.38 99.38 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 120.333 1.424 . . . . 0.0 113.401 173.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 49' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -49.92 -49.78 15.11 Favored 'Trans proline' 0 C--O 1.255 1.352 0 C-N-CA 122.391 2.061 . . . . 0.0 115.574 163.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -68.86 -21.47 25.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 O-C-N 120.168 -1.582 . . . . 0.0 110.356 -171.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.68 -49.61 74.57 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 122.031 0.919 . . . . 0.0 111.403 172.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.12 -54.92 32.91 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.937 1.295 . . . . 0.0 112.633 176.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 6.7 tp -71.57 -33.5 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-N 119.171 0.896 . . . . 0.0 111.054 -176.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 89.2 m -67.01 -32.97 74.54 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 118.997 0.817 . . . . 0.0 109.659 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -56.14 -51.88 66.37 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 4.6 mppt? -65.11 -46.3 81.59 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 55.2 mt -58.8 -45.73 89.22 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 120.509 1.504 . . . . 0.0 111.899 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -70.04 -40.86 74.89 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.613 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.59 -45.26 73.55 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 121.478 1.945 . . . . 0.0 113.91 171.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 29.1 ttm-85 -65.38 -23.36 66.95 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.101 1.36 . . . . 0.0 112.346 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.07 21.25 9.66 Favored Glycine 0 CA--C 1.505 -0.545 0 CA-C-O 122.12 0.845 . . . . 0.0 114.053 174.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 59.0 mt -85.16 135.14 25.49 Favored 'Isoleucine or valine' 0 C--O 1.249 1.055 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -79.61 86.73 5.21 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 7.7 p -95.7 122.68 47.41 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 CA-C-O 122.456 1.122 . . . . 0.0 108.894 178.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 9.6 mmm-85 -126.27 136.71 53.11 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 122.227 1.013 . . . . 0.0 110.102 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -87.92 74.28 9.01 Favored 'General case' 0 C--O 1.243 0.715 0 O-C-N 120.082 -1.636 . . . . 0.0 109.203 177.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.65 83.14 0.91 Allowed Glycine 0 CA--C 1.529 0.965 0 N-CA-C 109.084 -1.607 . . . . 0.0 109.084 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 16.5 mt -98.08 144.67 10.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 O-C-N 124.61 0.83 . . . . 0.0 111.066 -167.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -109.84 72.37 0.61 Allowed Pre-proline 0 C--O 1.242 0.69 0 N-CA-C 103.018 -2.956 . . . . 0.0 103.018 169.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 70' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -61.47 -20.23 67.65 Favored 'Trans proline' 0 C--N 1.341 0.148 1 C-N-CA 125.335 4.024 . . . . 0.0 113.96 -167.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.84 81.32 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 122.949 1.357 . . . . 0.0 107.555 161.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.85 97.09 3.04 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 119.38 -2.075 . . . . 0.0 112.834 -172.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.92 -75.53 1.28 Allowed Glycine 0 N--CA 1.44 -1.08 0 O-C-N 120.388 -1.445 . . . . 0.0 114.632 170.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -121.63 98.9 6.17 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -174.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 75.33 132.29 0.04 OUTLIER Pre-proline 0 C--N 1.35 0.625 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 168.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.32 150.07 84.75 Favored 'Trans proline' 0 C--O 1.239 0.57 0 C-N-CA 123.287 2.658 . . . . 0.0 114.487 174.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.18 -94.16 1.46 Allowed Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 106.964 -2.454 . . . . 0.0 106.964 -169.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 2.1 t60 26.33 -80.7 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 127.83 2.452 . . . . 0.0 116.048 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -59.5 -43.62 93.3 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.698 -1.251 . . . . 0.0 111.587 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -67.98 -44.95 75.46 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 121.652 -0.655 . . . . 0.0 109.643 -176.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 90.1 t -52.1 -50.88 33.77 Favored 'Isoleucine or valine' 0 C--O 1.249 1.074 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 168.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 3.5 mp -53.55 -39.75 65.01 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 174.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 11.7 tp -59.99 -46.41 89.55 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 124.385 1.053 . . . . 0.0 112.667 170.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.37 -39.95 77.09 Favored 'General case' 0 C--O 1.246 0.911 0 C-N-CA 124.253 1.021 . . . . 0.0 111.25 173.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -60.87 -40.1 91.71 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.015 0.526 . . . . 0.0 111.01 172.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.22 0.1 3.02 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 120.645 -1.285 . . . . 0.0 113.315 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp 61.8 51.77 3.72 Favored 'General case' 0 C--O 1.266 1.921 0 C-N-CA 127.873 2.469 . . . . 0.0 111.403 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 57.8 t -100.93 130.67 24.65 Favored Pre-proline 0 N--CA 1.444 -0.739 0 CA-C-N 112.855 -1.975 . . . . 0.0 106.164 172.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -55.4 111.19 0.68 Allowed 'Trans proline' 0 CA--C 1.509 -0.744 0 C-N-CA 124.889 3.726 . . . . 0.0 116.772 177.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.16 -16.49 20.42 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 108.992 -3.731 . . . . 0.0 118.289 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -69.58 -48.76 59.1 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-O 118.081 -0.962 . . . . 0.0 111.939 174.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 22.9 pt -70.86 -15.24 18.7 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-N 120.563 1.529 . . . . 0.0 114.738 174.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 86.4 t -69.36 98.51 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-O 124.111 1.91 . . . . 0.0 106.721 167.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 19.2 mt -105.02 87.76 2.72 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 110.258 -3.155 . . . . 0.0 108.155 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 95' ' ' GLU . . . . . 0.477 ' CD ' ' HZ3' ' A' 1162 ' ' LYS . 34.8 mp0 -69.1 103.91 2.01 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 111.349 -2.66 . . . . 0.0 109.865 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 92.9 mtp 56.96 25.93 11.21 Favored 'General case' 0 C--O 1.25 1.106 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 171.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -81.88 155.46 25.31 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 113.64 -1.618 . . . . 0.0 109.751 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -82.97 56.27 3.4 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 120.095 1.316 . . . . 0.0 109.353 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 11.1 tp -74.46 41.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 O-C-N 117.28 -3.387 . . . . 0.0 111.902 173.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -76.85 -27.19 55.0 Favored 'General case' 0 C--O 1.217 -0.607 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -162.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.12 -44.82 87.46 Favored 'General case' 0 C--O 1.24 0.599 0 O-C-N 124.519 1.137 . . . . 0.0 110.274 174.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.42 -39.5 92.21 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 117.131 -1.414 . . . . 0.0 110.729 173.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 103' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -47.84 -56.5 7.33 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-N 123.042 2.655 . . . . 0.0 114.021 169.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.51 -35.89 77.04 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 123.674 0.79 . . . . 0.0 113.128 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -67.52 -39.35 85.07 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 121.221 -0.925 . . . . 0.0 111.568 175.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 106' ' ' THR . . . . . . . . . . . . . 3.8 m -52.3 133.57 34.34 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-O 126.812 3.196 . . . . 0.0 113.577 -169.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 107' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -69.26 -70.41 0.28 Allowed 'General case' 0 C--N 1.3 -1.553 1 CA-C-N 107.035 -4.62 . . . . 0.0 108.635 171.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 8.4 m -121.19 124.99 46.05 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 120.949 1.704 . . . . 0.0 110.662 -174.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 109' ' ' VAL . . . . . . . . . . . . . 32.5 t -99.33 119.26 47.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 174.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 16.2 mt -95.89 85.35 4.06 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 122.765 1.269 . . . . 0.0 109.854 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 11.8 t -81.52 103.8 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 177.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 1.8 mm -81.34 106.45 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 O-C-N 118.164 -2.835 . . . . 0.0 109.142 -171.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.22 -78.78 1.63 Allowed Glycine 0 CA--C 1.487 -1.669 0 CA-C-O 125.422 2.679 . . . . 0.0 111.863 170.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.43 127.23 40.2 Favored 'General case' 0 C--O 1.21 -0.983 0 O-C-N 120.077 -1.837 . . . . 0.0 111.613 -162.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 115' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -66.42 -53.79 31.67 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 113.611 -1.631 . . . . 0.0 114.803 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 116' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -65.75 -16.03 63.4 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 117.736 2.495 . . . . 0.0 117.736 -167.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 4.7 m -41.28 -44.85 2.79 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 127.175 2.797 . . . . 0.0 110.067 168.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.55 67.64 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.507 0 O-C-N 124.339 1.024 . . . . 0.0 108.679 169.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -87.6 119.56 70.72 Favored Pre-proline 0 C--O 1.26 1.658 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 120' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -60.88 -45.42 20.36 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.851 3.034 . . . . 0.0 110.995 -177.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.64 -14.41 62.05 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.32 -38.1 86.91 Favored 'General case' 0 CA--C 1.552 1.049 0 O-C-N 120.663 -1.273 . . . . 0.0 110.796 170.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -75.95 -50.24 15.5 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-O 122.263 1.03 . . . . 0.0 108.739 177.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -80.76 -45.08 17.6 Favored 'General case' 0 C--O 1.247 0.947 0 N-CA-C 120.196 3.406 . . . . 0.0 120.196 -173.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -103.1 123.44 41.92 Favored Pre-proline 0 CA--C 1.55 0.958 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -162.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_exo -46.26 -31.99 9.94 Favored 'Trans proline' 0 CA--C 1.503 -1.061 0 C-N-CA 124.534 3.49 . . . . 0.0 118.347 175.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -69.51 -32.8 71.88 Favored 'General case' 0 C--N 1.317 -0.829 0 O-C-N 120.904 -1.123 . . . . 0.0 110.648 -174.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 128' ' ' SER . . . . . . . . . . . . . 13.4 m -56.66 133.4 78.1 Favored Pre-proline 0 N--CA 1.467 0.42 0 C-N-CA 125.254 1.422 . . . . 0.0 107.874 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 129' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -55.14 -46.03 36.1 Favored 'Trans proline' 0 C--O 1.221 -0.368 1 C-N-CA 125.464 4.11 . . . . 0.0 114.282 175.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 4.3 pt -86.9 66.54 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.405 0 O-C-N 119.507 -1.996 . . . . 0.0 107.385 170.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -74.3 111.87 9.9 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.429 -1.26 . . . . 0.0 109.048 -174.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.73 34.87 17.82 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 122.821 1.234 . . . . 0.0 111.863 -175.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 133' ' ' MET . . . . . . . . . . . . . 39.0 tpp -70.09 123.03 88.0 Favored Pre-proline 0 C--O 1.243 0.722 0 CA-C-N 113.476 -1.362 . . . . 0.0 109.915 173.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -68.66 88.15 0.43 Allowed 'Trans proline' 0 N--CA 1.442 -1.536 0 C-N-CA 122.625 2.217 . . . . 0.0 112.198 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 28.6 m -88.31 150.09 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-N 113.424 -1.716 . . . . 0.0 106.973 168.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 27.4 mt -77.71 111.57 13.64 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 102.318 -3.215 . . . . 0.0 102.318 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -70.24 96.61 1.12 Allowed 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 123.39 1.567 . . . . 0.0 113.047 -155.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 14.8 p -85.28 110.35 19.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 125.177 2.418 . . . . 0.0 109.074 169.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 76.3 m95 -129.97 138.49 50.88 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 118.945 -2.347 . . . . 0.0 105.308 174.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 140' ' ' LYS . . . . . . . . . . . . . 24.5 pttm 38.15 20.69 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.823 1 N-CA-C 123.057 4.466 . . . . 0.0 123.057 175.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.84 150.82 36.17 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 120.369 -1.457 . . . . 0.0 107.754 163.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -62.89 -42.88 99.93 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 117.12 2.267 . . . . 0.0 117.12 -160.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 143' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -140.33 120.83 14.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 121.339 1.881 . . . . 0.0 108.443 167.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 144' ' ' VAL . . . . . . . . . . . . . 44.1 t -102.02 85.39 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 101.882 -3.377 . . . . 0.0 101.882 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 145' ' ' ILE . . . . . . . . . . . . . 26.3 mt -82.57 104.37 11.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 125.84 2.733 . . . . 0.0 110.507 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 146' ' ' VAL . . . . . . . . . . . . . 47.8 t -97.77 109.07 22.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 110.711 -2.949 . . . . 0.0 105.083 178.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 147' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -71.59 82.01 0.83 Allowed 'General case' 0 C--O 1.258 1.528 0 O-C-N 120.472 -1.393 . . . . 0.0 111.293 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 148' ' ' LYS . . . . . 0.433 ' NZ ' ' OD1' ' C' ' 152' ' ' ASN . 28.5 mtpt -103.05 133.09 48.75 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 120.297 -1.502 . . . . 0.0 107.764 177.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 -72.2 -29.3 63.84 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 123.056 1.408 . . . . 0.0 111.793 -175.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 16.0 m -142.04 151.32 42.31 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.337 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -73.23 102.87 3.76 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 103.077 -2.934 . . . . 0.0 103.077 167.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 152' ' ' ASN . . . . . 0.433 ' OD1' ' NZ ' ' C' ' 148' ' ' LYS . 13.0 p-10 -152.72 164.06 38.49 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 23.8 m -53.38 159.0 1.51 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 130.044 3.337 . . . . 0.0 113.741 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -136.21 -137.34 3.66 Favored Glycine 0 C--O 1.249 1.034 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -87.66 -63.75 1.25 Allowed 'General case' 0 C--O 1.238 0.468 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 171.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 156' ' ' ALA . . . . . . . . . . . . . . . -76.0 -53.63 8.08 Favored 'General case' 0 C--N 1.364 1.229 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 166.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 67.33 -89.16 0.17 Allowed Glycine 0 N--CA 1.461 0.327 0 N-CA-C 106.822 -2.511 . . . . 0.0 106.822 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . 0.385 35.1 m 46.3 148.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 120.84 3.644 . . . . 0.0 120.84 -176.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.9 83.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 O-C-N 121.159 -0.963 . . . . 0.0 109.477 173.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 160' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -130.77 164.27 42.93 Favored Pre-proline 0 C--O 1.242 0.673 0 CA-C-O 117.472 -1.252 . . . . 0.0 110.616 -164.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -38.33 -51.08 2.17 Favored 'Trans proline' 0 N--CA 1.445 -1.375 0 C-N-CA 124.383 3.388 . . . . 0.0 117.893 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 162' ' ' LEU . . . . . . . . . . . . . 1.4 mp -50.46 -35.41 28.76 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 176.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 163' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -73.63 -30.79 63.17 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -107.59 -51.42 2.91 Favored 'General case' 0 C--O 1.257 1.462 0 CA-C-O 123.142 1.448 . . . . 0.0 114.494 -169.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 4.9 mmtm -61.81 153.32 29.06 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 115.983 1.845 . . . . 0.0 115.983 -171.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -85.41 -45.29 12.01 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -164.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -89.12 -42.44 11.69 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.186 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 168' ' ' THR . . . . . . . . . . . . . 56.2 m -89.44 77.47 7.31 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 106.789 -1.559 . . . . 0.0 106.789 177.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -136.09 135.07 39.03 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.71 -158.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 170' ' ' MET . . . . . . . . . . . . . 67.6 mtm -63.99 94.57 0.1 Allowed 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.227 -1.806 . . . . 0.0 107.173 163.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 171' ' ' LEU . . . . . . . . . . . . . 10.4 tp -79.38 117.45 20.37 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -70.65 93.21 0.91 Allowed 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 110.716 -2.947 . . . . 0.0 114.386 -168.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -166.32 159.74 33.1 Favored Glycine 0 C--O 1.248 1.029 0 O-C-N 125.222 1.576 . . . . 0.0 109.664 176.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 174' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -69.93 151.74 45.28 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 113.582 -1.309 . . . . 0.0 108.911 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.52 -49.04 72.84 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.164 -175.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.53 -47.81 37.99 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -176.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 177' ' ' ALA . . . . . . . . . . . . . . . -56.3 -47.41 78.74 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 122.113 0.959 . . . . 0.0 113.204 -175.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 49.6 m -63.62 -36.23 83.12 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 176.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 179' ' ' VAL . . . . . . . . . . . . . 44.3 t -75.04 -39.56 44.22 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -52.71 -44.5 66.36 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.845 172.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -64.79 -52.09 58.72 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 119.131 -0.461 . . . . 0.0 111.914 174.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 182' ' ' ILE . . . . . . . . . . . . . 20.4 pt -64.79 -33.15 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 O-C-N 123.796 0.685 . . . . 0.0 111.45 -169.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 183' ' ' LEU . . . . . . . . . . . . . 4.0 pp -67.64 -36.29 80.49 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 124.138 0.975 . . . . 0.0 111.66 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -77.23 -48.04 18.6 Favored 'General case' 0 C--O 1.206 -1.215 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -69.79 -71.24 0.24 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 -171.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 186' ' ' LEU . . . . . 0.432 ' C ' ' HZ1' ' C' ' 28' ' ' LYS 0.313 0.9 OUTLIER . . . . . 0 N--CA 1.476 0.873 0 N-CA-C 116.555 2.057 . . . . 0.0 116.555 -155.791 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' NAD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C 1001 ' ' NAP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 36.6 t-80 . . . . . 0 CA--C 1.508 -0.662 0 N-CA-C 105.874 -1.898 . . . . 65.739999999999995 105.874 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -61.83 76.86 0.02 OUTLIER Glycine 0 CA--C 1.538 1.497 0 N-CA-C 116.432 1.333 . . . . 48.659999999999997 116.432 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 26.5 ttp180 -118.71 138.03 52.92 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 123.394 1.568 . . . . 44.560000000000002 108.532 175.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1003 ' ' ILE . . . . . . . . . . . . . 36.8 mt -106.65 129.75 59.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 102.253 -3.24 . . . . 34.859999999999999 102.253 -176.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -91.88 135.76 12.92 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 106.793 -2.523 . . . . 30.75 106.793 170.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 19.5 mm -113.5 97.69 44.42 Favored Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 105.954 -1.869 . . . . 32.210000000000001 105.954 172.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -81.05 166.28 18.85 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 123.171 2.581 . . . . 32.979999999999997 114.275 170.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1007 ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -85.31 140.05 31.12 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 113.066 -1.879 . . . . 47.979999999999997 106.071 167.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1008 ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -68.94 157.55 36.45 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 123.76 1.743 . . . . 34.700000000000003 113.774 -175.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -138.08 132.75 32.57 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 112.324 -2.216 . . . . 53.369999999999997 108.352 -171.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 10.8 tp 170.02 -177.24 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 102.96 -2.978 . . . . 45.07 102.96 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1011 ' ' THR . . . . . . . . . . . . . 11.0 m -72.01 114.5 10.18 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 122.745 2.521 . . . . 40.359999999999999 107.718 -174.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 4.3 m-20 64.53 43.58 4.38 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 113.712 1.004 . . . . 40.609999999999999 113.712 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -87.81 137.42 32.35 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 119.42 -0.912 . . . . 33.759999999999998 110.99 -171.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1014 ' ' THR . . . . . . . . . . . . . 19.9 p -103.24 -41.7 5.97 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 122.352 1.072 . . . . 27.890000000000001 113.038 -173.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1015 ' ' ARG . . . . . . . . . . . . . 61.9 mtm180 -48.28 167.74 0.03 OUTLIER 'General case' 0 C--N 1.356 0.88 0 N-CA-C 120.083 3.364 . . . . 29.02 120.083 -173.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1016 ' ' VAL . . . . . . . . . . . . . 7.7 p -132.12 162.52 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 113.454 -1.703 . . . . 28.129999999999999 106.712 171.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1017 ' ' ALA . . . . . . . . . . . . . . . -66.47 -36.5 82.92 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 119.087 -2.258 . . . . 26.870000000000001 115.2 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -154.47 144.76 22.05 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 106.277 -1.749 . . . . 26.77 106.277 -174.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1019 ' ' THR . . . . . . . . . . . . . 1.7 p -98.5 170.74 6.6 Favored Pre-proline 0 N--CA 1.447 -0.583 0 CA-C-O 116.797 -1.573 . . . . 27.02 113.422 169.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1020 ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -29.45 -61.66 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 125.29 3.993 . . . . 30.57 120.024 173.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -66.85 -28.48 68.37 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 123.216 2.734 . . . . 47.810000000000002 110.842 -175.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1022 ' ' THR . . . . . . . . . . . . . 22.4 m -64.38 -47.98 77.19 Favored 'General case' 0 CA--C 1.554 1.118 0 O-C-N 121.621 -0.674 . . . . 30.77 110.178 169.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1023 ' ' VAL . . . . . . . . . . . . . 24.8 t -61.89 -38.6 80.99 Favored 'Isoleucine or valine' 0 C--O 1.254 1.33 0 O-C-N 120.996 -1.065 . . . . 33.590000000000003 109.043 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -64.56 -45.12 88.43 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 118.801 -1.16 . . . . 53.289999999999999 110.797 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -57.37 -40.15 77.54 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 118.762 0.71 . . . . 46.920000000000002 112.262 174.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1026 ' ' LEU . . . . . . . . . . . . . 74.7 mt -65.34 -34.67 78.86 Favored 'General case' 0 C--O 1.249 1.043 0 O-C-N 120.189 -1.57 . . . . 37.170000000000002 112.322 176.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 81.0 mt -70.87 -38.63 73.11 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.605 -0.887 . . . . 44.439999999999998 108.605 174.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -57.85 -36.74 72.75 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.972 0.805 . . . . 52.579999999999998 111.989 175.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1029 ' ' LEU . . . . . . . . . . . . . 90.3 mt -60.97 -27.51 68.32 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 114.435 1.272 . . . . 45.689999999999998 114.435 170.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 93.2 32.27 7.94 Favored Glycine 0 C--O 1.242 0.614 0 O-C-N 121.23 -0.919 . . . . 42.090000000000003 113.111 -174.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -106.14 154.62 20.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 105.756 -1.942 . . . . 40.719999999999999 105.756 165.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1032 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.38 145.85 25.27 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 123.066 1.413 . . . . 37.770000000000003 109.42 172.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1033 ' ' VAL . . . . . . . . . . . . . 20.8 t -117.01 136.07 55.34 Favored 'Isoleucine or valine' 0 C--O 1.25 1.092 0 O-C-N 119.927 -1.733 . . . . 33.539999999999999 111.756 -172.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -119.79 140.52 50.63 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 108.156 -1.053 . . . . 31.68 108.156 170.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1035 ' ' VAL . . . . . . . . . . . . . 74.0 t -121.67 146.62 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 122.654 1.216 . . . . 31.52 109.387 178.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1036 ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -71.76 136.54 47.17 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 113.552 -1.658 . . . . 41.039999999999999 111.124 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1037 ' ' SER . . . . . . . . . . . . . 49.2 m -70.56 117.8 12.55 Favored 'General case' 0 C--O 1.246 0.883 0 N-CA-C 107.4 -1.333 . . . . 31.829999999999998 107.4 175.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 103.96 -7.24 48.48 Favored Glycine 0 C--O 1.219 -0.796 0 O-C-N 120.411 -1.431 . . . . 29.359999999999999 110.42 -174.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -68.69 -27.18 65.74 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 118.961 1.381 . . . . 27.780000000000001 112.089 -177.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -79.59 -32.57 37.2 Favored Glycine 0 N--CA 1.437 -1.27 0 CA-C-O 122.189 0.883 . . . . 28.91 112.604 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -47.59 -69.17 0.13 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.002 -1.599 . . . . 51.18 114.565 -171.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1042 ' ' LEU . . . . . . . . . . . . . 13.8 mt -77.22 -20.26 55.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.913 1.339 . . . . 29.91 111.869 -174.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1043 ' ' ALA . . . . . . . . . . . . . . . -82.22 -9.62 59.43 Favored 'General case' 0 C--O 1.243 0.759 0 O-C-N 120.419 -1.426 . . . . 28.539999999999999 113.153 171.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1044 ' ' SER . . . . . . . . . . . . . 7.9 m 56.33 63.92 1.85 Allowed 'General case' 0 C--N 1.361 1.1 0 O-C-N 126.715 2.509 . . . . 33.060000000000002 112.476 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1045 ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.78 75.15 0.62 Allowed 'General case' 0 C--N 1.315 -0.931 1 N-CA-C 98.682 -4.562 . . . . 30.289999999999999 98.682 162.332 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -62.46 150.63 39.52 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.762 -1.108 . . . . 48.619999999999997 113.621 -160.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -46.09 -29.47 1.52 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 117.612 2.449 . . . . 36.740000000000002 117.612 -156.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 21.6 pttm -53.35 -33.91 55.44 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 112.956 0.724 . . . . 43.729999999999997 112.956 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -60.49 -35.94 77.13 Favored 'General case' 0 CA--C 1.522 -0.133 0 O-C-N 120.366 -1.459 . . . . 32.810000000000002 112.917 171.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1050 ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -72.1 -24.85 61.56 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 120.187 -1.571 . . . . 31.859999999999999 111.412 175.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 61.8 t -65.41 -47.32 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 118.236 -0.888 . . . . 33.219999999999999 109.435 170.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -56.35 -34.48 66.65 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.565 1.691 . . . . 50.829999999999998 115.565 171.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -74.41 -21.78 59.46 Favored 'General case' 0 C--O 1.25 1.117 0 N-CA-C 115.093 1.516 . . . . 33.119999999999997 115.093 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 101.34 83.22 1.72 Allowed Glycine 0 CA--C 1.526 0.752 0 C-N-CA 119.453 -1.356 . . . . 35.829999999999998 110.219 -177.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -150.58 138.65 20.14 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 119.44 -2.212 . . . . 34.82 115.159 176.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -66.4 121.17 14.68 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 105.511 -2.033 . . . . 49.049999999999997 105.511 165.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1057 ' ' ILE . . . . . . . . . . . . . 43.3 mm -100.03 118.2 46.33 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 O-C-N 119.649 -1.907 . . . . 38.530000000000001 107.732 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1058 ' ' VAL . . . . . . . . . . . . . 3.2 m -133.93 172.87 15.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 125.602 1.561 . . . . 42.109999999999999 111.119 -176.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -87.84 165.36 15.35 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 122.878 2.581 . . . . 58.0 108.202 173.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . -49.53 -51.42 27.55 Favored Glycine 0 C--O 1.238 0.368 0 O-C-N 120.718 -1.239 . . . . 52.119999999999997 116.044 -172.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 7.8 t30 -49.5 -40.27 36.97 Favored 'General case' 0 C--O 1.251 1.159 0 CA-C-O 122.092 0.948 . . . . 54.75 112.817 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1062 ' ' SER . . . . . . . . . . . . . 16.5 m -78.08 -35.82 48.92 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 119.984 -1.697 . . . . 50.340000000000003 114.608 173.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 1.1 p -64.62 -28.98 46.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 119.588 -1.945 . . . . 41.460000000000001 111.027 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1064 ' ' TRP . . . . . . . . . . . . . 59.6 m95 -80.67 -13.87 58.64 Favored 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 121.064 -1.022 . . . . 39.32 112.736 175.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -77.34 67.4 3.28 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 119.302 -2.124 . . . . 55.380000000000003 105.979 173.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1066 ' ' SER . . . . . . . . . . . . . 60.1 m -148.69 142.87 26.04 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 119.709 -1.87 . . . . 41.869999999999997 111.227 -170.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.78 -36.55 79.26 Favored 'General case' 0 N--CA 1.437 -1.104 0 O-C-N 125.671 1.857 . . . . 53.200000000000003 112.438 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 3.7 mp -121.9 144.47 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 106.515 -1.661 . . . . 41.899999999999999 106.515 176.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1069 ' ' ILE . . . . . . . . . . . . . 49.0 mm -130.63 129.24 64.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 N-CA-C 107.416 -1.328 . . . . 38.729999999999997 107.416 169.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1070 ' ' LEU . . . . . . . . . . . . . 44.9 mt -97.17 143.81 27.62 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.256 -2.498 . . . . 32.439999999999998 104.256 175.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1071 ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -148.12 130.51 15.7 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.647 0.779 . . . . 34.649999999999999 111.534 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1072 ' ' VAL . . . . . . . . . . . . . 2.1 t -89.32 -13.96 9.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-N 114.86 -1.063 . . . . 31.32 113.747 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -112.89 -176.65 2.95 Favored 'General case' 0 C--O 1.248 1.018 0 N-CA-C 106.583 -1.636 . . . . 33.939999999999998 106.583 163.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -73.2 155.12 90.25 Favored Pre-proline 0 C--O 1.259 1.567 0 N-CA-C 109.043 -0.725 . . . . 38.039999999999999 109.043 161.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1075 ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -70.83 117.31 5.08 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 123.599 2.866 . . . . 42.68 114.621 168.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 86.8 mt -71.21 162.64 29.09 Favored 'General case' 0 N--CA 1.434 -1.251 0 O-C-N 125.838 1.961 . . . . 46.740000000000002 107.868 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -42.73 -46.3 5.06 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 117.743 2.498 . . . . 58.609999999999999 117.743 -177.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 38.8 t70 -64.73 -41.33 96.04 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 113.567 0.951 . . . . 59.200000000000003 113.567 174.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1079 ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -66.69 -32.96 74.61 Favored 'General case' 0 C--O 1.211 -0.956 0 N-CA-C 108.347 -0.983 . . . . 50.630000000000003 108.347 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1080 ' ' ILE . . . . . . . . . . . . . 95.7 mt -59.6 -41.53 85.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 123.648 1.69 . . . . 51.479999999999997 110.728 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -62.62 -29.35 70.55 Favored 'General case' 0 C--O 1.211 -0.969 0 O-C-N 120.876 -1.14 . . . . 50.280000000000001 111.958 175.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 8.0 mt -70.47 -27.26 64.09 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 114.815 1.413 . . . . 50.210000000000001 114.815 173.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1083 ' ' LEU . . . . . . . . . . . . . 1.3 mm? -64.16 123.95 20.41 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 122.817 1.294 . . . . 49.060000000000002 112.099 -176.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -89.81 141.24 28.15 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 104.807 -2.294 . . . . 51.079999999999998 104.807 175.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -56.81 148.26 67.51 Favored 'Trans proline' 0 CA--C 1.503 -1.031 0 C-N-CA 122.745 2.297 . . . . 49.729999999999997 116.035 -177.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 84.05 -14.11 45.76 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 113.887 -1.506 . . . . 47.710000000000001 113.658 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1087 ' ' THR . . . . . . . . . . . . . 38.6 m -59.2 127.04 30.15 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 119.868 1.834 . . . . 45.469999999999999 113.293 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1088 ' ' THR . . . . . . . . . . . . . 31.0 m -75.31 96.46 3.38 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 105.66 -1.978 . . . . 42.039999999999999 105.66 173.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1089 ' ' LEU . . . . . . . . . . . . . 42.7 tp -89.09 113.36 24.5 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 113.301 -1.772 . . . . 38.060000000000002 108.028 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 3.3 t -108.37 109.06 26.89 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 N-CA-C 102.265 -3.235 . . . . 37.399999999999999 102.265 -173.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1091 ' ' SER . . . . . . . . . . . . . 19.7 m -145.67 153.87 41.49 Favored 'General case' 0 C--O 1.224 -0.285 0 O-C-N 120.686 -1.259 . . . . 36.159999999999997 112.888 -166.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 2.8 t80 -84.67 91.03 7.83 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 105.727 -1.953 . . . . 38.939999999999998 105.727 172.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 26.5 mm -83.86 -49.57 16.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 115.37 1.619 . . . . 42.170000000000002 115.37 -172.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 96.4 m95 60.42 73.0 0.67 Allowed Pre-proline 0 C--O 1.255 1.366 0 C-N-CA 125.243 1.417 . . . . 46.509999999999998 111.021 -159.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -59.76 -38.39 80.9 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 124.754 3.636 . . . . 49.759999999999998 116.566 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -55.69 -47.44 76.78 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.618 -1.628 . . . . 52.619999999999997 110.824 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -64.77 -27.49 68.93 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 113.361 -1.745 . . . . 60.740000000000002 113.577 174.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1098 ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -123.32 56.96 10.34 Favored Pre-proline 0 N--CA 1.449 -0.478 0 N-CA-C 119.363 3.097 . . . . 58.189999999999998 119.363 -164.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -59.19 -47.67 16.6 Favored 'Trans proline' 0 N--CA 1.479 0.633 0 C-N-CA 123.399 2.732 . . . . 54.590000000000003 115.257 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.38 -44.52 97.02 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 113.18 0.807 . . . . 63.280000000000001 113.18 177.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1101 ' ' LEU . . . . . . . . . . . . . 8.2 tp -62.5 -46.26 89.26 Favored 'General case' 0 N--CA 1.441 -0.898 0 O-C-N 124.608 1.192 . . . . 54.75 107.853 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1102 ' ' MET . . . . . . . . . . . . . 49.8 mmm -53.98 -45.56 71.42 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 123.366 0.667 . . . . 52.649999999999999 112.054 175.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -62.11 -34.41 76.28 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 118.017 -0.992 . . . . 66.260000000000005 112.364 175.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 86.2 mttt -66.58 -46.62 75.38 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.891 -0.781 . . . . 63.729999999999997 108.891 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.01 -39.08 84.59 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 121.191 -0.943 . . . . 54.68 110.513 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -69.56 -38.8 77.59 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.397 -0.814 . . . . 53.640000000000001 111.308 176.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -71.85 -18.87 62.04 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 120.292 1.405 . . . . 67.239999999999995 112.186 177.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -77.55 -4.78 47.44 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 116.124 1.898 . . . . 65.760000000000005 116.124 163.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 5.2 t30 55.17 40.8 31.85 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 126.166 1.786 . . . . 58.710000000000001 111.532 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1110 ' ' VAL . . . . . . . . . . . . . 30.8 m -98.27 153.67 4.01 Favored 'Isoleucine or valine' 0 C--N 1.344 0.357 0 O-C-N 121.24 -0.913 . . . . 46.630000000000003 113.007 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1111 ' ' THR . . . . . . . . . . . . . 53.6 m -88.89 100.22 13.01 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 104.704 -2.332 . . . . 44.130000000000003 104.704 176.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1112 ' ' VAL . . . . . . . . . . . . . 62.2 t -93.82 115.16 31.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 O-C-N 121.111 -0.993 . . . . 40.439999999999998 109.743 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1113 ' ' MET . . . . . . . . . . . . . 19.3 mtp -101.24 102.42 13.3 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.033 -1.894 . . . . 50.759999999999998 108.564 173.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1114 ' ' ALA . . . . . . . . . . . . . . . -80.08 108.07 13.37 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 122.936 1.351 . . . . 35.640000000000001 108.88 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1115 ' ' MET . . . . . . . . . . . . . 69.9 mmm -71.83 -20.71 61.79 Favored 'General case' 0 C--O 1.243 0.759 0 O-C-N 119.437 -2.04 . . . . 38.740000000000002 115.308 -174.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -66.08 -32.63 74.2 Favored 'General case' 0 C--O 1.246 0.915 0 CA-C-O 122.238 1.018 . . . . 40.140000000000001 109.289 164.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1117 ' ' SER . . . . . . . . . . . . . 68.9 m -91.09 34.47 0.93 Allowed 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 117.14 2.274 . . . . 44.789999999999999 117.14 -176.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1118 ' ' VAL . . . . . . . . . . . . . 3.5 t -75.56 129.03 82.81 Favored Pre-proline 0 N--CA 1.439 -1.011 0 O-C-N 121.718 -0.614 . . . . 43.75 109.547 165.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -61.19 137.97 74.55 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.714 2.276 . . . . 48.93 111.795 172.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 25.1 mmm-85 -90.16 32.86 0.9 Allowed 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.204 -1.56 . . . . 62.899999999999999 111.546 -152.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 30.8 pt -79.89 155.63 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 O-C-N 118.492 -2.63 . . . . 57.719999999999999 112.198 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1122 ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -43.27 -58.99 2.27 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 120.653 3.575 . . . . 57.259999999999998 120.653 -177.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1123 ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.09 -16.55 32.72 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 116.565 2.061 . . . . 62.899999999999999 116.565 175.027 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -80.41 -15.05 57.74 Favored 'General case' 0 N--CA 1.424 -1.755 0 O-C-N 118.67 -2.519 . . . . 49.829999999999998 113.472 177.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 69.6 mm-40 -66.99 -22.04 65.93 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 116.996 2.221 . . . . 52.369999999999997 116.996 -163.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1126 ' ' SER . . . . . . . . . . . . . 13.7 m -73.31 -19.18 61.09 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 115.174 1.546 . . . . 42.43 115.174 169.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1127 ' ' LEU . . . . . . . . . . . . . 2.7 mp -95.84 -30.64 13.56 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.591 -0.892 . . . . 43.740000000000002 108.591 173.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 65.6 t0 -65.06 106.91 1.37 Allowed 'General case' 0 C--O 1.247 0.954 0 CA-C-O 125.833 2.73 . . . . 43.210000000000001 112.045 -173.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -85.08 -28.72 25.43 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 109.576 -3.465 . . . . 35.740000000000002 110.12 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.82 -20.26 65.9 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-N 120.866 1.666 . . . . 38.090000000000003 109.107 177.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1131 ' ' SER . . . . . . . . . . . . . 65.4 m -82.5 -64.37 1.19 Allowed 'General case' 0 CA--C 1.545 0.766 0 O-C-N 119.413 -2.054 . . . . 36.909999999999997 110.327 161.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1132 ' ' SER . . . . . . . . . . . . . 19.4 m -66.92 -44.51 80.51 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 117.678 2.473 . . . . 35.789999999999999 117.678 -168.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1133 ' ' MET . . . . . . . . . . . . . 5.2 ttt -68.37 -35.18 77.34 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 121.784 2.084 . . . . 30.809999999999999 110.624 176.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1134 ' ' ALA . . . . . . . . . . . . . . . -60.51 -40.82 92.79 Favored 'General case' 0 C--O 1.251 1.18 0 N-CA-C 109.143 -0.688 . . . . 28.879999999999999 109.143 173.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1135 ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -53.8 -48.06 70.22 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.235 1.414 . . . . 40.759999999999998 112.285 175.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1136 ' ' ILE . . . . . . . . . . . . . 69.0 mt -57.87 -47.48 86.16 Favored 'Isoleucine or valine' 0 C--O 1.247 0.934 0 CA-C-N 114.388 -1.278 . . . . 31.539999999999999 110.985 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -60.83 -34.24 74.26 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.068 -1.423 . . . . 29.870000000000001 110.495 174.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -62.59 -48.5 81.17 Favored Glycine 0 C--O 1.211 -1.327 0 CA-C-N 119.296 0.953 . . . . 28.73 112.177 176.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 28.3 t80 -59.93 -42.06 93.15 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.596 -0.802 . . . . 30.390000000000001 110.317 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1140 ' ' ARG . . . . . 0.425 ' NH1' ' O ' ' A' 1318 ' ' ARG . 1.1 tpt180 -73.34 -22.6 60.27 Favored 'General case' 0 CA--C 1.497 -1.066 0 O-C-N 124.445 1.091 . . . . 26.09 113.178 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1141 ' ' ALA . . . . . . . . . . . . . . . -66.62 -48.02 70.78 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 105.545 -2.02 . . . . 27.100000000000001 105.545 171.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 25.8 mm -53.66 -43.43 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 C-N-CA 125.442 1.497 . . . . 28.48 111.541 175.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 75.4 t -58.55 -61.68 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 O-C-N 120.653 -1.279 . . . . 23.07 110.113 173.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1144 ' ' GLU . . . . . 0.418 ' CD ' HH21 ' A' 1140 ' ' ARG . 5.7 mm-40 -62.42 -28.28 69.68 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 122.126 2.239 . . . . 33.399999999999999 114.137 -177.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -57.38 -60.47 3.59 Favored 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 124.668 1.187 . . . . 24.219999999999999 109.721 169.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -65.39 -20.49 66.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.554 0.692 . . . . 24.890000000000001 111.038 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -76.61 -33.53 58.39 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-O 115.511 -2.185 . . . . 26.73 110.725 177.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1148 ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -110.16 3.38 20.09 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 122.221 2.282 . . . . 39.960000000000001 115.785 175.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1149 ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -67.08 145.94 54.82 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 126.063 1.745 . . . . 25.870000000000001 110.448 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1150 ' ' GLY . . . . . . . . . . . . . . . -69.75 -45.18 59.59 Favored Glycine 0 N--CA 1.43 -1.732 0 O-C-N 121.308 -0.87 . . . . 19.280000000000001 113.504 171.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1151 ' ' ARG . . . . . . . . . . . . . 69.7 mtm-85 -107.42 -173.79 2.37 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 124.362 1.065 . . . . 39.899999999999999 113.347 -166.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1152 ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -84.07 149.68 26.08 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 106.218 -1.771 . . . . 29.440000000000001 106.218 172.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1153 ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -64.95 -53.31 48.39 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 124.177 1.942 . . . . 32.600000000000001 110.18 152.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1154 ' ' THR . . . . . . . . . . . . 0.255 56.3 m -65.03 110.77 2.6 Favored 'General case' 0 C--O 1.249 1.068 0 CA-C-N 111.908 -2.406 . . . . 34.640000000000001 116.427 -174.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -64.07 138.85 41.89 Favored Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 109.579 -1.409 . . . . 37.140000000000001 109.579 163.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -173.63 158.84 3.45 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 122.53 1.157 . . . . 40.57 111.507 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1157 ' ' ILE . . . . . . . . . . . . . 6.5 tp -79.03 136.81 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 O-C-N 119.995 -1.691 . . . . 44.609999999999999 109.41 163.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1158 ' ' THR . . . . . . . . . . . . . 68.7 p -111.28 -160.12 0.7 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 105.469 -2.049 . . . . 40.700000000000003 105.469 169.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -83.28 -20.29 34.72 Favored 'General case' 0 CA--C 1.541 0.634 1 O-C-N 116.284 -4.01 . . . . 40.25 108.92 165.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -96.46 43.98 1.07 Allowed 'General case' 0 C--O 1.246 0.897 0 CA-C-O 123.32 1.533 . . . . 38.469999999999999 110.238 175.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . 74.97 -171.99 53.52 Favored Glycine 0 C--O 1.244 0.762 0 O-C-N 119.943 -1.723 . . . . 37.609999999999999 116.074 170.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -72.82 135.1 45.16 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 122.812 1.292 . . . . 48.899999999999999 112.186 -174.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1163 ' ' VAL . . . . . . . . . . . . . 84.0 t -93.86 127.08 46.87 Favored Pre-proline 0 C--O 1.25 1.089 0 N-CA-C 104.398 -2.445 . . . . 36.520000000000003 104.398 162.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1164 ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.09 145.86 40.22 Favored 'Trans proline' 0 N--CA 1.444 -1.403 0 C-N-CA 124.615 3.544 . . . . 35.079999999999998 109.838 173.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1165 ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -62.01 147.13 95.75 Favored 'Trans proline' 0 C--O 1.245 0.833 0 C-N-CA 123.889 3.059 . . . . 35.329999999999998 109.713 172.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -78.64 135.41 37.21 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.736 1.014 . . . . 34.689999999999998 113.736 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1167 ' ' LYS . . . . . . . . . . . . . 44.3 mttp -84.24 100.02 10.93 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 102.263 -3.236 . . . . 45.359999999999999 102.263 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 59.9 t -91.38 88.27 2.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 114.793 -1.094 . . . . 31.710000000000001 110.241 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1169 ' ' MET . . . . . . . . . . . . . 37.2 ttp -77.2 107.04 9.3 Favored 'General case' 0 CA--C 1.498 -1.037 0 O-C-N 119.49 -2.006 . . . . 42.280000000000001 107.884 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 59.4 t -92.29 121.81 43.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 117.27 -1.348 . . . . 30.510000000000002 109.612 176.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 20.8 mt -107.36 131.37 57.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 104.609 -2.367 . . . . 31.870000000000001 104.609 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 82.22 61.77 1.97 Allowed Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 108.584 -1.807 . . . . 34.539999999999999 108.584 174.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1173 ' ' ALA . . . . . . . . . . . . . . . -77.37 76.98 3.9 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 120.373 -1.663 . . . . 32.509999999999998 115.108 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -84.81 -160.77 32.72 Favored Glycine 0 C--O 1.219 -0.796 0 CA-C-O 116.774 -2.126 . . . . 29.899999999999999 110.25 156.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1175 ' ' VAL . . . . . . . . . . . . . 48.3 t -64.63 -31.09 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 1 CA-C-N 124.977 4.389 . . . . 33.109999999999999 114.32 -176.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -53.58 -47.58 69.98 Favored 'General case' 0 C--O 1.218 -0.559 0 O-C-N 121.885 -0.509 . . . . 28.100000000000001 111.602 165.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -63.71 -42.88 98.51 Favored Glycine 0 CA--C 1.507 -0.419 0 CA-C-O 118.846 -0.974 . . . . 28.539999999999999 111.759 176.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1178 ' ' LEU . . . . . . . . . . . . . 52.4 mt -62.9 -35.19 79.25 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 117.462 -1.256 . . . . 31.219999999999999 110.698 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -64.61 -34.88 79.3 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 121.769 2.077 . . . . 28.98 112.374 172.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -67.81 -45.78 73.79 Favored 'General case' 0 C--O 1.253 1.25 0 CA-C-N 115.249 -0.887 . . . . 27.829999999999998 112.079 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1181 ' ' ILE . . . . . . . . . . . . . 54.7 mt -57.32 -53.9 37.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.496 0 CA-C-N 114.93 -1.032 . . . . 30.25 109.07 175.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -52.72 -58.0 12.6 Favored Glycine 0 N--CA 1.471 1.005 0 O-C-N 125.161 1.538 . . . . 29.59 109.71 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -60.37 -48.78 80.29 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 115.338 1.607 . . . . 30.289999999999999 115.338 -175.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -69.75 -33.22 72.14 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 120.116 1.325 . . . . 30.469999999999999 114.394 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -65.99 -43.78 86.76 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.689 -0.856 . . . . 42.409999999999997 108.689 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1186 ' ' SER . . . . . . . . . . . . . 68.1 m -59.38 -48.18 82.61 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 121.073 -1.017 . . . . 39.380000000000003 112.586 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 10.6 mt -53.43 -34.47 57.94 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 117.207 2.299 . . . . 36.18 117.207 170.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 105.36 52.38 0.82 Allowed Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 109.124 -1.591 . . . . 33.780000000000001 109.124 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -135.54 143.93 45.99 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 107.488 -1.301 . . . . 33.93 107.488 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 7.5 mt -79.57 106.85 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 103.111 -2.922 . . . . 38.740000000000002 103.111 -170.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 44.0 t -76.21 135.26 27.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 105.974 -1.861 . . . . 33.090000000000003 105.974 173.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1192 ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -126.4 87.01 2.6 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 102.741 -3.059 . . . . 38.920000000000002 102.741 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -95.59 154.56 17.15 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 120.33 -1.481 . . . . 35.32 111.794 -170.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 35.6 t80 -155.91 164.31 38.66 Favored 'General case' 0 C--O 1.25 1.115 0 O-C-N 124.557 1.161 . . . . 39.350000000000001 108.064 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 10.6 t70 -164.77 162.63 21.22 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 104.492 -2.41 . . . . 40.460000000000001 104.492 174.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1196 ' ' THR . . . . . . . . . . . . . 5.6 m -58.36 -38.63 77.62 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.836 -1.075 . . . . 45.939999999999998 111.877 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1197 ' ' ARG . . . . . . . . . . . . . 40.5 mtm180 -90.06 113.86 58.76 Favored Pre-proline 0 N--CA 1.449 -0.498 0 C-N-CA 126.191 1.796 . . . . 56.020000000000003 108.214 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1198 ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -55.1 -22.27 30.89 Favored 'Trans proline' 0 N--CA 1.435 -1.955 0 C-N-CA 125.202 3.935 . . . . 51.270000000000003 116.361 173.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -47.86 -41.0 23.03 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 116.539 2.051 . . . . 59.100000000000001 116.539 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 32.8 m -64.16 -9.29 5.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 116.095 1.887 . . . . 51.060000000000002 116.095 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1201 ' ' LYS . . . . . 0.406 ' HZ1' ' CD ' ' A' 1213 ' ' GLU . 80.6 tttt -53.74 -40.81 66.45 Favored 'General case' 0 N--CA 1.436 -1.126 0 O-C-N 123.769 0.668 . . . . 57.380000000000003 111.908 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.91 -47.51 71.11 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 115.444 1.646 . . . . 62.409999999999997 115.444 174.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -61.89 -43.41 98.91 Favored 'General case' 0 C--O 1.256 1.44 0 CA-C-O 123.37 1.557 . . . . 57.780000000000001 112.538 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 42.2 t -53.68 -57.24 5.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 112.571 -2.104 . . . . 46.380000000000003 109.0 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -70.53 -31.57 68.7 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 113.106 -1.861 . . . . 50.700000000000003 112.313 -177.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1206 ' ' SER . . . . . . . . . . . . . 66.8 m -70.7 -45.02 65.74 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 119.797 1.18 . . . . 49.979999999999997 111.328 -177.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1207 ' ' MET . . . . . . . . . . . . . 59.3 mtm -68.19 -34.18 75.8 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 122.723 1.249 . . . . 52.990000000000002 112.988 175.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 123.42 96.25 1.23 Allowed Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 107.56 -2.216 . . . . 47.659999999999997 107.56 171.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -168.12 160.19 11.62 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 120.788 -0.365 . . . . 44.770000000000003 110.188 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -85.62 145.91 27.11 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 102.894 -3.002 . . . . 47.640000000000001 102.894 170.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1211 ' ' PHE . . . . . . . . . . . . . 71.6 t80 -112.93 145.28 41.04 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 103.341 -2.837 . . . . 45.659999999999997 103.341 173.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 80.0 mt -71.14 108.54 4.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 123.369 1.557 . . . . 46.060000000000002 112.233 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1213 ' ' GLU . . . . . 0.406 ' CD ' ' HZ1' ' A' 1201 ' ' LYS . 7.2 mm-40 -87.22 123.98 32.82 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 106.238 -1.764 . . . . 60.219999999999999 106.238 174.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 8.9 mp -90.34 144.81 25.48 Favored 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 115.259 1.577 . . . . 57.25 115.259 -176.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 35.6 t70 -71.59 83.56 0.85 Allowed 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 112.976 -1.92 . . . . 64.430000000000007 109.922 165.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 83.4 t80 . . . . . 0 C--O 1.216 -0.678 0 N-CA-C 102.38 -3.193 . . . . 66.900000000000006 102.38 -177.011 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 9.2 p-10 . . . . . 0 N--CA 1.437 -1.114 0 N-CA-C 106.779 -1.563 . . . . 39.090000000000003 106.779 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -49.33 -51.11 27.51 Favored Glycine 0 N--CA 1.474 1.185 0 C-N-CA 126.956 2.217 . . . . 39.32 112.943 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 60.3 t80 -64.86 -47.56 77.46 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 119.292 1.546 . . . . 39.299999999999997 111.739 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -63.91 -43.33 96.26 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 119.625 1.102 . . . . 36.299999999999997 113.105 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -57.07 -34.52 68.35 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 124.263 0.977 . . . . 37.380000000000003 112.144 174.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -63.43 -53.99 38.36 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 CA-C-N 121.106 1.775 . . . . 39.109999999999999 111.449 166.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1230 ' ' MET . . . . . . . . . . . . . 28.9 mmt -71.13 40.57 0.06 Allowed 'General case' 0 C--O 1.242 0.709 0 N-CA-C 113.706 1.002 . . . . 49.590000000000003 113.706 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1231 ' ' SER . . . . . . . . . . . . . 61.8 p -114.12 157.02 23.15 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 118.681 -2.512 . . . . 43.68 108.131 -174.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -55.11 -46.6 75.56 Favored 'General case' 0 C--N 1.356 0.865 0 CA-C-O 123.399 1.571 . . . . 55.57 110.289 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -70.76 -35.6 72.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 117.851 -1.071 . . . . 44.939999999999998 113.579 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 31.9 t80 -72.26 -48.44 42.61 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 122.535 2.425 . . . . 42.039999999999999 109.403 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 58.9 mt -64.3 -32.17 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 CA-C-N 118.645 0.657 . . . . 46.280000000000001 111.893 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 41.1 tttm -52.88 -53.72 44.91 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.783 -1.192 . . . . 47.869999999999997 107.783 167.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -62.85 -32.2 73.38 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 114.433 1.272 . . . . 41.609999999999999 114.433 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -54.43 -50.24 68.08 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 119.054 0.843 . . . . 50.649999999999999 112.614 165.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1239 ' ' MET . . . . . . . . . . . . . 34.3 mmt -61.15 -47.52 85.84 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 123.152 1.453 . . . . 48.869999999999997 110.075 -178.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -58.83 -40.08 83.15 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 112.949 -1.932 . . . . 54.799999999999997 109.613 175.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 3.5 mm? -75.19 -33.83 61.47 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 122.376 2.353 . . . . 43.210000000000001 112.453 176.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -69.81 -40.56 75.87 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 121.788 2.086 . . . . 38.659999999999997 109.681 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -64.73 -38.65 91.7 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 125.231 1.412 . . . . 37.920000000000002 111.464 171.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -63.69 -25.15 68.08 Favored 'General case' 0 C--O 1.246 0.882 0 O-C-N 120.026 -1.671 . . . . 37.280000000000001 112.567 171.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -84.09 -32.15 24.93 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-O 118.548 -0.739 . . . . 43.07 111.83 176.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -49.92 -45.19 50.76 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 113.443 0.905 . . . . 38.299999999999997 113.443 -158.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1247 ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.38 -11.53 59.69 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 119.423 -2.048 . . . . 47.600000000000001 111.757 -172.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -106.88 -31.65 8.26 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 118.548 -0.739 . . . . 45.420000000000002 110.672 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1249 ' ' VAL . . . . . . . . . . . . 0.307 12.2 m -68.45 152.86 9.26 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 N-CA-C 117.658 2.466 . . . . 36.259999999999998 117.658 -172.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1250 ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -113.74 -54.77 2.58 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 112.636 -2.074 . . . . 33.039999999999999 109.274 -171.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1251 ' ' ILE . . . . . . . . . . . . . 25.8 mm -124.13 122.8 65.2 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.692 0 N-CA-C 101.644 -3.465 . . . . 31.399999999999999 101.644 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1252 ' ' ILE . . . . . . . . . . . . . 55.5 mt -99.72 127.47 52.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 103.579 -2.749 . . . . 29.420000000000002 103.579 161.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 11.2 t -110.87 104.73 17.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 1 N-CA-C 100.141 -4.022 . . . . 30.370000000000001 100.141 176.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1254 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.91 84.77 6.64 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-O 125.619 2.628 . . . . 35.719999999999999 111.971 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1255 ' ' THR . . . . . . . . . . . . . 14.6 p -95.09 12.68 27.76 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 110.765 -2.925 . . . . 36.0 116.748 -176.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1256 ' ' ALA . . . . . . . . . . . . . . . -83.97 67.4 9.62 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 120.909 1.686 . . . . 40.93 112.011 -176.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 37.3 tp -82.24 99.27 9.2 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 106.561 -1.644 . . . . 47.82 106.561 176.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 30.8 mm -75.87 139.65 70.02 Favored Pre-proline 0 N--CA 1.433 -1.32 0 N-CA-C 108.071 -1.085 . . . . 52.700000000000003 108.071 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -59.78 114.04 1.9 Allowed 'Trans proline' 0 CA--C 1.512 -0.597 0 C-N-CA 122.573 2.182 . . . . 54.130000000000003 112.719 169.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 80.91 -75.47 2.27 Favored Glycine 0 C--O 1.255 1.44 0 N-CA-C 107.047 -2.421 . . . . 54.619999999999997 107.047 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 89.9 mttt -51.03 140.38 21.25 Favored Pre-proline 0 C--O 1.252 1.225 0 C-N-CA 126.064 1.746 . . . . 55.740000000000002 112.072 -177.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -56.64 136.29 75.21 Favored 'Trans proline' 0 N--CA 1.44 -1.634 1 C-N-CA 125.311 4.008 . . . . 51.149999999999999 111.043 176.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -54.98 130.81 67.49 Favored Pre-proline 0 N--CA 1.47 0.538 0 CA-C-O 121.791 0.805 . . . . 46.060000000000002 110.718 170.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -56.5 129.2 33.46 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 124.565 3.51 . . . . 41.079999999999998 110.68 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -77.6 70.15 3.94 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 124.923 2.297 . . . . 47.420000000000002 111.874 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 61.0 mt -69.91 -58.53 3.75 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 109.572 -3.467 . . . . 39.219999999999999 110.75 -164.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 31.9 mt -83.78 106.26 14.07 Favored 'Isoleucine or valine' 0 C--O 1.246 0.918 0 N-CA-C 106.987 -1.486 . . . . 42.5 106.987 -174.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1268 ' ' THR . . . . . . . . . . . . . 38.5 p -67.55 156.15 37.43 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 115.83 -0.623 . . . . 37.840000000000003 111.562 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -55.32 -34.73 64.43 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.513 -0.551 . . . . 54.799999999999997 109.513 171.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -48.73 -54.65 14.09 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 113.403 0.89 . . . . 54.359999999999999 113.403 166.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1271 ' ' MET . . . . . . . . . . . . . 26.5 mtm -68.23 -35.52 78.08 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.833 0.679 . . . . 39.520000000000003 112.833 -177.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1272 ' ' VAL . . . . . . . . . . . . . 79.2 t -62.82 -51.89 66.33 Favored 'Isoleucine or valine' 0 C--O 1.25 1.13 0 N-CA-C 106.611 -1.626 . . . . 38.25 106.611 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.05 -33.48 67.28 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 117.776 2.51 . . . . 40.770000000000003 117.776 170.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1274 ' ' SER . . . . . . . . . . . . . 41.0 m -80.39 -3.06 48.23 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 113.273 0.842 . . . . 36.579999999999998 113.273 174.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1275 ' ' MET . . . . . . . . . . . . . 16.2 mtp -69.31 158.63 34.67 Favored 'General case' 0 CA--C 1.51 -0.583 0 O-C-N 118.705 -2.497 . . . . 36.75 116.706 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1276 ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -65.21 139.65 58.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 124.343 2.021 . . . . 46.109999999999999 108.006 168.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1277 ' ' ALA . . . . . . . . . . . . 0.253 . . -75.64 157.85 33.18 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 108.588 -3.915 . . . . 33.520000000000003 109.889 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 73.21 24.1 76.2 Favored Glycine 0 C--N 1.347 1.167 0 N-CA-C 110.917 -0.873 . . . . 31.27 110.917 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1279 ' ' SER . . . . . . . . . . . . . 22.7 m -122.22 169.65 10.69 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.734 -0.733 . . . . 32.950000000000003 110.971 -171.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1280 ' ' VAL . . . . . . . . . . . . . 42.5 t -132.11 141.92 44.16 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 N-CA-C 108.347 -0.983 . . . . 27.43 108.347 -171.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1281 ' ' ILE . . . . . . . . . . . . . 84.9 mt -114.44 102.32 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 1 N-CA-C 99.335 -4.32 . . . . 30.300000000000001 99.335 164.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -87.91 96.44 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 CA-C-O 123.21 1.481 . . . . 28.629999999999999 107.343 172.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 4.9 t70 -87.76 100.01 12.52 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 113.989 -1.459 . . . . 36.270000000000003 110.941 -175.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1284 ' ' LEU . . . . . . . . . . . . . 5.5 tt -74.27 -34.57 63.62 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 123.664 1.697 . . . . 38.57 108.42 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -63.42 -13.45 40.18 Favored 'General case' 0 CA--C 1.508 -0.665 0 O-C-N 120.478 -1.389 . . . . 37.560000000000002 113.84 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . -34.19 -38.39 0.06 Allowed 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 121.674 3.953 . . . . 40.329999999999998 121.674 175.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -66.63 -22.74 66.11 Favored 'General case' 0 C--N 1.345 0.4 0 C-N-CA 118.662 -1.215 . . . . 56.850000000000001 113.88 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 30.2 t30 -142.06 86.99 2.01 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.145 -1.428 . . . . 45.859999999999999 107.145 177.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 106.16 -67.84 0.24 Allowed Glycine 0 CA--C 1.492 -1.361 0 C-N-CA 120.054 -1.07 . . . . 40.310000000000002 111.494 175.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 86.08 111.27 0.8 Allowed Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 105.769 -2.933 . . . . 38.890000000000001 105.769 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1291 ' ' ASN . . . . . . . . . . . . . 27.1 m120 -70.68 -22.93 62.42 Favored 'General case' 0 C--O 1.223 -0.309 0 O-C-N 120.183 -1.775 . . . . 37.229999999999997 113.393 -171.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1292 ' ' CYS . . . . . . . . . . . . . 35.6 t -89.46 143.81 26.53 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 104.335 -2.468 . . . . 36.5 104.335 171.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1293 ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -77.14 -21.21 54.49 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 123.402 1.572 . . . . 43.32 112.425 174.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.92 10.98 12.41 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 116.958 2.207 . . . . 41.32 116.958 170.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1295 ' ' THR . . . . . . . . . . . . . 89.9 m -68.82 113.97 6.74 Favored 'General case' 0 C--O 1.25 1.092 0 O-C-N 118.282 -2.761 . . . . 35.299999999999997 110.579 -175.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 10.4 t -84.19 116.06 63.12 Favored Pre-proline 0 N--CA 1.449 -0.505 0 N-CA-C 107.28 -1.378 . . . . 34.840000000000003 107.28 169.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.87 98.66 0.71 Allowed 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 122.866 2.377 . . . . 33.509999999999998 111.944 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 115.06 13.32 9.25 Favored Glycine 0 N--CA 1.432 -1.618 0 CA-C-N 114.316 -1.311 . . . . 32.189999999999998 112.874 170.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -159.21 168.69 25.88 Favored 'General case' 0 N--CA 1.435 -1.213 0 O-C-N 120.289 -1.712 . . . . 34.880000000000003 108.958 -174.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1300 ' ' ILE . . . . . . . . . . . . . 48.4 mt -89.32 115.36 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 104.284 -2.487 . . . . 32.289999999999999 104.284 175.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 52.9 t80 -85.83 150.15 24.75 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 105.777 -1.934 . . . . 37.25 105.777 162.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1302 ' ' THR . . . . . . . . . . . . . 88.5 m -135.16 122.15 21.26 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 119.294 0.952 . . . . 35.560000000000002 109.16 174.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1303 ' ' THR . . . . . . . . . . . . . 1.2 p -74.67 160.77 30.38 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 122.289 1.043 . . . . 36.399999999999999 111.575 173.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -68.23 -22.73 64.77 Favored 'General case' 0 C--O 1.249 1.069 0 O-C-N 120.376 -1.453 . . . . 52.32 111.747 -174.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -75.41 -10.64 59.63 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 118.402 -0.809 . . . . 40.039999999999999 110.82 175.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 94.15 43.74 3.71 Favored Glycine 0 N--CA 1.432 -1.625 0 O-C-N 124.085 0.865 . . . . 36.960000000000001 111.5 175.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1307 ' ' VAL . . . . . . . . . . . . . 76.8 t -108.55 123.71 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 117.746 -1.582 . . . . 33.399999999999999 107.567 168.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1308 ' ' LYS . . . . . . . . . . . . . 32.1 mmtt -86.29 98.4 10.94 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 121.878 0.847 . . . . 42.909999999999997 109.144 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 7.7 t -84.44 86.53 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 104.73 -2.322 . . . . 32.289999999999999 104.73 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1310 ' ' ILE . . . . . . . . . . . . . 33.9 mt -81.98 92.26 2.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 113.691 -1.595 . . . . 30.989999999999998 109.582 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -85.96 53.86 4.7 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 113.452 -1.704 . . . . 28.949999999999999 113.153 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1312 ' ' TYR . . . . . . . . . . . . . 1.4 m-30 -87.67 104.61 16.69 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 125.355 2.503 . . . . 31.690000000000001 107.233 -171.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1313 ' ' THR . . . . . . . . . . . . . 33.9 p -66.26 -42.56 88.35 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 110.815 -2.902 . . . . 34.170000000000002 111.113 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -68.34 8.27 0.48 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 111.79 -2.459 . . . . 36.859999999999999 116.981 -177.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1315 ' ' LEU . . . . . . . . . . . . . 96.2 mt -45.4 -39.18 9.19 Favored Pre-proline 0 N--CA 1.478 0.945 0 O-C-N 118.345 -2.722 . . . . 34.850000000000001 116.498 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -56.14 -46.18 32.78 Favored 'Trans proline' 0 C--O 1.247 0.95 0 C-N-CA 123.064 2.509 . . . . 29.149999999999999 113.842 168.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -60.35 -43.74 98.31 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-N 114.058 -1.428 . . . . 27.289999999999999 110.951 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1318 ' ' ARG . . . . . 0.425 ' O ' ' NH1' ' A' 1140 ' ' ARG . 85.3 mtt-85 -62.37 -29.17 70.28 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 122.027 0.918 . . . . 41.490000000000002 113.233 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1319 ' ' LEU . . . . . . . . . . . . . 3.9 tp -108.05 68.61 0.3 Allowed Pre-proline 0 N--CA 1.439 -0.982 0 O-C-N 120.002 -1.686 . . . . 27.609999999999999 111.074 168.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1320 ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -62.6 -58.25 0.36 Allowed 'Trans proline' 0 CA--C 1.499 -1.233 0 C-N-CA 124.553 3.502 . . . . 25.940000000000001 111.963 -163.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1321 ' ' THR . . . . . . . . . . . . . 1.8 m -60.55 -28.88 68.78 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 120.512 1.505 . . . . 25.010000000000002 110.178 -174.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1322 ' ' GLN . . . . . . . . . . . . . 9.4 tp60 -79.79 -33.87 40.12 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 117.618 -1.182 . . . . 29.390000000000001 110.002 -176.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1323 ' ' SER . . . . . . . . . . . . . 31.6 m -57.17 -56.18 25.09 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 119.902 1.228 . . . . 26.469999999999999 108.536 165.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1324 ' ' SER . . . . . . . . . . . . . 14.9 m -65.31 -21.67 66.74 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 122.136 0.969 . . . . 27.780000000000001 113.501 -172.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -93.12 -55.41 3.34 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 115.939 -1.981 . . . . 37.530000000000001 111.138 173.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1326 ' ' LEU . . . . . . . . . . . . . 93.0 mt -71.6 -56.44 5.86 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 122.193 2.27 . . . . 35.710000000000001 112.552 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1327 ' ' TYR . . . . . . . . . . . . . 86.0 t80 -58.71 -42.45 88.68 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 119.37 0.986 . . . . 31.59 108.933 172.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1328 ' ' GLY . . . . . . . . . . . . . . . -46.21 -50.51 12.82 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-N 118.44 0.564 . . . . 28.0 112.197 169.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1329 ' ' THR . . . . . . . . . . . . . 34.6 m -71.25 -20.95 62.17 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-O 117.771 -1.109 . . . . 32.149999999999999 112.258 174.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1330 ' ' ASN . . . . . . . . . . . . . 13.7 m120 -62.18 -46.17 90.13 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 124.755 3.434 . . . . 34.359999999999999 109.73 170.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1331 ' ' LEU . . . . . . . . . . . . . 15.7 mt -57.01 -52.18 66.31 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-N 113.159 -1.837 . . . . 33.369999999999997 112.689 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1332 ' ' VAL . . . . . . . . . . . . . 45.6 t -63.5 -42.25 95.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 105.388 -2.078 . . . . 35.270000000000003 105.388 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -59.81 -37.08 78.14 Favored 'General case' 0 CA--C 1.504 -0.794 0 O-C-N 119.534 -1.979 . . . . 37.659999999999997 113.562 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1334 ' ' LEU . . . . . . . . . . . . . 43.1 tp -60.03 -52.96 63.14 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.289 -0.634 . . . . 40.270000000000003 109.289 165.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1335 ' ' LEU . . . . . . . . . . . . . 19.0 mt -63.8 -18.15 63.81 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 115.308 1.596 . . . . 42.5 115.308 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1336 ' ' LYS . . . . . . . . . . . . . 78.8 mttt -69.36 -36.38 76.79 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 120.341 -1.474 . . . . 47.810000000000002 109.198 172.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1337 ' ' LEU . . . . . . . . . . . . . 10.2 mp -70.33 -40.33 74.2 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 122.864 1.316 . . . . 49.270000000000003 111.831 170.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1338 ' ' LEU . . . . . . . . . . . . . 3.1 mp -67.83 -47.6 68.54 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 116.793 2.146 . . . . 50.539999999999999 116.793 -177.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1339 ' ' CYS . . . . . . . . . . . . . 41.1 t -83.21 100.31 10.5 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 102.639 -3.097 . . . . 53.670000000000002 102.639 175.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 28.5 mtpt -84.04 -70.37 0.57 Allowed 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 118.878 -2.389 . . . . 63.380000000000003 111.883 -177.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -72.7 -15.35 61.69 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.25 0.833 . . . . 70.950000000000003 113.25 -171.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1342 ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? 49.11 58.11 5.73 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 116.892 -1.528 . . . . 65.25 111.77 -173.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1343 ' ' ASP . . . . . . . . . . . . 0.404 0.0 OUTLIER 63.72 -78.04 0.03 OUTLIER 'General case' 0 C--N 1.356 0.874 2 O-C-N 113.242 -5.911 . . . . 64.530000000000001 114.817 21.309 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A 1344 ' ' GLY . . . . . . . . . . . . . . . 71.58 52.04 14.05 Favored Glycine 0 C--O 1.217 -0.952 0 CA-C-N 120.908 1.685 . . . . 59.719999999999999 111.607 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 44.3 t30 -146.73 155.08 42.13 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 119.799 1.799 . . . . 64.090000000000003 106.663 172.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1346 ' ' ILE . . . . . . . . . . . . . 34.4 mt -88.94 124.05 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 CA-C-O 124.48 2.086 . . . . 58.82 112.121 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1347 ' ' THR . . . . . . . . . . . . . 33.7 m -100.63 109.54 21.61 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 110.392 -3.095 . . . . 54.960000000000001 107.683 167.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1348 ' ' VAL . . . . . . . . . . . . . 34.4 t -85.19 82.39 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 N-CA-C 106.173 -1.788 . . . . 55.640000000000001 106.173 176.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 24.2 t0 -78.36 106.25 10.16 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 112.766 -2.015 . . . . 61.450000000000003 115.449 -175.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -82.66 -13.07 57.09 Favored 'General case' 0 C--O 1.246 0.921 0 CA-C-N 112.472 -2.149 . . . . 58.630000000000003 112.751 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -65.12 -47.14 78.21 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 120.904 -1.122 . . . . 62.060000000000002 109.73 172.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 10.3 t70 -65.44 108.71 2.06 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 123.271 1.51 . . . . 54.07 108.994 174.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 22.1 m -43.82 -37.24 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.765 0 N-CA-C 117.614 2.449 . . . . 50.68 117.614 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1354 ' ' VAL . . . . . . . . . . . . 0.261 5.4 m -79.72 -43.75 23.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-O 118.099 -0.953 . . . . 47.68 110.374 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1355 ' ' ILE . . . . . . . . . . . . . 80.4 mt -60.76 -45.1 98.39 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 121.58 1.991 . . . . 48.490000000000002 109.612 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 40.7 tpt85 -43.23 -50.52 6.43 Favored 'General case' 0 C--O 1.249 1.069 0 N-CA-C 115.986 1.847 . . . . 48.270000000000003 115.986 163.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -61.15 -50.71 64.29 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.86 -0.967 . . . . 43.530000000000001 112.834 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1358 ' ' VAL . . . . . . . . . . . . . 21.2 t -60.58 -49.38 84.66 Favored 'Isoleucine or valine' 0 C--O 1.249 1.059 0 N-CA-C 106.202 -1.777 . . . . 45.119999999999997 106.202 -173.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1359 ' ' THR . . . . . . . . . . . . . 6.0 m -69.01 87.84 0.38 Allowed 'General case' 0 C--N 1.313 -0.98 0 O-C-N 120.581 -1.325 . . . . 42.939999999999998 108.626 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 30.9 m -77.68 -23.74 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 CA-C-N 114.865 -1.061 . . . . 43.259999999999998 110.971 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1361 ' ' ILE . . . . . . . . . . . . . 73.4 mt -135.58 119.02 23.91 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 N-CA-C 105.567 -2.012 . . . . 45.659999999999997 105.567 172.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1362 ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -100.65 110.3 22.42 Favored 'General case' 0 C--O 1.219 -0.525 0 O-C-N 119.172 -2.205 . . . . 61.340000000000003 106.584 167.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 31.87 79.0 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 O-C-N 126.388 2.305 . . . . 49.759999999999998 112.135 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 83.25 -40.54 2.84 Favored Glycine 0 CA--C 1.521 0.457 0 CA-C-O 118.59 -1.116 . . . . 50.0 112.645 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -77.05 111.0 12.16 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 105.87 -1.9 . . . . 56.920000000000002 105.87 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1366 ' ' ILE . . . . . . . . . . . . . 66.0 mt -70.11 106.53 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 104.406 -2.442 . . . . 52.780000000000001 104.406 173.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1367 ' ' THR . . . . . . . . . . . . . 2.0 p -88.41 -4.9 58.56 Favored 'General case' 0 CA--C 1.496 -1.124 0 N-CA-C 114.901 1.445 . . . . 49.439999999999998 114.901 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 1.7 t90 -70.73 148.62 95.0 Favored Pre-proline 0 C--O 1.248 1.016 0 N-CA-C 106.701 -1.592 . . . . 52.380000000000003 106.701 166.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -65.43 156.07 77.89 Favored 'Cis proline' 0 CA--C 1.498 -1.321 0 CA-C-N 124.96 2.807 . . . . 46.939999999999998 116.32 -7.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -112.04 151.84 43.88 Favored Pre-proline 0 N--CA 1.442 -0.858 0 CA-C-N 113.342 -1.754 . . . . 45.909999999999997 110.195 -175.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1371 ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -57.25 145.02 89.21 Favored 'Trans proline' 0 C--O 1.248 1.007 0 C-N-CA 122.789 2.326 . . . . 46.390000000000001 117.643 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -67.48 -20.45 47.78 Favored 'Trans proline' 0 CA--C 1.539 0.742 1 C-N-CA 125.345 4.03 . . . . 46.719999999999999 112.435 171.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.22 -5.055 0 CA-C-N 122.539 2.427 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 35.8 m80 . . . . . 0 N--CA 1.467 0.382 0 N-CA-C 107.738 -1.208 . . . . 63.439999999999998 107.738 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -73.54 74.53 1.46 Allowed 'General case' 0 C--O 1.242 0.673 0 CA-C-O 124.37 2.033 . . . . 51.740000000000002 115.041 -177.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1000 ' ' HIS . . . . . . . . . . . . . 63.9 t60 -72.62 128.45 35.6 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 114.499 -1.228 . . . . 54.07 108.573 -174.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 68.34 15.76 68.36 Favored Glycine 0 CA--C 1.506 -0.498 0 O-C-N 120.076 -1.64 . . . . 39.219999999999999 115.328 -172.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1002 ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -89.06 129.37 35.7 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 119.833 1.816 . . . . 38.119999999999997 108.557 176.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1003 ' ' ILE . . . . . . . . . . . . . 19.6 mt -84.48 134.78 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-N 111.28 -2.691 . . . . 29.699999999999999 105.611 166.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -114.84 125.65 6.87 Favored Glycine 0 CA--C 1.503 -0.701 0 N-CA-C 106.556 -2.617 . . . . 27.5 106.556 166.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1005 ' ' ILE . . . . . . . . . . . . . 27.5 mm -99.4 105.42 33.06 Favored Pre-proline 0 N--CA 1.426 -1.646 0 N-CA-C 104.94 -2.244 . . . . 24.829999999999998 104.94 173.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -74.76 145.69 32.75 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 C-N-CA 123.905 3.07 . . . . 27.190000000000001 108.977 173.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -74.47 113.16 11.39 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 109.198 -3.637 . . . . 41.460000000000001 104.127 171.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1008 ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -40.9 145.36 0.21 Allowed 'General case' 0 C--O 1.247 0.934 0 N-CA-C 120.015 3.339 . . . . 26.93 120.015 175.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 14.3 mmm-85 -120.27 -10.13 9.4 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-N 112.636 -2.075 . . . . 34.479999999999997 111.522 -175.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1010 ' ' LEU . . . . . . . . . . . . . 4.5 tp -64.7 143.52 57.87 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 122.098 0.951 . . . . 44.219999999999999 113.002 174.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1011 ' ' THR . . . . . . . . . . . . . 3.6 m -66.7 134.33 52.01 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 108.187 -1.042 . . . . 40.740000000000002 108.187 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 49.8 t30 51.21 53.42 12.97 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 115.948 1.832 . . . . 44.439999999999998 115.948 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1013 ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -136.67 116.48 13.11 Favored 'General case' 0 C--O 1.252 1.207 0 CA-C-N 114.245 -1.343 . . . . 29.870000000000001 108.965 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1014 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.99 -0.65 15.66 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.281 -0.872 . . . . 25.260000000000002 112.186 174.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -69.07 141.32 54.79 Favored 'General case' 0 C--O 1.248 0.995 0 N-CA-C 105.857 -1.905 . . . . 29.539999999999999 105.857 173.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1016 ' ' VAL . . . . . . . . . . . . . 11.6 p -139.36 -173.62 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 104.7 -2.333 . . . . 23.550000000000001 104.7 171.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1017 ' ' ALA . . . . . . . . . . . . . . . -110.0 0.67 18.6 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 118.992 -2.318 . . . . 23.59 113.636 175.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1018 ' ' ALA . . . . . . . . . . . . . . . -88.4 128.71 35.52 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 118.671 -0.681 . . . . 24.93 111.481 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1019 ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.34 148.05 17.12 Favored Pre-proline 0 N--CA 1.442 -0.835 0 N-CA-C 105.682 -1.97 . . . . 28.09 105.682 171.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -61.96 -54.04 1.75 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 124.549 3.499 . . . . 28.789999999999999 112.981 -174.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 77.9 tttt -49.49 -48.95 47.54 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 121.289 1.859 . . . . 47.280000000000001 108.874 176.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1022 ' ' THR . . . . . . . . . . . . . 39.5 m -49.86 -54.27 20.49 Favored 'General case' 0 C--O 1.203 -1.373 0 C-N-CA 125.63 1.572 . . . . 30.120000000000001 111.842 174.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1023 ' ' VAL . . . . . . . . . . . . . 54.0 t -60.63 -37.97 77.07 Favored 'Isoleucine or valine' 0 C--N 1.352 0.691 0 CA-C-N 120.702 1.592 . . . . 32.240000000000002 108.078 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1024 ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -67.9 -44.86 75.97 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 121.205 1.821 . . . . 49.619999999999997 111.401 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -58.43 -45.99 87.41 Favored 'General case' 0 N--CA 1.44 -0.959 0 O-C-N 125.457 1.723 . . . . 44.68 108.203 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 95.4 mt -63.39 -45.38 91.35 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 118.867 -0.587 . . . . 35.710000000000001 109.727 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1027 ' ' LEU . . . . . . . . . . . . . 27.2 mt -60.71 -35.19 75.69 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 118.894 0.77 . . . . 42.18 111.302 173.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 19.3 mttm -72.46 -30.11 64.28 Favored 'General case' 0 C--O 1.239 0.526 0 O-C-N 120.219 -1.551 . . . . 48.340000000000003 109.38 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1029 ' ' LEU . . . . . . . . . . . . . 87.3 mt -74.79 -21.03 59.54 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 118.249 -2.782 . . . . 38.689999999999998 109.604 169.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 101.22 18.47 19.35 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 117.935 -2.978 . . . . 32.280000000000001 110.327 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -98.08 118.48 34.79 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 106.432 -1.692 . . . . 35.939999999999998 106.432 170.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1032 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.12 139.94 57.53 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 111.598 -2.546 . . . . 33.369999999999997 111.156 171.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B 1033 ' ' VAL . . . . . . . . . . . . . 6.7 t -114.0 130.92 67.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.704 0 CA-C-N 121.162 1.801 . . . . 29.98 106.931 -174.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -123.59 135.98 54.27 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 104.901 -2.259 . . . . 28.18 104.901 166.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1035 ' ' VAL . . . . . . . . . . . . . 46.7 t -121.72 143.43 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 103.678 -2.712 . . . . 25.82 103.678 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1036 ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -79.68 137.85 37.19 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 120.038 -1.664 . . . . 32.439999999999998 110.978 173.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1037 ' ' SER . . . . . . . . . . . . . 16.5 m -52.68 115.72 1.94 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 127.081 2.152 . . . . 29.539999999999999 109.958 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 115.12 -19.17 15.44 Favored Glycine 0 N--CA 1.423 -2.221 0 CA-C-O 119.382 -0.677 . . . . 27.760000000000002 113.381 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1039 ' ' ALA . . . . . . . . . . . . . . . -67.0 -28.87 68.6 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 120.511 -0.475 . . . . 26.02 110.266 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -56.81 -55.18 31.43 Favored Glycine 0 C--O 1.246 0.886 0 N-CA-C 110.612 -0.995 . . . . 26.469999999999999 110.612 164.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -53.24 -39.81 64.1 Favored 'General case' 0 C--O 1.25 1.095 0 O-C-N 120.463 -1.61 . . . . 50.979999999999997 114.32 177.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 31.3 mt -52.84 -54.62 31.69 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 116.86 2.17 . . . . 29.300000000000001 116.86 163.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1043 ' ' ALA . . . . . . . . . . . . . . . -71.41 17.8 0.08 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 117.856 2.539 . . . . 26.739999999999998 117.856 172.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1044 ' ' SER . . . . . . . . . . . . . 6.7 m 52.57 41.91 31.26 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 125.187 2.422 . . . . 31.260000000000002 111.396 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1045 ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -127.96 167.3 16.85 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 111.62 -2.536 . . . . 33.259999999999998 107.124 -175.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 40.6 t0 -97.15 138.53 34.52 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 117.524 -1.671 . . . . 46.740000000000002 107.359 150.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -50.07 -36.3 28.73 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 126.887 2.617 . . . . 34.439999999999998 111.892 171.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -35.38 -44.05 0.27 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 116.323 1.972 . . . . 48.670000000000002 116.323 165.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -64.24 -27.91 69.37 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 120.205 -1.56 . . . . 35.259999999999998 112.988 177.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1050 ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -75.39 -38.75 59.77 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 117.276 -1.345 . . . . 32.170000000000002 109.196 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 8.3 t -53.44 -50.77 46.91 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 N-CA-C 107.884 -1.154 . . . . 38.369999999999997 107.884 171.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -53.53 -34.9 59.88 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 124.069 0.948 . . . . 45.770000000000003 112.736 175.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -80.31 -21.7 42.31 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.17 0.895 . . . . 37.829999999999998 111.858 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 128.26 20.78 1.56 Allowed Glycine 0 CA--C 1.519 0.304 0 O-C-N 119.658 -1.901 . . . . 35.82 109.571 170.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -100.41 140.71 34.27 Favored 'General case' 0 N--CA 1.435 -1.177 0 O-C-N 119.159 -2.377 . . . . 33.770000000000003 112.026 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -76.56 130.03 37.31 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.647 1.579 . . . . 51.020000000000003 108.545 171.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1057 ' ' ILE . . . . . . . . . . . . . 35.7 mm -97.92 129.84 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 106.188 -1.782 . . . . 38.469999999999999 106.188 168.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 6.6 m -111.21 153.72 12.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 125.337 1.455 . . . . 39.399999999999999 108.048 169.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.13 -48.97 71.7 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 120.491 -1.381 . . . . 57.07 114.57 -175.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . -155.83 -110.79 0.35 Allowed Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.076 -1.059 . . . . 44.829999999999998 111.018 -176.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 2.5 m120 -58.27 -25.53 61.89 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 126.385 1.874 . . . . 46.270000000000003 115.685 -170.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1062 ' ' SER . . . . . . . . . . . . . 16.4 m -48.4 -28.19 3.08 Favored 'General case' 0 C--N 1.317 -0.81 0 O-C-N 120.731 -1.231 . . . . 43.469999999999999 112.999 165.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 1.3 p -59.04 -28.32 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 O-C-N 120.108 -1.62 . . . . 36.979999999999997 115.233 171.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 92.4 m95 -74.53 -18.65 60.57 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 122.921 0.488 . . . . 37.899999999999999 111.933 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -83.15 66.83 8.91 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 107.966 -1.124 . . . . 46.189999999999998 107.966 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1066 ' ' SER . . . . . . . . . . . . . 28.2 m -155.29 148.15 24.42 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 103.923 -2.621 . . . . 37.060000000000002 103.923 -172.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1067 ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -82.51 -15.33 52.81 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 115.844 1.794 . . . . 43.950000000000003 115.844 -172.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1068 ' ' ILE . . . . . . . . . . . . . 1.4 mp -124.54 116.28 47.04 Favored 'Isoleucine or valine' 0 C--O 1.253 1.238 0 N-CA-C 103.129 -2.915 . . . . 33.5 103.129 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 26.0 mm -106.42 115.14 47.4 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 N-CA-C 106.733 -1.58 . . . . 30.57 106.733 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1070 ' ' LEU . . . . . . . . . . . . . 85.3 mt -106.85 78.69 1.26 Allowed 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 115.224 -0.898 . . . . 27.66 111.229 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1071 ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -80.75 166.64 20.81 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.836 -0.62 . . . . 28.399999999999999 110.749 171.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1072 ' ' VAL . . . . . . . . . . . . . 8.9 t -91.51 -84.92 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 104.231 -2.507 . . . . 23.18 104.231 169.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -101.78 -170.49 1.83 Allowed 'General case' 0 C--N 1.312 -1.034 0 O-C-N 118.434 -2.666 . . . . 25.469999999999999 111.913 -170.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -33.93 125.51 0.47 Allowed Pre-proline 0 CA--C 1.554 1.109 0 N-CA-C 118.157 2.651 . . . . 27.899999999999999 118.157 -172.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.48 126.89 14.79 Favored 'Trans proline' 0 N--CA 1.434 -2.009 0 C-N-CA 123.319 2.679 . . . . 31.620000000000001 111.474 166.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 45.2 mt -76.15 160.56 29.62 Favored 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 120.437 -1.414 . . . . 40.490000000000002 107.582 168.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.76 -35.5 43.88 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 117.358 2.355 . . . . 51.590000000000003 117.358 -174.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -63.97 -42.37 97.27 Favored 'General case' 0 C--O 1.208 -1.091 0 CA-C-O 118.972 -0.537 . . . . 42.359999999999999 111.004 172.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1079 ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -66.57 -35.74 80.96 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 125.586 1.804 . . . . 34.530000000000001 108.917 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1080 ' ' ILE . . . . . . . . . . . . . 63.3 mt -61.79 -51.8 68.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 125.983 2.052 . . . . 33.25 105.766 173.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -59.03 -29.4 67.25 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 120.969 1.713 . . . . 36.469999999999999 112.005 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1082 ' ' LEU . . . . . . . . . . . . . 10.2 mt -71.74 -28.06 63.41 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.353 1.242 . . . . 37.759999999999998 114.353 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1083 ' ' LEU . . . . . . . . . . . . . 33.9 mt -64.45 112.97 3.36 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 118.594 -1.242 . . . . 37.43 109.204 -175.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -71.12 139.42 84.98 Favored Pre-proline 0 C--O 1.254 1.306 0 CA-C-N 115.149 -0.932 . . . . 37.700000000000003 109.435 167.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -55.47 151.92 35.42 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.878 2.385 . . . . 35.509999999999998 116.379 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 74.79 -8.72 13.62 Favored Glycine 0 N--CA 1.445 -0.754 0 O-C-N 120.16 -1.587 . . . . 33.869999999999997 115.981 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1087 ' ' THR . . . . . . . . . . . . . 89.2 m -71.89 139.55 48.85 Favored 'General case' 0 C--O 1.261 1.688 0 O-C-N 119.608 -2.113 . . . . 32.5 108.062 178.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1088 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.53 97.09 7.66 Favored 'General case' 0 C--O 1.255 1.387 0 N-CA-C 106.591 -1.633 . . . . 30.219999999999999 106.591 -173.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B 1089 ' ' LEU . . . . . . . . . . . . . 31.3 tp -91.77 101.21 13.81 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 122.167 0.984 . . . . 27.239999999999998 111.214 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 11.7 t -104.11 107.35 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 111.089 -2.778 . . . . 25.390000000000001 109.795 -175.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1091 ' ' SER . . . . . . . . . . . . . 13.1 m -163.48 168.14 20.58 Favored 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 117.087 -3.508 . . . . 28.809999999999999 113.308 -170.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1092 ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -65.22 91.71 0.11 Allowed 'General case' 0 C--O 1.278 2.602 0 CA-C-O 124.212 1.958 . . . . 30.780000000000001 110.183 168.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 36.8 mm -89.9 -32.25 5.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 O-C-N 120.631 -1.293 . . . . 30.280000000000001 111.178 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1094 ' ' TRP . . . . . . . . . . . . . 67.6 m95 57.92 55.83 6.77 Favored Pre-proline 0 C--O 1.247 0.965 0 CA-C-N 114.823 -1.08 . . . . 34.07 112.021 -175.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -49.97 -34.89 39.18 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 124.952 3.768 . . . . 38.659999999999997 113.409 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -56.37 -56.15 24.73 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 120.841 -1.162 . . . . 41.32 110.776 169.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -78.94 -22.68 45.39 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 113.951 1.093 . . . . 51.659999999999997 113.951 -174.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -130.22 81.1 69.34 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 119.934 1.243 . . . . 40.32 111.02 -164.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -64.17 -48.93 4.19 Favored 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 120.987 1.124 . . . . 41.560000000000002 114.561 176.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -61.93 -35.87 79.7 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.399 -0.964 . . . . 54.109999999999999 108.399 -175.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1101 ' ' LEU . . . . . . . . . . . . . 17.0 tp -60.43 -47.17 87.27 Favored 'General case' 0 CA--C 1.515 -0.386 0 O-C-N 120.703 -1.248 . . . . 37.880000000000003 110.116 175.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1102 ' ' MET . . . . . . . . . . . . . 73.2 mmm -57.82 -38.62 75.91 Favored 'General case' 0 C--O 1.238 0.45 0 O-C-N 121.116 -0.99 . . . . 37.539999999999999 113.196 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -64.21 -45.77 86.82 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.869 -1.06 . . . . 47.009999999999998 113.398 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1104 ' ' LYS . . . . . . . . . . . . . 54.1 mttm -65.98 -35.26 80.1 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.506 -0.77 . . . . 48.68 110.264 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1105 ' ' LEU . . . . . . . . . . . . . 50.2 mt -72.86 -29.5 63.25 Favored 'General case' 0 C--O 1.269 2.127 0 O-C-N 120.546 -1.346 . . . . 32.210000000000001 112.583 177.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -61.63 -49.55 76.1 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 124.648 1.179 . . . . 33.729999999999997 108.098 172.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -54.1 -40.56 67.41 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 122.753 0.421 . . . . 51.469999999999999 111.702 172.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1108 ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -72.97 -9.92 59.25 Favored 'General case' 0 C--O 1.213 -0.847 0 O-C-N 120.241 -1.537 . . . . 43.899999999999999 113.617 177.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1109 ' ' ASN . . . . . . . . . . . . . 8.9 m120 62.93 30.83 16.46 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.556 1.142 . . . . 44.82 110.637 172.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1110 ' ' VAL . . . . . . . . . . . . . 2.7 m -92.76 155.0 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 O-C-N 120.557 -1.34 . . . . 30.52 112.404 -172.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1111 ' ' THR . . . . . . . . . . . . . 1.2 m -82.75 92.26 7.18 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 105.883 -1.895 . . . . 27.120000000000001 105.883 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1112 ' ' VAL . . . . . . . . . . . . . 39.9 t -88.27 121.72 38.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 O-C-N 120.322 -1.486 . . . . 26.399999999999999 110.58 -173.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1113 ' ' MET . . . . . . . . . . . . . 21.0 mtp -115.95 116.72 28.44 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 104.904 -2.258 . . . . 42.920000000000002 104.904 177.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -96.19 107.83 20.22 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 117.34 -1.744 . . . . 24.149999999999999 110.893 -172.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1115 ' ' MET . . . . . . . . . . . . . 83.5 mmm -55.16 -26.88 41.64 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 116.543 2.053 . . . . 29.949999999999999 116.543 -176.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1116 ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -86.54 -39.84 15.82 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.117 -1.856 . . . . 34.530000000000001 110.946 177.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1117 ' ' SER . . . . . . . . . . . . . 49.9 m -99.16 31.8 2.93 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-O 123.966 1.841 . . . . 33.490000000000002 111.409 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1118 ' ' VAL . . . . . . . . . . . . . 22.0 t -64.16 119.33 54.79 Favored Pre-proline 0 C--O 1.243 0.727 0 N-CA-C 102.402 -3.185 . . . . 34.020000000000003 102.402 151.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -62.67 159.64 36.11 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 123.0 2.467 . . . . 38.280000000000001 113.047 -176.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1120 ' ' ARG . . . . . 0.406 HH12 ' CG ' ' B' 1128 ' ' ASP . 1.9 mmp_? -77.37 50.53 0.79 Allowed 'General case' 0 C--N 1.354 0.776 0 CA-C-O 122.099 0.952 . . . . 55.049999999999997 109.826 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B 1121 ' ' ILE . . . . . . . . . . . . . 39.0 pt -119.21 143.96 28.98 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.844 0 O-C-N 121.232 -0.918 . . . . 42.090000000000003 110.042 -169.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1122 ' ' SER . . . . . . . . . . . . . 53.6 p -9.08 -88.82 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 120.479 3.511 . . . . 38.020000000000003 120.479 -176.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1123 ' ' ARG . . . . . . . . . . . . 0.254 18.7 ptt180 -71.5 -30.12 65.58 Favored 'General case' 0 C--N 1.357 0.892 0 CA-C-N 121.194 1.815 . . . . 34.289999999999999 114.502 178.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B 1124 ' ' ALA . . . . . . . . . . . . . . . -58.83 -34.4 71.51 Favored 'General case' 0 C--O 1.219 -0.525 0 O-C-N 124.056 0.847 . . . . 32.350000000000001 109.851 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1125 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.2 -9.06 1.86 Allowed 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 117.473 2.397 . . . . 47.170000000000002 117.473 176.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B 1126 ' ' SER . . . . . . . . . . . . . 22.9 p -90.9 -32.95 15.81 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.863 1.211 . . . . 31.710000000000001 112.687 169.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1127 ' ' LEU . . . . . . . . . . . . . 4.1 mp -71.36 -30.06 65.71 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 111.726 -2.488 . . . . 37.0 110.71 175.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1128 ' ' ASP . . . . . 0.406 ' CG ' HH12 ' B' 1120 ' ' ARG . 9.9 t70 -62.56 127.36 30.92 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 115.694 1.738 . . . . 40.399999999999999 115.694 -176.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B 1129 ' ' ALA . . . . . . . . . . . . . . . -70.06 -38.02 75.65 Favored 'General case' 0 C--O 1.212 -0.869 0 CA-C-N 113.746 -1.57 . . . . 26.559999999999999 108.1 177.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 36.2 mt -66.79 -13.85 61.96 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 115.039 1.496 . . . . 30.890000000000001 115.039 -174.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1131 ' ' SER . . . . . . . . . . . . . 66.5 p -69.24 -56.17 8.37 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 105.507 -2.035 . . . . 29.84 105.507 167.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1132 ' ' SER . . . . . . . . . . . . . 67.5 m -55.05 -55.64 28.74 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 124.332 1.053 . . . . 31.91 113.616 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1133 ' ' MET . . . . . . . . . . . . . 32.2 mmt -54.32 -45.1 72.54 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.463 0.705 . . . . 25.899999999999999 111.757 176.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1134 ' ' ALA . . . . . . . . . . . . . . . -56.64 -52.57 64.38 Favored 'General case' 0 C--O 1.209 -1.049 0 C-N-CA 119.477 -0.889 . . . . 26.620000000000001 112.898 170.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.66 -33.41 55.18 Favored 'General case' 0 C--O 1.22 -0.491 0 O-C-N 120.807 -1.183 . . . . 36.969999999999999 113.809 174.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B 1136 ' ' ILE . . . . . . . . . . . . . 37.2 mm -68.96 -54.66 19.07 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 N-CA-C 107.255 -1.387 . . . . 32.109999999999999 107.255 175.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -59.53 -30.09 68.35 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 117.087 -1.435 . . . . 24.140000000000001 111.95 -171.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -66.49 -58.05 9.21 Favored Glycine 0 N--CA 1.47 0.912 0 CA-C-N 119.27 0.941 . . . . 25.129999999999999 111.562 174.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 21.0 t80 -58.88 -49.32 78.2 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.232 -1.025 . . . . 32.729999999999997 108.232 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1140 ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -63.49 -28.95 70.31 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-O 117.806 -1.092 . . . . 26.359999999999999 108.94 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1141 ' ' ALA . . . . . . . . . . . . . . . -62.2 -47.92 82.32 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 122.412 2.369 . . . . 24.120000000000001 108.809 173.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 45.7 mm -60.92 -39.36 81.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.281 1.432 . . . . 23.370000000000001 109.298 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 40.6 t -63.84 -57.72 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 124.728 1.211 . . . . 24.960000000000001 111.931 176.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -63.6 -37.94 89.25 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 119.819 -1.801 . . . . 32.07 110.991 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1145 ' ' ALA . . . . . . . . . . . . . . . -53.35 -51.63 61.84 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 122.432 1.111 . . . . 24.870000000000001 113.743 170.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1146 ' ' ALA . . . . . . . . . . . . . . . -59.15 -37.14 76.6 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 113.835 -1.53 . . . . 24.670000000000002 114.677 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 42.5 t60 -60.79 -22.9 64.58 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.867 1.267 . . . . 28.579999999999998 111.692 177.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1148 ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -127.81 16.24 6.89 Favored 'General case' 0 N--CA 1.442 -0.867 0 O-C-N 119.666 -1.896 . . . . 36.82 113.625 173.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1149 ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -77.65 155.93 31.08 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 122.563 1.173 . . . . 31.969999999999999 108.621 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B 1150 ' ' GLY . . . . . . . . . . . . . . . -88.72 -23.72 35.16 Favored Glycine 0 C--O 1.208 -1.507 0 O-C-N 120.146 -1.596 . . . . 25.489999999999998 111.668 176.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1151 ' ' ARG . . . . . . . . . . . . . 71.3 mtm-85 -131.62 179.98 5.73 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.614 1.166 . . . . 59.840000000000003 112.644 -162.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1152 ' ' PHE . . . . . . . . . . . . . 5.9 m-30 -83.14 163.16 21.02 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 120.941 1.7 . . . . 34.450000000000003 111.177 171.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1153 ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -85.6 -48.68 8.67 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 112.46 -2.154 . . . . 31.170000000000002 109.271 166.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1154 ' ' THR . . . . . . . . . . . . . 6.3 m -72.1 135.57 46.29 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 114.636 -1.166 . . . . 33.890000000000001 108.162 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -80.6 73.67 2.49 Favored Glycine 0 CA--C 1.543 1.843 0 N-CA-C 106.47 -2.652 . . . . 38.950000000000003 106.47 171.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -75.17 124.17 26.57 Favored 'General case' 0 C--O 1.242 0.668 0 O-C-N 120.796 -1.414 . . . . 54.229999999999997 108.065 -174.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 26.8 mm -73.5 100.54 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 105.07 -2.196 . . . . 51.159999999999997 105.07 169.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1158 ' ' THR . . . . . . . . . . . . . 5.6 m -99.72 151.43 21.24 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 103.591 -2.744 . . . . 49.609999999999999 103.591 -172.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -57.92 -37.44 74.07 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 121.398 1.908 . . . . 49.049999999999997 113.707 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -53.52 -35.21 60.42 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 115.854 1.798 . . . . 47.649999999999999 115.854 169.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . 157.88 175.45 28.82 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 108.813 -1.715 . . . . 45.609999999999999 108.813 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 82.7 mttt -83.35 145.27 29.13 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 112.932 0.715 . . . . 57.460000000000001 112.932 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1163 ' ' VAL . . . . . . . . . . . . . 94.5 t -94.25 142.84 25.44 Favored Pre-proline 0 N--CA 1.433 -1.296 0 N-CA-C 106.385 -1.709 . . . . 42.93 106.385 170.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1164 ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -81.23 133.95 8.92 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 124.989 3.793 . . . . 39.289999999999999 104.74 168.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1165 ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -62.55 148.46 93.3 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 125.293 3.995 . . . . 34.170000000000002 108.199 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -75.17 134.7 41.17 Favored 'General case' 0 C--O 1.208 -1.124 0 CA-C-N 115.213 -0.903 . . . . 31.690000000000001 111.014 172.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1167 ' ' LYS . . . . . . . . . . . . . 98.4 mttt -91.6 113.59 25.9 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 124.05 1.881 . . . . 44.780000000000001 107.189 167.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 87.6 t -98.25 99.43 8.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 113.099 -1.864 . . . . 31.23 107.212 -174.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1169 ' ' MET . . . . . . . . . . . . . 36.5 ttp -83.42 100.85 10.97 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 119.14 -1.024 . . . . 37.090000000000003 108.313 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 45.2 t -91.07 111.76 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 106.948 -1.501 . . . . 30.170000000000002 106.948 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1171 ' ' ILE . . . . . . . . . . . . . 2.7 mt -97.84 135.43 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 107.303 -1.369 . . . . 33.740000000000002 107.303 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 71.76 71.94 0.99 Allowed Glycine 0 C--O 1.247 0.911 0 N-CA-C 108.564 -1.815 . . . . 32.590000000000003 108.564 -177.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1173 ' ' ALA . . . . . . . . . . . . . . . -76.25 74.31 3.06 Favored 'General case' 0 N--CA 1.44 -0.956 0 O-C-N 121.176 -1.191 . . . . 32.420000000000002 112.693 -174.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -81.0 -155.68 12.87 Favored Glycine 0 N--CA 1.44 -1.073 0 N-CA-C 109.652 -1.379 . . . . 31.739999999999998 109.652 169.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 47.9 t -65.11 -38.94 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.416 0 O-C-N 122.016 -0.696 . . . . 31.48 109.146 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1176 ' ' ALA . . . . . . . . . . . . . . . -65.65 -39.81 91.79 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 122.66 1.219 . . . . 26.120000000000001 110.186 174.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1177 ' ' GLY . . . . . . . . . . . . . . . -52.29 -54.68 25.54 Favored Glycine 0 CA--C 1.527 0.82 0 O-C-N 120.499 -1.376 . . . . 25.73 111.05 171.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1178 ' ' LEU . . . . . . . . . . . . . 65.5 mt -57.78 -39.21 76.93 Favored 'General case' 0 C--N 1.351 0.65 0 N-CA-C 112.863 0.69 . . . . 32.590000000000003 112.863 178.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -60.67 -46.15 91.42 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 124.664 1.227 . . . . 27.719999999999999 111.777 170.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -64.71 -39.35 93.51 Favored 'General case' 0 C--O 1.249 1.075 0 O-C-N 119.884 -1.76 . . . . 26.030000000000001 111.764 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1181 ' ' ILE . . . . . . . . . . . . . 37.7 mt -56.61 -60.7 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 N-CA-C 104.137 -2.542 . . . . 28.609999999999999 104.137 171.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -43.32 -49.7 6.72 Favored Glycine 0 C--O 1.214 -1.099 0 N-CA-C 116.05 1.18 . . . . 25.23 116.05 177.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -72.59 -57.02 4.46 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 112.115 0.413 . . . . 24.09 112.115 -174.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -60.59 -41.42 94.7 Favored 'General case' 0 C--O 1.246 0.892 0 O-C-N 121.518 -0.739 . . . . 26.68 112.689 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -65.7 -32.81 74.57 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-O 118.255 -0.878 . . . . 36.57 109.946 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1186 ' ' SER . . . . . . . . . . . . . 64.8 m -57.33 -49.27 76.67 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 122.48 2.4 . . . . 28.920000000000002 108.486 167.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1187 ' ' LEU . . . . . . . . . . . . . 19.6 mt -67.88 -6.51 22.13 Favored 'General case' 0 C--N 1.365 1.267 0 N-CA-C 115.511 1.671 . . . . 29.09 115.511 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 82.39 16.11 72.22 Favored Glycine 0 N--CA 1.447 -0.584 0 O-C-N 120.285 -1.509 . . . . 29.260000000000002 113.819 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1189 ' ' ALA . . . . . . . . . . . . . . . -86.81 139.74 30.39 Favored 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 120.514 -1.58 . . . . 30.16 108.407 175.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 8.3 mt -87.08 110.33 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 105.916 -1.883 . . . . 35.810000000000002 105.916 -164.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1191 ' ' VAL . . . . . . . . . . . . . 43.8 t -81.02 123.5 37.7 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 O-C-N 121.093 -1.004 . . . . 31.969999999999999 111.351 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1192 ' ' ARG . . . . . 0.412 HH12 ' CD ' ' B' 1248 ' ' GLU . 91.2 mtt180 -105.91 105.13 15.02 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 108.202 -1.036 . . . . 48.159999999999997 108.202 170.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -103.04 155.01 18.68 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 115.823 -2.351 . . . . 35.890000000000001 110.339 -176.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 39.5 t80 -141.42 136.84 31.75 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 106.318 -1.734 . . . . 41.880000000000003 106.318 170.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1195 ' ' ASP . . . . . . . . . . . . . 9.9 t0 -149.84 159.78 44.09 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 100.948 -3.723 . . . . 38.280000000000001 100.948 165.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1196 ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.75 -9.85 59.77 Favored 'General case' 0 N--CA 1.435 -1.206 0 O-C-N 120.892 -1.13 . . . . 40.619999999999997 112.593 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B 1197 ' ' ARG . . . . . . . . . . . . . 31.9 mtm105 -90.53 134.3 31.18 Favored Pre-proline 0 C--O 1.25 1.115 0 O-C-N 119.992 -1.692 . . . . 53.090000000000003 107.815 178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -61.81 -34.39 82.66 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 123.417 2.745 . . . . 42.560000000000002 116.378 -165.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -68.57 -17.9 64.23 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 115.018 1.488 . . . . 56.310000000000002 115.018 -165.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1200 ' ' VAL . . . . . . . . . . . . . 14.1 m -58.72 -29.05 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-N 115.137 -0.938 . . . . 42.909999999999997 113.335 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 37.9 tttm -60.3 -62.31 1.96 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.685 -1.228 . . . . 48.890000000000001 107.685 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -60.16 -26.77 66.56 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 114.909 1.448 . . . . 51.700000000000003 114.909 176.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1203 ' ' GLN . . . . . . . . . . . . . 67.6 mm-40 -62.04 -47.82 83.0 Favored 'General case' 0 C--O 1.253 1.283 0 CA-C-N 121.104 1.775 . . . . 52.57 111.449 171.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1204 ' ' VAL . . . . . . . . . . . . 0.257 34.5 m -67.23 -43.97 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 O-C-N 120.619 -1.3 . . . . 33.789999999999999 113.736 175.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -56.61 -52.08 66.23 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 117.068 -1.444 . . . . 36.579999999999998 110.876 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1206 ' ' SER . . . . . . . . . . . . . 90.3 p -61.46 -40.88 96.12 Favored 'General case' 0 C--O 1.253 1.288 0 CA-C-N 120.125 1.33 . . . . 39.609999999999999 112.196 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1207 ' ' MET . . . . . . . . . . . . . 11.7 ttm -72.78 -18.78 61.45 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 119.738 -1.851 . . . . 37.450000000000003 112.808 174.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 84.83 73.36 1.27 Allowed Glycine 0 C--O 1.248 0.995 0 O-C-N 119.368 -2.083 . . . . 31.870000000000001 109.933 -176.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -163.17 155.51 18.29 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 106.742 -1.577 . . . . 35.399999999999999 106.742 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -86.56 148.48 25.48 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 112.088 -2.324 . . . . 47.890000000000001 111.59 -171.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 30.7 t80 -113.92 125.3 53.88 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 120.198 -1.564 . . . . 45.530000000000001 108.14 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1212 ' ' LEU . . . . . . . . . . . . . 44.6 mt -74.36 108.49 7.17 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 103.832 -2.655 . . . . 46.329999999999998 103.832 170.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.41 159.64 21.75 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 113.357 -1.747 . . . . 60.409999999999997 112.313 -172.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.56 145.38 54.96 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 115.19 1.552 . . . . 57.380000000000003 115.19 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 34.4 t70 . . . . . 0 C--O 1.222 -0.349 0 CA-C-N 112.911 -1.95 . . . . 65.069999999999993 107.512 173.044 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B 1230 ' ' MET . . . . . . . . . . . . . 28.2 mmt . . . . . 0 N--CA 1.445 -0.696 0 N-CA-C 107.556 -1.275 . . . . 80.319999999999993 107.556 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B 1231 ' ' SER . . . . . . . . . . . . . 18.6 m -160.25 157.63 28.49 Favored 'General case' 0 C--O 1.224 -0.286 1 O-C-N 114.94 -4.85 . . . . 79.920000000000002 104.658 -10.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.93 -175.06 3.78 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-N 121.968 2.167 . . . . 77.909999999999997 105.685 155.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 60.9 -56.48 0.09 Allowed 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 117.032 2.234 . . . . 73.879999999999995 117.032 -170.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 4.9 t80 -38.87 -33.1 0.1 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.313 1.445 . . . . 68.980000000000004 113.703 169.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 35.9 pt -36.48 -39.63 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.384 0 N-CA-C 116.967 2.21 . . . . 64.530000000000001 116.967 167.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -62.52 -51.03 69.04 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 122.903 0.481 . . . . 66.359999999999999 110.986 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -67.26 -33.72 75.91 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 125.29 1.619 . . . . 56.600000000000001 109.15 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -56.71 -52.77 63.68 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 120.637 1.562 . . . . 56.789999999999999 109.805 171.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1239 ' ' MET . . . . . . . . . . . . . 31.1 mmt -56.44 -47.2 79.6 Favored 'General case' 0 C--O 1.238 0.471 0 O-C-N 124.558 1.161 . . . . 53.630000000000003 113.38 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -63.63 -25.63 68.31 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 115.211 1.56 . . . . 51.740000000000002 115.211 175.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 13.1 tp -67.06 -46.25 74.91 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 105.483 -2.043 . . . . 44.859999999999999 105.483 174.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 8.4 m-30 -70.48 -45.13 66.3 Favored 'General case' 0 C--O 1.216 -0.701 0 O-C-N 120.268 -1.52 . . . . 42.780000000000001 106.999 -173.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -52.82 -43.08 65.71 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.343 1.238 . . . . 40.960000000000001 114.343 171.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -62.78 -29.74 70.94 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 115.813 1.782 . . . . 43.060000000000002 115.813 170.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -79.72 -24.76 41.42 Favored 'General case' 0 C--O 1.202 -1.445 0 CA-C-O 117.013 -1.47 . . . . 46.450000000000003 113.03 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -35.2 -40.45 0.13 Allowed 'General case' 0 C--O 1.241 0.636 1 N-CA-C 121.959 4.059 . . . . 41.780000000000001 121.959 -174.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 7.9 mptt -101.74 -4.9 25.65 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-N 120.379 1.445 . . . . 52.200000000000003 113.866 175.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1248 ' ' GLU . . . . . 0.412 ' CD ' HH12 ' B' 1192 ' ' ARG . 36.2 mt-10 -81.74 -63.23 1.43 Allowed 'General case' 0 C--O 1.25 1.125 0 N-CA-C 108.006 -1.109 . . . . 53.549999999999997 108.006 167.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B 1249 ' ' VAL . . . . . . . . . . . . . 21.7 m -65.69 154.41 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 123.963 1.84 . . . . 34.409999999999997 115.146 -168.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1250 ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -118.1 -56.56 2.16 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 105.271 -2.122 . . . . 33.380000000000003 105.271 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1251 ' ' ILE . . . . . . . . . . . . . 32.5 mm -110.73 109.02 26.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 O-C-N 119.782 -1.824 . . . . 29.539999999999999 106.881 -169.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1252 ' ' ILE . . . . . . . . . . . . . 47.1 mt -88.59 117.86 32.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 119.833 -1.792 . . . . 32.439999999999998 108.545 171.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1253 ' ' VAL . . . . . . . . . . . . . 74.0 t -104.28 94.34 3.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 100.286 -3.968 . . . . 30.57 100.286 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1254 ' ' THR . . . . . . . . . . . . 0.294 6.5 t -94.78 101.56 13.39 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 125.681 2.658 . . . . 35.039999999999999 109.257 -176.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B 1255 ' ' THR . . . . . . . . . . . . . 33.3 m -100.72 -21.11 15.31 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 109.192 -3.64 . . . . 34.619999999999997 113.933 -163.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . -62.17 139.25 58.48 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-O 122.877 1.323 . . . . 42.719999999999999 113.051 -162.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 5.6 tt -153.61 126.8 8.47 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 111.165 -2.743 . . . . 52.43 104.945 175.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 58.3 mt -85.69 118.21 70.19 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 101.34 -3.578 . . . . 59.409999999999997 101.34 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -51.37 92.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 124.877 3.718 . . . . 62.68 114.974 -175.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 130.46 -64.27 0.61 Allowed Glycine 0 N--CA 1.425 -2.061 0 N-CA-C 107.008 -2.437 . . . . 64.159999999999997 107.008 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 79.7 mttt -59.1 166.52 2.66 Favored Pre-proline 0 CA--C 1.51 -0.58 0 C-N-CA 125.992 1.717 . . . . 68.530000000000001 115.582 171.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -67.67 166.45 24.09 Favored 'Trans proline' 0 C--O 1.249 1.034 0 C-N-CA 122.659 2.239 . . . . 61.990000000000002 114.459 169.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1263 ' ' ALA . . . . . . . . . . . . . . . -54.71 126.92 59.02 Favored Pre-proline 0 C--O 1.25 1.091 0 CA-C-N 111.819 -2.446 . . . . 57.149999999999999 111.52 166.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -60.95 141.49 94.68 Favored 'Trans proline' 0 C--N 1.324 -0.745 0 C-N-CA 123.998 3.132 . . . . 51.57 109.57 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -77.22 73.34 3.8 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-N 114.998 -1.001 . . . . 54.549999999999997 112.724 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 43.1 mt -76.02 -40.18 54.1 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 115.217 1.562 . . . . 46.859999999999999 115.217 -170.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1267 ' ' ILE . . . . . . . . . . . . . 40.1 mm -110.72 119.75 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 106.432 -1.692 . . . . 41.039999999999999 106.432 -173.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1268 ' ' THR . . . . . . . . . . . . . 19.0 p -84.13 159.0 21.18 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 113.03 -1.895 . . . . 39.579999999999998 110.108 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1269 ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 -63.62 -33.6 75.98 Favored 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 120.689 -1.257 . . . . 53.149999999999999 111.03 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -64.4 -43.91 92.93 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 109.046 -0.724 . . . . 42.960000000000001 109.046 176.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1271 ' ' MET . . . . . . . . . . . . . 5.8 ttm -62.18 -40.45 96.06 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 114.516 1.302 . . . . 43.890000000000001 114.516 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1272 ' ' VAL . . . . . . . . . . . . . 53.7 t -56.62 -59.12 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 120.339 -0.544 . . . . 38.369999999999997 111.53 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -66.84 -25.15 66.29 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 122.779 1.275 . . . . 47.460000000000001 114.02 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1274 ' ' SER . . . . . . . . . . . . . 33.2 m -74.71 -17.13 60.71 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 118.262 -2.774 . . . . 38.380000000000003 114.131 170.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1275 ' ' MET . . . . . . . . . . . . . 34.0 mtp -69.12 163.64 24.35 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 121.388 1.904 . . . . 37.810000000000002 112.808 -174.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.04 126.32 25.41 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 113.131 -1.85 . . . . 49.259999999999998 108.778 167.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -83.47 169.85 15.07 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 120.559 1.527 . . . . 34.460000000000001 114.003 -167.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 62.32 41.64 99.74 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-O 122.995 1.331 . . . . 33.530000000000001 110.639 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1279 ' ' SER . . . . . . . . . . . . . 70.4 m -134.59 158.98 42.62 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 110.204 -2.998 . . . . 31.309999999999999 104.224 -172.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1280 ' ' VAL . . . . . . . . . . . . . 41.4 t -128.66 142.1 44.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 106.708 -1.59 . . . . 29.32 106.708 -169.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1281 ' ' ILE . . . . . . . . . . . . . 43.4 mt -113.31 113.22 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 103.002 -2.962 . . . . 31.93 103.002 167.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1282 ' ' VAL . . . . . . . . . . . . . 5.1 t -97.09 127.57 49.17 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 N-CA-C 105.873 -1.899 . . . . 29.48 105.873 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 12.8 t0 -100.12 115.37 29.65 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 104.387 -2.449 . . . . 34.5 104.387 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1284 ' ' LEU . . . . . . . . . . . . . 6.9 mp -82.01 -22.74 36.35 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.727 1.01 . . . . 37.939999999999998 113.727 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -118.45 30.72 7.05 Favored 'General case' 0 N--CA 1.428 -1.551 0 O-C-N 119.374 -2.079 . . . . 40.920000000000002 111.115 -165.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -51.72 -38.2 54.24 Favored 'General case' 0 C--O 1.248 0.987 0 N-CA-C 117.647 2.462 . . . . 44.390000000000001 117.647 -169.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1287 ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -65.31 -22.98 66.9 Favored 'General case' 0 C--O 1.268 2.049 0 N-CA-C 117.226 2.306 . . . . 51.460000000000001 117.226 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 20.7 m120 -110.31 73.31 0.83 Allowed 'General case' 0 C--N 1.35 0.604 0 N-CA-C 105.65 -1.981 . . . . 57.75 105.65 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1289 ' ' GLY . . . . . . . . . . . . . . . 87.08 -64.05 3.93 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-O 116.443 -2.31 . . . . 49.850000000000001 112.484 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 106.26 120.61 4.68 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 118.903 1.352 . . . . 45.93 112.03 -167.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1291 ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -69.6 -36.95 76.66 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.37 1.468 . . . . 42.670000000000002 112.368 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1292 ' ' CYS . . . . . . . . . . . . . 31.5 t -99.16 145.37 27.27 Favored 'General case' 0 C--O 1.253 1.257 0 CA-C-N 123.216 2.735 . . . . 38.82 108.401 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1293 ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -60.47 -29.94 69.36 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 114.93 1.456 . . . . 46.710000000000001 114.93 175.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -72.09 -16.7 62.02 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 116.396 1.998 . . . . 47.229999999999997 116.396 176.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1295 ' ' THR . . . . . . . . . . . . . 85.9 m -56.19 122.35 11.55 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 123.854 1.788 . . . . 36.020000000000003 115.756 -165.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 7.2 t -107.03 124.18 36.11 Favored Pre-proline 0 N--CA 1.438 -1.054 1 N-CA-C 100.147 -4.02 . . . . 37.259999999999998 100.147 175.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -62.67 107.74 0.64 Allowed 'Trans proline' 0 C--O 1.243 0.752 0 C-N-CA 123.906 3.07 . . . . 35.090000000000003 112.459 -172.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 83.01 50.93 4.39 Favored Glycine 0 C--O 1.252 1.265 0 N-CA-C 108.035 -2.026 . . . . 35.969999999999999 108.035 173.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -151.74 145.25 24.87 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-O 122.181 0.991 . . . . 40.390000000000001 109.706 175.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1300 ' ' ILE . . . . . . . . . . . . . 77.1 mt -80.49 130.07 36.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 103.877 -2.638 . . . . 37.43 103.877 156.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 4.5 t80 -121.94 120.79 35.47 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 104.758 -2.312 . . . . 44.130000000000003 104.758 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1302 ' ' THR . . . . . . . . . . . . . 59.6 m -83.51 133.97 34.86 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.325 -1.307 . . . . 39.780000000000001 108.264 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1303 ' ' THR . . . . . . . . . . . . . 14.0 p -97.75 179.74 4.72 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 121.105 -0.997 . . . . 43.289999999999999 112.155 175.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -60.19 -51.69 68.51 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.64 0.733 . . . . 53.07 111.457 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 43.9 p-10 -74.57 -17.18 60.77 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 116.351 1.982 . . . . 43.969999999999999 116.351 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 85.25 33.69 16.6 Favored Glycine 0 N--CA 1.468 0.799 0 CA-C-N 114.626 -1.17 . . . . 41.119999999999997 113.994 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1307 ' ' VAL . . . . . . . . . . . . . 99.8 t -92.08 94.1 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 N-CA-C 105.374 -2.084 . . . . 38.119999999999997 105.374 163.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1308 ' ' LYS . . . . . . . . . . . . . 80.7 mttt -78.59 119.72 22.27 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.649 -1.614 . . . . 36.340000000000003 109.662 -165.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1309 ' ' VAL . . . . . . . . . . . . . 59.4 t -90.01 97.18 6.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 125.084 2.373 . . . . 30.399999999999999 109.195 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1310 ' ' ILE . . . . . . . . . . . . . 14.1 mt -87.39 80.21 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.891 0 CA-C-N 112.239 -2.255 . . . . 30.82 105.314 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1311 ' ' GLY . . . . . . . . . . . . . . . -81.41 109.42 3.0 Favored Glycine 0 CA--C 1.503 -0.71 0 O-C-N 119.897 -1.752 . . . . 26.530000000000001 109.847 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1312 ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -120.23 124.99 47.03 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 119.741 3.237 . . . . 38.0 119.741 -176.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1313 ' ' THR . . . . . . . . . . . . . 4.0 m -69.65 -33.02 72.02 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.3 -1.773 . . . . 29.800000000000001 110.419 164.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -118.74 24.14 11.05 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 114.145 -1.389 . . . . 39.039999999999999 114.001 -157.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1315 ' ' LEU . . . . . . . . . . . . . 18.7 mt -52.1 -41.93 83.08 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 114.728 1.381 . . . . 31.079999999999998 114.728 176.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1316 ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -67.17 -36.84 20.19 Favored 'Trans proline' 0 CA--C 1.499 -1.252 0 CA-C-N 123.831 2.404 . . . . 26.100000000000001 113.094 168.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -60.29 -44.96 96.96 Favored Glycine 0 CA--C 1.503 -0.685 0 CA-C-N 120.512 1.506 . . . . 23.170000000000002 110.606 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 56.1 mtt-85 -66.95 -0.21 2.96 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 116.149 1.907 . . . . 40.399999999999999 116.149 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 22.6 tp -120.37 78.79 27.73 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 105.325 -2.102 . . . . 23.600000000000001 105.325 172.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1320 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -58.41 -64.78 0.1 Allowed 'Trans proline' 0 CA--C 1.552 1.397 0 C-N-CA 125.158 3.905 . . . . 22.350000000000001 113.956 -161.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1321 ' ' THR . . . . . . . . . . . . . 6.3 m -66.16 -40.96 90.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 121.149 1.795 . . . . 26.52 112.874 -175.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1322 ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -69.67 -43.57 72.27 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 120.262 1.392 . . . . 24.379999999999999 110.83 -174.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1323 ' ' SER . . . . . . . . . . . . . 21.0 m -56.13 -50.22 71.72 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 119.217 -0.993 . . . . 22.800000000000001 111.091 170.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1324 ' ' SER . . . . . . . . . . . . . 15.1 m -57.57 -34.56 69.34 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 123.242 1.496 . . . . 21.25 112.731 176.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -67.23 -55.73 12.8 Favored 'General case' 0 N--CA 1.438 -1.036 0 O-C-N 119.594 -1.941 . . . . 31.34 111.387 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1326 ' ' LEU . . . . . . . . . . . . . 45.0 mt -69.32 -40.41 77.63 Favored 'General case' 0 N--CA 1.435 -1.19 0 O-C-N 120.886 -1.134 . . . . 31.559999999999999 111.764 -173.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1327 ' ' TYR . . . . . . . . . . . . . 27.4 t80 -53.42 -53.31 53.15 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.428 -1.323 . . . . 22.73 107.428 171.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1328 ' ' GLY . . . . . . . . . . . . . . . -44.84 -56.89 5.6 Favored Glycine 0 C--O 1.254 1.381 0 C-N-CA 124.539 1.066 . . . . 21.91 114.335 172.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1329 ' ' THR . . . . . . . . . . . . . 19.3 m -69.84 -23.64 63.32 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 121.428 -1.042 . . . . 22.149999999999999 110.421 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1330 ' ' ASN . . . . . . . . . . . . . 31.6 m120 -66.3 -42.66 87.99 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.076 -1.64 . . . . 26.18 107.004 172.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1331 ' ' LEU . . . . . . . . . . . . . 41.5 mt -66.6 -39.13 88.23 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.569 -0.9 . . . . 23.68 108.569 -178.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1332 ' ' VAL . . . . . . . . . . . . . 70.3 t -58.69 -46.73 90.35 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-O 116.958 -1.496 . . . . 26.57 108.622 171.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -56.53 -43.11 79.53 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 121.018 1.736 . . . . 28.079999999999998 113.592 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1334 ' ' LEU . . . . . . . . . . . . . 46.9 tp -59.6 -50.76 72.64 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 113.82 -1.536 . . . . 27.43 107.855 175.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1335 ' ' LEU . . . . . . . . . . . . . 65.1 mt -69.77 -23.99 63.44 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 119.011 -2.306 . . . . 30.5 111.841 -177.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1336 ' ' LYS . . . . . . . . . . . . . 90.9 mttt -64.42 -40.28 95.46 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 122.81 2.55 . . . . 41.649999999999999 109.891 169.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 12.4 tp -77.75 -31.09 51.91 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 113.472 0.916 . . . . 42.079999999999998 113.472 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1338 ' ' LEU . . . . . . . . . . . . . 95.1 mt -78.64 -69.77 0.54 Allowed 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 122.281 1.039 . . . . 35.030000000000001 109.61 173.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 42.4 t -81.1 72.35 8.12 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 124.397 2.046 . . . . 37.329999999999998 107.584 -174.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 58.9 mttp -70.18 -19.25 63.2 Favored 'General case' 0 CA--C 1.5 -0.952 0 O-C-N 118.376 -2.703 . . . . 50.509999999999998 114.929 -178.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -78.14 -9.18 59.06 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 113.169 0.803 . . . . 54.210000000000001 113.169 168.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 44.9 mttt 48.11 56.23 7.61 Favored 'General case' 0 C--N 1.364 1.224 0 C-N-CA 124.96 1.304 . . . . 50.990000000000002 113.359 -173.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 26.6 p-10 -122.38 -47.87 2.1 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.857 -0.737 . . . . 48.82 111.17 -172.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 150.37 -3.71 0.56 Allowed Glycine 0 CA--C 1.54 1.623 0 CA-C-O 123.369 1.538 . . . . 40.43 111.195 172.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 22.9 t30 -79.64 116.4 19.81 Favored 'General case' 0 N--CA 1.428 -1.53 0 O-C-N 119.463 -2.198 . . . . 47.560000000000002 114.292 175.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1346 ' ' ILE . . . . . . . . . . . . . 40.4 mm -59.74 97.62 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.246 0.902 0 CA-C-O 123.204 1.478 . . . . 42.490000000000002 112.234 169.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1347 ' ' THR . . . . . . . . . . . . . 48.2 m -101.38 93.99 5.69 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 113.394 -1.73 . . . . 38.119999999999997 107.504 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 85.5 t -87.0 94.84 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 O-C-N 119.309 -2.119 . . . . 37.5 107.802 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 16.2 t70 -75.12 101.97 4.75 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 107.228 -1.397 . . . . 43.850000000000001 107.228 170.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1350 ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.98 -5.24 45.39 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 113.244 -1.798 . . . . 39.810000000000002 113.168 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 24.2 t70 -79.81 -42.65 23.95 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 120.341 -1.474 . . . . 51.289999999999999 107.706 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 20.1 t0 -57.11 113.54 1.76 Allowed 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 122.756 1.265 . . . . 39.780000000000001 109.865 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 15.1 m -46.27 -35.24 2.31 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 CA-C-N 113.502 -1.681 . . . . 39.280000000000001 114.443 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1354 ' ' VAL . . . . . . . . . . . . . 47.4 t -67.72 -50.53 59.69 Favored 'Isoleucine or valine' 0 C--O 1.263 1.794 0 O-C-N 124.72 1.262 . . . . 35.700000000000003 110.751 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1355 ' ' ILE . . . . . . . . . . . . . 34.7 mm -69.0 -40.2 80.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 CA-C-N 120.046 1.294 . . . . 35.770000000000003 108.902 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 43.8 tpt85 -52.52 -32.18 39.16 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 125.44 1.496 . . . . 38.549999999999997 111.662 168.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -74.14 -59.64 3.86 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 110.229 -1.149 . . . . 29.579999999999998 110.229 176.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1358 ' ' VAL . . . . . . . . . . . . . 11.6 p -60.32 -38.55 77.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-N 118.393 1.096 . . . . 32.060000000000002 111.634 -172.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1359 ' ' THR . . . . . . . . . . . . . 5.6 m -81.78 92.17 6.61 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 123.049 1.404 . . . . 29.0 107.695 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1360 ' ' VAL . . . . . . . . . . . . . 31.2 m -82.27 -17.88 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 110.771 -2.922 . . . . 29.68 113.903 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 48.6 mt -133.7 106.88 9.68 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 N-CA-C 101.274 -3.602 . . . . 32.049999999999997 101.274 168.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1362 ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 -87.62 78.04 8.59 Favored 'General case' 0 C--O 1.243 0.727 0 O-C-N 118.341 -2.725 . . . . 32.520000000000003 109.182 174.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 58.62 89.1 0.06 Allowed 'General case' 0 C--O 1.246 0.912 0 CA-C-N 112.488 -2.142 . . . . 35.68 114.161 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 88.56 -72.68 2.3 Favored Glycine 0 N--CA 1.477 1.43 0 CA-C-N 114.733 -1.122 . . . . 34.259999999999998 111.253 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.03 117.64 6.73 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.182 0.993 . . . . 51.07 110.46 176.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 95.9 mt -74.24 104.13 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 104.93 -2.248 . . . . 39.869999999999997 104.93 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1367 ' ' THR . . . . . . . . . . . . . 7.2 p -94.2 -1.08 54.68 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.1 -1.409 . . . . 38.009999999999998 111.985 -174.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1368 ' ' TRP . . . . . . . . . . . . . 24.5 t90 -74.23 137.67 75.34 Favored Pre-proline 0 CA--C 1.548 0.876 0 O-C-N 120.236 -1.54 . . . . 42.140000000000001 108.009 162.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -72.94 161.22 94.17 Favored 'Cis proline' 0 CA--C 1.512 -0.624 0 CA-C-N 123.171 2.168 . . . . 43.259999999999998 116.785 -11.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1370 ' ' ALA . . . . . . . . . . . . . . . -87.38 170.42 11.99 Favored Pre-proline 0 N--CA 1.469 0.505 0 CA-C-O 117.12 -1.419 . . . . 46.520000000000003 111.072 176.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -47.93 144.26 12.1 Favored 'Trans proline' 0 CA--C 1.555 1.557 0 C-N-CA 123.43 2.753 . . . . 51.950000000000003 112.671 165.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.96 75.76 2.17 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.568 2.845 . . . . 56.270000000000003 114.85 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1373 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.92 128.76 38.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 104.895 -2.261 . . . . 60.829999999999998 104.895 173.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -68.25 123.23 20.15 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 115.707 1.743 . . . . 66.099999999999994 115.707 -173.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 14.4 t -60.88 123.23 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 1 O-C-N 129.208 4.068 . . . . 63.469999999999999 110.922 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.23 -4.627 0 O-C-N 119.795 -1.816 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.702 0 CA-C-O 118.828 -0.606 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -45.33 -30.25 1.25 Allowed 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 117.454 2.39 . . . . 0.0 117.454 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -46.57 -40.19 12.34 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.991 1.716 . . . . 0.0 109.436 177.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 22.4 m -55.97 -29.23 59.9 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -178.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.55 -47.28 86.25 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.276 -1.515 . . . . 0.0 111.104 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -66.56 -34.36 77.73 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.327 1.051 . . . . 0.0 108.284 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 mp -70.06 -31.31 68.86 Favored 'General case' 0 N--CA 1.426 -1.663 0 C-N-CA 123.825 0.85 . . . . 0.0 110.827 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 63.0 mt -61.14 -48.08 83.24 Favored 'General case' 0 CA--C 1.518 -0.282 0 O-C-N 119.431 -2.043 . . . . 0.0 115.334 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 28' ' ' LYS . . . . . . . . . . . . . 10.2 pttm -63.98 -28.2 69.65 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 119.063 -1.055 . . . . 0.0 113.213 172.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -73.87 -35.3 64.72 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 118.632 -0.699 . . . . 0.0 112.053 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 39.6 m -56.42 -17.79 9.15 Favored 'General case' 0 C--O 1.239 0.531 1 N-CA-C 124.137 4.865 . . . . 0.0 124.137 -163.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 44.2 m-70 66.67 -77.31 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 125.336 1.455 . . . . 0.0 109.726 -174.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 74.2 m -97.5 160.01 14.58 Favored 'General case' 0 C--O 1.242 0.661 0 O-C-N 120.158 -1.589 . . . . 0.0 108.318 168.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 12.8 t -132.23 118.01 34.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 O-C-N 119.01 -2.306 . . . . 0.0 105.658 174.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 27.3 mm -104.29 124.12 58.56 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 N-CA-C 105.882 -1.895 . . . . 0.0 105.882 175.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 92.3 mt -107.03 125.61 63.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 82.8 m -106.86 98.79 22.51 Favored Pre-proline 0 N--CA 1.44 -0.962 0 O-C-N 119.316 -2.115 . . . . 0.0 112.249 171.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -75.95 56.32 4.75 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.421 2.747 . . . . 0.0 114.526 175.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.92 89.03 1.42 Allowed Glycine 0 N--CA 1.443 -0.894 0 O-C-N 119.78 -1.825 . . . . 0.0 111.137 -170.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 40.1 t80 65.76 -72.71 0.07 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.895 1.278 . . . . 0.0 108.916 -177.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -28.46 -64.09 0.11 Allowed Glycine 0 C--N 1.349 1.285 0 N-CA-C 117.985 1.954 . . . . 0.0 117.985 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 9.2 ttm -49.83 -39.84 40.15 Favored 'General case' 0 C--O 1.25 1.126 0 N-CA-C 118.265 2.691 . . . . 0.0 118.265 173.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -85.35 -22.92 28.25 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 9.0 p -84.13 -38.09 13.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 O-C-N 119.078 -2.264 . . . . 0.0 110.945 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.67 9.57 2.71 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 117.4 2.37 . . . . 0.0 117.4 175.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 45' ' ' GLN . . . . . . . . . . . . 0.388 1.0 OUTLIER 41.75 48.1 3.64 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 119.124 3.009 . . . . 0.0 119.124 -159.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.51 -1.31 57.05 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.887 169.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.56 -48.84 57.3 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 118.335 -0.841 . . . . 0.0 111.455 177.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 48' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -71.42 -58.01 4.09 Favored Pre-proline 0 C--O 1.247 0.964 0 CA-C-O 116.87 -1.538 . . . . 0.0 113.922 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 49' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -50.9 -15.05 1.55 Allowed 'Trans proline' 0 C--N 1.367 1.53 0 N-CA-C 120.412 3.197 . . . . 0.0 120.412 172.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 5.5 p -63.6 -29.82 48.25 Favored 'Isoleucine or valine' 0 C--O 1.246 0.87 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.294 172.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.23 93.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 117.951 -2.968 . . . . 0.0 111.148 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -47.42 -48.87 26.12 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 171.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 53' ' ' ILE . . . . . . . . . . . . 0.253 8.4 tp -72.99 -46.26 52.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.902 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 60.5 m -53.13 -36.77 61.15 Favored 'General case' 0 C--O 1.256 1.419 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -52.67 -64.22 0.89 Allowed 'General case' 0 C--O 1.238 0.485 0 C-N-CA 127.045 2.138 . . . . 0.0 111.311 173.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -66.12 -33.09 74.99 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 117.373 -1.298 . . . . 0.0 109.732 -176.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 50.4 mt -60.54 -45.89 92.2 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 122.372 2.351 . . . . 0.0 108.845 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -66.36 -43.99 84.45 Favored 'General case' 0 C--O 1.255 1.369 0 O-C-N 121.3 -0.875 . . . . 0.0 111.747 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.63 -12.56 61.09 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 121.872 0.844 . . . . 0.0 112.67 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -76.87 -31.82 57.06 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-O 123.822 1.772 . . . . 0.0 110.045 171.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.47 42.01 2.62 Favored Glycine 0 N--CA 1.431 -1.638 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.654 -173.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 95.3 mt -109.11 132.1 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 121.568 0.699 . . . . 0.0 109.68 -177.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -68.94 91.74 0.48 Allowed 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 122.684 1.23 . . . . 0.0 108.255 169.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 8.9 p -96.98 122.43 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-O 122.525 1.155 . . . . 0.0 109.687 176.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 17.8 mmt-85 -129.27 153.43 47.8 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 175.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -112.93 141.67 46.49 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -126.74 99.54 0.54 Allowed Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 107.596 -2.202 . . . . 0.0 107.596 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mt -102.92 -154.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 O-C-N 124.411 0.712 . . . . 0.0 111.384 174.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -165.2 135.2 2.9 Favored Pre-proline 0 N--CA 1.473 0.68 0 O-C-N 119.243 -2.161 . . . . 0.0 105.61 -169.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 70' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -45.4 -61.51 0.58 Allowed 'Trans proline' 0 C--N 1.352 0.716 1 C-N-CA 126.428 4.752 . . . . 0.0 117.526 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 14.5 m -94.42 133.41 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.93 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 174.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.57 9.34 8.99 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 117.786 2.513 . . . . 0.0 117.786 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.88 -52.28 0.65 Allowed Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 -169.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -147.94 177.64 9.18 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 7.0 mt 53.71 44.39 1.87 Allowed Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 119.557 3.169 . . . . 0.0 119.557 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -63.31 133.74 41.89 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.691 2.927 . . . . 0.0 113.195 -174.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.22 -70.6 1.84 Allowed Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.385 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 78' ' ' HIS . . . . . . . . . . . . 0.258 0.2 OUTLIER -36.91 -34.2 0.07 Allowed 'General case' 0 C--O 1.25 1.124 0 N-CA-C 121.648 3.944 . . . . 0.0 121.648 177.115 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -54.36 -34.13 60.54 Favored 'General case' 0 C--N 1.347 0.46 0 O-C-N 118.942 -2.348 . . . . 0.0 113.926 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -77.0 -30.38 55.89 Favored 'General case' 0 CA--C 1.501 -0.912 0 O-C-N 120.822 -1.174 . . . . 0.0 112.107 175.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 6.5 t -67.06 -39.77 84.02 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 O-C-N 120.678 -1.264 . . . . 0.0 110.689 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 95.3 mt -54.97 -36.24 65.16 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.111 0.964 . . . . 0.0 112.381 171.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 8.1 mp -71.72 -31.23 66.49 Favored 'General case' 0 C--O 1.249 1.04 0 CA-C-N 119.997 1.272 . . . . 0.0 112.077 176.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.13 -30.15 64.76 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.681 173.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.25 -48.37 78.52 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-O 122.024 0.916 . . . . 0.0 109.146 166.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.03 -1.38 2.05 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 119.171 -2.205 . . . . 0.0 115.827 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp 55.29 53.11 10.42 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -171.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 14.5 t -111.27 125.55 30.33 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 101.483 -3.525 . . . . 0.0 101.483 169.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -61.66 120.97 8.86 Favored 'Trans proline' 0 C--O 1.241 0.653 1 C-N-CA 126.49 4.793 . . . . 0.0 115.949 -171.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.58 -26.73 45.32 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 126.66 1.984 . . . . 0.0 113.008 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -58.46 -51.3 70.43 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 119.965 1.257 . . . . 0.0 112.148 174.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 45.2 pt -77.73 -23.11 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 119.655 -1.903 . . . . 0.0 110.575 -175.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 67.9 t -68.35 83.55 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 174.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 20.7 mt -89.84 151.85 21.56 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 173.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -138.53 127.96 24.59 Favored 'General case' 0 C--O 1.249 1.066 0 O-C-N 118.597 -2.565 . . . . 0.0 108.44 176.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 50.3 ttp 45.11 75.17 0.11 Allowed 'General case' 0 C--N 1.354 0.8 0 CA-C-O 124.872 2.272 . . . . 0.0 113.732 -177.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -145.5 164.01 32.93 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 109.994 -3.275 . . . . 0.0 106.809 -162.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -79.97 13.41 2.24 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 112.934 -1.939 . . . . 0.0 111.66 -178.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 4.2 tt -45.42 -16.35 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 124.614 1.166 . . . . 0.0 111.652 153.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -33.91 -35.85 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 117.108 2.262 . . . . 0.0 117.108 162.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -65.45 -62.1 1.72 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 119.336 -0.945 . . . . 0.0 111.232 172.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -51.0 -32.79 22.3 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 175.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 103' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -55.71 -47.97 75.95 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 125.705 1.602 . . . . 0.0 109.958 170.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -79.97 -18.33 50.62 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 119.01 0.823 . . . . 0.0 111.774 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -73.08 -47.13 47.11 Favored 'General case' 0 C--O 1.239 0.501 0 O-C-N 120.459 -1.401 . . . . 0.0 111.548 171.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 106' ' ' THR . . . . . . . . . . . . . 77.0 m -54.14 133.8 44.19 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 122.342 0.257 . . . . 0.0 111.599 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 107' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -67.07 -65.59 0.66 Allowed 'General case' 0 C--O 1.234 0.252 0 O-C-N 124.076 0.86 . . . . 0.0 112.292 169.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 68.0 m -103.42 105.91 16.29 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 123.978 0.911 . . . . 0.0 109.64 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 109' ' ' VAL . . . . . . . . . . . . . 16.4 t -89.54 110.97 22.35 Favored 'Isoleucine or valine' 0 C--N 1.349 0.578 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 28.5 mt -77.96 84.26 4.25 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 123.219 1.485 . . . . 0.0 110.791 -175.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 93.1 t -90.65 96.3 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 CA-C-O 123.154 1.454 . . . . 0.0 108.622 -177.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 1.3 mm -83.67 89.52 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-O 124.001 1.858 . . . . 0.0 108.586 -171.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.55 -103.91 2.47 Favored Glycine 0 CA--C 1.496 -1.116 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.669 -172.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . 56.47 -57.11 0.02 OUTLIER 'General case' 0 C--O 1.249 1.063 0 N-CA-C 120.463 3.505 . . . . 0.0 120.463 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 115' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 59.67 -93.03 0.04 OUTLIER 'General case' 0 C--O 1.241 0.644 0 CA-C-N 122.553 2.433 . . . . 0.0 112.438 173.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 116' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -82.72 -19.38 38.11 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.123 -0.986 . . . . 0.0 111.977 -176.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 117' ' ' THR . . . . . . . . . . . . 0.254 1.0 OUTLIER -67.22 -15.28 63.61 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 176.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 16.5 m -122.81 30.66 2.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 124.612 1.165 . . . . 0.0 108.327 171.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -86.78 119.62 71.31 Favored Pre-proline 0 CA--C 1.506 -0.714 0 O-C-N 119.212 -2.18 . . . . 0.0 114.146 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 120' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -53.24 -53.22 7.05 Favored 'Trans proline' 0 C--O 1.243 0.733 0 C-N-CA 124.878 3.718 . . . . 0.0 113.127 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.9 -28.09 69.27 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -174.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 122' ' ' ALA . . . . . . . . . . . . . . . -54.51 -41.05 69.19 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-O 121.609 0.719 . . . . 0.0 111.622 172.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -92.57 -16.62 25.45 Favored 'General case' 0 C--O 1.245 0.846 0 O-C-N 118.499 -2.625 . . . . 0.0 114.074 173.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -98.77 -35.52 10.12 Favored 'General case' 0 C--O 1.241 0.647 0 O-C-N 121.242 -0.911 . . . . 0.0 112.846 -165.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -117.54 126.94 26.99 Favored Pre-proline 0 C--N 1.321 -0.639 0 C-N-CA 124.516 1.126 . . . . 0.0 113.112 -157.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -62.36 -38.03 56.53 Favored 'Trans proline' 0 CA--C 1.548 1.196 0 C-N-CA 124.971 3.781 . . . . 0.0 114.57 176.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? -63.75 -29.57 70.77 Favored 'General case' 0 C--N 1.314 -0.941 0 O-C-N 119.291 -2.131 . . . . 0.0 111.267 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 128' ' ' SER . . . . . . . . . . . . . 18.4 m -58.6 127.94 82.74 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 118.074 -0.965 . . . . 0.0 111.044 172.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 129' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -56.23 -31.36 83.74 Favored 'Trans proline' 0 C--O 1.257 1.428 0 CA-C-N 122.506 1.931 . . . . 0.0 116.17 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 10.5 pt -105.78 53.53 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-O 123.246 1.498 . . . . 0.0 109.278 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.85 120.8 14.17 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 123.3 1.524 . . . . 0.0 111.811 -171.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.61 38.97 10.02 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 133' ' ' MET . . . . . . . . . . . . . 42.8 tpp -73.72 134.98 78.23 Favored Pre-proline 0 N--CA 1.45 -0.444 0 O-C-N 119.819 -1.989 . . . . 0.0 110.535 172.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -68.25 90.24 0.39 Allowed 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 124.011 3.141 . . . . 0.0 110.418 173.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 1.5 m -110.95 150.8 13.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -175.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 28.7 mt -73.9 104.51 4.79 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.934 0.873 . . . . 0.0 112.589 -165.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -64.63 110.97 2.53 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -172.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 4.9 p -151.71 61.4 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 164.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 4.5 m95 -81.63 136.67 35.53 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.909 -1.496 . . . . 0.0 112.837 -166.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 41.65 45.54 2.97 Favored 'General case' 0 C--O 1.243 0.755 0 O-C-N 126.886 2.616 . . . . 0.0 116.603 175.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -166.3 162.48 17.29 Favored 'General case' 0 C--N 1.345 0.402 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -170.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 59.91 163.29 0.05 Allowed 'General case' 0 C--O 1.242 0.681 0 N-CA-C 117.77 2.507 . . . . 0.0 117.77 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 143' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -82.3 68.91 8.91 Favored 'General case' 0 C--O 1.248 1.01 0 O-C-N 120.979 -1.076 . . . . 0.0 109.269 176.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 144' ' ' VAL . . . . . . . . . . . . . 26.0 t -74.88 96.56 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 113.598 -1.637 . . . . 0.0 108.627 -177.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 145' ' ' ILE . . . . . . . . . . . . 0.266 7.9 tp -92.1 87.31 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-O 126.416 3.008 . . . . 0.0 113.3 -170.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 146' ' ' VAL . . . . . . . . . . . . . 26.7 t -77.73 97.42 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 CA-C-N 108.761 -3.836 . . . . 0.0 111.087 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 147' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -67.1 96.24 0.44 Allowed 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 148' ' ' LYS . . . . . 0.402 ' NZ ' ' OD1' ' C' ' 152' ' ' ASN . 48.2 tptt -123.38 131.01 53.52 Favored 'General case' 0 C--O 1.211 -0.938 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -174.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 9.8 tpp85 -63.65 -49.26 73.92 Favored 'General case' 0 C--O 1.256 1.437 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -171.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 1.5 m -143.45 170.47 15.73 Favored 'General case' 0 C--O 1.249 1.073 0 O-C-N 120.86 -1.15 . . . . 0.0 108.966 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 10.5 tpt -79.17 99.11 6.84 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 176.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 152' ' ' ASN . . . . . 0.402 ' OD1' ' NZ ' ' C' ' 148' ' ' LYS . 0.6 OUTLIER -155.29 157.51 37.33 Favored 'General case' 0 N--CA 1.426 -1.671 0 C-N-CA 118.131 -1.428 . . . . 0.0 109.973 -176.428 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 4.8 m -62.75 130.29 44.26 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 125.548 1.78 . . . . 0.0 106.639 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -72.32 -120.83 0.06 OUTLIER Glycine 0 N--CA 1.415 -2.732 0 O-C-N 120.745 -1.222 . . . . 0.0 113.387 171.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -86.41 -66.83 0.86 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 170.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 156' ' ' ALA . . . . . . . . . . . . . . . -85.18 -39.65 17.6 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 170.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 54.89 33.41 56.52 Favored Glycine 0 C--N 1.352 1.423 0 C-N-CA 124.692 1.139 . . . . 0.0 114.335 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 3.3 m -76.42 144.52 11.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 O-C-N 121.441 -1.035 . . . . 0.0 111.265 -173.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.58 136.43 57.98 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 -174.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 160' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -169.72 156.54 6.19 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -171.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -54.31 -31.42 67.08 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 124.642 3.561 . . . . 0.0 115.223 177.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 162' ' ' LEU . . . . . . . . . . . . . 4.1 tt -68.04 -24.12 65.05 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 118.665 -2.522 . . . . 0.0 111.516 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 163' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -79.16 -10.78 59.91 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 172.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -127.57 -30.93 2.52 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 -169.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 35.8 mmtt -74.83 161.78 29.26 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.25 -170.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -89.84 -38.26 13.88 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.843 -173.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -74.25 -57.27 4.06 Favored 'General case' 0 C--O 1.243 0.716 0 O-C-N 117.329 -3.357 . . . . 0.0 106.93 172.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 168' ' ' THR . . . . . . . . . . . . 0.258 4.2 m -82.53 85.0 7.04 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 103.183 -2.895 . . . . 0.0 103.183 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -129.75 132.03 46.45 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-O 122.953 1.358 . . . . 0.0 113.607 -162.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 170' ' ' MET . . . . . . . . . . . . . 51.4 mtm -73.18 99.65 2.89 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 110.337 -3.119 . . . . 0.0 110.069 165.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 171' ' ' LEU . . . . . . . . . . . . . 17.4 tp -76.71 122.49 24.78 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 104.247 -2.501 . . . . 0.0 104.247 177.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -89.26 77.93 7.37 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 120.24 -1.537 . . . . 0.0 111.792 -166.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -149.99 162.78 29.27 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-N 113.46 -1.7 . . . . 0.0 112.295 -172.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 174' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -75.0 144.91 42.88 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 -177.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.06 -39.73 93.37 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 125.367 1.667 . . . . 0.0 112.795 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.92 -51.45 18.49 Favored 'General case' 0 C--N 1.359 1.005 0 C-N-CA 117.759 -1.576 . . . . 0.0 108.511 174.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 177' ' ' ALA . . . . . . . . . . . . . . . -53.7 -55.94 21.73 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 125.939 1.696 . . . . 0.0 114.379 -168.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 4.5 m -57.99 -38.3 75.85 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-N 114.678 -1.146 . . . . 0.0 113.83 175.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 179' ' ' VAL . . . . . . . . . . . . . 40.0 t -72.24 -38.38 61.83 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -57.6 -40.71 79.68 Favored 'General case' 0 C--N 1.351 0.66 0 O-C-N 118.45 -2.656 . . . . 0.0 112.461 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -58.97 -53.37 59.15 Favored 'General case' 0 CA--C 1.552 1.022 0 O-C-N 121.506 -0.746 . . . . 0.0 111.812 170.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 182' ' ' ILE . . . . . . . . . . . . . 30.9 pt -78.15 -24.41 13.87 Favored 'Isoleucine or valine' 0 C--O 1.249 1.077 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -168.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 183' ' ' LEU . . . . . . . . . . . . . 4.7 pp -59.0 -24.78 63.08 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 118.831 -2.418 . . . . 0.0 114.815 171.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 28.6 tptt -96.71 -60.18 1.65 Allowed 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 175.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -88.88 107.25 18.89 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 123.172 1.463 . . . . 0.0 108.265 -171.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 186' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--O 1.218 -0.567 0 CA-C-N 114.519 -1.219 . . . . 0.0 112.352 160.851 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' NAD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C 1001 ' ' NAP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 48.6 t-80 . . . . . 0 CA--C 1.506 -0.723 0 N-CA-C 108.811 -0.811 . . . . 65.739999999999995 108.811 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -67.47 81.28 0.15 Allowed Glycine 0 N--CA 1.424 -2.122 0 CA-C-O 125.576 2.764 . . . . 48.659999999999997 114.539 176.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -100.85 118.7 37.43 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 111.07 -2.565 . . . . 44.560000000000002 104.154 172.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1003 ' ' ILE . . . . . . . . . . . . . 54.9 mt -101.46 101.91 12.76 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 103.332 -2.84 . . . . 34.859999999999999 103.332 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -76.41 122.25 6.37 Favored Glycine 0 C--O 1.256 1.477 0 CA-C-N 109.644 -3.434 . . . . 30.75 110.41 174.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 49.0 mm -105.01 98.02 14.55 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 105.912 -1.884 . . . . 32.210000000000001 105.912 177.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -73.81 155.16 48.92 Favored 'Trans proline' 0 CA--C 1.508 -0.8 0 C-N-CA 123.305 2.67 . . . . 32.979999999999997 112.133 167.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1007 ' ' ARG . . . . . . . . . . . . . 33.9 ttp85 -71.85 146.14 48.14 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 110.564 -3.016 . . . . 47.979999999999997 105.316 162.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1008 ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -75.31 119.49 19.49 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 123.603 1.668 . . . . 34.700000000000003 108.254 172.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 25.7 mtp-105 -104.43 7.65 35.54 Favored 'General case' 0 N--CA 1.423 -1.778 0 CA-C-N 109.734 -3.394 . . . . 53.369999999999997 108.052 -172.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 19.9 tp -62.88 127.11 29.7 Favored 'General case' 0 CA--C 1.505 -0.774 0 O-C-N 118.376 -2.702 . . . . 45.07 108.171 152.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1011 ' ' THR . . . . . . . . . . . . . 7.9 m -52.95 144.42 14.89 Favored 'General case' 0 C--O 1.255 1.365 0 C-N-CA 125.06 1.344 . . . . 40.359999999999999 112.067 -173.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 57.8 t30 70.19 -35.37 0.32 Allowed 'General case' 0 C--O 1.269 2.1 0 N-CA-C 114.728 1.381 . . . . 40.609999999999999 114.728 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -74.25 99.59 3.48 Favored 'General case' 0 C--O 1.254 1.331 0 CA-C-N 120.95 1.705 . . . . 33.759999999999998 110.647 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1014 ' ' THR . . . . . . . . . . . . . 5.3 p -75.81 94.83 3.37 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 112.186 -2.279 . . . . 27.890000000000001 106.314 174.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1015 ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -145.63 147.19 31.75 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 104.472 -2.418 . . . . 29.02 104.472 173.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1016 ' ' VAL . . . . . . . . . . . . . 11.7 p -110.85 160.83 9.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 O-C-N 118.791 -2.443 . . . . 28.129999999999999 106.245 168.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1017 ' ' ALA . . . . . . . . . . . . . . . -69.77 -23.34 63.34 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 118.583 -2.573 . . . . 26.870000000000001 114.673 -176.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -156.72 136.29 12.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.454 -0.943 . . . . 26.77 108.454 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1019 ' ' THR . . . . . . . . . . . . . 41.6 p -72.58 172.7 7.03 Favored Pre-proline 0 C--O 1.249 1.045 0 CA-C-N 119.822 1.192 . . . . 27.02 114.207 174.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1020 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -49.96 -38.98 49.9 Favored 'Trans proline' 0 C--O 1.245 0.832 0 C-N-CA 123.216 2.611 . . . . 30.57 113.813 166.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -63.78 -39.41 94.2 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 113.029 0.752 . . . . 47.810000000000002 113.029 173.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1022 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.66 -29.48 64.67 Favored 'General case' 0 C--N 1.312 -1.039 0 O-C-N 121.124 -0.985 . . . . 30.77 113.245 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1023 ' ' VAL . . . . . . . . . . . . . 48.7 t -61.52 -48.49 88.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.862 0 C-N-CA 125.909 1.684 . . . . 33.590000000000003 107.416 171.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -55.94 -34.37 65.6 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 120.327 -1.483 . . . . 53.289999999999999 112.616 175.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -64.7 -47.76 77.15 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 119.792 1.178 . . . . 46.920000000000002 110.596 174.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1026 ' ' LEU . . . . . . . . . . . . . 60.3 mt -59.14 -32.57 69.98 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.574 1.324 . . . . 37.170000000000002 114.574 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 1.9 tp -65.19 -34.86 79.39 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.874 -1.057 . . . . 44.439999999999998 111.689 168.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -67.49 -32.78 73.83 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 122.402 1.096 . . . . 52.579999999999998 112.22 175.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1029 ' ' LEU . . . . . . . . . . . . . 45.2 mt -76.23 -26.11 55.72 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.446 -1.252 . . . . 45.689999999999998 110.269 171.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 84.62 43.51 6.84 Favored Glycine 0 N--CA 1.431 -1.698 0 CA-C-O 124.117 1.954 . . . . 42.090000000000003 112.679 175.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -118.53 137.71 53.03 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 104.688 -2.338 . . . . 40.719999999999999 104.688 -176.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1032 ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.5 113.06 16.18 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.187 -1.412 . . . . 37.770000000000003 107.187 -172.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1033 ' ' VAL . . . . . . . . . . . . . 3.1 t -85.15 134.37 27.23 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 N-CA-C 107.318 -1.364 . . . . 33.539999999999999 107.318 -174.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -124.86 129.57 50.67 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 116.753 -1.594 . . . . 31.68 106.742 174.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1035 ' ' VAL . . . . . . . . . . . . . 90.5 t -122.16 145.84 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 123.589 2.904 . . . . 31.52 108.331 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1036 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.66 134.66 54.72 Favored 'General case' 0 N--CA 1.436 -1.158 0 O-C-N 125.249 1.593 . . . . 41.039999999999999 108.373 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1037 ' ' SER . . . . . . . . . . . . . 25.5 m -75.22 122.51 23.78 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-N 115.093 -0.958 . . . . 31.829999999999998 110.422 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 91.36 21.76 33.99 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 114.764 -1.107 . . . . 29.359999999999999 112.236 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -87.06 -46.01 10.19 Favored 'General case' 0 CA--C 1.495 -1.172 0 O-C-N 119.952 -1.911 . . . . 27.780000000000001 109.847 -178.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -70.44 -24.73 76.55 Favored Glycine 0 C--O 1.242 0.596 0 C-N-CA 120.182 -1.008 . . . . 28.91 113.047 -170.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -61.59 -38.11 86.35 Favored 'General case' 0 CA--C 1.505 -0.756 0 O-C-N 124.314 0.655 . . . . 51.18 111.401 175.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1042 ' ' LEU . . . . . . . . . . . . . 16.8 mt -70.59 -58.2 3.93 Favored 'General case' 0 CA--C 1.513 -0.459 0 O-C-N 121.468 -0.77 . . . . 29.91 110.118 169.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1043 ' ' ALA . . . . . . . . . . . . . . . -65.5 3.8 0.65 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.375 1.62 . . . . 28.539999999999999 115.375 -173.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1044 ' ' SER . . . . . . . . . . . . . 49.5 m 65.73 28.77 10.96 Favored 'General case' 0 C--O 1.244 0.791 0 O-C-N 120.259 -1.526 . . . . 33.060000000000002 114.95 172.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1045 ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -155.81 101.33 2.12 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 101.86 -3.385 . . . . 30.289999999999999 101.86 174.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 4.2 p30 -73.36 161.31 30.61 Favored 'General case' 0 C--O 1.248 0.984 0 N-CA-C 117.676 2.472 . . . . 48.619999999999997 117.676 -153.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -57.54 -23.4 50.19 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-N 112.493 -2.139 . . . . 36.740000000000002 114.993 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.9 -32.12 40.25 Favored 'General case' 0 C--O 1.24 0.605 0 O-C-N 121.156 -0.965 . . . . 43.729999999999997 111.298 174.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -72.09 -29.79 64.45 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.967 -0.753 . . . . 32.810000000000002 108.967 172.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1050 ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -58.42 -49.07 78.59 Favored 'General case' 0 C--N 1.346 0.442 0 N-CA-C 114.45 1.278 . . . . 31.859999999999999 114.45 165.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 6.9 t -59.16 -39.55 78.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 O-C-N 119.881 -1.762 . . . . 33.219999999999999 111.891 174.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -61.15 -40.65 94.64 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 123.244 0.617 . . . . 50.829999999999998 111.99 172.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -72.06 -23.8 61.42 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 118.98 -2.325 . . . . 33.119999999999997 110.822 173.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 101.8 49.31 1.28 Allowed Glycine 0 N--CA 1.439 -1.118 0 C-N-CA 118.247 -1.93 . . . . 35.829999999999998 112.443 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -101.98 135.89 42.76 Favored 'General case' 0 N--CA 1.423 -1.775 0 O-C-N 125.0 1.059 . . . . 34.82 111.369 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -77.65 99.04 5.65 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 104.968 -2.234 . . . . 49.049999999999997 104.968 -177.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1057 ' ' ILE . . . . . . . . . . . . . 32.0 mm -75.18 102.96 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 N-CA-C 108.535 -0.913 . . . . 38.530000000000001 108.535 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1058 ' ' VAL . . . . . . . . . . . . . 2.8 m -127.08 166.5 23.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 122.512 1.149 . . . . 42.109999999999999 108.287 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -114.47 141.34 47.81 Favored 'General case' 0 C--O 1.258 1.513 0 O-C-N 120.602 -1.311 . . . . 58.0 109.832 -161.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 44.25 -116.49 1.62 Allowed Glycine 0 N--CA 1.477 1.411 0 N-CA-C 115.736 1.055 . . . . 52.119999999999997 115.736 163.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 6.8 m120 -60.28 -38.44 83.59 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 120.153 -0.619 . . . . 54.75 110.046 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1062 ' ' SER . . . . . . . . . . . . . 14.6 m -74.66 -11.67 60.24 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 120.037 -1.664 . . . . 50.340000000000003 110.267 -173.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 11.6 p -88.79 -41.14 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 O-C-N 119.107 -2.246 . . . . 41.460000000000001 106.291 166.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1064 ' ' TRP . . . . . . . . . . . . . 24.9 m95 -64.44 -24.61 67.69 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 115.283 1.586 . . . . 39.32 115.283 -174.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -87.04 79.58 8.65 Favored 'General case' 0 C--O 1.247 0.94 0 O-C-N 120.943 -1.098 . . . . 55.380000000000003 109.729 174.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1066 ' ' SER . . . . . . . . . . . . . 69.2 m -135.41 166.06 24.03 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 120.264 -0.575 . . . . 41.869999999999997 111.032 175.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -68.24 -35.67 78.28 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-O 121.593 0.711 . . . . 53.200000000000003 110.241 -177.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 4.9 mp -124.55 141.24 45.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 O-C-N 119.193 -2.192 . . . . 41.899999999999999 107.825 173.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1069 ' ' ILE . . . . . . . . . . . . . 19.5 mm -126.34 118.76 52.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 104.139 -2.541 . . . . 38.729999999999997 104.139 171.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1070 ' ' LEU . . . . . . . . . . . . . 64.3 mt -93.02 135.74 33.92 Favored 'General case' 0 C--N 1.316 -0.859 0 O-C-N 124.419 1.075 . . . . 32.439999999999998 108.553 172.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1071 ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -137.21 147.16 45.65 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-O 123.528 1.632 . . . . 34.649999999999999 112.714 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1072 ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -86.75 -35.43 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 CA-C-N 110.088 -3.233 . . . . 31.32 111.094 -163.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -127.32 -175.96 3.59 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 106.83 -1.545 . . . . 33.939999999999998 106.83 165.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -53.97 132.68 58.46 Favored Pre-proline 0 N--CA 1.465 0.31 0 CA-C-N 113.984 -1.462 . . . . 38.039999999999999 108.247 166.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1075 ' ' PRO . . . . . . . . . . . . . 92.6 Cg_exo -65.88 145.88 81.49 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 123.677 2.918 . . . . 42.68 111.551 175.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 15.3 mt -71.65 159.63 34.06 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 106.49 -1.67 . . . . 46.740000000000002 106.49 173.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -50.45 -32.45 17.95 Favored 'General case' 0 C--O 1.242 0.687 0 O-C-N 119.744 -1.848 . . . . 58.609999999999999 113.683 171.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 12.4 t0 -51.98 -60.89 2.67 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 124.294 1.038 . . . . 59.200000000000003 109.887 167.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1079 ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -65.04 -36.83 85.62 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.047 -1.433 . . . . 50.630000000000003 114.016 -173.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1080 ' ' ILE . . . . . . . . . . . . . 66.3 mt -48.0 -52.46 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.125 1.77 . . . . 51.479999999999997 109.275 171.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -66.44 -25.85 66.94 Favored 'General case' 0 CA--C 1.512 -0.518 0 O-C-N 119.323 -2.111 . . . . 50.280000000000001 113.743 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 25.8 mt -77.81 -17.76 57.1 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 115.649 -0.705 . . . . 50.210000000000001 112.207 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1083 ' ' LEU . . . . . . . . . . . . . 1.2 mm? -58.84 134.1 56.59 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 119.305 -2.122 . . . . 49.060000000000002 111.329 168.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.72 152.02 42.03 Favored Pre-proline 0 N--CA 1.473 0.705 0 CA-C-O 117.832 -1.08 . . . . 51.079999999999998 109.874 -175.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -54.34 116.39 3.03 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 124.707 3.605 . . . . 49.729999999999997 110.052 172.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 110.45 -5.8 29.92 Favored Glycine 0 CA--C 1.489 -1.587 0 N-CA-C 112.3 -0.32 . . . . 47.710000000000001 112.3 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1087 ' ' THR . . . . . . . . . . . . . 84.0 m -83.54 132.84 34.9 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 118.097 -3.002 . . . . 45.469999999999999 109.905 -174.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1088 ' ' THR . . . . . . . . . . . . . 1.6 m -89.09 94.65 10.01 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.333 -1.729 . . . . 42.039999999999999 106.333 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1089 ' ' LEU . . . . . . . . . . . . . 54.2 tp -81.36 102.35 10.4 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.182 -0.949 . . . . 38.060000000000002 109.376 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 3.2 t -99.75 123.05 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 104.822 -2.288 . . . . 37.399999999999999 104.822 174.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1091 ' ' SER . . . . . . . . . . . . . 4.9 m -153.8 165.48 35.91 Favored 'General case' 0 CA--C 1.549 0.915 0 O-C-N 120.103 -1.623 . . . . 36.159999999999997 111.319 -175.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 15.2 t80 -86.66 101.97 13.76 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 106.048 -1.834 . . . . 38.939999999999998 106.048 166.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 40.3 mm -91.56 -65.34 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 123.046 1.403 . . . . 42.170000000000002 113.256 -170.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 29.7 m95 69.69 74.63 0.27 Allowed Pre-proline 0 C--N 1.354 0.773 0 CA-C-N 112.185 -2.28 . . . . 46.509999999999998 113.947 -159.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -59.03 -32.6 97.8 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 122.803 2.336 . . . . 49.759999999999998 115.301 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -63.23 -43.63 97.53 Favored 'General case' 0 C--N 1.356 0.889 0 CA-C-N 120.846 1.657 . . . . 52.619999999999997 110.834 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -66.33 -52.72 44.27 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-N 114.257 -1.338 . . . . 60.740000000000002 112.621 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1098 ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -120.48 80.43 30.2 Favored Pre-proline 0 C--O 1.239 0.528 0 O-C-N 118.111 -2.868 . . . . 58.189999999999998 115.525 -174.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.95 -28.37 58.12 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 124.667 3.578 . . . . 54.590000000000003 111.404 175.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -54.97 -48.39 73.3 Favored 'General case' 0 CA--C 1.504 -0.813 0 O-C-N 120.171 -1.58 . . . . 63.280000000000001 109.321 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1101 ' ' LEU . . . . . . . . . . . . . 1.3 mp -46.98 -52.62 14.24 Favored 'General case' 0 CA--C 1.513 -0.463 0 O-C-N 125.62 1.825 . . . . 54.75 113.685 172.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1102 ' ' MET . . . . . . . . . . . . . 72.8 mmm -57.8 -49.24 77.3 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 113.497 -1.683 . . . . 52.649999999999999 109.864 -176.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -58.66 -51.62 69.15 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 123.192 1.472 . . . . 66.260000000000005 109.025 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.47 -40.75 96.29 Favored 'General case' 0 C--O 1.239 0.539 0 O-C-N 118.599 -2.563 . . . . 63.729999999999997 110.884 -176.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 63.3 mt -69.16 -34.46 75.01 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.095 0.558 . . . . 54.68 111.117 176.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -65.3 -42.65 92.86 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 106.766 -1.568 . . . . 53.640000000000001 106.766 177.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -55.85 -40.84 73.45 Favored 'General case' 0 CA--C 1.501 -0.919 0 O-C-N 125.296 1.623 . . . . 67.239999999999995 112.826 170.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -65.86 -23.02 66.58 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 116.945 -1.503 . . . . 65.760000000000005 112.685 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 30.8 t30 61.43 60.81 1.62 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 126.895 3.236 . . . . 58.710000000000001 113.446 -175.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1110 ' ' VAL . . . . . . . . . . . . . 19.3 m -122.1 157.9 26.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 111.543 -2.572 . . . . 46.630000000000003 108.558 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1111 ' ' THR . . . . . . . . . . . . . 51.6 m -94.81 109.32 21.3 Favored 'General case' 0 N--CA 1.44 -0.961 0 O-C-N 120.999 -1.063 . . . . 44.130000000000003 111.426 171.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1112 ' ' VAL . . . . . . . . . . . . . 49.8 t -99.83 119.52 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-O 122.902 1.334 . . . . 40.439999999999998 109.366 -175.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1113 ' ' MET . . . . . . . . . . . . . 10.7 mtp -108.17 120.52 42.57 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 104.793 -2.299 . . . . 50.759999999999998 104.793 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1114 ' ' ALA . . . . . . . . . . . . . . . -107.89 108.84 20.18 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 118.204 -2.81 . . . . 35.640000000000001 108.363 -175.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1115 ' ' MET . . . . . . . . . . . . . 62.1 mmm -65.92 -19.12 65.76 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 117.947 2.573 . . . . 38.740000000000002 117.947 -173.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -71.88 -36.73 70.15 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 122.553 1.168 . . . . 40.140000000000001 108.582 166.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1117 ' ' SER . . . . . . . . . . . . . 58.3 m -86.35 28.63 0.82 Allowed 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 115.085 1.513 . . . . 44.789999999999999 115.085 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1118 ' ' VAL . . . . . . . . . . . . . 88.0 t -74.05 132.95 79.09 Favored Pre-proline 0 N--CA 1.471 0.611 0 N-CA-C 106.296 -1.742 . . . . 43.75 106.296 171.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -65.95 132.22 29.58 Favored 'Trans proline' 0 C--N 1.323 -0.777 0 C-N-CA 123.752 2.968 . . . . 48.93 108.211 175.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 30.9 mmm-85 -77.26 32.11 0.15 Allowed 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 116.667 2.099 . . . . 62.899999999999999 116.667 -164.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 31.8 pt -89.2 170.78 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 120.599 -1.313 . . . . 57.719999999999999 111.754 -169.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1122 ' ' SER . . . . . . . . . . . . . 11.4 p -57.2 -58.65 7.28 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 120.04 1.291 . . . . 57.259999999999998 114.286 -172.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 31.5 ptt85 -62.03 -19.1 62.52 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 116.576 2.065 . . . . 62.899999999999999 116.576 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -77.92 -15.99 58.56 Favored 'General case' 0 C--O 1.214 -0.77 0 O-C-N 120.254 -1.529 . . . . 49.829999999999998 113.965 172.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -56.78 -35.9 69.22 Favored 'General case' 0 C--O 1.258 1.521 0 CA-C-N 121.068 1.758 . . . . 52.369999999999997 115.019 -171.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1126 ' ' SER . . . . . . . . . . . . . 38.3 m -67.38 -23.55 65.6 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 119.51 -1.994 . . . . 42.43 111.226 176.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1127 ' ' LEU . . . . . . . . . . . . . 6.8 mp -89.79 -29.3 18.75 Favored 'General case' 0 C--O 1.221 -0.423 0 O-C-N 119.297 -2.127 . . . . 43.740000000000002 111.645 172.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 51.2 t0 -61.57 107.78 0.86 Allowed 'General case' 0 C--O 1.247 0.942 0 C-N-CA 125.358 1.463 . . . . 43.210000000000001 111.994 -170.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -71.62 -37.49 70.9 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 115.277 -0.874 . . . . 35.740000000000002 111.336 174.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 45.7 mt -66.47 -16.19 63.93 Favored 'General case' 0 C--O 1.244 0.799 0 O-C-N 119.97 -1.706 . . . . 38.090000000000003 112.047 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1131 ' ' SER . . . . . . . . . . . . . 70.6 m -86.63 -64.25 1.18 Allowed 'General case' 0 CA--C 1.55 0.959 0 O-C-N 120.656 -1.278 . . . . 36.909999999999997 109.194 163.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1132 ' ' SER . . . . . . . . . . . . . 1.6 m -76.6 -45.27 30.92 Favored 'General case' 0 C--O 1.244 0.802 0 O-C-N 117.789 -3.069 . . . . 35.789999999999999 114.594 -166.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1133 ' ' MET . . . . . . . . . . . . . 5.0 ttp -66.38 -42.81 87.39 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 122.08 2.218 . . . . 30.809999999999999 108.996 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1134 ' ' ALA . . . . . . . . . . . . . . . -50.71 -46.57 59.02 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.627 0.973 . . . . 28.879999999999999 113.627 166.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1135 ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -62.47 -36.62 83.04 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 119.762 1.164 . . . . 40.759999999999998 111.354 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1136 ' ' ILE . . . . . . . . . . . . . 57.3 mt -53.02 -57.1 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 O-C-N 121.597 -0.689 . . . . 31.539999999999999 110.274 170.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -60.07 -29.71 68.74 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.57 -0.741 . . . . 29.870000000000001 112.486 175.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -64.52 -44.53 95.03 Favored Glycine 0 CA--C 1.533 1.174 0 O-C-N 120.649 -1.282 . . . . 28.73 113.757 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 43.2 t80 -60.64 -50.53 73.14 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 123.587 1.66 . . . . 30.390000000000001 107.677 173.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1140 ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -61.68 -24.61 66.87 Favored 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 111.81 -2.45 . . . . 26.09 113.107 -178.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1141 ' ' ALA . . . . . . . . . . . . . . . -60.1 -38.83 84.13 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 122.136 0.97 . . . . 27.100000000000001 113.584 171.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 40.9 mm -66.43 -46.15 87.4 Favored 'Isoleucine or valine' 0 C--O 1.246 0.894 0 O-C-N 121.222 -0.924 . . . . 28.48 109.777 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 94.4 t -57.38 -60.12 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 114.394 -1.275 . . . . 23.07 110.207 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1144 ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -72.93 -21.28 60.91 Favored 'General case' 0 CA--C 1.502 -0.879 0 O-C-N 124.262 0.976 . . . . 33.399999999999999 113.322 -175.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -55.48 -57.65 11.03 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 124.013 0.821 . . . . 24.219999999999999 108.96 163.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -67.43 -16.18 64.08 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 124.522 1.139 . . . . 24.890000000000001 111.96 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 66.2 t-80 -72.34 -49.3 35.32 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 117.911 -1.042 . . . . 26.73 108.397 175.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1148 ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -81.63 -15.05 55.84 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 121.493 1.951 . . . . 39.960000000000001 115.139 175.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1149 ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -59.18 140.03 56.32 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 125.226 2.441 . . . . 25.870000000000001 109.767 -170.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1150 ' ' GLY . . . . . . . . . . . . . . . -79.99 -35.51 27.41 Favored Glycine 0 N--CA 1.426 -2.019 0 CA-C-N 109.823 -3.353 . . . . 19.280000000000001 109.248 170.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1151 ' ' ARG . . . . . . . . . . . . . 10.9 mtt-85 -108.48 -169.94 1.59 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.789 0.804 . . . . 39.899999999999999 112.756 -159.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1152 ' ' PHE . . . . . . . . . . . . . 1.7 t80 -110.98 145.92 37.57 Favored 'General case' 0 C--O 1.248 0.978 0 CA-C-O 118.178 -0.915 . . . . 29.440000000000001 109.078 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1153 ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -66.94 -50.74 61.41 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 120.924 1.693 . . . . 32.600000000000001 114.269 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1154 ' ' THR . . . . . . . . . . . . . 51.6 m -93.59 134.84 35.47 Favored 'General case' 0 CA--C 1.549 0.923 0 O-C-N 120.665 -1.272 . . . . 34.640000000000001 110.653 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -76.67 69.77 2.32 Favored Glycine 0 C--N 1.338 0.651 0 O-C-N 121.53 -0.731 . . . . 37.140000000000001 112.023 176.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -81.28 151.73 27.94 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 116.107 1.891 . . . . 40.57 116.107 -175.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1157 ' ' ILE . . . . . . . . . . . . . 6.9 tp -79.25 119.21 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 123.068 1.413 . . . . 44.609999999999999 110.58 165.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1158 ' ' THR . . . . . . . . . . . . . 37.7 p -92.15 -168.27 1.96 Allowed 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.489 -1.232 . . . . 40.700000000000003 109.59 174.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -76.13 -23.18 54.84 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 124.091 3.132 . . . . 40.25 108.596 173.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -85.37 -60.8 1.92 Allowed 'General case' 0 C--O 1.251 1.175 0 CA-C-N 115.804 -0.635 . . . . 38.469999999999999 110.012 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . 175.66 -157.55 23.98 Favored Glycine 0 CA--C 1.505 -0.575 0 O-C-N 118.625 -2.547 . . . . 37.609999999999999 110.471 -174.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 32.3 tttt -92.84 138.99 31.0 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 125.332 2.491 . . . . 48.899999999999999 113.335 -163.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1163 ' ' VAL . . . . . . . . . . . . . 24.9 t -83.9 147.11 50.61 Favored Pre-proline 0 C--N 1.305 -1.338 0 CA-C-N 109.202 -3.636 . . . . 36.520000000000003 109.241 167.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1164 ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.58 119.75 6.66 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 124.756 3.637 . . . . 35.079999999999998 116.106 162.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1165 ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -66.16 142.96 69.5 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.612 2.208 . . . . 35.329999999999998 115.17 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -82.36 126.63 32.39 Favored 'General case' 0 C--N 1.343 0.295 0 O-C-N 120.389 -1.444 . . . . 34.689999999999998 112.955 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1167 ' ' LYS . . . . . . . . . . . . . 61.7 mttp -86.52 102.07 13.77 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 106.293 -1.743 . . . . 45.359999999999999 106.293 168.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 16.2 t -88.58 86.36 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 112.567 -2.106 . . . . 31.710000000000001 110.006 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1169 ' ' MET . . . . . . . . . . . . . 62.4 ttp -79.34 103.53 9.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 123.933 1.825 . . . . 42.280000000000001 110.73 176.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 21.6 t -92.26 119.27 39.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 106.699 -1.593 . . . . 30.510000000000002 106.699 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 63.9 mt -108.92 126.84 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 104.898 -2.26 . . . . 31.870000000000001 104.898 -173.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 70.83 71.64 1.0 Allowed Glycine 0 C--N 1.352 1.449 0 C-N-CA 119.719 -1.229 . . . . 34.539999999999999 110.3 -175.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1173 ' ' ALA . . . . . . . . . . . . . . . -76.97 68.66 3.16 Favored 'General case' 0 C--O 1.243 0.752 0 O-C-N 121.188 -1.183 . . . . 32.509999999999998 111.854 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -78.7 -173.03 42.35 Favored Glycine 0 C--N 1.342 0.871 0 N-CA-C 107.667 -2.173 . . . . 29.899999999999999 107.667 164.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1175 ' ' VAL . . . . . . . . . . . . . 48.8 t -62.83 -31.22 51.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 121.58 2.69 . . . . 33.109999999999999 113.995 -172.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -58.7 -52.44 65.67 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 118.102 0.41 . . . . 28.100000000000001 110.621 168.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -56.72 -36.13 70.64 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.27 0.938 . . . . 28.539999999999999 112.653 173.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1178 ' ' LEU . . . . . . . . . . . . . 56.6 mt -65.64 -37.85 87.73 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 118.244 1.022 . . . . 31.219999999999999 110.702 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -64.11 -42.7 96.79 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 112.406 0.521 . . . . 28.98 112.406 173.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -58.98 -44.91 91.66 Favored 'General case' 0 C--N 1.352 0.683 0 O-C-N 125.012 1.445 . . . . 27.829999999999998 113.995 173.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1181 ' ' ILE . . . . . . . . . . . . . 47.1 mt -60.61 -51.08 77.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 O-C-N 122.045 -0.409 . . . . 30.25 111.232 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -60.67 -57.42 19.02 Favored Glycine 0 CA--C 1.525 0.665 0 O-C-N 126.523 2.389 . . . . 29.59 111.56 -174.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -55.09 -50.1 70.03 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 119.057 1.428 . . . . 30.289999999999999 111.534 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -70.31 -27.14 64.15 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 114.988 1.477 . . . . 30.469999999999999 114.988 -175.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -71.86 -40.31 69.06 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-O 116.144 -1.884 . . . . 42.409999999999997 110.181 172.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1186 ' ' SER . . . . . . . . . . . . . 1.5 m -64.52 -31.05 72.1 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-N 119.752 1.16 . . . . 39.380000000000003 110.617 172.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 58.9 mt -65.75 -33.36 75.7 Favored 'General case' 0 C--N 1.345 0.393 0 O-C-N 119.187 -2.196 . . . . 36.18 111.404 168.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 84.8 60.35 1.88 Allowed Glycine 0 N--CA 1.433 -1.542 0 CA-C-O 123.366 1.537 . . . . 33.780000000000001 110.076 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -119.11 160.22 22.48 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 113.751 -1.224 . . . . 33.93 108.722 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 79.0 mt -79.33 81.57 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.825 0 C-N-CA 118.841 -1.144 . . . . 38.740000000000002 108.915 -173.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 12.1 t -81.56 131.86 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.792 -1.188 . . . . 33.090000000000003 107.792 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1192 ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -139.58 103.29 4.66 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 104.926 -2.25 . . . . 38.920000000000002 104.926 177.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -95.46 131.96 41.05 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 110.883 -2.871 . . . . 35.32 110.983 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 71.5 t80 -111.93 140.12 46.86 Favored 'General case' 0 C--O 1.248 1.002 0 O-C-N 119.236 -2.165 . . . . 39.350000000000001 106.537 168.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 8.9 t0 -141.51 150.12 41.76 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 105.197 -2.149 . . . . 40.460000000000001 105.197 163.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1196 ' ' THR . . . . . . . . . . . . . 1.3 m -60.19 -32.33 70.97 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 111.816 -2.447 . . . . 45.939999999999998 110.064 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1197 ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -83.13 117.81 69.74 Favored Pre-proline 0 N--CA 1.447 -0.624 0 C-N-CA 124.99 1.316 . . . . 56.020000000000003 108.739 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1198 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.45 -19.06 49.53 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.891 2.394 . . . . 51.270000000000003 110.058 176.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -58.17 -37.97 75.74 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 124.248 1.019 . . . . 59.100000000000001 113.146 -174.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 16.1 m -83.96 5.2 2.36 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.583 0 N-CA-C 116.949 2.204 . . . . 51.060000000000002 116.949 -172.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 81.2 tttt -62.61 -55.47 26.83 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 126.194 1.798 . . . . 57.380000000000003 111.736 -172.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -54.9 -44.36 74.08 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 113.034 -1.894 . . . . 62.409999999999997 112.698 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -61.83 -47.87 83.12 Favored 'General case' 0 C--N 1.344 0.349 0 O-C-N 124.166 0.916 . . . . 57.780000000000001 112.794 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 82.6 t -49.39 -46.76 19.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 122.29 1.043 . . . . 46.380000000000003 113.428 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -69.61 -30.21 67.91 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 113.432 -1.713 . . . . 50.700000000000003 111.592 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1206 ' ' SER . . . . . . . . . . . . . 24.6 m -70.93 -22.1 62.27 Favored 'General case' 0 N--CA 1.435 -1.225 0 O-C-N 120.345 -1.472 . . . . 49.979999999999997 113.375 172.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1207 ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -76.58 -49.91 15.18 Favored 'General case' 0 C--N 1.362 1.131 0 O-C-N 118.974 -2.329 . . . . 52.990000000000002 108.341 164.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 126.67 58.1 0.14 Allowed Glycine 0 C--N 1.304 -1.233 0 N-CA-C 109.292 -1.523 . . . . 47.659999999999997 109.292 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -144.73 150.84 37.95 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 106.407 -1.701 . . . . 44.770000000000003 106.407 -177.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -65.98 137.99 57.51 Favored 'General case' 0 C--O 1.252 1.232 0 O-C-N 125.936 2.023 . . . . 47.640000000000001 106.587 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1211 ' ' PHE . . . . . . . . . . . . . 44.6 t80 -104.13 116.92 33.08 Favored 'General case' 0 C--N 1.31 -1.109 1 N-CA-C 99.786 -4.153 . . . . 45.659999999999997 99.786 166.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 97.1 mt -71.2 119.63 15.62 Favored 'General case' 0 C--O 1.201 -1.486 0 N-CA-C 106.627 -1.62 . . . . 46.060000000000002 106.627 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -82.62 140.47 33.17 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 127.45 2.969 . . . . 60.219999999999999 110.107 171.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 29.4 tp -81.21 125.81 30.75 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 127.328 3.442 . . . . 57.25 107.886 -166.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 24.6 t70 -74.59 87.66 2.14 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 111.729 -2.487 . . . . 64.430000000000007 109.613 165.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 47.8 t80 . . . . . 0 N--CA 1.432 -1.366 0 CA-C-N 113.178 -1.828 . . . . 66.900000000000006 107.394 -178.475 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 3.6 p-10 . . . . . 0 N--CA 1.442 -0.867 0 N-CA-C 107.655 -1.239 . . . . 39.090000000000003 107.655 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -54.33 -57.14 18.31 Favored Glycine 0 C--O 1.224 -0.474 0 O-C-N 127.301 2.876 . . . . 39.32 115.346 -174.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 24.7 t80 -72.76 -39.82 66.51 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-N 118.294 1.047 . . . . 39.299999999999997 111.277 -169.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -68.35 -42.38 79.31 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.675 -1.602 . . . . 36.299999999999997 106.675 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -58.9 -44.43 91.21 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 116.211 -1.852 . . . . 37.380000000000003 111.293 175.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -59.3 -51.79 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 125.036 1.46 . . . . 39.109999999999999 112.665 174.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1230 ' ' MET . . . . . . . . . . . . . 26.8 mmt -84.27 70.46 10.6 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 123.135 1.445 . . . . 49.590000000000003 110.211 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1231 ' ' SER . . . . . . . . . . . . . 61.5 m -138.93 154.62 48.36 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.556 -1.202 . . . . 43.68 109.152 176.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -58.63 -66.8 0.44 Allowed 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.311 1.045 . . . . 55.57 111.672 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -62.41 -23.83 67.06 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.092 -0.958 . . . . 44.939999999999998 113.006 -174.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 15.1 t80 -66.75 -51.89 50.59 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-O 117.522 -1.227 . . . . 42.039999999999999 109.383 171.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 13.3 mt -68.57 -26.0 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 123.554 2.888 . . . . 46.280000000000001 109.054 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 33.3 tttm -61.75 -46.14 90.9 Favored 'General case' 0 C--O 1.237 0.43 0 O-C-N 119.705 -1.872 . . . . 47.869999999999997 109.308 169.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -67.52 -36.52 81.18 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-N 115.816 -0.629 . . . . 41.609999999999999 111.81 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -58.5 -56.36 23.11 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.076 0.55 . . . . 50.649999999999999 110.142 173.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1239 ' ' MET . . . . . . . . . . . . . 3.2 mtm -52.66 -45.71 66.85 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 114.044 1.127 . . . . 48.869999999999997 114.044 173.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -68.91 -33.43 73.74 Favored 'General case' 0 C--N 1.315 -0.907 0 O-C-N 121.618 -0.676 . . . . 54.799999999999997 110.998 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.42 -45.12 85.14 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 105.334 -2.099 . . . . 43.210000000000001 105.334 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -67.17 -36.92 82.81 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.08 1.352 . . . . 38.659999999999997 113.202 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -62.26 -45.76 91.88 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 123.015 0.526 . . . . 37.920000000000002 112.289 175.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -67.16 -36.93 82.87 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 121.445 -0.784 . . . . 37.280000000000001 110.99 176.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -65.75 -30.38 71.03 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 112.971 0.73 . . . . 43.07 112.971 172.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -59.09 -34.18 71.69 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 112.565 0.58 . . . . 38.299999999999997 112.565 -175.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1247 ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.1 -15.55 63.46 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 119.521 -0.872 . . . . 47.600000000000001 112.869 178.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -114.2 -25.39 8.5 Favored 'General case' 0 N--CA 1.441 -0.924 0 O-C-N 119.077 -2.264 . . . . 45.420000000000002 115.988 176.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1249 ' ' VAL . . . . . . . . . . . . . 34.7 m -74.93 163.68 3.92 Favored 'Isoleucine or valine' 0 C--O 1.247 0.944 0 CA-C-N 121.74 2.064 . . . . 36.259999999999998 116.541 -173.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1250 ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -124.81 -57.45 1.53 Allowed 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 113.448 -1.705 . . . . 33.039999999999999 108.432 -170.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1251 ' ' ILE . . . . . . . . . . . . . 34.6 mm -110.91 131.67 61.49 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.977 0 N-CA-C 106.613 -1.625 . . . . 31.399999999999999 106.613 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1252 ' ' ILE . . . . . . . . . . . . . 52.3 mt -122.43 134.97 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 N-CA-C 103.912 -2.625 . . . . 29.420000000000002 103.912 170.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 9.2 t -117.45 92.31 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 103.102 -2.925 . . . . 30.370000000000001 103.102 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1254 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.35 98.02 6.55 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 123.189 1.471 . . . . 35.719999999999999 113.213 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1255 ' ' THR . . . . . . . . . . . . . 4.0 m -111.5 0.16 16.4 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.09 -1.414 . . . . 36.0 114.466 -168.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1256 ' ' ALA . . . . . . . . . . . . . . . -84.3 79.32 9.58 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 125.607 2.622 . . . . 40.93 113.553 -170.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 41.7 tp -94.36 109.53 21.37 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 112.024 -2.353 . . . . 47.82 106.777 172.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 28.1 mm -66.37 119.05 59.37 Favored Pre-proline 0 CA--C 1.554 1.116 0 N-CA-C 103.651 -2.722 . . . . 52.700000000000003 103.651 168.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -53.25 125.32 18.02 Favored 'Trans proline' 0 C--N 1.35 0.637 1 C-N-CA 126.002 4.468 . . . . 54.130000000000003 112.313 -173.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 76.2 6.12 82.55 Favored Glycine 0 CA--C 1.489 -1.576 0 CA-C-O 119.907 -0.385 . . . . 54.619999999999997 112.947 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 89.2 mttt -128.78 155.84 78.64 Favored Pre-proline 0 C--O 1.252 1.198 0 O-C-N 119.492 -2.181 . . . . 55.740000000000002 109.337 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -61.36 117.8 4.63 Favored 'Trans proline' 0 N--CA 1.44 -1.63 0 C-N-CA 121.905 1.737 . . . . 51.149999999999999 113.083 168.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -51.26 132.47 32.61 Favored Pre-proline 0 N--CA 1.473 0.695 0 CA-C-N 113.094 -1.866 . . . . 46.060000000000002 111.953 176.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -55.62 138.86 82.09 Favored 'Trans proline' 0 C--O 1.249 1.051 0 C-N-CA 124.974 3.782 . . . . 41.079999999999998 112.283 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -78.13 99.59 6.23 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 104.22 -2.511 . . . . 47.420000000000002 104.22 171.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 94.6 mt -98.89 -21.09 16.47 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 113.189 -1.823 . . . . 39.219999999999999 111.299 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 86.4 mt -117.55 114.23 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 O-C-N 118.298 -2.751 . . . . 42.5 106.718 172.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1268 ' ' THR . . . . . . . . . . . . . 5.0 p -80.31 162.49 24.54 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 115.665 1.728 . . . . 37.840000000000003 115.665 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -60.6 -41.87 95.61 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-O 116.381 -1.771 . . . . 54.799999999999997 112.764 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -53.06 -51.07 62.97 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 125.243 1.417 . . . . 54.359999999999999 110.825 171.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1271 ' ' MET . . . . . . . . . . . . . 43.0 ttm -55.49 -44.11 76.21 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 125.483 1.739 . . . . 39.520000000000003 112.485 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1272 ' ' VAL . . . . . . . . . . . . . 2.4 t -68.05 -45.57 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 120.781 1.628 . . . . 38.25 110.588 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -59.77 -28.27 67.25 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 114.64 1.348 . . . . 40.770000000000003 114.64 173.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1274 ' ' SER . . . . . . . . . . . . . 20.4 m -89.02 13.37 13.08 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 113.591 0.96 . . . . 36.579999999999998 113.591 172.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1275 ' ' MET . . . . . . . . . . . . . 36.0 ttm -85.69 164.53 17.6 Favored 'General case' 0 C--O 1.246 0.87 0 O-C-N 120.899 -1.125 . . . . 36.75 109.573 -175.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1276 ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -76.8 130.62 37.92 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 105.527 -2.027 . . . . 46.109999999999999 105.527 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1277 ' ' ALA . . . . . . . . . . . . . . . -86.01 172.17 10.85 Favored 'General case' 0 CA--C 1.504 -0.796 0 O-C-N 120.181 -1.574 . . . . 33.520000000000003 115.14 -168.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 86.26 14.99 65.32 Favored Glycine 0 C--O 1.217 -0.939 0 O-C-N 120.648 -1.283 . . . . 31.27 111.799 -171.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1279 ' ' SER . . . . . . . . . . . . . 36.9 m -130.45 163.88 26.01 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 124.108 0.963 . . . . 32.950000000000003 111.006 -156.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1280 ' ' VAL . . . . . . . . . . . . . 65.4 t -134.93 131.65 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 O-C-N 119.959 -1.713 . . . . 27.43 111.466 -170.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1281 ' ' ILE . . . . . . . . . . . . . 46.3 mt -106.36 104.35 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 106.213 -1.773 . . . . 30.300000000000001 106.213 171.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 43.9 t -88.9 109.74 20.52 Favored 'Isoleucine or valine' 0 C--O 1.252 1.215 0 O-C-N 119.189 -2.195 . . . . 28.629999999999999 106.773 175.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 5.0 t70 -86.15 96.64 9.97 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 123.277 1.513 . . . . 36.270000000000003 108.14 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1284 ' ' LEU . . . . . . . . . . . . . 21.1 mt -73.69 -12.73 60.82 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 112.604 -2.089 . . . . 38.57 112.889 172.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -77.24 -34.58 55.84 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 120.922 1.692 . . . . 37.560000000000002 110.179 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . 33.54 -74.33 0.0 OUTLIER 'General case' 0 C--O 1.246 0.883 1 N-CA-C 123.423 4.601 . . . . 40.329999999999998 123.423 171.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -55.15 -40.54 70.73 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 116.966 2.21 . . . . 56.850000000000001 116.966 -166.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 18.0 m120 -125.59 116.89 22.44 Favored 'General case' 0 CA--C 1.491 -1.317 0 O-C-N 119.688 -1.883 . . . . 45.859999999999999 107.211 177.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 73.82 -74.6 1.14 Allowed Glycine 0 C--N 1.345 1.033 0 N-CA-C 110.859 -0.896 . . . . 40.310000000000002 110.859 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 86.03 134.26 3.52 Favored Glycine 0 C--O 1.237 0.335 0 N-CA-C 109.493 -1.443 . . . . 38.890000000000001 109.493 -173.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1291 ' ' ASN . . . . . . . . . . . . . 25.6 m120 -70.93 -24.91 62.54 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-N 118.009 0.905 . . . . 37.229999999999997 112.391 -167.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1292 ' ' CYS . . . . . . . . . . . . . 53.7 t -91.58 155.65 18.21 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 120.835 -1.166 . . . . 36.5 111.853 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1293 ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -83.46 6.51 19.98 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 119.729 -1.857 . . . . 43.32 115.343 173.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -113.47 8.5 17.84 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-O 123.053 1.406 . . . . 41.32 111.99 171.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1295 ' ' THR . . . . . . . . . . . . . 33.5 m -75.84 95.14 3.43 Favored 'General case' 0 CA--C 1.501 -0.938 0 O-C-N 118.744 -2.472 . . . . 35.299999999999997 112.098 -176.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 60.1 t -92.07 115.94 65.57 Favored Pre-proline 0 N--CA 1.437 -1.124 0 CA-C-N 109.583 -3.462 . . . . 34.840000000000003 105.562 169.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -54.51 107.78 0.25 Allowed 'Trans proline' 0 C--O 1.247 0.975 0 C-N-CA 124.969 3.779 . . . . 33.509999999999998 115.202 174.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 85.65 28.12 30.39 Favored Glycine 0 N--CA 1.442 -0.9 0 CA-C-N 111.761 -2.472 . . . . 32.189999999999998 113.793 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -140.36 158.0 44.68 Favored 'General case' 0 C--O 1.242 0.685 0 O-C-N 118.935 -2.509 . . . . 34.880000000000003 111.475 177.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1300 ' ' ILE . . . . . . . . . . . . . 31.4 mt -94.88 124.46 47.39 Favored 'Isoleucine or valine' 0 C--O 1.254 1.315 0 N-CA-C 105.152 -2.166 . . . . 32.289999999999999 105.152 169.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -128.4 108.03 10.23 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 105.385 -2.08 . . . . 37.25 105.385 175.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1302 ' ' THR . . . . . . . . . . . . . 55.9 m -75.53 135.26 40.62 Favored 'General case' 0 C--O 1.243 0.736 0 O-C-N 120.847 -1.158 . . . . 35.560000000000002 108.529 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1303 ' ' THR . . . . . . . . . . . . . 35.8 p -85.07 172.36 11.32 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 119.581 -1.95 . . . . 36.399999999999999 109.981 176.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -61.97 -42.67 99.38 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 118.647 0.658 . . . . 52.32 111.914 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -64.56 -35.77 82.06 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.628 0.728 . . . . 40.039999999999999 112.644 176.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 117.17 44.79 0.55 Allowed Glycine 0 C--O 1.217 -0.912 0 O-C-N 120.063 -1.648 . . . . 36.960000000000001 110.157 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1307 ' ' VAL . . . . . . . . . . . . . 74.3 t -113.51 124.5 70.21 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.233 0 N-CA-C 104.273 -2.491 . . . . 33.399999999999999 104.273 171.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1308 ' ' LYS . . . . . . . . . . . . . 88.3 mttt -84.6 119.26 25.01 Favored 'General case' 0 CA--C 1.496 -1.127 0 C-N-CA 119.411 -0.916 . . . . 42.909999999999997 109.465 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 57.3 t -96.52 130.73 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.082 0 N-CA-C 106.919 -1.511 . . . . 32.289999999999999 106.919 172.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1310 ' ' ILE . . . . . . . . . . . . . 1.5 mt -125.06 111.27 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.369 0 O-C-N 120.512 -1.367 . . . . 30.989999999999998 108.125 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -83.31 59.3 4.99 Favored Glycine 0 N--CA 1.466 0.686 0 O-C-N 120.448 -1.408 . . . . 28.949999999999999 109.885 174.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1312 ' ' TYR . . . . . . . . . . . . 0.252 0.5 OUTLIER -73.98 85.77 1.79 Allowed 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 121.189 2.495 . . . . 31.690000000000001 116.952 -172.301 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 1313 ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -54.57 -53.44 54.58 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 113.906 -1.497 . . . . 34.170000000000002 112.823 168.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -65.42 5.9 0.36 Allowed 'General case' 0 C--O 1.248 1.021 0 N-CA-C 116.849 2.166 . . . . 36.859999999999999 116.849 -172.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1315 ' ' LEU . . . . . . . . . . . . . 58.5 mt -47.09 -39.92 20.48 Favored Pre-proline 0 CA--C 1.547 0.86 0 CA-C-N 121.544 1.975 . . . . 34.850000000000001 116.123 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -57.19 -43.12 55.94 Favored 'Trans proline' 0 CA--C 1.505 -0.953 0 CA-C-N 123.311 2.218 . . . . 29.149999999999999 116.542 168.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -66.04 -39.19 94.66 Favored Glycine 0 C--N 1.313 -0.709 0 O-C-N 119.918 -1.738 . . . . 27.289999999999999 111.859 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1318 ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -62.97 -25.03 68.18 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 124.747 1.219 . . . . 41.490000000000002 113.796 174.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1319 ' ' LEU . . . . . . . . . . . . . 12.7 tp -115.91 70.26 3.68 Favored Pre-proline 0 C--O 1.251 1.132 0 N-CA-C 107.748 -1.205 . . . . 27.609999999999999 107.748 172.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1320 ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -59.5 -59.68 0.4 Allowed 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 122.722 2.281 . . . . 25.940000000000001 115.057 -163.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1321 ' ' THR . . . . . . . . . . . . . 7.6 m -65.0 -36.45 84.45 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 108.735 -0.839 . . . . 25.010000000000002 108.735 -171.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1322 ' ' GLN . . . . . . . . . . . . . 31.6 tp60 -72.97 -32.31 65.13 Favored 'General case' 0 CA--C 1.502 -0.866 0 O-C-N 120.988 -1.07 . . . . 29.390000000000001 112.18 -172.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1323 ' ' SER . . . . . . . . . . . . . 40.2 m -65.68 -50.66 64.12 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 107.098 -1.445 . . . . 26.469999999999999 107.098 172.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1324 ' ' SER . . . . . . . . . . . . . 3.4 m -60.8 -23.62 65.18 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.962 0.905 . . . . 27.780000000000001 112.22 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 19.4 tm0? -86.43 -76.29 0.35 Allowed 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.782 -1.562 . . . . 37.530000000000001 106.782 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1326 ' ' LEU . . . . . . . . . . . . . 92.8 mt -54.76 -62.27 1.77 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 115.446 1.647 . . . . 35.710000000000001 115.446 -175.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1327 ' ' TYR . . . . . . . . . . . . . 30.3 t80 -63.85 -35.49 80.81 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 107.613 -1.254 . . . . 31.59 107.613 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1328 ' ' GLY . . . . . . . . . . . . . . . -54.06 -46.18 70.5 Favored Glycine 0 C--N 1.359 1.818 0 O-C-N 124.156 0.91 . . . . 28.0 111.699 171.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1329 ' ' THR . . . . . . . . . . . . . 28.5 m -71.29 -24.46 62.15 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 123.241 0.616 . . . . 32.149999999999999 110.922 175.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1330 ' ' ASN . . . . . . . . . . . . . 3.1 m120 -61.78 -54.07 47.41 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 116.911 -3.618 . . . . 34.359999999999999 107.246 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1331 ' ' LEU . . . . . . . . . . . . . 12.9 mt -47.01 -54.51 10.04 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 126.548 1.939 . . . . 33.369999999999997 111.155 170.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1332 ' ' VAL . . . . . . . . . . . . . 70.0 t -63.98 -32.71 58.27 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.729 0 CA-C-O 117.179 -1.391 . . . . 35.270000000000003 114.073 177.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -73.67 -31.19 63.34 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 124.191 3.178 . . . . 37.659999999999997 110.737 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1334 ' ' LEU . . . . . . . . . . . . . 43.3 tp -60.71 -51.11 70.74 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-N 118.687 0.676 . . . . 40.270000000000003 110.592 164.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1335 ' ' LEU . . . . . . . . . . . . . 55.2 mt -54.5 -34.96 62.58 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 114.793 1.405 . . . . 42.5 114.793 168.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1336 ' ' LYS . . . . . . . . . . . . . 90.0 mttt -60.69 -46.17 91.38 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 123.18 2.718 . . . . 47.810000000000002 112.977 174.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1337 ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.85 -36.99 78.0 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 124.365 1.041 . . . . 49.270000000000003 113.251 173.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1338 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.8 -32.51 70.99 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 124.628 1.171 . . . . 50.539999999999999 111.16 172.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1339 ' ' CYS . . . . . . . . . . . . . 64.8 m -79.48 88.78 5.04 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 124.052 1.882 . . . . 53.670000000000002 107.958 172.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -76.01 -66.26 0.81 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 113.67 -1.605 . . . . 63.380000000000003 106.734 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -85.69 -18.88 31.87 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.384 -0.826 . . . . 70.950000000000003 110.626 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1342 ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? 68.41 56.91 0.47 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.129 -1.396 . . . . 65.25 114.437 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1343 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 172.84 -38.49 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.389 2 O-C-N 112.345 -6.472 . . . . 64.530000000000001 107.714 -17.335 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 1344 ' ' GLY . . . . . . . . . . . . . . . 84.34 -62.45 4.57 Favored Glycine 0 C--N 1.346 1.118 0 O-C-N 117.491 -3.255 . . . . 59.719999999999999 111.129 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 4.6 t30 -116.62 132.23 56.74 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 103.666 -2.716 . . . . 64.090000000000003 103.666 169.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1346 ' ' ILE . . . . . . . . . . . . . 20.8 pt -62.92 164.47 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.256 1.409 0 O-C-N 123.891 0.744 . . . . 58.82 112.785 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1347 ' ' THR . . . . . . . . . . . . . 1.8 m -124.97 92.98 3.76 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 104.834 -2.284 . . . . 54.960000000000001 104.834 -176.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1348 ' ' VAL . . . . . . . . . . . . . 60.2 t -77.29 84.78 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 N-CA-C 105.201 -2.148 . . . . 55.640000000000001 105.201 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.67 126.63 30.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 124.113 1.911 . . . . 61.450000000000003 112.752 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -96.32 -5.48 39.95 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 118.182 2.66 . . . . 58.630000000000003 118.182 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -73.72 -39.89 63.98 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 118.351 -1.34 . . . . 62.060000000000002 110.095 172.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 17.3 t70 -70.57 112.5 6.87 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.038 -0.983 . . . . 54.07 112.144 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 15.8 m -59.51 -20.43 18.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 N-CA-C 116.33 1.974 . . . . 50.68 116.33 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1354 ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -79.77 -47.39 21.83 Favored 'Isoleucine or valine' 0 C--N 1.343 0.317 0 CA-C-N 121.485 1.948 . . . . 47.68 105.778 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1355 ' ' ILE . . . . . . . . . . . . . 89.9 mt -64.65 -55.14 22.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 108.476 -0.935 . . . . 48.490000000000002 108.476 -177.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 34.0 tpt85 -45.36 -46.77 13.28 Favored 'General case' 0 C--O 1.255 1.379 0 O-C-N 124.123 0.889 . . . . 48.270000000000003 113.362 167.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -59.39 -51.03 61.57 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-O 117.563 -1.687 . . . . 43.530000000000001 111.882 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1358 ' ' VAL . . . . . . . . . . . . . 17.5 t -63.37 -35.08 70.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 CA-C-N 118.808 1.304 . . . . 45.119999999999997 108.544 -175.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1359 ' ' THR . . . . . . . . . . . . . 18.1 m -75.84 93.84 3.24 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 123.959 1.838 . . . . 42.939999999999998 109.889 -176.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 16.6 m -80.02 -22.84 11.75 Favored 'Isoleucine or valine' 0 C--O 1.248 1.011 0 CA-C-N 110.998 -2.819 . . . . 43.259999999999998 113.858 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1361 ' ' ILE . . . . . . . . . . . . . 43.7 mt -137.11 119.39 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 N-CA-C 104.055 -2.572 . . . . 45.659999999999997 104.055 175.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1362 ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -106.92 113.28 26.67 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 104.311 -2.477 . . . . 61.340000000000003 104.311 170.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 32.95 77.38 0.03 OUTLIER 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 117.204 2.298 . . . . 49.759999999999998 117.204 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 86.52 -50.26 4.19 Favored Glycine 0 N--CA 1.481 1.685 0 CA-C-N 113.645 -1.616 . . . . 50.0 111.628 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -70.37 116.43 10.7 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 106.953 -1.499 . . . . 56.920000000000002 106.953 -176.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1366 ' ' ILE . . . . . . . . . . . . . 67.5 mt -72.83 101.57 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.066 0 CA-C-O 123.408 1.575 . . . . 52.780000000000001 109.006 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1367 ' ' THR . . . . . . . . . . . . . 10.9 p -92.94 10.49 31.02 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 112.857 -1.974 . . . . 49.439999999999998 116.16 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 1.9 t90 -58.82 145.77 77.66 Favored Pre-proline 0 C--O 1.254 1.333 0 O-C-N 117.972 -2.955 . . . . 52.380000000000003 105.683 163.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -85.76 -175.0 11.55 Favored 'Cis proline' 0 C--O 1.211 -0.829 0 CA-C-N 123.983 2.458 . . . . 46.939999999999998 113.553 4.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -83.19 138.66 42.21 Favored Pre-proline 0 CA--C 1.545 0.756 0 O-C-N 124.065 0.853 . . . . 45.909999999999997 108.84 164.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1371 ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -58.3 135.29 67.1 Favored 'Trans proline' 0 C--N 1.351 0.678 1 C-N-CA 125.777 4.318 . . . . 46.390000000000001 111.509 177.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -59.03 -35.35 98.57 Favored 'Trans proline' 0 CA--C 1.549 1.241 1 C-N-CA 125.36 4.04 . . . . 46.719999999999999 116.653 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.233 -4.489 0 O-C-N 118.331 -2.731 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 15.9 m80 . . . . . 0 N--CA 1.432 -1.347 0 N-CA-C 108.174 -1.047 . . . . 63.439999999999998 108.174 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -77.44 76.65 3.98 Favored 'General case' 0 C--O 1.254 1.304 0 O-C-N 121.093 -1.005 . . . . 51.740000000000002 112.402 -177.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1000 ' ' HIS . . . . . . . . . . . . . 12.0 t60 -72.55 118.38 15.38 Favored 'General case' 0 C--O 1.247 0.964 0 CA-C-O 122.694 1.235 . . . . 54.07 111.618 -166.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 64.27 27.11 71.11 Favored Glycine 0 C--O 1.209 -1.434 0 CA-C-O 123.46 1.589 . . . . 39.219999999999999 111.889 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1002 ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -97.21 134.52 40.42 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 105.515 -2.031 . . . . 38.119999999999997 105.515 173.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1003 ' ' ILE . . . . . . . . . . . . . 57.1 mt -84.92 149.97 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 CA-C-N 112.023 -2.353 . . . . 29.699999999999999 105.89 170.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -118.71 131.39 9.12 Favored Glycine 0 CA--C 1.492 -1.404 0 N-CA-C 108.351 -1.9 . . . . 27.5 108.351 164.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1005 ' ' ILE . . . . . . . . . . . . . 45.4 mm -102.69 110.08 62.4 Favored Pre-proline 0 C--N 1.313 -1.002 0 N-CA-C 104.852 -2.277 . . . . 24.829999999999998 104.852 172.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -83.83 155.0 13.4 Favored 'Trans proline' 0 C--O 1.238 0.514 0 C-N-CA 121.743 1.629 . . . . 27.190000000000001 111.966 173.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -77.39 114.97 16.77 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 112.031 -2.349 . . . . 41.460000000000001 106.013 169.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1008 ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -51.43 164.77 0.18 Allowed 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 116.463 2.023 . . . . 26.93 116.463 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -146.15 59.06 1.23 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 123.314 1.531 . . . . 34.479999999999997 108.566 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1010 ' ' LEU . . . . . . . . . . . . . 17.9 tp -104.37 152.94 21.67 Favored 'General case' 0 N--CA 1.469 0.511 1 O-C-N 116.287 -4.008 . . . . 44.219999999999999 107.743 174.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1011 ' ' THR . . . . . . . . . . . . . 24.3 m -58.99 114.42 2.57 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 123.779 0.832 . . . . 40.740000000000002 109.107 167.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 47.6 t30 54.62 80.08 0.13 Allowed 'General case' 0 C--N 1.35 0.624 0 C-N-CA 125.271 1.428 . . . . 44.439999999999998 111.861 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1013 ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -147.29 141.54 26.21 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 123.817 1.77 . . . . 29.870000000000001 109.857 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1014 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.43 2.96 5.64 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 113.173 -1.83 . . . . 25.260000000000002 111.535 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 65.4 mtm180 -76.95 145.29 38.23 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 123.925 1.821 . . . . 29.539999999999999 110.631 174.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1016 ' ' VAL . . . . . . . . . . . . . 2.2 p -126.64 -175.96 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-N 114.45 -1.25 . . . . 23.550000000000001 109.161 161.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1017 ' ' ALA . . . . . . . . . . . . . . . -93.64 7.95 42.76 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 115.339 1.607 . . . . 23.59 115.339 -176.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1018 ' ' ALA . . . . . . . . . . . . . . . -164.75 147.55 8.58 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 114.608 1.336 . . . . 24.93 114.608 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1019 ' ' THR . . . . . . . . . . . . . 68.7 p -98.91 172.77 4.4 Favored Pre-proline 0 C--O 1.242 0.688 0 N-CA-C 106.839 -1.541 . . . . 28.09 106.839 159.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -49.56 -51.28 11.05 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.404 3.402 . . . . 28.789999999999999 110.959 166.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 37.9 tttp -46.88 -48.29 21.19 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 123.533 2.879 . . . . 47.280000000000001 112.728 170.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1022 ' ' THR . . . . . . . . . . . . . 3.4 m -62.45 -32.39 73.26 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 117.715 0.234 . . . . 30.120000000000001 111.071 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1023 ' ' VAL . . . . . . . . . . . . . 91.6 t -64.21 -48.82 83.96 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 O-C-N 120.514 -1.367 . . . . 32.240000000000002 108.109 176.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1024 ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -60.36 -29.15 68.73 Favored 'General case' 0 C--O 1.246 0.921 0 O-C-N 121.937 -0.477 . . . . 49.619999999999997 111.305 176.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -66.44 -42.06 88.24 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-O 123.805 1.764 . . . . 44.68 113.034 176.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 34.2 mt -70.38 -37.8 74.62 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 113.71 -1.586 . . . . 35.710000000000001 109.392 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1027 ' ' LEU . . . . . . . . . . . . . 63.4 mt -67.47 -26.8 66.55 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 115.599 -0.728 . . . . 42.18 111.179 174.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 65.1 mttm -61.01 -33.82 73.86 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.273 0.942 . . . . 48.340000000000003 111.99 169.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1029 ' ' LEU . . . . . . . . . . . . . 7.8 mt -88.61 10.39 20.69 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 120.984 -1.072 . . . . 38.689999999999998 111.326 176.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 85.09 -10.45 63.24 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 116.169 1.228 . . . . 32.280000000000001 116.169 -175.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -78.19 120.21 22.67 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 119.447 1.624 . . . . 35.939999999999998 112.659 -170.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1032 ' ' THR . . . . . . . . . . . . . 34.8 m -73.74 132.51 42.72 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 106.596 -1.631 . . . . 33.369999999999997 106.596 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1033 ' ' VAL . . . . . . . . . . . . . 16.9 t -117.63 128.93 74.76 Favored 'Isoleucine or valine' 0 C--O 1.249 1.028 0 O-C-N 119.489 -2.007 . . . . 29.98 108.662 -171.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -108.56 143.61 37.36 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.31 -0.859 . . . . 28.18 110.228 166.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1035 ' ' VAL . . . . . . . . . . . . . 57.6 t -125.57 131.35 72.2 Favored 'Isoleucine or valine' 0 C--N 1.372 1.552 0 N-CA-C 108.107 -1.071 . . . . 25.82 108.107 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1036 ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -73.3 143.16 47.08 Favored 'General case' 0 C--O 1.252 1.223 0 O-C-N 120.455 -1.403 . . . . 32.439999999999998 108.996 177.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1037 ' ' SER . . . . . . . . . . . . . 1.2 m -65.95 137.98 57.51 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 119.612 -1.93 . . . . 29.539999999999999 111.64 174.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 103.09 -22.08 37.85 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 124.844 1.34 . . . . 27.760000000000002 111.165 -175.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1039 ' ' ALA . . . . . . . . . . . . . . . -65.46 -40.14 92.84 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 123.089 0.555 . . . . 26.02 110.428 174.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -55.05 -51.71 51.96 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 124.445 1.091 . . . . 26.469999999999999 112.093 169.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.19 -28.71 68.18 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 113.745 1.017 . . . . 50.979999999999997 113.745 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 76.9 mt -67.63 -52.68 35.38 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 119.951 1.251 . . . . 29.300000000000001 109.092 168.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1043 ' ' ALA . . . . . . . . . . . . . . . -72.26 29.81 0.05 Allowed 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 118.014 2.598 . . . . 26.739999999999998 118.014 174.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1044 ' ' SER . . . . . . . . . . . . . 28.4 m 47.66 36.51 5.6 Favored 'General case' 0 C--N 1.358 0.951 0 N-CA-C 117.713 2.486 . . . . 31.260000000000002 117.713 -173.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1045 ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -130.06 163.5 26.39 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 124.112 1.91 . . . . 33.259999999999998 112.626 -173.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 3.3 t70 -67.84 139.84 56.56 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 114.548 -1.205 . . . . 46.740000000000002 109.525 158.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -68.42 -36.59 79.3 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 121.057 1.753 . . . . 34.439999999999998 111.259 174.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.97 -15.08 62.56 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.463 0.649 . . . . 48.670000000000002 112.652 -175.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -58.56 -37.04 74.9 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 119.234 -2.166 . . . . 35.259999999999998 111.122 165.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1050 ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -65.29 -33.57 76.28 Favored 'General case' 0 CA--C 1.563 1.451 0 CA-C-O 117.843 -1.075 . . . . 32.170000000000002 111.725 170.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.1 -30.28 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 121.404 1.911 . . . . 38.369999999999997 108.702 176.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -63.59 -38.46 91.22 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.222 0.919 . . . . 45.770000000000003 109.883 173.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -76.97 -21.66 54.39 Favored 'General case' 0 C--N 1.36 1.065 0 CA-C-O 121.557 0.694 . . . . 37.829999999999998 112.685 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 118.73 31.12 1.52 Allowed Glycine 0 C--O 1.215 -1.07 0 O-C-N 120.515 -1.366 . . . . 35.82 113.346 176.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -102.05 135.73 43.12 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 123.175 1.464 . . . . 33.770000000000003 109.558 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -75.4 105.5 6.46 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 106.374 -1.713 . . . . 51.020000000000003 106.374 174.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1057 ' ' ILE . . . . . . . . . . . . . 37.5 mm -77.64 85.62 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 O-C-N 120.476 -1.39 . . . . 38.469999999999999 107.597 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 3.5 m -117.98 123.7 72.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 125.038 1.461 . . . . 39.399999999999999 110.712 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -90.58 155.77 18.63 Favored 'General case' 0 C--O 1.248 1.01 0 O-C-N 120.758 -1.214 . . . . 57.07 110.274 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . 65.23 -145.61 49.2 Favored Glycine 0 C--O 1.21 -1.375 0 CA-C-N 113.405 -1.725 . . . . 44.829999999999998 114.23 169.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 5.4 m120 -55.31 -20.26 10.93 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 115.586 1.699 . . . . 46.270000000000003 115.586 -177.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1062 ' ' SER . . . . . . . . . . . . . 28.9 m -59.54 -50.73 72.78 Favored 'General case' 0 CA--C 1.489 -1.395 0 O-C-N 120.166 -1.584 . . . . 43.469999999999999 111.9 164.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.41 -38.42 82.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 120.61 1.55 . . . . 36.979999999999997 109.91 177.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 98.9 m95 -66.48 -21.47 66.19 Favored 'General case' 0 C--O 1.269 2.108 0 N-CA-C 114.936 1.458 . . . . 37.899999999999999 114.936 178.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -83.74 90.25 7.29 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 104.687 -2.338 . . . . 46.189999999999998 104.687 169.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1066 ' ' SER . . . . . . . . . . . . . 73.4 m -154.36 150.88 28.41 Favored 'General case' 0 CA--C 1.49 -1.335 0 CA-C-N 113.213 -1.812 . . . . 37.060000000000002 108.512 176.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1067 ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -79.3 -17.87 53.78 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 120.799 -1.188 . . . . 43.950000000000003 113.783 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1068 ' ' ILE . . . . . . . . . . . . . 3.1 mp -126.67 143.99 38.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 103.233 -2.877 . . . . 33.5 103.233 173.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 16.5 mm -122.9 105.59 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 102.245 -3.243 . . . . 30.57 102.245 165.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1070 ' ' LEU . . . . . . . . . . . . . 81.5 mt -86.7 122.27 30.37 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 101.975 -3.343 . . . . 27.66 101.975 176.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1071 ' ' LYS . . . . . . . . . . . . . 34.0 tttm -146.58 158.21 43.86 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 108.255 -1.017 . . . . 28.399999999999999 108.255 -169.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1072 ' ' VAL . . . . . . . . . . . . . 58.7 t -90.82 -77.0 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 108.481 -0.933 . . . . 23.18 108.481 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -93.89 146.07 24.17 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 108.178 -1.045 . . . . 25.469999999999999 108.178 -165.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -50.11 115.38 5.28 Favored Pre-proline 0 C--O 1.249 1.028 0 N-CA-C 114.386 1.254 . . . . 27.899999999999999 114.386 -174.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -43.57 136.67 6.32 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.26 3.307 . . . . 31.620000000000001 115.587 -173.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 13.3 mt -69.75 166.79 18.51 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 112.047 -2.342 . . . . 40.490000000000002 107.905 173.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 27.7 t70 -58.76 -35.83 73.4 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 119.315 -0.954 . . . . 51.590000000000003 110.065 -174.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.39 -39.47 81.69 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 122.307 1.051 . . . . 42.359999999999999 109.549 -178.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1079 ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -68.11 -27.25 66.3 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 113.678 -1.601 . . . . 34.530000000000001 109.636 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1080 ' ' ILE . . . . . . . . . . . . . 88.3 mt -70.84 -37.75 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 120.461 1.482 . . . . 33.25 108.071 177.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -64.84 -46.99 79.58 Favored 'General case' 0 C--O 1.247 0.959 0 N-CA-C 109.822 -0.436 . . . . 36.469999999999999 109.822 174.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1082 ' ' LEU . . . . . . . . . . . . . 33.0 mt -53.96 -44.96 71.18 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 125.119 1.368 . . . . 37.759999999999998 113.314 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1083 ' ' LEU . . . . . . . . . . . . . 9.6 mt -57.89 125.09 21.55 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 122.396 1.093 . . . . 37.43 109.9 175.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -96.17 147.09 32.43 Favored Pre-proline 0 N--CA 1.438 -1.073 0 CA-C-N 114.279 -1.328 . . . . 37.700000000000003 108.522 -172.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -51.93 122.6 10.77 Favored 'Trans proline' 0 N--CA 1.451 -0.996 1 C-N-CA 126.114 4.543 . . . . 35.509999999999998 114.319 -178.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 98.22 -15.16 61.74 Favored Glycine 0 N--CA 1.466 0.678 0 CA-C-N 113.123 -1.853 . . . . 33.869999999999997 113.003 176.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1087 ' ' THR . . . . . . . . . . . . . 29.3 m -63.02 133.14 54.1 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 124.515 2.103 . . . . 32.5 111.299 174.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1088 ' ' THR . . . . . . . . . . . . . 4.8 m -74.42 92.53 2.33 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 113.233 -1.803 . . . . 30.219999999999999 111.059 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1089 ' ' LEU . . . . . . . . . . . . . 14.2 tp -76.89 119.69 20.99 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 122.374 1.083 . . . . 27.239999999999998 108.721 171.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 24.8 t -112.95 122.61 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 107.304 -1.369 . . . . 25.390000000000001 107.304 171.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1091 ' ' SER . . . . . . . . . . . . . 69.0 m -157.58 165.38 35.69 Favored 'General case' 0 CA--C 1.504 -0.799 0 O-C-N 120.122 -1.611 . . . . 28.809999999999999 109.995 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1092 ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -62.53 96.35 0.08 Allowed 'General case' 0 N--CA 1.466 0.351 0 O-C-N 119.374 -2.078 . . . . 30.780000000000001 107.978 159.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 44.0 mm -88.63 -27.7 5.4 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.184 0 O-C-N 121.087 -1.008 . . . . 30.280000000000001 112.683 -174.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1094 ' ' TRP . . . . . . . . . . . . . 76.1 m95 50.37 54.7 15.98 Favored Pre-proline 0 C--N 1.321 -0.654 0 O-C-N 124.486 1.116 . . . . 34.07 113.957 -177.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -41.5 -56.26 1.9 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 1 C-N-CA 125.776 4.317 . . . . 38.659999999999997 117.607 -164.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -66.99 -38.56 86.26 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 121.015 1.734 . . . . 41.32 111.826 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -68.61 -22.46 64.43 Favored 'General case' 0 C--O 1.209 -1.051 0 CA-C-N 113.644 -1.616 . . . . 51.659999999999997 111.199 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -126.25 68.84 66.69 Favored Pre-proline 0 N--CA 1.439 -0.987 0 O-C-N 120.364 -1.46 . . . . 40.32 109.94 -174.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -64.94 -62.18 0.09 OUTLIER 'Trans proline' 0 CA--C 1.559 1.756 0 C-N-CA 124.112 3.208 . . . . 41.560000000000002 109.85 -174.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -51.87 -44.0 63.5 Favored 'General case' 0 C--N 1.374 1.664 0 N-CA-C 114.101 1.149 . . . . 54.109999999999999 114.101 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1101 ' ' LEU . . . . . . . . . . . . . 9.1 mp -58.36 -48.16 81.46 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.472 -0.767 . . . . 37.880000000000003 110.034 175.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1102 ' ' MET . . . . . . . . . . . . . 39.6 mmm -57.19 -43.1 82.39 Favored 'General case' 0 C--O 1.241 0.607 0 O-C-N 121.459 -0.775 . . . . 37.539999999999999 112.446 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -71.62 -41.8 68.45 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 107.798 -1.186 . . . . 47.009999999999998 107.798 -171.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1104 ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -61.94 -40.73 96.51 Favored 'General case' 0 C--O 1.262 1.759 0 N-CA-C 114.849 1.425 . . . . 48.68 114.849 175.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1105 ' ' LEU . . . . . . . . . . . . . 61.6 mt -64.98 -37.79 88.83 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.779 1.231 . . . . 32.210000000000001 111.16 173.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -60.72 -45.78 92.91 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 117.524 -1.226 . . . . 33.729999999999997 113.138 172.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -55.98 -44.6 78.71 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 122.379 1.085 . . . . 51.469999999999999 112.296 171.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1108 ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -69.51 -6.49 30.99 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 120.747 -1.221 . . . . 43.899999999999999 113.205 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1109 ' ' ASN . . . . . . . . . . . . . 13.7 m-80 62.15 27.6 16.61 Favored 'General case' 0 CA--C 1.486 -1.493 0 N-CA-C 114.084 1.142 . . . . 44.82 114.084 170.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1110 ' ' VAL . . . . . . . . . . . . . 11.1 m -84.06 154.18 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 113.516 0.932 . . . . 30.52 113.516 174.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1111 ' ' THR . . . . . . . . . . . . . 4.1 m -86.59 90.85 8.38 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 120.749 -1.219 . . . . 27.120000000000001 109.22 178.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1112 ' ' VAL . . . . . . . . . . . . . 41.0 t -91.51 125.02 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 124.738 1.274 . . . . 26.399999999999999 112.644 -168.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1113 ' ' MET . . . . . . . . . . . . . 59.2 mtp -123.18 127.62 48.91 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 104.301 -2.481 . . . . 42.920000000000002 104.301 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -101.56 113.1 25.93 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 122.918 1.342 . . . . 24.149999999999999 112.2 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1115 ' ' MET . . . . . . . . . . . . . 24.0 mmm -66.81 -21.16 66.05 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 113.395 -1.729 . . . . 29.949999999999999 115.318 -173.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1116 ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -81.02 -52.65 7.19 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 111.253 -2.703 . . . . 34.530000000000001 112.793 172.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1117 ' ' SER . . . . . . . . . . . . . 57.8 m -90.11 68.22 7.09 Favored 'General case' 0 C--O 1.242 0.684 0 O-C-N 118.826 -2.421 . . . . 33.490000000000002 112.021 -171.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1118 ' ' VAL . . . . . . . . . . . . . 1.8 t -94.87 131.18 30.94 Favored Pre-proline 0 N--CA 1.467 0.376 0 CA-C-N 112.967 -1.924 . . . . 34.020000000000003 106.3 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -62.34 115.41 2.85 Favored 'Trans proline' 0 C--O 1.249 1.038 1 C-N-CA 125.711 4.274 . . . . 38.280000000000001 112.321 175.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1120 ' ' ARG . . . . . 0.427 HH12 ' CG ' ' B' 1128 ' ' ASP . 7.8 mmt180 -82.19 86.81 6.58 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 122.367 1.079 . . . . 55.049999999999997 112.74 -166.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1121 ' ' ILE . . . . . . . . . . . . . 11.1 pt -123.16 142.73 38.71 Favored 'Isoleucine or valine' 0 C--O 1.256 1.41 0 N-CA-C 101.351 -3.574 . . . . 42.090000000000003 101.351 151.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1122 ' ' SER . . . . . . . . . . . . . 2.5 m -37.05 -43.55 0.48 Allowed 'General case' 0 C--O 1.243 0.761 0 N-CA-C 121.466 3.876 . . . . 38.020000000000003 121.466 -161.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1123 ' ' ARG . . . . . . . . . . . . . 20.8 ptt-85 -47.9 -31.26 4.93 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 121.364 1.893 . . . . 34.289999999999999 115.549 175.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1124 ' ' ALA . . . . . . . . . . . . . . . -43.13 -47.53 6.15 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 114.623 1.342 . . . . 32.350000000000001 114.623 169.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1125 ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -52.5 -26.56 13.35 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 116.511 2.041 . . . . 47.170000000000002 116.511 -178.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1126 ' ' SER . . . . . . . . . . . . . 47.3 p -71.27 -32.25 68.48 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 124.135 1.922 . . . . 31.710000000000001 110.968 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1127 ' ' LEU . . . . . . . . . . . . . 4.3 mp -88.12 -32.02 18.89 Favored 'General case' 0 C--N 1.356 0.888 0 CA-C-N 113.949 -1.478 . . . . 37.0 110.268 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1128 ' ' ASP . . . . . 0.427 ' CG ' HH12 ' B' 1120 ' ' ARG . 14.7 t0 -58.73 103.87 0.19 Allowed 'General case' 0 CA--C 1.505 -0.773 0 O-C-N 120.291 -1.506 . . . . 40.399999999999999 113.114 -173.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1129 ' ' ALA . . . . . . . . . . . . . . . -63.86 -29.13 70.35 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 111.911 -2.404 . . . . 26.559999999999999 113.862 175.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 53.8 mt -67.95 -31.47 71.24 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-O 117.295 -1.336 . . . . 30.890000000000001 110.66 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1131 ' ' SER . . . . . . . . . . . . . 84.0 p -60.16 -53.14 61.21 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 122.301 2.319 . . . . 29.84 110.608 175.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1132 ' ' SER . . . . . . . . . . . . . 51.7 m -57.93 -49.46 76.68 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 113.451 0.908 . . . . 31.91 113.451 176.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1133 ' ' MET . . . . . . . . . . . . . 32.7 mmt -63.84 -37.63 88.09 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 122.678 1.227 . . . . 25.899999999999999 110.667 -175.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1134 ' ' ALA . . . . . . . . . . . . . . . -62.98 -48.12 80.24 Favored 'General case' 0 N--CA 1.426 -1.64 0 O-C-N 121.139 -0.976 . . . . 26.620000000000001 110.097 171.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -51.23 -51.28 55.46 Favored 'General case' 0 C--N 1.35 0.607 0 C-N-CA 125.287 1.435 . . . . 36.969999999999999 112.247 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1136 ' ' ILE . . . . . . . . . . . . . 29.7 mm -50.25 -58.62 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 C-N-CA 124.938 1.295 . . . . 32.109999999999999 108.893 169.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -58.92 -30.14 67.61 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 119.077 -0.487 . . . . 24.140000000000001 110.053 -175.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -66.3 -57.38 10.51 Favored Glycine 0 N--CA 1.479 1.555 0 N-CA-C 109.777 -1.329 . . . . 25.129999999999999 109.777 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 53.4 t80 -55.65 -47.21 77.06 Favored 'General case' 0 C--O 1.204 -1.32 0 CA-C-N 117.9 0.85 . . . . 32.729999999999997 111.706 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1140 ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -67.65 -23.43 65.34 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 116.975 -1.488 . . . . 26.359999999999999 110.848 -178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1141 ' ' ALA . . . . . . . . . . . . . . . -64.22 -45.33 88.74 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 122.126 2.239 . . . . 24.120000000000001 111.152 171.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 49.4 mm -60.49 -44.76 97.1 Favored 'Isoleucine or valine' 0 C--O 1.247 0.937 0 CA-C-N 115.718 -0.674 . . . . 23.370000000000001 110.323 176.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 98.0 t -53.83 -69.99 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 114.607 1.336 . . . . 24.960000000000001 114.607 171.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -59.12 -27.78 65.92 Favored 'General case' 0 C--O 1.243 0.736 0 O-C-N 121.724 -0.61 . . . . 32.07 111.922 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1145 ' ' ALA . . . . . . . . . . . . . . . -58.95 -63.89 1.14 Allowed 'General case' 0 C--O 1.246 0.883 0 CA-C-O 117.459 -1.258 . . . . 24.870000000000001 108.202 169.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1146 ' ' ALA . . . . . . . . . . . . . . . -58.68 -20.33 47.53 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 121.474 1.943 . . . . 24.670000000000002 115.326 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 74.9 t60 -62.39 -63.72 1.15 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.254 1.421 . . . . 28.579999999999998 107.674 170.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1148 ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -87.83 -1.65 58.11 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 118.663 2.838 . . . . 36.82 118.663 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1149 ' ' PHE . . . . . . . . . . . . . 2.7 t80 -69.22 141.65 54.43 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 122.801 1.286 . . . . 31.969999999999999 110.77 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1150 ' ' GLY . . . . . . . . . . . . . . . -66.79 -34.72 88.15 Favored Glycine 0 CA--C 1.536 1.36 0 CA-C-O 118.599 -1.111 . . . . 25.489999999999998 112.461 175.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1151 ' ' ARG . . . . . . . . . . . . . 71.6 mtm-85 -122.77 177.46 5.46 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 120.773 2.287 . . . . 59.840000000000003 109.6 -157.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1152 ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -78.67 156.8 28.82 Favored 'General case' 0 C--O 1.25 1.111 0 CA-C-N 119.79 1.177 . . . . 34.450000000000003 108.69 167.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1153 ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -68.03 -50.8 53.16 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.441 1.591 . . . . 31.170000000000002 108.865 163.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1154 ' ' THR . . . . . . . . . . . . . 2.8 m -61.74 124.32 20.41 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 113.264 -1.789 . . . . 33.890000000000001 115.618 -175.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -74.08 69.78 1.58 Allowed Glycine 0 N--CA 1.442 -0.948 0 O-C-N 120.942 -1.098 . . . . 38.950000000000003 110.738 175.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -99.57 133.02 44.5 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-O 123.436 1.589 . . . . 54.229999999999997 112.291 -168.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 20.6 mm -85.77 99.92 8.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 101.191 -3.633 . . . . 51.159999999999997 101.191 173.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1158 ' ' THR . . . . . . . . . . . . . 6.4 m -110.63 101.58 10.22 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.592 -1.186 . . . . 49.609999999999999 108.809 -171.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . 27.31 -71.41 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 120.28 3.437 . . . . 49.049999999999997 120.28 -175.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -69.13 -48.87 61.26 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 125.272 1.429 . . . . 47.649999999999999 112.926 175.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . -137.05 -171.56 12.23 Favored Glycine 0 C--O 1.243 0.663 0 CA-C-N 121.856 2.116 . . . . 45.609999999999999 111.283 -170.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 92.0 mttt -111.58 139.22 47.2 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 111.595 -2.303 . . . . 57.460000000000001 109.052 175.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1163 ' ' VAL . . . . . . . . . . . . . 74.4 t -98.96 130.91 26.48 Favored Pre-proline 0 N--CA 1.426 -1.662 0 CA-C-O 116.691 -1.623 . . . . 42.93 108.05 170.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1164 ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.78 140.2 42.02 Favored 'Trans proline' 0 N--CA 1.441 -1.609 0 C-N-CA 123.715 2.943 . . . . 39.289999999999999 110.432 171.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1165 ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -66.78 115.51 3.62 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 123.185 2.59 . . . . 34.170000000000002 111.72 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -64.49 125.59 25.16 Favored 'General case' 0 C--N 1.355 0.837 0 CA-C-N 119.496 1.044 . . . . 31.690000000000001 112.875 -177.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1167 ' ' LYS . . . . . . . . . . . . . 77.4 mttt -90.94 115.12 27.72 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 104.205 -2.517 . . . . 44.780000000000001 104.205 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 85.4 t -104.41 96.25 4.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 O-C-N 120.507 -1.371 . . . . 31.23 108.627 -174.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1169 ' ' MET . . . . . . . . . . . . . 57.1 ttp -77.36 94.85 4.28 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 122.63 1.205 . . . . 37.090000000000003 110.697 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 92.8 t -81.26 115.88 24.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 N-CA-C 107.075 -1.454 . . . . 30.170000000000002 107.075 175.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1171 ' ' ILE . . . . . . . . . . . . . 84.0 mt -98.85 112.76 31.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 104.456 -2.424 . . . . 33.740000000000002 104.456 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 98.19 91.39 1.95 Allowed Glycine 0 CA--C 1.486 -1.78 0 CA-C-N 113.547 -1.66 . . . . 32.590000000000003 109.166 175.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1173 ' ' ALA . . . . . . . . . . . . . . . -75.68 61.28 1.35 Allowed 'General case' 0 C--O 1.253 1.251 0 CA-C-O 123.46 1.6 . . . . 32.420000000000002 112.095 174.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -78.48 -170.06 36.54 Favored Glycine 0 C--O 1.224 -0.502 0 O-C-N 120.745 -1.222 . . . . 31.739999999999998 110.063 170.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 36.5 t -56.44 -44.98 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-N 119.224 1.512 . . . . 31.48 111.031 174.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1176 ' ' ALA . . . . . . . . . . . . . . . -55.19 -50.25 69.85 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 123.856 0.862 . . . . 26.120000000000001 112.136 172.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1177 ' ' GLY . . . . . . . . . . . . . . . -54.56 -47.39 70.3 Favored Glycine 0 C--N 1.344 1.01 0 O-C-N 125.008 1.442 . . . . 25.73 109.574 178.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1178 ' ' LEU . . . . . . . . . . . . . 81.3 mt -66.57 -34.94 79.01 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.778 -1.424 . . . . 32.590000000000003 112.684 -173.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -71.73 -33.93 69.13 Favored 'General case' 0 C--N 1.351 0.674 0 O-C-N 120.452 -1.405 . . . . 27.719999999999999 112.26 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -67.16 -42.58 84.08 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 123.044 1.402 . . . . 26.030000000000001 110.348 172.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1181 ' ' ILE . . . . . . . . . . . . . 60.0 mt -58.71 -45.82 90.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 O-C-N 119.6 -1.937 . . . . 28.609999999999999 112.314 174.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -53.94 -55.08 27.62 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-N 115.105 -0.952 . . . . 25.23 111.942 172.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -60.31 -50.05 75.18 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.985 1.393 . . . . 24.09 113.265 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -69.58 -33.78 73.2 Favored 'General case' 0 C--O 1.241 0.636 0 O-C-N 121.401 -0.812 . . . . 26.68 110.404 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -68.71 -41.11 79.55 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 120.379 -1.45 . . . . 36.57 111.027 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1186 ' ' SER . . . . . . . . . . . . . 70.7 m -51.62 -44.36 62.87 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 122.211 1.005 . . . . 28.920000000000002 113.497 163.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1187 ' ' LEU . . . . . . . . . . . . . 74.7 mt -78.92 -1.76 36.71 Favored 'General case' 0 N--CA 1.433 -1.298 0 O-C-N 119.893 -1.754 . . . . 29.09 113.92 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 71.17 42.19 58.63 Favored Glycine 0 C--O 1.219 -0.817 0 O-C-N 120.746 -1.221 . . . . 29.260000000000002 111.961 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1189 ' ' ALA . . . . . . . . . . . . 0.251 . . -104.59 154.06 20.41 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.491 -0.559 . . . . 30.16 109.491 172.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 65.1 mt -81.11 93.37 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 O-C-N 119.726 -1.859 . . . . 35.810000000000002 108.389 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1191 ' ' VAL . . . . . . . . . . . . . 4.4 t -78.4 125.57 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.289 -1.004 . . . . 31.969999999999999 108.289 -178.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1192 ' ' ARG . . . . . 0.479 HH12 ' CD ' ' B' 1248 ' ' GLU . 27.0 mmt85 -112.33 94.44 4.93 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 106.081 -1.822 . . . . 48.159999999999997 106.081 177.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -103.78 133.34 48.93 Favored 'General case' 0 C--N 1.355 0.845 0 O-C-N 119.223 -2.173 . . . . 35.890000000000001 115.044 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 38.4 t80 -108.16 156.46 19.29 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 105.02 -2.215 . . . . 41.880000000000003 105.02 176.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1195 ' ' ASP . . . . . . . . . . . . . 7.5 t70 -167.23 146.69 5.22 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 113.371 -1.741 . . . . 38.280000000000001 107.949 163.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1196 ' ' THR . . . . . . . . . . . . . 2.7 p -68.27 -31.49 70.98 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 115.474 1.657 . . . . 40.619999999999997 115.474 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1197 ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -79.02 139.85 57.29 Favored Pre-proline 0 C--N 1.304 -1.391 0 CA-C-O 122.341 1.067 . . . . 53.090000000000003 110.928 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -69.09 -37.33 10.94 Favored 'Trans proline' 0 C--O 1.236 0.414 0 N-CA-C 117.991 2.266 . . . . 42.560000000000002 117.991 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -30.28 71.47 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 122.286 2.312 . . . . 56.310000000000002 116.514 -170.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1200 ' ' VAL . . . . . . . . . . . . . 2.1 m -63.99 -29.07 46.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 114.654 -1.157 . . . . 42.909999999999997 113.201 174.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 41.6 tttm -43.03 -56.57 3.27 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 115.711 1.745 . . . . 48.890000000000001 115.711 175.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -56.75 -37.99 71.8 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.604 -1.18 . . . . 51.700000000000003 112.824 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1203 ' ' GLN . . . . . . . . . . . . . 47.3 mm-40 -60.19 -52.07 66.88 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 109.187 -0.671 . . . . 52.57 109.187 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1204 ' ' VAL . . . . . . . . . . . . . 99.7 t -61.79 -47.57 92.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 O-C-N 125.561 1.788 . . . . 33.789999999999999 110.671 -174.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -53.41 -49.34 67.5 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 125.366 1.466 . . . . 36.579999999999998 111.025 175.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1206 ' ' SER . . . . . . . . . . . . . 18.8 m -80.01 -3.38 48.2 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 114.149 1.166 . . . . 39.609999999999999 114.149 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1207 ' ' MET . . . . . . . . . . . . . 9.1 tpt -79.21 -22.38 44.95 Favored 'General case' 0 CA--C 1.511 -0.523 0 O-C-N 120.911 -1.118 . . . . 37.450000000000003 111.019 163.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 96.23 41.59 3.69 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 119.777 -1.827 . . . . 31.870000000000001 109.522 -173.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -144.95 142.79 30.13 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 123.759 0.824 . . . . 35.399999999999999 111.831 -171.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -80.74 130.69 35.22 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.981 -0.748 . . . . 47.890000000000001 108.981 -173.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 53.2 t80 -96.77 110.84 23.23 Favored 'General case' 0 C--O 1.247 0.925 0 N-CA-C 105.967 -1.864 . . . . 45.530000000000001 105.967 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1212 ' ' LEU . . . . . . . . . . . . . 78.6 mt -70.66 129.68 39.8 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 105.107 -2.182 . . . . 46.329999999999998 105.107 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -115.28 164.55 14.07 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 114.603 -1.18 . . . . 60.409999999999997 111.246 -170.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 4.9 mp -70.57 137.69 50.29 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-O 121.228 0.537 . . . . 57.380000000000003 109.875 -167.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 19.5 t70 . . . . . 0 N--CA 1.476 0.84 0 O-C-N 120.697 -1.252 . . . . 65.069999999999993 111.066 -169.699 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B 1230 ' ' MET . . . . . . . . . . . . . 28.5 mmt . . . . . 0 N--CA 1.422 -1.865 0 N-CA-C 109.654 -0.499 . . . . 80.319999999999993 109.654 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B 1231 ' ' SER . . . . . . . . . . . . . 40.0 m 70.05 174.51 0.29 Allowed 'General case' 0 N--CA 1.476 0.853 2 O-C-N 112.163 -6.586 . . . . 79.920000000000002 117.433 -1.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -114.3 -117.37 0.32 Allowed 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 105.254 -2.128 . . . . 77.909999999999997 105.254 175.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 57.99 -60.51 0.03 OUTLIER 'General case' 0 C--O 1.241 0.649 0 CA-C-N 123.073 2.669 . . . . 73.879999999999995 116.132 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.41 -26.3 66.59 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 120.218 1.372 . . . . 68.980000000000004 112.0 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 37.3 pt -31.27 -44.91 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.247 0.931 0 N-CA-C 116.056 1.873 . . . . 64.530000000000001 116.056 164.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -63.69 -39.17 93.65 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-O 121.336 0.589 . . . . 66.359999999999999 109.656 -177.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -68.02 -52.3 37.21 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.507 -0.77 . . . . 56.600000000000001 111.888 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -50.39 -66.2 0.43 Allowed 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 125.06 1.344 . . . . 56.789999999999999 110.405 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1239 ' ' MET . . . . . . . . . . . . . 82.7 mtp -50.49 -40.57 51.54 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 115.929 1.826 . . . . 53.630000000000003 115.929 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -57.27 -49.78 75.0 Favored 'General case' 0 C--O 1.259 1.601 0 O-C-N 124.511 1.132 . . . . 51.740000000000002 110.742 173.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 4.2 tt -66.34 -37.36 85.16 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 116.214 -0.448 . . . . 44.859999999999999 110.525 -174.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -67.17 -42.49 84.21 Favored 'General case' 0 N--CA 1.438 -1.041 0 O-C-N 126.257 2.223 . . . . 42.780000000000001 109.597 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -63.65 -40.84 97.86 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 120.294 -1.504 . . . . 40.960000000000001 108.607 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -67.41 -34.43 77.23 Favored 'General case' 0 C--O 1.246 0.907 0 O-C-N 120.58 -1.325 . . . . 43.060000000000002 110.798 175.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -70.03 -27.58 64.78 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.378 0.881 . . . . 46.450000000000003 113.378 168.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -57.43 -45.38 84.72 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 119.953 -1.717 . . . . 41.780000000000001 111.598 -176.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 21.1 tptt -62.26 -31.69 72.3 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.33 0.863 . . . . 52.200000000000003 113.33 173.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1248 ' ' GLU . . . . . 0.479 ' CD ' HH12 ' B' 1192 ' ' ARG . 0.5 OUTLIER -77.35 -43.64 32.23 Favored 'General case' 0 C--O 1.248 0.986 0 O-C-N 121.394 -0.816 . . . . 53.549999999999997 113.019 177.646 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B 1249 ' ' VAL . . . . . . . . . . . . . 30.0 m -81.49 -179.26 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.031 0 O-C-N 120.575 -1.328 . . . . 34.409999999999997 114.457 -160.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1250 ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -132.94 -37.94 0.99 Allowed 'General case' 0 C--O 1.247 0.948 0 CA-C-N 113.087 -1.869 . . . . 33.380000000000003 109.616 -172.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1251 ' ' ILE . . . . . . . . . . . . . 41.1 mm -129.8 138.11 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 N-CA-C 104.469 -2.419 . . . . 29.539999999999999 104.469 175.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1252 ' ' ILE . . . . . . . . . . . . . 78.7 mt -112.84 116.36 52.4 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 N-CA-C 103.641 -2.726 . . . . 32.439999999999998 103.641 166.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1253 ' ' VAL . . . . . . . . . . . . . 42.8 t -97.57 87.56 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.258 1.52 0 N-CA-C 102.139 -3.282 . . . . 30.57 102.139 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1254 ' ' THR . . . . . . . . . . . . 0.286 1.3 t -89.7 104.63 17.17 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 126.245 2.926 . . . . 35.039999999999999 109.141 -174.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1255 ' ' THR . . . . . . . . . . . . . 21.9 m -110.99 -5.26 14.86 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 109.021 -3.718 . . . . 34.619999999999997 113.099 -169.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . -71.08 79.7 0.68 Allowed 'General case' 0 C--O 1.247 0.921 0 CA-C-O 124.026 1.869 . . . . 42.719999999999999 112.45 -162.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 29.2 mt -92.56 120.9 33.47 Favored 'General case' 0 C--O 1.249 1.077 0 N-CA-C 106.912 -1.514 . . . . 52.43 106.912 169.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 70.1 mt -81.68 113.6 43.65 Favored Pre-proline 0 N--CA 1.449 -0.486 0 N-CA-C 102.055 -3.313 . . . . 59.409999999999997 102.055 176.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -57.02 94.44 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 124.077 3.185 . . . . 62.68 115.746 -171.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 135.56 -44.91 1.13 Allowed Glycine 0 CA--C 1.493 -1.285 0 CA-C-N 112.065 -2.334 . . . . 64.159999999999997 108.479 174.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 82.5 mttt -68.98 161.78 69.85 Favored Pre-proline 0 N--CA 1.446 -0.626 0 O-C-N 120.215 -1.756 . . . . 68.530000000000001 114.335 172.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -61.07 157.48 39.07 Favored 'Trans proline' 0 N--CA 1.44 -1.64 0 C-N-CA 122.235 1.957 . . . . 61.990000000000002 111.504 157.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1263 ' ' ALA . . . . . . . . . . . . . . . -66.14 128.23 93.7 Favored Pre-proline 0 N--CA 1.416 -2.142 0 O-C-N 120.761 -1.212 . . . . 57.149999999999999 112.811 174.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.15 137.94 42.04 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 123.787 2.991 . . . . 51.57 110.24 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -76.9 71.15 3.4 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 123.358 1.552 . . . . 54.549999999999997 111.248 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 63.4 mt -70.1 -42.58 72.51 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 124.086 1.898 . . . . 46.859999999999999 110.7 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1267 ' ' ILE . . . . . . . . . . . . . 44.4 mm -80.07 93.44 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 O-C-N 119.207 -2.183 . . . . 41.039999999999999 107.129 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1268 ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.81 152.63 31.0 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 113.429 -1.714 . . . . 39.579999999999998 112.8 170.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1269 ' ' ARG . . . . . . . . . . . . . 73.1 mtt85 -56.4 -37.97 70.86 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 120.782 -1.199 . . . . 53.149999999999999 111.675 172.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -43.85 -54.54 5.17 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 125.888 1.675 . . . . 42.960000000000001 114.376 168.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1271 ' ' MET . . . . . . . . . . . . . 48.7 ttm -64.37 -33.91 76.95 Favored 'General case' 0 C--N 1.353 0.758 0 CA-C-N 114.648 -1.16 . . . . 43.890000000000001 109.551 -174.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1272 ' ' VAL . . . . . . . . . . . . . 21.5 t -65.89 -48.58 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 123.315 1.531 . . . . 38.369999999999997 108.087 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -67.47 -14.63 63.1 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 120.802 -1.187 . . . . 47.460000000000001 114.155 173.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1274 ' ' SER . . . . . . . . . . . . . 48.6 m -86.73 0.2 55.14 Favored 'General case' 0 N--CA 1.44 -0.926 0 O-C-N 119.2 -2.187 . . . . 38.380000000000003 114.367 168.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1275 ' ' MET . . . . . . . . . . . . . 55.6 mtp -82.24 156.98 24.08 Favored 'General case' 0 CA--C 1.486 -1.499 0 O-C-N 118.502 -2.624 . . . . 37.810000000000002 112.946 173.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1276 ' ' LYS . . . . . 0.473 ' NZ ' ' O ' ' B' 1248 ' ' GLU . 8.0 ttmt -62.39 146.59 50.9 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 112.743 -2.026 . . . . 49.259999999999998 107.25 167.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -73.62 150.43 41.37 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 114.319 1.229 . . . . 34.460000000000001 114.319 -176.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 62.18 51.6 55.57 Favored Glycine 0 N--CA 1.479 1.521 0 CA-C-O 124.859 2.366 . . . . 33.530000000000001 111.698 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1279 ' ' SER . . . . . . . . . . . . . 45.4 m -134.49 154.27 51.51 Favored 'General case' 0 C--O 1.26 1.607 0 CA-C-N 111.543 -2.328 . . . . 31.309999999999999 105.348 -173.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1280 ' ' VAL . . . . . . . . . . . . . 63.3 t -120.65 138.99 49.33 Favored 'Isoleucine or valine' 0 C--O 1.247 0.961 0 O-C-N 119.459 -2.026 . . . . 29.32 109.108 -170.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1281 ' ' ILE . . . . . . . . . . . . . 40.7 mt -106.81 101.48 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 105.874 -1.899 . . . . 31.93 105.874 168.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1282 ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.81 114.65 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.179 0 CA-C-O 124.414 2.054 . . . . 29.48 107.498 176.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 22.5 t0 -94.51 108.48 20.42 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 113.192 -1.822 . . . . 34.5 106.439 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1284 ' ' LEU . . . . . . . . . . . . . 5.9 mp -84.78 -33.43 22.99 Favored 'General case' 0 C--O 1.255 1.354 0 CA-C-N 112.448 -2.16 . . . . 37.939999999999998 108.779 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -75.23 -9.67 58.76 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 113.298 -1.774 . . . . 40.920000000000002 110.881 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -42.65 -30.02 0.34 Allowed 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 118.709 2.855 . . . . 44.390000000000001 118.709 169.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1287 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.96 -36.56 83.68 Favored 'General case' 0 C--N 1.363 1.157 0 CA-C-N 121.385 1.902 . . . . 51.460000000000001 110.566 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 20.9 t30 -122.92 100.09 6.71 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 122.996 1.379 . . . . 57.75 109.328 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1289 ' ' GLY . . . . . . . . . . . . . . . 82.9 -60.85 4.85 Favored Glycine 0 C--O 1.259 1.693 0 O-C-N 119.858 -1.776 . . . . 49.850000000000001 114.274 177.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 90.61 128.35 3.84 Favored Glycine 0 C--O 1.252 1.234 0 O-C-N 120.674 -1.486 . . . . 45.93 111.535 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1291 ' ' ASN . . . . . . . . . . . . . 7.7 m120 -80.83 -31.57 35.46 Favored 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 124.298 0.646 . . . . 42.670000000000002 110.667 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1292 ' ' CYS . . . . . . . . . . . . . 52.5 t -92.1 140.49 29.59 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.285 -1.005 . . . . 38.82 108.285 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1293 ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -65.57 -45.28 83.89 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 113.376 0.88 . . . . 46.710000000000001 113.376 171.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -63.78 -15.57 59.03 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 117.458 2.392 . . . . 47.229999999999997 117.458 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1295 ' ' THR . . . . . . . . . . . . . 33.2 m -59.98 119.02 6.98 Favored 'General case' 0 C--O 1.262 1.755 0 O-C-N 120.986 -1.071 . . . . 36.020000000000003 111.41 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 60.8 t -79.49 121.42 82.69 Favored Pre-proline 0 N--CA 1.473 0.694 0 N-CA-C 102.767 -3.049 . . . . 37.259999999999998 102.767 163.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -62.45 92.63 0.13 Allowed 'Trans proline' 0 C--O 1.249 1.036 0 C-N-CA 124.592 3.528 . . . . 35.090000000000003 110.542 -177.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 114.66 27.02 3.43 Favored Glycine 0 N--CA 1.443 -0.886 0 O-C-N 120.861 -1.15 . . . . 35.969999999999999 112.237 175.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -153.04 171.4 18.44 Favored 'General case' 0 C--N 1.356 0.861 0 CA-C-N 121.001 2.401 . . . . 40.390000000000001 116.079 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1300 ' ' ILE . . . . . . . . . . . . . 18.9 mt -87.82 160.08 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 O-C-N 122.103 -0.373 . . . . 37.43 110.086 165.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 51.6 t80 -150.44 161.71 41.98 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 106.116 -1.809 . . . . 44.130000000000003 106.116 169.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1302 ' ' THR . . . . . . . . . . . . . 9.2 m -136.16 138.39 41.9 Favored 'General case' 0 C--O 1.253 1.249 0 O-C-N 120.519 -1.363 . . . . 39.780000000000001 109.483 173.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1303 ' ' THR . . . . . . . . . . . . . 41.4 p -98.37 168.49 10.18 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 126.004 2.065 . . . . 43.289999999999999 114.095 -167.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -47.74 -49.4 28.38 Favored 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 124.721 1.208 . . . . 53.07 113.161 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 32.9 p-10 -67.69 -39.95 84.39 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 115.226 1.565 . . . . 43.969999999999999 115.226 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 127.62 29.03 0.85 Allowed Glycine 0 CA--C 1.527 0.783 0 N-CA-C 109.547 -1.421 . . . . 41.119999999999997 109.547 177.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1307 ' ' VAL . . . . . . . . . . . . . 47.3 t -98.61 148.25 6.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 107.409 -1.33 . . . . 38.119999999999997 107.409 173.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1308 ' ' LYS . . . . . . . . . . . . . 90.6 mttt -113.27 128.51 56.49 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 118.718 -2.489 . . . . 36.340000000000003 105.482 -175.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1309 ' ' VAL . . . . . . . . . . . . . 42.7 t -110.06 130.41 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 103.294 -2.854 . . . . 30.399999999999999 103.294 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1310 ' ' ILE . . . . . . . . . . . . . 52.9 mt -127.14 113.01 30.48 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.411 0 N-CA-C 105.108 -2.182 . . . . 30.82 105.108 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1311 ' ' GLY . . . . . . . . . . . . . . . -132.98 117.54 1.97 Allowed Glycine 0 C--O 1.214 -1.134 0 N-CA-C 104.789 -3.324 . . . . 26.530000000000001 104.789 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1312 ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -117.59 128.03 54.55 Favored 'General case' 0 CA--C 1.493 -1.235 0 CA-C-N 118.345 1.073 . . . . 38.0 110.667 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1313 ' ' THR . . . . . . . . . . . . . 26.3 m -68.11 -28.42 67.31 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.511 -1.677 . . . . 29.800000000000001 107.601 167.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -89.4 18.61 5.09 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 124.835 1.254 . . . . 39.039999999999999 113.592 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1315 ' ' LEU . . . . . . . . . . . . . 6.9 mt -48.24 -40.21 34.34 Favored Pre-proline 0 CA--C 1.509 -0.633 0 N-CA-C 117.25 2.315 . . . . 31.079999999999998 117.25 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1316 ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -64.19 -44.56 11.92 Favored 'Trans proline' 0 CA--C 1.513 -0.548 0 C-N-CA 123.911 3.074 . . . . 26.100000000000001 111.968 169.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -56.02 -33.05 60.15 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 115.524 0.969 . . . . 23.170000000000002 115.524 172.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -54.9 -23.92 21.03 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 113.623 0.971 . . . . 40.399999999999999 113.623 171.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 12.6 tp -126.76 79.73 71.59 Favored Pre-proline 0 N--CA 1.442 -0.874 0 O-C-N 119.08 -2.263 . . . . 23.600000000000001 107.194 176.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1320 ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -58.65 -63.04 0.15 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.801 3.001 . . . . 22.350000000000001 119.246 -171.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1321 ' ' THR . . . . . . . . . . . . . 2.3 m -57.02 -43.82 82.23 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 119.666 1.121 . . . . 26.52 109.779 -175.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1322 ' ' GLN . . . . . . . . . . . . . 34.4 tp60 -74.13 -35.79 64.14 Favored 'General case' 0 CA--C 1.493 -1.218 0 O-C-N 121.626 -0.671 . . . . 24.379999999999999 112.442 -172.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1323 ' ' SER . . . . . . . . . . . . . 68.6 m -61.01 -45.28 95.46 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 113.905 1.076 . . . . 22.800000000000001 113.905 168.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1324 ' ' SER . . . . . . . . . . . . . 14.5 m -59.01 -37.94 78.07 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.89 0.476 . . . . 21.25 111.015 175.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 43.6 tp60 -63.05 -49.18 75.59 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 113.12 0.785 . . . . 31.34 113.12 171.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1326 ' ' LEU . . . . . . . . . . . . . 35.7 mt -78.57 -48.1 15.87 Favored 'General case' 0 CA--C 1.488 -1.439 0 O-C-N 120.092 -1.63 . . . . 31.559999999999999 113.02 -170.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1327 ' ' TYR . . . . . . . . . . . . . 38.7 t80 -57.26 -42.81 82.27 Favored 'General case' 0 C--N 1.359 1.003 0 N-CA-C 107.536 -1.283 . . . . 22.73 107.536 170.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1328 ' ' GLY . . . . . . . . . . . . . . . -52.37 -50.87 45.52 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 123.472 0.558 . . . . 21.91 112.438 171.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1329 ' ' THR . . . . . . . . . . . . . 34.6 m -65.39 -29.46 70.16 Favored 'General case' 0 C--O 1.245 0.84 0 O-C-N 119.004 -2.468 . . . . 22.149999999999999 111.265 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1330 ' ' ASN . . . . . . . . . . . . . 20.3 m120 -60.59 -49.19 78.53 Favored 'General case' 0 C--O 1.25 1.12 0 CA-C-O 122.446 1.117 . . . . 26.18 110.889 173.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1331 ' ' LEU . . . . . . . . . . . . . 36.4 mt -53.21 -46.16 68.95 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 113.278 -1.783 . . . . 23.68 113.16 171.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1332 ' ' VAL . . . . . . . . . . . . . 39.0 t -53.79 -50.0 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 115.754 -0.657 . . . . 26.57 110.643 171.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -69.55 -27.37 65.09 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 119.875 -1.766 . . . . 28.079999999999998 113.303 -177.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1334 ' ' LEU . . . . . . . . . . . . . 1.2 tt -66.96 -51.62 52.88 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 106.206 -1.775 . . . . 27.43 106.206 175.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1335 ' ' LEU . . . . . . . . . . . . . 86.3 mt -62.4 -29.75 70.71 Favored 'General case' 0 C--N 1.355 0.844 0 CA-C-N 115.162 -0.926 . . . . 30.5 111.255 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1336 ' ' LYS . . . . . . . . . . . . . 95.0 mttt -64.8 -45.73 85.05 Favored 'General case' 0 C--O 1.245 0.843 0 O-C-N 120.418 -1.426 . . . . 41.649999999999999 110.052 169.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 29.5 tp -76.04 -18.27 59.3 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 119.454 1.024 . . . . 42.079999999999998 112.227 -174.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1338 ' ' LEU . . . . . . . . . . . . . 26.8 mt -79.09 -67.92 0.71 Allowed 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 119.637 -1.914 . . . . 35.030000000000001 108.194 167.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 43.0 t -76.45 80.46 3.16 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 124.283 1.992 . . . . 37.329999999999998 108.282 -173.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -62.22 -27.64 69.13 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.531 -1.356 . . . . 50.509999999999998 111.984 174.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -84.63 -6.24 59.35 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 114.245 1.202 . . . . 54.210000000000001 114.245 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 90.7 mttt 39.07 39.8 0.42 Allowed 'General case' 0 C--O 1.257 1.477 0 N-CA-C 116.717 2.117 . . . . 50.990000000000002 116.717 -172.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -89.69 -14.52 34.6 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 113.885 -1.507 . . . . 48.82 107.542 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 89.98 27.99 19.58 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.052 -1.071 . . . . 40.43 112.351 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -136.68 160.84 37.62 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 120.289 2.044 . . . . 47.560000000000002 109.012 164.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1346 ' ' ILE . . . . . . . . . . . . . 45.0 mm -68.1 101.13 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 C-N-CA 119.612 -0.835 . . . . 42.490000000000002 108.898 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1347 ' ' THR . . . . . . . . . . . . . 17.6 m -71.91 105.56 3.88 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 103.412 -2.81 . . . . 38.119999999999997 103.412 163.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 47.3 t -69.03 84.97 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.144 -1.389 . . . . 37.5 109.292 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 24.5 t70 -81.29 164.13 22.44 Favored 'General case' 0 C--O 1.243 0.761 0 O-C-N 121.298 -0.876 . . . . 43.850000000000001 110.701 171.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1350 ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -155.0 3.09 0.2 Allowed 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 126.925 2.09 . . . . 39.810000000000002 111.17 158.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 10.6 t70 -72.94 -32.68 65.43 Favored 'General case' 0 C--O 1.247 0.939 0 CA-C-O 121.761 0.791 . . . . 51.289999999999999 112.234 -163.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.39 142.34 31.07 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.31 -0.859 . . . . 39.780000000000001 111.904 170.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 22.5 m -62.84 -26.47 40.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 114.956 1.465 . . . . 39.280000000000001 114.956 -178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1354 ' ' VAL . . . . . . . . . . . . . 81.1 t -71.06 -49.94 45.73 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.195 0 N-CA-C 106.389 -1.708 . . . . 35.700000000000003 106.389 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1355 ' ' ILE . . . . . . . . . . . . . 25.6 mm -62.49 -46.63 95.95 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 119.458 1.026 . . . . 35.770000000000003 111.766 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 45.1 tpt85 -46.15 -32.2 2.82 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 124.331 1.019 . . . . 38.549999999999997 113.091 172.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -97.28 -46.37 2.39 Favored Glycine 0 CA--C 1.497 -1.061 0 O-C-N 120.682 -1.261 . . . . 29.579999999999998 114.125 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1358 ' ' VAL . . . . . . . . . . . . . 10.9 p -65.52 -35.73 75.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 117.035 0.417 . . . . 32.060000000000002 111.848 -176.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1359 ' ' THR . . . . . . . . . . . . . 2.8 m -75.6 80.93 2.59 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.519 -1.66 . . . . 29.0 106.519 172.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1360 ' ' VAL . . . . . . . . . . . . . 15.6 m -68.39 -24.35 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 O-C-N 121.123 -0.986 . . . . 29.68 113.161 -172.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 74.7 mt -132.88 97.39 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 103.842 -2.651 . . . . 32.049999999999997 103.842 176.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1362 ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -79.71 92.63 5.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 124.442 3.292 . . . . 32.520000000000003 109.81 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 57.09 30.68 18.67 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 115.922 1.823 . . . . 35.68 115.922 168.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 147.97 -73.39 0.29 Allowed Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.26 -0.972 . . . . 34.259999999999998 110.887 177.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -69.28 141.45 54.34 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 113.565 0.95 . . . . 51.07 113.565 173.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 88.8 mt -86.66 113.33 24.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 125.198 2.428 . . . . 39.869999999999997 111.436 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1367 ' ' THR . . . . . . . . . . . . . 1.1 p -98.45 3.14 48.31 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 111.344 -2.662 . . . . 38.009999999999998 112.698 -172.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1368 ' ' TRP . . . . . . . . . . . . . 57.7 t90 -73.07 137.45 79.13 Favored Pre-proline 0 N--CA 1.447 -0.599 0 N-CA-C 107.757 -1.201 . . . . 42.140000000000001 107.757 167.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -94.49 -178.84 8.06 Favored 'Cis proline' 0 N--CA 1.452 -0.939 0 C-N-CA 124.695 -0.96 . . . . 43.259999999999998 111.464 -5.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1370 ' ' ALA . . . . . . . . . . . . . . . -76.08 163.54 65.95 Favored Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 124.718 1.207 . . . . 46.520000000000003 108.19 169.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -54.04 126.89 23.55 Favored 'Trans proline' 0 CA--C 1.553 1.46 0 C-N-CA 125.149 3.899 . . . . 51.950000000000003 111.003 166.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -37.88 109.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.365 1.442 1 C-N-CA 126.99 5.127 . . . . 56.270000000000003 113.375 -173.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1373 ' ' ILE . . . . . . . . . . . . . 8.3 tp -82.44 137.33 21.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 C-N-CA 126.655 1.982 . . . . 60.829999999999998 113.094 -174.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 16.1 mp0 -87.49 101.09 13.26 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-O 122.979 1.371 . . . . 66.099999999999994 110.188 175.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 43.1 t -73.97 118.34 19.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 112.396 -2.184 . . . . 63.469999999999999 108.12 176.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.217 -5.174 0 O-C-N 118.206 -2.809 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.541 0 CA-C-O 116.792 -1.575 . . . . 0.0 111.416 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -58.11 -23.24 54.17 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 122.655 2.479 . . . . 0.0 115.676 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 52.9 mp0 -52.49 -53.07 50.71 Favored 'General case' 0 C--O 1.215 -0.715 0 CA-C-O 122.027 0.918 . . . . 0.0 109.25 171.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 16.8 m -67.3 -43.53 81.48 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 114.561 -1.199 . . . . 0.0 109.791 -176.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.87 -36.38 67.52 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 123.993 0.917 . . . . 0.0 111.26 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.12 -57.87 3.62 Favored 'General case' 0 C--O 1.24 0.605 0 O-C-N 120.082 -1.636 . . . . 0.0 112.706 171.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 mp -46.82 -44.94 19.76 Favored 'General case' 0 C--O 1.21 -1.025 0 C-N-CA 125.664 1.585 . . . . 0.0 114.284 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 27.6 mt -62.77 -49.52 74.68 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 28' ' ' LYS . . . . . 0.538 ' HZ3' ' C ' ' C' ' 186' ' ' LEU . 20.0 pttm -67.6 -30.33 69.89 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 119.241 -0.983 . . . . 0.0 111.795 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -62.52 -43.2 99.4 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 124.06 0.944 . . . . 0.0 111.937 168.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 51.7 m -44.87 -31.7 1.34 Allowed 'General case' 0 CA--C 1.498 -1.028 1 N-CA-C 122.175 4.139 . . . . 0.0 122.175 -164.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 70.85 -62.67 0.44 Allowed 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.499 1.12 . . . . 0.0 111.607 -175.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 71.7 m -108.52 139.67 42.95 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 162.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 92.2 t -124.05 134.98 65.08 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 103.738 -2.69 . . . . 0.0 103.738 174.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 42.5 mm -109.95 123.73 66.09 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.305 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 165.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 66.9 mt -108.51 124.8 65.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 172.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 89.2 m -108.1 100.22 35.39 Favored Pre-proline 0 C--O 1.245 0.825 0 CA-C-N 113.359 -1.746 . . . . 0.0 109.147 173.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -61.76 82.47 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.482 3.455 . . . . 0.0 110.391 174.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.18 -132.91 3.65 Favored Glycine 0 N--CA 1.432 -1.61 0 CA-C-O 123.3 1.5 . . . . 0.0 110.503 169.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -59.28 -57.4 13.19 Favored 'General case' 0 CA--C 1.5 -0.966 0 O-C-N 121.306 -1.114 . . . . 0.0 110.834 -157.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -55.24 -34.92 59.41 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-O 118.392 -1.227 . . . . 0.0 112.328 -173.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 31.3 ttm -88.15 -37.55 16.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 118.539 1.169 . . . . 0.0 110.421 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.36 -2.37 37.86 Favored 'General case' 0 C--O 1.246 0.887 0 C-N-CA 122.416 0.287 . . . . 0.0 111.525 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 p -111.39 -43.53 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 166.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -135.9 179.03 6.59 Favored 'General case' 0 CA--C 1.507 -0.709 0 O-C-N 119.412 -2.055 . . . . 0.0 110.255 -167.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 45' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -63.64 16.02 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 120.583 3.549 . . . . 0.0 120.583 -169.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.9 -17.01 33.98 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 123.68 2.945 . . . . 0.0 115.048 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -44.22 96.92 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.157 0.983 . . . . 0.0 111.106 174.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 48' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -62.74 -47.26 88.01 Favored Pre-proline 0 C--O 1.253 1.265 0 CA-C-N 121.99 2.177 . . . . 0.0 110.011 177.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 49' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -53.95 -42.64 65.04 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 124.642 3.561 . . . . 0.0 114.884 169.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 p -65.95 -34.98 73.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 119.203 0.91 . . . . 0.0 111.09 -174.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.3 -50.07 70.53 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.175 0.99 . . . . 0.0 112.419 169.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -68.82 -29.41 67.74 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -178.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 9.4 tp -76.53 -46.05 32.35 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 N-CA-C 115.597 1.702 . . . . 0.0 115.597 166.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 96.9 m -57.63 -27.93 63.23 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 113.421 0.896 . . . . 0.0 113.421 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -47.43 -57.45 5.32 Favored 'General case' 0 N--CA 1.427 -1.618 0 C-N-CA 125.608 1.563 . . . . 0.0 114.017 167.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -81.17 -25.31 36.92 Favored 'General case' 0 N--CA 1.434 -1.244 0 O-C-N 120.76 -1.213 . . . . 0.0 112.271 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.77 -38.35 90.26 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 123.083 1.421 . . . . 0.0 111.488 171.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -73.42 -32.9 64.66 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.536 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.18 -23.08 66.39 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 167.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -81.71 -6.29 58.89 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 119.157 0.89 . . . . 0.0 110.97 168.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.01 41.74 80.43 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 120.52 -1.363 . . . . 0.0 114.465 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 25.2 mt -96.04 134.54 33.22 Favored 'Isoleucine or valine' 0 C--O 1.253 1.253 0 CA-C-O 123.756 1.741 . . . . 0.0 111.081 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -68.99 83.07 0.32 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 124.629 2.156 . . . . 0.0 110.182 168.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 p -100.39 92.0 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 113.748 -1.569 . . . . 0.0 107.749 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -91.62 128.08 37.32 Favored 'General case' 0 N--CA 1.442 -0.836 0 O-C-N 120.117 -1.614 . . . . 0.0 111.929 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -83.1 78.69 9.56 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 122.639 1.209 . . . . 0.0 109.047 176.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.48 89.06 0.35 Allowed Glycine 0 C--O 1.219 -0.804 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 20.6 mt -88.72 132.62 33.13 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.902 0 CA-C-O 120.953 0.406 . . . . 0.0 111.845 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -83.39 128.99 62.15 Favored Pre-proline 0 N--CA 1.472 0.654 0 CA-C-O 117.583 -1.199 . . . . 0.0 109.45 169.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 70' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -61.11 -66.36 0.06 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.526 0 C-N-CA 124.582 3.521 . . . . 0.0 117.934 -175.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 45.8 t -76.16 107.54 7.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 170.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -168.15 142.71 3.48 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-N 121.315 1.871 . . . . 0.0 111.901 -171.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 61.77 -113.75 6.05 Favored Glycine 0 C--N 1.346 1.103 0 O-C-N 121.208 -0.932 . . . . 0.0 111.493 171.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -128.72 105.88 8.56 Favored 'General case' 0 C--O 1.242 0.681 0 O-C-N 121.163 -1.199 . . . . 0.0 109.914 177.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . 0.25 2.0 mp 68.63 132.35 0.04 OUTLIER Pre-proline 0 CA--C 1.553 1.058 0 O-C-N 127.605 3.065 . . . . 0.0 116.269 -177.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.42 158.29 57.77 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 124.346 3.364 . . . . 0.0 107.784 167.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.04 -63.92 1.62 Allowed Glycine 0 C--O 1.212 -1.244 0 CA-C-O 116.802 -2.11 . . . . 0.0 111.856 -168.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -33.23 -50.25 0.29 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -172.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.37 -45.03 85.7 Favored 'General case' 0 C--O 1.245 0.819 0 O-C-N 124.294 0.996 . . . . 0.0 113.207 -178.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.16 -26.07 42.77 Favored 'General case' 0 C--O 1.246 0.908 0 O-C-N 120.266 -1.521 . . . . 0.0 109.409 -175.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 46.5 t -58.48 -52.87 54.24 Favored 'Isoleucine or valine' 0 C--N 1.347 0.477 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 166.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 63.0 mt -56.95 -29.5 63.21 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 11.1 mp -63.96 -44.98 91.14 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 121.756 -0.59 . . . . 0.0 111.12 167.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.53 -38.08 86.39 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 120.223 -1.548 . . . . 0.0 112.334 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -50.39 -53.79 26.59 Favored 'General case' 0 C--N 1.349 0.572 0 O-C-N 124.654 1.221 . . . . 0.0 113.167 163.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.51 10.31 3.27 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp 58.68 30.29 19.73 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.867 2.067 . . . . 0.0 112.243 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 65.9 t -70.16 127.36 92.33 Favored Pre-proline 0 C--O 1.242 0.697 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 -174.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -50.56 107.41 0.16 Allowed 'Trans proline' 0 C--O 1.243 0.758 1 C-N-CA 125.313 4.009 . . . . 0.0 112.513 -176.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.75 -26.67 64.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.107 -1.406 . . . . 0.0 112.462 -165.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -40.15 -44.11 1.76 Allowed 'General case' 0 C--O 1.245 0.844 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 174.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -90.87 -1.42 9.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 -173.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 10.6 t -83.36 121.73 36.59 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 O-C-N 120.686 -1.258 . . . . 0.0 114.38 -174.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 45.0 mt -125.59 81.78 2.01 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -170.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 27.7 mp0 -75.76 104.38 6.28 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 121.677 -0.64 . . . . 0.0 110.433 -174.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 41.5 ttp 49.31 59.65 4.33 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.35 -171.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -103.84 135.74 44.82 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 167.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -85.73 75.64 10.05 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 -172.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 8.3 tp -92.97 62.27 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-O 124.777 2.227 . . . . 0.0 110.585 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -60.04 -32.97 71.42 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 112.397 -2.183 . . . . 0.0 109.354 -170.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.83 -59.65 4.57 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 118.155 -0.926 . . . . 0.0 112.23 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.01 -28.66 69.73 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 128.266 3.479 . . . . 0.0 113.239 176.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 103' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -64.52 -39.92 94.67 Favored 'General case' 0 C--O 1.224 -0.269 0 O-C-N 120.415 -1.428 . . . . 0.0 111.231 174.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -103.32 60.76 0.77 Allowed 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 123.263 1.506 . . . . 0.0 109.453 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -168.79 -37.02 0.02 OUTLIER 'General case' 0 C--O 1.241 0.655 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 106' ' ' THR . . . . . . . . . . . . . 2.7 m -51.12 132.46 28.0 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 121.256 -0.902 . . . . 0.0 113.282 170.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 107' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -85.84 -60.49 2.0 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 34.6 m -109.22 130.67 55.49 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 118.572 -1.251 . . . . 0.0 112.563 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 109' ' ' VAL . . . . . . . . . . . . . 47.9 t -102.17 132.73 47.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 O-C-N 124.647 1.217 . . . . 0.0 108.225 173.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 15.3 mt -98.58 84.24 3.13 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 124.57 1.169 . . . . 0.0 109.679 176.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 61.8 t -78.55 104.74 6.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 124.461 2.077 . . . . 0.0 107.494 170.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 36.3 mm -72.62 76.47 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.185 0 CA-C-O 124.424 2.059 . . . . 0.0 113.779 -175.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.11 -58.21 3.57 Favored Glycine 0 C--N 1.346 1.128 0 O-C-N 118.18 -2.825 . . . . 0.0 114.568 171.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -82.75 95.05 7.75 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 123.153 1.454 . . . . 0.0 111.557 -171.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 115' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -52.25 -57.56 9.33 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 111.098 -2.774 . . . . 0.0 112.127 165.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 116' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -56.95 -34.03 67.63 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -169.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 20.7 m -43.46 -38.36 2.8 Favored 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 169.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 16.8 m -127.22 26.15 2.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 125.22 1.408 . . . . 0.0 110.826 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -75.54 120.71 82.93 Favored Pre-proline 0 CA--C 1.505 -0.775 0 CA-C-O 117.524 -1.227 . . . . 0.0 109.513 -177.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 120' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.25 -45.25 42.44 Favored 'Trans proline' 0 CA--C 1.51 -0.696 0 C-N-CA 124.639 3.559 . . . . 0.0 115.419 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -55.4 -32.88 63.02 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 120.675 1.579 . . . . 0.0 112.897 -176.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 122' ' ' ALA . . . . . . . . . . . . . . . -56.06 -20.15 15.81 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 120.774 -1.203 . . . . 0.0 113.121 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -119.11 -27.42 5.7 Favored 'General case' 0 C--O 1.221 -0.432 0 O-C-N 119.982 -1.699 . . . . 0.0 111.612 166.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -84.07 -11.08 57.26 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.26 -169.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -128.49 99.42 23.77 Favored Pre-proline 0 C--O 1.247 0.967 0 C-N-CA 119.314 -0.954 . . . . 0.0 111.096 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -64.19 69.25 0.21 Allowed 'Trans proline' 0 N--CA 1.441 -1.582 1 C-N-CA 125.62 4.213 . . . . 0.0 114.642 170.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -177.66 -28.11 0.01 OUTLIER 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 -174.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 128' ' ' SER . . . . . . . . . . . . . 66.2 m -59.46 129.39 86.94 Favored Pre-proline 0 C--O 1.222 -0.355 0 O-C-N 117.532 -3.23 . . . . 0.0 110.6 168.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 129' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -57.29 -46.82 25.54 Favored 'Trans proline' 0 N--CA 1.459 -0.522 1 C-N-CA 126.189 4.592 . . . . 0.0 115.738 -173.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 9.1 pt -84.11 63.7 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.842 0 CA-C-N 121.721 2.055 . . . . 0.0 111.038 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.75 153.44 43.36 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 118.111 2.634 . . . . 0.0 118.111 -168.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.15 22.83 77.46 Favored Glycine 0 C--O 1.213 -1.193 0 CA-C-N 110.232 -3.167 . . . . 0.0 111.553 177.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 133' ' ' MET . . . . . . . . . . . . . 34.0 tpp -74.15 119.32 75.76 Favored Pre-proline 0 C--O 1.238 0.481 0 CA-C-N 120.444 2.122 . . . . 0.0 107.956 -175.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.89 105.17 1.1 Allowed 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 121.112 1.208 . . . . 0.0 108.99 -175.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 4.5 m -117.93 103.71 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 103.503 -2.777 . . . . 0.0 103.503 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 42.2 mt -73.81 90.73 1.9 Allowed 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 110.777 -2.92 . . . . 0.0 113.123 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 51.68 -12.48 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 120.96 3.689 . . . . 0.0 120.96 163.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 8.4 p -80.8 82.88 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-N 125.177 3.626 . . . . 0.0 113.182 -171.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 44.6 p90 -163.71 173.12 13.27 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 111.799 -2.455 . . . . 0.0 106.754 173.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 140' ' ' LYS . . . . . . . . . . . . 0.398 25.2 pttm 68.31 -62.81 0.36 Allowed 'General case' 0 C--O 1.242 0.667 0 C-N-CA 128.233 2.613 . . . . 0.0 116.078 171.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.25 110.45 4.05 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-O 121.661 0.743 . . . . 0.0 111.961 169.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . 0.261 18.3 mm100 74.75 -163.27 0.08 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 172.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 143' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -91.03 69.37 6.26 Favored 'General case' 0 C--O 1.248 1.018 0 CA-C-O 124.605 2.145 . . . . 0.0 107.288 -159.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 144' ' ' VAL . . . . . . . . . . . . . 20.5 t -75.24 82.69 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 114.145 -1.389 . . . . 0.0 107.384 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 145' ' ' ILE . . . . . . . . . . . . . 1.3 mp -80.17 120.71 32.16 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -176.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 146' ' ' VAL . . . . . . . . . . . . . 92.9 t -98.6 115.53 39.19 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 N-CA-C 102.919 -2.993 . . . . 0.0 102.919 172.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 147' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -64.82 123.96 20.73 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.611 0.719 . . . . 0.0 111.739 173.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 148' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -126.54 146.41 50.14 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 2.1 tpp85 -89.02 -55.21 3.78 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 100.513 -3.884 . . . . 0.0 100.513 162.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 3.4 m -152.82 -179.82 7.98 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 167.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 10.6 tpt -115.61 111.83 21.23 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 171.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -84.13 -144.1 0.08 Allowed 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 111.802 -2.453 . . . . 0.0 107.371 167.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 91.8 m -97.01 133.9 41.08 Favored 'General case' 0 C--O 1.24 0.577 0 O-C-N 117.243 -3.411 . . . . 0.0 107.43 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -84.57 151.91 27.07 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 113.256 -1.793 . . . . 0.0 110.292 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 16.1 m-30 -59.93 -39.03 84.11 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 117.917 -3.107 . . . . 0.0 114.523 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 156' ' ' ALA . . . . . . . . . . . . . . . -85.17 -54.6 4.51 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 119.199 -2.188 . . . . 0.0 107.548 166.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 80.84 -77.25 2.03 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.302 -0.863 . . . . 0.0 114.56 171.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 20.2 m -63.57 159.93 3.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 117.73 2.493 . . . . 0.0 117.73 -162.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . 0.258 0.0 OUTLIER -2.48 104.56 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.527 1 N-CA-C 122.043 4.09 . . . . 0.0 122.043 -176.071 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' C' C ' 160' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -165.89 140.25 3.77 Favored Pre-proline 0 N--CA 1.434 -1.257 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.598 -173.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -45.56 -33.78 10.13 Favored 'Trans proline' 0 CA--C 1.512 -0.599 0 C-N-CA 123.521 2.814 . . . . 0.0 118.638 170.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 162' ' ' LEU . . . . . . . . . . . . . 6.6 tp -68.28 -25.75 65.31 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 121.575 -0.703 . . . . 0.0 111.608 -173.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 163' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -87.66 -39.15 15.26 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 120.483 -1.385 . . . . 0.0 113.553 165.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -74.78 -53.26 9.5 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 115.802 1.778 . . . . 0.0 115.802 -169.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 5.4 mtpt -69.8 165.49 21.35 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 117.876 2.547 . . . . 0.0 117.876 -160.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -39.84 65.49 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 127.106 2.162 . . . . 0.0 113.109 174.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -102.86 -46.19 4.76 Favored 'General case' 0 CA--C 1.498 -1.047 0 O-C-N 120.25 -1.531 . . . . 0.0 109.887 -174.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 168' ' ' THR . . . . . . . . . . . . . 54.4 m -74.27 91.84 2.2 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 102.92 -2.993 . . . . 0.0 102.92 161.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -132.08 135.38 46.41 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 -164.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 170' ' ' MET . . . . . . . . . . . . . 75.7 mtm -74.1 102.28 4.18 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 113.397 -1.729 . . . . 0.0 108.399 169.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 171' ' ' LEU . . . . . . . . . . . . . 54.6 tp -100.01 129.29 46.05 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 -173.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -76.4 96.29 3.99 Favored 'General case' 0 C--O 1.248 0.976 0 CA-C-O 123.969 1.842 . . . . 0.0 112.839 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -156.88 134.65 4.1 Favored Glycine 0 CA--C 1.503 -0.671 0 N-CA-C 106.323 -2.711 . . . . 0.0 106.323 168.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 174' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -60.17 143.12 53.17 Favored 'General case' 0 C--O 1.217 -0.631 0 O-C-N 121.734 -0.863 . . . . 0.0 111.296 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.48 -31.16 72.09 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -173.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.42 -61.53 1.7 Allowed 'General case' 0 C--O 1.236 0.357 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 168.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 177' ' ' ALA . . . . . . . . . . . . . . . -49.35 -44.76 44.88 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 -164.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 3.3 m -65.2 -42.59 93.38 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.58 177.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 179' ' ' VAL . . . . . . . . . . . . . 45.8 t -68.19 -40.95 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 119.451 1.023 . . . . 0.0 108.705 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -61.04 -28.98 69.45 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 114.996 -1.002 . . . . 0.0 113.184 174.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -77.69 -51.55 10.41 Favored 'General case' 0 N--CA 1.445 -0.688 0 O-C-N 117.366 -3.334 . . . . 0.0 112.323 171.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 182' ' ' ILE . . . . . . . . . . . . . 29.1 pt -62.68 -27.01 42.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 117.791 -1.1 . . . . 0.0 110.748 -174.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 183' ' ' LEU . . . . . . . . . . . . . 3.5 pp -58.42 -27.8 64.66 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 120.555 1.525 . . . . 0.0 114.315 174.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -94.38 -51.05 4.96 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -68.13 -72.57 0.17 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -175.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 186' ' ' LEU . . . . . 0.538 ' C ' ' HZ3' ' C' ' 28' ' ' LYS 0.293 0.5 OUTLIER . . . . . 0 CA--C 1.538 0.517 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -158.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' NAD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C 1001 ' ' NAP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 57.9 t-80 . . . . . 0 N--CA 1.44 -0.946 0 N-CA-C 106.322 -1.733 . . . . 65.739999999999995 106.322 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -52.48 88.01 0.01 OUTLIER Glycine 0 CA--C 1.526 0.753 0 O-C-N 119.562 -1.961 . . . . 48.659999999999997 110.462 160.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -130.1 131.39 45.71 Favored 'General case' 0 N--CA 1.431 -1.403 1 N-CA-C 97.445 -5.02 . . . . 44.560000000000002 97.445 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1003 ' ' ILE . . . . . . . . . . . . . 42.2 mt -100.46 112.18 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 N-CA-C 105.266 -2.124 . . . . 34.859999999999999 105.266 176.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -77.73 132.06 11.6 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 112.646 -2.07 . . . . 30.75 110.259 169.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 28.0 mm -119.18 91.05 43.07 Favored Pre-proline 0 CA--C 1.508 -0.642 0 N-CA-C 103.857 -2.645 . . . . 32.210000000000001 103.857 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -71.82 164.21 36.4 Favored 'Trans proline' 0 C--O 1.245 0.862 0 C-N-CA 123.421 2.747 . . . . 32.979999999999997 111.856 172.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1007 ' ' ARG . . . . . . . . . . . . . 40.0 ttp85 -87.22 141.83 28.36 Favored 'General case' 0 C--O 1.267 1.998 0 N-CA-C 103.401 -2.814 . . . . 47.979999999999997 103.401 161.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1008 ' ' GLU . . . . . 0.464 ' CD ' ' HZ1' ' A' 1071 ' ' LYS 0.267 22.3 mm-40 -63.95 150.26 45.49 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 114.298 1.222 . . . . 34.700000000000003 114.298 177.342 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 24.4 mtp-105 -121.01 37.81 4.23 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 115.356 1.613 . . . . 53.369999999999997 115.356 -175.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 11.1 tp -96.63 179.18 5.08 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.144 -1.058 . . . . 45.07 108.144 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1011 ' ' THR . . . . . . . . . . . . . 10.3 m -63.2 140.1 58.84 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 107.419 -1.326 . . . . 40.359999999999999 107.419 171.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 60.4 m-80 63.17 33.89 13.98 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 122.924 1.345 . . . . 40.609999999999999 114.501 169.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -98.4 151.02 21.01 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 116.898 2.185 . . . . 33.759999999999998 116.898 -158.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1014 ' ' THR . . . . . . . . . . . . . 5.0 m -136.13 -16.2 1.67 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 118.301 -0.857 . . . . 27.890000000000001 112.541 -177.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1015 ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -70.01 150.68 46.39 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 117.081 2.252 . . . . 29.02 117.081 -173.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1016 ' ' VAL . . . . . . . . . . . . . 4.3 p -113.96 166.76 7.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 103.976 -2.602 . . . . 28.129999999999999 103.976 159.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1017 ' ' ALA . . . . . . . . . . . . . . . -67.51 -47.88 68.67 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.099 -1.041 . . . . 26.870000000000001 113.205 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -146.68 133.44 20.03 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 118.635 -2.54 . . . . 26.77 109.071 -176.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1019 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.51 172.87 6.29 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-O 117.3 -1.333 . . . . 27.02 110.652 -177.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1020 ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -25.45 -71.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.006 1 C-N-CA 127.496 5.464 . . . . 30.57 119.573 178.41 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 14.3 mptt -54.58 -44.0 72.62 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 120.371 1.441 . . . . 47.810000000000002 114.082 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1022 ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.8 -37.33 85.97 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 120.017 1.281 . . . . 30.77 112.217 175.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1023 ' ' VAL . . . . . . . . . . . . . 25.5 t -59.52 -46.5 92.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 119.015 0.825 . . . . 33.590000000000003 110.3 170.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -59.95 -34.22 72.96 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 113.562 0.949 . . . . 53.289999999999999 113.562 172.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -64.36 -38.47 91.16 Favored 'General case' 0 N--CA 1.441 -0.883 0 O-C-N 120.73 -1.231 . . . . 46.920000000000002 112.122 171.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1026 ' ' LEU . . . . . . . . . . . . . 14.5 mt -68.37 -34.84 76.79 Favored 'General case' 0 C--O 1.249 1.078 0 O-C-N 121.082 -1.011 . . . . 37.170000000000002 110.195 175.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 10.8 mp -59.29 -42.58 91.61 Favored 'General case' 0 C--O 1.246 0.876 0 O-C-N 121.062 -1.024 . . . . 44.439999999999998 111.349 169.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -49.61 -51.21 39.03 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 124.361 1.038 . . . . 52.579999999999998 111.811 169.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1029 ' ' LEU . . . . . . . . . . . . . 59.7 mt -65.9 -11.64 48.55 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 114.279 1.214 . . . . 45.689999999999998 114.279 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 90.12 28.24 18.41 Favored Glycine 0 C--O 1.25 1.148 0 O-C-N 121.223 -0.923 . . . . 42.090000000000003 112.646 174.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -119.34 127.63 53.35 Favored 'General case' 0 CA--C 1.488 -1.413 0 CA-C-O 117.854 -1.069 . . . . 40.719999999999999 108.255 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1032 ' ' THR . . . . . . . . . . . . . 97.4 m -67.27 135.53 53.51 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 108.683 -0.858 . . . . 37.770000000000003 108.683 176.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1033 ' ' VAL . . . . . . . . . . . . . 57.9 t -103.53 134.41 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 O-C-N 119.365 -2.084 . . . . 33.539999999999999 108.353 -172.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -121.68 105.26 10.25 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 105.907 -1.886 . . . . 31.68 105.907 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1035 ' ' VAL . . . . . . . . . . . . . 21.9 t -99.16 138.69 22.84 Favored 'Isoleucine or valine' 0 C--O 1.246 0.917 0 CA-C-N 114.944 -1.026 . . . . 31.52 108.737 -173.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1036 ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -57.76 130.88 48.43 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 123.867 1.794 . . . . 41.039999999999999 113.277 173.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1037 ' ' SER . . . . . . . . . . . . . 7.1 t -60.89 132.67 54.59 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 113.176 -1.829 . . . . 31.829999999999998 112.746 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 77.02 -4.92 52.43 Favored Glycine 0 CA--C 1.525 0.696 0 O-C-N 119.876 -1.765 . . . . 29.359999999999999 111.54 173.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -62.61 -40.14 96.03 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 119.04 -2.447 . . . . 27.780000000000001 113.667 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -62.52 -18.73 59.21 Favored Glycine 0 C--O 1.25 1.121 0 N-CA-C 114.652 0.621 . . . . 28.91 114.652 -177.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -62.38 -47.53 83.74 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.099 -1.236 . . . . 51.18 110.957 173.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1042 ' ' LEU . . . . . . . . . . . . . 36.2 mt -64.39 -57.59 8.89 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.969 0.89 . . . . 29.91 112.528 167.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1043 ' ' ALA . . . . . . . . . . . . . . . -60.38 -7.57 2.12 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 115.241 1.571 . . . . 28.539999999999999 115.241 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1044 ' ' SER . . . . . . . . . . . . . 62.9 m 69.81 31.47 3.48 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 125.393 1.477 . . . . 33.060000000000002 111.2 169.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1045 ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -157.95 107.06 2.06 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 102.44 -3.17 . . . . 30.289999999999999 102.44 169.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1046 ' ' ASP . . . . . 0.449 ' CG ' ' HZ1' ' A' 1048 ' ' LYS . 0.3 OUTLIER -79.74 174.22 11.81 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 117.372 2.36 . . . . 48.619999999999997 117.372 -148.094 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 28.9 t70 -47.7 -49.64 27.26 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 112.659 -2.064 . . . . 36.740000000000002 113.355 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1048 ' ' LYS . . . . . 0.449 ' HZ1' ' CG ' ' A' 1046 ' ' ASP . 24.8 pttm -75.27 -26.72 59.01 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 120.947 -1.096 . . . . 43.729999999999997 110.206 176.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -62.35 -29.98 70.84 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 118.162 -2.837 . . . . 32.810000000000002 110.874 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1050 ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -62.46 -41.13 98.54 Favored 'General case' 0 C--O 1.219 -0.536 0 O-C-N 121.72 -0.613 . . . . 31.859999999999999 111.345 171.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 25.6 t -66.26 -40.81 87.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 119.889 -0.724 . . . . 33.219999999999999 111.771 172.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -56.68 -40.85 76.27 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 122.243 1.021 . . . . 50.829999999999998 111.163 176.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -61.98 -50.38 72.33 Favored 'General case' 0 C--O 1.263 1.815 0 N-CA-C 113.596 0.961 . . . . 33.119999999999997 113.596 168.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 131.65 47.63 0.12 Allowed Glycine 0 N--CA 1.443 -0.886 0 CA-C-O 119.337 -0.702 . . . . 35.829999999999998 113.617 175.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -126.82 150.53 49.14 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 114.698 1.37 . . . . 34.82 114.698 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -73.51 125.64 28.4 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 105.732 -1.951 . . . . 49.049999999999997 105.732 174.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1057 ' ' ILE . . . . . . . . . . . . . 6.9 mm -89.52 125.46 42.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 106.203 -1.777 . . . . 38.530000000000001 106.203 173.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1058 ' ' VAL . . . . . . . . . . . . . 29.8 m -115.99 135.15 57.06 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 107.609 -1.256 . . . . 42.109999999999999 107.609 -177.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -75.74 79.13 2.69 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-O 122.696 1.236 . . . . 58.0 114.169 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 76.2 -123.77 7.01 Favored Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 107.739 -2.145 . . . . 52.119999999999997 107.739 171.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 39.7 t30 -47.92 -23.65 0.83 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 118.476 2.769 . . . . 54.75 118.476 -172.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1062 ' ' SER . . . . . . . . . . . . . 1.3 m -53.26 -24.38 11.29 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 116.212 1.93 . . . . 50.340000000000003 116.212 171.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 6.1 p -44.71 -35.24 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 116.423 2.008 . . . . 41.460000000000001 116.423 172.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1064 ' ' TRP . . . . . . . . . . . . . 46.0 m95 -73.25 -22.41 60.41 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-N 119.64 1.109 . . . . 39.32 111.941 -169.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -69.22 70.39 0.24 Allowed 'General case' 0 CA--C 1.547 0.859 0 O-C-N 119.414 -2.054 . . . . 55.380000000000003 110.676 172.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1066 ' ' SER . . . . . . . . . . . . . 72.3 m -160.17 123.17 3.44 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 101.457 -3.535 . . . . 41.869999999999997 101.457 -171.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -74.56 2.08 10.54 Favored 'General case' 0 CA--C 1.508 -0.646 0 O-C-N 120.924 -1.11 . . . . 53.200000000000003 112.285 -178.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 4.9 mp -130.19 129.11 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 104.05 -2.574 . . . . 41.899999999999999 104.05 167.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1069 ' ' ILE . . . . . . . . . . . . . 25.7 mm -125.58 120.57 58.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 104.972 -2.233 . . . . 38.729999999999997 104.972 171.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1070 ' ' LEU . . . . . . . . . . . . . 80.1 mt -101.75 133.95 45.68 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.061 -2.2 . . . . 32.439999999999998 105.061 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1071 ' ' LYS . . . . . 0.464 ' HZ1' ' CD ' ' A' 1008 ' ' GLU . 2.5 mmmp? -133.68 141.78 47.73 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.134 -1.432 . . . . 34.649999999999999 107.134 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1072 ' ' VAL . . . . . . . . . . . . . 2.4 t -92.16 -4.1 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.016 0 O-C-N 119.87 -1.769 . . . . 31.32 111.031 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -142.09 159.41 42.28 Favored 'General case' 0 C--O 1.256 1.396 0 N-CA-C 102.393 -3.188 . . . . 33.939999999999998 102.393 173.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -42.1 140.89 1.47 Allowed Pre-proline 0 C--O 1.239 0.515 0 C-N-CA 124.872 1.269 . . . . 38.039999999999999 113.25 171.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1075 ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -67.36 99.67 0.52 Allowed 'Trans proline' 0 CA--C 1.492 -1.589 0 C-N-CA 122.18 1.92 . . . . 42.68 107.595 165.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 38.9 mt -73.02 167.35 21.28 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 112.219 -2.264 . . . . 46.740000000000002 108.61 -173.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -43.15 -32.94 0.8 Allowed 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 120.46 3.504 . . . . 58.609999999999999 120.46 -175.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 16.0 t70 -75.09 -44.08 49.44 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 118.412 -0.804 . . . . 59.200000000000003 109.772 176.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1079 ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -59.73 -40.63 88.65 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 119.525 -0.87 . . . . 50.630000000000003 112.378 173.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1080 ' ' ILE . . . . . . . . . . . . . 74.5 mt -54.15 -49.56 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 O-C-N 124.443 1.09 . . . . 51.479999999999997 108.36 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -57.15 -33.82 67.79 Favored 'General case' 0 C--O 1.249 1.075 0 N-CA-C 112.864 0.69 . . . . 50.280000000000001 112.864 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 42.0 mt -87.4 -16.75 34.03 Favored 'General case' 0 C--N 1.334 -0.078 0 O-C-N 120.29 -1.506 . . . . 50.210000000000001 114.239 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1083 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.81 132.88 48.23 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 118.841 -2.412 . . . . 49.060000000000002 116.476 -162.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 31.7 t30 -76.86 123.77 87.48 Favored Pre-proline 0 N--CA 1.452 -0.339 0 CA-C-N 114.293 -1.321 . . . . 51.079999999999998 113.651 174.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -61.27 155.59 50.74 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 124.249 3.3 . . . . 49.729999999999997 115.939 173.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 68.45 66.16 2.4 Favored Glycine 0 C--O 1.215 -1.058 0 CA-C-O 124.63 2.239 . . . . 47.710000000000001 109.539 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1087 ' ' THR . . . . . . . . . . . . . 33.0 m -146.22 137.75 24.74 Favored 'General case' 0 C--O 1.252 1.23 0 O-C-N 119.631 -2.1 . . . . 45.469999999999999 107.519 -171.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1088 ' ' THR . . . . . . . . . . . . . 3.0 m -80.21 94.98 6.15 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 104.169 -2.53 . . . . 42.039999999999999 104.169 165.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1089 ' ' LEU . . . . . . . . . . . . . 27.7 tp -94.35 87.71 5.29 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 106.469 -1.678 . . . . 38.060000000000002 106.469 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 33.8 t -92.95 121.1 43.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 104.544 -2.391 . . . . 37.399999999999999 104.544 -176.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1091 ' ' SER . . . . . . . . . . . . . 26.7 m -153.37 151.83 30.38 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.857 -1.152 . . . . 36.159999999999997 112.673 -169.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 5.2 t80 -77.92 109.73 12.21 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 118.748 -2.47 . . . . 38.939999999999998 105.561 169.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 29.9 mm -90.56 -45.46 14.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 113.295 0.85 . . . . 42.170000000000002 113.295 -168.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 86.3 m95 54.61 66.36 4.21 Favored Pre-proline 0 C--O 1.245 0.827 0 O-C-N 124.485 1.115 . . . . 46.509999999999998 111.423 -157.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -52.0 -36.08 63.51 Favored 'Trans proline' 0 N--CA 1.449 -1.124 1 C-N-CA 125.801 4.334 . . . . 49.759999999999998 116.268 -175.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -72.35 -31.88 66.0 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-N 119.334 0.97 . . . . 52.619999999999997 108.84 -177.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 10.2 mp0 -77.95 -20.65 52.33 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 118.858 0.754 . . . . 60.740000000000002 112.243 172.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1098 ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -118.99 38.85 0.29 Allowed Pre-proline 0 N--CA 1.44 -0.958 0 N-CA-C 117.945 2.572 . . . . 58.189999999999998 117.945 -172.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -66.87 -24.59 46.24 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 124.569 3.513 . . . . 54.590000000000003 113.04 -168.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.99 -39.0 18.58 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 113.05 0.759 . . . . 63.280000000000001 113.05 175.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1101 ' ' LEU . . . . . . . . . . . . . 10.2 tt -54.97 -39.78 69.32 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 109.765 -0.458 . . . . 54.75 109.765 166.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1102 ' ' MET . . . . . . . . . . . . . 49.2 mmm -57.74 -45.05 86.36 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.677 -1.264 . . . . 52.649999999999999 114.156 175.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -54.78 -43.35 72.75 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 112.536 0.569 . . . . 66.260000000000005 112.536 174.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 82.5 mttt -71.09 -41.67 70.32 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.435 0.636 . . . . 63.729999999999997 112.102 -175.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 71.8 mt -68.53 -32.38 72.29 Favored 'General case' 0 C--O 1.241 0.618 0 O-C-N 120.572 -1.33 . . . . 54.68 112.874 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -57.72 -51.52 69.2 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 120.455 1.479 . . . . 53.640000000000001 108.203 167.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -57.08 -25.68 59.14 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 122.14 2.246 . . . . 67.239999999999995 115.001 169.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -80.01 -3.85 50.15 Favored 'General case' 0 C--N 1.361 1.085 0 CA-C-N 121.177 1.808 . . . . 65.760000000000005 111.191 171.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 24.9 t-20 62.7 47.67 4.62 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 122.744 1.259 . . . . 58.710000000000001 109.578 168.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1110 ' ' VAL . . . . . . . . . . . . . 17.3 m -118.06 145.71 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 O-C-N 121.558 -0.714 . . . . 46.630000000000003 111.607 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1111 ' ' THR . . . . . . . . . . . . . 49.2 m -83.62 94.63 8.14 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-O 123.156 1.455 . . . . 44.130000000000003 107.681 174.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1112 ' ' VAL . . . . . . . . . . . . . 82.8 t -89.94 118.93 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.008 0 CA-C-N 113.624 -1.625 . . . . 40.439999999999998 109.414 -174.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1113 ' ' MET . . . . . . . . . . . . . 63.6 mtp -109.75 108.59 19.0 Favored 'General case' 0 C--O 1.252 1.229 0 N-CA-C 107.547 -1.279 . . . . 50.759999999999998 107.547 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1114 ' ' ALA . . . . . . . . . . . . . . . -85.12 108.42 17.67 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-O 123.736 1.731 . . . . 35.640000000000001 110.653 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1115 ' ' MET . . . . . . . . . . . . . 61.8 mmm -69.39 -14.35 62.86 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 112.049 -2.342 . . . . 38.740000000000002 115.467 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 3.6 p30 -71.14 -36.25 72.01 Favored 'General case' 0 C--N 1.352 0.674 0 CA-C-N 120.189 1.359 . . . . 40.140000000000001 111.122 162.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1117 ' ' SER . . . . . . . . . . . . . 49.2 m -80.97 23.33 0.56 Allowed 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 125.121 1.513 . . . . 44.789999999999999 114.551 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1118 ' ' VAL . . . . . . . . . . . . . 16.5 t -70.3 131.41 88.55 Favored Pre-proline 0 N--CA 1.445 -0.681 0 N-CA-C 104.576 -2.379 . . . . 43.75 104.576 166.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -58.36 146.25 90.48 Favored 'Trans proline' 0 C--O 1.252 1.216 0 C-N-CA 122.63 2.22 . . . . 48.93 113.556 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -66.6 -10.31 44.41 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 120.691 -1.255 . . . . 62.899999999999999 113.0 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 50.0 pt -62.19 152.19 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 N-CA-C 114.003 1.112 . . . . 57.719999999999999 114.003 -177.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1122 ' ' SER . . . . . . . . . . . . . 6.5 m -48.52 -52.63 21.61 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 118.304 2.705 . . . . 57.259999999999998 118.304 -177.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -56.64 -22.62 35.69 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 118.386 -2.696 . . . . 62.899999999999999 113.423 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -90.04 -21.52 22.31 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 117.025 -1.464 . . . . 49.829999999999998 111.773 -172.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -61.67 -26.73 68.2 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 116.444 2.016 . . . . 52.369999999999997 116.444 -163.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1126 ' ' SER . . . . . . . . . . . . . 5.8 p -66.83 -37.77 85.13 Favored 'General case' 0 C--O 1.245 0.821 0 O-C-N 119.058 -2.276 . . . . 42.43 111.999 170.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1127 ' ' LEU . . . . . . . . . . . . . 3.5 mp -77.23 -31.16 54.94 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 122.95 1.357 . . . . 43.740000000000002 110.739 176.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 6.1 t70 -53.82 109.78 0.5 Allowed 'General case' 0 C--O 1.252 1.227 0 CA-C-O 123.965 1.84 . . . . 43.210000000000001 113.649 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -80.06 -31.65 39.39 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 111.62 -2.536 . . . . 35.740000000000002 112.687 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 36.0 tp -54.45 -51.64 64.35 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.775 0.716 . . . . 38.090000000000003 110.538 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1131 ' ' SER . . . . . . . . . . . . . 7.3 m -50.47 -49.26 55.69 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.715 1.206 . . . . 36.909999999999997 111.347 174.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1132 ' ' SER . . . . . . . . . . . . . 1.4 m -73.28 -42.29 62.61 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 115.676 -0.693 . . . . 35.789999999999999 111.123 -171.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1133 ' ' MET . . . . . . . . . . . . . 28.6 mtp -63.2 -43.09 99.15 Favored 'General case' 0 N--CA 1.433 -1.308 0 O-C-N 120.479 -1.388 . . . . 30.809999999999999 110.564 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1134 ' ' ALA . . . . . . . . . . . . . . . -52.09 -47.17 65.38 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 122.99 1.376 . . . . 28.879999999999999 112.903 168.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1135 ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -59.01 -48.21 82.4 Favored 'General case' 0 C--N 1.347 0.463 0 O-C-N 120.832 -1.168 . . . . 40.759999999999998 112.18 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1136 ' ' ILE . . . . . . . . . . . . . 61.3 mt -59.18 -46.48 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 108.782 -0.821 . . . . 31.539999999999999 108.782 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -61.39 -30.46 70.56 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 115.905 -1.998 . . . . 29.870000000000001 112.771 175.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -75.14 -39.8 36.18 Favored Glycine 0 CA--C 1.499 -0.932 0 CA-C-N 121.472 1.942 . . . . 28.73 109.814 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 25.5 t80 -65.62 -45.68 82.18 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.21 -1.033 . . . . 30.390000000000001 108.21 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1140 ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -69.19 -24.82 64.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.906 0.86 . . . . 26.09 112.536 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1141 ' ' ALA . . . . . . . . . . . . . . . -62.13 -45.14 94.77 Favored 'General case' 0 C--O 1.245 0.858 0 O-C-N 120.353 -1.467 . . . . 27.100000000000001 109.409 168.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 46.7 mm -58.52 -44.48 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 120.444 1.475 . . . . 28.48 114.538 172.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 28.8 t -53.1 -59.62 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 114.72 -1.127 . . . . 23.07 111.266 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1144 ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -75.27 -23.9 57.51 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.982 -0.377 . . . . 33.399999999999999 109.982 -171.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -62.12 -51.55 67.44 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.334 -0.987 . . . . 24.219999999999999 108.334 171.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -64.07 -28.06 69.53 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 123.8 0.84 . . . . 24.890000000000001 112.348 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -65.51 -40.28 92.82 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 118.763 -0.637 . . . . 26.73 110.832 171.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1148 ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -101.68 5.78 41.6 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 119.009 -2.307 . . . . 39.960000000000001 113.043 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1149 ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -76.15 144.9 40.29 Favored 'General case' 0 CA--C 1.514 -0.427 0 O-C-N 120.067 -1.645 . . . . 25.870000000000001 112.816 -169.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1150 ' ' GLY . . . . . . . . . . . . . . . -71.21 -48.97 28.8 Favored Glycine 0 C--O 1.218 -0.9 0 N-CA-C 109.799 -1.32 . . . . 19.280000000000001 109.799 172.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1151 ' ' ARG . . . . . . . . . . . . . 74.2 mtm-85 -99.57 -172.17 2.2 Favored 'General case' 0 C--N 1.318 -0.795 0 O-C-N 120.906 -1.35 . . . . 39.899999999999999 114.071 -172.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1152 ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -96.51 144.69 26.36 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 103.856 -2.646 . . . . 29.440000000000001 103.856 177.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1153 ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -64.21 -57.19 10.2 Favored 'General case' 0 C--N 1.341 0.224 0 O-C-N 121.211 -0.931 . . . . 32.600000000000001 110.039 168.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1154 ' ' THR . . . . . . . . . . . . . 90.8 m -61.8 123.95 19.41 Favored 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 126.431 1.893 . . . . 34.640000000000001 116.015 -177.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -71.78 73.43 0.81 Allowed Glycine 0 N--CA 1.439 -1.158 0 CA-C-O 126.052 3.029 . . . . 37.140000000000001 111.259 175.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -108.93 136.2 48.86 Favored 'General case' 0 N--CA 1.434 -1.232 0 O-C-N 118.588 -2.713 . . . . 40.57 115.876 -177.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1157 ' ' ILE . . . . . . . . . . . . . 4.5 tp -90.87 110.2 21.97 Favored 'Isoleucine or valine' 0 C--O 1.256 1.431 0 CA-C-N 113.361 -1.745 . . . . 44.609999999999999 106.673 171.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1158 ' ' THR . . . . . . . . . . . . . 17.5 m -78.15 177.11 8.62 Favored 'General case' 0 C--O 1.252 1.202 0 O-C-N 120.87 -1.144 . . . . 40.700000000000003 110.563 169.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -65.09 -23.24 67.1 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 116.97 -3.581 . . . . 40.25 111.171 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -134.35 131.01 37.8 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 104.828 -2.286 . . . . 38.469999999999999 104.828 159.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . 111.93 115.05 3.42 Favored Glycine 0 C--O 1.247 0.93 0 C-N-CA 119.572 -1.299 . . . . 37.609999999999999 112.095 170.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 15.8 tttp -85.7 130.87 34.45 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 104.456 -2.424 . . . . 48.899999999999999 104.456 169.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1163 ' ' VAL . . . . . . . . . . . . . 69.7 t -85.98 128.19 59.09 Favored Pre-proline 0 N--CA 1.42 -1.933 0 O-C-N 120.01 -1.681 . . . . 36.520000000000003 107.896 164.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1164 ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -72.26 108.23 2.44 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.516 2.144 . . . . 35.079999999999998 108.904 155.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1165 ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -56.34 148.25 62.67 Favored 'Trans proline' 0 N--CA 1.444 -1.394 1 C-N-CA 126.314 4.676 . . . . 35.329999999999998 115.289 -176.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -66.12 129.02 38.39 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 125.159 1.537 . . . . 34.689999999999998 110.962 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1167 ' ' LYS . . . . . . . . . . . . . 64.4 mttp -92.41 106.99 18.88 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 105.17 -2.159 . . . . 45.359999999999999 105.17 172.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 60.6 t -91.58 91.57 3.57 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 106.967 -1.494 . . . . 31.710000000000001 106.967 -175.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1169 ' ' MET . . . . . . . . . . . . . 25.1 ttp -79.29 92.11 5.1 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 124.593 2.14 . . . . 42.280000000000001 108.717 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 13.8 t -75.29 115.14 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 112.128 -2.305 . . . . 30.510000000000002 106.629 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 64.5 mt -104.07 123.59 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 104.528 -2.397 . . . . 31.870000000000001 104.528 176.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 79.32 79.25 0.83 Allowed Glycine 0 CA--C 1.493 -1.332 0 CA-C-O 123.796 1.776 . . . . 34.539999999999999 109.81 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1173 ' ' ALA . . . . . . . . . . . . . . . -75.7 179.86 5.15 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 123.417 1.58 . . . . 32.509999999999998 109.669 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . 138.92 -157.69 24.89 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 106.182 -2.767 . . . . 29.899999999999999 106.182 -175.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1175 ' ' VAL . . . . . . . . . . . . . 34.3 t -70.49 -30.06 41.19 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 CA-C-N 122.188 2.994 . . . . 33.109999999999999 110.66 -170.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -65.35 -41.73 93.57 Favored 'General case' 0 C--N 1.348 0.517 0 CA-C-O 122.343 1.068 . . . . 28.100000000000001 108.832 171.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -60.67 -42.45 99.32 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 124.478 2.154 . . . . 28.539999999999999 109.997 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1178 ' ' LEU . . . . . . . . . . . . . 72.8 mt -67.83 -35.69 79.05 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 113.403 -1.399 . . . . 31.219999999999999 111.052 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -64.99 -44.59 88.79 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-N 122.832 2.56 . . . . 28.98 108.822 175.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -55.25 -45.46 76.08 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 126.317 2.26 . . . . 27.829999999999998 113.085 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1181 ' ' ILE . . . . . . . . . . . . . 33.5 mt -63.62 -54.28 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 O-C-N 120.237 -1.54 . . . . 30.25 108.819 175.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -52.29 -26.02 20.52 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 112.668 -2.06 . . . . 29.59 112.761 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -85.24 -60.25 2.09 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 115.323 1.601 . . . . 30.289999999999999 115.323 165.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -74.8 -39.73 61.52 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 115.386 1.624 . . . . 30.469999999999999 115.386 -167.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -60.22 -43.49 95.96 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 119.759 -1.838 . . . . 42.409999999999997 109.685 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1186 ' ' SER . . . . . . . . . . . . . 21.4 m -58.39 -46.11 87.03 Favored 'General case' 0 C--O 1.213 -0.827 0 CA-C-O 121.957 0.885 . . . . 39.380000000000003 111.078 175.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 44.0 mt -62.47 -30.44 71.26 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 114.909 1.448 . . . . 36.18 114.909 174.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 103.36 42.38 2.04 Favored Glycine 0 N--CA 1.428 -1.879 0 CA-C-N 114.839 -1.073 . . . . 33.780000000000001 111.015 176.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -115.9 144.2 44.38 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 106.915 -1.513 . . . . 33.93 106.915 174.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 45.7 mt -72.07 102.63 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 O-C-N 120.226 -1.546 . . . . 38.740000000000002 110.375 -174.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 17.0 t -86.84 121.27 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 O-C-N 119.817 -1.802 . . . . 33.090000000000003 106.854 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1192 ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -115.68 105.33 12.63 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 105.321 -2.103 . . . . 38.920000000000002 105.321 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -102.73 124.67 48.69 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 118.928 -1.109 . . . . 35.32 110.482 -176.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 69.7 t80 -110.59 140.74 44.63 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 122.133 0.968 . . . . 39.350000000000001 109.419 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 7.1 t0 -157.52 150.12 22.95 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.182 -1.044 . . . . 40.460000000000001 108.182 174.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1196 ' ' THR . . . . . . . . . . . . . 8.7 m -58.31 -38.98 78.16 Favored 'General case' 0 N--CA 1.445 -0.698 0 O-C-N 128.391 3.557 . . . . 45.939999999999998 109.493 171.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1197 ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -87.73 110.92 38.6 Favored Pre-proline 0 C--N 1.318 -0.776 0 C-N-CA 126.67 1.988 . . . . 56.020000000000003 109.777 -172.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1198 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -66.32 -13.32 39.38 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 121.457 1.438 . . . . 51.270000000000003 112.072 166.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -52.8 -30.49 33.54 Favored 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 118.66 -2.525 . . . . 59.100000000000001 115.1 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 35.6 m -93.92 -9.84 9.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 114.235 1.198 . . . . 51.060000000000002 114.235 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 86.4 tttt -52.17 -61.52 2.21 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 114.991 1.478 . . . . 57.380000000000003 114.991 -174.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 23.7 mp0 -69.37 -22.27 63.74 Favored 'General case' 0 C--O 1.211 -0.955 0 CA-C-N 119.934 1.243 . . . . 62.409999999999997 112.567 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -63.84 -50.79 67.51 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 113.174 0.805 . . . . 57.780000000000001 113.174 170.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 47.4 t -58.98 -41.01 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 113.751 -1.568 . . . . 46.380000000000003 110.634 173.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -68.19 -29.37 68.21 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 115.401 1.63 . . . . 50.700000000000003 115.401 173.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1206 ' ' SER . . . . . . . . . . . . . 64.0 m -74.59 -31.37 62.01 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 121.062 -1.024 . . . . 49.979999999999997 110.872 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1207 ' ' MET . . . . . . . . . . . . . 36.8 mtp -79.68 -15.2 58.0 Favored 'General case' 0 C--O 1.249 1.045 0 O-C-N 120.745 -1.222 . . . . 52.990000000000002 113.469 170.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 97.53 83.83 1.72 Allowed Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 109.009 -1.636 . . . . 47.659999999999997 109.009 173.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -161.27 145.82 13.49 Favored 'General case' 0 C--N 1.289 -2.03 0 O-C-N 119.093 -2.416 . . . . 44.770000000000003 107.311 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -76.76 123.04 25.59 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 103.74 -2.689 . . . . 47.640000000000001 103.74 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1211 ' ' PHE . . . . . . . . . . . . . 11.9 t80 -89.01 136.52 32.97 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 106.606 -1.627 . . . . 45.659999999999997 106.606 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 68.4 mt -94.51 119.22 32.87 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 107.521 -1.288 . . . . 46.060000000000002 107.521 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -71.76 144.25 49.28 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 112.79 -2.004 . . . . 60.219999999999999 111.875 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 17.2 tp -73.66 89.13 1.74 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 109.504 -3.498 . . . . 57.25 112.421 -171.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 23.6 t0 -71.53 87.09 0.89 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 114.086 1.143 . . . . 64.430000000000007 114.086 -174.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 85.4 t80 . . . . . 0 C--O 1.202 -1.413 0 O-C-N 124.794 1.309 . . . . 66.900000000000006 107.814 -170.507 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 30.9 t70 . . . . . 0 N--CA 1.447 -0.578 0 N-CA-C 107.071 -1.455 . . . . 39.090000000000003 107.071 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -67.34 -41.87 90.75 Favored Glycine 0 C--N 1.347 1.17 0 CA-C-N 114.484 -1.235 . . . . 39.32 111.598 -173.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 51.0 t80 -73.4 -42.09 62.53 Favored 'General case' 0 CA--C 1.504 -0.788 0 CA-C-O 118.151 -0.928 . . . . 39.299999999999997 108.696 -177.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -62.04 -38.51 89.01 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-N 119.539 1.063 . . . . 36.299999999999997 109.226 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -57.11 -45.94 83.02 Favored 'General case' 0 C--O 1.207 -1.159 0 CA-C-O 117.903 -1.046 . . . . 37.380000000000003 111.241 172.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -53.79 -31.12 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 113.15 0.796 . . . . 39.109999999999999 113.15 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1230 ' ' MET . . . . . . . . . . . . . 38.1 mmt -81.36 -23.97 37.37 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 116.394 1.998 . . . . 49.590000000000003 116.394 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1231 ' ' SER . . . . . . . . . . . . . 54.0 p -67.77 133.69 49.68 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.194 0.812 . . . . 43.68 113.194 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -50.23 -40.52 47.82 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 116.282 1.956 . . . . 55.57 116.282 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -64.72 -33.12 75.21 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 122.16 0.981 . . . . 44.939999999999998 110.271 178.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 26.0 t80 -76.16 -46.48 28.37 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.365 -0.834 . . . . 42.039999999999999 109.041 -178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 12.2 mt -59.26 -31.43 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 122.344 -0.222 . . . . 46.280000000000001 111.377 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 53.3 tttm -62.48 -48.46 79.51 Favored 'General case' 0 C--O 1.245 0.867 0 O-C-N 119.531 -1.981 . . . . 47.869999999999997 109.0 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -58.83 -51.68 68.98 Favored 'General case' 0 C--O 1.247 0.931 0 N-CA-C 113.859 1.059 . . . . 41.609999999999999 113.859 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -54.79 -53.67 52.16 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 114.615 -1.175 . . . . 50.649999999999999 109.629 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1239 ' ' MET . . . . . . . . . . . . . 43.1 ttm -57.95 -41.36 82.66 Favored 'General case' 0 C--O 1.22 -0.484 0 O-C-N 123.694 0.621 . . . . 48.869999999999997 110.582 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -76.48 -22.5 54.44 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 120.119 -1.613 . . . . 54.799999999999997 111.725 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 1.3 tm? -66.9 -47.35 72.08 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.512 -1.662 . . . . 43.210000000000001 106.512 169.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -60.05 -36.51 77.47 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-O 118.701 -0.666 . . . . 38.659999999999997 110.283 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -67.19 -47.96 69.37 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 121.003 1.729 . . . . 37.920000000000002 111.353 -177.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -56.97 -55.19 37.88 Favored 'General case' 0 C--O 1.249 1.047 0 O-C-N 121.357 -0.839 . . . . 37.280000000000001 110.769 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -55.95 -36.33 67.66 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.743 1.217 . . . . 43.07 113.943 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -56.46 -30.4 62.85 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.996 1.11 . . . . 38.299999999999997 113.996 -176.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1247 ' ' LYS . . . . . . . . . . . . . 16.4 mtmt -78.89 -10.63 59.87 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 114.94 1.459 . . . . 47.600000000000001 114.94 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -121.18 -16.53 7.95 Favored 'General case' 0 C--O 1.246 0.899 0 O-C-N 119.0 -2.313 . . . . 45.420000000000002 114.858 173.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1249 ' ' VAL . . . . . . . . . . . . . 27.7 m -85.33 175.21 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 O-C-N 119.199 -2.188 . . . . 36.259999999999998 111.193 -175.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1250 ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -134.27 -61.83 0.77 Allowed 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 112.818 -1.992 . . . . 33.039999999999999 109.371 -169.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1251 ' ' ILE . . . . . . . . . . . . . 39.3 mm -108.61 94.99 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 107.002 -1.481 . . . . 31.399999999999999 107.002 -173.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1252 ' ' ILE . . . . . . . . . . . . . 44.2 mt -77.7 107.65 9.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 106.13 -1.804 . . . . 29.420000000000002 106.13 171.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 5.5 t -99.28 105.19 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 104.635 -2.357 . . . . 30.370000000000001 104.635 173.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1254 ' ' THR . . . . . . . . . . . . . 29.1 m -74.37 84.58 1.95 Allowed 'General case' 0 C--O 1.248 1.004 0 CA-C-O 122.732 1.253 . . . . 35.719999999999999 109.561 171.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1255 ' ' THR . . . . . . . . . . . . . 1.1 p -75.89 -4.28 39.98 Favored 'General case' 0 C--O 1.25 1.093 0 N-CA-C 115.067 1.506 . . . . 36.0 115.067 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1256 ' ' ALA . . . . . . . . . . . . . . . -69.34 86.94 0.43 Allowed 'General case' 0 C--O 1.246 0.878 0 CA-C-O 121.65 0.738 . . . . 40.93 109.41 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 8.8 tp -73.13 91.96 1.67 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 105.653 -1.98 . . . . 47.82 105.653 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 41.8 mm -69.49 131.46 89.96 Favored Pre-proline 0 C--O 1.213 -0.865 0 CA-C-N 112.838 -1.983 . . . . 52.700000000000003 109.048 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -99.41 124.74 0.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.816 2.344 . . . . 54.130000000000003 114.387 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 78.2 -83.63 1.19 Allowed Glycine 0 C--N 1.343 0.962 0 CA-C-O 124.698 2.277 . . . . 54.619999999999997 114.786 173.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 55.2 pttt -42.84 146.91 0.7 Allowed Pre-proline 0 C--O 1.257 1.474 0 N-CA-C 117.711 2.486 . . . . 55.740000000000002 117.711 171.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -57.22 142.65 94.63 Favored 'Trans proline' 0 N--CA 1.451 -0.999 1 C-N-CA 125.336 4.024 . . . . 51.149999999999999 112.579 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -66.93 123.51 86.32 Favored Pre-proline 0 C--N 1.343 0.307 0 CA-C-N 113.446 -1.706 . . . . 46.060000000000002 111.169 174.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -58.43 115.58 2.64 Favored 'Trans proline' 0 CA--C 1.509 -0.743 0 C-N-CA 123.792 2.995 . . . . 41.079999999999998 115.769 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -75.6 89.58 2.76 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 122.495 1.141 . . . . 47.420000000000002 108.83 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 37.7 mt -97.67 -45.87 6.21 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.243 -1.391 . . . . 39.219999999999999 107.243 -177.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 7.9 mt -87.37 93.99 4.35 Favored 'Isoleucine or valine' 0 C--O 1.252 1.224 0 CA-C-O 126.19 2.9 . . . . 42.5 107.739 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1268 ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.75 143.68 30.01 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 111.97 -2.377 . . . . 37.840000000000003 112.383 175.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 56.3 mtt-85 -47.51 -39.18 15.54 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.072 0.949 . . . . 54.799999999999997 112.199 175.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -56.72 -50.09 73.24 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.388 -1.445 . . . . 54.359999999999999 109.154 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1271 ' ' MET . . . . . . . . . . . . . 10.0 mtt -68.78 -25.36 64.67 Favored 'General case' 0 CA--C 1.497 -1.09 0 O-C-N 123.789 0.68 . . . . 39.520000000000003 111.189 -170.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1272 ' ' VAL . . . . . . . . . . . . . 59.1 t -66.56 -49.62 73.5 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 O-C-N 126.179 2.174 . . . . 38.25 110.473 175.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -68.58 -26.43 65.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 119.985 -1.697 . . . . 40.770000000000003 112.445 174.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1274 ' ' SER . . . . . . . . . . . . . 7.2 m -68.76 -11.84 60.79 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 120.527 1.512 . . . . 36.579999999999998 114.442 169.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1275 ' ' MET . . . . . . . . . . . . . 62.7 mtp -62.52 145.69 53.63 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-O 124.478 2.085 . . . . 36.75 111.005 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1276 ' ' LYS . . . . . . . . . . . . . 74.1 tttt -50.64 137.38 19.88 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 110.967 -2.833 . . . . 46.109999999999999 106.468 165.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1277 ' ' ALA . . . . . . . . . . . . . . . -90.94 176.85 6.46 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 117.9 -1.52 . . . . 33.520000000000003 110.472 -169.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 63.42 31.01 79.31 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 111.404 -0.679 . . . . 31.27 111.404 -170.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1279 ' ' SER . . . . . . . . . . . . . 15.2 m -122.32 171.93 8.68 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 120.587 -1.537 . . . . 32.950000000000003 110.528 -171.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1280 ' ' VAL . . . . . . . . . . . . . 41.7 t -134.45 136.27 53.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 O-C-N 120.822 -1.174 . . . . 27.43 110.425 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1281 ' ' ILE . . . . . . . . . . . . . 66.0 mt -113.37 109.02 27.01 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 N-CA-C 103.122 -2.918 . . . . 30.300000000000001 103.122 170.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 2.4 t -101.15 97.86 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 105.104 -2.184 . . . . 28.629999999999999 105.104 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 9.4 t70 -95.63 101.18 12.86 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 113.568 -1.651 . . . . 36.270000000000003 107.155 -171.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1284 ' ' LEU . . . . . . . . . . . . . 31.2 mt -64.38 -37.69 88.41 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 119.608 -0.837 . . . . 38.57 110.688 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -59.23 -1.86 0.23 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 116.523 2.046 . . . . 37.560000000000002 116.523 173.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . -36.7 -42.52 0.37 Allowed 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 116.687 2.106 . . . . 40.329999999999998 116.687 161.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -51.33 -28.19 11.61 Favored 'General case' 0 C--N 1.348 0.534 0 N-CA-C 115.714 1.746 . . . . 56.850000000000001 115.714 174.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 11.4 m120 -113.97 22.88 13.49 Favored 'General case' 0 N--CA 1.433 -1.281 0 O-C-N 121.4 -0.813 . . . . 45.859999999999999 108.866 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 109.68 -23.11 22.75 Favored Glycine 0 N--CA 1.43 -1.731 0 O-C-N 118.196 -2.815 . . . . 40.310000000000002 114.338 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 87.62 127.92 2.63 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 120.853 2.327 . . . . 38.890000000000001 112.2 -177.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1291 ' ' ASN . . . . . . . . . . . . . 2.8 m120 -71.27 -26.22 62.79 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 113.345 -1.427 . . . . 37.229999999999997 113.804 175.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1292 ' ' CYS . . . . . . . . . . . . . 1.6 t -82.51 138.86 34.19 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.757 -1.11 . . . . 36.5 108.951 165.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1293 ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -68.8 -6.56 27.52 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 115.371 1.619 . . . . 43.32 115.371 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -102.81 -2.09 28.59 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 119.688 -1.883 . . . . 41.32 112.706 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1295 ' ' THR . . . . . . . . . . . . . 31.5 m -78.04 103.13 7.79 Favored 'General case' 0 C--N 1.355 0.832 0 O-C-N 120.845 -1.16 . . . . 35.299999999999997 112.827 -168.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 47.8 t -82.6 121.59 78.1 Favored Pre-proline 0 C--N 1.31 -1.131 0 O-C-N 125.292 1.62 . . . . 34.840000000000003 107.4 174.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -63.51 143.46 88.0 Favored 'Trans proline' 0 C--O 1.25 1.118 0 C-N-CA 122.984 2.456 . . . . 33.509999999999998 108.884 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 69.69 13.56 68.87 Favored Glycine 0 CA--C 1.544 1.9 0 CA-C-O 116.682 -2.177 . . . . 32.189999999999998 115.425 -175.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -147.37 169.98 18.32 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-N 123.988 3.894 . . . . 34.880000000000003 112.823 -172.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1300 ' ' ILE . . . . . . . . . . . . . 74.3 mt -107.92 141.44 23.16 Favored 'Isoleucine or valine' 0 C--O 1.248 0.992 0 N-CA-C 106.555 -1.646 . . . . 32.289999999999999 106.555 166.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 78.8 t80 -119.74 114.28 21.92 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 104.194 -2.521 . . . . 37.25 104.194 164.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1302 ' ' THR . . . . . . . . . . . . . 46.0 m -93.66 118.9 31.99 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 103.614 -2.735 . . . . 35.560000000000002 103.614 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1303 ' ' THR . . . . . . . . . . . . . 8.5 p -70.74 170.92 11.41 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 113.525 -1.671 . . . . 36.399999999999999 114.284 -171.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -75.23 -9.65 58.75 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 113.963 1.097 . . . . 52.32 113.963 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 37.3 p-10 -83.84 -46.14 12.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.363 0.601 . . . . 40.039999999999999 111.356 166.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 127.45 52.0 0.14 Allowed Glycine 0 N--CA 1.427 -1.903 0 CA-C-N 114.466 -1.243 . . . . 36.960000000000001 112.808 -177.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1307 ' ' VAL . . . . . . . . . . . . . 82.0 t -118.77 124.02 72.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 N-CA-C 104.943 -2.243 . . . . 33.399999999999999 104.943 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1308 ' ' LYS . . . . . . . . . . . . . 53.7 mmtt -80.21 95.11 6.18 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 106.116 -1.809 . . . . 42.909999999999997 106.116 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 38.4 t -84.22 92.68 3.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 106.357 -1.72 . . . . 32.289999999999999 106.357 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1310 ' ' ILE . . . . . . . . . . . . . 82.6 mt -82.44 103.41 9.62 Favored 'Isoleucine or valine' 0 C--N 1.351 0.642 0 CA-C-N 112.782 -2.008 . . . . 30.989999999999998 109.166 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -103.21 60.69 0.48 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 108.936 -1.666 . . . . 28.949999999999999 108.936 168.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1312 ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -83.25 95.73 8.24 Favored 'General case' 0 C--O 1.252 1.189 0 CA-C-O 125.278 2.466 . . . . 31.690000000000001 111.483 177.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1313 ' ' THR . . . . . . . . . . . . . 2.8 m -51.91 -37.92 54.35 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 112.46 -2.155 . . . . 34.170000000000002 111.567 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -84.77 10.38 11.58 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 113.381 -1.736 . . . . 36.859999999999999 111.679 -169.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1315 ' ' LEU . . . . . . . . . . . . . 96.9 mt -44.05 -44.36 17.0 Favored Pre-proline 0 N--CA 1.474 0.743 0 N-CA-C 119.356 3.095 . . . . 34.850000000000001 119.356 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -53.6 -33.46 68.88 Favored 'Trans proline' 0 C--O 1.258 1.518 0 C-N-CA 124.53 3.486 . . . . 29.149999999999999 115.025 170.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -76.32 -40.66 28.02 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 109.496 -1.442 . . . . 27.289999999999999 109.496 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1318 ' ' ARG . . . . . . . . . . . . . 58.1 mtt-85 -58.05 -26.62 62.73 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 115.641 1.719 . . . . 41.490000000000002 115.641 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1319 ' ' LEU . . . . . . . . . . . . . 13.1 tp -103.97 71.88 0.17 Allowed Pre-proline 0 C--O 1.238 0.486 0 O-C-N 119.587 -1.946 . . . . 27.609999999999999 109.141 168.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1320 ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -58.12 -54.87 2.67 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.854 3.036 . . . . 25.940000000000001 113.985 -166.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1321 ' ' THR . . . . . . . . . . . . . 4.3 m -63.7 -43.53 96.35 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.937 0.895 . . . . 25.010000000000002 109.621 -171.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1322 ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -67.56 -26.76 66.46 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 117.451 -1.261 . . . . 29.390000000000001 112.803 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1323 ' ' SER . . . . . . . . . . . . . 36.9 m -66.81 -51.29 57.34 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 120.346 1.43 . . . . 26.469999999999999 111.131 162.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1324 ' ' SER . . . . . . . . . . . . . 4.3 m -63.39 -17.83 63.04 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 116.296 1.962 . . . . 27.780000000000001 116.296 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -104.44 -54.87 2.45 Favored 'General case' 0 C--O 1.247 0.937 0 CA-C-N 114.787 -1.097 . . . . 37.530000000000001 110.811 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1326 ' ' LEU . . . . . . . . . . . . . 33.6 mt -69.3 -59.5 2.96 Favored 'General case' 0 CA--C 1.505 -0.761 0 O-C-N 118.015 -2.928 . . . . 35.710000000000001 112.274 175.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1327 ' ' TYR . . . . . . . . . . . . . 31.3 t80 -57.16 -37.5 72.18 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-O 122.31 1.052 . . . . 31.59 108.218 177.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1328 ' ' GLY . . . . . . . . . . . . . . . -46.77 -58.4 6.13 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.95 1.262 . . . . 28.0 113.226 168.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1329 ' ' THR . . . . . . . . . . . . . 17.3 m -70.14 -25.45 63.47 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.371 1.586 . . . . 32.149999999999999 110.619 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1330 ' ' ASN . . . . . . . . . . . . . 26.4 m120 -59.3 -49.97 75.79 Favored 'General case' 0 C--O 1.244 0.792 0 O-C-N 119.807 -1.808 . . . . 34.359999999999999 111.361 168.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1331 ' ' LEU . . . . . . . . . . . . . 13.2 mt -55.55 -48.96 73.91 Favored 'General case' 0 C--N 1.357 0.907 0 O-C-N 127.226 2.829 . . . . 33.369999999999997 108.747 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1332 ' ' VAL . . . . . . . . . . . . . 44.1 t -56.9 -42.66 78.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 O-C-N 124.782 1.301 . . . . 35.270000000000003 110.783 175.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -57.55 -49.33 76.71 Favored 'General case' 0 C--O 1.242 0.706 0 O-C-N 119.844 -1.785 . . . . 37.659999999999997 112.677 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1334 ' ' LEU . . . . . . . . . . . . . 53.6 tp -57.06 -54.02 51.52 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 124.736 1.273 . . . . 40.270000000000003 108.43 176.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1335 ' ' LEU . . . . . . . . . . . . . 46.6 mt -62.98 -23.81 67.61 Favored 'General case' 0 N--CA 1.436 -1.154 0 O-C-N 126.369 2.293 . . . . 42.5 111.146 -176.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1336 ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -69.02 -35.19 76.37 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 123.284 2.766 . . . . 47.810000000000002 111.944 173.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1337 ' ' LEU . . . . . . . . . . . . . 58.5 mt -67.84 -43.94 78.32 Favored 'General case' 0 CA--C 1.507 -0.709 0 O-C-N 120.84 -1.163 . . . . 49.270000000000003 108.297 172.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1338 ' ' LEU . . . . . . . . . . . . . 6.9 mp -66.91 -38.93 87.15 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 116.724 2.12 . . . . 50.539999999999999 116.724 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1339 ' ' CYS . . . . . . . . . . . . . 49.1 t -104.82 81.32 1.74 Allowed 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 104.761 -2.311 . . . . 53.670000000000002 104.761 -175.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 75.3 mttt -74.31 -52.13 13.16 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 124.312 2.006 . . . . 63.380000000000003 113.096 -165.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -76.48 -44.16 36.61 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 110.077 -3.238 . . . . 70.950000000000003 111.85 -166.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1342 ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? 59.84 67.5 0.87 Allowed 'General case' 0 C--N 1.356 0.881 0 C-N-CA 127.043 2.137 . . . . 65.25 113.216 176.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1343 ' ' ASP . . . . . . . . . . . . 0.468 0.0 OUTLIER 68.38 -72.14 0.1 Allowed 'General case' 0 C--N 1.375 1.712 1 O-C-N 115.001 -4.812 . . . . 64.530000000000001 118.904 8.507 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A 1344 ' ' GLY . . . . . . . . . . . . . . . 79.71 46.69 7.71 Favored Glycine 0 C--O 1.244 0.755 0 CA-C-N 121.238 1.835 . . . . 59.719999999999999 110.462 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 28.8 t30 -130.03 122.8 29.1 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 121.792 0.806 . . . . 64.090000000000003 111.081 166.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1346 ' ' ILE . . . . . . . . . . . . . 13.4 mt -79.99 109.9 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 CA-C-O 123.513 1.625 . . . . 58.82 109.382 170.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1347 ' ' THR . . . . . . . . . . . . . 28.6 m -96.84 107.2 19.65 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 110.275 -3.148 . . . . 54.960000000000001 104.533 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1348 ' ' VAL . . . . . . . . . . . . . 42.2 t -84.16 87.78 2.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 103.608 -2.738 . . . . 55.640000000000001 103.608 -178.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 29.8 t70 -73.16 111.54 8.37 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.539 -1.21 . . . . 61.450000000000003 112.605 178.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -79.79 4.51 16.21 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 114.946 1.461 . . . . 58.630000000000003 114.946 171.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -78.45 -33.04 48.71 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 117.12 -1.832 . . . . 62.060000000000002 112.377 173.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 5.1 t70 -84.31 123.96 30.73 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 124.703 2.192 . . . . 54.07 108.8 171.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 32.2 m -61.46 -29.83 46.83 Favored 'Isoleucine or valine' 0 C--O 1.247 0.973 0 CA-C-N 109.902 -3.317 . . . . 50.68 113.089 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1354 ' ' VAL . . . . . . . . . . . . . 5.8 m -69.45 -40.92 80.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 119.908 1.231 . . . . 47.68 109.7 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1355 ' ' ILE . . . . . . . . . . . . . 54.7 mt -68.11 -48.4 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.872 -1.159 . . . . 48.490000000000002 107.872 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 22.5 tpt85 -52.08 -40.52 61.34 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.687 1.195 . . . . 48.270000000000003 113.145 168.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -58.65 -53.43 46.17 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 125.67 1.605 . . . . 43.530000000000001 112.623 174.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1358 ' ' VAL . . . . . . . . . . . . . 10.9 t -62.92 -39.9 86.86 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.5 0 O-C-N 124.982 1.048 . . . . 45.119999999999997 109.079 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1359 ' ' THR . . . . . . . . . . . . . 21.4 m -74.16 88.68 1.97 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 123.278 1.513 . . . . 42.939999999999998 109.835 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 29.7 m -78.62 -23.0 13.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 113.874 1.065 . . . . 43.259999999999998 113.874 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1361 ' ' ILE . . . . . . . . . . . . . 57.7 mt -133.36 120.5 39.11 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.003 0 O-C-N 118.119 -2.863 . . . . 45.659999999999997 106.604 170.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1362 ' ' ARG . . . . . . . . . . . . . 12.9 ttt180 -102.09 109.78 21.57 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 118.474 -2.641 . . . . 61.340000000000003 106.358 170.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 43.16 39.92 2.16 Favored 'General case' 0 C--O 1.249 1.044 0 N-CA-C 117.278 2.325 . . . . 49.759999999999998 117.278 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 119.6 -34.75 4.12 Favored Glycine 0 C--N 1.349 1.283 0 C-N-CA 119.392 -1.385 . . . . 50.0 111.758 177.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -82.4 123.12 28.83 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.002 -1.481 . . . . 56.920000000000002 107.002 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1366 ' ' ILE . . . . . . . . . . . . . 93.4 mt -84.85 87.31 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 107.851 -1.166 . . . . 52.780000000000001 107.851 -177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1367 ' ' THR . . . . . . . . . . . . . 1.3 p -66.25 -6.76 14.92 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 116.031 1.863 . . . . 49.439999999999998 116.031 175.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 20.7 t90 -59.45 141.14 88.16 Favored Pre-proline 0 N--CA 1.442 -0.872 0 CA-C-O 116.13 -1.89 . . . . 52.380000000000003 108.128 164.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -67.06 160.32 78.85 Favored 'Cis proline' 0 C--N 1.362 1.258 0 N-CA-C 119.733 2.936 . . . . 46.939999999999998 119.733 -0.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -89.68 142.53 29.35 Favored Pre-proline 0 C--O 1.24 0.6 0 CA-C-N 114.862 -1.063 . . . . 45.909999999999997 113.208 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1371 ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -51.59 124.1 13.63 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 124.366 3.377 . . . . 46.390000000000001 114.77 169.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -72.29 -59.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.357 1.005 1 C-N-CA 126.839 5.026 . . . . 46.719999999999999 109.225 173.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.223 -4.904 0 CA-C-N 119.741 1.155 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 79.4 m80 . . . . . 0 CA--C 1.548 0.884 0 N-CA-C 102.436 -3.172 . . . . 63.439999999999998 102.436 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -124.02 50.72 1.62 Allowed 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 121.875 2.125 . . . . 51.740000000000002 111.849 170.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1000 ' ' HIS . . . . . . . . . . . . . 33.2 t60 -71.53 119.45 15.7 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 111.868 -2.424 . . . . 54.07 107.552 174.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 82.13 15.19 75.22 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 123.773 0.701 . . . . 39.219999999999999 111.442 -174.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1002 ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -107.59 128.05 54.19 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 124.534 2.112 . . . . 38.119999999999997 108.765 167.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1003 ' ' ILE . . . . . . . . . . . . . 14.9 mt -81.79 150.52 4.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 110.191 -3.186 . . . . 29.699999999999999 107.229 174.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -129.34 120.42 3.2 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 105.167 -3.173 . . . . 27.5 105.167 171.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1005 ' ' ILE . . . . . . . . . . . . . 45.8 mm -100.06 110.4 59.39 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 116.514 -1.708 . . . . 24.829999999999998 107.505 173.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -78.77 152.44 25.41 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 124.117 3.211 . . . . 27.190000000000001 110.757 175.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -79.97 110.27 15.19 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 102.938 -2.986 . . . . 41.460000000000001 102.938 160.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1008 ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -55.36 131.26 45.29 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 124.176 1.941 . . . . 26.93 115.757 -165.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 36.7 mmm-85 -84.95 -12.28 53.67 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 111.71 -2.496 . . . . 34.479999999999997 111.033 -169.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1010 ' ' LEU . . . . . . . . . . . . . 13.1 tp -55.74 133.67 51.02 Favored 'General case' 0 C--O 1.243 0.728 0 O-C-N 120.776 -1.203 . . . . 44.219999999999999 109.609 172.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1011 ' ' THR . . . . . . . . . . . . . 28.7 m -60.46 111.65 1.66 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 114.365 1.246 . . . . 40.740000000000002 114.365 -168.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 42.3 t30 54.69 55.73 7.56 Favored 'General case' 0 C--O 1.222 -0.368 0 O-C-N 124.51 1.131 . . . . 44.439999999999998 114.047 -170.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1013 ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -88.49 136.75 32.84 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 115.054 -0.976 . . . . 29.870000000000001 108.988 166.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1014 ' ' THR . . . . . . . . . . . . . 96.2 m -96.97 -26.18 15.13 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 111.422 -2.626 . . . . 25.260000000000002 109.906 -173.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -70.96 141.81 51.05 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 123.985 1.85 . . . . 29.539999999999999 112.218 175.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1016 ' ' VAL . . . . . . . . . . . . . 9.9 p -102.47 169.5 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 N-CA-C 105.586 -2.005 . . . . 23.550000000000001 105.586 151.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1017 ' ' ALA . . . . . . . . . . . . . . . -72.24 -35.93 68.97 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.294 1.22 . . . . 23.59 114.294 -174.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1018 ' ' ALA . . . . . . . . . . . . . . . -147.16 153.08 39.45 Favored 'General case' 0 CA--C 1.509 -0.612 0 O-C-N 124.001 0.813 . . . . 24.93 111.71 -172.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1019 ' ' THR . . . . . . . . . . . . . 12.7 p -91.57 163.75 27.09 Favored Pre-proline 0 C--O 1.25 1.11 0 CA-C-O 117.742 -1.123 . . . . 28.09 110.343 171.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -48.27 -41.76 34.54 Favored 'Trans proline' 0 CA--C 1.501 -1.166 1 C-N-CA 125.664 4.242 . . . . 28.789999999999999 111.966 173.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.4 -47.57 62.9 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 122.638 1.209 . . . . 47.280000000000001 112.182 174.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1022 ' ' THR . . . . . . . . . . . . . 9.6 p -78.41 -22.34 47.93 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 118.835 -1.146 . . . . 30.120000000000001 112.038 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1023 ' ' VAL . . . . . . . . . . . . . 51.6 t -66.24 -42.3 90.72 Favored 'Isoleucine or valine' 0 C--N 1.349 0.548 0 O-C-N 120.84 -1.162 . . . . 32.240000000000002 110.421 169.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1024 ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -54.57 -48.59 71.88 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 120.451 -1.405 . . . . 49.619999999999997 112.42 171.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -49.49 -48.36 47.93 Favored 'General case' 0 C--O 1.21 -0.975 0 N-CA-C 114.31 1.226 . . . . 44.68 114.31 169.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 70.8 mt -58.07 -41.09 82.63 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 120.063 -1.648 . . . . 35.710000000000001 111.432 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1027 ' ' LEU . . . . . . . . . . . . . 12.3 mt -70.05 -27.64 64.81 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.894 1.278 . . . . 42.18 114.247 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 51.5 mttm -66.11 -47.21 74.91 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 105.877 -1.898 . . . . 48.340000000000003 105.877 169.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1029 ' ' LEU . . . . . . . . . . . . . 74.1 mt -69.42 -10.99 60.4 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 120.426 -1.421 . . . . 38.689999999999998 113.714 175.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 97.05 10.52 54.79 Favored Glycine 0 C--N 1.353 1.522 0 C-N-CA 125.722 1.63 . . . . 32.280000000000001 113.015 166.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -77.12 140.59 40.28 Favored 'General case' 0 N--CA 1.44 -0.974 0 O-C-N 120.735 -1.45 . . . . 35.939999999999998 110.913 173.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1032 ' ' THR . . . . . . . . . . . . . 5.9 m -83.95 138.95 32.88 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 104.788 -2.301 . . . . 33.369999999999997 104.788 174.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1033 ' ' VAL . . . . . . . . . . . . . 10.0 t -122.34 144.39 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 124.045 3.111 . . . . 29.98 111.769 -172.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -129.57 144.93 51.49 Favored 'General case' 0 C--O 1.249 1.036 0 C-N-CA 125.791 1.636 . . . . 28.18 108.537 169.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1035 ' ' VAL . . . . . . . . . . . . . 47.0 t -136.84 142.47 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 105.831 -1.914 . . . . 25.82 105.831 -174.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1036 ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -76.95 141.33 40.5 Favored 'General case' 0 C--O 1.258 1.535 0 C-N-CA 118.886 -1.126 . . . . 32.439999999999998 113.968 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1037 ' ' SER . . . . . . . . . . . . . 49.6 m -52.24 128.06 23.92 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.117 0.961 . . . . 29.539999999999999 113.178 171.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 92.34 -13.2 67.81 Favored Glycine 0 CA--C 1.542 1.779 0 CA-C-N 115.292 -0.867 . . . . 27.760000000000002 113.475 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1039 ' ' ALA . . . . . . . . . . . . . . . -62.71 -39.37 93.81 Favored 'General case' 0 N--CA 1.438 -1.062 0 O-C-N 120.553 -1.557 . . . . 26.02 112.062 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -61.08 -45.81 95.83 Favored Glycine 0 C--N 1.304 -1.232 0 C-N-CA 119.315 -1.422 . . . . 26.469999999999999 110.962 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -68.17 -28.18 67.06 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 118.421 -2.811 . . . . 50.979999999999997 111.972 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 15.3 mt -58.91 -51.23 70.95 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 117.955 -2.965 . . . . 29.300000000000001 109.97 166.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1043 ' ' ALA . . . . . . . . . . . . . . . -68.2 17.13 0.04 OUTLIER 'General case' 0 C--O 1.213 -0.823 0 O-C-N 119.0 -2.313 . . . . 26.739999999999998 116.564 167.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1044 ' ' SER . . . . . . . . . . . . . 15.1 m 54.12 34.47 20.13 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 123.707 1.717 . . . . 31.260000000000002 114.792 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1045 ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -127.94 158.59 37.41 Favored 'General case' 0 C--O 1.241 0.65 0 O-C-N 121.172 -0.955 . . . . 33.259999999999998 108.712 -177.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 29.1 t0 -72.71 139.05 46.97 Favored 'General case' 0 C--O 1.245 0.835 0 O-C-N 120.755 -1.215 . . . . 46.740000000000002 108.824 170.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.54 -40.57 72.03 Favored 'General case' 0 C--O 1.214 -0.816 0 CA-C-O 122.572 1.177 . . . . 34.439999999999998 110.858 175.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.65 -2.41 17.14 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 120.635 -1.291 . . . . 48.670000000000002 113.134 -174.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -72.08 -35.68 69.3 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 118.302 -2.749 . . . . 35.259999999999998 108.365 167.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1050 ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -65.32 -41.63 93.81 Favored 'General case' 0 C--O 1.219 -0.524 0 O-C-N 120.335 -1.478 . . . . 32.170000000000002 108.438 176.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 17.5 t -50.8 -57.98 2.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 123.757 0.66 . . . . 38.369999999999997 111.98 168.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -42.77 -54.28 4.17 Favored 'General case' 0 C--O 1.213 -0.845 0 N-CA-C 113.511 0.93 . . . . 45.770000000000003 113.511 172.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -54.25 -38.4 65.75 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.376 1.251 . . . . 37.829999999999998 114.376 173.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 126.89 34.53 0.59 Allowed Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.845 -0.902 . . . . 35.82 110.845 174.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -112.23 147.21 36.71 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 107.985 -1.117 . . . . 33.770000000000003 107.985 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -76.85 132.82 39.37 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 107.19 -1.411 . . . . 51.020000000000003 107.19 168.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1057 ' ' ILE . . . . . . . . . . . . . 27.8 mm -100.96 124.68 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-O 122.92 1.343 . . . . 38.469999999999999 108.06 169.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.52 142.34 25.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 C-N-CA 124.942 1.297 . . . . 39.399999999999999 113.235 -171.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -82.17 123.13 28.72 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.998 -1.112 . . . . 57.07 107.998 -171.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . 57.0 -133.82 52.53 Favored Glycine 0 N--CA 1.432 -1.596 0 CA-C-O 122.605 1.114 . . . . 44.829999999999998 114.404 165.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -38.92 -40.52 0.65 Allowed 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 111.084 -2.558 . . . . 46.270000000000003 115.403 -172.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1062 ' ' SER . . . . . . . . . . . . . 5.5 m -45.71 -51.31 12.67 Favored 'General case' 0 C--N 1.349 0.586 0 N-CA-C 113.98 1.104 . . . . 43.469999999999999 113.98 173.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 3.6 p -69.3 -35.32 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 C-N-CA 123.371 0.668 . . . . 36.979999999999997 110.15 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -64.22 -28.57 69.83 Favored 'General case' 0 N--CA 1.422 -1.844 0 O-C-N 123.813 0.696 . . . . 37.899999999999999 111.908 175.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -82.29 82.91 7.61 Favored 'General case' 0 C--O 1.243 0.748 0 O-C-N 118.798 -2.439 . . . . 46.189999999999998 110.802 171.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1066 ' ' SER . . . . . . . . . . . . . 44.7 m -150.35 162.36 40.69 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.412 -1.267 . . . . 37.060000000000002 108.299 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1067 ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -72.02 -58.3 3.55 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 117.821 -1.551 . . . . 43.950000000000003 111.951 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1068 ' ' ILE . . . . . . . . . . . . . 4.4 mp -96.22 107.15 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 103.165 -2.902 . . . . 33.5 103.165 -169.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 48.9 mm -97.54 109.22 23.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 107.208 -1.404 . . . . 30.57 107.208 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1070 ' ' LEU . . . . . . . . . . . . . 83.6 mt -95.74 91.86 6.29 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 124.377 2.037 . . . . 27.66 107.174 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1071 ' ' LYS . . . . . . . . . . . . . 10.9 mtpt -90.69 161.27 15.44 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-N 112.59 -2.095 . . . . 28.399999999999999 109.491 176.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1072 ' ' VAL . . . . . . . . . . . . . 2.7 t -83.91 -56.91 4.97 Favored 'Isoleucine or valine' 0 C--N 1.351 0.637 0 N-CA-C 104.733 -2.321 . . . . 23.18 104.733 -177.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -113.46 173.88 6.19 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 113.808 -1.542 . . . . 25.469999999999999 107.448 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -49.41 146.93 6.08 Favored Pre-proline 0 C--O 1.264 1.832 0 C-N-CA 124.899 1.28 . . . . 27.899999999999999 113.66 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -60.52 151.89 72.06 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.455 2.77 . . . . 31.620000000000001 110.574 166.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 7.4 mp -89.7 165.74 14.01 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 113.828 -1.533 . . . . 40.490000000000002 107.171 166.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 10.1 t70 -58.71 -40.63 84.24 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 116.448 2.018 . . . . 51.590000000000003 116.448 -173.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -57.3 -43.43 83.22 Favored 'General case' 0 C--O 1.244 0.773 0 O-C-N 121.489 -0.757 . . . . 42.359999999999999 111.202 169.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1079 ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -64.8 -28.65 69.71 Favored 'General case' 0 C--O 1.221 -0.426 0 O-C-N 121.404 -0.81 . . . . 34.530000000000001 109.868 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1080 ' ' ILE . . . . . . . . . . . . . 69.5 mt -64.13 -41.21 91.73 Favored 'Isoleucine or valine' 0 C--N 1.36 1.053 0 O-C-N 119.926 -1.734 . . . . 33.25 110.231 171.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -62.73 -30.01 71.1 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.442 -1.411 . . . . 36.469999999999999 114.365 172.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1082 ' ' LEU . . . . . . . . . . . . . 65.4 mt -75.16 -28.34 60.05 Favored 'General case' 0 C--N 1.348 0.532 0 O-C-N 121.584 -0.698 . . . . 37.759999999999998 110.852 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1083 ' ' LEU . . . . . . . . . . . . . 34.1 mt -52.78 114.8 1.53 Allowed 'General case' 0 C--O 1.247 0.953 0 N-CA-C 114.928 1.455 . . . . 37.43 114.928 174.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.34 143.83 52.65 Favored Pre-proline 0 N--CA 1.453 -0.314 0 CA-C-N 111.289 -2.687 . . . . 37.700000000000003 107.587 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -54.67 123.69 14.33 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.176 3.251 . . . . 35.509999999999998 109.434 175.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 83.61 17.16 66.66 Favored Glycine 0 C--N 1.316 -0.565 0 CA-C-O 119.608 -0.551 . . . . 33.869999999999997 112.076 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1087 ' ' THR . . . . . . . . . . . . . 52.5 m -69.76 134.44 48.58 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 121.707 2.753 . . . . 32.5 108.72 163.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1088 ' ' THR . . . . . . . . . . . . . 38.9 m -92.93 97.94 11.05 Favored 'General case' 0 C--O 1.254 1.321 0 N-CA-C 105.528 -2.027 . . . . 30.219999999999999 105.528 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1089 ' ' LEU . . . . . . . . . . . . . 22.1 tp -96.17 130.19 43.29 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 120.829 -1.169 . . . . 27.239999999999998 108.639 -176.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 95.8 t -125.6 128.01 72.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 102.247 -3.242 . . . . 25.390000000000001 102.247 -175.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1091 ' ' SER . . . . . . . . . . . . . 3.9 m -160.23 168.38 25.51 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 121.893 2.133 . . . . 28.809999999999999 111.925 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1092 ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -66.71 108.25 2.42 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.549 -1.278 . . . . 30.780000000000001 107.549 155.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 26.2 mm -104.31 -36.67 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 O-C-N 118.837 -2.414 . . . . 30.280000000000001 114.267 -176.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1094 ' ' TRP . . . . . . . . . . . . . 61.9 m95 54.53 65.49 5.06 Favored Pre-proline 0 CA--C 1.548 0.886 0 O-C-N 124.319 1.012 . . . . 34.07 110.582 -175.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -47.99 -58.39 1.78 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 1 C-N-CA 127.375 5.383 . . . . 38.659999999999997 118.91 -166.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -82.29 -14.89 54.7 Favored 'General case' 0 N--CA 1.436 -1.163 0 O-C-N 119.734 -1.854 . . . . 41.32 110.437 -177.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -76.58 -21.96 54.91 Favored 'General case' 0 C--O 1.246 0.895 0 N-CA-C 108.579 -0.897 . . . . 51.659999999999997 108.579 166.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -121.36 42.39 0.56 Allowed Pre-proline 0 C--N 1.309 -1.168 0 N-CA-C 117.391 2.367 . . . . 40.32 117.391 -172.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -56.49 -42.54 64.47 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 123.633 2.889 . . . . 41.560000000000002 117.188 -167.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -61.25 -39.84 91.83 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.714 1.143 . . . . 54.109999999999999 113.316 175.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1101 ' ' LEU . . . . . . . . . . . . . 6.2 tp -62.78 -49.44 74.97 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 108.521 -0.918 . . . . 37.880000000000003 108.521 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1102 ' ' MET . . . . . . . . . . . . . 91.6 mmm -51.25 -55.73 16.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.712 -0.676 . . . . 37.539999999999999 110.381 177.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -49.34 -49.74 42.86 Favored 'General case' 0 C--O 1.244 0.775 0 O-C-N 121.694 -0.629 . . . . 47.009999999999998 112.483 176.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1104 ' ' LYS . . . . . . . . . . . . . 83.4 mttt -60.46 -38.25 83.6 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 114.991 1.478 . . . . 48.68 114.991 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1105 ' ' LEU . . . . . . . . . . . . . 31.3 mt -66.96 -36.82 83.07 Favored 'General case' 0 C--O 1.245 0.837 0 O-C-N 121.009 -1.057 . . . . 32.210000000000001 109.198 177.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -67.87 -28.24 67.36 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 108.871 -0.788 . . . . 33.729999999999997 108.871 177.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -68.44 -39.62 81.45 Favored 'General case' 0 CA--C 1.494 -1.197 0 O-C-N 119.412 -2.055 . . . . 51.469999999999999 110.207 175.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1108 ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -72.85 -4.05 29.38 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 115.026 1.491 . . . . 43.899999999999999 115.026 -178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1109 ' ' ASN . . . . . . . . . . . . . 9.9 m120 58.6 32.81 22.55 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 124.027 1.87 . . . . 44.82 113.436 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1110 ' ' VAL . . . . . . . . . . . . . 33.6 m -93.14 166.27 1.8 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.662 0 CA-C-N 114.351 -1.295 . . . . 30.52 111.454 177.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1111 ' ' THR . . . . . . . . . . . . . 87.2 m -109.65 103.26 12.09 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 105.532 -2.025 . . . . 27.120000000000001 105.532 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1112 ' ' VAL . . . . . . . . . . . . . 40.7 t -99.36 129.11 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-O 122.418 1.104 . . . . 26.399999999999999 109.496 -174.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1113 ' ' MET . . . . . . . . . . . . . 31.2 mtp -109.65 124.33 50.99 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.921 0.889 . . . . 42.920000000000002 110.128 171.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -102.51 106.18 16.85 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 119.716 1.144 . . . . 24.149999999999999 109.17 -174.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1115 ' ' MET . . . . . . . . . . . . . 80.2 mmm -71.29 -2.33 15.83 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 113.072 -1.876 . . . . 29.949999999999999 112.168 -169.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1116 ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -93.44 -52.07 4.68 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.745 1.218 . . . . 34.530000000000001 112.428 169.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1117 ' ' SER . . . . . . . . . . . . . 51.1 m -86.71 60.94 6.52 Favored 'General case' 0 C--N 1.343 0.298 0 O-C-N 120.401 -1.437 . . . . 33.490000000000002 111.118 -175.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1118 ' ' VAL . . . . . . . . . . . . . 17.9 t -95.62 146.56 31.54 Favored Pre-proline 0 C--O 1.245 0.868 0 N-CA-C 105.171 -2.159 . . . . 34.020000000000003 105.171 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -60.97 146.02 98.3 Favored 'Trans proline' 0 C--N 1.354 0.82 0 CA-C-N 124.661 2.7 . . . . 38.280000000000001 113.308 174.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1120 ' ' ARG . . . . . 0.54 HH12 ' CG ' ' B' 1128 ' ' ASP . 5.3 mmt180 -85.82 56.82 4.14 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 120.685 -1.259 . . . . 55.049999999999997 111.481 -167.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1121 ' ' ILE . . . . . . . . . . . . . 6.7 pt -132.26 164.28 35.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 CA-C-N 114.53 -1.213 . . . . 42.090000000000003 112.585 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1122 ' ' SER . . . . . . . . . . . . . 8.9 m -48.75 -63.94 0.95 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 119.12 3.008 . . . . 38.020000000000003 119.12 -162.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1123 ' ' ARG . . . . . . . . . . . . . 21.4 ptt-85 -70.53 -29.06 65.44 Favored 'General case' 0 C--N 1.354 0.804 1 O-C-N 116.114 -4.116 . . . . 34.289999999999999 110.924 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1124 ' ' ALA . . . . . . . . . . . . . . . -60.51 -40.62 92.08 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 113.282 -1.781 . . . . 32.350000000000001 108.151 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1125 ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -60.75 -24.67 65.91 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 115.744 1.757 . . . . 47.170000000000002 115.744 173.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1126 ' ' SER . . . . . . . . . . . . . 57.1 m -68.59 -36.66 79.01 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 119.05 -2.281 . . . . 31.710000000000001 114.667 165.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1127 ' ' LEU . . . . . . . . . . . . . 6.9 mp -72.84 -30.15 63.79 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.181 -0.949 . . . . 37.0 111.472 172.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1128 ' ' ASP . . . . . 0.54 ' CG ' HH12 ' B' 1120 ' ' ARG . 37.9 t70 -64.54 101.02 0.41 Allowed 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 115.59 -0.732 . . . . 40.399999999999999 110.977 -169.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1129 ' ' ALA . . . . . . . . . . . . . . . -72.52 -21.42 61.18 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 118.411 -1.316 . . . . 26.559999999999999 110.506 174.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 7.8 tt -55.13 -26.37 37.98 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.378 1.251 . . . . 30.890000000000001 114.378 168.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1131 ' ' SER . . . . . . . . . . . . . 13.6 p -77.59 -51.91 9.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 122.68 1.228 . . . . 29.84 113.118 172.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1132 ' ' SER . . . . . . . . . . . . . 16.6 m -58.23 -49.51 76.83 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.279 -1.513 . . . . 31.91 114.663 177.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1133 ' ' MET . . . . . . . . . . . . . 38.1 mmt -68.74 -36.58 78.56 Favored 'General case' 0 CA--C 1.509 -0.598 0 O-C-N 120.776 -1.202 . . . . 25.899999999999999 110.765 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1134 ' ' ALA . . . . . . . . . . . . . . . -55.62 -44.55 77.18 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 119.137 0.881 . . . . 26.620000000000001 113.289 164.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -58.03 -48.08 81.15 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 122.272 1.034 . . . . 36.969999999999999 112.096 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1136 ' ' ILE . . . . . . . . . . . . . 42.9 mm -52.3 -58.07 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-N 113.294 -1.775 . . . . 32.109999999999999 111.48 173.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -57.27 -30.36 64.62 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.888 1.069 . . . . 24.140000000000001 113.888 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -68.58 -49.28 44.96 Favored Glycine 0 N--CA 1.484 1.9 0 N-CA-C 110.202 -1.159 . . . . 25.129999999999999 110.202 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 55.3 t80 -63.72 -44.47 93.46 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 123.417 1.579 . . . . 32.729999999999997 112.748 173.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1140 ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -62.57 -33.94 75.96 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 114.041 -1.436 . . . . 26.359999999999999 110.914 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1141 ' ' ALA . . . . . . . . . . . . . . . -55.71 -49.38 73.16 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 123.232 0.613 . . . . 24.120000000000001 112.42 168.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 50.1 mm -58.78 -35.97 58.54 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 O-C-N 120.873 -1.142 . . . . 23.370000000000001 109.927 174.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 14.3 t -71.24 -46.19 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 O-C-N 119.555 -1.966 . . . . 24.960000000000001 111.837 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -72.0 -41.82 67.15 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 106.661 -1.607 . . . . 32.07 106.661 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1145 ' ' ALA . . . . . . . . . . . . . . . -53.38 -45.86 69.42 Favored 'General case' 0 C--O 1.206 -1.209 0 O-C-N 121.318 -0.864 . . . . 24.870000000000001 111.655 170.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1146 ' ' ALA . . . . . . . . . . . . . . . -63.99 -39.08 93.32 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 123.016 0.527 . . . . 24.670000000000002 109.658 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 16.5 t60 -59.06 -34.33 71.82 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 119.746 -1.846 . . . . 28.579999999999998 109.177 172.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1148 ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -93.93 -10.38 33.96 Favored 'General case' 0 C--O 1.25 1.088 0 O-C-N 120.118 -1.614 . . . . 36.82 113.8 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1149 ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -78.9 144.09 35.24 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-O 123.488 1.613 . . . . 31.969999999999999 109.257 -171.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1150 ' ' GLY . . . . . . . . . . . . . . . -93.93 -19.64 33.38 Favored Glycine 0 C--O 1.242 0.644 0 CA-C-N 114.313 -1.312 . . . . 25.489999999999998 113.239 174.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1151 ' ' ARG . . . . . . . . . . . . . 81.1 mtm-85 -112.65 166.75 11.06 Favored 'General case' 0 C--O 1.242 0.709 0 O-C-N 121.537 -0.978 . . . . 59.840000000000003 111.067 -169.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1152 ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -78.85 156.81 28.52 Favored 'General case' 0 C--O 1.239 0.543 0 O-C-N 119.803 -1.811 . . . . 34.450000000000003 108.647 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1153 ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -84.59 -43.74 14.17 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 123.837 1.78 . . . . 31.170000000000002 108.655 166.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1154 ' ' THR . . . . . . . . . . . . . 48.2 m -68.01 128.17 35.56 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 112.934 -1.939 . . . . 33.890000000000001 111.367 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -75.94 65.47 2.58 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 109.161 -1.576 . . . . 38.950000000000003 109.161 174.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -85.17 121.37 27.83 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 119.461 1.631 . . . . 54.229999999999997 109.476 -160.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 29.8 mm -70.82 95.09 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.883 0 O-C-N 119.906 -1.746 . . . . 51.159999999999997 106.406 173.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1158 ' ' THR . . . . . . . . . . . . . 1.7 m -109.22 138.8 45.02 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 107.783 -1.191 . . . . 49.609999999999999 107.783 -175.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -56.62 -30.57 63.42 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 121.034 1.743 . . . . 49.049999999999997 115.51 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -52.34 -53.09 48.94 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.245 0.545 . . . . 47.649999999999999 111.127 167.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . -179.02 156.14 17.86 Favored Glycine 0 C--O 1.215 -1.062 0 N-CA-C 108.071 -2.012 . . . . 45.609999999999999 108.071 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 79.9 mttt -76.91 128.15 34.03 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 120.197 1.998 . . . . 57.460000000000001 111.966 177.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1163 ' ' VAL . . . . . . . . . . . . . 23.3 t -80.18 129.6 69.18 Favored Pre-proline 0 CA--C 1.514 -0.425 0 CA-C-N 118.923 0.783 . . . . 42.93 110.08 177.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1164 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.74 142.67 64.51 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.618 2.212 . . . . 39.289999999999999 110.667 164.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1165 ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -59.85 153.77 54.56 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 C-N-CA 122.898 2.399 . . . . 34.170000000000002 114.943 170.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -83.25 159.85 21.87 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 113.088 -1.869 . . . . 31.690000000000001 108.383 168.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1167 ' ' LYS . . . . . . . . . . . . . 67.2 mttt -123.56 118.04 26.45 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 105.466 -2.05 . . . . 44.780000000000001 105.466 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 60.3 t -104.31 104.83 17.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 O-C-N 121.827 -0.546 . . . . 31.23 111.122 -174.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1169 ' ' MET . . . . . . . . . . . . . 42.7 ttp -82.82 98.11 8.97 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.088 -0.708 . . . . 37.090000000000003 109.088 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 53.1 t -89.74 119.35 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 N-CA-C 109.029 -0.73 . . . . 30.170000000000002 109.029 -177.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1171 ' ' ILE . . . . . . . . . . . . . 9.7 mt -113.52 132.76 61.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 CA-C-N 120.307 1.412 . . . . 33.740000000000002 107.578 -175.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 69.56 63.86 3.2 Favored Glycine 0 CA--C 1.502 -0.72 0 N-CA-C 110.046 -1.221 . . . . 32.590000000000003 110.046 -176.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1173 ' ' ALA . . . . . . . . . . . . . . . -79.89 75.6 6.6 Favored 'General case' 0 C--O 1.252 1.233 0 CA-C-O 124.17 1.938 . . . . 32.420000000000002 114.018 -174.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -86.52 -165.3 40.86 Favored Glycine 0 C--O 1.216 -0.982 0 N-CA-C 107.367 -2.293 . . . . 31.739999999999998 107.367 166.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 46.1 t -48.54 -38.14 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 122.11 2.955 . . . . 31.48 114.279 -176.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1176 ' ' ALA . . . . . . . . . . . . . . . -58.06 -51.67 68.73 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 113.462 -1.699 . . . . 26.120000000000001 114.063 171.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1177 ' ' GLY . . . . . . . . . . . . . . . -60.46 -48.61 85.35 Favored Glycine 0 CA--C 1.49 -1.473 0 N-CA-C 111.321 -0.712 . . . . 25.73 111.321 176.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1178 ' ' LEU . . . . . . . . . . . . . 91.5 mt -53.75 -38.26 64.2 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 114.899 1.444 . . . . 32.590000000000003 114.899 174.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -70.67 -38.68 73.8 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 119.298 0.953 . . . . 27.719999999999999 111.734 175.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -60.9 -46.7 89.59 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 114.602 1.334 . . . . 26.030000000000001 114.602 175.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1181 ' ' ILE . . . . . . . . . . . . . 79.0 mt -58.32 -48.04 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 123.707 0.803 . . . . 28.609999999999999 109.095 173.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -51.09 -53.11 28.61 Favored Glycine 0 C--N 1.373 2.611 0 CA-C-N 114.827 -1.079 . . . . 25.23 110.721 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -63.26 -50.78 68.83 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 114.419 1.266 . . . . 24.09 114.419 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -69.42 -42.81 74.52 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 121.195 -0.94 . . . . 26.68 112.579 -172.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -57.49 -47.11 82.78 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 115.713 -0.676 . . . . 36.57 111.271 174.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1186 ' ' SER . . . . . . . . . . . . . 75.4 m -58.81 -39.87 82.44 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-O 121.81 0.814 . . . . 28.920000000000002 112.338 177.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1187 ' ' LEU . . . . . . . . . . . . . 66.1 mt -61.78 -35.13 77.26 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 121.041 -1.037 . . . . 29.09 112.997 172.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 120.3 -7.07 11.65 Favored Glycine 0 CA--C 1.539 1.591 0 N-CA-C 111.113 -0.795 . . . . 29.260000000000002 111.113 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1189 ' ' ALA . . . . . . . . . . . . . . . -68.46 121.7 16.89 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 121.666 0.746 . . . . 30.16 112.272 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 37.2 mt -67.31 112.07 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-O 123.594 1.664 . . . . 35.810000000000002 109.718 -172.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1191 ' ' VAL . . . . . . . . . . . . . 93.2 t -82.46 128.75 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 107.706 -1.22 . . . . 31.969999999999999 107.706 -177.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1192 ' ' ARG . . . . . 0.414 HH12 ' CD ' ' B' 1248 ' ' GLU . 22.9 mmt85 -118.89 90.39 3.32 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 102.903 -2.999 . . . . 48.159999999999997 102.903 174.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -103.07 159.69 15.3 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 120.712 -1.242 . . . . 35.890000000000001 114.281 -172.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 35.2 t80 -150.13 152.41 34.68 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 123.041 1.4 . . . . 41.880000000000003 107.224 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1195 ' ' ASP . . . . . . . . . . . . . 10.0 t0 -158.55 155.61 28.68 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 103.666 -2.716 . . . . 38.280000000000001 103.666 168.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1196 ' ' THR . . . . . . . . . . . . . 43.0 m -59.23 -24.15 62.92 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 124.956 1.302 . . . . 40.619999999999997 110.53 172.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1197 ' ' ARG . . . . . . . . . . . . . 33.1 mtm105 -91.97 144.33 29.06 Favored Pre-proline 0 C--O 1.249 1.066 0 O-C-N 119.925 -1.735 . . . . 53.090000000000003 111.026 -174.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -71.95 -42.58 1.53 Allowed 'Trans proline' 0 CA--C 1.548 1.188 1 C-N-CA 125.637 4.225 . . . . 42.560000000000002 117.418 -174.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -29.4 70.55 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 121.269 1.85 . . . . 56.310000000000002 114.462 -168.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1200 ' ' VAL . . . . . . . . . . . . . 10.8 p -58.56 -28.65 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 115.133 -0.94 . . . . 42.909999999999997 112.596 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 35.1 tttm -45.05 -58.66 3.04 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 124.581 1.153 . . . . 48.890000000000001 113.535 168.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 16.0 mp0 -63.39 -28.37 69.94 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 114.265 1.209 . . . . 51.700000000000003 114.265 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1203 ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -66.13 -46.63 76.83 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.586 -0.734 . . . . 52.57 109.442 176.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1204 ' ' VAL . . . . . . . . . . . . . 40.0 t -72.69 -40.67 62.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.255 -1.017 . . . . 33.789999999999999 108.255 -173.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -60.98 -29.36 69.62 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 113.57 0.952 . . . . 36.579999999999998 113.57 176.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1206 ' ' SER . . . . . . . . . . . . . 44.7 m -68.67 -10.85 58.71 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 120.254 -1.529 . . . . 39.609999999999999 114.246 174.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1207 ' ' MET . . . . . . . . . . . . . 46.1 mmm -97.22 5.21 50.47 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.587 0.708 . . . . 37.450000000000003 109.579 174.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 60.5 32.28 77.34 Favored Glycine 0 N--CA 1.471 0.984 0 O-C-N 120.133 -1.604 . . . . 31.870000000000001 111.829 -165.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -119.6 163.23 17.66 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 105.328 -2.101 . . . . 35.399999999999999 105.328 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -108.62 137.23 46.9 Favored 'General case' 0 C--N 1.313 -1.014 0 O-C-N 119.859 -1.776 . . . . 47.890000000000001 111.999 -166.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 75.7 t80 -84.97 141.39 30.38 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 106.416 -1.698 . . . . 45.530000000000001 106.416 172.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1212 ' ' LEU . . . . . . . . . . . . . 73.8 mt -73.74 99.64 3.2 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 125.11 2.386 . . . . 46.329999999999998 116.641 -176.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -77.08 122.75 25.4 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 112.101 -2.318 . . . . 60.409999999999997 108.147 172.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.03 176.38 5.59 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 104.5 -2.407 . . . . 57.380000000000003 104.5 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 14.0 t70 . . . . . 0 CA--C 1.499 -0.994 0 CA-C-O 117.665 -1.159 . . . . 65.069999999999993 108.613 177.149 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B 1230 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.429 -1.48 0 N-CA-C 104.147 -2.538 . . . . 80.319999999999993 104.147 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1231 ' ' SER . . . . . . . . . . . . . 1.6 m 78.26 156.71 0.17 Allowed 'General case' 0 C--O 1.251 1.174 2 CA-C-N 127.914 4.87 . . . . 79.920000000000002 119.591 -8.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -88.7 -157.62 0.44 Allowed 'General case' 0 C--O 1.248 0.991 0 CA-C-N 112.584 -2.098 . . . . 77.909999999999997 111.872 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 66.38 -68.2 0.14 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 121.383 1.902 . . . . 73.879999999999995 111.036 -170.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 11.4 t80 -55.81 -33.18 64.2 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.75 1.22 . . . . 68.980000000000004 110.802 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 32.6 pt -42.94 -39.24 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 114.858 1.429 . . . . 64.530000000000001 114.858 170.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -58.95 -45.81 89.54 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 121.306 1.866 . . . . 66.359999999999999 111.306 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -67.01 -30.54 70.67 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 114.609 1.337 . . . . 56.600000000000001 114.609 170.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.9 -46.4 85.02 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 120.302 1.41 . . . . 56.789999999999999 108.643 171.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1239 ' ' MET . . . . . . . . . . . . . 31.0 mmt -67.79 -36.53 80.6 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 120.848 -1.157 . . . . 53.630000000000003 108.711 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -70.11 -39.63 75.37 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 119.52 -0.872 . . . . 51.740000000000002 109.347 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 17.4 tp -53.14 -53.59 48.25 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-O 118.17 -0.919 . . . . 44.859999999999999 110.116 170.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -64.27 -40.57 96.24 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 112.509 0.559 . . . . 42.780000000000001 112.509 -177.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -61.02 -49.41 77.54 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 124.522 1.129 . . . . 40.960000000000001 108.138 -178.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -59.35 -43.84 92.76 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.608 1.549 . . . . 43.060000000000002 112.215 175.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 46.5 mm-40 -62.01 -28.39 69.54 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.127 -1.397 . . . . 46.450000000000003 114.392 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -57.27 -27.44 62.11 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 123.263 1.506 . . . . 41.780000000000001 112.171 -174.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 10.5 tptt -77.98 -41.93 34.4 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 114.094 -1.412 . . . . 52.200000000000003 110.901 175.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1248 ' ' GLU . . . . . 0.414 ' CD ' HH12 ' B' 1192 ' ' ARG . 26.0 mt-10 -70.26 -41.45 73.46 Favored 'General case' 0 C--O 1.244 0.813 0 O-C-N 120.604 -1.31 . . . . 53.549999999999997 111.952 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1249 ' ' VAL . . . . . . . . . . . . 0.259 32.8 m -84.88 164.3 2.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 124.336 2.017 . . . . 34.409999999999997 113.504 -166.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1250 ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -122.63 -50.07 1.98 Allowed 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 113.663 -1.608 . . . . 33.380000000000003 107.602 -176.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1251 ' ' ILE . . . . . . . . . . . . . 24.5 mm -119.94 114.98 45.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 108.035 -1.098 . . . . 29.539999999999999 108.035 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1252 ' ' ILE . . . . . . . . . . . . . 82.3 mt -91.62 119.79 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 N-CA-C 104.477 -2.416 . . . . 32.439999999999998 104.477 169.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1253 ' ' VAL . . . . . . . . . . . . . 55.9 t -112.81 100.91 11.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 104.665 -2.346 . . . . 30.57 104.665 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1254 ' ' THR . . . . . . . . . . . . . 7.4 t -103.08 98.6 8.51 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 125.982 2.801 . . . . 35.039999999999999 108.894 -175.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1255 ' ' THR . . . . . . . . . . . . . 3.2 p -84.74 8.7 16.2 Favored 'General case' 0 N--CA 1.421 -1.888 1 CA-C-N 107.26 -4.518 . . . . 34.619999999999997 117.662 -176.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . -72.98 92.06 1.61 Allowed 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 114.115 1.154 . . . . 42.719999999999999 114.115 -174.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 13.7 mt -109.0 101.34 10.43 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 102.936 -2.987 . . . . 52.43 102.936 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 2.3 mp -93.99 128.87 39.58 Favored Pre-proline 0 N--CA 1.481 1.123 0 C-N-CA 118.962 -1.095 . . . . 59.409999999999997 110.014 -177.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -58.68 126.43 21.23 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.779 2.32 . . . . 62.68 107.831 170.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 81.8 -75.24 2.35 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 117.033 -1.982 . . . . 64.159999999999997 108.46 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 91.5 mttt -58.13 149.73 55.44 Favored Pre-proline 0 C--O 1.242 0.676 0 CA-C-N 121.838 2.819 . . . . 68.530000000000001 115.715 -174.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.76 118.49 3.47 Favored 'Trans proline' 0 C--O 1.246 0.9 0 C-N-CA 123.544 2.829 . . . . 61.990000000000002 113.178 167.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1263 ' ' ALA . . . . . . . . . . . . . . . -35.78 122.95 0.68 Allowed Pre-proline 0 C--O 1.245 0.831 0 C-N-CA 124.858 1.263 . . . . 57.149999999999999 111.052 164.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.13 158.6 33.85 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.292 1.995 . . . . 51.57 111.633 -172.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1265 ' ' LYS . . . . . 0.438 ' NZ ' ' O ' ' B' 1289 ' ' GLY . 46.6 mmtm -78.76 76.09 5.26 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 125.566 2.603 . . . . 54.549999999999997 110.751 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 40.3 mt -67.27 -52.99 34.03 Favored 'General case' 0 N--CA 1.438 -1.069 0 O-C-N 118.317 -2.739 . . . . 46.859999999999999 111.615 -177.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1267 ' ' ILE . . . . . . . . . . . . . 38.0 mm -89.15 99.19 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 107.13 -1.433 . . . . 41.039999999999999 107.13 -176.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1268 ' ' THR . . . . . . . . . . . . . 7.8 p -73.64 156.82 37.61 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 111.057 -2.792 . . . . 39.579999999999998 113.301 -175.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1269 ' ' ARG . . . . . . . . . . . . . 78.3 mtt85 -55.81 -41.08 73.65 Favored 'General case' 0 C--O 1.206 -1.21 0 N-CA-C 113.371 0.878 . . . . 53.149999999999999 113.371 -175.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -59.38 -46.52 88.46 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 124.64 1.212 . . . . 42.960000000000001 110.481 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1271 ' ' MET . . . . . . . . . . . . . 48.6 ttm -58.48 -48.08 81.96 Favored 'General case' 0 C--O 1.242 0.66 0 O-C-N 124.096 0.873 . . . . 43.890000000000001 110.252 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1272 ' ' VAL . . . . . . . . . . . . . 33.2 t -57.2 -50.26 77.16 Favored 'Isoleucine or valine' 0 C--O 1.257 1.45 0 O-C-N 125.637 1.836 . . . . 38.369999999999997 111.521 176.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.83 -29.59 67.03 Favored 'General case' 0 C--N 1.357 0.919 0 N-CA-C 115.364 1.616 . . . . 47.460000000000001 115.364 176.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1274 ' ' SER . . . . . . . . . . . . . 50.4 m -84.49 -7.35 59.3 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 126.022 1.729 . . . . 38.380000000000003 114.5 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1275 ' ' MET . . . . . . . . . . . . . 49.5 mtp -66.5 164.77 15.79 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 113.576 0.954 . . . . 37.810000000000002 113.576 -175.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -55.85 137.1 50.87 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 124.645 1.178 . . . . 49.259999999999998 108.506 169.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -67.96 140.99 56.43 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 121.55 -0.719 . . . . 34.460000000000001 111.136 -177.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 72.93 55.15 6.58 Favored Glycine 0 N--CA 1.434 -1.495 0 CA-C-O 122.669 1.149 . . . . 33.530000000000001 113.824 175.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1279 ' ' SER . . . . . . . . . . . . . 70.9 m -141.37 160.87 39.23 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 107.7 -1.222 . . . . 31.309999999999999 107.7 -167.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1280 ' ' VAL . . . . . . . . . . . . . 69.0 t -123.53 141.57 43.32 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 CA-C-N 120.039 1.29 . . . . 29.32 109.547 -169.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1281 ' ' ILE . . . . . . . . . . . . . 74.8 mt -118.2 98.95 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 105.367 -2.086 . . . . 31.93 105.367 170.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1282 ' ' VAL . . . . . . . . . . . . . 5.3 t -86.85 109.84 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 106.77 -1.567 . . . . 29.48 106.77 174.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 58.4 t0 -93.64 111.76 23.5 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 103.236 -2.876 . . . . 34.5 103.236 171.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1284 ' ' LEU . . . . . . . . . . . . . 7.2 mp -74.15 -40.44 62.59 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 113.686 -1.597 . . . . 37.939999999999998 106.718 172.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -76.03 11.52 1.43 Allowed 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 120.285 -1.509 . . . . 40.920000000000002 114.898 -160.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -47.73 -45.05 28.42 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 118.486 2.773 . . . . 44.390000000000001 118.486 176.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1287 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -28.94 68.74 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 122.588 1.185 . . . . 51.460000000000001 112.196 172.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -82.57 -33.9 27.91 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 114.671 1.36 . . . . 57.75 114.671 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1289 ' ' GLY . . . . . 0.438 ' O ' ' NZ ' ' B' 1265 ' ' LYS . . . 164.65 -21.95 0.14 Allowed Glycine 0 CA--C 1.536 1.4 0 C-N-CA 120.138 -1.029 . . . . 49.850000000000001 113.258 -172.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 80.48 112.01 0.29 Allowed Glycine 0 N--CA 1.464 0.535 0 CA-C-O 118.25 -1.305 . . . . 45.93 112.844 175.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1291 ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -89.93 -15.28 32.37 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 119.152 1.476 . . . . 42.670000000000002 114.711 178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1292 ' ' CYS . . . . . . . . . . . . . 48.5 t -105.88 144.06 33.13 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.287 0.847 . . . . 38.82 113.287 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1293 ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -69.5 -16.38 63.44 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 119.189 3.033 . . . . 46.710000000000001 119.189 -176.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -107.39 0.36 22.91 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 120.211 -1.555 . . . . 47.229999999999997 113.023 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1295 ' ' THR . . . . . . . . . . . . . 91.2 m -53.79 115.58 2.07 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 116.148 1.907 . . . . 36.020000000000003 116.148 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 46.5 t -97.13 121.03 60.08 Favored Pre-proline 0 N--CA 1.435 -1.199 0 N-CA-C 102.551 -3.129 . . . . 37.259999999999998 102.551 169.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -51.59 114.29 1.51 Allowed 'Trans proline' 0 C--O 1.238 0.475 0 C-N-CA 124.827 3.684 . . . . 35.090000000000003 116.612 -177.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 66.18 42.56 94.25 Favored Glycine 0 C--O 1.245 0.793 0 CA-C-O 116.342 -2.365 . . . . 35.969999999999999 114.016 -173.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -151.87 175.48 12.43 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 118.484 1.142 . . . . 40.390000000000001 111.17 175.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1300 ' ' ILE . . . . . . . . . . . . . 58.6 mt -110.19 133.49 55.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 107.536 -1.283 . . . . 37.43 107.536 170.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 69.3 t80 -107.8 124.78 50.57 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.509 -0.876 . . . . 44.130000000000003 110.347 163.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1302 ' ' THR . . . . . . . . . . . . . 96.0 m -92.84 126.79 38.09 Favored 'General case' 0 C--O 1.248 0.985 0 O-C-N 120.238 -1.539 . . . . 39.780000000000001 107.95 176.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1303 ' ' THR . . . . . . . . . . . . . 67.5 p -82.56 175.08 10.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 120.851 1.66 . . . . 43.289999999999999 113.249 166.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -69.81 -30.6 68.16 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 122.222 1.01 . . . . 53.07 109.882 -174.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -82.98 14.45 3.31 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 114.5 1.296 . . . . 43.969999999999999 114.5 173.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 70.31 32.23 68.59 Favored Glycine 0 C--O 1.211 -1.339 0 O-C-N 120.569 -1.332 . . . . 41.119999999999997 110.909 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1307 ' ' VAL . . . . . . . . . . . . . 73.6 t -98.67 109.45 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 105.075 -2.194 . . . . 38.119999999999997 105.075 173.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1308 ' ' LYS . . . . . . . . . . . . . 78.5 mttt -86.44 98.04 10.8 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 113.321 -1.763 . . . . 36.340000000000003 107.562 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1309 ' ' VAL . . . . . . . . . . . . . 44.4 t -71.34 90.96 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 CA-C-N 114.608 -1.178 . . . . 30.399999999999999 108.93 172.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1310 ' ' ILE . . . . . . . . . . . . . 37.0 mt -83.46 101.96 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 O-C-N 120.564 -1.335 . . . . 30.82 110.225 176.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1311 ' ' GLY . . . . . . . . . . . . . . . -99.5 63.38 0.7 Allowed Glycine 0 CA--C 1.499 -0.936 0 CA-C-N 114.137 -1.392 . . . . 26.530000000000001 111.317 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1312 ' ' TYR . . . . . . . . . . . . . 8.4 m-30 -82.08 100.44 9.77 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 119.635 -2.097 . . . . 38.0 113.995 -175.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1313 ' ' THR . . . . . . . . . . . . . 98.3 m -51.42 -38.0 51.39 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 114.082 -1.417 . . . . 29.800000000000001 109.733 168.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -95.59 14.86 21.52 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.965 2.106 . . . . 39.039999999999999 112.576 -166.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1315 ' ' LEU . . . . . . . . . . . . . 41.9 mt -50.58 -50.36 72.84 Favored Pre-proline 0 C--O 1.21 -1.019 0 CA-C-O 113.274 -3.25 . . . . 31.079999999999998 116.425 176.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1316 ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -51.73 -34.69 55.14 Favored 'Trans proline' 0 CA--C 1.536 0.581 1 C-N-CA 125.955 4.437 . . . . 26.100000000000001 113.646 174.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -66.16 -48.47 64.57 Favored Glycine 0 C--N 1.344 0.98 0 O-C-N 120.378 -1.451 . . . . 23.170000000000002 113.228 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 75.6 mtt-85 -50.34 -0.55 0.01 OUTLIER 'General case' 0 C--O 1.237 0.405 1 N-CA-C 124.683 5.068 . . . . 40.399999999999999 124.683 -169.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 13.5 tp -126.92 72.67 75.95 Favored Pre-proline 0 C--O 1.245 0.843 0 N-CA-C 104.872 -2.27 . . . . 23.600000000000001 104.872 176.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1320 ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -43.49 -72.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 124.882 3.721 . . . . 22.350000000000001 119.847 -160.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1321 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.9 -37.66 66.61 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 113.349 0.87 . . . . 26.52 113.349 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1322 ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -74.23 -41.96 60.5 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 118.653 -1.219 . . . . 24.379999999999999 110.066 -173.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1323 ' ' SER . . . . . . . . . . . . . 14.8 m -59.43 -40.81 87.93 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.601 -0.84 . . . . 22.800000000000001 112.284 170.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1324 ' ' SER . . . . . . . . . . . . . 13.7 m -64.22 -25.04 67.89 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 115.481 1.66 . . . . 21.25 115.481 170.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -74.05 -50.17 20.88 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.767 -0.583 . . . . 31.34 109.551 175.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1326 ' ' LEU . . . . . . . . . . . . . 13.7 mt -72.33 -51.84 18.85 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 108.125 -1.065 . . . . 31.559999999999999 108.125 -174.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1327 ' ' TYR . . . . . . . . . . . . . 18.7 t80 -51.19 -46.63 62.22 Favored 'General case' 0 C--N 1.377 1.774 0 O-C-N 118.984 -2.322 . . . . 22.73 111.613 172.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1328 ' ' GLY . . . . . . . . . . . . . . . -51.16 -52.91 29.69 Favored Glycine 0 C--O 1.244 0.763 0 CA-C-O 123.654 1.697 . . . . 21.91 112.115 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1329 ' ' THR . . . . . . . . . . . . . 20.1 m -65.69 -36.41 83.56 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.099 -1.074 . . . . 22.149999999999999 108.099 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1330 ' ' ASN . . . . . . . . . . . . . 23.7 m120 -60.56 -47.72 84.92 Favored 'General case' 0 N--CA 1.437 -1.082 0 O-C-N 118.673 -2.517 . . . . 26.18 110.275 178.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1331 ' ' LEU . . . . . . . . . . . . . 20.1 mt -57.61 -42.57 83.52 Favored 'General case' 0 N--CA 1.435 -1.179 0 O-C-N 125.853 1.97 . . . . 23.68 111.842 172.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1332 ' ' VAL . . . . . . . . . . . . . 97.9 t -59.56 -44.91 94.2 Favored 'Isoleucine or valine' 0 C--N 1.349 0.552 0 CA-C-O 121.436 0.636 . . . . 26.57 110.581 178.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -62.67 -45.72 91.5 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.953 0.901 . . . . 28.079999999999998 110.109 -177.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1334 ' ' LEU . . . . . . . . . . . . . 4.3 tp -52.0 -52.17 52.43 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 124.733 1.27 . . . . 27.43 109.616 174.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1335 ' ' LEU . . . . . . . . . . . . . 75.3 mt -72.7 -19.29 61.43 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 114.234 -1.348 . . . . 30.5 113.356 -178.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1336 ' ' LYS . . . . . . . . . . . . . 88.5 mttt -65.63 -48.17 73.11 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-N 122.9 2.591 . . . . 41.649999999999999 107.526 169.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 10.6 mp -75.1 -30.55 60.93 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.362 0.665 . . . . 42.079999999999998 110.663 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1338 ' ' LEU . . . . . . . . . . . . . 79.0 mt -71.11 -51.53 24.55 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 119.697 -1.877 . . . . 35.030000000000001 111.052 172.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 49.8 t -96.5 71.67 2.7 Favored 'General case' 0 C--O 1.254 1.298 0 CA-C-O 124.849 2.261 . . . . 37.329999999999998 107.462 -173.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 12.8 mttp -54.35 -39.08 66.78 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 111.827 -2.442 . . . . 50.509999999999998 112.472 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -98.93 20.06 13.9 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 112.998 0.74 . . . . 54.210000000000001 112.998 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 97.1 mttt 42.6 38.35 1.26 Allowed 'General case' 0 C--O 1.248 0.974 0 C-N-CA 127.758 2.423 . . . . 50.990000000000002 117.081 159.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -111.76 -2.95 15.12 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 112.456 -2.156 . . . . 48.82 109.808 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 89.08 26.1 27.19 Favored Glycine 0 C--O 1.214 -1.1 0 CA-C-O 116.849 -2.084 . . . . 40.43 111.711 -171.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -116.78 122.76 45.37 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-N 122.277 3.038 . . . . 47.560000000000002 113.013 174.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1346 ' ' ILE . . . . . . . . . . . . . 37.6 mm -68.28 113.18 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 124.265 1.026 . . . . 42.490000000000002 111.343 -174.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1347 ' ' THR . . . . . . . . . . . . . 11.2 m -106.13 106.28 16.72 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 104.84 -2.281 . . . . 38.119999999999997 104.84 170.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 98.9 t -81.04 100.97 5.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 106.573 -1.64 . . . . 37.5 106.573 -174.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 61.0 t0 -72.91 113.2 9.67 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.712 -1.131 . . . . 43.850000000000001 111.544 -174.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1350 ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.32 -6.54 25.7 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.567 -1.333 . . . . 39.810000000000002 110.909 176.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -76.51 -29.31 56.75 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.809 -0.632 . . . . 51.289999999999999 110.827 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 42.6 t0 -88.04 127.47 35.4 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 104.147 -2.538 . . . . 39.780000000000001 104.147 -176.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 15.5 m -63.44 -27.26 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 123.766 0.826 . . . . 39.280000000000001 111.519 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1354 ' ' VAL . . . . . . . . . . . . . 50.6 t -65.16 -56.01 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.796 0.838 . . . . 35.700000000000003 112.931 175.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1355 ' ' ILE . . . . . . . . . . . . . 27.5 mm -68.86 -45.62 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-O 117.284 -1.341 . . . . 35.770000000000003 109.263 178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 52.3 tpt85 -49.1 -32.1 9.23 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 120.158 1.344 . . . . 38.549999999999997 114.577 172.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -76.14 -61.33 2.86 Favored Glycine 0 CA--C 1.492 -1.402 0 CA-C-N 116.027 -0.533 . . . . 29.579999999999998 113.101 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1358 ' ' VAL . . . . . . . . . . . . . 13.1 p -64.97 -32.65 59.19 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 O-C-N 122.079 -0.659 . . . . 32.060000000000002 111.053 -172.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1359 ' ' THR . . . . . . . . . . . . . 4.2 m -71.92 81.78 0.92 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 122.85 1.309 . . . . 29.0 108.274 175.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1360 ' ' VAL . . . . . . . . . . . . . 34.8 m -71.13 -26.03 26.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 113.004 -1.907 . . . . 29.68 111.34 -175.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 83.9 mt -132.25 119.22 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 107.118 -1.438 . . . . 32.049999999999997 107.118 170.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1362 ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -106.8 125.34 50.87 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 105.571 -2.011 . . . . 32.520000000000003 105.571 172.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 45.62 37.3 3.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 117.542 2.423 . . . . 35.68 117.542 176.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 85.84 14.88 66.51 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 113.926 -1.488 . . . . 34.259999999999998 116.057 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -108.41 135.48 49.64 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.465 -0.939 . . . . 51.07 108.465 164.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 61.4 mt -69.6 90.71 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 106.57 -1.641 . . . . 39.869999999999997 106.57 173.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1367 ' ' THR . . . . . . . . . . . . 0.252 23.8 p -85.7 10.88 12.21 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 116.698 2.11 . . . . 38.009999999999998 116.698 176.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1368 ' ' TRP . . . . . . . . . . . . . 1.7 t90 -78.07 138.8 60.78 Favored Pre-proline 0 C--O 1.252 1.232 0 N-CA-C 107.586 -1.264 . . . . 42.140000000000001 107.586 166.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -94.3 179.77 9.28 Favored 'Cis proline' 0 C--N 1.35 0.627 0 N-CA-C 115.958 1.484 . . . . 43.259999999999998 115.958 -3.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1370 ' ' ALA . . . . . . . . . . . . . . . -81.97 149.99 64.28 Favored Pre-proline 0 C--O 1.242 0.686 0 CA-C-O 116.77 -1.586 . . . . 46.520000000000003 108.486 163.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -49.01 120.24 5.26 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 124.44 3.427 . . . . 51.950000000000003 110.734 175.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -48.83 100.95 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 125.121 3.88 . . . . 56.270000000000003 117.503 -172.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1373 ' ' ILE . . . . . . . . . . . . . 19.1 tt -76.37 126.16 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 106.34 -1.726 . . . . 60.829999999999998 106.34 172.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -72.02 106.57 4.34 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-O 125.566 2.603 . . . . 66.099999999999994 109.634 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 71.2 t -98.24 121.56 48.92 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 CA-C-N 111.45 -2.614 . . . . 63.469999999999999 106.279 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.218 -5.11 0 O-C-N 120.004 -1.685 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.414 -2.236 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.26 -31.82 71.63 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 124.789 1.235 . . . . 0.0 110.026 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -36.15 83.42 Favored 'General case' 0 C--O 1.252 1.19 0 CA-C-N 119.398 0.999 . . . . 0.0 109.787 175.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 84.8 m -67.04 -33.03 74.65 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 118.622 0.646 . . . . 0.0 109.91 171.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.65 -50.35 51.91 Favored 'General case' 0 C--O 1.246 0.87 0 O-C-N 119.41 -2.056 . . . . 0.0 110.973 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -41.72 -57.28 2.37 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.728 -1.233 . . . . 0.0 113.557 162.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 84.7 mt -60.96 -25.42 66.81 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 175.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 44.4 mt -58.37 -56.46 21.81 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 116.613 -1.66 . . . . 0.0 110.868 172.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 28' ' ' LYS . . . . . . . . . . . . . 12.3 pttt -67.9 -31.33 71.04 Favored 'General case' 0 C--O 1.257 1.459 0 CA-C-O 123.556 1.646 . . . . 0.0 110.272 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -64.46 -27.33 68.91 Favored 'General case' 0 C--O 1.212 -0.886 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 169.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 35.4 m -65.69 -31.85 73.08 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 116.582 2.068 . . . . 0.0 116.582 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 61.08 -60.79 0.08 Allowed 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.289 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 42.0 m -85.74 137.04 33.09 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 117.072 -3.518 . . . . 0.0 106.948 156.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 60.7 t -127.99 94.33 2.48 Favored 'Isoleucine or valine' 0 C--O 1.246 0.892 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 174.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 23.6 mm -74.11 110.25 7.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 O-C-N 118.607 -2.558 . . . . 0.0 107.666 168.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 33.6 mt -85.88 114.59 25.85 Favored 'Isoleucine or valine' 0 C--O 1.254 1.303 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 169.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 36.2 m -93.67 107.88 30.3 Favored Pre-proline 0 C--O 1.246 0.914 0 O-C-N 121.08 -1.013 . . . . 0.0 110.382 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -61.18 91.35 0.1 OUTLIER 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 123.294 2.663 . . . . 0.0 113.382 177.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.56 168.92 40.5 Favored Glycine 0 N--CA 1.432 -1.569 0 CA-C-N 113.086 -1.87 . . . . 0.0 108.624 169.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -57.43 -28.04 62.96 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -177.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.45 -32.71 69.06 Favored Glycine 0 C--O 1.244 0.758 0 O-C-N 120.83 -1.169 . . . . 0.0 112.536 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 16.1 ttm -55.64 -44.54 77.26 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.557 -0.822 . . . . 0.0 111.454 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.89 -51.97 10.29 Favored 'General case' 0 C--O 1.214 -0.777 0 O-C-N 124.967 1.417 . . . . 0.0 111.627 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 11.3 p -67.43 -41.47 86.17 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 C-N-CA 119.333 -0.947 . . . . 0.0 113.358 -168.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.47 19.71 6.97 Favored 'General case' 0 N--CA 1.424 -1.731 0 O-C-N 120.899 -1.125 . . . . 0.0 110.597 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 45' ' ' GLN . . . . . . . . . . . . 0.353 0.0 OUTLIER 30.31 56.65 0.19 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 117.819 2.525 . . . . 0.0 117.819 -167.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.26 -14.19 59.54 Favored 'General case' 0 C--O 1.202 -1.44 0 CA-C-N 111.891 -2.413 . . . . 0.0 114.094 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.89 -26.38 66.85 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 48' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -62.58 -52.2 66.95 Favored Pre-proline 0 N--CA 1.443 -0.787 0 CA-C-O 117.636 -1.174 . . . . 0.0 111.767 170.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 49' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -63.58 -39.34 36.12 Favored 'Trans proline' 0 CA--C 1.551 1.359 0 C-N-CA 122.846 2.364 . . . . 0.0 114.231 170.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 54.2 t -59.81 -37.4 71.39 Favored 'Isoleucine or valine' 0 C--N 1.346 0.442 0 CA-C-O 116.126 -1.892 . . . . 0.0 111.191 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.02 -46.8 89.26 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 122.971 2.623 . . . . 0.0 108.993 -176.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -69.57 -41.18 76.19 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.332 -1.304 . . . . 0.0 113.721 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 10.2 tp -60.45 -39.72 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 120.309 1.413 . . . . 0.0 113.002 172.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 95.0 m -60.68 -46.82 88.91 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.166 173.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -55.15 -50.82 68.33 Favored 'General case' 0 C--O 1.252 1.184 0 C-N-CA 127.178 2.191 . . . . 0.0 110.231 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -57.57 -50.73 72.14 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 116.59 2.071 . . . . 0.0 116.59 175.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 29.6 mt -63.06 -40.33 97.38 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.803 -0.561 . . . . 0.0 111.787 175.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -67.7 -46.04 73.41 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 118.787 -0.625 . . . . 0.0 109.882 -175.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.74 -31.72 72.98 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 120.231 1.378 . . . . 0.0 112.502 175.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -61.36 -28.52 69.29 Favored 'General case' 0 C--N 1.346 0.45 0 O-C-N 119.913 -1.742 . . . . 0.0 110.89 171.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.4 1.84 40.91 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -177.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 64.5 mt -73.28 137.18 23.88 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 CA-C-O 126.096 2.855 . . . . 0.0 107.131 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -81.52 67.01 7.31 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 112.275 -2.239 . . . . 0.0 111.754 -177.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 2.8 p -78.51 128.64 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 173.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 30.2 mmm-85 -137.42 148.78 46.42 Favored 'General case' 0 C--N 1.349 0.546 0 N-CA-C 103.468 -2.79 . . . . 0.0 103.468 -174.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -106.09 118.89 37.8 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 122.798 1.285 . . . . 0.0 111.048 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -97.29 83.05 0.72 Allowed Glycine 0 C--O 1.25 1.107 0 N-CA-C 107.919 -2.072 . . . . 0.0 107.919 -177.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 mp -73.03 126.38 33.59 Favored 'Isoleucine or valine' 0 C--N 1.348 0.518 0 CA-C-N 119.918 1.859 . . . . 0.0 110.191 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -118.16 91.98 41.59 Favored Pre-proline 0 CA--C 1.5 -0.945 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.911 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 70' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -54.39 -39.29 88.07 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 124.733 3.622 . . . . 0.0 118.307 -168.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 42.2 t -71.03 95.57 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 171.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -161.49 106.58 1.31 Allowed 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.445 1.117 . . . . 0.0 110.762 -172.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.31 -90.95 0.53 Allowed Glycine 0 N--CA 1.467 0.719 0 O-C-N 118.34 -2.725 . . . . 0.0 113.984 156.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -145.91 114.09 6.61 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -169.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 4.0 mp 60.36 119.89 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.416 0 O-C-N 127.079 2.737 . . . . 0.0 116.808 175.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -66.69 165.14 26.54 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 124.244 3.296 . . . . 0.0 109.423 167.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.39 -115.94 5.01 Favored Glycine 0 CA--C 1.505 -0.535 0 O-C-N 120.21 -1.556 . . . . 0.0 110.338 -169.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 49.56 -79.95 0.01 OUTLIER 'General case' 0 C--O 1.248 0.979 0 C-N-CA 124.819 1.248 . . . . 0.0 114.166 155.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -67.65 -35.43 78.87 Favored 'General case' 0 C--O 1.241 0.652 0 O-C-N 118.962 -2.336 . . . . 0.0 110.209 -177.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -64.13 -34.1 77.29 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 74.8 t -65.71 -41.03 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 122.139 -0.351 . . . . 0.0 111.351 176.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 45.9 mt -66.63 -30.27 70.5 Favored 'General case' 0 C--O 1.252 1.194 0 CA-C-O 123.361 1.553 . . . . 0.0 109.904 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 6.0 mp -66.89 -48.34 69.05 Favored 'General case' 0 C--O 1.24 0.568 0 O-C-N 120.869 -1.144 . . . . 0.0 110.162 172.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.18 -49.42 77.1 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 177.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -58.59 -55.04 40.18 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-O 117.873 -1.061 . . . . 0.0 109.075 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.77 9.08 0.3 Allowed 'General case' 0 C--O 1.246 0.874 0 CA-C-N 121.158 1.799 . . . . 0.0 114.05 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp 64.14 30.87 13.64 Favored 'General case' 0 C--O 1.257 1.5 0 CA-C-N 122.017 2.19 . . . . 0.0 115.012 172.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 60.7 t -72.34 120.24 79.33 Favored Pre-proline 0 C--O 1.262 1.722 0 N-CA-C 104.462 -2.421 . . . . 0.0 104.462 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -56.71 115.94 2.84 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.854 3.036 . . . . 0.0 116.37 -171.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -60.69 -22.37 63.85 Favored 'General case' 0 C--O 1.246 0.885 0 CA-C-O 123.381 1.562 . . . . 0.0 114.125 173.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -43.19 -56.75 3.28 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 124.87 1.268 . . . . 0.0 112.758 164.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 1.9 pt -96.43 -10.38 8.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.577 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 41.5 t -74.13 108.43 5.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-O 123.749 1.738 . . . . 0.0 110.656 175.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 6.0 mt -106.25 95.61 5.89 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 120.624 -1.297 . . . . 0.0 110.975 176.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -71.19 91.53 0.95 Allowed 'General case' 0 C--O 1.255 1.352 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.056 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 39.3 ttp 50.52 97.8 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 124.503 2.097 . . . . 0.0 116.445 -175.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -157.94 163.51 37.77 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 113.396 -1.729 . . . . 0.0 107.53 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -84.8 94.92 8.82 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 124.975 2.322 . . . . 0.0 111.471 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 10.3 tp -100.03 41.02 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 CA-C-N 109.079 -3.691 . . . . 0.0 107.386 164.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -76.91 -31.12 56.47 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 119.984 -1.698 . . . . 0.0 108.153 -161.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -63.45 -61.22 2.48 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 124.576 1.15 . . . . 0.0 113.93 170.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.83 -21.08 66.45 Favored 'General case' 0 C--N 1.355 0.818 0 O-C-N 123.852 0.72 . . . . 0.0 111.626 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.62 -60.17 3.94 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 123.304 0.642 . . . . 0.0 110.768 170.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.25 -31.35 72.48 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 173.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -66.24 -26.45 67.37 Favored 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 120.509 -1.369 . . . . 0.0 111.837 175.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 106' ' ' THR . . . . . . . . . . . . . 53.6 m -73.02 125.75 28.35 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 121.842 2.11 . . . . 0.0 108.946 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 107' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -72.36 -43.37 64.13 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 113.006 -1.906 . . . . 0.0 110.621 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 80.0 m -125.62 104.53 8.44 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 119.015 0.825 . . . . 0.0 111.622 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 109' ' ' VAL . . . . . . . . . . . . . 8.1 t -87.0 120.95 37.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -171.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 20.8 mt -90.32 93.77 9.47 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -171.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 19.1 t -84.81 109.31 17.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.037 170.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 6.5 mm -78.06 90.02 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.919 0 CA-C-O 121.888 0.851 . . . . 0.0 110.652 -174.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.79 -72.95 2.54 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-O 124.106 1.948 . . . . 0.0 113.969 168.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.77 108.29 8.52 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 120.773 -1.428 . . . . 0.0 112.819 -168.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 115' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -65.75 -58.46 5.62 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 113.106 -1.861 . . . . 0.0 115.213 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 116' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -57.62 -19.38 25.77 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 116.713 2.116 . . . . 0.0 116.713 -168.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 3.1 m -44.54 -43.47 8.03 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.658 1.983 . . . . 0.0 110.624 173.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 13.7 m -125.07 37.75 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.624 0 CA-C-O 122.952 1.358 . . . . 0.0 110.83 -177.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -77.82 114.22 39.55 Favored Pre-proline 0 C--O 1.243 0.73 0 O-C-N 120.463 -1.398 . . . . 0.0 110.832 -176.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 120' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -64.6 -34.0 53.69 Favored 'Trans proline' 0 CA--C 1.495 -1.471 0 C-N-CA 125.045 3.83 . . . . 0.0 114.183 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.23 -30.27 71.33 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 118.614 -1.235 . . . . 0.0 110.429 174.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.72 -19.83 64.37 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -86.7 -59.78 2.17 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 118.039 -2.913 . . . . 0.0 114.621 161.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -65.44 -45.05 85.33 Favored 'General case' 0 N--CA 1.438 -1.067 0 O-C-N 127.431 2.957 . . . . 0.0 115.042 -168.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.59 119.98 77.84 Favored Pre-proline 0 C--O 1.243 0.735 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -170.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -75.49 76.01 3.73 Favored 'Trans proline' 0 N--CA 1.436 -1.878 1 C-N-CA 125.843 4.362 . . . . 0.0 109.413 175.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? 174.98 -25.5 0.0 OUTLIER 'General case' 0 C--O 1.248 0.981 0 C-N-CA 125.98 1.712 . . . . 0.0 108.378 -173.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 128' ' ' SER . . . . . . . . . . . . . 73.8 m -68.17 126.62 92.87 Favored Pre-proline 0 N--CA 1.446 -0.658 0 CA-C-N 120.961 1.709 . . . . 0.0 112.024 175.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 129' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -56.72 -58.39 0.98 Allowed 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 123.836 3.024 . . . . 0.0 114.091 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 13.3 pt -73.21 66.32 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 C-N-CA 123.977 0.911 . . . . 0.0 112.308 171.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -72.93 150.9 42.15 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 122.695 1.236 . . . . 0.0 113.409 -170.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.03 53.36 27.0 Favored Glycine 0 CA--C 1.497 -1.045 0 CA-C-N 111.846 -2.434 . . . . 0.0 107.679 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 133' ' ' MET . . . . . . . . . . . . . 24.5 tpp -76.62 129.45 79.4 Favored Pre-proline 0 C--O 1.252 1.185 0 CA-C-N 118.69 1.245 . . . . 0.0 110.715 175.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -62.78 101.93 0.28 Allowed 'Trans proline' 0 CA--C 1.517 -0.341 0 C-N-CA 125.22 3.947 . . . . 0.0 110.981 171.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 15.7 t -120.45 93.88 2.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 1 N-CA-C 99.743 -4.169 . . . . 0.0 99.743 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 5.1 mt -73.5 78.84 1.43 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.451 0.643 . . . . 0.0 112.196 -170.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 48.68 5.05 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 120.243 3.423 . . . . 0.0 120.243 -167.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 138' ' ' VAL . . . . . . . . . . . . 0.291 13.0 p -76.22 61.9 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 117.457 2.391 . . . . 0.0 117.457 -173.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 17.7 p90 -158.2 178.18 10.47 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 123.302 0.641 . . . . 0.0 109.618 171.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 140' ' ' LYS . . . . . . . . . . . . . 15.4 pttm 63.58 -58.16 0.19 Allowed 'General case' 0 C--O 1.247 0.933 0 C-N-CA 126.998 2.119 . . . . 0.0 115.681 174.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -90.76 174.28 7.56 Favored 'General case' 0 C--N 1.319 -0.746 0 O-C-N 120.122 -1.611 . . . . 0.0 107.346 170.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 63.97 157.51 0.08 Allowed 'General case' 0 C--N 1.345 0.383 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 172.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 143' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -80.14 79.26 6.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 125.167 2.413 . . . . 0.0 107.075 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 144' ' ' VAL . . . . . . . . . . . . . 58.0 t -85.94 83.97 2.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 O-C-N 118.598 -2.564 . . . . 0.0 106.001 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 145' ' ' ILE . . . . . . . . . . . . . 35.7 mt -88.91 109.18 19.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 125.501 2.572 . . . . 0.0 114.823 -170.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 146' ' ' VAL . . . . . . . . . . . . . 27.1 t -96.05 108.58 21.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 109.444 -3.525 . . . . 0.0 107.142 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 147' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -70.75 102.58 2.35 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 148' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -131.28 133.77 45.73 Favored 'General case' 0 C--O 1.244 0.797 0 O-C-N 118.973 -2.329 . . . . 0.0 109.512 -175.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 19.6 ttm105 -83.37 -92.27 0.07 Allowed 'General case' 0 C--O 1.24 0.565 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 176.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 1.1 m -70.52 131.46 44.05 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 121.475 1.943 . . . . 0.0 111.056 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 5.7 tpt -75.58 92.86 2.96 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-O 125.823 2.725 . . . . 0.0 107.713 163.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 152' ' ' ASN . . . . . 0.415 ' ND2' HO3A ' C' 1001 ' ' NAP . 11.4 p-10 -133.85 152.02 51.73 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-N 110.698 -2.956 . . . . 0.0 109.523 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 73.2 m -63.46 150.63 43.27 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.396 172.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -111.2 -81.32 1.17 Allowed Glycine 0 C--N 1.353 1.527 0 N-CA-C 107.27 -2.332 . . . . 0.0 107.27 165.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -112.0 -46.94 3.17 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 117.51 -1.233 . . . . 0.0 110.876 174.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 156' ' ' ALA . . . . . . . . . . . . . . . -87.4 -69.18 0.7 Allowed 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 119.614 1.097 . . . . 0.0 110.403 166.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 50.15 32.08 20.17 Favored Glycine 0 C--N 1.34 0.802 0 N-CA-C 115.218 0.847 . . . . 0.0 115.218 -170.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 14.6 m -92.26 153.69 3.26 Favored 'Isoleucine or valine' 0 C--O 1.253 1.27 0 C-N-CA 123.41 0.684 . . . . 0.0 110.007 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -41.76 112.05 0.29 Allowed 'General case' 0 C--N 1.345 0.394 0 N-CA-C 119.75 3.241 . . . . 0.0 119.75 176.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 160' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -157.54 159.09 30.9 Favored Pre-proline 0 N--CA 1.436 -1.147 0 O-C-N 120.486 -1.384 . . . . 0.0 110.511 -173.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -38.38 -57.7 0.82 Allowed 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 124.43 3.42 . . . . 0.0 112.313 176.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 162' ' ' LEU . . . . . . . . . . . . . 9.6 mp -43.21 -31.34 0.59 Allowed 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 -175.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 163' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -88.11 -59.57 2.2 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.729 -1.578 . . . . 0.0 107.382 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -91.44 -10.16 42.0 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 116.579 2.066 . . . . 0.0 116.579 -161.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -84.58 152.62 23.74 Favored 'General case' 0 C--O 1.243 0.713 0 O-C-N 120.614 -1.304 . . . . 0.0 110.639 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -78.87 -34.08 45.25 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-N 112.936 -1.938 . . . . 0.0 110.546 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 40.3 p-10 -91.78 -63.16 1.28 Allowed 'General case' 0 C--O 1.245 0.848 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 168' ' ' THR . . . . . . . . . . . . . 25.1 m -72.02 102.71 3.03 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 117.091 -3.505 . . . . 0.0 103.328 172.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -143.72 136.57 27.42 Favored 'General case' 0 CA--C 1.5 -0.962 0 O-C-N 119.254 -2.154 . . . . 0.0 112.692 -153.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 170' ' ' MET . . . . . . . . . . . . . 76.9 mtm -67.12 119.97 12.93 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 120.526 -1.359 . . . . 0.0 109.057 163.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 171' ' ' LEU . . . . . . . . . . . . . 13.1 tp -83.92 144.65 29.06 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 168.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -89.22 99.27 12.3 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 -167.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . 154.79 166.4 15.18 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-O 124.466 2.148 . . . . 0.0 109.992 167.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 174' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -50.68 153.13 1.78 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.339 1.856 . . . . 0.0 112.648 169.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.9 -56.0 27.16 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.886 1.274 . . . . 0.0 110.842 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.81 -39.88 76.25 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 121.272 -0.892 . . . . 0.0 112.61 -177.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 177' ' ' ALA . . . . . . . . . . . . . . . -53.73 -44.1 69.62 Favored 'General case' 0 C--O 1.256 1.395 0 C-N-CA 125.249 1.42 . . . . 0.0 110.642 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 20.0 m -74.81 -42.5 57.93 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.0 -1.454 . . . . 0.0 111.456 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 179' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.17 -55.01 26.82 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-N 120.223 1.374 . . . . 0.0 112.335 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -55.87 -39.12 71.05 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 119.001 -2.312 . . . . 0.0 112.672 178.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -54.46 -56.59 17.23 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 117.479 -1.248 . . . . 0.0 111.172 169.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 182' ' ' ILE . . . . . . . . . . . . . 19.0 pt -66.59 -32.32 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 121.058 1.754 . . . . 0.0 114.583 -175.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 183' ' ' LEU . . . . . . . . . . . . . 59.3 tp -48.27 -57.14 6.38 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 127.002 2.121 . . . . 0.0 112.581 170.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 24.6 tptt -75.15 -33.48 61.52 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 124.83 1.332 . . . . 0.0 112.648 -178.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -67.78 -91.61 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.17 0 O-C-N 126.502 2.376 . . . . 0.0 110.972 177.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 186' ' ' LEU . . . . . . . . . . . . 0.25 8.8 mt . . . . . 0 C--O 1.205 -1.255 0 O-C-N 120.237 -1.54 . . . . 0.0 112.505 -152.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' NAD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C 1001 ' ' NAP . . . . . 0.415 HO3A ' ND2' ' C' ' 152' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 42.2 t-80 . . . . . 0 N--CA 1.419 -1.999 0 N-CA-C 105.757 -1.942 . . . . 65.739999999999995 105.757 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -69.1 66.88 0.5 Allowed Glycine 0 C--N 1.348 1.236 0 C-N-CA 123.937 0.779 . . . . 48.659999999999997 111.622 172.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -80.18 124.86 29.16 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 120.002 -0.679 . . . . 44.560000000000002 109.388 173.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1003 ' ' ILE . . . . . . . . . . . . . 34.8 mt -95.65 132.71 39.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 120.554 -1.341 . . . . 34.859999999999999 107.668 171.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -105.11 127.76 9.17 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 108.438 -1.865 . . . . 30.75 108.438 172.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 23.0 mm -103.01 108.63 59.29 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 102.903 -2.999 . . . . 32.210000000000001 102.903 172.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -74.09 167.09 28.03 Favored 'Trans proline' 0 N--CA 1.439 -1.68 0 C-N-CA 122.474 2.116 . . . . 32.979999999999997 111.104 171.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1007 ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -84.77 131.78 34.51 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 102.438 -3.171 . . . . 47.979999999999997 102.438 157.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1008 ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -55.81 134.19 51.58 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 117.157 2.28 . . . . 34.700000000000003 117.157 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 21.7 mtp-105 -101.18 0.44 37.61 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 113.658 -1.61 . . . . 53.369999999999997 110.796 -171.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 52.7 tp -70.57 136.78 49.53 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 106.314 -1.735 . . . . 45.07 106.314 169.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1011 ' ' THR . . . . . . . . . . . . . 45.8 m -57.27 135.39 56.46 Favored 'General case' 0 C--O 1.243 0.76 0 O-C-N 120.461 -1.4 . . . . 40.359999999999999 109.81 -174.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 84.3 m-20 60.34 27.92 17.51 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 116.412 2.004 . . . . 40.609999999999999 116.412 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -87.74 147.93 24.97 Favored 'General case' 0 CA--C 1.504 -0.811 0 C-N-CA 118.616 -1.234 . . . . 33.759999999999998 109.797 -174.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1014 ' ' THR . . . . . . . . . . . . . 1.9 m -117.06 -14.41 10.58 Favored 'General case' 0 C--O 1.257 1.483 0 CA-C-O 124.199 1.952 . . . . 27.890000000000001 110.81 176.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1015 ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -66.12 125.76 26.52 Favored 'General case' 0 C--O 1.214 -0.775 0 O-C-N 119.468 -2.02 . . . . 29.02 114.054 173.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1016 ' ' VAL . . . . . . . . . . . . . 3.4 t -120.52 150.81 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 106.721 -1.585 . . . . 28.129999999999999 106.721 165.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1017 ' ' ALA . . . . . . . . . . . . . . . -59.19 -53.24 60.6 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 117.311 2.337 . . . . 26.870000000000001 117.311 -177.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -129.52 143.05 50.67 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 112.22 0.452 . . . . 26.77 112.22 -167.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1019 ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.5 174.06 6.74 Favored Pre-proline 0 C--N 1.347 0.475 0 C-N-CA 124.176 0.99 . . . . 27.02 110.887 168.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1020 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -54.18 -34.96 81.03 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.33 2.687 . . . . 30.57 111.455 168.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -55.24 -58.02 9.4 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 114.055 -1.43 . . . . 47.810000000000002 112.461 173.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1022 ' ' THR . . . . . . . . . . . . 0.281 3.2 p -77.13 -21.75 53.67 Favored 'General case' 0 C--N 1.309 -1.17 0 O-C-N 120.312 -1.492 . . . . 30.77 112.892 -174.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1023 ' ' VAL . . . . . . . . . . . . . 8.9 t -56.89 -51.29 69.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 N-CA-C 108.594 -0.891 . . . . 33.590000000000003 108.594 164.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -65.8 -32.73 74.42 Favored 'General case' 0 C--N 1.35 0.617 0 N-CA-C 114.284 1.216 . . . . 53.289999999999999 114.284 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -58.2 -49.71 76.09 Favored 'General case' 0 C--O 1.254 1.336 0 CA-C-N 119.286 0.948 . . . . 46.920000000000002 112.125 170.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1026 ' ' LEU . . . . . . . . . . . . . 14.9 mt -59.75 -38.56 82.1 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 118.527 -2.608 . . . . 37.170000000000002 114.006 176.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 29.3 tp -59.11 -40.59 85.83 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 113.848 -1.523 . . . . 44.439999999999998 112.404 171.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -70.06 -26.29 63.94 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 119.526 -1.983 . . . . 52.579999999999998 113.71 173.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1029 ' ' LEU . . . . . . . . . . . . . 25.5 mt -65.51 -39.88 92.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.609 0.719 . . . . 45.689999999999998 111.019 162.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 115.55 15.57 7.47 Favored Glycine 0 CA--C 1.503 -0.715 0 O-C-N 118.708 -2.495 . . . . 42.090000000000003 110.97 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -92.82 147.54 22.77 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 107.299 -1.371 . . . . 40.719999999999999 107.299 168.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1032 ' ' THR . . . . . . . . . . . . . 10.7 m -99.17 118.68 36.44 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.056 -1.091 . . . . 37.770000000000003 108.056 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1033 ' ' VAL . . . . . . . . . . . . . 3.5 t -89.49 141.96 13.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.134 -0.939 . . . . 33.539999999999999 111.761 -171.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -128.58 135.01 48.77 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 104.445 -2.428 . . . . 31.68 104.445 176.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1035 ' ' VAL . . . . . . . . . . . . . 69.2 t -119.71 144.5 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 O-C-N 120.697 -1.252 . . . . 31.52 110.718 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1036 ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -72.7 130.2 39.99 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 124.155 0.91 . . . . 41.039999999999999 110.778 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1037 ' ' SER . . . . . . . . . . . . . 65.9 m -60.1 111.2 1.42 Allowed 'General case' 0 C--O 1.262 1.714 0 N-CA-C 107.293 -1.373 . . . . 31.829999999999998 107.293 165.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 130.01 -32.41 3.14 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.573 -0.822 . . . . 29.359999999999999 111.127 -172.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -64.08 -39.89 95.06 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 117.594 -1.193 . . . . 27.780000000000001 108.842 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -52.08 -47.32 55.03 Favored Glycine 0 C--N 1.359 1.809 0 CA-C-O 121.817 0.676 . . . . 28.91 112.325 169.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -66.24 -32.37 73.75 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.771 -0.841 . . . . 51.18 110.894 -175.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1042 ' ' LEU . . . . . . . . . . . . . 14.0 mt -69.93 -56.3 7.39 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 121.16 1.8 . . . . 29.91 111.528 165.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1043 ' ' ALA . . . . . . . . . . . . . . . -69.9 12.31 0.22 Allowed 'General case' 0 CA--C 1.556 1.2 0 O-C-N 119.334 -2.104 . . . . 28.539999999999999 112.636 -174.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1044 ' ' SER . . . . . . . . . . . . . 13.8 m 63.27 59.54 1.26 Allowed 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 124.454 2.073 . . . . 33.060000000000002 113.863 174.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1045 ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -150.58 167.15 28.1 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 111.088 -2.778 . . . . 30.289999999999999 106.52 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1046 ' ' ASP . . . . . 0.428 ' CG ' ' HZ1' ' A' 1048 ' ' LYS . 24.4 p-10 -97.25 151.34 19.95 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 106.624 -1.621 . . . . 48.619999999999997 106.624 151.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -59.84 -16.99 32.97 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 114.199 1.185 . . . . 36.740000000000002 114.199 -166.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1048 ' ' LYS . . . . . 0.428 ' HZ1' ' CG ' ' A' 1046 ' ' ASP . 20.5 pttm -55.05 -26.36 36.99 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 121.987 2.176 . . . . 43.729999999999997 110.91 174.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -52.73 -53.63 45.17 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 120.661 -1.274 . . . . 32.810000000000002 112.576 171.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1050 ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -63.09 -33.38 75.32 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.909 -1.041 . . . . 31.859999999999999 113.657 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 25.5 t -63.98 -41.27 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 O-C-N 121.157 -0.964 . . . . 33.219999999999999 109.313 173.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -64.41 -41.99 96.31 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 122.468 1.128 . . . . 50.829999999999998 111.586 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -60.48 -52.76 63.82 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 114.333 -1.303 . . . . 33.119999999999997 110.64 170.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 122.34 75.03 0.33 Allowed Glycine 0 CA--C 1.489 -1.555 0 CA-C-O 123.523 1.624 . . . . 35.829999999999998 110.057 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -143.26 127.22 17.34 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 105.809 -1.923 . . . . 34.82 105.809 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -62.28 118.57 7.61 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.283 -0.871 . . . . 49.049999999999997 111.718 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1057 ' ' ILE . . . . . . . . . . . . . 17.3 mm -89.04 124.62 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 124.538 2.113 . . . . 38.530000000000001 110.953 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1058 ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.11 158.55 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 110.877 -2.874 . . . . 42.109999999999999 107.133 -175.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -88.22 167.8 13.28 Favored 'General case' 0 C--O 1.259 1.592 0 N-CA-C 113.925 1.083 . . . . 58.0 113.925 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . -31.05 -69.66 0.09 OUTLIER Glycine 0 C--N 1.348 1.235 0 N-CA-C 117.881 1.912 . . . . 52.119999999999997 117.881 -172.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 5.4 m120 -64.37 -33.59 76.2 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 119.912 1.856 . . . . 54.75 112.215 -169.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1062 ' ' SER . . . . . . . . . . . . . 16.8 m -73.91 -40.33 63.22 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 125.972 2.045 . . . . 50.340000000000003 108.009 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 4.1 p -68.88 -25.95 31.46 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 CA-C-N 122.473 2.397 . . . . 41.460000000000001 111.415 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1064 ' ' TRP . . . . . . . . . . . . . 11.4 m95 -66.21 -29.56 69.84 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-N 115.303 -0.862 . . . . 39.32 112.837 173.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -81.31 79.44 7.94 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 123.423 1.582 . . . . 55.380000000000003 107.847 -174.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1066 ' ' SER . . . . . . . . . . . . . 58.7 m -147.63 161.4 41.23 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 120.553 -1.342 . . . . 41.869999999999997 108.771 -171.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -69.62 -44.78 69.98 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 107.009 -1.478 . . . . 53.200000000000003 107.009 -176.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 5.2 mp -120.12 139.44 47.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 103.605 -2.739 . . . . 41.899999999999999 103.605 -178.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1069 ' ' ILE . . . . . . . . . . . . . 9.7 mm -119.23 126.9 75.76 Favored 'Isoleucine or valine' 0 C--O 1.248 0.989 0 N-CA-C 105.292 -2.114 . . . . 38.729999999999997 105.292 170.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1070 ' ' LEU . . . . . . . . . . . . . 71.4 mt -107.47 87.6 2.54 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-O 122.618 1.199 . . . . 32.439999999999998 108.233 173.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1071 ' ' LYS . . . . . . . . . . . . . 3.5 mmmt -87.32 171.67 10.43 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 107.429 -1.322 . . . . 34.649999999999999 107.429 166.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1072 ' ' VAL . . . . . . . . . . . . . 8.0 t -100.37 -78.05 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 107.043 -1.465 . . . . 31.32 107.043 171.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -101.26 140.25 35.82 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 108.038 -1.097 . . . . 33.939999999999998 108.038 -161.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . 27.58 103.03 0.01 OUTLIER Pre-proline 0 C--O 1.247 0.933 0 N-CA-C 119.642 3.201 . . . . 38.039999999999999 119.642 171.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1075 ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -76.39 91.04 1.15 Allowed 'Trans proline' 0 CA--C 1.509 -0.77 0 C-N-CA 123.678 2.918 . . . . 42.68 109.541 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 65.3 mt -71.36 -179.75 2.59 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 114.425 -1.262 . . . . 46.740000000000002 114.043 -171.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.38 -35.6 67.9 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 116.907 2.188 . . . . 58.609999999999999 116.907 -173.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 16.4 t70 -67.2 -47.86 69.63 Favored 'General case' 0 C--O 1.26 1.641 0 C-N-CA 124.094 0.957 . . . . 59.200000000000003 110.388 173.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1079 ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -53.78 -37.35 63.36 Favored 'General case' 0 C--N 1.363 1.173 0 CA-C-O 117.108 -1.425 . . . . 50.630000000000003 110.753 174.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1080 ' ' ILE . . . . . . . . . . . . . 55.6 mt -54.4 -47.3 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-N 119.433 1.015 . . . . 51.479999999999997 111.05 175.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -64.19 -33.77 76.56 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.54 1.518 . . . . 50.280000000000001 109.843 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 34.6 mt -71.82 -27.04 62.64 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 114.044 1.127 . . . . 50.210000000000001 114.044 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1083 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.44 133.15 49.79 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-O 122.656 1.217 . . . . 49.060000000000002 112.205 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.02 125.96 62.65 Favored Pre-proline 0 N--CA 1.472 0.627 0 N-CA-C 101.431 -3.544 . . . . 51.079999999999998 101.431 177.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.87 63.92 0.03 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 124.165 3.243 . . . . 49.729999999999997 119.729 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 173.44 -33.68 0.11 Allowed Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.111 -1.195 . . . . 47.710000000000001 110.111 -168.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1087 ' ' THR . . . . . . . . . . . . . 98.0 m -44.78 130.13 7.12 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 117.42 2.378 . . . . 45.469999999999999 117.42 -175.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1088 ' ' THR . . . . . . . . . . . . . 1.4 m -75.53 93.82 3.06 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 113.427 -1.715 . . . . 42.039999999999999 108.956 170.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1089 ' ' LEU . . . . . . . . . . . . . 54.8 tp -90.67 92.83 9.0 Favored 'General case' 0 C--N 1.348 0.535 0 O-C-N 121.074 -1.016 . . . . 38.060000000000002 108.398 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 89.1 t -99.65 99.03 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 102.559 -3.126 . . . . 37.399999999999999 102.559 -172.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1091 ' ' SER . . . . . . . . . . . . . 49.5 m -152.55 166.31 32.44 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 115.51 1.67 . . . . 36.159999999999997 115.51 -174.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -66.42 88.28 0.13 Allowed 'General case' 0 C--O 1.253 1.274 0 O-C-N 118.118 -2.864 . . . . 38.939999999999998 109.822 161.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 26.2 mm -81.22 -32.43 12.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 122.935 1.35 . . . . 42.170000000000002 110.981 -173.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 77.8 m95 60.5 48.53 1.71 Allowed Pre-proline 0 C--O 1.243 0.717 0 C-N-CA 125.306 1.442 . . . . 46.509999999999998 111.108 -170.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -54.68 -44.62 47.91 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 124.691 3.594 . . . . 49.759999999999998 116.468 -169.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -67.41 -33.98 76.29 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 122.529 1.157 . . . . 52.619999999999997 110.724 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -85.2 -5.39 59.33 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 114.67 -1.15 . . . . 60.740000000000002 110.657 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1098 ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -130.94 64.17 72.83 Favored Pre-proline 0 N--CA 1.439 -0.975 0 N-CA-C 114.082 1.141 . . . . 58.189999999999998 114.082 -178.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -61.11 -42.97 32.28 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.759 2.973 . . . . 54.590000000000003 114.8 -174.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 52.2 mp0 -70.5 -42.73 70.96 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.541 -0.911 . . . . 63.280000000000001 108.541 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1101 ' ' LEU . . . . . . . . . . . . . 5.7 tp -57.39 -41.14 79.67 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.859 0.864 . . . . 54.75 109.309 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1102 ' ' MET . . . . . . . . . . . . . 43.1 mmm -54.93 -48.37 73.22 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 120.599 -1.313 . . . . 52.649999999999999 112.46 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -61.25 -41.11 96.35 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 124.305 1.042 . . . . 66.260000000000005 110.479 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -74.23 -34.1 63.57 Favored 'General case' 0 C--O 1.247 0.946 0 O-C-N 121.373 -0.829 . . . . 63.729999999999997 110.947 -177.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 79.3 mt -68.51 -35.13 77.06 Favored 'General case' 0 C--O 1.253 1.281 0 CA-C-O 121.218 0.532 . . . . 54.68 109.826 174.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -66.83 -40.37 87.97 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.59 0.709 . . . . 53.640000000000001 112.089 172.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -54.91 -33.13 61.76 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.607 2.363 . . . . 67.239999999999995 113.981 168.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.43 10.49 3.08 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 116.121 -1.895 . . . . 65.760000000000005 115.343 172.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 20.1 t30 53.65 21.17 2.47 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 123.136 2.698 . . . . 58.710000000000001 114.602 173.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1110 ' ' VAL . . . . . . . . . . . . . 17.9 m -90.67 175.08 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 O-C-N 118.412 -2.68 . . . . 46.630000000000003 114.422 -173.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1111 ' ' THR . . . . . . . . . . . . . 22.0 m -112.91 90.84 3.45 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 106.788 -1.56 . . . . 44.130000000000003 106.788 174.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1112 ' ' VAL . . . . . . . . . . . . . 53.0 t -92.14 109.98 22.15 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 CA-C-N 114.653 -1.158 . . . . 40.439999999999998 110.446 -173.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1113 ' ' MET . . . . . . . . . . . . . 64.6 mtp -102.93 115.52 30.76 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 112.326 -2.216 . . . . 50.759999999999998 110.489 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1114 ' ' ALA . . . . . . . . . . . . . . . -94.44 94.08 8.03 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-N 114.435 -1.257 . . . . 35.640000000000001 109.511 -169.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1115 ' ' MET . . . . . . . . . . . . . 83.8 mmm -57.7 -34.49 69.5 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 114.951 1.463 . . . . 38.740000000000002 114.951 -178.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -61.04 -38.69 87.04 Favored 'General case' 0 C--O 1.219 -0.525 0 O-C-N 121.694 -0.629 . . . . 40.140000000000001 110.533 174.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1117 ' ' SER . . . . . . . . . . . . . 47.9 m -94.68 27.88 2.87 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 115.058 1.503 . . . . 44.789999999999999 115.058 -176.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1118 ' ' VAL . . . . . . . . . . . . . 10.3 m -53.96 140.93 50.25 Favored Pre-proline 0 N--CA 1.436 -1.166 0 CA-C-O 117.49 -1.243 . . . . 43.75 112.072 168.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -66.2 125.71 14.51 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.373 2.716 . . . . 48.93 109.684 168.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 34.1 mmm-85 -78.81 20.31 0.47 Allowed 'General case' 0 C--O 1.249 1.041 0 N-CA-C 117.082 2.253 . . . . 62.899999999999999 117.082 -160.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 38.9 pt -72.86 167.99 2.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 114.538 1.31 . . . . 57.719999999999999 114.538 -167.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1122 ' ' SER . . . . . . . . . . . . . 6.7 m -59.73 -40.35 87.76 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-O 118.066 -0.968 . . . . 57.259999999999998 111.435 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -56.45 -36.23 68.79 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 121.443 1.929 . . . . 62.899999999999999 108.762 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -73.75 -24.34 59.86 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-O 116.114 -1.898 . . . . 49.829999999999998 115.68 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1125 ' ' GLN . . . . . . . . . . . . 0.28 73.4 mm-40 -46.8 -21.96 0.26 Allowed 'General case' 0 N--CA 1.474 0.754 1 N-CA-C 122.352 4.205 . . . . 52.369999999999997 122.352 -169.238 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A 1126 ' ' SER . . . . . . . . . . . . . 11.9 p -85.07 -35.66 21.7 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 119.199 -2.188 . . . . 42.43 109.971 172.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1127 ' ' LEU . . . . . . . . . . . . . 4.6 mp -84.78 -18.79 33.92 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.354 1.862 . . . . 43.740000000000002 112.394 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 53.8 t0 -70.97 92.92 0.95 Allowed 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 125.423 2.535 . . . . 43.210000000000001 110.645 -173.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -61.02 -40.98 95.67 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 110.024 -3.262 . . . . 35.740000000000002 111.273 177.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.95 -28.63 68.44 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 119.043 -2.286 . . . . 38.090000000000003 108.737 -176.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1131 ' ' SER . . . . . . . . . . . . . 75.0 m -67.71 -55.47 13.05 Favored 'General case' 0 CA--C 1.501 -0.935 0 O-C-N 119.487 -2.008 . . . . 36.909999999999997 113.634 172.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1132 ' ' SER . . . . . . . . . . . . . 4.1 m -61.99 -43.85 97.97 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 119.159 0.89 . . . . 35.789999999999999 113.203 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1133 ' ' MET . . . . . . . . . . . . . 13.9 mmm -59.58 -41.56 90.5 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 121.005 1.73 . . . . 30.809999999999999 109.897 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1134 ' ' ALA . . . . . . . . . . . . . . . -63.45 -45.03 92.74 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 123.636 0.775 . . . . 28.879999999999999 109.157 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1135 ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -59.5 -46.25 89.37 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.532 0.682 . . . . 40.759999999999998 112.237 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1136 ' ' ILE . . . . . . . . . . . . . 68.6 mt -55.9 -50.3 69.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 125.038 1.335 . . . . 31.539999999999999 109.4 173.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -62.55 -32.1 73.01 Favored 'General case' 0 C--N 1.344 0.352 0 N-CA-C 114.193 1.183 . . . . 29.870000000000001 114.193 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -70.53 -44.02 59.33 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 118.914 0.779 . . . . 28.73 112.412 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 20.1 t80 -66.76 -48.5 68.89 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 107.321 -1.363 . . . . 30.390000000000001 107.321 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1140 ' ' ARG . . . . . 0.44 ' NH1' ' O ' ' A' 1318 ' ' ARG . 6.0 tpt180 -65.19 -26.22 68.05 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 113.577 0.954 . . . . 26.09 113.577 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1141 ' ' ALA . . . . . . . . . . . . . . . -58.84 -53.5 57.68 Favored 'General case' 0 C--N 1.359 1.0 0 CA-C-O 118.521 -0.752 . . . . 27.100000000000001 109.914 167.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 32.8 mm -51.8 -43.58 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 O-C-N 124.238 0.961 . . . . 28.48 112.219 172.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 76.2 t -58.98 -62.02 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-N 119.655 1.116 . . . . 23.07 112.687 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1144 ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -64.73 -29.1 70.07 Favored 'General case' 0 C--N 1.343 0.296 0 O-C-N 120.703 -1.248 . . . . 33.399999999999999 111.551 -177.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -54.61 -63.95 0.99 Allowed 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 117.784 -1.103 . . . . 24.219999999999999 112.601 165.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -54.35 -23.17 14.35 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 122.881 1.324 . . . . 24.890000000000001 113.908 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -66.63 -69.03 0.33 Allowed 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 120.272 -1.518 . . . . 26.73 110.13 169.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1148 ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -73.72 -9.46 58.68 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 116.684 2.105 . . . . 39.960000000000001 116.684 -176.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1149 ' ' PHE . . . . . . . . . . . . . 1.2 t80 -59.99 146.18 43.53 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 123.272 1.511 . . . . 25.870000000000001 111.678 176.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1150 ' ' GLY . . . . . . . . . . . . . . . -80.63 -38.92 15.42 Favored Glycine 0 N--CA 1.429 -1.816 0 CA-C-N 113.374 -1.739 . . . . 19.280000000000001 109.617 173.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1151 ' ' ARG . . . . . . . . . . . . . 66.6 mtm-85 -113.84 -170.83 1.78 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 121.157 2.479 . . . . 39.899999999999999 114.774 -163.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1152 ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -83.49 152.97 24.67 Favored 'General case' 0 C--O 1.218 -0.557 0 O-C-N 119.369 -2.082 . . . . 29.440000000000001 113.637 165.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1153 ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -70.64 -49.75 44.2 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 113.232 -1.804 . . . . 32.600000000000001 107.509 157.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1154 ' ' THR . . . . . . . . . . . . . 1.8 m -76.47 115.57 16.34 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 125.236 1.414 . . . . 34.640000000000001 113.955 -165.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -69.47 109.06 2.71 Favored Glycine 0 C--O 1.251 1.176 0 N-CA-C 105.838 -2.905 . . . . 37.140000000000001 105.838 170.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -158.9 -169.3 2.64 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-N 117.918 0.859 . . . . 40.57 111.99 -174.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1157 ' ' ILE . . . . . . . . . . . . . 1.5 tp -137.02 142.51 37.43 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.201 0 C-N-CA 125.426 1.49 . . . . 44.609999999999999 111.298 -171.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1158 ' ' THR . . . . . . . . . . . . . 1.1 p -93.33 -143.07 0.22 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.592 -1.64 . . . . 40.700000000000003 109.03 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -103.09 -14.3 16.47 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.423 -1.695 . . . . 40.25 106.423 157.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -76.09 -58.19 3.43 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 117.198 2.296 . . . . 38.469999999999999 117.198 173.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . 175.92 -165.27 35.81 Favored Glycine 0 CA--C 1.505 -0.556 0 CA-C-O 124.58 2.211 . . . . 37.609999999999999 111.128 -170.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1162 ' ' LYS . . . . . 0.437 ' HZ3' ' CD ' ' C' ' 95' ' ' GLU . 8.8 tttp -64.29 130.55 44.29 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 111.823 -2.188 . . . . 48.899999999999999 111.327 -171.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1163 ' ' VAL . . . . . . . . . . . . . 10.1 t -100.93 114.69 65.82 Favored Pre-proline 0 N--CA 1.426 -1.661 0 CA-C-N 110.589 -3.005 . . . . 36.520000000000003 104.401 165.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1164 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -73.05 137.05 25.81 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 124.938 3.759 . . . . 35.079999999999998 116.827 -176.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1165 ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.01 138.69 28.71 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 124.003 3.135 . . . . 35.329999999999998 116.312 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -79.63 141.96 36.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.212 -1.358 . . . . 34.689999999999998 112.415 174.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1167 ' ' LYS . . . . . . . . . . . . . 44.1 mttp -100.69 115.14 29.55 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 113.099 -1.864 . . . . 45.359999999999999 107.298 172.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 49.9 t -100.38 91.38 2.15 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 CA-C-N 113.745 -1.571 . . . . 31.710000000000001 108.825 -174.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1169 ' ' MET . . . . . . . . . . . . . 35.3 ttp -76.85 92.67 3.64 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 123.749 1.737 . . . . 42.280000000000001 111.981 175.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 42.9 t -81.0 110.58 16.64 Favored 'Isoleucine or valine' 0 C--O 1.246 0.919 0 O-C-N 121.104 -0.997 . . . . 30.510000000000002 110.067 174.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 66.7 mt -88.84 119.63 36.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.194 -1.039 . . . . 31.870000000000001 108.194 176.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 87.13 87.23 1.09 Allowed Glycine 0 CA--C 1.537 1.428 0 N-CA-C 106.74 -2.544 . . . . 34.539999999999999 106.74 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1173 ' ' ALA . . . . . . . . . . . . . . . -85.05 57.3 4.37 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 120.45 2.125 . . . . 32.509999999999998 111.612 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -73.85 -163.73 9.27 Favored Glycine 0 N--CA 1.448 -0.566 0 O-C-N 120.224 -1.548 . . . . 29.899999999999999 109.439 160.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1175 ' ' VAL . . . . . . . . . . . . . 3.5 t -62.25 -36.6 75.34 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 O-C-N 121.342 -1.093 . . . . 33.109999999999999 111.651 -174.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -61.48 -43.12 99.42 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 113.626 -1.625 . . . . 28.100000000000001 114.363 170.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -63.32 -49.94 66.59 Favored Glycine 0 C--N 1.312 -0.752 0 N-CA-C 110.322 -1.111 . . . . 28.539999999999999 110.322 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1178 ' ' LEU . . . . . . . . . . . . . 70.3 mt -53.56 -51.6 62.4 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 117.693 0.747 . . . . 31.219999999999999 112.387 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -51.21 -46.34 62.19 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.624 0.972 . . . . 28.98 113.624 175.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -60.13 -41.1 91.96 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 116.664 2.098 . . . . 27.829999999999998 116.664 174.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1181 ' ' ILE . . . . . . . . . . . . . 55.8 mt -64.8 -50.47 75.19 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 O-C-N 121.252 -0.905 . . . . 30.25 109.678 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -50.36 -54.77 18.79 Favored Glycine 0 C--O 1.241 0.579 0 O-C-N 120.54 -1.35 . . . . 29.59 110.289 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -59.88 -48.0 83.46 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 116.243 1.942 . . . . 30.289999999999999 116.243 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -68.77 -43.94 74.73 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.478 -1.389 . . . . 30.469999999999999 112.537 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -60.18 -43.68 95.67 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 118.482 0.583 . . . . 42.409999999999997 110.906 176.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1186 ' ' SER . . . . . . . . . . . . . 72.4 m -48.65 -40.44 27.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.719 1.007 . . . . 39.380000000000003 113.719 164.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 27.2 mt -91.02 24.83 2.65 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 115.154 1.538 . . . . 36.18 115.154 173.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 69.38 8.9 60.19 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 115.535 0.974 . . . . 33.780000000000001 115.535 171.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -79.24 145.14 33.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 118.464 1.132 . . . . 33.93 111.63 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 9.5 mt -77.26 88.48 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 105.459 -2.052 . . . . 38.740000000000002 105.459 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 14.0 t -76.21 125.59 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 106.828 -1.545 . . . . 33.090000000000003 106.828 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1192 ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -114.39 99.75 7.81 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 105.045 -2.206 . . . . 38.920000000000002 105.045 170.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -92.91 144.35 25.35 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 119.58 -1.95 . . . . 35.32 111.126 177.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 37.6 t80 -128.76 157.05 42.5 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 106.904 -1.517 . . . . 39.350000000000001 106.904 171.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 8.0 t0 -163.1 148.09 11.49 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 105.983 -1.858 . . . . 40.460000000000001 105.983 168.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1196 ' ' THR . . . . . . . . . . . . . 1.1 p -77.38 -12.52 59.96 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 114.837 -1.074 . . . . 45.939999999999998 112.359 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1197 ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -94.06 115.74 65.56 Favored Pre-proline 0 N--CA 1.471 0.619 0 N-CA-C 106.146 -1.798 . . . . 56.020000000000003 106.146 172.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1198 ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -66.3 -14.71 45.38 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.305 2.003 . . . . 51.270000000000003 114.473 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -51.72 -54.41 28.7 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 122.328 1.061 . . . . 59.100000000000001 112.342 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 26.8 m -71.95 -2.91 3.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 115.402 1.63 . . . . 51.060000000000002 115.402 -169.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 83.5 tttt -55.36 -36.08 65.94 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 119.758 -1.839 . . . . 57.380000000000003 113.074 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -71.38 -37.73 71.58 Favored 'General case' 0 C--O 1.247 0.922 0 CA-C-N 118.552 0.614 . . . . 62.409999999999997 110.657 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -62.84 -37.79 88.2 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 120.739 -1.226 . . . . 57.780000000000001 112.719 171.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 25.4 t -58.49 -47.48 88.15 Favored 'Isoleucine or valine' 0 C--N 1.343 0.297 0 O-C-N 124.006 0.816 . . . . 46.380000000000003 111.432 173.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -54.09 -54.08 44.36 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.261 1.024 . . . . 50.700000000000003 113.349 171.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1206 ' ' SER . . . . . . . . . . . . . 6.4 m -62.32 -42.85 99.72 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 113.323 0.86 . . . . 49.979999999999997 113.323 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1207 ' ' MET . . . . . . . . . . . . . 29.0 mtp -77.49 -13.31 59.95 Favored 'General case' 0 C--O 1.242 0.692 0 O-C-N 117.635 -3.166 . . . . 52.990000000000002 114.107 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 97.7 59.64 0.96 Allowed Glycine 0 N--CA 1.429 -1.802 0 O-C-N 121.427 -0.795 . . . . 47.659999999999997 111.151 166.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -134.26 151.22 51.17 Favored 'General case' 0 N--CA 1.457 -0.087 0 O-C-N 120.126 -1.808 . . . . 44.770000000000003 110.709 167.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -76.15 145.73 39.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.805 -1.089 . . . . 47.640000000000001 108.763 165.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1211 ' ' PHE . . . . . . . . . . . . . 9.9 t80 -93.97 160.06 14.89 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 106.947 -1.501 . . . . 45.659999999999997 106.947 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 77.7 mt -85.39 106.4 16.73 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 104.613 -2.366 . . . . 46.060000000000002 104.613 171.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -73.86 97.59 2.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.314 -0.857 . . . . 60.219999999999999 108.793 168.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 5.8 tp -65.68 101.54 0.64 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.472 -0.785 . . . . 57.25 109.653 -174.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 19.7 t0 -61.08 100.27 0.11 Allowed 'General case' 0 C--O 1.247 0.925 0 O-C-N 124.73 1.268 . . . . 64.430000000000007 108.483 175.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 3.8 t80 . . . . . 0 C--O 1.212 -0.91 0 N-CA-C 102.556 -3.127 . . . . 66.900000000000006 102.556 179.27 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 2.8 p30 . . . . . 0 N--CA 1.426 -1.659 0 CA-C-O 118.765 -0.636 . . . . 39.090000000000003 109.569 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -57.35 -36.88 78.5 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 118.66 0.663 . . . . 39.32 113.565 -170.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 76.8 t80 -74.96 -43.67 52.74 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-O 116.901 -1.523 . . . . 39.299999999999997 110.287 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -58.14 -46.35 85.79 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.617 1.099 . . . . 36.299999999999997 111.057 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -62.54 -72.09 0.14 Allowed 'General case' 0 C--N 1.346 0.415 0 CA-C-O 117.332 -1.318 . . . . 37.380000000000003 110.326 173.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -50.18 -42.04 19.47 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 N-CA-C 117.468 2.396 . . . . 39.109999999999999 117.468 -172.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1230 ' ' MET . . . . . . . . . . . . . 21.0 mmt -86.23 1.67 49.94 Favored 'General case' 0 C--O 1.25 1.13 0 O-C-N 119.532 -1.98 . . . . 49.590000000000003 113.576 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1231 ' ' SER . . . . . . . . . . . . . 22.1 p -76.89 143.38 39.66 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 122.304 2.32 . . . . 43.68 110.52 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -49.08 -47.57 44.92 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.727 1.211 . . . . 55.57 112.961 -174.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -60.18 -34.04 73.05 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 113.333 0.864 . . . . 44.939999999999998 113.333 172.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 13.3 t80 -69.27 -49.82 52.57 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 120.46 1.482 . . . . 42.039999999999999 108.363 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 63.4 mt -58.53 -34.6 51.52 Favored 'Isoleucine or valine' 0 C--O 1.249 1.048 0 CA-C-O 118.325 -0.845 . . . . 46.280000000000001 110.026 175.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 25.8 tttm -62.43 -44.75 95.69 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 119.743 1.156 . . . . 47.869999999999997 108.844 171.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -60.71 -33.77 73.38 Favored 'General case' 0 C--O 1.25 1.104 0 O-C-N 119.406 -2.059 . . . . 41.609999999999999 112.755 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -56.22 -51.65 67.29 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 113.723 1.008 . . . . 50.649999999999999 113.723 168.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1239 ' ' MET . . . . . . . . . . . . . 8.3 mmm -57.55 -47.94 80.66 Favored 'General case' 0 C--O 1.247 0.972 0 C-N-CA 124.745 1.218 . . . . 48.869999999999997 112.018 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -58.65 -45.31 89.6 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 118.864 -0.588 . . . . 54.799999999999997 112.239 177.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 1.8 mm? -63.07 -39.09 93.68 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 123.672 0.608 . . . . 43.210000000000001 112.453 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -70.64 -39.34 73.73 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 125.492 1.745 . . . . 38.659999999999997 111.214 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -63.68 -29.49 70.71 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.131 1.772 . . . . 37.920000000000002 114.743 174.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -74.22 -66.23 0.75 Allowed 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 113.593 -1.64 . . . . 37.280000000000001 110.236 173.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -52.79 -31.48 38.82 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 124.699 1.2 . . . . 43.07 113.619 -177.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -45.17 -46.2 11.97 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.814 1.246 . . . . 38.299999999999997 111.857 175.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1247 ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -68.77 -18.21 64.16 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 116.682 -1.628 . . . . 47.600000000000001 113.736 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -113.29 -30.45 6.92 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 121.322 1.874 . . . . 45.420000000000002 114.896 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1249 ' ' VAL . . . . . . . . . . . . . 29.6 m -78.41 172.35 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 O-C-N 119.954 -1.716 . . . . 36.259999999999998 113.607 -171.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1250 ' ' ASP . . . . . 0.43 ' CG ' ' HZ3' ' A' 1276 ' ' LYS . 4.5 m-20 -121.71 -64.48 1.21 Allowed 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 124.018 0.824 . . . . 33.039999999999999 111.245 -173.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1251 ' ' ILE . . . . . . . . . . . . . 32.3 mm -102.73 123.21 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 N-CA-C 105.629 -1.989 . . . . 31.399999999999999 105.629 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1252 ' ' ILE . . . . . . . . . . . . . 68.3 mt -105.85 136.41 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 O-C-N 124.764 1.29 . . . . 29.420000000000002 107.83 165.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 65.3 t -119.23 108.69 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.008 0 N-CA-C 104.265 -2.495 . . . . 30.370000000000001 104.265 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1254 ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.53 95.82 7.56 Favored 'General case' 0 C--O 1.246 0.89 0 CA-C-N 121.828 2.103 . . . . 35.719999999999999 113.188 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1255 ' ' THR . . . . . . . . . . . . . 36.6 p -72.23 -24.99 61.47 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 119.068 2.988 . . . . 36.0 119.068 -166.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1256 ' ' ALA . . . . . . . . . . . . . . . -70.89 74.81 0.62 Allowed 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 117.571 2.434 . . . . 40.93 117.571 -151.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 14.0 tp -71.0 81.34 0.66 Allowed 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.174 -1.417 . . . . 47.82 107.174 167.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 42.6 mm -75.44 134.95 72.71 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 104.503 -2.406 . . . . 52.700000000000003 104.503 173.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -64.86 92.93 0.21 Allowed 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 122.131 1.887 . . . . 54.130000000000003 114.545 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 93.99 -57.51 2.14 Favored Glycine 0 CA--C 1.489 -1.57 0 O-C-N 121.019 -1.051 . . . . 54.619999999999997 112.754 166.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 25.1 mtmt -63.86 119.93 59.1 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-O 116.567 -1.682 . . . . 55.740000000000002 107.652 174.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -56.98 134.44 64.53 Favored 'Trans proline' 0 CA--C 1.5 -1.201 0 C-N-CA 124.131 3.221 . . . . 51.149999999999999 114.808 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -62.15 122.96 76.04 Favored Pre-proline 0 C--O 1.247 0.943 0 O-C-N 124.089 0.868 . . . . 46.060000000000002 110.114 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -49.59 133.26 31.87 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 125.282 3.988 . . . . 41.079999999999998 117.494 -175.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -68.07 83.36 0.22 Allowed 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.528 -0.916 . . . . 47.420000000000002 108.528 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 98.0 mt -79.42 -41.55 27.4 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 122.476 1.131 . . . . 39.219999999999999 108.473 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 21.7 mt -97.65 91.41 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 N-CA-C 105.013 -2.217 . . . . 42.5 105.013 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1268 ' ' THR . . . . . . . . . . . . . 39.6 p -71.16 153.84 42.18 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.589 -1.187 . . . . 37.840000000000003 111.233 176.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -47.0 -50.67 18.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.354 1.462 . . . . 54.799999999999997 111.136 -177.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -42.89 -46.6 5.39 Favored 'General case' 0 C--O 1.249 1.072 0 C-N-CA 124.123 0.969 . . . . 54.359999999999999 113.426 172.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1271 ' ' MET . . . . . . . . . . . . . 26.6 mtt -68.83 -41.57 78.38 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 118.522 -0.752 . . . . 39.520000000000003 112.213 177.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1272 ' ' VAL . . . . . . . . . . . . . 14.0 t -65.95 -44.53 92.37 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 CA-C-O 121.811 0.815 . . . . 38.25 109.648 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -54.66 -44.02 72.91 Favored 'General case' 0 C--O 1.249 1.048 0 C-N-CA 124.466 1.107 . . . . 40.770000000000003 111.793 171.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1274 ' ' SER . . . . . . . . . . . . . 76.5 p -86.05 12.3 9.83 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 119.579 -1.951 . . . . 36.579999999999998 115.072 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1275 ' ' MET . . . . . . . . . . . . . 52.5 mtp -70.89 160.92 31.93 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 123.521 1.629 . . . . 36.75 110.751 173.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1276 ' ' LYS . . . . . 0.43 ' HZ3' ' CG ' ' A' 1250 ' ' ASP . 36.4 ttpt -68.61 134.84 50.53 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 112.999 -1.909 . . . . 46.109999999999999 106.007 166.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1277 ' ' ALA . . . . . . . . . . . . . . . -85.69 -179.73 6.92 Favored 'General case' 0 C--O 1.261 1.677 0 N-CA-C 115.365 1.617 . . . . 33.520000000000003 115.365 -176.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 67.99 29.05 73.3 Favored Glycine 0 CA--C 1.538 1.515 0 O-C-N 120.315 -1.491 . . . . 31.27 109.697 -171.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1279 ' ' SER . . . . . . . . . . . . . 16.7 m -131.33 173.21 11.29 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.692 1.746 . . . . 32.950000000000003 110.833 -165.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1280 ' ' VAL . . . . . . . . . . . . . 98.5 t -140.77 144.63 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 O-C-N 118.623 -2.548 . . . . 27.43 104.783 -169.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1281 ' ' ILE . . . . . . . . . . . . . 59.9 mt -119.08 107.18 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.646 0 N-CA-C 101.813 -3.402 . . . . 30.300000000000001 101.813 164.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -92.36 104.2 15.39 Favored 'Isoleucine or valine' 0 C--O 1.25 1.102 0 N-CA-C 107.019 -1.474 . . . . 28.629999999999999 107.019 171.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 7.1 t70 -96.03 115.38 27.34 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 111.472 -2.604 . . . . 36.270000000000003 109.396 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1284 ' ' LEU . . . . . . . . . . . . . 90.9 mt -87.2 -29.19 21.91 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 112.237 -2.256 . . . . 38.57 111.194 -173.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -62.51 -41.67 98.99 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 114.711 -1.132 . . . . 37.560000000000002 111.293 176.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . 22.84 -75.97 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 120.158 3.392 . . . . 40.329999999999998 120.158 174.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -59.92 -42.73 94.57 Favored 'General case' 0 C--O 1.212 -0.875 0 CA-C-O 121.538 0.685 . . . . 56.850000000000001 111.44 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 29.9 t30 -85.34 65.29 9.12 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.094 -1.412 . . . . 45.859999999999999 108.633 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 84.34 -57.61 5.02 Favored Glycine 0 C--O 1.246 0.858 0 O-C-N 120.63 -1.294 . . . . 40.310000000000002 113.682 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 84.51 128.62 1.75 Allowed Glycine 0 CA--C 1.538 1.515 0 N-CA-C 108.531 -1.828 . . . . 38.890000000000001 108.531 -171.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1291 ' ' ASN . . . . . . . . . . . . . 33.8 m120 -74.9 -21.6 59.12 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.743 1.771 . . . . 37.229999999999997 111.545 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1292 ' ' CYS . . . . . . . . . . . . . 18.0 t -96.79 148.24 23.11 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.417 -1.427 . . . . 36.5 107.851 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1293 ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -75.13 -39.98 60.12 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 120.556 -1.34 . . . . 43.32 111.94 177.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -65.11 -5.88 7.69 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 115.291 1.589 . . . . 41.32 115.291 174.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1295 ' ' THR . . . . . . . . . . . . . 86.5 m -58.48 115.18 2.84 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 119.262 0.937 . . . . 35.299999999999997 110.514 174.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 35.4 t -96.77 114.28 64.27 Favored Pre-proline 0 C--N 1.313 -1.004 0 N-CA-C 102.126 -3.287 . . . . 34.840000000000003 102.126 169.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -54.34 118.01 4.56 Favored 'Trans proline' 0 CA--C 1.537 0.669 1 C-N-CA 125.787 4.324 . . . . 33.509999999999998 111.757 176.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 99.19 -16.06 59.65 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 113.144 -1.844 . . . . 32.189999999999998 113.063 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -135.61 162.91 31.38 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 125.009 2.338 . . . . 34.880000000000003 115.541 -167.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1300 ' ' ILE . . . . . . . . . . . . . 50.1 mt -75.58 140.59 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 CA-C-N 112.635 -2.075 . . . . 32.289999999999999 110.539 167.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 54.5 t80 -129.38 120.02 24.86 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 120.113 1.324 . . . . 37.25 108.194 159.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1302 ' ' THR . . . . . . . . . . . . . 34.8 m -79.14 125.05 28.92 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 104.198 -2.519 . . . . 35.560000000000002 104.198 172.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1303 ' ' THR . . . . . . . . . . . . . 76.3 p -85.45 -179.63 6.97 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 113.991 1.108 . . . . 36.399999999999999 113.991 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -67.84 -34.36 76.56 Favored 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 120.131 -1.606 . . . . 52.32 112.33 -170.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -74.99 -41.85 58.69 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.09 -1.414 . . . . 40.039999999999999 111.001 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 118.38 57.72 0.28 Allowed Glycine 0 N--CA 1.448 -0.512 0 O-C-N 119.901 -1.749 . . . . 36.960000000000001 109.207 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1307 ' ' VAL . . . . . . . . . . . . . 73.5 t -124.32 121.12 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.898 0 N-CA-C 101.336 -3.579 . . . . 33.399999999999999 101.336 174.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1308 ' ' LYS . . . . . . . . . . . . . 20.8 mmtp -81.81 95.68 7.37 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 113.4 -1.727 . . . . 42.909999999999997 108.507 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 44.0 t -85.83 93.44 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 O-C-N 121.125 -0.984 . . . . 32.289999999999999 108.618 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1310 ' ' ILE . . . . . . . . . . . . . 61.0 mt -89.52 95.33 5.36 Favored 'Isoleucine or valine' 0 C--O 1.256 1.419 0 N-CA-C 105.378 -2.082 . . . . 30.989999999999998 105.378 -174.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -91.37 56.75 3.15 Favored Glycine 0 N--CA 1.431 -1.641 0 N-CA-C 110.877 -0.889 . . . . 28.949999999999999 110.877 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1312 ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -78.66 113.54 16.81 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 120.602 2.201 . . . . 31.690000000000001 116.808 -170.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1313 ' ' THR . . . . . . . . . . . . . 4.6 p -71.8 -40.38 69.23 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 125.889 2.757 . . . . 34.170000000000002 109.841 -177.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -69.81 -0.88 7.91 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 110.072 -3.24 . . . . 36.859999999999999 115.802 176.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1315 ' ' LEU . . . . . . . . . . . . 0.342 42.0 mt -40.65 -45.9 5.9 Favored Pre-proline 0 N--CA 1.487 1.404 0 N-CA-C 121.241 3.793 . . . . 34.850000000000001 121.241 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -56.55 -47.26 24.71 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.916 2.411 . . . . 29.149999999999999 110.529 168.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -61.18 -44.81 97.65 Favored Glycine 0 CA--C 1.483 -1.936 0 CA-C-O 118.545 -1.142 . . . . 27.289999999999999 111.578 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1318 ' ' ARG . . . . . 0.44 ' O ' ' NH1' ' A' 1140 ' ' ARG . 59.2 mtt-85 -60.21 -15.72 26.96 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 114.204 1.187 . . . . 41.490000000000002 114.204 174.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1319 ' ' LEU . . . . . . . . . . . . . 14.0 tp -110.95 73.2 0.86 Allowed Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-N 123.258 2.754 . . . . 27.609999999999999 103.779 166.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1320 ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -59.06 -58.93 0.53 Allowed 'Trans proline' 0 C--O 1.213 -0.769 0 C-N-CA 122.85 2.367 . . . . 25.940000000000001 112.567 -159.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1321 ' ' THR . . . . . . . . . . . . . 3.1 m -58.37 -30.37 66.73 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 112.797 -2.001 . . . . 25.010000000000002 113.704 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1322 ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -74.23 -39.87 62.79 Favored 'General case' 0 N--CA 1.436 -1.166 0 O-C-N 120.589 -1.32 . . . . 29.390000000000001 110.852 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1323 ' ' SER . . . . . . . . . . . . . 75.0 m -52.7 -53.18 51.1 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 118.912 0.778 . . . . 26.469999999999999 109.449 168.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1324 ' ' SER . . . . . . . . . . . . . 2.3 m -61.0 -26.12 67.37 Favored 'General case' 0 C--O 1.25 1.121 0 N-CA-C 114.335 1.235 . . . . 27.780000000000001 114.335 175.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -75.37 -63.15 1.34 Allowed 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 117.739 -3.1 . . . . 37.530000000000001 110.228 172.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1326 ' ' LEU . . . . . . . . . . . . . 18.2 mt -77.98 -47.86 17.56 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 116.973 -1.489 . . . . 35.710000000000001 114.357 -170.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1327 ' ' TYR . . . . . . . . . . . . . 32.1 t80 -59.29 -47.29 85.92 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 105.877 -1.897 . . . . 31.59 105.877 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1328 ' ' GLY . . . . . . . . . . . . . . . -40.78 -54.47 3.51 Favored Glycine 0 CA--C 1.544 1.847 0 C-N-CA 124.668 1.127 . . . . 28.0 114.778 167.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1329 ' ' THR . . . . . . . . . . . . . 28.7 m -67.57 -35.09 78.36 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-O 118.106 -0.95 . . . . 32.149999999999999 109.449 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1330 ' ' ASN . . . . . . . . . . . . . 29.2 m120 -62.47 -43.86 97.79 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.579 -0.897 . . . . 34.359999999999999 108.579 174.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1331 ' ' LEU . . . . . . . . . . . . . 13.9 mt -59.96 -50.16 74.84 Favored 'General case' 0 C--O 1.213 -0.85 0 N-CA-C 109.367 -0.605 . . . . 33.369999999999997 109.367 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1332 ' ' VAL . . . . . . . . . . . . . 44.2 t -57.04 -40.17 71.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 118.787 -0.625 . . . . 35.270000000000003 111.181 174.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -68.02 -38.45 82.6 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 114.602 1.334 . . . . 37.659999999999997 114.602 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1334 ' ' LEU . . . . . . . . . . . . . 28.9 tp -60.97 -48.61 81.03 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 106.916 -1.513 . . . . 40.270000000000003 106.916 172.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1335 ' ' LEU . . . . . . . . . . . . . 20.5 mt -71.66 -4.4 27.11 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 114.625 1.343 . . . . 42.5 114.625 175.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1336 ' ' LYS . . . . . . . . . . . . . 82.6 mttt -74.76 -44.91 47.22 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 121.81 2.095 . . . . 47.810000000000002 111.774 161.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1337 ' ' LEU . . . . . . . . . . . . . 10.4 mp -62.34 -41.02 98.24 Favored 'General case' 0 C--O 1.216 -0.672 0 C-N-CA 118.555 -1.258 . . . . 49.270000000000003 113.8 172.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1338 ' ' LEU . . . . . . . . . . . . . 10.2 mp -70.8 -69.38 0.37 Allowed 'General case' 0 CA--C 1.51 -0.577 0 O-C-N 124.695 1.247 . . . . 50.539999999999999 113.054 172.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1339 ' ' CYS . . . . . . . . . . . . . 51.5 t -69.71 91.95 0.64 Allowed 'General case' 0 CA--C 1.503 -0.835 0 O-C-N 118.396 -2.69 . . . . 53.670000000000002 107.571 172.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 72.3 tttt -83.73 -62.56 1.54 Allowed 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.121 -1.4 . . . . 63.380000000000003 108.052 -165.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -74.88 -35.89 62.3 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 124.82 1.248 . . . . 70.950000000000003 114.057 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1342 ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? 62.22 83.88 0.15 Allowed 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 125.537 1.535 . . . . 65.25 113.484 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1343 ' ' ASP . . . . . . . . . . . . 0.38 0.0 OUTLIER 79.21 -78.81 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.775 2 O-C-N 112.593 -6.317 . . . . 64.530000000000001 120.076 -19.347 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A 1344 ' ' GLY . . . . . . . . . . . . . . . 104.39 10.73 33.02 Favored Glycine 0 CA--C 1.545 1.94 0 O-C-N 117.536 -3.227 . . . . 59.719999999999999 111.379 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 19.0 t30 -72.05 131.24 42.61 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 121.932 2.866 . . . . 64.090000000000003 112.929 174.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1346 ' ' ILE . . . . . . . . . . . . . 24.7 mt -80.31 79.37 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.83 0 O-C-N 120.018 -1.676 . . . . 58.82 109.063 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1347 ' ' THR . . . . . . . . . . . . . 5.3 m -66.43 85.14 0.1 Allowed 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 119.867 -1.771 . . . . 54.960000000000001 112.711 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1348 ' ' VAL . . . . . . . . . . . . . 40.0 t -76.46 98.45 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.803 0 N-CA-C 102.915 -2.994 . . . . 55.640000000000001 102.915 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 8.8 t70 -87.79 138.14 31.72 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 111.735 -2.484 . . . . 61.450000000000003 110.906 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -107.22 -12.39 15.38 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 117.443 2.386 . . . . 58.630000000000003 117.443 176.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -76.69 -48.47 18.83 Favored 'General case' 0 C--O 1.246 0.904 0 O-C-N 124.028 0.83 . . . . 62.060000000000002 109.073 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 28.0 t70 -65.76 118.82 10.17 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.651 0.738 . . . . 54.07 112.621 -177.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 13.7 m -40.23 -46.87 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 116.545 2.054 . . . . 50.68 116.545 173.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1354 ' ' VAL . . . . . . . . . . . . . 3.2 m -77.52 -41.85 29.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 122.426 2.375 . . . . 47.68 109.466 -174.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1355 ' ' ILE . . . . . . . . . . . . . 53.6 mt -64.88 -49.26 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.718 1.207 . . . . 48.490000000000002 107.791 -177.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1356 ' ' ARG . . . . . 0.41 ' NH1' ' O ' ' A' 1367 ' ' THR . 31.4 tpt85 -57.17 -40.71 77.86 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.592 0.96 . . . . 48.270000000000003 113.592 172.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -67.21 -39.9 92.37 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-O 119.018 -0.879 . . . . 43.530000000000001 111.911 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1358 ' ' VAL . . . . . . . . . . . . . 5.7 t -72.06 -36.35 56.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 CA-C-O 118.554 -0.736 . . . . 45.119999999999997 112.045 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1359 ' ' THR . . . . . . . . . . . . . 10.6 m -72.21 88.11 1.13 Allowed 'General case' 0 C--O 1.239 0.517 0 CA-C-N 119.346 0.975 . . . . 42.939999999999998 110.492 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 27.6 m -85.77 -25.51 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 CA-C-O 121.794 0.807 . . . . 43.259999999999998 110.805 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1361 ' ' ILE . . . . . . . . . . . . . 23.6 mm -126.55 114.71 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 117.705 -3.122 . . . . 45.659999999999997 102.994 171.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1362 ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -100.93 104.13 15.31 Favored 'General case' 0 CA--C 1.511 -0.548 0 O-C-N 119.128 -2.232 . . . . 61.340000000000003 109.687 172.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 54.54 51.34 14.21 Favored 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 114.367 1.247 . . . . 49.759999999999998 114.367 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 86.68 -27.38 5.89 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 117.997 1.959 . . . . 50.0 117.997 -175.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -81.71 138.19 35.28 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 120.476 2.138 . . . . 56.920000000000002 106.951 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1366 ' ' ILE . . . . . . . . . . . . . 70.1 mt -83.18 100.56 6.89 Favored 'Isoleucine or valine' 0 C--O 1.263 1.811 0 N-CA-C 105.629 -1.989 . . . . 52.780000000000001 105.629 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1367 ' ' THR . . . . . 0.41 ' O ' ' NH1' ' A' 1356 ' ' ARG . 10.8 p -94.22 10.92 32.05 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 112.916 -1.947 . . . . 49.439999999999998 110.199 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 6.7 t90 -73.32 150.39 89.5 Favored Pre-proline 0 C--O 1.251 1.141 0 N-CA-C 106.479 -1.674 . . . . 52.380000000000003 106.479 162.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -68.48 169.58 56.62 Favored 'Cis proline' 0 C--O 1.249 1.057 0 N-CA-C 121.017 3.43 . . . . 46.939999999999998 121.017 -0.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -86.99 124.89 68.08 Favored Pre-proline 0 CA--C 1.506 -0.728 0 CA-C-O 122.366 1.079 . . . . 45.909999999999997 109.404 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1371 ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -70.81 126.84 13.03 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 122.849 2.366 . . . . 46.390000000000001 111.974 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -77.31 -57.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 123.538 2.825 . . . . 46.719999999999999 108.332 169.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.221 -5.008 0 O-C-N 119.552 -1.968 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 15.4 m80 . . . . . 0 N--CA 1.432 -1.353 0 N-CA-C 104.361 -2.459 . . . . 63.439999999999998 104.361 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -126.03 56.03 1.44 Allowed 'General case' 0 C--N 1.352 0.698 0 CA-C-N 121.292 1.86 . . . . 51.740000000000002 109.792 175.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1000 ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -71.87 145.71 48.38 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 114.162 -1.381 . . . . 54.07 110.936 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 64.56 5.87 19.58 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 122.435 1.02 . . . . 39.219999999999999 112.675 -173.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1002 ' ' ARG . . . . . 0.402 ' NH2' ' O ' ' B' 1065 ' ' GLN . 28.0 ttp180 -104.62 141.41 36.48 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 119.523 -2.163 . . . . 38.119999999999997 106.8 -173.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B 1003 ' ' ILE . . . . . . . . . . . . . 87.4 mt -100.79 134.47 40.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 105.827 -1.916 . . . . 29.699999999999999 105.827 174.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -94.56 135.13 12.31 Favored Glycine 0 N--CA 1.419 -2.448 0 C-N-CA 119.914 -1.136 . . . . 27.5 111.136 156.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1005 ' ' ILE . . . . . . . . . . . . . 40.6 mm -104.61 104.86 47.76 Favored Pre-proline 0 CA--C 1.553 1.064 0 N-CA-C 102.244 -3.243 . . . . 24.829999999999998 102.244 171.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -66.25 157.47 59.84 Favored 'Trans proline' 0 C--N 1.361 1.214 1 C-N-CA 125.818 4.345 . . . . 27.190000000000001 114.811 172.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 44.1 ttt180 -86.26 101.78 13.36 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 113.765 -1.561 . . . . 41.460000000000001 107.874 173.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1008 ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -49.35 134.23 18.89 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 117.342 2.349 . . . . 26.93 117.342 -175.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 32.3 mmm-85 -107.52 -11.32 15.51 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 111.935 -2.393 . . . . 34.479999999999997 114.129 -163.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1010 ' ' LEU . . . . . . . . . . . . . 13.0 tp -63.31 145.5 55.43 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-N 119.796 1.18 . . . . 44.219999999999999 112.514 -174.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1011 ' ' THR . . . . . . . . . . . . . 33.1 m -32.95 106.65 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 115.75 1.759 . . . . 40.740000000000002 115.75 172.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 53.9 t30 46.25 49.69 12.6 Favored 'General case' 0 C--O 1.254 1.302 0 C-N-CA 125.552 1.541 . . . . 44.439999999999998 112.737 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1013 ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -79.97 133.57 36.19 Favored 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 118.292 -1.363 . . . . 29.870000000000001 108.102 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1014 ' ' THR . . . . . . . . . . . . . 3.4 m -112.76 -9.01 13.73 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 107.353 -1.351 . . . . 25.260000000000002 107.353 -178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -77.92 129.42 35.33 Favored 'General case' 0 CA--C 1.503 -0.854 0 O-C-N 120.359 -1.463 . . . . 29.539999999999999 110.694 174.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1016 ' ' VAL . . . . . . . . . . . . . 5.0 p -97.65 177.64 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 120.388 -1.445 . . . . 23.550000000000001 107.452 155.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1017 ' ' ALA . . . . . . . . . . . . . . . -79.89 -19.37 48.35 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.154 -1.591 . . . . 23.59 113.604 -177.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1018 ' ' ALA . . . . . . . . . . . . . . . -153.43 146.87 24.9 Favored 'General case' 0 N--CA 1.442 -0.825 0 O-C-N 119.908 -1.745 . . . . 24.93 114.143 -167.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1019 ' ' THR . . . . . . . . . . . . . 76.7 p -88.75 172.29 7.79 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 118.594 0.634 . . . . 28.09 112.509 169.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -55.25 -36.1 92.67 Favored 'Trans proline' 0 C--O 1.249 1.046 0 C-N-CA 122.448 2.098 . . . . 28.789999999999999 116.631 165.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 51.4 tttt -54.13 -51.12 65.25 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 119.013 -2.304 . . . . 47.280000000000001 113.325 161.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1022 ' ' THR . . . . . . . . . . . . . 22.8 m -52.77 -38.68 61.38 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 118.471 0.578 . . . . 30.120000000000001 109.873 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1023 ' ' VAL . . . . . . . . . . . . . 73.5 t -53.41 -53.37 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 O-C-N 121.254 -0.904 . . . . 32.240000000000002 109.156 174.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1024 ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -57.42 -41.94 81.38 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.906 0.86 . . . . 49.619999999999997 113.193 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -58.39 -47.77 82.79 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 123.044 1.402 . . . . 44.68 111.735 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 41.5 mt -72.13 -34.37 68.52 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.528 -1.215 . . . . 35.710000000000001 110.487 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1027 ' ' LEU . . . . . . . . . . . . . 50.5 mt -57.64 -40.52 79.41 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 122.927 1.346 . . . . 42.18 110.636 175.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 58.2 mttm -58.34 -36.45 73.43 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 115.211 -0.904 . . . . 48.340000000000003 111.425 173.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1029 ' ' LEU . . . . . . . . . . . . . 20.7 mt -77.33 -1.87 32.07 Favored 'General case' 0 C--O 1.259 1.56 0 N-CA-C 116.414 2.005 . . . . 38.689999999999998 116.414 175.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 90.03 25.0 28.04 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 125.877 1.703 . . . . 32.280000000000001 111.189 176.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -103.89 127.96 51.39 Favored 'General case' 0 C--O 1.252 1.236 0 N-CA-C 107.78 -1.193 . . . . 35.939999999999998 107.78 -177.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1032 ' ' THR . . . . . . . . . . . . . 11.9 m -72.22 122.2 20.65 Favored 'General case' 0 C--O 1.251 1.166 0 N-CA-C 103.165 -2.902 . . . . 33.369999999999997 103.165 167.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1033 ' ' VAL . . . . . . . . . . . . . 48.8 t -93.32 134.92 29.48 Favored 'Isoleucine or valine' 0 C--O 1.258 1.508 0 N-CA-C 104.681 -2.34 . . . . 29.98 104.681 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -123.0 140.11 53.38 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 104.063 -2.569 . . . . 28.18 104.063 172.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1035 ' ' VAL . . . . . . . . . . . . . 89.3 t -131.5 135.14 59.79 Favored 'Isoleucine or valine' 0 C--O 1.255 1.373 0 N-CA-C 104.29 -2.485 . . . . 25.82 104.29 -170.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1036 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.91 151.23 43.49 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-O 123.123 1.44 . . . . 32.439999999999998 109.755 177.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B 1037 ' ' SER . . . . . . . . . . . . . 47.1 p -65.99 130.09 42.06 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 111.839 -2.437 . . . . 29.539999999999999 112.413 177.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 92.96 -15.57 62.5 Favored Glycine 0 CA--C 1.504 -0.645 0 O-C-N 118.366 -2.709 . . . . 27.760000000000002 111.62 -177.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1039 ' ' ALA . . . . . . . . . . . . . . . -73.52 -33.93 64.99 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-O 122.29 1.043 . . . . 26.02 112.874 -171.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -59.86 -53.78 43.06 Favored Glycine 0 C--O 1.249 1.076 0 N-CA-C 110.477 -1.049 . . . . 26.469999999999999 110.477 167.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.07 -26.79 64.93 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 117.154 -1.403 . . . . 50.979999999999997 112.154 -177.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 58.3 mt -54.47 -48.84 71.31 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 120.944 1.702 . . . . 29.300000000000001 112.091 167.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1043 ' ' ALA . . . . . . . . . . . . . . . -88.27 36.37 0.78 Allowed 'General case' 0 C--O 1.238 0.486 0 CA-C-O 116.166 -1.873 . . . . 26.739999999999998 111.341 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1044 ' ' SER . . . . . . . . . . . . . 18.9 m 47.72 31.3 2.12 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 116.038 1.866 . . . . 31.260000000000002 116.038 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1045 ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.77 147.93 48.4 Favored 'General case' 0 C--N 1.36 1.051 0 CA-C-O 122.585 1.183 . . . . 33.259999999999998 109.366 177.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 11.3 t0 -71.2 123.75 22.92 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.153 -1.054 . . . . 46.740000000000002 108.153 173.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.75 -29.3 64.68 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 124.993 1.317 . . . . 34.439999999999998 112.1 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.32 -22.45 66.95 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 119.624 -1.923 . . . . 48.670000000000002 113.12 172.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -64.69 -26.5 68.4 Favored 'General case' 0 C--N 1.365 1.262 0 O-C-N 119.311 -2.118 . . . . 35.259999999999998 112.692 169.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1050 ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -69.1 -40.38 78.42 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 118.474 -0.774 . . . . 32.170000000000002 111.952 168.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 20.6 m -70.93 -29.25 36.47 Favored 'Isoleucine or valine' 0 C--N 1.347 0.477 0 CA-C-N 120.668 1.576 . . . . 38.369999999999997 111.155 175.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -60.18 -48.05 83.36 Favored 'General case' 0 C--O 1.205 -1.257 0 O-C-N 119.013 -2.304 . . . . 45.770000000000003 111.405 167.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -64.62 -16.56 62.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 115.29 1.589 . . . . 37.829999999999998 115.29 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 99.39 31.53 6.1 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.632 -0.987 . . . . 35.82 110.632 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -110.77 143.45 41.29 Favored 'General case' 0 C--N 1.356 0.858 0 O-C-N 120.859 -1.377 . . . . 33.770000000000003 108.448 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -90.81 115.88 28.22 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 120.113 -1.617 . . . . 51.020000000000003 109.46 -172.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1057 ' ' ILE . . . . . . . . . . . . . 11.8 mm -76.15 109.59 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 106.494 -1.669 . . . . 38.469999999999999 106.494 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 6.5 m -126.03 126.26 69.39 Favored 'Isoleucine or valine' 0 C--O 1.247 0.969 0 CA-C-O 123.613 1.673 . . . . 39.399999999999999 111.576 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -86.52 125.49 33.8 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.977 -1.011 . . . . 57.07 111.195 -162.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . 71.31 -124.66 11.24 Favored Glycine 0 CA--C 1.517 0.206 0 O-C-N 125.785 1.928 . . . . 44.829999999999998 112.795 167.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 5.8 m120 -57.84 -31.36 66.58 Favored 'General case' 0 CA--C 1.481 -1.709 0 CA-C-N 118.566 1.183 . . . . 46.270000000000003 113.946 -175.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1062 ' ' SER . . . . . . . . . . . . . 4.8 m -52.47 -51.17 60.68 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 116.727 -1.606 . . . . 43.469999999999999 107.407 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.21 -39.81 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 121.313 1.87 . . . . 36.979999999999997 110.59 -177.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 93.2 m95 -60.41 -38.46 84.11 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 117.072 2.249 . . . . 37.899999999999999 117.072 174.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1065 ' ' GLN . . . . . 0.402 ' O ' ' NH2' ' B' 1002 ' ' ARG . 6.0 mm-40 -74.0 106.92 5.91 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 122.875 2.58 . . . . 46.189999999999998 104.952 172.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B 1066 ' ' SER . . . . . . . . . . . . . 51.1 m -164.76 166.49 19.81 Favored 'General case' 0 C--O 1.25 1.121 0 N-CA-C 109.304 -0.628 . . . . 37.060000000000002 109.304 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1067 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.55 -53.36 43.08 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 125.662 1.851 . . . . 43.950000000000003 111.993 169.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B 1068 ' ' ILE . . . . . . . . . . . . . 4.5 mp -120.33 145.47 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 102.907 -2.997 . . . . 33.5 102.907 -173.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 16.8 mm -127.52 117.77 47.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 103.452 -2.796 . . . . 30.57 103.452 170.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1070 ' ' LEU . . . . . . . . . . . . . 96.8 mt -106.42 114.46 28.59 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 103.934 -2.617 . . . . 27.66 103.934 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1071 ' ' LYS . . . . . . . . . . . . . 43.6 tttm -133.99 153.71 51.6 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 106.848 -1.538 . . . . 28.399999999999999 106.848 -168.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1072 ' ' VAL . . . . . . . . . . . . . 61.5 t -85.03 -65.62 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 CA-C-N 119.517 1.053 . . . . 23.18 108.507 -174.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -107.02 165.34 11.42 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 105.865 -1.902 . . . . 25.469999999999999 105.865 -168.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -51.58 135.91 33.87 Favored Pre-proline 0 C--O 1.206 -1.22 0 CA-C-N 111.841 -2.436 . . . . 27.899999999999999 113.468 -171.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -60.22 123.49 13.26 Favored 'Trans proline' 0 N--CA 1.429 -2.279 0 C-N-CA 123.491 2.794 . . . . 31.620000000000001 113.425 171.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 91.6 mt -70.78 161.96 29.98 Favored 'General case' 0 C--O 1.244 0.802 0 O-C-N 125.61 1.818 . . . . 40.490000000000002 107.453 174.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 33.6 t70 -44.79 -42.28 7.68 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 120.072 3.36 . . . . 51.590000000000003 120.072 -173.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -68.09 -44.38 76.38 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 113.535 -1.666 . . . . 42.359999999999999 112.059 173.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1079 ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -61.63 -35.7 78.66 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.109 -1.071 . . . . 34.530000000000001 108.109 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1080 ' ' ILE . . . . . . . . . . . . . 76.5 mt -56.42 -50.91 70.15 Favored 'Isoleucine or valine' 0 C--O 1.25 1.082 0 O-C-N 119.936 -1.728 . . . . 33.25 108.524 172.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -63.59 -33.85 76.51 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 119.579 -1.95 . . . . 36.469999999999999 112.74 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1082 ' ' LEU . . . . . . . . . . . . . 67.5 mt -61.05 -38.43 86.13 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.873 -0.603 . . . . 37.759999999999998 112.119 174.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1083 ' ' LEU . . . . . . . . . . . . . 14.2 mt -58.66 154.31 14.74 Favored 'General case' 0 C--O 1.261 1.667 0 CA-C-O 123.594 1.664 . . . . 37.43 110.851 172.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -124.1 154.73 68.31 Favored Pre-proline 0 C--O 1.237 0.429 0 N-CA-C 106.747 -1.575 . . . . 37.700000000000003 106.747 -158.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -50.42 129.87 27.52 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 124.515 3.477 . . . . 35.509999999999998 110.667 171.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 93.58 -46.37 2.34 Favored Glycine 0 CA--C 1.542 1.738 0 CA-C-O 117.041 -1.977 . . . . 33.869999999999997 113.306 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1087 ' ' THR . . . . . . . . . . . . . 59.1 m -46.28 118.13 1.82 Allowed 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 114.906 1.446 . . . . 32.5 114.906 -164.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1088 ' ' THR . . . . . . . . . . . . . 54.6 m -69.17 101.27 1.42 Allowed 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 106.782 -1.562 . . . . 30.219999999999999 106.782 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1089 ' ' LEU . . . . . . . . . . . . . 13.2 tp -95.6 128.74 42.72 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-O 123.691 1.71 . . . . 27.239999999999998 110.245 174.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 19.2 t -123.53 115.59 45.8 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 N-CA-C 105.677 -1.972 . . . . 25.390000000000001 105.677 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1091 ' ' SER . . . . . . . . . . . . . 14.8 m -155.76 165.39 36.65 Favored 'General case' 0 C--N 1.352 0.685 0 O-C-N 120.654 -1.278 . . . . 28.809999999999999 110.123 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1092 ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -64.53 103.86 0.72 Allowed 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 107.119 -1.437 . . . . 30.780000000000001 107.119 158.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 26.9 mm -94.79 -37.92 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.221 0 CA-C-N 114.561 -1.2 . . . . 30.280000000000001 111.632 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1094 ' ' TRP . . . . . . . . . . . . . 82.6 m95 60.25 71.83 0.82 Allowed Pre-proline 0 C--O 1.242 0.659 0 N-CA-C 107.057 -1.461 . . . . 34.07 107.057 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -55.95 -58.06 1.24 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 125.24 3.96 . . . . 38.659999999999997 115.416 -170.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -66.22 -21.34 66.3 Favored 'General case' 0 CA--C 1.505 -0.762 0 O-C-N 120.627 -1.296 . . . . 41.32 112.321 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 12.6 mp0 -89.07 -20.89 23.77 Favored 'General case' 0 C--O 1.25 1.118 0 N-CA-C 107.23 -1.396 . . . . 51.659999999999997 107.23 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -135.57 54.92 11.36 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-N 120.7 1.591 . . . . 40.32 110.387 -176.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -55.51 -49.01 17.45 Favored 'Trans proline' 0 CA--C 1.54 0.819 1 C-N-CA 125.314 4.009 . . . . 41.560000000000002 119.478 -175.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.85 -40.38 88.4 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.538 0.94 . . . . 54.109999999999999 113.538 173.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B 1101 ' ' LEU . . . . . . . . . . . . . 9.3 tt -58.51 -49.51 77.13 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 125.194 1.398 . . . . 37.880000000000003 107.374 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1102 ' ' MET . . . . . . . . . . . . . 69.7 mmm -49.74 -45.64 49.59 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 113.934 1.087 . . . . 37.539999999999999 113.934 165.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -65.26 -44.14 89.08 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 121.288 1.858 . . . . 47.009999999999998 110.367 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1104 ' ' LYS . . . . . . . . . . . . . 74.1 mttt -60.36 -38.49 84.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 119.423 -2.048 . . . . 48.68 110.652 -178.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1105 ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.04 -41.44 99.5 Favored 'General case' 0 C--O 1.25 1.081 0 CA-C-O 122.888 1.327 . . . . 32.210000000000001 113.977 171.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -63.91 -44.59 92.48 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.26 1.824 . . . . 33.729999999999997 108.93 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -54.11 -49.33 69.4 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 121.406 -0.809 . . . . 51.469999999999999 110.056 170.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1108 ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -67.86 -16.46 64.1 Favored 'General case' 0 C--O 1.207 -1.179 0 CA-C-N 120.221 1.373 . . . . 43.899999999999999 110.92 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1109 ' ' ASN . . . . . . . . . . . . . 4.6 m-80 69.41 28.84 4.62 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 123.73 1.728 . . . . 44.82 113.158 174.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1110 ' ' VAL . . . . . . . . . . . . . 17.4 m -72.87 151.19 7.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 CA-C-N 114.179 -1.373 . . . . 30.52 109.45 174.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1111 ' ' THR . . . . . . . . . . . . . 6.4 m -94.77 107.3 19.31 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 106.524 -1.658 . . . . 27.120000000000001 106.524 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1112 ' ' VAL . . . . . . . . . . . . . 4.0 t -101.29 126.14 55.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 115.237 1.569 . . . . 26.399999999999999 115.237 -169.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1113 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.43 127.57 53.71 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 106.08 -1.822 . . . . 42.920000000000002 106.08 165.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -100.74 105.74 17.09 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 113.362 -1.745 . . . . 24.149999999999999 108.044 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1115 ' ' MET . . . . . . . . . . . . . 56.8 mmm -60.51 -23.33 64.45 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 112.896 -1.956 . . . . 29.949999999999999 116.24 -173.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1116 ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -78.46 -33.3 48.45 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 113.249 -1.796 . . . . 34.530000000000001 112.076 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1117 ' ' SER . . . . . . . . . . . . . 51.2 m -111.36 48.77 0.92 Allowed 'General case' 0 N--CA 1.435 -1.207 0 O-C-N 120.483 -1.386 . . . . 33.490000000000002 109.691 -178.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1118 ' ' VAL . . . . . . . . . . . . . 55.3 t -76.73 139.91 67.08 Favored Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 104.81 -2.293 . . . . 34.020000000000003 104.81 167.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -50.35 141.06 33.22 Favored 'Trans proline' 0 C--O 1.245 0.871 0 C-N-CA 123.021 2.481 . . . . 38.280000000000001 117.395 175.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1120 ' ' ARG . . . . . 0.43 HH12 ' CG ' ' B' 1128 ' ' ASP . 9.7 mmt-85 -74.69 36.35 0.11 Allowed 'General case' 0 C--O 1.242 0.694 0 N-CA-C 116.714 2.116 . . . . 55.049999999999997 116.714 177.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B 1121 ' ' ILE . . . . . . . . . . . . . 17.3 pt -118.8 142.75 32.29 Favored 'Isoleucine or valine' 0 C--N 1.347 0.466 0 O-C-N 117.702 -3.124 . . . . 42.090000000000003 106.695 -176.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1122 ' ' SER . . . . . . . . . . . . . 62.0 m -35.88 -47.96 0.54 Allowed 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 117.91 2.559 . . . . 38.020000000000003 117.91 -175.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1123 ' ' ARG . . . . . . . . . . . . . 37.9 ptt85 -74.86 -35.92 62.34 Favored 'General case' 0 C--O 1.208 -1.122 0 CA-C-N 123.581 2.9 . . . . 34.289999999999999 113.416 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1124 ' ' ALA . . . . . . . . . . . . . . . -68.51 -26.54 65.5 Favored 'General case' 0 C--O 1.218 -0.57 0 O-C-N 120.314 -1.491 . . . . 32.350000000000001 109.823 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1125 ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -60.01 -15.07 19.52 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 115.42 1.637 . . . . 47.170000000000002 115.42 171.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1126 ' ' SER . . . . . . . . . . . . . 97.1 p -77.47 -30.54 53.2 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 114.568 1.321 . . . . 31.710000000000001 114.568 170.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1127 ' ' LEU . . . . . . . . . . . . . 3.4 mp -83.58 -25.22 31.11 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 112.395 -2.184 . . . . 37.0 109.212 175.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1128 ' ' ASP . . . . . 0.43 ' CG ' HH12 ' B' 1120 ' ' ARG . 33.9 t70 -69.76 118.86 13.14 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 115.421 1.637 . . . . 40.399999999999999 115.421 -174.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B 1129 ' ' ALA . . . . . . . . . . . . . . . -62.93 -46.09 89.43 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 109.851 -3.34 . . . . 26.559999999999999 111.095 177.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 35.2 mt -53.95 -41.83 68.2 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 117.071 -1.442 . . . . 30.890000000000001 114.452 -173.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1131 ' ' SER . . . . . . . . . . . . . 16.3 p -62.09 -46.97 86.73 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 124.473 1.108 . . . . 29.84 113.271 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1132 ' ' SER . . . . . . . . . . . . . 14.6 m -65.13 -46.64 80.11 Favored 'General case' 0 N--CA 1.421 -1.881 0 O-C-N 119.421 -2.049 . . . . 31.91 111.17 174.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1133 ' ' MET . . . . . . . . . . . . . 38.8 mmt -59.32 -32.17 69.83 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 120.555 -1.341 . . . . 25.899999999999999 114.182 175.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1134 ' ' ALA . . . . . . . . . . . . . . . -75.07 -35.66 61.82 Favored 'General case' 0 C--O 1.203 -1.369 0 O-C-N 120.393 -1.442 . . . . 26.620000000000001 108.542 173.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -61.23 -41.71 97.34 Favored 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 119.092 -2.255 . . . . 36.969999999999999 110.527 176.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1136 ' ' ILE . . . . . . . . . . . . . 48.5 mm -59.33 -56.7 15.38 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 O-C-N 125.406 1.691 . . . . 32.109999999999999 108.47 171.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -55.69 -42.25 74.91 Favored 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 126.128 1.771 . . . . 24.140000000000001 114.682 -174.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -64.75 -45.47 92.64 Favored Glycine 0 C--N 1.316 -0.549 0 CA-C-N 122.031 2.196 . . . . 25.129999999999999 111.577 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 16.1 t80 -67.14 -43.21 82.94 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 122.683 1.23 . . . . 32.729999999999997 108.917 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1140 ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -68.0 -32.54 73.01 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.709 -0.849 . . . . 26.359999999999999 108.709 -175.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1141 ' ' ALA . . . . . . . . . . . . . . . -55.98 -53.9 51.34 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 113.015 0.746 . . . . 24.120000000000001 113.015 170.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 36.5 mm -52.38 -45.51 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 124.052 0.941 . . . . 23.370000000000001 110.163 174.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 75.5 t -60.05 -62.8 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 117.537 -1.22 . . . . 24.960000000000001 114.274 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -61.87 -36.13 80.35 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-N 120.764 1.62 . . . . 32.07 111.138 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1145 ' ' ALA . . . . . . . . . . . . . . . -54.28 -49.66 69.07 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 117.476 -1.25 . . . . 24.870000000000001 109.987 169.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1146 ' ' ALA . . . . . . . . . . . . . . . -67.26 -27.13 66.95 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 119.105 0.866 . . . . 24.670000000000002 110.792 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 51.9 t60 -57.85 -47.04 83.85 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 119.056 -0.497 . . . . 28.579999999999998 111.053 169.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1148 ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -94.53 -5.09 46.78 Favored 'General case' 0 CA--C 1.501 -0.912 0 O-C-N 120.102 -1.624 . . . . 36.82 113.462 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1149 ' ' PHE . . . . . . . . . . . . . 3.3 t80 -67.73 137.52 55.54 Favored 'General case' 0 C--O 1.254 1.313 0 C-N-CA 124.827 1.251 . . . . 31.969999999999999 108.945 -177.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1150 ' ' GLY . . . . . . . . . . . . . . . -75.31 -19.07 79.81 Favored Glycine 0 N--CA 1.44 -1.081 0 CA-C-O 118.135 -1.37 . . . . 25.489999999999998 114.083 174.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1151 ' ' ARG . . . . . . . . . . . . . 71.1 mtm-85 -130.34 177.59 7.22 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 122.811 3.305 . . . . 59.840000000000003 114.306 -158.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1152 ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -81.36 162.21 23.49 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 123.111 1.434 . . . . 34.450000000000003 109.238 170.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1153 ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -82.14 -50.15 9.36 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 112.949 -1.932 . . . . 31.170000000000002 108.834 165.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1154 ' ' THR . . . . . . . . . . . . . 3.5 m -77.19 126.68 31.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 112.273 -2.239 . . . . 33.890000000000001 108.666 -168.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -81.37 65.91 3.91 Favored Glycine 0 N--CA 1.433 -1.535 0 N-CA-C 110.132 -1.187 . . . . 38.950000000000003 110.132 -176.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -67.05 146.99 53.74 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.587 1.955 . . . . 54.229999999999997 115.786 -170.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 12.7 mm -90.87 125.89 43.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 102.012 -3.329 . . . . 51.159999999999997 102.012 173.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1158 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.75 138.08 51.91 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 102.327 -3.212 . . . . 49.609999999999999 102.327 172.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -58.65 -29.2 66.38 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.744 1.156 . . . . 49.049999999999997 110.817 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -55.0 -58.92 5.67 Favored 'General case' 0 C--N 1.363 1.171 0 N-CA-C 112.993 0.738 . . . . 47.649999999999999 112.993 165.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . -171.52 143.27 7.47 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 107.766 -2.133 . . . . 45.609999999999999 107.766 -165.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 92.7 mttt -78.25 138.56 38.69 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 118.584 1.192 . . . . 57.460000000000001 109.55 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1163 ' ' VAL . . . . . . . . . . . . . 48.0 t -88.01 133.34 37.49 Favored Pre-proline 0 C--O 1.251 1.144 0 N-CA-C 105.533 -2.025 . . . . 42.93 105.533 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1164 ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -67.48 145.06 69.56 Favored 'Trans proline' 0 C--N 1.323 -0.815 0 C-N-CA 123.265 2.643 . . . . 39.289999999999999 113.655 170.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1165 ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -65.54 152.77 80.84 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 CA-C-N 124.016 2.47 . . . . 34.170000000000002 113.836 176.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -88.42 143.65 26.86 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.57 -1.27 . . . . 31.690000000000001 107.57 167.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1167 ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -107.7 117.35 33.89 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 106.945 -1.502 . . . . 44.780000000000001 106.945 173.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 61.8 t -102.59 113.83 40.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 106.418 -1.697 . . . . 31.23 106.418 -174.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1169 ' ' MET . . . . . . . . . . . . . 43.0 ttp -95.94 97.52 9.68 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 120.892 0.377 . . . . 37.090000000000003 110.967 178.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 61.4 t -88.78 122.0 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.851 -1.166 . . . . 30.170000000000002 107.851 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1171 ' ' ILE . . . . . . . . . . . . . 44.4 mt -112.07 131.94 62.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 104.097 -2.557 . . . . 33.740000000000002 104.097 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 81.29 64.6 1.76 Allowed Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 108.11 -1.996 . . . . 32.590000000000003 108.11 -174.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1173 ' ' ALA . . . . . . . . . . . . . . . -62.93 -7.01 4.37 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 120.842 -1.387 . . . . 32.420000000000002 114.683 -177.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -58.11 129.19 49.2 Favored Glycine 0 C--O 1.245 0.799 0 CA-C-O 122.8 1.222 . . . . 31.739999999999998 112.23 175.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 1.5 t 48.81 -82.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 112.612 -1.794 . . . . 31.48 114.441 173.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1176 ' ' ALA . . . . . . . . . . . . . . . -65.34 -42.38 92.95 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.548 0.69 . . . . 26.120000000000001 112.609 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1177 ' ' GLY . . . . . . . . . . . . . . . -56.72 -45.22 91.11 Favored Glycine 0 N--CA 1.464 0.563 0 CA-C-N 113.123 -1.853 . . . . 25.73 108.781 174.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1178 ' ' LEU . . . . . . . . . . . . . 5.5 tp -58.62 -48.89 79.48 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 126.288 1.835 . . . . 32.590000000000003 108.336 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -58.74 -38.81 79.22 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 114.347 1.24 . . . . 27.719999999999999 114.347 175.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -65.82 -43.21 89.28 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.884 0.874 . . . . 26.030000000000001 112.034 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1181 ' ' ILE . . . . . . . . . . . . . 9.5 mt -56.12 -48.29 79.33 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 O-C-N 120.299 -1.5 . . . . 28.609999999999999 108.633 170.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -57.68 -49.88 70.17 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 117.749 -1.584 . . . . 25.23 112.986 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -63.48 -49.57 73.1 Favored 'General case' 0 C--O 1.249 1.063 0 CA-C-N 120.78 2.29 . . . . 24.09 113.253 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -68.02 -38.44 82.58 Favored 'General case' 0 C--O 1.24 0.605 0 O-C-N 121.497 -0.752 . . . . 26.68 109.323 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 45.5 t30 -62.32 -33.65 75.09 Favored 'General case' 0 C--O 1.249 1.042 0 O-C-N 118.075 -2.891 . . . . 36.57 111.004 174.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1186 ' ' SER . . . . . . . . . . . . . 61.4 m -67.42 -45.85 74.9 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 111.941 0.348 . . . . 28.920000000000002 111.941 174.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1187 ' ' LEU . . . . . . . . . . . . . 5.6 mt -60.49 -24.64 65.45 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.093 0.957 . . . . 29.09 111.477 169.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 93.75 34.74 6.42 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 121.559 1.981 . . . . 29.260000000000002 112.224 175.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1189 ' ' ALA . . . . . . . . . . . . . . . -104.3 146.02 29.4 Favored 'General case' 0 C--O 1.252 1.192 0 N-CA-C 107.772 -1.196 . . . . 30.16 107.772 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 69.9 mt -77.18 110.76 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 102.776 -3.046 . . . . 35.810000000000002 102.776 -173.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1191 ' ' VAL . . . . . . . . . . . . . 17.4 t -91.93 128.28 43.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 C-N-CA 118.485 -1.286 . . . . 31.969999999999999 108.024 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1192 ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -113.83 107.76 16.16 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 106.868 -1.53 . . . . 48.159999999999997 106.868 168.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -114.92 147.39 40.03 Favored 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 120.381 -1.449 . . . . 35.890000000000001 110.74 -173.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 42.0 t80 -135.9 146.96 47.92 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.304 -1.369 . . . . 41.880000000000003 107.304 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1195 ' ' ASP . . . . . . . . . . . . . 23.7 t0 -154.46 154.06 32.57 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 102.051 -3.314 . . . . 38.280000000000001 102.051 172.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1196 ' ' THR . . . . . . . . . . . . . 1.8 p -85.76 37.92 0.72 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 117.695 -1.145 . . . . 40.619999999999997 110.811 -170.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1197 ' ' ARG . . . . . . . . . . . . . 75.4 mtm180 -140.24 166.2 25.13 Favored Pre-proline 0 C--O 1.246 0.878 0 CA-C-N 121.955 2.161 . . . . 53.090000000000003 112.386 -166.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -72.35 -64.33 0.03 OUTLIER 'Trans proline' 0 C--O 1.254 1.299 0 N-CA-C 119.149 2.711 . . . . 42.560000000000002 119.149 168.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.02 -34.26 63.33 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 115.574 1.694 . . . . 56.310000000000002 115.574 -167.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B 1200 ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -43.96 -42.18 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 N-CA-C 116.102 1.89 . . . . 42.909999999999997 116.102 172.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 43.5 tttm -58.2 -51.79 68.27 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 120.038 -1.664 . . . . 48.890000000000001 110.216 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -61.34 -28.05 68.94 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 122.36 1.076 . . . . 51.700000000000003 112.847 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1203 ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -68.16 -46.55 70.45 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 107.641 -1.244 . . . . 52.57 107.641 173.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1204 ' ' VAL . . . . . . . . . . . . . 25.5 t -63.99 -34.34 67.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 120.383 1.447 . . . . 33.789999999999999 111.292 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -61.97 -34.92 77.03 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.806 0.843 . . . . 36.579999999999998 109.972 171.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1206 ' ' SER . . . . . . . . . . . . . 14.9 m -72.78 -1.64 17.35 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 115.359 1.615 . . . . 39.609999999999999 115.359 173.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1207 ' ' MET . . . . . . . . . . . . . 2.8 mpp? -98.42 -18.68 18.13 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 113.258 0.836 . . . . 37.450000000000003 113.258 165.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 72.04 43.97 46.98 Favored Glycine 0 N--CA 1.484 1.843 0 O-C-N 119.624 -1.923 . . . . 31.870000000000001 110.868 -167.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -126.38 166.96 16.21 Favored 'General case' 0 CA--C 1.505 -0.772 0 O-C-N 120.471 -1.605 . . . . 35.399999999999999 111.899 -176.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -81.0 125.56 30.32 Favored 'General case' 0 C--O 1.216 -0.663 0 O-C-N 120.529 -1.357 . . . . 47.890000000000001 108.989 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 70.9 t80 -92.1 130.7 37.77 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 104.33 -2.47 . . . . 45.530000000000001 104.33 165.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1212 ' ' LEU . . . . . . . . . . . . . 53.0 mt -76.25 106.89 8.12 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 105.2 -2.148 . . . . 46.329999999999998 105.2 167.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.17 150.79 37.09 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 124.07 1.89 . . . . 60.409999999999997 111.577 -173.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 8.0 mp -60.97 127.41 31.45 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 111.847 -2.433 . . . . 57.380000000000003 112.895 176.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 30.9 t0 . . . . . 0 N--CA 1.45 -0.465 0 C-N-CA 127.154 2.182 . . . . 65.069999999999993 110.46 -169.088 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B 1230 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.417 -2.123 0 N-CA-C 102.489 -3.152 . . . . 80.319999999999993 102.489 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1231 ' ' SER . . . . . . . . . . . . 0.298 2.6 p 58.75 169.15 0.06 Allowed 'General case' 0 N--CA 1.444 -0.762 2 CA-C-N 130.094 5.861 . . . . 79.920000000000002 116.365 2.152 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -61.04 -49.76 76.06 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.274 -1.517 . . . . 77.909999999999997 108.304 175.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 34.22 -77.56 0.0 OUTLIER 'General case' 0 C--O 1.248 1.012 0 N-CA-C 119.657 3.206 . . . . 73.879999999999995 119.657 175.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 8.3 m-30 -93.59 -0.25 56.29 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 120.98 1.718 . . . . 68.980000000000004 110.365 -168.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 13.5 pt -33.16 -33.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 119.213 3.042 . . . . 64.530000000000001 119.213 -174.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -80.27 -38.57 30.63 Favored 'General case' 0 C--O 1.245 0.859 0 O-C-N 120.74 -1.225 . . . . 66.359999999999999 113.79 173.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -63.89 -47.65 79.78 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-O 117.45 -1.262 . . . . 56.600000000000001 109.154 170.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -47.96 -61.14 2.11 Favored 'General case' 0 C--N 1.36 1.06 0 O-C-N 124.347 1.029 . . . . 56.789999999999999 112.284 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1239 ' ' MET . . . . . . . . . . . . . 14.1 ttm -54.28 -50.15 67.92 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 124.853 1.261 . . . . 53.630000000000003 111.029 -175.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -72.41 -27.9 62.64 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 117.432 2.382 . . . . 51.740000000000002 117.432 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 28.2 tp -63.48 -50.46 69.6 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 106.498 -1.667 . . . . 44.859999999999999 106.498 169.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -58.62 -41.91 86.99 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.998 1.436 . . . . 42.780000000000001 111.375 176.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -59.46 -44.77 92.91 Favored 'General case' 0 C--O 1.25 1.088 0 CA-C-N 120.577 1.535 . . . . 40.960000000000001 114.876 173.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -61.43 -51.84 67.07 Favored 'General case' 0 C--O 1.25 1.085 0 C-N-CA 120.169 -0.612 . . . . 43.060000000000002 110.063 174.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 -58.84 -28.64 66.26 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 116.203 1.927 . . . . 46.450000000000003 116.203 173.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -52.34 -33.09 41.21 Favored 'General case' 0 C--O 1.254 1.323 0 CA-C-N 119.291 0.95 . . . . 41.780000000000001 113.143 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 22.0 tptt -76.61 -31.56 57.52 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 120.932 -1.105 . . . . 52.200000000000003 112.322 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1248 ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -84.49 -42.12 15.87 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 120.818 -1.176 . . . . 53.549999999999997 112.697 178.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1249 ' ' VAL . . . . . . . . . . . . . 36.0 m -82.03 160.11 3.82 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.788 0 CA-C-O 123.154 1.454 . . . . 34.409999999999997 113.713 -162.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1250 ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -107.48 -69.72 0.83 Allowed 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 111.832 -2.44 . . . . 33.380000000000003 113.748 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1251 ' ' ILE . . . . . . . . . . . . . 44.2 mm -101.6 102.5 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 N-CA-C 108.04 -1.096 . . . . 29.539999999999999 108.04 -175.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1252 ' ' ILE . . . . . . . . . . . . . 75.0 mt -83.29 116.41 27.34 Favored 'Isoleucine or valine' 0 C--O 1.25 1.127 0 N-CA-C 107.082 -1.451 . . . . 32.439999999999998 107.082 168.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1253 ' ' VAL . . . . . . . . . . . . . 39.0 t -101.16 87.9 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 105.644 -1.984 . . . . 30.57 105.644 174.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1254 ' ' THR . . . . . . . . . . . . . 1.2 t -92.85 115.02 27.73 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-O 125.462 2.553 . . . . 35.039999999999999 111.331 -174.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1255 ' ' THR . . . . . . . . . . . . . 7.1 m -135.83 10.16 3.35 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 110.606 -2.997 . . . . 34.619999999999997 108.987 -161.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . -70.37 84.86 0.58 Allowed 'General case' 0 C--N 1.35 0.628 0 O-C-N 121.086 -1.009 . . . . 42.719999999999999 113.552 -172.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 41.1 mt -105.89 126.63 52.41 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 125.387 1.475 . . . . 52.43 110.103 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 2.6 mp -77.14 132.1 71.2 Favored Pre-proline 0 N--CA 1.438 -1.057 0 N-CA-C 103.151 -2.907 . . . . 59.409999999999997 103.151 168.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -65.22 69.87 0.29 Allowed 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 124.217 3.278 . . . . 62.68 111.967 169.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 153.19 -81.12 0.18 Allowed Glycine 0 CA--C 1.534 1.266 0 O-C-N 118.653 -2.53 . . . . 64.159999999999997 108.43 -171.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 38.3 tttt -64.69 138.45 97.46 Favored Pre-proline 0 N--CA 1.44 -0.968 0 N-CA-C 114.755 1.391 . . . . 68.530000000000001 114.755 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -55.31 132.08 50.07 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 124.703 3.602 . . . . 61.990000000000002 111.392 166.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1263 ' ' ALA . . . . . . . . . . . . . . . -59.53 128.18 85.73 Favored Pre-proline 0 C--O 1.239 0.544 0 CA-C-N 111.675 -2.511 . . . . 57.149999999999999 111.407 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -64.19 146.08 89.95 Favored 'Trans proline' 0 C--O 1.25 1.077 0 C-N-CA 124.69 3.594 . . . . 51.57 113.815 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1265 ' ' LYS . . . . . 0.463 ' NZ ' ' O ' ' B' 1289 ' ' GLY . 38.5 mmtm -71.7 97.44 1.75 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 123.56 1.647 . . . . 54.549999999999997 108.309 167.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 91.3 mt -94.14 -47.85 6.47 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 123.223 1.487 . . . . 46.859999999999999 112.134 172.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1267 ' ' ILE . . . . . . . . . . . . . 20.7 mm -84.06 82.36 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 104.651 -2.351 . . . . 41.039999999999999 104.651 -175.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1268 ' ' THR . . . . . . . . . . . . . 23.2 p -82.36 175.45 10.24 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 111.068 -2.787 . . . . 39.579999999999998 108.729 -175.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1269 ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 -52.56 -41.28 63.42 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.019 0.927 . . . . 53.149999999999999 111.765 175.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -60.57 -21.06 62.18 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 115.727 1.751 . . . . 42.960000000000001 115.727 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1271 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.42 -51.51 6.89 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 120.338 1.426 . . . . 43.890000000000001 110.725 162.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B 1272 ' ' VAL . . . . . . . . . . . . . 96.4 t -57.72 -60.68 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 CA-C-N 115.187 -0.915 . . . . 38.369999999999997 112.203 -168.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.26 -34.93 77.49 Favored 'General case' 0 C--O 1.247 0.97 0 O-C-N 119.541 -1.974 . . . . 47.460000000000001 112.708 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1274 ' ' SER . . . . . . . . . . . . . 5.2 m -74.32 -17.03 60.9 Favored 'General case' 0 C--O 1.244 0.786 0 O-C-N 120.044 -1.66 . . . . 38.380000000000003 111.16 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1275 ' ' MET . . . . . . . . . . . . . 38.3 mtp -53.75 145.07 16.53 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 118.747 2.869 . . . . 37.810000000000002 118.747 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -61.39 130.76 47.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.547 -1.206 . . . . 49.259999999999998 109.101 171.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -64.03 165.35 9.12 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 118.5 2.778 . . . . 34.460000000000001 118.5 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 67.34 26.47 73.52 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-O 124.711 2.284 . . . . 33.530000000000001 115.363 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1279 ' ' SER . . . . . . . . . . . . . 36.6 m -127.89 159.75 33.95 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 111.243 -2.478 . . . . 31.309999999999999 106.139 -168.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1280 ' ' VAL . . . . . . . . . . . . . 94.8 t -128.28 129.31 69.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.537 -0.912 . . . . 29.32 108.537 -165.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1281 ' ' ILE . . . . . . . . . . . . . 58.5 mt -99.49 96.28 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 N-CA-C 107.304 -1.369 . . . . 31.93 107.304 170.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1282 ' ' VAL . . . . . . . . . . . . . 14.2 t -80.63 110.99 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 O-C-N 120.383 -1.448 . . . . 29.48 110.793 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 33.6 t0 -90.57 95.81 10.34 Favored 'General case' 0 N--CA 1.417 -2.115 0 O-C-N 120.289 -1.507 . . . . 34.5 107.189 173.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1284 ' ' LEU . . . . . . . . . . . . . 5.0 mp -76.65 -21.97 54.72 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-N 113.18 -1.827 . . . . 37.939999999999998 111.207 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -87.0 8.01 25.2 Favored 'General case' 0 C--N 1.35 0.589 0 N-CA-C 115.656 1.724 . . . . 40.920000000000002 115.656 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -50.29 -42.66 52.79 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 119.524 3.157 . . . . 44.390000000000001 119.524 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1287 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.03 -28.86 70.09 Favored 'General case' 0 C--O 1.257 1.495 0 O-C-N 119.322 -2.111 . . . . 51.460000000000001 114.137 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 38.9 t30 -121.91 76.78 1.31 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.243 -1.021 . . . . 57.75 108.243 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1289 ' ' GLY . . . . . 0.463 ' O ' ' NZ ' ' B' 1265 ' ' LYS . . . 98.45 -60.68 0.9 Allowed Glycine 0 C--N 1.336 0.531 0 O-C-N 120.102 -1.624 . . . . 49.850000000000001 114.902 176.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 80.99 119.48 0.44 Allowed Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 121.247 2.523 . . . . 45.93 112.128 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1291 ' ' ASN . . . . . . . . . . . . . 27.0 m120 -81.5 -25.84 35.66 Favored 'General case' 0 C--N 1.346 0.429 0 N-CA-C 114.457 1.28 . . . . 42.670000000000002 114.457 -175.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1292 ' ' CYS . . . . . . . . . . . . . 48.2 t -95.14 144.44 25.77 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 120.399 -1.438 . . . . 38.82 111.754 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1293 ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -68.82 -34.25 75.2 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 113.784 1.031 . . . . 46.710000000000001 113.784 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -80.91 7.76 9.86 Favored 'General case' 0 C--O 1.248 0.982 0 N-CA-C 116.766 2.135 . . . . 47.229999999999997 116.766 -176.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1295 ' ' THR . . . . . . . . . . . . . 26.4 m -71.79 107.73 4.74 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 114.007 1.114 . . . . 36.020000000000003 114.007 -173.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 36.7 t -93.57 123.42 60.14 Favored Pre-proline 0 C--N 1.304 -1.394 0 N-CA-C 103.448 -2.797 . . . . 37.259999999999998 103.448 155.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -61.16 136.8 67.14 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.649 2.233 . . . . 35.090000000000003 114.268 177.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 71.69 40.73 58.16 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 113.699 -1.591 . . . . 35.969999999999999 112.691 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -148.91 152.75 36.94 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-O 124.882 2.277 . . . . 40.390000000000001 114.671 -172.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1300 ' ' ILE . . . . . . . . . . . . . 55.3 mt -99.84 107.61 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 101.422 -3.547 . . . . 37.43 101.422 166.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 15.2 t80 -104.78 103.12 12.68 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.07 -1.085 . . . . 44.130000000000003 108.07 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1302 ' ' THR . . . . . . . . . . . . . 17.7 m -82.98 120.42 25.69 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-O 123.337 1.541 . . . . 39.780000000000001 111.012 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1303 ' ' THR . . . . . . . . . . . . . 3.2 p -79.84 139.35 37.22 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 112.929 -1.941 . . . . 43.289999999999999 109.398 175.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -48.25 -31.22 5.59 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 117.352 2.352 . . . . 53.07 117.352 -175.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -59.88 -21.93 61.68 Favored 'General case' 0 C--O 1.262 1.713 0 C-N-CA 126.496 1.918 . . . . 43.969999999999999 116.062 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 113.35 1.09 24.94 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 110.987 -0.845 . . . . 41.119999999999997 110.987 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1307 ' ' VAL . . . . . . . . . . . . . 45.6 t -88.95 148.28 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-N 118.653 1.227 . . . . 38.119999999999997 109.437 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1308 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.09 114.87 27.97 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 107.726 -1.212 . . . . 36.340000000000003 107.726 177.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B 1309 ' ' VAL . . . . . . . . . . . . . 85.2 t -84.05 97.04 4.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 107.108 -1.441 . . . . 30.399999999999999 107.108 172.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1310 ' ' ILE . . . . . . . . . . . . . 19.0 mt -88.32 91.58 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 CA-C-O 122.912 1.339 . . . . 30.82 108.228 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1311 ' ' GLY . . . . . . . . . . . . . . . -88.97 93.32 1.88 Allowed Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 109.65 -1.38 . . . . 26.530000000000001 109.65 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1312 ' ' TYR . . . . . . . . . . . . . 13.9 m-30 -116.56 128.18 55.19 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 117.755 2.502 . . . . 38.0 117.755 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1313 ' ' THR . . . . . . . . . . . . . 24.0 p -81.83 -56.25 4.1 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 112.668 -2.06 . . . . 29.800000000000001 108.64 173.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -70.05 21.26 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 117.991 2.589 . . . . 39.039999999999999 117.991 -173.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1315 ' ' LEU . . . . . . . . . . . . . 63.8 mt -50.78 -34.29 11.57 Favored Pre-proline 0 CA--C 1.545 0.777 0 O-C-N 118.013 -2.93 . . . . 31.079999999999998 117.128 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1316 ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -61.87 -54.23 1.67 Allowed 'Trans proline' 0 C--O 1.24 0.589 0 C-N-CA 123.213 2.608 . . . . 26.100000000000001 112.173 166.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -58.1 -32.99 68.07 Favored Glycine 0 C--O 1.213 -1.168 0 O-C-N 121.548 -0.72 . . . . 23.170000000000002 113.004 -177.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 74.7 mtt-85 -60.24 -27.44 67.21 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 113.584 0.957 . . . . 40.399999999999999 113.584 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 14.1 tp -111.86 77.98 2.1 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 105.397 -2.075 . . . . 23.600000000000001 105.397 171.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1320 ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -59.71 -64.66 0.1 OUTLIER 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.309 2.673 . . . . 22.350000000000001 115.414 -163.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1321 ' ' THR . . . . . . . . . . . . . 1.5 m -60.6 -38.07 83.48 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 120.552 -1.342 . . . . 26.52 111.404 -172.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1322 ' ' GLN . . . . . . . . . . . . . 43.1 tp60 -72.34 -35.37 68.54 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 120.288 -1.508 . . . . 24.379999999999999 109.342 -175.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1323 ' ' SER . . . . . . . . . . . . . 68.8 m -61.56 -47.6 84.77 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 124.633 1.208 . . . . 22.800000000000001 111.433 171.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1324 ' ' SER . . . . . . . . . . . . . 7.6 m -60.71 -28.86 68.97 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 119.612 -1.93 . . . . 21.25 112.915 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -74.61 -47.27 33.25 Favored 'General case' 0 C--O 1.252 1.211 0 O-C-N 119.82 -1.8 . . . . 31.34 109.973 176.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1326 ' ' LEU . . . . . . . . . . . . . 86.1 mt -74.85 -47.35 30.76 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 120.343 1.429 . . . . 31.559999999999999 109.527 -173.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1327 ' ' TYR . . . . . . . . . . . . . 55.9 t80 -58.35 -45.1 88.81 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 109.547 -0.538 . . . . 22.73 109.547 174.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1328 ' ' GLY . . . . . . . . . . . . . . . -55.4 -46.49 80.15 Favored Glycine 0 C--N 1.357 1.719 0 N-CA-C 111.253 -0.739 . . . . 21.91 111.253 173.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1329 ' ' THR . . . . . . . . . . . . . 48.2 m -67.98 -25.24 65.32 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 120.323 -1.692 . . . . 22.149999999999999 111.217 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1330 ' ' ASN . . . . . . . . . . . . . 31.7 m120 -69.25 -48.47 61.75 Favored 'General case' 0 C--N 1.314 -0.941 0 O-C-N 119.637 -1.914 . . . . 26.18 107.252 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1331 ' ' LEU . . . . . . . . . . . . . 33.8 mt -56.7 -38.9 72.93 Favored 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 123.003 0.521 . . . . 23.68 110.663 176.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1332 ' ' VAL . . . . . . . . . . . . . 71.0 t -54.3 -53.76 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 CA-C-N 120.157 1.344 . . . . 26.57 111.897 171.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -61.9 -44.24 97.2 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 122.37 1.081 . . . . 28.079999999999998 111.387 -177.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1334 ' ' LEU . . . . . . . . . . . . . 5.0 tt -53.92 -47.84 70.78 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 123.745 1.735 . . . . 27.43 113.016 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1335 ' ' LEU . . . . . . . . . . . . . 39.1 mt -78.9 -15.29 58.52 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 119.844 -1.785 . . . . 30.5 109.606 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1336 ' ' LYS . . . . . . . . . . . . . 89.7 mttt -72.08 -36.68 69.6 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-N 119.583 1.083 . . . . 41.649999999999999 109.771 167.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 10.4 mp -67.33 -34.12 76.68 Favored 'General case' 0 N--CA 1.434 -1.251 0 O-C-N 120.086 -1.634 . . . . 42.079999999999998 113.749 169.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1338 ' ' LEU . . . . . . . . . . . . . 85.6 mt -81.78 -43.71 17.98 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 118.878 -2.389 . . . . 35.030000000000001 113.774 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 41.5 t -105.23 60.3 0.68 Allowed 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 105.462 -2.051 . . . . 37.329999999999998 105.462 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 56.7 mttp -57.83 -21.15 40.88 Favored 'General case' 0 N--CA 1.432 -1.339 0 O-C-N 118.964 -2.335 . . . . 50.509999999999998 115.906 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -85.52 -5.42 59.29 Favored 'General case' 0 C--O 1.249 1.053 0 N-CA-C 114.856 1.428 . . . . 54.210000000000001 114.856 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 45.7 mttp 56.85 56.57 5.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 123.826 1.774 . . . . 50.990000000000002 111.16 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -133.04 -1.97 3.25 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 113.344 -1.753 . . . . 48.82 113.809 -168.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 88.95 -30.72 5.32 Favored Glycine 0 CA--C 1.541 1.657 0 N-CA-C 117.509 1.764 . . . . 40.43 117.509 -170.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -86.4 124.22 32.5 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 117.839 -1.545 . . . . 47.560000000000002 110.369 -171.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1346 ' ' ILE . . . . . . . . . . . . . 39.4 mm -80.51 117.11 25.86 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.416 0 N-CA-C 107.12 -1.437 . . . . 42.490000000000002 107.12 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1347 ' ' THR . . . . . . . . . . . . . 35.6 m -82.73 106.44 14.58 Favored 'General case' 0 C--N 1.352 0.708 0 CA-C-O 123.748 1.737 . . . . 38.119999999999997 108.935 164.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 18.8 t -84.0 93.14 3.14 Favored 'Isoleucine or valine' 0 C--O 1.257 1.457 0 N-CA-C 107.259 -1.386 . . . . 37.5 107.259 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 4.4 t70 -68.86 167.09 16.33 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.179 -1.373 . . . . 43.850000000000001 109.296 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1350 ' ' PHE . . . . . . . . . . . . . 13.5 t80 -131.61 -42.32 1.04 Allowed 'General case' 0 C--N 1.314 -0.945 0 O-C-N 121.023 -1.048 . . . . 39.810000000000002 110.391 169.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -64.51 -39.86 94.57 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 114.607 1.336 . . . . 51.289999999999999 114.607 -174.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 34.4 t70 -62.42 112.95 2.66 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 121.523 -0.736 . . . . 39.780000000000001 111.991 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 27.0 m -47.99 -37.88 6.97 Favored 'Isoleucine or valine' 0 C--N 1.35 0.628 0 N-CA-C 114.101 1.149 . . . . 39.280000000000001 114.101 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1354 ' ' VAL . . . . . . . . . . . . . 99.5 t -67.79 -53.96 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 O-C-N 120.311 -1.493 . . . . 35.700000000000003 111.392 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1355 ' ' ILE . . . . . . . . . . . . . 25.0 mm -56.11 -51.79 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 114.153 1.168 . . . . 35.770000000000003 114.153 174.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 43.0 tpt85 -55.43 -31.47 61.92 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 115.725 1.75 . . . . 38.549999999999997 115.725 176.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -68.96 -58.84 6.39 Favored Glycine 0 C--N 1.341 0.857 0 C-N-CA 125.855 1.693 . . . . 29.579999999999998 109.934 172.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1358 ' ' VAL . . . . . . . . . . . . . 13.0 p -71.65 -36.67 60.32 Favored 'Isoleucine or valine' 0 C--O 1.249 1.072 0 O-C-N 120.763 -1.433 . . . . 32.060000000000002 112.152 -171.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1359 ' ' THR . . . . . . . . . . . . . 54.1 m -78.29 93.22 4.61 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 103.575 -2.75 . . . . 29.0 103.575 -176.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1360 ' ' VAL . . . . . . . . . . . . . 18.6 m -80.17 -27.88 12.08 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 CA-C-N 111.467 -2.606 . . . . 29.68 110.394 -175.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 97.7 mt -128.31 106.64 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.644 -1.243 . . . . 32.049999999999997 107.644 172.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1362 ' ' ARG . . . . . . . . . . . . . 46.1 ttt85 -83.08 90.45 7.05 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 105.643 -1.984 . . . . 32.520000000000003 105.643 172.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 47.35 71.66 0.31 Allowed 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 123.809 1.766 . . . . 35.68 112.786 170.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 85.85 -41.41 3.07 Favored Glycine 0 C--N 1.344 1.026 0 N-CA-C 116.311 1.284 . . . . 34.259999999999998 116.311 -173.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -78.87 112.24 15.84 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 106.508 -1.664 . . . . 51.07 106.508 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 65.5 mt -67.98 93.71 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 O-C-N 120.152 -1.593 . . . . 39.869999999999997 108.167 176.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1367 ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.02 -4.13 54.12 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 126.063 1.745 . . . . 38.009999999999998 113.247 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B 1368 ' ' TRP . . . . . . . . . . . . . 49.3 t90 -86.52 134.3 38.24 Favored Pre-proline 0 C--O 1.242 0.671 0 N-CA-C 103.248 -2.871 . . . . 42.140000000000001 103.248 168.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -64.6 140.89 43.49 Favored 'Cis proline' 0 N--CA 1.489 1.243 0 N-CA-C 121.457 3.599 . . . . 43.259999999999998 121.457 9.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1370 ' ' ALA . . . . . . . . . . . . . . . -87.57 160.97 46.57 Favored Pre-proline 0 C--N 1.307 -1.261 0 CA-C-N 113.527 -1.67 . . . . 46.520000000000003 107.243 -174.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -56.25 153.28 34.26 Favored 'Trans proline' 0 C--O 1.245 0.866 0 C-N-CA 125.212 3.941 . . . . 51.950000000000003 111.838 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -63.9 114.13 2.47 Favored 'Trans proline' 0 C--O 1.251 1.146 0 C-N-CA 122.804 2.336 . . . . 56.270000000000003 114.544 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1373 ' ' ILE . . . . . . . . . . . . . 37.2 mm -93.81 129.85 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 114.588 -1.187 . . . . 60.829999999999998 108.558 -171.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -70.03 121.57 17.69 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-O 123.642 1.687 . . . . 66.099999999999994 109.035 166.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 59.7 t -109.96 127.25 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 113.827 -1.533 . . . . 63.469999999999999 108.545 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1376 ' ' SER . . . . . 0.502 ' N ' HO3N ' B' ' 1' ' ' NAD . . . . . . . . 1 C--N 1.226 -4.764 0 CA-C-N 120.254 1.388 . . . . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.209 -1.044 0 CA-C-O 118.445 -0.788 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -47.53 -36.86 11.05 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 123.769 1.747 . . . . 0.0 113.915 168.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 35.4 mp0 -56.14 -42.0 76.27 Favored 'General case' 0 C--O 1.249 1.075 0 C-N-CA 126.308 1.843 . . . . 0.0 108.904 176.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 14.6 m -66.05 -32.62 74.2 Favored 'General case' 0 C--O 1.24 0.583 0 O-C-N 120.026 -1.671 . . . . 0.0 111.122 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.31 -46.81 81.92 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 121.438 1.926 . . . . 0.0 111.249 175.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -57.38 -35.17 69.65 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 126.356 2.285 . . . . 0.0 113.62 174.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 14.6 tp -68.12 -60.81 2.2 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.31 -1.314 . . . . 0.0 111.219 177.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 7.9 mt -48.4 -43.46 33.98 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 115.931 -1.985 . . . . 0.0 113.746 -169.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 28' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -58.05 -30.48 66.21 Favored 'General case' 0 C--O 1.244 0.783 0 O-C-N 125.076 1.485 . . . . 0.0 114.813 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -93.12 -23.76 18.5 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 174.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 53.2 m -57.85 -16.91 13.26 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 120.201 3.408 . . . . 0.0 120.201 -168.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . 0.45 1.3 p-80 53.9 -55.4 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 117.373 2.36 . . . . 0.0 117.373 -174.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 68.0 m -108.53 133.88 52.06 Favored 'General case' 0 CA--C 1.476 -1.902 0 O-C-N 118.419 -2.676 . . . . 0.0 110.426 167.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 42.6 t -134.38 115.01 19.46 Favored 'Isoleucine or valine' 0 C--N 1.355 0.833 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 174.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 42.5 mt -106.22 100.76 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 84.4 mt -81.59 108.36 14.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 103.719 -2.697 . . . . 0.0 103.719 -177.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 89.2 m -103.56 95.31 7.1 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -171.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -63.29 114.1 2.35 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.091 2.528 . . . . 0.0 113.21 176.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.85 -166.44 33.16 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 158.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -50.08 -21.18 1.17 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 175.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.24 -38.46 94.57 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-N 121.154 1.797 . . . . 0.0 111.365 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 26.4 ttm -74.98 -6.73 50.89 Favored 'General case' 0 C--O 1.248 1.018 0 O-C-N 121.271 -1.135 . . . . 0.0 113.887 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.78 -52.26 3.5 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 121.147 1.794 . . . . 0.0 109.16 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.09 -45.57 90.14 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.557 0 O-C-N 123.734 0.646 . . . . 0.0 110.691 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.23 144.62 25.67 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 174.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.7 55.58 0.52 Allowed 'General case' 0 CA--C 1.552 1.022 0 CA-C-O 123.118 1.437 . . . . 0.0 112.475 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.26 -16.13 60.47 Favored 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 120.617 -1.302 . . . . 0.0 111.047 -171.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.97 -38.04 75.95 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 117.68 2.474 . . . . 0.0 117.68 177.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 48' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -62.22 -36.66 30.33 Favored Pre-proline 0 CA--C 1.517 -0.308 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -175.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 49' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.19 -28.98 8.4 Favored 'Trans proline' 0 C--N 1.318 -1.026 0 C-N-CA 122.34 2.026 . . . . 0.0 115.223 164.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.93 -35.54 61.4 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 O-C-N 118.38 -2.7 . . . . 0.0 115.318 -170.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.17 -27.12 67.76 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.45 -30.49 66.09 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.2 176.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 10.9 tp -76.76 -41.5 33.19 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 O-C-N 120.056 -1.653 . . . . 0.0 107.664 170.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 27.5 m -53.77 -27.26 27.79 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 121.256 1.844 . . . . 0.0 113.662 172.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -57.32 -57.18 13.74 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 121.014 -1.053 . . . . 0.0 108.963 172.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -74.89 -27.87 60.41 Favored 'General case' 0 C--O 1.253 1.266 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 95.9 mt -66.16 -47.68 73.23 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -66.5 -44.22 83.16 Favored 'General case' 0 C--N 1.359 0.988 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.583 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.72 -30.18 55.39 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 171.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -89.83 8.14 33.51 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.97 36.75 91.46 Favored Glycine 0 N--CA 1.432 -1.589 0 O-C-N 119.896 -1.753 . . . . 0.0 110.418 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 64.1 mt -94.66 126.61 47.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -62.99 91.5 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.326 171.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 7.1 p -107.71 129.68 61.32 Favored 'Isoleucine or valine' 0 C--O 1.258 1.522 0 C-N-CA 119.629 -0.828 . . . . 0.0 108.811 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 23.1 mmm-85 -127.01 156.35 41.77 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 175.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -117.71 105.4 11.97 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-O 122.65 1.215 . . . . 0.0 108.434 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.92 80.14 1.85 Allowed Glycine 0 C--O 1.24 0.477 0 CA-C-O 117.347 -1.807 . . . . 0.0 109.593 -174.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.06 126.25 32.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 121.447 2.624 . . . . 0.0 109.639 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -94.67 126.43 47.54 Favored Pre-proline 0 N--CA 1.437 -1.082 0 C-N-CA 117.626 -1.63 . . . . 0.0 108.728 -177.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 70' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -57.92 -62.74 0.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.967 2.444 . . . . 0.0 112.806 175.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 42.4 t -64.01 92.33 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.211 -0.927 0 CA-C-O 123.252 1.501 . . . . 0.0 107.096 166.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.19 -32.79 24.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 113.451 -1.704 . . . . 0.0 114.134 -174.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 129.97 -51.23 0.86 Allowed Glycine 0 CA--C 1.504 -0.63 0 CA-C-N 113.302 -1.772 . . . . 0.0 109.26 -171.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -130.86 129.2 42.0 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 101.625 -3.472 . . . . 0.0 101.625 163.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 1.9 mp 68.59 153.38 0.14 Allowed Pre-proline 0 N--CA 1.441 -0.892 0 C-N-CA 127.034 2.133 . . . . 0.0 115.8 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -57.46 88.31 0.05 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 123.689 2.926 . . . . 0.0 110.659 158.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 46.17 48.47 15.11 Favored Glycine 0 C--O 1.216 -1.001 0 N-CA-C 118.139 2.016 . . . . 0.0 118.139 175.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -49.91 -24.19 2.37 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 122.032 2.916 . . . . 0.0 116.346 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -63.81 -25.89 68.38 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -69.14 -22.52 63.94 Favored 'General case' 0 CA--C 1.561 1.369 0 O-C-N 124.102 0.876 . . . . 0.0 111.751 -176.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 40.7 t -66.13 -52.97 42.09 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 169.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 6.9 mp -57.64 -30.32 65.29 Favored 'General case' 0 CA--C 1.512 -0.499 0 O-C-N 119.944 -1.723 . . . . 0.0 114.319 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 5.3 mp -64.46 -22.22 66.9 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 117.836 -1.078 . . . . 0.0 113.063 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.99 -34.89 76.02 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 120.338 1.426 . . . . 0.0 113.178 173.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -69.07 -42.3 76.4 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 172.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.37 -21.69 66.24 Favored 'General case' 0 C--O 1.213 -0.833 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 177.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp 70.73 45.49 0.57 Allowed 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 128.165 2.586 . . . . 0.0 108.436 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 45.6 t -81.58 130.8 60.1 Favored Pre-proline 0 C--N 1.351 0.672 0 CA-C-O 117.664 -1.16 . . . . 0.0 108.259 174.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -61.81 115.4 2.78 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 124.025 3.15 . . . . 0.0 114.143 176.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -60.76 -13.09 12.92 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-N 114.765 -1.107 . . . . 0.0 113.481 -177.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -59.16 -51.73 68.76 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 166.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 26.3 pt -82.64 -15.71 11.77 Favored 'Isoleucine or valine' 0 C--O 1.249 1.047 0 CA-C-N 119.169 0.895 . . . . 0.0 110.447 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 73.5 t -75.59 99.99 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 123.026 1.394 . . . . 0.0 109.453 175.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 53.0 mt -103.7 100.44 10.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 113.707 -1.588 . . . . 0.0 112.621 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 95' ' ' GLU . . . . . 0.437 ' CD ' ' HZ3' ' A' 1162 ' ' LYS . 40.9 mp0 -81.06 91.8 6.15 Favored 'General case' 0 C--O 1.267 1.989 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 -178.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 31.8 ttp 47.94 73.47 0.21 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 123.892 1.806 . . . . 0.0 115.606 -171.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -91.74 144.42 25.52 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 168.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -92.82 51.9 1.77 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 123.844 1.783 . . . . 0.0 112.247 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 99' ' ' ILE . . . . . . . . . . . . 0.286 10.2 tt -87.22 70.0 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-O 126.978 3.275 . . . . 0.0 108.852 -166.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -54.73 -52.49 62.33 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 108.834 -3.803 . . . . 0.0 114.935 -174.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -62.49 -42.98 99.86 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 118.368 -0.825 . . . . 0.0 112.861 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.54 -39.32 81.18 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-N 119.974 1.261 . . . . 0.0 108.785 -174.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 103' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -55.34 -52.5 63.29 Favored 'General case' 0 C--O 1.251 1.173 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 168.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.85 -26.02 67.06 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -75.62 -39.53 57.73 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 106' ' ' THR . . . . . . . . . . . . . 96.0 m -61.34 141.52 57.53 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 -162.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 107' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -71.53 -87.8 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 124.019 0.928 . . . . 0.0 108.714 161.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.09 112.35 23.31 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 122.448 1.118 . . . . 0.0 112.395 -165.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 109' ' ' VAL . . . . . . . . . . . . . 4.4 t -102.92 104.2 16.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 174.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 95.9 mt -88.3 90.6 8.46 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.521 -172.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 28.2 t -81.19 104.84 10.33 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 CA-C-O 124.338 2.018 . . . . 0.0 107.771 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 45.1 mm -78.24 97.79 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 CA-C-O 122.635 1.207 . . . . 0.0 108.45 -171.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.21 -70.45 3.1 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-N 111.275 -2.693 . . . . 0.0 113.738 165.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -87.57 121.84 30.51 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 120.775 -1.427 . . . . 0.0 112.441 -163.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 115' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -85.09 -55.1 4.22 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 118.156 -0.926 . . . . 0.0 113.192 -173.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.19 -38.89 66.12 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 121.298 1.863 . . . . 0.0 109.915 -175.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 67.6 m -33.61 -36.31 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 118.751 2.871 . . . . 0.0 118.751 166.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 26.7 m -119.58 2.53 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-O 117.646 -1.168 . . . . 0.0 110.459 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -52.09 117.77 10.81 Favored Pre-proline 0 C--O 1.257 1.454 0 CA-C-N 122.472 2.396 . . . . 0.0 115.708 -164.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 120' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -45.1 -59.92 1.0 Allowed 'Trans proline' 0 C--N 1.363 1.339 1 C-N-CA 127.954 5.77 . . . . 0.0 110.706 174.293 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -48.28 -38.75 19.56 Favored 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.92 -16.54 63.42 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 118.618 -1.233 . . . . 0.0 114.256 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.25 -41.68 6.61 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 117.359 -1.736 . . . . 0.0 110.892 165.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.68 -60.95 2.98 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 126.297 1.839 . . . . 0.0 114.27 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 125' ' ' ASP . . . . . 0.416 ' CG ' ' HZ2' ' C' ' 127' ' ' LYS . 16.4 t70 -82.09 117.04 66.92 Favored Pre-proline 0 C--O 1.246 0.918 0 O-C-N 124.851 1.345 . . . . 0.0 111.222 173.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -67.52 -26.53 40.19 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.732 3.621 . . . . 0.0 112.157 176.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . 0.416 ' HZ2' ' CG ' ' C' ' 125' ' ' ASP . 6.0 ttpm? -64.96 -28.34 69.45 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 122.445 1.117 . . . . 0.0 113.934 -175.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 128' ' ' SER . . . . . . . . . . . . . 70.3 m -32.9 116.66 0.42 Allowed Pre-proline 0 C--N 1.357 0.92 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 166.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 129' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -50.03 -48.84 18.03 Favored 'Trans proline' 0 C--O 1.241 0.67 0 C-N-CA 124.042 3.162 . . . . 0.0 111.58 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 13.1 pt -73.97 84.07 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 O-C-N 119.732 -1.855 . . . . 0.0 108.669 168.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.93 119.17 19.54 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -172.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 73.76 78.36 0.57 Allowed Glycine 0 N--CA 1.48 1.57 0 CA-C-N 114.715 -1.13 . . . . 0.0 113.113 177.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 133' ' ' MET . . . . . . . . . . . . . 41.6 tpp -76.01 124.06 88.32 Favored Pre-proline 0 C--N 1.313 -0.999 0 O-C-N 118.965 -2.491 . . . . 0.0 109.638 171.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -70.62 85.52 0.74 Allowed 'Trans proline' 0 CA--C 1.5 -1.188 0 C-N-CA 123.562 2.841 . . . . 0.0 113.734 176.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.93 137.54 50.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 124.889 2.28 . . . . 0.0 111.233 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -105.17 137.59 42.7 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 111.839 -2.437 . . . . 0.0 107.134 167.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . 0.258 6.3 mm-40 23.23 40.68 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.964 1 N-CA-C 122.531 4.271 . . . . 0.0 122.531 166.429 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 13.7 p -88.01 48.35 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 126.228 2.918 . . . . 0.0 109.386 174.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -159.0 148.54 18.92 Favored 'General case' 0 C--O 1.256 1.434 0 CA-C-N 111.185 -2.734 . . . . 0.0 104.597 -172.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 140' ' ' LYS . . . . . . . . . . . . 0.356 23.6 pttm 65.63 -26.57 0.1 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 118.017 2.599 . . . . 0.0 118.017 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -45.4 146.71 0.93 Allowed 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 125.665 1.586 . . . . 0.0 113.614 161.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -58.62 -28.88 66.05 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 120.136 3.384 . . . . 0.0 120.136 -151.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 143' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -153.57 87.51 1.24 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 172.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 144' ' ' VAL . . . . . . . . . . . . . 37.4 t -81.24 89.76 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.146 0 O-C-N 119.803 -1.811 . . . . 0.0 107.358 177.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 145' ' ' ILE . . . . . . . . . . . . . 21.7 mt -92.28 104.63 15.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 125.545 2.593 . . . . 0.0 107.977 -173.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 146' ' ' VAL . . . . . . . . . . . . . 10.0 t -86.25 102.7 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 CA-C-N 111.38 -2.645 . . . . 0.0 107.552 176.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 147' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -64.34 94.48 0.11 Allowed 'General case' 0 C--O 1.242 0.7 0 CA-C-O 122.372 1.082 . . . . 0.0 112.105 177.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 148' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -128.22 111.59 13.59 Favored 'General case' 0 CA--C 1.485 -1.541 0 C-N-CA 123.98 0.912 . . . . 0.0 109.352 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 10.7 ptp85 -54.0 -31.96 52.59 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 174.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 19.4 m -153.0 155.47 36.98 Favored 'General case' 0 C--O 1.249 1.067 0 O-C-N 118.682 -2.511 . . . . 0.0 106.185 -170.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 151' ' ' MET . . . . . 0.608 ' SD ' ' SD ' ' C' ' 170' ' ' MET . 6.8 tpt -88.03 67.17 8.87 Favored 'General case' 0 C--O 1.254 1.329 0 CA-C-O 125.865 2.745 . . . . 0.0 108.074 177.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -94.93 117.32 29.93 Favored 'General case' 0 N--CA 1.44 -0.958 0 O-C-N 119.636 -1.915 . . . . 0.0 106.109 170.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 7.4 m -64.18 138.99 58.72 Favored 'General case' 0 C--O 1.249 1.074 0 CA-C-N 113.286 -1.779 . . . . 0.0 107.696 171.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -86.85 -53.42 2.87 Favored Glycine 0 C--O 1.214 -1.105 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -132.17 -78.3 0.5 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 118.002 0.901 . . . . 0.0 108.901 164.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 156' ' ' ALA . . . . . . . . . . . . . . . -86.71 -61.44 1.73 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -170.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.81 28.85 5.69 Favored Glycine 0 C--N 1.353 1.475 0 C-N-CA 127.387 2.422 . . . . 0.0 114.654 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 6.1 m -54.76 138.97 14.26 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 N-CA-C 119.414 3.116 . . . . 0.0 119.414 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . 0.263 0.0 OUTLIER 6.76 92.53 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.974 1 N-CA-C 122.811 4.375 . . . . 0.0 122.811 173.663 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' C' C ' 160' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -150.1 152.16 33.25 Favored Pre-proline 0 N--CA 1.469 0.493 0 CA-C-O 117.602 -1.19 . . . . 0.0 112.952 -174.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.76 -27.85 37.41 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 124.551 3.501 . . . . 0.0 114.025 167.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 162' ' ' LEU . . . . . . . . . . . . . 16.3 tp -43.8 -31.5 0.84 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 119.415 3.117 . . . . 0.0 119.415 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 163' ' ' PHE . . . . . . . . . . . . . 14.0 m-30 -85.7 -60.62 1.97 Allowed 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 124.611 2.148 . . . . 0.0 109.749 171.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -82.8 -7.43 59.66 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-N 111.752 -2.476 . . . . 0.0 113.97 -158.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -91.71 177.16 6.28 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 122.0 0.905 . . . . 0.0 110.611 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.77 -51.98 4.66 Favored 'General case' 0 C--O 1.254 1.316 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -174.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -78.88 -45.55 20.44 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 120.552 -1.342 . . . . 0.0 111.344 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 168' ' ' THR . . . . . . . . . . . . . 3.0 m -89.75 95.15 10.12 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 101.495 -3.52 . . . . 0.0 101.495 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -150.26 132.3 15.27 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 123.662 1.696 . . . . 0.0 112.302 -162.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 170' ' ' MET . . . . . 0.608 ' SD ' ' SD ' ' C' ' 151' ' ' MET . 33.7 mtm -64.88 110.78 2.55 Favored 'General case' 0 C--O 1.253 1.288 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 165.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 171' ' ' LEU . . . . . . . . . . . . . 15.2 tp -91.16 124.01 35.05 Favored 'General case' 0 C--O 1.256 1.401 0 N-CA-C 103.545 -2.761 . . . . 0.0 103.545 172.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -70.76 82.74 0.63 Allowed 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 111.774 -2.466 . . . . 0.0 115.317 -175.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -157.97 147.5 15.52 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 106.611 -2.595 . . . . 0.0 106.611 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 174' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -63.69 147.69 50.99 Favored 'General case' 0 N--CA 1.431 -1.378 0 O-C-N 121.706 -0.879 . . . . 0.0 112.609 172.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -52.24 -60.22 3.47 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -48.8 62.14 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 -171.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 177' ' ' ALA . . . . . . . . . . . . . . . -55.25 -50.55 69.18 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 127.03 2.706 . . . . 0.0 109.978 -176.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 44.2 m -68.26 -32.87 73.35 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.941 -1.1 . . . . 0.0 110.697 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 179' ' ' VAL . . . . . . . . . . . . . 86.9 t -62.87 -45.51 98.68 Favored 'Isoleucine or valine' 0 C--N 1.343 0.287 0 CA-C-N 119.642 1.11 . . . . 0.0 108.421 176.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -68.06 -28.9 67.77 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 119.966 -1.709 . . . . 0.0 111.471 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -64.99 -56.27 14.12 Favored 'General case' 0 C--N 1.348 0.536 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 182' ' ' ILE . . . . . . . . . . . . . 23.8 pt -64.29 -33.47 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 183' ' ' LEU . . . . . . . . . . . . . 5.9 tp -32.02 -50.62 0.22 Allowed 'General case' 0 C--O 1.248 1.012 0 C-N-CA 128.934 2.894 . . . . 0.0 118.565 -171.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -123.79 -7.11 7.92 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.633 169.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -62.39 -44.12 97.2 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -170.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 186' ' ' LEU . . . . . . . . . . . . 0.331 88.1 mt . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 121.588 3.922 . . . . 0.0 121.588 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' NAD . . . . . 0.502 HO3N ' N ' ' B' 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C 1001 ' ' NAP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 9.8 t-80 . . . . . 0 N--CA 1.444 -0.738 0 N-CA-C 103.958 -2.608 . . . . 65.739999999999995 103.958 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -75.04 78.28 1.09 Allowed Glycine 0 C--O 1.256 1.487 0 CA-C-O 119.067 -0.852 . . . . 48.659999999999997 112.326 -174.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 24.2 ttp180 -86.81 131.98 33.97 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 120.045 1.922 . . . . 44.560000000000002 106.289 153.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1003 ' ' ILE . . . . . . . . . . . . . 39.9 mt -101.4 124.74 55.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 102.471 -3.159 . . . . 34.859999999999999 102.471 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -88.1 129.25 9.47 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 107.486 -2.245 . . . . 30.75 107.486 165.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 48.2 mm -98.63 99.55 7.77 Favored Pre-proline 0 C--O 1.249 1.027 0 N-CA-C 105.647 -1.982 . . . . 32.210000000000001 105.647 174.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -71.51 131.03 18.1 Favored 'Trans proline' 0 CA--C 1.499 -1.24 0 C-N-CA 123.779 2.986 . . . . 32.979999999999997 109.317 174.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1007 ' ' ARG . . . . . . . . . . . . . 7.1 ttp85 -73.86 121.34 20.75 Favored 'General case' 0 C--O 1.255 1.347 0 CA-C-N 110.284 -3.144 . . . . 47.979999999999997 106.734 155.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1008 ' ' GLU . . . . . 0.423 ' CD ' ' HZ1' ' A' 1071 ' ' LYS . 6.4 tp10 -73.33 133.33 43.81 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 123.306 1.527 . . . . 34.700000000000003 112.956 -165.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -97.86 9.43 42.7 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 112.805 -1.998 . . . . 53.369999999999997 111.456 -174.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 17.7 tp -70.28 146.54 50.53 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 117.211 -1.796 . . . . 45.07 106.396 168.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1011 ' ' THR . . . . . . . . . . . . . 5.7 m -54.58 146.42 16.51 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-O 117.7 -1.143 . . . . 40.359999999999999 110.698 174.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 76.8 m-20 61.81 -10.67 0.07 Allowed 'General case' 0 C--O 1.258 1.508 0 N-CA-C 119.089 2.996 . . . . 40.609999999999999 119.089 -175.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -68.99 114.93 7.73 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 124.35 2.024 . . . . 33.759999999999998 113.838 -160.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1014 ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.56 -26.95 68.93 Favored 'General case' 0 N--CA 1.427 -1.597 1 CA-C-N 108.27 -4.059 . . . . 27.890000000000001 114.86 174.518 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 1015 ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -79.81 151.32 30.35 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 126.65 3.119 . . . . 29.02 116.621 -171.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1016 ' ' VAL . . . . . . . . . . . . . 2.6 p -115.8 169.02 6.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 1 CA-C-N 107.745 -4.298 . . . . 28.129999999999999 106.655 160.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1017 ' ' ALA . . . . . . . . . . . . . . . -60.98 -46.92 88.81 Favored 'General case' 0 C--O 1.217 -0.617 0 O-C-N 119.296 -2.128 . . . . 26.870000000000001 113.45 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -155.82 133.55 11.15 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 120.838 -1.164 . . . . 26.77 108.516 -175.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1019 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.41 167.39 25.6 Favored Pre-proline 0 C--O 1.239 0.517 0 O-C-N 120.36 -1.462 . . . . 27.02 114.539 177.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1020 ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -42.87 -53.57 3.87 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 124.667 3.578 . . . . 30.57 119.546 -174.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 9.5 tttp -58.28 -39.26 78.81 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 124.111 1.91 . . . . 47.810000000000002 112.853 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1022 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.57 -40.38 92.71 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 113.188 -1.824 . . . . 30.77 109.833 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1023 ' ' VAL . . . . . . . . . . . . . 8.9 t -59.75 -42.61 89.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 118.953 -0.546 . . . . 33.590000000000003 110.475 176.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -49.32 -46.44 46.68 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 124.165 0.915 . . . . 53.289999999999999 112.05 172.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -68.04 -32.74 73.32 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.97 0.89 . . . . 46.920000000000002 111.383 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1026 ' ' LEU . . . . . . . . . . . . . 99.0 mt -68.61 -41.53 79.41 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.166 -1.584 . . . . 37.170000000000002 112.434 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 36.0 tp -61.67 -50.69 71.47 Favored 'General case' 0 C--O 1.254 1.294 0 CA-C-N 111.928 -2.396 . . . . 44.439999999999998 107.039 173.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -48.79 -41.62 33.15 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 116.762 2.134 . . . . 52.579999999999998 116.762 171.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1029 ' ' LEU . . . . . . . . . . . . . 77.0 mt -71.78 -11.32 60.76 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 121.467 1.939 . . . . 45.689999999999998 110.21 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 110.84 33.28 2.45 Favored Glycine 0 C--O 1.244 0.756 0 CA-C-O 122.971 1.317 . . . . 42.090000000000003 111.641 166.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1031 ' ' PHE . . . . . 0.438 ' CZ ' ' SG ' ' A' 1339 ' ' CYS . 50.1 m-85 -117.19 155.14 29.9 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 118.584 -2.715 . . . . 40.719999999999999 109.785 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1032 ' ' THR . . . . . . . . . . . . . 40.1 m -86.62 114.93 23.74 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 104.225 -2.509 . . . . 37.770000000000003 104.225 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1033 ' ' VAL . . . . . . . . . . . . . 19.3 t -88.77 125.78 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 105.837 -1.912 . . . . 33.539999999999999 105.837 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -117.26 126.37 52.63 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 104.446 -2.428 . . . . 31.68 104.446 173.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1035 ' ' VAL . . . . . . . . . . . . . 59.4 t -116.01 145.69 21.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 105.1 -2.185 . . . . 31.52 105.1 -177.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1036 ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -69.38 133.47 47.84 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 122.971 0.509 . . . . 41.039999999999999 111.915 174.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1037 ' ' SER . . . . . . . . . . . . . 54.4 m -54.89 123.33 13.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 123.926 1.822 . . . . 31.829999999999998 114.414 168.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 99.83 -8.14 59.5 Favored Glycine 0 N--CA 1.444 -0.806 0 O-C-N 119.035 -2.29 . . . . 29.359999999999999 112.159 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -64.53 -34.19 77.67 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 113.898 1.073 . . . . 27.780000000000001 113.898 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -59.76 -19.48 49.49 Favored Glycine 0 N--CA 1.427 -1.963 0 CA-C-N 112.14 -2.3 . . . . 28.91 114.648 175.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -76.24 -44.94 35.26 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 120.076 1.938 . . . . 51.18 110.646 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1042 ' ' LEU . . . . . . . . . . . . . 20.6 mt -64.32 -50.01 69.5 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.949 0.881 . . . . 29.91 111.39 173.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1043 ' ' ALA . . . . . . . . . . . . 0.267 . . -53.5 -22.65 8.46 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 112.807 -1.997 . . . . 28.539999999999999 114.477 172.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1044 ' ' SER . . . . . . . . . . . . . 15.5 m 53.98 44.93 28.65 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 124.688 2.185 . . . . 33.060000000000002 110.281 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1045 ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -167.59 102.82 0.5 Allowed 'General case' 0 C--O 1.249 1.066 0 N-CA-C 100.292 -3.966 . . . . 30.289999999999999 100.292 178.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -84.51 168.85 15.05 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 123.479 1.609 . . . . 48.619999999999997 114.464 -151.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -46.01 -45.85 16.16 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 112.499 -2.137 . . . . 36.740000000000002 115.609 -172.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 22.5 pttm -54.21 -40.71 67.88 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 115.191 1.552 . . . . 43.729999999999997 115.191 169.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -65.02 -31.52 72.8 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 119.752 1.16 . . . . 32.810000000000002 112.275 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1050 ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -64.01 -42.37 97.16 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 111.612 0.227 . . . . 31.859999999999999 111.612 169.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 41.3 t -61.68 -46.61 96.18 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 N-CA-C 106.774 -1.565 . . . . 33.219999999999999 106.774 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -55.15 -37.06 66.47 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 123.914 0.885 . . . . 50.829999999999998 112.521 174.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -62.56 -41.45 98.93 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 120.065 1.302 . . . . 33.119999999999997 112.578 172.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 120.31 81.36 0.67 Allowed Glycine 0 C--O 1.21 -1.399 0 N-CA-C 106.039 -2.824 . . . . 35.829999999999998 106.039 -177.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -161.06 132.22 5.45 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 125.162 1.154 . . . . 34.82 109.204 -173.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -71.19 135.3 47.48 Favored 'General case' 0 N--CA 1.44 -0.945 0 O-C-N 126.727 2.517 . . . . 49.049999999999997 107.201 166.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1057 ' ' ILE . . . . . . . . . . . . . 36.1 mm -104.43 125.95 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 101.951 -3.351 . . . . 38.530000000000001 101.951 169.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1058 ' ' VAL . . . . . . . . . . . . . 44.1 t -102.29 135.72 37.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 103.566 -2.753 . . . . 42.109999999999999 103.566 174.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -69.38 76.08 0.38 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 114.13 1.159 . . . . 58.0 114.13 178.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 80.08 -129.83 9.38 Favored Glycine 0 N--CA 1.422 -2.253 0 C-N-CA 121.092 -0.575 . . . . 52.119999999999997 113.187 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 29.4 t30 -46.79 -40.14 13.13 Favored 'General case' 0 C--O 1.217 -0.612 0 N-CA-C 117.963 2.579 . . . . 54.75 117.963 -156.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1062 ' ' SER . . . . . . . . . . . . . 15.3 m -67.79 -9.36 43.58 Favored 'General case' 0 C--O 1.247 0.932 0 O-C-N 118.23 -2.794 . . . . 50.340000000000003 116.468 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 8.3 p -64.08 -26.57 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 O-C-N 120.763 -1.211 . . . . 41.460000000000001 111.444 169.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1064 ' ' TRP . . . . . . . . . . . . . 76.8 m95 -72.42 -23.01 61.02 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.941 1.296 . . . . 39.32 112.312 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -83.49 73.58 10.18 Favored 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 120.743 -1.223 . . . . 55.380000000000003 109.058 175.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1066 ' ' SER . . . . . . . . . . . . . 70.5 m -146.34 164.7 31.56 Favored 'General case' 0 C--O 1.257 1.468 0 CA-C-O 121.661 0.743 . . . . 41.869999999999997 109.983 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.11 -66.84 0.63 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.04 -0.982 . . . . 53.200000000000003 109.571 -176.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 31.4 mt -88.63 110.48 21.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 O-C-N 118.236 -2.79 . . . . 41.899999999999999 104.97 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1069 ' ' ILE . . . . . . . . . . . . . 28.1 mm -102.12 119.42 50.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 107.046 -1.465 . . . . 38.729999999999997 107.046 168.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1070 ' ' LEU . . . . . . . . . . . . . 81.6 mt -88.02 74.83 8.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.736 -1.12 . . . . 32.439999999999998 110.126 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1071 ' ' LYS . . . . . 0.423 ' HZ1' ' CD ' ' A' 1008 ' ' GLU . 5.1 mmmt -71.54 128.65 36.53 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 121.98 0.895 . . . . 34.649999999999999 111.111 -176.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1072 ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -82.04 -30.7 10.08 Favored 'Isoleucine or valine' 0 C--O 1.251 1.17 0 N-CA-C 109.167 -0.679 . . . . 31.32 109.167 -163.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -128.61 -171.1 2.38 Favored 'General case' 0 C--O 1.246 0.902 0 N-CA-C 108.305 -0.998 . . . . 33.939999999999998 108.305 171.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -54.5 141.89 52.85 Favored Pre-proline 0 N--CA 1.47 0.556 0 CA-C-N 119.783 1.174 . . . . 38.039999999999999 112.069 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1075 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -72.76 130.56 15.93 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.37 2.047 . . . . 42.68 112.892 173.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 17.8 mt -105.98 165.13 11.43 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 103.969 -2.604 . . . . 46.740000000000002 103.969 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -31.01 -58.7 0.22 Allowed 'General case' 0 C--N 1.357 0.909 0 N-CA-C 117.057 2.243 . . . . 58.609999999999999 117.057 -173.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 13.8 t70 -62.79 -43.63 98.28 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 113.496 0.924 . . . . 59.200000000000003 113.496 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1079 ' ' GLU . . . . . 0.418 ' CD ' ' HZ2' ' A' 1071 ' ' LYS . 33.4 mt-10 -64.93 -37.88 89.1 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 113.581 0.956 . . . . 50.630000000000003 113.581 176.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1080 ' ' ILE . . . . . . . . . . . . . 25.0 mt -54.01 -54.03 23.48 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.88 0 CA-C-N 112.906 -1.952 . . . . 51.479999999999997 108.882 175.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -59.34 -25.69 64.41 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 123.812 1.768 . . . . 50.280000000000001 114.315 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 61.5 mt -77.92 -41.88 34.98 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 120.48 -1.387 . . . . 50.210000000000001 111.424 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1083 ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.27 139.92 40.88 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 123.93 1.824 . . . . 49.060000000000002 112.936 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -101.8 152.69 38.17 Favored Pre-proline 0 N--CA 1.435 -1.185 0 CA-C-N 112.197 -2.274 . . . . 51.079999999999998 108.543 -156.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -64.07 109.67 1.18 Allowed 'Trans proline' 0 C--N 1.322 -0.824 0 CA-C-N 121.446 1.552 . . . . 49.729999999999997 114.006 170.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 110.94 -7.04 29.3 Favored Glycine 0 C--N 1.316 -0.539 0 C-N-CA 119.103 -1.522 . . . . 47.710000000000001 113.424 -171.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1087 ' ' THR . . . . . . . . . . . . . 2.8 m -64.18 118.35 8.46 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 117.487 0.643 . . . . 45.469999999999999 110.921 176.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1088 ' ' THR . . . . . . . . . . . . . 99.2 m -83.86 93.51 8.02 Favored 'General case' 0 N--CA 1.411 -2.4 0 N-CA-C 104.491 -2.411 . . . . 42.039999999999999 104.491 172.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1089 ' ' LEU . . . . . . . . . . . . . 55.0 tp -84.88 87.31 7.33 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 110.321 -3.127 . . . . 38.060000000000002 108.796 -174.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 15.8 t -83.11 120.16 33.91 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.813 0 N-CA-C 105.2 -2.148 . . . . 37.399999999999999 105.2 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1091 ' ' SER . . . . . . . . . . . . . 13.7 p -154.46 143.38 20.99 Favored 'General case' 0 C--O 1.247 0.974 0 O-C-N 119.454 -2.029 . . . . 36.159999999999997 114.897 -168.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 45.5 t80 -84.26 82.48 8.36 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-O 124.138 1.923 . . . . 38.939999999999998 109.694 168.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.28 -31.39 3.7 Favored 'Isoleucine or valine' 0 C--O 1.254 1.294 0 N-CA-C 116.865 2.172 . . . . 42.170000000000002 116.865 -169.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 99.0 m95 58.5 75.08 0.55 Allowed Pre-proline 0 C--O 1.247 0.932 0 CA-C-O 122.782 1.277 . . . . 46.509999999999998 113.039 -168.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -60.04 -40.81 58.05 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 124.613 3.542 . . . . 49.759999999999998 115.687 -172.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -61.15 -29.31 69.71 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.633 1.206 . . . . 52.619999999999997 113.84 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 28.0 mp0 -83.84 -24.27 30.99 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 106.276 -1.75 . . . . 60.740000000000002 106.276 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1098 ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -122.15 55.05 5.9 Favored Pre-proline 0 C--O 1.239 0.514 0 O-C-N 119.817 -1.802 . . . . 58.189999999999998 115.426 -168.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.01 -41.57 73.64 Favored 'Trans proline' 0 N--CA 1.476 0.478 1 C-N-CA 125.891 4.394 . . . . 54.590000000000003 114.218 -176.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -47.69 77.2 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.027 -0.988 . . . . 63.280000000000001 111.845 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1101 ' ' LEU . . . . . . . . . . . . . 7.6 tp -56.89 -41.43 78.07 Favored 'General case' 0 C--O 1.254 1.307 0 CA-C-N 113.304 -1.771 . . . . 54.75 112.288 178.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1102 ' ' MET . . . . . . . . . . . . . 75.0 mmm -57.09 -49.0 77.22 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 126.204 2.19 . . . . 52.649999999999999 109.598 174.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -65.01 -35.34 80.89 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.41 1.005 . . . . 66.260000000000005 111.116 -175.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -64.87 -43.88 91.53 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 109.136 -0.69 . . . . 63.729999999999997 109.136 177.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 49.0 mt -69.51 -30.57 68.45 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.926 0.869 . . . . 54.68 112.593 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -55.63 -48.92 74.13 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.482 0.919 . . . . 53.640000000000001 113.482 165.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -52.57 -46.58 66.92 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 114.479 1.289 . . . . 67.239999999999995 114.479 173.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -58.39 -22.16 52.87 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.702 -0.681 . . . . 65.760000000000005 111.95 174.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 45.2 t30 68.58 44.33 1.23 Allowed 'General case' 0 C--O 1.239 0.552 0 CA-C-O 124.322 2.011 . . . . 58.710000000000001 112.075 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1110 ' ' VAL . . . . . . . . . . . . . 28.3 m -93.11 165.7 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 O-C-N 119.288 -2.132 . . . . 46.630000000000003 112.109 175.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1111 ' ' THR . . . . . . . . . . . . . 58.7 m -102.32 101.4 11.65 Favored 'General case' 0 C--O 1.214 -0.794 0 O-C-N 119.281 -2.137 . . . . 44.130000000000003 110.078 165.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1112 ' ' VAL . . . . . . . . . . . . . 48.6 t -90.96 117.58 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 109.513 -0.551 . . . . 40.439999999999998 109.513 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1113 ' ' MET . . . . . . . . . . . . . 58.3 mtp -112.61 108.16 17.13 Favored 'General case' 0 N--CA 1.422 -1.842 0 C-N-CA 124.105 0.962 . . . . 50.759999999999998 108.788 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1114 ' ' ALA . . . . . . . . . . . . . . . -81.37 115.42 20.71 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 116.065 -0.516 . . . . 35.640000000000001 111.575 -172.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1115 ' ' MET . . . . . . . . . . . . . 93.5 mmm -76.0 -21.0 57.37 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 123.616 1.674 . . . . 38.740000000000002 114.877 -176.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -62.73 -50.38 71.33 Favored 'General case' 0 CA--C 1.482 -1.643 0 CA-C-N 112.767 -2.015 . . . . 40.140000000000001 111.692 163.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1117 ' ' SER . . . . . . . . . . . . . 75.8 m -76.12 22.22 0.16 Allowed 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 118.866 2.913 . . . . 44.789999999999999 118.866 -175.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1118 ' ' VAL . . . . . . . . . . . . . 59.9 t -66.12 130.75 94.36 Favored Pre-proline 0 C--O 1.249 1.063 0 N-CA-C 107.322 -1.362 . . . . 43.75 107.322 175.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -61.63 133.64 46.53 Favored 'Trans proline' 0 N--CA 1.428 -2.33 0 N-CA-C 107.903 -1.614 . . . . 48.93 107.903 175.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 23.4 mmm-85 -79.5 41.02 0.46 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 113.861 -1.518 . . . . 62.899999999999999 114.665 -161.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 18.1 pt -116.56 155.15 18.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 O-C-N 119.978 -1.701 . . . . 57.719999999999999 113.132 -167.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1122 ' ' SER . . . . . . . . . . . . . 2.8 m -27.23 -64.73 0.08 Allowed 'General case' 0 C--N 1.312 -1.024 0 O-C-N 127.07 2.731 . . . . 57.259999999999998 116.637 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 39.9 ptt85 -68.53 -22.36 64.52 Favored 'General case' 0 C--N 1.353 0.726 0 O-C-N 119.655 -1.903 . . . . 62.899999999999999 112.428 -172.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -77.68 -13.66 59.84 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 115.108 1.521 . . . . 49.829999999999998 115.108 174.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 42.0 mm-40 -59.85 -29.22 68.14 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 119.04 2.978 . . . . 52.369999999999997 119.04 -165.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1126 ' ' SER . . . . . . . . . . . . . 15.8 m -69.96 -22.28 63.17 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 115.43 1.641 . . . . 42.43 115.43 168.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1127 ' ' LEU . . . . . . . . . . . . . 3.3 mp -88.22 -45.48 10.05 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.179 -2.156 . . . . 43.740000000000002 105.179 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 30.3 t0 -50.45 109.23 0.29 Allowed 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 116.238 1.94 . . . . 43.210000000000001 116.238 -176.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -79.04 -30.06 43.9 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.68 -1.6 . . . . 35.740000000000002 113.134 176.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 80.8 mt -72.7 -6.52 45.01 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 119.545 -1.972 . . . . 38.090000000000003 111.945 175.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1131 ' ' SER . . . . . . . . . . . . . 32.9 m -94.73 -57.66 2.4 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 107.801 -1.185 . . . . 36.909999999999997 107.801 161.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1132 ' ' SER . . . . . . . . . . . . . 22.2 m -77.28 -51.9 10.1 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 117.094 -1.431 . . . . 35.789999999999999 113.848 -169.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1133 ' ' MET . . . . . . . . . . . . . 81.6 mtp -58.25 -37.81 75.67 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 124.274 3.215 . . . . 30.809999999999999 110.045 173.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1134 ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.19 77.53 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 120.538 -0.465 . . . . 28.879999999999999 110.333 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1135 ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -60.79 -46.21 91.4 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 120.704 -1.248 . . . . 40.759999999999998 108.938 173.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1136 ' ' ILE . . . . . . . . . . . . . 16.8 mt -56.78 -50.65 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 117.631 -1.176 . . . . 31.539999999999999 111.745 172.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -53.56 -38.41 63.85 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 114.672 1.36 . . . . 29.870000000000001 114.672 169.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -63.9 -41.41 98.73 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-O 123.41 1.561 . . . . 28.73 111.652 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 17.0 t80 -71.68 -46.37 59.03 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-N 114.16 -1.02 . . . . 30.390000000000001 110.428 176.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1140 ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -67.94 -19.97 65.03 Favored 'General case' 0 C--N 1.356 0.884 0 N-CA-C 107.949 -1.13 . . . . 26.09 107.949 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1141 ' ' ALA . . . . . . . . . . . . . . . -62.89 -48.66 78.04 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 106.833 -1.543 . . . . 27.100000000000001 106.833 172.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 36.3 mm -64.53 -42.68 95.9 Favored 'Isoleucine or valine' 0 C--N 1.346 0.44 0 CA-C-N 119.343 0.974 . . . . 28.48 109.792 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 21.8 t -54.86 -60.04 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 113.533 0.938 . . . . 23.07 113.533 175.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1144 ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -71.7 -27.98 63.4 Favored 'General case' 0 C--O 1.248 0.989 0 O-C-N 119.561 -1.962 . . . . 33.399999999999999 112.456 -174.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -62.18 -49.04 77.38 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 106.54 -1.652 . . . . 24.219999999999999 106.54 175.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -58.76 -33.74 70.62 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 115.375 1.62 . . . . 24.890000000000001 115.375 171.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -61.96 -31.62 71.98 Favored 'General case' 0 C--N 1.372 1.569 0 CA-C-O 117.925 -1.036 . . . . 26.73 111.628 175.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1148 ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -109.77 1.63 19.5 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 115.706 1.743 . . . . 39.960000000000001 115.706 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1149 ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -64.47 138.38 58.38 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 126.06 1.744 . . . . 25.870000000000001 110.516 -170.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1150 ' ' GLY . . . . . . . . . . . . . . . -73.01 -55.46 6.34 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 110.259 -1.136 . . . . 19.280000000000001 110.259 171.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1151 ' ' ARG . . . . . 0.403 ' NH2' ' OG ' ' A' 1279 ' ' SER . 33.4 mtm-85 -94.37 -178.8 4.7 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 113.025 0.75 . . . . 39.899999999999999 113.025 -174.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1152 ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -85.68 160.6 19.52 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 116.578 -2.049 . . . . 29.440000000000001 111.716 171.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1153 ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -73.27 -58.45 3.31 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 122.45 1.119 . . . . 32.600000000000001 108.523 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1154 ' ' THR . . . . . . . . . . . . . 20.9 m -62.86 123.93 19.74 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 125.536 1.534 . . . . 34.640000000000001 110.379 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -80.48 71.26 2.85 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 109.957 -1.257 . . . . 37.140000000000001 109.957 174.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -90.75 139.36 30.8 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 120.848 -0.341 . . . . 40.57 111.113 -166.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1157 ' ' ILE . . . . . . . . . . . . . 2.6 tp -73.77 112.28 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 107.86 -1.163 . . . . 44.609999999999999 107.86 168.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1158 ' ' THR . . . . . . . . . . . . . 42.6 p -91.21 174.53 7.35 Favored 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 109.013 -0.736 . . . . 40.700000000000003 109.013 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -49.06 -39.97 29.64 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 115.469 1.655 . . . . 40.25 115.469 167.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -86.55 -46.69 9.91 Favored 'General case' 0 C--O 1.253 1.255 0 N-CA-C 116.194 1.924 . . . . 38.469999999999999 116.194 178.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . -172.24 179.07 44.08 Favored Glycine 0 N--CA 1.475 1.259 0 CA-C-O 124.456 2.142 . . . . 37.609999999999999 116.493 -170.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 17.1 tttt -76.27 115.06 15.65 Favored 'General case' 0 C--O 1.251 1.168 0 CA-C-N 111.995 -2.103 . . . . 48.899999999999999 108.788 -178.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1163 ' ' VAL . . . . . . . . . . . . . 38.8 t -69.36 128.97 92.11 Favored Pre-proline 0 C--O 1.243 0.747 0 CA-C-O 116.662 -1.637 . . . . 36.520000000000003 108.977 171.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1164 ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -77.29 103.79 1.79 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 124.047 3.165 . . . . 35.079999999999998 112.151 177.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1165 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -46.86 151.37 2.18 Favored 'Trans proline' 0 N--CA 1.455 -0.762 1 C-N-CA 125.46 4.107 . . . . 35.329999999999998 117.67 -173.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -79.27 137.47 37.39 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.948 1.356 . . . . 34.689999999999998 109.284 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1167 ' ' LYS . . . . . . . . . . . . . 6.7 mptt -99.91 105.86 17.62 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 103.972 -2.603 . . . . 45.359999999999999 103.972 171.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 58.8 t -90.57 90.2 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 N-CA-C 105.039 -2.208 . . . . 31.710000000000001 105.039 -176.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1169 ' ' MET . . . . . . . . . . . . . 6.2 ttp -80.5 116.81 20.74 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.449 -1.315 . . . . 42.280000000000001 107.449 172.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 86.0 t -91.08 136.06 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 105.574 -2.01 . . . . 30.510000000000002 105.574 176.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 15.8 mt -109.92 120.5 61.12 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 N-CA-C 104.46 -2.422 . . . . 31.870000000000001 104.46 170.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 87.3 80.73 1.22 Allowed Glycine 0 C--O 1.256 1.489 0 N-CA-C 109.63 -1.388 . . . . 34.539999999999999 109.63 175.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1173 ' ' ALA . . . . . . . . . . . . . . . -87.34 118.83 27.04 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 122.726 1.25 . . . . 32.509999999999998 109.819 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -148.34 -149.8 5.06 Favored Glycine 0 N--CA 1.437 -1.249 0 N-CA-C 106.513 -2.635 . . . . 29.899999999999999 106.513 164.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1175 ' ' VAL . . . . . . . . . . . . . 54.1 t -57.21 -41.67 78.45 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 CA-C-N 121.101 2.45 . . . . 33.109999999999999 111.382 -175.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -60.02 -49.5 77.42 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-N 114.301 -1.318 . . . . 28.100000000000001 111.659 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -59.52 -46.96 93.1 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 108.458 -1.857 . . . . 28.539999999999999 108.458 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1178 ' ' LEU . . . . . . . . . . . . . 47.9 mt -58.77 -29.72 67.0 Favored 'General case' 0 C--O 1.241 0.62 0 O-C-N 119.129 -2.395 . . . . 31.219999999999999 113.447 175.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -58.68 -55.74 31.24 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-O 122.356 1.074 . . . . 28.98 110.88 168.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -55.85 -43.43 77.06 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 113.886 -1.507 . . . . 27.829999999999998 114.446 177.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1181 ' ' ILE . . . . . . . . . . . . . 74.8 mt -62.05 -49.52 83.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 107.89 -1.152 . . . . 30.25 107.89 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -54.47 -34.54 55.08 Favored Glycine 0 C--N 1.343 0.928 0 O-C-N 126.744 2.527 . . . . 29.59 113.512 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -74.92 -61.77 1.77 Allowed 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 117.503 0.652 . . . . 30.289999999999999 112.52 170.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -59.69 -32.21 70.29 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-O 121.752 0.787 . . . . 30.469999999999999 113.088 -166.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -56.49 -53.3 59.04 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.622 1.169 . . . . 42.409999999999997 112.206 173.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1186 ' ' SER . . . . . . . . . . . . . 3.6 m -64.41 -39.66 94.28 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.765 -1.107 . . . . 39.380000000000003 109.295 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 25.8 mt -55.87 -34.71 65.73 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 115.826 1.787 . . . . 36.18 115.826 173.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 93.27 48.37 2.84 Favored Glycine 0 CA--C 1.534 1.259 0 O-C-N 124.108 0.88 . . . . 33.780000000000001 112.317 -177.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -113.98 162.02 16.94 Favored 'General case' 0 C--O 1.247 0.958 0 O-C-N 126.114 1.714 . . . . 33.93 108.756 172.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 66.1 mt -84.8 103.02 11.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 104.55 -2.389 . . . . 38.740000000000002 104.55 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 3.5 t -94.48 142.5 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 O-C-N 120.958 -1.089 . . . . 33.090000000000003 108.847 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1192 ' ' ARG . . . . . 0.43 HH12 ' CD ' ' A' 1248 ' ' GLU . 98.6 mtt180 -143.76 108.78 4.97 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.06 -1.089 . . . . 38.920000000000002 108.06 177.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -96.42 120.16 36.22 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 120.335 -1.478 . . . . 35.32 113.988 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 87.4 t80 -80.34 131.13 35.59 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 114.984 -1.007 . . . . 39.350000000000001 109.501 166.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 8.0 t70 -150.74 178.56 9.0 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 105.397 -2.075 . . . . 40.460000000000001 105.397 153.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1196 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.08 -31.98 9.91 Favored 'General case' 0 N--CA 1.428 -1.556 0 O-C-N 119.569 -1.957 . . . . 45.939999999999998 108.875 175.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1197 ' ' ARG . . . . . . . . . . . . . 53.0 mtm180 -69.63 133.44 88.73 Favored Pre-proline 0 N--CA 1.445 -0.684 0 O-C-N 120.832 -1.167 . . . . 56.020000000000003 109.916 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1198 ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -67.08 -28.29 41.31 Favored 'Trans proline' 0 C--O 1.242 0.719 0 C-N-CA 124.537 3.491 . . . . 51.270000000000003 118.276 173.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -55.71 -55.14 35.8 Favored 'General case' 0 C--O 1.254 1.334 0 O-C-N 119.925 -1.734 . . . . 59.100000000000001 114.037 -168.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 18.5 m -53.8 -25.35 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 116.749 2.129 . . . . 51.060000000000002 116.749 176.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 98.9 mttt -47.36 -43.45 23.13 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 115.774 1.768 . . . . 57.380000000000003 115.774 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -54.17 -51.29 64.8 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 122.942 1.353 . . . . 62.409999999999997 113.542 -175.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -70.87 -41.72 71.02 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 111.31 -2.677 . . . . 57.780000000000001 112.97 177.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 4.8 t -45.29 -49.88 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.448 1.499 . . . . 46.380000000000003 112.429 174.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -68.22 -52.82 29.85 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 113.639 -1.618 . . . . 50.700000000000003 112.435 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1206 ' ' SER . . . . . . . . . . . . . 41.0 p -66.87 -28.39 68.3 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.65 -0.705 . . . . 49.979999999999997 112.37 -172.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1207 ' ' MET . . . . . . . . . . . . . 12.3 mtt -66.55 -67.79 0.42 Allowed 'General case' 0 C--O 1.249 1.055 0 N-CA-C 106.562 -1.644 . . . . 52.990000000000002 106.562 166.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 154.9 60.25 0.01 OUTLIER Glycine 0 CA--C 1.522 0.522 0 CA-C-O 123.217 1.454 . . . . 47.659999999999997 112.955 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -141.44 145.5 35.36 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 112.347 -1.926 . . . . 44.770000000000003 111.32 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -74.01 155.51 38.51 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 104.068 -2.568 . . . . 47.640000000000001 104.068 163.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1211 ' ' PHE . . . . . . . . . . . . . 44.0 t80 -94.61 131.58 40.24 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 105.772 -1.936 . . . . 45.659999999999997 105.772 163.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 72.7 mt -88.33 108.42 19.33 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 106.993 -1.484 . . . . 46.060000000000002 106.993 174.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -82.19 133.26 35.25 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 111.801 -2.454 . . . . 60.219999999999999 109.012 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 4.9 tp -41.72 133.51 2.72 Favored 'General case' 0 C--O 1.241 0.609 0 O-C-N 127.858 3.224 . . . . 57.25 110.69 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 27.8 t0 -76.58 75.16 3.29 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 123.509 1.623 . . . . 64.430000000000007 114.013 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 3.2 t80 . . . . . 0 C--O 1.213 -0.853 0 N-CA-C 102.801 -3.037 . . . . 66.900000000000006 102.801 -171.806 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 N--CA 1.421 -1.886 0 N-CA-C 107.917 -1.142 . . . . 39.090000000000003 107.917 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -61.62 -45.26 96.68 Favored Glycine 0 CA--C 1.535 1.285 0 N-CA-C 115.988 1.155 . . . . 39.32 115.988 -174.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 91.5 t80 -72.98 -43.53 62.11 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 120.455 2.128 . . . . 39.299999999999997 112.639 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -69.31 -27.17 65.15 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 118.311 -2.743 . . . . 36.299999999999997 112.4 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -61.89 -60.44 3.64 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 120.089 -1.632 . . . . 37.380000000000003 106.988 163.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -52.42 -61.13 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.581 0 N-CA-C 116.769 2.137 . . . . 39.109999999999999 116.769 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1230 ' ' MET . . . . . . . . . . . . . 34.7 mmt -89.94 49.38 1.71 Allowed 'General case' 0 C--O 1.251 1.166 0 O-C-N 118.197 -2.814 . . . . 49.590000000000003 116.202 -174.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1231 ' ' SER . . . . . . . . . . . . . 67.7 p -98.57 163.85 12.5 Favored 'General case' 0 C--O 1.253 1.286 0 CA-C-N 113.972 -1.467 . . . . 43.68 108.999 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.43 -36.85 83.84 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 116.172 -0.467 . . . . 55.57 110.928 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -60.31 -54.79 41.53 Favored 'General case' 0 C--O 1.215 -0.748 0 C-N-CA 125.403 1.481 . . . . 44.939999999999998 112.157 173.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -60.63 -52.49 64.91 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 115.23 1.566 . . . . 42.039999999999999 115.23 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 94.8 mt -57.28 -32.26 40.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-O 123.491 1.615 . . . . 46.280000000000001 113.65 173.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 47.9 tttm -58.12 -57.67 11.81 Favored 'General case' 0 C--O 1.252 1.21 0 CA-C-O 124.525 2.107 . . . . 47.869999999999997 111.323 170.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -70.92 -11.89 61.23 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 115.731 1.752 . . . . 41.609999999999999 115.731 -175.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -67.73 -62.94 1.17 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.714 -1.587 . . . . 50.649999999999999 106.714 170.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1239 ' ' MET . . . . . . . . . . . . . 2.4 mtm -58.44 -35.42 72.1 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 121.158 -0.964 . . . . 48.869999999999997 113.249 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -68.73 -26.64 65.36 Favored 'General case' 0 C--O 1.25 1.11 0 C-N-CA 120.79 -0.364 . . . . 54.799999999999997 111.379 176.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 2.3 tm? -69.83 -56.99 5.64 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.962 -0.755 . . . . 43.210000000000001 108.962 166.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 22.9 m-30 -57.95 -41.79 83.58 Favored 'General case' 0 C--O 1.221 -0.409 0 O-C-N 124.76 1.287 . . . . 38.659999999999997 111.749 -166.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -68.84 -38.07 79.55 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.402 1.001 . . . . 37.920000000000002 111.764 -175.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -63.38 -51.0 67.69 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 120.266 -1.521 . . . . 37.280000000000001 109.994 174.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 -59.2 -34.36 72.06 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.232 1.413 . . . . 43.07 109.897 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -62.77 -17.95 61.86 Favored 'General case' 0 N--CA 1.439 -1.021 0 O-C-N 119.314 -2.116 . . . . 38.299999999999997 116.272 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1247 ' ' LYS . . . . . . . . . . . . . 16.5 mtmm -81.83 -1.93 49.18 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 122.532 1.158 . . . . 47.600000000000001 112.929 174.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1248 ' ' GLU . . . . . 0.43 ' CD ' HH12 ' A' 1192 ' ' ARG . 14.6 pt-20 -129.35 -35.69 1.75 Allowed 'General case' 0 C--O 1.239 0.537 0 CA-C-O 116.117 -1.897 . . . . 45.420000000000002 113.6 177.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1249 ' ' VAL . . . . . . . . . . . . . 33.0 m -75.71 161.77 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 121.635 2.016 . . . . 36.259999999999998 114.614 -168.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1250 ' ' ASP . . . . . 0.414 ' CG ' ' HZ2' ' A' 1276 ' ' LYS . 4.7 m-20 -108.84 -60.32 1.76 Allowed 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.129 -1.396 . . . . 33.039999999999999 109.647 -175.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1251 ' ' ILE . . . . . . . . . . . . . 51.5 mm -110.91 112.89 42.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 107.436 -1.32 . . . . 31.399999999999999 107.436 -168.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1252 ' ' ILE . . . . . . . . . . . . . 64.2 mt -100.6 102.8 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 104.249 -2.5 . . . . 29.420000000000002 104.249 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 89.9 t -84.78 97.74 5.56 Favored 'Isoleucine or valine' 0 C--O 1.251 1.173 0 N-CA-C 104.296 -2.483 . . . . 30.370000000000001 104.296 175.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1254 ' ' THR . . . . . . . . . . . . . 3.8 m -93.58 70.48 4.22 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 104.449 -2.426 . . . . 35.719999999999999 104.449 -167.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1255 ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.48 0.88 24.23 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 119.443 -2.036 . . . . 36.0 115.844 -175.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1256 ' ' ALA . . . . . . . . . . . . . . . -64.77 68.83 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 118.297 2.702 . . . . 40.93 118.297 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 60.4 tp -77.8 91.81 4.15 Favored 'General case' 0 C--O 1.246 0.909 0 N-CA-C 106.456 -1.683 . . . . 47.82 106.456 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 39.3 mm -64.53 128.85 93.86 Favored Pre-proline 0 C--O 1.241 0.608 0 N-CA-C 108.275 -1.009 . . . . 52.700000000000003 108.275 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -62.05 108.49 0.67 Allowed 'Trans proline' 0 N--CA 1.439 -1.701 0 C-N-CA 123.933 3.089 . . . . 54.130000000000003 109.786 -175.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 82.44 -64.95 4.19 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-O 118.186 -1.341 . . . . 54.619999999999997 113.589 168.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 13.5 mttp -65.9 137.03 95.87 Favored Pre-proline 0 C--O 1.216 -0.677 0 C-N-CA 125.468 1.507 . . . . 55.740000000000002 110.728 173.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -52.81 144.79 42.56 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.636 2.891 . . . . 51.149999999999999 116.371 176.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -67.28 133.72 93.31 Favored Pre-proline 0 CA--C 1.529 0.157 0 O-C-N 121.996 -0.44 . . . . 46.060000000000002 110.933 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -63.51 145.38 91.95 Favored 'Trans proline' 0 C--N 1.344 0.308 1 C-N-CA 125.914 4.409 . . . . 41.079999999999998 111.596 -178.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -78.14 78.92 4.61 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 122.147 0.975 . . . . 47.420000000000002 109.785 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 62.4 mt -83.82 -37.08 22.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.034 -1.439 . . . . 39.219999999999999 110.109 -171.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 15.4 mt -94.5 97.41 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 103.783 -2.673 . . . . 42.5 103.783 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1268 ' ' THR . . . . . . . . . . . . . 16.5 p -70.51 157.01 38.63 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 114.631 -1.168 . . . . 37.840000000000003 111.309 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -52.09 -41.4 62.38 Favored 'General case' 0 CA--C 1.512 -0.499 0 O-C-N 120.994 -1.066 . . . . 54.799999999999997 111.833 168.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -44.37 -62.57 1.12 Allowed 'General case' 0 N--CA 1.476 0.836 0 O-C-N 125.362 1.664 . . . . 54.359999999999999 111.547 164.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1271 ' ' MET . . . . . . . . . . . . . 34.0 ttm -58.52 -44.36 89.48 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 120.726 1.603 . . . . 39.520000000000003 111.36 -173.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1272 ' ' VAL . . . . . . . . . . . . . 20.0 t -66.77 -46.58 85.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 115.793 -0.64 . . . . 38.25 111.553 -175.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.44 -3.84 26.65 Favored 'General case' 0 CA--C 1.506 -0.713 0 O-C-N 119.943 -1.723 . . . . 40.770000000000003 115.583 172.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1274 ' ' SER . . . . . . . . . . . . . 8.6 m -113.03 14.75 19.67 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 116.085 1.883 . . . . 36.579999999999998 116.085 164.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1275 ' ' MET . . . . . . . . . . . . . 4.8 ttt -85.35 162.44 19.06 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.362 -0.977 . . . . 36.75 108.362 -178.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1276 ' ' LYS . . . . . 0.414 ' HZ2' ' CG ' ' A' 1250 ' ' ASP . 31.6 ttpt -63.07 132.48 52.05 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 124.198 1.951 . . . . 46.109999999999999 109.536 174.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1277 ' ' ALA . . . . . . . . . . . . . . . -70.56 162.22 29.26 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 111.736 -2.484 . . . . 33.520000000000003 113.713 -172.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 67.28 27.54 73.52 Favored Glycine 0 N--CA 1.479 1.535 0 O-C-N 119.485 -2.01 . . . . 31.27 113.449 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1279 ' ' SER . . . . . 0.403 ' OG ' ' NH2' ' A' 1151 ' ' ARG . 14.0 m -132.0 154.21 49.57 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 113.671 -1.265 . . . . 32.950000000000003 107.912 -168.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1280 ' ' VAL . . . . . . . . . . . . . 18.5 t -126.52 123.88 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 122.082 0.944 . . . . 27.43 112.988 -171.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1281 ' ' ILE . . . . . . . . . . . . . 52.1 mt -91.66 108.37 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 105.973 -1.862 . . . . 30.300000000000001 105.973 166.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -89.13 124.0 41.66 Favored 'Isoleucine or valine' 0 C--O 1.25 1.108 0 O-C-N 120.813 -1.179 . . . . 28.629999999999999 108.729 170.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 14.5 t0 -96.42 121.72 38.54 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 120.595 1.543 . . . . 36.270000000000003 110.482 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1284 ' ' LEU . . . . . . . . . . . . . 2.1 mm? -107.01 -9.08 16.33 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-O 122.968 1.366 . . . . 38.57 112.149 -176.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -76.99 -29.85 55.68 Favored 'General case' 0 C--O 1.243 0.736 0 O-C-N 120.691 -1.256 . . . . 37.560000000000002 108.092 164.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . 28.06 -82.79 0.0 OUTLIER 'General case' 0 C--N 1.361 1.094 0 N-CA-C 118.545 2.795 . . . . 40.329999999999998 118.545 173.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -66.33 -41.93 88.92 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 113.905 1.076 . . . . 56.850000000000001 113.905 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 46.9 t30 -85.7 82.32 8.26 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 122.65 1.214 . . . . 45.859999999999999 111.824 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 73.52 -67.14 1.59 Allowed Glycine 0 CA--C 1.538 1.524 0 O-C-N 119.498 -2.001 . . . . 40.310000000000002 111.724 -175.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 89.26 129.49 3.62 Favored Glycine 0 CA--C 1.536 1.356 0 N-CA-C 110.357 -1.097 . . . . 38.890000000000001 110.357 -177.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1291 ' ' ASN . . . . . . . . . . . . . 32.2 m120 -73.47 -17.06 61.28 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.469 1.634 . . . . 37.229999999999997 115.3 -172.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1292 ' ' CYS . . . . . . . . . . . . . 49.1 t -91.75 146.33 23.85 Favored 'General case' 0 C--O 1.248 1.016 0 CA-C-O 125.36 2.505 . . . . 36.5 110.359 173.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1293 ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -75.67 -7.99 55.7 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 119.259 -2.151 . . . . 43.32 115.782 172.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -109.05 26.56 10.48 Favored 'General case' 0 C--O 1.215 -0.735 0 O-C-N 120.124 -1.61 . . . . 41.32 113.629 175.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1295 ' ' THR . . . . . . . . . . . . . 54.6 m -81.3 81.15 7.55 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 125.868 2.747 . . . . 35.299999999999997 108.925 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 72.5 t -76.58 124.11 87.79 Favored Pre-proline 0 N--CA 1.424 -1.733 0 O-C-N 119.794 -1.817 . . . . 34.840000000000003 108.389 -176.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.47 99.21 0.08 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.684 0 C-N-CA 124.362 3.375 . . . . 33.509999999999998 115.291 -167.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 81.83 37.8 15.43 Favored Glycine 0 N--CA 1.437 -1.266 0 CA-C-N 112.565 -2.107 . . . . 32.189999999999998 111.575 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -145.3 153.6 41.45 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 124.234 1.969 . . . . 34.880000000000003 110.151 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1300 ' ' ILE . . . . . . . . . . . . . 77.2 mt -83.75 157.6 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 CA-C-N 111.203 -2.726 . . . . 32.289999999999999 105.328 161.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 58.3 t80 -137.47 147.31 45.21 Favored 'General case' 0 C--O 1.253 1.262 0 N-CA-C 104.948 -2.241 . . . . 37.25 104.948 176.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1302 ' ' THR . . . . . . . . . . . . . 8.3 m -126.65 134.68 50.69 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 106.098 -1.816 . . . . 35.560000000000002 106.098 170.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1303 ' ' THR . . . . . . . . . . . . . 24.9 p -79.78 174.71 11.31 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 112.705 0.631 . . . . 36.399999999999999 112.705 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -53.32 -56.34 17.46 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 121.335 -0.853 . . . . 52.32 111.218 171.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -68.46 10.01 0.29 Allowed 'General case' 0 C--N 1.352 0.684 0 N-CA-C 117.189 2.292 . . . . 40.039999999999999 117.189 176.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 70.67 38.12 67.4 Favored Glycine 0 C--O 1.244 0.753 0 O-C-N 121.909 -0.494 . . . . 36.960000000000001 112.9 169.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1307 ' ' VAL . . . . . . . . . . . . . 87.5 t -99.83 133.9 41.13 Favored 'Isoleucine or valine' 0 C--O 1.262 1.715 0 N-CA-C 101.412 -3.551 . . . . 33.399999999999999 101.412 170.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1308 ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -94.93 136.41 35.27 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 111.659 -2.519 . . . . 42.909999999999997 108.809 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 21.8 t -118.13 116.75 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 N-CA-C 106.581 -1.637 . . . . 32.289999999999999 106.581 171.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1310 ' ' ILE . . . . . . . . . . . . . 27.3 mt -102.61 98.09 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 105.423 -2.066 . . . . 30.989999999999998 105.423 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -103.68 51.29 0.83 Allowed Glycine 0 CA--C 1.529 0.962 0 N-CA-C 106.353 -2.699 . . . . 28.949999999999999 106.353 175.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1312 ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -72.64 101.82 3.14 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 105.037 -2.209 . . . . 31.690000000000001 105.037 171.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1313 ' ' THR . . . . . . . . . . . . . 1.6 p -53.3 -31.79 45.67 Favored 'General case' 0 C--O 1.243 0.719 0 O-C-N 121.022 -1.049 . . . . 34.170000000000002 111.426 177.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -81.46 7.74 11.12 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 118.695 2.85 . . . . 36.859999999999999 118.695 174.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1315 ' ' LEU . . . . . . . . . . . . . 26.7 mt -47.69 -39.35 22.47 Favored Pre-proline 0 C--O 1.252 1.223 0 CA-C-N 123.798 2.999 . . . . 34.850000000000001 118.511 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -59.15 -35.83 96.98 Favored 'Trans proline' 0 C--O 1.205 -1.17 0 C-N-CA 123.143 2.562 . . . . 29.149999999999999 112.961 173.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -94.74 -12.87 55.09 Favored Glycine 0 CA--C 1.495 -1.209 0 O-C-N 120.5 -1.375 . . . . 27.289999999999999 116.173 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1318 ' ' ARG . . . . . . . . . . . . . 8.2 ttt-85 -64.76 6.1 0.25 Allowed 'General case' 0 C--O 1.244 0.777 0 N-CA-C 117.057 2.243 . . . . 41.490000000000002 117.057 -175.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1319 ' ' LEU . . . . . . . . . . . . . 15.4 tp -116.6 78.96 9.11 Favored Pre-proline 0 N--CA 1.439 -1.008 0 CA-C-N 123.23 2.741 . . . . 27.609999999999999 107.011 173.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1320 ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -40.89 -57.87 1.19 Allowed 'Trans proline' 0 CA--C 1.504 -0.988 0 C-N-CA 124.476 3.45 . . . . 25.940000000000001 118.126 -155.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1321 ' ' THR . . . . . . . . . . . . . 3.0 m -72.04 -33.65 68.16 Favored 'General case' 0 N--CA 1.437 -1.125 0 O-C-N 118.597 -2.564 . . . . 25.010000000000002 109.678 -174.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1322 ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -84.88 -39.08 18.66 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 120.26 1.391 . . . . 29.390000000000001 110.575 -171.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1323 ' ' SER . . . . . . . . . . . . . 17.6 m -47.5 -56.69 6.54 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.963 1.098 . . . . 26.469999999999999 113.963 158.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1324 ' ' SER . . . . . . . . . . . . . 14.4 m -68.93 -17.28 63.93 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.274 0.842 . . . . 27.780000000000001 113.274 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -75.62 -67.91 0.62 Allowed 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 103.856 -2.646 . . . . 37.530000000000001 103.856 174.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1326 ' ' LEU . . . . . . . . . . . . . 89.8 mt -72.42 -43.83 63.3 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 115.042 -2.409 . . . . 35.710000000000001 112.921 -168.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1327 ' ' TYR . . . . . . . . . . . . . 73.8 t80 -58.02 -43.63 86.84 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-N 122.501 2.41 . . . . 31.59 107.703 169.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1328 ' ' GLY . . . . . . . . . . . . . . . -58.17 -37.28 85.92 Favored Glycine 0 C--N 1.345 1.058 0 N-CA-C 110.884 -0.886 . . . . 28.0 110.884 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1329 ' ' THR . . . . . . . . . . . . . 36.5 m -77.8 -28.7 50.49 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 118.938 1.369 . . . . 32.149999999999999 111.415 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1330 ' ' ASN . . . . . . . . . . . . . 16.2 m120 -55.31 -48.31 74.31 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 120.693 1.588 . . . . 34.359999999999999 111.611 164.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1331 ' ' LEU . . . . . . . . . . . . . 19.6 mt -56.1 -53.35 58.08 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 124.507 1.123 . . . . 33.369999999999997 111.241 175.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1332 ' ' VAL . . . . . . . . . . . . . 59.8 t -49.13 -47.45 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 C-N-CA 125.898 1.679 . . . . 35.270000000000003 111.125 175.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -70.19 -30.35 67.45 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-O 117.243 -1.361 . . . . 37.659999999999997 113.85 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1334 ' ' LEU . . . . . . . . . . . . . 18.3 tp -62.76 -48.67 78.15 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 122.887 1.327 . . . . 40.270000000000003 108.451 169.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1335 ' ' LEU . . . . . . . . . . . . . 82.0 mt -66.12 -23.65 66.53 Favored 'General case' 0 C--O 1.246 0.899 0 O-C-N 120.252 -1.53 . . . . 42.5 110.096 -175.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1336 ' ' LYS . . . . . . . . . . . . . 96.9 mttt -60.24 -45.31 93.67 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.445 -1.41 . . . . 47.810000000000002 112.836 168.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1337 ' ' LEU . . . . . . . . . . . . . 8.1 mp -75.03 -38.97 61.33 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 113.218 -1.81 . . . . 49.270000000000003 113.049 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1338 ' ' LEU . . . . . . . . . . . . . 6.3 mp -72.56 -58.37 3.43 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 125.818 1.647 . . . . 50.539999999999999 111.204 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1339 ' ' CYS . . . . . 0.438 ' SG ' ' CZ ' ' A' 1031 ' ' PHE . 58.7 m -92.38 68.45 4.95 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-O 124.408 2.051 . . . . 53.670000000000002 106.35 -177.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 75.3 tttt -76.02 -47.93 22.95 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 111.526 -2.579 . . . . 63.380000000000003 109.016 -158.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -70.08 -25.64 63.62 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 113.425 0.898 . . . . 70.950000000000003 113.425 -175.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1342 ' ' LYS . . . . . . . . . . . . . 46.5 mtpt 52.12 68.27 0.84 Allowed 'General case' 0 C--O 1.253 1.26 0 N-CA-C 118.106 2.632 . . . . 65.25 118.106 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1343 ' ' ASP . . . . . . . . . . . . 0.278 10.9 t70 67.04 -88.14 0.03 OUTLIER 'General case' 0 C--O 1.236 0.387 2 O-C-N 110.921 -7.362 . . . . 64.530000000000001 119.784 -0.177 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A 1344 ' ' GLY . . . . . . . . . . . . . . . 86.29 17.85 60.02 Favored Glycine 0 N--CA 1.425 -2.036 0 O-C-N 119.98 -1.7 . . . . 59.719999999999999 115.963 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 19.5 t30 -80.4 143.24 33.63 Favored 'General case' 0 N--CA 1.434 -1.226 0 O-C-N 120.469 -1.607 . . . . 64.090000000000003 108.767 160.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1346 ' ' ILE . . . . . . . . . . . . . 14.7 mt -91.6 100.18 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 104.49 -2.411 . . . . 58.82 104.49 -167.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1347 ' ' THR . . . . . . . . . . . . . 6.9 m -84.08 98.8 10.07 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 104.339 -2.467 . . . . 54.960000000000001 104.339 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1348 ' ' VAL . . . . . . . . . . . . . 19.5 t -93.4 80.02 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.257 1.475 0 N-CA-C 105.448 -2.056 . . . . 55.640000000000001 105.448 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 12.9 t70 -76.68 135.17 39.09 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 115.238 1.57 . . . . 61.450000000000003 115.238 -167.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -80.89 -28.28 35.99 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-N 114.864 -1.062 . . . . 58.630000000000003 111.882 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -85.82 -31.82 22.08 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 119.977 -1.702 . . . . 62.060000000000002 114.747 -170.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 9.9 t70 -64.07 123.08 18.11 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 125.046 1.466 . . . . 54.07 109.238 169.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 18.6 m -57.44 -45.66 85.66 Favored 'Isoleucine or valine' 0 C--O 1.253 1.268 0 N-CA-C 113.508 0.929 . . . . 50.68 113.508 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1354 ' ' VAL . . . . . . . . . . . . . 12.9 m -77.45 -38.53 26.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 119.971 -0.692 . . . . 47.68 110.188 -172.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1355 ' ' ILE . . . . . . . . . . . . . 90.3 mt -62.39 -54.05 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-N 121.141 1.791 . . . . 48.490000000000002 108.589 174.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 45.3 tpt85 -55.92 -37.92 69.58 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 112.107 0.41 . . . . 48.270000000000003 112.107 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -59.72 -46.92 93.22 Favored Glycine 0 N--CA 1.469 0.846 0 O-C-N 125.41 1.694 . . . . 43.530000000000001 112.466 174.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1358 ' ' VAL . . . . . . . . . . . . . 30.2 t -75.08 -28.69 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 O-C-N 118.428 -2.807 . . . . 45.119999999999997 109.726 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1359 ' ' THR . . . . . . . . . . . . . 26.2 m -64.71 96.16 0.17 Allowed 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 118.082 -2.886 . . . . 42.939999999999998 114.706 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 17.5 m -96.55 -30.62 3.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 112.214 0.449 . . . . 43.259999999999998 112.214 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1361 ' ' ILE . . . . . . . . . . . . . 95.7 mt -131.49 136.22 57.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 101.919 -3.363 . . . . 45.659999999999997 101.919 163.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1362 ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -124.62 125.77 44.67 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 104.428 -2.434 . . . . 61.340000000000003 104.428 165.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 48.89 55.7 8.83 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 125.507 1.754 . . . . 49.759999999999998 113.996 172.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 82.08 -42.33 2.85 Favored Glycine 0 C--O 1.218 -0.871 0 CA-C-N 113.021 -1.899 . . . . 50.0 112.569 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -69.9 126.47 29.81 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 119.953 1.876 . . . . 56.920000000000002 107.071 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1366 ' ' ILE . . . . . . . . . . . . . 96.5 mt -74.59 96.18 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.391 0 N-CA-C 107.19 -1.411 . . . . 52.780000000000001 107.19 178.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1367 ' ' THR . . . . . . . . . . . . . 17.6 p -82.75 1.52 38.39 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 115.932 1.827 . . . . 49.439999999999998 115.932 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 29.6 t90 -78.66 133.71 62.35 Favored Pre-proline 0 N--CA 1.442 -0.872 0 N-CA-C 105.313 -2.106 . . . . 52.380000000000003 105.313 161.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -58.28 130.09 4.53 Favored 'Cis proline' 0 C--N 1.329 -0.47 0 N-CA-C 119.687 2.918 . . . . 46.939999999999998 119.687 5.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -72.84 112.53 15.65 Favored Pre-proline 0 C--O 1.245 0.838 0 C-N-CA 124.567 1.147 . . . . 45.909999999999997 110.837 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1371 ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -67.61 120.65 7.68 Favored 'Trans proline' 0 N--CA 1.433 -2.082 0 C-N-CA 124.636 3.558 . . . . 46.390000000000001 118.104 -173.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -71.89 -62.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 123.179 2.586 . . . . 46.719999999999999 109.968 164.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.239 -4.238 0 CA-C-N 120.642 1.564 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 23.1 m80 . . . . . 0 C--O 1.245 0.826 0 N-CA-C 107.24 -1.393 . . . . 63.439999999999998 107.24 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -120.75 59.74 0.91 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.857 -0.794 . . . . 51.740000000000002 108.857 164.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1000 ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -77.18 139.53 39.93 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 102.795 -3.039 . . . . 54.07 102.795 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 81.88 -0.46 88.37 Favored Glycine 0 C--O 1.26 1.721 0 CA-C-N 113.728 -1.578 . . . . 39.219999999999999 111.814 -171.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1002 ' ' ARG . . . . . . . . . . . . . 34.1 ttp180 -108.52 148.36 30.38 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 119.59 1.695 . . . . 38.119999999999997 106.677 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1003 ' ' ILE . . . . . . . . . . . . . 24.3 mt -102.61 147.27 9.38 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 N-CA-C 105.724 -1.954 . . . . 29.699999999999999 105.724 172.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -107.38 121.72 6.58 Favored Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 108.492 -1.843 . . . . 27.5 108.492 167.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1005 ' ' ILE . . . . . . . . . . . . . 40.7 mm -105.77 106.51 56.8 Favored Pre-proline 0 N--CA 1.439 -1.006 0 N-CA-C 106.689 -1.597 . . . . 24.829999999999998 106.689 171.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -80.12 176.82 8.93 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 124.687 3.591 . . . . 27.190000000000001 108.35 -175.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 22.9 ttm105 -84.82 131.51 34.52 Favored 'General case' 0 C--N 1.318 -0.773 0 O-C-N 120.128 -1.608 . . . . 41.460000000000001 108.124 165.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1008 ' ' GLU . . . . . . . . . . . . 0.311 25.2 mm-40 -68.93 136.18 52.16 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 119.612 3.19 . . . . 26.93 119.612 173.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 47.6 mmm-85 -99.08 -3.76 33.95 Favored 'General case' 0 C--O 1.253 1.285 0 CA-C-N 111.512 -2.585 . . . . 34.479999999999997 116.068 -165.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1010 ' ' LEU . . . . . . . . . . . . . 65.6 tp -58.21 138.6 56.14 Favored 'General case' 0 N--CA 1.441 -0.875 0 O-C-N 121.177 -0.952 . . . . 44.219999999999999 112.108 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1011 ' ' THR . . . . . . . . . . . . . 1.3 m -59.72 111.93 1.63 Allowed 'General case' 0 C--N 1.319 -0.759 0 O-C-N 124.573 1.171 . . . . 40.740000000000002 108.187 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 38.8 t30 60.63 92.75 0.05 OUTLIER 'General case' 0 C--O 1.252 1.199 0 O-C-N 126.657 2.473 . . . . 44.439999999999998 107.894 -171.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1013 ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -130.99 132.72 45.2 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 124.88 2.276 . . . . 29.870000000000001 109.609 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1014 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.16 -32.49 50.27 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-N 108.816 -3.811 . . . . 25.260000000000002 117.642 176.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 43.5 mtm180 -95.64 159.86 14.78 Favored 'General case' 0 C--O 1.252 1.201 0 CA-C-O 124.021 1.867 . . . . 29.539999999999999 115.179 -161.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1016 ' ' VAL . . . . . . . . . . . . . 4.7 p -128.86 -176.5 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 102.936 -2.987 . . . . 23.550000000000001 102.936 159.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1017 ' ' ALA . . . . . . . . . . . . . . . -90.34 -8.81 49.84 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 116.854 2.168 . . . . 23.59 116.854 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1018 ' ' ALA . . . . . . . . . . . . . . . -159.75 145.72 15.86 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-O 121.528 0.68 . . . . 24.93 110.313 -177.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1019 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.8 165.45 12.64 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-O 116.682 -1.628 . . . . 28.09 111.924 172.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -47.88 -43.2 30.15 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 124.331 3.354 . . . . 28.789999999999999 116.652 175.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 47.7 tptt -50.71 -41.53 56.16 Favored 'General case' 0 C--O 1.256 1.446 0 N-CA-C 113.358 0.873 . . . . 47.280000000000001 113.358 168.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1022 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.63 -38.49 67.73 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 118.83 -0.605 . . . . 30.120000000000001 111.63 177.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1023 ' ' VAL . . . . . . . . . . . . . 79.8 t -49.23 -48.63 17.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-O 122.61 1.195 . . . . 32.240000000000002 113.156 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1024 ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -53.25 -48.16 68.45 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 112.684 -2.053 . . . . 49.619999999999997 110.492 174.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -61.71 -43.24 99.24 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 120.831 -1.168 . . . . 44.68 110.316 -174.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 51.1 mt -64.93 -39.03 92.89 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 115.069 1.507 . . . . 35.710000000000001 115.069 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1027 ' ' LEU . . . . . . . . . . . . . 58.1 mt -64.78 -41.58 95.74 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 125.581 1.552 . . . . 42.18 109.006 174.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 31.4 mttm -63.5 -35.9 81.97 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 123.731 0.644 . . . . 48.340000000000003 110.652 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1029 ' ' LEU . . . . . . . . . . . . . 82.0 mt -59.47 -62.36 1.93 Allowed 'General case' 0 CA--C 1.504 -0.808 0 C-N-CA 123.618 0.767 . . . . 38.689999999999998 109.212 170.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 143.35 45.02 0.05 OUTLIER Glycine 0 C--N 1.312 -0.758 0 N-CA-C 110.309 -1.116 . . . . 32.280000000000001 110.309 168.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -133.17 122.7 24.39 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 123.038 1.399 . . . . 35.939999999999998 108.733 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1032 ' ' THR . . . . . . . . . . . . . 28.0 m -66.3 133.2 50.06 Favored 'General case' 0 C--O 1.25 1.098 0 CA-C-N 114.121 -1.399 . . . . 33.369999999999997 108.414 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1033 ' ' VAL . . . . . . . . . . . . . 22.2 t -107.38 126.88 63.57 Favored 'Isoleucine or valine' 0 C--O 1.251 1.169 0 O-C-N 120.068 -1.645 . . . . 29.98 107.271 -169.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -122.45 139.15 54.2 Favored 'General case' 0 C--O 1.243 0.714 0 O-C-N 124.134 0.896 . . . . 28.18 111.553 168.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1035 ' ' VAL . . . . . . . . . . . . . 21.2 t -127.35 149.33 32.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 105.866 -1.901 . . . . 25.82 105.866 -175.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1036 ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -62.67 145.61 54.22 Favored 'General case' 0 C--O 1.257 1.473 0 N-CA-C 113.7 1.0 . . . . 32.439999999999998 113.7 171.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1037 ' ' SER . . . . . . . . . . . . . 13.0 m -70.54 148.13 48.54 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 106.038 -1.838 . . . . 29.539999999999999 106.038 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 82.11 -53.2 4.73 Favored Glycine 0 CA--C 1.534 1.27 0 O-C-N 119.205 -2.184 . . . . 27.760000000000002 110.401 -172.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1039 ' ' ALA . . . . . . . . . . . . . . . -51.61 -40.99 60.91 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-N 119.434 1.617 . . . . 26.02 112.547 172.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -57.59 -49.08 76.68 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 120.465 -0.874 . . . . 26.469999999999999 112.288 171.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -59.12 -40.62 85.98 Favored 'General case' 0 C--O 1.246 0.877 0 C-N-CA 123.233 0.613 . . . . 50.979999999999997 110.429 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 46.2 mt -66.5 -26.51 67.2 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.771 1.026 . . . . 29.300000000000001 113.771 -171.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1043 ' ' ALA . . . . . . . . . . . . . . . -83.88 40.48 0.75 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 119.521 1.055 . . . . 26.739999999999998 111.926 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1044 ' ' SER . . . . . . . . . . . . . 38.6 m 44.3 54.62 6.07 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 126.284 1.833 . . . . 31.260000000000002 110.899 -166.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1045 ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.68 -167.39 2.64 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.439 -1.255 . . . . 33.259999999999998 109.775 -174.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 22.3 t70 -131.06 140.22 50.02 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 105.805 -1.924 . . . . 46.740000000000002 105.805 174.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -68.06 -37.47 81.31 Favored 'General case' 0 CA--C 1.502 -0.866 0 O-C-N 125.954 2.034 . . . . 34.439999999999998 111.407 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -77.85 -23.95 48.75 Favored 'General case' 0 N--CA 1.435 -1.2 0 O-C-N 119.279 -2.138 . . . . 48.670000000000002 109.955 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -58.45 -43.42 88.8 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 118.762 -0.637 . . . . 35.259999999999998 111.896 163.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1050 ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -60.87 -37.85 83.57 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 120.889 1.677 . . . . 32.170000000000002 112.167 170.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 98.0 t -59.67 -45.74 94.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 O-C-N 119.585 -1.947 . . . . 38.369999999999997 108.503 174.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -63.76 -23.36 67.33 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 116.261 1.949 . . . . 45.770000000000003 116.261 174.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -78.35 -4.67 49.26 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 124.91 1.284 . . . . 37.829999999999998 112.269 170.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 87.75 34.57 9.99 Favored Glycine 0 CA--C 1.5 -0.866 0 CA-C-N 120.29 1.404 . . . . 35.82 110.681 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -114.62 138.1 51.09 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-O 124.151 1.929 . . . . 33.770000000000003 107.401 174.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -77.45 134.77 38.29 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 104.487 -2.412 . . . . 51.020000000000003 104.487 173.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1057 ' ' ILE . . . . . . . . . . . . . 19.5 mm -108.46 107.16 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 106.259 -1.756 . . . . 38.469999999999999 106.259 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 88.1 t -86.29 132.77 31.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 CA-C-N 113.163 -1.835 . . . . 39.399999999999999 108.045 -173.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -72.5 95.82 1.85 Allowed 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 123.291 1.519 . . . . 57.07 110.576 168.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . 82.27 -151.16 29.54 Favored Glycine 0 C--O 1.248 1.026 0 CA-C-O 125.093 2.496 . . . . 44.829999999999998 116.191 166.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 5.0 m120 -58.64 -21.28 53.44 Favored 'General case' 0 C--O 1.212 -0.869 0 N-CA-C 118.91 2.93 . . . . 46.270000000000003 118.91 -167.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1062 ' ' SER . . . . . . . . . . . . . 4.2 m -53.65 -22.12 8.2 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.188 -1.57 . . . . 43.469999999999999 112.677 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 1.5 p -53.28 -35.31 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 O-C-N 120.983 -1.073 . . . . 36.979999999999997 111.181 176.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 55.2 m95 -63.16 -23.35 67.39 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 116.155 1.909 . . . . 37.899999999999999 116.155 177.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -83.44 93.58 7.82 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 124.475 2.083 . . . . 46.189999999999998 108.923 173.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1066 ' ' SER . . . . . . . . . . . . . 71.4 m -149.77 179.7 7.81 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 111.206 -2.725 . . . . 37.060000000000002 107.211 -174.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1067 ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -83.37 -51.3 7.52 Favored 'General case' 0 N--CA 1.437 -1.103 0 O-C-N 123.792 0.683 . . . . 43.950000000000003 109.952 166.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1068 ' ' ILE . . . . . . . . . . . . . 1.3 mt -108.99 145.15 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 N-CA-C 107.061 -1.459 . . . . 33.5 107.061 178.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 46.0 mm -109.0 118.26 56.15 Favored 'Isoleucine or valine' 0 C--O 1.254 1.299 0 N-CA-C 104.33 -2.47 . . . . 30.57 104.33 158.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1070 ' ' LEU . . . . . . . . . . . . . 94.5 mt -101.8 117.75 35.51 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 106.674 -1.602 . . . . 27.66 106.674 170.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1071 ' ' LYS . . . . . . . . . . . . 0.279 13.6 tttm -140.83 160.16 40.64 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 125.994 2.059 . . . . 28.399999999999999 111.042 -170.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1072 ' ' VAL . . . . . . . . . . . . . 99.7 t -94.63 -70.76 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.429 0 O-C-N 120.629 -1.294 . . . . 23.18 108.155 -173.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -97.4 152.68 18.69 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.893 -1.129 . . . . 25.469999999999999 108.011 -170.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -53.3 133.05 52.35 Favored Pre-proline 0 C--O 1.243 0.725 0 C-N-CA 126.29 1.836 . . . . 27.899999999999999 111.907 -173.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -60.32 129.75 31.13 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 122.752 2.301 . . . . 31.620000000000001 114.949 -173.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 49.2 mt -72.65 158.56 35.41 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.202 -1.036 . . . . 40.490000000000002 108.202 173.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.23 -29.7 10.04 Favored 'General case' 0 C--O 1.214 -0.768 0 O-C-N 118.937 -2.352 . . . . 51.590000000000003 117.014 -171.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -67.28 -46.21 74.3 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-N 114.986 -1.006 . . . . 42.359999999999999 110.017 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1079 ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -63.07 -40.49 97.83 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 123.162 1.458 . . . . 34.530000000000001 109.029 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1080 ' ' ILE . . . . . . . . . . . . . 84.3 mt -59.1 -48.81 85.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 108.333 -0.988 . . . . 33.25 108.333 175.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -56.84 -39.7 74.73 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 119.143 0.883 . . . . 36.469999999999999 112.874 175.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1082 ' ' LEU . . . . . . . . . . . . . 28.6 mt -61.12 -38.51 86.61 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 125.762 1.625 . . . . 37.759999999999998 111.08 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1083 ' ' LEU . . . . . . . . . . . . . 21.8 mt -56.73 121.11 9.02 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 123.17 0.588 . . . . 37.43 110.679 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -78.07 148.7 75.45 Favored Pre-proline 0 CA--C 1.558 1.271 0 N-CA-C 106.953 -1.499 . . . . 37.700000000000003 106.953 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -40.3 102.37 0.04 OUTLIER 'Trans proline' 0 C--O 1.239 0.562 0 C-N-CA 122.826 2.35 . . . . 35.509999999999998 115.564 169.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 84.49 26.38 39.46 Favored Glycine 0 C--N 1.345 1.04 0 CA-C-N 112.652 -2.067 . . . . 33.869999999999997 114.532 177.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1087 ' ' THR . . . . . . . . . . . . . 16.8 m -66.67 155.79 37.03 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 120.956 2.378 . . . . 32.5 108.491 166.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1088 ' ' THR . . . . . . . . . . . . . 4.1 m -87.49 131.37 34.38 Favored 'General case' 0 C--O 1.205 -1.245 0 N-CA-C 105.088 -2.189 . . . . 30.219999999999999 105.088 174.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1089 ' ' LEU . . . . . . . . . . . . . 39.3 tp -122.87 127.65 49.28 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 107.926 -1.139 . . . . 27.239999999999998 107.926 173.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 44.2 t -120.2 120.1 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 N-CA-C 103.326 -2.842 . . . . 25.390000000000001 103.326 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1091 ' ' SER . . . . . . . . . . . . . 2.6 m -164.53 160.31 20.2 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.528 1.513 . . . . 28.809999999999999 108.857 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1092 ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -59.48 99.43 0.06 Allowed 'General case' 0 C--O 1.247 0.971 0 O-C-N 121.088 -1.008 . . . . 30.780000000000001 111.204 158.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 32.2 mm -95.73 -28.53 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 109.199 -0.667 . . . . 30.280000000000001 109.199 -171.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1094 ' ' TRP . . . . . . . . . . . . . 68.5 m95 52.06 56.08 15.48 Favored Pre-proline 0 N--CA 1.472 0.659 0 O-C-N 121.129 -0.982 . . . . 34.07 112.551 -175.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -53.43 -51.05 11.82 Favored 'Trans proline' 0 CA--C 1.505 -0.952 1 C-N-CA 126.541 4.828 . . . . 38.659999999999997 115.999 -162.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -69.17 -28.77 66.71 Favored 'General case' 0 C--O 1.247 0.929 0 O-C-N 120.714 -1.241 . . . . 41.32 110.684 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.04 -17.82 48.87 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 120.71 -1.244 . . . . 51.659999999999997 111.197 172.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -125.73 61.19 36.82 Favored Pre-proline 0 C--O 1.243 0.728 0 N-CA-C 114.719 1.377 . . . . 40.32 114.719 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -60.45 -38.68 72.18 Favored 'Trans proline' 0 CA--C 1.506 -0.887 0 C-N-CA 123.743 2.962 . . . . 41.560000000000002 113.13 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -69.52 -45.24 69.32 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 106.863 -1.532 . . . . 54.109999999999999 106.863 -174.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1101 ' ' LEU . . . . . . . . . . . . . 7.0 tt -60.64 -48.77 80.29 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.645 -1.243 . . . . 37.880000000000003 107.645 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1102 ' ' MET . . . . . . . . . . . . . 43.2 mmm -50.86 -46.76 60.37 Favored 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 120.616 -1.302 . . . . 37.539999999999999 114.341 173.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -64.55 -39.0 92.96 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 123.173 1.463 . . . . 47.009999999999998 112.794 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1104 ' ' LYS . . . . . . . . . . . . . 52.5 mttm -60.98 -45.47 94.68 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 118.928 -2.358 . . . . 48.68 111.77 175.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1105 ' ' LEU . . . . . . . . . . . . . 52.2 mt -62.05 -39.25 91.74 Favored 'General case' 0 C--O 1.252 1.235 0 O-C-N 120.668 -1.27 . . . . 32.210000000000001 109.604 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -57.36 -37.05 71.99 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 112.968 0.729 . . . . 33.729999999999997 112.968 171.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -67.63 -45.92 73.97 Favored 'General case' 0 CA--C 1.504 -0.824 0 O-C-N 118.888 -2.383 . . . . 51.469999999999999 112.105 172.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1108 ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -61.42 -11.64 11.24 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 120.577 -1.327 . . . . 43.899999999999999 112.013 169.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1109 ' ' ASN . . . . . . . . . . . . . 27.0 m-80 63.04 24.86 14.73 Favored 'General case' 0 C--N 1.358 0.96 0 O-C-N 120.024 -1.673 . . . . 44.82 114.253 172.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1110 ' ' VAL . . . . . . . . . . . . . 18.4 m -83.59 167.87 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 N-CA-C 112.563 0.579 . . . . 30.52 112.563 -171.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1111 ' ' THR . . . . . . . . . . . . . 95.9 m -109.74 111.14 22.41 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.439 -1.689 . . . . 27.120000000000001 106.439 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1112 ' ' VAL . . . . . . . . . . . . . 63.6 t -113.27 120.3 62.86 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.621 0 N-CA-C 108.178 -1.045 . . . . 26.399999999999999 108.178 -165.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1113 ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -94.79 105.92 17.88 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-O 123.596 1.665 . . . . 42.920000000000002 109.376 164.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -86.4 108.55 18.52 Favored 'General case' 0 CA--C 1.5 -0.958 0 O-C-N 119.302 -2.124 . . . . 24.149999999999999 108.444 177.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1115 ' ' MET . . . . . . . . . . . . . 82.1 mmm -67.98 -16.93 64.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 111.971 -2.377 . . . . 29.949999999999999 113.32 -173.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1116 ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -79.6 -35.01 40.25 Favored 'General case' 0 C--O 1.253 1.244 0 O-C-N 120.018 -1.676 . . . . 34.530000000000001 109.481 171.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1117 ' ' SER . . . . . . . . . . . . . 69.1 m -87.62 31.13 0.77 Allowed 'General case' 0 C--O 1.247 0.97 0 C-N-CA 126.293 1.837 . . . . 33.490000000000002 114.451 -166.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1118 ' ' VAL . . . . . . . . . . . . . 15.1 t -77.98 136.96 61.7 Favored Pre-proline 0 C--O 1.259 1.555 0 N-CA-C 107.887 -1.153 . . . . 34.020000000000003 107.887 -177.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -62.06 132.31 38.7 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 124.226 3.284 . . . . 38.280000000000001 108.232 174.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1120 ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -73.27 29.36 0.07 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 119.158 3.022 . . . . 55.049999999999997 119.158 -160.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1121 ' ' ILE . . . . . . . . . . . . . 23.8 pt -90.51 162.74 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 CA-C-N 119.176 0.898 . . . . 42.090000000000003 110.582 -169.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1122 ' ' SER . . . . . . . . . . . . . 1.1 m -51.29 -40.91 59.98 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 112.954 -1.93 . . . . 38.020000000000003 115.576 -175.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1123 ' ' ARG . . . . . . . . . . . . . 24.1 ptt-85 -72.37 -41.48 66.32 Favored 'General case' 0 C--N 1.361 1.084 0 O-C-N 119.921 -1.737 . . . . 34.289999999999999 112.632 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1124 ' ' ALA . . . . . . . . . . . . . . . -53.49 -35.3 60.46 Favored 'General case' 0 N--CA 1.434 -1.232 0 O-C-N 124.957 1.411 . . . . 32.350000000000001 114.766 175.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1125 ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -58.71 -20.77 51.77 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 117.964 2.579 . . . . 47.170000000000002 117.964 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1126 ' ' SER . . . . . . . . . . . . . 73.3 p -70.72 -35.89 72.93 Favored 'General case' 0 C--O 1.251 1.178 0 O-C-N 120.05 -1.656 . . . . 31.710000000000001 112.099 170.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1127 ' ' LEU . . . . . . . . . . . . . 4.5 mp -86.56 -16.85 35.57 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.884 -1.053 . . . . 37.0 112.35 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1128 ' ' ASP . . . . . . . . . . . . . 24.3 t70 -75.09 117.38 16.87 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 126.49 3.043 . . . . 40.399999999999999 117.06 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1129 ' ' ALA . . . . . . . . . . . . . . . -70.13 -33.83 72.31 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-N 109.924 -3.307 . . . . 26.559999999999999 107.419 -176.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 32.0 mt -61.98 -35.34 78.19 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 124.045 0.938 . . . . 30.890000000000001 110.664 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1131 ' ' SER . . . . . . . . . . . . . 61.4 m -71.39 -51.43 24.06 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 120.937 1.699 . . . . 29.84 109.164 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1132 ' ' SER . . . . . . . . . . . . . 55.5 m -55.85 -44.45 78.02 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.51 1.505 . . . . 31.91 112.47 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1133 ' ' MET . . . . . . . . . . . . . 36.7 mmt -71.56 -33.66 69.3 Favored 'General case' 0 CA--C 1.51 -0.57 0 O-C-N 121.175 -0.953 . . . . 25.899999999999999 111.101 -178.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1134 ' ' ALA . . . . . . . . . . . . . . . -66.72 -38.15 86.12 Favored 'General case' 0 C--O 1.201 -1.483 0 O-C-N 119.767 -1.833 . . . . 26.620000000000001 110.558 170.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.45 -30.75 71.17 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 120.126 1.33 . . . . 36.969999999999999 113.064 176.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1136 ' ' ILE . . . . . . . . . . . . . 39.3 mm -58.37 -56.96 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 CA-C-O 117.492 -1.242 . . . . 32.109999999999999 110.231 164.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -53.76 -37.96 63.92 Favored 'General case' 0 CA--C 1.508 -0.64 0 O-C-N 124.901 1.376 . . . . 24.140000000000001 112.985 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -71.74 -40.71 57.91 Favored Glycine 0 N--CA 1.441 -1.033 0 CA-C-O 122.22 0.9 . . . . 25.129999999999999 111.492 -176.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 4.5 t80 -68.25 -41.86 80.52 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 120.847 -1.384 . . . . 32.729999999999997 108.405 174.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1140 ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -71.2 -19.68 62.36 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 118.51 -0.757 . . . . 26.359999999999999 110.901 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1141 ' ' ALA . . . . . . . . . . . . . . . -60.34 -52.72 64.07 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 119.721 1.146 . . . . 24.120000000000001 108.682 171.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 42.6 mm -64.98 -36.08 76.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 O-C-N 124.219 0.949 . . . . 23.370000000000001 111.623 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 57.2 t -65.58 -67.39 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 C-N-CA 124.018 0.927 . . . . 24.960000000000001 112.112 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -55.56 -31.95 62.59 Favored 'General case' 0 C--N 1.354 0.783 0 O-C-N 120.103 -1.623 . . . . 32.07 114.116 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1145 ' ' ALA . . . . . . . . . . . . . . . -58.21 -57.2 13.92 Favored 'General case' 0 C--O 1.203 -1.388 0 CA-C-N 115.817 -0.629 . . . . 24.870000000000001 109.589 170.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1146 ' ' ALA . . . . . . . . . . . . . . . -58.04 -38.95 77.21 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.831 0.824 . . . . 24.670000000000002 113.051 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 83.4 t60 -51.7 -56.96 10.68 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.699 -1.137 . . . . 28.579999999999998 111.152 170.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1148 ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -90.13 1.76 56.04 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 115.557 1.688 . . . . 36.82 115.557 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1149 ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -72.23 153.06 41.79 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.886 1.674 . . . . 31.969999999999999 109.277 -174.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1150 ' ' GLY . . . . . . . . . . . . . . . -86.24 -36.06 10.25 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 117.211 -1.883 . . . . 25.489999999999998 112.685 169.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1151 ' ' ARG . . . . . . . . . . . . . 25.8 mtm-85 -119.05 -177.95 3.45 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 122.717 3.258 . . . . 59.840000000000003 115.893 -168.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1152 ' ' PHE . . . . . . . . . . . . . 18.2 m-30 -81.75 165.66 20.74 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 124.124 1.916 . . . . 34.450000000000003 110.092 175.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1153 ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -82.31 -49.89 9.55 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.415 -1.266 . . . . 31.170000000000002 111.605 166.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1154 ' ' THR . . . . . . . . . . . . . 3.1 m -65.31 142.42 58.26 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.684 1.193 . . . . 33.890000000000001 111.31 -176.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -80.52 72.35 2.68 Favored Glycine 0 C--N 1.34 0.786 0 O-C-N 117.871 -3.018 . . . . 38.950000000000003 108.754 169.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -89.82 114.53 26.27 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 123.169 1.461 . . . . 54.229999999999997 110.77 -163.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 6.9 mm -67.87 95.07 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 113.441 -1.709 . . . . 51.159999999999997 106.426 166.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1158 ' ' THR . . . . . . . . . . . . . 10.3 m -95.9 157.24 15.99 Favored 'General case' 0 C--O 1.249 1.069 0 N-CA-C 108.03 -1.1 . . . . 49.609999999999999 108.03 -172.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -46.92 -51.56 16.56 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.024 0.75 . . . . 49.049999999999997 113.024 174.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -63.65 -58.27 7.44 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 114.659 1.355 . . . . 47.649999999999999 114.659 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . -159.87 179.18 35.6 Favored Glycine 0 C--O 1.25 1.119 0 CA-C-O 118.079 -1.401 . . . . 45.609999999999999 110.864 -168.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 95.6 mttt -94.46 140.14 30.21 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.169 -1.048 . . . . 57.460000000000001 108.169 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1163 ' ' VAL . . . . . . . . . . . . . 59.2 t -97.41 128.57 34.32 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-N 114.59 -1.186 . . . . 42.93 112.573 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1164 ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.21 130.42 17.54 Favored 'Trans proline' 0 N--CA 1.483 0.911 0 C-N-CA 122.84 2.36 . . . . 39.289999999999999 108.322 174.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1165 ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -68.27 146.1 68.25 Favored 'Trans proline' 0 C--O 1.245 0.829 0 C-N-CA 123.251 2.634 . . . . 34.170000000000002 111.02 -172.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -68.98 119.41 13.23 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-O 123.731 1.729 . . . . 31.690000000000001 111.438 170.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1167 ' ' LYS . . . . . . . . . . . . . 87.9 mttt -89.41 98.04 11.54 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 125.42 2.533 . . . . 44.780000000000001 107.566 171.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 60.5 t -89.03 100.48 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 109.739 -3.391 . . . . 31.23 108.867 -178.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1169 ' ' MET . . . . . . . . . . . . . 42.6 ttp -85.02 89.93 7.72 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.29 -0.868 . . . . 37.090000000000003 108.908 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 62.8 t -83.22 105.45 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-O 122.728 1.252 . . . . 30.170000000000002 108.415 177.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1171 ' ' ILE . . . . . . . . . . . . . 97.3 mt -88.93 87.86 2.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 105.285 -2.117 . . . . 33.740000000000002 105.285 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 134.37 95.85 0.54 Allowed Glycine 0 N--CA 1.437 -1.298 0 CA-C-N 113.499 -1.682 . . . . 32.590000000000003 109.962 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1173 ' ' ALA . . . . . . . . . . . . . . . -92.99 46.09 1.21 Allowed 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 119.911 1.856 . . . . 32.420000000000002 112.978 -175.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -134.22 151.94 20.44 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 108.241 -1.944 . . . . 31.739999999999998 108.241 -174.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 23.4 t 24.97 -84.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 127.324 2.249 . . . . 31.48 115.242 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1176 ' ' ALA . . . . . . . . . . . . . . . -62.61 -41.36 98.95 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 123.418 1.58 . . . . 26.120000000000001 111.137 -175.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1177 ' ' GLY . . . . . . . . . . . . . . . -68.95 -31.37 72.52 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 113.093 -1.867 . . . . 25.73 111.284 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1178 ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.0 -48.41 81.67 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 121.445 2.622 . . . . 32.590000000000003 108.126 175.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -61.43 -46.78 88.69 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 112.764 0.653 . . . . 27.719999999999999 112.764 176.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -56.86 -46.52 81.72 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 121.993 0.902 . . . . 26.030000000000001 112.875 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1181 ' ' ILE . . . . . . . . . . . . . 72.5 mt -60.11 -50.55 79.74 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.435 0 C-N-CA 126.559 1.944 . . . . 28.609999999999999 107.784 174.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -48.07 -55.78 9.78 Favored Glycine 0 N--CA 1.44 -1.042 0 O-C-N 124.228 0.955 . . . . 25.23 113.151 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -63.9 -51.09 66.12 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 117.754 -1.117 . . . . 24.09 110.882 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -62.23 -43.77 98.08 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-O 123.549 1.642 . . . . 26.68 113.963 -175.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -67.24 -40.35 86.29 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 119.346 -2.096 . . . . 36.57 109.02 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1186 ' ' SER . . . . . . . . . . . . . 61.0 m -66.44 -23.63 66.32 Favored 'General case' 0 C--O 1.25 1.088 0 CA-C-N 119.914 1.234 . . . . 28.920000000000002 113.226 173.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1187 ' ' LEU . . . . . . . . . . . . . 19.5 mt -84.32 6.8 21.61 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 119.871 -1.768 . . . . 29.09 112.997 165.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 83.62 14.05 74.27 Favored Glycine 0 CA--C 1.538 1.524 0 O-C-N 118.546 -2.596 . . . . 29.260000000000002 114.33 172.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1189 ' ' ALA . . . . . . . . . . . . . . . -88.98 143.76 26.63 Favored 'General case' 0 N--CA 1.433 -1.276 0 O-C-N 120.843 -1.386 . . . . 30.16 112.396 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 97.0 mt -76.77 97.43 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 105.13 -2.174 . . . . 35.810000000000002 105.13 174.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1191 ' ' VAL . . . . . . . . . . . . . 47.7 t -74.35 115.95 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 104.955 -2.239 . . . . 31.969999999999999 104.955 176.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1192 ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -103.3 77.91 1.57 Allowed 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 106.438 -1.69 . . . . 48.159999999999997 106.438 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -87.07 155.64 20.06 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 114.719 1.377 . . . . 35.890000000000001 114.719 -172.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 44.7 t80 -138.87 139.25 38.05 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 104.872 -2.27 . . . . 41.880000000000003 104.872 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1195 ' ' ASP . . . . . . . . . . . . . 8.8 t0 -146.1 150.07 35.23 Favored 'General case' 0 C--O 1.245 0.857 0 N-CA-C 102.289 -3.226 . . . . 38.280000000000001 102.289 165.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1196 ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -72.15 -27.47 62.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 120.383 -1.448 . . . . 40.619999999999997 111.605 176.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1197 ' ' ARG . . . . . . . . . . . . . 36.5 mtm180 -84.4 132.09 48.34 Favored Pre-proline 0 N--CA 1.444 -0.759 0 N-CA-C 115.876 1.806 . . . . 53.090000000000003 115.876 -171.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -69.31 -30.32 24.58 Favored 'Trans proline' 0 CA--C 1.498 -1.291 0 C-N-CA 122.906 2.404 . . . . 42.560000000000002 117.35 -176.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -54.89 -26.74 37.83 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 113.199 0.814 . . . . 56.310000000000002 113.199 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1200 ' ' VAL . . . . . . . . . . . . . 3.5 m -114.5 20.34 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 CA-C-O 123.59 1.662 . . . . 42.909999999999997 114.717 -173.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 58.0 tttm -69.94 -56.12 7.86 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 122.53 1.157 . . . . 48.890000000000001 110.931 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -55.66 -43.51 76.36 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 115.957 1.836 . . . . 51.700000000000003 115.957 -165.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1203 ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -43.37 -38.51 2.76 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 119.307 3.077 . . . . 52.57 119.307 -175.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1204 ' ' VAL . . . . . . . . . . . . . 43.7 t -71.91 -47.05 57.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 106.058 -1.83 . . . . 33.789999999999999 106.058 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -62.65 -44.58 95.9 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.773 -0.455 . . . . 36.579999999999998 109.773 175.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1206 ' ' SER . . . . . . . . . . . . . 16.8 m -60.87 -22.24 64.06 Favored 'General case' 0 CA--C 1.504 -0.808 0 C-N-CA 127.186 2.194 . . . . 39.609999999999999 115.333 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1207 ' ' MET . . . . . . . . . . . . . 27.0 mtp -87.59 -23.59 24.25 Favored 'General case' 0 C--O 1.253 1.249 0 CA-C-O 123.98 1.848 . . . . 37.450000000000003 111.523 175.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 95.32 73.58 1.19 Allowed Glycine 0 CA--C 1.5 -0.858 0 O-C-N 118.274 -2.766 . . . . 31.870000000000001 107.158 -175.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -169.67 -170.96 1.12 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 109.842 -3.179 . . . . 35.399999999999999 106.448 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -125.45 147.55 49.16 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 121.581 1.992 . . . . 47.890000000000001 111.885 -172.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 14.9 t80 -105.92 138.95 41.22 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 105.673 -1.973 . . . . 45.530000000000001 105.673 173.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1212 ' ' LEU . . . . . . . . . . . . . 78.9 mt -86.86 128.06 35.04 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 122.449 1.119 . . . . 46.329999999999998 111.344 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -94.44 145.2 24.94 Favored 'General case' 0 C--O 1.254 1.317 0 CA-C-N 112.299 -2.228 . . . . 60.409999999999997 111.72 177.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.62 153.51 17.68 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 114.184 -1.371 . . . . 57.380000000000003 108.775 -175.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 18.2 t70 . . . . . 0 CA--C 1.506 -0.738 0 N-CA-C 112.72 0.637 . . . . 65.069999999999993 112.72 -178.329 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B 1230 ' ' MET . . . . . . . . . . . . . 16.3 mmt . . . . . 0 N--CA 1.432 -1.372 1 N-CA-C 99.374 -4.306 . . . . 80.319999999999993 99.374 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1231 ' ' SER . . . . . . . . . . . . . 67.1 m 127.5 147.28 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.348 3 O-C-N 110.924 -7.36 . . . . 79.920000000000002 107.109 -10.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -63.79 150.54 44.43 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 120.618 1.554 . . . . 77.909999999999997 110.338 -172.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 65.92 -43.11 0.38 Allowed 'General case' 0 C--N 1.356 0.888 0 C-N-CA 125.065 1.346 . . . . 73.879999999999995 114.08 -170.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 12.0 t80 -56.35 -50.91 70.14 Favored 'General case' 0 CA--C 1.507 -0.707 0 O-C-N 118.935 -2.353 . . . . 68.980000000000004 109.996 172.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 30.3 pt -54.77 -31.87 24.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 112.57 -2.104 . . . . 64.530000000000001 113.048 172.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -74.43 -30.45 61.91 Favored 'General case' 0 C--O 1.218 -0.598 0 O-C-N 117.947 -2.971 . . . . 66.359999999999999 111.632 172.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -64.61 -41.75 96.01 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-N 119.629 1.104 . . . . 56.600000000000001 110.645 170.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -55.85 -52.66 63.27 Favored 'General case' 0 C--O 1.249 1.065 0 O-C-N 121.606 -0.684 . . . . 56.789999999999999 111.368 169.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1239 ' ' MET . . . . . . . . . . . . . 14.2 mtm -49.05 -45.05 42.34 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 114.589 1.329 . . . . 53.630000000000003 114.589 174.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -65.59 -37.1 85.67 Favored 'General case' 0 C--O 1.247 0.971 0 CA-C-O 123.042 1.401 . . . . 51.740000000000002 109.995 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 31.4 tp -63.17 -44.75 94.55 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 118.319 -2.738 . . . . 44.859999999999999 107.474 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 11.4 m-30 -68.85 -37.57 79.22 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.362 -1.29 . . . . 42.780000000000001 109.772 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -62.48 -33.73 75.45 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 121.123 1.783 . . . . 40.960000000000001 109.58 175.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -66.23 -47.52 73.53 Favored 'General case' 0 C--N 1.345 0.413 0 CA-C-O 122.253 1.025 . . . . 43.060000000000002 110.278 173.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -63.97 -25.54 68.18 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.588 -1.642 . . . . 46.450000000000003 113.241 176.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -31.85 -51.16 0.22 Allowed 'General case' 0 N--CA 1.472 0.671 1 N-CA-C 122.109 4.114 . . . . 41.780000000000001 122.109 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 6.2 tptt -86.08 -18.28 32.84 Favored 'General case' 0 C--N 1.347 0.49 0 O-C-N 120.438 -1.414 . . . . 52.200000000000003 111.874 176.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1248 ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -80.96 -48.15 12.68 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 118.745 -2.472 . . . . 53.549999999999997 112.618 172.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1249 ' ' VAL . . . . . . . . . . . . 0.255 26.8 m -71.02 137.38 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 CA-C-O 126.54 3.067 . . . . 34.409999999999997 114.933 -168.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1250 ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -98.29 -51.43 3.99 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 108.62 -3.9 . . . . 33.380000000000003 111.225 -176.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1251 ' ' ILE . . . . . . . . . . . . . 40.4 mm -126.39 111.7 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 O-C-N 118.439 -2.663 . . . . 29.539999999999999 106.543 -174.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1252 ' ' ILE . . . . . . . . . . . . . 61.8 mt -98.28 108.62 22.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 105.947 -1.871 . . . . 32.439999999999998 105.947 176.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1253 ' ' VAL . . . . . . . . . . . . . 39.9 t -90.71 87.13 2.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 N-CA-C 102.342 -3.207 . . . . 30.57 102.342 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1254 ' ' THR . . . . . . . . . . . . 0.275 2.0 t -88.33 96.17 10.47 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 103.452 -2.795 . . . . 35.039999999999999 103.452 -176.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1255 ' ' THR . . . . . . . . . . . . . 21.6 m -90.11 -73.56 0.52 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 109.795 -3.366 . . . . 34.619999999999997 108.515 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . 45.3 1.51 0.0 OUTLIER 'General case' 0 C--O 1.242 0.671 1 N-CA-C 123.175 4.509 . . . . 42.719999999999999 123.175 -178.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 2.6 mp -65.64 92.79 0.15 Allowed 'General case' 0 C--O 1.242 0.68 0 CA-C-N 123.173 2.715 . . . . 52.43 113.863 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -76.0 137.59 69.21 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 112.319 -2.218 . . . . 59.409999999999997 108.7 171.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -55.22 113.3 1.35 Allowed 'Trans proline' 0 N--CA 1.444 -1.411 0 C-N-CA 124.499 3.466 . . . . 62.68 116.391 -165.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 89.77 -36.4 3.54 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 109.772 -1.331 . . . . 64.159999999999997 109.772 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 70.6 mttt -75.16 135.69 73.12 Favored Pre-proline 0 C--O 1.247 0.95 0 CA-C-N 120.886 2.343 . . . . 68.530000000000001 107.63 -175.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.58 145.49 98.72 Favored 'Trans proline' 0 CA--C 1.5 -1.205 0 C-N-CA 123.895 3.064 . . . . 61.990000000000002 113.097 161.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1263 ' ' ALA . . . . . . . . . . . . . . . -81.92 128.81 67.14 Favored Pre-proline 0 C--O 1.24 0.561 0 O-C-N 120.618 -1.301 . . . . 57.149999999999999 112.833 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -64.32 153.03 78.93 Favored 'Trans proline' 0 C--O 1.247 0.969 0 C-N-CA 122.416 2.077 . . . . 51.57 116.101 169.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1265 ' ' LYS . . . . . 0.427 ' NZ ' ' O ' ' B' 1289 ' ' GLY . 41.9 mmtm -77.22 88.59 3.67 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 122.603 1.192 . . . . 54.549999999999997 110.065 -174.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 68.6 mt -80.35 -43.49 21.06 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 115.102 1.519 . . . . 46.859999999999999 115.102 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1267 ' ' ILE . . . . . . . . . . . . . 35.1 mm -87.7 101.94 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 105.809 -1.923 . . . . 41.039999999999999 105.809 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1268 ' ' THR . . . . . . . . . . . . . 24.4 p -73.96 159.16 33.15 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-N 113.858 -1.519 . . . . 39.579999999999998 112.484 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1269 ' ' ARG . . . . . . . . . . . . . 79.1 mtt85 -55.45 -43.42 75.42 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 115.997 -0.547 . . . . 53.149999999999999 110.471 172.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -56.37 -41.33 76.01 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 113.816 1.043 . . . . 42.960000000000001 113.816 175.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1271 ' ' MET . . . . . . . . . . . . . 43.4 ttm -65.94 -47.79 73.48 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.704 -0.68 . . . . 43.890000000000001 110.189 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1272 ' ' VAL . . . . . . . . . . . . . 38.5 t -65.68 -41.97 91.67 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.671 0 CA-C-O 121.467 0.651 . . . . 38.369999999999997 110.922 -177.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -63.13 -35.78 81.43 Favored 'General case' 0 C--O 1.239 0.541 0 O-C-N 118.53 -2.606 . . . . 47.460000000000001 112.664 173.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1274 ' ' SER . . . . . . . . . . . . . 72.8 m -70.14 -25.34 63.43 Favored 'General case' 0 N--CA 1.441 -0.917 0 O-C-N 120.845 -1.16 . . . . 38.380000000000003 113.868 173.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1275 ' ' MET . . . . . . . . . . . . . 40.2 mtp -60.79 163.53 5.57 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 117.95 2.574 . . . . 37.810000000000002 117.95 -174.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 81.8 tttt -62.95 131.79 49.88 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 110.242 -3.163 . . . . 49.259999999999998 108.97 166.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -84.24 166.37 17.58 Favored 'General case' 0 CA--C 1.51 -0.594 0 O-C-N 124.83 1.331 . . . . 34.460000000000001 110.023 -177.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 63.2 30.53 77.81 Favored Glycine 0 C--N 1.334 0.467 0 O-C-N 120.886 -1.134 . . . . 33.530000000000001 111.861 -172.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1279 ' ' SER . . . . . . . . . . . . . 42.3 m -126.5 146.81 49.97 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 106.062 -1.829 . . . . 31.309999999999999 106.062 -176.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1280 ' ' VAL . . . . . . . . . . . . . 58.1 t -117.66 135.36 58.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 122.592 1.187 . . . . 29.32 109.278 -171.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1281 ' ' ILE . . . . . . . . . . . . . 67.4 mt -110.62 104.09 16.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 103.601 -2.74 . . . . 31.93 103.601 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1282 ' ' VAL . . . . . . . . . . . . . 31.7 t -95.78 111.72 26.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 N-CA-C 101.681 -3.451 . . . . 29.48 101.681 -175.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 36.8 t0 -87.67 107.01 18.42 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.231 -1.349 . . . . 34.5 108.544 175.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1284 ' ' LEU . . . . . . . . . . . . . 19.6 mt -79.02 -17.21 55.72 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 118.609 -1.236 . . . . 37.939999999999998 111.045 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -102.12 29.23 5.22 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.664 0.745 . . . . 40.920000000000002 111.868 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -51.83 -36.59 48.63 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.64 1.976 . . . . 44.390000000000001 115.797 177.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1287 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.19 -38.86 21.74 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.497 1.119 . . . . 51.460000000000001 110.347 171.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 11.3 t30 -98.37 71.95 2.07 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-O 121.482 0.658 . . . . 57.75 111.574 -171.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1289 ' ' GLY . . . . . 0.427 ' O ' ' NZ ' ' B' 1265 ' ' LYS . . . 86.61 -40.74 3.07 Favored Glycine 0 N--CA 1.47 0.948 0 CA-C-O 117.949 -1.473 . . . . 49.850000000000001 113.614 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 72.57 119.73 0.06 OUTLIER Glycine 0 CA--C 1.541 1.672 0 CA-C-N 121.42 2.61 . . . . 45.93 112.195 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1291 ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -85.52 -21.75 28.46 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.625 1.17 . . . . 42.670000000000002 110.034 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1292 ' ' CYS . . . . . . . . . . . . . 27.1 t -110.83 132.19 54.41 Favored 'General case' 0 CA--C 1.51 -0.582 0 O-C-N 118.503 -2.623 . . . . 38.82 111.608 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1293 ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -58.17 -41.79 84.62 Favored 'General case' 0 C--O 1.245 0.856 0 CA-C-O 121.399 0.619 . . . . 46.710000000000001 111.928 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -75.56 -7.71 54.91 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 115.37 1.618 . . . . 47.229999999999997 115.37 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1295 ' ' THR . . . . . . . . . . . . . 38.6 m -53.89 122.3 9.75 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.239 0.616 . . . . 36.020000000000003 112.551 172.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 26.3 t -89.0 106.31 12.84 Favored Pre-proline 0 N--CA 1.488 1.452 0 N-CA-C 101.993 -3.336 . . . . 37.259999999999998 101.993 161.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -59.97 76.15 0.06 OUTLIER 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 125.227 3.951 . . . . 35.090000000000003 115.536 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 149.24 -14.92 1.12 Allowed Glycine 0 CA--C 1.528 0.887 0 CA-C-N 113.218 -1.81 . . . . 35.969999999999999 111.679 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -139.48 -174.31 3.85 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 123.487 3.643 . . . . 40.390000000000001 112.262 -174.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1300 ' ' ILE . . . . . . . . . . . . . 30.7 mt -88.44 133.91 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-N 113.917 -1.492 . . . . 37.43 109.374 166.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 61.8 t80 -108.66 116.84 32.74 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 107.223 -1.399 . . . . 44.130000000000003 107.223 159.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1302 ' ' THR . . . . . . . . . . . . . 13.9 m -84.82 112.38 20.48 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.632 -1.618 . . . . 39.780000000000001 106.632 172.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1303 ' ' THR . . . . . . . . . . . . . 34.5 p -74.36 162.32 28.99 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 120.879 -1.138 . . . . 43.289999999999999 111.628 175.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -49.96 -47.72 52.49 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 125.192 1.397 . . . . 53.07 114.313 -168.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 47.7 p30 -70.51 -23.96 62.74 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 115.531 1.678 . . . . 43.969999999999999 115.531 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 114.38 21.13 5.62 Favored Glycine 0 CA--C 1.529 0.932 0 O-C-N 121.177 -0.952 . . . . 41.119999999999997 111.885 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1307 ' ' VAL . . . . . . . . . . . . . 47.6 t -80.08 128.56 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 O-C-N 119.6 -2.118 . . . . 38.119999999999997 106.439 163.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1308 ' ' LYS . . . . . . . . . . . . . 92.6 mttt -109.76 114.67 28.43 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-N 120.58 1.536 . . . . 36.340000000000003 109.285 -176.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1309 ' ' VAL . . . . . . . . . . . . . 44.0 t -89.88 103.26 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 O-C-N 120.589 -1.32 . . . . 30.399999999999999 110.059 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1310 ' ' ILE . . . . . . . . . . . . . 40.4 mt -92.93 104.4 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.98 0 N-CA-C 104.921 -2.252 . . . . 30.82 104.921 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1311 ' ' GLY . . . . . . . . . . . . . . . -124.09 81.59 0.35 Allowed Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 104.246 -3.542 . . . . 26.530000000000001 104.246 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1312 ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -92.4 137.82 32.04 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 120.452 -1.617 . . . . 38.0 111.849 176.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1313 ' ' THR . . . . . . . . . . . . . 3.4 p -61.72 -36.37 80.76 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.79 -1.189 . . . . 29.800000000000001 107.79 168.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -83.49 12.13 6.04 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 118.143 2.645 . . . . 39.039999999999999 118.143 -175.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1315 ' ' LEU . . . . . . . . . . . . . 12.2 mt -58.37 -42.76 96.45 Favored Pre-proline 0 C--O 1.245 0.831 0 O-C-N 118.671 -2.518 . . . . 31.079999999999998 114.992 170.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1316 ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -67.22 -3.45 9.9 Favored 'Trans proline' 0 C--O 1.24 0.602 0 C-N-CA 122.509 2.139 . . . . 26.100000000000001 113.361 169.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -89.12 -57.26 1.81 Allowed Glycine 0 CA--C 1.536 1.373 0 O-C-N 119.243 -2.16 . . . . 23.170000000000002 110.409 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -68.89 52.65 0.09 Allowed 'General case' 0 CA--C 1.529 0.139 1 N-CA-C 122.582 4.29 . . . . 40.399999999999999 122.582 -158.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -133.66 76.47 66.33 Favored Pre-proline 0 C--O 1.236 0.394 0 O-C-N 118.579 -2.576 . . . . 23.600000000000001 104.94 151.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1320 ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -35.32 -70.78 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.199 3.266 . . . . 22.350000000000001 120.553 -166.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1321 ' ' THR . . . . . . . . . . . . . 2.8 m -55.69 -43.45 76.43 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 114.858 1.429 . . . . 26.52 114.858 173.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1322 ' ' GLN . . . . . . . . . . . . . 42.3 tp60 -72.94 -37.59 67.1 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 118.144 -2.847 . . . . 24.379999999999999 109.296 -173.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1323 ' ' SER . . . . . . . . . . . . . 49.7 m -61.13 -54.37 45.4 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 116.925 -1.512 . . . . 22.800000000000001 107.653 174.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1324 ' ' SER . . . . . . . . . . . . . 15.2 m -54.16 -35.88 62.75 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 114.417 1.266 . . . . 21.25 114.417 173.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -67.44 -57.41 6.61 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 120.921 -1.112 . . . . 31.34 110.783 173.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1326 ' ' LEU . . . . . . . . . . . . . 97.3 mt -73.3 -32.6 64.71 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-N 121.765 2.075 . . . . 31.559999999999999 108.349 -166.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1327 ' ' TYR . . . . . . . . . . . . . 24.7 t80 -60.94 -56.97 14.83 Favored 'General case' 0 C--O 1.257 1.471 0 N-CA-C 105.421 -2.066 . . . . 22.73 105.421 169.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1328 ' ' GLY . . . . . . . . . . . . . . . -48.24 -41.55 23.58 Favored Glycine 0 N--CA 1.467 0.725 0 CA-C-O 119.786 -0.452 . . . . 21.91 114.162 173.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1329 ' ' THR . . . . . . . . . . . . . 16.5 m -72.0 -31.17 65.97 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 118.709 1.255 . . . . 22.149999999999999 110.598 -175.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1330 ' ' ASN . . . . . . . . . . . . . 33.0 m120 -63.6 -46.46 85.69 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.291 -0.881 . . . . 26.18 109.885 170.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1331 ' ' LEU . . . . . . . . . . . . . 73.1 mt -53.72 -48.13 69.9 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.77 0.828 . . . . 23.68 112.224 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1332 ' ' VAL . . . . . . . . . . . . . 90.8 t -51.92 -57.49 3.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 O-C-N 124.638 1.212 . . . . 26.57 110.804 169.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -55.06 -37.49 66.81 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.79 1.177 . . . . 28.079999999999998 112.165 -177.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1334 ' ' LEU . . . . . . . . . . . . . 32.4 tp -64.78 -49.29 71.28 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 124.779 1.3 . . . . 27.43 111.39 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1335 ' ' LEU . . . . . . . . . . . . . 64.4 mt -62.13 -35.43 78.72 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 114.68 -1.146 . . . . 30.5 109.616 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1336 ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.87 -42.04 83.71 Favored 'General case' 0 CA--C 1.512 -0.498 0 O-C-N 121.486 -0.758 . . . . 41.649999999999999 112.555 171.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 8.2 mp -72.74 -34.85 67.31 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 113.164 0.801 . . . . 42.079999999999998 113.164 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1338 ' ' LEU . . . . . . . . . . . . . 47.0 mt -74.59 -72.81 0.27 Allowed 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 122.804 1.288 . . . . 35.030000000000001 107.967 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 50.0 m -81.02 69.93 7.73 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-O 123.442 1.591 . . . . 37.329999999999998 113.982 -175.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 55.4 mttp -67.69 -6.28 19.91 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 113.65 -1.613 . . . . 50.509999999999998 115.262 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -95.07 -24.62 16.8 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.508 0.723 . . . . 54.210000000000001 110.753 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.23 34.85 21.25 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.957 1.703 . . . . 50.990000000000002 111.501 -174.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -82.7 -30.11 29.4 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 114.177 -1.374 . . . . 48.82 111.658 -172.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 116.16 22.61 4.47 Favored Glycine 0 N--CA 1.473 1.141 0 CA-C-O 118.335 -1.258 . . . . 40.43 110.319 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -134.32 140.14 46.17 Favored 'General case' 0 C--O 1.25 1.102 0 CA-C-N 120.955 2.378 . . . . 47.560000000000002 108.149 173.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1346 ' ' ILE . . . . . . . . . . . . . 22.6 mm -63.9 92.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 CA-C-O 126.284 2.945 . . . . 42.490000000000002 108.807 171.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1347 ' ' THR . . . . . . . . . . . . . 61.1 m -80.19 99.36 7.75 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 100.778 -3.786 . . . . 38.119999999999997 100.778 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 6.7 t -82.32 102.42 8.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 106.515 -1.661 . . . . 37.5 106.515 -176.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 29.0 t70 -67.14 164.61 17.68 Favored 'General case' 0 C--O 1.214 -0.767 0 O-C-N 125.645 1.841 . . . . 43.850000000000001 110.264 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1350 ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.7 5.42 0.69 Allowed 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.769 -0.826 . . . . 39.810000000000002 108.769 177.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 32.4 t70 -92.18 -56.59 3.0 Favored 'General case' 0 C--O 1.247 0.946 0 N-CA-C 114.26 1.207 . . . . 51.289999999999999 114.26 -174.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 7.7 t0 -65.06 134.68 54.35 Favored 'General case' 0 C--O 1.258 1.513 0 CA-C-O 121.703 0.764 . . . . 39.780000000000001 110.381 -174.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 30.6 m -48.71 -38.52 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 116.813 2.153 . . . . 39.280000000000001 116.813 175.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1354 ' ' VAL . . . . . . . . . . . . . 95.0 t -58.84 -59.34 3.87 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 CA-C-N 114.805 -1.089 . . . . 35.700000000000003 109.306 173.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1355 ' ' ILE . . . . . . . . . . . . . 43.6 mm -61.06 -42.95 95.11 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.93 0 O-C-N 124.319 1.012 . . . . 35.770000000000003 109.557 -173.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 39.9 tpt85 -58.98 -25.01 63.22 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 120.002 -1.686 . . . . 38.549999999999997 113.865 175.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -82.33 -67.03 1.52 Allowed Glycine 0 CA--C 1.535 1.316 0 N-CA-C 110.1 -1.2 . . . . 29.579999999999998 110.1 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1358 ' ' VAL . . . . . . . . . . . . . 10.0 p -54.42 -35.34 30.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 116.025 1.861 . . . . 32.060000000000002 116.025 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1359 ' ' THR . . . . . . . . . . . . . 8.0 m -85.09 83.21 8.11 Favored 'General case' 0 CA--C 1.513 -0.464 0 O-C-N 118.413 -2.679 . . . . 29.0 108.173 178.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1360 ' ' VAL . . . . . . . . . . . . . 36.0 m -76.06 -21.99 15.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 109.905 -3.316 . . . . 29.68 112.478 -168.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 60.6 mt -133.17 129.45 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 101.832 -3.396 . . . . 32.049999999999997 101.832 172.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1362 ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -112.45 104.83 12.97 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 123.484 1.611 . . . . 32.520000000000003 108.327 168.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 50.9 60.03 4.18 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 122.711 1.243 . . . . 35.68 111.706 171.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 94.46 -43.69 2.33 Favored Glycine 0 CA--C 1.529 0.911 0 O-C-N 119.019 -2.301 . . . . 34.259999999999998 110.743 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -72.45 117.59 14.3 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-O 117.711 -1.138 . . . . 51.07 109.769 -174.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 54.1 mt -73.92 94.87 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.34 0 CA-C-O 123.39 1.567 . . . . 39.869999999999997 108.368 174.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1367 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.14 -14.08 59.33 Favored 'General case' 0 C--O 1.25 1.092 0 CA-C-N 111.903 -2.408 . . . . 38.009999999999998 114.701 -173.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1368 ' ' TRP . . . . . . . . . . . . . 73.8 t90 -59.81 140.05 89.93 Favored Pre-proline 0 N--CA 1.47 0.529 0 CA-C-N 110.941 -2.845 . . . . 42.140000000000001 106.362 170.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -78.77 178.07 35.85 Favored 'Cis proline' 0 N--CA 1.446 -1.31 0 CA-C-N 124.811 2.754 . . . . 43.259999999999998 118.12 4.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1370 ' ' ALA . . . . . . . . . . . . . . . -76.84 149.03 80.0 Favored Pre-proline 0 C--O 1.248 1.021 0 CA-C-N 110.897 -2.865 . . . . 46.520000000000003 110.718 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -62.71 142.63 90.03 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.573 2.182 . . . . 51.950000000000003 113.702 170.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.0 72.57 1.55 Allowed 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 124.853 3.702 . . . . 56.270000000000003 113.648 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1373 ' ' ILE . . . . . . . . . . . . 0.26 0.1 OUTLIER -79.71 135.12 26.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 O-C-N 119.627 -1.921 . . . . 60.829999999999998 106.929 173.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -75.31 116.62 16.23 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.032 -1.47 . . . . 66.099999999999994 107.032 -176.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 49.1 t -104.06 109.1 26.25 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 CA-C-N 113.061 -1.882 . . . . 63.469999999999999 106.712 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.223 -4.929 0 O-C-N 118.967 -2.333 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.818 0 CA-C-O 121.723 0.773 . . . . 0.0 111.997 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.66 -42.86 65.08 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 175.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.93 -43.73 77.67 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 122.572 2.442 . . . . 0.0 108.456 177.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 85.6 m -64.11 -37.91 89.15 Favored 'General case' 0 C--O 1.249 1.077 0 CA-C-O 117.924 -1.036 . . . . 0.0 111.846 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.2 -51.58 69.37 Favored 'General case' 0 CA--C 1.559 1.326 0 CA-C-N 120.016 1.28 . . . . 0.0 110.625 173.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.99 -33.09 62.22 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.515 1.126 . . . . 0.0 110.897 174.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.7 -54.33 33.31 Favored 'General case' 0 C--O 1.214 -0.78 0 O-C-N 119.608 -1.933 . . . . 0.0 111.556 171.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -47.81 -59.02 3.62 Favored 'General case' 0 C--O 1.247 0.949 0 C-N-CA 127.187 2.195 . . . . 0.0 113.382 -175.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 28' ' ' LYS . . . . . . . . . . . . . 27.2 pttt -59.32 -35.91 74.68 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.328 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -79.05 -30.37 44.01 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 69.7 m -43.25 -35.99 1.64 Allowed 'General case' 0 CA--C 1.508 -0.659 1 N-CA-C 122.869 4.396 . . . . 0.0 122.869 -167.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 67.73 -41.62 0.43 Allowed 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.887 1.675 . . . . 0.0 112.309 -171.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 12.0 m -121.15 139.42 53.37 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 120.028 1.285 . . . . 0.0 109.533 162.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 89.0 t -130.08 125.88 60.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 175.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 41.5 mm -104.74 123.56 58.82 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 O-C-N 118.93 -2.356 . . . . 0.0 106.071 169.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 29.7 mt -100.97 128.22 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 172.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 52.7 m -113.91 107.85 51.83 Favored Pre-proline 0 N--CA 1.426 -1.643 0 C-N-CA 125.565 1.546 . . . . 0.0 108.721 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -64.69 117.59 4.65 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.311 3.341 . . . . 0.0 110.16 170.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.39 -155.63 10.87 Favored Glycine 0 N--CA 1.416 -2.634 0 CA-C-N 111.906 -2.406 . . . . 0.0 110.465 164.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -66.82 -42.57 85.62 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.512 -0.993 . . . . 0.0 111.202 -173.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.52 -39.84 96.95 Favored Glycine 0 N--CA 1.437 -1.247 0 CA-C-O 117.483 -1.732 . . . . 0.0 110.781 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 9.1 ttm -56.66 -43.47 80.41 Favored 'General case' 0 C--N 1.36 1.036 0 CA-C-N 122.221 3.01 . . . . 0.0 111.284 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.36 -36.72 26.55 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 121.617 -0.677 . . . . 0.0 112.47 -171.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 85.6 t -77.79 -64.09 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.965 1.306 . . . . 0.0 110.533 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.95 65.81 2.97 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.535 1.159 . . . . 0.0 109.626 -172.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 45' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 17.71 36.18 0.0 OUTLIER 'General case' 0 C--O 1.245 0.863 1 N-CA-C 123.805 4.743 . . . . 0.0 123.805 175.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.81 -14.94 61.18 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 119.033 2.975 . . . . 0.0 119.033 -176.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . 0.251 0.0 OUTLIER -65.83 -46.85 77.03 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 114.721 -2.561 . . . . 0.0 114.762 -178.358 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 48' ' ' TYR . . . . . . . . . . . . 0.37 2.8 p90 -65.88 -32.59 6.0 Favored Pre-proline 0 N--CA 1.474 0.771 0 CA-C-N 125.389 3.722 . . . . 0.0 115.294 174.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 49' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -58.96 -44.85 32.04 Favored 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 123.042 2.494 . . . . 0.0 111.293 164.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 23.2 t -55.55 -40.64 60.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 119.59 1.086 . . . . 0.0 109.655 173.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.33 -42.04 77.03 Favored 'General case' 0 C--N 1.367 1.334 0 CA-C-N 121.004 1.729 . . . . 0.0 112.763 175.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -60.81 -40.03 91.18 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 173.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 8.2 tp -75.93 -31.53 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 120.368 1.44 . . . . 0.0 109.659 177.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 89.6 m -68.89 -29.34 67.6 Favored 'General case' 0 CA--C 1.498 -1.028 0 O-C-N 119.833 -1.792 . . . . 0.0 112.458 -174.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -48.93 -67.82 0.23 Allowed 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 163.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -57.59 -41.4 81.08 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -172.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 58.0 mt -61.91 -52.25 64.84 Favored 'General case' 0 N--CA 1.434 -1.249 0 O-C-N 124.779 1.3 . . . . 0.0 109.443 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -70.07 -36.1 74.71 Favored 'General case' 0 C--O 1.245 0.865 0 O-C-N 120.27 -1.519 . . . . 0.0 108.74 -174.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.54 -27.55 64.65 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 173.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 30.3 ttm-85 -87.8 2.34 51.58 Favored 'General case' 0 CA--C 1.543 0.712 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 175.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.22 3.36 84.89 Favored Glycine 0 C--N 1.343 0.962 0 O-C-N 118.557 -2.589 . . . . 0.0 111.782 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 88.2 mt -66.87 130.05 31.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 CA-C-N 118.732 1.266 . . . . 0.0 109.676 -177.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -70.11 75.67 0.5 Allowed 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 122.844 1.307 . . . . 0.0 109.111 169.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 2.9 p -86.64 103.28 12.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-O 123.096 1.427 . . . . 0.0 107.76 173.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 50.0 mmm-85 -108.74 151.4 26.25 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 124.833 2.254 . . . . 0.0 109.573 173.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -106.94 114.5 28.62 Favored 'General case' 0 C--O 1.251 1.142 0 C-N-CA 117.664 -1.614 . . . . 0.0 108.049 -176.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -98.99 98.57 2.01 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 106.79 -2.524 . . . . 0.0 106.79 176.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 3.2 mp -89.93 140.25 16.2 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -114.21 121.74 35.84 Favored Pre-proline 0 CA--C 1.506 -0.747 0 CA-C-O 116.034 -1.936 . . . . 0.0 106.029 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 70' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -61.56 -50.52 5.42 Favored 'Trans proline' 0 N--CA 1.482 0.823 0 C-N-CA 124.237 3.291 . . . . 0.0 112.214 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 73.0 t -72.86 96.71 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.256 1.397 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 168.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -158.54 128.58 5.92 Favored 'General case' 0 C--O 1.259 1.585 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 176.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.23 -102.79 0.83 Allowed Glycine 0 C--N 1.319 -0.397 0 O-C-N 121.535 -0.728 . . . . 0.0 111.454 167.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.14 122.34 5.05 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -172.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 67.09 115.76 0.03 OUTLIER Pre-proline 0 N--CA 1.444 -0.734 0 C-N-CA 125.73 1.612 . . . . 0.0 111.598 -177.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.09 172.48 11.91 Favored 'Trans proline' 0 C--O 1.26 1.614 0 C-N-CA 123.508 2.805 . . . . 0.0 114.386 169.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.63 -104.69 1.35 Allowed Glycine 0 N--CA 1.441 -0.971 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 -166.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 34.02 -78.07 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 127.256 2.222 . . . . 0.0 116.018 160.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -61.86 -41.44 97.84 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 119.404 1.002 . . . . 0.0 113.078 -175.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -85.82 -23.46 27.15 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 113.944 -1.48 . . . . 0.0 112.249 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 98.7 t -62.37 -51.78 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 171.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 11.1 mt -57.95 -29.78 65.44 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 170.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 11.8 tp -62.0 -37.26 84.18 Favored 'General case' 0 C--O 1.239 0.517 0 O-C-N 119.673 -1.892 . . . . 0.0 111.498 167.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.4 -43.16 74.03 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 120.542 -1.349 . . . . 0.0 109.704 173.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -60.05 -31.05 69.62 Favored 'General case' 0 C--N 1.348 0.5 0 O-C-N 120.089 -1.632 . . . . 0.0 113.391 173.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . 0.261 . . -73.24 -5.93 42.65 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 120.245 -1.534 . . . . 0.0 112.236 171.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 65.49 29.44 11.19 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 118.515 -2.616 . . . . 0.0 116.735 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 78.0 t -82.83 123.0 78.45 Favored Pre-proline 0 N--CA 1.438 -1.031 0 CA-C-N 112.711 -2.041 . . . . 0.0 106.281 172.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -60.12 103.59 0.21 Allowed 'Trans proline' 0 CA--C 1.545 1.037 1 C-N-CA 125.69 4.26 . . . . 0.0 116.681 -176.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 1.4 m-30 -50.41 -16.99 0.4 Allowed 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 177.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -61.62 -59.82 4.62 Favored 'General case' 0 C--N 1.344 0.349 0 O-C-N 121.383 -0.823 . . . . 0.0 110.554 165.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 5.6 pt -74.94 -18.13 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 118.392 -2.693 . . . . 0.0 111.736 -175.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 51.7 t -70.05 135.56 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 127.186 2.195 . . . . 0.0 106.574 170.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 16.4 tp -138.2 101.72 4.47 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 124.361 2.029 . . . . 0.0 108.353 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -74.91 84.08 2.21 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 112.004 -2.362 . . . . 0.0 111.06 -177.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 24.8 ttp 43.73 60.58 2.61 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 119.548 3.166 . . . . 0.0 119.548 176.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -119.13 -152.02 0.5 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 111.275 -2.693 . . . . 0.0 105.824 -175.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -77.1 54.34 1.05 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 125.098 3.59 . . . . 0.0 113.512 -177.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 9.6 tp -79.11 3.01 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 O-C-N 120.753 -1.217 . . . . 0.0 111.334 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -44.48 -52.49 7.86 Favored 'General case' 0 C--N 1.362 1.121 0 C-N-CA 125.58 1.552 . . . . 0.0 114.144 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -57.05 -55.09 39.27 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 124.778 1.299 . . . . 0.0 110.681 -174.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.0 -41.78 77.33 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 113.724 -1.58 . . . . 0.0 107.832 -174.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.53 -57.41 13.08 Favored 'General case' 0 C--N 1.358 0.962 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -172.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.44 -15.42 63.28 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 118.979 0.809 . . . . 0.0 112.465 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -73.33 -39.2 65.42 Favored 'General case' 0 CA--C 1.568 1.66 0 O-C-N 119.755 -1.84 . . . . 0.0 110.499 174.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 106' ' ' THR . . . . . . . . . . . . . 19.9 m -52.28 146.16 9.76 Favored 'General case' 0 C--O 1.247 0.948 0 O-C-N 126.984 2.678 . . . . 0.0 116.087 -165.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 107' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -81.06 -83.06 0.11 Allowed 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 111.907 -2.406 . . . . 0.0 108.386 165.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 31.4 m -89.82 118.35 29.35 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 120.565 1.529 . . . . 0.0 112.866 -174.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 109' ' ' VAL . . . . . . . . . . . . . 84.2 t -101.49 100.05 9.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 C-N-CA 124.266 1.026 . . . . 0.0 109.76 169.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 29.2 mt -72.12 93.29 1.41 Allowed 'General case' 0 C--O 1.236 0.356 0 O-C-N 124.286 0.992 . . . . 0.0 108.776 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 38.3 t -85.51 94.14 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 8.5 mm -81.13 92.52 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-O 122.697 1.236 . . . . 0.0 111.096 -171.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.69 65.81 1.99 Allowed Glycine 0 C--N 1.315 -0.598 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 168.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -170.98 -166.71 0.5 Allowed 'General case' 0 CA--C 1.504 -0.803 0 O-C-N 122.048 -0.677 . . . . 0.0 110.895 -174.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 115' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -174.01 -53.74 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 166.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 116' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -61.26 -25.32 67.01 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 123.58 1.657 . . . . 0.0 112.575 -172.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.6 -43.49 62.52 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 176.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 3.6 m -124.49 13.32 4.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 112.276 -2.238 . . . . 0.0 112.26 -176.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -68.26 112.49 11.07 Favored Pre-proline 0 C--N 1.364 1.201 0 O-C-N 118.372 -2.705 . . . . 0.0 111.814 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 120' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -45.17 -45.38 14.79 Favored 'Trans proline' 0 N--CA 1.444 -1.394 1 C-N-CA 125.353 4.035 . . . . 0.0 115.584 -176.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.06 -31.72 65.49 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 124.93 1.292 . . . . 0.0 111.864 -177.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.69 -12.77 61.22 Favored 'General case' 0 N--CA 1.438 -1.035 0 O-C-N 120.325 -1.484 . . . . 0.0 112.883 -174.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -106.97 -35.19 6.97 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 120.662 -1.274 . . . . 0.0 110.341 159.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -65.32 -65.2 0.7 Allowed 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 123.251 1.5 . . . . 0.0 111.253 -172.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 125' ' ' ASP . . . . . 0.414 ' CG ' ' HZ2' ' C' ' 127' ' ' LYS . 14.6 t70 -84.07 119.16 72.96 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-N 112.783 -2.008 . . . . 0.0 112.469 -173.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -70.83 -11.54 29.59 Favored 'Trans proline' 0 N--CA 1.449 -1.145 1 C-N-CA 125.534 4.156 . . . . 0.0 111.984 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . 0.414 ' HZ2' ' CG ' ' C' ' 125' ' ' ASP . 6.4 ttpm? -77.09 -0.63 25.46 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 119.337 0.971 . . . . 0.0 112.646 176.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 128' ' ' SER . . . . . . . . . . . . . 70.0 m -59.07 121.19 53.52 Favored Pre-proline 0 C--N 1.355 0.824 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 172.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 129' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -58.82 -45.36 29.39 Favored 'Trans proline' 0 C--N 1.353 0.774 1 C-N-CA 126.181 4.587 . . . . 0.0 116.816 173.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 15.0 pt -69.54 92.62 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.716 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 165.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.91 110.2 1.27 Allowed 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 125.801 2.715 . . . . 0.0 112.151 -169.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.89 72.57 0.48 Allowed Glycine 0 N--CA 1.462 0.428 0 CA-C-N 109.11 -3.677 . . . . 0.0 113.411 -176.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 133' ' ' MET . . . . . . . . . . . . . 62.0 tpp -82.69 127.6 69.56 Favored Pre-proline 0 C--O 1.249 1.053 0 CA-C-N 118.207 1.004 . . . . 0.0 110.291 -177.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -78.95 67.37 8.58 Favored 'Trans proline' 0 C--O 1.243 0.746 0 C-N-CA 124.777 3.651 . . . . 0.0 113.275 -174.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 27.7 m -68.96 136.5 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-N 113.414 -1.721 . . . . 0.0 112.464 -177.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 97.4 mt -77.54 153.23 33.57 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.288 -1.778 . . . . 0.0 108.68 -174.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -67.63 59.5 0.06 Allowed 'General case' 0 C--O 1.211 -0.967 0 N-CA-C 118.218 2.673 . . . . 0.0 118.218 -162.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 4.5 p -82.25 20.16 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.254 1.331 0 CA-C-O 123.864 1.792 . . . . 0.0 112.826 -173.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -70.73 133.12 46.32 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.831 -162.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 140' ' ' LYS . . . . . . . . . . . . . 20.3 pttm 36.62 42.32 0.2 Allowed 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 -169.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.13 152.02 41.34 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 120.574 -1.329 . . . . 0.0 112.154 174.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -77.23 -9.21 58.65 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -159.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 143' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -164.49 95.29 0.73 Allowed 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.636 1.574 . . . . 0.0 108.672 169.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 144' ' ' VAL . . . . . . . . . . . . . 21.9 t -89.8 101.0 11.74 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 145' ' ' ILE . . . . . . . . . . . . . 10.1 tp -110.8 102.34 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.352 0 CA-C-O 125.333 2.492 . . . . 0.0 107.359 -166.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 146' ' ' VAL . . . . . . . . . . . . . 28.8 t -95.82 100.67 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 111.728 -2.487 . . . . 0.0 110.998 -168.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 147' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -60.61 115.07 3.35 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 119.752 -1.842 . . . . 0.0 109.845 178.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 148' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -141.1 138.57 33.62 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 166.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 8.4 tpp85 -59.37 -38.98 81.84 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 117.528 -1.225 . . . . 0.0 111.513 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 20.2 m -148.16 164.49 33.76 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 120.936 1.698 . . . . 0.0 108.816 173.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 8.0 tpt -54.88 108.87 0.44 Allowed 'General case' 0 CA--C 1.502 -0.876 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.239 171.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -155.42 124.18 6.07 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.567 -173.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 46.2 m -62.16 136.52 57.98 Favored 'General case' 0 N--CA 1.434 -1.232 0 O-C-N 125.767 1.917 . . . . 0.0 107.889 175.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -76.08 -146.3 1.79 Allowed Glycine 0 N--CA 1.443 -0.855 0 O-C-N 119.641 -1.912 . . . . 0.0 110.371 172.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -60.97 -63.25 1.36 Allowed 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 120.955 -1.321 . . . . 0.0 109.438 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 156' ' ' ALA . . . . . . . . . . . . . . . -83.24 -52.36 6.65 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.899 -176.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 65.31 -85.31 0.08 OUTLIER Glycine 0 CA--C 1.531 1.038 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -165.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . 0.293 17.3 m 30.91 104.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 50.45 12.67 0.1 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -171.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 160' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -53.05 94.73 0.06 OUTLIER Pre-proline 0 C--N 1.35 0.629 0 N-CA-C 117.338 2.348 . . . . 0.0 117.338 -159.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -57.81 -34.42 98.23 Favored 'Trans proline' 0 N--CA 1.482 0.795 0 C-N-CA 123.361 2.708 . . . . 0.0 109.974 -169.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 162' ' ' LEU . . . . . . . . . . . . . 13.3 mt -54.29 -17.99 3.52 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 116.966 2.21 . . . . 0.0 116.966 -176.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 163' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -91.74 -45.14 8.59 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 123.022 1.392 . . . . 0.0 107.756 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -86.47 -51.8 5.97 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 111.446 -2.615 . . . . 0.0 112.732 -158.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 17.1 mmmt -73.2 -176.16 2.08 Favored 'General case' 0 C--O 1.246 0.871 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -157.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -69.5 -70.0 0.31 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.362 1.065 . . . . 0.0 108.168 -165.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -86.45 -19.04 30.21 Favored 'General case' 0 C--N 1.347 0.478 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 175.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 168' ' ' THR . . . . . . . . . . . . 0.275 37.6 m -93.67 86.33 5.13 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -150.47 155.74 40.1 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 123.075 1.417 . . . . 0.0 107.877 -164.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 170' ' ' MET . . . . . . . . . . . . . 76.7 mtm -73.33 140.38 46.68 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 171' ' ' LEU . . . . . . . . . . . . . 40.8 tp -92.18 107.51 19.27 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 103.448 -2.797 . . . . 0.0 103.448 167.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -78.4 102.79 7.95 Favored 'General case' 0 C--O 1.253 1.253 0 CA-C-N 111.902 -2.408 . . . . 0.0 111.279 -174.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . 167.97 175.36 37.65 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.203 175.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 174' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -62.67 149.13 44.39 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 114.422 -0.889 . . . . 0.0 111.4 173.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.57 -59.78 4.84 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 120.088 -1.632 . . . . 0.0 113.651 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.59 -66.47 0.39 Allowed 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 124.579 1.175 . . . . 0.0 108.133 176.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 177' ' ' ALA . . . . . . . . . . . . . . . -48.16 -39.23 20.1 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 117.781 2.511 . . . . 0.0 117.781 -177.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 56.2 m -67.82 -43.34 79.81 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 120.545 1.52 . . . . 0.0 111.301 173.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 179' ' ' VAL . . . . . . . . . . . . . 3.1 t -64.5 -39.68 86.44 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 CA-C-N 121.028 1.74 . . . . 0.0 108.175 175.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -56.78 -45.75 81.94 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 122.786 1.279 . . . . 0.0 112.55 176.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -56.58 -31.22 64.03 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 182' ' ' ILE . . . . . . . . . . . . . 42.9 pt -98.21 -25.81 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 183' ' ' LEU . . . . . . . . . . . . . 2.9 pp -59.44 -20.16 52.93 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 120.287 3.44 . . . . 0.0 120.287 -164.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -126.65 -34.75 2.4 Favored 'General case' 0 CA--C 1.492 -1.28 0 O-C-N 125.371 1.669 . . . . 0.0 107.118 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -73.06 -14.94 61.5 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 120.299 -1.5 . . . . 0.0 114.151 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 186' ' ' LEU . . . . . . . . . . . . . 2.6 pt? . . . . . 0 C--O 1.219 -0.547 0 N-CA-C 119.796 3.258 . . . . 0.0 119.796 -167.96 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' NAD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C 1001 ' ' NAP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 19.6 t-80 . . . . . 0 C--O 1.236 0.346 0 N-CA-C 102.441 -3.17 . . . . 65.739999999999995 102.441 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -67.64 81.47 0.16 Allowed Glycine 0 CA--C 1.544 1.864 0 CA-C-O 123.33 1.516 . . . . 48.659999999999997 111.332 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -116.06 122.92 46.6 Favored 'General case' 0 N--CA 1.419 -1.982 1 N-CA-C 100.1 -4.037 . . . . 44.560000000000002 100.1 175.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1003 ' ' ILE . . . . . . . . . . . . . 30.4 mt -99.13 121.51 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.163 0 N-CA-C 106.024 -1.843 . . . . 34.859999999999999 106.024 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -79.47 135.15 14.76 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 108.35 -1.9 . . . . 30.75 108.35 165.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 32.8 mm -110.82 96.25 27.94 Favored Pre-proline 0 C--O 1.242 0.696 0 N-CA-C 101.564 -3.495 . . . . 32.210000000000001 101.564 170.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -71.6 171.59 16.03 Favored 'Trans proline' 0 CA--C 1.504 -0.992 0 C-N-CA 122.529 2.153 . . . . 32.979999999999997 111.312 170.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1007 ' ' ARG . . . . . . . . . . . . . 19.0 ttp85 -104.32 141.36 36.44 Favored 'General case' 0 C--O 1.258 1.549 0 CA-C-N 110.976 -2.829 . . . . 47.979999999999997 106.726 169.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1008 ' ' GLU . . . . . 0.462 ' CD ' ' HZ1' ' A' 1071 ' ' LYS . 57.1 mm-40 -65.25 143.32 57.88 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 123.456 1.598 . . . . 34.700000000000003 112.699 -178.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 37.7 mtp180 -108.74 22.29 16.12 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-O 123.473 1.606 . . . . 53.369999999999997 113.553 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 30.0 tp -77.96 149.65 34.11 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.588 -1.264 . . . . 45.07 107.588 170.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1011 ' ' THR . . . . . . . . . . . . . 23.5 m -74.77 143.99 43.78 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 122.378 2.354 . . . . 40.359999999999999 110.023 -174.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 32.4 t30 41.64 64.4 1.06 Allowed 'General case' 0 N--CA 1.439 -0.997 0 CA-C-O 125.178 2.418 . . . . 40.609999999999999 113.283 -176.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -134.04 147.61 50.96 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 109.932 -3.304 . . . . 33.759999999999998 104.424 -169.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1014 ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.15 1.1 8.51 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 112.935 0.717 . . . . 27.890000000000001 112.935 177.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1015 ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -68.13 130.57 43.34 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 119.884 -1.76 . . . . 29.02 112.161 -176.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1016 ' ' VAL . . . . . . . . . . . . . 83.9 t -132.17 141.73 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 110.644 -2.98 . . . . 28.129999999999999 103.862 168.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1017 ' ' ALA . . . . . . . . . . . . . . . -56.54 -37.23 70.22 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 118.024 2.601 . . . . 26.870000000000001 118.024 -171.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -136.08 143.01 44.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 120.077 1.308 . . . . 26.77 110.64 -165.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1019 ' ' THR . . . . . . . . . . . . . 75.5 p -77.67 173.4 7.64 Favored Pre-proline 0 C--N 1.346 0.444 0 O-C-N 120.104 -1.622 . . . . 27.02 108.25 163.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1020 ' ' PRO . . . . . . . . . . . . . 2.5 Cg_exo -55.39 -35.3 91.53 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 123.837 3.025 . . . . 30.57 111.741 164.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -62.49 -49.55 74.94 Favored 'General case' 0 C--N 1.358 0.957 0 CA-C-N 118.98 0.809 . . . . 47.810000000000002 110.826 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1022 ' ' THR . . . . . . . . . . . . . 6.7 p -65.74 -29.16 69.63 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.573 0.953 . . . . 30.77 113.573 176.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1023 ' ' VAL . . . . . . . . . . . . . 3.4 t -62.74 -44.83 99.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 107.65 -1.241 . . . . 33.590000000000003 107.65 175.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -59.75 -44.22 93.91 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 117.609 -1.186 . . . . 53.289999999999999 111.847 173.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -54.71 -38.69 67.36 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-N 119.998 1.272 . . . . 46.920000000000002 114.333 170.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1026 ' ' LEU . . . . . . . . . . . . . 91.2 mt -68.75 -38.63 80.27 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 119.141 0.882 . . . . 37.170000000000002 109.278 177.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 12.7 tp -63.83 -43.29 96.62 Favored 'General case' 0 CA--C 1.556 1.183 0 O-C-N 124.074 0.859 . . . . 44.439999999999998 109.064 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -59.67 -41.21 90.13 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 123.292 0.637 . . . . 52.579999999999998 109.698 175.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1029 ' ' LEU . . . . . . . . . . . . . 61.9 mt -72.44 7.23 1.9 Allowed 'General case' 0 C--O 1.253 1.247 0 N-CA-C 116.654 2.094 . . . . 45.689999999999998 116.654 174.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 94.74 -5.19 69.45 Favored Glycine 0 CA--C 1.494 -1.272 0 O-C-N 121.004 -1.06 . . . . 42.090000000000003 112.303 171.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -86.66 137.07 32.76 Favored 'General case' 0 N--CA 1.443 -0.803 0 O-C-N 119.352 -2.264 . . . . 40.719999999999999 106.86 -171.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1032 ' ' THR . . . . . . . . . . . . . 37.8 m -76.69 127.38 32.67 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 104.915 -2.254 . . . . 37.770000000000003 104.915 162.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1033 ' ' VAL . . . . . . . . . . . . . 4.1 t -94.06 133.71 34.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 103.225 -2.88 . . . . 33.539999999999999 103.225 177.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -126.84 116.61 21.12 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 104.803 -2.295 . . . . 31.68 104.803 172.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1035 ' ' VAL . . . . . . . . . . . . . 21.2 t -109.29 142.34 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 O-C-N 120.91 -1.119 . . . . 31.52 109.765 -174.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1036 ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -65.17 139.14 58.64 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.32 -1.363 . . . . 41.039999999999999 107.32 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1037 ' ' SER . . . . . . . . . . . . . 8.6 t -73.56 132.7 43.12 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 106.176 -1.787 . . . . 31.829999999999998 106.176 176.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 100.04 -20.91 47.01 Favored Glycine 0 C--O 1.22 -0.773 0 N-CA-C 109.278 -1.529 . . . . 29.359999999999999 109.278 -175.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -67.73 -34.91 77.79 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 121.484 -1.009 . . . . 27.780000000000001 110.649 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -59.98 -43.18 98.4 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-O 123.429 1.571 . . . . 28.91 110.622 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -52.15 -49.12 64.36 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 112.218 -1.991 . . . . 51.18 113.652 172.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1042 ' ' LEU . . . . . . . . . . . . . 10.7 mt -78.54 -38.47 40.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.541 -1.974 . . . . 29.91 114.119 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1043 ' ' ALA . . . . . . . . . . . . . . . -61.26 -14.95 30.06 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 113.719 1.007 . . . . 28.539999999999999 113.719 169.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1044 ' ' SER . . . . . . . . . . . . . 51.1 m 68.27 34.56 3.81 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 120.246 -1.534 . . . . 33.060000000000002 108.596 173.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1045 ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -161.58 97.74 1.09 Allowed 'General case' 0 C--O 1.247 0.96 0 N-CA-C 101.092 -3.669 . . . . 30.289999999999999 101.092 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -71.92 165.77 23.49 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 120.854 3.65 . . . . 48.619999999999997 120.854 -149.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.42 -53.97 12.58 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 112.35 -2.205 . . . . 36.740000000000002 111.438 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 3.4 pttm -65.02 -39.02 92.79 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-N 121.76 2.073 . . . . 43.729999999999997 111.132 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -62.25 -29.86 70.7 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.398 -1.439 . . . . 32.810000000000002 112.198 175.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1050 ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -62.52 -50.01 73.08 Favored 'General case' 0 C--O 1.255 1.352 0 C-N-CA 120.246 -0.581 . . . . 31.859999999999999 112.494 169.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 11.0 t -62.95 -42.45 96.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 O-C-N 121.101 -0.999 . . . . 33.219999999999999 109.289 -176.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -51.01 -44.87 61.04 Favored 'General case' 0 C--O 1.256 1.434 0 C-N-CA 125.212 1.405 . . . . 50.829999999999998 110.599 172.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -65.87 -44.82 84.27 Favored 'General case' 0 C--O 1.246 0.91 0 CA-C-O 124.819 2.247 . . . . 33.119999999999997 113.016 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 147.56 33.88 0.06 OUTLIER Glycine 0 N--CA 1.464 0.511 0 CA-C-N 113.141 -1.845 . . . . 35.829999999999998 114.553 -177.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -111.04 139.37 46.46 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-N 118.66 1.23 . . . . 34.82 110.138 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -84.09 121.56 27.59 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 103.297 -2.853 . . . . 49.049999999999997 103.297 167.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1057 ' ' ILE . . . . . . . . . . . . . 26.2 mm -85.32 122.49 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 O-C-N 118.105 -2.872 . . . . 38.530000000000001 108.807 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1058 ' ' VAL . . . . . . . . . . . . . 12.0 m -122.31 147.05 26.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 105.4 -2.074 . . . . 42.109999999999999 105.4 -173.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -121.4 135.01 55.11 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 126.026 2.822 . . . . 58.0 111.632 -171.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 57.3 -141.9 43.32 Favored Glycine 0 N--CA 1.465 0.616 0 CA-C-N 110.451 -3.068 . . . . 52.119999999999997 113.444 -176.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 1.4 t30 -48.12 -25.34 1.42 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 116.527 2.047 . . . . 54.75 116.527 -176.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1062 ' ' SER . . . . . . . . . . . . . 15.2 m -60.22 -20.73 60.09 Favored 'General case' 0 CA--C 1.552 1.048 0 N-CA-C 114.028 1.122 . . . . 50.340000000000003 114.028 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 14.9 p -70.03 -48.36 63.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 107.309 -1.367 . . . . 41.460000000000001 107.309 169.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1064 ' ' TRP . . . . . . . . . . . . . 75.4 m95 -65.34 -30.73 71.6 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 124.397 1.079 . . . . 39.32 110.907 -172.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.43 81.05 4.79 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 113.489 -1.687 . . . . 55.380000000000003 109.427 172.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1066 ' ' SER . . . . . . . . . . . . . 68.5 m -145.72 -178.91 6.34 Favored 'General case' 0 C--O 1.242 0.67 0 O-C-N 120.431 -1.418 . . . . 41.869999999999997 111.128 172.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -69.77 -62.81 1.23 Allowed 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.183 -1.414 . . . . 53.200000000000003 107.183 174.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 5.3 mp -107.56 142.17 20.94 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 N-CA-C 105.482 -2.044 . . . . 41.899999999999999 105.482 -178.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1069 ' ' ILE . . . . . . . . . . . . . 5.4 mm -124.38 121.28 61.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 104.177 -2.527 . . . . 38.729999999999997 104.177 168.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1070 ' ' LEU . . . . . . . . . . . . . 77.2 mt -98.74 87.05 3.67 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 104.302 -2.481 . . . . 32.439999999999998 104.302 172.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1071 ' ' LYS . . . . . 0.462 ' HZ1' ' CD ' ' A' 1008 ' ' GLU . 1.1 mmmt -83.59 162.09 20.94 Favored 'General case' 0 C--O 1.257 1.48 0 N-CA-C 105.403 -2.073 . . . . 34.649999999999999 105.403 167.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1072 ' ' VAL . . . . . . . . . . . . . 18.8 t -88.18 -86.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.705 0 C-N-CA 119.588 -0.845 . . . . 31.32 110.844 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -84.4 151.89 24.39 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.133 -1.432 . . . . 33.939999999999998 107.133 -170.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -33.92 120.29 0.5 Allowed Pre-proline 0 C--O 1.253 1.271 0 C-N-CA 125.084 1.353 . . . . 38.039999999999999 114.646 170.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1075 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -56.81 128.2 28.97 Favored 'Trans proline' 0 N--CA 1.441 -1.579 0 C-N-CA 125.074 3.85 . . . . 42.68 114.887 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 33.0 mt -72.88 158.25 35.87 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 120.712 -1.242 . . . . 46.740000000000002 108.295 170.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -45.98 -39.63 9.25 Favored 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 118.515 2.783 . . . . 58.609999999999999 118.515 -176.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 15.7 t70 -61.98 -48.71 79.12 Favored 'General case' 0 C--N 1.352 0.686 0 CA-C-N 119.144 0.884 . . . . 59.200000000000003 109.706 173.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1079 ' ' GLU . . . . . 0.433 ' CD ' ' HZ2' ' A' 1071 ' ' LYS . 35.5 mt-10 -62.88 -32.42 73.66 Favored 'General case' 0 C--O 1.259 1.559 0 CA-C-N 114.024 -1.444 . . . . 50.630000000000003 109.109 -178.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1080 ' ' ILE . . . . . . . . . . . . . 73.7 mt -62.88 -44.51 99.64 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-N 118.899 0.772 . . . . 51.479999999999997 109.59 173.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -62.53 -26.22 68.44 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 119.789 -1.82 . . . . 50.280000000000001 112.321 175.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 15.7 mt -80.96 -24.33 38.16 Favored 'General case' 0 C--O 1.25 1.102 0 O-C-N 119.339 -2.1 . . . . 50.210000000000001 112.206 174.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1083 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.22 120.26 10.01 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 124.477 2.084 . . . . 49.060000000000002 111.501 176.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -82.99 134.81 45.82 Favored Pre-proline 0 CA--C 1.515 -0.385 0 CA-C-N 112.483 -2.144 . . . . 51.079999999999998 111.756 -167.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -48.96 113.18 0.81 Allowed 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 125.106 3.871 . . . . 49.729999999999997 119.159 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 104.31 -27.16 20.41 Favored Glycine 0 N--CA 1.436 -1.309 0 O-C-N 124.9 1.375 . . . . 47.710000000000001 114.021 177.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1087 ' ' THR . . . . . . . . . . . . . 39.4 m -49.92 128.87 19.45 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 118.316 2.71 . . . . 45.469999999999999 118.316 -174.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1088 ' ' THR . . . . . . . . . . . . . 41.2 m -68.77 88.86 0.38 Allowed 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 123.354 1.549 . . . . 42.039999999999999 113.047 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1089 ' ' LEU . . . . . . . . . . . . . 57.2 tp -83.43 98.32 9.44 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 104.291 -2.485 . . . . 38.060000000000002 104.291 -176.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 45.5 t -96.49 109.37 22.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 104.719 -2.326 . . . . 37.399999999999999 104.719 175.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1091 ' ' SER . . . . . . . . . . . . . 13.4 m -152.26 162.91 40.45 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 116.537 2.051 . . . . 36.159999999999997 116.537 -175.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 51.4 t80 -74.33 79.42 1.85 Allowed 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 123.133 1.444 . . . . 38.939999999999998 107.652 170.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 21.8 mm -82.27 -42.72 18.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 126.571 1.948 . . . . 42.170000000000002 114.966 -168.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 2.9 m95 66.67 60.57 0.94 Allowed Pre-proline 0 N--CA 1.436 -1.175 0 C-N-CA 125.113 1.365 . . . . 46.509999999999998 114.625 -174.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.43 -33.44 92.1 Favored 'Trans proline' 0 C--O 1.253 1.269 0 C-N-CA 124.87 3.713 . . . . 49.759999999999998 114.319 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -60.65 -51.8 67.86 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.118 -1.401 . . . . 52.619999999999997 111.61 174.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -78.96 -14.4 59.23 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 115.32 1.6 . . . . 60.740000000000002 115.32 177.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1098 ' ' ASN . . . . . . . . . . . . . 43.6 m-20 -125.36 65.91 51.85 Favored Pre-proline 0 N--CA 1.441 -0.901 0 N-CA-C 115.765 1.765 . . . . 58.189999999999998 115.765 -173.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -66.24 -41.6 12.28 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.715 2.944 . . . . 54.590000000000003 113.308 -175.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.23 -42.09 85.54 Favored 'General case' 0 C--O 1.253 1.237 0 CA-C-O 123.335 1.54 . . . . 63.280000000000001 112.696 176.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1101 ' ' LEU . . . . . . . . . . . . . 21.3 tp -55.78 -37.03 68.03 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 113.162 -1.835 . . . . 54.75 109.928 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1102 ' ' MET . . . . . . . . . . . . . 82.3 mmm -61.06 -45.3 95.34 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 108.667 -0.864 . . . . 52.649999999999999 108.667 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -64.8 -45.0 88.11 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-N 114.642 -1.163 . . . . 66.260000000000005 112.197 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 95.0 mttt -61.62 -41.84 98.04 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 123.132 1.444 . . . . 63.729999999999997 110.352 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 95.8 mt -74.83 -35.5 62.41 Favored 'General case' 0 C--O 1.246 0.884 0 O-C-N 118.485 -2.635 . . . . 54.68 109.227 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -62.84 -38.87 92.51 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 117.427 -1.273 . . . . 53.640000000000001 109.953 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -60.67 -41.19 94.57 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 124.277 0.985 . . . . 67.239999999999995 110.671 169.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 12.0 mmt85 -76.28 -0.05 21.02 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 114.281 1.215 . . . . 65.760000000000005 114.281 173.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 35.7 t30 61.22 15.22 6.2 Favored 'General case' 0 C--N 1.346 0.422 0 N-CA-C 114.431 1.271 . . . . 58.710000000000001 114.431 175.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1110 ' ' VAL . . . . . . . . . . . . . 29.8 m -79.39 132.97 30.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 O-C-N 120.111 -1.618 . . . . 46.630000000000003 108.623 -169.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1111 ' ' THR . . . . . . . . . . . . . 56.5 m -74.72 93.91 2.64 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.509 0.671 . . . . 44.130000000000003 110.02 -176.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1112 ' ' VAL . . . . . . . . . . . . . 38.9 t -92.84 115.97 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 123.874 1.797 . . . . 40.439999999999998 111.376 -170.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1113 ' ' MET . . . . . . . . . . . . . 73.9 mtp -107.86 105.93 15.97 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 104.525 -2.398 . . . . 50.759999999999998 104.525 173.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1114 ' ' ALA . . . . . . . . . . . . . . . -86.63 109.07 18.91 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.399 -0.819 . . . . 35.640000000000001 111.608 -177.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1115 ' ' MET . . . . . . . . . . . . . 90.9 mmm -66.19 -21.59 66.32 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 115.929 1.826 . . . . 38.740000000000002 115.929 -175.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -73.09 -32.84 65.23 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 114.234 -1.348 . . . . 40.140000000000001 109.948 169.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1117 ' ' SER . . . . . . . . . . . . . 29.5 m -82.97 13.19 4.13 Favored 'General case' 0 C--O 1.244 0.772 0 O-C-N 119.777 -1.827 . . . . 44.789999999999999 114.937 -175.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1118 ' ' VAL . . . . . . . . . . . . . 12.0 t -64.14 124.3 85.0 Favored Pre-proline 0 N--CA 1.484 1.26 0 CA-C-O 117.246 -1.359 . . . . 43.75 107.426 169.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -55.88 134.64 65.31 Favored 'Trans proline' 0 C--O 1.242 0.698 0 C-N-CA 124.93 3.753 . . . . 48.93 110.745 173.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 41.8 mmm-85 -69.12 17.56 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 120.018 3.34 . . . . 62.899999999999999 120.018 -163.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 26.9 pt -85.67 171.46 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 C-N-CA 123.344 0.658 . . . . 57.719999999999999 112.562 -165.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1122 ' ' SER . . . . . . . . . . . . . 1.1 p -51.48 -53.79 33.68 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 118.822 -2.424 . . . . 57.259999999999998 114.743 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -64.58 -2.19 2.24 Favored 'General case' 0 C--O 1.248 0.997 0 CA-C-N 121.359 1.89 . . . . 62.899999999999999 115.875 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -106.41 -11.68 15.88 Favored 'General case' 0 C--O 1.2 -1.521 0 CA-C-O 116.381 -1.771 . . . . 49.829999999999998 114.198 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -57.99 -29.36 65.19 Favored 'General case' 0 CA--C 1.488 -1.415 0 N-CA-C 115.628 1.714 . . . . 52.369999999999997 115.628 -170.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1126 ' ' SER . . . . . . . . . . . . . 64.0 p -65.16 -41.14 94.98 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 115.102 1.519 . . . . 42.43 115.102 169.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1127 ' ' LEU . . . . . . . . . . . . . 1.6 mp -81.43 -28.44 34.24 Favored 'General case' 0 C--O 1.208 -1.096 0 CA-C-N 115.492 -0.777 . . . . 43.740000000000002 111.013 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 61.3 t0 -67.88 101.11 1.03 Allowed 'General case' 0 N--CA 1.439 -0.985 0 O-C-N 119.699 -1.876 . . . . 43.210000000000001 110.063 -164.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -74.2 -34.23 63.66 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.963 -0.562 . . . . 35.740000000000002 109.977 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.16 -26.81 66.6 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 119.029 -2.294 . . . . 38.090000000000003 108.627 177.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1131 ' ' SER . . . . . . . . . . . . . 61.9 m -84.92 -56.34 3.62 Favored 'General case' 0 C--O 1.216 -0.677 0 O-C-N 120.928 -1.107 . . . . 36.909999999999997 110.441 168.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1132 ' ' SER . . . . . . . . . . . . . 13.8 m -73.17 -43.72 61.04 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 116.854 2.168 . . . . 35.789999999999999 116.854 -168.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1133 ' ' MET . . . . . . . . . . . . . 53.1 mtp -57.55 -45.45 85.08 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 122.463 1.125 . . . . 30.809999999999999 113.103 169.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1134 ' ' ALA . . . . . . . . . . . . . . . -57.03 -39.17 74.27 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 112.91 -1.95 . . . . 28.879999999999999 111.144 170.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1135 ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -58.54 -51.59 69.25 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 120.389 -1.444 . . . . 40.759999999999998 113.743 175.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1136 ' ' ILE . . . . . . . . . . . . . 14.6 mt -52.34 -46.68 46.35 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 CA-C-O 118.163 -0.923 . . . . 31.539999999999999 108.977 172.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -67.02 -27.11 67.14 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 124.925 1.29 . . . . 29.870000000000001 113.6 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -74.61 -44.2 27.11 Favored Glycine 0 C--N 1.313 -0.713 0 O-C-N 120.865 -1.147 . . . . 28.73 110.812 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 16.1 t80 -61.85 -46.34 89.88 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.206 -1.173 . . . . 30.390000000000001 108.506 171.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1140 ' ' ARG . . . . . 0.413 ' NH2' ' O ' ' B' 1147 ' ' HIS . 5.6 tpt180 -63.33 -29.75 71.0 Favored 'General case' 0 CA--C 1.493 -1.229 0 O-C-N 121.339 -0.851 . . . . 26.09 112.427 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1141 ' ' ALA . . . . . . . . . . . . . . . -63.29 -43.68 97.19 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 119.905 -1.747 . . . . 27.100000000000001 110.674 173.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 47.1 mm -54.3 -45.64 68.3 Favored 'Isoleucine or valine' 0 C--N 1.347 0.488 0 O-C-N 120.693 -1.255 . . . . 28.48 111.77 168.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 25.1 t -62.38 -55.26 25.1 Favored 'Isoleucine or valine' 0 C--O 1.252 1.223 0 CA-C-O 115.88 -2.01 . . . . 23.07 114.243 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1144 ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -70.19 -22.36 62.95 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 123.563 2.892 . . . . 33.399999999999999 110.159 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -63.61 -56.33 16.71 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 119.458 -0.897 . . . . 24.219999999999999 109.708 167.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -59.28 -21.33 59.49 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-O 117.871 -1.061 . . . . 24.890000000000001 112.496 174.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -66.35 -41.51 89.44 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 120.59 1.541 . . . . 26.73 111.691 169.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1148 ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -105.98 -2.62 22.63 Favored 'General case' 0 C--O 1.252 1.207 0 N-CA-C 114.991 1.478 . . . . 39.960000000000001 114.991 -176.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1149 ' ' PHE . . . . . . . . . . . . . 1.3 t80 -70.18 149.03 47.95 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 116.167 -0.469 . . . . 25.870000000000001 111.546 -178.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1150 ' ' GLY . . . . . . . . . . . . . . . -75.71 -49.9 8.51 Favored Glycine 0 N--CA 1.43 -1.702 0 CA-C-N 114.479 -1.237 . . . . 19.280000000000001 113.616 172.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1151 ' ' ARG . . . . . . . . . . . . . 29.1 mtm-85 -97.94 170.68 8.78 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-O 123.308 1.527 . . . . 39.899999999999999 113.865 -168.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1152 ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -72.97 142.63 47.79 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.46 -0.941 . . . . 29.440000000000001 108.46 166.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1153 ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -58.03 -46.87 84.63 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 114.528 1.307 . . . . 32.600000000000001 114.528 168.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1154 ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -72.29 145.92 47.53 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 125.068 1.347 . . . . 34.640000000000001 109.215 -178.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -77.88 65.99 3.15 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 119.214 -2.179 . . . . 37.140000000000001 108.272 169.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -92.1 136.38 33.22 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 107.772 -1.196 . . . . 40.57 107.772 -167.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1157 ' ' ILE . . . . . . . . . . . . . 3.8 tp -96.16 135.58 29.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 105.075 -2.194 . . . . 44.609999999999999 105.075 163.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1158 ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.65 -123.72 0.1 Allowed 'General case' 0 C--O 1.242 0.696 0 CA-C-O 117.171 -1.395 . . . . 40.700000000000003 112.435 173.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -84.18 -45.71 12.65 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 122.034 2.197 . . . . 40.25 106.94 160.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -126.13 153.53 44.42 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 113.261 -1.791 . . . . 38.469999999999999 107.704 170.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . 87.26 103.95 0.85 Allowed Glycine 0 CA--C 1.496 -1.099 0 C-N-CA 119.632 -1.27 . . . . 37.609999999999999 113.559 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1162 ' ' LYS . . . . . 0.488 ' HZ3' ' CD ' ' C' ' 95' ' ' GLU . 1.5 tmtp? -102.53 122.05 43.58 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 126.642 2.025 . . . . 48.899999999999999 106.026 171.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1163 ' ' VAL . . . . . . . . . . . . . 45.8 t -82.0 133.67 51.0 Favored Pre-proline 0 C--O 1.247 0.943 0 CA-C-O 117.451 -1.262 . . . . 36.520000000000003 109.438 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1164 ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -73.3 109.49 2.85 Favored 'Trans proline' 0 N--CA 1.43 -2.248 0 CA-C-N 124.326 2.581 . . . . 35.079999999999998 109.739 160.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1165 ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -50.96 161.74 1.34 Allowed 'Trans proline' 0 N--CA 1.483 0.865 1 C-N-CA 125.957 4.438 . . . . 35.329999999999998 118.696 -169.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -74.54 122.04 22.48 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.863 -1.162 . . . . 34.689999999999998 107.863 -176.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1167 ' ' LYS . . . . . . . . . . . . . 76.6 mttt -88.2 104.99 17.23 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-O 124.007 1.86 . . . . 45.359999999999999 106.628 166.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 58.7 t -94.58 89.99 2.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 113.681 -1.6 . . . . 31.710000000000001 108.259 -175.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1169 ' ' MET . . . . . . . . . . . . . 5.6 ttp -77.9 92.1 4.24 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 113.407 -1.724 . . . . 42.280000000000001 111.828 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 81.0 t -88.79 112.5 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 106.146 -1.798 . . . . 30.510000000000002 106.146 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 57.7 mt -98.24 123.1 50.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 109.631 -0.507 . . . . 31.870000000000001 109.631 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 77.13 81.58 0.6 Allowed Glycine 0 N--CA 1.436 -1.346 0 CA-C-O 122.77 1.206 . . . . 34.539999999999999 113.716 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1173 ' ' ALA . . . . . . . . . . . . . . . -82.07 80.05 8.42 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 111.773 -2.214 . . . . 32.509999999999998 109.212 -172.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -85.09 -157.0 27.14 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 108.056 -2.018 . . . . 29.899999999999999 108.056 163.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1175 ' ' VAL . . . . . . . . . . . . . 67.2 t -74.02 -26.9 21.54 Favored 'Isoleucine or valine' 0 C--O 1.259 1.598 0 CA-C-N 120.378 2.089 . . . . 33.109999999999999 108.765 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -50.22 -47.27 54.95 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.596 0.712 . . . . 28.100000000000001 112.623 162.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -61.25 -52.21 53.18 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 113.475 -1.693 . . . . 28.539999999999999 110.115 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1178 ' ' LEU . . . . . . . . . . . . . 94.3 mt -53.14 -43.89 67.33 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 118.923 1.361 . . . . 31.219999999999999 113.177 178.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -66.47 -34.75 78.62 Favored 'General case' 0 C--O 1.245 0.822 0 O-C-N 118.088 -2.883 . . . . 28.98 114.115 174.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -65.62 -45.74 81.96 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.069 0.85 . . . . 27.829999999999998 109.498 176.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1181 ' ' ILE . . . . . . . . . . . . . 55.6 mt -59.33 -52.68 58.04 Favored 'Isoleucine or valine' 0 C--N 1.349 0.561 0 C-N-CA 124.571 1.148 . . . . 30.25 109.89 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -51.67 -54.88 22.85 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 125.735 1.636 . . . . 29.59 110.53 176.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -65.26 -43.23 91.94 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 114.176 1.176 . . . . 30.289999999999999 114.176 -175.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -68.96 -43.56 74.76 Favored 'General case' 0 N--CA 1.425 -1.699 0 C-N-CA 123.771 0.828 . . . . 30.469999999999999 109.404 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -64.76 -35.61 81.63 Favored 'General case' 0 C--O 1.243 0.755 0 O-C-N 120.693 -1.254 . . . . 42.409999999999997 109.376 173.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1186 ' ' SER . . . . . . . . . . . . . 72.9 m -60.25 -36.95 78.95 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 121.509 1.959 . . . . 39.380000000000003 112.354 169.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 89.4 mt -82.18 18.68 1.33 Allowed 'General case' 0 C--O 1.244 0.791 0 CA-C-N 120.361 1.437 . . . . 36.18 114.001 169.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 78.93 2.35 86.46 Favored Glycine 0 N--CA 1.47 0.952 0 CA-C-N 119.876 1.217 . . . . 33.780000000000001 115.003 170.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -73.34 151.14 41.38 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 124.106 0.962 . . . . 33.93 113.009 -175.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 18.5 mt -86.36 101.67 10.89 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 N-CA-C 103.153 -2.906 . . . . 38.740000000000002 103.153 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 3.0 t -86.99 127.78 40.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 112.921 -1.945 . . . . 33.090000000000003 107.231 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1192 ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -119.85 107.33 13.02 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 106.761 -1.57 . . . . 38.920000000000002 106.761 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -108.39 121.75 45.57 Favored 'General case' 0 C--O 1.248 0.982 0 O-C-N 120.626 -1.297 . . . . 35.32 109.571 -174.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 75.5 t80 -93.85 147.73 22.8 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 105.517 -2.031 . . . . 39.350000000000001 105.517 169.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 7.2 t70 -149.29 157.41 43.32 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 105.874 -1.899 . . . . 40.460000000000001 105.874 154.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1196 ' ' THR . . . . . . . . . . . . . 2.7 m -67.08 -43.39 82.71 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 104.962 -2.236 . . . . 45.939999999999998 104.962 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1197 ' ' ARG . . . . . . . . . . . . . 72.4 mtm180 -72.48 116.69 52.06 Favored Pre-proline 0 N--CA 1.453 -0.322 0 O-C-N 120.966 -1.084 . . . . 56.020000000000003 111.721 -175.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1198 ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -62.05 -26.94 78.78 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 125.244 3.963 . . . . 51.270000000000003 116.826 175.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -54.23 -34.65 61.18 Favored 'General case' 0 C--O 1.248 1.023 0 CA-C-N 114.557 -1.201 . . . . 59.100000000000001 112.598 -176.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 34.6 m -75.35 -10.7 13.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 117.23 2.307 . . . . 51.060000000000002 117.23 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1201 ' ' LYS . . . . . 0.516 ' HZ1' ' CD ' ' A' 1213 ' ' GLU . 83.3 tttt -51.2 -46.21 62.1 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 124.709 1.204 . . . . 57.380000000000003 111.852 -176.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -72.99 -29.79 63.31 Favored 'General case' 0 CA--C 1.512 -0.482 0 O-C-N 120.472 -1.393 . . . . 62.409999999999997 109.845 -173.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -66.3 -42.46 88.27 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.294 -1.373 . . . . 57.780000000000001 107.294 173.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 5.3 t -60.93 -50.23 81.41 Favored 'Isoleucine or valine' 0 C--N 1.344 0.357 0 C-N-CA 124.928 1.291 . . . . 46.380000000000003 109.141 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -56.54 -44.59 81.02 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 114.421 1.267 . . . . 50.700000000000003 114.421 173.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1206 ' ' SER . . . . . . . . . . . . . 48.7 m -58.44 -34.91 71.34 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.028 1.492 . . . . 49.979999999999997 115.028 174.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1207 ' ' MET . . . . . . . . . . . . . 61.4 mtp -92.54 11.02 27.83 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 119.759 -1.838 . . . . 52.990000000000002 111.08 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 78.28 51.19 5.81 Favored Glycine 0 CA--C 1.549 2.218 0 CA-C-O 124.39 2.106 . . . . 47.659999999999997 111.481 168.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -129.67 143.3 50.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 113.059 -1.57 . . . . 44.770000000000003 114.19 171.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -69.84 132.5 46.12 Favored 'General case' 0 C--N 1.347 0.468 0 N-CA-C 105.957 -1.868 . . . . 47.640000000000001 105.957 167.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1211 ' ' PHE . . . . . . . . . . . . . 26.5 t80 -86.76 134.32 33.58 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 104.739 -2.319 . . . . 45.659999999999997 104.739 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 51.7 mt -84.93 109.09 17.9 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 123.719 1.724 . . . . 46.060000000000002 108.41 165.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1213 ' ' GLU . . . . . 0.516 ' CD ' ' HZ1' ' A' 1201 ' ' LYS . 1.9 mm-40 -79.32 145.23 33.57 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 113.703 -1.589 . . . . 60.219999999999999 109.414 -175.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 9.2 tp -79.94 85.36 5.57 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 124.369 2.033 . . . . 57.25 108.953 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 12.3 t70 -76.71 111.89 12.71 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 110.978 -2.828 . . . . 64.430000000000007 104.696 -176.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 33.4 t80 . . . . . 0 CA--C 1.516 -0.362 0 N-CA-C 107.765 -1.198 . . . . 66.900000000000006 107.765 -175.257 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 2.2 p-10 . . . . . 0 N--CA 1.446 -0.663 0 CA-C-O 120.954 0.407 . . . . 39.090000000000003 110.978 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -42.26 -57.07 3.81 Favored Glycine 0 C--O 1.208 -1.492 0 O-C-N 126.427 2.329 . . . . 39.32 113.912 175.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 79.0 t80 -60.9 -47.89 84.34 Favored 'General case' 0 N--CA 1.44 -0.955 0 O-C-N 120.98 -1.306 . . . . 39.299999999999997 110.739 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -63.07 -35.98 82.05 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 120.645 -1.284 . . . . 36.299999999999997 114.42 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -65.4 -59.83 3.61 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 117.695 -1.145 . . . . 37.380000000000003 110.476 176.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -54.23 -47.78 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 121.065 1.757 . . . . 39.109999999999999 114.047 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1230 ' ' MET . . . . . . . . . . . . . 20.3 mmt -90.21 68.61 7.06 Favored 'General case' 0 C--O 1.247 0.933 0 CA-C-O 123.094 1.426 . . . . 49.590000000000003 112.708 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1231 ' ' SER . . . . . . . . . . . . . 1.9 p -142.43 132.69 24.79 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.222 -1.399 . . . . 43.68 107.222 165.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -49.08 -42.37 38.6 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 116.426 2.01 . . . . 55.57 116.426 -172.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -59.57 -39.02 82.72 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 119.109 0.868 . . . . 44.939999999999998 113.158 174.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -55.0 -60.59 3.16 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 114.435 1.272 . . . . 42.039999999999999 114.435 170.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 59.3 mt -57.89 -42.41 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 124.425 2.059 . . . . 46.280000000000001 109.854 -176.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 45.2 tttm -50.86 -53.12 35.07 Favored 'General case' 0 C--O 1.25 1.095 0 CA-C-N 113.289 -1.778 . . . . 47.869999999999997 114.15 166.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -63.47 -33.41 75.51 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 120.419 1.463 . . . . 41.609999999999999 110.703 -176.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -55.13 -59.66 4.46 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 124.883 1.273 . . . . 50.649999999999999 107.708 169.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1239 ' ' MET . . . . . . . . . . . . . 32.7 mtm -56.31 -31.69 63.93 Favored 'General case' 0 C--O 1.238 0.498 0 O-C-N 120.135 -1.603 . . . . 48.869999999999997 113.368 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -64.54 -39.72 94.28 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 112.166 0.432 . . . . 54.799999999999997 112.166 175.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 1.6 mm? -65.6 -46.24 80.12 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 120.598 -1.314 . . . . 43.210000000000001 108.738 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -64.0 -34.38 77.86 Favored 'General case' 0 CA--C 1.508 -0.666 0 O-C-N 126.922 2.639 . . . . 38.659999999999997 112.635 -168.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -59.19 -54.12 50.54 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 120.403 1.456 . . . . 37.920000000000002 113.394 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -67.23 -42.94 83.18 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 119.803 1.183 . . . . 37.280000000000001 110.242 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -54.19 -40.97 68.07 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 121.383 -0.823 . . . . 43.07 112.297 177.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -55.49 -37.08 67.37 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.076 0.95 . . . . 38.299999999999997 112.172 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1247 ' ' LYS . . . . . . . . . . . . . 12.8 ttmm -54.9 -35.93 64.64 Favored 'General case' 0 C--O 1.258 1.517 0 C-N-CA 125.115 1.366 . . . . 47.600000000000001 110.905 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -111.24 -20.29 12.37 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.477 1.288 . . . . 45.420000000000002 114.477 -175.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1249 ' ' VAL . . . . . . . . . . . . . 31.2 m -78.27 162.63 4.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 115.303 1.594 . . . . 36.259999999999998 115.303 -173.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1250 ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -109.42 -60.47 1.77 Allowed 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 115.076 -0.965 . . . . 33.039999999999999 111.381 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1251 ' ' ILE . . . . . . . . . . . . . 36.1 mm -112.76 102.08 13.43 Favored 'Isoleucine or valine' 0 C--O 1.247 0.934 0 N-CA-C 105.709 -1.96 . . . . 31.399999999999999 105.709 -170.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1252 ' ' ILE . . . . . . . . . . . . . 64.9 mt -80.63 117.15 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 104.354 -2.462 . . . . 29.420000000000002 104.354 167.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 18.2 t -103.92 109.75 28.14 Favored 'Isoleucine or valine' 0 C--O 1.248 0.985 0 N-CA-C 100.694 -3.817 . . . . 30.370000000000001 100.694 175.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1254 ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.53 82.4 5.34 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 124.904 2.287 . . . . 35.719999999999999 110.65 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1255 ' ' THR . . . . . . . . . . . . . 1.1 p -86.29 -16.95 35.93 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 112.09 -2.323 . . . . 36.0 115.112 -174.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1256 ' ' ALA . . . . . . . . . . . . . . . -57.81 64.45 0.0 OUTLIER 'General case' 0 C--O 1.261 1.675 0 N-CA-C 116.927 2.195 . . . . 40.93 116.927 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 44.4 tp -83.67 101.14 11.32 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 124.356 2.027 . . . . 47.82 110.369 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 32.8 mm -82.51 120.99 77.87 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-N 111.883 -2.417 . . . . 52.700000000000003 108.24 173.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -72.79 148.7 46.81 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 124.887 3.724 . . . . 54.130000000000003 111.366 175.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 74.69 -88.8 0.74 Allowed Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.699 -0.96 . . . . 54.619999999999997 110.699 176.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 41.1 mttt -56.78 124.93 66.63 Favored Pre-proline 0 CA--C 1.55 0.946 0 O-C-N 121.288 -1.125 . . . . 55.740000000000002 108.194 173.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -57.76 135.31 68.4 Favored 'Trans proline' 0 CA--C 1.521 -0.142 0 C-N-CA 123.306 2.671 . . . . 51.149999999999999 109.483 177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -57.53 130.59 81.44 Favored Pre-proline 0 N--CA 1.482 1.14 0 O-C-N 124.049 0.843 . . . . 46.060000000000002 110.042 -178.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -60.01 143.74 99.54 Favored 'Trans proline' 0 C--O 1.242 0.679 0 C-N-CA 124.187 3.258 . . . . 41.079999999999998 117.17 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -79.65 85.54 5.36 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-O 124.423 2.058 . . . . 47.420000000000002 106.684 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 74.0 mt -84.43 -42.17 15.9 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 109.378 -3.555 . . . . 39.219999999999999 108.848 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 4.0 mp -99.07 108.76 22.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.842 0 N-CA-C 102.242 -3.244 . . . . 42.5 102.242 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1268 ' ' THR . . . . . . . . . . . . . 27.1 p -80.2 163.23 24.2 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 113.931 -1.486 . . . . 37.840000000000003 114.31 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 59.2 mtt-85 -58.27 -39.72 79.98 Favored 'General case' 0 C--O 1.212 -0.921 0 CA-C-N 115.883 -0.599 . . . . 54.799999999999997 110.487 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -60.15 -53.72 54.33 Favored 'General case' 0 N--CA 1.426 -1.654 0 O-C-N 124.851 1.344 . . . . 54.359999999999999 109.443 174.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1271 ' ' MET . . . . . . . . . . . . . 42.1 ttm -58.04 -37.46 74.4 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.087 0.955 . . . . 39.520000000000003 113.423 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1272 ' ' VAL . . . . . . . . . . . . . 13.5 t -67.45 -48.48 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 108.72 -0.844 . . . . 38.25 108.72 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.89 -29.18 70.03 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.491 0.922 . . . . 40.770000000000003 113.491 175.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1274 ' ' SER . . . . . . . . . . . . . 28.6 m -73.94 -12.43 60.65 Favored 'General case' 0 C--O 1.256 1.395 0 O-C-N 120.863 -1.148 . . . . 36.579999999999998 113.81 173.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1275 ' ' MET . . . . . . . . . . . . . 70.3 mtp -63.16 155.77 27.11 Favored 'General case' 0 C--O 1.245 0.854 0 O-C-N 119.084 -2.26 . . . . 36.75 113.601 -177.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1276 ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -61.21 133.52 56.03 Favored 'General case' 0 C--N 1.347 0.471 0 N-CA-C 106.596 -1.631 . . . . 46.109999999999999 106.596 171.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1277 ' ' ALA . . . . . . . . . . . . . . . -71.29 175.15 5.6 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 122.441 1.115 . . . . 33.520000000000003 112.978 -172.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 67.34 28.16 73.62 Favored Glycine 0 C--O 1.22 -0.76 0 O-C-N 120.907 -1.12 . . . . 31.27 111.932 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1279 ' ' SER . . . . . . . . . . . . . 50.4 m -125.75 170.2 11.81 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.389 -1.065 . . . . 32.950000000000003 112.097 -165.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1280 ' ' VAL . . . . . . . . . . . . . 65.2 t -130.82 133.45 63.16 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 O-C-N 119.472 -2.017 . . . . 27.43 108.66 -167.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1281 ' ' ILE . . . . . . . . . . . . . 48.4 mt -110.98 100.75 11.41 Favored 'Isoleucine or valine' 0 C--O 1.251 1.179 0 N-CA-C 103.624 -2.732 . . . . 30.300000000000001 103.624 166.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.64 97.82 7.67 Favored 'Isoleucine or valine' 0 C--O 1.249 1.065 0 N-CA-C 107.108 -1.441 . . . . 28.629999999999999 107.108 176.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 4.4 t70 -86.95 108.72 18.94 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 106.819 -1.549 . . . . 36.270000000000003 106.819 -173.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1284 ' ' LEU . . . . . . . . . . . . . 9.6 tt -80.14 -35.62 36.4 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.88 0.847 . . . . 38.57 109.207 171.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -63.57 -12.71 35.02 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.497 -0.774 . . . . 37.560000000000002 112.765 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . -41.04 -29.51 0.11 Allowed 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 117.011 2.226 . . . . 40.329999999999998 117.011 162.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -51.19 -40.55 58.91 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-O 117.978 -1.01 . . . . 56.850000000000001 110.8 171.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 48.4 t30 -141.45 96.25 2.95 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 118.976 0.807 . . . . 45.859999999999999 110.1 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 92.28 -59.8 2.64 Favored Glycine 0 C--N 1.348 1.196 0 O-C-N 120.305 -1.497 . . . . 40.310000000000002 112.607 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 81.63 128.93 1.03 Allowed Glycine 0 N--CA 1.471 0.975 0 CA-C-N 120.485 2.143 . . . . 38.890000000000001 114.053 -171.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1291 ' ' ASN . . . . . . . . . . . . . 20.3 m120 -82.02 -22.51 36.43 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 116.311 1.967 . . . . 37.229999999999997 116.311 -170.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1292 ' ' CYS . . . . . . . . . . . . . 29.6 t -94.29 144.36 25.59 Favored 'General case' 0 C--O 1.252 1.228 0 N-CA-C 102.461 -3.163 . . . . 36.5 102.461 174.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1293 ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -64.96 -51.46 61.69 Favored 'General case' 0 CA--C 1.56 1.336 0 CA-C-O 122.811 1.291 . . . . 43.32 107.868 172.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -54.78 -18.68 5.06 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 119.916 3.302 . . . . 41.32 119.916 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1295 ' ' THR . . . . . . . . . . . . . 58.4 m -49.75 103.97 0.06 Allowed 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 122.423 1.106 . . . . 35.299999999999997 112.77 167.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 94.6 t -86.1 121.29 72.8 Favored Pre-proline 0 C--O 1.246 0.887 0 N-CA-C 100.913 -3.736 . . . . 34.840000000000003 100.913 164.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -65.49 125.09 13.82 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.855 2.37 . . . . 33.509999999999998 107.597 -176.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 93.42 -3.23 71.84 Favored Glycine 0 N--CA 1.433 -1.556 0 CA-C-O 117.777 -1.568 . . . . 32.189999999999998 113.699 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -130.46 172.28 12.06 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 123.656 3.728 . . . . 34.880000000000003 117.206 -177.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1300 ' ' ILE . . . . . . . . . . . . . 59.3 mt -98.72 98.17 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 101.744 -3.428 . . . . 32.289999999999999 101.744 170.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 61.9 t80 -71.99 148.56 45.82 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 103.905 -2.628 . . . . 37.25 103.905 161.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1302 ' ' THR . . . . . . . . . . . . . 86.4 m -132.46 141.67 48.92 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 105.644 -1.984 . . . . 35.560000000000002 105.644 169.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1303 ' ' THR . . . . . . . . . . . . . 16.8 p -81.23 163.71 22.81 Favored 'General case' 0 N--CA 1.425 -1.693 0 C-N-CA 125.333 1.453 . . . . 36.399999999999999 109.795 168.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -55.84 -49.66 72.7 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 124.924 1.29 . . . . 52.32 109.568 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 39.4 p-10 -66.44 -19.56 65.83 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.854 1.057 . . . . 40.039999999999999 113.854 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 97.94 63.12 0.88 Allowed Glycine 0 N--CA 1.426 -2.025 0 CA-C-N 113.865 -1.516 . . . . 36.960000000000001 112.036 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1307 ' ' VAL . . . . . . . . . . . . . 45.6 t -118.18 114.5 45.38 Favored 'Isoleucine or valine' 0 C--O 1.251 1.158 0 N-CA-C 108.221 -1.029 . . . . 33.399999999999999 108.221 163.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1308 ' ' LYS . . . . . . . . . . . . . 78.2 mttt -92.75 108.19 19.8 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.943 0.878 . . . . 42.909999999999997 112.686 -171.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 14.0 t -94.62 83.43 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 106.025 -1.842 . . . . 32.289999999999999 106.025 -174.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1310 ' ' ILE . . . . . . . . . . . . . 47.8 mt -80.83 91.33 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.35 0 CA-C-N 110.737 -2.938 . . . . 30.989999999999998 108.648 -173.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -87.47 71.17 2.7 Favored Glycine 0 CA--C 1.537 1.442 0 O-C-N 118.284 -2.76 . . . . 28.949999999999999 112.318 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1312 ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -90.63 93.9 9.46 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 118.815 -1.154 . . . . 31.690000000000001 112.529 -172.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1313 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.53 -36.81 62.18 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 112.985 -1.916 . . . . 34.170000000000002 109.756 172.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 29.1 p-10 -84.74 3.87 35.41 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 118.192 2.664 . . . . 36.859999999999999 118.192 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1315 ' ' LEU . . . . . . . . . . . . . 28.7 mt -37.11 -50.85 2.26 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 118.322 2.712 . . . . 34.850000000000001 118.322 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -53.35 -46.82 31.1 Favored 'Trans proline' 0 C--N 1.355 0.9 0 CA-C-N 125.655 3.056 . . . . 29.149999999999999 112.791 171.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -63.41 -29.89 75.93 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 115.097 0.799 . . . . 27.289999999999999 115.097 -175.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1318 ' ' ARG . . . . . . . . . . . . . 52.3 mtt-85 -65.88 -19.94 66.05 Favored 'General case' 0 C--O 1.255 1.376 0 O-C-N 126.348 1.852 . . . . 41.490000000000002 115.345 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1319 ' ' LEU . . . . . . . . . . . . . 13.3 tp -118.2 72.09 9.23 Favored Pre-proline 0 N--CA 1.438 -1.031 0 N-CA-C 105.232 -2.136 . . . . 27.609999999999999 105.232 178.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1320 ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -56.04 -53.82 4.91 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.571 2.847 . . . . 25.940000000000001 114.698 -164.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1321 ' ' THR . . . . . . . . . . . . . 1.8 m -67.64 -39.52 84.63 Favored 'General case' 0 CA--C 1.499 -0.995 0 O-C-N 119.485 -2.009 . . . . 25.010000000000002 110.41 -168.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1322 ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -68.77 -26.57 65.29 Favored 'General case' 0 CA--C 1.511 -0.519 0 O-C-N 118.19 -2.819 . . . . 29.390000000000001 110.838 176.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1323 ' ' SER . . . . . . . . . . . . . 70.6 m -64.59 -53.11 52.9 Favored 'General case' 0 CA--C 1.501 -0.913 0 O-C-N 119.569 -1.957 . . . . 26.469999999999999 109.91 167.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1324 ' ' SER . . . . . . . . . . . . . 4.6 m -55.66 -27.5 50.28 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.96 0.886 . . . . 27.780000000000001 113.001 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -86.54 -51.68 6.03 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 118.319 -1.352 . . . . 37.530000000000001 110.81 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1326 ' ' LEU . . . . . . . . . . . . . 92.9 mt -79.94 -52.2 8.15 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 118.182 -0.913 . . . . 35.710000000000001 111.261 -172.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1327 ' ' TYR . . . . . . . . . . . . . 66.8 t80 -57.47 -43.39 84.02 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.799 0.809 . . . . 31.59 110.99 170.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1328 ' ' GLY . . . . . . . . . . . . . . . -49.72 -50.11 32.4 Favored Glycine 0 N--CA 1.468 0.798 0 CA-C-O 118.149 -1.362 . . . . 28.0 110.816 171.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1329 ' ' THR . . . . . . . . . . . . . 52.4 m -72.5 -27.7 62.43 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 118.76 -1.176 . . . . 32.149999999999999 112.484 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1330 ' ' ASN . . . . . . . . . . . . . 28.5 m120 -60.1 -43.73 95.34 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 118.007 -2.933 . . . . 34.359999999999999 108.957 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1331 ' ' LEU . . . . . . . . . . . . . 27.7 mt -59.79 -48.8 80.21 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 112.774 -2.012 . . . . 33.369999999999997 108.027 177.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1332 ' ' VAL . . . . . . . . . . . . . 77.5 t -54.0 -47.75 64.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 C-N-CA 124.712 1.205 . . . . 35.270000000000003 111.682 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -61.3 -34.09 74.65 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 115.343 1.608 . . . . 37.659999999999997 115.343 -177.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1334 ' ' LEU . . . . . . . . . . . . . 44.2 tp -72.09 -47.3 52.39 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 106.35 -1.722 . . . . 40.270000000000003 106.35 173.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1335 ' ' LEU . . . . . . . . . . . . . 20.2 mt -64.94 -21.05 66.76 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 115.512 1.671 . . . . 42.5 115.512 -176.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1336 ' ' LYS . . . . . . . . . . . . . 94.4 mttt -56.33 -42.93 78.46 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 119.617 -1.927 . . . . 47.810000000000002 112.145 164.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1337 ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.01 -33.69 44.68 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.044 -0.98 . . . . 49.270000000000003 111.318 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1338 ' ' LEU . . . . . . . . . . . . . 8.3 mp -65.86 -37.52 86.39 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 114.075 1.139 . . . . 50.539999999999999 114.075 174.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1339 ' ' CYS . . . . . . . . . . . . . 27.0 m -116.73 87.19 2.64 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 124.301 2.001 . . . . 53.670000000000002 112.538 169.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 96.7 mttt -76.46 -52.8 9.13 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 112.2 -2.273 . . . . 63.380000000000003 108.954 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -74.61 -44.87 48.56 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-O 122.707 1.241 . . . . 70.950000000000003 110.837 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1342 ' ' LYS . . . . . . . . . . . . . 2.8 mtpt 61.41 90.44 0.07 Allowed 'General case' 0 C--O 1.214 -0.766 0 C-N-CA 126.122 1.769 . . . . 65.25 113.336 -173.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1343 ' ' ASP . . . . . . . . . . . . . 24.8 t70 70.27 160.75 0.21 Allowed 'General case' 0 C--O 1.247 0.928 2 O-C-N 111.146 -7.221 . . . . 64.530000000000001 115.526 -6.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1344 ' ' GLY . . . . . . . . . . . . . . . -140.61 2.18 2.18 Favored Glycine 0 N--CA 1.433 -1.501 0 CA-C-O 122.267 0.926 . . . . 59.719999999999999 112.013 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 10.2 t30 -80.03 85.59 5.61 Favored 'General case' 0 C--O 1.247 0.933 0 O-C-N 119.218 -2.342 . . . . 64.090000000000003 106.88 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1346 ' ' ILE . . . . . . . . . . . . . 1.2 pp -54.26 117.18 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 109.877 -3.329 . . . . 58.82 111.176 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1347 ' ' THR . . . . . . . . . . . . . 4.0 m -78.47 96.04 5.29 Favored 'General case' 0 C--N 1.348 0.52 0 N-CA-C 103.779 -2.674 . . . . 54.960000000000001 103.779 -177.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1348 ' ' VAL . . . . . . . . . . . . . 3.5 t -75.96 85.27 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 N-CA-C 104.511 -2.403 . . . . 55.640000000000001 104.511 170.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 33.4 t70 -73.39 150.6 41.63 Favored 'General case' 0 C--O 1.254 1.296 0 CA-C-N 112.065 -2.334 . . . . 61.450000000000003 112.805 -169.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -111.79 -30.16 7.41 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 113.12 -1.855 . . . . 58.630000000000003 108.527 171.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -69.58 -23.47 63.55 Favored 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 120.381 -1.449 . . . . 62.060000000000002 114.21 -159.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 10.1 t70 -91.53 136.66 32.96 Favored 'General case' 0 C--O 1.253 1.254 0 N-CA-C 106.429 -1.693 . . . . 54.07 106.429 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 4.6 m -50.42 -41.47 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 123.671 0.788 . . . . 50.68 112.151 177.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1354 ' ' VAL . . . . . . . . . . . . . 15.2 m -71.83 -41.74 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 C-N-CA 117.137 -1.825 . . . . 47.68 109.143 -175.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1355 ' ' ILE . . . . . . . . . . . . . 26.6 mt -74.13 -29.05 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 120.167 -0.613 . . . . 48.490000000000002 111.697 -176.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 32.6 tpt85 -60.96 -24.75 66.32 Favored 'General case' 0 C--O 1.248 0.983 0 O-C-N 120.047 -1.658 . . . . 48.270000000000003 112.352 170.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -82.97 -32.58 26.05 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-O 123.839 1.8 . . . . 43.530000000000001 110.945 175.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1358 ' ' VAL . . . . . . . . . . . . . 21.7 t -76.1 -46.04 34.87 Favored 'Isoleucine or valine' 0 C--O 1.256 1.433 0 O-C-N 121.636 -0.92 . . . . 45.119999999999997 108.701 -176.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1359 ' ' THR . . . . . . . . . . . . . 22.1 m -64.82 84.83 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 123.788 1.756 . . . . 42.939999999999998 110.474 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 27.2 m -92.22 -34.95 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 114.828 -1.078 . . . . 43.259999999999998 111.883 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1361 ' ' ILE . . . . . . . . . . . . . 79.6 mt -130.86 109.54 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 106.308 -1.738 . . . . 45.659999999999997 106.308 171.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1362 ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -94.82 121.58 36.57 Favored 'General case' 0 C--O 1.207 -1.134 0 O-C-N 118.258 -2.776 . . . . 61.340000000000003 107.826 169.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 45.25 61.15 2.68 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.184 1.179 . . . . 49.759999999999998 114.184 166.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 88.3 -47.52 3.5 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 114.016 -1.447 . . . . 50.0 112.042 -178.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -77.83 130.8 37.12 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 118.12 0.96 . . . . 56.920000000000002 109.293 -173.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1366 ' ' ILE . . . . . . . . . . . . . 31.2 mt -81.34 93.88 2.4 Favored 'Isoleucine or valine' 0 C--O 1.249 1.053 0 N-CA-C 105.02 -2.215 . . . . 52.780000000000001 105.02 177.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1367 ' ' THR . . . . . . . . . . . . . 26.0 p -72.12 -9.91 59.07 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 112.832 -1.985 . . . . 49.439999999999998 113.836 176.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 1.4 t90 -65.28 143.96 98.89 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 106.615 -1.624 . . . . 52.380000000000003 106.615 164.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -67.93 167.7 61.82 Favored 'Cis proline' 0 C--O 1.244 0.82 0 CA-C-N 124.811 2.754 . . . . 46.939999999999998 118.616 2.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -111.3 121.71 39.63 Favored Pre-proline 0 N--CA 1.437 -1.086 0 N-CA-C 106.076 -1.824 . . . . 45.909999999999997 106.076 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1371 ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -51.05 139.52 42.02 Favored 'Trans proline' 0 C--O 1.247 0.959 0 C-N-CA 123.67 2.913 . . . . 46.390000000000001 110.379 174.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -57.44 -31.09 90.33 Favored 'Trans proline' 0 N--CA 1.44 -1.621 0 C-N-CA 124.761 3.641 . . . . 46.719999999999999 112.719 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.231 -4.556 0 O-C-N 119.731 -1.856 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.441 -0.893 0 CA-C-O 117.6 -1.191 . . . . 63.439999999999998 110.644 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -79.68 55.6 2.05 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 123.652 2.933 . . . . 51.740000000000002 111.034 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1000 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.84 125.34 28.61 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 124.488 1.115 . . . . 54.07 111.407 -172.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 65.76 17.77 65.37 Favored Glycine 0 CA--C 1.531 1.079 0 O-C-N 121.688 -0.633 . . . . 39.219999999999999 112.7 -169.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1002 ' ' ARG . . . . . . . . . . . . . 13.7 ttp180 -90.19 118.66 29.88 Favored 'General case' 0 C--O 1.211 -0.939 0 CA-C-N 120.327 2.063 . . . . 38.119999999999997 111.381 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1003 ' ' ILE . . . . . . . . . . . . . 21.8 mt -75.63 150.04 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 112.25 -2.25 . . . . 29.699999999999999 110.36 169.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -123.36 118.39 3.51 Favored Glycine 0 C--O 1.241 0.582 0 N-CA-C 110.472 -1.051 . . . . 27.5 110.472 165.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1005 ' ' ILE . . . . . . . . . . . . . 23.3 mm -97.55 116.81 65.86 Favored Pre-proline 0 CA--C 1.558 1.278 0 N-CA-C 105.915 -1.883 . . . . 24.829999999999998 105.915 173.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -86.81 162.7 9.1 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.709 2.94 . . . . 27.190000000000001 112.446 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -77.59 101.3 6.48 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 102.028 -3.323 . . . . 41.460000000000001 102.028 163.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1008 ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -58.71 140.62 54.5 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-O 122.369 1.081 . . . . 26.93 113.663 -178.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 43.0 mmm-85 -86.89 -25.46 24.43 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.226 -1.352 . . . . 34.479999999999997 109.787 -162.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1010 ' ' LEU . . . . . . . . . . . . . 4.8 tp -59.42 155.64 14.52 Favored 'General case' 0 C--O 1.25 1.093 0 N-CA-C 115.175 1.546 . . . . 44.219999999999999 115.175 -157.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1011 ' ' THR . . . . . . . . . . . . . 28.7 m -61.17 120.06 9.6 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.885 -0.598 . . . . 40.740000000000002 111.155 174.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 67.37 41.53 2.42 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 123.523 1.63 . . . . 44.439999999999998 112.151 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B 1013 ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -102.16 128.4 48.68 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.596 -1.184 . . . . 29.870000000000001 111.687 -175.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1014 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.01 -11.35 7.09 Favored 'General case' 0 C--O 1.247 0.934 0 O-C-N 125.456 1.723 . . . . 25.260000000000002 110.286 176.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -76.97 98.32 4.9 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 120.174 -1.579 . . . . 29.539999999999999 112.633 -175.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1016 ' ' VAL . . . . . . . . . . . . . 44.0 t -96.56 141.95 14.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 105.02 -2.215 . . . . 23.550000000000001 105.02 168.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1017 ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.32 92.93 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 118.307 2.706 . . . . 23.59 118.307 -155.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1018 ' ' ALA . . . . . . . . . . . . . . . -128.12 149.95 50.19 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 119.255 -2.153 . . . . 24.93 111.76 -168.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1019 ' ' THR . . . . . . . . . . . . . 13.2 p -84.9 166.16 33.33 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-O 117.361 -1.304 . . . . 28.09 111.101 165.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -55.02 -39.75 89.35 Favored 'Trans proline' 0 CA--C 1.549 1.241 0 C-N-CA 123.163 2.576 . . . . 28.789999999999999 112.838 165.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 70.7 tttt -57.49 -49.1 77.38 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 120.17 -1.581 . . . . 47.280000000000001 111.144 175.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1022 ' ' THR . . . . . . . . . . . . . 11.8 p -73.64 -27.33 61.2 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 117.068 -1.444 . . . . 30.120000000000001 110.275 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1023 ' ' VAL . . . . . . . . . . . . . 46.0 t -53.2 -50.32 47.1 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 CA-C-N 120.624 1.556 . . . . 32.240000000000002 108.638 165.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1024 ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.4 -35.61 80.99 Favored 'General case' 0 CA--C 1.511 -0.553 0 O-C-N 120.42 -1.425 . . . . 49.619999999999997 113.038 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -63.74 -43.23 97.08 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.438 -0.789 . . . . 44.68 109.849 172.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 19.2 mt -63.79 -35.41 80.49 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 115.651 1.722 . . . . 35.710000000000001 115.651 176.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1027 ' ' LEU . . . . . . . . . . . . . 68.1 mt -62.4 -45.2 94.19 Favored 'General case' 0 C--O 1.237 0.445 0 O-C-N 124.254 0.971 . . . . 42.18 109.937 170.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 62.9 mttm -61.12 -30.06 70.15 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.205 1.187 . . . . 48.340000000000003 114.205 172.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1029 ' ' LEU . . . . . . . . . . . . . 85.6 mt -69.27 -30.98 69.21 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-O 122.978 1.37 . . . . 38.689999999999998 112.832 165.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 113.34 31.6 2.36 Favored Glycine 0 N--CA 1.465 0.576 0 O-C-N 118.518 -2.614 . . . . 32.280000000000001 108.749 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -126.64 112.7 15.78 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 120.551 -1.558 . . . . 35.939999999999998 109.158 -177.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1032 ' ' THR . . . . . . . . . . . . . 15.0 m -71.5 137.55 48.25 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 106.942 -1.503 . . . . 33.369999999999997 106.942 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1033 ' ' VAL . . . . . . . . . . . . . 61.0 t -106.17 119.47 55.6 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 CA-C-N 120.272 1.396 . . . . 29.98 112.774 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -96.07 140.31 30.98 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 106.802 -1.555 . . . . 28.18 106.802 169.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1035 ' ' VAL . . . . . . . . . . . . . 39.8 t -133.36 140.56 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 119.02 -2.3 . . . . 25.82 105.923 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1036 ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -65.63 142.51 58.03 Favored 'General case' 0 C--O 1.247 0.971 0 O-C-N 121.004 -1.06 . . . . 32.439999999999998 112.956 175.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1037 ' ' SER . . . . . . . . . . . . . 24.0 m -59.15 124.35 19.68 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 121.587 -0.695 . . . . 29.539999999999999 111.268 170.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 93.65 -18.08 57.24 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.04 -0.824 . . . . 27.760000000000002 111.04 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1039 ' ' ALA . . . . . . . . . . . . . . . -66.48 -40.4 89.3 Favored 'General case' 0 C--O 1.243 0.759 0 O-C-N 120.778 -1.425 . . . . 26.02 111.495 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -56.09 -51.36 56.22 Favored Glycine 0 CA--C 1.5 -0.891 0 N-CA-C 110.077 -1.209 . . . . 26.469999999999999 110.077 171.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -58.42 -29.49 66.15 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 120.661 -1.494 . . . . 50.979999999999997 113.033 173.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 65.0 mt -70.55 -48.27 56.26 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 123.045 2.657 . . . . 29.300000000000001 110.631 176.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1043 ' ' ALA . . . . . . . . . . . . . . . -63.68 -17.96 63.49 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 114.928 -1.033 . . . . 26.739999999999998 111.834 174.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1044 ' ' SER . . . . . . . . . . . . . 29.0 m 69.11 47.47 0.74 Allowed 'General case' 0 C--N 1.352 0.694 0 CA-C-O 127.408 3.48 . . . . 31.260000000000002 109.813 175.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1045 ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -146.9 105.25 3.78 Favored 'General case' 0 N--CA 1.442 -0.866 1 N-CA-C 97.413 -5.032 . . . . 33.259999999999998 97.413 171.464 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 26.7 t0 -57.46 146.86 28.19 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 123.614 1.673 . . . . 46.740000000000002 115.465 -164.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -49.4 -43.17 44.12 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 110.803 -2.908 . . . . 34.439999999999998 110.091 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -66.14 -28.52 68.86 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.228 -0.92 . . . . 48.670000000000002 113.218 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -66.4 -32.29 73.58 Favored 'General case' 0 C--O 1.246 0.889 0 O-C-N 120.618 -1.301 . . . . 35.259999999999998 111.272 167.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1050 ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -70.98 -33.46 70.45 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 119.334 0.97 . . . . 32.170000000000002 109.005 170.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 76.7 t -58.98 -40.19 79.98 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 O-C-N 119.706 -1.871 . . . . 38.369999999999997 112.726 170.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -61.16 -38.94 88.26 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-O 118.427 -0.797 . . . . 45.770000000000003 112.19 171.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -68.15 -22.92 64.83 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 124.281 0.988 . . . . 37.829999999999998 113.064 172.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 76.34 59.04 3.44 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 109.782 -1.327 . . . . 35.82 109.782 -175.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -109.99 140.63 43.78 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 122.186 0.993 . . . . 33.770000000000003 108.49 166.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -78.34 96.51 5.33 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 118.207 -2.808 . . . . 51.020000000000003 108.887 -175.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1057 ' ' ILE . . . . . . . . . . . . . 34.4 mm -72.97 110.13 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 106.712 -1.588 . . . . 38.469999999999999 106.712 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 2.9 m -127.1 143.78 39.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 112.195 -2.275 . . . . 39.399999999999999 110.988 -174.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -77.44 124.16 27.52 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 122.181 0.991 . . . . 57.07 110.454 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . 50.3 -107.78 0.4 Allowed Glycine 0 CA--C 1.497 -1.074 0 N-CA-C 117.423 1.729 . . . . 44.829999999999998 117.423 164.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 25.9 m120 -63.73 -27.85 69.48 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.911 0.862 . . . . 46.270000000000003 111.934 -164.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1062 ' ' SER . . . . . . . . . . . . . 3.1 m -55.48 -39.96 71.07 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 113.848 -1.524 . . . . 43.469999999999999 111.822 175.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.71 -27.13 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 O-C-N 119.992 -1.692 . . . . 36.979999999999997 113.645 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 96.5 m95 -71.42 -27.49 63.33 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 124.042 1.877 . . . . 37.899999999999999 111.993 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -79.12 80.24 5.48 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 118.744 -2.473 . . . . 46.189999999999998 108.869 176.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1066 ' ' SER . . . . . . . . . . . . . 72.9 m -156.39 165.05 37.46 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.093 -0.958 . . . . 37.060000000000002 109.786 -172.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1067 ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.31 -39.15 25.62 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 114.504 -1.225 . . . . 43.950000000000003 109.236 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B 1068 ' ' ILE . . . . . . . . . . . . . 4.1 mp -123.93 140.45 47.34 Favored 'Isoleucine or valine' 0 C--O 1.251 1.142 0 N-CA-C 104.034 -2.58 . . . . 33.5 104.034 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 43.8 mm -112.31 135.65 51.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 N-CA-C 103.599 -2.741 . . . . 30.57 103.599 165.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1070 ' ' LEU . . . . . . . . . . . . . 84.9 mt -114.27 75.67 0.94 Allowed 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 121.391 1.905 . . . . 27.66 105.913 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1071 ' ' LYS . . . . . . . . . . . . . 4.6 mttm -73.34 152.93 40.72 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 124.371 1.068 . . . . 28.399999999999999 111.656 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1072 ' ' VAL . . . . . . . . . . . . . 15.6 t -94.01 -31.93 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-O 118.967 -0.539 . . . . 23.18 110.729 176.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -111.85 -167.84 1.23 Allowed 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 124.242 1.017 . . . . 25.469999999999999 111.303 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -71.38 162.36 73.21 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 119.166 0.894 . . . . 27.899999999999999 111.902 165.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -76.8 143.77 23.89 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.605 2.203 . . . . 31.620000000000001 113.727 164.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 31.9 mt -88.86 178.14 6.51 Favored 'General case' 0 CA--C 1.555 1.166 0 O-C-N 120.916 -1.115 . . . . 40.490000000000002 109.305 170.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 28.3 t70 -62.16 -31.68 72.2 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 122.418 2.372 . . . . 51.590000000000003 114.691 -172.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -68.7 -39.58 80.43 Favored 'General case' 0 N--CA 1.439 -0.991 0 O-C-N 120.844 -1.16 . . . . 42.359999999999999 112.112 175.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1079 ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -69.58 -35.95 75.83 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.985 -1.007 . . . . 34.530000000000001 109.049 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1080 ' ' ILE . . . . . . . . . . . . . 86.5 mt -59.49 -45.28 93.92 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 C-N-CA 124.447 1.099 . . . . 33.25 110.78 171.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -61.23 -39.6 90.9 Favored 'General case' 0 C--O 1.251 1.166 0 N-CA-C 113.095 0.776 . . . . 36.469999999999999 113.095 173.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1082 ' ' LEU . . . . . . . . . . . . . 51.7 mt -67.25 -34.04 76.6 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 115.365 1.616 . . . . 37.759999999999998 115.365 173.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1083 ' ' LEU . . . . . . . . . . . . . 16.6 mt -56.74 112.01 1.18 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 123.467 1.603 . . . . 37.43 111.045 175.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -69.67 136.07 88.07 Favored Pre-proline 0 C--O 1.219 -0.509 0 CA-C-N 111.754 -2.476 . . . . 37.700000000000003 113.267 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -51.69 109.92 0.37 Allowed 'Trans proline' 0 C--O 1.246 0.896 0 C-N-CA 124.383 3.389 . . . . 35.509999999999998 116.982 171.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 101.72 3.83 52.36 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 113.726 -1.579 . . . . 33.869999999999997 115.253 -172.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1087 ' ' THR . . . . . . . . . . . . . 52.0 m -74.23 127.72 33.69 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-N 119.523 1.661 . . . . 32.5 109.266 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1088 ' ' THR . . . . . . . . . . . . . 1.2 m -62.87 101.23 0.25 Allowed 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 105.312 -2.107 . . . . 30.219999999999999 105.312 170.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1089 ' ' LEU . . . . . . . . . . . . . 43.3 tp -96.85 109.69 22.34 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 104.719 -2.326 . . . . 27.239999999999998 104.719 -176.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 70.3 t -94.05 123.51 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 105.835 -1.913 . . . . 25.390000000000001 105.835 169.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1091 ' ' SER . . . . . . . . . . . . . 58.0 m -156.15 164.62 38.16 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 123.613 1.673 . . . . 28.809999999999999 110.544 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1092 ' ' PHE . . . . . . . . . . . . . 10.8 t80 -93.12 95.85 9.68 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 101.557 -3.498 . . . . 30.780000000000001 101.557 174.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 37.3 mm -83.43 -52.77 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-O 117.349 -1.31 . . . . 30.280000000000001 113.036 -172.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1094 ' ' TRP . . . . . . . . . . . . . 20.9 m95 52.96 75.9 0.59 Allowed Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 118.631 0.65 . . . . 34.07 109.657 -154.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -57.15 -49.51 13.92 Favored 'Trans proline' 0 CA--C 1.511 -0.638 1 C-N-CA 125.707 4.271 . . . . 38.659999999999997 113.502 -171.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -71.52 -14.38 62.09 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 118.643 0.656 . . . . 41.32 111.302 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -103.86 -4.89 22.92 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.794 1.238 . . . . 51.659999999999997 109.59 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -137.53 62.65 37.34 Favored Pre-proline 0 C--O 1.24 0.573 0 O-C-N 120.456 -1.402 . . . . 40.32 109.087 167.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -63.07 -45.94 11.46 Favored 'Trans proline' 0 CA--C 1.536 0.604 1 C-N-CA 128.191 5.927 . . . . 41.560000000000002 113.92 -171.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.14 -38.86 89.17 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 123.945 0.898 . . . . 54.109999999999999 108.84 176.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B 1101 ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.31 -48.76 80.35 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.727 0.775 . . . . 37.880000000000003 109.006 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1102 ' ' MET . . . . . . . . . . . . . 62.1 mmm -53.44 -45.14 69.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.086 -0.961 . . . . 37.539999999999999 112.994 171.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -62.6 -33.1 74.31 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.92 1.082 . . . . 47.009999999999998 113.92 175.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1104 ' ' LYS . . . . . . . . . . . . . 82.0 mttt -73.02 -32.07 64.88 Favored 'General case' 0 C--O 1.213 -0.827 0 O-C-N 119.994 -1.691 . . . . 48.68 111.539 173.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1105 ' ' LEU . . . . . . . . . . . . . 66.6 mt -66.11 -34.51 78.23 Favored 'General case' 0 C--O 1.256 1.447 0 O-C-N 121.609 -0.682 . . . . 32.210000000000001 110.244 174.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -61.18 -46.89 88.64 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 123.209 0.604 . . . . 33.729999999999997 111.541 168.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -58.22 -47.75 82.53 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 125.783 2.706 . . . . 51.469999999999999 117.016 174.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1108 ' ' ARG . . . . . . . . . . . . . 31.6 mmm180 -69.17 -10.54 58.2 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 112.728 -2.033 . . . . 43.899999999999999 111.218 171.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1109 ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.19 42.82 18.02 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 123.504 1.621 . . . . 44.82 111.586 170.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B 1110 ' ' VAL . . . . . . . . . . . . . 12.4 m -93.32 149.89 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 115.032 -0.986 . . . . 30.52 109.124 -177.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1111 ' ' THR . . . . . . . . . . . . . 88.5 m -86.33 92.39 8.79 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.963 -0.754 . . . . 27.120000000000001 108.963 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1112 ' ' VAL . . . . . . . . . . . . . 4.1 t -94.99 124.88 47.68 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 120.297 1.408 . . . . 26.399999999999999 110.781 -168.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1113 ' ' MET . . . . . . . . . . . . . 1.3 mpt? -102.33 115.7 31.11 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 124.388 2.042 . . . . 42.920000000000002 107.932 163.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -93.75 106.93 18.87 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 120.55 -1.344 . . . . 24.149999999999999 110.216 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1115 ' ' MET . . . . . . . . . . . . . 14.2 mmm -63.94 -11.14 25.64 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 117.303 2.334 . . . . 29.949999999999999 117.303 -176.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1116 ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -84.81 -41.86 15.69 Favored 'General case' 0 C--O 1.218 -0.58 0 C-N-CA 123.721 0.809 . . . . 34.530000000000001 109.323 169.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1117 ' ' SER . . . . . . . . . . . . . 25.0 m -91.45 37.49 0.95 Allowed 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 120.066 -1.646 . . . . 33.490000000000002 109.666 -173.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1118 ' ' VAL . . . . . . . . . . . . . 1.8 t -78.38 147.67 72.59 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 103.988 -2.597 . . . . 34.020000000000003 103.988 166.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 1.6 Cg_exo -58.13 165.56 6.87 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.971 2.447 . . . . 38.280000000000001 114.192 169.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1120 ' ' ARG . . . . . 0.466 HH12 ' CG ' ' B' 1128 ' ' ASP . 5.0 mmp_? -92.27 -0.07 57.42 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 120.924 -1.11 . . . . 55.049999999999997 112.186 -178.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B 1121 ' ' ILE . . . . . . . . . . . . . 30.3 pt -68.76 141.82 16.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 119.964 1.256 . . . . 42.090000000000003 108.65 175.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1122 ' ' SER . . . . . . . . . . . . . 5.0 m -58.73 -28.45 65.86 Favored 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 116.982 2.216 . . . . 38.020000000000003 116.982 -158.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1123 ' ' ARG . . . . . . . . . . . . . 19.4 ptt-85 -66.45 -39.59 88.94 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 121.359 1.891 . . . . 34.289999999999999 107.849 174.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1124 ' ' ALA . . . . . . . . . . . . . . . -68.03 -38.44 82.53 Favored 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 106.764 -1.569 . . . . 32.350000000000001 106.764 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1125 ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -51.15 -38.97 55.15 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 118.197 2.666 . . . . 47.170000000000002 118.197 170.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1126 ' ' SER . . . . . . . . . . . . . 3.9 p -69.18 -19.68 63.99 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 122.107 0.956 . . . . 31.710000000000001 113.549 175.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1127 ' ' LEU . . . . . . . . . . . . . 5.2 mp -90.26 -36.06 14.94 Favored 'General case' 0 C--N 1.347 0.48 0 N-CA-C 107.911 -1.144 . . . . 37.0 107.911 173.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1128 ' ' ASP . . . . . 0.466 ' CG ' HH12 ' B' 1120 ' ' ARG . 4.6 t70 -62.88 130.08 43.27 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 125.958 1.703 . . . . 40.399999999999999 115.107 -164.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B 1129 ' ' ALA . . . . . . . . . . . . . . . -72.14 -36.93 69.49 Favored 'General case' 0 C--O 1.255 1.393 0 N-CA-C 106.713 -1.588 . . . . 26.559999999999999 106.713 -176.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 56.9 mt -59.83 -24.63 64.35 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 121.191 1.814 . . . . 30.890000000000001 112.494 -172.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1131 ' ' SER . . . . . . . . . . . . . 93.9 p -69.23 -60.48 2.32 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 106.035 -1.839 . . . . 29.84 106.035 176.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1132 ' ' SER . . . . . . . . . . . . . 16.0 m -62.64 -34.86 77.91 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 115.438 1.644 . . . . 31.91 115.438 -178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1133 ' ' MET . . . . . . . . . . . . . 35.3 mmt -72.68 -36.53 67.91 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.872 0.844 . . . . 25.899999999999999 111.596 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1134 ' ' ALA . . . . . . . . . . . . . . . -60.84 -39.44 89.08 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 115.259 -0.882 . . . . 26.620000000000001 109.959 167.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -60.37 -50.09 74.98 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 117.782 -1.104 . . . . 36.969999999999999 113.738 173.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1136 ' ' ILE . . . . . . . . . . . . . 16.4 mm -53.48 -52.02 36.49 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 O-C-N 124.686 1.241 . . . . 32.109999999999999 108.416 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -61.87 -35.88 79.6 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 114.132 1.16 . . . . 24.140000000000001 114.132 176.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -71.53 -41.55 57.47 Favored Glycine 0 CA--C 1.503 -0.713 0 N-CA-C 109.262 -1.535 . . . . 25.129999999999999 109.262 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 17.8 t80 -61.74 -55.6 28.54 Favored 'General case' 0 C--O 1.211 -0.958 0 O-C-N 120.928 -1.337 . . . . 32.729999999999997 109.689 169.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1140 ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -59.36 -25.18 64.01 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 119.15 0.886 . . . . 26.359999999999999 111.75 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1141 ' ' ALA . . . . . . . . . . . . . . . -62.91 -55.65 24.2 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.466 1.106 . . . . 24.120000000000001 109.971 170.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 21.4 mm -57.94 -40.7 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 107.839 -1.171 . . . . 23.370000000000001 107.839 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 19.4 t -59.29 -66.49 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.662 0 CA-C-O 117.8 -1.095 . . . . 24.960000000000001 112.356 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -61.1 -33.2 72.97 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.518 1.127 . . . . 32.07 112.09 -175.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1145 ' ' ALA . . . . . . . . . . . . . . . -60.54 -59.37 5.5 Favored 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 106.386 -1.709 . . . . 24.870000000000001 106.386 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1146 ' ' ALA . . . . . . . . . . . . . . . -58.27 -33.64 69.62 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 120.577 1.535 . . . . 24.670000000000002 111.727 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1147 ' ' HIS . . . . . 0.413 ' O ' ' NH2' ' A' 1140 ' ' ARG . 73.8 t60 -59.72 -44.63 93.65 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.052 1.341 . . . . 28.579999999999998 111.282 174.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B 1148 ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -96.8 -6.81 35.22 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 122.614 1.197 . . . . 36.82 113.933 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1149 ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -76.26 148.84 37.32 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 113.235 -1.802 . . . . 31.969999999999999 110.263 -176.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B 1150 ' ' GLY . . . . . . . . . . . . . . . -92.73 -19.34 37.72 Favored Glycine 0 N--CA 1.427 -1.964 0 CA-C-N 113.474 -1.694 . . . . 25.489999999999998 115.42 173.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1151 ' ' ARG . . . . . . . . . . . . . 86.5 mtm-85 -121.17 177.22 5.23 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 119.738 1.769 . . . . 59.840000000000003 110.97 -169.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1152 ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -84.99 155.04 21.75 Favored 'General case' 0 C--N 1.352 0.691 0 CA-C-N 121.544 1.975 . . . . 34.450000000000003 108.857 175.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1153 ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -74.93 -46.82 33.22 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.529 -1.214 . . . . 31.170000000000002 109.794 164.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1154 ' ' THR . . . . . . . . . . . . . 22.4 m -71.58 122.64 20.87 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 113.379 -1.737 . . . . 33.890000000000001 109.362 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -75.18 103.47 1.59 Allowed Glycine 0 C--O 1.269 2.287 0 N-CA-C 106.837 -2.505 . . . . 38.950000000000003 106.837 172.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -112.09 112.39 23.97 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 105.638 -1.986 . . . . 54.229999999999997 105.638 -169.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 29.6 mm -81.53 96.88 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 102.954 -2.98 . . . . 51.159999999999997 102.954 172.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1158 ' ' THR . . . . . . . . . . . . . 34.9 m -95.13 153.93 17.42 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 112.841 -1.981 . . . . 49.609999999999999 107.382 -163.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -36.95 -51.35 0.91 Allowed 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 116.64 2.089 . . . . 49.049999999999997 116.64 175.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -55.74 -56.15 23.83 Favored 'General case' 0 C--N 1.349 0.577 0 N-CA-C 114.833 1.42 . . . . 47.649999999999999 114.833 169.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . 177.53 -165.79 35.77 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 108.773 -1.731 . . . . 45.609999999999999 108.773 -175.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 89.3 mttt -95.49 149.46 21.38 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 122.38 1.086 . . . . 57.460000000000001 112.968 -166.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1163 ' ' VAL . . . . . . . . . . . . . 99.1 t -116.69 121.59 32.79 Favored Pre-proline 0 CA--C 1.499 -0.994 0 CA-C-N 113.067 -1.878 . . . . 42.93 106.279 166.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1164 ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.82 137.55 38.61 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.478 2.118 . . . . 39.289999999999999 109.66 168.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1165 ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -62.93 149.08 92.59 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.548 2.832 . . . . 34.170000000000002 113.193 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -73.47 122.1 21.6 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 124.837 1.336 . . . . 31.690000000000001 109.11 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1167 ' ' LYS . . . . . . . . . . . . . 80.4 mttt -79.59 104.05 9.92 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 105.63 -1.989 . . . . 44.780000000000001 105.63 171.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 62.0 t -102.02 99.59 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 N-CA-C 106.69 -1.596 . . . . 31.23 106.69 -170.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1169 ' ' MET . . . . . . . . . . . . . 30.2 ttp -82.29 112.2 19.06 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 119.419 -0.913 . . . . 37.090000000000003 109.132 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 60.0 t -104.03 107.21 21.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 N-CA-C 105.511 -2.033 . . . . 30.170000000000002 105.511 -177.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1171 ' ' ILE . . . . . . . . . . . . . 70.4 mt -97.49 127.17 50.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 108.222 -1.029 . . . . 33.740000000000002 108.222 -177.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 88.72 67.21 1.27 Allowed Glycine 0 C--N 1.318 -0.44 0 CA-C-O 124.502 2.168 . . . . 32.590000000000003 108.458 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1173 ' ' ALA . . . . . . . . . . . . . . . -74.42 42.25 0.16 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 117.975 2.583 . . . . 32.420000000000002 117.975 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -79.78 -155.26 10.03 Favored Glycine 0 CA--C 1.524 0.601 0 O-C-N 117.573 -3.204 . . . . 31.739999999999998 110.397 164.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 86.7 t -48.58 -50.8 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-N 120.762 2.281 . . . . 31.48 115.289 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1176 ' ' ALA . . . . . . . . . . . . . . . -49.46 -50.83 39.42 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 123.591 1.663 . . . . 26.120000000000001 113.324 172.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1177 ' ' GLY . . . . . . . . . . . . . . . -63.73 -49.79 66.16 Favored Glycine 0 C--O 1.211 -1.3 0 CA-C-N 112.748 -2.024 . . . . 25.73 110.765 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1178 ' ' LEU . . . . . . . . . . . . . 46.3 mt -56.59 -33.38 66.14 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 123.94 0.896 . . . . 32.590000000000003 112.718 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -62.34 -57.96 9.42 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.893 -1.049 . . . . 27.719999999999999 110.602 172.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -57.78 -39.78 78.29 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 114.137 1.162 . . . . 26.030000000000001 114.137 177.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1181 ' ' ILE . . . . . . . . . . . . . 96.4 mt -57.06 -45.84 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 108.413 -0.958 . . . . 28.609999999999999 108.413 172.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -55.25 -54.39 34.46 Favored Glycine 0 N--CA 1.465 0.583 0 N-CA-C 110.4 -1.08 . . . . 25.23 110.4 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -56.93 -61.42 2.45 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.276 1.213 . . . . 24.09 114.276 174.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -67.3 -35.73 80.06 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-O 119.178 -0.439 . . . . 26.68 111.504 -169.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -66.91 -45.32 78.28 Favored 'General case' 0 CA--C 1.502 -0.873 0 O-C-N 120.554 -1.341 . . . . 36.57 110.071 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1186 ' ' SER . . . . . . . . . . . . . 61.3 m -66.04 -32.31 73.71 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 119.923 -0.711 . . . . 28.920000000000002 112.823 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1187 ' ' LEU . . . . . . . . . . . . . 25.8 mt -57.87 -23.68 54.13 Favored 'General case' 0 C--O 1.247 0.941 0 N-CA-C 113.4 0.889 . . . . 29.09 113.4 165.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 89.68 20.91 42.04 Favored Glycine 0 CA--C 1.534 1.247 0 N-CA-C 108.593 -1.803 . . . . 29.260000000000002 108.593 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1189 ' ' ALA . . . . . . . . . . . . . . . -82.29 149.64 27.69 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 118.385 -0.817 . . . . 30.16 109.461 174.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 74.8 mt -80.51 90.93 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 120.094 1.315 . . . . 35.810000000000002 108.32 -176.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1191 ' ' VAL . . . . . . . . . . . . . 67.1 t -77.3 109.24 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 105.421 -2.066 . . . . 31.969999999999999 105.421 -172.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1192 ' ' ARG . . . . . 0.442 HH12 ' CD ' ' B' 1248 ' ' GLU . 47.5 mtt180 -101.21 85.58 2.84 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-O 123.776 1.75 . . . . 48.159999999999997 106.911 172.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -93.62 152.91 18.69 Favored 'General case' 0 C--O 1.259 1.598 0 CA-C-N 112.223 -2.262 . . . . 35.890000000000001 112.227 -171.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 87.7 t80 -144.75 148.72 34.45 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 124.567 2.127 . . . . 41.880000000000003 105.592 -176.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1195 ' ' ASP . . . . . . . . . . . . . 22.4 t0 -159.77 154.04 23.65 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 101.513 -3.514 . . . . 38.280000000000001 101.513 163.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1196 ' ' THR . . . . . . . . . . . . . 1.1 m -73.53 -27.16 61.2 Favored 'General case' 0 C--O 1.247 0.942 0 C-N-CA 119.654 -0.818 . . . . 40.619999999999997 111.469 -176.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1197 ' ' ARG . . . . . . . . . . . . . 22.9 mtm105 -73.41 103.37 0.79 Allowed Pre-proline 0 CA--C 1.565 1.542 0 O-C-N 121.079 -1.013 . . . . 53.090000000000003 108.832 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -56.34 -26.2 60.93 Favored 'Trans proline' 0 C--N 1.347 0.481 1 C-N-CA 125.775 4.316 . . . . 42.560000000000002 119.25 -162.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.91 -12.74 19.53 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 119.726 -1.859 . . . . 56.310000000000002 113.828 -177.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B 1200 ' ' VAL . . . . . . . . . . . . . 23.3 m -57.98 -20.88 15.79 Favored 'Isoleucine or valine' 0 C--O 1.25 1.106 0 O-C-N 119.873 -1.767 . . . . 42.909999999999997 112.298 172.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 46.2 tttm -50.55 -55.9 14.1 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 122.901 0.48 . . . . 48.890000000000001 111.712 166.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -70.07 -34.0 72.62 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 120.727 -1.233 . . . . 51.700000000000003 110.488 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1203 ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -50.47 -52.09 41.24 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 120.999 -1.063 . . . . 52.57 111.815 176.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1204 ' ' VAL . . . . . . . . . . . . . 18.6 m -73.42 -36.95 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 O-C-N 121.247 -0.908 . . . . 33.789999999999999 112.16 175.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -53.6 -39.63 65.03 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 114.957 1.465 . . . . 36.579999999999998 114.957 174.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1206 ' ' SER . . . . . . . . . . . . . 84.4 p -60.62 -45.84 92.51 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.45 -1.406 . . . . 39.609999999999999 109.096 175.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1207 ' ' MET . . . . . . . . . . . . . 5.0 mtp -68.6 -18.14 64.26 Favored 'General case' 0 N--CA 1.44 -0.959 0 O-C-N 119.519 -1.988 . . . . 37.450000000000003 113.632 177.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 77.62 56.6 3.82 Favored Glycine 0 N--CA 1.475 1.238 0 N-CA-C 108.686 -1.766 . . . . 31.870000000000001 108.686 -172.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -139.87 159.52 41.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.886 1.274 . . . . 35.399999999999999 111.131 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -90.46 136.21 33.2 Favored 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 120.559 -1.338 . . . . 47.890000000000001 110.038 -165.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 29.1 t80 -86.94 141.7 28.53 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.743 -1.206 . . . . 45.530000000000001 107.743 167.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1212 ' ' LEU . . . . . . . . . . . . . 32.2 mt -81.85 102.92 11.15 Favored 'General case' 0 N--CA 1.433 -1.32 0 O-C-N 121.396 -0.815 . . . . 46.329999999999998 111.02 167.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -83.51 124.48 30.78 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 103.864 -2.643 . . . . 60.409999999999997 103.864 -176.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 4.6 mp -68.32 164.52 20.59 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 114.075 -1.42 . . . . 57.380000000000003 110.108 -177.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 28.0 t70 . . . . . 0 N--CA 1.444 -0.752 0 CA-C-O 116.326 -1.797 . . . . 65.069999999999993 107.083 168.932 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B 1230 ' ' MET . . . . . . . . . . . . . 3.7 mmt . . . . . 0 N--CA 1.435 -1.217 0 N-CA-C 101.725 -3.435 . . . . 80.319999999999993 101.725 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B 1231 ' ' SER . . . . . . . . . . . . 0.275 19.4 m 112.66 155.47 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 3 CA-C-N 130.408 6.003 . . . . 79.920000000000002 115.221 -9.924 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 28.6 t70 -43.12 140.24 1.55 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 116.203 1.927 . . . . 77.909999999999997 116.203 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 67.46 -54.38 0.48 Allowed 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 115.846 1.795 . . . . 73.879999999999995 115.846 -166.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 1.5 t80 -61.23 -21.68 64.09 Favored 'General case' 0 C--O 1.254 1.293 0 CA-C-N 120.096 1.316 . . . . 68.980000000000004 112.92 176.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 1.9 pp -42.05 -38.71 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 O-C-N 120.795 -1.191 . . . . 64.530000000000001 113.361 159.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -69.29 -29.26 67.09 Favored 'General case' 0 CA--C 1.501 -0.919 0 O-C-N 120.124 -1.61 . . . . 66.359999999999999 112.89 174.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -62.4 -31.11 71.74 Favored 'General case' 0 N--CA 1.438 -1.061 0 O-C-N 117.575 -3.203 . . . . 56.600000000000001 111.333 171.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -68.97 -61.41 1.81 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.86 0.864 . . . . 56.789999999999999 111.289 170.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1239 ' ' MET . . . . . . . . . . . . . 14.4 mtt -59.01 -44.79 91.75 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 114.842 1.423 . . . . 53.630000000000003 114.842 -177.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -68.53 -35.38 77.37 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 120.497 1.499 . . . . 51.740000000000002 112.828 -176.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 46.3 tp -54.27 -49.18 70.14 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.983 -1.008 . . . . 44.859999999999999 110.856 166.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 13.0 m-30 -62.68 -38.59 90.99 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 114.096 1.147 . . . . 42.780000000000001 114.096 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -59.3 -41.47 89.08 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 114.685 -1.143 . . . . 40.960000000000001 110.935 170.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -77.55 -8.66 58.15 Favored 'General case' 0 C--O 1.249 1.049 0 O-C-N 120.385 -1.447 . . . . 43.060000000000002 112.361 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -82.23 -26.4 33.28 Favored 'General case' 0 C--O 1.207 -1.14 0 N-CA-C 114.407 1.262 . . . . 46.450000000000003 114.407 164.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -54.69 -38.18 66.7 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 118.941 2.941 . . . . 41.780000000000001 118.941 -167.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 11.9 mptt -68.97 -30.22 68.61 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 115.011 1.485 . . . . 52.200000000000003 115.011 174.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1248 ' ' GLU . . . . . 0.442 ' CD ' HH12 ' B' 1192 ' ' ARG . 33.5 mt-10 -85.09 -39.91 17.4 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 115.055 1.502 . . . . 53.549999999999997 115.055 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B 1249 ' ' VAL . . . . . . . . . . . . 0.266 18.4 m -68.94 135.4 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 124.165 1.936 . . . . 34.409999999999997 115.575 -163.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B 1250 ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -97.57 -48.91 5.07 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 111.969 -2.378 . . . . 33.380000000000003 110.387 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1251 ' ' ILE . . . . . . . . . . . . . 30.1 mm -128.23 126.3 65.77 Favored 'Isoleucine or valine' 0 C--O 1.248 0.988 0 N-CA-C 103.434 -2.802 . . . . 29.539999999999999 103.434 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1252 ' ' ILE . . . . . . . . . . . . . 53.6 mt -90.49 97.91 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 107.013 -1.477 . . . . 32.439999999999998 107.013 159.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1253 ' ' VAL . . . . . . . . . . . . . 4.0 t -83.99 93.05 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 103.181 -2.896 . . . . 30.57 103.181 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1254 ' ' THR . . . . . . . . . . . . 0.353 8.8 t -90.42 84.63 6.01 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 124.207 1.956 . . . . 35.039999999999999 107.158 -178.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B 1255 ' ' THR . . . . . . . . . . . . . 2.7 p -69.73 -16.5 63.33 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 110.927 -2.851 . . . . 34.619999999999997 114.305 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . -57.46 82.84 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 124.172 0.989 . . . . 42.719999999999999 112.773 176.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 3.4 tt -90.82 85.5 6.04 Favored 'General case' 0 CA--C 1.54 0.562 1 N-CA-C 99.175 -4.379 . . . . 52.43 99.175 173.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 2.6 mp -55.5 125.54 60.26 Favored Pre-proline 0 C--N 1.353 0.759 0 O-C-N 120.996 -1.065 . . . . 59.409999999999997 111.144 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -57.31 110.45 0.61 Allowed 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 125.119 3.879 . . . . 62.68 111.928 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 77.73 -79.01 1.45 Allowed Glycine 0 CA--C 1.55 2.238 0 O-C-N 119.846 -1.784 . . . . 64.159999999999997 113.229 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 37.2 mttm -46.44 125.79 7.68 Favored Pre-proline 0 C--O 1.239 0.549 0 CA-C-O 116.535 -1.698 . . . . 68.530000000000001 113.667 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -55.16 120.93 9.0 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 124.027 3.151 . . . . 61.990000000000002 111.068 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1263 ' ' ALA . . . . . . . . . . . . . . . -48.73 122.78 11.19 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 117.402 2.371 . . . . 57.149999999999999 117.402 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -58.26 141.67 96.91 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 124.477 3.451 . . . . 51.57 111.903 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -75.89 82.37 2.8 Favored 'General case' 0 C--O 1.21 -1.026 0 O-C-N 121.13 -0.981 . . . . 54.549999999999997 110.977 -178.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 49.7 mt -74.96 -56.34 4.84 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.352 -1.295 . . . . 46.859999999999999 109.567 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1267 ' ' ILE . . . . . . . . . . . . . 32.1 mm -84.43 89.35 2.56 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 N-CA-C 103.655 -2.72 . . . . 41.039999999999999 103.655 -175.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1268 ' ' THR . . . . . . . . . . . . . 1.1 p -80.63 160.09 25.17 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 113.001 -1.909 . . . . 39.579999999999998 112.286 -176.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1269 ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -53.31 -54.87 30.11 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 117.467 2.395 . . . . 53.149999999999999 117.467 -168.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -55.46 -40.35 71.51 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 125.1 1.5 . . . . 42.960000000000001 113.892 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1271 ' ' MET . . . . . . . . . . . . . 41.6 ttm -56.89 -58.27 8.87 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 117.673 -1.156 . . . . 43.890000000000001 108.394 168.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1272 ' ' VAL . . . . . . . . . . . . . 24.6 t -52.7 -59.83 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.808 0 CA-C-N 120.001 1.273 . . . . 38.369999999999997 111.877 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1273 ' ' ASP . . . . . . . . . . . . 0.265 1.2 m-20 -68.28 14.31 0.07 Allowed 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 120.358 3.466 . . . . 47.460000000000001 120.358 176.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B 1274 ' ' SER . . . . . . . . . . . . . 54.7 p -124.36 -2.28 8.04 Favored 'General case' 0 C--O 1.247 0.93 0 O-C-N 119.956 -1.715 . . . . 38.380000000000003 110.432 170.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1275 ' ' MET . . . . . . . . . . . . . 40.6 mtp -63.88 162.99 12.69 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 114.093 1.145 . . . . 37.810000000000002 114.093 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.06 134.67 52.76 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.182 -0.949 . . . . 49.259999999999998 112.721 175.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -64.84 141.43 58.78 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 123.311 1.529 . . . . 34.460000000000001 113.332 -173.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 70.38 24.23 76.88 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 114.922 -1.035 . . . . 33.530000000000001 112.165 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1279 ' ' SER . . . . . . . . . . . . . 59.0 m -95.7 153.72 17.59 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 122.91 0.484 . . . . 31.309999999999999 109.736 176.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1280 ' ' VAL . . . . . . . . . . . . . 84.4 t -118.01 144.29 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 O-C-N 119.307 -2.12 . . . . 29.32 106.815 -170.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1281 ' ' ILE . . . . . . . . . . . . . 75.8 mt -121.5 120.22 61.21 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 N-CA-C 101.054 -3.684 . . . . 31.93 101.054 170.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1282 ' ' VAL . . . . . . . . . . . . . 12.3 t -108.22 113.58 44.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 105.983 -1.858 . . . . 29.48 105.983 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 5.6 t0 -87.33 102.73 14.79 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-N 113.826 -1.534 . . . . 34.5 110.885 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1284 ' ' LEU . . . . . . . . . . . . . 8.5 mp -69.46 -23.72 63.7 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 113.977 1.103 . . . . 37.939999999999998 113.977 172.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -88.38 16.09 6.89 Favored 'General case' 0 C--N 1.364 1.216 0 O-C-N 121.548 -0.72 . . . . 40.920000000000002 111.454 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -45.42 -37.5 5.16 Favored 'General case' 0 C--O 1.214 -0.786 0 N-CA-C 115.986 1.847 . . . . 44.390000000000001 115.986 174.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1287 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.43 -24.54 39.53 Favored 'General case' 0 C--N 1.313 -1.014 0 O-C-N 119.527 -1.983 . . . . 51.460000000000001 112.047 176.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 1.5 t30 -114.06 64.7 0.66 Allowed 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 125.101 1.361 . . . . 57.75 109.13 -170.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1289 ' ' GLY . . . . . . . . . . . . . . . 92.34 -39.62 2.98 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-O 117.056 -1.969 . . . . 49.850000000000001 114.663 170.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 87.02 117.2 1.1 Allowed Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 120.531 2.166 . . . . 45.93 112.292 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1291 ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -77.25 -29.63 54.08 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 119.761 1.78 . . . . 42.670000000000002 111.03 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1292 ' ' CYS . . . . . . . . . . . . . 40.9 t -95.84 146.03 24.88 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 118.704 -2.497 . . . . 38.82 108.442 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1293 ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -69.74 -38.64 76.9 Favored 'General case' 0 CA--C 1.502 -0.882 0 O-C-N 119.927 -1.733 . . . . 46.710000000000001 114.564 172.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -74.33 -3.84 32.68 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.273 0.842 . . . . 47.229999999999997 113.273 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1295 ' ' THR . . . . . . . . . . . . . 88.2 m -59.6 110.77 1.2 Allowed 'General case' 0 C--O 1.243 0.759 0 CA-C-N 120.077 1.308 . . . . 36.020000000000003 111.238 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 51.2 t -78.34 100.25 0.5 Allowed Pre-proline 0 N--CA 1.44 -0.933 0 CA-C-N 112.604 -2.089 . . . . 37.259999999999998 105.437 163.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -65.46 78.22 0.25 Allowed 'Trans proline' 0 N--CA 1.44 -1.672 0 C-N-CA 125.024 3.816 . . . . 35.090000000000003 112.464 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 169.09 -43.52 0.22 Allowed Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 109.045 -1.622 . . . . 35.969999999999999 109.045 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -134.35 -179.27 5.47 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 115.406 1.632 . . . . 40.390000000000001 115.406 -165.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1300 ' ' ILE . . . . . . . . . . . . . 21.2 mt -82.63 140.6 16.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 107.563 -1.273 . . . . 37.43 107.563 172.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 58.6 t80 -119.96 112.66 19.45 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 104.706 -2.331 . . . . 44.130000000000003 104.706 163.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1302 ' ' THR . . . . . . . . . . . . . 29.4 m -79.72 137.03 36.92 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 119.92 -1.737 . . . . 39.780000000000001 109.623 167.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1303 ' ' THR . . . . . . . . . . . . . 35.7 p -93.32 -179.72 5.15 Favored 'General case' 0 C--O 1.251 1.184 0 N-CA-C 114.54 1.311 . . . . 43.289999999999999 114.54 177.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -75.97 -27.34 57.45 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 120.323 -1.486 . . . . 53.07 109.692 -169.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -84.55 2.55 40.7 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 124.519 2.104 . . . . 43.969999999999999 110.008 173.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 78.63 38.99 22.83 Favored Glycine 0 CA--C 1.539 1.533 0 O-C-N 118.217 -2.802 . . . . 41.119999999999997 113.495 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1307 ' ' VAL . . . . . . . . . . . . . 18.0 t -100.72 127.4 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-O 122.252 1.025 . . . . 38.119999999999997 109.705 172.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1308 ' ' LYS . . . . . . . . . . . . . 98.1 mttt -97.59 99.86 11.26 Favored 'General case' 0 N--CA 1.437 -1.093 0 O-C-N 119.01 -2.306 . . . . 36.340000000000003 109.782 -171.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1309 ' ' VAL . . . . . . . . . . . . . 23.9 t -82.53 99.67 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 106.941 -1.503 . . . . 30.399999999999999 106.941 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1310 ' ' ILE . . . . . . . . . . . . . 72.4 mt -82.82 107.64 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 N-CA-C 106.425 -1.695 . . . . 30.82 106.425 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1311 ' ' GLY . . . . . . . . . . . . . . . -116.0 61.52 0.39 Allowed Glycine 0 C--N 1.354 1.535 0 C-N-CA 118.567 -1.778 . . . . 26.530000000000001 111.6 176.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1312 ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -81.52 123.3 28.52 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 118.526 1.163 . . . . 38.0 108.984 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1313 ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.1 -48.87 70.25 Favored 'General case' 0 C--O 1.256 1.428 0 CA-C-O 123.839 1.78 . . . . 29.800000000000001 108.56 167.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -72.41 16.66 0.13 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 116.453 2.02 . . . . 39.039999999999999 116.453 -176.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1315 ' ' LEU . . . . . . . . . . . . . 25.4 mt -53.72 -43.63 96.48 Favored Pre-proline 0 C--O 1.224 -0.272 0 O-C-N 119.549 -1.969 . . . . 31.079999999999998 113.995 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1316 ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -63.97 -50.97 2.53 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.909 3.073 . . . . 26.100000000000001 112.475 168.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -50.76 -35.39 30.85 Favored Glycine 0 C--N 1.343 0.962 0 C-N-CA 125.867 1.698 . . . . 23.170000000000002 115.015 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 53.3 mtt180 -66.52 -7.22 18.39 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 117.492 2.404 . . . . 40.399999999999999 117.492 177.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 38.4 tp -127.48 117.64 21.39 Favored Pre-proline 0 C--N 1.347 0.488 0 O-C-N 119.395 -2.065 . . . . 23.600000000000001 110.24 -173.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1320 ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.62 -95.48 0.01 OUTLIER 'Trans proline' 0 N--CA 1.481 0.774 0 N-CA-C 121.428 3.588 . . . . 22.350000000000001 121.428 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1321 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.49 -31.25 61.86 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 116.125 1.898 . . . . 26.52 116.125 -162.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B 1322 ' ' GLN . . . . . . . . . . . . . 35.8 tp60 -52.86 -51.3 61.54 Favored 'General case' 0 C--O 1.248 1.018 0 CA-C-N 113.13 -1.85 . . . . 24.379999999999999 109.67 173.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1323 ' ' SER . . . . . . . . . . . . . 8.1 m -62.77 -48.35 79.56 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 118.121 -0.942 . . . . 22.800000000000001 112.578 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1324 ' ' SER . . . . . . . . . . . . . 3.0 m -49.49 -35.7 20.67 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 123.797 1.761 . . . . 21.25 115.263 174.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 45.8 tp60 -78.15 -60.82 2.21 Favored 'General case' 0 CA--C 1.505 -0.788 0 O-C-N 119.587 -1.946 . . . . 31.34 110.571 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1326 ' ' LEU . . . . . . . . . . . . . 12.5 mt -62.7 -59.07 5.41 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 117.182 -1.39 . . . . 31.559999999999999 110.372 -174.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1327 ' ' TYR . . . . . . . . . . . . . 57.9 t80 -63.06 -40.32 97.35 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 119.033 0.833 . . . . 22.73 109.798 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1328 ' ' GLY . . . . . . . . . . . . . . . -42.8 -49.01 6.14 Favored Glycine 0 C--N 1.308 -1.006 0 O-C-N 124.716 1.26 . . . . 21.91 115.122 165.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1329 ' ' THR . . . . . . . . . . . . . 8.7 m -72.56 -35.28 67.95 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 117.669 0.734 . . . . 22.149999999999999 109.631 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1330 ' ' ASN . . . . . . . . . . . . . 9.5 m120 -55.1 -46.07 75.5 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 123.765 0.666 . . . . 26.18 110.362 172.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1331 ' ' LEU . . . . . . . . . . . . . 14.6 mt -66.54 -41.22 89.04 Favored 'General case' 0 C--O 1.253 1.246 0 O-C-N 119.729 -1.857 . . . . 23.68 110.339 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1332 ' ' VAL . . . . . . . . . . . . . 69.7 t -55.09 -48.77 75.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 O-C-N 123.493 0.495 . . . . 26.57 109.807 174.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -62.09 -35.18 77.91 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 124.327 1.051 . . . . 28.079999999999998 112.13 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1334 ' ' LEU . . . . . . . . . . . . . 32.3 tp -64.85 -58.9 4.96 Favored 'General case' 0 CA--C 1.492 -1.256 0 C-N-CA 124.446 1.099 . . . . 27.43 109.818 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1335 ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.11 -39.46 86.26 Favored 'General case' 0 C--O 1.242 0.694 0 O-C-N 124.708 1.255 . . . . 30.5 112.977 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1336 ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -54.64 -44.98 73.68 Favored 'General case' 0 CA--C 1.495 -1.17 0 C-N-CA 124.483 1.113 . . . . 41.649999999999999 113.16 171.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 13.5 tp -85.75 -25.39 26.45 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.26 -0.9 . . . . 42.079999999999998 113.267 -174.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1338 ' ' LEU . . . . . . . . . . . . . 7.3 mt -73.08 -67.97 0.53 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.45 -1.315 . . . . 35.030000000000001 107.45 170.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 43.8 t -85.43 73.23 10.55 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 107.187 -1.412 . . . . 37.329999999999998 107.187 -174.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 61.7 mttp -68.18 -22.28 64.83 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 119.471 -2.018 . . . . 50.509999999999998 111.743 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -78.11 -10.51 59.66 Favored 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 120.271 -1.518 . . . . 54.210000000000001 113.021 174.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 91.3 mttt 52.31 41.99 30.74 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-O 125.793 2.711 . . . . 50.990000000000002 111.787 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -105.73 -43.98 4.77 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 126.196 1.798 . . . . 48.82 109.548 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 132.69 -9.29 5.24 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 109.069 -1.612 . . . . 40.43 109.069 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -82.49 120.8 25.95 Favored 'General case' 0 C--O 1.242 0.665 0 O-C-N 119.256 -2.32 . . . . 47.560000000000002 109.453 175.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1346 ' ' ILE . . . . . . . . . . . . . 31.4 mm -68.11 90.5 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-N 114.171 -1.377 . . . . 42.490000000000002 110.413 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1347 ' ' THR . . . . . . . . . . . . . 92.5 m -74.47 90.88 2.22 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 123.869 1.795 . . . . 38.119999999999997 109.555 -177.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 39.4 t -84.17 90.53 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 106.697 -1.594 . . . . 37.5 106.697 171.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 10.5 t70 -77.7 147.21 35.56 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 109.067 -3.697 . . . . 43.850000000000001 108.409 175.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1350 ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -109.5 -16.83 13.9 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 118.599 -1.24 . . . . 39.810000000000002 113.689 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -91.35 -16.23 27.77 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 114.094 1.146 . . . . 51.289999999999999 114.094 -175.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 54.6 t0 -83.92 116.32 22.73 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 105.027 -2.212 . . . . 39.780000000000001 105.027 158.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 11.1 m -55.5 -25.33 17.51 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 C-N-CA 125.186 1.394 . . . . 39.280000000000001 109.822 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1354 ' ' VAL . . . . . . . . . . . . . 73.9 t -64.48 -50.75 74.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 117.68 -1.152 . . . . 35.700000000000003 110.907 175.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1355 ' ' ILE . . . . . . . . . . . . . 23.1 mm -70.95 -42.39 77.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 119.634 -0.826 . . . . 35.770000000000003 110.563 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 48.5 tpt85 -52.37 -36.91 54.99 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 112.849 -1.978 . . . . 38.549999999999997 113.059 169.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -80.8 -51.05 4.97 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 121.88 2.127 . . . . 29.579999999999998 112.525 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1358 ' ' VAL . . . . . . . . . . . . . 10.6 p -63.27 -35.68 73.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 118.917 1.358 . . . . 32.060000000000002 112.132 -171.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1359 ' ' THR . . . . . . . . . . . . . 14.0 m -84.21 88.22 7.21 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 103.268 -2.864 . . . . 29.0 103.268 -178.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1360 ' ' VAL . . . . . . . . . . . . . 35.7 m -70.83 -25.42 26.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 114.816 -1.083 . . . . 29.68 112.428 -176.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 75.7 mt -139.79 136.92 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 103.121 -2.918 . . . . 32.049999999999997 103.121 175.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1362 ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -120.66 108.82 14.47 Favored 'General case' 0 C--O 1.254 1.318 0 N-CA-C 105.392 -2.077 . . . . 32.520000000000003 105.392 171.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 35.87 77.36 0.04 OUTLIER 'General case' 0 C--O 1.241 0.617 0 N-CA-C 116.335 1.976 . . . . 35.68 116.335 -170.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 80.65 -43.74 2.83 Favored Glycine 0 C--N 1.308 -1.013 0 CA-C-N 114.005 -1.452 . . . . 34.259999999999998 115.005 176.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -68.01 116.05 8.21 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 119.609 1.704 . . . . 51.07 112.04 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 83.5 mt -68.91 110.55 2.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 121.166 -0.959 . . . . 39.869999999999997 109.299 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1367 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.55 -20.14 25.44 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 115.474 1.657 . . . . 38.009999999999998 115.474 168.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B 1368 ' ' TRP . . . . . . . . . . . . . 15.2 t90 -57.71 146.07 67.65 Favored Pre-proline 0 C--O 1.244 0.774 0 C-N-CA 123.281 0.632 . . . . 42.140000000000001 110.767 176.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -78.1 -172.21 10.94 Favored 'Cis proline' 0 C--N 1.369 1.644 0 CA-C-N 121.362 1.522 . . . . 43.259999999999998 115.046 -5.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1370 ' ' ALA . . . . . . . . . . . . . . . -78.8 162.01 66.77 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 114.624 -1.171 . . . . 46.520000000000003 108.72 166.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -59.59 153.01 58.15 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 123.918 3.078 . . . . 51.950000000000003 108.995 162.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -57.53 113.61 1.58 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 1 C-N-CA 126.662 4.908 . . . . 56.270000000000003 115.056 -177.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B 1373 ' ' ILE . . . . . . . . . . . . . 50.7 mm -92.49 120.28 41.5 Favored 'Isoleucine or valine' 0 C--O 1.255 1.377 0 O-C-N 120.715 -1.24 . . . . 60.829999999999998 110.927 -174.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -92.46 127.88 38.11 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.961 -1.126 . . . . 66.099999999999994 107.961 174.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 19.9 t -124.72 118.57 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 113.401 -1.727 . . . . 63.469999999999999 107.693 -170.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.223 -4.906 0 O-C-N 117.774 -3.079 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.582 0 CA-C-O 118.926 -0.559 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -23.76 67.37 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 121.18 1.809 . . . . 0.0 113.323 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 32.7 mp0 -53.91 -50.68 65.84 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 123.107 1.432 . . . . 0.0 110.734 165.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 3.3 m -65.0 -38.21 90.19 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 113.579 -1.646 . . . . 0.0 109.362 -171.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.95 76.13 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-O 124.193 1.949 . . . . 0.0 114.682 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -70.25 -52.22 24.71 Favored 'General case' 0 C--O 1.249 1.076 0 CA-C-N 114.044 -1.434 . . . . 0.0 112.343 172.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 74.8 mt -62.58 -43.08 99.7 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-O 116.965 -1.493 . . . . 0.0 113.368 -175.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 43.7 mt -52.39 -51.32 59.61 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 28' ' ' LYS . . . . . . . . . . . . . 13.3 pttm -65.93 -26.49 67.62 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -72.32 -35.67 68.68 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.304 1.041 . . . . 0.0 110.178 170.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 58.2 m -54.28 -43.99 71.5 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 120.941 3.682 . . . . 0.0 120.941 -167.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . 0.27 56.3 p-80 43.58 -18.22 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 123.418 2.827 . . . . 0.0 117.288 -160.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 19.3 m -136.17 127.32 28.04 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.652 -3.78 . . . . 0.0 104.936 169.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 77.3 t -137.03 126.88 38.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 104.104 -2.554 . . . . 0.0 104.104 -174.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 21.8 mm -109.26 132.91 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 172.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 55.5 mt -98.64 117.06 43.06 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 170.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 89.8 m -113.47 99.78 50.29 Favored Pre-proline 0 N--CA 1.44 -0.971 0 CA-C-O 122.597 1.189 . . . . 0.0 110.779 175.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -81.84 147.26 15.12 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 124.573 3.516 . . . . 0.0 114.973 178.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -159.95 120.29 0.95 Allowed Glycine 0 N--CA 1.415 -2.718 0 N-CA-C 108.014 -2.035 . . . . 0.0 108.014 166.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 4.3 t80 61.45 -67.35 0.06 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.212 1.405 . . . . 0.0 113.839 -175.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -47.85 -43.3 23.12 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-N 121.394 1.906 . . . . 0.0 116.117 -170.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 5.6 ttm -47.24 -46.98 24.79 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 123.097 1.427 . . . . 0.0 113.49 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.16 -56.27 4.34 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.68 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 p -62.81 -30.46 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 N-CA-C 117.392 2.367 . . . . 0.0 117.392 -168.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.18 18.75 17.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.366 -0.833 . . . . 0.0 108.857 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 45' ' ' GLN . . . . . . . . . . . . 0.255 0.1 OUTLIER 35.31 46.73 0.27 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 124.95 2.31 . . . . 0.0 112.899 -158.347 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.81 -20.16 63.46 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 114.203 -1.362 . . . . 0.0 113.523 -175.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.95 -39.13 77.34 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 176.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 48' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -59.2 -41.2 86.45 Favored Pre-proline 0 CA--C 1.553 1.07 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 49' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -67.32 -39.76 12.3 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 123.267 2.645 . . . . 0.0 111.671 164.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 64.2 t -58.93 -33.67 50.48 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 O-C-N 121.57 -0.706 . . . . 0.0 110.304 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.35 -54.07 50.97 Favored 'General case' 0 C--O 1.243 0.739 0 O-C-N 120.308 -1.495 . . . . 0.0 107.386 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -54.94 -37.64 66.7 Favored 'General case' 0 C--O 1.249 1.037 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 9.0 tp -78.05 -44.47 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 O-C-N 121.466 -0.771 . . . . 0.0 111.493 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 88.3 m -59.87 -34.67 73.45 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -58.98 -52.95 63.57 Favored 'General case' 0 C--O 1.266 1.944 0 C-N-CA 124.658 1.183 . . . . 0.0 107.936 -175.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -74.85 -32.96 62.05 Favored 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 120.753 -1.217 . . . . 0.0 112.597 -177.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 93.6 mt -60.87 -42.08 97.21 Favored 'General case' 0 C--O 1.211 -0.93 0 O-C-N 120.659 -1.275 . . . . 0.0 110.566 174.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -78.01 -27.78 49.01 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 119.743 -1.848 . . . . 0.0 110.934 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.05 -34.27 77.69 Favored 'General case' 0 C--N 1.349 0.548 0 O-C-N 121.587 -0.696 . . . . 0.0 109.89 173.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 9.2 ttm-85 -79.61 3.34 19.27 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 118.877 0.762 . . . . 0.0 111.182 174.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.44 36.92 78.46 Favored Glycine 0 C--O 1.251 1.185 0 O-C-N 120.395 -1.441 . . . . 0.0 111.067 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 7.0 mt -85.31 140.15 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -68.3 75.87 0.25 Allowed 'General case' 0 C--O 1.239 0.53 0 O-C-N 121.149 -0.969 . . . . 0.0 109.069 166.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 8.1 p -97.06 118.72 44.03 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 175.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 31.7 mmm-85 -126.2 144.35 50.8 Favored 'General case' 0 C--N 1.312 -1.036 0 O-C-N 124.842 1.339 . . . . 0.0 109.004 -173.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -100.08 98.11 8.87 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 123.666 1.698 . . . . 0.0 112.618 -176.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.88 83.11 1.63 Allowed Glycine 0 C--N 1.34 0.786 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . 0.273 1.7 mp -77.89 112.89 16.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 122.006 0.908 . . . . 0.0 110.989 178.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -86.13 86.54 0.09 OUTLIER Pre-proline 0 N--CA 1.449 -0.477 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 165.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 70' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -48.25 -52.87 7.61 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 125.211 3.94 . . . . 0.0 118.055 -165.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.6 92.07 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 N-CA-C 102.13 -3.285 . . . . 0.0 102.13 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -153.68 104.84 2.74 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 123.224 1.487 . . . . 0.0 113.387 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.94 -98.32 2.35 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 111.723 -2.489 . . . . 0.0 108.149 177.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -128.15 111.89 13.96 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 125.184 1.167 . . . . 0.0 112.549 -170.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 6.7 mp 71.62 134.04 0.04 OUTLIER Pre-proline 0 C--O 1.254 1.322 0 O-C-N 125.766 1.916 . . . . 0.0 112.481 -170.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.35 124.64 12.78 Favored 'Trans proline' 0 N--CA 1.432 -2.091 0 C-N-CA 121.951 1.767 . . . . 0.0 107.708 167.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 78.26 3.94 86.12 Favored Glycine 0 CA--C 1.54 1.626 0 CA-C-N 114.053 -1.431 . . . . 0.0 114.051 169.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 21.3 t-160 -54.49 -31.46 55.93 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -44.15 97.24 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 172.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -65.81 -36.49 83.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 122.413 1.102 . . . . 0.0 109.638 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 51.1 t -61.08 -43.65 96.67 Favored 'Isoleucine or valine' 0 C--N 1.357 0.903 0 CA-C-O 116.815 -1.564 . . . . 0.0 108.594 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 10.9 mp -82.61 -16.97 46.39 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 120.658 1.572 . . . . 0.0 112.104 174.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 15.0 tp -63.42 -32.15 73.51 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 117.492 -3.255 . . . . 0.0 110.576 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.75 -33.73 64.57 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 169.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -67.27 -45.21 77.31 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 120.274 -1.516 . . . . 0.0 113.598 166.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.52 -11.22 41.66 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt 64.78 22.8 12.61 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 169.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 74.9 t -84.55 121.75 74.93 Favored Pre-proline 0 C--O 1.249 1.034 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 173.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -50.39 124.81 13.84 Favored 'Trans proline' 0 N--CA 1.442 -1.541 1 C-N-CA 126.392 4.728 . . . . 0.0 114.339 177.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -63.18 -16.34 59.82 Favored 'General case' 0 C--N 1.363 1.168 0 O-C-N 120.144 -1.598 . . . . 0.0 115.052 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -61.75 -40.04 93.74 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 123.345 0.658 . . . . 0.0 111.485 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 22.5 pt -75.44 -8.29 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 O-C-N 118.023 -2.923 . . . . 0.0 117.387 173.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 16.8 t -88.06 121.47 38.5 Favored 'Isoleucine or valine' 0 C--O 1.248 1.02 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 6.2 mp -104.27 97.26 7.23 Favored 'General case' 0 C--O 1.25 1.107 0 CA-C-N 113.335 -1.757 . . . . 0.0 108.564 168.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 95' ' ' GLU . . . . . 0.488 ' CD ' ' HZ3' ' A' 1162 ' ' LYS . 53.7 mp0 -81.84 93.45 6.87 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 4.0 tpp 56.55 29.57 15.74 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.451 1.9 . . . . 0.0 112.271 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -92.11 172.7 8.25 Favored 'General case' 0 C--O 1.251 1.163 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 173.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -67.7 87.67 0.23 Allowed 'General case' 0 C--N 1.347 0.491 0 CA-C-O 123.724 1.726 . . . . 0.0 113.464 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 6.5 tp -101.29 7.31 9.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-N 110.712 -2.949 . . . . 0.0 110.543 174.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -58.94 -49.11 79.08 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 119.765 -1.834 . . . . 0.0 112.168 -171.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -79.42 -29.54 41.95 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.839 0.828 . . . . 0.0 110.833 -174.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.73 -32.12 73.51 Favored 'General case' 0 N--CA 1.433 -1.319 0 O-C-N 121.051 -1.031 . . . . 0.0 112.826 169.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 103' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -63.22 -48.54 77.86 Favored 'General case' 0 N--CA 1.426 -1.657 0 O-C-N 119.606 -1.934 . . . . 0.0 111.617 169.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.15 -27.67 69.11 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 124.319 1.012 . . . . 0.0 112.959 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -72.16 -40.57 67.89 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.799 1.285 . . . . 0.0 112.179 174.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 106' ' ' THR . . . . . . . . . . . . . 3.1 m -60.6 143.58 53.6 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 112.901 -1.954 . . . . 0.0 114.856 -174.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 107' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -92.56 -62.87 1.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 112.337 -2.21 . . . . 0.0 107.948 175.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 97.0 m -108.44 126.19 52.61 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-O 123.789 1.757 . . . . 0.0 111.134 -178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 109' ' ' VAL . . . . . . . . . . . . . 3.2 t -108.96 119.93 59.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.985 0 CA-C-N 113.191 -1.822 . . . . 0.0 106.73 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 34.7 mt -91.14 91.54 8.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 123.745 1.736 . . . . 0.0 110.019 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 12.0 t -90.87 99.87 10.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 -175.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 26.4 mm -78.86 97.9 2.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 CA-C-N 112.314 -2.221 . . . . 0.0 110.394 -171.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.04 -100.76 1.16 Allowed Glycine 0 C--N 1.334 0.467 0 N-CA-C 107.233 -2.347 . . . . 0.0 107.233 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . 57.41 -56.55 0.03 OUTLIER 'General case' 0 C--O 1.25 1.113 1 N-CA-C 126.336 5.68 . . . . 0.0 126.336 162.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 115' ' ' ASN . . . . . . . . . . . . 0.344 2.7 p-10 24.48 -80.44 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 120.391 3.478 . . . . 0.0 120.391 -169.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 116' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -64.35 -18.38 64.6 Favored 'General case' 0 C--O 1.241 0.648 0 O-C-N 118.067 -2.896 . . . . 0.0 114.36 -177.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 30.8 m -45.66 -35.96 4.52 Favored 'General case' 0 C--O 1.248 0.993 0 C-N-CA 125.627 1.571 . . . . 0.0 111.792 169.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 4.3 m -127.44 20.45 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 O-C-N 120.28 -1.512 . . . . 0.0 113.184 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -73.12 108.36 4.47 Favored Pre-proline 0 C--N 1.32 -0.688 0 O-C-N 119.656 -1.902 . . . . 0.0 111.025 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 120' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -56.3 -27.19 65.65 Favored 'Trans proline' 0 N--CA 1.441 -1.601 0 C-N-CA 125.041 3.827 . . . . 0.0 115.868 -172.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -55.88 -39.16 71.15 Favored 'General case' 0 C--O 1.204 -1.324 0 O-C-N 125.719 1.887 . . . . 0.0 111.874 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 122' ' ' ALA . . . . . . . . . . . . . . . -57.35 -21.86 38.5 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 117.998 2.592 . . . . 0.0 117.998 177.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -102.45 -43.92 5.51 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 117.859 -1.536 . . . . 0.0 112.591 169.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.37 -30.13 47.78 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 122.98 1.372 . . . . 0.0 111.66 -171.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -107.94 101.7 42.18 Favored Pre-proline 0 N--CA 1.429 -1.477 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 -169.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -55.13 -39.06 92.92 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 124.009 3.139 . . . . 0.0 114.26 171.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -53.4 -21.09 5.35 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 128' ' ' SER . . . . . . . . . . . . . 22.3 m -48.1 134.49 11.95 Favored Pre-proline 0 N--CA 1.434 -1.227 0 O-C-N 120.685 -1.26 . . . . 0.0 113.822 172.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 129' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -55.39 -38.0 94.26 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 124.912 3.742 . . . . 0.0 117.777 172.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 130' ' ' ILE . . . . . . . . . . . . 0.291 39.3 pt -77.19 104.64 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.367 168.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.7 115.02 4.37 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 113.125 -1.852 . . . . 0.0 111.363 -168.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 29.56 69.18 0.08 OUTLIER Glycine 0 N--CA 1.473 1.108 0 CA-C-O 116.525 -2.264 . . . . 0.0 114.192 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 133' ' ' MET . . . . . . . . . . . . . 5.9 tpp -96.2 126.22 45.0 Favored Pre-proline 0 N--CA 1.434 -1.247 0 CA-C-N 119.638 1.719 . . . . 0.0 113.344 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -66.54 81.05 0.32 Allowed 'Trans proline' 0 C--O 1.262 1.707 1 C-N-CA 125.696 4.264 . . . . 0.0 107.247 168.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 6.3 m -69.38 137.0 25.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.363 171.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 7.8 tp -78.53 83.42 4.73 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.301 -1.318 . . . . 0.0 113.564 -166.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . 0.28 34.2 mm-40 42.04 -26.44 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.329 1 N-CA-C 128.213 6.375 . . . . 0.0 128.213 160.092 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 4.4 p -73.96 14.78 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.491 0 O-C-N 117.144 -3.472 . . . . 0.0 117.152 -160.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 5.3 p90 -69.19 142.67 54.22 Favored 'General case' 0 C--O 1.244 0.772 0 O-C-N 119.45 -2.031 . . . . 0.0 109.006 176.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.77 24.46 0.34 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 127.055 2.142 . . . . 0.0 116.588 -166.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -101.12 70.47 1.34 Allowed 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 123.154 1.454 . . . . 0.0 110.112 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 64.75 -135.66 0.26 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 112.271 -2.241 . . . . 0.0 114.487 171.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 143' ' ' ASN . . . . . . . . . . . . . 53.8 m-20 -85.57 84.87 7.48 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 118.986 -1.086 . . . . 0.0 109.102 -168.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 144' ' ' VAL . . . . . . . . . . . . . 58.2 t -88.51 88.25 2.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 102.617 -3.105 . . . . 0.0 102.617 -173.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 145' ' ' ILE . . . . . . . . . . . . . 97.4 mt -88.92 97.79 7.31 Favored 'Isoleucine or valine' 0 C--O 1.251 1.171 0 CA-C-O 123.308 1.528 . . . . 0.0 107.802 -173.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 146' ' ' VAL . . . . . . . . . . . . . 48.7 t -85.44 104.22 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 113.298 -1.774 . . . . 0.0 106.967 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 147' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -67.55 91.64 0.29 Allowed 'General case' 0 C--O 1.242 0.661 0 O-C-N 120.625 -1.297 . . . . 0.0 109.646 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 148' ' ' LYS . . . . . 0.428 ' NZ ' ' OD1' ' C' ' 152' ' ' ASN . 15.7 mmmt -118.62 110.45 17.34 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.171 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -64.35 -36.0 82.7 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.046 1.338 . . . . 0.0 109.683 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 10.7 m -139.5 137.41 35.48 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 5.2 tpt -77.35 98.31 5.19 Favored 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 118.791 -2.443 . . . . 0.0 109.007 170.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 152' ' ' ASN . . . . . 0.428 ' OD1' ' NZ ' ' C' ' 148' ' ' LYS . 38.5 p30 -140.68 152.17 45.15 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 110.837 -2.892 . . . . 0.0 108.952 177.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 98.6 m -65.17 120.39 12.62 Favored 'General case' 0 C--N 1.358 0.977 0 O-C-N 125.073 1.483 . . . . 0.0 107.797 176.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -78.58 -115.76 0.21 Allowed Glycine 0 N--CA 1.424 -2.118 0 CA-C-N 112.358 -2.201 . . . . 0.0 108.272 167.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -79.7 -53.65 6.61 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 156' ' ' ALA . . . . . . . . . . . . . . . -92.57 -60.32 1.86 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.362 0.983 . . . . 0.0 108.37 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.46 44.5 93.66 Favored Glycine 0 CA--C 1.492 -1.368 0 CA-C-N 113.544 -1.662 . . . . 0.0 112.257 -176.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 28.4 m -123.37 157.56 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-O 122.309 1.052 . . . . 0.0 112.503 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -30.59 123.67 0.19 Allowed 'General case' 0 C--O 1.242 0.679 1 N-CA-C 122.008 4.077 . . . . 0.0 122.008 178.491 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 160' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -168.22 163.59 8.66 Favored Pre-proline 0 C--O 1.268 2.052 0 C-N-CA 126.088 1.755 . . . . 0.0 109.99 -176.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.74 -36.23 1.66 Allowed 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 124.106 3.204 . . . . 0.0 115.212 169.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 162' ' ' LEU . . . . . . . . . . . . . 8.1 tt -58.07 -35.66 71.7 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -166.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 163' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -70.39 -29.0 65.52 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 118.298 -2.751 . . . . 0.0 113.361 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -102.94 -17.9 15.27 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.169 -1.378 . . . . 0.0 114.206 -162.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -73.64 -177.26 2.65 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.698 1.237 . . . . 0.0 111.986 -170.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -88.63 -63.17 1.34 Allowed 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 120.361 -1.462 . . . . 0.0 109.616 -164.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -86.94 -26.15 24.01 Favored 'General case' 0 C--O 1.243 0.753 0 O-C-N 120.329 -1.482 . . . . 0.0 112.442 170.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 168' ' ' THR . . . . . . . . . . . . . 96.3 m -88.81 91.11 8.69 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 124.45 2.072 . . . . 0.0 105.467 165.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -146.89 137.79 23.91 Favored 'General case' 0 N--CA 1.432 -1.34 0 O-C-N 118.682 -2.511 . . . . 0.0 111.585 -160.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 170' ' ' MET . . . . . . . . . . . . . 54.3 mtm -69.97 107.58 3.66 Favored 'General case' 0 N--CA 1.418 -2.044 0 O-C-N 121.507 -0.746 . . . . 0.0 110.077 162.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 171' ' ' LEU . . . . . . . . . . . . . 7.5 mp -79.22 130.56 35.6 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 172.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -82.5 85.73 6.89 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 125.675 1.86 . . . . 0.0 110.853 -167.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -162.68 150.14 18.86 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 124.561 1.077 . . . . 0.0 111.388 -173.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 174' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -68.07 149.42 49.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.607 -0.796 . . . . 0.0 112.01 176.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.82 -51.67 45.96 Favored 'General case' 0 C--O 1.241 0.653 0 O-C-N 121.329 -0.857 . . . . 0.0 108.879 -175.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.66 -54.5 19.08 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 116.39 -1.767 . . . . 0.0 106.277 178.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 177' ' ' ALA . . . . . . . . . . . . . . . -53.47 -55.99 20.69 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 -174.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 6.4 m -60.71 -37.52 81.98 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 121.622 -0.674 . . . . 0.0 110.869 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 179' ' ' VAL . . . . . . . . . . . . . 50.9 t -67.56 -36.99 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 120.617 -1.302 . . . . 0.0 110.366 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -59.39 -39.17 82.5 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 125.934 1.694 . . . . 0.0 109.661 174.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.34 -52.98 62.41 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 120.926 0.393 . . . . 0.0 110.075 173.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 182' ' ' ILE . . . . . . . . . . . . . 20.8 pt -75.53 -19.77 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 O-C-N 119.592 -1.943 . . . . 0.0 114.106 -175.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 183' ' ' LEU . . . . . . . . . . . . . 4.2 pp -58.57 -44.85 89.87 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 122.106 2.23 . . . . 0.0 115.271 -167.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -96.12 -14.4 22.87 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.575 168.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -80.19 -74.47 0.31 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 119.251 -0.98 . . . . 0.0 111.607 -176.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 186' ' ' LEU . . . . . . . . . . . . 0.301 1.9 pt? . . . . . 0 C--N 1.363 1.158 0 N-CA-C 117.582 2.438 . . . . 0.0 117.582 -171.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' NAD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C 1001 ' ' NAP . . . . . 0.424 ' O3B' ' NZ ' ' C' ' 148' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 26.4 t-80 . . . . . 0 CA--C 1.512 -0.505 0 N-CA-C 102.757 -3.053 . . . . 65.739999999999995 102.757 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -69.17 78.13 0.3 Allowed Glycine 0 CA--C 1.533 1.176 0 CA-C-O 122.337 0.965 . . . . 48.659999999999997 112.565 -167.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 21.1 ttp180 -125.55 141.06 52.24 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 103.323 -2.843 . . . . 44.560000000000002 103.323 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1003 ' ' ILE . . . . . . . . . . . . . 96.0 mt -105.88 127.07 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 O-C-N 117.995 -2.941 . . . . 34.859999999999999 104.787 169.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -92.89 136.71 13.3 Favored Glycine 0 N--CA 1.434 -1.487 0 CA-C-N 115.463 -0.79 . . . . 30.75 111.419 170.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 37.5 mm -109.87 99.31 38.05 Favored Pre-proline 0 C--O 1.248 0.99 0 N-CA-C 103.75 -2.685 . . . . 32.210000000000001 103.75 173.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -80.57 144.68 15.95 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 124.536 3.491 . . . . 32.979999999999997 112.636 174.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1007 ' ' ARG . . . . . . . . . . . . . 10.0 ttp85 -75.42 155.11 36.68 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 113.25 -1.795 . . . . 47.979999999999997 107.878 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1008 ' ' GLU . . . . . 0.473 ' CD ' ' HZ1' ' A' 1071 ' ' LYS . 4.7 mm-40 -83.9 146.23 28.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 118.409 2.744 . . . . 34.700000000000003 118.409 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -83.45 -30.28 27.37 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 111.704 -2.498 . . . . 53.369999999999997 110.792 166.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 2.5 mp -49.32 135.64 16.96 Favored 'General case' 0 C--O 1.251 1.175 0 C-N-CA 125.024 1.33 . . . . 45.07 113.389 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1011 ' ' THR . . . . . . . . . . . . . 2.3 m -68.95 147.17 52.03 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 123.289 1.518 . . . . 40.359999999999999 107.205 -177.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 10.7 t30 65.06 -17.01 0.09 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 112.795 -2.002 . . . . 40.609999999999999 114.354 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -69.53 112.92 6.37 Favored 'General case' 0 C--O 1.243 0.713 0 O-C-N 119.398 -2.064 . . . . 33.759999999999998 111.049 -165.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1014 ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.36 -13.19 23.43 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 112.727 0.64 . . . . 27.890000000000001 112.727 173.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1015 ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.02 136.88 39.96 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 118.988 -2.32 . . . . 29.02 106.555 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1016 ' ' VAL . . . . . . . . . . . . . 4.2 p -109.72 -178.51 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.101 0 N-CA-C 106.42 -1.696 . . . . 28.129999999999999 106.42 168.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1017 ' ' ALA . . . . . . . . . . . . . . . -68.99 -53.65 19.45 Favored 'General case' 0 C--N 1.309 -1.18 0 O-C-N 120.538 -1.351 . . . . 26.870000000000001 111.817 -176.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -136.03 140.76 44.1 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.675 0.75 . . . . 26.77 112.404 -173.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1019 ' ' THR . . . . . . . . . . . . . 3.4 p -79.6 166.66 39.69 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 124.311 1.044 . . . . 27.02 111.494 172.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1020 ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -51.07 -38.94 60.81 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.614 2.876 . . . . 30.57 114.585 171.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 52.2 mttp -56.1 -48.89 75.29 Favored 'General case' 0 C--O 1.219 -0.541 0 O-C-N 123.965 0.791 . . . . 47.810000000000002 111.802 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1022 ' ' THR . . . . . . . . . . . . . 1.9 p -74.44 -40.08 62.16 Favored 'General case' 0 C--N 1.348 0.505 0 C-N-CA 119.354 -0.938 . . . . 30.77 111.11 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1023 ' ' VAL . . . . . . . . . . . . . 3.3 t -51.65 -42.46 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 113.091 0.775 . . . . 33.590000000000003 113.091 170.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -59.4 -43.77 92.94 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 124.278 1.031 . . . . 53.289999999999999 109.545 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -69.06 -40.38 78.56 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 125.294 1.438 . . . . 46.920000000000002 110.014 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1026 ' ' LEU . . . . . . . . . . . . . 91.0 mt -54.51 -46.49 73.51 Favored 'General case' 0 C--O 1.248 0.974 0 C-N-CA 124.036 0.934 . . . . 37.170000000000002 112.364 171.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 14.3 mt -57.85 -43.0 85.6 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-O 118.177 -0.916 . . . . 44.439999999999998 111.922 170.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 55.7 mmtt -60.38 -20.29 58.98 Favored 'General case' 0 C--O 1.257 1.493 0 C-N-CA 124.296 1.039 . . . . 52.579999999999998 113.714 174.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1029 ' ' LEU . . . . . . . . . . . . . 32.3 mt -78.35 24.31 0.27 Allowed 'General case' 0 N--CA 1.472 0.67 0 O-C-N 119.617 -1.927 . . . . 45.689999999999998 114.791 164.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 68.94 13.75 66.99 Favored Glycine 0 C--N 1.343 0.933 0 O-C-N 119.899 -1.75 . . . . 42.090000000000003 113.546 -176.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -93.29 159.44 15.27 Favored 'General case' 0 C--O 1.251 1.176 0 CA-C-N 121.91 2.855 . . . . 40.719999999999999 110.928 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1032 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.95 155.2 19.96 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 103.707 -2.701 . . . . 37.770000000000003 103.707 158.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1033 ' ' VAL . . . . . . . . . . . . . 87.2 t -135.51 131.3 51.11 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 O-C-N 120.037 -1.665 . . . . 33.539999999999999 108.511 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -116.07 143.59 45.26 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 119.217 0.917 . . . . 31.68 109.46 171.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1035 ' ' VAL . . . . . . . . . . . . . 80.0 t -128.77 137.0 58.46 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.52 0 O-C-N 119.452 -2.03 . . . . 31.52 108.273 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1036 ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -73.3 119.43 17.52 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 119.542 -1.974 . . . . 41.039999999999999 108.419 174.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1037 ' ' SER . . . . . . . . . . . . . 19.7 t -63.49 144.18 57.2 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.853 0.835 . . . . 31.829999999999998 110.072 -171.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 110.27 -31.61 7.29 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 107.378 -2.289 . . . . 29.359999999999999 107.378 -169.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -52.44 -34.03 46.77 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.456 1.28 . . . . 27.780000000000001 114.456 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -60.6 -48.85 84.14 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 120.306 1.412 . . . . 28.91 112.25 172.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -65.05 -31.72 73.09 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 114.507 -0.847 . . . . 51.18 112.518 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1042 ' ' LEU . . . . . . . . . . . . . 8.9 mp -67.91 -66.9 0.51 Allowed 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.587 0.708 . . . . 29.91 109.407 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1043 ' ' ALA . . . . . . . . . . . . . . . -66.36 -5.54 11.11 Favored 'General case' 0 N--CA 1.439 -1.0 0 O-C-N 121.239 -0.913 . . . . 28.539999999999999 111.496 -171.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1044 ' ' SER . . . . . . . . . . . . . 16.6 m 62.45 72.59 0.49 Allowed 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 126.967 3.27 . . . . 33.060000000000002 110.077 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1045 ' ' PHE . . . . . . . . . . . . . 1.9 t80 -157.57 155.03 29.49 Favored 'General case' 0 N--CA 1.423 -1.784 1 CA-C-N 108.063 -4.153 . . . . 30.289999999999999 101.896 -172.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 10.7 t0 -68.18 123.83 21.77 Favored 'General case' 0 N--CA 1.439 -0.999 0 O-C-N 120.394 -1.441 . . . . 48.619999999999997 109.688 171.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.65 -49.34 77.93 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 122.811 1.291 . . . . 36.740000000000002 111.69 176.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.01 -13.71 62.35 Favored 'General case' 0 N--CA 1.434 -1.273 0 O-C-N 119.031 -2.293 . . . . 43.729999999999997 112.081 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -65.19 -15.63 62.65 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 116.957 -1.497 . . . . 32.810000000000002 113.904 168.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1050 ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -65.82 -47.0 76.51 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 106.464 -1.68 . . . . 31.859999999999999 106.464 167.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 76.6 t -60.71 -38.55 78.99 Favored 'Isoleucine or valine' 0 C--O 1.254 1.318 0 CA-C-O 118.266 -0.873 . . . . 33.219999999999999 111.242 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -52.91 -50.58 63.66 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 119.398 0.999 . . . . 50.829999999999998 113.009 171.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -61.37 -33.89 74.39 Favored 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 124.339 1.056 . . . . 33.119999999999997 112.213 173.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 114.24 15.96 8.05 Favored Glycine 0 C--O 1.257 1.552 0 O-C-N 120.436 -1.415 . . . . 35.829999999999998 111.326 175.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -84.42 140.15 31.73 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 107.374 -1.343 . . . . 34.82 107.374 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -70.09 121.3 17.21 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 117.534 -1.222 . . . . 49.049999999999997 111.101 172.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1057 ' ' ILE . . . . . . . . . . . . . 3.6 mm -90.11 103.16 13.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 104.9 -2.259 . . . . 38.530000000000001 104.9 177.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1058 ' ' VAL . . . . . . . . . . . . . 34.6 m -110.98 172.15 2.78 Favored 'Isoleucine or valine' 0 C--O 1.252 1.236 0 CA-C-N 113.309 -1.769 . . . . 42.109999999999999 108.432 -170.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -119.35 131.99 55.79 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 106.666 -1.605 . . . . 58.0 106.666 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 54.86 -129.14 44.7 Favored Glycine 0 CA--C 1.526 0.736 0 O-C-N 125.375 1.672 . . . . 52.119999999999997 112.918 169.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 1.4 t30 -57.0 -26.43 60.22 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 112.807 -1.697 . . . . 54.75 112.643 -168.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1062 ' ' SER . . . . . . . . . . . . . 3.0 m -55.83 -37.31 68.53 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-O 122.56 1.172 . . . . 50.340000000000003 111.863 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 9.3 p -62.26 -33.43 58.83 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.186 0 O-C-N 119.19 -2.194 . . . . 41.460000000000001 116.183 176.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1064 ' ' TRP . . . . . . . . . . . . . 93.2 m95 -74.0 -15.86 61.08 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 113.551 0.945 . . . . 39.32 113.551 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -82.63 83.02 7.77 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.408 1.099 . . . . 55.380000000000003 108.427 170.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1066 ' ' SER . . . . . . . . . . . . . 66.1 m -153.65 173.9 15.19 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 113.769 -1.56 . . . . 41.869999999999997 110.549 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.74 -57.16 3.96 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 106.976 -1.49 . . . . 53.200000000000003 106.976 173.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 5.4 mp -109.68 149.22 12.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 105.45 -2.056 . . . . 41.899999999999999 105.45 -176.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1069 ' ' ILE . . . . . . . . . . . . . 20.6 mm -128.78 120.16 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 N-CA-C 104.39 -2.448 . . . . 38.729999999999997 104.39 172.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1070 ' ' LEU . . . . . . . . . . . . . 33.9 mt -97.69 97.93 9.44 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 104.908 -2.256 . . . . 32.439999999999998 104.908 175.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1071 ' ' LYS . . . . . 0.473 ' HZ1' ' CD ' ' A' 1008 ' ' GLU . 7.5 tmtt? -90.36 141.51 28.66 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 125.608 2.623 . . . . 34.649999999999999 109.074 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1072 ' ' VAL . . . . . . . . . . . . . 15.1 t -62.86 -46.34 96.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 111.531 -2.577 . . . . 31.32 109.888 -168.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -127.42 -160.11 0.98 Allowed 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.082 -1.081 . . . . 33.939999999999998 108.082 172.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -67.96 147.56 98.46 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 121.869 2.122 . . . . 38.039999999999999 111.481 173.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1075 ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -63.38 132.46 36.02 Favored 'Trans proline' 0 C--O 1.266 1.89 0 C-N-CA 123.332 2.688 . . . . 42.68 111.065 163.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 11.8 mt -90.81 175.98 6.8 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 105.51 -2.033 . . . . 46.740000000000002 105.51 170.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.71 -31.82 49.56 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.655 1.724 . . . . 58.609999999999999 115.655 -171.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 13.1 t70 -65.9 -52.06 53.35 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.037 -0.727 . . . . 59.200000000000003 109.037 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1079 ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -62.92 -31.03 72.02 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 114.294 1.22 . . . . 50.630000000000003 114.294 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1080 ' ' ILE . . . . . . . . . . . . . 57.5 mt -61.97 -44.88 99.52 Favored 'Isoleucine or valine' 0 C--N 1.346 0.418 0 CA-C-N 115.948 -0.569 . . . . 51.479999999999997 111.109 170.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -59.49 -33.23 71.07 Favored 'General case' 0 C--O 1.25 1.112 0 CA-C-O 122.755 1.264 . . . . 50.280000000000001 113.646 170.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 66.2 mt -72.33 -26.77 62.06 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.228 -1.351 . . . . 50.210000000000001 112.49 173.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1083 ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.81 149.73 34.97 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 125.73 2.681 . . . . 49.060000000000002 113.574 172.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -113.3 136.84 21.86 Favored Pre-proline 0 N--CA 1.437 -1.106 0 CA-C-N 111.361 -2.654 . . . . 51.079999999999998 107.097 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -60.2 124.59 15.53 Favored 'Trans proline' 0 N--CA 1.435 -1.914 0 C-N-CA 121.4 1.4 . . . . 49.729999999999997 115.014 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 91.7 8.43 63.77 Favored Glycine 0 C--O 1.259 1.709 0 N-CA-C 111.158 -0.777 . . . . 47.710000000000001 111.158 -177.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1087 ' ' THR . . . . . . . . . . . . . 72.7 m -84.66 145.64 27.87 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 123.208 1.48 . . . . 45.469999999999999 110.652 167.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1088 ' ' THR . . . . . . . . . . . . . 52.3 m -91.98 121.53 33.65 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 118.19 -2.819 . . . . 42.039999999999999 104.295 173.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1089 ' ' LEU . . . . . . . . . . . . . 55.6 tp -106.84 116.66 32.3 Favored 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 123.961 0.904 . . . . 38.060000000000002 109.029 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 38.5 t -114.62 124.49 71.32 Favored 'Isoleucine or valine' 0 C--O 1.25 1.081 0 N-CA-C 105.184 -2.154 . . . . 37.399999999999999 105.184 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1091 ' ' SER . . . . . . . . . . . . . 3.5 m -158.46 168.56 26.62 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 122.424 1.107 . . . . 36.159999999999997 113.049 -174.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -82.23 94.85 7.38 Favored 'General case' 0 C--O 1.25 1.087 0 O-C-N 119.579 -1.951 . . . . 38.939999999999998 108.486 165.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 26.6 mm -84.76 -34.63 9.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 113.864 1.061 . . . . 42.170000000000002 113.864 -172.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 84.0 m95 57.99 60.06 6.29 Favored Pre-proline 0 C--N 1.357 0.921 0 C-N-CA 123.086 0.554 . . . . 46.509999999999998 111.56 -169.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -62.78 -34.22 73.59 Favored 'Trans proline' 0 C--O 1.241 0.646 0 C-N-CA 124.185 3.257 . . . . 49.759999999999998 117.013 -165.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -69.2 -35.99 76.82 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 124.643 1.215 . . . . 52.619999999999997 108.784 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -76.78 -30.28 56.42 Favored 'General case' 0 C--O 1.216 -0.669 0 CA-C-N 115.151 -0.931 . . . . 60.740000000000002 109.34 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1098 ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -109.84 36.03 0.11 Allowed Pre-proline 0 CA--C 1.557 1.215 1 N-CA-C 124.96 5.17 . . . . 58.189999999999998 124.96 -169.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -52.09 -24.08 18.96 Favored 'Trans proline' 0 C--N 1.366 1.493 0 C-N-CA 124.655 3.57 . . . . 54.590000000000003 113.961 175.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -57.84 -59.53 5.09 Favored 'General case' 0 C--O 1.253 1.287 0 CA-C-O 124.396 2.046 . . . . 63.280000000000001 110.019 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1101 ' ' LEU . . . . . . . . . . . . . 5.4 mp -70.55 -42.07 71.66 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 111.526 -2.579 . . . . 54.75 107.587 -175.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1102 ' ' MET . . . . . . . . . . . . . 72.0 mtm -56.74 -39.22 73.56 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 114.757 1.391 . . . . 52.649999999999999 114.757 174.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -62.78 -38.33 90.2 Favored 'General case' 0 C--N 1.35 0.608 0 O-C-N 119.968 -1.707 . . . . 66.260000000000005 110.329 -178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 87.7 mttt -74.18 -36.76 64.07 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 114.262 -1.335 . . . . 63.729999999999997 110.49 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 22.6 mt -63.64 -35.1 79.41 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 120.652 -1.28 . . . . 54.68 112.699 169.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -65.97 -41.45 91.17 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 106.907 -1.516 . . . . 53.640000000000001 106.907 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -51.46 -46.01 62.91 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 113.94 1.089 . . . . 67.239999999999995 113.94 168.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -67.18 1.12 2.24 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 115.848 1.796 . . . . 65.760000000000005 115.848 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 10.0 t30 49.81 44.55 25.03 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 125.088 2.375 . . . . 58.710000000000001 113.925 177.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1110 ' ' VAL . . . . . . . . . . . . . 3.7 m -110.75 152.6 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 113.944 -1.48 . . . . 46.630000000000003 109.421 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1111 ' ' THR . . . . . . . . . . . . . 89.4 m -89.14 99.85 12.75 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 106.881 -1.526 . . . . 44.130000000000003 106.881 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1112 ' ' VAL . . . . . . . . . . . . . 91.6 t -91.56 128.01 43.55 Favored 'Isoleucine or valine' 0 C--O 1.253 1.25 0 CA-C-O 123.829 1.776 . . . . 40.439999999999998 110.366 -176.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1113 ' ' MET . . . . . . . . . . . . . 35.2 mtp -119.27 123.18 43.63 Favored 'General case' 0 C--O 1.255 1.367 0 N-CA-C 105.79 -1.93 . . . . 50.759999999999998 105.79 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1114 ' ' ALA . . . . . . . . . . . . . . . -99.42 96.62 7.82 Favored 'General case' 0 N--CA 1.428 -1.575 0 O-C-N 124.106 0.879 . . . . 35.640000000000001 111.896 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1115 ' ' MET . . . . . . . . . . . . . 36.0 mmm -65.33 -17.77 64.78 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 116.765 2.135 . . . . 38.740000000000002 116.765 -173.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -73.67 -36.52 65.35 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 118.179 -0.915 . . . . 40.140000000000001 108.561 168.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1117 ' ' SER . . . . . . . . . . . . . 63.6 m -102.37 62.3 0.86 Allowed 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 125.05 2.357 . . . . 44.789999999999999 109.801 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1118 ' ' VAL . . . . . . . . . . . . . 87.4 t -90.94 134.31 30.5 Favored Pre-proline 0 C--O 1.243 0.739 0 N-CA-C 106.55 -1.648 . . . . 43.75 106.55 174.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -46.13 120.9 3.96 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.732 3.622 . . . . 48.93 111.299 171.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -63.3 -4.56 2.66 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 117.502 2.408 . . . . 62.899999999999999 117.502 -169.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 45.1 pt -66.77 158.14 5.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 115.172 1.545 . . . . 57.719999999999999 115.172 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1122 ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.66 -49.19 68.48 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 125.499 1.75 . . . . 57.259999999999998 114.242 -173.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 21.4 ptt85 -63.21 -13.34 36.43 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 118.36 -2.712 . . . . 62.899999999999999 115.286 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -89.65 -21.37 22.81 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 120.394 -1.441 . . . . 49.829999999999998 108.573 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -61.27 -20.51 62.96 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 115.532 1.679 . . . . 52.369999999999997 115.532 -163.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1126 ' ' SER . . . . . . . . . . . . . 6.0 p -68.52 -39.0 81.36 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.184 0.902 . . . . 42.43 112.341 168.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1127 ' ' LEU . . . . . . . . . . . . . 5.1 mp -82.56 -23.68 34.36 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.277 -0.874 . . . . 43.740000000000002 110.977 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 10.1 t0 -68.04 105.03 1.91 Allowed 'General case' 0 C--O 1.246 0.908 0 CA-C-O 124.658 2.17 . . . . 43.210000000000001 112.361 -167.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -72.37 -41.22 66.63 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 111.159 -2.746 . . . . 35.740000000000002 111.502 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 9.0 tp -54.94 -40.94 70.47 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 118.889 0.768 . . . . 38.090000000000003 112.009 175.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1131 ' ' SER . . . . . . . . . . . . . 68.1 m -54.8 -53.01 60.82 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-N 119.979 1.263 . . . . 36.909999999999997 112.732 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1132 ' ' SER . . . . . . . . . . . . . 4.6 m -65.2 -37.49 87.48 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 119.312 0.96 . . . . 35.789999999999999 113.303 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1133 ' ' MET . . . . . . . . . . . . . 24.8 mmt -59.46 -45.46 91.56 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 121.893 2.133 . . . . 30.809999999999999 115.69 171.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1134 ' ' ALA . . . . . . . . . . . . . . . -69.29 -39.75 78.13 Favored 'General case' 0 CA--C 1.504 -0.803 0 O-C-N 124.275 0.984 . . . . 28.879999999999999 109.936 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1135 ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -53.27 -47.76 68.86 Favored 'General case' 0 C--O 1.245 0.86 0 O-C-N 123.972 0.795 . . . . 40.759999999999998 112.518 169.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1136 ' ' ILE . . . . . . . . . . . . . 71.4 mt -59.95 -44.71 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 107.951 -1.129 . . . . 31.539999999999999 107.951 177.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -60.06 -44.01 95.02 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-O 117.251 -1.357 . . . . 29.870000000000001 111.109 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -62.3 -46.79 93.17 Favored Glycine 0 N--CA 1.439 -1.155 0 CA-C-N 123.074 2.67 . . . . 28.73 112.478 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 36.5 t80 -59.87 -48.97 79.52 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 122.353 1.073 . . . . 30.390000000000001 109.226 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1140 ' ' ARG . . . . . 0.403 HH21 ' CD ' ' A' 1144 ' ' GLU . 3.7 tpt180 -65.58 -24.46 67.08 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 112.895 0.702 . . . . 26.09 112.895 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1141 ' ' ALA . . . . . . . . . . . . . . . -65.73 -44.83 84.82 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 109.655 -0.498 . . . . 27.100000000000001 109.655 173.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 42.2 mm -57.36 -38.67 63.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 123.984 0.914 . . . . 28.48 109.664 175.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 97.7 t -68.05 -59.89 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-O 121.242 0.544 . . . . 23.07 111.804 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1144 ' ' GLU . . . . . 0.403 ' CD ' HH21 ' A' 1140 ' ' ARG . 4.4 mm-40 -61.05 -28.56 69.16 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 120.637 -1.289 . . . . 33.399999999999999 111.642 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -65.73 -60.71 2.62 Favored 'General case' 0 C--O 1.206 -1.209 0 CA-C-O 115.256 -2.307 . . . . 24.219999999999999 107.227 171.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -55.17 -18.62 6.11 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 121.922 2.146 . . . . 24.890000000000001 115.881 176.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -68.21 -56.36 8.97 Favored 'General case' 0 N--CA 1.439 -1.011 0 O-C-N 120.438 -1.413 . . . . 26.73 111.267 169.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1148 ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -90.35 -12.67 36.96 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 118.025 2.602 . . . . 39.960000000000001 118.025 -174.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1149 ' ' PHE . . . . . . . . . . . . . 2.9 t80 -67.92 152.24 45.86 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 124.086 1.898 . . . . 25.870000000000001 108.186 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1150 ' ' GLY . . . . . . . . . . . . . . . -74.01 -48.62 15.31 Favored Glycine 0 N--CA 1.41 -3.058 0 CA-C-N 111.554 -2.566 . . . . 19.280000000000001 113.075 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1151 ' ' ARG . . . . . . . . . . . . . 61.8 mtm-85 -103.56 176.25 5.21 Favored 'General case' 0 C--O 1.25 1.1 0 N-CA-C 109.241 -0.652 . . . . 39.899999999999999 109.241 -164.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1152 ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -76.24 161.11 29.04 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 120.87 -1.144 . . . . 29.440000000000001 108.122 169.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1153 ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -78.78 -48.61 14.51 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 122.891 1.329 . . . . 32.600000000000001 108.662 168.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1154 ' ' THR . . . . . . . . . . . . . 9.7 m -64.45 116.62 6.3 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 115.252 1.575 . . . . 34.640000000000001 115.252 -170.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -66.49 88.67 0.13 Allowed Glycine 0 C--O 1.24 0.486 0 N-CA-C 110.666 -0.973 . . . . 37.140000000000001 110.666 173.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -139.45 178.89 6.88 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 124.883 2.278 . . . . 40.57 111.137 -173.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1157 ' ' ILE . . . . . . . . . . . . . 3.1 tp -107.53 153.44 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 112.928 -1.942 . . . . 44.609999999999999 107.548 167.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1158 ' ' THR . . . . . . . . . . . . . 24.5 p -103.76 -143.63 0.36 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.539 -1.282 . . . . 40.700000000000003 107.539 169.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -94.45 -25.15 17.02 Favored 'General case' 0 C--O 1.246 0.869 0 O-C-N 119.301 -2.124 . . . . 40.25 110.233 167.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -82.78 -56.53 3.78 Favored 'General case' 0 C--O 1.249 1.059 0 O-C-N 121.914 -0.491 . . . . 38.469999999999999 111.952 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . -169.02 -173.42 36.71 Favored Glycine 0 N--CA 1.476 1.333 0 N-CA-C 111.894 -0.483 . . . . 37.609999999999999 111.894 -164.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 15.6 tttp -78.35 151.8 32.68 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 126.057 1.743 . . . . 48.899999999999999 111.772 -170.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1163 ' ' VAL . . . . . . . . . . . . . 92.5 t -102.07 123.86 42.04 Favored Pre-proline 0 N--CA 1.44 -0.942 0 CA-C-N 113.197 -1.82 . . . . 36.520000000000003 108.019 161.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1164 ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -62.82 114.47 2.43 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 123.897 3.064 . . . . 35.079999999999998 115.046 162.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1165 ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -61.91 130.8 32.34 Favored 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 124.142 3.228 . . . . 35.329999999999998 113.42 -171.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -66.8 123.39 20.01 Favored 'General case' 0 CA--C 1.501 -0.925 0 O-C-N 125.043 1.464 . . . . 34.689999999999998 112.055 172.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1167 ' ' LYS . . . . . . . . . . . . . 7.1 mttp -96.89 94.32 7.16 Favored 'General case' 0 CA--C 1.486 -1.494 0 N-CA-C 105.227 -2.138 . . . . 45.359999999999999 105.227 176.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 20.2 t -82.19 97.83 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 C-N-CA 124.479 1.111 . . . . 31.710000000000001 108.215 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1169 ' ' MET . . . . . . . . . . . . . 59.2 ttp -77.96 125.78 29.85 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.037 -1.468 . . . . 42.280000000000001 107.037 166.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 94.6 t -111.86 112.04 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 106.828 -1.545 . . . . 30.510000000000002 106.828 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 75.8 mt -88.69 116.29 30.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 119.979 -1.701 . . . . 31.870000000000001 109.412 173.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 93.61 89.51 1.61 Allowed Glycine 0 C--O 1.215 -1.043 0 N-CA-C 109.215 -1.554 . . . . 34.539999999999999 109.215 171.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1173 ' ' ALA . . . . . . . . . . . . . . . -80.95 67.73 6.96 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 123.05 1.405 . . . . 32.509999999999998 110.19 176.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -100.98 -153.73 26.5 Favored Glycine 0 C--O 1.217 -0.95 0 CA-C-O 117.101 -1.944 . . . . 29.899999999999999 108.369 167.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1175 ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -58.45 -49.03 83.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 CA-C-N 121.438 2.619 . . . . 33.109999999999999 111.931 -178.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1176 ' ' ALA . . . . . . . . . . . . 0.26 . . -59.89 -36.98 78.11 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 121.984 0.897 . . . . 28.100000000000001 110.538 174.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -63.96 -55.05 26.57 Favored Glycine 0 C--O 1.215 -1.057 0 N-CA-C 109.63 -1.388 . . . . 28.539999999999999 109.63 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1178 ' ' LEU . . . . . . . . . . . . . 29.5 mt -65.7 -30.76 71.49 Favored 'General case' 0 C--O 1.254 1.303 0 CA-C-N 114.231 -0.984 . . . . 31.219999999999999 110.869 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -66.28 -40.34 90.03 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.022 -1.674 . . . . 28.98 112.391 173.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -65.03 -42.18 94.59 Favored 'General case' 0 C--O 1.221 -0.433 0 O-C-N 119.23 -2.169 . . . . 27.829999999999998 112.261 173.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1181 ' ' ILE . . . . . . . . . . . . . 71.1 mt -54.07 -55.09 15.94 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 CA-C-O 118.46 -0.781 . . . . 30.25 110.055 172.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -59.3 -53.27 47.64 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-O 122.957 1.309 . . . . 29.59 111.633 -175.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -50.39 -64.22 0.88 Allowed 'General case' 0 C--N 1.348 0.535 0 O-C-N 120.022 -1.869 . . . . 30.289999999999999 113.535 173.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -60.8 -37.86 83.4 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 115.86 1.8 . . . . 30.469999999999999 115.86 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -60.11 -45.91 91.4 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 107.923 -1.14 . . . . 42.409999999999997 107.923 174.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1186 ' ' SER . . . . . . . . . . . . . 67.4 m -62.77 -44.33 96.47 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 123.458 1.599 . . . . 39.380000000000003 113.026 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 25.2 tp -63.87 -30.94 71.98 Favored 'General case' 0 C--O 1.244 0.796 0 O-C-N 119.765 -1.834 . . . . 36.18 110.36 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 108.89 40.14 1.61 Allowed Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 125.722 1.629 . . . . 33.780000000000001 114.114 170.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -108.75 161.18 15.34 Favored 'General case' 0 CA--C 1.49 -1.332 0 O-C-N 121.164 -1.198 . . . . 33.93 110.745 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 67.8 mt -72.56 120.29 20.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 104.996 -2.224 . . . . 38.740000000000002 104.996 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 10.1 t -110.65 129.2 66.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.15 -1.426 . . . . 33.090000000000003 107.15 175.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1192 ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -127.59 101.89 6.6 Favored 'General case' 0 N--CA 1.438 -1.027 0 O-C-N 125.399 1.687 . . . . 38.920000000000002 108.022 173.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -100.47 152.3 20.54 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.619 0.723 . . . . 35.32 112.536 -175.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 79.1 t80 -128.67 148.35 50.81 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 127.751 2.42 . . . . 39.350000000000001 105.231 -172.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 7.9 t70 -166.59 161.89 16.22 Favored 'General case' 0 C--O 1.243 0.714 0 O-C-N 124.483 1.114 . . . . 40.460000000000001 109.966 170.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1196 ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.86 -42.41 81.36 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 113.625 -1.625 . . . . 45.939999999999998 107.734 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1197 ' ' ARG . . . . . . . . . . . . . 47.7 mtm180 -94.26 117.67 67.08 Favored Pre-proline 0 C--O 1.212 -0.892 0 C-N-CA 123.97 0.908 . . . . 56.020000000000003 109.65 -162.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1198 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.12 -8.82 23.89 Favored 'Trans proline' 0 C--N 1.36 1.142 0 C-N-CA 124.125 3.217 . . . . 51.270000000000003 114.555 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.44 -35.63 34.73 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 120.299 -1.501 . . . . 59.100000000000001 108.485 -177.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 15.0 m -71.36 -26.39 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 113.662 0.986 . . . . 51.060000000000002 113.662 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 74.9 tttt -39.39 -42.41 1.07 Allowed 'General case' 0 C--O 1.239 0.512 0 N-CA-C 115.878 1.807 . . . . 57.380000000000003 115.878 166.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -57.37 -47.85 80.59 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 114.814 -1.085 . . . . 62.409999999999997 111.114 177.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -69.46 -41.61 75.97 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 118.752 -0.642 . . . . 57.780000000000001 109.634 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 99.9 t -51.95 -54.65 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 120.276 1.398 . . . . 46.380000000000003 114.529 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -53.42 -51.22 63.29 Favored 'General case' 0 N--CA 1.427 -1.585 0 C-N-CA 125.208 1.403 . . . . 50.700000000000003 112.452 169.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1206 ' ' SER . . . . . . . . . . . . . 7.1 m -78.41 4.15 13.86 Favored 'General case' 0 C--O 1.261 1.663 0 O-C-N 119.429 -2.044 . . . . 49.979999999999997 115.531 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1207 ' ' MET . . . . . . . . . . . . . 75.6 mtp -99.69 -1.86 36.83 Favored 'General case' 0 C--O 1.244 0.784 0 O-C-N 119.87 -1.769 . . . . 52.990000000000002 111.828 169.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 86.79 48.93 4.26 Favored Glycine 0 C--N 1.346 1.13 0 C-N-CA 120.304 -0.95 . . . . 47.659999999999997 111.112 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -137.62 153.67 49.86 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 124.532 2.11 . . . . 44.770000000000003 108.353 170.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -85.44 134.17 34.07 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 113.094 -1.866 . . . . 47.640000000000001 106.351 172.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1211 ' ' PHE . . . . . . . . . . . . . 39.2 t80 -86.09 128.06 34.8 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 120.42 -1.425 . . . . 45.659999999999997 109.174 175.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 32.5 mt -99.44 115.02 28.32 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 106.072 -1.825 . . . . 46.060000000000002 106.072 171.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -88.02 167.88 13.31 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-O 122.708 1.242 . . . . 60.219999999999999 109.876 167.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 4.9 mp -74.22 136.41 42.76 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 106.471 -1.677 . . . . 57.25 106.471 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.75 92.46 1.57 Allowed 'General case' 0 C--O 1.243 0.734 0 N-CA-C 107.411 -1.329 . . . . 64.430000000000007 107.411 166.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 5.1 t80 . . . . . 0 CA--C 1.506 -0.734 0 CA-C-N 114.326 -1.306 . . . . 66.900000000000006 111.277 -167.368 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 6.1 p-10 . . . . . 0 N--CA 1.443 -0.816 0 N-CA-C 103.313 -2.847 . . . . 39.090000000000003 103.313 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -55.09 -37.36 63.28 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.61 -0.723 . . . . 39.32 113.089 -175.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 84.2 t80 -69.3 -54.26 15.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 117.759 0.78 . . . . 39.299999999999997 111.11 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -67.05 -34.01 76.75 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 119.277 0.944 . . . . 36.299999999999997 112.917 -177.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -62.01 -37.41 84.75 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 113.122 0.786 . . . . 37.380000000000003 113.122 168.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -70.87 -36.1 62.8 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 CA-C-N 121.429 1.922 . . . . 39.109999999999999 110.579 169.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1230 ' ' MET . . . . . . . . . . . . . 33.2 mmt -90.22 63.5 5.78 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 124.101 1.905 . . . . 49.590000000000003 110.97 -177.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1231 ' ' SER . . . . . . . . . . . . . 67.0 m -151.68 126.64 9.73 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 110.847 -2.888 . . . . 43.68 107.141 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -56.78 -18.27 12.1 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 114.136 1.162 . . . . 55.57 114.136 -176.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -56.75 -49.02 76.49 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 114.238 1.199 . . . . 44.939999999999998 114.238 167.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 19.5 t80 -63.07 -56.6 15.49 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 124.835 1.254 . . . . 42.039999999999999 108.151 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 93.0 mt -51.72 -45.32 37.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 114.532 -1.213 . . . . 46.280000000000001 110.173 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 26.7 tttm -66.16 -39.9 90.12 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 115.69 -2.1 . . . . 47.869999999999997 111.791 175.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -64.08 -37.5 87.68 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-N 121.98 2.173 . . . . 41.609999999999999 112.629 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -55.59 -56.87 15.24 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 106.524 -1.658 . . . . 50.649999999999999 106.524 170.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1239 ' ' MET . . . . . 0.415 ' SD ' ' O ' ' A' 1266 ' ' LEU . 97.7 mmm -50.0 -48.91 52.17 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.713 1.005 . . . . 48.869999999999997 113.713 178.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -62.72 -40.17 96.36 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 119.462 -2.024 . . . . 54.799999999999997 110.749 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.32 -46.56 79.81 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.455 0.702 . . . . 43.210000000000001 111.855 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -64.33 -47.34 79.77 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 106.659 -1.608 . . . . 38.659999999999997 106.659 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -62.63 -32.9 74.02 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 122.761 1.267 . . . . 37.920000000000002 114.14 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -70.02 -51.94 28.13 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.634 -0.876 . . . . 37.280000000000001 108.634 174.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -61.31 -29.05 69.64 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 113.593 0.96 . . . . 43.07 113.593 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -51.1 -34.24 29.64 Favored 'General case' 0 C--O 1.248 1.01 0 C-N-CA 126.249 1.82 . . . . 38.299999999999997 112.612 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1247 ' ' LYS . . . . . . . . . . . . . 11.3 mtmm -57.7 -22.3 45.49 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 118.505 2.78 . . . . 47.600000000000001 118.505 174.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.78 -30.73 0.81 Allowed 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 117.383 2.364 . . . . 45.420000000000002 117.383 -171.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1249 ' ' VAL . . . . . . . . . . . . . 34.6 m -70.06 158.6 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 123.661 1.696 . . . . 36.259999999999998 111.386 -173.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1250 ' ' ASP . . . . . 0.467 ' CG ' ' HZ3' ' A' 1276 ' ' LYS . 7.4 m-20 -103.04 -50.78 3.41 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 113.884 -1.507 . . . . 33.039999999999999 111.641 -172.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1251 ' ' ILE . . . . . . . . . . . . . 51.7 mm -121.05 138.33 51.82 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 N-CA-C 103.938 -2.616 . . . . 31.399999999999999 103.938 -177.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1252 ' ' ILE . . . . . . . . . . . . . 39.5 mt -120.87 113.68 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 105.798 -1.927 . . . . 29.420000000000002 105.798 166.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 27.7 t -97.0 111.46 26.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 104.504 -2.406 . . . . 30.370000000000001 104.504 176.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1254 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.58 112.01 24.13 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 102.468 -3.16 . . . . 35.719999999999999 102.468 -173.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1255 ' ' THR . . . . . . . . . . . . . 66.1 p -98.89 -27.55 13.85 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 120.004 3.335 . . . . 36.0 120.004 -159.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1256 ' ' ALA . . . . . . . . . . . . . . . -71.19 82.31 0.72 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 118.579 2.807 . . . . 40.93 118.579 -140.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 52.9 tp -84.39 84.18 7.73 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 104.897 -2.26 . . . . 47.82 104.897 175.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 26.0 mm -70.26 131.14 88.77 Favored Pre-proline 0 N--CA 1.431 -1.417 0 CA-C-N 112.701 -2.045 . . . . 52.700000000000003 107.83 172.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -59.78 133.75 52.99 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.3 2.667 . . . . 54.130000000000003 111.144 176.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 76.64 -67.44 2.6 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 122.581 1.101 . . . . 54.619999999999997 115.418 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 85.3 mttt -80.8 129.05 69.58 Favored Pre-proline 0 C--O 1.24 0.575 0 N-CA-C 114.839 1.422 . . . . 55.740000000000002 114.839 -173.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -46.0 134.02 14.58 Favored 'Trans proline' 0 N--CA 1.451 -0.976 1 C-N-CA 127.395 5.397 . . . . 51.149999999999999 112.14 167.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -64.94 131.88 95.32 Favored Pre-proline 0 C--O 1.246 0.881 0 CA-C-O 117.194 -1.384 . . . . 46.060000000000002 111.95 171.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -66.66 148.56 83.3 Favored 'Trans proline' 0 C--O 1.255 1.352 0 C-N-CA 123.379 2.719 . . . . 41.079999999999998 111.581 -177.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 61.8 mttm -85.75 79.09 9.42 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 124.356 2.026 . . . . 47.420000000000002 112.347 -175.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1266 ' ' LEU . . . . . 0.415 ' O ' ' SD ' ' A' 1239 ' ' MET . 93.5 mt -74.19 -59.01 2.92 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 110.737 -2.938 . . . . 39.219999999999999 113.125 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 63.8 mt -75.29 112.43 12.83 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 CA-C-N 120.884 1.675 . . . . 42.5 107.801 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1268 ' ' THR . . . . . . . . . . . . . 1.1 p -76.92 163.04 27.11 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.005 -1.452 . . . . 37.840000000000003 113.202 -176.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 58.7 mtt-85 -62.5 -40.46 96.78 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-O 121.793 0.806 . . . . 54.799999999999997 112.836 172.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -50.38 -51.86 42.36 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 124.874 1.27 . . . . 54.359999999999999 113.1 167.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1271 ' ' MET . . . . . . . . . . . . . 30.0 ttm -60.43 -48.04 83.47 Favored 'General case' 0 C--O 1.253 1.249 0 C-N-CA 124.831 1.252 . . . . 39.520000000000003 112.136 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1272 ' ' VAL . . . . . . . . . . . . . 60.0 t -57.33 -50.02 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 C-N-CA 123.69 0.796 . . . . 38.25 111.895 176.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -54.05 -43.89 70.61 Favored 'General case' 0 C--O 1.262 1.761 0 O-C-N 119.666 -1.896 . . . . 40.770000000000003 114.432 171.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1274 ' ' SER . . . . . . . . . . . . . 10.5 p -73.02 3.18 5.69 Favored 'General case' 0 CA--C 1.556 1.203 0 O-C-N 120.219 -1.55 . . . . 36.579999999999998 113.646 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1275 ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -78.63 151.65 32.19 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 118.641 -2.537 . . . . 36.75 108.245 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1276 ' ' LYS . . . . . 0.467 ' HZ3' ' CG ' ' A' 1250 ' ' ASP . 31.4 ttpt -66.4 142.0 57.75 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.056 1.742 . . . . 46.109999999999999 113.007 177.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1277 ' ' ALA . . . . . . . . . . . . . . . -72.69 153.06 41.37 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 115.327 1.603 . . . . 33.520000000000003 115.327 -169.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 80.02 37.66 21.41 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 108.694 -1.762 . . . . 31.27 108.694 174.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1279 ' ' SER . . . . . . . . . . . . . 19.7 m -139.56 163.27 32.99 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 119.27 1.535 . . . . 32.950000000000003 111.065 -160.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1280 ' ' VAL . . . . . . . . . . . . . 92.7 t -123.78 148.78 27.76 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 O-C-N 118.496 -2.628 . . . . 27.43 111.175 -173.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1281 ' ' ILE . . . . . . . . . . . . . 60.9 mt -121.83 112.18 33.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 103.872 -2.64 . . . . 30.300000000000001 103.872 164.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 4.1 t -98.5 134.59 36.55 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 104.984 -2.228 . . . . 28.629999999999999 104.984 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 6.1 t0 -111.55 121.32 44.86 Favored 'General case' 0 C--O 1.254 1.32 0 CA-C-N 114.692 -1.14 . . . . 36.270000000000003 108.956 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1284 ' ' LEU . . . . . . . . . . . . . 72.4 mt -105.96 14.5 27.86 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.678 -0.692 . . . . 38.57 109.814 -175.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -104.95 -40.3 5.97 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 122.862 1.315 . . . . 37.560000000000002 109.015 169.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . 49.32 -81.0 0.01 OUTLIER 'General case' 0 C--O 1.263 1.809 0 N-CA-C 117.992 2.59 . . . . 40.329999999999998 117.992 173.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -76.61 -36.13 57.66 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 123.938 0.895 . . . . 56.850000000000001 111.865 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 52.4 t30 -80.13 77.98 6.81 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 104.802 -2.296 . . . . 45.859999999999999 104.802 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 72.16 -72.51 0.93 Allowed Glycine 0 CA--C 1.5 -0.854 0 N-CA-C 109.444 -1.462 . . . . 40.310000000000002 109.444 -176.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 87.16 117.32 1.13 Allowed Glycine 0 C--O 1.22 -0.722 0 N-CA-C 106.755 -2.538 . . . . 38.890000000000001 106.755 -175.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1291 ' ' ASN . . . . . . . . . . . . . 12.4 m120 -65.46 -16.78 63.99 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 115.633 1.716 . . . . 37.229999999999997 115.633 -172.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1292 ' ' CYS . . . . . . . . . . . . . 36.0 t -103.34 157.08 17.27 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 119.45 1.023 . . . . 36.5 109.497 173.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1293 ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -82.53 -9.17 59.52 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 115.331 1.604 . . . . 43.32 115.331 173.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -96.38 9.02 42.54 Favored 'General case' 0 C--O 1.244 0.778 0 O-C-N 117.55 -3.219 . . . . 41.32 111.699 172.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1295 ' ' THR . . . . . . . . . . . . . 85.3 m -75.61 98.8 4.12 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.871 0.843 . . . . 35.299999999999997 111.072 -173.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 2.3 t -81.94 128.25 69.12 Favored Pre-proline 0 C--O 1.251 1.166 0 N-CA-C 102.622 -3.103 . . . . 34.840000000000003 102.622 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -51.42 105.34 0.11 Allowed 'Trans proline' 0 C--O 1.251 1.137 0 C-N-CA 124.773 3.649 . . . . 33.509999999999998 113.04 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 76.98 23.43 69.12 Favored Glycine 0 CA--C 1.504 -0.635 0 CA-C-N 113.328 -1.76 . . . . 32.189999999999998 113.937 175.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -131.6 170.58 14.56 Favored 'General case' 0 C--O 1.246 0.916 0 CA-C-N 118.86 1.33 . . . . 34.880000000000003 112.905 -175.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1300 ' ' ILE . . . . . . . . . . . . . 43.3 mt -108.58 121.84 62.23 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.198 0 N-CA-C 106.044 -1.835 . . . . 32.289999999999999 106.044 169.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 16.0 t80 -97.96 126.5 43.4 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 103.624 -2.732 . . . . 37.25 103.624 169.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1302 ' ' THR . . . . . . . . . . . . . 8.2 m -106.41 123.91 48.8 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 119.735 1.152 . . . . 35.560000000000002 108.628 174.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1303 ' ' THR . . . . . . . . . . . . . 2.6 p -86.7 165.17 16.3 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 118.37 -0.824 . . . . 36.399999999999999 113.191 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -53.96 -41.1 67.44 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 121.254 1.843 . . . . 52.32 115.704 -176.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -62.18 -24.05 66.97 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.369 -1.287 . . . . 40.039999999999999 111.741 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 98.23 44.51 2.56 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.294 -1.122 . . . . 36.960000000000001 110.294 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1307 ' ' VAL . . . . . . . . . . . . . 59.7 t -107.08 120.11 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 123.617 1.675 . . . . 33.399999999999999 108.584 168.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1308 ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -87.3 102.78 14.83 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 110.541 -3.027 . . . . 42.909999999999997 106.986 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 39.3 t -88.98 95.22 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.676 0 O-C-N 119.469 -2.019 . . . . 32.289999999999999 108.212 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1310 ' ' ILE . . . . . . . . . . . . . 91.1 mt -89.54 95.17 5.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 O-C-N 120.76 -1.212 . . . . 30.989999999999998 110.093 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -97.33 57.9 1.17 Allowed Glycine 0 N--CA 1.441 -1.012 0 O-C-N 120.483 -1.386 . . . . 28.949999999999999 113.798 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1312 ' ' TYR . . . . . . . . . . . . . 7.0 m-30 -77.36 131.82 38.26 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 122.914 1.34 . . . . 31.690000000000001 113.374 -169.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1313 ' ' THR . . . . . . . . . . . . . 8.8 p -86.6 -49.79 7.28 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 120.965 -1.084 . . . . 34.170000000000002 110.596 174.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -72.29 14.27 0.25 Allowed 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 117.367 2.358 . . . . 36.859999999999999 117.367 -167.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1315 ' ' LEU . . . . . . . . . . . . . 28.5 mt -51.04 -39.45 56.12 Favored Pre-proline 0 C--N 1.347 0.495 0 O-C-N 119.827 -1.796 . . . . 34.850000000000001 114.256 -173.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.74 -43.98 40.02 Favored 'Trans proline' 0 C--O 1.257 1.431 0 CA-C-N 124.408 2.61 . . . . 29.149999999999999 113.207 170.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -58.25 -45.12 94.55 Favored Glycine 0 CA--C 1.543 1.807 0 N-CA-C 109.124 -1.59 . . . . 27.289999999999999 109.124 174.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1318 ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -58.35 -23.38 56.6 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 116.47 2.026 . . . . 41.490000000000002 116.47 177.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1319 ' ' LEU . . . . . . . . . . . . . 12.3 tp -123.07 67.27 32.9 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 104.018 -2.586 . . . . 27.609999999999999 104.018 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1320 ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -58.14 -53.05 4.67 Favored 'Trans proline' 0 C--O 1.257 1.456 1 C-N-CA 125.396 4.064 . . . . 25.940000000000001 114.67 -163.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1321 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.86 -39.79 91.05 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 109.868 -0.419 . . . . 25.010000000000002 109.868 -173.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1322 ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -64.83 -43.82 91.84 Favored 'General case' 0 CA--C 1.51 -0.563 0 O-C-N 123.968 0.792 . . . . 29.390000000000001 109.78 -175.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1323 ' ' SER . . . . . . . . . . . . . 49.6 m -58.47 -53.52 57.41 Favored 'General case' 0 CA--C 1.486 -1.514 0 CA-C-N 114.16 -1.382 . . . . 26.469999999999999 113.166 173.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1324 ' ' SER . . . . . . . . . . . . . 5.0 m -65.01 -29.37 70.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.324 -0.86 . . . . 27.780000000000001 110.002 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -68.81 -59.66 2.93 Favored 'General case' 0 C--N 1.348 0.519 0 O-C-N 121.653 -0.654 . . . . 37.530000000000001 110.783 172.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1326 ' ' LEU . . . . . . . . . . . . . 59.5 mt -72.29 -51.79 19.23 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 115.838 -2.03 . . . . 35.710000000000001 111.102 -170.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1327 ' ' TYR . . . . . . . . . . . . . 7.3 t80 -48.83 -48.26 41.84 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 121.364 1.893 . . . . 31.59 110.96 170.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1328 ' ' GLY . . . . . . . . . . . . . . . -47.46 -52.52 14.06 Favored Glycine 0 N--CA 1.465 0.61 0 C-N-CA 124.229 0.918 . . . . 28.0 112.49 170.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1329 ' ' THR . . . . . . . . . . . . . 77.2 m -70.4 -34.81 72.97 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 120.344 -1.68 . . . . 32.149999999999999 110.188 -173.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1330 ' ' ASN . . . . . . . . . . . . . 29.4 m120 -64.65 -43.6 93.13 Favored 'General case' 0 C--O 1.21 -0.997 0 C-N-CA 119.521 -0.871 . . . . 34.359999999999999 111.28 173.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1331 ' ' LEU . . . . . . . . . . . . . 80.6 mt -53.09 -44.83 67.88 Favored 'General case' 0 C--O 1.219 -0.534 0 O-C-N 124.71 1.256 . . . . 33.369999999999997 111.527 173.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1332 ' ' VAL . . . . . . . . . . . . . 6.8 t -70.62 -37.12 68.37 Favored 'Isoleucine or valine' 0 C--O 1.245 0.842 0 CA-C-N 114.849 -1.069 . . . . 35.270000000000003 110.125 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -69.89 -28.69 65.84 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 121.414 0.626 . . . . 37.659999999999997 111.227 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1334 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.52 -51.99 20.62 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 108.805 -0.813 . . . . 40.270000000000003 108.805 171.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1335 ' ' LEU . . . . . . . . . . . . . 37.1 mt -68.41 -5.91 21.7 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 115.564 1.69 . . . . 42.5 115.564 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1336 ' ' LYS . . . . . . . . . . . . . 74.8 mttt -66.96 -35.75 80.68 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 119.85 -1.781 . . . . 47.810000000000002 111.823 162.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1337 ' ' LEU . . . . . . . . . . . . . 4.8 mp -78.08 -46.74 19.99 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 120.9 -1.125 . . . . 49.270000000000003 109.995 169.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1338 ' ' LEU . . . . . . . . . . . . . 6.0 mp -76.81 16.96 0.46 Allowed 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 115.786 1.773 . . . . 50.539999999999999 115.786 176.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1339 ' ' CYS . . . . . . . . . . . . . 36.5 t -156.98 80.34 0.92 Allowed 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 126.042 2.829 . . . . 53.670000000000002 104.768 164.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 82.6 mttt -79.08 -40.66 30.61 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 113.431 -1.713 . . . . 63.380000000000003 111.139 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -69.69 -51.26 36.1 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 113.706 1.002 . . . . 70.950000000000003 113.706 -166.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1342 ' ' LYS . . . . . . . . . . . . . 36.3 mtpt 52.77 67.08 1.05 Allowed 'General case' 0 C--O 1.239 0.535 0 N-CA-C 117.499 2.407 . . . . 65.25 117.499 171.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1343 ' ' ASP . . . . . . . . . . . . 0.262 7.8 t70 59.82 -94.19 0.05 OUTLIER 'General case' 0 CA--C 1.502 -0.869 2 O-C-N 110.915 -7.365 . . . . 64.530000000000001 117.847 4.486 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A 1344 ' ' GLY . . . . . . . . . . . . . . . 117.86 70.15 0.38 Allowed Glycine 0 C--N 1.348 1.212 0 N-CA-C 107.764 -2.134 . . . . 59.719999999999999 107.764 172.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -167.78 149.56 5.52 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 113.683 -1.259 . . . . 64.090000000000003 108.12 -177.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1346 ' ' ILE . . . . . . . . . . . . . 8.4 pt -55.38 125.22 10.03 Favored 'Isoleucine or valine' 0 C--O 1.247 0.95 0 N-CA-C 115.211 1.56 . . . . 58.82 115.211 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1347 ' ' THR . . . . . . . . . . . . . 7.8 m -97.91 100.12 11.45 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 103.309 -2.848 . . . . 54.960000000000001 103.309 163.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1348 ' ' VAL . . . . . . . . . . . . . 15.1 t -90.87 113.08 26.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 106.663 -1.606 . . . . 55.640000000000001 106.663 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 27.9 t70 -112.55 145.22 40.69 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 122.194 0.997 . . . . 61.450000000000003 110.094 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 60.2 t80 -116.23 4.19 13.51 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.509 1.124 . . . . 58.630000000000003 109.238 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.77 -62.71 1.25 Allowed 'General case' 0 N--CA 1.477 0.893 0 O-C-N 119.723 -1.861 . . . . 62.060000000000002 110.469 -169.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 7.3 t70 -69.83 143.95 52.73 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 114.571 1.322 . . . . 54.07 114.571 -170.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 20.3 m -65.49 -29.73 48.01 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 CA-C-N 119.541 1.064 . . . . 50.68 111.114 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1354 ' ' VAL . . . . . . . . . . . . . 4.3 m -76.53 -17.26 14.97 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 O-C-N 120.284 -1.51 . . . . 47.68 110.404 -176.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1355 ' ' ILE . . . . . . . . . . . . . 74.8 mt -100.34 -69.79 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.867 0 N-CA-C 106.636 -1.616 . . . . 48.490000000000002 106.636 171.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 40.4 tpt85 -55.73 -31.99 62.98 Favored 'General case' 0 C--N 1.349 0.548 0 O-C-N 120.653 -1.28 . . . . 48.270000000000003 114.286 -175.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -62.27 -46.18 94.45 Favored Glycine 0 CA--C 1.525 0.662 0 O-C-N 120.025 -1.672 . . . . 43.530000000000001 111.749 171.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1358 ' ' VAL . . . . . . . . . . . . . 42.4 t -72.18 -35.27 52.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 122.042 0.925 . . . . 45.119999999999997 111.025 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1359 ' ' THR . . . . . . . . . . . . . 25.6 m -69.07 88.43 0.41 Allowed 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 122.817 1.294 . . . . 42.939999999999998 109.162 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 16.1 m -76.83 -22.82 14.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-O 122.317 1.056 . . . . 43.259999999999998 113.122 176.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1361 ' ' ILE . . . . . . . . . . . . . 30.5 mt -133.29 135.52 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 103.563 -2.754 . . . . 45.659999999999997 103.563 169.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1362 ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -117.68 113.11 21.4 Favored 'General case' 0 C--O 1.252 1.228 0 N-CA-C 104.879 -2.267 . . . . 61.340000000000003 104.879 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 26.53 73.6 0.03 OUTLIER 'General case' 0 C--O 1.231 0.115 0 C-N-CA 127.047 2.139 . . . . 49.759999999999998 113.186 -166.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 88.9 -38.1 3.24 Favored Glycine 0 CA--C 1.529 0.911 0 O-C-N 119.902 -1.749 . . . . 50.0 112.443 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -74.46 124.0 25.75 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 119.416 1.608 . . . . 56.920000000000002 109.168 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1366 ' ' ILE . . . . . . . . . . . . . 10.2 mt -77.13 86.3 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.256 1.401 0 CA-C-O 123.07 1.414 . . . . 52.780000000000001 111.748 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1367 ' ' THR . . . . . . . . . . . . . 16.6 p -70.95 -11.88 61.22 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 111.728 -2.487 . . . . 49.439999999999998 114.624 -174.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 26.3 t90 -47.44 133.81 10.05 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 127.362 2.265 . . . . 52.380000000000003 110.157 170.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -81.79 -166.61 5.19 Favored 'Cis proline' 0 C--O 1.238 0.497 0 N-CA-C 117.443 2.055 . . . . 46.939999999999998 117.443 4.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -73.63 140.69 78.65 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 117.113 -1.422 . . . . 45.909999999999997 110.925 164.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1371 ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -70.43 139.74 38.58 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.691 2.927 . . . . 46.390000000000001 107.052 164.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -65.64 -35.86 35.69 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.778 2.319 . . . . 46.719999999999999 117.073 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.235 -4.412 0 CA-C-N 120.726 1.603 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 7.1 m80 . . . . . 0 N--CA 1.438 -1.043 0 N-CA-C 104.143 -2.54 . . . . 63.439999999999998 104.143 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -106.14 65.49 0.69 Allowed 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 102.939 -2.985 . . . . 51.740000000000002 102.939 159.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1000 ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -76.1 128.03 34.16 Favored 'General case' 0 C--N 1.36 1.054 0 O-C-N 120.584 -1.322 . . . . 54.07 109.986 -173.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 86.23 -6.47 81.6 Favored Glycine 0 C--O 1.218 -0.885 0 CA-C-O 121.656 0.587 . . . . 39.219999999999999 113.696 -169.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1002 ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -93.12 138.85 31.18 Favored 'General case' 0 C--O 1.252 1.185 0 CA-C-O 124.854 2.264 . . . . 38.119999999999997 109.482 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1003 ' ' ILE . . . . . . . . . . . . . 49.0 mt -98.25 141.63 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 110.835 -2.893 . . . . 29.699999999999999 105.201 169.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -111.0 123.79 6.67 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 108.659 -1.776 . . . . 27.5 108.659 172.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1005 ' ' ILE . . . . . . . . . . . . . 41.1 mm -109.8 111.77 58.64 Favored Pre-proline 0 N--CA 1.447 -0.582 0 N-CA-C 106.515 -1.661 . . . . 24.829999999999998 106.515 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -74.7 156.36 44.36 Favored 'Trans proline' 0 N--CA 1.44 -1.626 0 C-N-CA 123.473 2.782 . . . . 27.190000000000001 115.944 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -79.0 96.65 5.82 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 118.782 -2.449 . . . . 41.460000000000001 106.468 162.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1008 ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -51.94 151.5 3.55 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 118.734 2.864 . . . . 26.93 118.734 -170.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 45.1 mmm-85 -92.97 -20.72 20.32 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 112.528 -2.124 . . . . 34.479999999999997 115.535 -164.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1010 ' ' LEU . . . . . . . . . . . . . 4.7 tp -67.74 160.21 28.59 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 119.386 0.994 . . . . 44.219999999999999 113.678 -173.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1011 ' ' THR . . . . . . . . . . . . . 63.3 m -68.25 132.61 47.44 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 106.018 -1.845 . . . . 40.740000000000002 106.018 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 27.0 m-80 62.22 22.22 13.01 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 113.984 -1.462 . . . . 44.439999999999998 112.119 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1013 ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -78.1 118.7 20.6 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 117.748 -1.581 . . . . 29.870000000000001 111.85 -173.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1014 ' ' THR . . . . . . . . . . . . . 1.6 p -105.17 -9.62 17.63 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 111.514 -2.585 . . . . 25.260000000000002 112.413 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1015 ' ' ARG . . . . . 0.481 ' NH1' ' SD ' ' B' 1133 ' ' MET . 77.4 mtm180 -77.01 110.3 11.53 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 123.546 1.641 . . . . 29.539999999999999 113.188 -176.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B 1016 ' ' VAL . . . . . . . . . . . . . 7.2 p -87.69 120.54 36.98 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 N-CA-C 104.153 -2.536 . . . . 23.550000000000001 104.153 164.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1017 ' ' ALA . . . . . . . . . . . . . . . -62.71 -5.96 3.18 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 116.29 1.959 . . . . 23.59 116.29 -177.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1018 ' ' ALA . . . . . . . . . . . . . . . -150.34 111.95 4.48 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 123.996 1.855 . . . . 24.93 107.059 170.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1019 ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.43 164.38 40.81 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 115.14 -2.362 . . . . 28.09 111.696 172.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 0.7 OUTLIER -38.93 -46.35 2.74 Favored 'Trans proline' 0 C--N 1.362 1.245 1 C-N-CA 125.669 4.246 . . . . 28.789999999999999 117.717 -176.528 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 77.3 tttt -63.67 -49.21 74.09 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 120.086 1.312 . . . . 47.280000000000001 107.743 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1022 ' ' THR . . . . . . . . . . . . . 39.0 m -61.39 -34.98 76.26 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 114.001 1.111 . . . . 30.120000000000001 114.001 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1023 ' ' VAL . . . . . . . . . . . . . 75.4 t -51.11 -52.96 16.44 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 CA-C-N 121.239 1.836 . . . . 32.240000000000002 110.381 167.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1024 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.04 -37.1 86.2 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 113.973 1.101 . . . . 49.619999999999997 113.973 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -56.5 -46.4 80.55 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 114.373 -1.285 . . . . 44.68 109.871 177.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 14.4 mt -72.49 -35.86 68.26 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 114.341 1.238 . . . . 35.710000000000001 114.341 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1027 ' ' LEU . . . . . . . . . . . . . 75.8 mt -63.51 -41.51 98.51 Favored 'General case' 0 C--N 1.346 0.436 0 N-CA-C 109.896 -0.409 . . . . 42.18 109.896 176.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 55.1 mttm -57.96 -40.87 81.66 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 115.897 1.814 . . . . 48.340000000000003 115.897 169.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1029 ' ' LEU . . . . . . . . . . . . . 65.4 mt -69.67 -10.51 58.57 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 121.442 -0.787 . . . . 38.689999999999998 110.719 173.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 106.12 3.51 38.81 Favored Glycine 0 C--N 1.321 -0.294 0 O-C-N 119.861 -1.774 . . . . 32.280000000000001 112.407 166.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -90.77 158.61 16.76 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 119.957 -1.908 . . . . 35.939999999999998 108.879 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1032 ' ' THR . . . . . . . . . . . . . 5.9 m -101.06 137.33 39.56 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 103.834 -2.654 . . . . 33.369999999999997 103.834 172.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1033 ' ' VAL . . . . . . . . . . . . . 5.1 t -107.88 137.65 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 0 O-C-N 118.222 -2.799 . . . . 29.98 106.701 -172.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -128.21 131.62 48.84 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.243 -1.391 . . . . 28.18 107.243 168.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1035 ' ' VAL . . . . . . . . . . . . . 87.5 t -115.79 137.34 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.286 0 CA-C-N 113.225 -1.807 . . . . 25.82 110.216 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1036 ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -74.13 125.98 29.55 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 107.425 -1.324 . . . . 32.439999999999998 107.425 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1037 ' ' SER . . . . . . . . . . . . . 2.8 t -58.08 121.89 11.73 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 124.313 2.006 . . . . 29.539999999999999 113.309 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 119.45 -26.72 7.22 Favored Glycine 0 C--O 1.259 1.678 0 CA-C-N 113.187 -1.824 . . . . 27.760000000000002 109.413 -175.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1039 ' ' ALA . . . . . . . . . . . . . . . -59.43 -32.21 69.99 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.243 1.02 . . . . 26.02 113.057 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -57.99 -51.63 57.15 Favored Glycine 0 N--CA 1.466 0.686 0 CA-C-N 113.148 -1.842 . . . . 26.469999999999999 111.918 165.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -59.46 -30.19 68.34 Favored 'General case' 0 C--O 1.251 1.149 0 CA-C-N 118.254 1.027 . . . . 50.979999999999997 112.272 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 75.2 mt -64.65 -58.01 7.47 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-N 115.784 -0.644 . . . . 29.300000000000001 110.598 167.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1043 ' ' ALA . . . . . . . . . . . . . . . -74.66 14.73 0.44 Allowed 'General case' 0 C--O 1.215 -0.737 0 O-C-N 119.776 -1.828 . . . . 26.739999999999998 112.611 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1044 ' ' SER . . . . . . . . . . . . . 72.7 m 63.61 49.3 3.08 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 127.321 3.439 . . . . 31.260000000000002 112.646 174.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1045 ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.59 155.25 44.22 Favored 'General case' 0 N--CA 1.432 -1.352 0 O-C-N 119.314 -2.116 . . . . 33.259999999999998 107.056 -168.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 14.2 t70 -82.88 127.32 33.39 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 107.385 -1.339 . . . . 46.740000000000002 107.385 168.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -57.45 -32.32 66.81 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 124.439 1.096 . . . . 34.439999999999998 112.47 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -14.28 62.92 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 121.024 -1.048 . . . . 48.670000000000002 111.316 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -68.32 -28.9 67.56 Favored 'General case' 0 C--O 1.216 -0.662 0 O-C-N 120.241 -1.537 . . . . 35.259999999999998 110.851 169.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1050 ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -69.47 -31.14 69.25 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 108.142 -1.059 . . . . 32.170000000000002 108.142 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 83.9 t -70.16 -41.55 78.95 Favored 'Isoleucine or valine' 0 C--O 1.25 1.123 0 N-CA-C 106.305 -1.739 . . . . 38.369999999999997 106.305 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -60.49 -29.59 69.17 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 123.133 1.444 . . . . 45.770000000000003 110.118 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -77.48 -40.17 43.92 Favored 'General case' 0 CA--C 1.5 -0.957 0 O-C-N 120.421 -1.425 . . . . 37.829999999999998 112.905 168.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 137.03 18.89 0.64 Allowed Glycine 0 C--N 1.334 0.468 0 O-C-N 120.178 -1.576 . . . . 35.82 113.834 172.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -88.93 144.32 26.26 Favored 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 120.512 2.156 . . . . 33.770000000000003 112.724 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -73.83 124.6 26.4 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 103.844 -2.65 . . . . 51.020000000000003 103.844 168.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1057 ' ' ILE . . . . . . . . . . . . . 39.0 mm -89.42 116.75 31.45 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 O-C-N 120.155 -1.591 . . . . 38.469999999999999 107.752 168.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 2.8 m -112.56 139.37 37.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 O-C-N 125.785 1.928 . . . . 39.399999999999999 106.345 174.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -100.65 100.54 11.26 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 123.729 0.812 . . . . 57.07 110.012 -172.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . 102.78 -178.95 26.27 Favored Glycine 0 C--O 1.248 0.983 0 CA-C-O 123.005 1.336 . . . . 44.829999999999998 112.353 -175.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 30.2 m120 -64.47 2.59 0.6 Allowed 'General case' 0 C--O 1.239 0.523 0 N-CA-C 118.229 2.677 . . . . 46.270000000000003 118.229 -168.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1062 ' ' SER . . . . . . . . . . . . . 13.3 m -41.07 -40.77 1.55 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 127.75 2.42 . . . . 43.469999999999999 107.325 156.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -52.62 -30.34 14.77 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 O-C-N 119.125 -2.235 . . . . 36.979999999999997 114.566 176.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 52.1 m95 -76.41 -22.08 55.19 Favored 'General case' 0 N--CA 1.439 -0.99 0 O-C-N 120.867 -1.145 . . . . 37.899999999999999 110.68 -174.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -85.65 84.46 7.58 Favored 'General case' 0 C--O 1.205 -1.283 0 N-CA-C 103.482 -2.785 . . . . 46.189999999999998 103.482 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1066 ' ' SER . . . . . . . . . . . . . 56.6 m -151.08 173.41 14.39 Favored 'General case' 0 C--O 1.261 1.685 0 C-N-CA 126.117 1.767 . . . . 37.060000000000002 107.523 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1067 ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -82.61 -40.55 20.65 Favored 'General case' 0 N--CA 1.433 -1.298 0 O-C-N 120.428 -1.42 . . . . 43.950000000000003 111.512 174.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1068 ' ' ILE . . . . . . . . . . . . . 1.2 mp -120.8 135.09 62.13 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 N-CA-C 103.777 -2.675 . . . . 33.5 103.777 -175.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 37.1 mm -120.21 116.06 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 101.208 -3.627 . . . . 30.57 101.208 172.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1070 ' ' LEU . . . . . . . . . . . . . 30.1 mt -102.8 105.62 16.06 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 102.845 -3.02 . . . . 27.66 102.845 172.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1071 ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -127.77 147.17 50.41 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 103.873 -2.64 . . . . 28.399999999999999 103.873 -168.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1072 ' ' VAL . . . . . . . . . . . . . 25.5 t -81.4 -65.07 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.85 0 CA-C-O 117.723 -1.132 . . . . 23.18 112.201 -171.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -106.45 -159.42 0.7 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 120.843 1.656 . . . . 25.469999999999999 111.817 -161.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -64.28 142.28 98.29 Favored Pre-proline 0 CA--C 1.517 -0.317 0 CA-C-N 120.691 1.587 . . . . 27.899999999999999 111.222 -177.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -70.94 118.71 5.84 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.024 3.149 . . . . 31.620000000000001 117.116 164.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 5.3 mp -74.48 170.75 15.07 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 124.652 2.168 . . . . 40.490000000000002 107.47 166.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 36.6 t70 -56.22 -39.26 72.22 Favored 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 125.222 1.409 . . . . 51.590000000000003 113.707 -175.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -67.89 -39.12 83.69 Favored 'General case' 0 C--N 1.348 0.5 0 O-C-N 120.626 -1.296 . . . . 42.359999999999999 108.19 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1079 ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -63.5 -45.54 90.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 123.501 1.619 . . . . 34.530000000000001 108.94 -178.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1080 ' ' ILE . . . . . . . . . . . . . 61.3 mt -60.67 -37.07 74.67 Favored 'Isoleucine or valine' 0 C--O 1.261 1.694 0 CA-C-N 113.354 -1.748 . . . . 33.25 110.959 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -74.13 -28.92 61.56 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 115.614 1.709 . . . . 36.469999999999999 115.614 172.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1082 ' ' LEU . . . . . . . . . . . . . 23.3 mt -71.36 -28.26 63.93 Favored 'General case' 0 C--N 1.317 -0.821 0 O-C-N 119.933 -1.729 . . . . 37.759999999999998 110.644 173.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1083 ' ' LEU . . . . . . . . . . . . . 28.7 mt -58.77 127.79 33.96 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 123.037 1.398 . . . . 37.43 111.997 171.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.38 133.55 42.17 Favored Pre-proline 0 C--O 1.243 0.759 0 CA-C-N 112.892 -1.958 . . . . 37.700000000000003 107.572 177.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -44.42 111.42 0.27 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 123.996 3.131 . . . . 35.509999999999998 113.68 169.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 130.2 -48.96 0.94 Allowed Glycine 0 C--N 1.31 -0.911 0 CA-C-N 110.954 -2.839 . . . . 33.869999999999997 109.645 175.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1087 ' ' THR . . . . . . . . . . . . . 72.5 m -43.74 126.84 4.82 Favored 'General case' 0 C--O 1.252 1.21 0 C-N-CA 126.051 1.74 . . . . 32.5 114.504 -165.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1088 ' ' THR . . . . . . . . . . . . . 50.1 m -78.97 91.71 4.86 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-O 124.037 1.875 . . . . 30.219999999999999 109.843 -176.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1089 ' ' LEU . . . . . . . . . . . . . 36.0 tp -76.15 137.39 40.04 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 113.112 -1.858 . . . . 27.239999999999998 111.084 170.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 56.7 t -133.95 112.12 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 103.589 -2.745 . . . . 25.390000000000001 103.589 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1091 ' ' SER . . . . . . . . . . . . . 48.7 m -160.45 163.84 32.71 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 120.43 -1.419 . . . . 28.809999999999999 111.201 -171.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1092 ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -71.18 102.88 2.62 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.005 -1.059 . . . . 30.780000000000001 110.606 165.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 29.7 mm -85.29 -45.21 17.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 120.261 1.391 . . . . 30.280000000000001 111.807 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1094 ' ' TRP . . . . . . . . . . . . . 93.1 m95 56.21 73.52 0.82 Allowed Pre-proline 0 C--O 1.244 0.809 0 O-C-N 125.091 1.495 . . . . 34.07 110.403 -157.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -55.28 -50.16 13.88 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 123.819 3.013 . . . . 38.659999999999997 115.951 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -64.67 -33.05 75.03 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-O 123.057 1.408 . . . . 41.32 110.096 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 8.4 mp0 -80.25 -17.58 51.8 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 116.711 -1.614 . . . . 51.659999999999997 110.378 175.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -142.46 59.89 9.33 Favored Pre-proline 0 N--CA 1.481 1.092 0 CA-C-N 122.588 2.449 . . . . 40.32 111.591 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -59.55 -32.72 96.59 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 123.621 2.881 . . . . 41.560000000000002 112.955 177.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -63.46 -47.71 80.72 Favored 'General case' 0 C--O 1.206 -1.196 0 CA-C-O 123.001 1.381 . . . . 54.109999999999999 109.217 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1101 ' ' LEU . . . . . . . . . . . . . 5.1 tp -62.95 -45.71 91.18 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 113.313 -1.767 . . . . 37.880000000000003 108.547 -176.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1102 ' ' MET . . . . . . . . . . . . . 67.9 mmm -49.77 -51.31 40.2 Favored 'General case' 0 CA--C 1.498 -1.03 0 C-N-CA 124.122 0.969 . . . . 37.539999999999999 109.994 169.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 42.3 tp60 -62.83 -36.13 82.22 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 118.772 -1.171 . . . . 47.009999999999998 113.922 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1104 ' ' LYS . . . . . . . . . . . . . 93.2 mttt -60.95 -45.8 93.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 120.139 -0.624 . . . . 48.68 112.352 173.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1105 ' ' LEU . . . . . . . . . . . . . 73.9 mt -57.89 -43.35 86.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 124.839 2.257 . . . . 32.210000000000001 114.95 175.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -56.24 -55.59 31.45 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 112.089 -2.323 . . . . 33.729999999999997 111.717 172.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.51 -20.69 66.45 Favored 'General case' 0 C--N 1.359 1.01 0 O-C-N 118.811 -2.431 . . . . 51.469999999999999 114.159 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1108 ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -82.96 -1.51 52.65 Favored 'General case' 0 C--N 1.348 0.543 0 N-CA-C 114.249 1.204 . . . . 43.899999999999999 114.249 170.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1109 ' ' ASN . . . . . . . . . . . . . 12.1 m-80 61.93 28.87 17.6 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 118.813 2.894 . . . . 44.82 118.813 171.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1110 ' ' VAL . . . . . . . . . . . . . 30.0 m -89.77 170.04 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.28 0 CA-C-N 113.486 -1.688 . . . . 30.52 111.921 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1111 ' ' THR . . . . . . . . . . . . . 59.1 m -111.21 119.02 37.55 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 104.417 -2.438 . . . . 27.120000000000001 104.417 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1112 ' ' VAL . . . . . . . . . . . . . 34.3 t -119.15 126.5 75.41 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 CA-C-O 118.726 -0.654 . . . . 26.399999999999999 110.129 -171.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1113 ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -101.01 115.41 30.43 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 106.011 -1.848 . . . . 42.920000000000002 106.011 168.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -85.91 104.11 15.26 Favored 'General case' 0 N--CA 1.426 -1.631 0 C-N-CA 119.118 -1.033 . . . . 24.149999999999999 109.909 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1115 ' ' MET . . . . . . . . . . . . . 44.2 mmm -59.35 -14.86 13.24 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 116.326 1.972 . . . . 29.949999999999999 116.326 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1116 ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -86.42 -37.95 17.85 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 108.246 -1.02 . . . . 34.530000000000001 108.246 172.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1117 ' ' SER . . . . . . . . . . . . . 68.4 m -95.05 38.51 1.13 Allowed 'General case' 0 C--N 1.316 -0.863 0 O-C-N 118.605 -2.56 . . . . 33.490000000000002 110.066 -173.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1118 ' ' VAL . . . . . . . . . . . . . 2.2 t -78.47 133.22 63.78 Favored Pre-proline 0 N--CA 1.468 0.453 0 N-CA-C 105.8 -1.926 . . . . 34.020000000000003 105.8 169.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -47.21 142.16 12.34 Favored 'Trans proline' 0 C--N 1.328 -0.507 1 C-N-CA 126.321 4.681 . . . . 38.280000000000001 115.224 -176.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B 1120 ' ' ARG . . . . . 0.459 HH12 ' CG ' ' B' 1128 ' ' ASP . 0.4 OUTLIER -81.58 56.62 3.04 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 114.226 1.195 . . . . 55.049999999999997 114.226 -175.528 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B 1121 ' ' ILE . . . . . . . . . . . . . 13.1 pt -129.4 149.22 33.45 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 107.969 -1.123 . . . . 42.090000000000003 107.969 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1122 ' ' SER . . . . . . . . . . . . . 48.6 m -51.14 -32.48 23.16 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 116.894 2.183 . . . . 38.020000000000003 116.894 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1123 ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -58.02 -39.05 77.37 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.642 1.577 . . . . 34.289999999999999 109.219 174.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1124 ' ' ALA . . . . . . . . . . . . . . . -84.19 -30.82 25.48 Favored 'General case' 0 C--O 1.206 -1.191 0 O-C-N 121.241 -0.912 . . . . 32.350000000000001 111.419 175.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1125 ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -58.85 -26.84 64.57 Favored 'General case' 0 C--N 1.348 0.534 0 N-CA-C 118.304 2.705 . . . . 47.170000000000002 118.304 -165.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1126 ' ' SER . . . . . . . . . . . . . 1.4 p -72.04 -34.49 68.81 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 124.183 1.944 . . . . 31.710000000000001 110.805 173.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1127 ' ' LEU . . . . . . . . . . . . . 2.5 mp -80.64 -30.84 36.6 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 113.304 -1.771 . . . . 37.0 110.363 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1128 ' ' ASP . . . . . 0.459 ' CG ' HH12 ' B' 1120 ' ' ARG . 10.1 t70 -62.74 123.43 18.42 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 114.554 1.316 . . . . 40.399999999999999 114.554 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B 1129 ' ' ALA . . . . . . . . . . . . . . . -70.12 -35.17 73.91 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 115.671 -0.695 . . . . 26.559999999999999 112.359 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 46.7 mt -57.48 -33.53 68.09 Favored 'General case' 0 CA--C 1.557 1.248 0 CA-C-O 115.635 -2.126 . . . . 30.890000000000001 111.751 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1131 ' ' SER . . . . . . . . . . . . . 59.7 p -57.15 -56.99 14.58 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 119.825 1.193 . . . . 29.84 113.047 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1132 ' ' SER . . . . . . . . . . . . . 24.9 m -64.93 -39.29 93.28 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 126.121 2.138 . . . . 31.91 111.862 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1133 ' ' MET . . . . . 0.481 ' SD ' ' NH1' ' B' 1015 ' ' ARG . 36.4 mmt -69.73 -30.61 68.26 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 113.102 0.779 . . . . 25.899999999999999 113.102 178.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B 1134 ' ' ALA . . . . . . . . . . . . . . . -72.52 -39.04 67.89 Favored 'General case' 0 N--CA 1.415 -2.222 0 CA-C-N 114.447 -1.251 . . . . 26.620000000000001 107.95 174.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.85 -35.22 79.54 Favored 'General case' 0 C--O 1.215 -0.763 0 CA-C-N 119.506 1.048 . . . . 36.969999999999999 110.902 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B 1136 ' ' ILE . . . . . . . . . . . . . 39.5 mm -64.09 -53.67 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 102.457 -3.164 . . . . 32.109999999999999 102.457 174.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -55.25 -37.16 66.86 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 114.23 1.196 . . . . 24.140000000000001 114.23 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -71.64 -43.28 52.53 Favored Glycine 0 C--N 1.308 -1.018 0 CA-C-N 118.273 0.488 . . . . 25.129999999999999 114.291 178.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 34.6 t80 -71.01 -41.59 70.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 123.316 1.531 . . . . 32.729999999999997 112.535 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1140 ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -67.98 -28.59 67.58 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 113.463 -1.699 . . . . 26.359999999999999 110.552 175.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1141 ' ' ALA . . . . . . . . . . . . . . . -58.95 -51.46 69.96 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 105.931 -1.877 . . . . 24.120000000000001 105.931 174.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 20.6 mm -59.03 -42.29 85.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-O 117.84 -1.076 . . . . 23.370000000000001 109.686 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 76.4 t -58.97 -62.41 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 119.528 1.058 . . . . 24.960000000000001 113.454 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -62.85 -35.58 80.43 Favored 'General case' 0 C--O 1.267 1.983 0 O-C-N 124.384 1.053 . . . . 32.07 110.258 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1145 ' ' ALA . . . . . . . . . . . . . . . -54.65 -61.58 2.22 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.124 0.57 . . . . 24.870000000000001 112.085 167.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1146 ' ' ALA . . . . . . . . . . . . . . . -58.85 -27.5 65.2 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 118.965 -2.334 . . . . 24.670000000000002 114.893 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 62.1 t60 -63.57 -45.87 88.51 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 114.374 -1.285 . . . . 28.579999999999998 109.973 170.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1148 ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -100.59 4.89 43.76 Favored 'General case' 0 C--O 1.255 1.343 0 N-CA-C 114.628 1.344 . . . . 36.82 114.628 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1149 ' ' PHE . . . . . . . . . . . . . 1.4 t80 -76.45 146.09 38.83 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 123.719 1.723 . . . . 31.969999999999999 108.099 -174.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1150 ' ' GLY . . . . . . . . . . . . . . . -66.29 -43.82 92.05 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 113.355 -1.748 . . . . 25.489999999999998 109.682 170.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1151 ' ' ARG . . . . . . . . . . . . . 75.2 mtm-85 -119.89 -171.58 2.17 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 117.983 0.892 . . . . 59.840000000000003 113.374 -163.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1152 ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -88.65 159.11 18.0 Favored 'General case' 0 C--O 1.238 0.486 0 O-C-N 120.264 -1.522 . . . . 34.450000000000003 111.759 169.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1153 ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -77.02 -56.59 4.45 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 114.205 -1.361 . . . . 31.170000000000002 112.809 171.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1154 ' ' THR . . . . . . . . . . . . . 12.1 m -65.05 142.07 58.53 Favored 'General case' 0 C--O 1.25 1.131 0 CA-C-O 121.899 0.857 . . . . 33.890000000000001 109.956 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -73.06 59.0 1.83 Allowed Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 110.515 -1.034 . . . . 38.950000000000003 110.515 170.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -77.24 134.6 38.54 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 124.938 1.295 . . . . 54.229999999999997 110.646 -160.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 15.0 mm -80.68 116.58 25.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 101.454 -3.535 . . . . 51.159999999999997 101.454 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1158 ' ' THR . . . . . . . . . . . . . 31.5 m -122.22 155.07 36.6 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.305 1.05 . . . . 49.609999999999999 108.396 -175.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -26.36 -61.2 0.08 Allowed 'General case' 0 C--O 1.212 -0.907 0 N-CA-C 119.422 3.119 . . . . 49.049999999999997 119.422 172.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -57.94 -51.03 71.32 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 114.299 1.222 . . . . 47.649999999999999 114.299 170.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . 179.6 178.59 48.5 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-O 122.225 0.903 . . . . 45.609999999999999 113.717 -165.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 84.4 mttt -79.3 140.61 37.52 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 123.083 1.42 . . . . 57.460000000000001 109.764 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1163 ' ' VAL . . . . . . . . . . . . . 48.6 t -90.99 130.11 41.62 Favored Pre-proline 0 C--N 1.299 -1.624 0 CA-C-O 116.5 -1.714 . . . . 42.93 107.603 173.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1164 ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -59.33 135.83 68.0 Favored 'Trans proline' 0 N--CA 1.479 0.667 0 C-N-CA 123.906 3.071 . . . . 39.289999999999999 111.865 167.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1165 ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -67.31 141.46 56.68 Favored 'Trans proline' 0 C--O 1.255 1.327 0 C-N-CA 123.287 2.658 . . . . 34.170000000000002 114.254 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -73.09 127.68 33.29 Favored 'General case' 0 C--O 1.253 1.266 0 N-CA-C 105.826 -1.916 . . . . 31.690000000000001 105.826 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1167 ' ' LYS . . . . . . . . . . . . . 93.6 mttt -93.81 108.27 20.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 123.201 1.477 . . . . 44.780000000000001 107.949 168.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 87.7 t -94.24 95.44 5.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 113.766 -1.561 . . . . 31.23 108.153 -172.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1169 ' ' MET . . . . . . . . . . . . . 54.8 ttp -79.83 95.69 6.11 Favored 'General case' 0 C--O 1.245 0.831 0 O-C-N 120.534 -1.354 . . . . 37.090000000000003 108.759 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 24.3 t -93.22 99.2 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 N-CA-C 106.435 -1.691 . . . . 30.170000000000002 106.435 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1171 ' ' ILE . . . . . . . . . . . . . 35.4 mt -93.38 119.75 41.66 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 N-CA-C 105.677 -1.972 . . . . 33.740000000000002 105.677 -175.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 98.68 62.52 0.86 Allowed Glycine 0 C--N 1.346 1.131 0 N-CA-C 108.44 -1.864 . . . . 32.590000000000003 108.44 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1173 ' ' ALA . . . . . . . . . . . . . . . -74.44 60.34 0.86 Allowed 'General case' 0 C--O 1.247 0.944 0 N-CA-C 114.89 1.441 . . . . 32.420000000000002 114.89 176.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -87.95 -158.76 33.64 Favored Glycine 0 C--O 1.213 -1.203 0 N-CA-C 105.642 -2.983 . . . . 31.739999999999998 105.642 160.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 3.7 t -54.42 -39.1 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-N 120.432 2.116 . . . . 31.48 112.439 -172.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1176 ' ' ALA . . . . . . . . . . . . . . . -67.14 -38.24 85.17 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 120.689 -1.257 . . . . 26.120000000000001 110.977 178.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1177 ' ' GLY . . . . . . . . . . . . . . . -55.29 -54.12 36.34 Favored Glycine 0 C--O 1.208 -1.519 0 C-N-CA 124.534 1.064 . . . . 25.73 110.759 174.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1178 ' ' LEU . . . . . . . . . . . . . 15.6 mt -65.39 -30.03 70.8 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 113.285 -1.457 . . . . 32.590000000000003 110.846 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -68.82 -42.19 77.58 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.765 -0.584 . . . . 27.719999999999999 109.782 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -70.25 -37.57 74.96 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 107.498 -1.297 . . . . 26.030000000000001 107.498 -174.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1181 ' ' ILE . . . . . . . . . . . . . 13.3 mt -63.06 -48.8 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 107.342 -1.355 . . . . 28.609999999999999 107.342 171.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -58.38 -26.7 59.66 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-O 118.724 -1.042 . . . . 25.23 115.203 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -90.11 -60.78 1.84 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 118.683 1.241 . . . . 24.09 111.308 174.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -61.05 -44.92 96.67 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 116.097 1.888 . . . . 26.68 116.097 -175.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 5.0 t30 -66.14 -45.91 79.37 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 118.099 -0.953 . . . . 36.57 109.344 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1186 ' ' SER . . . . . . . . . . . . . 16.1 m -56.21 -45.61 79.8 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 120.577 1.535 . . . . 28.920000000000002 112.876 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1187 ' ' LEU . . . . . . . . . . . . . 58.6 mt -45.1 -52.35 9.23 Favored 'General case' 0 C--O 1.246 0.879 0 O-C-N 123.934 0.771 . . . . 29.09 112.788 165.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 128.41 27.24 0.91 Allowed Glycine 0 N--CA 1.438 -1.175 0 O-C-N 121.26 -0.9 . . . . 29.260000000000002 112.969 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1189 ' ' ALA . . . . . . . . . . . . 0.259 . . -102.48 146.11 28.59 Favored 'General case' 0 C--O 1.251 1.176 0 N-CA-C 107.747 -1.205 . . . . 30.16 107.747 -179.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 74.0 mt -83.82 103.94 11.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 103.178 -2.897 . . . . 35.810000000000002 103.178 -171.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1191 ' ' VAL . . . . . . . . . . . . . 53.0 t -81.26 131.85 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.646 0 N-CA-C 104.903 -2.258 . . . . 31.969999999999999 104.903 176.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1192 ' ' ARG . . . . . . . . . . . . . 33.2 mtt180 -120.57 89.85 3.21 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 109.827 -3.351 . . . . 48.159999999999997 104.946 171.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -90.31 130.29 36.43 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.401 -1.272 . . . . 35.890000000000001 113.151 -176.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 35.2 t80 -106.31 144.12 33.45 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.72 -1.215 . . . . 41.880000000000003 107.72 175.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1195 ' ' ASP . . . . . . . . . . . . . 8.9 t70 -157.98 153.26 25.82 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 104.417 -2.438 . . . . 38.280000000000001 104.417 160.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1196 ' ' THR . . . . . . . . . . . . . 13.4 p -84.25 -10.04 58.0 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.114 0.783 . . . . 40.619999999999997 113.114 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1197 ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -91.43 126.6 53.93 Favored Pre-proline 0 C--O 1.247 0.969 0 C-N-CA 124.294 1.038 . . . . 53.090000000000003 108.353 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -52.6 -45.7 38.37 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 N-CA-C 121.264 3.525 . . . . 42.560000000000002 121.264 177.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.66 -8.42 55.21 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 118.351 -2.718 . . . . 56.310000000000002 114.094 -157.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B 1200 ' ' VAL . . . . . . . . . . . . . 34.5 m -85.06 -17.46 9.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 120.799 -1.188 . . . . 42.909999999999997 111.257 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 49.1 tttm -50.39 -54.26 23.12 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 121.428 1.922 . . . . 48.890000000000001 112.252 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 20.6 mp0 -64.64 -21.96 66.85 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 116.715 2.117 . . . . 51.700000000000003 116.715 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1203 ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -64.98 -48.16 74.98 Favored 'General case' 0 C--O 1.248 1.0 0 O-C-N 118.647 -2.533 . . . . 52.57 110.197 172.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1204 ' ' VAL . . . . . . . . . . . . . 12.1 t -59.97 -54.2 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 112.144 -2.298 . . . . 33.789999999999999 108.504 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -51.08 -51.73 50.4 Favored 'General case' 0 C--O 1.203 -1.362 0 C-N-CA 124.579 1.152 . . . . 36.579999999999998 112.88 177.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1206 ' ' SER . . . . . . . . . . . . . 16.5 m -71.41 -7.58 48.23 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 115.634 1.716 . . . . 39.609999999999999 115.634 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1207 ' ' MET . . . . . . . . . . . . . 27.5 mtp -80.21 -38.71 30.58 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 123.118 1.437 . . . . 37.450000000000003 112.012 167.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 121.58 46.87 0.31 Allowed Glycine 0 CA--C 1.519 0.297 0 CA-C-N 112.035 -2.348 . . . . 31.870000000000001 108.031 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -142.36 150.28 40.51 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 114.033 -1.083 . . . . 35.399999999999999 110.233 -168.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -81.58 139.51 35.02 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 125.677 1.861 . . . . 47.890000000000001 107.421 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 87.7 t80 -107.21 114.24 28.16 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 106.244 -1.761 . . . . 45.530000000000001 106.244 170.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1212 ' ' LEU . . . . . . . . . . . . . 62.7 mt -65.94 116.65 7.31 Favored 'General case' 0 N--CA 1.441 -0.913 0 O-C-N 120.616 -1.303 . . . . 46.329999999999998 108.075 170.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -80.99 175.81 10.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 122.964 1.364 . . . . 60.409999999999997 111.932 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 25.4 mt -56.92 132.0 51.33 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 112.705 -2.043 . . . . 57.380000000000003 108.998 168.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 15.1 t70 . . . . . 0 N--CA 1.443 -0.777 0 C-N-CA 124.354 1.062 . . . . 65.069999999999993 108.848 -177.102 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B 1230 ' ' MET . . . . . . . . . . . . . 3.0 mmt . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 105.121 -2.178 . . . . 80.319999999999993 105.121 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B 1231 ' ' SER . . . . . . . . . . . . . 4.8 m 103.83 159.49 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.085 2 O-C-N 114.398 -5.189 . . . . 79.920000000000002 114.175 -18.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -56.06 154.0 8.22 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 116.579 2.066 . . . . 77.909999999999997 116.579 -172.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 66.39 -53.79 0.41 Allowed 'General case' 0 C--N 1.356 0.873 0 C-N-CA 126.273 1.829 . . . . 73.879999999999995 112.688 -172.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 32.2 t80 -60.5 -35.7 76.59 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-N 121.025 1.739 . . . . 68.980000000000004 109.227 171.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 15.4 pt -47.46 -32.69 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 120.22 1.373 . . . . 64.530000000000001 114.175 169.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -60.17 -46.02 91.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 117.994 -2.941 . . . . 66.359999999999999 111.75 169.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -69.5 -29.94 67.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 123.229 1.49 . . . . 56.600000000000001 111.527 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -63.79 -48.38 77.13 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 114.16 -1.382 . . . . 56.789999999999999 109.196 175.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1239 ' ' MET . . . . . . . . . . . . . 29.6 mmt -57.47 -55.98 27.73 Favored 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 125.359 1.464 . . . . 53.630000000000003 107.343 177.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -53.9 -29.44 41.91 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 114.643 1.349 . . . . 51.740000000000002 114.643 176.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 58.3 tp -70.02 -43.46 71.29 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 108.978 -0.749 . . . . 44.859999999999999 108.978 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -74.08 -39.94 63.1 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 124.722 1.264 . . . . 42.780000000000001 111.408 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.97 93.77 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.373 -0.831 . . . . 40.960000000000001 109.86 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -60.25 -49.13 78.81 Favored 'General case' 0 C--N 1.316 -0.879 0 O-C-N 121.195 -0.941 . . . . 43.060000000000002 110.368 172.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -65.38 -24.19 67.16 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 113.052 -1.885 . . . . 46.450000000000003 110.842 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -48.84 -39.75 26.8 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 119.589 3.181 . . . . 41.780000000000001 119.589 -174.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 12.3 mptt -67.91 -31.7 71.65 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.224 -1.548 . . . . 52.200000000000003 112.324 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1248 ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -80.97 -44.17 18.57 Favored 'General case' 0 C--O 1.251 1.158 0 CA-C-N 114.168 -1.378 . . . . 53.549999999999997 111.885 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1249 ' ' VAL . . . . . . . . . . . . . 35.2 m -85.72 150.36 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 124.454 2.073 . . . . 34.409999999999997 111.135 -165.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1250 ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -108.08 -47.59 3.53 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 110.749 -2.932 . . . . 33.380000000000003 111.328 -176.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1251 ' ' ILE . . . . . . . . . . . . . 33.0 mm -119.21 125.15 74.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 105.978 -1.86 . . . . 29.539999999999999 105.978 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1252 ' ' ILE . . . . . . . . . . . . . 79.8 mt -103.68 118.56 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 104.583 -2.377 . . . . 32.439999999999998 104.583 172.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1253 ' ' VAL . . . . . . . . . . . . . 52.9 t -111.39 89.99 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.072 0 N-CA-C 104.433 -2.432 . . . . 30.57 104.433 177.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1254 ' ' THR . . . . . . . . . . . . . 14.1 t -101.44 131.94 47.3 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 113.736 -1.575 . . . . 35.039999999999999 109.027 -169.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1255 ' ' THR . . . . . . . . . . . . . 2.6 m -146.93 31.43 0.94 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.875 -1.057 . . . . 34.619999999999997 113.14 -157.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . -73.7 75.62 1.55 Allowed 'General case' 0 C--O 1.244 0.804 0 O-C-N 117.842 -3.036 . . . . 42.719999999999999 111.483 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 32.7 mt -83.83 79.18 9.56 Favored 'General case' 0 C--O 1.248 0.976 0 CA-C-O 123.677 1.703 . . . . 52.43 108.084 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 27.2 pt -81.86 132.91 52.88 Favored Pre-proline 0 N--CA 1.448 -0.568 0 CA-C-N 113.357 -1.747 . . . . 59.409999999999997 109.985 -173.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -49.59 99.33 0.04 OUTLIER 'Trans proline' 0 CA--C 1.495 -1.451 0 N-CA-C 120.113 3.082 . . . . 62.68 120.113 -166.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 74.09 3.81 65.93 Favored Glycine 0 N--CA 1.432 -1.574 0 CA-C-N 112.604 -2.089 . . . . 64.159999999999997 112.698 173.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 95.0 mttt -105.53 164.7 14.51 Favored Pre-proline 0 C--O 1.211 -0.946 0 CA-C-O 115.919 -1.991 . . . . 68.530000000000001 110.991 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -70.92 142.24 42.36 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 CA-C-N 126.654 3.412 . . . . 61.990000000000002 111.957 167.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1263 ' ' ALA . . . . . . . . . . . . . . . -62.68 135.91 95.96 Favored Pre-proline 0 C--O 1.249 1.073 0 N-CA-C 113.851 1.056 . . . . 57.149999999999999 113.851 173.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -64.91 154.26 73.98 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 121.991 1.794 . . . . 51.57 114.647 173.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -81.96 82.69 7.49 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 118.649 -1.221 . . . . 54.549999999999997 109.019 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 62.5 mt -64.98 -48.19 74.87 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-O 123.125 1.441 . . . . 46.859999999999999 113.399 175.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1267 ' ' ILE . . . . . . . . . . . . . 22.9 mm -96.0 97.56 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 122.088 0.947 . . . . 41.039999999999999 108.896 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1268 ' ' THR . . . . . . . . . . . . . 18.1 p -76.5 162.04 28.14 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 113.732 -1.576 . . . . 39.579999999999998 113.197 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1269 ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -59.24 -36.05 74.78 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 124.376 1.07 . . . . 53.149999999999999 111.296 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -50.65 -58.65 5.34 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 114.57 -1.196 . . . . 42.960000000000001 111.638 167.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1271 ' ' MET . . . . . . . . . . . . . 28.6 ttm -60.08 -33.55 72.22 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.637 1.347 . . . . 43.890000000000001 114.637 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1272 ' ' VAL . . . . . . . . . . . . . 58.1 t -66.27 -48.05 82.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 109.048 -0.723 . . . . 38.369999999999997 109.048 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 4.7 t70 -77.25 -27.43 53.28 Favored 'General case' 0 C--O 1.244 0.776 0 O-C-N 121.617 -0.677 . . . . 47.460000000000001 110.059 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1274 ' ' SER . . . . . . . . . . . . . 67.3 m -74.13 -24.27 59.4 Favored 'General case' 0 C--O 1.246 0.878 0 CA-C-N 115.962 -0.563 . . . . 38.380000000000003 111.814 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1275 ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -60.51 163.19 5.53 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 115.553 1.686 . . . . 37.810000000000002 115.553 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -56.12 130.04 42.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 113.742 -1.572 . . . . 49.259999999999998 110.219 169.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -60.59 159.63 10.34 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.732 -1.576 . . . . 34.460000000000001 111.141 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 64.78 33.54 87.51 Favored Glycine 0 CA--C 1.521 0.421 0 O-C-N 121.427 -0.795 . . . . 33.530000000000001 113.526 172.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1279 ' ' SER . . . . . . . . . . . . . 15.2 m -133.94 167.28 20.89 Favored 'General case' 0 C--O 1.262 1.763 0 C-N-CA 123.481 0.712 . . . . 31.309999999999999 111.598 -164.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1280 ' ' VAL . . . . . . . . . . . . . 66.9 t -127.01 131.06 71.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 O-C-N 119.868 -1.77 . . . . 29.32 111.118 -173.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1281 ' ' ILE . . . . . . . . . . . . . 91.3 mt -103.25 99.37 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 102.505 -3.146 . . . . 31.93 102.505 169.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1282 ' ' VAL . . . . . . . . . . . . . 17.4 t -82.52 115.04 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 105.121 -2.177 . . . . 29.48 105.121 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 42.8 t0 -97.99 112.64 24.5 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 123.819 1.771 . . . . 34.5 106.76 174.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1284 ' ' LEU . . . . . . . . . . . . . 7.3 mp -90.6 -21.28 21.8 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 113.64 -1.618 . . . . 37.939999999999998 110.215 -176.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -96.87 16.68 18.64 Favored 'General case' 0 C--O 1.25 1.115 0 CA-C-O 121.503 0.668 . . . . 40.920000000000002 111.784 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -63.5 -34.89 78.76 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 122.756 1.265 . . . . 44.390000000000001 112.399 -167.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1287 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -45.99 74.36 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 115.237 -0.892 . . . . 51.460000000000001 109.656 174.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.4 37.75 1.62 Allowed 'General case' 0 C--O 1.245 0.843 0 CA-C-O 125.214 2.435 . . . . 57.75 108.856 -167.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B 1289 ' ' GLY . . . . . . . . . . . . . . . 139.57 -61.75 0.56 Allowed Glycine 0 N--CA 1.433 -1.532 0 O-C-N 119.147 -2.221 . . . . 49.850000000000001 111.869 175.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 96.19 114.39 2.98 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 107.519 -2.232 . . . . 45.93 107.519 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1291 ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -72.86 -16.26 61.59 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.314 -0.995 . . . . 42.670000000000002 108.314 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1292 ' ' CYS . . . . . . . . . . . . . 25.3 t -118.93 139.09 52.24 Favored 'General case' 0 N--CA 1.432 -1.33 0 O-C-N 118.748 -2.47 . . . . 38.82 113.265 -175.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1293 ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -66.81 -40.84 88.21 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 118.745 -0.645 . . . . 46.710000000000001 112.441 177.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.08 -6.41 50.99 Favored 'General case' 0 C--O 1.239 0.531 0 O-C-N 125.866 1.979 . . . . 47.229999999999997 113.124 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B 1295 ' ' THR . . . . . . . . . . . . . 74.1 m -52.67 137.76 30.24 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 124.955 2.312 . . . . 36.020000000000003 112.025 172.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 3.7 t -117.42 105.14 48.94 Favored Pre-proline 0 C--N 1.321 -0.643 1 N-CA-C 96.65 -5.315 . . . . 37.259999999999998 96.65 168.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -56.7 128.42 29.93 Favored 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 124.968 3.779 . . . . 35.090000000000003 111.311 177.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 96.12 -17.46 59.24 Favored Glycine 0 C--N 1.315 -0.615 0 CA-C-O 122.288 0.938 . . . . 35.969999999999999 112.296 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -123.44 173.64 7.88 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 123.822 1.772 . . . . 40.390000000000001 110.751 -171.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1300 ' ' ILE . . . . . . . . . . . . . 96.4 mt -113.55 105.96 19.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 110.744 -2.935 . . . . 37.43 103.088 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 76.6 t80 -73.1 148.5 43.92 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.347 -1.353 . . . . 44.130000000000003 107.347 171.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1302 ' ' THR . . . . . . . . . . . . . 40.7 m -140.46 119.41 12.65 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 122.773 2.533 . . . . 39.780000000000001 106.538 175.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1303 ' ' THR . . . . . . . . . . . . . 2.7 p -74.21 175.15 7.82 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.854 0.835 . . . . 43.289999999999999 109.801 171.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -74.66 -25.39 59.15 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-O 121.849 0.833 . . . . 53.07 109.801 -174.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -80.47 -7.99 59.38 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.342 -0.984 . . . . 43.969999999999999 108.342 173.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 90.3 37.46 6.64 Favored Glycine 0 N--CA 1.462 0.382 0 O-C-N 119.752 -1.842 . . . . 41.119999999999997 111.382 174.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1307 ' ' VAL . . . . . . . . . . . . . 43.2 t -97.69 108.79 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-O 125.837 2.732 . . . . 38.119999999999997 104.019 170.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1308 ' ' LYS . . . . . . . . . . . . . 83.9 mttt -84.67 102.56 13.05 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 108.783 -3.826 . . . . 36.340000000000003 109.498 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1309 ' ' VAL . . . . . . . . . . . . . 22.0 t -85.02 100.17 7.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 105.483 -2.043 . . . . 30.399999999999999 105.483 177.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1310 ' ' ILE . . . . . . . . . . . . . 27.1 mt -81.8 90.53 2.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 107.032 -1.47 . . . . 30.82 107.032 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1311 ' ' GLY . . . . . . . . . . . . . . . -89.57 83.02 1.41 Allowed Glycine 0 C--N 1.301 -1.411 0 N-CA-C 108.751 -1.739 . . . . 26.530000000000001 108.751 -172.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1312 ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -98.57 133.05 43.47 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 119.306 3.076 . . . . 38.0 119.306 -170.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1313 ' ' THR . . . . . . . . . . . . . 2.6 p -76.87 -63.86 1.26 Allowed 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 109.222 -3.626 . . . . 29.800000000000001 108.509 166.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 4.3 p30 -69.62 6.85 0.98 Allowed 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 120.405 3.483 . . . . 39.039999999999999 120.405 -171.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1315 ' ' LEU . . . . . . . . . . . . . 28.4 mt -46.6 -50.42 41.87 Favored Pre-proline 0 C--N 1.352 0.703 0 N-CA-C 118.952 2.945 . . . . 31.079999999999998 118.952 175.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1316 ' ' PRO . . . . . . . . . . . . . 92.6 Cg_exo -55.45 -33.39 85.81 Favored 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 123.956 3.104 . . . . 26.100000000000001 112.072 174.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -82.56 -53.73 3.5 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 120.424 -1.423 . . . . 23.170000000000002 111.247 -175.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 71.3 mtt-85 -36.95 -16.5 0.0 OUTLIER 'General case' 0 C--O 1.235 0.318 1 N-CA-C 124.077 4.843 . . . . 40.399999999999999 124.077 -170.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 1.3 tp -105.52 77.35 0.38 Allowed Pre-proline 0 C--O 1.252 1.232 0 CA-C-N 124.031 3.105 . . . . 23.600000000000001 106.684 -176.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1320 ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -39.79 -72.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 124.79 3.66 . . . . 22.350000000000001 117.926 -151.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1321 ' ' THR . . . . . . . . . . . . . 2.0 m -66.64 -31.83 72.77 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 112.904 0.705 . . . . 26.52 112.904 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1322 ' ' GLN . . . . . . . . . . . . . 45.8 tp60 -75.81 -44.66 40.07 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 119.097 -2.252 . . . . 24.379999999999999 110.267 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1323 ' ' SER . . . . . . . . . . . . . 50.6 m -46.97 -52.1 15.47 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 120.272 -1.517 . . . . 22.800000000000001 110.394 169.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1324 ' ' SER . . . . . . . . . . . . . 29.0 m -57.1 -59.58 4.88 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 113.495 -1.684 . . . . 21.25 113.457 173.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 66.3 tp60 -52.84 -40.58 63.46 Favored 'General case' 0 C--N 1.344 0.346 0 O-C-N 120.303 -1.498 . . . . 31.34 113.957 -177.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1326 ' ' LEU . . . . . . . . . . . . . 63.4 mt -73.54 -46.94 44.55 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 113.665 0.987 . . . . 31.559999999999999 113.665 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1327 ' ' TYR . . . . . . . . . . . . . 47.2 t80 -54.22 -51.68 63.66 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-O 122.947 1.356 . . . . 22.73 108.6 173.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1328 ' ' GLY . . . . . . . . . . . . . . . -41.06 -57.22 3.04 Favored Glycine 0 CA--C 1.496 -1.151 0 CA-C-N 112.614 -2.085 . . . . 21.91 115.793 168.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1329 ' ' THR . . . . . . . . . . . . . 62.4 m -66.92 -28.96 68.73 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 114.605 1.335 . . . . 22.149999999999999 114.605 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1330 ' ' ASN . . . . . . . . . . . . . 30.5 m120 -53.45 -51.42 62.72 Favored 'General case' 0 C--O 1.24 0.573 0 O-C-N 121.365 -0.834 . . . . 26.18 109.952 167.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1331 ' ' LEU . . . . . . . . . . . . . 20.2 mt -65.95 -39.0 90.07 Favored 'General case' 0 CA--C 1.508 -0.653 0 O-C-N 125.413 1.696 . . . . 23.68 110.404 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1332 ' ' VAL . . . . . . . . . . . . . 59.6 t -55.49 -51.31 58.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 120.073 1.306 . . . . 26.57 109.545 171.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -61.33 -39.86 92.1 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 114.371 -1.286 . . . . 28.079999999999998 109.771 -173.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1334 ' ' LEU . . . . . . . . . . . . . 15.2 tp -70.95 -42.78 69.33 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 126.315 1.846 . . . . 27.43 107.482 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1335 ' ' LEU . . . . . . . . . . . . . 79.7 mt -69.6 -24.19 63.63 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 121.195 1.816 . . . . 30.5 111.495 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1336 ' ' LYS . . . . . . . . . . . . . 76.1 mttt -67.94 -40.57 83.25 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 120.166 1.348 . . . . 41.649999999999999 109.649 169.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 11.5 tp -81.31 -25.88 36.1 Favored 'General case' 0 C--O 1.244 0.802 0 O-C-N 119.266 -2.146 . . . . 42.079999999999998 110.985 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1338 ' ' LEU . . . . . . . . . . . . . 12.8 mt -68.81 -78.94 0.06 Allowed 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 122.753 1.263 . . . . 35.030000000000001 109.946 164.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 18.0 t -78.75 76.5 5.24 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.278 -1.379 . . . . 37.329999999999998 107.278 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 58.2 mttp -65.47 -24.76 67.24 Favored 'General case' 0 C--N 1.35 0.595 0 N-CA-C 113.901 1.074 . . . . 50.509999999999998 113.901 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -73.83 -3.3 27.86 Favored 'General case' 0 C--O 1.25 1.097 0 N-CA-C 115.41 1.633 . . . . 54.210000000000001 115.41 169.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? 33.43 66.58 0.22 Allowed 'General case' 0 C--N 1.357 0.923 0 CA-C-O 125.141 2.4 . . . . 50.990000000000002 116.891 -173.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -134.76 -37.01 0.83 Allowed 'General case' 0 C--O 1.248 0.981 0 CA-C-N 112.975 -1.92 . . . . 48.82 111.315 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 148.23 -31.37 1.3 Allowed Glycine 0 N--CA 1.434 -1.483 0 CA-C-N 122.64 2.473 . . . . 40.43 109.583 -178.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -75.82 113.96 13.88 Favored 'General case' 0 C--N 1.361 1.087 0 CA-C-N 119.442 1.621 . . . . 47.560000000000002 109.758 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1346 ' ' ILE . . . . . . . . . . . . . 46.1 mm -69.4 107.05 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 CA-C-O 125.715 2.674 . . . . 42.490000000000002 107.589 177.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1347 ' ' THR . . . . . . . . . . . . . 9.2 m -83.11 108.24 16.24 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 103.154 -2.906 . . . . 38.119999999999997 103.154 176.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 11.7 t -84.16 84.78 2.01 Favored 'Isoleucine or valine' 0 C--O 1.257 1.478 0 N-CA-C 108.049 -1.093 . . . . 37.5 108.049 -175.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 50.5 t0 -80.86 129.78 34.71 Favored 'General case' 0 CA--C 1.5 -0.951 0 O-C-N 124.053 0.846 . . . . 43.850000000000001 111.244 -169.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1350 ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -114.67 -8.89 12.65 Favored 'General case' 0 C--O 1.251 1.147 0 O-C-N 118.668 -2.52 . . . . 39.810000000000002 110.3 175.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 34.3 t70 -72.78 -49.07 32.98 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 120.306 -1.496 . . . . 51.289999999999999 110.075 177.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 2.6 t70 -64.1 135.63 56.54 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 122.098 2.226 . . . . 39.780000000000001 109.787 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 7.4 m -57.48 -34.32 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 114.507 -1.224 . . . . 39.280000000000001 113.266 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1354 ' ' VAL . . . . . . . . . . . . . 35.8 t -76.02 -48.37 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.408 0 CA-C-N 120.124 1.329 . . . . 35.700000000000003 109.353 -174.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1355 ' ' ILE . . . . . . . . . . . . 0.257 24.1 mm -69.58 -32.86 54.26 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 CA-C-O 116.825 -1.56 . . . . 35.770000000000003 112.917 176.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 39.5 tpt85 -54.79 -49.16 71.63 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 120.488 1.495 . . . . 38.549999999999997 109.287 166.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -64.39 -55.96 20.3 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 119.62 1.1 . . . . 29.579999999999998 112.91 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1358 ' ' VAL . . . . . . . . . . . . . 5.0 p -67.85 -34.19 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 124.334 1.054 . . . . 32.060000000000002 112.704 -174.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1359 ' ' THR . . . . . . . . . . . . . 6.2 m -78.34 92.16 4.52 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-O 125.264 2.459 . . . . 29.0 108.733 177.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1360 ' ' VAL . . . . . . . . . . . . . 18.9 m -78.51 -31.68 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.978 0 CA-C-N 108.898 -3.774 . . . . 29.68 108.257 -175.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 70.0 mt -128.97 119.95 50.7 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 N-CA-C 107.027 -1.471 . . . . 32.049999999999997 107.027 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1362 ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -97.67 113.13 24.82 Favored 'General case' 0 C--O 1.249 1.035 0 O-C-N 119.171 -2.205 . . . . 32.520000000000003 105.187 171.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 26.04 70.75 0.04 OUTLIER 'General case' 0 C--O 1.256 1.432 0 N-CA-C 118.028 2.603 . . . . 35.68 118.028 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 95.06 -50.1 1.94 Allowed Glycine 0 N--CA 1.428 -1.886 0 O-C-N 120.437 -1.414 . . . . 34.259999999999998 114.126 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -66.18 126.41 28.58 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.231 -0.655 . . . . 51.07 109.231 -175.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 49.7 mt -76.44 103.38 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.819 0 O-C-N 119.046 -2.284 . . . . 39.869999999999997 107.885 169.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1367 ' ' THR . . . . . . . . . . . . . 7.3 p -90.79 1.0 57.28 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 116.167 1.914 . . . . 38.009999999999998 116.167 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1368 ' ' TRP . . . . . . . . . . . . . 62.2 t90 -65.26 140.92 98.01 Favored Pre-proline 0 N--CA 1.432 -1.359 0 N-CA-C 105.017 -2.216 . . . . 42.140000000000001 105.017 160.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -70.22 157.69 93.1 Favored 'Cis proline' 0 C--O 1.252 1.184 0 N-CA-C 119.223 2.74 . . . . 43.259999999999998 119.223 10.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1370 ' ' ALA . . . . . . . . . . . . . . . -82.86 113.0 42.35 Favored Pre-proline 0 C--O 1.247 0.95 0 N-CA-C 104.427 -2.435 . . . . 46.520000000000003 104.427 168.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -49.46 132.91 30.67 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.796 2.997 . . . . 51.950000000000003 116.411 -173.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -55.83 83.48 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.838 1 C-N-CA 126.144 4.563 . . . . 56.270000000000003 113.604 176.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B 1373 ' ' ILE . . . . . . . . . . . . . 12.8 tt -75.46 140.78 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-N 114.335 -1.302 . . . . 60.829999999999998 110.552 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -67.4 108.47 2.8 Favored 'General case' 0 C--O 1.249 1.064 0 N-CA-C 107.27 -1.381 . . . . 66.099999999999994 107.27 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 60.8 t -102.97 113.64 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 106.437 -1.69 . . . . 63.469999999999999 106.437 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.206 -5.637 0 O-C-N 120.889 -1.132 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.422 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -52.96 -36.65 60.27 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 116.739 2.126 . . . . 0.0 116.739 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -37.96 -43.68 0.73 Allowed 'General case' 0 C--O 1.242 0.676 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 174.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 22.0 m -42.47 -30.04 0.32 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.678 1.591 . . . . 0.0 114.056 176.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.1 -46.93 86.88 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 123.919 1.819 . . . . 0.0 114.508 171.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -67.23 -46.11 74.79 Favored 'General case' 0 C--O 1.252 1.202 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.105 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 10.9 mp -52.68 -48.66 66.37 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.638 173.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -60.85 -40.36 92.57 Favored 'General case' 0 C--O 1.223 -0.297 0 O-C-N 119.654 -1.904 . . . . 0.0 115.187 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 28' ' ' LYS . . . . . . . . . . . . . 3.0 pttm -67.09 -29.29 69.01 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 118.496 -1.282 . . . . 0.0 113.729 168.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -79.28 -20.12 48.85 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -53.38 -21.34 5.71 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 118.467 2.766 . . . . 0.0 118.467 -160.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 48.4 m-70 71.63 -69.3 0.19 Allowed 'General case' 0 C--N 1.352 0.682 0 CA-C-N 122.925 2.602 . . . . 0.0 109.137 -176.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 48.7 m -120.12 158.62 26.51 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 159.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 32.7 t -123.06 114.56 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.155 0 N-CA-C 101.946 -3.353 . . . . 0.0 101.946 -178.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 18.5 mm -99.32 113.69 35.12 Favored 'Isoleucine or valine' 0 C--O 1.249 1.055 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 175.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 75.9 mt -97.03 116.34 39.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 174.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 93.2 m -99.68 100.74 11.59 Favored Pre-proline 0 C--O 1.239 0.552 0 CA-C-N 114.867 -1.06 . . . . 0.0 113.22 174.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -62.48 149.1 92.11 Favored 'Trans proline' 0 C--O 1.238 0.519 1 C-N-CA 125.879 4.386 . . . . 0.0 109.615 176.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.18 -153.8 7.92 Favored Glycine 0 C--O 1.217 -0.959 0 CA-C-N 109.694 -3.412 . . . . 0.0 108.62 174.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -65.59 -41.35 92.92 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 110.127 -3.037 . . . . 0.0 108.165 -170.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -51.74 -54.76 23.6 Favored Glycine 0 C--N 1.347 1.19 0 O-C-N 120.543 -1.348 . . . . 0.0 113.972 174.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 30.4 ttm -58.97 -35.47 73.24 Favored 'General case' 0 C--O 1.215 -0.722 0 C-N-CA 124.484 1.114 . . . . 0.0 110.307 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.94 -60.59 2.15 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 2.9 p -75.03 -35.49 35.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 CA-C-N 118.422 0.555 . . . . 0.0 111.1 -168.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -112.5 100.16 8.53 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 103.933 -2.617 . . . . 0.0 103.933 166.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 45' ' ' GLN . . . . . . . . . . . . . 16.3 pm0 -46.97 72.64 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 117.955 2.576 . . . . 0.0 117.955 -175.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.21 -22.69 54.97 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.914 -1.741 . . . . 0.0 111.507 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.24 -33.38 65.35 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 -176.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 48' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -65.3 -57.78 14.11 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 120.803 1.638 . . . . 0.0 110.59 172.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 49' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -58.47 -29.09 87.55 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 CA-C-N 125.526 3.009 . . . . 0.0 116.619 171.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 20.3 t -58.16 -51.44 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 120.478 -1.389 . . . . 0.0 108.016 168.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.18 -36.39 79.72 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.324 0.965 . . . . 0.0 112.656 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.28 -53.98 40.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 117.424 -1.274 . . . . 0.0 112.758 173.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 9.6 tp -62.83 -36.48 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 121.991 2.178 . . . . 0.0 110.398 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 74.2 m -47.89 -39.29 18.4 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 176.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -59.9 -42.54 94.08 Favored 'General case' 0 N--CA 1.437 -1.12 0 O-C-N 121.874 -0.517 . . . . 0.0 111.7 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.41 -39.27 59.21 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -176.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 72.9 mt -65.59 -33.23 75.42 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.658 1.183 . . . . 0.0 108.72 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.58 -32.49 53.76 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 120.231 -1.543 . . . . 0.0 108.882 177.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.89 -46.93 61.71 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-N 121.005 1.73 . . . . 0.0 109.388 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -42.93 -42.42 3.72 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.329 1.452 . . . . 0.0 112.844 162.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.44 54.72 2.61 Favored Glycine 0 N--CA 1.437 -1.271 0 O-C-N 126.016 2.072 . . . . 0.0 112.154 176.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 93.8 mt -103.35 142.7 16.67 Favored 'Isoleucine or valine' 0 C--O 1.248 1.006 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -71.41 74.52 0.75 Allowed 'General case' 0 C--O 1.257 1.466 0 CA-C-O 123.418 1.58 . . . . 0.0 109.418 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.14 115.34 28.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 117.551 -1.659 . . . . 0.0 108.211 -176.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 14.3 mmm-85 -114.84 134.25 55.29 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.273 -177.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -93.5 79.48 4.35 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 123.01 1.386 . . . . 0.0 109.857 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.95 78.04 0.4 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-N 110.316 -3.129 . . . . 0.0 111.809 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 12.9 mt -77.72 148.62 6.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 -103.15 134.39 19.81 Favored Pre-proline 0 C--O 1.242 0.699 0 N-CA-C 104.152 -2.536 . . . . 0.0 104.152 168.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 70' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -59.6 -72.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.123 0 C-N-CA 123.862 3.041 . . . . 0.0 114.887 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 23.0 t -70.87 95.53 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 170.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -165.26 161.34 19.16 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 123.252 1.501 . . . . 0.0 108.608 175.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 54.15 -110.55 1.58 Allowed Glycine 0 CA--C 1.535 1.296 0 CA-C-N 112.934 -1.939 . . . . 0.0 109.824 171.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -130.85 108.28 9.73 Favored 'General case' 0 C--O 1.259 1.605 0 O-C-N 121.959 -0.73 . . . . 0.0 111.234 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 4.5 tt 63.83 114.67 0.02 OUTLIER Pre-proline 0 N--CA 1.445 -0.682 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 174.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -56.89 104.28 0.14 Allowed 'Trans proline' 0 C--N 1.32 -0.925 1 C-N-CA 126.037 4.491 . . . . 0.0 107.805 175.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 132.01 -68.34 0.55 Allowed Glycine 0 N--CA 1.435 -1.395 0 N-CA-C 106.818 -2.513 . . . . 0.0 106.818 -171.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -63.37 -29.19 70.53 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -159.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -42.43 94.67 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 119.406 1.003 . . . . 0.0 110.493 175.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -72.83 -32.16 65.3 Favored 'General case' 0 C--N 1.368 1.377 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.562 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 48.7 t -73.01 -26.22 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 123.893 1.806 . . . . 0.0 110.303 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.9 tp -75.11 -31.92 61.26 Favored 'General case' 0 C--N 1.312 -1.03 0 O-C-N 120.55 -1.343 . . . . 0.0 108.397 166.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 9.0 mp -63.86 -30.52 71.6 Favored 'General case' 0 C--O 1.241 0.653 0 O-C-N 116.976 -3.577 . . . . 0.0 112.872 166.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.21 -49.24 76.54 Favored 'General case' 0 N--CA 1.442 -0.849 0 O-C-N 124.57 1.169 . . . . 0.0 111.877 168.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -55.55 -40.02 71.36 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.225 1.01 . . . . 0.0 111.845 171.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.43 -21.27 53.27 Favored 'General case' 0 C--O 1.254 1.324 0 O-C-N 121.069 -1.019 . . . . 0.0 112.274 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp 77.36 50.82 0.04 OUTLIER 'General case' 0 C--O 1.242 0.682 0 CA-C-O 125.627 2.632 . . . . 0.0 112.95 -177.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 66.5 t -91.56 131.58 35.69 Favored Pre-proline 0 C--N 1.319 -0.751 0 O-C-N 118.885 -2.385 . . . . 0.0 112.146 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -61.28 99.57 0.16 Allowed 'Trans proline' 0 C--O 1.242 0.703 0 C-N-CA 124.471 3.447 . . . . 0.0 116.264 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -54.49 -26.07 29.15 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -174.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.97 -47.78 77.04 Favored 'General case' 0 C--O 1.248 1.004 0 O-C-N 120.116 -1.615 . . . . 0.0 112.024 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 5.0 pt -88.47 -8.54 10.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 84.8 t -71.19 119.77 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 165.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 65.0 mt -123.77 99.72 6.42 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.711 -1.132 . . . . 0.0 109.129 -175.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -91.79 74.47 5.74 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 -171.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 6.2 ttp 62.83 124.5 0.01 OUTLIER 'General case' 0 CA--C 1.497 -1.089 0 CA-C-N 111.322 -2.672 . . . . 0.0 111.602 -167.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -159.34 -172.35 3.7 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-N 112.657 -2.065 . . . . 0.0 106.973 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -76.49 61.19 1.71 Allowed 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 121.082 -1.012 . . . . 0.0 111.223 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 6.2 tp -92.64 27.66 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.778 0 CA-C-O 124.851 2.262 . . . . 0.0 109.92 -168.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -71.64 -60.82 2.03 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.602 -1.311 . . . . 0.0 114.115 -166.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -70.3 -32.49 70.28 Favored 'General case' 0 C--O 1.215 -0.753 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -56.97 -41.44 78.36 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 117.11 -1.424 . . . . 0.0 110.697 173.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 103' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -54.98 -45.08 74.98 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 120.185 1.357 . . . . 0.0 113.153 169.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.21 -33.19 73.96 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 122.411 1.101 . . . . 0.0 108.722 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -68.03 -33.13 74.01 Favored 'General case' 0 C--O 1.243 0.711 0 O-C-N 118.87 -2.394 . . . . 0.0 111.367 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 106' ' ' THR . . . . . . . . . . . . . 51.7 m -76.11 122.42 24.26 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.745 1.26 . . . . 0.0 109.183 -175.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.26 -57.97 3.98 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.594 169.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 4.3 m -104.05 104.99 15.02 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -169.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 109' ' ' VAL . . . . . . . . . . . . . 24.4 t -94.95 107.95 20.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 172.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 80.2 mt -78.23 86.37 4.35 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.901 -0.499 . . . . 0.0 111.827 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 98.8 t -79.93 83.1 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-O 124.315 2.007 . . . . 0.0 108.237 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 7.4 mt -78.05 77.22 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.747 0 CA-C-O 123.321 1.534 . . . . 0.0 113.03 -172.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 113' ' ' GLY . . . . . . . . . . . . . . . 71.19 42.07 58.71 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.054 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -107.83 -24.8 11.52 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 120.84 -1.388 . . . . 0.0 110.321 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 115' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.94 -85.79 0.02 OUTLIER 'General case' 0 C--N 1.352 0.709 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 162.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 116' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -83.61 -22.74 32.16 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -174.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 2.7 p -80.01 9.99 4.82 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 117.303 2.335 . . . . 0.0 117.303 -175.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.66 13.06 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 112.947 -1.933 . . . . 0.0 109.645 169.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -90.08 121.02 69.19 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-O 118.475 -0.774 . . . . 0.0 111.17 -169.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 120' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -52.75 -28.33 37.66 Favored 'Trans proline' 0 C--O 1.251 1.153 0 C-N-CA 123.401 2.734 . . . . 0.0 113.701 175.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.97 12.48 0.04 OUTLIER 'General case' 0 C--N 1.354 0.784 0 N-CA-C 116.644 2.091 . . . . 0.0 116.644 174.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 122' ' ' ALA . . . . . . . . . . . . . . . -109.61 -2.34 17.58 Favored 'General case' 0 N--CA 1.426 -1.653 0 O-C-N 120.628 -1.295 . . . . 0.0 113.993 171.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.9 -39.85 0.09 Allowed 'General case' 0 C--N 1.351 0.671 0 CA-C-O 125.021 2.344 . . . . 0.0 115.969 169.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -66.12 -38.6 88.6 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 119.351 -2.093 . . . . 0.0 111.818 173.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -102.63 121.08 50.91 Favored Pre-proline 0 C--N 1.347 0.457 0 O-C-N 124.19 0.931 . . . . 0.0 110.707 171.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -77.6 -18.28 13.73 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 124.461 3.441 . . . . 0.0 115.677 174.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -62.95 -58.93 5.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 122.061 0.934 . . . . 0.0 112.47 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 128' ' ' SER . . . . . . . . . . . . . 66.6 m -57.36 149.52 48.3 Favored Pre-proline 0 C--O 1.24 0.595 0 N-CA-C 116.496 2.036 . . . . 0.0 116.496 -163.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 129' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -55.18 -17.73 15.98 Favored 'Trans proline' 0 CA--C 1.564 2.012 1 C-N-CA 126.003 4.469 . . . . 0.0 115.296 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 8.8 pt -101.67 12.8 6.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 120.004 1.275 . . . . 0.0 114.283 173.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -71.77 86.04 0.94 Allowed 'General case' 0 C--O 1.239 0.549 0 CA-C-O 124.353 2.025 . . . . 0.0 109.147 -172.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 149.5 53.83 0.02 OUTLIER Glycine 0 N--CA 1.423 -2.17 0 CA-C-N 111.963 -2.381 . . . . 0.0 108.777 -175.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 133' ' ' MET . . . . . . . . . . . . . 6.6 tpp -147.54 125.3 5.88 Favored Pre-proline 0 CA--C 1.548 0.865 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -78.1 83.6 2.17 Favored 'Trans proline' 0 C--O 1.238 0.492 1 C-N-CA 125.612 4.208 . . . . 0.0 107.479 -175.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 8.3 m -64.7 154.02 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 CA-C-N 113.681 -1.6 . . . . 0.0 113.288 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 88.3 mt -74.87 120.51 20.52 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -21.29 -28.02 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.159 1 N-CA-C 123.738 4.718 . . . . 0.0 123.738 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 8.3 p -79.6 83.35 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -175.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 34.7 p90 -125.91 171.01 11.09 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-N 112.206 -2.27 . . . . 0.0 109.008 165.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 140' ' ' LYS . . . . . . . . . . . . . 21.0 pttm 56.55 -0.55 0.06 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 117.598 2.444 . . . . 0.0 117.598 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -141.76 165.62 26.97 Favored 'General case' 0 C--O 1.256 1.423 0 CA-C-O 116.015 -1.945 . . . . 0.0 109.731 -175.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 64.35 168.1 0.17 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 161.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 143' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -84.24 73.49 10.43 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 124.52 2.105 . . . . 0.0 109.667 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 144' ' ' VAL . . . . . . . . . . . . . 3.2 t -81.34 100.58 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 103.393 -2.818 . . . . 0.0 103.393 175.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 145' ' ' ILE . . . . . . . . . . . . 0.287 13.0 tt -98.87 99.27 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 112.31 -2.223 . . . . 0.0 112.062 -173.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 146' ' ' VAL . . . . . . . . . . . . . 39.5 t -84.11 113.38 22.85 Favored 'Isoleucine or valine' 0 C--N 1.343 0.298 0 CA-C-N 112.702 -2.044 . . . . 0.0 107.013 -171.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 147' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -66.41 112.73 4.2 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 122.647 1.213 . . . . 0.0 110.427 177.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 148' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -146.26 108.76 4.48 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 105.909 -1.885 . . . . 0.0 105.909 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -64.97 -40.7 95.38 Favored 'General case' 0 C--N 1.344 0.333 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.78 145.13 51.88 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 103.988 -2.597 . . . . 0.0 103.988 -174.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -84.02 68.94 10.24 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 170.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -87.16 168.06 13.59 Favored 'General case' 0 C--O 1.258 1.536 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.294 173.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 13.3 m -71.43 119.52 15.7 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -72.94 -133.16 0.18 Allowed Glycine 0 N--CA 1.478 1.441 0 O-C-N 118.797 -2.439 . . . . 0.0 108.75 172.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -77.03 -50.86 12.15 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 117.135 -1.826 . . . . 0.0 109.881 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 156' ' ' ALA . . . . . . . . . . . . . . . -94.83 -53.32 3.89 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 161.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 65.96 14.68 61.48 Favored Glycine 0 C--O 1.254 1.349 0 CA-C-O 122.504 1.058 . . . . 0.0 114.253 -173.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 13.5 m -89.6 124.84 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -162.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . 0.301 0.0 OUTLIER 37.0 24.61 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 118.266 2.691 . . . . 0.0 118.266 172.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 160' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -62.57 111.63 5.1 Favored Pre-proline 0 C--O 1.239 0.535 0 O-C-N 120.461 -1.399 . . . . 0.0 110.22 -171.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -56.18 -41.94 71.46 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.885 2.39 . . . . 0.0 112.48 -177.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 162' ' ' LEU . . . . . . . . . . . . . 16.0 mt -17.48 -40.91 0.0 OUTLIER 'General case' 0 C--O 1.244 0.794 0 N-CA-C 120.62 3.563 . . . . 0.0 120.62 155.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 163' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -82.02 -48.33 11.55 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-O 124.385 2.041 . . . . 0.0 111.777 176.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -91.06 -17.04 26.88 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 111.963 -2.38 . . . . 0.0 113.611 -158.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -87.88 172.43 9.62 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 121.818 2.099 . . . . 0.0 110.863 -168.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -55.75 10.62 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 120.406 -1.434 . . . . 0.0 114.479 177.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -82.53 -49.97 9.31 Favored 'General case' 0 C--O 1.239 0.538 0 O-C-N 124.848 1.342 . . . . 0.0 108.115 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 168' ' ' THR . . . . . . . . . . . . . 4.8 m -82.84 91.9 7.17 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 123.328 1.537 . . . . 0.0 107.443 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -142.41 142.82 32.44 Favored 'General case' 0 N--CA 1.439 -1.013 0 O-C-N 120.88 -1.137 . . . . 0.0 111.686 -154.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 170' ' ' MET . . . . . . . . . . . . . 54.1 mtm -58.41 126.83 29.21 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 121.169 -0.957 . . . . 0.0 108.878 166.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 171' ' ' LEU . . . . . . . . . . . . . 39.4 tp -89.06 108.78 19.78 Favored 'General case' 0 C--O 1.254 1.329 0 N-CA-C 104.103 -2.554 . . . . 0.0 104.103 166.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -82.22 91.51 6.74 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -174.69 168.19 40.74 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 106.139 -2.784 . . . . 0.0 106.139 175.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 174' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -72.57 151.7 42.23 Favored 'General case' 0 C--O 1.252 1.225 0 O-C-N 119.026 -2.455 . . . . 0.0 111.528 170.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.85 -50.79 72.42 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 126.251 1.82 . . . . 0.0 111.676 -170.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.67 -55.9 6.84 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 177' ' ' ALA . . . . . . . . . . . . . . . -41.35 -44.83 2.88 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 117.851 2.537 . . . . 0.0 117.851 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 9.3 m -64.48 -41.34 96.53 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 175.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 179' ' ' VAL . . . . . . . . . . . . . 5.2 t -72.45 -32.05 40.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 119.278 -2.138 . . . . 0.0 107.615 177.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -67.67 -33.17 74.39 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 117.912 -2.992 . . . . 0.0 111.321 176.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.69 -30.61 70.86 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.202 173.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 182' ' ' ILE . . . . . . . . . . . . . 31.0 pt -87.22 -39.14 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 CA-C-O 122.668 1.223 . . . . 0.0 113.672 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 183' ' ' LEU . . . . . . . . . . . . . 12.9 tp -11.42 -66.9 0.01 OUTLIER 'General case' 0 C--N 1.355 0.838 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -107.7 -19.76 13.44 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 118.365 -1.334 . . . . 0.0 114.486 176.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -70.07 -65.28 0.74 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.941 -1.027 . . . . 0.0 113.743 -172.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 186' ' ' LEU . . . . . . . . . . . . 0.345 2.2 pt? . . . . . 0 N--CA 1.43 -1.433 0 N-CA-C 118.969 2.951 . . . . 0.0 118.969 -165.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' NAD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C 1001 ' ' NAP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 11.9 t-80 . . . . . 0 N--CA 1.418 -2.064 0 N-CA-C 106.906 -1.516 . . . . 65.739999999999995 106.906 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -54.63 77.17 0.01 OUTLIER Glycine 0 C--O 1.223 -0.574 0 C-N-CA 125.581 1.562 . . . . 48.659999999999997 114.438 164.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 26.1 ttp180 -110.0 134.79 51.75 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.128 -1.536 . . . . 44.560000000000002 107.299 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1003 ' ' ILE . . . . . . . . . . . . . 30.2 mt -99.75 139.22 21.86 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.757 0 O-C-N 124.482 1.114 . . . . 34.859999999999999 110.0 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -109.7 135.17 12.68 Favored Glycine 0 C--O 1.25 1.146 0 N-CA-C 107.376 -2.29 . . . . 30.75 107.376 172.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 43.6 mm -106.76 112.05 63.63 Favored Pre-proline 0 N--CA 1.427 -1.578 0 N-CA-C 102.008 -3.33 . . . . 32.210000000000001 102.008 175.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -71.45 143.86 43.96 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 123.137 2.558 . . . . 32.979999999999997 111.438 168.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1007 ' ' ARG . . . . . . . . . . . . . 25.3 ttp85 -67.8 126.61 29.95 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 104.248 -2.501 . . . . 47.979999999999997 104.248 162.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1008 ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -62.81 130.96 47.18 Favored 'General case' 0 CA--C 1.513 -0.478 0 O-C-N 120.247 -1.533 . . . . 34.700000000000003 113.219 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -86.68 -11.48 51.13 Favored 'General case' 0 C--O 1.252 1.191 0 O-C-N 121.125 -0.984 . . . . 53.369999999999997 113.579 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 5.9 mp -63.17 148.45 47.99 Favored 'General case' 0 C--O 1.214 -0.786 0 CA-C-O 123.034 1.397 . . . . 45.07 112.529 -176.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1011 ' ' THR . . . . . . . . . . . . . 7.3 m -64.23 107.59 1.35 Allowed 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 114.048 -1.433 . . . . 40.359999999999999 111.89 -167.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 33.8 t30 68.31 69.07 0.32 Allowed 'General case' 0 C--O 1.215 -0.73 0 CA-C-N 113.173 -1.831 . . . . 40.609999999999999 110.264 176.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -104.08 146.1 29.21 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 120.034 -0.666 . . . . 33.759999999999998 112.207 -168.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1014 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.93 -6.23 21.5 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 122.758 1.266 . . . . 27.890000000000001 112.664 178.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1015 ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -106.19 147.3 29.21 Favored 'General case' 0 N--CA 1.44 -0.932 0 O-C-N 120.691 -1.255 . . . . 29.02 113.413 -172.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1016 ' ' VAL . . . . . . . . . . . . . 8.6 p -148.48 138.93 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 N-CA-C 104.033 -2.58 . . . . 28.129999999999999 104.033 159.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1017 ' ' ALA . . . . . . . . . . . . . . . -63.44 -12.94 35.24 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 117.742 -3.098 . . . . 26.870000000000001 116.749 -176.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -84.11 112.1 19.93 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 123.734 1.73 . . . . 26.77 111.204 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1019 ' ' THR . . . . . . . . . . . . . 67.8 p -118.26 167.74 10.85 Favored Pre-proline 0 N--CA 1.416 -2.138 0 N-CA-C 106.297 -1.742 . . . . 27.02 106.297 158.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1020 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -48.0 -57.48 2.31 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 124.767 3.645 . . . . 30.57 109.782 163.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 21.0 mttp -53.7 -31.12 46.73 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.856 1.662 . . . . 47.810000000000002 113.966 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1022 ' ' THR . . . . . . . . . . . . . 5.0 m -62.67 -65.57 0.67 Allowed 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 120.435 1.47 . . . . 30.77 108.758 169.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1023 ' ' VAL . . . . . . . . . . . . . 59.0 t -56.75 -55.91 17.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 O-C-N 126.611 2.444 . . . . 33.590000000000003 113.11 -171.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -49.66 -52.24 32.3 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.036 1.334 . . . . 53.289999999999999 114.568 -176.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -75.44 -34.46 60.98 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 114.389 -1.278 . . . . 46.920000000000002 113.122 -173.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1026 ' ' LEU . . . . . . . . . . . . . 95.9 mt -66.87 -39.38 87.51 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.219 -0.901 . . . . 37.170000000000002 110.025 177.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 96.5 mt -54.53 -50.03 68.84 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 118.241 -0.885 . . . . 44.439999999999998 110.673 172.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 42.5 mttm -57.61 -37.86 73.97 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.94 1.296 . . . . 52.579999999999998 112.051 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1029 ' ' LEU . . . . . . . . . . . . . 98.6 mt -66.97 -40.23 87.4 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 119.015 0.825 . . . . 45.689999999999998 110.625 173.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 148.88 -30.31 1.24 Allowed Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.832 -0.699 . . . . 42.090000000000003 111.46 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -74.85 109.36 8.25 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 124.72 2.2 . . . . 40.719999999999999 108.884 -172.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1032 ' ' THR . . . . . . . . . . . . . 18.6 m -74.51 131.14 40.76 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 105.611 -1.996 . . . . 37.770000000000003 105.611 176.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1033 ' ' VAL . . . . . . . . . . . . . 61.1 t -109.83 136.78 44.73 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.784 0 CA-C-O 121.536 0.684 . . . . 33.539999999999999 109.66 -171.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -119.37 130.94 55.58 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 126.789 2.556 . . . . 31.68 109.456 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1035 ' ' VAL . . . . . . . . . . . . . 77.6 t -115.34 135.87 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 105.765 -1.939 . . . . 31.52 105.765 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1036 ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -62.31 141.67 58.15 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 123.703 1.716 . . . . 41.039999999999999 110.626 169.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1037 ' ' SER . . . . . . . . . . . . . 19.5 m -70.05 151.16 45.83 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.46 -1.245 . . . . 31.829999999999998 108.736 174.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 91.71 -29.27 7.49 Favored Glycine 0 C--O 1.213 -1.192 0 C-N-CA 120.057 -1.068 . . . . 29.359999999999999 110.561 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -62.37 -21.11 65.07 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 116.825 2.158 . . . . 27.780000000000001 116.825 -169.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -61.78 -43.2 99.55 Favored Glycine 0 CA--C 1.538 1.492 0 O-C-N 119.795 -1.816 . . . . 28.91 114.342 -175.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.79 -28.31 68.91 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 116.35 1.982 . . . . 51.18 116.35 -174.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1042 ' ' LEU . . . . . . . . . . . . . 19.5 mt -52.82 -60.79 2.83 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 123.615 1.674 . . . . 29.91 107.898 171.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1043 ' ' ALA . . . . . . . . . . . . . . . -84.88 17.8 2.7 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.854 -1.066 . . . . 28.539999999999999 112.792 -173.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1044 ' ' SER . . . . . . . . . . . . . 60.8 m 52.56 63.79 2.1 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-O 124.13 1.919 . . . . 33.060000000000002 112.959 -174.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1045 ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -128.66 157.08 42.34 Favored 'General case' 0 C--O 1.245 0.842 0 O-C-N 120.849 -1.157 . . . . 30.289999999999999 110.675 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 2.4 t70 -85.26 127.65 34.39 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 111.125 -2.762 . . . . 48.619999999999997 104.506 164.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -65.17 -39.34 92.8 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 123.068 1.413 . . . . 36.740000000000002 112.342 -174.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 25.5 pttm -66.84 -12.53 59.45 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 120.059 -1.651 . . . . 43.729999999999997 113.918 173.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -71.64 -21.65 61.8 Favored 'General case' 0 C--O 1.247 0.964 0 CA-C-O 122.776 1.274 . . . . 32.810000000000002 110.819 168.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1050 ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -78.84 -32.21 46.05 Favored 'General case' 0 CA--C 1.505 -0.773 0 O-C-N 119.492 -2.005 . . . . 31.859999999999999 110.056 169.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 62.2 t -62.87 -50.66 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-O 122.452 1.12 . . . . 33.219999999999999 109.095 173.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -43.65 -53.38 5.78 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.038 1.735 . . . . 50.829999999999998 112.676 165.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -56.75 -29.99 63.13 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-O 118.298 -0.858 . . . . 33.119999999999997 111.389 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 104.32 31.28 4.7 Favored Glycine 0 C--N 1.343 0.96 0 N-CA-C 111.896 -0.482 . . . . 35.829999999999998 111.896 176.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -90.59 149.51 22.1 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 121.783 -0.834 . . . . 34.82 109.92 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -83.04 122.21 28.02 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 106.295 -1.743 . . . . 49.049999999999997 106.295 167.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1057 ' ' ILE . . . . . . . . . . . . . 27.3 mm -98.41 83.71 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.879 0 N-CA-C 106.389 -1.708 . . . . 38.530000000000001 106.389 -165.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1058 ' ' VAL . . . . . . . . . . . . . 48.7 t -80.11 130.11 36.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 O-C-N 124.312 1.008 . . . . 42.109999999999999 111.976 -173.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -79.62 78.55 6.17 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 123.994 1.854 . . . . 58.0 111.537 177.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 101.84 -142.49 15.68 Favored Glycine 0 CA--C 1.49 -1.531 0 CA-C-N 113.599 -1.637 . . . . 52.119999999999997 110.631 167.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 2.1 t30 -58.19 -26.4 62.74 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 111.33 -2.435 . . . . 54.75 114.12 -156.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1062 ' ' SER . . . . . . . . . . . . . 49.0 m -63.18 -14.3 47.36 Favored 'General case' 0 N--CA 1.427 -1.617 0 O-C-N 119.4 -2.062 . . . . 50.340000000000003 111.194 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -61.47 -29.29 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 O-C-N 119.839 -1.788 . . . . 41.460000000000001 109.634 172.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1064 ' ' TRP . . . . . . . . . . . . . 87.7 m95 -65.28 -26.31 68.03 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 114.791 1.404 . . . . 39.32 114.791 171.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -79.49 75.34 6.11 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 122.508 1.147 . . . . 55.380000000000003 109.125 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1066 ' ' SER . . . . . . . . . . . . . 69.6 m -152.32 151.4 30.84 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 107.118 -1.438 . . . . 41.869999999999997 107.118 -172.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -66.74 -29.55 69.55 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-O 123.519 1.628 . . . . 53.200000000000003 112.324 -174.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 60.4 mt -131.04 143.21 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 102.868 -3.012 . . . . 41.899999999999999 102.868 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1069 ' ' ILE . . . . . . . . . . . . . 23.2 mm -123.97 114.29 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 N-CA-C 103.221 -2.881 . . . . 38.729999999999997 103.221 175.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1070 ' ' LEU . . . . . . . . . . . . . 95.9 mt -90.05 94.27 9.72 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-N 116.144 -0.48 . . . . 32.439999999999998 112.07 172.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1071 ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -91.81 154.3 19.0 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 106.675 -1.602 . . . . 34.649999999999999 106.675 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1072 ' ' VAL . . . . . . . . . . . . . 12.2 t -90.73 -67.32 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.964 0 N-CA-C 105.038 -2.208 . . . . 31.32 105.038 172.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -88.04 179.24 6.45 Favored 'General case' 0 CA--C 1.508 -0.658 0 O-C-N 120.39 -1.444 . . . . 33.939999999999998 110.571 -170.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -52.61 128.89 44.36 Favored Pre-proline 0 N--CA 1.441 -0.894 0 N-CA-C 114.079 1.141 . . . . 38.039999999999999 114.079 165.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1075 ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -67.13 128.39 18.48 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.089 2.526 . . . . 42.68 109.048 174.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 53.4 mt -78.16 158.06 29.19 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 112.557 -2.111 . . . . 46.740000000000002 106.068 175.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -45.39 -35.82 3.88 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 118.054 2.613 . . . . 58.609999999999999 118.054 -169.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -68.6 -47.47 66.63 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 125.027 1.454 . . . . 59.200000000000003 110.729 173.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1079 ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -60.44 -37.77 82.0 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 109.361 -0.607 . . . . 50.630000000000003 109.361 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1080 ' ' ILE . . . . . . . . . . . . . 96.6 mt -56.5 -56.79 11.86 Favored 'Isoleucine or valine' 0 C--N 1.355 0.836 0 O-C-N 120.942 -1.099 . . . . 51.479999999999997 108.077 176.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -62.59 -20.91 65.2 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.712 -1.243 . . . . 50.280000000000001 113.028 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 75.2 mt -79.17 -16.22 56.92 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 114.954 1.465 . . . . 50.210000000000001 114.954 175.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1083 ' ' LEU . . . . . . . . . . . . . 2.3 mm? -59.68 141.04 55.91 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.02 1.282 . . . . 49.060000000000002 109.549 172.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -86.61 142.61 35.0 Favored Pre-proline 0 C--O 1.217 -0.626 0 N-CA-C 103.413 -2.81 . . . . 51.079999999999998 103.413 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -54.39 120.96 8.88 Favored 'Trans proline' 0 N--CA 1.42 -2.829 0 C-N-CA 124.306 3.337 . . . . 49.729999999999997 109.83 168.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 98.67 -3.68 59.27 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-O 117.925 -1.486 . . . . 47.710000000000001 112.757 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1087 ' ' THR . . . . . . . . . . . . . 87.1 m -68.09 129.43 39.89 Favored 'General case' 0 C--O 1.251 1.134 0 CA-C-N 119.139 1.47 . . . . 45.469999999999999 111.819 173.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1088 ' ' THR . . . . . . . . . . . . . 2.8 m -68.75 110.51 4.35 Favored 'General case' 0 C--O 1.244 0.803 0 O-C-N 119.324 -2.11 . . . . 42.039999999999999 108.739 165.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1089 ' ' LEU . . . . . . . . . . . . . 33.1 tp -98.89 118.88 36.66 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 105.741 -1.948 . . . . 38.060000000000002 105.741 173.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 24.4 t -113.26 126.43 70.68 Favored 'Isoleucine or valine' 0 C--O 1.256 1.433 0 N-CA-C 104.642 -2.355 . . . . 37.399999999999999 104.642 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1091 ' ' SER . . . . . . . . . . . . . 5.1 m -162.17 168.98 21.61 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 121.172 1.805 . . . . 36.159999999999997 111.05 -176.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -69.46 99.82 1.3 Allowed 'General case' 0 C--N 1.349 0.562 0 O-C-N 120.962 -1.086 . . . . 38.939999999999998 109.672 159.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 40.7 mm -90.21 -46.93 14.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 113.316 0.858 . . . . 42.170000000000002 113.316 175.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 23.8 m95 61.52 63.35 2.32 Favored Pre-proline 0 N--CA 1.469 0.499 0 C-N-CA 124.02 0.928 . . . . 46.509999999999998 112.037 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -55.96 -27.85 65.81 Favored 'Trans proline' 0 C--N 1.346 0.423 0 N-CA-C 120.494 3.229 . . . . 49.759999999999998 120.494 -166.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -77.2 -29.57 54.35 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 121.546 1.975 . . . . 52.619999999999997 112.538 175.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -86.75 -24.16 25.22 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 124.456 2.074 . . . . 60.740000000000002 111.233 173.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1098 ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -127.33 74.24 77.48 Favored Pre-proline 0 N--CA 1.431 -1.422 0 O-C-N 120.024 -1.672 . . . . 58.189999999999998 112.81 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -70.96 -29.42 18.17 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.947 2.431 . . . . 54.590000000000003 113.508 177.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -80.89 -28.02 36.09 Favored 'General case' 0 N--CA 1.434 -1.225 0 O-C-N 119.424 -2.047 . . . . 63.280000000000001 106.067 -163.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1101 ' ' LEU . . . . . . . . . . . . . 15.1 mt -50.72 -41.97 56.73 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 124.917 1.287 . . . . 54.75 110.31 171.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1102 ' ' MET . . . . . . . . . . . . . 18.6 mmm -66.77 -47.44 72.17 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 118.676 0.671 . . . . 52.649999999999999 111.533 -168.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -64.16 -38.02 89.57 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 120.735 -1.228 . . . . 66.260000000000005 112.673 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 86.1 mttt -67.42 -42.33 83.41 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 123.037 1.399 . . . . 63.729999999999997 112.926 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 47.8 mt -71.83 -28.41 63.56 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.834 -1.075 . . . . 54.68 112.63 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -65.12 -41.95 94.39 Favored 'General case' 0 C--O 1.243 0.751 0 O-C-N 120.694 -1.254 . . . . 53.640000000000001 110.473 170.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -56.28 -39.25 72.36 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.074 0.95 . . . . 67.239999999999995 109.696 169.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -69.82 -20.93 63.43 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 115.446 1.647 . . . . 65.760000000000005 115.446 173.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 53.7 t30 68.83 38.69 2.06 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 124.594 2.14 . . . . 58.710000000000001 109.106 177.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1110 ' ' VAL . . . . . . . . . . . . . 27.1 m -97.92 161.05 2.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 N-CA-C 115.41 1.633 . . . . 46.630000000000003 115.41 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1111 ' ' THR . . . . . . . . . . . . . 95.0 m -97.68 95.22 7.43 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 106.446 -1.687 . . . . 44.130000000000003 106.446 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1112 ' ' VAL . . . . . . . . . . . . . 49.1 t -86.57 110.7 20.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 O-C-N 121.147 -0.971 . . . . 40.439999999999998 112.306 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1113 ' ' MET . . . . . . . . . . . . . 46.8 mtp -101.74 110.65 22.68 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 106.344 -1.724 . . . . 50.759999999999998 106.344 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1114 ' ' ALA . . . . . . . . . . . . . . . -83.99 116.52 22.86 Favored 'General case' 0 C--O 1.253 1.244 0 O-C-N 121.369 -0.832 . . . . 35.640000000000001 108.989 -176.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1115 ' ' MET . . . . . . . . . . . . . 32.7 mmm -70.62 -30.65 67.36 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 113.369 0.877 . . . . 38.740000000000002 113.369 -176.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -60.33 -35.19 75.07 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 124.486 1.114 . . . . 40.140000000000001 112.141 164.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1117 ' ' SER . . . . . . . . . . . . . 48.5 m -87.58 11.88 13.88 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 118.466 2.765 . . . . 44.789999999999999 118.466 177.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1118 ' ' VAL . . . . . . . . . . . . . 40.8 t -60.96 128.39 89.06 Favored Pre-proline 0 N--CA 1.473 0.685 0 N-CA-C 103.755 -2.683 . . . . 43.75 103.755 168.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -46.6 140.78 11.8 Favored 'Trans proline' 0 CA--C 1.543 0.928 1 C-N-CA 127.7 5.6 . . . . 48.93 117.762 179.279 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -64.32 -0.3 1.23 Allowed 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 116.798 2.147 . . . . 62.899999999999999 116.798 -174.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 14.5 pt -83.26 148.98 4.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 114.281 1.215 . . . . 57.719999999999999 114.281 -170.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1122 ' ' SER . . . . . . . . . . . . . 8.5 m -45.54 -51.56 11.67 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 126.512 1.925 . . . . 57.259999999999998 114.432 -176.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.62 -24.19 66.53 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 120.676 -1.265 . . . . 62.899999999999999 112.258 -178.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -87.41 -19.0 28.69 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-O 116.642 -1.647 . . . . 49.829999999999998 111.097 -176.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -61.31 -21.34 63.88 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 115.941 1.83 . . . . 52.369999999999997 115.941 -167.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1126 ' ' SER . . . . . . . . . . . . . 31.9 m -68.47 -38.77 81.35 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 122.587 1.184 . . . . 42.43 111.117 172.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1127 ' ' LEU . . . . . . . . . . . . . 4.6 mp -77.64 -35.81 52.18 Favored 'General case' 0 C--N 1.35 0.609 0 CA-C-N 115.009 -0.996 . . . . 43.740000000000002 110.986 172.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 37.0 t70 -59.71 108.15 0.7 Allowed 'General case' 0 C--N 1.352 0.709 0 CA-C-O 125.892 2.758 . . . . 43.210000000000001 115.953 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -68.09 -29.06 67.9 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 110.459 -3.064 . . . . 35.740000000000002 112.293 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 43.3 mt -60.36 -37.09 79.62 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 114.934 -1.03 . . . . 38.090000000000003 112.854 172.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1131 ' ' SER . . . . . . . . . . . . . 16.5 m -58.95 -48.32 81.92 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 119.255 0.934 . . . . 36.909999999999997 111.367 173.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1132 ' ' SER . . . . . . . . . . . . . 73.9 m -59.82 -58.3 9.18 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 119.098 0.863 . . . . 35.789999999999999 111.757 175.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1133 ' ' MET . . . . . . . . . . . . . 27.1 mmt -61.24 -31.17 70.97 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 117.635 2.457 . . . . 30.809999999999999 117.635 -176.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1134 ' ' ALA . . . . . . . . . . . . . . . -68.81 -57.06 6.12 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.029 -0.987 . . . . 28.879999999999999 112.467 169.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1135 ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -54.8 -48.87 72.22 Favored 'General case' 0 C--O 1.245 0.864 0 C-N-CA 124.379 1.071 . . . . 40.759999999999998 110.604 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1136 ' ' ILE . . . . . . . . . . . . . 42.4 mt -56.31 -50.63 70.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 113.02 0.748 . . . . 31.539999999999999 113.02 174.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -57.83 -31.55 66.74 Favored 'General case' 0 C--O 1.213 -0.867 0 N-CA-C 114.208 1.188 . . . . 29.870000000000001 114.208 174.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -68.07 -51.09 35.74 Favored Glycine 0 N--CA 1.443 -0.863 0 O-C-N 120.54 -1.35 . . . . 28.73 111.287 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 15.7 t80 -62.21 -38.76 90.4 Favored 'General case' 0 C--O 1.217 -0.607 0 O-C-N 122.208 -0.583 . . . . 30.390000000000001 110.634 175.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1140 ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -74.54 -24.43 58.95 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.864 1.266 . . . . 26.09 112.521 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1141 ' ' ALA . . . . . . . . . . . . . . . -68.15 -40.14 82.44 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.16 -1.422 . . . . 27.100000000000001 107.16 170.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 35.3 mm -64.03 -39.74 86.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 108.259 -1.015 . . . . 28.48 108.259 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 54.4 t -59.97 -64.54 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-O 118.694 -0.67 . . . . 23.07 110.792 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1144 ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -71.88 -23.72 61.55 Favored 'General case' 0 C--O 1.247 0.959 0 CA-C-N 121.257 1.844 . . . . 33.399999999999999 114.015 -168.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -58.36 -59.06 5.93 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 115.951 -1.976 . . . . 24.219999999999999 108.657 164.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -60.87 -28.21 68.7 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.285 0.991 . . . . 24.890000000000001 110.528 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -64.5 -37.23 86.82 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 112.865 0.691 . . . . 26.73 112.865 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1148 ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -107.74 -3.63 18.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 117.981 -1.488 . . . . 39.960000000000001 112.41 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1149 ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -64.67 134.72 54.85 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 107.976 -1.12 . . . . 25.870000000000001 107.976 178.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1150 ' ' GLY . . . . . . . . . . . . . . . -74.12 -38.74 46.76 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 110.638 -0.985 . . . . 19.280000000000001 110.638 173.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1151 ' ' ARG . . . . . . . . . . . . . 46.1 mtm-85 -94.97 177.09 6.0 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 120.67 -1.488 . . . . 39.899999999999999 111.48 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1152 ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -79.48 157.46 27.47 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 120.021 1.282 . . . . 29.440000000000001 109.288 169.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1153 ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -66.46 -56.05 12.77 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 105.819 -1.919 . . . . 32.600000000000001 105.819 155.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1154 ' ' THR . . . . . . . . . . . . . 25.9 m -51.57 89.24 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 128.352 2.661 . . . . 34.640000000000001 116.433 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -69.05 83.95 0.23 Allowed Glycine 0 C--O 1.215 -1.05 0 CA-C-O 122.291 0.939 . . . . 37.140000000000001 111.328 174.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -117.23 -170.68 1.89 Allowed 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 112.365 -1.917 . . . . 40.57 108.931 168.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1157 ' ' ILE . . . . . . . . . . . . . 1.1 tp -141.83 148.7 20.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 103.404 -2.813 . . . . 44.609999999999999 103.404 -175.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1158 ' ' THR . . . . . . . . . . . . . 16.7 p -98.8 -144.23 0.32 Allowed 'General case' 0 C--O 1.249 1.075 0 CA-C-O 116.628 -1.653 . . . . 40.700000000000003 110.349 175.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -95.39 -29.47 14.42 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 121.866 2.121 . . . . 40.25 106.932 163.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -76.27 -83.5 0.07 Allowed 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 109.713 -0.477 . . . . 38.469999999999999 109.713 173.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . -122.3 169.43 14.93 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-O 123.85 1.806 . . . . 37.609999999999999 113.574 -160.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 23.2 tttp -102.01 140.98 35.56 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-N 109.908 -3.146 . . . . 48.899999999999999 108.667 -172.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1163 ' ' VAL . . . . . . . . . . . . . 47.0 t -98.27 114.98 65.84 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-N 113.658 -1.61 . . . . 36.520000000000003 106.8 167.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1164 ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -54.92 123.53 14.0 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.97 2.447 . . . . 35.079999999999998 112.103 165.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1165 ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -60.39 119.9 7.35 Favored 'Trans proline' 0 N--CA 1.432 -2.138 0 C-N-CA 125.091 3.86 . . . . 35.329999999999998 109.532 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -67.87 126.11 28.4 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 113.838 -1.528 . . . . 34.689999999999998 114.615 -167.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1167 ' ' LYS . . . . . . . . . . . . . 9.4 mptt -73.53 90.67 1.76 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 124.662 1.226 . . . . 45.359999999999999 109.535 172.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 34.3 t -83.7 89.85 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-O 124.439 2.066 . . . . 31.710000000000001 105.823 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1169 ' ' MET . . . . . . . . . . . . . 25.7 ttp -74.98 134.09 41.56 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 113.917 -1.492 . . . . 42.280000000000001 108.888 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 99.1 t -125.26 136.99 59.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 104.442 -2.429 . . . . 30.510000000000002 104.442 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 61.3 mt -121.69 127.57 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 103.979 -2.6 . . . . 31.870000000000001 103.979 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 73.82 70.51 1.23 Allowed Glycine 0 CA--C 1.535 1.304 0 N-CA-C 107.557 -2.217 . . . . 34.539999999999999 107.557 -170.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1173 ' ' ALA . . . . . . . . . . . . . . . -72.95 59.96 0.52 Allowed 'General case' 0 N--CA 1.445 -0.725 0 O-C-N 120.311 -1.699 . . . . 32.509999999999998 109.577 173.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -86.95 -148.98 13.78 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 107.987 -2.045 . . . . 29.899999999999999 107.987 -177.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1175 ' ' VAL . . . . . . . . . . . . . 57.7 t -60.03 -40.43 83.15 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 O-C-N 119.329 -2.277 . . . . 33.109999999999999 108.832 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -69.62 -52.75 23.13 Favored 'General case' 0 C--O 1.224 -0.277 0 O-C-N 121.858 -0.526 . . . . 28.100000000000001 110.712 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -56.27 -48.02 77.94 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 110.892 -0.883 . . . . 28.539999999999999 110.892 -176.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1178 ' ' LEU . . . . . . . . . . . . . 51.4 mt -58.57 -39.4 80.17 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.939 1.459 . . . . 31.219999999999999 114.939 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -68.84 -36.49 78.23 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.708 -0.62 . . . . 28.98 112.355 173.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -63.92 -37.31 86.93 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.399 0.518 . . . . 27.829999999999998 112.399 171.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1181 ' ' ILE . . . . . . . . . . . . . 90.0 mt -62.46 -53.28 49.33 Favored 'Isoleucine or valine' 0 C--O 1.246 0.904 0 C-N-CA 125.622 1.569 . . . . 30.25 108.775 175.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -50.25 -52.3 28.02 Favored Glycine 0 N--CA 1.435 -1.399 0 O-C-N 125.481 1.738 . . . . 29.59 114.134 175.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -61.42 -45.24 95.13 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.982 0.734 . . . . 30.289999999999999 112.982 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -74.15 -36.82 64.14 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 113.457 0.91 . . . . 30.469999999999999 113.457 -173.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -57.73 -48.77 78.67 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 108.369 -0.974 . . . . 42.409999999999997 108.369 167.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1186 ' ' SER . . . . . . . . . . . . . 74.1 m -56.68 -37.23 70.56 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 123.153 1.454 . . . . 39.380000000000003 112.546 176.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 13.5 mt -69.39 -34.84 75.12 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 118.141 -2.849 . . . . 36.18 114.548 173.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 105.11 76.08 1.05 Allowed Glycine 0 C--N 1.308 -0.995 0 O-C-N 119.929 -1.732 . . . . 33.780000000000001 112.057 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -151.64 168.41 25.06 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 113.635 -1.282 . . . . 33.93 109.362 -168.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 86.3 mt -90.67 95.38 5.48 Favored 'Isoleucine or valine' 0 C--O 1.253 1.288 0 N-CA-C 107.122 -1.436 . . . . 38.740000000000002 107.122 177.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 10.8 t -86.93 133.47 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 106.806 -1.553 . . . . 33.090000000000003 106.806 -178.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1192 ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -133.02 121.52 22.85 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 105.295 -2.113 . . . . 38.920000000000002 105.295 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -127.39 149.41 50.09 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 115.089 1.514 . . . . 35.32 115.089 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 47.5 t80 -137.39 154.0 50.08 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.425 -2.065 . . . . 39.350000000000001 105.425 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 13.4 t0 -146.91 159.16 43.88 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 103.352 -2.833 . . . . 40.460000000000001 103.352 173.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1196 ' ' THR . . . . . . . . . . . . . 53.5 m -63.7 -30.7 71.77 Favored 'General case' 0 C--O 1.254 1.32 0 CA-C-N 111.574 -2.557 . . . . 45.939999999999998 108.692 171.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1197 ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -101.47 100.69 14.56 Favored Pre-proline 0 CA--C 1.509 -0.629 0 N-CA-C 105.391 -2.078 . . . . 56.020000000000003 105.391 176.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1198 ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -59.59 -12.57 17.99 Favored 'Trans proline' 0 C--O 1.257 1.44 0 C-N-CA 122.621 2.214 . . . . 51.270000000000003 114.914 175.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -48.37 -16.61 0.11 Allowed 'General case' 0 C--O 1.234 0.257 0 N-CA-C 121.219 3.785 . . . . 59.100000000000001 121.219 167.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 33.8 m -80.65 -10.26 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 116.273 1.953 . . . . 51.060000000000002 116.273 169.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 75.0 tttt -50.59 -54.4 22.97 Favored 'General case' 0 C--N 1.348 0.516 0 N-CA-C 117.431 2.382 . . . . 57.380000000000003 117.431 -167.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.65 -30.78 63.14 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 115.368 -0.833 . . . . 62.409999999999997 108.776 -176.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -66.82 -33.2 75.09 Favored 'General case' 0 CA--C 1.501 -0.914 0 O-C-N 119.795 -1.815 . . . . 57.780000000000001 111.976 173.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 25.1 t -64.41 -47.9 87.5 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 C-N-CA 124.571 1.148 . . . . 46.380000000000003 109.3 172.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 21.6 mm100 -60.3 -45.62 92.74 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 122.006 -0.434 . . . . 50.700000000000003 111.403 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1206 ' ' SER . . . . . . . . . . . . . 47.5 m -69.54 -24.38 63.71 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 113.098 0.777 . . . . 49.979999999999997 113.098 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1207 ' ' MET . . . . . . . . . . . . . 36.6 mtp -86.67 9.77 17.73 Favored 'General case' 0 N--CA 1.443 -0.824 0 O-C-N 120.9 -1.125 . . . . 52.990000000000002 113.834 173.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 89.18 49.31 3.54 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 118.565 0.621 . . . . 47.659999999999997 112.648 170.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -158.28 160.88 37.55 Favored 'General case' 0 C--O 1.246 0.91 0 C-N-CA 124.116 0.966 . . . . 44.770000000000003 112.814 -174.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -96.4 147.52 23.73 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 105.476 -2.046 . . . . 47.640000000000001 105.476 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1211 ' ' PHE . . . . . . . . . . . . . 44.8 t80 -95.48 130.78 42.19 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.792 -1.188 . . . . 45.659999999999997 107.792 166.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 84.6 mt -65.43 105.6 1.2 Allowed 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 113.508 0.929 . . . . 46.060000000000002 113.508 -177.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -79.11 124.33 28.21 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 122.58 1.181 . . . . 60.219999999999999 110.024 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 9.6 mp -76.5 133.8 39.67 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 112.736 -2.029 . . . . 57.25 108.321 174.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 28.6 t70 -85.56 81.01 8.85 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 104.801 -2.296 . . . . 64.430000000000007 104.801 177.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 14.8 t80 . . . . . 0 CA--C 1.503 -0.836 0 CA-C-N 113.483 -1.69 . . . . 66.900000000000006 112.66 -167.278 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 CA--C 1.561 1.394 0 CA-C-O 116.809 -1.567 . . . . 39.090000000000003 108.576 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -52.12 -49.67 48.79 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 120.689 1.586 . . . . 39.32 114.242 173.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 74.3 t80 -64.25 -41.47 96.94 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.878 0.847 . . . . 39.299999999999997 109.738 -175.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -62.05 -41.89 98.61 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 114.479 -1.237 . . . . 36.299999999999997 111.466 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -58.14 -49.8 75.72 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 124.078 0.861 . . . . 37.380000000000003 109.364 170.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -65.99 -11.17 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 114.77 1.396 . . . . 39.109999999999999 114.77 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1230 ' ' MET . . . . . . . . . . . . . 26.4 mmt -107.93 -7.39 16.23 Favored 'General case' 0 C--O 1.244 0.789 0 O-C-N 121.103 -0.998 . . . . 49.590000000000003 110.235 175.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1231 ' ' SER . . . . . . . . . . . . . 69.4 m -87.12 132.74 33.75 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 118.919 0.781 . . . . 43.68 109.06 176.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -49.46 -58.34 5.34 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 114.462 1.282 . . . . 55.57 114.462 -167.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -64.94 -30.13 71.1 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 113.86 1.059 . . . . 44.939999999999998 113.86 -173.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 32.5 t80 -66.29 -48.74 69.43 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 115.483 -2.199 . . . . 42.039999999999999 107.994 172.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 2.9 mt -59.2 -30.92 44.94 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 CA-C-O 123.627 1.679 . . . . 46.280000000000001 112.8 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 33.3 tttm -74.49 -42.15 59.49 Favored 'General case' 0 C--O 1.215 -0.761 0 O-C-N 119.156 -2.215 . . . . 47.869999999999997 105.585 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -61.18 -31.03 70.78 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 119.551 1.069 . . . . 41.609999999999999 112.012 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -62.14 -59.1 5.54 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.741 -1.207 . . . . 50.649999999999999 107.741 168.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1239 ' ' MET . . . . . . . . . . . . . 38.6 mtt -55.33 -40.15 70.84 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 121.688 0.756 . . . . 48.869999999999997 112.667 -178.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -61.43 -51.46 68.65 Favored 'General case' 0 C--O 1.254 1.291 0 O-C-N 120.267 -1.521 . . . . 54.799999999999997 108.984 176.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 1.5 tm? -65.43 -37.39 86.77 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.703 -0.851 . . . . 43.210000000000001 108.703 -172.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -66.94 -43.06 84.2 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.685 -1.143 . . . . 38.659999999999997 112.256 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -58.41 -45.09 89.08 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 120.799 1.636 . . . . 37.920000000000002 111.288 175.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -60.8 -48.57 81.18 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 114.337 -1.301 . . . . 37.280000000000001 110.28 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -63.93 -43.45 95.82 Favored 'General case' 0 C--O 1.214 -0.783 0 CA-C-O 115.413 -2.232 . . . . 43.07 112.496 170.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -57.59 -38.75 75.4 Favored 'General case' 0 C--O 1.212 -0.892 0 CA-C-N 122.471 2.396 . . . . 38.299999999999997 110.186 -170.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1247 ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -62.71 -22.1 66.26 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 115.658 1.725 . . . . 47.600000000000001 115.658 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -118.56 -14.36 9.65 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-O 117.914 -1.041 . . . . 45.420000000000002 112.444 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1249 ' ' VAL . . . . . . . . . . . . 0.277 34.7 m -78.79 175.66 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 120.801 1.637 . . . . 36.259999999999998 113.304 -178.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1250 ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -124.28 -47.4 1.88 Allowed 'General case' 0 N--CA 1.432 -1.339 0 O-C-N 124.586 1.179 . . . . 33.039999999999999 112.823 -171.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1251 ' ' ILE . . . . . . . . . . . . . 38.0 mm -127.04 137.61 57.34 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 N-CA-C 105.147 -2.168 . . . . 31.399999999999999 105.147 -178.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1252 ' ' ILE . . . . . . . . . . . . . 33.0 mt -125.14 113.14 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 C-N-CA 119.282 -0.967 . . . . 29.420000000000002 108.526 167.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 48.5 t -90.65 102.93 13.87 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 CA-C-O 124.394 2.045 . . . . 30.370000000000001 106.728 176.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1254 ' ' THR . . . . . . . . . . . . . 21.8 m -100.36 99.17 9.77 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 110.473 -3.058 . . . . 35.719999999999999 104.04 -158.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1255 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.4 22.75 2.96 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.758 -1.565 . . . . 36.0 113.845 -168.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1256 ' ' ALA . . . . . . . . . . . . . . . -78.48 85.84 4.54 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 118.166 -2.834 . . . . 40.93 110.223 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 10.2 tp -142.55 124.2 14.99 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 111.514 -2.585 . . . . 47.82 109.311 -168.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 8.4 mm -78.13 120.71 82.24 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 100.916 -3.735 . . . . 52.700000000000003 100.916 160.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 1.3 Cg_exo -44.18 113.33 0.42 Allowed 'Trans proline' 0 C--N 1.319 -0.982 1 C-N-CA 125.551 4.167 . . . . 54.130000000000003 116.373 -167.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 78.71 3.96 87.55 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 112.243 -2.253 . . . . 54.619999999999997 115.727 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -111.22 145.16 31.92 Favored Pre-proline 0 C--O 1.219 -0.539 0 CA-C-N 121.561 2.68 . . . . 55.740000000000002 105.581 -174.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -48.16 108.27 0.17 Allowed 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 125.08 3.853 . . . . 51.149999999999999 116.055 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -65.12 154.85 85.99 Favored Pre-proline 0 C--O 1.222 -0.358 0 CA-C-N 112.579 -2.1 . . . . 46.060000000000002 112.725 -176.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.44 126.26 15.27 Favored 'Trans proline' 0 C--O 1.248 0.983 0 C-N-CA 123.737 2.958 . . . . 41.079999999999998 109.826 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 50.1 mmtt -77.56 105.63 8.83 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 106.385 -1.709 . . . . 47.420000000000002 106.385 176.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 52.4 mt -107.59 -52.35 2.78 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 113.112 -1.858 . . . . 39.219999999999999 110.246 -174.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 61.1 mt -88.03 100.46 10.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 104.882 -2.266 . . . . 42.5 104.882 -169.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1268 ' ' THR . . . . . . . . . . . . . 12.3 p -68.05 157.6 34.81 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 126.146 1.778 . . . . 37.840000000000003 113.934 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -57.49 -34.15 68.76 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 115.223 1.564 . . . . 54.799999999999997 115.223 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -67.37 -47.24 70.97 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 114.355 -1.293 . . . . 54.359999999999999 110.889 172.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1271 ' ' MET . . . . . . . . . . . . . 54.6 ttm -58.33 -45.41 88.15 Favored 'General case' 0 C--O 1.251 1.18 0 C-N-CA 124.297 1.039 . . . . 39.520000000000003 109.862 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1272 ' ' VAL . . . . . . . . . . . . . 21.2 t -57.4 -54.44 30.88 Favored 'Isoleucine or valine' 0 C--O 1.249 1.069 0 CA-C-N 115.843 -0.617 . . . . 38.25 110.379 178.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.41 -11.91 60.14 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 114.096 1.147 . . . . 40.770000000000003 114.096 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1274 ' ' SER . . . . . . . . . . . . . 70.7 m -78.28 -18.96 54.58 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 116.631 -1.652 . . . . 36.579999999999998 112.875 172.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1275 ' ' MET . . . . . . . . . . . . . 85.0 mtp -53.4 155.03 3.05 Favored 'General case' 0 CA--C 1.51 -0.571 0 O-C-N 125.222 1.576 . . . . 36.75 115.156 -176.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1276 ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -60.93 139.99 57.87 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 105.532 -2.025 . . . . 46.109999999999999 105.532 166.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1277 ' ' ALA . . . . . . . . . . . . . . . -85.57 165.37 17.12 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 123.182 1.468 . . . . 33.520000000000003 110.304 -171.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 74.02 36.5 51.64 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.697 1.141 . . . . 31.27 111.977 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1279 ' ' SER . . . . . . . . . . . . . 37.3 m -134.42 166.27 23.24 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 114.2 -1.0 . . . . 32.950000000000003 108.539 -165.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1280 ' ' VAL . . . . . . . . . . . . . 48.4 t -133.65 142.94 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 O-C-N 118.939 -2.35 . . . . 27.43 111.474 -176.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1281 ' ' ILE . . . . . . . . . . . . . 74.7 mt -110.49 103.23 15.15 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 N-CA-C 102.167 -3.272 . . . . 30.300000000000001 102.167 164.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -86.85 95.86 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 N-CA-C 107.291 -1.374 . . . . 28.629999999999999 107.291 174.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 19.7 t0 -85.96 106.92 17.48 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 105.547 -2.019 . . . . 36.270000000000003 105.547 -173.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1284 ' ' LEU . . . . . . . . . . . . . 91.0 mt -89.59 -31.9 17.36 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 114.924 -1.035 . . . . 38.57 108.584 175.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -66.43 -11.25 50.86 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 122.449 1.119 . . . . 37.560000000000002 110.861 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . -42.48 -20.36 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 126.509 1.924 . . . . 40.329999999999998 115.304 163.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -47.92 -41.25 24.22 Favored 'General case' 0 CA--C 1.553 1.071 0 O-C-N 121.378 -0.826 . . . . 56.850000000000001 110.675 173.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 1.4 t30 -137.07 99.26 3.95 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 119.787 -0.765 . . . . 45.859999999999999 109.509 170.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 82.18 -50.34 4.29 Favored Glycine 0 N--CA 1.476 1.317 0 O-C-N 119.693 -1.879 . . . . 40.310000000000002 113.863 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 101.39 164.47 27.41 Favored Glycine 0 N--CA 1.477 1.373 0 CA-C-N 119.749 1.775 . . . . 38.890000000000001 113.241 -176.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1291 ' ' ASN . . . . . . . . . . . . . 33.5 m120 -93.14 -35.84 12.96 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 117.954 0.877 . . . . 37.229999999999997 109.1 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1292 ' ' CYS . . . . . . . . . . . . . 20.5 t -78.49 153.67 31.16 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 122.885 1.326 . . . . 36.5 109.265 173.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1293 ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -82.89 -50.5 8.55 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 113.104 -1.862 . . . . 43.32 109.666 174.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.64 -24.94 59.19 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 117.454 2.39 . . . . 41.32 117.454 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1295 ' ' THR . . . . . . . . . . . . . 98.0 m -38.48 112.52 0.23 Allowed 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 124.915 1.286 . . . . 35.299999999999997 113.585 167.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 29.6 t -87.65 111.65 43.34 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 102.921 -2.992 . . . . 34.840000000000003 102.921 163.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -64.92 86.44 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.697 1 C-N-CA 125.327 4.018 . . . . 33.509999999999998 107.056 174.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 154.77 -27.94 0.66 Allowed Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 107.722 -2.151 . . . . 32.189999999999998 107.722 178.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -130.94 164.63 24.9 Favored 'General case' 0 C--O 1.251 1.135 0 CA-C-N 122.067 2.934 . . . . 34.880000000000003 113.975 -168.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1300 ' ' ILE . . . . . . . . . . . . . 84.1 mt -77.13 124.45 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 104.563 -2.384 . . . . 32.289999999999999 104.563 156.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 50.9 t80 -108.0 113.14 26.11 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 102.387 -3.19 . . . . 37.25 102.387 170.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1302 ' ' THR . . . . . . . . . . . . . 5.5 m -94.08 108.42 20.25 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 120.067 -1.646 . . . . 35.560000000000002 107.066 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1303 ' ' THR . . . . . . . . . . . . . 8.8 p -74.96 166.32 23.85 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 115.517 1.673 . . . . 36.399999999999999 115.517 -174.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.41 -26.53 65.58 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 120.561 -1.337 . . . . 52.32 112.039 -164.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 49.1 p-10 -66.75 -42.99 85.29 Favored 'General case' 0 C--O 1.239 0.552 0 O-C-N 121.116 -0.99 . . . . 40.039999999999999 112.116 171.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 123.61 43.15 0.35 Allowed Glycine 0 N--CA 1.414 -2.785 0 CA-C-O 123.244 1.469 . . . . 36.960000000000001 111.663 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1307 ' ' VAL . . . . . . . . . . . . . 41.5 t -113.52 140.89 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-N 113.728 -1.236 . . . . 33.399999999999999 109.253 176.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1308 ' ' LYS . . . . . . . . . . . . . 34.6 mmtt -97.81 110.73 23.24 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 112.658 -2.064 . . . . 42.909999999999997 107.902 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 5.3 t -99.62 87.42 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.817 0 N-CA-C 104.73 -2.322 . . . . 32.289999999999999 104.73 -176.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1310 ' ' ILE . . . . . . . . . . . . . 75.2 mt -88.57 83.09 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 113.979 -1.464 . . . . 30.989999999999998 109.232 -171.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -82.11 54.83 4.9 Favored Glycine 0 N--CA 1.437 -1.282 0 CA-C-O 123.415 1.564 . . . . 28.949999999999999 112.249 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1312 ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -82.58 98.73 9.13 Favored 'General case' 0 CA--C 1.502 -0.881 0 O-C-N 118.242 -2.916 . . . . 31.690000000000001 114.314 -173.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1313 ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -52.05 -44.26 64.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 112.041 -2.345 . . . . 34.170000000000002 111.806 170.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -64.9 -10.12 26.3 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 117.827 2.529 . . . . 36.859999999999999 117.827 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1315 ' ' LEU . . . . . . . . . . . . . 45.9 mt -62.55 -29.24 4.45 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 118.713 2.857 . . . . 34.850000000000001 118.713 -175.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 0.7 OUTLIER -59.92 -27.61 85.3 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.446 2.764 . . . . 29.149999999999999 114.267 165.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -79.98 -48.97 6.23 Favored Glycine 0 CA--C 1.502 -0.764 0 N-CA-C 107.55 -2.22 . . . . 27.289999999999999 107.55 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1318 ' ' ARG . . . . . . . . . . . . . 4.7 ttm180 -87.05 57.1 4.31 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 113.627 0.973 . . . . 41.490000000000002 113.627 -159.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1319 ' ' LEU . . . . . . . . . . . . . 15.1 tp -135.89 73.31 60.11 Favored Pre-proline 0 C--N 1.32 -0.715 1 N-CA-C 99.327 -4.323 . . . . 27.609999999999999 99.327 156.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1320 ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -42.25 -64.18 0.27 Allowed 'Trans proline' 0 N--CA 1.442 -1.531 1 C-N-CA 126.171 4.581 . . . . 25.940000000000001 117.999 -158.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1321 ' ' THR . . . . . . . . . . . . . 6.7 m -58.07 -45.58 86.89 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 119.803 -0.759 . . . . 25.010000000000002 111.016 176.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1322 ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -67.38 -48.07 68.48 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 123.767 0.667 . . . . 29.390000000000001 109.76 -169.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1323 ' ' SER . . . . . . . . . . . . . 20.4 m -56.08 -48.67 75.66 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 118.391 -0.814 . . . . 26.469999999999999 112.946 174.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1324 ' ' SER . . . . . . . . . . . . . 36.0 m -65.03 -29.76 70.69 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 123.069 1.414 . . . . 27.780000000000001 112.581 175.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -72.6 -58.84 3.06 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 106.641 -1.614 . . . . 37.530000000000001 106.641 -174.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1326 ' ' LEU . . . . . . . . . . . . . 37.9 mt -71.21 -42.01 69.51 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 118.385 -0.817 . . . . 35.710000000000001 109.151 -172.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1327 ' ' TYR . . . . . . . . . . . . . 53.0 t80 -60.55 -41.32 94.29 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 119.636 1.107 . . . . 31.59 110.857 173.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1328 ' ' GLY . . . . . . . . . . . . . . . -61.71 -47.01 93.0 Favored Glycine 0 C--O 1.256 1.487 0 O-C-N 121.336 -0.852 . . . . 28.0 111.653 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1329 ' ' THR . . . . . . . . . . . . . 6.5 m -71.99 -24.05 61.52 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 113.964 -1.118 . . . . 32.149999999999999 109.251 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1330 ' ' ASN . . . . . . . . . . . . . 17.6 m120 -60.74 -49.28 78.15 Favored 'General case' 0 C--O 1.24 0.595 0 O-C-N 119.067 -2.27 . . . . 34.359999999999999 111.851 168.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1331 ' ' LEU . . . . . . . . . . . . . 16.4 mt -62.41 -37.81 87.22 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 114.758 -1.11 . . . . 33.369999999999997 111.136 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1332 ' ' VAL . . . . . . . . . . . . . 64.1 t -63.76 -45.64 96.69 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 N-CA-C 108.634 -0.876 . . . . 35.270000000000003 108.634 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -57.8 -44.82 86.58 Favored 'General case' 0 C--O 1.241 0.613 0 O-C-N 118.979 -2.325 . . . . 37.659999999999997 112.679 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1334 ' ' LEU . . . . . . . . . . . . . 41.3 tp -53.64 -59.22 4.88 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.886 -1.052 . . . . 40.270000000000003 110.443 169.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1335 ' ' LEU . . . . . . . . . . . . . 32.0 mt -62.9 -14.23 44.05 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 117.472 2.397 . . . . 42.5 117.472 174.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1336 ' ' LYS . . . . . . . . . . . . . 94.5 mttt -66.52 -46.21 76.93 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 121.749 2.068 . . . . 47.810000000000002 107.123 169.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1337 ' ' LEU . . . . . . . . . . . . . 10.9 mp -72.51 -39.68 67.41 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 114.657 -1.156 . . . . 49.270000000000003 112.792 177.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1338 ' ' LEU . . . . . . . . . . . . . 9.4 mp -66.85 -32.73 74.19 Favored 'General case' 0 C--O 1.246 0.877 0 O-C-N 120.457 -1.402 . . . . 50.539999999999999 112.821 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1339 ' ' CYS . . . . . . . . . . . . . 50.2 t -116.38 68.47 0.73 Allowed 'General case' 0 C--O 1.25 1.079 0 O-C-N 118.711 -2.493 . . . . 53.670000000000002 105.532 175.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -75.02 -42.71 56.74 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.354 1.073 . . . . 63.380000000000003 111.132 174.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -68.44 -44.94 73.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 123.63 1.681 . . . . 70.950000000000003 114.069 -177.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1342 ' ' LYS . . . . . . . . . . . . . 18.3 mtpt 59.77 67.61 0.86 Allowed 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 128.072 2.549 . . . . 65.25 112.859 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1343 ' ' ASP . . . . . . . . . . . . 0.269 37.5 t70 60.42 -122.11 0.96 Allowed 'General case' 0 N--CA 1.426 -1.66 2 O-C-N 111.602 -6.936 . . . . 64.530000000000001 111.795 9.594 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A 1344 ' ' GLY . . . . . . . . . . . . . . . 109.97 31.25 3.18 Favored Glycine 0 C--O 1.252 1.225 0 O-C-N 117.289 -3.382 . . . . 59.719999999999999 111.461 -174.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 28.5 t30 -84.21 149.0 26.42 Favored 'General case' 0 N--CA 1.436 -1.156 0 O-C-N 120.492 -1.593 . . . . 64.090000000000003 107.105 164.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1346 ' ' ILE . . . . . . . . . . . . . 2.6 mp -81.36 83.56 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 103.198 -2.89 . . . . 58.82 103.198 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1347 ' ' THR . . . . . . . . . . . . . 3.3 m -76.91 83.43 3.46 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 105.798 -1.926 . . . . 54.960000000000001 105.798 -177.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1348 ' ' VAL . . . . . . . . . . . . . 21.8 t -78.33 76.13 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 124.406 2.051 . . . . 55.640000000000001 106.508 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 27.0 t70 -75.13 138.38 42.0 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 112.113 -2.312 . . . . 61.450000000000003 112.518 -165.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 11.4 m-30 -103.49 -6.35 21.89 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 112.082 -2.326 . . . . 58.630000000000003 112.898 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 15.1 t70 -71.71 -48.24 48.49 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 118.797 0.726 . . . . 62.060000000000002 110.072 177.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 18.2 t0 -66.25 130.57 43.67 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.538 -0.756 . . . . 54.07 109.397 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 31.8 m -67.95 -28.31 40.81 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 N-CA-C 113.077 0.769 . . . . 50.68 113.077 -176.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1354 ' ' VAL . . . . . . . . . . . . . 3.1 m -80.23 -43.65 22.14 Favored 'Isoleucine or valine' 0 C--O 1.246 0.876 0 N-CA-C 105.471 -2.048 . . . . 47.68 105.471 -174.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1355 ' ' ILE . . . . . . . . . . . . . 62.2 mt -65.77 -44.08 93.2 Favored 'Isoleucine or valine' 0 C--O 1.25 1.115 0 C-N-CA 119.423 -0.911 . . . . 48.490000000000002 109.731 -177.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 35.2 tpt85 -53.61 -48.04 69.67 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 115.269 -2.3 . . . . 48.270000000000003 113.329 168.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -57.9 -45.58 93.47 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 122.124 2.238 . . . . 43.530000000000001 114.995 174.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1358 ' ' VAL . . . . . . . . . . . . . 11.6 t -59.44 -49.82 82.18 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 C-N-CA 125.041 1.337 . . . . 45.119999999999997 110.913 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1359 ' ' THR . . . . . . . . . . . . . 18.5 m -70.74 87.73 0.7 Allowed 'General case' 0 C--O 1.244 0.774 0 CA-C-O 125.011 2.338 . . . . 42.939999999999998 112.479 -177.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 16.5 m -78.13 -28.83 15.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 112.642 -2.072 . . . . 43.259999999999998 111.461 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1361 ' ' ILE . . . . . . . . . . . . . 96.5 mt -131.98 119.83 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 102.972 -2.973 . . . . 45.659999999999997 102.972 175.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1362 ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -106.41 124.42 49.57 Favored 'General case' 0 C--O 1.253 1.241 1 CA-C-N 126.254 4.116 . . . . 61.340000000000003 106.762 168.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 43.81 54.6 5.58 Favored 'General case' 0 C--O 1.241 0.627 0 O-C-N 126.447 2.342 . . . . 49.759999999999998 115.192 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 86.04 -24.08 8.49 Favored Glycine 0 CA--C 1.526 0.74 0 O-C-N 120.014 -1.678 . . . . 50.0 114.301 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -88.78 124.93 34.62 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 103.692 -2.707 . . . . 56.920000000000002 103.692 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1366 ' ' ILE . . . . . . . . . . . . . 92.4 mt -75.18 89.32 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.753 0 CA-C-O 123.073 1.416 . . . . 52.780000000000001 108.065 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1367 ' ' THR . . . . . . . . . . . . . 17.1 p -75.76 53.05 0.71 Allowed 'General case' 0 C--O 1.252 1.211 0 CA-C-O 125.951 2.786 . . . . 49.439999999999998 113.767 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 57.1 t90 -132.37 144.07 51.49 Favored Pre-proline 0 CA--C 1.545 0.787 0 O-C-N 119.525 -1.984 . . . . 52.380000000000003 108.491 -170.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.39 170.81 70.84 Favored 'Cis proline' 0 C--O 1.25 1.11 0 CA-C-N 123.101 2.143 . . . . 46.939999999999998 114.164 -4.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -128.75 117.98 19.7 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 108.5 -0.926 . . . . 45.909999999999997 108.5 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1371 ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -61.22 137.62 72.12 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 125.198 3.932 . . . . 46.390000000000001 112.823 -174.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.35 8.61 3.51 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 121.105 1.204 . . . . 46.719999999999999 113.797 160.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.214 -5.31 0 O-C-N 119.541 -1.974 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 60.3 m80 . . . . . 0 N--CA 1.436 -1.16 0 N-CA-C 102.989 -2.967 . . . . 63.439999999999998 102.989 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -111.05 43.53 1.44 Allowed 'General case' 0 C--O 1.243 0.739 0 CA-C-O 123.21 1.481 . . . . 51.740000000000002 109.045 148.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1000 ' ' HIS . . . . . . . . . . . . . 18.7 t60 -84.61 135.61 34.11 Favored 'General case' 0 C--O 1.247 0.96 0 N-CA-C 104.924 -2.25 . . . . 54.07 104.924 -166.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 67.01 13.22 61.49 Favored Glycine 0 N--CA 1.451 -0.341 0 O-C-N 119.304 -2.122 . . . . 39.219999999999999 111.806 -172.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1002 ' ' ARG . . . . . 0.424 ' NH2' ' O ' ' B' 1065 ' ' GLN . 16.6 ttp180 -97.74 121.93 40.24 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.049 -1.463 . . . . 38.119999999999997 107.049 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B 1003 ' ' ILE . . . . . . . . . . . . 0.279 46.6 mt -78.79 149.94 5.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 106.378 -1.712 . . . . 29.699999999999999 106.378 172.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -121.18 130.09 8.05 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 108.568 -1.813 . . . . 27.5 108.568 162.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1005 ' ' ILE . . . . . . . . . . . . . 38.4 mm -104.91 103.14 39.63 Favored Pre-proline 0 C--O 1.243 0.748 0 N-CA-C 105.371 -2.085 . . . . 24.829999999999998 105.371 170.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -74.15 162.47 38.71 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 124.399 3.399 . . . . 27.190000000000001 108.993 171.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -80.52 137.33 36.42 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 104.449 -2.426 . . . . 41.460000000000001 104.449 157.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1008 ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -68.82 158.84 33.6 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-N 115.076 -0.965 . . . . 26.93 110.779 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 35.0 mmm-85 -113.91 -35.16 5.2 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 111.975 -2.375 . . . . 34.479999999999997 112.848 -171.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1010 ' ' LEU . . . . . . . . . . . . . 7.3 mp -61.04 153.31 25.72 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 115.713 1.746 . . . . 44.219999999999999 115.713 -169.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1011 ' ' THR . . . . . . . . . . . . . 20.1 m -62.82 131.82 50.09 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 113.74 -1.573 . . . . 40.740000000000002 110.781 -173.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 5.2 t30 38.64 47.65 1.17 Allowed 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 129.492 3.117 . . . . 44.439999999999998 116.042 -166.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1013 ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -105.19 118.58 36.9 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 112.217 -2.265 . . . . 29.870000000000001 106.809 175.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1014 ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.0 0.51 25.73 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 115.14 1.533 . . . . 25.260000000000002 115.14 176.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -80.6 144.42 32.4 Favored 'General case' 0 C--O 1.241 0.62 0 O-C-N 119.53 -1.981 . . . . 29.539999999999999 112.957 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1016 ' ' VAL . . . . . . . . . . . . . 4.7 p -111.42 175.63 1.8 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 103.992 -2.596 . . . . 23.550000000000001 103.992 165.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1017 ' ' ALA . . . . . . . . . . . . . . . -75.91 -40.33 54.49 Favored 'General case' 0 C--N 1.344 0.356 0 O-C-N 117.939 -2.976 . . . . 23.59 115.042 -176.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1018 ' ' ALA . . . . . . . . . . . . . . . -152.19 145.47 24.71 Favored 'General case' 0 C--O 1.247 0.935 0 N-CA-C 105.28 -2.118 . . . . 24.93 105.28 -176.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1019 ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.14 172.6 5.02 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 115.725 -2.083 . . . . 28.09 111.521 -178.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -51.61 -42.65 55.14 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 CA-C-N 127.155 3.591 . . . . 28.789999999999999 118.161 -172.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 83.6 tttt -54.96 -48.76 72.79 Favored 'General case' 0 CA--C 1.502 -0.89 0 O-C-N 121.236 -0.915 . . . . 47.280000000000001 112.617 169.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1022 ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.77 -24.22 65.3 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 120.755 -1.215 . . . . 30.120000000000001 113.253 177.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B 1023 ' ' VAL . . . . . . . . . . . . . 43.0 t -67.41 -47.57 80.42 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.711 0 O-C-N 120.244 -1.535 . . . . 32.240000000000002 107.713 171.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1024 ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -62.73 -36.09 81.87 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 118.776 -0.63 . . . . 49.619999999999997 112.684 176.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -58.68 -43.78 90.06 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 124.305 1.003 . . . . 44.68 113.271 169.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 35.1 mt -62.14 -43.45 98.8 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 119.895 -1.753 . . . . 35.710000000000001 113.217 171.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1027 ' ' LEU . . . . . . . . . . . . . 24.7 mt -58.24 -27.16 63.71 Favored 'General case' 0 C--N 1.348 0.542 0 O-C-N 119.808 -1.807 . . . . 42.18 112.332 174.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 62.7 mttm -61.75 -21.48 64.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 121.097 1.772 . . . . 48.340000000000003 112.38 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1029 ' ' LEU . . . . . . . . . . . . . 49.6 mt -86.45 -4.16 59.13 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 114.233 1.197 . . . . 38.689999999999998 114.233 175.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 78.58 21.98 68.08 Favored Glycine 0 N--CA 1.446 -0.693 0 O-C-N 120.314 -1.491 . . . . 32.280000000000001 113.301 -174.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -99.35 132.44 44.67 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 105.419 -2.067 . . . . 35.939999999999998 105.419 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1032 ' ' THR . . . . . . . . . . . . . 3.6 m -89.35 123.97 34.01 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 107.971 -1.122 . . . . 33.369999999999997 107.971 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1033 ' ' VAL . . . . . . . . . . . . . 22.8 t -95.34 134.12 33.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.637 -1.616 . . . . 29.98 106.637 -171.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -111.77 145.83 38.68 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.911 -1.144 . . . . 28.18 107.911 159.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1035 ' ' VAL . . . . . . . . . . . . . 97.1 t -122.5 149.73 26.06 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 N-CA-C 103.713 -2.699 . . . . 25.82 103.713 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1036 ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -73.3 147.27 44.65 Favored 'General case' 0 C--O 1.213 -0.835 0 C-N-CA 123.252 0.621 . . . . 32.439999999999998 111.293 176.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1037 ' ' SER . . . . . . . . . . . . . 44.0 m -60.25 112.72 2.03 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.347 -1.297 . . . . 29.539999999999999 111.015 172.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 77.92 20.4 73.39 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 111.695 -2.502 . . . . 27.760000000000002 113.941 -175.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1039 ' ' ALA . . . . . . . . . . . . . . . -64.81 -57.8 7.93 Favored 'General case' 0 C--O 1.25 1.12 0 N-CA-C 115.69 1.737 . . . . 26.02 115.69 -176.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -67.58 -15.1 65.83 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 114.201 -1.363 . . . . 26.469999999999999 113.543 -173.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -53.36 -35.72 60.59 Favored 'General case' 0 C--O 1.255 1.347 0 O-C-N 119.615 -2.109 . . . . 50.979999999999997 113.133 172.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 60.8 mt -53.03 -54.47 34.79 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 123.028 2.649 . . . . 29.300000000000001 110.03 167.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1043 ' ' ALA . . . . . . . . . . . . . . . -66.67 2.81 1.19 Allowed 'General case' 0 C--O 1.241 0.641 0 N-CA-C 115.706 1.743 . . . . 26.739999999999998 115.706 174.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1044 ' ' SER . . . . . . . . . . . . . 24.3 m 62.28 35.67 15.12 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 123.702 1.715 . . . . 31.260000000000002 114.668 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1045 ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.5 108.81 9.36 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 105.005 -2.221 . . . . 33.259999999999998 105.005 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 8.5 t70 -61.52 144.31 54.5 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 114.975 1.472 . . . . 46.740000000000002 114.975 -177.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 43.0 p-10 -65.13 -20.4 66.44 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 114.146 1.165 . . . . 34.439999999999998 114.146 -175.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -56.72 -23.47 42.62 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 117.371 2.36 . . . . 48.670000000000002 117.371 165.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -83.81 -24.21 31.08 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 123.672 0.789 . . . . 35.259999999999998 110.371 172.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1050 ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -74.22 -28.33 61.2 Favored 'General case' 0 C--O 1.251 1.184 0 O-C-N 119.156 -2.215 . . . . 32.170000000000002 110.262 171.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 91.6 t -62.43 -50.29 80.46 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 N-CA-C 105.918 -1.882 . . . . 38.369999999999997 105.918 167.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -51.6 -41.52 61.29 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.135 1.531 . . . . 45.770000000000003 115.135 172.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -65.42 -41.69 93.3 Favored 'General case' 0 C--O 1.218 -0.558 0 O-C-N 123.618 0.574 . . . . 37.829999999999998 111.78 173.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 111.61 53.21 0.53 Allowed Glycine 0 C--N 1.35 1.317 0 N-CA-C 110.704 -0.959 . . . . 35.82 110.704 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -120.69 150.26 41.22 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-O 123.854 1.788 . . . . 33.770000000000003 109.365 171.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -63.76 142.83 58.26 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 112.227 -2.261 . . . . 51.020000000000003 108.493 167.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1057 ' ' ILE . . . . . . . . . . . . . 46.2 mm -120.17 112.74 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 N-CA-C 106.17 -1.789 . . . . 38.469999999999999 106.17 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 1.8 m -133.74 142.23 42.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 115.445 1.646 . . . . 39.399999999999999 115.445 -171.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -72.82 105.01 4.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 113.479 -1.691 . . . . 57.07 114.762 -169.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . 59.96 -113.7 5.61 Favored Glycine 0 N--CA 1.433 -1.558 0 CA-C-N 114.425 -1.261 . . . . 44.829999999999998 112.554 165.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -61.96 -25.1 67.41 Favored 'General case' 0 C--O 1.241 0.632 0 O-C-N 120.459 -1.613 . . . . 46.270000000000003 111.922 -171.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1062 ' ' SER . . . . . . . . . . . . . 66.5 m -59.08 -41.89 89.1 Favored 'General case' 0 N--CA 1.426 -1.642 0 C-N-CA 124.349 1.06 . . . . 43.469999999999999 111.21 173.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 2.0 p -66.91 -31.53 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 O-C-N 118.593 -2.567 . . . . 36.979999999999997 109.347 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 38.8 m95 -68.87 -30.55 69.09 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 113.994 1.109 . . . . 37.899999999999999 113.994 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1065 ' ' GLN . . . . . 0.424 ' O ' ' NH2' ' B' 1002 ' ' ARG . 47.1 mm-40 -77.47 92.88 4.04 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.03 -1.1 . . . . 46.189999999999998 108.03 175.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B 1066 ' ' SER . . . . . . . . . . . . . 53.5 m -159.94 165.79 31.39 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 119.929 -1.732 . . . . 37.060000000000002 110.906 -169.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1067 ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -65.47 -52.52 52.35 Favored 'General case' 0 C--O 1.22 -0.468 0 O-C-N 124.643 1.214 . . . . 43.950000000000003 111.277 170.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1068 ' ' ILE . . . . . . . . . . . . . 23.9 mt -123.74 131.81 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 104.888 -2.264 . . . . 33.5 104.888 -173.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 26.4 mm -111.4 116.92 53.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 104.779 -2.304 . . . . 30.57 104.779 171.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1070 ' ' LEU . . . . . . . . . . . . . 73.7 mt -102.27 114.96 29.57 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 101.72 -3.437 . . . . 27.66 101.72 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1071 ' ' LYS . . . . . . . . . . . . . 18.9 tttm -140.14 157.73 45.16 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 106.182 -1.784 . . . . 28.399999999999999 106.182 -169.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1072 ' ' VAL . . . . . . . . . . . . . 67.6 t -83.27 -81.14 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.828 0 C-N-CA 117.547 -1.661 . . . . 23.18 110.188 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -87.04 156.89 19.56 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 114.174 1.176 . . . . 25.469999999999999 114.174 -167.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -46.65 117.14 4.21 Favored Pre-proline 0 C--O 1.249 1.075 0 C-N-CA 124.129 0.972 . . . . 27.899999999999999 113.049 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -54.48 136.14 68.69 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.903 2.402 . . . . 31.620000000000001 114.074 -173.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 38.3 mt -71.33 160.28 33.07 Favored 'General case' 0 CA--C 1.506 -0.74 0 O-C-N 126.51 2.381 . . . . 40.490000000000002 106.776 173.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.49 -38.68 63.91 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 115.923 1.823 . . . . 51.590000000000003 115.923 -168.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -68.69 -36.13 78.1 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-O 120.84 0.352 . . . . 42.359999999999999 111.751 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1079 ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -64.07 -36.02 82.64 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-O 123.551 1.643 . . . . 34.530000000000001 111.37 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1080 ' ' ILE . . . . . . . . . . . . . 57.6 mt -60.45 -50.78 78.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 113.119 -1.855 . . . . 33.25 109.64 174.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -57.15 -34.01 67.99 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 115.486 1.661 . . . . 36.469999999999999 115.486 173.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1082 ' ' LEU . . . . . . . . . . . . . 86.0 mt -62.94 -26.88 69.03 Favored 'General case' 0 CA--C 1.491 -1.31 0 O-C-N 125.391 1.682 . . . . 37.759999999999998 114.303 173.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1083 ' ' LEU . . . . . . . . . . . . . 68.8 mt -55.28 156.63 4.11 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 113.865 1.061 . . . . 37.43 113.865 167.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1084 ' ' ASN . . . . . . . . . . . . 0.252 1.5 m-80 -130.56 148.53 70.36 Favored Pre-proline 0 C--N 1.319 -0.753 0 N-CA-C 103.673 -2.714 . . . . 37.700000000000003 103.673 -167.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -55.82 114.0 1.69 Allowed 'Trans proline' 0 C--O 1.25 1.11 0 C-N-CA 125.004 3.803 . . . . 35.509999999999998 109.673 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 120.71 -37.65 2.96 Favored Glycine 0 N--CA 1.437 -1.246 0 CA-C-N 111.624 -2.535 . . . . 33.869999999999997 114.332 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1087 ' ' THR . . . . . . . . . . . . . 26.4 m -56.2 122.24 11.3 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 114.513 1.301 . . . . 32.5 114.513 -164.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1088 ' ' THR . . . . . . . . . . . . . 13.5 m -70.49 94.72 0.99 Allowed 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 113.633 -1.621 . . . . 30.219999999999999 107.268 174.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1089 ' ' LEU . . . . . . . . . . . . . 42.4 tp -85.77 111.36 20.08 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 118.951 0.796 . . . . 27.239999999999998 110.05 174.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 6.0 t -112.76 104.53 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 104.037 -2.579 . . . . 25.390000000000001 104.037 -175.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1091 ' ' SER . . . . . . . . . . . . . 45.5 m -154.86 163.4 40.34 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.043 -1.435 . . . . 28.809999999999999 113.282 -171.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1092 ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -73.64 99.77 3.18 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 104.233 -2.506 . . . . 30.780000000000001 104.233 171.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 37.6 mm -85.38 -33.71 8.04 Favored 'Isoleucine or valine' 0 C--N 1.355 0.843 0 CA-C-O 118.254 -0.879 . . . . 30.280000000000001 111.909 -175.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1094 ' ' TRP . . . . . . . . . . . . . 70.6 m95 53.59 62.23 9.57 Favored Pre-proline 0 C--O 1.248 0.994 0 C-N-CA 124.811 1.245 . . . . 34.07 113.274 -167.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -50.1 -49.2 16.89 Favored 'Trans proline' 0 C--O 1.248 0.992 0 C-N-CA 125.104 3.87 . . . . 38.659999999999997 114.089 -170.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -75.18 -19.7 59.7 Favored 'General case' 0 C--O 1.241 0.621 0 O-C-N 120.617 -1.302 . . . . 41.32 110.142 -175.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -85.43 -22.9 28.11 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 122.272 1.034 . . . . 51.659999999999997 111.279 173.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -127.84 48.87 3.74 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 113.869 1.063 . . . . 40.32 113.869 -170.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -60.98 -40.26 53.79 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 124.044 3.163 . . . . 41.560000000000002 118.051 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -64.11 -39.13 93.37 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 109.206 -0.664 . . . . 54.109999999999999 109.206 175.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1101 ' ' LEU . . . . . . . . . . . . . 9.9 mp -61.89 -45.21 94.75 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 118.17 0.441 . . . . 37.880000000000003 111.873 172.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1102 ' ' MET . . . . . . . . . . . . . 75.1 mmm -55.42 -42.63 74.42 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 123.214 0.605 . . . . 37.539999999999999 112.432 173.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -66.55 -40.77 89.23 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-O 122.407 1.098 . . . . 47.009999999999998 108.434 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1104 ' ' LYS . . . . . . . . . . . . . 37.8 mtmt -65.65 -27.72 68.57 Favored 'General case' 0 CA--C 1.481 -1.681 0 O-C-N 118.101 -2.875 . . . . 48.68 116.043 170.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1105 ' ' LEU . . . . . . . . . . . . . 31.3 mt -70.82 -38.81 73.29 Favored 'General case' 0 C--O 1.265 1.869 0 O-C-N 120.385 -1.447 . . . . 32.210000000000001 110.374 173.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -61.77 -42.21 98.7 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 109.019 -0.734 . . . . 33.729999999999997 109.019 175.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -60.14 -44.92 94.58 Favored 'General case' 0 CA--C 1.497 -1.075 0 O-C-N 121.039 -1.038 . . . . 51.469999999999999 113.773 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1108 ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -62.2 -24.5 67.25 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.649 -1.282 . . . . 43.899999999999999 114.332 173.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1109 ' ' ASN . . . . . . . . . . . . . 14.9 m-80 72.01 47.12 0.32 Allowed 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 125.12 2.391 . . . . 44.82 110.94 173.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1110 ' ' VAL . . . . . . . . . . . . . 16.5 m -96.46 169.38 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-N 110.081 -3.236 . . . . 30.52 113.826 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1111 ' ' THR . . . . . . . . . . . . . 8.1 m -104.65 97.87 7.7 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 107.548 -1.278 . . . . 27.120000000000001 107.548 171.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1112 ' ' VAL . . . . . . . . . . . . . 93.4 t -92.8 123.85 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 O-C-N 119.556 -1.965 . . . . 26.399999999999999 108.736 -173.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1113 ' ' MET . . . . . . . . . . . . . 21.0 mtp -116.87 103.12 9.98 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.986 -1.487 . . . . 42.920000000000002 106.986 174.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -79.75 88.04 5.23 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 113.457 -1.701 . . . . 24.149999999999999 113.782 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1115 ' ' MET . . . . . . . . . . . . . 95.0 mmm -54.71 -19.23 5.79 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 117.073 2.249 . . . . 29.949999999999999 117.073 -173.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1116 ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -72.7 -46.23 54.79 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.115 -1.402 . . . . 34.530000000000001 114.503 168.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1117 ' ' SER . . . . . . . . . . . . . 66.1 m -93.8 52.87 1.73 Allowed 'General case' 0 C--O 1.255 1.347 0 O-C-N 119.181 -2.199 . . . . 33.490000000000002 112.028 -167.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1118 ' ' VAL . . . . . . . . . . . . . 40.5 t -89.53 137.38 28.86 Favored Pre-proline 0 N--CA 1.445 -0.718 0 N-CA-C 106.565 -1.643 . . . . 34.020000000000003 106.565 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -63.63 131.07 30.04 Favored 'Trans proline' 0 CA--C 1.512 -0.602 0 C-N-CA 123.765 2.976 . . . . 38.280000000000001 108.336 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1120 ' ' ARG . . . . . 0.503 HH12 ' CG ' ' B' 1128 ' ' ASP . 1.8 mmt180 -74.77 50.2 0.44 Allowed 'General case' 0 C--O 1.247 0.97 0 N-CA-C 115.09 1.515 . . . . 55.049999999999997 115.09 -163.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B 1121 ' ' ILE . . . . . . . . . . . . . 36.1 pt -102.08 172.51 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.912 0 O-C-N 117.082 -3.511 . . . . 42.090000000000003 115.969 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1122 ' ' SER . . . . . . . . . . . . . 2.9 m -62.29 -32.73 73.5 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 117.718 2.488 . . . . 38.020000000000003 117.718 -172.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1123 ' ' ARG . . . . . . . . . . . . . 11.3 ptt-85 -67.25 -35.76 80.21 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 119.378 -0.929 . . . . 34.289999999999999 113.407 162.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1124 ' ' ALA . . . . . . . . . . . . . . . -62.22 -36.08 80.88 Favored 'General case' 0 C--N 1.359 0.98 0 N-CA-C 116.877 2.177 . . . . 32.350000000000001 116.877 -158.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1125 ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -64.94 -8.73 16.88 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 115.415 1.635 . . . . 47.170000000000002 115.415 -172.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1126 ' ' SER . . . . . . . . . . . . . 21.1 p -75.05 -41.82 58.29 Favored 'General case' 0 C--O 1.24 0.585 0 O-C-N 120.414 -1.429 . . . . 31.710000000000001 109.074 173.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1127 ' ' LEU . . . . . . . . . . . . . 3.5 mp -80.13 -40.85 26.58 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-N 113.248 -1.796 . . . . 37.0 111.159 174.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1128 ' ' ASP . . . . . 0.503 ' CG ' HH12 ' B' 1120 ' ' ARG . 9.3 t70 -61.6 119.89 9.52 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 123.743 1.735 . . . . 40.399999999999999 115.001 -173.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B 1129 ' ' ALA . . . . . . . . . . . . . . . -68.63 -34.98 76.68 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 111.629 -2.532 . . . . 26.559999999999999 109.277 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 58.8 mt -67.8 -28.93 68.01 Favored 'General case' 0 C--N 1.31 -1.111 0 O-C-N 118.957 -2.339 . . . . 30.890000000000001 112.451 -169.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1131 ' ' SER . . . . . . . . . . . . . 57.9 p -65.5 -56.11 14.15 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 107.685 -1.228 . . . . 29.84 107.685 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1132 ' ' SER . . . . . . . . . . . . . 5.8 m -55.54 -47.69 75.92 Favored 'General case' 0 CA--C 1.507 -0.675 0 O-C-N 125.727 1.892 . . . . 31.91 110.174 178.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1133 ' ' MET . . . . . . . . . . . . . 33.2 mmt -65.87 -31.35 72.24 Favored 'General case' 0 C--N 1.361 1.073 0 N-CA-C 115.72 1.748 . . . . 25.899999999999999 115.72 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1134 ' ' ALA . . . . . . . . . . . . . . . -67.06 -43.62 82.18 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 107.602 -1.258 . . . . 26.620000000000001 107.602 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.97 -35.59 78.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 121.501 1.955 . . . . 36.969999999999999 110.466 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B 1136 ' ' ILE . . . . . . . . . . . . . 23.5 mm -52.02 -56.81 4.97 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 O-C-N 121.393 -0.817 . . . . 32.109999999999999 110.313 167.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -69.75 -20.32 63.51 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 116.968 -1.491 . . . . 24.140000000000001 110.551 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -69.15 -48.16 48.46 Favored Glycine 0 N--CA 1.471 1.002 0 CA-C-N 120.909 1.686 . . . . 25.129999999999999 110.545 173.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 81.9 t80 -66.33 -51.85 53.03 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 105.595 -2.002 . . . . 32.729999999999997 105.595 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1140 ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -54.63 -25.78 28.81 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-O 115.538 -2.172 . . . . 26.359999999999999 113.4 173.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1141 ' ' ALA . . . . . . . . . . . . . . . -62.17 -54.28 43.26 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 121.381 1.901 . . . . 24.120000000000001 109.055 173.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 45.7 mm -57.69 -43.37 83.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 CA-C-O 122.734 1.254 . . . . 23.370000000000001 110.96 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 75.3 t -63.46 -56.76 15.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 114.523 1.305 . . . . 24.960000000000001 114.523 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -70.16 -29.74 66.72 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 120.47 -1.394 . . . . 32.07 111.639 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1145 ' ' ALA . . . . . . . . . . . . . . . -55.99 -60.3 3.67 Favored 'General case' 0 C--N 1.346 0.418 0 N-CA-C 107.68 -1.23 . . . . 24.870000000000001 107.68 168.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1146 ' ' ALA . . . . . . . . . . . . . . . -48.4 -32.48 7.68 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.248 1.573 . . . . 24.670000000000002 115.248 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 80.7 t60 -53.59 -50.53 65.41 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 119.76 1.164 . . . . 28.579999999999998 111.988 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1148 ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -108.14 -5.38 16.97 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 119.561 -1.962 . . . . 36.82 114.377 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1149 ' ' PHE . . . . . . . . . . . . . 2.8 t80 -54.09 138.94 36.55 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 126.029 2.823 . . . . 31.969999999999999 109.141 177.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1150 ' ' GLY . . . . . . . . . . . . . . . -68.6 -35.35 80.71 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 109.784 -3.371 . . . . 25.489999999999998 113.816 175.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1151 ' ' ARG . . . . . . . . . . . . . 55.3 mtm-85 -128.37 -170.56 2.27 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 123.048 3.424 . . . . 59.840000000000003 110.022 -162.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1152 ' ' PHE . . . . . . . . . . . . . 19.0 m-30 -81.7 161.29 23.43 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 107.734 -1.21 . . . . 34.450000000000003 107.734 168.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1153 ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -79.91 -47.91 14.3 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.102 -1.814 . . . . 31.170000000000002 106.102 166.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1154 ' ' THR . . . . . . . . . . . . . 57.5 m -54.77 134.82 47.82 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 112.28 -2.237 . . . . 33.890000000000001 112.411 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -78.02 62.64 3.63 Favored Glycine 0 N--CA 1.44 -1.094 0 O-C-N 123.881 0.738 . . . . 38.950000000000003 112.86 169.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -83.79 125.04 31.53 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 122.984 1.373 . . . . 54.229999999999997 111.767 -166.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 18.8 mm -78.09 89.39 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 105.375 -2.083 . . . . 51.159999999999997 105.375 172.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1158 ' ' THR . . . . . . . . . . . . . 6.2 m -97.79 146.46 25.37 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 107.157 -1.423 . . . . 49.609999999999999 107.157 -177.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -44.15 -57.3 3.49 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 115.09 1.515 . . . . 49.049999999999997 115.09 -171.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -60.43 -37.27 80.38 Favored 'General case' 0 C--O 1.207 -1.144 0 C-N-CA 125.175 1.39 . . . . 47.649999999999999 112.011 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . 179.87 157.52 20.23 Favored Glycine 0 CA--C 1.498 -1.026 0 N-CA-C 109.421 -1.472 . . . . 45.609999999999999 109.421 -177.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 85.6 mttt -75.1 125.63 29.34 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.044 -1.078 . . . . 57.460000000000001 110.605 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1163 ' ' VAL . . . . . . . . . . . . . 57.1 t -75.81 128.0 84.41 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-O 118.332 -0.842 . . . . 42.93 108.864 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1164 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.92 122.46 9.81 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 124.826 3.684 . . . . 39.289999999999999 108.442 172.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1165 ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -64.88 142.48 75.8 Favored 'Trans proline' 0 C--O 1.248 1.013 0 O-C-N 124.289 1.678 . . . . 34.170000000000002 109.452 -171.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -76.89 120.77 22.49 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 123.833 1.778 . . . . 31.690000000000001 108.898 -173.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1167 ' ' LYS . . . . . . . . . . . . . 87.4 mttt -86.54 101.86 13.59 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 103.085 -2.931 . . . . 44.780000000000001 103.085 174.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 35.7 t -97.31 91.59 2.65 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 CA-C-N 112.805 -1.998 . . . . 31.23 109.46 -175.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1169 ' ' MET . . . . . . . . . . . . . 48.3 ttp -77.48 99.68 5.75 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 105.442 -2.058 . . . . 37.090000000000003 105.442 -177.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 93.3 t -87.6 96.42 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 106.668 -1.605 . . . . 30.170000000000002 106.668 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1171 ' ' ILE . . . . . . . . . . . . . 61.3 mt -90.03 113.08 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 N-CA-C 107.132 -1.433 . . . . 33.740000000000002 107.132 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 94.91 73.85 1.21 Allowed Glycine 0 CA--C 1.5 -0.895 0 C-N-CA 119.561 -1.304 . . . . 32.590000000000003 110.455 170.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1173 ' ' ALA . . . . . . . . . . . . . . . -78.47 57.16 1.9 Allowed 'General case' 0 C--N 1.329 -0.295 0 O-C-N 126.465 1.921 . . . . 32.420000000000002 113.79 -175.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -86.83 -162.52 37.54 Favored Glycine 0 C--O 1.211 -1.3 0 N-CA-C 108.185 -1.966 . . . . 31.739999999999998 108.185 164.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 41.4 t -47.37 -46.9 10.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 CA-C-N 121.538 2.669 . . . . 31.48 116.521 -171.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1176 ' ' ALA . . . . . . . . . . . . . . . -53.97 -56.15 20.5 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 115.665 1.728 . . . . 26.120000000000001 115.665 169.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1177 ' ' GLY . . . . . . . . . . . . . . . -51.3 -52.19 33.31 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-N 113.474 -1.694 . . . . 25.73 111.185 176.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1178 ' ' LEU . . . . . . . . . . . . . 37.8 mt -62.13 -44.34 96.84 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 126.02 1.728 . . . . 32.590000000000003 113.158 -174.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -59.9 -39.36 85.13 Favored 'General case' 0 C--N 1.348 0.517 0 N-CA-C 113.762 1.023 . . . . 27.719999999999999 113.762 171.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -66.53 -39.53 88.66 Favored 'General case' 0 C--O 1.244 0.767 0 O-C-N 124.0 0.813 . . . . 26.030000000000001 111.784 178.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1181 ' ' ILE . . . . . . . . . . . . . 62.9 mt -57.03 -52.85 50.74 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 118.375 -0.821 . . . . 28.609999999999999 111.3 171.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -46.8 -61.85 4.07 Favored Glycine 0 C--N 1.346 1.106 0 O-C-N 126.148 2.155 . . . . 25.23 109.495 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -64.45 -47.27 79.67 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 121.799 0.809 . . . . 24.09 112.921 -171.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -64.67 -37.78 88.77 Favored 'General case' 0 CA--C 1.509 -0.632 0 O-C-N 121.04 -1.038 . . . . 26.68 112.483 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -66.38 -45.52 79.8 Favored 'General case' 0 C--O 1.252 1.208 0 C-N-CA 124.155 0.982 . . . . 36.57 110.009 176.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1186 ' ' SER . . . . . . . . . . . . . 69.1 m -58.29 -37.3 74.76 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 113.138 0.792 . . . . 28.920000000000002 113.138 173.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1187 ' ' LEU . . . . . . . . . . . . . 19.1 mt -69.49 -16.54 63.48 Favored 'General case' 0 C--O 1.249 1.03 0 N-CA-C 114.853 1.427 . . . . 29.09 114.853 173.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 80.42 52.38 4.52 Favored Glycine 0 C--O 1.251 1.187 0 O-C-N 119.151 -2.218 . . . . 29.260000000000002 109.168 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1189 ' ' ALA . . . . . . . . . . . . . . . -115.52 155.34 27.72 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 113.325 -1.438 . . . . 30.16 108.597 170.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 80.2 mt -81.48 94.89 2.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 103.413 -2.81 . . . . 35.810000000000002 103.413 -175.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1191 ' ' VAL . . . . . . . . . . . . . 23.8 t -71.0 121.8 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 C-N-CA 118.228 -1.389 . . . . 31.969999999999999 108.223 170.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1192 ' ' ARG . . . . . 0.401 HH12 ' CD ' ' B' 1248 ' ' GLU . 26.6 mmt85 -104.85 85.12 2.24 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 113.279 -1.782 . . . . 48.159999999999997 106.197 173.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -96.3 149.94 21.12 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 118.368 -2.708 . . . . 35.890000000000001 114.257 -165.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 20.2 t80 -147.54 153.4 39.43 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 120.397 -1.439 . . . . 41.880000000000003 108.615 -177.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1195 ' ' ASP . . . . . . . . . . . . . 8.9 t0 -162.97 159.9 24.06 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 103.409 -2.812 . . . . 38.280000000000001 103.409 167.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1196 ' ' THR . . . . . . . . . . . . . 4.7 m -65.48 -47.17 76.97 Favored 'General case' 0 N--CA 1.427 -1.611 0 C-N-CA 125.38 1.472 . . . . 40.619999999999997 108.203 171.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1197 ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -75.43 130.56 79.45 Favored Pre-proline 0 C--N 1.345 0.387 0 C-N-CA 124.14 0.976 . . . . 53.090000000000003 109.929 -171.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -58.01 -34.58 98.57 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.892 2.395 . . . . 42.560000000000002 117.522 -172.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -35.83 81.48 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.539 -1.351 . . . . 56.310000000000002 113.252 -150.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B 1200 ' ' VAL . . . . . . . . . . . . . 17.0 m -59.48 -22.36 22.81 Favored 'Isoleucine or valine' 0 C--O 1.249 1.076 0 CA-C-N 112.699 -2.046 . . . . 42.909999999999997 113.44 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 51.8 tttm -52.66 -45.94 66.95 Favored 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 124.665 1.186 . . . . 48.890000000000001 113.744 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -65.94 -31.17 71.93 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.823 0.82 . . . . 51.700000000000003 112.815 -176.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1203 ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -61.37 -48.76 79.8 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.945 -1.131 . . . . 52.57 107.945 172.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1204 ' ' VAL . . . . . . . . . . . . . 18.9 t -72.87 -33.91 44.96 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.222 0 CA-C-O 125.358 2.504 . . . . 33.789999999999999 110.606 -167.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -57.38 -52.25 66.11 Favored 'General case' 0 C--O 1.256 1.435 0 CA-C-N 112.997 -1.911 . . . . 36.579999999999998 110.47 168.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1206 ' ' SER . . . . . . . . . . . . . 17.7 m -62.62 -25.39 68.08 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 121.864 2.12 . . . . 39.609999999999999 112.135 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1207 ' ' MET . . . . . . . . . . . . . 20.4 mtp -75.04 -21.21 59.2 Favored 'General case' 0 C--N 1.359 0.988 0 N-CA-C 116.348 1.981 . . . . 37.450000000000003 116.348 172.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 74.7 52.76 6.94 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-O 125.354 2.641 . . . . 31.870000000000001 110.54 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -148.22 151.74 36.01 Favored 'General case' 0 C--O 1.25 1.118 0 N-CA-C 103.382 -2.821 . . . . 35.399999999999999 103.382 -173.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -89.61 126.71 35.72 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 119.602 1.092 . . . . 47.890000000000001 113.548 -169.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 59.4 t80 -85.52 115.96 23.54 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 103.501 -2.777 . . . . 45.530000000000001 103.501 169.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1212 ' ' LEU . . . . . . . . . . . . . 97.3 mt -70.27 93.31 0.83 Allowed 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 114.57 -1.196 . . . . 46.329999999999998 108.163 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -76.31 150.85 36.87 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 122.61 1.195 . . . . 60.409999999999997 111.23 172.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 97.2 mt -70.7 144.64 50.94 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 110.53 -3.032 . . . . 57.380000000000003 112.548 174.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 36.3 t0 . . . . . 0 N--CA 1.425 -1.68 0 O-C-N 125.445 1.716 . . . . 65.069999999999993 107.678 173.934 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B 1230 ' ' MET . . . . . . . . . . . . . 15.2 mmt . . . . . 0 N--CA 1.442 -0.836 0 N-CA-C 103.197 -2.89 . . . . 80.319999999999993 103.197 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B 1231 ' ' SER . . . . . . . . . . . . 0.324 66.8 m 75.53 132.8 0.05 OUTLIER 'General case' 0 C--O 1.212 -0.912 2 CA-C-N 129.98 5.809 . . . . 79.920000000000002 121.428 -0.032 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -70.29 -158.81 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.188 0 O-C-N 125.307 1.63 . . . . 77.909999999999997 111.096 -176.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 68.71 -52.9 0.56 Allowed 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 126.043 1.737 . . . . 73.879999999999995 110.969 -160.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 10.9 t80 -39.77 -51.57 2.36 Favored 'General case' 0 CA--C 1.5 -0.965 0 C-N-CA 127.96 2.504 . . . . 68.980000000000004 110.937 162.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 46.9 pt -52.4 -25.8 8.16 Favored 'Isoleucine or valine' 0 C--O 1.248 1.01 0 N-CA-C 115.84 1.793 . . . . 64.530000000000001 115.84 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -77.97 -48.31 16.54 Favored 'General case' 0 CA--C 1.511 -0.529 0 O-C-N 119.883 -1.761 . . . . 66.359999999999999 110.064 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -60.09 -36.15 76.76 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 123.978 0.911 . . . . 56.600000000000001 109.832 177.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -59.08 -62.11 2.13 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.259 -1.015 . . . . 56.789999999999999 108.259 171.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1239 ' ' MET . . . . . . . . . . . . . 20.3 mmt -59.26 -34.3 72.07 Favored 'General case' 0 C--O 1.222 -0.392 0 O-C-N 119.41 -2.056 . . . . 53.630000000000003 114.356 -173.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -46.33 -54.34 9.16 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 113.871 1.063 . . . . 51.740000000000002 113.871 168.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 48.8 tp -68.24 -49.16 62.56 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 112.488 -2.142 . . . . 44.859999999999999 106.38 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -64.95 -44.22 90.12 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 119.494 -2.004 . . . . 42.780000000000001 111.644 -172.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -65.73 -24.05 66.88 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 114.688 1.366 . . . . 40.960000000000001 114.688 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -76.63 -58.04 3.51 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 104.834 -2.284 . . . . 43.060000000000002 104.834 171.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 75.7 mm-40 -53.45 -30.32 40.05 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.901 1.281 . . . . 46.450000000000003 112.195 -173.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -57.67 -35.98 71.29 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.946 1.248 . . . . 41.780000000000001 113.003 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 31.4 tptt -67.04 -23.76 65.92 Favored 'General case' 0 C--O 1.241 0.637 0 O-C-N 119.369 -2.082 . . . . 52.200000000000003 113.6 176.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1248 ' ' GLU . . . . . 0.401 ' CD ' HH12 ' B' 1192 ' ' ARG . 20.8 mt-10 -95.12 -44.84 7.47 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 114.179 -1.373 . . . . 53.549999999999997 113.76 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B 1249 ' ' VAL . . . . . . . . . . . . . 29.0 m -77.99 143.13 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-O 126.352 2.977 . . . . 34.409999999999997 114.21 -162.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1250 ' ' ASP . . . . . 0.41 ' CG ' ' HZ2' ' B' 1276 ' ' LYS . 8.3 m-20 -100.05 -37.35 9.02 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 109.066 -3.697 . . . . 33.380000000000003 107.247 -177.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B 1251 ' ' ILE . . . . . . . . . . . . . 37.0 mm -128.98 125.64 63.2 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.755 0 O-C-N 119.789 -1.82 . . . . 29.539999999999999 107.083 176.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1252 ' ' ILE . . . . . . . . . . . . . 64.8 mt -103.34 109.2 26.27 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.734 0 N-CA-C 103.927 -2.62 . . . . 32.439999999999998 103.927 166.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1253 ' ' VAL . . . . . . . . . . . . . 95.4 t -84.76 82.31 1.86 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.976 0 N-CA-C 103.924 -2.621 . . . . 30.57 103.924 169.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1254 ' ' THR . . . . . . . . . . . . 0.283 2.8 t -84.13 91.16 7.62 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-O 127.243 3.402 . . . . 35.039999999999999 110.037 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B 1255 ' ' THR . . . . . . . . . . . . . 27.1 m -85.45 -71.24 0.54 Allowed 'General case' 0 C--O 1.242 0.703 0 CA-C-N 110.001 -3.272 . . . . 34.619999999999997 108.136 -175.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . 44.1 24.74 0.09 Allowed 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 120.973 3.694 . . . . 42.719999999999999 120.973 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 39.3 mt -66.2 112.25 3.85 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-O 123.255 1.502 . . . . 52.43 110.576 -172.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 55.6 mt -91.92 109.01 34.28 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 105.066 -2.198 . . . . 59.409999999999997 105.066 175.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -56.3 97.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 123.441 2.761 . . . . 62.68 114.864 -175.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 68.61 47.92 53.46 Favored Glycine 0 N--CA 1.466 0.652 0 N-CA-C 109.353 -1.499 . . . . 64.159999999999997 109.353 174.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 55.5 tttt -155.76 149.1 18.56 Favored Pre-proline 0 C--O 1.248 1.019 0 N-CA-C 102.258 -3.238 . . . . 68.530000000000001 102.258 168.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.53 132.22 37.09 Favored 'Trans proline' 0 C--N 1.364 1.376 0 C-N-CA 124.746 3.631 . . . . 61.990000000000002 112.765 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1263 ' ' ALA . . . . . . . . . . . . . . . -71.69 143.08 86.72 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-N 112.933 -1.94 . . . . 57.149999999999999 112.201 175.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -73.08 147.87 43.71 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 124.156 3.237 . . . . 51.57 116.003 -176.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -71.46 82.63 0.8 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 118.567 -2.583 . . . . 54.549999999999997 109.58 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 84.9 mt -71.3 -64.4 0.92 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.103 -1.408 . . . . 46.859999999999999 113.946 178.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1267 ' ' ILE . . . . . . . . . . . . . 26.5 mm -87.66 89.66 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 107.389 -1.337 . . . . 41.039999999999999 107.389 -170.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1268 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.86 150.64 47.56 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 111.504 -2.589 . . . . 39.579999999999998 116.51 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B 1269 ' ' ARG . . . . . . . . . . . . . 44.3 mtt85 -54.28 -44.27 71.76 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 114.516 1.302 . . . . 53.149999999999999 114.516 -169.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -57.53 -44.6 85.23 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.261 0.624 . . . . 42.960000000000001 112.551 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1271 ' ' MET . . . . . . . . . . . . . 30.1 ttm -58.91 -52.2 66.78 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 125.687 1.867 . . . . 43.890000000000001 109.966 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1272 ' ' VAL . . . . . . . . . . . . . 40.2 t -54.95 -47.09 76.67 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 C-N-CA 124.176 0.99 . . . . 38.369999999999997 108.618 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.99 -26.7 67.78 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 115.634 1.716 . . . . 47.460000000000001 115.634 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B 1274 ' ' SER . . . . . . . . . . . . . 3.2 p -92.42 -6.39 50.08 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 114.53 1.307 . . . . 38.380000000000003 114.53 174.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1275 ' ' MET . . . . . . . . . . . . . 11.2 ttt -67.02 159.72 28.06 Favored 'General case' 0 C--O 1.24 0.586 0 O-C-N 121.22 -0.925 . . . . 37.810000000000002 112.56 -176.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1276 ' ' LYS . . . . . 0.41 ' HZ2' ' CG ' ' B' 1250 ' ' ASP . 83.1 tttt -55.62 147.98 17.01 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 124.627 1.171 . . . . 49.259999999999998 113.059 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -76.35 150.15 36.89 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 108.195 -1.039 . . . . 34.460000000000001 108.195 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 68.28 26.59 74.12 Favored Glycine 0 N--CA 1.466 0.657 0 C-N-CA 125.006 1.289 . . . . 33.530000000000001 112.118 173.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1279 ' ' SER . . . . . . . . . . . . . 36.6 m -113.17 156.49 23.14 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 106.198 -1.779 . . . . 31.309999999999999 106.198 -171.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1280 ' ' VAL . . . . . . . . . . . . . 52.9 t -115.62 140.04 39.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 O-C-N 119.535 -1.978 . . . . 29.32 109.314 -171.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1281 ' ' ILE . . . . . . . . . . . . . 19.5 mt -109.27 105.18 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 104.953 -2.24 . . . . 31.93 104.953 165.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1282 ' ' VAL . . . . . . . . . . . . . 15.8 t -84.35 114.92 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 N-CA-C 101.078 -3.675 . . . . 29.48 101.078 176.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 45.7 t0 -97.98 96.62 8.29 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.208 -1.405 . . . . 34.5 107.208 175.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1284 ' ' LEU . . . . . . . . . . . . . 6.6 mp -68.48 -32.84 73.12 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 113.548 -1.66 . . . . 37.939999999999998 110.727 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -89.03 20.23 3.74 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 125.54 1.775 . . . . 40.920000000000002 112.35 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -48.48 -34.23 10.8 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 120.917 1.69 . . . . 44.390000000000001 115.062 177.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1287 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.56 -20.51 22.54 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 113.165 0.802 . . . . 51.460000000000001 113.165 175.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -91.21 -17.16 26.49 Favored 'General case' 0 C--O 1.215 -0.727 0 O-C-N 120.515 -1.366 . . . . 57.75 113.575 -177.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1289 ' ' GLY . . . . . . . . . . . . . . . 173.17 -19.55 0.06 OUTLIER Glycine 0 C--O 1.243 0.699 0 CA-C-O 116.82 -2.1 . . . . 49.850000000000001 112.97 177.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 74.89 88.3 0.23 Allowed Glycine 0 CA--C 1.524 0.65 0 CA-C-N 122.12 2.96 . . . . 45.93 108.806 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1291 ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -71.41 -30.58 66.27 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 123.015 1.388 . . . . 42.670000000000002 113.616 -173.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1292 ' ' CYS . . . . . . . . . . . . . 33.2 t -98.57 145.83 26.43 Favored 'General case' 0 C--O 1.241 0.619 0 O-C-N 121.445 -0.785 . . . . 38.82 109.134 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1293 ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -73.57 -35.85 65.52 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.463 -0.495 . . . . 46.710000000000001 111.07 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -72.94 -13.64 61.29 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.188 0.81 . . . . 47.229999999999997 113.188 -178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1295 ' ' THR . . . . . . . . . . . . . 98.1 m -53.39 102.39 0.06 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.992 0.738 . . . . 36.020000000000003 112.992 173.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 82.8 t -73.24 113.97 26.99 Favored Pre-proline 0 N--CA 1.429 -1.503 0 N-CA-C 104.298 -2.482 . . . . 37.259999999999998 104.298 158.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -62.01 131.06 33.13 Favored 'Trans proline' 0 CA--C 1.507 -0.868 0 C-N-CA 122.773 2.315 . . . . 35.090000000000003 114.125 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 81.07 8.78 86.99 Favored Glycine 0 CA--C 1.543 1.826 0 CA-C-O 118.174 -1.348 . . . . 35.969999999999999 110.692 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -143.61 172.5 12.72 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 120.82 2.31 . . . . 40.390000000000001 112.075 -173.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1300 ' ' ILE . . . . . . . . . . . . . 67.4 mt -101.11 148.1 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 103.848 -2.649 . . . . 37.43 103.848 170.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 65.3 t80 -123.7 125.21 44.36 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 101.561 -3.496 . . . . 44.130000000000003 101.561 164.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1302 ' ' THR . . . . . . . . . . . . . 90.8 m -98.03 110.72 23.24 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.476 -1.305 . . . . 39.780000000000001 107.476 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1303 ' ' THR . . . . . . . . . . . . . 40.5 p -72.62 162.48 29.43 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 113.515 0.932 . . . . 43.289999999999999 113.515 -174.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -53.7 -37.1 62.91 Favored 'General case' 0 C--N 1.354 0.789 0 O-C-N 120.338 -1.476 . . . . 53.07 112.085 173.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -77.81 12.71 1.6 Allowed 'General case' 0 C--N 1.349 0.555 0 O-C-N 120.192 -1.567 . . . . 43.969999999999999 114.437 174.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 72.13 34.89 61.14 Favored Glycine 0 CA--C 1.546 1.997 0 C-N-CA 119.078 -1.534 . . . . 41.119999999999997 111.879 173.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1307 ' ' VAL . . . . . . . . . . . . . 68.0 t -104.87 133.68 48.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 116.723 -3.81 . . . . 38.119999999999997 102.381 175.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1308 ' ' LYS . . . . . . . . . . . . . 41.7 mmtt -97.68 97.71 9.25 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 105.938 -1.875 . . . . 36.340000000000003 105.938 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1309 ' ' VAL . . . . . . . . . . . . . 21.8 t -85.62 92.22 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 N-CA-C 106.68 -1.6 . . . . 30.399999999999999 106.68 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1310 ' ' ILE . . . . . . . . . . . . . 56.8 mt -89.45 87.51 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 C-N-CA 124.615 1.166 . . . . 30.82 111.378 -177.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1311 ' ' GLY . . . . . . . . . . . . . . . -94.48 62.44 1.71 Allowed Glycine 0 C--O 1.245 0.839 0 N-CA-C 110.825 -0.91 . . . . 26.530000000000001 110.825 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1312 ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -83.0 99.27 9.73 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 124.02 1.866 . . . . 38.0 111.732 -176.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1313 ' ' THR . . . . . . . . . . . . . 26.9 m -51.76 -37.87 53.1 Favored 'General case' 0 C--O 1.255 1.365 0 C-N-CA 126.006 1.722 . . . . 29.800000000000001 113.226 170.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -81.09 17.57 1.22 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 116.292 1.96 . . . . 39.039999999999999 116.292 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1315 ' ' LEU . . . . . . . . . . . . . 42.9 mt -45.51 -46.76 36.27 Favored Pre-proline 0 C--O 1.254 1.323 0 N-CA-C 117.214 2.301 . . . . 31.079999999999998 117.214 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1316 ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -61.5 -33.03 88.55 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.244 2.629 . . . . 26.100000000000001 115.19 167.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -70.51 -40.69 67.49 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 118.447 -1.835 . . . . 23.170000000000002 112.608 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -60.84 -2.74 0.6 Allowed 'General case' 0 C--O 1.246 0.894 0 N-CA-C 118.384 2.735 . . . . 40.399999999999999 118.384 -174.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 3.3 tp -120.52 58.41 6.26 Favored Pre-proline 0 C--N 1.327 -0.38 0 O-C-N 118.843 -2.411 . . . . 23.600000000000001 107.003 -176.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1320 ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -54.19 -60.93 0.49 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 124.429 3.419 . . . . 22.350000000000001 117.588 -152.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1321 ' ' THR . . . . . . . . . . . . . 1.3 m -57.03 -49.81 74.67 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.504 1.502 . . . . 26.52 111.375 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1322 ' ' GLN . . . . . . . . . . . . . 39.1 tp60 -73.26 -33.81 65.47 Favored 'General case' 0 N--CA 1.435 -1.223 0 O-C-N 122.15 -0.344 . . . . 24.379999999999999 110.903 -172.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1323 ' ' SER . . . . . . . . . . . . . 68.3 m -57.84 -46.57 84.56 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 123.702 0.801 . . . . 22.800000000000001 112.488 165.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1324 ' ' SER . . . . . . . . . . . . . 15.7 m -69.48 -30.74 68.69 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 120.24 -1.538 . . . . 21.25 110.416 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -73.64 -36.54 65.43 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 121.093 1.77 . . . . 31.34 108.692 176.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1326 ' ' LEU . . . . . . . . . . . . . 11.3 mt -70.92 -58.21 3.81 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.871 1.669 . . . . 31.559999999999999 108.346 -175.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1327 ' ' TYR . . . . . . . . . . . . . 12.4 t80 -52.63 -45.25 66.55 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 125.44 1.496 . . . . 22.73 110.747 173.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1328 ' ' GLY . . . . . . . . . . . . . . . -51.87 -50.98 41.97 Favored Glycine 0 C--O 1.249 1.08 0 CA-C-O 118.951 -0.916 . . . . 21.91 111.552 170.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1329 ' ' THR . . . . . . . . . . . . . 8.5 m -66.87 -28.62 68.48 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 121.4 2.6 . . . . 22.149999999999999 109.377 -177.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1330 ' ' ASN . . . . . . . . . . . . . 10.1 m120 -60.86 -50.17 74.5 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.312 -0.868 . . . . 26.18 110.649 174.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1331 ' ' LEU . . . . . . . . . . . . . 18.7 mt -60.22 -36.76 78.42 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 126.904 2.081 . . . . 23.68 112.123 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1332 ' ' VAL . . . . . . . . . . . . . 20.9 t -65.15 -48.7 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 N-CA-C 107.301 -1.37 . . . . 26.57 107.301 175.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -59.63 -47.75 84.38 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 109.641 -0.503 . . . . 28.079999999999998 109.641 -174.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1334 ' ' LEU . . . . . . . . . . . . . 6.1 tt -56.25 -50.82 70.24 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 113.486 0.921 . . . . 27.43 113.486 170.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1335 ' ' LEU . . . . . . . . . . . . . 93.0 mt -64.88 -16.89 63.78 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 114.96 1.466 . . . . 30.5 114.96 177.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1336 ' ' LYS . . . . . . . . . . . . . 86.8 mttt -72.6 -46.28 55.01 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 120.256 1.389 . . . . 41.649999999999999 107.292 170.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 11.6 tp -64.63 -32.88 74.74 Favored 'General case' 0 N--CA 1.441 -0.91 0 O-C-N 120.329 -1.482 . . . . 42.079999999999998 110.731 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1338 ' ' LEU . . . . . . . . . . . . . 24.2 mt -73.2 -47.01 47.07 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 118.896 -0.573 . . . . 35.030000000000001 110.289 168.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1339 ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' B' 1344 ' ' GLY . 0.5 OUTLIER -88.3 81.95 7.17 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 121.522 1.964 . . . . 37.329999999999998 109.328 -175.171 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -27.56 66.85 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.7 -1.136 . . . . 50.509999999999998 112.207 -160.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -117.14 18.18 14.62 Favored 'General case' 0 C--O 1.242 0.703 0 O-C-N 123.949 0.781 . . . . 54.210000000000001 110.831 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1342 ' ' LYS . . . . . 0.431 ' HZ2' ' CD ' ' C' ' 98' ' ' GLU . 49.0 mttp 49.09 59.42 4.47 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 124.572 2.129 . . . . 50.990000000000002 109.303 -166.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -127.67 31.58 5.13 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 111.683 -2.508 . . . . 48.82 111.083 -165.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1344 ' ' GLY . . . . . 0.528 ' N ' ' SG ' ' B' 1339 ' ' CYS . . . 47.3 24.07 2.19 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 116.912 1.525 . . . . 40.43 116.912 175.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 40.0 t30 -127.28 151.12 49.15 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.775 -1.194 . . . . 47.560000000000002 107.775 -169.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1346 ' ' ILE . . . . . . . . . . . . . 32.9 mm -100.24 86.65 1.26 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 105.012 -2.218 . . . . 42.490000000000002 105.012 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1347 ' ' THR . . . . . . . . . . . . . 33.2 p -87.34 102.48 14.56 Favored 'General case' 0 C--O 1.241 0.632 0 O-C-N 118.157 -2.839 . . . . 38.119999999999997 109.839 164.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 61.0 t -90.84 111.89 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 107.094 -1.447 . . . . 37.5 107.094 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 23.6 t70 -97.69 127.92 44.0 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 106.051 -1.833 . . . . 43.850000000000001 106.051 172.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1350 ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.62 -0.12 46.27 Favored 'General case' 0 C--O 1.257 1.476 0 O-C-N 119.92 -1.737 . . . . 39.810000000000002 114.016 175.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -73.17 -37.21 66.63 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 121.441 1.928 . . . . 51.289999999999999 109.122 176.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 22.1 t0 -54.66 118.3 4.09 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 119.754 -0.779 . . . . 39.780000000000001 110.754 167.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 33.9 m -55.93 -31.18 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 O-C-N 123.868 0.73 . . . . 39.280000000000001 112.843 176.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1354 ' ' VAL . . . . . . . . . . . . . 83.7 t -70.37 -51.73 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 N-CA-C 106.637 -1.616 . . . . 35.700000000000003 106.637 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1355 ' ' ILE . . . . . . . . . . . . . 50.4 mm -62.27 -46.02 97.4 Favored 'Isoleucine or valine' 0 C--N 1.359 0.99 0 CA-C-N 121.82 2.1 . . . . 35.770000000000003 113.464 173.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 49.5 tpt85 -49.73 -33.63 16.7 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 114.505 1.298 . . . . 38.549999999999997 114.505 171.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -83.71 -54.16 3.17 Favored Glycine 0 C--N 1.343 0.963 0 N-CA-C 109.454 -1.458 . . . . 29.579999999999998 109.454 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1358 ' ' VAL . . . . . . . . . . . . . 14.8 p -62.95 -42.54 96.98 Favored 'Isoleucine or valine' 0 C--O 1.256 1.413 0 CA-C-O 121.916 0.865 . . . . 32.060000000000002 112.531 -173.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1359 ' ' THR . . . . . . . . . . . . . 3.6 m -83.83 81.96 8.54 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 124.13 1.919 . . . . 29.0 109.42 -174.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1360 ' ' VAL . . . . . . . . . . . . . 10.0 m -71.23 -16.98 19.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 113.022 -1.899 . . . . 29.68 113.907 -173.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 57.7 mt -134.98 110.22 12.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 N-CA-C 107.041 -1.466 . . . . 32.049999999999997 107.041 170.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1362 ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -98.74 110.43 23.03 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 104.99 -2.226 . . . . 32.520000000000003 104.99 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 48.26 60.77 3.39 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 112.922 -1.944 . . . . 35.68 113.528 172.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 83.58 -46.24 3.61 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 115.495 0.958 . . . . 34.259999999999998 115.495 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -64.62 124.56 22.21 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 119.277 -0.969 . . . . 51.07 111.802 172.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 69.7 mt -78.47 118.08 25.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 N-CA-C 103.265 -2.865 . . . . 39.869999999999997 103.265 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1367 ' ' THR . . . . . . . . . . . . . 1.4 p -107.03 11.57 29.56 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 113.883 -1.508 . . . . 38.009999999999998 112.039 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1368 ' ' TRP . . . . . . . . . . . . . 20.7 t90 -82.74 131.96 53.08 Favored Pre-proline 0 C--O 1.241 0.657 0 N-CA-C 103.531 -2.766 . . . . 42.140000000000001 103.531 164.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -82.23 171.89 53.15 Favored 'Cis proline' 0 C--N 1.353 0.812 0 N-CA-C 116.805 1.81 . . . . 43.259999999999998 116.805 -2.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1370 ' ' ALA . . . . . . . . . . . . . . . -113.74 130.14 24.07 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 105.712 -1.958 . . . . 46.520000000000003 105.712 173.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -62.73 106.36 0.51 Allowed 'Trans proline' 0 CA--C 1.552 1.419 0 C-N-CA 123.384 2.723 . . . . 51.950000000000003 108.671 173.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -65.66 140.56 62.68 Favored 'Trans proline' 0 N--CA 1.441 -1.579 0 C-N-CA 123.584 2.856 . . . . 56.270000000000003 119.118 -170.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1373 ' ' ILE . . . . . . . . . . . . . 14.9 tt -74.61 145.67 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 113.902 -1.499 . . . . 60.829999999999998 108.02 170.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -65.83 108.9 2.29 Favored 'General case' 0 C--N 1.317 -0.845 0 O-C-N 120.91 -1.119 . . . . 66.099999999999994 110.054 176.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 76.9 t -102.01 108.86 24.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 106.082 -1.822 . . . . 63.469999999999999 106.082 -169.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.23 -4.619 0 O-C-N 120.601 -1.312 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.274 0 CA-C-O 121.637 0.732 . . . . 0.0 112.4 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -58.09 -28.01 64.21 Favored 'General case' 0 C--O 1.251 1.162 0 O-C-N 119.141 -2.225 . . . . 0.0 114.1 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -66.08 -53.25 40.47 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 176.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 29.2 m -56.33 -34.11 66.27 Favored 'General case' 0 C--O 1.209 -1.064 0 C-N-CA 126.043 1.737 . . . . 0.0 112.516 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.32 -36.82 83.35 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.59 0.756 . . . . 0.0 112.089 174.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.78 -50.12 16.15 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.917 171.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.3 -43.62 64.58 Favored 'General case' 0 C--O 1.213 -0.867 0 C-N-CA 126.239 1.816 . . . . 0.0 113.175 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 81.1 mt -60.16 -51.23 70.49 Favored 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 118.63 -2.544 . . . . 0.0 115.315 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 28' ' ' LYS . . . . . 0.432 ' HZ3' ' C ' ' C' ' 186' ' ' LEU . 18.5 pttm -67.66 -17.41 64.58 Favored 'General case' 0 CA--C 1.555 1.169 0 O-C-N 121.113 -0.992 . . . . 0.0 110.022 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -75.21 -46.85 31.31 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 119.746 1.157 . . . . 0.0 111.048 164.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 38.9 m -50.28 -35.52 27.53 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 121.229 3.788 . . . . 0.0 121.229 -163.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . 0.4 3.7 p-80 54.32 -38.86 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 119.121 3.008 . . . . 0.0 119.121 -170.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 17.7 m -123.99 133.61 53.65 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 103.019 -2.956 . . . . 0.0 103.019 169.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 64.3 t -131.7 125.17 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 -174.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 34.4 mm -102.97 128.94 55.43 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 N-CA-C 103.467 -2.79 . . . . 0.0 103.467 172.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 31.8 mt -103.59 117.5 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 172.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 93.2 m -111.24 92.42 15.71 Favored Pre-proline 0 C--N 1.347 0.485 0 C-N-CA 124.255 1.022 . . . . 0.0 109.294 176.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -78.7 154.88 27.09 Favored 'Trans proline' 0 C--O 1.246 0.911 0 C-N-CA 123.614 2.876 . . . . 0.0 112.856 169.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.77 -143.78 3.79 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 109.766 -3.379 . . . . 0.0 105.096 174.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -61.34 -34.49 75.36 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 117.393 -1.289 . . . . 0.0 113.449 -168.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.08 -32.55 63.01 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-O 116.528 -2.262 . . . . 0.0 112.474 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 32.8 ttm -75.82 -26.13 56.94 Favored 'General case' 0 C--O 1.253 1.266 0 CA-C-N 119.556 1.678 . . . . 0.0 111.294 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.68 -38.82 58.39 Favored 'General case' 0 C--O 1.221 -0.443 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.274 175.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 59.9 t -74.95 -66.08 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 O-C-N 121.215 -0.928 . . . . 0.0 110.495 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -91.04 113.51 25.79 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 45' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -72.0 79.5 0.92 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 124.514 2.102 . . . . 0.0 110.265 -169.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.41 -6.13 22.92 Favored 'General case' 0 C--O 1.239 0.534 0 O-C-N 120.332 -1.48 . . . . 0.0 112.974 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.21 -41.81 48.19 Favored 'General case' 0 C--O 1.249 1.05 0 O-C-N 120.155 -1.591 . . . . 0.0 114.235 -159.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 48' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -61.34 -43.74 90.63 Favored Pre-proline 0 CA--C 1.55 0.971 0 O-C-N 119.964 -1.71 . . . . 0.0 113.352 168.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 49' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -54.34 -41.44 76.44 Favored 'Trans proline' 0 C--N 1.351 0.696 0 CA-C-N 124.069 2.489 . . . . 0.0 116.536 165.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 48.6 t -60.87 -41.58 89.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 O-C-N 119.971 -1.706 . . . . 0.0 112.509 175.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.08 -33.72 76.05 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 171.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -67.09 -39.41 86.76 Favored 'General case' 0 C--N 1.351 0.638 0 CA-C-O 118.284 -0.865 . . . . 0.0 113.277 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 10.2 tp -76.04 -37.27 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.718 0 CA-C-N 119.775 1.171 . . . . 0.0 110.429 175.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 26.1 m -64.78 -37.53 87.91 Favored 'General case' 0 C--O 1.244 0.814 0 O-C-N 120.219 -1.55 . . . . 0.0 112.889 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -34.12 -43.36 0.15 Allowed 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 126.808 2.043 . . . . 0.0 112.858 159.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -87.95 -44.57 10.93 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 120.254 1.388 . . . . 0.0 109.92 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 74.8 mt -62.91 -48.74 77.65 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 121.017 -1.052 . . . . 0.0 111.309 -167.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -72.38 -34.51 68.0 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 121.334 1.879 . . . . 0.0 108.901 -171.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.28 -19.42 54.87 Favored 'General case' 0 C--N 1.345 0.384 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 166.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 28.8 ttm-85 -94.35 14.14 21.4 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-O 120.96 0.409 . . . . 0.0 110.557 173.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.48 22.89 66.2 Favored Glycine 0 C--O 1.24 0.52 0 O-C-N 120.647 -1.283 . . . . 0.0 114.425 -177.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 15.0 mt -76.66 119.93 25.9 Favored 'Isoleucine or valine' 0 C--O 1.254 1.298 0 CA-C-O 122.062 0.934 . . . . 0.0 113.191 177.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -63.23 84.66 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.561 0 CA-C-O 123.935 1.826 . . . . 0.0 106.285 171.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 9.2 p -100.51 135.08 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 5.1 mmm-85 -137.84 140.06 40.26 Favored 'General case' 0 C--O 1.253 1.281 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -101.44 84.05 2.54 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -176.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.95 69.42 2.68 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.399 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 10.1 mt -70.07 142.3 16.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 120.763 -1.433 . . . . 0.0 112.772 -174.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -114.66 89.59 19.17 Favored Pre-proline 0 N--CA 1.475 0.794 0 O-C-N 120.277 -1.514 . . . . 0.0 107.054 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 70' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.84 -53.09 2.36 Favored 'Trans proline' 0 CA--C 1.513 -0.575 1 C-N-CA 125.504 4.136 . . . . 0.0 117.919 -163.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 51.8 t -67.26 104.79 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 168.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -171.89 119.26 0.43 Allowed 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 113.121 -1.854 . . . . 0.0 106.374 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.87 -97.82 2.08 Favored Glycine 0 C--O 1.213 -1.161 0 O-C-N 120.209 -1.557 . . . . 0.0 112.115 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -149.17 171.22 16.8 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 103.384 -2.821 . . . . 0.0 103.384 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . 0.268 33.0 mt 60.43 103.59 0.03 OUTLIER Pre-proline 0 C--O 1.236 0.385 0 N-CA-C 117.21 2.3 . . . . 0.0 117.21 -175.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -63.53 90.16 0.15 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.891 2.394 . . . . 0.0 112.137 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.08 -7.64 62.87 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-O 116.125 -2.486 . . . . 0.0 115.507 175.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -51.29 -28.01 10.88 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 123.733 3.766 . . . . 0.0 119.592 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -58.52 -32.27 68.69 Favored 'General case' 0 C--O 1.243 0.757 0 O-C-N 118.925 -2.359 . . . . 0.0 113.748 169.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -66.88 -37.79 85.07 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 122.586 0.354 . . . . 0.0 111.054 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 92.9 t -68.74 -42.76 83.12 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.718 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.383 -175.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 34.9 mt -53.56 -41.55 66.59 Favored 'General case' 0 C--N 1.35 0.619 0 C-N-CA 125.319 1.448 . . . . 0.0 113.144 170.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 21.4 tp -65.24 -46.4 80.74 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.181 0.991 . . . . 0.0 110.379 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.44 -35.26 77.08 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-O 118.107 -0.949 . . . . 0.0 112.38 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -64.51 -43.88 92.67 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.597 0.561 . . . . 0.0 112.283 173.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.35 -3.31 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 119.131 3.011 . . . . 0.0 119.131 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp 60.3 65.9 1.02 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 125.278 2.466 . . . . 0.0 112.184 -175.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 87.0 t -115.29 149.96 43.65 Favored Pre-proline 0 N--CA 1.481 1.1 0 CA-C-N 108.748 -3.842 . . . . 0.0 104.208 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -55.94 76.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.476 0.47 1 C-N-CA 127.178 5.252 . . . . 0.0 113.823 164.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -60.4 -30.24 69.47 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 113.062 -1.881 . . . . 0.0 107.004 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -39.02 -39.76 0.59 Allowed 'General case' 0 C--N 1.354 0.763 0 CA-C-O 116.359 -1.781 . . . . 0.0 115.436 168.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 2.3 pt -107.52 24.92 2.59 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 CA-C-O 124.034 1.873 . . . . 0.0 111.881 -176.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 53.4 t -87.52 128.68 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 O-C-N 120.623 -1.298 . . . . 0.0 109.304 174.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 4.7 mp -117.36 83.45 1.99 Allowed 'General case' 0 C--O 1.259 1.58 0 CA-C-O 123.644 1.688 . . . . 0.0 110.495 172.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -75.94 111.8 11.7 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 119.876 -1.765 . . . . 0.0 106.729 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 68.35 -9.08 0.54 Allowed 'General case' 0 C--O 1.251 1.182 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 173.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -68.09 -177.01 0.78 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 118.109 -0.948 . . . . 0.0 113.089 175.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . 0.431 ' CD ' ' HZ2' ' B' 1342 ' ' LYS . 83.9 mt-10 -77.22 57.84 1.51 Allowed 'General case' 0 C--O 1.24 0.603 0 CA-C-O 125.627 2.632 . . . . 0.0 117.168 -171.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 8.6 tp -77.75 -2.52 4.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 O-C-N 119.174 -2.204 . . . . 0.0 111.334 173.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -57.79 -45.33 86.18 Favored 'General case' 0 C--N 1.354 0.768 0 O-C-N 121.292 -0.88 . . . . 0.0 113.226 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -57.05 -43.19 81.74 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 122.936 1.35 . . . . 0.0 113.87 174.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -68.42 -24.32 64.73 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.853 -175.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 103' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -53.67 -43.48 68.89 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 116.078 -1.915 . . . . 0.0 111.23 167.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.7 -45.73 88.69 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 121.128 1.785 . . . . 0.0 111.066 173.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -57.26 -31.41 65.55 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 106' ' ' THR . . . . . . . . . . . . . 10.2 m -79.11 159.34 27.52 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-N 113.414 -1.721 . . . . 0.0 113.143 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 107' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -99.98 -84.76 0.41 Allowed 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 165.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 57.2 m -79.01 111.44 15.21 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 125.307 2.48 . . . . 0.0 116.535 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 109' ' ' VAL . . . . . . . . . . . . . 21.0 t -90.3 105.61 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 112.208 -2.269 . . . . 0.0 107.857 174.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 15.4 mt -71.55 87.79 0.91 Allowed 'General case' 0 C--O 1.25 1.125 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 173.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 89.9 t -82.29 83.07 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 O-C-N 120.277 -1.514 . . . . 0.0 109.862 178.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 56.0 mt -82.53 92.54 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 123.31 1.528 . . . . 0.0 110.185 -175.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 113' ' ' GLY . . . . . . . . . . . . . . . 57.95 29.61 62.32 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 110.513 -3.04 . . . . 0.0 113.681 175.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -82.66 -28.84 30.41 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 118.485 -1.286 . . . . 0.0 112.322 173.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 115' ' ' ASN . . . . . 0.517 ' ND2' ' H ' ' C' ' 116' ' ' ASP . 6.2 t30 64.93 -163.26 0.26 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 116.377 -1.773 . . . . 0.0 112.564 161.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 116' ' ' ASP . . . . . 0.517 ' H ' ' ND2' ' C' ' 115' ' ' ASN . 1.9 p30 -51.99 -14.48 0.4 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 125.31 3.687 . . . . 0.0 116.881 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 1.3 m -63.64 -14.07 48.37 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 169.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 21.3 m -106.55 12.96 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 117.242 -3.411 . . . . 0.0 112.871 167.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -102.15 131.81 22.22 Favored Pre-proline 0 N--CA 1.478 0.961 0 O-C-N 118.904 -2.372 . . . . 0.0 114.392 -166.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 120' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -50.89 -40.01 58.22 Favored 'Trans proline' 0 C--O 1.242 0.707 0 C-N-CA 123.939 3.093 . . . . 0.0 113.869 -178.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.87 -14.28 8.58 Favored 'General case' 0 C--O 1.208 -1.092 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 -167.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.98 -37.97 78.04 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 119.241 -2.162 . . . . 0.0 112.365 170.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -95.02 -41.38 9.17 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.369 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -67.77 -46.88 70.77 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 124.305 1.042 . . . . 0.0 111.129 -170.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -108.55 94.85 14.74 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 120.272 1.396 . . . . 0.0 109.264 172.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -49.58 -15.43 0.96 Allowed 'Trans proline' 0 C--O 1.257 1.451 1 C-N-CA 125.677 4.251 . . . . 0.0 112.362 172.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -68.06 -32.62 73.09 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 118.654 -2.528 . . . . 0.0 109.177 176.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 128' ' ' SER . . . . . . . . . . . . . 44.6 m -53.44 123.01 34.59 Favored Pre-proline 0 N--CA 1.449 -0.501 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 129' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -52.18 -39.72 70.78 Favored 'Trans proline' 0 N--CA 1.435 -1.93 1 C-N-CA 125.701 4.267 . . . . 0.0 115.076 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 28.4 pt -78.11 130.6 36.0 Favored 'Isoleucine or valine' 0 C--O 1.252 1.205 0 CA-C-N 120.615 1.552 . . . . 0.0 110.931 170.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -108.8 124.95 51.41 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-O 122.698 1.237 . . . . 0.0 113.396 -174.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.03 134.14 2.59 Favored Glycine 0 N--CA 1.474 1.225 0 CA-C-N 113.482 -1.69 . . . . 0.0 112.353 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 133' ' ' MET . . . . . . . . . . . . . 34.0 tpp -129.25 131.73 23.85 Favored Pre-proline 0 CA--C 1.506 -0.717 0 N-CA-C 104.932 -2.247 . . . . 0.0 104.932 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -57.54 149.93 63.7 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.748 2.299 . . . . 0.0 113.178 165.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 3.2 m -64.08 5.96 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.052 0 N-CA-C 119.054 2.983 . . . . 0.0 119.054 -168.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 27.6 mt -80.77 52.49 1.72 Allowed 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 120.193 -1.567 . . . . 0.0 110.199 171.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -82.22 96.37 7.84 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 -177.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 13.4 p -94.12 77.89 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 113.475 -1.693 . . . . 0.0 109.294 -171.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -131.79 165.76 23.07 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 173.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 140' ' ' LYS . . . . . . . . . . . . 0.29 0.8 OUTLIER 61.9 -24.01 0.05 OUTLIER 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 126.708 2.003 . . . . 0.0 113.777 173.79 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -52.51 153.91 2.83 Favored 'General case' 0 C--O 1.252 1.234 0 CA-C-N 123.017 2.644 . . . . 0.0 116.409 163.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -35.67 -44.69 0.33 Allowed 'General case' 0 C--N 1.354 0.8 0 N-CA-C 120.147 3.388 . . . . 0.0 120.147 -160.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 143' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -157.56 93.79 1.32 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 122.643 1.211 . . . . 0.0 112.967 162.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 144' ' ' VAL . . . . . . . . . . . . . 90.2 t -87.67 104.27 14.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 103.923 -2.621 . . . . 0.0 103.923 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 145' ' ' ILE . . . . . . . . . . . . . 3.7 tp -101.73 104.81 16.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 123.696 1.712 . . . . 0.0 111.748 -177.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 146' ' ' VAL . . . . . . . . . . . . . 27.2 t -91.51 98.83 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 O-C-N 119.658 -1.901 . . . . 0.0 109.453 -169.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 147' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -67.95 115.3 7.31 Favored 'General case' 0 C--O 1.249 1.079 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 148' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -155.5 137.09 14.2 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 149' ' ' ARG . . . . . 0.447 ' NH2' ' N6A' ' C' 1001 ' ' NAP . 7.3 tpp85 -48.41 -60.65 2.51 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 110.633 -2.985 . . . . 0.0 113.924 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 8.0 m -133.7 159.75 39.6 Favored 'General case' 0 CA--C 1.552 1.022 0 O-C-N 119.977 -1.702 . . . . 0.0 112.865 -171.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 10.7 tpt -67.51 93.81 0.37 Allowed 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 168.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -155.99 160.38 40.01 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.178 0.991 . . . . 0.0 109.259 -176.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 8.9 m -62.86 161.33 12.93 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.94 0.896 . . . . 0.0 112.997 175.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -106.8 -92.35 2.26 Favored Glycine 0 CA--C 1.508 -0.382 0 N-CA-C 105.49 -3.044 . . . . 0.0 105.49 153.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -114.92 -20.11 10.68 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 172.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 156' ' ' ALA . . . . . . . . . . . . . . . -103.32 -81.05 0.51 Allowed 'General case' 0 C--N 1.322 -0.614 0 O-C-N 119.121 -2.237 . . . . 0.0 110.703 168.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 88.71 -61.25 3.83 Favored Glycine 0 C--N 1.347 1.139 0 CA-C-N 121.594 1.997 . . . . 0.0 112.064 168.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 34.0 m -37.34 98.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-O 123.951 1.834 . . . . 0.0 115.465 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 35.72 34.62 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 120.515 3.524 . . . . 0.0 120.515 -174.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 160' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -70.75 118.65 67.03 Favored Pre-proline 0 C--N 1.347 0.491 0 CA-C-N 113.193 -1.822 . . . . 0.0 111.075 -170.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -46.64 -25.95 3.99 Favored 'Trans proline' 0 CA--C 1.509 -0.725 1 C-N-CA 126.007 4.471 . . . . 0.0 117.102 -172.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 162' ' ' LEU . . . . . . . . . . . . . 13.6 tp -50.71 -39.64 52.16 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 125.338 1.455 . . . . 0.0 113.529 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 163' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -84.6 -23.1 29.75 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 118.887 -1.125 . . . . 0.0 108.688 -172.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -102.67 -34.21 9.14 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 118.246 2.684 . . . . 0.0 118.246 -160.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -57.16 157.57 5.99 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 -175.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.5 -40.14 96.29 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -99.21 -22.98 15.38 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 119.292 0.951 . . . . 0.0 111.894 173.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 168' ' ' THR . . . . . . . . . . . . . 89.5 m -101.24 93.91 5.68 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.91 146.87 36.21 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.07 -1.052 . . . . 0.0 108.73 -171.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 170' ' ' MET . . . . . . . . . . . . . 30.8 mtm -62.16 130.49 45.69 Favored 'General case' 0 C--N 1.36 1.056 0 CA-C-O 123.94 1.829 . . . . 0.0 115.123 167.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 171' ' ' LEU . . . . . . . . . . . . . 20.8 tp -92.96 104.25 16.49 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 101.338 -3.578 . . . . 0.0 101.338 167.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -72.44 136.32 45.98 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 113.059 -1.882 . . . . 0.0 110.04 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . 128.66 166.64 12.02 Favored Glycine 0 N--CA 1.432 -1.589 0 CA-C-O 124.525 2.18 . . . . 0.0 110.113 -177.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 174' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -62.75 149.2 44.54 Favored 'General case' 0 C--O 1.252 1.198 0 CA-C-N 112.197 -2.001 . . . . 0.0 112.902 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.93 -53.44 57.27 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 121.421 -0.799 . . . . 0.0 113.02 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -62.49 -62.94 1.4 Allowed 'General case' 0 C--O 1.217 -0.623 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 177' ' ' ALA . . . . . . . . . . . . . . . -51.42 -36.38 43.53 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -176.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 14.7 m -68.6 -39.16 81.0 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 173.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 179' ' ' VAL . . . . . . . . . . . . . 5.7 t -74.47 -37.23 43.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 124.041 1.877 . . . . 0.0 109.239 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -58.89 -40.77 85.46 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-N 114.299 -1.318 . . . . 0.0 110.67 176.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.04 -29.34 69.67 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.611 175.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 182' ' ' ILE . . . . . . . . . . . . . 19.9 pt -101.07 -16.2 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 183' ' ' LEU . . . . . . . . . . . . 0.265 2.0 pp -48.29 -35.22 11.8 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 118.981 2.956 . . . . 0.0 118.981 -170.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -131.85 -21.21 2.46 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.909 171.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -88.23 60.24 5.65 Favored 'General case' 0 C--O 1.243 0.747 0 O-C-N 119.869 -1.77 . . . . 0.0 109.546 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 186' ' ' LEU . . . . . 0.432 ' C ' ' HZ3' ' C' ' 28' ' ' LYS . 1.7 pt? . . . . . 0 N--CA 1.436 -1.16 0 CA-C-O 114.698 -2.573 . . . . 0.0 113.962 176.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' NAD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C 1001 ' ' NAP . . . . . 0.447 ' N6A' ' NH2' ' C' ' 149' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 20.5 t-80 . . . . . 0 CA--C 1.488 -1.441 0 N-CA-C 108.418 -0.956 . . . . 65.739999999999995 108.418 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -72.05 86.71 0.48 Allowed Glycine 0 C--O 1.246 0.866 0 N-CA-C 108.839 -1.704 . . . . 48.659999999999997 108.839 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1002 ' ' ARG . . . . . 0.583 ' HD2' ' HB2' ' A' 1034 ' ' ALA . 50.4 ttp180 -118.85 131.38 56.07 Favored 'General case' 0 C--O 1.255 1.382 0 N-CA-C 105.49 -2.041 . . . . 44.560000000000002 105.49 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1003 ' ' ILE . . . . . 0.591 HD13 HD22 ' A' 1026 ' ' LEU . 96.9 mt -88.74 130.32 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 103.356 -2.831 . . . . 34.859999999999999 103.356 173.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -107.22 123.26 7.2 Favored Glycine 0 C--N 1.316 -0.579 0 N-CA-C 106.398 -2.681 . . . . 30.75 106.398 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.876 HG23 ' HB3' ' A' 1017 ' ' ALA . 39.5 mm -107.56 104.04 51.28 Favored Pre-proline 0 C--O 1.249 1.055 0 N-CA-C 102.832 -3.025 . . . . 32.210000000000001 102.832 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -83.01 161.31 15.74 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.973 2.449 . . . . 32.979999999999997 113.718 171.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1007 ' ' ARG . . . . . 0.426 ' NH2' ' HG2' ' A' 1009 ' ' ARG . 54.0 ttp85 -69.51 149.57 48.1 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 111.094 -2.776 . . . . 47.979999999999997 106.808 161.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1008 ' ' GLU . . . . . 0.477 ' HG2' ' HG2' ' A' 1013 ' ' GLU 0.297 13.9 tp10 -83.17 118.65 23.74 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 116.057 -2.257 . . . . 34.700000000000003 109.392 170.729 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 1009 ' ' ARG . . . . . 0.763 ' NH1' ' HG2' ' A' 1079 ' ' GLU . 14.5 mtp-105 -95.19 -3.91 46.89 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 109.635 -3.439 . . . . 53.369999999999997 112.371 -173.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 65.1 tp -65.24 132.61 49.53 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 105.53 -2.026 . . . . 45.07 105.53 167.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1011 ' ' THR . . . . . . . . . . . . . 5.2 m -55.41 123.01 12.5 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 125.525 1.53 . . . . 40.359999999999999 112.179 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 23.9 m120 58.41 28.92 17.5 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 118.259 2.689 . . . . 40.609999999999999 118.259 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1013 ' ' GLU . . . . . 0.477 ' HG2' ' HG2' ' A' 1008 ' ' GLU . 8.7 tp10 -89.7 147.08 24.07 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.441 -1.688 . . . . 33.759999999999998 106.441 167.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1014 ' ' THR . . . . . 0.512 HG22 ' HB3' ' A' 1320 ' ' PRO . 1.9 m -110.19 -4.54 15.7 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 113.574 0.954 . . . . 27.890000000000001 113.574 -170.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1015 ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -83.18 163.37 20.84 Favored 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 120.251 -1.53 . . . . 29.02 114.746 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1016 ' ' VAL . . . . . . . . . . . . . 12.5 p -121.49 162.06 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 103.782 -2.673 . . . . 28.129999999999999 103.782 159.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1017 ' ' ALA . . . . . 0.876 ' HB3' HG23 ' A' 1005 ' ' ILE . . . -61.09 -42.45 98.54 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 115.962 1.838 . . . . 26.870000000000001 115.962 -178.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -145.45 142.48 29.31 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 122.832 1.301 . . . . 26.77 110.255 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1019 ' ' THR . . . . . . . . . . . . . 8.2 p -84.77 161.19 54.09 Favored Pre-proline 0 N--CA 1.438 -1.071 0 O-C-N 118.877 -2.39 . . . . 27.02 108.468 171.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1020 ' ' PRO . . . . . 0.451 ' HB3' ' HB2' ' A' 1053 ' ' ALA . 0.0 OUTLIER -40.9 -45.31 4.97 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 123.706 2.937 . . . . 30.57 117.009 175.03 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -57.54 -41.05 80.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 123.753 1.739 . . . . 47.810000000000002 113.213 177.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1022 ' ' THR . . . . . 0.444 HG21 ' O ' ' A' 1325 ' ' GLN . 1.1 p -77.73 -32.5 52.85 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 114.191 1.182 . . . . 30.77 114.191 175.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1023 ' ' VAL . . . . . 0.584 ' HA ' HD12 ' A' 1026 ' ' LEU . 80.1 t -54.68 -44.96 72.44 Favored 'Isoleucine or valine' 0 C--N 1.345 0.385 0 O-C-N 121.257 -0.902 . . . . 33.590000000000003 110.815 170.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -48.62 -46.81 40.14 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.268 1.027 . . . . 53.289999999999999 111.184 172.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1025 ' ' GLN . . . . . 0.401 ' HB3' HG11 ' A' 1332 ' ' VAL . 40.6 mt-30 -64.66 -36.4 84.14 Favored 'General case' 0 N--CA 1.436 -1.144 0 O-C-N 123.563 0.54 . . . . 46.920000000000002 110.936 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1026 ' ' LEU . . . . . 0.591 HD22 HD13 ' A' 1003 ' ' ILE . 17.4 mt -66.15 -35.38 80.32 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 117.942 -1.027 . . . . 37.170000000000002 112.591 171.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.81 -43.55 98.03 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.75 1.159 . . . . 44.439999999999998 111.575 173.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 22.9 mmmt -57.7 -36.7 72.34 Favored 'General case' 0 C--O 1.217 -0.648 0 C-N-CA 123.671 0.788 . . . . 52.579999999999998 111.674 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1029 ' ' LEU . . . . . 0.547 HD12 ' HA ' ' A' 1026 ' ' LEU . 90.4 mt -58.48 -11.29 2.77 Favored 'General case' 0 C--O 1.249 1.03 0 N-CA-C 115.721 1.749 . . . . 45.689999999999998 115.721 173.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 88.21 22.91 39.41 Favored Glycine 0 CA--C 1.506 -0.516 0 O-C-N 118.115 -2.866 . . . . 42.090000000000003 112.345 170.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -113.76 162.47 16.26 Favored 'General case' 0 C--O 1.254 1.326 0 N-CA-C 105.905 -1.887 . . . . 40.719999999999999 105.905 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1032 ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -80.2 139.59 36.68 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 119.933 -1.73 . . . . 37.770000000000003 106.704 173.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1033 ' ' VAL . . . . . . . . . . . . . 11.0 t -121.54 127.18 75.57 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 O-C-N 117.803 -3.061 . . . . 33.539999999999999 108.187 -176.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1034 ' ' ALA . . . . . 0.583 ' HB2' ' HD2' ' A' 1002 ' ' ARG . . . -125.75 135.99 52.66 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 106.285 -1.746 . . . . 31.68 106.285 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1035 ' ' VAL . . . . . 0.489 HG22 ' HB ' ' A' 1005 ' ' ILE . 47.1 t -121.21 145.91 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 104.636 -2.357 . . . . 31.52 104.636 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1036 ' ' GLU . . . . . 0.696 ' HB3' ' HB2' ' A' 1039 ' ' ALA . 41.4 tt0 -58.89 154.36 15.32 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 119.52 -0.276 . . . . 41.039999999999999 111.584 173.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1037 ' ' SER . . . . . 0.465 ' OG ' ' HA ' ' A' 1059 ' ' GLU . 4.7 m -47.27 96.09 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 113.619 0.97 . . . . 31.829999999999998 113.619 173.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 61.25 38.87 96.37 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 114.674 -1.148 . . . . 29.359999999999999 112.669 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1039 ' ' ALA . . . . . 0.696 ' HB2' ' HB3' ' A' 1036 ' ' GLU . . . -52.43 -26.35 12.46 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 118.023 2.601 . . . . 27.780000000000001 118.023 -174.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1040 ' ' GLY . . . . . 0.461 ' H ' ' HE2' ' A' 1050 ' ' PHE . . . -91.69 13.0 67.85 Favored Glycine 0 N--CA 1.43 -1.731 0 CA-C-O 116.237 -2.424 . . . . 28.91 113.02 -175.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -62.67 -26.95 68.91 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 123.319 3.56 . . . . 51.18 113.482 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1042 ' ' LEU . . . . . . . . . . . . . 96.0 mt -54.94 -44.22 74.12 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 122.003 0.906 . . . . 29.91 110.915 167.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1043 ' ' ALA . . . . . 0.585 ' HA ' ' HB2' ' A' 1320 ' ' PRO . . . -104.1 35.84 2.55 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 114.303 -1.317 . . . . 28.539999999999999 109.491 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1044 ' ' SER . . . . . . . . . . . . . 3.0 m 65.8 0.36 1.5 Allowed 'General case' 0 C--O 1.239 0.548 0 N-CA-C 121.51 3.893 . . . . 33.060000000000002 121.51 172.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1045 ' ' PHE . . . . . 0.565 ' HD2' ' HB1' ' A' 1049 ' ' ALA . 86.3 m-85 -106.51 118.72 37.38 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 120.952 1.706 . . . . 30.289999999999999 114.15 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.9 -176.43 6.31 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 115.399 1.629 . . . . 48.619999999999997 115.399 178.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -43.55 -67.39 0.28 Allowed 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 125.642 1.838 . . . . 36.740000000000002 111.829 170.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 13.3 pttm -64.7 -24.15 67.48 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.347 0.976 . . . . 43.729999999999997 111.786 -172.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1049 ' ' ALA . . . . . 0.565 ' HB1' ' HD2' ' A' 1045 ' ' PHE . . . -63.48 -45.74 89.4 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.831 -1.174 . . . . 32.810000000000002 107.831 170.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1050 ' ' PHE . . . . . 0.461 ' HE2' ' H ' ' A' 1040 ' ' GLY . 87.3 m-85 -70.95 -23.03 62.15 Favored 'General case' 0 C--O 1.211 -0.931 0 O-C-N 120.275 -1.516 . . . . 31.859999999999999 110.847 173.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 78.5 t -69.39 -27.95 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 O-C-N 118.495 -2.628 . . . . 33.219999999999999 109.543 170.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -62.16 -45.63 92.55 Favored 'General case' 0 CA--C 1.509 -0.622 0 O-C-N 119.461 -2.024 . . . . 50.829999999999998 110.401 174.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1053 ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' 1020 ' ' PRO . . . -65.38 -38.07 88.9 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 115.86 -0.609 . . . . 33.119999999999997 111.705 172.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 99.16 69.21 0.91 Allowed Glycine 0 C--O 1.245 0.832 0 N-CA-C 105.485 -3.046 . . . . 35.829999999999998 105.485 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1055 ' ' ALA . . . . . 0.539 ' HB2' HG11 ' A' 1023 ' ' VAL . . . -119.7 138.03 53.55 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 113.662 -1.269 . . . . 34.82 108.059 176.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -66.13 124.63 23.14 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.474 -1.676 . . . . 49.049999999999997 106.474 171.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1057 ' ' ILE . . . . . 0.446 HG23 ' HA ' ' A' 1037 ' ' SER . 30.4 mm -90.23 98.77 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.25 0 O-C-N 117.699 -3.126 . . . . 38.530000000000001 107.792 177.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1058 ' ' VAL . . . . . 0.401 HG21 ' HA ' ' A' 1063 ' ' VAL . 2.5 m -79.81 123.23 36.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 125.44 2.543 . . . . 42.109999999999999 106.155 176.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1059 ' ' GLU . . . . . 0.465 ' HA ' ' OG ' ' A' 1037 ' ' SER . 6.4 mm-40 -76.7 82.91 3.33 Favored 'General case' 0 C--N 1.31 -1.126 1 CA-C-N 107.367 -4.469 . . . . 58.0 110.01 -174.41 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 75.51 -133.0 13.88 Favored Glycine 0 C--O 1.223 -0.589 0 N-CA-C 109.784 -1.326 . . . . 52.119999999999997 109.784 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 3.3 t30 -56.49 -25.66 51.95 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 117.427 2.38 . . . . 54.75 117.427 -161.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1062 ' ' SER . . . . . . . . . . . . . 70.5 m -55.66 -15.66 3.28 Favored 'General case' 0 C--O 1.25 1.113 0 O-C-N 120.012 -1.68 . . . . 50.340000000000003 113.125 174.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1063 ' ' VAL . . . . . 0.401 ' HA ' HG21 ' A' 1058 ' ' VAL . 14.8 p -57.17 -37.22 54.71 Favored 'Isoleucine or valine' 0 C--N 1.37 1.496 0 O-C-N 120.609 -1.307 . . . . 41.460000000000001 113.536 170.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1064 ' ' TRP . . . . . . . . . . . . . 97.9 m95 -70.2 -24.38 63.11 Favored 'General case' 0 N--CA 1.435 -1.216 0 O-C-N 125.525 1.766 . . . . 39.32 114.222 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -87.95 72.04 9.34 Favored 'General case' 0 C--O 1.246 0.883 0 N-CA-C 107.83 -1.174 . . . . 55.380000000000003 107.83 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1066 ' ' SER . . . . . . . . . . . . . 11.1 m -151.74 144.61 24.42 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-O 118.552 -0.737 . . . . 41.869999999999997 109.376 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.4 -12.28 60.22 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 119.03 2.974 . . . . 53.200000000000003 119.03 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1068 ' ' ILE . . . . . 0.43 ' HB ' ' HA ' ' A' 1003 ' ' ILE . 2.4 mp -127.06 124.66 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 104.241 -2.503 . . . . 41.899999999999999 104.241 167.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1069 ' ' ILE . . . . . 0.596 HG12 HG21 ' A' 1087 ' ' THR . 46.6 mm -119.08 111.14 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.069 0 N-CA-C 104.337 -2.468 . . . . 38.729999999999997 104.337 173.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1070 ' ' LEU . . . . . 0.668 HD13 HD13 ' A' 1331 ' ' LEU . 94.5 mt -90.22 85.17 6.17 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 105.665 -1.976 . . . . 32.439999999999998 105.665 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1071 ' ' LYS . . . . . 0.562 ' HE3' ' O ' ' A' 1073 ' ' ASN . 3.8 mmmt -81.79 145.83 30.24 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 107.049 -1.463 . . . . 34.649999999999999 107.049 -177.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1072 ' ' VAL . . . . . . . . . . . . . 2.6 t -86.89 -25.9 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-O 124.107 1.908 . . . . 31.32 111.871 -165.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1073 ' ' ASN . . . . . 0.562 ' O ' ' HE3' ' A' 1071 ' ' LYS . 61.9 m-20 -140.86 -173.82 3.82 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 105.694 -1.965 . . . . 33.939999999999998 105.694 168.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -52.0 142.7 25.72 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 116.734 2.124 . . . . 38.039999999999999 116.734 172.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1075 ' ' PRO . . . . . 0.539 ' HG2' HD21 ' A' 1089 ' ' LEU . 46.4 Cg_exo -63.77 119.21 6.18 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.652 2.902 . . . . 42.68 112.454 162.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 50.8 mt -71.31 158.45 36.32 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 113.036 -1.893 . . . . 46.740000000000002 107.098 161.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -57.88 -32.11 67.38 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 119.953 -1.717 . . . . 58.609999999999999 114.934 -172.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 14.2 t70 -44.85 -53.38 7.57 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 123.067 1.413 . . . . 59.200000000000003 111.858 164.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1079 ' ' GLU . . . . . 0.763 ' HG2' ' NH1' ' A' 1009 ' ' ARG . 18.2 mt-10 -78.2 -34.81 49.21 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.96 -1.018 . . . . 50.630000000000003 109.859 -174.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1080 ' ' ILE . . . . . . . . . . . . . 66.3 mt -49.13 -48.05 17.5 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 CA-C-O 123.169 1.461 . . . . 51.479999999999997 111.175 170.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -63.47 -38.65 91.94 Favored 'General case' 0 C--O 1.25 1.106 0 CA-C-N 113.73 -1.577 . . . . 50.280000000000001 110.332 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 87.2 mt -71.52 -24.64 61.99 Favored 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 120.922 -1.112 . . . . 50.210000000000001 113.765 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1083 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.27 161.36 29.41 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 120.211 1.369 . . . . 49.060000000000002 109.467 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -123.88 140.28 34.21 Favored Pre-proline 0 C--O 1.248 0.991 0 N-CA-C 105.399 -2.074 . . . . 51.079999999999998 105.399 -176.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1085 ' ' PRO . . . . . 0.447 ' HB3' ' HB3' ' A' 1109 ' ' ASN . 64.5 Cg_exo -56.08 155.16 24.83 Favored 'Trans proline' 0 N--CA 1.446 -1.277 1 C-N-CA 125.382 4.055 . . . . 49.729999999999997 113.64 175.437 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 81.58 -10.46 50.64 Favored Glycine 0 C--N 1.314 -0.65 0 O-C-N 121.158 -0.964 . . . . 47.710000000000001 112.296 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1087 ' ' THR . . . . . 0.596 HG21 HG12 ' A' 1069 ' ' ILE . 92.9 m -82.52 137.91 34.46 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 119.411 1.605 . . . . 45.469999999999999 110.187 -171.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1088 ' ' THR . . . . . 0.451 ' HA ' ' HB ' ' A' 1111 ' ' THR . 2.7 m -75.94 87.53 2.9 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 107.311 -1.366 . . . . 42.039999999999999 107.311 174.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1089 ' ' LEU . . . . . 0.539 HD21 ' HG2' ' A' 1075 ' ' PRO . 56.4 tp -82.62 97.08 8.32 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 122.733 1.254 . . . . 38.060000000000002 108.663 177.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1090 ' ' VAL . . . . . 0.564 HG22 ' HB2' ' A' 1113 ' ' MET . 96.7 t -97.52 116.3 39.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 102.679 -3.082 . . . . 37.399999999999999 102.679 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1091 ' ' SER . . . . . . . . . . . . . 1.9 m -153.94 160.98 42.32 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 120.325 1.42 . . . . 36.159999999999997 113.179 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1092 ' ' PHE . . . . . 0.434 ' HB2' ' HA ' ' A' 1073 ' ' ASN . 0.8 OUTLIER -58.79 97.51 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.757 0 O-C-N 119.434 -2.041 . . . . 38.939999999999998 111.305 154.281 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 1093 ' ' ILE . . . . . 0.42 HG13 ' CG1' ' A' 1112 ' ' VAL . 25.2 mm -96.47 -36.93 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 C-N-CA 123.115 0.566 . . . . 42.170000000000002 109.98 -175.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 45.8 m95 58.16 56.6 6.63 Favored Pre-proline 0 C--O 1.256 1.418 0 O-C-N 124.867 1.354 . . . . 46.509999999999998 110.98 -172.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -50.15 -39.41 51.58 Favored 'Trans proline' 0 CA--C 1.504 -1.001 0 C-N-CA 124.414 3.409 . . . . 49.759999999999998 116.364 -173.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -72.84 -24.59 60.91 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 120.004 1.275 . . . . 52.619999999999997 113.247 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -90.32 -11.76 39.76 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 122.279 1.037 . . . . 60.740000000000002 110.032 172.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1098 ' ' ASN . . . . . 0.409 ' HB3' ' HB3' ' A' 1101 ' ' LEU . 10.3 m120 -133.05 47.85 3.02 Favored Pre-proline 0 N--CA 1.451 -0.398 0 O-C-N 118.211 -2.806 . . . . 58.189999999999998 115.456 -174.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -55.31 -31.21 75.89 Favored 'Trans proline' 0 C--O 1.244 0.78 0 C-N-CA 124.664 3.576 . . . . 54.590000000000003 112.84 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1100 ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' 1104 ' ' LYS . 29.4 mp0 -61.46 -53.65 53.71 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.692 1.197 . . . . 63.280000000000001 109.971 175.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1101 ' ' LEU . . . . . 0.409 ' HB3' ' HB3' ' A' 1098 ' ' ASN . 24.2 tp -56.54 -40.64 75.43 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 124.027 0.931 . . . . 54.75 109.831 174.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1102 ' ' MET . . . . . . . . . . . . . 81.4 mmm -55.16 -50.72 68.58 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.929 1.24 . . . . 52.649999999999999 110.087 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -57.87 -39.95 79.02 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 124.96 1.304 . . . . 66.260000000000005 109.16 176.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1104 ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' 1100 ' ' GLU . 51.1 mtmt -71.72 -42.62 67.12 Favored 'General case' 0 C--N 1.313 -0.988 0 O-C-N 120.999 -1.063 . . . . 63.729999999999997 111.884 -176.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 68.3 mt -76.35 -21.28 56.32 Favored 'General case' 0 C--O 1.268 2.054 0 O-C-N 119.936 -1.728 . . . . 54.68 111.136 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -62.85 -42.54 99.79 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 120.646 -1.284 . . . . 53.640000000000001 111.759 167.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -62.47 -44.98 95.08 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 109.878 -0.415 . . . . 67.239999999999995 109.878 172.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.45 -2.79 12.07 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 117.055 -3.528 . . . . 65.760000000000005 114.347 174.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1109 ' ' ASN . . . . . 0.731 ' HA ' ' HA2' ' A' 1364 ' ' GLY . 2.1 t30 61.1 35.43 18.68 Favored 'General case' 0 C--O 1.247 0.942 0 O-C-N 118.984 -2.323 . . . . 58.710000000000001 113.717 169.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1110 ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.95 156.6 3.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 106.78 -1.563 . . . . 46.630000000000003 106.78 -171.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1111 ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' 1362 ' ' ARG . 53.9 m -81.62 97.32 7.81 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 105.878 -1.897 . . . . 44.130000000000003 105.878 165.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1112 ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' 1361 ' ' ILE . 42.7 t -95.55 111.69 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-O 123.584 1.659 . . . . 40.439999999999998 109.11 -177.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1113 ' ' MET . . . . . 0.564 ' HB2' HG22 ' A' 1090 ' ' VAL . 47.7 mtp -106.21 107.33 18.28 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 112.913 -1.948 . . . . 50.759999999999998 109.487 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1114 ' ' ALA . . . . . 0.46 ' HB3' ' HB2' ' A' 1117 ' ' SER . . . -87.64 105.44 17.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 126.338 2.97 . . . . 35.640000000000001 111.901 -177.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1115 ' ' MET . . . . . . . . . . . . . 74.2 mmm -60.19 -28.89 68.32 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 110.741 -2.936 . . . . 38.740000000000002 117.988 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -66.21 -44.17 84.65 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 113.293 -1.776 . . . . 40.140000000000001 109.737 167.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1117 ' ' SER . . . . . 0.46 ' HB2' ' HB3' ' A' 1114 ' ' ALA . 74.5 m -80.38 48.4 1.02 Allowed 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 118.509 2.781 . . . . 44.789999999999999 118.509 -175.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1118 ' ' VAL . . . . . . . . . . . . . 37.4 t -89.8 134.9 31.2 Favored Pre-proline 0 C--O 1.25 1.124 0 N-CA-C 107.112 -1.44 . . . . 43.75 107.112 173.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1119 ' ' PRO . . . . . 0.551 ' HG2' ' HA ' ' A' 1354 ' ' VAL . 0.5 OUTLIER -50.22 122.96 10.18 Favored 'Trans proline' 0 N--CA 1.459 -0.546 1 C-N-CA 125.688 4.259 . . . . 48.93 112.119 170.376 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 42.3 mmm-85 -75.31 61.1 1.17 Allowed 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 123.812 0.845 . . . . 62.899999999999999 111.905 -169.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 15.6 pt -116.78 167.65 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 O-C-N 118.042 -2.911 . . . . 57.719999999999999 110.733 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1122 ' ' SER . . . . . . . . . . . . . 4.2 p -39.0 -65.86 0.33 Allowed 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 117.592 2.442 . . . . 57.259999999999998 117.592 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -57.28 -33.29 67.48 Favored 'General case' 0 C--N 1.36 1.06 0 O-C-N 121.012 -1.055 . . . . 62.899999999999999 113.381 -176.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -82.17 -15.81 51.98 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-N 113.366 -1.743 . . . . 49.829999999999998 109.682 -169.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -56.02 -30.49 61.94 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 122.826 2.557 . . . . 52.369999999999997 114.159 -172.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1126 ' ' SER . . . . . . . . . . . . . 16.9 p -66.85 -31.73 72.54 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 122.715 1.245 . . . . 42.43 113.169 172.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1127 ' ' LEU . . . . . 0.411 HD21 HD12 ' A' 1337 ' ' LEU . 3.6 mp -83.65 -25.67 30.55 Favored 'General case' 0 C--N 1.346 0.436 0 O-C-N 121.197 -0.939 . . . . 43.740000000000002 111.971 172.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 62.0 t0 -69.84 89.32 0.57 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 123.736 1.731 . . . . 43.210000000000001 113.209 -172.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -67.92 -31.73 71.69 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 112.588 -2.096 . . . . 35.740000000000002 112.94 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 44.5 tp -54.18 -58.19 8.29 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 124.854 1.346 . . . . 38.090000000000003 108.702 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1131 ' ' SER . . . . . . . . . . . . . 7.0 m -69.77 -37.17 76.29 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 113.63 -1.623 . . . . 36.909999999999997 111.632 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1132 ' ' SER . . . . . . . . . . . . . 61.0 m -65.16 -38.27 90.04 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 123.048 2.658 . . . . 35.789999999999999 110.528 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1133 ' ' MET . . . . . . . . . . . . . 34.3 mmt -77.46 -40.16 44.11 Favored 'General case' 0 CA--C 1.489 -1.384 0 O-C-N 119.586 -1.946 . . . . 30.809999999999999 109.748 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1134 ' ' ALA . . . . . 0.604 ' HB1' ' HB2' ' A' 1176 ' ' ALA . . . -52.33 -43.16 64.41 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.094 0.557 . . . . 28.879999999999999 111.734 168.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1135 ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -63.93 -51.43 64.46 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.232 1.015 . . . . 40.759999999999998 109.796 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1136 ' ' ILE . . . . . 0.508 HD11 HD12 ' A' 1326 ' ' LEU . 94.0 mt -55.07 -42.62 65.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 114.838 -1.074 . . . . 31.539999999999999 113.343 171.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -66.54 -31.7 72.58 Favored 'General case' 0 C--O 1.219 -0.544 0 C-N-CA 124.709 1.203 . . . . 29.870000000000001 112.645 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -66.08 -50.5 51.41 Favored Glycine 0 C--O 1.216 -1.019 0 O-C-N 120.048 -1.657 . . . . 28.73 110.408 176.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 19.6 t80 -55.58 -47.11 76.97 Favored 'General case' 0 C--O 1.248 0.98 0 C-N-CA 124.187 0.995 . . . . 30.390000000000001 109.377 172.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1140 ' ' ARG . . . . . 0.476 ' HE ' ' HG2' ' A' 1144 ' ' GLU . 5.4 tpt180 -68.66 -24.45 64.53 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 114.171 1.174 . . . . 26.09 114.171 177.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1141 ' ' ALA . . . . . 0.466 ' HB2' HD21 ' A' 1284 ' ' LEU . . . -71.32 -40.35 70.84 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 121.572 1.987 . . . . 27.100000000000001 106.817 176.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 19.7 mm -63.1 -41.03 91.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.399 -0.593 . . . . 28.48 109.399 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 54.9 t -54.97 -64.85 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.607 0 C-N-CA 123.24 0.616 . . . . 23.07 111.534 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1144 ' ' GLU . . . . . 0.476 ' HG2' ' HE ' ' A' 1140 ' ' ARG . 6.1 mm-40 -68.36 -19.64 64.65 Favored 'General case' 0 C--O 1.244 0.785 0 O-C-N 120.336 -1.477 . . . . 33.399999999999999 113.253 -175.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1145 ' ' ALA . . . . . 0.735 ' HA ' HG11 ' A' 1280 ' ' VAL . . . -62.65 -56.96 12.98 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 107.154 -1.425 . . . . 24.219999999999999 107.154 164.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -59.75 -20.48 56.88 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 117.477 -3.265 . . . . 24.890000000000001 112.655 175.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 29.1 t-80 -66.73 -38.43 86.65 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 117.901 -3.0 . . . . 26.73 111.06 174.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1148 ' ' GLU . . . . . 0.753 ' HB3' ' HD2' ' A' 1308 ' ' LYS . 59.2 mm-40 -109.21 0.07 19.5 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 115.533 1.679 . . . . 39.960000000000001 115.533 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1149 ' ' PHE . . . . . 0.476 ' CZ ' ' HB3' ' A' 1250 ' ' ASP . 1.3 t80 -68.19 148.29 51.07 Favored 'General case' 0 C--O 1.246 0.888 0 O-C-N 120.988 -1.07 . . . . 25.870000000000001 108.709 -174.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1150 ' ' GLY . . . . . 0.635 ' HA2' ' HG2' ' B' 1320 ' ' PRO . . . -72.81 -40.37 52.72 Favored Glycine 0 N--CA 1.438 -1.197 0 C-N-CA 118.633 -1.746 . . . . 19.280000000000001 112.044 173.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1151 ' ' ARG . . . . . 0.803 ' HA ' ' HB2' ' B' 1322 ' ' GLN . 23.9 mtm-85 -108.21 -177.91 3.46 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.236 -1.155 . . . . 39.899999999999999 113.845 -166.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1152 ' ' PHE . . . . . 0.609 ' HB2' HG11 ' A' 1163 ' ' VAL . 2.1 m-30 -81.96 154.25 25.84 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 116.562 -2.055 . . . . 29.440000000000001 109.887 168.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1153 ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -70.47 -57.43 4.79 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 124.244 1.973 . . . . 32.600000000000001 107.177 156.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1154 ' ' THR . . . . . . . . . . . . . 3.5 m -60.16 92.24 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 110.562 -3.017 . . . . 34.640000000000001 111.425 -175.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -60.35 128.47 45.79 Favored Glycine 0 C--N 1.344 1.01 0 O-C-N 120.3 -1.5 . . . . 37.140000000000001 112.611 175.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1156 ' ' GLN . . . . . 0.449 ' H ' ' HB ' ' A' 1163 ' ' VAL . 3.7 pt20 -159.49 137.57 10.32 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 113.896 1.072 . . . . 40.57 113.896 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1157 ' ' ILE . . . . . 0.533 ' HB ' ' HB3' ' C' ' 95' ' ' GLU . 5.2 tp -80.36 125.15 39.02 Favored 'Isoleucine or valine' 0 C--O 1.257 1.491 0 N-CA-C 102.891 -3.003 . . . . 44.609999999999999 102.891 169.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1158 ' ' THR . . . . . 0.433 ' O ' ' HG3' ' C' ' 70' ' ' PRO . 56.0 p -98.44 -173.3 2.52 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 113.394 -1.73 . . . . 40.700000000000003 106.607 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -72.02 -19.0 61.92 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 121.48 1.945 . . . . 40.25 109.562 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1160 ' ' ALA . . . . . 0.448 ' HB2' ' ND2' ' B' 1330 ' ' ASN . . . -103.91 -47.81 4.09 Favored 'General case' 0 C--O 1.249 1.038 0 CA-C-N 119.972 1.26 . . . . 38.469999999999999 113.888 172.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . -148.54 162.01 28.76 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 117.723 -2.179 . . . . 37.609999999999999 114.693 -159.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 26.9 tttt -79.95 124.01 28.31 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 123.188 1.47 . . . . 48.899999999999999 113.318 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1163 ' ' VAL . . . . . 0.609 HG11 ' HB2' ' A' 1152 ' ' PHE . 79.4 t -95.29 117.0 66.81 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 105.962 -1.866 . . . . 36.520000000000003 105.962 165.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1164 ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -71.27 140.62 37.51 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.636 2.224 . . . . 35.079999999999998 112.753 172.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1165 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -59.0 125.63 18.72 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 CA-C-N 122.258 1.842 . . . . 35.329999999999998 112.861 169.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -63.85 140.57 58.88 Favored 'General case' 0 C--O 1.244 0.814 0 N-CA-C 114.773 1.398 . . . . 34.689999999999998 114.773 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1167 ' ' LYS . . . . . . . . . . . . . 79.4 mttt -88.21 113.13 23.52 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 119.845 1.202 . . . . 45.359999999999999 113.061 170.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 64.9 t -101.99 115.5 43.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.063 -1.088 . . . . 31.710000000000001 108.063 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1169 ' ' MET . . . . . 0.449 ' O ' ' HA ' ' A' 1252 ' ' ILE . 12.4 ttt -100.03 113.75 26.57 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 121.75 2.068 . . . . 42.280000000000001 109.24 170.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1170 ' ' VAL . . . . . 0.409 HG21 HG13 ' A' 1181 ' ' ILE . 68.9 t -82.92 128.69 38.48 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 N-CA-C 105.919 -1.882 . . . . 30.510000000000002 105.919 169.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 42.3 mt -119.55 136.46 56.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 O-C-N 119.63 -1.919 . . . . 31.870000000000001 106.068 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1172 ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' 1256 ' ' ALA . . . 74.91 58.26 4.12 Favored Glycine 0 CA--C 1.539 1.587 0 N-CA-C 110.043 -1.223 . . . . 34.539999999999999 110.043 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1173 ' ' ALA . . . . . . . . . . . . . . . -72.28 85.1 1.07 Allowed 'General case' 0 C--O 1.259 1.555 0 CA-C-O 122.487 1.137 . . . . 32.509999999999998 113.867 -166.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -76.16 -175.11 38.87 Favored Glycine 0 CA--C 1.554 2.498 0 N-CA-C 108.325 -1.91 . . . . 29.899999999999999 108.325 163.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1175 ' ' VAL . . . . . . . . . . . . . 79.2 t -59.42 -37.12 68.04 Favored 'Isoleucine or valine' 0 C--O 1.25 1.125 0 CA-C-N 118.49 1.145 . . . . 33.109999999999999 110.621 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1176 ' ' ALA . . . . . 0.604 ' HB2' ' HB1' ' A' 1134 ' ' ALA . . . -52.52 -42.42 64.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.322 -1.308 . . . . 28.100000000000001 114.333 169.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -64.94 -40.13 96.98 Favored Glycine 0 CA--C 1.545 1.91 0 N-CA-C 110.014 -1.234 . . . . 28.539999999999999 110.014 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1178 ' ' LEU . . . . . 0.711 HD13 ' HG2' ' A' 1203 ' ' GLN . 69.6 mt -63.31 -48.38 78.3 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.704 -0.85 . . . . 31.219999999999999 108.704 178.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -64.44 -34.18 77.59 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 120.259 -1.526 . . . . 28.98 114.937 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -57.95 -40.78 81.36 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 115.82 1.785 . . . . 27.829999999999998 115.82 171.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1181 ' ' ILE . . . . . 0.722 ' HA ' HG11 ' A' 1191 ' ' VAL . 96.7 mt -56.96 -49.15 80.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.507 -0.77 . . . . 30.25 111.672 169.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -58.08 -40.63 93.8 Favored Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 111.313 -0.715 . . . . 29.59 111.313 175.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -67.43 -52.43 39.81 Favored 'General case' 0 C--O 1.243 0.728 0 O-C-N 119.51 -2.17 . . . . 30.289999999999999 112.906 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -58.6 -40.44 83.25 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-O 122.962 1.363 . . . . 30.469999999999999 111.64 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 2.5 t30 -62.48 -43.51 98.64 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 114.932 -1.031 . . . . 42.409999999999997 112.592 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1186 ' ' SER . . . . . 0.817 ' HB3' ' HA ' ' B' 1187 ' ' LEU . 43.9 m -58.16 -50.8 72.26 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 123.985 0.914 . . . . 39.380000000000003 109.566 172.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 29.5 mt -60.48 -18.76 53.72 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 116.975 2.213 . . . . 36.18 116.975 171.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 97.34 33.33 5.99 Favored Glycine 0 C--N 1.356 1.664 0 CA-C-N 121.876 2.125 . . . . 33.780000000000001 112.418 174.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -99.92 155.82 17.47 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 123.249 0.62 . . . . 33.93 112.478 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 34.2 mt -79.26 103.29 6.05 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.462 0 N-CA-C 104.31 -2.478 . . . . 38.740000000000002 104.31 175.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1191 ' ' VAL . . . . . 0.722 HG11 ' HA ' ' A' 1181 ' ' ILE . 1.4 t -93.92 148.74 4.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 N-CA-C 106.556 -1.646 . . . . 33.090000000000003 106.556 -172.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1192 ' ' ARG . . . . . 0.59 ' HG2' ' HB2' ' A' 1210 ' ' GLU . 90.2 mtt180 -141.76 158.76 43.41 Favored 'General case' 0 C--O 1.252 1.2 0 C-N-CA 124.647 1.179 . . . . 38.920000000000002 108.39 176.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1193 ' ' ALA . . . . . 0.562 ' HB2' HD11 ' A' 1181 ' ' ILE . . . -152.24 148.3 27.41 Favored 'General case' 0 C--O 1.25 1.106 0 N-CA-C 114.405 1.261 . . . . 35.32 114.405 176.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 42.3 t80 -138.23 147.64 43.94 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 113.705 -1.589 . . . . 39.350000000000001 107.648 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 10.5 t70 -170.78 167.51 7.61 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 103.109 -2.923 . . . . 40.460000000000001 103.109 170.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1196 ' ' THR . . . . . . . . . . . . . 4.0 m -69.92 -43.16 72.25 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 125.015 1.326 . . . . 45.939999999999998 110.068 175.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1197 ' ' ARG . . . . . 0.441 ' HA ' ' HD2' ' A' 1198 ' ' PRO . 39.6 mtm180 -79.49 112.74 31.21 Favored Pre-proline 0 C--O 1.222 -0.357 0 N-CA-C 114.951 1.463 . . . . 56.020000000000003 114.951 -165.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1198 ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' 1197 ' ' ARG . 57.4 Cg_endo -58.39 -20.88 50.58 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.722 2.281 . . . . 51.270000000000003 117.666 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -55.68 -25.53 40.21 Favored 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 117.01 2.226 . . . . 59.100000000000001 117.01 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 27.7 m -87.55 -14.14 10.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 114.729 1.381 . . . . 51.060000000000002 114.729 -175.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 90.8 mttt -62.98 -38.79 92.56 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.123 -0.944 . . . . 57.380000000000003 113.443 -169.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -56.38 -48.68 76.36 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 124.638 1.211 . . . . 62.409999999999997 110.707 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1203 ' ' GLN . . . . . 0.711 ' HG2' HD13 ' A' 1178 ' ' LEU . 4.7 tp60 -65.35 -44.34 87.99 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 124.918 1.386 . . . . 57.780000000000001 110.579 175.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1204 ' ' VAL . . . . . 0.457 HG11 ' HD2' ' A' 1211 ' ' PHE . 54.1 t -55.49 -47.02 78.99 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 CA-C-N 121.083 1.765 . . . . 46.380000000000003 111.323 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -66.11 -36.09 82.25 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-N 115.008 -0.997 . . . . 50.700000000000003 110.037 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1206 ' ' SER . . . . . . . . . . . . . 59.8 m -71.2 -51.04 26.96 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 112.724 0.639 . . . . 49.979999999999997 112.724 -176.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1207 ' ' MET . . . . . . . . . . . . . 45.7 mtp -68.35 -25.78 65.26 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 123.499 0.499 . . . . 52.990000000000002 111.008 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 131.3 68.14 0.1 OUTLIER Glycine 0 N--CA 1.475 1.289 0 O-C-N 120.018 -1.677 . . . . 47.659999999999997 113.27 156.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1209 ' ' ALA . . . . . 0.474 ' HB2' HG23 ' A' 1181 ' ' ILE . . . -155.46 161.88 40.86 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 122.683 1.23 . . . . 44.770000000000003 113.173 -174.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1210 ' ' GLU . . . . . 0.59 ' HB2' ' HG2' ' A' 1192 ' ' ARG . 42.0 mt-10 -89.97 113.86 25.6 Favored 'General case' 0 C--N 1.318 -0.787 0 O-C-N 118.961 -2.337 . . . . 47.640000000000001 108.313 173.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1211 ' ' PHE . . . . . 0.457 ' HD2' HG11 ' A' 1204 ' ' VAL . 21.7 t80 -84.3 115.32 22.42 Favored 'General case' 0 N--CA 1.432 -1.375 0 C-N-CA 117.885 -1.526 . . . . 45.659999999999997 107.229 173.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 37.1 mt -71.01 116.42 11.28 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 125.955 1.702 . . . . 46.060000000000002 108.682 -176.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -69.44 144.72 53.22 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 118.444 -1.302 . . . . 60.219999999999999 112.84 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1214 ' ' LEU . . . . . 0.704 ' HG ' ' HB2' ' A' 1216 ' ' PHE . 66.6 tp -62.55 95.39 0.07 Allowed 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 113.589 -1.641 . . . . 57.25 109.72 167.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 16.3 t70 -69.45 90.67 0.54 Allowed 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 105.403 -2.073 . . . . 64.430000000000007 105.403 172.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1216 ' ' PHE . . . . . 0.704 ' HB2' ' HG ' ' A' 1214 ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.303 -1.428 0 O-C-N 126.325 2.265 . . . . 66.900000000000006 106.898 -172.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.429 -1.482 0 CA-C-O 122.174 0.988 . . . . 39.090000000000003 108.962 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -59.81 -38.66 94.31 Favored Glycine 0 CA--C 1.543 1.796 0 O-C-N 120.529 -1.357 . . . . 39.32 114.227 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 68.0 t80 -65.88 -46.35 78.72 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 117.336 0.568 . . . . 39.299999999999997 111.973 170.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -59.53 -49.46 77.68 Favored 'General case' 0 C--N 1.349 0.556 0 O-C-N 121.96 -0.463 . . . . 36.299999999999997 109.995 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -50.99 -56.98 9.81 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-O 117.432 -1.271 . . . . 37.380000000000003 111.973 168.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -51.91 -30.42 12.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 118.261 2.689 . . . . 39.109999999999999 118.261 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1230 ' ' MET . . . . . . . . . . . . . 38.7 mmt -79.21 -28.86 42.59 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 113.079 0.77 . . . . 49.590000000000003 113.079 174.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1231 ' ' SER . . . . . 0.509 ' O ' ' HB3' ' A' 1234 ' ' PHE . 23.1 m -58.21 140.43 53.09 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 117.142 2.275 . . . . 43.68 117.142 -169.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -58.96 -49.79 76.51 Favored 'General case' 0 C--O 1.214 -0.78 0 N-CA-C 116.251 1.945 . . . . 55.57 116.251 175.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -61.44 -25.44 67.22 Favored 'General case' 0 C--O 1.206 -1.19 0 N-CA-C 112.487 0.551 . . . . 44.939999999999998 112.487 174.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1234 ' ' PHE . . . . . 0.509 ' HB3' ' O ' ' A' 1231 ' ' SER . 70.7 t80 -69.22 -49.59 55.03 Favored 'General case' 0 N--CA 1.428 -1.569 0 O-C-N 124.299 0.999 . . . . 42.039999999999999 110.031 175.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 63.1 mt -62.05 -33.86 60.47 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 O-C-N 123.437 0.46 . . . . 46.280000000000001 111.982 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1236 ' ' LYS . . . . . 0.565 ' O ' ' HG3' ' A' 1240 ' ' GLU . 48.3 tttm -57.5 -53.12 61.72 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 118.085 -0.96 . . . . 47.869999999999997 111.049 164.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -60.43 -40.4 90.91 Favored 'General case' 0 C--O 1.259 1.558 0 N-CA-C 113.729 1.011 . . . . 41.609999999999999 113.729 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -57.13 -52.39 65.5 Favored 'General case' 0 C--O 1.254 1.321 0 O-C-N 121.557 -0.714 . . . . 50.649999999999999 109.567 173.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1239 ' ' MET . . . . . 0.541 ' SD ' ' HD2' ' A' 1242 ' ' PHE . 92.9 mmm -62.43 -25.14 67.81 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 113.586 0.958 . . . . 48.869999999999997 113.586 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1240 ' ' GLU . . . . . 0.565 ' HG3' ' O ' ' A' 1236 ' ' LYS . 34.7 mt-10 -71.45 -42.73 67.82 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 119.952 1.251 . . . . 54.799999999999997 111.596 168.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 2.3 mm? -59.0 -45.18 91.3 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 119.495 -2.003 . . . . 43.210000000000001 108.098 172.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1242 ' ' PHE . . . . . 0.541 ' HD2' ' SD ' ' A' 1239 ' ' MET . 12.3 m-30 -62.49 -46.17 89.7 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 125.478 1.511 . . . . 38.659999999999997 111.486 178.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -61.49 -39.83 92.39 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 123.589 1.662 . . . . 37.920000000000002 111.588 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1244 ' ' ALA . . . . . 0.442 ' HA ' ' NZ ' ' A' 1247 ' ' LYS . . . -65.11 -53.31 47.28 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 120.353 -1.467 . . . . 37.280000000000001 111.464 177.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -66.46 -31.16 71.73 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 120.825 -1.172 . . . . 43.07 112.662 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -53.37 -34.36 57.3 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 123.288 0.635 . . . . 38.299999999999997 112.099 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1247 ' ' LYS . . . . . 0.442 ' NZ ' ' HA ' ' A' 1244 ' ' ALA . 30.3 mtmm -67.42 -29.0 68.37 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.139 -0.937 . . . . 47.600000000000001 113.054 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -114.9 -37.1 4.26 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 114.195 1.183 . . . . 45.420000000000002 114.195 -168.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1249 ' ' VAL . . . . . . . . . . . . . 20.7 m -68.94 166.9 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.863 0 CA-C-O 123.624 1.678 . . . . 36.259999999999998 114.967 -166.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1250 ' ' ASP . . . . . 0.476 ' HB3' ' CZ ' ' A' 1149 ' ' PHE . 9.7 m-20 -123.68 -43.24 2.15 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 110.935 -2.848 . . . . 33.039999999999999 109.439 -172.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1251 ' ' ILE . . . . . 0.592 HD12 ' HB1' ' A' 1145 ' ' ALA . 48.4 mm -123.84 138.28 54.09 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.878 0 O-C-N 118.811 -2.43 . . . . 31.399999999999999 105.445 174.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1252 ' ' ILE . . . . . 0.737 ' HB ' HG12 ' A' 1281 ' ' ILE . 19.8 mt -114.44 130.95 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 106.351 -1.722 . . . . 29.420000000000002 106.351 162.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 13.4 t -110.22 106.49 20.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 O-C-N 121.14 -0.975 . . . . 30.370000000000001 109.222 172.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1254 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.06 108.88 20.0 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 125.022 2.344 . . . . 35.719999999999999 110.802 -178.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1255 ' ' THR . . . . . . . . . . . . . 8.5 m -109.5 -27.25 9.54 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 111.441 -2.618 . . . . 36.0 117.437 -158.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1256 ' ' ALA . . . . . 0.434 ' HB2' ' HA3' ' A' 1172 ' ' GLY . . . -70.09 77.78 0.5 Allowed 'General case' 0 C--O 1.246 0.889 0 N-CA-C 115.211 1.56 . . . . 40.93 115.211 -168.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 29.8 tp -90.8 130.27 36.79 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 124.588 1.155 . . . . 47.82 107.944 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 16.7 mm -109.57 138.61 20.64 Favored Pre-proline 0 C--O 1.246 0.91 0 N-CA-C 101.523 -3.51 . . . . 52.700000000000003 101.523 176.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -64.9 132.64 33.05 Favored 'Trans proline' 0 N--CA 1.43 -2.222 0 C-N-CA 121.589 1.526 . . . . 54.130000000000003 110.539 161.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 90.74 -69.56 2.2 Favored Glycine 0 CA--C 1.507 -0.423 0 N-CA-C 109.419 -1.472 . . . . 54.619999999999997 109.419 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 69.3 mttt -71.71 140.22 83.89 Favored Pre-proline 0 C--O 1.251 1.132 0 O-C-N 121.578 -0.954 . . . . 55.740000000000002 108.965 -176.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.36 143.95 94.39 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 123.916 3.077 . . . . 51.149999999999999 108.96 163.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -59.07 132.44 87.29 Favored Pre-proline 0 N--CA 1.446 -0.67 0 C-N-CA 126.524 1.93 . . . . 46.060000000000002 109.784 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -56.82 122.29 11.56 Favored 'Trans proline' 0 N--CA 1.445 -1.328 1 C-N-CA 125.961 4.441 . . . . 41.079999999999998 110.275 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1265 ' ' LYS . . . . . 0.596 ' HD3' ' HA ' ' A' 1293 ' ' GLU . 44.3 mttm -79.35 97.78 6.46 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 125.016 2.341 . . . . 47.420000000000002 107.721 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 48.9 mt -77.17 -63.9 1.26 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 110.931 -2.849 . . . . 39.219999999999999 109.319 -174.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 3.0 mt -87.22 111.71 22.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 CA-C-N 115.284 -0.871 . . . . 42.5 110.551 -166.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1268 ' ' THR . . . . . . . . . . . . . 63.7 m -64.39 141.95 58.59 Favored 'General case' 0 C--N 1.316 -0.85 0 O-C-N 124.728 1.267 . . . . 37.840000000000003 111.132 176.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1269 ' ' ARG . . . . . 0.424 ' HG3' ' HB2' ' A' 1293 ' ' GLU . 86.2 mtt180 -49.98 -47.77 52.67 Favored 'General case' 0 C--O 1.214 -0.812 0 N-CA-C 115.655 1.724 . . . . 54.799999999999997 115.655 -170.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -41.4 -50.46 3.83 Favored 'General case' 0 C--N 1.345 0.407 0 C-N-CA 126.392 1.877 . . . . 54.359999999999999 112.26 172.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1271 ' ' MET . . . . . . . . . . . . . 21.2 ttm -71.15 -25.0 62.37 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 122.661 1.219 . . . . 39.520000000000003 114.01 -173.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1272 ' ' VAL . . . . . 0.42 HG12 HG21 ' A' 1303 ' ' THR . 57.2 t -67.89 -41.9 85.27 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 O-C-N 121.003 -1.061 . . . . 38.25 111.273 174.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -59.1 -38.29 79.19 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 122.902 1.335 . . . . 40.770000000000003 111.95 172.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1274 ' ' SER . . . . . . . . . . . . . 11.8 m -67.64 -7.43 26.57 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 115.925 1.824 . . . . 36.579999999999998 115.925 174.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1275 ' ' MET . . . . . 0.49 ' HB3' HG21 ' A' 1307 ' ' VAL . 8.7 ttt -77.34 151.38 34.95 Favored 'General case' 0 C--O 1.247 0.969 0 O-C-N 120.664 -1.273 . . . . 36.75 108.128 -174.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1276 ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -55.22 126.67 25.86 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 114.007 -1.451 . . . . 46.109999999999999 110.698 175.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1277 ' ' ALA . . . . . 0.485 ' HB1' ' HA ' ' B' 1045 ' ' PHE . . . -72.1 170.76 13.26 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 117.012 2.227 . . . . 33.520000000000003 117.012 -175.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 68.44 30.28 73.22 Favored Glycine 0 C--O 1.25 1.102 0 C-N-CA 127.267 2.365 . . . . 31.27 111.748 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1279 ' ' SER . . . . . 0.458 ' HB2' HG22 ' A' 1307 ' ' VAL . 64.8 m -125.79 169.17 12.87 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 125.703 1.601 . . . . 32.950000000000003 111.216 -167.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1280 ' ' VAL . . . . . 0.735 HG11 ' HA ' ' A' 1145 ' ' ALA . 50.5 t -128.59 149.28 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 O-C-N 119.935 -1.728 . . . . 27.43 108.204 -176.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1281 ' ' ILE . . . . . 0.737 HG12 ' HB ' ' A' 1252 ' ' ILE . 16.4 mt -120.33 103.46 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 104.686 -2.339 . . . . 30.300000000000001 104.686 161.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.34 113.64 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 118.782 -1.167 . . . . 28.629999999999999 110.681 173.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 5.6 t0 -97.79 104.93 17.0 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 122.176 0.988 . . . . 36.270000000000003 109.094 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1284 ' ' LEU . . . . . 0.466 HD21 ' HB2' ' A' 1141 ' ' ALA . 49.1 mt -72.2 -36.31 69.16 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 112.033 -2.349 . . . . 38.57 107.602 176.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -73.38 -6.22 44.83 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 113.841 1.052 . . . . 37.560000000000002 113.841 -172.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . -43.41 -30.31 0.53 Allowed 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 127.173 2.189 . . . . 40.329999999999998 115.706 176.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1287 ' ' GLN . . . . . 0.604 ' HA ' HG23 ' A' 1313 ' ' THR . 7.8 pt20 -67.86 -2.31 7.09 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 116.017 1.858 . . . . 56.850000000000001 116.017 174.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -157.77 97.34 1.56 Allowed 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 102.983 -2.969 . . . . 45.859999999999999 102.983 159.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 90.93 -59.9 3.16 Favored Glycine 0 C--O 1.213 -1.168 0 O-C-N 119.222 -2.174 . . . . 40.310000000000002 111.931 169.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 80.1 134.97 1.33 Allowed Glycine 0 C--N 1.344 1.005 0 CA-C-N 120.14 1.97 . . . . 38.890000000000001 112.423 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1291 ' ' ASN . . . . . . . . . . . . . 33.1 m120 -84.53 -16.5 42.08 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.921 1.452 . . . . 37.229999999999997 114.921 -166.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1292 ' ' CYS . . . . . . . . . . . . . 37.2 t -88.75 150.27 23.04 Favored 'General case' 0 C--O 1.259 1.571 0 N-CA-C 105.595 -2.002 . . . . 36.5 105.595 171.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1293 ' ' GLU . . . . . 0.596 ' HA ' ' HD3' ' A' 1265 ' ' LYS . 24.7 mt-10 -78.61 -14.15 59.47 Favored 'General case' 0 C--O 1.216 -0.697 0 N-CA-C 116.877 2.177 . . . . 43.32 116.877 170.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1294 ' ' TYR . . . . . 0.447 ' CZ ' HG23 ' A' 1303 ' ' THR . 1.5 m-85 -75.34 -24.41 57.34 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 113.486 0.921 . . . . 41.32 113.486 178.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1295 ' ' THR . . . . . . . . . . . . . 24.0 m -60.96 105.35 0.46 Allowed 'General case' 0 C--O 1.249 1.036 0 C-N-CA 124.662 1.185 . . . . 35.299999999999997 113.894 -165.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 93.5 t -89.47 114.61 61.11 Favored Pre-proline 0 C--O 1.245 0.827 1 N-CA-C 99.662 -4.199 . . . . 34.840000000000003 99.662 166.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -56.85 148.89 63.98 Favored 'Trans proline' 0 CA--C 1.513 -0.546 0 C-N-CA 121.546 1.497 . . . . 33.509999999999998 111.97 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 90.35 -43.35 2.92 Favored Glycine 0 C--N 1.302 -1.343 0 CA-C-O 115.581 -2.788 . . . . 32.189999999999998 113.248 -174.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -104.91 171.39 7.34 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 121.482 2.641 . . . . 34.880000000000003 117.964 -168.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1300 ' ' ILE . . . . . 0.526 HD13 ' HG3' ' A' 1148 ' ' GLU . 50.1 mt -96.42 112.2 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 101.157 -3.645 . . . . 32.289999999999999 101.157 167.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.8 113.73 25.59 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 101.484 -3.524 . . . . 37.25 101.484 173.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1302 ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' 1308 ' ' LYS . 60.4 m -83.18 111.59 19.06 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.528 -1.656 . . . . 35.560000000000002 106.528 174.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1303 ' ' THR . . . . . 0.447 HG23 ' CZ ' ' A' 1294 ' ' TYR . 18.0 m -61.19 137.91 58.23 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 116.656 -1.64 . . . . 36.399999999999999 106.78 172.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -57.26 -10.89 1.44 Allowed 'General case' 0 C--N 1.353 0.719 0 N-CA-C 118.047 2.61 . . . . 52.32 118.047 -172.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -79.74 -37.17 36.12 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 125.056 1.473 . . . . 40.039999999999999 108.435 172.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1306 ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' B' 1044 ' ' SER . . . 123.44 31.97 0.93 Allowed Glycine 0 N--CA 1.419 -2.441 0 N-CA-C 111.161 -0.776 . . . . 36.960000000000001 111.161 -178.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1307 ' ' VAL . . . . . 0.49 HG21 ' HB3' ' A' 1275 ' ' MET . 42.1 t -102.75 109.8 27.65 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 N-CA-C 103.719 -2.697 . . . . 33.399999999999999 103.719 171.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1308 ' ' LYS . . . . . 0.753 ' HD2' ' HB3' ' A' 1148 ' ' GLU . 52.2 mttt -85.34 105.4 15.97 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 106.759 -1.571 . . . . 42.909999999999997 106.759 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 54.9 t -84.61 101.78 9.62 Favored 'Isoleucine or valine' 0 C--O 1.249 1.071 0 N-CA-C 106.043 -1.836 . . . . 32.289999999999999 106.043 176.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1310 ' ' ILE . . . . . 0.648 HD11 ' HB2' ' A' 1148 ' ' GLU . 48.5 mt -96.91 96.39 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 CA-C-N 113.058 -1.883 . . . . 30.989999999999998 108.033 -173.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -89.39 61.06 3.62 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 116.423 -0.353 . . . . 28.949999999999999 112.403 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1312 ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -80.47 98.52 7.59 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 117.564 -1.654 . . . . 31.690000000000001 110.276 -171.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1313 ' ' THR . . . . . 0.604 HG23 ' HA ' ' A' 1287 ' ' GLN . 2.8 m -59.81 -36.29 76.47 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 126.463 1.905 . . . . 34.170000000000002 108.46 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -79.54 3.9 17.42 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 114.106 1.15 . . . . 36.859999999999999 114.106 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1315 ' ' LEU . . . . . . . . . . . . . 16.6 mt -44.67 -43.83 18.87 Favored Pre-proline 0 C--O 1.22 -0.454 0 N-CA-C 119.028 2.973 . . . . 34.850000000000001 119.028 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -65.37 -21.6 60.84 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 123.653 2.902 . . . . 29.149999999999999 112.7 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -81.49 -40.29 11.27 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 110.611 -0.996 . . . . 27.289999999999999 110.611 173.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1318 ' ' ARG . . . . . . . . . . . . . 44.7 mtt-85 -50.64 -21.06 1.4 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 120.634 3.568 . . . . 41.490000000000002 120.634 -167.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1319 ' ' LEU . . . . . . . . . . . . . 14.4 tp -110.47 78.56 1.49 Allowed Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 104.557 -2.386 . . . . 27.609999999999999 104.557 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1320 ' ' PRO . . . . . 0.585 ' HB2' ' HA ' ' A' 1043 ' ' ALA . 98.8 Cg_endo -55.53 -61.45 0.36 Allowed 'Trans proline' 0 CA--C 1.514 -0.516 0 C-N-CA 123.793 2.995 . . . . 25.940000000000001 114.082 -157.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1321 ' ' THR . . . . . 0.441 HG23 ' HE1' ' A' 1045 ' ' PHE . 15.8 m -64.14 -31.86 73.21 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 120.157 1.344 . . . . 25.010000000000002 112.254 -177.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1322 ' ' GLN . . . . . 0.622 ' HB2' ' HA ' ' B' 1151 ' ' ARG . 21.6 tp60 -68.76 -52.72 27.42 Favored 'General case' 0 CA--C 1.506 -0.714 0 O-C-N 119.472 -2.017 . . . . 29.390000000000001 109.386 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1323 ' ' SER . . . . . . . . . . . . . 13.7 m -59.18 -41.14 87.76 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 125.143 1.527 . . . . 26.469999999999999 109.884 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1324 ' ' SER . . . . . . . . . . . . . 39.5 m -64.55 -42.99 95.34 Favored 'General case' 0 C--O 1.223 -0.337 0 O-C-N 123.948 0.78 . . . . 27.780000000000001 110.667 176.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1325 ' ' GLN . . . . . 0.444 ' O ' HG21 ' A' 1022 ' ' THR . 53.7 tp60 -63.57 -51.31 65.91 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.047 -1.033 . . . . 37.530000000000001 108.276 -175.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1326 ' ' LEU . . . . . 0.531 HD22 ' HB3' ' B' 1160 ' ' ALA . 96.2 mt -77.23 -35.27 55.61 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-O 116.803 -1.57 . . . . 35.710000000000001 113.309 -174.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1327 ' ' TYR . . . . . . . . . . . . . 37.1 t80 -55.94 -52.85 62.68 Favored 'General case' 0 C--N 1.362 1.139 0 CA-C-N 122.028 2.195 . . . . 31.59 108.595 168.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1328 ' ' GLY . . . . . 0.544 ' O ' HG23 ' A' 1332 ' ' VAL . . . -45.15 -46.37 10.29 Favored Glycine 0 N--CA 1.443 -0.838 0 O-C-N 126.037 2.086 . . . . 28.0 111.758 168.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1329 ' ' THR . . . . . 0.599 HG21 ' HA3' ' B' 1161 ' ' GLY . 11.9 m -69.79 -36.41 75.67 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 118.775 -2.603 . . . . 32.149999999999999 110.783 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1330 ' ' ASN . . . . . . . . . . . . . 33.7 m120 -61.73 -42.73 99.34 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 120.039 1.29 . . . . 34.359999999999999 108.918 171.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1331 ' ' LEU . . . . . 0.668 HD13 HD13 ' A' 1070 ' ' LEU . 22.4 mt -68.49 -39.14 81.43 Favored 'General case' 0 C--O 1.216 -0.663 0 O-C-N 121.439 -0.788 . . . . 33.369999999999997 112.515 -177.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1332 ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' 1328 ' ' GLY . 73.1 t -61.76 -46.38 96.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 105.403 -2.073 . . . . 35.270000000000003 105.403 175.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -55.51 -43.26 75.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 115.409 1.633 . . . . 37.659999999999997 115.409 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1334 ' ' LEU . . . . . . . . . . . . . 14.9 tp -62.92 -54.19 42.4 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 125.157 1.536 . . . . 40.270000000000003 109.831 174.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1335 ' ' LEU . . . . . 0.686 ' HA ' ' HB2' ' A' 1338 ' ' LEU . 39.6 mt -65.73 -17.31 64.52 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 118.16 -0.924 . . . . 42.5 113.391 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1336 ' ' LYS . . . . . . . . . . . . . 79.0 mttt -63.07 -49.09 75.9 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.033 -1.099 . . . . 47.810000000000002 108.033 169.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1337 ' ' LEU . . . . . 0.411 HD12 HD21 ' A' 1127 ' ' LEU . 77.4 mt -81.99 -20.28 38.81 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-O 124.212 1.958 . . . . 49.270000000000003 112.06 -176.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1338 ' ' LEU . . . . . 0.686 ' HB2' ' HA ' ' A' 1335 ' ' LEU . 9.2 mp -75.99 -24.96 55.37 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 113.546 -1.661 . . . . 50.539999999999999 112.503 169.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1339 ' ' CYS . . . . . . . . . . . . . 47.3 t -131.5 71.66 1.48 Allowed 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 102.57 -3.122 . . . . 53.670000000000002 102.57 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -67.77 -40.6 84.01 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 115.69 -0.686 . . . . 63.380000000000003 112.302 -177.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -72.06 -43.45 64.88 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 118.169 2.655 . . . . 70.950000000000003 118.169 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1342 ' ' LYS . . . . . 0.54 ' N ' ' HB3' ' A' 1343 ' ' ASP . 7.3 mtpm? 55.1 77.42 0.22 Allowed 'General case' 0 C--O 1.241 0.631 0 C-N-CA 125.505 1.522 . . . . 65.25 114.771 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1343 ' ' ASP . . . . . 0.54 ' HB3' ' N ' ' A' 1342 ' ' LYS 0.34 1.9 t70 78.3 -80.88 0.03 OUTLIER 'General case' 0 C--O 1.251 1.159 2 O-C-N 113.511 -5.743 . . . . 64.530000000000001 116.93 -6.638 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A 1344 ' ' GLY . . . . . 0.503 ' H ' ' HA ' ' A' 1342 ' ' LYS . . . 76.16 65.09 2.08 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 119.005 0.82 . . . . 59.719999999999999 112.855 -170.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 11.0 t30 -144.14 140.61 29.49 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.764 -0.458 . . . . 64.090000000000003 109.764 171.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1346 ' ' ILE . . . . . 0.504 HD12 ' H ' ' A' 1346 ' ' ILE . 3.4 mp -79.51 90.29 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 122.961 1.363 . . . . 58.82 107.628 -171.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1347 ' ' THR . . . . . . . . . . . . . 28.6 m -89.62 89.96 8.04 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-O 124.916 2.293 . . . . 54.960000000000001 109.147 175.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1348 ' ' VAL . . . . . . . . . . . . . 92.8 t -74.2 120.34 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 112.678 -2.055 . . . . 55.640000000000001 106.524 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1349 ' ' ASP . . . . . 0.441 ' H ' HG21 ' A' 1355 ' ' ILE . 1.5 t70 -94.44 148.64 22.03 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 119.544 1.065 . . . . 61.450000000000003 109.856 -176.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -109.28 -38.33 5.53 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.131 -0.941 . . . . 58.630000000000003 113.011 170.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 46.2 t0 -68.97 -29.8 68.1 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 123.463 1.601 . . . . 62.060000000000002 109.16 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 10.8 t70 -76.34 96.99 4.11 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 105.576 -2.009 . . . . 54.07 105.576 169.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1353 ' ' VAL . . . . . 0.577 ' HA ' ' HB3' ' A' 1356 ' ' ARG . 33.8 m -57.66 -29.7 35.25 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.669 0 CA-C-O 116.099 -1.905 . . . . 50.68 113.138 -174.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1354 ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' 1358 ' ' VAL . 1.5 m -69.05 -35.56 69.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 123.218 2.735 . . . . 47.68 112.633 176.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1355 ' ' ILE . . . . . 0.441 HG21 ' H ' ' A' 1349 ' ' ASP . 75.1 mt -68.93 -45.13 80.92 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 N-CA-C 107.066 -1.457 . . . . 48.490000000000002 107.066 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1356 ' ' ARG . . . . . 0.577 ' HB3' ' HA ' ' A' 1353 ' ' VAL . 46.3 tpt85 -52.1 -34.99 46.52 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 119.868 -1.77 . . . . 48.270000000000003 112.997 172.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -59.69 -62.91 5.59 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 114.685 0.634 . . . . 43.530000000000001 114.685 168.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1358 ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' 1354 ' ' VAL . 14.9 t -58.46 -37.08 62.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 O-C-N 124.848 0.97 . . . . 45.119999999999997 111.699 -177.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1359 ' ' THR . . . . . . . . . . . . . 12.7 m -72.16 78.05 0.96 Allowed 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 124.609 2.147 . . . . 42.939999999999998 109.803 175.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 29.6 m -74.56 -35.77 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 CA-C-N 113.249 -1.796 . . . . 43.259999999999998 109.719 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1361 ' ' ILE . . . . . 0.531 ' HB ' ' HB ' ' A' 1112 ' ' VAL . 60.9 mt -133.08 134.19 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 103.301 -2.852 . . . . 45.659999999999997 103.301 176.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1362 ' ' ARG . . . . . 0.494 ' HA ' ' HA ' ' A' 1111 ' ' THR . 30.2 ttt180 -123.02 121.18 35.44 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 122.689 2.495 . . . . 61.340000000000003 111.328 169.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 46.69 44.21 13.58 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 127.354 2.909 . . . . 49.759999999999998 110.322 173.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1364 ' ' GLY . . . . . 0.731 ' HA2' ' HA ' ' A' 1109 ' ' ASN . . . 115.94 -60.99 0.4 Allowed Glycine 0 C--N 1.347 1.154 0 N-CA-C 117.444 1.738 . . . . 50.0 117.444 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -82.88 130.92 35.2 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 119.619 -0.832 . . . . 56.920000000000002 110.321 -175.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1366 ' ' ILE . . . . . 0.491 HG12 HG12 ' A' 1361 ' ' ILE . 71.9 mt -64.64 118.74 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 N-CA-C 108.388 -0.967 . . . . 52.780000000000001 108.388 174.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1367 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.79 -0.13 43.22 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 112.613 -2.085 . . . . 49.439999999999998 115.975 173.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 7.2 t90 -63.45 150.08 90.6 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-O 115.312 -2.28 . . . . 52.380000000000003 112.412 173.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -78.21 -150.69 0.62 Allowed 'Cis proline' 0 CA--C 1.544 1.021 1 CA-C-N 129.259 4.342 . . . . 46.939999999999998 111.722 -8.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1370 ' ' ALA . . . . . . . . . . . . 0.264 . . -150.38 156.15 36.9 Favored Pre-proline 0 C--N 1.352 0.708 0 N-CA-C 108.328 -0.99 . . . . 45.909999999999997 108.328 -175.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1371 ' ' PRO . . . . . 0.451 ' HA ' ' HD2' ' A' 1372 ' ' PRO . 7.1 Cg_exo -43.16 117.98 1.16 Allowed 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 125.105 3.87 . . . . 46.390000000000001 114.782 169.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1372 ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' 1371 ' ' PRO . 72.1 Cg_endo -74.39 4.35 4.5 Favored 'Trans proline' 0 N--CA 1.485 0.994 0 C-N-CA 123.973 3.115 . . . . 46.719999999999999 116.93 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.217 -5.184 0 O-C-N 120.477 -1.389 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 73.9 m80 . . . . . 0 N--CA 1.427 -1.586 0 N-CA-C 105.691 -1.966 . . . . 63.439999999999998 105.691 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -123.62 43.56 2.93 Favored 'General case' 0 C--O 1.256 1.419 0 O-C-N 117.999 -2.938 . . . . 51.740000000000002 114.885 -173.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1000 ' ' HIS . . . . . 0.625 ' HA ' ' HB2' ' B' 1067 ' ' GLU . 17.1 m-70 -69.97 144.11 52.43 Favored 'General case' 0 C--O 1.258 1.533 0 CA-C-O 123.742 1.734 . . . . 54.07 108.096 167.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1001 ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' B' 1344 ' ' GLY . . . 76.98 -12.18 12.49 Favored Glycine 0 CA--C 1.534 1.259 0 O-C-N 120.967 -1.083 . . . . 39.219999999999999 112.169 -168.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1002 ' ' ARG . . . . . 0.438 ' O ' ' HB3' ' B' 1066 ' ' SER . 35.7 ttp180 -97.96 142.02 30.2 Favored 'General case' 0 CA--C 1.491 -1.299 0 CA-C-N 120.105 1.953 . . . . 38.119999999999997 109.37 174.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1003 ' ' ILE . . . . . . . . . . . . . 21.1 mt -98.74 154.77 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 N-CA-C 106.03 -1.841 . . . . 29.699999999999999 106.03 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -123.59 128.08 6.81 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 108.604 -1.799 . . . . 27.5 108.604 164.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1005 ' ' ILE . . . . . 0.783 HG23 ' HB3' ' B' 1017 ' ' ALA . 40.8 mm -116.33 112.11 41.81 Favored Pre-proline 0 C--O 1.243 0.729 0 N-CA-C 104.161 -2.533 . . . . 24.829999999999998 104.161 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1006 ' ' PRO . . . . . 0.519 ' HG2' ' HG2' ' B' 1071 ' ' LYS . 85.4 Cg_exo -74.88 154.2 42.94 Favored 'Trans proline' 0 N--CA 1.446 -1.314 1 C-N-CA 125.814 4.343 . . . . 27.190000000000001 111.189 176.37 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 63.6 ttt-85 -78.08 125.0 28.71 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 101.877 -3.379 . . . . 41.460000000000001 101.877 164.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1008 ' ' GLU . . . . . 0.607 ' HG3' ' HB ' ' B' 1072 ' ' VAL 0.411 0.3 OUTLIER -78.43 126.68 31.11 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 118.899 2.925 . . . . 26.93 118.899 -175.436 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 37.2 mtm180 -98.1 11.46 37.59 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 113.466 -1.697 . . . . 34.479999999999997 113.374 -170.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1010 ' ' LEU . . . . . . . . . . . . . 31.9 tp -66.95 143.41 56.82 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 119.803 -1.81 . . . . 44.219999999999999 109.051 175.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1011 ' ' THR . . . . . . . . . . . . . 57.9 m -67.57 147.69 52.42 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 122.304 2.32 . . . . 40.740000000000002 110.097 165.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 60.8 m-80 58.36 58.06 3.6 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-O 124.231 1.967 . . . . 44.439999999999998 110.836 -175.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1013 ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -137.75 143.89 41.38 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.87 -1.514 . . . . 29.870000000000001 109.269 -174.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1014 ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' B' 1320 ' ' PRO . 0.2 OUTLIER -137.65 3.37 2.51 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-O 124.088 1.899 . . . . 25.260000000000002 110.284 174.54 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 50.5 mtm180 -82.8 142.68 31.37 Favored 'General case' 0 C--O 1.24 0.586 0 O-C-N 119.66 -1.9 . . . . 29.539999999999999 112.559 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1016 ' ' VAL . . . . . 0.505 HG21 ' HB1' ' B' 1039 ' ' ALA . 11.1 p -106.43 162.86 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 103.137 -2.912 . . . . 23.550000000000001 103.137 154.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1017 ' ' ALA . . . . . 0.783 ' HB3' HG23 ' B' 1005 ' ' ILE . . . -68.2 -21.01 64.89 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 115.557 1.688 . . . . 23.59 115.557 177.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1018 ' ' ALA . . . . . 0.645 ' HB1' ' HB ' ' B' 1022 ' ' THR . . . -158.33 128.15 5.91 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 119.192 0.905 . . . . 24.93 109.254 175.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1019 ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.29 169.96 17.03 Favored Pre-proline 0 N--CA 1.477 0.895 0 CA-C-O 115.34 -2.267 . . . . 28.09 113.397 172.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -45.22 -50.93 8.38 Favored 'Trans proline' 0 CA--C 1.537 0.631 1 C-N-CA 125.371 4.047 . . . . 28.789999999999999 116.657 175.39 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 56.2 tttt -55.96 -39.45 71.77 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 113.486 0.921 . . . . 47.280000000000001 113.486 173.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1022 ' ' THR . . . . . 0.717 HG21 ' HA3' ' B' 1328 ' ' GLY . 0.3 OUTLIER -70.81 -34.02 71.32 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.401 -0.592 . . . . 30.120000000000001 109.401 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B 1023 ' ' VAL . . . . . 0.522 HG11 ' HB2' ' B' 1055 ' ' ALA . 39.7 t -61.93 -43.12 97.05 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 N-CA-C 108.921 -0.77 . . . . 32.240000000000002 108.921 176.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1024 ' ' GLU . . . . . 0.403 ' HG3' ' HB1' ' B' 1053 ' ' ALA . 40.9 mt-10 -61.5 -39.54 91.33 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 123.446 0.698 . . . . 49.619999999999997 112.35 174.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -55.87 -47.86 76.6 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 122.35 1.072 . . . . 44.68 111.45 174.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 86.1 mt -64.56 -32.48 74.14 Favored 'General case' 0 C--N 1.366 1.294 0 CA-C-N 113.013 -1.903 . . . . 35.710000000000001 110.694 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1027 ' ' LEU . . . . . 0.581 HD11 ' HA3' ' B' 1054 ' ' GLY . 86.5 mt -67.81 -41.22 83.42 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 122.314 1.055 . . . . 42.18 112.739 175.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 61.8 mttm -61.21 -32.8 72.57 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-N 112.918 -1.946 . . . . 48.340000000000003 111.645 176.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1029 ' ' LEU . . . . . 0.548 HD11 HG13 ' B' 1332 ' ' VAL . 93.9 mt -70.13 -3.61 17.51 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 115.637 1.718 . . . . 38.689999999999998 115.637 174.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 96.17 6.72 58.8 Favored Glycine 0 N--CA 1.471 1.007 0 N-CA-C 110.417 -1.073 . . . . 32.280000000000001 110.417 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -97.93 170.81 8.69 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.655 -1.239 . . . . 35.939999999999998 107.655 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1032 ' ' THR . . . . . . . . . . . . . 1.4 p -113.14 148.89 34.44 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 105.906 -1.887 . . . . 33.369999999999997 105.906 170.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1033 ' ' VAL . . . . . 0.444 HG11 HG22 ' B' 1023 ' ' VAL . 15.5 t -114.16 146.81 18.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 O-C-N 117.786 -3.071 . . . . 29.98 108.534 -176.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -125.1 140.84 52.52 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 107.109 -1.441 . . . . 28.18 107.109 163.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1035 ' ' VAL . . . . . 0.453 ' HB ' HD13 ' B' 1057 ' ' ILE . 21.8 t -129.31 146.61 33.96 Favored 'Isoleucine or valine' 0 C--N 1.348 0.528 0 N-CA-C 108.234 -1.024 . . . . 25.82 108.234 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1036 ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -66.11 139.91 58.19 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 121.442 0.639 . . . . 32.439999999999998 112.545 167.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1037 ' ' SER . . . . . . . . . . . . . 48.7 m -52.81 139.52 26.61 Favored 'General case' 0 C--O 1.257 1.478 0 CA-C-N 114.207 -1.36 . . . . 29.539999999999999 114.489 165.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 89.63 0.2 79.28 Favored Glycine 0 C--O 1.252 1.274 0 C-N-CA 121.322 -0.466 . . . . 27.760000000000002 113.271 176.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1039 ' ' ALA . . . . . 0.505 ' HB1' HG21 ' B' 1016 ' ' VAL . . . -64.83 -43.4 93.19 Favored 'General case' 0 CA--C 1.504 -0.796 0 O-C-N 124.502 0.766 . . . . 26.02 110.832 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -49.55 -47.85 36.12 Favored Glycine 0 N--CA 1.419 -2.458 0 C-N-CA 125.663 1.601 . . . . 26.469999999999999 111.118 173.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -53.21 -46.28 68.99 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-N 119.525 1.663 . . . . 50.979999999999997 112.514 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 94.7 mt -61.24 -57.62 11.64 Favored 'General case' 0 C--O 1.211 -0.964 0 N-CA-C 108.074 -1.084 . . . . 29.300000000000001 108.074 174.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1043 ' ' ALA . . . . . . . . . . . . . . . -72.62 11.85 0.57 Allowed 'General case' 0 C--O 1.248 0.982 0 N-CA-C 116.587 2.069 . . . . 26.739999999999998 116.587 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1044 ' ' SER . . . . . 0.435 ' O ' ' HA3' ' A' 1306 ' ' GLY . 17.3 m 46.89 25.24 0.44 Allowed 'General case' 0 C--O 1.248 0.987 0 C-N-CA 126.361 1.864 . . . . 31.260000000000002 113.717 -176.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1045 ' ' PHE . . . . . 0.485 ' HA ' ' HB1' ' A' 1277 ' ' ALA . 0.9 OUTLIER -112.86 155.93 23.82 Favored 'General case' 0 C--O 1.244 0.797 0 O-C-N 119.885 -1.76 . . . . 33.259999999999998 106.962 -177.174 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 11.3 t70 -67.96 126.04 28.22 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.869 -0.789 . . . . 46.740000000000002 108.869 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.8 -42.43 90.68 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 107.621 -1.251 . . . . 34.439999999999998 107.621 -173.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -53.03 -34.84 58.24 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 113.306 0.854 . . . . 48.670000000000002 113.306 172.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1049 ' ' ALA . . . . . 0.521 ' HA ' ' HB2' ' B' 1052 ' ' GLN . . . -62.94 -19.79 64.59 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 116.06 1.874 . . . . 35.259999999999998 116.06 176.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1050 ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -62.77 -42.72 99.82 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 123.396 1.57 . . . . 32.170000000000002 109.996 168.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 18.0 t -67.4 -50.74 59.37 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 O-C-N 119.546 -1.971 . . . . 38.369999999999997 107.061 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1052 ' ' GLN . . . . . 0.521 ' HB2' ' HA ' ' B' 1049 ' ' ALA . 21.5 mt-30 -52.17 -29.72 23.61 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.74 1.216 . . . . 45.770000000000003 114.174 175.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1053 ' ' ALA . . . . . 0.403 ' HB1' ' HG3' ' B' 1024 ' ' GLU . . . -80.55 -40.66 25.51 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 123.936 0.773 . . . . 37.829999999999998 110.584 176.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1054 ' ' GLY . . . . . 0.581 ' HA3' HD11 ' B' 1027 ' ' LEU . . . 134.81 48.73 0.08 OUTLIER Glycine 0 CA--C 1.532 1.141 0 CA-C-O 123.028 1.349 . . . . 35.82 111.657 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1055 ' ' ALA . . . . . 0.522 ' HB2' HG11 ' B' 1023 ' ' VAL . . . -128.74 140.9 51.51 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 108.206 -1.035 . . . . 33.770000000000003 108.206 177.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -76.38 106.79 8.21 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 104.513 -2.403 . . . . 51.020000000000003 104.513 166.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1057 ' ' ILE . . . . . 0.453 HD13 ' HB ' ' B' 1035 ' ' VAL . 13.6 mm -82.5 102.82 8.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 N-CA-C 102.079 -3.304 . . . . 38.469999999999999 102.079 173.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 30.1 m -86.71 159.34 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-N 109.143 -3.662 . . . . 39.399999999999999 108.29 175.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -71.48 -29.24 64.6 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.258 -1.337 . . . . 57.07 114.438 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . 172.79 -97.25 0.12 Allowed Glycine 0 CA--C 1.53 0.976 0 O-C-N 120.359 -1.463 . . . . 44.829999999999998 111.541 176.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -58.6 -32.0 68.58 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 125.632 1.573 . . . . 46.270000000000003 114.057 -170.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1062 ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -44.32 -33.87 1.76 Allowed 'General case' 0 C--O 1.24 0.578 0 N-CA-C 115.215 1.561 . . . . 43.469999999999999 115.215 171.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -54.05 -38.77 38.89 Favored 'Isoleucine or valine' 0 C--N 1.355 0.828 0 C-N-CA 124.385 1.074 . . . . 36.979999999999997 111.491 176.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 96.9 m95 -67.72 -14.38 62.9 Favored 'General case' 0 C--O 1.211 -0.949 0 N-CA-C 116.877 2.177 . . . . 37.899999999999999 116.877 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -99.83 81.58 2.47 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 104.338 -2.467 . . . . 46.189999999999998 104.338 -176.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1066 ' ' SER . . . . . 0.438 ' HB3' ' O ' ' B' 1002 ' ' ARG . 68.5 m -150.65 -178.53 6.61 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 119.006 -2.309 . . . . 37.060000000000002 108.244 -174.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1067 ' ' GLU . . . . . 0.625 ' HB2' ' HA ' ' B' 1000 ' ' HIS . 8.8 tp10 -69.8 -56.12 7.98 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 120.457 -1.402 . . . . 43.950000000000003 109.473 173.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1068 ' ' ILE . . . . . 0.562 HG23 HG13 ' B' 1346 ' ' ILE . 0.8 OUTLIER -123.07 137.88 54.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 107.411 -1.329 . . . . 33.5 107.411 -178.012 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 24.1 mm -111.28 106.81 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 N-CA-C 103.561 -2.755 . . . . 30.57 103.561 170.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1070 ' ' LEU . . . . . 0.715 HD22 HD22 ' B' 1331 ' ' LEU . 86.7 mt -97.23 118.46 33.73 Favored 'General case' 0 CA--C 1.505 -0.781 1 N-CA-C 98.117 -4.771 . . . . 27.66 98.117 -175.812 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B 1071 ' ' LYS . . . . . 0.519 ' HG2' ' HG2' ' B' 1006 ' ' PRO . 10.8 tmtt? -141.33 146.77 37.13 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 104.818 -2.29 . . . . 28.399999999999999 104.818 -164.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1072 ' ' VAL . . . . . 0.607 ' HB ' ' HG3' ' B' 1008 ' ' GLU . 61.8 t -79.93 -61.68 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-N 120.278 1.399 . . . . 23.18 112.462 -170.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1073 ' ' ASN . . . . . 0.468 ' HA ' ' HB2' ' B' 1092 ' ' PHE . 52.9 m-80 -105.95 -161.76 0.82 Allowed 'General case' 0 C--O 1.237 0.443 0 N-CA-C 106.269 -1.752 . . . . 25.469999999999999 106.269 -173.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -61.65 148.68 86.4 Favored Pre-proline 0 C--O 1.259 1.564 0 N-CA-C 112.999 0.74 . . . . 27.899999999999999 112.999 177.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -66.56 125.49 13.95 Favored 'Trans proline' 0 CA--C 1.556 1.608 0 N-CA-C 107.939 -1.6 . . . . 31.620000000000001 107.939 162.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 57.1 mt -69.14 162.18 27.55 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 107.696 -1.224 . . . . 40.490000000000002 107.696 169.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1077 ' ' ASP . . . . . 0.541 ' HA ' HD12 ' B' 1080 ' ' ILE . 1.3 m-20 -69.16 -23.63 63.97 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 118.711 2.856 . . . . 51.590000000000003 118.711 -160.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -66.27 -51.36 58.28 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 112.835 -1.984 . . . . 42.359999999999999 110.553 166.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1079 ' ' GLU . . . . . 0.419 ' HA ' HD12 ' B' 1082 ' ' LEU . 58.6 mt-10 -55.62 -37.35 68.04 Favored 'General case' 0 C--O 1.249 1.042 0 O-C-N 120.667 -1.271 . . . . 34.530000000000001 109.116 173.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1080 ' ' ILE . . . . . 0.612 HD11 HD12 ' B' 1101 ' ' LEU . 73.1 mt -59.28 -50.43 79.86 Favored 'Isoleucine or valine' 0 C--N 1.356 0.891 0 C-N-CA 123.666 0.786 . . . . 33.25 110.355 173.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -63.45 -15.14 56.82 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 118.544 -0.741 . . . . 36.469999999999999 112.837 174.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1082 ' ' LEU . . . . . 0.419 HD12 ' HA ' ' B' 1079 ' ' GLU . 41.3 mt -86.45 -24.31 25.68 Favored 'General case' 0 C--N 1.353 0.728 0 CA-C-N 120.466 1.485 . . . . 37.759999999999998 113.553 171.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1083 ' ' LEU . . . . . 0.674 ' HB3' HG11 ' B' 1110 ' ' VAL . 12.7 mt -55.2 123.99 15.51 Favored 'General case' 0 C--O 1.25 1.125 0 N-CA-C 115.629 1.714 . . . . 37.43 115.629 -178.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.09 129.35 56.37 Favored Pre-proline 0 N--CA 1.439 -0.991 0 CA-C-N 114.797 -1.092 . . . . 37.700000000000003 110.891 -172.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -58.63 123.07 12.75 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 124.55 3.5 . . . . 35.509999999999998 109.11 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 115.36 -60.49 0.4 Allowed Glycine 0 C--O 1.244 0.771 0 O-C-N 126.955 2.659 . . . . 33.869999999999997 108.097 -172.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1087 ' ' THR . . . . . . . . . . . . . 97.9 m -41.57 130.97 3.09 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 126.757 2.023 . . . . 32.5 116.059 -165.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1088 ' ' THR . . . . . 0.682 ' HA ' ' HB ' ' B' 1111 ' ' THR . 10.0 m -73.68 106.75 5.57 Favored 'General case' 0 C--O 1.216 -0.7 0 N-CA-C 107.306 -1.368 . . . . 30.219999999999999 107.306 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1089 ' ' LEU . . . . . 0.476 HD13 HD21 ' B' 1083 ' ' LEU . 20.7 tp -96.91 133.05 42.05 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 103.38 -2.822 . . . . 27.239999999999998 103.38 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1090 ' ' VAL . . . . . 0.6 HG13 ' HB2' ' B' 1113 ' ' MET . 15.1 t -134.48 109.93 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 106.889 -1.523 . . . . 25.390000000000001 106.889 -174.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1091 ' ' SER . . . . . . . . . . . . . 2.6 m -159.23 168.92 25.28 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.84 0.829 . . . . 28.809999999999999 112.127 -166.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1092 ' ' PHE . . . . . 0.536 ' CD1' ' HB3' ' B' 1116 ' ' ASP . 19.9 m-85 -66.1 107.41 1.91 Allowed 'General case' 0 C--O 1.247 0.973 0 CA-C-O 124.42 2.057 . . . . 30.780000000000001 110.933 161.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 45.3 mm -103.53 -37.84 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 O-C-N 120.172 -1.58 . . . . 30.280000000000001 110.552 -176.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1094 ' ' TRP . . . . . 0.436 ' HB2' ' OD1' ' B' 1098 ' ' ASN . 58.8 m95 53.57 54.79 12.61 Favored Pre-proline 0 C--O 1.249 1.078 0 O-C-N 124.456 1.098 . . . . 34.07 110.342 -174.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1095 ' ' PRO . . . . . 0.458 ' HG2' HG11 ' B' 1360 ' ' VAL . 71.1 Cg_exo -39.6 -60.65 0.51 Allowed 'Trans proline' 0 C--N 1.355 0.872 1 C-N-CA 126.5 4.8 . . . . 38.659999999999997 118.433 -167.046 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -62.94 -28.27 69.95 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 119.287 -2.133 . . . . 41.32 112.838 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -82.65 -22.11 34.77 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 122.543 1.163 . . . . 51.659999999999997 112.578 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1098 ' ' ASN . . . . . 0.447 ' HB3' ' HB3' ' B' 1101 ' ' LEU . 20.5 m120 -119.09 58.41 4.01 Favored Pre-proline 0 N--CA 1.447 -0.62 0 N-CA-C 115.511 1.671 . . . . 40.32 115.511 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -57.16 -43.15 55.78 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.561 3.507 . . . . 41.560000000000002 111.593 -173.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -76.51 -32.74 58.47 Favored 'General case' 0 C--O 1.208 -1.091 0 N-CA-C 113.139 0.792 . . . . 54.109999999999999 113.139 -174.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1101 ' ' LEU . . . . . 0.612 HD12 HD11 ' B' 1080 ' ' ILE . 26.6 tp -61.59 -47.99 82.98 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 107.693 -1.225 . . . . 37.880000000000003 107.693 174.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1102 ' ' MET . . . . . . . . . . . . . 69.2 mmm -47.61 -55.15 9.93 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 125.601 1.813 . . . . 37.539999999999999 111.154 173.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -55.98 -45.46 78.95 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-O 118.487 -0.768 . . . . 47.009999999999998 111.527 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1104 ' ' LYS . . . . . . . . . . . . . 88.9 mttt -61.82 -36.99 82.77 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 124.544 2.116 . . . . 48.68 114.146 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1105 ' ' LEU . . . . . . . . . . . . . 43.6 mt -74.63 -32.82 62.41 Favored 'General case' 0 C--O 1.247 0.931 0 O-C-N 119.614 -1.929 . . . . 32.210000000000001 110.03 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -67.69 -43.6 79.74 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.392 0.677 . . . . 33.729999999999997 111.177 175.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -59.45 -41.28 89.3 Favored 'General case' 0 C--O 1.25 1.101 0 N-CA-C 115.128 1.529 . . . . 51.469999999999999 115.128 169.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1108 ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -71.38 -3.83 22.93 Favored 'General case' 0 C--N 1.345 0.407 0 N-CA-C 113.693 0.997 . . . . 43.899999999999999 113.693 170.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1109 ' ' ASN . . . . . . . . . . . . . 8.1 m-80 59.03 32.57 22.35 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.835 1.791 . . . . 44.82 115.835 167.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1110 ' ' VAL . . . . . 0.674 HG11 ' HB3' ' B' 1083 ' ' LEU . 5.8 m -94.92 150.82 3.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-N 114.516 -1.22 . . . . 30.52 109.794 -174.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1111 ' ' THR . . . . . 0.682 ' HB ' ' HA ' ' B' 1088 ' ' THR . 29.9 m -83.16 86.06 7.09 Favored 'General case' 0 C--O 1.247 0.958 0 CA-C-O 122.126 0.965 . . . . 27.120000000000001 110.517 178.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1112 ' ' VAL . . . . . 0.405 ' CG2' HG23 ' B' 1110 ' ' VAL . 6.7 t -86.21 130.72 36.12 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 CA-C-O 121.986 0.898 . . . . 26.399999999999999 109.192 -169.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1113 ' ' MET . . . . . 0.6 ' HB2' HG13 ' B' 1090 ' ' VAL . 10.8 mtt -120.19 124.71 46.39 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 102.651 -3.092 . . . . 42.920000000000002 102.651 175.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -90.65 96.61 10.73 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 113.703 -1.59 . . . . 24.149999999999999 113.888 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1115 ' ' MET . . . . . 0.454 ' CG ' HG12 ' B' 1090 ' ' VAL . 78.9 mmm -56.03 -25.54 45.09 Favored 'General case' 0 C--O 1.22 -0.451 0 N-CA-C 115.479 1.659 . . . . 29.949999999999999 115.479 -178.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1116 ' ' ASP . . . . . 0.536 ' HB3' ' CD1' ' B' 1092 ' ' PHE . 10.6 p-10 -80.14 -37.14 34.12 Favored 'General case' 0 N--CA 1.439 -0.984 0 O-C-N 121.521 -0.737 . . . . 34.530000000000001 109.647 174.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1117 ' ' SER . . . . . . . . . . . . . 57.0 m -102.52 48.16 0.87 Allowed 'General case' 0 C--N 1.355 0.823 0 O-C-N 120.167 -1.583 . . . . 33.490000000000002 108.824 -168.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1118 ' ' VAL . . . . . 0.572 HG21 ' HA ' ' B' 1128 ' ' ASP . 54.5 t -81.63 124.08 80.15 Favored Pre-proline 0 N--CA 1.48 1.048 0 N-CA-C 102.357 -3.201 . . . . 34.020000000000003 102.357 176.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1119 ' ' PRO . . . . . 0.432 ' HG2' ' HA3' ' B' 1357 ' ' GLY . 90.7 Cg_exo -58.06 103.14 0.14 Allowed 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 124.904 3.736 . . . . 38.280000000000001 110.842 -173.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1120 ' ' ARG . . . . . . . . . . . . . 13.6 mtm-85 -72.55 71.84 0.98 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 120.338 3.459 . . . . 55.049999999999997 120.338 -159.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1121 ' ' ILE . . . . . . . . . . . . . 44.5 pt -104.48 -161.11 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.815 0 N-CA-C 104.641 -2.355 . . . . 42.090000000000003 104.641 171.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1122 ' ' SER . . . . . . . . . . . . . 31.4 m -74.56 -48.27 27.81 Favored 'General case' 0 N--CA 1.434 -1.259 0 O-C-N 118.12 -2.862 . . . . 38.020000000000003 118.226 -173.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1123 ' ' ARG . . . . . 0.732 ' HD2' HD21 ' B' 1337 ' ' LEU . 10.2 ptt180 -74.71 -21.38 59.41 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 124.305 3.23 . . . . 34.289999999999999 114.125 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1124 ' ' ALA . . . . . . . . . . . . . . . -54.46 -48.92 71.21 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 109.182 -3.644 . . . . 32.350000000000001 109.759 170.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1125 ' ' GLN . . . . . 0.418 ' HA ' ' HB3' ' B' 1128 ' ' ASP . 16.2 mm-40 -54.75 -38.12 66.78 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 114.42 1.267 . . . . 47.170000000000002 114.42 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1126 ' ' SER . . . . . . . . . . . . . 73.9 m -57.03 -36.03 69.98 Favored 'General case' 0 C--O 1.248 1.0 0 CA-C-N 121.088 1.767 . . . . 31.710000000000001 114.093 170.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1127 ' ' LEU . . . . . 0.655 HD11 HD13 ' B' 1337 ' ' LEU . 8.4 mp -87.82 -23.77 23.92 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 114.946 -1.025 . . . . 37.0 112.982 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1128 ' ' ASP . . . . . 0.572 ' HA ' HG21 ' B' 1118 ' ' VAL . 12.5 t70 -78.93 118.77 21.26 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-O 123.434 1.587 . . . . 40.399999999999999 112.549 -170.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1129 ' ' ALA . . . . . 0.435 ' HB2' ' HB3' ' B' 1115 ' ' MET . . . -62.32 -36.55 82.53 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 110.44 -3.073 . . . . 26.559999999999999 111.793 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 39.6 mt -63.09 -23.73 67.58 Favored 'General case' 0 C--O 1.248 0.976 0 CA-C-O 116.512 -1.708 . . . . 30.890000000000001 112.251 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1131 ' ' SER . . . . . . . . . . . . . 86.0 p -65.84 -57.5 7.79 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 122.611 2.46 . . . . 29.84 107.932 177.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1132 ' ' SER . . . . . . . . . . . . . 73.4 m -60.74 -43.24 98.19 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.259 -1.337 . . . . 31.91 111.223 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1133 ' ' MET . . . . . 0.509 ' HB3' ' HB3' ' B' 1316 ' ' PRO . 31.2 mmt -60.56 -37.98 83.04 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 115.504 1.668 . . . . 25.899999999999999 115.504 174.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1134 ' ' ALA . . . . . 0.76 ' HB1' ' HB2' ' B' 1176 ' ' ALA . . . -68.77 -41.75 78.39 Favored 'General case' 0 C--N 1.352 0.679 0 C-N-CA 119.929 -0.708 . . . . 26.620000000000001 109.182 174.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.27 -38.82 90.8 Favored 'General case' 0 C--O 1.206 -1.195 0 C-N-CA 125.076 1.35 . . . . 36.969999999999999 109.997 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1136 ' ' ILE . . . . . 0.602 HD13 ' HE1' ' A' 1152 ' ' PHE . 15.0 mm -58.7 -55.4 23.21 Favored 'Isoleucine or valine' 0 C--N 1.352 0.695 0 N-CA-C 106.337 -1.727 . . . . 32.109999999999999 106.337 172.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1137 ' ' ALA . . . . . 0.463 ' HA ' ' HB3' ' B' 1140 ' ' ARG . . . -61.95 -25.79 67.81 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 116.019 1.859 . . . . 24.140000000000001 116.019 178.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -65.5 -57.83 10.58 Favored Glycine 0 N--CA 1.466 0.699 0 CA-C-N 120.982 1.719 . . . . 25.129999999999999 110.28 174.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 77.9 t80 -53.55 -43.8 68.74 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 123.663 1.697 . . . . 32.729999999999997 110.534 172.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1140 ' ' ARG . . . . . 0.463 ' HB3' ' HA ' ' B' 1137 ' ' ALA . 9.1 tpt180 -70.61 -25.95 63.28 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 113.78 -1.555 . . . . 26.359999999999999 110.492 -174.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1141 ' ' ALA . . . . . 0.405 ' HA ' HG11 ' B' 1282 ' ' VAL . . . -62.89 -49.63 74.05 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 120.661 1.573 . . . . 24.120000000000001 107.978 172.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 32.5 mm -56.94 -43.89 81.46 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 CA-C-O 118.697 -0.668 . . . . 23.370000000000001 110.801 175.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 70.4 t -68.1 -59.26 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 N-CA-C 112.573 0.582 . . . . 24.960000000000001 112.573 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1144 ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' B' 1147 ' ' HIS . 67.4 mm-40 -60.1 -35.83 76.08 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 119.145 -0.455 . . . . 32.07 110.306 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1145 ' ' ALA . . . . . 0.558 ' HB1' HD12 ' B' 1251 ' ' ILE . . . -51.74 -60.32 3.3 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 119.145 0.884 . . . . 24.870000000000001 111.365 167.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1146 ' ' ALA . . . . . 0.559 ' HB2' ' HE1' ' B' 1153 ' ' PHE . . . -58.53 -22.94 57.01 Favored 'General case' 0 C--N 1.348 0.506 0 N-CA-C 114.663 1.357 . . . . 24.670000000000002 114.663 177.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1147 ' ' HIS . . . . . 0.465 ' HB3' ' O ' ' B' 1144 ' ' GLU . 26.8 t60 -63.15 -43.94 96.92 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 120.84 -1.163 . . . . 28.579999999999998 108.97 171.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1148 ' ' GLU . . . . . 0.588 ' HG3' HD13 ' B' 1300 ' ' ILE . 69.7 mm-40 -107.07 3.92 26.39 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 116.996 2.221 . . . . 36.82 116.996 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1149 ' ' PHE . . . . . 0.404 ' HE2' ' HB2' ' B' 1166 ' ' ALA . 1.1 t80 -71.53 140.69 49.99 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-O 124.733 2.206 . . . . 31.969999999999999 107.015 -178.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1150 ' ' GLY . . . . . . . . . . . . . . . -71.29 -42.17 57.84 Favored Glycine 0 N--CA 1.42 -2.423 0 CA-C-N 111.079 -2.782 . . . . 25.489999999999998 110.858 170.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1151 ' ' ARG . . . . . 0.622 ' HA ' ' HB2' ' A' 1322 ' ' GLN . 58.7 mtm-85 -110.58 179.36 4.09 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 123.961 3.881 . . . . 59.840000000000003 113.46 -168.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1152 ' ' PHE . . . . . 0.516 ' HB2' HG11 ' B' 1163 ' ' VAL . 12.1 m-30 -72.9 163.52 28.03 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 120.147 -1.596 . . . . 34.450000000000003 109.383 167.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1153 ' ' PHE . . . . . 0.559 ' HE1' ' HB2' ' B' 1146 ' ' ALA . 17.2 m-85 -82.24 -51.7 7.67 Favored 'General case' 0 C--O 1.257 1.484 0 N-CA-C 107.586 -1.265 . . . . 31.170000000000002 107.586 166.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1154 ' ' THR . . . . . . . . . . . . . 45.5 m -65.55 127.98 34.06 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 113.02 -1.9 . . . . 33.890000000000001 109.724 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -78.86 72.22 2.47 Favored Glycine 0 C--O 1.251 1.217 0 N-CA-C 109.247 -1.541 . . . . 38.950000000000003 109.247 172.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -85.03 131.75 34.42 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 103.983 -2.599 . . . . 54.229999999999997 103.983 -176.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 24.7 mm -84.16 93.54 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 N-CA-C 100.719 -3.808 . . . . 51.159999999999997 100.719 173.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1158 ' ' THR . . . . . . . . . . . . . 26.0 m -81.33 166.52 20.4 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.083 -1.08 . . . . 49.609999999999999 108.083 -170.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -51.09 -58.32 6.4 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 117.403 -1.285 . . . . 49.049999999999997 112.769 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1160 ' ' ALA . . . . . 0.531 ' HB3' HD22 ' A' 1326 ' ' LEU . . . -44.3 -53.12 7.0 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 116.984 2.216 . . . . 47.649999999999999 116.984 170.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1161 ' ' GLY . . . . . 0.599 ' HA3' HG21 ' A' 1329 ' ' THR . . . -177.96 -177.05 46.44 Favored Glycine 0 N--CA 1.426 -1.974 0 N-CA-C 109.103 -1.599 . . . . 45.609999999999999 109.103 -174.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 87.8 mttt -75.24 138.21 41.75 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.181 -1.009 . . . . 57.460000000000001 108.538 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1163 ' ' VAL . . . . . 0.516 HG11 ' HB2' ' B' 1152 ' ' PHE . 45.7 t -91.34 125.85 56.72 Favored Pre-proline 0 CA--C 1.511 -0.529 0 O-C-N 121.395 -0.816 . . . . 42.93 109.322 170.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1164 ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' B' 1165 ' ' PRO . 49.7 Cg_exo -66.22 122.06 9.49 Favored 'Trans proline' 0 C--O 1.26 1.587 0 C-N-CA 123.917 3.078 . . . . 39.289999999999999 106.029 158.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1165 ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' B' 1164 ' ' PRO . 31.3 Cg_exo -76.61 168.24 24.03 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.876 3.717 . . . . 34.170000000000002 114.091 -174.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1166 ' ' ALA . . . . . 0.426 ' HB2' ' HA ' ' B' 1153 ' ' PHE . . . -76.5 123.49 26.12 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 114.309 -1.314 . . . . 31.690000000000001 112.633 170.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1167 ' ' LYS . . . . . 0.718 ' HB2' ' HA ' ' B' 1249 ' ' VAL . 70.7 mttt -92.4 107.56 19.31 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 125.228 2.442 . . . . 44.780000000000001 110.495 165.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 40.2 t -91.76 94.68 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 113.902 -1.499 . . . . 31.23 109.314 -171.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1169 ' ' MET . . . . . 0.644 ' HB2' HG11 ' B' 1249 ' ' VAL . 40.6 ttp -88.99 96.36 10.7 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 123.415 1.579 . . . . 37.090000000000003 107.167 -177.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1170 ' ' VAL . . . . . 0.46 ' HA ' ' HB ' ' B' 1253 ' ' VAL . 38.8 t -83.75 114.78 24.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 113.242 -1.799 . . . . 30.170000000000002 107.974 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1171 ' ' ILE . . . . . 0.464 ' CD1' HD11 ' B' 1267 ' ' ILE . 78.9 mt -104.23 114.65 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 106.943 -1.502 . . . . 33.740000000000002 106.943 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 94.74 66.09 1.0 Allowed Glycine 0 N--CA 1.421 -2.313 0 N-CA-C 108.504 -1.839 . . . . 32.590000000000003 108.504 -177.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1173 ' ' ALA . . . . . 0.583 ' H ' ' HB2' ' B' 1195 ' ' ASP . . . -59.05 -9.03 1.68 Allowed 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 116.638 2.088 . . . . 32.420000000000002 116.638 -177.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -61.53 128.68 43.9 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 115.122 0.809 . . . . 31.739999999999998 115.122 173.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 22.4 t 56.19 -82.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 127.453 2.301 . . . . 31.48 111.407 170.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1176 ' ' ALA . . . . . 0.76 ' HB2' ' HB1' ' B' 1134 ' ' ALA . . . -65.53 -42.93 91.44 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.7 -1.222 . . . . 26.120000000000001 107.7 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1177 ' ' GLY . . . . . 0.502 ' O ' HG13 ' B' 1181 ' ' ILE . . . -52.71 -52.79 36.24 Favored Glycine 0 N--CA 1.43 -1.763 0 CA-C-N 118.665 0.666 . . . . 25.73 113.2 172.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1178 ' ' LEU . . . . . 0.524 ' HB3' ' HD2' ' C' ' 76' ' ' PRO . 96.6 mt -53.3 -46.67 69.44 Favored 'General case' 0 C--O 1.241 0.65 0 O-C-N 120.79 -1.418 . . . . 32.590000000000003 113.858 173.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -61.82 -40.17 94.34 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 120.23 -0.588 . . . . 27.719999999999999 111.365 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -66.34 -38.32 87.38 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 120.686 1.585 . . . . 26.030000000000001 108.907 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1181 ' ' ILE . . . . . 0.735 HG23 HG11 ' B' 1191 ' ' VAL . 70.9 mt -65.27 -47.16 88.36 Favored 'Isoleucine or valine' 0 C--N 1.36 1.033 0 O-C-N 125.347 1.654 . . . . 28.609999999999999 110.229 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -52.5 -55.24 23.47 Favored Glycine 0 N--CA 1.435 -1.374 0 C-N-CA 125.792 1.663 . . . . 25.23 111.376 174.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -61.96 -51.8 66.62 Favored 'General case' 0 C--O 1.251 1.166 0 C-N-CA 123.346 0.659 . . . . 24.09 111.425 -174.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -62.52 -41.09 98.63 Favored 'General case' 0 C--O 1.247 0.948 0 O-C-N 123.75 0.657 . . . . 26.68 111.123 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -63.31 -37.93 89.18 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 120.13 -1.606 . . . . 36.57 113.009 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1186 ' ' SER . . . . . . . . . . . . . 73.2 m -57.85 -49.83 75.37 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-O 122.804 1.287 . . . . 28.920000000000002 110.15 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1187 ' ' LEU . . . . . 0.817 ' HA ' ' HB3' ' A' 1186 ' ' SER . 12.6 mt -62.11 -21.89 65.36 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 118.192 2.664 . . . . 29.09 118.192 169.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 75.02 35.38 49.95 Favored Glycine 0 N--CA 1.433 -1.53 0 N-CA-C 109.053 -1.619 . . . . 29.260000000000002 109.053 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1189 ' ' ALA . . . . . . . . . . . . . . . -81.46 151.02 28.05 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.098 -1.816 . . . . 30.16 106.098 167.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1190 ' ' ILE . . . . . 0.458 ' HB ' ' HG2' ' B' 1167 ' ' LYS . 73.8 mt -78.74 97.49 2.35 Favored 'Isoleucine or valine' 0 C--O 1.246 0.914 0 N-CA-C 106.603 -1.629 . . . . 35.810000000000002 106.603 -174.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1191 ' ' VAL . . . . . 0.735 HG11 HG23 ' B' 1181 ' ' ILE . 57.7 t -79.94 136.75 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-N 115.408 -0.815 . . . . 31.969999999999999 109.102 -178.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1192 ' ' ARG . . . . . 0.69 ' HG2' ' HB2' ' B' 1210 ' ' GLU . 89.7 mtt180 -131.9 127.27 36.1 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 104.426 -2.435 . . . . 48.159999999999997 104.426 167.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -134.64 158.21 44.63 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 124.084 1.897 . . . . 35.890000000000001 115.618 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1194 ' ' PHE . . . . . 0.446 ' HB2' HD12 ' B' 1212 ' ' LEU . 35.5 t80 -139.28 132.98 30.63 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 114.029 -1.441 . . . . 41.880000000000003 107.167 -171.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1195 ' ' ASP . . . . . 0.829 ' HB3' HG21 ' B' 1200 ' ' VAL . 10.0 t70 -159.08 152.44 22.6 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 106.448 -1.686 . . . . 38.280000000000001 106.448 167.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1196 ' ' THR . . . . . . . . . . . . . 2.2 p -63.01 -44.3 96.37 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 113.997 1.11 . . . . 40.619999999999997 113.997 -177.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1197 ' ' ARG . . . . . 0.418 ' O ' HG22 ' B' 1200 ' ' VAL . 28.4 mtm180 -74.09 125.99 89.62 Favored Pre-proline 0 C--O 1.252 1.195 0 C-N-CA 119.67 -0.812 . . . . 53.090000000000003 111.711 -168.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -44.23 -33.79 6.32 Favored 'Trans proline' 0 C--O 1.248 0.984 1 C-N-CA 125.724 4.283 . . . . 42.560000000000002 118.219 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -54.05 -30.07 46.45 Favored 'General case' 0 C--N 1.347 0.479 0 N-CA-C 116.929 2.196 . . . . 56.310000000000002 116.929 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1200 ' ' VAL . . . . . 0.829 HG21 ' HB3' ' B' 1195 ' ' ASP . 6.4 m -71.82 -29.47 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 O-C-N 124.554 1.159 . . . . 42.909999999999997 110.196 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 34.9 tttm -54.58 -48.14 72.47 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 125.714 1.884 . . . . 48.890000000000001 113.6 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.93 -48.87 77.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 117.658 -1.163 . . . . 51.700000000000003 108.869 175.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1203 ' ' GLN . . . . . 0.846 ' HG2' ' HG3' ' C' ' 74' ' ' ARG . 54.5 mt-30 -58.89 -46.37 88.02 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 125.225 1.578 . . . . 52.57 113.978 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1204 ' ' VAL . . . . . 0.445 ' O ' ' HB3' ' B' 1209 ' ' ALA . 48.5 t -62.52 -46.48 96.29 Favored 'Isoleucine or valine' 0 C--O 1.257 1.498 0 CA-C-N 120.429 1.468 . . . . 33.789999999999999 107.744 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -54.85 -38.77 67.86 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.563 1.145 . . . . 36.579999999999998 114.025 173.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1206 ' ' SER . . . . . . . . . . . . . 12.0 m -63.38 -37.03 85.68 Favored 'General case' 0 C--N 1.347 0.482 0 O-C-N 121.171 -0.955 . . . . 39.609999999999999 110.215 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1207 ' ' MET . . . . . 0.534 ' SD ' HD22 ' C' ' 75' ' ' LEU . 4.9 mtt -87.63 28.34 1.01 Allowed 'General case' 0 C--O 1.248 1.013 0 O-C-N 117.659 -3.151 . . . . 37.450000000000003 113.906 -175.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 55.45 30.57 55.85 Favored Glycine 0 CA--C 1.538 1.516 0 O-C-N 120.589 -1.319 . . . . 31.870000000000001 113.737 -176.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1209 ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' B' 1204 ' ' VAL . . . -119.04 142.01 48.22 Favored 'General case' 0 N--CA 1.428 -1.541 0 O-C-N 119.582 -2.128 . . . . 35.399999999999999 108.87 -164.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1210 ' ' GLU . . . . . 0.69 ' HB2' ' HG2' ' B' 1192 ' ' ARG . 34.5 mt-10 -80.61 129.08 34.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 118.694 -1.202 . . . . 47.890000000000001 108.846 -176.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 45.5 t80 -90.09 132.7 35.28 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 101.473 -3.529 . . . . 45.530000000000001 101.473 178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1212 ' ' LEU . . . . . 0.446 HD12 ' HB2' ' B' 1194 ' ' PHE . 63.4 mt -84.73 121.58 27.89 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 103.689 -2.708 . . . . 46.329999999999998 103.689 173.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -68.81 147.94 51.02 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 115.496 1.665 . . . . 60.409999999999997 115.496 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 21.5 mt -66.6 140.64 57.96 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 112.588 -2.096 . . . . 57.380000000000003 107.002 167.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1215 ' ' ASP . . . . . 0.43 ' H ' ' HE1' ' B' 1234 ' ' PHE . 23.4 t70 . . . . . 0 N--CA 1.433 -1.325 0 N-CA-C 107.472 -1.307 . . . . 65.069999999999993 107.472 177.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1230 ' ' MET . . . . . 0.417 ' HB3' ' CB ' ' B' 1234 ' ' PHE . 5.4 mmm . . . . . 0 N--CA 1.433 -1.319 0 N-CA-C 104.705 -2.331 . . . . 80.319999999999993 104.705 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1231 ' ' SER . . . . . . . . . . . . . 2.6 m 78.84 -173.11 0.06 Allowed 'General case' 0 CA--C 1.539 0.542 2 O-C-N 111.99 -6.694 . . . . 79.920000000000002 118.805 -17.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1232 ' ' ASP . . . . . 0.544 ' HA ' HG12 ' B' 1235 ' ' ILE . 23.8 p-10 -43.25 154.99 0.07 Allowed 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 119.203 3.038 . . . . 77.909999999999997 119.203 -177.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 62.97 -59.19 0.15 Allowed 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 112.253 -2.248 . . . . 73.879999999999995 109.439 -159.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1234 ' ' PHE . . . . . 0.43 ' HE1' ' H ' ' B' 1215 ' ' ASP . 8.3 t80 -55.76 -44.78 77.99 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 120.044 -1.66 . . . . 68.980000000000004 113.765 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1235 ' ' ILE . . . . . 0.544 HG12 ' HA ' ' B' 1232 ' ' ASP . 8.0 pt -44.6 -38.88 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 121.772 2.078 . . . . 64.530000000000001 112.754 175.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1236 ' ' LYS . . . . . 0.489 ' HG2' HG13 ' B' 1235 ' ' ILE . 23.7 mmmt -75.83 -38.03 58.48 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 118.055 -0.974 . . . . 66.359999999999999 109.627 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -65.22 -26.22 68.03 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 120.91 1.687 . . . . 56.600000000000001 113.243 175.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -66.45 -47.99 71.4 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 106.786 -1.561 . . . . 56.789999999999999 106.786 175.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1239 ' ' MET . . . . . 0.474 ' HB2' ' O ' ' B' 1236 ' ' LYS . 19.6 mmm -49.84 -49.18 50.06 Favored 'General case' 0 C--O 1.25 1.087 0 O-C-N 124.528 1.143 . . . . 53.630000000000003 111.666 171.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.76 -37.06 85.3 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 121.243 0.544 . . . . 51.740000000000002 110.817 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1241 ' ' LEU . . . . . 0.437 HD21 ' HB3' ' B' 1212 ' ' LEU . 60.3 tp -64.78 -47.94 76.31 Favored 'General case' 0 C--N 1.342 0.25 0 O-C-N 120.555 -1.34 . . . . 44.859999999999999 107.57 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1242 ' ' PHE . . . . . 0.604 ' HE2' HD13 ' B' 1266 ' ' LEU . 14.8 m-30 -65.88 -34.06 77.26 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 124.546 1.138 . . . . 42.780000000000001 111.26 -174.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1243 ' ' ALA . . . . . 0.441 ' HA ' ' HG3' ' B' 1271 ' ' MET . . . -67.14 -51.3 55.61 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 113.929 1.085 . . . . 40.960000000000001 113.929 172.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -69.59 -28.92 66.36 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 122.492 1.139 . . . . 43.060000000000002 108.763 -173.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1245 ' ' GLN . . . . . 0.4 ' O ' HG22 ' B' 1249 ' ' VAL . 43.3 mm-40 -75.53 -37.27 60.18 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.369 -1.457 . . . . 46.450000000000003 112.608 171.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1246 ' ' ALA . . . . . 0.485 ' HA ' HG22 ' B' 1249 ' ' VAL . . . -60.67 -23.42 64.81 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 115.284 1.587 . . . . 41.780000000000001 115.284 177.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1247 ' ' LYS . . . . . 0.404 ' HD2' ' HA ' ' B' 1247 ' ' LYS . 26.0 tptt -62.44 -41.85 99.04 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.196 -0.911 . . . . 52.200000000000003 109.42 171.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1248 ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -91.26 -30.8 16.41 Favored 'General case' 0 C--O 1.244 0.808 0 O-C-N 121.586 -0.696 . . . . 53.549999999999997 112.705 -172.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1249 ' ' VAL . . . . . 0.718 ' HA ' ' HB2' ' B' 1167 ' ' LYS . 19.1 m -84.2 169.43 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 124.684 2.183 . . . . 34.409999999999997 114.808 -173.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1250 ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -111.99 -61.89 1.65 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 111.635 -2.53 . . . . 33.380000000000003 111.573 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1251 ' ' ILE . . . . . 0.582 ' HA ' ' O ' ' B' 1280 ' ' VAL . 48.5 mm -107.24 106.69 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 123.839 0.712 . . . . 29.539999999999999 109.097 -173.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1252 ' ' ILE . . . . . 0.634 ' HB ' HG12 ' B' 1281 ' ' ILE . 51.1 mt -92.41 118.5 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 N-CA-C 105.086 -2.19 . . . . 32.439999999999998 105.086 176.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1253 ' ' VAL . . . . . 0.46 ' HB ' ' HA ' ' B' 1170 ' ' VAL . 72.2 t -102.32 87.29 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.254 1.339 0 N-CA-C 104.634 -2.358 . . . . 30.57 104.634 -178.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1254 ' ' THR . . . . . . . . . . . . 0.331 1.4 t -91.3 103.53 16.18 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 127.096 3.331 . . . . 35.039999999999999 112.739 -175.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1255 ' ' THR . . . . . . . . . . . . . 17.1 m -99.7 -26.89 13.91 Favored 'General case' 0 C--N 1.318 -0.797 1 CA-C-N 106.0 -5.091 . . . . 34.619999999999997 109.451 -177.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1256 ' ' ALA . . . . . 0.495 ' HB3' ' ND2' ' B' 1291 ' ' ASN . . . -47.79 96.65 0.01 OUTLIER 'General case' 0 C--O 1.257 1.475 0 CA-C-N 123.499 2.863 . . . . 42.719999999999999 117.74 -169.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1257 ' ' LEU . . . . . 0.431 HD11 ' HB3' ' B' 1288 ' ' ASN . 3.7 tt -133.9 146.0 50.14 Favored 'General case' 0 C--O 1.251 1.156 0 N-CA-C 101.845 -3.391 . . . . 52.43 101.845 -173.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 64.4 mt -119.08 122.14 29.82 Favored Pre-proline 0 C--N 1.313 -1.002 1 N-CA-C 100.102 -4.036 . . . . 59.409999999999997 100.102 177.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -56.0 126.73 23.35 Favored 'Trans proline' 0 C--O 1.247 0.955 0 C-N-CA 123.441 2.76 . . . . 62.68 115.659 -173.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 82.26 2.0 90.5 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 112.955 -1.929 . . . . 64.159999999999997 111.366 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 85.3 mttt -120.39 145.79 41.36 Favored Pre-proline 0 N--CA 1.475 0.801 0 O-C-N 118.474 -2.78 . . . . 68.530000000000001 105.181 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -56.19 136.56 75.85 Favored 'Trans proline' 0 C--N 1.362 1.273 0 C-N-CA 123.899 3.066 . . . . 61.990000000000002 112.077 164.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1263 ' ' ALA . . . . . 0.549 ' H ' ' HA3' ' B' 1289 ' ' GLY . . . -61.3 119.83 49.66 Favored Pre-proline 0 C--O 1.242 0.671 0 CA-C-N 113.024 -1.898 . . . . 57.149999999999999 112.28 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1264 ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' B' 1263 ' ' ALA . 94.6 Cg_endo -55.08 146.49 58.53 Favored 'Trans proline' 0 CA--C 1.501 -1.157 0 C-N-CA 124.718 3.612 . . . . 51.57 112.339 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -87.91 68.31 9.25 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 122.916 1.341 . . . . 54.549999999999997 109.342 -171.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1266 ' ' LEU . . . . . 0.604 HD13 ' HE2' ' B' 1242 ' ' PHE . 91.0 mt -81.03 -30.15 34.92 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 111.51 -2.586 . . . . 46.859999999999999 111.798 -172.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1267 ' ' ILE . . . . . 0.588 ' HB ' ' HA ' ' B' 1292 ' ' CYS . 28.3 mm -96.82 100.35 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 N-CA-C 104.665 -2.346 . . . . 41.039999999999999 104.665 177.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1268 ' ' THR . . . . . . . . . . . . . 1.1 p -75.03 151.42 38.73 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 125.486 1.741 . . . . 39.579999999999998 113.222 175.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1269 ' ' ARG . . . . . . . . . . . . . 78.1 mtt85 -57.65 -40.85 80.23 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-N 119.805 1.184 . . . . 53.149999999999999 111.5 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -54.61 -43.6 72.37 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 114.759 1.392 . . . . 42.960000000000001 114.759 169.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1271 ' ' MET . . . . . 0.441 ' HG3' ' HA ' ' B' 1243 ' ' ALA . 39.4 ttm -60.8 -47.95 84.0 Favored 'General case' 0 C--O 1.241 0.613 0 O-C-N 120.945 -1.097 . . . . 43.890000000000001 111.846 176.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1272 ' ' VAL . . . . . 0.474 HG13 HD12 ' B' 1281 ' ' ILE . 15.3 t -55.26 -52.4 45.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-N 115.091 -0.959 . . . . 38.369999999999997 110.113 175.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.94 2.24 7.25 Favored 'General case' 0 C--N 1.362 1.129 0 N-CA-C 115.039 1.496 . . . . 47.460000000000001 115.039 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1274 ' ' SER . . . . . . . . . . . . . 50.3 m -97.26 -14.58 21.29 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 114.79 1.404 . . . . 38.380000000000003 114.79 172.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1275 ' ' MET . . . . . 0.487 ' SD ' HD11 ' B' 1281 ' ' ILE . 94.1 mtp -64.14 171.27 3.08 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 116.484 2.031 . . . . 37.810000000000002 116.484 -177.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -66.63 147.21 53.58 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 114.28 -1.327 . . . . 49.259999999999998 109.723 165.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -79.1 161.47 26.49 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.859 0.837 . . . . 34.460000000000001 112.931 174.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 81.3 25.22 55.32 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 112.712 -2.04 . . . . 33.530000000000001 112.926 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1279 ' ' SER . . . . . . . . . . . . . 13.0 m -126.64 165.35 19.38 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 116.439 -1.743 . . . . 31.309999999999999 111.363 -163.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1280 ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' B' 1251 ' ' ILE . 73.8 t -136.7 136.89 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 124.165 3.166 . . . . 29.32 109.856 -171.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1281 ' ' ILE . . . . . 0.634 HG12 ' HB ' ' B' 1252 ' ' ILE . 76.0 mt -113.26 113.36 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 103.735 -2.691 . . . . 31.93 103.735 171.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1282 ' ' VAL . . . . . 0.405 HG11 ' HA ' ' B' 1141 ' ' ALA . 4.0 t -99.33 123.27 51.92 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 N-CA-C 106.408 -1.701 . . . . 29.48 106.408 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 18.2 t0 -93.69 108.76 20.46 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 114.797 -1.092 . . . . 34.5 109.013 174.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1284 ' ' LEU . . . . . 0.495 ' HA ' HD12 ' B' 1315 ' ' LEU . 7.9 mp -84.27 -37.28 21.92 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 104.621 -2.363 . . . . 37.939999999999998 104.621 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -80.57 8.23 8.3 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 122.497 1.141 . . . . 40.920000000000002 113.277 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1286 ' ' ALA . . . . . 0.551 ' HA ' ' HA2' ' B' 1290 ' ' GLY . . . -43.46 -47.0 7.03 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 117.839 2.533 . . . . 44.390000000000001 117.839 175.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1287 ' ' GLN . . . . . 0.443 ' HA ' HG22 ' B' 1313 ' ' THR . 0.6 OUTLIER -75.17 -30.09 60.61 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 112.931 0.715 . . . . 51.460000000000001 112.931 -175.332 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B 1288 ' ' ASN . . . . . 0.431 ' HB3' HD11 ' B' 1257 ' ' LEU . 0.5 OUTLIER -107.52 48.1 0.86 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 122.931 1.348 . . . . 57.75 108.559 178.748 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B 1289 ' ' GLY . . . . . 0.549 ' HA3' ' H ' ' B' 1263 ' ' ALA . . . 129.21 -29.43 3.88 Favored Glycine 0 N--CA 1.428 -1.883 0 O-C-N 119.46 -2.025 . . . . 49.850000000000001 116.381 169.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1290 ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' B' 1286 ' ' ALA . . . 76.88 100.79 0.16 Allowed Glycine 0 C--O 1.245 0.804 0 CA-C-N 119.111 1.456 . . . . 45.93 109.775 -176.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1291 ' ' ASN . . . . . 0.495 ' ND2' ' HB3' ' B' 1256 ' ' ALA . 22.8 t-20 -71.48 -39.99 70.53 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 119.406 -2.232 . . . . 42.670000000000002 113.647 175.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1292 ' ' CYS . . . . . 0.588 ' HA ' ' HB ' ' B' 1267 ' ' ILE . 36.1 t -83.4 150.69 25.9 Favored 'General case' 0 C--O 1.24 0.593 0 O-C-N 119.911 -1.743 . . . . 38.82 106.821 171.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1293 ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -75.39 -49.86 17.68 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 122.58 1.181 . . . . 46.710000000000001 109.251 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1294 ' ' TYR . . . . . 0.444 ' HB3' HG11 ' B' 1309 ' ' VAL . 0.1 OUTLIER -59.13 -18.29 34.44 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 115.655 1.724 . . . . 47.229999999999997 115.655 -174.503 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B 1295 ' ' THR . . . . . 0.515 ' O ' ' HD3' ' B' 1297 ' ' PRO . 97.0 m -37.69 105.17 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 115.64 1.719 . . . . 36.020000000000003 115.64 168.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 71.4 t -88.34 106.18 11.69 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 105.785 -1.931 . . . . 37.259999999999998 105.785 170.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1297 ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' B' 1295 ' ' THR . 60.5 Cg_exo -58.89 111.42 0.89 Allowed 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 123.241 2.627 . . . . 35.090000000000003 115.811 -177.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 95.55 10.69 56.58 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 113.307 -1.77 . . . . 35.969999999999999 111.059 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -148.01 -178.03 6.06 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 124.9 2.286 . . . . 40.390000000000001 110.046 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1300 ' ' ILE . . . . . 0.588 HD13 ' HG3' ' B' 1148 ' ' GLU . 30.3 mt -110.71 162.79 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 111.006 -2.815 . . . . 37.43 105.367 172.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 61.0 t80 -150.77 130.38 13.08 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 104.052 -2.573 . . . . 44.130000000000003 104.052 170.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1302 ' ' THR . . . . . . . . . . . . . 25.7 m -95.62 136.16 36.37 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.447 -0.945 . . . . 39.780000000000001 108.447 173.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1303 ' ' THR . . . . . . . . . . . . . 46.6 p -77.25 177.22 8.07 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.287 -1.324 . . . . 43.289999999999999 113.015 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -57.63 -59.02 5.82 Favored 'General case' 0 N--CA 1.435 -1.214 0 O-C-N 121.091 -1.006 . . . . 53.07 110.805 162.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -60.5 -22.75 63.89 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 113.759 1.022 . . . . 43.969999999999999 113.759 -174.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 108.62 47.42 0.91 Allowed Glycine 0 N--CA 1.432 -1.583 0 CA-C-O 122.57 1.094 . . . . 41.119999999999997 112.713 166.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1307 ' ' VAL . . . . . 0.435 HG21 ' HB2' ' B' 1275 ' ' MET . 95.1 t -122.95 128.16 75.06 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 N-CA-C 102.226 -3.25 . . . . 38.119999999999997 102.226 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1308 ' ' LYS . . . . . 0.477 ' HB2' HG22 ' B' 1280 ' ' VAL . 43.7 mmtt -83.53 109.02 17.04 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 103.013 -2.958 . . . . 36.340000000000003 103.013 176.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1309 ' ' VAL . . . . . 0.444 HG11 ' HB3' ' B' 1294 ' ' TYR . 44.9 t -88.1 113.44 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 O-C-N 117.288 -3.382 . . . . 30.399999999999999 103.284 168.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1310 ' ' ILE . . . . . 0.49 HG12 HG23 ' B' 1300 ' ' ILE . 19.2 mt -102.41 100.16 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-N 113.617 -1.629 . . . . 30.82 107.626 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1311 ' ' GLY . . . . . 0.494 ' HA3' HG23 ' B' 1295 ' ' THR . . . -97.57 53.59 1.29 Allowed Glycine 0 C--N 1.352 1.426 0 C-N-CA 119.084 -1.531 . . . . 26.530000000000001 110.704 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1312 ' ' TYR . . . . . 0.438 ' O ' ' HG ' ' B' 1315 ' ' LEU . 0.6 OUTLIER -74.88 94.37 2.79 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 120.759 -1.436 . . . . 38.0 108.745 -171.889 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B 1313 ' ' THR . . . . . 0.443 HG22 ' HA ' ' B' 1287 ' ' GLN . 0.7 OUTLIER -54.76 -35.33 63.65 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 121.077 -1.014 . . . . 29.800000000000001 112.24 174.551 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -75.1 4.28 7.08 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 126.758 2.023 . . . . 39.039999999999999 115.376 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1315 ' ' LEU . . . . . 0.495 HD12 ' HA ' ' B' 1284 ' ' LEU . 34.6 mt -43.9 -50.99 18.52 Favored Pre-proline 0 N--CA 1.465 0.301 0 N-CA-C 118.231 2.678 . . . . 31.079999999999998 118.231 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1316 ' ' PRO . . . . . 0.509 ' HB3' ' HB3' ' B' 1133 ' ' MET . 34.3 Cg_exo -56.84 -27.5 72.31 Favored 'Trans proline' 0 CA--C 1.546 1.094 0 C-N-CA 123.628 2.886 . . . . 26.100000000000001 115.315 174.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -82.06 -35.01 22.5 Favored Glycine 0 N--CA 1.435 -1.407 0 O-C-N 120.715 -1.24 . . . . 23.170000000000002 110.139 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -52.52 3.43 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.588 1 N-CA-C 123.437 4.606 . . . . 40.399999999999999 123.437 -171.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 21.3 tp -132.75 66.54 76.71 Favored Pre-proline 0 C--O 1.243 0.741 0 O-C-N 118.746 -2.471 . . . . 23.600000000000001 108.269 -175.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1320 ' ' PRO . . . . . 0.635 ' HG2' ' HA2' ' A' 1150 ' ' GLY . 19.1 Cg_endo -26.57 -71.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.053 1 C-N-CA 126.196 4.597 . . . . 22.350000000000001 118.72 -166.323 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B 1321 ' ' THR . . . . . 0.483 HG23 ' HD2' ' B' 1045 ' ' PHE . 3.3 m -67.48 -40.62 85.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 119.952 1.251 . . . . 26.52 108.995 -169.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1322 ' ' GLN . . . . . 0.803 ' HB2' ' HA ' ' A' 1151 ' ' ARG . 32.4 tp60 -79.11 -33.14 44.6 Favored 'General case' 0 CA--C 1.488 -1.41 0 O-C-N 120.66 -1.275 . . . . 24.379999999999999 110.882 -173.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1323 ' ' SER . . . . . . . . . . . . . 71.3 m -63.07 -47.5 82.66 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 109.184 -0.673 . . . . 22.800000000000001 109.184 176.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1324 ' ' SER . . . . . . . . . . . . . 22.0 m -58.32 -37.0 74.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 122.881 1.324 . . . . 21.25 114.248 175.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1325 ' ' GLN . . . . . 0.489 ' NE2' HG23 ' B' 1022 ' ' THR . 51.6 tp60 -65.03 -54.36 31.43 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.468 -1.242 . . . . 31.34 111.804 176.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1326 ' ' LEU . . . . . . . . . . . . . 23.8 mt -73.09 -40.4 65.03 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 117.688 -1.149 . . . . 31.559999999999999 110.944 -172.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1327 ' ' TYR . . . . . . . . . . . . . 42.5 t80 -57.94 -50.95 71.62 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 106.118 -1.808 . . . . 22.73 106.118 173.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1328 ' ' GLY . . . . . 0.717 ' HA3' HG21 ' B' 1022 ' ' THR . . . -52.36 -42.63 56.91 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 114.582 0.593 . . . . 21.91 114.582 174.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1329 ' ' THR . . . . . . . . . . . . . 5.5 m -71.94 -25.45 61.89 Favored 'General case' 0 C--O 1.249 1.057 0 O-C-N 120.52 -1.577 . . . . 22.149999999999999 111.936 176.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1330 ' ' ASN . . . . . 0.448 ' ND2' ' HB2' ' A' 1160 ' ' ALA . 24.7 m120 -62.56 -37.45 86.21 Favored 'General case' 0 C--O 1.249 1.04 0 CA-C-N 120.893 1.679 . . . . 26.18 110.58 170.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1331 ' ' LEU . . . . . 0.715 HD22 HD22 ' B' 1070 ' ' LEU . 59.1 mt -68.65 -44.0 75.07 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 113.859 -1.519 . . . . 23.68 109.977 176.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1332 ' ' VAL . . . . . 0.548 HG13 HD11 ' B' 1029 ' ' LEU . 69.9 t -53.4 -55.36 13.32 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 CA-C-O 116.846 -1.55 . . . . 26.57 108.139 174.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1333 ' ' ASN . . . . . 0.693 ' HA ' ' HD2' ' B' 1336 ' ' LYS . 84.4 m-20 -55.8 -40.29 72.52 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 115.459 1.652 . . . . 28.079999999999998 115.459 175.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1334 ' ' LEU . . . . . 0.457 ' CD2' HG11 ' B' 1090 ' ' VAL . 12.9 tp -56.54 -48.24 77.7 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 124.722 1.209 . . . . 27.43 111.357 169.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1335 ' ' LEU . . . . . 0.458 ' HA ' ' HB2' ' B' 1338 ' ' LEU . 7.2 mt -71.62 -22.32 61.72 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 119.92 -0.712 . . . . 30.5 111.648 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1336 ' ' LYS . . . . . 0.693 ' HD2' ' HA ' ' B' 1333 ' ' ASN . 97.0 mttt -67.01 -47.98 69.79 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.297 -1.001 . . . . 41.649999999999999 108.297 171.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1337 ' ' LEU . . . . . 0.732 HD21 ' HD2' ' B' 1123 ' ' ARG . 6.6 mp -71.21 -35.08 71.39 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 119.591 -1.943 . . . . 42.079999999999998 112.053 176.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1338 ' ' LEU . . . . . 0.458 ' HB2' ' HA ' ' B' 1335 ' ' LEU . 35.9 mt -69.78 -68.27 0.43 Allowed 'General case' 0 N--CA 1.438 -1.048 0 O-C-N 119.638 -1.914 . . . . 35.030000000000001 110.446 176.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1339 ' ' CYS . . . . . 0.515 ' SG ' ' HA ' ' B' 1342 ' ' LYS . 52.6 t -93.32 69.86 4.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.929 1.347 . . . . 37.329999999999998 108.595 -174.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 57.3 mttp -65.88 -27.81 68.49 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 114.193 1.183 . . . . 50.509999999999998 114.193 -175.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -71.44 -21.32 61.99 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 120.998 -1.064 . . . . 54.210000000000001 112.646 168.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1342 ' ' LYS . . . . . 0.515 ' HA ' ' SG ' ' B' 1339 ' ' CYS . 7.3 mptt 52.07 50.48 18.42 Favored 'General case' 0 C--O 1.252 1.199 0 CA-C-O 124.969 2.319 . . . . 50.990000000000002 111.575 -163.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -76.55 -33.24 58.54 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 111.264 -2.698 . . . . 48.82 111.274 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1344 ' ' GLY . . . . . 0.424 ' O ' ' HA2' ' B' 1001 ' ' GLY . . . 108.34 14.45 16.35 Favored Glycine 0 C--O 1.244 0.77 0 CA-C-O 117.748 -1.585 . . . . 40.43 112.194 174.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -131.09 156.47 45.16 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 104.835 -2.283 . . . . 47.560000000000002 104.835 166.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1346 ' ' ILE . . . . . 0.562 HG13 HG23 ' B' 1068 ' ' ILE . 26.2 mm -81.95 94.23 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 O-C-N 118.955 -2.34 . . . . 42.490000000000002 112.195 -172.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1347 ' ' THR . . . . . . . . . . . . . 88.1 m -59.21 105.31 0.32 Allowed 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 106.919 -1.511 . . . . 38.119999999999997 106.919 159.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 21.7 t -90.46 96.43 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 104.761 -2.311 . . . . 37.5 104.761 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 6.6 t70 -75.39 129.03 36.67 Favored 'General case' 0 C--O 1.265 1.891 0 CA-C-N 110.995 -2.821 . . . . 43.850000000000001 110.301 -175.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1350 ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -117.24 0.82 12.37 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.934 -1.104 . . . . 39.810000000000002 111.508 175.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 7.9 t70 -81.13 -43.86 18.77 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 119.236 0.926 . . . . 51.289999999999999 109.857 -175.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.2 145.13 51.64 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-O 122.105 0.955 . . . . 39.780000000000001 110.936 174.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1353 ' ' VAL . . . . . 0.467 ' HB ' HG13 ' B' 1373 ' ' ILE . 28.7 m -68.47 -36.67 75.75 Favored 'Isoleucine or valine' 0 C--O 1.25 1.131 0 CA-C-N 114.952 -1.022 . . . . 39.280000000000001 110.726 -173.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1354 ' ' VAL . . . . . 0.629 HG21 ' HG3' ' B' 1123 ' ' ARG . 49.7 t -70.41 -47.71 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 O-C-N 121.799 -0.563 . . . . 35.700000000000003 111.19 -172.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1355 ' ' ILE . . . . . 0.717 ' HA ' HG12 ' B' 1358 ' ' VAL . 38.7 mm -70.11 -41.52 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 O-C-N 121.398 -0.813 . . . . 35.770000000000003 109.797 176.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 47.3 tpt85 -47.63 -32.54 5.67 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 115.375 1.62 . . . . 38.549999999999997 115.375 169.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1357 ' ' GLY . . . . . 0.585 ' CA ' ' HB2' ' B' 1370 ' ' ALA . . . -91.94 -40.87 5.12 Favored Glycine 0 N--CA 1.442 -0.901 0 O-C-N 121.627 -0.67 . . . . 29.579999999999998 114.011 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1358 ' ' VAL . . . . . 0.717 HG12 ' HA ' ' B' 1355 ' ' ILE . 4.0 p -66.76 -36.42 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 114.454 1.279 . . . . 32.060000000000002 114.454 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1359 ' ' THR . . . . . . . . . . . . . 4.1 m -72.35 81.16 1.03 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 123.3 1.524 . . . . 29.0 107.205 175.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1360 ' ' VAL . . . . . 0.458 HG11 ' HG2' ' B' 1095 ' ' PRO . 14.6 m -63.24 -29.23 46.73 Favored 'Isoleucine or valine' 0 C--O 1.248 1.001 0 O-C-N 121.129 -0.982 . . . . 29.68 113.392 177.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 49.1 mt -138.3 108.6 4.83 Favored 'Isoleucine or valine' 0 C--O 1.249 1.058 0 N-CA-C 104.173 -2.529 . . . . 32.049999999999997 104.173 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1362 ' ' ARG . . . . . 0.664 ' HA ' HG23 ' B' 1111 ' ' THR . 57.1 ttt180 -91.5 105.08 17.5 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 117.99 -2.944 . . . . 32.520000000000003 107.396 169.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1363 ' ' ALA . . . . . 0.654 ' H ' ' HA ' ' B' 1111 ' ' THR . . . 45.45 58.82 3.94 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 116.91 2.189 . . . . 35.68 116.91 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 91.96 -47.27 2.7 Favored Glycine 0 CA--C 1.538 1.53 0 CA-C-O 118.017 -1.435 . . . . 34.259999999999998 112.646 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -68.32 115.31 7.62 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 123.265 1.507 . . . . 51.07 109.58 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 24.4 mt -74.76 95.8 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.981 0 CA-C-O 123.427 1.584 . . . . 39.869999999999997 112.54 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1367 ' ' THR . . . . . . . . . . . . . 11.8 p -90.43 13.63 15.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 110.445 -3.071 . . . . 38.009999999999998 113.039 -174.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1368 ' ' TRP . . . . . . . . . . . . . 32.2 t90 -77.96 135.8 62.78 Favored Pre-proline 0 C--O 1.233 0.197 0 C-N-CA 125.582 1.553 . . . . 42.140000000000001 111.024 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -91.19 -167.83 3.03 Favored 'Cis proline' 0 CA--C 1.542 0.877 0 CA-C-N 123.616 2.327 . . . . 43.259999999999998 110.21 -9.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1370 ' ' ALA . . . . . 0.585 ' HB2' ' CA ' ' B' 1357 ' ' GLY . . . -72.34 167.86 28.64 Favored Pre-proline 0 C--O 1.244 0.8 0 CA-C-O 117.142 -1.408 . . . . 46.520000000000003 110.136 163.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1371 ' ' PRO . . . . . 0.514 ' O ' HG12 ' B' 1373 ' ' ILE . 29.6 Cg_endo -56.55 151.48 46.02 Favored 'Trans proline' 0 CA--C 1.548 1.191 0 CA-C-N 125.864 3.13 . . . . 51.950000000000003 109.07 164.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -64.65 100.44 0.34 Allowed 'Trans proline' 0 C--O 1.24 0.589 0 C-N-CA 122.477 2.118 . . . . 56.270000000000003 113.779 -168.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1373 ' ' ILE . . . . . 0.514 HG12 ' O ' ' B' 1371 ' ' PRO . 17.0 mm -100.63 101.33 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 102.22 -3.252 . . . . 60.829999999999998 102.22 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -62.55 120.23 10.74 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 122.78 1.276 . . . . 66.099999999999994 109.764 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 16.4 t -81.76 121.89 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 104.213 -2.514 . . . . 63.469999999999999 104.213 176.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.227 -4.724 0 O-C-N 121.92 -0.488 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.291 0 CA-C-O 120.375 0.131 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.35 -32.81 40.12 Favored 'General case' 0 C--O 1.214 -0.789 0 C-N-CA 124.74 1.216 . . . . 0.0 113.983 176.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -70.14 -63.33 1.1 Allowed 'General case' 0 C--O 1.245 0.865 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 170.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 23' ' ' THR . . . . . 0.564 ' HA ' HD22 ' C' ' 26' ' ' LEU . 0.2 OUTLIER -45.36 -34.84 3.22 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 125.748 1.619 . . . . 0.0 115.061 -174.486 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.45 -67.0 0.29 Allowed 'General case' 0 C--O 1.256 1.419 0 N-CA-C 115.238 1.569 . . . . 0.0 115.238 166.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -55.43 -38.09 68.54 Favored 'General case' 0 C--N 1.356 0.88 0 O-C-N 119.942 -1.724 . . . . 0.0 113.457 173.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.564 HD22 ' HA ' ' C' ' 23' ' ' THR . 4.8 mp -59.25 -43.4 92.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.438 176.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.555 HD11 HD12 ' C' ' 182' ' ' ILE . 13.6 mt -58.2 -53.46 58.01 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 125.139 1.375 . . . . 0.0 114.268 177.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 28' ' ' LYS . . . . . . . . . . . . . 11.9 pttm -58.58 -31.86 68.41 Favored 'General case' 0 C--O 1.242 0.708 0 O-C-N 120.004 -1.685 . . . . 0.0 113.726 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -65.62 -32.31 73.81 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 174.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.536 ' HA ' ' HB3' ' C' ' 107' ' ' ASP . 67.1 m -58.45 -34.55 70.96 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 119.609 3.188 . . . . 0.0 119.609 -158.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 59.98 -76.93 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 122.509 2.413 . . . . 0.0 107.396 -165.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 32' ' ' SER . . . . . 0.746 ' HB2' ' HA ' ' C' ' 106' ' ' THR . 15.4 m -96.32 136.2 37.12 Favored 'General case' 0 C--O 1.243 0.724 0 O-C-N 118.087 -2.883 . . . . 0.0 110.089 175.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 91.3 t -129.89 122.96 55.68 Favored 'Isoleucine or valine' 0 C--O 1.247 0.962 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.777 ' HB ' HG13 ' C' ' 109' ' ' VAL . 26.9 mm -100.12 117.99 46.13 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 168.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 27.7 mt -94.36 118.04 39.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 119.481 1.037 . . . . 0.0 109.663 170.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 36' ' ' THR . . . . . 0.501 ' HA ' ' HD3' ' C' ' 37' ' ' PRO . 3.6 m -102.96 108.28 57.98 Favored Pre-proline 0 CA--C 1.55 0.95 0 O-C-N 120.172 -1.58 . . . . 0.0 112.424 -176.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 37' ' ' PRO . . . . . 0.707 ' HG2' HG13 ' C' ' 68' ' ' ILE . 32.5 Cg_exo -74.17 37.74 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 1 C-N-CA 125.657 4.238 . . . . 0.0 118.772 -175.067 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 38' ' ' GLY . . . . . 0.499 ' HA3' ' HB2' ' C' ' 114' ' ' ALA . . . -88.24 94.35 1.98 Allowed Glycine 0 C--N 1.335 0.489 0 O-C-N 119.555 -1.966 . . . . 0.0 111.987 -166.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 39' ' ' TYR . . . . . 0.59 ' HB2' ' HA3' ' C' ' 73' ' ' GLY . 23.4 t80 68.66 -57.07 0.51 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 116.922 -1.513 . . . . 0.0 114.648 175.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -49.07 -46.87 33.29 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-N 120.39 1.45 . . . . 0.0 113.301 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 41' ' ' MET . . . . . 0.575 ' HA ' ' HB3' ' C' ' 46' ' ' ALA . 49.1 ttm -44.67 -52.07 8.58 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 173.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.86 -59.15 2.85 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.812 -175.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 8.2 p -57.84 -43.81 85.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 122.881 1.325 . . . . 0.0 109.179 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 44' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' C' ' 176' ' ' LYS . . . -85.44 6.66 25.79 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 119.801 -1.812 . . . . 0.0 113.496 -176.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 45' ' ' GLN . . . . . . . . . . . . 0.348 0.0 OUTLIER 49.52 25.87 1.53 Allowed 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 118.175 2.657 . . . . 0.0 118.175 -169.17 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.575 ' HB3' ' HA ' ' C' ' 41' ' ' MET . . . -70.2 -8.33 49.08 Favored 'General case' 0 C--O 1.255 1.359 0 O-C-N 120.352 -1.467 . . . . 0.0 111.266 -177.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 47' ' ' GLN . . . . . 0.451 ' O ' HG12 ' C' ' 50' ' ' VAL 0.365 0.0 OUTLIER -69.54 -38.22 77.41 Favored 'General case' 0 CA--C 1.51 -0.568 0 O-C-N 118.677 -2.514 . . . . 0.0 115.532 174.836 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' C' C ' 48' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -58.98 -58.45 19.43 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-O 115.292 -2.29 . . . . 0.0 111.313 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 49' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -61.71 -36.57 73.89 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 124.324 3.349 . . . . 0.0 111.711 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 50' ' ' VAL . . . . . 0.506 ' HA ' HG22 ' C' ' 53' ' ' ILE . 0.8 OUTLIER -53.16 -39.09 32.44 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-N 122.047 2.203 . . . . 0.0 112.839 177.254 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.34 -38.98 69.45 Favored 'General case' 0 C--O 1.247 0.927 0 O-C-N 121.66 -0.65 . . . . 0.0 112.007 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -75.65 -48.77 20.67 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 120.746 -1.221 . . . . 0.0 108.277 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 53' ' ' ILE . . . . . 0.556 ' HB ' HD12 ' C' ' 183' ' ' LEU . 8.1 tp -63.38 -37.4 79.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 C-N-CA 119.416 -0.914 . . . . 0.0 113.084 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 54' ' ' THR . . . . . 0.541 HG21 ' HE1' ' C' ' 66' ' ' PHE . 90.0 m -68.56 -41.99 78.96 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 119.961 -1.712 . . . . 0.0 109.49 -178.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -53.67 -42.39 67.86 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 124.626 1.17 . . . . 0.0 112.066 168.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -66.44 -39.44 88.89 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 120.927 -1.108 . . . . 0.0 111.378 173.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 57' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' C' ' 53' ' ' ILE . 97.9 mt -67.63 -33.52 75.14 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 119.862 1.21 . . . . 0.0 107.896 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 58' ' ' ARG . . . . . 0.458 ' HD2' ' HA ' ' C' ' 58' ' ' ARG . 0.8 OUTLIER -63.9 -46.51 84.49 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 121.897 0.856 . . . . 0.0 111.473 178.559 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.67 -35.97 71.28 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 124.068 1.89 . . . . 0.0 114.029 173.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -68.06 -24.07 65.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.495 -1.23 . . . . 0.0 113.53 173.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.91 79.75 1.11 Allowed Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 mt -141.94 125.97 16.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 112.89 -1.655 . . . . 0.0 107.913 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 63' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' C' ' 32' ' ' SER . 17.3 t30 -72.41 87.91 1.18 Allowed 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 125.214 1.406 . . . . 0.0 109.601 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.473 HG21 HG23 ' C' ' 54' ' ' THR . 9.2 p -93.17 139.98 17.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 CA-C-O 122.11 0.957 . . . . 0.0 111.591 -177.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 65' ' ' ARG . . . . . 0.416 ' HB2' HD13 ' C' ' 34' ' ' ILE . 84.1 mmt-85 -138.38 120.6 15.79 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 103.19 -2.892 . . . . 0.0 103.19 177.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 66' ' ' PHE . . . . . 0.541 ' HE1' HG21 ' C' ' 54' ' ' THR . 8.2 m-85 -79.87 126.13 30.6 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 165.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -100.53 86.37 0.64 Allowed Glycine 0 N--CA 1.478 1.45 0 O-C-N 119.002 -2.312 . . . . 0.0 109.509 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 68' ' ' ILE . . . . . 0.707 HG13 ' HG2' ' C' ' 37' ' ' PRO . 3.2 mp -87.09 84.93 2.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 O-C-N 118.982 -2.481 . . . . 0.0 107.857 -172.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -74.24 116.91 57.32 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-O 116.569 -1.681 . . . . 0.0 108.527 170.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 70' ' ' PRO . . . . . 0.479 ' HD3' HG12 ' A' 1157 ' ' ILE . 58.4 Cg_endo -54.62 -59.29 0.89 Allowed 'Trans proline' 0 C--N 1.333 -0.247 0 C-N-CA 124.383 3.389 . . . . 0.0 117.255 -170.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 4.4 m -68.23 95.56 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 113.303 -1.771 . . . . 0.0 108.506 169.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -161.17 109.91 1.58 Allowed 'General case' 0 C--O 1.242 0.66 0 CA-C-N 109.031 -3.713 . . . . 0.0 107.16 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 73' ' ' GLY . . . . . 0.613 ' C ' ' HD2' ' C' ' 74' ' ' ARG . . . 69.48 -90.96 0.3 Allowed Glycine 0 CA--C 1.506 -0.498 0 CA-C-O 118.285 -1.286 . . . . 0.0 112.975 172.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 74' ' ' ARG . . . . . 0.846 ' HG3' ' HG2' ' B' 1203 ' ' GLN . 1.7 mpt_? -133.17 114.06 13.41 Favored 'General case' 0 C--O 1.256 1.419 0 CA-C-N 118.196 0.998 . . . . 0.0 111.935 -167.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.534 HD22 ' SD ' ' B' 1207 ' ' MET . 1.7 mp 63.13 142.84 0.06 OUTLIER Pre-proline 0 C--O 1.236 0.344 0 C-N-CA 128.173 2.589 . . . . 0.0 117.069 169.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 76' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' B' 1178 ' ' LEU . 83.1 Cg_endo -71.47 149.9 56.91 Favored 'Trans proline' 0 C--N 1.364 1.365 0 C-N-CA 123.289 2.659 . . . . 0.0 111.093 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 70.81 -96.53 0.59 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -171.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 48.55 -84.32 0.01 OUTLIER 'General case' 0 C--O 1.24 0.602 0 C-N-CA 126.089 1.756 . . . . 0.0 111.677 173.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 79' ' ' MET . . . . . 0.548 ' HA ' ' HB2' ' C' ' 82' ' ' LEU . 0.0 OUTLIER -60.05 -25.81 65.64 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.226 1.01 . . . . 0.0 113.1 177.229 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -58.02 -55.02 40.35 Favored 'General case' 0 C--O 1.24 0.576 0 O-C-N 121.659 -0.651 . . . . 0.0 111.497 170.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 69.8 t -73.3 -38.06 53.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 O-C-N 119.664 -1.898 . . . . 0.0 108.896 177.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.548 ' HB2' ' HA ' ' C' ' 79' ' ' MET . 96.0 mt -48.73 -31.77 7.44 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 122.595 2.452 . . . . 0.0 114.234 169.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.444 HD13 ' O ' ' C' ' 79' ' ' MET . 0.7 OUTLIER -74.82 -32.06 61.86 Favored 'General case' 0 C--O 1.221 -0.399 0 O-C-N 121.429 -0.794 . . . . 0.0 111.2 173.823 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.08 -32.67 74.5 Favored 'General case' 0 CA--C 1.497 -1.078 0 O-C-N 120.007 -1.683 . . . . 0.0 113.709 170.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -64.3 -50.05 69.36 Favored 'General case' 0 C--O 1.251 1.182 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 172.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.15 -18.18 60.15 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 172.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp 63.1 62.13 1.03 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-O 124.888 2.28 . . . . 0.0 109.558 -173.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 98.2 t -103.84 127.6 29.05 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 111.337 -2.665 . . . . 0.0 105.619 168.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -56.39 126.89 23.8 Favored 'Trans proline' 0 C--O 1.219 -0.469 0 C-N-CA 122.935 2.424 . . . . 0.0 117.965 175.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 90' ' ' TYR . . . . . 0.568 ' HA ' ' HB ' ' C' ' 93' ' ' VAL . 4.2 m-85 -59.3 -12.41 5.59 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 173.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -62.45 -47.48 83.86 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 119.96 1.254 . . . . 0.0 111.555 171.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 39.5 pt -84.09 -14.42 11.46 Favored 'Isoleucine or valine' 0 C--O 1.255 1.351 0 CA-C-O 121.984 0.897 . . . . 0.0 111.521 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 93' ' ' VAL . . . . . 0.568 ' HB ' ' HA ' ' C' ' 90' ' ' TYR . 50.5 t -76.84 104.56 4.92 Favored 'Isoleucine or valine' 0 C--O 1.247 0.951 0 O-C-N 119.69 -1.881 . . . . 0.0 106.882 175.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 10.8 mp -104.29 103.44 13.19 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 124.831 2.253 . . . . 0.0 109.559 174.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 95' ' ' GLU . . . . . 0.533 ' HB3' ' HB ' ' A' 1157 ' ' ILE . 11.0 mp0 -85.36 117.16 24.12 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 119.675 -1.891 . . . . 0.0 108.28 -176.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.402 ' HB2' ' HD3' ' C' ' 70' ' ' PRO . 12.2 ttp 42.81 29.59 0.19 Allowed 'General case' 0 C--N 1.345 0.385 0 C-N-CA 127.801 2.441 . . . . 0.0 115.162 -178.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -79.92 128.63 33.68 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 103.387 -2.819 . . . . 0.0 103.387 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -87.13 79.56 8.6 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 99' ' ' ILE . . . . . 0.821 HG13 ' HB2' ' C' ' 102' ' ' ASP . 9.5 tp -85.21 58.97 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 112.482 -2.145 . . . . 0.0 108.265 -173.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 100' ' ' ASN . . . . . 0.467 ' HA ' ' CD2' ' C' ' 103' ' ' PHE . 14.3 t-20 -73.31 -38.58 65.79 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 112.837 -1.983 . . . . 0.0 111.801 -166.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.96 -39.38 79.54 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.079 -1.419 . . . . 0.0 112.437 177.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 102' ' ' ASP . . . . . 0.821 ' HB2' HG13 ' C' ' 99' ' ' ILE . 1.8 m-20 -67.74 -28.43 67.63 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 120.172 -1.58 . . . . 0.0 113.25 167.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 103' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' C' ' 100' ' ' ASN . 6.8 m-30 -56.54 -51.19 69.49 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-O 121.575 0.703 . . . . 0.0 111.95 175.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.99 -45.51 82.91 Favored 'General case' 0 C--O 1.208 -1.117 0 CA-C-N 114.524 -1.217 . . . . 0.0 112.594 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -66.31 -29.18 69.33 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 106' ' ' THR . . . . . 0.746 ' HA ' ' HB2' ' C' ' 32' ' ' SER . 69.6 m -64.92 135.52 55.79 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 177.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 107' ' ' ASP . . . . . 0.665 ' HA ' ' HB3' ' C' ' 142' ' ' GLN . 23.2 t70 -86.94 -102.68 0.07 Allowed 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 112.373 -2.194 . . . . 0.0 109.027 166.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 53.8 m -69.83 91.77 0.66 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 124.398 3.272 . . . . 0.0 113.356 -171.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 109' ' ' VAL . . . . . 0.777 HG13 ' HB ' ' C' ' 34' ' ' ILE . 21.3 t -74.27 110.6 8.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 167.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 110' ' ' LEU . . . . . 0.465 HD11 HD21 ' C' ' 27' ' ' LEU . 96.0 mt -85.6 95.44 9.34 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 111' ' ' VAL . . . . . 0.649 ' HB ' ' HA ' ' C' ' 146' ' ' VAL . 50.3 t -87.1 87.68 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 -176.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 25.3 mm -72.05 79.32 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -171.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 113' ' ' GLY . . . . . 0.429 ' H ' ' HB2' ' C' ' 147' ' ' PHE . . . 88.69 -110.26 3.64 Favored Glycine 0 C--O 1.239 0.409 0 N-CA-C 107.25 -2.34 . . . . 0.0 107.25 -171.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 114' ' ' ALA . . . . . 0.499 ' HB2' ' HA3' ' C' ' 38' ' ' GLY . . . 47.73 9.13 0.01 OUTLIER 'General case' 0 C--N 1.352 0.686 1 N-CA-C 121.817 4.006 . . . . 0.0 121.817 163.093 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.29 -41.94 51.61 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 117.258 2.318 . . . . 0.0 117.258 -175.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 116' ' ' ASP . . . . . 0.553 ' HA ' ' HB2' ' C' ' 119' ' ' ASN . 9.1 m-20 -76.51 -28.01 56.23 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 19.4 m -72.83 -13.3 61.26 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.9 -1.125 . . . . 0.0 108.642 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.701 HG12 ' HB2' ' C' ' 136' ' ' LEU . 18.3 m -120.03 16.86 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 CA-C-N 119.762 1.165 . . . . 0.0 109.873 174.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 119' ' ' ASN . . . . . 0.553 ' HB2' ' HA ' ' C' ' 116' ' ' ASP . 18.4 t30 -79.64 112.28 27.93 Favored Pre-proline 0 N--CA 1.451 -0.391 0 O-C-N 120.118 -1.614 . . . . 0.0 115.188 -171.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 120' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -58.91 -36.47 96.84 Favored 'Trans proline' 0 C--N 1.368 1.602 0 C-N-CA 123.557 2.838 . . . . 0.0 113.288 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.58 4.98 1.55 Allowed 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 122' ' ' ALA . . . . . 0.482 ' HB1' ' HB3' ' C' ' 133' ' ' MET . . . -94.2 -31.7 14.01 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 120.344 -1.472 . . . . 0.0 113.124 173.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -116.03 -52.37 2.61 Favored 'General case' 0 C--O 1.22 -0.49 0 C-N-CA 118.839 -1.144 . . . . 0.0 109.68 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -62.17 -51.01 69.53 Favored 'General case' 0 C--N 1.363 1.188 0 CA-C-O 122.735 1.255 . . . . 0.0 108.905 -173.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -95.54 132.07 28.27 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 102.869 -3.011 . . . . 0.0 102.869 164.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -78.05 46.58 2.11 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 122.223 1.949 . . . . 0.0 110.829 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -107.06 -33.2 7.54 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -152.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 128' ' ' SER . . . . . . . . . . . . . 36.3 m -79.57 144.36 60.94 Favored Pre-proline 0 C--O 1.24 0.559 0 O-C-N 124.735 1.272 . . . . 0.0 111.647 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 129' ' ' PRO . . . . . 0.638 ' HD2' ' HB2' ' C' ' 156' ' ' ALA . 4.6 Cg_exo -44.38 -40.0 12.85 Favored 'Trans proline' 0 CA--C 1.51 -0.677 0 C-N-CA 123.785 2.99 . . . . 0.0 114.69 176.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 35.4 pt -65.61 72.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.88 0 CA-C-O 124.4 2.048 . . . . 0.0 110.413 164.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.71 119.52 10.71 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.511 -1.222 . . . . 0.0 112.987 -172.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 61.71 50.38 66.75 Favored Glycine 0 N--CA 1.431 -1.648 0 CA-C-N 113.083 -1.871 . . . . 0.0 112.149 -175.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 133' ' ' MET . . . . . 0.668 ' SD ' ' HD2' ' C' ' 134' ' ' PRO . 26.5 tpp -75.98 123.79 88.27 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 119.481 1.641 . . . . 0.0 112.099 171.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 134' ' ' PRO . . . . . 0.668 ' HD2' ' SD ' ' C' ' 133' ' ' MET . 61.1 Cg_endo -71.68 82.71 1.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.969 1 C-N-CA 125.833 4.355 . . . . 0.0 107.498 177.216 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 21.7 m -80.99 151.83 4.39 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.183 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.25 -176.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 136' ' ' LEU . . . . . 0.701 ' HB2' HG12 ' C' ' 118' ' ' VAL . 87.5 mt -74.59 109.27 7.93 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.696 0.76 . . . . 0.0 110.214 -178.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -72.81 80.02 1.14 Allowed 'General case' 0 N--CA 1.423 -1.789 0 CA-C-O 122.964 1.364 . . . . 0.0 112.134 -169.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 3.9 p -113.63 -1.79 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -176.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 13.1 p90 -56.56 148.71 19.0 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.131 -1.606 . . . . 0.0 111.118 174.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 140' ' ' LYS . . . . . . . . . . . . 0.378 0.0 OUTLIER 37.19 46.37 0.57 Allowed 'General case' 0 C--O 1.244 0.765 0 N-CA-C 116.55 2.056 . . . . 0.0 116.55 -160.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.5 -156.36 0.04 OUTLIER 'General case' 0 C--O 1.24 0.596 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 159.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 142' ' ' GLN . . . . . 0.665 ' HB3' ' HA ' ' C' ' 107' ' ' ASP . 0.0 OUTLIER -84.08 -32.81 24.59 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 119.754 -1.841 . . . . 0.0 113.787 170.88 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 143' ' ' ASN . . . . . 0.833 ' HA ' ' HB2' ' C' ' 167' ' ' ASN . 16.6 t30 -158.55 138.2 11.9 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 121.837 2.108 . . . . 0.0 110.239 170.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 144' ' ' VAL . . . . . 0.62 ' HB ' HG22 ' C' ' 168' ' ' THR . 21.8 t -136.46 90.43 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.598 0 O-C-N 119.051 -2.28 . . . . 0.0 105.104 -176.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 145' ' ' ILE . . . . . 0.541 HG13 ' HB2' ' C' ' 171' ' ' LEU . 10.5 tp -93.13 102.02 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 -170.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 146' ' ' VAL . . . . . 0.649 ' HA ' ' HB ' ' C' ' 111' ' ' VAL . 26.0 t -90.99 107.41 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 -170.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 147' ' ' PHE . . . . . 0.448 ' CE2' ' HB2' ' C' ' 178' ' ' SER . 2.1 m-85 -70.3 94.09 0.9 Allowed 'General case' 0 C--N 1.35 0.618 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 -177.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 148' ' ' LYS . . . . . 0.467 ' NZ ' ' OD1' ' C' ' 152' ' ' ASN . 26.1 mtpp -140.93 117.67 11.0 Favored 'General case' 0 C--O 1.253 1.254 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 173.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -70.03 -4.47 21.12 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 1.3 m -157.72 159.87 37.33 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 124.256 1.979 . . . . 0.0 108.704 175.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.44 77.72 5.99 Favored 'General case' 0 C--O 1.252 1.194 0 O-C-N 118.901 -2.374 . . . . 0.0 105.992 169.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 152' ' ' ASN . . . . . 0.467 ' OD1' ' NZ ' ' C' ' 148' ' ' LYS . 2.1 p-10 -113.85 157.95 21.67 Favored 'General case' 0 N--CA 1.438 -1.027 0 O-C-N 125.775 1.922 . . . . 0.0 108.826 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 45.7 m -67.55 125.82 27.37 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 123.848 0.717 . . . . 0.0 111.895 174.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -84.74 -108.85 0.63 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 104.7 -3.36 . . . . 0.0 104.7 173.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -91.53 -15.34 28.86 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 164.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 156' ' ' ALA . . . . . 0.638 ' HB2' ' HD2' ' C' ' 129' ' ' PRO . . . -165.54 -93.55 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 159.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 74.93 41.8 32.03 Favored Glycine 0 N--CA 1.437 -1.286 0 CA-C-N 120.876 1.671 . . . . 0.0 110.372 -165.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 15.5 m -80.81 127.94 39.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 O-C-N 120.085 -1.832 . . . . 0.0 108.941 171.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . 0.3 0.0 OUTLIER 43.2 16.31 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 120.613 3.56 . . . . 0.0 120.613 173.5 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 160' ' ' ASN . . . . . 0.734 HD22 HD12 ' C' ' 162' ' ' LEU . 16.9 p-10 -73.9 125.98 89.83 Favored Pre-proline 0 CA--C 1.532 0.269 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -178.075 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -49.86 -25.63 12.33 Favored 'Trans proline' 0 C--N 1.367 1.548 1 C-N-CA 126.725 4.95 . . . . 0.0 113.367 -176.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 162' ' ' LEU . . . . . 0.88 ' HA ' ' HB ' ' C' ' 168' ' ' THR . 13.2 mt -53.61 -20.14 4.8 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 173.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 163' ' ' PHE . . . . . 0.591 ' HA ' ' HG3' ' C' ' 170' ' ' MET . 9.2 m-30 -82.09 -42.16 19.56 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 123.092 1.425 . . . . 0.0 112.285 175.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -103.11 -41.23 6.16 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 113.18 -1.827 . . . . 0.0 110.099 -153.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 16.0 mttm -74.34 178.92 4.86 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 -164.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -77.43 -56.81 4.22 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-N 113.965 -1.471 . . . . 0.0 108.792 -165.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 167' ' ' ASN . . . . . 0.833 ' HB2' ' HA ' ' C' ' 143' ' ' ASN . 45.9 p30 -75.25 -45.84 37.53 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-O 117.383 -1.294 . . . . 0.0 110.591 168.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 168' ' ' THR . . . . . 0.88 ' HB ' ' HA ' ' C' ' 162' ' ' LEU . 13.6 p -87.54 94.89 9.85 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-N 121.932 2.151 . . . . 0.0 107.829 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -140.18 142.7 35.9 Favored 'General case' 0 C--N 1.353 0.743 0 O-C-N 120.419 -1.426 . . . . 0.0 110.757 -163.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 170' ' ' MET . . . . . 0.591 ' HG3' ' HA ' ' C' ' 163' ' ' PHE . 78.1 mtm -75.66 112.15 11.72 Favored 'General case' 0 CA--C 1.48 -1.72 0 CA-C-O 123.451 1.596 . . . . 0.0 115.232 174.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 171' ' ' LEU . . . . . 0.541 ' HB2' HG13 ' C' ' 145' ' ' ILE . 22.6 tp -71.95 109.81 6.03 Favored 'General case' 0 C--O 1.254 1.31 0 CA-C-N 114.146 -1.388 . . . . 0.0 107.847 169.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -83.26 68.24 9.56 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 126.194 2.902 . . . . 0.0 112.537 -173.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -153.03 163.42 30.51 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 110.161 -3.2 . . . . 0.0 109.735 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 174' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -74.41 155.32 38.21 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 111.868 -2.166 . . . . 0.0 109.146 173.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.47 -55.74 30.81 Favored 'General case' 0 CA--C 1.496 -1.121 0 CA-C-N 110.292 -3.14 . . . . 0.0 111.91 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 176' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' C' ' 44' ' ' ALA . 0.4 OUTLIER -66.3 -54.44 24.77 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 116.845 -1.55 . . . . 0.0 107.541 176.996 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 177' ' ' ALA . . . . . . . . . . . . . . . -51.21 -48.98 61.88 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.192 0.997 . . . . 0.0 112.619 -170.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 178' ' ' SER . . . . . 0.448 ' HB2' ' CE2' ' C' ' 147' ' ' PHE . 38.5 m -62.61 -46.46 88.18 Favored 'General case' 0 C--O 1.246 0.877 0 O-C-N 121.004 -1.06 . . . . 0.0 110.746 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 179' ' ' VAL . . . . . 0.433 ' HA ' HG12 ' C' ' 182' ' ' ILE . 22.1 t -61.09 -41.81 90.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 O-C-N 119.789 -1.819 . . . . 0.0 108.14 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 180' ' ' ASP . . . . . 0.417 ' HB2' ' HD2' ' C' ' 176' ' ' LYS . 12.2 t70 -63.97 -37.78 88.67 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.559 -174.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -70.9 -49.72 42.7 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.56 1.073 . . . . 0.0 109.769 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 182' ' ' ILE . . . . . 0.555 HD12 HD11 ' C' ' 27' ' ' LEU . 16.8 pt -63.06 -25.35 38.34 Favored 'Isoleucine or valine' 0 C--N 1.363 1.178 0 O-C-N 119.415 -2.053 . . . . 0.0 112.943 -174.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 183' ' ' LEU . . . . . 0.556 HD12 ' HB ' ' C' ' 53' ' ' ILE . 12.8 tp -49.9 -36.6 28.04 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 126.743 2.017 . . . . 0.0 112.97 170.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 18.7 tptt -112.95 -34.75 5.65 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -57.43 -63.99 1.04 Allowed 'General case' 0 C--O 1.257 1.478 0 N-CA-C 118.823 2.897 . . . . 0.0 118.823 172.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 186' ' ' LEU . . . . . . . . . . . . 0.327 1.3 pt? . . . . . 0 C--O 1.218 -0.586 0 C-N-CA 127.753 2.421 . . . . 0.0 117.349 -167.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 22.3 t-80 . . . . . 0 N--CA 1.436 -1.134 0 N-CA-C 104.856 -2.275 . . . . 65.739999999999995 104.856 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -69.94 82.09 0.33 Allowed Glycine 0 C--O 1.222 -0.638 0 O-C-N 117.868 -3.02 . . . . 48.659999999999997 112.313 169.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -113.44 109.47 18.72 Favored 'General case' 0 CA--C 1.478 -1.81 0 N-CA-C 103.633 -2.728 . . . . 44.560000000000002 103.633 170.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1003 ' ' ILE . . . . . . . . . . . . . 61.8 mt -80.18 110.51 15.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 112.179 -2.282 . . . . 34.859999999999999 109.187 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1004 ' ' GLY . . . . . 0.551 ' O ' ' HD3' ' A' 1006 ' ' PRO . . . -75.83 122.11 6.53 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.122 -1.191 . . . . 30.75 110.122 163.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.774 HG23 ' HB3' ' A' 1017 ' ' ALA . 16.8 mm -99.58 105.48 34.04 Favored Pre-proline 0 C--O 1.242 0.688 0 N-CA-C 102.567 -3.123 . . . . 32.210000000000001 102.567 176.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1006 ' ' PRO . . . . . 0.551 ' HD3' ' O ' ' A' 1004 ' ' GLY . 67.8 Cg_exo -85.8 158.35 10.38 Favored 'Trans proline' 0 N--CA 1.451 -1.007 1 C-N-CA 126.222 4.615 . . . . 32.979999999999997 110.468 175.46 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 1007 ' ' ARG . . . . . 0.558 ' HG3' HD12 ' A' 1042 ' ' LEU . 1.8 ttp85 -84.98 138.42 32.48 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 103.181 -2.896 . . . . 47.979999999999997 103.181 153.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1008 ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -63.44 137.85 58.3 Favored 'General case' 0 N--CA 1.441 -0.89 0 O-C-N 124.41 1.068 . . . . 34.700000000000003 109.398 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1009 ' ' ARG . . . . . 0.632 HH11 ' HG2' ' A' 1079 ' ' GLU . 80.9 mtp180 -93.82 -27.53 16.4 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 114.725 -1.125 . . . . 53.369999999999997 113.558 -175.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 3.9 mp -52.81 129.2 29.25 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-O 123.018 1.39 . . . . 45.07 111.52 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1011 ' ' THR . . . . . . . . . . . . . 20.7 m -48.19 119.79 3.16 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 113.076 -1.874 . . . . 40.359999999999999 112.137 -171.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 12.5 m120 63.28 -4.67 0.28 Allowed 'General case' 0 C--O 1.243 0.753 0 N-CA-C 117.419 2.377 . . . . 40.609999999999999 117.419 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -88.1 71.97 9.22 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 104.424 -2.436 . . . . 33.759999999999998 104.424 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1014 ' ' THR . . . . . 0.627 HG23 HD13 ' A' 1042 ' ' LEU . 47.1 m -73.29 66.7 0.93 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 125.72 2.676 . . . . 27.890000000000001 111.914 -172.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1015 ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -108.51 163.29 13.36 Favored 'General case' 0 C--O 1.224 -0.262 0 O-C-N 120.002 -1.686 . . . . 29.02 108.942 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1016 ' ' VAL . . . . . 0.472 HG22 ' HA ' ' A' 1007 ' ' ARG . 39.4 t -137.05 151.59 27.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 101.505 -3.517 . . . . 28.129999999999999 101.505 171.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1017 ' ' ALA . . . . . 0.774 ' HB3' HG23 ' A' 1005 ' ' ILE . . . -55.18 -54.57 41.63 Favored 'General case' 0 C--O 1.256 1.426 0 N-CA-C 119.067 2.988 . . . . 26.870000000000001 119.067 -176.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -144.25 159.36 42.81 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 120.478 1.49 . . . . 26.77 112.566 -170.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1019 ' ' THR . . . . . . . . . . . . . 19.2 p -84.25 155.86 63.25 Favored Pre-proline 0 C--O 1.245 0.833 0 CA-C-O 117.762 -1.113 . . . . 27.02 111.423 176.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1020 ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -48.5 -40.16 36.92 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 124.059 3.172 . . . . 30.57 114.41 169.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1021 ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' 1024 ' ' GLU . 2.2 ttmp? -52.33 -48.98 65.15 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.284 1.216 . . . . 47.810000000000002 114.284 168.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1022 ' ' THR . . . . . 0.676 ' HB ' HG21 ' A' 1332 ' ' VAL . 2.6 p -75.15 -30.87 60.88 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 124.057 1.885 . . . . 30.77 109.426 -172.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1023 ' ' VAL . . . . . 0.496 HG11 ' HB2' ' A' 1055 ' ' ALA . 55.5 t -56.98 -52.23 58.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 C-N-CA 125.141 1.376 . . . . 33.590000000000003 108.691 168.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1024 ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' 1021 ' ' LYS . 26.3 mt-10 -46.2 -51.62 13.89 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 120.694 1.588 . . . . 53.289999999999999 110.755 172.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -54.38 -52.4 61.79 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.673 1.36 . . . . 46.920000000000002 114.673 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1026 ' ' LEU . . . . . 0.415 HD23 HD12 ' A' 1029 ' ' LEU . 91.7 mt -53.94 -42.79 69.23 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 115.019 1.488 . . . . 37.170000000000002 115.019 177.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 7.1 mp -54.32 -49.9 68.62 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.711 -1.131 . . . . 44.439999999999998 113.442 168.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1028 ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' 1024 ' ' GLU . 27.4 mmmt -62.08 -29.27 70.19 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 120.367 0.127 . . . . 52.579999999999998 111.094 175.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1029 ' ' LEU . . . . . 0.415 HD12 HD23 ' A' 1026 ' ' LEU . 95.3 mt -72.26 -42.33 65.73 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 119.749 -1.844 . . . . 45.689999999999998 109.784 175.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 138.06 -8.04 3.52 Favored Glycine 0 CA--C 1.507 -0.411 0 C-N-CA 120.877 -0.678 . . . . 42.090000000000003 111.949 173.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -80.15 130.68 35.41 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 118.917 -0.563 . . . . 40.719999999999999 112.301 -173.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1032 ' ' THR . . . . . . . . . . . . . 55.8 m -74.11 127.71 33.62 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.707 -1.22 . . . . 37.770000000000003 107.707 176.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1033 ' ' VAL . . . . . 0.49 HG11 HG22 ' A' 1023 ' ' VAL . 94.8 t -109.7 123.58 65.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 104.639 -2.356 . . . . 33.539999999999999 104.639 -177.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -120.1 113.12 20.01 Favored 'General case' 0 C--O 1.249 1.032 0 N-CA-C 105.966 -1.864 . . . . 31.68 105.966 175.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1035 ' ' VAL . . . . . 0.448 ' HA ' ' HB ' ' A' 1005 ' ' ILE . 17.3 t -94.34 144.3 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 O-C-N 121.553 -0.717 . . . . 31.52 109.282 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1036 ' ' GLU . . . . . 0.445 ' HB2' HG21 ' A' 1063 ' ' VAL . 50.3 tt0 -61.44 140.63 58.02 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 123.392 1.568 . . . . 41.039999999999999 111.329 170.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1037 ' ' SER . . . . . . . . . . . . . 1.4 t -61.49 126.75 28.48 Favored 'General case' 0 N--CA 1.44 -0.951 0 O-C-N 120.187 -1.571 . . . . 31.829999999999998 114.201 171.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 83.95 9.96 81.68 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 113.976 -1.465 . . . . 29.359999999999999 112.032 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -79.04 -41.05 29.76 Favored 'General case' 0 C--N 1.347 0.462 0 O-C-N 121.058 -1.26 . . . . 27.780000000000001 110.049 -176.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -52.48 -39.21 52.48 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 122.82 1.233 . . . . 28.91 113.73 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 12.6 tp-100 -46.44 -55.63 7.15 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.055 -1.072 . . . . 51.18 113.318 170.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1042 ' ' LEU . . . . . 0.627 HD13 HG23 ' A' 1014 ' ' THR . 27.0 mt -72.35 -42.28 65.49 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 120.727 -1.233 . . . . 29.91 111.213 175.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1043 ' ' ALA . . . . . . . . . . . . . . . -54.9 -22.5 15.02 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.567 0.699 . . . . 28.539999999999999 112.35 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1044 ' ' SER . . . . . 0.426 ' HB3' ' CA ' ' B' 1278 ' ' GLY . 67.4 m 63.53 42.28 6.69 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 124.746 2.212 . . . . 33.060000000000002 108.628 174.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1045 ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -172.31 92.15 0.12 Allowed 'General case' 0 N--CA 1.441 -0.914 1 N-CA-C 97.761 -4.903 . . . . 30.289999999999999 97.761 178.977 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.67 171.27 15.19 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-N 111.402 -2.635 . . . . 48.619999999999997 116.585 -147.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1047 ' ' ASP . . . . . 0.474 ' O ' HG23 ' A' 1051 ' ' VAL . 6.9 m-20 -56.77 -42.07 78.74 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 113.776 -1.556 . . . . 36.740000000000002 113.085 -176.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 21.7 pttm -69.9 -25.73 63.83 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.543 1.519 . . . . 43.729999999999997 113.661 176.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -71.07 -37.35 72.48 Favored 'General case' 0 CA--C 1.498 -1.04 0 O-C-N 119.862 -1.774 . . . . 32.810000000000002 109.801 170.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1050 ' ' PHE . . . . . 0.402 ' CD1' HG21 ' A' 1035 ' ' VAL . 26.4 m-85 -57.82 -42.22 83.86 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 120.429 1.468 . . . . 31.859999999999999 112.735 167.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1051 ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' 1047 ' ' ASP . 21.8 t -61.28 -44.9 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 114.578 -1.192 . . . . 33.219999999999999 113.081 174.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -58.17 -37.56 74.95 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.568 0.699 . . . . 50.829999999999998 112.718 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -59.46 -46.35 89.02 Favored 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 121.62 -0.675 . . . . 33.119999999999997 110.062 173.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 128.14 9.48 3.75 Favored Glycine 0 C--N 1.349 1.26 0 C-N-CA 118.905 -1.616 . . . . 35.829999999999998 112.188 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1055 ' ' ALA . . . . . 0.496 ' HB2' HG11 ' A' 1023 ' ' VAL . . . -73.49 146.72 44.69 Favored 'General case' 0 N--CA 1.436 -1.169 0 O-C-N 121.975 -0.72 . . . . 34.82 111.151 -177.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -77.52 136.79 38.35 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 101.932 -3.359 . . . . 49.049999999999997 101.932 171.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1057 ' ' ILE . . . . . . . . . . . . . 25.7 mm -102.46 134.68 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 N-CA-C 107.063 -1.458 . . . . 38.530000000000001 107.063 172.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1058 ' ' VAL . . . . . . . . . . . . . 3.1 m -129.41 143.25 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-O 123.354 1.549 . . . . 42.109999999999999 109.444 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -106.21 128.53 54.01 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 113.452 -1.704 . . . . 58.0 108.379 -165.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 66.49 -138.93 36.56 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-O 123.379 1.544 . . . . 52.119999999999997 114.019 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1061 ' ' ASN . . . . . 0.541 ' HA ' ' HD1' ' A' 1064 ' ' TRP . 8.2 t30 -64.21 -18.94 64.99 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 113.359 -1.42 . . . . 54.75 111.976 -170.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1062 ' ' SER . . . . . . . . . . . . . 49.9 m -63.05 -8.63 7.85 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 116.743 2.127 . . . . 50.340000000000003 116.743 176.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1063 ' ' VAL . . . . . 0.445 HG21 ' HB2' ' A' 1036 ' ' GLU . 9.7 p -72.52 -38.13 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-O 121.921 0.867 . . . . 41.460000000000001 110.347 167.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1064 ' ' TRP . . . . . 0.541 ' HD1' ' HA ' ' A' 1061 ' ' ASN . 86.1 m95 -73.07 -20.21 61.01 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.013 0.925 . . . . 39.32 110.389 174.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -77.21 64.57 2.65 Favored 'General case' 0 C--O 1.224 -0.272 0 O-C-N 120.31 -1.494 . . . . 55.380000000000003 111.36 171.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1066 ' ' SER . . . . . . . . . . . . . 47.8 m -152.17 129.06 10.95 Favored 'General case' 0 N--CA 1.444 -0.734 0 O-C-N 120.69 -1.256 . . . . 41.869999999999997 108.054 -174.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -74.54 4.49 6.01 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 120.093 3.368 . . . . 53.200000000000003 120.093 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1068 ' ' ILE . . . . . 0.644 HG12 ' HB ' ' A' 1088 ' ' THR . 96.9 mt -128.41 134.76 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 104.135 -2.543 . . . . 41.899999999999999 104.135 158.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1069 ' ' ILE . . . . . . . . . . . . . 34.9 mm -128.08 132.95 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 104.677 -2.342 . . . . 38.729999999999997 104.677 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1070 ' ' LEU . . . . . 0.803 HD13 HD13 ' A' 1331 ' ' LEU . 19.8 mt -108.13 79.15 1.23 Allowed 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 125.385 2.517 . . . . 32.439999999999998 112.164 172.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1071 ' ' LYS . . . . . 0.451 ' HE3' ' O ' ' A' 1073 ' ' ASN . 8.7 mmmt -65.67 127.55 32.38 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 113.302 -1.772 . . . . 34.649999999999999 111.005 169.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1072 ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -92.23 -14.32 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 CA-C-N 114.131 -1.395 . . . . 31.32 110.623 -160.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1073 ' ' ASN . . . . . 0.451 ' O ' ' HE3' ' A' 1071 ' ' LYS . 46.9 t30 -149.42 178.23 8.99 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 107.842 -1.17 . . . . 33.939999999999998 107.842 173.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1074 ' ' ALA . . . . . 0.468 ' HA ' ' HD3' ' A' 1075 ' ' PRO . . . -38.8 146.57 0.31 Allowed Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 127.547 2.339 . . . . 38.039999999999999 116.026 172.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1075 ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' 1074 ' ' ALA . 21.9 Cg_exo -80.8 157.6 21.19 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.932 3.088 . . . . 42.68 119.122 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 42.5 mt -107.77 161.27 15.04 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 105.133 -2.173 . . . . 46.740000000000002 105.133 162.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 25.5 t0 -70.27 -21.9 62.92 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.539 -0.726 . . . . 58.609999999999999 110.758 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 21.8 t0 -54.12 -56.39 18.52 Favored 'General case' 0 C--N 1.344 0.359 0 N-CA-C 108.134 -1.061 . . . . 59.200000000000003 108.134 162.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1079 ' ' GLU . . . . . 0.632 ' HG2' HH11 ' A' 1009 ' ' ARG . 33.0 mt-10 -66.67 -31.22 71.75 Favored 'General case' 0 CA--C 1.501 -0.927 0 O-C-N 121.616 -0.677 . . . . 50.630000000000003 110.543 -174.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1080 ' ' ILE . . . . . . . . . . . . . 82.8 mt -68.25 -31.56 52.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 O-C-N 120.996 -1.065 . . . . 51.479999999999997 111.704 176.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -70.61 -43.24 69.74 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 118.689 -2.507 . . . . 50.280000000000001 110.707 171.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 8.0 mp -69.07 -23.94 64.1 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 114.101 1.148 . . . . 50.210000000000001 114.101 177.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1083 ' ' LEU . . . . . 0.571 HD11 HD13 ' A' 1089 ' ' LEU . 0.1 OUTLIER -67.49 116.37 8.15 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 105.41 -2.07 . . . . 49.060000000000002 105.41 175.579 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -75.09 150.64 85.74 Favored Pre-proline 0 N--CA 1.432 -1.325 0 CA-C-O 118.561 -0.733 . . . . 51.079999999999998 110.908 171.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -55.91 165.9 3.43 Favored 'Trans proline' 0 C--O 1.249 1.053 0 C-N-CA 123.99 3.127 . . . . 49.729999999999997 113.853 167.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 81.78 -28.38 3.2 Favored Glycine 0 C--N 1.338 0.671 0 O-C-N 120.489 -1.382 . . . . 47.710000000000001 114.052 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1087 ' ' THR . . . . . . . . . . . . . 13.9 m -51.09 129.74 24.64 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 117.654 2.464 . . . . 45.469999999999999 117.654 -174.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1088 ' ' THR . . . . . 0.644 ' HB ' HG12 ' A' 1068 ' ' ILE . 30.0 m -79.6 90.39 5.14 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 106.713 -1.588 . . . . 42.039999999999999 106.713 161.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1089 ' ' LEU . . . . . 0.571 HD13 HD11 ' A' 1083 ' ' LEU . 63.5 tp -79.85 80.74 6.21 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 105.451 -2.055 . . . . 38.060000000000002 105.451 -174.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1090 ' ' VAL . . . . . 0.584 ' HA ' ' HB2' ' A' 1113 ' ' MET . 36.2 t -81.44 104.67 10.33 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 N-CA-C 101.964 -3.347 . . . . 37.399999999999999 101.964 177.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1091 ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' 1114 ' ' ALA . 60.5 m -155.05 164.76 38.42 Favored 'General case' 0 C--O 1.251 1.145 0 O-C-N 119.816 -1.803 . . . . 36.159999999999997 113.769 -167.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 17.0 t80 -92.11 90.75 7.48 Favored 'General case' 0 C--O 1.246 0.915 0 O-C-N 120.111 -1.618 . . . . 38.939999999999998 107.432 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 30.9 mm -95.15 -30.37 4.1 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 N-CA-C 113.006 0.743 . . . . 42.170000000000002 113.006 -160.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 90.7 m95 56.93 74.09 0.72 Allowed Pre-proline 0 C--O 1.236 0.346 0 C-N-CA 125.635 1.574 . . . . 46.509999999999998 111.89 -171.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -62.51 -56.24 0.71 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 123.536 2.824 . . . . 49.759999999999998 115.815 -167.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -70.34 -11.79 61.14 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 118.138 -2.851 . . . . 52.619999999999997 113.514 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -86.53 -32.11 20.9 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 105.938 -1.875 . . . . 60.740000000000002 105.938 176.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1098 ' ' ASN . . . . . 0.425 ' HB3' ' HB2' ' A' 1101 ' ' LEU . 76.7 m-20 -119.83 55.96 3.77 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 117.178 2.288 . . . . 58.189999999999998 117.178 -177.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.41 -42.77 31.89 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.767 2.978 . . . . 54.590000000000003 114.647 -174.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -60.77 -46.47 90.36 Favored 'General case' 0 C--O 1.251 1.171 0 O-C-N 119.943 -1.723 . . . . 63.280000000000001 111.918 174.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1101 ' ' LEU . . . . . 0.425 ' HB2' ' HB3' ' A' 1098 ' ' ASN . 20.6 mt -61.7 -33.37 73.9 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.602 -1.181 . . . . 54.75 111.24 176.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1102 ' ' MET . . . . . . . . . . . . . 46.4 mmm -61.58 -48.39 81.17 Favored 'General case' 0 C--O 1.245 0.861 0 O-C-N 121.662 -0.649 . . . . 52.649999999999999 111.657 175.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -60.3 -39.61 87.58 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.318 -0.856 . . . . 66.260000000000005 108.917 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 88.4 mttt -64.61 -32.51 74.2 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 118.865 0.757 . . . . 63.729999999999997 112.006 174.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 34.2 mt -76.15 -26.85 56.7 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 120.308 -1.495 . . . . 54.68 111.877 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -64.48 -47.65 78.16 Favored 'General case' 0 C--O 1.245 0.858 0 O-C-N 120.713 -1.242 . . . . 53.640000000000001 111.705 168.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -56.05 -33.69 65.21 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.397 -1.729 . . . . 67.239999999999995 114.163 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -60.5 -24.79 65.58 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 117.276 2.324 . . . . 65.760000000000005 117.276 170.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1109 ' ' ASN . . . . . 0.499 ' HA ' ' HA3' ' A' 1364 ' ' GLY . 3.7 t30 56.91 67.83 0.94 Allowed 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 123.445 1.593 . . . . 58.710000000000001 111.972 -165.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1110 ' ' VAL . . . . . 0.455 HG23 HG23 ' A' 1112 ' ' VAL . 17.0 m -133.28 151.69 34.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 113.89 -1.505 . . . . 46.630000000000003 108.299 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1111 ' ' THR . . . . . 0.55 HG21 HG21 ' A' 1348 ' ' VAL . 94.8 m -91.55 93.38 8.93 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 123.027 1.394 . . . . 44.130000000000003 110.61 171.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1112 ' ' VAL . . . . . 0.496 HG22 HD23 ' A' 1089 ' ' LEU . 41.3 t -83.55 108.44 16.08 Favored 'Isoleucine or valine' 0 C--O 1.252 1.21 0 O-C-N 119.774 -1.829 . . . . 40.439999999999998 109.806 -178.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1113 ' ' MET . . . . . 0.584 ' HB2' ' HA ' ' A' 1090 ' ' VAL . 22.8 mtp -100.97 93.07 5.32 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 111.59 -2.55 . . . . 50.759999999999998 109.122 173.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1114 ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' 1091 ' ' SER . . . -85.51 118.39 25.01 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 119.185 -1.006 . . . . 35.640000000000001 109.324 -173.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1115 ' ' MET . . . . . 0.436 ' O ' HG23 ' A' 1118 ' ' VAL . 79.5 mmm -66.04 -29.39 69.74 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 115.611 1.708 . . . . 38.740000000000002 115.611 -175.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.62 -44.48 69.53 Favored 'General case' 0 C--O 1.25 1.093 0 CA-C-O 121.682 0.753 . . . . 40.140000000000001 111.475 165.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1117 ' ' SER . . . . . . . . . . . . . 74.0 m -75.11 14.08 0.6 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 119.487 3.143 . . . . 44.789999999999999 119.487 -176.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1118 ' ' VAL . . . . . 0.785 HG22 HG22 ' A' 1358 ' ' VAL . 13.6 t -72.77 133.67 82.12 Favored Pre-proline 0 C--O 1.215 -0.751 0 O-C-N 118.432 -2.668 . . . . 43.75 107.057 177.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -60.65 152.24 70.37 Favored 'Trans proline' 0 N--CA 1.443 -1.455 1 C-N-CA 125.785 4.323 . . . . 48.93 115.451 173.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -70.1 12.88 0.19 Allowed 'General case' 0 C--O 1.255 1.39 0 N-CA-C 121.027 3.714 . . . . 62.899999999999999 121.027 -173.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1121 ' ' ILE . . . . . 0.406 HG12 ' H ' ' A' 1121 ' ' ILE . 10.5 pt -86.2 169.35 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 O-C-N 119.088 -2.257 . . . . 57.719999999999999 112.951 -170.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1122 ' ' SER . . . . . 0.422 ' HA ' ' HG2' ' A' 1125 ' ' GLN . 69.7 m -63.37 -46.19 87.66 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 124.398 1.079 . . . . 57.259999999999998 113.721 -173.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -59.24 -36.11 74.88 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 122.922 2.601 . . . . 62.899999999999999 112.128 175.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1124 ' ' ALA . . . . . 0.511 ' HB1' HG12 ' A' 1118 ' ' VAL . . . -71.16 -23.63 62.09 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 125.012 1.445 . . . . 49.829999999999998 111.904 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1125 ' ' GLN . . . . . 0.422 ' HG2' ' HA ' ' A' 1122 ' ' SER . 54.1 mm-40 -56.28 -23.69 38.16 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 118.241 2.682 . . . . 52.369999999999997 118.241 -171.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1126 ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.83 -35.12 57.77 Favored 'General case' 0 C--O 1.252 1.198 0 N-CA-C 116.463 2.023 . . . . 42.43 116.463 169.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1127 ' ' LEU . . . . . 0.473 ' O ' ' HB3' ' A' 1330 ' ' ASN . 4.5 mp -78.63 -35.82 44.93 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 113.3 -1.773 . . . . 43.740000000000002 111.504 177.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 13.3 t70 -73.64 123.04 23.27 Favored 'General case' 0 C--O 1.246 0.892 0 O-C-N 120.244 -1.535 . . . . 43.210000000000001 114.764 -165.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -75.39 -27.59 59.15 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 114.231 1.197 . . . . 35.740000000000002 114.231 175.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 69.1 mt -67.19 -11.86 58.49 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 118.679 0.672 . . . . 38.090000000000003 112.524 170.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1131 ' ' SER . . . . . 0.563 ' HA ' HG11 ' A' 1175 ' ' VAL . 6.4 m -73.86 -77.13 0.11 Allowed 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.274 -0.639 . . . . 36.909999999999997 109.274 153.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1132 ' ' SER . . . . . 0.731 ' HB3' ' HB3' ' A' 1326 ' ' LEU . 8.3 m -58.24 -55.71 31.52 Favored 'General case' 0 C--N 1.347 0.491 0 O-C-N 120.899 -1.125 . . . . 35.789999999999999 113.278 -162.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1133 ' ' MET . . . . . 0.552 ' HA ' HD12 ' A' 1136 ' ' ILE . 18.3 mtp -62.97 -34.75 78.19 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 113.067 0.766 . . . . 30.809999999999999 113.067 -177.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1134 ' ' ALA . . . . . . . . . . . . . . . -66.75 -40.79 88.41 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.536 0.607 . . . . 28.879999999999999 109.506 174.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1135 ' ' ASN . . . . . 0.404 ' HB3' ' O ' ' A' 1132 ' ' SER . 10.6 t-20 -57.32 -45.04 84.64 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 117.882 -1.056 . . . . 40.759999999999998 111.204 171.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1136 ' ' ILE . . . . . 0.552 HD12 ' HA ' ' A' 1133 ' ' MET . 83.7 mt -56.46 -44.63 80.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-O 122.51 1.147 . . . . 31.539999999999999 110.767 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -60.62 -49.2 78.49 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 112.669 -2.06 . . . . 29.870000000000001 112.15 175.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1138 ' ' GLY . . . . . 0.447 ' HA2' HD11 ' A' 1284 ' ' LEU . . . -57.44 -46.78 91.54 Favored Glycine 0 N--CA 1.468 0.819 0 O-C-N 120.806 -1.184 . . . . 28.73 111.393 -177.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 18.4 t80 -65.01 -49.29 70.78 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 118.821 -0.609 . . . . 30.390000000000001 110.391 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1140 ' ' ARG . . . . . 0.546 ' HG3' HD22 ' A' 1315 ' ' LEU . 5.7 tpt180 -70.69 -19.26 62.79 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 117.155 -1.818 . . . . 26.09 111.951 -175.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1141 ' ' ALA . . . . . 0.721 ' HB2' HD21 ' A' 1284 ' ' LEU . . . -69.76 -45.55 67.83 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 106.957 -1.497 . . . . 27.100000000000001 106.957 176.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1142 ' ' ILE . . . . . 0.419 HD13 ' HA ' ' A' 1142 ' ' ILE . 28.5 mm -50.45 -44.82 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 C-N-CA 123.588 0.755 . . . . 28.48 111.929 169.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 58.6 t -62.31 -58.94 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 112.797 0.665 . . . . 23.07 112.797 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1144 ' ' GLU . . . . . 0.468 ' CD ' HH21 ' A' 1140 ' ' ARG . 6.0 mm-40 -63.85 -31.51 72.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.839 0.828 . . . . 33.399999999999999 112.562 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1145 ' ' ALA . . . . . 0.7 ' HB1' HD12 ' A' 1251 ' ' ILE . . . -56.88 -54.5 45.85 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 115.859 -2.019 . . . . 24.219999999999999 111.554 164.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1146 ' ' ALA . . . . . 0.576 ' HA ' ' HB2' ' A' 1149 ' ' PHE . . . -58.4 -22.91 55.69 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 116.019 1.859 . . . . 24.890000000000001 116.019 174.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -70.0 -54.23 14.13 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 105.827 -1.916 . . . . 26.73 105.827 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1148 ' ' GLU . . . . . 0.828 ' HB2' HD11 ' A' 1310 ' ' ILE . 25.3 mm-40 -97.49 21.6 10.0 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 116.955 2.205 . . . . 39.960000000000001 116.955 176.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1149 ' ' PHE . . . . . 0.576 ' HB2' ' HA ' ' A' 1146 ' ' ALA . 1.0 OUTLIER -71.92 136.49 46.89 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 106.938 -1.504 . . . . 25.870000000000001 106.938 177.488 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 1150 ' ' GLY . . . . . 0.452 ' HA2' ' HG2' ' B' 1320 ' ' PRO . . . -74.66 -52.75 6.99 Favored Glycine 0 CA--C 1.502 -0.73 0 O-C-N 127.262 2.851 . . . . 19.280000000000001 109.916 170.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1151 ' ' ARG . . . . . 0.72 ' NH2' ' HB2' ' A' 1164 ' ' PRO . 0.4 OUTLIER -101.17 -164.93 1.15 Allowed 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 120.8 -1.412 . . . . 39.899999999999999 113.768 -170.536 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 1152 ' ' PHE . . . . . 0.521 ' HD2' ' HG2' ' B' 1322 ' ' GLN . 0.7 OUTLIER -107.23 141.21 38.9 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 120.466 -1.396 . . . . 29.440000000000001 109.129 -170.223 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 1153 ' ' PHE . . . . . 0.536 ' HE2' ' HB2' ' A' 1146 ' ' ALA . 16.9 m-85 -65.22 -58.67 5.39 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 117.804 -3.06 . . . . 32.600000000000001 110.181 169.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1154 ' ' THR . . . . . . . . . . . . . 3.0 m -71.75 116.54 12.24 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 124.412 1.07 . . . . 34.640000000000001 111.234 -172.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -64.39 96.03 0.19 Allowed Glycine 0 CA--C 1.547 2.04 0 N-CA-C 106.253 -2.739 . . . . 37.140000000000001 106.253 165.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -136.1 -158.28 0.86 Allowed 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 118.935 -0.555 . . . . 40.57 112.191 -175.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1157 ' ' ILE . . . . . 0.861 HG21 ' HB2' ' C' ' 70' ' ' PRO . 3.3 tp -155.41 125.68 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 O-C-N 119.615 -1.928 . . . . 44.609999999999999 110.22 -159.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1158 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.74 -160.76 1.18 Allowed 'General case' 0 C--O 1.253 1.245 0 N-CA-C 105.436 -2.061 . . . . 40.700000000000003 105.436 176.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -48.29 -31.97 6.71 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 119.138 -2.226 . . . . 40.25 116.774 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1160 ' ' ALA . . . . . 0.51 ' HA ' ' HB ' ' B' 1329 ' ' THR . . . -64.58 -11.65 36.94 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-O 117.929 -1.034 . . . . 38.469999999999999 113.335 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . 76.8 -117.48 4.91 Favored Glycine 0 N--CA 1.432 -1.617 0 N-CA-C 107.771 -2.132 . . . . 37.609999999999999 107.771 -171.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 7.1 tttp -67.89 108.2 2.93 Favored 'General case' 0 CA--C 1.482 -1.672 0 N-CA-C 107.306 -1.368 . . . . 48.899999999999999 107.306 171.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1163 ' ' VAL . . . . . . . . . . . . . 38.8 t -82.13 106.17 5.9 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 102.843 -3.021 . . . . 36.520000000000003 102.843 163.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1164 ' ' PRO . . . . . 0.72 ' HB2' ' NH2' ' A' 1151 ' ' ARG . 10.2 Cg_endo -65.38 122.21 9.85 Favored 'Trans proline' 0 N--CA 1.443 -1.443 0 C-N-CA 124.504 3.47 . . . . 35.079999999999998 116.688 -171.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1165 ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' 1164 ' ' PRO . 95.3 Cg_endo -68.14 156.17 66.78 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 N-CA-C 118.454 2.444 . . . . 35.329999999999998 118.454 -177.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -62.92 122.68 16.59 Favored 'General case' 0 N--CA 1.417 -2.098 0 CA-C-N 113.448 -1.705 . . . . 34.689999999999998 112.779 169.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1167 ' ' LYS . . . . . 0.674 ' HB2' ' HA ' ' A' 1249 ' ' VAL . 99.0 mttt -93.84 114.35 26.58 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 104.974 -2.232 . . . . 45.359999999999999 104.974 164.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1168 ' ' VAL . . . . . 0.415 HG22 ' HB ' ' A' 1251 ' ' ILE . 59.8 t -99.89 134.53 39.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 103.967 -2.605 . . . . 31.710000000000001 103.967 -173.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1169 ' ' MET . . . . . . . . . . . . . 46.2 ttp -118.64 105.95 12.11 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 106.416 -1.698 . . . . 42.280000000000001 106.416 168.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 38.2 t -78.29 126.4 38.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 107.788 -1.19 . . . . 30.510000000000002 107.788 168.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 61.8 mt -112.41 126.16 69.77 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 108.787 -0.82 . . . . 31.870000000000001 108.787 171.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 79.6 79.65 0.82 Allowed Glycine 0 CA--C 1.536 1.346 0 N-CA-C 108.65 -1.78 . . . . 34.539999999999999 108.65 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1173 ' ' ALA . . . . . . . . . . . . . . . -85.87 89.43 7.77 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 125.568 2.604 . . . . 32.509999999999998 110.109 -172.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -113.35 -147.82 9.98 Favored Glycine 0 C--O 1.246 0.906 0 CA-C-N 110.788 -2.915 . . . . 29.899999999999999 108.882 174.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1175 ' ' VAL . . . . . 0.563 HG11 ' HA ' ' A' 1131 ' ' SER . 2.7 t -75.57 -37.35 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 119.261 1.531 . . . . 33.109999999999999 109.706 -175.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -55.77 -39.87 71.81 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 120.917 -1.115 . . . . 28.100000000000001 112.139 165.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -57.35 -49.4 73.06 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-O 118.738 -1.035 . . . . 28.539999999999999 110.572 174.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1178 ' ' LEU . . . . . . . . . . . . . 53.3 mt -56.37 -47.1 79.58 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 117.987 0.894 . . . . 31.219999999999999 110.588 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -57.28 -46.75 82.81 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 114.085 1.142 . . . . 28.98 114.085 177.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -64.02 -41.65 97.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.284 -0.871 . . . . 27.829999999999998 111.026 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1181 ' ' ILE . . . . . . . . . . . . . 92.2 mt -63.86 -46.23 94.84 Favored 'Isoleucine or valine' 0 C--N 1.361 1.085 0 CA-C-O 119.75 -0.167 . . . . 30.25 110.717 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -58.8 -54.54 37.1 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 108.64 -1.784 . . . . 29.59 108.64 -177.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -51.94 -56.1 16.25 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 118.115 0.958 . . . . 30.289999999999999 113.309 176.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -63.51 -44.49 94.15 Favored 'General case' 0 C--O 1.254 1.3 0 N-CA-C 115.274 1.583 . . . . 30.469999999999999 115.274 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -60.21 -53.25 59.93 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 124.624 1.17 . . . . 42.409999999999997 109.284 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1186 ' ' SER . . . . . 0.485 ' HB2' ' HA ' ' B' 1187 ' ' LEU . 85.2 p -57.5 -40.67 79.17 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 120.557 1.526 . . . . 39.380000000000003 115.032 175.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 5.6 mt -60.6 -21.57 62.8 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 114.71 1.374 . . . . 36.18 114.71 169.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 93.96 32.75 7.35 Favored Glycine 0 C--O 1.24 0.477 0 CA-C-O 123.085 1.38 . . . . 33.780000000000001 110.905 170.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -96.35 168.94 10.26 Favored 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 121.78 -0.836 . . . . 33.93 109.393 176.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 8.4 mt -93.9 109.11 21.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 102.511 -3.144 . . . . 38.740000000000002 102.511 -176.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 5.8 t -97.74 131.81 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 118.831 -1.148 . . . . 33.090000000000003 109.769 -170.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1192 ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -123.76 151.21 43.51 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 104.054 -2.573 . . . . 38.920000000000002 104.054 175.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -143.59 147.91 35.1 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 108.382 -0.97 . . . . 35.32 108.382 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 5.9 t80 -133.18 132.63 41.8 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.006 -1.85 . . . . 39.350000000000001 106.006 -178.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 9.0 t0 -156.74 154.5 30.09 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 105.526 -2.027 . . . . 40.460000000000001 105.526 170.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1196 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.28 -40.78 81.72 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 120.138 -0.625 . . . . 45.939999999999998 109.88 175.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1197 ' ' ARG . . . . . 0.447 ' HA ' ' HD2' ' A' 1198 ' ' PRO . 71.4 mtm180 -71.61 112.15 12.97 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 124.235 1.014 . . . . 56.020000000000003 113.516 -168.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1198 ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' 1197 ' ' ARG . 72.6 Cg_endo -60.87 -14.78 34.32 Favored 'Trans proline' 0 C--N 1.325 -0.69 0 C-N-CA 124.775 3.65 . . . . 51.270000000000003 116.411 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -69.97 -58.96 3.23 Favored 'General case' 0 C--N 1.356 0.859 0 O-C-N 120.231 -1.543 . . . . 59.100000000000001 111.561 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 17.5 m -53.29 -25.02 9.38 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.897 0 N-CA-C 113.262 0.838 . . . . 51.060000000000002 113.262 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 86.4 tttt -41.14 -38.3 1.05 Allowed 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 126.593 1.957 . . . . 57.380000000000003 114.863 169.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -66.45 -57.93 6.33 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 115.792 -2.051 . . . . 62.409999999999997 111.915 172.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -57.18 -28.62 62.98 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 123.924 3.056 . . . . 57.780000000000001 116.309 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1204 ' ' VAL . . . . . 0.597 HG11 ' HD1' ' A' 1211 ' ' PHE . 49.8 t -58.5 -60.51 2.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 O-C-N 121.555 -0.716 . . . . 46.380000000000003 109.924 168.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -69.92 -49.18 54.53 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 105.958 -1.867 . . . . 50.700000000000003 105.958 -170.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1206 ' ' SER . . . . . . . . . . . . . 45.8 m -45.75 -46.83 15.36 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.689 1.737 . . . . 49.979999999999997 115.689 169.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1207 ' ' MET . . . . . . . . . . . . . 18.2 mtp -73.21 -11.22 60.44 Favored 'General case' 0 CA--C 1.504 -0.79 0 O-C-N 119.024 -2.298 . . . . 52.990000000000002 113.06 175.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 105.27 64.95 0.66 Allowed Glycine 0 N--CA 1.439 -1.136 0 N-CA-C 109.931 -1.268 . . . . 47.659999999999997 109.931 166.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -152.81 144.52 23.53 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.099 -1.05 . . . . 44.770000000000003 110.147 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -75.49 133.19 41.11 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 105.738 -1.949 . . . . 47.640000000000001 105.738 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1211 ' ' PHE . . . . . 0.597 ' HD1' HG11 ' A' 1204 ' ' VAL . 35.1 t80 -99.22 105.93 18.02 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 117.075 -1.85 . . . . 45.659999999999997 108.974 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 55.6 mt -67.13 111.31 3.84 Favored 'General case' 0 C--O 1.252 1.229 0 CA-C-O 123.405 1.574 . . . . 46.060000000000002 109.9 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -79.18 165.37 23.37 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 113.379 -1.737 . . . . 60.219999999999999 115.318 174.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 8.4 mp -72.25 104.99 3.85 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-N 112.827 -1.988 . . . . 57.25 107.241 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1215 ' ' ASP . . . . . 0.45 ' HB3' HD21 ' A' 1241 ' ' LEU . 23.4 t70 -74.13 99.02 3.26 Favored 'General case' 0 CA--C 1.497 -1.071 0 O-C-N 118.416 -2.678 . . . . 64.430000000000007 106.617 166.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 14.5 t80 . . . . . 0 CA--C 1.54 0.558 0 CA-C-N 111.055 -2.793 . . . . 66.900000000000006 108.203 175.518 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 N--CA 1.425 -1.678 0 CA-C-O 121.843 0.83 . . . . 39.090000000000003 109.865 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -65.57 -29.38 75.03 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 126.927 2.203 . . . . 39.32 111.123 -169.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.7 -53.25 9.62 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 118.995 1.398 . . . . 39.299999999999997 107.546 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -55.6 -41.63 73.69 Favored 'General case' 0 C--O 1.211 -0.936 0 N-CA-C 113.358 0.873 . . . . 36.299999999999997 113.358 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -51.21 -64.77 0.7 Allowed 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 114.093 1.145 . . . . 37.380000000000003 114.093 162.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -63.62 -24.03 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 116.731 2.123 . . . . 39.109999999999999 116.731 -171.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1230 ' ' MET . . . . . . . . . . . . . 33.7 mmt -79.91 -23.57 41.7 Favored 'General case' 0 C--O 1.241 0.644 0 O-C-N 120.964 -1.085 . . . . 49.590000000000003 112.522 178.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1231 ' ' SER . . . . . . . . . . . . . 12.6 p -89.47 137.88 31.94 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 120.484 3.512 . . . . 43.68 120.484 -163.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -41.4 -45.58 3.14 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 117.457 2.392 . . . . 55.57 117.457 -174.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -73.01 -32.98 65.48 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 120.317 -1.489 . . . . 44.939999999999998 114.432 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -64.44 -53.9 41.03 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 106.804 -1.554 . . . . 42.039999999999999 106.804 172.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 35.9 mt -56.47 -27.5 24.93 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 N-CA-C 114.905 1.446 . . . . 46.280000000000001 114.905 173.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -59.08 -56.11 26.46 Favored 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 121.221 -0.924 . . . . 47.869999999999997 111.585 170.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -59.91 -52.92 63.35 Favored 'General case' 0 CA--C 1.496 -1.096 0 O-C-N 127.028 2.705 . . . . 41.609999999999999 111.339 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -48.68 -48.21 40.19 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 123.851 0.861 . . . . 50.649999999999999 112.316 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1239 ' ' MET . . . . . . . . . . . . . 28.4 ttm -55.02 -44.04 74.24 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 124.583 1.177 . . . . 48.869999999999997 109.149 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -72.07 -30.33 65.02 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.337 -0.945 . . . . 54.799999999999997 113.493 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1241 ' ' LEU . . . . . 0.45 HD21 ' HB3' ' A' 1215 ' ' ASP . 4.1 mm? -60.9 -43.54 98.36 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 118.833 -1.147 . . . . 43.210000000000001 113.824 169.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -62.15 -43.61 98.45 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.552 1.158 . . . . 38.659999999999997 109.37 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -57.15 -52.95 63.24 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.605 0.595 . . . . 37.920000000000002 112.605 171.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -54.35 -29.54 48.6 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 114.046 1.128 . . . . 37.280000000000001 114.046 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -85.31 -40.02 17.02 Favored 'General case' 0 C--N 1.315 -0.902 0 O-C-N 123.736 0.647 . . . . 43.07 110.588 174.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1246 ' ' ALA . . . . . 0.803 ' HB1' ' HG2' ' A' 1275 ' ' MET . . . -66.49 -15.5 63.42 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 116.742 2.127 . . . . 38.299999999999997 116.742 -158.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1247 ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -87.05 -18.46 30.52 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 113.391 -1.731 . . . . 47.600000000000001 113.792 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -105.33 -45.53 4.45 Favored 'General case' 0 C--N 1.358 0.968 0 O-C-N 120.435 -1.415 . . . . 45.420000000000002 112.839 165.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1249 ' ' VAL . . . . . 0.674 ' HA ' ' HB2' ' A' 1167 ' ' LYS . 31.4 m -64.67 148.14 12.07 Favored 'Isoleucine or valine' 0 C--N 1.345 0.382 0 CA-C-O 123.221 1.486 . . . . 36.259999999999998 114.256 -175.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1250 ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -91.37 -71.97 0.61 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.718 1.247 . . . . 33.039999999999999 111.036 -176.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1251 ' ' ILE . . . . . 0.7 HD12 ' HB1' ' A' 1145 ' ' ALA . 37.4 mm -97.68 101.29 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.946 0 C-N-CA 117.462 -1.695 . . . . 31.399999999999999 107.776 -171.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1252 ' ' ILE . . . . . . . . . . . . . 68.0 mt -77.09 94.15 1.25 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 106.563 -1.643 . . . . 29.420000000000002 106.563 166.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1253 ' ' VAL . . . . . 0.652 ' HA ' HG23 ' A' 1282 ' ' VAL . 2.0 t -81.3 98.61 4.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 104.5 -2.408 . . . . 30.370000000000001 104.5 175.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1254 ' ' THR . . . . . 0.767 HG21 ' HB2' ' A' 1291 ' ' ASN . 22.3 m -86.76 82.16 7.94 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 124.587 2.137 . . . . 35.719999999999999 105.914 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1255 ' ' THR . . . . . 0.476 HG22 HD12 ' A' 1284 ' ' LEU . 1.9 p -73.8 5.11 4.34 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 120.067 3.358 . . . . 36.0 120.067 -176.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1256 ' ' ALA . . . . . . . . . . . . . . . -85.64 63.03 7.83 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 124.105 1.907 . . . . 40.93 112.76 -170.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 57.1 tp -70.6 91.72 0.81 Allowed 'General case' 0 C--N 1.353 0.733 0 N-CA-C 103.546 -2.761 . . . . 47.82 103.546 172.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 39.5 mm -87.08 108.15 17.63 Favored Pre-proline 0 C--O 1.22 -0.489 0 N-CA-C 104.14 -2.541 . . . . 52.700000000000003 104.14 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -56.63 109.52 0.46 Allowed 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 124.398 3.399 . . . . 54.130000000000003 116.34 -170.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 78.34 16.32 79.69 Favored Glycine 0 N--CA 1.461 0.343 0 CA-C-N 112.025 -2.352 . . . . 54.619999999999997 111.945 174.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 92.1 mttt -125.78 141.72 40.11 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 119.628 1.714 . . . . 55.740000000000002 109.022 -176.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -66.46 97.85 0.38 Allowed 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 123.299 2.666 . . . . 51.149999999999999 107.031 172.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -56.58 125.02 65.8 Favored Pre-proline 0 N--CA 1.433 -1.294 0 CA-C-O 117.375 -1.298 . . . . 46.060000000000002 112.519 176.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -50.15 128.39 22.35 Favored 'Trans proline' 0 C--O 1.25 1.09 1 C-N-CA 126.622 4.881 . . . . 41.079999999999998 112.645 -166.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -61.7 97.06 0.07 Allowed 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.933 -1.03 . . . . 47.420000000000002 110.408 172.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 83.4 mt -94.77 -54.54 3.44 Favored 'General case' 0 N--CA 1.434 -1.23 0 O-C-N 120.693 -1.254 . . . . 39.219999999999999 109.68 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1267 ' ' ILE . . . . . 0.484 ' HB ' ' HA ' ' A' 1292 ' ' CYS . 12.3 mt -78.46 104.36 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 107.937 -1.135 . . . . 42.5 107.937 -172.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1268 ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.54 148.56 48.44 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 119.078 2.992 . . . . 37.840000000000003 119.078 175.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 40.6 mtt180 -52.28 -59.45 4.38 Favored 'General case' 0 C--O 1.248 0.996 0 N-CA-C 117.159 2.281 . . . . 54.799999999999997 117.159 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.55 -27.01 68.96 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 118.819 0.736 . . . . 54.359999999999999 111.919 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1271 ' ' MET . . . . . . . . . . . . . 59.5 ttm -68.45 -36.76 79.47 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.986 1.314 . . . . 39.520000000000003 111.704 175.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1272 ' ' VAL . . . . . . . . . . . . . 92.3 t -63.25 -47.94 89.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 N-CA-C 107.503 -1.295 . . . . 38.25 107.503 171.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -57.6 -26.16 61.13 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 113.731 1.012 . . . . 40.770000000000003 113.731 175.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1274 ' ' SER . . . . . . . . . . . . . 5.1 m -85.67 -8.24 58.33 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 121.261 1.846 . . . . 36.579999999999998 114.945 173.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1275 ' ' MET . . . . . 0.803 ' HG2' ' HB1' ' A' 1246 ' ' ALA . 87.1 mtp -60.76 165.19 4.11 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 116.521 2.045 . . . . 36.75 116.521 176.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1276 ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -67.47 144.47 55.69 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 122.514 1.149 . . . . 46.109999999999999 111.585 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1277 ' ' ALA . . . . . 0.494 ' HB1' ' HA ' ' B' 1045 ' ' PHE . . . -60.25 139.89 57.34 Favored 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 124.423 1.089 . . . . 33.520000000000003 109.008 176.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 76.43 -0.79 63.14 Favored Glycine 0 CA--C 1.538 1.479 0 O-C-N 119.943 -1.723 . . . . 31.27 113.267 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1279 ' ' SER . . . . . . . . . . . . . 47.0 m -74.56 160.53 30.76 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 118.771 -2.605 . . . . 32.950000000000003 109.37 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1280 ' ' VAL . . . . . 0.554 HG11 ' HA ' ' A' 1145 ' ' ALA . 82.9 t -127.49 135.88 62.05 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 O-C-N 119.776 -1.828 . . . . 27.43 108.38 -178.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1281 ' ' ILE . . . . . 0.449 HD12 HG22 ' A' 1309 ' ' VAL . 83.7 mt -108.62 98.62 7.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 103.193 -2.891 . . . . 30.300000000000001 103.193 169.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1282 ' ' VAL . . . . . 0.652 HG23 ' HA ' ' A' 1253 ' ' VAL . 0.0 OUTLIER -85.42 97.28 5.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.577 -1.268 . . . . 28.629999999999999 107.577 171.216 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 1283 ' ' ASP . . . . . 0.646 ' HA ' ' HB ' ' A' 1254 ' ' THR . 19.6 t0 -87.83 109.39 19.72 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.019 -1.474 . . . . 36.270000000000003 107.019 178.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1284 ' ' LEU . . . . . 0.721 HD21 ' HB2' ' A' 1141 ' ' ALA . 25.4 mt -74.98 -28.96 60.76 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 112.909 -1.95 . . . . 38.57 115.214 173.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -65.99 -53.18 42.16 Favored 'General case' 0 C--O 1.218 -0.569 0 O-C-N 120.304 -1.497 . . . . 37.560000000000002 110.098 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1286 ' ' ALA . . . . . 0.503 ' HA ' HG21 ' A' 1295 ' ' THR . . . 38.02 -74.81 0.0 OUTLIER 'General case' 0 N--CA 1.413 -2.291 0 C-N-CA 128.511 2.724 . . . . 40.329999999999998 116.172 176.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -63.07 -47.32 83.46 Favored 'General case' 0 N--CA 1.482 1.175 0 O-C-N 120.365 -1.46 . . . . 56.850000000000001 109.634 173.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 5.5 m120 -72.83 70.1 0.97 Allowed 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 124.718 1.261 . . . . 45.859999999999999 109.43 175.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 74.26 -58.91 2.36 Favored Glycine 0 CA--C 1.538 1.524 0 N-CA-C 117.657 1.823 . . . . 40.310000000000002 117.657 -176.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 84.35 121.79 0.95 Allowed Glycine 0 C--O 1.22 -0.728 0 N-CA-C 108.835 -1.706 . . . . 38.890000000000001 108.835 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1291 ' ' ASN . . . . . 0.767 ' HB2' HG21 ' A' 1254 ' ' THR . 24.4 m120 -76.45 -20.6 56.87 Favored 'General case' 0 CA--C 1.492 -1.281 0 CA-C-N 121.26 2.53 . . . . 37.229999999999997 112.324 -176.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1292 ' ' CYS . . . . . 0.484 ' HA ' ' HB ' ' A' 1267 ' ' ILE . 36.9 t -85.44 142.99 28.84 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 120.249 -1.532 . . . . 36.5 109.638 170.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1293 ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -74.36 -13.96 60.81 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 116.218 1.932 . . . . 43.32 116.218 169.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -90.03 -4.25 57.5 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 116.018 1.858 . . . . 41.32 116.018 169.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1295 ' ' THR . . . . . 0.503 HG21 ' HA ' ' A' 1286 ' ' ALA . 52.5 m -65.96 119.22 10.96 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 119.375 -2.078 . . . . 35.299999999999997 110.971 -175.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1296 ' ' VAL . . . . . 0.577 ' HB ' ' HB2' ' A' 1299 ' ' GLU . 48.4 t -95.53 112.26 58.32 Favored Pre-proline 0 C--O 1.248 1.015 0 N-CA-C 101.575 -3.491 . . . . 34.840000000000003 101.575 171.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -55.86 104.54 0.13 Allowed 'Trans proline' 0 C--O 1.22 -0.408 0 C-N-CA 124.114 3.21 . . . . 33.509999999999998 111.902 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 112.23 9.77 19.22 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 113.561 -1.654 . . . . 32.189999999999998 111.048 172.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1299 ' ' GLU . . . . . 0.577 ' HB2' ' HB ' ' A' 1296 ' ' VAL . 8.7 mm-40 -132.89 162.34 31.85 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 121.248 2.524 . . . . 34.880000000000003 116.451 -163.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1300 ' ' ILE . . . . . 0.438 HG23 HG12 ' A' 1310 ' ' ILE . 80.2 mt -90.76 105.82 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 N-CA-C 101.671 -3.455 . . . . 32.289999999999999 101.671 163.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1301 ' ' PHE . . . . . 0.68 ' HB3' ' HB ' ' A' 1309 ' ' VAL . 35.5 t80 -81.9 110.67 17.4 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 104.73 -2.322 . . . . 37.25 104.73 166.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1302 ' ' THR . . . . . . . . . . . . . 54.0 m -93.44 119.07 32.1 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.136 -1.802 . . . . 35.560000000000002 106.136 175.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1303 ' ' THR . . . . . . . . . . . . . 2.1 m -103.18 142.6 33.88 Favored 'General case' 0 C--O 1.247 0.946 0 N-CA-C 107.643 -1.243 . . . . 36.399999999999999 107.643 -173.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -52.4 -42.6 64.17 Favored 'General case' 0 C--O 1.247 0.921 0 C-N-CA 126.285 1.834 . . . . 52.32 113.445 -168.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1305 ' ' ASN . . . . . 0.691 ' HA ' ' HB2' ' B' 1046 ' ' ASP . 38.3 p-10 -61.07 -22.0 64.19 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 115.628 1.714 . . . . 40.039999999999999 115.628 175.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 120.56 0.11 12.37 Favored Glycine 0 N--CA 1.413 -2.891 0 C-N-CA 120.333 -0.937 . . . . 36.960000000000001 111.223 177.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1307 ' ' VAL . . . . . 0.613 HG21 ' HB2' ' A' 1275 ' ' MET . 71.0 t -82.53 131.51 33.6 Favored 'Isoleucine or valine' 0 C--N 1.347 0.493 0 O-C-N 118.452 -2.793 . . . . 33.399999999999999 110.147 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1308 ' ' LYS . . . . . 0.686 ' HG3' ' HB3' ' A' 1148 ' ' GLU . 26.2 mmtp -99.15 94.91 6.76 Favored 'General case' 0 C--O 1.248 1.0 0 N-CA-C 106.226 -1.768 . . . . 42.909999999999997 106.226 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1309 ' ' VAL . . . . . 0.68 ' HB ' ' HB3' ' A' 1301 ' ' PHE . 24.0 t -76.08 85.88 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.608 0 CA-C-O 122.296 1.046 . . . . 32.289999999999999 109.803 174.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1310 ' ' ILE . . . . . 0.828 HD11 ' HB2' ' A' 1148 ' ' GLU . 55.0 mt -89.95 95.83 5.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 124.566 2.127 . . . . 30.989999999999998 106.263 -174.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -90.55 71.26 2.06 Favored Glycine 0 N--CA 1.436 -1.364 0 O-C-N 119.515 -1.991 . . . . 28.949999999999999 110.778 171.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1312 ' ' TYR . . . . . 0.482 ' HD1' ' HA ' ' A' 1312 ' ' TYR . 0.0 OUTLIER -91.65 124.52 35.86 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 119.167 1.483 . . . . 31.690000000000001 111.187 -171.105 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 1313 ' ' THR . . . . . . . . . . . . . 4.5 p -103.71 -21.65 13.67 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 118.862 -1.135 . . . . 34.170000000000002 113.827 -175.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -81.85 24.53 0.61 Allowed 'General case' 0 C--O 1.256 1.432 0 CA-C-O 122.06 0.933 . . . . 36.859999999999999 112.752 -173.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1315 ' ' LEU . . . . . 0.546 HD22 ' HG3' ' A' 1140 ' ' ARG . 88.3 mt -69.84 -42.52 18.45 Favored Pre-proline 0 N--CA 1.439 -1.012 0 N-CA-C 118.075 2.62 . . . . 34.850000000000001 118.075 -168.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -59.54 -35.58 95.24 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 CA-C-N 123.672 2.347 . . . . 29.149999999999999 113.8 171.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -65.2 -35.72 91.99 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-O 122.165 0.87 . . . . 27.289999999999999 111.413 172.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1318 ' ' ARG . . . . . 0.49 ' HD2' HD23 ' A' 1315 ' ' LEU . 79.7 mtt-85 -64.38 -3.16 2.68 Favored 'General case' 0 C--O 1.24 0.563 0 O-C-N 120.438 -1.625 . . . . 41.490000000000002 114.697 168.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1319 ' ' LEU . . . . . 0.471 HD23 HG23 ' A' 1136 ' ' ILE . 8.0 tp -143.51 69.53 17.38 Favored Pre-proline 0 N--CA 1.437 -1.114 0 O-C-N 118.487 -2.633 . . . . 27.609999999999999 111.018 178.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1320 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -53.88 -62.72 0.28 Allowed 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 124.948 3.765 . . . . 25.940000000000001 116.451 -169.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1321 ' ' THR . . . . . 0.415 HG21 HH11 ' B' 1151 ' ' ARG . 0.2 OUTLIER -59.4 -22.95 62.17 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 121.361 1.891 . . . . 25.010000000000002 111.407 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 1322 ' ' GLN . . . . . 0.498 ' HG3' HG12 ' A' 1136 ' ' ILE . 4.1 tp-100 -75.18 -37.57 61.17 Favored 'General case' 0 C--O 1.217 -0.617 0 O-C-N 120.192 -1.568 . . . . 29.390000000000001 109.088 176.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1323 ' ' SER . . . . . . . . . . . . . 73.6 m -60.4 -66.54 0.51 Allowed 'General case' 0 C--O 1.251 1.149 0 CA-C-O 118.185 -0.912 . . . . 26.469999999999999 109.897 166.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1324 ' ' SER . . . . . . . . . . . . . 14.5 m -45.29 -36.36 4.01 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 116.883 2.179 . . . . 27.780000000000001 116.883 177.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -77.88 -64.96 1.03 Allowed 'General case' 0 C--O 1.216 -0.701 0 O-C-N 119.805 -1.809 . . . . 37.530000000000001 114.723 170.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1326 ' ' LEU . . . . . 0.731 ' HB3' ' HB3' ' A' 1132 ' ' SER . 22.1 mt -70.39 -51.39 29.98 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 120.961 1.71 . . . . 35.710000000000001 113.544 -169.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1327 ' ' TYR . . . . . 0.468 ' HA ' ' OD1' ' A' 1330 ' ' ASN . 64.4 t80 -66.14 -46.05 78.86 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 106.779 -1.563 . . . . 31.59 106.779 174.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1328 ' ' GLY . . . . . 0.564 ' HA2' HD12 ' A' 1331 ' ' LEU . . . -40.42 -52.82 3.58 Favored Glycine 0 CA--C 1.541 1.664 0 CA-C-N 119.994 1.27 . . . . 28.0 113.829 166.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1329 ' ' THR . . . . . 0.402 ' HA ' ' HB ' ' A' 1332 ' ' VAL . 1.1 m -79.44 -18.28 52.51 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 117.328 -3.454 . . . . 32.149999999999999 108.353 -173.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1330 ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' 1127 ' ' LEU . 29.4 m120 -57.91 -53.96 52.26 Favored 'General case' 0 C--O 1.246 0.893 0 O-C-N 118.344 -2.722 . . . . 34.359999999999999 110.487 167.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1331 ' ' LEU . . . . . 0.803 HD13 HD13 ' A' 1070 ' ' LEU . 11.7 mt -57.0 -47.5 80.69 Favored 'General case' 0 C--N 1.353 0.726 0 CA-C-N 113.63 -1.623 . . . . 33.369999999999997 110.388 175.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1332 ' ' VAL . . . . . 0.676 HG21 ' HB ' ' A' 1022 ' ' THR . 59.9 t -58.86 -37.53 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 124.884 1.274 . . . . 35.270000000000003 109.98 176.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -70.59 -41.75 71.94 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-N 121.801 2.091 . . . . 37.659999999999997 112.475 -176.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1334 ' ' LEU . . . . . 0.536 HD23 HG13 ' A' 1090 ' ' VAL . 60.2 tp -58.74 -53.31 59.85 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 121.51 0.671 . . . . 40.270000000000003 109.669 170.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1335 ' ' LEU . . . . . 0.484 ' HA ' ' HB2' ' A' 1338 ' ' LEU . 13.5 mt -60.92 -21.11 63.06 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 115.511 1.671 . . . . 42.5 115.511 176.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1336 ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' 1332 ' ' VAL . 96.1 mttt -65.23 -46.83 79.01 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 118.626 0.648 . . . . 47.810000000000002 109.589 168.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1337 ' ' LEU . . . . . . . . . . . . . 36.7 mt -63.67 -41.22 98.21 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 124.03 1.871 . . . . 49.270000000000003 111.569 178.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1338 ' ' LEU . . . . . 0.484 ' HB2' ' HA ' ' A' 1335 ' ' LEU . 10.3 mp -59.74 -41.49 91.05 Favored 'General case' 0 C--N 1.355 0.823 0 CA-C-O 122.923 1.344 . . . . 50.539999999999999 112.624 175.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1339 ' ' CYS . . . . . 0.724 ' SG ' ' HA ' ' A' 1342 ' ' LYS . 18.1 t -74.93 82.01 2.18 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 123.734 1.731 . . . . 53.670000000000002 111.905 173.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -58.9 -55.23 37.76 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 112.543 -2.117 . . . . 63.380000000000003 113.229 -175.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -115.57 -0.47 13.03 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 115.351 1.611 . . . . 70.950000000000003 115.351 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1342 ' ' LYS . . . . . 0.724 ' HA ' ' SG ' ' A' 1339 ' ' CYS . 31.3 mtmm 56.3 66.41 1.2 Allowed 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 118.716 2.858 . . . . 65.25 118.716 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1343 ' ' ASP . . . . . 0.464 ' HB3' ' N ' ' A' 1342 ' ' LYS 0.462 0.0 OUTLIER 87.79 -73.96 0.01 OUTLIER 'General case' 0 C--N 1.359 0.987 3 O-C-N 113.169 -5.957 . . . . 64.530000000000001 120.278 -10.645 . . . . . . . . 5 4 . 1 . 002 nuclear build core ' A' A 1344 ' ' GLY . . . . . . . . . . . . . . . 68.55 46.6 61.53 Favored Glycine 0 C--O 1.257 1.553 0 O-C-N 120.764 -1.21 . . . . 59.719999999999999 115.562 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1345 ' ' ASN . . . . . 0.444 ' HB2' ' OD2' ' A' 1343 ' ' ASP . 9.1 t-20 -78.81 149.33 32.61 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 115.729 1.751 . . . . 64.090000000000003 115.729 176.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1346 ' ' ILE . . . . . . . . . . . . . 2.8 mp -85.04 86.69 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 N-CA-C 100.847 -3.76 . . . . 58.82 100.847 170.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1347 ' ' THR . . . . . . . . . . . . . 9.7 m -93.2 91.94 7.51 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 123.57 1.652 . . . . 54.960000000000001 113.859 172.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1348 ' ' VAL . . . . . 0.55 HG21 HG21 ' A' 1111 ' ' THR . 10.4 t -88.01 93.15 4.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 101.294 -3.595 . . . . 55.640000000000001 101.294 174.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 21.5 t70 -86.36 133.17 33.81 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-O 123.476 1.608 . . . . 61.450000000000003 107.806 169.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -99.88 -8.95 23.42 Favored 'General case' 0 N--CA 1.442 -0.838 0 O-C-N 119.991 -1.693 . . . . 58.630000000000003 113.127 176.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -73.36 -35.08 65.92 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-N 115.551 -0.75 . . . . 62.060000000000002 112.767 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 7.3 t70 -82.75 125.53 31.37 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.537 -1.283 . . . . 54.07 107.537 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 27.2 m -55.61 -30.79 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 113.53 -1.668 . . . . 50.68 114.088 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1354 ' ' VAL . . . . . 0.474 ' O ' HG23 ' A' 1358 ' ' VAL 0.251 6.0 m -71.03 -49.66 47.8 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 C-N-CA 118.955 -1.098 . . . . 47.68 112.374 178.796 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 1355 ' ' ILE . . . . . . . . . . . . . 72.0 mt -71.36 -37.7 66.25 Favored 'Isoleucine or valine' 0 C--O 1.253 1.241 0 N-CA-C 108.623 -0.881 . . . . 48.490000000000002 108.623 -173.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 46.5 tpt85 -57.36 -33.38 67.73 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 113.56 0.948 . . . . 48.270000000000003 113.56 167.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -65.72 -52.54 37.7 Favored Glycine 0 N--CA 1.436 -1.357 0 C-N-CA 123.52 0.581 . . . . 43.530000000000001 112.486 172.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1358 ' ' VAL . . . . . 0.785 HG22 HG22 ' A' 1118 ' ' VAL . 3.5 t -66.18 -37.93 80.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 107.401 -1.333 . . . . 45.119999999999997 107.401 -175.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1359 ' ' THR . . . . . . . . . . . . . 30.3 m -76.43 87.74 3.19 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 119.869 -1.77 . . . . 42.939999999999998 111.228 -174.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 33.4 m -77.93 -31.43 16.89 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 O-C-N 121.025 -1.047 . . . . 43.259999999999998 110.647 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1361 ' ' ILE . . . . . 0.475 HG12 HG12 ' A' 1366 ' ' ILE . 94.8 mt -128.56 119.62 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 N-CA-C 105.844 -1.91 . . . . 45.659999999999997 105.844 176.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1362 ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -103.45 120.29 40.53 Favored 'General case' 0 C--N 1.364 1.209 0 CA-C-N 123.445 2.838 . . . . 61.340000000000003 106.365 174.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 36.01 48.5 0.52 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 112.14 -2.3 . . . . 49.759999999999998 115.999 -177.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1364 ' ' GLY . . . . . 0.499 ' HA3' ' HA ' ' A' 1109 ' ' ASN . . . 89.23 12.73 62.89 Favored Glycine 0 C--O 1.222 -0.603 0 CA-C-O 116.944 -2.031 . . . . 50.0 113.062 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -122.83 127.07 48.56 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 102.322 -3.214 . . . . 56.920000000000002 102.322 172.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1366 ' ' ILE . . . . . 0.475 HG12 HG12 ' A' 1361 ' ' ILE . 43.5 mt -73.75 92.89 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 CA-C-O 123.01 1.386 . . . . 52.780000000000001 109.184 -176.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1367 ' ' THR . . . . . . . . . . . . . 6.9 p -76.55 -5.69 48.74 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 123.55 1.643 . . . . 49.439999999999998 114.609 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 20.1 t90 -60.42 143.56 89.48 Favored Pre-proline 0 N--CA 1.44 -0.931 0 CA-C-O 116.227 -1.844 . . . . 52.380000000000003 110.365 171.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -81.37 -163.88 3.55 Favored 'Cis proline' 0 C--O 1.248 1.005 0 CA-C-N 123.417 2.256 . . . . 46.939999999999998 112.571 -6.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -129.14 158.3 73.32 Favored Pre-proline 0 N--CA 1.428 -1.561 0 CA-C-O 117.188 -1.387 . . . . 45.909999999999997 108.742 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1371 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -47.28 120.83 4.69 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 124.901 3.734 . . . . 46.390000000000001 111.216 170.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -65.66 -41.26 15.17 Favored 'Trans proline' 0 CA--C 1.557 1.64 0 C-N-CA 125.076 3.851 . . . . 46.719999999999999 112.077 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.228 -4.699 0 CA-C-N 121.508 1.958 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 20.2 m80 . . . . . 0 N--CA 1.425 -1.697 0 N-CA-C 105.958 -1.867 . . . . 63.439999999999998 105.958 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 999' ' ' HIS . . . . . 0.512 ' HB3' ' HB3' ' B' 1002 ' ' ARG . 89.7 m-70 -93.94 57.36 2.43 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 119.485 -2.009 . . . . 51.740000000000002 107.449 173.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1000 ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -81.46 118.45 22.72 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 106.792 -1.559 . . . . 54.07 106.792 -167.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 72.78 18.97 79.13 Favored Glycine 0 C--O 1.224 -0.529 0 CA-C-N 114.716 -1.129 . . . . 39.219999999999999 111.927 -168.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1002 ' ' ARG . . . . . 0.544 ' HD2' ' HB2' ' B' 1034 ' ' ALA . 33.9 ttp180 -100.6 124.93 46.85 Favored 'General case' 0 C--O 1.256 1.419 0 CA-C-N 121.387 2.594 . . . . 38.119999999999997 109.994 169.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1003 ' ' ILE . . . . . . . . . . . . . 51.6 mt -81.41 142.61 13.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 108.942 -3.753 . . . . 29.699999999999999 105.029 171.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -112.44 128.56 8.55 Favored Glycine 0 N--CA 1.436 -1.332 0 N-CA-C 106.217 -2.753 . . . . 27.5 106.217 166.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1005 ' ' ILE . . . . . 0.567 ' HB ' ' HA ' ' B' 1035 ' ' VAL . 47.6 mm -105.62 99.71 22.92 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 101.166 -3.642 . . . . 24.829999999999998 101.166 173.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -83.88 166.62 13.14 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.672 2.248 . . . . 27.190000000000001 112.148 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 30.2 ttm105 -77.17 143.61 38.95 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 103.039 -2.949 . . . . 41.460000000000001 103.039 167.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1008 ' ' GLU . . . . . 0.485 ' OE2' ' HG2' ' B' 1071 ' ' LYS . 8.6 mm-40 -63.9 129.8 41.52 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 116.83 2.159 . . . . 26.93 116.83 169.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 48.5 mmm-85 -83.73 -5.7 59.26 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 110.704 -2.953 . . . . 34.479999999999997 111.339 171.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1010 ' ' LEU . . . . . 0.401 HD23 ' HB2' ' B' 1013 ' ' GLU . 4.1 tp -60.93 126.16 26.37 Favored 'General case' 0 C--O 1.244 0.792 0 O-C-N 120.805 -1.184 . . . . 44.219999999999999 108.919 168.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1011 ' ' THR . . . . . . . . . . . . . 86.9 m -64.93 116.47 6.41 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-O 122.452 1.12 . . . . 40.740000000000002 108.95 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 21.7 t30 63.15 92.16 0.06 Allowed 'General case' 0 C--N 1.339 0.15 0 CA-C-N 112.308 -2.224 . . . . 44.439999999999998 112.546 -174.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1013 ' ' GLU . . . . . 0.401 ' HB2' HD23 ' B' 1010 ' ' LEU . 10.3 tp10 -137.88 138.72 39.36 Favored 'General case' 0 N--CA 1.415 -2.217 0 CA-C-N 111.147 -2.752 . . . . 29.870000000000001 104.385 176.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1014 ' ' THR . . . . . 0.454 HG22 ' HB3' ' B' 1320 ' ' PRO . 0.2 OUTLIER -104.38 -5.07 22.07 Favored 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 120.247 -1.533 . . . . 25.260000000000002 111.331 177.846 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B 1015 ' ' ARG . . . . . 0.701 ' HG3' ' HA2' ' B' 1317 ' ' GLY . 23.6 mtm180 -88.37 148.05 24.44 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 119.904 1.229 . . . . 29.539999999999999 113.517 177.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1016 ' ' VAL . . . . . 0.535 HG13 ' H ' ' B' 1018 ' ' ALA . 4.4 p -113.94 -173.19 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 105.643 -1.984 . . . . 23.550000000000001 105.643 151.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1017 ' ' ALA . . . . . . . . . . . . . . . -106.37 11.75 30.57 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 121.485 1.948 . . . . 23.59 115.686 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1018 ' ' ALA . . . . . 0.535 ' H ' HG13 ' B' 1016 ' ' VAL . . . -149.98 156.16 41.22 Favored 'General case' 0 C--O 1.211 -0.939 0 CA-C-O 123.018 1.389 . . . . 24.93 113.677 -176.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1019 ' ' THR . . . . . 0.524 HG22 ' HZ ' ' B' 1045 ' ' PHE . 26.1 p -135.12 163.48 50.81 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 110.812 -2.904 . . . . 28.09 103.308 176.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -49.97 -39.25 49.91 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.86 2.374 . . . . 28.789999999999999 113.541 168.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1021 ' ' LYS . . . . . 0.4 ' O ' ' HG3' ' B' 1025 ' ' GLN . 76.4 tttt -67.9 -44.7 76.38 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 112.535 0.568 . . . . 47.280000000000001 112.535 177.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1022 ' ' THR . . . . . . . . . . . . . 13.7 p -67.99 -29.61 68.66 Favored 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 120.223 -1.548 . . . . 30.120000000000001 111.956 178.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1023 ' ' VAL . . . . . . . . . . . . . 69.1 t -56.55 -53.84 35.97 Favored 'Isoleucine or valine' 0 C--N 1.351 0.637 0 N-CA-C 107.107 -1.442 . . . . 32.240000000000002 107.107 170.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1024 ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -55.96 -39.36 71.66 Favored 'General case' 0 C--O 1.215 -0.732 0 N-CA-C 114.324 1.231 . . . . 49.619999999999997 114.324 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1025 ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' B' 1021 ' ' LYS . 43.9 mt-30 -65.97 -43.26 88.4 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 122.496 1.141 . . . . 44.68 109.869 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1026 ' ' LEU . . . . . 0.404 ' CD2' HG22 ' B' 1332 ' ' VAL . 42.6 mt -67.82 -32.17 72.52 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 119.103 -2.248 . . . . 35.710000000000001 114.641 173.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1027 ' ' LEU . . . . . . . . . . . . . 98.1 mt -62.9 -39.91 95.96 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.072 -1.017 . . . . 42.18 110.493 172.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 24.8 mttm -62.17 -47.65 83.56 Favored 'General case' 0 C--O 1.251 1.154 0 N-CA-C 109.21 -0.663 . . . . 48.340000000000003 109.21 172.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1029 ' ' LEU . . . . . 0.627 HD21 ' HG2' ' B' 1336 ' ' LYS . 79.8 mt -64.84 -4.27 4.24 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 116.972 2.212 . . . . 38.689999999999998 116.972 172.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 88.95 20.95 44.37 Favored Glycine 0 N--CA 1.433 -1.551 0 CA-C-O 122.934 1.296 . . . . 32.280000000000001 114.355 166.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -99.05 143.95 28.75 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 123.163 1.459 . . . . 35.939999999999998 108.212 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1032 ' ' THR . . . . . . . . . . . . . 31.9 m -79.04 117.14 19.81 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 106.532 -1.655 . . . . 33.369999999999997 106.532 164.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1033 ' ' VAL . . . . . . . . . . . . . 2.9 t -91.89 108.62 20.27 Favored 'Isoleucine or valine' 0 C--O 1.262 1.741 0 O-C-N 120.599 -1.313 . . . . 29.98 107.708 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1034 ' ' ALA . . . . . 0.544 ' HB2' ' HD2' ' B' 1002 ' ' ARG . . . -99.84 140.17 34.44 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 107.376 -1.342 . . . . 28.18 107.376 172.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1035 ' ' VAL . . . . . 0.567 ' HA ' ' HB ' ' B' 1005 ' ' ILE . 88.3 t -124.26 145.53 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 103.652 -2.721 . . . . 25.82 103.652 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1036 ' ' GLU . . . . . 0.603 ' HB3' ' HB2' ' B' 1039 ' ' ALA . 26.9 tt0 -65.89 129.75 40.88 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.472 -1.24 . . . . 32.439999999999998 112.585 173.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1037 ' ' SER . . . . . . . . . . . . . 12.7 m -57.16 133.9 55.43 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.239 -1.346 . . . . 29.539999999999999 108.884 172.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 88.88 -43.59 3.09 Favored Glycine 0 CA--C 1.498 -0.98 0 O-C-N 117.424 -3.297 . . . . 27.760000000000002 110.886 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1039 ' ' ALA . . . . . 0.603 ' HB2' ' HB3' ' B' 1036 ' ' GLU . . . -37.52 -37.37 0.2 Allowed 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 118.304 2.705 . . . . 26.02 118.304 -175.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -62.99 -31.13 79.62 Favored Glycine 0 N--CA 1.42 -2.411 0 C-N-CA 126.029 1.776 . . . . 26.469999999999999 113.62 -175.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1041 ' ' GLN . . . . . 0.426 ' NE2' ' HA ' ' B' 1046 ' ' ASP . 3.1 mp0 -56.9 -40.62 76.6 Favored 'General case' 0 CA--C 1.518 -0.26 0 O-C-N 120.137 -1.802 . . . . 50.979999999999997 114.101 -175.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 29.9 mt -63.5 -44.19 95.04 Favored 'General case' 0 C--O 1.247 0.923 0 O-C-N 121.594 -0.691 . . . . 29.300000000000001 109.502 175.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1043 ' ' ALA . . . . . . . . . . . . . . . -87.3 17.41 4.41 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 120.732 -1.23 . . . . 26.739999999999998 113.491 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1044 ' ' SER . . . . . . . . . . . . . 10.5 m 67.83 46.24 1.29 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 123.909 1.814 . . . . 31.260000000000002 112.191 170.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1045 ' ' PHE . . . . . 0.524 ' HZ ' HG22 ' B' 1019 ' ' THR . 85.3 m-85 -130.86 162.86 28.68 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 104.79 -2.3 . . . . 33.259999999999998 104.79 175.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1046 ' ' ASP . . . . . 0.691 ' HB2' ' HA ' ' A' 1305 ' ' ASN . 22.9 t70 -104.19 161.3 14.15 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.011 -1.477 . . . . 46.740000000000002 107.011 158.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.55 -39.23 92.94 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 122.399 1.095 . . . . 34.439999999999998 111.094 -175.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.6 -22.01 63.29 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 115.443 1.646 . . . . 48.670000000000002 115.443 -176.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -62.73 -42.94 99.91 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 118.93 -2.356 . . . . 35.259999999999998 110.48 166.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1050 ' ' PHE . . . . . 0.446 ' HB2' HD11 ' B' 1057 ' ' ILE . 91.4 m-85 -69.82 -36.35 75.55 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 119.622 -1.924 . . . . 32.170000000000002 110.446 176.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 42.5 t -57.3 -43.34 81.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 116.08 -0.509 . . . . 38.369999999999997 110.585 171.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -71.26 -27.26 63.32 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 118.527 0.603 . . . . 45.770000000000003 111.504 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -73.02 -23.98 60.68 Favored 'General case' 0 N--CA 1.443 -0.775 0 O-C-N 120.723 -1.236 . . . . 37.829999999999998 112.407 174.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 95.15 39.33 4.57 Favored Glycine 0 C--O 1.221 -0.703 0 O-C-N 124.556 1.16 . . . . 35.82 112.85 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -102.21 139.13 38.23 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 124.082 0.953 . . . . 33.770000000000003 110.251 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -73.96 101.02 3.7 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.635 1.174 . . . . 51.020000000000003 107.955 -177.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1057 ' ' ILE . . . . . 0.446 HD11 ' HB2' ' B' 1050 ' ' PHE . 50.2 mm -88.86 100.4 10.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 119.442 -2.036 . . . . 38.469999999999999 106.08 -172.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1058 ' ' VAL . . . . . 0.42 HG23 ' HB ' ' B' 1063 ' ' VAL . 3.2 m -123.87 158.89 29.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 107.267 -1.383 . . . . 39.399999999999999 107.267 -173.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -72.33 167.19 20.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 118.421 -0.799 . . . . 57.07 112.732 -175.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1060 ' ' GLY . . . . . 0.411 ' O ' HG12 ' B' 1063 ' ' VAL . . . -52.5 -61.37 6.77 Favored Glycine 0 C--N 1.344 1.021 0 O-C-N 124.695 1.247 . . . . 44.829999999999998 114.129 -164.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 2.3 t30 -70.82 -32.55 69.65 Favored 'General case' 0 C--O 1.223 -0.303 0 O-C-N 119.546 -2.149 . . . . 46.270000000000003 110.486 -173.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1062 ' ' SER . . . . . . . . . . . . . 5.8 m -61.4 -41.2 96.74 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 113.125 -1.852 . . . . 43.469999999999999 113.336 171.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1063 ' ' VAL . . . . . 0.42 ' HB ' HG23 ' B' 1058 ' ' VAL . 6.4 p -72.83 -31.11 35.03 Favored 'Isoleucine or valine' 0 C--O 1.26 1.616 0 CA-C-N 121.069 1.759 . . . . 36.979999999999997 109.788 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1064 ' ' TRP . . . . . 0.591 ' HZ3' ' HG ' ' B' 1083 ' ' LEU . 0.1 OUTLIER -63.53 -31.26 72.37 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-O 122.347 1.07 . . . . 37.899999999999999 112.662 174.034 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -79.54 80.79 5.88 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 119.594 -1.941 . . . . 46.189999999999998 111.172 174.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1066 ' ' SER . . . . . 0.505 ' HB3' ' O ' ' B' 1002 ' ' ARG . 49.3 m -138.23 168.41 19.8 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 121.645 -0.659 . . . . 37.060000000000002 110.118 176.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1067 ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -79.42 -25.86 41.97 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 124.217 1.007 . . . . 43.950000000000003 109.914 176.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1068 ' ' ILE . . . . . 0.492 HG12 HD11 ' B' 1346 ' ' ILE . 3.5 mp -130.78 138.86 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 O-C-N 119.254 -2.154 . . . . 33.5 108.186 171.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1069 ' ' ILE . . . . . 0.632 HG22 ' HB2' ' B' 1071 ' ' LYS . 35.8 mm -124.31 120.72 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 104.036 -2.579 . . . . 30.57 104.036 176.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1070 ' ' LEU . . . . . 0.819 ' HB3' HD13 ' B' 1331 ' ' LEU . 56.9 mt -103.77 109.48 21.22 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 101.347 -3.575 . . . . 27.66 101.347 175.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1071 ' ' LYS . . . . . 0.632 ' HB2' HG22 ' B' 1069 ' ' ILE . 28.1 tttm -135.93 152.01 50.55 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 103.196 -2.89 . . . . 28.399999999999999 103.196 -167.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1072 ' ' VAL . . . . . 0.457 ' HA ' ' CE2' ' B' 1327 ' ' TYR . 45.4 t -80.43 -60.92 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.566 0 N-CA-C 107.717 -1.216 . . . . 23.18 107.717 -171.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 16.9 m120 -114.86 -173.97 2.4 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 120.265 -1.522 . . . . 25.469999999999999 110.803 -166.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1074 ' ' ALA . . . . . 0.407 ' HA ' ' HD2' ' B' 1075 ' ' PRO . . . -46.93 133.74 8.58 Favored Pre-proline 0 C--N 1.367 1.333 0 C-N-CA 124.602 1.161 . . . . 27.899999999999999 113.62 175.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1075 ' ' PRO . . . . . 0.544 ' HG2' HD11 ' B' 1101 ' ' LEU . 20.0 Cg_endo -65.62 139.34 57.85 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.892 2.395 . . . . 31.620000000000001 109.526 166.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 9.1 mt -80.65 164.1 23.11 Favored 'General case' 0 C--O 1.246 0.908 0 CA-C-N 113.89 -1.504 . . . . 40.490000000000002 109.672 166.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1077 ' ' ASP . . . . . 0.542 ' HA ' HD12 ' B' 1080 ' ' ILE . 0.7 OUTLIER -50.81 -34.32 27.17 Favored 'General case' 0 C--O 1.257 1.487 0 CA-C-N 119.821 1.192 . . . . 51.590000000000003 114.144 -175.254 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -73.18 -42.84 62.28 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 121.254 -0.904 . . . . 42.359999999999999 109.934 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1079 ' ' GLU . . . . . 0.429 ' HA ' HD12 ' B' 1082 ' ' LEU . 23.2 mt-10 -59.88 -35.23 74.4 Favored 'General case' 0 C--O 1.267 1.986 0 C-N-CA 123.805 0.842 . . . . 34.530000000000001 109.834 176.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1080 ' ' ILE . . . . . 0.706 ' HA ' HD12 ' B' 1083 ' ' LEU . 97.7 mt -63.33 -43.78 98.76 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 CA-C-O 123.965 1.84 . . . . 33.25 110.268 173.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -65.38 -29.77 70.52 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 118.039 -2.913 . . . . 36.469999999999999 114.852 176.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1082 ' ' LEU . . . . . 0.429 HD12 ' HA ' ' B' 1079 ' ' GLU . 41.8 mt -64.6 -40.88 96.31 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 112.836 -1.984 . . . . 37.759999999999998 113.663 168.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1083 ' ' LEU . . . . . 0.706 HD12 ' HA ' ' B' 1080 ' ' ILE . 5.6 mt -59.68 107.34 0.58 Allowed 'General case' 0 CA--C 1.495 -1.169 0 CA-C-O 123.322 1.534 . . . . 37.43 110.209 174.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -95.47 143.06 25.47 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 111.347 -2.66 . . . . 37.700000000000003 108.58 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1085 ' ' PRO . . . . . 0.633 ' HB3' ' HB2' ' B' 1109 ' ' ASN . 18.2 Cg_endo -52.62 113.86 1.43 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.937 3.092 . . . . 35.509999999999998 109.671 177.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 128.74 -32.81 3.24 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 112.357 -2.201 . . . . 33.869999999999997 112.433 -173.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1087 ' ' THR . . . . . . . . . . . . . 61.4 m -67.16 139.21 57.45 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-O 123.875 1.798 . . . . 32.5 108.682 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1088 ' ' THR . . . . . . . . . . . . . 7.8 m -98.71 110.61 23.19 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 103.498 -2.778 . . . . 30.219999999999999 103.498 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1089 ' ' LEU . . . . . 0.582 HD13 HD21 ' B' 1083 ' ' LEU . 40.1 tp -95.78 118.67 32.87 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 106.715 -1.587 . . . . 27.239999999999998 106.715 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1090 ' ' VAL . . . . . 0.459 HG13 ' HB2' ' B' 1113 ' ' MET . 4.2 t -118.22 107.1 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 107.44 -1.318 . . . . 25.390000000000001 107.44 176.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1091 ' ' SER . . . . . 0.497 ' OG ' ' HB3' ' B' 1071 ' ' LYS . 19.7 m -161.02 163.8 31.37 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.723 -0.672 . . . . 28.809999999999999 112.712 -167.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1092 ' ' PHE . . . . . 0.616 ' HZ ' ' HG3' ' B' 1133 ' ' MET . 40.8 m-85 -69.22 105.09 2.38 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-O 123.586 1.66 . . . . 30.780000000000001 106.534 166.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1093 ' ' ILE . . . . . 0.402 HG13 ' CG1' ' B' 1112 ' ' VAL . 32.9 mm -95.54 -37.56 7.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 O-C-N 119.883 -1.761 . . . . 30.280000000000001 110.968 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1094 ' ' TRP . . . . . 0.524 ' HB3' ' HB2' ' B' 1097 ' ' GLN . 96.4 m95 55.34 60.62 9.22 Favored Pre-proline 0 CA--C 1.55 0.955 0 O-C-N 124.868 1.355 . . . . 34.07 112.496 -173.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -51.68 -51.47 11.11 Favored 'Trans proline' 0 C--O 1.253 1.273 0 C-N-CA 125.207 3.938 . . . . 38.659999999999997 115.466 -171.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -62.98 -28.93 70.43 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-N 120.301 1.41 . . . . 41.32 112.147 176.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1097 ' ' GLN . . . . . 0.524 ' HB2' ' HB3' ' B' 1094 ' ' TRP . 18.6 mp0 -82.75 -22.74 34.25 Favored 'General case' 0 C--O 1.26 1.648 0 N-CA-C 108.066 -1.087 . . . . 51.659999999999997 108.066 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -127.82 57.71 27.66 Favored Pre-proline 0 C--O 1.223 -0.341 0 CA-C-N 120.754 1.615 . . . . 40.32 115.207 -175.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 0.7 OUTLIER -52.46 -37.02 72.16 Favored 'Trans proline' 0 C--O 1.248 0.993 0 C-N-CA 124.871 3.714 . . . . 41.560000000000002 115.116 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -59.66 -57.85 11.16 Favored 'General case' 0 C--O 1.217 -0.624 0 O-C-N 124.744 1.278 . . . . 54.109999999999999 107.69 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1101 ' ' LEU . . . . . 0.544 HD11 ' HG2' ' B' 1075 ' ' PRO . 9.6 tp -51.27 -44.78 61.88 Favored 'General case' 0 C--O 1.211 -0.964 0 CA-C-O 116.656 -1.64 . . . . 37.880000000000003 109.452 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1102 ' ' MET . . . . . . . . . . . . . 61.1 mmm -55.75 -49.64 72.54 Favored 'General case' 0 C--O 1.252 1.209 0 CA-C-O 123.26 1.505 . . . . 37.539999999999999 113.601 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1103 ' ' GLN . . . . . 0.406 ' O ' ' HB3' ' B' 1106 ' ' ALA . 0.0 OUTLIER -67.12 -39.97 86.73 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 114.211 -1.359 . . . . 47.009999999999998 110.73 -175.894 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B 1104 ' ' LYS . . . . . 0.444 ' HD3' HD13 ' B' 1080 ' ' ILE . 43.3 mttm -55.69 -54.42 44.44 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.395 1.078 . . . . 48.68 110.453 174.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1105 ' ' LEU . . . . . 0.625 HD13 HG21 ' B' 1112 ' ' VAL . 41.4 mt -61.57 -29.42 70.01 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 120.35 -1.469 . . . . 32.210000000000001 111.916 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1106 ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' B' 1103 ' ' GLN . . . -66.76 -39.54 87.93 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 117.278 -1.344 . . . . 33.729999999999997 111.399 173.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -64.25 -43.26 95.43 Favored 'General case' 0 C--O 1.249 1.04 0 O-C-N 124.36 1.038 . . . . 51.469999999999999 110.394 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1108 ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -67.27 -16.63 64.39 Favored 'General case' 0 C--N 1.309 -1.152 0 O-C-N 125.831 1.957 . . . . 43.899999999999999 114.031 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1109 ' ' ASN . . . . . 0.633 ' HB2' ' HB3' ' B' 1085 ' ' PRO . 13.9 m120 59.07 49.76 9.01 Favored 'General case' 0 C--N 1.348 0.533 0 CA-C-O 126.397 2.999 . . . . 44.82 115.957 178.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1110 ' ' VAL . . . . . 0.639 HG11 ' HB3' ' B' 1083 ' ' LEU . 12.8 m -107.7 163.77 5.34 Favored 'Isoleucine or valine' 0 C--O 1.248 0.992 0 O-C-N 119.517 -1.989 . . . . 30.52 111.528 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1111 ' ' THR . . . . . . . . . . . . . 18.1 m -107.04 97.5 7.27 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 123.61 1.672 . . . . 27.120000000000001 107.547 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1112 ' ' VAL . . . . . 0.67 ' HB ' ' HB ' ' B' 1361 ' ' ILE . 70.6 t -97.31 115.46 37.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 112.563 -2.108 . . . . 26.399999999999999 113.457 -170.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1113 ' ' MET . . . . . 0.463 ' HG2' HD21 ' B' 1334 ' ' LEU . 1.8 mpt? -100.13 118.45 36.5 Favored 'General case' 0 CA--C 1.504 -0.821 0 O-C-N 121.37 -0.831 . . . . 42.920000000000002 108.901 170.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -88.48 104.74 17.09 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 120.013 -0.675 . . . . 24.149999999999999 110.007 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1115 ' ' MET . . . . . 0.536 ' SD ' HD13 ' B' 1334 ' ' LEU . 72.4 mmm -65.61 -17.84 64.88 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 116.583 2.068 . . . . 29.949999999999999 116.583 -177.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1116 ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -84.73 -38.37 19.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 113.624 -1.625 . . . . 34.530000000000001 109.54 171.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1117 ' ' SER . . . . . . . . . . . . . 70.1 m -97.64 38.45 1.28 Allowed 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 123.44 1.59 . . . . 33.490000000000002 111.819 -176.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1118 ' ' VAL . . . . . 0.681 HG21 ' HA ' ' B' 1128 ' ' ASP . 12.3 t -77.59 124.52 86.62 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 102.278 -3.23 . . . . 34.020000000000003 102.278 172.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1119 ' ' PRO . . . . . 0.615 ' HB2' HG12 ' B' 1121 ' ' ILE . 75.3 Cg_exo -52.75 153.84 13.81 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.518 2.812 . . . . 38.280000000000001 115.964 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1120 ' ' ARG . . . . . 0.533 HH21 HD12 ' B' 1130 ' ' LEU . 0.0 OUTLIER -77.68 47.06 0.58 Allowed 'General case' 0 C--O 1.216 -0.679 0 O-C-N 121.757 -0.589 . . . . 55.049999999999997 110.008 178.113 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B 1121 ' ' ILE . . . . . 0.615 HG12 ' HB2' ' B' 1119 ' ' PRO . 37.3 pt -119.94 168.86 11.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 O-C-N 119.182 -2.199 . . . . 42.090000000000003 110.146 -172.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1122 ' ' SER . . . . . 0.52 ' HB3' ' HA ' ' C' ' 133' ' ' MET . 62.2 m -49.92 -80.23 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 117.618 2.451 . . . . 38.020000000000003 117.618 -161.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1123 ' ' ARG . . . . . 0.808 ' HG3' HG21 ' B' 1354 ' ' VAL . 11.2 ptt180 -66.62 -12.77 59.58 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 124.169 3.168 . . . . 34.289999999999999 114.329 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1124 ' ' ALA . . . . . 0.607 ' HB1' HG12 ' B' 1118 ' ' VAL . . . -67.16 -32.04 72.87 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 117.974 -1.012 . . . . 32.350000000000001 110.005 175.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1125 ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -58.32 -21.9 51.05 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 121.111 1.778 . . . . 47.170000000000002 114.678 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1126 ' ' SER . . . . . . . . . . . . . 10.2 m -71.6 -34.61 70.03 Favored 'General case' 0 C--O 1.246 0.885 0 O-C-N 121.119 -0.988 . . . . 31.710000000000001 111.351 173.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1127 ' ' LEU . . . . . . . . . . . . . 5.6 mp -83.9 -33.37 24.76 Favored 'General case' 0 CA--C 1.487 -1.463 0 N-CA-C 106.878 -1.527 . . . . 37.0 106.878 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1128 ' ' ASP . . . . . 0.681 ' HA ' HG21 ' B' 1118 ' ' VAL . 25.8 t70 -61.85 111.32 1.84 Allowed 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 124.303 2.001 . . . . 40.399999999999999 114.524 -168.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1129 ' ' ALA . . . . . . . . . . . . . . . -75.53 -20.62 58.59 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 113.22 -1.809 . . . . 26.559999999999999 109.52 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1130 ' ' LEU . . . . . 0.533 HD12 HH21 ' B' 1120 ' ' ARG . 17.1 mt -62.81 -40.34 97.07 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 122.294 2.315 . . . . 30.890000000000001 111.336 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1131 ' ' SER . . . . . . . . . . . . . 52.7 p -64.33 -53.78 43.47 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 118.051 -0.976 . . . . 29.84 110.782 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1132 ' ' SER . . . . . 0.451 ' HB3' ' HB3' ' B' 1326 ' ' LEU . 40.2 m -50.42 -47.23 56.66 Favored 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 124.967 1.307 . . . . 31.91 114.082 172.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1133 ' ' MET . . . . . 0.637 ' HB3' ' HB3' ' B' 1316 ' ' PRO . 37.3 mmt -70.43 -33.52 71.42 Favored 'General case' 0 CA--C 1.493 -1.221 0 O-C-N 124.37 1.044 . . . . 25.899999999999999 112.468 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1134 ' ' ALA . . . . . 0.55 ' HB1' ' HB2' ' B' 1176 ' ' ALA . . . -67.33 -41.56 85.05 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 121.17 -0.956 . . . . 26.620000000000001 111.92 171.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -56.32 -53.45 57.14 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 108.292 -1.003 . . . . 36.969999999999999 108.292 174.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1136 ' ' ILE . . . . . 0.441 HD13 ' HE2' ' A' 1152 ' ' PHE . 34.9 mm -52.37 -51.73 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 124.285 1.034 . . . . 32.109999999999999 109.95 174.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1137 ' ' ALA . . . . . 0.524 ' HB1' HD22 ' B' 1284 ' ' LEU . . . -57.13 -42.49 81.01 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 117.078 -1.439 . . . . 24.140000000000001 112.638 177.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -65.28 -45.22 91.89 Favored Glycine 0 C--O 1.253 1.328 0 CA-C-N 122.405 2.366 . . . . 25.129999999999999 111.33 -174.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1139 ' ' TYR . . . . . 0.446 ' O ' ' HB ' ' B' 1142 ' ' ILE . 16.0 t80 -63.32 -43.27 98.28 Favored 'General case' 0 C--O 1.21 -1.011 0 CA-C-N 113.241 -1.48 . . . . 32.729999999999997 112.22 171.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1140 ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -70.89 -22.4 62.27 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 119.101 -0.476 . . . . 26.359999999999999 110.0 -176.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1141 ' ' ALA . . . . . 0.774 ' HA ' HG11 ' B' 1282 ' ' VAL . . . -63.77 -43.98 94.75 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.242 -1.021 . . . . 24.120000000000001 108.242 167.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1142 ' ' ILE . . . . . 0.507 HG23 ' CE2' ' B' 1153 ' ' PHE . 16.2 mm -59.31 -47.31 90.92 Favored 'Isoleucine or valine' 0 C--N 1.359 1.004 0 CA-C-O 121.835 0.826 . . . . 23.370000000000001 111.765 177.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 71.1 t -53.51 -68.33 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.848 0 N-CA-C 113.477 0.917 . . . . 24.960000000000001 113.477 171.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -61.75 -31.14 71.3 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 113.72 1.008 . . . . 32.07 113.72 -172.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1145 ' ' ALA . . . . . 0.777 ' HB1' HD12 ' B' 1251 ' ' ILE . . . -55.11 -57.42 11.81 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.687 -0.688 . . . . 24.870000000000001 110.36 168.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1146 ' ' ALA . . . . . 0.56 ' HA ' ' HB2' ' B' 1149 ' ' PHE . . . -64.49 -19.33 65.51 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 115.895 1.813 . . . . 24.670000000000002 115.895 176.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 86.0 t60 -65.52 -26.66 68.0 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 116.986 -1.483 . . . . 28.579999999999998 112.278 169.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1148 ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -123.89 8.74 8.74 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 123.117 2.69 . . . . 36.82 115.955 170.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1149 ' ' PHE . . . . . 0.56 ' HB2' ' HA ' ' B' 1146 ' ' ALA . 0.8 OUTLIER -65.46 154.07 39.56 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-O 124.255 1.978 . . . . 31.969999999999999 111.877 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B 1150 ' ' GLY . . . . . . . . . . . . . . . -86.39 -32.09 17.39 Favored Glycine 0 N--CA 1.432 -1.613 0 CA-C-N 114.05 -1.432 . . . . 25.489999999999998 112.313 174.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1151 ' ' ARG . . . . . 0.415 HH11 HG21 ' A' 1321 ' ' THR . 64.4 mtm-85 -119.59 -174.23 2.7 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 115.981 1.845 . . . . 59.840000000000003 115.981 -166.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1152 ' ' PHE . . . . . 0.421 ' HD1' ' H ' ' B' 1154 ' ' THR . 0.8 OUTLIER -88.14 145.81 25.74 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-O 118.499 -0.762 . . . . 34.450000000000003 111.873 172.372 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B 1153 ' ' PHE . . . . . 0.507 ' CE2' HG23 ' B' 1142 ' ' ILE . 8.8 m-85 -63.16 -52.08 63.85 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 119.17 0.895 . . . . 31.170000000000002 112.294 169.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1154 ' ' THR . . . . . 0.421 ' H ' ' HD1' ' B' 1152 ' ' PHE . 7.6 m -73.88 131.08 41.12 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.896 -1.047 . . . . 33.890000000000001 110.434 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -72.34 81.84 0.58 Allowed Glycine 0 C--N 1.343 0.93 0 O-C-N 119.689 -1.882 . . . . 38.950000000000003 111.029 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -75.27 114.85 14.27 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.556 0.693 . . . . 54.229999999999997 111.794 -173.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1157 ' ' ILE . . . . . 0.416 HG23 ' HG2' ' B' 1162 ' ' LYS . 45.1 mm -92.53 104.78 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 1 N-CA-C 99.316 -4.327 . . . . 51.159999999999997 99.316 177.917 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B 1158 ' ' THR . . . . . . . . . . . . . 1.5 m -115.11 138.88 50.4 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 103.002 -2.962 . . . . 49.609999999999999 103.002 -172.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -52.61 -32.69 42.85 Favored 'General case' 0 C--O 1.248 1.016 0 CA-C-O 123.777 1.751 . . . . 49.049999999999997 115.009 175.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -59.16 -81.04 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 113.303 -1.771 . . . . 47.649999999999999 110.088 162.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . -146.68 155.2 26.42 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 121.366 1.894 . . . . 45.609999999999999 110.035 -174.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1162 ' ' LYS . . . . . 0.416 ' HG2' HG23 ' B' 1157 ' ' ILE . 89.0 mttt -89.39 132.12 35.13 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.648 1.213 . . . . 57.460000000000001 108.352 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1163 ' ' VAL . . . . . 0.444 ' HA ' ' HD2' ' B' 1164 ' ' PRO . 90.6 t -100.3 128.56 30.16 Favored Pre-proline 0 C--O 1.247 0.925 0 CA-C-N 113.771 -1.559 . . . . 42.93 108.484 176.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1164 ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' B' 1163 ' ' VAL . 45.9 Cg_endo -67.22 133.2 29.87 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.568 3.512 . . . . 39.289999999999999 110.689 166.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1165 ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' B' 1164 ' ' PRO . 16.9 Cg_exo -69.0 161.64 44.99 Favored 'Trans proline' 0 N--CA 1.479 0.629 0 C-N-CA 121.255 1.303 . . . . 34.170000000000002 110.04 -172.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -70.56 111.78 6.33 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 118.04 -1.464 . . . . 31.690000000000001 108.816 172.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1167 ' ' LYS . . . . . 0.644 ' HB2' ' HA ' ' B' 1249 ' ' VAL . 86.4 mttt -77.65 87.48 3.94 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.144 -1.428 . . . . 44.780000000000001 107.144 174.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1168 ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' B' 1191 ' ' VAL . 48.4 t -77.05 94.92 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 114.168 -1.378 . . . . 31.23 108.556 -174.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1169 ' ' MET . . . . . 0.575 ' HA ' ' O ' ' B' 1192 ' ' ARG . 55.5 ttp -86.19 110.37 19.54 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 122.459 1.123 . . . . 37.090000000000003 108.433 177.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 50.7 t -97.59 118.76 44.64 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 N-CA-C 107.611 -1.255 . . . . 30.170000000000002 107.611 -177.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1171 ' ' ILE . . . . . 0.487 HD13 HG23 ' B' 1252 ' ' ILE . 1.7 mp -91.94 95.97 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 103.848 -2.649 . . . . 33.740000000000002 103.848 171.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 115.4 85.18 1.23 Allowed Glycine 0 C--N 1.339 0.707 0 N-CA-C 108.657 -1.777 . . . . 32.590000000000003 108.657 170.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1173 ' ' ALA . . . . . 0.455 ' HA ' ' HA3' ' B' 1177 ' ' GLY . . . -84.16 50.33 1.83 Allowed 'General case' 0 C--O 1.255 1.346 0 CA-C-O 124.302 2.001 . . . . 32.420000000000002 110.849 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -81.15 -165.56 34.44 Favored Glycine 0 C--N 1.342 0.884 0 O-C-N 118.59 -2.569 . . . . 31.739999999999998 107.754 163.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 19.1 t -51.36 -39.96 22.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 O-C-N 119.304 -2.292 . . . . 31.48 114.352 -176.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1176 ' ' ALA . . . . . 0.55 ' HB2' ' HB1' ' B' 1134 ' ' ALA . . . -55.86 -46.82 78.15 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.934 1.087 . . . . 26.120000000000001 113.934 171.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1177 ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' B' 1173 ' ' ALA . . . -68.85 -45.8 62.8 Favored Glycine 0 C--N 1.345 1.046 0 N-CA-C 109.106 -1.598 . . . . 25.73 109.106 -176.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1178 ' ' LEU . . . . . 0.544 ' HA ' HD12 ' B' 1181 ' ' ILE . 51.4 mt -60.46 -36.36 78.07 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 118.244 -0.884 . . . . 32.590000000000003 108.9 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -68.24 -44.09 76.43 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 119.342 0.973 . . . . 27.719999999999999 110.456 176.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -58.63 -36.64 74.4 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 118.192 -0.908 . . . . 26.030000000000001 108.773 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1181 ' ' ILE . . . . . 0.544 HD12 ' HA ' ' B' 1178 ' ' LEU . 38.2 mt -61.27 -50.0 82.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 CA-C-N 120.628 1.558 . . . . 28.609999999999999 107.783 171.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -62.67 -19.95 61.14 Favored Glycine 0 CA--C 1.543 1.808 0 CA-C-O 118.363 -1.243 . . . . 25.23 114.108 -173.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -97.96 -56.64 2.43 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 117.993 0.896 . . . . 24.09 109.895 171.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -72.01 -38.5 69.6 Favored 'General case' 0 CA--C 1.509 -0.619 0 O-C-N 119.027 -2.296 . . . . 26.68 115.861 -171.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -61.61 -39.02 89.75 Favored 'General case' 0 C--O 1.247 0.966 0 O-C-N 120.589 -1.319 . . . . 36.57 111.429 174.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1186 ' ' SER . . . . . . . . . . . . . 2.0 m -62.33 -38.73 90.62 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 112.952 -1.931 . . . . 28.920000000000002 111.559 174.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1187 ' ' LEU . . . . . 0.485 ' HA ' ' HB2' ' A' 1186 ' ' SER . 4.2 mt -61.02 -31.18 70.81 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 116.038 -0.528 . . . . 29.09 110.914 172.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 111.05 -7.55 29.15 Favored Glycine 0 CA--C 1.525 0.717 0 O-C-N 121.426 -0.796 . . . . 29.260000000000002 111.25 -176.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1189 ' ' ALA . . . . . . . . . . . . . . . -62.05 134.72 56.98 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 122.234 1.016 . . . . 30.16 109.559 175.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 18.3 mt -77.19 94.97 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 104.684 -2.339 . . . . 35.810000000000002 104.684 -174.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1191 ' ' VAL . . . . . 0.488 HG11 HG12 ' B' 1181 ' ' ILE . 40.6 t -78.24 100.23 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 O-C-N 120.242 -1.536 . . . . 31.969999999999999 109.66 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1192 ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' B' 1169 ' ' MET . 98.8 mtt180 -87.07 80.84 8.24 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 124.146 1.927 . . . . 48.159999999999997 108.637 174.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -84.93 144.82 28.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 111.438 -2.619 . . . . 35.890000000000001 111.335 -172.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 82.1 t80 -134.57 145.39 48.65 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.018 -1.475 . . . . 41.880000000000003 107.018 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1195 ' ' ASP . . . . . . . . . . . . . 5.5 t70 -153.03 154.59 35.22 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 103.992 -2.596 . . . . 38.280000000000001 103.992 161.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1196 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.42 -21.19 56.28 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 114.468 -1.242 . . . . 40.619999999999997 110.59 174.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1197 ' ' ARG . . . . . 0.45 ' O ' HG22 ' B' 1200 ' ' VAL . 40.2 mtm180 -78.06 126.15 84.15 Favored Pre-proline 0 N--CA 1.435 -1.183 0 C-N-CA 120.164 -0.614 . . . . 53.090000000000003 110.978 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1198 ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' B' 1197 ' ' ARG . 37.3 Cg_endo -53.04 -46.39 34.29 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 125.273 3.982 . . . . 42.560000000000002 116.611 -176.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 10.6 pm0 -70.24 -13.98 62.41 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 115.787 1.773 . . . . 56.310000000000002 115.787 -161.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1200 ' ' VAL . . . . . 0.45 HG22 ' O ' ' B' 1197 ' ' ARG . 26.7 m -74.09 -22.17 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 116.145 -0.48 . . . . 42.909999999999997 111.24 175.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 26.0 tttm -47.83 -56.45 7.45 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 114.549 1.315 . . . . 48.890000000000001 114.549 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -55.7 -42.55 75.4 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 112.716 -2.038 . . . . 51.700000000000003 112.565 174.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1203 ' ' GLN . . . . . 0.649 ' HG2' ' HG3' ' C' ' 74' ' ' ARG . 52.1 mt-30 -64.11 -47.84 78.45 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.308 -0.86 . . . . 52.57 109.4 -174.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1204 ' ' VAL . . . . . . . . . . . . . 55.9 t -64.02 -49.84 79.8 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-O 122.677 1.227 . . . . 33.789999999999999 108.486 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -57.39 -29.78 64.36 Favored 'General case' 0 C--N 1.359 1.007 0 N-CA-C 115.812 1.782 . . . . 36.579999999999998 115.812 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1206 ' ' SER . . . . . . . . . . . . . 43.3 p -71.86 -18.26 62.07 Favored 'General case' 0 C--O 1.248 0.978 0 CA-C-N 119.423 1.011 . . . . 39.609999999999999 110.89 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1207 ' ' MET . . . . . 0.531 ' SD ' HG22 ' B' 1181 ' ' ILE . 26.1 mtp -87.39 -9.28 55.19 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 120.954 -1.091 . . . . 37.450000000000003 112.469 172.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 68.5 46.74 61.18 Favored Glycine 0 C--O 1.224 -0.484 0 O-C-N 119.319 -2.113 . . . . 31.870000000000001 109.548 -168.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -122.71 146.56 47.38 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 103.623 -2.732 . . . . 35.399999999999999 103.623 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1210 ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' B' 1192 ' ' ARG . 8.7 tt0 -85.09 116.55 23.53 Favored 'General case' 0 N--CA 1.435 -1.225 0 O-C-N 120.418 -1.426 . . . . 47.890000000000001 109.355 -164.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 70.0 t80 -89.5 120.95 31.26 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 107.982 -1.118 . . . . 45.530000000000001 107.982 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1212 ' ' LEU . . . . . 0.544 ' HB3' HD21 ' B' 1241 ' ' LEU . 57.8 mt -71.25 115.17 10.09 Favored 'General case' 0 N--CA 1.44 -0.964 0 O-C-N 121.323 -0.861 . . . . 46.329999999999998 109.271 174.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -98.38 141.4 31.3 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 124.7 2.19 . . . . 60.409999999999997 108.904 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 43.7 mt -66.32 161.33 22.64 Favored 'General case' 0 C--O 1.251 1.148 0 CA-C-N 112.2 -2.273 . . . . 57.380000000000003 114.597 168.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 27.0 t70 . . . . . 0 CA--C 1.518 -0.288 0 CA-C-N 114.264 -1.334 . . . . 65.069999999999993 110.19 -178.447 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B 1230 ' ' MET . . . . . 0.486 ' SD ' ' HB2' ' B' 1234 ' ' PHE . 13.8 mmt . . . . . 0 N--CA 1.448 -0.557 1 N-CA-C 98.674 -4.565 . . . . 80.319999999999993 98.674 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1231 ' ' SER . . . . . 0.4 ' O ' HG23 ' B' 1235 ' ' ILE 0.3 0.1 OUTLIER 63.05 173.77 0.15 Allowed 'General case' 0 C--N 1.356 0.879 2 CA-C-N 127.1 4.5 . . . . 79.920000000000002 119.458 0.628 . . . . . . . . 5 4 . 1 . 002 nuclear build core ' B' B 1232 ' ' ASP . . . . . 0.565 ' HA ' HG12 ' B' 1235 ' ' ILE . 5.6 p-10 -67.01 -166.92 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 115.719 1.748 . . . . 77.909999999999997 115.719 -172.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 71.0 -80.03 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 107.447 -1.316 . . . . 73.879999999999995 107.447 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1234 ' ' PHE . . . . . 0.486 ' HB2' ' SD ' ' B' 1230 ' ' MET . 2.2 m-85 -51.51 -33.45 31.76 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 115.651 1.723 . . . . 68.980000000000004 115.651 171.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1235 ' ' ILE . . . . . 0.565 HG12 ' HA ' ' B' 1232 ' ' ASP . 36.1 pt -47.72 -36.5 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 120.271 1.396 . . . . 64.530000000000001 113.12 169.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1236 ' ' LYS . . . . . 0.46 ' HD3' ' HA ' ' B' 1236 ' ' LYS . 69.6 mmtt -62.24 -41.62 98.58 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 120.049 -1.657 . . . . 66.359999999999999 111.011 172.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -67.34 -42.63 83.24 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 119.418 -0.913 . . . . 56.600000000000001 111.533 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -56.18 -51.74 66.94 Favored 'General case' 0 C--O 1.241 0.65 0 O-C-N 124.306 1.003 . . . . 56.789999999999999 111.966 171.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1239 ' ' MET . . . . . . . . . . . . . 10.4 tmm? -56.27 -56.74 17.27 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 118.168 -0.92 . . . . 53.630000000000003 112.976 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -55.56 -36.32 66.69 Favored 'General case' 0 C--N 1.36 1.028 0 CA-C-N 119.428 1.013 . . . . 51.740000000000002 111.111 -177.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1241 ' ' LEU . . . . . 0.544 HD21 ' HB3' ' B' 1212 ' ' LEU . 16.2 tp -57.44 -50.77 71.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 121.067 -1.021 . . . . 44.859999999999999 111.475 178.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -64.81 -39.61 93.87 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 125.99 2.056 . . . . 42.780000000000001 113.03 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1243 ' ' ALA . . . . . 0.517 ' HA ' ' HG3' ' B' 1271 ' ' MET . . . -64.94 -23.72 67.31 Favored 'General case' 0 C--N 1.36 1.048 0 N-CA-C 113.574 0.953 . . . . 40.960000000000001 113.574 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -82.01 -53.99 5.67 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 118.72 -2.488 . . . . 43.060000000000002 108.898 172.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 61.0 mm-40 -56.32 -31.99 64.23 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 124.748 1.219 . . . . 46.450000000000003 112.861 -176.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1246 ' ' ALA . . . . . 0.412 ' HA ' HG22 ' B' 1249 ' ' VAL . . . -44.46 -34.54 2.1 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 125.435 1.494 . . . . 41.780000000000001 114.885 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1247 ' ' LYS . . . . . 0.472 ' HA ' ' HD2' ' B' 1247 ' ' LYS . 34.3 tptt -63.55 -43.78 96.06 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 124.206 1.955 . . . . 52.200000000000003 111.863 -176.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1248 ' ' GLU . . . . . 0.465 ' CD ' HH12 ' B' 1192 ' ' ARG . 39.1 mt-10 -84.5 -39.91 18.29 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 113.14 -1.846 . . . . 53.549999999999997 114.283 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1249 ' ' VAL . . . . . 0.644 ' HA ' ' HB2' ' B' 1167 ' ' LYS 0.301 10.6 m -76.94 160.91 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 118.907 2.929 . . . . 34.409999999999997 118.907 -167.255 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B 1250 ' ' ASP . . . . . 0.456 ' HA ' ' HB3' ' B' 1279 ' ' SER . 16.9 m-20 -117.9 -73.09 0.66 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 124.389 2.042 . . . . 33.380000000000003 110.454 -169.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1251 ' ' ILE . . . . . 0.777 HD12 ' HB1' ' B' 1145 ' ' ALA . 23.5 mm -98.11 99.69 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 114.0 -1.455 . . . . 29.539999999999999 108.484 -169.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1252 ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' B' 1169 ' ' MET . 17.5 mt -89.54 96.13 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 105.607 -1.998 . . . . 32.439999999999998 105.607 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1253 ' ' VAL . . . . . . . . . . . . . 96.7 t -83.16 96.51 4.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 102.369 -3.197 . . . . 30.57 102.369 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1254 ' ' THR . . . . . 0.489 ' HB ' HG22 ' B' 1252 ' ' ILE . 2.4 t -104.99 138.93 40.44 Favored 'General case' 0 N--CA 1.432 -1.339 0 O-C-N 119.877 -1.764 . . . . 35.039999999999999 111.89 -175.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1255 ' ' THR . . . . . 0.403 HG22 ' HB2' ' B' 1284 ' ' LEU . 40.1 p -134.09 -83.25 0.44 Allowed 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 114.377 -1.283 . . . . 34.619999999999997 108.772 -177.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . 56.72 41.9 27.59 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.254 1.822 . . . . 42.719999999999999 114.777 -170.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 45.8 mt -89.85 93.78 9.56 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-O 123.797 1.761 . . . . 52.43 107.309 -174.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1258 ' ' ILE . . . . . 0.414 ' HB ' ' HD2' ' B' 1261 ' ' LYS . 24.7 mt -90.08 129.1 47.19 Favored Pre-proline 0 N--CA 1.438 -1.063 0 N-CA-C 107.043 -1.466 . . . . 59.409999999999997 107.043 171.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -57.03 133.31 57.08 Favored 'Trans proline' 0 N--CA 1.441 -1.577 0 C-N-CA 124.707 3.605 . . . . 62.68 114.466 -177.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 66.59 29.49 74.85 Favored Glycine 0 C--O 1.218 -0.856 0 CA-C-O 117.149 -1.917 . . . . 64.159999999999997 114.088 -174.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1261 ' ' LYS . . . . . 0.414 ' HD2' ' HB ' ' B' 1258 ' ' ILE . 59.6 mttm -138.32 148.16 58.41 Favored Pre-proline 0 CA--C 1.503 -0.827 0 CA-C-N 121.009 2.404 . . . . 68.530000000000001 111.822 172.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.63 136.96 29.27 Favored 'Trans proline' 0 C--O 1.245 0.844 0 CA-C-N 122.856 2.056 . . . . 61.990000000000002 107.486 164.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1263 ' ' ALA . . . . . 0.462 ' HA ' ' HD3' ' B' 1264 ' ' PRO . . . -51.63 116.07 7.35 Favored Pre-proline 0 C--O 1.248 1.021 0 N-CA-C 113.24 0.83 . . . . 57.149999999999999 113.24 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1264 ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' B' 1263 ' ' ALA . 87.6 Cg_exo -53.61 135.67 62.4 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 124.779 3.653 . . . . 51.57 110.5 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -78.25 84.37 4.46 Favored 'General case' 0 C--O 1.248 0.994 0 C-N-CA 123.785 0.834 . . . . 54.549999999999997 109.161 -173.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1266 ' ' LEU . . . . . 0.464 ' HB2' HD21 ' B' 1291 ' ' ASN . 94.9 mt -91.4 -41.31 10.95 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 113.185 0.809 . . . . 46.859999999999999 113.185 177.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1267 ' ' ILE . . . . . . . . . . . . . 32.1 mm -78.53 86.96 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 124.432 2.063 . . . . 41.039999999999999 111.467 171.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1268 ' ' THR . . . . . 0.597 ' HA ' ' HG3' ' B' 1293 ' ' GLU . 36.2 p -84.54 151.98 24.2 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 112.316 -2.22 . . . . 39.579999999999998 112.892 -170.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1269 ' ' ARG . . . . . 0.502 ' HG3' ' HB2' ' B' 1293 ' ' GLU . 84.2 mtt85 -52.22 -39.6 60.45 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 118.256 -2.778 . . . . 53.149999999999999 117.194 -176.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -58.27 -40.78 82.78 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-O 123.517 1.627 . . . . 42.960000000000001 112.392 173.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1271 ' ' MET . . . . . 0.517 ' HG3' ' HA ' ' B' 1243 ' ' ALA . 54.2 ttm -65.71 -42.61 90.93 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 113.048 -1.887 . . . . 43.890000000000001 110.669 -178.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1272 ' ' VAL . . . . . . . . . . . . . 10.4 t -54.78 -48.52 73.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 113.816 -1.538 . . . . 38.369999999999997 110.977 170.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 25.9 t70 -58.39 -40.71 83.08 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 114.251 1.204 . . . . 47.460000000000001 114.251 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1274 ' ' SER . . . . . . . . . . . . . 49.5 m -68.86 -22.99 64.17 Favored 'General case' 0 C--O 1.238 0.494 0 O-C-N 121.698 -0.626 . . . . 38.380000000000003 112.687 174.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1275 ' ' MET . . . . . . . . . . . . . 71.7 mtp -62.12 162.16 9.89 Favored 'General case' 0 C--O 1.252 1.197 0 CA-C-O 124.548 2.118 . . . . 37.810000000000002 114.014 -173.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 66.6 tttt -68.07 137.46 55.01 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 111.868 -2.423 . . . . 49.259999999999998 109.562 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -75.62 151.06 37.87 Favored 'General case' 0 C--O 1.246 0.874 0 O-C-N 124.121 0.888 . . . . 34.460000000000001 110.267 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1278 ' ' GLY . . . . . 0.438 ' O ' ' HD1' ' B' 1149 ' ' PHE . . . 74.55 14.51 81.06 Favored Glycine 0 N--CA 1.47 0.922 0 C-N-CA 120.514 -0.85 . . . . 33.530000000000001 112.645 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1279 ' ' SER . . . . . 0.456 ' HB3' ' HA ' ' B' 1250 ' ' ASP . 61.0 m -106.16 148.45 27.85 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 125.322 1.449 . . . . 31.309999999999999 109.67 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1280 ' ' VAL . . . . . 0.607 HG22 ' HB2' ' B' 1308 ' ' LYS . 25.9 t -127.07 119.94 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 O-C-N 120.634 -1.291 . . . . 29.32 109.886 -163.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1281 ' ' ILE . . . . . 0.44 HD12 HG22 ' B' 1309 ' ' VAL . 19.5 mt -86.8 112.26 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 102.655 -3.091 . . . . 31.93 102.655 175.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1282 ' ' VAL . . . . . 0.774 HG11 ' HA ' ' B' 1141 ' ' ALA . 21.2 t -106.5 107.71 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 N-CA-C 101.857 -3.386 . . . . 29.48 101.857 175.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 24.3 t0 -87.93 109.08 19.52 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 110.475 -3.057 . . . . 34.5 107.653 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1284 ' ' LEU . . . . . 0.703 HD21 ' HB2' ' B' 1141 ' ' ALA . 71.4 mt -79.58 -23.05 43.0 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-O 121.138 0.494 . . . . 37.939999999999998 110.467 177.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -87.52 -5.62 58.71 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 115.371 -0.831 . . . . 40.920000000000002 111.525 -175.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -18.72 -54.32 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.736 1 N-CA-C 122.173 4.138 . . . . 44.390000000000001 122.173 174.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1287 ' ' GLN . . . . . 0.578 ' HB3' HG23 ' B' 1313 ' ' THR . 0.1 OUTLIER -70.27 -43.89 69.56 Favored 'General case' 0 CA--C 1.501 -0.935 0 C-N-CA 123.431 0.692 . . . . 51.460000000000001 111.483 178.773 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 4.9 t30 -97.21 75.68 2.59 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-O 123.915 1.817 . . . . 57.75 109.378 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1289 ' ' GLY . . . . . . . . . . . . . . . 87.88 -76.72 1.95 Allowed Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 107.209 -2.356 . . . . 49.850000000000001 107.209 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 99.45 136.74 9.48 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 109.371 -1.492 . . . . 45.93 109.371 -167.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1291 ' ' ASN . . . . . 0.464 HD21 ' HB2' ' B' 1266 ' ' LEU . 24.5 t-20 -88.88 -35.17 16.68 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 120.15 1.975 . . . . 42.670000000000002 112.927 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1292 ' ' CYS . . . . . 0.515 ' HB3' ' OG1' ' B' 1295 ' ' THR . 40.4 t -77.87 143.91 37.39 Favored 'General case' 0 N--CA 1.441 -0.923 0 O-C-N 118.944 -2.348 . . . . 38.82 110.829 171.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1293 ' ' GLU . . . . . 0.597 ' HG3' ' HA ' ' B' 1268 ' ' THR . 24.2 mt-10 -69.08 -37.43 78.45 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.702 -1.135 . . . . 46.710000000000001 112.049 174.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -82.9 -8.13 59.6 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 115.564 1.691 . . . . 47.229999999999997 115.564 -173.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1295 ' ' THR . . . . . 0.67 HG23 ' HA3' ' B' 1311 ' ' GLY . 49.1 m -52.35 120.4 5.49 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 116.135 1.902 . . . . 36.020000000000003 116.135 177.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 2.9 t -88.79 108.11 21.37 Favored Pre-proline 0 N--CA 1.448 -0.559 0 CA-C-O 116.007 -1.949 . . . . 37.259999999999998 106.396 172.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -64.28 88.39 0.16 Allowed 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 124.29 3.327 . . . . 35.090000000000003 113.479 -176.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 139.46 -17.46 3.09 Favored Glycine 0 C--O 1.251 1.18 0 CA-C-N 113.243 -1.798 . . . . 35.969999999999999 110.013 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -133.71 -176.69 4.25 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 121.458 2.629 . . . . 40.390000000000001 114.554 -161.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1300 ' ' ILE . . . . . 0.491 HG23 HG12 ' B' 1310 ' ' ILE . 9.6 mt -99.8 155.58 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.045 0 N-CA-C 105.759 -1.941 . . . . 37.43 105.759 170.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 65.9 t80 -142.85 105.89 4.55 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 123.008 1.385 . . . . 44.130000000000003 107.63 167.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1302 ' ' THR . . . . . . . . . . . . . 96.5 m -75.46 118.58 18.49 Favored 'General case' 0 N--CA 1.438 -1.029 0 O-C-N 119.434 -2.041 . . . . 39.780000000000001 106.291 168.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1303 ' ' THR . . . . . . . . . . . . . 76.0 p -69.7 169.42 12.88 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 115.903 1.816 . . . . 43.289999999999999 115.903 172.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -48.37 -48.02 36.93 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 124.343 1.057 . . . . 53.07 113.02 167.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -85.8 23.52 1.42 Allowed 'General case' 0 C--O 1.244 0.81 0 N-CA-C 114.68 1.363 . . . . 43.969999999999999 114.68 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 69.38 23.5 76.4 Favored Glycine 0 C--N 1.358 1.761 0 O-C-N 119.332 -2.105 . . . . 41.119999999999997 114.961 170.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1307 ' ' VAL . . . . . . . . . . . . . 94.7 t -93.46 136.13 26.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 105.767 -1.938 . . . . 38.119999999999997 105.767 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1308 ' ' LYS . . . . . 0.607 ' HB2' HG22 ' B' 1280 ' ' VAL . 65.1 mmtt -92.77 99.54 12.19 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.757 -1.201 . . . . 36.340000000000003 107.757 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1309 ' ' VAL . . . . . 0.44 HG22 HD12 ' B' 1281 ' ' ILE . 18.0 t -90.02 92.97 4.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 105.602 -1.999 . . . . 30.399999999999999 105.602 177.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1310 ' ' ILE . . . . . 0.491 HG12 HG23 ' B' 1300 ' ' ILE . 12.1 mt -87.4 134.2 28.32 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.002 0 C-N-CA 126.02 1.728 . . . . 30.82 107.85 173.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1311 ' ' GLY . . . . . 0.67 ' HA3' HG23 ' B' 1295 ' ' THR . . . -149.09 86.95 0.15 Allowed Glycine 0 CA--C 1.493 -1.34 0 N-CA-C 108.396 -1.882 . . . . 26.530000000000001 108.396 171.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1312 ' ' TYR . . . . . 0.794 ' HB2' ' HG ' ' B' 1315 ' ' LEU . 43.6 m-85 -97.8 119.66 36.79 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 118.055 0.927 . . . . 38.0 108.848 -172.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1313 ' ' THR . . . . . 0.578 HG23 ' HB3' ' B' 1287 ' ' GLN . 39.3 m -49.83 -40.37 41.83 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 124.079 1.895 . . . . 29.800000000000001 114.355 172.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1314 ' ' ASP . . . . . 0.474 ' OD1' ' HB3' ' B' 1312 ' ' TYR . 22.8 p-10 -78.56 -2.96 41.35 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 112.834 -1.985 . . . . 39.039999999999999 116.201 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1315 ' ' LEU . . . . . 0.794 ' HG ' ' HB2' ' B' 1312 ' ' TYR . 13.4 mt -43.29 -51.35 14.45 Favored Pre-proline 0 N--CA 1.47 0.527 0 N-CA-C 119.062 2.986 . . . . 31.079999999999998 119.062 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1316 ' ' PRO . . . . . 0.637 ' HB3' ' HB3' ' B' 1133 ' ' MET . 87.7 Cg_exo -65.62 -25.06 54.86 Favored 'Trans proline' 0 C--O 1.218 -0.5 0 CA-C-N 124.606 2.681 . . . . 26.100000000000001 112.866 176.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1317 ' ' GLY . . . . . 0.701 ' HA2' ' HG3' ' B' 1015 ' ' ARG . . . -67.53 -49.23 52.17 Favored Glycine 0 N--CA 1.431 -1.688 0 O-C-N 120.496 -1.378 . . . . 23.170000000000002 109.964 169.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -39.69 -16.71 0.01 OUTLIER 'General case' 0 C--O 1.246 0.878 1 N-CA-C 125.201 5.26 . . . . 40.399999999999999 125.201 -161.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 15.9 tp -102.12 78.58 0.24 Allowed Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 121.301 1.864 . . . . 23.600000000000001 108.158 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1320 ' ' PRO . . . . . 0.454 ' HB3' HG22 ' B' 1014 ' ' THR . 48.3 Cg_endo -43.53 -64.28 0.26 Allowed 'Trans proline' 0 CA--C 1.51 -0.719 1 C-N-CA 125.416 4.077 . . . . 22.350000000000001 119.138 -156.628 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B 1321 ' ' THR . . . . . 0.417 HG23 ' CE1' ' B' 1045 ' ' PHE . 4.2 m -61.97 -44.79 96.01 Favored 'General case' 0 C--O 1.218 -0.578 0 O-C-N 121.17 -0.957 . . . . 26.52 112.293 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1322 ' ' GLN . . . . . 0.609 ' HB2' ' HA ' ' A' 1151 ' ' ARG . 11.5 tp60 -72.48 -43.44 63.67 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 118.657 -0.687 . . . . 24.379999999999999 112.471 -173.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1323 ' ' SER . . . . . 0.533 ' HB3' ' HG2' ' B' 1015 ' ' ARG . 66.6 m -48.78 -49.32 39.21 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 124.176 0.99 . . . . 22.800000000000001 110.837 164.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1324 ' ' SER . . . . . . . . . . . . . 11.4 m -61.69 -33.2 73.58 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 122.567 1.175 . . . . 21.25 113.436 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -69.43 -40.38 77.27 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 118.404 -2.685 . . . . 31.34 114.18 170.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1326 ' ' LEU . . . . . 0.451 ' HB3' ' HB3' ' B' 1132 ' ' SER . 3.6 mm? -68.89 -55.8 9.91 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.951 0.881 . . . . 31.559999999999999 112.241 -177.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1327 ' ' TYR . . . . . 0.494 ' O ' ' HB2' ' B' 1330 ' ' ASN . 31.3 t80 -56.2 -44.57 79.61 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-N 113.992 -1.458 . . . . 22.73 110.179 175.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1328 ' ' GLY . . . . . 0.672 ' HA2' HD12 ' B' 1331 ' ' LEU . . . -56.7 -60.45 8.98 Favored Glycine 0 C--N 1.343 0.929 0 O-C-N 124.153 0.908 . . . . 21.91 112.794 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1329 ' ' THR . . . . . 0.51 ' HB ' ' HA ' ' A' 1160 ' ' ALA . 9.2 m -58.44 -23.51 57.72 Favored 'General case' 0 C--O 1.252 1.185 0 CA-C-O 116.365 -1.778 . . . . 22.149999999999999 111.893 174.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1330 ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' B' 1327 ' ' TYR . 12.1 m120 -63.79 -46.72 83.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 125.4 3.727 . . . . 26.18 110.549 170.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1331 ' ' LEU . . . . . 0.819 HD13 ' HB3' ' B' 1070 ' ' LEU . 13.9 mt -61.14 -37.28 82.27 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.079 -0.964 . . . . 23.68 109.254 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1332 ' ' VAL . . . . . 0.752 HG12 ' HE3' ' B' 1336 ' ' LYS . 96.6 t -69.22 -45.21 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 106.847 -1.538 . . . . 26.57 106.847 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -58.69 -43.73 90.06 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 113.353 0.871 . . . . 28.079999999999998 113.353 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1334 ' ' LEU . . . . . 0.536 HD13 ' SD ' ' B' 1115 ' ' MET . 3.9 tt -56.95 -47.31 80.99 Favored 'General case' 0 C--O 1.247 0.929 0 C-N-CA 123.933 0.893 . . . . 27.43 109.337 170.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1335 ' ' LEU . . . . . 0.755 HD23 HD12 ' B' 1338 ' ' LEU . 68.2 mt -74.42 -12.25 60.46 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 120.924 -1.11 . . . . 30.5 113.601 -177.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1336 ' ' LYS . . . . . 0.752 ' HE3' HG12 ' B' 1332 ' ' VAL . 85.5 mttt -72.89 -49.5 29.41 Favored 'General case' 0 CA--C 1.504 -0.793 0 O-C-N 120.828 -1.17 . . . . 41.649999999999999 109.225 166.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 7.7 mp -67.51 -26.84 66.54 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 113.258 0.836 . . . . 42.079999999999998 113.258 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1338 ' ' LEU . . . . . 0.755 HD12 HD23 ' B' 1335 ' ' LEU . 95.3 mt -72.34 -67.11 0.57 Allowed 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 108.373 -0.973 . . . . 35.030000000000001 108.373 168.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 43.6 t -85.34 73.69 10.51 Favored 'General case' 0 N--CA 1.436 -1.161 0 O-C-N 118.699 -2.501 . . . . 37.329999999999998 108.185 -170.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 58.0 mttp -57.44 -33.4 67.88 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 125.323 1.449 . . . . 50.509999999999998 114.353 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -80.55 -11.61 59.64 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 114.372 1.249 . . . . 54.210000000000001 114.372 178.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 60.0 mttp 60.32 34.81 20.75 Favored 'General case' 0 C--N 1.347 0.488 0 CA-C-O 122.884 1.326 . . . . 50.990000000000002 111.608 -172.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -99.6 -34.22 10.31 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 114.959 -1.018 . . . . 48.82 111.273 -176.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 125.31 9.52 5.0 Favored Glycine 0 N--CA 1.433 -1.551 0 O-C-N 124.543 1.152 . . . . 40.43 113.407 175.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -98.67 141.17 31.84 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 125.503 1.521 . . . . 47.560000000000002 113.639 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1346 ' ' ILE . . . . . 0.492 HD11 HG12 ' B' 1068 ' ' ILE . 43.1 mm -82.79 76.18 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.63 0 CA-C-O 123.136 1.446 . . . . 42.490000000000002 108.728 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1347 ' ' THR . . . . . 0.433 ' HB ' ' O ' ' B' 1338 ' ' LEU . 2.4 m -73.82 78.92 1.59 Allowed 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.598 -1.183 . . . . 38.119999999999997 109.326 172.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 10.9 t -62.29 121.66 11.35 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 O-C-N 119.598 -1.939 . . . . 37.5 109.379 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 23.1 t0 -96.96 111.08 23.46 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 122.505 1.145 . . . . 43.850000000000001 108.565 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1350 ' ' PHE . . . . . 0.569 ' HE2' HG21 ' B' 1367 ' ' THR . 1.4 m-30 -100.52 -0.59 37.55 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 116.385 1.994 . . . . 39.810000000000002 116.385 175.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -81.41 -43.55 18.8 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 121.728 0.775 . . . . 51.289999999999999 110.776 167.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 14.4 t0 -66.75 121.8 16.23 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 124.373 2.035 . . . . 39.780000000000001 111.995 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 3.7 m -52.25 -37.21 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 CA-C-N 110.752 -2.931 . . . . 39.280000000000001 112.686 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1354 ' ' VAL . . . . . 0.808 HG21 ' HG3' ' B' 1123 ' ' ARG . 23.1 t -70.6 -54.01 19.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-N 114.894 -1.048 . . . . 35.700000000000003 112.355 -177.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1355 ' ' ILE . . . . . 0.42 ' HA ' HG12 ' B' 1358 ' ' VAL . 27.1 mm -64.68 -47.59 88.19 Favored 'Isoleucine or valine' 0 C--N 1.359 1.007 0 CA-C-O 116.95 -1.5 . . . . 35.770000000000003 112.073 176.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 42.3 tpt85 -54.1 -37.09 63.89 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 114.168 1.173 . . . . 38.549999999999997 114.168 173.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1357 ' ' GLY . . . . . 0.476 ' HA2' ' HB2' ' B' 1370 ' ' ALA . . . -62.63 -54.6 32.67 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 124.621 1.105 . . . . 29.579999999999998 115.437 171.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1358 ' ' VAL . . . . . 0.42 HG12 ' HA ' ' B' 1355 ' ' ILE . 9.1 p -69.08 -38.82 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 108.668 -0.864 . . . . 32.060000000000002 108.668 -174.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1359 ' ' THR . . . . . 0.44 ' HB ' ' HE1' ' B' 1350 ' ' PHE . 14.8 m -76.46 84.83 3.18 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-O 123.892 1.806 . . . . 29.0 107.944 -177.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1360 ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' B' 1368 ' ' TRP . 22.1 m -73.27 -19.55 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 111.692 -2.504 . . . . 29.68 111.252 -174.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1361 ' ' ILE . . . . . 0.67 ' HB ' ' HB ' ' B' 1112 ' ' VAL . 85.1 mt -139.16 116.28 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 105.76 -1.941 . . . . 32.049999999999997 105.76 177.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1362 ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -108.66 119.38 39.37 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 119.205 -2.184 . . . . 32.520000000000003 108.885 175.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 36.86 44.08 0.33 Allowed 'General case' 0 C--O 1.246 0.92 0 CA-C-O 124.454 2.073 . . . . 35.68 116.113 -172.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1364 ' ' GLY . . . . . 0.6 ' HA3' ' HA ' ' B' 1109 ' ' ASN . . . 93.36 -7.28 75.38 Favored Glycine 0 CA--C 1.54 1.647 0 CA-C-O 117.225 -1.875 . . . . 34.259999999999998 114.356 174.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1365 ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' B' 1361 ' ' ILE . 0.2 OUTLIER -88.6 132.52 34.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 104.653 -2.351 . . . . 51.07 104.653 170.718 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 59.5 mt -88.75 94.05 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 N-CA-C 107.402 -1.333 . . . . 39.869999999999997 107.402 -176.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1367 ' ' THR . . . . . 0.569 HG21 ' HE2' ' B' 1350 ' ' PHE . 3.3 p -84.77 -1.39 56.26 Favored 'General case' 0 N--CA 1.424 -1.735 0 O-C-N 126.528 2.393 . . . . 38.009999999999998 114.858 -175.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1368 ' ' TRP . . . . . 0.419 ' HB2' ' HB ' ' B' 1360 ' ' VAL . 35.0 t90 -52.05 142.26 27.29 Favored Pre-proline 0 C--O 1.241 0.635 0 C-N-CA 124.255 1.022 . . . . 42.140000000000001 111.674 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -87.91 -114.77 0.0 OUTLIER 'Cis proline' 0 N--CA 1.451 -0.996 0 CA-C-N 122.575 1.955 . . . . 43.259999999999998 113.21 -7.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1370 ' ' ALA . . . . . 0.476 ' HB2' ' HA2' ' B' 1357 ' ' GLY . . . -117.97 153.67 51.18 Favored Pre-proline 0 C--N 1.32 -0.696 0 O-C-N 120.104 -1.623 . . . . 46.520000000000003 107.297 166.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1371 ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' B' 1372 ' ' PRO . 93.1 Cg_endo -59.52 133.62 53.01 Favored 'Trans proline' 0 C--N 1.33 -0.438 0 CA-C-N 122.589 1.96 . . . . 51.950000000000003 110.954 172.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1372 ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' B' 1371 ' ' PRO . 0.1 OUTLIER -36.91 87.7 0.01 OUTLIER 'Trans proline' 0 C--O 1.25 1.091 0 C-N-CA 125.133 3.889 . . . . 56.270000000000003 118.108 -174.729 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B 1373 ' ' ILE . . . . . 0.473 HG21 HD13 ' B' 1121 ' ' ILE . 0.0 OUTLIER -104.13 140.78 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 103.099 -2.926 . . . . 60.829999999999998 103.099 177.04 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -107.48 146.64 31.52 Favored 'General case' 0 C--O 1.256 1.423 0 O-C-N 120.203 -1.561 . . . . 66.099999999999994 108.184 -174.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 96.2 t -78.95 135.86 24.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 O-C-N 125.454 1.721 . . . . 63.469999999999999 111.49 -171.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.23 -4.627 0 O-C-N 120.891 -1.13 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.274 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.6 -16.23 24.29 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.071 1.348 . . . . 0.0 114.464 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 28.7 mp0 -49.54 -42.22 43.37 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.068 -1.02 . . . . 0.0 110.531 172.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 6.6 m -56.67 -46.96 80.81 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 123.593 0.757 . . . . 0.0 111.696 173.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 24' ' ' ALA . . . . . 0.476 ' HB2' HG22 ' C' ' 182' ' ' ILE . . . -62.24 -49.81 74.23 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 123.714 0.805 . . . . 0.0 109.674 -173.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -48.82 -51.07 31.45 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 127.849 3.218 . . . . 0.0 111.409 173.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 13.5 tp -65.28 -39.41 92.53 Favored 'General case' 0 N--CA 1.44 -0.938 0 O-C-N 120.764 -1.21 . . . . 0.0 113.59 -177.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 74.1 mt -53.68 -39.62 65.26 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 118.58 2.808 . . . . 0.0 118.58 -174.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 28' ' ' LYS . . . . . . . . . . . . . 34.5 pttt -63.93 -28.65 69.97 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.082 -0.963 . . . . 0.0 113.015 175.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -82.87 -33.01 27.13 Favored 'General case' 0 C--O 1.246 0.88 0 O-C-N 125.349 1.656 . . . . 0.0 109.823 174.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.437 ' HA ' ' OD2' ' C' ' 107' ' ' ASP . 58.0 m -54.87 127.27 27.85 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -170.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -82.55 -58.37 2.94 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 113.956 -1.475 . . . . 0.0 109.041 -174.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 32' ' ' SER . . . . . 0.432 ' HB2' ' HA ' ' C' ' 106' ' ' THR . 55.5 m -116.15 143.39 45.56 Favored 'General case' 0 C--O 1.251 1.135 0 O-C-N 120.801 -1.187 . . . . 0.0 110.55 166.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 96.6 t -128.44 120.2 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.52 HD13 ' HB2' ' C' ' 65' ' ' ARG . 38.7 mm -101.69 111.41 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 101.598 -3.482 . . . . 0.0 101.598 177.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 35' ' ' ILE . . . . . 0.705 HG22 ' HD3' ' C' ' 37' ' ' PRO . 42.9 mt -83.7 122.73 38.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 169.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 13.7 m -115.97 92.94 36.65 Favored Pre-proline 0 C--O 1.246 0.919 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.129 173.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 37' ' ' PRO . . . . . 0.77 ' HD2' HG12 ' C' ' 68' ' ' ILE . 0.5 OUTLIER -56.3 116.66 3.34 Favored 'Trans proline' 0 N--CA 1.449 -1.107 1 C-N-CA 125.47 4.113 . . . . 0.0 112.347 168.926 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' C' C ' 38' ' ' GLY . . . . . 0.418 ' HA3' ' HB3' ' C' ' 114' ' ' ALA . . . -102.29 -175.23 27.52 Favored Glycine 0 N--CA 1.433 -1.558 0 O-C-N 120.869 -1.145 . . . . 0.0 110.441 167.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -38.18 -41.59 0.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.187 1.395 . . . . 0.0 114.605 168.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 40' ' ' GLY . . . . . 0.936 ' HA3' ' HA3' ' C' ' 113' ' ' GLY . . . -52.78 -47.96 57.73 Favored Glycine 0 C--O 1.249 1.08 0 CA-C-O 118.789 -1.006 . . . . 0.0 112.371 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 41' ' ' MET . . . . . 0.456 ' HG3' ' HB3' ' C' ' 46' ' ' ALA . 24.2 ttm -61.27 -31.48 71.3 Favored 'General case' 0 C--N 1.356 0.889 0 CA-C-N 119.801 1.801 . . . . 0.0 113.529 172.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 42' ' ' ALA . . . . . 0.65 ' HB2' ' HB3' ' C' ' 79' ' ' MET . . . -70.04 -33.33 71.82 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.548 -0.739 . . . . 0.0 110.816 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 43' ' ' VAL . . . . . 0.431 HG13 ' H ' ' C' ' 44' ' ' ALA . 7.4 p -90.31 -70.95 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 118.448 -0.787 . . . . 0.0 110.6 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 44' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' C' ' 175' ' ' ALA . . . -79.27 100.2 7.42 Favored 'General case' 0 C--O 1.252 1.206 0 CA-C-N 120.432 1.469 . . . . 0.0 107.658 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 45' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -69.49 82.73 0.4 Allowed 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -161.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.456 ' HB3' ' HG3' ' C' ' 41' ' ' MET . . . -81.11 -4.42 55.24 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 111.164 -2.744 . . . . 0.0 114.363 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 47' ' ' GLN . . . . . 0.447 ' HG2' ' HB3' ' C' ' 82' ' ' LEU . 0.0 OUTLIER -71.24 -46.94 59.95 Favored 'General case' 0 C--O 1.25 1.086 0 O-C-N 119.66 -1.9 . . . . 0.0 113.659 -173.481 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 48' ' ' TYR . . . . . 0.422 ' CE1' ' HA ' ' C' ' 86' ' ' ALA . 95.0 m-85 -57.8 -44.38 99.38 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 120.333 1.424 . . . . 0.0 113.401 173.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 49' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -49.92 -49.78 15.11 Favored 'Trans proline' 0 C--O 1.255 1.352 0 C-N-CA 122.391 2.061 . . . . 0.0 115.574 163.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 50' ' ' VAL . . . . . 0.439 ' HA ' HG22 ' C' ' 53' ' ' ILE . 0.8 OUTLIER -68.86 -21.47 25.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 O-C-N 120.168 -1.582 . . . . 0.0 110.356 -171.852 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.68 -49.61 74.57 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 122.031 0.919 . . . . 0.0 111.403 172.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.12 -54.92 32.91 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.937 1.295 . . . . 0.0 112.633 176.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 53' ' ' ILE . . . . . 0.439 HG22 ' HA ' ' C' ' 50' ' ' VAL . 6.7 tp -71.57 -33.5 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-N 119.171 0.896 . . . . 0.0 111.054 -176.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 89.2 m -67.01 -32.97 74.54 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 118.997 0.817 . . . . 0.0 109.659 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -56.14 -51.88 66.37 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 4.6 mppt? -65.11 -46.3 81.59 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 57' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' C' ' 53' ' ' ILE . 55.2 mt -58.8 -45.73 89.22 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 120.509 1.504 . . . . 0.0 111.899 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -70.04 -40.86 74.89 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.613 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.59 -45.26 73.55 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 121.478 1.945 . . . . 0.0 113.91 171.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 29.1 ttm-85 -65.38 -23.36 66.95 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.101 1.36 . . . . 0.0 112.346 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.07 21.25 9.66 Favored Glycine 0 CA--C 1.505 -0.545 0 CA-C-O 122.12 0.845 . . . . 0.0 114.053 174.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 59.0 mt -85.16 135.14 25.49 Favored 'Isoleucine or valine' 0 C--O 1.249 1.055 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -79.61 86.73 5.21 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 7.7 p -95.7 122.68 47.41 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 CA-C-O 122.456 1.122 . . . . 0.0 108.894 178.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 65' ' ' ARG . . . . . 0.52 ' HB2' HD13 ' C' ' 34' ' ' ILE . 9.6 mmm-85 -126.27 136.71 53.11 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 122.227 1.013 . . . . 0.0 110.102 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 66' ' ' PHE . . . . . 0.472 ' O ' HG13 ' C' ' 68' ' ' ILE . 29.8 m-85 -87.92 74.28 9.01 Favored 'General case' 0 C--O 1.243 0.715 0 O-C-N 120.082 -1.636 . . . . 0.0 109.203 177.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.65 83.14 0.91 Allowed Glycine 0 CA--C 1.529 0.965 0 N-CA-C 109.084 -1.607 . . . . 0.0 109.084 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 68' ' ' ILE . . . . . 0.77 HG12 ' HD2' ' C' ' 37' ' ' PRO . 16.5 mt -98.08 144.67 10.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 O-C-N 124.61 0.83 . . . . 0.0 111.066 -167.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -109.84 72.37 0.61 Allowed Pre-proline 0 C--O 1.242 0.69 0 N-CA-C 103.018 -2.956 . . . . 0.0 103.018 169.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 70' ' ' PRO . . . . . 0.861 ' HB2' HG21 ' A' 1157 ' ' ILE . 43.0 Cg_exo -61.47 -20.23 67.65 Favored 'Trans proline' 0 C--N 1.341 0.148 1 C-N-CA 125.335 4.024 . . . . 0.0 113.96 -167.816 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.84 81.32 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 122.949 1.357 . . . . 0.0 107.555 161.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 72' ' ' ALA . . . . . 0.759 ' HB3' ' SD ' ' C' ' 79' ' ' MET . . . -142.85 97.09 3.04 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 119.38 -2.075 . . . . 0.0 112.834 -172.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 73' ' ' GLY . . . . . 0.51 ' C ' ' HD2' ' C' ' 74' ' ' ARG . . . 74.92 -75.53 1.28 Allowed Glycine 0 N--CA 1.44 -1.08 0 O-C-N 120.388 -1.445 . . . . 0.0 114.632 170.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 74' ' ' ARG . . . . . 0.649 ' HG3' ' HG2' ' B' 1203 ' ' GLN . 1.5 mpt_? -121.63 98.9 6.17 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -174.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.469 ' HG ' HD22 ' B' 1178 ' ' LEU . 0.3 OUTLIER 75.33 132.29 0.04 OUTLIER Pre-proline 0 C--N 1.35 0.625 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 168.997 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.32 150.07 84.75 Favored 'Trans proline' 0 C--O 1.239 0.57 0 C-N-CA 123.287 2.658 . . . . 0.0 114.487 174.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.18 -94.16 1.46 Allowed Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 106.964 -2.454 . . . . 0.0 106.964 -169.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 2.1 t60 26.33 -80.7 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 127.83 2.452 . . . . 0.0 116.048 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 79' ' ' MET . . . . . 0.759 ' SD ' ' HB3' ' C' ' 72' ' ' ALA . 0.8 OUTLIER -59.5 -43.62 93.3 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.698 -1.251 . . . . 0.0 111.587 179.545 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -67.98 -44.95 75.46 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 121.652 -0.655 . . . . 0.0 109.643 -176.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.425 ' O ' ' HB3' ' C' ' 84' ' ' ALA . 90.1 t -52.1 -50.88 33.77 Favored 'Isoleucine or valine' 0 C--O 1.249 1.074 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 168.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.447 ' HB3' ' HG2' ' C' ' 47' ' ' GLN . 3.5 mp -53.55 -39.75 65.01 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 174.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 11.7 tp -59.99 -46.41 89.55 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 124.385 1.053 . . . . 0.0 112.667 170.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 84' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' C' ' 81' ' ' VAL . . . -57.37 -39.95 77.09 Favored 'General case' 0 C--O 1.246 0.911 0 C-N-CA 124.253 1.021 . . . . 0.0 111.25 173.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -60.87 -40.1 91.71 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.015 0.526 . . . . 0.0 111.01 172.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 86' ' ' ALA . . . . . 0.422 ' HA ' ' CE1' ' C' ' 48' ' ' TYR . . . -67.22 0.1 3.02 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 120.645 -1.285 . . . . 0.0 113.315 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp 61.8 51.77 3.72 Favored 'General case' 0 C--O 1.266 1.921 0 C-N-CA 127.873 2.469 . . . . 0.0 111.403 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 88' ' ' VAL . . . . . 0.482 ' HA ' ' HD2' ' C' ' 89' ' ' PRO . 57.8 t -100.93 130.67 24.65 Favored Pre-proline 0 N--CA 1.444 -0.739 0 CA-C-N 112.855 -1.975 . . . . 0.0 106.164 172.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 89' ' ' PRO . . . . . 0.482 ' HD2' ' HA ' ' C' ' 88' ' ' VAL . 27.7 Cg_endo -55.4 111.19 0.68 Allowed 'Trans proline' 0 CA--C 1.509 -0.744 0 C-N-CA 124.889 3.726 . . . . 0.0 116.772 177.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.16 -16.49 20.42 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 108.992 -3.731 . . . . 0.0 118.289 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -69.58 -48.76 59.1 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-O 118.081 -0.962 . . . . 0.0 111.939 174.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 22.9 pt -70.86 -15.24 18.7 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-N 120.563 1.529 . . . . 0.0 114.738 174.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 93' ' ' VAL . . . . . 0.456 ' HA ' ' HB2' ' C' ' 66' ' ' PHE . 86.4 t -69.36 98.51 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-O 124.111 1.91 . . . . 0.0 106.721 167.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 19.2 mt -105.02 87.76 2.72 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 110.258 -3.155 . . . . 0.0 108.155 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 95' ' ' GLU . . . . . 0.765 ' HB3' HD13 ' A' 1157 ' ' ILE . 34.8 mp0 -69.1 103.91 2.01 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 111.349 -2.66 . . . . 0.0 109.865 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 92.9 mtp 56.96 25.93 11.21 Favored 'General case' 0 C--O 1.25 1.106 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 171.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -81.88 155.46 25.31 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 113.64 -1.618 . . . . 0.0 109.751 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -82.97 56.27 3.4 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 120.095 1.316 . . . . 0.0 109.353 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 99' ' ' ILE . . . . . 0.606 HG13 ' HB2' ' C' ' 102' ' ' ASP . 11.1 tp -74.46 41.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 O-C-N 117.28 -3.387 . . . . 0.0 111.902 173.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -76.85 -27.19 55.0 Favored 'General case' 0 C--O 1.217 -0.607 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -162.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.12 -44.82 87.46 Favored 'General case' 0 C--O 1.24 0.599 0 O-C-N 124.519 1.137 . . . . 0.0 110.274 174.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 102' ' ' ASP . . . . . 0.606 ' HB2' HG13 ' C' ' 99' ' ' ILE . 0.9 OUTLIER -65.42 -39.5 92.21 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 117.131 -1.414 . . . . 0.0 110.729 173.896 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 103' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -47.84 -56.5 7.33 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-N 123.042 2.655 . . . . 0.0 114.021 169.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.51 -35.89 77.04 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 123.674 0.79 . . . . 0.0 113.128 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -67.52 -39.35 85.07 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 121.221 -0.925 . . . . 0.0 111.568 175.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 106' ' ' THR . . . . . 0.432 ' HA ' ' HB2' ' C' ' 32' ' ' SER . 3.8 m -52.3 133.57 34.34 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-O 126.812 3.196 . . . . 0.0 113.577 -169.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 107' ' ' ASP . . . . . 0.437 ' OD2' ' HA ' ' C' ' 30' ' ' SER . 5.0 t0 -69.26 -70.41 0.28 Allowed 'General case' 0 C--N 1.3 -1.553 1 CA-C-N 107.035 -4.62 . . . . 0.0 108.635 171.656 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 8.4 m -121.19 124.99 46.05 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 120.949 1.704 . . . . 0.0 110.662 -174.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 109' ' ' VAL . . . . . . . . . . . . . 32.5 t -99.33 119.26 47.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 174.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 16.2 mt -95.89 85.35 4.06 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 122.765 1.269 . . . . 0.0 109.854 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 111' ' ' VAL . . . . . 0.42 ' HB ' ' HA ' ' C' ' 146' ' ' VAL . 11.8 t -81.52 103.8 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 177.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 112' ' ' ILE . . . . . 0.571 ' HA ' ' HD2' ' C' ' 147' ' ' PHE . 1.8 mm -81.34 106.45 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 O-C-N 118.164 -2.835 . . . . 0.0 109.142 -171.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 113' ' ' GLY . . . . . 0.936 ' HA3' ' HA3' ' C' ' 40' ' ' GLY . . . 89.22 -78.78 1.63 Allowed Glycine 0 CA--C 1.487 -1.669 0 CA-C-O 125.422 2.679 . . . . 0.0 111.863 170.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 114' ' ' ALA . . . . . 0.418 ' HB3' ' HA3' ' C' ' 38' ' ' GLY . . . -94.43 127.23 40.2 Favored 'General case' 0 C--O 1.21 -0.983 0 O-C-N 120.077 -1.837 . . . . 0.0 111.613 -162.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 115' ' ' ASN . . . . . 0.471 ' HB2' HD23 ' C' ' 162' ' ' LEU . 5.7 p-10 -66.42 -53.79 31.67 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 113.611 -1.631 . . . . 0.0 114.803 -178.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 116' ' ' ASP . . . . . 0.646 ' HA ' ' HB2' ' C' ' 119' ' ' ASN . 61.8 m-20 -65.75 -16.03 63.4 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 117.736 2.495 . . . . 0.0 117.736 -167.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 4.7 m -41.28 -44.85 2.79 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 127.175 2.797 . . . . 0.0 110.067 168.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.468 ' HA ' ' HB ' ' C' ' 135' ' ' VAL . 3.2 m -137.55 67.64 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.507 0 O-C-N 124.339 1.024 . . . . 0.0 108.679 169.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 119' ' ' ASN . . . . . 0.646 ' HB2' ' HA ' ' C' ' 116' ' ' ASP . 28.7 t-20 -87.6 119.56 70.72 Favored Pre-proline 0 C--O 1.26 1.658 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 120' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -60.88 -45.42 20.36 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.851 3.034 . . . . 0.0 110.995 -177.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.64 -14.41 62.05 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.32 -38.1 86.91 Favored 'General case' 0 CA--C 1.552 1.049 0 O-C-N 120.663 -1.273 . . . . 0.0 110.796 170.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 123' ' ' GLN . . . . . 0.718 ' HB2' HG22 ' C' ' 135' ' ' VAL . 22.9 tp60 -75.95 -50.24 15.5 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-O 122.263 1.03 . . . . 0.0 108.739 177.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -80.76 -45.08 17.6 Favored 'General case' 0 C--O 1.247 0.947 0 N-CA-C 120.196 3.406 . . . . 0.0 120.196 -173.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 125' ' ' ASP . . . . . 0.405 ' HA ' ' HD3' ' C' ' 126' ' ' PRO . 32.3 t70 -103.1 123.44 41.92 Favored Pre-proline 0 CA--C 1.55 0.958 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -162.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 126' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' C' ' 125' ' ' ASP . 1.5 Cg_exo -46.26 -31.99 9.94 Favored 'Trans proline' 0 CA--C 1.503 -1.061 0 C-N-CA 124.534 3.49 . . . . 0.0 118.347 175.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 127' ' ' LYS . . . . . 0.462 ' HB3' ' HE2' ' C' ' 127' ' ' LYS . 25.2 ttpt -69.51 -32.8 71.88 Favored 'General case' 0 C--N 1.317 -0.829 0 O-C-N 120.904 -1.123 . . . . 0.0 110.648 -174.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 128' ' ' SER . . . . . . . . . . . . . 13.4 m -56.66 133.4 78.1 Favored Pre-proline 0 N--CA 1.467 0.42 0 C-N-CA 125.254 1.422 . . . . 0.0 107.874 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 129' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -55.14 -46.03 36.1 Favored 'Trans proline' 0 C--O 1.221 -0.368 1 C-N-CA 125.464 4.11 . . . . 0.0 114.282 175.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 130' ' ' ILE . . . . . 0.657 ' HB ' ' HB2' ' C' ' 133' ' ' MET . 4.3 pt -86.9 66.54 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.405 0 O-C-N 119.507 -1.996 . . . . 0.0 107.385 170.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -74.3 111.87 9.9 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.429 -1.26 . . . . 0.0 109.048 -174.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.73 34.87 17.82 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 122.821 1.234 . . . . 0.0 111.863 -175.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 133' ' ' MET . . . . . 0.657 ' HB2' ' HB ' ' C' ' 130' ' ' ILE . 39.0 tpp -70.09 123.03 88.0 Favored Pre-proline 0 C--O 1.243 0.722 0 CA-C-N 113.476 -1.362 . . . . 0.0 109.915 173.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 134' ' ' PRO . . . . . 0.56 ' HD2' ' SD ' ' C' ' 133' ' ' MET . 89.0 Cg_endo -68.66 88.15 0.43 Allowed 'Trans proline' 0 N--CA 1.442 -1.536 0 C-N-CA 122.625 2.217 . . . . 0.0 112.198 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 135' ' ' VAL . . . . . 0.718 HG22 ' HB2' ' C' ' 123' ' ' GLN . 28.6 m -88.31 150.09 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-N 113.424 -1.716 . . . . 0.0 106.973 168.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 27.4 mt -77.71 111.57 13.64 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 102.318 -3.215 . . . . 0.0 102.318 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 137' ' ' GLU . . . . . 0.55 ' HB3' ' NE1' ' C' ' 139' ' ' TRP . 48.5 mt-10 -70.24 96.61 1.12 Allowed 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 123.39 1.567 . . . . 0.0 113.047 -155.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 14.8 p -85.28 110.35 19.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 125.177 2.418 . . . . 0.0 109.074 169.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 139' ' ' TRP . . . . . 0.55 ' NE1' ' HB3' ' C' ' 137' ' ' GLU . 76.3 m95 -129.97 138.49 50.88 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 118.945 -2.347 . . . . 0.0 105.308 174.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 140' ' ' LYS . . . . . . . . . . . . . 24.5 pttm 38.15 20.69 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.823 1 N-CA-C 123.057 4.466 . . . . 0.0 123.057 175.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.84 150.82 36.17 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 120.369 -1.457 . . . . 0.0 107.754 163.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 142' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' C' ' 167' ' ' ASN . 16.7 mt-30 -62.89 -42.88 99.93 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 117.12 2.267 . . . . 0.0 117.12 -160.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 143' ' ' ASN . . . . . 0.402 ' HB3' HG13 ' C' ' 145' ' ' ILE . 3.8 m-80 -140.33 120.83 14.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 121.339 1.881 . . . . 0.0 108.443 167.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 144' ' ' VAL . . . . . 0.686 ' HB ' ' HA ' ' C' ' 168' ' ' THR . 44.1 t -102.02 85.39 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 101.882 -3.377 . . . . 0.0 101.882 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 145' ' ' ILE . . . . . 0.402 HG13 ' HB3' ' C' ' 143' ' ' ASN . 26.3 mt -82.57 104.37 11.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 125.84 2.733 . . . . 0.0 110.507 -178.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 146' ' ' VAL . . . . . 0.639 HG21 ' HG ' ' C' ' 162' ' ' LEU . 47.8 t -97.77 109.07 22.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 110.711 -2.949 . . . . 0.0 105.083 178.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 147' ' ' PHE . . . . . 0.571 ' HD2' ' HA ' ' C' ' 112' ' ' ILE . 82.9 m-85 -71.59 82.01 0.83 Allowed 'General case' 0 C--O 1.258 1.528 0 O-C-N 120.472 -1.393 . . . . 0.0 111.293 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 148' ' ' LYS . . . . . 0.826 ' HD3' ' SD ' ' C' ' 170' ' ' MET . 28.5 mtpt -103.05 133.09 48.75 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 120.297 -1.502 . . . . 0.0 107.764 177.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 -72.2 -29.3 63.84 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 123.056 1.408 . . . . 0.0 111.793 -175.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 16.0 m -142.04 151.32 42.31 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.337 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -73.23 102.87 3.76 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 103.077 -2.934 . . . . 0.0 103.077 167.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -152.72 164.06 38.49 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 23.8 m -53.38 159.0 1.51 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 130.044 3.337 . . . . 0.0 113.741 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -136.21 -137.34 3.66 Favored Glycine 0 C--O 1.249 1.034 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -87.66 -63.75 1.25 Allowed 'General case' 0 C--O 1.238 0.468 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 171.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 156' ' ' ALA . . . . . . . . . . . . . . . -76.0 -53.63 8.08 Favored 'General case' 0 C--N 1.364 1.229 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 166.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 67.33 -89.16 0.17 Allowed Glycine 0 N--CA 1.461 0.327 0 N-CA-C 106.822 -2.511 . . . . 0.0 106.822 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 158' ' ' VAL . . . . . 0.575 HG23 ' HB3' ' C' ' 160' ' ' ASN 0.385 35.1 m 46.3 148.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 120.84 3.644 . . . . 0.0 120.84 -176.002 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.9 83.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 O-C-N 121.159 -0.963 . . . . 0.0 109.477 173.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 160' ' ' ASN . . . . . 0.575 ' HB3' HG23 ' C' ' 158' ' ' VAL . 5.5 p30 -130.77 164.27 42.93 Favored Pre-proline 0 C--O 1.242 0.673 0 CA-C-O 117.472 -1.252 . . . . 0.0 110.616 -164.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -38.33 -51.08 2.17 Favored 'Trans proline' 0 N--CA 1.445 -1.375 0 C-N-CA 124.383 3.388 . . . . 0.0 117.893 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 162' ' ' LEU . . . . . 0.639 ' HG ' HG21 ' C' ' 146' ' ' VAL . 1.4 mp -50.46 -35.41 28.76 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 176.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 163' ' ' PHE . . . . . 0.41 ' HA ' ' HE2' ' C' ' 170' ' ' MET . 12.1 m-85 -73.63 -30.79 63.17 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -107.59 -51.42 2.91 Favored 'General case' 0 C--O 1.257 1.462 0 CA-C-O 123.142 1.448 . . . . 0.0 114.494 -169.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 4.9 mmtm -61.81 153.32 29.06 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 115.983 1.845 . . . . 0.0 115.983 -171.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -85.41 -45.29 12.01 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -164.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 167' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' C' ' 142' ' ' GLN . 27.4 p-10 -89.12 -42.44 11.69 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.186 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 168' ' ' THR . . . . . 0.686 ' HA ' ' HB ' ' C' ' 144' ' ' VAL . 56.2 m -89.44 77.47 7.31 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 106.789 -1.559 . . . . 0.0 106.789 177.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -136.09 135.07 39.03 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.71 -158.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 170' ' ' MET . . . . . 0.826 ' SD ' ' HD3' ' C' ' 148' ' ' LYS . 67.6 mtm -63.99 94.57 0.1 Allowed 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.227 -1.806 . . . . 0.0 107.173 163.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 171' ' ' LEU . . . . . . . . . . . . . 10.4 tp -79.38 117.45 20.37 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 172' ' ' PHE . . . . . 0.564 ' HA ' ' O ' ' C' ' 148' ' ' LYS . 57.7 m-85 -70.65 93.21 0.91 Allowed 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 110.716 -2.947 . . . . 0.0 114.386 -168.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -166.32 159.74 33.1 Favored Glycine 0 C--O 1.248 1.029 0 O-C-N 125.222 1.576 . . . . 0.0 109.664 176.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 174' ' ' ASP . . . . . 0.615 ' HB3' ' HB3' ' C' ' 177' ' ' ALA . 31.6 t70 -69.93 151.74 45.28 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 113.582 -1.309 . . . . 0.0 108.911 177.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 175' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' C' ' 44' ' ' ALA . . . -64.52 -49.04 72.84 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.164 -175.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.53 -47.81 37.99 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -176.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 177' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' C' ' 174' ' ' ASP . . . -56.3 -47.41 78.74 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 122.113 0.959 . . . . 0.0 113.204 -175.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 49.6 m -63.62 -36.23 83.12 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 176.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 179' ' ' VAL . . . . . 0.655 ' HA ' HG12 ' C' ' 182' ' ' ILE . 44.3 t -75.04 -39.56 44.22 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -52.71 -44.5 66.36 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.845 172.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -64.79 -52.09 58.72 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 119.131 -0.461 . . . . 0.0 111.914 174.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 182' ' ' ILE . . . . . 0.655 HG12 ' HA ' ' C' ' 179' ' ' VAL . 20.4 pt -64.79 -33.15 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 O-C-N 123.796 0.685 . . . . 0.0 111.45 -169.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 183' ' ' LEU . . . . . . . . . . . . . 4.0 pp -67.64 -36.29 80.49 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 124.138 0.975 . . . . 0.0 111.66 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -77.23 -48.04 18.6 Favored 'General case' 0 C--O 1.206 -1.215 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -69.79 -71.24 0.24 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 -171.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 186' ' ' LEU . . . . . 0.421 ' HA ' ' HB1' ' C' ' 24' ' ' ALA 0.313 0.9 OUTLIER . . . . . 0 N--CA 1.476 0.873 0 N-CA-C 116.555 2.057 . . . . 0.0 116.555 -155.791 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 36.6 t-80 . . . . . 0 CA--C 1.508 -0.662 0 N-CA-C 105.874 -1.898 . . . . 65.739999999999995 105.874 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -61.83 76.86 0.02 OUTLIER Glycine 0 CA--C 1.538 1.497 0 N-CA-C 116.432 1.333 . . . . 48.659999999999997 116.432 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 26.5 ttp180 -118.71 138.03 52.92 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 123.394 1.568 . . . . 44.560000000000002 108.532 175.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1003 ' ' ILE . . . . . 0.472 HG12 HD13 ' A' 1068 ' ' ILE . 36.8 mt -106.65 129.75 59.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 102.253 -3.24 . . . . 34.859999999999999 102.253 -176.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -91.88 135.76 12.92 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 106.793 -2.523 . . . . 30.75 106.793 170.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.888 HG23 ' HB3' ' A' 1017 ' ' ALA . 19.5 mm -113.5 97.69 44.42 Favored Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 105.954 -1.869 . . . . 32.210000000000001 105.954 172.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -81.05 166.28 18.85 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 123.171 2.581 . . . . 32.979999999999997 114.275 170.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1007 ' ' ARG . . . . . 0.454 ' HB2' ' HA ' ' A' 1039 ' ' ALA . 6.5 tmm_? -85.31 140.05 31.12 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 113.066 -1.879 . . . . 47.979999999999997 106.071 167.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1008 ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -68.94 157.55 36.45 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 123.76 1.743 . . . . 34.700000000000003 113.774 -175.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -138.08 132.75 32.57 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 112.324 -2.216 . . . . 53.369999999999997 108.352 -171.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 10.8 tp 170.02 -177.24 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 102.96 -2.978 . . . . 45.07 102.96 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1011 ' ' THR . . . . . . . . . . . . . 11.0 m -72.01 114.5 10.18 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 122.745 2.521 . . . . 40.359999999999999 107.718 -174.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 4.3 m-20 64.53 43.58 4.38 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 113.712 1.004 . . . . 40.609999999999999 113.712 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -87.81 137.42 32.35 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 119.42 -0.912 . . . . 33.759999999999998 110.99 -171.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1014 ' ' THR . . . . . . . . . . . . . 19.9 p -103.24 -41.7 5.97 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 122.352 1.072 . . . . 27.890000000000001 113.038 -173.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1015 ' ' ARG . . . . . 0.565 ' HG3' ' HA2' ' A' 1317 ' ' GLY . 61.9 mtm180 -48.28 167.74 0.03 OUTLIER 'General case' 0 C--N 1.356 0.88 0 N-CA-C 120.083 3.364 . . . . 29.02 120.083 -173.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1016 ' ' VAL . . . . . 0.595 HG23 ' HB1' ' A' 1039 ' ' ALA . 7.7 p -132.12 162.52 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 113.454 -1.703 . . . . 28.129999999999999 106.712 171.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1017 ' ' ALA . . . . . 0.888 ' HB3' HG23 ' A' 1005 ' ' ILE . . . -66.47 -36.5 82.92 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 119.087 -2.258 . . . . 26.870000000000001 115.2 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -154.47 144.76 22.05 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 106.277 -1.749 . . . . 26.77 106.277 -174.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1019 ' ' THR . . . . . 0.405 HG21 HG23 ' A' 1321 ' ' THR . 1.7 p -98.5 170.74 6.6 Favored Pre-proline 0 N--CA 1.447 -0.583 0 CA-C-O 116.797 -1.573 . . . . 27.02 113.422 169.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1020 ' ' PRO . . . . . 0.401 ' HD3' ' CE1' ' A' 1050 ' ' PHE . 0.0 OUTLIER -29.45 -61.66 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 125.29 3.993 . . . . 30.57 120.024 173.796 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -66.85 -28.48 68.37 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 123.216 2.734 . . . . 47.810000000000002 110.842 -175.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1022 ' ' THR . . . . . . . . . . . . . 22.4 m -64.38 -47.98 77.19 Favored 'General case' 0 CA--C 1.554 1.118 0 O-C-N 121.621 -0.674 . . . . 30.77 110.178 169.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1023 ' ' VAL . . . . . . . . . . . . . 24.8 t -61.89 -38.6 80.99 Favored 'Isoleucine or valine' 0 C--O 1.254 1.33 0 O-C-N 120.996 -1.065 . . . . 33.590000000000003 109.043 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -64.56 -45.12 88.43 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 118.801 -1.16 . . . . 53.289999999999999 110.797 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1025 ' ' GLN . . . . . 0.619 ' HB3' HG11 ' A' 1332 ' ' VAL . 78.1 mt-30 -57.37 -40.15 77.54 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 118.762 0.71 . . . . 46.920000000000002 112.262 174.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1026 ' ' LEU . . . . . . . . . . . . . 74.7 mt -65.34 -34.67 78.86 Favored 'General case' 0 C--O 1.249 1.043 0 O-C-N 120.189 -1.57 . . . . 37.170000000000002 112.322 176.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 81.0 mt -70.87 -38.63 73.11 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.605 -0.887 . . . . 44.439999999999998 108.605 174.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -57.85 -36.74 72.75 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.972 0.805 . . . . 52.579999999999998 111.989 175.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1029 ' ' LEU . . . . . 0.54 ' HA ' ' HE2' ' A' 1342 ' ' LYS . 90.3 mt -60.97 -27.51 68.32 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 114.435 1.272 . . . . 45.689999999999998 114.435 170.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 93.2 32.27 7.94 Favored Glycine 0 C--O 1.242 0.614 0 O-C-N 121.23 -0.919 . . . . 42.090000000000003 113.111 -174.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -106.14 154.62 20.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 105.756 -1.942 . . . . 40.719999999999999 105.756 165.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1032 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.38 145.85 25.27 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 123.066 1.413 . . . . 37.770000000000003 109.42 172.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1033 ' ' VAL . . . . . . . . . . . . . 20.8 t -117.01 136.07 55.34 Favored 'Isoleucine or valine' 0 C--O 1.25 1.092 0 O-C-N 119.927 -1.733 . . . . 33.539999999999999 111.756 -172.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -119.79 140.52 50.63 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 108.156 -1.053 . . . . 31.68 108.156 170.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1035 ' ' VAL . . . . . . . . . . . . . 74.0 t -121.67 146.62 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 122.654 1.216 . . . . 31.52 109.387 178.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1036 ' ' GLU . . . . . 0.529 ' HB3' ' HB2' ' A' 1039 ' ' ALA . 34.3 tt0 -71.76 136.54 47.17 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 113.552 -1.658 . . . . 41.039999999999999 111.124 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1037 ' ' SER . . . . . . . . . . . . . 49.2 m -70.56 117.8 12.55 Favored 'General case' 0 C--O 1.246 0.883 0 N-CA-C 107.4 -1.333 . . . . 31.829999999999998 107.4 175.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 103.96 -7.24 48.48 Favored Glycine 0 C--O 1.219 -0.796 0 O-C-N 120.411 -1.431 . . . . 29.359999999999999 110.42 -174.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1039 ' ' ALA . . . . . 0.595 ' HB1' HG23 ' A' 1016 ' ' VAL . . . -68.69 -27.18 65.74 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 118.961 1.381 . . . . 27.780000000000001 112.089 -177.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -79.59 -32.57 37.2 Favored Glycine 0 N--CA 1.437 -1.27 0 CA-C-O 122.189 0.883 . . . . 28.91 112.604 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -47.59 -69.17 0.13 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.002 -1.599 . . . . 51.18 114.565 -171.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1042 ' ' LEU . . . . . . . . . . . . . 13.8 mt -77.22 -20.26 55.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.913 1.339 . . . . 29.91 111.869 -174.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1043 ' ' ALA . . . . . . . . . . . . . . . -82.22 -9.62 59.43 Favored 'General case' 0 C--O 1.243 0.759 0 O-C-N 120.419 -1.426 . . . . 28.539999999999999 113.153 171.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1044 ' ' SER . . . . . . . . . . . . . 7.9 m 56.33 63.92 1.85 Allowed 'General case' 0 C--N 1.361 1.1 0 O-C-N 126.715 2.509 . . . . 33.060000000000002 112.476 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1045 ' ' PHE . . . . . 0.556 ' HD1' ' HB3' ' B' 1277 ' ' ALA . 0.0 OUTLIER -159.78 75.15 0.62 Allowed 'General case' 0 C--N 1.315 -0.931 1 N-CA-C 98.682 -4.562 . . . . 30.289999999999999 98.682 162.332 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -62.46 150.63 39.52 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.762 -1.108 . . . . 48.619999999999997 113.621 -160.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1047 ' ' ASP . . . . . 0.534 ' HA ' ' HD2' ' A' 1050 ' ' PHE . 1.3 m-20 -46.09 -29.47 1.52 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 117.612 2.449 . . . . 36.740000000000002 117.612 -156.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 21.6 pttm -53.35 -33.91 55.44 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 112.956 0.724 . . . . 43.729999999999997 112.956 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -60.49 -35.94 77.13 Favored 'General case' 0 CA--C 1.522 -0.133 0 O-C-N 120.366 -1.459 . . . . 32.810000000000002 112.917 171.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1050 ' ' PHE . . . . . 0.534 ' HD2' ' HA ' ' A' 1047 ' ' ASP . 95.1 m-85 -72.1 -24.85 61.56 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 120.187 -1.571 . . . . 31.859999999999999 111.412 175.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 61.8 t -65.41 -47.32 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 118.236 -0.888 . . . . 33.219999999999999 109.435 170.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -56.35 -34.48 66.65 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.565 1.691 . . . . 50.829999999999998 115.565 171.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -74.41 -21.78 59.46 Favored 'General case' 0 C--O 1.25 1.117 0 N-CA-C 115.093 1.516 . . . . 33.119999999999997 115.093 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 101.34 83.22 1.72 Allowed Glycine 0 CA--C 1.526 0.752 0 C-N-CA 119.453 -1.356 . . . . 35.829999999999998 110.219 -177.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -150.58 138.65 20.14 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 119.44 -2.212 . . . . 34.82 115.159 176.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -66.4 121.17 14.68 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 105.511 -2.033 . . . . 49.049999999999997 105.511 165.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1057 ' ' ILE . . . . . . . . . . . . . 43.3 mm -100.03 118.2 46.33 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 O-C-N 119.649 -1.907 . . . . 38.530000000000001 107.732 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1058 ' ' VAL . . . . . . . . . . . . . 3.2 m -133.93 172.87 15.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 125.602 1.561 . . . . 42.109999999999999 111.119 -176.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -87.84 165.36 15.35 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 122.878 2.581 . . . . 58.0 108.202 173.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1060 ' ' GLY . . . . . 0.456 ' HA2' HG12 ' A' 1063 ' ' VAL . . . -49.53 -51.42 27.55 Favored Glycine 0 C--O 1.238 0.368 0 O-C-N 120.718 -1.239 . . . . 52.119999999999997 116.044 -172.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1061 ' ' ASN . . . . . 0.443 ' O ' ' HG2' ' A' 1065 ' ' GLN . 7.8 t30 -49.5 -40.27 36.97 Favored 'General case' 0 C--O 1.251 1.159 0 CA-C-O 122.092 0.948 . . . . 54.75 112.817 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1062 ' ' SER . . . . . . . . . . . . . 16.5 m -78.08 -35.82 48.92 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 119.984 -1.697 . . . . 50.340000000000003 114.608 173.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1063 ' ' VAL . . . . . 0.456 HG12 ' HA2' ' A' 1060 ' ' GLY . 1.1 p -64.62 -28.98 46.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 119.588 -1.945 . . . . 41.460000000000001 111.027 -178.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1064 ' ' TRP . . . . . 0.415 ' HB2' HD22 ' A' 1082 ' ' LEU . 59.6 m95 -80.67 -13.87 58.64 Favored 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 121.064 -1.022 . . . . 39.32 112.736 175.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1065 ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' 1061 ' ' ASN . 92.2 mm-40 -77.34 67.4 3.28 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 119.302 -2.124 . . . . 55.380000000000003 105.979 173.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1066 ' ' SER . . . . . . . . . . . . . 60.1 m -148.69 142.87 26.04 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 119.709 -1.87 . . . . 41.869999999999997 111.227 -170.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.78 -36.55 79.26 Favored 'General case' 0 N--CA 1.437 -1.104 0 O-C-N 125.671 1.857 . . . . 53.200000000000003 112.438 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1068 ' ' ILE . . . . . 0.472 HD13 HG12 ' A' 1003 ' ' ILE . 3.7 mp -121.9 144.47 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 106.515 -1.661 . . . . 41.899999999999999 106.515 176.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1069 ' ' ILE . . . . . 0.458 HG12 HG21 ' A' 1087 ' ' THR . 49.0 mm -130.63 129.24 64.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 N-CA-C 107.416 -1.328 . . . . 38.729999999999997 107.416 169.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1070 ' ' LEU . . . . . 0.411 ' HB2' ' HB1' ' A' 1017 ' ' ALA . 44.9 mt -97.17 143.81 27.62 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.256 -2.498 . . . . 32.439999999999998 104.256 175.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1071 ' ' LYS . . . . . 0.556 ' HB2' ' OG ' ' A' 1091 ' ' SER . 16.0 mmmt -148.12 130.51 15.7 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.647 0.779 . . . . 34.649999999999999 111.534 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1072 ' ' VAL . . . . . 0.516 HG13 ' CD2' ' A' 1327 ' ' TYR . 2.1 t -89.32 -13.96 9.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-N 114.86 -1.063 . . . . 31.32 113.747 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -112.89 -176.65 2.95 Favored 'General case' 0 C--O 1.248 1.018 0 N-CA-C 106.583 -1.636 . . . . 33.939999999999998 106.583 163.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -73.2 155.12 90.25 Favored Pre-proline 0 C--O 1.259 1.567 0 N-CA-C 109.043 -0.725 . . . . 38.039999999999999 109.043 161.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1075 ' ' PRO . . . . . 0.743 ' HG2' HD21 ' A' 1089 ' ' LEU . 3.9 Cg_exo -70.83 117.31 5.08 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 123.599 2.866 . . . . 42.68 114.621 168.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 86.8 mt -71.21 162.64 29.09 Favored 'General case' 0 N--CA 1.434 -1.251 0 O-C-N 125.838 1.961 . . . . 46.740000000000002 107.868 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1077 ' ' ASP . . . . . 0.468 ' HA ' HD12 ' A' 1080 ' ' ILE . 0.5 OUTLIER -42.73 -46.3 5.06 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 117.743 2.498 . . . . 58.609999999999999 117.743 -177.233 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 38.8 t70 -64.73 -41.33 96.04 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 113.567 0.951 . . . . 59.200000000000003 113.567 174.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1079 ' ' GLU . . . . . 0.596 ' HA ' HD12 ' A' 1082 ' ' LEU . 38.2 mt-10 -66.69 -32.96 74.61 Favored 'General case' 0 C--O 1.211 -0.956 0 N-CA-C 108.347 -0.983 . . . . 50.630000000000003 108.347 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1080 ' ' ILE . . . . . 0.636 ' HA ' HD23 ' A' 1083 ' ' LEU . 95.7 mt -59.6 -41.53 85.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 123.648 1.69 . . . . 51.479999999999997 110.728 175.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -62.62 -29.35 70.55 Favored 'General case' 0 C--O 1.211 -0.969 0 O-C-N 120.876 -1.14 . . . . 50.280000000000001 111.958 175.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1082 ' ' LEU . . . . . 0.596 HD12 ' HA ' ' A' 1079 ' ' GLU . 8.0 mt -70.47 -27.26 64.09 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 114.815 1.413 . . . . 50.210000000000001 114.815 173.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1083 ' ' LEU . . . . . 0.636 HD23 ' HA ' ' A' 1080 ' ' ILE . 1.3 mm? -64.16 123.95 20.41 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 122.817 1.294 . . . . 49.060000000000002 112.099 -176.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -89.81 141.24 28.15 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 104.807 -2.294 . . . . 51.079999999999998 104.807 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -56.81 148.26 67.51 Favored 'Trans proline' 0 CA--C 1.503 -1.031 0 C-N-CA 122.745 2.297 . . . . 49.729999999999997 116.035 -177.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 84.05 -14.11 45.76 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 113.887 -1.506 . . . . 47.710000000000001 113.658 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1087 ' ' THR . . . . . 0.458 HG21 HG12 ' A' 1069 ' ' ILE . 38.6 m -59.2 127.04 30.15 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 119.868 1.834 . . . . 45.469999999999999 113.293 -175.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1088 ' ' THR . . . . . . . . . . . . . 31.0 m -75.31 96.46 3.38 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 105.66 -1.978 . . . . 42.039999999999999 105.66 173.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1089 ' ' LEU . . . . . 0.743 HD21 ' HG2' ' A' 1075 ' ' PRO . 42.7 tp -89.09 113.36 24.5 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 113.301 -1.772 . . . . 38.060000000000002 108.028 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 3.3 t -108.37 109.06 26.89 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 N-CA-C 102.265 -3.235 . . . . 37.399999999999999 102.265 -173.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1091 ' ' SER . . . . . 0.556 ' OG ' ' HB2' ' A' 1071 ' ' LYS . 19.7 m -145.67 153.87 41.49 Favored 'General case' 0 C--O 1.224 -0.285 0 O-C-N 120.686 -1.259 . . . . 36.159999999999997 112.888 -166.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 2.8 t80 -84.67 91.03 7.83 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 105.727 -1.953 . . . . 38.939999999999998 105.727 172.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 26.5 mm -83.86 -49.57 16.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 115.37 1.619 . . . . 42.170000000000002 115.37 -172.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 96.4 m95 60.42 73.0 0.67 Allowed Pre-proline 0 C--O 1.255 1.366 0 C-N-CA 125.243 1.417 . . . . 46.509999999999998 111.021 -159.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -59.76 -38.39 80.9 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 124.754 3.636 . . . . 49.759999999999998 116.566 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -55.69 -47.44 76.78 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.618 -1.628 . . . . 52.619999999999997 110.824 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -64.77 -27.49 68.93 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 113.361 -1.745 . . . . 60.740000000000002 113.577 174.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1098 ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -123.32 56.96 10.34 Favored Pre-proline 0 N--CA 1.449 -0.478 0 N-CA-C 119.363 3.097 . . . . 58.189999999999998 119.363 -164.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -59.19 -47.67 16.6 Favored 'Trans proline' 0 N--CA 1.479 0.633 0 C-N-CA 123.399 2.732 . . . . 54.590000000000003 115.257 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1100 ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' 1104 ' ' LYS . 0.0 OUTLIER -61.38 -44.52 97.02 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 113.18 0.807 . . . . 63.280000000000001 113.18 177.837 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 1101 ' ' LEU . . . . . . . . . . . . . 8.2 tp -62.5 -46.26 89.26 Favored 'General case' 0 N--CA 1.441 -0.898 0 O-C-N 124.608 1.192 . . . . 54.75 107.853 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1102 ' ' MET . . . . . . . . . . . . . 49.8 mmm -53.98 -45.56 71.42 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 123.366 0.667 . . . . 52.649999999999999 112.054 175.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -62.11 -34.41 76.28 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 118.017 -0.992 . . . . 66.260000000000005 112.364 175.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1104 ' ' LYS . . . . . 0.453 ' HB3' HG21 ' A' 1080 ' ' ILE . 86.2 mttt -66.58 -46.62 75.38 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.891 -0.781 . . . . 63.729999999999997 108.891 175.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.01 -39.08 84.59 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 121.191 -0.943 . . . . 54.68 110.513 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -69.56 -38.8 77.59 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.397 -0.814 . . . . 53.640000000000001 111.308 176.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -71.85 -18.87 62.04 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 120.292 1.405 . . . . 67.239999999999995 112.186 177.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -77.55 -4.78 47.44 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 116.124 1.898 . . . . 65.760000000000005 116.124 163.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 5.2 t30 55.17 40.8 31.85 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 126.166 1.786 . . . . 58.710000000000001 111.532 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1110 ' ' VAL . . . . . 0.419 HG23 HG23 ' A' 1112 ' ' VAL . 30.8 m -98.27 153.67 4.01 Favored 'Isoleucine or valine' 0 C--N 1.344 0.357 0 O-C-N 121.24 -0.913 . . . . 46.630000000000003 113.007 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1111 ' ' THR . . . . . 0.415 HG23 ' HA ' ' A' 1362 ' ' ARG . 53.6 m -88.89 100.22 13.01 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 104.704 -2.332 . . . . 44.130000000000003 104.704 176.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1112 ' ' VAL . . . . . 0.483 HG22 HD23 ' A' 1089 ' ' LEU . 62.2 t -93.82 115.16 31.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 O-C-N 121.111 -0.993 . . . . 40.439999999999998 109.743 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1113 ' ' MET . . . . . 0.484 ' HB3' HG12 ' A' 1358 ' ' VAL . 19.3 mtp -101.24 102.42 13.3 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.033 -1.894 . . . . 50.759999999999998 108.564 173.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1114 ' ' ALA . . . . . 0.486 ' HB3' ' HB2' ' A' 1117 ' ' SER . . . -80.08 108.07 13.37 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 122.936 1.351 . . . . 35.640000000000001 108.88 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1115 ' ' MET . . . . . 0.558 ' SD ' HD22 ' A' 1334 ' ' LEU . 69.9 mmm -71.83 -20.71 61.79 Favored 'General case' 0 C--O 1.243 0.759 0 O-C-N 119.437 -2.04 . . . . 38.740000000000002 115.308 -174.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1116 ' ' ASP . . . . . 0.464 ' O ' HD12 ' A' 1130 ' ' LEU . 8.4 p-10 -66.08 -32.63 74.2 Favored 'General case' 0 C--O 1.246 0.915 0 CA-C-O 122.238 1.018 . . . . 40.140000000000001 109.289 164.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1117 ' ' SER . . . . . 0.486 ' HB2' ' HB3' ' A' 1114 ' ' ALA . 68.9 m -91.09 34.47 0.93 Allowed 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 117.14 2.274 . . . . 44.789999999999999 117.14 -176.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1118 ' ' VAL . . . . . . . . . . . . . 3.5 t -75.56 129.03 82.81 Favored Pre-proline 0 N--CA 1.439 -1.011 0 O-C-N 121.718 -0.614 . . . . 43.75 109.547 165.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -61.19 137.97 74.55 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.714 2.276 . . . . 48.93 111.795 172.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 25.1 mmm-85 -90.16 32.86 0.9 Allowed 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.204 -1.56 . . . . 62.899999999999999 111.546 -152.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 30.8 pt -79.89 155.63 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 O-C-N 118.492 -2.63 . . . . 57.719999999999999 112.198 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1122 ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -43.27 -58.99 2.27 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 120.653 3.575 . . . . 57.259999999999998 120.653 -177.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1123 ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' 1123 ' ' ARG 0.269 0.0 OUTLIER -60.09 -16.55 32.72 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 116.565 2.061 . . . . 62.899999999999999 116.565 175.027 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A 1124 ' ' ALA . . . . . 0.806 ' HB2' HG11 ' A' 1354 ' ' VAL . . . -80.41 -15.05 57.74 Favored 'General case' 0 N--CA 1.424 -1.755 0 O-C-N 118.67 -2.519 . . . . 49.829999999999998 113.472 177.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 69.6 mm-40 -66.99 -22.04 65.93 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 116.996 2.221 . . . . 52.369999999999997 116.996 -163.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1126 ' ' SER . . . . . . . . . . . . . 13.7 m -73.31 -19.18 61.09 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 115.174 1.546 . . . . 42.43 115.174 169.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1127 ' ' LEU . . . . . . . . . . . . . 2.7 mp -95.84 -30.64 13.56 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.591 -0.892 . . . . 43.740000000000002 108.591 173.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 65.6 t0 -65.06 106.91 1.37 Allowed 'General case' 0 C--O 1.247 0.954 0 CA-C-O 125.833 2.73 . . . . 43.210000000000001 112.045 -173.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1129 ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' 1115 ' ' MET . . . -85.08 -28.72 25.43 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 109.576 -3.465 . . . . 35.740000000000002 110.12 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1130 ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' 1116 ' ' ASP . 0.5 OUTLIER -66.82 -20.26 65.9 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-N 120.866 1.666 . . . . 38.090000000000003 109.107 177.133 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 1131 ' ' SER . . . . . 0.447 ' HB3' HG21 ' A' 1175 ' ' VAL . 65.4 m -82.5 -64.37 1.19 Allowed 'General case' 0 CA--C 1.545 0.766 0 O-C-N 119.413 -2.054 . . . . 36.909999999999997 110.327 161.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1132 ' ' SER . . . . . 0.538 ' O ' ' HB3' ' A' 1135 ' ' ASN . 19.4 m -66.92 -44.51 80.51 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 117.678 2.473 . . . . 35.789999999999999 117.678 -168.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1133 ' ' MET . . . . . 0.564 ' HA ' HD12 ' A' 1136 ' ' ILE . 5.2 ttt -68.37 -35.18 77.34 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 121.784 2.084 . . . . 30.809999999999999 110.624 176.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1134 ' ' ALA . . . . . . . . . . . . . . . -60.51 -40.82 92.79 Favored 'General case' 0 C--O 1.251 1.18 0 N-CA-C 109.143 -0.688 . . . . 28.879999999999999 109.143 173.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1135 ' ' ASN . . . . . 0.882 ' HB2' HG12 ' A' 1175 ' ' VAL . 1.8 t30 -53.8 -48.06 70.22 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.235 1.414 . . . . 40.759999999999998 112.285 175.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1136 ' ' ILE . . . . . 0.631 HD13 ' HA ' ' A' 1323 ' ' SER . 69.0 mt -57.87 -47.48 86.16 Favored 'Isoleucine or valine' 0 C--O 1.247 0.934 0 CA-C-N 114.388 -1.278 . . . . 31.539999999999999 110.985 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -60.83 -34.24 74.26 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.068 -1.423 . . . . 29.870000000000001 110.495 174.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -62.59 -48.5 81.17 Favored Glycine 0 C--O 1.211 -1.327 0 CA-C-N 119.296 0.953 . . . . 28.73 112.177 176.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 28.3 t80 -59.93 -42.06 93.15 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.596 -0.802 . . . . 30.390000000000001 110.317 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1140 ' ' ARG . . . . . 0.708 ' HD3' HD13 ' A' 1319 ' ' LEU . 1.1 tpt180 -73.34 -22.6 60.27 Favored 'General case' 0 CA--C 1.497 -1.066 0 O-C-N 124.445 1.091 . . . . 26.09 113.178 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1141 ' ' ALA . . . . . . . . . . . . . . . -66.62 -48.02 70.78 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 105.545 -2.02 . . . . 27.100000000000001 105.545 171.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 25.8 mm -53.66 -43.43 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 C-N-CA 125.442 1.497 . . . . 28.48 111.541 175.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 75.4 t -58.55 -61.68 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 O-C-N 120.653 -1.279 . . . . 23.07 110.113 173.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1144 ' ' GLU . . . . . 0.428 ' CD ' HH21 ' A' 1140 ' ' ARG . 5.7 mm-40 -62.42 -28.28 69.68 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 122.126 2.239 . . . . 33.399999999999999 114.137 -177.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1145 ' ' ALA . . . . . 0.78 ' HB1' HD12 ' A' 1251 ' ' ILE . . . -57.38 -60.47 3.59 Favored 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 124.668 1.187 . . . . 24.219999999999999 109.721 169.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -65.39 -20.49 66.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.554 0.692 . . . . 24.890000000000001 111.038 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -76.61 -33.53 58.39 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-O 115.511 -2.185 . . . . 26.73 110.725 177.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1148 ' ' GLU . . . . . 0.657 ' HB2' HD11 ' A' 1310 ' ' ILE . 40.0 mm-40 -110.16 3.38 20.09 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 122.221 2.282 . . . . 39.960000000000001 115.785 175.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1149 ' ' PHE . . . . . 0.613 ' CZ ' ' HB3' ' A' 1250 ' ' ASP . 0.9 OUTLIER -67.08 145.94 54.82 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 126.063 1.745 . . . . 25.870000000000001 110.448 -178.359 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 1150 ' ' GLY . . . . . . . . . . . . . . . -69.75 -45.18 59.59 Favored Glycine 0 N--CA 1.43 -1.732 0 O-C-N 121.308 -0.87 . . . . 19.280000000000001 113.504 171.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1151 ' ' ARG . . . . . 0.703 ' HA ' ' HB2' ' B' 1322 ' ' GLN . 69.7 mtm-85 -107.42 -173.79 2.37 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 124.362 1.065 . . . . 39.899999999999999 113.347 -166.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1152 ' ' PHE . . . . . 0.539 ' CD1' ' HG2' ' B' 1322 ' ' GLN . 5.3 m-30 -84.07 149.68 26.08 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 106.218 -1.771 . . . . 29.440000000000001 106.218 172.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1153 ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -64.95 -53.31 48.39 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 124.177 1.942 . . . . 32.600000000000001 110.18 152.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1154 ' ' THR . . . . . . . . . . . . 0.255 56.3 m -65.03 110.77 2.6 Favored 'General case' 0 C--O 1.249 1.068 0 CA-C-N 111.908 -2.406 . . . . 34.640000000000001 116.427 -174.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -64.07 138.85 41.89 Favored Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 109.579 -1.409 . . . . 37.140000000000001 109.579 163.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -173.63 158.84 3.45 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 122.53 1.157 . . . . 40.57 111.507 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1157 ' ' ILE . . . . . 0.52 HD13 ' HB2' ' C' ' 95' ' ' GLU . 6.5 tp -79.03 136.81 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 O-C-N 119.995 -1.691 . . . . 44.609999999999999 109.41 163.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1158 ' ' THR . . . . . 0.565 ' O ' ' HB3' ' C' ' 70' ' ' PRO . 68.7 p -111.28 -160.12 0.7 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 105.469 -2.049 . . . . 40.700000000000003 105.469 169.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1159 ' ' ALA . . . . . 0.54 ' HB1' ' HA ' ' B' 1126 ' ' SER . . . -83.28 -20.29 34.72 Favored 'General case' 0 CA--C 1.541 0.634 1 O-C-N 116.284 -4.01 . . . . 40.25 108.92 165.526 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -96.46 43.98 1.07 Allowed 'General case' 0 C--O 1.246 0.897 0 CA-C-O 123.32 1.533 . . . . 38.469999999999999 110.238 175.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . 74.97 -171.99 53.52 Favored Glycine 0 C--O 1.244 0.762 0 O-C-N 119.943 -1.723 . . . . 37.609999999999999 116.074 170.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -72.82 135.1 45.16 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 122.812 1.292 . . . . 48.899999999999999 112.186 -174.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1163 ' ' VAL . . . . . 0.527 HG11 ' HB2' ' A' 1152 ' ' PHE . 84.0 t -93.86 127.08 46.87 Favored Pre-proline 0 C--O 1.25 1.089 0 N-CA-C 104.398 -2.445 . . . . 36.520000000000003 104.398 162.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1164 ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.09 145.86 40.22 Favored 'Trans proline' 0 N--CA 1.444 -1.403 0 C-N-CA 124.615 3.544 . . . . 35.079999999999998 109.838 173.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1165 ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -62.01 147.13 95.75 Favored 'Trans proline' 0 C--O 1.245 0.833 0 C-N-CA 123.889 3.059 . . . . 35.329999999999998 109.713 172.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -78.64 135.41 37.21 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.736 1.014 . . . . 34.689999999999998 113.736 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1167 ' ' LYS . . . . . . . . . . . . . 44.3 mttp -84.24 100.02 10.93 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 102.263 -3.236 . . . . 45.359999999999999 102.263 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 59.9 t -91.38 88.27 2.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 114.793 -1.094 . . . . 31.710000000000001 110.241 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1169 ' ' MET . . . . . 0.498 ' HA ' ' O ' ' A' 1192 ' ' ARG . 37.2 ttp -77.2 107.04 9.3 Favored 'General case' 0 CA--C 1.498 -1.037 0 O-C-N 119.49 -2.006 . . . . 42.280000000000001 107.884 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 59.4 t -92.29 121.81 43.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 117.27 -1.348 . . . . 30.510000000000002 109.612 176.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 20.8 mt -107.36 131.37 57.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 104.609 -2.367 . . . . 31.870000000000001 104.609 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 82.22 61.77 1.97 Allowed Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 108.584 -1.807 . . . . 34.539999999999999 108.584 174.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1173 ' ' ALA . . . . . 0.557 ' HA ' ' HA3' ' A' 1177 ' ' GLY . . . -77.37 76.98 3.9 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 120.373 -1.663 . . . . 32.509999999999998 115.108 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -84.81 -160.77 32.72 Favored Glycine 0 C--O 1.219 -0.796 0 CA-C-O 116.774 -2.126 . . . . 29.899999999999999 110.25 156.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1175 ' ' VAL . . . . . 0.882 HG12 ' HB2' ' A' 1135 ' ' ASN . 48.3 t -64.63 -31.09 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 1 CA-C-N 124.977 4.389 . . . . 33.109999999999999 114.32 -176.655 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 1176 ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' 1135 ' ' ASN . . . -53.58 -47.58 69.98 Favored 'General case' 0 C--O 1.218 -0.559 0 O-C-N 121.885 -0.509 . . . . 28.100000000000001 111.602 165.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1177 ' ' GLY . . . . . 0.557 ' HA3' ' HA ' ' A' 1173 ' ' ALA . . . -63.71 -42.88 98.51 Favored Glycine 0 CA--C 1.507 -0.419 0 CA-C-O 118.846 -0.974 . . . . 28.539999999999999 111.759 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1178 ' ' LEU . . . . . 0.408 HD12 HG22 ' A' 1175 ' ' VAL . 52.4 mt -62.9 -35.19 79.25 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 117.462 -1.256 . . . . 31.219999999999999 110.698 177.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -64.61 -34.88 79.3 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 121.769 2.077 . . . . 28.98 112.374 172.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -67.81 -45.78 73.79 Favored 'General case' 0 C--O 1.253 1.25 0 CA-C-N 115.249 -0.887 . . . . 27.829999999999998 112.079 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1181 ' ' ILE . . . . . 0.573 HG12 HG11 ' A' 1191 ' ' VAL . 54.7 mt -57.32 -53.9 37.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.496 0 CA-C-N 114.93 -1.032 . . . . 30.25 109.07 175.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -52.72 -58.0 12.6 Favored Glycine 0 N--CA 1.471 1.005 0 O-C-N 125.161 1.538 . . . . 29.59 109.71 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -60.37 -48.78 80.29 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 115.338 1.607 . . . . 30.289999999999999 115.338 -175.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -69.75 -33.22 72.14 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 120.116 1.325 . . . . 30.469999999999999 114.394 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -65.99 -43.78 86.76 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.689 -0.856 . . . . 42.409999999999997 108.689 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1186 ' ' SER . . . . . . . . . . . . . 68.1 m -59.38 -48.18 82.61 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 121.073 -1.017 . . . . 39.380000000000003 112.586 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1187 ' ' LEU . . . . . 0.454 ' HA ' ' HB3' ' B' 1186 ' ' SER . 10.6 mt -53.43 -34.47 57.94 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 117.207 2.299 . . . . 36.18 117.207 170.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 105.36 52.38 0.82 Allowed Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 109.124 -1.591 . . . . 33.780000000000001 109.124 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -135.54 143.93 45.99 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 107.488 -1.301 . . . . 33.93 107.488 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 7.5 mt -79.57 106.85 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 103.111 -2.922 . . . . 38.740000000000002 103.111 -170.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1191 ' ' VAL . . . . . 0.573 HG11 HG12 ' A' 1181 ' ' ILE . 44.0 t -76.21 135.26 27.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 105.974 -1.861 . . . . 33.090000000000003 105.974 173.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1192 ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' 1169 ' ' MET . 95.0 mtt180 -126.4 87.01 2.6 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 102.741 -3.059 . . . . 38.920000000000002 102.741 176.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -95.59 154.56 17.15 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 120.33 -1.481 . . . . 35.32 111.794 -170.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 35.6 t80 -155.91 164.31 38.66 Favored 'General case' 0 C--O 1.25 1.115 0 O-C-N 124.557 1.161 . . . . 39.350000000000001 108.064 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1195 ' ' ASP . . . . . 0.44 ' HB2' ' H ' ' A' 1173 ' ' ALA . 10.6 t70 -164.77 162.63 21.22 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 104.492 -2.41 . . . . 40.460000000000001 104.492 174.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1196 ' ' THR . . . . . . . . . . . . . 5.6 m -58.36 -38.63 77.62 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.836 -1.075 . . . . 45.939999999999998 111.877 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1197 ' ' ARG . . . . . 0.45 ' HA ' ' HD2' ' A' 1198 ' ' PRO . 40.5 mtm180 -90.06 113.86 58.76 Favored Pre-proline 0 N--CA 1.449 -0.498 0 C-N-CA 126.191 1.796 . . . . 56.020000000000003 108.214 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1198 ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' 1197 ' ' ARG . 39.9 Cg_endo -55.1 -22.27 30.89 Favored 'Trans proline' 0 N--CA 1.435 -1.955 0 C-N-CA 125.202 3.935 . . . . 51.270000000000003 116.361 173.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -47.86 -41.0 23.03 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 116.539 2.051 . . . . 59.100000000000001 116.539 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 32.8 m -64.16 -9.29 5.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 116.095 1.887 . . . . 51.060000000000002 116.095 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 80.6 tttt -53.74 -40.81 66.45 Favored 'General case' 0 N--CA 1.436 -1.126 0 O-C-N 123.769 0.668 . . . . 57.380000000000003 111.908 -178.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.91 -47.51 71.11 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 115.444 1.646 . . . . 62.409999999999997 115.444 174.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -61.89 -43.41 98.91 Favored 'General case' 0 C--O 1.256 1.44 0 CA-C-O 123.37 1.557 . . . . 57.780000000000001 112.538 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 42.2 t -53.68 -57.24 5.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 112.571 -2.104 . . . . 46.380000000000003 109.0 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -70.53 -31.57 68.7 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 113.106 -1.861 . . . . 50.700000000000003 112.313 -177.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1206 ' ' SER . . . . . . . . . . . . . 66.8 m -70.7 -45.02 65.74 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 119.797 1.18 . . . . 49.979999999999997 111.328 -177.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1207 ' ' MET . . . . . . . . . . . . . 59.3 mtm -68.19 -34.18 75.8 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 122.723 1.249 . . . . 52.990000000000002 112.988 175.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 123.42 96.25 1.23 Allowed Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 107.56 -2.216 . . . . 47.659999999999997 107.56 171.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -168.12 160.19 11.62 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 120.788 -0.365 . . . . 44.770000000000003 110.188 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -85.62 145.91 27.11 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 102.894 -3.002 . . . . 47.640000000000001 102.894 170.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1211 ' ' PHE . . . . . . . . . . . . . 71.6 t80 -112.93 145.28 41.04 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 103.341 -2.837 . . . . 45.659999999999997 103.341 173.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 80.0 mt -71.14 108.54 4.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 123.369 1.557 . . . . 46.060000000000002 112.233 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -87.22 123.98 32.82 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 106.238 -1.764 . . . . 60.219999999999999 106.238 174.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 8.9 mp -90.34 144.81 25.48 Favored 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 115.259 1.577 . . . . 57.25 115.259 -176.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 35.6 t70 -71.59 83.56 0.85 Allowed 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 112.976 -1.92 . . . . 64.430000000000007 109.922 165.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 83.4 t80 . . . . . 0 C--O 1.216 -0.678 0 N-CA-C 102.38 -3.193 . . . . 66.900000000000006 102.38 -177.011 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 9.2 p-10 . . . . . 0 N--CA 1.437 -1.114 0 N-CA-C 106.779 -1.563 . . . . 39.090000000000003 106.779 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -49.33 -51.11 27.51 Favored Glycine 0 N--CA 1.474 1.185 0 C-N-CA 126.956 2.217 . . . . 39.32 112.943 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 60.3 t80 -64.86 -47.56 77.46 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 119.292 1.546 . . . . 39.299999999999997 111.739 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -63.91 -43.33 96.26 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 119.625 1.102 . . . . 36.299999999999997 113.105 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -57.07 -34.52 68.35 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 124.263 0.977 . . . . 37.380000000000003 112.144 174.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -63.43 -53.99 38.36 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 CA-C-N 121.106 1.775 . . . . 39.109999999999999 111.449 166.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1230 ' ' MET . . . . . . . . . . . . . 28.9 mmt -71.13 40.57 0.06 Allowed 'General case' 0 C--O 1.242 0.709 0 N-CA-C 113.706 1.002 . . . . 49.590000000000003 113.706 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1231 ' ' SER . . . . . . . . . . . . . 61.8 p -114.12 157.02 23.15 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 118.681 -2.512 . . . . 43.68 108.131 -174.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -55.11 -46.6 75.56 Favored 'General case' 0 C--N 1.356 0.865 0 CA-C-O 123.399 1.571 . . . . 55.57 110.289 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -70.76 -35.6 72.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 117.851 -1.071 . . . . 44.939999999999998 113.579 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 31.9 t80 -72.26 -48.44 42.61 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 122.535 2.425 . . . . 42.039999999999999 109.403 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 58.9 mt -64.3 -32.17 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 CA-C-N 118.645 0.657 . . . . 46.280000000000001 111.893 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 41.1 tttm -52.88 -53.72 44.91 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.783 -1.192 . . . . 47.869999999999997 107.783 167.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -62.85 -32.2 73.38 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 114.433 1.272 . . . . 41.609999999999999 114.433 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -54.43 -50.24 68.08 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 119.054 0.843 . . . . 50.649999999999999 112.614 165.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1239 ' ' MET . . . . . . . . . . . . . 34.3 mmt -61.15 -47.52 85.84 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 123.152 1.453 . . . . 48.869999999999997 110.075 -178.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -58.83 -40.08 83.15 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 112.949 -1.932 . . . . 54.799999999999997 109.613 175.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 3.5 mm? -75.19 -33.83 61.47 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 122.376 2.353 . . . . 43.210000000000001 112.453 176.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -69.81 -40.56 75.87 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 121.788 2.086 . . . . 38.659999999999997 109.681 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -64.73 -38.65 91.7 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 125.231 1.412 . . . . 37.920000000000002 111.464 171.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -63.69 -25.15 68.08 Favored 'General case' 0 C--O 1.246 0.882 0 O-C-N 120.026 -1.671 . . . . 37.280000000000001 112.567 171.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1245 ' ' GLN . . . . . 0.438 ' HG3' ' SD ' ' A' 1169 ' ' MET . 96.5 mm-40 -84.09 -32.15 24.93 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-O 118.548 -0.739 . . . . 43.07 111.83 176.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -49.92 -45.19 50.76 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 113.443 0.905 . . . . 38.299999999999997 113.443 -158.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1247 ' ' LYS . . . . . 0.49 ' HD2' ' H ' ' A' 1247 ' ' LYS . 0.4 OUTLIER -80.38 -11.53 59.69 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 119.423 -2.048 . . . . 47.600000000000001 111.757 -172.741 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -106.88 -31.65 8.26 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 118.548 -0.739 . . . . 45.420000000000002 110.672 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1249 ' ' VAL . . . . . . . . . . . . 0.307 12.2 m -68.45 152.86 9.26 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 N-CA-C 117.658 2.466 . . . . 36.259999999999998 117.658 -172.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1250 ' ' ASP . . . . . 0.613 ' HB3' ' CZ ' ' A' 1149 ' ' PHE . 12.2 m-20 -113.74 -54.77 2.58 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 112.636 -2.074 . . . . 33.039999999999999 109.274 -171.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1251 ' ' ILE . . . . . 0.78 HD12 ' HB1' ' A' 1145 ' ' ALA . 25.8 mm -124.13 122.8 65.2 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.692 0 N-CA-C 101.644 -3.465 . . . . 31.399999999999999 101.644 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1252 ' ' ILE . . . . . 0.508 HG21 HD11 ' A' 1267 ' ' ILE . 55.5 mt -99.72 127.47 52.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 103.579 -2.749 . . . . 29.420000000000002 103.579 161.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1253 ' ' VAL . . . . . 0.567 HG12 HG23 ' A' 1255 ' ' THR . 11.2 t -110.87 104.73 17.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 1 N-CA-C 100.141 -4.022 . . . . 30.370000000000001 100.141 176.923 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 1254 ' ' THR . . . . . 0.41 HG23 HG22 ' A' 1252 ' ' ILE . 0.6 OUTLIER -88.91 84.77 6.64 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-O 125.619 2.628 . . . . 35.719999999999999 111.971 -179.658 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 1255 ' ' THR . . . . . 0.601 HG22 HD13 ' A' 1284 ' ' LEU . 14.6 p -95.09 12.68 27.76 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 110.765 -2.925 . . . . 36.0 116.748 -176.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1256 ' ' ALA . . . . . 0.418 ' HB3' HD21 ' A' 1291 ' ' ASN . . . -83.97 67.4 9.62 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 120.909 1.686 . . . . 40.93 112.011 -176.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 37.3 tp -82.24 99.27 9.2 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 106.561 -1.644 . . . . 47.82 106.561 176.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1258 ' ' ILE . . . . . 0.474 ' HA ' ' HD2' ' A' 1259 ' ' PRO . 30.8 mm -75.87 139.65 70.02 Favored Pre-proline 0 N--CA 1.433 -1.32 0 N-CA-C 108.071 -1.085 . . . . 52.700000000000003 108.071 -175.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1259 ' ' PRO . . . . . 0.474 ' HD2' ' HA ' ' A' 1258 ' ' ILE . 29.0 Cg_endo -59.78 114.04 1.9 Allowed 'Trans proline' 0 CA--C 1.512 -0.597 0 C-N-CA 122.573 2.182 . . . . 54.130000000000003 112.719 169.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 80.91 -75.47 2.27 Favored Glycine 0 C--O 1.255 1.44 0 N-CA-C 107.047 -2.421 . . . . 54.619999999999997 107.047 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 89.9 mttt -51.03 140.38 21.25 Favored Pre-proline 0 C--O 1.252 1.225 0 C-N-CA 126.064 1.746 . . . . 55.740000000000002 112.072 -177.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -56.64 136.29 75.21 Favored 'Trans proline' 0 N--CA 1.44 -1.634 1 C-N-CA 125.311 4.008 . . . . 51.149999999999999 111.043 176.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1263 ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' 1264 ' ' PRO . . . -54.98 130.81 67.49 Favored Pre-proline 0 N--CA 1.47 0.538 0 CA-C-O 121.791 0.805 . . . . 46.060000000000002 110.718 170.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1264 ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' 1263 ' ' ALA . 76.1 Cg_exo -56.5 129.2 33.46 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 124.565 3.51 . . . . 41.079999999999998 110.68 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -77.6 70.15 3.94 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 124.923 2.297 . . . . 47.420000000000002 111.874 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 61.0 mt -69.91 -58.53 3.75 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 109.572 -3.467 . . . . 39.219999999999999 110.75 -164.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1267 ' ' ILE . . . . . 0.508 HD11 HG21 ' A' 1252 ' ' ILE . 31.9 mt -83.78 106.26 14.07 Favored 'Isoleucine or valine' 0 C--O 1.246 0.918 0 N-CA-C 106.987 -1.486 . . . . 42.5 106.987 -174.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1268 ' ' THR . . . . . . . . . . . . . 38.5 p -67.55 156.15 37.43 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 115.83 -0.623 . . . . 37.840000000000003 111.562 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -55.32 -34.73 64.43 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.513 -0.551 . . . . 54.799999999999997 109.513 171.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -48.73 -54.65 14.09 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 113.403 0.89 . . . . 54.359999999999999 113.403 166.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1271 ' ' MET . . . . . . . . . . . . . 26.5 mtm -68.23 -35.52 78.08 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.833 0.679 . . . . 39.520000000000003 112.833 -177.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1272 ' ' VAL . . . . . 0.422 HG12 HG21 ' A' 1303 ' ' THR . 79.2 t -62.82 -51.89 66.33 Favored 'Isoleucine or valine' 0 C--O 1.25 1.13 0 N-CA-C 106.611 -1.626 . . . . 38.25 106.611 178.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.05 -33.48 67.28 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 117.776 2.51 . . . . 40.770000000000003 117.776 170.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1274 ' ' SER . . . . . . . . . . . . . 41.0 m -80.39 -3.06 48.23 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 113.273 0.842 . . . . 36.579999999999998 113.273 174.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1275 ' ' MET . . . . . . . . . . . . . 16.2 mtp -69.31 158.63 34.67 Favored 'General case' 0 CA--C 1.51 -0.583 0 O-C-N 118.705 -2.497 . . . . 36.75 116.706 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1276 ' ' LYS . . . . . 0.446 ' HE3' ' NH2' ' A' 1151 ' ' ARG . 39.5 ttpt -65.21 139.65 58.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 124.343 2.021 . . . . 46.109999999999999 108.006 168.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1277 ' ' ALA . . . . . 0.628 ' HB1' ' HA ' ' B' 1045 ' ' PHE 0.253 . . -75.64 157.85 33.18 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 108.588 -3.915 . . . . 33.520000000000003 109.889 -179.37 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 73.21 24.1 76.2 Favored Glycine 0 C--N 1.347 1.167 0 N-CA-C 110.917 -0.873 . . . . 31.27 110.917 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1279 ' ' SER . . . . . 0.43 ' HB3' ' O ' ' A' 1250 ' ' ASP . 22.7 m -122.22 169.65 10.69 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.734 -0.733 . . . . 32.950000000000003 110.971 -171.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1280 ' ' VAL . . . . . 0.72 HG11 ' HA ' ' A' 1145 ' ' ALA . 42.5 t -132.11 141.92 44.16 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 N-CA-C 108.347 -0.983 . . . . 27.43 108.347 -171.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1281 ' ' ILE . . . . . 0.466 HG12 HD12 ' A' 1252 ' ' ILE . 84.9 mt -114.44 102.32 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 1 N-CA-C 99.335 -4.32 . . . . 30.300000000000001 99.335 164.948 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -87.91 96.44 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 CA-C-O 123.21 1.481 . . . . 28.629999999999999 107.343 172.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 4.9 t70 -87.76 100.01 12.52 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 113.989 -1.459 . . . . 36.270000000000003 110.941 -175.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1284 ' ' LEU . . . . . 0.601 HD13 HG22 ' A' 1255 ' ' THR . 5.5 tt -74.27 -34.57 63.62 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 123.664 1.697 . . . . 38.57 108.42 177.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -63.42 -13.45 40.18 Favored 'General case' 0 CA--C 1.508 -0.665 0 O-C-N 120.478 -1.389 . . . . 37.560000000000002 113.84 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . -34.19 -38.39 0.06 Allowed 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 121.674 3.953 . . . . 40.329999999999998 121.674 175.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -66.63 -22.74 66.11 Favored 'General case' 0 C--N 1.345 0.4 0 C-N-CA 118.662 -1.215 . . . . 56.850000000000001 113.88 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 30.2 t30 -142.06 86.99 2.01 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.145 -1.428 . . . . 45.859999999999999 107.145 177.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 106.16 -67.84 0.24 Allowed Glycine 0 CA--C 1.492 -1.361 0 C-N-CA 120.054 -1.07 . . . . 40.310000000000002 111.494 175.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 86.08 111.27 0.8 Allowed Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 105.769 -2.933 . . . . 38.890000000000001 105.769 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1291 ' ' ASN . . . . . 0.418 HD21 ' HB3' ' A' 1256 ' ' ALA . 27.1 m120 -70.68 -22.93 62.42 Favored 'General case' 0 C--O 1.223 -0.309 0 O-C-N 120.183 -1.775 . . . . 37.229999999999997 113.393 -171.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1292 ' ' CYS . . . . . 0.54 ' HB3' ' OG1' ' A' 1295 ' ' THR . 35.6 t -89.46 143.81 26.53 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 104.335 -2.468 . . . . 36.5 104.335 171.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1293 ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -77.14 -21.21 54.49 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 123.402 1.572 . . . . 43.32 112.425 174.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.92 10.98 12.41 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 116.958 2.207 . . . . 41.32 116.958 170.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1295 ' ' THR . . . . . 0.54 ' OG1' ' HB3' ' A' 1292 ' ' CYS . 89.9 m -68.82 113.97 6.74 Favored 'General case' 0 C--O 1.25 1.092 0 O-C-N 118.282 -2.761 . . . . 35.299999999999997 110.579 -175.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 10.4 t -84.19 116.06 63.12 Favored Pre-proline 0 N--CA 1.449 -0.505 0 N-CA-C 107.28 -1.378 . . . . 34.840000000000003 107.28 169.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.87 98.66 0.71 Allowed 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 122.866 2.377 . . . . 33.509999999999998 111.944 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 115.06 13.32 9.25 Favored Glycine 0 N--CA 1.432 -1.618 0 CA-C-N 114.316 -1.311 . . . . 32.189999999999998 112.874 170.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -159.21 168.69 25.88 Favored 'General case' 0 N--CA 1.435 -1.213 0 O-C-N 120.289 -1.712 . . . . 34.880000000000003 108.958 -174.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1300 ' ' ILE . . . . . 0.578 HD13 ' HG3' ' A' 1148 ' ' GLU . 48.4 mt -89.32 115.36 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 104.284 -2.487 . . . . 32.289999999999999 104.284 175.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 52.9 t80 -85.83 150.15 24.75 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 105.777 -1.934 . . . . 37.25 105.777 162.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1302 ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' 1307 ' ' VAL . 88.5 m -135.16 122.15 21.26 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 119.294 0.952 . . . . 35.560000000000002 109.16 174.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1303 ' ' THR . . . . . 0.422 HG21 HG12 ' A' 1272 ' ' VAL . 1.2 p -74.67 160.77 30.38 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 122.289 1.043 . . . . 36.399999999999999 111.575 173.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -68.23 -22.73 64.77 Favored 'General case' 0 C--O 1.249 1.069 0 O-C-N 120.376 -1.453 . . . . 52.32 111.747 -174.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1305 ' ' ASN . . . . . 0.875 ' HA ' ' HB2' ' B' 1046 ' ' ASP . 52.8 p-10 -75.41 -10.64 59.63 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 118.402 -0.809 . . . . 40.039999999999999 110.82 175.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 94.15 43.74 3.71 Favored Glycine 0 N--CA 1.432 -1.625 0 O-C-N 124.085 0.865 . . . . 36.960000000000001 111.5 175.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1307 ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' 1302 ' ' THR . 76.8 t -108.55 123.71 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 117.746 -1.582 . . . . 33.399999999999999 107.567 168.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1308 ' ' LYS . . . . . 0.573 ' HB2' HG22 ' A' 1280 ' ' VAL . 32.1 mmtt -86.29 98.4 10.94 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 121.878 0.847 . . . . 42.909999999999997 109.144 176.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 7.7 t -84.44 86.53 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 104.73 -2.322 . . . . 32.289999999999999 104.73 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1310 ' ' ILE . . . . . 0.657 HD11 ' HB2' ' A' 1148 ' ' GLU . 33.9 mt -81.98 92.26 2.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 113.691 -1.595 . . . . 30.989999999999998 109.582 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -85.96 53.86 4.7 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 113.452 -1.704 . . . . 28.949999999999999 113.153 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1312 ' ' TYR . . . . . 0.535 ' O ' ' HG ' ' A' 1315 ' ' LEU . 1.4 m-30 -87.67 104.61 16.69 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 125.355 2.503 . . . . 31.690000000000001 107.233 -171.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1313 ' ' THR . . . . . . . . . . . . . 33.9 p -66.26 -42.56 88.35 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 110.815 -2.902 . . . . 34.170000000000002 111.113 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -68.34 8.27 0.48 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 111.79 -2.459 . . . . 36.859999999999999 116.981 -177.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1315 ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' 1312 ' ' TYR . 96.2 mt -45.4 -39.18 9.19 Favored Pre-proline 0 N--CA 1.478 0.945 0 O-C-N 118.345 -2.722 . . . . 34.850000000000001 116.498 177.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -56.14 -46.18 32.78 Favored 'Trans proline' 0 C--O 1.247 0.95 0 C-N-CA 123.064 2.509 . . . . 29.149999999999999 113.842 168.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1317 ' ' GLY . . . . . 0.565 ' HA2' ' HG3' ' A' 1015 ' ' ARG . . . -60.35 -43.74 98.31 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-N 114.058 -1.428 . . . . 27.289999999999999 110.951 178.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1318 ' ' ARG . . . . . 0.508 ' HB3' ' CZ ' ' A' 1140 ' ' ARG . 85.3 mtt-85 -62.37 -29.17 70.28 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 122.027 0.918 . . . . 41.490000000000002 113.233 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1319 ' ' LEU . . . . . 0.708 HD13 ' HD3' ' A' 1140 ' ' ARG . 3.9 tp -108.05 68.61 0.3 Allowed Pre-proline 0 N--CA 1.439 -0.982 0 O-C-N 120.002 -1.686 . . . . 27.609999999999999 111.074 168.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1320 ' ' PRO . . . . . 0.612 ' HD2' ' HA2' ' B' 1150 ' ' GLY . 95.8 Cg_endo -62.6 -58.25 0.36 Allowed 'Trans proline' 0 CA--C 1.499 -1.233 0 C-N-CA 124.553 3.502 . . . . 25.940000000000001 111.963 -163.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1321 ' ' THR . . . . . 0.405 HG23 HG21 ' A' 1019 ' ' THR . 1.8 m -60.55 -28.88 68.78 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 120.512 1.505 . . . . 25.010000000000002 110.178 -174.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1322 ' ' GLN . . . . . 0.679 ' HB2' ' HA ' ' B' 1151 ' ' ARG . 9.4 tp60 -79.79 -33.87 40.12 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 117.618 -1.182 . . . . 29.390000000000001 110.002 -176.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1323 ' ' SER . . . . . 0.631 ' HA ' HD13 ' A' 1136 ' ' ILE . 31.6 m -57.17 -56.18 25.09 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 119.902 1.228 . . . . 26.469999999999999 108.536 165.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1324 ' ' SER . . . . . . . . . . . . . 14.9 m -65.31 -21.67 66.74 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 122.136 0.969 . . . . 27.780000000000001 113.501 -172.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -93.12 -55.41 3.34 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 115.939 -1.981 . . . . 37.530000000000001 111.138 173.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1326 ' ' LEU . . . . . 0.55 ' HB2' HD11 ' A' 1136 ' ' ILE . 93.0 mt -71.6 -56.44 5.86 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 122.193 2.27 . . . . 35.710000000000001 112.552 -178.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1327 ' ' TYR . . . . . 0.516 ' CD2' HG13 ' A' 1072 ' ' VAL . 86.0 t80 -58.71 -42.45 88.68 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 119.37 0.986 . . . . 31.59 108.933 172.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1328 ' ' GLY . . . . . 0.806 ' HA2' HD12 ' A' 1331 ' ' LEU . . . -46.21 -50.51 12.82 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-N 118.44 0.564 . . . . 28.0 112.197 169.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1329 ' ' THR . . . . . . . . . . . . . 34.6 m -71.25 -20.95 62.17 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-O 117.771 -1.109 . . . . 32.149999999999999 112.258 174.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1330 ' ' ASN . . . . . 0.417 ' OD1' ' HB2' ' A' 1132 ' ' SER . 13.7 m120 -62.18 -46.17 90.13 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 124.755 3.434 . . . . 34.359999999999999 109.73 170.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1331 ' ' LEU . . . . . 0.806 HD12 ' HA2' ' A' 1328 ' ' GLY . 15.7 mt -57.01 -52.18 66.31 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-N 113.159 -1.837 . . . . 33.369999999999997 112.689 176.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1332 ' ' VAL . . . . . 0.619 HG11 ' HB3' ' A' 1025 ' ' GLN . 45.6 t -63.5 -42.25 95.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 105.388 -2.078 . . . . 35.270000000000003 105.388 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1333 ' ' ASN . . . . . 0.499 ' HA ' ' HD2' ' A' 1336 ' ' LYS . 92.1 m-20 -59.81 -37.08 78.14 Favored 'General case' 0 CA--C 1.504 -0.794 0 O-C-N 119.534 -1.979 . . . . 37.659999999999997 113.562 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1334 ' ' LEU . . . . . 0.558 HD22 ' SD ' ' A' 1115 ' ' MET . 43.1 tp -60.03 -52.96 63.14 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.289 -0.634 . . . . 40.270000000000003 109.289 165.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1335 ' ' LEU . . . . . 0.511 HD23 HD22 ' A' 1338 ' ' LEU . 19.0 mt -63.8 -18.15 63.81 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 115.308 1.596 . . . . 42.5 115.308 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1336 ' ' LYS . . . . . 0.499 ' HD2' ' HA ' ' A' 1333 ' ' ASN . 78.8 mttt -69.36 -36.38 76.79 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 120.341 -1.474 . . . . 47.810000000000002 109.198 172.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1337 ' ' LEU . . . . . . . . . . . . . 10.2 mp -70.33 -40.33 74.2 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 122.864 1.316 . . . . 49.270000000000003 111.831 170.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1338 ' ' LEU . . . . . 0.511 HD22 HD23 ' A' 1335 ' ' LEU . 3.1 mp -67.83 -47.6 68.54 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 116.793 2.146 . . . . 50.539999999999999 116.793 -177.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1339 ' ' CYS . . . . . 0.493 ' SG ' ' HA2' ' A' 1344 ' ' GLY . 41.1 t -83.21 100.31 10.5 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 102.639 -3.097 . . . . 53.670000000000002 102.639 175.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 28.5 mtpt -84.04 -70.37 0.57 Allowed 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 118.878 -2.389 . . . . 63.380000000000003 111.883 -177.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1341 ' ' GLU . . . . . 0.542 ' HB2' ' HB3' ' A' 1343 ' ' ASP . 4.3 mp0 -72.7 -15.35 61.69 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.25 0.833 . . . . 70.950000000000003 113.25 -171.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1342 ' ' LYS . . . . . 0.57 ' HA ' ' H ' ' A' 1344 ' ' GLY . 9.3 mtpm? 49.11 58.11 5.73 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 116.892 -1.528 . . . . 65.25 111.77 -173.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1343 ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' A' 1341 ' ' GLU 0.404 0.0 OUTLIER 63.72 -78.04 0.03 OUTLIER 'General case' 0 C--N 1.356 0.874 2 O-C-N 113.242 -5.911 . . . . 64.530000000000001 114.817 21.309 . . . . . . . . 5 4 . 1 . 003 nuclear build core ' A' A 1344 ' ' GLY . . . . . 0.57 ' H ' ' HA ' ' A' 1342 ' ' LYS . . . 71.58 52.04 14.05 Favored Glycine 0 C--O 1.217 -0.952 0 CA-C-N 120.908 1.685 . . . . 59.719999999999999 111.607 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 44.3 t30 -146.73 155.08 42.13 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 119.799 1.799 . . . . 64.090000000000003 106.663 172.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1346 ' ' ILE . . . . . . . . . . . . . 34.4 mt -88.94 124.05 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 CA-C-O 124.48 2.086 . . . . 58.82 112.121 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1347 ' ' THR . . . . . . . . . . . . . 33.7 m -100.63 109.54 21.61 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 110.392 -3.095 . . . . 54.960000000000001 107.683 167.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1348 ' ' VAL . . . . . . . . . . . . . 34.4 t -85.19 82.39 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 N-CA-C 106.173 -1.788 . . . . 55.640000000000001 106.173 176.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 24.2 t0 -78.36 106.25 10.16 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 112.766 -2.015 . . . . 61.450000000000003 115.449 -175.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -82.66 -13.07 57.09 Favored 'General case' 0 C--O 1.246 0.921 0 CA-C-N 112.472 -2.149 . . . . 58.630000000000003 112.751 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -65.12 -47.14 78.21 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 120.904 -1.122 . . . . 62.060000000000002 109.73 172.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 10.3 t70 -65.44 108.71 2.06 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 123.271 1.51 . . . . 54.07 108.994 174.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 22.1 m -43.82 -37.24 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.765 0 N-CA-C 117.614 2.449 . . . . 50.68 117.614 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1354 ' ' VAL . . . . . 0.806 HG11 ' HB2' ' A' 1124 ' ' ALA 0.261 5.4 m -79.72 -43.75 23.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-O 118.099 -0.953 . . . . 47.68 110.374 179.61 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 1355 ' ' ILE . . . . . . . . . . . . . 80.4 mt -60.76 -45.1 98.39 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 121.58 1.991 . . . . 48.490000000000002 109.612 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 40.7 tpt85 -43.23 -50.52 6.43 Favored 'General case' 0 C--O 1.249 1.069 0 N-CA-C 115.986 1.847 . . . . 48.270000000000003 115.986 163.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -61.15 -50.71 64.29 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.86 -0.967 . . . . 43.530000000000001 112.834 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1358 ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' 1354 ' ' VAL . 21.2 t -60.58 -49.38 84.66 Favored 'Isoleucine or valine' 0 C--O 1.249 1.059 0 N-CA-C 106.202 -1.777 . . . . 45.119999999999997 106.202 -173.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1359 ' ' THR . . . . . . . . . . . . . 6.0 m -69.01 87.84 0.38 Allowed 'General case' 0 C--N 1.313 -0.98 0 O-C-N 120.581 -1.325 . . . . 42.939999999999998 108.626 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 30.9 m -77.68 -23.74 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 CA-C-N 114.865 -1.061 . . . . 43.259999999999998 110.971 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1361 ' ' ILE . . . . . 0.494 HG12 HG12 ' A' 1366 ' ' ILE . 73.4 mt -135.58 119.02 23.91 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 N-CA-C 105.567 -2.012 . . . . 45.659999999999997 105.567 172.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1362 ' ' ARG . . . . . 0.415 ' HA ' HG23 ' A' 1111 ' ' THR . 33.3 ttt180 -100.65 110.3 22.42 Favored 'General case' 0 C--O 1.219 -0.525 0 O-C-N 119.172 -2.205 . . . . 61.340000000000003 106.584 167.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 31.87 79.0 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 O-C-N 126.388 2.305 . . . . 49.759999999999998 112.135 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 83.25 -40.54 2.84 Favored Glycine 0 CA--C 1.521 0.457 0 CA-C-O 118.59 -1.116 . . . . 50.0 112.645 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -77.05 111.0 12.16 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 105.87 -1.9 . . . . 56.920000000000002 105.87 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1366 ' ' ILE . . . . . 0.494 HG12 HG12 ' A' 1361 ' ' ILE . 66.0 mt -70.11 106.53 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 104.406 -2.442 . . . . 52.780000000000001 104.406 173.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1367 ' ' THR . . . . . . . . . . . . . 2.0 p -88.41 -4.9 58.56 Favored 'General case' 0 CA--C 1.496 -1.124 0 N-CA-C 114.901 1.445 . . . . 49.439999999999998 114.901 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 1.7 t90 -70.73 148.62 95.0 Favored Pre-proline 0 C--O 1.248 1.016 0 N-CA-C 106.701 -1.592 . . . . 52.380000000000003 106.701 166.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -65.43 156.07 77.89 Favored 'Cis proline' 0 CA--C 1.498 -1.321 0 CA-C-N 124.96 2.807 . . . . 46.939999999999998 116.32 -7.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -112.04 151.84 43.88 Favored Pre-proline 0 N--CA 1.442 -0.858 0 CA-C-N 113.342 -1.754 . . . . 45.909999999999997 110.195 -175.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1371 ' ' PRO . . . . . 0.463 ' HA ' ' HD3' ' A' 1372 ' ' PRO . 18.5 Cg_exo -57.25 145.02 89.21 Favored 'Trans proline' 0 C--O 1.248 1.007 0 C-N-CA 122.789 2.326 . . . . 46.390000000000001 117.643 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1372 ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' 1371 ' ' PRO . 51.5 Cg_exo -67.48 -20.45 47.78 Favored 'Trans proline' 0 CA--C 1.539 0.742 1 C-N-CA 125.345 4.03 . . . . 46.719999999999999 112.435 171.0 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.22 -5.055 0 CA-C-N 122.539 2.427 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 35.8 m80 . . . . . 0 N--CA 1.467 0.382 0 N-CA-C 107.738 -1.208 . . . . 63.439999999999998 107.738 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 999' ' ' HIS . . . . . 0.498 ' HB3' ' HB2' ' B' 1002 ' ' ARG . 98.8 m-70 -73.54 74.53 1.46 Allowed 'General case' 0 C--O 1.242 0.673 0 CA-C-O 124.37 2.033 . . . . 51.740000000000002 115.041 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1000 ' ' HIS . . . . . . . . . . . . . 63.9 t60 -72.62 128.45 35.6 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 114.499 -1.228 . . . . 54.07 108.573 -174.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 68.34 15.76 68.36 Favored Glycine 0 CA--C 1.506 -0.498 0 O-C-N 120.076 -1.64 . . . . 39.219999999999999 115.328 -172.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1002 ' ' ARG . . . . . 0.498 ' HB2' ' HB3' ' B' ' 999' ' ' HIS . 30.5 ttp180 -89.06 129.37 35.7 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 119.833 1.816 . . . . 38.119999999999997 108.557 176.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1003 ' ' ILE . . . . . 0.643 HG12 ' HB ' ' B' 1068 ' ' ILE . 19.6 mt -84.48 134.78 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-N 111.28 -2.691 . . . . 29.699999999999999 105.611 166.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1004 ' ' GLY . . . . . 0.417 ' O ' ' HD3' ' B' 1006 ' ' PRO . . . -114.84 125.65 6.87 Favored Glycine 0 CA--C 1.503 -0.701 0 N-CA-C 106.556 -2.617 . . . . 27.5 106.556 166.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1005 ' ' ILE . . . . . 0.476 HD12 ' HB3' ' B' 1017 ' ' ALA . 27.5 mm -99.4 105.42 33.06 Favored Pre-proline 0 N--CA 1.426 -1.646 0 N-CA-C 104.94 -2.244 . . . . 24.829999999999998 104.94 173.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1006 ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' B' 1004 ' ' GLY . 52.9 Cg_exo -74.76 145.69 32.75 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 C-N-CA 123.905 3.07 . . . . 27.190000000000001 108.977 173.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1007 ' ' ARG . . . . . 0.404 ' HD2' ' O ' ' B' 1037 ' ' SER . 73.1 ttt180 -74.47 113.16 11.39 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 109.198 -3.637 . . . . 41.460000000000001 104.127 171.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1008 ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -40.9 145.36 0.21 Allowed 'General case' 0 C--O 1.247 0.934 0 N-CA-C 120.015 3.339 . . . . 26.93 120.015 175.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1009 ' ' ARG . . . . . 0.446 HH11 ' HG3' ' B' 1009 ' ' ARG . 14.3 mmm-85 -120.27 -10.13 9.4 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-N 112.636 -2.075 . . . . 34.479999999999997 111.522 -175.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1010 ' ' LEU . . . . . . . . . . . . . 4.5 tp -64.7 143.52 57.87 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 122.098 0.951 . . . . 44.219999999999999 113.002 174.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1011 ' ' THR . . . . . . . . . . . . . 3.6 m -66.7 134.33 52.01 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 108.187 -1.042 . . . . 40.740000000000002 108.187 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 49.8 t30 51.21 53.42 12.97 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 115.948 1.832 . . . . 44.439999999999998 115.948 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1013 ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -136.67 116.48 13.11 Favored 'General case' 0 C--O 1.252 1.207 0 CA-C-N 114.245 -1.343 . . . . 29.870000000000001 108.965 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1014 ' ' THR . . . . . 0.589 ' HA ' HD22 ' B' 1042 ' ' LEU . 0.9 OUTLIER -111.99 -0.65 15.66 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.281 -0.872 . . . . 25.260000000000002 112.186 174.522 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B 1015 ' ' ARG . . . . . 0.695 ' HG3' ' HA2' ' B' 1317 ' ' GLY . 65.2 mtm180 -69.07 141.32 54.79 Favored 'General case' 0 C--O 1.248 0.995 0 N-CA-C 105.857 -1.905 . . . . 29.539999999999999 105.857 173.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1016 ' ' VAL . . . . . 0.782 HG21 ' HB1' ' B' 1039 ' ' ALA . 11.6 p -139.36 -173.62 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 104.7 -2.333 . . . . 23.550000000000001 104.7 171.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1017 ' ' ALA . . . . . 0.476 ' HB3' HD12 ' B' 1005 ' ' ILE . . . -110.0 0.67 18.6 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 118.992 -2.318 . . . . 23.59 113.636 175.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1018 ' ' ALA . . . . . . . . . . . . . . . -88.4 128.71 35.52 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 118.671 -0.681 . . . . 24.93 111.481 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1019 ' ' THR . . . . . 0.403 ' O ' ' HB ' ' B' 1022 ' ' THR . 0.0 OUTLIER -156.34 148.05 17.12 Favored Pre-proline 0 N--CA 1.442 -0.835 0 N-CA-C 105.682 -1.97 . . . . 28.09 105.682 171.055 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -61.96 -54.04 1.75 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 124.549 3.499 . . . . 28.789999999999999 112.981 -174.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1021 ' ' LYS . . . . . 0.684 ' HB3' HE22 ' B' 1325 ' ' GLN . 77.9 tttt -49.49 -48.95 47.54 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 121.289 1.859 . . . . 47.280000000000001 108.874 176.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1022 ' ' THR . . . . . 0.403 ' HB ' ' O ' ' B' 1019 ' ' THR . 39.5 m -49.86 -54.27 20.49 Favored 'General case' 0 C--O 1.203 -1.373 0 C-N-CA 125.63 1.572 . . . . 30.120000000000001 111.842 174.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1023 ' ' VAL . . . . . 0.653 HG22 HG11 ' B' 1033 ' ' VAL . 54.0 t -60.63 -37.97 77.07 Favored 'Isoleucine or valine' 0 C--N 1.352 0.691 0 CA-C-N 120.702 1.592 . . . . 32.240000000000002 108.078 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1024 ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -67.9 -44.86 75.97 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 121.205 1.821 . . . . 49.619999999999997 111.401 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1025 ' ' GLN . . . . . 0.548 ' HG3' ' O ' ' B' 1021 ' ' LYS . 52.8 mt-30 -58.43 -45.99 87.41 Favored 'General case' 0 N--CA 1.44 -0.959 0 O-C-N 125.457 1.723 . . . . 44.68 108.203 176.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 95.4 mt -63.39 -45.38 91.35 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 118.867 -0.587 . . . . 35.710000000000001 109.727 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1027 ' ' LEU . . . . . . . . . . . . . 27.2 mt -60.71 -35.19 75.69 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 118.894 0.77 . . . . 42.18 111.302 173.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 19.3 mttm -72.46 -30.11 64.28 Favored 'General case' 0 C--O 1.239 0.526 0 O-C-N 120.219 -1.551 . . . . 48.340000000000003 109.38 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1029 ' ' LEU . . . . . . . . . . . . . 87.3 mt -74.79 -21.03 59.54 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 118.249 -2.782 . . . . 38.689999999999998 109.604 169.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 101.22 18.47 19.35 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 117.935 -2.978 . . . . 32.280000000000001 110.327 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -98.08 118.48 34.79 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 106.432 -1.692 . . . . 35.939999999999998 106.432 170.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1032 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.12 139.94 57.53 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 111.598 -2.546 . . . . 33.369999999999997 111.156 171.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1033 ' ' VAL . . . . . 0.653 HG11 HG22 ' B' 1023 ' ' VAL . 6.7 t -114.0 130.92 67.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.704 0 CA-C-N 121.162 1.801 . . . . 29.98 106.931 -174.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1034 ' ' ALA . . . . . 0.493 ' HB2' ' HD2' ' B' 1002 ' ' ARG . . . -123.59 135.98 54.27 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 104.901 -2.259 . . . . 28.18 104.901 166.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1035 ' ' VAL . . . . . . . . . . . . . 46.7 t -121.72 143.43 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 103.678 -2.712 . . . . 25.82 103.678 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1036 ' ' GLU . . . . . 0.518 ' HG3' ' HA2' ' B' 1060 ' ' GLY . 78.4 tt0 -79.68 137.85 37.19 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 120.038 -1.664 . . . . 32.439999999999998 110.978 173.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1037 ' ' SER . . . . . 0.404 ' O ' ' HD2' ' B' 1007 ' ' ARG . 16.5 m -52.68 115.72 1.94 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 127.081 2.152 . . . . 29.539999999999999 109.958 177.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 115.12 -19.17 15.44 Favored Glycine 0 N--CA 1.423 -2.221 0 CA-C-O 119.382 -0.677 . . . . 27.760000000000002 113.381 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1039 ' ' ALA . . . . . 0.782 ' HB1' HG21 ' B' 1016 ' ' VAL . . . -67.0 -28.87 68.6 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 120.511 -0.475 . . . . 26.02 110.266 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -56.81 -55.18 31.43 Favored Glycine 0 C--O 1.246 0.886 0 N-CA-C 110.612 -0.995 . . . . 26.469999999999999 110.612 164.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1041 ' ' GLN . . . . . 0.511 ' NE2' ' HA ' ' B' 1046 ' ' ASP . 3.4 mp0 -53.24 -39.81 64.1 Favored 'General case' 0 C--O 1.25 1.095 0 O-C-N 120.463 -1.61 . . . . 50.979999999999997 114.32 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1042 ' ' LEU . . . . . 0.589 HD22 ' HA ' ' B' 1014 ' ' THR . 31.3 mt -52.84 -54.62 31.69 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 116.86 2.17 . . . . 29.300000000000001 116.86 163.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1043 ' ' ALA . . . . . . . . . . . . . . . -71.41 17.8 0.08 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 117.856 2.539 . . . . 26.739999999999998 117.856 172.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1044 ' ' SER . . . . . . . . . . . . . 6.7 m 52.57 41.91 31.26 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 125.187 2.422 . . . . 31.260000000000002 111.396 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1045 ' ' PHE . . . . . 0.628 ' HA ' ' HB1' ' A' 1277 ' ' ALA . 1.1 m-85 -127.96 167.3 16.85 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 111.62 -2.536 . . . . 33.259999999999998 107.124 -175.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1046 ' ' ASP . . . . . 0.875 ' HB2' ' HA ' ' A' 1305 ' ' ASN . 40.6 t0 -97.15 138.53 34.52 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 117.524 -1.671 . . . . 46.740000000000002 107.359 150.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -50.07 -36.3 28.73 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 126.887 2.617 . . . . 34.439999999999998 111.892 171.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -35.38 -44.05 0.27 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 116.323 1.972 . . . . 48.670000000000002 116.323 165.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -64.24 -27.91 69.37 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 120.205 -1.56 . . . . 35.259999999999998 112.988 177.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1050 ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -75.39 -38.75 59.77 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 117.276 -1.345 . . . . 32.170000000000002 109.196 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1051 ' ' VAL . . . . . 0.415 HG22 HG12 ' B' 1057 ' ' ILE . 8.3 t -53.44 -50.77 46.91 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 N-CA-C 107.884 -1.154 . . . . 38.369999999999997 107.884 171.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -53.53 -34.9 59.88 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 124.069 0.948 . . . . 45.770000000000003 112.736 175.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -80.31 -21.7 42.31 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.17 0.895 . . . . 37.829999999999998 111.858 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 128.26 20.78 1.56 Allowed Glycine 0 CA--C 1.519 0.304 0 O-C-N 119.658 -1.901 . . . . 35.82 109.571 170.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -100.41 140.71 34.27 Favored 'General case' 0 N--CA 1.435 -1.177 0 O-C-N 119.159 -2.377 . . . . 33.770000000000003 112.026 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -76.56 130.03 37.31 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.647 1.579 . . . . 51.020000000000003 108.545 171.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1057 ' ' ILE . . . . . 0.415 HG12 HG22 ' B' 1051 ' ' VAL . 35.7 mm -97.92 129.84 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 106.188 -1.782 . . . . 38.469999999999999 106.188 168.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 6.6 m -111.21 153.72 12.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 125.337 1.455 . . . . 39.399999999999999 108.048 169.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.13 -48.97 71.7 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 120.491 -1.381 . . . . 57.07 114.57 -175.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1060 ' ' GLY . . . . . 0.518 ' HA2' ' HG3' ' B' 1036 ' ' GLU . . . -155.83 -110.79 0.35 Allowed Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.076 -1.059 . . . . 44.829999999999998 111.018 -176.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1061 ' ' ASN . . . . . 0.573 ' HA ' ' HD1' ' B' 1064 ' ' TRP . 59.2 m-20 -58.27 -25.53 61.89 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 126.385 1.874 . . . . 46.270000000000003 115.685 -170.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1062 ' ' SER . . . . . . . . . . . . . 16.4 m -48.4 -28.19 3.08 Favored 'General case' 0 C--N 1.317 -0.81 0 O-C-N 120.731 -1.231 . . . . 43.469999999999999 112.999 165.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 1.3 p -59.04 -28.32 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 O-C-N 120.108 -1.62 . . . . 36.979999999999997 115.233 171.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1064 ' ' TRP . . . . . 0.573 ' HD1' ' HA ' ' B' 1061 ' ' ASN . 92.4 m95 -74.53 -18.65 60.57 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 122.921 0.488 . . . . 37.899999999999999 111.933 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -83.15 66.83 8.91 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 107.966 -1.124 . . . . 46.189999999999998 107.966 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1066 ' ' SER . . . . . 0.406 ' HB3' ' O ' ' B' 1002 ' ' ARG . 28.2 m -155.29 148.15 24.42 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 103.923 -2.621 . . . . 37.060000000000002 103.923 -172.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1067 ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -82.51 -15.33 52.81 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 115.844 1.794 . . . . 43.950000000000003 115.844 -172.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1068 ' ' ILE . . . . . 0.643 ' HB ' HG12 ' B' 1003 ' ' ILE . 1.4 mp -124.54 116.28 47.04 Favored 'Isoleucine or valine' 0 C--O 1.253 1.238 0 N-CA-C 103.129 -2.915 . . . . 33.5 103.129 177.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 26.0 mm -106.42 115.14 47.4 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 N-CA-C 106.733 -1.58 . . . . 30.57 106.733 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1070 ' ' LEU . . . . . 0.945 HD13 HD13 ' B' 1331 ' ' LEU . 85.3 mt -106.85 78.69 1.26 Allowed 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 115.224 -0.898 . . . . 27.66 111.229 -175.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1071 ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -80.75 166.64 20.81 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.836 -0.62 . . . . 28.399999999999999 110.749 171.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1072 ' ' VAL . . . . . 0.471 HG11 ' HB2' ' B' 1015 ' ' ARG . 8.9 t -91.51 -84.92 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 104.231 -2.507 . . . . 23.18 104.231 169.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -101.78 -170.49 1.83 Allowed 'General case' 0 C--N 1.312 -1.034 0 O-C-N 118.434 -2.666 . . . . 25.469999999999999 111.913 -170.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1074 ' ' ALA . . . . . 0.5 ' HA ' ' HD2' ' B' 1075 ' ' PRO . . . -33.93 125.51 0.47 Allowed Pre-proline 0 CA--C 1.554 1.109 0 N-CA-C 118.157 2.651 . . . . 27.899999999999999 118.157 -172.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1075 ' ' PRO . . . . . 0.5 ' HD2' ' HA ' ' B' 1074 ' ' ALA . 40.3 Cg_endo -68.48 126.89 14.79 Favored 'Trans proline' 0 N--CA 1.434 -2.009 0 C-N-CA 123.319 2.679 . . . . 31.620000000000001 111.474 166.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 45.2 mt -76.15 160.56 29.62 Favored 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 120.437 -1.414 . . . . 40.490000000000002 107.582 168.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.76 -35.5 43.88 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 117.358 2.355 . . . . 51.590000000000003 117.358 -174.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -63.97 -42.37 97.27 Favored 'General case' 0 C--O 1.208 -1.091 0 CA-C-O 118.972 -0.537 . . . . 42.359999999999999 111.004 172.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1079 ' ' GLU . . . . . 0.631 ' HA ' HD12 ' B' 1082 ' ' LEU . 20.2 mt-10 -66.57 -35.74 80.96 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 125.586 1.804 . . . . 34.530000000000001 108.917 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1080 ' ' ILE . . . . . 0.458 HG13 ' HB2' ' B' 1075 ' ' PRO . 63.3 mt -61.79 -51.8 68.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 125.983 2.052 . . . . 33.25 105.766 173.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -59.03 -29.4 67.25 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 120.969 1.713 . . . . 36.469999999999999 112.005 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1082 ' ' LEU . . . . . 0.631 HD12 ' HA ' ' B' 1079 ' ' GLU . 10.2 mt -71.74 -28.06 63.41 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.353 1.242 . . . . 37.759999999999998 114.353 177.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1083 ' ' LEU . . . . . . . . . . . . . 33.9 mt -64.45 112.97 3.36 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 118.594 -1.242 . . . . 37.43 109.204 -175.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -71.12 139.42 84.98 Favored Pre-proline 0 C--O 1.254 1.306 0 CA-C-N 115.149 -0.932 . . . . 37.700000000000003 109.435 167.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1085 ' ' PRO . . . . . 0.729 ' HB3' ' HB2' ' B' 1109 ' ' ASN . 35.1 Cg_exo -55.47 151.92 35.42 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.878 2.385 . . . . 35.509999999999998 116.379 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 74.79 -8.72 13.62 Favored Glycine 0 N--CA 1.445 -0.754 0 O-C-N 120.16 -1.587 . . . . 33.869999999999997 115.981 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1087 ' ' THR . . . . . . . . . . . . . 89.2 m -71.89 139.55 48.85 Favored 'General case' 0 C--O 1.261 1.688 0 O-C-N 119.608 -2.113 . . . . 32.5 108.062 178.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1088 ' ' THR . . . . . 0.545 ' HA ' ' HB ' ' B' 1111 ' ' THR . 0.2 OUTLIER -81.53 97.09 7.66 Favored 'General case' 0 C--O 1.255 1.387 0 N-CA-C 106.591 -1.633 . . . . 30.219999999999999 106.591 -173.613 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B 1089 ' ' LEU . . . . . . . . . . . . . 31.3 tp -91.77 101.21 13.81 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 122.167 0.984 . . . . 27.239999999999998 111.214 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1090 ' ' VAL . . . . . 0.644 HG13 ' HB2' ' B' 1113 ' ' MET . 11.7 t -104.11 107.35 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 111.089 -2.778 . . . . 25.390000000000001 109.795 -175.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1091 ' ' SER . . . . . . . . . . . . . 13.1 m -163.48 168.14 20.58 Favored 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 117.087 -3.508 . . . . 28.809999999999999 113.308 -170.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1092 ' ' PHE . . . . . 0.662 ' HD1' ' HB3' ' B' 1116 ' ' ASP . 68.6 m-85 -65.22 91.71 0.11 Allowed 'General case' 0 C--O 1.278 2.602 0 CA-C-O 124.212 1.958 . . . . 30.780000000000001 110.183 168.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 36.8 mm -89.9 -32.25 5.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 O-C-N 120.631 -1.293 . . . . 30.280000000000001 111.178 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1094 ' ' TRP . . . . . 0.555 ' HB2' ' ND2' ' B' 1098 ' ' ASN . 67.6 m95 57.92 55.83 6.77 Favored Pre-proline 0 C--O 1.247 0.965 0 CA-C-N 114.823 -1.08 . . . . 34.07 112.021 -175.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -49.97 -34.89 39.18 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 124.952 3.768 . . . . 38.659999999999997 113.409 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -56.37 -56.15 24.73 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 120.841 -1.162 . . . . 41.32 110.776 169.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -78.94 -22.68 45.39 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 113.951 1.093 . . . . 51.659999999999997 113.951 -174.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1098 ' ' ASN . . . . . 0.555 ' ND2' ' HB2' ' B' 1094 ' ' TRP . 75.9 m-20 -130.22 81.1 69.34 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 119.934 1.243 . . . . 40.32 111.02 -164.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -64.17 -48.93 4.19 Favored 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 120.987 1.124 . . . . 41.560000000000002 114.561 176.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -61.93 -35.87 79.7 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.399 -0.964 . . . . 54.109999999999999 108.399 -175.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1101 ' ' LEU . . . . . . . . . . . . . 17.0 tp -60.43 -47.17 87.27 Favored 'General case' 0 CA--C 1.515 -0.386 0 O-C-N 120.703 -1.248 . . . . 37.880000000000003 110.116 175.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1102 ' ' MET . . . . . . . . . . . . . 73.2 mmm -57.82 -38.62 75.91 Favored 'General case' 0 C--O 1.238 0.45 0 O-C-N 121.116 -0.99 . . . . 37.539999999999999 113.196 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -64.21 -45.77 86.82 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.869 -1.06 . . . . 47.009999999999998 113.398 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1104 ' ' LYS . . . . . 0.478 ' O ' ' HG2' ' B' 1108 ' ' ARG . 54.1 mttm -65.98 -35.26 80.1 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.506 -0.77 . . . . 48.68 110.264 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1105 ' ' LEU . . . . . . . . . . . . . 50.2 mt -72.86 -29.5 63.25 Favored 'General case' 0 C--O 1.269 2.127 0 O-C-N 120.546 -1.346 . . . . 32.210000000000001 112.583 177.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -61.63 -49.55 76.1 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 124.648 1.179 . . . . 33.729999999999997 108.098 172.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -54.1 -40.56 67.41 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 122.753 0.421 . . . . 51.469999999999999 111.702 172.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1108 ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' B' 1104 ' ' LYS . 20.6 mmm180 -72.97 -9.92 59.25 Favored 'General case' 0 C--O 1.213 -0.847 0 O-C-N 120.241 -1.537 . . . . 43.899999999999999 113.617 177.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1109 ' ' ASN . . . . . 0.729 ' HB2' ' HB3' ' B' 1085 ' ' PRO . 8.9 m120 62.93 30.83 16.46 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.556 1.142 . . . . 44.82 110.637 172.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1110 ' ' VAL . . . . . . . . . . . . . 2.7 m -92.76 155.0 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 O-C-N 120.557 -1.34 . . . . 30.52 112.404 -172.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1111 ' ' THR . . . . . 0.545 ' HB ' ' HA ' ' B' 1088 ' ' THR . 1.2 m -82.75 92.26 7.18 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 105.883 -1.895 . . . . 27.120000000000001 105.883 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1112 ' ' VAL . . . . . 0.441 ' HB ' ' HB ' ' B' 1361 ' ' ILE . 39.9 t -88.27 121.72 38.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 O-C-N 120.322 -1.486 . . . . 26.399999999999999 110.58 -173.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1113 ' ' MET . . . . . 0.644 ' HB2' HG13 ' B' 1090 ' ' VAL . 21.0 mtp -115.95 116.72 28.44 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 104.904 -2.258 . . . . 42.920000000000002 104.904 177.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -96.19 107.83 20.22 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 117.34 -1.744 . . . . 24.149999999999999 110.893 -172.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1115 ' ' MET . . . . . 0.476 ' HB3' ' HB2' ' B' 1129 ' ' ALA . 83.5 mmm -55.16 -26.88 41.64 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 116.543 2.053 . . . . 29.949999999999999 116.543 -176.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1116 ' ' ASP . . . . . 0.662 ' HB3' ' HD1' ' B' 1092 ' ' PHE . 6.9 p-10 -86.54 -39.84 15.82 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.117 -1.856 . . . . 34.530000000000001 110.946 177.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1117 ' ' SER . . . . . . . . . . . . . 49.9 m -99.16 31.8 2.93 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-O 123.966 1.841 . . . . 33.490000000000002 111.409 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1118 ' ' VAL . . . . . 0.766 HG22 HG23 ' B' 1358 ' ' VAL . 22.0 t -64.16 119.33 54.79 Favored Pre-proline 0 C--O 1.243 0.727 0 N-CA-C 102.402 -3.185 . . . . 34.020000000000003 102.402 151.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1119 ' ' PRO . . . . . 0.574 ' HB2' HG12 ' B' 1121 ' ' ILE . 73.1 Cg_exo -62.67 159.64 36.11 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 123.0 2.467 . . . . 38.280000000000001 113.047 -176.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1120 ' ' ARG . . . . . 0.787 ' HB2' HG13 ' B' 1375 ' ' VAL . 1.9 mmp_? -77.37 50.53 0.79 Allowed 'General case' 0 C--N 1.354 0.776 0 CA-C-O 122.099 0.952 . . . . 55.049999999999997 109.826 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1121 ' ' ILE . . . . . 0.574 HG12 ' HB2' ' B' 1119 ' ' PRO . 39.0 pt -119.21 143.96 28.98 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.844 0 O-C-N 121.232 -0.918 . . . . 42.090000000000003 110.042 -169.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1122 ' ' SER . . . . . . . . . . . . . 53.6 p -9.08 -88.82 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 120.479 3.511 . . . . 38.020000000000003 120.479 -176.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1123 ' ' ARG . . . . . 0.643 ' HA ' ' HD3' ' C' ' 134' ' ' PRO 0.254 18.7 ptt180 -71.5 -30.12 65.58 Favored 'General case' 0 C--N 1.357 0.892 0 CA-C-N 121.194 1.815 . . . . 34.289999999999999 114.502 178.669 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B 1124 ' ' ALA . . . . . 0.562 ' HB2' HG13 ' B' 1354 ' ' VAL . . . -58.83 -34.4 71.51 Favored 'General case' 0 C--O 1.219 -0.525 0 O-C-N 124.056 0.847 . . . . 32.350000000000001 109.851 -177.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1125 ' ' GLN . . . . . 0.401 ' NE2' ' HB3' ' B' 1131 ' ' SER . 0.0 OUTLIER -59.2 -9.06 1.86 Allowed 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 117.473 2.397 . . . . 47.170000000000002 117.473 176.909 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B 1126 ' ' SER . . . . . 0.54 ' HA ' ' HB1' ' A' 1159 ' ' ALA . 22.9 p -90.9 -32.95 15.81 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.863 1.211 . . . . 31.710000000000001 112.687 169.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1127 ' ' LEU . . . . . 0.601 ' HG ' ' HA ' ' B' 1334 ' ' LEU . 4.1 mp -71.36 -30.06 65.71 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 111.726 -2.488 . . . . 37.0 110.71 175.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1128 ' ' ASP . . . . . 0.402 ' CG ' HH12 ' B' 1120 ' ' ARG . 9.9 t70 -62.56 127.36 30.92 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 115.694 1.738 . . . . 40.399999999999999 115.694 -176.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1129 ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' B' 1115 ' ' MET . . . -70.06 -38.02 75.65 Favored 'General case' 0 C--O 1.212 -0.869 0 CA-C-N 113.746 -1.57 . . . . 26.559999999999999 108.1 177.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 36.2 mt -66.79 -13.85 61.96 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 115.039 1.496 . . . . 30.890000000000001 115.039 -174.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1131 ' ' SER . . . . . 0.401 ' HB3' ' NE2' ' B' 1125 ' ' GLN . 66.5 p -69.24 -56.17 8.37 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 105.507 -2.035 . . . . 29.84 105.507 167.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1132 ' ' SER . . . . . . . . . . . . . 67.5 m -55.05 -55.64 28.74 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 124.332 1.053 . . . . 31.91 113.616 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1133 ' ' MET . . . . . . . . . . . . . 32.2 mmt -54.32 -45.1 72.54 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.463 0.705 . . . . 25.899999999999999 111.757 176.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1134 ' ' ALA . . . . . 0.436 ' HB1' ' N ' ' B' 1176 ' ' ALA . . . -56.64 -52.57 64.38 Favored 'General case' 0 C--O 1.209 -1.049 0 C-N-CA 119.477 -0.889 . . . . 26.620000000000001 112.898 170.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1135 ' ' ASN . . . . . 0.484 ' HA ' ' HB2' ' B' 1179 ' ' ALA . 0.1 OUTLIER -53.66 -33.41 55.18 Favored 'General case' 0 C--O 1.22 -0.491 0 O-C-N 120.807 -1.183 . . . . 36.969999999999999 113.809 174.162 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B 1136 ' ' ILE . . . . . 0.464 HG21 ' HA ' ' B' 1316 ' ' PRO . 37.2 mm -68.96 -54.66 19.07 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 N-CA-C 107.255 -1.387 . . . . 32.109999999999999 107.255 175.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -59.53 -30.09 68.35 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 117.087 -1.435 . . . . 24.140000000000001 111.95 -171.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -66.49 -58.05 9.21 Favored Glycine 0 N--CA 1.47 0.912 0 CA-C-N 119.27 0.941 . . . . 25.129999999999999 111.562 174.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 21.0 t80 -58.88 -49.32 78.2 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.232 -1.025 . . . . 32.729999999999997 108.232 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1140 ' ' ARG . . . . . 0.4 ' HA ' ' HB ' ' B' 1143 ' ' VAL . 12.6 tpt180 -63.49 -28.95 70.31 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-O 117.806 -1.092 . . . . 26.359999999999999 108.94 -178.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1141 ' ' ALA . . . . . 0.462 ' HA ' HG11 ' B' 1282 ' ' VAL . . . -62.2 -47.92 82.32 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 122.412 2.369 . . . . 24.120000000000001 108.809 173.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 45.7 mm -60.92 -39.36 81.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.281 1.432 . . . . 23.370000000000001 109.298 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1143 ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' B' 1140 ' ' ARG . 40.6 t -63.84 -57.72 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 124.728 1.211 . . . . 24.960000000000001 111.931 176.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -63.6 -37.94 89.25 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 119.819 -1.801 . . . . 32.07 110.991 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1145 ' ' ALA . . . . . 0.772 ' HB1' HD12 ' B' 1251 ' ' ILE . . . -53.35 -51.63 61.84 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 122.432 1.111 . . . . 24.870000000000001 113.743 170.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1146 ' ' ALA . . . . . 0.685 ' HB2' ' HE1' ' B' 1153 ' ' PHE . . . -59.15 -37.14 76.6 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 113.835 -1.53 . . . . 24.670000000000002 114.677 177.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 42.5 t60 -60.79 -22.9 64.58 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.867 1.267 . . . . 28.579999999999998 111.692 177.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1148 ' ' GLU . . . . . 0.784 ' HB3' ' HD2' ' B' 1308 ' ' LYS . 60.9 mm-40 -127.81 16.24 6.89 Favored 'General case' 0 N--CA 1.442 -0.867 0 O-C-N 119.666 -1.896 . . . . 36.82 113.625 173.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1149 ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -77.65 155.93 31.08 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 122.563 1.173 . . . . 31.969999999999999 108.621 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1150 ' ' GLY . . . . . 0.612 ' HA2' ' HD2' ' A' 1320 ' ' PRO . . . -88.72 -23.72 35.16 Favored Glycine 0 C--O 1.208 -1.507 0 O-C-N 120.146 -1.596 . . . . 25.489999999999998 111.668 176.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1151 ' ' ARG . . . . . 0.679 ' HA ' ' HB2' ' A' 1322 ' ' GLN . 71.3 mtm-85 -131.62 179.98 5.73 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.614 1.166 . . . . 59.840000000000003 112.644 -162.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1152 ' ' PHE . . . . . 0.713 ' HB2' HG11 ' B' 1163 ' ' VAL . 5.9 m-30 -83.14 163.16 21.02 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 120.941 1.7 . . . . 34.450000000000003 111.177 171.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1153 ' ' PHE . . . . . 0.685 ' HE1' ' HB2' ' B' 1146 ' ' ALA . 46.1 m-85 -85.6 -48.68 8.67 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 112.46 -2.154 . . . . 31.170000000000002 109.271 166.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1154 ' ' THR . . . . . . . . . . . . . 6.3 m -72.1 135.57 46.29 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 114.636 -1.166 . . . . 33.890000000000001 108.162 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -80.6 73.67 2.49 Favored Glycine 0 CA--C 1.543 1.843 0 N-CA-C 106.47 -2.652 . . . . 38.950000000000003 106.47 171.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -75.17 124.17 26.57 Favored 'General case' 0 C--O 1.242 0.668 0 O-C-N 120.796 -1.414 . . . . 54.229999999999997 108.065 -174.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1157 ' ' ILE . . . . . 0.411 HD12 ' HG2' ' B' 1162 ' ' LYS . 26.8 mm -73.5 100.54 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 105.07 -2.196 . . . . 51.159999999999997 105.07 169.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1158 ' ' THR . . . . . . . . . . . . . 5.6 m -99.72 151.43 21.24 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 103.591 -2.744 . . . . 49.609999999999999 103.591 -172.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -57.92 -37.44 74.07 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 121.398 1.908 . . . . 49.049999999999997 113.707 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -53.52 -35.21 60.42 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 115.854 1.798 . . . . 47.649999999999999 115.854 169.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . 157.88 175.45 28.82 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 108.813 -1.715 . . . . 45.609999999999999 108.813 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1162 ' ' LYS . . . . . 0.411 ' HG2' HD12 ' B' 1157 ' ' ILE . 82.7 mttt -83.35 145.27 29.13 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 112.932 0.715 . . . . 57.460000000000001 112.932 -177.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1163 ' ' VAL . . . . . 0.713 HG11 ' HB2' ' B' 1152 ' ' PHE . 94.5 t -94.25 142.84 25.44 Favored Pre-proline 0 N--CA 1.433 -1.296 0 N-CA-C 106.385 -1.709 . . . . 42.93 106.385 170.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1164 ' ' PRO . . . . . 0.425 ' HA ' ' HD2' ' B' 1165 ' ' PRO . 98.6 Cg_endo -81.23 133.95 8.92 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 124.989 3.793 . . . . 39.289999999999999 104.74 168.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1165 ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' B' 1164 ' ' PRO . 50.3 Cg_endo -62.55 148.46 93.3 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 125.293 3.995 . . . . 34.170000000000002 108.199 176.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -75.17 134.7 41.17 Favored 'General case' 0 C--O 1.208 -1.124 0 CA-C-N 115.213 -0.903 . . . . 31.690000000000001 111.014 172.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1167 ' ' LYS . . . . . 0.59 ' HB2' ' HA ' ' B' 1249 ' ' VAL . 98.4 mttt -91.6 113.59 25.9 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 124.05 1.881 . . . . 44.780000000000001 107.189 167.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 87.6 t -98.25 99.43 8.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 113.099 -1.864 . . . . 31.23 107.212 -174.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1169 ' ' MET . . . . . 0.781 ' HB2' HG11 ' B' 1249 ' ' VAL . 36.5 ttp -83.42 100.85 10.97 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 119.14 -1.024 . . . . 37.090000000000003 108.313 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1170 ' ' VAL . . . . . 0.519 HG22 ' HB ' ' B' 1253 ' ' VAL . 45.2 t -91.07 111.76 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 106.948 -1.501 . . . . 30.170000000000002 106.948 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1171 ' ' ILE . . . . . . . . . . . . . 2.7 mt -97.84 135.43 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 107.303 -1.369 . . . . 33.740000000000002 107.303 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 71.76 71.94 0.99 Allowed Glycine 0 C--O 1.247 0.911 0 N-CA-C 108.564 -1.815 . . . . 32.590000000000003 108.564 -177.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1173 ' ' ALA . . . . . 0.483 ' H ' ' HB2' ' B' 1195 ' ' ASP . . . -76.25 74.31 3.06 Favored 'General case' 0 N--CA 1.44 -0.956 0 O-C-N 121.176 -1.191 . . . . 32.420000000000002 112.693 -174.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -81.0 -155.68 12.87 Favored Glycine 0 N--CA 1.44 -1.073 0 N-CA-C 109.652 -1.379 . . . . 31.739999999999998 109.652 169.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 47.9 t -65.11 -38.94 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.416 0 O-C-N 122.016 -0.696 . . . . 31.48 109.146 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1176 ' ' ALA . . . . . 0.436 ' N ' ' HB1' ' B' 1134 ' ' ALA . . . -65.65 -39.81 91.79 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 122.66 1.219 . . . . 26.120000000000001 110.186 174.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1177 ' ' GLY . . . . . 0.415 ' HA2' HG11 ' B' 1170 ' ' VAL . . . -52.29 -54.68 25.54 Favored Glycine 0 CA--C 1.527 0.82 0 O-C-N 120.499 -1.376 . . . . 25.73 111.05 171.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1178 ' ' LEU . . . . . 0.676 ' HA ' HD12 ' B' 1181 ' ' ILE . 65.5 mt -57.78 -39.21 76.93 Favored 'General case' 0 C--N 1.351 0.65 0 N-CA-C 112.863 0.69 . . . . 32.590000000000003 112.863 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1179 ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' B' 1135 ' ' ASN . . . -60.67 -46.15 91.42 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 124.664 1.227 . . . . 27.719999999999999 111.777 170.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -64.71 -39.35 93.51 Favored 'General case' 0 C--O 1.249 1.075 0 O-C-N 119.884 -1.76 . . . . 26.030000000000001 111.764 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1181 ' ' ILE . . . . . 0.676 HD12 ' HA ' ' B' 1178 ' ' LEU . 37.7 mt -56.61 -60.7 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 N-CA-C 104.137 -2.542 . . . . 28.609999999999999 104.137 171.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -43.32 -49.7 6.72 Favored Glycine 0 C--O 1.214 -1.099 0 N-CA-C 116.05 1.18 . . . . 25.23 116.05 177.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1183 ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' B' 1186 ' ' SER . . . -72.59 -57.02 4.46 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 112.115 0.413 . . . . 24.09 112.115 -174.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -60.59 -41.42 94.7 Favored 'General case' 0 C--O 1.246 0.892 0 O-C-N 121.518 -0.739 . . . . 26.68 112.689 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -65.7 -32.81 74.57 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-O 118.255 -0.878 . . . . 36.57 109.946 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1186 ' ' SER . . . . . 0.471 ' HB2' ' O ' ' B' 1183 ' ' ALA . 64.8 m -57.33 -49.27 76.67 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 122.48 2.4 . . . . 28.920000000000002 108.486 167.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1187 ' ' LEU . . . . . . . . . . . . . 19.6 mt -67.88 -6.51 22.13 Favored 'General case' 0 C--N 1.365 1.267 0 N-CA-C 115.511 1.671 . . . . 29.09 115.511 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 82.39 16.11 72.22 Favored Glycine 0 N--CA 1.447 -0.584 0 O-C-N 120.285 -1.509 . . . . 29.260000000000002 113.819 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1189 ' ' ALA . . . . . . . . . . . . . . . -86.81 139.74 30.39 Favored 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 120.514 -1.58 . . . . 30.16 108.407 175.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 8.3 mt -87.08 110.33 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 105.916 -1.883 . . . . 35.810000000000002 105.916 -164.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1191 ' ' VAL . . . . . 0.491 HG21 ' HA ' ' B' 1181 ' ' ILE . 43.8 t -81.02 123.5 37.7 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 O-C-N 121.093 -1.004 . . . . 31.969999999999999 111.351 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1192 ' ' ARG . . . . . 0.737 ' HG2' ' HB2' ' B' 1210 ' ' GLU . 91.2 mtt180 -105.91 105.13 15.02 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 108.202 -1.036 . . . . 48.159999999999997 108.202 170.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -103.04 155.01 18.68 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 115.823 -2.351 . . . . 35.890000000000001 110.339 -176.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1194 ' ' PHE . . . . . 0.534 ' HB2' ' HB2' ' B' 1212 ' ' LEU . 39.5 t80 -141.42 136.84 31.75 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 106.318 -1.734 . . . . 41.880000000000003 106.318 170.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1195 ' ' ASP . . . . . 0.483 ' HB2' ' H ' ' B' 1173 ' ' ALA . 9.9 t0 -149.84 159.78 44.09 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 100.948 -3.723 . . . . 38.280000000000001 100.948 165.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1196 ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.75 -9.85 59.77 Favored 'General case' 0 N--CA 1.435 -1.206 0 O-C-N 120.892 -1.13 . . . . 40.619999999999997 112.593 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1197 ' ' ARG . . . . . 0.402 HH11 ' HD2' ' B' 1197 ' ' ARG . 31.9 mtm105 -90.53 134.3 31.18 Favored Pre-proline 0 C--O 1.25 1.115 0 O-C-N 119.992 -1.692 . . . . 53.090000000000003 107.815 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -61.81 -34.39 82.66 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 123.417 2.745 . . . . 42.560000000000002 116.378 -165.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1199 ' ' GLU . . . . . 0.574 ' O ' ' HG2' ' B' 1203 ' ' GLN . 2.8 pm0 -68.57 -17.9 64.23 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 115.018 1.488 . . . . 56.310000000000002 115.018 -165.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1200 ' ' VAL . . . . . . . . . . . . . 14.1 m -58.72 -29.05 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-N 115.137 -0.938 . . . . 42.909999999999997 113.335 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 37.9 tttm -60.3 -62.31 1.96 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.685 -1.228 . . . . 48.890000000000001 107.685 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -60.16 -26.77 66.56 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 114.909 1.448 . . . . 51.700000000000003 114.909 176.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1203 ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' B' 1199 ' ' GLU . 67.6 mm-40 -62.04 -47.82 83.0 Favored 'General case' 0 C--O 1.253 1.283 0 CA-C-N 121.104 1.775 . . . . 52.57 111.449 171.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1204 ' ' VAL . . . . . 0.56 ' HB ' ' HB3' ' B' 1209 ' ' ALA 0.257 34.5 m -67.23 -43.97 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 O-C-N 120.619 -1.3 . . . . 33.789999999999999 113.736 175.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -56.61 -52.08 66.23 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 117.068 -1.444 . . . . 36.579999999999998 110.876 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1206 ' ' SER . . . . . . . . . . . . . 90.3 p -61.46 -40.88 96.12 Favored 'General case' 0 C--O 1.253 1.288 0 CA-C-N 120.125 1.33 . . . . 39.609999999999999 112.196 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1207 ' ' MET . . . . . . . . . . . . . 11.7 ttm -72.78 -18.78 61.45 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 119.738 -1.851 . . . . 37.450000000000003 112.808 174.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 84.83 73.36 1.27 Allowed Glycine 0 C--O 1.248 0.995 0 O-C-N 119.368 -2.083 . . . . 31.870000000000001 109.933 -176.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1209 ' ' ALA . . . . . 0.56 ' HB3' ' HB ' ' B' 1204 ' ' VAL . . . -163.17 155.51 18.29 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 106.742 -1.577 . . . . 35.399999999999999 106.742 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1210 ' ' GLU . . . . . 0.737 ' HB2' ' HG2' ' B' 1192 ' ' ARG . 50.1 mt-10 -86.56 148.48 25.48 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 112.088 -2.324 . . . . 47.890000000000001 111.59 -171.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 30.7 t80 -113.92 125.3 53.88 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 120.198 -1.564 . . . . 45.530000000000001 108.14 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1212 ' ' LEU . . . . . 0.534 ' HB2' ' HB2' ' B' 1194 ' ' PHE . 44.6 mt -74.36 108.49 7.17 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 103.832 -2.655 . . . . 46.329999999999998 103.832 170.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.41 159.64 21.75 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 113.357 -1.747 . . . . 60.409999999999997 112.313 -172.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.56 145.38 54.96 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 115.19 1.552 . . . . 57.380000000000003 115.19 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 34.4 t70 . . . . . 0 C--O 1.222 -0.349 0 CA-C-N 112.911 -1.95 . . . . 65.069999999999993 107.512 173.044 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B 1230 ' ' MET . . . . . . . . . . . . . 28.2 mmt . . . . . 0 N--CA 1.445 -0.696 0 N-CA-C 107.556 -1.275 . . . . 80.319999999999993 107.556 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B 1231 ' ' SER . . . . . . . . . . . . . 18.6 m -160.25 157.63 28.49 Favored 'General case' 0 C--O 1.224 -0.286 1 O-C-N 114.94 -4.85 . . . . 79.920000000000002 104.658 -10.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.93 -175.06 3.78 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-N 121.968 2.167 . . . . 77.909999999999997 105.685 155.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 60.9 -56.48 0.09 Allowed 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 117.032 2.234 . . . . 73.879999999999995 117.032 -170.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 4.9 t80 -38.87 -33.1 0.1 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.313 1.445 . . . . 68.980000000000004 113.703 169.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1235 ' ' ILE . . . . . 0.514 ' O ' ' HG2' ' B' 1239 ' ' MET . 35.9 pt -36.48 -39.63 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.384 0 N-CA-C 116.967 2.21 . . . . 64.530000000000001 116.967 167.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1236 ' ' LYS . . . . . 0.487 ' HA ' ' HD3' ' B' 1236 ' ' LYS . 71.2 mmtt -62.52 -51.03 69.04 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 122.903 0.481 . . . . 66.359999999999999 110.986 175.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -67.26 -33.72 75.91 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 125.29 1.619 . . . . 56.600000000000001 109.15 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -56.71 -52.77 63.68 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 120.637 1.562 . . . . 56.789999999999999 109.805 171.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1239 ' ' MET . . . . . 0.514 ' HG2' ' O ' ' B' 1235 ' ' ILE . 31.1 mmt -56.44 -47.2 79.6 Favored 'General case' 0 C--O 1.238 0.471 0 O-C-N 124.558 1.161 . . . . 53.630000000000003 113.38 176.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -63.63 -25.63 68.31 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 115.211 1.56 . . . . 51.740000000000002 115.211 175.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 13.1 tp -67.06 -46.25 74.91 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 105.483 -2.043 . . . . 44.859999999999999 105.483 174.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 8.4 m-30 -70.48 -45.13 66.3 Favored 'General case' 0 C--O 1.216 -0.701 0 O-C-N 120.268 -1.52 . . . . 42.780000000000001 106.999 -173.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -52.82 -43.08 65.71 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.343 1.238 . . . . 40.960000000000001 114.343 171.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -62.78 -29.74 70.94 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 115.813 1.782 . . . . 43.060000000000002 115.813 170.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -79.72 -24.76 41.42 Favored 'General case' 0 C--O 1.202 -1.445 0 CA-C-O 117.013 -1.47 . . . . 46.450000000000003 113.03 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -35.2 -40.45 0.13 Allowed 'General case' 0 C--O 1.241 0.636 1 N-CA-C 121.959 4.059 . . . . 41.780000000000001 121.959 -174.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1247 ' ' LYS . . . . . 0.491 ' HA ' ' HB2' ' B' 1276 ' ' LYS . 7.9 mptt -101.74 -4.9 25.65 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-N 120.379 1.445 . . . . 52.200000000000003 113.866 175.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1248 ' ' GLU . . . . . 0.483 ' HB3' ' HD2' ' B' 1167 ' ' LYS . 36.2 mt-10 -81.74 -63.23 1.43 Allowed 'General case' 0 C--O 1.25 1.125 0 N-CA-C 108.006 -1.109 . . . . 53.549999999999997 108.006 167.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1249 ' ' VAL . . . . . 0.781 HG11 ' HB2' ' B' 1169 ' ' MET . 21.7 m -65.69 154.41 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 123.963 1.84 . . . . 34.409999999999997 115.146 -168.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1250 ' ' ASP . . . . . 0.441 ' O ' ' HB3' ' B' 1279 ' ' SER . 2.8 m-20 -118.1 -56.56 2.16 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 105.271 -2.122 . . . . 33.380000000000003 105.271 -177.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1251 ' ' ILE . . . . . 0.772 HD12 ' HB1' ' B' 1145 ' ' ALA . 32.5 mm -110.73 109.02 26.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 O-C-N 119.782 -1.824 . . . . 29.539999999999999 106.881 -169.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1252 ' ' ILE . . . . . 0.435 HD11 ' SD ' ' B' 1275 ' ' MET . 47.1 mt -88.59 117.86 32.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 119.833 -1.792 . . . . 32.439999999999998 108.545 171.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1253 ' ' VAL . . . . . 0.519 ' HB ' HG22 ' B' 1170 ' ' VAL . 74.0 t -104.28 94.34 3.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 100.286 -3.968 . . . . 30.57 100.286 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1254 ' ' THR . . . . . . . . . . . . 0.294 6.5 t -94.78 101.56 13.39 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 125.681 2.658 . . . . 35.039999999999999 109.257 -176.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1255 ' ' THR . . . . . 0.446 HG23 HD22 ' B' 1284 ' ' LEU . 33.3 m -100.72 -21.11 15.31 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 109.192 -3.64 . . . . 34.619999999999997 113.933 -163.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . -62.17 139.25 58.48 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-O 122.877 1.323 . . . . 42.719999999999999 113.051 -162.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 5.6 tt -153.61 126.8 8.47 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 111.165 -2.743 . . . . 52.43 104.945 175.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1258 ' ' ILE . . . . . 0.692 ' HB ' ' HB2' ' B' 1261 ' ' LYS . 58.3 mt -85.69 118.21 70.19 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 101.34 -3.578 . . . . 59.409999999999997 101.34 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -51.37 92.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 124.877 3.718 . . . . 62.68 114.974 -175.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 130.46 -64.27 0.61 Allowed Glycine 0 N--CA 1.425 -2.061 0 N-CA-C 107.008 -2.437 . . . . 64.159999999999997 107.008 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1261 ' ' LYS . . . . . 0.692 ' HB2' ' HB ' ' B' 1258 ' ' ILE . 79.7 mttt -59.1 166.52 2.66 Favored Pre-proline 0 CA--C 1.51 -0.58 0 C-N-CA 125.992 1.717 . . . . 68.530000000000001 115.582 171.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -67.67 166.45 24.09 Favored 'Trans proline' 0 C--O 1.249 1.034 0 C-N-CA 122.659 2.239 . . . . 61.990000000000002 114.459 169.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1263 ' ' ALA . . . . . 0.427 ' HB1' ' ND2' ' B' 1291 ' ' ASN . . . -54.71 126.92 59.02 Favored Pre-proline 0 C--O 1.25 1.091 0 CA-C-N 111.819 -2.446 . . . . 57.149999999999999 111.52 166.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -60.95 141.49 94.68 Favored 'Trans proline' 0 C--N 1.324 -0.745 0 C-N-CA 123.998 3.132 . . . . 51.57 109.57 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -77.22 73.34 3.8 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-N 114.998 -1.001 . . . . 54.549999999999997 112.724 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 43.1 mt -76.02 -40.18 54.1 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 115.217 1.562 . . . . 46.859999999999999 115.217 -170.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1267 ' ' ILE . . . . . 0.48 HG21 HD13 ' B' 1281 ' ' ILE . 40.1 mm -110.72 119.75 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 106.432 -1.692 . . . . 41.039999999999999 106.432 -173.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1268 ' ' THR . . . . . 0.437 ' O ' HG23 ' B' 1272 ' ' VAL . 19.0 p -84.13 159.0 21.18 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 113.03 -1.895 . . . . 39.579999999999998 110.108 177.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1269 ' ' ARG . . . . . 0.494 ' HG3' ' HB2' ' B' 1293 ' ' GLU . 64.8 mtt85 -63.62 -33.6 75.98 Favored 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 120.689 -1.257 . . . . 53.149999999999999 111.03 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -64.4 -43.91 92.93 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 109.046 -0.724 . . . . 42.960000000000001 109.046 176.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1271 ' ' MET . . . . . . . . . . . . . 5.8 ttm -62.18 -40.45 96.06 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 114.516 1.302 . . . . 43.890000000000001 114.516 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1272 ' ' VAL . . . . . 0.545 HG21 ' HD2' ' B' 1294 ' ' TYR . 53.7 t -56.62 -59.12 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 120.339 -0.544 . . . . 38.369999999999997 111.53 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -66.84 -25.15 66.29 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 122.779 1.275 . . . . 47.460000000000001 114.02 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1274 ' ' SER . . . . . . . . . . . . . 33.2 m -74.71 -17.13 60.71 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 118.262 -2.774 . . . . 38.380000000000003 114.131 170.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1275 ' ' MET . . . . . 0.435 ' SD ' HD11 ' B' 1252 ' ' ILE . 34.0 mtp -69.12 163.64 24.35 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 121.388 1.904 . . . . 37.810000000000002 112.808 -174.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1276 ' ' LYS . . . . . 0.491 ' HB2' ' HA ' ' B' 1247 ' ' LYS . 87.8 tttt -56.04 126.32 25.41 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 113.131 -1.85 . . . . 49.259999999999998 108.778 167.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1277 ' ' ALA . . . . . 0.556 ' HB3' ' HD1' ' A' 1045 ' ' PHE . . . -83.47 169.85 15.07 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 120.559 1.527 . . . . 34.460000000000001 114.003 -167.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 62.32 41.64 99.74 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-O 122.995 1.331 . . . . 33.530000000000001 110.639 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1279 ' ' SER . . . . . 0.441 ' HB3' ' O ' ' B' 1250 ' ' ASP . 70.4 m -134.59 158.98 42.62 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 110.204 -2.998 . . . . 31.309999999999999 104.224 -172.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1280 ' ' VAL . . . . . 0.662 HG11 ' HA ' ' B' 1145 ' ' ALA . 41.4 t -128.66 142.1 44.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 106.708 -1.59 . . . . 29.32 106.708 -169.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1281 ' ' ILE . . . . . 0.48 HD13 HG21 ' B' 1267 ' ' ILE . 43.4 mt -113.31 113.22 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 103.002 -2.962 . . . . 31.93 103.002 167.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1282 ' ' VAL . . . . . 0.462 HG11 ' HA ' ' B' 1141 ' ' ALA . 5.1 t -97.09 127.57 49.17 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 N-CA-C 105.873 -1.899 . . . . 29.48 105.873 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1283 ' ' ASP . . . . . 0.566 ' HB3' ' HA2' ' B' 1311 ' ' GLY . 12.8 t0 -100.12 115.37 29.65 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 104.387 -2.449 . . . . 34.5 104.387 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1284 ' ' LEU . . . . . 0.542 ' HA ' HD12 ' B' 1315 ' ' LEU . 6.9 mp -82.01 -22.74 36.35 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.727 1.01 . . . . 37.939999999999998 113.727 -178.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -118.45 30.72 7.05 Favored 'General case' 0 N--CA 1.428 -1.551 0 O-C-N 119.374 -2.079 . . . . 40.920000000000002 111.115 -165.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -51.72 -38.2 54.24 Favored 'General case' 0 C--O 1.248 0.987 0 N-CA-C 117.647 2.462 . . . . 44.390000000000001 117.647 -169.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1287 ' ' GLN . . . . . 0.78 ' HB3' HG23 ' B' 1313 ' ' THR . 3.7 pm0 -65.31 -22.98 66.9 Favored 'General case' 0 C--O 1.268 2.049 0 N-CA-C 117.226 2.306 . . . . 51.460000000000001 117.226 176.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 20.7 m120 -110.31 73.31 0.83 Allowed 'General case' 0 C--N 1.35 0.604 0 N-CA-C 105.65 -1.981 . . . . 57.75 105.65 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1289 ' ' GLY . . . . . . . . . . . . . . . 87.08 -64.05 3.93 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-O 116.443 -2.31 . . . . 49.850000000000001 112.484 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 106.26 120.61 4.68 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 118.903 1.352 . . . . 45.93 112.03 -167.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1291 ' ' ASN . . . . . 0.427 ' ND2' ' HB1' ' B' 1263 ' ' ALA . 2.1 m-80 -69.6 -36.95 76.66 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.37 1.468 . . . . 42.670000000000002 112.368 176.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1292 ' ' CYS . . . . . . . . . . . . . 31.5 t -99.16 145.37 27.27 Favored 'General case' 0 C--O 1.253 1.257 0 CA-C-N 123.216 2.735 . . . . 38.82 108.401 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1293 ' ' GLU . . . . . 0.494 ' HB2' ' HG3' ' B' 1269 ' ' ARG . 67.6 mt-10 -60.47 -29.94 69.36 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 114.93 1.456 . . . . 46.710000000000001 114.93 175.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1294 ' ' TYR . . . . . 0.545 ' HD2' HG21 ' B' 1272 ' ' VAL . 21.3 m-85 -72.09 -16.7 62.02 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 116.396 1.998 . . . . 47.229999999999997 116.396 176.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1295 ' ' THR . . . . . 0.579 HG23 ' HA3' ' B' 1311 ' ' GLY . 85.9 m -56.19 122.35 11.55 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 123.854 1.788 . . . . 36.020000000000003 115.756 -165.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 7.2 t -107.03 124.18 36.11 Favored Pre-proline 0 N--CA 1.438 -1.054 1 N-CA-C 100.147 -4.02 . . . . 37.259999999999998 100.147 175.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -62.67 107.74 0.64 Allowed 'Trans proline' 0 C--O 1.243 0.752 0 C-N-CA 123.906 3.07 . . . . 35.090000000000003 112.459 -172.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 83.01 50.93 4.39 Favored Glycine 0 C--O 1.252 1.265 0 N-CA-C 108.035 -2.026 . . . . 35.969999999999999 108.035 173.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -151.74 145.25 24.87 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-O 122.181 0.991 . . . . 40.390000000000001 109.706 175.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1300 ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' B' 1310 ' ' ILE . 77.1 mt -80.49 130.07 36.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 103.877 -2.638 . . . . 37.43 103.877 156.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 4.5 t80 -121.94 120.79 35.47 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 104.758 -2.312 . . . . 44.130000000000003 104.758 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1302 ' ' THR . . . . . . . . . . . . . 59.6 m -83.51 133.97 34.86 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.325 -1.307 . . . . 39.780000000000001 108.264 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1303 ' ' THR . . . . . 0.519 HG21 HG11 ' B' 1272 ' ' VAL . 14.0 p -97.75 179.74 4.72 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 121.105 -0.997 . . . . 43.289999999999999 112.155 175.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -60.19 -51.69 68.51 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.64 0.733 . . . . 53.07 111.457 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 43.9 p-10 -74.57 -17.18 60.77 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 116.351 1.982 . . . . 43.969999999999999 116.351 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 85.25 33.69 16.6 Favored Glycine 0 N--CA 1.468 0.799 0 CA-C-N 114.626 -1.17 . . . . 41.119999999999997 113.994 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1307 ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' B' 1279 ' ' SER . 99.8 t -92.08 94.1 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 N-CA-C 105.374 -2.084 . . . . 38.119999999999997 105.374 163.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1308 ' ' LYS . . . . . 0.784 ' HD2' ' HB3' ' B' 1148 ' ' GLU . 80.7 mttt -78.59 119.72 22.27 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.649 -1.614 . . . . 36.340000000000003 109.662 -165.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1309 ' ' VAL . . . . . 0.412 HG22 HD12 ' B' 1281 ' ' ILE . 59.4 t -90.01 97.18 6.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 125.084 2.373 . . . . 30.399999999999999 109.195 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1310 ' ' ILE . . . . . 0.502 HD11 ' HB2' ' B' 1148 ' ' GLU . 14.1 mt -87.39 80.21 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.891 0 CA-C-N 112.239 -2.255 . . . . 30.82 105.314 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1311 ' ' GLY . . . . . 0.579 ' HA3' HG23 ' B' 1295 ' ' THR . . . -81.41 109.42 3.0 Favored Glycine 0 CA--C 1.503 -0.71 0 O-C-N 119.897 -1.752 . . . . 26.530000000000001 109.847 -179.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1312 ' ' TYR . . . . . 0.426 ' HB2' ' HG ' ' B' 1315 ' ' LEU . 9.8 m-30 -120.23 124.99 47.03 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 119.741 3.237 . . . . 38.0 119.741 -176.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1313 ' ' THR . . . . . 0.78 HG23 ' HB3' ' B' 1287 ' ' GLN . 4.0 m -69.65 -33.02 72.02 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.3 -1.773 . . . . 29.800000000000001 110.419 164.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -118.74 24.14 11.05 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 114.145 -1.389 . . . . 39.039999999999999 114.001 -157.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1315 ' ' LEU . . . . . 0.542 HD12 ' HA ' ' B' 1284 ' ' LEU . 18.7 mt -52.1 -41.93 83.08 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 114.728 1.381 . . . . 31.079999999999998 114.728 176.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1316 ' ' PRO . . . . . 0.464 ' HA ' HG21 ' B' 1136 ' ' ILE . 96.2 Cg_exo -67.17 -36.84 20.19 Favored 'Trans proline' 0 CA--C 1.499 -1.252 0 CA-C-N 123.831 2.404 . . . . 26.100000000000001 113.094 168.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1317 ' ' GLY . . . . . 0.695 ' HA2' ' HG3' ' B' 1015 ' ' ARG . . . -60.29 -44.96 96.96 Favored Glycine 0 CA--C 1.503 -0.685 0 CA-C-N 120.512 1.506 . . . . 23.170000000000002 110.606 -177.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 56.1 mtt-85 -66.95 -0.21 2.96 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 116.149 1.907 . . . . 40.399999999999999 116.149 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 22.6 tp -120.37 78.79 27.73 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 105.325 -2.102 . . . . 23.600000000000001 105.325 172.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1320 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -58.41 -64.78 0.1 Allowed 'Trans proline' 0 CA--C 1.552 1.397 0 C-N-CA 125.158 3.905 . . . . 22.350000000000001 113.956 -161.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1321 ' ' THR . . . . . . . . . . . . . 6.3 m -66.16 -40.96 90.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 121.149 1.795 . . . . 26.52 112.874 -175.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1322 ' ' GLN . . . . . 0.703 ' HB2' ' HA ' ' A' 1151 ' ' ARG . 60.0 tp60 -69.67 -43.57 72.27 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 120.262 1.392 . . . . 24.379999999999999 110.83 -174.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1323 ' ' SER . . . . . . . . . . . . . 21.0 m -56.13 -50.22 71.72 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 119.217 -0.993 . . . . 22.800000000000001 111.091 170.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1324 ' ' SER . . . . . . . . . . . . . 15.1 m -57.57 -34.56 69.34 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 123.242 1.496 . . . . 21.25 112.731 176.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1325 ' ' GLN . . . . . 0.684 HE22 ' HB3' ' B' 1021 ' ' LYS . 9.3 tp-100 -67.23 -55.73 12.8 Favored 'General case' 0 N--CA 1.438 -1.036 0 O-C-N 119.594 -1.941 . . . . 31.34 111.387 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1326 ' ' LEU . . . . . 0.448 ' HG ' HE21 ' B' 1322 ' ' GLN . 45.0 mt -69.32 -40.41 77.63 Favored 'General case' 0 N--CA 1.435 -1.19 0 O-C-N 120.886 -1.134 . . . . 31.559999999999999 111.764 -173.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1327 ' ' TYR . . . . . 0.406 ' O ' ' HG ' ' B' 1331 ' ' LEU . 27.4 t80 -53.42 -53.31 53.15 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.428 -1.323 . . . . 22.73 107.428 171.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1328 ' ' GLY . . . . . . . . . . . . . . . -44.84 -56.89 5.6 Favored Glycine 0 C--O 1.254 1.381 0 C-N-CA 124.539 1.066 . . . . 21.91 114.335 172.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1329 ' ' THR . . . . . . . . . . . . . 19.3 m -69.84 -23.64 63.32 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 121.428 -1.042 . . . . 22.149999999999999 110.421 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1330 ' ' ASN . . . . . . . . . . . . . 31.6 m120 -66.3 -42.66 87.99 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.076 -1.64 . . . . 26.18 107.004 172.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1331 ' ' LEU . . . . . 0.945 HD13 HD13 ' B' 1070 ' ' LEU . 41.5 mt -66.6 -39.13 88.23 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.569 -0.9 . . . . 23.68 108.569 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1332 ' ' VAL . . . . . 0.531 HG12 ' HE3' ' B' 1336 ' ' LYS . 70.3 t -58.69 -46.73 90.35 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-O 116.958 -1.496 . . . . 26.57 108.622 171.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -56.53 -43.11 79.53 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 121.018 1.736 . . . . 28.079999999999998 113.592 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1334 ' ' LEU . . . . . 0.601 ' HA ' ' HG ' ' B' 1127 ' ' LEU . 46.9 tp -59.6 -50.76 72.64 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 113.82 -1.536 . . . . 27.43 107.855 175.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1335 ' ' LEU . . . . . 0.507 HD23 HD12 ' B' 1338 ' ' LEU . 65.1 mt -69.77 -23.99 63.44 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 119.011 -2.306 . . . . 30.5 111.841 -177.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1336 ' ' LYS . . . . . 0.531 ' HE3' HG12 ' B' 1332 ' ' VAL . 90.9 mttt -64.42 -40.28 95.46 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 122.81 2.55 . . . . 41.649999999999999 109.891 169.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 12.4 tp -77.75 -31.09 51.91 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 113.472 0.916 . . . . 42.079999999999998 113.472 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1338 ' ' LEU . . . . . 0.507 HD12 HD23 ' B' 1335 ' ' LEU . 95.1 mt -78.64 -69.77 0.54 Allowed 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 122.281 1.039 . . . . 35.030000000000001 109.61 173.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 42.4 t -81.1 72.35 8.12 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 124.397 2.046 . . . . 37.329999999999998 107.584 -174.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 58.9 mttp -70.18 -19.25 63.2 Favored 'General case' 0 CA--C 1.5 -0.952 0 O-C-N 118.376 -2.703 . . . . 50.509999999999998 114.929 -178.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -78.14 -9.18 59.06 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 113.169 0.803 . . . . 54.210000000000001 113.169 168.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 44.9 mttt 48.11 56.23 7.61 Favored 'General case' 0 C--N 1.364 1.224 0 C-N-CA 124.96 1.304 . . . . 50.990000000000002 113.359 -173.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 26.6 p-10 -122.38 -47.87 2.1 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.857 -0.737 . . . . 48.82 111.17 -172.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 150.37 -3.71 0.56 Allowed Glycine 0 CA--C 1.54 1.623 0 CA-C-O 123.369 1.538 . . . . 40.43 111.195 172.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 22.9 t30 -79.64 116.4 19.81 Favored 'General case' 0 N--CA 1.428 -1.53 0 O-C-N 119.463 -2.198 . . . . 47.560000000000002 114.292 175.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1346 ' ' ILE . . . . . . . . . . . . . 40.4 mm -59.74 97.62 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.246 0.902 0 CA-C-O 123.204 1.478 . . . . 42.490000000000002 112.234 169.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1347 ' ' THR . . . . . . . . . . . . . 48.2 m -101.38 93.99 5.69 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 113.394 -1.73 . . . . 38.119999999999997 107.504 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 85.5 t -87.0 94.84 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 O-C-N 119.309 -2.119 . . . . 37.5 107.802 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 16.2 t70 -75.12 101.97 4.75 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 107.228 -1.397 . . . . 43.850000000000001 107.228 170.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1350 ' ' PHE . . . . . 0.715 ' HE1' ' HB ' ' B' 1359 ' ' THR . 0.1 OUTLIER -75.98 -5.24 45.39 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 113.244 -1.798 . . . . 39.810000000000002 113.168 -179.284 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 24.2 t70 -79.81 -42.65 23.95 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 120.341 -1.474 . . . . 51.289999999999999 107.706 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 20.1 t0 -57.11 113.54 1.76 Allowed 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 122.756 1.265 . . . . 39.780000000000001 109.865 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 15.1 m -46.27 -35.24 2.31 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 CA-C-N 113.502 -1.681 . . . . 39.280000000000001 114.443 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1354 ' ' VAL . . . . . 0.562 HG13 ' HB2' ' B' 1124 ' ' ALA . 47.4 t -67.72 -50.53 59.69 Favored 'Isoleucine or valine' 0 C--O 1.263 1.794 0 O-C-N 124.72 1.262 . . . . 35.700000000000003 110.751 177.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1355 ' ' ILE . . . . . 0.575 ' HA ' HG12 ' B' 1358 ' ' VAL . 34.7 mm -69.0 -40.2 80.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 CA-C-N 120.046 1.294 . . . . 35.770000000000003 108.902 178.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 43.8 tpt85 -52.52 -32.18 39.16 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 125.44 1.496 . . . . 38.549999999999997 111.662 168.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -74.14 -59.64 3.86 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 110.229 -1.149 . . . . 29.579999999999998 110.229 176.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1358 ' ' VAL . . . . . 0.766 HG23 HG22 ' B' 1118 ' ' VAL . 11.6 p -60.32 -38.55 77.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-N 118.393 1.096 . . . . 32.060000000000002 111.634 -172.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1359 ' ' THR . . . . . 0.715 ' HB ' ' HE1' ' B' 1350 ' ' PHE . 5.6 m -81.78 92.17 6.61 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 123.049 1.404 . . . . 29.0 107.695 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1360 ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' B' 1368 ' ' TRP . 31.2 m -82.27 -17.88 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 110.771 -2.922 . . . . 29.68 113.903 -176.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1361 ' ' ILE . . . . . 0.461 HG12 ' HA ' ' B' 1366 ' ' ILE . 48.6 mt -133.7 106.88 9.68 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 N-CA-C 101.274 -3.602 . . . . 32.049999999999997 101.274 168.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1362 ' ' ARG . . . . . 0.53 HH11 ' HB2' ' B' 1350 ' ' PHE . 46.8 ttt180 -87.62 78.04 8.59 Favored 'General case' 0 C--O 1.243 0.727 0 O-C-N 118.341 -2.725 . . . . 32.520000000000003 109.182 174.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 58.62 89.1 0.06 Allowed 'General case' 0 C--O 1.246 0.912 0 CA-C-N 112.488 -2.142 . . . . 35.68 114.161 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 88.56 -72.68 2.3 Favored Glycine 0 N--CA 1.477 1.43 0 CA-C-N 114.733 -1.122 . . . . 34.259999999999998 111.253 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.03 117.64 6.73 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.182 0.993 . . . . 51.07 110.46 176.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1366 ' ' ILE . . . . . 0.461 ' HA ' HG12 ' B' 1361 ' ' ILE . 95.9 mt -74.24 104.13 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 104.93 -2.248 . . . . 39.869999999999997 104.93 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1367 ' ' THR . . . . . . . . . . . . . 7.2 p -94.2 -1.08 54.68 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.1 -1.409 . . . . 38.009999999999998 111.985 -174.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1368 ' ' TRP . . . . . 0.467 ' HB2' ' HB ' ' B' 1360 ' ' VAL . 24.5 t90 -74.23 137.67 75.34 Favored Pre-proline 0 CA--C 1.548 0.876 0 O-C-N 120.236 -1.54 . . . . 42.140000000000001 108.009 162.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -72.94 161.22 94.17 Favored 'Cis proline' 0 CA--C 1.512 -0.624 0 CA-C-N 123.171 2.168 . . . . 43.259999999999998 116.785 -11.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1370 ' ' ALA . . . . . . . . . . . . . . . -87.38 170.42 11.99 Favored Pre-proline 0 N--CA 1.469 0.505 0 CA-C-O 117.12 -1.419 . . . . 46.520000000000003 111.072 176.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -47.93 144.26 12.1 Favored 'Trans proline' 0 CA--C 1.555 1.557 0 C-N-CA 123.43 2.753 . . . . 51.950000000000003 112.671 165.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.96 75.76 2.17 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.568 2.845 . . . . 56.270000000000003 114.85 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1373 ' ' ILE . . . . . 0.523 HG23 HG21 ' B' 1121 ' ' ILE . 0.0 OUTLIER -82.92 128.76 38.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 104.895 -2.261 . . . . 60.829999999999998 104.895 173.618 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -68.25 123.23 20.15 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 115.707 1.743 . . . . 66.099999999999994 115.707 -173.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1375 ' ' VAL . . . . . 0.787 HG13 ' HB2' ' B' 1120 ' ' ARG . 14.4 t -60.88 123.23 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 1 O-C-N 129.208 4.068 . . . . 63.469999999999999 110.922 175.835 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.23 -4.627 0 O-C-N 119.795 -1.816 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 20' ' ' ALA . . . . . 0.814 ' HA ' HD21 ' C' ' 171' ' ' LEU . . . . . . . . 0 C--O 1.242 0.702 0 CA-C-O 118.828 -0.606 . . . . 0.0 111.508 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -45.33 -30.25 1.25 Allowed 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 117.454 2.39 . . . . 0.0 117.454 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -46.57 -40.19 12.34 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.991 1.716 . . . . 0.0 109.436 177.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 23' ' ' THR . . . . . 0.501 ' HA ' HD22 ' C' ' 26' ' ' LEU . 22.4 m -55.97 -29.23 59.9 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -178.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.55 -47.28 86.25 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.276 -1.515 . . . . 0.0 111.104 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -66.56 -34.36 77.73 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.327 1.051 . . . . 0.0 108.284 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.501 HD22 ' HA ' ' C' ' 23' ' ' THR . 2.2 mp -70.06 -31.31 68.86 Favored 'General case' 0 N--CA 1.426 -1.663 0 C-N-CA 123.825 0.85 . . . . 0.0 110.827 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 63.0 mt -61.14 -48.08 83.24 Favored 'General case' 0 CA--C 1.518 -0.282 0 O-C-N 119.431 -2.043 . . . . 0.0 115.334 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 28' ' ' LYS . . . . . . . . . . . . . 10.2 pttm -63.98 -28.2 69.65 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 119.063 -1.055 . . . . 0.0 113.213 172.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -73.87 -35.3 64.72 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 118.632 -0.699 . . . . 0.0 112.053 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.77 ' HA ' ' HB3' ' C' ' 107' ' ' ASP . 39.6 m -56.42 -17.79 9.15 Favored 'General case' 0 C--O 1.239 0.531 1 N-CA-C 124.137 4.865 . . . . 0.0 124.137 -163.677 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 44.2 m-70 66.67 -77.31 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 125.336 1.455 . . . . 0.0 109.726 -174.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 74.2 m -97.5 160.01 14.58 Favored 'General case' 0 C--O 1.242 0.661 0 O-C-N 120.158 -1.589 . . . . 0.0 108.318 168.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 12.8 t -132.23 118.01 34.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 O-C-N 119.01 -2.306 . . . . 0.0 105.658 174.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.629 HD11 ' HB3' ' C' ' 102' ' ' ASP . 27.3 mm -104.29 124.12 58.56 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 N-CA-C 105.882 -1.895 . . . . 0.0 105.882 175.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 35' ' ' ILE . . . . . 0.583 HG12 HD12 ' C' ' 110' ' ' LEU . 92.3 mt -107.03 125.61 63.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 176.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 82.8 m -106.86 98.79 22.51 Favored Pre-proline 0 N--CA 1.44 -0.962 0 O-C-N 119.316 -2.115 . . . . 0.0 112.249 171.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 37' ' ' PRO . . . . . 0.804 ' HD2' HG12 ' C' ' 68' ' ' ILE . 84.2 Cg_exo -75.95 56.32 4.75 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.421 2.747 . . . . 0.0 114.526 175.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.92 89.03 1.42 Allowed Glycine 0 N--CA 1.443 -0.894 0 O-C-N 119.78 -1.825 . . . . 0.0 111.137 -170.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 40.1 t80 65.76 -72.71 0.07 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.895 1.278 . . . . 0.0 108.916 -177.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -28.46 -64.09 0.11 Allowed Glycine 0 C--N 1.349 1.285 0 N-CA-C 117.985 1.954 . . . . 0.0 117.985 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 9.2 ttm -49.83 -39.84 40.15 Favored 'General case' 0 C--O 1.25 1.126 0 N-CA-C 118.265 2.691 . . . . 0.0 118.265 173.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -85.35 -22.92 28.25 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 9.0 p -84.13 -38.09 13.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 O-C-N 119.078 -2.264 . . . . 0.0 110.945 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.67 9.57 2.71 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 117.4 2.37 . . . . 0.0 117.4 175.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 45' ' ' GLN . . . . . . . . . . . . 0.388 1.0 OUTLIER 41.75 48.1 3.64 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 119.124 3.009 . . . . 0.0 119.124 -159.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.51 -1.31 57.05 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.887 169.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 47' ' ' GLN . . . . . 0.526 ' O ' HG12 ' C' ' 50' ' ' VAL . 0.0 OUTLIER -50.56 -48.84 57.3 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 118.335 -0.841 . . . . 0.0 111.455 177.424 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 48' ' ' TYR . . . . . 0.645 ' HB2' ' HD3' ' C' ' 49' ' ' PRO . 18.7 m-85 -71.42 -58.01 4.09 Favored Pre-proline 0 C--O 1.247 0.964 0 CA-C-O 116.87 -1.538 . . . . 0.0 113.922 177.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 49' ' ' PRO . . . . . 0.645 ' HD3' ' HB2' ' C' ' 48' ' ' TYR . 88.5 Cg_exo -50.9 -15.05 1.55 Allowed 'Trans proline' 0 C--N 1.367 1.53 0 N-CA-C 120.412 3.197 . . . . 0.0 120.412 172.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 50' ' ' VAL . . . . . 0.526 HG12 ' O ' ' C' ' 47' ' ' GLN . 5.5 p -63.6 -29.82 48.25 Favored 'Isoleucine or valine' 0 C--O 1.246 0.87 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.294 172.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.23 93.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 117.951 -2.968 . . . . 0.0 111.148 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 52' ' ' GLU . . . . . 0.519 ' HB3' ' HB2' ' C' ' 183' ' ' LEU . 3.1 mm-40 -47.42 -48.87 26.12 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 171.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 53' ' ' ILE . . . . . . . . . . . . 0.253 8.4 tp -72.99 -46.26 52.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.902 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 60.5 m -53.13 -36.77 61.15 Favored 'General case' 0 C--O 1.256 1.419 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -52.67 -64.22 0.89 Allowed 'General case' 0 C--O 1.238 0.485 0 C-N-CA 127.045 2.138 . . . . 0.0 111.311 173.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 56' ' ' LYS . . . . . 0.411 ' HE2' ' HB2' ' C' ' 56' ' ' LYS . 3.1 mppt? -66.12 -33.09 74.99 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 117.373 -1.298 . . . . 0.0 109.732 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 50.4 mt -60.54 -45.89 92.2 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 122.372 2.351 . . . . 0.0 108.845 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 58' ' ' ARG . . . . . 0.487 ' HD2' ' HA ' ' C' ' 58' ' ' ARG . 2.3 tpt180 -66.36 -43.99 84.45 Favored 'General case' 0 C--O 1.255 1.369 0 O-C-N 121.3 -0.875 . . . . 0.0 111.747 -178.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.63 -12.56 61.09 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 121.872 0.844 . . . . 0.0 112.67 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 60' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' C' ' 60' ' ' ARG . 1.8 tpm_? -76.87 -31.82 57.06 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-O 123.822 1.772 . . . . 0.0 110.045 171.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.47 42.01 2.62 Favored Glycine 0 N--CA 1.431 -1.638 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.654 -173.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 95.3 mt -109.11 132.1 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 121.568 0.699 . . . . 0.0 109.68 -177.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -68.94 91.74 0.48 Allowed 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 122.684 1.23 . . . . 0.0 108.255 169.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 8.9 p -96.98 122.43 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-O 122.525 1.155 . . . . 0.0 109.687 176.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 65' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' C' ' 34' ' ' ILE . 17.8 mmt-85 -129.27 153.43 47.8 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 175.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 66' ' ' PHE . . . . . 0.757 ' HB2' ' HA ' ' C' ' 93' ' ' VAL . 6.1 m-85 -112.93 141.67 46.49 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -126.74 99.54 0.54 Allowed Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 107.596 -2.202 . . . . 0.0 107.596 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 68' ' ' ILE . . . . . 0.804 HG12 ' HD2' ' C' ' 37' ' ' PRO . 1.1 mt -102.92 -154.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 O-C-N 124.411 0.712 . . . . 0.0 111.384 174.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -165.2 135.2 2.9 Favored Pre-proline 0 N--CA 1.473 0.68 0 O-C-N 119.243 -2.161 . . . . 0.0 105.61 -169.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 70' ' ' PRO . . . . . 0.565 ' HB3' ' O ' ' A' 1158 ' ' THR . 14.0 Cg_endo -45.4 -61.51 0.58 Allowed 'Trans proline' 0 C--N 1.352 0.716 1 C-N-CA 126.428 4.752 . . . . 0.0 117.526 -179.351 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 14.5 m -94.42 133.41 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.93 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 174.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.57 9.34 8.99 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 117.786 2.513 . . . . 0.0 117.786 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.88 -52.28 0.65 Allowed Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 -169.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 74' ' ' ARG . . . . . 0.453 ' HA ' ' OE1' ' B' 1203 ' ' GLN . 3.3 mpt_? -147.94 177.64 9.18 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 175.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 7.0 mt 53.71 44.39 1.87 Allowed Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 119.557 3.169 . . . . 0.0 119.557 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -63.31 133.74 41.89 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.691 2.927 . . . . 0.0 113.195 -174.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.22 -70.6 1.84 Allowed Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.385 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 78' ' ' HIS . . . . . . . . . . . . 0.258 0.8 OUTLIER -36.91 -34.2 0.07 Allowed 'General case' 0 C--O 1.25 1.124 0 N-CA-C 121.648 3.944 . . . . 0.0 121.648 177.115 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -54.36 -34.13 60.54 Favored 'General case' 0 C--N 1.347 0.46 0 O-C-N 118.942 -2.348 . . . . 0.0 113.926 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -77.0 -30.38 55.89 Favored 'General case' 0 CA--C 1.501 -0.912 0 O-C-N 120.822 -1.174 . . . . 0.0 112.107 175.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 6.5 t -67.06 -39.77 84.02 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 O-C-N 120.678 -1.264 . . . . 0.0 110.689 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 95.3 mt -54.97 -36.24 65.16 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.111 0.964 . . . . 0.0 112.381 171.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.514 HD21 ' HG2' ' C' ' 37' ' ' PRO . 8.1 mp -71.72 -31.23 66.49 Favored 'General case' 0 C--O 1.249 1.04 0 CA-C-N 119.997 1.272 . . . . 0.0 112.077 176.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.13 -30.15 64.76 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.681 173.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.25 -48.37 78.52 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-O 122.024 0.916 . . . . 0.0 109.146 166.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.03 -1.38 2.05 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 119.171 -2.205 . . . . 0.0 115.827 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp 55.29 53.11 10.42 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -171.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 88' ' ' VAL . . . . . 0.501 HG21 HG13 ' C' ' 50' ' ' VAL . 14.5 t -111.27 125.55 30.33 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 101.483 -3.525 . . . . 0.0 101.483 169.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 89' ' ' PRO . . . . . 0.568 ' HG2' HG12 ' C' ' 92' ' ' ILE . 92.8 Cg_endo -61.66 120.97 8.86 Favored 'Trans proline' 0 C--O 1.241 0.653 1 C-N-CA 126.49 4.793 . . . . 0.0 115.949 -171.005 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.58 -26.73 45.32 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 126.66 1.984 . . . . 0.0 113.008 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -58.46 -51.3 70.43 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 119.965 1.257 . . . . 0.0 112.148 174.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 92' ' ' ILE . . . . . 0.568 HG12 ' HG2' ' C' ' 89' ' ' PRO . 45.2 pt -77.73 -23.11 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 119.655 -1.903 . . . . 0.0 110.575 -175.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 93' ' ' VAL . . . . . 0.757 ' HA ' ' HB2' ' C' ' 66' ' ' PHE . 67.9 t -68.35 83.55 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 174.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 20.7 mt -89.84 151.85 21.56 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 173.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 95' ' ' GLU . . . . . 0.52 ' HB2' HD13 ' A' 1157 ' ' ILE . 9.6 mp0 -138.53 127.96 24.59 Favored 'General case' 0 C--O 1.249 1.066 0 O-C-N 118.597 -2.565 . . . . 0.0 108.44 176.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 50.3 ttp 45.11 75.17 0.11 Allowed 'General case' 0 C--N 1.354 0.8 0 CA-C-O 124.872 2.272 . . . . 0.0 113.732 -177.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -145.5 164.01 32.93 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 109.994 -3.275 . . . . 0.0 106.809 -162.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -79.97 13.41 2.24 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 112.934 -1.939 . . . . 0.0 111.66 -178.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 4.2 tt -45.42 -16.35 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 124.614 1.166 . . . . 0.0 111.652 153.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 100' ' ' ASN . . . . . 0.457 ' ND2' ' HB2' ' C' ' 137' ' ' GLU . 1.7 t-20 -33.91 -35.85 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 117.108 2.262 . . . . 0.0 117.108 162.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -65.45 -62.1 1.72 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 119.336 -0.945 . . . . 0.0 111.232 172.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 102' ' ' ASP . . . . . 0.629 ' HB3' HD11 ' C' ' 34' ' ' ILE . 5.1 m-20 -51.0 -32.79 22.3 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 175.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 103' ' ' PHE . . . . . 0.448 ' HB3' ' HB ' ' C' ' 138' ' ' VAL . 3.6 m-85 -55.71 -47.97 75.95 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 125.705 1.602 . . . . 0.0 109.958 170.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -79.97 -18.33 50.62 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 119.01 0.823 . . . . 0.0 111.774 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -73.08 -47.13 47.11 Favored 'General case' 0 C--O 1.239 0.501 0 O-C-N 120.459 -1.401 . . . . 0.0 111.548 171.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 106' ' ' THR . . . . . 0.53 HG21 ' H ' ' C' ' 34' ' ' ILE . 77.0 m -54.14 133.8 44.19 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 122.342 0.257 . . . . 0.0 111.599 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 107' ' ' ASP . . . . . 0.77 ' HB3' ' HA ' ' C' ' 30' ' ' SER . 11.0 t70 -67.07 -65.59 0.66 Allowed 'General case' 0 C--O 1.234 0.252 0 O-C-N 124.076 0.86 . . . . 0.0 112.292 169.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 108' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' C' ' 143' ' ' ASN . 68.0 m -103.42 105.91 16.29 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 123.978 0.911 . . . . 0.0 109.64 -178.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 109' ' ' VAL . . . . . 0.612 HG13 ' HB ' ' C' ' 34' ' ' ILE . 16.4 t -89.54 110.97 22.35 Favored 'Isoleucine or valine' 0 C--N 1.349 0.578 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -176.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 110' ' ' LEU . . . . . 0.583 HD12 HG12 ' C' ' 35' ' ' ILE . 28.5 mt -77.96 84.26 4.25 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 123.219 1.485 . . . . 0.0 110.791 -175.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 111' ' ' VAL . . . . . 0.568 HG11 HG21 ' C' ' 118' ' ' VAL . 93.1 t -90.65 96.3 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 CA-C-O 123.154 1.454 . . . . 0.0 108.622 -177.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 112' ' ' ILE . . . . . 0.427 HD11 HG23 ' C' ' 35' ' ' ILE . 1.3 mm -83.67 89.52 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-O 124.001 1.858 . . . . 0.0 108.586 -171.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.55 -103.91 2.47 Favored Glycine 0 CA--C 1.496 -1.116 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.669 -172.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . 56.47 -57.11 0.02 OUTLIER 'General case' 0 C--O 1.249 1.063 0 N-CA-C 120.463 3.505 . . . . 0.0 120.463 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 115' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 59.67 -93.03 0.04 OUTLIER 'General case' 0 C--O 1.241 0.644 0 CA-C-N 122.553 2.433 . . . . 0.0 112.438 173.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 116' ' ' ASP . . . . . 0.765 ' HA ' ' HB2' ' C' ' 119' ' ' ASN . 34.4 m-20 -82.72 -19.38 38.11 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.123 -0.986 . . . . 0.0 111.977 -176.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 117' ' ' THR . . . . . . . . . . . . 0.254 1.0 OUTLIER -67.22 -15.28 63.61 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 176.947 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.568 HG21 HG11 ' C' ' 111' ' ' VAL . 16.5 m -122.81 30.66 2.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 124.612 1.165 . . . . 0.0 108.327 171.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 119' ' ' ASN . . . . . 0.765 ' HB2' ' HA ' ' C' ' 116' ' ' ASP . 46.7 t-20 -86.78 119.62 71.31 Favored Pre-proline 0 CA--C 1.506 -0.714 0 O-C-N 119.212 -2.18 . . . . 0.0 114.146 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 120' ' ' PRO . . . . . 0.425 ' HG3' ' CE3' ' C' ' 139' ' ' TRP . 40.7 Cg_exo -53.24 -53.22 7.05 Favored 'Trans proline' 0 C--O 1.243 0.733 0 C-N-CA 124.878 3.718 . . . . 0.0 113.127 175.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 121' ' ' ALA . . . . . 0.457 ' HA ' ' HB3' ' C' ' 124' ' ' ASP . . . -61.9 -28.09 69.27 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -174.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 122' ' ' ALA . . . . . 0.42 ' HB1' ' HB3' ' C' ' 133' ' ' MET . . . -54.51 -41.05 69.19 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-O 121.609 0.719 . . . . 0.0 111.622 172.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -92.57 -16.62 25.45 Favored 'General case' 0 C--O 1.245 0.846 0 O-C-N 118.499 -2.625 . . . . 0.0 114.074 173.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 124' ' ' ASP . . . . . 0.457 ' HB3' ' HA ' ' C' ' 121' ' ' ALA . 12.4 t70 -98.77 -35.52 10.12 Favored 'General case' 0 C--O 1.241 0.647 0 O-C-N 121.242 -0.911 . . . . 0.0 112.846 -165.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 125' ' ' ASP . . . . . 0.422 ' OD2' ' HB3' ' C' ' 127' ' ' LYS . 25.4 t70 -117.54 126.94 26.99 Favored Pre-proline 0 C--N 1.321 -0.639 0 C-N-CA 124.516 1.126 . . . . 0.0 113.112 -157.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -62.36 -38.03 56.53 Favored 'Trans proline' 0 CA--C 1.548 1.196 0 C-N-CA 124.971 3.781 . . . . 0.0 114.57 176.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 127' ' ' LYS . . . . . 0.422 ' HB3' ' OD2' ' C' ' 125' ' ' ASP . 4.2 ttpm? -63.75 -29.57 70.77 Favored 'General case' 0 C--N 1.314 -0.941 0 O-C-N 119.291 -2.131 . . . . 0.0 111.267 -178.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 128' ' ' SER . . . . . 0.471 ' HA ' HG11 ' C' ' 158' ' ' VAL . 18.4 m -58.6 127.94 82.74 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 118.074 -0.965 . . . . 0.0 111.044 172.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 129' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -56.23 -31.36 83.74 Favored 'Trans proline' 0 C--O 1.257 1.428 0 CA-C-N 122.506 1.931 . . . . 0.0 116.17 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 10.5 pt -105.78 53.53 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-O 123.246 1.498 . . . . 0.0 109.278 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.85 120.8 14.17 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 123.3 1.524 . . . . 0.0 111.811 -171.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.61 38.97 10.02 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 133' ' ' MET . . . . . 0.682 ' SD ' ' HD2' ' C' ' 134' ' ' PRO . 42.8 tpp -73.72 134.98 78.23 Favored Pre-proline 0 N--CA 1.45 -0.444 0 O-C-N 119.819 -1.989 . . . . 0.0 110.535 172.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 134' ' ' PRO . . . . . 0.682 ' HD2' ' SD ' ' C' ' 133' ' ' MET . 92.8 Cg_endo -68.25 90.24 0.39 Allowed 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 124.011 3.141 . . . . 0.0 110.418 173.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 135' ' ' VAL . . . . . 0.402 HG22 ' O ' ' C' ' 133' ' ' MET . 1.5 m -110.95 150.8 13.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -175.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 136' ' ' LEU . . . . . 0.456 ' HB2' HG12 ' C' ' 118' ' ' VAL . 28.7 mt -73.9 104.51 4.79 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.934 0.873 . . . . 0.0 112.589 -165.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 137' ' ' GLU . . . . . 0.457 ' HB2' ' ND2' ' C' ' 100' ' ' ASN . 20.4 mt-10 -64.63 110.97 2.53 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -172.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 138' ' ' VAL . . . . . 0.448 ' HB ' ' HB3' ' C' ' 103' ' ' PHE . 4.9 p -151.71 61.4 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 164.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 139' ' ' TRP . . . . . 0.425 ' CE3' ' HG3' ' C' ' 120' ' ' PRO . 4.5 m95 -81.63 136.67 35.53 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.909 -1.496 . . . . 0.0 112.837 -166.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 41.65 45.54 2.97 Favored 'General case' 0 C--O 1.243 0.755 0 O-C-N 126.886 2.616 . . . . 0.0 116.603 175.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -166.3 162.48 17.29 Favored 'General case' 0 C--N 1.345 0.402 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -170.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 59.91 163.29 0.05 Allowed 'General case' 0 C--O 1.242 0.681 0 N-CA-C 117.77 2.507 . . . . 0.0 117.77 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 143' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' C' ' 108' ' ' THR . 20.6 t-20 -82.3 68.91 8.91 Favored 'General case' 0 C--O 1.248 1.01 0 O-C-N 120.979 -1.076 . . . . 0.0 109.269 176.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 144' ' ' VAL . . . . . . . . . . . . . 26.0 t -74.88 96.56 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 113.598 -1.637 . . . . 0.0 108.627 -177.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 145' ' ' ILE . . . . . 0.461 HD11 HD13 ' C' ' 171' ' ' LEU 0.266 7.9 tp -92.1 87.31 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-O 126.416 3.008 . . . . 0.0 113.3 -170.018 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 146' ' ' VAL . . . . . 0.506 ' HA ' ' HB ' ' C' ' 111' ' ' VAL . 26.7 t -77.73 97.42 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 CA-C-N 108.761 -3.836 . . . . 0.0 111.087 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 147' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -67.1 96.24 0.44 Allowed 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 148' ' ' LYS . . . . . 0.599 ' O ' ' HA ' ' C' ' 172' ' ' PHE . 48.2 tptt -123.38 131.01 53.52 Favored 'General case' 0 C--O 1.211 -0.938 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -174.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 9.8 tpp85 -63.65 -49.26 73.92 Favored 'General case' 0 C--O 1.256 1.437 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -171.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 150' ' ' SER . . . . . 0.508 ' O ' ' HE3' ' C' ' 148' ' ' LYS . 1.5 m -143.45 170.47 15.73 Favored 'General case' 0 C--O 1.249 1.073 0 O-C-N 120.86 -1.15 . . . . 0.0 108.966 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 10.5 tpt -79.17 99.11 6.84 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 176.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -155.29 157.51 37.33 Favored 'General case' 0 N--CA 1.426 -1.671 0 C-N-CA 118.131 -1.428 . . . . 0.0 109.973 -176.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 4.8 m -62.75 130.29 44.26 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 125.548 1.78 . . . . 0.0 106.639 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -72.32 -120.83 0.06 OUTLIER Glycine 0 N--CA 1.415 -2.732 0 O-C-N 120.745 -1.222 . . . . 0.0 113.387 171.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -86.41 -66.83 0.86 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 170.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 156' ' ' ALA . . . . . . . . . . . . . . . -85.18 -39.65 17.6 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 170.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 54.89 33.41 56.52 Favored Glycine 0 C--N 1.352 1.423 0 C-N-CA 124.692 1.139 . . . . 0.0 114.335 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 158' ' ' VAL . . . . . 0.471 HG11 ' HA ' ' C' ' 128' ' ' SER . 3.3 m -76.42 144.52 11.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 O-C-N 121.441 -1.035 . . . . 0.0 111.265 -173.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.58 136.43 57.98 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 -174.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 160' ' ' ASN . . . . . 0.405 ' OD1' ' HB3' ' C' ' 162' ' ' LEU . 13.8 p30 -169.72 156.54 6.19 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -171.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -54.31 -31.42 67.08 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 124.642 3.561 . . . . 0.0 115.223 177.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 162' ' ' LEU . . . . . 0.405 ' HB3' ' OD1' ' C' ' 160' ' ' ASN . 4.1 tt -68.04 -24.12 65.05 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 118.665 -2.522 . . . . 0.0 111.516 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 163' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -79.16 -10.78 59.91 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 172.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -127.57 -30.93 2.52 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 -169.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 35.8 mmtt -74.83 161.78 29.26 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.25 -170.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -89.84 -38.26 13.88 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.843 -173.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -74.25 -57.27 4.06 Favored 'General case' 0 C--O 1.243 0.716 0 O-C-N 117.329 -3.357 . . . . 0.0 106.93 172.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 168' ' ' THR . . . . . . . . . . . . 0.258 4.2 m -82.53 85.0 7.04 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 103.183 -2.895 . . . . 0.0 103.183 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -129.75 132.03 46.45 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-O 122.953 1.358 . . . . 0.0 113.607 -162.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 170' ' ' MET . . . . . 0.47 ' HA ' ' HB ' ' C' ' 146' ' ' VAL . 51.4 mtm -73.18 99.65 2.89 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 110.337 -3.119 . . . . 0.0 110.069 165.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 171' ' ' LEU . . . . . 0.814 HD21 ' HA ' ' C' ' 20' ' ' ALA . 17.4 tp -76.71 122.49 24.78 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 104.247 -2.501 . . . . 0.0 104.247 177.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 172' ' ' PHE . . . . . 0.599 ' HA ' ' O ' ' C' ' 148' ' ' LYS . 46.3 m-85 -89.26 77.93 7.37 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 120.24 -1.537 . . . . 0.0 111.792 -166.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -149.99 162.78 29.27 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-N 113.46 -1.7 . . . . 0.0 112.295 -172.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 174' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -75.0 144.91 42.88 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 -177.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.06 -39.73 93.37 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 125.367 1.667 . . . . 0.0 112.795 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.92 -51.45 18.49 Favored 'General case' 0 C--N 1.359 1.005 0 C-N-CA 117.759 -1.576 . . . . 0.0 108.511 174.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 177' ' ' ALA . . . . . . . . . . . . . . . -53.7 -55.94 21.73 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 125.939 1.696 . . . . 0.0 114.379 -168.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 4.5 m -57.99 -38.3 75.85 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-N 114.678 -1.146 . . . . 0.0 113.83 175.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 179' ' ' VAL . . . . . 0.458 ' HA ' HG12 ' C' ' 182' ' ' ILE . 40.0 t -72.24 -38.38 61.83 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -57.6 -40.71 79.68 Favored 'General case' 0 C--N 1.351 0.66 0 O-C-N 118.45 -2.656 . . . . 0.0 112.461 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -58.97 -53.37 59.15 Favored 'General case' 0 CA--C 1.552 1.022 0 O-C-N 121.506 -0.746 . . . . 0.0 111.812 170.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 182' ' ' ILE . . . . . 0.458 HG12 ' HA ' ' C' ' 179' ' ' VAL . 30.9 pt -78.15 -24.41 13.87 Favored 'Isoleucine or valine' 0 C--O 1.249 1.077 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -168.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 183' ' ' LEU . . . . . 0.519 ' HB2' ' HB3' ' C' ' 52' ' ' GLU . 4.7 pp -59.0 -24.78 63.08 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 118.831 -2.418 . . . . 0.0 114.815 171.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 28.6 tptt -96.71 -60.18 1.65 Allowed 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 175.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -88.88 107.25 18.89 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 123.172 1.463 . . . . 0.0 108.265 -171.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 186' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--O 1.218 -0.567 0 CA-C-N 114.519 -1.219 . . . . 0.0 112.352 160.851 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 48.6 t-80 . . . . . 0 CA--C 1.506 -0.723 0 N-CA-C 108.811 -0.811 . . . . 65.739999999999995 108.811 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -67.47 81.28 0.15 Allowed Glycine 0 N--CA 1.424 -2.122 0 CA-C-O 125.576 2.764 . . . . 48.659999999999997 114.539 176.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1002 ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' 1032 ' ' THR . 30.6 ttp180 -100.85 118.7 37.43 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 111.07 -2.565 . . . . 44.560000000000002 104.154 172.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1003 ' ' ILE . . . . . 0.594 HD13 HD13 ' A' 1335 ' ' LEU . 54.9 mt -101.46 101.91 12.76 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 103.332 -2.84 . . . . 34.859999999999999 103.332 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -76.41 122.25 6.37 Favored Glycine 0 C--O 1.256 1.477 0 CA-C-N 109.644 -3.434 . . . . 30.75 110.41 174.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.587 HG23 ' HB3' ' A' 1017 ' ' ALA . 49.0 mm -105.01 98.02 14.55 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 105.912 -1.884 . . . . 32.210000000000001 105.912 177.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1006 ' ' PRO . . . . . 0.444 ' HA ' ' HB2' ' A' 1036 ' ' GLU . 80.0 Cg_exo -73.81 155.16 48.92 Favored 'Trans proline' 0 CA--C 1.508 -0.8 0 C-N-CA 123.305 2.67 . . . . 32.979999999999997 112.133 167.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1007 ' ' ARG . . . . . 0.448 ' O ' ' HG3' ' A' 1009 ' ' ARG . 33.9 ttp85 -71.85 146.14 48.14 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 110.564 -3.016 . . . . 47.979999999999997 105.316 162.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1008 ' ' GLU . . . . . 0.42 ' CD ' ' HZ2' ' A' 1071 ' ' LYS . 4.2 tp10 -75.31 119.49 19.49 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 123.603 1.668 . . . . 34.700000000000003 108.254 172.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1009 ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' 1007 ' ' ARG . 25.7 mtp-105 -104.43 7.65 35.54 Favored 'General case' 0 N--CA 1.423 -1.778 0 CA-C-N 109.734 -3.394 . . . . 53.369999999999997 108.052 -172.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 19.9 tp -62.88 127.11 29.7 Favored 'General case' 0 CA--C 1.505 -0.774 0 O-C-N 118.376 -2.702 . . . . 45.07 108.171 152.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1011 ' ' THR . . . . . . . . . . . . . 7.9 m -52.95 144.42 14.89 Favored 'General case' 0 C--O 1.255 1.365 0 C-N-CA 125.06 1.344 . . . . 40.359999999999999 112.067 -173.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 57.8 t30 70.19 -35.37 0.32 Allowed 'General case' 0 C--O 1.269 2.1 0 N-CA-C 114.728 1.381 . . . . 40.609999999999999 114.728 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -74.25 99.59 3.48 Favored 'General case' 0 C--O 1.254 1.331 0 CA-C-N 120.95 1.705 . . . . 33.759999999999998 110.647 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1014 ' ' THR . . . . . 0.453 HG22 ' HB3' ' A' 1042 ' ' LEU . 5.3 p -75.81 94.83 3.37 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 112.186 -2.279 . . . . 27.890000000000001 106.314 174.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1015 ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -145.63 147.19 31.75 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 104.472 -2.418 . . . . 29.02 104.472 173.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1016 ' ' VAL . . . . . 0.539 HG11 ' HZ ' ' A' 1050 ' ' PHE . 11.7 p -110.85 160.83 9.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 O-C-N 118.791 -2.443 . . . . 28.129999999999999 106.245 168.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1017 ' ' ALA . . . . . 0.587 ' HB3' HG23 ' A' 1005 ' ' ILE . . . -69.77 -23.34 63.34 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 118.583 -2.573 . . . . 26.870000000000001 114.673 -176.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1018 ' ' ALA . . . . . 0.85 ' HB1' ' HB ' ' A' 1022 ' ' THR . . . -156.72 136.29 12.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.454 -0.943 . . . . 26.77 108.454 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1019 ' ' THR . . . . . 0.422 HG23 ' HB2' ' A' 1324 ' ' SER . 41.6 p -72.58 172.7 7.03 Favored Pre-proline 0 C--O 1.249 1.045 0 CA-C-N 119.822 1.192 . . . . 27.02 114.207 174.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1020 ' ' PRO . . . . . 0.524 ' HD2' ' CD2' ' A' 1045 ' ' PHE . 0.1 OUTLIER -49.96 -38.98 49.9 Favored 'Trans proline' 0 C--O 1.245 0.832 0 C-N-CA 123.216 2.611 . . . . 30.57 113.813 166.262 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -63.78 -39.41 94.2 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 113.029 0.752 . . . . 47.810000000000002 113.029 173.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1022 ' ' THR . . . . . 0.85 ' HB ' ' HB1' ' A' 1018 ' ' ALA . 0.2 OUTLIER -71.66 -29.48 64.67 Favored 'General case' 0 C--N 1.312 -1.039 0 O-C-N 121.124 -0.985 . . . . 30.77 113.245 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 1023 ' ' VAL . . . . . 0.689 HG22 HG11 ' A' 1033 ' ' VAL . 48.7 t -61.52 -48.49 88.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.862 0 C-N-CA 125.909 1.684 . . . . 33.590000000000003 107.416 171.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -55.94 -34.37 65.6 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 120.327 -1.483 . . . . 53.289999999999999 112.616 175.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -64.7 -47.76 77.15 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 119.792 1.178 . . . . 46.920000000000002 110.596 174.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1026 ' ' LEU . . . . . 0.711 HD21 HG22 ' A' 1332 ' ' VAL . 60.3 mt -59.14 -32.57 69.98 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.574 1.324 . . . . 37.170000000000002 114.574 177.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 1.9 tp -65.19 -34.86 79.39 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.874 -1.057 . . . . 44.439999999999998 111.689 168.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -67.49 -32.78 73.83 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 122.402 1.096 . . . . 52.579999999999998 112.22 175.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1029 ' ' LEU . . . . . 0.605 ' HA ' ' HE2' ' A' 1342 ' ' LYS . 45.2 mt -76.23 -26.11 55.72 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.446 -1.252 . . . . 45.689999999999998 110.269 171.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 84.62 43.51 6.84 Favored Glycine 0 N--CA 1.431 -1.698 0 CA-C-O 124.117 1.954 . . . . 42.090000000000003 112.679 175.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -118.53 137.71 53.03 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 104.688 -2.338 . . . . 40.719999999999999 104.688 -176.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1032 ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' 1002 ' ' ARG . 0.1 OUTLIER -78.5 113.06 16.18 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.187 -1.412 . . . . 37.770000000000003 107.187 -172.577 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 1033 ' ' VAL . . . . . 0.689 HG11 HG22 ' A' 1023 ' ' VAL . 3.1 t -85.15 134.37 27.23 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 N-CA-C 107.318 -1.364 . . . . 33.539999999999999 107.318 -174.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1034 ' ' ALA . . . . . 0.637 ' HA ' ' HB3' ' A' 1056 ' ' GLU . . . -124.86 129.57 50.67 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 116.753 -1.594 . . . . 31.68 106.742 174.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1035 ' ' VAL . . . . . 0.491 HG22 ' HB ' ' A' 1005 ' ' ILE . 90.5 t -122.16 145.84 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 123.589 2.904 . . . . 31.52 108.331 -178.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1036 ' ' GLU . . . . . 0.6 ' HG2' HG11 ' A' 1063 ' ' VAL . 0.1 OUTLIER -64.66 134.66 54.72 Favored 'General case' 0 N--CA 1.436 -1.158 0 O-C-N 125.249 1.593 . . . . 41.039999999999999 108.373 178.509 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 1037 ' ' SER . . . . . . . . . . . . . 25.5 m -75.22 122.51 23.78 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-N 115.093 -0.958 . . . . 31.829999999999998 110.422 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 91.36 21.76 33.99 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 114.764 -1.107 . . . . 29.359999999999999 112.236 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1039 ' ' ALA . . . . . 0.438 ' HA ' ' HD3' ' A' 1007 ' ' ARG . . . -87.06 -46.01 10.19 Favored 'General case' 0 CA--C 1.495 -1.172 0 O-C-N 119.952 -1.911 . . . . 27.780000000000001 109.847 -178.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -70.44 -24.73 76.55 Favored Glycine 0 C--O 1.242 0.596 0 C-N-CA 120.182 -1.008 . . . . 28.91 113.047 -170.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -61.59 -38.11 86.35 Favored 'General case' 0 CA--C 1.505 -0.756 0 O-C-N 124.314 0.655 . . . . 51.18 111.401 175.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1042 ' ' LEU . . . . . 0.453 ' HB3' HG22 ' A' 1014 ' ' THR . 16.8 mt -70.59 -58.2 3.93 Favored 'General case' 0 CA--C 1.513 -0.459 0 O-C-N 121.468 -0.77 . . . . 29.91 110.118 169.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1043 ' ' ALA . . . . . . . . . . . . . . . -65.5 3.8 0.65 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.375 1.62 . . . . 28.539999999999999 115.375 -173.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1044 ' ' SER . . . . . . . . . . . . . 49.5 m 65.73 28.77 10.96 Favored 'General case' 0 C--O 1.244 0.791 0 O-C-N 120.259 -1.526 . . . . 33.060000000000002 114.95 172.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1045 ' ' PHE . . . . . 0.524 ' CD2' ' HD2' ' A' 1020 ' ' PRO . 0.8 OUTLIER -155.81 101.33 2.12 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 101.86 -3.385 . . . . 30.289999999999999 101.86 174.069 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 4.2 p30 -73.36 161.31 30.61 Favored 'General case' 0 C--O 1.248 0.984 0 N-CA-C 117.676 2.472 . . . . 48.619999999999997 117.676 -153.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1047 ' ' ASP . . . . . 0.677 ' HA ' ' HD2' ' A' 1050 ' ' PHE . 5.5 m-20 -57.54 -23.4 50.19 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-N 112.493 -2.139 . . . . 36.740000000000002 114.993 177.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.9 -32.12 40.25 Favored 'General case' 0 C--O 1.24 0.605 0 O-C-N 121.156 -0.965 . . . . 43.729999999999997 111.298 174.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -72.09 -29.79 64.45 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.967 -0.753 . . . . 32.810000000000002 108.967 172.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1050 ' ' PHE . . . . . 0.677 ' HD2' ' HA ' ' A' 1047 ' ' ASP . 48.3 m-85 -58.42 -49.07 78.59 Favored 'General case' 0 C--N 1.346 0.442 0 N-CA-C 114.45 1.278 . . . . 31.859999999999999 114.45 165.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 6.9 t -59.16 -39.55 78.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 O-C-N 119.881 -1.762 . . . . 33.219999999999999 111.891 174.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -61.15 -40.65 94.64 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 123.244 0.617 . . . . 50.829999999999998 111.99 172.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -72.06 -23.8 61.42 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 118.98 -2.325 . . . . 33.119999999999997 110.822 173.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 101.8 49.31 1.28 Allowed Glycine 0 N--CA 1.439 -1.118 0 C-N-CA 118.247 -1.93 . . . . 35.829999999999998 112.443 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1055 ' ' ALA . . . . . 0.436 ' HB1' HG23 ' A' 1035 ' ' VAL . . . -101.98 135.89 42.76 Favored 'General case' 0 N--CA 1.423 -1.775 0 O-C-N 125.0 1.059 . . . . 34.82 111.369 175.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1056 ' ' GLU . . . . . 0.637 ' HB3' ' HA ' ' A' 1034 ' ' ALA . 46.9 tt0 -77.65 99.04 5.65 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 104.968 -2.234 . . . . 49.049999999999997 104.968 -177.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1057 ' ' ILE . . . . . 0.427 HD13 ' HB ' ' A' 1035 ' ' VAL . 32.0 mm -75.18 102.96 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 N-CA-C 108.535 -0.913 . . . . 38.530000000000001 108.535 -177.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1058 ' ' VAL . . . . . 0.403 HG23 ' HB ' ' A' 1063 ' ' VAL . 2.8 m -127.08 166.5 23.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 122.512 1.149 . . . . 42.109999999999999 108.287 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -114.47 141.34 47.81 Favored 'General case' 0 C--O 1.258 1.513 0 O-C-N 120.602 -1.311 . . . . 58.0 109.832 -161.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 44.25 -116.49 1.62 Allowed Glycine 0 N--CA 1.477 1.411 0 N-CA-C 115.736 1.055 . . . . 52.119999999999997 115.736 163.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 6.8 m120 -60.28 -38.44 83.59 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 120.153 -0.619 . . . . 54.75 110.046 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1062 ' ' SER . . . . . . . . . . . . . 14.6 m -74.66 -11.67 60.24 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 120.037 -1.664 . . . . 50.340000000000003 110.267 -173.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1063 ' ' VAL . . . . . 0.6 HG11 ' HG2' ' A' 1036 ' ' GLU . 11.6 p -88.79 -41.14 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 O-C-N 119.107 -2.246 . . . . 41.460000000000001 106.291 166.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1064 ' ' TRP . . . . . 0.513 ' CH2' ' HB3' ' A' 1079 ' ' GLU . 24.9 m95 -64.44 -24.61 67.69 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 115.283 1.586 . . . . 39.32 115.283 -174.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -87.04 79.58 8.65 Favored 'General case' 0 C--O 1.247 0.94 0 O-C-N 120.943 -1.098 . . . . 55.380000000000003 109.729 174.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1066 ' ' SER . . . . . 0.43 ' HB3' ' O ' ' A' 1002 ' ' ARG . 69.2 m -135.41 166.06 24.03 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 120.264 -0.575 . . . . 41.869999999999997 111.032 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -68.24 -35.67 78.28 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-O 121.593 0.711 . . . . 53.200000000000003 110.241 -177.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1068 ' ' ILE . . . . . 0.447 ' HB ' HG12 ' A' 1003 ' ' ILE . 4.9 mp -124.55 141.24 45.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 O-C-N 119.193 -2.192 . . . . 41.899999999999999 107.825 173.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1069 ' ' ILE . . . . . . . . . . . . . 19.5 mm -126.34 118.76 52.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 104.139 -2.541 . . . . 38.729999999999997 104.139 171.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1070 ' ' LEU . . . . . 0.756 HD21 HD11 ' A' 1335 ' ' LEU . 64.3 mt -93.02 135.74 33.92 Favored 'General case' 0 C--N 1.316 -0.859 0 O-C-N 124.419 1.075 . . . . 32.439999999999998 108.553 172.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1071 ' ' LYS . . . . . 0.42 ' HZ2' ' CD ' ' A' 1008 ' ' GLU . 14.1 mmmt -137.21 147.16 45.65 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-O 123.528 1.632 . . . . 34.649999999999999 112.714 -175.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1072 ' ' VAL . . . . . 0.581 ' HA ' ' HE2' ' A' 1327 ' ' TYR . 0.0 OUTLIER -86.75 -35.43 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 CA-C-N 110.088 -3.233 . . . . 31.32 111.094 -163.199 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -127.32 -175.96 3.59 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 106.83 -1.545 . . . . 33.939999999999998 106.83 165.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1074 ' ' ALA . . . . . 0.558 ' HB1' HD21 ' A' 1101 ' ' LEU . . . -53.97 132.68 58.46 Favored Pre-proline 0 N--CA 1.465 0.31 0 CA-C-N 113.984 -1.462 . . . . 38.039999999999999 108.247 166.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1075 ' ' PRO . . . . . 0.497 ' HG2' HD21 ' A' 1089 ' ' LEU . 92.6 Cg_exo -65.88 145.88 81.49 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 123.677 2.918 . . . . 42.68 111.551 175.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 15.3 mt -71.65 159.63 34.06 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 106.49 -1.67 . . . . 46.740000000000002 106.49 173.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -50.45 -32.45 17.95 Favored 'General case' 0 C--O 1.242 0.687 0 O-C-N 119.744 -1.848 . . . . 58.609999999999999 113.683 171.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 12.4 t0 -51.98 -60.89 2.67 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 124.294 1.038 . . . . 59.200000000000003 109.887 167.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1079 ' ' GLU . . . . . 0.513 ' HB3' ' CH2' ' A' 1064 ' ' TRP . 55.6 mt-10 -65.04 -36.83 85.62 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.047 -1.433 . . . . 50.630000000000003 114.016 -173.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1080 ' ' ILE . . . . . 0.661 ' HA ' HD23 ' A' 1083 ' ' LEU . 66.3 mt -48.0 -52.46 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.125 1.77 . . . . 51.479999999999997 109.275 171.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -66.44 -25.85 66.94 Favored 'General case' 0 CA--C 1.512 -0.518 0 O-C-N 119.323 -2.111 . . . . 50.280000000000001 113.743 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 25.8 mt -77.81 -17.76 57.1 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 115.649 -0.705 . . . . 50.210000000000001 112.207 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1083 ' ' LEU . . . . . 0.661 HD23 ' HA ' ' A' 1080 ' ' ILE . 1.2 mm? -58.84 134.1 56.59 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 119.305 -2.122 . . . . 49.060000000000002 111.329 168.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.72 152.02 42.03 Favored Pre-proline 0 N--CA 1.473 0.705 0 CA-C-O 117.832 -1.08 . . . . 51.079999999999998 109.874 -175.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -54.34 116.39 3.03 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 124.707 3.605 . . . . 49.729999999999997 110.052 172.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 110.45 -5.8 29.92 Favored Glycine 0 CA--C 1.489 -1.587 0 N-CA-C 112.3 -0.32 . . . . 47.710000000000001 112.3 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1087 ' ' THR . . . . . . . . . . . . . 84.0 m -83.54 132.84 34.9 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 118.097 -3.002 . . . . 45.469999999999999 109.905 -174.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1088 ' ' THR . . . . . . . . . . . . . 1.6 m -89.09 94.65 10.01 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.333 -1.729 . . . . 42.039999999999999 106.333 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1089 ' ' LEU . . . . . 0.56 HD13 HD11 ' A' 1083 ' ' LEU . 54.2 tp -81.36 102.35 10.4 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.182 -0.949 . . . . 38.060000000000002 109.376 176.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1090 ' ' VAL . . . . . 0.752 HG13 ' HB2' ' A' 1113 ' ' MET . 3.2 t -99.75 123.05 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 104.822 -2.288 . . . . 37.399999999999999 104.822 174.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1091 ' ' SER . . . . . 0.415 ' OG ' ' HB2' ' A' 1071 ' ' LYS . 4.9 m -153.8 165.48 35.91 Favored 'General case' 0 CA--C 1.549 0.915 0 O-C-N 120.103 -1.623 . . . . 36.159999999999997 111.319 -175.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 15.2 t80 -86.66 101.97 13.76 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 106.048 -1.834 . . . . 38.939999999999998 106.048 166.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 40.3 mm -91.56 -65.34 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 123.046 1.403 . . . . 42.170000000000002 113.256 -170.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1094 ' ' TRP . . . . . 0.454 ' CZ2' HD21 ' A' 1130 ' ' LEU . 29.7 m95 69.69 74.63 0.27 Allowed Pre-proline 0 C--N 1.354 0.773 0 CA-C-N 112.185 -2.28 . . . . 46.509999999999998 113.947 -159.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -59.03 -32.6 97.8 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 122.803 2.336 . . . . 49.759999999999998 115.301 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -63.23 -43.63 97.53 Favored 'General case' 0 C--N 1.356 0.889 0 CA-C-N 120.846 1.657 . . . . 52.619999999999997 110.834 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -66.33 -52.72 44.27 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-N 114.257 -1.338 . . . . 60.740000000000002 112.621 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1098 ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -120.48 80.43 30.2 Favored Pre-proline 0 C--O 1.239 0.528 0 O-C-N 118.111 -2.868 . . . . 58.189999999999998 115.525 -174.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.95 -28.37 58.12 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 124.667 3.578 . . . . 54.590000000000003 111.404 175.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -54.97 -48.39 73.3 Favored 'General case' 0 CA--C 1.504 -0.813 0 O-C-N 120.171 -1.58 . . . . 63.280000000000001 109.321 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1101 ' ' LEU . . . . . 0.558 HD21 ' HB1' ' A' 1074 ' ' ALA . 1.3 mp -46.98 -52.62 14.24 Favored 'General case' 0 CA--C 1.513 -0.463 0 O-C-N 125.62 1.825 . . . . 54.75 113.685 172.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1102 ' ' MET . . . . . . . . . . . . . 72.8 mmm -57.8 -49.24 77.3 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 113.497 -1.683 . . . . 52.649999999999999 109.864 -176.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1103 ' ' GLN . . . . . 0.481 ' O ' ' HG2' ' A' 1107 ' ' GLU . 33.6 mt-30 -58.66 -51.62 69.15 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 123.192 1.472 . . . . 66.260000000000005 109.025 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1104 ' ' LYS . . . . . 0.492 ' HB3' HG21 ' A' 1080 ' ' ILE . 98.7 mttt -64.47 -40.75 96.29 Favored 'General case' 0 C--O 1.239 0.539 0 O-C-N 118.599 -2.563 . . . . 63.729999999999997 110.884 -176.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 63.3 mt -69.16 -34.46 75.01 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.095 0.558 . . . . 54.68 111.117 176.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -65.3 -42.65 92.86 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 106.766 -1.568 . . . . 53.640000000000001 106.766 177.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1107 ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' 1103 ' ' GLN . 47.4 mm-40 -55.85 -40.84 73.45 Favored 'General case' 0 CA--C 1.501 -0.919 0 O-C-N 125.296 1.623 . . . . 67.239999999999995 112.826 170.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1108 ' ' ARG . . . . . 0.405 ' HA ' ' NE ' ' A' 1108 ' ' ARG . 3.4 mmp_? -65.86 -23.02 66.58 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 116.945 -1.503 . . . . 65.760000000000005 112.685 175.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 30.8 t30 61.43 60.81 1.62 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 126.895 3.236 . . . . 58.710000000000001 113.446 -175.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1110 ' ' VAL . . . . . 0.508 HG11 ' HB3' ' A' 1083 ' ' LEU . 19.3 m -122.1 157.9 26.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 111.543 -2.572 . . . . 46.630000000000003 108.558 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1111 ' ' THR . . . . . . . . . . . . . 51.6 m -94.81 109.32 21.3 Favored 'General case' 0 N--CA 1.44 -0.961 0 O-C-N 120.999 -1.063 . . . . 44.130000000000003 111.426 171.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1112 ' ' VAL . . . . . . . . . . . . . 49.8 t -99.83 119.52 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-O 122.902 1.334 . . . . 40.439999999999998 109.366 -175.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1113 ' ' MET . . . . . 0.752 ' HB2' HG13 ' A' 1090 ' ' VAL . 10.7 mtp -108.17 120.52 42.57 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 104.793 -2.299 . . . . 50.759999999999998 104.793 177.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1114 ' ' ALA . . . . . 0.497 ' HB3' ' HB2' ' A' 1117 ' ' SER . . . -107.89 108.84 20.18 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 118.204 -2.81 . . . . 35.640000000000001 108.363 -175.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1115 ' ' MET . . . . . . . . . . . . . 62.1 mmm -65.92 -19.12 65.76 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 117.947 2.573 . . . . 38.740000000000002 117.947 -173.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -71.88 -36.73 70.15 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 122.553 1.168 . . . . 40.140000000000001 108.582 166.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1117 ' ' SER . . . . . 0.497 ' HB2' ' HB3' ' A' 1114 ' ' ALA . 58.3 m -86.35 28.63 0.82 Allowed 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 115.085 1.513 . . . . 44.789999999999999 115.085 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1118 ' ' VAL . . . . . 0.533 ' HA ' HG22 ' A' 1358 ' ' VAL . 88.0 t -74.05 132.95 79.09 Favored Pre-proline 0 N--CA 1.471 0.611 0 N-CA-C 106.296 -1.742 . . . . 43.75 106.296 171.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -65.95 132.22 29.58 Favored 'Trans proline' 0 C--N 1.323 -0.777 0 C-N-CA 123.752 2.968 . . . . 48.93 108.211 175.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 30.9 mmm-85 -77.26 32.11 0.15 Allowed 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 116.667 2.099 . . . . 62.899999999999999 116.667 -164.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 31.8 pt -89.2 170.78 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 120.599 -1.313 . . . . 57.719999999999999 111.754 -169.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1122 ' ' SER . . . . . . . . . . . . . 11.4 p -57.2 -58.65 7.28 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 120.04 1.291 . . . . 57.259999999999998 114.286 -172.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 31.5 ptt85 -62.03 -19.1 62.52 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 116.576 2.065 . . . . 62.899999999999999 116.576 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -77.92 -15.99 58.56 Favored 'General case' 0 C--O 1.214 -0.77 0 O-C-N 120.254 -1.529 . . . . 49.829999999999998 113.965 172.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -56.78 -35.9 69.22 Favored 'General case' 0 C--O 1.258 1.521 0 CA-C-N 121.068 1.758 . . . . 52.369999999999997 115.019 -171.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1126 ' ' SER . . . . . . . . . . . . . 38.3 m -67.38 -23.55 65.6 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 119.51 -1.994 . . . . 42.43 111.226 176.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1127 ' ' LEU . . . . . . . . . . . . . 6.8 mp -89.79 -29.3 18.75 Favored 'General case' 0 C--O 1.221 -0.423 0 O-C-N 119.297 -2.127 . . . . 43.740000000000002 111.645 172.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 51.2 t0 -61.57 107.78 0.86 Allowed 'General case' 0 C--O 1.247 0.942 0 C-N-CA 125.358 1.463 . . . . 43.210000000000001 111.994 -170.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -71.62 -37.49 70.9 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 115.277 -0.874 . . . . 35.740000000000002 111.336 174.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1130 ' ' LEU . . . . . 0.454 HD21 ' CZ2' ' A' 1094 ' ' TRP . 45.7 mt -66.47 -16.19 63.93 Favored 'General case' 0 C--O 1.244 0.799 0 O-C-N 119.97 -1.706 . . . . 38.090000000000003 112.047 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1131 ' ' SER . . . . . 0.417 ' HA ' ' HB ' ' A' 1175 ' ' VAL . 70.6 m -86.63 -64.25 1.18 Allowed 'General case' 0 CA--C 1.55 0.959 0 O-C-N 120.656 -1.278 . . . . 36.909999999999997 109.194 163.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1132 ' ' SER . . . . . 0.566 ' HB2' ' OD1' ' A' 1330 ' ' ASN . 1.6 m -76.6 -45.27 30.92 Favored 'General case' 0 C--O 1.244 0.802 0 O-C-N 117.789 -3.069 . . . . 35.789999999999999 114.594 -166.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1133 ' ' MET . . . . . 0.833 ' HA ' HD12 ' A' 1136 ' ' ILE . 5.0 ttp -66.38 -42.81 87.39 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 122.08 2.218 . . . . 30.809999999999999 108.996 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1134 ' ' ALA . . . . . 0.635 ' HB1' ' HB2' ' A' 1176 ' ' ALA . . . -50.71 -46.57 59.02 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.627 0.973 . . . . 28.879999999999999 113.627 166.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1135 ' ' ASN . . . . . 0.553 ' ND2' ' HB2' ' A' 1179 ' ' ALA . 11.3 t-20 -62.47 -36.62 83.04 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 119.762 1.164 . . . . 40.759999999999998 111.354 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1136 ' ' ILE . . . . . 0.833 HD12 ' HA ' ' A' 1133 ' ' MET . 57.3 mt -53.02 -57.1 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 O-C-N 121.597 -0.689 . . . . 31.539999999999999 110.274 170.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -60.07 -29.71 68.74 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.57 -0.741 . . . . 29.870000000000001 112.486 175.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -64.52 -44.53 95.03 Favored Glycine 0 CA--C 1.533 1.174 0 O-C-N 120.649 -1.282 . . . . 28.73 113.757 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 43.2 t80 -60.64 -50.53 73.14 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 123.587 1.66 . . . . 30.390000000000001 107.677 173.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1140 ' ' ARG . . . . . 0.704 ' HG3' HD22 ' A' 1315 ' ' LEU . 4.0 tpt180 -61.68 -24.61 66.87 Favored 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 111.81 -2.45 . . . . 26.09 113.107 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1141 ' ' ALA . . . . . 0.627 ' HB2' HD21 ' A' 1284 ' ' LEU . . . -60.1 -38.83 84.13 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 122.136 0.97 . . . . 27.100000000000001 113.584 171.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 40.9 mm -66.43 -46.15 87.4 Favored 'Isoleucine or valine' 0 C--O 1.246 0.894 0 O-C-N 121.222 -0.924 . . . . 28.48 109.777 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 94.4 t -57.38 -60.12 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 114.394 -1.275 . . . . 23.07 110.207 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1144 ' ' GLU . . . . . 0.451 ' HG2' ' HE ' ' A' 1140 ' ' ARG . 5.4 mm-40 -72.93 -21.28 60.91 Favored 'General case' 0 CA--C 1.502 -0.879 0 O-C-N 124.262 0.976 . . . . 33.399999999999999 113.322 -175.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1145 ' ' ALA . . . . . 0.842 ' HB1' HD12 ' A' 1251 ' ' ILE . . . -55.48 -57.65 11.03 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 124.013 0.821 . . . . 24.219999999999999 108.96 163.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1146 ' ' ALA . . . . . 0.565 ' HB2' ' HE2' ' A' 1153 ' ' PHE . . . -67.43 -16.18 64.08 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 124.522 1.139 . . . . 24.890000000000001 111.96 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 66.2 t-80 -72.34 -49.3 35.32 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 117.911 -1.042 . . . . 26.73 108.397 175.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1148 ' ' GLU . . . . . 0.825 ' HB3' ' HD2' ' A' 1308 ' ' LYS . 13.1 mm-40 -81.63 -15.05 55.84 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 121.493 1.951 . . . . 39.960000000000001 115.139 175.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1149 ' ' PHE . . . . . 0.557 ' HB2' ' HA ' ' A' 1146 ' ' ALA . 0.6 OUTLIER -59.18 140.03 56.32 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 125.226 2.441 . . . . 25.870000000000001 109.767 -170.499 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 1150 ' ' GLY . . . . . . . . . . . . . . . -79.99 -35.51 27.41 Favored Glycine 0 N--CA 1.426 -2.019 0 CA-C-N 109.823 -3.353 . . . . 19.280000000000001 109.248 170.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1151 ' ' ARG . . . . . 0.568 ' HA ' ' HB2' ' B' 1322 ' ' GLN . 10.9 mtt-85 -108.48 -169.94 1.59 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.789 0.804 . . . . 39.899999999999999 112.756 -159.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1152 ' ' PHE . . . . . 0.551 ' HB2' ' HG2' ' B' 1322 ' ' GLN . 1.7 t80 -110.98 145.92 37.57 Favored 'General case' 0 C--O 1.248 0.978 0 CA-C-O 118.178 -0.915 . . . . 29.440000000000001 109.078 178.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1153 ' ' PHE . . . . . 0.565 ' HE2' ' HB2' ' A' 1146 ' ' ALA . 25.5 m-85 -66.94 -50.74 61.41 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 120.924 1.693 . . . . 32.600000000000001 114.269 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1154 ' ' THR . . . . . 0.438 HG21 HG22 ' C' ' 81' ' ' VAL . 51.6 m -93.59 134.84 35.47 Favored 'General case' 0 CA--C 1.549 0.923 0 O-C-N 120.665 -1.272 . . . . 34.640000000000001 110.653 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -76.67 69.77 2.32 Favored Glycine 0 C--N 1.338 0.651 0 O-C-N 121.53 -0.731 . . . . 37.140000000000001 112.023 176.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -81.28 151.73 27.94 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 116.107 1.891 . . . . 40.57 116.107 -175.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1157 ' ' ILE . . . . . 0.443 HG23 ' H ' ' C' ' 77' ' ' GLY . 6.9 tp -79.25 119.21 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 123.068 1.413 . . . . 44.609999999999999 110.58 165.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1158 ' ' THR . . . . . . . . . . . . . 37.7 p -92.15 -168.27 1.96 Allowed 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.489 -1.232 . . . . 40.700000000000003 109.59 174.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -76.13 -23.18 54.84 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 124.091 3.132 . . . . 40.25 108.596 173.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -85.37 -60.8 1.92 Allowed 'General case' 0 C--O 1.251 1.175 0 CA-C-N 115.804 -0.635 . . . . 38.469999999999999 110.012 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1161 ' ' GLY . . . . . 0.628 ' HA3' HG21 ' B' 1329 ' ' THR . . . 175.66 -157.55 23.98 Favored Glycine 0 CA--C 1.505 -0.575 0 O-C-N 118.625 -2.547 . . . . 37.609999999999999 110.471 -174.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1162 ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' 1163 ' ' VAL . 32.3 tttt -92.84 138.99 31.0 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 125.332 2.491 . . . . 48.899999999999999 113.335 -163.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1163 ' ' VAL . . . . . 0.527 HG11 ' HB3' ' A' 1152 ' ' PHE . 24.9 t -83.9 147.11 50.61 Favored Pre-proline 0 C--N 1.305 -1.338 0 CA-C-N 109.202 -3.636 . . . . 36.520000000000003 109.241 167.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1164 ' ' PRO . . . . . 0.435 ' HD2' ' HG2' ' B' 1325 ' ' GLN . 45.5 Cg_endo -69.58 119.75 6.66 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 124.756 3.637 . . . . 35.079999999999998 116.106 162.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1165 ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' 1164 ' ' PRO . 97.5 Cg_endo -66.16 142.96 69.5 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.612 2.208 . . . . 35.329999999999998 115.17 176.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -82.36 126.63 32.39 Favored 'General case' 0 C--N 1.343 0.295 0 O-C-N 120.389 -1.444 . . . . 34.689999999999998 112.955 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1167 ' ' LYS . . . . . 0.583 ' HB2' ' HA ' ' A' 1249 ' ' VAL . 61.7 mttp -86.52 102.07 13.77 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 106.293 -1.743 . . . . 45.359999999999999 106.293 168.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 16.2 t -88.58 86.36 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 112.567 -2.106 . . . . 31.710000000000001 110.006 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1169 ' ' MET . . . . . 0.65 ' HA ' ' O ' ' A' 1192 ' ' ARG . 62.4 ttp -79.34 103.53 9.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 123.933 1.825 . . . . 42.280000000000001 110.73 176.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 21.6 t -92.26 119.27 39.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 106.699 -1.593 . . . . 30.510000000000002 106.699 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 63.9 mt -108.92 126.84 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 104.898 -2.26 . . . . 31.870000000000001 104.898 -173.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1172 ' ' GLY . . . . . 0.584 ' O ' ' HB ' ' A' 1255 ' ' THR . . . 70.83 71.64 1.0 Allowed Glycine 0 C--N 1.352 1.449 0 C-N-CA 119.719 -1.229 . . . . 34.539999999999999 110.3 -175.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1173 ' ' ALA . . . . . . . . . . . . . . . -76.97 68.66 3.16 Favored 'General case' 0 C--O 1.243 0.752 0 O-C-N 121.188 -1.183 . . . . 32.509999999999998 111.854 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -78.7 -173.03 42.35 Favored Glycine 0 C--N 1.342 0.871 0 N-CA-C 107.667 -2.173 . . . . 29.899999999999999 107.667 164.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1175 ' ' VAL . . . . . 0.488 HG12 ' HB2' ' A' 1135 ' ' ASN . 48.8 t -62.83 -31.22 51.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 121.58 2.69 . . . . 33.109999999999999 113.995 -172.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1176 ' ' ALA . . . . . 0.635 ' HB2' ' HB1' ' A' 1134 ' ' ALA . . . -58.7 -52.44 65.67 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 118.102 0.41 . . . . 28.100000000000001 110.621 168.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -56.72 -36.13 70.64 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.27 0.938 . . . . 28.539999999999999 112.653 173.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1178 ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' 1175 ' ' VAL . 56.6 mt -65.64 -37.85 87.73 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 118.244 1.022 . . . . 31.219999999999999 110.702 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1179 ' ' ALA . . . . . 0.553 ' HB2' ' ND2' ' A' 1135 ' ' ASN . . . -64.11 -42.7 96.79 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 112.406 0.521 . . . . 28.98 112.406 173.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -58.98 -44.91 91.66 Favored 'General case' 0 C--N 1.352 0.683 0 O-C-N 125.012 1.445 . . . . 27.829999999999998 113.995 173.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1181 ' ' ILE . . . . . 0.571 HD13 HG22 ' A' 1204 ' ' VAL . 47.1 mt -60.61 -51.08 77.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 O-C-N 122.045 -0.409 . . . . 30.25 111.232 178.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -60.67 -57.42 19.02 Favored Glycine 0 CA--C 1.525 0.665 0 O-C-N 126.523 2.389 . . . . 29.59 111.56 -174.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -55.09 -50.1 70.03 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 119.057 1.428 . . . . 30.289999999999999 111.534 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1184 ' ' ALA . . . . . 0.579 ' HA ' HD12 ' A' 1187 ' ' LEU . . . -70.31 -27.14 64.15 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 114.988 1.477 . . . . 30.469999999999999 114.988 -175.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -71.86 -40.31 69.06 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-O 116.144 -1.884 . . . . 42.409999999999997 110.181 172.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1186 ' ' SER . . . . . . . . . . . . . 1.5 m -64.52 -31.05 72.1 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-N 119.752 1.16 . . . . 39.380000000000003 110.617 172.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1187 ' ' LEU . . . . . 0.846 ' HA ' ' HB3' ' B' 1186 ' ' SER . 58.9 mt -65.75 -33.36 75.7 Favored 'General case' 0 C--N 1.345 0.393 0 O-C-N 119.187 -2.196 . . . . 36.18 111.404 168.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 84.8 60.35 1.88 Allowed Glycine 0 N--CA 1.433 -1.542 0 CA-C-O 123.366 1.537 . . . . 33.780000000000001 110.076 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -119.11 160.22 22.48 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 113.751 -1.224 . . . . 33.93 108.722 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 79.0 mt -79.33 81.57 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.825 0 C-N-CA 118.841 -1.144 . . . . 38.740000000000002 108.915 -173.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 12.1 t -81.56 131.86 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.792 -1.188 . . . . 33.090000000000003 107.792 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1192 ' ' ARG . . . . . 0.65 ' O ' ' HA ' ' A' 1169 ' ' MET . 1.2 ptp180 -139.58 103.29 4.66 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 104.926 -2.25 . . . . 38.920000000000002 104.926 177.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -95.46 131.96 41.05 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 110.883 -2.871 . . . . 35.32 110.983 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1194 ' ' PHE . . . . . 0.47 ' HD1' ' O ' ' A' 1212 ' ' LEU . 71.5 t80 -111.93 140.12 46.86 Favored 'General case' 0 C--O 1.248 1.002 0 O-C-N 119.236 -2.165 . . . . 39.350000000000001 106.537 168.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 8.9 t0 -141.51 150.12 41.76 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 105.197 -2.149 . . . . 40.460000000000001 105.197 163.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1196 ' ' THR . . . . . . . . . . . . . 1.3 m -60.19 -32.33 70.97 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 111.816 -2.447 . . . . 45.939999999999998 110.064 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1197 ' ' ARG . . . . . 0.432 ' HA ' ' HD2' ' A' 1198 ' ' PRO . 59.9 mtm180 -83.13 117.81 69.74 Favored Pre-proline 0 N--CA 1.447 -0.624 0 C-N-CA 124.99 1.316 . . . . 56.020000000000003 108.739 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1198 ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' 1197 ' ' ARG . 74.5 Cg_endo -67.45 -19.06 49.53 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.891 2.394 . . . . 51.270000000000003 110.058 176.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -58.17 -37.97 75.74 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 124.248 1.019 . . . . 59.100000000000001 113.146 -174.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 16.1 m -83.96 5.2 2.36 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.583 0 N-CA-C 116.949 2.204 . . . . 51.060000000000002 116.949 -172.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1201 ' ' LYS . . . . . 0.403 ' HA ' ' CD1' ' A' 1211 ' ' PHE . 81.2 tttt -62.61 -55.47 26.83 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 126.194 1.798 . . . . 57.380000000000003 111.736 -172.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -54.9 -44.36 74.08 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 113.034 -1.894 . . . . 62.409999999999997 112.698 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -61.83 -47.87 83.12 Favored 'General case' 0 C--N 1.344 0.349 0 O-C-N 124.166 0.916 . . . . 57.780000000000001 112.794 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1204 ' ' VAL . . . . . 0.571 HG22 HD13 ' A' 1181 ' ' ILE . 82.6 t -49.39 -46.76 19.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 122.29 1.043 . . . . 46.380000000000003 113.428 176.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -69.61 -30.21 67.91 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 113.432 -1.713 . . . . 50.700000000000003 111.592 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1206 ' ' SER . . . . . . . . . . . . . 24.6 m -70.93 -22.1 62.27 Favored 'General case' 0 N--CA 1.435 -1.225 0 O-C-N 120.345 -1.472 . . . . 49.979999999999997 113.375 172.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1207 ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -76.58 -49.91 15.18 Favored 'General case' 0 C--N 1.362 1.131 0 O-C-N 118.974 -2.329 . . . . 52.990000000000002 108.341 164.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 126.67 58.1 0.14 Allowed Glycine 0 C--N 1.304 -1.233 0 N-CA-C 109.292 -1.523 . . . . 47.659999999999997 109.292 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -144.73 150.84 37.95 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 106.407 -1.701 . . . . 44.770000000000003 106.407 -177.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -65.98 137.99 57.51 Favored 'General case' 0 C--O 1.252 1.232 0 O-C-N 125.936 2.023 . . . . 47.640000000000001 106.587 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1211 ' ' PHE . . . . . 0.403 ' CD1' ' HA ' ' A' 1201 ' ' LYS . 44.6 t80 -104.13 116.92 33.08 Favored 'General case' 0 C--N 1.31 -1.109 1 N-CA-C 99.786 -4.153 . . . . 45.659999999999997 99.786 166.796 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 1212 ' ' LEU . . . . . 0.47 ' O ' ' HD1' ' A' 1194 ' ' PHE . 97.1 mt -71.2 119.63 15.62 Favored 'General case' 0 C--O 1.201 -1.486 0 N-CA-C 106.627 -1.62 . . . . 46.060000000000002 106.627 -177.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -82.62 140.47 33.17 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 127.45 2.969 . . . . 60.219999999999999 110.107 171.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 29.4 tp -81.21 125.81 30.75 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 127.328 3.442 . . . . 57.25 107.886 -166.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 24.6 t70 -74.59 87.66 2.14 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 111.729 -2.487 . . . . 64.430000000000007 109.613 165.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 47.8 t80 . . . . . 0 N--CA 1.432 -1.366 0 CA-C-N 113.178 -1.828 . . . . 66.900000000000006 107.394 -178.475 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 3.6 p-10 . . . . . 0 N--CA 1.442 -0.867 0 N-CA-C 107.655 -1.239 . . . . 39.090000000000003 107.655 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -54.33 -57.14 18.31 Favored Glycine 0 C--O 1.224 -0.474 0 O-C-N 127.301 2.876 . . . . 39.32 115.346 -174.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 24.7 t80 -72.76 -39.82 66.51 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-N 118.294 1.047 . . . . 39.299999999999997 111.277 -169.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -68.35 -42.38 79.31 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.675 -1.602 . . . . 36.299999999999997 106.675 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -58.9 -44.43 91.21 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 116.211 -1.852 . . . . 37.380000000000003 111.293 175.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -59.3 -51.79 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 125.036 1.46 . . . . 39.109999999999999 112.665 174.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1230 ' ' MET . . . . . . . . . . . . . 26.8 mmt -84.27 70.46 10.6 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 123.135 1.445 . . . . 49.590000000000003 110.211 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1231 ' ' SER . . . . . . . . . . . . . 61.5 m -138.93 154.62 48.36 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.556 -1.202 . . . . 43.68 109.152 176.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -58.63 -66.8 0.44 Allowed 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.311 1.045 . . . . 55.57 111.672 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1233 ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' 1236 ' ' LYS . . . -62.41 -23.83 67.06 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.092 -0.958 . . . . 44.939999999999998 113.006 -174.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 15.1 t80 -66.75 -51.89 50.59 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-O 117.522 -1.227 . . . . 42.039999999999999 109.383 171.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 13.3 mt -68.57 -26.0 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 123.554 2.888 . . . . 46.280000000000001 109.054 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1236 ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' 1233 ' ' ALA . 33.3 tttm -61.75 -46.14 90.9 Favored 'General case' 0 C--O 1.237 0.43 0 O-C-N 119.705 -1.872 . . . . 47.869999999999997 109.308 169.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -67.52 -36.52 81.18 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-N 115.816 -0.629 . . . . 41.609999999999999 111.81 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -58.5 -56.36 23.11 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.076 0.55 . . . . 50.649999999999999 110.142 173.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1239 ' ' MET . . . . . . . . . . . . . 3.2 mtm -52.66 -45.71 66.85 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 114.044 1.127 . . . . 48.869999999999997 114.044 173.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -68.91 -33.43 73.74 Favored 'General case' 0 C--N 1.315 -0.907 0 O-C-N 121.618 -0.676 . . . . 54.799999999999997 110.998 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.42 -45.12 85.14 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 105.334 -2.099 . . . . 43.210000000000001 105.334 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -67.17 -36.92 82.81 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.08 1.352 . . . . 38.659999999999997 113.202 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1243 ' ' ALA . . . . . 0.568 ' HA ' ' HG3' ' A' 1271 ' ' MET . . . -62.26 -45.76 91.88 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 123.015 0.526 . . . . 37.920000000000002 112.289 175.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -67.16 -36.93 82.87 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 121.445 -0.784 . . . . 37.280000000000001 110.99 176.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -65.75 -30.38 71.03 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 112.971 0.73 . . . . 43.07 112.971 172.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -59.09 -34.18 71.69 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 112.565 0.58 . . . . 38.299999999999997 112.565 -175.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1247 ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.1 -15.55 63.46 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 119.521 -0.872 . . . . 47.600000000000001 112.869 178.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -114.2 -25.39 8.5 Favored 'General case' 0 N--CA 1.441 -0.924 0 O-C-N 119.077 -2.264 . . . . 45.420000000000002 115.988 176.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1249 ' ' VAL . . . . . 0.583 ' HA ' ' HB2' ' A' 1167 ' ' LYS . 34.7 m -74.93 163.68 3.92 Favored 'Isoleucine or valine' 0 C--O 1.247 0.944 0 CA-C-N 121.74 2.064 . . . . 36.259999999999998 116.541 -173.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1250 ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' 1279 ' ' SER . 2.4 m-20 -124.81 -57.45 1.53 Allowed 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 113.448 -1.705 . . . . 33.039999999999999 108.432 -170.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1251 ' ' ILE . . . . . 0.842 HD12 ' HB1' ' A' 1145 ' ' ALA . 34.6 mm -110.91 131.67 61.49 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.977 0 N-CA-C 106.613 -1.625 . . . . 31.399999999999999 106.613 175.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1252 ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' 1169 ' ' MET . 52.3 mt -122.43 134.97 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 N-CA-C 103.912 -2.625 . . . . 29.420000000000002 103.912 170.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 9.2 t -117.45 92.31 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 103.102 -2.925 . . . . 30.370000000000001 103.102 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1254 ' ' THR . . . . . 0.514 ' HB ' ' HB2' ' A' 1291 ' ' ASN . 0.7 OUTLIER -79.35 98.02 6.55 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 123.189 1.471 . . . . 35.719999999999999 113.213 179.421 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 1255 ' ' THR . . . . . 0.584 ' HB ' ' O ' ' A' 1172 ' ' GLY . 4.0 m -111.5 0.16 16.4 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.09 -1.414 . . . . 36.0 114.466 -168.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1256 ' ' ALA . . . . . . . . . . . . . . . -84.3 79.32 9.58 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 125.607 2.622 . . . . 40.93 113.553 -170.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 41.7 tp -94.36 109.53 21.37 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 112.024 -2.353 . . . . 47.82 106.777 172.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 28.1 mm -66.37 119.05 59.37 Favored Pre-proline 0 CA--C 1.554 1.116 0 N-CA-C 103.651 -2.722 . . . . 52.700000000000003 103.651 168.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -53.25 125.32 18.02 Favored 'Trans proline' 0 C--N 1.35 0.637 1 C-N-CA 126.002 4.468 . . . . 54.130000000000003 112.313 -173.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 76.2 6.12 82.55 Favored Glycine 0 CA--C 1.489 -1.576 0 CA-C-O 119.907 -0.385 . . . . 54.619999999999997 112.947 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 89.2 mttt -128.78 155.84 78.64 Favored Pre-proline 0 C--O 1.252 1.198 0 O-C-N 119.492 -2.181 . . . . 55.740000000000002 109.337 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -61.36 117.8 4.63 Favored 'Trans proline' 0 N--CA 1.44 -1.63 0 C-N-CA 121.905 1.737 . . . . 51.149999999999999 113.083 168.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -51.26 132.47 32.61 Favored Pre-proline 0 N--CA 1.473 0.695 0 CA-C-N 113.094 -1.866 . . . . 46.060000000000002 111.953 176.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1264 ' ' PRO . . . . . 0.46 ' O ' ' HA ' ' A' 1291 ' ' ASN . 57.4 Cg_endo -55.62 138.86 82.09 Favored 'Trans proline' 0 C--O 1.249 1.051 0 C-N-CA 124.974 3.782 . . . . 41.079999999999998 112.283 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -78.13 99.59 6.23 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 104.22 -2.511 . . . . 47.420000000000002 104.22 171.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 94.6 mt -98.89 -21.09 16.47 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 113.189 -1.823 . . . . 39.219999999999999 111.299 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1267 ' ' ILE . . . . . 0.664 HG23 ' SD ' ' A' 1271 ' ' MET . 86.4 mt -117.55 114.23 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 O-C-N 118.298 -2.751 . . . . 42.5 106.718 172.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1268 ' ' THR . . . . . 0.401 ' H ' ' HE3' ' A' 1271 ' ' MET . 5.0 p -80.31 162.49 24.54 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 115.665 1.728 . . . . 37.840000000000003 115.665 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -60.6 -41.87 95.61 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-O 116.381 -1.771 . . . . 54.799999999999997 112.764 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -53.06 -51.07 62.97 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 125.243 1.417 . . . . 54.359999999999999 110.825 171.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1271 ' ' MET . . . . . 0.664 ' SD ' HG23 ' A' 1267 ' ' ILE . 43.0 ttm -55.49 -44.11 76.21 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 125.483 1.739 . . . . 39.520000000000003 112.485 -178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1272 ' ' VAL . . . . . 0.408 ' CG1' HG21 ' A' 1303 ' ' THR . 2.4 t -68.05 -45.57 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 120.781 1.628 . . . . 38.25 110.588 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -59.77 -28.27 67.25 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 114.64 1.348 . . . . 40.770000000000003 114.64 173.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1274 ' ' SER . . . . . . . . . . . . . 20.4 m -89.02 13.37 13.08 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 113.591 0.96 . . . . 36.579999999999998 113.591 172.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1275 ' ' MET . . . . . 0.583 ' HB3' HG21 ' A' 1307 ' ' VAL . 36.0 ttm -85.69 164.53 17.6 Favored 'General case' 0 C--O 1.246 0.87 0 O-C-N 120.899 -1.125 . . . . 36.75 109.573 -175.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1276 ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -76.8 130.62 37.92 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 105.527 -2.027 . . . . 46.109999999999999 105.527 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1277 ' ' ALA . . . . . 0.451 ' HB3' ' CD1' ' B' 1045 ' ' PHE . . . -86.01 172.17 10.85 Favored 'General case' 0 CA--C 1.504 -0.796 0 O-C-N 120.181 -1.574 . . . . 33.520000000000003 115.14 -168.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 86.26 14.99 65.32 Favored Glycine 0 C--O 1.217 -0.939 0 O-C-N 120.648 -1.283 . . . . 31.27 111.799 -171.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1279 ' ' SER . . . . . 0.468 ' HB3' ' O ' ' A' 1250 ' ' ASP . 36.9 m -130.45 163.88 26.01 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 124.108 0.963 . . . . 32.950000000000003 111.006 -156.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1280 ' ' VAL . . . . . . . . . . . . . 65.4 t -134.93 131.65 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 O-C-N 119.959 -1.713 . . . . 27.43 111.466 -170.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1281 ' ' ILE . . . . . 0.553 HD11 ' SD ' ' A' 1275 ' ' MET . 46.3 mt -106.36 104.35 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 106.213 -1.773 . . . . 30.300000000000001 106.213 171.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 43.9 t -88.9 109.74 20.52 Favored 'Isoleucine or valine' 0 C--O 1.252 1.215 0 O-C-N 119.189 -2.195 . . . . 28.629999999999999 106.773 175.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 5.0 t70 -86.15 96.64 9.97 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 123.277 1.513 . . . . 36.270000000000003 108.14 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1284 ' ' LEU . . . . . 0.627 HD21 ' HB2' ' A' 1141 ' ' ALA . 21.1 mt -73.69 -12.73 60.82 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 112.604 -2.089 . . . . 38.57 112.889 172.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -77.24 -34.58 55.84 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 120.922 1.692 . . . . 37.560000000000002 110.179 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1286 ' ' ALA . . . . . 0.572 ' HB1' HG23 ' A' 1313 ' ' THR . . . 33.54 -74.33 0.0 OUTLIER 'General case' 0 C--O 1.246 0.883 1 N-CA-C 123.423 4.601 . . . . 40.329999999999998 123.423 171.191 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -55.15 -40.54 70.73 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 116.966 2.21 . . . . 56.850000000000001 116.966 -166.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 18.0 m120 -125.59 116.89 22.44 Favored 'General case' 0 CA--C 1.491 -1.317 0 O-C-N 119.688 -1.883 . . . . 45.859999999999999 107.211 177.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 73.82 -74.6 1.14 Allowed Glycine 0 C--N 1.345 1.033 0 N-CA-C 110.859 -0.896 . . . . 40.310000000000002 110.859 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 86.03 134.26 3.52 Favored Glycine 0 C--O 1.237 0.335 0 N-CA-C 109.493 -1.443 . . . . 38.890000000000001 109.493 -173.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1291 ' ' ASN . . . . . 0.514 ' HB2' ' HB ' ' A' 1254 ' ' THR . 25.6 m120 -70.93 -24.91 62.54 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-N 118.009 0.905 . . . . 37.229999999999997 112.391 -167.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1292 ' ' CYS . . . . . 0.426 ' HB3' ' OG1' ' A' 1295 ' ' THR . 53.7 t -91.58 155.65 18.21 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 120.835 -1.166 . . . . 36.5 111.853 177.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1293 ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -83.46 6.51 19.98 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 119.729 -1.857 . . . . 43.32 115.343 173.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -113.47 8.5 17.84 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-O 123.053 1.406 . . . . 41.32 111.99 171.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1295 ' ' THR . . . . . 0.426 ' OG1' ' HB3' ' A' 1292 ' ' CYS . 33.5 m -75.84 95.14 3.43 Favored 'General case' 0 CA--C 1.501 -0.938 0 O-C-N 118.744 -2.472 . . . . 35.299999999999997 112.098 -176.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 60.1 t -92.07 115.94 65.57 Favored Pre-proline 0 N--CA 1.437 -1.124 0 CA-C-N 109.583 -3.462 . . . . 34.840000000000003 105.562 169.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -54.51 107.78 0.25 Allowed 'Trans proline' 0 C--O 1.247 0.975 0 C-N-CA 124.969 3.779 . . . . 33.509999999999998 115.202 174.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 85.65 28.12 30.39 Favored Glycine 0 N--CA 1.442 -0.9 0 CA-C-N 111.761 -2.472 . . . . 32.189999999999998 113.793 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -140.36 158.0 44.68 Favored 'General case' 0 C--O 1.242 0.685 0 O-C-N 118.935 -2.509 . . . . 34.880000000000003 111.475 177.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1300 ' ' ILE . . . . . . . . . . . . . 31.4 mt -94.88 124.46 47.39 Favored 'Isoleucine or valine' 0 C--O 1.254 1.315 0 N-CA-C 105.152 -2.166 . . . . 32.289999999999999 105.152 169.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -128.4 108.03 10.23 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 105.385 -2.08 . . . . 37.25 105.385 175.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1302 ' ' THR . . . . . . . . . . . . . 55.9 m -75.53 135.26 40.62 Favored 'General case' 0 C--O 1.243 0.736 0 O-C-N 120.847 -1.158 . . . . 35.560000000000002 108.529 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1303 ' ' THR . . . . . 0.408 HG21 ' CG1' ' A' 1272 ' ' VAL . 35.8 p -85.07 172.36 11.32 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 119.581 -1.95 . . . . 36.399999999999999 109.981 176.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -61.97 -42.67 99.38 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 118.647 0.658 . . . . 52.32 111.914 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -64.56 -35.77 82.06 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.628 0.728 . . . . 40.039999999999999 112.644 176.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 117.17 44.79 0.55 Allowed Glycine 0 C--O 1.217 -0.912 0 O-C-N 120.063 -1.648 . . . . 36.960000000000001 110.157 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1307 ' ' VAL . . . . . 0.583 HG21 ' HB3' ' A' 1275 ' ' MET . 74.3 t -113.51 124.5 70.21 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.233 0 N-CA-C 104.273 -2.491 . . . . 33.399999999999999 104.273 171.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1308 ' ' LYS . . . . . 0.825 ' HD2' ' HB3' ' A' 1148 ' ' GLU . 88.3 mttt -84.6 119.26 25.01 Favored 'General case' 0 CA--C 1.496 -1.127 0 C-N-CA 119.411 -0.916 . . . . 42.909999999999997 109.465 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 57.3 t -96.52 130.73 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.082 0 N-CA-C 106.919 -1.511 . . . . 32.289999999999999 106.919 172.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1310 ' ' ILE . . . . . . . . . . . . . 1.5 mt -125.06 111.27 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.369 0 O-C-N 120.512 -1.367 . . . . 30.989999999999998 108.125 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -83.31 59.3 4.99 Favored Glycine 0 N--CA 1.466 0.686 0 O-C-N 120.448 -1.408 . . . . 28.949999999999999 109.885 174.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1312 ' ' TYR . . . . . 0.437 ' HD1' ' HA ' ' A' 1312 ' ' TYR 0.252 0.5 OUTLIER -73.98 85.77 1.79 Allowed 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 121.189 2.495 . . . . 31.690000000000001 116.952 -172.301 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A 1313 ' ' THR . . . . . 0.572 HG23 ' HB1' ' A' 1286 ' ' ALA . 0.8 OUTLIER -54.57 -53.44 54.58 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 113.906 -1.497 . . . . 34.170000000000002 112.823 168.414 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -65.42 5.9 0.36 Allowed 'General case' 0 C--O 1.248 1.021 0 N-CA-C 116.849 2.166 . . . . 36.859999999999999 116.849 -172.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1315 ' ' LEU . . . . . 0.704 HD22 ' HG3' ' A' 1140 ' ' ARG . 58.5 mt -47.09 -39.92 20.48 Favored Pre-proline 0 CA--C 1.547 0.86 0 CA-C-N 121.544 1.975 . . . . 34.850000000000001 116.123 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -57.19 -43.12 55.94 Favored 'Trans proline' 0 CA--C 1.505 -0.953 0 CA-C-N 123.311 2.218 . . . . 29.149999999999999 116.542 168.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -66.04 -39.19 94.66 Favored Glycine 0 C--N 1.313 -0.709 0 O-C-N 119.918 -1.738 . . . . 27.289999999999999 111.859 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1318 ' ' ARG . . . . . 0.488 ' HB3' ' NH2' ' A' 1140 ' ' ARG . 92.7 mtt-85 -62.97 -25.03 68.18 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 124.747 1.219 . . . . 41.490000000000002 113.796 174.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1319 ' ' LEU . . . . . 0.482 HD23 HG23 ' A' 1136 ' ' ILE . 12.7 tp -115.91 70.26 3.68 Favored Pre-proline 0 C--O 1.251 1.132 0 N-CA-C 107.748 -1.205 . . . . 27.609999999999999 107.748 172.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1320 ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -59.5 -59.68 0.4 Allowed 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 122.722 2.281 . . . . 25.940000000000001 115.057 -163.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1321 ' ' THR . . . . . . . . . . . . . 7.6 m -65.0 -36.45 84.45 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 108.735 -0.839 . . . . 25.010000000000002 108.735 -171.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1322 ' ' GLN . . . . . 0.461 ' HB2' ' HA ' ' B' 1151 ' ' ARG . 31.6 tp60 -72.97 -32.31 65.13 Favored 'General case' 0 CA--C 1.502 -0.866 0 O-C-N 120.988 -1.07 . . . . 29.390000000000001 112.18 -172.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1323 ' ' SER . . . . . 0.586 ' HA ' HD13 ' A' 1136 ' ' ILE . 40.2 m -65.68 -50.66 64.12 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 107.098 -1.445 . . . . 26.469999999999999 107.098 172.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1324 ' ' SER . . . . . 0.422 ' HB2' HG23 ' A' 1019 ' ' THR . 3.4 m -60.8 -23.62 65.18 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.962 0.905 . . . . 27.780000000000001 112.22 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 19.4 tm0? -86.43 -76.29 0.35 Allowed 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.782 -1.562 . . . . 37.530000000000001 106.782 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1326 ' ' LEU . . . . . 0.55 ' HB2' HD11 ' A' 1136 ' ' ILE . 92.8 mt -54.76 -62.27 1.77 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 115.446 1.647 . . . . 35.710000000000001 115.446 -175.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1327 ' ' TYR . . . . . 0.581 ' HE2' ' HA ' ' A' 1072 ' ' VAL . 30.3 t80 -63.85 -35.49 80.81 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 107.613 -1.254 . . . . 31.59 107.613 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1328 ' ' GLY . . . . . 0.547 ' HA2' HD12 ' A' 1331 ' ' LEU . . . -54.06 -46.18 70.5 Favored Glycine 0 C--N 1.359 1.818 0 O-C-N 124.156 0.91 . . . . 28.0 111.699 171.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1329 ' ' THR . . . . . 0.507 ' HA ' ' HB ' ' A' 1332 ' ' VAL . 28.5 m -71.29 -24.46 62.15 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 123.241 0.616 . . . . 32.149999999999999 110.922 175.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1330 ' ' ASN . . . . . 0.566 ' OD1' ' HB2' ' A' 1132 ' ' SER . 3.1 m120 -61.78 -54.07 47.41 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 116.911 -3.618 . . . . 34.359999999999999 107.246 174.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1331 ' ' LEU . . . . . 0.657 HD13 ' HB3' ' A' 1070 ' ' LEU . 12.9 mt -47.01 -54.51 10.04 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 126.548 1.939 . . . . 33.369999999999997 111.155 170.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1332 ' ' VAL . . . . . 0.711 HG22 HD21 ' A' 1026 ' ' LEU . 70.0 t -63.98 -32.71 58.27 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.729 0 CA-C-O 117.179 -1.391 . . . . 35.270000000000003 114.073 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -73.67 -31.19 63.34 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 124.191 3.178 . . . . 37.659999999999997 110.737 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1334 ' ' LEU . . . . . . . . . . . . . 43.3 tp -60.71 -51.11 70.74 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-N 118.687 0.676 . . . . 40.270000000000003 110.592 164.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1335 ' ' LEU . . . . . 0.756 HD11 HD21 ' A' 1070 ' ' LEU . 55.2 mt -54.5 -34.96 62.58 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 114.793 1.405 . . . . 42.5 114.793 168.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1336 ' ' LYS . . . . . 0.597 ' HG2' HD21 ' A' 1029 ' ' LEU . 90.0 mttt -60.69 -46.17 91.38 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 123.18 2.718 . . . . 47.810000000000002 112.977 174.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1337 ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.85 -36.99 78.0 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 124.365 1.041 . . . . 49.270000000000003 113.251 173.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1338 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.8 -32.51 70.99 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 124.628 1.171 . . . . 50.539999999999999 111.16 172.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1339 ' ' CYS . . . . . 0.591 ' HB3' ' HG2' ' A' 1342 ' ' LYS . 64.8 m -79.48 88.78 5.04 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 124.052 1.882 . . . . 53.670000000000002 107.958 172.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -76.01 -66.26 0.81 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 113.67 -1.605 . . . . 63.380000000000003 106.734 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -85.69 -18.88 31.87 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.384 -0.826 . . . . 70.950000000000003 110.626 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1342 ' ' LYS . . . . . 0.605 ' HE2' ' HA ' ' A' 1029 ' ' LEU . 5.8 mtpm? 68.41 56.91 0.47 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.129 -1.396 . . . . 65.25 114.437 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1343 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 172.84 -38.49 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.389 2 O-C-N 112.345 -6.472 . . . . 64.530000000000001 107.714 -17.335 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 1344 ' ' GLY . . . . . . . . . . . . . . . 84.34 -62.45 4.57 Favored Glycine 0 C--N 1.346 1.118 0 O-C-N 117.491 -3.255 . . . . 59.719999999999999 111.129 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 4.6 t30 -116.62 132.23 56.74 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 103.666 -2.716 . . . . 64.090000000000003 103.666 169.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1346 ' ' ILE . . . . . . . . . . . . . 20.8 pt -62.92 164.47 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.256 1.409 0 O-C-N 123.891 0.744 . . . . 58.82 112.785 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1347 ' ' THR . . . . . . . . . . . . . 1.8 m -124.97 92.98 3.76 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 104.834 -2.284 . . . . 54.960000000000001 104.834 -176.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1348 ' ' VAL . . . . . . . . . . . . . 60.2 t -77.29 84.78 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 N-CA-C 105.201 -2.148 . . . . 55.640000000000001 105.201 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.67 126.63 30.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 124.113 1.911 . . . . 61.450000000000003 112.752 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -96.32 -5.48 39.95 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 118.182 2.66 . . . . 58.630000000000003 118.182 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -73.72 -39.89 63.98 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 118.351 -1.34 . . . . 62.060000000000002 110.095 172.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 17.3 t70 -70.57 112.5 6.87 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.038 -0.983 . . . . 54.07 112.144 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 15.8 m -59.51 -20.43 18.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 N-CA-C 116.33 1.974 . . . . 50.68 116.33 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1354 ' ' VAL . . . . . 0.576 ' O ' HG23 ' A' 1358 ' ' VAL . 0.9 OUTLIER -79.77 -47.39 21.83 Favored 'Isoleucine or valine' 0 C--N 1.343 0.317 0 CA-C-N 121.485 1.948 . . . . 47.68 105.778 177.749 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 1355 ' ' ILE . . . . . . . . . . . . . 89.9 mt -64.65 -55.14 22.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 108.476 -0.935 . . . . 48.490000000000002 108.476 -177.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 34.0 tpt85 -45.36 -46.77 13.28 Favored 'General case' 0 C--O 1.255 1.379 0 O-C-N 124.123 0.889 . . . . 48.270000000000003 113.362 167.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -59.39 -51.03 61.57 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-O 117.563 -1.687 . . . . 43.530000000000001 111.882 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1358 ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' 1354 ' ' VAL . 17.5 t -63.37 -35.08 70.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 CA-C-N 118.808 1.304 . . . . 45.119999999999997 108.544 -175.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1359 ' ' THR . . . . . . . . . . . . . 18.1 m -75.84 93.84 3.24 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 123.959 1.838 . . . . 42.939999999999998 109.889 -176.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 16.6 m -80.02 -22.84 11.75 Favored 'Isoleucine or valine' 0 C--O 1.248 1.011 0 CA-C-N 110.998 -2.819 . . . . 43.259999999999998 113.858 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1361 ' ' ILE . . . . . . . . . . . . . 43.7 mt -137.11 119.39 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 N-CA-C 104.055 -2.572 . . . . 45.659999999999997 104.055 175.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1362 ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -106.92 113.28 26.67 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 104.311 -2.477 . . . . 61.340000000000003 104.311 170.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 32.95 77.38 0.03 OUTLIER 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 117.204 2.298 . . . . 49.759999999999998 117.204 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 86.52 -50.26 4.19 Favored Glycine 0 N--CA 1.481 1.685 0 CA-C-N 113.645 -1.616 . . . . 50.0 111.628 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -70.37 116.43 10.7 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 106.953 -1.499 . . . . 56.920000000000002 106.953 -176.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1366 ' ' ILE . . . . . . . . . . . . . 67.5 mt -72.83 101.57 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.066 0 CA-C-O 123.408 1.575 . . . . 52.780000000000001 109.006 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1367 ' ' THR . . . . . . . . . . . . . 10.9 p -92.94 10.49 31.02 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 112.857 -1.974 . . . . 49.439999999999998 116.16 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1368 ' ' TRP . . . . . 0.518 ' CD1' ' HA ' ' A' 1369 ' ' PRO . 1.9 t90 -58.82 145.77 77.66 Favored Pre-proline 0 C--O 1.254 1.333 0 O-C-N 117.972 -2.955 . . . . 52.380000000000003 105.683 163.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1369 ' ' PRO . . . . . 0.518 ' HA ' ' CD1' ' A' 1368 ' ' TRP . 42.0 Cg_endo -85.76 -175.0 11.55 Favored 'Cis proline' 0 C--O 1.211 -0.829 0 CA-C-N 123.983 2.458 . . . . 46.939999999999998 113.553 4.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -83.19 138.66 42.21 Favored Pre-proline 0 CA--C 1.545 0.756 0 O-C-N 124.065 0.853 . . . . 45.909999999999997 108.84 164.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1371 ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -58.3 135.29 67.1 Favored 'Trans proline' 0 C--N 1.351 0.678 1 C-N-CA 125.777 4.318 . . . . 46.390000000000001 111.509 177.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -59.03 -35.35 98.57 Favored 'Trans proline' 0 CA--C 1.549 1.241 1 C-N-CA 125.36 4.04 . . . . 46.719999999999999 116.653 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.233 -4.489 0 O-C-N 118.331 -2.731 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 15.9 m80 . . . . . 0 N--CA 1.432 -1.347 0 N-CA-C 108.174 -1.047 . . . . 63.439999999999998 108.174 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -77.44 76.65 3.98 Favored 'General case' 0 C--O 1.254 1.304 0 O-C-N 121.093 -1.005 . . . . 51.740000000000002 112.402 -177.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1000 ' ' HIS . . . . . 0.456 ' HA ' ' OE2' ' B' 1067 ' ' GLU . 12.0 t60 -72.55 118.38 15.38 Favored 'General case' 0 C--O 1.247 0.964 0 CA-C-O 122.694 1.235 . . . . 54.07 111.618 -166.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 64.27 27.11 71.11 Favored Glycine 0 C--O 1.209 -1.434 0 CA-C-O 123.46 1.589 . . . . 39.219999999999999 111.889 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1002 ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -97.21 134.52 40.42 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 105.515 -2.031 . . . . 38.119999999999997 105.515 173.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1003 ' ' ILE . . . . . 0.536 HD12 HG22 ' B' 1033 ' ' VAL . 57.1 mt -84.92 149.97 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 CA-C-N 112.023 -2.353 . . . . 29.699999999999999 105.89 170.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -118.71 131.39 9.12 Favored Glycine 0 CA--C 1.492 -1.404 0 N-CA-C 108.351 -1.9 . . . . 27.5 108.351 164.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1005 ' ' ILE . . . . . 0.683 HG23 ' HB3' ' B' 1017 ' ' ALA . 45.4 mm -102.69 110.08 62.4 Favored Pre-proline 0 C--N 1.313 -1.002 0 N-CA-C 104.852 -2.277 . . . . 24.829999999999998 104.852 172.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -83.83 155.0 13.4 Favored 'Trans proline' 0 C--O 1.238 0.514 0 C-N-CA 121.743 1.629 . . . . 27.190000000000001 111.966 173.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -77.39 114.97 16.77 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 112.031 -2.349 . . . . 41.460000000000001 106.013 169.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1008 ' ' GLU . . . . . 0.503 ' OE2' ' HG2' ' B' 1071 ' ' LYS . 25.4 mm-40 -51.43 164.77 0.18 Allowed 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 116.463 2.023 . . . . 26.93 116.463 -178.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1009 ' ' ARG . . . . . 0.428 ' NH2' ' HG2' ' B' 1079 ' ' GLU . 14.4 mtm180 -146.15 59.06 1.23 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 123.314 1.531 . . . . 34.479999999999997 108.566 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1010 ' ' LEU . . . . . 0.564 ' HB3' ' HB2' ' B' 1013 ' ' GLU . 17.9 tp -104.37 152.94 21.67 Favored 'General case' 0 N--CA 1.469 0.511 1 O-C-N 116.287 -4.008 . . . . 44.219999999999999 107.743 174.246 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B 1011 ' ' THR . . . . . . . . . . . . . 24.3 m -58.99 114.42 2.57 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 123.779 0.832 . . . . 40.740000000000002 109.107 167.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 47.6 t30 54.62 80.08 0.13 Allowed 'General case' 0 C--N 1.35 0.624 0 C-N-CA 125.271 1.428 . . . . 44.439999999999998 111.861 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1013 ' ' GLU . . . . . 0.564 ' HB2' ' HB3' ' B' 1010 ' ' LEU . 9.5 tp10 -147.29 141.54 26.21 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 123.817 1.77 . . . . 29.870000000000001 109.857 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1014 ' ' THR . . . . . 0.617 ' HB ' ' HB3' ' B' 1320 ' ' PRO . 0.2 OUTLIER -128.43 2.96 5.64 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 113.173 -1.83 . . . . 25.260000000000002 111.535 -178.756 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 65.4 mtm180 -76.95 145.29 38.23 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 123.925 1.821 . . . . 29.539999999999999 110.631 174.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1016 ' ' VAL . . . . . 0.633 HG21 ' HB1' ' B' 1039 ' ' ALA . 2.2 p -126.64 -175.96 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-N 114.45 -1.25 . . . . 23.550000000000001 109.161 161.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1017 ' ' ALA . . . . . 0.683 ' HB3' HG23 ' B' 1005 ' ' ILE . . . -93.64 7.95 42.76 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 115.339 1.607 . . . . 23.59 115.339 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1018 ' ' ALA . . . . . 0.487 ' H ' HG13 ' B' 1016 ' ' VAL . . . -164.75 147.55 8.58 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 114.608 1.336 . . . . 24.93 114.608 -177.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1019 ' ' THR . . . . . . . . . . . . . 68.7 p -98.91 172.77 4.4 Favored Pre-proline 0 C--O 1.242 0.688 0 N-CA-C 106.839 -1.541 . . . . 28.09 106.839 159.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -49.56 -51.28 11.05 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.404 3.402 . . . . 28.789999999999999 110.959 166.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 37.9 tttp -46.88 -48.29 21.19 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 123.533 2.879 . . . . 47.280000000000001 112.728 170.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1022 ' ' THR . . . . . 0.41 HG21 ' HA3' ' B' 1328 ' ' GLY . 3.4 m -62.45 -32.39 73.26 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 117.715 0.234 . . . . 30.120000000000001 111.071 -177.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1023 ' ' VAL . . . . . 0.5 HG13 ' HB ' ' B' 1033 ' ' VAL . 91.6 t -64.21 -48.82 83.96 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 O-C-N 120.514 -1.367 . . . . 32.240000000000002 108.109 176.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1024 ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' B' 1028 ' ' LYS . 31.3 mt-10 -60.36 -29.15 68.73 Favored 'General case' 0 C--O 1.246 0.921 0 O-C-N 121.937 -0.477 . . . . 49.619999999999997 111.305 176.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -66.44 -42.06 88.24 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-O 123.805 1.764 . . . . 44.68 113.034 176.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 34.2 mt -70.38 -37.8 74.62 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 113.71 -1.586 . . . . 35.710000000000001 109.392 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1027 ' ' LEU . . . . . 0.461 HD12 ' HA ' ' B' 1024 ' ' GLU . 63.4 mt -67.47 -26.8 66.55 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 115.599 -0.728 . . . . 42.18 111.179 174.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1028 ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' B' 1024 ' ' GLU . 65.1 mttm -61.01 -33.82 73.86 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.273 0.942 . . . . 48.340000000000003 111.99 169.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1029 ' ' LEU . . . . . 0.503 ' HB2' ' HD2' ' B' 1031 ' ' PHE . 7.8 mt -88.61 10.39 20.69 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 120.984 -1.072 . . . . 38.689999999999998 111.326 176.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 85.09 -10.45 63.24 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 116.169 1.228 . . . . 32.280000000000001 116.169 -175.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1031 ' ' PHE . . . . . 0.503 ' HD2' ' HB2' ' B' 1029 ' ' LEU . 66.4 m-85 -78.19 120.21 22.67 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 119.447 1.624 . . . . 35.939999999999998 112.659 -170.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1032 ' ' THR . . . . . . . . . . . . . 34.8 m -73.74 132.51 42.72 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 106.596 -1.631 . . . . 33.369999999999997 106.596 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1033 ' ' VAL . . . . . 0.536 HG22 HD12 ' B' 1003 ' ' ILE . 16.9 t -117.63 128.93 74.76 Favored 'Isoleucine or valine' 0 C--O 1.249 1.028 0 O-C-N 119.489 -2.007 . . . . 29.98 108.662 -171.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -108.56 143.61 37.36 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.31 -0.859 . . . . 28.18 110.228 166.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1035 ' ' VAL . . . . . 0.432 HG23 ' HB1' ' B' 1055 ' ' ALA . 57.6 t -125.57 131.35 72.2 Favored 'Isoleucine or valine' 0 C--N 1.372 1.552 0 N-CA-C 108.107 -1.071 . . . . 25.82 108.107 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1036 ' ' GLU . . . . . 0.449 ' HB2' HG11 ' B' 1063 ' ' VAL . 30.5 tt0 -73.3 143.16 47.08 Favored 'General case' 0 C--O 1.252 1.223 0 O-C-N 120.455 -1.403 . . . . 32.439999999999998 108.996 177.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1037 ' ' SER . . . . . 0.586 ' H ' ' HG3' ' B' 1059 ' ' GLU . 1.2 m -65.95 137.98 57.51 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 119.612 -1.93 . . . . 29.539999999999999 111.64 174.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 103.09 -22.08 37.85 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 124.844 1.34 . . . . 27.760000000000002 111.165 -175.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1039 ' ' ALA . . . . . 0.633 ' HB1' HG21 ' B' 1016 ' ' VAL . . . -65.46 -40.14 92.84 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 123.089 0.555 . . . . 26.02 110.428 174.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -55.05 -51.71 51.96 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 124.445 1.091 . . . . 26.469999999999999 112.093 169.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.19 -28.71 68.18 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 113.745 1.017 . . . . 50.979999999999997 113.745 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1042 ' ' LEU . . . . . 0.584 HD22 ' HA ' ' B' 1014 ' ' THR . 76.9 mt -67.63 -52.68 35.38 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 119.951 1.251 . . . . 29.300000000000001 109.092 168.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1043 ' ' ALA . . . . . 0.51 ' HB2' HG12 ' B' 1016 ' ' VAL . . . -72.26 29.81 0.05 Allowed 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 118.014 2.598 . . . . 26.739999999999998 118.014 174.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1044 ' ' SER . . . . . . . . . . . . . 28.4 m 47.66 36.51 5.6 Favored 'General case' 0 C--N 1.358 0.951 0 N-CA-C 117.713 2.486 . . . . 31.260000000000002 117.713 -173.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1045 ' ' PHE . . . . . 0.451 ' CD1' ' HB3' ' A' 1277 ' ' ALA . 0.8 OUTLIER -130.06 163.5 26.39 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 124.112 1.91 . . . . 33.259999999999998 112.626 -173.834 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 3.3 t70 -67.84 139.84 56.56 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 114.548 -1.205 . . . . 46.740000000000002 109.525 158.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -68.42 -36.59 79.3 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 121.057 1.753 . . . . 34.439999999999998 111.259 174.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1048 ' ' LYS . . . . . 0.427 ' O ' HG12 ' B' 1051 ' ' VAL . 0.1 OUTLIER -70.97 -15.08 62.56 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.463 0.649 . . . . 48.670000000000002 112.652 -175.011 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -58.56 -37.04 74.9 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 119.234 -2.166 . . . . 35.259999999999998 111.122 165.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1050 ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -65.29 -33.57 76.28 Favored 'General case' 0 CA--C 1.563 1.451 0 CA-C-O 117.843 -1.075 . . . . 32.170000000000002 111.725 170.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1051 ' ' VAL . . . . . 0.427 HG12 ' O ' ' B' 1048 ' ' LYS . 0.3 OUTLIER -68.1 -30.28 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 121.404 1.911 . . . . 38.369999999999997 108.702 176.93 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -63.59 -38.46 91.22 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.222 0.919 . . . . 45.770000000000003 109.883 173.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -76.97 -21.66 54.39 Favored 'General case' 0 C--N 1.36 1.065 0 CA-C-O 121.557 0.694 . . . . 37.829999999999998 112.685 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 118.73 31.12 1.52 Allowed Glycine 0 C--O 1.215 -1.07 0 O-C-N 120.515 -1.366 . . . . 35.82 113.346 176.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1055 ' ' ALA . . . . . 0.432 ' HB1' HG23 ' B' 1035 ' ' VAL . . . -102.05 135.73 43.12 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 123.175 1.464 . . . . 33.770000000000003 109.558 178.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -75.4 105.5 6.46 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 106.374 -1.713 . . . . 51.020000000000003 106.374 174.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1057 ' ' ILE . . . . . . . . . . . . . 37.5 mm -77.64 85.62 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 O-C-N 120.476 -1.39 . . . . 38.469999999999999 107.597 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1058 ' ' VAL . . . . . 0.469 ' O ' ' HB ' ' B' 1063 ' ' VAL . 3.5 m -117.98 123.7 72.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 125.038 1.461 . . . . 39.399999999999999 110.712 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1059 ' ' GLU . . . . . 0.586 ' HG3' ' H ' ' B' 1037 ' ' SER . 5.4 mp0 -90.58 155.77 18.63 Favored 'General case' 0 C--O 1.248 1.01 0 O-C-N 120.758 -1.214 . . . . 57.07 110.274 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1060 ' ' GLY . . . . . 0.408 ' O ' HG12 ' B' 1063 ' ' VAL . . . 65.23 -145.61 49.2 Favored Glycine 0 C--O 1.21 -1.375 0 CA-C-N 113.405 -1.725 . . . . 44.829999999999998 114.23 169.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 5.4 m120 -55.31 -20.26 10.93 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 115.586 1.699 . . . . 46.270000000000003 115.586 -177.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1062 ' ' SER . . . . . . . . . . . . . 28.9 m -59.54 -50.73 72.78 Favored 'General case' 0 CA--C 1.489 -1.395 0 O-C-N 120.166 -1.584 . . . . 43.469999999999999 111.9 164.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1063 ' ' VAL . . . . . 0.469 ' HB ' ' O ' ' B' 1058 ' ' VAL . 0.8 OUTLIER -65.41 -38.42 82.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 120.61 1.55 . . . . 36.979999999999997 109.91 177.55 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 98.9 m95 -66.48 -21.47 66.19 Favored 'General case' 0 C--O 1.269 2.108 0 N-CA-C 114.936 1.458 . . . . 37.899999999999999 114.936 178.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -83.74 90.25 7.29 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 104.687 -2.338 . . . . 46.189999999999998 104.687 169.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1066 ' ' SER . . . . . . . . . . . . . 73.4 m -154.36 150.88 28.41 Favored 'General case' 0 CA--C 1.49 -1.335 0 CA-C-N 113.213 -1.812 . . . . 37.060000000000002 108.512 176.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1067 ' ' GLU . . . . . 0.456 ' OE2' ' HA ' ' B' 1000 ' ' HIS . 78.4 mt-10 -79.3 -17.87 53.78 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 120.799 -1.188 . . . . 43.950000000000003 113.783 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1068 ' ' ILE . . . . . . . . . . . . . 3.1 mp -126.67 143.99 38.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 103.233 -2.877 . . . . 33.5 103.233 173.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 16.5 mm -122.9 105.59 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 102.245 -3.243 . . . . 30.57 102.245 165.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1070 ' ' LEU . . . . . 0.805 ' HB3' HD13 ' B' 1331 ' ' LEU . 81.5 mt -86.7 122.27 30.37 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 101.975 -3.343 . . . . 27.66 101.975 176.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1071 ' ' LYS . . . . . 0.503 ' HG2' ' OE2' ' B' 1008 ' ' GLU . 34.0 tttm -146.58 158.21 43.86 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 108.255 -1.017 . . . . 28.399999999999999 108.255 -169.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1072 ' ' VAL . . . . . 0.471 ' HA ' ' CZ ' ' B' 1327 ' ' TYR . 58.7 t -90.82 -77.0 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 108.481 -0.933 . . . . 23.18 108.481 -176.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1073 ' ' ASN . . . . . 0.441 HD21 ' HG2' ' B' 1013 ' ' GLU . 62.8 m-80 -93.89 146.07 24.17 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 108.178 -1.045 . . . . 25.469999999999999 108.178 -165.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1074 ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' B' 1092 ' ' PHE . . . -50.11 115.38 5.28 Favored Pre-proline 0 C--O 1.249 1.028 0 N-CA-C 114.386 1.254 . . . . 27.899999999999999 114.386 -174.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1075 ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' B' 1074 ' ' ALA . 35.8 Cg_endo -43.57 136.67 6.32 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.26 3.307 . . . . 31.620000000000001 115.587 -173.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1076 ' ' LEU . . . . . 0.41 ' O ' HG13 ' B' 1080 ' ' ILE . 13.3 mt -69.75 166.79 18.51 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 112.047 -2.342 . . . . 40.490000000000002 107.905 173.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1077 ' ' ASP . . . . . 0.598 ' HA ' HD12 ' B' 1080 ' ' ILE . 27.7 t70 -58.76 -35.83 73.4 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 119.315 -0.954 . . . . 51.590000000000003 110.065 -174.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.39 -39.47 81.69 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 122.307 1.051 . . . . 42.359999999999999 109.549 -178.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1079 ' ' GLU . . . . . 0.468 ' HA ' HD12 ' B' 1082 ' ' LEU . 27.9 mt-10 -68.11 -27.25 66.3 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 113.678 -1.601 . . . . 34.530000000000001 109.636 175.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1080 ' ' ILE . . . . . 0.598 HD12 ' HA ' ' B' 1077 ' ' ASP . 88.3 mt -70.84 -37.75 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 120.461 1.482 . . . . 33.25 108.071 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -64.84 -46.99 79.58 Favored 'General case' 0 C--O 1.247 0.959 0 N-CA-C 109.822 -0.436 . . . . 36.469999999999999 109.822 174.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1082 ' ' LEU . . . . . 0.468 HD12 ' HA ' ' B' 1079 ' ' GLU . 33.0 mt -53.96 -44.96 71.18 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 125.119 1.368 . . . . 37.759999999999998 113.314 177.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1083 ' ' LEU . . . . . 0.583 ' HB3' HG11 ' B' 1110 ' ' VAL . 9.6 mt -57.89 125.09 21.55 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 122.396 1.093 . . . . 37.43 109.9 175.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -96.17 147.09 32.43 Favored Pre-proline 0 N--CA 1.438 -1.073 0 CA-C-N 114.279 -1.328 . . . . 37.700000000000003 108.522 -172.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -51.93 122.6 10.77 Favored 'Trans proline' 0 N--CA 1.451 -0.996 1 C-N-CA 126.114 4.543 . . . . 35.509999999999998 114.319 -178.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 98.22 -15.16 61.74 Favored Glycine 0 N--CA 1.466 0.678 0 CA-C-N 113.123 -1.853 . . . . 33.869999999999997 113.003 176.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1087 ' ' THR . . . . . . . . . . . . . 29.3 m -63.02 133.14 54.1 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 124.515 2.103 . . . . 32.5 111.299 174.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1088 ' ' THR . . . . . 0.677 ' HA ' ' HB ' ' B' 1111 ' ' THR . 4.8 m -74.42 92.53 2.33 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 113.233 -1.803 . . . . 30.219999999999999 111.059 176.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1089 ' ' LEU . . . . . 0.475 HD13 HD11 ' B' 1083 ' ' LEU . 14.2 tp -76.89 119.69 20.99 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 122.374 1.083 . . . . 27.239999999999998 108.721 171.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 24.8 t -112.95 122.61 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 107.304 -1.369 . . . . 25.390000000000001 107.304 171.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1091 ' ' SER . . . . . 0.42 ' OG ' ' HB3' ' B' 1071 ' ' LYS . 69.0 m -157.58 165.38 35.69 Favored 'General case' 0 CA--C 1.504 -0.799 0 O-C-N 120.122 -1.611 . . . . 28.809999999999999 109.995 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1092 ' ' PHE . . . . . 0.449 ' O ' ' HB2' ' B' 1074 ' ' ALA . 2.2 m-85 -62.53 96.35 0.08 Allowed 'General case' 0 N--CA 1.466 0.351 0 O-C-N 119.374 -2.078 . . . . 30.780000000000001 107.978 159.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1093 ' ' ILE . . . . . 0.407 ' CD1' ' HB2' ' B' 1091 ' ' SER . 44.0 mm -88.63 -27.7 5.4 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.184 0 O-C-N 121.087 -1.008 . . . . 30.280000000000001 112.683 -174.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1094 ' ' TRP . . . . . . . . . . . . . 76.1 m95 50.37 54.7 15.98 Favored Pre-proline 0 C--N 1.321 -0.654 0 O-C-N 124.486 1.116 . . . . 34.07 113.957 -177.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -41.5 -56.26 1.9 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 1 C-N-CA 125.776 4.317 . . . . 38.659999999999997 117.607 -164.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -66.99 -38.56 86.26 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 121.015 1.734 . . . . 41.32 111.826 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -68.61 -22.46 64.43 Favored 'General case' 0 C--O 1.209 -1.051 0 CA-C-N 113.644 -1.616 . . . . 51.659999999999997 111.199 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1098 ' ' ASN . . . . . 0.567 ' HB3' ' HB2' ' B' 1101 ' ' LEU . 96.0 m-20 -126.25 68.84 66.69 Favored Pre-proline 0 N--CA 1.439 -0.987 0 O-C-N 120.364 -1.46 . . . . 40.32 109.94 -174.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -64.94 -62.18 0.09 OUTLIER 'Trans proline' 0 CA--C 1.559 1.756 0 C-N-CA 124.112 3.208 . . . . 41.560000000000002 109.85 -174.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -51.87 -44.0 63.5 Favored 'General case' 0 C--N 1.374 1.664 0 N-CA-C 114.101 1.149 . . . . 54.109999999999999 114.101 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1101 ' ' LEU . . . . . 0.567 ' HB2' ' HB3' ' B' 1098 ' ' ASN . 9.1 mp -58.36 -48.16 81.46 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.472 -0.767 . . . . 37.880000000000003 110.034 175.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1102 ' ' MET . . . . . . . . . . . . . 39.6 mmm -57.19 -43.1 82.39 Favored 'General case' 0 C--O 1.241 0.607 0 O-C-N 121.459 -0.775 . . . . 37.539999999999999 112.446 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -71.62 -41.8 68.45 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 107.798 -1.186 . . . . 47.009999999999998 107.798 -171.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1104 ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -61.94 -40.73 96.51 Favored 'General case' 0 C--O 1.262 1.759 0 N-CA-C 114.849 1.425 . . . . 48.68 114.849 175.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1105 ' ' LEU . . . . . 0.479 ' HB3' HG21 ' B' 1112 ' ' VAL . 61.6 mt -64.98 -37.79 88.83 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.779 1.231 . . . . 32.210000000000001 111.16 173.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -60.72 -45.78 92.91 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 117.524 -1.226 . . . . 33.729999999999997 113.138 172.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -55.98 -44.6 78.71 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 122.379 1.085 . . . . 51.469999999999999 112.296 171.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1108 ' ' ARG . . . . . 0.426 ' HG3' HG22 ' B' 1080 ' ' ILE . 24.1 mmm180 -69.51 -6.49 30.99 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 120.747 -1.221 . . . . 43.899999999999999 113.205 178.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1109 ' ' ASN . . . . . 0.463 ' HA ' ' HA2' ' B' 1364 ' ' GLY . 13.7 m-80 62.15 27.6 16.61 Favored 'General case' 0 CA--C 1.486 -1.493 0 N-CA-C 114.084 1.142 . . . . 44.82 114.084 170.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1110 ' ' VAL . . . . . 0.583 HG11 ' HB3' ' B' 1083 ' ' LEU . 11.1 m -84.06 154.18 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 113.516 0.932 . . . . 30.52 113.516 174.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1111 ' ' THR . . . . . 0.677 ' HB ' ' HA ' ' B' 1088 ' ' THR . 4.1 m -86.59 90.85 8.38 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 120.749 -1.219 . . . . 27.120000000000001 109.22 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1112 ' ' VAL . . . . . 0.479 HG21 ' HB3' ' B' 1105 ' ' LEU . 41.0 t -91.51 125.02 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 124.738 1.274 . . . . 26.399999999999999 112.644 -168.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1113 ' ' MET . . . . . 0.679 ' SD ' HD21 ' B' 1334 ' ' LEU . 59.2 mtp -123.18 127.62 48.91 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 104.301 -2.481 . . . . 42.920000000000002 104.301 -176.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -101.56 113.1 25.93 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 122.918 1.342 . . . . 24.149999999999999 112.2 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1115 ' ' MET . . . . . 0.479 ' HB3' ' HB2' ' B' 1129 ' ' ALA . 24.0 mmm -66.81 -21.16 66.05 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 113.395 -1.729 . . . . 29.949999999999999 115.318 -173.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1116 ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -81.02 -52.65 7.19 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 111.253 -2.703 . . . . 34.530000000000001 112.793 172.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1117 ' ' SER . . . . . . . . . . . . . 57.8 m -90.11 68.22 7.09 Favored 'General case' 0 C--O 1.242 0.684 0 O-C-N 118.826 -2.421 . . . . 33.490000000000002 112.021 -171.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1118 ' ' VAL . . . . . . . . . . . . . 1.8 t -94.87 131.18 30.94 Favored Pre-proline 0 N--CA 1.467 0.376 0 CA-C-N 112.967 -1.924 . . . . 34.020000000000003 106.3 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1119 ' ' PRO . . . . . 0.552 ' HG2' ' HA3' ' B' 1357 ' ' GLY . 86.8 Cg_exo -62.34 115.41 2.85 Favored 'Trans proline' 0 C--O 1.249 1.038 1 C-N-CA 125.711 4.274 . . . . 38.280000000000001 112.321 175.204 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B 1120 ' ' ARG . . . . . 0.42 HH12 ' CG ' ' B' 1128 ' ' ASP . 7.8 mmt180 -82.19 86.81 6.58 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 122.367 1.079 . . . . 55.049999999999997 112.74 -166.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1121 ' ' ILE . . . . . 0.519 HG12 HD11 ' B' 1373 ' ' ILE . 11.1 pt -123.16 142.73 38.71 Favored 'Isoleucine or valine' 0 C--O 1.256 1.41 0 N-CA-C 101.351 -3.574 . . . . 42.090000000000003 101.351 151.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1122 ' ' SER . . . . . 0.679 ' HB2' ' HA ' ' C' ' 133' ' ' MET . 2.5 m -37.05 -43.55 0.48 Allowed 'General case' 0 C--O 1.243 0.761 0 N-CA-C 121.466 3.876 . . . . 38.020000000000003 121.466 -161.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1123 ' ' ARG . . . . . 0.515 ' HG3' HG21 ' B' 1354 ' ' VAL . 20.8 ptt-85 -47.9 -31.26 4.93 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 121.364 1.893 . . . . 34.289999999999999 115.549 175.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1124 ' ' ALA . . . . . . . . . . . . . . . -43.13 -47.53 6.15 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 114.623 1.342 . . . . 32.350000000000001 114.623 169.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1125 ' ' GLN . . . . . 0.454 ' HA ' ' HB3' ' B' 1128 ' ' ASP . 30.1 mm100 -52.5 -26.56 13.35 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 116.511 2.041 . . . . 47.170000000000002 116.511 -178.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1126 ' ' SER . . . . . . . . . . . . . 47.3 p -71.27 -32.25 68.48 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 124.135 1.922 . . . . 31.710000000000001 110.968 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1127 ' ' LEU . . . . . . . . . . . . . 4.3 mp -88.12 -32.02 18.89 Favored 'General case' 0 C--N 1.356 0.888 0 CA-C-N 113.949 -1.478 . . . . 37.0 110.268 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1128 ' ' ASP . . . . . 0.454 ' HB3' ' HA ' ' B' 1125 ' ' GLN . 14.7 t0 -58.73 103.87 0.19 Allowed 'General case' 0 CA--C 1.505 -0.773 0 O-C-N 120.291 -1.506 . . . . 40.399999999999999 113.114 -173.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1129 ' ' ALA . . . . . 0.479 ' HB2' ' HB3' ' B' 1115 ' ' MET . . . -63.86 -29.13 70.35 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 111.911 -2.404 . . . . 26.559999999999999 113.862 175.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 53.8 mt -67.95 -31.47 71.24 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-O 117.295 -1.336 . . . . 30.890000000000001 110.66 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1131 ' ' SER . . . . . 0.42 ' HB3' ' NE2' ' B' 1125 ' ' GLN . 84.0 p -60.16 -53.14 61.21 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 122.301 2.319 . . . . 29.84 110.608 175.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1132 ' ' SER . . . . . 0.454 ' HB3' ' HB3' ' B' 1326 ' ' LEU . 51.7 m -57.93 -49.46 76.68 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 113.451 0.908 . . . . 31.91 113.451 176.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1133 ' ' MET . . . . . . . . . . . . . 32.7 mmt -63.84 -37.63 88.09 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 122.678 1.227 . . . . 25.899999999999999 110.667 -175.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1134 ' ' ALA . . . . . 0.864 ' HB1' ' HB2' ' B' 1176 ' ' ALA . . . -62.98 -48.12 80.24 Favored 'General case' 0 N--CA 1.426 -1.64 0 O-C-N 121.139 -0.976 . . . . 26.620000000000001 110.097 171.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -51.23 -51.28 55.46 Favored 'General case' 0 C--N 1.35 0.607 0 C-N-CA 125.287 1.435 . . . . 36.969999999999999 112.247 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1136 ' ' ILE . . . . . 0.536 HG21 ' HA ' ' B' 1316 ' ' PRO . 29.7 mm -50.25 -58.62 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 C-N-CA 124.938 1.295 . . . . 32.109999999999999 108.893 169.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -58.92 -30.14 67.61 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 119.077 -0.487 . . . . 24.140000000000001 110.053 -175.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1138 ' ' GLY . . . . . 0.423 ' HA2' HD21 ' B' 1284 ' ' LEU . . . -66.3 -57.38 10.51 Favored Glycine 0 N--CA 1.479 1.555 0 N-CA-C 109.777 -1.329 . . . . 25.129999999999999 109.777 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 53.4 t80 -55.65 -47.21 77.06 Favored 'General case' 0 C--O 1.204 -1.32 0 CA-C-N 117.9 0.85 . . . . 32.729999999999997 111.706 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1140 ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -67.65 -23.43 65.34 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 116.975 -1.488 . . . . 26.359999999999999 110.848 -178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1141 ' ' ALA . . . . . 0.43 ' HB1' HG21 ' B' 1282 ' ' VAL . . . -64.22 -45.33 88.74 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 122.126 2.239 . . . . 24.120000000000001 111.152 171.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1142 ' ' ILE . . . . . 0.584 HG13 ' HB3' ' B' 1183 ' ' ALA . 49.4 mm -60.49 -44.76 97.1 Favored 'Isoleucine or valine' 0 C--O 1.247 0.937 0 CA-C-N 115.718 -0.674 . . . . 23.370000000000001 110.323 176.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 98.0 t -53.83 -69.99 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 114.607 1.336 . . . . 24.960000000000001 114.607 171.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1144 ' ' GLU . . . . . 0.48 ' HG3' ' HE2' ' B' 1312 ' ' TYR . 43.9 mm-40 -59.12 -27.78 65.92 Favored 'General case' 0 C--O 1.243 0.736 0 O-C-N 121.724 -0.61 . . . . 32.07 111.922 -176.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1145 ' ' ALA . . . . . 0.881 ' HB1' HD12 ' B' 1251 ' ' ILE . . . -58.95 -63.89 1.14 Allowed 'General case' 0 C--O 1.246 0.883 0 CA-C-O 117.459 -1.258 . . . . 24.870000000000001 108.202 169.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1146 ' ' ALA . . . . . . . . . . . . . . . -58.68 -20.33 47.53 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 121.474 1.943 . . . . 24.670000000000002 115.326 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1147 ' ' HIS . . . . . 0.471 ' HB3' ' O ' ' B' 1144 ' ' GLU . 74.9 t60 -62.39 -63.72 1.15 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.254 1.421 . . . . 28.579999999999998 107.674 170.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1148 ' ' GLU . . . . . 0.565 ' HB2' HD11 ' B' 1310 ' ' ILE . 59.2 mm-40 -87.83 -1.65 58.11 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 118.663 2.838 . . . . 36.82 118.663 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1149 ' ' PHE . . . . . 0.441 ' HE1' ' NH2' ' B' 1151 ' ' ARG . 2.7 t80 -69.22 141.65 54.43 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 122.801 1.286 . . . . 31.969999999999999 110.77 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1150 ' ' GLY . . . . . . . . . . . . . . . -66.79 -34.72 88.15 Favored Glycine 0 CA--C 1.536 1.36 0 CA-C-O 118.599 -1.111 . . . . 25.489999999999998 112.461 175.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1151 ' ' ARG . . . . . 0.461 ' HA ' ' HB2' ' A' 1322 ' ' GLN . 71.6 mtm-85 -122.77 177.46 5.46 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 120.773 2.287 . . . . 59.840000000000003 109.6 -157.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1152 ' ' PHE . . . . . 0.968 ' HB2' HG11 ' B' 1163 ' ' VAL . 7.7 m-30 -78.67 156.8 28.82 Favored 'General case' 0 C--O 1.25 1.111 0 CA-C-N 119.79 1.177 . . . . 34.450000000000003 108.69 167.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1153 ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -68.03 -50.8 53.16 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.441 1.591 . . . . 31.170000000000002 108.865 163.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1154 ' ' THR . . . . . . . . . . . . . 2.8 m -61.74 124.32 20.41 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 113.264 -1.789 . . . . 33.890000000000001 115.618 -175.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -74.08 69.78 1.58 Allowed Glycine 0 N--CA 1.442 -0.948 0 O-C-N 120.942 -1.098 . . . . 38.950000000000003 110.738 175.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1156 ' ' GLN . . . . . 0.483 ' H ' ' HB ' ' B' 1163 ' ' VAL . 18.1 tt0 -99.57 133.02 44.5 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-O 123.436 1.589 . . . . 54.229999999999997 112.291 -168.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 20.6 mm -85.77 99.92 8.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 101.191 -3.633 . . . . 51.159999999999997 101.191 173.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1158 ' ' THR . . . . . . . . . . . . . 6.4 m -110.63 101.58 10.22 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.592 -1.186 . . . . 49.609999999999999 108.809 -171.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . 27.31 -71.41 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 120.28 3.437 . . . . 49.049999999999997 120.28 -175.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1160 ' ' ALA . . . . . 0.539 ' HB2' ' ND2' ' A' 1330 ' ' ASN . . . -69.13 -48.87 61.26 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 125.272 1.429 . . . . 47.649999999999999 112.926 175.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . -137.05 -171.56 12.23 Favored Glycine 0 C--O 1.243 0.663 0 CA-C-N 121.856 2.116 . . . . 45.609999999999999 111.283 -170.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 92.0 mttt -111.58 139.22 47.2 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 111.595 -2.303 . . . . 57.460000000000001 109.052 175.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1163 ' ' VAL . . . . . 0.968 HG11 ' HB2' ' B' 1152 ' ' PHE . 74.4 t -98.96 130.91 26.48 Favored Pre-proline 0 N--CA 1.426 -1.662 0 CA-C-O 116.691 -1.623 . . . . 42.93 108.05 170.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1164 ' ' PRO . . . . . 0.506 ' HA ' ' HD3' ' B' 1165 ' ' PRO . 73.0 Cg_endo -69.78 140.2 42.02 Favored 'Trans proline' 0 N--CA 1.441 -1.609 0 C-N-CA 123.715 2.943 . . . . 39.289999999999999 110.432 171.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1165 ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' B' 1164 ' ' PRO . 70.4 Cg_exo -66.78 115.51 3.62 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 123.185 2.59 . . . . 34.170000000000002 111.72 178.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -64.49 125.59 25.16 Favored 'General case' 0 C--N 1.355 0.837 0 CA-C-N 119.496 1.044 . . . . 31.690000000000001 112.875 -177.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1167 ' ' LYS . . . . . 0.625 ' HB2' ' HA ' ' B' 1249 ' ' VAL . 77.4 mttt -90.94 115.12 27.72 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 104.205 -2.517 . . . . 44.780000000000001 104.205 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 85.4 t -104.41 96.25 4.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 O-C-N 120.507 -1.371 . . . . 31.23 108.627 -174.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1169 ' ' MET . . . . . 0.833 ' HB2' HG11 ' B' 1249 ' ' VAL . 57.1 ttp -77.36 94.85 4.28 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 122.63 1.205 . . . . 37.090000000000003 110.697 177.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1170 ' ' VAL . . . . . 0.471 HG22 ' HB ' ' B' 1253 ' ' VAL . 92.8 t -81.26 115.88 24.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 N-CA-C 107.075 -1.454 . . . . 30.170000000000002 107.075 175.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1171 ' ' ILE . . . . . 0.519 HG22 ' HB2' ' B' 1256 ' ' ALA . 84.0 mt -98.85 112.76 31.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 104.456 -2.424 . . . . 33.740000000000002 104.456 174.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 98.19 91.39 1.95 Allowed Glycine 0 CA--C 1.486 -1.78 0 CA-C-N 113.547 -1.66 . . . . 32.590000000000003 109.166 175.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1173 ' ' ALA . . . . . 0.474 ' H ' ' HB2' ' B' 1195 ' ' ASP . . . -75.68 61.28 1.35 Allowed 'General case' 0 C--O 1.253 1.251 0 CA-C-O 123.46 1.6 . . . . 32.420000000000002 112.095 174.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -78.48 -170.06 36.54 Favored Glycine 0 C--O 1.224 -0.502 0 O-C-N 120.745 -1.222 . . . . 31.739999999999998 110.063 170.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 36.5 t -56.44 -44.98 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-N 119.224 1.512 . . . . 31.48 111.031 174.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1176 ' ' ALA . . . . . 0.864 ' HB2' ' HB1' ' B' 1134 ' ' ALA . . . -55.19 -50.25 69.85 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 123.856 0.862 . . . . 26.120000000000001 112.136 172.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1177 ' ' GLY . . . . . . . . . . . . . . . -54.56 -47.39 70.3 Favored Glycine 0 C--N 1.344 1.01 0 O-C-N 125.008 1.442 . . . . 25.73 109.574 178.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1178 ' ' LEU . . . . . 0.478 ' HA ' HD12 ' B' 1181 ' ' ILE . 81.3 mt -66.57 -34.94 79.01 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.778 -1.424 . . . . 32.590000000000003 112.684 -173.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -71.73 -33.93 69.13 Favored 'General case' 0 C--N 1.351 0.674 0 O-C-N 120.452 -1.405 . . . . 27.719999999999999 112.26 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -67.16 -42.58 84.08 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 123.044 1.402 . . . . 26.030000000000001 110.348 172.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1181 ' ' ILE . . . . . 0.752 HG22 ' HG2' ' B' 1207 ' ' MET . 60.0 mt -58.71 -45.82 90.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 O-C-N 119.6 -1.937 . . . . 28.609999999999999 112.314 174.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -53.94 -55.08 27.62 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-N 115.105 -0.952 . . . . 25.23 111.942 172.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1183 ' ' ALA . . . . . 0.584 ' HB3' HG13 ' B' 1142 ' ' ILE . . . -60.31 -50.05 75.18 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.985 1.393 . . . . 24.09 113.265 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -69.58 -33.78 73.2 Favored 'General case' 0 C--O 1.241 0.636 0 O-C-N 121.401 -0.812 . . . . 26.68 110.404 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -68.71 -41.11 79.55 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 120.379 -1.45 . . . . 36.57 111.027 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1186 ' ' SER . . . . . 0.846 ' HB3' ' HA ' ' A' 1187 ' ' LEU . 70.7 m -51.62 -44.36 62.87 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 122.211 1.005 . . . . 28.920000000000002 113.497 163.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1187 ' ' LEU . . . . . . . . . . . . . 74.7 mt -78.92 -1.76 36.71 Favored 'General case' 0 N--CA 1.433 -1.298 0 O-C-N 119.893 -1.754 . . . . 29.09 113.92 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 71.17 42.19 58.63 Favored Glycine 0 C--O 1.219 -0.817 0 O-C-N 120.746 -1.221 . . . . 29.260000000000002 111.961 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1189 ' ' ALA . . . . . . . . . . . . 0.251 . . -104.59 154.06 20.41 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.491 -0.559 . . . . 30.16 109.491 172.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1190 ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' B' 1167 ' ' LYS . 65.1 mt -81.11 93.37 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 O-C-N 119.726 -1.859 . . . . 35.810000000000002 108.389 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1191 ' ' VAL . . . . . 0.437 HG11 HG12 ' B' 1181 ' ' ILE . 4.4 t -78.4 125.57 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.289 -1.004 . . . . 31.969999999999999 108.289 -178.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1192 ' ' ARG . . . . . 0.512 HH12 ' CD ' ' B' 1248 ' ' GLU . 27.0 mmt85 -112.33 94.44 4.93 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 106.081 -1.822 . . . . 48.159999999999997 106.081 177.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -103.78 133.34 48.93 Favored 'General case' 0 C--N 1.355 0.845 0 O-C-N 119.223 -2.173 . . . . 35.890000000000001 115.044 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 38.4 t80 -108.16 156.46 19.29 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 105.02 -2.215 . . . . 41.880000000000003 105.02 176.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1195 ' ' ASP . . . . . 0.474 ' HB2' ' H ' ' B' 1173 ' ' ALA . 7.5 t70 -167.23 146.69 5.22 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 113.371 -1.741 . . . . 38.280000000000001 107.949 163.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1196 ' ' THR . . . . . . . . . . . . . 2.7 p -68.27 -31.49 70.98 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 115.474 1.657 . . . . 40.619999999999997 115.474 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1197 ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -79.02 139.85 57.29 Favored Pre-proline 0 C--N 1.304 -1.391 0 CA-C-O 122.341 1.067 . . . . 53.090000000000003 110.928 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -69.09 -37.33 10.94 Favored 'Trans proline' 0 C--O 1.236 0.414 0 N-CA-C 117.991 2.266 . . . . 42.560000000000002 117.991 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -30.28 71.47 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 122.286 2.312 . . . . 56.310000000000002 116.514 -170.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1200 ' ' VAL . . . . . 0.537 ' HA ' ' HG2' ' B' 1203 ' ' GLN . 2.1 m -63.99 -29.07 46.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 114.654 -1.157 . . . . 42.909999999999997 113.201 174.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 41.6 tttm -43.03 -56.57 3.27 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 115.711 1.745 . . . . 48.890000000000001 115.711 175.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -56.75 -37.99 71.8 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.604 -1.18 . . . . 51.700000000000003 112.824 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1203 ' ' GLN . . . . . 0.604 ' OE1' ' HA ' ' C' ' 74' ' ' ARG . 47.3 mm-40 -60.19 -52.07 66.88 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 109.187 -0.671 . . . . 52.57 109.187 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1204 ' ' VAL . . . . . 0.488 HG22 HD13 ' B' 1181 ' ' ILE . 99.7 t -61.79 -47.57 92.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 O-C-N 125.561 1.788 . . . . 33.789999999999999 110.671 -174.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -53.41 -49.34 67.5 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 125.366 1.466 . . . . 36.579999999999998 111.025 175.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1206 ' ' SER . . . . . . . . . . . . . 18.8 m -80.01 -3.38 48.2 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 114.149 1.166 . . . . 39.609999999999999 114.149 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1207 ' ' MET . . . . . 0.752 ' HG2' HG22 ' B' 1181 ' ' ILE . 9.1 tpt -79.21 -22.38 44.95 Favored 'General case' 0 CA--C 1.511 -0.523 0 O-C-N 120.911 -1.118 . . . . 37.450000000000003 111.019 163.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 96.23 41.59 3.69 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 119.777 -1.827 . . . . 31.870000000000001 109.522 -173.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -144.95 142.79 30.13 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 123.759 0.824 . . . . 35.399999999999999 111.831 -171.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -80.74 130.69 35.22 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.981 -0.748 . . . . 47.890000000000001 108.981 -173.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 53.2 t80 -96.77 110.84 23.23 Favored 'General case' 0 C--O 1.247 0.925 0 N-CA-C 105.967 -1.864 . . . . 45.530000000000001 105.967 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1212 ' ' LEU . . . . . . . . . . . . . 78.6 mt -70.66 129.68 39.8 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 105.107 -2.182 . . . . 46.329999999999998 105.107 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -115.28 164.55 14.07 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 114.603 -1.18 . . . . 60.409999999999997 111.246 -170.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 4.9 mp -70.57 137.69 50.29 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-O 121.228 0.537 . . . . 57.380000000000003 109.875 -167.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1215 ' ' ASP . . . . . 0.885 ' HB3' ' HB1' ' B' 1237 ' ' ALA . 19.5 t70 . . . . . 0 N--CA 1.476 0.84 0 O-C-N 120.697 -1.252 . . . . 65.069999999999993 111.066 -169.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1230 ' ' MET . . . . . 0.493 ' HA ' ' HB2' ' B' 1231 ' ' SER . 28.5 mmt . . . . . 0 N--CA 1.422 -1.865 0 N-CA-C 109.654 -0.499 . . . . 80.319999999999993 109.654 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1231 ' ' SER . . . . . 0.493 ' HB2' ' HA ' ' B' 1230 ' ' MET . 40.0 m 70.05 174.51 0.29 Allowed 'General case' 0 N--CA 1.476 0.853 2 O-C-N 112.163 -6.586 . . . . 79.920000000000002 117.433 -1.584 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -114.3 -117.37 0.32 Allowed 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 105.254 -2.128 . . . . 77.909999999999997 105.254 175.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 57.99 -60.51 0.03 OUTLIER 'General case' 0 C--O 1.241 0.649 0 CA-C-N 123.073 2.669 . . . . 73.879999999999995 116.132 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.41 -26.3 66.59 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 120.218 1.372 . . . . 68.980000000000004 112.0 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 37.3 pt -31.27 -44.91 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.247 0.931 0 N-CA-C 116.056 1.873 . . . . 64.530000000000001 116.056 164.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -63.69 -39.17 93.65 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-O 121.336 0.589 . . . . 66.359999999999999 109.656 -177.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1237 ' ' ALA . . . . . 0.885 ' HB1' ' HB3' ' B' 1215 ' ' ASP . . . -68.02 -52.3 37.21 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.507 -0.77 . . . . 56.600000000000001 111.888 176.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1238 ' ' GLU . . . . . 0.414 ' HB3' ' CE2' ' B' 1242 ' ' PHE . 75.1 mt-10 -50.39 -66.2 0.43 Allowed 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 125.06 1.344 . . . . 56.789999999999999 110.405 176.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1239 ' ' MET . . . . . . . . . . . . . 82.7 mtp -50.49 -40.57 51.54 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 115.929 1.826 . . . . 53.630000000000003 115.929 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -57.27 -49.78 75.0 Favored 'General case' 0 C--O 1.259 1.601 0 O-C-N 124.511 1.132 . . . . 51.740000000000002 110.742 173.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 4.2 tt -66.34 -37.36 85.16 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 116.214 -0.448 . . . . 44.859999999999999 110.525 -174.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1242 ' ' PHE . . . . . 0.414 ' CE2' ' HB3' ' B' 1238 ' ' GLU . 23.1 m-30 -67.17 -42.49 84.21 Favored 'General case' 0 N--CA 1.438 -1.041 0 O-C-N 126.257 2.223 . . . . 42.780000000000001 109.597 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1243 ' ' ALA . . . . . 0.509 ' HA ' ' HG3' ' B' 1271 ' ' MET . . . -63.65 -40.84 97.86 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 120.294 -1.504 . . . . 40.960000000000001 108.607 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -67.41 -34.43 77.23 Favored 'General case' 0 C--O 1.246 0.907 0 O-C-N 120.58 -1.325 . . . . 43.060000000000002 110.798 175.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1245 ' ' GLN . . . . . 0.432 ' O ' HG22 ' B' 1249 ' ' VAL . 25.5 mm-40 -70.03 -27.58 64.78 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.378 0.881 . . . . 46.450000000000003 113.378 168.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -57.43 -45.38 84.72 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 119.953 -1.717 . . . . 41.780000000000001 111.598 -176.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 21.1 tptt -62.26 -31.69 72.3 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.33 0.863 . . . . 52.200000000000003 113.33 173.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1248 ' ' GLU . . . . . 0.512 ' CD ' HH12 ' B' 1192 ' ' ARG . 0.5 OUTLIER -77.35 -43.64 32.23 Favored 'General case' 0 C--O 1.248 0.986 0 O-C-N 121.394 -0.816 . . . . 53.549999999999997 113.019 177.646 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B 1249 ' ' VAL . . . . . 0.833 HG11 ' HB2' ' B' 1169 ' ' MET . 30.0 m -81.49 -179.26 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.031 0 O-C-N 120.575 -1.328 . . . . 34.409999999999997 114.457 -160.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1250 ' ' ASP . . . . . 0.42 ' O ' ' HB3' ' B' 1279 ' ' SER . 6.2 m-20 -132.94 -37.94 0.99 Allowed 'General case' 0 C--O 1.247 0.948 0 CA-C-N 113.087 -1.869 . . . . 33.380000000000003 109.616 -172.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1251 ' ' ILE . . . . . 0.881 HD12 ' HB1' ' B' 1145 ' ' ALA . 41.1 mm -129.8 138.11 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 N-CA-C 104.469 -2.419 . . . . 29.539999999999999 104.469 175.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1252 ' ' ILE . . . . . 0.489 HG22 ' HB ' ' B' 1254 ' ' THR . 78.7 mt -112.84 116.36 52.4 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 N-CA-C 103.641 -2.726 . . . . 32.439999999999998 103.641 166.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1253 ' ' VAL . . . . . 0.484 HG13 HD11 ' B' 1284 ' ' LEU . 42.8 t -97.57 87.56 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.258 1.52 0 N-CA-C 102.139 -3.282 . . . . 30.57 102.139 176.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1254 ' ' THR . . . . . 0.489 ' HB ' HG22 ' B' 1252 ' ' ILE 0.286 1.3 t -89.7 104.63 17.17 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 126.245 2.926 . . . . 35.039999999999999 109.141 -174.274 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B 1255 ' ' THR . . . . . 0.433 ' CG2' ' HB3' ' B' 1176 ' ' ALA . 21.9 m -110.99 -5.26 14.86 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 109.021 -3.718 . . . . 34.619999999999997 113.099 -169.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1256 ' ' ALA . . . . . 0.519 ' HB2' HG22 ' B' 1171 ' ' ILE . . . -71.08 79.7 0.68 Allowed 'General case' 0 C--O 1.247 0.921 0 CA-C-O 124.026 1.869 . . . . 42.719999999999999 112.45 -162.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1257 ' ' LEU . . . . . 0.583 HD23 ' HB2' ' B' 1263 ' ' ALA . 29.2 mt -92.56 120.9 33.47 Favored 'General case' 0 C--O 1.249 1.077 0 N-CA-C 106.912 -1.514 . . . . 52.43 106.912 169.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 70.1 mt -81.68 113.6 43.65 Favored Pre-proline 0 N--CA 1.449 -0.486 0 N-CA-C 102.055 -3.313 . . . . 59.409999999999997 102.055 176.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -57.02 94.44 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 124.077 3.185 . . . . 62.68 115.746 -171.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 135.56 -44.91 1.13 Allowed Glycine 0 CA--C 1.493 -1.285 0 CA-C-N 112.065 -2.334 . . . . 64.159999999999997 108.479 174.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 82.5 mttt -68.98 161.78 69.85 Favored Pre-proline 0 N--CA 1.446 -0.626 0 O-C-N 120.215 -1.756 . . . . 68.530000000000001 114.335 172.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -61.07 157.48 39.07 Favored 'Trans proline' 0 N--CA 1.44 -1.64 0 C-N-CA 122.235 1.957 . . . . 61.990000000000002 111.504 157.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1263 ' ' ALA . . . . . 0.583 ' HB2' HD23 ' B' 1257 ' ' LEU . . . -66.14 128.23 93.7 Favored Pre-proline 0 N--CA 1.416 -2.142 0 O-C-N 120.761 -1.212 . . . . 57.149999999999999 112.811 174.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1264 ' ' PRO . . . . . 0.462 ' HD2' ' O ' ' B' 1256 ' ' ALA . 73.1 Cg_endo -68.15 137.94 42.04 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 123.787 2.991 . . . . 51.57 110.24 -176.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -76.9 71.15 3.4 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 123.358 1.552 . . . . 54.549999999999997 111.248 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 63.4 mt -70.1 -42.58 72.51 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 124.086 1.898 . . . . 46.859999999999999 110.7 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1267 ' ' ILE . . . . . 0.742 ' HB ' ' HA ' ' B' 1292 ' ' CYS . 44.4 mm -80.07 93.44 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 O-C-N 119.207 -2.183 . . . . 41.039999999999999 107.129 -177.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1268 ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.81 152.63 31.0 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 113.429 -1.714 . . . . 39.579999999999998 112.8 170.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1269 ' ' ARG . . . . . . . . . . . . . 73.1 mtt85 -56.4 -37.97 70.86 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 120.782 -1.199 . . . . 53.149999999999999 111.675 172.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -43.85 -54.54 5.17 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 125.888 1.675 . . . . 42.960000000000001 114.376 168.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1271 ' ' MET . . . . . 0.509 ' HG3' ' HA ' ' B' 1243 ' ' ALA . 48.7 ttm -64.37 -33.91 76.95 Favored 'General case' 0 C--N 1.353 0.758 0 CA-C-N 114.648 -1.16 . . . . 43.890000000000001 109.551 -174.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1272 ' ' VAL . . . . . 0.656 HG11 HG21 ' B' 1303 ' ' THR . 21.5 t -65.89 -48.58 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 123.315 1.531 . . . . 38.369999999999997 108.087 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -67.47 -14.63 63.1 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 120.802 -1.187 . . . . 47.460000000000001 114.155 173.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1274 ' ' SER . . . . . . . . . . . . . 48.6 m -86.73 0.2 55.14 Favored 'General case' 0 N--CA 1.44 -0.926 0 O-C-N 119.2 -2.187 . . . . 38.380000000000003 114.367 168.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1275 ' ' MET . . . . . 0.653 ' HB2' HG21 ' B' 1307 ' ' VAL . 55.6 mtp -82.24 156.98 24.08 Favored 'General case' 0 CA--C 1.486 -1.499 0 O-C-N 118.502 -2.624 . . . . 37.810000000000002 112.946 173.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -62.39 146.59 50.9 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 112.743 -2.026 . . . . 49.259999999999998 107.25 167.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -73.62 150.43 41.37 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 114.319 1.229 . . . . 34.460000000000001 114.319 -176.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 62.18 51.6 55.57 Favored Glycine 0 N--CA 1.479 1.521 0 CA-C-O 124.859 2.366 . . . . 33.530000000000001 111.698 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1279 ' ' SER . . . . . 0.42 ' HB3' ' O ' ' B' 1250 ' ' ASP . 45.4 m -134.49 154.27 51.51 Favored 'General case' 0 C--O 1.26 1.607 0 CA-C-N 111.543 -2.328 . . . . 31.309999999999999 105.348 -173.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1280 ' ' VAL . . . . . . . . . . . . . 63.3 t -120.65 138.99 49.33 Favored 'Isoleucine or valine' 0 C--O 1.247 0.961 0 O-C-N 119.459 -2.026 . . . . 29.32 109.108 -170.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1281 ' ' ILE . . . . . . . . . . . . . 40.7 mt -106.81 101.48 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 105.874 -1.899 . . . . 31.93 105.874 168.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1282 ' ' VAL . . . . . 0.472 HG23 ' HA ' ' B' 1253 ' ' VAL . 0.0 OUTLIER -89.81 114.65 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.179 0 CA-C-O 124.414 2.054 . . . . 29.48 107.498 176.719 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B 1283 ' ' ASP . . . . . 0.408 ' HA ' HG22 ' B' 1254 ' ' THR . 22.5 t0 -94.51 108.48 20.42 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 113.192 -1.822 . . . . 34.5 106.439 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1284 ' ' LEU . . . . . 0.484 HD11 HG13 ' B' 1253 ' ' VAL . 5.9 mp -84.78 -33.43 22.99 Favored 'General case' 0 C--O 1.255 1.354 0 CA-C-N 112.448 -2.16 . . . . 37.939999999999998 108.779 174.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1285 ' ' ALA . . . . . 0.519 ' HB1' ' CB ' ' B' 1263 ' ' ALA . . . -75.23 -9.67 58.76 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 113.298 -1.774 . . . . 40.920000000000002 110.881 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -42.65 -30.02 0.34 Allowed 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 118.709 2.855 . . . . 44.390000000000001 118.709 169.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1287 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.96 -36.56 83.68 Favored 'General case' 0 C--N 1.363 1.157 0 CA-C-N 121.385 1.902 . . . . 51.460000000000001 110.566 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 20.9 t30 -122.92 100.09 6.71 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 122.996 1.379 . . . . 57.75 109.328 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1289 ' ' GLY . . . . . . . . . . . . . . . 82.9 -60.85 4.85 Favored Glycine 0 C--O 1.259 1.693 0 O-C-N 119.858 -1.776 . . . . 49.850000000000001 114.274 177.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 90.61 128.35 3.84 Favored Glycine 0 C--O 1.252 1.234 0 O-C-N 120.674 -1.486 . . . . 45.93 111.535 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1291 ' ' ASN . . . . . . . . . . . . . 7.7 m120 -80.83 -31.57 35.46 Favored 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 124.298 0.646 . . . . 42.670000000000002 110.667 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1292 ' ' CYS . . . . . 0.742 ' HA ' ' HB ' ' B' 1267 ' ' ILE . 52.5 t -92.1 140.49 29.59 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.285 -1.005 . . . . 38.82 108.285 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1293 ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -65.57 -45.28 83.89 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 113.376 0.88 . . . . 46.710000000000001 113.376 171.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1294 ' ' TYR . . . . . 0.513 ' HD2' HG21 ' B' 1272 ' ' VAL . 26.2 m-85 -63.78 -15.57 59.03 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 117.458 2.392 . . . . 47.229999999999997 117.458 -178.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1295 ' ' THR . . . . . 0.589 ' OG1' ' HB3' ' B' 1292 ' ' CYS . 33.2 m -59.98 119.02 6.98 Favored 'General case' 0 C--O 1.262 1.755 0 O-C-N 120.986 -1.071 . . . . 36.020000000000003 111.41 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 60.8 t -79.49 121.42 82.69 Favored Pre-proline 0 N--CA 1.473 0.694 0 N-CA-C 102.767 -3.049 . . . . 37.259999999999998 102.767 163.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -62.45 92.63 0.13 Allowed 'Trans proline' 0 C--O 1.249 1.036 0 C-N-CA 124.592 3.528 . . . . 35.090000000000003 110.542 -177.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1298 ' ' GLY . . . . . 0.656 ' HA2' ' HA ' ' B' 1312 ' ' TYR . . . 114.66 27.02 3.43 Favored Glycine 0 N--CA 1.443 -0.886 0 O-C-N 120.861 -1.15 . . . . 35.969999999999999 112.237 175.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -153.04 171.4 18.44 Favored 'General case' 0 C--N 1.356 0.861 0 CA-C-N 121.001 2.401 . . . . 40.390000000000001 116.079 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1300 ' ' ILE . . . . . 0.681 HG23 HG12 ' B' 1310 ' ' ILE . 18.9 mt -87.82 160.08 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 O-C-N 122.103 -0.373 . . . . 37.43 110.086 165.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 51.6 t80 -150.44 161.71 41.98 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 106.116 -1.809 . . . . 44.130000000000003 106.116 169.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1302 ' ' THR . . . . . . . . . . . . . 9.2 m -136.16 138.39 41.9 Favored 'General case' 0 C--O 1.253 1.249 0 O-C-N 120.519 -1.363 . . . . 39.780000000000001 109.483 173.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1303 ' ' THR . . . . . 0.656 HG21 HG11 ' B' 1272 ' ' VAL . 41.4 p -98.37 168.49 10.18 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 126.004 2.065 . . . . 43.289999999999999 114.095 -167.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -47.74 -49.4 28.38 Favored 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 124.721 1.208 . . . . 53.07 113.161 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 32.9 p-10 -67.69 -39.95 84.39 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 115.226 1.565 . . . . 43.969999999999999 115.226 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 127.62 29.03 0.85 Allowed Glycine 0 CA--C 1.527 0.783 0 N-CA-C 109.547 -1.421 . . . . 41.119999999999997 109.547 177.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1307 ' ' VAL . . . . . 0.653 HG21 ' HB2' ' B' 1275 ' ' MET . 47.3 t -98.61 148.25 6.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 107.409 -1.33 . . . . 38.119999999999997 107.409 173.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1308 ' ' LYS . . . . . 0.454 ' CD ' ' HB3' ' B' 1148 ' ' GLU . 90.6 mttt -113.27 128.51 56.49 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 118.718 -2.489 . . . . 36.340000000000003 105.482 -175.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1309 ' ' VAL . . . . . . . . . . . . . 42.7 t -110.06 130.41 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 103.294 -2.854 . . . . 30.399999999999999 103.294 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1310 ' ' ILE . . . . . 0.681 HG12 HG23 ' B' 1300 ' ' ILE . 52.9 mt -127.14 113.01 30.48 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.411 0 N-CA-C 105.108 -2.182 . . . . 30.82 105.108 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1311 ' ' GLY . . . . . 0.585 ' HA3' HG23 ' B' 1295 ' ' THR . . . -132.98 117.54 1.97 Allowed Glycine 0 C--O 1.214 -1.134 0 N-CA-C 104.789 -3.324 . . . . 26.530000000000001 104.789 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1312 ' ' TYR . . . . . 0.666 ' HB2' ' HG ' ' B' 1315 ' ' LEU . 36.0 m-85 -117.59 128.03 54.55 Favored 'General case' 0 CA--C 1.493 -1.235 0 CA-C-N 118.345 1.073 . . . . 38.0 110.667 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1313 ' ' THR . . . . . . . . . . . . . 26.3 m -68.11 -28.42 67.31 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.511 -1.677 . . . . 29.800000000000001 107.601 167.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -89.4 18.61 5.09 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 124.835 1.254 . . . . 39.039999999999999 113.592 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1315 ' ' LEU . . . . . 0.666 ' HG ' ' HB2' ' B' 1312 ' ' TYR . 6.9 mt -48.24 -40.21 34.34 Favored Pre-proline 0 CA--C 1.509 -0.633 0 N-CA-C 117.25 2.315 . . . . 31.079999999999998 117.25 177.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1316 ' ' PRO . . . . . 0.536 ' HA ' HG21 ' B' 1136 ' ' ILE . 17.9 Cg_exo -64.19 -44.56 11.92 Favored 'Trans proline' 0 CA--C 1.513 -0.548 0 C-N-CA 123.911 3.074 . . . . 26.100000000000001 111.968 169.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -56.02 -33.05 60.15 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 115.524 0.969 . . . . 23.170000000000002 115.524 172.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -54.9 -23.92 21.03 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 113.623 0.971 . . . . 40.399999999999999 113.623 171.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 12.6 tp -126.76 79.73 71.59 Favored Pre-proline 0 N--CA 1.442 -0.874 0 O-C-N 119.08 -2.263 . . . . 23.600000000000001 107.194 176.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1320 ' ' PRO . . . . . 0.617 ' HB3' ' HB ' ' B' 1014 ' ' THR . 51.6 Cg_endo -58.65 -63.04 0.15 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.801 3.001 . . . . 22.350000000000001 119.246 -171.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1321 ' ' THR . . . . . . . . . . . . . 2.3 m -57.02 -43.82 82.23 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 119.666 1.121 . . . . 26.52 109.779 -175.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1322 ' ' GLN . . . . . 0.568 ' HB2' ' HA ' ' A' 1151 ' ' ARG . 34.4 tp60 -74.13 -35.79 64.14 Favored 'General case' 0 CA--C 1.493 -1.218 0 O-C-N 121.626 -0.671 . . . . 24.379999999999999 112.442 -172.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1323 ' ' SER . . . . . . . . . . . . . 68.6 m -61.01 -45.28 95.46 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 113.905 1.076 . . . . 22.800000000000001 113.905 168.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1324 ' ' SER . . . . . . . . . . . . . 14.5 m -59.01 -37.94 78.07 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.89 0.476 . . . . 21.25 111.015 175.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1325 ' ' GLN . . . . . 0.435 ' HG2' ' HD2' ' A' 1164 ' ' PRO . 43.6 tp60 -63.05 -49.18 75.59 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 113.12 0.785 . . . . 31.34 113.12 171.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1326 ' ' LEU . . . . . 0.471 ' HA ' HD23 ' B' 1326 ' ' LEU . 35.7 mt -78.57 -48.1 15.87 Favored 'General case' 0 CA--C 1.488 -1.439 0 O-C-N 120.092 -1.63 . . . . 31.559999999999999 113.02 -170.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1327 ' ' TYR . . . . . 0.471 ' CZ ' ' HA ' ' B' 1072 ' ' VAL . 38.7 t80 -57.26 -42.81 82.27 Favored 'General case' 0 C--N 1.359 1.003 0 N-CA-C 107.536 -1.283 . . . . 22.73 107.536 170.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1328 ' ' GLY . . . . . 0.803 ' HA2' HD12 ' B' 1331 ' ' LEU . . . -52.37 -50.87 45.52 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 123.472 0.558 . . . . 21.91 112.438 171.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1329 ' ' THR . . . . . 0.628 HG21 ' HA3' ' A' 1161 ' ' GLY . 34.6 m -65.39 -29.46 70.16 Favored 'General case' 0 C--O 1.245 0.84 0 O-C-N 119.004 -2.468 . . . . 22.149999999999999 111.265 177.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1330 ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' B' 1327 ' ' TYR . 20.3 m120 -60.59 -49.19 78.53 Favored 'General case' 0 C--O 1.25 1.12 0 CA-C-O 122.446 1.117 . . . . 26.18 110.889 173.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1331 ' ' LEU . . . . . 0.805 HD13 ' HB3' ' B' 1070 ' ' LEU . 36.4 mt -53.21 -46.16 68.95 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 113.278 -1.783 . . . . 23.68 113.16 171.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1332 ' ' VAL . . . . . 0.574 HG12 ' HE3' ' B' 1336 ' ' LYS . 39.0 t -53.79 -50.0 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 115.754 -0.657 . . . . 26.57 110.643 171.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1333 ' ' ASN . . . . . 0.59 ' HA ' ' HD2' ' B' 1336 ' ' LYS . 76.3 m-20 -69.55 -27.37 65.09 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 119.875 -1.766 . . . . 28.079999999999998 113.303 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1334 ' ' LEU . . . . . 0.679 HD21 ' SD ' ' B' 1113 ' ' MET . 1.2 tt -66.96 -51.62 52.88 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 106.206 -1.775 . . . . 27.43 106.206 175.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1335 ' ' LEU . . . . . . . . . . . . . 86.3 mt -62.4 -29.75 70.71 Favored 'General case' 0 C--N 1.355 0.844 0 CA-C-N 115.162 -0.926 . . . . 30.5 111.255 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1336 ' ' LYS . . . . . 0.59 ' HD2' ' HA ' ' B' 1333 ' ' ASN . 95.0 mttt -64.8 -45.73 85.05 Favored 'General case' 0 C--O 1.245 0.843 0 O-C-N 120.418 -1.426 . . . . 41.649999999999999 110.052 169.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 29.5 tp -76.04 -18.27 59.3 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 119.454 1.024 . . . . 42.079999999999998 112.227 -174.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1338 ' ' LEU . . . . . 0.539 HD13 HD12 ' B' 1346 ' ' ILE . 26.8 mt -79.09 -67.92 0.71 Allowed 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 119.637 -1.914 . . . . 35.030000000000001 108.194 167.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1339 ' ' CYS . . . . . 0.506 ' SG ' ' HA ' ' B' 1342 ' ' LYS . 43.0 t -76.45 80.46 3.16 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 124.283 1.992 . . . . 37.329999999999998 108.282 -173.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1340 ' ' LYS . . . . . 0.422 ' HD2' ' O ' ' B' 1338 ' ' LEU . 2.6 mptp? -62.22 -27.64 69.13 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.531 -1.356 . . . . 50.509999999999998 111.984 174.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -84.63 -6.24 59.35 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 114.245 1.202 . . . . 54.210000000000001 114.245 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1342 ' ' LYS . . . . . 0.506 ' HA ' ' SG ' ' B' 1339 ' ' CYS . 90.7 mttt 39.07 39.8 0.42 Allowed 'General case' 0 C--O 1.257 1.477 0 N-CA-C 116.717 2.117 . . . . 50.990000000000002 116.717 -172.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -89.69 -14.52 34.6 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 113.885 -1.507 . . . . 48.82 107.542 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 89.98 27.99 19.58 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.052 -1.071 . . . . 40.43 112.351 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -136.68 160.84 37.62 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 120.289 2.044 . . . . 47.560000000000002 109.012 164.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1346 ' ' ILE . . . . . 0.539 HD12 HD13 ' B' 1338 ' ' LEU . 45.0 mm -68.1 101.13 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 C-N-CA 119.612 -0.835 . . . . 42.490000000000002 108.898 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1347 ' ' THR . . . . . . . . . . . . . 17.6 m -71.91 105.56 3.88 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 103.412 -2.81 . . . . 38.119999999999997 103.412 163.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 47.3 t -69.03 84.97 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.144 -1.389 . . . . 37.5 109.292 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1349 ' ' ASP . . . . . 0.442 ' HB3' HG21 ' B' 1355 ' ' ILE . 24.5 t70 -81.29 164.13 22.44 Favored 'General case' 0 C--O 1.243 0.761 0 O-C-N 121.298 -0.876 . . . . 43.850000000000001 110.701 171.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1350 ' ' PHE . . . . . 0.521 ' HE1' ' HB ' ' B' 1359 ' ' THR . 0.0 OUTLIER -155.0 3.09 0.2 Allowed 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 126.925 2.09 . . . . 39.810000000000002 111.17 158.302 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 10.6 t70 -72.94 -32.68 65.43 Favored 'General case' 0 C--O 1.247 0.939 0 CA-C-O 121.761 0.791 . . . . 51.289999999999999 112.234 -163.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.39 142.34 31.07 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.31 -0.859 . . . . 39.780000000000001 111.904 170.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1353 ' ' VAL . . . . . 0.436 ' HA ' ' HB3' ' B' 1356 ' ' ARG . 22.5 m -62.84 -26.47 40.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 114.956 1.465 . . . . 39.280000000000001 114.956 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1354 ' ' VAL . . . . . 0.515 HG21 ' HG3' ' B' 1123 ' ' ARG . 81.1 t -71.06 -49.94 45.73 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.195 0 N-CA-C 106.389 -1.708 . . . . 35.700000000000003 106.389 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1355 ' ' ILE . . . . . 0.442 HG21 ' HB3' ' B' 1349 ' ' ASP . 25.6 mm -62.49 -46.63 95.95 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 119.458 1.026 . . . . 35.770000000000003 111.766 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1356 ' ' ARG . . . . . 0.436 ' HB3' ' HA ' ' B' 1353 ' ' VAL . 45.1 tpt85 -46.15 -32.2 2.82 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 124.331 1.019 . . . . 38.549999999999997 113.091 172.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1357 ' ' GLY . . . . . 0.552 ' HA3' ' HG2' ' B' 1119 ' ' PRO . . . -97.28 -46.37 2.39 Favored Glycine 0 CA--C 1.497 -1.061 0 O-C-N 120.682 -1.261 . . . . 29.579999999999998 114.125 -176.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1358 ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' B' 1113 ' ' MET . 10.9 p -65.52 -35.73 75.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 117.035 0.417 . . . . 32.060000000000002 111.848 -176.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1359 ' ' THR . . . . . 0.521 ' HB ' ' HE1' ' B' 1350 ' ' PHE . 2.8 m -75.6 80.93 2.59 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.519 -1.66 . . . . 29.0 106.519 172.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1360 ' ' VAL . . . . . . . . . . . . . 15.6 m -68.39 -24.35 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 O-C-N 121.123 -0.986 . . . . 29.68 113.161 -172.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1361 ' ' ILE . . . . . 0.612 HG12 HG12 ' B' 1366 ' ' ILE . 74.7 mt -132.88 97.39 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 103.842 -2.651 . . . . 32.049999999999997 103.842 176.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1362 ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -79.71 92.63 5.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 124.442 3.292 . . . . 32.520000000000003 109.81 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1363 ' ' ALA . . . . . 0.48 ' H ' ' HA ' ' B' 1111 ' ' THR . . . 57.09 30.68 18.67 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 115.922 1.823 . . . . 35.68 115.922 168.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1364 ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' B' 1109 ' ' ASN . . . 147.97 -73.39 0.29 Allowed Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.26 -0.972 . . . . 34.259999999999998 110.887 177.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -69.28 141.45 54.34 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 113.565 0.95 . . . . 51.07 113.565 173.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1366 ' ' ILE . . . . . 0.612 HG12 HG12 ' B' 1361 ' ' ILE . 88.8 mt -86.66 113.33 24.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 125.198 2.428 . . . . 39.869999999999997 111.436 -175.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1367 ' ' THR . . . . . . . . . . . . . 1.1 p -98.45 3.14 48.31 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 111.344 -2.662 . . . . 38.009999999999998 112.698 -172.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1368 ' ' TRP . . . . . 0.411 ' HA ' ' HA ' ' B' 1369 ' ' PRO . 57.7 t90 -73.07 137.45 79.13 Favored Pre-proline 0 N--CA 1.447 -0.599 0 N-CA-C 107.757 -1.201 . . . . 42.140000000000001 107.757 167.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1369 ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' B' 1368 ' ' TRP . 31.5 Cg_exo -94.49 -178.84 8.06 Favored 'Cis proline' 0 N--CA 1.452 -0.939 0 C-N-CA 124.695 -0.96 . . . . 43.259999999999998 111.464 -5.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1370 ' ' ALA . . . . . 0.51 ' HB2' ' HA3' ' B' 1357 ' ' GLY . . . -76.08 163.54 65.95 Favored Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 124.718 1.207 . . . . 46.520000000000003 108.19 169.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -54.04 126.89 23.55 Favored 'Trans proline' 0 CA--C 1.553 1.46 0 C-N-CA 125.149 3.899 . . . . 51.950000000000003 111.003 166.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -37.88 109.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.365 1.442 1 C-N-CA 126.99 5.127 . . . . 56.270000000000003 113.375 -173.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1373 ' ' ILE . . . . . 0.519 HD11 HG12 ' B' 1121 ' ' ILE . 8.3 tp -82.44 137.33 21.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 C-N-CA 126.655 1.982 . . . . 60.829999999999998 113.094 -174.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 16.1 mp0 -87.49 101.09 13.26 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-O 122.979 1.371 . . . . 66.099999999999994 110.188 175.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 43.1 t -73.97 118.34 19.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 112.396 -2.184 . . . . 63.469999999999999 108.12 176.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.217 -5.174 0 O-C-N 118.206 -2.809 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.541 0 CA-C-O 116.792 -1.575 . . . . 0.0 111.416 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -58.11 -23.24 54.17 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 122.655 2.479 . . . . 0.0 115.676 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 52.9 mp0 -52.49 -53.07 50.71 Favored 'General case' 0 C--O 1.215 -0.715 0 CA-C-O 122.027 0.918 . . . . 0.0 109.25 171.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 23' ' ' THR . . . . . 0.551 HG21 ' HZ ' ' C' ' 147' ' ' PHE . 16.8 m -67.3 -43.53 81.48 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 114.561 -1.199 . . . . 0.0 109.791 -176.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 24' ' ' ALA . . . . . 0.521 ' HB2' HG22 ' C' ' 182' ' ' ILE . . . -55.87 -36.38 67.52 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 123.993 0.917 . . . . 0.0 111.26 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.12 -57.87 3.62 Favored 'General case' 0 C--O 1.24 0.605 0 O-C-N 120.082 -1.636 . . . . 0.0 112.706 171.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 mp -46.82 -44.94 19.76 Favored 'General case' 0 C--O 1.21 -1.025 0 C-N-CA 125.664 1.585 . . . . 0.0 114.284 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.426 HD11 HD11 ' C' ' 110' ' ' LEU . 27.6 mt -62.77 -49.52 74.68 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 28' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -67.6 -30.33 69.89 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 119.241 -0.983 . . . . 0.0 111.795 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -62.52 -43.2 99.4 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 124.06 0.944 . . . . 0.0 111.937 168.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.778 ' HA ' ' HB3' ' C' ' 107' ' ' ASP . 51.7 m -44.87 -31.7 1.34 Allowed 'General case' 0 CA--C 1.498 -1.028 1 N-CA-C 122.175 4.139 . . . . 0.0 122.175 -164.22 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 31' ' ' HIS . . . . . 0.538 ' O ' HG23 ' C' ' 62' ' ' ILE . 5.6 m-70 70.85 -62.67 0.44 Allowed 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.499 1.12 . . . . 0.0 111.607 -175.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 32' ' ' SER . . . . . 0.454 ' HB2' ' HA ' ' C' ' 106' ' ' THR . 71.7 m -108.52 139.67 42.95 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 162.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 92.2 t -124.05 134.98 65.08 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 103.738 -2.69 . . . . 0.0 103.738 174.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 42.5 mm -109.95 123.73 66.09 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.305 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 165.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 35' ' ' ILE . . . . . 0.417 ' O ' ' HD3' ' C' ' 37' ' ' PRO . 66.9 mt -108.51 124.8 65.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 172.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 89.2 m -108.1 100.22 35.39 Favored Pre-proline 0 C--O 1.245 0.825 0 CA-C-N 113.359 -1.746 . . . . 0.0 109.147 173.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 37' ' ' PRO . . . . . 0.687 ' HD2' HG12 ' C' ' 68' ' ' ILE . 66.4 Cg_exo -61.76 82.47 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.482 3.455 . . . . 0.0 110.391 174.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.18 -132.91 3.65 Favored Glycine 0 N--CA 1.432 -1.61 0 CA-C-O 123.3 1.5 . . . . 0.0 110.503 169.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 39' ' ' TYR . . . . . 0.78 ' HB2' ' HB2' ' C' ' 114' ' ' ALA . 4.2 t80 -59.28 -57.4 13.19 Favored 'General case' 0 CA--C 1.5 -0.966 0 O-C-N 121.306 -1.114 . . . . 0.0 110.834 -157.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -55.24 -34.92 59.41 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-O 118.392 -1.227 . . . . 0.0 112.328 -173.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 41' ' ' MET . . . . . 0.44 ' SD ' ' HB3' ' C' ' 37' ' ' PRO . 31.3 ttm -88.15 -37.55 16.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 118.539 1.169 . . . . 0.0 110.421 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.36 -2.37 37.86 Favored 'General case' 0 C--O 1.246 0.887 0 C-N-CA 122.416 0.287 . . . . 0.0 111.525 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 p -111.39 -43.53 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 166.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -135.9 179.03 6.59 Favored 'General case' 0 CA--C 1.507 -0.709 0 O-C-N 119.412 -2.055 . . . . 0.0 110.255 -167.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 45' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -63.64 16.02 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 120.583 3.549 . . . . 0.0 120.583 -169.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.417 ' HA ' ' HG2' ' C' ' 176' ' ' LYS . . . -59.9 -17.01 33.98 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 123.68 2.945 . . . . 0.0 115.048 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 47' ' ' GLN . . . . . 0.834 ' HG2' ' HB3' ' C' ' 82' ' ' LEU . 0.0 OUTLIER -62.46 -44.22 96.92 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.157 0.983 . . . . 0.0 111.106 174.516 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 48' ' ' TYR . . . . . 0.568 ' HB2' ' HD3' ' C' ' 49' ' ' PRO . 28.1 m-85 -62.74 -47.26 88.01 Favored Pre-proline 0 C--O 1.253 1.265 0 CA-C-N 121.99 2.177 . . . . 0.0 110.011 177.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 49' ' ' PRO . . . . . 0.568 ' HD3' ' HB2' ' C' ' 48' ' ' TYR . 0.1 OUTLIER -53.95 -42.64 65.04 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 124.642 3.561 . . . . 0.0 114.884 169.714 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 50' ' ' VAL . . . . . 0.415 ' HA ' HG22 ' C' ' 53' ' ' ILE . 1.4 p -65.95 -34.98 73.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 119.203 0.91 . . . . 0.0 111.09 -174.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.3 -50.07 70.53 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.175 0.99 . . . . 0.0 112.419 169.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 52' ' ' GLU . . . . . 0.417 ' HB3' ' HB2' ' C' ' 183' ' ' LEU . 1.5 tm-20 -68.82 -29.41 67.74 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -178.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 53' ' ' ILE . . . . . 0.415 HG22 ' HA ' ' C' ' 50' ' ' VAL . 9.4 tp -76.53 -46.05 32.35 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 N-CA-C 115.597 1.702 . . . . 0.0 115.597 166.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 96.9 m -57.63 -27.93 63.23 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 113.421 0.896 . . . . 0.0 113.421 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -47.43 -57.45 5.32 Favored 'General case' 0 N--CA 1.427 -1.618 0 C-N-CA 125.608 1.563 . . . . 0.0 114.017 167.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -81.17 -25.31 36.92 Favored 'General case' 0 N--CA 1.434 -1.244 0 O-C-N 120.76 -1.213 . . . . 0.0 112.271 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.77 -38.35 90.26 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 123.083 1.421 . . . . 0.0 111.488 171.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 58' ' ' ARG . . . . . 0.425 ' HA ' ' HD2' ' C' ' 58' ' ' ARG . 8.6 tpt180 -73.42 -32.9 64.66 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.536 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.18 -23.08 66.39 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 167.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -81.71 -6.29 58.89 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 119.157 0.89 . . . . 0.0 110.97 168.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.01 41.74 80.43 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 120.52 -1.363 . . . . 0.0 114.465 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 62' ' ' ILE . . . . . 0.538 HG23 ' O ' ' C' ' 31' ' ' HIS . 25.2 mt -96.04 134.54 33.22 Favored 'Isoleucine or valine' 0 C--O 1.253 1.253 0 CA-C-O 123.756 1.741 . . . . 0.0 111.081 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -68.99 83.07 0.32 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 124.629 2.156 . . . . 0.0 110.182 168.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.642 HG13 HD12 ' C' ' 92' ' ' ILE . 1.9 p -100.39 92.0 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 113.748 -1.569 . . . . 0.0 107.749 -176.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -91.62 128.08 37.32 Favored 'General case' 0 N--CA 1.442 -0.836 0 O-C-N 120.117 -1.614 . . . . 0.0 111.929 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 66' ' ' PHE . . . . . 0.517 ' HB2' ' HA ' ' C' ' 93' ' ' VAL . 25.6 m-85 -83.1 78.69 9.56 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 122.639 1.209 . . . . 0.0 109.047 176.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.48 89.06 0.35 Allowed Glycine 0 C--O 1.219 -0.804 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 68' ' ' ILE . . . . . 0.687 HG12 ' HD2' ' C' ' 37' ' ' PRO . 20.6 mt -88.72 132.62 33.13 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.902 0 CA-C-O 120.953 0.406 . . . . 0.0 111.845 -176.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -83.39 128.99 62.15 Favored Pre-proline 0 N--CA 1.472 0.654 0 CA-C-O 117.583 -1.199 . . . . 0.0 109.45 169.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 70' ' ' PRO . . . . . 0.792 ' HD3' ' HB2' ' C' ' 96' ' ' MET . 57.8 Cg_endo -61.11 -66.36 0.06 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.526 0 C-N-CA 124.582 3.521 . . . . 0.0 117.934 -175.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 45.8 t -76.16 107.54 7.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 170.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -168.15 142.71 3.48 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-N 121.315 1.871 . . . . 0.0 111.901 -171.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 61.77 -113.75 6.05 Favored Glycine 0 C--N 1.346 1.103 0 O-C-N 121.208 -0.932 . . . . 0.0 111.493 171.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 74' ' ' ARG . . . . . 0.604 ' HA ' ' OE1' ' B' 1203 ' ' GLN . 1.0 OUTLIER -128.72 105.88 8.56 Favored 'General case' 0 C--O 1.242 0.681 0 O-C-N 121.163 -1.199 . . . . 0.0 109.914 177.326 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.512 ' HB2' ' HB2' ' C' ' 78' ' ' HIS 0.25 2.0 mp 68.63 132.35 0.04 OUTLIER Pre-proline 0 CA--C 1.553 1.058 0 O-C-N 127.605 3.065 . . . . 0.0 116.269 -177.071 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.42 158.29 57.77 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 124.346 3.364 . . . . 0.0 107.784 167.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 77' ' ' GLY . . . . . 0.443 ' H ' HG23 ' A' 1157 ' ' ILE . . . 73.04 -63.92 1.62 Allowed Glycine 0 C--O 1.212 -1.244 0 CA-C-O 116.802 -2.11 . . . . 0.0 111.856 -168.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 78' ' ' HIS . . . . . 0.512 ' HB2' ' HB2' ' C' ' 75' ' ' LEU . 10.2 t-80 -33.23 -50.25 0.29 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -172.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.37 -45.03 85.7 Favored 'General case' 0 C--O 1.245 0.819 0 O-C-N 124.294 0.996 . . . . 0.0 113.207 -178.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.16 -26.07 42.77 Favored 'General case' 0 C--O 1.246 0.908 0 O-C-N 120.266 -1.521 . . . . 0.0 109.409 -175.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.438 HG22 HG21 ' A' 1154 ' ' THR . 46.5 t -58.48 -52.87 54.24 Favored 'Isoleucine or valine' 0 C--N 1.347 0.477 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 166.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.834 ' HB3' ' HG2' ' C' ' 47' ' ' GLN . 63.0 mt -56.95 -29.5 63.21 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 11.1 mp -63.96 -44.98 91.14 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 121.756 -0.59 . . . . 0.0 111.12 167.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.53 -38.08 86.39 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 120.223 -1.548 . . . . 0.0 112.334 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -50.39 -53.79 26.59 Favored 'General case' 0 C--N 1.349 0.572 0 O-C-N 124.654 1.221 . . . . 0.0 113.167 163.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.51 10.31 3.27 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp 58.68 30.29 19.73 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.867 2.067 . . . . 0.0 112.243 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 65.9 t -70.16 127.36 92.33 Favored Pre-proline 0 C--O 1.242 0.697 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 -174.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -50.56 107.41 0.16 Allowed 'Trans proline' 0 C--O 1.243 0.758 1 C-N-CA 125.313 4.009 . . . . 0.0 112.513 -176.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.75 -26.67 64.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.107 -1.406 . . . . 0.0 112.462 -165.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -40.15 -44.11 1.76 Allowed 'General case' 0 C--O 1.245 0.844 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 174.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 92' ' ' ILE . . . . . 0.642 HD12 HG13 ' C' ' 64' ' ' VAL . 0.5 OUTLIER -90.87 -1.42 9.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 -173.437 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 93' ' ' VAL . . . . . 0.517 ' HA ' ' HB2' ' C' ' 66' ' ' PHE . 10.6 t -83.36 121.73 36.59 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 O-C-N 120.686 -1.258 . . . . 0.0 114.38 -174.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 45.0 mt -125.59 81.78 2.01 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -170.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 95' ' ' GLU . . . . . 0.446 ' HA ' ' HB ' ' C' ' 68' ' ' ILE . 27.7 mp0 -75.76 104.38 6.28 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 121.677 -0.64 . . . . 0.0 110.433 -174.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.792 ' HB2' ' HD3' ' C' ' 70' ' ' PRO . 41.5 ttp 49.31 59.65 4.33 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.35 -171.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -103.84 135.74 44.82 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 167.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -85.73 75.64 10.05 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 -172.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 8.3 tp -92.97 62.27 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-O 124.777 2.227 . . . . 0.0 110.585 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -60.04 -32.97 71.42 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 112.397 -2.183 . . . . 0.0 109.354 -170.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.83 -59.65 4.57 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 118.155 -0.926 . . . . 0.0 112.23 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.01 -28.66 69.73 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 128.266 3.479 . . . . 0.0 113.239 176.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 103' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -64.52 -39.92 94.67 Favored 'General case' 0 C--O 1.224 -0.269 0 O-C-N 120.415 -1.428 . . . . 0.0 111.231 174.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -103.32 60.76 0.77 Allowed 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 123.263 1.506 . . . . 0.0 109.453 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -168.79 -37.02 0.02 OUTLIER 'General case' 0 C--O 1.241 0.655 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 106' ' ' THR . . . . . 0.454 ' HA ' ' HB2' ' C' ' 32' ' ' SER . 2.7 m -51.12 132.46 28.0 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 121.256 -0.902 . . . . 0.0 113.282 170.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 107' ' ' ASP . . . . . 0.778 ' HB3' ' HA ' ' C' ' 30' ' ' SER . 1.7 t70 -85.84 -60.49 2.0 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 34.6 m -109.22 130.67 55.49 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 118.572 -1.251 . . . . 0.0 112.563 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 109' ' ' VAL . . . . . 0.668 ' HB ' ' HA ' ' C' ' 144' ' ' VAL . 47.9 t -102.17 132.73 47.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 O-C-N 124.647 1.217 . . . . 0.0 108.225 173.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 110' ' ' LEU . . . . . 0.426 HD11 HD11 ' C' ' 27' ' ' LEU . 15.3 mt -98.58 84.24 3.13 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 124.57 1.169 . . . . 0.0 109.679 176.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 61.8 t -78.55 104.74 6.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 124.461 2.077 . . . . 0.0 107.494 170.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 36.3 mm -72.62 76.47 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.185 0 CA-C-O 124.424 2.059 . . . . 0.0 113.779 -175.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.11 -58.21 3.57 Favored Glycine 0 C--N 1.346 1.128 0 O-C-N 118.18 -2.825 . . . . 0.0 114.568 171.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 114' ' ' ALA . . . . . 0.78 ' HB2' ' HB2' ' C' ' 39' ' ' TYR . . . -82.75 95.05 7.75 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 123.153 1.454 . . . . 0.0 111.557 -171.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 115' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -52.25 -57.56 9.33 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 111.098 -2.774 . . . . 0.0 112.127 165.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 116' ' ' ASP . . . . . 0.589 ' HA ' ' HB2' ' C' ' 119' ' ' ASN . 15.1 m-20 -56.95 -34.03 67.63 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -169.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 20.7 m -43.46 -38.36 2.8 Favored 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 169.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 16.8 m -127.22 26.15 2.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 125.22 1.408 . . . . 0.0 110.826 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 119' ' ' ASN . . . . . 0.589 ' HB2' ' HA ' ' C' ' 116' ' ' ASP . 33.6 t-20 -75.54 120.71 82.93 Favored Pre-proline 0 CA--C 1.505 -0.775 0 CA-C-O 117.524 -1.227 . . . . 0.0 109.513 -177.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 120' ' ' PRO . . . . . 1.039 ' HG2' ' HB2' ' C' ' 160' ' ' ASN . 10.1 Cg_endo -53.25 -45.25 42.44 Favored 'Trans proline' 0 CA--C 1.51 -0.696 0 C-N-CA 124.639 3.559 . . . . 0.0 115.419 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 121' ' ' ALA . . . . . 0.47 ' HB2' ' HB3' ' C' ' 160' ' ' ASN . . . -55.4 -32.88 63.02 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 120.675 1.579 . . . . 0.0 112.897 -176.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 122' ' ' ALA . . . . . 0.535 ' HB1' ' HB3' ' C' ' 133' ' ' MET . . . -56.06 -20.15 15.81 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 120.774 -1.203 . . . . 0.0 113.121 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -119.11 -27.42 5.7 Favored 'General case' 0 C--O 1.221 -0.432 0 O-C-N 119.982 -1.699 . . . . 0.0 111.612 166.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -84.07 -11.08 57.26 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.26 -169.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -128.49 99.42 23.77 Favored Pre-proline 0 C--O 1.247 0.967 0 C-N-CA 119.314 -0.954 . . . . 0.0 111.096 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -64.19 69.25 0.21 Allowed 'Trans proline' 0 N--CA 1.441 -1.582 1 C-N-CA 125.62 4.213 . . . . 0.0 114.642 170.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 127' ' ' LYS . . . . . 0.499 ' HB3' ' HZ3' ' C' ' 127' ' ' LYS . 5.6 ttpm? -177.66 -28.11 0.01 OUTLIER 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 -174.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 128' ' ' SER . . . . . . . . . . . . . 66.2 m -59.46 129.39 86.94 Favored Pre-proline 0 C--O 1.222 -0.355 0 O-C-N 117.532 -3.23 . . . . 0.0 110.6 168.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 129' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -57.29 -46.82 25.54 Favored 'Trans proline' 0 N--CA 1.459 -0.522 1 C-N-CA 126.189 4.592 . . . . 0.0 115.738 -173.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 9.1 pt -84.11 63.7 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.842 0 CA-C-N 121.721 2.055 . . . . 0.0 111.038 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.75 153.44 43.36 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 118.111 2.634 . . . . 0.0 118.111 -168.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.15 22.83 77.46 Favored Glycine 0 C--O 1.213 -1.193 0 CA-C-N 110.232 -3.167 . . . . 0.0 111.553 177.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 133' ' ' MET . . . . . 0.755 ' SD ' ' HD2' ' C' ' 134' ' ' PRO . 34.0 tpp -74.15 119.32 75.76 Favored Pre-proline 0 C--O 1.238 0.481 0 CA-C-N 120.444 2.122 . . . . 0.0 107.956 -175.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 134' ' ' PRO . . . . . 0.755 ' HD2' ' SD ' ' C' ' 133' ' ' MET . 71.6 Cg_endo -67.89 105.17 1.1 Allowed 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 121.112 1.208 . . . . 0.0 108.99 -175.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 4.5 m -117.93 103.71 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 103.503 -2.777 . . . . 0.0 103.503 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 42.2 mt -73.81 90.73 1.9 Allowed 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 110.777 -2.92 . . . . 0.0 113.123 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 51.68 -12.48 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 120.96 3.689 . . . . 0.0 120.96 163.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 8.4 p -80.8 82.88 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-N 125.177 3.626 . . . . 0.0 113.182 -171.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 139' ' ' TRP . . . . . 0.517 ' HA ' HG21 ' C' ' 144' ' ' VAL . 44.6 p90 -163.71 173.12 13.27 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 111.799 -2.455 . . . . 0.0 106.754 173.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 140' ' ' LYS . . . . . . . . . . . . 0.398 25.2 pttm 68.31 -62.81 0.36 Allowed 'General case' 0 C--O 1.242 0.667 0 C-N-CA 128.233 2.613 . . . . 0.0 116.078 171.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.25 110.45 4.05 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-O 121.661 0.743 . . . . 0.0 111.961 169.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 142' ' ' GLN . . . . . 0.427 ' HB3' ' H ' ' C' ' 143' ' ' ASN 0.261 18.3 mm100 74.75 -163.27 0.08 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 172.189 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 143' ' ' ASN . . . . . 0.427 ' H ' ' HB3' ' C' ' 142' ' ' GLN . 2.1 m-20 -91.03 69.37 6.26 Favored 'General case' 0 C--O 1.248 1.018 0 CA-C-O 124.605 2.145 . . . . 0.0 107.288 -159.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 144' ' ' VAL . . . . . 0.668 ' HA ' ' HB ' ' C' ' 109' ' ' VAL . 20.5 t -75.24 82.69 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 114.145 -1.389 . . . . 0.0 107.384 178.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 145' ' ' ILE . . . . . . . . . . . . . 1.3 mp -80.17 120.71 32.16 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -176.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 146' ' ' VAL . . . . . . . . . . . . . 92.9 t -98.6 115.53 39.19 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 N-CA-C 102.919 -2.993 . . . . 0.0 102.919 172.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 147' ' ' PHE . . . . . 0.551 ' HZ ' HG21 ' C' ' 23' ' ' THR . 37.9 m-85 -64.82 123.96 20.73 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.611 0.719 . . . . 0.0 111.739 173.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 148' ' ' LYS . . . . . 0.61 ' HE3' ' SD ' ' C' ' 151' ' ' MET . 62.6 mmtt -126.54 146.41 50.14 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 2.1 tpp85 -89.02 -55.21 3.78 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 100.513 -3.884 . . . . 0.0 100.513 162.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 150' ' ' SER . . . . . 0.514 ' O ' ' HD2' ' C' ' 148' ' ' LYS . 3.4 m -152.82 -179.82 7.98 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 167.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 151' ' ' MET . . . . . 0.61 ' SD ' ' HE3' ' C' ' 148' ' ' LYS . 10.6 tpt -115.61 111.83 21.23 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 171.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -84.13 -144.1 0.08 Allowed 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 111.802 -2.453 . . . . 0.0 107.371 167.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 91.8 m -97.01 133.9 41.08 Favored 'General case' 0 C--O 1.24 0.577 0 O-C-N 117.243 -3.411 . . . . 0.0 107.43 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -84.57 151.91 27.07 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 113.256 -1.793 . . . . 0.0 110.292 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 16.1 m-30 -59.93 -39.03 84.11 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 117.917 -3.107 . . . . 0.0 114.523 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 156' ' ' ALA . . . . . . . . . . . . . . . -85.17 -54.6 4.51 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 119.199 -2.188 . . . . 0.0 107.548 166.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 80.84 -77.25 2.03 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.302 -0.863 . . . . 0.0 114.56 171.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 20.2 m -63.57 159.93 3.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 117.73 2.493 . . . . 0.0 117.73 -162.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . 0.258 0.0 OUTLIER -2.48 104.56 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.527 1 N-CA-C 122.043 4.09 . . . . 0.0 122.043 -176.071 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' C' C ' 160' ' ' ASN . . . . . 1.039 ' HB2' ' HG2' ' C' ' 120' ' ' PRO . 12.3 p30 -165.89 140.25 3.77 Favored Pre-proline 0 N--CA 1.434 -1.257 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.598 -173.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 161' ' ' PRO . . . . . 0.566 ' HG2' ' HG3' ' C' ' 120' ' ' PRO . 3.4 Cg_endo -45.56 -33.78 10.13 Favored 'Trans proline' 0 CA--C 1.512 -0.599 0 C-N-CA 123.521 2.814 . . . . 0.0 118.638 170.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 162' ' ' LEU . . . . . 0.588 ' HA ' HG22 ' C' ' 168' ' ' THR . 6.6 tp -68.28 -25.75 65.31 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 121.575 -0.703 . . . . 0.0 111.608 -173.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 163' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -87.66 -39.15 15.26 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 120.483 -1.385 . . . . 0.0 113.553 165.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -74.78 -53.26 9.5 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 115.802 1.778 . . . . 0.0 115.802 -169.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 165' ' ' LYS . . . . . 0.449 ' HB2' ' HB ' ' C' ' 168' ' ' THR . 5.4 mtpt -69.8 165.49 21.35 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 117.876 2.547 . . . . 0.0 117.876 -160.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 166' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' C' ' 169' ' ' HIS . 0.0 OUTLIER -73.09 -39.84 65.49 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 127.106 2.162 . . . . 0.0 113.109 174.179 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 167' ' ' ASN . . . . . 0.408 ' O ' ' HA ' ' C' ' 143' ' ' ASN . 42.1 p-10 -102.86 -46.19 4.76 Favored 'General case' 0 CA--C 1.498 -1.047 0 O-C-N 120.25 -1.531 . . . . 0.0 109.887 -174.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 168' ' ' THR . . . . . 0.599 HG23 ' HB ' ' C' ' 144' ' ' VAL . 54.4 m -74.27 91.84 2.2 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 102.92 -2.993 . . . . 0.0 102.92 161.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 169' ' ' HIS . . . . . 0.438 ' HB2' ' O ' ' C' ' 166' ' ' GLU . 16.6 t-80 -132.08 135.38 46.41 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 -164.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 170' ' ' MET . . . . . . . . . . . . . 75.7 mtm -74.1 102.28 4.18 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 113.397 -1.729 . . . . 0.0 108.399 169.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 171' ' ' LEU . . . . . . . . . . . . . 54.6 tp -100.01 129.29 46.05 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 -173.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -76.4 96.29 3.99 Favored 'General case' 0 C--O 1.248 0.976 0 CA-C-O 123.969 1.842 . . . . 0.0 112.839 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -156.88 134.65 4.1 Favored Glycine 0 CA--C 1.503 -0.671 0 N-CA-C 106.323 -2.711 . . . . 0.0 106.323 168.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 174' ' ' ASP . . . . . 0.803 ' HB3' ' HB3' ' C' ' 177' ' ' ALA . 22.5 t70 -60.17 143.12 53.17 Favored 'General case' 0 C--O 1.217 -0.631 0 O-C-N 121.734 -0.863 . . . . 0.0 111.296 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.48 -31.16 72.09 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -173.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 176' ' ' LYS . . . . . 0.516 ' HD3' ' HG2' ' C' ' 49' ' ' PRO . 0.1 OUTLIER -87.42 -61.53 1.7 Allowed 'General case' 0 C--O 1.236 0.357 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 168.507 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 177' ' ' ALA . . . . . 0.803 ' HB3' ' HB3' ' C' ' 174' ' ' ASP . . . -49.35 -44.76 44.88 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 -164.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 3.3 m -65.2 -42.59 93.38 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.58 177.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 179' ' ' VAL . . . . . 0.606 ' HA ' HG12 ' C' ' 182' ' ' ILE . 45.8 t -68.19 -40.95 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 119.451 1.023 . . . . 0.0 108.705 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -61.04 -28.98 69.45 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 114.996 -1.002 . . . . 0.0 113.184 174.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -77.69 -51.55 10.41 Favored 'General case' 0 N--CA 1.445 -0.688 0 O-C-N 117.366 -3.334 . . . . 0.0 112.323 171.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 182' ' ' ILE . . . . . 0.606 HG12 ' HA ' ' C' ' 179' ' ' VAL . 29.1 pt -62.68 -27.01 42.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 117.791 -1.1 . . . . 0.0 110.748 -174.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 183' ' ' LEU . . . . . 0.417 ' HB2' ' HB3' ' C' ' 52' ' ' GLU . 3.5 pp -58.42 -27.8 64.66 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 120.555 1.525 . . . . 0.0 114.315 174.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -94.38 -51.05 4.96 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -68.13 -72.57 0.17 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -175.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 186' ' ' LEU . . . . . . . . . . . . 0.293 0.5 OUTLIER . . . . . 0 CA--C 1.538 0.517 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -158.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 57.9 t-80 . . . . . 0 N--CA 1.44 -0.946 0 N-CA-C 106.322 -1.733 . . . . 65.739999999999995 106.322 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -52.48 88.01 0.01 OUTLIER Glycine 0 CA--C 1.526 0.753 0 O-C-N 119.562 -1.961 . . . . 48.659999999999997 110.462 160.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -130.1 131.39 45.71 Favored 'General case' 0 N--CA 1.431 -1.403 1 N-CA-C 97.445 -5.02 . . . . 44.560000000000002 97.445 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1003 ' ' ILE . . . . . 0.487 HD12 ' HB3' ' A' 1026 ' ' LEU . 42.2 mt -100.46 112.18 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 N-CA-C 105.266 -2.124 . . . . 34.859999999999999 105.266 176.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -77.73 132.06 11.6 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 112.646 -2.07 . . . . 30.75 110.259 169.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.623 HG23 ' HB3' ' A' 1017 ' ' ALA . 28.0 mm -119.18 91.05 43.07 Favored Pre-proline 0 CA--C 1.508 -0.642 0 N-CA-C 103.857 -2.645 . . . . 32.210000000000001 103.857 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -71.82 164.21 36.4 Favored 'Trans proline' 0 C--O 1.245 0.862 0 C-N-CA 123.421 2.747 . . . . 32.979999999999997 111.856 172.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1007 ' ' ARG . . . . . 0.56 ' HD2' HD12 ' A' 1042 ' ' LEU . 40.0 ttp85 -87.22 141.83 28.36 Favored 'General case' 0 C--O 1.267 1.998 0 N-CA-C 103.401 -2.814 . . . . 47.979999999999997 103.401 161.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1008 ' ' GLU . . . . . . . . . . . . 0.267 22.3 mm-40 -63.95 150.26 45.49 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 114.298 1.222 . . . . 34.700000000000003 114.298 177.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 24.4 mtp-105 -121.01 37.81 4.23 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 115.356 1.613 . . . . 53.369999999999997 115.356 -175.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1010 ' ' LEU . . . . . 0.639 HD12 HD11 ' A' 1076 ' ' LEU . 11.1 tp -96.63 179.18 5.08 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.144 -1.058 . . . . 45.07 108.144 -176.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1011 ' ' THR . . . . . . . . . . . . . 10.3 m -63.2 140.1 58.84 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 107.419 -1.326 . . . . 40.359999999999999 107.419 171.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 23.8 m120 63.17 33.89 13.98 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 122.924 1.345 . . . . 40.609999999999999 114.501 169.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -98.4 151.02 21.01 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 116.898 2.185 . . . . 33.759999999999998 116.898 -158.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1014 ' ' THR . . . . . 0.451 ' HB ' ' O ' ' A' 1317 ' ' GLY . 5.0 m -136.13 -16.2 1.67 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 118.301 -0.857 . . . . 27.890000000000001 112.541 -177.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1015 ' ' ARG . . . . . 0.495 HH11 HG12 ' A' 1072 ' ' VAL . 69.7 mtm180 -70.01 150.68 46.39 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 117.081 2.252 . . . . 29.02 117.081 -173.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1016 ' ' VAL . . . . . 0.473 ' HB ' ' HB2' ' A' 1043 ' ' ALA . 4.3 p -113.96 166.76 7.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 103.976 -2.602 . . . . 28.129999999999999 103.976 159.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1017 ' ' ALA . . . . . 0.623 ' HB3' HG23 ' A' 1005 ' ' ILE . . . -67.51 -47.88 68.67 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.099 -1.041 . . . . 26.870000000000001 113.205 177.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -146.68 133.44 20.03 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 118.635 -2.54 . . . . 26.77 109.071 -176.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1019 ' ' THR . . . . . 0.685 HG21 HG23 ' A' 1321 ' ' THR . 0.7 OUTLIER -90.51 172.87 6.29 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-O 117.3 -1.333 . . . . 27.02 110.652 -177.89 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 1020 ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -25.45 -71.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.006 1 C-N-CA 127.496 5.464 . . . . 30.57 119.573 178.41 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 14.3 mptt -54.58 -44.0 72.62 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 120.371 1.441 . . . . 47.810000000000002 114.082 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1022 ' ' THR . . . . . 0.536 ' O ' ' HG ' ' A' 1026 ' ' LEU . 0.5 OUTLIER -65.8 -37.33 85.97 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 120.017 1.281 . . . . 30.77 112.217 175.83 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 1023 ' ' VAL . . . . . . . . . . . . . 25.5 t -59.52 -46.5 92.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 119.015 0.825 . . . . 33.590000000000003 110.3 170.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -59.95 -34.22 72.96 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 113.562 0.949 . . . . 53.289999999999999 113.562 172.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1025 ' ' GLN . . . . . 0.518 ' HB3' HG11 ' A' 1332 ' ' VAL . 37.4 mt-30 -64.36 -38.47 91.16 Favored 'General case' 0 N--CA 1.441 -0.883 0 O-C-N 120.73 -1.231 . . . . 46.920000000000002 112.122 171.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1026 ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' 1022 ' ' THR . 14.5 mt -68.37 -34.84 76.79 Favored 'General case' 0 C--O 1.249 1.078 0 O-C-N 121.082 -1.011 . . . . 37.170000000000002 110.195 175.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1027 ' ' LEU . . . . . 0.467 HD21 ' HA3' ' A' 1054 ' ' GLY . 10.8 mp -59.29 -42.58 91.61 Favored 'General case' 0 C--O 1.246 0.876 0 O-C-N 121.062 -1.024 . . . . 44.439999999999998 111.349 169.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -49.61 -51.21 39.03 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 124.361 1.038 . . . . 52.579999999999998 111.811 169.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1029 ' ' LEU . . . . . 0.664 ' HA ' ' HE2' ' A' 1342 ' ' LYS . 59.7 mt -65.9 -11.64 48.55 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 114.279 1.214 . . . . 45.689999999999998 114.279 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 90.12 28.24 18.41 Favored Glycine 0 C--O 1.25 1.148 0 O-C-N 121.223 -0.923 . . . . 42.090000000000003 112.646 174.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -119.34 127.63 53.35 Favored 'General case' 0 CA--C 1.488 -1.413 0 CA-C-O 117.854 -1.069 . . . . 40.719999999999999 108.255 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1032 ' ' THR . . . . . . . . . . . . . 97.4 m -67.27 135.53 53.51 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 108.683 -0.858 . . . . 37.770000000000003 108.683 176.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1033 ' ' VAL . . . . . . . . . . . . . 57.9 t -103.53 134.41 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 O-C-N 119.365 -2.084 . . . . 33.539999999999999 108.353 -172.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -121.68 105.26 10.25 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 105.907 -1.886 . . . . 31.68 105.907 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1035 ' ' VAL . . . . . . . . . . . . . 21.9 t -99.16 138.69 22.84 Favored 'Isoleucine or valine' 0 C--O 1.246 0.917 0 CA-C-N 114.944 -1.026 . . . . 31.52 108.737 -173.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1036 ' ' GLU . . . . . 0.443 ' HB3' ' HB2' ' A' 1039 ' ' ALA . 25.4 tt0 -57.76 130.88 48.43 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 123.867 1.794 . . . . 41.039999999999999 113.277 173.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1037 ' ' SER . . . . . . . . . . . . . 7.1 t -60.89 132.67 54.59 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 113.176 -1.829 . . . . 31.829999999999998 112.746 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 77.02 -4.92 52.43 Favored Glycine 0 CA--C 1.525 0.696 0 O-C-N 119.876 -1.765 . . . . 29.359999999999999 111.54 173.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1039 ' ' ALA . . . . . 0.443 ' HB2' ' HB3' ' A' 1036 ' ' GLU . . . -62.61 -40.14 96.03 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 119.04 -2.447 . . . . 27.780000000000001 113.667 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1040 ' ' GLY . . . . . 0.643 ' HA2' ' HB3' ' A' 1043 ' ' ALA . . . -62.52 -18.73 59.21 Favored Glycine 0 C--O 1.25 1.121 0 N-CA-C 114.652 0.621 . . . . 28.91 114.652 -177.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -62.38 -47.53 83.74 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.099 -1.236 . . . . 51.18 110.957 173.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1042 ' ' LEU . . . . . 0.56 HD12 ' HD2' ' A' 1007 ' ' ARG . 36.2 mt -64.39 -57.59 8.89 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.969 0.89 . . . . 29.91 112.528 167.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1043 ' ' ALA . . . . . 0.643 ' HB3' ' HA2' ' A' 1040 ' ' GLY . . . -60.38 -7.57 2.12 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 115.241 1.571 . . . . 28.539999999999999 115.241 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1044 ' ' SER . . . . . . . . . . . . . 62.9 m 69.81 31.47 3.48 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 125.393 1.477 . . . . 33.060000000000002 111.2 169.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1045 ' ' PHE . . . . . 0.695 ' HD1' ' HB3' ' B' 1277 ' ' ALA . 0.1 OUTLIER -157.95 107.06 2.06 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 102.44 -3.17 . . . . 30.289999999999999 102.44 169.671 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 1046 ' ' ASP . . . . . 0.471 ' OD2' ' HG2' ' A' 1048 ' ' LYS . 0.3 OUTLIER -79.74 174.22 11.81 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 117.372 2.36 . . . . 48.619999999999997 117.372 -148.094 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 28.9 t70 -47.7 -49.64 27.26 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 112.659 -2.064 . . . . 36.740000000000002 113.355 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1048 ' ' LYS . . . . . 0.471 ' HG2' ' OD2' ' A' 1046 ' ' ASP . 24.8 pttm -75.27 -26.72 59.01 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 120.947 -1.096 . . . . 43.729999999999997 110.206 176.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -62.35 -29.98 70.84 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 118.162 -2.837 . . . . 32.810000000000002 110.874 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1050 ' ' PHE . . . . . 0.481 ' HB2' HD11 ' A' 1057 ' ' ILE . 64.4 m-85 -62.46 -41.13 98.54 Favored 'General case' 0 C--O 1.219 -0.536 0 O-C-N 121.72 -0.613 . . . . 31.859999999999999 111.345 171.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 25.6 t -66.26 -40.81 87.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 119.889 -0.724 . . . . 33.219999999999999 111.771 172.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -56.68 -40.85 76.27 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 122.243 1.021 . . . . 50.829999999999998 111.163 176.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -61.98 -50.38 72.33 Favored 'General case' 0 C--O 1.263 1.815 0 N-CA-C 113.596 0.961 . . . . 33.119999999999997 113.596 168.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1054 ' ' GLY . . . . . 0.467 ' HA3' HD21 ' A' 1027 ' ' LEU . . . 131.65 47.63 0.12 Allowed Glycine 0 N--CA 1.443 -0.886 0 CA-C-O 119.337 -0.702 . . . . 35.829999999999998 113.617 175.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -126.82 150.53 49.14 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 114.698 1.37 . . . . 34.82 114.698 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -73.51 125.64 28.4 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 105.732 -1.951 . . . . 49.049999999999997 105.732 174.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1057 ' ' ILE . . . . . 0.481 HD11 ' HB2' ' A' 1050 ' ' PHE . 6.9 mm -89.52 125.46 42.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 106.203 -1.777 . . . . 38.530000000000001 106.203 173.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1058 ' ' VAL . . . . . 0.686 ' HB ' ' HB2' ' A' 1062 ' ' SER . 29.8 m -115.99 135.15 57.06 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 107.609 -1.256 . . . . 42.109999999999999 107.609 -177.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -75.74 79.13 2.69 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-O 122.696 1.236 . . . . 58.0 114.169 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 76.2 -123.77 7.01 Favored Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 107.739 -2.145 . . . . 52.119999999999997 107.739 171.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 39.7 t30 -47.92 -23.65 0.83 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 118.476 2.769 . . . . 54.75 118.476 -172.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1062 ' ' SER . . . . . 0.686 ' HB2' ' HB ' ' A' 1058 ' ' VAL . 1.3 m -53.26 -24.38 11.29 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 116.212 1.93 . . . . 50.340000000000003 116.212 171.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 6.1 p -44.71 -35.24 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 116.423 2.008 . . . . 41.460000000000001 116.423 172.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1064 ' ' TRP . . . . . . . . . . . . . 46.0 m95 -73.25 -22.41 60.41 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-N 119.64 1.109 . . . . 39.32 111.941 -169.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -69.22 70.39 0.24 Allowed 'General case' 0 CA--C 1.547 0.859 0 O-C-N 119.414 -2.054 . . . . 55.380000000000003 110.676 172.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1066 ' ' SER . . . . . . . . . . . . . 72.3 m -160.17 123.17 3.44 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 101.457 -3.535 . . . . 41.869999999999997 101.457 -171.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -74.56 2.08 10.54 Favored 'General case' 0 CA--C 1.508 -0.646 0 O-C-N 120.924 -1.11 . . . . 53.200000000000003 112.285 -178.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1068 ' ' ILE . . . . . 0.43 ' HB ' HG12 ' A' 1003 ' ' ILE . 4.9 mp -130.19 129.11 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 104.05 -2.574 . . . . 41.899999999999999 104.05 167.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1069 ' ' ILE . . . . . . . . . . . . . 25.7 mm -125.58 120.57 58.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 104.972 -2.233 . . . . 38.729999999999997 104.972 171.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1070 ' ' LEU . . . . . 0.851 HD13 HD13 ' A' 1331 ' ' LEU . 80.1 mt -101.75 133.95 45.68 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.061 -2.2 . . . . 32.439999999999998 105.061 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1071 ' ' LYS . . . . . 0.508 ' HB2' ' OG ' ' A' 1091 ' ' SER . 2.5 mmmp? -133.68 141.78 47.73 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.134 -1.432 . . . . 34.649999999999999 107.134 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1072 ' ' VAL . . . . . 0.495 HG12 HH11 ' A' 1015 ' ' ARG . 2.4 t -92.16 -4.1 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.016 0 O-C-N 119.87 -1.769 . . . . 31.32 111.031 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -142.09 159.41 42.28 Favored 'General case' 0 C--O 1.256 1.396 0 N-CA-C 102.393 -3.188 . . . . 33.939999999999998 102.393 173.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -42.1 140.89 1.47 Allowed Pre-proline 0 C--O 1.239 0.515 0 C-N-CA 124.872 1.269 . . . . 38.039999999999999 113.25 171.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1075 ' ' PRO . . . . . 0.741 ' HG2' HD21 ' A' 1089 ' ' LEU . 44.9 Cg_exo -67.36 99.67 0.52 Allowed 'Trans proline' 0 CA--C 1.492 -1.589 0 C-N-CA 122.18 1.92 . . . . 42.68 107.595 165.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1076 ' ' LEU . . . . . 0.639 HD11 HD12 ' A' 1010 ' ' LEU . 38.9 mt -73.02 167.35 21.28 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 112.219 -2.264 . . . . 46.740000000000002 108.61 -173.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1077 ' ' ASP . . . . . 0.449 ' HA ' HD12 ' A' 1080 ' ' ILE . 10.8 m-20 -43.15 -32.94 0.8 Allowed 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 120.46 3.504 . . . . 58.609999999999999 120.46 -175.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 16.0 t70 -75.09 -44.08 49.44 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 118.412 -0.804 . . . . 59.200000000000003 109.772 176.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1079 ' ' GLU . . . . . 0.434 ' HG2' ' HE2' ' A' 1071 ' ' LYS . 1.8 mp0 -59.73 -40.63 88.65 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 119.525 -0.87 . . . . 50.630000000000003 112.378 173.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1080 ' ' ILE . . . . . 0.716 HD11 ' HG ' ' A' 1101 ' ' LEU . 74.5 mt -54.15 -49.56 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 O-C-N 124.443 1.09 . . . . 51.479999999999997 108.36 176.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -57.15 -33.82 67.79 Favored 'General case' 0 C--O 1.249 1.075 0 N-CA-C 112.864 0.69 . . . . 50.280000000000001 112.864 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 42.0 mt -87.4 -16.75 34.03 Favored 'General case' 0 C--N 1.334 -0.078 0 O-C-N 120.29 -1.506 . . . . 50.210000000000001 114.239 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1083 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.81 132.88 48.23 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 118.841 -2.412 . . . . 49.060000000000002 116.476 -162.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 31.7 t30 -76.86 123.77 87.48 Favored Pre-proline 0 N--CA 1.452 -0.339 0 CA-C-N 114.293 -1.321 . . . . 51.079999999999998 113.651 174.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -61.27 155.59 50.74 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 124.249 3.3 . . . . 49.729999999999997 115.939 173.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 68.45 66.16 2.4 Favored Glycine 0 C--O 1.215 -1.058 0 CA-C-O 124.63 2.239 . . . . 47.710000000000001 109.539 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1087 ' ' THR . . . . . . . . . . . . . 33.0 m -146.22 137.75 24.74 Favored 'General case' 0 C--O 1.252 1.23 0 O-C-N 119.631 -2.1 . . . . 45.469999999999999 107.519 -171.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1088 ' ' THR . . . . . . . . . . . . . 3.0 m -80.21 94.98 6.15 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 104.169 -2.53 . . . . 42.039999999999999 104.169 165.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1089 ' ' LEU . . . . . 0.741 HD21 ' HG2' ' A' 1075 ' ' PRO . 27.7 tp -94.35 87.71 5.29 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 106.469 -1.678 . . . . 38.060000000000002 106.469 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1090 ' ' VAL . . . . . 0.408 ' HB ' HD23 ' A' 1070 ' ' LEU . 33.8 t -92.95 121.1 43.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 104.544 -2.391 . . . . 37.399999999999999 104.544 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1091 ' ' SER . . . . . 0.508 ' OG ' ' HB2' ' A' 1071 ' ' LYS . 26.7 m -153.37 151.83 30.38 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.857 -1.152 . . . . 36.159999999999997 112.673 -169.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 5.2 t80 -77.92 109.73 12.21 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 118.748 -2.47 . . . . 38.939999999999998 105.561 169.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 29.9 mm -90.56 -45.46 14.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 113.295 0.85 . . . . 42.170000000000002 113.295 -168.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 86.3 m95 54.61 66.36 4.21 Favored Pre-proline 0 C--O 1.245 0.827 0 O-C-N 124.485 1.115 . . . . 46.509999999999998 111.423 -157.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -52.0 -36.08 63.51 Favored 'Trans proline' 0 N--CA 1.449 -1.124 1 C-N-CA 125.801 4.334 . . . . 49.759999999999998 116.268 -175.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -72.35 -31.88 66.0 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-N 119.334 0.97 . . . . 52.619999999999997 108.84 -177.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 10.2 mp0 -77.95 -20.65 52.33 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 118.858 0.754 . . . . 60.740000000000002 112.243 172.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1098 ' ' ASN . . . . . 0.619 ' HB3' ' HB3' ' A' 1101 ' ' LEU . 69.4 m-80 -118.99 38.85 0.29 Allowed Pre-proline 0 N--CA 1.44 -0.958 0 N-CA-C 117.945 2.572 . . . . 58.189999999999998 117.945 -172.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -66.87 -24.59 46.24 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 124.569 3.513 . . . . 54.590000000000003 113.04 -168.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.99 -39.0 18.58 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 113.05 0.759 . . . . 63.280000000000001 113.05 175.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1101 ' ' LEU . . . . . 0.716 ' HG ' HD11 ' A' 1080 ' ' ILE . 10.2 tt -54.97 -39.78 69.32 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 109.765 -0.458 . . . . 54.75 109.765 166.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1102 ' ' MET . . . . . 0.417 ' HG2' ' O ' ' A' 1098 ' ' ASN . 49.2 mmm -57.74 -45.05 86.36 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.677 -1.264 . . . . 52.649999999999999 114.156 175.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -54.78 -43.35 72.75 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 112.536 0.569 . . . . 66.260000000000005 112.536 174.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1104 ' ' LYS . . . . . 0.632 ' HB3' HG21 ' A' 1080 ' ' ILE . 82.5 mttt -71.09 -41.67 70.32 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.435 0.636 . . . . 63.729999999999997 112.102 -175.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 71.8 mt -68.53 -32.38 72.29 Favored 'General case' 0 C--O 1.241 0.618 0 O-C-N 120.572 -1.33 . . . . 54.68 112.874 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -57.72 -51.52 69.2 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 120.455 1.479 . . . . 53.640000000000001 108.203 167.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -57.08 -25.68 59.14 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 122.14 2.246 . . . . 67.239999999999995 115.001 169.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -80.01 -3.85 50.15 Favored 'General case' 0 C--N 1.361 1.085 0 CA-C-N 121.177 1.808 . . . . 65.760000000000005 111.191 171.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 24.9 t-20 62.7 47.67 4.62 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 122.744 1.259 . . . . 58.710000000000001 109.578 168.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1110 ' ' VAL . . . . . . . . . . . . . 17.3 m -118.06 145.71 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 O-C-N 121.558 -0.714 . . . . 46.630000000000003 111.607 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1111 ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' 1361 ' ' ILE . 49.2 m -83.62 94.63 8.14 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-O 123.156 1.455 . . . . 44.130000000000003 107.681 174.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1112 ' ' VAL . . . . . 0.556 HG22 HD23 ' A' 1089 ' ' LEU . 82.8 t -89.94 118.93 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.008 0 CA-C-N 113.624 -1.625 . . . . 40.439999999999998 109.414 -174.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1113 ' ' MET . . . . . 0.696 ' HB3' HG12 ' A' 1358 ' ' VAL . 63.6 mtp -109.75 108.59 19.0 Favored 'General case' 0 C--O 1.252 1.229 0 N-CA-C 107.547 -1.279 . . . . 50.759999999999998 107.547 -177.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1114 ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' 1091 ' ' SER . . . -85.12 108.42 17.67 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-O 123.736 1.731 . . . . 35.640000000000001 110.653 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1115 ' ' MET . . . . . 0.489 ' HB3' ' CB ' ' A' 1129 ' ' ALA . 61.8 mmm -69.39 -14.35 62.86 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 112.049 -2.342 . . . . 38.740000000000002 115.467 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1116 ' ' ASP . . . . . 0.595 ' HA ' ' HB2' ' A' 1130 ' ' LEU . 3.6 p30 -71.14 -36.25 72.01 Favored 'General case' 0 C--N 1.352 0.674 0 CA-C-N 120.189 1.359 . . . . 40.140000000000001 111.122 162.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1117 ' ' SER . . . . . . . . . . . . . 49.2 m -80.97 23.33 0.56 Allowed 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 125.121 1.513 . . . . 44.789999999999999 114.551 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1118 ' ' VAL . . . . . 0.583 HG12 ' HB1' ' A' 1124 ' ' ALA . 16.5 t -70.3 131.41 88.55 Favored Pre-proline 0 N--CA 1.445 -0.681 0 N-CA-C 104.576 -2.379 . . . . 43.75 104.576 166.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1119 ' ' PRO . . . . . 0.487 ' HB2' HG12 ' A' 1121 ' ' ILE . 91.6 Cg_exo -58.36 146.25 90.48 Favored 'Trans proline' 0 C--O 1.252 1.216 0 C-N-CA 122.63 2.22 . . . . 48.93 113.556 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -66.6 -10.31 44.41 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 120.691 -1.255 . . . . 62.899999999999999 113.0 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1121 ' ' ILE . . . . . 0.487 HG12 ' HB2' ' A' 1119 ' ' PRO . 50.0 pt -62.19 152.19 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 N-CA-C 114.003 1.112 . . . . 57.719999999999999 114.003 -177.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1122 ' ' SER . . . . . . . . . . . . . 6.5 m -48.52 -52.63 21.61 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 118.304 2.705 . . . . 57.259999999999998 118.304 -177.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -56.64 -22.62 35.69 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 118.386 -2.696 . . . . 62.899999999999999 113.423 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1124 ' ' ALA . . . . . 0.583 ' HB1' HG12 ' A' 1118 ' ' VAL . . . -90.04 -21.52 22.31 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 117.025 -1.464 . . . . 49.829999999999998 111.773 -172.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -61.67 -26.73 68.2 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 116.444 2.016 . . . . 52.369999999999997 116.444 -163.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1126 ' ' SER . . . . . . . . . . . . . 5.8 p -66.83 -37.77 85.13 Favored 'General case' 0 C--O 1.245 0.821 0 O-C-N 119.058 -2.276 . . . . 42.43 111.999 170.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1127 ' ' LEU . . . . . . . . . . . . . 3.5 mp -77.23 -31.16 54.94 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 122.95 1.357 . . . . 43.740000000000002 110.739 176.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1128 ' ' ASP . . . . . 0.406 ' HA ' HG21 ' A' 1118 ' ' VAL . 6.1 t70 -53.82 109.78 0.5 Allowed 'General case' 0 C--O 1.252 1.227 0 CA-C-O 123.965 1.84 . . . . 43.210000000000001 113.649 -176.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1129 ' ' ALA . . . . . 0.489 ' CB ' ' HB3' ' A' 1115 ' ' MET . . . -80.06 -31.65 39.39 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 111.62 -2.536 . . . . 35.740000000000002 112.687 177.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1130 ' ' LEU . . . . . 0.595 ' HB2' ' HA ' ' A' 1116 ' ' ASP . 36.0 tp -54.45 -51.64 64.35 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.775 0.716 . . . . 38.090000000000003 110.538 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1131 ' ' SER . . . . . 0.464 ' HB3' HG21 ' A' 1175 ' ' VAL . 7.3 m -50.47 -49.26 55.69 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.715 1.206 . . . . 36.909999999999997 111.347 174.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1132 ' ' SER . . . . . . . . . . . . . 1.4 m -73.28 -42.29 62.61 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 115.676 -0.693 . . . . 35.789999999999999 111.123 -171.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1133 ' ' MET . . . . . 0.517 ' HA ' HD12 ' A' 1136 ' ' ILE . 28.6 mtp -63.2 -43.09 99.15 Favored 'General case' 0 N--CA 1.433 -1.308 0 O-C-N 120.479 -1.388 . . . . 30.809999999999999 110.564 177.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1134 ' ' ALA . . . . . 0.651 ' HB1' ' HB2' ' A' 1176 ' ' ALA . . . -52.09 -47.17 65.38 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 122.99 1.376 . . . . 28.879999999999999 112.903 168.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1135 ' ' ASN . . . . . 0.774 ' HB2' HG12 ' A' 1175 ' ' VAL . 25.0 t-20 -59.01 -48.21 82.4 Favored 'General case' 0 C--N 1.347 0.463 0 O-C-N 120.832 -1.168 . . . . 40.759999999999998 112.18 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1136 ' ' ILE . . . . . 0.575 HD13 ' HA ' ' A' 1323 ' ' SER . 61.3 mt -59.18 -46.48 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 108.782 -0.821 . . . . 31.539999999999999 108.782 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -61.39 -30.46 70.56 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 115.905 -1.998 . . . . 29.870000000000001 112.771 175.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -75.14 -39.8 36.18 Favored Glycine 0 CA--C 1.499 -0.932 0 CA-C-N 121.472 1.942 . . . . 28.73 109.814 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 25.5 t80 -65.62 -45.68 82.18 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.21 -1.033 . . . . 30.390000000000001 108.21 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1140 ' ' ARG . . . . . 0.459 ' HG3' HD22 ' A' 1315 ' ' LEU . 8.7 tpt180 -69.19 -24.82 64.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.906 0.86 . . . . 26.09 112.536 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1141 ' ' ALA . . . . . 0.604 ' HB2' HD21 ' A' 1284 ' ' LEU . . . -62.13 -45.14 94.77 Favored 'General case' 0 C--O 1.245 0.858 0 O-C-N 120.353 -1.467 . . . . 27.100000000000001 109.409 168.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 46.7 mm -58.52 -44.48 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 120.444 1.475 . . . . 28.48 114.538 172.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 28.8 t -53.1 -59.62 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 114.72 -1.127 . . . . 23.07 111.266 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1144 ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -75.27 -23.9 57.51 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.982 -0.377 . . . . 33.399999999999999 109.982 -171.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1145 ' ' ALA . . . . . 0.531 ' HA ' HG11 ' A' 1280 ' ' VAL . . . -62.12 -51.55 67.44 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.334 -0.987 . . . . 24.219999999999999 108.334 171.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -64.07 -28.06 69.53 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 123.8 0.84 . . . . 24.890000000000001 112.348 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -65.51 -40.28 92.82 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 118.763 -0.637 . . . . 26.73 110.832 171.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1148 ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -101.68 5.78 41.6 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 119.009 -2.307 . . . . 39.960000000000001 113.043 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1149 ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -76.15 144.9 40.29 Favored 'General case' 0 CA--C 1.514 -0.427 0 O-C-N 120.067 -1.645 . . . . 25.870000000000001 112.816 -169.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1150 ' ' GLY . . . . . 0.653 ' HA2' ' HG2' ' B' 1320 ' ' PRO . . . -71.21 -48.97 28.8 Favored Glycine 0 C--O 1.218 -0.9 0 N-CA-C 109.799 -1.32 . . . . 19.280000000000001 109.799 172.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1151 ' ' ARG . . . . . 0.866 ' HA ' ' HB2' ' B' 1322 ' ' GLN . 74.2 mtm-85 -99.57 -172.17 2.2 Favored 'General case' 0 C--N 1.318 -0.795 0 O-C-N 120.906 -1.35 . . . . 39.899999999999999 114.071 -172.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1152 ' ' PHE . . . . . 0.44 ' HD2' ' HG2' ' B' 1322 ' ' GLN . 0.4 OUTLIER -96.51 144.69 26.36 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 103.856 -2.646 . . . . 29.440000000000001 103.856 177.282 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 1153 ' ' PHE . . . . . 0.421 ' CZ ' HG13 ' A' 1251 ' ' ILE . 8.7 m-85 -64.21 -57.19 10.2 Favored 'General case' 0 C--N 1.341 0.224 0 O-C-N 121.211 -0.931 . . . . 32.600000000000001 110.039 168.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1154 ' ' THR . . . . . 0.519 HG22 ' HB3' ' A' 1156 ' ' GLN . 90.8 m -61.8 123.95 19.41 Favored 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 126.431 1.893 . . . . 34.640000000000001 116.015 -177.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -71.78 73.43 0.81 Allowed Glycine 0 N--CA 1.439 -1.158 0 CA-C-O 126.052 3.029 . . . . 37.140000000000001 111.259 175.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1156 ' ' GLN . . . . . 0.519 ' HB3' HG22 ' A' 1154 ' ' THR . 4.2 pp0? -108.93 136.2 48.86 Favored 'General case' 0 N--CA 1.434 -1.232 0 O-C-N 118.588 -2.713 . . . . 40.57 115.876 -177.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1157 ' ' ILE . . . . . 0.773 HG13 ' HB3' ' C' ' 70' ' ' PRO . 4.5 tp -90.87 110.2 21.97 Favored 'Isoleucine or valine' 0 C--O 1.256 1.431 0 CA-C-N 113.361 -1.745 . . . . 44.609999999999999 106.673 171.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1158 ' ' THR . . . . . . . . . . . . . 17.5 m -78.15 177.11 8.62 Favored 'General case' 0 C--O 1.252 1.202 0 O-C-N 120.87 -1.144 . . . . 40.700000000000003 110.563 169.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -65.09 -23.24 67.1 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 116.97 -3.581 . . . . 40.25 111.171 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1160 ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' B' 1126 ' ' SER . . . -134.35 131.01 37.8 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 104.828 -2.286 . . . . 38.469999999999999 104.828 159.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . 111.93 115.05 3.42 Favored Glycine 0 C--O 1.247 0.93 0 C-N-CA 119.572 -1.299 . . . . 37.609999999999999 112.095 170.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 15.8 tttp -85.7 130.87 34.45 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 104.456 -2.424 . . . . 48.899999999999999 104.456 169.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1163 ' ' VAL . . . . . 0.496 HG22 ' NE2' ' B' 1322 ' ' GLN . 69.7 t -85.98 128.19 59.09 Favored Pre-proline 0 N--CA 1.42 -1.933 0 O-C-N 120.01 -1.681 . . . . 36.520000000000003 107.896 164.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1164 ' ' PRO . . . . . 0.508 ' HA ' ' HD2' ' A' 1165 ' ' PRO . 28.6 Cg_endo -72.26 108.23 2.44 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.516 2.144 . . . . 35.079999999999998 108.904 155.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1165 ' ' PRO . . . . . 0.508 ' HD2' ' HA ' ' A' 1164 ' ' PRO . 30.4 Cg_endo -56.34 148.25 62.67 Favored 'Trans proline' 0 N--CA 1.444 -1.394 1 C-N-CA 126.314 4.676 . . . . 35.329999999999998 115.289 -176.524 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 1166 ' ' ALA . . . . . 0.443 ' O ' ' HB1' ' A' 1189 ' ' ALA . . . -66.12 129.02 38.39 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 125.159 1.537 . . . . 34.689999999999998 110.962 177.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1167 ' ' LYS . . . . . 0.611 ' HB2' ' HA ' ' A' 1249 ' ' VAL . 64.4 mttp -92.41 106.99 18.88 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 105.17 -2.159 . . . . 45.359999999999999 105.17 172.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 60.6 t -91.58 91.57 3.57 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 106.967 -1.494 . . . . 31.710000000000001 106.967 -175.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1169 ' ' MET . . . . . 0.465 ' HA ' ' O ' ' A' 1192 ' ' ARG . 25.1 ttp -79.29 92.11 5.1 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 124.593 2.14 . . . . 42.280000000000001 108.717 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1170 ' ' VAL . . . . . 0.438 HG13 ' OG1' ' A' 1255 ' ' THR . 13.8 t -75.29 115.14 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 112.128 -2.305 . . . . 30.510000000000002 106.629 176.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 64.5 mt -104.07 123.59 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 104.528 -2.397 . . . . 31.870000000000001 104.528 176.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 79.32 79.25 0.83 Allowed Glycine 0 CA--C 1.493 -1.332 0 CA-C-O 123.796 1.776 . . . . 34.539999999999999 109.81 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1173 ' ' ALA . . . . . 0.613 ' HB3' HG21 ' A' 1200 ' ' VAL . . . -75.7 179.86 5.15 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 123.417 1.58 . . . . 32.509999999999998 109.669 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . 138.92 -157.69 24.89 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 106.182 -2.767 . . . . 29.899999999999999 106.182 -175.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1175 ' ' VAL . . . . . 0.774 HG12 ' HB2' ' A' 1135 ' ' ASN . 34.3 t -70.49 -30.06 41.19 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 CA-C-N 122.188 2.994 . . . . 33.109999999999999 110.66 -170.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1176 ' ' ALA . . . . . 0.651 ' HB2' ' HB1' ' A' 1134 ' ' ALA . . . -65.35 -41.73 93.57 Favored 'General case' 0 C--N 1.348 0.517 0 CA-C-O 122.343 1.068 . . . . 28.100000000000001 108.832 171.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -60.67 -42.45 99.32 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 124.478 2.154 . . . . 28.539999999999999 109.997 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1178 ' ' LEU . . . . . 0.534 ' HA ' HD12 ' A' 1181 ' ' ILE . 72.8 mt -67.83 -35.69 79.05 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 113.403 -1.399 . . . . 31.219999999999999 111.052 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1179 ' ' ALA . . . . . 0.485 ' HB2' ' ND2' ' A' 1135 ' ' ASN . . . -64.99 -44.59 88.79 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-N 122.832 2.56 . . . . 28.98 108.822 175.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -55.25 -45.46 76.08 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 126.317 2.26 . . . . 27.829999999999998 113.085 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1181 ' ' ILE . . . . . 0.534 HD12 ' HA ' ' A' 1178 ' ' LEU . 33.5 mt -63.62 -54.28 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 O-C-N 120.237 -1.54 . . . . 30.25 108.819 175.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -52.29 -26.02 20.52 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 112.668 -2.06 . . . . 29.59 112.761 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -85.24 -60.25 2.09 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 115.323 1.601 . . . . 30.289999999999999 115.323 165.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -74.8 -39.73 61.52 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 115.386 1.624 . . . . 30.469999999999999 115.386 -167.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -60.22 -43.49 95.96 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 119.759 -1.838 . . . . 42.409999999999997 109.685 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1186 ' ' SER . . . . . 0.492 ' O ' ' HB3' ' B' 1186 ' ' SER . 21.4 m -58.39 -46.11 87.03 Favored 'General case' 0 C--O 1.213 -0.827 0 CA-C-O 121.957 0.885 . . . . 39.380000000000003 111.078 175.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 44.0 mt -62.47 -30.44 71.26 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 114.909 1.448 . . . . 36.18 114.909 174.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 103.36 42.38 2.04 Favored Glycine 0 N--CA 1.428 -1.879 0 CA-C-N 114.839 -1.073 . . . . 33.780000000000001 111.015 176.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1189 ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' 1166 ' ' ALA . . . -115.9 144.2 44.38 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 106.915 -1.513 . . . . 33.93 106.915 174.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 45.7 mt -72.07 102.63 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 O-C-N 120.226 -1.546 . . . . 38.740000000000002 110.375 -174.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1191 ' ' VAL . . . . . 0.451 HG21 ' HA ' ' A' 1181 ' ' ILE . 17.0 t -86.84 121.27 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 O-C-N 119.817 -1.802 . . . . 33.090000000000003 106.854 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1192 ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' 1169 ' ' MET . 73.8 mtt180 -115.68 105.33 12.63 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 105.321 -2.103 . . . . 38.920000000000002 105.321 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1193 ' ' ALA . . . . . 0.463 ' HB3' HG11 ' A' 1204 ' ' VAL . . . -102.73 124.67 48.69 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 118.928 -1.109 . . . . 35.32 110.482 -176.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1194 ' ' PHE . . . . . 0.54 ' HB2' HD12 ' A' 1212 ' ' LEU . 69.7 t80 -110.59 140.74 44.63 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 122.133 0.968 . . . . 39.350000000000001 109.419 175.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 7.1 t0 -157.52 150.12 22.95 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.182 -1.044 . . . . 40.460000000000001 108.182 174.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1196 ' ' THR . . . . . 0.541 HG23 ' CE2' ' A' 1234 ' ' PHE . 8.7 m -58.31 -38.98 78.16 Favored 'General case' 0 N--CA 1.445 -0.698 0 O-C-N 128.391 3.557 . . . . 45.939999999999998 109.493 171.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1197 ' ' ARG . . . . . 0.417 ' HA ' ' HD2' ' A' 1198 ' ' PRO . 86.5 mtm180 -87.73 110.92 38.6 Favored Pre-proline 0 C--N 1.318 -0.776 0 C-N-CA 126.67 1.988 . . . . 56.020000000000003 109.777 -172.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1198 ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' 1197 ' ' ARG . 72.6 Cg_endo -66.32 -13.32 39.38 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 121.457 1.438 . . . . 51.270000000000003 112.072 166.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -52.8 -30.49 33.54 Favored 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 118.66 -2.525 . . . . 59.100000000000001 115.1 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1200 ' ' VAL . . . . . 0.613 HG21 ' HB3' ' A' 1173 ' ' ALA . 35.6 m -93.92 -9.84 9.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 114.235 1.198 . . . . 51.060000000000002 114.235 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 86.4 tttt -52.17 -61.52 2.21 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 114.991 1.478 . . . . 57.380000000000003 114.991 -174.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1202 ' ' GLU . . . . . 0.4 ' HA ' ' HB2' ' A' 1205 ' ' GLN . 23.7 mp0 -69.37 -22.27 63.74 Favored 'General case' 0 C--O 1.211 -0.955 0 CA-C-N 119.934 1.243 . . . . 62.409999999999997 112.567 -177.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -63.84 -50.79 67.51 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 113.174 0.805 . . . . 57.780000000000001 113.174 170.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1204 ' ' VAL . . . . . 0.463 HG11 ' HB3' ' A' 1193 ' ' ALA . 47.4 t -58.98 -41.01 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 113.751 -1.568 . . . . 46.380000000000003 110.634 173.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1205 ' ' GLN . . . . . 0.4 ' HB2' ' HA ' ' A' 1202 ' ' GLU . 97.7 mt-30 -68.19 -29.37 68.21 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 115.401 1.63 . . . . 50.700000000000003 115.401 173.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1206 ' ' SER . . . . . . . . . . . . . 64.0 m -74.59 -31.37 62.01 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 121.062 -1.024 . . . . 49.979999999999997 110.872 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1207 ' ' MET . . . . . 0.413 ' SD ' ' HB3' ' A' 1178 ' ' LEU . 36.8 mtp -79.68 -15.2 58.0 Favored 'General case' 0 C--O 1.249 1.045 0 O-C-N 120.745 -1.222 . . . . 52.990000000000002 113.469 170.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 97.53 83.83 1.72 Allowed Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 109.009 -1.636 . . . . 47.659999999999997 109.009 173.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1209 ' ' ALA . . . . . 0.448 ' HB3' ' CG1' ' A' 1204 ' ' VAL . . . -161.27 145.82 13.49 Favored 'General case' 0 C--N 1.289 -2.03 0 O-C-N 119.093 -2.416 . . . . 44.770000000000003 107.311 176.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -76.76 123.04 25.59 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 103.74 -2.689 . . . . 47.640000000000001 103.74 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1211 ' ' PHE . . . . . . . . . . . . . 11.9 t80 -89.01 136.52 32.97 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 106.606 -1.627 . . . . 45.659999999999997 106.606 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1212 ' ' LEU . . . . . 0.54 HD12 ' HB2' ' A' 1194 ' ' PHE . 68.4 mt -94.51 119.22 32.87 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 107.521 -1.288 . . . . 46.060000000000002 107.521 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -71.76 144.25 49.28 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 112.79 -2.004 . . . . 60.219999999999999 111.875 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1214 ' ' LEU . . . . . 0.537 HD21 ' HZ ' ' A' 1234 ' ' PHE . 17.2 tp -73.66 89.13 1.74 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 109.504 -3.498 . . . . 57.25 112.421 -171.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1215 ' ' ASP . . . . . 0.481 ' O ' ' HB1' ' A' 1237 ' ' ALA . 23.6 t0 -71.53 87.09 0.89 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 114.086 1.143 . . . . 64.430000000000007 114.086 -174.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 85.4 t80 . . . . . 0 C--O 1.202 -1.413 0 O-C-N 124.794 1.309 . . . . 66.900000000000006 107.814 -170.507 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 30.9 t70 . . . . . 0 N--CA 1.447 -0.578 0 N-CA-C 107.071 -1.455 . . . . 39.090000000000003 107.071 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -67.34 -41.87 90.75 Favored Glycine 0 C--N 1.347 1.17 0 CA-C-N 114.484 -1.235 . . . . 39.32 111.598 -173.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 51.0 t80 -73.4 -42.09 62.53 Favored 'General case' 0 CA--C 1.504 -0.788 0 CA-C-O 118.151 -0.928 . . . . 39.299999999999997 108.696 -177.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -62.04 -38.51 89.01 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-N 119.539 1.063 . . . . 36.299999999999997 109.226 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -57.11 -45.94 83.02 Favored 'General case' 0 C--O 1.207 -1.159 0 CA-C-O 117.903 -1.046 . . . . 37.380000000000003 111.241 172.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -53.79 -31.12 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 113.15 0.796 . . . . 39.109999999999999 113.15 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1230 ' ' MET . . . . . . . . . . . . . 38.1 mmt -81.36 -23.97 37.37 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 116.394 1.998 . . . . 49.590000000000003 116.394 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1231 ' ' SER . . . . . . . . . . . . . 54.0 p -67.77 133.69 49.68 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.194 0.812 . . . . 43.68 113.194 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -50.23 -40.52 47.82 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 116.282 1.956 . . . . 55.57 116.282 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -64.72 -33.12 75.21 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 122.16 0.981 . . . . 44.939999999999998 110.271 178.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1234 ' ' PHE . . . . . 0.541 ' CE2' HG23 ' A' 1196 ' ' THR . 26.0 t80 -76.16 -46.48 28.37 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.365 -0.834 . . . . 42.039999999999999 109.041 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 12.2 mt -59.26 -31.43 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 122.344 -0.222 . . . . 46.280000000000001 111.377 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 53.3 tttm -62.48 -48.46 79.51 Favored 'General case' 0 C--O 1.245 0.867 0 O-C-N 119.531 -1.981 . . . . 47.869999999999997 109.0 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1237 ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' A' 1215 ' ' ASP . . . -58.83 -51.68 68.98 Favored 'General case' 0 C--O 1.247 0.931 0 N-CA-C 113.859 1.059 . . . . 41.609999999999999 113.859 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -54.79 -53.67 52.16 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 114.615 -1.175 . . . . 50.649999999999999 109.629 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1239 ' ' MET . . . . . . . . . . . . . 43.1 ttm -57.95 -41.36 82.66 Favored 'General case' 0 C--O 1.22 -0.484 0 O-C-N 123.694 0.621 . . . . 48.869999999999997 110.582 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -76.48 -22.5 54.44 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 120.119 -1.613 . . . . 54.799999999999997 111.725 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 1.3 tm? -66.9 -47.35 72.08 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.512 -1.662 . . . . 43.210000000000001 106.512 169.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -60.05 -36.51 77.47 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-O 118.701 -0.666 . . . . 38.659999999999997 110.283 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -67.19 -47.96 69.37 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 121.003 1.729 . . . . 37.920000000000002 111.353 -177.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -56.97 -55.19 37.88 Favored 'General case' 0 C--O 1.249 1.047 0 O-C-N 121.357 -0.839 . . . . 37.280000000000001 110.769 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -55.95 -36.33 67.66 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.743 1.217 . . . . 43.07 113.943 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1246 ' ' ALA . . . . . 0.458 ' HA ' HG22 ' A' 1249 ' ' VAL . . . -56.46 -30.4 62.85 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.996 1.11 . . . . 38.299999999999997 113.996 -176.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1247 ' ' LYS . . . . . . . . . . . . . 16.4 mtmt -78.89 -10.63 59.87 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 114.94 1.459 . . . . 47.600000000000001 114.94 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -121.18 -16.53 7.95 Favored 'General case' 0 C--O 1.246 0.899 0 O-C-N 119.0 -2.313 . . . . 45.420000000000002 114.858 173.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1249 ' ' VAL . . . . . 0.611 ' HA ' ' HB2' ' A' 1167 ' ' LYS . 27.7 m -85.33 175.21 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 O-C-N 119.199 -2.188 . . . . 36.259999999999998 111.193 -175.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1250 ' ' ASP . . . . . 0.427 ' O ' ' HB3' ' A' 1279 ' ' SER . 10.4 m-20 -134.27 -61.83 0.77 Allowed 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 112.818 -1.992 . . . . 33.039999999999999 109.371 -169.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1251 ' ' ILE . . . . . 0.523 HD12 ' HB1' ' A' 1145 ' ' ALA . 39.3 mm -108.61 94.99 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 107.002 -1.481 . . . . 31.399999999999999 107.002 -173.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1252 ' ' ILE . . . . . 0.436 ' HB ' HG23 ' A' 1281 ' ' ILE . 44.2 mt -77.7 107.65 9.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 106.13 -1.804 . . . . 29.420000000000002 106.13 171.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 5.5 t -99.28 105.19 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 104.635 -2.357 . . . . 30.370000000000001 104.635 173.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1254 ' ' THR . . . . . 0.667 HG21 ' HB2' ' A' 1291 ' ' ASN . 29.1 m -74.37 84.58 1.95 Allowed 'General case' 0 C--O 1.248 1.004 0 CA-C-O 122.732 1.253 . . . . 35.719999999999999 109.561 171.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1255 ' ' THR . . . . . 0.438 ' OG1' HG13 ' A' 1170 ' ' VAL . 1.1 p -75.89 -4.28 39.98 Favored 'General case' 0 C--O 1.25 1.093 0 N-CA-C 115.067 1.506 . . . . 36.0 115.067 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1256 ' ' ALA . . . . . . . . . . . . . . . -69.34 86.94 0.43 Allowed 'General case' 0 C--O 1.246 0.878 0 CA-C-O 121.65 0.738 . . . . 40.93 109.41 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1257 ' ' LEU . . . . . 0.553 HD22 ' HB2' ' A' 1134 ' ' ALA . 8.8 tp -73.13 91.96 1.67 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 105.653 -1.98 . . . . 47.82 105.653 178.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1258 ' ' ILE . . . . . 0.41 ' HA ' ' HD3' ' A' 1259 ' ' PRO . 41.8 mm -69.49 131.46 89.96 Favored Pre-proline 0 C--O 1.213 -0.865 0 CA-C-N 112.838 -1.983 . . . . 52.700000000000003 109.048 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1259 ' ' PRO . . . . . 0.433 ' O ' ' HG2' ' A' 1261 ' ' LYS . 6.8 Cg_exo -99.41 124.74 0.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.816 2.344 . . . . 54.130000000000003 114.387 177.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 78.2 -83.63 1.19 Allowed Glycine 0 C--N 1.343 0.962 0 CA-C-O 124.698 2.277 . . . . 54.619999999999997 114.786 173.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1261 ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' 1259 ' ' PRO . 55.2 pttt -42.84 146.91 0.7 Allowed Pre-proline 0 C--O 1.257 1.474 0 N-CA-C 117.711 2.486 . . . . 55.740000000000002 117.711 171.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -57.22 142.65 94.63 Favored 'Trans proline' 0 N--CA 1.451 -0.999 1 C-N-CA 125.336 4.024 . . . . 51.149999999999999 112.579 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1263 ' ' ALA . . . . . 0.414 ' HA ' ' HD2' ' A' 1264 ' ' PRO . . . -66.93 123.51 86.32 Favored Pre-proline 0 C--N 1.343 0.307 0 CA-C-N 113.446 -1.706 . . . . 46.060000000000002 111.169 174.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1264 ' ' PRO . . . . . 0.59 ' HG2' HD21 ' A' 1291 ' ' ASN . 43.7 Cg_endo -58.43 115.58 2.64 Favored 'Trans proline' 0 CA--C 1.509 -0.743 0 C-N-CA 123.792 2.995 . . . . 41.079999999999998 115.769 175.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1265 ' ' LYS . . . . . 0.435 ' HB3' ' HG2' ' A' 1293 ' ' GLU . 72.7 mmtt -75.6 89.58 2.76 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 122.495 1.141 . . . . 47.420000000000002 108.83 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 37.7 mt -97.67 -45.87 6.21 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.243 -1.391 . . . . 39.219999999999999 107.243 -177.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 7.9 mt -87.37 93.99 4.35 Favored 'Isoleucine or valine' 0 C--O 1.252 1.224 0 CA-C-O 126.19 2.9 . . . . 42.5 107.739 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1268 ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.75 143.68 30.01 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 111.97 -2.377 . . . . 37.840000000000003 112.383 175.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1269 ' ' ARG . . . . . 0.569 ' HG3' ' HB2' ' A' 1293 ' ' GLU . 56.3 mtt-85 -47.51 -39.18 15.54 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.072 0.949 . . . . 54.799999999999997 112.199 175.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -56.72 -50.09 73.24 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.388 -1.445 . . . . 54.359999999999999 109.154 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1271 ' ' MET . . . . . . . . . . . . . 10.0 mtt -68.78 -25.36 64.67 Favored 'General case' 0 CA--C 1.497 -1.09 0 O-C-N 123.789 0.68 . . . . 39.520000000000003 111.189 -170.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1272 ' ' VAL . . . . . 0.476 HG12 HG21 ' A' 1303 ' ' THR . 59.1 t -66.56 -49.62 73.5 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 O-C-N 126.179 2.174 . . . . 38.25 110.473 175.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -68.58 -26.43 65.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 119.985 -1.697 . . . . 40.770000000000003 112.445 174.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1274 ' ' SER . . . . . . . . . . . . . 7.2 m -68.76 -11.84 60.79 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 120.527 1.512 . . . . 36.579999999999998 114.442 169.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1275 ' ' MET . . . . . . . . . . . . . 62.7 mtp -62.52 145.69 53.63 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-O 124.478 2.085 . . . . 36.75 111.005 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1276 ' ' LYS . . . . . . . . . . . . . 74.1 tttt -50.64 137.38 19.88 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 110.967 -2.833 . . . . 46.109999999999999 106.468 165.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1277 ' ' ALA . . . . . 0.418 ' HB3' ' CD1' ' B' 1045 ' ' PHE . . . -90.94 176.85 6.46 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 117.9 -1.52 . . . . 33.520000000000003 110.472 -169.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 63.42 31.01 79.31 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 111.404 -0.679 . . . . 31.27 111.404 -170.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1279 ' ' SER . . . . . 0.427 ' HB3' ' O ' ' A' 1250 ' ' ASP . 15.2 m -122.32 171.93 8.68 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 120.587 -1.537 . . . . 32.950000000000003 110.528 -171.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1280 ' ' VAL . . . . . 0.531 HG11 ' HA ' ' A' 1145 ' ' ALA . 41.7 t -134.45 136.27 53.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 O-C-N 120.822 -1.174 . . . . 27.43 110.425 -173.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1281 ' ' ILE . . . . . 0.436 HG23 ' HB ' ' A' 1252 ' ' ILE . 66.0 mt -113.37 109.02 27.01 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 N-CA-C 103.122 -2.918 . . . . 30.300000000000001 103.122 170.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1282 ' ' VAL . . . . . 0.448 HG21 ' HB2' ' A' 1145 ' ' ALA . 2.4 t -101.15 97.86 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 105.104 -2.184 . . . . 28.629999999999999 105.104 176.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1283 ' ' ASP . . . . . 0.621 ' HA ' ' HB ' ' A' 1254 ' ' THR . 9.4 t70 -95.63 101.18 12.86 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 113.568 -1.651 . . . . 36.270000000000003 107.155 -171.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1284 ' ' LEU . . . . . 0.604 HD21 ' HB2' ' A' 1141 ' ' ALA . 31.2 mt -64.38 -37.69 88.41 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 119.608 -0.837 . . . . 38.57 110.688 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -59.23 -1.86 0.23 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 116.523 2.046 . . . . 37.560000000000002 116.523 173.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . -36.7 -42.52 0.37 Allowed 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 116.687 2.106 . . . . 40.329999999999998 116.687 161.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -51.33 -28.19 11.61 Favored 'General case' 0 C--N 1.348 0.534 0 N-CA-C 115.714 1.746 . . . . 56.850000000000001 115.714 174.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 11.4 m120 -113.97 22.88 13.49 Favored 'General case' 0 N--CA 1.433 -1.281 0 O-C-N 121.4 -0.813 . . . . 45.859999999999999 108.866 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 109.68 -23.11 22.75 Favored Glycine 0 N--CA 1.43 -1.731 0 O-C-N 118.196 -2.815 . . . . 40.310000000000002 114.338 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1290 ' ' GLY . . . . . 0.491 ' HA3' ' HB ' ' A' 1295 ' ' THR . . . 87.62 127.92 2.63 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 120.853 2.327 . . . . 38.890000000000001 112.2 -177.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1291 ' ' ASN . . . . . 0.667 ' HB2' HG21 ' A' 1254 ' ' THR . 2.8 m120 -71.27 -26.22 62.79 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 113.345 -1.427 . . . . 37.229999999999997 113.804 175.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1292 ' ' CYS . . . . . 0.425 ' SG ' HG21 ' A' 1272 ' ' VAL . 1.6 t -82.51 138.86 34.19 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.757 -1.11 . . . . 36.5 108.951 165.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1293 ' ' GLU . . . . . 0.569 ' HB2' ' HG3' ' A' 1269 ' ' ARG . 78.5 mt-10 -68.8 -6.56 27.52 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 115.371 1.619 . . . . 43.32 115.371 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -102.81 -2.09 28.59 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 119.688 -1.883 . . . . 41.32 112.706 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1295 ' ' THR . . . . . 0.491 ' HB ' ' HA3' ' A' 1290 ' ' GLY . 31.5 m -78.04 103.13 7.79 Favored 'General case' 0 C--N 1.355 0.832 0 O-C-N 120.845 -1.16 . . . . 35.299999999999997 112.827 -168.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 47.8 t -82.6 121.59 78.1 Favored Pre-proline 0 C--N 1.31 -1.131 0 O-C-N 125.292 1.62 . . . . 34.840000000000003 107.4 174.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -63.51 143.46 88.0 Favored 'Trans proline' 0 C--O 1.25 1.118 0 C-N-CA 122.984 2.456 . . . . 33.509999999999998 108.884 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 69.69 13.56 68.87 Favored Glycine 0 CA--C 1.544 1.9 0 CA-C-O 116.682 -2.177 . . . . 32.189999999999998 115.425 -175.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -147.37 169.98 18.32 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-N 123.988 3.894 . . . . 34.880000000000003 112.823 -172.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1300 ' ' ILE . . . . . 0.452 HG12 HG12 ' A' 1310 ' ' ILE . 74.3 mt -107.92 141.44 23.16 Favored 'Isoleucine or valine' 0 C--O 1.248 0.992 0 N-CA-C 106.555 -1.646 . . . . 32.289999999999999 106.555 166.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 78.8 t80 -119.74 114.28 21.92 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 104.194 -2.521 . . . . 37.25 104.194 164.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1302 ' ' THR . . . . . . . . . . . . . 46.0 m -93.66 118.9 31.99 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 103.614 -2.735 . . . . 35.560000000000002 103.614 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1303 ' ' THR . . . . . 0.476 HG21 HG12 ' A' 1272 ' ' VAL . 8.5 p -70.74 170.92 11.41 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 113.525 -1.671 . . . . 36.399999999999999 114.284 -171.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -75.23 -9.65 58.75 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 113.963 1.097 . . . . 52.32 113.963 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 37.3 p-10 -83.84 -46.14 12.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.363 0.601 . . . . 40.039999999999999 111.356 166.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 127.45 52.0 0.14 Allowed Glycine 0 N--CA 1.427 -1.903 0 CA-C-N 114.466 -1.243 . . . . 36.960000000000001 112.808 -177.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1307 ' ' VAL . . . . . . . . . . . . . 82.0 t -118.77 124.02 72.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 N-CA-C 104.943 -2.243 . . . . 33.399999999999999 104.943 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1308 ' ' LYS . . . . . 0.44 ' HB2' HG22 ' A' 1280 ' ' VAL . 53.7 mmtt -80.21 95.11 6.18 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 106.116 -1.809 . . . . 42.909999999999997 106.116 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 38.4 t -84.22 92.68 3.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 106.357 -1.72 . . . . 32.289999999999999 106.357 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1310 ' ' ILE . . . . . 0.452 HG12 HG12 ' A' 1300 ' ' ILE . 82.6 mt -82.44 103.41 9.62 Favored 'Isoleucine or valine' 0 C--N 1.351 0.642 0 CA-C-N 112.782 -2.008 . . . . 30.989999999999998 109.166 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -103.21 60.69 0.48 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 108.936 -1.666 . . . . 28.949999999999999 108.936 168.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1312 ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -83.25 95.73 8.24 Favored 'General case' 0 C--O 1.252 1.189 0 CA-C-O 125.278 2.466 . . . . 31.690000000000001 111.483 177.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1313 ' ' THR . . . . . . . . . . . . . 2.8 m -51.91 -37.92 54.35 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 112.46 -2.155 . . . . 34.170000000000002 111.567 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -84.77 10.38 11.58 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 113.381 -1.736 . . . . 36.859999999999999 111.679 -169.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1315 ' ' LEU . . . . . 0.459 HD22 ' HG3' ' A' 1140 ' ' ARG . 96.9 mt -44.05 -44.36 17.0 Favored Pre-proline 0 N--CA 1.474 0.743 0 N-CA-C 119.356 3.095 . . . . 34.850000000000001 119.356 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -53.6 -33.46 68.88 Favored 'Trans proline' 0 C--O 1.258 1.518 0 C-N-CA 124.53 3.486 . . . . 29.149999999999999 115.025 170.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1317 ' ' GLY . . . . . 0.451 ' O ' ' HB ' ' A' 1014 ' ' THR . . . -76.32 -40.66 28.02 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 109.496 -1.442 . . . . 27.289999999999999 109.496 177.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1318 ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' 1318 ' ' ARG . 58.1 mtt-85 -58.05 -26.62 62.73 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 115.641 1.719 . . . . 41.490000000000002 115.641 177.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1319 ' ' LEU . . . . . 0.459 HD23 HG23 ' A' 1136 ' ' ILE . 13.1 tp -103.97 71.88 0.17 Allowed Pre-proline 0 C--O 1.238 0.486 0 O-C-N 119.587 -1.946 . . . . 27.609999999999999 109.141 168.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1320 ' ' PRO . . . . . 0.706 ' HD2' ' HA2' ' B' 1150 ' ' GLY . 86.1 Cg_endo -58.12 -54.87 2.67 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.854 3.036 . . . . 25.940000000000001 113.985 -166.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1321 ' ' THR . . . . . 0.685 HG23 HG21 ' A' 1019 ' ' THR . 4.3 m -63.7 -43.53 96.35 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.937 0.895 . . . . 25.010000000000002 109.621 -171.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1322 ' ' GLN . . . . . 0.504 HE21 ' HG ' ' A' 1326 ' ' LEU . 9.3 tp60 -67.56 -26.76 66.46 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 117.451 -1.261 . . . . 29.390000000000001 112.803 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1323 ' ' SER . . . . . 0.575 ' HA ' HD13 ' A' 1136 ' ' ILE . 36.9 m -66.81 -51.29 57.34 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 120.346 1.43 . . . . 26.469999999999999 111.131 162.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1324 ' ' SER . . . . . . . . . . . . . 4.3 m -63.39 -17.83 63.04 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 116.296 1.962 . . . . 27.780000000000001 116.296 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -104.44 -54.87 2.45 Favored 'General case' 0 C--O 1.247 0.937 0 CA-C-N 114.787 -1.097 . . . . 37.530000000000001 110.811 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1326 ' ' LEU . . . . . 0.504 ' HG ' HE21 ' A' 1322 ' ' GLN . 33.6 mt -69.3 -59.5 2.96 Favored 'General case' 0 CA--C 1.505 -0.761 0 O-C-N 118.015 -2.928 . . . . 35.710000000000001 112.274 175.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1327 ' ' TYR . . . . . 0.531 ' HB3' ' O ' ' A' 1323 ' ' SER . 31.3 t80 -57.16 -37.5 72.18 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-O 122.31 1.052 . . . . 31.59 108.218 177.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1328 ' ' GLY . . . . . 0.463 ' HA2' HD12 ' A' 1331 ' ' LEU . . . -46.77 -58.4 6.13 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.95 1.262 . . . . 28.0 113.226 168.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1329 ' ' THR . . . . . . . . . . . . . 17.3 m -70.14 -25.45 63.47 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.371 1.586 . . . . 32.149999999999999 110.619 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1330 ' ' ASN . . . . . . . . . . . . . 26.4 m120 -59.3 -49.97 75.79 Favored 'General case' 0 C--O 1.244 0.792 0 O-C-N 119.807 -1.808 . . . . 34.359999999999999 111.361 168.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1331 ' ' LEU . . . . . 0.851 HD13 HD13 ' A' 1070 ' ' LEU . 13.2 mt -55.55 -48.96 73.91 Favored 'General case' 0 C--N 1.357 0.907 0 O-C-N 127.226 2.829 . . . . 33.369999999999997 108.747 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1332 ' ' VAL . . . . . 0.518 HG11 ' HB3' ' A' 1025 ' ' GLN . 44.1 t -56.9 -42.66 78.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 O-C-N 124.782 1.301 . . . . 35.270000000000003 110.783 175.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -57.55 -49.33 76.71 Favored 'General case' 0 C--O 1.242 0.706 0 O-C-N 119.844 -1.785 . . . . 37.659999999999997 112.677 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1334 ' ' LEU . . . . . 0.405 HD22 ' SD ' ' A' 1115 ' ' MET . 53.6 tp -57.06 -54.02 51.52 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 124.736 1.273 . . . . 40.270000000000003 108.43 176.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1335 ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' 1331 ' ' LEU . 46.6 mt -62.98 -23.81 67.61 Favored 'General case' 0 N--CA 1.436 -1.154 0 O-C-N 126.369 2.293 . . . . 42.5 111.146 -176.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1336 ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -69.02 -35.19 76.37 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 123.284 2.766 . . . . 47.810000000000002 111.944 173.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1337 ' ' LEU . . . . . 0.443 ' O ' ' HG2' ' A' 1340 ' ' LYS . 58.5 mt -67.84 -43.94 78.32 Favored 'General case' 0 CA--C 1.507 -0.709 0 O-C-N 120.84 -1.163 . . . . 49.270000000000003 108.297 172.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1338 ' ' LEU . . . . . 0.642 HD23 HG23 ' A' 1346 ' ' ILE . 6.9 mp -66.91 -38.93 87.15 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 116.724 2.12 . . . . 50.539999999999999 116.724 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1339 ' ' CYS . . . . . . . . . . . . . 49.1 t -104.82 81.32 1.74 Allowed 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 104.761 -2.311 . . . . 53.670000000000002 104.761 -175.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1340 ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' 1337 ' ' LEU . 75.3 mttt -74.31 -52.13 13.16 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 124.312 2.006 . . . . 63.380000000000003 113.096 -165.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1341 ' ' GLU . . . . . 0.412 ' HB2' ' HB3' ' A' 1343 ' ' ASP . 15.8 mt-10 -76.48 -44.16 36.61 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 110.077 -3.238 . . . . 70.950000000000003 111.85 -166.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1342 ' ' LYS . . . . . 0.664 ' HE2' ' HA ' ' A' 1029 ' ' LEU . 7.6 mtpm? 59.84 67.5 0.87 Allowed 'General case' 0 C--N 1.356 0.881 0 C-N-CA 127.043 2.137 . . . . 65.25 113.216 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1343 ' ' ASP . . . . . 0.412 ' HB3' ' HB2' ' A' 1341 ' ' GLU 0.468 0.0 OUTLIER 68.38 -72.14 0.1 Allowed 'General case' 0 C--N 1.375 1.712 1 O-C-N 115.001 -4.812 . . . . 64.530000000000001 118.904 8.507 . . . . . . . . 5 4 . 1 . 005 nuclear build core ' A' A 1344 ' ' GLY . . . . . 0.658 ' H ' ' HA ' ' A' 1342 ' ' LYS . . . 79.71 46.69 7.71 Favored Glycine 0 C--O 1.244 0.755 0 CA-C-N 121.238 1.835 . . . . 59.719999999999999 110.462 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -130.03 122.8 29.1 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 121.792 0.806 . . . . 64.090000000000003 111.081 166.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1346 ' ' ILE . . . . . 0.642 HG23 HD23 ' A' 1338 ' ' LEU . 13.4 mt -79.99 109.9 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 CA-C-O 123.513 1.625 . . . . 58.82 109.382 170.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1347 ' ' THR . . . . . . . . . . . . . 28.6 m -96.84 107.2 19.65 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 110.275 -3.148 . . . . 54.960000000000001 104.533 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1348 ' ' VAL . . . . . 0.417 ' HB ' ' NH2' ' A' 1362 ' ' ARG . 42.2 t -84.16 87.78 2.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 103.608 -2.738 . . . . 55.640000000000001 103.608 -178.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 29.8 t70 -73.16 111.54 8.37 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.539 -1.21 . . . . 61.450000000000003 112.605 178.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1350 ' ' PHE . . . . . 0.454 ' HE2' HG21 ' A' 1367 ' ' THR . 3.1 m-85 -79.79 4.51 16.21 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 114.946 1.461 . . . . 58.630000000000003 114.946 171.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -78.45 -33.04 48.71 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 117.12 -1.832 . . . . 62.060000000000002 112.377 173.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 5.1 t70 -84.31 123.96 30.73 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 124.703 2.192 . . . . 54.07 108.8 171.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 32.2 m -61.46 -29.83 46.83 Favored 'Isoleucine or valine' 0 C--O 1.247 0.973 0 CA-C-N 109.902 -3.317 . . . . 50.68 113.089 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1354 ' ' VAL . . . . . 0.638 ' O ' HG23 ' A' 1358 ' ' VAL . 5.8 m -69.45 -40.92 80.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 119.908 1.231 . . . . 47.68 109.7 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1355 ' ' ILE . . . . . 0.501 HG23 HD11 ' A' 1338 ' ' LEU . 54.7 mt -68.11 -48.4 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.872 -1.159 . . . . 48.490000000000002 107.872 -176.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1356 ' ' ARG . . . . . 0.465 ' HG3' ' HG2' ' A' 1371 ' ' PRO . 22.5 tpt85 -52.08 -40.52 61.34 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.687 1.195 . . . . 48.270000000000003 113.145 168.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -58.65 -53.43 46.17 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 125.67 1.605 . . . . 43.530000000000001 112.623 174.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1358 ' ' VAL . . . . . 0.696 HG12 ' HB3' ' A' 1113 ' ' MET . 10.9 t -62.92 -39.9 86.86 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.5 0 O-C-N 124.982 1.048 . . . . 45.119999999999997 109.079 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1359 ' ' THR . . . . . . . . . . . . . 21.4 m -74.16 88.68 1.97 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 123.278 1.513 . . . . 42.939999999999998 109.835 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1360 ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' 1368 ' ' TRP . 29.7 m -78.62 -23.0 13.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 113.874 1.065 . . . . 43.259999999999998 113.874 178.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1361 ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' 1111 ' ' THR . 57.7 mt -133.36 120.5 39.11 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.003 0 O-C-N 118.119 -2.863 . . . . 45.659999999999997 106.604 170.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1362 ' ' ARG . . . . . 0.417 ' NH2' ' HB ' ' A' 1348 ' ' VAL . 12.9 ttt180 -102.09 109.78 21.57 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 118.474 -2.641 . . . . 61.340000000000003 106.358 170.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 43.16 39.92 2.16 Favored 'General case' 0 C--O 1.249 1.044 0 N-CA-C 117.278 2.325 . . . . 49.759999999999998 117.278 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1364 ' ' GLY . . . . . 0.44 ' H ' HG22 ' A' 1361 ' ' ILE . . . 119.6 -34.75 4.12 Favored Glycine 0 C--N 1.349 1.283 0 C-N-CA 119.392 -1.385 . . . . 50.0 111.758 177.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -82.4 123.12 28.83 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.002 -1.481 . . . . 56.920000000000002 107.002 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1366 ' ' ILE . . . . . 0.42 HG12 HG12 ' A' 1361 ' ' ILE . 93.4 mt -84.85 87.31 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 107.851 -1.166 . . . . 52.780000000000001 107.851 -177.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1367 ' ' THR . . . . . 0.454 HG21 ' HE2' ' A' 1350 ' ' PHE . 1.3 p -66.25 -6.76 14.92 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 116.031 1.863 . . . . 49.439999999999998 116.031 175.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1368 ' ' TRP . . . . . 0.571 ' CD1' ' HA ' ' A' 1369 ' ' PRO . 20.7 t90 -59.45 141.14 88.16 Favored Pre-proline 0 N--CA 1.442 -0.872 0 CA-C-O 116.13 -1.89 . . . . 52.380000000000003 108.128 164.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1369 ' ' PRO . . . . . 0.571 ' HA ' ' CD1' ' A' 1368 ' ' TRP . 72.6 Cg_exo -67.06 160.32 78.85 Favored 'Cis proline' 0 C--N 1.362 1.258 0 N-CA-C 119.733 2.936 . . . . 46.939999999999998 119.733 -0.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -89.68 142.53 29.35 Favored Pre-proline 0 C--O 1.24 0.6 0 CA-C-N 114.862 -1.063 . . . . 45.909999999999997 113.208 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1371 ' ' PRO . . . . . 0.465 ' HG2' ' HG3' ' A' 1356 ' ' ARG . 0.4 OUTLIER -51.59 124.1 13.63 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 124.366 3.377 . . . . 46.390000000000001 114.77 169.295 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 1372 ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' 1371 ' ' PRO . 56.0 Cg_exo -72.29 -59.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.357 1.005 1 C-N-CA 126.839 5.026 . . . . 46.719999999999999 109.225 173.381 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.223 -4.904 0 CA-C-N 119.741 1.155 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 79.4 m80 . . . . . 0 CA--C 1.548 0.884 0 N-CA-C 102.436 -3.172 . . . . 63.439999999999998 102.436 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 999' ' ' HIS . . . . . 0.552 ' HB3' ' HB3' ' B' 1002 ' ' ARG . 28.4 m170 -124.02 50.72 1.62 Allowed 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 121.875 2.125 . . . . 51.740000000000002 111.849 170.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1000 ' ' HIS . . . . . . . . . . . . . 33.2 t60 -71.53 119.45 15.7 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 111.868 -2.424 . . . . 54.07 107.552 174.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 82.13 15.19 75.22 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 123.773 0.701 . . . . 39.219999999999999 111.442 -174.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1002 ' ' ARG . . . . . 0.552 ' HB3' ' HB3' ' B' ' 999' ' ' HIS . 30.6 ttp180 -107.59 128.05 54.19 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 124.534 2.112 . . . . 38.119999999999997 108.765 167.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1003 ' ' ILE . . . . . 0.678 HG12 ' HB ' ' B' 1068 ' ' ILE . 14.9 mt -81.79 150.52 4.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 110.191 -3.186 . . . . 29.699999999999999 107.229 174.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -129.34 120.42 3.2 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 105.167 -3.173 . . . . 27.5 105.167 171.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1005 ' ' ILE . . . . . 0.639 HG23 ' HB3' ' B' 1017 ' ' ALA . 45.8 mm -100.06 110.4 59.39 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 116.514 -1.708 . . . . 24.829999999999998 107.505 173.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -78.77 152.44 25.41 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 124.117 3.211 . . . . 27.190000000000001 110.757 175.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1007 ' ' ARG . . . . . 0.449 ' HB3' ' OE1' ' B' 1036 ' ' GLU . 18.2 ttt180 -79.97 110.27 15.19 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 102.938 -2.986 . . . . 41.460000000000001 102.938 160.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1008 ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -55.36 131.26 45.29 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 124.176 1.941 . . . . 26.93 115.757 -165.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 36.7 mmm-85 -84.95 -12.28 53.67 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 111.71 -2.496 . . . . 34.479999999999997 111.033 -169.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1010 ' ' LEU . . . . . 0.429 ' HB3' ' HB2' ' B' 1013 ' ' GLU . 13.1 tp -55.74 133.67 51.02 Favored 'General case' 0 C--O 1.243 0.728 0 O-C-N 120.776 -1.203 . . . . 44.219999999999999 109.609 172.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1011 ' ' THR . . . . . . . . . . . . . 28.7 m -60.46 111.65 1.66 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 114.365 1.246 . . . . 40.740000000000002 114.365 -168.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 42.3 t30 54.69 55.73 7.56 Favored 'General case' 0 C--O 1.222 -0.368 0 O-C-N 124.51 1.131 . . . . 44.439999999999998 114.047 -170.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1013 ' ' GLU . . . . . 0.429 ' HB2' ' HB3' ' B' 1010 ' ' LEU . 10.7 tp10 -88.49 136.75 32.84 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 115.054 -0.976 . . . . 29.870000000000001 108.988 166.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1014 ' ' THR . . . . . 0.523 HG22 ' HB3' ' B' 1320 ' ' PRO . 96.2 m -96.97 -26.18 15.13 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 111.422 -2.626 . . . . 25.260000000000002 109.906 -173.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1015 ' ' ARG . . . . . 0.676 ' HG3' ' HA2' ' B' 1317 ' ' GLY . 85.0 mtm180 -70.96 141.81 51.05 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 123.985 1.85 . . . . 29.539999999999999 112.218 175.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1016 ' ' VAL . . . . . 0.648 HG12 ' HB2' ' B' 1043 ' ' ALA . 9.9 p -102.47 169.5 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 N-CA-C 105.586 -2.005 . . . . 23.550000000000001 105.586 151.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1017 ' ' ALA . . . . . 0.639 ' HB3' HG23 ' B' 1005 ' ' ILE . . . -72.24 -35.93 68.97 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.294 1.22 . . . . 23.59 114.294 -174.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1018 ' ' ALA . . . . . . . . . . . . . . . -147.16 153.08 39.45 Favored 'General case' 0 CA--C 1.509 -0.612 0 O-C-N 124.001 0.813 . . . . 24.93 111.71 -172.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1019 ' ' THR . . . . . . . . . . . . . 12.7 p -91.57 163.75 27.09 Favored Pre-proline 0 C--O 1.25 1.11 0 CA-C-O 117.742 -1.123 . . . . 28.09 110.343 171.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -48.27 -41.76 34.54 Favored 'Trans proline' 0 CA--C 1.501 -1.166 1 C-N-CA 125.664 4.242 . . . . 28.789999999999999 111.966 173.672 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B 1021 ' ' LYS . . . . . 0.567 ' HD2' HE22 ' B' 1325 ' ' GLN . 0.5 OUTLIER -51.4 -47.57 62.9 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 122.638 1.209 . . . . 47.280000000000001 112.182 174.502 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B 1022 ' ' THR . . . . . 0.513 ' O ' ' HG ' ' B' 1026 ' ' LEU . 9.6 p -78.41 -22.34 47.93 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 118.835 -1.146 . . . . 30.120000000000001 112.038 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1023 ' ' VAL . . . . . . . . . . . . . 51.6 t -66.24 -42.3 90.72 Favored 'Isoleucine or valine' 0 C--N 1.349 0.548 0 O-C-N 120.84 -1.162 . . . . 32.240000000000002 110.421 169.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1024 ' ' GLU . . . . . 0.513 ' HA ' HD12 ' B' 1027 ' ' LEU . 43.6 mt-10 -54.57 -48.59 71.88 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 120.451 -1.405 . . . . 49.619999999999997 112.42 171.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -49.49 -48.36 47.93 Favored 'General case' 0 C--O 1.21 -0.975 0 N-CA-C 114.31 1.226 . . . . 44.68 114.31 169.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1026 ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' B' 1022 ' ' THR . 70.8 mt -58.07 -41.09 82.63 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 120.063 -1.648 . . . . 35.710000000000001 111.432 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1027 ' ' LEU . . . . . 0.513 HD12 ' HA ' ' B' 1024 ' ' GLU . 12.3 mt -70.05 -27.64 64.81 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.894 1.278 . . . . 42.18 114.247 177.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 51.5 mttm -66.11 -47.21 74.91 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 105.877 -1.898 . . . . 48.340000000000003 105.877 169.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1029 ' ' LEU . . . . . . . . . . . . . 74.1 mt -69.42 -10.99 60.4 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 120.426 -1.421 . . . . 38.689999999999998 113.714 175.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 97.05 10.52 54.79 Favored Glycine 0 C--N 1.353 1.522 0 C-N-CA 125.722 1.63 . . . . 32.280000000000001 113.015 166.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -77.12 140.59 40.28 Favored 'General case' 0 N--CA 1.44 -0.974 0 O-C-N 120.735 -1.45 . . . . 35.939999999999998 110.913 173.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1032 ' ' THR . . . . . . . . . . . . . 5.9 m -83.95 138.95 32.88 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 104.788 -2.301 . . . . 33.369999999999997 104.788 174.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1033 ' ' VAL . . . . . . . . . . . . . 10.0 t -122.34 144.39 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 124.045 3.111 . . . . 29.98 111.769 -172.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -129.57 144.93 51.49 Favored 'General case' 0 C--O 1.249 1.036 0 C-N-CA 125.791 1.636 . . . . 28.18 108.537 169.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1035 ' ' VAL . . . . . . . . . . . . . 47.0 t -136.84 142.47 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 105.831 -1.914 . . . . 25.82 105.831 -174.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1036 ' ' GLU . . . . . 0.595 ' HB2' HG11 ' B' 1063 ' ' VAL . 27.7 tt0 -76.95 141.33 40.5 Favored 'General case' 0 C--O 1.258 1.535 0 C-N-CA 118.886 -1.126 . . . . 32.439999999999998 113.968 -174.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1037 ' ' SER . . . . . . . . . . . . . 49.6 m -52.24 128.06 23.92 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.117 0.961 . . . . 29.539999999999999 113.178 171.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 92.34 -13.2 67.81 Favored Glycine 0 CA--C 1.542 1.779 0 CA-C-N 115.292 -0.867 . . . . 27.760000000000002 113.475 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1039 ' ' ALA . . . . . 0.624 ' HB1' HG21 ' B' 1016 ' ' VAL . . . -62.71 -39.37 93.81 Favored 'General case' 0 N--CA 1.438 -1.062 0 O-C-N 120.553 -1.557 . . . . 26.02 112.062 178.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -61.08 -45.81 95.83 Favored Glycine 0 C--N 1.304 -1.232 0 C-N-CA 119.315 -1.422 . . . . 26.469999999999999 110.962 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -68.17 -28.18 67.06 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 118.421 -2.811 . . . . 50.979999999999997 111.972 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 15.3 mt -58.91 -51.23 70.95 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 117.955 -2.965 . . . . 29.300000000000001 109.97 166.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1043 ' ' ALA . . . . . 0.648 ' HB2' HG12 ' B' 1016 ' ' VAL . . . -68.2 17.13 0.04 OUTLIER 'General case' 0 C--O 1.213 -0.823 0 O-C-N 119.0 -2.313 . . . . 26.739999999999998 116.564 167.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1044 ' ' SER . . . . . . . . . . . . . 15.1 m 54.12 34.47 20.13 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 123.707 1.717 . . . . 31.260000000000002 114.792 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1045 ' ' PHE . . . . . 0.418 ' CD1' ' HB3' ' A' 1277 ' ' ALA . 0.1 OUTLIER -127.94 158.59 37.41 Favored 'General case' 0 C--O 1.241 0.65 0 O-C-N 121.172 -0.955 . . . . 33.259999999999998 108.712 -177.528 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 29.1 t0 -72.71 139.05 46.97 Favored 'General case' 0 C--O 1.245 0.835 0 O-C-N 120.755 -1.215 . . . . 46.740000000000002 108.824 170.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.54 -40.57 72.03 Favored 'General case' 0 C--O 1.214 -0.816 0 CA-C-O 122.572 1.177 . . . . 34.439999999999998 110.858 175.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.65 -2.41 17.14 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 120.635 -1.291 . . . . 48.670000000000002 113.134 -174.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -72.08 -35.68 69.3 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 118.302 -2.749 . . . . 35.259999999999998 108.365 167.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1050 ' ' PHE . . . . . 0.661 ' HB2' HD11 ' B' 1057 ' ' ILE . 64.2 m-85 -65.32 -41.63 93.81 Favored 'General case' 0 C--O 1.219 -0.524 0 O-C-N 120.335 -1.478 . . . . 32.170000000000002 108.438 176.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1051 ' ' VAL . . . . . 0.629 HG23 HG12 ' B' 1057 ' ' ILE . 17.5 t -50.8 -57.98 2.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 123.757 0.66 . . . . 38.369999999999997 111.98 168.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -42.77 -54.28 4.17 Favored 'General case' 0 C--O 1.213 -0.845 0 N-CA-C 113.511 0.93 . . . . 45.770000000000003 113.511 172.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -54.25 -38.4 65.75 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.376 1.251 . . . . 37.829999999999998 114.376 173.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 126.89 34.53 0.59 Allowed Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.845 -0.902 . . . . 35.82 110.845 174.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -112.23 147.21 36.71 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 107.985 -1.117 . . . . 33.770000000000003 107.985 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -76.85 132.82 39.37 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 107.19 -1.411 . . . . 51.020000000000003 107.19 168.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1057 ' ' ILE . . . . . 0.661 HD11 ' HB2' ' B' 1050 ' ' PHE . 27.8 mm -100.96 124.68 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-O 122.92 1.343 . . . . 38.469999999999999 108.06 169.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1058 ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' B' 1036 ' ' GLU . 0.0 OUTLIER -143.52 142.34 25.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 C-N-CA 124.942 1.297 . . . . 39.399999999999999 113.235 -171.553 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -82.17 123.13 28.72 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.998 -1.112 . . . . 57.07 107.998 -171.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1060 ' ' GLY . . . . . 0.495 ' O ' HG12 ' B' 1063 ' ' VAL . . . 57.0 -133.82 52.53 Favored Glycine 0 N--CA 1.432 -1.596 0 CA-C-O 122.605 1.114 . . . . 44.829999999999998 114.404 165.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -38.92 -40.52 0.65 Allowed 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 111.084 -2.558 . . . . 46.270000000000003 115.403 -172.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1062 ' ' SER . . . . . . . . . . . . . 5.5 m -45.71 -51.31 12.67 Favored 'General case' 0 C--N 1.349 0.586 0 N-CA-C 113.98 1.104 . . . . 43.469999999999999 113.98 173.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1063 ' ' VAL . . . . . 0.595 HG11 ' HB2' ' B' 1036 ' ' GLU . 3.6 p -69.3 -35.32 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 C-N-CA 123.371 0.668 . . . . 36.979999999999997 110.15 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -64.22 -28.57 69.83 Favored 'General case' 0 N--CA 1.422 -1.844 0 O-C-N 123.813 0.696 . . . . 37.899999999999999 111.908 175.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -82.29 82.91 7.61 Favored 'General case' 0 C--O 1.243 0.748 0 O-C-N 118.798 -2.439 . . . . 46.189999999999998 110.802 171.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1066 ' ' SER . . . . . . . . . . . . . 44.7 m -150.35 162.36 40.69 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.412 -1.267 . . . . 37.060000000000002 108.299 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1067 ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -72.02 -58.3 3.55 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 117.821 -1.551 . . . . 43.950000000000003 111.951 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1068 ' ' ILE . . . . . 0.678 ' HB ' HG12 ' B' 1003 ' ' ILE . 4.4 mp -96.22 107.15 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 103.165 -2.902 . . . . 33.5 103.165 -169.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 48.9 mm -97.54 109.22 23.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 107.208 -1.404 . . . . 30.57 107.208 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1070 ' ' LEU . . . . . 0.681 HD22 HD22 ' B' 1331 ' ' LEU . 83.6 mt -95.74 91.86 6.29 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 124.377 2.037 . . . . 27.66 107.174 177.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1071 ' ' LYS . . . . . . . . . . . . . 10.9 mtpt -90.69 161.27 15.44 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-N 112.59 -2.095 . . . . 28.399999999999999 109.491 176.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1072 ' ' VAL . . . . . . . . . . . . . 2.7 t -83.91 -56.91 4.97 Favored 'Isoleucine or valine' 0 C--N 1.351 0.637 0 N-CA-C 104.733 -2.321 . . . . 23.18 104.733 -177.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -113.46 173.88 6.19 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 113.808 -1.542 . . . . 25.469999999999999 107.448 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -49.41 146.93 6.08 Favored Pre-proline 0 C--O 1.264 1.832 0 C-N-CA 124.899 1.28 . . . . 27.899999999999999 113.66 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1075 ' ' PRO . . . . . 0.525 ' HG3' HD21 ' B' 1105 ' ' LEU . 59.7 Cg_endo -60.52 151.89 72.06 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.455 2.77 . . . . 31.620000000000001 110.574 166.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 7.4 mp -89.7 165.74 14.01 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 113.828 -1.533 . . . . 40.490000000000002 107.171 166.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1077 ' ' ASP . . . . . 0.582 ' HA ' HD12 ' B' 1080 ' ' ILE . 10.1 t70 -58.71 -40.63 84.24 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 116.448 2.018 . . . . 51.590000000000003 116.448 -173.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -57.3 -43.43 83.22 Favored 'General case' 0 C--O 1.244 0.773 0 O-C-N 121.489 -0.757 . . . . 42.359999999999999 111.202 169.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1079 ' ' GLU . . . . . 0.438 ' OE1' ' HA ' ' B' 1075 ' ' PRO . 43.2 mt-10 -64.8 -28.65 69.71 Favored 'General case' 0 C--O 1.221 -0.426 0 O-C-N 121.404 -0.81 . . . . 34.530000000000001 109.868 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1080 ' ' ILE . . . . . 0.843 ' HA ' HD12 ' B' 1083 ' ' LEU . 69.5 mt -64.13 -41.21 91.73 Favored 'Isoleucine or valine' 0 C--N 1.36 1.053 0 O-C-N 119.926 -1.734 . . . . 33.25 110.231 171.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -62.73 -30.01 71.1 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.442 -1.411 . . . . 36.469999999999999 114.365 172.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1082 ' ' LEU . . . . . 0.42 HD12 ' HA ' ' B' 1079 ' ' GLU . 65.4 mt -75.16 -28.34 60.05 Favored 'General case' 0 C--N 1.348 0.532 0 O-C-N 121.584 -0.698 . . . . 37.759999999999998 110.852 175.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1083 ' ' LEU . . . . . 0.843 HD12 ' HA ' ' B' 1080 ' ' ILE . 34.1 mt -52.78 114.8 1.53 Allowed 'General case' 0 C--O 1.247 0.953 0 N-CA-C 114.928 1.455 . . . . 37.43 114.928 174.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.34 143.83 52.65 Favored Pre-proline 0 N--CA 1.453 -0.314 0 CA-C-N 111.289 -2.687 . . . . 37.700000000000003 107.587 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -54.67 123.69 14.33 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.176 3.251 . . . . 35.509999999999998 109.434 175.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 83.61 17.16 66.66 Favored Glycine 0 C--N 1.316 -0.565 0 CA-C-O 119.608 -0.551 . . . . 33.869999999999997 112.076 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1087 ' ' THR . . . . . . . . . . . . . 52.5 m -69.76 134.44 48.58 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 121.707 2.753 . . . . 32.5 108.72 163.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1088 ' ' THR . . . . . . . . . . . . . 38.9 m -92.93 97.94 11.05 Favored 'General case' 0 C--O 1.254 1.321 0 N-CA-C 105.528 -2.027 . . . . 30.219999999999999 105.528 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1089 ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' B' 1112 ' ' VAL . 22.1 tp -96.17 130.19 43.29 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 120.829 -1.169 . . . . 27.239999999999998 108.639 -176.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 95.8 t -125.6 128.01 72.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 102.247 -3.242 . . . . 25.390000000000001 102.247 -175.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1091 ' ' SER . . . . . . . . . . . . . 3.9 m -160.23 168.38 25.51 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 121.893 2.133 . . . . 28.809999999999999 111.925 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1092 ' ' PHE . . . . . 0.421 ' CD2' ' HB3' ' B' 1116 ' ' ASP . 25.2 m-85 -66.71 108.25 2.42 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.549 -1.278 . . . . 30.780000000000001 107.549 155.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 26.2 mm -104.31 -36.67 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 O-C-N 118.837 -2.414 . . . . 30.280000000000001 114.267 -176.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1094 ' ' TRP . . . . . . . . . . . . . 61.9 m95 54.53 65.49 5.06 Favored Pre-proline 0 CA--C 1.548 0.886 0 O-C-N 124.319 1.012 . . . . 34.07 110.582 -175.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -47.99 -58.39 1.78 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 1 C-N-CA 127.375 5.383 . . . . 38.659999999999997 118.91 -166.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1096 ' ' ALA . . . . . 0.512 ' HB2' ' HZ3' ' B' 1368 ' ' TRP . . . -82.29 -14.89 54.7 Favored 'General case' 0 N--CA 1.436 -1.163 0 O-C-N 119.734 -1.854 . . . . 41.32 110.437 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -76.58 -21.96 54.91 Favored 'General case' 0 C--O 1.246 0.895 0 N-CA-C 108.579 -0.897 . . . . 51.659999999999997 108.579 166.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 9.5 m120 -121.36 42.39 0.56 Allowed Pre-proline 0 C--N 1.309 -1.168 0 N-CA-C 117.391 2.367 . . . . 40.32 117.391 -172.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -56.49 -42.54 64.47 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 123.633 2.889 . . . . 41.560000000000002 117.188 -167.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -61.25 -39.84 91.83 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.714 1.143 . . . . 54.109999999999999 113.316 175.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1101 ' ' LEU . . . . . 0.403 ' O ' ' HG ' ' B' 1105 ' ' LEU . 6.2 tp -62.78 -49.44 74.97 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 108.521 -0.918 . . . . 37.880000000000003 108.521 176.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1102 ' ' MET . . . . . . . . . . . . . 91.6 mmm -51.25 -55.73 16.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.712 -0.676 . . . . 37.539999999999999 110.381 177.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -49.34 -49.74 42.86 Favored 'General case' 0 C--O 1.244 0.775 0 O-C-N 121.694 -0.629 . . . . 47.009999999999998 112.483 176.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1104 ' ' LYS . . . . . 0.405 ' HB3' HG21 ' B' 1080 ' ' ILE . 83.4 mttt -60.46 -38.25 83.6 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 114.991 1.478 . . . . 48.68 114.991 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1105 ' ' LEU . . . . . 0.622 HD13 HG21 ' B' 1112 ' ' VAL . 31.3 mt -66.96 -36.82 83.07 Favored 'General case' 0 C--O 1.245 0.837 0 O-C-N 121.009 -1.057 . . . . 32.210000000000001 109.198 177.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1106 ' ' ALA . . . . . 0.501 ' HA ' ' HA2' ' B' 1364 ' ' GLY . . . -67.87 -28.24 67.36 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 108.871 -0.788 . . . . 33.729999999999997 108.871 177.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -68.44 -39.62 81.45 Favored 'General case' 0 CA--C 1.494 -1.197 0 O-C-N 119.412 -2.055 . . . . 51.469999999999999 110.207 175.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1108 ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -72.85 -4.05 29.38 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 115.026 1.491 . . . . 43.899999999999999 115.026 -178.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1109 ' ' ASN . . . . . 0.584 ' HA ' ' HA3' ' B' 1364 ' ' GLY . 9.9 m120 58.6 32.81 22.55 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 124.027 1.87 . . . . 44.82 113.436 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1110 ' ' VAL . . . . . 0.754 HG11 HD22 ' B' 1083 ' ' LEU . 33.6 m -93.14 166.27 1.8 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.662 0 CA-C-N 114.351 -1.295 . . . . 30.52 111.454 177.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1111 ' ' THR . . . . . 0.597 HG23 ' HA ' ' B' 1362 ' ' ARG . 87.2 m -109.65 103.26 12.09 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 105.532 -2.025 . . . . 27.120000000000001 105.532 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1112 ' ' VAL . . . . . 0.622 HG21 HD13 ' B' 1105 ' ' LEU . 40.7 t -99.36 129.11 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-O 122.418 1.104 . . . . 26.399999999999999 109.496 -174.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1113 ' ' MET . . . . . 0.572 ' SD ' HD11 ' B' 1338 ' ' LEU . 31.2 mtp -109.65 124.33 50.99 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.921 0.889 . . . . 42.920000000000002 110.128 171.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -102.51 106.18 16.85 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 119.716 1.144 . . . . 24.149999999999999 109.17 -174.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1115 ' ' MET . . . . . . . . . . . . . 80.2 mmm -71.29 -2.33 15.83 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 113.072 -1.876 . . . . 29.949999999999999 112.168 -169.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1116 ' ' ASP . . . . . 0.509 ' HA ' ' HB2' ' B' 1130 ' ' LEU . 7.5 p-10 -93.44 -52.07 4.68 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.745 1.218 . . . . 34.530000000000001 112.428 169.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1117 ' ' SER . . . . . . . . . . . . . 51.1 m -86.71 60.94 6.52 Favored 'General case' 0 C--N 1.343 0.298 0 O-C-N 120.401 -1.437 . . . . 33.490000000000002 111.118 -175.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1118 ' ' VAL . . . . . . . . . . . . . 17.9 t -95.62 146.56 31.54 Favored Pre-proline 0 C--O 1.245 0.868 0 N-CA-C 105.171 -2.159 . . . . 34.020000000000003 105.171 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -60.97 146.02 98.3 Favored 'Trans proline' 0 C--N 1.354 0.82 0 CA-C-N 124.661 2.7 . . . . 38.280000000000001 113.308 174.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1120 ' ' ARG . . . . . 0.518 HH12 ' CG ' ' B' 1128 ' ' ASP . 5.3 mmt180 -85.82 56.82 4.14 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 120.685 -1.259 . . . . 55.049999999999997 111.481 -167.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1121 ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' C' ' 131' ' ' ALA . 6.7 pt -132.26 164.28 35.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 CA-C-N 114.53 -1.213 . . . . 42.090000000000003 112.585 -176.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1122 ' ' SER . . . . . . . . . . . . . 8.9 m -48.75 -63.94 0.95 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 119.12 3.008 . . . . 38.020000000000003 119.12 -162.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1123 ' ' ARG . . . . . 0.465 ' HD2' HD21 ' B' 1337 ' ' LEU . 21.4 ptt-85 -70.53 -29.06 65.44 Favored 'General case' 0 C--N 1.354 0.804 1 O-C-N 116.114 -4.116 . . . . 34.289999999999999 110.924 -179.288 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B 1124 ' ' ALA . . . . . 0.72 ' HB2' HG22 ' B' 1354 ' ' VAL . . . -60.51 -40.62 92.08 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 113.282 -1.781 . . . . 32.350000000000001 108.151 176.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1125 ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -60.75 -24.67 65.91 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 115.744 1.757 . . . . 47.170000000000002 115.744 173.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1126 ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' 1160 ' ' ALA . 57.1 m -68.59 -36.66 79.01 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 119.05 -2.281 . . . . 31.710000000000001 114.667 165.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1127 ' ' LEU . . . . . 0.717 HD23 HD12 ' B' 1334 ' ' LEU . 6.9 mp -72.84 -30.15 63.79 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.181 -0.949 . . . . 37.0 111.472 172.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1128 ' ' ASP . . . . . 0.518 ' CG ' HH12 ' B' 1120 ' ' ARG . 37.9 t70 -64.54 101.02 0.41 Allowed 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 115.59 -0.732 . . . . 40.399999999999999 110.977 -169.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1129 ' ' ALA . . . . . . . . . . . . . . . -72.52 -21.42 61.18 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 118.411 -1.316 . . . . 26.559999999999999 110.506 174.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1130 ' ' LEU . . . . . 0.509 ' HB2' ' HA ' ' B' 1116 ' ' ASP . 7.8 tt -55.13 -26.37 37.98 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.378 1.251 . . . . 30.890000000000001 114.378 168.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1131 ' ' SER . . . . . . . . . . . . . 13.6 p -77.59 -51.91 9.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 122.68 1.228 . . . . 29.84 113.118 172.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1132 ' ' SER . . . . . 0.423 ' HB3' ' HB3' ' B' 1326 ' ' LEU . 16.6 m -58.23 -49.51 76.83 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.279 -1.513 . . . . 31.91 114.663 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1133 ' ' MET . . . . . 0.645 ' HB3' ' HB3' ' B' 1316 ' ' PRO . 38.1 mmt -68.74 -36.58 78.56 Favored 'General case' 0 CA--C 1.509 -0.598 0 O-C-N 120.776 -1.202 . . . . 25.899999999999999 110.765 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1134 ' ' ALA . . . . . 0.809 ' HB1' ' HB2' ' B' 1176 ' ' ALA . . . -55.62 -44.55 77.18 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 119.137 0.881 . . . . 26.620000000000001 113.289 164.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -58.03 -48.08 81.15 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 122.272 1.034 . . . . 36.969999999999999 112.096 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1136 ' ' ILE . . . . . . . . . . . . . 42.9 mm -52.3 -58.07 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-N 113.294 -1.775 . . . . 32.109999999999999 111.48 173.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -57.27 -30.36 64.62 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.888 1.069 . . . . 24.140000000000001 113.888 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -68.58 -49.28 44.96 Favored Glycine 0 N--CA 1.484 1.9 0 N-CA-C 110.202 -1.159 . . . . 25.129999999999999 110.202 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 55.3 t80 -63.72 -44.47 93.46 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 123.417 1.579 . . . . 32.729999999999997 112.748 173.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1140 ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -62.57 -33.94 75.96 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 114.041 -1.436 . . . . 26.359999999999999 110.914 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1141 ' ' ALA . . . . . . . . . . . . . . . -55.71 -49.38 73.16 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 123.232 0.613 . . . . 24.120000000000001 112.42 168.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 50.1 mm -58.78 -35.97 58.54 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 O-C-N 120.873 -1.142 . . . . 23.370000000000001 109.927 174.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 14.3 t -71.24 -46.19 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 O-C-N 119.555 -1.966 . . . . 24.960000000000001 111.837 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -72.0 -41.82 67.15 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 106.661 -1.607 . . . . 32.07 106.661 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1145 ' ' ALA . . . . . 0.693 ' HA ' HG11 ' B' 1280 ' ' VAL . . . -53.38 -45.86 69.42 Favored 'General case' 0 C--O 1.206 -1.209 0 O-C-N 121.318 -0.864 . . . . 24.870000000000001 111.655 170.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1146 ' ' ALA . . . . . . . . . . . . . . . -63.99 -39.08 93.32 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 123.016 0.527 . . . . 24.670000000000002 109.658 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 16.5 t60 -59.06 -34.33 71.82 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 119.746 -1.846 . . . . 28.579999999999998 109.177 172.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1148 ' ' GLU . . . . . 0.418 ' HB3' ' CD ' ' B' 1308 ' ' LYS . 44.0 mm-40 -93.93 -10.38 33.96 Favored 'General case' 0 C--O 1.25 1.088 0 O-C-N 120.118 -1.614 . . . . 36.82 113.8 178.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1149 ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -78.9 144.09 35.24 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-O 123.488 1.613 . . . . 31.969999999999999 109.257 -171.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1150 ' ' GLY . . . . . 0.706 ' HA2' ' HD2' ' A' 1320 ' ' PRO . . . -93.93 -19.64 33.38 Favored Glycine 0 C--O 1.242 0.644 0 CA-C-N 114.313 -1.312 . . . . 25.489999999999998 113.239 174.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1151 ' ' ARG . . . . . . . . . . . . . 81.1 mtm-85 -112.65 166.75 11.06 Favored 'General case' 0 C--O 1.242 0.709 0 O-C-N 121.537 -0.978 . . . . 59.840000000000003 111.067 -169.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1152 ' ' PHE . . . . . 0.717 ' HB2' HG11 ' B' 1163 ' ' VAL . 3.3 m-30 -78.85 156.81 28.52 Favored 'General case' 0 C--O 1.239 0.543 0 O-C-N 119.803 -1.811 . . . . 34.450000000000003 108.647 174.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1153 ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -84.59 -43.74 14.17 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 123.837 1.78 . . . . 31.170000000000002 108.655 166.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1154 ' ' THR . . . . . . . . . . . . . 48.2 m -68.01 128.17 35.56 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 112.934 -1.939 . . . . 33.890000000000001 111.367 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -75.94 65.47 2.58 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 109.161 -1.576 . . . . 38.950000000000003 109.161 174.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1156 ' ' GLN . . . . . 0.463 ' H ' ' HB ' ' B' 1163 ' ' VAL . 15.4 tt0 -85.17 121.37 27.83 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 119.461 1.631 . . . . 54.229999999999997 109.476 -160.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 29.8 mm -70.82 95.09 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.883 0 O-C-N 119.906 -1.746 . . . . 51.159999999999997 106.406 173.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1158 ' ' THR . . . . . . . . . . . . . 1.7 m -109.22 138.8 45.02 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 107.783 -1.191 . . . . 49.609999999999999 107.783 -175.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -56.62 -30.57 63.42 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 121.034 1.743 . . . . 49.049999999999997 115.51 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -52.34 -53.09 48.94 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.245 0.545 . . . . 47.649999999999999 111.127 167.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . -179.02 156.14 17.86 Favored Glycine 0 C--O 1.215 -1.062 0 N-CA-C 108.071 -2.012 . . . . 45.609999999999999 108.071 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 79.9 mttt -76.91 128.15 34.03 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 120.197 1.998 . . . . 57.460000000000001 111.966 177.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1163 ' ' VAL . . . . . 0.717 HG11 ' HB2' ' B' 1152 ' ' PHE . 23.3 t -80.18 129.6 69.18 Favored Pre-proline 0 CA--C 1.514 -0.425 0 CA-C-N 118.923 0.783 . . . . 42.93 110.08 177.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1164 ' ' PRO . . . . . 0.435 ' O ' HG12 ' B' 1163 ' ' VAL . 58.4 Cg_endo -66.74 142.67 64.51 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.618 2.212 . . . . 39.289999999999999 110.667 164.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1165 ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -59.85 153.77 54.56 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 C-N-CA 122.898 2.399 . . . . 34.170000000000002 114.943 170.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -83.25 159.85 21.87 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 113.088 -1.869 . . . . 31.690000000000001 108.383 168.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1167 ' ' LYS . . . . . 0.8 ' HB2' ' HA ' ' B' 1249 ' ' VAL . 67.2 mttt -123.56 118.04 26.45 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 105.466 -2.05 . . . . 44.780000000000001 105.466 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1168 ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' B' 1251 ' ' ILE . 60.3 t -104.31 104.83 17.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 O-C-N 121.827 -0.546 . . . . 31.23 111.122 -174.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1169 ' ' MET . . . . . 0.676 ' HB2' HG11 ' B' 1249 ' ' VAL . 42.7 ttp -82.82 98.11 8.97 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.088 -0.708 . . . . 37.090000000000003 109.088 -178.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 53.1 t -89.74 119.35 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 N-CA-C 109.029 -0.73 . . . . 30.170000000000002 109.029 -177.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1171 ' ' ILE . . . . . . . . . . . . . 9.7 mt -113.52 132.76 61.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 CA-C-N 120.307 1.412 . . . . 33.740000000000002 107.578 -175.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 69.56 63.86 3.2 Favored Glycine 0 CA--C 1.502 -0.72 0 N-CA-C 110.046 -1.221 . . . . 32.590000000000003 110.046 -176.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1173 ' ' ALA . . . . . 0.539 ' HA ' ' HA3' ' B' 1177 ' ' GLY . . . -79.89 75.6 6.6 Favored 'General case' 0 C--O 1.252 1.233 0 CA-C-O 124.17 1.938 . . . . 32.420000000000002 114.018 -174.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -86.52 -165.3 40.86 Favored Glycine 0 C--O 1.216 -0.982 0 N-CA-C 107.367 -2.293 . . . . 31.739999999999998 107.367 166.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 46.1 t -48.54 -38.14 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 122.11 2.955 . . . . 31.48 114.279 -176.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1176 ' ' ALA . . . . . 0.809 ' HB2' ' HB1' ' B' 1134 ' ' ALA . . . -58.06 -51.67 68.73 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 113.462 -1.699 . . . . 26.120000000000001 114.063 171.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1177 ' ' GLY . . . . . 0.539 ' HA3' ' HA ' ' B' 1173 ' ' ALA . . . -60.46 -48.61 85.35 Favored Glycine 0 CA--C 1.49 -1.473 0 N-CA-C 111.321 -0.712 . . . . 25.73 111.321 176.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1178 ' ' LEU . . . . . 0.669 HD22 ' HG ' ' C' ' 75' ' ' LEU . 91.5 mt -53.75 -38.26 64.2 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 114.899 1.444 . . . . 32.590000000000003 114.899 174.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -70.67 -38.68 73.8 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 119.298 0.953 . . . . 27.719999999999999 111.734 175.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -60.9 -46.7 89.59 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 114.602 1.334 . . . . 26.030000000000001 114.602 175.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1181 ' ' ILE . . . . . 0.779 HG12 HG11 ' B' 1191 ' ' VAL . 79.0 mt -58.32 -48.04 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 123.707 0.803 . . . . 28.609999999999999 109.095 173.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1182 ' ' GLY . . . . . 0.413 ' HA2' ' HE1' ' B' 1207 ' ' MET . . . -51.09 -53.11 28.61 Favored Glycine 0 C--N 1.373 2.611 0 CA-C-N 114.827 -1.079 . . . . 25.23 110.721 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -63.26 -50.78 68.83 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 114.419 1.266 . . . . 24.09 114.419 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -69.42 -42.81 74.52 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 121.195 -0.94 . . . . 26.68 112.579 -172.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -57.49 -47.11 82.78 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 115.713 -0.676 . . . . 36.57 111.271 174.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1186 ' ' SER . . . . . 0.492 ' HB3' ' O ' ' A' 1186 ' ' SER . 75.4 m -58.81 -39.87 82.44 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-O 121.81 0.814 . . . . 28.920000000000002 112.338 177.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1187 ' ' LEU . . . . . . . . . . . . . 66.1 mt -61.78 -35.13 77.26 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 121.041 -1.037 . . . . 29.09 112.997 172.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 120.3 -7.07 11.65 Favored Glycine 0 CA--C 1.539 1.591 0 N-CA-C 111.113 -0.795 . . . . 29.260000000000002 111.113 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1189 ' ' ALA . . . . . . . . . . . . . . . -68.46 121.7 16.89 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 121.666 0.746 . . . . 30.16 112.272 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 37.2 mt -67.31 112.07 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-O 123.594 1.664 . . . . 35.810000000000002 109.718 -172.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1191 ' ' VAL . . . . . 0.779 HG11 HG12 ' B' 1181 ' ' ILE . 93.2 t -82.46 128.75 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 107.706 -1.22 . . . . 31.969999999999999 107.706 -177.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1192 ' ' ARG . . . . . 0.492 ' O ' ' HA ' ' B' 1169 ' ' MET . 22.9 mmt85 -118.89 90.39 3.32 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 102.903 -2.999 . . . . 48.159999999999997 102.903 174.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1193 ' ' ALA . . . . . 0.65 ' HB3' HG21 ' B' 1204 ' ' VAL . . . -103.07 159.69 15.3 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 120.712 -1.242 . . . . 35.890000000000001 114.281 -172.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 35.2 t80 -150.13 152.41 34.68 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 123.041 1.4 . . . . 41.880000000000003 107.224 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1195 ' ' ASP . . . . . 0.445 ' HB3' HG11 ' B' 1200 ' ' VAL . 10.0 t0 -158.55 155.61 28.68 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 103.666 -2.716 . . . . 38.280000000000001 103.666 168.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1196 ' ' THR . . . . . 0.433 HG23 ' HB2' ' B' 1230 ' ' MET . 43.0 m -59.23 -24.15 62.92 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 124.956 1.302 . . . . 40.619999999999997 110.53 172.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1197 ' ' ARG . . . . . 0.429 HH11 ' HD2' ' B' 1197 ' ' ARG . 33.1 mtm105 -91.97 144.33 29.06 Favored Pre-proline 0 C--O 1.249 1.066 0 O-C-N 119.925 -1.735 . . . . 53.090000000000003 111.026 -174.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -71.95 -42.58 1.53 Allowed 'Trans proline' 0 CA--C 1.548 1.188 1 C-N-CA 125.637 4.225 . . . . 42.560000000000002 117.418 -174.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -29.4 70.55 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 121.269 1.85 . . . . 56.310000000000002 114.462 -168.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1200 ' ' VAL . . . . . 0.504 ' O ' HG23 ' B' 1204 ' ' VAL . 10.8 p -58.56 -28.65 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 115.133 -0.94 . . . . 42.909999999999997 112.596 177.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 35.1 tttm -45.05 -58.66 3.04 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 124.581 1.153 . . . . 48.890000000000001 113.535 168.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 16.0 mp0 -63.39 -28.37 69.94 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 114.265 1.209 . . . . 51.700000000000003 114.265 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1203 ' ' GLN . . . . . 0.816 ' HG2' ' HG3' ' C' ' 74' ' ' ARG . 51.4 mt-30 -66.13 -46.63 76.83 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.586 -0.734 . . . . 52.57 109.442 176.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1204 ' ' VAL . . . . . 0.65 HG21 ' HB3' ' B' 1193 ' ' ALA . 40.0 t -72.69 -40.67 62.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.255 -1.017 . . . . 33.789999999999999 108.255 -173.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -60.98 -29.36 69.62 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 113.57 0.952 . . . . 36.579999999999998 113.57 176.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1206 ' ' SER . . . . . . . . . . . . . 44.7 m -68.67 -10.85 58.71 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 120.254 -1.529 . . . . 39.609999999999999 114.246 174.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1207 ' ' MET . . . . . 0.413 ' HE1' ' HA2' ' B' 1182 ' ' GLY . 46.1 mmm -97.22 5.21 50.47 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.587 0.708 . . . . 37.450000000000003 109.579 174.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 60.5 32.28 77.34 Favored Glycine 0 N--CA 1.471 0.984 0 O-C-N 120.133 -1.604 . . . . 31.870000000000001 111.829 -165.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1209 ' ' ALA . . . . . 0.502 ' HB1' ' HB ' ' B' 1191 ' ' VAL . . . -119.6 163.23 17.66 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 105.328 -2.101 . . . . 35.399999999999999 105.328 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1210 ' ' GLU . . . . . 0.478 ' HB3' ' HD3' ' B' 1192 ' ' ARG . 36.0 tt0 -108.62 137.23 46.9 Favored 'General case' 0 C--N 1.313 -1.014 0 O-C-N 119.859 -1.776 . . . . 47.890000000000001 111.999 -166.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 75.7 t80 -84.97 141.39 30.38 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 106.416 -1.698 . . . . 45.530000000000001 106.416 172.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1212 ' ' LEU . . . . . 0.549 ' HB3' HD21 ' B' 1241 ' ' LEU . 73.8 mt -73.74 99.64 3.2 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 125.11 2.386 . . . . 46.329999999999998 116.641 -176.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -77.08 122.75 25.4 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 112.101 -2.318 . . . . 60.409999999999997 108.147 172.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1214 ' ' LEU . . . . . 0.798 ' HG ' HD22 ' B' 1241 ' ' LEU . 1.0 OUTLIER -99.03 176.38 5.59 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 104.5 -2.407 . . . . 57.380000000000003 104.5 -178.173 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 14.0 t70 . . . . . 0 CA--C 1.499 -0.994 0 CA-C-O 117.665 -1.159 . . . . 65.069999999999993 108.613 177.149 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B 1230 ' ' MET . . . . . 0.433 ' HB2' HG23 ' B' 1196 ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.429 -1.48 0 N-CA-C 104.147 -2.538 . . . . 80.319999999999993 104.147 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1231 ' ' SER . . . . . 0.414 ' HB2' ' HA ' ' B' 1230 ' ' MET . 1.6 m 78.26 156.71 0.17 Allowed 'General case' 0 C--O 1.251 1.174 2 CA-C-N 127.914 4.87 . . . . 79.920000000000002 119.591 -8.597 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -88.7 -157.62 0.44 Allowed 'General case' 0 C--O 1.248 0.991 0 CA-C-N 112.584 -2.098 . . . . 77.909999999999997 111.872 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 66.38 -68.2 0.14 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 121.383 1.902 . . . . 73.879999999999995 111.036 -170.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 11.4 t80 -55.81 -33.18 64.2 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.75 1.22 . . . . 68.980000000000004 110.802 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1235 ' ' ILE . . . . . 0.595 ' O ' ' HG2' ' B' 1239 ' ' MET . 32.6 pt -42.94 -39.24 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 114.858 1.429 . . . . 64.530000000000001 114.858 170.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1236 ' ' LYS . . . . . 0.45 ' HA ' ' HD2' ' B' 1236 ' ' LYS . 28.6 mmmt -58.95 -45.81 89.54 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 121.306 1.866 . . . . 66.359999999999999 111.306 176.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -67.01 -30.54 70.67 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 114.609 1.337 . . . . 56.600000000000001 114.609 170.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.9 -46.4 85.02 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 120.302 1.41 . . . . 56.789999999999999 108.643 171.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1239 ' ' MET . . . . . 0.595 ' HG2' ' O ' ' B' 1235 ' ' ILE . 31.0 mmt -67.79 -36.53 80.6 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 120.848 -1.157 . . . . 53.630000000000003 108.711 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -70.11 -39.63 75.37 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 119.52 -0.872 . . . . 51.740000000000002 109.347 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1241 ' ' LEU . . . . . 0.798 HD22 ' HG ' ' B' 1214 ' ' LEU . 17.4 tp -53.14 -53.59 48.25 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-O 118.17 -0.919 . . . . 44.859999999999999 110.116 170.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -64.27 -40.57 96.24 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 112.509 0.559 . . . . 42.780000000000001 112.509 -177.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -61.02 -49.41 77.54 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 124.522 1.129 . . . . 40.960000000000001 108.138 -178.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -59.35 -43.84 92.76 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.608 1.549 . . . . 43.060000000000002 112.215 175.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1245 ' ' GLN . . . . . 0.472 ' O ' HG22 ' B' 1249 ' ' VAL . 46.5 mm-40 -62.01 -28.39 69.54 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.127 -1.397 . . . . 46.450000000000003 114.392 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -57.27 -27.44 62.11 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 123.263 1.506 . . . . 41.780000000000001 112.171 -174.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 10.5 tptt -77.98 -41.93 34.4 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 114.094 -1.412 . . . . 52.200000000000003 110.901 175.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1248 ' ' GLU . . . . . 0.436 ' CD ' HH12 ' B' 1192 ' ' ARG . 26.0 mt-10 -70.26 -41.45 73.46 Favored 'General case' 0 C--O 1.244 0.813 0 O-C-N 120.604 -1.31 . . . . 53.549999999999997 111.952 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1249 ' ' VAL . . . . . 0.8 ' HA ' ' HB2' ' B' 1167 ' ' LYS 0.259 32.8 m -84.88 164.3 2.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 124.336 2.017 . . . . 34.409999999999997 113.504 -166.203 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B 1250 ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' B' 1279 ' ' SER . 2.6 m-20 -122.63 -50.07 1.98 Allowed 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 113.663 -1.608 . . . . 33.380000000000003 107.602 -176.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1251 ' ' ILE . . . . . 0.514 HD12 ' HB1' ' B' 1145 ' ' ALA . 24.5 mm -119.94 114.98 45.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 108.035 -1.098 . . . . 29.539999999999999 108.035 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1252 ' ' ILE . . . . . . . . . . . . . 82.3 mt -91.62 119.79 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 N-CA-C 104.477 -2.416 . . . . 32.439999999999998 104.477 169.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1253 ' ' VAL . . . . . 0.617 HG12 HG23 ' B' 1255 ' ' THR . 55.9 t -112.81 100.91 11.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 104.665 -2.346 . . . . 30.57 104.665 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1254 ' ' THR . . . . . . . . . . . . . 7.4 t -103.08 98.6 8.51 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 125.982 2.801 . . . . 35.039999999999999 108.894 -175.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1255 ' ' THR . . . . . 0.617 HG23 HG12 ' B' 1253 ' ' VAL . 3.2 p -84.74 8.7 16.2 Favored 'General case' 0 N--CA 1.421 -1.888 1 CA-C-N 107.26 -4.518 . . . . 34.619999999999997 117.662 -176.618 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . -72.98 92.06 1.61 Allowed 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 114.115 1.154 . . . . 42.719999999999999 114.115 -174.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 13.7 mt -109.0 101.34 10.43 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 102.936 -2.987 . . . . 52.43 102.936 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 2.3 mp -93.99 128.87 39.58 Favored Pre-proline 0 N--CA 1.481 1.123 0 C-N-CA 118.962 -1.095 . . . . 59.409999999999997 110.014 -177.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -58.68 126.43 21.23 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.779 2.32 . . . . 62.68 107.831 170.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 81.8 -75.24 2.35 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 117.033 -1.982 . . . . 64.159999999999997 108.46 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 91.5 mttt -58.13 149.73 55.44 Favored Pre-proline 0 C--O 1.242 0.676 0 CA-C-N 121.838 2.819 . . . . 68.530000000000001 115.715 -174.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.76 118.49 3.47 Favored 'Trans proline' 0 C--O 1.246 0.9 0 C-N-CA 123.544 2.829 . . . . 61.990000000000002 113.178 167.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1263 ' ' ALA . . . . . 0.501 ' HB1' ' ND2' ' B' 1291 ' ' ASN . . . -35.78 122.95 0.68 Allowed Pre-proline 0 C--O 1.245 0.831 0 C-N-CA 124.858 1.263 . . . . 57.149999999999999 111.052 164.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1264 ' ' PRO . . . . . 0.574 ' O ' ' HA ' ' B' 1291 ' ' ASN . 97.1 Cg_endo -77.13 158.6 33.85 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.292 1.995 . . . . 51.57 111.633 -172.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1265 ' ' LYS . . . . . 0.438 ' NZ ' ' O ' ' B' 1289 ' ' GLY . 46.6 mmtm -78.76 76.09 5.26 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 125.566 2.603 . . . . 54.549999999999997 110.751 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 40.3 mt -67.27 -52.99 34.03 Favored 'General case' 0 N--CA 1.438 -1.069 0 O-C-N 118.317 -2.739 . . . . 46.859999999999999 111.615 -177.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1267 ' ' ILE . . . . . 0.537 HG21 HD13 ' B' 1281 ' ' ILE . 38.0 mm -89.15 99.19 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 107.13 -1.433 . . . . 41.039999999999999 107.13 -176.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1268 ' ' THR . . . . . 0.691 ' HA ' ' HG3' ' B' 1293 ' ' GLU . 7.8 p -73.64 156.82 37.61 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 111.057 -2.792 . . . . 39.579999999999998 113.301 -175.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1269 ' ' ARG . . . . . 0.416 ' HG3' ' HB3' ' B' 1293 ' ' GLU . 78.3 mtt85 -55.81 -41.08 73.65 Favored 'General case' 0 C--O 1.206 -1.21 0 N-CA-C 113.371 0.878 . . . . 53.149999999999999 113.371 -175.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -59.38 -46.52 88.46 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 124.64 1.212 . . . . 42.960000000000001 110.481 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1271 ' ' MET . . . . . . . . . . . . . 48.6 ttm -58.48 -48.08 81.96 Favored 'General case' 0 C--O 1.242 0.66 0 O-C-N 124.096 0.873 . . . . 43.890000000000001 110.252 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1272 ' ' VAL . . . . . 0.413 HG23 ' O ' ' B' 1268 ' ' THR . 33.2 t -57.2 -50.26 77.16 Favored 'Isoleucine or valine' 0 C--O 1.257 1.45 0 O-C-N 125.637 1.836 . . . . 38.369999999999997 111.521 176.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.83 -29.59 67.03 Favored 'General case' 0 C--N 1.357 0.919 0 N-CA-C 115.364 1.616 . . . . 47.460000000000001 115.364 176.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1274 ' ' SER . . . . . . . . . . . . . 50.4 m -84.49 -7.35 59.3 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 126.022 1.729 . . . . 38.380000000000003 114.5 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1275 ' ' MET . . . . . 0.563 ' HB2' HG21 ' B' 1307 ' ' VAL . 49.5 mtp -66.5 164.77 15.79 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 113.576 0.954 . . . . 37.810000000000002 113.576 -175.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -55.85 137.1 50.87 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 124.645 1.178 . . . . 49.259999999999998 108.506 169.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1277 ' ' ALA . . . . . 0.695 ' HB3' ' HD1' ' A' 1045 ' ' PHE . . . -67.96 140.99 56.43 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 121.55 -0.719 . . . . 34.460000000000001 111.136 -177.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 72.93 55.15 6.58 Favored Glycine 0 N--CA 1.434 -1.495 0 CA-C-O 122.669 1.149 . . . . 33.530000000000001 113.824 175.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1279 ' ' SER . . . . . 0.555 ' O ' ' HA ' ' B' 1307 ' ' VAL . 70.9 m -141.37 160.87 39.23 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 107.7 -1.222 . . . . 31.309999999999999 107.7 -167.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1280 ' ' VAL . . . . . 0.693 HG11 ' HA ' ' B' 1145 ' ' ALA . 69.0 t -123.53 141.57 43.32 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 CA-C-N 120.039 1.29 . . . . 29.32 109.547 -169.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1281 ' ' ILE . . . . . 0.537 HD13 HG21 ' B' 1267 ' ' ILE . 74.8 mt -118.2 98.95 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 105.367 -2.086 . . . . 31.93 105.367 170.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1282 ' ' VAL . . . . . . . . . . . . . 5.3 t -86.85 109.84 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 106.77 -1.567 . . . . 29.48 106.77 174.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 58.4 t0 -93.64 111.76 23.5 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 103.236 -2.876 . . . . 34.5 103.236 171.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1284 ' ' LEU . . . . . 0.438 HD22 ' HA ' ' B' 1255 ' ' THR . 7.2 mp -74.15 -40.44 62.59 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 113.686 -1.597 . . . . 37.939999999999998 106.718 172.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -76.03 11.52 1.43 Allowed 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 120.285 -1.509 . . . . 40.920000000000002 114.898 -160.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -47.73 -45.05 28.42 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 118.486 2.773 . . . . 44.390000000000001 118.486 176.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1287 ' ' GLN . . . . . 0.838 ' HB3' HG23 ' B' 1313 ' ' THR . 0.0 OUTLIER -66.87 -28.94 68.74 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 122.588 1.185 . . . . 51.460000000000001 112.196 172.623 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -82.57 -33.9 27.91 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 114.671 1.36 . . . . 57.75 114.671 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1289 ' ' GLY . . . . . 0.438 ' O ' ' NZ ' ' B' 1265 ' ' LYS . . . 164.65 -21.95 0.14 Allowed Glycine 0 CA--C 1.536 1.4 0 C-N-CA 120.138 -1.029 . . . . 49.850000000000001 113.258 -172.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 80.48 112.01 0.29 Allowed Glycine 0 N--CA 1.464 0.535 0 CA-C-O 118.25 -1.305 . . . . 45.93 112.844 175.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1291 ' ' ASN . . . . . 0.574 ' HA ' ' O ' ' B' 1264 ' ' PRO . 29.2 m120 -89.93 -15.28 32.37 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 119.152 1.476 . . . . 42.670000000000002 114.711 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1292 ' ' CYS . . . . . . . . . . . . . 48.5 t -105.88 144.06 33.13 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.287 0.847 . . . . 38.82 113.287 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1293 ' ' GLU . . . . . 0.691 ' HG3' ' HA ' ' B' 1268 ' ' THR . 6.8 mt-10 -69.5 -16.38 63.44 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 119.189 3.033 . . . . 46.710000000000001 119.189 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1294 ' ' TYR . . . . . 0.43 ' HB2' HG21 ' B' 1309 ' ' VAL . 58.5 m-85 -107.39 0.36 22.91 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 120.211 -1.555 . . . . 47.229999999999997 113.023 -178.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1295 ' ' THR . . . . . 0.712 HG23 ' HA3' ' B' 1311 ' ' GLY . 91.2 m -53.79 115.58 2.07 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 116.148 1.907 . . . . 36.020000000000003 116.148 -178.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1296 ' ' VAL . . . . . 0.466 ' HB ' ' HB3' ' B' 1299 ' ' GLU . 46.5 t -97.13 121.03 60.08 Favored Pre-proline 0 N--CA 1.435 -1.199 0 N-CA-C 102.551 -3.129 . . . . 37.259999999999998 102.551 169.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -51.59 114.29 1.51 Allowed 'Trans proline' 0 C--O 1.238 0.475 0 C-N-CA 124.827 3.684 . . . . 35.090000000000003 116.612 -177.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1298 ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' B' 1312 ' ' TYR . . . 66.18 42.56 94.25 Favored Glycine 0 C--O 1.245 0.793 0 CA-C-O 116.342 -2.365 . . . . 35.969999999999999 114.016 -173.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1299 ' ' GLU . . . . . 0.466 ' HB3' ' HB ' ' B' 1296 ' ' VAL . 18.2 tt0 -151.87 175.48 12.43 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 118.484 1.142 . . . . 40.390000000000001 111.17 175.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1300 ' ' ILE . . . . . 0.485 HG12 HG12 ' B' 1310 ' ' ILE . 58.6 mt -110.19 133.49 55.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 107.536 -1.283 . . . . 37.43 107.536 170.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 69.3 t80 -107.8 124.78 50.57 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.509 -0.876 . . . . 44.130000000000003 110.347 163.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1302 ' ' THR . . . . . . . . . . . . . 96.0 m -92.84 126.79 38.09 Favored 'General case' 0 C--O 1.248 0.985 0 O-C-N 120.238 -1.539 . . . . 39.780000000000001 107.95 176.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1303 ' ' THR . . . . . . . . . . . . . 67.5 p -82.56 175.08 10.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 120.851 1.66 . . . . 43.289999999999999 113.249 166.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -69.81 -30.6 68.16 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 122.222 1.01 . . . . 53.07 109.882 -174.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -82.98 14.45 3.31 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 114.5 1.296 . . . . 43.969999999999999 114.5 173.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 70.31 32.23 68.59 Favored Glycine 0 C--O 1.211 -1.339 0 O-C-N 120.569 -1.332 . . . . 41.119999999999997 110.909 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1307 ' ' VAL . . . . . 0.563 HG21 ' HB2' ' B' 1275 ' ' MET . 73.6 t -98.67 109.45 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 105.075 -2.194 . . . . 38.119999999999997 105.075 173.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1308 ' ' LYS . . . . . 0.418 ' CD ' ' HB3' ' B' 1148 ' ' GLU . 78.5 mttt -86.44 98.04 10.8 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 113.321 -1.763 . . . . 36.340000000000003 107.562 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1309 ' ' VAL . . . . . 0.43 HG21 ' HB2' ' B' 1294 ' ' TYR . 44.4 t -71.34 90.96 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 CA-C-N 114.608 -1.178 . . . . 30.399999999999999 108.93 172.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1310 ' ' ILE . . . . . 0.485 HG12 HG12 ' B' 1300 ' ' ILE . 37.0 mt -83.46 101.96 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 O-C-N 120.564 -1.335 . . . . 30.82 110.225 176.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1311 ' ' GLY . . . . . 0.712 ' HA3' HG23 ' B' 1295 ' ' THR . . . -99.5 63.38 0.7 Allowed Glycine 0 CA--C 1.499 -0.936 0 CA-C-N 114.137 -1.392 . . . . 26.530000000000001 111.317 178.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1312 ' ' TYR . . . . . 0.519 ' HB2' ' HG ' ' B' 1315 ' ' LEU . 8.4 m-30 -82.08 100.44 9.77 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 119.635 -2.097 . . . . 38.0 113.995 -175.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1313 ' ' THR . . . . . 0.838 HG23 ' HB3' ' B' 1287 ' ' GLN . 98.3 m -51.42 -38.0 51.39 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 114.082 -1.417 . . . . 29.800000000000001 109.733 168.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -95.59 14.86 21.52 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.965 2.106 . . . . 39.039999999999999 112.576 -166.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1315 ' ' LEU . . . . . 0.519 ' HG ' ' HB2' ' B' 1312 ' ' TYR . 41.9 mt -50.58 -50.36 72.84 Favored Pre-proline 0 C--O 1.21 -1.019 0 CA-C-O 113.274 -3.25 . . . . 31.079999999999998 116.425 176.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1316 ' ' PRO . . . . . 0.645 ' HB3' ' HB3' ' B' 1133 ' ' MET . 68.2 Cg_exo -51.73 -34.69 55.14 Favored 'Trans proline' 0 CA--C 1.536 0.581 1 C-N-CA 125.955 4.437 . . . . 26.100000000000001 113.646 174.981 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B 1317 ' ' GLY . . . . . 0.676 ' HA2' ' HG3' ' B' 1015 ' ' ARG . . . -66.16 -48.47 64.57 Favored Glycine 0 C--N 1.344 0.98 0 O-C-N 120.378 -1.451 . . . . 23.170000000000002 113.228 176.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1318 ' ' ARG . . . . . 0.424 ' HD2' HD23 ' B' 1315 ' ' LEU . 75.6 mtt-85 -50.34 -0.55 0.01 OUTLIER 'General case' 0 C--O 1.237 0.405 1 N-CA-C 124.683 5.068 . . . . 40.399999999999999 124.683 -169.733 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 13.5 tp -126.92 72.67 75.95 Favored Pre-proline 0 C--O 1.245 0.843 0 N-CA-C 104.872 -2.27 . . . . 23.600000000000001 104.872 176.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1320 ' ' PRO . . . . . 0.653 ' HG2' ' HA2' ' A' 1150 ' ' GLY . 95.7 Cg_endo -43.49 -72.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 124.882 3.721 . . . . 22.350000000000001 119.847 -160.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1321 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.9 -37.66 66.61 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 113.349 0.87 . . . . 26.52 113.349 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1322 ' ' GLN . . . . . 0.866 ' HB2' ' HA ' ' A' 1151 ' ' ARG . 55.5 tp60 -74.23 -41.96 60.5 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 118.653 -1.219 . . . . 24.379999999999999 110.066 -173.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1323 ' ' SER . . . . . 0.445 ' HB2' ' HG2' ' B' 1015 ' ' ARG . 14.8 m -59.43 -40.81 87.93 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.601 -0.84 . . . . 22.800000000000001 112.284 170.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1324 ' ' SER . . . . . . . . . . . . . 13.7 m -64.22 -25.04 67.89 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 115.481 1.66 . . . . 21.25 115.481 170.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1325 ' ' GLN . . . . . 0.567 HE22 ' HD2' ' B' 1021 ' ' LYS . 67.5 tp60 -74.05 -50.17 20.88 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.767 -0.583 . . . . 31.34 109.551 175.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1326 ' ' LEU . . . . . 0.423 ' HB3' ' HB3' ' B' 1132 ' ' SER . 13.7 mt -72.33 -51.84 18.85 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 108.125 -1.065 . . . . 31.559999999999999 108.125 -174.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1327 ' ' TYR . . . . . 0.439 ' O ' ' HG ' ' B' 1331 ' ' LEU . 18.7 t80 -51.19 -46.63 62.22 Favored 'General case' 0 C--N 1.377 1.774 0 O-C-N 118.984 -2.322 . . . . 22.73 111.613 172.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1328 ' ' GLY . . . . . 0.461 ' O ' HG23 ' B' 1332 ' ' VAL . . . -51.16 -52.91 29.69 Favored Glycine 0 C--O 1.244 0.763 0 CA-C-O 123.654 1.697 . . . . 21.91 112.115 175.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1329 ' ' THR . . . . . . . . . . . . . 20.1 m -65.69 -36.41 83.56 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.099 -1.074 . . . . 22.149999999999999 108.099 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1330 ' ' ASN . . . . . . . . . . . . . 23.7 m120 -60.56 -47.72 84.92 Favored 'General case' 0 N--CA 1.437 -1.082 0 O-C-N 118.673 -2.517 . . . . 26.18 110.275 178.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1331 ' ' LEU . . . . . 0.681 HD22 HD22 ' B' 1070 ' ' LEU . 20.1 mt -57.61 -42.57 83.52 Favored 'General case' 0 N--CA 1.435 -1.179 0 O-C-N 125.853 1.97 . . . . 23.68 111.842 172.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1332 ' ' VAL . . . . . 0.598 HG12 ' HE3' ' B' 1336 ' ' LYS . 97.9 t -59.56 -44.91 94.2 Favored 'Isoleucine or valine' 0 C--N 1.349 0.552 0 CA-C-O 121.436 0.636 . . . . 26.57 110.581 178.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1333 ' ' ASN . . . . . 0.622 ' HA ' ' HD2' ' B' 1336 ' ' LYS . 82.4 m-20 -62.67 -45.72 91.5 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.953 0.901 . . . . 28.079999999999998 110.109 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1334 ' ' LEU . . . . . 0.717 HD12 HD23 ' B' 1127 ' ' LEU . 4.3 tp -52.0 -52.17 52.43 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 124.733 1.27 . . . . 27.43 109.616 174.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1335 ' ' LEU . . . . . 0.749 HD23 HD12 ' B' 1338 ' ' LEU . 75.3 mt -72.7 -19.29 61.43 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 114.234 -1.348 . . . . 30.5 113.356 -178.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1336 ' ' LYS . . . . . 0.622 ' HD2' ' HA ' ' B' 1333 ' ' ASN . 88.5 mttt -65.63 -48.17 73.11 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-N 122.9 2.591 . . . . 41.649999999999999 107.526 169.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1337 ' ' LEU . . . . . 0.465 HD21 ' HD2' ' B' 1123 ' ' ARG . 10.6 mp -75.1 -30.55 60.93 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.362 0.665 . . . . 42.079999999999998 110.663 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1338 ' ' LEU . . . . . 0.749 HD12 HD23 ' B' 1335 ' ' LEU . 79.0 mt -71.11 -51.53 24.55 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 119.697 -1.877 . . . . 35.030000000000001 111.052 172.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 49.8 t -96.5 71.67 2.7 Favored 'General case' 0 C--O 1.254 1.298 0 CA-C-O 124.849 2.261 . . . . 37.329999999999998 107.462 -173.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 12.8 mttp -54.35 -39.08 66.78 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 111.827 -2.442 . . . . 50.509999999999998 112.472 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -98.93 20.06 13.9 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 112.998 0.74 . . . . 54.210000000000001 112.998 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 97.1 mttt 42.6 38.35 1.26 Allowed 'General case' 0 C--O 1.248 0.974 0 C-N-CA 127.758 2.423 . . . . 50.990000000000002 117.081 159.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -111.76 -2.95 15.12 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 112.456 -2.156 . . . . 48.82 109.808 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 89.08 26.1 27.19 Favored Glycine 0 C--O 1.214 -1.1 0 CA-C-O 116.849 -2.084 . . . . 40.43 111.711 -171.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -116.78 122.76 45.37 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-N 122.277 3.038 . . . . 47.560000000000002 113.013 174.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1346 ' ' ILE . . . . . . . . . . . . . 37.6 mm -68.28 113.18 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 124.265 1.026 . . . . 42.490000000000002 111.343 -174.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1347 ' ' THR . . . . . . . . . . . . . 11.2 m -106.13 106.28 16.72 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 104.84 -2.281 . . . . 38.119999999999997 104.84 170.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 98.9 t -81.04 100.97 5.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 106.573 -1.64 . . . . 37.5 106.573 -174.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 61.0 t0 -72.91 113.2 9.67 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.712 -1.131 . . . . 43.850000000000001 111.544 -174.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1350 ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.32 -6.54 25.7 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.567 -1.333 . . . . 39.810000000000002 110.909 176.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -76.51 -29.31 56.75 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.809 -0.632 . . . . 51.289999999999999 110.827 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 42.6 t0 -88.04 127.47 35.4 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 104.147 -2.538 . . . . 39.780000000000001 104.147 -176.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 15.5 m -63.44 -27.26 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 123.766 0.826 . . . . 39.280000000000001 111.519 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1354 ' ' VAL . . . . . 0.72 HG22 ' HB2' ' B' 1124 ' ' ALA . 50.6 t -65.16 -56.01 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.796 0.838 . . . . 35.700000000000003 112.931 175.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1355 ' ' ILE . . . . . 0.406 ' HA ' HG12 ' B' 1358 ' ' VAL . 27.5 mm -68.86 -45.62 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-O 117.284 -1.341 . . . . 35.770000000000003 109.263 178.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 52.3 tpt85 -49.1 -32.1 9.23 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 120.158 1.344 . . . . 38.549999999999997 114.577 172.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1357 ' ' GLY . . . . . 0.538 ' HA2' ' HB2' ' B' 1370 ' ' ALA . . . -76.14 -61.33 2.86 Favored Glycine 0 CA--C 1.492 -1.402 0 CA-C-N 116.027 -0.533 . . . . 29.579999999999998 113.101 175.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1358 ' ' VAL . . . . . 0.462 HG13 ' HE2' ' B' 1113 ' ' MET . 13.1 p -64.97 -32.65 59.19 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 O-C-N 122.079 -0.659 . . . . 32.060000000000002 111.053 -172.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1359 ' ' THR . . . . . . . . . . . . . 4.2 m -71.92 81.78 0.92 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 122.85 1.309 . . . . 29.0 108.274 175.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1360 ' ' VAL . . . . . 0.442 HG12 ' CD1' ' B' 1368 ' ' TRP . 34.8 m -71.13 -26.03 26.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 113.004 -1.907 . . . . 29.68 111.34 -175.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1361 ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' B' 1365 ' ' GLU . 83.9 mt -132.25 119.22 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 107.118 -1.438 . . . . 32.049999999999997 107.118 170.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1362 ' ' ARG . . . . . 0.597 ' HA ' HG23 ' B' 1111 ' ' THR . 27.1 ttt180 -106.8 125.34 50.87 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 105.571 -2.011 . . . . 32.520000000000003 105.571 172.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 45.62 37.3 3.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 117.542 2.423 . . . . 35.68 117.542 176.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1364 ' ' GLY . . . . . 0.584 ' HA3' ' HA ' ' B' 1109 ' ' ASN . . . 85.84 14.88 66.51 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 113.926 -1.488 . . . . 34.259999999999998 116.057 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1365 ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' B' 1361 ' ' ILE . 20.8 mm-40 -108.41 135.48 49.64 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.465 -0.939 . . . . 51.07 108.465 164.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1366 ' ' ILE . . . . . 0.439 ' HA ' HG12 ' B' 1361 ' ' ILE . 61.4 mt -69.6 90.71 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 106.57 -1.641 . . . . 39.869999999999997 106.57 173.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1367 ' ' THR . . . . . . . . . . . . 0.252 23.8 p -85.7 10.88 12.21 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 116.698 2.11 . . . . 38.009999999999998 116.698 176.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1368 ' ' TRP . . . . . 0.512 ' HZ3' ' HB2' ' B' 1096 ' ' ALA . 1.7 t90 -78.07 138.8 60.78 Favored Pre-proline 0 C--O 1.252 1.232 0 N-CA-C 107.586 -1.264 . . . . 42.140000000000001 107.586 166.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1369 ' ' PRO . . . . . 0.403 ' HA ' ' CD1' ' B' 1368 ' ' TRP . 7.9 Cg_exo -94.3 179.77 9.28 Favored 'Cis proline' 0 C--N 1.35 0.627 0 N-CA-C 115.958 1.484 . . . . 43.259999999999998 115.958 -3.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1370 ' ' ALA . . . . . 0.538 ' HB2' ' HA2' ' B' 1357 ' ' GLY . . . -81.97 149.99 64.28 Favored Pre-proline 0 C--O 1.242 0.686 0 CA-C-O 116.77 -1.586 . . . . 46.520000000000003 108.486 163.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -49.01 120.24 5.26 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 124.44 3.427 . . . . 51.950000000000003 110.734 175.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -48.83 100.95 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 125.121 3.88 . . . . 56.270000000000003 117.503 -172.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1373 ' ' ILE . . . . . . . . . . . . . 19.1 tt -76.37 126.16 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 106.34 -1.726 . . . . 60.829999999999998 106.34 172.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -72.02 106.57 4.34 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-O 125.566 2.603 . . . . 66.099999999999994 109.634 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 71.2 t -98.24 121.56 48.92 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 CA-C-N 111.45 -2.614 . . . . 63.469999999999999 106.279 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.218 -5.11 0 O-C-N 120.004 -1.685 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.414 -2.236 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.26 -31.82 71.63 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 124.789 1.235 . . . . 0.0 110.026 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -36.15 83.42 Favored 'General case' 0 C--O 1.252 1.19 0 CA-C-N 119.398 0.999 . . . . 0.0 109.787 175.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 84.8 m -67.04 -33.03 74.65 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 118.622 0.646 . . . . 0.0 109.91 171.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 24' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' C' ' 27' ' ' LEU . . . -68.65 -50.35 51.91 Favored 'General case' 0 C--O 1.246 0.87 0 O-C-N 119.41 -2.056 . . . . 0.0 110.973 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 25' ' ' GLU . . . . . 0.587 ' HA ' ' HE2' ' C' ' 28' ' ' LYS . 0.7 OUTLIER -41.72 -57.28 2.37 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.728 -1.233 . . . . 0.0 113.557 162.281 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.618 ' HA ' ' HB3' ' C' ' 29' ' ' ASN . 84.7 mt -60.96 -25.42 66.81 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 175.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.608 HD21 HD21 ' C' ' 110' ' ' LEU . 44.4 mt -58.37 -56.46 21.81 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 116.613 -1.66 . . . . 0.0 110.868 172.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 28' ' ' LYS . . . . . 0.587 ' HE2' ' HA ' ' C' ' 25' ' ' GLU . 12.3 pttt -67.9 -31.33 71.04 Favored 'General case' 0 C--O 1.257 1.459 0 CA-C-O 123.556 1.646 . . . . 0.0 110.272 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 29' ' ' ASN . . . . . 0.618 ' HB3' ' HA ' ' C' ' 26' ' ' LEU . 22.6 t-20 -64.46 -27.33 68.91 Favored 'General case' 0 C--O 1.212 -0.886 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 169.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.647 ' HA ' ' HB3' ' C' ' 107' ' ' ASP . 35.4 m -65.69 -31.85 73.08 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 116.582 2.068 . . . . 0.0 116.582 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 31' ' ' HIS . . . . . 0.482 ' O ' HG23 ' C' ' 62' ' ' ILE . 19.7 m-70 61.08 -60.79 0.08 Allowed 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.289 -178.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 32' ' ' SER . . . . . 0.544 ' O ' ' HB3' ' C' ' 30' ' ' SER . 42.0 m -85.74 137.04 33.09 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 117.072 -3.518 . . . . 0.0 106.948 156.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 33' ' ' VAL . . . . . 0.413 ' HA ' HG23 ' C' ' 106' ' ' THR . 60.7 t -127.99 94.33 2.48 Favored 'Isoleucine or valine' 0 C--O 1.246 0.892 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 174.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.646 HG13 ' HA ' ' C' ' 103' ' ' PHE . 23.6 mm -74.11 110.25 7.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 O-C-N 118.607 -2.558 . . . . 0.0 107.666 168.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 35' ' ' ILE . . . . . 0.521 HG12 HD12 ' C' ' 110' ' ' LEU . 33.6 mt -85.88 114.59 25.85 Favored 'Isoleucine or valine' 0 C--O 1.254 1.303 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 169.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 36.2 m -93.67 107.88 30.3 Favored Pre-proline 0 C--O 1.246 0.914 0 O-C-N 121.08 -1.013 . . . . 0.0 110.382 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 37' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' C' ' 35' ' ' ILE . 80.2 Cg_exo -61.18 91.35 0.1 OUTLIER 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 123.294 2.663 . . . . 0.0 113.382 177.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.56 168.92 40.5 Favored Glycine 0 N--CA 1.432 -1.569 0 CA-C-N 113.086 -1.87 . . . . 0.0 108.624 169.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 39' ' ' TYR . . . . . 0.436 ' HB3' ' HB2' ' C' ' 114' ' ' ALA . 46.9 t80 -57.43 -28.04 62.96 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -177.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 40' ' ' GLY . . . . . 0.465 ' HA2' HG12 ' C' ' 43' ' ' VAL . . . -58.45 -32.71 69.06 Favored Glycine 0 C--O 1.244 0.758 0 O-C-N 120.83 -1.169 . . . . 0.0 112.536 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 41' ' ' MET . . . . . 0.833 ' HA ' ' HB3' ' C' ' 46' ' ' ALA . 16.1 ttm -55.64 -44.54 77.26 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.557 -0.822 . . . . 0.0 111.454 177.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.89 -51.97 10.29 Favored 'General case' 0 C--O 1.214 -0.777 0 O-C-N 124.967 1.417 . . . . 0.0 111.627 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 43' ' ' VAL . . . . . 0.465 HG12 ' HA2' ' C' ' 40' ' ' GLY . 11.3 p -67.43 -41.47 86.17 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 C-N-CA 119.333 -0.947 . . . . 0.0 113.358 -168.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 44' ' ' ALA . . . . . 0.43 ' HB1' ' HB2' ' C' ' 176' ' ' LYS . . . -92.47 19.71 6.97 Favored 'General case' 0 N--CA 1.424 -1.731 0 O-C-N 120.899 -1.125 . . . . 0.0 110.597 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 45' ' ' GLN . . . . . . . . . . . . 0.353 0.0 OUTLIER 30.31 56.65 0.19 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 117.819 2.525 . . . . 0.0 117.819 -167.669 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.833 ' HB3' ' HA ' ' C' ' 41' ' ' MET . . . -78.26 -14.19 59.54 Favored 'General case' 0 C--O 1.202 -1.44 0 CA-C-N 111.891 -2.413 . . . . 0.0 114.094 -178.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 47' ' ' GLN . . . . . 0.486 ' HA ' ' HB ' ' C' ' 50' ' ' VAL . 0.0 OUTLIER -66.89 -26.38 66.85 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 179.386 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 48' ' ' TYR . . . . . 0.592 ' HB2' ' HD3' ' C' ' 49' ' ' PRO . 47.0 m-85 -62.58 -52.2 66.95 Favored Pre-proline 0 N--CA 1.443 -0.787 0 CA-C-O 117.636 -1.174 . . . . 0.0 111.767 170.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 49' ' ' PRO . . . . . 0.592 ' HD3' ' HB2' ' C' ' 48' ' ' TYR . 8.2 Cg_exo -63.58 -39.34 36.12 Favored 'Trans proline' 0 CA--C 1.551 1.359 0 C-N-CA 122.846 2.364 . . . . 0.0 114.231 170.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 50' ' ' VAL . . . . . 0.577 ' HA ' HG22 ' C' ' 53' ' ' ILE . 54.2 t -59.81 -37.4 71.39 Favored 'Isoleucine or valine' 0 C--N 1.346 0.442 0 CA-C-O 116.126 -1.892 . . . . 0.0 111.191 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.02 -46.8 89.26 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 122.971 2.623 . . . . 0.0 108.993 -176.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 52' ' ' GLU . . . . . 0.54 ' HB3' HD11 ' C' ' 183' ' ' LEU . 3.6 tm-20 -69.57 -41.18 76.19 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.332 -1.304 . . . . 0.0 113.721 -178.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 53' ' ' ILE . . . . . 0.643 HD13 ' HA ' ' C' ' 183' ' ' LEU . 10.2 tp -60.45 -39.72 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 120.309 1.413 . . . . 0.0 113.002 172.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 95.0 m -60.68 -46.82 88.91 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.166 173.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -55.15 -50.82 68.33 Favored 'General case' 0 C--O 1.252 1.184 0 C-N-CA 127.178 2.191 . . . . 0.0 110.231 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 56' ' ' LYS . . . . . 0.431 ' HG2' HD12 ' C' ' 186' ' ' LEU . 4.3 ttpt -57.57 -50.73 72.14 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 116.59 2.071 . . . . 0.0 116.59 175.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 57' ' ' LEU . . . . . 0.479 ' O ' ' HB3' ' C' ' 60' ' ' ARG . 29.6 mt -63.06 -40.33 97.38 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.803 -0.561 . . . . 0.0 111.787 175.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 58' ' ' ARG . . . . . 0.516 ' NH1' ' HA ' ' C' ' 63' ' ' ASN . 2.5 tpt180 -67.7 -46.04 73.41 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 118.787 -0.625 . . . . 0.0 109.882 -175.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.74 -31.72 72.98 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 120.231 1.378 . . . . 0.0 112.502 175.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 60' ' ' ARG . . . . . 0.479 ' HB3' ' O ' ' C' ' 57' ' ' LEU . 1.7 tpm_? -61.36 -28.52 69.29 Favored 'General case' 0 C--N 1.346 0.45 0 O-C-N 119.913 -1.742 . . . . 0.0 110.89 171.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.4 1.84 40.91 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -177.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 62' ' ' ILE . . . . . 0.482 HG23 ' O ' ' C' ' 31' ' ' HIS . 64.5 mt -73.28 137.18 23.88 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 CA-C-O 126.096 2.855 . . . . 0.0 107.131 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 63' ' ' ASN . . . . . 0.516 ' HA ' ' NH1' ' C' ' 58' ' ' ARG . 59.3 t30 -81.52 67.01 7.31 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 112.275 -2.239 . . . . 0.0 111.754 -177.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 2.8 p -78.51 128.64 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 173.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 30.2 mmm-85 -137.42 148.78 46.42 Favored 'General case' 0 C--N 1.349 0.546 0 N-CA-C 103.468 -2.79 . . . . 0.0 103.468 -174.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 66' ' ' PHE . . . . . 0.73 ' HB2' ' HA ' ' C' ' 93' ' ' VAL . 22.4 m-85 -106.09 118.89 37.8 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 122.798 1.285 . . . . 0.0 111.048 -176.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -97.29 83.05 0.72 Allowed Glycine 0 C--O 1.25 1.107 0 N-CA-C 107.919 -2.072 . . . . 0.0 107.919 -177.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 68' ' ' ILE . . . . . 0.76 ' HB ' ' HA ' ' C' ' 95' ' ' GLU . 1.7 mp -73.03 126.38 33.59 Favored 'Isoleucine or valine' 0 C--N 1.348 0.518 0 CA-C-N 119.918 1.859 . . . . 0.0 110.191 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 69' ' ' HIS . . . . . 0.503 ' NE2' ' HG2' ' C' ' 134' ' ' PRO . 18.1 t-80 -118.16 91.98 41.59 Favored Pre-proline 0 CA--C 1.5 -0.945 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.911 -178.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 70' ' ' PRO . . . . . 0.773 ' HB3' HG13 ' A' 1157 ' ' ILE . 98.3 Cg_endo -54.39 -39.29 88.07 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 124.733 3.622 . . . . 0.0 118.307 -168.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 42.2 t -71.03 95.57 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 171.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -161.49 106.58 1.31 Allowed 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.445 1.117 . . . . 0.0 110.762 -172.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 73' ' ' GLY . . . . . 0.466 ' C ' ' HD2' ' C' ' 74' ' ' ARG . . . 72.31 -90.95 0.53 Allowed Glycine 0 N--CA 1.467 0.719 0 O-C-N 118.34 -2.725 . . . . 0.0 113.984 156.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 74' ' ' ARG . . . . . 0.816 ' HG3' ' HG2' ' B' 1203 ' ' GLN . 2.4 mpt_? -145.91 114.09 6.61 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -169.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.669 ' HG ' HD22 ' B' 1178 ' ' LEU . 4.0 mp 60.36 119.89 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.416 0 O-C-N 127.079 2.737 . . . . 0.0 116.808 175.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 76' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' C' ' 75' ' ' LEU . 73.0 Cg_endo -66.69 165.14 26.54 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 124.244 3.296 . . . . 0.0 109.423 167.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.39 -115.94 5.01 Favored Glycine 0 CA--C 1.505 -0.535 0 O-C-N 120.21 -1.556 . . . . 0.0 110.338 -169.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 49.56 -79.95 0.01 OUTLIER 'General case' 0 C--O 1.248 0.979 0 C-N-CA 124.819 1.248 . . . . 0.0 114.166 155.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -67.65 -35.43 78.87 Favored 'General case' 0 C--O 1.241 0.652 0 O-C-N 118.962 -2.336 . . . . 0.0 110.209 -177.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -64.13 -34.1 77.29 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 74.8 t -65.71 -41.03 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 122.139 -0.351 . . . . 0.0 111.351 176.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 45.9 mt -66.63 -30.27 70.5 Favored 'General case' 0 C--O 1.252 1.194 0 CA-C-O 123.361 1.553 . . . . 0.0 109.904 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.793 HD11 ' SD ' ' C' ' 41' ' ' MET . 6.0 mp -66.89 -48.34 69.05 Favored 'General case' 0 C--O 1.24 0.568 0 O-C-N 120.869 -1.144 . . . . 0.0 110.162 172.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.18 -49.42 77.1 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 177.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -58.59 -55.04 40.18 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-O 117.873 -1.061 . . . . 0.0 109.075 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.77 9.08 0.3 Allowed 'General case' 0 C--O 1.246 0.874 0 CA-C-N 121.158 1.799 . . . . 0.0 114.05 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp 64.14 30.87 13.64 Favored 'General case' 0 C--O 1.257 1.5 0 CA-C-N 122.017 2.19 . . . . 0.0 115.012 172.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 60.7 t -72.34 120.24 79.33 Favored Pre-proline 0 C--O 1.262 1.722 0 N-CA-C 104.462 -2.421 . . . . 0.0 104.462 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -56.71 115.94 2.84 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.854 3.036 . . . . 0.0 116.37 -171.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 90' ' ' TYR . . . . . 0.753 ' HA ' ' HB ' ' C' ' 93' ' ' VAL . 16.4 m-85 -60.69 -22.37 63.85 Favored 'General case' 0 C--O 1.246 0.885 0 CA-C-O 123.381 1.562 . . . . 0.0 114.125 173.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -43.19 -56.75 3.28 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 124.87 1.268 . . . . 0.0 112.758 164.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 1.9 pt -96.43 -10.38 8.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.577 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 93' ' ' VAL . . . . . 0.753 ' HB ' ' HA ' ' C' ' 90' ' ' TYR . 41.5 t -74.13 108.43 5.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-O 123.749 1.738 . . . . 0.0 110.656 175.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 6.0 mt -106.25 95.61 5.89 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 120.624 -1.297 . . . . 0.0 110.975 176.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 95' ' ' GLU . . . . . 0.76 ' HA ' ' HB ' ' C' ' 68' ' ' ILE . 3.1 mp0 -71.19 91.53 0.95 Allowed 'General case' 0 C--O 1.255 1.352 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.056 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 39.3 ttp 50.52 97.8 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 124.503 2.097 . . . . 0.0 116.445 -175.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -157.94 163.51 37.77 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 113.396 -1.729 . . . . 0.0 107.53 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -84.8 94.92 8.82 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 124.975 2.322 . . . . 0.0 111.471 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 10.3 tp -100.03 41.02 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 CA-C-N 109.079 -3.691 . . . . 0.0 107.386 164.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -76.91 -31.12 56.47 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 119.984 -1.698 . . . . 0.0 108.153 -161.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -63.45 -61.22 2.48 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 124.576 1.15 . . . . 0.0 113.93 170.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 102' ' ' ASP . . . . . 0.438 ' HA ' ' HB3' ' C' ' 105' ' ' ASP . 1.4 m-20 -65.83 -21.08 66.45 Favored 'General case' 0 C--N 1.355 0.818 0 O-C-N 123.852 0.72 . . . . 0.0 111.626 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 103' ' ' PHE . . . . . 0.646 ' HA ' HG13 ' C' ' 34' ' ' ILE . 0.1 OUTLIER -56.62 -60.17 3.94 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 123.304 0.642 . . . . 0.0 110.768 170.608 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.25 -31.35 72.48 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 173.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 105' ' ' ASP . . . . . 0.438 ' HB3' ' HA ' ' C' ' 102' ' ' ASP . 8.6 t70 -66.24 -26.45 67.37 Favored 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 120.509 -1.369 . . . . 0.0 111.837 175.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 106' ' ' THR . . . . . 0.557 ' OG1' HG12 ' C' ' 34' ' ' ILE . 53.6 m -73.02 125.75 28.35 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 121.842 2.11 . . . . 0.0 108.946 177.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 107' ' ' ASP . . . . . 0.647 ' HB3' ' HA ' ' C' ' 30' ' ' SER . 11.7 t70 -72.36 -43.37 64.13 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 113.006 -1.906 . . . . 0.0 110.621 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 108' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' C' ' 143' ' ' ASN . 80.0 m -125.62 104.53 8.44 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 119.015 0.825 . . . . 0.0 111.622 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 109' ' ' VAL . . . . . 0.445 HG11 HG21 ' C' ' 138' ' ' VAL . 8.1 t -87.0 120.95 37.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -171.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 110' ' ' LEU . . . . . 0.608 HD21 HD21 ' C' ' 27' ' ' LEU . 20.8 mt -90.32 93.77 9.47 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -171.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 19.1 t -84.81 109.31 17.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.037 170.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 112' ' ' ILE . . . . . 0.52 HD11 HG23 ' C' ' 35' ' ' ILE . 6.5 mm -78.06 90.02 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.919 0 CA-C-O 121.888 0.851 . . . . 0.0 110.652 -174.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 113' ' ' GLY . . . . . 0.558 ' HA2' ' O ' ' C' ' 147' ' ' PHE . . . 86.79 -72.95 2.54 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-O 124.106 1.948 . . . . 0.0 113.969 168.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 114' ' ' ALA . . . . . 0.436 ' HB2' ' HB3' ' C' ' 39' ' ' TYR . . . -75.77 108.29 8.52 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 120.773 -1.428 . . . . 0.0 112.819 -168.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 115' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -65.75 -58.46 5.62 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 113.106 -1.861 . . . . 0.0 115.213 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 116' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' C' ' 119' ' ' ASN . 81.8 m-20 -57.62 -19.38 25.77 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 116.713 2.116 . . . . 0.0 116.713 -168.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 3.1 m -44.54 -43.47 8.03 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.658 1.983 . . . . 0.0 110.624 173.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.523 HG23 HD21 ' C' ' 162' ' ' LEU . 13.7 m -125.07 37.75 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.624 0 CA-C-O 122.952 1.358 . . . . 0.0 110.83 -177.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 119' ' ' ASN . . . . . 0.506 ' HB2' ' HA ' ' C' ' 116' ' ' ASP . 40.7 t-20 -77.82 114.22 39.55 Favored Pre-proline 0 C--O 1.243 0.73 0 O-C-N 120.463 -1.398 . . . . 0.0 110.832 -176.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 120' ' ' PRO . . . . . 0.416 ' HG2' ' HB2' ' C' ' 160' ' ' ASN . 71.7 Cg_endo -64.6 -34.0 53.69 Favored 'Trans proline' 0 CA--C 1.495 -1.471 0 C-N-CA 125.045 3.83 . . . . 0.0 114.183 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 121' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' C' ' 125' ' ' ASP . . . -64.23 -30.27 71.33 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 118.614 -1.235 . . . . 0.0 110.429 174.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 122' ' ' ALA . . . . . 0.555 ' HA ' ' CB ' ' C' ' 128' ' ' SER . . . -68.72 -19.83 64.37 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 174.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 123' ' ' GLN . . . . . 0.48 ' HB3' ' O ' ' C' ' 133' ' ' MET . 3.9 pt20 -86.7 -59.78 2.17 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 118.039 -2.913 . . . . 0.0 114.621 161.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -65.44 -45.05 85.33 Favored 'General case' 0 N--CA 1.438 -1.067 0 O-C-N 127.431 2.957 . . . . 0.0 115.042 -168.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 125' ' ' ASP . . . . . 0.459 ' HA ' ' HD3' ' C' ' 126' ' ' PRO . 0.9 OUTLIER -80.59 119.98 77.84 Favored Pre-proline 0 C--O 1.243 0.735 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -170.639 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 126' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' C' ' 125' ' ' ASP . 33.1 Cg_exo -75.49 76.01 3.73 Favored 'Trans proline' 0 N--CA 1.436 -1.878 1 C-N-CA 125.843 4.362 . . . . 0.0 109.413 175.114 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 127' ' ' LYS . . . . . 0.41 ' HB3' ' OD2' ' C' ' 125' ' ' ASP . 6.0 ttpm? 174.98 -25.5 0.0 OUTLIER 'General case' 0 C--O 1.248 0.981 0 C-N-CA 125.98 1.712 . . . . 0.0 108.378 -173.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 128' ' ' SER . . . . . 0.558 ' OG ' HG21 ' C' ' 158' ' ' VAL . 73.8 m -68.17 126.62 92.87 Favored Pre-proline 0 N--CA 1.446 -0.658 0 CA-C-N 120.961 1.709 . . . . 0.0 112.024 175.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 129' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' C' ' 128' ' ' SER . 17.0 Cg_endo -56.72 -58.39 0.98 Allowed 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 123.836 3.024 . . . . 0.0 114.091 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 13.3 pt -73.21 66.32 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 C-N-CA 123.977 0.911 . . . . 0.0 112.308 171.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 131' ' ' ALA . . . . . 0.474 ' O ' ' HB ' ' B' 1121 ' ' ILE . . . -72.93 150.9 42.15 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 122.695 1.236 . . . . 0.0 113.409 -170.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.03 53.36 27.0 Favored Glycine 0 CA--C 1.497 -1.045 0 CA-C-N 111.846 -2.434 . . . . 0.0 107.679 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 133' ' ' MET . . . . . 0.48 ' O ' ' HB3' ' C' ' 123' ' ' GLN . 24.5 tpp -76.62 129.45 79.4 Favored Pre-proline 0 C--O 1.252 1.185 0 CA-C-N 118.69 1.245 . . . . 0.0 110.715 175.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 134' ' ' PRO . . . . . 0.503 ' HG2' ' NE2' ' C' ' 69' ' ' HIS . 40.7 Cg_endo -62.78 101.93 0.28 Allowed 'Trans proline' 0 CA--C 1.517 -0.341 0 C-N-CA 125.22 3.947 . . . . 0.0 110.981 171.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 15.7 t -120.45 93.88 2.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 1 N-CA-C 99.743 -4.169 . . . . 0.0 99.743 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 5.1 mt -73.5 78.84 1.43 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.451 0.643 . . . . 0.0 112.196 -170.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 48.68 5.05 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 120.243 3.423 . . . . 0.0 120.243 -167.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 138' ' ' VAL . . . . . 0.445 HG21 HG11 ' C' ' 109' ' ' VAL 0.291 13.0 p -76.22 61.9 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 117.457 2.391 . . . . 0.0 117.457 -173.435 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 17.7 p90 -158.2 178.18 10.47 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 123.302 0.641 . . . . 0.0 109.618 171.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 140' ' ' LYS . . . . . . . . . . . . . 15.4 pttm 63.58 -58.16 0.19 Allowed 'General case' 0 C--O 1.247 0.933 0 C-N-CA 126.998 2.119 . . . . 0.0 115.681 174.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -90.76 174.28 7.56 Favored 'General case' 0 C--N 1.319 -0.746 0 O-C-N 120.122 -1.611 . . . . 0.0 107.346 170.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 63.97 157.51 0.08 Allowed 'General case' 0 C--N 1.345 0.383 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 172.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 143' ' ' ASN . . . . . 0.46 ' O ' ' HA ' ' C' ' 108' ' ' THR . 52.9 m-80 -80.14 79.26 6.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 125.167 2.413 . . . . 0.0 107.075 177.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 144' ' ' VAL . . . . . 0.647 ' HB ' HG23 ' C' ' 168' ' ' THR . 58.0 t -85.94 83.97 2.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 O-C-N 118.598 -2.564 . . . . 0.0 106.001 -178.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 145' ' ' ILE . . . . . 0.721 HG23 ' HB2' ' C' ' 171' ' ' LEU . 35.7 mt -88.91 109.18 19.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 125.501 2.572 . . . . 0.0 114.823 -170.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 146' ' ' VAL . . . . . . . . . . . . . 27.1 t -96.05 108.58 21.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 109.444 -3.525 . . . . 0.0 107.142 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 147' ' ' PHE . . . . . 0.558 ' O ' ' HA2' ' C' ' 113' ' ' GLY . 13.8 m-85 -70.75 102.58 2.35 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 148' ' ' LYS . . . . . 0.771 ' HE3' ' HA ' ' C' ' 151' ' ' MET . 60.2 tttp -131.28 133.77 45.73 Favored 'General case' 0 C--O 1.244 0.797 0 O-C-N 118.973 -2.329 . . . . 0.0 109.512 -175.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 149' ' ' ARG . . . . . 0.564 ' HE ' ' HB2' ' C' ' 174' ' ' ASP . 19.6 ttm105 -83.37 -92.27 0.07 Allowed 'General case' 0 C--O 1.24 0.565 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 176.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 1.1 m -70.52 131.46 44.05 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 121.475 1.943 . . . . 0.0 111.056 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 151' ' ' MET . . . . . 0.771 ' HA ' ' HE3' ' C' ' 148' ' ' LYS . 5.7 tpt -75.58 92.86 2.96 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-O 125.823 2.725 . . . . 0.0 107.713 163.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -133.85 152.02 51.73 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-N 110.698 -2.956 . . . . 0.0 109.523 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 153' ' ' THR . . . . . 0.436 ' HA ' ' HA3' ' C' ' 157' ' ' GLY . 73.2 m -63.46 150.63 43.27 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.396 172.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -111.2 -81.32 1.17 Allowed Glycine 0 C--N 1.353 1.527 0 N-CA-C 107.27 -2.332 . . . . 0.0 107.27 165.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -112.0 -46.94 3.17 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 117.51 -1.233 . . . . 0.0 110.876 174.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 156' ' ' ALA . . . . . 0.408 ' HB1' HG22 ' C' ' 158' ' ' VAL . . . -87.4 -69.18 0.7 Allowed 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 119.614 1.097 . . . . 0.0 110.403 166.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 157' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' C' ' 153' ' ' THR . . . 50.15 32.08 20.17 Favored Glycine 0 C--N 1.34 0.802 0 N-CA-C 115.218 0.847 . . . . 0.0 115.218 -170.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 158' ' ' VAL . . . . . 0.558 HG21 ' OG ' ' C' ' 128' ' ' SER . 14.6 m -92.26 153.69 3.26 Favored 'Isoleucine or valine' 0 C--O 1.253 1.27 0 C-N-CA 123.41 0.684 . . . . 0.0 110.007 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -41.76 112.05 0.29 Allowed 'General case' 0 C--N 1.345 0.394 0 N-CA-C 119.75 3.241 . . . . 0.0 119.75 176.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 160' ' ' ASN . . . . . 0.416 ' HB2' ' HG2' ' C' ' 120' ' ' PRO . 3.4 p30 -157.54 159.09 30.9 Favored Pre-proline 0 N--CA 1.436 -1.147 0 O-C-N 120.486 -1.384 . . . . 0.0 110.511 -173.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -38.38 -57.7 0.82 Allowed 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 124.43 3.42 . . . . 0.0 112.313 176.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 162' ' ' LEU . . . . . 0.523 HD21 HG23 ' C' ' 118' ' ' VAL . 9.6 mp -43.21 -31.34 0.59 Allowed 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 163' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -88.11 -59.57 2.2 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.729 -1.578 . . . . 0.0 107.382 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -91.44 -10.16 42.0 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 116.579 2.066 . . . . 0.0 116.579 -161.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -84.58 152.62 23.74 Favored 'General case' 0 C--O 1.243 0.713 0 O-C-N 120.614 -1.304 . . . . 0.0 110.639 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -78.87 -34.08 45.25 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-N 112.936 -1.938 . . . . 0.0 110.546 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 40.3 p-10 -91.78 -63.16 1.28 Allowed 'General case' 0 C--O 1.245 0.848 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 168' ' ' THR . . . . . 0.647 HG23 ' HB ' ' C' ' 144' ' ' VAL . 25.1 m -72.02 102.71 3.03 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 117.091 -3.505 . . . . 0.0 103.328 172.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -143.72 136.57 27.42 Favored 'General case' 0 CA--C 1.5 -0.962 0 O-C-N 119.254 -2.154 . . . . 0.0 112.692 -153.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 170' ' ' MET . . . . . 0.52 ' SD ' ' HD3' ' C' ' 148' ' ' LYS . 76.9 mtm -67.12 119.97 12.93 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 120.526 -1.359 . . . . 0.0 109.057 163.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 171' ' ' LEU . . . . . 0.721 ' HB2' HG23 ' C' ' 145' ' ' ILE . 13.1 tp -83.92 144.65 29.06 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 168.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -89.22 99.27 12.3 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 -167.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . 154.79 166.4 15.18 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-O 124.466 2.148 . . . . 0.0 109.992 167.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 174' ' ' ASP . . . . . 0.564 ' HB2' ' HE ' ' C' ' 149' ' ' ARG . 21.2 t70 -50.68 153.13 1.78 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.339 1.856 . . . . 0.0 112.648 169.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.9 -56.0 27.16 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.886 1.274 . . . . 0.0 110.842 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 176' ' ' LYS . . . . . 0.448 ' HD3' ' HG2' ' C' ' 49' ' ' PRO . 0.1 OUTLIER -69.81 -39.88 76.25 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 121.272 -0.892 . . . . 0.0 112.61 -177.131 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 177' ' ' ALA . . . . . . . . . . . . . . . -53.73 -44.1 69.62 Favored 'General case' 0 C--O 1.256 1.395 0 C-N-CA 125.249 1.42 . . . . 0.0 110.642 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 20.0 m -74.81 -42.5 57.93 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.0 -1.454 . . . . 0.0 111.456 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 179' ' ' VAL . . . . . 0.449 ' HA ' HG12 ' C' ' 182' ' ' ILE . 58.1 t -62.17 -55.01 26.82 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-N 120.223 1.374 . . . . 0.0 112.335 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -55.87 -39.12 71.05 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 119.001 -2.312 . . . . 0.0 112.672 178.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -54.46 -56.59 17.23 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 117.479 -1.248 . . . . 0.0 111.172 169.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 182' ' ' ILE . . . . . 0.449 HG12 ' HA ' ' C' ' 179' ' ' VAL . 19.0 pt -66.59 -32.32 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 121.058 1.754 . . . . 0.0 114.583 -175.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 183' ' ' LEU . . . . . 0.643 ' HA ' HD13 ' C' ' 53' ' ' ILE . 59.3 tp -48.27 -57.14 6.38 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 127.002 2.121 . . . . 0.0 112.581 170.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 184' ' ' LYS . . . . . 0.459 ' HA ' ' HD2' ' C' ' 184' ' ' LYS . 24.6 tptt -75.15 -33.48 61.52 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 124.83 1.332 . . . . 0.0 112.648 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -67.78 -91.61 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.17 0 O-C-N 126.502 2.376 . . . . 0.0 110.972 177.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 186' ' ' LEU . . . . . 0.431 HD12 ' HG2' ' C' ' 56' ' ' LYS 0.25 8.8 mt . . . . . 0 C--O 1.205 -1.255 0 O-C-N 120.237 -1.54 . . . . 0.0 112.505 -152.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 42.2 t-80 . . . . . 0 N--CA 1.419 -1.999 0 N-CA-C 105.757 -1.942 . . . . 65.739999999999995 105.757 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -69.1 66.88 0.5 Allowed Glycine 0 C--N 1.348 1.236 0 C-N-CA 123.937 0.779 . . . . 48.659999999999997 111.622 172.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -80.18 124.86 29.16 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 120.002 -0.679 . . . . 44.560000000000002 109.388 173.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1003 ' ' ILE . . . . . 0.84 HG12 ' HB ' ' A' 1068 ' ' ILE . 34.8 mt -95.65 132.71 39.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 120.554 -1.341 . . . . 34.859999999999999 107.668 171.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -105.11 127.76 9.17 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 108.438 -1.865 . . . . 30.75 108.438 172.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.496 HG23 ' HB3' ' A' 1017 ' ' ALA . 23.0 mm -103.01 108.63 59.29 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 102.903 -2.999 . . . . 32.210000000000001 102.903 172.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -74.09 167.09 28.03 Favored 'Trans proline' 0 N--CA 1.439 -1.68 0 C-N-CA 122.474 2.116 . . . . 32.979999999999997 111.104 171.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1007 ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -84.77 131.78 34.51 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 102.438 -3.171 . . . . 47.979999999999997 102.438 157.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1008 ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -55.81 134.19 51.58 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 117.157 2.28 . . . . 34.700000000000003 117.157 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 21.7 mtp-105 -101.18 0.44 37.61 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 113.658 -1.61 . . . . 53.369999999999997 110.796 -171.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 52.7 tp -70.57 136.78 49.53 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 106.314 -1.735 . . . . 45.07 106.314 169.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1011 ' ' THR . . . . . . . . . . . . . 45.8 m -57.27 135.39 56.46 Favored 'General case' 0 C--O 1.243 0.76 0 O-C-N 120.461 -1.4 . . . . 40.359999999999999 109.81 -174.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 84.3 m-20 60.34 27.92 17.51 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 116.412 2.004 . . . . 40.609999999999999 116.412 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -87.74 147.93 24.97 Favored 'General case' 0 CA--C 1.504 -0.811 0 C-N-CA 118.616 -1.234 . . . . 33.759999999999998 109.797 -174.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1014 ' ' THR . . . . . 0.488 HG22 ' HB3' ' A' 1320 ' ' PRO . 1.9 m -117.06 -14.41 10.58 Favored 'General case' 0 C--O 1.257 1.483 0 CA-C-O 124.199 1.952 . . . . 27.890000000000001 110.81 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1015 ' ' ARG . . . . . 0.612 ' HG3' ' HA2' ' A' 1317 ' ' GLY . 12.9 mtm180 -66.12 125.76 26.52 Favored 'General case' 0 C--O 1.214 -0.775 0 O-C-N 119.468 -2.02 . . . . 29.02 114.054 173.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1016 ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' 1043 ' ' ALA . 3.4 t -120.52 150.81 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 106.721 -1.585 . . . . 28.129999999999999 106.721 165.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1017 ' ' ALA . . . . . 0.496 ' HB3' HG23 ' A' 1005 ' ' ILE . . . -59.19 -53.24 60.6 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 117.311 2.337 . . . . 26.870000000000001 117.311 -177.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -129.52 143.05 50.67 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 112.22 0.452 . . . . 26.77 112.22 -167.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1019 ' ' THR . . . . . 0.577 HG23 ' HB2' ' A' 1324 ' ' SER . 1.0 OUTLIER -80.5 174.06 6.74 Favored Pre-proline 0 C--N 1.347 0.475 0 C-N-CA 124.176 0.99 . . . . 27.02 110.887 168.178 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 1020 ' ' PRO . . . . . 0.482 ' HB3' ' HB2' ' A' 1053 ' ' ALA . 0.1 OUTLIER -54.18 -34.96 81.03 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.33 2.687 . . . . 30.57 111.455 168.457 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -55.24 -58.02 9.4 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 114.055 -1.43 . . . . 47.810000000000002 112.461 173.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1022 ' ' THR . . . . . . . . . . . . 0.281 3.2 p -77.13 -21.75 53.67 Favored 'General case' 0 C--N 1.309 -1.17 0 O-C-N 120.312 -1.492 . . . . 30.77 112.892 -174.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1023 ' ' VAL . . . . . 0.569 HG22 HG11 ' A' 1033 ' ' VAL . 8.9 t -56.89 -51.29 69.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 N-CA-C 108.594 -0.891 . . . . 33.590000000000003 108.594 164.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -65.8 -32.73 74.42 Favored 'General case' 0 C--N 1.35 0.617 0 N-CA-C 114.284 1.216 . . . . 53.289999999999999 114.284 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1025 ' ' GLN . . . . . 0.662 ' HB3' HG11 ' A' 1332 ' ' VAL . 68.2 mt-30 -58.2 -49.71 76.09 Favored 'General case' 0 C--O 1.254 1.336 0 CA-C-N 119.286 0.948 . . . . 46.920000000000002 112.125 170.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1026 ' ' LEU . . . . . 0.583 ' HA ' HD12 ' A' 1029 ' ' LEU . 14.9 mt -59.75 -38.56 82.1 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 118.527 -2.608 . . . . 37.170000000000002 114.006 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 29.3 tp -59.11 -40.59 85.83 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 113.848 -1.523 . . . . 44.439999999999998 112.404 171.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1028 ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' 1028 ' ' LYS . 12.3 mmmm -70.06 -26.29 63.94 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 119.526 -1.983 . . . . 52.579999999999998 113.71 173.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1029 ' ' LEU . . . . . 0.583 HD12 ' HA ' ' A' 1026 ' ' LEU . 25.5 mt -65.51 -39.88 92.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.609 0.719 . . . . 45.689999999999998 111.019 162.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 115.55 15.57 7.47 Favored Glycine 0 CA--C 1.503 -0.715 0 O-C-N 118.708 -2.495 . . . . 42.090000000000003 110.97 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -92.82 147.54 22.77 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 107.299 -1.371 . . . . 40.719999999999999 107.299 168.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1032 ' ' THR . . . . . . . . . . . . . 10.7 m -99.17 118.68 36.44 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.056 -1.091 . . . . 37.770000000000003 108.056 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1033 ' ' VAL . . . . . 0.569 HG11 HG22 ' A' 1023 ' ' VAL . 3.5 t -89.49 141.96 13.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.134 -0.939 . . . . 33.539999999999999 111.761 -171.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -128.58 135.01 48.77 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 104.445 -2.428 . . . . 31.68 104.445 176.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1035 ' ' VAL . . . . . . . . . . . . . 69.2 t -119.71 144.5 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 O-C-N 120.697 -1.252 . . . . 31.52 110.718 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1036 ' ' GLU . . . . . 0.462 ' HB2' HG11 ' A' 1063 ' ' VAL . 35.5 tt0 -72.7 130.2 39.99 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 124.155 0.91 . . . . 41.039999999999999 110.778 176.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1037 ' ' SER . . . . . . . . . . . . . 65.9 m -60.1 111.2 1.42 Allowed 'General case' 0 C--O 1.262 1.714 0 N-CA-C 107.293 -1.373 . . . . 31.829999999999998 107.293 165.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 130.01 -32.41 3.14 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.573 -0.822 . . . . 29.359999999999999 111.127 -172.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -64.08 -39.89 95.06 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 117.594 -1.193 . . . . 27.780000000000001 108.842 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -52.08 -47.32 55.03 Favored Glycine 0 C--N 1.359 1.809 0 CA-C-O 121.817 0.676 . . . . 28.91 112.325 169.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -66.24 -32.37 73.75 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.771 -0.841 . . . . 51.18 110.894 -175.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1042 ' ' LEU . . . . . . . . . . . . . 14.0 mt -69.93 -56.3 7.39 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 121.16 1.8 . . . . 29.91 111.528 165.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1043 ' ' ALA . . . . . 0.497 ' HA ' ' HB2' ' A' 1320 ' ' PRO . . . -69.9 12.31 0.22 Allowed 'General case' 0 CA--C 1.556 1.2 0 O-C-N 119.334 -2.104 . . . . 28.539999999999999 112.636 -174.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1044 ' ' SER . . . . . . . . . . . . . 13.8 m 63.27 59.54 1.26 Allowed 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 124.454 2.073 . . . . 33.060000000000002 113.863 174.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1045 ' ' PHE . . . . . 0.406 ' HA ' ' HB1' ' B' 1277 ' ' ALA . 97.0 m-85 -150.58 167.15 28.1 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 111.088 -2.778 . . . . 30.289999999999999 106.52 177.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -97.25 151.34 19.95 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 106.624 -1.621 . . . . 48.619999999999997 106.624 151.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -59.84 -16.99 32.97 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 114.199 1.185 . . . . 36.740000000000002 114.199 -166.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 20.5 pttm -55.05 -26.36 36.99 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 121.987 2.176 . . . . 43.729999999999997 110.91 174.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -52.73 -53.63 45.17 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 120.661 -1.274 . . . . 32.810000000000002 112.576 171.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1050 ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -63.09 -33.38 75.32 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.909 -1.041 . . . . 31.859999999999999 113.657 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 25.5 t -63.98 -41.27 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 O-C-N 121.157 -0.964 . . . . 33.219999999999999 109.313 173.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -64.41 -41.99 96.31 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 122.468 1.128 . . . . 50.829999999999998 111.586 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1053 ' ' ALA . . . . . 0.482 ' HB2' ' HB3' ' A' 1020 ' ' PRO . . . -60.48 -52.76 63.82 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 114.333 -1.303 . . . . 33.119999999999997 110.64 170.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 122.34 75.03 0.33 Allowed Glycine 0 CA--C 1.489 -1.555 0 CA-C-O 123.523 1.624 . . . . 35.829999999999998 110.057 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -143.26 127.22 17.34 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 105.809 -1.923 . . . . 34.82 105.809 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -62.28 118.57 7.61 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.283 -0.871 . . . . 49.049999999999997 111.718 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1057 ' ' ILE . . . . . . . . . . . . . 17.3 mm -89.04 124.62 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 124.538 2.113 . . . . 38.530000000000001 110.953 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1058 ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' 1036 ' ' GLU . 0.0 OUTLIER -144.11 158.55 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 110.877 -2.874 . . . . 42.109999999999999 107.133 -175.612 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -88.22 167.8 13.28 Favored 'General case' 0 C--O 1.259 1.592 0 N-CA-C 113.925 1.083 . . . . 58.0 113.925 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . -31.05 -69.66 0.09 OUTLIER Glycine 0 C--N 1.348 1.235 0 N-CA-C 117.881 1.912 . . . . 52.119999999999997 117.881 -172.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 5.4 m120 -64.37 -33.59 76.2 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 119.912 1.856 . . . . 54.75 112.215 -169.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1062 ' ' SER . . . . . . . . . . . . . 16.8 m -73.91 -40.33 63.22 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 125.972 2.045 . . . . 50.340000000000003 108.009 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1063 ' ' VAL . . . . . 0.462 HG11 ' HB2' ' A' 1036 ' ' GLU . 4.1 p -68.88 -25.95 31.46 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 CA-C-N 122.473 2.397 . . . . 41.460000000000001 111.415 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1064 ' ' TRP . . . . . 0.402 ' HA ' HD11 ' A' 1069 ' ' ILE . 11.4 m95 -66.21 -29.56 69.84 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-N 115.303 -0.862 . . . . 39.32 112.837 173.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -81.31 79.44 7.94 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 123.423 1.582 . . . . 55.380000000000003 107.847 -174.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1066 ' ' SER . . . . . . . . . . . . . 58.7 m -147.63 161.4 41.23 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 120.553 -1.342 . . . . 41.869999999999997 108.771 -171.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1067 ' ' GLU . . . . . 0.591 ' HB3' HD12 ' A' 1068 ' ' ILE . 1.5 tp10 -69.62 -44.78 69.98 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 107.009 -1.478 . . . . 53.200000000000003 107.009 -176.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1068 ' ' ILE . . . . . 0.84 ' HB ' HG12 ' A' 1003 ' ' ILE . 5.2 mp -120.12 139.44 47.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 103.605 -2.739 . . . . 41.899999999999999 103.605 -178.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1069 ' ' ILE . . . . . 0.437 HD13 ' HA ' ' A' 1069 ' ' ILE . 9.7 mm -119.23 126.9 75.76 Favored 'Isoleucine or valine' 0 C--O 1.248 0.989 0 N-CA-C 105.292 -2.114 . . . . 38.729999999999997 105.292 170.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1070 ' ' LEU . . . . . 0.629 HD22 HD22 ' A' 1331 ' ' LEU . 71.4 mt -107.47 87.6 2.54 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-O 122.618 1.199 . . . . 32.439999999999998 108.233 173.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1071 ' ' LYS . . . . . . . . . . . . . 3.5 mmmt -87.32 171.67 10.43 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 107.429 -1.322 . . . . 34.649999999999999 107.429 166.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1072 ' ' VAL . . . . . 0.579 HG21 ' HB3' ' A' 1015 ' ' ARG . 8.0 t -100.37 -78.05 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 107.043 -1.465 . . . . 31.32 107.043 171.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -101.26 140.25 35.82 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 108.038 -1.097 . . . . 33.939999999999998 108.038 -161.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . 27.58 103.03 0.01 OUTLIER Pre-proline 0 C--O 1.247 0.933 0 N-CA-C 119.642 3.201 . . . . 38.039999999999999 119.642 171.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1075 ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' 1093 ' ' ILE . 34.8 Cg_exo -76.39 91.04 1.15 Allowed 'Trans proline' 0 CA--C 1.509 -0.77 0 C-N-CA 123.678 2.918 . . . . 42.68 109.541 177.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 65.3 mt -71.36 -179.75 2.59 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 114.425 -1.262 . . . . 46.740000000000002 114.043 -171.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.38 -35.6 67.9 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 116.907 2.188 . . . . 58.609999999999999 116.907 -173.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 16.4 t70 -67.2 -47.86 69.63 Favored 'General case' 0 C--O 1.26 1.641 0 C-N-CA 124.094 0.957 . . . . 59.200000000000003 110.388 173.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1079 ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -53.78 -37.35 63.36 Favored 'General case' 0 C--N 1.363 1.173 0 CA-C-O 117.108 -1.425 . . . . 50.630000000000003 110.753 174.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1080 ' ' ILE . . . . . 0.531 ' HA ' HD23 ' A' 1083 ' ' LEU . 55.6 mt -54.4 -47.3 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-N 119.433 1.015 . . . . 51.479999999999997 111.05 175.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -64.19 -33.77 76.56 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.54 1.518 . . . . 50.280000000000001 109.843 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 34.6 mt -71.82 -27.04 62.64 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 114.044 1.127 . . . . 50.210000000000001 114.044 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1083 ' ' LEU . . . . . 0.531 HD23 ' HA ' ' A' 1080 ' ' ILE . 0.4 OUTLIER -55.44 133.15 49.79 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-O 122.656 1.217 . . . . 49.060000000000002 112.205 174.428 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.02 125.96 62.65 Favored Pre-proline 0 N--CA 1.472 0.627 0 N-CA-C 101.431 -3.544 . . . . 51.079999999999998 101.431 177.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.87 63.92 0.03 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 124.165 3.243 . . . . 49.729999999999997 119.729 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1086 ' ' GLY . . . . . 0.537 ' H ' HG12 ' A' 1110 ' ' VAL . . . 173.44 -33.68 0.11 Allowed Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.111 -1.195 . . . . 47.710000000000001 110.111 -168.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1087 ' ' THR . . . . . . . . . . . . . 98.0 m -44.78 130.13 7.12 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 117.42 2.378 . . . . 45.469999999999999 117.42 -175.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1088 ' ' THR . . . . . . . . . . . . . 1.4 m -75.53 93.82 3.06 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 113.427 -1.715 . . . . 42.039999999999999 108.956 170.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1089 ' ' LEU . . . . . 0.483 HD22 HD21 ' A' 1083 ' ' LEU . 54.8 tp -90.67 92.83 9.0 Favored 'General case' 0 C--N 1.348 0.535 0 O-C-N 121.074 -1.016 . . . . 38.060000000000002 108.398 -178.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 89.1 t -99.65 99.03 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 102.559 -3.126 . . . . 37.399999999999999 102.559 -172.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1091 ' ' SER . . . . . . . . . . . . . 49.5 m -152.55 166.31 32.44 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 115.51 1.67 . . . . 36.159999999999997 115.51 -174.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1092 ' ' PHE . . . . . 0.417 ' HE1' ' HB1' ' A' 1129 ' ' ALA . 2.6 m-85 -66.42 88.28 0.13 Allowed 'General case' 0 C--O 1.253 1.274 0 O-C-N 118.118 -2.864 . . . . 38.939999999999998 109.822 161.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1093 ' ' ILE . . . . . 0.478 HG12 ' HA ' ' A' 1114 ' ' ALA . 26.2 mm -81.22 -32.43 12.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 122.935 1.35 . . . . 42.170000000000002 110.981 -173.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1094 ' ' TRP . . . . . 0.431 ' HH2' HD21 ' A' 1257 ' ' LEU . 77.8 m95 60.5 48.53 1.71 Allowed Pre-proline 0 C--O 1.243 0.717 0 C-N-CA 125.306 1.442 . . . . 46.509999999999998 111.108 -170.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1095 ' ' PRO . . . . . 0.441 ' HD3' ' HB ' ' A' 1093 ' ' ILE . 92.2 Cg_endo -54.68 -44.62 47.91 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 124.691 3.594 . . . . 49.759999999999998 116.468 -169.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1096 ' ' ALA . . . . . 0.589 ' HB3' ' NE2' ' A' 1097 ' ' GLN . . . -67.41 -33.98 76.29 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 122.529 1.157 . . . . 52.619999999999997 110.724 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1097 ' ' GLN . . . . . 0.589 ' NE2' ' HB3' ' A' 1096 ' ' ALA . 7.8 mp0 -85.2 -5.39 59.33 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 114.67 -1.15 . . . . 60.740000000000002 110.657 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1098 ' ' ASN . . . . . 0.515 ' HB3' ' HB3' ' A' 1101 ' ' LEU . 18.5 m120 -130.94 64.17 72.83 Favored Pre-proline 0 N--CA 1.439 -0.975 0 N-CA-C 114.082 1.141 . . . . 58.189999999999998 114.082 -178.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -61.11 -42.97 32.28 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.759 2.973 . . . . 54.590000000000003 114.8 -174.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 52.2 mp0 -70.5 -42.73 70.96 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.541 -0.911 . . . . 63.280000000000001 108.541 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1101 ' ' LEU . . . . . 0.515 ' HB3' ' HB3' ' A' 1098 ' ' ASN . 5.7 tp -57.39 -41.14 79.67 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.859 0.864 . . . . 54.75 109.309 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1102 ' ' MET . . . . . . . . . . . . . 43.1 mmm -54.93 -48.37 73.22 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 120.599 -1.313 . . . . 52.649999999999999 112.46 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -61.25 -41.11 96.35 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 124.305 1.042 . . . . 66.260000000000005 110.479 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -74.23 -34.1 63.57 Favored 'General case' 0 C--O 1.247 0.946 0 O-C-N 121.373 -0.829 . . . . 63.729999999999997 110.947 -177.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 79.3 mt -68.51 -35.13 77.06 Favored 'General case' 0 C--O 1.253 1.281 0 CA-C-O 121.218 0.532 . . . . 54.68 109.826 174.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -66.83 -40.37 87.97 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.59 0.709 . . . . 53.640000000000001 112.089 172.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -54.91 -33.13 61.76 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.607 2.363 . . . . 67.239999999999995 113.981 168.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1108 ' ' ARG . . . . . 0.4 ' O ' HG13 ' A' 1110 ' ' VAL . 0.1 OUTLIER -78.43 10.49 3.08 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 116.121 -1.895 . . . . 65.760000000000005 115.343 172.141 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 20.1 t30 53.65 21.17 2.47 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 123.136 2.698 . . . . 58.710000000000001 114.602 173.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1110 ' ' VAL . . . . . 0.688 HG23 HG23 ' A' 1112 ' ' VAL . 17.9 m -90.67 175.08 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 O-C-N 118.412 -2.68 . . . . 46.630000000000003 114.422 -173.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1111 ' ' THR . . . . . . . . . . . . . 22.0 m -112.91 90.84 3.45 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 106.788 -1.56 . . . . 44.130000000000003 106.788 174.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1112 ' ' VAL . . . . . 0.688 HG23 HG23 ' A' 1110 ' ' VAL . 53.0 t -92.14 109.98 22.15 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 CA-C-N 114.653 -1.158 . . . . 40.439999999999998 110.446 -173.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1113 ' ' MET . . . . . 0.507 ' HB3' HG12 ' A' 1358 ' ' VAL . 64.6 mtp -102.93 115.52 30.76 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 112.326 -2.216 . . . . 50.759999999999998 110.489 178.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1114 ' ' ALA . . . . . 0.478 ' HA ' HG12 ' A' 1093 ' ' ILE . . . -94.44 94.08 8.03 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-N 114.435 -1.257 . . . . 35.640000000000001 109.511 -169.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1115 ' ' MET . . . . . 0.541 ' SD ' HD22 ' A' 1334 ' ' LEU . 83.8 mmm -57.7 -34.49 69.5 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 114.951 1.463 . . . . 38.740000000000002 114.951 -178.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1116 ' ' ASP . . . . . 0.424 ' OD2' ' HD2' ' A' 1095 ' ' PRO . 9.4 p-10 -61.04 -38.69 87.04 Favored 'General case' 0 C--O 1.219 -0.525 0 O-C-N 121.694 -0.629 . . . . 40.140000000000001 110.533 174.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1117 ' ' SER . . . . . . . . . . . . . 47.9 m -94.68 27.88 2.87 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 115.058 1.503 . . . . 44.789999999999999 115.058 -176.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1118 ' ' VAL . . . . . . . . . . . . . 10.3 m -53.96 140.93 50.25 Favored Pre-proline 0 N--CA 1.436 -1.166 0 CA-C-O 117.49 -1.243 . . . . 43.75 112.072 168.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -66.2 125.71 14.51 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.373 2.716 . . . . 48.93 109.684 168.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 34.1 mmm-85 -78.81 20.31 0.47 Allowed 'General case' 0 C--O 1.249 1.041 0 N-CA-C 117.082 2.253 . . . . 62.899999999999999 117.082 -160.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 38.9 pt -72.86 167.99 2.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 114.538 1.31 . . . . 57.719999999999999 114.538 -167.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1122 ' ' SER . . . . . . . . . . . . . 6.7 m -59.73 -40.35 87.76 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-O 118.066 -0.968 . . . . 57.259999999999998 111.435 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -56.45 -36.23 68.79 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 121.443 1.929 . . . . 62.899999999999999 108.762 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -73.75 -24.34 59.86 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-O 116.114 -1.898 . . . . 49.829999999999998 115.68 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1125 ' ' GLN . . . . . . . . . . . . 0.28 73.4 mm-40 -46.8 -21.96 0.26 Allowed 'General case' 0 N--CA 1.474 0.754 1 N-CA-C 122.352 4.205 . . . . 52.369999999999997 122.352 -169.238 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A 1126 ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' B' 1160 ' ' ALA . 11.9 p -85.07 -35.66 21.7 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 119.199 -2.188 . . . . 42.43 109.971 172.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1127 ' ' LEU . . . . . 0.663 HD21 HD22 ' A' 1337 ' ' LEU . 4.6 mp -84.78 -18.79 33.92 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.354 1.862 . . . . 43.740000000000002 112.394 176.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 53.8 t0 -70.97 92.92 0.95 Allowed 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 125.423 2.535 . . . . 43.210000000000001 110.645 -173.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1129 ' ' ALA . . . . . 0.417 ' HB1' ' HE1' ' A' 1092 ' ' PHE . . . -61.02 -40.98 95.67 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 110.024 -3.262 . . . . 35.740000000000002 111.273 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.95 -28.63 68.44 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 119.043 -2.286 . . . . 38.090000000000003 108.737 -176.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1131 ' ' SER . . . . . . . . . . . . . 75.0 m -67.71 -55.47 13.05 Favored 'General case' 0 CA--C 1.501 -0.935 0 O-C-N 119.487 -2.008 . . . . 36.909999999999997 113.634 172.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1132 ' ' SER . . . . . 0.477 ' HB3' ' HB3' ' A' 1326 ' ' LEU . 4.1 m -61.99 -43.85 97.97 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 119.159 0.89 . . . . 35.789999999999999 113.203 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1133 ' ' MET . . . . . 0.422 ' HA ' HD12 ' A' 1136 ' ' ILE . 13.9 mmm -59.58 -41.56 90.5 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 121.005 1.73 . . . . 30.809999999999999 109.897 176.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1134 ' ' ALA . . . . . 0.652 ' HB1' ' HB2' ' A' 1176 ' ' ALA . . . -63.45 -45.03 92.74 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 123.636 0.775 . . . . 28.879999999999999 109.157 175.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1135 ' ' ASN . . . . . 0.646 ' HB2' HG12 ' A' 1175 ' ' VAL . 16.3 t-20 -59.5 -46.25 89.37 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.532 0.682 . . . . 40.759999999999998 112.237 -177.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1136 ' ' ILE . . . . . 0.682 HD13 ' HA ' ' A' 1323 ' ' SER . 68.6 mt -55.9 -50.3 69.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 125.038 1.335 . . . . 31.539999999999999 109.4 173.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1137 ' ' ALA . . . . . 0.423 ' HB2' ' HG3' ' A' 1316 ' ' PRO . . . -62.55 -32.1 73.01 Favored 'General case' 0 C--N 1.344 0.352 0 N-CA-C 114.193 1.183 . . . . 29.870000000000001 114.193 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -70.53 -44.02 59.33 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 118.914 0.779 . . . . 28.73 112.412 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 20.1 t80 -66.76 -48.5 68.89 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 107.321 -1.363 . . . . 30.390000000000001 107.321 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1140 ' ' ARG . . . . . 0.548 ' HE ' ' HG2' ' A' 1144 ' ' GLU . 6.0 tpt180 -65.19 -26.22 68.05 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 113.577 0.954 . . . . 26.09 113.577 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1141 ' ' ALA . . . . . 0.69 ' HB2' HD21 ' A' 1284 ' ' LEU . . . -58.84 -53.5 57.68 Favored 'General case' 0 C--N 1.359 1.0 0 CA-C-O 118.521 -0.752 . . . . 27.100000000000001 109.914 167.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 32.8 mm -51.8 -43.58 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 O-C-N 124.238 0.961 . . . . 28.48 112.219 172.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 76.2 t -58.98 -62.02 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-N 119.655 1.116 . . . . 23.07 112.687 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1144 ' ' GLU . . . . . 0.548 ' HG2' ' HE ' ' A' 1140 ' ' ARG . 5.6 mm-40 -64.73 -29.1 70.07 Favored 'General case' 0 C--N 1.343 0.296 0 O-C-N 120.703 -1.248 . . . . 33.399999999999999 111.551 -177.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1145 ' ' ALA . . . . . 0.591 ' HA ' HG11 ' A' 1280 ' ' VAL . . . -54.61 -63.95 0.99 Allowed 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 117.784 -1.103 . . . . 24.219999999999999 112.601 165.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -54.35 -23.17 14.35 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 122.881 1.324 . . . . 24.890000000000001 113.908 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -66.63 -69.03 0.33 Allowed 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 120.272 -1.518 . . . . 26.73 110.13 169.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1148 ' ' GLU . . . . . 0.721 ' HB2' HD11 ' A' 1310 ' ' ILE . 68.5 mm-40 -73.72 -9.46 58.68 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 116.684 2.105 . . . . 39.960000000000001 116.684 -176.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1149 ' ' PHE . . . . . 0.471 ' HB2' ' O ' ' A' 1145 ' ' ALA . 1.2 t80 -59.99 146.18 43.53 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 123.272 1.511 . . . . 25.870000000000001 111.678 176.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1150 ' ' GLY . . . . . . . . . . . . . . . -80.63 -38.92 15.42 Favored Glycine 0 N--CA 1.429 -1.816 0 CA-C-N 113.374 -1.739 . . . . 19.280000000000001 109.617 173.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1151 ' ' ARG . . . . . 0.92 ' HA ' ' HB2' ' B' 1322 ' ' GLN . 66.6 mtm-85 -113.84 -170.83 1.78 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 121.157 2.479 . . . . 39.899999999999999 114.774 -163.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1152 ' ' PHE . . . . . 0.575 ' CD1' ' HG2' ' B' 1322 ' ' GLN . 2.8 m-85 -83.49 152.97 24.67 Favored 'General case' 0 C--O 1.218 -0.557 0 O-C-N 119.369 -2.082 . . . . 29.440000000000001 113.637 165.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1153 ' ' PHE . . . . . 0.419 ' CZ ' HG13 ' A' 1251 ' ' ILE . 10.0 m-85 -70.64 -49.75 44.2 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 113.232 -1.804 . . . . 32.600000000000001 107.509 157.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1154 ' ' THR . . . . . . . . . . . . . 1.8 m -76.47 115.57 16.34 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 125.236 1.414 . . . . 34.640000000000001 113.955 -165.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -69.47 109.06 2.71 Favored Glycine 0 C--O 1.251 1.176 0 N-CA-C 105.838 -2.905 . . . . 37.140000000000001 105.838 170.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -158.9 -169.3 2.64 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-N 117.918 0.859 . . . . 40.57 111.99 -174.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1157 ' ' ILE . . . . . 0.708 HD13 ' HB3' ' C' ' 95' ' ' GLU . 1.5 tp -137.02 142.51 37.43 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.201 0 C-N-CA 125.426 1.49 . . . . 44.609999999999999 111.298 -171.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1158 ' ' THR . . . . . 0.404 ' HB ' ' H ' ' A' 1159 ' ' ALA . 1.1 p -93.33 -143.07 0.22 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.592 -1.64 . . . . 40.700000000000003 109.03 177.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1159 ' ' ALA . . . . . 0.404 ' H ' ' HB ' ' A' 1158 ' ' THR . . . -103.09 -14.3 16.47 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.423 -1.695 . . . . 40.25 106.423 157.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1160 ' ' ALA . . . . . 0.433 ' HB2' ' ND2' ' B' 1330 ' ' ASN . . . -76.09 -58.19 3.43 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 117.198 2.296 . . . . 38.469999999999999 117.198 173.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . 175.92 -165.27 35.81 Favored Glycine 0 CA--C 1.505 -0.556 0 CA-C-O 124.58 2.211 . . . . 37.609999999999999 111.128 -170.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 8.8 tttp -64.29 130.55 44.29 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 111.823 -2.188 . . . . 48.899999999999999 111.327 -171.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1163 ' ' VAL . . . . . 0.608 HG22 HD21 ' B' 1326 ' ' LEU . 10.1 t -100.93 114.69 65.82 Favored Pre-proline 0 N--CA 1.426 -1.661 0 CA-C-N 110.589 -3.005 . . . . 36.520000000000003 104.401 165.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1164 ' ' PRO . . . . . 0.46 ' HD2' HE22 ' B' 1322 ' ' GLN . 74.9 Cg_endo -73.05 137.05 25.81 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 124.938 3.759 . . . . 35.079999999999998 116.827 -176.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1165 ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.01 138.69 28.71 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 124.003 3.135 . . . . 35.329999999999998 116.312 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -79.63 141.96 36.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.212 -1.358 . . . . 34.689999999999998 112.415 174.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1167 ' ' LYS . . . . . 0.552 ' HB2' ' HA ' ' A' 1249 ' ' VAL . 44.1 mttp -100.69 115.14 29.55 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 113.099 -1.864 . . . . 45.359999999999999 107.298 172.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 49.9 t -100.38 91.38 2.15 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 CA-C-N 113.745 -1.571 . . . . 31.710000000000001 108.825 -174.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1169 ' ' MET . . . . . 0.426 ' HA ' ' O ' ' A' 1192 ' ' ARG . 35.3 ttp -76.85 92.67 3.64 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 123.749 1.737 . . . . 42.280000000000001 111.981 175.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 42.9 t -81.0 110.58 16.64 Favored 'Isoleucine or valine' 0 C--O 1.246 0.919 0 O-C-N 121.104 -0.997 . . . . 30.510000000000002 110.067 174.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 66.7 mt -88.84 119.63 36.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.194 -1.039 . . . . 31.870000000000001 108.194 176.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 87.13 87.23 1.09 Allowed Glycine 0 CA--C 1.537 1.428 0 N-CA-C 106.74 -2.544 . . . . 34.539999999999999 106.74 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1173 ' ' ALA . . . . . 0.531 ' HA ' ' HA3' ' A' 1177 ' ' GLY . . . -85.05 57.3 4.37 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 120.45 2.125 . . . . 32.509999999999998 111.612 176.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1174 ' ' GLY . . . . . 0.458 ' HA2' HH22 ' A' 1197 ' ' ARG . . . -73.85 -163.73 9.27 Favored Glycine 0 N--CA 1.448 -0.566 0 O-C-N 120.224 -1.548 . . . . 29.899999999999999 109.439 160.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1175 ' ' VAL . . . . . 0.646 HG12 ' HB2' ' A' 1135 ' ' ASN . 3.5 t -62.25 -36.6 75.34 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 O-C-N 121.342 -1.093 . . . . 33.109999999999999 111.651 -174.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1176 ' ' ALA . . . . . 0.652 ' HB2' ' HB1' ' A' 1134 ' ' ALA . . . -61.48 -43.12 99.42 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 113.626 -1.625 . . . . 28.100000000000001 114.363 170.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1177 ' ' GLY . . . . . 0.531 ' HA3' ' HA ' ' A' 1173 ' ' ALA . . . -63.32 -49.94 66.59 Favored Glycine 0 C--N 1.312 -0.752 0 N-CA-C 110.322 -1.111 . . . . 28.539999999999999 110.322 176.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1178 ' ' LEU . . . . . 0.58 ' HB3' ' SD ' ' A' 1207 ' ' MET . 70.3 mt -53.56 -51.6 62.4 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 117.693 0.747 . . . . 31.219999999999999 112.387 177.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -51.21 -46.34 62.19 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.624 0.972 . . . . 28.98 113.624 175.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -60.13 -41.1 91.96 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 116.664 2.098 . . . . 27.829999999999998 116.664 174.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1181 ' ' ILE . . . . . 0.471 HD12 ' HA ' ' A' 1178 ' ' LEU . 55.8 mt -64.8 -50.47 75.19 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 O-C-N 121.252 -0.905 . . . . 30.25 109.678 174.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -50.36 -54.77 18.79 Favored Glycine 0 C--O 1.241 0.579 0 O-C-N 120.54 -1.35 . . . . 29.59 110.289 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -59.88 -48.0 83.46 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 116.243 1.942 . . . . 30.289999999999999 116.243 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1184 ' ' ALA . . . . . 0.485 ' HB1' ' HB3' ' A' 1189 ' ' ALA . . . -68.77 -43.94 74.73 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.478 -1.389 . . . . 30.469999999999999 112.537 178.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -60.18 -43.68 95.67 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 118.482 0.583 . . . . 42.409999999999997 110.906 176.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1186 ' ' SER . . . . . 0.557 ' O ' ' HB3' ' B' 1186 ' ' SER . 72.4 m -48.65 -40.44 27.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.719 1.007 . . . . 39.380000000000003 113.719 164.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 27.2 mt -91.02 24.83 2.65 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 115.154 1.538 . . . . 36.18 115.154 173.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 69.38 8.9 60.19 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 115.535 0.974 . . . . 33.780000000000001 115.535 171.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1189 ' ' ALA . . . . . 0.485 ' HB3' ' HB1' ' A' 1184 ' ' ALA . . . -79.24 145.14 33.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 118.464 1.132 . . . . 33.93 111.63 -177.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 9.5 mt -77.26 88.48 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 105.459 -2.052 . . . . 38.740000000000002 105.459 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 14.0 t -76.21 125.59 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 106.828 -1.545 . . . . 33.090000000000003 106.828 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1192 ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' 1169 ' ' MET . 94.0 mtt180 -114.39 99.75 7.81 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 105.045 -2.206 . . . . 38.920000000000002 105.045 170.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1193 ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' A' 1211 ' ' PHE . . . -92.91 144.35 25.35 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 119.58 -1.95 . . . . 35.32 111.126 177.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1194 ' ' PHE . . . . . 0.646 ' HB2' HD12 ' A' 1212 ' ' LEU . 37.6 t80 -128.76 157.05 42.5 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 106.904 -1.517 . . . . 39.350000000000001 106.904 171.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1195 ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' 1173 ' ' ALA . 8.0 t0 -163.1 148.09 11.49 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 105.983 -1.858 . . . . 40.460000000000001 105.983 168.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1196 ' ' THR . . . . . . . . . . . . . 1.1 p -77.38 -12.52 59.96 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 114.837 -1.074 . . . . 45.939999999999998 112.359 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1197 ' ' ARG . . . . . 0.458 HH22 ' HA2' ' A' 1174 ' ' GLY . 74.4 mtm180 -94.06 115.74 65.56 Favored Pre-proline 0 N--CA 1.471 0.619 0 N-CA-C 106.146 -1.798 . . . . 56.020000000000003 106.146 172.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1198 ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -66.3 -14.71 45.38 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.305 2.003 . . . . 51.270000000000003 114.473 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -51.72 -54.41 28.7 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 122.328 1.061 . . . . 59.100000000000001 112.342 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 26.8 m -71.95 -2.91 3.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 115.402 1.63 . . . . 51.060000000000002 115.402 -169.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 83.5 tttt -55.36 -36.08 65.94 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 119.758 -1.839 . . . . 57.380000000000003 113.074 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -71.38 -37.73 71.58 Favored 'General case' 0 C--O 1.247 0.922 0 CA-C-N 118.552 0.614 . . . . 62.409999999999997 110.657 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -62.84 -37.79 88.2 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 120.739 -1.226 . . . . 57.780000000000001 112.719 171.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1204 ' ' VAL . . . . . 0.675 HG13 ' HB3' ' A' 1209 ' ' ALA . 25.4 t -58.49 -47.48 88.15 Favored 'Isoleucine or valine' 0 C--N 1.343 0.297 0 O-C-N 124.006 0.816 . . . . 46.380000000000003 111.432 173.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -54.09 -54.08 44.36 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.261 1.024 . . . . 50.700000000000003 113.349 171.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1206 ' ' SER . . . . . . . . . . . . . 6.4 m -62.32 -42.85 99.72 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 113.323 0.86 . . . . 49.979999999999997 113.323 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1207 ' ' MET . . . . . 0.58 ' SD ' ' HB3' ' A' 1178 ' ' LEU . 29.0 mtp -77.49 -13.31 59.95 Favored 'General case' 0 C--O 1.242 0.692 0 O-C-N 117.635 -3.166 . . . . 52.990000000000002 114.107 176.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 97.7 59.64 0.96 Allowed Glycine 0 N--CA 1.429 -1.802 0 O-C-N 121.427 -0.795 . . . . 47.659999999999997 111.151 166.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1209 ' ' ALA . . . . . 0.675 ' HB3' HG13 ' A' 1204 ' ' VAL . . . -134.26 151.22 51.17 Favored 'General case' 0 N--CA 1.457 -0.087 0 O-C-N 120.126 -1.808 . . . . 44.770000000000003 110.709 167.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1210 ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' 1192 ' ' ARG . 56.3 tt0 -76.15 145.73 39.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.805 -1.089 . . . . 47.640000000000001 108.763 165.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1211 ' ' PHE . . . . . 0.582 ' HD1' HG11 ' A' 1204 ' ' VAL . 9.9 t80 -93.97 160.06 14.89 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 106.947 -1.501 . . . . 45.659999999999997 106.947 -178.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1212 ' ' LEU . . . . . 0.646 HD12 ' HB2' ' A' 1194 ' ' PHE . 77.7 mt -85.39 106.4 16.73 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 104.613 -2.366 . . . . 46.060000000000002 104.613 171.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -73.86 97.59 2.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.314 -0.857 . . . . 60.219999999999999 108.793 168.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1214 ' ' LEU . . . . . 0.663 HD11 ' HA ' ' A' 1238 ' ' GLU . 5.8 tp -65.68 101.54 0.64 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.472 -0.785 . . . . 57.25 109.653 -174.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 19.7 t0 -61.08 100.27 0.11 Allowed 'General case' 0 C--O 1.247 0.925 0 O-C-N 124.73 1.268 . . . . 64.430000000000007 108.483 175.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 3.8 t80 . . . . . 0 C--O 1.212 -0.91 0 N-CA-C 102.556 -3.127 . . . . 66.900000000000006 102.556 179.27 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 2.8 p30 . . . . . 0 N--CA 1.426 -1.659 0 CA-C-O 118.765 -0.636 . . . . 39.090000000000003 109.569 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -57.35 -36.88 78.5 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 118.66 0.663 . . . . 39.32 113.565 -170.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 76.8 t80 -74.96 -43.67 52.74 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-O 116.901 -1.523 . . . . 39.299999999999997 110.287 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -58.14 -46.35 85.79 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.617 1.099 . . . . 36.299999999999997 111.057 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -62.54 -72.09 0.14 Allowed 'General case' 0 C--N 1.346 0.415 0 CA-C-O 117.332 -1.318 . . . . 37.380000000000003 110.326 173.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1229 ' ' VAL . . . . . 0.425 ' HA ' ' CD2' ' A' 1234 ' ' PHE . . . -50.18 -42.04 19.47 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 N-CA-C 117.468 2.396 . . . . 39.109999999999999 117.468 -172.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1230 ' ' MET . . . . . . . . . . . . . 21.0 mmt -86.23 1.67 49.94 Favored 'General case' 0 C--O 1.25 1.13 0 O-C-N 119.532 -1.98 . . . . 49.590000000000003 113.576 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1231 ' ' SER . . . . . . . . . . . . . 22.1 p -76.89 143.38 39.66 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 122.304 2.32 . . . . 43.68 110.52 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -49.08 -47.57 44.92 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.727 1.211 . . . . 55.57 112.961 -174.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -60.18 -34.04 73.05 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 113.333 0.864 . . . . 44.939999999999998 113.333 172.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1234 ' ' PHE . . . . . 0.425 ' CD2' ' HA ' ' A' 1229 ' ' VAL . 13.3 t80 -69.27 -49.82 52.57 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 120.46 1.482 . . . . 42.039999999999999 108.363 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1235 ' ' ILE . . . . . 0.522 ' O ' ' HG2' ' A' 1239 ' ' MET . 63.4 mt -58.53 -34.6 51.52 Favored 'Isoleucine or valine' 0 C--O 1.249 1.048 0 CA-C-O 118.325 -0.845 . . . . 46.280000000000001 110.026 175.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 25.8 tttm -62.43 -44.75 95.69 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 119.743 1.156 . . . . 47.869999999999997 108.844 171.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -60.71 -33.77 73.38 Favored 'General case' 0 C--O 1.25 1.104 0 O-C-N 119.406 -2.059 . . . . 41.609999999999999 112.755 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1238 ' ' GLU . . . . . 0.663 ' HA ' HD11 ' A' 1214 ' ' LEU . 38.3 mt-10 -56.22 -51.65 67.29 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 113.723 1.008 . . . . 50.649999999999999 113.723 168.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1239 ' ' MET . . . . . 0.522 ' HG2' ' O ' ' A' 1235 ' ' ILE . 8.3 mmm -57.55 -47.94 80.66 Favored 'General case' 0 C--O 1.247 0.972 0 C-N-CA 124.745 1.218 . . . . 48.869999999999997 112.018 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -58.65 -45.31 89.6 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 118.864 -0.588 . . . . 54.799999999999997 112.239 177.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 1.8 mm? -63.07 -39.09 93.68 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 123.672 0.608 . . . . 43.210000000000001 112.453 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -70.64 -39.34 73.73 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 125.492 1.745 . . . . 38.659999999999997 111.214 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -63.68 -29.49 70.71 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.131 1.772 . . . . 37.920000000000002 114.743 174.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -74.22 -66.23 0.75 Allowed 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 113.593 -1.64 . . . . 37.280000000000001 110.236 173.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -52.79 -31.48 38.82 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 124.699 1.2 . . . . 43.07 113.619 -177.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1246 ' ' ALA . . . . . 0.424 ' HB1' ' HG2' ' A' 1275 ' ' MET . . . -45.17 -46.2 11.97 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.814 1.246 . . . . 38.299999999999997 111.857 175.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1247 ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' 1276 ' ' LYS . 22.4 mtmm -68.77 -18.21 64.16 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 116.682 -1.628 . . . . 47.600000000000001 113.736 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -113.29 -30.45 6.92 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 121.322 1.874 . . . . 45.420000000000002 114.896 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1249 ' ' VAL . . . . . 0.552 ' HA ' ' HB2' ' A' 1167 ' ' LYS . 29.6 m -78.41 172.35 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 O-C-N 119.954 -1.716 . . . . 36.259999999999998 113.607 -171.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1250 ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' 1279 ' ' SER . 4.5 m-20 -121.71 -64.48 1.21 Allowed 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 124.018 0.824 . . . . 33.039999999999999 111.245 -173.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1251 ' ' ILE . . . . . 0.484 HD12 ' HB1' ' A' 1145 ' ' ALA . 32.3 mm -102.73 123.21 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 N-CA-C 105.629 -1.989 . . . . 31.399999999999999 105.629 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1252 ' ' ILE . . . . . . . . . . . . . 68.3 mt -105.85 136.41 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 O-C-N 124.764 1.29 . . . . 29.420000000000002 107.83 165.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 65.3 t -119.23 108.69 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.008 0 N-CA-C 104.265 -2.495 . . . . 30.370000000000001 104.265 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1254 ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.53 95.82 7.56 Favored 'General case' 0 C--O 1.246 0.89 0 CA-C-N 121.828 2.103 . . . . 35.719999999999999 113.188 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1255 ' ' THR . . . . . 0.535 HG22 HD12 ' A' 1284 ' ' LEU . 36.6 p -72.23 -24.99 61.47 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 119.068 2.988 . . . . 36.0 119.068 -166.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1256 ' ' ALA . . . . . . . . . . . . . . . -70.89 74.81 0.62 Allowed 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 117.571 2.434 . . . . 40.93 117.571 -151.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1257 ' ' LEU . . . . . 0.431 HD21 ' HH2' ' A' 1094 ' ' TRP . 14.0 tp -71.0 81.34 0.66 Allowed 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.174 -1.417 . . . . 47.82 107.174 167.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 42.6 mm -75.44 134.95 72.71 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 104.503 -2.406 . . . . 52.700000000000003 104.503 173.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -64.86 92.93 0.21 Allowed 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 122.131 1.887 . . . . 54.130000000000003 114.545 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1260 ' ' GLY . . . . . 0.437 ' HA2' ' HG3' ' A' 1097 ' ' GLN . . . 93.99 -57.51 2.14 Favored Glycine 0 CA--C 1.489 -1.57 0 O-C-N 121.019 -1.051 . . . . 54.619999999999997 112.754 166.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1261 ' ' LYS . . . . . 0.431 ' HB2' ' HE3' ' A' 1261 ' ' LYS . 25.1 mtmt -63.86 119.93 59.1 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-O 116.567 -1.682 . . . . 55.740000000000002 107.652 174.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -56.98 134.44 64.53 Favored 'Trans proline' 0 CA--C 1.5 -1.201 0 C-N-CA 124.131 3.221 . . . . 51.149999999999999 114.808 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -62.15 122.96 76.04 Favored Pre-proline 0 C--O 1.247 0.943 0 O-C-N 124.089 0.868 . . . . 46.060000000000002 110.114 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -49.59 133.26 31.87 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 125.282 3.988 . . . . 41.079999999999998 117.494 -175.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -68.07 83.36 0.22 Allowed 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.528 -0.916 . . . . 47.420000000000002 108.528 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1266 ' ' LEU . . . . . 0.456 ' HA ' ' SD ' ' A' 1239 ' ' MET . 98.0 mt -79.42 -41.55 27.4 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 122.476 1.131 . . . . 39.219999999999999 108.473 -177.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 21.7 mt -97.65 91.41 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 N-CA-C 105.013 -2.217 . . . . 42.5 105.013 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1268 ' ' THR . . . . . 0.601 ' HA ' ' HG3' ' A' 1293 ' ' GLU . 39.6 p -71.16 153.84 42.18 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.589 -1.187 . . . . 37.840000000000003 111.233 176.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1269 ' ' ARG . . . . . 0.549 ' HG3' ' HB2' ' A' 1293 ' ' GLU . 95.5 mtt180 -47.0 -50.67 18.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.354 1.462 . . . . 54.799999999999997 111.136 -177.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -42.89 -46.6 5.39 Favored 'General case' 0 C--O 1.249 1.072 0 C-N-CA 124.123 0.969 . . . . 54.359999999999999 113.426 172.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1271 ' ' MET . . . . . . . . . . . . . 26.6 mtt -68.83 -41.57 78.38 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 118.522 -0.752 . . . . 39.520000000000003 112.213 177.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1272 ' ' VAL . . . . . 0.489 HG21 ' SG ' ' A' 1292 ' ' CYS . 14.0 t -65.95 -44.53 92.37 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 CA-C-O 121.811 0.815 . . . . 38.25 109.648 -177.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -54.66 -44.02 72.91 Favored 'General case' 0 C--O 1.249 1.048 0 C-N-CA 124.466 1.107 . . . . 40.770000000000003 111.793 171.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1274 ' ' SER . . . . . . . . . . . . . 76.5 p -86.05 12.3 9.83 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 119.579 -1.951 . . . . 36.579999999999998 115.072 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1275 ' ' MET . . . . . 0.442 ' HG3' ' HA ' ' A' 1272 ' ' VAL . 52.5 mtp -70.89 160.92 31.93 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 123.521 1.629 . . . . 36.75 110.751 173.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1276 ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' 1247 ' ' LYS . 36.4 ttpt -68.61 134.84 50.53 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 112.999 -1.909 . . . . 46.109999999999999 106.007 166.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1277 ' ' ALA . . . . . . . . . . . . . . . -85.69 -179.73 6.92 Favored 'General case' 0 C--O 1.261 1.677 0 N-CA-C 115.365 1.617 . . . . 33.520000000000003 115.365 -176.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 67.99 29.05 73.3 Favored Glycine 0 CA--C 1.538 1.515 0 O-C-N 120.315 -1.491 . . . . 31.27 109.697 -171.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1279 ' ' SER . . . . . 0.525 ' HB3' ' O ' ' A' 1250 ' ' ASP . 16.7 m -131.33 173.21 11.29 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.692 1.746 . . . . 32.950000000000003 110.833 -165.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1280 ' ' VAL . . . . . 0.591 HG11 ' HA ' ' A' 1145 ' ' ALA . 98.5 t -140.77 144.63 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 O-C-N 118.623 -2.548 . . . . 27.43 104.783 -169.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1281 ' ' ILE . . . . . . . . . . . . . 59.9 mt -119.08 107.18 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.646 0 N-CA-C 101.813 -3.402 . . . . 30.300000000000001 101.813 164.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -92.36 104.2 15.39 Favored 'Isoleucine or valine' 0 C--O 1.25 1.102 0 N-CA-C 107.019 -1.474 . . . . 28.629999999999999 107.019 171.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 7.1 t70 -96.03 115.38 27.34 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 111.472 -2.604 . . . . 36.270000000000003 109.396 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1284 ' ' LEU . . . . . 0.69 HD21 ' HB2' ' A' 1141 ' ' ALA . 90.9 mt -87.2 -29.19 21.91 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 112.237 -2.256 . . . . 38.57 111.194 -173.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -62.51 -41.67 98.99 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 114.711 -1.132 . . . . 37.560000000000002 111.293 176.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . 22.84 -75.97 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 120.158 3.392 . . . . 40.329999999999998 120.158 174.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -59.92 -42.73 94.57 Favored 'General case' 0 C--O 1.212 -0.875 0 CA-C-O 121.538 0.685 . . . . 56.850000000000001 111.44 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 29.9 t30 -85.34 65.29 9.12 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.094 -1.412 . . . . 45.859999999999999 108.633 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 84.34 -57.61 5.02 Favored Glycine 0 C--O 1.246 0.858 0 O-C-N 120.63 -1.294 . . . . 40.310000000000002 113.682 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 84.51 128.62 1.75 Allowed Glycine 0 CA--C 1.538 1.515 0 N-CA-C 108.531 -1.828 . . . . 38.890000000000001 108.531 -171.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1291 ' ' ASN . . . . . . . . . . . . . 33.8 m120 -74.9 -21.6 59.12 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.743 1.771 . . . . 37.229999999999997 111.545 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1292 ' ' CYS . . . . . 0.489 ' SG ' HG21 ' A' 1272 ' ' VAL . 18.0 t -96.79 148.24 23.11 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.417 -1.427 . . . . 36.5 107.851 175.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1293 ' ' GLU . . . . . 0.601 ' HG3' ' HA ' ' A' 1268 ' ' THR . 27.7 mt-10 -75.13 -39.98 60.12 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 120.556 -1.34 . . . . 43.32 111.94 177.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -65.11 -5.88 7.69 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 115.291 1.589 . . . . 41.32 115.291 174.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1295 ' ' THR . . . . . 0.417 ' OG1' ' HB3' ' A' 1292 ' ' CYS . 86.5 m -58.48 115.18 2.84 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 119.262 0.937 . . . . 35.299999999999997 110.514 174.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 35.4 t -96.77 114.28 64.27 Favored Pre-proline 0 C--N 1.313 -1.004 0 N-CA-C 102.126 -3.287 . . . . 34.840000000000003 102.126 169.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -54.34 118.01 4.56 Favored 'Trans proline' 0 CA--C 1.537 0.669 1 C-N-CA 125.787 4.324 . . . . 33.509999999999998 111.757 176.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 99.19 -16.06 59.65 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 113.144 -1.844 . . . . 32.189999999999998 113.063 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -135.61 162.91 31.38 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 125.009 2.338 . . . . 34.880000000000003 115.541 -167.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1300 ' ' ILE . . . . . 0.799 HG12 HG12 ' A' 1310 ' ' ILE . 50.1 mt -75.58 140.59 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 CA-C-N 112.635 -2.075 . . . . 32.289999999999999 110.539 167.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 54.5 t80 -129.38 120.02 24.86 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 120.113 1.324 . . . . 37.25 108.194 159.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1302 ' ' THR . . . . . . . . . . . . . 34.8 m -79.14 125.05 28.92 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 104.198 -2.519 . . . . 35.560000000000002 104.198 172.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1303 ' ' THR . . . . . . . . . . . . . 76.3 p -85.45 -179.63 6.97 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 113.991 1.108 . . . . 36.399999999999999 113.991 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -67.84 -34.36 76.56 Favored 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 120.131 -1.606 . . . . 52.32 112.33 -170.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -74.99 -41.85 58.69 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.09 -1.414 . . . . 40.039999999999999 111.001 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 118.38 57.72 0.28 Allowed Glycine 0 N--CA 1.448 -0.512 0 O-C-N 119.901 -1.749 . . . . 36.960000000000001 109.207 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1307 ' ' VAL . . . . . . . . . . . . . 73.5 t -124.32 121.12 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.898 0 N-CA-C 101.336 -3.579 . . . . 33.399999999999999 101.336 174.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1308 ' ' LYS . . . . . 0.431 ' HB2' HG22 ' A' 1280 ' ' VAL . 20.8 mmtp -81.81 95.68 7.37 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 113.4 -1.727 . . . . 42.909999999999997 108.507 -178.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 44.0 t -85.83 93.44 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 O-C-N 121.125 -0.984 . . . . 32.289999999999999 108.618 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1310 ' ' ILE . . . . . 0.799 HG12 HG12 ' A' 1300 ' ' ILE . 61.0 mt -89.52 95.33 5.36 Favored 'Isoleucine or valine' 0 C--O 1.256 1.419 0 N-CA-C 105.378 -2.082 . . . . 30.989999999999998 105.378 -174.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1311 ' ' GLY . . . . . 0.417 ' HA3' HG23 ' A' 1295 ' ' THR . . . -91.37 56.75 3.15 Favored Glycine 0 N--CA 1.431 -1.641 0 N-CA-C 110.877 -0.889 . . . . 28.949999999999999 110.877 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1312 ' ' TYR . . . . . 0.613 ' HB2' ' HG ' ' A' 1315 ' ' LEU . 9.1 m-30 -78.66 113.54 16.81 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 120.602 2.201 . . . . 31.690000000000001 116.808 -170.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1313 ' ' THR . . . . . . . . . . . . . 4.6 p -71.8 -40.38 69.23 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 125.889 2.757 . . . . 34.170000000000002 109.841 -177.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -69.81 -0.88 7.91 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 110.072 -3.24 . . . . 36.859999999999999 115.802 176.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1315 ' ' LEU . . . . . 0.613 ' HG ' ' HB2' ' A' 1312 ' ' TYR 0.342 42.0 mt -40.65 -45.9 5.9 Favored Pre-proline 0 N--CA 1.487 1.404 0 N-CA-C 121.241 3.793 . . . . 34.850000000000001 121.241 178.512 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 1316 ' ' PRO . . . . . 0.509 ' HB2' ' HD3' ' A' 1015 ' ' ARG . 46.1 Cg_exo -56.55 -47.26 24.71 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.916 2.411 . . . . 29.149999999999999 110.529 168.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1317 ' ' GLY . . . . . 0.612 ' HA2' ' HG3' ' A' 1015 ' ' ARG . . . -61.18 -44.81 97.65 Favored Glycine 0 CA--C 1.483 -1.936 0 CA-C-O 118.545 -1.142 . . . . 27.289999999999999 111.578 -177.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1318 ' ' ARG . . . . . 0.447 ' HB3' ' NH2' ' A' 1140 ' ' ARG . 59.2 mtt-85 -60.21 -15.72 26.96 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 114.204 1.187 . . . . 41.490000000000002 114.204 174.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1319 ' ' LEU . . . . . 0.525 HD22 ' HB2' ' A' 1140 ' ' ARG . 14.0 tp -110.95 73.2 0.86 Allowed Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-N 123.258 2.754 . . . . 27.609999999999999 103.779 166.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1320 ' ' PRO . . . . . 0.615 ' HD2' ' HA2' ' B' 1150 ' ' GLY . 57.4 Cg_endo -59.06 -58.93 0.53 Allowed 'Trans proline' 0 C--O 1.213 -0.769 0 C-N-CA 122.85 2.367 . . . . 25.940000000000001 112.567 -159.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1321 ' ' THR . . . . . 0.414 ' H ' ' HG2' ' A' 1320 ' ' PRO . 3.1 m -58.37 -30.37 66.73 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 112.797 -2.001 . . . . 25.010000000000002 113.704 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1322 ' ' GLN . . . . . 0.409 HE22 HG13 ' B' 1163 ' ' VAL . 55.0 tp60 -74.23 -39.87 62.79 Favored 'General case' 0 N--CA 1.436 -1.166 0 O-C-N 120.589 -1.32 . . . . 29.390000000000001 110.852 176.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1323 ' ' SER . . . . . 0.682 ' HA ' HD13 ' A' 1136 ' ' ILE . 75.0 m -52.7 -53.18 51.1 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 118.912 0.778 . . . . 26.469999999999999 109.449 168.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1324 ' ' SER . . . . . 0.577 ' HB2' HG23 ' A' 1019 ' ' THR . 2.3 m -61.0 -26.12 67.37 Favored 'General case' 0 C--O 1.25 1.121 0 N-CA-C 114.335 1.235 . . . . 27.780000000000001 114.335 175.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -75.37 -63.15 1.34 Allowed 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 117.739 -3.1 . . . . 37.530000000000001 110.228 172.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1326 ' ' LEU . . . . . 0.562 ' HB2' HD11 ' A' 1136 ' ' ILE . 18.2 mt -77.98 -47.86 17.56 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 116.973 -1.489 . . . . 35.710000000000001 114.357 -170.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1327 ' ' TYR . . . . . . . . . . . . . 32.1 t80 -59.29 -47.29 85.92 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 105.877 -1.897 . . . . 31.59 105.877 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1328 ' ' GLY . . . . . 0.698 ' HA2' HD12 ' A' 1331 ' ' LEU . . . -40.78 -54.47 3.51 Favored Glycine 0 CA--C 1.544 1.847 0 C-N-CA 124.668 1.127 . . . . 28.0 114.778 167.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1329 ' ' THR . . . . . . . . . . . . . 28.7 m -67.57 -35.09 78.36 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-O 118.106 -0.95 . . . . 32.149999999999999 109.449 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1330 ' ' ASN . . . . . . . . . . . . . 29.2 m120 -62.47 -43.86 97.79 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.579 -0.897 . . . . 34.359999999999999 108.579 174.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1331 ' ' LEU . . . . . 0.698 HD12 ' HA2' ' A' 1328 ' ' GLY . 13.9 mt -59.96 -50.16 74.84 Favored 'General case' 0 C--O 1.213 -0.85 0 N-CA-C 109.367 -0.605 . . . . 33.369999999999997 109.367 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1332 ' ' VAL . . . . . 0.662 HG11 ' HB3' ' A' 1025 ' ' GLN . 44.2 t -57.04 -40.17 71.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 118.787 -0.625 . . . . 35.270000000000003 111.181 174.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -68.02 -38.45 82.6 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 114.602 1.334 . . . . 37.659999999999997 114.602 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1334 ' ' LEU . . . . . 0.541 HD22 ' SD ' ' A' 1115 ' ' MET . 28.9 tp -60.97 -48.61 81.03 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 106.916 -1.513 . . . . 40.270000000000003 106.916 172.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1335 ' ' LEU . . . . . 0.552 ' HA ' ' HB2' ' A' 1338 ' ' LEU . 20.5 mt -71.66 -4.4 27.11 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 114.625 1.343 . . . . 42.5 114.625 175.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1336 ' ' LYS . . . . . 0.515 ' HE3' HG12 ' A' 1332 ' ' VAL . 82.6 mttt -74.76 -44.91 47.22 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 121.81 2.095 . . . . 47.810000000000002 111.774 161.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1337 ' ' LEU . . . . . 0.663 HD22 HD21 ' A' 1127 ' ' LEU . 10.4 mp -62.34 -41.02 98.24 Favored 'General case' 0 C--O 1.216 -0.672 0 C-N-CA 118.555 -1.258 . . . . 49.270000000000003 113.8 172.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1338 ' ' LEU . . . . . 0.552 ' HB2' ' HA ' ' A' 1335 ' ' LEU . 10.2 mp -70.8 -69.38 0.37 Allowed 'General case' 0 CA--C 1.51 -0.577 0 O-C-N 124.695 1.247 . . . . 50.539999999999999 113.054 172.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1339 ' ' CYS . . . . . 0.603 ' SG ' ' HA2' ' A' 1344 ' ' GLY . 51.5 t -69.71 91.95 0.64 Allowed 'General case' 0 CA--C 1.503 -0.835 0 O-C-N 118.396 -2.69 . . . . 53.670000000000002 107.571 172.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 72.3 tttt -83.73 -62.56 1.54 Allowed 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.121 -1.4 . . . . 63.380000000000003 108.052 -165.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -74.88 -35.89 62.3 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 124.82 1.248 . . . . 70.950000000000003 114.057 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1342 ' ' LYS . . . . . 0.428 ' HE2' ' HA ' ' A' 1029 ' ' LEU . 3.2 mtpm? 62.22 83.88 0.15 Allowed 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 125.537 1.535 . . . . 65.25 113.484 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1343 ' ' ASP . . . . . . . . . . . . 0.38 0.0 OUTLIER 79.21 -78.81 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.775 2 O-C-N 112.593 -6.317 . . . . 64.530000000000001 120.076 -19.347 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A 1344 ' ' GLY . . . . . 0.603 ' HA2' ' SG ' ' A' 1339 ' ' CYS . . . 104.39 10.73 33.02 Favored Glycine 0 CA--C 1.545 1.94 0 O-C-N 117.536 -3.227 . . . . 59.719999999999999 111.379 178.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1345 ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' 1339 ' ' CYS . 19.0 t30 -72.05 131.24 42.61 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 121.932 2.866 . . . . 64.090000000000003 112.929 174.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1346 ' ' ILE . . . . . . . . . . . . . 24.7 mt -80.31 79.37 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.83 0 O-C-N 120.018 -1.676 . . . . 58.82 109.063 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1347 ' ' THR . . . . . . . . . . . . . 5.3 m -66.43 85.14 0.1 Allowed 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 119.867 -1.771 . . . . 54.960000000000001 112.711 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1348 ' ' VAL . . . . . 0.518 ' HB ' ' NH2' ' A' 1362 ' ' ARG . 40.0 t -76.46 98.45 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.803 0 N-CA-C 102.915 -2.994 . . . . 55.640000000000001 102.915 178.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 8.8 t70 -87.79 138.14 31.72 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 111.735 -2.484 . . . . 61.450000000000003 110.906 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1350 ' ' PHE . . . . . 0.401 ' CE1' ' HD2' ' A' 1362 ' ' ARG . 1.0 OUTLIER -107.22 -12.39 15.38 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 117.443 2.386 . . . . 58.630000000000003 117.443 176.692 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -76.69 -48.47 18.83 Favored 'General case' 0 C--O 1.246 0.904 0 O-C-N 124.028 0.83 . . . . 62.060000000000002 109.073 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 28.0 t70 -65.76 118.82 10.17 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.651 0.738 . . . . 54.07 112.621 -177.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 13.7 m -40.23 -46.87 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 116.545 2.054 . . . . 50.68 116.545 173.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1354 ' ' VAL . . . . . 0.547 ' O ' HG23 ' A' 1358 ' ' VAL . 3.2 m -77.52 -41.85 29.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 122.426 2.375 . . . . 47.68 109.466 -174.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1355 ' ' ILE . . . . . 0.47 HD11 HD23 ' A' 1337 ' ' LEU . 53.6 mt -64.88 -49.26 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.718 1.207 . . . . 48.490000000000002 107.791 -177.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1356 ' ' ARG . . . . . 0.41 ' NH1' ' O ' ' A' 1367 ' ' THR . 31.4 tpt85 -57.17 -40.71 77.86 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.592 0.96 . . . . 48.270000000000003 113.592 172.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -67.21 -39.9 92.37 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-O 119.018 -0.879 . . . . 43.530000000000001 111.911 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1358 ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' 1354 ' ' VAL . 5.7 t -72.06 -36.35 56.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 CA-C-O 118.554 -0.736 . . . . 45.119999999999997 112.045 176.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1359 ' ' THR . . . . . . . . . . . . . 10.6 m -72.21 88.11 1.13 Allowed 'General case' 0 C--O 1.239 0.517 0 CA-C-N 119.346 0.975 . . . . 42.939999999999998 110.492 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 27.6 m -85.77 -25.51 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 CA-C-O 121.794 0.807 . . . . 43.259999999999998 110.805 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1361 ' ' ILE . . . . . 0.618 ' HB ' ' HB ' ' A' 1112 ' ' VAL . 23.6 mm -126.55 114.71 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 117.705 -3.122 . . . . 45.659999999999997 102.994 171.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1362 ' ' ARG . . . . . 0.518 ' NH2' ' HB ' ' A' 1348 ' ' VAL . 32.4 ttt180 -100.93 104.13 15.31 Favored 'General case' 0 CA--C 1.511 -0.548 0 O-C-N 119.128 -2.232 . . . . 61.340000000000003 109.687 172.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 54.54 51.34 14.21 Favored 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 114.367 1.247 . . . . 49.759999999999998 114.367 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 86.68 -27.38 5.89 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 117.997 1.959 . . . . 50.0 117.997 -175.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -81.71 138.19 35.28 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 120.476 2.138 . . . . 56.920000000000002 106.951 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1366 ' ' ILE . . . . . . . . . . . . . 70.1 mt -83.18 100.56 6.89 Favored 'Isoleucine or valine' 0 C--O 1.263 1.811 0 N-CA-C 105.629 -1.989 . . . . 52.780000000000001 105.629 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1367 ' ' THR . . . . . 0.41 ' O ' ' NH1' ' A' 1356 ' ' ARG . 10.8 p -94.22 10.92 32.05 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 112.916 -1.947 . . . . 49.439999999999998 110.199 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 6.7 t90 -73.32 150.39 89.5 Favored Pre-proline 0 C--O 1.251 1.141 0 N-CA-C 106.479 -1.674 . . . . 52.380000000000003 106.479 162.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -68.48 169.58 56.62 Favored 'Cis proline' 0 C--O 1.249 1.057 0 N-CA-C 121.017 3.43 . . . . 46.939999999999998 121.017 -0.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1370 ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' 1371 ' ' PRO . . . -86.99 124.89 68.08 Favored Pre-proline 0 CA--C 1.506 -0.728 0 CA-C-O 122.366 1.079 . . . . 45.909999999999997 109.404 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1371 ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' 1370 ' ' ALA . 85.3 Cg_exo -70.81 126.84 13.03 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 122.849 2.366 . . . . 46.390000000000001 111.974 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -77.31 -57.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 123.538 2.825 . . . . 46.719999999999999 108.332 169.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.221 -5.008 0 O-C-N 119.552 -1.968 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 15.4 m80 . . . . . 0 N--CA 1.432 -1.353 0 N-CA-C 104.361 -2.459 . . . . 63.439999999999998 104.361 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 999' ' ' HIS . . . . . 0.568 ' HB2' ' HA ' ' B' 1066 ' ' SER . 96.8 m-70 -126.03 56.03 1.44 Allowed 'General case' 0 C--N 1.352 0.698 0 CA-C-N 121.292 1.86 . . . . 51.740000000000002 109.792 175.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1000 ' ' HIS . . . . . 0.454 ' HA ' ' HB2' ' B' 1067 ' ' GLU . 20.0 m-70 -71.87 145.71 48.38 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 114.162 -1.381 . . . . 54.07 110.936 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 64.56 5.87 19.58 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 122.435 1.02 . . . . 39.219999999999999 112.675 -173.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1002 ' ' ARG . . . . . 0.658 ' HG3' ' HB ' ' B' 1032 ' ' THR . 28.0 ttp180 -104.62 141.41 36.48 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 119.523 -2.163 . . . . 38.119999999999997 106.8 -173.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1003 ' ' ILE . . . . . 0.489 HG12 ' HB ' ' B' 1068 ' ' ILE . 87.4 mt -100.79 134.47 40.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 105.827 -1.916 . . . . 29.699999999999999 105.827 174.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -94.56 135.13 12.31 Favored Glycine 0 N--CA 1.419 -2.448 0 C-N-CA 119.914 -1.136 . . . . 27.5 111.136 156.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1005 ' ' ILE . . . . . . . . . . . . . 40.6 mm -104.61 104.86 47.76 Favored Pre-proline 0 CA--C 1.553 1.064 0 N-CA-C 102.244 -3.243 . . . . 24.829999999999998 102.244 171.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -66.25 157.47 59.84 Favored 'Trans proline' 0 C--N 1.361 1.214 1 C-N-CA 125.818 4.345 . . . . 27.190000000000001 114.811 172.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 44.1 ttt180 -86.26 101.78 13.36 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 113.765 -1.561 . . . . 41.460000000000001 107.874 173.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1008 ' ' GLU . . . . . 0.423 ' HG3' ' HB ' ' B' 1072 ' ' VAL . 5.4 mm-40 -49.35 134.23 18.89 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 117.342 2.349 . . . . 26.93 117.342 -175.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 32.3 mmm-85 -107.52 -11.32 15.51 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 111.935 -2.393 . . . . 34.479999999999997 114.129 -163.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1010 ' ' LEU . . . . . 0.675 ' HB3' ' HB2' ' B' 1013 ' ' GLU . 13.0 tp -63.31 145.5 55.43 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-N 119.796 1.18 . . . . 44.219999999999999 112.514 -174.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1011 ' ' THR . . . . . . . . . . . . . 33.1 m -32.95 106.65 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 115.75 1.759 . . . . 40.740000000000002 115.75 172.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 53.9 t30 46.25 49.69 12.6 Favored 'General case' 0 C--O 1.254 1.302 0 C-N-CA 125.552 1.541 . . . . 44.439999999999998 112.737 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1013 ' ' GLU . . . . . 0.675 ' HB2' ' HB3' ' B' 1010 ' ' LEU . 7.9 tp10 -79.97 133.57 36.19 Favored 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 118.292 -1.363 . . . . 29.870000000000001 108.102 177.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1014 ' ' THR . . . . . 0.479 ' HB ' ' O ' ' B' 1317 ' ' GLY . 3.4 m -112.76 -9.01 13.73 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 107.353 -1.351 . . . . 25.260000000000002 107.353 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1015 ' ' ARG . . . . . 0.626 ' HG3' ' HA2' ' B' 1317 ' ' GLY . 67.9 mtm180 -77.92 129.42 35.33 Favored 'General case' 0 CA--C 1.503 -0.854 0 O-C-N 120.359 -1.463 . . . . 29.539999999999999 110.694 174.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1016 ' ' VAL . . . . . 0.678 HG21 ' HB1' ' B' 1039 ' ' ALA . 5.0 p -97.65 177.64 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 120.388 -1.445 . . . . 23.550000000000001 107.452 155.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1017 ' ' ALA . . . . . 0.591 ' H ' HG22 ' B' 1016 ' ' VAL . . . -79.89 -19.37 48.35 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.154 -1.591 . . . . 23.59 113.604 -177.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1018 ' ' ALA . . . . . 0.532 ' HB1' ' HB ' ' B' 1022 ' ' THR . . . -153.43 146.87 24.9 Favored 'General case' 0 N--CA 1.442 -0.825 0 O-C-N 119.908 -1.745 . . . . 24.93 114.143 -167.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1019 ' ' THR . . . . . . . . . . . . . 76.7 p -88.75 172.29 7.79 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 118.594 0.634 . . . . 28.09 112.509 169.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1020 ' ' PRO . . . . . 0.475 ' O ' ' HB ' ' B' 1023 ' ' VAL . 42.7 Cg_exo -55.25 -36.1 92.67 Favored 'Trans proline' 0 C--O 1.249 1.046 0 C-N-CA 122.448 2.098 . . . . 28.789999999999999 116.631 165.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 51.4 tttt -54.13 -51.12 65.25 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 119.013 -2.304 . . . . 47.280000000000001 113.325 161.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1022 ' ' THR . . . . . 0.532 ' HB ' ' HB1' ' B' 1018 ' ' ALA . 22.8 m -52.77 -38.68 61.38 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 118.471 0.578 . . . . 30.120000000000001 109.873 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1023 ' ' VAL . . . . . 0.521 ' HA ' HG21 ' B' 1033 ' ' VAL . 73.5 t -53.41 -53.37 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 O-C-N 121.254 -0.904 . . . . 32.240000000000002 109.156 174.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1024 ' ' GLU . . . . . 0.545 ' O ' ' HG3' ' B' 1028 ' ' LYS . 15.1 mt-10 -57.42 -41.94 81.38 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.906 0.86 . . . . 49.619999999999997 113.193 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -58.39 -47.77 82.79 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 123.044 1.402 . . . . 44.68 111.735 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 41.5 mt -72.13 -34.37 68.52 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.528 -1.215 . . . . 35.710000000000001 110.487 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1027 ' ' LEU . . . . . 0.51 HD23 ' O ' ' B' 1031 ' ' PHE . 50.5 mt -57.64 -40.52 79.41 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 122.927 1.346 . . . . 42.18 110.636 175.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1028 ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' B' 1024 ' ' GLU . 58.2 mttm -58.34 -36.45 73.43 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 115.211 -0.904 . . . . 48.340000000000003 111.425 173.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1029 ' ' LEU . . . . . 0.724 HD21 ' HG2' ' B' 1336 ' ' LYS . 20.7 mt -77.33 -1.87 32.07 Favored 'General case' 0 C--O 1.259 1.56 0 N-CA-C 116.414 2.005 . . . . 38.689999999999998 116.414 175.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 90.03 25.0 28.04 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 125.877 1.703 . . . . 32.280000000000001 111.189 176.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1031 ' ' PHE . . . . . 0.51 ' O ' HD23 ' B' 1027 ' ' LEU . 55.0 m-85 -103.89 127.96 51.39 Favored 'General case' 0 C--O 1.252 1.236 0 N-CA-C 107.78 -1.193 . . . . 35.939999999999998 107.78 -177.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1032 ' ' THR . . . . . 0.658 ' HB ' ' HG3' ' B' 1002 ' ' ARG . 11.9 m -72.22 122.2 20.65 Favored 'General case' 0 C--O 1.251 1.166 0 N-CA-C 103.165 -2.902 . . . . 33.369999999999997 103.165 167.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1033 ' ' VAL . . . . . 0.521 HG21 ' HA ' ' B' 1023 ' ' VAL . 48.8 t -93.32 134.92 29.48 Favored 'Isoleucine or valine' 0 C--O 1.258 1.508 0 N-CA-C 104.681 -2.34 . . . . 29.98 104.681 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -123.0 140.11 53.38 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 104.063 -2.569 . . . . 28.18 104.063 172.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1035 ' ' VAL . . . . . 0.442 HG21 ' CD2' ' B' 1050 ' ' PHE . 89.3 t -131.5 135.14 59.79 Favored 'Isoleucine or valine' 0 C--O 1.255 1.373 0 N-CA-C 104.29 -2.485 . . . . 25.82 104.29 -170.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1036 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.91 151.23 43.49 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-O 123.123 1.44 . . . . 32.439999999999998 109.755 177.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1037 ' ' SER . . . . . . . . . . . . . 47.1 p -65.99 130.09 42.06 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 111.839 -2.437 . . . . 29.539999999999999 112.413 177.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 92.96 -15.57 62.5 Favored Glycine 0 CA--C 1.504 -0.645 0 O-C-N 118.366 -2.709 . . . . 27.760000000000002 111.62 -177.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1039 ' ' ALA . . . . . 0.678 ' HB1' HG21 ' B' 1016 ' ' VAL . . . -73.52 -33.93 64.99 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-O 122.29 1.043 . . . . 26.02 112.874 -171.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -59.86 -53.78 43.06 Favored Glycine 0 C--O 1.249 1.076 0 N-CA-C 110.477 -1.049 . . . . 26.469999999999999 110.477 167.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.07 -26.79 64.93 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 117.154 -1.403 . . . . 50.979999999999997 112.154 -177.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 58.3 mt -54.47 -48.84 71.31 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 120.944 1.702 . . . . 29.300000000000001 112.091 167.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1043 ' ' ALA . . . . . 0.507 ' HA ' ' HB2' ' B' 1320 ' ' PRO . . . -88.27 36.37 0.78 Allowed 'General case' 0 C--O 1.238 0.486 0 CA-C-O 116.166 -1.873 . . . . 26.739999999999998 111.341 -177.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1044 ' ' SER . . . . . . . . . . . . . 18.9 m 47.72 31.3 2.12 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 116.038 1.866 . . . . 31.260000000000002 116.038 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1045 ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.77 147.93 48.4 Favored 'General case' 0 C--N 1.36 1.051 0 CA-C-O 122.585 1.183 . . . . 33.259999999999998 109.366 177.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 11.3 t0 -71.2 123.75 22.92 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.153 -1.054 . . . . 46.740000000000002 108.153 173.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.75 -29.3 64.68 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 124.993 1.317 . . . . 34.439999999999998 112.1 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1048 ' ' LYS . . . . . 0.506 ' HA ' HG22 ' B' 1051 ' ' VAL . 0.8 OUTLIER -64.32 -22.45 66.95 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 119.624 -1.923 . . . . 48.670000000000002 113.12 172.327 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -64.69 -26.5 68.4 Favored 'General case' 0 C--N 1.365 1.262 0 O-C-N 119.311 -2.118 . . . . 35.259999999999998 112.692 169.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1050 ' ' PHE . . . . . 0.442 ' CD2' HG21 ' B' 1035 ' ' VAL . 64.4 m-85 -69.1 -40.38 78.42 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 118.474 -0.774 . . . . 32.170000000000002 111.952 168.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1051 ' ' VAL . . . . . 0.506 HG22 ' HA ' ' B' 1048 ' ' LYS . 20.6 m -70.93 -29.25 36.47 Favored 'Isoleucine or valine' 0 C--N 1.347 0.477 0 CA-C-N 120.668 1.576 . . . . 38.369999999999997 111.155 175.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -60.18 -48.05 83.36 Favored 'General case' 0 C--O 1.205 -1.257 0 O-C-N 119.013 -2.304 . . . . 45.770000000000003 111.405 167.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -64.62 -16.56 62.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 115.29 1.589 . . . . 37.829999999999998 115.29 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 99.39 31.53 6.1 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.632 -0.987 . . . . 35.82 110.632 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -110.77 143.45 41.29 Favored 'General case' 0 C--N 1.356 0.858 0 O-C-N 120.859 -1.377 . . . . 33.770000000000003 108.448 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -90.81 115.88 28.22 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 120.113 -1.617 . . . . 51.020000000000003 109.46 -172.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1057 ' ' ILE . . . . . . . . . . . . . 11.8 mm -76.15 109.59 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 106.494 -1.669 . . . . 38.469999999999999 106.494 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 6.5 m -126.03 126.26 69.39 Favored 'Isoleucine or valine' 0 C--O 1.247 0.969 0 CA-C-O 123.613 1.673 . . . . 39.399999999999999 111.576 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -86.52 125.49 33.8 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.977 -1.011 . . . . 57.07 111.195 -162.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . 71.31 -124.66 11.24 Favored Glycine 0 CA--C 1.517 0.206 0 O-C-N 125.785 1.928 . . . . 44.829999999999998 112.795 167.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -57.84 -31.36 66.58 Favored 'General case' 0 CA--C 1.481 -1.709 0 CA-C-N 118.566 1.183 . . . . 46.270000000000003 113.946 -175.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1062 ' ' SER . . . . . . . . . . . . . 4.8 m -52.47 -51.17 60.68 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 116.727 -1.606 . . . . 43.469999999999999 107.407 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.21 -39.81 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 121.313 1.87 . . . . 36.979999999999997 110.59 -177.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 93.2 m95 -60.41 -38.46 84.11 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 117.072 2.249 . . . . 37.899999999999999 117.072 174.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1065 ' ' GLN . . . . . 0.417 ' O ' ' NH2' ' B' 1002 ' ' ARG . 6.0 mm-40 -74.0 106.92 5.91 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 122.875 2.58 . . . . 46.189999999999998 104.952 172.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1066 ' ' SER . . . . . 0.568 ' HA ' ' HB2' ' B' ' 999' ' ' HIS . 51.1 m -164.76 166.49 19.81 Favored 'General case' 0 C--O 1.25 1.121 0 N-CA-C 109.304 -0.628 . . . . 37.060000000000002 109.304 -178.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1067 ' ' GLU . . . . . 0.454 ' HB2' ' HA ' ' B' 1000 ' ' HIS . 1.0 OUTLIER -65.55 -53.36 43.08 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 125.662 1.851 . . . . 43.950000000000003 111.993 169.586 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B 1068 ' ' ILE . . . . . 0.489 ' HB ' HG12 ' B' 1003 ' ' ILE . 4.5 mp -120.33 145.47 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 102.907 -2.997 . . . . 33.5 102.907 -173.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 16.8 mm -127.52 117.77 47.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 103.452 -2.796 . . . . 30.57 103.452 170.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1070 ' ' LEU . . . . . 0.741 HD22 HD22 ' B' 1331 ' ' LEU . 96.8 mt -106.42 114.46 28.59 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 103.934 -2.617 . . . . 27.66 103.934 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1071 ' ' LYS . . . . . 0.503 ' HB3' ' OG ' ' B' 1091 ' ' SER . 43.6 tttm -133.99 153.71 51.6 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 106.848 -1.538 . . . . 28.399999999999999 106.848 -168.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1072 ' ' VAL . . . . . 0.423 ' HB ' ' HG3' ' B' 1008 ' ' GLU . 61.5 t -85.03 -65.62 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 CA-C-N 119.517 1.053 . . . . 23.18 108.507 -174.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -107.02 165.34 11.42 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 105.865 -1.902 . . . . 25.469999999999999 105.865 -168.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -51.58 135.91 33.87 Favored Pre-proline 0 C--O 1.206 -1.22 0 CA-C-N 111.841 -2.436 . . . . 27.899999999999999 113.468 -171.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -60.22 123.49 13.26 Favored 'Trans proline' 0 N--CA 1.429 -2.279 0 C-N-CA 123.491 2.794 . . . . 31.620000000000001 113.425 171.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 91.6 mt -70.78 161.96 29.98 Favored 'General case' 0 C--O 1.244 0.802 0 O-C-N 125.61 1.818 . . . . 40.490000000000002 107.453 174.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1077 ' ' ASP . . . . . 0.471 ' HA ' HD12 ' B' 1080 ' ' ILE . 33.6 t70 -44.79 -42.28 7.68 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 120.072 3.36 . . . . 51.590000000000003 120.072 -173.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -68.09 -44.38 76.38 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 113.535 -1.666 . . . . 42.359999999999999 112.059 173.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1079 ' ' GLU . . . . . 0.431 ' HA ' HD12 ' B' 1082 ' ' LEU . 36.3 mt-10 -61.63 -35.7 78.66 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.109 -1.071 . . . . 34.530000000000001 108.109 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1080 ' ' ILE . . . . . 0.601 HG21 ' HB3' ' B' 1104 ' ' LYS . 76.5 mt -56.42 -50.91 70.15 Favored 'Isoleucine or valine' 0 C--O 1.25 1.082 0 O-C-N 119.936 -1.728 . . . . 33.25 108.524 172.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -63.59 -33.85 76.51 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 119.579 -1.95 . . . . 36.469999999999999 112.74 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1082 ' ' LEU . . . . . 0.431 HD12 ' HA ' ' B' 1079 ' ' GLU . 67.5 mt -61.05 -38.43 86.13 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.873 -0.603 . . . . 37.759999999999998 112.119 174.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1083 ' ' LEU . . . . . 0.448 ' HB3' HG11 ' B' 1110 ' ' VAL . 14.2 mt -58.66 154.31 14.74 Favored 'General case' 0 C--O 1.261 1.667 0 CA-C-O 123.594 1.664 . . . . 37.43 110.851 172.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1084 ' ' ASN . . . . . 0.407 ' HB2' ' OG1' ' B' 1087 ' ' THR . 3.0 m-80 -124.1 154.73 68.31 Favored Pre-proline 0 C--O 1.237 0.429 0 N-CA-C 106.747 -1.575 . . . . 37.700000000000003 106.747 -158.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -50.42 129.87 27.52 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 124.515 3.477 . . . . 35.509999999999998 110.667 171.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 93.58 -46.37 2.34 Favored Glycine 0 CA--C 1.542 1.738 0 CA-C-O 117.041 -1.977 . . . . 33.869999999999997 113.306 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1087 ' ' THR . . . . . 0.407 ' OG1' ' HB2' ' B' 1084 ' ' ASN . 59.1 m -46.28 118.13 1.82 Allowed 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 114.906 1.446 . . . . 32.5 114.906 -164.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1088 ' ' THR . . . . . . . . . . . . . 54.6 m -69.17 101.27 1.42 Allowed 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 106.782 -1.562 . . . . 30.219999999999999 106.782 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1089 ' ' LEU . . . . . 0.443 HD13 HD21 ' B' 1083 ' ' LEU . 13.2 tp -95.6 128.74 42.72 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-O 123.691 1.71 . . . . 27.239999999999998 110.245 174.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1090 ' ' VAL . . . . . 0.465 HG13 ' HB2' ' B' 1113 ' ' MET . 19.2 t -123.53 115.59 45.8 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 N-CA-C 105.677 -1.972 . . . . 25.390000000000001 105.677 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1091 ' ' SER . . . . . 0.503 ' OG ' ' HB3' ' B' 1071 ' ' LYS . 14.8 m -155.76 165.39 36.65 Favored 'General case' 0 C--N 1.352 0.685 0 O-C-N 120.654 -1.278 . . . . 28.809999999999999 110.123 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1092 ' ' PHE . . . . . 0.651 ' HZ ' ' HG3' ' B' 1133 ' ' MET . 88.4 m-85 -64.53 103.86 0.72 Allowed 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 107.119 -1.437 . . . . 30.780000000000001 107.119 158.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 26.9 mm -94.79 -37.92 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.221 0 CA-C-N 114.561 -1.2 . . . . 30.280000000000001 111.632 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1094 ' ' TRP . . . . . 0.469 ' HB3' ' HB2' ' B' 1097 ' ' GLN . 82.6 m95 60.25 71.83 0.82 Allowed Pre-proline 0 C--O 1.242 0.659 0 N-CA-C 107.057 -1.461 . . . . 34.07 107.057 -178.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -55.95 -58.06 1.24 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 125.24 3.96 . . . . 38.659999999999997 115.416 -170.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -66.22 -21.34 66.3 Favored 'General case' 0 CA--C 1.505 -0.762 0 O-C-N 120.627 -1.296 . . . . 41.32 112.321 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1097 ' ' GLN . . . . . 0.469 ' HB2' ' HB3' ' B' 1094 ' ' TRP . 12.6 mp0 -89.07 -20.89 23.77 Favored 'General case' 0 C--O 1.25 1.118 0 N-CA-C 107.23 -1.396 . . . . 51.659999999999997 107.23 -176.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1098 ' ' ASN . . . . . 0.416 ' HB3' ' HB3' ' B' 1101 ' ' LEU . 73.6 m-20 -135.57 54.92 11.36 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-N 120.7 1.591 . . . . 40.32 110.387 -176.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1099 ' ' PRO . . . . . 0.452 ' O ' ' HB2' ' B' 1102 ' ' MET . 58.8 Cg_endo -55.51 -49.01 17.45 Favored 'Trans proline' 0 CA--C 1.54 0.819 1 C-N-CA 125.314 4.009 . . . . 41.560000000000002 119.478 -175.343 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.85 -40.38 88.4 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.538 0.94 . . . . 54.109999999999999 113.538 173.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1101 ' ' LEU . . . . . 0.416 ' HB3' ' HB3' ' B' 1098 ' ' ASN . 9.3 tt -58.51 -49.51 77.13 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 125.194 1.398 . . . . 37.880000000000003 107.374 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1102 ' ' MET . . . . . 0.452 ' HB2' ' O ' ' B' 1099 ' ' PRO . 69.7 mmm -49.74 -45.64 49.59 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 113.934 1.087 . . . . 37.539999999999999 113.934 165.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -65.26 -44.14 89.08 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 121.288 1.858 . . . . 47.009999999999998 110.367 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1104 ' ' LYS . . . . . 0.601 ' HB3' HG21 ' B' 1080 ' ' ILE . 74.1 mttt -60.36 -38.49 84.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 119.423 -2.048 . . . . 48.68 110.652 -178.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1105 ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.04 -41.44 99.5 Favored 'General case' 0 C--O 1.25 1.081 0 CA-C-O 122.888 1.327 . . . . 32.210000000000001 113.977 171.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -63.91 -44.59 92.48 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.26 1.824 . . . . 33.729999999999997 108.93 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -54.11 -49.33 69.4 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 121.406 -0.809 . . . . 51.469999999999999 110.056 170.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1108 ' ' ARG . . . . . 0.589 ' HG2' ' O ' ' B' 1104 ' ' LYS . 13.9 mmm180 -67.86 -16.46 64.1 Favored 'General case' 0 C--O 1.207 -1.179 0 CA-C-N 120.221 1.373 . . . . 43.899999999999999 110.92 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1109 ' ' ASN . . . . . . . . . . . . . 4.6 m-80 69.41 28.84 4.62 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 123.73 1.728 . . . . 44.82 113.158 174.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1110 ' ' VAL . . . . . 0.448 HG11 ' HB3' ' B' 1083 ' ' LEU . 17.4 m -72.87 151.19 7.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 CA-C-N 114.179 -1.373 . . . . 30.52 109.45 174.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1111 ' ' THR . . . . . 0.431 ' HA ' ' H ' ' B' 1363 ' ' ALA . 6.4 m -94.77 107.3 19.31 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 106.524 -1.658 . . . . 27.120000000000001 106.524 176.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1112 ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' B' 1089 ' ' LEU . 4.0 t -101.29 126.14 55.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 115.237 1.569 . . . . 26.399999999999999 115.237 -169.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1113 ' ' MET . . . . . 0.465 ' HB2' HG13 ' B' 1090 ' ' VAL . 0.0 OUTLIER -107.43 127.57 53.71 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 106.08 -1.822 . . . . 42.920000000000002 106.08 165.209 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -100.74 105.74 17.09 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 113.362 -1.745 . . . . 24.149999999999999 108.044 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1115 ' ' MET . . . . . 0.491 ' HB3' ' HB2' ' B' 1129 ' ' ALA . 56.8 mmm -60.51 -23.33 64.45 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 112.896 -1.956 . . . . 29.949999999999999 116.24 -173.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1116 ' ' ASP . . . . . 0.603 ' HB3' ' HD1' ' B' 1092 ' ' PHE . 9.2 p-10 -78.46 -33.3 48.45 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 113.249 -1.796 . . . . 34.530000000000001 112.076 176.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1117 ' ' SER . . . . . . . . . . . . . 51.2 m -111.36 48.77 0.92 Allowed 'General case' 0 N--CA 1.435 -1.207 0 O-C-N 120.483 -1.386 . . . . 33.490000000000002 109.691 -178.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1118 ' ' VAL . . . . . 0.503 HG21 ' HA ' ' B' 1128 ' ' ASP . 55.3 t -76.73 139.91 67.08 Favored Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 104.81 -2.293 . . . . 34.020000000000003 104.81 167.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -50.35 141.06 33.22 Favored 'Trans proline' 0 C--O 1.245 0.871 0 C-N-CA 123.021 2.481 . . . . 38.280000000000001 117.395 175.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1120 ' ' ARG . . . . . 0.431 ' NH2' HD12 ' B' 1130 ' ' LEU . 9.7 mmt-85 -74.69 36.35 0.11 Allowed 'General case' 0 C--O 1.242 0.694 0 N-CA-C 116.714 2.116 . . . . 55.049999999999997 116.714 177.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1121 ' ' ILE . . . . . 0.411 ' HB ' ' O ' ' C' ' 131' ' ' ALA . 17.3 pt -118.8 142.75 32.29 Favored 'Isoleucine or valine' 0 C--N 1.347 0.466 0 O-C-N 117.702 -3.124 . . . . 42.090000000000003 106.695 -176.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1122 ' ' SER . . . . . . . . . . . . . 62.0 m -35.88 -47.96 0.54 Allowed 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 117.91 2.559 . . . . 38.020000000000003 117.91 -175.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1123 ' ' ARG . . . . . 0.462 ' HG3' HG21 ' B' 1354 ' ' VAL . 37.9 ptt85 -74.86 -35.92 62.34 Favored 'General case' 0 C--O 1.208 -1.122 0 CA-C-N 123.581 2.9 . . . . 34.289999999999999 113.416 177.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1124 ' ' ALA . . . . . 0.598 ' HA ' HD13 ' B' 1127 ' ' LEU . . . -68.51 -26.54 65.5 Favored 'General case' 0 C--O 1.218 -0.57 0 O-C-N 120.314 -1.491 . . . . 32.350000000000001 109.823 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1125 ' ' GLN . . . . . 0.406 ' HA ' ' HB3' ' B' 1128 ' ' ASP . 13.1 mm100 -60.01 -15.07 19.52 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 115.42 1.637 . . . . 47.170000000000002 115.42 171.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1126 ' ' SER . . . . . . . . . . . . . 97.1 p -77.47 -30.54 53.2 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 114.568 1.321 . . . . 31.710000000000001 114.568 170.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1127 ' ' LEU . . . . . 0.598 HD13 ' HA ' ' B' 1124 ' ' ALA . 3.4 mp -83.58 -25.22 31.11 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 112.395 -2.184 . . . . 37.0 109.212 175.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1128 ' ' ASP . . . . . 0.503 ' HA ' HG21 ' B' 1118 ' ' VAL . 33.9 t70 -69.76 118.86 13.14 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 115.421 1.637 . . . . 40.399999999999999 115.421 -174.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1129 ' ' ALA . . . . . 0.491 ' HB2' ' HB3' ' B' 1115 ' ' MET . . . -62.93 -46.09 89.43 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 109.851 -3.34 . . . . 26.559999999999999 111.095 177.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1130 ' ' LEU . . . . . 0.431 HD12 ' NH2' ' B' 1120 ' ' ARG . 35.2 mt -53.95 -41.83 68.2 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 117.071 -1.442 . . . . 30.890000000000001 114.452 -173.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1131 ' ' SER . . . . . . . . . . . . . 16.3 p -62.09 -46.97 86.73 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 124.473 1.108 . . . . 29.84 113.271 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1132 ' ' SER . . . . . 0.654 ' HB3' ' HB3' ' B' 1326 ' ' LEU . 14.6 m -65.13 -46.64 80.11 Favored 'General case' 0 N--CA 1.421 -1.881 0 O-C-N 119.421 -2.049 . . . . 31.91 111.17 174.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1133 ' ' MET . . . . . 0.651 ' HG3' ' HZ ' ' B' 1092 ' ' PHE . 38.8 mmt -59.32 -32.17 69.83 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 120.555 -1.341 . . . . 25.899999999999999 114.182 175.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1134 ' ' ALA . . . . . 0.611 ' HB1' ' HB2' ' B' 1176 ' ' ALA . . . -75.07 -35.66 61.82 Favored 'General case' 0 C--O 1.203 -1.369 0 O-C-N 120.393 -1.442 . . . . 26.620000000000001 108.542 173.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 40.7 t30 -61.23 -41.71 97.34 Favored 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 119.092 -2.255 . . . . 36.969999999999999 110.527 176.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1136 ' ' ILE . . . . . 0.62 HG21 ' HA ' ' B' 1316 ' ' PRO . 48.5 mm -59.33 -56.7 15.38 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 O-C-N 125.406 1.691 . . . . 32.109999999999999 108.47 171.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -55.69 -42.25 74.91 Favored 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 126.128 1.771 . . . . 24.140000000000001 114.682 -174.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -64.75 -45.47 92.64 Favored Glycine 0 C--N 1.316 -0.549 0 CA-C-N 122.031 2.196 . . . . 25.129999999999999 111.577 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 16.1 t80 -67.14 -43.21 82.94 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 122.683 1.23 . . . . 32.729999999999997 108.917 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1140 ' ' ARG . . . . . 0.584 HH11 HD13 ' B' 1319 ' ' LEU . 8.6 tpt180 -68.0 -32.54 73.01 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.709 -0.849 . . . . 26.359999999999999 108.709 -175.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1141 ' ' ALA . . . . . . . . . . . . . . . -55.98 -53.9 51.34 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 113.015 0.746 . . . . 24.120000000000001 113.015 170.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 36.5 mm -52.38 -45.51 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 124.052 0.941 . . . . 23.370000000000001 110.163 174.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 75.5 t -60.05 -62.8 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 117.537 -1.22 . . . . 24.960000000000001 114.274 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1144 ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' B' 1147 ' ' HIS . 59.5 mm-40 -61.87 -36.13 80.35 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-N 120.764 1.62 . . . . 32.07 111.138 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1145 ' ' ALA . . . . . 0.741 ' HA ' HG11 ' B' 1280 ' ' VAL . . . -54.28 -49.66 69.07 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 117.476 -1.25 . . . . 24.870000000000001 109.987 169.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1146 ' ' ALA . . . . . . . . . . . . . . . -67.26 -27.13 66.95 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 119.105 0.866 . . . . 24.670000000000002 110.792 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1147 ' ' HIS . . . . . 0.416 ' CD2' ' HG2' ' B' 1148 ' ' GLU . 51.9 t60 -57.85 -47.04 83.85 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 119.056 -0.497 . . . . 28.579999999999998 111.053 169.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1148 ' ' GLU . . . . . 0.416 ' HG2' ' CD2' ' B' 1147 ' ' HIS . 68.3 mm-40 -94.53 -5.09 46.78 Favored 'General case' 0 CA--C 1.501 -0.912 0 O-C-N 120.102 -1.624 . . . . 36.82 113.462 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1149 ' ' PHE . . . . . . . . . . . . . 3.3 t80 -67.73 137.52 55.54 Favored 'General case' 0 C--O 1.254 1.313 0 C-N-CA 124.827 1.251 . . . . 31.969999999999999 108.945 -177.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1150 ' ' GLY . . . . . 0.615 ' HA2' ' HD2' ' A' 1320 ' ' PRO . . . -75.31 -19.07 79.81 Favored Glycine 0 N--CA 1.44 -1.081 0 CA-C-O 118.135 -1.37 . . . . 25.489999999999998 114.083 174.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1151 ' ' ARG . . . . . . . . . . . . . 71.1 mtm-85 -130.34 177.59 7.22 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 122.811 3.305 . . . . 59.840000000000003 114.306 -158.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1152 ' ' PHE . . . . . 0.59 ' HB2' HG11 ' B' 1163 ' ' VAL . 7.1 m-30 -81.36 162.21 23.49 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 123.111 1.434 . . . . 34.450000000000003 109.238 170.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1153 ' ' PHE . . . . . 0.484 ' HB3' ' HB2' ' B' 1189 ' ' ALA . 77.4 m-85 -82.14 -50.15 9.36 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 112.949 -1.932 . . . . 31.170000000000002 108.834 165.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1154 ' ' THR . . . . . . . . . . . . . 3.5 m -77.19 126.68 31.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 112.273 -2.239 . . . . 33.890000000000001 108.666 -168.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -81.37 65.91 3.91 Favored Glycine 0 N--CA 1.433 -1.535 0 N-CA-C 110.132 -1.187 . . . . 38.950000000000003 110.132 -176.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -67.05 146.99 53.74 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.587 1.955 . . . . 54.229999999999997 115.786 -170.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 12.7 mm -90.87 125.89 43.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 102.012 -3.329 . . . . 51.159999999999997 102.012 173.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1158 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.75 138.08 51.91 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 102.327 -3.212 . . . . 49.609999999999999 102.327 172.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -58.65 -29.2 66.38 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.744 1.156 . . . . 49.049999999999997 110.817 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1160 ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' 1126 ' ' SER . . . -55.0 -58.92 5.67 Favored 'General case' 0 C--N 1.363 1.171 0 N-CA-C 112.993 0.738 . . . . 47.649999999999999 112.993 165.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . -171.52 143.27 7.47 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 107.766 -2.133 . . . . 45.609999999999999 107.766 -165.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 92.7 mttt -78.25 138.56 38.69 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 118.584 1.192 . . . . 57.460000000000001 109.55 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1163 ' ' VAL . . . . . 0.59 HG11 ' HB2' ' B' 1152 ' ' PHE . 48.0 t -88.01 133.34 37.49 Favored Pre-proline 0 C--O 1.251 1.144 0 N-CA-C 105.533 -2.025 . . . . 42.93 105.533 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1164 ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' B' 1165 ' ' PRO . 48.2 Cg_endo -67.48 145.06 69.56 Favored 'Trans proline' 0 C--N 1.323 -0.815 0 C-N-CA 123.265 2.643 . . . . 39.289999999999999 113.655 170.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1165 ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' B' 1164 ' ' PRO . 75.7 Cg_exo -65.54 152.77 80.84 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 CA-C-N 124.016 2.47 . . . . 34.170000000000002 113.836 176.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -88.42 143.65 26.86 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.57 -1.27 . . . . 31.690000000000001 107.57 167.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1167 ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -107.7 117.35 33.89 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 106.945 -1.502 . . . . 44.780000000000001 106.945 173.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1168 ' ' VAL . . . . . 0.529 HG22 ' HB ' ' B' 1251 ' ' ILE . 61.8 t -102.59 113.83 40.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 106.418 -1.697 . . . . 31.23 106.418 -174.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1169 ' ' MET . . . . . 0.628 ' HB2' HG11 ' B' 1249 ' ' VAL . 43.0 ttp -95.94 97.52 9.68 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 120.892 0.377 . . . . 37.090000000000003 110.967 178.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1170 ' ' VAL . . . . . 0.448 HG22 ' HB ' ' B' 1253 ' ' VAL . 61.4 t -88.78 122.0 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.851 -1.166 . . . . 30.170000000000002 107.851 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1171 ' ' ILE . . . . . 0.409 HG22 ' HB2' ' B' 1256 ' ' ALA . 44.4 mt -112.07 131.94 62.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 104.097 -2.557 . . . . 33.740000000000002 104.097 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 81.29 64.6 1.76 Allowed Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 108.11 -1.996 . . . . 32.590000000000003 108.11 -174.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1173 ' ' ALA . . . . . 0.469 ' H ' ' HB2' ' B' 1195 ' ' ASP . . . -62.93 -7.01 4.37 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 120.842 -1.387 . . . . 32.420000000000002 114.683 -177.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -58.11 129.19 49.2 Favored Glycine 0 C--O 1.245 0.799 0 CA-C-O 122.8 1.222 . . . . 31.739999999999998 112.23 175.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 1.5 t 48.81 -82.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 112.612 -1.794 . . . . 31.48 114.441 173.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1176 ' ' ALA . . . . . 0.611 ' HB2' ' HB1' ' B' 1134 ' ' ALA . . . -65.34 -42.38 92.95 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.548 0.69 . . . . 26.120000000000001 112.609 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1177 ' ' GLY . . . . . . . . . . . . . . . -56.72 -45.22 91.11 Favored Glycine 0 N--CA 1.464 0.563 0 CA-C-N 113.123 -1.853 . . . . 25.73 108.781 174.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1178 ' ' LEU . . . . . 0.592 ' HA ' HD12 ' B' 1181 ' ' ILE . 5.5 tp -58.62 -48.89 79.48 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 126.288 1.835 . . . . 32.590000000000003 108.336 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -58.74 -38.81 79.22 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 114.347 1.24 . . . . 27.719999999999999 114.347 175.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -65.82 -43.21 89.28 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.884 0.874 . . . . 26.030000000000001 112.034 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1181 ' ' ILE . . . . . 0.599 HD13 HG22 ' B' 1204 ' ' VAL . 9.5 mt -56.12 -48.29 79.33 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 O-C-N 120.299 -1.5 . . . . 28.609999999999999 108.633 170.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -57.68 -49.88 70.17 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 117.749 -1.584 . . . . 25.23 112.986 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -63.48 -49.57 73.1 Favored 'General case' 0 C--O 1.249 1.063 0 CA-C-N 120.78 2.29 . . . . 24.09 113.253 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -68.02 -38.44 82.58 Favored 'General case' 0 C--O 1.24 0.605 0 O-C-N 121.497 -0.752 . . . . 26.68 109.323 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 45.5 t30 -62.32 -33.65 75.09 Favored 'General case' 0 C--O 1.249 1.042 0 O-C-N 118.075 -2.891 . . . . 36.57 111.004 174.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1186 ' ' SER . . . . . 0.557 ' HB3' ' O ' ' A' 1186 ' ' SER . 61.4 m -67.42 -45.85 74.9 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 111.941 0.348 . . . . 28.920000000000002 111.941 174.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1187 ' ' LEU . . . . . 0.513 ' HA ' ' HB3' ' A' 1186 ' ' SER . 5.6 mt -60.49 -24.64 65.45 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.093 0.957 . . . . 29.09 111.477 169.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 93.75 34.74 6.42 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 121.559 1.981 . . . . 29.260000000000002 112.224 175.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1189 ' ' ALA . . . . . 0.484 ' HB2' ' HB3' ' B' 1153 ' ' PHE . . . -104.3 146.02 29.4 Favored 'General case' 0 C--O 1.252 1.192 0 N-CA-C 107.772 -1.196 . . . . 30.16 107.772 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 69.9 mt -77.18 110.76 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 102.776 -3.046 . . . . 35.810000000000002 102.776 -173.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1191 ' ' VAL . . . . . . . . . . . . . 17.4 t -91.93 128.28 43.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 C-N-CA 118.485 -1.286 . . . . 31.969999999999999 108.024 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1192 ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' B' 1169 ' ' MET . 87.6 mtt180 -113.83 107.76 16.16 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 106.868 -1.53 . . . . 48.159999999999997 106.868 168.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -114.92 147.39 40.03 Favored 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 120.381 -1.449 . . . . 35.890000000000001 110.74 -173.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1194 ' ' PHE . . . . . 0.537 ' HB2' ' HB2' ' B' 1212 ' ' LEU . 42.0 t80 -135.9 146.96 47.92 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.304 -1.369 . . . . 41.880000000000003 107.304 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1195 ' ' ASP . . . . . 0.871 ' HB3' HG21 ' B' 1200 ' ' VAL . 23.7 t0 -154.46 154.06 32.57 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 102.051 -3.314 . . . . 38.280000000000001 102.051 172.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1196 ' ' THR . . . . . 0.459 ' HB ' ' HG2' ' B' 1230 ' ' MET . 1.8 p -85.76 37.92 0.72 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 117.695 -1.145 . . . . 40.619999999999997 110.811 -170.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1197 ' ' ARG . . . . . . . . . . . . . 75.4 mtm180 -140.24 166.2 25.13 Favored Pre-proline 0 C--O 1.246 0.878 0 CA-C-N 121.955 2.161 . . . . 53.090000000000003 112.386 -166.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -72.35 -64.33 0.03 OUTLIER 'Trans proline' 0 C--O 1.254 1.299 0 N-CA-C 119.149 2.711 . . . . 42.560000000000002 119.149 168.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.02 -34.26 63.33 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 115.574 1.694 . . . . 56.310000000000002 115.574 -167.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1200 ' ' VAL . . . . . 0.871 HG21 ' HB3' ' B' 1195 ' ' ASP . 0.3 OUTLIER -43.96 -42.18 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 N-CA-C 116.102 1.89 . . . . 42.909999999999997 116.102 172.417 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 43.5 tttm -58.2 -51.79 68.27 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 120.038 -1.664 . . . . 48.890000000000001 110.216 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -61.34 -28.05 68.94 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 122.36 1.076 . . . . 51.700000000000003 112.847 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1203 ' ' GLN . . . . . 0.551 ' HG2' ' HA ' ' B' 1200 ' ' VAL . 34.7 mm-40 -68.16 -46.55 70.45 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 107.641 -1.244 . . . . 52.57 107.641 173.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1204 ' ' VAL . . . . . 0.599 HG22 HD13 ' B' 1181 ' ' ILE . 25.5 t -63.99 -34.34 67.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 120.383 1.447 . . . . 33.789999999999999 111.292 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -61.97 -34.92 77.03 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.806 0.843 . . . . 36.579999999999998 109.972 171.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1206 ' ' SER . . . . . . . . . . . . . 14.9 m -72.78 -1.64 17.35 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 115.359 1.615 . . . . 39.609999999999999 115.359 173.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1207 ' ' MET . . . . . 0.469 ' SD ' HD11 ' C' ' 75' ' ' LEU . 2.8 mpp? -98.42 -18.68 18.13 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 113.258 0.836 . . . . 37.450000000000003 113.258 165.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 72.04 43.97 46.98 Favored Glycine 0 N--CA 1.484 1.843 0 O-C-N 119.624 -1.923 . . . . 31.870000000000001 110.868 -167.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -126.38 166.96 16.21 Favored 'General case' 0 CA--C 1.505 -0.772 0 O-C-N 120.471 -1.605 . . . . 35.399999999999999 111.899 -176.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -81.0 125.56 30.32 Favored 'General case' 0 C--O 1.216 -0.663 0 O-C-N 120.529 -1.357 . . . . 47.890000000000001 108.989 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 70.9 t80 -92.1 130.7 37.77 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 104.33 -2.47 . . . . 45.530000000000001 104.33 165.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1212 ' ' LEU . . . . . 0.537 ' HB2' ' HB2' ' B' 1194 ' ' PHE . 53.0 mt -76.25 106.89 8.12 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 105.2 -2.148 . . . . 46.329999999999998 105.2 167.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.17 150.79 37.09 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 124.07 1.89 . . . . 60.409999999999997 111.577 -173.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1214 ' ' LEU . . . . . 0.566 ' HB3' ' HE2' ' B' 1234 ' ' PHE . 8.0 mp -60.97 127.41 31.45 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 111.847 -2.433 . . . . 57.380000000000003 112.895 176.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 30.9 t0 . . . . . 0 N--CA 1.45 -0.465 0 C-N-CA 127.154 2.182 . . . . 65.069999999999993 110.46 -169.088 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B 1230 ' ' MET . . . . . 0.459 ' HG2' ' HB ' ' B' 1196 ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.417 -2.123 0 N-CA-C 102.489 -3.152 . . . . 80.319999999999993 102.489 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1231 ' ' SER . . . . . . . . . . . . 0.298 2.6 p 58.75 169.15 0.06 Allowed 'General case' 0 N--CA 1.444 -0.762 2 CA-C-N 130.094 5.861 . . . . 79.920000000000002 116.365 2.152 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -61.04 -49.76 76.06 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.274 -1.517 . . . . 77.909999999999997 108.304 175.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 34.22 -77.56 0.0 OUTLIER 'General case' 0 C--O 1.248 1.012 0 N-CA-C 119.657 3.206 . . . . 73.879999999999995 119.657 175.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1234 ' ' PHE . . . . . 0.566 ' HE2' ' HB3' ' B' 1214 ' ' LEU . 8.3 m-30 -93.59 -0.25 56.29 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 120.98 1.718 . . . . 68.980000000000004 110.365 -168.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 13.5 pt -33.16 -33.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 119.213 3.042 . . . . 64.530000000000001 119.213 -174.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -80.27 -38.57 30.63 Favored 'General case' 0 C--O 1.245 0.859 0 O-C-N 120.74 -1.225 . . . . 66.359999999999999 113.79 173.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -63.89 -47.65 79.78 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-O 117.45 -1.262 . . . . 56.600000000000001 109.154 170.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1238 ' ' GLU . . . . . 0.48 ' HG2' ' HE2' ' B' 1194 ' ' PHE . 47.7 mt-10 -47.96 -61.14 2.11 Favored 'General case' 0 C--N 1.36 1.06 0 O-C-N 124.347 1.029 . . . . 56.789999999999999 112.284 174.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1239 ' ' MET . . . . . . . . . . . . . 14.1 ttm -54.28 -50.15 67.92 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 124.853 1.261 . . . . 53.630000000000003 111.029 -175.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -72.41 -27.9 62.64 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 117.432 2.382 . . . . 51.740000000000002 117.432 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 28.2 tp -63.48 -50.46 69.6 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 106.498 -1.667 . . . . 44.859999999999999 106.498 169.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1242 ' ' PHE . . . . . 0.453 ' HE2' HD13 ' B' 1266 ' ' LEU . 18.3 m-30 -58.62 -41.91 86.99 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.998 1.436 . . . . 42.780000000000001 111.375 176.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -59.46 -44.77 92.91 Favored 'General case' 0 C--O 1.25 1.088 0 CA-C-N 120.577 1.535 . . . . 40.960000000000001 114.876 173.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -61.43 -51.84 67.07 Favored 'General case' 0 C--O 1.25 1.085 0 C-N-CA 120.169 -0.612 . . . . 43.060000000000002 110.063 174.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 -58.84 -28.64 66.26 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 116.203 1.927 . . . . 46.450000000000003 116.203 173.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -52.34 -33.09 41.21 Favored 'General case' 0 C--O 1.254 1.323 0 CA-C-N 119.291 0.95 . . . . 41.780000000000001 113.143 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1247 ' ' LYS . . . . . 0.438 ' HA ' ' HD2' ' B' 1247 ' ' LYS . 22.0 tptt -76.61 -31.56 57.52 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 120.932 -1.105 . . . . 52.200000000000003 112.322 177.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1248 ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -84.49 -42.12 15.87 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 120.818 -1.176 . . . . 53.549999999999997 112.697 178.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1249 ' ' VAL . . . . . 0.628 HG11 ' HB2' ' B' 1169 ' ' MET . 36.0 m -82.03 160.11 3.82 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.788 0 CA-C-O 123.154 1.454 . . . . 34.409999999999997 113.713 -162.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1250 ' ' ASP . . . . . 0.603 ' O ' ' HB3' ' B' 1279 ' ' SER . 3.7 m-20 -107.48 -69.72 0.83 Allowed 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 111.832 -2.44 . . . . 33.380000000000003 113.748 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1251 ' ' ILE . . . . . 0.714 HD12 ' HB1' ' B' 1145 ' ' ALA . 44.2 mm -101.6 102.5 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 N-CA-C 108.04 -1.096 . . . . 29.539999999999999 108.04 -175.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1252 ' ' ILE . . . . . 0.56 HD12 HG12 ' B' 1281 ' ' ILE . 75.0 mt -83.29 116.41 27.34 Favored 'Isoleucine or valine' 0 C--O 1.25 1.127 0 N-CA-C 107.082 -1.451 . . . . 32.439999999999998 107.082 168.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1253 ' ' VAL . . . . . 0.545 HG13 HD11 ' B' 1284 ' ' LEU . 39.0 t -101.16 87.9 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 105.644 -1.984 . . . . 30.57 105.644 174.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1254 ' ' THR . . . . . . . . . . . . . 1.2 t -92.85 115.02 27.73 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-O 125.462 2.553 . . . . 35.039999999999999 111.331 -174.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1255 ' ' THR . . . . . . . . . . . . . 7.1 m -135.83 10.16 3.35 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 110.606 -2.997 . . . . 34.619999999999997 108.987 -161.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1256 ' ' ALA . . . . . 0.409 ' HB2' HG22 ' B' 1171 ' ' ILE . . . -70.37 84.86 0.58 Allowed 'General case' 0 C--N 1.35 0.628 0 O-C-N 121.086 -1.009 . . . . 42.719999999999999 113.552 -172.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 41.1 mt -105.89 126.63 52.41 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 125.387 1.475 . . . . 52.43 110.103 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1258 ' ' ILE . . . . . 0.407 ' HA ' ' HD2' ' B' 1259 ' ' PRO . 2.6 mp -77.14 132.1 71.2 Favored Pre-proline 0 N--CA 1.438 -1.057 0 N-CA-C 103.151 -2.907 . . . . 59.409999999999997 103.151 168.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1259 ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' B' 1258 ' ' ILE . 67.7 Cg_endo -65.22 69.87 0.29 Allowed 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 124.217 3.278 . . . . 62.68 111.967 169.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 153.19 -81.12 0.18 Allowed Glycine 0 CA--C 1.534 1.266 0 O-C-N 118.653 -2.53 . . . . 64.159999999999997 108.43 -171.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 38.3 tttt -64.69 138.45 97.46 Favored Pre-proline 0 N--CA 1.44 -0.968 0 N-CA-C 114.755 1.391 . . . . 68.530000000000001 114.755 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -55.31 132.08 50.07 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 124.703 3.602 . . . . 61.990000000000002 111.392 166.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1263 ' ' ALA . . . . . . . . . . . . . . . -59.53 128.18 85.73 Favored Pre-proline 0 C--O 1.239 0.544 0 CA-C-N 111.675 -2.511 . . . . 57.149999999999999 111.407 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1264 ' ' PRO . . . . . 0.475 ' O ' ' HA ' ' B' 1291 ' ' ASN . 97.1 Cg_endo -64.19 146.08 89.95 Favored 'Trans proline' 0 C--O 1.25 1.077 0 C-N-CA 124.69 3.594 . . . . 51.57 113.815 177.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1265 ' ' LYS . . . . . 0.463 ' NZ ' ' O ' ' B' 1289 ' ' GLY . 38.5 mmtm -71.7 97.44 1.75 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 123.56 1.647 . . . . 54.549999999999997 108.309 167.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1266 ' ' LEU . . . . . 0.453 HD13 ' HE2' ' B' 1242 ' ' PHE . 91.3 mt -94.14 -47.85 6.47 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 123.223 1.487 . . . . 46.859999999999999 112.134 172.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1267 ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' B' 1292 ' ' CYS . 20.7 mm -84.06 82.36 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 104.651 -2.351 . . . . 41.039999999999999 104.651 -175.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1268 ' ' THR . . . . . 0.643 ' HA ' ' HG3' ' B' 1293 ' ' GLU . 23.2 p -82.36 175.45 10.24 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 111.068 -2.787 . . . . 39.579999999999998 108.729 -175.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1269 ' ' ARG . . . . . 0.457 ' HG2' ' CE2' ' B' 1294 ' ' TYR . 64.8 mtt85 -52.56 -41.28 63.42 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.019 0.927 . . . . 53.149999999999999 111.765 175.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -60.57 -21.06 62.18 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 115.727 1.751 . . . . 42.960000000000001 115.727 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1271 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.42 -51.51 6.89 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 120.338 1.426 . . . . 43.890000000000001 110.725 162.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1272 ' ' VAL . . . . . 0.41 HG23 ' O ' ' B' 1268 ' ' THR . 96.4 t -57.72 -60.68 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 CA-C-N 115.187 -0.915 . . . . 38.369999999999997 112.203 -168.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.26 -34.93 77.49 Favored 'General case' 0 C--O 1.247 0.97 0 O-C-N 119.541 -1.974 . . . . 47.460000000000001 112.708 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1274 ' ' SER . . . . . . . . . . . . . 5.2 m -74.32 -17.03 60.9 Favored 'General case' 0 C--O 1.244 0.786 0 O-C-N 120.044 -1.66 . . . . 38.380000000000003 111.16 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1275 ' ' MET . . . . . 0.581 ' SD ' HD11 ' B' 1281 ' ' ILE . 38.3 mtp -53.75 145.07 16.53 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 118.747 2.869 . . . . 37.810000000000002 118.747 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -61.39 130.76 47.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.547 -1.206 . . . . 49.259999999999998 109.101 171.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1277 ' ' ALA . . . . . 0.406 ' HB1' ' HA ' ' A' 1045 ' ' PHE . . . -64.03 165.35 9.12 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 118.5 2.778 . . . . 34.460000000000001 118.5 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 67.34 26.47 73.52 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-O 124.711 2.284 . . . . 33.530000000000001 115.363 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1279 ' ' SER . . . . . 0.603 ' HB3' ' O ' ' B' 1250 ' ' ASP . 36.6 m -127.89 159.75 33.95 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 111.243 -2.478 . . . . 31.309999999999999 106.139 -168.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1280 ' ' VAL . . . . . 0.741 HG11 ' HA ' ' B' 1145 ' ' ALA . 94.8 t -128.28 129.31 69.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.537 -0.912 . . . . 29.32 108.537 -165.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1281 ' ' ILE . . . . . 0.581 HD11 ' SD ' ' B' 1275 ' ' MET . 58.5 mt -99.49 96.28 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 N-CA-C 107.304 -1.369 . . . . 31.93 107.304 170.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1282 ' ' VAL . . . . . . . . . . . . . 14.2 t -80.63 110.99 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 O-C-N 120.383 -1.448 . . . . 29.48 110.793 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 33.6 t0 -90.57 95.81 10.34 Favored 'General case' 0 N--CA 1.417 -2.115 0 O-C-N 120.289 -1.507 . . . . 34.5 107.189 173.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1284 ' ' LEU . . . . . 0.545 HD11 HG13 ' B' 1253 ' ' VAL . 5.0 mp -76.65 -21.97 54.72 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-N 113.18 -1.827 . . . . 37.939999999999998 111.207 173.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -87.0 8.01 25.2 Favored 'General case' 0 C--N 1.35 0.589 0 N-CA-C 115.656 1.724 . . . . 40.920000000000002 115.656 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -50.29 -42.66 52.79 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 119.524 3.157 . . . . 44.390000000000001 119.524 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1287 ' ' GLN . . . . . 0.452 ' HB3' HG22 ' B' 1313 ' ' THR . 1.7 pm0 -64.03 -28.86 70.09 Favored 'General case' 0 C--O 1.257 1.495 0 O-C-N 119.322 -2.111 . . . . 51.460000000000001 114.137 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 38.9 t30 -121.91 76.78 1.31 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.243 -1.021 . . . . 57.75 108.243 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1289 ' ' GLY . . . . . 0.463 ' O ' ' NZ ' ' B' 1265 ' ' LYS . . . 98.45 -60.68 0.9 Allowed Glycine 0 C--N 1.336 0.531 0 O-C-N 120.102 -1.624 . . . . 49.850000000000001 114.902 176.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 80.99 119.48 0.44 Allowed Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 121.247 2.523 . . . . 45.93 112.128 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1291 ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' B' 1264 ' ' PRO . 27.0 m120 -81.5 -25.84 35.66 Favored 'General case' 0 C--N 1.346 0.429 0 N-CA-C 114.457 1.28 . . . . 42.670000000000002 114.457 -175.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1292 ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' B' 1267 ' ' ILE . 48.2 t -95.14 144.44 25.77 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 120.399 -1.438 . . . . 38.82 111.754 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1293 ' ' GLU . . . . . 0.643 ' HG3' ' HA ' ' B' 1268 ' ' THR . 22.7 mt-10 -68.82 -34.25 75.2 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 113.784 1.031 . . . . 46.710000000000001 113.784 178.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1294 ' ' TYR . . . . . 0.457 ' CE2' ' HG2' ' B' 1269 ' ' ARG . 52.7 m-85 -80.91 7.76 9.86 Favored 'General case' 0 C--O 1.248 0.982 0 N-CA-C 116.766 2.135 . . . . 47.229999999999997 116.766 -176.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1295 ' ' THR . . . . . 0.455 ' OG1' ' HB3' ' B' 1292 ' ' CYS . 26.4 m -71.79 107.73 4.74 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 114.007 1.114 . . . . 36.020000000000003 114.007 -173.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 36.7 t -93.57 123.42 60.14 Favored Pre-proline 0 C--N 1.304 -1.394 0 N-CA-C 103.448 -2.797 . . . . 37.259999999999998 103.448 155.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -61.16 136.8 67.14 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.649 2.233 . . . . 35.090000000000003 114.268 177.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 71.69 40.73 58.16 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 113.699 -1.591 . . . . 35.969999999999999 112.691 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -148.91 152.75 36.94 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-O 124.882 2.277 . . . . 40.390000000000001 114.671 -172.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1300 ' ' ILE . . . . . . . . . . . . . 55.3 mt -99.84 107.61 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 101.422 -3.547 . . . . 37.43 101.422 166.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 15.2 t80 -104.78 103.12 12.68 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.07 -1.085 . . . . 44.130000000000003 108.07 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1302 ' ' THR . . . . . . . . . . . . . 17.7 m -82.98 120.42 25.69 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-O 123.337 1.541 . . . . 39.780000000000001 111.012 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1303 ' ' THR . . . . . . . . . . . . . 3.2 p -79.84 139.35 37.22 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 112.929 -1.941 . . . . 43.289999999999999 109.398 175.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -48.25 -31.22 5.59 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 117.352 2.352 . . . . 53.07 117.352 -175.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -59.88 -21.93 61.68 Favored 'General case' 0 C--O 1.262 1.713 0 C-N-CA 126.496 1.918 . . . . 43.969999999999999 116.062 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 113.35 1.09 24.94 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 110.987 -0.845 . . . . 41.119999999999997 110.987 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1307 ' ' VAL . . . . . . . . . . . . . 45.6 t -88.95 148.28 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-N 118.653 1.227 . . . . 38.119999999999997 109.437 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1308 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.09 114.87 27.97 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 107.726 -1.212 . . . . 36.340000000000003 107.726 177.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1309 ' ' VAL . . . . . 0.405 HG21 ' HB2' ' B' 1294 ' ' TYR . 85.2 t -84.05 97.04 4.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 107.108 -1.441 . . . . 30.399999999999999 107.108 172.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1310 ' ' ILE . . . . . . . . . . . . . 19.0 mt -88.32 91.58 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 CA-C-O 122.912 1.339 . . . . 30.82 108.228 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1311 ' ' GLY . . . . . 0.415 ' HA3' HG23 ' B' 1295 ' ' THR . . . -88.97 93.32 1.88 Allowed Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 109.65 -1.38 . . . . 26.530000000000001 109.65 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1312 ' ' TYR . . . . . . . . . . . . . 13.9 m-30 -116.56 128.18 55.19 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 117.755 2.502 . . . . 38.0 117.755 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1313 ' ' THR . . . . . 0.452 HG22 ' HB3' ' B' 1287 ' ' GLN . 24.0 p -81.83 -56.25 4.1 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 112.668 -2.06 . . . . 29.800000000000001 108.64 173.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -70.05 21.26 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 117.991 2.589 . . . . 39.039999999999999 117.991 -173.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1315 ' ' LEU . . . . . . . . . . . . . 63.8 mt -50.78 -34.29 11.57 Favored Pre-proline 0 CA--C 1.545 0.777 0 O-C-N 118.013 -2.93 . . . . 31.079999999999998 117.128 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1316 ' ' PRO . . . . . 0.62 ' HA ' HG21 ' B' 1136 ' ' ILE . 51.3 Cg_exo -61.87 -54.23 1.67 Allowed 'Trans proline' 0 C--O 1.24 0.589 0 C-N-CA 123.213 2.608 . . . . 26.100000000000001 112.173 166.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1317 ' ' GLY . . . . . 0.626 ' HA2' ' HG3' ' B' 1015 ' ' ARG . . . -58.1 -32.99 68.07 Favored Glycine 0 C--O 1.213 -1.168 0 O-C-N 121.548 -0.72 . . . . 23.170000000000002 113.004 -177.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 74.7 mtt-85 -60.24 -27.44 67.21 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 113.584 0.957 . . . . 40.399999999999999 113.584 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1319 ' ' LEU . . . . . 0.584 HD13 HH11 ' B' 1140 ' ' ARG . 14.1 tp -111.86 77.98 2.1 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 105.397 -2.075 . . . . 23.600000000000001 105.397 171.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1320 ' ' PRO . . . . . 0.507 ' HB2' ' HA ' ' B' 1043 ' ' ALA . 81.2 Cg_endo -59.71 -64.66 0.1 OUTLIER 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.309 2.673 . . . . 22.350000000000001 115.414 -163.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1321 ' ' THR . . . . . . . . . . . . . 1.5 m -60.6 -38.07 83.48 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 120.552 -1.342 . . . . 26.52 111.404 -172.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1322 ' ' GLN . . . . . 0.92 ' HB2' ' HA ' ' A' 1151 ' ' ARG . 43.1 tp60 -72.34 -35.37 68.54 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 120.288 -1.508 . . . . 24.379999999999999 109.342 -175.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1323 ' ' SER . . . . . . . . . . . . . 68.8 m -61.56 -47.6 84.77 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 124.633 1.208 . . . . 22.800000000000001 111.433 171.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1324 ' ' SER . . . . . . . . . . . . . 7.6 m -60.71 -28.86 68.97 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 119.612 -1.93 . . . . 21.25 112.915 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -74.61 -47.27 33.25 Favored 'General case' 0 C--O 1.252 1.211 0 O-C-N 119.82 -1.8 . . . . 31.34 109.973 176.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1326 ' ' LEU . . . . . 0.654 ' HB3' ' HB3' ' B' 1132 ' ' SER . 86.1 mt -74.85 -47.35 30.76 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 120.343 1.429 . . . . 31.559999999999999 109.527 -173.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1327 ' ' TYR . . . . . 0.409 ' O ' ' HG ' ' B' 1331 ' ' LEU . 55.9 t80 -58.35 -45.1 88.81 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 109.547 -0.538 . . . . 22.73 109.547 174.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1328 ' ' GLY . . . . . 0.632 ' HA2' HD12 ' B' 1331 ' ' LEU . . . -55.4 -46.49 80.15 Favored Glycine 0 C--N 1.357 1.719 0 N-CA-C 111.253 -0.739 . . . . 21.91 111.253 173.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1329 ' ' THR . . . . . . . . . . . . . 48.2 m -67.98 -25.24 65.32 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 120.323 -1.692 . . . . 22.149999999999999 111.217 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1330 ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' B' 1127 ' ' LEU . 31.7 m120 -69.25 -48.47 61.75 Favored 'General case' 0 C--N 1.314 -0.941 0 O-C-N 119.637 -1.914 . . . . 26.18 107.252 173.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1331 ' ' LEU . . . . . 0.741 HD22 HD22 ' B' 1070 ' ' LEU . 33.8 mt -56.7 -38.9 72.93 Favored 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 123.003 0.521 . . . . 23.68 110.663 176.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1332 ' ' VAL . . . . . 0.489 HG23 ' O ' ' B' 1328 ' ' GLY . 71.0 t -54.3 -53.76 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 CA-C-N 120.157 1.344 . . . . 26.57 111.897 171.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -61.9 -44.24 97.2 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 122.37 1.081 . . . . 28.079999999999998 111.387 -177.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1334 ' ' LEU . . . . . . . . . . . . . 5.0 tt -53.92 -47.84 70.78 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 123.745 1.735 . . . . 27.43 113.016 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1335 ' ' LEU . . . . . 0.526 HD11 HD21 ' B' 1070 ' ' LEU . 39.1 mt -78.9 -15.29 58.52 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 119.844 -1.785 . . . . 30.5 109.606 -177.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1336 ' ' LYS . . . . . 0.724 ' HG2' HD21 ' B' 1029 ' ' LEU . 89.7 mttt -72.08 -36.68 69.6 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-N 119.583 1.083 . . . . 41.649999999999999 109.771 167.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1337 ' ' LEU . . . . . 0.592 HD22 HD21 ' B' 1127 ' ' LEU . 10.4 mp -67.33 -34.12 76.68 Favored 'General case' 0 N--CA 1.434 -1.251 0 O-C-N 120.086 -1.634 . . . . 42.079999999999998 113.749 169.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1338 ' ' LEU . . . . . 0.605 ' HB3' HG23 ' B' 1346 ' ' ILE . 85.6 mt -81.78 -43.71 17.98 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 118.878 -2.389 . . . . 35.030000000000001 113.774 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 41.5 t -105.23 60.3 0.68 Allowed 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 105.462 -2.051 . . . . 37.329999999999998 105.462 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 56.7 mttp -57.83 -21.15 40.88 Favored 'General case' 0 N--CA 1.432 -1.339 0 O-C-N 118.964 -2.335 . . . . 50.509999999999998 115.906 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -85.52 -5.42 59.29 Favored 'General case' 0 C--O 1.249 1.053 0 N-CA-C 114.856 1.428 . . . . 54.210000000000001 114.856 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1342 ' ' LYS . . . . . 0.534 ' HG2' HD23 ' B' 1029 ' ' LEU . 45.7 mttp 56.85 56.57 5.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 123.826 1.774 . . . . 50.990000000000002 111.16 -176.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -133.04 -1.97 3.25 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 113.344 -1.753 . . . . 48.82 113.809 -168.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 88.95 -30.72 5.32 Favored Glycine 0 CA--C 1.541 1.657 0 N-CA-C 117.509 1.764 . . . . 40.43 117.509 -170.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -86.4 124.22 32.5 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 117.839 -1.545 . . . . 47.560000000000002 110.369 -171.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1346 ' ' ILE . . . . . 0.605 HG23 ' HB3' ' B' 1338 ' ' LEU . 39.4 mm -80.51 117.11 25.86 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.416 0 N-CA-C 107.12 -1.437 . . . . 42.490000000000002 107.12 -177.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1347 ' ' THR . . . . . . . . . . . . . 35.6 m -82.73 106.44 14.58 Favored 'General case' 0 C--N 1.352 0.708 0 CA-C-O 123.748 1.737 . . . . 38.119999999999997 108.935 164.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 18.8 t -84.0 93.14 3.14 Favored 'Isoleucine or valine' 0 C--O 1.257 1.457 0 N-CA-C 107.259 -1.386 . . . . 37.5 107.259 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 4.4 t70 -68.86 167.09 16.33 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.179 -1.373 . . . . 43.850000000000001 109.296 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1350 ' ' PHE . . . . . . . . . . . . . 13.5 t80 -131.61 -42.32 1.04 Allowed 'General case' 0 C--N 1.314 -0.945 0 O-C-N 121.023 -1.048 . . . . 39.810000000000002 110.391 169.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -64.51 -39.86 94.57 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 114.607 1.336 . . . . 51.289999999999999 114.607 -174.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 34.4 t70 -62.42 112.95 2.66 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 121.523 -0.736 . . . . 39.780000000000001 111.991 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 27.0 m -47.99 -37.88 6.97 Favored 'Isoleucine or valine' 0 C--N 1.35 0.628 0 N-CA-C 114.101 1.149 . . . . 39.280000000000001 114.101 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1354 ' ' VAL . . . . . 0.499 HG13 ' HB2' ' B' 1124 ' ' ALA . 99.5 t -67.79 -53.96 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 O-C-N 120.311 -1.493 . . . . 35.700000000000003 111.392 -178.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1355 ' ' ILE . . . . . . . . . . . . . 25.0 mm -56.11 -51.79 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 114.153 1.168 . . . . 35.770000000000003 114.153 174.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 43.0 tpt85 -55.43 -31.47 61.92 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 115.725 1.75 . . . . 38.549999999999997 115.725 176.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1357 ' ' GLY . . . . . 0.451 ' HA2' ' HB1' ' B' 1370 ' ' ALA . . . -68.96 -58.84 6.39 Favored Glycine 0 C--N 1.341 0.857 0 C-N-CA 125.855 1.693 . . . . 29.579999999999998 109.934 172.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1358 ' ' VAL . . . . . 0.426 HG22 ' HB3' ' B' 1113 ' ' MET . 13.0 p -71.65 -36.67 60.32 Favored 'Isoleucine or valine' 0 C--O 1.249 1.072 0 O-C-N 120.763 -1.433 . . . . 32.060000000000002 112.152 -171.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1359 ' ' THR . . . . . 0.42 HG23 ' HE3' ' B' 1113 ' ' MET . 54.1 m -78.29 93.22 4.61 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 103.575 -2.75 . . . . 29.0 103.575 -176.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1360 ' ' VAL . . . . . . . . . . . . . 18.6 m -80.17 -27.88 12.08 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 CA-C-N 111.467 -2.606 . . . . 29.68 110.394 -175.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 97.7 mt -128.31 106.64 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.644 -1.243 . . . . 32.049999999999997 107.644 172.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1362 ' ' ARG . . . . . . . . . . . . . 46.1 ttt85 -83.08 90.45 7.05 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 105.643 -1.984 . . . . 32.520000000000003 105.643 172.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1363 ' ' ALA . . . . . 0.431 ' H ' ' HA ' ' B' 1111 ' ' THR . . . 47.35 71.66 0.31 Allowed 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 123.809 1.766 . . . . 35.68 112.786 170.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 85.85 -41.41 3.07 Favored Glycine 0 C--N 1.344 1.026 0 N-CA-C 116.311 1.284 . . . . 34.259999999999998 116.311 -173.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -78.87 112.24 15.84 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 106.508 -1.664 . . . . 51.07 106.508 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 65.5 mt -67.98 93.71 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 O-C-N 120.152 -1.593 . . . . 39.869999999999997 108.167 176.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1367 ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.02 -4.13 54.12 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 126.063 1.745 . . . . 38.009999999999998 113.247 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1368 ' ' TRP . . . . . . . . . . . . . 49.3 t90 -86.52 134.3 38.24 Favored Pre-proline 0 C--O 1.242 0.671 0 N-CA-C 103.248 -2.871 . . . . 42.140000000000001 103.248 168.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -64.6 140.89 43.49 Favored 'Cis proline' 0 N--CA 1.489 1.243 0 N-CA-C 121.457 3.599 . . . . 43.259999999999998 121.457 9.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1370 ' ' ALA . . . . . 0.451 ' HB1' ' HA2' ' B' 1357 ' ' GLY . . . -87.57 160.97 46.57 Favored Pre-proline 0 C--N 1.307 -1.261 0 CA-C-N 113.527 -1.67 . . . . 46.520000000000003 107.243 -174.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -56.25 153.28 34.26 Favored 'Trans proline' 0 C--O 1.245 0.866 0 C-N-CA 125.212 3.941 . . . . 51.950000000000003 111.838 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -63.9 114.13 2.47 Favored 'Trans proline' 0 C--O 1.251 1.146 0 C-N-CA 122.804 2.336 . . . . 56.270000000000003 114.544 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1373 ' ' ILE . . . . . 0.414 HG21 ' H ' ' B' 1120 ' ' ARG . 37.2 mm -93.81 129.85 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 114.588 -1.187 . . . . 60.829999999999998 108.558 -171.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -70.03 121.57 17.69 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-O 123.642 1.687 . . . . 66.099999999999994 109.035 166.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 59.7 t -109.96 127.25 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 113.827 -1.533 . . . . 63.469999999999999 108.545 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.226 -4.764 0 CA-C-N 120.254 1.388 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.209 -1.044 0 CA-C-O 118.445 -0.788 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -47.53 -36.86 11.05 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 123.769 1.747 . . . . 0.0 113.915 168.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 35.4 mp0 -56.14 -42.0 76.27 Favored 'General case' 0 C--O 1.249 1.075 0 C-N-CA 126.308 1.843 . . . . 0.0 108.904 176.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 14.6 m -66.05 -32.62 74.2 Favored 'General case' 0 C--O 1.24 0.583 0 O-C-N 120.026 -1.671 . . . . 0.0 111.122 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 24' ' ' ALA . . . . . 0.498 ' HB1' ' HA ' ' C' ' 186' ' ' LEU . . . -64.31 -46.81 81.92 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 121.438 1.926 . . . . 0.0 111.249 175.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 25' ' ' GLU . . . . . 0.442 ' HA ' ' HE2' ' C' ' 28' ' ' LYS . 24.2 mm-40 -57.38 -35.17 69.65 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 126.356 2.285 . . . . 0.0 113.62 174.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 14.6 tp -68.12 -60.81 2.2 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.31 -1.314 . . . . 0.0 111.219 177.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 7.9 mt -48.4 -43.46 33.98 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 115.931 -1.985 . . . . 0.0 113.746 -169.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 28' ' ' LYS . . . . . 0.442 ' HE2' ' HA ' ' C' ' 25' ' ' GLU . 34.4 pttt -58.05 -30.48 66.21 Favored 'General case' 0 C--O 1.244 0.783 0 O-C-N 125.076 1.485 . . . . 0.0 114.813 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -93.12 -23.76 18.5 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 174.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 53.2 m -57.85 -16.91 13.26 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 120.201 3.408 . . . . 0.0 120.201 -168.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 31' ' ' HIS . . . . . . . . . . . . 0.45 1.3 p-80 53.9 -55.4 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 117.373 2.36 . . . . 0.0 117.373 -174.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 32' ' ' SER . . . . . 0.564 ' HB2' ' HA ' ' C' ' 106' ' ' THR . 68.0 m -108.53 133.88 52.06 Favored 'General case' 0 CA--C 1.476 -1.902 0 O-C-N 118.419 -2.676 . . . . 0.0 110.426 167.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 33' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' C' ' 64' ' ' VAL . 42.6 t -134.38 115.01 19.46 Favored 'Isoleucine or valine' 0 C--N 1.355 0.833 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 174.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 42.5 mt -106.22 100.76 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 35' ' ' ILE . . . . . 0.643 ' O ' ' HD3' ' C' ' 37' ' ' PRO . 84.4 mt -81.59 108.36 14.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 103.719 -2.697 . . . . 0.0 103.719 -177.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 89.2 m -103.56 95.31 7.1 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -171.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 37' ' ' PRO . . . . . 0.643 ' HD3' ' O ' ' C' ' 35' ' ' ILE . 37.6 Cg_exo -63.29 114.1 2.35 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.091 2.528 . . . . 0.0 113.21 176.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.85 -166.44 33.16 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 158.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 39' ' ' TYR . . . . . 0.61 ' HB3' ' HB2' ' C' ' 114' ' ' ALA . 41.0 t80 -50.08 -21.18 1.17 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 175.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 40' ' ' GLY . . . . . 0.569 ' HA3' ' HA3' ' C' ' 113' ' ' GLY . . . -60.24 -38.46 94.57 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-N 121.154 1.797 . . . . 0.0 111.365 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 41' ' ' MET . . . . . 0.614 ' SD ' HD11 ' C' ' 83' ' ' LEU . 26.4 ttm -74.98 -6.73 50.89 Favored 'General case' 0 C--O 1.248 1.018 0 O-C-N 121.271 -1.135 . . . . 0.0 113.887 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.78 -52.26 3.5 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 121.147 1.794 . . . . 0.0 109.16 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.09 -45.57 90.14 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.557 0 O-C-N 123.734 0.646 . . . . 0.0 110.691 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 44' ' ' ALA . . . . . 0.491 ' HB1' ' HB2' ' C' ' 176' ' ' LYS . . . -95.23 144.62 25.67 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 174.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.7 55.58 0.52 Allowed 'General case' 0 CA--C 1.552 1.022 0 CA-C-O 123.118 1.437 . . . . 0.0 112.475 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' C' ' 41' ' ' MET . . . -75.26 -16.13 60.47 Favored 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 120.617 -1.302 . . . . 0.0 111.047 -171.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 47' ' ' GLN . . . . . 0.549 ' HB2' ' HB2' ' C' ' 86' ' ' ALA . 0.0 OUTLIER -69.97 -38.04 75.95 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 117.68 2.474 . . . . 0.0 117.68 177.615 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 48' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -62.22 -36.66 30.33 Favored Pre-proline 0 CA--C 1.517 -0.308 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -175.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 49' ' ' PRO . . . . . 0.586 ' O ' HD11 ' C' ' 183' ' ' LEU . 98.0 Cg_endo -75.19 -28.98 8.4 Favored 'Trans proline' 0 C--N 1.318 -1.026 0 C-N-CA 122.34 2.026 . . . . 0.0 115.223 164.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.93 -35.54 61.4 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 O-C-N 118.38 -2.7 . . . . 0.0 115.318 -170.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.17 -27.12 67.76 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.45 -30.49 66.09 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.2 176.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 53' ' ' ILE . . . . . 0.607 ' HB ' HD12 ' C' ' 183' ' ' LEU . 10.9 tp -76.76 -41.5 33.19 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 O-C-N 120.056 -1.653 . . . . 0.0 107.664 170.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 27.5 m -53.77 -27.26 27.79 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 121.256 1.844 . . . . 0.0 113.662 172.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -57.32 -57.18 13.74 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 121.014 -1.053 . . . . 0.0 108.963 172.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -74.89 -27.87 60.41 Favored 'General case' 0 C--O 1.253 1.266 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 57' ' ' LEU . . . . . 0.422 ' HA ' HD12 ' C' ' 62' ' ' ILE . 95.9 mt -66.16 -47.68 73.23 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 58' ' ' ARG . . . . . 0.462 ' HA ' ' HD2' ' C' ' 58' ' ' ARG . 1.8 tpt180 -66.5 -44.22 83.16 Favored 'General case' 0 C--N 1.359 0.988 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.583 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.72 -30.18 55.39 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 171.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 60' ' ' ARG . . . . . 0.409 ' HD3' HH11 ' C' ' 60' ' ' ARG . 3.9 ttm180 -89.83 8.14 33.51 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 175.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.97 36.75 91.46 Favored Glycine 0 N--CA 1.432 -1.589 0 O-C-N 119.896 -1.753 . . . . 0.0 110.418 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 62' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' C' ' 57' ' ' LEU . 64.1 mt -94.66 126.61 47.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -62.99 91.5 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.326 171.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 7.1 p -107.71 129.68 61.32 Favored 'Isoleucine or valine' 0 C--O 1.258 1.522 0 C-N-CA 119.629 -0.828 . . . . 0.0 108.811 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 23.1 mmm-85 -127.01 156.35 41.77 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 175.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 66' ' ' PHE . . . . . 0.559 ' HB2' ' HA ' ' C' ' 93' ' ' VAL . 33.5 m-85 -117.71 105.4 11.97 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-O 122.65 1.215 . . . . 0.0 108.434 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.92 80.14 1.85 Allowed Glycine 0 C--O 1.24 0.477 0 CA-C-O 117.347 -1.807 . . . . 0.0 109.593 -174.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 68' ' ' ILE . . . . . 0.577 HD13 HG13 ' C' ' 93' ' ' VAL . 1.8 mp -72.06 126.25 32.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 121.447 2.624 . . . . 0.0 109.639 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -94.67 126.43 47.54 Favored Pre-proline 0 N--CA 1.437 -1.082 0 C-N-CA 117.626 -1.63 . . . . 0.0 108.728 -177.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 70' ' ' PRO . . . . . 0.439 ' O ' ' HA ' ' C' ' 76' ' ' PRO . 28.3 Cg_endo -57.92 -62.74 0.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.967 2.444 . . . . 0.0 112.806 175.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 71' ' ' VAL . . . . . 0.408 ' O ' HG23 ' C' ' 117' ' ' THR . 42.4 t -64.01 92.33 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.211 -0.927 0 CA-C-O 123.252 1.501 . . . . 0.0 107.096 166.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 72' ' ' ALA . . . . . 0.406 ' HB2' ' HA2' ' C' ' 77' ' ' GLY . . . -84.19 -32.79 24.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 113.451 -1.704 . . . . 0.0 114.134 -174.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 129.97 -51.23 0.86 Allowed Glycine 0 CA--C 1.504 -0.63 0 CA-C-N 113.302 -1.772 . . . . 0.0 109.26 -171.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 74' ' ' ARG . . . . . 0.506 ' HD3' ' CZ ' ' C' ' 39' ' ' TYR . 2.4 mpt_? -130.86 129.2 42.0 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 101.625 -3.472 . . . . 0.0 101.625 163.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.469 HD11 ' SD ' ' B' 1207 ' ' MET . 1.9 mp 68.59 153.38 0.14 Allowed Pre-proline 0 N--CA 1.441 -0.892 0 C-N-CA 127.034 2.133 . . . . 0.0 115.8 177.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 76' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' C' ' 70' ' ' PRO . 14.9 Cg_endo -57.46 88.31 0.05 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 123.689 2.926 . . . . 0.0 110.659 158.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 77' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' C' ' 72' ' ' ALA . . . 46.17 48.47 15.11 Favored Glycine 0 C--O 1.216 -1.001 0 N-CA-C 118.139 2.016 . . . . 0.0 118.139 175.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -49.91 -24.19 2.37 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 122.032 2.916 . . . . 0.0 116.346 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -63.81 -25.89 68.38 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -69.14 -22.52 63.94 Favored 'General case' 0 CA--C 1.561 1.369 0 O-C-N 124.102 0.876 . . . . 0.0 111.751 -176.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 40.7 t -66.13 -52.97 42.09 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 169.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.462 ' HB3' ' HG2' ' C' ' 47' ' ' GLN . 6.9 mp -57.64 -30.32 65.29 Favored 'General case' 0 CA--C 1.512 -0.499 0 O-C-N 119.944 -1.723 . . . . 0.0 114.319 178.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.614 HD11 ' SD ' ' C' ' 41' ' ' MET . 5.3 mp -64.46 -22.22 66.9 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 117.836 -1.078 . . . . 0.0 113.063 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.99 -34.89 76.02 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 120.338 1.426 . . . . 0.0 113.178 173.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -69.07 -42.3 76.4 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 172.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 86' ' ' ALA . . . . . 0.549 ' HB2' ' HB2' ' C' ' 47' ' ' GLN . . . -66.37 -21.69 66.24 Favored 'General case' 0 C--O 1.213 -0.833 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 177.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp 70.73 45.49 0.57 Allowed 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 128.165 2.586 . . . . 0.0 108.436 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 45.6 t -81.58 130.8 60.1 Favored Pre-proline 0 C--N 1.351 0.672 0 CA-C-O 117.664 -1.16 . . . . 0.0 108.259 174.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -61.81 115.4 2.78 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 124.025 3.15 . . . . 0.0 114.143 176.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 90' ' ' TYR . . . . . 0.582 ' HA ' ' HB ' ' C' ' 93' ' ' VAL . 35.4 m-85 -60.76 -13.09 12.92 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-N 114.765 -1.107 . . . . 0.0 113.481 -177.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -59.16 -51.73 68.76 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 166.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 26.3 pt -82.64 -15.71 11.77 Favored 'Isoleucine or valine' 0 C--O 1.249 1.047 0 CA-C-N 119.169 0.895 . . . . 0.0 110.447 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 93' ' ' VAL . . . . . 0.582 ' HB ' ' HA ' ' C' ' 90' ' ' TYR . 73.5 t -75.59 99.99 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 123.026 1.394 . . . . 0.0 109.453 175.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 94' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' C' ' 97' ' ' ASP . 53.0 mt -103.7 100.44 10.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 113.707 -1.588 . . . . 0.0 112.621 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 95' ' ' GLU . . . . . 0.708 ' HB3' HD13 ' A' 1157 ' ' ILE . 40.9 mp0 -81.06 91.8 6.15 Favored 'General case' 0 C--O 1.267 1.989 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 -178.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.643 ' SD ' ' HB2' ' C' ' 134' ' ' PRO . 31.8 ttp 47.94 73.47 0.21 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 123.892 1.806 . . . . 0.0 115.606 -171.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 97' ' ' ASP . . . . . 0.496 ' HB2' ' HB3' ' C' ' 94' ' ' LEU . 4.2 t70 -91.74 144.42 25.52 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 168.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -92.82 51.9 1.77 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 123.844 1.783 . . . . 0.0 112.247 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 99' ' ' ILE . . . . . 0.557 HG12 ' HB2' ' C' ' 102' ' ' ASP 0.286 10.2 tt -87.22 70.0 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-O 126.978 3.275 . . . . 0.0 108.852 -166.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -54.73 -52.49 62.33 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 108.834 -3.803 . . . . 0.0 114.935 -174.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -62.49 -42.98 99.86 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 118.368 -0.825 . . . . 0.0 112.861 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 102' ' ' ASP . . . . . 0.557 ' HB2' HG12 ' C' ' 99' ' ' ILE . 0.5 OUTLIER -68.54 -39.32 81.18 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-N 119.974 1.261 . . . . 0.0 108.785 -174.257 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 103' ' ' PHE . . . . . 0.458 ' HB3' ' HB2' ' C' ' 137' ' ' GLU . 4.6 m-85 -55.34 -52.5 63.29 Favored 'General case' 0 C--O 1.251 1.173 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 168.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.85 -26.02 67.06 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -75.62 -39.53 57.73 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 106' ' ' THR . . . . . 0.564 ' HA ' ' HB2' ' C' ' 32' ' ' SER . 96.0 m -61.34 141.52 57.53 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 -162.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 107' ' ' ASP . . . . . 0.87 ' HA ' ' HB2' ' C' ' 142' ' ' GLN . 9.9 t0 -71.53 -87.8 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 124.019 0.928 . . . . 0.0 108.714 161.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 108' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' C' ' 143' ' ' ASN . 0.3 OUTLIER -89.09 112.35 23.31 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 122.448 1.118 . . . . 0.0 112.395 -165.362 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 109' ' ' VAL . . . . . 0.682 HG11 HG23 ' C' ' 138' ' ' VAL . 4.4 t -102.92 104.2 16.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 174.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 110' ' ' LEU . . . . . 0.589 HD12 HG12 ' C' ' 35' ' ' ILE . 95.9 mt -88.3 90.6 8.46 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.521 -172.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 28.2 t -81.19 104.84 10.33 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 CA-C-O 124.338 2.018 . . . . 0.0 107.771 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 112' ' ' ILE . . . . . 0.421 ' HB ' ' HA ' ' C' ' 37' ' ' PRO . 45.1 mm -78.24 97.79 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 CA-C-O 122.635 1.207 . . . . 0.0 108.45 -171.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 113' ' ' GLY . . . . . 0.569 ' HA3' ' HA3' ' C' ' 40' ' ' GLY . . . 85.21 -70.45 3.1 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-N 111.275 -2.693 . . . . 0.0 113.738 165.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 114' ' ' ALA . . . . . 0.61 ' HB2' ' HB3' ' C' ' 39' ' ' TYR . . . -87.57 121.84 30.51 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 120.775 -1.427 . . . . 0.0 112.441 -163.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 115' ' ' ASN . . . . . 0.481 ' HB2' ' HE1' ' C' ' 163' ' ' PHE . 10.2 p-10 -85.09 -55.1 4.22 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 118.156 -0.926 . . . . 0.0 113.192 -173.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.19 -38.89 66.12 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 121.298 1.863 . . . . 0.0 109.915 -175.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 117' ' ' THR . . . . . 0.408 HG23 ' O ' ' C' ' 71' ' ' VAL . 67.6 m -33.61 -36.31 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 118.751 2.871 . . . . 0.0 118.751 166.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.46 ' HB ' HG11 ' C' ' 138' ' ' VAL . 26.7 m -119.58 2.53 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-O 117.646 -1.168 . . . . 0.0 110.459 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 119' ' ' ASN . . . . . 0.551 HD21 ' HB3' ' C' ' 121' ' ' ALA . 23.1 t30 -52.09 117.77 10.81 Favored Pre-proline 0 C--O 1.257 1.454 0 CA-C-N 122.472 2.396 . . . . 0.0 115.708 -164.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 120' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' C' ' 119' ' ' ASN . 0.8 OUTLIER -45.1 -59.92 1.0 Allowed 'Trans proline' 0 C--N 1.363 1.339 1 C-N-CA 127.954 5.77 . . . . 0.0 110.706 174.293 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' C' C ' 121' ' ' ALA . . . . . 0.551 ' HB3' HD21 ' C' ' 119' ' ' ASN . . . -48.28 -38.75 19.56 Favored 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 176.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.92 -16.54 63.42 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 118.618 -1.233 . . . . 0.0 114.256 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 123' ' ' GLN . . . . . 0.602 ' HG2' HG23 ' C' ' 135' ' ' VAL . 0.0 OUTLIER -101.25 -41.68 6.61 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 117.359 -1.736 . . . . 0.0 110.892 165.692 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.68 -60.95 2.98 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 126.297 1.839 . . . . 0.0 114.27 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -82.09 117.04 66.92 Favored Pre-proline 0 C--O 1.246 0.918 0 O-C-N 124.851 1.345 . . . . 0.0 111.222 173.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -67.52 -26.53 40.19 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.732 3.621 . . . . 0.0 112.157 176.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 127' ' ' LYS . . . . . 0.49 ' HB3' ' HZ3' ' C' ' 127' ' ' LYS . 6.0 ttpm? -64.96 -28.34 69.45 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 122.445 1.117 . . . . 0.0 113.934 -175.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 128' ' ' SER . . . . . 0.423 ' HA ' ' HD2' ' C' ' 129' ' ' PRO . 70.3 m -32.9 116.66 0.42 Allowed Pre-proline 0 C--N 1.357 0.92 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 166.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 129' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' C' ' 128' ' ' SER . 16.1 Cg_endo -50.03 -48.84 18.03 Favored 'Trans proline' 0 C--O 1.241 0.67 0 C-N-CA 124.042 3.162 . . . . 0.0 111.58 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 13.1 pt -73.97 84.07 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 O-C-N 119.732 -1.855 . . . . 0.0 108.669 168.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 131' ' ' ALA . . . . . 0.411 ' O ' ' HB ' ' B' 1121 ' ' ILE . . . -75.93 119.17 19.54 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -172.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 73.76 78.36 0.57 Allowed Glycine 0 N--CA 1.48 1.57 0 CA-C-N 114.715 -1.13 . . . . 0.0 113.113 177.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 133' ' ' MET . . . . . 0.417 ' SD ' ' HD2' ' C' ' 134' ' ' PRO . 41.6 tpp -76.01 124.06 88.32 Favored Pre-proline 0 C--N 1.313 -0.999 0 O-C-N 118.965 -2.491 . . . . 0.0 109.638 171.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 134' ' ' PRO . . . . . 0.643 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 49.2 Cg_endo -70.62 85.52 0.74 Allowed 'Trans proline' 0 CA--C 1.5 -1.188 0 C-N-CA 123.562 2.841 . . . . 0.0 113.734 176.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 135' ' ' VAL . . . . . 0.602 HG23 ' HG2' ' C' ' 123' ' ' GLN . 0.5 OUTLIER -134.93 137.54 50.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 124.889 2.28 . . . . 0.0 111.233 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -105.17 137.59 42.7 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 111.839 -2.437 . . . . 0.0 107.134 167.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 137' ' ' GLU . . . . . 0.458 ' HB2' ' HB3' ' C' ' 103' ' ' PHE 0.258 6.3 mm-40 23.23 40.68 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.964 1 N-CA-C 122.531 4.271 . . . . 0.0 122.531 166.429 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' C' C ' 138' ' ' VAL . . . . . 0.682 HG23 HG11 ' C' ' 109' ' ' VAL . 13.7 p -88.01 48.35 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 126.228 2.918 . . . . 0.0 109.386 174.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -159.0 148.54 18.92 Favored 'General case' 0 C--O 1.256 1.434 0 CA-C-N 111.185 -2.734 . . . . 0.0 104.597 -172.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 140' ' ' LYS . . . . . . . . . . . . 0.356 23.6 pttm 65.63 -26.57 0.1 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 118.017 2.599 . . . . 0.0 118.017 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -45.4 146.71 0.93 Allowed 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 125.665 1.586 . . . . 0.0 113.614 161.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 142' ' ' GLN . . . . . 0.87 ' HB2' ' HA ' ' C' ' 107' ' ' ASP . 21.0 mt-30 -58.62 -28.88 66.05 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 120.136 3.384 . . . . 0.0 120.136 -151.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 143' ' ' ASN . . . . . 0.511 ' O ' ' HA ' ' C' ' 108' ' ' THR . 2.5 t-20 -153.57 87.51 1.24 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 172.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 144' ' ' VAL . . . . . 0.684 ' HB ' ' HA ' ' C' ' 168' ' ' THR . 37.4 t -81.24 89.76 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.146 0 O-C-N 119.803 -1.811 . . . . 0.0 107.358 177.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 145' ' ' ILE . . . . . . . . . . . . . 21.7 mt -92.28 104.63 15.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 125.545 2.593 . . . . 0.0 107.977 -173.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 146' ' ' VAL . . . . . 0.652 ' HB ' ' HA ' ' C' ' 170' ' ' MET . 10.0 t -86.25 102.7 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 CA-C-N 111.38 -2.645 . . . . 0.0 107.552 176.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 147' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -64.34 94.48 0.11 Allowed 'General case' 0 C--O 1.242 0.7 0 CA-C-O 122.372 1.082 . . . . 0.0 112.105 177.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 148' ' ' LYS . . . . . 0.642 ' O ' ' HA ' ' C' ' 172' ' ' PHE . 20.9 mmmt -128.22 111.59 13.59 Favored 'General case' 0 CA--C 1.485 -1.541 0 C-N-CA 123.98 0.912 . . . . 0.0 109.352 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 10.7 ptp85 -54.0 -31.96 52.59 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 174.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 19.4 m -153.0 155.47 36.98 Favored 'General case' 0 C--O 1.249 1.067 0 O-C-N 118.682 -2.511 . . . . 0.0 106.185 -170.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 151' ' ' MET . . . . . 0.608 ' SD ' ' SD ' ' C' ' 170' ' ' MET . 6.8 tpt -88.03 67.17 8.87 Favored 'General case' 0 C--O 1.254 1.329 0 CA-C-O 125.865 2.745 . . . . 0.0 108.074 177.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -94.93 117.32 29.93 Favored 'General case' 0 N--CA 1.44 -0.958 0 O-C-N 119.636 -1.915 . . . . 0.0 106.109 170.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 7.4 m -64.18 138.99 58.72 Favored 'General case' 0 C--O 1.249 1.074 0 CA-C-N 113.286 -1.779 . . . . 0.0 107.696 171.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -86.85 -53.42 2.87 Favored Glycine 0 C--O 1.214 -1.105 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -132.17 -78.3 0.5 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 118.002 0.901 . . . . 0.0 108.901 164.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 156' ' ' ALA . . . . . . . . . . . . . . . -86.71 -61.44 1.73 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -170.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.81 28.85 5.69 Favored Glycine 0 C--N 1.353 1.475 0 C-N-CA 127.387 2.422 . . . . 0.0 114.654 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 6.1 m -54.76 138.97 14.26 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 N-CA-C 119.414 3.116 . . . . 0.0 119.414 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . 0.263 0.0 OUTLIER 6.76 92.53 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.974 1 N-CA-C 122.811 4.375 . . . . 0.0 122.811 173.663 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' C' C ' 160' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -150.1 152.16 33.25 Favored Pre-proline 0 N--CA 1.469 0.493 0 CA-C-O 117.602 -1.19 . . . . 0.0 112.952 -174.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.76 -27.85 37.41 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 124.551 3.501 . . . . 0.0 114.025 167.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 162' ' ' LEU . . . . . 0.583 ' HA ' HG22 ' C' ' 168' ' ' THR . 16.3 tp -43.8 -31.5 0.84 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 119.415 3.117 . . . . 0.0 119.415 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 163' ' ' PHE . . . . . 0.532 ' HA ' ' HG3' ' C' ' 170' ' ' MET . 14.0 m-30 -85.7 -60.62 1.97 Allowed 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 124.611 2.148 . . . . 0.0 109.749 171.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -82.8 -7.43 59.66 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-N 111.752 -2.476 . . . . 0.0 113.97 -158.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -91.71 177.16 6.28 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 122.0 0.905 . . . . 0.0 110.611 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.77 -51.98 4.66 Favored 'General case' 0 C--O 1.254 1.316 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -174.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 167' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' C' ' 142' ' ' GLN . 20.7 p-10 -78.88 -45.55 20.44 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 120.552 -1.342 . . . . 0.0 111.344 177.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 168' ' ' THR . . . . . 0.684 ' HA ' ' HB ' ' C' ' 144' ' ' VAL . 3.0 m -89.75 95.15 10.12 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 101.495 -3.52 . . . . 0.0 101.495 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -150.26 132.3 15.27 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 123.662 1.696 . . . . 0.0 112.302 -162.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 170' ' ' MET . . . . . 0.652 ' HA ' ' HB ' ' C' ' 146' ' ' VAL . 33.7 mtm -64.88 110.78 2.55 Favored 'General case' 0 C--O 1.253 1.288 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 165.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 171' ' ' LEU . . . . . . . . . . . . . 15.2 tp -91.16 124.01 35.05 Favored 'General case' 0 C--O 1.256 1.401 0 N-CA-C 103.545 -2.761 . . . . 0.0 103.545 172.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 172' ' ' PHE . . . . . 0.642 ' HA ' ' O ' ' C' ' 148' ' ' LYS . 3.6 m-85 -70.76 82.74 0.63 Allowed 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 111.774 -2.466 . . . . 0.0 115.317 -175.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -157.97 147.5 15.52 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 106.611 -2.595 . . . . 0.0 106.611 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 174' ' ' ASP . . . . . 0.641 ' HB3' ' HB3' ' C' ' 177' ' ' ALA . 14.1 t70 -63.69 147.69 50.99 Favored 'General case' 0 N--CA 1.431 -1.378 0 O-C-N 121.706 -0.879 . . . . 0.0 112.609 172.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -52.24 -60.22 3.47 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 176' ' ' LYS . . . . . 0.491 ' HB2' ' HB1' ' C' ' 44' ' ' ALA . 0.0 OUTLIER -69.01 -48.8 62.14 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 -171.892 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 177' ' ' ALA . . . . . 0.641 ' HB3' ' HB3' ' C' ' 174' ' ' ASP . . . -55.25 -50.55 69.18 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 127.03 2.706 . . . . 0.0 109.978 -176.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 44.2 m -68.26 -32.87 73.35 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.941 -1.1 . . . . 0.0 110.697 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 179' ' ' VAL . . . . . . . . . . . . . 86.9 t -62.87 -45.51 98.68 Favored 'Isoleucine or valine' 0 C--N 1.343 0.287 0 CA-C-N 119.642 1.11 . . . . 0.0 108.421 176.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -68.06 -28.9 67.77 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 119.966 -1.709 . . . . 0.0 111.471 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -64.99 -56.27 14.12 Favored 'General case' 0 C--N 1.348 0.536 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 182' ' ' ILE . . . . . 0.432 ' HA ' ' HB2' ' C' ' 24' ' ' ALA . 23.8 pt -64.29 -33.47 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 183' ' ' LEU . . . . . 0.607 HD12 ' HB ' ' C' ' 53' ' ' ILE . 5.9 tp -32.02 -50.62 0.22 Allowed 'General case' 0 C--O 1.248 1.012 0 C-N-CA 128.934 2.894 . . . . 0.0 118.565 -171.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -123.79 -7.11 7.92 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.633 169.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -62.39 -44.12 97.2 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -170.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 186' ' ' LEU . . . . . 0.498 ' HA ' ' HB1' ' C' ' 24' ' ' ALA 0.331 88.1 mt . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 121.588 3.922 . . . . 0.0 121.588 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 9.8 t-80 . . . . . 0 N--CA 1.444 -0.738 0 N-CA-C 103.958 -2.608 . . . . 65.739999999999995 103.958 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -75.04 78.28 1.09 Allowed Glycine 0 C--O 1.256 1.487 0 CA-C-O 119.067 -0.852 . . . . 48.659999999999997 112.326 -174.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 24.2 ttp180 -86.81 131.98 33.97 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 120.045 1.922 . . . . 44.560000000000002 106.289 153.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1003 ' ' ILE . . . . . 0.522 ' HA ' ' O ' ' A' 1068 ' ' ILE . 39.9 mt -101.4 124.74 55.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 102.471 -3.159 . . . . 34.859999999999999 102.471 177.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1004 ' ' GLY . . . . . 0.663 ' O ' ' HD3' ' A' 1006 ' ' PRO . . . -88.1 129.25 9.47 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 107.486 -2.245 . . . . 30.75 107.486 165.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.746 HG23 ' HB3' ' A' 1017 ' ' ALA . 48.2 mm -98.63 99.55 7.77 Favored Pre-proline 0 C--O 1.249 1.027 0 N-CA-C 105.647 -1.982 . . . . 32.210000000000001 105.647 174.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1006 ' ' PRO . . . . . 0.663 ' HD3' ' O ' ' A' 1004 ' ' GLY . 99.5 Cg_exo -71.51 131.03 18.1 Favored 'Trans proline' 0 CA--C 1.499 -1.24 0 C-N-CA 123.779 2.986 . . . . 32.979999999999997 109.317 174.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1007 ' ' ARG . . . . . 0.481 ' HG2' HD12 ' A' 1042 ' ' LEU . 7.1 ttp85 -73.86 121.34 20.75 Favored 'General case' 0 C--O 1.255 1.347 0 CA-C-N 110.284 -3.144 . . . . 47.979999999999997 106.734 155.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1008 ' ' GLU . . . . . 0.428 ' CD ' ' HZ2' ' A' 1071 ' ' LYS . 6.4 tp10 -73.33 133.33 43.81 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 123.306 1.527 . . . . 34.700000000000003 112.956 -165.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -97.86 9.43 42.7 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 112.805 -1.998 . . . . 53.369999999999997 111.456 -174.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 17.7 tp -70.28 146.54 50.53 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 117.211 -1.796 . . . . 45.07 106.396 168.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1011 ' ' THR . . . . . . . . . . . . . 5.7 m -54.58 146.42 16.51 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-O 117.7 -1.143 . . . . 40.359999999999999 110.698 174.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 76.8 m-20 61.81 -10.67 0.07 Allowed 'General case' 0 C--O 1.258 1.508 0 N-CA-C 119.089 2.996 . . . . 40.609999999999999 119.089 -175.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1013 ' ' GLU . . . . . 0.544 ' HG3' ' H ' ' A' 1015 ' ' ARG . 8.6 tp10 -68.99 114.93 7.73 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 124.35 2.024 . . . . 33.759999999999998 113.838 -160.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1014 ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.56 -26.95 68.93 Favored 'General case' 0 N--CA 1.427 -1.597 1 CA-C-N 108.27 -4.059 . . . . 27.890000000000001 114.86 174.518 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 1015 ' ' ARG . . . . . 0.676 ' HB3' HG11 ' A' 1072 ' ' VAL . 57.8 mtm180 -79.81 151.32 30.35 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 126.65 3.119 . . . . 29.02 116.621 -171.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1016 ' ' VAL . . . . . . . . . . . . . 2.6 p -115.8 169.02 6.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 1 CA-C-N 107.745 -4.298 . . . . 28.129999999999999 106.655 160.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1017 ' ' ALA . . . . . 0.746 ' HB3' HG23 ' A' 1005 ' ' ILE . . . -60.98 -46.92 88.81 Favored 'General case' 0 C--O 1.217 -0.617 0 O-C-N 119.296 -2.128 . . . . 26.870000000000001 113.45 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -155.82 133.55 11.15 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 120.838 -1.164 . . . . 26.77 108.516 -175.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1019 ' ' THR . . . . . 0.471 HG21 HG23 ' A' 1321 ' ' THR . 0.6 OUTLIER -85.41 167.39 25.6 Favored Pre-proline 0 C--O 1.239 0.517 0 O-C-N 120.36 -1.462 . . . . 27.02 114.539 177.173 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 1020 ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -42.87 -53.57 3.87 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 124.667 3.578 . . . . 30.57 119.546 -174.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 9.5 tttp -58.28 -39.26 78.81 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 124.111 1.91 . . . . 47.810000000000002 112.853 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1022 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.57 -40.38 92.71 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 113.188 -1.824 . . . . 30.77 109.833 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1023 ' ' VAL . . . . . 0.518 HG13 HG11 ' A' 1033 ' ' VAL . 8.9 t -59.75 -42.61 89.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 118.953 -0.546 . . . . 33.590000000000003 110.475 176.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -49.32 -46.44 46.68 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 124.165 0.915 . . . . 53.289999999999999 112.05 172.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -68.04 -32.74 73.32 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.97 0.89 . . . . 46.920000000000002 111.383 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1026 ' ' LEU . . . . . 0.419 ' CD2' HG22 ' A' 1332 ' ' VAL . 99.0 mt -68.61 -41.53 79.41 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.166 -1.584 . . . . 37.170000000000002 112.434 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1027 ' ' LEU . . . . . 0.44 HD22 ' HA3' ' A' 1054 ' ' GLY . 36.0 tp -61.67 -50.69 71.47 Favored 'General case' 0 C--O 1.254 1.294 0 CA-C-N 111.928 -2.396 . . . . 44.439999999999998 107.039 173.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -48.79 -41.62 33.15 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 116.762 2.134 . . . . 52.579999999999998 116.762 171.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1029 ' ' LEU . . . . . . . . . . . . . 77.0 mt -71.78 -11.32 60.76 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 121.467 1.939 . . . . 45.689999999999998 110.21 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 110.84 33.28 2.45 Favored Glycine 0 C--O 1.244 0.756 0 CA-C-O 122.971 1.317 . . . . 42.090000000000003 111.641 166.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1031 ' ' PHE . . . . . 0.646 ' HZ ' ' SG ' ' A' 1339 ' ' CYS . 50.1 m-85 -117.19 155.14 29.9 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 118.584 -2.715 . . . . 40.719999999999999 109.785 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1032 ' ' THR . . . . . . . . . . . . . 40.1 m -86.62 114.93 23.74 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 104.225 -2.509 . . . . 37.770000000000003 104.225 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1033 ' ' VAL . . . . . 0.518 HG11 HG13 ' A' 1023 ' ' VAL . 19.3 t -88.77 125.78 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 105.837 -1.912 . . . . 33.539999999999999 105.837 -177.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -117.26 126.37 52.63 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 104.446 -2.428 . . . . 31.68 104.446 173.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1035 ' ' VAL . . . . . 0.541 ' HA ' ' HB ' ' A' 1005 ' ' ILE . 59.4 t -116.01 145.69 21.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 105.1 -2.185 . . . . 31.52 105.1 -177.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1036 ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -69.38 133.47 47.84 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 122.971 0.509 . . . . 41.039999999999999 111.915 174.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1037 ' ' SER . . . . . . . . . . . . . 54.4 m -54.89 123.33 13.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 123.926 1.822 . . . . 31.829999999999998 114.414 168.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 99.83 -8.14 59.5 Favored Glycine 0 N--CA 1.444 -0.806 0 O-C-N 119.035 -2.29 . . . . 29.359999999999999 112.159 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -64.53 -34.19 77.67 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 113.898 1.073 . . . . 27.780000000000001 113.898 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1040 ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' 1046 ' ' ASP . . . -59.76 -19.48 49.49 Favored Glycine 0 N--CA 1.427 -1.963 0 CA-C-N 112.14 -2.3 . . . . 28.91 114.648 175.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -76.24 -44.94 35.26 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 120.076 1.938 . . . . 51.18 110.646 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1042 ' ' LEU . . . . . 0.481 HD12 ' HG2' ' A' 1007 ' ' ARG . 20.6 mt -64.32 -50.01 69.5 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.949 0.881 . . . . 29.91 111.39 173.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1043 ' ' ALA . . . . . 0.411 ' HB3' ' HA2' ' A' 1040 ' ' GLY 0.267 . . -53.5 -22.65 8.46 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 112.807 -1.997 . . . . 28.539999999999999 114.477 172.853 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 1044 ' ' SER . . . . . . . . . . . . . 15.5 m 53.98 44.93 28.65 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 124.688 2.185 . . . . 33.060000000000002 110.281 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1045 ' ' PHE . . . . . 0.437 ' HA ' ' HB3' ' B' 1277 ' ' ALA . 0.1 OUTLIER -167.59 102.82 0.5 Allowed 'General case' 0 C--O 1.249 1.066 0 N-CA-C 100.292 -3.966 . . . . 30.289999999999999 100.292 178.105 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 1046 ' ' ASP . . . . . 0.5 ' HA ' ' HA3' ' A' 1040 ' ' GLY . 2.9 p-10 -84.51 168.85 15.05 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 123.479 1.609 . . . . 48.619999999999997 114.464 -151.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1047 ' ' ASP . . . . . 0.479 ' HA ' ' HD2' ' A' 1050 ' ' PHE . 2.8 m-20 -46.01 -45.85 16.16 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 112.499 -2.137 . . . . 36.740000000000002 115.609 -172.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 22.5 pttm -54.21 -40.71 67.88 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 115.191 1.552 . . . . 43.729999999999997 115.191 169.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -65.02 -31.52 72.8 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 119.752 1.16 . . . . 32.810000000000002 112.275 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1050 ' ' PHE . . . . . 0.479 ' HD2' ' HA ' ' A' 1047 ' ' ASP . 58.4 m-85 -64.01 -42.37 97.16 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 111.612 0.227 . . . . 31.859999999999999 111.612 169.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 41.3 t -61.68 -46.61 96.18 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 N-CA-C 106.774 -1.565 . . . . 33.219999999999999 106.774 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -55.15 -37.06 66.47 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 123.914 0.885 . . . . 50.829999999999998 112.521 174.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -62.56 -41.45 98.93 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 120.065 1.302 . . . . 33.119999999999997 112.578 172.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1054 ' ' GLY . . . . . 0.44 ' HA3' HD22 ' A' 1027 ' ' LEU . . . 120.31 81.36 0.67 Allowed Glycine 0 C--O 1.21 -1.399 0 N-CA-C 106.039 -2.824 . . . . 35.829999999999998 106.039 -177.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -161.06 132.22 5.45 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 125.162 1.154 . . . . 34.82 109.204 -173.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -71.19 135.3 47.48 Favored 'General case' 0 N--CA 1.44 -0.945 0 O-C-N 126.727 2.517 . . . . 49.049999999999997 107.201 166.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1057 ' ' ILE . . . . . . . . . . . . . 36.1 mm -104.43 125.95 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 101.951 -3.351 . . . . 38.530000000000001 101.951 169.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1058 ' ' VAL . . . . . 0.556 ' HB ' ' HB ' ' A' 1063 ' ' VAL . 44.1 t -102.29 135.72 37.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 103.566 -2.753 . . . . 42.109999999999999 103.566 174.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -69.38 76.08 0.38 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 114.13 1.159 . . . . 58.0 114.13 178.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1060 ' ' GLY . . . . . 0.466 ' O ' HG12 ' A' 1063 ' ' VAL . . . 80.08 -129.83 9.38 Favored Glycine 0 N--CA 1.422 -2.253 0 C-N-CA 121.092 -0.575 . . . . 52.119999999999997 113.187 177.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 29.4 t30 -46.79 -40.14 13.13 Favored 'General case' 0 C--O 1.217 -0.612 0 N-CA-C 117.963 2.579 . . . . 54.75 117.963 -156.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1062 ' ' SER . . . . . . . . . . . . . 15.3 m -67.79 -9.36 43.58 Favored 'General case' 0 C--O 1.247 0.932 0 O-C-N 118.23 -2.794 . . . . 50.340000000000003 116.468 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1063 ' ' VAL . . . . . 0.556 ' HB ' ' HB ' ' A' 1058 ' ' VAL . 8.3 p -64.08 -26.57 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 O-C-N 120.763 -1.211 . . . . 41.460000000000001 111.444 169.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1064 ' ' TRP . . . . . . . . . . . . . 76.8 m95 -72.42 -23.01 61.02 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.941 1.296 . . . . 39.32 112.312 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -83.49 73.58 10.18 Favored 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 120.743 -1.223 . . . . 55.380000000000003 109.058 175.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1066 ' ' SER . . . . . . . . . . . . . 70.5 m -146.34 164.7 31.56 Favored 'General case' 0 C--O 1.257 1.468 0 CA-C-O 121.661 0.743 . . . . 41.869999999999997 109.983 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.11 -66.84 0.63 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.04 -0.982 . . . . 53.200000000000003 109.571 -176.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1068 ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' 1003 ' ' ILE . 31.4 mt -88.63 110.48 21.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 O-C-N 118.236 -2.79 . . . . 41.899999999999999 104.97 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1069 ' ' ILE . . . . . . . . . . . . . 28.1 mm -102.12 119.42 50.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 107.046 -1.465 . . . . 38.729999999999997 107.046 168.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1070 ' ' LEU . . . . . 0.681 ' HB3' HD13 ' A' 1331 ' ' LEU . 81.6 mt -88.02 74.83 8.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.736 -1.12 . . . . 32.439999999999998 110.126 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1071 ' ' LYS . . . . . 0.576 ' HE2' ' HA ' ' A' 1075 ' ' PRO . 5.1 mmmt -71.54 128.65 36.53 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 121.98 0.895 . . . . 34.649999999999999 111.111 -176.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1072 ' ' VAL . . . . . 0.676 HG11 ' HB3' ' A' 1015 ' ' ARG . 0.8 OUTLIER -82.04 -30.7 10.08 Favored 'Isoleucine or valine' 0 C--O 1.251 1.17 0 N-CA-C 109.167 -0.679 . . . . 31.32 109.167 -163.083 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 1073 ' ' ASN . . . . . 0.448 ' O ' ' HE3' ' A' 1071 ' ' LYS . 73.1 m-20 -128.61 -171.1 2.38 Favored 'General case' 0 C--O 1.246 0.902 0 N-CA-C 108.305 -0.998 . . . . 33.939999999999998 108.305 171.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -54.5 141.89 52.85 Favored Pre-proline 0 N--CA 1.47 0.556 0 CA-C-N 119.783 1.174 . . . . 38.039999999999999 112.069 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1075 ' ' PRO . . . . . 0.69 ' HG2' HD21 ' A' 1089 ' ' LEU . 82.2 Cg_exo -72.76 130.56 15.93 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.37 2.047 . . . . 42.68 112.892 173.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 17.8 mt -105.98 165.13 11.43 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 103.969 -2.604 . . . . 46.740000000000002 103.969 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1077 ' ' ASP . . . . . 0.422 ' O ' ' HB ' ' A' 1080 ' ' ILE . 75.3 m-20 -31.01 -58.7 0.22 Allowed 'General case' 0 C--N 1.357 0.909 0 N-CA-C 117.057 2.243 . . . . 58.609999999999999 117.057 -173.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 13.8 t70 -62.79 -43.63 98.28 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 113.496 0.924 . . . . 59.200000000000003 113.496 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1079 ' ' GLU . . . . . 0.433 ' CD ' ' HZ3' ' A' 1071 ' ' LYS . 33.4 mt-10 -64.93 -37.88 89.1 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 113.581 0.956 . . . . 50.630000000000003 113.581 176.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1080 ' ' ILE . . . . . 0.522 HG12 HD21 ' A' 1105 ' ' LEU . 25.0 mt -54.01 -54.03 23.48 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.88 0 CA-C-N 112.906 -1.952 . . . . 51.479999999999997 108.882 175.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -59.34 -25.69 64.41 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 123.812 1.768 . . . . 50.280000000000001 114.315 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 61.5 mt -77.92 -41.88 34.98 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 120.48 -1.387 . . . . 50.210000000000001 111.424 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1083 ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' 1080 ' ' ILE . 0.0 OUTLIER -55.27 139.92 40.88 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 123.93 1.824 . . . . 49.060000000000002 112.936 -178.119 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -101.8 152.69 38.17 Favored Pre-proline 0 N--CA 1.435 -1.185 0 CA-C-N 112.197 -2.274 . . . . 51.079999999999998 108.543 -156.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -64.07 109.67 1.18 Allowed 'Trans proline' 0 C--N 1.322 -0.824 0 CA-C-N 121.446 1.552 . . . . 49.729999999999997 114.006 170.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 110.94 -7.04 29.3 Favored Glycine 0 C--N 1.316 -0.539 0 C-N-CA 119.103 -1.522 . . . . 47.710000000000001 113.424 -171.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1087 ' ' THR . . . . . 0.6 ' HB ' HG12 ' A' 1110 ' ' VAL . 2.8 m -64.18 118.35 8.46 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 117.487 0.643 . . . . 45.469999999999999 110.921 176.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1088 ' ' THR . . . . . . . . . . . . . 99.2 m -83.86 93.51 8.02 Favored 'General case' 0 N--CA 1.411 -2.4 0 N-CA-C 104.491 -2.411 . . . . 42.039999999999999 104.491 172.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1089 ' ' LEU . . . . . 0.69 HD21 ' HG2' ' A' 1075 ' ' PRO . 55.0 tp -84.88 87.31 7.33 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 110.321 -3.127 . . . . 38.060000000000002 108.796 -174.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 15.8 t -83.11 120.16 33.91 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.813 0 N-CA-C 105.2 -2.148 . . . . 37.399999999999999 105.2 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1091 ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' 1071 ' ' LYS . 13.7 p -154.46 143.38 20.99 Favored 'General case' 0 C--O 1.247 0.974 0 O-C-N 119.454 -2.029 . . . . 36.159999999999997 114.897 -168.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 45.5 t80 -84.26 82.48 8.36 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-O 124.138 1.923 . . . . 38.939999999999998 109.694 168.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.28 -31.39 3.7 Favored 'Isoleucine or valine' 0 C--O 1.254 1.294 0 N-CA-C 116.865 2.172 . . . . 42.170000000000002 116.865 -169.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 99.0 m95 58.5 75.08 0.55 Allowed Pre-proline 0 C--O 1.247 0.932 0 CA-C-O 122.782 1.277 . . . . 46.509999999999998 113.039 -168.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1095 ' ' PRO . . . . . 0.563 ' HG3' HG11 ' A' 1360 ' ' VAL . 46.7 Cg_endo -60.04 -40.81 58.05 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 124.613 3.542 . . . . 49.759999999999998 115.687 -172.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1096 ' ' ALA . . . . . 0.457 ' HA ' ' HZ2' ' A' 1368 ' ' TRP . . . -61.15 -29.31 69.71 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.633 1.206 . . . . 52.619999999999997 113.84 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1097 ' ' GLN . . . . . 0.537 ' NE2' ' HA2' ' A' 1260 ' ' GLY . 28.0 mp0 -83.84 -24.27 30.99 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 106.276 -1.75 . . . . 60.740000000000002 106.276 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1098 ' ' ASN . . . . . 0.487 ' HB3' ' HB3' ' A' 1101 ' ' LEU . 61.1 m-80 -122.15 55.05 5.9 Favored Pre-proline 0 C--O 1.239 0.514 0 O-C-N 119.817 -1.802 . . . . 58.189999999999998 115.426 -168.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.01 -41.57 73.64 Favored 'Trans proline' 0 N--CA 1.476 0.478 1 C-N-CA 125.891 4.394 . . . . 54.590000000000003 114.218 -176.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -47.69 77.2 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.027 -0.988 . . . . 63.280000000000001 111.845 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1101 ' ' LEU . . . . . 0.487 ' HB3' ' HB3' ' A' 1098 ' ' ASN . 7.6 tp -56.89 -41.43 78.07 Favored 'General case' 0 C--O 1.254 1.307 0 CA-C-N 113.304 -1.771 . . . . 54.75 112.288 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1102 ' ' MET . . . . . 0.46 ' HE1' ' HB ' ' A' 1360 ' ' VAL . 75.0 mmm -57.09 -49.0 77.22 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 126.204 2.19 . . . . 52.649999999999999 109.598 174.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -65.01 -35.34 80.89 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.41 1.005 . . . . 66.260000000000005 111.116 -175.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -64.87 -43.88 91.53 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 109.136 -0.69 . . . . 63.729999999999997 109.136 177.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1105 ' ' LEU . . . . . 0.522 HD21 HG12 ' A' 1080 ' ' ILE . 49.0 mt -69.51 -30.57 68.45 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.926 0.869 . . . . 54.68 112.593 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -55.63 -48.92 74.13 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.482 0.919 . . . . 53.640000000000001 113.482 165.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -52.57 -46.58 66.92 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 114.479 1.289 . . . . 67.239999999999995 114.479 173.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -58.39 -22.16 52.87 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.702 -0.681 . . . . 65.760000000000005 111.95 174.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 45.2 t30 68.58 44.33 1.23 Allowed 'General case' 0 C--O 1.239 0.552 0 CA-C-O 124.322 2.011 . . . . 58.710000000000001 112.075 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1110 ' ' VAL . . . . . 0.6 HG12 ' HB ' ' A' 1087 ' ' THR . 28.3 m -93.11 165.7 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 O-C-N 119.288 -2.132 . . . . 46.630000000000003 112.109 175.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1111 ' ' THR . . . . . 0.485 HG21 HG21 ' A' 1348 ' ' VAL . 58.7 m -102.32 101.4 11.65 Favored 'General case' 0 C--O 1.214 -0.794 0 O-C-N 119.281 -2.137 . . . . 44.130000000000003 110.078 165.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1112 ' ' VAL . . . . . 0.679 HG22 HD23 ' A' 1089 ' ' LEU . 48.6 t -90.96 117.58 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 109.513 -0.551 . . . . 40.439999999999998 109.513 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1113 ' ' MET . . . . . 0.744 ' SD ' HD21 ' A' 1338 ' ' LEU . 58.3 mtp -112.61 108.16 17.13 Favored 'General case' 0 N--CA 1.422 -1.842 0 C-N-CA 124.105 0.962 . . . . 50.759999999999998 108.788 178.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1114 ' ' ALA . . . . . 0.603 ' HB3' ' HB2' ' A' 1117 ' ' SER . . . -81.37 115.42 20.71 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 116.065 -0.516 . . . . 35.640000000000001 111.575 -172.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1115 ' ' MET . . . . . 0.502 ' SD ' HD22 ' A' 1334 ' ' LEU . 93.5 mmm -76.0 -21.0 57.37 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 123.616 1.674 . . . . 38.740000000000002 114.877 -176.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -62.73 -50.38 71.33 Favored 'General case' 0 CA--C 1.482 -1.643 0 CA-C-N 112.767 -2.015 . . . . 40.140000000000001 111.692 163.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1117 ' ' SER . . . . . 0.603 ' HB2' ' HB3' ' A' 1114 ' ' ALA . 75.8 m -76.12 22.22 0.16 Allowed 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 118.866 2.913 . . . . 44.789999999999999 118.866 -175.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1118 ' ' VAL . . . . . 0.499 ' HA ' HG22 ' A' 1358 ' ' VAL . 59.9 t -66.12 130.75 94.36 Favored Pre-proline 0 C--O 1.249 1.063 0 N-CA-C 107.322 -1.362 . . . . 43.75 107.322 175.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -61.63 133.64 46.53 Favored 'Trans proline' 0 N--CA 1.428 -2.33 0 N-CA-C 107.903 -1.614 . . . . 48.93 107.903 175.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1120 ' ' ARG . . . . . 0.456 ' HD2' ' O ' ' A' 1118 ' ' VAL . 23.4 mmm-85 -79.5 41.02 0.46 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 113.861 -1.518 . . . . 62.899999999999999 114.665 -161.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 18.1 pt -116.56 155.15 18.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 O-C-N 119.978 -1.701 . . . . 57.719999999999999 113.132 -167.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1122 ' ' SER . . . . . . . . . . . . . 2.8 m -27.23 -64.73 0.08 Allowed 'General case' 0 C--N 1.312 -1.024 0 O-C-N 127.07 2.731 . . . . 57.259999999999998 116.637 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 39.9 ptt85 -68.53 -22.36 64.52 Favored 'General case' 0 C--N 1.353 0.726 0 O-C-N 119.655 -1.903 . . . . 62.899999999999999 112.428 -172.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1124 ' ' ALA . . . . . 0.409 ' HA ' HD13 ' A' 1127 ' ' LEU . . . -77.68 -13.66 59.84 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 115.108 1.521 . . . . 49.829999999999998 115.108 174.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 42.0 mm-40 -59.85 -29.22 68.14 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 119.04 2.978 . . . . 52.369999999999997 119.04 -165.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1126 ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' B' 1160 ' ' ALA . 15.8 m -69.96 -22.28 63.17 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 115.43 1.641 . . . . 42.43 115.43 168.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1127 ' ' LEU . . . . . 0.566 HD23 HD12 ' A' 1334 ' ' LEU . 3.3 mp -88.22 -45.48 10.05 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.179 -2.156 . . . . 43.740000000000002 105.179 177.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 30.3 t0 -50.45 109.23 0.29 Allowed 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 116.238 1.94 . . . . 43.210000000000001 116.238 -176.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -79.04 -30.06 43.9 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.68 -1.6 . . . . 35.740000000000002 113.134 176.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 80.8 mt -72.7 -6.52 45.01 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 119.545 -1.972 . . . . 38.090000000000003 111.945 175.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1131 ' ' SER . . . . . 0.556 ' HB3' HG11 ' A' 1175 ' ' VAL . 32.9 m -94.73 -57.66 2.4 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 107.801 -1.185 . . . . 36.909999999999997 107.801 161.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1132 ' ' SER . . . . . . . . . . . . . 22.2 m -77.28 -51.9 10.1 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 117.094 -1.431 . . . . 35.789999999999999 113.848 -169.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1133 ' ' MET . . . . . 0.582 ' HA ' HD12 ' A' 1136 ' ' ILE . 81.6 mtp -58.25 -37.81 75.67 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 124.274 3.215 . . . . 30.809999999999999 110.045 173.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1134 ' ' ALA . . . . . 0.514 ' HB1' ' HB2' ' A' 1176 ' ' ALA . . . -65.98 -34.19 77.53 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 120.538 -0.465 . . . . 28.879999999999999 110.333 177.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1135 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.79 -46.21 91.4 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 120.704 -1.248 . . . . 40.759999999999998 108.938 173.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1136 ' ' ILE . . . . . 0.893 HD13 ' HA ' ' A' 1323 ' ' SER . 16.8 mt -56.78 -50.65 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 117.631 -1.176 . . . . 31.539999999999999 111.745 172.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1137 ' ' ALA . . . . . 0.526 ' HB2' ' HG3' ' A' 1316 ' ' PRO . . . -53.56 -38.41 63.85 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 114.672 1.36 . . . . 29.870000000000001 114.672 169.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -63.9 -41.41 98.73 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-O 123.41 1.561 . . . . 28.73 111.652 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 17.0 t80 -71.68 -46.37 59.03 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-N 114.16 -1.02 . . . . 30.390000000000001 110.428 176.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1140 ' ' ARG . . . . . 0.513 HH11 HD13 ' A' 1319 ' ' LEU . 14.9 tpt180 -67.94 -19.97 65.03 Favored 'General case' 0 C--N 1.356 0.884 0 N-CA-C 107.949 -1.13 . . . . 26.09 107.949 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1141 ' ' ALA . . . . . 0.445 ' HB1' HG21 ' A' 1282 ' ' VAL . . . -62.89 -48.66 78.04 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 106.833 -1.543 . . . . 27.100000000000001 106.833 172.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 36.3 mm -64.53 -42.68 95.9 Favored 'Isoleucine or valine' 0 C--N 1.346 0.44 0 CA-C-N 119.343 0.974 . . . . 28.48 109.792 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1143 ' ' VAL . . . . . 0.408 ' HB ' ' HA ' ' A' 1140 ' ' ARG . 21.8 t -54.86 -60.04 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 113.533 0.938 . . . . 23.07 113.533 175.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1144 ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -71.7 -27.98 63.4 Favored 'General case' 0 C--O 1.248 0.989 0 O-C-N 119.561 -1.962 . . . . 33.399999999999999 112.456 -174.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1145 ' ' ALA . . . . . 0.701 ' HB1' HD12 ' A' 1251 ' ' ILE . . . -62.18 -49.04 77.38 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 106.54 -1.652 . . . . 24.219999999999999 106.54 175.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1146 ' ' ALA . . . . . 0.557 ' HA ' ' HB2' ' A' 1149 ' ' PHE . . . -58.76 -33.74 70.62 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 115.375 1.62 . . . . 24.890000000000001 115.375 171.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -61.96 -31.62 71.98 Favored 'General case' 0 C--N 1.372 1.569 0 CA-C-O 117.925 -1.036 . . . . 26.73 111.628 175.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1148 ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -109.77 1.63 19.5 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 115.706 1.743 . . . . 39.960000000000001 115.706 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1149 ' ' PHE . . . . . 0.557 ' HB2' ' HA ' ' A' 1146 ' ' ALA . 0.6 OUTLIER -64.47 138.38 58.38 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 126.06 1.744 . . . . 25.870000000000001 110.516 -170.125 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 1150 ' ' GLY . . . . . 0.566 ' HA2' ' HG2' ' B' 1320 ' ' PRO . . . -73.01 -55.46 6.34 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 110.259 -1.136 . . . . 19.280000000000001 110.259 171.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1151 ' ' ARG . . . . . 0.759 ' HA ' ' HB2' ' B' 1322 ' ' GLN . 33.4 mtm-85 -94.37 -178.8 4.7 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 113.025 0.75 . . . . 39.899999999999999 113.025 -174.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1152 ' ' PHE . . . . . 0.821 ' HB2' HG11 ' A' 1163 ' ' VAL . 19.3 m-30 -85.68 160.6 19.52 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 116.578 -2.049 . . . . 29.440000000000001 111.716 171.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1153 ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -73.27 -58.45 3.31 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 122.45 1.119 . . . . 32.600000000000001 108.523 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1154 ' ' THR . . . . . . . . . . . . . 20.9 m -62.86 123.93 19.74 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 125.536 1.534 . . . . 34.640000000000001 110.379 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -80.48 71.26 2.85 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 109.957 -1.257 . . . . 37.140000000000001 109.957 174.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -90.75 139.36 30.8 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 120.848 -0.341 . . . . 40.57 111.113 -166.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1157 ' ' ILE . . . . . 0.659 HG13 ' HB3' ' C' ' 70' ' ' PRO . 2.6 tp -73.77 112.28 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 107.86 -1.163 . . . . 44.609999999999999 107.86 168.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1158 ' ' THR . . . . . . . . . . . . . 42.6 p -91.21 174.53 7.35 Favored 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 109.013 -0.736 . . . . 40.700000000000003 109.013 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -49.06 -39.97 29.64 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 115.469 1.655 . . . . 40.25 115.469 167.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -86.55 -46.69 9.91 Favored 'General case' 0 C--O 1.253 1.255 0 N-CA-C 116.194 1.924 . . . . 38.469999999999999 116.194 178.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1161 ' ' GLY . . . . . 0.533 ' HA3' HG21 ' B' 1329 ' ' THR . . . -172.24 179.07 44.08 Favored Glycine 0 N--CA 1.475 1.259 0 CA-C-O 124.456 2.142 . . . . 37.609999999999999 116.493 -170.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1162 ' ' LYS . . . . . 0.486 ' HB2' ' HB2' ' C' ' 95' ' ' GLU . 17.1 tttt -76.27 115.06 15.65 Favored 'General case' 0 C--O 1.251 1.168 0 CA-C-N 111.995 -2.103 . . . . 48.899999999999999 108.788 -178.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1163 ' ' VAL . . . . . 0.821 HG11 ' HB2' ' A' 1152 ' ' PHE . 38.8 t -69.36 128.97 92.11 Favored Pre-proline 0 C--O 1.243 0.747 0 CA-C-O 116.662 -1.637 . . . . 36.520000000000003 108.977 171.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1164 ' ' PRO . . . . . 0.502 ' HA ' ' HD2' ' A' 1165 ' ' PRO . 42.6 Cg_exo -77.29 103.79 1.79 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 124.047 3.165 . . . . 35.079999999999998 112.151 177.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1165 ' ' PRO . . . . . 0.502 ' HD2' ' HA ' ' A' 1164 ' ' PRO . 55.5 Cg_endo -46.86 151.37 2.18 Favored 'Trans proline' 0 N--CA 1.455 -0.762 1 C-N-CA 125.46 4.107 . . . . 35.329999999999998 117.67 -173.072 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -79.27 137.47 37.39 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.948 1.356 . . . . 34.689999999999998 109.284 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1167 ' ' LYS . . . . . 0.606 ' HB2' ' HA ' ' A' 1249 ' ' VAL . 6.7 mptt -99.91 105.86 17.62 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 103.972 -2.603 . . . . 45.359999999999999 103.972 171.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 58.8 t -90.57 90.2 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 N-CA-C 105.039 -2.208 . . . . 31.710000000000001 105.039 -176.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1169 ' ' MET . . . . . 0.456 ' O ' ' HA ' ' A' 1252 ' ' ILE . 6.2 ttp -80.5 116.81 20.74 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.449 -1.315 . . . . 42.280000000000001 107.449 172.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 86.0 t -91.08 136.06 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 105.574 -2.01 . . . . 30.510000000000002 105.574 176.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 15.8 mt -109.92 120.5 61.12 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 N-CA-C 104.46 -2.422 . . . . 31.870000000000001 104.46 170.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1172 ' ' GLY . . . . . 0.457 ' HA3' ' HB2' ' A' 1256 ' ' ALA . . . 87.3 80.73 1.22 Allowed Glycine 0 C--O 1.256 1.489 0 N-CA-C 109.63 -1.388 . . . . 34.539999999999999 109.63 175.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1173 ' ' ALA . . . . . . . . . . . . . . . -87.34 118.83 27.04 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 122.726 1.25 . . . . 32.509999999999998 109.819 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1174 ' ' GLY . . . . . 0.587 ' HA2' HG11 ' A' 1200 ' ' VAL . . . -148.34 -149.8 5.06 Favored Glycine 0 N--CA 1.437 -1.249 0 N-CA-C 106.513 -2.635 . . . . 29.899999999999999 106.513 164.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1175 ' ' VAL . . . . . 0.556 HG11 ' HB3' ' A' 1131 ' ' SER . 54.1 t -57.21 -41.67 78.45 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 CA-C-N 121.101 2.45 . . . . 33.109999999999999 111.382 -175.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1176 ' ' ALA . . . . . 0.514 ' HB2' ' HB1' ' A' 1134 ' ' ALA . . . -60.02 -49.5 77.42 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-N 114.301 -1.318 . . . . 28.100000000000001 111.659 176.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -59.52 -46.96 93.1 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 108.458 -1.857 . . . . 28.539999999999999 108.458 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1178 ' ' LEU . . . . . . . . . . . . . 47.9 mt -58.77 -29.72 67.0 Favored 'General case' 0 C--O 1.241 0.62 0 O-C-N 119.129 -2.395 . . . . 31.219999999999999 113.447 175.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -58.68 -55.74 31.24 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-O 122.356 1.074 . . . . 28.98 110.88 168.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -55.85 -43.43 77.06 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 113.886 -1.507 . . . . 27.829999999999998 114.446 177.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1181 ' ' ILE . . . . . . . . . . . . . 74.8 mt -62.05 -49.52 83.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 107.89 -1.152 . . . . 30.25 107.89 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -54.47 -34.54 55.08 Favored Glycine 0 C--N 1.343 0.928 0 O-C-N 126.744 2.527 . . . . 29.59 113.512 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -74.92 -61.77 1.77 Allowed 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 117.503 0.652 . . . . 30.289999999999999 112.52 170.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1184 ' ' ALA . . . . . 0.427 ' HA ' HD12 ' A' 1187 ' ' LEU . . . -59.69 -32.21 70.29 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-O 121.752 0.787 . . . . 30.469999999999999 113.088 -166.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1185 ' ' ASN . . . . . 0.439 ' OD1' ' HA3' ' A' 1208 ' ' GLY . 10.2 t30 -56.49 -53.3 59.04 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.622 1.169 . . . . 42.409999999999997 112.206 173.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1186 ' ' SER . . . . . . . . . . . . . 3.6 m -64.41 -39.66 94.28 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.765 -1.107 . . . . 39.380000000000003 109.295 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1187 ' ' LEU . . . . . 0.942 ' HA ' ' HB3' ' B' 1186 ' ' SER . 25.8 mt -55.87 -34.71 65.73 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 115.826 1.787 . . . . 36.18 115.826 173.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 93.27 48.37 2.84 Favored Glycine 0 CA--C 1.534 1.259 0 O-C-N 124.108 0.88 . . . . 33.780000000000001 112.317 -177.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -113.98 162.02 16.94 Favored 'General case' 0 C--O 1.247 0.958 0 O-C-N 126.114 1.714 . . . . 33.93 108.756 172.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 66.1 mt -84.8 103.02 11.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 104.55 -2.389 . . . . 38.740000000000002 104.55 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 3.5 t -94.48 142.5 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 O-C-N 120.958 -1.089 . . . . 33.090000000000003 108.847 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1192 ' ' ARG . . . . . 0.498 ' HB3' ' HG ' ' A' 1212 ' ' LEU . 98.6 mtt180 -143.76 108.78 4.97 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.06 -1.089 . . . . 38.920000000000002 108.06 177.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -96.42 120.16 36.22 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 120.335 -1.478 . . . . 35.32 113.988 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 87.4 t80 -80.34 131.13 35.59 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 114.984 -1.007 . . . . 39.350000000000001 109.501 166.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 8.0 t70 -150.74 178.56 9.0 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 105.397 -2.075 . . . . 40.460000000000001 105.397 153.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1196 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.08 -31.98 9.91 Favored 'General case' 0 N--CA 1.428 -1.556 0 O-C-N 119.569 -1.957 . . . . 45.939999999999998 108.875 175.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1197 ' ' ARG . . . . . . . . . . . . . 53.0 mtm180 -69.63 133.44 88.73 Favored Pre-proline 0 N--CA 1.445 -0.684 0 O-C-N 120.832 -1.167 . . . . 56.020000000000003 109.916 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1198 ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -67.08 -28.29 41.31 Favored 'Trans proline' 0 C--O 1.242 0.719 0 C-N-CA 124.537 3.491 . . . . 51.270000000000003 118.276 173.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -55.71 -55.14 35.8 Favored 'General case' 0 C--O 1.254 1.334 0 O-C-N 119.925 -1.734 . . . . 59.100000000000001 114.037 -168.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1200 ' ' VAL . . . . . 0.587 HG11 ' HA2' ' A' 1174 ' ' GLY . 18.5 m -53.8 -25.35 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 116.749 2.129 . . . . 51.060000000000002 116.749 176.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 98.9 mttt -47.36 -43.45 23.13 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 115.774 1.768 . . . . 57.380000000000003 115.774 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -54.17 -51.29 64.8 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 122.942 1.353 . . . . 62.409999999999997 113.542 -175.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -70.87 -41.72 71.02 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 111.31 -2.677 . . . . 57.780000000000001 112.97 177.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1204 ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' 1209 ' ' ALA . 4.8 t -45.29 -49.88 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.448 1.499 . . . . 46.380000000000003 112.429 174.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -68.22 -52.82 29.85 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 113.639 -1.618 . . . . 50.700000000000003 112.435 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1206 ' ' SER . . . . . . . . . . . . . 41.0 p -66.87 -28.39 68.3 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.65 -0.705 . . . . 49.979999999999997 112.37 -172.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1207 ' ' MET . . . . . . . . . . . . . 12.3 mtt -66.55 -67.79 0.42 Allowed 'General case' 0 C--O 1.249 1.055 0 N-CA-C 106.562 -1.644 . . . . 52.990000000000002 106.562 166.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1208 ' ' GLY . . . . . 0.439 ' HA3' ' OD1' ' A' 1185 ' ' ASN . . . 154.9 60.25 0.01 OUTLIER Glycine 0 CA--C 1.522 0.522 0 CA-C-O 123.217 1.454 . . . . 47.659999999999997 112.955 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1209 ' ' ALA . . . . . 0.421 ' HB3' HG13 ' A' 1204 ' ' VAL . . . -141.44 145.5 35.36 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 112.347 -1.926 . . . . 44.770000000000003 111.32 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1210 ' ' GLU . . . . . 0.407 ' HB2' ' HG2' ' A' 1192 ' ' ARG . 37.3 mt-10 -74.01 155.51 38.51 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 104.068 -2.568 . . . . 47.640000000000001 104.068 163.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1211 ' ' PHE . . . . . . . . . . . . . 44.0 t80 -94.61 131.58 40.24 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 105.772 -1.936 . . . . 45.659999999999997 105.772 163.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1212 ' ' LEU . . . . . 0.498 ' HG ' ' HB3' ' A' 1192 ' ' ARG . 72.7 mt -88.33 108.42 19.33 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 106.993 -1.484 . . . . 46.060000000000002 106.993 174.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -82.19 133.26 35.25 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 111.801 -2.454 . . . . 60.219999999999999 109.012 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 4.9 tp -41.72 133.51 2.72 Favored 'General case' 0 C--O 1.241 0.609 0 O-C-N 127.858 3.224 . . . . 57.25 110.69 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 27.8 t0 -76.58 75.16 3.29 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 123.509 1.623 . . . . 64.430000000000007 114.013 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 3.2 t80 . . . . . 0 C--O 1.213 -0.853 0 N-CA-C 102.801 -3.037 . . . . 66.900000000000006 102.801 -171.806 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 N--CA 1.421 -1.886 0 N-CA-C 107.917 -1.142 . . . . 39.090000000000003 107.917 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -61.62 -45.26 96.68 Favored Glycine 0 CA--C 1.535 1.285 0 N-CA-C 115.988 1.155 . . . . 39.32 115.988 -174.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 91.5 t80 -72.98 -43.53 62.11 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 120.455 2.128 . . . . 39.299999999999997 112.639 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -69.31 -27.17 65.15 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 118.311 -2.743 . . . . 36.299999999999997 112.4 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -61.89 -60.44 3.64 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 120.089 -1.632 . . . . 37.380000000000003 106.988 163.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -52.42 -61.13 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.581 0 N-CA-C 116.769 2.137 . . . . 39.109999999999999 116.769 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1230 ' ' MET . . . . . 0.507 ' SD ' HD11 ' A' 1235 ' ' ILE . 34.7 mmt -89.94 49.38 1.71 Allowed 'General case' 0 C--O 1.251 1.166 0 O-C-N 118.197 -2.814 . . . . 49.590000000000003 116.202 -174.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1231 ' ' SER . . . . . . . . . . . . . 67.7 p -98.57 163.85 12.5 Favored 'General case' 0 C--O 1.253 1.286 0 CA-C-N 113.972 -1.467 . . . . 43.68 108.999 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.43 -36.85 83.84 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 116.172 -0.467 . . . . 55.57 110.928 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1233 ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' A' 1236 ' ' LYS . . . -60.31 -54.79 41.53 Favored 'General case' 0 C--O 1.215 -0.748 0 C-N-CA 125.403 1.481 . . . . 44.939999999999998 112.157 173.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -60.63 -52.49 64.91 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 115.23 1.566 . . . . 42.039999999999999 115.23 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1235 ' ' ILE . . . . . 0.507 HD11 ' SD ' ' A' 1230 ' ' MET . 94.8 mt -57.28 -32.26 40.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-O 123.491 1.615 . . . . 46.280000000000001 113.65 173.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1236 ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' 1233 ' ' ALA . 47.9 tttm -58.12 -57.67 11.81 Favored 'General case' 0 C--O 1.252 1.21 0 CA-C-O 124.525 2.107 . . . . 47.869999999999997 111.323 170.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1237 ' ' ALA . . . . . 0.422 ' HA ' ' HB2' ' A' 1240 ' ' GLU . . . -70.92 -11.89 61.23 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 115.731 1.752 . . . . 41.609999999999999 115.731 -175.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -67.73 -62.94 1.17 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.714 -1.587 . . . . 50.649999999999999 106.714 170.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1239 ' ' MET . . . . . . . . . . . . . 2.4 mtm -58.44 -35.42 72.1 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 121.158 -0.964 . . . . 48.869999999999997 113.249 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1240 ' ' GLU . . . . . 0.422 ' HB2' ' HA ' ' A' 1237 ' ' ALA . 91.0 mt-10 -68.73 -26.64 65.36 Favored 'General case' 0 C--O 1.25 1.11 0 C-N-CA 120.79 -0.364 . . . . 54.799999999999997 111.379 176.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 2.3 tm? -69.83 -56.99 5.64 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.962 -0.755 . . . . 43.210000000000001 108.962 166.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1242 ' ' PHE . . . . . 0.573 ' HE2' HD13 ' A' 1266 ' ' LEU . 22.9 m-30 -57.95 -41.79 83.58 Favored 'General case' 0 C--O 1.221 -0.409 0 O-C-N 124.76 1.287 . . . . 38.659999999999997 111.749 -166.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -68.84 -38.07 79.55 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.402 1.001 . . . . 37.920000000000002 111.764 -175.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -63.38 -51.0 67.69 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 120.266 -1.521 . . . . 37.280000000000001 109.994 174.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 -59.2 -34.36 72.06 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.232 1.413 . . . . 43.07 109.897 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1246 ' ' ALA . . . . . 0.438 ' HB1' ' HG3' ' A' 1275 ' ' MET . . . -62.77 -17.95 61.86 Favored 'General case' 0 N--CA 1.439 -1.021 0 O-C-N 119.314 -2.116 . . . . 38.299999999999997 116.272 176.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1247 ' ' LYS . . . . . . . . . . . . . 16.5 mtmm -81.83 -1.93 49.18 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 122.532 1.158 . . . . 47.600000000000001 112.929 174.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1248 ' ' GLU . . . . . 0.448 ' CD ' HH12 ' A' 1192 ' ' ARG . 14.6 pt-20 -129.35 -35.69 1.75 Allowed 'General case' 0 C--O 1.239 0.537 0 CA-C-O 116.117 -1.897 . . . . 45.420000000000002 113.6 177.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1249 ' ' VAL . . . . . 0.606 ' HA ' ' HB2' ' A' 1167 ' ' LYS . 33.0 m -75.71 161.77 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 121.635 2.016 . . . . 36.259999999999998 114.614 -168.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1250 ' ' ASP . . . . . 0.506 ' O ' ' HB3' ' A' 1279 ' ' SER . 4.7 m-20 -108.84 -60.32 1.76 Allowed 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.129 -1.396 . . . . 33.039999999999999 109.647 -175.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1251 ' ' ILE . . . . . 0.701 HD12 ' HB1' ' A' 1145 ' ' ALA . 51.5 mm -110.91 112.89 42.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 107.436 -1.32 . . . . 31.399999999999999 107.436 -168.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1252 ' ' ILE . . . . . 0.652 HD12 HG12 ' A' 1281 ' ' ILE . 64.2 mt -100.6 102.8 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 104.249 -2.5 . . . . 29.420000000000002 104.249 176.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1253 ' ' VAL . . . . . 0.586 ' HA ' HG23 ' A' 1282 ' ' VAL . 89.9 t -84.78 97.74 5.56 Favored 'Isoleucine or valine' 0 C--O 1.251 1.173 0 N-CA-C 104.296 -2.483 . . . . 30.370000000000001 104.296 175.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1254 ' ' THR . . . . . 0.479 ' CG2' ' HB2' ' A' 1291 ' ' ASN . 3.8 m -93.58 70.48 4.22 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 104.449 -2.426 . . . . 35.719999999999999 104.449 -167.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1255 ' ' THR . . . . . 0.663 ' HA ' ' HB2' ' A' 1284 ' ' LEU . 0.8 OUTLIER -78.48 0.88 24.23 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 119.443 -2.036 . . . . 36.0 115.844 -175.235 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 1256 ' ' ALA . . . . . 0.457 ' HB2' ' HA3' ' A' 1172 ' ' GLY . . . -64.77 68.83 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 118.297 2.702 . . . . 40.93 118.297 176.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 60.4 tp -77.8 91.81 4.15 Favored 'General case' 0 C--O 1.246 0.909 0 N-CA-C 106.456 -1.683 . . . . 47.82 106.456 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1258 ' ' ILE . . . . . 0.527 ' HA ' ' HD3' ' A' 1259 ' ' PRO . 39.3 mm -64.53 128.85 93.86 Favored Pre-proline 0 C--O 1.241 0.608 0 N-CA-C 108.275 -1.009 . . . . 52.700000000000003 108.275 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1259 ' ' PRO . . . . . 0.527 ' HD3' ' HA ' ' A' 1258 ' ' ILE . 51.0 Cg_exo -62.05 108.49 0.67 Allowed 'Trans proline' 0 N--CA 1.439 -1.701 0 C-N-CA 123.933 3.089 . . . . 54.130000000000003 109.786 -175.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1260 ' ' GLY . . . . . 0.537 ' HA2' ' NE2' ' A' 1097 ' ' GLN . . . 82.44 -64.95 4.19 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-O 118.186 -1.341 . . . . 54.619999999999997 113.589 168.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 13.5 mttp -65.9 137.03 95.87 Favored Pre-proline 0 C--O 1.216 -0.677 0 C-N-CA 125.468 1.507 . . . . 55.740000000000002 110.728 173.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -52.81 144.79 42.56 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.636 2.891 . . . . 51.149999999999999 116.371 176.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -67.28 133.72 93.31 Favored Pre-proline 0 CA--C 1.529 0.157 0 O-C-N 121.996 -0.44 . . . . 46.060000000000002 110.933 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -63.51 145.38 91.95 Favored 'Trans proline' 0 C--N 1.344 0.308 1 C-N-CA 125.914 4.409 . . . . 41.079999999999998 111.596 -178.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1265 ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' 1265 ' ' LYS . 67.8 mmtt -78.14 78.92 4.61 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 122.147 0.975 . . . . 47.420000000000002 109.785 -178.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1266 ' ' LEU . . . . . 0.573 HD13 ' HE2' ' A' 1242 ' ' PHE . 62.4 mt -83.82 -37.08 22.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.034 -1.439 . . . . 39.219999999999999 110.109 -171.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 15.4 mt -94.5 97.41 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 103.783 -2.673 . . . . 42.5 103.783 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1268 ' ' THR . . . . . 0.571 ' O ' HG23 ' A' 1272 ' ' VAL . 16.5 p -70.51 157.01 38.63 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 114.631 -1.168 . . . . 37.840000000000003 111.309 -176.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1269 ' ' ARG . . . . . 0.585 ' HG3' ' HB3' ' A' 1293 ' ' GLU . 97.5 mtt180 -52.09 -41.4 62.38 Favored 'General case' 0 CA--C 1.512 -0.499 0 O-C-N 120.994 -1.066 . . . . 54.799999999999997 111.833 168.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -44.37 -62.57 1.12 Allowed 'General case' 0 N--CA 1.476 0.836 0 O-C-N 125.362 1.664 . . . . 54.359999999999999 111.547 164.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1271 ' ' MET . . . . . . . . . . . . . 34.0 ttm -58.52 -44.36 89.48 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 120.726 1.603 . . . . 39.520000000000003 111.36 -173.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1272 ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' 1268 ' ' THR . 20.0 t -66.77 -46.58 85.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 115.793 -0.64 . . . . 38.25 111.553 -175.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.44 -3.84 26.65 Favored 'General case' 0 CA--C 1.506 -0.713 0 O-C-N 119.943 -1.723 . . . . 40.770000000000003 115.583 172.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1274 ' ' SER . . . . . . . . . . . . . 8.6 m -113.03 14.75 19.67 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 116.085 1.883 . . . . 36.579999999999998 116.085 164.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1275 ' ' MET . . . . . 0.633 ' HB3' HG21 ' A' 1307 ' ' VAL . 4.8 ttt -85.35 162.44 19.06 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.362 -0.977 . . . . 36.75 108.362 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1276 ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -63.07 132.48 52.05 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 124.198 1.951 . . . . 46.109999999999999 109.536 174.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1277 ' ' ALA . . . . . 0.68 ' HB1' ' HA ' ' B' 1045 ' ' PHE . . . -70.56 162.22 29.26 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 111.736 -2.484 . . . . 33.520000000000003 113.713 -172.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 67.28 27.54 73.52 Favored Glycine 0 N--CA 1.479 1.535 0 O-C-N 119.485 -2.01 . . . . 31.27 113.449 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1279 ' ' SER . . . . . 0.506 ' HB3' ' O ' ' A' 1250 ' ' ASP . 14.0 m -132.0 154.21 49.57 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 113.671 -1.265 . . . . 32.950000000000003 107.912 -168.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1280 ' ' VAL . . . . . 0.432 HG11 ' HA ' ' A' 1145 ' ' ALA . 18.5 t -126.52 123.88 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 122.082 0.944 . . . . 27.43 112.988 -171.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1281 ' ' ILE . . . . . 0.652 HG12 HD12 ' A' 1252 ' ' ILE . 52.1 mt -91.66 108.37 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 105.973 -1.862 . . . . 30.300000000000001 105.973 166.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1282 ' ' VAL . . . . . 0.586 HG23 ' HA ' ' A' 1253 ' ' VAL . 0.1 OUTLIER -89.13 124.0 41.66 Favored 'Isoleucine or valine' 0 C--O 1.25 1.108 0 O-C-N 120.813 -1.179 . . . . 28.629999999999999 108.729 170.575 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 1283 ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' 1286 ' ' ALA . 14.5 t0 -96.42 121.72 38.54 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 120.595 1.543 . . . . 36.270000000000003 110.482 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1284 ' ' LEU . . . . . 0.663 ' HB2' ' HA ' ' A' 1255 ' ' THR . 2.1 mm? -107.01 -9.08 16.33 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-O 122.968 1.366 . . . . 38.57 112.149 -176.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1285 ' ' ALA . . . . . 0.56 ' HB3' ' HA2' ' A' 1290 ' ' GLY . . . -76.99 -29.85 55.68 Favored 'General case' 0 C--O 1.243 0.736 0 O-C-N 120.691 -1.256 . . . . 37.560000000000002 108.092 164.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1286 ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' 1283 ' ' ASP . . . 28.06 -82.79 0.0 OUTLIER 'General case' 0 C--N 1.361 1.094 0 N-CA-C 118.545 2.795 . . . . 40.329999999999998 118.545 173.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -66.33 -41.93 88.92 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 113.905 1.076 . . . . 56.850000000000001 113.905 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 46.9 t30 -85.7 82.32 8.26 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 122.65 1.214 . . . . 45.859999999999999 111.824 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 73.52 -67.14 1.59 Allowed Glycine 0 CA--C 1.538 1.524 0 O-C-N 119.498 -2.001 . . . . 40.310000000000002 111.724 -175.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1290 ' ' GLY . . . . . 0.56 ' HA2' ' HB3' ' A' 1285 ' ' ALA . . . 89.26 129.49 3.62 Favored Glycine 0 CA--C 1.536 1.356 0 N-CA-C 110.357 -1.097 . . . . 38.890000000000001 110.357 -177.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1291 ' ' ASN . . . . . 0.479 ' HB2' ' CG2' ' A' 1254 ' ' THR . 32.2 m120 -73.47 -17.06 61.28 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.469 1.634 . . . . 37.229999999999997 115.3 -172.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1292 ' ' CYS . . . . . 0.476 ' SG ' HG11 ' A' 1309 ' ' VAL . 49.1 t -91.75 146.33 23.85 Favored 'General case' 0 C--O 1.248 1.016 0 CA-C-O 125.36 2.505 . . . . 36.5 110.359 173.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1293 ' ' GLU . . . . . 0.585 ' HB3' ' HG3' ' A' 1269 ' ' ARG . 6.5 mt-10 -75.67 -7.99 55.7 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 119.259 -2.151 . . . . 43.32 115.782 172.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -109.05 26.56 10.48 Favored 'General case' 0 C--O 1.215 -0.735 0 O-C-N 120.124 -1.61 . . . . 41.32 113.629 175.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1295 ' ' THR . . . . . . . . . . . . . 54.6 m -81.3 81.15 7.55 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 125.868 2.747 . . . . 35.299999999999997 108.925 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1296 ' ' VAL . . . . . 0.467 ' HA ' ' HD3' ' A' 1297 ' ' PRO . 72.5 t -76.58 124.11 87.79 Favored Pre-proline 0 N--CA 1.424 -1.733 0 O-C-N 119.794 -1.817 . . . . 34.840000000000003 108.389 -176.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1297 ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' 1296 ' ' VAL . 50.4 Cg_exo -56.47 99.21 0.08 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.684 0 C-N-CA 124.362 3.375 . . . . 33.509999999999998 115.291 -167.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 81.83 37.8 15.43 Favored Glycine 0 N--CA 1.437 -1.266 0 CA-C-N 112.565 -2.107 . . . . 32.189999999999998 111.575 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -145.3 153.6 41.45 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 124.234 1.969 . . . . 34.880000000000003 110.151 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1300 ' ' ILE . . . . . 0.54 HG12 HG12 ' A' 1310 ' ' ILE . 77.2 mt -83.75 157.6 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 CA-C-N 111.203 -2.726 . . . . 32.289999999999999 105.328 161.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 58.3 t80 -137.47 147.31 45.21 Favored 'General case' 0 C--O 1.253 1.262 0 N-CA-C 104.948 -2.241 . . . . 37.25 104.948 176.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1302 ' ' THR . . . . . . . . . . . . . 8.3 m -126.65 134.68 50.69 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 106.098 -1.816 . . . . 35.560000000000002 106.098 170.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1303 ' ' THR . . . . . 0.424 HG21 HG12 ' A' 1272 ' ' VAL . 24.9 p -79.78 174.71 11.31 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 112.705 0.631 . . . . 36.399999999999999 112.705 176.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -53.32 -56.34 17.46 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 121.335 -0.853 . . . . 52.32 111.218 171.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -68.46 10.01 0.29 Allowed 'General case' 0 C--N 1.352 0.684 0 N-CA-C 117.189 2.292 . . . . 40.039999999999999 117.189 176.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 70.67 38.12 67.4 Favored Glycine 0 C--O 1.244 0.753 0 O-C-N 121.909 -0.494 . . . . 36.960000000000001 112.9 169.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1307 ' ' VAL . . . . . 0.633 HG21 ' HB3' ' A' 1275 ' ' MET . 87.5 t -99.83 133.9 41.13 Favored 'Isoleucine or valine' 0 C--O 1.262 1.715 0 N-CA-C 101.412 -3.551 . . . . 33.399999999999999 101.412 170.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1308 ' ' LYS . . . . . 0.426 ' HB2' HG22 ' A' 1280 ' ' VAL . 67.2 mmtt -94.93 136.41 35.27 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 111.659 -2.519 . . . . 42.909999999999997 108.809 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1309 ' ' VAL . . . . . 0.476 HG11 ' SG ' ' A' 1292 ' ' CYS . 21.8 t -118.13 116.75 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 N-CA-C 106.581 -1.637 . . . . 32.289999999999999 106.581 171.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1310 ' ' ILE . . . . . 0.54 HG12 HG12 ' A' 1300 ' ' ILE . 27.3 mt -102.61 98.09 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 105.423 -2.066 . . . . 30.989999999999998 105.423 -178.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -103.68 51.29 0.83 Allowed Glycine 0 CA--C 1.529 0.962 0 N-CA-C 106.353 -2.699 . . . . 28.949999999999999 106.353 175.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1312 ' ' TYR . . . . . 0.594 ' HB2' ' HG ' ' A' 1315 ' ' LEU . 5.0 m-85 -72.64 101.82 3.14 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 105.037 -2.209 . . . . 31.690000000000001 105.037 171.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1313 ' ' THR . . . . . 0.409 ' HA ' ' HB1' ' A' 1286 ' ' ALA . 1.6 p -53.3 -31.79 45.67 Favored 'General case' 0 C--O 1.243 0.719 0 O-C-N 121.022 -1.049 . . . . 34.170000000000002 111.426 177.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -81.46 7.74 11.12 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 118.695 2.85 . . . . 36.859999999999999 118.695 174.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1315 ' ' LEU . . . . . 0.594 ' HG ' ' HB2' ' A' 1312 ' ' TYR . 26.7 mt -47.69 -39.35 22.47 Favored Pre-proline 0 C--O 1.252 1.223 0 CA-C-N 123.798 2.999 . . . . 34.850000000000001 118.511 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1316 ' ' PRO . . . . . 0.526 ' HG3' ' HB2' ' A' 1137 ' ' ALA . 73.0 Cg_exo -59.15 -35.83 96.98 Favored 'Trans proline' 0 C--O 1.205 -1.17 0 C-N-CA 123.143 2.562 . . . . 29.149999999999999 112.961 173.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1317 ' ' GLY . . . . . 0.42 ' HA3' ' HE ' ' A' 1015 ' ' ARG . . . -94.74 -12.87 55.09 Favored Glycine 0 CA--C 1.495 -1.209 0 O-C-N 120.5 -1.375 . . . . 27.289999999999999 116.173 -177.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1318 ' ' ARG . . . . . . . . . . . . . 8.2 ttt-85 -64.76 6.1 0.25 Allowed 'General case' 0 C--O 1.244 0.777 0 N-CA-C 117.057 2.243 . . . . 41.490000000000002 117.057 -175.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1319 ' ' LEU . . . . . 0.513 HD13 HH11 ' A' 1140 ' ' ARG . 15.4 tp -116.6 78.96 9.11 Favored Pre-proline 0 N--CA 1.439 -1.008 0 CA-C-N 123.23 2.741 . . . . 27.609999999999999 107.011 173.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1320 ' ' PRO . . . . . 0.561 ' HG2' ' HA2' ' B' 1150 ' ' GLY . 20.4 Cg_endo -40.89 -57.87 1.19 Allowed 'Trans proline' 0 CA--C 1.504 -0.988 0 C-N-CA 124.476 3.45 . . . . 25.940000000000001 118.126 -155.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1321 ' ' THR . . . . . 0.471 HG23 HG21 ' A' 1019 ' ' THR . 3.0 m -72.04 -33.65 68.16 Favored 'General case' 0 N--CA 1.437 -1.125 0 O-C-N 118.597 -2.564 . . . . 25.010000000000002 109.678 -174.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1322 ' ' GLN . . . . . 0.843 ' HB2' ' HA ' ' B' 1151 ' ' ARG . 61.3 tp60 -84.88 -39.08 18.66 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 120.26 1.391 . . . . 29.390000000000001 110.575 -171.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1323 ' ' SER . . . . . 0.893 ' HA ' HD13 ' A' 1136 ' ' ILE . 17.6 m -47.5 -56.69 6.54 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.963 1.098 . . . . 26.469999999999999 113.963 158.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1324 ' ' SER . . . . . . . . . . . . . 14.4 m -68.93 -17.28 63.93 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.274 0.842 . . . . 27.780000000000001 113.274 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -75.62 -67.91 0.62 Allowed 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 103.856 -2.646 . . . . 37.530000000000001 103.856 174.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1326 ' ' LEU . . . . . 0.758 ' HB2' HD11 ' A' 1136 ' ' ILE . 89.8 mt -72.42 -43.83 63.3 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 115.042 -2.409 . . . . 35.710000000000001 112.921 -168.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1327 ' ' TYR . . . . . 0.415 ' HE2' ' HA ' ' A' 1072 ' ' VAL . 73.8 t80 -58.02 -43.63 86.84 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-N 122.501 2.41 . . . . 31.59 107.703 169.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1328 ' ' GLY . . . . . 0.656 ' HA2' HD12 ' A' 1331 ' ' LEU . . . -58.17 -37.28 85.92 Favored Glycine 0 C--N 1.345 1.058 0 N-CA-C 110.884 -0.886 . . . . 28.0 110.884 176.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1329 ' ' THR . . . . . 0.418 HG21 ' HA3' ' B' 1161 ' ' GLY . 36.5 m -77.8 -28.7 50.49 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 118.938 1.369 . . . . 32.149999999999999 111.415 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1330 ' ' ASN . . . . . 0.4 ' HA ' ' O ' ' A' 1126 ' ' SER . 16.2 m120 -55.31 -48.31 74.31 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 120.693 1.588 . . . . 34.359999999999999 111.611 164.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1331 ' ' LEU . . . . . 0.681 HD13 ' HB3' ' A' 1070 ' ' LEU . 19.6 mt -56.1 -53.35 58.08 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 124.507 1.123 . . . . 33.369999999999997 111.241 175.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1332 ' ' VAL . . . . . 0.58 HG12 ' HE3' ' A' 1336 ' ' LYS . 59.8 t -49.13 -47.45 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 C-N-CA 125.898 1.679 . . . . 35.270000000000003 111.125 175.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -70.19 -30.35 67.45 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-O 117.243 -1.361 . . . . 37.659999999999997 113.85 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1334 ' ' LEU . . . . . 0.566 HD12 HD23 ' A' 1127 ' ' LEU . 18.3 tp -62.76 -48.67 78.15 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 122.887 1.327 . . . . 40.270000000000003 108.451 169.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1335 ' ' LEU . . . . . . . . . . . . . 82.0 mt -66.12 -23.65 66.53 Favored 'General case' 0 C--O 1.246 0.899 0 O-C-N 120.252 -1.53 . . . . 42.5 110.096 -175.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1336 ' ' LYS . . . . . 0.58 ' HE3' HG12 ' A' 1332 ' ' VAL . 96.9 mttt -60.24 -45.31 93.67 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.445 -1.41 . . . . 47.810000000000002 112.836 168.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1337 ' ' LEU . . . . . 0.486 HD22 HD21 ' A' 1127 ' ' LEU . 8.1 mp -75.03 -38.97 61.33 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 113.218 -1.81 . . . . 49.270000000000003 113.049 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1338 ' ' LEU . . . . . 0.744 HD21 ' SD ' ' A' 1113 ' ' MET . 6.3 mp -72.56 -58.37 3.43 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 125.818 1.647 . . . . 50.539999999999999 111.204 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1339 ' ' CYS . . . . . 0.675 ' HB3' ' HA2' ' A' 1344 ' ' GLY . 58.7 m -92.38 68.45 4.95 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-O 124.408 2.051 . . . . 53.670000000000002 106.35 -177.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 75.3 tttt -76.02 -47.93 22.95 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 111.526 -2.579 . . . . 63.380000000000003 109.016 -158.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -70.08 -25.64 63.62 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 113.425 0.898 . . . . 70.950000000000003 113.425 -175.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1342 ' ' LYS . . . . . 0.487 ' N ' ' HB3' ' A' 1343 ' ' ASP . 46.5 mtpt 52.12 68.27 0.84 Allowed 'General case' 0 C--O 1.253 1.26 0 N-CA-C 118.106 2.632 . . . . 65.25 118.106 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1343 ' ' ASP . . . . . 0.487 ' HB3' ' N ' ' A' 1342 ' ' LYS 0.278 10.9 t70 67.04 -88.14 0.03 OUTLIER 'General case' 0 C--O 1.236 0.387 2 O-C-N 110.921 -7.362 . . . . 64.530000000000001 119.784 -0.177 . . . . . . . . 4 3 . 1 . 007 nuclear build core ' A' A 1344 ' ' GLY . . . . . 0.675 ' HA2' ' HB3' ' A' 1339 ' ' CYS . . . 86.29 17.85 60.02 Favored Glycine 0 N--CA 1.425 -2.036 0 O-C-N 119.98 -1.7 . . . . 59.719999999999999 115.963 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 19.5 t30 -80.4 143.24 33.63 Favored 'General case' 0 N--CA 1.434 -1.226 0 O-C-N 120.469 -1.607 . . . . 64.090000000000003 108.767 160.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1346 ' ' ILE . . . . . 0.414 ' HA ' ' SG ' ' A' 1339 ' ' CYS . 14.7 mt -91.6 100.18 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 104.49 -2.411 . . . . 58.82 104.49 -167.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1347 ' ' THR . . . . . . . . . . . . . 6.9 m -84.08 98.8 10.07 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 104.339 -2.467 . . . . 54.960000000000001 104.339 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1348 ' ' VAL . . . . . 0.485 HG21 HG21 ' A' 1111 ' ' THR . 19.5 t -93.4 80.02 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.257 1.475 0 N-CA-C 105.448 -2.056 . . . . 55.640000000000001 105.448 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 12.9 t70 -76.68 135.17 39.09 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 115.238 1.57 . . . . 61.450000000000003 115.238 -167.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -80.89 -28.28 35.99 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-N 114.864 -1.062 . . . . 58.630000000000003 111.882 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -85.82 -31.82 22.08 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 119.977 -1.702 . . . . 62.060000000000002 114.747 -170.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 9.9 t70 -64.07 123.08 18.11 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 125.046 1.466 . . . . 54.07 109.238 169.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 18.6 m -57.44 -45.66 85.66 Favored 'Isoleucine or valine' 0 C--O 1.253 1.268 0 N-CA-C 113.508 0.929 . . . . 50.68 113.508 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1354 ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' 1358 ' ' VAL . 12.9 m -77.45 -38.53 26.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 119.971 -0.692 . . . . 47.68 110.188 -172.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1355 ' ' ILE . . . . . . . . . . . . . 90.3 mt -62.39 -54.05 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-N 121.141 1.791 . . . . 48.490000000000002 108.589 174.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1356 ' ' ARG . . . . . 0.451 ' HG3' ' HD2' ' A' 1371 ' ' PRO . 45.3 tpt85 -55.92 -37.92 69.58 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 112.107 0.41 . . . . 48.270000000000003 112.107 178.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -59.72 -46.92 93.22 Favored Glycine 0 N--CA 1.469 0.846 0 O-C-N 125.41 1.694 . . . . 43.530000000000001 112.466 174.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1358 ' ' VAL . . . . . 0.499 HG22 ' HA ' ' A' 1118 ' ' VAL . 30.2 t -75.08 -28.69 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 O-C-N 118.428 -2.807 . . . . 45.119999999999997 109.726 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1359 ' ' THR . . . . . 0.466 ' CG2' ' HB2' ' A' 1362 ' ' ARG . 26.2 m -64.71 96.16 0.17 Allowed 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 118.082 -2.886 . . . . 42.939999999999998 114.706 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1360 ' ' VAL . . . . . 0.563 HG11 ' HG3' ' A' 1095 ' ' PRO . 17.5 m -96.55 -30.62 3.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 112.214 0.449 . . . . 43.259999999999998 112.214 -177.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1361 ' ' ILE . . . . . . . . . . . . . 95.7 mt -131.49 136.22 57.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 101.919 -3.363 . . . . 45.659999999999997 101.919 163.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1362 ' ' ARG . . . . . 0.466 ' HB2' ' CG2' ' A' 1359 ' ' THR . 50.4 ttt180 -124.62 125.77 44.67 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 104.428 -2.434 . . . . 61.340000000000003 104.428 165.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 48.89 55.7 8.83 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 125.507 1.754 . . . . 49.759999999999998 113.996 172.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 82.08 -42.33 2.85 Favored Glycine 0 C--O 1.218 -0.871 0 CA-C-N 113.021 -1.899 . . . . 50.0 112.569 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -69.9 126.47 29.81 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 119.953 1.876 . . . . 56.920000000000002 107.071 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1366 ' ' ILE . . . . . . . . . . . . . 96.5 mt -74.59 96.18 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.391 0 N-CA-C 107.19 -1.411 . . . . 52.780000000000001 107.19 178.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1367 ' ' THR . . . . . . . . . . . . . 17.6 p -82.75 1.52 38.39 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 115.932 1.827 . . . . 49.439999999999998 115.932 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1368 ' ' TRP . . . . . 0.457 ' HZ2' ' HA ' ' A' 1096 ' ' ALA . 29.6 t90 -78.66 133.71 62.35 Favored Pre-proline 0 N--CA 1.442 -0.872 0 N-CA-C 105.313 -2.106 . . . . 52.380000000000003 105.313 161.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -58.28 130.09 4.53 Favored 'Cis proline' 0 C--N 1.329 -0.47 0 N-CA-C 119.687 2.918 . . . . 46.939999999999998 119.687 5.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1370 ' ' ALA . . . . . 0.461 ' HA ' ' HD3' ' A' 1371 ' ' PRO . . . -72.84 112.53 15.65 Favored Pre-proline 0 C--O 1.245 0.838 0 C-N-CA 124.567 1.147 . . . . 45.909999999999997 110.837 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1371 ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' 1370 ' ' ALA . 32.3 Cg_exo -67.61 120.65 7.68 Favored 'Trans proline' 0 N--CA 1.433 -2.082 0 C-N-CA 124.636 3.558 . . . . 46.390000000000001 118.104 -173.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -71.89 -62.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 123.179 2.586 . . . . 46.719999999999999 109.968 164.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.239 -4.238 0 CA-C-N 120.642 1.564 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 23.1 m80 . . . . . 0 C--O 1.245 0.826 0 N-CA-C 107.24 -1.393 . . . . 63.439999999999998 107.24 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 999' ' ' HIS . . . . . 0.475 ' HB3' ' HB3' ' B' 1002 ' ' ARG . 23.2 m-70 -120.75 59.74 0.91 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.857 -0.794 . . . . 51.740000000000002 108.857 164.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1000 ' ' HIS . . . . . 0.599 ' HA ' ' HB2' ' B' 1067 ' ' GLU . 10.1 t60 -77.18 139.53 39.93 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 102.795 -3.039 . . . . 54.07 102.795 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 81.88 -0.46 88.37 Favored Glycine 0 C--O 1.26 1.721 0 CA-C-N 113.728 -1.578 . . . . 39.219999999999999 111.814 -171.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1002 ' ' ARG . . . . . 0.475 ' HB3' ' HB3' ' B' ' 999' ' ' HIS . 34.1 ttp180 -108.52 148.36 30.38 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 119.59 1.695 . . . . 38.119999999999997 106.677 177.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1003 ' ' ILE . . . . . 0.714 HG12 HD12 ' B' 1068 ' ' ILE . 24.3 mt -102.61 147.27 9.38 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 N-CA-C 105.724 -1.954 . . . . 29.699999999999999 105.724 172.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -107.38 121.72 6.58 Favored Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 108.492 -1.843 . . . . 27.5 108.492 167.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1005 ' ' ILE . . . . . 0.515 HG23 ' HB3' ' B' 1017 ' ' ALA . 40.7 mm -105.77 106.51 56.8 Favored Pre-proline 0 N--CA 1.439 -1.006 0 N-CA-C 106.689 -1.597 . . . . 24.829999999999998 106.689 171.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1006 ' ' PRO . . . . . 0.58 ' HA ' ' HG3' ' B' 1036 ' ' GLU . 26.4 Cg_exo -80.12 176.82 8.93 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 124.687 3.591 . . . . 27.190000000000001 108.35 -175.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 22.9 ttm105 -84.82 131.51 34.52 Favored 'General case' 0 C--N 1.318 -0.773 0 O-C-N 120.128 -1.608 . . . . 41.460000000000001 108.124 165.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1008 ' ' GLU . . . . . 0.649 ' HG3' ' HB ' ' B' 1072 ' ' VAL 0.311 25.2 mm-40 -68.93 136.18 52.16 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 119.612 3.19 . . . . 26.93 119.612 173.71 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 47.6 mmm-85 -99.08 -3.76 33.95 Favored 'General case' 0 C--O 1.253 1.285 0 CA-C-N 111.512 -2.585 . . . . 34.479999999999997 116.068 -165.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1010 ' ' LEU . . . . . . . . . . . . . 65.6 tp -58.21 138.6 56.14 Favored 'General case' 0 N--CA 1.441 -0.875 0 O-C-N 121.177 -0.952 . . . . 44.219999999999999 112.108 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1011 ' ' THR . . . . . . . . . . . . . 1.3 m -59.72 111.93 1.63 Allowed 'General case' 0 C--N 1.319 -0.759 0 O-C-N 124.573 1.171 . . . . 40.740000000000002 108.187 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 38.8 t30 60.63 92.75 0.05 OUTLIER 'General case' 0 C--O 1.252 1.199 0 O-C-N 126.657 2.473 . . . . 44.439999999999998 107.894 -171.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1013 ' ' GLU . . . . . 0.539 ' HG2' ' HB3' ' B' 1008 ' ' GLU . 9.3 tp10 -130.99 132.72 45.2 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 124.88 2.276 . . . . 29.870000000000001 109.609 -177.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1014 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.16 -32.49 50.27 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-N 108.816 -3.811 . . . . 25.260000000000002 117.642 176.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 43.5 mtm180 -95.64 159.86 14.78 Favored 'General case' 0 C--O 1.252 1.201 0 CA-C-O 124.021 1.867 . . . . 29.539999999999999 115.179 -161.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1016 ' ' VAL . . . . . 0.553 HG13 ' H ' ' B' 1018 ' ' ALA . 4.7 p -128.86 -176.5 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 102.936 -2.987 . . . . 23.550000000000001 102.936 159.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1017 ' ' ALA . . . . . 0.515 ' HB3' HG23 ' B' 1005 ' ' ILE . . . -90.34 -8.81 49.84 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 116.854 2.168 . . . . 23.59 116.854 -178.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1018 ' ' ALA . . . . . 0.553 ' H ' HG13 ' B' 1016 ' ' VAL . . . -159.75 145.72 15.86 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-O 121.528 0.68 . . . . 24.93 110.313 -177.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1019 ' ' THR . . . . . 0.516 HG21 HG23 ' B' 1321 ' ' THR . 0.7 OUTLIER -108.8 165.45 12.64 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-O 116.682 -1.628 . . . . 28.09 111.924 172.297 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B 1020 ' ' PRO . . . . . 0.482 ' HB3' ' HB2' ' B' 1053 ' ' ALA . 0.2 OUTLIER -47.88 -43.2 30.15 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 124.331 3.354 . . . . 28.789999999999999 116.652 175.251 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 47.7 tptt -50.71 -41.53 56.16 Favored 'General case' 0 C--O 1.256 1.446 0 N-CA-C 113.358 0.873 . . . . 47.280000000000001 113.358 168.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1022 ' ' THR . . . . . 0.539 HG21 ' HA3' ' B' 1328 ' ' GLY . 0.2 OUTLIER -72.63 -38.49 67.73 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 118.83 -0.605 . . . . 30.120000000000001 111.63 177.679 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B 1023 ' ' VAL . . . . . 0.427 HG22 HG11 ' B' 1033 ' ' VAL . 79.8 t -49.23 -48.63 17.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-O 122.61 1.195 . . . . 32.240000000000002 113.156 -178.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1024 ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -53.25 -48.16 68.45 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 112.684 -2.053 . . . . 49.619999999999997 110.492 174.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -61.71 -43.24 99.24 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 120.831 -1.168 . . . . 44.68 110.316 -174.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 51.1 mt -64.93 -39.03 92.89 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 115.069 1.507 . . . . 35.710000000000001 115.069 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1027 ' ' LEU . . . . . . . . . . . . . 58.1 mt -64.78 -41.58 95.74 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 125.581 1.552 . . . . 42.18 109.006 174.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 31.4 mttm -63.5 -35.9 81.97 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 123.731 0.644 . . . . 48.340000000000003 110.652 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1029 ' ' LEU . . . . . . . . . . . . . 82.0 mt -59.47 -62.36 1.93 Allowed 'General case' 0 CA--C 1.504 -0.808 0 C-N-CA 123.618 0.767 . . . . 38.689999999999998 109.212 170.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 143.35 45.02 0.05 OUTLIER Glycine 0 C--N 1.312 -0.758 0 N-CA-C 110.309 -1.116 . . . . 32.280000000000001 110.309 168.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -133.17 122.7 24.39 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 123.038 1.399 . . . . 35.939999999999998 108.733 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1032 ' ' THR . . . . . . . . . . . . . 28.0 m -66.3 133.2 50.06 Favored 'General case' 0 C--O 1.25 1.098 0 CA-C-N 114.121 -1.399 . . . . 33.369999999999997 108.414 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1033 ' ' VAL . . . . . 0.427 HG11 HG22 ' B' 1023 ' ' VAL . 22.2 t -107.38 126.88 63.57 Favored 'Isoleucine or valine' 0 C--O 1.251 1.169 0 O-C-N 120.068 -1.645 . . . . 29.98 107.271 -169.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -122.45 139.15 54.2 Favored 'General case' 0 C--O 1.243 0.714 0 O-C-N 124.134 0.896 . . . . 28.18 111.553 168.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1035 ' ' VAL . . . . . 0.605 ' HB ' HD13 ' B' 1057 ' ' ILE . 21.2 t -127.35 149.33 32.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 105.866 -1.901 . . . . 25.82 105.866 -175.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1036 ' ' GLU . . . . . 0.58 ' HG3' ' HA ' ' B' 1006 ' ' PRO . 13.3 mt-10 -62.67 145.61 54.22 Favored 'General case' 0 C--O 1.257 1.473 0 N-CA-C 113.7 1.0 . . . . 32.439999999999998 113.7 171.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1037 ' ' SER . . . . . . . . . . . . . 13.0 m -70.54 148.13 48.54 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 106.038 -1.838 . . . . 29.539999999999999 106.038 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 82.11 -53.2 4.73 Favored Glycine 0 CA--C 1.534 1.27 0 O-C-N 119.205 -2.184 . . . . 27.760000000000002 110.401 -172.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1039 ' ' ALA . . . . . . . . . . . . . . . -51.61 -40.99 60.91 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-N 119.434 1.617 . . . . 26.02 112.547 172.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -57.59 -49.08 76.68 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 120.465 -0.874 . . . . 26.469999999999999 112.288 171.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1041 ' ' GLN . . . . . 0.517 ' OE1' ' HA ' ' B' 1046 ' ' ASP . 1.1 tp-100 -59.12 -40.62 85.98 Favored 'General case' 0 C--O 1.246 0.877 0 C-N-CA 123.233 0.613 . . . . 50.979999999999997 110.429 178.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 46.2 mt -66.5 -26.51 67.2 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.771 1.026 . . . . 29.300000000000001 113.771 -171.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1043 ' ' ALA . . . . . . . . . . . . . . . -83.88 40.48 0.75 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 119.521 1.055 . . . . 26.739999999999998 111.926 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1044 ' ' SER . . . . . . . . . . . . . 38.6 m 44.3 54.62 6.07 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 126.284 1.833 . . . . 31.260000000000002 110.899 -166.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1045 ' ' PHE . . . . . 0.68 ' HA ' ' HB1' ' A' 1277 ' ' ALA . 0.2 OUTLIER -144.68 -167.39 2.64 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.439 -1.255 . . . . 33.259999999999998 109.775 -174.526 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B 1046 ' ' ASP . . . . . 0.517 ' HA ' ' OE1' ' B' 1041 ' ' GLN . 22.3 t70 -131.06 140.22 50.02 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 105.805 -1.924 . . . . 46.740000000000002 105.805 174.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -68.06 -37.47 81.31 Favored 'General case' 0 CA--C 1.502 -0.866 0 O-C-N 125.954 2.034 . . . . 34.439999999999998 111.407 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -77.85 -23.95 48.75 Favored 'General case' 0 N--CA 1.435 -1.2 0 O-C-N 119.279 -2.138 . . . . 48.670000000000002 109.955 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1049 ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' B' 1046 ' ' ASP . . . -58.45 -43.42 88.8 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 118.762 -0.637 . . . . 35.259999999999998 111.896 163.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1050 ' ' PHE . . . . . 0.461 ' HD1' ' O ' ' B' 1046 ' ' ASP . 31.1 m-85 -60.87 -37.85 83.57 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 120.889 1.677 . . . . 32.170000000000002 112.167 170.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 98.0 t -59.67 -45.74 94.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 O-C-N 119.585 -1.947 . . . . 38.369999999999997 108.503 174.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -63.76 -23.36 67.33 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 116.261 1.949 . . . . 45.770000000000003 116.261 174.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1053 ' ' ALA . . . . . 0.482 ' HB2' ' HB3' ' B' 1020 ' ' PRO . . . -78.35 -4.67 49.26 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 124.91 1.284 . . . . 37.829999999999998 112.269 170.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 87.75 34.57 9.99 Favored Glycine 0 CA--C 1.5 -0.866 0 CA-C-N 120.29 1.404 . . . . 35.82 110.681 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -114.62 138.1 51.09 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-O 124.151 1.929 . . . . 33.770000000000003 107.401 174.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -77.45 134.77 38.29 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 104.487 -2.412 . . . . 51.020000000000003 104.487 173.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1057 ' ' ILE . . . . . 0.605 HD13 ' HB ' ' B' 1035 ' ' VAL . 19.5 mm -108.46 107.16 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 106.259 -1.756 . . . . 38.469999999999999 106.259 175.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 88.1 t -86.29 132.77 31.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 CA-C-N 113.163 -1.835 . . . . 39.399999999999999 108.045 -173.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -72.5 95.82 1.85 Allowed 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 123.291 1.519 . . . . 57.07 110.576 168.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . 82.27 -151.16 29.54 Favored Glycine 0 C--O 1.248 1.026 0 CA-C-O 125.093 2.496 . . . . 44.829999999999998 116.191 166.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -58.64 -21.28 53.44 Favored 'General case' 0 C--O 1.212 -0.869 0 N-CA-C 118.91 2.93 . . . . 46.270000000000003 118.91 -167.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1062 ' ' SER . . . . . . . . . . . . . 4.2 m -53.65 -22.12 8.2 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.188 -1.57 . . . . 43.469999999999999 112.677 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 1.5 p -53.28 -35.31 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 O-C-N 120.983 -1.073 . . . . 36.979999999999997 111.181 176.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1064 ' ' TRP . . . . . 0.549 ' HA ' HD11 ' B' 1069 ' ' ILE . 55.2 m95 -63.16 -23.35 67.39 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 116.155 1.909 . . . . 37.899999999999999 116.155 177.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -83.44 93.58 7.82 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 124.475 2.083 . . . . 46.189999999999998 108.923 173.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1066 ' ' SER . . . . . 0.427 ' HB3' ' O ' ' B' 1002 ' ' ARG . 71.4 m -149.77 179.7 7.81 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 111.206 -2.725 . . . . 37.060000000000002 107.211 -174.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1067 ' ' GLU . . . . . 0.599 ' HB2' ' HA ' ' B' 1000 ' ' HIS . 35.2 tt0 -83.37 -51.3 7.52 Favored 'General case' 0 N--CA 1.437 -1.103 0 O-C-N 123.792 0.683 . . . . 43.950000000000003 109.952 166.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1068 ' ' ILE . . . . . 0.714 HD12 HG12 ' B' 1003 ' ' ILE . 1.3 mt -108.99 145.15 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 N-CA-C 107.061 -1.459 . . . . 33.5 107.061 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1069 ' ' ILE . . . . . 0.549 HD11 ' HA ' ' B' 1064 ' ' TRP . 46.0 mm -109.0 118.26 56.15 Favored 'Isoleucine or valine' 0 C--O 1.254 1.299 0 N-CA-C 104.33 -2.47 . . . . 30.57 104.33 158.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1070 ' ' LEU . . . . . 0.83 HD22 HD22 ' B' 1331 ' ' LEU . 94.5 mt -101.8 117.75 35.51 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 106.674 -1.602 . . . . 27.66 106.674 170.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1071 ' ' LYS . . . . . 0.54 ' HG2' ' OE2' ' B' 1008 ' ' GLU 0.279 13.6 tttm -140.83 160.16 40.64 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 125.994 2.059 . . . . 28.399999999999999 111.042 -170.025 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B 1072 ' ' VAL . . . . . 0.649 ' HB ' ' HG3' ' B' 1008 ' ' GLU . 99.7 t -94.63 -70.76 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.429 0 O-C-N 120.629 -1.294 . . . . 23.18 108.155 -173.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -97.4 152.68 18.69 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.893 -1.129 . . . . 25.469999999999999 108.011 -170.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -53.3 133.05 52.35 Favored Pre-proline 0 C--O 1.243 0.725 0 C-N-CA 126.29 1.836 . . . . 27.899999999999999 111.907 -173.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -60.32 129.75 31.13 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 122.752 2.301 . . . . 31.620000000000001 114.949 -173.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 49.2 mt -72.65 158.56 35.41 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.202 -1.036 . . . . 40.490000000000002 108.202 173.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.23 -29.7 10.04 Favored 'General case' 0 C--O 1.214 -0.768 0 O-C-N 118.937 -2.352 . . . . 51.590000000000003 117.014 -171.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -67.28 -46.21 74.3 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-N 114.986 -1.006 . . . . 42.359999999999999 110.017 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1079 ' ' GLU . . . . . 0.472 ' HA ' HD12 ' B' 1082 ' ' LEU . 31.8 mt-10 -63.07 -40.49 97.83 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 123.162 1.458 . . . . 34.530000000000001 109.029 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1080 ' ' ILE . . . . . 0.487 HG21 ' HB3' ' B' 1104 ' ' LYS . 84.3 mt -59.1 -48.81 85.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 108.333 -0.988 . . . . 33.25 108.333 175.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -56.84 -39.7 74.73 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 119.143 0.883 . . . . 36.469999999999999 112.874 175.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1082 ' ' LEU . . . . . 0.472 HD12 ' HA ' ' B' 1079 ' ' GLU . 28.6 mt -61.12 -38.51 86.61 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 125.762 1.625 . . . . 37.759999999999998 111.08 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1083 ' ' LEU . . . . . 0.447 HD11 HD22 ' B' 1089 ' ' LEU . 21.8 mt -56.73 121.11 9.02 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 123.17 0.588 . . . . 37.43 110.679 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -78.07 148.7 75.45 Favored Pre-proline 0 CA--C 1.558 1.271 0 N-CA-C 106.953 -1.499 . . . . 37.700000000000003 106.953 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1085 ' ' PRO . . . . . 0.647 ' HA ' ' O ' ' B' 1108 ' ' ARG . 0.1 OUTLIER -40.3 102.37 0.04 OUTLIER 'Trans proline' 0 C--O 1.239 0.562 0 C-N-CA 122.826 2.35 . . . . 35.509999999999998 115.564 169.674 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B 1086 ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' B' 1110 ' ' VAL . . . 84.49 26.38 39.46 Favored Glycine 0 C--N 1.345 1.04 0 CA-C-N 112.652 -2.067 . . . . 33.869999999999997 114.532 177.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1087 ' ' THR . . . . . . . . . . . . . 16.8 m -66.67 155.79 37.03 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 120.956 2.378 . . . . 32.5 108.491 166.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1088 ' ' THR . . . . . 0.655 ' HB ' ' HA ' ' B' 1068 ' ' ILE . 4.1 m -87.49 131.37 34.38 Favored 'General case' 0 C--O 1.205 -1.245 0 N-CA-C 105.088 -2.189 . . . . 30.219999999999999 105.088 174.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1089 ' ' LEU . . . . . 0.447 HD22 HD11 ' B' 1083 ' ' LEU . 39.3 tp -122.87 127.65 49.28 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 107.926 -1.139 . . . . 27.239999999999998 107.926 173.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 44.2 t -120.2 120.1 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 N-CA-C 103.326 -2.842 . . . . 25.390000000000001 103.326 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1091 ' ' SER . . . . . 0.549 ' O ' ' HA ' ' B' 1114 ' ' ALA . 2.6 m -164.53 160.31 20.2 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.528 1.513 . . . . 28.809999999999999 108.857 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1092 ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -59.48 99.43 0.06 Allowed 'General case' 0 C--O 1.247 0.971 0 O-C-N 121.088 -1.008 . . . . 30.780000000000001 111.204 158.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 32.2 mm -95.73 -28.53 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 109.199 -0.667 . . . . 30.280000000000001 109.199 -171.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1094 ' ' TRP . . . . . 0.441 ' HB2' HD22 ' B' 1098 ' ' ASN . 68.5 m95 52.06 56.08 15.48 Favored Pre-proline 0 N--CA 1.472 0.659 0 O-C-N 121.129 -0.982 . . . . 34.07 112.551 -175.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -53.43 -51.05 11.82 Favored 'Trans proline' 0 CA--C 1.505 -0.952 1 C-N-CA 126.541 4.828 . . . . 38.659999999999997 115.999 -162.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -69.17 -28.77 66.71 Favored 'General case' 0 C--O 1.247 0.929 0 O-C-N 120.714 -1.241 . . . . 41.32 110.684 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.04 -17.82 48.87 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 120.71 -1.244 . . . . 51.659999999999997 111.197 172.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1098 ' ' ASN . . . . . 0.534 ' HB3' ' HB3' ' B' 1101 ' ' LEU . 70.7 m-20 -125.73 61.19 36.82 Favored Pre-proline 0 C--O 1.243 0.728 0 N-CA-C 114.719 1.377 . . . . 40.32 114.719 176.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -60.45 -38.68 72.18 Favored 'Trans proline' 0 CA--C 1.506 -0.887 0 C-N-CA 123.743 2.962 . . . . 41.560000000000002 113.13 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -69.52 -45.24 69.32 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 106.863 -1.532 . . . . 54.109999999999999 106.863 -174.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1101 ' ' LEU . . . . . 0.534 ' HB3' ' HB3' ' B' 1098 ' ' ASN . 7.0 tt -60.64 -48.77 80.29 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.645 -1.243 . . . . 37.880000000000003 107.645 177.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1102 ' ' MET . . . . . . . . . . . . . 43.2 mmm -50.86 -46.76 60.37 Favored 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 120.616 -1.302 . . . . 37.539999999999999 114.341 173.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -64.55 -39.0 92.96 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 123.173 1.463 . . . . 47.009999999999998 112.794 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1104 ' ' LYS . . . . . 0.487 ' HB3' HG21 ' B' 1080 ' ' ILE . 52.5 mttm -60.98 -45.47 94.68 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 118.928 -2.358 . . . . 48.68 111.77 175.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1105 ' ' LEU . . . . . 0.673 HD13 HG21 ' B' 1112 ' ' VAL . 52.2 mt -62.05 -39.25 91.74 Favored 'General case' 0 C--O 1.252 1.235 0 O-C-N 120.668 -1.27 . . . . 32.210000000000001 109.604 177.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -57.36 -37.05 71.99 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 112.968 0.729 . . . . 33.729999999999997 112.968 171.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -67.63 -45.92 73.97 Favored 'General case' 0 CA--C 1.504 -0.824 0 O-C-N 118.888 -2.383 . . . . 51.469999999999999 112.105 172.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1108 ' ' ARG . . . . . 0.647 ' O ' ' HA ' ' B' 1085 ' ' PRO . 21.9 mmm180 -61.42 -11.64 11.24 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 120.577 -1.327 . . . . 43.899999999999999 112.013 169.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1109 ' ' ASN . . . . . 0.407 ' HA ' ' HA2' ' B' 1364 ' ' GLY . 27.0 m-80 63.04 24.86 14.73 Favored 'General case' 0 C--N 1.358 0.96 0 O-C-N 120.024 -1.673 . . . . 44.82 114.253 172.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1110 ' ' VAL . . . . . 0.478 ' HA ' ' HA2' ' B' 1086 ' ' GLY . 18.4 m -83.59 167.87 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 N-CA-C 112.563 0.579 . . . . 30.52 112.563 -171.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1111 ' ' THR . . . . . 0.702 HG23 ' HA ' ' B' 1362 ' ' ARG . 95.9 m -109.74 111.14 22.41 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.439 -1.689 . . . . 27.120000000000001 106.439 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1112 ' ' VAL . . . . . 0.673 HG21 HD13 ' B' 1105 ' ' LEU . 63.6 t -113.27 120.3 62.86 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.621 0 N-CA-C 108.178 -1.045 . . . . 26.399999999999999 108.178 -165.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1113 ' ' MET . . . . . 0.453 ' SD ' HD11 ' B' 1338 ' ' LEU . 0.8 OUTLIER -94.79 105.92 17.88 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-O 123.596 1.665 . . . . 42.920000000000002 109.376 164.274 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B 1114 ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' B' 1091 ' ' SER . . . -86.4 108.55 18.52 Favored 'General case' 0 CA--C 1.5 -0.958 0 O-C-N 119.302 -2.124 . . . . 24.149999999999999 108.444 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1115 ' ' MET . . . . . 0.565 ' HB3' ' CB ' ' B' 1129 ' ' ALA . 82.1 mmm -67.98 -16.93 64.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 111.971 -2.377 . . . . 29.949999999999999 113.32 -173.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1116 ' ' ASP . . . . . 0.573 ' HA ' ' HG ' ' B' 1130 ' ' LEU . 9.8 p-10 -79.6 -35.01 40.25 Favored 'General case' 0 C--O 1.253 1.244 0 O-C-N 120.018 -1.676 . . . . 34.530000000000001 109.481 171.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1117 ' ' SER . . . . . . . . . . . . . 69.1 m -87.62 31.13 0.77 Allowed 'General case' 0 C--O 1.247 0.97 0 C-N-CA 126.293 1.837 . . . . 33.490000000000002 114.451 -166.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1118 ' ' VAL . . . . . 0.624 HG12 ' HB1' ' B' 1124 ' ' ALA . 15.1 t -77.98 136.96 61.7 Favored Pre-proline 0 C--O 1.259 1.555 0 N-CA-C 107.887 -1.153 . . . . 34.020000000000003 107.887 -177.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1119 ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' B' 1118 ' ' VAL . 55.4 Cg_exo -62.06 132.31 38.7 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 124.226 3.284 . . . . 38.280000000000001 108.232 174.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1120 ' ' ARG . . . . . 0.552 ' HB2' HG11 ' B' 1375 ' ' VAL . 2.0 mmt180 -73.27 29.36 0.07 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 119.158 3.022 . . . . 55.049999999999997 119.158 -160.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1121 ' ' ILE . . . . . 0.54 HG21 HD12 ' B' 1373 ' ' ILE . 23.8 pt -90.51 162.74 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 CA-C-N 119.176 0.898 . . . . 42.090000000000003 110.582 -169.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1122 ' ' SER . . . . . 0.648 ' HB2' ' HA ' ' C' ' 133' ' ' MET . 1.1 m -51.29 -40.91 59.98 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 112.954 -1.93 . . . . 38.020000000000003 115.576 -175.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1123 ' ' ARG . . . . . . . . . . . . . 24.1 ptt-85 -72.37 -41.48 66.32 Favored 'General case' 0 C--N 1.361 1.084 0 O-C-N 119.921 -1.737 . . . . 34.289999999999999 112.632 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1124 ' ' ALA . . . . . 0.624 ' HB1' HG12 ' B' 1118 ' ' VAL . . . -53.49 -35.3 60.46 Favored 'General case' 0 N--CA 1.434 -1.232 0 O-C-N 124.957 1.411 . . . . 32.350000000000001 114.766 175.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1125 ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -58.71 -20.77 51.77 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 117.964 2.579 . . . . 47.170000000000002 117.964 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1126 ' ' SER . . . . . 0.525 ' OG ' HD12 ' B' 1127 ' ' LEU . 73.3 p -70.72 -35.89 72.93 Favored 'General case' 0 C--O 1.251 1.178 0 O-C-N 120.05 -1.656 . . . . 31.710000000000001 112.099 170.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1127 ' ' LEU . . . . . 0.604 HD22 HG11 ' B' 1354 ' ' VAL . 4.5 mp -86.56 -16.85 35.57 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.884 -1.053 . . . . 37.0 112.35 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1128 ' ' ASP . . . . . . . . . . . . . 24.3 t70 -75.09 117.38 16.87 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 126.49 3.043 . . . . 40.399999999999999 117.06 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1129 ' ' ALA . . . . . 0.565 ' CB ' ' HB3' ' B' 1115 ' ' MET . . . -70.13 -33.83 72.31 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-N 109.924 -3.307 . . . . 26.559999999999999 107.419 -176.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1130 ' ' LEU . . . . . 0.573 ' HG ' ' HA ' ' B' 1116 ' ' ASP . 32.0 mt -61.98 -35.34 78.19 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 124.045 0.938 . . . . 30.890000000000001 110.664 177.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1131 ' ' SER . . . . . . . . . . . . . 61.4 m -71.39 -51.43 24.06 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 120.937 1.699 . . . . 29.84 109.164 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1132 ' ' SER . . . . . . . . . . . . . 55.5 m -55.85 -44.45 78.02 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.51 1.505 . . . . 31.91 112.47 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1133 ' ' MET . . . . . 0.607 ' HB3' ' HB3' ' B' 1316 ' ' PRO . 36.7 mmt -71.56 -33.66 69.3 Favored 'General case' 0 CA--C 1.51 -0.57 0 O-C-N 121.175 -0.953 . . . . 25.899999999999999 111.101 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1134 ' ' ALA . . . . . 0.609 ' HB1' ' HB2' ' B' 1176 ' ' ALA . . . -66.72 -38.15 86.12 Favored 'General case' 0 C--O 1.201 -1.483 0 O-C-N 119.767 -1.833 . . . . 26.620000000000001 110.558 170.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.45 -30.75 71.17 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 120.126 1.33 . . . . 36.969999999999999 113.064 176.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1136 ' ' ILE . . . . . . . . . . . . . 39.3 mm -58.37 -56.96 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 CA-C-O 117.492 -1.242 . . . . 32.109999999999999 110.231 164.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1137 ' ' ALA . . . . . 0.427 ' HB2' ' HG3' ' B' 1316 ' ' PRO . . . -53.76 -37.96 63.92 Favored 'General case' 0 CA--C 1.508 -0.64 0 O-C-N 124.901 1.376 . . . . 24.140000000000001 112.985 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -71.74 -40.71 57.91 Favored Glycine 0 N--CA 1.441 -1.033 0 CA-C-O 122.22 0.9 . . . . 25.129999999999999 111.492 -176.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 4.5 t80 -68.25 -41.86 80.52 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 120.847 -1.384 . . . . 32.729999999999997 108.405 174.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1140 ' ' ARG . . . . . 0.495 ' HA ' ' HB ' ' B' 1143 ' ' VAL . 11.5 tpt180 -71.2 -19.68 62.36 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 118.51 -0.757 . . . . 26.359999999999999 110.901 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1141 ' ' ALA . . . . . 0.74 ' HB2' HD21 ' B' 1284 ' ' LEU . . . -60.34 -52.72 64.07 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 119.721 1.146 . . . . 24.120000000000001 108.682 171.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 42.6 mm -64.98 -36.08 76.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 O-C-N 124.219 0.949 . . . . 23.370000000000001 111.623 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1143 ' ' VAL . . . . . 0.495 ' HB ' ' HA ' ' B' 1140 ' ' ARG . 57.2 t -65.58 -67.39 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 C-N-CA 124.018 0.927 . . . . 24.960000000000001 112.112 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -55.56 -31.95 62.59 Favored 'General case' 0 C--N 1.354 0.783 0 O-C-N 120.103 -1.623 . . . . 32.07 114.116 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1145 ' ' ALA . . . . . 0.634 ' HB1' HD12 ' B' 1251 ' ' ILE . . . -58.21 -57.2 13.92 Favored 'General case' 0 C--O 1.203 -1.388 0 CA-C-N 115.817 -0.629 . . . . 24.870000000000001 109.589 170.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1146 ' ' ALA . . . . . . . . . . . . . . . -58.04 -38.95 77.21 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.831 0.824 . . . . 24.670000000000002 113.051 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 83.4 t60 -51.7 -56.96 10.68 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.699 -1.137 . . . . 28.579999999999998 111.152 170.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1148 ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -90.13 1.76 56.04 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 115.557 1.688 . . . . 36.82 115.557 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1149 ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' B' 1145 ' ' ALA . 0.7 OUTLIER -72.23 153.06 41.79 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.886 1.674 . . . . 31.969999999999999 109.277 -174.386 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B 1150 ' ' GLY . . . . . 0.561 ' HA2' ' HG2' ' A' 1320 ' ' PRO . . . -86.24 -36.06 10.25 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 117.211 -1.883 . . . . 25.489999999999998 112.685 169.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1151 ' ' ARG . . . . . 0.843 ' HA ' ' HB2' ' A' 1322 ' ' GLN . 25.8 mtm-85 -119.05 -177.95 3.45 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 122.717 3.258 . . . . 59.840000000000003 115.893 -168.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1152 ' ' PHE . . . . . 0.723 ' HB2' HG11 ' B' 1163 ' ' VAL . 18.2 m-30 -81.75 165.66 20.74 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 124.124 1.916 . . . . 34.450000000000003 110.092 175.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1153 ' ' PHE . . . . . 0.523 ' HB3' ' HB2' ' B' 1189 ' ' ALA . 56.7 m-85 -82.31 -49.89 9.55 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.415 -1.266 . . . . 31.170000000000002 111.605 166.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1154 ' ' THR . . . . . . . . . . . . . 3.1 m -65.31 142.42 58.26 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.684 1.193 . . . . 33.890000000000001 111.31 -176.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -80.52 72.35 2.68 Favored Glycine 0 C--N 1.34 0.786 0 O-C-N 117.871 -3.018 . . . . 38.950000000000003 108.754 169.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1156 ' ' GLN . . . . . 0.439 ' H ' ' HB ' ' B' 1163 ' ' VAL . 39.0 tt0 -89.82 114.53 26.27 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 123.169 1.461 . . . . 54.229999999999997 110.77 -163.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 6.9 mm -67.87 95.07 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 113.441 -1.709 . . . . 51.159999999999997 106.426 166.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1158 ' ' THR . . . . . 0.561 HG21 HD13 ' A' 1326 ' ' LEU . 10.3 m -95.9 157.24 15.99 Favored 'General case' 0 C--O 1.249 1.069 0 N-CA-C 108.03 -1.1 . . . . 49.609999999999999 108.03 -172.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -46.92 -51.56 16.56 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.024 0.75 . . . . 49.049999999999997 113.024 174.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1160 ' ' ALA . . . . . 0.535 ' HA ' ' HA ' ' A' 1126 ' ' SER . . . -63.65 -58.27 7.44 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 114.659 1.355 . . . . 47.649999999999999 114.659 173.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1161 ' ' GLY . . . . . 0.418 ' HA3' HG21 ' A' 1329 ' ' THR . . . -159.87 179.18 35.6 Favored Glycine 0 C--O 1.25 1.119 0 CA-C-O 118.079 -1.401 . . . . 45.609999999999999 110.864 -168.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 95.6 mttt -94.46 140.14 30.21 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.169 -1.048 . . . . 57.460000000000001 108.169 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1163 ' ' VAL . . . . . 0.723 HG11 ' HB2' ' B' 1152 ' ' PHE . 59.2 t -97.41 128.57 34.32 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-N 114.59 -1.186 . . . . 42.93 112.573 176.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1164 ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' B' 1165 ' ' PRO . 92.7 Cg_endo -71.21 130.42 17.54 Favored 'Trans proline' 0 N--CA 1.483 0.911 0 C-N-CA 122.84 2.36 . . . . 39.289999999999999 108.322 174.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1165 ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' B' 1164 ' ' PRO . 39.4 Cg_exo -68.27 146.1 68.25 Favored 'Trans proline' 0 C--O 1.245 0.829 0 C-N-CA 123.251 2.634 . . . . 34.170000000000002 111.02 -172.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1166 ' ' ALA . . . . . 0.417 ' CB ' ' HA ' ' B' 1153 ' ' PHE . . . -68.98 119.41 13.23 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-O 123.731 1.729 . . . . 31.690000000000001 111.438 170.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1167 ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' B' 1190 ' ' ILE . 87.9 mttt -89.41 98.04 11.54 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 125.42 2.533 . . . . 44.780000000000001 107.566 171.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1168 ' ' VAL . . . . . 0.446 HG12 HG23 ' B' 1170 ' ' VAL . 60.5 t -89.03 100.48 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 109.739 -3.391 . . . . 31.23 108.867 -178.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1169 ' ' MET . . . . . 0.468 ' HA ' ' O ' ' B' 1192 ' ' ARG . 42.6 ttp -85.02 89.93 7.72 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.29 -0.868 . . . . 37.090000000000003 108.908 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1170 ' ' VAL . . . . . 0.446 HG23 HG12 ' B' 1168 ' ' VAL . 62.8 t -83.22 105.45 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-O 122.728 1.252 . . . . 30.170000000000002 108.415 177.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1171 ' ' ILE . . . . . 0.566 ' HB ' ' HA ' ' B' 1254 ' ' THR . 97.3 mt -88.93 87.86 2.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 105.285 -2.117 . . . . 33.740000000000002 105.285 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1172 ' ' GLY . . . . . 0.477 ' O ' ' HA3' ' B' 1177 ' ' GLY . . . 134.37 95.85 0.54 Allowed Glycine 0 N--CA 1.437 -1.298 0 CA-C-N 113.499 -1.682 . . . . 32.590000000000003 109.962 178.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1173 ' ' ALA . . . . . . . . . . . . . . . -92.99 46.09 1.21 Allowed 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 119.911 1.856 . . . . 32.420000000000002 112.978 -175.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -134.22 151.94 20.44 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 108.241 -1.944 . . . . 31.739999999999998 108.241 -174.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 23.4 t 24.97 -84.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 127.324 2.249 . . . . 31.48 115.242 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1176 ' ' ALA . . . . . 0.609 ' HB2' ' HB1' ' B' 1134 ' ' ALA . . . -62.61 -41.36 98.95 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 123.418 1.58 . . . . 26.120000000000001 111.137 -175.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1177 ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' B' 1172 ' ' GLY . . . -68.95 -31.37 72.52 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 113.093 -1.867 . . . . 25.73 111.284 177.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1178 ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.0 -48.41 81.67 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 121.445 2.622 . . . . 32.590000000000003 108.126 175.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -61.43 -46.78 88.69 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 112.764 0.653 . . . . 27.719999999999999 112.764 176.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -56.86 -46.52 81.72 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 121.993 0.902 . . . . 26.030000000000001 112.875 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1181 ' ' ILE . . . . . 0.605 HG22 ' SD ' ' B' 1207 ' ' MET . 72.5 mt -60.11 -50.55 79.74 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.435 0 C-N-CA 126.559 1.944 . . . . 28.609999999999999 107.784 174.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -48.07 -55.78 9.78 Favored Glycine 0 N--CA 1.44 -1.042 0 O-C-N 124.228 0.955 . . . . 25.23 113.151 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -63.9 -51.09 66.12 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 117.754 -1.117 . . . . 24.09 110.882 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -62.23 -43.77 98.08 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-O 123.549 1.642 . . . . 26.68 113.963 -175.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -67.24 -40.35 86.29 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 119.346 -2.096 . . . . 36.57 109.02 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1186 ' ' SER . . . . . 0.942 ' HB3' ' HA ' ' A' 1187 ' ' LEU . 61.0 m -66.44 -23.63 66.32 Favored 'General case' 0 C--O 1.25 1.088 0 CA-C-N 119.914 1.234 . . . . 28.920000000000002 113.226 173.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1187 ' ' LEU . . . . . 0.405 ' HG ' HD21 ' A' 1187 ' ' LEU . 19.5 mt -84.32 6.8 21.61 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 119.871 -1.768 . . . . 29.09 112.997 165.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 83.62 14.05 74.27 Favored Glycine 0 CA--C 1.538 1.524 0 O-C-N 118.546 -2.596 . . . . 29.260000000000002 114.33 172.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1189 ' ' ALA . . . . . 0.523 ' HB2' ' HB3' ' B' 1153 ' ' PHE . . . -88.98 143.76 26.63 Favored 'General case' 0 N--CA 1.433 -1.276 0 O-C-N 120.843 -1.386 . . . . 30.16 112.396 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1190 ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' B' 1167 ' ' LYS . 97.0 mt -76.77 97.43 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 105.13 -2.174 . . . . 35.810000000000002 105.13 174.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1191 ' ' VAL . . . . . 0.441 HG11 HG12 ' B' 1181 ' ' ILE . 47.7 t -74.35 115.95 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 104.955 -2.239 . . . . 31.969999999999999 104.955 176.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1192 ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' B' 1169 ' ' MET . 83.3 mtt180 -103.3 77.91 1.57 Allowed 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 106.438 -1.69 . . . . 48.159999999999997 106.438 174.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1193 ' ' ALA . . . . . 0.625 ' HB3' HG21 ' B' 1204 ' ' VAL . . . -87.07 155.64 20.06 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 114.719 1.377 . . . . 35.890000000000001 114.719 -172.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 44.7 t80 -138.87 139.25 38.05 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 104.872 -2.27 . . . . 41.880000000000003 104.872 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1195 ' ' ASP . . . . . . . . . . . . . 8.8 t0 -146.1 150.07 35.23 Favored 'General case' 0 C--O 1.245 0.857 0 N-CA-C 102.289 -3.226 . . . . 38.280000000000001 102.289 165.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1196 ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -72.15 -27.47 62.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 120.383 -1.448 . . . . 40.619999999999997 111.605 176.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1197 ' ' ARG . . . . . . . . . . . . . 36.5 mtm180 -84.4 132.09 48.34 Favored Pre-proline 0 N--CA 1.444 -0.759 0 N-CA-C 115.876 1.806 . . . . 53.090000000000003 115.876 -171.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -69.31 -30.32 24.58 Favored 'Trans proline' 0 CA--C 1.498 -1.291 0 C-N-CA 122.906 2.404 . . . . 42.560000000000002 117.35 -176.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -54.89 -26.74 37.83 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 113.199 0.814 . . . . 56.310000000000002 113.199 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1200 ' ' VAL . . . . . 0.56 ' HB ' ' NE2' ' B' 1203 ' ' GLN . 3.5 m -114.5 20.34 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 CA-C-O 123.59 1.662 . . . . 42.909999999999997 114.717 -173.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 58.0 tttm -69.94 -56.12 7.86 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 122.53 1.157 . . . . 48.890000000000001 110.931 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -55.66 -43.51 76.36 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 115.957 1.836 . . . . 51.700000000000003 115.957 -165.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1203 ' ' GLN . . . . . 0.56 ' NE2' ' HB ' ' B' 1200 ' ' VAL . 9.6 pt20 -43.37 -38.51 2.76 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 119.307 3.077 . . . . 52.57 119.307 -175.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1204 ' ' VAL . . . . . 0.625 HG21 ' HB3' ' B' 1193 ' ' ALA . 43.7 t -71.91 -47.05 57.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 106.058 -1.83 . . . . 33.789999999999999 106.058 -177.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -62.65 -44.58 95.9 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.773 -0.455 . . . . 36.579999999999998 109.773 175.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1206 ' ' SER . . . . . . . . . . . . . 16.8 m -60.87 -22.24 64.06 Favored 'General case' 0 CA--C 1.504 -0.808 0 C-N-CA 127.186 2.194 . . . . 39.609999999999999 115.333 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1207 ' ' MET . . . . . 0.694 ' SD ' ' HG ' ' C' ' 75' ' ' LEU . 27.0 mtp -87.59 -23.59 24.25 Favored 'General case' 0 C--O 1.253 1.249 0 CA-C-O 123.98 1.848 . . . . 37.450000000000003 111.523 175.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 95.32 73.58 1.19 Allowed Glycine 0 CA--C 1.5 -0.858 0 O-C-N 118.274 -2.766 . . . . 31.870000000000001 107.158 -175.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1209 ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' B' 1191 ' ' VAL . . . -169.67 -170.96 1.12 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 109.842 -3.179 . . . . 35.399999999999999 106.448 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -125.45 147.55 49.16 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 121.581 1.992 . . . . 47.890000000000001 111.885 -172.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 14.9 t80 -105.92 138.95 41.22 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 105.673 -1.973 . . . . 45.530000000000001 105.673 173.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1212 ' ' LEU . . . . . . . . . . . . . 78.9 mt -86.86 128.06 35.04 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 122.449 1.119 . . . . 46.329999999999998 111.344 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -94.44 145.2 24.94 Favored 'General case' 0 C--O 1.254 1.317 0 CA-C-N 112.299 -2.228 . . . . 60.409999999999997 111.72 177.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.62 153.51 17.68 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 114.184 -1.371 . . . . 57.380000000000003 108.775 -175.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 18.2 t70 . . . . . 0 CA--C 1.506 -0.738 0 N-CA-C 112.72 0.637 . . . . 65.069999999999993 112.72 -178.329 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B 1230 ' ' MET . . . . . 0.645 ' N ' ' HG ' ' B' 1231 ' ' SER . 16.3 mmt . . . . . 0 N--CA 1.432 -1.372 1 N-CA-C 99.374 -4.306 . . . . 80.319999999999993 99.374 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1231 ' ' SER . . . . . 0.645 ' HG ' ' N ' ' B' 1230 ' ' MET . 67.1 m 127.5 147.28 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.348 3 O-C-N 110.924 -7.36 . . . . 79.920000000000002 107.109 -10.319 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -63.79 150.54 44.43 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 120.618 1.554 . . . . 77.909999999999997 110.338 -172.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 65.92 -43.11 0.38 Allowed 'General case' 0 C--N 1.356 0.888 0 C-N-CA 125.065 1.346 . . . . 73.879999999999995 114.08 -170.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 12.0 t80 -56.35 -50.91 70.14 Favored 'General case' 0 CA--C 1.507 -0.707 0 O-C-N 118.935 -2.353 . . . . 68.980000000000004 109.996 172.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 30.3 pt -54.77 -31.87 24.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 112.57 -2.104 . . . . 64.530000000000001 113.048 172.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -74.43 -30.45 61.91 Favored 'General case' 0 C--O 1.218 -0.598 0 O-C-N 117.947 -2.971 . . . . 66.359999999999999 111.632 172.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -64.61 -41.75 96.01 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-N 119.629 1.104 . . . . 56.600000000000001 110.645 170.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -55.85 -52.66 63.27 Favored 'General case' 0 C--O 1.249 1.065 0 O-C-N 121.606 -0.684 . . . . 56.789999999999999 111.368 169.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1239 ' ' MET . . . . . 0.403 ' HG2' ' O ' ' B' 1266 ' ' LEU . 14.2 mtm -49.05 -45.05 42.34 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 114.589 1.329 . . . . 53.630000000000003 114.589 174.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -65.59 -37.1 85.67 Favored 'General case' 0 C--O 1.247 0.971 0 CA-C-O 123.042 1.401 . . . . 51.740000000000002 109.995 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 31.4 tp -63.17 -44.75 94.55 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 118.319 -2.738 . . . . 44.859999999999999 107.474 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 11.4 m-30 -68.85 -37.57 79.22 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.362 -1.29 . . . . 42.780000000000001 109.772 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -62.48 -33.73 75.45 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 121.123 1.783 . . . . 40.960000000000001 109.58 175.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -66.23 -47.52 73.53 Favored 'General case' 0 C--N 1.345 0.413 0 CA-C-O 122.253 1.025 . . . . 43.060000000000002 110.278 173.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -63.97 -25.54 68.18 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.588 -1.642 . . . . 46.450000000000003 113.241 176.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -31.85 -51.16 0.22 Allowed 'General case' 0 N--CA 1.472 0.671 1 N-CA-C 122.109 4.114 . . . . 41.780000000000001 122.109 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 6.2 tptt -86.08 -18.28 32.84 Favored 'General case' 0 C--N 1.347 0.49 0 O-C-N 120.438 -1.414 . . . . 52.200000000000003 111.874 176.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1248 ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -80.96 -48.15 12.68 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 118.745 -2.472 . . . . 53.549999999999997 112.618 172.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1249 ' ' VAL . . . . . . . . . . . . 0.255 26.8 m -71.02 137.38 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 CA-C-O 126.54 3.067 . . . . 34.409999999999997 114.933 -168.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1250 ' ' ASP . . . . . 0.435 ' HB3' ' CZ ' ' B' 1149 ' ' PHE . 3.8 m-20 -98.29 -51.43 3.99 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 108.62 -3.9 . . . . 33.380000000000003 111.225 -176.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1251 ' ' ILE . . . . . 0.634 HD12 ' HB1' ' B' 1145 ' ' ALA . 40.4 mm -126.39 111.7 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 O-C-N 118.439 -2.663 . . . . 29.539999999999999 106.543 -174.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1252 ' ' ILE . . . . . 0.468 HG22 ' HB ' ' B' 1254 ' ' THR . 61.8 mt -98.28 108.62 22.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 105.947 -1.871 . . . . 32.439999999999998 105.947 176.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1253 ' ' VAL . . . . . 0.441 ' HB ' ' HA ' ' B' 1170 ' ' VAL . 39.9 t -90.71 87.13 2.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 N-CA-C 102.342 -3.207 . . . . 30.57 102.342 176.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1254 ' ' THR . . . . . 0.568 HG23 ' HB2' ' B' 1291 ' ' ASN 0.275 2.0 t -88.33 96.17 10.47 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 103.452 -2.795 . . . . 35.039999999999999 103.452 -176.361 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B 1255 ' ' THR . . . . . 0.582 ' HA ' ' HB2' ' B' 1284 ' ' LEU . 21.6 m -90.11 -73.56 0.52 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 109.795 -3.366 . . . . 34.619999999999997 108.515 -175.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1256 ' ' ALA . . . . . 0.539 ' HB3' ' OD1' ' B' 1291 ' ' ASN . . . 45.3 1.51 0.0 OUTLIER 'General case' 0 C--O 1.242 0.671 1 N-CA-C 123.175 4.509 . . . . 42.719999999999999 123.175 -178.778 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 2.6 mp -65.64 92.79 0.15 Allowed 'General case' 0 C--O 1.242 0.68 0 CA-C-N 123.173 2.715 . . . . 52.43 113.863 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1258 ' ' ILE . . . . . 0.499 HG13 ' HB2' ' B' 1261 ' ' LYS . 0.3 OUTLIER -76.0 137.59 69.21 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 112.319 -2.218 . . . . 59.409999999999997 108.7 171.612 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -55.22 113.3 1.35 Allowed 'Trans proline' 0 N--CA 1.444 -1.411 0 C-N-CA 124.499 3.466 . . . . 62.68 116.391 -165.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 89.77 -36.4 3.54 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 109.772 -1.331 . . . . 64.159999999999997 109.772 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1261 ' ' LYS . . . . . 0.499 ' HB2' HG13 ' B' 1258 ' ' ILE . 70.6 mttt -75.16 135.69 73.12 Favored Pre-proline 0 C--O 1.247 0.95 0 CA-C-N 120.886 2.343 . . . . 68.530000000000001 107.63 -175.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.58 145.49 98.72 Favored 'Trans proline' 0 CA--C 1.5 -1.205 0 C-N-CA 123.895 3.064 . . . . 61.990000000000002 113.097 161.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1263 ' ' ALA . . . . . . . . . . . . . . . -81.92 128.81 67.14 Favored Pre-proline 0 C--O 1.24 0.561 0 O-C-N 120.618 -1.301 . . . . 57.149999999999999 112.833 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -64.32 153.03 78.93 Favored 'Trans proline' 0 C--O 1.247 0.969 0 C-N-CA 122.416 2.077 . . . . 51.57 116.101 169.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1265 ' ' LYS . . . . . 0.416 ' NZ ' ' O ' ' B' 1289 ' ' GLY . 41.9 mmtm -77.22 88.59 3.67 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 122.603 1.192 . . . . 54.549999999999997 110.065 -174.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1266 ' ' LEU . . . . . 0.403 ' O ' ' HG2' ' B' 1239 ' ' MET . 68.6 mt -80.35 -43.49 21.06 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 115.102 1.519 . . . . 46.859999999999999 115.102 178.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1267 ' ' ILE . . . . . 0.591 HG21 HD13 ' B' 1281 ' ' ILE . 35.1 mm -87.7 101.94 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 105.809 -1.923 . . . . 41.039999999999999 105.809 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1268 ' ' THR . . . . . 0.482 ' O ' HG23 ' B' 1272 ' ' VAL . 24.4 p -73.96 159.16 33.15 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-N 113.858 -1.519 . . . . 39.579999999999998 112.484 -178.002 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1269 ' ' ARG . . . . . . . . . . . . . 79.1 mtt85 -55.45 -43.42 75.42 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 115.997 -0.547 . . . . 53.149999999999999 110.471 172.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -56.37 -41.33 76.01 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 113.816 1.043 . . . . 42.960000000000001 113.816 175.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1271 ' ' MET . . . . . 0.44 ' SD ' HG23 ' B' 1267 ' ' ILE . 43.4 ttm -65.94 -47.79 73.48 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.704 -0.68 . . . . 43.890000000000001 110.189 -177.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1272 ' ' VAL . . . . . 0.482 HG23 ' O ' ' B' 1268 ' ' THR . 38.5 t -65.68 -41.97 91.67 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.671 0 CA-C-O 121.467 0.651 . . . . 38.369999999999997 110.922 -177.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -63.13 -35.78 81.43 Favored 'General case' 0 C--O 1.239 0.541 0 O-C-N 118.53 -2.606 . . . . 47.460000000000001 112.664 173.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1274 ' ' SER . . . . . . . . . . . . . 72.8 m -70.14 -25.34 63.43 Favored 'General case' 0 N--CA 1.441 -0.917 0 O-C-N 120.845 -1.16 . . . . 38.380000000000003 113.868 173.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1275 ' ' MET . . . . . 0.491 ' SD ' HD11 ' B' 1281 ' ' ILE . 40.2 mtp -60.79 163.53 5.57 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 117.95 2.574 . . . . 37.810000000000002 117.95 -174.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 81.8 tttt -62.95 131.79 49.88 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 110.242 -3.163 . . . . 49.259999999999998 108.97 166.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1277 ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' 1045 ' ' PHE . . . -84.24 166.37 17.58 Favored 'General case' 0 CA--C 1.51 -0.594 0 O-C-N 124.83 1.331 . . . . 34.460000000000001 110.023 -177.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 63.2 30.53 77.81 Favored Glycine 0 C--N 1.334 0.467 0 O-C-N 120.886 -1.134 . . . . 33.530000000000001 111.861 -172.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1279 ' ' SER . . . . . . . . . . . . . 42.3 m -126.5 146.81 49.97 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 106.062 -1.829 . . . . 31.309999999999999 106.062 -176.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1280 ' ' VAL . . . . . 0.412 HG11 ' HA ' ' B' 1145 ' ' ALA . 58.1 t -117.66 135.36 58.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 122.592 1.187 . . . . 29.32 109.278 -171.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1281 ' ' ILE . . . . . 0.591 HD13 HG21 ' B' 1267 ' ' ILE . 67.4 mt -110.62 104.09 16.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 103.601 -2.74 . . . . 31.93 103.601 178.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1282 ' ' VAL . . . . . 0.698 HG11 ' HA ' ' B' 1141 ' ' ALA . 31.7 t -95.78 111.72 26.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 N-CA-C 101.681 -3.451 . . . . 29.48 101.681 -175.002 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 36.8 t0 -87.67 107.01 18.42 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.231 -1.349 . . . . 34.5 108.544 175.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1284 ' ' LEU . . . . . 0.74 HD21 ' HB2' ' B' 1141 ' ' ALA . 19.6 mt -79.02 -17.21 55.72 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 118.609 -1.236 . . . . 37.939999999999998 111.045 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -102.12 29.23 5.22 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.664 0.745 . . . . 40.920000000000002 111.868 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -51.83 -36.59 48.63 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.64 1.976 . . . . 44.390000000000001 115.797 177.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1287 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.19 -38.86 21.74 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.497 1.119 . . . . 51.460000000000001 110.347 171.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 11.3 t30 -98.37 71.95 2.07 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-O 121.482 0.658 . . . . 57.75 111.574 -171.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1289 ' ' GLY . . . . . 0.416 ' O ' ' NZ ' ' B' 1265 ' ' LYS . . . 86.61 -40.74 3.07 Favored Glycine 0 N--CA 1.47 0.948 0 CA-C-O 117.949 -1.473 . . . . 49.850000000000001 113.614 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 72.57 119.73 0.06 OUTLIER Glycine 0 CA--C 1.541 1.672 0 CA-C-N 121.42 2.61 . . . . 45.93 112.195 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1291 ' ' ASN . . . . . 0.568 ' HB2' HG23 ' B' 1254 ' ' THR . 54.8 m-80 -85.52 -21.75 28.46 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.625 1.17 . . . . 42.670000000000002 110.034 -175.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1292 ' ' CYS . . . . . 0.486 ' HB3' ' OG1' ' B' 1295 ' ' THR . 27.1 t -110.83 132.19 54.41 Favored 'General case' 0 CA--C 1.51 -0.582 0 O-C-N 118.503 -2.623 . . . . 38.82 111.608 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1293 ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -58.17 -41.79 84.62 Favored 'General case' 0 C--O 1.245 0.856 0 CA-C-O 121.399 0.619 . . . . 46.710000000000001 111.928 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -75.56 -7.71 54.91 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 115.37 1.618 . . . . 47.229999999999997 115.37 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1295 ' ' THR . . . . . 0.563 HG23 ' HA3' ' B' 1311 ' ' GLY . 38.6 m -53.89 122.3 9.75 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.239 0.616 . . . . 36.020000000000003 112.551 172.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1296 ' ' VAL . . . . . 0.558 HG23 ' HB2' ' B' 1301 ' ' PHE . 26.3 t -89.0 106.31 12.84 Favored Pre-proline 0 N--CA 1.488 1.452 0 N-CA-C 101.993 -3.336 . . . . 37.259999999999998 101.993 161.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -59.97 76.15 0.06 OUTLIER 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 125.227 3.951 . . . . 35.090000000000003 115.536 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1298 ' ' GLY . . . . . 0.567 ' HA2' ' H ' ' B' 1313 ' ' THR . . . 149.24 -14.92 1.12 Allowed Glycine 0 CA--C 1.528 0.887 0 CA-C-N 113.218 -1.81 . . . . 35.969999999999999 111.679 -178.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -139.48 -174.31 3.85 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 123.487 3.643 . . . . 40.390000000000001 112.262 -174.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1300 ' ' ILE . . . . . 0.756 HG12 HG12 ' B' 1310 ' ' ILE . 30.7 mt -88.44 133.91 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-N 113.917 -1.492 . . . . 37.43 109.374 166.081 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1301 ' ' PHE . . . . . 0.558 ' HB2' HG23 ' B' 1296 ' ' VAL . 61.8 t80 -108.66 116.84 32.74 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 107.223 -1.399 . . . . 44.130000000000003 107.223 159.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1302 ' ' THR . . . . . 0.659 HG23 ' HG2' ' B' 1308 ' ' LYS . 13.9 m -84.82 112.38 20.48 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.632 -1.618 . . . . 39.780000000000001 106.632 172.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1303 ' ' THR . . . . . . . . . . . . . 34.5 p -74.36 162.32 28.99 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 120.879 -1.138 . . . . 43.289999999999999 111.628 175.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -49.96 -47.72 52.49 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 125.192 1.397 . . . . 53.07 114.313 -168.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1305 ' ' ASN . . . . . 0.537 ' OD1' HG23 ' B' 1307 ' ' VAL . 47.7 p30 -70.51 -23.96 62.74 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 115.531 1.678 . . . . 43.969999999999999 115.531 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 114.38 21.13 5.62 Favored Glycine 0 CA--C 1.529 0.932 0 O-C-N 121.177 -0.952 . . . . 41.119999999999997 111.885 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1307 ' ' VAL . . . . . 0.537 HG23 ' OD1' ' B' 1305 ' ' ASN . 47.6 t -80.08 128.56 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 O-C-N 119.6 -2.118 . . . . 38.119999999999997 106.439 163.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1308 ' ' LYS . . . . . 0.659 ' HG2' HG23 ' B' 1302 ' ' THR . 92.6 mttt -109.76 114.67 28.43 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-N 120.58 1.536 . . . . 36.340000000000003 109.285 -176.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1309 ' ' VAL . . . . . . . . . . . . . 44.0 t -89.88 103.26 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 O-C-N 120.589 -1.32 . . . . 30.399999999999999 110.059 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1310 ' ' ILE . . . . . 0.756 HG12 HG12 ' B' 1300 ' ' ILE . 40.4 mt -92.93 104.4 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.98 0 N-CA-C 104.921 -2.252 . . . . 30.82 104.921 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1311 ' ' GLY . . . . . 0.563 ' HA3' HG23 ' B' 1295 ' ' THR . . . -124.09 81.59 0.35 Allowed Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 104.246 -3.542 . . . . 26.530000000000001 104.246 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1312 ' ' TYR . . . . . 0.692 ' HB2' ' HG ' ' B' 1315 ' ' LEU . 16.9 m-85 -92.4 137.82 32.04 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 120.452 -1.617 . . . . 38.0 111.849 176.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1313 ' ' THR . . . . . 0.567 ' H ' ' HA2' ' B' 1298 ' ' GLY . 3.4 p -61.72 -36.37 80.76 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.79 -1.189 . . . . 29.800000000000001 107.79 168.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -83.49 12.13 6.04 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 118.143 2.645 . . . . 39.039999999999999 118.143 -175.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1315 ' ' LEU . . . . . 0.692 ' HG ' ' HB2' ' B' 1312 ' ' TYR . 12.2 mt -58.37 -42.76 96.45 Favored Pre-proline 0 C--O 1.245 0.831 0 O-C-N 118.671 -2.518 . . . . 31.079999999999998 114.992 170.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1316 ' ' PRO . . . . . 0.607 ' HB3' ' HB3' ' B' 1133 ' ' MET . 83.4 Cg_exo -67.22 -3.45 9.9 Favored 'Trans proline' 0 C--O 1.24 0.602 0 C-N-CA 122.509 2.139 . . . . 26.100000000000001 113.361 169.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -89.12 -57.26 1.81 Allowed Glycine 0 CA--C 1.536 1.373 0 O-C-N 119.243 -2.16 . . . . 23.170000000000002 110.409 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1318 ' ' ARG . . . . . 0.431 ' HB2' ' HG2' ' B' 1140 ' ' ARG . 79.0 mtt180 -68.89 52.65 0.09 Allowed 'General case' 0 CA--C 1.529 0.139 1 N-CA-C 122.582 4.29 . . . . 40.399999999999999 122.582 -158.088 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -133.66 76.47 66.33 Favored Pre-proline 0 C--O 1.236 0.394 0 O-C-N 118.579 -2.576 . . . . 23.600000000000001 104.94 151.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1320 ' ' PRO . . . . . 0.566 ' HG2' ' HA2' ' A' 1150 ' ' GLY . 18.1 Cg_endo -35.32 -70.78 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.199 3.266 . . . . 22.350000000000001 120.553 -166.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1321 ' ' THR . . . . . 0.516 HG23 HG21 ' B' 1019 ' ' THR . 2.8 m -55.69 -43.45 76.43 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 114.858 1.429 . . . . 26.52 114.858 173.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1322 ' ' GLN . . . . . 0.759 ' HB2' ' HA ' ' A' 1151 ' ' ARG . 42.3 tp60 -72.94 -37.59 67.1 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 118.144 -2.847 . . . . 24.379999999999999 109.296 -173.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1323 ' ' SER . . . . . . . . . . . . . 49.7 m -61.13 -54.37 45.4 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 116.925 -1.512 . . . . 22.800000000000001 107.653 174.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1324 ' ' SER . . . . . . . . . . . . . 15.2 m -54.16 -35.88 62.75 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 114.417 1.266 . . . . 21.25 114.417 173.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -67.44 -57.41 6.61 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 120.921 -1.112 . . . . 31.34 110.783 173.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1326 ' ' LEU . . . . . 0.539 ' HG ' HE21 ' B' 1322 ' ' GLN . 97.3 mt -73.3 -32.6 64.71 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-N 121.765 2.075 . . . . 31.559999999999999 108.349 -166.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1327 ' ' TYR . . . . . 0.403 ' CZ ' ' HA ' ' B' 1072 ' ' VAL . 24.7 t80 -60.94 -56.97 14.83 Favored 'General case' 0 C--O 1.257 1.471 0 N-CA-C 105.421 -2.066 . . . . 22.73 105.421 169.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1328 ' ' GLY . . . . . 0.694 ' HA2' HD12 ' B' 1331 ' ' LEU . . . -48.24 -41.55 23.58 Favored Glycine 0 N--CA 1.467 0.725 0 CA-C-O 119.786 -0.452 . . . . 21.91 114.162 173.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1329 ' ' THR . . . . . 0.533 HG21 ' HA3' ' A' 1161 ' ' GLY . 16.5 m -72.0 -31.17 65.97 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 118.709 1.255 . . . . 22.149999999999999 110.598 -175.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1330 ' ' ASN . . . . . . . . . . . . . 33.0 m120 -63.6 -46.46 85.69 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.291 -0.881 . . . . 26.18 109.885 170.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1331 ' ' LEU . . . . . 0.83 HD22 HD22 ' B' 1070 ' ' LEU . 73.1 mt -53.72 -48.13 69.9 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.77 0.828 . . . . 23.68 112.224 176.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1332 ' ' VAL . . . . . 0.432 HG12 ' HE3' ' B' 1336 ' ' LYS . 90.8 t -51.92 -57.49 3.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 O-C-N 124.638 1.212 . . . . 26.57 110.804 169.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -55.06 -37.49 66.81 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.79 1.177 . . . . 28.079999999999998 112.165 -177.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1334 ' ' LEU . . . . . . . . . . . . . 32.4 tp -64.78 -49.29 71.28 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 124.779 1.3 . . . . 27.43 111.39 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1335 ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' B' 1331 ' ' LEU . 64.4 mt -62.13 -35.43 78.72 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 114.68 -1.146 . . . . 30.5 109.616 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1336 ' ' LYS . . . . . 0.473 ' NZ ' ' HG3' ' C' ' 98' ' ' GLU . 83.2 mttt -57.87 -42.04 83.71 Favored 'General case' 0 CA--C 1.512 -0.498 0 O-C-N 121.486 -0.758 . . . . 41.649999999999999 112.555 171.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 8.2 mp -72.74 -34.85 67.31 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 113.164 0.801 . . . . 42.079999999999998 113.164 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1338 ' ' LEU . . . . . 0.453 HD11 ' SD ' ' B' 1113 ' ' MET . 47.0 mt -74.59 -72.81 0.27 Allowed 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 122.804 1.288 . . . . 35.030000000000001 107.967 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1339 ' ' CYS . . . . . 0.509 ' SG ' HD13 ' B' 1346 ' ' ILE . 50.0 m -81.02 69.93 7.73 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-O 123.442 1.591 . . . . 37.329999999999998 113.982 -175.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 55.4 mttp -67.69 -6.28 19.91 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 113.65 -1.613 . . . . 50.509999999999998 115.262 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -95.07 -24.62 16.8 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.508 0.723 . . . . 54.210000000000001 110.753 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.23 34.85 21.25 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.957 1.703 . . . . 50.990000000000002 111.501 -174.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -82.7 -30.11 29.4 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 114.177 -1.374 . . . . 48.82 111.658 -172.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 116.16 22.61 4.47 Favored Glycine 0 N--CA 1.473 1.141 0 CA-C-O 118.335 -1.258 . . . . 40.43 110.319 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -134.32 140.14 46.17 Favored 'General case' 0 C--O 1.25 1.102 0 CA-C-N 120.955 2.378 . . . . 47.560000000000002 108.149 173.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1346 ' ' ILE . . . . . 0.509 HD13 ' SG ' ' B' 1339 ' ' CYS . 22.6 mm -63.9 92.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 CA-C-O 126.284 2.945 . . . . 42.490000000000002 108.807 171.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1347 ' ' THR . . . . . . . . . . . . . 61.1 m -80.19 99.36 7.75 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 100.778 -3.786 . . . . 38.119999999999997 100.778 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1348 ' ' VAL . . . . . 0.466 HG22 HG22 ' B' 1346 ' ' ILE . 6.7 t -82.32 102.42 8.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 106.515 -1.661 . . . . 37.5 106.515 -176.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1349 ' ' ASP . . . . . 0.765 ' HB3' HG21 ' B' 1355 ' ' ILE . 29.0 t70 -67.14 164.61 17.68 Favored 'General case' 0 C--O 1.214 -0.767 0 O-C-N 125.645 1.841 . . . . 43.850000000000001 110.264 178.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1350 ' ' PHE . . . . . 0.401 ' HD1' ' HA ' ' B' 1350 ' ' PHE . 0.1 OUTLIER -148.7 5.42 0.69 Allowed 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.769 -0.826 . . . . 39.810000000000002 108.769 177.969 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 32.4 t70 -92.18 -56.59 3.0 Favored 'General case' 0 C--O 1.247 0.946 0 N-CA-C 114.26 1.207 . . . . 51.289999999999999 114.26 -174.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 7.7 t0 -65.06 134.68 54.35 Favored 'General case' 0 C--O 1.258 1.513 0 CA-C-O 121.703 0.764 . . . . 39.780000000000001 110.381 -174.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1353 ' ' VAL . . . . . 0.487 HG21 HG13 ' B' 1373 ' ' ILE . 30.6 m -48.71 -38.52 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 116.813 2.153 . . . . 39.280000000000001 116.813 175.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1354 ' ' VAL . . . . . 0.604 HG11 HD22 ' B' 1127 ' ' LEU . 95.0 t -58.84 -59.34 3.87 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 CA-C-N 114.805 -1.089 . . . . 35.700000000000003 109.306 173.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1355 ' ' ILE . . . . . 0.765 HG21 ' HB3' ' B' 1349 ' ' ASP . 43.6 mm -61.06 -42.95 95.11 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.93 0 O-C-N 124.319 1.012 . . . . 35.770000000000003 109.557 -173.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1356 ' ' ARG . . . . . 0.636 ' HG3' ' HD3' ' B' 1371 ' ' PRO . 39.9 tpt85 -58.98 -25.01 63.22 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 120.002 -1.686 . . . . 38.549999999999997 113.865 175.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -82.33 -67.03 1.52 Allowed Glycine 0 CA--C 1.535 1.316 0 N-CA-C 110.1 -1.2 . . . . 29.579999999999998 110.1 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1358 ' ' VAL . . . . . 0.44 HG12 ' HA ' ' B' 1355 ' ' ILE . 10.0 p -54.42 -35.34 30.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 116.025 1.861 . . . . 32.060000000000002 116.025 -177.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1359 ' ' THR . . . . . . . . . . . . . 8.0 m -85.09 83.21 8.11 Favored 'General case' 0 CA--C 1.513 -0.464 0 O-C-N 118.413 -2.679 . . . . 29.0 108.173 178.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1360 ' ' VAL . . . . . 0.499 ' HB ' ' HB2' ' B' 1368 ' ' TRP . 36.0 m -76.06 -21.99 15.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 109.905 -3.316 . . . . 29.68 112.478 -168.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 60.6 mt -133.17 129.45 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 101.832 -3.396 . . . . 32.049999999999997 101.832 172.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1362 ' ' ARG . . . . . 0.702 ' HA ' HG23 ' B' 1111 ' ' THR . 11.7 mtp180 -112.45 104.83 12.97 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 123.484 1.611 . . . . 32.520000000000003 108.327 168.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 50.9 60.03 4.18 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 122.711 1.243 . . . . 35.68 111.706 171.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1364 ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' B' 1109 ' ' ASN . . . 94.46 -43.69 2.33 Favored Glycine 0 CA--C 1.529 0.911 0 O-C-N 119.019 -2.301 . . . . 34.259999999999998 110.743 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -72.45 117.59 14.3 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-O 117.711 -1.138 . . . . 51.07 109.769 -174.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 54.1 mt -73.92 94.87 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.34 0 CA-C-O 123.39 1.567 . . . . 39.869999999999997 108.368 174.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1367 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.14 -14.08 59.33 Favored 'General case' 0 C--O 1.25 1.092 0 CA-C-N 111.903 -2.408 . . . . 38.009999999999998 114.701 -173.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1368 ' ' TRP . . . . . 0.499 ' HB2' ' HB ' ' B' 1360 ' ' VAL . 73.8 t90 -59.81 140.05 89.93 Favored Pre-proline 0 N--CA 1.47 0.529 0 CA-C-N 110.941 -2.845 . . . . 42.140000000000001 106.362 170.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -78.77 178.07 35.85 Favored 'Cis proline' 0 N--CA 1.446 -1.31 0 CA-C-N 124.811 2.754 . . . . 43.259999999999998 118.12 4.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1370 ' ' ALA . . . . . . . . . . . . . . . -76.84 149.03 80.0 Favored Pre-proline 0 C--O 1.248 1.021 0 CA-C-N 110.897 -2.865 . . . . 46.520000000000003 110.718 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1371 ' ' PRO . . . . . 0.636 ' HD3' ' HG3' ' B' 1356 ' ' ARG . 92.6 Cg_endo -62.71 142.63 90.03 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.573 2.182 . . . . 51.950000000000003 113.702 170.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.0 72.57 1.55 Allowed 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 124.853 3.702 . . . . 56.270000000000003 113.648 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1373 ' ' ILE . . . . . 0.54 HD12 HG21 ' B' 1121 ' ' ILE 0.26 0.1 OUTLIER -79.71 135.12 26.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 O-C-N 119.627 -1.921 . . . . 60.829999999999998 106.929 173.957 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -75.31 116.62 16.23 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.032 -1.47 . . . . 66.099999999999994 107.032 -176.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1375 ' ' VAL . . . . . 0.552 HG11 ' HB2' ' B' 1120 ' ' ARG . 49.1 t -104.06 109.1 26.25 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 CA-C-N 113.061 -1.882 . . . . 63.469999999999999 106.712 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.223 -4.929 0 O-C-N 118.967 -2.333 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.818 0 CA-C-O 121.723 0.773 . . . . 0.0 111.997 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.66 -42.86 65.08 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 175.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.93 -43.73 77.67 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 122.572 2.442 . . . . 0.0 108.456 177.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 85.6 m -64.11 -37.91 89.15 Favored 'General case' 0 C--O 1.249 1.077 0 CA-C-O 117.924 -1.036 . . . . 0.0 111.846 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 24' ' ' ALA . . . . . 0.84 ' HB1' ' HA ' ' C' ' 186' ' ' LEU . . . -59.2 -51.58 69.37 Favored 'General case' 0 CA--C 1.559 1.326 0 CA-C-N 120.016 1.28 . . . . 0.0 110.625 173.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 25' ' ' GLU . . . . . 0.763 ' HA ' ' HE2' ' C' ' 28' ' ' LYS . 0.8 OUTLIER -54.99 -33.09 62.22 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.515 1.126 . . . . 0.0 110.897 174.637 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.7 -54.33 33.31 Favored 'General case' 0 C--O 1.214 -0.78 0 O-C-N 119.608 -1.933 . . . . 0.0 111.556 171.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.626 HD21 HD21 ' C' ' 110' ' ' LEU . 2.3 mm? -47.81 -59.02 3.62 Favored 'General case' 0 C--O 1.247 0.949 0 C-N-CA 127.187 2.195 . . . . 0.0 113.382 -175.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 28' ' ' LYS . . . . . 0.763 ' HE2' ' HA ' ' C' ' 25' ' ' GLU . 27.2 pttt -59.32 -35.91 74.68 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.328 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -79.05 -30.37 44.01 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.434 ' HB3' ' HB3' ' C' ' 107' ' ' ASP . 69.7 m -43.25 -35.99 1.64 Allowed 'General case' 0 CA--C 1.508 -0.659 1 N-CA-C 122.869 4.396 . . . . 0.0 122.869 -167.385 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 67.73 -41.62 0.43 Allowed 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.887 1.675 . . . . 0.0 112.309 -171.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 12.0 m -121.15 139.42 53.37 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 120.028 1.285 . . . . 0.0 109.533 162.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 33' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' C' ' 64' ' ' VAL . 89.0 t -130.08 125.88 60.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 175.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.597 ' HB ' HG22 ' C' ' 109' ' ' VAL . 41.5 mm -104.74 123.56 58.82 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 O-C-N 118.93 -2.356 . . . . 0.0 106.071 169.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 35' ' ' ILE . . . . . 0.417 HD12 ' CZ ' ' C' ' 66' ' ' PHE . 29.7 mt -100.97 128.22 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 172.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 52.7 m -113.91 107.85 51.83 Favored Pre-proline 0 N--CA 1.426 -1.643 0 C-N-CA 125.565 1.546 . . . . 0.0 108.721 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 37' ' ' PRO . . . . . 0.481 ' HG3' ' SD ' ' C' ' 41' ' ' MET . 32.5 Cg_exo -64.69 117.59 4.65 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.311 3.341 . . . . 0.0 110.16 170.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 38' ' ' GLY . . . . . 0.645 ' HA3' ' HB2' ' C' ' 114' ' ' ALA . . . -115.39 -155.63 10.87 Favored Glycine 0 N--CA 1.416 -2.634 0 CA-C-N 111.906 -2.406 . . . . 0.0 110.465 164.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -66.82 -42.57 85.62 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.512 -0.993 . . . . 0.0 111.202 -173.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 40' ' ' GLY . . . . . 0.625 ' HA3' ' HA3' ' C' ' 113' ' ' GLY . . . -60.52 -39.84 96.95 Favored Glycine 0 N--CA 1.437 -1.247 0 CA-C-O 117.483 -1.732 . . . . 0.0 110.781 -178.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 41' ' ' MET . . . . . 0.587 ' HA ' ' HB3' ' C' ' 46' ' ' ALA . 9.1 ttm -56.66 -43.47 80.41 Favored 'General case' 0 C--N 1.36 1.036 0 CA-C-N 122.221 3.01 . . . . 0.0 111.284 177.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.36 -36.72 26.55 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 121.617 -0.677 . . . . 0.0 112.47 -171.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 85.6 t -77.79 -64.09 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.965 1.306 . . . . 0.0 110.533 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.95 65.81 2.97 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.535 1.159 . . . . 0.0 109.626 -172.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 45' ' ' GLN . . . . . 0.592 ' HG3' ' HG3' ' C' ' 176' ' ' LYS . 8.9 pt20 17.71 36.18 0.0 OUTLIER 'General case' 0 C--O 1.245 0.863 1 N-CA-C 123.805 4.743 . . . . 0.0 123.805 175.006 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.587 ' HB3' ' HA ' ' C' ' 41' ' ' MET . . . -73.81 -14.94 61.18 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 119.033 2.975 . . . . 0.0 119.033 -176.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 47' ' ' GLN . . . . . . . . . . . . 0.251 0.0 OUTLIER -65.83 -46.85 77.03 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 114.721 -2.561 . . . . 0.0 114.762 -178.358 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 48' ' ' TYR . . . . . 0.525 ' CD1' ' HD3' ' C' ' 49' ' ' PRO 0.37 2.8 p90 -65.88 -32.59 6.0 Favored Pre-proline 0 N--CA 1.474 0.771 0 CA-C-N 125.389 3.722 . . . . 0.0 115.294 174.124 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 49' ' ' PRO . . . . . 0.525 ' HD3' ' CD1' ' C' ' 48' ' ' TYR . 8.8 Cg_exo -58.96 -44.85 32.04 Favored 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 123.042 2.494 . . . . 0.0 111.293 164.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 50' ' ' VAL . . . . . 0.447 ' HA ' HG22 ' C' ' 53' ' ' ILE . 23.2 t -55.55 -40.64 60.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 119.59 1.086 . . . . 0.0 109.655 173.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.33 -42.04 77.03 Favored 'General case' 0 C--N 1.367 1.334 0 CA-C-N 121.004 1.729 . . . . 0.0 112.763 175.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -60.81 -40.03 91.18 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 173.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 53' ' ' ILE . . . . . 0.73 HD13 ' HA ' ' C' ' 183' ' ' LEU . 8.2 tp -75.93 -31.53 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 120.368 1.44 . . . . 0.0 109.659 177.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 89.6 m -68.89 -29.34 67.6 Favored 'General case' 0 CA--C 1.498 -1.028 0 O-C-N 119.833 -1.792 . . . . 0.0 112.458 -174.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -48.93 -67.82 0.23 Allowed 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 163.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -57.59 -41.4 81.08 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -172.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 57' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' C' ' 53' ' ' ILE . 58.0 mt -61.91 -52.25 64.84 Favored 'General case' 0 N--CA 1.434 -1.249 0 O-C-N 124.779 1.3 . . . . 0.0 109.443 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 58' ' ' ARG . . . . . 0.446 ' HD2' ' HA ' ' C' ' 58' ' ' ARG . 10.1 tpt180 -70.07 -36.1 74.71 Favored 'General case' 0 C--O 1.245 0.865 0 O-C-N 120.27 -1.519 . . . . 0.0 108.74 -174.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.54 -27.55 64.65 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 173.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 30.3 ttm-85 -87.8 2.34 51.58 Favored 'General case' 0 CA--C 1.543 0.712 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 175.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.22 3.36 84.89 Favored Glycine 0 C--N 1.343 0.962 0 O-C-N 118.557 -2.589 . . . . 0.0 111.782 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 88.2 mt -66.87 130.05 31.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 CA-C-N 118.732 1.266 . . . . 0.0 109.676 -177.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -70.11 75.67 0.5 Allowed 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 122.844 1.307 . . . . 0.0 109.111 169.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 2.9 p -86.64 103.28 12.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-O 123.096 1.427 . . . . 0.0 107.76 173.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 65' ' ' ARG . . . . . 0.532 ' NH2' HD22 ' C' ' 94' ' ' LEU . 50.0 mmm-85 -108.74 151.4 26.25 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 124.833 2.254 . . . . 0.0 109.573 173.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 66' ' ' PHE . . . . . 0.869 ' HB2' ' HA ' ' C' ' 93' ' ' VAL . 19.8 m-85 -106.94 114.5 28.62 Favored 'General case' 0 C--O 1.251 1.142 0 C-N-CA 117.664 -1.614 . . . . 0.0 108.049 -176.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 67' ' ' GLY . . . . . 0.473 ' HA3' ' HE2' ' C' ' 103' ' ' PHE . . . -98.99 98.57 2.01 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 106.79 -2.524 . . . . 0.0 106.79 176.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 68' ' ' ILE . . . . . 0.636 HD11 HG13 ' C' ' 93' ' ' VAL . 3.2 mp -89.93 140.25 16.2 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -114.21 121.74 35.84 Favored Pre-proline 0 CA--C 1.506 -0.747 0 CA-C-O 116.034 -1.936 . . . . 0.0 106.029 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 70' ' ' PRO . . . . . 0.659 ' HB3' HG13 ' A' 1157 ' ' ILE . 32.1 Cg_endo -61.56 -50.52 5.42 Favored 'Trans proline' 0 N--CA 1.482 0.823 0 C-N-CA 124.237 3.291 . . . . 0.0 112.214 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 73.0 t -72.86 96.71 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.256 1.397 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 168.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -158.54 128.58 5.92 Favored 'General case' 0 C--O 1.259 1.585 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 176.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.23 -102.79 0.83 Allowed Glycine 0 C--N 1.319 -0.397 0 O-C-N 121.535 -0.728 . . . . 0.0 111.454 167.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.14 122.34 5.05 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -172.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.694 ' HG ' ' SD ' ' B' 1207 ' ' MET . 0.2 OUTLIER 67.09 115.76 0.03 OUTLIER Pre-proline 0 N--CA 1.444 -0.734 0 C-N-CA 125.73 1.612 . . . . 0.0 111.598 -177.313 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 76' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' C' ' 75' ' ' LEU . 72.0 Cg_endo -69.09 172.48 11.91 Favored 'Trans proline' 0 C--O 1.26 1.614 0 C-N-CA 123.508 2.805 . . . . 0.0 114.386 169.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.63 -104.69 1.35 Allowed Glycine 0 N--CA 1.441 -0.971 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 -166.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 34.02 -78.07 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 127.256 2.222 . . . . 0.0 116.018 160.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -61.86 -41.44 97.84 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 119.404 1.002 . . . . 0.0 113.078 -175.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -85.82 -23.46 27.15 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 113.944 -1.48 . . . . 0.0 112.249 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 98.7 t -62.37 -51.78 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 171.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 11.1 mt -57.95 -29.78 65.44 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 170.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.568 ' HG ' ' HB ' ' C' ' 88' ' ' VAL . 11.8 tp -62.0 -37.26 84.18 Favored 'General case' 0 C--O 1.239 0.517 0 O-C-N 119.673 -1.892 . . . . 0.0 111.498 167.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.4 -43.16 74.03 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 120.542 -1.349 . . . . 0.0 109.704 173.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -60.05 -31.05 69.62 Favored 'General case' 0 C--N 1.348 0.5 0 O-C-N 120.089 -1.632 . . . . 0.0 113.391 173.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 86' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' C' ' 83' ' ' LEU 0.261 . . -73.24 -5.93 42.65 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 120.245 -1.534 . . . . 0.0 112.236 171.752 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 65.49 29.44 11.19 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 118.515 -2.616 . . . . 0.0 116.735 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 88' ' ' VAL . . . . . 0.568 ' HB ' ' HG ' ' C' ' 83' ' ' LEU . 78.0 t -82.83 123.0 78.45 Favored Pre-proline 0 N--CA 1.438 -1.031 0 CA-C-N 112.711 -2.041 . . . . 0.0 106.281 172.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -60.12 103.59 0.21 Allowed 'Trans proline' 0 CA--C 1.545 1.037 1 C-N-CA 125.69 4.26 . . . . 0.0 116.681 -176.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 90' ' ' TYR . . . . . 0.747 ' HA ' ' HB ' ' C' ' 93' ' ' VAL . 1.4 m-30 -50.41 -16.99 0.4 Allowed 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -61.62 -59.82 4.62 Favored 'General case' 0 C--N 1.344 0.349 0 O-C-N 121.383 -0.823 . . . . 0.0 110.554 165.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 5.6 pt -74.94 -18.13 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 118.392 -2.693 . . . . 0.0 111.736 -175.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 93' ' ' VAL . . . . . 0.869 ' HA ' ' HB2' ' C' ' 66' ' ' PHE . 51.7 t -70.05 135.56 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 127.186 2.195 . . . . 0.0 106.574 170.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 94' ' ' LEU . . . . . 0.532 HD22 ' NH2' ' C' ' 65' ' ' ARG . 16.4 tp -138.2 101.72 4.47 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 124.361 2.029 . . . . 0.0 108.353 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 95' ' ' GLU . . . . . 0.618 ' HB3' HD13 ' A' 1157 ' ' ILE . 4.0 mp0 -74.91 84.08 2.21 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 112.004 -2.362 . . . . 0.0 111.06 -177.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.485 ' SD ' ' HD2' ' C' ' 70' ' ' PRO . 24.8 ttp 43.73 60.58 2.61 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 119.548 3.166 . . . . 0.0 119.548 176.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -119.13 -152.02 0.5 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 111.275 -2.693 . . . . 0.0 105.824 -175.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 98' ' ' GLU . . . . . 0.473 ' HG3' ' NZ ' ' B' 1336 ' ' LYS . 8.6 mt-10 -77.1 54.34 1.05 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 125.098 3.59 . . . . 0.0 113.512 -177.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 9.6 tp -79.11 3.01 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 O-C-N 120.753 -1.217 . . . . 0.0 111.334 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -44.48 -52.49 7.86 Favored 'General case' 0 C--N 1.362 1.121 0 C-N-CA 125.58 1.552 . . . . 0.0 114.144 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -57.05 -55.09 39.27 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 124.778 1.299 . . . . 0.0 110.681 -174.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.0 -41.78 77.33 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 113.724 -1.58 . . . . 0.0 107.832 -174.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 103' ' ' PHE . . . . . 0.473 ' HE2' ' HA3' ' C' ' 67' ' ' GLY . 0.2 OUTLIER -59.53 -57.41 13.08 Favored 'General case' 0 C--N 1.358 0.962 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -172.088 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.44 -15.42 63.28 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 118.979 0.809 . . . . 0.0 112.465 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -73.33 -39.2 65.42 Favored 'General case' 0 CA--C 1.568 1.66 0 O-C-N 119.755 -1.84 . . . . 0.0 110.499 174.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 106' ' ' THR . . . . . 0.41 HG21 HG12 ' C' ' 34' ' ' ILE . 19.9 m -52.28 146.16 9.76 Favored 'General case' 0 C--O 1.247 0.948 0 O-C-N 126.984 2.678 . . . . 0.0 116.087 -165.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 107' ' ' ASP . . . . . 0.72 ' HA ' ' HB2' ' C' ' 142' ' ' GLN . 9.5 t70 -81.06 -83.06 0.11 Allowed 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 111.907 -2.406 . . . . 0.0 108.386 165.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 108' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' C' ' 143' ' ' ASN . 31.4 m -89.82 118.35 29.35 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 120.565 1.529 . . . . 0.0 112.866 -174.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 109' ' ' VAL . . . . . 0.667 HG21 HG23 ' C' ' 138' ' ' VAL . 84.2 t -101.49 100.05 9.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 C-N-CA 124.266 1.026 . . . . 0.0 109.76 169.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 110' ' ' LEU . . . . . 0.626 HD21 HD21 ' C' ' 27' ' ' LEU . 29.2 mt -72.12 93.29 1.41 Allowed 'General case' 0 C--O 1.236 0.356 0 O-C-N 124.286 0.992 . . . . 0.0 108.776 177.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 111' ' ' VAL . . . . . 0.656 ' HB ' ' HA ' ' C' ' 146' ' ' VAL . 38.3 t -85.51 94.14 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 177.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 8.5 mm -81.13 92.52 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-O 122.697 1.236 . . . . 0.0 111.096 -171.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 113' ' ' GLY . . . . . 0.625 ' HA3' ' HA3' ' C' ' 40' ' ' GLY . . . 75.69 65.81 1.99 Allowed Glycine 0 C--N 1.315 -0.598 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 168.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 114' ' ' ALA . . . . . 0.645 ' HB2' ' HA3' ' C' ' 38' ' ' GLY . . . -170.98 -166.71 0.5 Allowed 'General case' 0 CA--C 1.504 -0.803 0 O-C-N 122.048 -0.677 . . . . 0.0 110.895 -174.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 115' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -174.01 -53.74 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 166.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 116' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -61.26 -25.32 67.01 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 123.58 1.657 . . . . 0.0 112.575 -172.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.6 -43.49 62.52 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 176.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 3.6 m -124.49 13.32 4.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 112.276 -2.238 . . . . 0.0 112.26 -176.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 119' ' ' ASN . . . . . 0.424 ' HA ' ' HD2' ' C' ' 120' ' ' PRO . 25.3 t30 -68.26 112.49 11.07 Favored Pre-proline 0 C--N 1.364 1.201 0 O-C-N 118.372 -2.705 . . . . 0.0 111.814 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 120' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' C' ' 119' ' ' ASN . 10.7 Cg_endo -45.17 -45.38 14.79 Favored 'Trans proline' 0 N--CA 1.444 -1.394 1 C-N-CA 125.353 4.035 . . . . 0.0 115.584 -176.215 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 121' ' ' ALA . . . . . 0.571 ' HA ' ' HB3' ' C' ' 124' ' ' ASP . . . -57.06 -31.72 65.49 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 124.93 1.292 . . . . 0.0 111.864 -177.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 122' ' ' ALA . . . . . 0.773 ' HB1' ' HB3' ' C' ' 133' ' ' MET . . . -67.69 -12.77 61.22 Favored 'General case' 0 N--CA 1.438 -1.035 0 O-C-N 120.325 -1.484 . . . . 0.0 112.883 -174.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -106.97 -35.19 6.97 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 120.662 -1.274 . . . . 0.0 110.341 159.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 124' ' ' ASP . . . . . 0.571 ' HB3' ' HA ' ' C' ' 121' ' ' ALA . 11.3 t70 -65.32 -65.2 0.7 Allowed 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 123.251 1.5 . . . . 0.0 111.253 -172.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 125' ' ' ASP . . . . . 0.489 ' HA ' ' HD3' ' C' ' 126' ' ' PRO . 14.6 t70 -84.07 119.16 72.96 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-N 112.783 -2.008 . . . . 0.0 112.469 -173.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 126' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' C' ' 125' ' ' ASP . 34.6 Cg_exo -70.83 -11.54 29.59 Favored 'Trans proline' 0 N--CA 1.449 -1.145 1 C-N-CA 125.534 4.156 . . . . 0.0 111.984 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 127' ' ' LYS . . . . . 0.603 ' HB3' ' HZ3' ' C' ' 127' ' ' LYS . 6.4 ttpm? -77.09 -0.63 25.46 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 119.337 0.971 . . . . 0.0 112.646 176.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 128' ' ' SER . . . . . 0.438 ' HA ' ' HD2' ' C' ' 129' ' ' PRO . 70.0 m -59.07 121.19 53.52 Favored Pre-proline 0 C--N 1.355 0.824 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 172.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 129' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' C' ' 128' ' ' SER . 42.9 Cg_endo -58.82 -45.36 29.39 Favored 'Trans proline' 0 C--N 1.353 0.774 1 C-N-CA 126.181 4.587 . . . . 0.0 116.816 173.567 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 130' ' ' ILE . . . . . 0.617 HG12 ' HB2' ' C' ' 156' ' ' ALA . 15.0 pt -69.54 92.62 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.716 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 165.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.91 110.2 1.27 Allowed 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 125.801 2.715 . . . . 0.0 112.151 -169.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.89 72.57 0.48 Allowed Glycine 0 N--CA 1.462 0.428 0 CA-C-N 109.11 -3.677 . . . . 0.0 113.411 -176.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 133' ' ' MET . . . . . 0.773 ' HB3' ' HB1' ' C' ' 122' ' ' ALA . 62.0 tpp -82.69 127.6 69.56 Favored Pre-proline 0 C--O 1.249 1.053 0 CA-C-N 118.207 1.004 . . . . 0.0 110.291 -177.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 134' ' ' PRO . . . . . 0.584 ' HD2' ' SD ' ' C' ' 133' ' ' MET . 40.2 Cg_endo -78.95 67.37 8.58 Favored 'Trans proline' 0 C--O 1.243 0.746 0 C-N-CA 124.777 3.651 . . . . 0.0 113.275 -174.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 135' ' ' VAL . . . . . 0.539 HG23 ' HH2' ' C' ' 139' ' ' TRP . 27.7 m -68.96 136.5 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-N 113.414 -1.721 . . . . 0.0 112.464 -177.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 97.4 mt -77.54 153.23 33.57 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.288 -1.778 . . . . 0.0 108.68 -174.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -67.63 59.5 0.06 Allowed 'General case' 0 C--O 1.211 -0.967 0 N-CA-C 118.218 2.673 . . . . 0.0 118.218 -162.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 138' ' ' VAL . . . . . 0.667 HG23 HG21 ' C' ' 109' ' ' VAL . 4.5 p -82.25 20.16 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.254 1.331 0 CA-C-O 123.864 1.792 . . . . 0.0 112.826 -173.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 139' ' ' TRP . . . . . 0.539 ' HH2' HG23 ' C' ' 135' ' ' VAL . 2.2 m95 -70.73 133.12 46.32 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.831 -162.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 140' ' ' LYS . . . . . . . . . . . . . 20.3 pttm 36.62 42.32 0.2 Allowed 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 -169.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 141' ' ' ALA . . . . . 0.469 ' HB3' HG22 ' C' ' 144' ' ' VAL . . . -73.13 152.02 41.34 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 120.574 -1.329 . . . . 0.0 112.154 174.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 142' ' ' GLN . . . . . 0.72 ' HB2' ' HA ' ' C' ' 107' ' ' ASP . 85.7 mm-40 -77.23 -9.21 58.65 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -159.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 143' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' C' ' 108' ' ' THR . 14.4 t30 -164.49 95.29 0.73 Allowed 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.636 1.574 . . . . 0.0 108.672 169.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 144' ' ' VAL . . . . . 0.522 ' HB ' ' HA ' ' C' ' 168' ' ' THR . 21.9 t -89.8 101.0 11.74 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 145' ' ' ILE . . . . . 0.691 HG13 ' HB2' ' C' ' 171' ' ' LEU . 10.1 tp -110.8 102.34 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.352 0 CA-C-O 125.333 2.492 . . . . 0.0 107.359 -166.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 146' ' ' VAL . . . . . 0.921 HG21 ' HB3' ' C' ' 162' ' ' LEU . 28.8 t -95.82 100.67 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 111.728 -2.487 . . . . 0.0 110.998 -168.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 147' ' ' PHE . . . . . 0.554 ' HB2' ' H ' ' C' ' 113' ' ' GLY . 0.7 OUTLIER -60.61 115.07 3.35 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 119.752 -1.842 . . . . 0.0 109.845 178.756 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 148' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -141.1 138.57 33.62 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 166.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 8.4 tpp85 -59.37 -38.98 81.84 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 117.528 -1.225 . . . . 0.0 111.513 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 20.2 m -148.16 164.49 33.76 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 120.936 1.698 . . . . 0.0 108.816 173.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 8.0 tpt -54.88 108.87 0.44 Allowed 'General case' 0 CA--C 1.502 -0.876 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.239 171.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -155.42 124.18 6.07 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.567 -173.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 153' ' ' THR . . . . . 0.655 HG23 ' HA3' ' C' ' 157' ' ' GLY . 46.2 m -62.16 136.52 57.98 Favored 'General case' 0 N--CA 1.434 -1.232 0 O-C-N 125.767 1.917 . . . . 0.0 107.889 175.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -76.08 -146.3 1.79 Allowed Glycine 0 N--CA 1.443 -0.855 0 O-C-N 119.641 -1.912 . . . . 0.0 110.371 172.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -60.97 -63.25 1.36 Allowed 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 120.955 -1.321 . . . . 0.0 109.438 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 156' ' ' ALA . . . . . 0.617 ' HB2' HG12 ' C' ' 130' ' ' ILE . . . -83.24 -52.36 6.65 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.899 -176.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 157' ' ' GLY . . . . . 0.655 ' HA3' HG23 ' C' ' 153' ' ' THR . . . 65.31 -85.31 0.08 OUTLIER Glycine 0 CA--C 1.531 1.038 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -165.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 158' ' ' VAL . . . . . 0.473 HG22 ' HB1' ' C' ' 156' ' ' ALA 0.293 17.3 m 30.91 104.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 -179.172 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 50.45 12.67 0.1 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -171.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 160' ' ' ASN . . . . . 0.63 ' HB2' ' O ' ' C' ' 157' ' ' GLY . 1.4 t30 -53.05 94.73 0.06 OUTLIER Pre-proline 0 C--N 1.35 0.629 0 N-CA-C 117.338 2.348 . . . . 0.0 117.338 -159.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 161' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' C' ' 160' ' ' ASN . 84.8 Cg_exo -57.81 -34.42 98.23 Favored 'Trans proline' 0 N--CA 1.482 0.795 0 C-N-CA 123.361 2.708 . . . . 0.0 109.974 -169.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 162' ' ' LEU . . . . . 0.921 ' HB3' HG21 ' C' ' 146' ' ' VAL . 13.3 mt -54.29 -17.99 3.52 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 116.966 2.21 . . . . 0.0 116.966 -176.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 163' ' ' PHE . . . . . 0.604 ' HA ' ' HG3' ' C' ' 170' ' ' MET . 20.9 m-30 -91.74 -45.14 8.59 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 123.022 1.392 . . . . 0.0 107.756 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -86.47 -51.8 5.97 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 111.446 -2.615 . . . . 0.0 112.732 -158.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 165' ' ' LYS . . . . . 0.664 ' HB2' ' HB ' ' C' ' 168' ' ' THR . 17.1 mmmt -73.2 -176.16 2.08 Favored 'General case' 0 C--O 1.246 0.871 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -157.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -69.5 -70.0 0.31 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.362 1.065 . . . . 0.0 108.168 -165.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -86.45 -19.04 30.21 Favored 'General case' 0 C--N 1.347 0.478 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 175.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 168' ' ' THR . . . . . 0.697 HG22 ' HA ' ' C' ' 162' ' ' LEU 0.275 37.6 m -93.67 86.33 5.13 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.207 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -150.47 155.74 40.1 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 123.075 1.417 . . . . 0.0 107.877 -164.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 170' ' ' MET . . . . . 0.604 ' HG3' ' HA ' ' C' ' 163' ' ' PHE . 76.7 mtm -73.33 140.38 46.68 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 176.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 171' ' ' LEU . . . . . 0.691 ' HB2' HG13 ' C' ' 145' ' ' ILE . 40.8 tp -92.18 107.51 19.27 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 103.448 -2.797 . . . . 0.0 103.448 167.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -78.4 102.79 7.95 Favored 'General case' 0 C--O 1.253 1.253 0 CA-C-N 111.902 -2.408 . . . . 0.0 111.279 -174.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . 167.97 175.36 37.65 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.203 175.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 174' ' ' ASP . . . . . 0.517 ' HB3' ' HB3' ' C' ' 177' ' ' ALA . 20.6 t70 -62.67 149.13 44.39 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 114.422 -0.889 . . . . 0.0 111.4 173.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 175' ' ' ALA . . . . . 0.411 ' O ' HG23 ' C' ' 179' ' ' VAL . . . -58.57 -59.78 4.84 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 120.088 -1.632 . . . . 0.0 113.651 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 176' ' ' LYS . . . . . 0.592 ' HG3' ' HG3' ' C' ' 45' ' ' GLN . 0.5 OUTLIER -54.59 -66.47 0.39 Allowed 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 124.579 1.175 . . . . 0.0 108.133 176.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 177' ' ' ALA . . . . . 0.517 ' HB3' ' HB3' ' C' ' 174' ' ' ASP . . . -48.16 -39.23 20.1 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 117.781 2.511 . . . . 0.0 117.781 -177.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 56.2 m -67.82 -43.34 79.81 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 120.545 1.52 . . . . 0.0 111.301 173.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 179' ' ' VAL . . . . . 0.411 HG23 ' O ' ' C' ' 175' ' ' ALA . 3.1 t -64.5 -39.68 86.44 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 CA-C-N 121.028 1.74 . . . . 0.0 108.175 175.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -56.78 -45.75 81.94 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 122.786 1.279 . . . . 0.0 112.55 176.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -56.58 -31.22 64.03 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 182' ' ' ILE . . . . . 0.437 HG22 ' HB2' ' C' ' 24' ' ' ALA . 42.9 pt -98.21 -25.81 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -178.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 183' ' ' LEU . . . . . 0.73 ' HA ' HD13 ' C' ' 53' ' ' ILE . 2.9 pp -59.44 -20.16 52.93 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 120.287 3.44 . . . . 0.0 120.287 -164.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -126.65 -34.75 2.4 Favored 'General case' 0 CA--C 1.492 -1.28 0 O-C-N 125.371 1.669 . . . . 0.0 107.118 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -73.06 -14.94 61.5 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 120.299 -1.5 . . . . 0.0 114.151 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 186' ' ' LEU . . . . . 0.84 ' HA ' ' HB1' ' C' ' 24' ' ' ALA . 2.6 pt? . . . . . 0 C--O 1.219 -0.547 0 N-CA-C 119.796 3.258 . . . . 0.0 119.796 -167.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 19.6 t-80 . . . . . 0 C--O 1.236 0.346 0 N-CA-C 102.441 -3.17 . . . . 65.739999999999995 102.441 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -67.64 81.47 0.16 Allowed Glycine 0 CA--C 1.544 1.864 0 CA-C-O 123.33 1.516 . . . . 48.659999999999997 111.332 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -116.06 122.92 46.6 Favored 'General case' 0 N--CA 1.419 -1.982 1 N-CA-C 100.1 -4.037 . . . . 44.560000000000002 100.1 175.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1003 ' ' ILE . . . . . 0.455 HG12 ' HB ' ' A' 1068 ' ' ILE . 30.4 mt -99.13 121.51 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.163 0 N-CA-C 106.024 -1.843 . . . . 34.859999999999999 106.024 177.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1004 ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' 1034 ' ' ALA . . . -79.47 135.15 14.76 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 108.35 -1.9 . . . . 30.75 108.35 165.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.637 HG23 ' HB3' ' A' 1017 ' ' ALA . 32.8 mm -110.82 96.25 27.94 Favored Pre-proline 0 C--O 1.242 0.696 0 N-CA-C 101.564 -3.495 . . . . 32.210000000000001 101.564 170.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -71.6 171.59 16.03 Favored 'Trans proline' 0 CA--C 1.504 -0.992 0 C-N-CA 122.529 2.153 . . . . 32.979999999999997 111.312 170.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1007 ' ' ARG . . . . . 0.433 ' HA ' HG22 ' A' 1016 ' ' VAL . 19.0 ttp85 -104.32 141.36 36.44 Favored 'General case' 0 C--O 1.258 1.549 0 CA-C-N 110.976 -2.829 . . . . 47.979999999999997 106.726 169.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1008 ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -65.25 143.32 57.88 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 123.456 1.598 . . . . 34.700000000000003 112.699 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1009 ' ' ARG . . . . . 0.479 HH11 ' HD3' ' A' 1009 ' ' ARG . 37.7 mtp180 -108.74 22.29 16.12 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-O 123.473 1.606 . . . . 53.369999999999997 113.553 176.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 30.0 tp -77.96 149.65 34.11 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.588 -1.264 . . . . 45.07 107.588 170.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1011 ' ' THR . . . . . . . . . . . . . 23.5 m -74.77 143.99 43.78 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 122.378 2.354 . . . . 40.359999999999999 110.023 -174.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 32.4 t30 41.64 64.4 1.06 Allowed 'General case' 0 N--CA 1.439 -0.997 0 CA-C-O 125.178 2.418 . . . . 40.609999999999999 113.283 -176.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1013 ' ' GLU . . . . . 0.435 ' O ' HD13 ' A' 1042 ' ' LEU . 8.3 tp10 -134.04 147.61 50.96 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 109.932 -3.304 . . . . 33.759999999999998 104.424 -169.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1014 ' ' THR . . . . . 0.823 ' HB ' ' HB3' ' A' 1320 ' ' PRO . 0.0 OUTLIER -124.15 1.1 8.51 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 112.935 0.717 . . . . 27.890000000000001 112.935 177.949 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 1015 ' ' ARG . . . . . 0.932 ' HD2' HG11 ' A' 1072 ' ' VAL . 21.0 mtm180 -68.13 130.57 43.34 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 119.884 -1.76 . . . . 29.02 112.161 -176.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1016 ' ' VAL . . . . . 0.554 ' HB ' ' HB2' ' A' 1043 ' ' ALA . 83.9 t -132.17 141.73 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 110.644 -2.98 . . . . 28.129999999999999 103.862 168.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1017 ' ' ALA . . . . . 0.637 ' HB3' HG23 ' A' 1005 ' ' ILE . . . -56.54 -37.23 70.22 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 118.024 2.601 . . . . 26.870000000000001 118.024 -171.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -136.08 143.01 44.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 120.077 1.308 . . . . 26.77 110.64 -165.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1019 ' ' THR . . . . . . . . . . . . . 75.5 p -77.67 173.4 7.64 Favored Pre-proline 0 C--N 1.346 0.444 0 O-C-N 120.104 -1.622 . . . . 27.02 108.25 163.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1020 ' ' PRO . . . . . 0.478 ' HB3' ' HB2' ' A' 1053 ' ' ALA . 2.5 Cg_exo -55.39 -35.3 91.53 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 123.837 3.025 . . . . 30.57 111.741 164.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -62.49 -49.55 74.94 Favored 'General case' 0 C--N 1.358 0.957 0 CA-C-N 118.98 0.809 . . . . 47.810000000000002 110.826 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1022 ' ' THR . . . . . . . . . . . . . 6.7 p -65.74 -29.16 69.63 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.573 0.953 . . . . 30.77 113.573 176.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1023 ' ' VAL . . . . . 0.892 HG22 HG11 ' A' 1033 ' ' VAL . 3.4 t -62.74 -44.83 99.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 107.65 -1.241 . . . . 33.590000000000003 107.65 175.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1024 ' ' GLU . . . . . 0.625 ' O ' ' HG2' ' A' 1028 ' ' LYS . 48.6 mt-10 -59.75 -44.22 93.91 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 117.609 -1.186 . . . . 53.289999999999999 111.847 173.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -54.71 -38.69 67.36 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-N 119.998 1.272 . . . . 46.920000000000002 114.333 170.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1026 ' ' LEU . . . . . . . . . . . . . 91.2 mt -68.75 -38.63 80.27 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 119.141 0.882 . . . . 37.170000000000002 109.278 177.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 12.7 tp -63.83 -43.29 96.62 Favored 'General case' 0 CA--C 1.556 1.183 0 O-C-N 124.074 0.859 . . . . 44.439999999999998 109.064 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1028 ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' 1024 ' ' GLU . 28.0 mmmt -59.67 -41.21 90.13 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 123.292 0.637 . . . . 52.579999999999998 109.698 175.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1029 ' ' LEU . . . . . 0.478 ' HA ' ' HE3' ' A' 1342 ' ' LYS . 61.9 mt -72.44 7.23 1.9 Allowed 'General case' 0 C--O 1.253 1.247 0 N-CA-C 116.654 2.094 . . . . 45.689999999999998 116.654 174.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 94.74 -5.19 69.45 Favored Glycine 0 CA--C 1.494 -1.272 0 O-C-N 121.004 -1.06 . . . . 42.090000000000003 112.303 171.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -86.66 137.07 32.76 Favored 'General case' 0 N--CA 1.443 -0.803 0 O-C-N 119.352 -2.264 . . . . 40.719999999999999 106.86 -171.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1032 ' ' THR . . . . . . . . . . . . . 37.8 m -76.69 127.38 32.67 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 104.915 -2.254 . . . . 37.770000000000003 104.915 162.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1033 ' ' VAL . . . . . 0.892 HG11 HG22 ' A' 1023 ' ' VAL . 4.1 t -94.06 133.71 34.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 103.225 -2.88 . . . . 33.539999999999999 103.225 177.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1034 ' ' ALA . . . . . 0.414 ' O ' ' HA2' ' A' 1004 ' ' GLY . . . -126.84 116.61 21.12 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 104.803 -2.295 . . . . 31.68 104.803 172.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1035 ' ' VAL . . . . . . . . . . . . . 21.2 t -109.29 142.34 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 O-C-N 120.91 -1.119 . . . . 31.52 109.765 -174.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1036 ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -65.17 139.14 58.64 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.32 -1.363 . . . . 41.039999999999999 107.32 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1037 ' ' SER . . . . . . . . . . . . . 8.6 t -73.56 132.7 43.12 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 106.176 -1.787 . . . . 31.829999999999998 106.176 176.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1038 ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' 1041 ' ' GLN . . . 100.04 -20.91 47.01 Favored Glycine 0 C--O 1.22 -0.773 0 N-CA-C 109.278 -1.529 . . . . 29.359999999999999 109.278 -175.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -67.73 -34.91 77.79 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 121.484 -1.009 . . . . 27.780000000000001 110.649 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1040 ' ' GLY . . . . . 0.583 ' HA2' ' HE2' ' A' 1050 ' ' PHE . . . -59.98 -43.18 98.4 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-O 123.429 1.571 . . . . 28.91 110.622 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1041 ' ' GLN . . . . . 0.418 ' HB3' ' O ' ' A' 1038 ' ' GLY . 8.5 tp60 -52.15 -49.12 64.36 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 112.218 -1.991 . . . . 51.18 113.652 172.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1042 ' ' LEU . . . . . 0.435 HD13 ' O ' ' A' 1013 ' ' GLU . 10.7 mt -78.54 -38.47 40.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.541 -1.974 . . . . 29.91 114.119 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1043 ' ' ALA . . . . . 0.554 ' HB2' ' HB ' ' A' 1016 ' ' VAL . . . -61.26 -14.95 30.06 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 113.719 1.007 . . . . 28.539999999999999 113.719 169.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1044 ' ' SER . . . . . . . . . . . . . 51.1 m 68.27 34.56 3.81 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 120.246 -1.534 . . . . 33.060000000000002 108.596 173.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1045 ' ' PHE . . . . . 0.439 ' HD2' ' HD2' ' A' 1020 ' ' PRO . 0.0 OUTLIER -161.58 97.74 1.09 Allowed 'General case' 0 C--O 1.247 0.96 0 N-CA-C 101.092 -3.669 . . . . 30.289999999999999 101.092 -178.988 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -71.92 165.77 23.49 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 120.854 3.65 . . . . 48.619999999999997 120.854 -149.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.42 -53.97 12.58 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 112.35 -2.205 . . . . 36.740000000000002 111.438 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 3.4 pttm -65.02 -39.02 92.79 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-N 121.76 2.073 . . . . 43.729999999999997 111.132 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -62.25 -29.86 70.7 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.398 -1.439 . . . . 32.810000000000002 112.198 175.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1050 ' ' PHE . . . . . 0.583 ' HE2' ' HA2' ' A' 1040 ' ' GLY . 21.9 m-85 -62.52 -50.01 73.08 Favored 'General case' 0 C--O 1.255 1.352 0 C-N-CA 120.246 -0.581 . . . . 31.859999999999999 112.494 169.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1051 ' ' VAL . . . . . 0.517 HG22 HG12 ' A' 1057 ' ' ILE . 11.0 t -62.95 -42.45 96.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 O-C-N 121.101 -0.999 . . . . 33.219999999999999 109.289 -176.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -51.01 -44.87 61.04 Favored 'General case' 0 C--O 1.256 1.434 0 C-N-CA 125.212 1.405 . . . . 50.829999999999998 110.599 172.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1053 ' ' ALA . . . . . 0.478 ' HB2' ' HB3' ' A' 1020 ' ' PRO . . . -65.87 -44.82 84.27 Favored 'General case' 0 C--O 1.246 0.91 0 CA-C-O 124.819 2.247 . . . . 33.119999999999997 113.016 -176.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 147.56 33.88 0.06 OUTLIER Glycine 0 N--CA 1.464 0.511 0 CA-C-N 113.141 -1.845 . . . . 35.829999999999998 114.553 -177.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -111.04 139.37 46.46 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-N 118.66 1.23 . . . . 34.82 110.138 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -84.09 121.56 27.59 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 103.297 -2.853 . . . . 49.049999999999997 103.297 167.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1057 ' ' ILE . . . . . 0.517 HG12 HG22 ' A' 1051 ' ' VAL . 26.2 mm -85.32 122.49 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 O-C-N 118.105 -2.872 . . . . 38.530000000000001 108.807 177.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1058 ' ' VAL . . . . . . . . . . . . . 12.0 m -122.31 147.05 26.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 105.4 -2.074 . . . . 42.109999999999999 105.4 -173.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -121.4 135.01 55.11 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 126.026 2.822 . . . . 58.0 111.632 -171.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 57.3 -141.9 43.32 Favored Glycine 0 N--CA 1.465 0.616 0 CA-C-N 110.451 -3.068 . . . . 52.119999999999997 113.444 -176.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1061 ' ' ASN . . . . . 0.878 ' HA ' ' HD1' ' A' 1064 ' ' TRP . 1.4 t30 -48.12 -25.34 1.42 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 116.527 2.047 . . . . 54.75 116.527 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1062 ' ' SER . . . . . . . . . . . . . 15.2 m -60.22 -20.73 60.09 Favored 'General case' 0 CA--C 1.552 1.048 0 N-CA-C 114.028 1.122 . . . . 50.340000000000003 114.028 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1063 ' ' VAL . . . . . 0.493 ' O ' HD11 ' A' 1069 ' ' ILE . 14.9 p -70.03 -48.36 63.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 107.309 -1.367 . . . . 41.460000000000001 107.309 169.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1064 ' ' TRP . . . . . 0.878 ' HD1' ' HA ' ' A' 1061 ' ' ASN . 75.4 m95 -65.34 -30.73 71.6 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 124.397 1.079 . . . . 39.32 110.907 -172.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.43 81.05 4.79 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 113.489 -1.687 . . . . 55.380000000000003 109.427 172.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1066 ' ' SER . . . . . . . . . . . . . 68.5 m -145.72 -178.91 6.34 Favored 'General case' 0 C--O 1.242 0.67 0 O-C-N 120.431 -1.418 . . . . 41.869999999999997 111.128 172.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1067 ' ' GLU . . . . . 0.447 ' HB3' HD12 ' A' 1068 ' ' ILE . 22.0 tp10 -69.77 -62.81 1.23 Allowed 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.183 -1.414 . . . . 53.200000000000003 107.183 174.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1068 ' ' ILE . . . . . 0.455 ' HB ' HG12 ' A' 1003 ' ' ILE . 5.3 mp -107.56 142.17 20.94 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 N-CA-C 105.482 -2.044 . . . . 41.899999999999999 105.482 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1069 ' ' ILE . . . . . 0.493 HD11 ' O ' ' A' 1063 ' ' VAL . 5.4 mm -124.38 121.28 61.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 104.177 -2.527 . . . . 38.729999999999997 104.177 168.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1070 ' ' LEU . . . . . 0.674 HD22 HD22 ' A' 1331 ' ' LEU . 77.2 mt -98.74 87.05 3.67 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 104.302 -2.481 . . . . 32.439999999999998 104.302 172.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1071 ' ' LYS . . . . . 0.407 ' HB3' ' HE3' ' A' 1071 ' ' LYS . 1.1 mmmt -83.59 162.09 20.94 Favored 'General case' 0 C--O 1.257 1.48 0 N-CA-C 105.403 -2.073 . . . . 34.649999999999999 105.403 167.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1072 ' ' VAL . . . . . 0.932 HG11 ' HD2' ' A' 1015 ' ' ARG . 18.8 t -88.18 -86.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.705 0 C-N-CA 119.588 -0.845 . . . . 31.32 110.844 175.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -84.4 151.89 24.39 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.133 -1.432 . . . . 33.939999999999998 107.133 -170.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1074 ' ' ALA . . . . . 0.448 ' HA ' ' HD2' ' A' 1075 ' ' PRO . . . -33.92 120.29 0.5 Allowed Pre-proline 0 C--O 1.253 1.271 0 C-N-CA 125.084 1.353 . . . . 38.039999999999999 114.646 170.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1075 ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' 1074 ' ' ALA . 72.6 Cg_endo -56.81 128.2 28.97 Favored 'Trans proline' 0 N--CA 1.441 -1.579 0 C-N-CA 125.074 3.85 . . . . 42.68 114.887 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 33.0 mt -72.88 158.25 35.87 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 120.712 -1.242 . . . . 46.740000000000002 108.295 170.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1077 ' ' ASP . . . . . 0.497 ' HA ' HD12 ' A' 1080 ' ' ILE . 7.4 m-20 -45.98 -39.63 9.25 Favored 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 118.515 2.783 . . . . 58.609999999999999 118.515 -176.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 15.7 t70 -61.98 -48.71 79.12 Favored 'General case' 0 C--N 1.352 0.686 0 CA-C-N 119.144 0.884 . . . . 59.200000000000003 109.706 173.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1079 ' ' GLU . . . . . 0.427 ' HG2' HH11 ' A' 1009 ' ' ARG . 35.5 mt-10 -62.88 -32.42 73.66 Favored 'General case' 0 C--O 1.259 1.559 0 CA-C-N 114.024 -1.444 . . . . 50.630000000000003 109.109 -178.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1080 ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' 1077 ' ' ASP . 73.7 mt -62.88 -44.51 99.64 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-N 118.899 0.772 . . . . 51.479999999999997 109.59 173.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -62.53 -26.22 68.44 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 119.789 -1.82 . . . . 50.280000000000001 112.321 175.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 15.7 mt -80.96 -24.33 38.16 Favored 'General case' 0 C--O 1.25 1.102 0 O-C-N 119.339 -2.1 . . . . 50.210000000000001 112.206 174.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1083 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.22 120.26 10.01 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 124.477 2.084 . . . . 49.060000000000002 111.501 176.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -82.99 134.81 45.82 Favored Pre-proline 0 CA--C 1.515 -0.385 0 CA-C-N 112.483 -2.144 . . . . 51.079999999999998 111.756 -167.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -48.96 113.18 0.81 Allowed 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 125.106 3.871 . . . . 49.729999999999997 119.159 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 104.31 -27.16 20.41 Favored Glycine 0 N--CA 1.436 -1.309 0 O-C-N 124.9 1.375 . . . . 47.710000000000001 114.021 177.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1087 ' ' THR . . . . . . . . . . . . . 39.4 m -49.92 128.87 19.45 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 118.316 2.71 . . . . 45.469999999999999 118.316 -174.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1088 ' ' THR . . . . . . . . . . . . . 41.2 m -68.77 88.86 0.38 Allowed 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 123.354 1.549 . . . . 42.039999999999999 113.047 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1089 ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' 1112 ' ' VAL . 57.2 tp -83.43 98.32 9.44 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 104.291 -2.485 . . . . 38.060000000000002 104.291 -176.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1090 ' ' VAL . . . . . 0.625 ' HB ' HD23 ' A' 1070 ' ' LEU . 45.5 t -96.49 109.37 22.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 104.719 -2.326 . . . . 37.399999999999999 104.719 175.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1091 ' ' SER . . . . . 0.46 ' HA ' ' OH ' ' A' 1327 ' ' TYR . 13.4 m -152.26 162.91 40.45 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 116.537 2.051 . . . . 36.159999999999997 116.537 -175.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1092 ' ' PHE . . . . . 0.438 ' CD1' ' HB3' ' A' 1116 ' ' ASP . 51.4 t80 -74.33 79.42 1.85 Allowed 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 123.133 1.444 . . . . 38.939999999999998 107.652 170.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 21.8 mm -82.27 -42.72 18.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 126.571 1.948 . . . . 42.170000000000002 114.966 -168.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 2.9 m95 66.67 60.57 0.94 Allowed Pre-proline 0 N--CA 1.436 -1.175 0 C-N-CA 125.113 1.365 . . . . 46.509999999999998 114.625 -174.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1095 ' ' PRO . . . . . 0.404 ' HG2' HG11 ' A' 1360 ' ' VAL . 52.4 Cg_exo -56.43 -33.44 92.1 Favored 'Trans proline' 0 C--O 1.253 1.269 0 C-N-CA 124.87 3.713 . . . . 49.759999999999998 114.319 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -60.65 -51.8 67.86 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.118 -1.401 . . . . 52.619999999999997 111.61 174.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -78.96 -14.4 59.23 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 115.32 1.6 . . . . 60.740000000000002 115.32 177.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1098 ' ' ASN . . . . . 0.463 ' HB3' ' HB3' ' A' 1101 ' ' LEU . 43.6 m-20 -125.36 65.91 51.85 Favored Pre-proline 0 N--CA 1.441 -0.901 0 N-CA-C 115.765 1.765 . . . . 58.189999999999998 115.765 -173.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -66.24 -41.6 12.28 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.715 2.944 . . . . 54.590000000000003 113.308 -175.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.23 -42.09 85.54 Favored 'General case' 0 C--O 1.253 1.237 0 CA-C-O 123.335 1.54 . . . . 63.280000000000001 112.696 176.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1101 ' ' LEU . . . . . 0.463 ' HB3' ' HB3' ' A' 1098 ' ' ASN . 21.3 tp -55.78 -37.03 68.03 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 113.162 -1.835 . . . . 54.75 109.928 -178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1102 ' ' MET . . . . . . . . . . . . . 82.3 mmm -61.06 -45.3 95.34 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 108.667 -0.864 . . . . 52.649999999999999 108.667 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -64.8 -45.0 88.11 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-N 114.642 -1.163 . . . . 66.260000000000005 112.197 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 95.0 mttt -61.62 -41.84 98.04 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 123.132 1.444 . . . . 63.729999999999997 110.352 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1105 ' ' LEU . . . . . 0.424 HD13 HG21 ' A' 1112 ' ' VAL . 95.8 mt -74.83 -35.5 62.41 Favored 'General case' 0 C--O 1.246 0.884 0 O-C-N 118.485 -2.635 . . . . 54.68 109.227 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -62.84 -38.87 92.51 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 117.427 -1.273 . . . . 53.640000000000001 109.953 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -60.67 -41.19 94.57 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 124.277 0.985 . . . . 67.239999999999995 110.671 169.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1108 ' ' ARG . . . . . 0.482 ' HA ' ' HD3' ' A' 1108 ' ' ARG . 12.0 mmt85 -76.28 -0.05 21.02 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 114.281 1.215 . . . . 65.760000000000005 114.281 173.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1109 ' ' ASN . . . . . 0.588 ' HA ' ' HA2' ' A' 1364 ' ' GLY . 35.7 t30 61.22 15.22 6.2 Favored 'General case' 0 C--N 1.346 0.422 0 N-CA-C 114.431 1.271 . . . . 58.710000000000001 114.431 175.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1110 ' ' VAL . . . . . . . . . . . . . 29.8 m -79.39 132.97 30.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 O-C-N 120.111 -1.618 . . . . 46.630000000000003 108.623 -169.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1111 ' ' THR . . . . . 0.652 HG21 HG21 ' A' 1348 ' ' VAL . 56.5 m -74.72 93.91 2.64 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.509 0.671 . . . . 44.130000000000003 110.02 -176.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1112 ' ' VAL . . . . . 0.424 HG21 HD13 ' A' 1105 ' ' LEU . 38.9 t -92.84 115.97 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 123.874 1.797 . . . . 40.439999999999998 111.376 -170.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1113 ' ' MET . . . . . 0.565 ' SD ' HG13 ' A' 1348 ' ' VAL . 73.9 mtp -107.86 105.93 15.97 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 104.525 -2.398 . . . . 50.759999999999998 104.525 173.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1114 ' ' ALA . . . . . . . . . . . . . . . -86.63 109.07 18.91 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.399 -0.819 . . . . 35.640000000000001 111.608 -177.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1115 ' ' MET . . . . . 0.639 ' SD ' HD22 ' A' 1334 ' ' LEU . 90.9 mmm -66.19 -21.59 66.32 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 115.929 1.826 . . . . 38.740000000000002 115.929 -175.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1116 ' ' ASP . . . . . 0.438 ' HB3' ' CD1' ' A' 1092 ' ' PHE . 6.5 p-10 -73.09 -32.84 65.23 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 114.234 -1.348 . . . . 40.140000000000001 109.948 169.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1117 ' ' SER . . . . . . . . . . . . . 29.5 m -82.97 13.19 4.13 Favored 'General case' 0 C--O 1.244 0.772 0 O-C-N 119.777 -1.827 . . . . 44.789999999999999 114.937 -175.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1118 ' ' VAL . . . . . 0.676 HG22 HG22 ' A' 1358 ' ' VAL . 12.0 t -64.14 124.3 85.0 Favored Pre-proline 0 N--CA 1.484 1.26 0 CA-C-O 117.246 -1.359 . . . . 43.75 107.426 169.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1119 ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' 1354 ' ' VAL . 47.8 Cg_exo -55.88 134.64 65.31 Favored 'Trans proline' 0 C--O 1.242 0.698 0 C-N-CA 124.93 3.753 . . . . 48.93 110.745 173.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1120 ' ' ARG . . . . . 0.649 ' HD3' HD13 ' A' 1130 ' ' LEU . 41.8 mmm-85 -69.12 17.56 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 120.018 3.34 . . . . 62.899999999999999 120.018 -163.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 26.9 pt -85.67 171.46 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 C-N-CA 123.344 0.658 . . . . 57.719999999999999 112.562 -165.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1122 ' ' SER . . . . . . . . . . . . . 1.1 p -51.48 -53.79 33.68 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 118.822 -2.424 . . . . 57.259999999999998 114.743 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -64.58 -2.19 2.24 Favored 'General case' 0 C--O 1.248 0.997 0 CA-C-N 121.359 1.89 . . . . 62.899999999999999 115.875 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1124 ' ' ALA . . . . . 0.454 ' HB2' HG11 ' A' 1354 ' ' VAL . . . -106.41 -11.68 15.88 Favored 'General case' 0 C--O 1.2 -1.521 0 CA-C-O 116.381 -1.771 . . . . 49.829999999999998 114.198 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -57.99 -29.36 65.19 Favored 'General case' 0 CA--C 1.488 -1.415 0 N-CA-C 115.628 1.714 . . . . 52.369999999999997 115.628 -170.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1126 ' ' SER . . . . . . . . . . . . . 64.0 p -65.16 -41.14 94.98 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 115.102 1.519 . . . . 42.43 115.102 169.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1127 ' ' LEU . . . . . . . . . . . . . 1.6 mp -81.43 -28.44 34.24 Favored 'General case' 0 C--O 1.208 -1.096 0 CA-C-N 115.492 -0.777 . . . . 43.740000000000002 111.013 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 61.3 t0 -67.88 101.11 1.03 Allowed 'General case' 0 N--CA 1.439 -0.985 0 O-C-N 119.699 -1.876 . . . . 43.210000000000001 110.063 -164.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -74.2 -34.23 63.66 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.963 -0.562 . . . . 35.740000000000002 109.977 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1130 ' ' LEU . . . . . 0.649 HD13 ' HD3' ' A' 1120 ' ' ARG . 0.7 OUTLIER -60.16 -26.81 66.6 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 119.029 -2.294 . . . . 38.090000000000003 108.627 177.282 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 1131 ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' 1134 ' ' ALA . 61.9 m -84.92 -56.34 3.62 Favored 'General case' 0 C--O 1.216 -0.677 0 O-C-N 120.928 -1.107 . . . . 36.909999999999997 110.441 168.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1132 ' ' SER . . . . . 0.489 ' O ' ' HB3' ' A' 1135 ' ' ASN . 13.8 m -73.17 -43.72 61.04 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 116.854 2.168 . . . . 35.789999999999999 116.854 -168.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1133 ' ' MET . . . . . 0.891 ' HA ' HD12 ' A' 1136 ' ' ILE . 53.1 mtp -57.55 -45.45 85.08 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 122.463 1.125 . . . . 30.809999999999999 113.103 169.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1134 ' ' ALA . . . . . 0.978 ' HB1' ' HB2' ' A' 1176 ' ' ALA . . . -57.03 -39.17 74.27 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 112.91 -1.95 . . . . 28.879999999999999 111.144 170.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1135 ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' 1132 ' ' SER . 1.6 t30 -58.54 -51.59 69.25 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 120.389 -1.444 . . . . 40.759999999999998 113.743 175.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1136 ' ' ILE . . . . . 0.891 HD12 ' HA ' ' A' 1133 ' ' MET . 14.6 mt -52.34 -46.68 46.35 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 CA-C-O 118.163 -0.923 . . . . 31.539999999999999 108.977 172.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1137 ' ' ALA . . . . . 0.731 ' HB2' ' HG3' ' A' 1316 ' ' PRO . . . -67.02 -27.11 67.14 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 124.925 1.29 . . . . 29.870000000000001 113.6 176.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -74.61 -44.2 27.11 Favored Glycine 0 C--N 1.313 -0.713 0 O-C-N 120.865 -1.147 . . . . 28.73 110.812 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 16.1 t80 -61.85 -46.34 89.88 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.206 -1.173 . . . . 30.390000000000001 108.506 171.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1140 ' ' ARG . . . . . 0.679 ' HD3' ' HB2' ' A' 1319 ' ' LEU . 5.6 tpt180 -63.33 -29.75 71.0 Favored 'General case' 0 CA--C 1.493 -1.229 0 O-C-N 121.339 -0.851 . . . . 26.09 112.427 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1141 ' ' ALA . . . . . . . . . . . . . . . -63.29 -43.68 97.19 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 119.905 -1.747 . . . . 27.100000000000001 110.674 173.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 47.1 mm -54.3 -45.64 68.3 Favored 'Isoleucine or valine' 0 C--N 1.347 0.488 0 O-C-N 120.693 -1.255 . . . . 28.48 111.77 168.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 25.1 t -62.38 -55.26 25.1 Favored 'Isoleucine or valine' 0 C--O 1.252 1.223 0 CA-C-O 115.88 -2.01 . . . . 23.07 114.243 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1144 ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -70.19 -22.36 62.95 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 123.563 2.892 . . . . 33.399999999999999 110.159 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1145 ' ' ALA . . . . . 0.737 ' HA ' HG11 ' A' 1280 ' ' VAL . . . -63.61 -56.33 16.71 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 119.458 -0.897 . . . . 24.219999999999999 109.708 167.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -59.28 -21.33 59.49 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-O 117.871 -1.061 . . . . 24.890000000000001 112.496 174.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1147 ' ' HIS . . . . . 0.419 ' HA ' ' CG1' ' B' 1143 ' ' VAL . 49.2 t-80 -66.35 -41.51 89.44 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 120.59 1.541 . . . . 26.73 111.691 169.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1148 ' ' GLU . . . . . 0.799 ' HB3' ' HD2' ' A' 1308 ' ' LYS . 77.6 mm-40 -105.98 -2.62 22.63 Favored 'General case' 0 C--O 1.252 1.207 0 N-CA-C 114.991 1.478 . . . . 39.960000000000001 114.991 -176.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1149 ' ' PHE . . . . . . . . . . . . . 1.3 t80 -70.18 149.03 47.95 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 116.167 -0.469 . . . . 25.870000000000001 111.546 -178.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1150 ' ' GLY . . . . . 0.614 ' HA2' ' HG2' ' B' 1320 ' ' PRO . . . -75.71 -49.9 8.51 Favored Glycine 0 N--CA 1.43 -1.702 0 CA-C-N 114.479 -1.237 . . . . 19.280000000000001 113.616 172.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1151 ' ' ARG . . . . . 0.489 ' HG3' ' HB ' ' B' 1321 ' ' THR . 29.1 mtm-85 -97.94 170.68 8.78 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-O 123.308 1.527 . . . . 39.899999999999999 113.865 -168.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1152 ' ' PHE . . . . . 0.491 ' HA ' ' CZ ' ' B' 1139 ' ' TYR . 0.3 OUTLIER -72.97 142.63 47.79 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.46 -0.941 . . . . 29.440000000000001 108.46 166.011 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 1153 ' ' PHE . . . . . 0.428 ' HD1' ' OH ' ' B' 1139 ' ' TYR . 25.0 m-85 -58.03 -46.87 84.63 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 114.528 1.307 . . . . 32.600000000000001 114.528 168.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1154 ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -72.29 145.92 47.53 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 125.068 1.347 . . . . 34.640000000000001 109.215 -178.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -77.88 65.99 3.15 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 119.214 -2.179 . . . . 37.140000000000001 108.272 169.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -92.1 136.38 33.22 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 107.772 -1.196 . . . . 40.57 107.772 -167.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1157 ' ' ILE . . . . . 0.462 HG12 ' HB3' ' C' ' 95' ' ' GLU . 3.8 tp -96.16 135.58 29.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 105.075 -2.194 . . . . 44.609999999999999 105.075 163.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1158 ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.65 -123.72 0.1 Allowed 'General case' 0 C--O 1.242 0.696 0 CA-C-O 117.171 -1.395 . . . . 40.700000000000003 112.435 173.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -84.18 -45.71 12.65 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 122.034 2.197 . . . . 40.25 106.94 160.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -126.13 153.53 44.42 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 113.261 -1.791 . . . . 38.469999999999999 107.704 170.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1161 ' ' GLY . . . . . 0.683 ' HA3' ' HA ' ' B' 1326 ' ' LEU . . . 87.26 103.95 0.85 Allowed Glycine 0 CA--C 1.496 -1.099 0 C-N-CA 119.632 -1.27 . . . . 37.609999999999999 113.559 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1162 ' ' LYS . . . . . 0.428 ' HG3' ' CD ' ' C' ' 95' ' ' GLU . 1.5 tmtp? -102.53 122.05 43.58 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 126.642 2.025 . . . . 48.899999999999999 106.026 171.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1163 ' ' VAL . . . . . . . . . . . . . 45.8 t -82.0 133.67 51.0 Favored Pre-proline 0 C--O 1.247 0.943 0 CA-C-O 117.451 -1.262 . . . . 36.520000000000003 109.438 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1164 ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -73.3 109.49 2.85 Favored 'Trans proline' 0 N--CA 1.43 -2.248 0 CA-C-N 124.326 2.581 . . . . 35.079999999999998 109.739 160.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1165 ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -50.96 161.74 1.34 Allowed 'Trans proline' 0 N--CA 1.483 0.865 1 C-N-CA 125.957 4.438 . . . . 35.329999999999998 118.696 -169.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -74.54 122.04 22.48 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.863 -1.162 . . . . 34.689999999999998 107.863 -176.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1167 ' ' LYS . . . . . 0.426 ' HB2' ' HA ' ' A' 1249 ' ' VAL . 76.6 mttt -88.2 104.99 17.23 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-O 124.007 1.86 . . . . 45.359999999999999 106.628 166.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 58.7 t -94.58 89.99 2.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 113.681 -1.6 . . . . 31.710000000000001 108.259 -175.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1169 ' ' MET . . . . . 0.482 ' SD ' ' HB3' ' A' 1245 ' ' GLN . 5.6 ttp -77.9 92.1 4.24 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 113.407 -1.724 . . . . 42.280000000000001 111.828 177.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 81.0 t -88.79 112.5 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 106.146 -1.798 . . . . 30.510000000000002 106.146 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 57.7 mt -98.24 123.1 50.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 109.631 -0.507 . . . . 31.870000000000001 109.631 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1172 ' ' GLY . . . . . 0.444 ' HA3' ' HB2' ' A' 1256 ' ' ALA . . . 77.13 81.58 0.6 Allowed Glycine 0 N--CA 1.436 -1.346 0 CA-C-O 122.77 1.206 . . . . 34.539999999999999 113.716 -178.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1173 ' ' ALA . . . . . 0.446 ' HA ' ' HA3' ' A' 1177 ' ' GLY . . . -82.07 80.05 8.42 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 111.773 -2.214 . . . . 32.509999999999998 109.212 -172.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -85.09 -157.0 27.14 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 108.056 -2.018 . . . . 29.899999999999999 108.056 163.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1175 ' ' VAL . . . . . . . . . . . . . 67.2 t -74.02 -26.9 21.54 Favored 'Isoleucine or valine' 0 C--O 1.259 1.598 0 CA-C-N 120.378 2.089 . . . . 33.109999999999999 108.765 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1176 ' ' ALA . . . . . 0.978 ' HB2' ' HB1' ' A' 1134 ' ' ALA . . . -50.22 -47.27 54.95 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.596 0.712 . . . . 28.100000000000001 112.623 162.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1177 ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' A' 1173 ' ' ALA . . . -61.25 -52.21 53.18 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 113.475 -1.693 . . . . 28.539999999999999 110.115 176.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1178 ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' 1181 ' ' ILE . 94.3 mt -53.14 -43.89 67.33 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 118.923 1.361 . . . . 31.219999999999999 113.177 178.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -66.47 -34.75 78.62 Favored 'General case' 0 C--O 1.245 0.822 0 O-C-N 118.088 -2.883 . . . . 28.98 114.115 174.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -65.62 -45.74 81.96 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.069 0.85 . . . . 27.829999999999998 109.498 176.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1181 ' ' ILE . . . . . 0.562 ' HA ' HG11 ' A' 1191 ' ' VAL . 55.6 mt -59.33 -52.68 58.04 Favored 'Isoleucine or valine' 0 C--N 1.349 0.561 0 C-N-CA 124.571 1.148 . . . . 30.25 109.89 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -51.67 -54.88 22.85 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 125.735 1.636 . . . . 29.59 110.53 176.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -65.26 -43.23 91.94 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 114.176 1.176 . . . . 30.289999999999999 114.176 -175.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -68.96 -43.56 74.76 Favored 'General case' 0 N--CA 1.425 -1.699 0 C-N-CA 123.771 0.828 . . . . 30.469999999999999 109.404 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -64.76 -35.61 81.63 Favored 'General case' 0 C--O 1.243 0.755 0 O-C-N 120.693 -1.254 . . . . 42.409999999999997 109.376 173.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1186 ' ' SER . . . . . 1.075 ' HB3' ' HA ' ' B' 1187 ' ' LEU . 72.9 m -60.25 -36.95 78.95 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 121.509 1.959 . . . . 39.380000000000003 112.354 169.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 89.4 mt -82.18 18.68 1.33 Allowed 'General case' 0 C--O 1.244 0.791 0 CA-C-N 120.361 1.437 . . . . 36.18 114.001 169.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 78.93 2.35 86.46 Favored Glycine 0 N--CA 1.47 0.952 0 CA-C-N 119.876 1.217 . . . . 33.780000000000001 115.003 170.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -73.34 151.14 41.38 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 124.106 0.962 . . . . 33.93 113.009 -175.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 18.5 mt -86.36 101.67 10.89 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 N-CA-C 103.153 -2.906 . . . . 38.740000000000002 103.153 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1191 ' ' VAL . . . . . 0.562 HG11 ' HA ' ' A' 1181 ' ' ILE . 3.0 t -86.99 127.78 40.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 112.921 -1.945 . . . . 33.090000000000003 107.231 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1192 ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -119.85 107.33 13.02 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 106.761 -1.57 . . . . 38.920000000000002 106.761 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -108.39 121.75 45.57 Favored 'General case' 0 C--O 1.248 0.982 0 O-C-N 120.626 -1.297 . . . . 35.32 109.571 -174.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 75.5 t80 -93.85 147.73 22.8 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 105.517 -2.031 . . . . 39.350000000000001 105.517 169.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 7.2 t70 -149.29 157.41 43.32 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 105.874 -1.899 . . . . 40.460000000000001 105.874 154.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1196 ' ' THR . . . . . . . . . . . . . 2.7 m -67.08 -43.39 82.71 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 104.962 -2.236 . . . . 45.939999999999998 104.962 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1197 ' ' ARG . . . . . . . . . . . . . 72.4 mtm180 -72.48 116.69 52.06 Favored Pre-proline 0 N--CA 1.453 -0.322 0 O-C-N 120.966 -1.084 . . . . 56.020000000000003 111.721 -175.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1198 ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -62.05 -26.94 78.78 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 125.244 3.963 . . . . 51.270000000000003 116.826 175.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -54.23 -34.65 61.18 Favored 'General case' 0 C--O 1.248 1.023 0 CA-C-N 114.557 -1.201 . . . . 59.100000000000001 112.598 -176.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 34.6 m -75.35 -10.7 13.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 117.23 2.307 . . . . 51.060000000000002 117.23 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 83.3 tttt -51.2 -46.21 62.1 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 124.709 1.204 . . . . 57.380000000000003 111.852 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -72.99 -29.79 63.31 Favored 'General case' 0 CA--C 1.512 -0.482 0 O-C-N 120.472 -1.393 . . . . 62.409999999999997 109.845 -173.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -66.3 -42.46 88.27 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.294 -1.373 . . . . 57.780000000000001 107.294 173.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1204 ' ' VAL . . . . . 0.61 HG13 ' HB3' ' A' 1209 ' ' ALA . 5.3 t -60.93 -50.23 81.41 Favored 'Isoleucine or valine' 0 C--N 1.344 0.357 0 C-N-CA 124.928 1.291 . . . . 46.380000000000003 109.141 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -56.54 -44.59 81.02 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 114.421 1.267 . . . . 50.700000000000003 114.421 173.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1206 ' ' SER . . . . . . . . . . . . . 48.7 m -58.44 -34.91 71.34 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.028 1.492 . . . . 49.979999999999997 115.028 174.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1207 ' ' MET . . . . . . . . . . . . . 61.4 mtp -92.54 11.02 27.83 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 119.759 -1.838 . . . . 52.990000000000002 111.08 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 78.28 51.19 5.81 Favored Glycine 0 CA--C 1.549 2.218 0 CA-C-O 124.39 2.106 . . . . 47.659999999999997 111.481 168.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1209 ' ' ALA . . . . . 0.61 ' HB3' HG13 ' A' 1204 ' ' VAL . . . -129.67 143.3 50.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 113.059 -1.57 . . . . 44.770000000000003 114.19 171.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -69.84 132.5 46.12 Favored 'General case' 0 C--N 1.347 0.468 0 N-CA-C 105.957 -1.868 . . . . 47.640000000000001 105.957 167.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1211 ' ' PHE . . . . . 0.526 ' HD1' HG11 ' A' 1204 ' ' VAL . 26.5 t80 -86.76 134.32 33.58 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 104.739 -2.319 . . . . 45.659999999999997 104.739 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 51.7 mt -84.93 109.09 17.9 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 123.719 1.724 . . . . 46.060000000000002 108.41 165.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -79.32 145.23 33.57 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 113.703 -1.589 . . . . 60.219999999999999 109.414 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 9.2 tp -79.94 85.36 5.57 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 124.369 2.033 . . . . 57.25 108.953 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1215 ' ' ASP . . . . . 0.644 ' H ' HD21 ' A' 1241 ' ' LEU . 12.3 t70 -76.71 111.89 12.71 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 110.978 -2.828 . . . . 64.430000000000007 104.696 -176.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1216 ' ' PHE . . . . . 0.642 ' HE1' ' HB1' ' A' 1233 ' ' ALA . 33.4 t80 . . . . . 0 CA--C 1.516 -0.362 0 N-CA-C 107.765 -1.198 . . . . 66.900000000000006 107.765 -175.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 2.2 p-10 . . . . . 0 N--CA 1.446 -0.663 0 CA-C-O 120.954 0.407 . . . . 39.090000000000003 110.978 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -42.26 -57.07 3.81 Favored Glycine 0 C--O 1.208 -1.492 0 O-C-N 126.427 2.329 . . . . 39.32 113.912 175.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 79.0 t80 -60.9 -47.89 84.34 Favored 'General case' 0 N--CA 1.44 -0.955 0 O-C-N 120.98 -1.306 . . . . 39.299999999999997 110.739 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -63.07 -35.98 82.05 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 120.645 -1.284 . . . . 36.299999999999997 114.42 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -65.4 -59.83 3.61 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 117.695 -1.145 . . . . 37.380000000000003 110.476 176.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -54.23 -47.78 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 121.065 1.757 . . . . 39.109999999999999 114.047 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1230 ' ' MET . . . . . . . . . . . . . 20.3 mmt -90.21 68.61 7.06 Favored 'General case' 0 C--O 1.247 0.933 0 CA-C-O 123.094 1.426 . . . . 49.590000000000003 112.708 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1231 ' ' SER . . . . . . . . . . . . . 1.9 p -142.43 132.69 24.79 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.222 -1.399 . . . . 43.68 107.222 165.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -49.08 -42.37 38.6 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 116.426 2.01 . . . . 55.57 116.426 -172.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1233 ' ' ALA . . . . . 0.642 ' HB1' ' HE1' ' A' 1216 ' ' PHE . . . -59.57 -39.02 82.72 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 119.109 0.868 . . . . 44.939999999999998 113.158 174.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -55.0 -60.59 3.16 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 114.435 1.272 . . . . 42.039999999999999 114.435 170.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 59.3 mt -57.89 -42.41 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 124.425 2.059 . . . . 46.280000000000001 109.854 -176.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 45.2 tttm -50.86 -53.12 35.07 Favored 'General case' 0 C--O 1.25 1.095 0 CA-C-N 113.289 -1.778 . . . . 47.869999999999997 114.15 166.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -63.47 -33.41 75.51 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 120.419 1.463 . . . . 41.609999999999999 110.703 -176.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -55.13 -59.66 4.46 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 124.883 1.273 . . . . 50.649999999999999 107.708 169.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1239 ' ' MET . . . . . . . . . . . . . 32.7 mtm -56.31 -31.69 63.93 Favored 'General case' 0 C--O 1.238 0.498 0 O-C-N 120.135 -1.603 . . . . 48.869999999999997 113.368 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -64.54 -39.72 94.28 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 112.166 0.432 . . . . 54.799999999999997 112.166 175.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1241 ' ' LEU . . . . . 0.644 HD21 ' H ' ' A' 1215 ' ' ASP . 1.6 mm? -65.6 -46.24 80.12 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 120.598 -1.314 . . . . 43.210000000000001 108.738 177.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -64.0 -34.38 77.86 Favored 'General case' 0 CA--C 1.508 -0.666 0 O-C-N 126.922 2.639 . . . . 38.659999999999997 112.635 -168.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -59.19 -54.12 50.54 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 120.403 1.456 . . . . 37.920000000000002 113.394 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -67.23 -42.94 83.18 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 119.803 1.183 . . . . 37.280000000000001 110.242 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1245 ' ' GLN . . . . . 0.482 ' HB3' ' SD ' ' A' 1169 ' ' MET . 96.7 mm-40 -54.19 -40.97 68.07 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 121.383 -0.823 . . . . 43.07 112.297 177.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -55.49 -37.08 67.37 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.076 0.95 . . . . 38.299999999999997 112.172 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1247 ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' A' 1276 ' ' LYS . 12.8 ttmm -54.9 -35.93 64.64 Favored 'General case' 0 C--O 1.258 1.517 0 C-N-CA 125.115 1.366 . . . . 47.600000000000001 110.905 177.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -111.24 -20.29 12.37 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.477 1.288 . . . . 45.420000000000002 114.477 -175.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1249 ' ' VAL . . . . . 0.437 HG11 ' HB2' ' A' 1169 ' ' MET . 31.2 m -78.27 162.63 4.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 115.303 1.594 . . . . 36.259999999999998 115.303 -173.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1250 ' ' ASP . . . . . 0.581 ' O ' ' HB3' ' A' 1279 ' ' SER . 3.6 m-20 -109.42 -60.47 1.77 Allowed 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 115.076 -0.965 . . . . 33.039999999999999 111.381 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1251 ' ' ILE . . . . . 0.449 HD12 ' HB1' ' A' 1145 ' ' ALA . 36.1 mm -112.76 102.08 13.43 Favored 'Isoleucine or valine' 0 C--O 1.247 0.934 0 N-CA-C 105.709 -1.96 . . . . 31.399999999999999 105.709 -170.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1252 ' ' ILE . . . . . 0.436 ' HB ' HG12 ' A' 1281 ' ' ILE . 64.9 mt -80.63 117.15 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 104.354 -2.462 . . . . 29.420000000000002 104.354 167.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1253 ' ' VAL . . . . . 0.598 HG12 HG23 ' A' 1255 ' ' THR . 18.2 t -103.92 109.75 28.14 Favored 'Isoleucine or valine' 0 C--O 1.248 0.985 0 N-CA-C 100.694 -3.817 . . . . 30.370000000000001 100.694 175.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1254 ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.53 82.4 5.34 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 124.904 2.287 . . . . 35.719999999999999 110.65 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1255 ' ' THR . . . . . 0.742 HG22 HD13 ' A' 1284 ' ' LEU . 1.1 p -86.29 -16.95 35.93 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 112.09 -2.323 . . . . 36.0 115.112 -174.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1256 ' ' ALA . . . . . 0.444 ' HB2' ' HA3' ' A' 1172 ' ' GLY . . . -57.81 64.45 0.0 OUTLIER 'General case' 0 C--O 1.261 1.675 0 N-CA-C 116.927 2.195 . . . . 40.93 116.927 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 44.4 tp -83.67 101.14 11.32 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 124.356 2.027 . . . . 47.82 110.369 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 32.8 mm -82.51 120.99 77.87 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-N 111.883 -2.417 . . . . 52.700000000000003 108.24 173.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -72.79 148.7 46.81 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 124.887 3.724 . . . . 54.130000000000003 111.366 175.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 74.69 -88.8 0.74 Allowed Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.699 -0.96 . . . . 54.619999999999997 110.699 176.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 41.1 mttt -56.78 124.93 66.63 Favored Pre-proline 0 CA--C 1.55 0.946 0 O-C-N 121.288 -1.125 . . . . 55.740000000000002 108.194 173.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -57.76 135.31 68.4 Favored 'Trans proline' 0 CA--C 1.521 -0.142 0 C-N-CA 123.306 2.671 . . . . 51.149999999999999 109.483 177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1263 ' ' ALA . . . . . 0.557 ' HB1' ' ND2' ' A' 1291 ' ' ASN . . . -57.53 130.59 81.44 Favored Pre-proline 0 N--CA 1.482 1.14 0 O-C-N 124.049 0.843 . . . . 46.060000000000002 110.042 -178.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -60.01 143.74 99.54 Favored 'Trans proline' 0 C--O 1.242 0.679 0 C-N-CA 124.187 3.258 . . . . 41.079999999999998 117.17 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1265 ' ' LYS . . . . . 0.589 ' HD2' ' HA ' ' A' 1293 ' ' GLU . 69.7 mmtt -79.65 85.54 5.36 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-O 124.423 2.058 . . . . 47.420000000000002 106.684 177.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 74.0 mt -84.43 -42.17 15.9 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 109.378 -3.555 . . . . 39.219999999999999 108.848 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 4.0 mp -99.07 108.76 22.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.842 0 N-CA-C 102.242 -3.244 . . . . 42.5 102.242 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1268 ' ' THR . . . . . 0.531 ' O ' HG23 ' A' 1272 ' ' VAL . 27.1 p -80.2 163.23 24.2 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 113.931 -1.486 . . . . 37.840000000000003 114.31 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 59.2 mtt-85 -58.27 -39.72 79.98 Favored 'General case' 0 C--O 1.212 -0.921 0 CA-C-N 115.883 -0.599 . . . . 54.799999999999997 110.487 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -60.15 -53.72 54.33 Favored 'General case' 0 N--CA 1.426 -1.654 0 O-C-N 124.851 1.344 . . . . 54.359999999999999 109.443 174.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1271 ' ' MET . . . . . . . . . . . . . 42.1 ttm -58.04 -37.46 74.4 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.087 0.955 . . . . 39.520000000000003 113.423 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1272 ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' 1268 ' ' THR . 13.5 t -67.45 -48.48 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 108.72 -0.844 . . . . 38.25 108.72 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.89 -29.18 70.03 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.491 0.922 . . . . 40.770000000000003 113.491 175.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1274 ' ' SER . . . . . . . . . . . . . 28.6 m -73.94 -12.43 60.65 Favored 'General case' 0 C--O 1.256 1.395 0 O-C-N 120.863 -1.148 . . . . 36.579999999999998 113.81 173.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1275 ' ' MET . . . . . 0.475 ' SD ' HD11 ' A' 1281 ' ' ILE . 70.3 mtp -63.16 155.77 27.11 Favored 'General case' 0 C--O 1.245 0.854 0 O-C-N 119.084 -2.26 . . . . 36.75 113.601 -177.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1276 ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' 1247 ' ' LYS . 36.1 ttpt -61.21 133.52 56.03 Favored 'General case' 0 C--N 1.347 0.471 0 N-CA-C 106.596 -1.631 . . . . 46.109999999999999 106.596 171.079 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1277 ' ' ALA . . . . . . . . . . . . . . . -71.29 175.15 5.6 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 122.441 1.115 . . . . 33.520000000000003 112.978 -172.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 67.34 28.16 73.62 Favored Glycine 0 C--O 1.22 -0.76 0 O-C-N 120.907 -1.12 . . . . 31.27 111.932 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1279 ' ' SER . . . . . 0.581 ' HB3' ' O ' ' A' 1250 ' ' ASP . 50.4 m -125.75 170.2 11.81 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.389 -1.065 . . . . 32.950000000000003 112.097 -165.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1280 ' ' VAL . . . . . 0.737 HG11 ' HA ' ' A' 1145 ' ' ALA . 65.2 t -130.82 133.45 63.16 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 O-C-N 119.472 -2.017 . . . . 27.43 108.66 -167.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1281 ' ' ILE . . . . . 0.475 HD11 ' SD ' ' A' 1275 ' ' MET . 48.4 mt -110.98 100.75 11.41 Favored 'Isoleucine or valine' 0 C--O 1.251 1.179 0 N-CA-C 103.624 -2.732 . . . . 30.300000000000001 103.624 166.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1282 ' ' VAL . . . . . 0.483 HG23 ' HA ' ' A' 1253 ' ' VAL . 0.0 OUTLIER -91.64 97.82 7.67 Favored 'Isoleucine or valine' 0 C--O 1.249 1.065 0 N-CA-C 107.108 -1.441 . . . . 28.629999999999999 107.108 176.929 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 4.4 t70 -86.95 108.72 18.94 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 106.819 -1.549 . . . . 36.270000000000003 106.819 -173.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1284 ' ' LEU . . . . . 0.742 HD13 HG22 ' A' 1255 ' ' THR . 9.6 tt -80.14 -35.62 36.4 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.88 0.847 . . . . 38.57 109.207 171.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -63.57 -12.71 35.02 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.497 -0.774 . . . . 37.560000000000002 112.765 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . -41.04 -29.51 0.11 Allowed 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 117.011 2.226 . . . . 40.329999999999998 117.011 162.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -51.19 -40.55 58.91 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-O 117.978 -1.01 . . . . 56.850000000000001 110.8 171.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 48.4 t30 -141.45 96.25 2.95 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 118.976 0.807 . . . . 45.859999999999999 110.1 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 92.28 -59.8 2.64 Favored Glycine 0 C--N 1.348 1.196 0 O-C-N 120.305 -1.497 . . . . 40.310000000000002 112.607 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 81.63 128.93 1.03 Allowed Glycine 0 N--CA 1.471 0.975 0 CA-C-N 120.485 2.143 . . . . 38.890000000000001 114.053 -171.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1291 ' ' ASN . . . . . 0.557 ' ND2' ' HB1' ' A' 1263 ' ' ALA . 20.3 m120 -82.02 -22.51 36.43 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 116.311 1.967 . . . . 37.229999999999997 116.311 -170.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1292 ' ' CYS . . . . . 0.565 ' HB3' ' OG1' ' A' 1295 ' ' THR . 29.6 t -94.29 144.36 25.59 Favored 'General case' 0 C--O 1.252 1.228 0 N-CA-C 102.461 -3.163 . . . . 36.5 102.461 174.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1293 ' ' GLU . . . . . 0.589 ' HA ' ' HD2' ' A' 1265 ' ' LYS . 30.5 mt-10 -64.96 -51.46 61.69 Favored 'General case' 0 CA--C 1.56 1.336 0 CA-C-O 122.811 1.291 . . . . 43.32 107.868 172.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -54.78 -18.68 5.06 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 119.916 3.302 . . . . 41.32 119.916 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1295 ' ' THR . . . . . 0.565 ' OG1' ' HB3' ' A' 1292 ' ' CYS . 58.4 m -49.75 103.97 0.06 Allowed 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 122.423 1.106 . . . . 35.299999999999997 112.77 167.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 94.6 t -86.1 121.29 72.8 Favored Pre-proline 0 C--O 1.246 0.887 0 N-CA-C 100.913 -3.736 . . . . 34.840000000000003 100.913 164.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -65.49 125.09 13.82 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.855 2.37 . . . . 33.509999999999998 107.597 -176.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 93.42 -3.23 71.84 Favored Glycine 0 N--CA 1.433 -1.556 0 CA-C-O 117.777 -1.568 . . . . 32.189999999999998 113.699 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -130.46 172.28 12.06 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 123.656 3.728 . . . . 34.880000000000003 117.206 -177.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1300 ' ' ILE . . . . . 0.576 HG23 HG12 ' A' 1310 ' ' ILE . 59.3 mt -98.72 98.17 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 101.744 -3.428 . . . . 32.289999999999999 101.744 170.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1301 ' ' PHE . . . . . 0.533 ' HB3' ' HB ' ' A' 1309 ' ' VAL . 61.9 t80 -71.99 148.56 45.82 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 103.905 -2.628 . . . . 37.25 103.905 161.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1302 ' ' THR . . . . . 0.486 HG22 ' O ' ' A' 1303 ' ' THR . 86.4 m -132.46 141.67 48.92 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 105.644 -1.984 . . . . 35.560000000000002 105.644 169.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1303 ' ' THR . . . . . 0.486 ' O ' HG22 ' A' 1302 ' ' THR . 16.8 p -81.23 163.71 22.81 Favored 'General case' 0 N--CA 1.425 -1.693 0 C-N-CA 125.333 1.453 . . . . 36.399999999999999 109.795 168.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -55.84 -49.66 72.7 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 124.924 1.29 . . . . 52.32 109.568 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 39.4 p-10 -66.44 -19.56 65.83 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.854 1.057 . . . . 40.039999999999999 113.854 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 97.94 63.12 0.88 Allowed Glycine 0 N--CA 1.426 -2.025 0 CA-C-N 113.865 -1.516 . . . . 36.960000000000001 112.036 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1307 ' ' VAL . . . . . 0.462 HG11 ' SD ' ' A' 1275 ' ' MET . 45.6 t -118.18 114.5 45.38 Favored 'Isoleucine or valine' 0 C--O 1.251 1.158 0 N-CA-C 108.221 -1.029 . . . . 33.399999999999999 108.221 163.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1308 ' ' LYS . . . . . 0.799 ' HD2' ' HB3' ' A' 1148 ' ' GLU . 78.2 mttt -92.75 108.19 19.8 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.943 0.878 . . . . 42.909999999999997 112.686 -171.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1309 ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' 1301 ' ' PHE . 14.0 t -94.62 83.43 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 106.025 -1.842 . . . . 32.289999999999999 106.025 -174.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1310 ' ' ILE . . . . . 0.576 HG12 HG23 ' A' 1300 ' ' ILE . 47.8 mt -80.83 91.33 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.35 0 CA-C-N 110.737 -2.938 . . . . 30.989999999999998 108.648 -173.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1311 ' ' GLY . . . . . 0.408 ' HA3' HG23 ' A' 1295 ' ' THR . . . -87.47 71.17 2.7 Favored Glycine 0 CA--C 1.537 1.442 0 O-C-N 118.284 -2.76 . . . . 28.949999999999999 112.318 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1312 ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -90.63 93.9 9.46 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 118.815 -1.154 . . . . 31.690000000000001 112.529 -172.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1313 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.53 -36.81 62.18 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 112.985 -1.916 . . . . 34.170000000000002 109.756 172.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 29.1 p-10 -84.74 3.87 35.41 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 118.192 2.664 . . . . 36.859999999999999 118.192 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1315 ' ' LEU . . . . . . . . . . . . . 28.7 mt -37.11 -50.85 2.26 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 118.322 2.712 . . . . 34.850000000000001 118.322 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1316 ' ' PRO . . . . . 0.731 ' HG3' ' HB2' ' A' 1137 ' ' ALA . 82.5 Cg_exo -53.35 -46.82 31.1 Favored 'Trans proline' 0 C--N 1.355 0.9 0 CA-C-N 125.655 3.056 . . . . 29.149999999999999 112.791 171.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1317 ' ' GLY . . . . . 0.615 ' HA2' ' HG3' ' A' 1015 ' ' ARG . . . -63.41 -29.89 75.93 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 115.097 0.799 . . . . 27.289999999999999 115.097 -175.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1318 ' ' ARG . . . . . 0.479 ' HB3' ' NH2' ' A' 1140 ' ' ARG . 52.3 mtt-85 -65.88 -19.94 66.05 Favored 'General case' 0 C--O 1.255 1.376 0 O-C-N 126.348 1.852 . . . . 41.490000000000002 115.345 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1319 ' ' LEU . . . . . 0.679 ' HB2' ' HD3' ' A' 1140 ' ' ARG . 13.3 tp -118.2 72.09 9.23 Favored Pre-proline 0 N--CA 1.438 -1.031 0 N-CA-C 105.232 -2.136 . . . . 27.609999999999999 105.232 178.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1320 ' ' PRO . . . . . 0.823 ' HB3' ' HB ' ' A' 1014 ' ' THR . 38.3 Cg_endo -56.04 -53.82 4.91 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.571 2.847 . . . . 25.940000000000001 114.698 -164.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1321 ' ' THR . . . . . . . . . . . . . 1.8 m -67.64 -39.52 84.63 Favored 'General case' 0 CA--C 1.499 -0.995 0 O-C-N 119.485 -2.009 . . . . 25.010000000000002 110.41 -168.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1322 ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -68.77 -26.57 65.29 Favored 'General case' 0 CA--C 1.511 -0.519 0 O-C-N 118.19 -2.819 . . . . 29.390000000000001 110.838 176.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1323 ' ' SER . . . . . 0.767 ' HA ' HD13 ' A' 1136 ' ' ILE . 70.6 m -64.59 -53.11 52.9 Favored 'General case' 0 CA--C 1.501 -0.913 0 O-C-N 119.569 -1.957 . . . . 26.469999999999999 109.91 167.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1324 ' ' SER . . . . . . . . . . . . . 4.6 m -55.66 -27.5 50.28 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.96 0.886 . . . . 27.780000000000001 113.001 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -86.54 -51.68 6.03 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 118.319 -1.352 . . . . 37.530000000000001 110.81 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1326 ' ' LEU . . . . . 0.407 ' HB2' HD11 ' A' 1136 ' ' ILE . 92.9 mt -79.94 -52.2 8.15 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 118.182 -0.913 . . . . 35.710000000000001 111.261 -172.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1327 ' ' TYR . . . . . 0.46 ' OH ' ' HA ' ' A' 1091 ' ' SER . 66.8 t80 -57.47 -43.39 84.02 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.799 0.809 . . . . 31.59 110.99 170.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1328 ' ' GLY . . . . . 0.564 ' HA2' HD12 ' A' 1331 ' ' LEU . . . -49.72 -50.11 32.4 Favored Glycine 0 N--CA 1.468 0.798 0 CA-C-O 118.149 -1.362 . . . . 28.0 110.816 171.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1329 ' ' THR . . . . . . . . . . . . . 52.4 m -72.5 -27.7 62.43 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 118.76 -1.176 . . . . 32.149999999999999 112.484 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1330 ' ' ASN . . . . . . . . . . . . . 28.5 m120 -60.1 -43.73 95.34 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 118.007 -2.933 . . . . 34.359999999999999 108.957 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1331 ' ' LEU . . . . . 0.674 HD22 HD22 ' A' 1070 ' ' LEU . 27.7 mt -59.79 -48.8 80.21 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 112.774 -2.012 . . . . 33.369999999999997 108.027 177.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1332 ' ' VAL . . . . . 0.497 HG12 ' HE3' ' A' 1336 ' ' LYS . 77.5 t -54.0 -47.75 64.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 C-N-CA 124.712 1.205 . . . . 35.270000000000003 111.682 175.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1333 ' ' ASN . . . . . 0.424 ' HA ' ' HD2' ' A' 1336 ' ' LYS . 82.9 m-20 -61.3 -34.09 74.65 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 115.343 1.608 . . . . 37.659999999999997 115.343 -177.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1334 ' ' LEU . . . . . 0.639 HD22 ' SD ' ' A' 1115 ' ' MET . 44.2 tp -72.09 -47.3 52.39 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 106.35 -1.722 . . . . 40.270000000000003 106.35 173.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1335 ' ' LEU . . . . . 0.615 ' HA ' ' HB2' ' A' 1338 ' ' LEU . 20.2 mt -64.94 -21.05 66.76 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 115.512 1.671 . . . . 42.5 115.512 -176.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1336 ' ' LYS . . . . . 0.497 ' HE3' HG12 ' A' 1332 ' ' VAL . 94.4 mttt -56.33 -42.93 78.46 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 119.617 -1.927 . . . . 47.810000000000002 112.145 164.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1337 ' ' LEU . . . . . 0.636 HD13 HD11 ' A' 1355 ' ' ILE . 96.0 mt -79.01 -33.69 44.68 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.044 -0.98 . . . . 49.270000000000003 111.318 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1338 ' ' LEU . . . . . 0.615 ' HB2' ' HA ' ' A' 1335 ' ' LEU . 8.3 mp -65.86 -37.52 86.39 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 114.075 1.139 . . . . 50.539999999999999 114.075 174.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1339 ' ' CYS . . . . . . . . . . . . . 27.0 m -116.73 87.19 2.64 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 124.301 2.001 . . . . 53.670000000000002 112.538 169.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1340 ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' 1337 ' ' LEU . 96.7 mttt -76.46 -52.8 9.13 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 112.2 -2.273 . . . . 63.380000000000003 108.954 -176.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -74.61 -44.87 48.56 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-O 122.707 1.241 . . . . 70.950000000000003 110.837 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1342 ' ' LYS . . . . . 0.478 ' HE3' ' HA ' ' A' 1029 ' ' LEU . 2.8 mtpt 61.41 90.44 0.07 Allowed 'General case' 0 C--O 1.214 -0.766 0 C-N-CA 126.122 1.769 . . . . 65.25 113.336 -173.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1343 ' ' ASP . . . . . 0.4 ' HB3' ' N ' ' A' 1342 ' ' LYS . 24.8 t70 70.27 160.75 0.21 Allowed 'General case' 0 C--O 1.247 0.928 2 O-C-N 111.146 -7.221 . . . . 64.530000000000001 115.526 -6.082 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 1344 ' ' GLY . . . . . . . . . . . . . . . -140.61 2.18 2.18 Favored Glycine 0 N--CA 1.433 -1.501 0 CA-C-O 122.267 0.926 . . . . 59.719999999999999 112.013 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 10.2 t30 -80.03 85.59 5.61 Favored 'General case' 0 C--O 1.247 0.933 0 O-C-N 119.218 -2.342 . . . . 64.090000000000003 106.88 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1346 ' ' ILE . . . . . 0.441 ' H ' HG13 ' A' 1346 ' ' ILE . 1.2 pp -54.26 117.18 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 109.877 -3.329 . . . . 58.82 111.176 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1347 ' ' THR . . . . . . . . . . . . . 4.0 m -78.47 96.04 5.29 Favored 'General case' 0 C--N 1.348 0.52 0 N-CA-C 103.779 -2.674 . . . . 54.960000000000001 103.779 -177.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1348 ' ' VAL . . . . . 0.652 HG21 HG21 ' A' 1111 ' ' THR . 3.5 t -75.96 85.27 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 N-CA-C 104.511 -2.403 . . . . 55.640000000000001 104.511 170.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 33.4 t70 -73.39 150.6 41.63 Favored 'General case' 0 C--O 1.254 1.296 0 CA-C-N 112.065 -2.334 . . . . 61.450000000000003 112.805 -169.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1350 ' ' PHE . . . . . 0.434 ' O ' ' HB2' ' A' 1356 ' ' ARG . 49.8 m-85 -111.79 -30.16 7.41 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 113.12 -1.855 . . . . 58.630000000000003 108.527 171.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -69.58 -23.47 63.55 Favored 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 120.381 -1.449 . . . . 62.060000000000002 114.21 -159.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 10.1 t70 -91.53 136.66 32.96 Favored 'General case' 0 C--O 1.253 1.254 0 N-CA-C 106.429 -1.693 . . . . 54.07 106.429 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 4.6 m -50.42 -41.47 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 123.671 0.788 . . . . 50.68 112.151 177.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1354 ' ' VAL . . . . . 0.525 ' O ' HG23 ' A' 1358 ' ' VAL . 15.2 m -71.83 -41.74 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 C-N-CA 117.137 -1.825 . . . . 47.68 109.143 -175.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1355 ' ' ILE . . . . . 0.636 HD11 HD13 ' A' 1337 ' ' LEU . 26.6 mt -74.13 -29.05 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 120.167 -0.613 . . . . 48.490000000000002 111.697 -176.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1356 ' ' ARG . . . . . 0.471 ' HA ' ' HD2' ' A' 1356 ' ' ARG . 32.6 tpt85 -60.96 -24.75 66.32 Favored 'General case' 0 C--O 1.248 0.983 0 O-C-N 120.047 -1.658 . . . . 48.270000000000003 112.352 170.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1357 ' ' GLY . . . . . 0.409 ' HA3' ' HD3' ' A' 1119 ' ' PRO . . . -82.97 -32.58 26.05 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-O 123.839 1.8 . . . . 43.530000000000001 110.945 175.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1358 ' ' VAL . . . . . 0.676 HG22 HG22 ' A' 1118 ' ' VAL . 21.7 t -76.1 -46.04 34.87 Favored 'Isoleucine or valine' 0 C--O 1.256 1.433 0 O-C-N 121.636 -0.92 . . . . 45.119999999999997 108.701 -176.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1359 ' ' THR . . . . . . . . . . . . . 22.1 m -64.82 84.83 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 123.788 1.756 . . . . 42.939999999999998 110.474 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1360 ' ' VAL . . . . . 0.404 HG11 ' HG2' ' A' 1095 ' ' PRO . 27.2 m -92.22 -34.95 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 114.828 -1.078 . . . . 43.259999999999998 111.883 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1361 ' ' ILE . . . . . 0.417 ' HB ' ' HB ' ' A' 1112 ' ' VAL . 79.6 mt -130.86 109.54 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 106.308 -1.738 . . . . 45.659999999999997 106.308 171.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1362 ' ' ARG . . . . . 0.549 ' HA ' HG23 ' A' 1111 ' ' THR . 61.0 ttt180 -94.82 121.58 36.57 Favored 'General case' 0 C--O 1.207 -1.134 0 O-C-N 118.258 -2.776 . . . . 61.340000000000003 107.826 169.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 45.25 61.15 2.68 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.184 1.179 . . . . 49.759999999999998 114.184 166.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1364 ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' 1109 ' ' ASN . . . 88.3 -47.52 3.5 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 114.016 -1.447 . . . . 50.0 112.042 -178.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -77.83 130.8 37.12 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 118.12 0.96 . . . . 56.920000000000002 109.293 -173.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1366 ' ' ILE . . . . . . . . . . . . . 31.2 mt -81.34 93.88 2.4 Favored 'Isoleucine or valine' 0 C--O 1.249 1.053 0 N-CA-C 105.02 -2.215 . . . . 52.780000000000001 105.02 177.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1367 ' ' THR . . . . . . . . . . . . . 26.0 p -72.12 -9.91 59.07 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 112.832 -1.985 . . . . 49.439999999999998 113.836 176.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 1.4 t90 -65.28 143.96 98.89 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 106.615 -1.624 . . . . 52.380000000000003 106.615 164.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -67.93 167.7 61.82 Favored 'Cis proline' 0 C--O 1.244 0.82 0 CA-C-N 124.811 2.754 . . . . 46.939999999999998 118.616 2.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -111.3 121.71 39.63 Favored Pre-proline 0 N--CA 1.437 -1.086 0 N-CA-C 106.076 -1.824 . . . . 45.909999999999997 106.076 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1371 ' ' PRO . . . . . 0.441 ' HD2' ' HG3' ' A' 1356 ' ' ARG . 17.5 Cg_exo -51.05 139.52 42.02 Favored 'Trans proline' 0 C--O 1.247 0.959 0 C-N-CA 123.67 2.913 . . . . 46.390000000000001 110.379 174.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -57.44 -31.09 90.33 Favored 'Trans proline' 0 N--CA 1.44 -1.621 0 C-N-CA 124.761 3.641 . . . . 46.719999999999999 112.719 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.231 -4.556 0 O-C-N 119.731 -1.856 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.441 -0.893 0 CA-C-O 117.6 -1.191 . . . . 63.439999999999998 110.644 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -79.68 55.6 2.05 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 123.652 2.933 . . . . 51.740000000000002 111.034 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1000 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.84 125.34 28.61 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 124.488 1.115 . . . . 54.07 111.407 -172.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 65.76 17.77 65.37 Favored Glycine 0 CA--C 1.531 1.079 0 O-C-N 121.688 -0.633 . . . . 39.219999999999999 112.7 -169.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1002 ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' B' 1066 ' ' SER . 13.7 ttp180 -90.19 118.66 29.88 Favored 'General case' 0 C--O 1.211 -0.939 0 CA-C-N 120.327 2.063 . . . . 38.119999999999997 111.381 177.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1003 ' ' ILE . . . . . 0.52 HD13 HD11 ' B' 1070 ' ' LEU . 21.8 mt -75.63 150.04 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 112.25 -2.25 . . . . 29.699999999999999 110.36 169.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -123.36 118.39 3.51 Favored Glycine 0 C--O 1.241 0.582 0 N-CA-C 110.472 -1.051 . . . . 27.5 110.472 165.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1005 ' ' ILE . . . . . 0.525 HG23 ' HB3' ' B' 1017 ' ' ALA . 23.3 mm -97.55 116.81 65.86 Favored Pre-proline 0 CA--C 1.558 1.278 0 N-CA-C 105.915 -1.883 . . . . 24.829999999999998 105.915 173.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -86.81 162.7 9.1 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.709 2.94 . . . . 27.190000000000001 112.446 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1007 ' ' ARG . . . . . 0.53 ' HG3' ' HB3' ' B' 1036 ' ' GLU . 19.7 mtp180 -77.59 101.3 6.48 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 102.028 -3.323 . . . . 41.460000000000001 102.028 163.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1008 ' ' GLU . . . . . 0.611 ' HG3' ' HB ' ' B' 1072 ' ' VAL . 3.2 mm-40 -58.71 140.62 54.5 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-O 122.369 1.081 . . . . 26.93 113.663 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 43.0 mmm-85 -86.89 -25.46 24.43 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.226 -1.352 . . . . 34.479999999999997 109.787 -162.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1010 ' ' LEU . . . . . 0.446 ' HB3' ' HB2' ' B' 1013 ' ' GLU . 4.8 tp -59.42 155.64 14.52 Favored 'General case' 0 C--O 1.25 1.093 0 N-CA-C 115.175 1.546 . . . . 44.219999999999999 115.175 -157.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1011 ' ' THR . . . . . . . . . . . . . 28.7 m -61.17 120.06 9.6 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.885 -0.598 . . . . 40.740000000000002 111.155 174.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 67.37 41.53 2.42 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 123.523 1.63 . . . . 44.439999999999998 112.151 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1013 ' ' GLU . . . . . 0.446 ' HB2' ' HB3' ' B' 1010 ' ' LEU . 8.5 tp10 -102.16 128.4 48.68 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.596 -1.184 . . . . 29.870000000000001 111.687 -175.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1014 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.01 -11.35 7.09 Favored 'General case' 0 C--O 1.247 0.934 0 O-C-N 125.456 1.723 . . . . 25.260000000000002 110.286 176.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -76.97 98.32 4.9 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 120.174 -1.579 . . . . 29.539999999999999 112.633 -175.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1016 ' ' VAL . . . . . 0.989 ' HB ' ' HB2' ' B' 1043 ' ' ALA . 44.0 t -96.56 141.95 14.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 105.02 -2.215 . . . . 23.550000000000001 105.02 168.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1017 ' ' ALA . . . . . 0.525 ' HB3' HG23 ' B' 1005 ' ' ILE . . . -62.42 -39.32 92.93 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 118.307 2.706 . . . . 23.59 118.307 -155.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1018 ' ' ALA . . . . . . . . . . . . . . . -128.12 149.95 50.19 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 119.255 -2.153 . . . . 24.93 111.76 -168.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1019 ' ' THR . . . . . 0.409 ' O ' HG23 ' B' 1023 ' ' VAL . 13.2 p -84.9 166.16 33.33 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-O 117.361 -1.304 . . . . 28.09 111.101 165.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1020 ' ' PRO . . . . . 0.471 ' HB3' ' HB2' ' B' 1053 ' ' ALA . 41.0 Cg_exo -55.02 -39.75 89.35 Favored 'Trans proline' 0 CA--C 1.549 1.241 0 C-N-CA 123.163 2.576 . . . . 28.789999999999999 112.838 165.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 70.7 tttt -57.49 -49.1 77.38 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 120.17 -1.581 . . . . 47.280000000000001 111.144 175.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1022 ' ' THR . . . . . . . . . . . . . 11.8 p -73.64 -27.33 61.2 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 117.068 -1.444 . . . . 30.120000000000001 110.275 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1023 ' ' VAL . . . . . 0.438 HG11 ' HB2' ' B' 1055 ' ' ALA . 46.0 t -53.2 -50.32 47.1 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 CA-C-N 120.624 1.556 . . . . 32.240000000000002 108.638 165.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1024 ' ' GLU . . . . . 0.462 ' HA ' HD12 ' B' 1027 ' ' LEU . 48.6 mt-10 -63.4 -35.61 80.99 Favored 'General case' 0 CA--C 1.511 -0.553 0 O-C-N 120.42 -1.425 . . . . 49.619999999999997 113.038 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -63.74 -43.23 97.08 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.438 -0.789 . . . . 44.68 109.849 172.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1026 ' ' LEU . . . . . 0.584 ' HG ' HG22 ' B' 1332 ' ' VAL . 19.2 mt -63.79 -35.41 80.49 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 115.651 1.722 . . . . 35.710000000000001 115.651 176.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1027 ' ' LEU . . . . . 0.462 HD12 ' HA ' ' B' 1024 ' ' GLU . 68.1 mt -62.4 -45.2 94.19 Favored 'General case' 0 C--O 1.237 0.445 0 O-C-N 124.254 0.971 . . . . 42.18 109.937 170.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 62.9 mttm -61.12 -30.06 70.15 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.205 1.187 . . . . 48.340000000000003 114.205 172.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1029 ' ' LEU . . . . . 0.446 HD12 HD23 ' B' 1026 ' ' LEU . 85.6 mt -69.27 -30.98 69.21 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-O 122.978 1.37 . . . . 38.689999999999998 112.832 165.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 113.34 31.6 2.36 Favored Glycine 0 N--CA 1.465 0.576 0 O-C-N 118.518 -2.614 . . . . 32.280000000000001 108.749 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -126.64 112.7 15.78 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 120.551 -1.558 . . . . 35.939999999999998 109.158 -177.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1032 ' ' THR . . . . . . . . . . . . . 15.0 m -71.5 137.55 48.25 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 106.942 -1.503 . . . . 33.369999999999997 106.942 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1033 ' ' VAL . . . . . 0.428 ' HB ' HG13 ' B' 1023 ' ' VAL . 61.0 t -106.17 119.47 55.6 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 CA-C-N 120.272 1.396 . . . . 29.98 112.774 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -96.07 140.31 30.98 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 106.802 -1.555 . . . . 28.18 106.802 169.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1035 ' ' VAL . . . . . 0.59 ' HB ' HD13 ' B' 1057 ' ' ILE . 39.8 t -133.36 140.56 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 119.02 -2.3 . . . . 25.82 105.923 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1036 ' ' GLU . . . . . 0.53 ' HB3' ' HG3' ' B' 1007 ' ' ARG . 10.5 mt-10 -65.63 142.51 58.03 Favored 'General case' 0 C--O 1.247 0.971 0 O-C-N 121.004 -1.06 . . . . 32.439999999999998 112.956 175.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1037 ' ' SER . . . . . 0.411 ' O ' ' HD2' ' B' 1007 ' ' ARG . 24.0 m -59.15 124.35 19.68 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 121.587 -0.695 . . . . 29.539999999999999 111.268 170.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 93.65 -18.08 57.24 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.04 -0.824 . . . . 27.760000000000002 111.04 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1039 ' ' ALA . . . . . . . . . . . . . . . -66.48 -40.4 89.3 Favored 'General case' 0 C--O 1.243 0.759 0 O-C-N 120.778 -1.425 . . . . 26.02 111.495 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -56.09 -51.36 56.22 Favored Glycine 0 CA--C 1.5 -0.891 0 N-CA-C 110.077 -1.209 . . . . 26.469999999999999 110.077 171.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -58.42 -29.49 66.15 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 120.661 -1.494 . . . . 50.979999999999997 113.033 173.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 65.0 mt -70.55 -48.27 56.26 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 123.045 2.657 . . . . 29.300000000000001 110.631 176.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1043 ' ' ALA . . . . . 0.989 ' HB2' ' HB ' ' B' 1016 ' ' VAL . . . -63.68 -17.96 63.49 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 114.928 -1.033 . . . . 26.739999999999998 111.834 174.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1044 ' ' SER . . . . . . . . . . . . . 29.0 m 69.11 47.47 0.74 Allowed 'General case' 0 C--N 1.352 0.694 0 CA-C-O 127.408 3.48 . . . . 31.260000000000002 109.813 175.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1045 ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -146.9 105.25 3.78 Favored 'General case' 0 N--CA 1.442 -0.866 1 N-CA-C 97.413 -5.032 . . . . 33.259999999999998 97.413 171.464 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 26.7 t0 -57.46 146.86 28.19 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 123.614 1.673 . . . . 46.740000000000002 115.465 -164.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -49.4 -43.17 44.12 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 110.803 -2.908 . . . . 34.439999999999998 110.091 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1048 ' ' LYS . . . . . 0.405 ' O ' ' HB ' ' B' 1051 ' ' VAL . 1.1 mptm? -66.14 -28.52 68.86 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.228 -0.92 . . . . 48.670000000000002 113.218 177.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -66.4 -32.29 73.58 Favored 'General case' 0 C--O 1.246 0.889 0 O-C-N 120.618 -1.301 . . . . 35.259999999999998 111.272 167.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1050 ' ' PHE . . . . . 0.631 ' HB2' HD11 ' B' 1057 ' ' ILE . 77.6 m-85 -70.98 -33.46 70.45 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 119.334 0.97 . . . . 32.170000000000002 109.005 170.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1051 ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' B' 1048 ' ' LYS . 76.7 t -58.98 -40.19 79.98 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 O-C-N 119.706 -1.871 . . . . 38.369999999999997 112.726 170.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -61.16 -38.94 88.26 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-O 118.427 -0.797 . . . . 45.770000000000003 112.19 171.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1053 ' ' ALA . . . . . 0.471 ' HB2' ' HB3' ' B' 1020 ' ' PRO . . . -68.15 -22.92 64.83 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 124.281 0.988 . . . . 37.829999999999998 113.064 172.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 76.34 59.04 3.44 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 109.782 -1.327 . . . . 35.82 109.782 -175.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1055 ' ' ALA . . . . . 0.438 ' HB2' HG11 ' B' 1023 ' ' VAL . . . -109.99 140.63 43.78 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 122.186 0.993 . . . . 33.770000000000003 108.49 166.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -78.34 96.51 5.33 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 118.207 -2.808 . . . . 51.020000000000003 108.887 -175.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1057 ' ' ILE . . . . . 0.631 HD11 ' HB2' ' B' 1050 ' ' PHE . 34.4 mm -72.97 110.13 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 106.712 -1.588 . . . . 38.469999999999999 106.712 176.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1058 ' ' VAL . . . . . 0.677 ' HB ' ' HB2' ' B' 1062 ' ' SER . 2.9 m -127.1 143.78 39.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 112.195 -2.275 . . . . 39.399999999999999 110.988 -174.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -77.44 124.16 27.52 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 122.181 0.991 . . . . 57.07 110.454 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . 50.3 -107.78 0.4 Allowed Glycine 0 CA--C 1.497 -1.074 0 N-CA-C 117.423 1.729 . . . . 44.829999999999998 117.423 164.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -63.73 -27.85 69.48 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.911 0.862 . . . . 46.270000000000003 111.934 -164.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1062 ' ' SER . . . . . 0.677 ' HB2' ' HB ' ' B' 1058 ' ' VAL . 3.1 m -55.48 -39.96 71.07 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 113.848 -1.524 . . . . 43.469999999999999 111.822 175.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.71 -27.13 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 O-C-N 119.992 -1.692 . . . . 36.979999999999997 113.645 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 96.5 m95 -71.42 -27.49 63.33 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 124.042 1.877 . . . . 37.899999999999999 111.993 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -79.12 80.24 5.48 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 118.744 -2.473 . . . . 46.189999999999998 108.869 176.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1066 ' ' SER . . . . . 0.45 ' HB3' ' O ' ' B' 1002 ' ' ARG . 72.9 m -156.39 165.05 37.46 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.093 -0.958 . . . . 37.060000000000002 109.786 -172.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1067 ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' 1068 ' ' ILE . 0.5 OUTLIER -81.31 -39.15 25.62 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 114.504 -1.225 . . . . 43.950000000000003 109.236 -178.683 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B 1068 ' ' ILE . . . . . 0.409 HD12 ' HB3' ' B' 1067 ' ' GLU . 4.1 mp -123.93 140.45 47.34 Favored 'Isoleucine or valine' 0 C--O 1.251 1.142 0 N-CA-C 104.034 -2.58 . . . . 33.5 104.034 -179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 43.8 mm -112.31 135.65 51.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 N-CA-C 103.599 -2.741 . . . . 30.57 103.599 165.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1070 ' ' LEU . . . . . 0.552 HD13 HD13 ' B' 1331 ' ' LEU . 84.9 mt -114.27 75.67 0.94 Allowed 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 121.391 1.905 . . . . 27.66 105.913 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1071 ' ' LYS . . . . . . . . . . . . . 4.6 mttm -73.34 152.93 40.72 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 124.371 1.068 . . . . 28.399999999999999 111.656 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1072 ' ' VAL . . . . . 0.611 ' HB ' ' HG3' ' B' 1008 ' ' GLU . 15.6 t -94.01 -31.93 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-O 118.967 -0.539 . . . . 23.18 110.729 176.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -111.85 -167.84 1.23 Allowed 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 124.242 1.017 . . . . 25.469999999999999 111.303 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -71.38 162.36 73.21 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 119.166 0.894 . . . . 27.899999999999999 111.902 165.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1075 ' ' PRO . . . . . 0.412 ' O ' HD11 ' B' 1101 ' ' LEU . 38.2 Cg_endo -76.8 143.77 23.89 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.605 2.203 . . . . 31.620000000000001 113.727 164.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 31.9 mt -88.86 178.14 6.51 Favored 'General case' 0 CA--C 1.555 1.166 0 O-C-N 120.916 -1.115 . . . . 40.490000000000002 109.305 170.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 28.3 t70 -62.16 -31.68 72.2 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 122.418 2.372 . . . . 51.590000000000003 114.691 -172.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -68.7 -39.58 80.43 Favored 'General case' 0 N--CA 1.439 -0.991 0 O-C-N 120.844 -1.16 . . . . 42.359999999999999 112.112 175.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1079 ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -69.58 -35.95 75.83 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.985 -1.007 . . . . 34.530000000000001 109.049 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1080 ' ' ILE . . . . . 0.538 ' HA ' HD12 ' B' 1083 ' ' LEU . 86.5 mt -59.49 -45.28 93.92 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 C-N-CA 124.447 1.099 . . . . 33.25 110.78 171.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -61.23 -39.6 90.9 Favored 'General case' 0 C--O 1.251 1.166 0 N-CA-C 113.095 0.776 . . . . 36.469999999999999 113.095 173.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1082 ' ' LEU . . . . . . . . . . . . . 51.7 mt -67.25 -34.04 76.6 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 115.365 1.616 . . . . 37.759999999999998 115.365 173.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1083 ' ' LEU . . . . . 0.85 HD21 HD13 ' B' 1089 ' ' LEU . 16.6 mt -56.74 112.01 1.18 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 123.467 1.603 . . . . 37.43 111.045 175.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -69.67 136.07 88.07 Favored Pre-proline 0 C--O 1.219 -0.509 0 CA-C-N 111.754 -2.476 . . . . 37.700000000000003 113.267 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -51.69 109.92 0.37 Allowed 'Trans proline' 0 C--O 1.246 0.896 0 C-N-CA 124.383 3.389 . . . . 35.509999999999998 116.982 171.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 101.72 3.83 52.36 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 113.726 -1.579 . . . . 33.869999999999997 115.253 -172.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1087 ' ' THR . . . . . . . . . . . . . 52.0 m -74.23 127.72 33.69 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-N 119.523 1.661 . . . . 32.5 109.266 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1088 ' ' THR . . . . . 0.549 ' HA ' ' HB ' ' B' 1111 ' ' THR . 1.2 m -62.87 101.23 0.25 Allowed 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 105.312 -2.107 . . . . 30.219999999999999 105.312 170.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1089 ' ' LEU . . . . . 0.85 HD13 HD21 ' B' 1083 ' ' LEU . 43.3 tp -96.85 109.69 22.34 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 104.719 -2.326 . . . . 27.239999999999998 104.719 -176.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1090 ' ' VAL . . . . . 0.533 HG22 ' HB2' ' B' 1113 ' ' MET . 70.3 t -94.05 123.51 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 105.835 -1.913 . . . . 25.390000000000001 105.835 169.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1091 ' ' SER . . . . . . . . . . . . . 58.0 m -156.15 164.62 38.16 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 123.613 1.673 . . . . 28.809999999999999 110.544 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1092 ' ' PHE . . . . . . . . . . . . . 10.8 t80 -93.12 95.85 9.68 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 101.557 -3.498 . . . . 30.780000000000001 101.557 174.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 37.3 mm -83.43 -52.77 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-O 117.349 -1.31 . . . . 30.280000000000001 113.036 -172.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1094 ' ' TRP . . . . . 0.508 ' HB3' ' HB2' ' B' 1097 ' ' GLN . 20.9 m95 52.96 75.9 0.59 Allowed Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 118.631 0.65 . . . . 34.07 109.657 -154.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -57.15 -49.51 13.92 Favored 'Trans proline' 0 CA--C 1.511 -0.638 1 C-N-CA 125.707 4.271 . . . . 38.659999999999997 113.502 -171.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -71.52 -14.38 62.09 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 118.643 0.656 . . . . 41.32 111.302 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1097 ' ' GLN . . . . . 0.508 ' HB2' ' HB3' ' B' 1094 ' ' TRP . 15.3 mp0 -103.86 -4.89 22.92 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.794 1.238 . . . . 51.659999999999997 109.59 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1098 ' ' ASN . . . . . 0.445 ' N ' ' HD3' ' B' 1099 ' ' PRO . 57.8 m-80 -137.53 62.65 37.34 Favored Pre-proline 0 C--O 1.24 0.573 0 O-C-N 120.456 -1.402 . . . . 40.32 109.087 167.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1099 ' ' PRO . . . . . 0.445 ' HD3' ' N ' ' B' 1098 ' ' ASN . 52.2 Cg_exo -63.07 -45.94 11.46 Favored 'Trans proline' 0 CA--C 1.536 0.604 1 C-N-CA 128.191 5.927 . . . . 41.560000000000002 113.92 -171.881 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B 1100 ' ' GLU . . . . . 0.495 ' H ' ' CD ' ' B' 1100 ' ' GLU . 0.6 OUTLIER -66.14 -38.86 89.17 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 123.945 0.898 . . . . 54.109999999999999 108.84 176.663 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B 1101 ' ' LEU . . . . . 0.44 ' O ' ' HG ' ' B' 1105 ' ' LEU . 6.3 tt -60.31 -48.76 80.35 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.727 0.775 . . . . 37.880000000000003 109.006 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1102 ' ' MET . . . . . . . . . . . . . 62.1 mmm -53.44 -45.14 69.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.086 -0.961 . . . . 37.539999999999999 112.994 171.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -62.6 -33.1 74.31 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.92 1.082 . . . . 47.009999999999998 113.92 175.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1104 ' ' LYS . . . . . 0.403 ' HB3' HG21 ' B' 1080 ' ' ILE . 82.0 mttt -73.02 -32.07 64.88 Favored 'General case' 0 C--O 1.213 -0.827 0 O-C-N 119.994 -1.691 . . . . 48.68 111.539 173.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1105 ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' B' 1101 ' ' LEU . 66.6 mt -66.11 -34.51 78.23 Favored 'General case' 0 C--O 1.256 1.447 0 O-C-N 121.609 -0.682 . . . . 32.210000000000001 110.244 174.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -61.18 -46.89 88.64 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 123.209 0.604 . . . . 33.729999999999997 111.541 168.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -58.22 -47.75 82.53 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 125.783 2.706 . . . . 51.469999999999999 117.016 174.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1108 ' ' ARG . . . . . . . . . . . . . 31.6 mmm180 -69.17 -10.54 58.2 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 112.728 -2.033 . . . . 43.899999999999999 111.218 171.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1109 ' ' ASN . . . . . 0.409 ' HA ' ' CA ' ' B' 1364 ' ' GLY . 0.6 OUTLIER 59.19 42.82 18.02 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 123.504 1.621 . . . . 44.82 111.586 170.84 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B 1110 ' ' VAL . . . . . 0.432 HG11 ' HB3' ' B' 1083 ' ' LEU . 12.4 m -93.32 149.89 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 115.032 -0.986 . . . . 30.52 109.124 -177.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1111 ' ' THR . . . . . 0.549 ' HB ' ' HA ' ' B' 1088 ' ' THR . 88.5 m -86.33 92.39 8.79 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.963 -0.754 . . . . 27.120000000000001 108.963 177.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1112 ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' B' 1089 ' ' LEU . 4.1 t -94.99 124.88 47.68 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 120.297 1.408 . . . . 26.399999999999999 110.781 -168.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1113 ' ' MET . . . . . 0.533 ' HB2' HG22 ' B' 1090 ' ' VAL . 1.3 mpt? -102.33 115.7 31.11 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 124.388 2.042 . . . . 42.920000000000002 107.932 163.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -93.75 106.93 18.87 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 120.55 -1.344 . . . . 24.149999999999999 110.216 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1115 ' ' MET . . . . . 0.517 ' HB3' ' HB2' ' B' 1129 ' ' ALA . 14.2 mmm -63.94 -11.14 25.64 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 117.303 2.334 . . . . 29.949999999999999 117.303 -176.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1116 ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -84.81 -41.86 15.69 Favored 'General case' 0 C--O 1.218 -0.58 0 C-N-CA 123.721 0.809 . . . . 34.530000000000001 109.323 169.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1117 ' ' SER . . . . . . . . . . . . . 25.0 m -91.45 37.49 0.95 Allowed 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 120.066 -1.646 . . . . 33.490000000000002 109.666 -173.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1118 ' ' VAL . . . . . 0.749 HG12 ' HB1' ' B' 1124 ' ' ALA . 1.8 t -78.38 147.67 72.59 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 103.988 -2.597 . . . . 34.020000000000003 103.988 166.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 1.6 Cg_exo -58.13 165.56 6.87 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.971 2.447 . . . . 38.280000000000001 114.192 169.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1120 ' ' ARG . . . . . 0.718 ' HB2' HG21 ' B' 1375 ' ' VAL . 5.0 mmp_? -92.27 -0.07 57.42 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 120.924 -1.11 . . . . 55.049999999999997 112.186 -178.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1121 ' ' ILE . . . . . 0.722 HG22 ' HB1' ' C' ' 131' ' ' ALA . 30.3 pt -68.76 141.82 16.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 119.964 1.256 . . . . 42.090000000000003 108.65 175.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1122 ' ' SER . . . . . 0.68 ' HB2' ' HA ' ' C' ' 133' ' ' MET . 5.0 m -58.73 -28.45 65.86 Favored 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 116.982 2.216 . . . . 38.020000000000003 116.982 -158.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1123 ' ' ARG . . . . . 0.621 ' HG3' HG21 ' B' 1354 ' ' VAL . 19.4 ptt-85 -66.45 -39.59 88.94 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 121.359 1.891 . . . . 34.289999999999999 107.849 174.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1124 ' ' ALA . . . . . 0.749 ' HB1' HG12 ' B' 1118 ' ' VAL . . . -68.03 -38.44 82.53 Favored 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 106.764 -1.569 . . . . 32.350000000000001 106.764 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1125 ' ' GLN . . . . . 0.622 ' NE2' ' HB3' ' B' 1131 ' ' SER . 17.9 mm100 -51.15 -38.97 55.15 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 118.197 2.666 . . . . 47.170000000000002 118.197 170.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1126 ' ' SER . . . . . . . . . . . . . 3.9 p -69.18 -19.68 63.99 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 122.107 0.956 . . . . 31.710000000000001 113.549 175.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1127 ' ' LEU . . . . . 0.739 ' HG ' ' HA ' ' B' 1334 ' ' LEU . 5.2 mp -90.26 -36.06 14.94 Favored 'General case' 0 C--N 1.347 0.48 0 N-CA-C 107.911 -1.144 . . . . 37.0 107.911 173.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1128 ' ' ASP . . . . . 0.506 ' HB3' ' HA ' ' B' 1125 ' ' GLN . 4.6 t70 -62.88 130.08 43.27 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 125.958 1.703 . . . . 40.399999999999999 115.107 -164.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1129 ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' B' 1115 ' ' MET . . . -72.14 -36.93 69.49 Favored 'General case' 0 C--O 1.255 1.393 0 N-CA-C 106.713 -1.588 . . . . 26.559999999999999 106.713 -176.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 56.9 mt -59.83 -24.63 64.35 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 121.191 1.814 . . . . 30.890000000000001 112.494 -172.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1131 ' ' SER . . . . . 0.622 ' HB3' ' NE2' ' B' 1125 ' ' GLN . 93.9 p -69.23 -60.48 2.32 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 106.035 -1.839 . . . . 29.84 106.035 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1132 ' ' SER . . . . . 0.557 ' O ' HG12 ' B' 1136 ' ' ILE . 16.0 m -62.64 -34.86 77.91 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 115.438 1.644 . . . . 31.91 115.438 -178.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1133 ' ' MET . . . . . . . . . . . . . 35.3 mmt -72.68 -36.53 67.91 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.872 0.844 . . . . 25.899999999999999 111.596 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1134 ' ' ALA . . . . . 0.851 ' HB1' ' HB2' ' B' 1176 ' ' ALA . . . -60.84 -39.44 89.08 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 115.259 -0.882 . . . . 26.620000000000001 109.959 167.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -60.37 -50.09 74.98 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 117.782 -1.104 . . . . 36.969999999999999 113.738 173.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1136 ' ' ILE . . . . . 0.557 HG12 ' O ' ' B' 1132 ' ' SER . 16.4 mm -53.48 -52.02 36.49 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 O-C-N 124.686 1.241 . . . . 32.109999999999999 108.416 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1137 ' ' ALA . . . . . 0.45 ' HB2' ' HG3' ' B' 1316 ' ' PRO . . . -61.87 -35.88 79.6 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 114.132 1.16 . . . . 24.140000000000001 114.132 176.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -71.53 -41.55 57.47 Favored Glycine 0 CA--C 1.503 -0.713 0 N-CA-C 109.262 -1.535 . . . . 25.129999999999999 109.262 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1139 ' ' TYR . . . . . 0.698 ' HD2' HD21 ' B' 1319 ' ' LEU . 17.8 t80 -61.74 -55.6 28.54 Favored 'General case' 0 C--O 1.211 -0.958 0 O-C-N 120.928 -1.337 . . . . 32.729999999999997 109.689 169.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1140 ' ' ARG . . . . . 0.464 ' HA ' ' HB ' ' B' 1143 ' ' VAL . 18.3 tpt180 -59.36 -25.18 64.01 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 119.15 0.886 . . . . 26.359999999999999 111.75 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1141 ' ' ALA . . . . . 0.663 ' HA ' HG11 ' B' 1282 ' ' VAL . . . -62.91 -55.65 24.2 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.466 1.106 . . . . 24.120000000000001 109.971 170.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 21.4 mm -57.94 -40.7 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 107.839 -1.171 . . . . 23.370000000000001 107.839 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1143 ' ' VAL . . . . . 0.464 ' HB ' ' HA ' ' B' 1140 ' ' ARG . 19.4 t -59.29 -66.49 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.662 0 CA-C-O 117.8 -1.095 . . . . 24.960000000000001 112.356 177.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -61.1 -33.2 72.97 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.518 1.127 . . . . 32.07 112.09 -175.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1145 ' ' ALA . . . . . 0.659 ' HA ' HG11 ' B' 1280 ' ' VAL . . . -60.54 -59.37 5.5 Favored 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 106.386 -1.709 . . . . 24.870000000000001 106.386 174.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1146 ' ' ALA . . . . . 0.463 ' HB2' ' HE1' ' B' 1153 ' ' PHE . . . -58.27 -33.64 69.62 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 120.577 1.535 . . . . 24.670000000000002 111.727 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1147 ' ' HIS . . . . . 0.413 ' O ' ' NH2' ' A' 1140 ' ' ARG . 73.8 t60 -59.72 -44.63 93.65 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.052 1.341 . . . . 28.579999999999998 111.282 174.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1148 ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -96.8 -6.81 35.22 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 122.614 1.197 . . . . 36.82 113.933 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1149 ' ' PHE . . . . . 0.525 ' CZ ' ' HB3' ' B' 1250 ' ' ASP . 1.0 OUTLIER -76.26 148.84 37.32 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 113.235 -1.802 . . . . 31.969999999999999 110.263 -176.65 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B 1150 ' ' GLY . . . . . 0.408 ' HA2' ' HD2' ' A' 1320 ' ' PRO . . . -92.73 -19.34 37.72 Favored Glycine 0 N--CA 1.427 -1.964 0 CA-C-N 113.474 -1.694 . . . . 25.489999999999998 115.42 173.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1151 ' ' ARG . . . . . . . . . . . . . 86.5 mtm-85 -121.17 177.22 5.23 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 119.738 1.769 . . . . 59.840000000000003 110.97 -169.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1152 ' ' PHE . . . . . 0.574 ' HB2' HG11 ' B' 1163 ' ' VAL . 15.7 m-30 -84.99 155.04 21.75 Favored 'General case' 0 C--N 1.352 0.691 0 CA-C-N 121.544 1.975 . . . . 34.450000000000003 108.857 175.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1153 ' ' PHE . . . . . 0.463 ' HE1' ' HB2' ' B' 1146 ' ' ALA . 33.0 m-85 -74.93 -46.82 33.22 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.529 -1.214 . . . . 31.170000000000002 109.794 164.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1154 ' ' THR . . . . . . . . . . . . . 22.4 m -71.58 122.64 20.87 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 113.379 -1.737 . . . . 33.890000000000001 109.362 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1155 ' ' GLY . . . . . 0.681 ' HA3' ' HG3' ' B' 1165 ' ' PRO . . . -75.18 103.47 1.59 Allowed Glycine 0 C--O 1.269 2.287 0 N-CA-C 106.837 -2.505 . . . . 38.950000000000003 106.837 172.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1156 ' ' GLN . . . . . 0.685 ' H ' ' HB ' ' B' 1163 ' ' VAL . 49.5 tt0 -112.09 112.39 23.97 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 105.638 -1.986 . . . . 54.229999999999997 105.638 -169.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1157 ' ' ILE . . . . . 0.854 HG23 ' HG2' ' B' 1162 ' ' LYS . 29.6 mm -81.53 96.88 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 102.954 -2.98 . . . . 51.159999999999997 102.954 172.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1158 ' ' THR . . . . . . . . . . . . . 34.9 m -95.13 153.93 17.42 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 112.841 -1.981 . . . . 49.609999999999999 107.382 -163.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -36.95 -51.35 0.91 Allowed 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 116.64 2.089 . . . . 49.049999999999997 116.64 175.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -55.74 -56.15 23.83 Favored 'General case' 0 C--N 1.349 0.577 0 N-CA-C 114.833 1.42 . . . . 47.649999999999999 114.833 169.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . 177.53 -165.79 35.77 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 108.773 -1.731 . . . . 45.609999999999999 108.773 -175.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1162 ' ' LYS . . . . . 0.854 ' HG2' HG23 ' B' 1157 ' ' ILE . 89.3 mttt -95.49 149.46 21.38 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 122.38 1.086 . . . . 57.460000000000001 112.968 -166.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1163 ' ' VAL . . . . . 0.685 ' HB ' ' H ' ' B' 1156 ' ' GLN . 99.1 t -116.69 121.59 32.79 Favored Pre-proline 0 CA--C 1.499 -0.994 0 CA-C-N 113.067 -1.878 . . . . 42.93 106.279 166.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1164 ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' B' 1163 ' ' VAL . 36.5 Cg_endo -68.82 137.55 38.61 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.478 2.118 . . . . 39.289999999999999 109.66 168.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1165 ' ' PRO . . . . . 0.681 ' HG3' ' HA3' ' B' 1155 ' ' GLY . 64.2 Cg_exo -62.93 149.08 92.59 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.548 2.832 . . . . 34.170000000000002 113.193 -177.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -73.47 122.1 21.6 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 124.837 1.336 . . . . 31.690000000000001 109.11 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1167 ' ' LYS . . . . . 0.437 ' HD3' ' HB3' ' B' 1248 ' ' GLU . 80.4 mttt -79.59 104.05 9.92 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 105.63 -1.989 . . . . 44.780000000000001 105.63 171.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 62.0 t -102.02 99.59 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 N-CA-C 106.69 -1.596 . . . . 31.23 106.69 -170.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1169 ' ' MET . . . . . 0.499 ' HA ' ' O ' ' B' 1192 ' ' ARG . 30.2 ttp -82.29 112.2 19.06 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 119.419 -0.913 . . . . 37.090000000000003 109.132 178.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 60.0 t -104.03 107.21 21.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 N-CA-C 105.511 -2.033 . . . . 30.170000000000002 105.511 -177.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1171 ' ' ILE . . . . . . . . . . . . . 70.4 mt -97.49 127.17 50.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 108.222 -1.029 . . . . 33.740000000000002 108.222 -177.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 88.72 67.21 1.27 Allowed Glycine 0 C--N 1.318 -0.44 0 CA-C-O 124.502 2.168 . . . . 32.590000000000003 108.458 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1173 ' ' ALA . . . . . 0.681 ' HA ' ' HA3' ' B' 1177 ' ' GLY . . . -74.42 42.25 0.16 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 117.975 2.583 . . . . 32.420000000000002 117.975 178.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -79.78 -155.26 10.03 Favored Glycine 0 CA--C 1.524 0.601 0 O-C-N 117.573 -3.204 . . . . 31.739999999999998 110.397 164.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 86.7 t -48.58 -50.8 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-N 120.762 2.281 . . . . 31.48 115.289 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1176 ' ' ALA . . . . . 0.851 ' HB2' ' HB1' ' B' 1134 ' ' ALA . . . -49.46 -50.83 39.42 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 123.591 1.663 . . . . 26.120000000000001 113.324 172.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1177 ' ' GLY . . . . . 0.681 ' HA3' ' HA ' ' B' 1173 ' ' ALA . . . -63.73 -49.79 66.16 Favored Glycine 0 C--O 1.211 -1.3 0 CA-C-N 112.748 -2.024 . . . . 25.73 110.765 -178.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1178 ' ' LEU . . . . . 0.421 HD23 HD12 ' B' 1181 ' ' ILE . 46.3 mt -56.59 -33.38 66.14 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 123.94 0.896 . . . . 32.590000000000003 112.718 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -62.34 -57.96 9.42 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.893 -1.049 . . . . 27.719999999999999 110.602 172.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -57.78 -39.78 78.29 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 114.137 1.162 . . . . 26.030000000000001 114.137 177.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1181 ' ' ILE . . . . . 0.72 HG22 ' SD ' ' B' 1207 ' ' MET . 96.4 mt -57.06 -45.84 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 108.413 -0.958 . . . . 28.609999999999999 108.413 172.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -55.25 -54.39 34.46 Favored Glycine 0 N--CA 1.465 0.583 0 N-CA-C 110.4 -1.08 . . . . 25.23 110.4 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -56.93 -61.42 2.45 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.276 1.213 . . . . 24.09 114.276 174.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -67.3 -35.73 80.06 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-O 119.178 -0.439 . . . . 26.68 111.504 -169.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -66.91 -45.32 78.28 Favored 'General case' 0 CA--C 1.502 -0.873 0 O-C-N 120.554 -1.341 . . . . 36.57 110.071 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1186 ' ' SER . . . . . . . . . . . . . 61.3 m -66.04 -32.31 73.71 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 119.923 -0.711 . . . . 28.920000000000002 112.823 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1187 ' ' LEU . . . . . 1.075 ' HA ' ' HB3' ' A' 1186 ' ' SER . 25.8 mt -57.87 -23.68 54.13 Favored 'General case' 0 C--O 1.247 0.941 0 N-CA-C 113.4 0.889 . . . . 29.09 113.4 165.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 89.68 20.91 42.04 Favored Glycine 0 CA--C 1.534 1.247 0 N-CA-C 108.593 -1.803 . . . . 29.260000000000002 108.593 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1189 ' ' ALA . . . . . . . . . . . . . . . -82.29 149.64 27.69 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 118.385 -0.817 . . . . 30.16 109.461 174.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 74.8 mt -80.51 90.93 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 120.094 1.315 . . . . 35.810000000000002 108.32 -176.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1191 ' ' VAL . . . . . 0.43 HG11 HG23 ' B' 1181 ' ' ILE . 67.1 t -77.3 109.24 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 105.421 -2.066 . . . . 31.969999999999999 105.421 -172.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1192 ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' B' 1169 ' ' MET . 47.5 mtt180 -101.21 85.58 2.84 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-O 123.776 1.75 . . . . 48.159999999999997 106.911 172.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1193 ' ' ALA . . . . . 0.787 ' HB3' HG11 ' B' 1204 ' ' VAL . . . -93.62 152.91 18.69 Favored 'General case' 0 C--O 1.259 1.598 0 CA-C-N 112.223 -2.262 . . . . 35.890000000000001 112.227 -171.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 87.7 t80 -144.75 148.72 34.45 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 124.567 2.127 . . . . 41.880000000000003 105.592 -176.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1195 ' ' ASP . . . . . 0.479 ' HB2' ' H ' ' B' 1173 ' ' ALA . 22.4 t0 -159.77 154.04 23.65 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 101.513 -3.514 . . . . 38.280000000000001 101.513 163.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1196 ' ' THR . . . . . . . . . . . . . 1.1 m -73.53 -27.16 61.2 Favored 'General case' 0 C--O 1.247 0.942 0 C-N-CA 119.654 -0.818 . . . . 40.619999999999997 111.469 -176.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1197 ' ' ARG . . . . . . . . . . . . . 22.9 mtm105 -73.41 103.37 0.79 Allowed Pre-proline 0 CA--C 1.565 1.542 0 O-C-N 121.079 -1.013 . . . . 53.090000000000003 108.832 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -56.34 -26.2 60.93 Favored 'Trans proline' 0 C--N 1.347 0.481 1 C-N-CA 125.775 4.316 . . . . 42.560000000000002 119.25 -162.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.91 -12.74 19.53 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 119.726 -1.859 . . . . 56.310000000000002 113.828 -177.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1200 ' ' VAL . . . . . 0.537 ' HA ' ' HG3' ' B' 1203 ' ' GLN . 23.3 m -57.98 -20.88 15.79 Favored 'Isoleucine or valine' 0 C--O 1.25 1.106 0 O-C-N 119.873 -1.767 . . . . 42.909999999999997 112.298 172.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1201 ' ' LYS . . . . . 0.467 ' HA ' ' HB2' ' B' 1211 ' ' PHE . 46.2 tttm -50.55 -55.9 14.1 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 122.901 0.48 . . . . 48.890000000000001 111.712 166.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1202 ' ' GLU . . . . . 0.572 ' HA ' ' HB2' ' B' 1205 ' ' GLN . 18.2 mp0 -70.07 -34.0 72.62 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 120.727 -1.233 . . . . 51.700000000000003 110.488 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1203 ' ' GLN . . . . . 0.589 ' OE1' ' HA ' ' C' ' 74' ' ' ARG . 13.6 mm100 -50.47 -52.09 41.24 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 120.999 -1.063 . . . . 52.57 111.815 176.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1204 ' ' VAL . . . . . 0.787 HG11 ' HB3' ' B' 1193 ' ' ALA . 18.6 m -73.42 -36.95 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 O-C-N 121.247 -0.908 . . . . 33.789999999999999 112.16 175.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1205 ' ' GLN . . . . . 0.572 ' HB2' ' HA ' ' B' 1202 ' ' GLU . 39.3 mt-30 -53.6 -39.63 65.03 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 114.957 1.465 . . . . 36.579999999999998 114.957 174.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1206 ' ' SER . . . . . . . . . . . . . 84.4 p -60.62 -45.84 92.51 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.45 -1.406 . . . . 39.609999999999999 109.096 175.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1207 ' ' MET . . . . . 0.72 ' SD ' HG22 ' B' 1181 ' ' ILE . 5.0 mtp -68.6 -18.14 64.26 Favored 'General case' 0 N--CA 1.44 -0.959 0 O-C-N 119.519 -1.988 . . . . 37.450000000000003 113.632 177.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 77.62 56.6 3.82 Favored Glycine 0 N--CA 1.475 1.238 0 N-CA-C 108.686 -1.766 . . . . 31.870000000000001 108.686 -172.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1209 ' ' ALA . . . . . 0.595 ' HB3' ' HB ' ' B' 1204 ' ' VAL . . . -139.87 159.52 41.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.886 1.274 . . . . 35.399999999999999 111.131 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -90.46 136.21 33.2 Favored 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 120.559 -1.338 . . . . 47.890000000000001 110.038 -165.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1211 ' ' PHE . . . . . 0.467 ' HB2' ' HA ' ' B' 1201 ' ' LYS . 29.1 t80 -86.94 141.7 28.53 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.743 -1.206 . . . . 45.530000000000001 107.743 167.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1212 ' ' LEU . . . . . 0.873 ' HB3' HD21 ' B' 1241 ' ' LEU . 32.2 mt -81.85 102.92 11.15 Favored 'General case' 0 N--CA 1.433 -1.32 0 O-C-N 121.396 -0.815 . . . . 46.329999999999998 111.02 167.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -83.51 124.48 30.78 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 103.864 -2.643 . . . . 60.409999999999997 103.864 -176.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1214 ' ' LEU . . . . . 0.459 ' H ' HD12 ' B' 1214 ' ' LEU . 4.6 mp -68.32 164.52 20.59 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 114.075 -1.42 . . . . 57.380000000000003 110.108 -177.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 28.0 t70 . . . . . 0 N--CA 1.444 -0.752 0 CA-C-O 116.326 -1.797 . . . . 65.069999999999993 107.083 168.932 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B 1230 ' ' MET . . . . . 0.677 ' N ' ' HG ' ' B' 1231 ' ' SER . 3.7 mmt . . . . . 0 N--CA 1.435 -1.217 0 N-CA-C 101.725 -3.435 . . . . 80.319999999999993 101.725 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1231 ' ' SER . . . . . 0.677 ' HG ' ' N ' ' B' 1230 ' ' MET 0.275 19.4 m 112.66 155.47 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 3 CA-C-N 130.408 6.003 . . . . 79.920000000000002 115.221 -9.924 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 28.6 t70 -43.12 140.24 1.55 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 116.203 1.927 . . . . 77.909999999999997 116.203 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 67.46 -54.38 0.48 Allowed 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 115.846 1.795 . . . . 73.879999999999995 115.846 -166.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1234 ' ' PHE . . . . . 0.435 ' HE2' HD22 ' B' 1214 ' ' LEU . 1.5 t80 -61.23 -21.68 64.09 Favored 'General case' 0 C--O 1.254 1.293 0 CA-C-N 120.096 1.316 . . . . 68.980000000000004 112.92 176.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 1.9 pp -42.05 -38.71 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 O-C-N 120.795 -1.191 . . . . 64.530000000000001 113.361 159.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -69.29 -29.26 67.09 Favored 'General case' 0 CA--C 1.501 -0.919 0 O-C-N 120.124 -1.61 . . . . 66.359999999999999 112.89 174.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -62.4 -31.11 71.74 Favored 'General case' 0 N--CA 1.438 -1.061 0 O-C-N 117.575 -3.203 . . . . 56.600000000000001 111.333 171.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1238 ' ' GLU . . . . . 0.475 ' O ' ' HB3' ' B' 1241 ' ' LEU . 39.0 mt-10 -68.97 -61.41 1.81 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.86 0.864 . . . . 56.789999999999999 111.289 170.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1239 ' ' MET . . . . . . . . . . . . . 14.4 mtt -59.01 -44.79 91.75 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 114.842 1.423 . . . . 53.630000000000003 114.842 -177.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -68.53 -35.38 77.37 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 120.497 1.499 . . . . 51.740000000000002 112.828 -176.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1241 ' ' LEU . . . . . 0.873 HD21 ' HB3' ' B' 1212 ' ' LEU . 46.3 tp -54.27 -49.18 70.14 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.983 -1.008 . . . . 44.859999999999999 110.856 166.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 13.0 m-30 -62.68 -38.59 90.99 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 114.096 1.147 . . . . 42.780000000000001 114.096 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -59.3 -41.47 89.08 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 114.685 -1.143 . . . . 40.960000000000001 110.935 170.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -77.55 -8.66 58.15 Favored 'General case' 0 C--O 1.249 1.049 0 O-C-N 120.385 -1.447 . . . . 43.060000000000002 112.361 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1245 ' ' GLN . . . . . 0.433 ' OE1' ' HD3' ' B' 1192 ' ' ARG . 92.6 mm-40 -82.23 -26.4 33.28 Favored 'General case' 0 C--O 1.207 -1.14 0 N-CA-C 114.407 1.262 . . . . 46.450000000000003 114.407 164.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -54.69 -38.18 66.7 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 118.941 2.941 . . . . 41.780000000000001 118.941 -167.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 11.9 mptt -68.97 -30.22 68.61 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 115.011 1.485 . . . . 52.200000000000003 115.011 174.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1248 ' ' GLU . . . . . 0.474 ' CD ' HH12 ' B' 1192 ' ' ARG . 33.5 mt-10 -85.09 -39.91 17.4 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 115.055 1.502 . . . . 53.549999999999997 115.055 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1249 ' ' VAL . . . . . . . . . . . . 0.266 18.4 m -68.94 135.4 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 124.165 1.936 . . . . 34.409999999999997 115.575 -163.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1250 ' ' ASP . . . . . 0.525 ' HB3' ' CZ ' ' B' 1149 ' ' PHE . 2.7 m-20 -97.57 -48.91 5.07 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 111.969 -2.378 . . . . 33.380000000000003 110.387 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1251 ' ' ILE . . . . . 0.631 HD12 ' HB1' ' B' 1145 ' ' ALA . 30.1 mm -128.23 126.3 65.77 Favored 'Isoleucine or valine' 0 C--O 1.248 0.988 0 N-CA-C 103.434 -2.802 . . . . 29.539999999999999 103.434 177.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1252 ' ' ILE . . . . . . . . . . . . . 53.6 mt -90.49 97.91 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 107.013 -1.477 . . . . 32.439999999999998 107.013 159.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1253 ' ' VAL . . . . . 0.676 HG12 HG23 ' B' 1255 ' ' THR . 4.0 t -83.99 93.05 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 103.181 -2.896 . . . . 30.57 103.181 175.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1254 ' ' THR . . . . . 0.698 HG23 ' HA ' ' B' 1283 ' ' ASP 0.353 8.8 t -90.42 84.63 6.01 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 124.207 1.956 . . . . 35.039999999999999 107.158 -178.027 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B 1255 ' ' THR . . . . . 0.676 HG23 HG12 ' B' 1253 ' ' VAL . 2.7 p -69.73 -16.5 63.33 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 110.927 -2.851 . . . . 34.619999999999997 114.305 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1256 ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' B' 1285 ' ' ALA . . . -57.46 82.84 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 124.172 0.989 . . . . 42.719999999999999 112.773 176.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 3.4 tt -90.82 85.5 6.04 Favored 'General case' 0 CA--C 1.54 0.562 1 N-CA-C 99.175 -4.379 . . . . 52.43 99.175 173.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 2.6 mp -55.5 125.54 60.26 Favored Pre-proline 0 C--N 1.353 0.759 0 O-C-N 120.996 -1.065 . . . . 59.409999999999997 111.144 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -57.31 110.45 0.61 Allowed 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 125.119 3.879 . . . . 62.68 111.928 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 77.73 -79.01 1.45 Allowed Glycine 0 CA--C 1.55 2.238 0 O-C-N 119.846 -1.784 . . . . 64.159999999999997 113.229 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 37.2 mttm -46.44 125.79 7.68 Favored Pre-proline 0 C--O 1.239 0.549 0 CA-C-O 116.535 -1.698 . . . . 68.530000000000001 113.667 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -55.16 120.93 9.0 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 124.027 3.151 . . . . 61.990000000000002 111.068 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1263 ' ' ALA . . . . . . . . . . . . . . . -48.73 122.78 11.19 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 117.402 2.371 . . . . 57.149999999999999 117.402 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -58.26 141.67 96.91 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 124.477 3.451 . . . . 51.57 111.903 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1265 ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' B' 1265 ' ' LYS . 35.2 mmtm -75.89 82.37 2.8 Favored 'General case' 0 C--O 1.21 -1.026 0 O-C-N 121.13 -0.981 . . . . 54.549999999999997 110.977 -178.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 49.7 mt -74.96 -56.34 4.84 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.352 -1.295 . . . . 46.859999999999999 109.567 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1267 ' ' ILE . . . . . 0.581 HG22 HG22 ' B' 1272 ' ' VAL . 32.1 mm -84.43 89.35 2.56 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 N-CA-C 103.655 -2.72 . . . . 41.039999999999999 103.655 -175.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1268 ' ' THR . . . . . 0.497 ' HA ' ' HG3' ' B' 1293 ' ' GLU . 1.1 p -80.63 160.09 25.17 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 113.001 -1.909 . . . . 39.579999999999998 112.286 -176.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1269 ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -53.31 -54.87 30.11 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 117.467 2.395 . . . . 53.149999999999999 117.467 -168.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -55.46 -40.35 71.51 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 125.1 1.5 . . . . 42.960000000000001 113.892 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1271 ' ' MET . . . . . 0.406 ' HB3' ' O ' ' B' 1268 ' ' THR . 41.6 ttm -56.89 -58.27 8.87 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 117.673 -1.156 . . . . 43.890000000000001 108.394 168.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1272 ' ' VAL . . . . . 0.581 HG22 HG22 ' B' 1267 ' ' ILE . 24.6 t -52.7 -59.83 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.808 0 CA-C-N 120.001 1.273 . . . . 38.369999999999997 111.877 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1273 ' ' ASP . . . . . . . . . . . . 0.265 1.2 m-20 -68.28 14.31 0.07 Allowed 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 120.358 3.466 . . . . 47.460000000000001 120.358 176.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1274 ' ' SER . . . . . . . . . . . . . 54.7 p -124.36 -2.28 8.04 Favored 'General case' 0 C--O 1.247 0.93 0 O-C-N 119.956 -1.715 . . . . 38.380000000000003 110.432 170.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1275 ' ' MET . . . . . 0.653 ' HB2' HG21 ' B' 1307 ' ' VAL . 40.6 mtp -63.88 162.99 12.69 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 114.093 1.145 . . . . 37.810000000000002 114.093 177.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.06 134.67 52.76 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.182 -0.949 . . . . 49.259999999999998 112.721 175.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -64.84 141.43 58.78 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 123.311 1.529 . . . . 34.460000000000001 113.332 -173.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 70.38 24.23 76.88 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 114.922 -1.035 . . . . 33.530000000000001 112.165 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1279 ' ' SER . . . . . . . . . . . . . 59.0 m -95.7 153.72 17.59 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 122.91 0.484 . . . . 31.309999999999999 109.736 176.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1280 ' ' VAL . . . . . 0.659 HG11 ' HA ' ' B' 1145 ' ' ALA . 84.4 t -118.01 144.29 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 O-C-N 119.307 -2.12 . . . . 29.32 106.815 -170.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1281 ' ' ILE . . . . . 0.452 HD13 HG21 ' B' 1267 ' ' ILE . 75.8 mt -121.5 120.22 61.21 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 N-CA-C 101.054 -3.684 . . . . 31.93 101.054 170.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1282 ' ' VAL . . . . . 0.663 HG11 ' HA ' ' B' 1141 ' ' ALA . 12.3 t -108.22 113.58 44.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 105.983 -1.858 . . . . 29.48 105.983 175.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1283 ' ' ASP . . . . . 0.698 ' HA ' HG23 ' B' 1254 ' ' THR . 5.6 t0 -87.33 102.73 14.79 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-N 113.826 -1.534 . . . . 34.5 110.885 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1284 ' ' LEU . . . . . 0.62 HD22 ' HA ' ' B' 1255 ' ' THR . 8.5 mp -69.46 -23.72 63.7 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 113.977 1.103 . . . . 37.939999999999998 113.977 172.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1285 ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' B' 1256 ' ' ALA . . . -88.38 16.09 6.89 Favored 'General case' 0 C--N 1.364 1.216 0 O-C-N 121.548 -0.72 . . . . 40.920000000000002 111.454 176.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1286 ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' B' 1297 ' ' PRO . . . -45.42 -37.5 5.16 Favored 'General case' 0 C--O 1.214 -0.786 0 N-CA-C 115.986 1.847 . . . . 44.390000000000001 115.986 174.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1287 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.43 -24.54 39.53 Favored 'General case' 0 C--N 1.313 -1.014 0 O-C-N 119.527 -1.983 . . . . 51.460000000000001 112.047 176.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 1.5 t30 -114.06 64.7 0.66 Allowed 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 125.101 1.361 . . . . 57.75 109.13 -170.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1289 ' ' GLY . . . . . . . . . . . . . . . 92.34 -39.62 2.98 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-O 117.056 -1.969 . . . . 49.850000000000001 114.663 170.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 87.02 117.2 1.1 Allowed Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 120.531 2.166 . . . . 45.93 112.292 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1291 ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -77.25 -29.63 54.08 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 119.761 1.78 . . . . 42.670000000000002 111.03 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1292 ' ' CYS . . . . . 0.612 ' HB3' ' OG1' ' B' 1295 ' ' THR . 40.9 t -95.84 146.03 24.88 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 118.704 -2.497 . . . . 38.82 108.442 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1293 ' ' GLU . . . . . 0.497 ' HG3' ' HA ' ' B' 1268 ' ' THR . 25.0 mt-10 -69.74 -38.64 76.9 Favored 'General case' 0 CA--C 1.502 -0.882 0 O-C-N 119.927 -1.733 . . . . 46.710000000000001 114.564 172.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -74.33 -3.84 32.68 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.273 0.842 . . . . 47.229999999999997 113.273 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1295 ' ' THR . . . . . 0.62 HG23 ' HA3' ' B' 1311 ' ' GLY . 88.2 m -59.6 110.77 1.2 Allowed 'General case' 0 C--O 1.243 0.759 0 CA-C-N 120.077 1.308 . . . . 36.020000000000003 111.238 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 51.2 t -78.34 100.25 0.5 Allowed Pre-proline 0 N--CA 1.44 -0.933 0 CA-C-N 112.604 -2.089 . . . . 37.259999999999998 105.437 163.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1297 ' ' PRO . . . . . 0.412 ' HB3' ' O ' ' B' 1286 ' ' ALA . 37.2 Cg_exo -65.46 78.22 0.25 Allowed 'Trans proline' 0 N--CA 1.44 -1.672 0 C-N-CA 125.024 3.816 . . . . 35.090000000000003 112.464 -177.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 169.09 -43.52 0.22 Allowed Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 109.045 -1.622 . . . . 35.969999999999999 109.045 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -134.35 -179.27 5.47 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 115.406 1.632 . . . . 40.390000000000001 115.406 -165.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1300 ' ' ILE . . . . . 0.547 HG12 HG12 ' B' 1310 ' ' ILE . 21.2 mt -82.63 140.6 16.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 107.563 -1.273 . . . . 37.43 107.563 172.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 58.6 t80 -119.96 112.66 19.45 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 104.706 -2.331 . . . . 44.130000000000003 104.706 163.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1302 ' ' THR . . . . . . . . . . . . . 29.4 m -79.72 137.03 36.92 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 119.92 -1.737 . . . . 39.780000000000001 109.623 167.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1303 ' ' THR . . . . . . . . . . . . . 35.7 p -93.32 -179.72 5.15 Favored 'General case' 0 C--O 1.251 1.184 0 N-CA-C 114.54 1.311 . . . . 43.289999999999999 114.54 177.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -75.97 -27.34 57.45 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 120.323 -1.486 . . . . 53.07 109.692 -169.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -84.55 2.55 40.7 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 124.519 2.104 . . . . 43.969999999999999 110.008 173.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 78.63 38.99 22.83 Favored Glycine 0 CA--C 1.539 1.533 0 O-C-N 118.217 -2.802 . . . . 41.119999999999997 113.495 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1307 ' ' VAL . . . . . 0.653 HG21 ' HB2' ' B' 1275 ' ' MET . 18.0 t -100.72 127.4 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-O 122.252 1.025 . . . . 38.119999999999997 109.705 172.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1308 ' ' LYS . . . . . . . . . . . . . 98.1 mttt -97.59 99.86 11.26 Favored 'General case' 0 N--CA 1.437 -1.093 0 O-C-N 119.01 -2.306 . . . . 36.340000000000003 109.782 -171.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1309 ' ' VAL . . . . . 0.419 HG22 HD12 ' B' 1281 ' ' ILE . 23.9 t -82.53 99.67 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 106.941 -1.503 . . . . 30.399999999999999 106.941 175.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1310 ' ' ILE . . . . . 0.547 HG12 HG12 ' B' 1300 ' ' ILE . 72.4 mt -82.82 107.64 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 N-CA-C 106.425 -1.695 . . . . 30.82 106.425 175.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1311 ' ' GLY . . . . . 0.62 ' HA3' HG23 ' B' 1295 ' ' THR . . . -116.0 61.52 0.39 Allowed Glycine 0 C--N 1.354 1.535 0 C-N-CA 118.567 -1.778 . . . . 26.530000000000001 111.6 176.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1312 ' ' TYR . . . . . 0.586 ' HB2' ' HG ' ' B' 1315 ' ' LEU . 14.9 m-85 -81.52 123.3 28.52 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 118.526 1.163 . . . . 38.0 108.984 -176.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1313 ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.1 -48.87 70.25 Favored 'General case' 0 C--O 1.256 1.428 0 CA-C-O 123.839 1.78 . . . . 29.800000000000001 108.56 167.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -72.41 16.66 0.13 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 116.453 2.02 . . . . 39.039999999999999 116.453 -176.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1315 ' ' LEU . . . . . 0.586 ' HG ' ' HB2' ' B' 1312 ' ' TYR . 25.4 mt -53.72 -43.63 96.48 Favored Pre-proline 0 C--O 1.224 -0.272 0 O-C-N 119.549 -1.969 . . . . 31.079999999999998 113.995 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1316 ' ' PRO . . . . . 0.45 ' HG3' ' HB2' ' B' 1137 ' ' ALA . 66.8 Cg_exo -63.97 -50.97 2.53 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.909 3.073 . . . . 26.100000000000001 112.475 168.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -50.76 -35.39 30.85 Favored Glycine 0 C--N 1.343 0.962 0 C-N-CA 125.867 1.698 . . . . 23.170000000000002 115.015 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 53.3 mtt180 -66.52 -7.22 18.39 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 117.492 2.404 . . . . 40.399999999999999 117.492 177.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1319 ' ' LEU . . . . . 0.698 HD21 ' HD2' ' B' 1139 ' ' TYR . 38.4 tp -127.48 117.64 21.39 Favored Pre-proline 0 C--N 1.347 0.488 0 O-C-N 119.395 -2.065 . . . . 23.600000000000001 110.24 -173.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1320 ' ' PRO . . . . . 0.614 ' HG2' ' HA2' ' A' 1150 ' ' GLY . 87.3 Cg_endo -73.62 -95.48 0.01 OUTLIER 'Trans proline' 0 N--CA 1.481 0.774 0 N-CA-C 121.428 3.588 . . . . 22.350000000000001 121.428 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1321 ' ' THR . . . . . 0.489 ' HB ' ' HG3' ' A' 1151 ' ' ARG . 0.2 OUTLIER -55.49 -31.25 61.86 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 116.125 1.898 . . . . 26.52 116.125 -162.614 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B 1322 ' ' GLN . . . . . . . . . . . . . 35.8 tp60 -52.86 -51.3 61.54 Favored 'General case' 0 C--O 1.248 1.018 0 CA-C-N 113.13 -1.85 . . . . 24.379999999999999 109.67 173.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1323 ' ' SER . . . . . . . . . . . . . 8.1 m -62.77 -48.35 79.56 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 118.121 -0.942 . . . . 22.800000000000001 112.578 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1324 ' ' SER . . . . . . . . . . . . . 3.0 m -49.49 -35.7 20.67 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 123.797 1.761 . . . . 21.25 115.263 174.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 45.8 tp60 -78.15 -60.82 2.21 Favored 'General case' 0 CA--C 1.505 -0.788 0 O-C-N 119.587 -1.946 . . . . 31.34 110.571 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1326 ' ' LEU . . . . . 0.683 ' HA ' ' HA3' ' A' 1161 ' ' GLY . 12.5 mt -62.7 -59.07 5.41 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 117.182 -1.39 . . . . 31.559999999999999 110.372 -174.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1327 ' ' TYR . . . . . . . . . . . . . 57.9 t80 -63.06 -40.32 97.35 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 119.033 0.833 . . . . 22.73 109.798 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1328 ' ' GLY . . . . . 0.463 ' HA2' HD12 ' B' 1331 ' ' LEU . . . -42.8 -49.01 6.14 Favored Glycine 0 C--N 1.308 -1.006 0 O-C-N 124.716 1.26 . . . . 21.91 115.122 165.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1329 ' ' THR . . . . . . . . . . . . . 8.7 m -72.56 -35.28 67.95 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 117.669 0.734 . . . . 22.149999999999999 109.631 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1330 ' ' ASN . . . . . . . . . . . . . 9.5 m120 -55.1 -46.07 75.5 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 123.765 0.666 . . . . 26.18 110.362 172.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1331 ' ' LEU . . . . . 0.552 HD13 HD13 ' B' 1070 ' ' LEU . 14.6 mt -66.54 -41.22 89.04 Favored 'General case' 0 C--O 1.253 1.246 0 O-C-N 119.729 -1.857 . . . . 23.68 110.339 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1332 ' ' VAL . . . . . 0.584 HG22 ' HG ' ' B' 1026 ' ' LEU . 69.7 t -55.09 -48.77 75.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 O-C-N 123.493 0.495 . . . . 26.57 109.807 174.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -62.09 -35.18 77.91 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 124.327 1.051 . . . . 28.079999999999998 112.13 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1334 ' ' LEU . . . . . 0.739 ' HA ' ' HG ' ' B' 1127 ' ' LEU . 32.3 tp -64.85 -58.9 4.96 Favored 'General case' 0 CA--C 1.492 -1.256 0 C-N-CA 124.446 1.099 . . . . 27.43 109.818 178.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1335 ' ' LEU . . . . . 0.469 HD21 HD21 ' B' 1070 ' ' LEU . 3.8 mm? -60.11 -39.46 86.26 Favored 'General case' 0 C--O 1.242 0.694 0 O-C-N 124.708 1.255 . . . . 30.5 112.977 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1336 ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' B' 1332 ' ' VAL . 31.9 ttmt -54.64 -44.98 73.68 Favored 'General case' 0 CA--C 1.495 -1.17 0 C-N-CA 124.483 1.113 . . . . 41.649999999999999 113.16 171.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 13.5 tp -85.75 -25.39 26.45 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.26 -0.9 . . . . 42.079999999999998 113.267 -174.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1338 ' ' LEU . . . . . 0.555 ' O ' ' HB ' ' B' 1347 ' ' THR . 7.3 mt -73.08 -67.97 0.53 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.45 -1.315 . . . . 35.030000000000001 107.45 170.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 43.8 t -85.43 73.23 10.55 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 107.187 -1.412 . . . . 37.329999999999998 107.187 -174.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 61.7 mttp -68.18 -22.28 64.83 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 119.471 -2.018 . . . . 50.509999999999998 111.743 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -78.11 -10.51 59.66 Favored 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 120.271 -1.518 . . . . 54.210000000000001 113.021 174.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 91.3 mttt 52.31 41.99 30.74 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-O 125.793 2.711 . . . . 50.990000000000002 111.787 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -105.73 -43.98 4.77 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 126.196 1.798 . . . . 48.82 109.548 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 132.69 -9.29 5.24 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 109.069 -1.612 . . . . 40.43 109.069 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -82.49 120.8 25.95 Favored 'General case' 0 C--O 1.242 0.665 0 O-C-N 119.256 -2.32 . . . . 47.560000000000002 109.453 175.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1346 ' ' ILE . . . . . . . . . . . . . 31.4 mm -68.11 90.5 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-N 114.171 -1.377 . . . . 42.490000000000002 110.413 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1347 ' ' THR . . . . . 0.555 ' HB ' ' O ' ' B' 1338 ' ' LEU . 92.5 m -74.47 90.88 2.22 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 123.869 1.795 . . . . 38.119999999999997 109.555 -177.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 39.4 t -84.17 90.53 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 106.697 -1.594 . . . . 37.5 106.697 171.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 10.5 t70 -77.7 147.21 35.56 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 109.067 -3.697 . . . . 43.850000000000001 108.409 175.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1350 ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -109.5 -16.83 13.9 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 118.599 -1.24 . . . . 39.810000000000002 113.689 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -91.35 -16.23 27.77 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 114.094 1.146 . . . . 51.289999999999999 114.094 -175.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 54.6 t0 -83.92 116.32 22.73 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 105.027 -2.212 . . . . 39.780000000000001 105.027 158.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 11.1 m -55.5 -25.33 17.51 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 C-N-CA 125.186 1.394 . . . . 39.280000000000001 109.822 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1354 ' ' VAL . . . . . 0.621 HG21 ' HG3' ' B' 1123 ' ' ARG . 73.9 t -64.48 -50.75 74.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 117.68 -1.152 . . . . 35.700000000000003 110.907 175.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1355 ' ' ILE . . . . . 0.52 HD12 HD23 ' B' 1338 ' ' LEU . 23.1 mm -70.95 -42.39 77.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 119.634 -0.826 . . . . 35.770000000000003 110.563 -177.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 48.5 tpt85 -52.37 -36.91 54.99 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 112.849 -1.978 . . . . 38.549999999999997 113.059 169.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -80.8 -51.05 4.97 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 121.88 2.127 . . . . 29.579999999999998 112.525 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1358 ' ' VAL . . . . . 0.521 HG23 HG22 ' B' 1118 ' ' VAL . 10.6 p -63.27 -35.68 73.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 118.917 1.358 . . . . 32.060000000000002 112.132 -171.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1359 ' ' THR . . . . . . . . . . . . . 14.0 m -84.21 88.22 7.21 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 103.268 -2.864 . . . . 29.0 103.268 -178.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1360 ' ' VAL . . . . . 0.455 HG12 ' HD1' ' B' 1368 ' ' TRP . 35.7 m -70.83 -25.42 26.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 114.816 -1.083 . . . . 29.68 112.428 -176.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 75.7 mt -139.79 136.92 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 103.121 -2.918 . . . . 32.049999999999997 103.121 175.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1362 ' ' ARG . . . . . 0.485 ' HA ' HG23 ' B' 1111 ' ' THR . 64.5 ttt180 -120.66 108.82 14.47 Favored 'General case' 0 C--O 1.254 1.318 0 N-CA-C 105.392 -2.077 . . . . 32.520000000000003 105.392 171.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 35.87 77.36 0.04 OUTLIER 'General case' 0 C--O 1.241 0.617 0 N-CA-C 116.335 1.976 . . . . 35.68 116.335 -170.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1364 ' ' GLY . . . . . 0.409 ' CA ' ' HA ' ' B' 1109 ' ' ASN . . . 80.65 -43.74 2.83 Favored Glycine 0 C--N 1.308 -1.013 0 CA-C-N 114.005 -1.452 . . . . 34.259999999999998 115.005 176.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -68.01 116.05 8.21 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 119.609 1.704 . . . . 51.07 112.04 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 83.5 mt -68.91 110.55 2.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 121.166 -0.959 . . . . 39.869999999999997 109.299 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1367 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.55 -20.14 25.44 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 115.474 1.657 . . . . 38.009999999999998 115.474 168.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1368 ' ' TRP . . . . . 0.455 ' HD1' HG12 ' B' 1360 ' ' VAL . 15.2 t90 -57.71 146.07 67.65 Favored Pre-proline 0 C--O 1.244 0.774 0 C-N-CA 123.281 0.632 . . . . 42.140000000000001 110.767 176.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1369 ' ' PRO . . . . . 0.417 ' HA ' ' CD1' ' B' 1368 ' ' TRP . 25.1 Cg_endo -78.1 -172.21 10.94 Favored 'Cis proline' 0 C--N 1.369 1.644 0 CA-C-N 121.362 1.522 . . . . 43.259999999999998 115.046 -5.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1370 ' ' ALA . . . . . . . . . . . . . . . -78.8 162.01 66.77 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 114.624 -1.171 . . . . 46.520000000000003 108.72 166.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -59.59 153.01 58.15 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 123.918 3.078 . . . . 51.950000000000003 108.995 162.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -57.53 113.61 1.58 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 1 C-N-CA 126.662 4.908 . . . . 56.270000000000003 115.056 -177.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1373 ' ' ILE . . . . . . . . . . . . . 50.7 mm -92.49 120.28 41.5 Favored 'Isoleucine or valine' 0 C--O 1.255 1.377 0 O-C-N 120.715 -1.24 . . . . 60.829999999999998 110.927 -174.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -92.46 127.88 38.11 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.961 -1.126 . . . . 66.099999999999994 107.961 174.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1375 ' ' VAL . . . . . 0.718 HG21 ' HB2' ' B' 1120 ' ' ARG . 19.9 t -124.72 118.57 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 113.401 -1.727 . . . . 63.469999999999999 107.693 -170.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.223 -4.906 0 O-C-N 117.774 -3.079 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.582 0 CA-C-O 118.926 -0.559 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -23.76 67.37 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 121.18 1.809 . . . . 0.0 113.323 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 32.7 mp0 -53.91 -50.68 65.84 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 123.107 1.432 . . . . 0.0 110.734 165.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 3.3 m -65.0 -38.21 90.19 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 113.579 -1.646 . . . . 0.0 109.362 -171.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.95 76.13 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-O 124.193 1.949 . . . . 0.0 114.682 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -70.25 -52.22 24.71 Favored 'General case' 0 C--O 1.249 1.076 0 CA-C-N 114.044 -1.434 . . . . 0.0 112.343 172.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.511 ' HB3' ' OG1' ' C' ' 108' ' ' THR . 74.8 mt -62.58 -43.08 99.7 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-O 116.965 -1.493 . . . . 0.0 113.368 -175.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.521 HD11 HD12 ' C' ' 182' ' ' ILE . 43.7 mt -52.39 -51.32 59.61 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -177.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 28' ' ' LYS . . . . . . . . . . . . . 13.3 pttm -65.93 -26.49 67.62 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -72.32 -35.67 68.68 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.304 1.041 . . . . 0.0 110.178 170.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 58.2 m -54.28 -43.99 71.5 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 120.941 3.682 . . . . 0.0 120.941 -167.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 31' ' ' HIS . . . . . . . . . . . . 0.27 56.3 p-80 43.58 -18.22 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 123.418 2.827 . . . . 0.0 117.288 -160.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 32' ' ' SER . . . . . 0.535 ' HB2' ' HA ' ' C' ' 106' ' ' THR . 19.3 m -136.17 127.32 28.04 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.652 -3.78 . . . . 0.0 104.936 169.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 33' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' C' ' 64' ' ' VAL . 77.3 t -137.03 126.88 38.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 104.104 -2.554 . . . . 0.0 104.104 -174.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.489 HD12 HD11 ' C' ' 99' ' ' ILE . 21.8 mm -109.26 132.91 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 172.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 35' ' ' ILE . . . . . 0.699 HG12 ' HB2' ' C' ' 110' ' ' LEU . 55.5 mt -98.64 117.06 43.06 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 170.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 89.8 m -113.47 99.78 50.29 Favored Pre-proline 0 N--CA 1.44 -0.971 0 CA-C-O 122.597 1.189 . . . . 0.0 110.779 175.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -81.84 147.26 15.12 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 124.573 3.516 . . . . 0.0 114.973 178.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -159.95 120.29 0.95 Allowed Glycine 0 N--CA 1.415 -2.718 0 N-CA-C 108.014 -2.035 . . . . 0.0 108.014 166.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 39' ' ' TYR . . . . . 0.542 ' HB2' ' HA3' ' C' ' 73' ' ' GLY . 4.3 t80 61.45 -67.35 0.06 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.212 1.405 . . . . 0.0 113.839 -175.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -47.85 -43.3 23.12 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-N 121.394 1.906 . . . . 0.0 116.117 -170.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 41' ' ' MET . . . . . 0.822 ' HA ' ' HB3' ' C' ' 46' ' ' ALA . 5.6 ttm -47.24 -46.98 24.79 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 123.097 1.427 . . . . 0.0 113.49 178.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.16 -56.27 4.34 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.68 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 p -62.81 -30.46 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 N-CA-C 117.392 2.367 . . . . 0.0 117.392 -168.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.18 18.75 17.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.366 -0.833 . . . . 0.0 108.857 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 45' ' ' GLN . . . . . . . . . . . . 0.255 0.1 OUTLIER 35.31 46.73 0.27 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 124.95 2.31 . . . . 0.0 112.899 -158.347 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.822 ' HB3' ' HA ' ' C' ' 41' ' ' MET . . . -69.81 -20.16 63.46 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 114.203 -1.362 . . . . 0.0 113.523 -175.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 47' ' ' GLN . . . . . 0.526 ' HB2' ' HB2' ' C' ' 86' ' ' ALA . 0.0 OUTLIER -57.95 -39.13 77.34 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 176.577 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 48' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -59.2 -41.2 86.45 Favored Pre-proline 0 CA--C 1.553 1.07 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 49' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -67.32 -39.76 12.3 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 123.267 2.645 . . . . 0.0 111.671 164.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 50' ' ' VAL . . . . . 0.452 ' HA ' HG22 ' C' ' 53' ' ' ILE . 64.2 t -58.93 -33.67 50.48 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 O-C-N 121.57 -0.706 . . . . 0.0 110.304 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.35 -54.07 50.97 Favored 'General case' 0 C--O 1.243 0.739 0 O-C-N 120.308 -1.495 . . . . 0.0 107.386 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 52' ' ' GLU . . . . . 0.728 ' HB3' ' HB2' ' C' ' 183' ' ' LEU . 2.5 mm-40 -54.94 -37.64 66.7 Favored 'General case' 0 C--O 1.249 1.037 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -178.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 53' ' ' ILE . . . . . 0.452 HG22 ' HA ' ' C' ' 50' ' ' VAL . 9.0 tp -78.05 -44.47 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 O-C-N 121.466 -0.771 . . . . 0.0 111.493 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 88.3 m -59.87 -34.67 73.45 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -58.98 -52.95 63.57 Favored 'General case' 0 C--O 1.266 1.944 0 C-N-CA 124.658 1.183 . . . . 0.0 107.936 -175.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -74.85 -32.96 62.05 Favored 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 120.753 -1.217 . . . . 0.0 112.597 -177.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 93.6 mt -60.87 -42.08 97.21 Favored 'General case' 0 C--O 1.211 -0.93 0 O-C-N 120.659 -1.275 . . . . 0.0 110.566 174.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 58' ' ' ARG . . . . . 0.485 ' HD3' HG12 ' C' ' 64' ' ' VAL . 12.9 tpt180 -78.01 -27.78 49.01 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 119.743 -1.848 . . . . 0.0 110.934 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.05 -34.27 77.69 Favored 'General case' 0 C--N 1.349 0.548 0 O-C-N 121.587 -0.696 . . . . 0.0 109.89 173.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 9.2 ttm-85 -79.61 3.34 19.27 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 118.877 0.762 . . . . 0.0 111.182 174.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.44 36.92 78.46 Favored Glycine 0 C--O 1.251 1.185 0 O-C-N 120.395 -1.441 . . . . 0.0 111.067 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 7.0 mt -85.31 140.15 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -68.3 75.87 0.25 Allowed 'General case' 0 C--O 1.239 0.53 0 O-C-N 121.149 -0.969 . . . . 0.0 109.069 166.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 8.1 p -97.06 118.72 44.03 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 175.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 31.7 mmm-85 -126.2 144.35 50.8 Favored 'General case' 0 C--N 1.312 -1.036 0 O-C-N 124.842 1.339 . . . . 0.0 109.004 -173.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 66' ' ' PHE . . . . . 0.533 ' HB3' HD13 ' C' ' 68' ' ' ILE . 5.5 m-85 -100.08 98.11 8.87 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 123.666 1.698 . . . . 0.0 112.618 -176.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.88 83.11 1.63 Allowed Glycine 0 C--N 1.34 0.786 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 68' ' ' ILE . . . . . 0.533 HD13 ' HB3' ' C' ' 66' ' ' PHE 0.273 1.7 mp -77.89 112.89 16.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 122.006 0.908 . . . . 0.0 110.989 178.742 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -86.13 86.54 0.09 OUTLIER Pre-proline 0 N--CA 1.449 -0.477 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 165.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 70' ' ' PRO . . . . . 0.413 ' HG2' ' H ' ' C' ' 71' ' ' VAL . 94.6 Cg_endo -48.25 -52.87 7.61 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 125.211 3.94 . . . . 0.0 118.055 -165.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 71' ' ' VAL . . . . . 0.688 HG22 ' HB3' ' C' ' 76' ' ' PRO . 21.8 t -80.6 92.07 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 N-CA-C 102.13 -3.285 . . . . 0.0 102.13 178.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -153.68 104.84 2.74 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 123.224 1.487 . . . . 0.0 113.387 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 73' ' ' GLY . . . . . 0.542 ' HA3' ' HB2' ' C' ' 39' ' ' TYR . . . 86.94 -98.32 2.35 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 111.723 -2.489 . . . . 0.0 108.149 177.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 74' ' ' ARG . . . . . 0.589 ' HA ' ' OE1' ' B' 1203 ' ' GLN . 0.8 OUTLIER -128.15 111.89 13.96 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 125.184 1.167 . . . . 0.0 112.549 -170.47 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.634 ' HB2' ' HB2' ' C' ' 78' ' ' HIS . 6.7 mp 71.62 134.04 0.04 OUTLIER Pre-proline 0 C--O 1.254 1.322 0 O-C-N 125.766 1.916 . . . . 0.0 112.481 -170.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 76' ' ' PRO . . . . . 0.688 ' HB3' HG22 ' C' ' 71' ' ' VAL . 56.6 Cg_endo -66.35 124.64 12.78 Favored 'Trans proline' 0 N--CA 1.432 -2.091 0 C-N-CA 121.951 1.767 . . . . 0.0 107.708 167.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 78.26 3.94 86.12 Favored Glycine 0 CA--C 1.54 1.626 0 CA-C-N 114.053 -1.431 . . . . 0.0 114.051 169.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 78' ' ' HIS . . . . . 0.634 ' HB2' ' HB2' ' C' ' 75' ' ' LEU . 21.3 t-160 -54.49 -31.46 55.93 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 79' ' ' MET . . . . . 0.619 ' HB2' ' SD ' ' C' ' 41' ' ' MET . 0.0 OUTLIER -62.18 -44.15 97.24 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 172.384 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -65.81 -36.49 83.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 122.413 1.102 . . . . 0.0 109.638 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 51.1 t -61.08 -43.65 96.67 Favored 'Isoleucine or valine' 0 C--N 1.357 0.903 0 CA-C-O 116.815 -1.564 . . . . 0.0 108.594 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 10.9 mp -82.61 -16.97 46.39 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 120.658 1.572 . . . . 0.0 112.104 174.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 15.0 tp -63.42 -32.15 73.51 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 117.492 -3.255 . . . . 0.0 110.576 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.75 -33.73 64.57 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 169.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -67.27 -45.21 77.31 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 120.274 -1.516 . . . . 0.0 113.598 166.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 86' ' ' ALA . . . . . 0.526 ' HB2' ' HB2' ' C' ' 47' ' ' GLN . . . -65.52 -11.22 41.66 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 176.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt 64.78 22.8 12.61 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 169.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 88' ' ' VAL . . . . . 0.435 ' HA ' ' HD2' ' C' ' 89' ' ' PRO . 74.9 t -84.55 121.75 74.93 Favored Pre-proline 0 C--O 1.249 1.034 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 173.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 89' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' C' ' 88' ' ' VAL . 37.1 Cg_endo -50.39 124.81 13.84 Favored 'Trans proline' 0 N--CA 1.442 -1.541 1 C-N-CA 126.392 4.728 . . . . 0.0 114.339 177.28 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -63.18 -16.34 59.82 Favored 'General case' 0 C--N 1.363 1.168 0 O-C-N 120.144 -1.598 . . . . 0.0 115.052 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -61.75 -40.04 93.74 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 123.345 0.658 . . . . 0.0 111.485 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 22.5 pt -75.44 -8.29 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 O-C-N 118.023 -2.923 . . . . 0.0 117.387 173.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 93' ' ' VAL . . . . . 0.519 HG13 HD13 ' C' ' 68' ' ' ILE . 16.8 t -88.06 121.47 38.5 Favored 'Isoleucine or valine' 0 C--O 1.248 1.02 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 -177.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 94' ' ' LEU . . . . . 0.553 ' HB3' ' HB3' ' C' ' 97' ' ' ASP . 6.2 mp -104.27 97.26 7.23 Favored 'General case' 0 C--O 1.25 1.107 0 CA-C-N 113.335 -1.757 . . . . 0.0 108.564 168.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 95' ' ' GLU . . . . . 0.462 ' HB3' HG12 ' A' 1157 ' ' ILE . 53.7 mp0 -81.84 93.45 6.87 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 4.0 tpp 56.55 29.57 15.74 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.451 1.9 . . . . 0.0 112.271 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 97' ' ' ASP . . . . . 0.553 ' HB3' ' HB3' ' C' ' 94' ' ' LEU . 18.7 t70 -92.11 172.7 8.25 Favored 'General case' 0 C--O 1.251 1.163 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 173.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -67.7 87.67 0.23 Allowed 'General case' 0 C--N 1.347 0.491 0 CA-C-O 123.724 1.726 . . . . 0.0 113.464 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 99' ' ' ILE . . . . . 0.489 HD11 HD12 ' C' ' 34' ' ' ILE . 6.5 tp -101.29 7.31 9.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-N 110.712 -2.949 . . . . 0.0 110.543 174.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -58.94 -49.11 79.08 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 119.765 -1.834 . . . . 0.0 112.168 -171.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -79.42 -29.54 41.95 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.839 0.828 . . . . 0.0 110.833 -174.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 102' ' ' ASP . . . . . 0.414 ' HB3' HD11 ' C' ' 34' ' ' ILE . 0.8 OUTLIER -63.73 -32.12 73.51 Favored 'General case' 0 N--CA 1.433 -1.319 0 O-C-N 121.051 -1.031 . . . . 0.0 112.826 169.213 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 103' ' ' PHE . . . . . 0.468 ' CE2' HG23 ' C' ' 99' ' ' ILE . 35.1 m-85 -63.22 -48.54 77.86 Favored 'General case' 0 N--CA 1.426 -1.657 0 O-C-N 119.606 -1.934 . . . . 0.0 111.617 169.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.15 -27.67 69.11 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 124.319 1.012 . . . . 0.0 112.959 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -72.16 -40.57 67.89 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.799 1.285 . . . . 0.0 112.179 174.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 106' ' ' THR . . . . . 0.535 ' HA ' ' HB2' ' C' ' 32' ' ' SER . 3.1 m -60.6 143.58 53.6 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 112.901 -1.954 . . . . 0.0 114.856 -174.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 107' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -92.56 -62.87 1.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 112.337 -2.21 . . . . 0.0 107.948 175.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 108' ' ' THR . . . . . 0.511 ' OG1' ' HB3' ' C' ' 26' ' ' LEU . 97.0 m -108.44 126.19 52.61 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-O 123.789 1.757 . . . . 0.0 111.134 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 109' ' ' VAL . . . . . 0.594 HG11 HG21 ' C' ' 138' ' ' VAL . 3.2 t -108.96 119.93 59.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.985 0 CA-C-N 113.191 -1.822 . . . . 0.0 106.73 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 110' ' ' LEU . . . . . 0.699 ' HB2' HG12 ' C' ' 35' ' ' ILE . 34.7 mt -91.14 91.54 8.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 123.745 1.736 . . . . 0.0 110.019 177.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 111' ' ' VAL . . . . . 0.806 ' HB ' ' HA ' ' C' ' 146' ' ' VAL . 12.0 t -90.87 99.87 10.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 -175.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 26.4 mm -78.86 97.9 2.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 CA-C-N 112.314 -2.221 . . . . 0.0 110.394 -171.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.04 -100.76 1.16 Allowed Glycine 0 C--N 1.334 0.467 0 N-CA-C 107.233 -2.347 . . . . 0.0 107.233 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 114' ' ' ALA . . . . . 0.544 ' HB3' HG12 ' C' ' 111' ' ' VAL . . . 57.41 -56.55 0.03 OUTLIER 'General case' 0 C--O 1.25 1.113 1 N-CA-C 126.336 5.68 . . . . 0.0 126.336 162.818 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 115' ' ' ASN . . . . . 0.406 ' HB2' ' CE1' ' C' ' 163' ' ' PHE 0.344 2.7 p-10 24.48 -80.44 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 120.391 3.478 . . . . 0.0 120.391 -169.392 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 116' ' ' ASP . . . . . 0.514 ' HA ' ' HB2' ' C' ' 119' ' ' ASN . 69.7 m-20 -64.35 -18.38 64.6 Favored 'General case' 0 C--O 1.241 0.648 0 O-C-N 118.067 -2.896 . . . . 0.0 114.36 -177.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 117' ' ' THR . . . . . 0.509 ' HB ' ' HB1' ' C' ' 114' ' ' ALA . 30.8 m -45.66 -35.96 4.52 Favored 'General case' 0 C--O 1.248 0.993 0 C-N-CA 125.627 1.571 . . . . 0.0 111.792 169.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.481 ' HA ' ' HB ' ' C' ' 135' ' ' VAL . 4.3 m -127.44 20.45 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 O-C-N 120.28 -1.512 . . . . 0.0 113.184 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 119' ' ' ASN . . . . . 0.514 ' HB2' ' HA ' ' C' ' 116' ' ' ASP . 61.0 t-20 -73.12 108.36 4.47 Favored Pre-proline 0 C--N 1.32 -0.688 0 O-C-N 119.656 -1.902 . . . . 0.0 111.025 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 120' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -56.3 -27.19 65.65 Favored 'Trans proline' 0 N--CA 1.441 -1.601 0 C-N-CA 125.041 3.827 . . . . 0.0 115.868 -172.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -55.88 -39.16 71.15 Favored 'General case' 0 C--O 1.204 -1.324 0 O-C-N 125.719 1.887 . . . . 0.0 111.874 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 122' ' ' ALA . . . . . 0.51 ' HB1' ' HB3' ' C' ' 133' ' ' MET . . . -57.35 -21.86 38.5 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 117.998 2.592 . . . . 0.0 117.998 177.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -102.45 -43.92 5.51 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 117.859 -1.536 . . . . 0.0 112.591 169.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 124' ' ' ASP . . . . . 0.405 ' O ' ' HD3' ' C' ' 126' ' ' PRO . 38.7 t70 -78.37 -30.13 47.78 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 122.98 1.372 . . . . 0.0 111.66 -171.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -107.94 101.7 42.18 Favored Pre-proline 0 N--CA 1.429 -1.477 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 -169.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 126' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' C' ' 124' ' ' ASP . 27.5 Cg_exo -55.13 -39.06 92.92 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 124.009 3.139 . . . . 0.0 114.26 171.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -53.4 -21.09 5.35 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 128' ' ' SER . . . . . 0.509 ' HA ' ' HD2' ' C' ' 129' ' ' PRO . 22.3 m -48.1 134.49 11.95 Favored Pre-proline 0 N--CA 1.434 -1.227 0 O-C-N 120.685 -1.26 . . . . 0.0 113.822 172.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 129' ' ' PRO . . . . . 0.565 ' HG2' ' HA ' ' C' ' 156' ' ' ALA . 36.5 Cg_endo -55.39 -38.0 94.26 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 124.912 3.742 . . . . 0.0 117.777 172.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 130' ' ' ILE . . . . . 0.954 HG12 ' HB2' ' C' ' 156' ' ' ALA 0.291 39.3 pt -77.19 104.64 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.367 168.198 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 131' ' ' ALA . . . . . 0.722 ' HB1' HG22 ' B' 1121 ' ' ILE . . . -63.7 115.02 4.37 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 113.125 -1.852 . . . . 0.0 111.363 -168.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 29.56 69.18 0.08 OUTLIER Glycine 0 N--CA 1.473 1.108 0 CA-C-O 116.525 -2.264 . . . . 0.0 114.192 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 133' ' ' MET . . . . . 0.68 ' HA ' ' HB2' ' B' 1122 ' ' SER . 5.9 tpp -96.2 126.22 45.0 Favored Pre-proline 0 N--CA 1.434 -1.247 0 CA-C-N 119.638 1.719 . . . . 0.0 113.344 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 134' ' ' PRO . . . . . 0.516 ' HD2' ' SD ' ' C' ' 133' ' ' MET . 72.8 Cg_endo -66.54 81.05 0.32 Allowed 'Trans proline' 0 C--O 1.262 1.707 1 C-N-CA 125.696 4.264 . . . . 0.0 107.247 168.889 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 135' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' C' ' 118' ' ' VAL . 6.3 m -69.38 137.0 25.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.363 171.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 7.8 tp -78.53 83.42 4.73 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.301 -1.318 . . . . 0.0 113.564 -166.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . 0.28 34.2 mm-40 42.04 -26.44 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.329 1 N-CA-C 128.213 6.375 . . . . 0.0 128.213 160.092 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' C' C ' 138' ' ' VAL . . . . . 0.594 HG21 HG11 ' C' ' 109' ' ' VAL . 4.4 p -73.96 14.78 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.491 0 O-C-N 117.144 -3.472 . . . . 0.0 117.152 -160.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 5.3 p90 -69.19 142.67 54.22 Favored 'General case' 0 C--O 1.244 0.772 0 O-C-N 119.45 -2.031 . . . . 0.0 109.006 176.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.77 24.46 0.34 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 127.055 2.142 . . . . 0.0 116.588 -166.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -101.12 70.47 1.34 Allowed 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 123.154 1.454 . . . . 0.0 110.112 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 142' ' ' GLN . . . . . 0.43 ' HB3' ' H ' ' C' ' 143' ' ' ASN . 0.2 OUTLIER 64.75 -135.66 0.26 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 112.271 -2.241 . . . . 0.0 114.487 171.771 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 143' ' ' ASN . . . . . 0.439 ' HB2' ' HA ' ' C' ' 108' ' ' THR . 53.8 m-20 -85.57 84.87 7.48 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 118.986 -1.086 . . . . 0.0 109.102 -168.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 144' ' ' VAL . . . . . 0.481 ' HA ' ' HB ' ' C' ' 109' ' ' VAL . 58.2 t -88.51 88.25 2.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 102.617 -3.105 . . . . 0.0 102.617 -173.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 145' ' ' ILE . . . . . 0.46 HD12 HG23 ' C' ' 108' ' ' THR . 97.4 mt -88.92 97.79 7.31 Favored 'Isoleucine or valine' 0 C--O 1.251 1.171 0 CA-C-O 123.308 1.528 . . . . 0.0 107.802 -173.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 146' ' ' VAL . . . . . 0.806 ' HA ' ' HB ' ' C' ' 111' ' ' VAL . 48.7 t -85.44 104.22 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 113.298 -1.774 . . . . 0.0 106.967 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 147' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -67.55 91.64 0.29 Allowed 'General case' 0 C--O 1.242 0.661 0 O-C-N 120.625 -1.297 . . . . 0.0 109.646 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 148' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' C' ' 172' ' ' PHE . 15.7 mmmt -118.62 110.45 17.34 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.171 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -64.35 -36.0 82.7 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.046 1.338 . . . . 0.0 109.683 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 150' ' ' SER . . . . . 0.424 ' O ' ' HE3' ' C' ' 148' ' ' LYS . 10.7 m -139.5 137.41 35.48 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 151' ' ' MET . . . . . 0.466 ' SD ' ' HE1' ' C' ' 170' ' ' MET . 5.2 tpt -77.35 98.31 5.19 Favored 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 118.791 -2.443 . . . . 0.0 109.007 170.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 152' ' ' ASN . . . . . 0.416 ' OD1' ' NZ ' ' C' ' 148' ' ' LYS . 38.5 p30 -140.68 152.17 45.15 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 110.837 -2.892 . . . . 0.0 108.952 177.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 153' ' ' THR . . . . . 0.646 HG23 ' HA3' ' C' ' 157' ' ' GLY . 98.6 m -65.17 120.39 12.62 Favored 'General case' 0 C--N 1.358 0.977 0 O-C-N 125.073 1.483 . . . . 0.0 107.797 176.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -78.58 -115.76 0.21 Allowed Glycine 0 N--CA 1.424 -2.118 0 CA-C-N 112.358 -2.201 . . . . 0.0 108.272 167.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 155' ' ' TYR . . . . . 0.57 ' HB3' HG21 ' C' ' 130' ' ' ILE . 0.6 OUTLIER -79.7 -53.65 6.61 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 179.157 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 156' ' ' ALA . . . . . 0.954 ' HB2' HG12 ' C' ' 130' ' ' ILE . . . -92.57 -60.32 1.86 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.362 0.983 . . . . 0.0 108.37 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 157' ' ' GLY . . . . . 0.646 ' HA3' HG23 ' C' ' 153' ' ' THR . . . 57.46 44.5 93.66 Favored Glycine 0 CA--C 1.492 -1.368 0 CA-C-N 113.544 -1.662 . . . . 0.0 112.257 -176.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 158' ' ' VAL . . . . . 0.472 HG22 ' HB1' ' C' ' 156' ' ' ALA . 28.4 m -123.37 157.56 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-O 122.309 1.052 . . . . 0.0 112.503 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -30.59 123.67 0.19 Allowed 'General case' 0 C--O 1.242 0.679 1 N-CA-C 122.008 4.077 . . . . 0.0 122.008 178.491 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 160' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -168.22 163.59 8.66 Favored Pre-proline 0 C--O 1.268 2.052 0 C-N-CA 126.088 1.755 . . . . 0.0 109.99 -176.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.74 -36.23 1.66 Allowed 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 124.106 3.204 . . . . 0.0 115.212 169.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 162' ' ' LEU . . . . . . . . . . . . . 8.1 tt -58.07 -35.66 71.7 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -166.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 163' ' ' PHE . . . . . 0.406 ' CE1' ' HB2' ' C' ' 115' ' ' ASN . 12.9 m-30 -70.39 -29.0 65.52 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 118.298 -2.751 . . . . 0.0 113.361 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -102.94 -17.9 15.27 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.169 -1.378 . . . . 0.0 114.206 -162.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 165' ' ' LYS . . . . . 0.448 ' HB2' ' HB ' ' C' ' 168' ' ' THR . 20.5 mmmt -73.64 -177.26 2.65 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.698 1.237 . . . . 0.0 111.986 -170.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -88.63 -63.17 1.34 Allowed 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 120.361 -1.462 . . . . 0.0 109.616 -164.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.94 -26.15 24.01 Favored 'General case' 0 C--O 1.243 0.753 0 O-C-N 120.329 -1.482 . . . . 0.0 112.442 170.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 168' ' ' THR . . . . . 0.448 ' HB ' ' HB2' ' C' ' 165' ' ' LYS . 96.3 m -88.81 91.11 8.69 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 124.45 2.072 . . . . 0.0 105.467 165.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -146.89 137.79 23.91 Favored 'General case' 0 N--CA 1.432 -1.34 0 O-C-N 118.682 -2.511 . . . . 0.0 111.585 -160.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 170' ' ' MET . . . . . 0.649 ' HA ' ' HB ' ' C' ' 146' ' ' VAL . 54.3 mtm -69.97 107.58 3.66 Favored 'General case' 0 N--CA 1.418 -2.044 0 O-C-N 121.507 -0.746 . . . . 0.0 110.077 162.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 171' ' ' LEU . . . . . 0.401 ' HB2' HG23 ' C' ' 145' ' ' ILE . 7.5 mp -79.22 130.56 35.6 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 172.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 172' ' ' PHE . . . . . 0.543 ' HA ' ' O ' ' C' ' 148' ' ' LYS . 68.9 m-85 -82.5 85.73 6.89 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 125.675 1.86 . . . . 0.0 110.853 -167.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -162.68 150.14 18.86 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 124.561 1.077 . . . . 0.0 111.388 -173.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 174' ' ' ASP . . . . . 0.638 ' HB3' ' HB3' ' C' ' 177' ' ' ALA . 9.7 t70 -68.07 149.42 49.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.607 -0.796 . . . . 0.0 112.01 176.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.82 -51.67 45.96 Favored 'General case' 0 C--O 1.241 0.653 0 O-C-N 121.329 -0.857 . . . . 0.0 108.879 -175.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.66 -54.5 19.08 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 116.39 -1.767 . . . . 0.0 106.277 178.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 177' ' ' ALA . . . . . 0.638 ' HB3' ' HB3' ' C' ' 174' ' ' ASP . . . -53.47 -55.99 20.69 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 -174.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 6.4 m -60.71 -37.52 81.98 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 121.622 -0.674 . . . . 0.0 110.869 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 179' ' ' VAL . . . . . 0.522 ' HA ' HG12 ' C' ' 182' ' ' ILE . 50.9 t -67.56 -36.99 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 120.617 -1.302 . . . . 0.0 110.366 175.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -59.39 -39.17 82.5 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 125.934 1.694 . . . . 0.0 109.661 174.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.34 -52.98 62.41 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 120.926 0.393 . . . . 0.0 110.075 173.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 182' ' ' ILE . . . . . 0.522 HG12 ' HA ' ' C' ' 179' ' ' VAL . 20.8 pt -75.53 -19.77 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 O-C-N 119.592 -1.943 . . . . 0.0 114.106 -175.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 183' ' ' LEU . . . . . 0.728 ' HB2' ' HB3' ' C' ' 52' ' ' GLU . 4.2 pp -58.57 -44.85 89.87 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 122.106 2.23 . . . . 0.0 115.271 -167.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 184' ' ' LYS . . . . . 0.483 ' N ' HD12 ' C' ' 183' ' ' LEU . 13.5 tttp -96.12 -14.4 22.87 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.575 168.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 185' ' ' ALA . . . . . 0.447 ' HB3' ' HA ' ' C' ' 182' ' ' ILE . . . -80.19 -74.47 0.31 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 119.251 -0.98 . . . . 0.0 111.607 -176.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 186' ' ' LEU . . . . . . . . . . . . 0.301 1.9 pt? . . . . . 0 C--N 1.363 1.158 0 N-CA-C 117.582 2.438 . . . . 0.0 117.582 -171.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1000 ' ' HIS . . . . . 0.426 ' O ' ' HB2' ' A' 1067 ' ' GLU . 26.4 t-80 . . . . . 0 CA--C 1.512 -0.505 0 N-CA-C 102.757 -3.053 . . . . 65.739999999999995 102.757 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1001 ' ' GLY . . . . . 0.41 ' HA2' ' HB2' ' A' 1067 ' ' GLU . . . -69.17 78.13 0.3 Allowed Glycine 0 CA--C 1.533 1.176 0 CA-C-O 122.337 0.965 . . . . 48.659999999999997 112.565 -167.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1002 ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' 1032 ' ' THR . 21.1 ttp180 -125.55 141.06 52.24 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 103.323 -2.843 . . . . 44.560000000000002 103.323 177.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1003 ' ' ILE . . . . . 0.496 HG12 ' HB ' ' A' 1068 ' ' ILE . 96.0 mt -105.88 127.07 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 O-C-N 117.995 -2.941 . . . . 34.859999999999999 104.787 169.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -92.89 136.71 13.3 Favored Glycine 0 N--CA 1.434 -1.487 0 CA-C-N 115.463 -0.79 . . . . 30.75 111.419 170.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.729 HG23 ' HB3' ' A' 1017 ' ' ALA . 37.5 mm -109.87 99.31 38.05 Favored Pre-proline 0 C--O 1.248 0.99 0 N-CA-C 103.75 -2.685 . . . . 32.210000000000001 103.75 173.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -80.57 144.68 15.95 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 124.536 3.491 . . . . 32.979999999999997 112.636 174.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1007 ' ' ARG . . . . . . . . . . . . . 10.0 ttp85 -75.42 155.11 36.68 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 113.25 -1.795 . . . . 47.979999999999997 107.878 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1008 ' ' GLU . . . . . 0.486 ' CD ' ' HZ3' ' A' 1071 ' ' LYS . 4.7 mm-40 -83.9 146.23 28.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 118.409 2.744 . . . . 34.700000000000003 118.409 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -83.45 -30.28 27.37 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 111.704 -2.498 . . . . 53.369999999999997 110.792 166.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1010 ' ' LEU . . . . . 0.441 HD22 ' ND2' ' A' 1073 ' ' ASN . 2.5 mp -49.32 135.64 16.96 Favored 'General case' 0 C--O 1.251 1.175 0 C-N-CA 125.024 1.33 . . . . 45.07 113.389 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1011 ' ' THR . . . . . . . . . . . . . 2.3 m -68.95 147.17 52.03 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 123.289 1.518 . . . . 40.359999999999999 107.205 -177.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 10.7 t30 65.06 -17.01 0.09 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 112.795 -2.002 . . . . 40.609999999999999 114.354 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -69.53 112.92 6.37 Favored 'General case' 0 C--O 1.243 0.713 0 O-C-N 119.398 -2.064 . . . . 33.759999999999998 111.049 -165.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1014 ' ' THR . . . . . 0.57 ' HB ' ' HB3' ' A' 1320 ' ' PRO . 0.0 OUTLIER -96.36 -13.19 23.43 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 112.727 0.64 . . . . 27.890000000000001 112.727 173.914 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 1015 ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.02 136.88 39.96 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 118.988 -2.32 . . . . 29.02 106.555 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1016 ' ' VAL . . . . . 0.568 HG12 ' HB2' ' A' 1043 ' ' ALA . 4.2 p -109.72 -178.51 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.101 0 N-CA-C 106.42 -1.696 . . . . 28.129999999999999 106.42 168.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1017 ' ' ALA . . . . . 0.729 ' HB3' HG23 ' A' 1005 ' ' ILE . . . -68.99 -53.65 19.45 Favored 'General case' 0 C--N 1.309 -1.18 0 O-C-N 120.538 -1.351 . . . . 26.870000000000001 111.817 -176.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -136.03 140.76 44.1 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.675 0.75 . . . . 26.77 112.404 -173.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1019 ' ' THR . . . . . 0.477 HG23 ' HB2' ' A' 1324 ' ' SER . 3.4 p -79.6 166.66 39.69 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 124.311 1.044 . . . . 27.02 111.494 172.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1020 ' ' PRO . . . . . 0.472 ' O ' ' HB2' ' A' 1024 ' ' GLU . 0.2 OUTLIER -51.07 -38.94 60.81 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.614 2.876 . . . . 30.57 114.585 171.262 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 52.2 mttp -56.1 -48.89 75.29 Favored 'General case' 0 C--O 1.219 -0.541 0 O-C-N 123.965 0.791 . . . . 47.810000000000002 111.802 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1022 ' ' THR . . . . . . . . . . . . . 1.9 p -74.44 -40.08 62.16 Favored 'General case' 0 C--N 1.348 0.505 0 C-N-CA 119.354 -0.938 . . . . 30.77 111.11 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1023 ' ' VAL . . . . . 0.567 ' HA ' HD12 ' A' 1026 ' ' LEU . 3.3 t -51.65 -42.46 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 113.091 0.775 . . . . 33.590000000000003 113.091 170.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1024 ' ' GLU . . . . . 0.583 ' HA ' HD12 ' A' 1027 ' ' LEU . 23.2 tt0 -59.4 -43.77 92.94 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 124.278 1.031 . . . . 53.289999999999999 109.545 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -69.06 -40.38 78.56 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 125.294 1.438 . . . . 46.920000000000002 110.014 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1026 ' ' LEU . . . . . 0.567 HD12 ' HA ' ' A' 1023 ' ' VAL . 91.0 mt -54.51 -46.49 73.51 Favored 'General case' 0 C--O 1.248 0.974 0 C-N-CA 124.036 0.934 . . . . 37.170000000000002 112.364 171.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1027 ' ' LEU . . . . . 0.583 HD12 ' HA ' ' A' 1024 ' ' GLU . 14.3 mt -57.85 -43.0 85.6 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-O 118.177 -0.916 . . . . 44.439999999999998 111.922 170.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 55.7 mmtt -60.38 -20.29 58.98 Favored 'General case' 0 C--O 1.257 1.493 0 C-N-CA 124.296 1.039 . . . . 52.579999999999998 113.714 174.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1029 ' ' LEU . . . . . 0.502 HD23 ' HE3' ' A' 1342 ' ' LYS . 32.3 mt -78.35 24.31 0.27 Allowed 'General case' 0 N--CA 1.472 0.67 0 O-C-N 119.617 -1.927 . . . . 45.689999999999998 114.791 164.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 68.94 13.75 66.99 Favored Glycine 0 C--N 1.343 0.933 0 O-C-N 119.899 -1.75 . . . . 42.090000000000003 113.546 -176.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -93.29 159.44 15.27 Favored 'General case' 0 C--O 1.251 1.176 0 CA-C-N 121.91 2.855 . . . . 40.719999999999999 110.928 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1032 ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' 1002 ' ' ARG . 0.6 OUTLIER -87.95 155.2 19.96 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 103.707 -2.701 . . . . 37.770000000000003 103.707 158.562 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 1033 ' ' VAL . . . . . . . . . . . . . 87.2 t -135.51 131.3 51.11 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 O-C-N 120.037 -1.665 . . . . 33.539999999999999 108.511 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -116.07 143.59 45.26 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 119.217 0.917 . . . . 31.68 109.46 171.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1035 ' ' VAL . . . . . 0.503 HG21 ' CD1' ' A' 1050 ' ' PHE . 80.0 t -128.77 137.0 58.46 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.52 0 O-C-N 119.452 -2.03 . . . . 31.52 108.273 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1036 ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -73.3 119.43 17.52 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 119.542 -1.974 . . . . 41.039999999999999 108.419 174.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1037 ' ' SER . . . . . 0.538 ' HB2' HG23 ' A' 1057 ' ' ILE . 19.7 t -63.49 144.18 57.2 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.853 0.835 . . . . 31.829999999999998 110.072 -171.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 110.27 -31.61 7.29 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 107.378 -2.289 . . . . 29.359999999999999 107.378 -169.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -52.44 -34.03 46.77 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.456 1.28 . . . . 27.780000000000001 114.456 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -60.6 -48.85 84.14 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 120.306 1.412 . . . . 28.91 112.25 172.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -65.05 -31.72 73.09 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 114.507 -0.847 . . . . 51.18 112.518 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1042 ' ' LEU . . . . . . . . . . . . . 8.9 mp -67.91 -66.9 0.51 Allowed 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.587 0.708 . . . . 29.91 109.407 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1043 ' ' ALA . . . . . 0.568 ' HB2' HG12 ' A' 1016 ' ' VAL . . . -66.36 -5.54 11.11 Favored 'General case' 0 N--CA 1.439 -1.0 0 O-C-N 121.239 -0.913 . . . . 28.539999999999999 111.496 -171.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1044 ' ' SER . . . . . 0.446 ' HB3' ' HA2' ' B' 1278 ' ' GLY . 16.6 m 62.45 72.59 0.49 Allowed 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 126.967 3.27 . . . . 33.060000000000002 110.077 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1045 ' ' PHE . . . . . . . . . . . . . 1.9 t80 -157.57 155.03 29.49 Favored 'General case' 0 N--CA 1.423 -1.784 1 CA-C-N 108.063 -4.153 . . . . 30.289999999999999 101.896 -172.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 10.7 t0 -68.18 123.83 21.77 Favored 'General case' 0 N--CA 1.439 -0.999 0 O-C-N 120.394 -1.441 . . . . 48.619999999999997 109.688 171.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.65 -49.34 77.93 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 122.811 1.291 . . . . 36.740000000000002 111.69 176.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.01 -13.71 62.35 Favored 'General case' 0 N--CA 1.434 -1.273 0 O-C-N 119.031 -2.293 . . . . 43.729999999999997 112.081 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -65.19 -15.63 62.65 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 116.957 -1.497 . . . . 32.810000000000002 113.904 168.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1050 ' ' PHE . . . . . 0.503 ' CD1' HG21 ' A' 1035 ' ' VAL . 62.9 m-85 -65.82 -47.0 76.51 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 106.464 -1.68 . . . . 31.859999999999999 106.464 167.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 76.6 t -60.71 -38.55 78.99 Favored 'Isoleucine or valine' 0 C--O 1.254 1.318 0 CA-C-O 118.266 -0.873 . . . . 33.219999999999999 111.242 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -52.91 -50.58 63.66 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 119.398 0.999 . . . . 50.829999999999998 113.009 171.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -61.37 -33.89 74.39 Favored 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 124.339 1.056 . . . . 33.119999999999997 112.213 173.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 114.24 15.96 8.05 Favored Glycine 0 C--O 1.257 1.552 0 O-C-N 120.436 -1.415 . . . . 35.829999999999998 111.326 175.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1055 ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' A' 1050 ' ' PHE . . . -84.42 140.15 31.73 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 107.374 -1.343 . . . . 34.82 107.374 177.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -70.09 121.3 17.21 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 117.534 -1.222 . . . . 49.049999999999997 111.101 172.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1057 ' ' ILE . . . . . 0.538 HG23 ' HB2' ' A' 1037 ' ' SER . 3.6 mm -90.11 103.16 13.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 104.9 -2.259 . . . . 38.530000000000001 104.9 177.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1058 ' ' VAL . . . . . 0.474 ' HB ' ' HB2' ' A' 1062 ' ' SER . 34.6 m -110.98 172.15 2.78 Favored 'Isoleucine or valine' 0 C--O 1.252 1.236 0 CA-C-N 113.309 -1.769 . . . . 42.109999999999999 108.432 -170.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -119.35 131.99 55.79 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 106.666 -1.605 . . . . 58.0 106.666 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1060 ' ' GLY . . . . . 0.542 ' O ' HG12 ' A' 1063 ' ' VAL . . . 54.86 -129.14 44.7 Favored Glycine 0 CA--C 1.526 0.736 0 O-C-N 125.375 1.672 . . . . 52.119999999999997 112.918 169.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 1.4 t30 -57.0 -26.43 60.22 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 112.807 -1.697 . . . . 54.75 112.643 -168.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1062 ' ' SER . . . . . 0.474 ' HB2' ' HB ' ' A' 1058 ' ' VAL . 3.0 m -55.83 -37.31 68.53 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-O 122.56 1.172 . . . . 50.340000000000003 111.863 -179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1063 ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' 1060 ' ' GLY . 9.3 p -62.26 -33.43 58.83 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.186 0 O-C-N 119.19 -2.194 . . . . 41.460000000000001 116.183 176.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1064 ' ' TRP . . . . . 0.435 ' HA ' HD11 ' A' 1069 ' ' ILE . 93.2 m95 -74.0 -15.86 61.08 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 113.551 0.945 . . . . 39.32 113.551 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -82.63 83.02 7.77 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.408 1.099 . . . . 55.380000000000003 108.427 170.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1066 ' ' SER . . . . . . . . . . . . . 66.1 m -153.65 173.9 15.19 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 113.769 -1.56 . . . . 41.869999999999997 110.549 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1067 ' ' GLU . . . . . 0.731 ' HB3' HD12 ' A' 1068 ' ' ILE . 0.3 OUTLIER -77.74 -57.16 3.96 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 106.976 -1.49 . . . . 53.200000000000003 106.976 173.341 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 1068 ' ' ILE . . . . . 0.731 HD12 ' HB3' ' A' 1067 ' ' GLU . 5.4 mp -109.68 149.22 12.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 105.45 -2.056 . . . . 41.899999999999999 105.45 -176.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1069 ' ' ILE . . . . . 0.435 HD11 ' HA ' ' A' 1064 ' ' TRP . 20.6 mm -128.78 120.16 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 N-CA-C 104.39 -2.448 . . . . 38.729999999999997 104.39 172.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1070 ' ' LEU . . . . . 0.591 HD22 HD22 ' A' 1331 ' ' LEU . 33.9 mt -97.69 97.93 9.44 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 104.908 -2.256 . . . . 32.439999999999998 104.908 175.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1071 ' ' LYS . . . . . 0.486 ' HZ3' ' CD ' ' A' 1008 ' ' GLU . 7.5 tmtt? -90.36 141.51 28.66 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 125.608 2.623 . . . . 34.649999999999999 109.074 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1072 ' ' VAL . . . . . 0.434 ' HA ' ' HE2' ' A' 1327 ' ' TYR . 15.1 t -62.86 -46.34 96.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 111.531 -2.577 . . . . 31.32 109.888 -168.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1073 ' ' ASN . . . . . 0.489 ' HA ' ' HB2' ' A' 1092 ' ' PHE . 63.3 m-80 -127.42 -160.11 0.98 Allowed 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.082 -1.081 . . . . 33.939999999999998 108.082 172.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -67.96 147.56 98.46 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 121.869 2.122 . . . . 38.039999999999999 111.481 173.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1075 ' ' PRO . . . . . 0.605 ' HG2' HD21 ' A' 1089 ' ' LEU . 22.9 Cg_exo -63.38 132.46 36.02 Favored 'Trans proline' 0 C--O 1.266 1.89 0 C-N-CA 123.332 2.688 . . . . 42.68 111.065 163.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 11.8 mt -90.81 175.98 6.8 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 105.51 -2.033 . . . . 46.740000000000002 105.51 170.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.71 -31.82 49.56 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.655 1.724 . . . . 58.609999999999999 115.655 -171.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 13.1 t70 -65.9 -52.06 53.35 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.037 -0.727 . . . . 59.200000000000003 109.037 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1079 ' ' GLU . . . . . 0.578 ' HA ' HD12 ' A' 1082 ' ' LEU . 1.9 mp0 -62.92 -31.03 72.02 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 114.294 1.22 . . . . 50.630000000000003 114.294 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1080 ' ' ILE . . . . . 0.447 HD13 ' HB2' ' A' 1104 ' ' LYS . 57.5 mt -61.97 -44.88 99.52 Favored 'Isoleucine or valine' 0 C--N 1.346 0.418 0 CA-C-N 115.948 -0.569 . . . . 51.479999999999997 111.109 170.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -59.49 -33.23 71.07 Favored 'General case' 0 C--O 1.25 1.112 0 CA-C-O 122.755 1.264 . . . . 50.280000000000001 113.646 170.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1082 ' ' LEU . . . . . 0.578 HD12 ' HA ' ' A' 1079 ' ' GLU . 66.2 mt -72.33 -26.77 62.06 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.228 -1.351 . . . . 50.210000000000001 112.49 173.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1083 ' ' LEU . . . . . 0.627 HD12 HG11 ' A' 1110 ' ' VAL . 3.6 mm? -60.81 149.73 34.97 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 125.73 2.681 . . . . 49.060000000000002 113.574 172.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 4.9 m120 -113.3 136.84 21.86 Favored Pre-proline 0 N--CA 1.437 -1.106 0 CA-C-N 111.361 -2.654 . . . . 51.079999999999998 107.097 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -60.2 124.59 15.53 Favored 'Trans proline' 0 N--CA 1.435 -1.914 0 C-N-CA 121.4 1.4 . . . . 49.729999999999997 115.014 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 91.7 8.43 63.77 Favored Glycine 0 C--O 1.259 1.709 0 N-CA-C 111.158 -0.777 . . . . 47.710000000000001 111.158 -177.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1087 ' ' THR . . . . . 0.406 HG21 HG12 ' A' 1069 ' ' ILE . 72.7 m -84.66 145.64 27.87 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 123.208 1.48 . . . . 45.469999999999999 110.652 167.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1088 ' ' THR . . . . . . . . . . . . . 52.3 m -91.98 121.53 33.65 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 118.19 -2.819 . . . . 42.039999999999999 104.295 173.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1089 ' ' LEU . . . . . 0.605 HD21 ' HG2' ' A' 1075 ' ' PRO . 55.6 tp -106.84 116.66 32.3 Favored 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 123.961 0.904 . . . . 38.060000000000002 109.029 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 38.5 t -114.62 124.49 71.32 Favored 'Isoleucine or valine' 0 C--O 1.25 1.081 0 N-CA-C 105.184 -2.154 . . . . 37.399999999999999 105.184 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1091 ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' 1073 ' ' ASN . 3.5 m -158.46 168.56 26.62 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 122.424 1.107 . . . . 36.159999999999997 113.049 -174.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1092 ' ' PHE . . . . . 0.489 ' HB2' ' HA ' ' A' 1073 ' ' ASN . 14.9 m-85 -82.23 94.85 7.38 Favored 'General case' 0 C--O 1.25 1.087 0 O-C-N 119.579 -1.951 . . . . 38.939999999999998 108.486 165.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 26.6 mm -84.76 -34.63 9.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 113.864 1.061 . . . . 42.170000000000002 113.864 -172.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 84.0 m95 57.99 60.06 6.29 Favored Pre-proline 0 C--N 1.357 0.921 0 C-N-CA 123.086 0.554 . . . . 46.509999999999998 111.56 -169.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -62.78 -34.22 73.59 Favored 'Trans proline' 0 C--O 1.241 0.646 0 C-N-CA 124.185 3.257 . . . . 49.759999999999998 117.013 -165.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -69.2 -35.99 76.82 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 124.643 1.215 . . . . 52.619999999999997 108.784 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -76.78 -30.28 56.42 Favored 'General case' 0 C--O 1.216 -0.669 0 CA-C-N 115.151 -0.931 . . . . 60.740000000000002 109.34 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1098 ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -109.84 36.03 0.11 Allowed Pre-proline 0 CA--C 1.557 1.215 1 N-CA-C 124.96 5.17 . . . . 58.189999999999998 124.96 -169.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -52.09 -24.08 18.96 Favored 'Trans proline' 0 C--N 1.366 1.493 0 C-N-CA 124.655 3.57 . . . . 54.590000000000003 113.961 175.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -57.84 -59.53 5.09 Favored 'General case' 0 C--O 1.253 1.287 0 CA-C-O 124.396 2.046 . . . . 63.280000000000001 110.019 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1101 ' ' LEU . . . . . . . . . . . . . 5.4 mp -70.55 -42.07 71.66 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 111.526 -2.579 . . . . 54.75 107.587 -175.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1102 ' ' MET . . . . . . . . . . . . . 72.0 mtm -56.74 -39.22 73.56 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 114.757 1.391 . . . . 52.649999999999999 114.757 174.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -62.78 -38.33 90.2 Favored 'General case' 0 C--N 1.35 0.608 0 O-C-N 119.968 -1.707 . . . . 66.260000000000005 110.329 -178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1104 ' ' LYS . . . . . 0.447 ' HB2' HD13 ' A' 1080 ' ' ILE . 87.7 mttt -74.18 -36.76 64.07 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 114.262 -1.335 . . . . 63.729999999999997 110.49 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 22.6 mt -63.64 -35.1 79.41 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 120.652 -1.28 . . . . 54.68 112.699 169.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -65.97 -41.45 91.17 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 106.907 -1.516 . . . . 53.640000000000001 106.907 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -51.46 -46.01 62.91 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 113.94 1.089 . . . . 67.239999999999995 113.94 168.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -67.18 1.12 2.24 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 115.848 1.796 . . . . 65.760000000000005 115.848 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 12.6 t-20 49.81 44.55 25.03 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 125.088 2.375 . . . . 58.710000000000001 113.925 177.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1110 ' ' VAL . . . . . 0.627 HG11 HD12 ' A' 1083 ' ' LEU . 3.7 m -110.75 152.6 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 113.944 -1.48 . . . . 46.630000000000003 109.421 -178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1111 ' ' THR . . . . . . . . . . . . . 89.4 m -89.14 99.85 12.75 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 106.881 -1.526 . . . . 44.130000000000003 106.881 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1112 ' ' VAL . . . . . 0.57 ' HB ' ' HB ' ' A' 1361 ' ' ILE . 91.6 t -91.56 128.01 43.55 Favored 'Isoleucine or valine' 0 C--O 1.253 1.25 0 CA-C-O 123.829 1.776 . . . . 40.439999999999998 110.366 -176.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1113 ' ' MET . . . . . 0.648 ' SD ' HD21 ' A' 1334 ' ' LEU . 35.2 mtp -119.27 123.18 43.63 Favored 'General case' 0 C--O 1.255 1.367 0 N-CA-C 105.79 -1.93 . . . . 50.759999999999998 105.79 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1114 ' ' ALA . . . . . . . . . . . . . . . -99.42 96.62 7.82 Favored 'General case' 0 N--CA 1.428 -1.575 0 O-C-N 124.106 0.879 . . . . 35.640000000000001 111.896 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1115 ' ' MET . . . . . 0.563 ' HB3' ' HB3' ' A' 1129 ' ' ALA . 36.0 mmm -65.33 -17.77 64.78 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 116.765 2.135 . . . . 38.740000000000002 116.765 -173.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1116 ' ' ASP . . . . . 0.462 ' HA ' ' HB2' ' A' 1130 ' ' LEU . 7.5 p-10 -73.67 -36.52 65.35 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 118.179 -0.915 . . . . 40.140000000000001 108.561 168.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1117 ' ' SER . . . . . . . . . . . . . 63.6 m -102.37 62.3 0.86 Allowed 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 125.05 2.357 . . . . 44.789999999999999 109.801 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1118 ' ' VAL . . . . . . . . . . . . . 87.4 t -90.94 134.31 30.5 Favored Pre-proline 0 C--O 1.243 0.739 0 N-CA-C 106.55 -1.648 . . . . 43.75 106.55 174.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -46.13 120.9 3.96 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.732 3.622 . . . . 48.93 111.299 171.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -63.3 -4.56 2.66 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 117.502 2.408 . . . . 62.899999999999999 117.502 -169.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 45.1 pt -66.77 158.14 5.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 115.172 1.545 . . . . 57.719999999999999 115.172 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1122 ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.66 -49.19 68.48 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 125.499 1.75 . . . . 57.259999999999998 114.242 -173.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 21.4 ptt85 -63.21 -13.34 36.43 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 118.36 -2.712 . . . . 62.899999999999999 115.286 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -89.65 -21.37 22.81 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 120.394 -1.441 . . . . 49.829999999999998 108.573 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -61.27 -20.51 62.96 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 115.532 1.679 . . . . 52.369999999999997 115.532 -163.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1126 ' ' SER . . . . . . . . . . . . . 6.0 p -68.52 -39.0 81.36 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.184 0.902 . . . . 42.43 112.341 168.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1127 ' ' LEU . . . . . 0.438 ' O ' ' HB3' ' A' 1330 ' ' ASN . 5.1 mp -82.56 -23.68 34.36 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.277 -0.874 . . . . 43.740000000000002 110.977 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 10.1 t0 -68.04 105.03 1.91 Allowed 'General case' 0 C--O 1.246 0.908 0 CA-C-O 124.658 2.17 . . . . 43.210000000000001 112.361 -167.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1129 ' ' ALA . . . . . 0.563 ' HB3' ' HB3' ' A' 1115 ' ' MET . . . -72.37 -41.22 66.63 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 111.159 -2.746 . . . . 35.740000000000002 111.502 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1130 ' ' LEU . . . . . 0.462 ' HB2' ' HA ' ' A' 1116 ' ' ASP . 9.0 tp -54.94 -40.94 70.47 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 118.889 0.768 . . . . 38.090000000000003 112.009 175.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1131 ' ' SER . . . . . 0.651 ' HA ' HG21 ' A' 1175 ' ' VAL . 68.1 m -54.8 -53.01 60.82 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-N 119.979 1.263 . . . . 36.909999999999997 112.732 176.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1132 ' ' SER . . . . . . . . . . . . . 4.6 m -65.2 -37.49 87.48 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 119.312 0.96 . . . . 35.789999999999999 113.303 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1133 ' ' MET . . . . . 0.478 ' HE2' HD12 ' A' 1136 ' ' ILE . 24.8 mmt -59.46 -45.46 91.56 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 121.893 2.133 . . . . 30.809999999999999 115.69 171.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1134 ' ' ALA . . . . . 0.439 ' HB1' ' HB2' ' A' 1176 ' ' ALA . . . -69.29 -39.75 78.13 Favored 'General case' 0 CA--C 1.504 -0.803 0 O-C-N 124.275 0.984 . . . . 28.879999999999999 109.936 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1135 ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -53.27 -47.76 68.86 Favored 'General case' 0 C--O 1.245 0.86 0 O-C-N 123.972 0.795 . . . . 40.759999999999998 112.518 169.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1136 ' ' ILE . . . . . 0.744 HG23 HD23 ' A' 1319 ' ' LEU . 71.4 mt -59.95 -44.71 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 107.951 -1.129 . . . . 31.539999999999999 107.951 177.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -60.06 -44.01 95.02 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-O 117.251 -1.357 . . . . 29.870000000000001 111.109 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -62.3 -46.79 93.17 Favored Glycine 0 N--CA 1.439 -1.155 0 CA-C-N 123.074 2.67 . . . . 28.73 112.478 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 36.5 t80 -59.87 -48.97 79.52 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 122.353 1.073 . . . . 30.390000000000001 109.226 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1140 ' ' ARG . . . . . 0.66 HH11 HD13 ' A' 1319 ' ' LEU . 3.7 tpt180 -65.58 -24.46 67.08 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 112.895 0.702 . . . . 26.09 112.895 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1141 ' ' ALA . . . . . 0.839 ' HB2' HD21 ' A' 1284 ' ' LEU . . . -65.73 -44.83 84.82 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 109.655 -0.498 . . . . 27.100000000000001 109.655 173.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1142 ' ' ILE . . . . . 0.461 HG13 ' HB3' ' A' 1183 ' ' ALA . 42.2 mm -57.36 -38.67 63.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 123.984 0.914 . . . . 28.48 109.664 175.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 97.7 t -68.05 -59.89 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-O 121.242 0.544 . . . . 23.07 111.804 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1144 ' ' GLU . . . . . 0.421 ' CD ' HH21 ' A' 1140 ' ' ARG . 4.4 mm-40 -61.05 -28.56 69.16 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 120.637 -1.289 . . . . 33.399999999999999 111.642 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1145 ' ' ALA . . . . . 0.525 ' HB1' HD12 ' A' 1251 ' ' ILE . . . -65.73 -60.71 2.62 Favored 'General case' 0 C--O 1.206 -1.209 0 CA-C-O 115.256 -2.307 . . . . 24.219999999999999 107.227 171.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -55.17 -18.62 6.11 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 121.922 2.146 . . . . 24.890000000000001 115.881 176.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -68.21 -56.36 8.97 Favored 'General case' 0 N--CA 1.439 -1.011 0 O-C-N 120.438 -1.413 . . . . 26.73 111.267 169.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1148 ' ' GLU . . . . . 0.666 ' HB2' HD11 ' A' 1310 ' ' ILE . 54.3 mm-40 -90.35 -12.67 36.96 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 118.025 2.602 . . . . 39.960000000000001 118.025 -174.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1149 ' ' PHE . . . . . . . . . . . . . 2.9 t80 -67.92 152.24 45.86 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 124.086 1.898 . . . . 25.870000000000001 108.186 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1150 ' ' GLY . . . . . . . . . . . . . . . -74.01 -48.62 15.31 Favored Glycine 0 N--CA 1.41 -3.058 0 CA-C-N 111.554 -2.566 . . . . 19.280000000000001 113.075 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1151 ' ' ARG . . . . . 0.765 ' HA ' ' HB2' ' B' 1322 ' ' GLN . 61.8 mtm-85 -103.56 176.25 5.21 Favored 'General case' 0 C--O 1.25 1.1 0 N-CA-C 109.241 -0.652 . . . . 39.899999999999999 109.241 -164.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1152 ' ' PHE . . . . . 0.7 ' HB2' HG11 ' A' 1163 ' ' VAL . 12.0 m-30 -76.24 161.11 29.04 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 120.87 -1.144 . . . . 29.440000000000001 108.122 169.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1153 ' ' PHE . . . . . 0.606 ' HB3' ' HB2' ' A' 1189 ' ' ALA . 7.8 m-85 -78.78 -48.61 14.51 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 122.891 1.329 . . . . 32.600000000000001 108.662 168.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1154 ' ' THR . . . . . . . . . . . . . 9.7 m -64.45 116.62 6.3 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 115.252 1.575 . . . . 34.640000000000001 115.252 -170.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -66.49 88.67 0.13 Allowed Glycine 0 C--O 1.24 0.486 0 N-CA-C 110.666 -0.973 . . . . 37.140000000000001 110.666 173.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -139.45 178.89 6.88 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 124.883 2.278 . . . . 40.57 111.137 -173.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1157 ' ' ILE . . . . . 0.693 ' HB ' ' HG2' ' C' ' 95' ' ' GLU . 3.1 tp -107.53 153.44 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 112.928 -1.942 . . . . 44.609999999999999 107.548 167.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1158 ' ' THR . . . . . 0.501 ' O ' HG13 ' A' 1157 ' ' ILE . 24.5 p -103.76 -143.63 0.36 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.539 -1.282 . . . . 40.700000000000003 107.539 169.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -94.45 -25.15 17.02 Favored 'General case' 0 C--O 1.246 0.869 0 O-C-N 119.301 -2.124 . . . . 40.25 110.233 167.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -82.78 -56.53 3.78 Favored 'General case' 0 C--O 1.249 1.059 0 O-C-N 121.914 -0.491 . . . . 38.469999999999999 111.952 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1161 ' ' GLY . . . . . 0.623 ' HA3' HG21 ' B' 1329 ' ' THR . . . -169.02 -173.42 36.71 Favored Glycine 0 N--CA 1.476 1.333 0 N-CA-C 111.894 -0.483 . . . . 37.609999999999999 111.894 -164.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 15.6 tttp -78.35 151.8 32.68 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 126.057 1.743 . . . . 48.899999999999999 111.772 -170.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1163 ' ' VAL . . . . . 0.7 HG11 ' HB2' ' A' 1152 ' ' PHE . 92.5 t -102.07 123.86 42.04 Favored Pre-proline 0 N--CA 1.44 -0.942 0 CA-C-N 113.197 -1.82 . . . . 36.520000000000003 108.019 161.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1164 ' ' PRO . . . . . 0.502 ' HD2' ' HA ' ' A' 1163 ' ' VAL . 47.2 Cg_endo -62.82 114.47 2.43 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 123.897 3.064 . . . . 35.079999999999998 115.046 162.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1165 ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' 1164 ' ' PRO . 61.8 Cg_exo -61.91 130.8 32.34 Favored 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 124.142 3.228 . . . . 35.329999999999998 113.42 -171.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1166 ' ' ALA . . . . . 0.427 ' HB2' ' HA ' ' A' 1153 ' ' PHE . . . -66.8 123.39 20.01 Favored 'General case' 0 CA--C 1.501 -0.925 0 O-C-N 125.043 1.464 . . . . 34.689999999999998 112.055 172.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1167 ' ' LYS . . . . . 0.522 ' HA ' ' HB ' ' A' 1190 ' ' ILE . 7.1 mttp -96.89 94.32 7.16 Favored 'General case' 0 CA--C 1.486 -1.494 0 N-CA-C 105.227 -2.138 . . . . 45.359999999999999 105.227 176.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 20.2 t -82.19 97.83 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 C-N-CA 124.479 1.111 . . . . 31.710000000000001 108.215 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1169 ' ' MET . . . . . 0.483 ' O ' ' HA ' ' A' 1252 ' ' ILE . 59.2 ttp -77.96 125.78 29.85 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.037 -1.468 . . . . 42.280000000000001 107.037 166.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 94.6 t -111.86 112.04 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 106.828 -1.545 . . . . 30.510000000000002 106.828 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1171 ' ' ILE . . . . . 0.535 HD12 HG23 ' A' 1254 ' ' THR . 75.8 mt -88.69 116.29 30.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 119.979 -1.701 . . . . 31.870000000000001 109.412 173.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 93.61 89.51 1.61 Allowed Glycine 0 C--O 1.215 -1.043 0 N-CA-C 109.215 -1.554 . . . . 34.539999999999999 109.215 171.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1173 ' ' ALA . . . . . 0.489 ' HA ' ' HA3' ' A' 1177 ' ' GLY . . . -80.95 67.73 6.96 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 123.05 1.405 . . . . 32.509999999999998 110.19 176.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -100.98 -153.73 26.5 Favored Glycine 0 C--O 1.217 -0.95 0 CA-C-O 117.101 -1.944 . . . . 29.899999999999999 108.369 167.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1175 ' ' VAL . . . . . 0.651 HG21 ' HA ' ' A' 1131 ' ' SER . 0.0 OUTLIER -58.45 -49.03 83.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 CA-C-N 121.438 2.619 . . . . 33.109999999999999 111.931 -178.542 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 1176 ' ' ALA . . . . . 0.439 ' HB2' ' HB1' ' A' 1134 ' ' ALA 0.26 . . -59.89 -36.98 78.11 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 121.984 0.897 . . . . 28.100000000000001 110.538 174.91 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 1177 ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' 1173 ' ' ALA . . . -63.96 -55.05 26.57 Favored Glycine 0 C--O 1.215 -1.057 0 N-CA-C 109.63 -1.388 . . . . 28.539999999999999 109.63 -175.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1178 ' ' LEU . . . . . 0.673 HD23 HD12 ' A' 1181 ' ' ILE . 29.5 mt -65.7 -30.76 71.49 Favored 'General case' 0 C--O 1.254 1.303 0 CA-C-N 114.231 -0.984 . . . . 31.219999999999999 110.869 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -66.28 -40.34 90.03 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.022 -1.674 . . . . 28.98 112.391 173.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -65.03 -42.18 94.59 Favored 'General case' 0 C--O 1.221 -0.433 0 O-C-N 119.23 -2.169 . . . . 27.829999999999998 112.261 173.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1181 ' ' ILE . . . . . 0.673 HD12 HD23 ' A' 1178 ' ' LEU . 71.1 mt -54.07 -55.09 15.94 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 CA-C-O 118.46 -0.781 . . . . 30.25 110.055 172.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -59.3 -53.27 47.64 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-O 122.957 1.309 . . . . 29.59 111.633 -175.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1183 ' ' ALA . . . . . 0.461 ' HB3' HG13 ' A' 1142 ' ' ILE . . . -50.39 -64.22 0.88 Allowed 'General case' 0 C--N 1.348 0.535 0 O-C-N 120.022 -1.869 . . . . 30.289999999999999 113.535 173.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -60.8 -37.86 83.4 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 115.86 1.8 . . . . 30.469999999999999 115.86 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -60.11 -45.91 91.4 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 107.923 -1.14 . . . . 42.409999999999997 107.923 174.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1186 ' ' SER . . . . . . . . . . . . . 67.4 m -62.77 -44.33 96.47 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 123.458 1.599 . . . . 39.380000000000003 113.026 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 25.2 tp -63.87 -30.94 71.98 Favored 'General case' 0 C--O 1.244 0.796 0 O-C-N 119.765 -1.834 . . . . 36.18 110.36 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 108.89 40.14 1.61 Allowed Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 125.722 1.629 . . . . 33.780000000000001 114.114 170.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1189 ' ' ALA . . . . . 0.606 ' HB2' ' HB3' ' A' 1153 ' ' PHE . . . -108.75 161.18 15.34 Favored 'General case' 0 CA--C 1.49 -1.332 0 O-C-N 121.164 -1.198 . . . . 33.93 110.745 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1190 ' ' ILE . . . . . 0.522 ' HB ' ' HA ' ' A' 1167 ' ' LYS . 67.8 mt -72.56 120.29 20.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 104.996 -2.224 . . . . 38.740000000000002 104.996 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1191 ' ' VAL . . . . . 0.507 HG11 ' HA ' ' A' 1181 ' ' ILE . 10.1 t -110.65 129.2 66.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.15 -1.426 . . . . 33.090000000000003 107.15 175.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1192 ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' 1210 ' ' GLU . 71.9 mtt180 -127.59 101.89 6.6 Favored 'General case' 0 N--CA 1.438 -1.027 0 O-C-N 125.399 1.687 . . . . 38.920000000000002 108.022 173.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -100.47 152.3 20.54 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.619 0.723 . . . . 35.32 112.536 -175.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1194 ' ' PHE . . . . . 0.455 ' HZ ' ' HG2' ' A' 1238 ' ' GLU . 79.1 t80 -128.67 148.35 50.81 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 127.751 2.42 . . . . 39.350000000000001 105.231 -172.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 7.9 t70 -166.59 161.89 16.22 Favored 'General case' 0 C--O 1.243 0.714 0 O-C-N 124.483 1.114 . . . . 40.460000000000001 109.966 170.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1196 ' ' THR . . . . . 0.441 HG23 ' CE2' ' A' 1234 ' ' PHE . 0.8 OUTLIER -67.86 -42.41 81.36 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 113.625 -1.625 . . . . 45.939999999999998 107.734 179.684 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 1197 ' ' ARG . . . . . . . . . . . . . 47.7 mtm180 -94.26 117.67 67.08 Favored Pre-proline 0 C--O 1.212 -0.892 0 C-N-CA 123.97 0.908 . . . . 56.020000000000003 109.65 -162.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1198 ' ' PRO . . . . . 0.47 ' O ' ' HB3' ' A' 1201 ' ' LYS . 74.5 Cg_endo -68.12 -8.82 23.89 Favored 'Trans proline' 0 C--N 1.36 1.142 0 C-N-CA 124.125 3.217 . . . . 51.270000000000003 114.555 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.44 -35.63 34.73 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 120.299 -1.501 . . . . 59.100000000000001 108.485 -177.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 15.0 m -71.36 -26.39 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 113.662 0.986 . . . . 51.060000000000002 113.662 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1201 ' ' LYS . . . . . 0.47 ' HB3' ' O ' ' A' 1198 ' ' PRO . 74.9 tttt -39.39 -42.41 1.07 Allowed 'General case' 0 C--O 1.239 0.512 0 N-CA-C 115.878 1.807 . . . . 57.380000000000003 115.878 166.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -57.37 -47.85 80.59 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 114.814 -1.085 . . . . 62.409999999999997 111.114 177.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -69.46 -41.61 75.97 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 118.752 -0.642 . . . . 57.780000000000001 109.634 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1204 ' ' VAL . . . . . 0.404 HG11 ' HD1' ' A' 1211 ' ' PHE . 99.9 t -51.95 -54.65 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 120.276 1.398 . . . . 46.380000000000003 114.529 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -53.42 -51.22 63.29 Favored 'General case' 0 N--CA 1.427 -1.585 0 C-N-CA 125.208 1.403 . . . . 50.700000000000003 112.452 169.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1206 ' ' SER . . . . . . . . . . . . . 7.1 m -78.41 4.15 13.86 Favored 'General case' 0 C--O 1.261 1.663 0 O-C-N 119.429 -2.044 . . . . 49.979999999999997 115.531 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1207 ' ' MET . . . . . . . . . . . . . 75.6 mtp -99.69 -1.86 36.83 Favored 'General case' 0 C--O 1.244 0.784 0 O-C-N 119.87 -1.769 . . . . 52.990000000000002 111.828 169.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 86.79 48.93 4.26 Favored Glycine 0 C--N 1.346 1.13 0 C-N-CA 120.304 -0.95 . . . . 47.659999999999997 111.112 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -137.62 153.67 49.86 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 124.532 2.11 . . . . 44.770000000000003 108.353 170.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1210 ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' 1192 ' ' ARG . 20.9 tt0 -85.44 134.17 34.07 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 113.094 -1.866 . . . . 47.640000000000001 106.351 172.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1211 ' ' PHE . . . . . 0.404 ' HD1' HG11 ' A' 1204 ' ' VAL . 39.2 t80 -86.09 128.06 34.8 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 120.42 -1.425 . . . . 45.659999999999997 109.174 175.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 32.5 mt -99.44 115.02 28.32 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 106.072 -1.825 . . . . 46.060000000000002 106.072 171.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -88.02 167.88 13.31 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-O 122.708 1.242 . . . . 60.219999999999999 109.876 167.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1214 ' ' LEU . . . . . 0.464 HD23 ' HB3' ' A' 1237 ' ' ALA . 4.9 mp -74.22 136.41 42.76 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 106.471 -1.677 . . . . 57.25 106.471 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.75 92.46 1.57 Allowed 'General case' 0 C--O 1.243 0.734 0 N-CA-C 107.411 -1.329 . . . . 64.430000000000007 107.411 166.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 5.1 t80 . . . . . 0 CA--C 1.506 -0.734 0 CA-C-N 114.326 -1.306 . . . . 66.900000000000006 111.277 -167.368 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 6.1 p-10 . . . . . 0 N--CA 1.443 -0.816 0 N-CA-C 103.313 -2.847 . . . . 39.090000000000003 103.313 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -55.09 -37.36 63.28 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.61 -0.723 . . . . 39.32 113.089 -175.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 84.2 t80 -69.3 -54.26 15.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 117.759 0.78 . . . . 39.299999999999997 111.11 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -67.05 -34.01 76.75 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 119.277 0.944 . . . . 36.299999999999997 112.917 -177.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -62.01 -37.41 84.75 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 113.122 0.786 . . . . 37.380000000000003 113.122 168.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -70.87 -36.1 62.8 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 CA-C-N 121.429 1.922 . . . . 39.109999999999999 110.579 169.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1230 ' ' MET . . . . . . . . . . . . . 33.2 mmt -90.22 63.5 5.78 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 124.101 1.905 . . . . 49.590000000000003 110.97 -177.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1231 ' ' SER . . . . . . . . . . . . . 67.0 m -151.68 126.64 9.73 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 110.847 -2.888 . . . . 43.68 107.141 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -56.78 -18.27 12.1 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 114.136 1.162 . . . . 55.57 114.136 -176.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -56.75 -49.02 76.49 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 114.238 1.199 . . . . 44.939999999999998 114.238 167.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1234 ' ' PHE . . . . . 0.441 ' CE2' HG23 ' A' 1196 ' ' THR . 19.5 t80 -63.07 -56.6 15.49 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 124.835 1.254 . . . . 42.039999999999999 108.151 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1235 ' ' ILE . . . . . 0.415 ' O ' ' HG2' ' A' 1239 ' ' MET . 93.0 mt -51.72 -45.32 37.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 114.532 -1.213 . . . . 46.280000000000001 110.173 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1236 ' ' LYS . . . . . 0.624 ' O ' ' HG3' ' A' 1240 ' ' GLU . 26.7 tttm -66.16 -39.9 90.12 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 115.69 -2.1 . . . . 47.869999999999997 111.791 175.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1237 ' ' ALA . . . . . 0.464 ' HB3' HD23 ' A' 1214 ' ' LEU . . . -64.08 -37.5 87.68 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-N 121.98 2.173 . . . . 41.609999999999999 112.629 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1238 ' ' GLU . . . . . 0.455 ' HG2' ' HZ ' ' A' 1194 ' ' PHE . 48.5 mt-10 -55.59 -56.87 15.24 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 106.524 -1.658 . . . . 50.649999999999999 106.524 170.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1239 ' ' MET . . . . . 0.415 ' HG2' ' O ' ' A' 1235 ' ' ILE . 97.7 mmm -50.0 -48.91 52.17 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.713 1.005 . . . . 48.869999999999997 113.713 178.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1240 ' ' GLU . . . . . 0.624 ' HG3' ' O ' ' A' 1236 ' ' LYS . 29.5 mt-10 -62.72 -40.17 96.36 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 119.462 -2.024 . . . . 54.799999999999997 110.749 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.32 -46.56 79.81 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.455 0.702 . . . . 43.210000000000001 111.855 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -64.33 -47.34 79.77 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 106.659 -1.608 . . . . 38.659999999999997 106.659 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -62.63 -32.9 74.02 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 122.761 1.267 . . . . 37.920000000000002 114.14 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1244 ' ' ALA . . . . . 0.45 ' O ' ' HE2' ' A' 1247 ' ' LYS . . . -70.02 -51.94 28.13 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.634 -0.876 . . . . 37.280000000000001 108.634 174.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -61.31 -29.05 69.64 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 113.593 0.96 . . . . 43.07 113.593 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -51.1 -34.24 29.64 Favored 'General case' 0 C--O 1.248 1.01 0 C-N-CA 126.249 1.82 . . . . 38.299999999999997 112.612 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1247 ' ' LYS . . . . . 0.45 ' HE2' ' O ' ' A' 1244 ' ' ALA . 11.3 mtmm -57.7 -22.3 45.49 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 118.505 2.78 . . . . 47.600000000000001 118.505 174.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.78 -30.73 0.81 Allowed 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 117.383 2.364 . . . . 45.420000000000002 117.383 -171.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1249 ' ' VAL . . . . . . . . . . . . . 34.6 m -70.06 158.6 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 123.661 1.696 . . . . 36.259999999999998 111.386 -173.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1250 ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -103.04 -50.78 3.41 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 113.884 -1.507 . . . . 33.039999999999999 111.641 -172.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1251 ' ' ILE . . . . . 0.525 HD12 ' HB1' ' A' 1145 ' ' ALA . 51.7 mm -121.05 138.33 51.82 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 N-CA-C 103.938 -2.616 . . . . 31.399999999999999 103.938 -177.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1252 ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' 1169 ' ' MET . 39.5 mt -120.87 113.68 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 105.798 -1.927 . . . . 29.420000000000002 105.798 166.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 27.7 t -97.0 111.46 26.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 104.504 -2.406 . . . . 30.370000000000001 104.504 176.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1254 ' ' THR . . . . . 0.535 HG23 HD12 ' A' 1171 ' ' ILE . 0.2 OUTLIER -108.58 112.01 24.13 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 102.468 -3.16 . . . . 35.719999999999999 102.468 -173.532 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 1255 ' ' THR . . . . . 0.522 HG22 HD12 ' A' 1284 ' ' LEU . 66.1 p -98.89 -27.55 13.85 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 120.004 3.335 . . . . 36.0 120.004 -159.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1256 ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' 1263 ' ' ALA . . . -71.19 82.31 0.72 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 118.579 2.807 . . . . 40.93 118.579 -140.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 52.9 tp -84.39 84.18 7.73 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 104.897 -2.26 . . . . 47.82 104.897 175.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 26.0 mm -70.26 131.14 88.77 Favored Pre-proline 0 N--CA 1.431 -1.417 0 CA-C-N 112.701 -2.045 . . . . 52.700000000000003 107.83 172.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -59.78 133.75 52.99 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.3 2.667 . . . . 54.130000000000003 111.144 176.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 76.64 -67.44 2.6 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 122.581 1.101 . . . . 54.619999999999997 115.418 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1261 ' ' LYS . . . . . 0.422 ' HA ' ' HD2' ' A' 1262 ' ' PRO . 85.3 mttt -80.8 129.05 69.58 Favored Pre-proline 0 C--O 1.24 0.575 0 N-CA-C 114.839 1.422 . . . . 55.740000000000002 114.839 -173.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1262 ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' 1261 ' ' LYS . 11.0 Cg_endo -46.0 134.02 14.58 Favored 'Trans proline' 0 N--CA 1.451 -0.976 1 C-N-CA 127.395 5.397 . . . . 51.149999999999999 112.14 167.396 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 1263 ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' 1256 ' ' ALA . . . -64.94 131.88 95.32 Favored Pre-proline 0 C--O 1.246 0.881 0 CA-C-O 117.194 -1.384 . . . . 46.060000000000002 111.95 171.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -66.66 148.56 83.3 Favored 'Trans proline' 0 C--O 1.255 1.352 0 C-N-CA 123.379 2.719 . . . . 41.079999999999998 111.581 -177.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1265 ' ' LYS . . . . . 0.512 ' HD3' ' HA ' ' A' 1293 ' ' GLU . 61.8 mttm -85.75 79.09 9.42 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 124.356 2.026 . . . . 47.420000000000002 112.347 -175.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1266 ' ' LEU . . . . . 0.415 ' O ' ' SD ' ' A' 1239 ' ' MET . 93.5 mt -74.19 -59.01 2.92 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 110.737 -2.938 . . . . 39.219999999999999 113.125 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 63.8 mt -75.29 112.43 12.83 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 CA-C-N 120.884 1.675 . . . . 42.5 107.801 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1268 ' ' THR . . . . . . . . . . . . . 1.1 p -76.92 163.04 27.11 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.005 -1.452 . . . . 37.840000000000003 113.202 -176.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1269 ' ' ARG . . . . . 0.476 ' HG3' ' HB2' ' A' 1293 ' ' GLU . 58.7 mtt-85 -62.5 -40.46 96.78 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-O 121.793 0.806 . . . . 54.799999999999997 112.836 172.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -50.38 -51.86 42.36 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 124.874 1.27 . . . . 54.359999999999999 113.1 167.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1271 ' ' MET . . . . . . . . . . . . . 30.0 ttm -60.43 -48.04 83.47 Favored 'General case' 0 C--O 1.253 1.249 0 C-N-CA 124.831 1.252 . . . . 39.520000000000003 112.136 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1272 ' ' VAL . . . . . . . . . . . . . 60.0 t -57.33 -50.02 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 C-N-CA 123.69 0.796 . . . . 38.25 111.895 176.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -54.05 -43.89 70.61 Favored 'General case' 0 C--O 1.262 1.761 0 O-C-N 119.666 -1.896 . . . . 40.770000000000003 114.432 171.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1274 ' ' SER . . . . . . . . . . . . . 10.5 p -73.02 3.18 5.69 Favored 'General case' 0 CA--C 1.556 1.203 0 O-C-N 120.219 -1.55 . . . . 36.579999999999998 113.646 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1275 ' ' MET . . . . . 0.629 ' HB3' HG21 ' A' 1307 ' ' VAL . 0.3 OUTLIER -78.63 151.65 32.19 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 118.641 -2.537 . . . . 36.75 108.245 -179.071 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 1276 ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -66.4 142.0 57.75 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.056 1.742 . . . . 46.109999999999999 113.007 177.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1277 ' ' ALA . . . . . . . . . . . . . . . -72.69 153.06 41.37 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 115.327 1.603 . . . . 33.520000000000003 115.327 -169.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 80.02 37.66 21.41 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 108.694 -1.762 . . . . 31.27 108.694 174.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1279 ' ' SER . . . . . . . . . . . . . 19.7 m -139.56 163.27 32.99 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 119.27 1.535 . . . . 32.950000000000003 111.065 -160.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1280 ' ' VAL . . . . . 0.629 HG22 ' HB2' ' A' 1308 ' ' LYS . 92.7 t -123.78 148.78 27.76 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 O-C-N 118.496 -2.628 . . . . 27.43 111.175 -173.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1281 ' ' ILE . . . . . 0.406 HG12 ' HB ' ' A' 1252 ' ' ILE . 60.9 mt -121.83 112.18 33.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 103.872 -2.64 . . . . 30.300000000000001 103.872 164.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 4.1 t -98.5 134.59 36.55 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 104.984 -2.228 . . . . 28.629999999999999 104.984 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 6.1 t0 -111.55 121.32 44.86 Favored 'General case' 0 C--O 1.254 1.32 0 CA-C-N 114.692 -1.14 . . . . 36.270000000000003 108.956 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1284 ' ' LEU . . . . . 0.839 HD21 ' HB2' ' A' 1141 ' ' ALA . 72.4 mt -105.96 14.5 27.86 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.678 -0.692 . . . . 38.57 109.814 -175.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1285 ' ' ALA . . . . . 0.459 ' HB3' ' HA2' ' A' 1290 ' ' GLY . . . -104.95 -40.3 5.97 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 122.862 1.315 . . . . 37.560000000000002 109.015 169.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1286 ' ' ALA . . . . . 0.471 ' HA ' HG21 ' A' 1295 ' ' THR . . . 49.32 -81.0 0.01 OUTLIER 'General case' 0 C--O 1.263 1.809 0 N-CA-C 117.992 2.59 . . . . 40.329999999999998 117.992 173.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -76.61 -36.13 57.66 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 123.938 0.895 . . . . 56.850000000000001 111.865 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 52.4 t30 -80.13 77.98 6.81 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 104.802 -2.296 . . . . 45.859999999999999 104.802 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 72.16 -72.51 0.93 Allowed Glycine 0 CA--C 1.5 -0.854 0 N-CA-C 109.444 -1.462 . . . . 40.310000000000002 109.444 -176.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1290 ' ' GLY . . . . . 0.459 ' HA2' ' HB3' ' A' 1285 ' ' ALA . . . 87.16 117.32 1.13 Allowed Glycine 0 C--O 1.22 -0.722 0 N-CA-C 106.755 -2.538 . . . . 38.890000000000001 106.755 -175.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1291 ' ' ASN . . . . . 0.457 ' ND2' ' HB1' ' A' 1263 ' ' ALA . 12.4 m120 -65.46 -16.78 63.99 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 115.633 1.716 . . . . 37.229999999999997 115.633 -172.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1292 ' ' CYS . . . . . . . . . . . . . 36.0 t -103.34 157.08 17.27 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 119.45 1.023 . . . . 36.5 109.497 173.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1293 ' ' GLU . . . . . 0.512 ' HA ' ' HD3' ' A' 1265 ' ' LYS . 57.0 mt-10 -82.53 -9.17 59.52 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 115.331 1.604 . . . . 43.32 115.331 173.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -96.38 9.02 42.54 Favored 'General case' 0 C--O 1.244 0.778 0 O-C-N 117.55 -3.219 . . . . 41.32 111.699 172.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1295 ' ' THR . . . . . 0.483 HG23 ' HA3' ' A' 1311 ' ' GLY . 85.3 m -75.61 98.8 4.12 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.871 0.843 . . . . 35.299999999999997 111.072 -173.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1296 ' ' VAL . . . . . 0.819 ' HB ' ' HB2' ' A' 1299 ' ' GLU . 2.3 t -81.94 128.25 69.12 Favored Pre-proline 0 C--O 1.251 1.166 0 N-CA-C 102.622 -3.103 . . . . 34.840000000000003 102.622 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -51.42 105.34 0.11 Allowed 'Trans proline' 0 C--O 1.251 1.137 0 C-N-CA 124.773 3.649 . . . . 33.509999999999998 113.04 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1298 ' ' GLY . . . . . 0.482 ' HA2' ' H ' ' A' 1313 ' ' THR . . . 76.98 23.43 69.12 Favored Glycine 0 CA--C 1.504 -0.635 0 CA-C-N 113.328 -1.76 . . . . 32.189999999999998 113.937 175.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1299 ' ' GLU . . . . . 0.819 ' HB2' ' HB ' ' A' 1296 ' ' VAL . 45.5 mt-10 -131.6 170.58 14.56 Favored 'General case' 0 C--O 1.246 0.916 0 CA-C-N 118.86 1.33 . . . . 34.880000000000003 112.905 -175.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1300 ' ' ILE . . . . . 0.586 HG12 HG12 ' A' 1310 ' ' ILE . 43.3 mt -108.58 121.84 62.23 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.198 0 N-CA-C 106.044 -1.835 . . . . 32.289999999999999 106.044 169.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 16.0 t80 -97.96 126.5 43.4 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 103.624 -2.732 . . . . 37.25 103.624 169.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1302 ' ' THR . . . . . . . . . . . . . 8.2 m -106.41 123.91 48.8 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 119.735 1.152 . . . . 35.560000000000002 108.628 174.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1303 ' ' THR . . . . . . . . . . . . . 2.6 p -86.7 165.17 16.3 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 118.37 -0.824 . . . . 36.399999999999999 113.191 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -53.96 -41.1 67.44 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 121.254 1.843 . . . . 52.32 115.704 -176.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1305 ' ' ASN . . . . . 0.532 ' HA ' ' HB2' ' B' 1046 ' ' ASP . 53.2 p-10 -62.18 -24.05 66.97 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.369 -1.287 . . . . 40.039999999999999 111.741 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 98.23 44.51 2.56 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.294 -1.122 . . . . 36.960000000000001 110.294 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1307 ' ' VAL . . . . . 0.629 HG21 ' HB3' ' A' 1275 ' ' MET . 59.7 t -107.08 120.11 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 123.617 1.675 . . . . 33.399999999999999 108.584 168.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1308 ' ' LYS . . . . . 0.629 ' HB2' HG22 ' A' 1280 ' ' VAL . 61.2 mmtt -87.3 102.78 14.83 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 110.541 -3.027 . . . . 42.909999999999997 106.986 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 39.3 t -88.98 95.22 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.676 0 O-C-N 119.469 -2.019 . . . . 32.289999999999999 108.212 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1310 ' ' ILE . . . . . 0.666 HD11 ' HB2' ' A' 1148 ' ' GLU . 91.1 mt -89.54 95.17 5.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 O-C-N 120.76 -1.212 . . . . 30.989999999999998 110.093 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1311 ' ' GLY . . . . . 0.483 ' HA3' HG23 ' A' 1295 ' ' THR . . . -97.33 57.9 1.17 Allowed Glycine 0 N--CA 1.441 -1.012 0 O-C-N 120.483 -1.386 . . . . 28.949999999999999 113.798 178.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1312 ' ' TYR . . . . . . . . . . . . . 7.0 m-30 -77.36 131.82 38.26 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 122.914 1.34 . . . . 31.690000000000001 113.374 -169.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1313 ' ' THR . . . . . 0.482 ' H ' ' HA2' ' A' 1298 ' ' GLY . 8.8 p -86.6 -49.79 7.28 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 120.965 -1.084 . . . . 34.170000000000002 110.596 174.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -72.29 14.27 0.25 Allowed 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 117.367 2.358 . . . . 36.859999999999999 117.367 -167.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1315 ' ' LEU . . . . . . . . . . . . . 28.5 mt -51.04 -39.45 56.12 Favored Pre-proline 0 C--N 1.347 0.495 0 O-C-N 119.827 -1.796 . . . . 34.850000000000001 114.256 -173.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.74 -43.98 40.02 Favored 'Trans proline' 0 C--O 1.257 1.431 0 CA-C-N 124.408 2.61 . . . . 29.149999999999999 113.207 170.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -58.25 -45.12 94.55 Favored Glycine 0 CA--C 1.543 1.807 0 N-CA-C 109.124 -1.59 . . . . 27.289999999999999 109.124 174.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1318 ' ' ARG . . . . . 0.435 ' HB3' ' NH2' ' A' 1140 ' ' ARG . 90.2 mtt-85 -58.35 -23.38 56.6 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 116.47 2.026 . . . . 41.490000000000002 116.47 177.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1319 ' ' LEU . . . . . 0.744 HD23 HG23 ' A' 1136 ' ' ILE . 12.3 tp -123.07 67.27 32.9 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 104.018 -2.586 . . . . 27.609999999999999 104.018 175.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1320 ' ' PRO . . . . . 0.57 ' HB3' ' HB ' ' A' 1014 ' ' THR . 64.9 Cg_endo -58.14 -53.05 4.67 Favored 'Trans proline' 0 C--O 1.257 1.456 1 C-N-CA 125.396 4.064 . . . . 25.940000000000001 114.67 -163.243 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 1321 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.86 -39.79 91.05 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 109.868 -0.419 . . . . 25.010000000000002 109.868 -173.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1322 ' ' GLN . . . . . 0.699 ' HB2' ' HA ' ' B' 1151 ' ' ARG . 24.1 tp60 -64.83 -43.82 91.84 Favored 'General case' 0 CA--C 1.51 -0.563 0 O-C-N 123.968 0.792 . . . . 29.390000000000001 109.78 -175.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1323 ' ' SER . . . . . . . . . . . . . 49.6 m -58.47 -53.52 57.41 Favored 'General case' 0 CA--C 1.486 -1.514 0 CA-C-N 114.16 -1.382 . . . . 26.469999999999999 113.166 173.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1324 ' ' SER . . . . . 0.477 ' HB2' HG23 ' A' 1019 ' ' THR . 5.0 m -65.01 -29.37 70.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.324 -0.86 . . . . 27.780000000000001 110.002 -178.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -68.81 -59.66 2.93 Favored 'General case' 0 C--N 1.348 0.519 0 O-C-N 121.653 -0.654 . . . . 37.530000000000001 110.783 172.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1326 ' ' LEU . . . . . 0.506 HD12 HD11 ' A' 1136 ' ' ILE . 59.5 mt -72.29 -51.79 19.23 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 115.838 -2.03 . . . . 35.710000000000001 111.102 -170.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1327 ' ' TYR . . . . . 0.434 ' HE2' ' HA ' ' A' 1072 ' ' VAL . 7.3 t80 -48.83 -48.26 41.84 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 121.364 1.893 . . . . 31.59 110.96 170.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1328 ' ' GLY . . . . . 0.509 ' O ' HG23 ' A' 1332 ' ' VAL . . . -47.46 -52.52 14.06 Favored Glycine 0 N--CA 1.465 0.61 0 C-N-CA 124.229 0.918 . . . . 28.0 112.49 170.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1329 ' ' THR . . . . . 0.654 ' HB ' ' HB1' ' B' 1160 ' ' ALA . 77.2 m -70.4 -34.81 72.97 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 120.344 -1.68 . . . . 32.149999999999999 110.188 -173.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1330 ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' 1127 ' ' LEU . 29.4 m120 -64.65 -43.6 93.13 Favored 'General case' 0 C--O 1.21 -0.997 0 C-N-CA 119.521 -0.871 . . . . 34.359999999999999 111.28 173.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1331 ' ' LEU . . . . . 0.591 HD22 HD22 ' A' 1070 ' ' LEU . 80.6 mt -53.09 -44.83 67.88 Favored 'General case' 0 C--O 1.219 -0.534 0 O-C-N 124.71 1.256 . . . . 33.369999999999997 111.527 173.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1332 ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' 1328 ' ' GLY . 6.8 t -70.62 -37.12 68.37 Favored 'Isoleucine or valine' 0 C--O 1.245 0.842 0 CA-C-N 114.849 -1.069 . . . . 35.270000000000003 110.125 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1333 ' ' ASN . . . . . 0.629 ' HA ' ' HD2' ' A' 1336 ' ' LYS . 76.9 m-20 -69.89 -28.69 65.84 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 121.414 0.626 . . . . 37.659999999999997 111.227 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1334 ' ' LEU . . . . . 0.648 HD21 ' SD ' ' A' 1113 ' ' MET . 0.4 OUTLIER -71.52 -51.99 20.62 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 108.805 -0.813 . . . . 40.270000000000003 108.805 171.331 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 1335 ' ' LEU . . . . . 0.484 HD11 HD21 ' A' 1070 ' ' LEU . 37.1 mt -68.41 -5.91 21.7 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 115.564 1.69 . . . . 42.5 115.564 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1336 ' ' LYS . . . . . 0.629 ' HD2' ' HA ' ' A' 1333 ' ' ASN . 74.8 mttt -66.96 -35.75 80.68 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 119.85 -1.781 . . . . 47.810000000000002 111.823 162.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1337 ' ' LEU . . . . . 0.472 ' O ' ' HG3' ' A' 1340 ' ' LYS . 4.8 mp -78.08 -46.74 19.99 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 120.9 -1.125 . . . . 49.270000000000003 109.995 169.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1338 ' ' LEU . . . . . 0.466 ' HB2' ' HA ' ' A' 1335 ' ' LEU . 6.0 mp -76.81 16.96 0.46 Allowed 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 115.786 1.773 . . . . 50.539999999999999 115.786 176.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1339 ' ' CYS . . . . . . . . . . . . . 36.5 t -156.98 80.34 0.92 Allowed 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 126.042 2.829 . . . . 53.670000000000002 104.768 164.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1340 ' ' LYS . . . . . 0.604 ' HD2' HG21 ' A' 1347 ' ' THR . 82.6 mttt -79.08 -40.66 30.61 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 113.431 -1.713 . . . . 63.380000000000003 111.139 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -69.69 -51.26 36.1 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 113.706 1.002 . . . . 70.950000000000003 113.706 -166.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1342 ' ' LYS . . . . . 0.502 ' HE3' HD23 ' A' 1029 ' ' LEU . 36.3 mtpt 52.77 67.08 1.05 Allowed 'General case' 0 C--O 1.239 0.535 0 N-CA-C 117.499 2.407 . . . . 65.25 117.499 171.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1343 ' ' ASP . . . . . . . . . . . . 0.262 7.8 t70 59.82 -94.19 0.05 OUTLIER 'General case' 0 CA--C 1.502 -0.869 2 O-C-N 110.915 -7.365 . . . . 64.530000000000001 117.847 4.486 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A 1344 ' ' GLY . . . . . . . . . . . . . . . 117.86 70.15 0.38 Allowed Glycine 0 C--N 1.348 1.212 0 N-CA-C 107.764 -2.134 . . . . 59.719999999999999 107.764 172.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -167.78 149.56 5.52 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 113.683 -1.259 . . . . 64.090000000000003 108.12 -177.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1346 ' ' ILE . . . . . 0.442 HG23 HD11 ' A' 1068 ' ' ILE . 8.4 pt -55.38 125.22 10.03 Favored 'Isoleucine or valine' 0 C--O 1.247 0.95 0 N-CA-C 115.211 1.56 . . . . 58.82 115.211 178.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1347 ' ' THR . . . . . 0.604 HG21 ' HD2' ' A' 1340 ' ' LYS . 7.8 m -97.91 100.12 11.45 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 103.309 -2.848 . . . . 54.960000000000001 103.309 163.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1348 ' ' VAL . . . . . . . . . . . . . 15.1 t -90.87 113.08 26.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 106.663 -1.606 . . . . 55.640000000000001 106.663 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 27.9 t70 -112.55 145.22 40.69 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 122.194 0.997 . . . . 61.450000000000003 110.094 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 60.2 t80 -116.23 4.19 13.51 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.509 1.124 . . . . 58.630000000000003 109.238 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.77 -62.71 1.25 Allowed 'General case' 0 N--CA 1.477 0.893 0 O-C-N 119.723 -1.861 . . . . 62.060000000000002 110.469 -169.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 7.3 t70 -69.83 143.95 52.73 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 114.571 1.322 . . . . 54.07 114.571 -170.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 20.3 m -65.49 -29.73 48.01 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 CA-C-N 119.541 1.064 . . . . 50.68 111.114 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1354 ' ' VAL . . . . . . . . . . . . . 4.3 m -76.53 -17.26 14.97 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 O-C-N 120.284 -1.51 . . . . 47.68 110.404 -176.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1355 ' ' ILE . . . . . 0.406 HG23 HD11 ' A' 1338 ' ' LEU . 74.8 mt -100.34 -69.79 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.867 0 N-CA-C 106.636 -1.616 . . . . 48.490000000000002 106.636 171.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 40.4 tpt85 -55.73 -31.99 62.98 Favored 'General case' 0 C--N 1.349 0.548 0 O-C-N 120.653 -1.28 . . . . 48.270000000000003 114.286 -175.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -62.27 -46.18 94.45 Favored Glycine 0 CA--C 1.525 0.662 0 O-C-N 120.025 -1.672 . . . . 43.530000000000001 111.749 171.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1358 ' ' VAL . . . . . . . . . . . . . 42.4 t -72.18 -35.27 52.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 122.042 0.925 . . . . 45.119999999999997 111.025 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1359 ' ' THR . . . . . . . . . . . . . 25.6 m -69.07 88.43 0.41 Allowed 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 122.817 1.294 . . . . 42.939999999999998 109.162 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 16.1 m -76.83 -22.82 14.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-O 122.317 1.056 . . . . 43.259999999999998 113.122 176.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1361 ' ' ILE . . . . . 0.57 ' HB ' ' HB ' ' A' 1112 ' ' VAL . 30.5 mt -133.29 135.52 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 103.563 -2.754 . . . . 45.659999999999997 103.563 169.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1362 ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -117.68 113.11 21.4 Favored 'General case' 0 C--O 1.252 1.228 0 N-CA-C 104.879 -2.267 . . . . 61.340000000000003 104.879 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 26.53 73.6 0.03 OUTLIER 'General case' 0 C--O 1.231 0.115 0 C-N-CA 127.047 2.139 . . . . 49.759999999999998 113.186 -166.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 88.9 -38.1 3.24 Favored Glycine 0 CA--C 1.529 0.911 0 O-C-N 119.902 -1.749 . . . . 50.0 112.443 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -74.46 124.0 25.75 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 119.416 1.608 . . . . 56.920000000000002 109.168 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1366 ' ' ILE . . . . . 0.463 HG22 ' HB3' ' A' 1368 ' ' TRP . 10.2 mt -77.13 86.3 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.256 1.401 0 CA-C-O 123.07 1.414 . . . . 52.780000000000001 111.748 -178.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1367 ' ' THR . . . . . . . . . . . . . 16.6 p -70.95 -11.88 61.22 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 111.728 -2.487 . . . . 49.439999999999998 114.624 -174.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1368 ' ' TRP . . . . . 0.463 ' HB3' HG22 ' A' 1366 ' ' ILE . 26.3 t90 -47.44 133.81 10.05 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 127.362 2.265 . . . . 52.380000000000003 110.157 170.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -81.79 -166.61 5.19 Favored 'Cis proline' 0 C--O 1.238 0.497 0 N-CA-C 117.443 2.055 . . . . 46.939999999999998 117.443 4.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -73.63 140.69 78.65 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 117.113 -1.422 . . . . 45.909999999999997 110.925 164.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1371 ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -70.43 139.74 38.58 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.691 2.927 . . . . 46.390000000000001 107.052 164.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -65.64 -35.86 35.69 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.778 2.319 . . . . 46.719999999999999 117.073 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.235 -4.412 0 CA-C-N 120.726 1.603 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 7.1 m80 . . . . . 0 N--CA 1.438 -1.043 0 N-CA-C 104.143 -2.54 . . . . 63.439999999999998 104.143 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -106.14 65.49 0.69 Allowed 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 102.939 -2.985 . . . . 51.740000000000002 102.939 159.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1000 ' ' HIS . . . . . 0.478 ' HA ' ' CG ' ' B' 1067 ' ' GLU . 5.3 t-80 -76.1 128.03 34.16 Favored 'General case' 0 C--N 1.36 1.054 0 O-C-N 120.584 -1.322 . . . . 54.07 109.986 -173.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1001 ' ' GLY . . . . . 0.486 ' H ' ' HG3' ' B' 1067 ' ' GLU . . . 86.23 -6.47 81.6 Favored Glycine 0 C--O 1.218 -0.885 0 CA-C-O 121.656 0.587 . . . . 39.219999999999999 113.696 -169.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1002 ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -93.12 138.85 31.18 Favored 'General case' 0 C--O 1.252 1.185 0 CA-C-O 124.854 2.264 . . . . 38.119999999999997 109.482 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1003 ' ' ILE . . . . . 0.415 HG12 ' HB ' ' B' 1068 ' ' ILE . 49.0 mt -98.25 141.63 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 110.835 -2.893 . . . . 29.699999999999999 105.201 169.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1004 ' ' GLY . . . . . 0.421 ' CA ' HG22 ' B' 1063 ' ' VAL . . . -111.0 123.79 6.67 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 108.659 -1.776 . . . . 27.5 108.659 172.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1005 ' ' ILE . . . . . . . . . . . . . 41.1 mm -109.8 111.77 58.64 Favored Pre-proline 0 N--CA 1.447 -0.582 0 N-CA-C 106.515 -1.661 . . . . 24.829999999999998 106.515 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -74.7 156.36 44.36 Favored 'Trans proline' 0 N--CA 1.44 -1.626 0 C-N-CA 123.473 2.782 . . . . 27.190000000000001 115.944 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1007 ' ' ARG . . . . . 0.553 ' NH1' ' HA3' ' B' 1038 ' ' GLY . 37.3 ttt180 -79.0 96.65 5.82 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 118.782 -2.449 . . . . 41.460000000000001 106.468 162.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1008 ' ' GLU . . . . . 0.57 ' HG3' ' HB ' ' B' 1072 ' ' VAL . 2.8 mm-40 -51.94 151.5 3.55 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 118.734 2.864 . . . . 26.93 118.734 -170.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 45.1 mmm-85 -92.97 -20.72 20.32 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 112.528 -2.124 . . . . 34.479999999999997 115.535 -164.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1010 ' ' LEU . . . . . 0.545 ' HB3' ' HB2' ' B' 1013 ' ' GLU . 4.7 tp -67.74 160.21 28.59 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 119.386 0.994 . . . . 44.219999999999999 113.678 -173.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1011 ' ' THR . . . . . . . . . . . . . 63.3 m -68.25 132.61 47.44 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 106.018 -1.845 . . . . 40.740000000000002 106.018 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 12.5 m120 62.22 22.22 13.01 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 113.984 -1.462 . . . . 44.439999999999998 112.119 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1013 ' ' GLU . . . . . 0.545 ' HB2' ' HB3' ' B' 1010 ' ' LEU . 4.7 tp10 -78.1 118.7 20.6 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 117.748 -1.581 . . . . 29.870000000000001 111.85 -173.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1014 ' ' THR . . . . . . . . . . . . . 1.6 p -105.17 -9.62 17.63 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 111.514 -2.585 . . . . 25.260000000000002 112.413 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1015 ' ' ARG . . . . . 0.501 ' HD3' ' SD ' ' B' 1133 ' ' MET . 77.4 mtm180 -77.01 110.3 11.53 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 123.546 1.641 . . . . 29.539999999999999 113.188 -176.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1016 ' ' VAL . . . . . 0.431 HG12 ' HB2' ' B' 1043 ' ' ALA . 7.2 p -87.69 120.54 36.98 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 N-CA-C 104.153 -2.536 . . . . 23.550000000000001 104.153 164.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1017 ' ' ALA . . . . . . . . . . . . . . . -62.71 -5.96 3.18 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 116.29 1.959 . . . . 23.59 116.29 -177.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1018 ' ' ALA . . . . . . . . . . . . . . . -150.34 111.95 4.48 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 123.996 1.855 . . . . 24.93 107.059 170.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1019 ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.43 164.38 40.81 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 115.14 -2.362 . . . . 28.09 111.696 172.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 0.7 OUTLIER -38.93 -46.35 2.74 Favored 'Trans proline' 0 C--N 1.362 1.245 1 C-N-CA 125.669 4.246 . . . . 28.789999999999999 117.717 -176.528 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 77.3 tttt -63.67 -49.21 74.09 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 120.086 1.312 . . . . 47.280000000000001 107.743 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1022 ' ' THR . . . . . . . . . . . . . 39.0 m -61.39 -34.98 76.26 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 114.001 1.111 . . . . 30.120000000000001 114.001 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1023 ' ' VAL . . . . . . . . . . . . . 75.4 t -51.11 -52.96 16.44 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 CA-C-N 121.239 1.836 . . . . 32.240000000000002 110.381 167.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1024 ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' B' 1028 ' ' LYS . 45.6 mt-10 -64.04 -37.1 86.2 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 113.973 1.101 . . . . 49.619999999999997 113.973 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1025 ' ' GLN . . . . . 0.473 ' O ' ' HG ' ' B' 1029 ' ' LEU . 39.2 mt-30 -56.5 -46.4 80.55 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 114.373 -1.285 . . . . 44.68 109.871 177.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 14.4 mt -72.49 -35.86 68.26 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 114.341 1.238 . . . . 35.710000000000001 114.341 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1027 ' ' LEU . . . . . . . . . . . . . 75.8 mt -63.51 -41.51 98.51 Favored 'General case' 0 C--N 1.346 0.436 0 N-CA-C 109.896 -0.409 . . . . 42.18 109.896 176.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1028 ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' B' 1024 ' ' GLU . 55.1 mttm -57.96 -40.87 81.66 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 115.897 1.814 . . . . 48.340000000000003 115.897 169.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1029 ' ' LEU . . . . . 0.518 HD11 HG13 ' B' 1332 ' ' VAL . 65.4 mt -69.67 -10.51 58.57 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 121.442 -0.787 . . . . 38.689999999999998 110.719 173.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 106.12 3.51 38.81 Favored Glycine 0 C--N 1.321 -0.294 0 O-C-N 119.861 -1.774 . . . . 32.280000000000001 112.407 166.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -90.77 158.61 16.76 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 119.957 -1.908 . . . . 35.939999999999998 108.879 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1032 ' ' THR . . . . . . . . . . . . . 5.9 m -101.06 137.33 39.56 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 103.834 -2.654 . . . . 33.369999999999997 103.834 172.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1033 ' ' VAL . . . . . . . . . . . . . 5.1 t -107.88 137.65 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 0 O-C-N 118.222 -2.799 . . . . 29.98 106.701 -172.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -128.21 131.62 48.84 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.243 -1.391 . . . . 28.18 107.243 168.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1035 ' ' VAL . . . . . 0.423 ' HB ' HD13 ' B' 1057 ' ' ILE . 87.5 t -115.79 137.34 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.286 0 CA-C-N 113.225 -1.807 . . . . 25.82 110.216 177.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1036 ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -74.13 125.98 29.55 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 107.425 -1.324 . . . . 32.439999999999998 107.425 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1037 ' ' SER . . . . . . . . . . . . . 2.8 t -58.08 121.89 11.73 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 124.313 2.006 . . . . 29.539999999999999 113.309 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1038 ' ' GLY . . . . . 0.553 ' HA3' ' NH1' ' B' 1007 ' ' ARG . . . 119.45 -26.72 7.22 Favored Glycine 0 C--O 1.259 1.678 0 CA-C-N 113.187 -1.824 . . . . 27.760000000000002 109.413 -175.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1039 ' ' ALA . . . . . . . . . . . . . . . -59.43 -32.21 69.99 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.243 1.02 . . . . 26.02 113.057 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -57.99 -51.63 57.15 Favored Glycine 0 N--CA 1.466 0.686 0 CA-C-N 113.148 -1.842 . . . . 26.469999999999999 111.918 165.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -59.46 -30.19 68.34 Favored 'General case' 0 C--O 1.251 1.149 0 CA-C-N 118.254 1.027 . . . . 50.979999999999997 112.272 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 75.2 mt -64.65 -58.01 7.47 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-N 115.784 -0.644 . . . . 29.300000000000001 110.598 167.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1043 ' ' ALA . . . . . 0.431 ' HB2' HG12 ' B' 1016 ' ' VAL . . . -74.66 14.73 0.44 Allowed 'General case' 0 C--O 1.215 -0.737 0 O-C-N 119.776 -1.828 . . . . 26.739999999999998 112.611 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1044 ' ' SER . . . . . . . . . . . . . 72.7 m 63.61 49.3 3.08 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 127.321 3.439 . . . . 31.260000000000002 112.646 174.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1045 ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.59 155.25 44.22 Favored 'General case' 0 N--CA 1.432 -1.352 0 O-C-N 119.314 -2.116 . . . . 33.259999999999998 107.056 -168.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1046 ' ' ASP . . . . . 0.532 ' HB2' ' HA ' ' A' 1305 ' ' ASN . 14.2 t70 -82.88 127.32 33.39 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 107.385 -1.339 . . . . 46.740000000000002 107.385 168.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -57.45 -32.32 66.81 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 124.439 1.096 . . . . 34.439999999999998 112.47 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1048 ' ' LYS . . . . . 0.572 ' HD3' ' H ' ' B' 1048 ' ' LYS . 0.0 OUTLIER -68.67 -14.28 62.92 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 121.024 -1.048 . . . . 48.670000000000002 111.316 178.918 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -68.32 -28.9 67.56 Favored 'General case' 0 C--O 1.216 -0.662 0 O-C-N 120.241 -1.537 . . . . 35.259999999999998 110.851 169.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1050 ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -69.47 -31.14 69.25 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 108.142 -1.059 . . . . 32.170000000000002 108.142 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 83.9 t -70.16 -41.55 78.95 Favored 'Isoleucine or valine' 0 C--O 1.25 1.123 0 N-CA-C 106.305 -1.739 . . . . 38.369999999999997 106.305 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -60.49 -29.59 69.17 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 123.133 1.444 . . . . 45.770000000000003 110.118 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1053 ' ' ALA . . . . . 0.405 ' HB1' ' HG3' ' B' 1024 ' ' GLU . . . -77.48 -40.17 43.92 Favored 'General case' 0 CA--C 1.5 -0.957 0 O-C-N 120.421 -1.425 . . . . 37.829999999999998 112.905 168.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 137.03 18.89 0.64 Allowed Glycine 0 C--N 1.334 0.468 0 O-C-N 120.178 -1.576 . . . . 35.82 113.834 172.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -88.93 144.32 26.26 Favored 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 120.512 2.156 . . . . 33.770000000000003 112.724 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -73.83 124.6 26.4 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 103.844 -2.65 . . . . 51.020000000000003 103.844 168.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1057 ' ' ILE . . . . . 0.423 HD13 ' HB ' ' B' 1035 ' ' VAL . 39.0 mm -89.42 116.75 31.45 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 O-C-N 120.155 -1.591 . . . . 38.469999999999999 107.752 168.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 2.8 m -112.56 139.37 37.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 O-C-N 125.785 1.928 . . . . 39.399999999999999 106.345 174.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -100.65 100.54 11.26 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 123.729 0.812 . . . . 57.07 110.012 -172.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . 102.78 -178.95 26.27 Favored Glycine 0 C--O 1.248 0.983 0 CA-C-O 123.005 1.336 . . . . 44.829999999999998 112.353 -175.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 30.2 m120 -64.47 2.59 0.6 Allowed 'General case' 0 C--O 1.239 0.523 0 N-CA-C 118.229 2.677 . . . . 46.270000000000003 118.229 -168.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1062 ' ' SER . . . . . . . . . . . . . 13.3 m -41.07 -40.77 1.55 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 127.75 2.42 . . . . 43.469999999999999 107.325 156.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1063 ' ' VAL . . . . . 0.421 HG22 ' CA ' ' B' 1004 ' ' GLY . 0.3 OUTLIER -52.62 -30.34 14.77 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 O-C-N 119.125 -2.235 . . . . 36.979999999999997 114.566 176.051 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 52.1 m95 -76.41 -22.08 55.19 Favored 'General case' 0 N--CA 1.439 -0.99 0 O-C-N 120.867 -1.145 . . . . 37.899999999999999 110.68 -174.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -85.65 84.46 7.58 Favored 'General case' 0 C--O 1.205 -1.283 0 N-CA-C 103.482 -2.785 . . . . 46.189999999999998 103.482 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1066 ' ' SER . . . . . . . . . . . . . 56.6 m -151.08 173.41 14.39 Favored 'General case' 0 C--O 1.261 1.685 0 C-N-CA 126.117 1.767 . . . . 37.060000000000002 107.523 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1067 ' ' GLU . . . . . 0.676 ' HB2' HD12 ' B' 1068 ' ' ILE . 70.9 mm-40 -82.61 -40.55 20.65 Favored 'General case' 0 N--CA 1.433 -1.298 0 O-C-N 120.428 -1.42 . . . . 43.950000000000003 111.512 174.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1068 ' ' ILE . . . . . 0.676 HD12 ' HB2' ' B' 1067 ' ' GLU . 1.2 mp -120.8 135.09 62.13 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 N-CA-C 103.777 -2.675 . . . . 33.5 103.777 -175.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1069 ' ' ILE . . . . . 0.483 HG22 ' HB2' ' B' 1071 ' ' LYS . 37.1 mm -120.21 116.06 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 101.208 -3.627 . . . . 30.57 101.208 172.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1070 ' ' LEU . . . . . 0.624 ' HB3' HD13 ' B' 1331 ' ' LEU . 30.1 mt -102.8 105.62 16.06 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 102.845 -3.02 . . . . 27.66 102.845 172.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1071 ' ' LYS . . . . . 0.483 ' HB2' HG22 ' B' 1069 ' ' ILE . 3.2 tmtm? -127.77 147.17 50.41 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 103.873 -2.64 . . . . 28.399999999999999 103.873 -168.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1072 ' ' VAL . . . . . 0.57 ' HB ' ' HG3' ' B' 1008 ' ' GLU . 25.5 t -81.4 -65.07 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.85 0 CA-C-O 117.723 -1.132 . . . . 23.18 112.201 -171.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -106.45 -159.42 0.7 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 120.843 1.656 . . . . 25.469999999999999 111.817 -161.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -64.28 142.28 98.29 Favored Pre-proline 0 CA--C 1.517 -0.317 0 CA-C-N 120.691 1.587 . . . . 27.899999999999999 111.222 -177.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -70.94 118.71 5.84 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.024 3.149 . . . . 31.620000000000001 117.116 164.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 5.3 mp -74.48 170.75 15.07 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 124.652 2.168 . . . . 40.490000000000002 107.47 166.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 36.6 t70 -56.22 -39.26 72.22 Favored 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 125.222 1.409 . . . . 51.590000000000003 113.707 -175.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -67.89 -39.12 83.69 Favored 'General case' 0 C--N 1.348 0.5 0 O-C-N 120.626 -1.296 . . . . 42.359999999999999 108.19 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1079 ' ' GLU . . . . . 0.661 ' HA ' HD12 ' B' 1082 ' ' LEU . 32.8 mt-10 -63.5 -45.54 90.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 123.501 1.619 . . . . 34.530000000000001 108.94 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1080 ' ' ILE . . . . . 0.646 HG22 ' HG3' ' B' 1108 ' ' ARG . 61.3 mt -60.67 -37.07 74.67 Favored 'Isoleucine or valine' 0 C--O 1.261 1.694 0 CA-C-N 113.354 -1.748 . . . . 33.25 110.959 176.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -74.13 -28.92 61.56 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 115.614 1.709 . . . . 36.469999999999999 115.614 172.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1082 ' ' LEU . . . . . 0.661 HD12 ' HA ' ' B' 1079 ' ' GLU . 23.3 mt -71.36 -28.26 63.93 Favored 'General case' 0 C--N 1.317 -0.821 0 O-C-N 119.933 -1.729 . . . . 37.759999999999998 110.644 173.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1083 ' ' LEU . . . . . 0.767 HD11 HD22 ' B' 1089 ' ' LEU . 28.7 mt -58.77 127.79 33.96 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 123.037 1.398 . . . . 37.43 111.997 171.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.38 133.55 42.17 Favored Pre-proline 0 C--O 1.243 0.759 0 CA-C-N 112.892 -1.958 . . . . 37.700000000000003 107.572 177.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -44.42 111.42 0.27 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 123.996 3.131 . . . . 35.509999999999998 113.68 169.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 130.2 -48.96 0.94 Allowed Glycine 0 C--N 1.31 -0.911 0 CA-C-N 110.954 -2.839 . . . . 33.869999999999997 109.645 175.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1087 ' ' THR . . . . . . . . . . . . . 72.5 m -43.74 126.84 4.82 Favored 'General case' 0 C--O 1.252 1.21 0 C-N-CA 126.051 1.74 . . . . 32.5 114.504 -165.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1088 ' ' THR . . . . . 0.432 ' HA ' ' O ' ' B' 1111 ' ' THR . 50.1 m -78.97 91.71 4.86 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-O 124.037 1.875 . . . . 30.219999999999999 109.843 -176.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1089 ' ' LEU . . . . . 0.767 HD22 HD11 ' B' 1083 ' ' LEU . 36.0 tp -76.15 137.39 40.04 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 113.112 -1.858 . . . . 27.239999999999998 111.084 170.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 56.7 t -133.95 112.12 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 103.589 -2.745 . . . . 25.390000000000001 103.589 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1091 ' ' SER . . . . . 0.405 ' OG ' ' HB3' ' B' 1071 ' ' LYS . 48.7 m -160.45 163.84 32.71 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 120.43 -1.419 . . . . 28.809999999999999 111.201 -171.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1092 ' ' PHE . . . . . 0.56 ' HD1' ' HB3' ' B' 1116 ' ' ASP . 84.5 m-85 -71.18 102.88 2.62 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.005 -1.059 . . . . 30.780000000000001 110.606 165.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 29.7 mm -85.29 -45.21 17.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 120.261 1.391 . . . . 30.280000000000001 111.807 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1094 ' ' TRP . . . . . . . . . . . . . 93.1 m95 56.21 73.52 0.82 Allowed Pre-proline 0 C--O 1.244 0.809 0 O-C-N 125.091 1.495 . . . . 34.07 110.403 -157.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -55.28 -50.16 13.88 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 123.819 3.013 . . . . 38.659999999999997 115.951 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -64.67 -33.05 75.03 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-O 123.057 1.408 . . . . 41.32 110.096 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 8.4 mp0 -80.25 -17.58 51.8 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 116.711 -1.614 . . . . 51.659999999999997 110.378 175.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -142.46 59.89 9.33 Favored Pre-proline 0 N--CA 1.481 1.092 0 CA-C-N 122.588 2.449 . . . . 40.32 111.591 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -59.55 -32.72 96.59 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 123.621 2.881 . . . . 41.560000000000002 112.955 177.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -63.46 -47.71 80.72 Favored 'General case' 0 C--O 1.206 -1.196 0 CA-C-O 123.001 1.381 . . . . 54.109999999999999 109.217 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1101 ' ' LEU . . . . . . . . . . . . . 5.1 tp -62.95 -45.71 91.18 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 113.313 -1.767 . . . . 37.880000000000003 108.547 -176.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1102 ' ' MET . . . . . . . . . . . . . 67.9 mmm -49.77 -51.31 40.2 Favored 'General case' 0 CA--C 1.498 -1.03 0 C-N-CA 124.122 0.969 . . . . 37.539999999999999 109.994 169.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -62.83 -36.13 82.22 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 118.772 -1.171 . . . . 47.009999999999998 113.922 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1104 ' ' LYS . . . . . . . . . . . . . 93.2 mttt -60.95 -45.8 93.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 120.139 -0.624 . . . . 48.68 112.352 173.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1105 ' ' LEU . . . . . 0.64 HD13 HG21 ' B' 1112 ' ' VAL . 73.9 mt -57.89 -43.35 86.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 124.839 2.257 . . . . 32.210000000000001 114.95 175.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -56.24 -55.59 31.45 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 112.089 -2.323 . . . . 33.729999999999997 111.717 172.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.51 -20.69 66.45 Favored 'General case' 0 C--N 1.359 1.01 0 O-C-N 118.811 -2.431 . . . . 51.469999999999999 114.159 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1108 ' ' ARG . . . . . 0.646 ' HG3' HG22 ' B' 1080 ' ' ILE . 26.4 mmm180 -82.96 -1.51 52.65 Favored 'General case' 0 C--N 1.348 0.543 0 N-CA-C 114.249 1.204 . . . . 43.899999999999999 114.249 170.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1109 ' ' ASN . . . . . . . . . . . . . 12.1 m-80 61.93 28.87 17.6 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 118.813 2.894 . . . . 44.82 118.813 171.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1110 ' ' VAL . . . . . 0.664 HG11 ' HB3' ' B' 1083 ' ' LEU . 30.0 m -89.77 170.04 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.28 0 CA-C-N 113.486 -1.688 . . . . 30.52 111.921 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1111 ' ' THR . . . . . 0.432 ' O ' ' HA ' ' B' 1088 ' ' THR . 59.1 m -111.21 119.02 37.55 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 104.417 -2.438 . . . . 27.120000000000001 104.417 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1112 ' ' VAL . . . . . 0.64 HG21 HD13 ' B' 1105 ' ' LEU . 34.3 t -119.15 126.5 75.41 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 CA-C-O 118.726 -0.654 . . . . 26.399999999999999 110.129 -171.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1113 ' ' MET . . . . . 0.53 ' HA ' ' O ' ' B' 1358 ' ' VAL . 0.9 OUTLIER -101.01 115.41 30.43 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 106.011 -1.848 . . . . 42.920000000000002 106.011 168.048 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B 1114 ' ' ALA . . . . . 0.452 ' HB3' ' HB2' ' B' 1117 ' ' SER . . . -85.91 104.11 15.26 Favored 'General case' 0 N--CA 1.426 -1.631 0 C-N-CA 119.118 -1.033 . . . . 24.149999999999999 109.909 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1115 ' ' MET . . . . . . . . . . . . . 44.2 mmm -59.35 -14.86 13.24 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 116.326 1.972 . . . . 29.949999999999999 116.326 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1116 ' ' ASP . . . . . 0.56 ' HB3' ' HD1' ' B' 1092 ' ' PHE . 7.5 p-10 -86.42 -37.95 17.85 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 108.246 -1.02 . . . . 34.530000000000001 108.246 172.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1117 ' ' SER . . . . . 0.452 ' HB2' ' HB3' ' B' 1114 ' ' ALA . 68.4 m -95.05 38.51 1.13 Allowed 'General case' 0 C--N 1.316 -0.863 0 O-C-N 118.605 -2.56 . . . . 33.490000000000002 110.066 -173.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1118 ' ' VAL . . . . . 0.648 HG12 ' HB1' ' B' 1124 ' ' ALA . 2.2 t -78.47 133.22 63.78 Favored Pre-proline 0 N--CA 1.468 0.453 0 N-CA-C 105.8 -1.926 . . . . 34.020000000000003 105.8 169.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -47.21 142.16 12.34 Favored 'Trans proline' 0 C--N 1.328 -0.507 1 C-N-CA 126.321 4.681 . . . . 38.280000000000001 115.224 -176.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1120 ' ' ARG . . . . . 0.477 HH12 ' CG ' ' B' 1128 ' ' ASP . 0.4 OUTLIER -81.58 56.62 3.04 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 114.226 1.195 . . . . 55.049999999999997 114.226 -175.528 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B 1121 ' ' ILE . . . . . 0.609 HD12 ' HB3' ' B' 1123 ' ' ARG . 13.1 pt -129.4 149.22 33.45 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 107.969 -1.123 . . . . 42.090000000000003 107.969 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1122 ' ' SER . . . . . . . . . . . . . 48.6 m -51.14 -32.48 23.16 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 116.894 2.183 . . . . 38.020000000000003 116.894 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1123 ' ' ARG . . . . . 0.609 ' HB3' HD12 ' B' 1121 ' ' ILE . 6.9 tpt180 -58.02 -39.05 77.37 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.642 1.577 . . . . 34.289999999999999 109.219 174.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1124 ' ' ALA . . . . . 0.648 ' HB1' HG12 ' B' 1118 ' ' VAL . . . -84.19 -30.82 25.48 Favored 'General case' 0 C--O 1.206 -1.191 0 O-C-N 121.241 -0.912 . . . . 32.350000000000001 111.419 175.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1125 ' ' GLN . . . . . 0.466 ' HA ' ' HB3' ' B' 1128 ' ' ASP . 13.9 mm100 -58.85 -26.84 64.57 Favored 'General case' 0 C--N 1.348 0.534 0 N-CA-C 118.304 2.705 . . . . 47.170000000000002 118.304 -165.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1126 ' ' SER . . . . . . . . . . . . . 1.4 p -72.04 -34.49 68.81 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 124.183 1.944 . . . . 31.710000000000001 110.805 173.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1127 ' ' LEU . . . . . 0.656 HD23 HD12 ' B' 1334 ' ' LEU . 2.5 mp -80.64 -30.84 36.6 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 113.304 -1.771 . . . . 37.0 110.363 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1128 ' ' ASP . . . . . 0.579 ' HA ' HG21 ' B' 1118 ' ' VAL . 10.1 t70 -62.74 123.43 18.42 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 114.554 1.316 . . . . 40.399999999999999 114.554 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1129 ' ' ALA . . . . . . . . . . . . . . . -70.12 -35.17 73.91 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 115.671 -0.695 . . . . 26.559999999999999 112.359 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 46.7 mt -57.48 -33.53 68.09 Favored 'General case' 0 CA--C 1.557 1.248 0 CA-C-O 115.635 -2.126 . . . . 30.890000000000001 111.751 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1131 ' ' SER . . . . . . . . . . . . . 59.7 p -57.15 -56.99 14.58 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 119.825 1.193 . . . . 29.84 113.047 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1132 ' ' SER . . . . . 0.414 ' HB3' ' HB3' ' B' 1326 ' ' LEU . 24.9 m -64.93 -39.29 93.28 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 126.121 2.138 . . . . 31.91 111.862 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1133 ' ' MET . . . . . 0.614 ' HB3' ' HB3' ' B' 1316 ' ' PRO . 36.4 mmt -69.73 -30.61 68.26 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 113.102 0.779 . . . . 25.899999999999999 113.102 178.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1134 ' ' ALA . . . . . . . . . . . . . . . -72.52 -39.04 67.89 Favored 'General case' 0 N--CA 1.415 -2.222 0 CA-C-N 114.447 -1.251 . . . . 26.620000000000001 107.95 174.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.85 -35.22 79.54 Favored 'General case' 0 C--O 1.215 -0.763 0 CA-C-N 119.506 1.048 . . . . 36.969999999999999 110.902 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1136 ' ' ILE . . . . . 0.428 HG21 ' O ' ' B' 1316 ' ' PRO . 39.5 mm -64.09 -53.67 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 102.457 -3.164 . . . . 32.109999999999999 102.457 174.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -55.25 -37.16 66.86 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 114.23 1.196 . . . . 24.140000000000001 114.23 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -71.64 -43.28 52.53 Favored Glycine 0 C--N 1.308 -1.018 0 CA-C-N 118.273 0.488 . . . . 25.129999999999999 114.291 178.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 34.6 t80 -71.01 -41.59 70.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 123.316 1.531 . . . . 32.729999999999997 112.535 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1140 ' ' ARG . . . . . 0.61 HH11 HD13 ' B' 1319 ' ' LEU . 13.2 tpt180 -67.98 -28.59 67.58 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 113.463 -1.699 . . . . 26.359999999999999 110.552 175.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1141 ' ' ALA . . . . . . . . . . . . . . . -58.95 -51.46 69.96 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 105.931 -1.877 . . . . 24.120000000000001 105.931 174.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 20.6 mm -59.03 -42.29 85.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-O 117.84 -1.076 . . . . 23.370000000000001 109.686 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 76.4 t -58.97 -62.41 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 119.528 1.058 . . . . 24.960000000000001 113.454 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -62.85 -35.58 80.43 Favored 'General case' 0 C--O 1.267 1.983 0 O-C-N 124.384 1.053 . . . . 32.07 110.258 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1145 ' ' ALA . . . . . 0.655 ' HB1' HD12 ' B' 1251 ' ' ILE . . . -54.65 -61.58 2.22 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.124 0.57 . . . . 24.870000000000001 112.085 167.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1146 ' ' ALA . . . . . 0.402 ' HB2' ' CE1' ' B' 1153 ' ' PHE . . . -58.85 -27.5 65.2 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 118.965 -2.334 . . . . 24.670000000000002 114.893 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 62.1 t60 -63.57 -45.87 88.51 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 114.374 -1.285 . . . . 28.579999999999998 109.973 170.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1148 ' ' GLU . . . . . 0.689 ' HB3' ' HD2' ' B' 1308 ' ' LYS . 71.5 mm-40 -100.59 4.89 43.76 Favored 'General case' 0 C--O 1.255 1.343 0 N-CA-C 114.628 1.344 . . . . 36.82 114.628 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1149 ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' B' 1145 ' ' ALA . 1.4 t80 -76.45 146.09 38.83 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 123.719 1.723 . . . . 31.969999999999999 108.099 -174.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1150 ' ' GLY . . . . . . . . . . . . . . . -66.29 -43.82 92.05 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 113.355 -1.748 . . . . 25.489999999999998 109.682 170.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1151 ' ' ARG . . . . . 0.699 ' HA ' ' HB2' ' A' 1322 ' ' GLN . 75.2 mtm-85 -119.89 -171.58 2.17 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 117.983 0.892 . . . . 59.840000000000003 113.374 -163.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1152 ' ' PHE . . . . . 0.574 ' HB2' HG11 ' B' 1163 ' ' VAL . 17.4 m-30 -88.65 159.11 18.0 Favored 'General case' 0 C--O 1.238 0.486 0 O-C-N 120.264 -1.522 . . . . 34.450000000000003 111.759 169.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1153 ' ' PHE . . . . . 0.431 ' CZ ' HG13 ' B' 1251 ' ' ILE . 14.5 m-85 -77.02 -56.59 4.45 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 114.205 -1.361 . . . . 31.170000000000002 112.809 171.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1154 ' ' THR . . . . . . . . . . . . . 12.1 m -65.05 142.07 58.53 Favored 'General case' 0 C--O 1.25 1.131 0 CA-C-O 121.899 0.857 . . . . 33.890000000000001 109.956 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1155 ' ' GLY . . . . . 0.496 ' HA3' ' HG3' ' B' 1165 ' ' PRO . . . -73.06 59.0 1.83 Allowed Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 110.515 -1.034 . . . . 38.950000000000003 110.515 170.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -77.24 134.6 38.54 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 124.938 1.295 . . . . 54.229999999999997 110.646 -160.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 15.0 mm -80.68 116.58 25.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 101.454 -3.535 . . . . 51.159999999999997 101.454 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1158 ' ' THR . . . . . . . . . . . . . 31.5 m -122.22 155.07 36.6 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.305 1.05 . . . . 49.609999999999999 108.396 -175.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -26.36 -61.2 0.08 Allowed 'General case' 0 C--O 1.212 -0.907 0 N-CA-C 119.422 3.119 . . . . 49.049999999999997 119.422 172.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1160 ' ' ALA . . . . . 0.654 ' HB1' ' HB ' ' A' 1329 ' ' THR . . . -57.94 -51.03 71.32 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 114.299 1.222 . . . . 47.649999999999999 114.299 170.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . 179.6 178.59 48.5 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-O 122.225 0.903 . . . . 45.609999999999999 113.717 -165.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 84.4 mttt -79.3 140.61 37.52 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 123.083 1.42 . . . . 57.460000000000001 109.764 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1163 ' ' VAL . . . . . 0.574 HG11 ' HB2' ' B' 1152 ' ' PHE . 48.6 t -90.99 130.11 41.62 Favored Pre-proline 0 C--N 1.299 -1.624 0 CA-C-O 116.5 -1.714 . . . . 42.93 107.603 173.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1164 ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' B' 1165 ' ' PRO . 37.9 Cg_endo -59.33 135.83 68.0 Favored 'Trans proline' 0 N--CA 1.479 0.667 0 C-N-CA 123.906 3.071 . . . . 39.289999999999999 111.865 167.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1165 ' ' PRO . . . . . 0.496 ' HG3' ' HA3' ' B' 1155 ' ' GLY . 27.9 Cg_exo -67.31 141.46 56.68 Favored 'Trans proline' 0 C--O 1.255 1.327 0 C-N-CA 123.287 2.658 . . . . 34.170000000000002 114.254 177.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -73.09 127.68 33.29 Favored 'General case' 0 C--O 1.253 1.266 0 N-CA-C 105.826 -1.916 . . . . 31.690000000000001 105.826 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1167 ' ' LYS . . . . . 0.658 ' HB2' ' HA ' ' B' 1249 ' ' VAL . 93.6 mttt -93.81 108.27 20.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 123.201 1.477 . . . . 44.780000000000001 107.949 168.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 87.7 t -94.24 95.44 5.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 113.766 -1.561 . . . . 31.23 108.153 -172.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1169 ' ' MET . . . . . 0.563 ' HB2' HG11 ' B' 1249 ' ' VAL . 54.8 ttp -79.83 95.69 6.11 Favored 'General case' 0 C--O 1.245 0.831 0 O-C-N 120.534 -1.354 . . . . 37.090000000000003 108.759 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 24.3 t -93.22 99.2 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 N-CA-C 106.435 -1.691 . . . . 30.170000000000002 106.435 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1171 ' ' ILE . . . . . 0.401 HG23 ' HD2' ' B' 1194 ' ' PHE . 35.4 mt -93.38 119.75 41.66 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 N-CA-C 105.677 -1.972 . . . . 33.740000000000002 105.677 -175.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 98.68 62.52 0.86 Allowed Glycine 0 C--N 1.346 1.131 0 N-CA-C 108.44 -1.864 . . . . 32.590000000000003 108.44 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1173 ' ' ALA . . . . . 0.809 ' HA ' ' HA3' ' B' 1177 ' ' GLY . . . -74.44 60.34 0.86 Allowed 'General case' 0 C--O 1.247 0.944 0 N-CA-C 114.89 1.441 . . . . 32.420000000000002 114.89 176.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -87.95 -158.76 33.64 Favored Glycine 0 C--O 1.213 -1.203 0 N-CA-C 105.642 -2.983 . . . . 31.739999999999998 105.642 160.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 3.7 t -54.42 -39.1 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-N 120.432 2.116 . . . . 31.48 112.439 -172.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1176 ' ' ALA . . . . . 0.614 ' HB3' HG21 ' B' 1255 ' ' THR . . . -67.14 -38.24 85.17 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 120.689 -1.257 . . . . 26.120000000000001 110.977 178.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1177 ' ' GLY . . . . . 0.809 ' HA3' ' HA ' ' B' 1173 ' ' ALA . . . -55.29 -54.12 36.34 Favored Glycine 0 C--O 1.208 -1.519 0 C-N-CA 124.534 1.064 . . . . 25.73 110.759 174.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1178 ' ' LEU . . . . . 0.447 ' HA ' HD12 ' B' 1181 ' ' ILE . 15.6 mt -65.39 -30.03 70.8 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 113.285 -1.457 . . . . 32.590000000000003 110.846 -177.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -68.82 -42.19 77.58 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.765 -0.584 . . . . 27.719999999999999 109.782 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -70.25 -37.57 74.96 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 107.498 -1.297 . . . . 26.030000000000001 107.498 -174.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1181 ' ' ILE . . . . . 0.748 HG12 HG11 ' B' 1191 ' ' VAL . 13.3 mt -63.06 -48.8 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 107.342 -1.355 . . . . 28.609999999999999 107.342 171.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -58.38 -26.7 59.66 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-O 118.724 -1.042 . . . . 25.23 115.203 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -90.11 -60.78 1.84 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 118.683 1.241 . . . . 24.09 111.308 174.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -61.05 -44.92 96.67 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 116.097 1.888 . . . . 26.68 116.097 -175.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 5.0 t30 -66.14 -45.91 79.37 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 118.099 -0.953 . . . . 36.57 109.344 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1186 ' ' SER . . . . . . . . . . . . . 16.1 m -56.21 -45.61 79.8 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 120.577 1.535 . . . . 28.920000000000002 112.876 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1187 ' ' LEU . . . . . . . . . . . . . 58.6 mt -45.1 -52.35 9.23 Favored 'General case' 0 C--O 1.246 0.879 0 O-C-N 123.934 0.771 . . . . 29.09 112.788 165.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 128.41 27.24 0.91 Allowed Glycine 0 N--CA 1.438 -1.175 0 O-C-N 121.26 -0.9 . . . . 29.260000000000002 112.969 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1189 ' ' ALA . . . . . 0.428 ' HB2' ' HB3' ' B' 1153 ' ' PHE 0.259 . . -102.48 146.11 28.59 Favored 'General case' 0 C--O 1.251 1.176 0 N-CA-C 107.747 -1.205 . . . . 30.16 107.747 -179.115 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B 1190 ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' B' 1167 ' ' LYS . 74.0 mt -83.82 103.94 11.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 103.178 -2.897 . . . . 35.810000000000002 103.178 -171.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1191 ' ' VAL . . . . . 0.748 HG11 HG12 ' B' 1181 ' ' ILE . 53.0 t -81.26 131.85 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.646 0 N-CA-C 104.903 -2.258 . . . . 31.969999999999999 104.903 176.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1192 ' ' ARG . . . . . 0.454 ' HG2' ' HB3' ' B' 1210 ' ' GLU . 33.2 mtt180 -120.57 89.85 3.21 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 109.827 -3.351 . . . . 48.159999999999997 104.946 171.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -90.31 130.29 36.43 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.401 -1.272 . . . . 35.890000000000001 113.151 -176.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1194 ' ' PHE . . . . . 0.401 ' HD2' HG23 ' B' 1171 ' ' ILE . 35.2 t80 -106.31 144.12 33.45 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.72 -1.215 . . . . 41.880000000000003 107.72 175.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1195 ' ' ASP . . . . . . . . . . . . . 8.9 t70 -157.98 153.26 25.82 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 104.417 -2.438 . . . . 38.280000000000001 104.417 160.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1196 ' ' THR . . . . . . . . . . . . . 13.4 p -84.25 -10.04 58.0 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.114 0.783 . . . . 40.619999999999997 113.114 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1197 ' ' ARG . . . . . 0.403 ' HA ' ' HD2' ' B' 1198 ' ' PRO . 39.9 mtm180 -91.43 126.6 53.93 Favored Pre-proline 0 C--O 1.247 0.969 0 C-N-CA 124.294 1.038 . . . . 53.090000000000003 108.353 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1198 ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' B' 1197 ' ' ARG . 13.9 Cg_endo -52.6 -45.7 38.37 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 N-CA-C 121.264 3.525 . . . . 42.560000000000002 121.264 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1199 ' ' GLU . . . . . 0.862 ' HB2' ' HE1' ' C' ' 155' ' ' TYR . 0.0 OUTLIER -72.66 -8.42 55.21 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 118.351 -2.718 . . . . 56.310000000000002 114.094 -157.493 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B 1200 ' ' VAL . . . . . 0.541 ' HA ' ' HG2' ' B' 1203 ' ' GLN . 34.5 m -85.06 -17.46 9.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 120.799 -1.188 . . . . 42.909999999999997 111.257 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1201 ' ' LYS . . . . . 0.494 ' HG3' ' CD2' ' B' 1211 ' ' PHE . 49.1 tttm -50.39 -54.26 23.12 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 121.428 1.922 . . . . 48.890000000000001 112.252 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 20.6 mp0 -64.64 -21.96 66.85 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 116.715 2.117 . . . . 51.700000000000003 116.715 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1203 ' ' GLN . . . . . 0.581 ' OE1' ' HA ' ' C' ' 74' ' ' ARG . 29.9 mm-40 -64.98 -48.16 74.98 Favored 'General case' 0 C--O 1.248 1.0 0 O-C-N 118.647 -2.533 . . . . 52.57 110.197 172.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1204 ' ' VAL . . . . . 0.444 HG22 HD13 ' B' 1181 ' ' ILE . 12.1 t -59.97 -54.2 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 112.144 -2.298 . . . . 33.789999999999999 108.504 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -51.08 -51.73 50.4 Favored 'General case' 0 C--O 1.203 -1.362 0 C-N-CA 124.579 1.152 . . . . 36.579999999999998 112.88 177.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1206 ' ' SER . . . . . . . . . . . . . 16.5 m -71.41 -7.58 48.23 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 115.634 1.716 . . . . 39.609999999999999 115.634 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1207 ' ' MET . . . . . 0.495 ' SD ' HG22 ' B' 1181 ' ' ILE . 27.5 mtp -80.21 -38.71 30.58 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 123.118 1.437 . . . . 37.450000000000003 112.012 167.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 121.58 46.87 0.31 Allowed Glycine 0 CA--C 1.519 0.297 0 CA-C-N 112.035 -2.348 . . . . 31.870000000000001 108.031 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -142.36 150.28 40.51 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 114.033 -1.083 . . . . 35.399999999999999 110.233 -168.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1210 ' ' GLU . . . . . 0.454 ' HB3' ' HG2' ' B' 1192 ' ' ARG . 10.4 tt0 -81.58 139.51 35.02 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 125.677 1.861 . . . . 47.890000000000001 107.421 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1211 ' ' PHE . . . . . 0.494 ' CD2' ' HG3' ' B' 1201 ' ' LYS . 87.7 t80 -107.21 114.24 28.16 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 106.244 -1.761 . . . . 45.530000000000001 106.244 170.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1212 ' ' LEU . . . . . . . . . . . . . 62.7 mt -65.94 116.65 7.31 Favored 'General case' 0 N--CA 1.441 -0.913 0 O-C-N 120.616 -1.303 . . . . 46.329999999999998 108.075 170.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -80.99 175.81 10.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 122.964 1.364 . . . . 60.409999999999997 111.932 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 25.4 mt -56.92 132.0 51.33 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 112.705 -2.043 . . . . 57.380000000000003 108.998 168.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 15.1 t70 . . . . . 0 N--CA 1.443 -0.777 0 C-N-CA 124.354 1.062 . . . . 65.069999999999993 108.848 -177.102 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B 1230 ' ' MET . . . . . 0.62 ' N ' ' HG ' ' B' 1231 ' ' SER . 3.0 mmt . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 105.121 -2.178 . . . . 80.319999999999993 105.121 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1231 ' ' SER . . . . . 0.62 ' HG ' ' N ' ' B' 1230 ' ' MET . 4.8 m 103.83 159.49 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.085 2 O-C-N 114.398 -5.189 . . . . 79.920000000000002 114.175 -18.343 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -56.06 154.0 8.22 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 116.579 2.066 . . . . 77.909999999999997 116.579 -172.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 66.39 -53.79 0.41 Allowed 'General case' 0 C--N 1.356 0.873 0 C-N-CA 126.273 1.829 . . . . 73.879999999999995 112.688 -172.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 32.2 t80 -60.5 -35.7 76.59 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-N 121.025 1.739 . . . . 68.980000000000004 109.227 171.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1235 ' ' ILE . . . . . 0.472 ' O ' ' HG2' ' B' 1239 ' ' MET . 15.4 pt -47.46 -32.69 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 120.22 1.373 . . . . 64.530000000000001 114.175 169.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -60.17 -46.02 91.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 117.994 -2.941 . . . . 66.359999999999999 111.75 169.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -69.5 -29.94 67.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 123.229 1.49 . . . . 56.600000000000001 111.527 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -63.79 -48.38 77.13 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 114.16 -1.382 . . . . 56.789999999999999 109.196 175.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1239 ' ' MET . . . . . 0.472 ' HG2' ' O ' ' B' 1235 ' ' ILE . 29.6 mmt -57.47 -55.98 27.73 Favored 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 125.359 1.464 . . . . 53.630000000000003 107.343 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -53.9 -29.44 41.91 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 114.643 1.349 . . . . 51.740000000000002 114.643 176.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 58.3 tp -70.02 -43.46 71.29 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 108.978 -0.749 . . . . 44.859999999999999 108.978 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1242 ' ' PHE . . . . . 0.408 ' HB3' ' HE3' ' B' 1169 ' ' MET . 8.9 m-30 -74.08 -39.94 63.1 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 124.722 1.264 . . . . 42.780000000000001 111.408 -178.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.97 93.77 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.373 -0.831 . . . . 40.960000000000001 109.86 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -60.25 -49.13 78.81 Favored 'General case' 0 C--N 1.316 -0.879 0 O-C-N 121.195 -0.941 . . . . 43.060000000000002 110.368 172.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -65.38 -24.19 67.16 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 113.052 -1.885 . . . . 46.450000000000003 110.842 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1246 ' ' ALA . . . . . 0.547 ' HB1' ' HA ' ' B' 1275 ' ' MET . . . -48.84 -39.75 26.8 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 119.589 3.181 . . . . 41.780000000000001 119.589 -174.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 12.3 mptt -67.91 -31.7 71.65 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.224 -1.548 . . . . 52.200000000000003 112.324 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1248 ' ' GLU . . . . . 0.498 ' HB3' ' HD2' ' B' 1167 ' ' LYS . 33.5 mt-10 -80.97 -44.17 18.57 Favored 'General case' 0 C--O 1.251 1.158 0 CA-C-N 114.168 -1.378 . . . . 53.549999999999997 111.885 -177.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1249 ' ' VAL . . . . . 0.658 ' HA ' ' HB2' ' B' 1167 ' ' LYS . 35.2 m -85.72 150.36 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 124.454 2.073 . . . . 34.409999999999997 111.135 -165.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1250 ' ' ASP . . . . . 0.578 ' O ' ' HB3' ' B' 1279 ' ' SER . 1.5 m-20 -108.08 -47.59 3.53 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 110.749 -2.932 . . . . 33.380000000000003 111.328 -176.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1251 ' ' ILE . . . . . 0.655 HD12 ' HB1' ' B' 1145 ' ' ALA . 33.0 mm -119.21 125.15 74.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 105.978 -1.86 . . . . 29.539999999999999 105.978 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1252 ' ' ILE . . . . . 0.517 HD12 HG12 ' B' 1281 ' ' ILE . 79.8 mt -103.68 118.56 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 104.583 -2.377 . . . . 32.439999999999998 104.583 172.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1253 ' ' VAL . . . . . 0.426 HG23 HG22 ' B' 1251 ' ' ILE . 52.9 t -111.39 89.99 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.072 0 N-CA-C 104.433 -2.432 . . . . 30.57 104.433 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1254 ' ' THR . . . . . . . . . . . . . 14.1 t -101.44 131.94 47.3 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 113.736 -1.575 . . . . 35.039999999999999 109.027 -169.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1255 ' ' THR . . . . . 0.614 HG21 ' HB3' ' B' 1176 ' ' ALA . 2.6 m -146.93 31.43 0.94 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.875 -1.057 . . . . 34.619999999999997 113.14 -157.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . -73.7 75.62 1.55 Allowed 'General case' 0 C--O 1.244 0.804 0 O-C-N 117.842 -3.036 . . . . 42.719999999999999 111.483 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 32.7 mt -83.83 79.18 9.56 Favored 'General case' 0 C--O 1.248 0.976 0 CA-C-O 123.677 1.703 . . . . 52.43 108.084 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1258 ' ' ILE . . . . . 0.461 HG13 ' HB2' ' B' 1261 ' ' LYS . 27.2 pt -81.86 132.91 52.88 Favored Pre-proline 0 N--CA 1.448 -0.568 0 CA-C-N 113.357 -1.747 . . . . 59.409999999999997 109.985 -173.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -49.59 99.33 0.04 OUTLIER 'Trans proline' 0 CA--C 1.495 -1.451 0 N-CA-C 120.113 3.082 . . . . 62.68 120.113 -166.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 74.09 3.81 65.93 Favored Glycine 0 N--CA 1.432 -1.574 0 CA-C-N 112.604 -2.089 . . . . 64.159999999999997 112.698 173.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1261 ' ' LYS . . . . . 0.461 ' HB2' HG13 ' B' 1258 ' ' ILE . 95.0 mttt -105.53 164.7 14.51 Favored Pre-proline 0 C--O 1.211 -0.946 0 CA-C-O 115.919 -1.991 . . . . 68.530000000000001 110.991 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -70.92 142.24 42.36 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 CA-C-N 126.654 3.412 . . . . 61.990000000000002 111.957 167.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1263 ' ' ALA . . . . . 0.545 ' H ' ' HA3' ' B' 1289 ' ' GLY . . . -62.68 135.91 95.96 Favored Pre-proline 0 C--O 1.249 1.073 0 N-CA-C 113.851 1.056 . . . . 57.149999999999999 113.851 173.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -64.91 154.26 73.98 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 121.991 1.794 . . . . 51.57 114.647 173.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -81.96 82.69 7.49 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 118.649 -1.221 . . . . 54.549999999999997 109.019 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 62.5 mt -64.98 -48.19 74.87 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-O 123.125 1.441 . . . . 46.859999999999999 113.399 175.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1267 ' ' ILE . . . . . 0.827 HG21 HD13 ' B' 1281 ' ' ILE . 22.9 mm -96.0 97.56 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 122.088 0.947 . . . . 41.039999999999999 108.896 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1268 ' ' THR . . . . . 0.424 ' O ' HG23 ' B' 1272 ' ' VAL . 18.1 p -76.5 162.04 28.14 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 113.732 -1.576 . . . . 39.579999999999998 113.197 177.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1269 ' ' ARG . . . . . 0.547 ' HG3' ' HB2' ' B' 1293 ' ' GLU . 82.4 mtt85 -59.24 -36.05 74.78 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 124.376 1.07 . . . . 53.149999999999999 111.296 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -50.65 -58.65 5.34 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 114.57 -1.196 . . . . 42.960000000000001 111.638 167.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1271 ' ' MET . . . . . . . . . . . . . 28.6 ttm -60.08 -33.55 72.22 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.637 1.347 . . . . 43.890000000000001 114.637 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1272 ' ' VAL . . . . . 0.424 HG23 ' O ' ' B' 1268 ' ' THR . 58.1 t -66.27 -48.05 82.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 109.048 -0.723 . . . . 38.369999999999997 109.048 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 4.7 t70 -77.25 -27.43 53.28 Favored 'General case' 0 C--O 1.244 0.776 0 O-C-N 121.617 -0.677 . . . . 47.460000000000001 110.059 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1274 ' ' SER . . . . . . . . . . . . . 67.3 m -74.13 -24.27 59.4 Favored 'General case' 0 C--O 1.246 0.878 0 CA-C-N 115.962 -0.563 . . . . 38.380000000000003 111.814 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1275 ' ' MET . . . . . 0.547 ' HA ' ' HB1' ' B' 1246 ' ' ALA . 1.0 OUTLIER -60.51 163.19 5.53 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 115.553 1.686 . . . . 37.810000000000002 115.553 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -56.12 130.04 42.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 113.742 -1.572 . . . . 49.259999999999998 110.219 169.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -60.59 159.63 10.34 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.732 -1.576 . . . . 34.460000000000001 111.141 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1278 ' ' GLY . . . . . 0.446 ' HA2' ' HB3' ' A' 1044 ' ' SER . . . 64.78 33.54 87.51 Favored Glycine 0 CA--C 1.521 0.421 0 O-C-N 121.427 -0.795 . . . . 33.530000000000001 113.526 172.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1279 ' ' SER . . . . . 0.578 ' HB3' ' O ' ' B' 1250 ' ' ASP . 15.2 m -133.94 167.28 20.89 Favored 'General case' 0 C--O 1.262 1.763 0 C-N-CA 123.481 0.712 . . . . 31.309999999999999 111.598 -164.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1280 ' ' VAL . . . . . 0.466 HG11 ' HA ' ' B' 1145 ' ' ALA . 66.9 t -127.01 131.06 71.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 O-C-N 119.868 -1.77 . . . . 29.32 111.118 -173.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1281 ' ' ILE . . . . . 0.827 HD13 HG21 ' B' 1267 ' ' ILE . 91.3 mt -103.25 99.37 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 102.505 -3.146 . . . . 31.93 102.505 169.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1282 ' ' VAL . . . . . . . . . . . . . 17.4 t -82.52 115.04 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 105.121 -2.177 . . . . 29.48 105.121 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1283 ' ' ASP . . . . . 0.453 ' HB3' ' HA2' ' B' 1311 ' ' GLY . 42.8 t0 -97.99 112.64 24.5 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 123.819 1.771 . . . . 34.5 106.76 174.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1284 ' ' LEU . . . . . 0.58 ' HG ' HD13 ' B' 1315 ' ' LEU . 7.3 mp -90.6 -21.28 21.8 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 113.64 -1.618 . . . . 37.939999999999998 110.215 -176.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -96.87 16.68 18.64 Favored 'General case' 0 C--O 1.25 1.115 0 CA-C-O 121.503 0.668 . . . . 40.920000000000002 111.784 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1286 ' ' ALA . . . . . 0.707 ' HA ' ' HA2' ' B' 1290 ' ' GLY . . . -63.5 -34.89 78.76 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 122.756 1.265 . . . . 44.390000000000001 112.399 -167.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1287 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -45.99 74.36 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 115.237 -0.892 . . . . 51.460000000000001 109.656 174.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.4 37.75 1.62 Allowed 'General case' 0 C--O 1.245 0.843 0 CA-C-O 125.214 2.435 . . . . 57.75 108.856 -167.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1289 ' ' GLY . . . . . 0.545 ' HA3' ' H ' ' B' 1263 ' ' ALA . . . 139.57 -61.75 0.56 Allowed Glycine 0 N--CA 1.433 -1.532 0 O-C-N 119.147 -2.221 . . . . 49.850000000000001 111.869 175.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1290 ' ' GLY . . . . . 0.707 ' HA2' ' HA ' ' B' 1286 ' ' ALA . . . 96.19 114.39 2.98 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 107.519 -2.232 . . . . 45.93 107.519 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1291 ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -72.86 -16.26 61.59 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.314 -0.995 . . . . 42.670000000000002 108.314 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1292 ' ' CYS . . . . . 0.52 ' HB3' ' OG1' ' B' 1295 ' ' THR . 25.3 t -118.93 139.09 52.24 Favored 'General case' 0 N--CA 1.432 -1.33 0 O-C-N 118.748 -2.47 . . . . 38.82 113.265 -175.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1293 ' ' GLU . . . . . 0.547 ' HB2' ' HG3' ' B' 1269 ' ' ARG . 51.2 mt-10 -66.81 -40.84 88.21 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 118.745 -0.645 . . . . 46.710000000000001 112.441 177.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.08 -6.41 50.99 Favored 'General case' 0 C--O 1.239 0.531 0 O-C-N 125.866 1.979 . . . . 47.229999999999997 113.124 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1295 ' ' THR . . . . . 0.713 HG23 ' HA3' ' B' 1311 ' ' GLY . 74.1 m -52.67 137.76 30.24 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 124.955 2.312 . . . . 36.020000000000003 112.025 172.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1296 ' ' VAL . . . . . 0.476 ' HB ' ' HB2' ' B' 1299 ' ' GLU . 3.7 t -117.42 105.14 48.94 Favored Pre-proline 0 C--N 1.321 -0.643 1 N-CA-C 96.65 -5.315 . . . . 37.259999999999998 96.65 168.382 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -56.7 128.42 29.93 Favored 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 124.968 3.779 . . . . 35.090000000000003 111.311 177.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 96.12 -17.46 59.24 Favored Glycine 0 C--N 1.315 -0.615 0 CA-C-O 122.288 0.938 . . . . 35.969999999999999 112.296 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1299 ' ' GLU . . . . . 0.476 ' HB2' ' HB ' ' B' 1296 ' ' VAL . 28.6 mt-10 -123.44 173.64 7.88 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 123.822 1.772 . . . . 40.390000000000001 110.751 -171.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1300 ' ' ILE . . . . . 0.6 HD13 ' HG3' ' B' 1148 ' ' GLU . 96.4 mt -113.55 105.96 19.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 110.744 -2.935 . . . . 37.43 103.088 177.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1301 ' ' PHE . . . . . 0.507 ' HB3' ' HB ' ' B' 1309 ' ' VAL . 76.6 t80 -73.1 148.5 43.92 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.347 -1.353 . . . . 44.130000000000003 107.347 171.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1302 ' ' THR . . . . . . . . . . . . . 40.7 m -140.46 119.41 12.65 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 122.773 2.533 . . . . 39.780000000000001 106.538 175.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1303 ' ' THR . . . . . 0.454 HG23 ' HE2' ' B' 1301 ' ' PHE . 2.7 p -74.21 175.15 7.82 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.854 0.835 . . . . 43.289999999999999 109.801 171.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -74.66 -25.39 59.15 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-O 121.849 0.833 . . . . 53.07 109.801 -174.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -80.47 -7.99 59.38 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.342 -0.984 . . . . 43.969999999999999 108.342 173.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 90.3 37.46 6.64 Favored Glycine 0 N--CA 1.462 0.382 0 O-C-N 119.752 -1.842 . . . . 41.119999999999997 111.382 174.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1307 ' ' VAL . . . . . . . . . . . . . 43.2 t -97.69 108.79 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-O 125.837 2.732 . . . . 38.119999999999997 104.019 170.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1308 ' ' LYS . . . . . 0.689 ' HD2' ' HB3' ' B' 1148 ' ' GLU . 83.9 mttt -84.67 102.56 13.05 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 108.783 -3.826 . . . . 36.340000000000003 109.498 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1309 ' ' VAL . . . . . 0.507 ' HB ' ' HB3' ' B' 1301 ' ' PHE . 22.0 t -85.02 100.17 7.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 105.483 -2.043 . . . . 30.399999999999999 105.483 177.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1310 ' ' ILE . . . . . 0.647 HD11 ' HB2' ' B' 1148 ' ' GLU . 27.1 mt -81.8 90.53 2.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 107.032 -1.47 . . . . 30.82 107.032 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1311 ' ' GLY . . . . . 0.713 ' HA3' HG23 ' B' 1295 ' ' THR . . . -89.57 83.02 1.41 Allowed Glycine 0 C--N 1.301 -1.411 0 N-CA-C 108.751 -1.739 . . . . 26.530000000000001 108.751 -172.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1312 ' ' TYR . . . . . 0.504 ' CB ' ' HG ' ' B' 1315 ' ' LEU . 6.6 m-30 -98.57 133.05 43.47 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 119.306 3.076 . . . . 38.0 119.306 -170.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1313 ' ' THR . . . . . . . . . . . . . 2.6 p -76.87 -63.86 1.26 Allowed 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 109.222 -3.626 . . . . 29.800000000000001 108.509 166.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 4.3 p30 -69.62 6.85 0.98 Allowed 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 120.405 3.483 . . . . 39.039999999999999 120.405 -171.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1315 ' ' LEU . . . . . 0.58 HD13 ' HG ' ' B' 1284 ' ' LEU . 28.4 mt -46.6 -50.42 41.87 Favored Pre-proline 0 C--N 1.352 0.703 0 N-CA-C 118.952 2.945 . . . . 31.079999999999998 118.952 175.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1316 ' ' PRO . . . . . 0.614 ' HB3' ' HB3' ' B' 1133 ' ' MET . 92.6 Cg_exo -55.45 -33.39 85.81 Favored 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 123.956 3.104 . . . . 26.100000000000001 112.072 174.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -82.56 -53.73 3.5 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 120.424 -1.423 . . . . 23.170000000000002 111.247 -175.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1318 ' ' ARG . . . . . 0.4 HH11 ' HD3' ' B' 1318 ' ' ARG . 71.3 mtt-85 -36.95 -16.5 0.0 OUTLIER 'General case' 0 C--O 1.235 0.318 1 N-CA-C 124.077 4.843 . . . . 40.399999999999999 124.077 -170.256 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B 1319 ' ' LEU . . . . . 0.61 HD13 HH11 ' B' 1140 ' ' ARG . 1.3 tp -105.52 77.35 0.38 Allowed Pre-proline 0 C--O 1.252 1.232 0 CA-C-N 124.031 3.105 . . . . 23.600000000000001 106.684 -176.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1320 ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -39.79 -72.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 124.79 3.66 . . . . 22.350000000000001 117.926 -151.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1321 ' ' THR . . . . . . . . . . . . . 2.0 m -66.64 -31.83 72.77 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 112.904 0.705 . . . . 26.52 112.904 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1322 ' ' GLN . . . . . 0.765 ' HB2' ' HA ' ' A' 1151 ' ' ARG . 45.8 tp60 -75.81 -44.66 40.07 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 119.097 -2.252 . . . . 24.379999999999999 110.267 -178.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1323 ' ' SER . . . . . . . . . . . . . 50.6 m -46.97 -52.1 15.47 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 120.272 -1.517 . . . . 22.800000000000001 110.394 169.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1324 ' ' SER . . . . . . . . . . . . . 29.0 m -57.1 -59.58 4.88 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 113.495 -1.684 . . . . 21.25 113.457 173.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 66.3 tp60 -52.84 -40.58 63.46 Favored 'General case' 0 C--N 1.344 0.346 0 O-C-N 120.303 -1.498 . . . . 31.34 113.957 -177.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1326 ' ' LEU . . . . . 0.428 ' CD1' HG21 ' A' 1158 ' ' THR . 63.4 mt -73.54 -46.94 44.55 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 113.665 0.987 . . . . 31.559999999999999 113.665 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1327 ' ' TYR . . . . . 0.428 ' O ' ' HG ' ' B' 1331 ' ' LEU . 47.2 t80 -54.22 -51.68 63.66 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-O 122.947 1.356 . . . . 22.73 108.6 173.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1328 ' ' GLY . . . . . 0.535 ' HA2' HD12 ' B' 1331 ' ' LEU . . . -41.06 -57.22 3.04 Favored Glycine 0 CA--C 1.496 -1.151 0 CA-C-N 112.614 -2.085 . . . . 21.91 115.793 168.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1329 ' ' THR . . . . . 0.623 HG21 ' HA3' ' A' 1161 ' ' GLY . 62.4 m -66.92 -28.96 68.73 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 114.605 1.335 . . . . 22.149999999999999 114.605 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1330 ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' B' 1127 ' ' LEU . 30.5 m120 -53.45 -51.42 62.72 Favored 'General case' 0 C--O 1.24 0.573 0 O-C-N 121.365 -0.834 . . . . 26.18 109.952 167.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1331 ' ' LEU . . . . . 0.624 HD13 ' HB3' ' B' 1070 ' ' LEU . 20.2 mt -65.95 -39.0 90.07 Favored 'General case' 0 CA--C 1.508 -0.653 0 O-C-N 125.413 1.696 . . . . 23.68 110.404 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1332 ' ' VAL . . . . . 0.671 HG12 ' HE3' ' B' 1336 ' ' LYS . 59.6 t -55.49 -51.31 58.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 120.073 1.306 . . . . 26.57 109.545 171.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -61.33 -39.86 92.1 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 114.371 -1.286 . . . . 28.079999999999998 109.771 -173.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1334 ' ' LEU . . . . . 0.656 HD12 HD23 ' B' 1127 ' ' LEU . 15.2 tp -70.95 -42.78 69.33 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 126.315 1.846 . . . . 27.43 107.482 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1335 ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' B' 1331 ' ' LEU . 79.7 mt -69.6 -24.19 63.63 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 121.195 1.816 . . . . 30.5 111.495 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1336 ' ' LYS . . . . . 0.671 ' HE3' HG12 ' B' 1332 ' ' VAL . 76.1 mttt -67.94 -40.57 83.25 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 120.166 1.348 . . . . 41.649999999999999 109.649 169.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 11.5 tp -81.31 -25.88 36.1 Favored 'General case' 0 C--O 1.244 0.802 0 O-C-N 119.266 -2.146 . . . . 42.079999999999998 110.985 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1338 ' ' LEU . . . . . 0.477 HD22 HG23 ' B' 1346 ' ' ILE . 12.8 mt -68.81 -78.94 0.06 Allowed 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 122.753 1.263 . . . . 35.030000000000001 109.946 164.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 18.0 t -78.75 76.5 5.24 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.278 -1.379 . . . . 37.329999999999998 107.278 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 58.2 mttp -65.47 -24.76 67.24 Favored 'General case' 0 C--N 1.35 0.595 0 N-CA-C 113.901 1.074 . . . . 50.509999999999998 113.901 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -73.83 -3.3 27.86 Favored 'General case' 0 C--O 1.25 1.097 0 N-CA-C 115.41 1.633 . . . . 54.210000000000001 115.41 169.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1342 ' ' LYS . . . . . 0.404 ' HD2' HD22 ' B' 1029 ' ' LEU . 9.3 mtmp? 33.43 66.58 0.22 Allowed 'General case' 0 C--N 1.357 0.923 0 CA-C-O 125.141 2.4 . . . . 50.990000000000002 116.891 -173.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -134.76 -37.01 0.83 Allowed 'General case' 0 C--O 1.248 0.981 0 CA-C-N 112.975 -1.92 . . . . 48.82 111.315 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 148.23 -31.37 1.3 Allowed Glycine 0 N--CA 1.434 -1.483 0 CA-C-N 122.64 2.473 . . . . 40.43 109.583 -178.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -75.82 113.96 13.88 Favored 'General case' 0 C--N 1.361 1.087 0 CA-C-N 119.442 1.621 . . . . 47.560000000000002 109.758 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1346 ' ' ILE . . . . . 0.477 HG23 HD22 ' B' 1338 ' ' LEU . 46.1 mm -69.4 107.05 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 CA-C-O 125.715 2.674 . . . . 42.490000000000002 107.589 177.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1347 ' ' THR . . . . . . . . . . . . . 9.2 m -83.11 108.24 16.24 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 103.154 -2.906 . . . . 38.119999999999997 103.154 176.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 11.7 t -84.16 84.78 2.01 Favored 'Isoleucine or valine' 0 C--O 1.257 1.478 0 N-CA-C 108.049 -1.093 . . . . 37.5 108.049 -175.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 50.5 t0 -80.86 129.78 34.71 Favored 'General case' 0 CA--C 1.5 -0.951 0 O-C-N 124.053 0.846 . . . . 43.850000000000001 111.244 -169.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1350 ' ' PHE . . . . . 0.478 ' HD1' ' HD2' ' B' 1356 ' ' ARG . 46.2 m-85 -114.67 -8.89 12.65 Favored 'General case' 0 C--O 1.251 1.147 0 O-C-N 118.668 -2.52 . . . . 39.810000000000002 110.3 175.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 34.3 t70 -72.78 -49.07 32.98 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 120.306 -1.496 . . . . 51.289999999999999 110.075 177.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 2.6 t70 -64.1 135.63 56.54 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 122.098 2.226 . . . . 39.780000000000001 109.787 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 7.4 m -57.48 -34.32 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 114.507 -1.224 . . . . 39.280000000000001 113.266 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1354 ' ' VAL . . . . . 0.562 HG21 ' HG3' ' B' 1123 ' ' ARG . 35.8 t -76.02 -48.37 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.408 0 CA-C-N 120.124 1.329 . . . . 35.700000000000003 109.353 -174.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1355 ' ' ILE . . . . . 0.736 ' HA ' HG12 ' B' 1358 ' ' VAL 0.257 24.1 mm -69.58 -32.86 54.26 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 CA-C-O 116.825 -1.56 . . . . 35.770000000000003 112.917 176.516 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B 1356 ' ' ARG . . . . . 0.478 ' HD2' ' HD1' ' B' 1350 ' ' PHE . 39.5 tpt85 -54.79 -49.16 71.63 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 120.488 1.495 . . . . 38.549999999999997 109.287 166.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -64.39 -55.96 20.3 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 119.62 1.1 . . . . 29.579999999999998 112.91 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1358 ' ' VAL . . . . . 0.736 HG12 ' HA ' ' B' 1355 ' ' ILE . 5.0 p -67.85 -34.19 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 124.334 1.054 . . . . 32.060000000000002 112.704 -174.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1359 ' ' THR . . . . . . . . . . . . . 6.2 m -78.34 92.16 4.52 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-O 125.264 2.459 . . . . 29.0 108.733 177.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1360 ' ' VAL . . . . . . . . . . . . . 18.9 m -78.51 -31.68 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.978 0 CA-C-N 108.898 -3.774 . . . . 29.68 108.257 -175.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 70.0 mt -128.97 119.95 50.7 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 N-CA-C 107.027 -1.471 . . . . 32.049999999999997 107.027 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1362 ' ' ARG . . . . . 0.454 ' HB2' ' CZ ' ' B' 1350 ' ' PHE . 19.8 ttt180 -97.67 113.13 24.82 Favored 'General case' 0 C--O 1.249 1.035 0 O-C-N 119.171 -2.205 . . . . 32.520000000000003 105.187 171.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 26.04 70.75 0.04 OUTLIER 'General case' 0 C--O 1.256 1.432 0 N-CA-C 118.028 2.603 . . . . 35.68 118.028 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 95.06 -50.1 1.94 Allowed Glycine 0 N--CA 1.428 -1.886 0 O-C-N 120.437 -1.414 . . . . 34.259999999999998 114.126 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -66.18 126.41 28.58 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.231 -0.655 . . . . 51.07 109.231 -175.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 49.7 mt -76.44 103.38 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.819 0 O-C-N 119.046 -2.284 . . . . 39.869999999999997 107.885 169.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1367 ' ' THR . . . . . . . . . . . . . 7.3 p -90.79 1.0 57.28 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 116.167 1.914 . . . . 38.009999999999998 116.167 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1368 ' ' TRP . . . . . . . . . . . . . 62.2 t90 -65.26 140.92 98.01 Favored Pre-proline 0 N--CA 1.432 -1.359 0 N-CA-C 105.017 -2.216 . . . . 42.140000000000001 105.017 160.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -70.22 157.69 93.1 Favored 'Cis proline' 0 C--O 1.252 1.184 0 N-CA-C 119.223 2.74 . . . . 43.259999999999998 119.223 10.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1370 ' ' ALA . . . . . . . . . . . . . . . -82.86 113.0 42.35 Favored Pre-proline 0 C--O 1.247 0.95 0 N-CA-C 104.427 -2.435 . . . . 46.520000000000003 104.427 168.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1371 ' ' PRO . . . . . 0.425 ' HA ' ' HD3' ' B' 1372 ' ' PRO . 83.8 Cg_endo -49.46 132.91 30.67 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.796 2.997 . . . . 51.950000000000003 116.411 -173.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1372 ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' B' 1371 ' ' PRO . 8.1 Cg_exo -55.83 83.48 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.838 1 C-N-CA 126.144 4.563 . . . . 56.270000000000003 113.604 176.871 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B 1373 ' ' ILE . . . . . . . . . . . . . 12.8 tt -75.46 140.78 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-N 114.335 -1.302 . . . . 60.829999999999998 110.552 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -67.4 108.47 2.8 Favored 'General case' 0 C--O 1.249 1.064 0 N-CA-C 107.27 -1.381 . . . . 66.099999999999994 107.27 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 60.8 t -102.97 113.64 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 106.437 -1.69 . . . . 63.469999999999999 106.437 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.206 -5.637 0 O-C-N 120.889 -1.132 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 20' ' ' ALA . . . . . 0.468 ' HA ' HD11 ' C' ' 171' ' ' LEU . . . . . . . . 0 N--CA 1.431 -1.422 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -52.96 -36.65 60.27 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 116.739 2.126 . . . . 0.0 116.739 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 22' ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' C' ' 22' ' ' GLU . 1.9 mp0 -37.96 -43.68 0.73 Allowed 'General case' 0 C--O 1.242 0.676 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 174.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 22.0 m -42.47 -30.04 0.32 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.678 1.591 . . . . 0.0 114.056 176.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.1 -46.93 86.88 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 123.919 1.819 . . . . 0.0 114.508 171.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 25' ' ' GLU . . . . . 0.822 ' HA ' ' HE2' ' C' ' 28' ' ' LYS . 2.5 mp0 -67.23 -46.11 74.79 Favored 'General case' 0 C--O 1.252 1.202 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.105 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 10.9 mp -52.68 -48.66 66.37 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.638 173.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.579 HD21 HD11 ' C' ' 110' ' ' LEU . 1.3 mm? -60.85 -40.36 92.57 Favored 'General case' 0 C--O 1.223 -0.297 0 O-C-N 119.654 -1.904 . . . . 0.0 115.187 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 28' ' ' LYS . . . . . 0.822 ' HE2' ' HA ' ' C' ' 25' ' ' GLU . 3.0 pttm -67.09 -29.29 69.01 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 118.496 -1.282 . . . . 0.0 113.729 168.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -79.28 -20.12 48.85 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -53.38 -21.34 5.71 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 118.467 2.766 . . . . 0.0 118.467 -160.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 31' ' ' HIS . . . . . 0.413 ' O ' HG23 ' C' ' 62' ' ' ILE . 48.4 m-70 71.63 -69.3 0.19 Allowed 'General case' 0 C--N 1.352 0.682 0 CA-C-N 122.925 2.602 . . . . 0.0 109.137 -176.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 32' ' ' SER . . . . . 0.503 ' HB2' ' OG1' ' C' ' 106' ' ' THR . 48.7 m -120.12 158.62 26.51 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 159.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 33' ' ' VAL . . . . . 0.442 ' HB ' HG23 ' C' ' 64' ' ' VAL . 32.7 t -123.06 114.56 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.155 0 N-CA-C 101.946 -3.353 . . . . 0.0 101.946 -178.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.494 HD12 HD11 ' C' ' 99' ' ' ILE . 18.5 mm -99.32 113.69 35.12 Favored 'Isoleucine or valine' 0 C--O 1.249 1.055 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 175.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 35' ' ' ILE . . . . . 0.52 HG12 HD12 ' C' ' 110' ' ' LEU . 75.9 mt -97.03 116.34 39.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 174.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 36' ' ' THR . . . . . 0.429 ' HB ' ' HA ' ' C' ' 111' ' ' VAL . 93.2 m -99.68 100.74 11.59 Favored Pre-proline 0 C--O 1.239 0.552 0 CA-C-N 114.867 -1.06 . . . . 0.0 113.22 174.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 37' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' C' ' 35' ' ' ILE . 15.4 Cg_exo -62.48 149.1 92.11 Favored 'Trans proline' 0 C--O 1.238 0.519 1 C-N-CA 125.879 4.386 . . . . 0.0 109.615 176.154 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.18 -153.8 7.92 Favored Glycine 0 C--O 1.217 -0.959 0 CA-C-N 109.694 -3.412 . . . . 0.0 108.62 174.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 39' ' ' TYR . . . . . 0.517 ' CD1' ' HD3' ' C' ' 74' ' ' ARG . 6.8 t80 -65.59 -41.35 92.92 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 110.127 -3.037 . . . . 0.0 108.165 -170.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 40' ' ' GLY . . . . . 0.478 ' H ' ' HA3' ' C' ' 113' ' ' GLY . . . -51.74 -54.76 23.6 Favored Glycine 0 C--N 1.347 1.19 0 O-C-N 120.543 -1.348 . . . . 0.0 113.972 174.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 30.4 ttm -58.97 -35.47 73.24 Favored 'General case' 0 C--O 1.215 -0.722 0 C-N-CA 124.484 1.114 . . . . 0.0 110.307 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.94 -60.59 2.15 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 2.9 p -75.03 -35.49 35.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 CA-C-N 118.422 0.555 . . . . 0.0 111.1 -168.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 44' ' ' ALA . . . . . 0.419 ' HB3' ' HB3' ' C' ' 175' ' ' ALA . . . -112.5 100.16 8.53 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 103.933 -2.617 . . . . 0.0 103.933 166.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 45' ' ' GLN . . . . . . . . . . . . . 16.3 pm0 -46.97 72.64 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 117.955 2.576 . . . . 0.0 117.955 -175.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.21 -22.69 54.97 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.914 -1.741 . . . . 0.0 111.507 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 47' ' ' GLN . . . . . 0.434 ' HA ' ' HB ' ' C' ' 50' ' ' VAL . 0.0 OUTLIER -56.24 -33.38 65.35 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 -176.185 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 48' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -65.3 -57.78 14.11 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 120.803 1.638 . . . . 0.0 110.59 172.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 49' ' ' PRO . . . . . 0.513 ' HB3' HD13 ' C' ' 183' ' ' LEU . 12.1 Cg_endo -58.47 -29.09 87.55 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 CA-C-N 125.526 3.009 . . . . 0.0 116.619 171.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 50' ' ' VAL . . . . . 0.503 HG23 HG11 ' C' ' 179' ' ' VAL . 20.3 t -58.16 -51.44 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 120.478 -1.389 . . . . 0.0 108.016 168.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.18 -36.39 79.72 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.324 0.965 . . . . 0.0 112.656 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 52' ' ' GLU . . . . . 0.52 ' O ' ' HE2' ' C' ' 56' ' ' LYS . 0.6 OUTLIER -64.28 -53.98 40.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 117.424 -1.274 . . . . 0.0 112.758 173.407 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 9.6 tp -62.83 -36.48 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 121.991 2.178 . . . . 0.0 110.398 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 74.2 m -47.89 -39.29 18.4 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 176.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -59.9 -42.54 94.08 Favored 'General case' 0 N--CA 1.437 -1.12 0 O-C-N 121.874 -0.517 . . . . 0.0 111.7 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 56' ' ' LYS . . . . . 0.52 ' HE2' ' O ' ' C' ' 52' ' ' GLU . 0.0 OUTLIER -75.41 -39.27 59.21 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -176.719 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 57' ' ' LEU . . . . . 0.558 HD21 HD12 ' C' ' 27' ' ' LEU . 72.9 mt -65.59 -33.23 75.42 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.658 1.183 . . . . 0.0 108.72 -176.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 58' ' ' ARG . . . . . 0.412 ' HD2' ' HA ' ' C' ' 58' ' ' ARG . 0.2 OUTLIER -77.58 -32.49 53.76 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 120.231 -1.543 . . . . 0.0 108.882 177.822 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.89 -46.93 61.71 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-N 121.005 1.73 . . . . 0.0 109.388 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -42.93 -42.42 3.72 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.329 1.452 . . . . 0.0 112.844 162.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.44 54.72 2.61 Favored Glycine 0 N--CA 1.437 -1.271 0 O-C-N 126.016 2.072 . . . . 0.0 112.154 176.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 62' ' ' ILE . . . . . 0.413 HG23 ' O ' ' C' ' 31' ' ' HIS . 93.8 mt -103.35 142.7 16.67 Favored 'Isoleucine or valine' 0 C--O 1.248 1.006 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 63' ' ' ASN . . . . . 0.403 ' OD1' ' HD3' ' C' ' 65' ' ' ARG . 31.0 t30 -71.41 74.52 0.75 Allowed 'General case' 0 C--O 1.257 1.466 0 CA-C-O 123.418 1.58 . . . . 0.0 109.418 174.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.442 HG23 ' HB ' ' C' ' 33' ' ' VAL . 3.5 p -88.14 115.34 28.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 117.551 -1.659 . . . . 0.0 108.211 -176.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 65' ' ' ARG . . . . . 0.483 HH21 HD11 ' C' ' 94' ' ' LEU . 14.3 mmm-85 -114.84 134.25 55.29 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.273 -177.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 66' ' ' PHE . . . . . 0.713 ' HB2' ' HA ' ' C' ' 93' ' ' VAL . 36.9 m-85 -93.5 79.48 4.35 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 123.01 1.386 . . . . 0.0 109.857 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.95 78.04 0.4 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-N 110.316 -3.129 . . . . 0.0 111.809 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 68' ' ' ILE . . . . . 0.512 HD11 HD22 ' C' ' 83' ' ' LEU . 12.9 mt -77.72 148.62 6.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 69' ' ' HIS . . . . . 0.478 ' HB3' ' HB2' ' C' ' 72' ' ' ALA . 32.0 t-80 -103.15 134.39 19.81 Favored Pre-proline 0 C--O 1.242 0.699 0 N-CA-C 104.152 -2.536 . . . . 0.0 104.152 168.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 70' ' ' PRO . . . . . 0.537 ' HB3' HD11 ' A' 1157 ' ' ILE . 27.6 Cg_endo -59.6 -72.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.123 0 C-N-CA 123.862 3.041 . . . . 0.0 114.887 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 23.0 t -70.87 95.53 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 170.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 72' ' ' ALA . . . . . 0.478 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . . . -165.26 161.34 19.16 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 123.252 1.501 . . . . 0.0 108.608 175.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 73' ' ' GLY . . . . . 0.47 ' O ' ' HD2' ' C' ' 74' ' ' ARG . . . 54.15 -110.55 1.58 Allowed Glycine 0 CA--C 1.535 1.296 0 CA-C-N 112.934 -1.939 . . . . 0.0 109.824 171.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 74' ' ' ARG . . . . . 0.581 ' HA ' ' OE1' ' B' 1203 ' ' GLN . 1.5 mpt_? -130.85 108.28 9.73 Favored 'General case' 0 C--O 1.259 1.605 0 O-C-N 121.959 -0.73 . . . . 0.0 111.234 -177.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.455 ' HA ' ' HD2' ' C' ' 76' ' ' PRO . 4.5 tt 63.83 114.67 0.02 OUTLIER Pre-proline 0 N--CA 1.445 -0.682 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 174.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 76' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' C' ' 75' ' ' LEU . 71.8 Cg_endo -56.89 104.28 0.14 Allowed 'Trans proline' 0 C--N 1.32 -0.925 1 C-N-CA 126.037 4.491 . . . . 0.0 107.805 175.469 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 132.01 -68.34 0.55 Allowed Glycine 0 N--CA 1.435 -1.395 0 N-CA-C 106.818 -2.513 . . . . 0.0 106.818 -171.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 78' ' ' HIS . . . . . 0.4 ' HB2' HD22 ' C' ' 75' ' ' LEU . 19.2 t-80 -63.37 -29.19 70.53 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -159.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -42.43 94.67 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 119.406 1.003 . . . . 0.0 110.493 175.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -72.83 -32.16 65.3 Favored 'General case' 0 C--N 1.368 1.377 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.562 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 48.7 t -73.01 -26.22 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 123.893 1.806 . . . . 0.0 110.303 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.9 tp -75.11 -31.92 61.26 Favored 'General case' 0 C--N 1.312 -1.03 0 O-C-N 120.55 -1.343 . . . . 0.0 108.397 166.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.512 HD22 HD11 ' C' ' 68' ' ' ILE . 9.0 mp -63.86 -30.52 71.6 Favored 'General case' 0 C--O 1.241 0.653 0 O-C-N 116.976 -3.577 . . . . 0.0 112.872 166.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 84' ' ' ALA . . . . . 0.479 ' HB2' ' OH ' ' C' ' 90' ' ' TYR . . . -62.21 -49.24 76.54 Favored 'General case' 0 N--CA 1.442 -0.849 0 O-C-N 124.57 1.169 . . . . 0.0 111.877 168.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -55.55 -40.02 71.36 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.225 1.01 . . . . 0.0 111.845 171.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.43 -21.27 53.27 Favored 'General case' 0 C--O 1.254 1.324 0 O-C-N 121.069 -1.019 . . . . 0.0 112.274 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp 77.36 50.82 0.04 OUTLIER 'General case' 0 C--O 1.242 0.682 0 CA-C-O 125.627 2.632 . . . . 0.0 112.95 -177.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 66.5 t -91.56 131.58 35.69 Favored Pre-proline 0 C--N 1.319 -0.751 0 O-C-N 118.885 -2.385 . . . . 0.0 112.146 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -61.28 99.57 0.16 Allowed 'Trans proline' 0 C--O 1.242 0.703 0 C-N-CA 124.471 3.447 . . . . 0.0 116.264 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 90' ' ' TYR . . . . . 0.479 ' OH ' ' HB2' ' C' ' 84' ' ' ALA . 82.2 m-85 -54.49 -26.07 29.15 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -174.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.97 -47.78 77.04 Favored 'General case' 0 C--O 1.248 1.004 0 O-C-N 120.116 -1.615 . . . . 0.0 112.024 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 5.0 pt -88.47 -8.54 10.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 93' ' ' VAL . . . . . 0.713 ' HA ' ' HB2' ' C' ' 66' ' ' PHE . 84.8 t -71.19 119.77 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 165.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 94' ' ' LEU . . . . . 0.523 HD12 HD13 ' C' ' 99' ' ' ILE . 65.0 mt -123.77 99.72 6.42 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.711 -1.132 . . . . 0.0 109.129 -175.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 95' ' ' GLU . . . . . 0.693 ' HG2' ' HB ' ' A' 1157 ' ' ILE . 12.9 mp0 -91.79 74.47 5.74 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 -171.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 6.2 ttp 62.83 124.5 0.01 OUTLIER 'General case' 0 CA--C 1.497 -1.089 0 CA-C-N 111.322 -2.672 . . . . 0.0 111.602 -167.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -159.34 -172.35 3.7 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-N 112.657 -2.065 . . . . 0.0 106.973 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -76.49 61.19 1.71 Allowed 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 121.082 -1.012 . . . . 0.0 111.223 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 99' ' ' ILE . . . . . 0.523 HD13 HD12 ' C' ' 94' ' ' LEU . 6.2 tp -92.64 27.66 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.778 0 CA-C-O 124.851 2.262 . . . . 0.0 109.92 -168.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 100' ' ' ASN . . . . . 0.447 ' O ' ' HB2' ' C' ' 103' ' ' PHE . 2.2 t-20 -71.64 -60.82 2.03 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.602 -1.311 . . . . 0.0 114.115 -166.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -70.3 -32.49 70.28 Favored 'General case' 0 C--O 1.215 -0.753 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -56.97 -41.44 78.36 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 117.11 -1.424 . . . . 0.0 110.697 173.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 103' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' C' ' 100' ' ' ASN . 3.4 m-85 -54.98 -45.08 74.98 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 120.185 1.357 . . . . 0.0 113.153 169.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.21 -33.19 73.96 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 122.411 1.101 . . . . 0.0 108.722 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -68.03 -33.13 74.01 Favored 'General case' 0 C--O 1.243 0.711 0 O-C-N 118.87 -2.394 . . . . 0.0 111.367 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 106' ' ' THR . . . . . 0.503 ' OG1' ' HB2' ' C' ' 32' ' ' SER . 51.7 m -76.11 122.42 24.26 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.745 1.26 . . . . 0.0 109.183 -175.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.26 -57.97 3.98 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.594 169.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 4.3 m -104.05 104.99 15.02 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -169.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 109' ' ' VAL . . . . . 0.559 ' HB ' ' HA ' ' C' ' 144' ' ' VAL . 24.4 t -94.95 107.95 20.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 172.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 110' ' ' LEU . . . . . 0.579 HD11 HD21 ' C' ' 27' ' ' LEU . 80.2 mt -78.23 86.37 4.35 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.901 -0.499 . . . . 0.0 111.827 178.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 111' ' ' VAL . . . . . 0.543 HG13 ' HB3' ' C' ' 114' ' ' ALA . 98.8 t -79.93 83.1 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-O 124.315 2.007 . . . . 0.0 108.237 177.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 7.4 mt -78.05 77.22 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.747 0 CA-C-O 123.321 1.534 . . . . 0.0 113.03 -172.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 113' ' ' GLY . . . . . 0.478 ' HA3' ' H ' ' C' ' 40' ' ' GLY . . . 71.19 42.07 58.71 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.054 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 114' ' ' ALA . . . . . 0.543 ' HB3' HG13 ' C' ' 111' ' ' VAL . . . -107.83 -24.8 11.52 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 120.84 -1.388 . . . . 0.0 110.321 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 115' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.94 -85.79 0.02 OUTLIER 'General case' 0 C--N 1.352 0.709 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 162.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 116' ' ' ASP . . . . . 0.615 ' HB3' HD13 ' C' ' 130' ' ' ILE . 45.9 m-20 -83.61 -22.74 32.16 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -174.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 2.7 p -80.01 9.99 4.82 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 117.303 2.335 . . . . 0.0 117.303 -175.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.569 HG12 ' HB2' ' C' ' 136' ' ' LEU . 3.0 m -124.66 13.06 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 112.947 -1.933 . . . . 0.0 109.645 169.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 119' ' ' ASN . . . . . 0.481 ' HA ' ' HD2' ' C' ' 120' ' ' PRO . 37.4 t30 -90.08 121.02 69.19 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-O 118.475 -0.774 . . . . 0.0 111.17 -169.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 120' ' ' PRO . . . . . 0.481 ' HD2' ' HA ' ' C' ' 119' ' ' ASN . 36.9 Cg_endo -52.75 -28.33 37.66 Favored 'Trans proline' 0 C--O 1.251 1.153 0 C-N-CA 123.401 2.734 . . . . 0.0 113.701 175.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 121' ' ' ALA . . . . . 0.871 ' HA ' ' HB3' ' C' ' 125' ' ' ASP . . . -64.97 12.48 0.04 OUTLIER 'General case' 0 C--N 1.354 0.784 0 N-CA-C 116.644 2.091 . . . . 0.0 116.644 174.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 122' ' ' ALA . . . . . 0.659 ' HB1' ' HB3' ' C' ' 133' ' ' MET . . . -109.61 -2.34 17.58 Favored 'General case' 0 N--CA 1.426 -1.653 0 O-C-N 120.628 -1.295 . . . . 0.0 113.993 171.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.9 -39.85 0.09 Allowed 'General case' 0 C--N 1.351 0.671 0 CA-C-O 125.021 2.344 . . . . 0.0 115.969 169.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -66.12 -38.6 88.6 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 119.351 -2.093 . . . . 0.0 111.818 173.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 125' ' ' ASP . . . . . 0.871 ' HB3' ' HA ' ' C' ' 121' ' ' ALA . 22.7 t70 -102.63 121.08 50.91 Favored Pre-proline 0 C--N 1.347 0.457 0 O-C-N 124.19 0.931 . . . . 0.0 110.707 171.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 126' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' C' ' 125' ' ' ASP . 9.4 Cg_exo -77.6 -18.28 13.73 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 124.461 3.441 . . . . 0.0 115.677 174.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -62.95 -58.93 5.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 122.061 0.934 . . . . 0.0 112.47 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 128' ' ' SER . . . . . 0.571 ' HB3' HG21 ' C' ' 158' ' ' VAL . 66.6 m -57.36 149.52 48.3 Favored Pre-proline 0 C--O 1.24 0.595 0 N-CA-C 116.496 2.036 . . . . 0.0 116.496 -163.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 129' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -55.18 -17.73 15.98 Favored 'Trans proline' 0 CA--C 1.564 2.012 1 C-N-CA 126.003 4.469 . . . . 0.0 115.296 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 130' ' ' ILE . . . . . 0.615 HD13 ' HB3' ' C' ' 116' ' ' ASP . 8.8 pt -101.67 12.8 6.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 120.004 1.275 . . . . 0.0 114.283 173.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 131' ' ' ALA . . . . . 0.571 ' HA ' ' HA ' ' C' ' 122' ' ' ALA . . . -71.77 86.04 0.94 Allowed 'General case' 0 C--O 1.239 0.549 0 CA-C-O 124.353 2.025 . . . . 0.0 109.147 -172.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 149.5 53.83 0.02 OUTLIER Glycine 0 N--CA 1.423 -2.17 0 CA-C-N 111.963 -2.381 . . . . 0.0 108.777 -175.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 133' ' ' MET . . . . . 0.705 ' SD ' ' HD2' ' C' ' 134' ' ' PRO . 6.6 tpp -147.54 125.3 5.88 Favored Pre-proline 0 CA--C 1.548 0.865 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 134' ' ' PRO . . . . . 0.705 ' HD2' ' SD ' ' C' ' 133' ' ' MET . 22.4 Cg_endo -78.1 83.6 2.17 Favored 'Trans proline' 0 C--O 1.238 0.492 1 C-N-CA 125.612 4.208 . . . . 0.0 107.479 -175.954 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 135' ' ' VAL . . . . . 0.427 HG23 ' CZ3' ' C' ' 139' ' ' TRP . 8.3 m -64.7 154.02 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 CA-C-N 113.681 -1.6 . . . . 0.0 113.288 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 136' ' ' LEU . . . . . 0.569 ' HB2' HG12 ' C' ' 118' ' ' VAL . 88.3 mt -74.87 120.51 20.52 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -177.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 137' ' ' GLU . . . . . 0.428 ' HA ' ' CZ3' ' C' ' 139' ' ' TRP . 42.9 mm-40 -21.29 -28.02 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.159 1 N-CA-C 123.738 4.718 . . . . 0.0 123.738 179.162 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 138' ' ' VAL . . . . . 0.521 HG21 HG21 ' C' ' 109' ' ' VAL . 8.3 p -79.6 83.35 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -175.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 139' ' ' TRP . . . . . 0.428 ' CZ3' ' HA ' ' C' ' 137' ' ' GLU . 34.7 p90 -125.91 171.01 11.09 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-N 112.206 -2.27 . . . . 0.0 109.008 165.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 140' ' ' LYS . . . . . . . . . . . . . 21.0 pttm 56.55 -0.55 0.06 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 117.598 2.444 . . . . 0.0 117.598 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -141.76 165.62 26.97 Favored 'General case' 0 C--O 1.256 1.423 0 CA-C-O 116.015 -1.945 . . . . 0.0 109.731 -175.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 64.35 168.1 0.17 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 161.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 143' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -84.24 73.49 10.43 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 124.52 2.105 . . . . 0.0 109.667 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 144' ' ' VAL . . . . . 0.559 ' HA ' ' HB ' ' C' ' 109' ' ' VAL . 3.2 t -81.34 100.58 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 103.393 -2.818 . . . . 0.0 103.393 175.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 145' ' ' ILE . . . . . 0.804 HG12 ' HB2' ' C' ' 171' ' ' LEU 0.287 13.0 tt -98.87 99.27 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 112.31 -2.223 . . . . 0.0 112.062 -173.636 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 146' ' ' VAL . . . . . 0.608 HG21 ' HB3' ' C' ' 162' ' ' LEU . 39.5 t -84.11 113.38 22.85 Favored 'Isoleucine or valine' 0 C--N 1.343 0.298 0 CA-C-N 112.702 -2.044 . . . . 0.0 107.013 -171.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 147' ' ' PHE . . . . . 0.449 ' HD2' ' HA ' ' C' ' 175' ' ' ALA . 1.3 m-85 -66.41 112.73 4.2 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 122.647 1.213 . . . . 0.0 110.427 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 148' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -146.26 108.76 4.48 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 105.909 -1.885 . . . . 0.0 105.909 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -64.97 -40.7 95.38 Favored 'General case' 0 C--N 1.344 0.333 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.78 145.13 51.88 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 103.988 -2.597 . . . . 0.0 103.988 -174.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 151' ' ' MET . . . . . 0.526 ' HG2' ' SD ' ' C' ' 170' ' ' MET . 0.3 OUTLIER -84.02 68.94 10.24 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 170.909 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -87.16 168.06 13.59 Favored 'General case' 0 C--O 1.258 1.536 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.294 173.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 13.3 m -71.43 119.52 15.7 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -72.94 -133.16 0.18 Allowed Glycine 0 N--CA 1.478 1.441 0 O-C-N 118.797 -2.439 . . . . 0.0 108.75 172.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 155' ' ' TYR . . . . . 0.862 ' HE1' ' HB2' ' B' 1199 ' ' GLU . 2.8 m-85 -77.03 -50.86 12.15 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 117.135 -1.826 . . . . 0.0 109.881 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 156' ' ' ALA . . . . . 0.631 ' HB1' HG22 ' C' ' 158' ' ' VAL . . . -94.83 -53.32 3.89 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 161.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 65.96 14.68 61.48 Favored Glycine 0 C--O 1.254 1.349 0 CA-C-O 122.504 1.058 . . . . 0.0 114.253 -173.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 158' ' ' VAL . . . . . 0.631 HG22 ' HB1' ' C' ' 156' ' ' ALA . 13.5 m -89.6 124.84 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -162.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . 0.301 0.0 OUTLIER 37.0 24.61 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 118.266 2.691 . . . . 0.0 118.266 172.981 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 160' ' ' ASN . . . . . 0.71 ' HB3' HD12 ' C' ' 162' ' ' LEU . 3.7 m120 -62.57 111.63 5.1 Favored Pre-proline 0 C--O 1.239 0.535 0 O-C-N 120.461 -1.399 . . . . 0.0 110.22 -171.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -56.18 -41.94 71.46 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.885 2.39 . . . . 0.0 112.48 -177.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 162' ' ' LEU . . . . . 1.003 ' HA ' HG22 ' C' ' 168' ' ' THR . 16.0 mt -17.48 -40.91 0.0 OUTLIER 'General case' 0 C--O 1.244 0.794 0 N-CA-C 120.62 3.563 . . . . 0.0 120.62 155.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 163' ' ' PHE . . . . . 0.409 ' HA ' ' HG3' ' C' ' 170' ' ' MET . 12.9 m-30 -82.02 -48.33 11.55 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-O 124.385 2.041 . . . . 0.0 111.777 176.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -91.06 -17.04 26.88 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 111.963 -2.38 . . . . 0.0 113.611 -158.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -87.88 172.43 9.62 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 121.818 2.099 . . . . 0.0 110.863 -168.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -55.75 10.62 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 120.406 -1.434 . . . . 0.0 114.479 177.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -82.53 -49.97 9.31 Favored 'General case' 0 C--O 1.239 0.538 0 O-C-N 124.848 1.342 . . . . 0.0 108.115 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 168' ' ' THR . . . . . 1.003 HG22 ' HA ' ' C' ' 162' ' ' LEU . 4.8 m -82.84 91.9 7.17 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 123.328 1.537 . . . . 0.0 107.443 177.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -142.41 142.82 32.44 Favored 'General case' 0 N--CA 1.439 -1.013 0 O-C-N 120.88 -1.137 . . . . 0.0 111.686 -154.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 170' ' ' MET . . . . . 0.526 ' SD ' ' HG2' ' C' ' 151' ' ' MET . 54.1 mtm -58.41 126.83 29.21 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 121.169 -0.957 . . . . 0.0 108.878 166.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 171' ' ' LEU . . . . . 0.804 ' HB2' HG12 ' C' ' 145' ' ' ILE . 39.4 tp -89.06 108.78 19.78 Favored 'General case' 0 C--O 1.254 1.329 0 N-CA-C 104.103 -2.554 . . . . 0.0 104.103 166.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -82.22 91.51 6.74 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -174.69 168.19 40.74 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 106.139 -2.784 . . . . 0.0 106.139 175.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 174' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -72.57 151.7 42.23 Favored 'General case' 0 C--O 1.252 1.225 0 O-C-N 119.026 -2.455 . . . . 0.0 111.528 170.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 175' ' ' ALA . . . . . 0.449 ' HA ' ' HD2' ' C' ' 147' ' ' PHE . . . -59.85 -50.79 72.42 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 126.251 1.82 . . . . 0.0 111.676 -170.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.67 -55.9 6.84 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 177' ' ' ALA . . . . . . . . . . . . . . . -41.35 -44.83 2.88 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 117.851 2.537 . . . . 0.0 117.851 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 9.3 m -64.48 -41.34 96.53 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 175.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 179' ' ' VAL . . . . . 0.503 HG11 HG23 ' C' ' 50' ' ' VAL . 5.2 t -72.45 -32.05 40.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 119.278 -2.138 . . . . 0.0 107.615 177.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -67.67 -33.17 74.39 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 117.912 -2.992 . . . . 0.0 111.321 176.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.69 -30.61 70.86 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.202 173.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 182' ' ' ILE . . . . . 0.459 HD12 ' HG ' ' C' ' 27' ' ' LEU . 31.0 pt -87.22 -39.14 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 CA-C-O 122.668 1.223 . . . . 0.0 113.672 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 183' ' ' LEU . . . . . 0.513 HD13 ' HB3' ' C' ' 49' ' ' PRO . 12.9 tp -11.42 -66.9 0.01 OUTLIER 'General case' 0 C--N 1.355 0.838 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -107.7 -19.76 13.44 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 118.365 -1.334 . . . . 0.0 114.486 176.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -70.07 -65.28 0.74 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.941 -1.027 . . . . 0.0 113.743 -172.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 186' ' ' LEU . . . . . . . . . . . . 0.345 2.2 pt? . . . . . 0 N--CA 1.43 -1.433 0 N-CA-C 118.969 2.951 . . . . 0.0 118.969 -165.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 47.7 t60 . . . . . 0 N--CA 1.418 -2.064 0 N-CA-C 106.906 -1.516 . . . . 65.739999999999995 106.906 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -54.63 77.17 0.01 OUTLIER Glycine 0 C--O 1.223 -0.574 0 C-N-CA 125.581 1.562 . . . . 48.659999999999997 114.438 164.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 26.1 ttp180 -110.0 134.79 51.75 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.128 -1.536 . . . . 44.560000000000002 107.299 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1003 ' ' ILE . . . . . 0.597 HG12 ' HB ' ' A' 1068 ' ' ILE . 30.2 mt -99.75 139.22 21.86 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.757 0 O-C-N 124.482 1.114 . . . . 34.859999999999999 110.0 176.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -109.7 135.17 12.68 Favored Glycine 0 C--O 1.25 1.146 0 N-CA-C 107.376 -2.29 . . . . 30.75 107.376 172.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.441 HG21 ' HB2' ' A' 1018 ' ' ALA . 43.6 mm -106.76 112.05 63.63 Favored Pre-proline 0 N--CA 1.427 -1.578 0 N-CA-C 102.008 -3.33 . . . . 32.210000000000001 102.008 175.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -71.45 143.86 43.96 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 123.137 2.558 . . . . 32.979999999999997 111.438 168.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1007 ' ' ARG . . . . . 0.493 ' HG3' HD11 ' A' 1042 ' ' LEU . 25.3 ttp85 -67.8 126.61 29.95 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 104.248 -2.501 . . . . 47.979999999999997 104.248 162.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1008 ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -62.81 130.96 47.18 Favored 'General case' 0 CA--C 1.513 -0.478 0 O-C-N 120.247 -1.533 . . . . 34.700000000000003 113.219 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -86.68 -11.48 51.13 Favored 'General case' 0 C--O 1.252 1.191 0 O-C-N 121.125 -0.984 . . . . 53.369999999999997 113.579 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 5.9 mp -63.17 148.45 47.99 Favored 'General case' 0 C--O 1.214 -0.786 0 CA-C-O 123.034 1.397 . . . . 45.07 112.529 -176.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1011 ' ' THR . . . . . . . . . . . . . 7.3 m -64.23 107.59 1.35 Allowed 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 114.048 -1.433 . . . . 40.359999999999999 111.89 -167.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 33.8 t30 68.31 69.07 0.32 Allowed 'General case' 0 C--O 1.215 -0.73 0 CA-C-N 113.173 -1.831 . . . . 40.609999999999999 110.264 176.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1013 ' ' GLU . . . . . 0.616 ' HG3' ' H ' ' A' 1015 ' ' ARG . 8.3 tp10 -104.08 146.1 29.21 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 120.034 -0.666 . . . . 33.759999999999998 112.207 -168.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1014 ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' 1043 ' ' ALA . 0.6 OUTLIER -103.93 -6.23 21.5 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 122.758 1.266 . . . . 27.890000000000001 112.664 178.517 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 1015 ' ' ARG . . . . . 0.802 ' HD2' HG11 ' A' 1072 ' ' VAL . 69.5 mtm180 -106.19 147.3 29.21 Favored 'General case' 0 N--CA 1.44 -0.932 0 O-C-N 120.691 -1.255 . . . . 29.02 113.413 -172.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1016 ' ' VAL . . . . . 0.699 HG21 ' HB1' ' A' 1039 ' ' ALA . 8.6 p -148.48 138.93 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 N-CA-C 104.033 -2.58 . . . . 28.129999999999999 104.033 159.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1017 ' ' ALA . . . . . . . . . . . . . . . -63.44 -12.94 35.24 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 117.742 -3.098 . . . . 26.870000000000001 116.749 -176.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1018 ' ' ALA . . . . . 0.441 ' HB2' HG21 ' A' 1005 ' ' ILE . . . -84.11 112.1 19.93 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 123.734 1.73 . . . . 26.77 111.204 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1019 ' ' THR . . . . . 0.672 HG21 ' HA ' ' A' 1325 ' ' GLN . 67.8 p -118.26 167.74 10.85 Favored Pre-proline 0 N--CA 1.416 -2.138 0 N-CA-C 106.297 -1.742 . . . . 27.02 106.297 158.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1020 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -48.0 -57.48 2.31 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 124.767 3.645 . . . . 30.57 109.782 163.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1021 ' ' LYS . . . . . 0.415 ' HB2' ' OE1' ' A' 1325 ' ' GLN . 21.0 mttp -53.7 -31.12 46.73 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.856 1.662 . . . . 47.810000000000002 113.966 178.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1022 ' ' THR . . . . . . . . . . . . . 5.0 m -62.67 -65.57 0.67 Allowed 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 120.435 1.47 . . . . 30.77 108.758 169.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1023 ' ' VAL . . . . . 0.513 HG13 ' HB ' ' A' 1033 ' ' VAL . 59.0 t -56.75 -55.91 17.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 O-C-N 126.611 2.444 . . . . 33.590000000000003 113.11 -171.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -49.66 -52.24 32.3 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.036 1.334 . . . . 53.289999999999999 114.568 -176.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1025 ' ' GLN . . . . . 0.582 ' OE1' ' HE2' ' A' 1336 ' ' LYS . 8.2 tt0 -75.44 -34.46 60.98 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 114.389 -1.278 . . . . 46.920000000000002 113.122 -173.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1026 ' ' LEU . . . . . 0.571 HD21 ' HA ' ' A' 1332 ' ' VAL . 95.9 mt -66.87 -39.38 87.51 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.219 -0.901 . . . . 37.170000000000002 110.025 177.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1027 ' ' LEU . . . . . 0.501 HD23 ' HA ' ' A' 1032 ' ' THR . 96.5 mt -54.53 -50.03 68.84 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 118.241 -0.885 . . . . 44.439999999999998 110.673 172.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 42.5 mttm -57.61 -37.86 73.97 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.94 1.296 . . . . 52.579999999999998 112.051 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1029 ' ' LEU . . . . . 0.643 ' HA ' ' HE3' ' A' 1342 ' ' LYS . 98.6 mt -66.97 -40.23 87.4 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 119.015 0.825 . . . . 45.689999999999998 110.625 173.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 148.88 -30.31 1.24 Allowed Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.832 -0.699 . . . . 42.090000000000003 111.46 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -74.85 109.36 8.25 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 124.72 2.2 . . . . 40.719999999999999 108.884 -172.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1032 ' ' THR . . . . . 0.501 ' HA ' HD23 ' A' 1027 ' ' LEU . 18.6 m -74.51 131.14 40.76 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 105.611 -1.996 . . . . 37.770000000000003 105.611 176.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1033 ' ' VAL . . . . . 0.513 ' HB ' HG13 ' A' 1023 ' ' VAL . 61.1 t -109.83 136.78 44.73 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.784 0 CA-C-O 121.536 0.684 . . . . 33.539999999999999 109.66 -171.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -119.37 130.94 55.58 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 126.789 2.556 . . . . 31.68 109.456 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1035 ' ' VAL . . . . . 0.402 HG11 ' CD2' ' A' 1050 ' ' PHE . 77.6 t -115.34 135.87 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 105.765 -1.939 . . . . 31.52 105.765 -175.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1036 ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -62.31 141.67 58.15 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 123.703 1.716 . . . . 41.039999999999999 110.626 169.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1037 ' ' SER . . . . . . . . . . . . . 19.5 m -70.05 151.16 45.83 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.46 -1.245 . . . . 31.829999999999998 108.736 174.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 91.71 -29.27 7.49 Favored Glycine 0 C--O 1.213 -1.192 0 C-N-CA 120.057 -1.068 . . . . 29.359999999999999 110.561 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1039 ' ' ALA . . . . . 0.699 ' HB1' HG21 ' A' 1016 ' ' VAL . . . -62.37 -21.11 65.07 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 116.825 2.158 . . . . 27.780000000000001 116.825 -169.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -61.78 -43.2 99.55 Favored Glycine 0 CA--C 1.538 1.492 0 O-C-N 119.795 -1.816 . . . . 28.91 114.342 -175.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.79 -28.31 68.91 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 116.35 1.982 . . . . 51.18 116.35 -174.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1042 ' ' LEU . . . . . 0.493 HD11 ' HG3' ' A' 1007 ' ' ARG . 19.5 mt -52.82 -60.79 2.83 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 123.615 1.674 . . . . 29.91 107.898 171.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1043 ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' 1014 ' ' THR . . . -84.88 17.8 2.7 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.854 -1.066 . . . . 28.539999999999999 112.792 -173.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1044 ' ' SER . . . . . 0.619 ' HB3' ' HA2' ' B' 1278 ' ' GLY . 60.8 m 52.56 63.79 2.1 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-O 124.13 1.919 . . . . 33.060000000000002 112.959 -174.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1045 ' ' PHE . . . . . 0.62 ' HA ' ' HB1' ' B' 1277 ' ' ALA . 22.4 m-85 -128.66 157.08 42.34 Favored 'General case' 0 C--O 1.245 0.842 0 O-C-N 120.849 -1.157 . . . . 30.289999999999999 110.675 176.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 2.4 t70 -85.26 127.65 34.39 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 111.125 -2.762 . . . . 48.619999999999997 104.506 164.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -65.17 -39.34 92.8 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 123.068 1.413 . . . . 36.740000000000002 112.342 -174.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 25.5 pttm -66.84 -12.53 59.45 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 120.059 -1.651 . . . . 43.729999999999997 113.918 173.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -71.64 -21.65 61.8 Favored 'General case' 0 C--O 1.247 0.964 0 CA-C-O 122.776 1.274 . . . . 32.810000000000002 110.819 168.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1050 ' ' PHE . . . . . 0.402 ' CD2' HG11 ' A' 1035 ' ' VAL . 22.3 m-30 -78.84 -32.21 46.05 Favored 'General case' 0 CA--C 1.505 -0.773 0 O-C-N 119.492 -2.005 . . . . 31.859999999999999 110.056 169.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1051 ' ' VAL . . . . . 0.485 HG22 HG13 ' A' 1057 ' ' ILE . 62.2 t -62.87 -50.66 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-O 122.452 1.12 . . . . 33.219999999999999 109.095 173.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -43.65 -53.38 5.78 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.038 1.735 . . . . 50.829999999999998 112.676 165.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -56.75 -29.99 63.13 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-O 118.298 -0.858 . . . . 33.119999999999997 111.389 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 104.32 31.28 4.7 Favored Glycine 0 C--N 1.343 0.96 0 N-CA-C 111.896 -0.482 . . . . 35.829999999999998 111.896 176.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -90.59 149.51 22.1 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 121.783 -0.834 . . . . 34.82 109.92 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -83.04 122.21 28.02 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 106.295 -1.743 . . . . 49.049999999999997 106.295 167.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1057 ' ' ILE . . . . . 0.485 HG13 HG22 ' A' 1051 ' ' VAL . 27.3 mm -98.41 83.71 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.879 0 N-CA-C 106.389 -1.708 . . . . 38.530000000000001 106.389 -165.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1058 ' ' VAL . . . . . . . . . . . . . 48.7 t -80.11 130.11 36.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 O-C-N 124.312 1.008 . . . . 42.109999999999999 111.976 -173.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -79.62 78.55 6.17 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 123.994 1.854 . . . . 58.0 111.537 177.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 101.84 -142.49 15.68 Favored Glycine 0 CA--C 1.49 -1.531 0 CA-C-N 113.599 -1.637 . . . . 52.119999999999997 110.631 167.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -58.19 -26.4 62.74 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 111.33 -2.435 . . . . 54.75 114.12 -156.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1062 ' ' SER . . . . . . . . . . . . . 49.0 m -63.18 -14.3 47.36 Favored 'General case' 0 N--CA 1.427 -1.617 0 O-C-N 119.4 -2.062 . . . . 50.340000000000003 111.194 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -61.47 -29.29 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 O-C-N 119.839 -1.788 . . . . 41.460000000000001 109.634 172.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1064 ' ' TRP . . . . . 0.479 ' CH2' ' HB3' ' A' 1079 ' ' GLU . 87.7 m95 -65.28 -26.31 68.03 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 114.791 1.404 . . . . 39.32 114.791 171.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -79.49 75.34 6.11 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 122.508 1.147 . . . . 55.380000000000003 109.125 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1066 ' ' SER . . . . . . . . . . . . . 69.6 m -152.32 151.4 30.84 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 107.118 -1.438 . . . . 41.869999999999997 107.118 -172.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -66.74 -29.55 69.55 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-O 123.519 1.628 . . . . 53.200000000000003 112.324 -174.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1068 ' ' ILE . . . . . 0.597 ' HB ' HG12 ' A' 1003 ' ' ILE . 60.4 mt -131.04 143.21 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 102.868 -3.012 . . . . 41.899999999999999 102.868 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1069 ' ' ILE . . . . . 0.439 HG12 HG21 ' A' 1087 ' ' THR . 23.2 mm -123.97 114.29 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 N-CA-C 103.221 -2.881 . . . . 38.729999999999997 103.221 175.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1070 ' ' LEU . . . . . 0.599 HD22 HD22 ' A' 1331 ' ' LEU . 95.9 mt -90.05 94.27 9.72 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-N 116.144 -0.48 . . . . 32.439999999999998 112.07 172.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1071 ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -91.81 154.3 19.0 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 106.675 -1.602 . . . . 34.649999999999999 106.675 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1072 ' ' VAL . . . . . 0.802 HG11 ' HD2' ' A' 1015 ' ' ARG . 12.2 t -90.73 -67.32 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.964 0 N-CA-C 105.038 -2.208 . . . . 31.32 105.038 172.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -88.04 179.24 6.45 Favored 'General case' 0 CA--C 1.508 -0.658 0 O-C-N 120.39 -1.444 . . . . 33.939999999999998 110.571 -170.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -52.61 128.89 44.36 Favored Pre-proline 0 N--CA 1.441 -0.894 0 N-CA-C 114.079 1.141 . . . . 38.039999999999999 114.079 165.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1075 ' ' PRO . . . . . 0.491 ' HG2' HD21 ' A' 1089 ' ' LEU . 77.9 Cg_exo -67.13 128.39 18.48 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.089 2.526 . . . . 42.68 109.048 174.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 53.4 mt -78.16 158.06 29.19 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 112.557 -2.111 . . . . 46.740000000000002 106.068 175.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1077 ' ' ASP . . . . . 0.587 ' HA ' HD12 ' A' 1080 ' ' ILE . 4.1 m-20 -45.39 -35.82 3.88 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 118.054 2.613 . . . . 58.609999999999999 118.054 -169.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -68.6 -47.47 66.63 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 125.027 1.454 . . . . 59.200000000000003 110.729 173.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1079 ' ' GLU . . . . . 0.479 ' HB3' ' CH2' ' A' 1064 ' ' TRP . 33.0 mt-10 -60.44 -37.77 82.0 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 109.361 -0.607 . . . . 50.630000000000003 109.361 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1080 ' ' ILE . . . . . 0.587 HD12 ' HA ' ' A' 1077 ' ' ASP . 96.6 mt -56.5 -56.79 11.86 Favored 'Isoleucine or valine' 0 C--N 1.355 0.836 0 O-C-N 120.942 -1.099 . . . . 51.479999999999997 108.077 176.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -62.59 -20.91 65.2 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.712 -1.243 . . . . 50.280000000000001 113.028 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 75.2 mt -79.17 -16.22 56.92 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 114.954 1.465 . . . . 50.210000000000001 114.954 175.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1083 ' ' LEU . . . . . 0.62 HD11 HD13 ' A' 1089 ' ' LEU . 2.3 mm? -59.68 141.04 55.91 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.02 1.282 . . . . 49.060000000000002 109.549 172.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -86.61 142.61 35.0 Favored Pre-proline 0 C--O 1.217 -0.626 0 N-CA-C 103.413 -2.81 . . . . 51.079999999999998 103.413 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -54.39 120.96 8.88 Favored 'Trans proline' 0 N--CA 1.42 -2.829 0 C-N-CA 124.306 3.337 . . . . 49.729999999999997 109.83 168.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 98.67 -3.68 59.27 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-O 117.925 -1.486 . . . . 47.710000000000001 112.757 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1087 ' ' THR . . . . . 0.439 HG21 HG12 ' A' 1069 ' ' ILE . 87.1 m -68.09 129.43 39.89 Favored 'General case' 0 C--O 1.251 1.134 0 CA-C-N 119.139 1.47 . . . . 45.469999999999999 111.819 173.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1088 ' ' THR . . . . . 0.434 ' HA ' ' HB ' ' A' 1111 ' ' THR . 2.8 m -68.75 110.51 4.35 Favored 'General case' 0 C--O 1.244 0.803 0 O-C-N 119.324 -2.11 . . . . 42.039999999999999 108.739 165.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1089 ' ' LEU . . . . . 0.62 HD13 HD11 ' A' 1083 ' ' LEU . 33.1 tp -98.89 118.88 36.66 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 105.741 -1.948 . . . . 38.060000000000002 105.741 173.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 24.4 t -113.26 126.43 70.68 Favored 'Isoleucine or valine' 0 C--O 1.256 1.433 0 N-CA-C 104.642 -2.355 . . . . 37.399999999999999 104.642 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1091 ' ' SER . . . . . . . . . . . . . 5.1 m -162.17 168.98 21.61 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 121.172 1.805 . . . . 36.159999999999997 111.05 -176.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1092 ' ' PHE . . . . . 0.4 ' CE2' ' HG3' ' A' 1133 ' ' MET . 6.5 m-85 -69.46 99.82 1.3 Allowed 'General case' 0 C--N 1.349 0.562 0 O-C-N 120.962 -1.086 . . . . 38.939999999999998 109.672 159.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 40.7 mm -90.21 -46.93 14.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 113.316 0.858 . . . . 42.170000000000002 113.316 175.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1094 ' ' TRP . . . . . 0.446 ' HB3' ' NE2' ' A' 1097 ' ' GLN . 23.8 m95 61.52 63.35 2.32 Favored Pre-proline 0 N--CA 1.469 0.499 0 C-N-CA 124.02 0.928 . . . . 46.509999999999998 112.037 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -55.96 -27.85 65.81 Favored 'Trans proline' 0 C--N 1.346 0.423 0 N-CA-C 120.494 3.229 . . . . 49.759999999999998 120.494 -166.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -77.2 -29.57 54.35 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 121.546 1.975 . . . . 52.619999999999997 112.538 175.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1097 ' ' GLN . . . . . 0.446 ' NE2' ' HB3' ' A' 1094 ' ' TRP . 1.5 mp0 -86.75 -24.16 25.22 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 124.456 2.074 . . . . 60.740000000000002 111.233 173.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1098 ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -127.33 74.24 77.48 Favored Pre-proline 0 N--CA 1.431 -1.422 0 O-C-N 120.024 -1.672 . . . . 58.189999999999998 112.81 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1099 ' ' PRO . . . . . 0.546 ' HG2' ' HG3' ' A' 1100 ' ' GLU . 94.5 Cg_endo -70.96 -29.42 18.17 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.947 2.431 . . . . 54.590000000000003 113.508 177.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1100 ' ' GLU . . . . . 0.546 ' HG3' ' HG2' ' A' 1099 ' ' PRO . 27.2 mt-10 -80.89 -28.02 36.09 Favored 'General case' 0 N--CA 1.434 -1.225 0 O-C-N 119.424 -2.047 . . . . 63.280000000000001 106.067 -163.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1101 ' ' LEU . . . . . 0.406 HD23 HD11 ' A' 1080 ' ' ILE . 15.1 mt -50.72 -41.97 56.73 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 124.917 1.287 . . . . 54.75 110.31 171.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1102 ' ' MET . . . . . 0.423 ' SD ' HD11 ' A' 1361 ' ' ILE . 18.6 mmm -66.77 -47.44 72.17 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 118.676 0.671 . . . . 52.649999999999999 111.533 -168.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -64.16 -38.02 89.57 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 120.735 -1.228 . . . . 66.260000000000005 112.673 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 86.1 mttt -67.42 -42.33 83.41 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 123.037 1.399 . . . . 63.729999999999997 112.926 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 47.8 mt -71.83 -28.41 63.56 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.834 -1.075 . . . . 54.68 112.63 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -65.12 -41.95 94.39 Favored 'General case' 0 C--O 1.243 0.751 0 O-C-N 120.694 -1.254 . . . . 53.640000000000001 110.473 170.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -56.28 -39.25 72.36 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.074 0.95 . . . . 67.239999999999995 109.696 169.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -69.82 -20.93 63.43 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 115.446 1.647 . . . . 65.760000000000005 115.446 173.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 53.7 t30 68.83 38.69 2.06 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 124.594 2.14 . . . . 58.710000000000001 109.106 177.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1110 ' ' VAL . . . . . 0.552 HG11 ' HB3' ' A' 1083 ' ' LEU . 27.1 m -97.92 161.05 2.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 N-CA-C 115.41 1.633 . . . . 46.630000000000003 115.41 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1111 ' ' THR . . . . . 0.628 HG23 ' HG3' ' A' 1362 ' ' ARG . 95.0 m -97.68 95.22 7.43 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 106.446 -1.687 . . . . 44.130000000000003 106.446 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1112 ' ' VAL . . . . . 0.605 ' HB ' ' HB ' ' A' 1361 ' ' ILE . 49.1 t -86.57 110.7 20.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 O-C-N 121.147 -0.971 . . . . 40.439999999999998 112.306 -176.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1113 ' ' MET . . . . . 0.685 ' HB3' HG12 ' A' 1358 ' ' VAL . 46.8 mtp -101.74 110.65 22.68 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 106.344 -1.724 . . . . 50.759999999999998 106.344 174.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1114 ' ' ALA . . . . . 0.478 ' HB3' ' HB2' ' A' 1117 ' ' SER . . . -83.99 116.52 22.86 Favored 'General case' 0 C--O 1.253 1.244 0 O-C-N 121.369 -0.832 . . . . 35.640000000000001 108.989 -176.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1115 ' ' MET . . . . . 0.441 ' O ' HG23 ' A' 1118 ' ' VAL . 32.7 mmm -70.62 -30.65 67.36 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 113.369 0.877 . . . . 38.740000000000002 113.369 -176.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -60.33 -35.19 75.07 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 124.486 1.114 . . . . 40.140000000000001 112.141 164.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1117 ' ' SER . . . . . 0.478 ' HB2' ' HB3' ' A' 1114 ' ' ALA . 48.5 m -87.58 11.88 13.88 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 118.466 2.765 . . . . 44.789999999999999 118.466 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1118 ' ' VAL . . . . . 0.509 ' HA ' HG22 ' A' 1358 ' ' VAL . 40.8 t -60.96 128.39 89.06 Favored Pre-proline 0 N--CA 1.473 0.685 0 N-CA-C 103.755 -2.683 . . . . 43.75 103.755 168.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -46.6 140.78 11.8 Favored 'Trans proline' 0 CA--C 1.543 0.928 1 C-N-CA 127.7 5.6 . . . . 48.93 117.762 179.279 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -64.32 -0.3 1.23 Allowed 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 116.798 2.147 . . . . 62.899999999999999 116.798 -174.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 14.5 pt -83.26 148.98 4.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 114.281 1.215 . . . . 57.719999999999999 114.281 -170.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1122 ' ' SER . . . . . . . . . . . . . 8.5 m -45.54 -51.56 11.67 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 126.512 1.925 . . . . 57.259999999999998 114.432 -176.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.62 -24.19 66.53 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 120.676 -1.265 . . . . 62.899999999999999 112.258 -178.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -87.41 -19.0 28.69 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-O 116.642 -1.647 . . . . 49.829999999999998 111.097 -176.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1125 ' ' GLN . . . . . 0.607 ' HA ' ' HB3' ' A' 1128 ' ' ASP . 5.4 mm-40 -61.31 -21.34 63.88 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 115.941 1.83 . . . . 52.369999999999997 115.941 -167.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1126 ' ' SER . . . . . . . . . . . . . 31.9 m -68.47 -38.77 81.35 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 122.587 1.184 . . . . 42.43 111.117 172.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1127 ' ' LEU . . . . . 0.606 HD21 HD22 ' A' 1337 ' ' LEU . 4.6 mp -77.64 -35.81 52.18 Favored 'General case' 0 C--N 1.35 0.609 0 CA-C-N 115.009 -0.996 . . . . 43.740000000000002 110.986 172.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1128 ' ' ASP . . . . . 0.607 ' HB3' ' HA ' ' A' 1125 ' ' GLN . 37.0 t70 -59.71 108.15 0.7 Allowed 'General case' 0 C--N 1.352 0.709 0 CA-C-O 125.892 2.758 . . . . 43.210000000000001 115.953 -177.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1129 ' ' ALA . . . . . 0.409 ' CB ' ' HB3' ' A' 1115 ' ' MET . . . -68.09 -29.06 67.9 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 110.459 -3.064 . . . . 35.740000000000002 112.293 -176.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 43.3 mt -60.36 -37.09 79.62 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 114.934 -1.03 . . . . 38.090000000000003 112.854 172.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1131 ' ' SER . . . . . 0.45 ' HA ' HG11 ' A' 1175 ' ' VAL . 16.5 m -58.95 -48.32 81.92 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 119.255 0.934 . . . . 36.909999999999997 111.367 173.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1132 ' ' SER . . . . . . . . . . . . . 73.9 m -59.82 -58.3 9.18 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 119.098 0.863 . . . . 35.789999999999999 111.757 175.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1133 ' ' MET . . . . . 0.4 ' HG3' ' CE2' ' A' 1092 ' ' PHE . 27.1 mmt -61.24 -31.17 70.97 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 117.635 2.457 . . . . 30.809999999999999 117.635 -176.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1134 ' ' ALA . . . . . . . . . . . . . . . -68.81 -57.06 6.12 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.029 -0.987 . . . . 28.879999999999999 112.467 169.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1135 ' ' ASN . . . . . . . . . . . . . 1.4 t30 -54.8 -48.87 72.22 Favored 'General case' 0 C--O 1.245 0.864 0 C-N-CA 124.379 1.071 . . . . 40.759999999999998 110.604 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1136 ' ' ILE . . . . . 0.719 HD13 ' HA ' ' A' 1323 ' ' SER . 42.4 mt -56.31 -50.63 70.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 113.02 0.748 . . . . 31.539999999999999 113.02 174.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1137 ' ' ALA . . . . . 0.699 ' HB2' ' HG3' ' A' 1316 ' ' PRO . . . -57.83 -31.55 66.74 Favored 'General case' 0 C--O 1.213 -0.867 0 N-CA-C 114.208 1.188 . . . . 29.870000000000001 114.208 174.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -68.07 -51.09 35.74 Favored Glycine 0 N--CA 1.443 -0.863 0 O-C-N 120.54 -1.35 . . . . 28.73 111.287 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 15.7 t80 -62.21 -38.76 90.4 Favored 'General case' 0 C--O 1.217 -0.607 0 O-C-N 122.208 -0.583 . . . . 30.390000000000001 110.634 175.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1140 ' ' ARG . . . . . 0.638 ' HG3' HD22 ' A' 1315 ' ' LEU . 7.6 tpt180 -74.54 -24.43 58.95 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.864 1.266 . . . . 26.09 112.521 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1141 ' ' ALA . . . . . 0.551 ' HB2' HD21 ' A' 1284 ' ' LEU . . . -68.15 -40.14 82.44 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.16 -1.422 . . . . 27.100000000000001 107.16 170.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1142 ' ' ILE . . . . . 0.443 HG13 ' HB3' ' A' 1183 ' ' ALA . 35.3 mm -64.03 -39.74 86.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 108.259 -1.015 . . . . 28.48 108.259 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 54.4 t -59.97 -64.54 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-O 118.694 -0.67 . . . . 23.07 110.792 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1144 ' ' GLU . . . . . 0.453 ' HG3' HD21 ' A' 1315 ' ' LEU . 6.0 mm-40 -71.88 -23.72 61.55 Favored 'General case' 0 C--O 1.247 0.959 0 CA-C-N 121.257 1.844 . . . . 33.399999999999999 114.015 -168.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1145 ' ' ALA . . . . . 0.857 ' HB1' HD12 ' A' 1251 ' ' ILE . . . -58.36 -59.06 5.93 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 115.951 -1.976 . . . . 24.219999999999999 108.657 164.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -60.87 -28.21 68.7 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.285 0.991 . . . . 24.890000000000001 110.528 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -64.5 -37.23 86.82 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 112.865 0.691 . . . . 26.73 112.865 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1148 ' ' GLU . . . . . 0.461 ' HB2' HD11 ' A' 1310 ' ' ILE . 29.0 mm-40 -107.74 -3.63 18.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 117.981 -1.488 . . . . 39.960000000000001 112.41 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1149 ' ' PHE . . . . . 0.611 ' CZ ' ' HB3' ' A' 1250 ' ' ASP . 0.8 OUTLIER -64.67 134.72 54.85 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 107.976 -1.12 . . . . 25.870000000000001 107.976 178.045 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 1150 ' ' GLY . . . . . 0.507 ' HA2' ' HD2' ' B' 1320 ' ' PRO . . . -74.12 -38.74 46.76 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 110.638 -0.985 . . . . 19.280000000000001 110.638 173.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1151 ' ' ARG . . . . . 0.962 ' HA ' ' HB2' ' B' 1322 ' ' GLN . 46.1 mtm-85 -94.97 177.09 6.0 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 120.67 -1.488 . . . . 39.899999999999999 111.48 -178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1152 ' ' PHE . . . . . 0.945 ' HB2' HG11 ' A' 1163 ' ' VAL . 2.6 m-30 -79.48 157.46 27.47 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 120.021 1.282 . . . . 29.440000000000001 109.288 169.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1153 ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -66.46 -56.05 12.77 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 105.819 -1.919 . . . . 32.600000000000001 105.819 155.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1154 ' ' THR . . . . . . . . . . . . . 25.9 m -51.57 89.24 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 128.352 2.661 . . . . 34.640000000000001 116.433 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1155 ' ' GLY . . . . . 0.497 ' HA3' ' HG3' ' A' 1165 ' ' PRO . . . -69.05 83.95 0.23 Allowed Glycine 0 C--O 1.215 -1.05 0 CA-C-O 122.291 0.939 . . . . 37.140000000000001 111.328 174.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -117.23 -170.68 1.89 Allowed 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 112.365 -1.917 . . . . 40.57 108.931 168.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1157 ' ' ILE . . . . . 0.718 HG12 ' HG2' ' C' ' 70' ' ' PRO . 1.1 tp -141.83 148.7 20.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 103.404 -2.813 . . . . 44.609999999999999 103.404 -175.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1158 ' ' THR . . . . . . . . . . . . . 16.7 p -98.8 -144.23 0.32 Allowed 'General case' 0 C--O 1.249 1.075 0 CA-C-O 116.628 -1.653 . . . . 40.700000000000003 110.349 175.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1159 ' ' ALA . . . . . 0.417 ' HB2' HG21 ' C' ' 71' ' ' VAL . . . -95.39 -29.47 14.42 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 121.866 2.121 . . . . 40.25 106.932 163.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1160 ' ' ALA . . . . . 0.439 ' HB2' ' ND2' ' B' 1330 ' ' ASN . . . -76.27 -83.5 0.07 Allowed 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 109.713 -0.477 . . . . 38.469999999999999 109.713 173.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . -122.3 169.43 14.93 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-O 123.85 1.806 . . . . 37.609999999999999 113.574 -160.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 23.2 tttp -102.01 140.98 35.56 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-N 109.908 -3.146 . . . . 48.899999999999999 108.667 -172.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1163 ' ' VAL . . . . . 0.945 HG11 ' HB2' ' A' 1152 ' ' PHE . 47.0 t -98.27 114.98 65.84 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-N 113.658 -1.61 . . . . 36.520000000000003 106.8 167.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1164 ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -54.92 123.53 14.0 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.97 2.447 . . . . 35.079999999999998 112.103 165.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1165 ' ' PRO . . . . . 0.497 ' HG3' ' HA3' ' A' 1155 ' ' GLY . 91.8 Cg_exo -60.39 119.9 7.35 Favored 'Trans proline' 0 N--CA 1.432 -2.138 0 C-N-CA 125.091 3.86 . . . . 35.329999999999998 109.532 176.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1166 ' ' ALA . . . . . 0.435 ' O ' ' HB1' ' A' 1189 ' ' ALA . . . -67.87 126.11 28.4 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 113.838 -1.528 . . . . 34.689999999999998 114.615 -167.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1167 ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' A' 1190 ' ' ILE . 9.4 mptt -73.53 90.67 1.76 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 124.662 1.226 . . . . 45.359999999999999 109.535 172.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 34.3 t -83.7 89.85 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-O 124.439 2.066 . . . . 31.710000000000001 105.823 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1169 ' ' MET . . . . . 0.602 ' HG3' HD11 ' A' 1212 ' ' LEU . 25.7 ttp -74.98 134.09 41.56 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 113.917 -1.492 . . . . 42.280000000000001 108.888 174.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 99.1 t -125.26 136.99 59.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 104.442 -2.429 . . . . 30.510000000000002 104.442 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1171 ' ' ILE . . . . . 0.46 HG22 ' HB2' ' A' 1256 ' ' ALA . 61.3 mt -121.69 127.57 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 103.979 -2.6 . . . . 31.870000000000001 103.979 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 73.82 70.51 1.23 Allowed Glycine 0 CA--C 1.535 1.304 0 N-CA-C 107.557 -2.217 . . . . 34.539999999999999 107.557 -170.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1173 ' ' ALA . . . . . 0.669 ' HA ' ' HA3' ' A' 1177 ' ' GLY . . . -72.95 59.96 0.52 Allowed 'General case' 0 N--CA 1.445 -0.725 0 O-C-N 120.311 -1.699 . . . . 32.509999999999998 109.577 173.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1174 ' ' GLY . . . . . 0.605 ' HA2' ' NH2' ' A' 1197 ' ' ARG . . . -86.95 -148.98 13.78 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 107.987 -2.045 . . . . 29.899999999999999 107.987 -177.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1175 ' ' VAL . . . . . 0.45 HG11 ' HA ' ' A' 1131 ' ' SER . 57.7 t -60.03 -40.43 83.15 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 O-C-N 119.329 -2.277 . . . . 33.109999999999999 108.832 176.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1176 ' ' ALA . . . . . 0.641 ' HB3' HG21 ' A' 1255 ' ' THR . . . -69.62 -52.75 23.13 Favored 'General case' 0 C--O 1.224 -0.277 0 O-C-N 121.858 -0.526 . . . . 28.100000000000001 110.712 177.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1177 ' ' GLY . . . . . 0.669 ' HA3' ' HA ' ' A' 1173 ' ' ALA . . . -56.27 -48.02 77.94 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 110.892 -0.883 . . . . 28.539999999999999 110.892 -176.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1178 ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' 1181 ' ' ILE . 51.4 mt -58.57 -39.4 80.17 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.939 1.459 . . . . 31.219999999999999 114.939 177.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -68.84 -36.49 78.23 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.708 -0.62 . . . . 28.98 112.355 173.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -63.92 -37.31 86.93 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.399 0.518 . . . . 27.829999999999998 112.399 171.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1181 ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' 1178 ' ' LEU . 90.0 mt -62.46 -53.28 49.33 Favored 'Isoleucine or valine' 0 C--O 1.246 0.904 0 C-N-CA 125.622 1.569 . . . . 30.25 108.775 175.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -50.25 -52.3 28.02 Favored Glycine 0 N--CA 1.435 -1.399 0 O-C-N 125.481 1.738 . . . . 29.59 114.134 175.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1183 ' ' ALA . . . . . 0.443 ' HB3' HG13 ' A' 1142 ' ' ILE . . . -61.42 -45.24 95.13 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.982 0.734 . . . . 30.289999999999999 112.982 178.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -74.15 -36.82 64.14 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 113.457 0.91 . . . . 30.469999999999999 113.457 -173.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -57.73 -48.77 78.67 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 108.369 -0.974 . . . . 42.409999999999997 108.369 167.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1186 ' ' SER . . . . . 0.632 ' HB3' ' HA ' ' B' 1187 ' ' LEU . 74.1 m -56.68 -37.23 70.56 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 123.153 1.454 . . . . 39.380000000000003 112.546 176.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1187 ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' 1187 ' ' LEU . 13.5 mt -69.39 -34.84 75.12 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 118.141 -2.849 . . . . 36.18 114.548 173.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 105.11 76.08 1.05 Allowed Glycine 0 C--N 1.308 -0.995 0 O-C-N 119.929 -1.732 . . . . 33.780000000000001 112.057 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1189 ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' A' 1166 ' ' ALA . . . -151.64 168.41 25.06 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 113.635 -1.282 . . . . 33.93 109.362 -168.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1190 ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' 1167 ' ' LYS . 86.3 mt -90.67 95.38 5.48 Favored 'Isoleucine or valine' 0 C--O 1.253 1.288 0 N-CA-C 107.122 -1.436 . . . . 38.740000000000002 107.122 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 10.8 t -86.93 133.47 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 106.806 -1.553 . . . . 33.090000000000003 106.806 -178.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1192 ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' 1169 ' ' MET . 99.0 mtt180 -133.02 121.52 22.85 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 105.295 -2.113 . . . . 38.920000000000002 105.295 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -127.39 149.41 50.09 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 115.089 1.514 . . . . 35.32 115.089 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1194 ' ' PHE . . . . . 0.515 ' HB2' HD12 ' A' 1212 ' ' LEU . 47.5 t80 -137.39 154.0 50.08 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.425 -2.065 . . . . 39.350000000000001 105.425 176.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 13.4 t0 -146.91 159.16 43.88 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 103.352 -2.833 . . . . 40.460000000000001 103.352 173.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1196 ' ' THR . . . . . . . . . . . . . 53.5 m -63.7 -30.7 71.77 Favored 'General case' 0 C--O 1.254 1.32 0 CA-C-N 111.574 -2.557 . . . . 45.939999999999998 108.692 171.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1197 ' ' ARG . . . . . 0.605 ' NH2' ' HA2' ' A' 1174 ' ' GLY . 58.2 mtm180 -101.47 100.69 14.56 Favored Pre-proline 0 CA--C 1.509 -0.629 0 N-CA-C 105.391 -2.078 . . . . 56.020000000000003 105.391 176.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1198 ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -59.59 -12.57 17.99 Favored 'Trans proline' 0 C--O 1.257 1.44 0 C-N-CA 122.621 2.214 . . . . 51.270000000000003 114.914 175.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -48.37 -16.61 0.11 Allowed 'General case' 0 C--O 1.234 0.257 0 N-CA-C 121.219 3.785 . . . . 59.100000000000001 121.219 167.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1200 ' ' VAL . . . . . 0.637 HG21 ' HB3' ' A' 1173 ' ' ALA . 33.8 m -80.65 -10.26 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 116.273 1.953 . . . . 51.060000000000002 116.273 169.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 75.0 tttt -50.59 -54.4 22.97 Favored 'General case' 0 C--N 1.348 0.516 0 N-CA-C 117.431 2.382 . . . . 57.380000000000003 117.431 -167.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.65 -30.78 63.14 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 115.368 -0.833 . . . . 62.409999999999997 108.776 -176.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -66.82 -33.2 75.09 Favored 'General case' 0 CA--C 1.501 -0.914 0 O-C-N 119.795 -1.815 . . . . 57.780000000000001 111.976 173.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 25.1 t -64.41 -47.9 87.5 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 C-N-CA 124.571 1.148 . . . . 46.380000000000003 109.3 172.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1205 ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' 1209 ' ' ALA . 21.6 mm100 -60.3 -45.62 92.74 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 122.006 -0.434 . . . . 50.700000000000003 111.403 177.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1206 ' ' SER . . . . . . . . . . . . . 47.5 m -69.54 -24.38 63.71 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 113.098 0.777 . . . . 49.979999999999997 113.098 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1207 ' ' MET . . . . . . . . . . . . . 36.6 mtp -86.67 9.77 17.73 Favored 'General case' 0 N--CA 1.443 -0.824 0 O-C-N 120.9 -1.125 . . . . 52.990000000000002 113.834 173.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 89.18 49.31 3.54 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 118.565 0.621 . . . . 47.659999999999997 112.648 170.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1209 ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' 1205 ' ' GLN . . . -158.28 160.88 37.55 Favored 'General case' 0 C--O 1.246 0.91 0 C-N-CA 124.116 0.966 . . . . 44.770000000000003 112.814 -174.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -96.4 147.52 23.73 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 105.476 -2.046 . . . . 47.640000000000001 105.476 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1211 ' ' PHE . . . . . . . . . . . . . 44.8 t80 -95.48 130.78 42.19 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.792 -1.188 . . . . 45.659999999999997 107.792 166.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1212 ' ' LEU . . . . . 0.602 HD11 ' HG3' ' A' 1169 ' ' MET . 84.6 mt -65.43 105.6 1.2 Allowed 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 113.508 0.929 . . . . 46.060000000000002 113.508 -177.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -79.11 124.33 28.21 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 122.58 1.181 . . . . 60.219999999999999 110.024 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1214 ' ' LEU . . . . . 0.548 ' HA ' ' HG ' ' A' 1241 ' ' LEU . 9.6 mp -76.5 133.8 39.67 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 112.736 -2.029 . . . . 57.25 108.321 174.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 28.6 t70 -85.56 81.01 8.85 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 104.801 -2.296 . . . . 64.430000000000007 104.801 177.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 14.8 t80 . . . . . 0 CA--C 1.503 -0.836 0 CA-C-N 113.483 -1.69 . . . . 66.900000000000006 112.66 -167.278 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 CA--C 1.561 1.394 0 CA-C-O 116.809 -1.567 . . . . 39.090000000000003 108.576 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -52.12 -49.67 48.79 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 120.689 1.586 . . . . 39.32 114.242 173.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 74.3 t80 -64.25 -41.47 96.94 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.878 0.847 . . . . 39.299999999999997 109.738 -175.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -62.05 -41.89 98.61 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 114.479 -1.237 . . . . 36.299999999999997 111.466 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -58.14 -49.8 75.72 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 124.078 0.861 . . . . 37.380000000000003 109.364 170.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -65.99 -11.17 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 114.77 1.396 . . . . 39.109999999999999 114.77 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1230 ' ' MET . . . . . . . . . . . . . 26.4 mmt -107.93 -7.39 16.23 Favored 'General case' 0 C--O 1.244 0.789 0 O-C-N 121.103 -0.998 . . . . 49.590000000000003 110.235 175.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1231 ' ' SER . . . . . 0.495 ' O ' HG13 ' A' 1235 ' ' ILE . 69.4 m -87.12 132.74 33.75 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 118.919 0.781 . . . . 43.68 109.06 176.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -49.46 -58.34 5.34 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 114.462 1.282 . . . . 55.57 114.462 -167.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -64.94 -30.13 71.1 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 113.86 1.059 . . . . 44.939999999999998 113.86 -173.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 32.5 t80 -66.29 -48.74 69.43 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 115.483 -2.199 . . . . 42.039999999999999 107.994 172.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1235 ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' 1231 ' ' SER . 2.9 mt -59.2 -30.92 44.94 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 CA-C-O 123.627 1.679 . . . . 46.280000000000001 112.8 177.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 33.3 tttm -74.49 -42.15 59.49 Favored 'General case' 0 C--O 1.215 -0.761 0 O-C-N 119.156 -2.215 . . . . 47.869999999999997 105.585 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -61.18 -31.03 70.78 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 119.551 1.069 . . . . 41.609999999999999 112.012 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -62.14 -59.1 5.54 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.741 -1.207 . . . . 50.649999999999999 107.741 168.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1239 ' ' MET . . . . . . . . . . . . . 38.6 mtt -55.33 -40.15 70.84 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 121.688 0.756 . . . . 48.869999999999997 112.667 -178.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -61.43 -51.46 68.65 Favored 'General case' 0 C--O 1.254 1.291 0 O-C-N 120.267 -1.521 . . . . 54.799999999999997 108.984 176.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1241 ' ' LEU . . . . . 0.548 ' HG ' ' HA ' ' A' 1214 ' ' LEU . 1.5 tm? -65.43 -37.39 86.77 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.703 -0.851 . . . . 43.210000000000001 108.703 -172.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -66.94 -43.06 84.2 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.685 -1.143 . . . . 38.659999999999997 112.256 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1243 ' ' ALA . . . . . 0.504 ' HA ' ' HG3' ' A' 1271 ' ' MET . . . -58.41 -45.09 89.08 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 120.799 1.636 . . . . 37.920000000000002 111.288 175.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -60.8 -48.57 81.18 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 114.337 -1.301 . . . . 37.280000000000001 110.28 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -63.93 -43.45 95.82 Favored 'General case' 0 C--O 1.214 -0.783 0 CA-C-O 115.413 -2.232 . . . . 43.07 112.496 170.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1246 ' ' ALA . . . . . 0.626 ' HB1' ' HG2' ' A' 1275 ' ' MET . . . -57.59 -38.75 75.4 Favored 'General case' 0 C--O 1.212 -0.892 0 CA-C-N 122.471 2.396 . . . . 38.299999999999997 110.186 -170.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1247 ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' 1274 ' ' SER . 38.2 mtmt -62.71 -22.1 66.26 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 115.658 1.725 . . . . 47.600000000000001 115.658 176.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -118.56 -14.36 9.65 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-O 117.914 -1.041 . . . . 45.420000000000002 112.444 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1249 ' ' VAL . . . . . 0.544 HG22 ' HA ' ' A' 1246 ' ' ALA 0.277 34.7 m -78.79 175.66 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 120.801 1.637 . . . . 36.259999999999998 113.304 -178.48 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 1250 ' ' ASP . . . . . 0.611 ' HB3' ' CZ ' ' A' 1149 ' ' PHE . 13.1 m-20 -124.28 -47.4 1.88 Allowed 'General case' 0 N--CA 1.432 -1.339 0 O-C-N 124.586 1.179 . . . . 33.039999999999999 112.823 -171.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1251 ' ' ILE . . . . . 0.857 HD12 ' HB1' ' A' 1145 ' ' ALA . 38.0 mm -127.04 137.61 57.34 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 N-CA-C 105.147 -2.168 . . . . 31.399999999999999 105.147 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1252 ' ' ILE . . . . . 0.685 HD12 HG12 ' A' 1281 ' ' ILE . 33.0 mt -125.14 113.14 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 C-N-CA 119.282 -0.967 . . . . 29.420000000000002 108.526 167.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 48.5 t -90.65 102.93 13.87 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 CA-C-O 124.394 2.045 . . . . 30.370000000000001 106.728 176.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1254 ' ' THR . . . . . 0.86 ' HB ' ' HA ' ' A' 1283 ' ' ASP . 21.8 m -100.36 99.17 9.77 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 110.473 -3.058 . . . . 35.719999999999999 104.04 -158.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1255 ' ' THR . . . . . 0.641 HG21 ' HB3' ' A' 1176 ' ' ALA . 0.2 OUTLIER -137.4 22.75 2.96 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.758 -1.565 . . . . 36.0 113.845 -168.216 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 1256 ' ' ALA . . . . . 0.46 ' HB2' HG22 ' A' 1171 ' ' ILE . . . -78.48 85.84 4.54 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 118.166 -2.834 . . . . 40.93 110.223 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 10.2 tp -142.55 124.2 14.99 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 111.514 -2.585 . . . . 47.82 109.311 -168.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 8.4 mm -78.13 120.71 82.24 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 100.916 -3.735 . . . . 52.700000000000003 100.916 160.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 1.3 Cg_exo -44.18 113.33 0.42 Allowed 'Trans proline' 0 C--N 1.319 -0.982 1 C-N-CA 125.551 4.167 . . . . 54.130000000000003 116.373 -167.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 78.71 3.96 87.55 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 112.243 -2.253 . . . . 54.619999999999997 115.727 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -111.22 145.16 31.92 Favored Pre-proline 0 C--O 1.219 -0.539 0 CA-C-N 121.561 2.68 . . . . 55.740000000000002 105.581 -174.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -48.16 108.27 0.17 Allowed 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 125.08 3.853 . . . . 51.149999999999999 116.055 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1263 ' ' ALA . . . . . 0.46 ' HB1' ' ND2' ' A' 1291 ' ' ASN . . . -65.12 154.85 85.99 Favored Pre-proline 0 C--O 1.222 -0.358 0 CA-C-N 112.579 -2.1 . . . . 46.060000000000002 112.725 -176.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.44 126.26 15.27 Favored 'Trans proline' 0 C--O 1.248 0.983 0 C-N-CA 123.737 2.958 . . . . 41.079999999999998 109.826 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 50.1 mmtt -77.56 105.63 8.83 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 106.385 -1.709 . . . . 47.420000000000002 106.385 176.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 52.4 mt -107.59 -52.35 2.78 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 113.112 -1.858 . . . . 39.219999999999999 110.246 -174.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1267 ' ' ILE . . . . . 0.623 ' HA ' ' SD ' ' A' 1271 ' ' MET . 61.1 mt -88.03 100.46 10.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 104.882 -2.266 . . . . 42.5 104.882 -169.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1268 ' ' THR . . . . . 0.545 ' O ' HG23 ' A' 1272 ' ' VAL . 12.3 p -68.05 157.6 34.81 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 126.146 1.778 . . . . 37.840000000000003 113.934 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -57.49 -34.15 68.76 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 115.223 1.564 . . . . 54.799999999999997 115.223 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -67.37 -47.24 70.97 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 114.355 -1.293 . . . . 54.359999999999999 110.889 172.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1271 ' ' MET . . . . . 0.623 ' SD ' ' HA ' ' A' 1267 ' ' ILE . 54.6 ttm -58.33 -45.41 88.15 Favored 'General case' 0 C--O 1.251 1.18 0 C-N-CA 124.297 1.039 . . . . 39.520000000000003 109.862 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1272 ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' 1268 ' ' THR . 21.2 t -57.4 -54.44 30.88 Favored 'Isoleucine or valine' 0 C--O 1.249 1.069 0 CA-C-N 115.843 -0.617 . . . . 38.25 110.379 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.41 -11.91 60.14 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 114.096 1.147 . . . . 40.770000000000003 114.096 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1274 ' ' SER . . . . . 0.474 ' O ' ' HG2' ' A' 1247 ' ' LYS . 70.7 m -78.28 -18.96 54.58 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 116.631 -1.652 . . . . 36.579999999999998 112.875 172.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1275 ' ' MET . . . . . 0.626 ' HG2' ' HB1' ' A' 1246 ' ' ALA . 85.0 mtp -53.4 155.03 3.05 Favored 'General case' 0 CA--C 1.51 -0.571 0 O-C-N 125.222 1.576 . . . . 36.75 115.156 -176.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1276 ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' 1247 ' ' LYS . 39.8 ttpt -60.93 139.99 57.87 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 105.532 -2.025 . . . . 46.109999999999999 105.532 166.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1277 ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' B' 1044 ' ' SER . . . -85.57 165.37 17.12 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 123.182 1.468 . . . . 33.520000000000003 110.304 -171.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 74.02 36.5 51.64 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.697 1.141 . . . . 31.27 111.977 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1279 ' ' SER . . . . . 0.48 ' HB2' HG22 ' A' 1307 ' ' VAL . 37.3 m -134.42 166.27 23.24 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 114.2 -1.0 . . . . 32.950000000000003 108.539 -165.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1280 ' ' VAL . . . . . 0.782 HG22 ' HB2' ' A' 1308 ' ' LYS . 48.4 t -133.65 142.94 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 O-C-N 118.939 -2.35 . . . . 27.43 111.474 -176.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1281 ' ' ILE . . . . . 0.685 HG12 HD12 ' A' 1252 ' ' ILE . 74.7 mt -110.49 103.23 15.15 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 N-CA-C 102.167 -3.272 . . . . 30.300000000000001 102.167 164.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -86.85 95.86 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 N-CA-C 107.291 -1.374 . . . . 28.629999999999999 107.291 174.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1283 ' ' ASP . . . . . 0.86 ' HA ' ' HB ' ' A' 1254 ' ' THR . 19.7 t0 -85.96 106.92 17.48 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 105.547 -2.019 . . . . 36.270000000000003 105.547 -173.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1284 ' ' LEU . . . . . 0.551 HD21 ' HB2' ' A' 1141 ' ' ALA . 91.0 mt -89.59 -31.9 17.36 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 114.924 -1.035 . . . . 38.57 108.584 175.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -66.43 -11.25 50.86 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 122.449 1.119 . . . . 37.560000000000002 110.861 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . -42.48 -20.36 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 126.509 1.924 . . . . 40.329999999999998 115.304 163.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -47.92 -41.25 24.22 Favored 'General case' 0 CA--C 1.553 1.071 0 O-C-N 121.378 -0.826 . . . . 56.850000000000001 110.675 173.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 1.4 t30 -137.07 99.26 3.95 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 119.787 -0.765 . . . . 45.859999999999999 109.509 170.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 82.18 -50.34 4.29 Favored Glycine 0 N--CA 1.476 1.317 0 O-C-N 119.693 -1.879 . . . . 40.310000000000002 113.863 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 101.39 164.47 27.41 Favored Glycine 0 N--CA 1.477 1.373 0 CA-C-N 119.749 1.775 . . . . 38.890000000000001 113.241 -176.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1291 ' ' ASN . . . . . 0.565 ' HB2' HG22 ' A' 1254 ' ' THR . 33.5 m120 -93.14 -35.84 12.96 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 117.954 0.877 . . . . 37.229999999999997 109.1 171.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1292 ' ' CYS . . . . . 0.598 ' HB3' ' OG1' ' A' 1295 ' ' THR . 20.5 t -78.49 153.67 31.16 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 122.885 1.326 . . . . 36.5 109.265 173.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1293 ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -82.89 -50.5 8.55 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 113.104 -1.862 . . . . 43.32 109.666 174.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.64 -24.94 59.19 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 117.454 2.39 . . . . 41.32 117.454 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1295 ' ' THR . . . . . 0.598 ' OG1' ' HB3' ' A' 1292 ' ' CYS . 98.0 m -38.48 112.52 0.23 Allowed 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 124.915 1.286 . . . . 35.299999999999997 113.585 167.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 29.6 t -87.65 111.65 43.34 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 102.921 -2.992 . . . . 34.840000000000003 102.921 163.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -64.92 86.44 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.697 1 C-N-CA 125.327 4.018 . . . . 33.509999999999998 107.056 174.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 154.77 -27.94 0.66 Allowed Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 107.722 -2.151 . . . . 32.189999999999998 107.722 178.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -130.94 164.63 24.9 Favored 'General case' 0 C--O 1.251 1.135 0 CA-C-N 122.067 2.934 . . . . 34.880000000000003 113.975 -168.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1300 ' ' ILE . . . . . 0.681 HG12 HG12 ' A' 1310 ' ' ILE . 84.1 mt -77.13 124.45 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 104.563 -2.384 . . . . 32.289999999999999 104.563 156.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 50.9 t80 -108.0 113.14 26.11 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 102.387 -3.19 . . . . 37.25 102.387 170.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1302 ' ' THR . . . . . . . . . . . . . 5.5 m -94.08 108.42 20.25 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 120.067 -1.646 . . . . 35.560000000000002 107.066 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1303 ' ' THR . . . . . . . . . . . . . 8.8 p -74.96 166.32 23.85 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 115.517 1.673 . . . . 36.399999999999999 115.517 -174.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.41 -26.53 65.58 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 120.561 -1.337 . . . . 52.32 112.039 -164.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1305 ' ' ASN . . . . . 0.455 HD21 ' HB2' ' A' 1275 ' ' MET . 49.1 p-10 -66.75 -42.99 85.29 Favored 'General case' 0 C--O 1.239 0.552 0 O-C-N 121.116 -0.99 . . . . 40.039999999999999 112.116 171.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 123.61 43.15 0.35 Allowed Glycine 0 N--CA 1.414 -2.785 0 CA-C-O 123.244 1.469 . . . . 36.960000000000001 111.663 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1307 ' ' VAL . . . . . 0.48 HG22 ' HB2' ' A' 1279 ' ' SER . 41.5 t -113.52 140.89 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-N 113.728 -1.236 . . . . 33.399999999999999 109.253 176.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1308 ' ' LYS . . . . . 0.782 ' HB2' HG22 ' A' 1280 ' ' VAL . 34.6 mmtt -97.81 110.73 23.24 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 112.658 -2.064 . . . . 42.909999999999997 107.902 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 5.3 t -99.62 87.42 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.817 0 N-CA-C 104.73 -2.322 . . . . 32.289999999999999 104.73 -176.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1310 ' ' ILE . . . . . 0.681 HG12 HG12 ' A' 1300 ' ' ILE . 75.2 mt -88.57 83.09 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 113.979 -1.464 . . . . 30.989999999999998 109.232 -171.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -82.11 54.83 4.9 Favored Glycine 0 N--CA 1.437 -1.282 0 CA-C-O 123.415 1.564 . . . . 28.949999999999999 112.249 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1312 ' ' TYR . . . . . 0.545 ' CB ' ' HG ' ' A' 1315 ' ' LEU . 11.1 m-30 -82.58 98.73 9.13 Favored 'General case' 0 CA--C 1.502 -0.881 0 O-C-N 118.242 -2.916 . . . . 31.690000000000001 114.314 -173.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1313 ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -52.05 -44.26 64.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 112.041 -2.345 . . . . 34.170000000000002 111.806 170.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -64.9 -10.12 26.3 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 117.827 2.529 . . . . 36.859999999999999 117.827 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1315 ' ' LEU . . . . . 0.638 HD22 ' HG3' ' A' 1140 ' ' ARG . 45.9 mt -62.55 -29.24 4.45 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 118.713 2.857 . . . . 34.850000000000001 118.713 -175.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1316 ' ' PRO . . . . . 0.699 ' HG3' ' HB2' ' A' 1137 ' ' ALA . 0.7 OUTLIER -59.92 -27.61 85.3 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.446 2.764 . . . . 29.149999999999999 114.267 165.223 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -79.98 -48.97 6.23 Favored Glycine 0 CA--C 1.502 -0.764 0 N-CA-C 107.55 -2.22 . . . . 27.289999999999999 107.55 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1318 ' ' ARG . . . . . . . . . . . . . 4.7 ttm180 -87.05 57.1 4.31 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 113.627 0.973 . . . . 41.490000000000002 113.627 -159.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1319 ' ' LEU . . . . . . . . . . . . . 15.1 tp -135.89 73.31 60.11 Favored Pre-proline 0 C--N 1.32 -0.715 1 N-CA-C 99.327 -4.323 . . . . 27.609999999999999 99.327 156.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1320 ' ' PRO . . . . . 0.613 ' HG2' ' HA2' ' B' 1150 ' ' GLY . 60.7 Cg_endo -42.25 -64.18 0.27 Allowed 'Trans proline' 0 N--CA 1.442 -1.531 1 C-N-CA 126.171 4.581 . . . . 25.940000000000001 117.999 -158.934 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 1321 ' ' THR . . . . . 0.528 HG23 ' CZ ' ' A' 1045 ' ' PHE . 6.7 m -58.07 -45.58 86.89 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 119.803 -0.759 . . . . 25.010000000000002 111.016 176.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1322 ' ' GLN . . . . . 0.652 ' HB2' ' HA ' ' B' 1151 ' ' ARG . 33.8 tp60 -67.38 -48.07 68.48 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 123.767 0.667 . . . . 29.390000000000001 109.76 -169.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1323 ' ' SER . . . . . 0.719 ' HA ' HD13 ' A' 1136 ' ' ILE . 20.4 m -56.08 -48.67 75.66 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 118.391 -0.814 . . . . 26.469999999999999 112.946 174.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1324 ' ' SER . . . . . . . . . . . . . 36.0 m -65.03 -29.76 70.69 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 123.069 1.414 . . . . 27.780000000000001 112.581 175.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1325 ' ' GLN . . . . . 0.672 ' HA ' HG21 ' A' 1019 ' ' THR . 5.3 tp-100 -72.6 -58.84 3.06 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 106.641 -1.614 . . . . 37.530000000000001 106.641 -174.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1326 ' ' LEU . . . . . 0.458 ' HG ' HE21 ' A' 1322 ' ' GLN . 37.9 mt -71.21 -42.01 69.51 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 118.385 -0.817 . . . . 35.710000000000001 109.151 -172.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1327 ' ' TYR . . . . . 0.496 ' O ' ' HB2' ' A' 1330 ' ' ASN . 53.0 t80 -60.55 -41.32 94.29 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 119.636 1.107 . . . . 31.59 110.857 173.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1328 ' ' GLY . . . . . 0.511 ' HA2' HD12 ' A' 1331 ' ' LEU . . . -61.71 -47.01 93.0 Favored Glycine 0 C--O 1.256 1.487 0 O-C-N 121.336 -0.852 . . . . 28.0 111.653 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1329 ' ' THR . . . . . . . . . . . . . 6.5 m -71.99 -24.05 61.52 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 113.964 -1.118 . . . . 32.149999999999999 109.251 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1330 ' ' ASN . . . . . 0.496 ' HB2' ' O ' ' A' 1327 ' ' TYR . 17.6 m120 -60.74 -49.28 78.15 Favored 'General case' 0 C--O 1.24 0.595 0 O-C-N 119.067 -2.27 . . . . 34.359999999999999 111.851 168.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1331 ' ' LEU . . . . . 0.599 HD22 HD22 ' A' 1070 ' ' LEU . 16.4 mt -62.41 -37.81 87.22 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 114.758 -1.11 . . . . 33.369999999999997 111.136 178.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1332 ' ' VAL . . . . . 0.571 ' HA ' HD21 ' A' 1026 ' ' LEU . 64.1 t -63.76 -45.64 96.69 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 N-CA-C 108.634 -0.876 . . . . 35.270000000000003 108.634 173.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1333 ' ' ASN . . . . . 0.402 ' HA ' ' HD2' ' A' 1336 ' ' LYS . 37.0 m-80 -57.8 -44.82 86.58 Favored 'General case' 0 C--O 1.241 0.613 0 O-C-N 118.979 -2.325 . . . . 37.659999999999997 112.679 -178.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1334 ' ' LEU . . . . . . . . . . . . . 41.3 tp -53.64 -59.22 4.88 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.886 -1.052 . . . . 40.270000000000003 110.443 169.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1335 ' ' LEU . . . . . 0.528 ' HA ' ' HB2' ' A' 1338 ' ' LEU . 32.0 mt -62.9 -14.23 44.05 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 117.472 2.397 . . . . 42.5 117.472 174.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1336 ' ' LYS . . . . . 0.582 ' HE2' ' OE1' ' A' 1025 ' ' GLN . 94.5 mttt -66.52 -46.21 76.93 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 121.749 2.068 . . . . 47.810000000000002 107.123 169.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1337 ' ' LEU . . . . . 0.606 HD22 HD21 ' A' 1127 ' ' LEU . 10.9 mp -72.51 -39.68 67.41 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 114.657 -1.156 . . . . 49.270000000000003 112.792 177.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1338 ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' 1347 ' ' THR . 9.4 mp -66.85 -32.73 74.19 Favored 'General case' 0 C--O 1.246 0.877 0 O-C-N 120.457 -1.402 . . . . 50.539999999999999 112.821 175.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1339 ' ' CYS . . . . . 0.575 ' SG ' ' HA2' ' A' 1344 ' ' GLY . 50.2 t -116.38 68.47 0.73 Allowed 'General case' 0 C--O 1.25 1.079 0 O-C-N 118.711 -2.493 . . . . 53.670000000000002 105.532 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1340 ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' 1337 ' ' LEU . 40.2 mtmt -75.02 -42.71 56.74 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.354 1.073 . . . . 63.380000000000003 111.132 174.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -68.44 -44.94 73.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 123.63 1.681 . . . . 70.950000000000003 114.069 -177.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1342 ' ' LYS . . . . . 0.643 ' HE3' ' HA ' ' A' 1029 ' ' LEU . 18.3 mtpt 59.77 67.61 0.86 Allowed 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 128.072 2.549 . . . . 65.25 112.859 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1343 ' ' ASP . . . . . 0.489 ' HB3' ' N ' ' A' 1342 ' ' LYS 0.269 37.5 t70 60.42 -122.11 0.96 Allowed 'General case' 0 N--CA 1.426 -1.66 2 O-C-N 111.602 -6.936 . . . . 64.530000000000001 111.795 9.594 . . . . . . . . 4 3 . 1 . 010 nuclear build core ' A' A 1344 ' ' GLY . . . . . 0.575 ' HA2' ' SG ' ' A' 1339 ' ' CYS . . . 109.97 31.25 3.18 Favored Glycine 0 C--O 1.252 1.225 0 O-C-N 117.289 -3.382 . . . . 59.719999999999999 111.461 -174.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 28.5 t30 -84.21 149.0 26.42 Favored 'General case' 0 N--CA 1.436 -1.156 0 O-C-N 120.492 -1.593 . . . . 64.090000000000003 107.105 164.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1346 ' ' ILE . . . . . 0.435 HD12 ' H ' ' A' 1346 ' ' ILE . 2.6 mp -81.36 83.56 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 103.198 -2.89 . . . . 58.82 103.198 176.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1347 ' ' THR . . . . . 0.533 ' O ' ' HG ' ' A' 1338 ' ' LEU . 3.3 m -76.91 83.43 3.46 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 105.798 -1.926 . . . . 54.960000000000001 105.798 -177.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1348 ' ' VAL . . . . . 0.456 HG21 HG21 ' A' 1111 ' ' THR . 21.8 t -78.33 76.13 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 124.406 2.051 . . . . 55.640000000000001 106.508 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 27.0 t70 -75.13 138.38 42.0 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 112.113 -2.312 . . . . 61.450000000000003 112.518 -165.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1350 ' ' PHE . . . . . 0.451 ' CZ ' ' HD3' ' A' 1362 ' ' ARG . 11.4 m-30 -103.49 -6.35 21.89 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 112.082 -2.326 . . . . 58.630000000000003 112.898 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 15.1 t70 -71.71 -48.24 48.49 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 118.797 0.726 . . . . 62.060000000000002 110.072 177.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 18.2 t0 -66.25 130.57 43.67 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.538 -0.756 . . . . 54.07 109.397 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 31.8 m -67.95 -28.31 40.81 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 N-CA-C 113.077 0.769 . . . . 50.68 113.077 -176.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1354 ' ' VAL . . . . . 0.66 ' O ' HG23 ' A' 1358 ' ' VAL . 3.1 m -80.23 -43.65 22.14 Favored 'Isoleucine or valine' 0 C--O 1.246 0.876 0 N-CA-C 105.471 -2.048 . . . . 47.68 105.471 -174.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1355 ' ' ILE . . . . . 0.543 HD11 ' HB3' ' A' 1337 ' ' LEU . 62.2 mt -65.77 -44.08 93.2 Favored 'Isoleucine or valine' 0 C--O 1.25 1.115 0 C-N-CA 119.423 -0.911 . . . . 48.490000000000002 109.731 -177.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 35.2 tpt85 -53.61 -48.04 69.67 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 115.269 -2.3 . . . . 48.270000000000003 113.329 168.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -57.9 -45.58 93.47 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 122.124 2.238 . . . . 43.530000000000001 114.995 174.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1358 ' ' VAL . . . . . 0.685 HG12 ' HB3' ' A' 1113 ' ' MET . 11.6 t -59.44 -49.82 82.18 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 C-N-CA 125.041 1.337 . . . . 45.119999999999997 110.913 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1359 ' ' THR . . . . . . . . . . . . . 18.5 m -70.74 87.73 0.7 Allowed 'General case' 0 C--O 1.244 0.774 0 CA-C-O 125.011 2.338 . . . . 42.939999999999998 112.479 -177.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 16.5 m -78.13 -28.83 15.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 112.642 -2.072 . . . . 43.259999999999998 111.461 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1361 ' ' ILE . . . . . 0.605 ' HB ' ' HB ' ' A' 1112 ' ' VAL . 96.5 mt -131.98 119.83 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 102.972 -2.973 . . . . 45.659999999999997 102.972 175.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1362 ' ' ARG . . . . . 0.628 ' HG3' HG23 ' A' 1111 ' ' THR . 2.0 ttp180 -106.41 124.42 49.57 Favored 'General case' 0 C--O 1.253 1.241 1 CA-C-N 126.254 4.116 . . . . 61.340000000000003 106.762 168.489 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 43.81 54.6 5.58 Favored 'General case' 0 C--O 1.241 0.627 0 O-C-N 126.447 2.342 . . . . 49.759999999999998 115.192 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 86.04 -24.08 8.49 Favored Glycine 0 CA--C 1.526 0.74 0 O-C-N 120.014 -1.678 . . . . 50.0 114.301 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -88.78 124.93 34.62 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 103.692 -2.707 . . . . 56.920000000000002 103.692 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1366 ' ' ILE . . . . . 0.518 HG22 ' HB3' ' A' 1368 ' ' TRP . 92.4 mt -75.18 89.32 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.753 0 CA-C-O 123.073 1.416 . . . . 52.780000000000001 108.065 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1367 ' ' THR . . . . . . . . . . . . . 17.1 p -75.76 53.05 0.71 Allowed 'General case' 0 C--O 1.252 1.211 0 CA-C-O 125.951 2.786 . . . . 49.439999999999998 113.767 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1368 ' ' TRP . . . . . 0.518 ' HB3' HG22 ' A' 1366 ' ' ILE . 57.1 t90 -132.37 144.07 51.49 Favored Pre-proline 0 CA--C 1.545 0.787 0 O-C-N 119.525 -1.984 . . . . 52.380000000000003 108.491 -170.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1369 ' ' PRO . . . . . 0.435 ' HA ' ' CD1' ' A' 1368 ' ' TRP . 60.9 Cg_endo -75.39 170.81 70.84 Favored 'Cis proline' 0 C--O 1.25 1.11 0 CA-C-N 123.101 2.143 . . . . 46.939999999999998 114.164 -4.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -128.75 117.98 19.7 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 108.5 -0.926 . . . . 45.909999999999997 108.5 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1371 ' ' PRO . . . . . 0.469 ' HA ' ' HD2' ' A' 1372 ' ' PRO . 51.6 Cg_exo -61.22 137.62 72.12 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 125.198 3.932 . . . . 46.390000000000001 112.823 -174.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1372 ' ' PRO . . . . . 0.469 ' HD2' ' HA ' ' A' 1371 ' ' PRO . 86.9 Cg_endo -78.35 8.61 3.51 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 121.105 1.204 . . . . 46.719999999999999 113.797 160.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.214 -5.31 0 O-C-N 119.541 -1.974 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 998' ' ' HIS . . . . . 0.729 ' HB2' ' HB2' ' B' 1000 ' ' HIS . 60.3 m80 . . . . . 0 N--CA 1.436 -1.16 0 N-CA-C 102.989 -2.967 . . . . 63.439999999999998 102.989 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -111.05 43.53 1.44 Allowed 'General case' 0 C--O 1.243 0.739 0 CA-C-O 123.21 1.481 . . . . 51.740000000000002 109.045 148.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1000 ' ' HIS . . . . . 0.729 ' HB2' ' HB2' ' B' ' 998' ' ' HIS . 18.7 t60 -84.61 135.61 34.11 Favored 'General case' 0 C--O 1.247 0.96 0 N-CA-C 104.924 -2.25 . . . . 54.07 104.924 -166.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 67.01 13.22 61.49 Favored Glycine 0 N--CA 1.451 -0.341 0 O-C-N 119.304 -2.122 . . . . 39.219999999999999 111.806 -172.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1002 ' ' ARG . . . . . 0.434 ' NH2' ' O ' ' B' 1065 ' ' GLN . 16.6 ttp180 -97.74 121.93 40.24 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.049 -1.463 . . . . 38.119999999999997 107.049 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1003 ' ' ILE . . . . . 0.463 HD13 HD13 ' B' 1026 ' ' LEU 0.279 46.6 mt -78.79 149.94 5.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 106.378 -1.712 . . . . 29.699999999999999 106.378 172.054 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -121.18 130.09 8.05 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 108.568 -1.813 . . . . 27.5 108.568 162.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1005 ' ' ILE . . . . . 0.483 ' HB ' ' HA ' ' B' 1035 ' ' VAL . 38.4 mm -104.91 103.14 39.63 Favored Pre-proline 0 C--O 1.243 0.748 0 N-CA-C 105.371 -2.085 . . . . 24.829999999999998 105.371 170.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -74.15 162.47 38.71 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 124.399 3.399 . . . . 27.190000000000001 108.993 171.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1007 ' ' ARG . . . . . 0.693 ' HB2' ' HA ' ' B' 1039 ' ' ALA . 29.2 ttp180 -80.52 137.33 36.42 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 104.449 -2.426 . . . . 41.460000000000001 104.449 157.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1008 ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -68.82 158.84 33.6 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-N 115.076 -0.965 . . . . 26.93 110.779 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1009 ' ' ARG . . . . . 0.416 HH22 ' CG ' ' B' 1078 ' ' ASP . 35.0 mmm-85 -113.91 -35.16 5.2 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 111.975 -2.375 . . . . 34.479999999999997 112.848 -171.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1010 ' ' LEU . . . . . 0.476 HD13 ' HB2' ' B' 1073 ' ' ASN . 7.3 mp -61.04 153.31 25.72 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 115.713 1.746 . . . . 44.219999999999999 115.713 -169.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1011 ' ' THR . . . . . . . . . . . . . 20.1 m -62.82 131.82 50.09 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 113.74 -1.573 . . . . 40.740000000000002 110.781 -173.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 5.2 t30 38.64 47.65 1.17 Allowed 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 129.492 3.117 . . . . 44.439999999999998 116.042 -166.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1013 ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -105.19 118.58 36.9 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 112.217 -2.265 . . . . 29.870000000000001 106.809 175.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1014 ' ' THR . . . . . 0.407 ' HA ' ' HB3' ' B' 1042 ' ' LEU . 1.0 OUTLIER -106.0 0.51 25.73 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 115.14 1.533 . . . . 25.260000000000002 115.14 176.577 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -80.6 144.42 32.4 Favored 'General case' 0 C--O 1.241 0.62 0 O-C-N 119.53 -1.981 . . . . 29.539999999999999 112.957 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1016 ' ' VAL . . . . . . . . . . . . . 4.7 p -111.42 175.63 1.8 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 103.992 -2.596 . . . . 23.550000000000001 103.992 165.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1017 ' ' ALA . . . . . 0.42 ' HB3' HD12 ' B' 1005 ' ' ILE . . . -75.91 -40.33 54.49 Favored 'General case' 0 C--N 1.344 0.356 0 O-C-N 117.939 -2.976 . . . . 23.59 115.042 -176.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1018 ' ' ALA . . . . . 0.65 ' HB1' ' HB ' ' B' 1022 ' ' THR . . . -152.19 145.47 24.71 Favored 'General case' 0 C--O 1.247 0.935 0 N-CA-C 105.28 -2.118 . . . . 24.93 105.28 -176.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1019 ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.14 172.6 5.02 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 115.725 -2.083 . . . . 28.09 111.521 -178.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1020 ' ' PRO . . . . . 0.462 ' HB3' ' HB2' ' B' 1053 ' ' ALA . 82.8 Cg_exo -51.61 -42.65 55.14 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 CA-C-N 127.155 3.591 . . . . 28.789999999999999 118.161 -172.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 83.6 tttt -54.96 -48.76 72.79 Favored 'General case' 0 CA--C 1.502 -0.89 0 O-C-N 121.236 -0.915 . . . . 47.280000000000001 112.617 169.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1022 ' ' THR . . . . . 0.65 ' HB ' ' HB1' ' B' 1018 ' ' ALA . 0.0 OUTLIER -67.77 -24.22 65.3 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 120.755 -1.215 . . . . 30.120000000000001 113.253 177.611 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B 1023 ' ' VAL . . . . . 0.487 HG21 ' HD2' ' B' 1050 ' ' PHE . 43.0 t -67.41 -47.57 80.42 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.711 0 O-C-N 120.244 -1.535 . . . . 32.240000000000002 107.713 171.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1024 ' ' GLU . . . . . 0.631 ' HA ' HD12 ' B' 1027 ' ' LEU . 27.6 mt-10 -62.73 -36.09 81.87 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 118.776 -0.63 . . . . 49.619999999999997 112.684 176.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -58.68 -43.78 90.06 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 124.305 1.003 . . . . 44.68 113.271 169.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1026 ' ' LEU . . . . . 0.478 HD12 ' HA ' ' B' 1023 ' ' VAL . 35.1 mt -62.14 -43.45 98.8 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 119.895 -1.753 . . . . 35.710000000000001 113.217 171.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1027 ' ' LEU . . . . . 0.631 HD12 ' HA ' ' B' 1024 ' ' GLU . 24.7 mt -58.24 -27.16 63.71 Favored 'General case' 0 C--N 1.348 0.542 0 O-C-N 119.808 -1.807 . . . . 42.18 112.332 174.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 62.7 mttm -61.75 -21.48 64.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 121.097 1.772 . . . . 48.340000000000003 112.38 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1029 ' ' LEU . . . . . 0.489 HD23 ' HG2' ' B' 1342 ' ' LYS . 49.6 mt -86.45 -4.16 59.13 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 114.233 1.197 . . . . 38.689999999999998 114.233 175.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 78.58 21.98 68.08 Favored Glycine 0 N--CA 1.446 -0.693 0 O-C-N 120.314 -1.491 . . . . 32.280000000000001 113.301 -174.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1031 ' ' PHE . . . . . 0.433 ' HE2' ' HB3' ' B' 1335 ' ' LEU . 22.5 m-85 -99.35 132.44 44.67 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 105.419 -2.067 . . . . 35.939999999999998 105.419 176.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1032 ' ' THR . . . . . . . . . . . . . 3.6 m -89.35 123.97 34.01 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 107.971 -1.122 . . . . 33.369999999999997 107.971 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1033 ' ' VAL . . . . . . . . . . . . . 22.8 t -95.34 134.12 33.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.637 -1.616 . . . . 29.98 106.637 -171.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -111.77 145.83 38.68 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.911 -1.144 . . . . 28.18 107.911 159.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1035 ' ' VAL . . . . . 0.526 ' HB ' HD13 ' B' 1057 ' ' ILE . 97.1 t -122.5 149.73 26.06 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 N-CA-C 103.713 -2.699 . . . . 25.82 103.713 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1036 ' ' GLU . . . . . 0.625 ' HB3' ' HB2' ' B' 1039 ' ' ALA . 19.1 tt0 -73.3 147.27 44.65 Favored 'General case' 0 C--O 1.213 -0.835 0 C-N-CA 123.252 0.621 . . . . 32.439999999999998 111.293 176.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1037 ' ' SER . . . . . . . . . . . . . 44.0 m -60.25 112.72 2.03 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.347 -1.297 . . . . 29.539999999999999 111.015 172.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 77.92 20.4 73.39 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 111.695 -2.502 . . . . 27.760000000000002 113.941 -175.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1039 ' ' ALA . . . . . 0.693 ' HA ' ' HB2' ' B' 1007 ' ' ARG . . . -64.81 -57.8 7.93 Favored 'General case' 0 C--O 1.25 1.12 0 N-CA-C 115.69 1.737 . . . . 26.02 115.69 -176.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -67.58 -15.1 65.83 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 114.201 -1.363 . . . . 26.469999999999999 113.543 -173.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -53.36 -35.72 60.59 Favored 'General case' 0 C--O 1.255 1.347 0 O-C-N 119.615 -2.109 . . . . 50.979999999999997 113.133 172.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1042 ' ' LEU . . . . . 0.407 ' HB3' ' HA ' ' B' 1014 ' ' THR . 60.8 mt -53.03 -54.47 34.79 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 123.028 2.649 . . . . 29.300000000000001 110.03 167.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1043 ' ' ALA . . . . . 0.775 ' HA ' ' HB2' ' B' 1320 ' ' PRO . . . -66.67 2.81 1.19 Allowed 'General case' 0 C--O 1.241 0.641 0 N-CA-C 115.706 1.743 . . . . 26.739999999999998 115.706 174.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1044 ' ' SER . . . . . 0.47 ' O ' ' HB1' ' A' 1277 ' ' ALA . 24.3 m 62.28 35.67 15.12 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 123.702 1.715 . . . . 31.260000000000002 114.668 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1045 ' ' PHE . . . . . 0.405 ' HA ' ' CB ' ' A' 1277 ' ' ALA . 0.3 OUTLIER -132.5 108.81 9.36 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 105.005 -2.221 . . . . 33.259999999999998 105.005 177.066 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 8.5 t70 -61.52 144.31 54.5 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 114.975 1.472 . . . . 46.740000000000002 114.975 -177.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1047 ' ' ASP . . . . . 0.515 ' HA ' ' HD1' ' B' 1050 ' ' PHE . 43.0 p-10 -65.13 -20.4 66.44 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 114.146 1.165 . . . . 34.439999999999998 114.146 -175.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -56.72 -23.47 42.62 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 117.371 2.36 . . . . 48.670000000000002 117.371 165.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -83.81 -24.21 31.08 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 123.672 0.789 . . . . 35.259999999999998 110.371 172.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1050 ' ' PHE . . . . . 0.515 ' HD1' ' HA ' ' B' 1047 ' ' ASP . 75.3 m-85 -74.22 -28.33 61.2 Favored 'General case' 0 C--O 1.251 1.184 0 O-C-N 119.156 -2.215 . . . . 32.170000000000002 110.262 171.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 91.6 t -62.43 -50.29 80.46 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 N-CA-C 105.918 -1.882 . . . . 38.369999999999997 105.918 167.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -51.6 -41.52 61.29 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.135 1.531 . . . . 45.770000000000003 115.135 172.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1053 ' ' ALA . . . . . 0.462 ' HB2' ' HB3' ' B' 1020 ' ' PRO . . . -65.42 -41.69 93.3 Favored 'General case' 0 C--O 1.218 -0.558 0 O-C-N 123.618 0.574 . . . . 37.829999999999998 111.78 173.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 111.61 53.21 0.53 Allowed Glycine 0 C--N 1.35 1.317 0 N-CA-C 110.704 -0.959 . . . . 35.82 110.704 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -120.69 150.26 41.22 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-O 123.854 1.788 . . . . 33.770000000000003 109.365 171.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -63.76 142.83 58.26 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 112.227 -2.261 . . . . 51.020000000000003 108.493 167.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1057 ' ' ILE . . . . . 0.526 HD13 ' HB ' ' B' 1035 ' ' VAL . 46.2 mm -120.17 112.74 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 N-CA-C 106.17 -1.789 . . . . 38.469999999999999 106.17 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 1.8 m -133.74 142.23 42.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 115.445 1.646 . . . . 39.399999999999999 115.445 -171.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -72.82 105.01 4.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 113.479 -1.691 . . . . 57.07 114.762 -169.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1060 ' ' GLY . . . . . 0.422 ' O ' HG12 ' B' 1063 ' ' VAL . . . 59.96 -113.7 5.61 Favored Glycine 0 N--CA 1.433 -1.558 0 CA-C-N 114.425 -1.261 . . . . 44.829999999999998 112.554 165.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1061 ' ' ASN . . . . . 0.416 ' O ' ' HG2' ' B' 1065 ' ' GLN . 13.8 m-20 -61.96 -25.1 67.41 Favored 'General case' 0 C--O 1.241 0.632 0 O-C-N 120.459 -1.613 . . . . 46.270000000000003 111.922 -171.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1062 ' ' SER . . . . . . . . . . . . . 66.5 m -59.08 -41.89 89.1 Favored 'General case' 0 N--CA 1.426 -1.642 0 C-N-CA 124.349 1.06 . . . . 43.469999999999999 111.21 173.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1063 ' ' VAL . . . . . 0.422 HG12 ' O ' ' B' 1060 ' ' GLY . 2.0 p -66.91 -31.53 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 O-C-N 118.593 -2.567 . . . . 36.979999999999997 109.347 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 38.8 m95 -68.87 -30.55 69.09 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 113.994 1.109 . . . . 37.899999999999999 113.994 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1065 ' ' GLN . . . . . 0.434 ' O ' ' NH2' ' B' 1002 ' ' ARG . 47.1 mm-40 -77.47 92.88 4.04 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.03 -1.1 . . . . 46.189999999999998 108.03 175.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1066 ' ' SER . . . . . . . . . . . . . 53.5 m -159.94 165.79 31.39 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 119.929 -1.732 . . . . 37.060000000000002 110.906 -169.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1067 ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -65.47 -52.52 52.35 Favored 'General case' 0 C--O 1.22 -0.468 0 O-C-N 124.643 1.214 . . . . 43.950000000000003 111.277 170.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1068 ' ' ILE . . . . . 0.6 HD11 HD11 ' B' 1346 ' ' ILE . 23.9 mt -123.74 131.81 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 104.888 -2.264 . . . . 33.5 104.888 -173.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1069 ' ' ILE . . . . . 0.433 HD13 ' HA ' ' B' 1069 ' ' ILE . 26.4 mm -111.4 116.92 53.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 104.779 -2.304 . . . . 30.57 104.779 171.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1070 ' ' LEU . . . . . 0.706 HD22 HD22 ' B' 1331 ' ' LEU . 73.7 mt -102.27 114.96 29.57 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 101.72 -3.437 . . . . 27.66 101.72 178.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1071 ' ' LYS . . . . . . . . . . . . . 18.9 tttm -140.14 157.73 45.16 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 106.182 -1.784 . . . . 28.399999999999999 106.182 -169.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1072 ' ' VAL . . . . . . . . . . . . . 67.6 t -83.27 -81.14 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.828 0 C-N-CA 117.547 -1.661 . . . . 23.18 110.188 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1073 ' ' ASN . . . . . 0.476 ' HB2' HD13 ' B' 1010 ' ' LEU . 24.9 m120 -87.04 156.89 19.56 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 114.174 1.176 . . . . 25.469999999999999 114.174 -167.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -46.65 117.14 4.21 Favored Pre-proline 0 C--O 1.249 1.075 0 C-N-CA 124.129 0.972 . . . . 27.899999999999999 113.049 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -54.48 136.14 68.69 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.903 2.402 . . . . 31.620000000000001 114.074 -173.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 38.3 mt -71.33 160.28 33.07 Favored 'General case' 0 CA--C 1.506 -0.74 0 O-C-N 126.51 2.381 . . . . 40.490000000000002 106.776 173.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.49 -38.68 63.91 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 115.923 1.823 . . . . 51.590000000000003 115.923 -168.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1078 ' ' ASP . . . . . 0.416 ' CG ' HH22 ' B' 1009 ' ' ARG . 9.8 p-10 -68.69 -36.13 78.1 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-O 120.84 0.352 . . . . 42.359999999999999 111.751 175.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1079 ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -64.07 -36.02 82.64 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-O 123.551 1.643 . . . . 34.530000000000001 111.37 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1080 ' ' ILE . . . . . 0.442 ' O ' ' HG3' ' B' 1108 ' ' ARG . 57.6 mt -60.45 -50.78 78.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 113.119 -1.855 . . . . 33.25 109.64 174.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -57.15 -34.01 67.99 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 115.486 1.661 . . . . 36.469999999999999 115.486 173.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1082 ' ' LEU . . . . . . . . . . . . . 86.0 mt -62.94 -26.88 69.03 Favored 'General case' 0 CA--C 1.491 -1.31 0 O-C-N 125.391 1.682 . . . . 37.759999999999998 114.303 173.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1083 ' ' LEU . . . . . 0.755 HD11 HD22 ' B' 1089 ' ' LEU . 68.8 mt -55.28 156.63 4.11 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 113.865 1.061 . . . . 37.43 113.865 167.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1084 ' ' ASN . . . . . . . . . . . . 0.252 1.5 m-80 -130.56 148.53 70.36 Favored Pre-proline 0 C--N 1.319 -0.753 0 N-CA-C 103.673 -2.714 . . . . 37.700000000000003 103.673 -167.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -55.82 114.0 1.69 Allowed 'Trans proline' 0 C--O 1.25 1.11 0 C-N-CA 125.004 3.803 . . . . 35.509999999999998 109.673 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 120.71 -37.65 2.96 Favored Glycine 0 N--CA 1.437 -1.246 0 CA-C-N 111.624 -2.535 . . . . 33.869999999999997 114.332 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1087 ' ' THR . . . . . . . . . . . . . 26.4 m -56.2 122.24 11.3 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 114.513 1.301 . . . . 32.5 114.513 -164.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1088 ' ' THR . . . . . 0.408 ' HA ' ' HB ' ' B' 1111 ' ' THR . 13.5 m -70.49 94.72 0.99 Allowed 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 113.633 -1.621 . . . . 30.219999999999999 107.268 174.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1089 ' ' LEU . . . . . 0.755 HD22 HD11 ' B' 1083 ' ' LEU . 42.4 tp -85.77 111.36 20.08 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 118.951 0.796 . . . . 27.239999999999998 110.05 174.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 6.0 t -112.76 104.53 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 104.037 -2.579 . . . . 25.390000000000001 104.037 -175.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1091 ' ' SER . . . . . . . . . . . . . 45.5 m -154.86 163.4 40.34 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.043 -1.435 . . . . 28.809999999999999 113.282 -171.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1092 ' ' PHE . . . . . 0.483 ' HZ ' ' HG3' ' B' 1133 ' ' MET . 53.2 m-85 -73.64 99.77 3.18 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 104.233 -2.506 . . . . 30.780000000000001 104.233 171.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1093 ' ' ILE . . . . . 0.467 HG13 ' CG1' ' B' 1112 ' ' VAL . 37.6 mm -85.38 -33.71 8.04 Favored 'Isoleucine or valine' 0 C--N 1.355 0.843 0 CA-C-O 118.254 -0.879 . . . . 30.280000000000001 111.909 -175.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1094 ' ' TRP . . . . . . . . . . . . . 70.6 m95 53.59 62.23 9.57 Favored Pre-proline 0 C--O 1.248 0.994 0 C-N-CA 124.811 1.245 . . . . 34.07 113.274 -167.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -50.1 -49.2 16.89 Favored 'Trans proline' 0 C--O 1.248 0.992 0 C-N-CA 125.104 3.87 . . . . 38.659999999999997 114.089 -170.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -75.18 -19.7 59.7 Favored 'General case' 0 C--O 1.241 0.621 0 O-C-N 120.617 -1.302 . . . . 41.32 110.142 -175.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -85.43 -22.9 28.11 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 122.272 1.034 . . . . 51.659999999999997 111.279 173.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1098 ' ' ASN . . . . . 0.405 ' N ' ' HD3' ' B' 1099 ' ' PRO . 27.7 m-20 -127.84 48.87 3.74 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 113.869 1.063 . . . . 40.32 113.869 -170.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1099 ' ' PRO . . . . . 0.405 ' HD3' ' N ' ' B' 1098 ' ' ASN . 77.5 Cg_exo -60.98 -40.26 53.79 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 124.044 3.163 . . . . 41.560000000000002 118.051 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -64.11 -39.13 93.37 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 109.206 -0.664 . . . . 54.109999999999999 109.206 175.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1101 ' ' LEU . . . . . 0.461 ' O ' ' HG ' ' B' 1105 ' ' LEU . 9.9 mp -61.89 -45.21 94.75 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 118.17 0.441 . . . . 37.880000000000003 111.873 172.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1102 ' ' MET . . . . . 0.642 ' HA ' HD12 ' B' 1105 ' ' LEU . 75.1 mmm -55.42 -42.63 74.42 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 123.214 0.605 . . . . 37.539999999999999 112.432 173.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -66.55 -40.77 89.23 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-O 122.407 1.098 . . . . 47.009999999999998 108.434 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1104 ' ' LYS . . . . . . . . . . . . . 37.8 mtmt -65.65 -27.72 68.57 Favored 'General case' 0 CA--C 1.481 -1.681 0 O-C-N 118.101 -2.875 . . . . 48.68 116.043 170.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1105 ' ' LEU . . . . . 0.642 HD12 ' HA ' ' B' 1102 ' ' MET . 31.3 mt -70.82 -38.81 73.29 Favored 'General case' 0 C--O 1.265 1.869 0 O-C-N 120.385 -1.447 . . . . 32.210000000000001 110.374 173.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -61.77 -42.21 98.7 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 109.019 -0.734 . . . . 33.729999999999997 109.019 175.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -60.14 -44.92 94.58 Favored 'General case' 0 CA--C 1.497 -1.075 0 O-C-N 121.039 -1.038 . . . . 51.469999999999999 113.773 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1108 ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' B' 1080 ' ' ILE . 16.4 mmm180 -62.2 -24.5 67.25 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.649 -1.282 . . . . 43.899999999999999 114.332 173.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1109 ' ' ASN . . . . . . . . . . . . . 14.9 m-80 72.01 47.12 0.32 Allowed 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 125.12 2.391 . . . . 44.82 110.94 173.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1110 ' ' VAL . . . . . 0.579 HG11 ' HB3' ' B' 1083 ' ' LEU . 16.5 m -96.46 169.38 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-N 110.081 -3.236 . . . . 30.52 113.826 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1111 ' ' THR . . . . . 0.408 ' HB ' ' HA ' ' B' 1088 ' ' THR . 8.1 m -104.65 97.87 7.7 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 107.548 -1.278 . . . . 27.120000000000001 107.548 171.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1112 ' ' VAL . . . . . 0.467 ' CG1' HG13 ' B' 1093 ' ' ILE . 93.4 t -92.8 123.85 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 O-C-N 119.556 -1.965 . . . . 26.399999999999999 108.736 -173.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1113 ' ' MET . . . . . 0.691 ' SD ' HD21 ' B' 1334 ' ' LEU . 21.0 mtp -116.87 103.12 9.98 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.986 -1.487 . . . . 42.920000000000002 106.986 174.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -79.75 88.04 5.23 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 113.457 -1.701 . . . . 24.149999999999999 113.782 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1115 ' ' MET . . . . . 0.48 ' SD ' HD13 ' B' 1334 ' ' LEU . 95.0 mmm -54.71 -19.23 5.79 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 117.073 2.249 . . . . 29.949999999999999 117.073 -173.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1116 ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -72.7 -46.23 54.79 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.115 -1.402 . . . . 34.530000000000001 114.503 168.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1117 ' ' SER . . . . . . . . . . . . . 66.1 m -93.8 52.87 1.73 Allowed 'General case' 0 C--O 1.255 1.347 0 O-C-N 119.181 -2.199 . . . . 33.490000000000002 112.028 -167.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1118 ' ' VAL . . . . . . . . . . . . . 40.5 t -89.53 137.38 28.86 Favored Pre-proline 0 N--CA 1.445 -0.718 0 N-CA-C 106.565 -1.643 . . . . 34.020000000000003 106.565 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -63.63 131.07 30.04 Favored 'Trans proline' 0 CA--C 1.512 -0.602 0 C-N-CA 123.765 2.976 . . . . 38.280000000000001 108.336 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1120 ' ' ARG . . . . . 0.752 ' HB2' HG11 ' B' 1375 ' ' VAL . 1.8 mmt180 -74.77 50.2 0.44 Allowed 'General case' 0 C--O 1.247 0.97 0 N-CA-C 115.09 1.515 . . . . 55.049999999999997 115.09 -163.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1121 ' ' ILE . . . . . 0.526 ' HB ' ' O ' ' C' ' 131' ' ' ALA . 36.1 pt -102.08 172.51 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.912 0 O-C-N 117.082 -3.511 . . . . 42.090000000000003 115.969 -177.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1122 ' ' SER . . . . . . . . . . . . . 2.9 m -62.29 -32.73 73.5 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 117.718 2.488 . . . . 38.020000000000003 117.718 -172.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1123 ' ' ARG . . . . . 0.416 ' HA ' ' HD3' ' C' ' 134' ' ' PRO . 11.3 ptt-85 -67.25 -35.76 80.21 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 119.378 -0.929 . . . . 34.289999999999999 113.407 162.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1124 ' ' ALA . . . . . . . . . . . . . . . -62.22 -36.08 80.88 Favored 'General case' 0 C--N 1.359 0.98 0 N-CA-C 116.877 2.177 . . . . 32.350000000000001 116.877 -158.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1125 ' ' GLN . . . . . 0.803 ' HA ' ' HB3' ' B' 1128 ' ' ASP . 2.3 mp0 -64.94 -8.73 16.88 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 115.415 1.635 . . . . 47.170000000000002 115.415 -172.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1126 ' ' SER . . . . . . . . . . . . . 21.1 p -75.05 -41.82 58.29 Favored 'General case' 0 C--O 1.24 0.585 0 O-C-N 120.414 -1.429 . . . . 31.710000000000001 109.074 173.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1127 ' ' LEU . . . . . . . . . . . . . 3.5 mp -80.13 -40.85 26.58 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-N 113.248 -1.796 . . . . 37.0 111.159 174.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1128 ' ' ASP . . . . . 0.803 ' HB3' ' HA ' ' B' 1125 ' ' GLN . 9.3 t70 -61.6 119.89 9.52 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 123.743 1.735 . . . . 40.399999999999999 115.001 -173.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1129 ' ' ALA . . . . . . . . . . . . . . . -68.63 -34.98 76.68 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 111.629 -2.532 . . . . 26.559999999999999 109.277 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 58.8 mt -67.8 -28.93 68.01 Favored 'General case' 0 C--N 1.31 -1.111 0 O-C-N 118.957 -2.339 . . . . 30.890000000000001 112.451 -169.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1131 ' ' SER . . . . . 0.632 ' HB3' ' HG3' ' B' 1125 ' ' GLN . 57.9 p -65.5 -56.11 14.15 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 107.685 -1.228 . . . . 29.84 107.685 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1132 ' ' SER . . . . . 0.66 ' HB3' ' HB3' ' B' 1326 ' ' LEU . 5.8 m -55.54 -47.69 75.92 Favored 'General case' 0 CA--C 1.507 -0.675 0 O-C-N 125.727 1.892 . . . . 31.91 110.174 178.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1133 ' ' MET . . . . . 0.483 ' HG3' ' HZ ' ' B' 1092 ' ' PHE . 33.2 mmt -65.87 -31.35 72.24 Favored 'General case' 0 C--N 1.361 1.073 0 N-CA-C 115.72 1.748 . . . . 25.899999999999999 115.72 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1134 ' ' ALA . . . . . . . . . . . . . . . -67.06 -43.62 82.18 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 107.602 -1.258 . . . . 26.620000000000001 107.602 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -67.97 -35.59 78.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 121.501 1.955 . . . . 36.969999999999999 110.466 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1136 ' ' ILE . . . . . 0.691 HD13 ' HE1' ' A' 1152 ' ' PHE . 23.5 mm -52.02 -56.81 4.97 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 O-C-N 121.393 -0.817 . . . . 32.109999999999999 110.313 167.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -69.75 -20.32 63.51 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 116.968 -1.491 . . . . 24.140000000000001 110.551 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -69.15 -48.16 48.46 Favored Glycine 0 N--CA 1.471 1.002 0 CA-C-N 120.909 1.686 . . . . 25.129999999999999 110.545 173.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 81.9 t80 -66.33 -51.85 53.03 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 105.595 -2.002 . . . . 32.729999999999997 105.595 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1140 ' ' ARG . . . . . 0.43 ' HA ' ' HB ' ' B' 1143 ' ' VAL . 7.1 tpt180 -54.63 -25.78 28.81 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-O 115.538 -2.172 . . . . 26.359999999999999 113.4 173.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1141 ' ' ALA . . . . . 0.557 ' HA ' HG11 ' B' 1282 ' ' VAL . . . -62.17 -54.28 43.26 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 121.381 1.901 . . . . 24.120000000000001 109.055 173.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 45.7 mm -57.69 -43.37 83.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 CA-C-O 122.734 1.254 . . . . 23.370000000000001 110.96 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1143 ' ' VAL . . . . . 0.43 ' HB ' ' HA ' ' B' 1140 ' ' ARG . 75.3 t -63.46 -56.76 15.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 114.523 1.305 . . . . 24.960000000000001 114.523 177.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1144 ' ' GLU . . . . . 0.415 ' OE2' ' HD3' ' B' 1318 ' ' ARG . 20.3 mm-40 -70.16 -29.74 66.72 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 120.47 -1.394 . . . . 32.07 111.639 -178.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1145 ' ' ALA . . . . . 0.825 ' HB1' HD12 ' B' 1251 ' ' ILE . . . -55.99 -60.3 3.67 Favored 'General case' 0 C--N 1.346 0.418 0 N-CA-C 107.68 -1.23 . . . . 24.870000000000001 107.68 168.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1146 ' ' ALA . . . . . 0.648 ' HB2' ' HE1' ' B' 1153 ' ' PHE . . . -48.4 -32.48 7.68 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.248 1.573 . . . . 24.670000000000002 115.248 175.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 80.7 t60 -53.59 -50.53 65.41 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 119.76 1.164 . . . . 28.579999999999998 111.988 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1148 ' ' GLU . . . . . 0.733 ' HB2' HD11 ' B' 1310 ' ' ILE . 28.7 mm-40 -108.14 -5.38 16.97 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 119.561 -1.962 . . . . 36.82 114.377 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1149 ' ' PHE . . . . . . . . . . . . . 2.8 t80 -54.09 138.94 36.55 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 126.029 2.823 . . . . 31.969999999999999 109.141 177.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1150 ' ' GLY . . . . . 0.613 ' HA2' ' HG2' ' A' 1320 ' ' PRO . . . -68.6 -35.35 80.71 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 109.784 -3.371 . . . . 25.489999999999998 113.816 175.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1151 ' ' ARG . . . . . 0.652 ' HA ' ' HB2' ' A' 1322 ' ' GLN . 55.3 mtm-85 -128.37 -170.56 2.27 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 123.048 3.424 . . . . 59.840000000000003 110.022 -162.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1152 ' ' PHE . . . . . 0.804 ' HB2' HG11 ' B' 1163 ' ' VAL . 19.0 m-30 -81.7 161.29 23.43 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 107.734 -1.21 . . . . 34.450000000000003 107.734 168.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1153 ' ' PHE . . . . . 0.648 ' HE1' ' HB2' ' B' 1146 ' ' ALA . 53.2 m-85 -79.91 -47.91 14.3 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.102 -1.814 . . . . 31.170000000000002 106.102 166.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1154 ' ' THR . . . . . . . . . . . . . 57.5 m -54.77 134.82 47.82 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 112.28 -2.237 . . . . 33.890000000000001 112.411 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -78.02 62.64 3.63 Favored Glycine 0 N--CA 1.44 -1.094 0 O-C-N 123.881 0.738 . . . . 38.950000000000003 112.86 169.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -83.79 125.04 31.53 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 122.984 1.373 . . . . 54.229999999999997 111.767 -166.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1157 ' ' ILE . . . . . 0.545 HG23 ' HE2' ' B' 1162 ' ' LYS . 18.8 mm -78.09 89.39 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 105.375 -2.083 . . . . 51.159999999999997 105.375 172.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1158 ' ' THR . . . . . . . . . . . . . 6.2 m -97.79 146.46 25.37 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 107.157 -1.423 . . . . 49.609999999999999 107.157 -177.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -44.15 -57.3 3.49 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 115.09 1.515 . . . . 49.049999999999997 115.09 -171.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -60.43 -37.27 80.38 Favored 'General case' 0 C--O 1.207 -1.144 0 C-N-CA 125.175 1.39 . . . . 47.649999999999999 112.011 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . 179.87 157.52 20.23 Favored Glycine 0 CA--C 1.498 -1.026 0 N-CA-C 109.421 -1.472 . . . . 45.609999999999999 109.421 -177.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1162 ' ' LYS . . . . . 0.545 ' HE2' HG23 ' B' 1157 ' ' ILE . 85.6 mttt -75.1 125.63 29.34 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.044 -1.078 . . . . 57.460000000000001 110.605 -177.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1163 ' ' VAL . . . . . 0.804 HG11 ' HB2' ' B' 1152 ' ' PHE . 57.1 t -75.81 128.0 84.41 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-O 118.332 -0.842 . . . . 42.93 108.864 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1164 ' ' PRO . . . . . 0.526 ' HA ' ' HD3' ' B' 1165 ' ' PRO . 74.0 Cg_endo -66.92 122.46 9.81 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 124.826 3.684 . . . . 39.289999999999999 108.442 172.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1165 ' ' PRO . . . . . 0.526 ' HD3' ' HA ' ' B' 1164 ' ' PRO . 81.1 Cg_exo -64.88 142.48 75.8 Favored 'Trans proline' 0 C--O 1.248 1.013 0 O-C-N 124.289 1.678 . . . . 34.170000000000002 109.452 -171.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1166 ' ' ALA . . . . . 0.442 ' HB2' ' HA ' ' B' 1153 ' ' PHE . . . -76.89 120.77 22.49 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 123.833 1.778 . . . . 31.690000000000001 108.898 -173.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1167 ' ' LYS . . . . . 0.629 ' HB2' ' HA ' ' B' 1249 ' ' VAL . 87.4 mttt -86.54 101.86 13.59 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 103.085 -2.931 . . . . 44.780000000000001 103.085 174.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 35.7 t -97.31 91.59 2.65 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 CA-C-N 112.805 -1.998 . . . . 31.23 109.46 -175.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1169 ' ' MET . . . . . 0.811 ' HB2' HG11 ' B' 1249 ' ' VAL . 48.3 ttp -77.48 99.68 5.75 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 105.442 -2.058 . . . . 37.090000000000003 105.442 -177.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 93.3 t -87.6 96.42 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 106.668 -1.605 . . . . 30.170000000000002 106.668 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1171 ' ' ILE . . . . . . . . . . . . . 61.3 mt -90.03 113.08 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 N-CA-C 107.132 -1.433 . . . . 33.740000000000002 107.132 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 94.91 73.85 1.21 Allowed Glycine 0 CA--C 1.5 -0.895 0 C-N-CA 119.561 -1.304 . . . . 32.590000000000003 110.455 170.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1173 ' ' ALA . . . . . 0.677 ' HA ' ' HA3' ' B' 1177 ' ' GLY . . . -78.47 57.16 1.9 Allowed 'General case' 0 C--N 1.329 -0.295 0 O-C-N 126.465 1.921 . . . . 32.420000000000002 113.79 -175.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -86.83 -162.52 37.54 Favored Glycine 0 C--O 1.211 -1.3 0 N-CA-C 108.185 -1.966 . . . . 31.739999999999998 108.185 164.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 41.4 t -47.37 -46.9 10.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 CA-C-N 121.538 2.669 . . . . 31.48 116.521 -171.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1176 ' ' ALA . . . . . . . . . . . . . . . -53.97 -56.15 20.5 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 115.665 1.728 . . . . 26.120000000000001 115.665 169.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1177 ' ' GLY . . . . . 0.677 ' HA3' ' HA ' ' B' 1173 ' ' ALA . . . -51.3 -52.19 33.31 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-N 113.474 -1.694 . . . . 25.73 111.185 176.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1178 ' ' LEU . . . . . 0.494 HD21 HG12 ' B' 1200 ' ' VAL . 37.8 mt -62.13 -44.34 96.84 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 126.02 1.728 . . . . 32.590000000000003 113.158 -174.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -59.9 -39.36 85.13 Favored 'General case' 0 C--N 1.348 0.517 0 N-CA-C 113.762 1.023 . . . . 27.719999999999999 113.762 171.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -66.53 -39.53 88.66 Favored 'General case' 0 C--O 1.244 0.767 0 O-C-N 124.0 0.813 . . . . 26.030000000000001 111.784 178.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1181 ' ' ILE . . . . . 0.672 HG23 HG11 ' B' 1191 ' ' VAL . 62.9 mt -57.03 -52.85 50.74 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 118.375 -0.821 . . . . 28.609999999999999 111.3 171.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -46.8 -61.85 4.07 Favored Glycine 0 C--N 1.346 1.106 0 O-C-N 126.148 2.155 . . . . 25.23 109.495 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -64.45 -47.27 79.67 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 121.799 0.809 . . . . 24.09 112.921 -171.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -64.67 -37.78 88.77 Favored 'General case' 0 CA--C 1.509 -0.632 0 O-C-N 121.04 -1.038 . . . . 26.68 112.483 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -66.38 -45.52 79.8 Favored 'General case' 0 C--O 1.252 1.208 0 C-N-CA 124.155 0.982 . . . . 36.57 110.009 176.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1186 ' ' SER . . . . . . . . . . . . . 69.1 m -58.29 -37.3 74.76 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 113.138 0.792 . . . . 28.920000000000002 113.138 173.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1187 ' ' LEU . . . . . 0.632 ' HA ' ' HB3' ' A' 1186 ' ' SER . 19.1 mt -69.49 -16.54 63.48 Favored 'General case' 0 C--O 1.249 1.03 0 N-CA-C 114.853 1.427 . . . . 29.09 114.853 173.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 80.42 52.38 4.52 Favored Glycine 0 C--O 1.251 1.187 0 O-C-N 119.151 -2.218 . . . . 29.260000000000002 109.168 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1189 ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' B' 1153 ' ' PHE . . . -115.52 155.34 27.72 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 113.325 -1.438 . . . . 30.16 108.597 170.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 80.2 mt -81.48 94.89 2.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 103.413 -2.81 . . . . 35.810000000000002 103.413 -175.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1191 ' ' VAL . . . . . 0.672 HG11 HG23 ' B' 1181 ' ' ILE . 23.8 t -71.0 121.8 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 C-N-CA 118.228 -1.389 . . . . 31.969999999999999 108.223 170.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1192 ' ' ARG . . . . . 0.516 ' HD2' HD21 ' B' 1212 ' ' LEU . 26.6 mmt85 -104.85 85.12 2.24 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 113.279 -1.782 . . . . 48.159999999999997 106.197 173.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -96.3 149.94 21.12 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 118.368 -2.708 . . . . 35.890000000000001 114.257 -165.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 20.2 t80 -147.54 153.4 39.43 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 120.397 -1.439 . . . . 41.880000000000003 108.615 -177.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1195 ' ' ASP . . . . . . . . . . . . . 8.9 t0 -162.97 159.9 24.06 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 103.409 -2.812 . . . . 38.280000000000001 103.409 167.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1196 ' ' THR . . . . . . . . . . . . . 4.7 m -65.48 -47.17 76.97 Favored 'General case' 0 N--CA 1.427 -1.611 0 C-N-CA 125.38 1.472 . . . . 40.619999999999997 108.203 171.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1197 ' ' ARG . . . . . 0.421 HH11 ' HD2' ' B' 1197 ' ' ARG . 12.2 mtm180 -75.43 130.56 79.45 Favored Pre-proline 0 C--N 1.345 0.387 0 C-N-CA 124.14 0.976 . . . . 53.090000000000003 109.929 -171.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -58.01 -34.58 98.57 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.892 2.395 . . . . 42.560000000000002 117.522 -172.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1199 ' ' GLU . . . . . 0.706 ' HB2' ' NH2' ' C' ' 74' ' ' ARG . 0.0 OUTLIER -66.19 -35.83 81.48 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.539 -1.351 . . . . 56.310000000000002 113.252 -150.331 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B 1200 ' ' VAL . . . . . 0.494 HG12 HD21 ' B' 1178 ' ' LEU . 17.0 m -59.48 -22.36 22.81 Favored 'Isoleucine or valine' 0 C--O 1.249 1.076 0 CA-C-N 112.699 -2.046 . . . . 42.909999999999997 113.44 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 51.8 tttm -52.66 -45.94 66.95 Favored 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 124.665 1.186 . . . . 48.890000000000001 113.744 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -65.94 -31.17 71.93 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.823 0.82 . . . . 51.700000000000003 112.815 -176.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1203 ' ' GLN . . . . . 0.431 ' OE1' HD22 ' B' 1178 ' ' LEU . 23.8 tt0 -61.37 -48.76 79.8 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.945 -1.131 . . . . 52.57 107.945 172.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1204 ' ' VAL . . . . . 0.453 HG23 ' O ' ' B' 1200 ' ' VAL . 18.9 t -72.87 -33.91 44.96 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.222 0 CA-C-O 125.358 2.504 . . . . 33.789999999999999 110.606 -167.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -57.38 -52.25 66.11 Favored 'General case' 0 C--O 1.256 1.435 0 CA-C-N 112.997 -1.911 . . . . 36.579999999999998 110.47 168.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1206 ' ' SER . . . . . . . . . . . . . 17.7 m -62.62 -25.39 68.08 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 121.864 2.12 . . . . 39.609999999999999 112.135 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1207 ' ' MET . . . . . . . . . . . . . 20.4 mtp -75.04 -21.21 59.2 Favored 'General case' 0 C--N 1.359 0.988 0 N-CA-C 116.348 1.981 . . . . 37.450000000000003 116.348 172.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 74.7 52.76 6.94 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-O 125.354 2.641 . . . . 31.870000000000001 110.54 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -148.22 151.74 36.01 Favored 'General case' 0 C--O 1.25 1.118 0 N-CA-C 103.382 -2.821 . . . . 35.399999999999999 103.382 -173.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -89.61 126.71 35.72 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 119.602 1.092 . . . . 47.890000000000001 113.548 -169.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 59.4 t80 -85.52 115.96 23.54 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 103.501 -2.777 . . . . 45.530000000000001 103.501 169.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1212 ' ' LEU . . . . . 0.516 HD21 ' HD2' ' B' 1192 ' ' ARG . 97.3 mt -70.27 93.31 0.83 Allowed 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 114.57 -1.196 . . . . 46.329999999999998 108.163 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -76.31 150.85 36.87 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 122.61 1.195 . . . . 60.409999999999997 111.23 172.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1214 ' ' LEU . . . . . 0.409 HD11 ' HE1' ' B' 1234 ' ' PHE . 97.2 mt -70.7 144.64 50.94 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 110.53 -3.032 . . . . 57.380000000000003 112.548 174.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 36.3 t0 . . . . . 0 N--CA 1.425 -1.68 0 O-C-N 125.445 1.716 . . . . 65.069999999999993 107.678 173.934 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B 1230 ' ' MET . . . . . . . . . . . . . 15.2 mmt . . . . . 0 N--CA 1.442 -0.836 0 N-CA-C 103.197 -2.89 . . . . 80.319999999999993 103.197 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B 1231 ' ' SER . . . . . . . . . . . . 0.324 66.8 m 75.53 132.8 0.05 OUTLIER 'General case' 0 C--O 1.212 -0.912 2 CA-C-N 129.98 5.809 . . . . 79.920000000000002 121.428 -0.032 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -70.29 -158.81 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.188 0 O-C-N 125.307 1.63 . . . . 77.909999999999997 111.096 -176.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 68.71 -52.9 0.56 Allowed 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 126.043 1.737 . . . . 73.879999999999995 110.969 -160.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1234 ' ' PHE . . . . . 0.409 ' HE1' HD11 ' B' 1214 ' ' LEU . 10.9 t80 -39.77 -51.57 2.36 Favored 'General case' 0 CA--C 1.5 -0.965 0 C-N-CA 127.96 2.504 . . . . 68.980000000000004 110.937 162.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 46.9 pt -52.4 -25.8 8.16 Favored 'Isoleucine or valine' 0 C--O 1.248 1.01 0 N-CA-C 115.84 1.793 . . . . 64.530000000000001 115.84 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -77.97 -48.31 16.54 Favored 'General case' 0 CA--C 1.511 -0.529 0 O-C-N 119.883 -1.761 . . . . 66.359999999999999 110.064 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -60.09 -36.15 76.76 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 123.978 0.911 . . . . 56.600000000000001 109.832 177.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -59.08 -62.11 2.13 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.259 -1.015 . . . . 56.789999999999999 108.259 171.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1239 ' ' MET . . . . . . . . . . . . . 20.3 mmt -59.26 -34.3 72.07 Favored 'General case' 0 C--O 1.222 -0.392 0 O-C-N 119.41 -2.056 . . . . 53.630000000000003 114.356 -173.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -46.33 -54.34 9.16 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 113.871 1.063 . . . . 51.740000000000002 113.871 168.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 48.8 tp -68.24 -49.16 62.56 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 112.488 -2.142 . . . . 44.859999999999999 106.38 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -64.95 -44.22 90.12 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 119.494 -2.004 . . . . 42.780000000000001 111.644 -172.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -65.73 -24.05 66.88 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 114.688 1.366 . . . . 40.960000000000001 114.688 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -76.63 -58.04 3.51 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 104.834 -2.284 . . . . 43.060000000000002 104.834 171.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 75.7 mm-40 -53.45 -30.32 40.05 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.901 1.281 . . . . 46.450000000000003 112.195 -173.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -57.67 -35.98 71.29 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.946 1.248 . . . . 41.780000000000001 113.003 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 31.4 tptt -67.04 -23.76 65.92 Favored 'General case' 0 C--O 1.241 0.637 0 O-C-N 119.369 -2.082 . . . . 52.200000000000003 113.6 176.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1248 ' ' GLU . . . . . 0.422 ' CD ' HH12 ' B' 1192 ' ' ARG . 20.8 mt-10 -95.12 -44.84 7.47 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 114.179 -1.373 . . . . 53.549999999999997 113.76 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1249 ' ' VAL . . . . . 0.811 HG11 ' HB2' ' B' 1169 ' ' MET . 29.0 m -77.99 143.13 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-O 126.352 2.977 . . . . 34.409999999999997 114.21 -162.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1250 ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -100.05 -37.35 9.02 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 109.066 -3.697 . . . . 33.380000000000003 107.247 -177.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1251 ' ' ILE . . . . . 0.825 HD12 ' HB1' ' B' 1145 ' ' ALA . 37.0 mm -128.98 125.64 63.2 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.755 0 O-C-N 119.789 -1.82 . . . . 29.539999999999999 107.083 176.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1252 ' ' ILE . . . . . 0.484 HG22 ' HB ' ' B' 1254 ' ' THR . 64.8 mt -103.34 109.2 26.27 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.734 0 N-CA-C 103.927 -2.62 . . . . 32.439999999999998 103.927 166.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1253 ' ' VAL . . . . . . . . . . . . . 95.4 t -84.76 82.31 1.86 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.976 0 N-CA-C 103.924 -2.621 . . . . 30.57 103.924 169.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1254 ' ' THR . . . . . 0.484 ' HB ' HG22 ' B' 1252 ' ' ILE 0.283 2.8 t -84.13 91.16 7.62 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-O 127.243 3.402 . . . . 35.039999999999999 110.037 -179.618 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B 1255 ' ' THR . . . . . 0.596 ' HA ' ' HB2' ' B' 1284 ' ' LEU . 27.1 m -85.45 -71.24 0.54 Allowed 'General case' 0 C--O 1.242 0.703 0 CA-C-N 110.001 -3.272 . . . . 34.619999999999997 108.136 -175.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . 44.1 24.74 0.09 Allowed 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 120.973 3.694 . . . . 42.719999999999999 120.973 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 39.3 mt -66.2 112.25 3.85 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-O 123.255 1.502 . . . . 52.43 110.576 -172.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 55.6 mt -91.92 109.01 34.28 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 105.066 -2.198 . . . . 59.409999999999997 105.066 175.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -56.3 97.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 123.441 2.761 . . . . 62.68 114.864 -175.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 68.61 47.92 53.46 Favored Glycine 0 N--CA 1.466 0.652 0 N-CA-C 109.353 -1.499 . . . . 64.159999999999997 109.353 174.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 55.5 tttt -155.76 149.1 18.56 Favored Pre-proline 0 C--O 1.248 1.019 0 N-CA-C 102.258 -3.238 . . . . 68.530000000000001 102.258 168.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.53 132.22 37.09 Favored 'Trans proline' 0 C--N 1.364 1.376 0 C-N-CA 124.746 3.631 . . . . 61.990000000000002 112.765 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1263 ' ' ALA . . . . . . . . . . . . . . . -71.69 143.08 86.72 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-N 112.933 -1.94 . . . . 57.149999999999999 112.201 175.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -73.08 147.87 43.71 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 124.156 3.237 . . . . 51.57 116.003 -176.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -71.46 82.63 0.8 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 118.567 -2.583 . . . . 54.549999999999997 109.58 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 84.9 mt -71.3 -64.4 0.92 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.103 -1.408 . . . . 46.859999999999999 113.946 178.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1267 ' ' ILE . . . . . 0.704 HG21 HD13 ' B' 1281 ' ' ILE . 26.5 mm -87.66 89.66 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 107.389 -1.337 . . . . 41.039999999999999 107.389 -170.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1268 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.86 150.64 47.56 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 111.504 -2.589 . . . . 39.579999999999998 116.51 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1269 ' ' ARG . . . . . 0.513 ' HG3' ' HB2' ' B' 1293 ' ' GLU . 44.3 mtt85 -54.28 -44.27 71.76 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 114.516 1.302 . . . . 53.149999999999999 114.516 -169.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -57.53 -44.6 85.23 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.261 0.624 . . . . 42.960000000000001 112.551 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1271 ' ' MET . . . . . . . . . . . . . 30.1 ttm -58.91 -52.2 66.78 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 125.687 1.867 . . . . 43.890000000000001 109.966 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1272 ' ' VAL . . . . . 0.416 HG22 HG22 ' B' 1267 ' ' ILE . 40.2 t -54.95 -47.09 76.67 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 C-N-CA 124.176 0.99 . . . . 38.369999999999997 108.618 -177.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.99 -26.7 67.78 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 115.634 1.716 . . . . 47.460000000000001 115.634 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1274 ' ' SER . . . . . . . . . . . . . 3.2 p -92.42 -6.39 50.08 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 114.53 1.307 . . . . 38.380000000000003 114.53 174.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1275 ' ' MET . . . . . . . . . . . . . 11.2 ttt -67.02 159.72 28.06 Favored 'General case' 0 C--O 1.24 0.586 0 O-C-N 121.22 -0.925 . . . . 37.810000000000002 112.56 -176.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 83.1 tttt -55.62 147.98 17.01 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 124.627 1.171 . . . . 49.259999999999998 113.059 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1277 ' ' ALA . . . . . 0.62 ' HB1' ' HA ' ' A' 1045 ' ' PHE . . . -76.35 150.15 36.89 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 108.195 -1.039 . . . . 34.460000000000001 108.195 -176.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1278 ' ' GLY . . . . . 0.619 ' HA2' ' HB3' ' A' 1044 ' ' SER . . . 68.28 26.59 74.12 Favored Glycine 0 N--CA 1.466 0.657 0 C-N-CA 125.006 1.289 . . . . 33.530000000000001 112.118 173.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1279 ' ' SER . . . . . . . . . . . . . 36.6 m -113.17 156.49 23.14 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 106.198 -1.779 . . . . 31.309999999999999 106.198 -171.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1280 ' ' VAL . . . . . 0.771 HG11 ' HA ' ' B' 1145 ' ' ALA . 52.9 t -115.62 140.04 39.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 O-C-N 119.535 -1.978 . . . . 29.32 109.314 -171.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1281 ' ' ILE . . . . . 0.704 HD13 HG21 ' B' 1267 ' ' ILE . 19.5 mt -109.27 105.18 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 104.953 -2.24 . . . . 31.93 104.953 165.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1282 ' ' VAL . . . . . 0.557 HG11 ' HA ' ' B' 1141 ' ' ALA . 15.8 t -84.35 114.92 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 N-CA-C 101.078 -3.675 . . . . 29.48 101.078 176.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 45.7 t0 -97.98 96.62 8.29 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.208 -1.405 . . . . 34.5 107.208 175.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1284 ' ' LEU . . . . . 0.596 ' HB2' ' HA ' ' B' 1255 ' ' THR . 6.6 mp -68.48 -32.84 73.12 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 113.548 -1.66 . . . . 37.939999999999998 110.727 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -89.03 20.23 3.74 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 125.54 1.775 . . . . 40.920000000000002 112.35 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -48.48 -34.23 10.8 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 120.917 1.69 . . . . 44.390000000000001 115.062 177.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1287 ' ' GLN . . . . . 0.895 ' HB3' HG23 ' B' 1313 ' ' THR . 0.0 OUTLIER -90.56 -20.51 22.54 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 113.165 0.802 . . . . 51.460000000000001 113.165 175.886 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -91.21 -17.16 26.49 Favored 'General case' 0 C--O 1.215 -0.727 0 O-C-N 120.515 -1.366 . . . . 57.75 113.575 -177.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1289 ' ' GLY . . . . . . . . . . . . . . . 173.17 -19.55 0.06 OUTLIER Glycine 0 C--O 1.243 0.699 0 CA-C-O 116.82 -2.1 . . . . 49.850000000000001 112.97 177.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 74.89 88.3 0.23 Allowed Glycine 0 CA--C 1.524 0.65 0 CA-C-N 122.12 2.96 . . . . 45.93 108.806 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1291 ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -71.41 -30.58 66.27 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 123.015 1.388 . . . . 42.670000000000002 113.616 -173.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1292 ' ' CYS . . . . . 0.503 ' HB3' ' OG1' ' B' 1295 ' ' THR . 33.2 t -98.57 145.83 26.43 Favored 'General case' 0 C--O 1.241 0.619 0 O-C-N 121.445 -0.785 . . . . 38.82 109.134 175.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1293 ' ' GLU . . . . . 0.513 ' HB2' ' HG3' ' B' 1269 ' ' ARG . 37.2 mt-10 -73.57 -35.85 65.52 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.463 -0.495 . . . . 46.710000000000001 111.07 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -72.94 -13.64 61.29 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.188 0.81 . . . . 47.229999999999997 113.188 -178.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1295 ' ' THR . . . . . 0.808 HG23 ' HA3' ' B' 1311 ' ' GLY . 98.1 m -53.39 102.39 0.06 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.992 0.738 . . . . 36.020000000000003 112.992 173.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 82.8 t -73.24 113.97 26.99 Favored Pre-proline 0 N--CA 1.429 -1.503 0 N-CA-C 104.298 -2.482 . . . . 37.259999999999998 104.298 158.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -62.01 131.06 33.13 Favored 'Trans proline' 0 CA--C 1.507 -0.868 0 C-N-CA 122.773 2.315 . . . . 35.090000000000003 114.125 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 81.07 8.78 86.99 Favored Glycine 0 CA--C 1.543 1.826 0 CA-C-O 118.174 -1.348 . . . . 35.969999999999999 110.692 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -143.61 172.5 12.72 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 120.82 2.31 . . . . 40.390000000000001 112.075 -173.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1300 ' ' ILE . . . . . 0.493 HG12 HG12 ' B' 1310 ' ' ILE . 67.4 mt -101.11 148.1 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 103.848 -2.649 . . . . 37.43 103.848 170.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 65.3 t80 -123.7 125.21 44.36 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 101.561 -3.496 . . . . 44.130000000000003 101.561 164.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1302 ' ' THR . . . . . . . . . . . . . 90.8 m -98.03 110.72 23.24 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.476 -1.305 . . . . 39.780000000000001 107.476 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1303 ' ' THR . . . . . . . . . . . . . 40.5 p -72.62 162.48 29.43 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 113.515 0.932 . . . . 43.289999999999999 113.515 -174.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -53.7 -37.1 62.91 Favored 'General case' 0 C--N 1.354 0.789 0 O-C-N 120.338 -1.476 . . . . 53.07 112.085 173.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -77.81 12.71 1.6 Allowed 'General case' 0 C--N 1.349 0.555 0 O-C-N 120.192 -1.567 . . . . 43.969999999999999 114.437 174.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 72.13 34.89 61.14 Favored Glycine 0 CA--C 1.546 1.997 0 C-N-CA 119.078 -1.534 . . . . 41.119999999999997 111.879 173.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1307 ' ' VAL . . . . . . . . . . . . . 68.0 t -104.87 133.68 48.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 116.723 -3.81 . . . . 38.119999999999997 102.381 175.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1308 ' ' LYS . . . . . 0.651 ' HB2' HG22 ' B' 1280 ' ' VAL . 41.7 mmtt -97.68 97.71 9.25 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 105.938 -1.875 . . . . 36.340000000000003 105.938 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1309 ' ' VAL . . . . . 0.414 HG22 HD12 ' B' 1281 ' ' ILE . 21.8 t -85.62 92.22 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 N-CA-C 106.68 -1.6 . . . . 30.399999999999999 106.68 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1310 ' ' ILE . . . . . 0.733 HD11 ' HB2' ' B' 1148 ' ' GLU . 56.8 mt -89.45 87.51 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 C-N-CA 124.615 1.166 . . . . 30.82 111.378 -177.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1311 ' ' GLY . . . . . 0.808 ' HA3' HG23 ' B' 1295 ' ' THR . . . -94.48 62.44 1.71 Allowed Glycine 0 C--O 1.245 0.839 0 N-CA-C 110.825 -0.91 . . . . 26.530000000000001 110.825 -178.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1312 ' ' TYR . . . . . 0.497 ' O ' ' HG ' ' B' 1315 ' ' LEU . 5.5 m-85 -83.0 99.27 9.73 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 124.02 1.866 . . . . 38.0 111.732 -176.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1313 ' ' THR . . . . . 0.895 HG23 ' HB3' ' B' 1287 ' ' GLN . 26.9 m -51.76 -37.87 53.1 Favored 'General case' 0 C--O 1.255 1.365 0 C-N-CA 126.006 1.722 . . . . 29.800000000000001 113.226 170.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -81.09 17.57 1.22 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 116.292 1.96 . . . . 39.039999999999999 116.292 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1315 ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' B' 1312 ' ' TYR . 42.9 mt -45.51 -46.76 36.27 Favored Pre-proline 0 C--O 1.254 1.323 0 N-CA-C 117.214 2.301 . . . . 31.079999999999998 117.214 174.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1316 ' ' PRO . . . . . 0.417 ' HA ' ' CG2' ' B' 1136 ' ' ILE . 52.5 Cg_exo -61.5 -33.03 88.55 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.244 2.629 . . . . 26.100000000000001 115.19 167.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -70.51 -40.69 67.49 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 118.447 -1.835 . . . . 23.170000000000002 112.608 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1318 ' ' ARG . . . . . 0.415 ' HD3' ' OE2' ' B' 1144 ' ' GLU . 94.0 mtt-85 -60.84 -2.74 0.6 Allowed 'General case' 0 C--O 1.246 0.894 0 N-CA-C 118.384 2.735 . . . . 40.399999999999999 118.384 -174.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1319 ' ' LEU . . . . . 0.468 HD23 HG23 ' B' 1136 ' ' ILE . 3.3 tp -120.52 58.41 6.26 Favored Pre-proline 0 C--N 1.327 -0.38 0 O-C-N 118.843 -2.411 . . . . 23.600000000000001 107.003 -176.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1320 ' ' PRO . . . . . 0.775 ' HB2' ' HA ' ' B' 1043 ' ' ALA . 84.9 Cg_endo -54.19 -60.93 0.49 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 124.429 3.419 . . . . 22.350000000000001 117.588 -152.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1321 ' ' THR . . . . . 0.479 ' OG1' ' HA3' ' A' 1150 ' ' GLY . 1.3 m -57.03 -49.81 74.67 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.504 1.502 . . . . 26.52 111.375 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1322 ' ' GLN . . . . . 0.962 ' HB2' ' HA ' ' A' 1151 ' ' ARG . 39.1 tp60 -73.26 -33.81 65.47 Favored 'General case' 0 N--CA 1.435 -1.223 0 O-C-N 122.15 -0.344 . . . . 24.379999999999999 110.903 -172.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1323 ' ' SER . . . . . . . . . . . . . 68.3 m -57.84 -46.57 84.56 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 123.702 0.801 . . . . 22.800000000000001 112.488 165.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1324 ' ' SER . . . . . . . . . . . . . 15.7 m -69.48 -30.74 68.69 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 120.24 -1.538 . . . . 21.25 110.416 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -73.64 -36.54 65.43 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 121.093 1.77 . . . . 31.34 108.692 176.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1326 ' ' LEU . . . . . 0.66 ' HB3' ' HB3' ' B' 1132 ' ' SER . 11.3 mt -70.92 -58.21 3.81 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.871 1.669 . . . . 31.559999999999999 108.346 -175.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1327 ' ' TYR . . . . . 0.493 ' O ' ' HB2' ' B' 1330 ' ' ASN . 12.4 t80 -52.63 -45.25 66.55 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 125.44 1.496 . . . . 22.73 110.747 173.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1328 ' ' GLY . . . . . 0.563 ' O ' HG23 ' B' 1332 ' ' VAL . . . -51.87 -50.98 41.97 Favored Glycine 0 C--O 1.249 1.08 0 CA-C-O 118.951 -0.916 . . . . 21.91 111.552 170.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1329 ' ' THR . . . . . . . . . . . . . 8.5 m -66.87 -28.62 68.48 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 121.4 2.6 . . . . 22.149999999999999 109.377 -177.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1330 ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' B' 1327 ' ' TYR . 10.1 m120 -60.86 -50.17 74.5 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.312 -0.868 . . . . 26.18 110.649 174.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1331 ' ' LEU . . . . . 0.706 HD22 HD22 ' B' 1070 ' ' LEU . 18.7 mt -60.22 -36.76 78.42 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 126.904 2.081 . . . . 23.68 112.123 174.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1332 ' ' VAL . . . . . 0.563 HG23 ' O ' ' B' 1328 ' ' GLY . 20.9 t -65.15 -48.7 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 N-CA-C 107.301 -1.37 . . . . 26.57 107.301 175.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1333 ' ' ASN . . . . . 0.676 ' HA ' ' HD2' ' B' 1336 ' ' LYS . 62.8 m-20 -59.63 -47.75 84.38 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 109.641 -0.503 . . . . 28.079999999999998 109.641 -174.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1334 ' ' LEU . . . . . 0.691 HD21 ' SD ' ' B' 1113 ' ' MET . 6.1 tt -56.25 -50.82 70.24 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 113.486 0.921 . . . . 27.43 113.486 170.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1335 ' ' LEU . . . . . 0.443 HD11 HD21 ' B' 1070 ' ' LEU . 93.0 mt -64.88 -16.89 63.78 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 114.96 1.466 . . . . 30.5 114.96 177.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1336 ' ' LYS . . . . . 0.676 ' HD2' ' HA ' ' B' 1333 ' ' ASN . 86.8 mttt -72.6 -46.28 55.01 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 120.256 1.389 . . . . 41.649999999999999 107.292 170.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 11.6 tp -64.63 -32.88 74.74 Favored 'General case' 0 N--CA 1.441 -0.91 0 O-C-N 120.329 -1.482 . . . . 42.079999999999998 110.731 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1338 ' ' LEU . . . . . 0.683 HD13 HG23 ' B' 1346 ' ' ILE . 24.2 mt -73.2 -47.01 47.07 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 118.896 -0.573 . . . . 35.030000000000001 110.289 168.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1339 ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' B' 1344 ' ' GLY . 0.5 OUTLIER -88.3 81.95 7.17 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 121.522 1.964 . . . . 37.329999999999998 109.328 -175.171 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -27.56 66.85 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.7 -1.136 . . . . 50.509999999999998 112.207 -160.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -117.14 18.18 14.62 Favored 'General case' 0 C--O 1.242 0.703 0 O-C-N 123.949 0.781 . . . . 54.210000000000001 110.831 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1342 ' ' LYS . . . . . 0.489 ' HG2' HD23 ' B' 1029 ' ' LEU . 49.0 mttp 49.09 59.42 4.47 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 124.572 2.129 . . . . 50.990000000000002 109.303 -166.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -127.67 31.58 5.13 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 111.683 -2.508 . . . . 48.82 111.083 -165.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1344 ' ' GLY . . . . . 0.528 ' N ' ' SG ' ' B' 1339 ' ' CYS . . . 47.3 24.07 2.19 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 116.912 1.525 . . . . 40.43 116.912 175.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 40.0 t30 -127.28 151.12 49.15 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.775 -1.194 . . . . 47.560000000000002 107.775 -169.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1346 ' ' ILE . . . . . 0.683 HG23 HD13 ' B' 1338 ' ' LEU . 32.9 mm -100.24 86.65 1.26 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 105.012 -2.218 . . . . 42.490000000000002 105.012 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1347 ' ' THR . . . . . . . . . . . . . 33.2 p -87.34 102.48 14.56 Favored 'General case' 0 C--O 1.241 0.632 0 O-C-N 118.157 -2.839 . . . . 38.119999999999997 109.839 164.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1348 ' ' VAL . . . . . 0.595 HG23 HG22 ' B' 1346 ' ' ILE . 61.0 t -90.84 111.89 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 107.094 -1.447 . . . . 37.5 107.094 -177.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 23.6 t70 -97.69 127.92 44.0 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 106.051 -1.833 . . . . 43.850000000000001 106.051 172.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1350 ' ' PHE . . . . . 0.434 ' CE1' ' HB ' ' B' 1359 ' ' THR . 0.3 OUTLIER -97.62 -0.12 46.27 Favored 'General case' 0 C--O 1.257 1.476 0 O-C-N 119.92 -1.737 . . . . 39.810000000000002 114.016 175.356 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -73.17 -37.21 66.63 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 121.441 1.928 . . . . 51.289999999999999 109.122 176.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 22.1 t0 -54.66 118.3 4.09 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 119.754 -0.779 . . . . 39.780000000000001 110.754 167.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1353 ' ' VAL . . . . . 0.41 ' HA ' ' HB3' ' B' 1356 ' ' ARG . 33.9 m -55.93 -31.18 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 O-C-N 123.868 0.73 . . . . 39.280000000000001 112.843 176.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1354 ' ' VAL . . . . . 0.462 ' O ' HG12 ' B' 1358 ' ' VAL . 83.7 t -70.37 -51.73 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 N-CA-C 106.637 -1.616 . . . . 35.700000000000003 106.637 -177.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1355 ' ' ILE . . . . . 0.6 ' HA ' HG12 ' B' 1358 ' ' VAL . 50.4 mm -62.27 -46.02 97.4 Favored 'Isoleucine or valine' 0 C--N 1.359 0.99 0 CA-C-N 121.82 2.1 . . . . 35.770000000000003 113.464 173.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1356 ' ' ARG . . . . . 0.41 ' HB3' ' HA ' ' B' 1353 ' ' VAL . 49.5 tpt85 -49.73 -33.63 16.7 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 114.505 1.298 . . . . 38.549999999999997 114.505 171.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -83.71 -54.16 3.17 Favored Glycine 0 C--N 1.343 0.963 0 N-CA-C 109.454 -1.458 . . . . 29.579999999999998 109.454 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1358 ' ' VAL . . . . . 0.6 HG12 ' HA ' ' B' 1355 ' ' ILE . 14.8 p -62.95 -42.54 96.98 Favored 'Isoleucine or valine' 0 C--O 1.256 1.413 0 CA-C-O 121.916 0.865 . . . . 32.060000000000002 112.531 -173.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1359 ' ' THR . . . . . 0.434 ' HB ' ' CE1' ' B' 1350 ' ' PHE . 3.6 m -83.83 81.96 8.54 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 124.13 1.919 . . . . 29.0 109.42 -174.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1360 ' ' VAL . . . . . . . . . . . . . 10.0 m -71.23 -16.98 19.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 113.022 -1.899 . . . . 29.68 113.907 -173.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 57.7 mt -134.98 110.22 12.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 N-CA-C 107.041 -1.466 . . . . 32.049999999999997 107.041 170.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1362 ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -98.74 110.43 23.03 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 104.99 -2.226 . . . . 32.520000000000003 104.99 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 48.26 60.77 3.39 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 112.922 -1.944 . . . . 35.68 113.528 172.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 83.58 -46.24 3.61 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 115.495 0.958 . . . . 34.259999999999998 115.495 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -64.62 124.56 22.21 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 119.277 -0.969 . . . . 51.07 111.802 172.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 69.7 mt -78.47 118.08 25.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 N-CA-C 103.265 -2.865 . . . . 39.869999999999997 103.265 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1367 ' ' THR . . . . . . . . . . . . . 1.4 p -107.03 11.57 29.56 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 113.883 -1.508 . . . . 38.009999999999998 112.039 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1368 ' ' TRP . . . . . . . . . . . . . 20.7 t90 -82.74 131.96 53.08 Favored Pre-proline 0 C--O 1.241 0.657 0 N-CA-C 103.531 -2.766 . . . . 42.140000000000001 103.531 164.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -82.23 171.89 53.15 Favored 'Cis proline' 0 C--N 1.353 0.812 0 N-CA-C 116.805 1.81 . . . . 43.259999999999998 116.805 -2.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1370 ' ' ALA . . . . . 0.408 ' HA ' ' HD2' ' B' 1371 ' ' PRO . . . -113.74 130.14 24.07 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 105.712 -1.958 . . . . 46.520000000000003 105.712 173.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1371 ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' B' 1370 ' ' ALA . 37.8 Cg_endo -62.73 106.36 0.51 Allowed 'Trans proline' 0 CA--C 1.552 1.419 0 C-N-CA 123.384 2.723 . . . . 51.950000000000003 108.671 173.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -65.66 140.56 62.68 Favored 'Trans proline' 0 N--CA 1.441 -1.579 0 C-N-CA 123.584 2.856 . . . . 56.270000000000003 119.118 -170.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1373 ' ' ILE . . . . . 0.466 HD13 HD13 ' B' 1121 ' ' ILE . 14.9 tt -74.61 145.67 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 113.902 -1.499 . . . . 60.829999999999998 108.02 170.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -65.83 108.9 2.29 Favored 'General case' 0 C--N 1.317 -0.845 0 O-C-N 120.91 -1.119 . . . . 66.099999999999994 110.054 176.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1375 ' ' VAL . . . . . 0.752 HG11 ' HB2' ' B' 1120 ' ' ARG . 76.9 t -102.01 108.86 24.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 106.082 -1.822 . . . . 63.469999999999999 106.082 -169.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.23 -4.619 0 O-C-N 120.601 -1.312 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 20' ' ' ALA . . . . . 0.585 ' HA ' HD21 ' C' ' 171' ' ' LEU . . . . . . . . 0 C--O 1.253 1.274 0 CA-C-O 121.637 0.732 . . . . 0.0 112.4 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -58.09 -28.01 64.21 Favored 'General case' 0 C--O 1.251 1.162 0 O-C-N 119.141 -2.225 . . . . 0.0 114.1 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -66.08 -53.25 40.47 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 176.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 23' ' ' THR . . . . . 0.464 ' HA ' ' HB2' ' C' ' 26' ' ' LEU . 29.2 m -56.33 -34.11 66.27 Favored 'General case' 0 C--O 1.209 -1.064 0 C-N-CA 126.043 1.737 . . . . 0.0 112.516 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 24' ' ' ALA . . . . . 0.624 ' HB2' HG22 ' C' ' 182' ' ' ILE . . . -62.32 -36.82 83.35 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.59 0.756 . . . . 0.0 112.089 174.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.78 -50.12 16.15 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.917 171.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.464 ' HB2' ' HA ' ' C' ' 23' ' ' THR . 0.2 OUTLIER -52.3 -43.62 64.58 Favored 'General case' 0 C--O 1.213 -0.867 0 C-N-CA 126.239 1.816 . . . . 0.0 113.175 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.558 HD21 HD21 ' C' ' 110' ' ' LEU . 81.1 mt -60.16 -51.23 70.49 Favored 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 118.63 -2.544 . . . . 0.0 115.315 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 28' ' ' LYS . . . . . 0.435 ' HZ2' ' C ' ' C' ' 186' ' ' LEU . 18.5 pttm -67.66 -17.41 64.58 Favored 'General case' 0 CA--C 1.555 1.169 0 O-C-N 121.113 -0.992 . . . . 0.0 110.022 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -75.21 -46.85 31.31 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 119.746 1.157 . . . . 0.0 111.048 164.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 38.9 m -50.28 -35.52 27.53 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 121.229 3.788 . . . . 0.0 121.229 -163.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 31' ' ' HIS . . . . . 0.488 ' HA ' HG12 ' C' ' 62' ' ' ILE 0.4 3.7 p-80 54.32 -38.86 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 119.121 3.008 . . . . 0.0 119.121 -170.477 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 32' ' ' SER . . . . . 0.69 ' HB2' ' HA ' ' C' ' 106' ' ' THR . 17.7 m -123.99 133.61 53.65 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 103.019 -2.956 . . . . 0.0 103.019 169.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 64.3 t -131.7 125.17 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 -174.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.629 HG21 ' HE1' ' C' ' 103' ' ' PHE . 34.4 mm -102.97 128.94 55.43 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 N-CA-C 103.467 -2.79 . . . . 0.0 103.467 172.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 31.8 mt -103.59 117.5 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 172.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 36' ' ' THR . . . . . 0.423 HG21 HG11 ' C' ' 118' ' ' VAL . 93.2 m -111.24 92.42 15.71 Favored Pre-proline 0 C--N 1.347 0.485 0 C-N-CA 124.255 1.022 . . . . 0.0 109.294 176.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 37' ' ' PRO . . . . . 0.853 ' HD2' HG12 ' C' ' 68' ' ' ILE . 90.2 Cg_exo -78.7 154.88 27.09 Favored 'Trans proline' 0 C--O 1.246 0.911 0 C-N-CA 123.614 2.876 . . . . 0.0 112.856 169.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 38' ' ' GLY . . . . . 0.557 ' HA3' ' HA ' ' C' ' 114' ' ' ALA . . . -150.77 -143.78 3.79 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 109.766 -3.379 . . . . 0.0 105.096 174.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -61.34 -34.49 75.36 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 117.393 -1.289 . . . . 0.0 113.449 -168.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 40' ' ' GLY . . . . . 0.474 ' HA3' ' HA3' ' C' ' 113' ' ' GLY . . . -57.08 -32.55 63.01 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-O 116.528 -2.262 . . . . 0.0 112.474 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 32.8 ttm -75.82 -26.13 56.94 Favored 'General case' 0 C--O 1.253 1.266 0 CA-C-N 119.556 1.678 . . . . 0.0 111.294 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.68 -38.82 58.39 Favored 'General case' 0 C--O 1.221 -0.443 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.274 175.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 59.9 t -74.95 -66.08 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 O-C-N 121.215 -0.928 . . . . 0.0 110.495 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 44' ' ' ALA . . . . . 0.485 ' HB3' ' HB3' ' C' ' 175' ' ' ALA . . . -91.04 113.51 25.79 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 174.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 45' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -72.0 79.5 0.92 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 124.514 2.102 . . . . 0.0 110.265 -169.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.41 -6.13 22.92 Favored 'General case' 0 C--O 1.239 0.534 0 O-C-N 120.332 -1.48 . . . . 0.0 112.974 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 47' ' ' GLN . . . . . 0.656 ' HG2' ' HB3' ' C' ' 82' ' ' LEU . 0.0 OUTLIER -76.21 -41.81 48.19 Favored 'General case' 0 C--O 1.249 1.05 0 O-C-N 120.155 -1.591 . . . . 0.0 114.235 -159.766 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 48' ' ' TYR . . . . . 0.524 ' CZ ' ' HA ' ' C' ' 86' ' ' ALA . 61.6 m-85 -61.34 -43.74 90.63 Favored Pre-proline 0 CA--C 1.55 0.971 0 O-C-N 119.964 -1.71 . . . . 0.0 113.352 168.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 49' ' ' PRO . . . . . 0.42 ' HA ' ' HB2' ' C' ' 52' ' ' GLU . 11.6 Cg_exo -54.34 -41.44 76.44 Favored 'Trans proline' 0 C--N 1.351 0.696 0 CA-C-N 124.069 2.489 . . . . 0.0 116.536 165.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 48.6 t -60.87 -41.58 89.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 O-C-N 119.971 -1.706 . . . . 0.0 112.509 175.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 51' ' ' ALA . . . . . 0.449 ' HB2' HG22 ' C' ' 88' ' ' VAL . . . -63.08 -33.72 76.05 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 171.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 52' ' ' GLU . . . . . 0.636 ' HB3' ' HB2' ' C' ' 183' ' ' LEU . 1.5 mm-40 -67.09 -39.41 86.76 Favored 'General case' 0 C--N 1.351 0.638 0 CA-C-O 118.284 -0.865 . . . . 0.0 113.277 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 10.2 tp -76.04 -37.27 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.718 0 CA-C-N 119.775 1.171 . . . . 0.0 110.429 175.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 26.1 m -64.78 -37.53 87.91 Favored 'General case' 0 C--O 1.244 0.814 0 O-C-N 120.219 -1.55 . . . . 0.0 112.889 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 55' ' ' GLU . . . . . 0.447 ' HB3' ' O ' ' C' ' 52' ' ' GLU . 8.1 tp10 -34.12 -43.36 0.15 Allowed 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 126.808 2.043 . . . . 0.0 112.858 159.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -87.95 -44.57 10.93 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 120.254 1.388 . . . . 0.0 109.92 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 74.8 mt -62.91 -48.74 77.65 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 121.017 -1.052 . . . . 0.0 111.309 -167.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -72.38 -34.51 68.0 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 121.334 1.879 . . . . 0.0 108.901 -171.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.28 -19.42 54.87 Favored 'General case' 0 C--N 1.345 0.384 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 166.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 60' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' C' ' 60' ' ' ARG . 28.8 ttm-85 -94.35 14.14 21.4 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-O 120.96 0.409 . . . . 0.0 110.557 173.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.48 22.89 66.2 Favored Glycine 0 C--O 1.24 0.52 0 O-C-N 120.647 -1.283 . . . . 0.0 114.425 -177.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 62' ' ' ILE . . . . . 0.488 HG12 ' HA ' ' C' ' 31' ' ' HIS . 15.0 mt -76.66 119.93 25.9 Favored 'Isoleucine or valine' 0 C--O 1.254 1.298 0 CA-C-O 122.062 0.934 . . . . 0.0 113.191 177.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 63' ' ' ASN . . . . . 0.433 ' O ' ' HA ' ' C' ' 32' ' ' SER . 12.0 t30 -63.23 84.66 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.561 0 CA-C-O 123.935 1.826 . . . . 0.0 106.285 171.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.478 ' O ' HD12 ' C' ' 92' ' ' ILE . 9.2 p -100.51 135.08 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 5.1 mmm-85 -137.84 140.06 40.26 Favored 'General case' 0 C--O 1.253 1.281 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 66' ' ' PHE . . . . . 0.601 ' HB2' HG22 ' C' ' 93' ' ' VAL . 33.4 m-85 -101.44 84.05 2.54 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -176.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.95 69.42 2.68 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.399 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 68' ' ' ILE . . . . . 0.853 HG12 ' HD2' ' C' ' 37' ' ' PRO . 10.1 mt -70.07 142.3 16.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 120.763 -1.433 . . . . 0.0 112.772 -174.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 69' ' ' HIS . . . . . 0.426 ' HA ' ' HD3' ' C' ' 70' ' ' PRO . 20.5 t-80 -114.66 89.59 19.17 Favored Pre-proline 0 N--CA 1.475 0.794 0 O-C-N 120.277 -1.514 . . . . 0.0 107.054 176.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 70' ' ' PRO . . . . . 0.718 ' HG2' HG12 ' A' 1157 ' ' ILE . 51.2 Cg_exo -61.84 -53.09 2.36 Favored 'Trans proline' 0 CA--C 1.513 -0.575 1 C-N-CA 125.504 4.136 . . . . 0.0 117.919 -163.126 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 71' ' ' VAL . . . . . 0.417 HG21 ' HB2' ' A' 1159 ' ' ALA . 51.8 t -67.26 104.79 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 168.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -171.89 119.26 0.43 Allowed 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 113.121 -1.854 . . . . 0.0 106.374 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.87 -97.82 2.08 Favored Glycine 0 C--O 1.213 -1.161 0 O-C-N 120.209 -1.557 . . . . 0.0 112.115 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 74' ' ' ARG . . . . . 0.706 ' NH2' ' HB2' ' B' 1199 ' ' GLU . 1.9 mpt_? -149.17 171.22 16.8 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 103.384 -2.821 . . . . 0.0 103.384 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.513 ' HA ' ' HD2' ' C' ' 76' ' ' PRO 0.268 33.0 mt 60.43 103.59 0.03 OUTLIER Pre-proline 0 C--O 1.236 0.385 0 N-CA-C 117.21 2.3 . . . . 0.0 117.21 -175.769 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 76' ' ' PRO . . . . . 0.513 ' HD2' ' HA ' ' C' ' 75' ' ' LEU . 72.9 Cg_endo -63.53 90.16 0.15 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.891 2.394 . . . . 0.0 112.137 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.08 -7.64 62.87 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-O 116.125 -2.486 . . . . 0.0 115.507 175.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -51.29 -28.01 10.88 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 123.733 3.766 . . . . 0.0 119.592 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 79' ' ' MET . . . . . 0.716 ' HA ' HD12 ' C' ' 82' ' ' LEU . 0.7 OUTLIER -58.52 -32.27 68.69 Favored 'General case' 0 C--O 1.243 0.757 0 O-C-N 118.925 -2.359 . . . . 0.0 113.748 169.63 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -66.88 -37.79 85.07 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 122.586 0.354 . . . . 0.0 111.054 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' 1155 ' ' GLY . 92.9 t -68.74 -42.76 83.12 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.718 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.383 -175.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.716 HD12 ' HA ' ' C' ' 79' ' ' MET . 34.9 mt -53.56 -41.55 66.59 Favored 'General case' 0 C--N 1.35 0.619 0 C-N-CA 125.319 1.448 . . . . 0.0 113.144 170.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 21.4 tp -65.24 -46.4 80.74 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.181 0.991 . . . . 0.0 110.379 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.44 -35.26 77.08 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-O 118.107 -0.949 . . . . 0.0 112.38 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -64.51 -43.88 92.67 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.597 0.561 . . . . 0.0 112.283 173.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 86' ' ' ALA . . . . . 0.524 ' HA ' ' CZ ' ' C' ' 48' ' ' TYR . . . -54.35 -3.31 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 119.131 3.011 . . . . 0.0 119.131 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 87' ' ' LYS . . . . . 0.429 ' HD3' ' HA ' ' C' ' 87' ' ' LYS . 31.7 mmtp 60.3 65.9 1.02 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 125.278 2.466 . . . . 0.0 112.184 -175.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 88' ' ' VAL . . . . . 0.449 HG22 ' HB2' ' C' ' 51' ' ' ALA . 87.0 t -115.29 149.96 43.65 Favored Pre-proline 0 N--CA 1.481 1.1 0 CA-C-N 108.748 -3.842 . . . . 0.0 104.208 -178.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -55.94 76.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.476 0.47 1 C-N-CA 127.178 5.252 . . . . 0.0 113.823 164.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -60.4 -30.24 69.47 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 113.062 -1.881 . . . . 0.0 107.004 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -39.02 -39.76 0.59 Allowed 'General case' 0 C--N 1.354 0.763 0 CA-C-O 116.359 -1.781 . . . . 0.0 115.436 168.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 92' ' ' ILE . . . . . 0.478 HD12 ' O ' ' C' ' 64' ' ' VAL . 2.3 pt -107.52 24.92 2.59 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 CA-C-O 124.034 1.873 . . . . 0.0 111.881 -176.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 93' ' ' VAL . . . . . 0.601 HG22 ' HB2' ' C' ' 66' ' ' PHE . 53.4 t -87.52 128.68 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 O-C-N 120.623 -1.298 . . . . 0.0 109.304 174.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 94' ' ' LEU . . . . . 0.59 HD23 ' HB3' ' C' ' 97' ' ' ASP . 4.7 mp -117.36 83.45 1.99 Allowed 'General case' 0 C--O 1.259 1.58 0 CA-C-O 123.644 1.688 . . . . 0.0 110.495 172.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -75.94 111.8 11.7 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 119.876 -1.765 . . . . 0.0 106.729 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.51 ' HA ' HD11 ' C' ' 136' ' ' LEU . 0.9 OUTLIER 68.35 -9.08 0.54 Allowed 'General case' 0 C--O 1.251 1.182 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 173.038 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 97' ' ' ASP . . . . . 0.59 ' HB3' HD23 ' C' ' 94' ' ' LEU . 3.3 t70 -68.09 -177.01 0.78 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 118.109 -0.948 . . . . 0.0 113.089 175.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -77.22 57.84 1.51 Allowed 'General case' 0 C--O 1.24 0.603 0 CA-C-O 125.627 2.632 . . . . 0.0 117.168 -171.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 8.6 tp -77.75 -2.52 4.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 O-C-N 119.174 -2.204 . . . . 0.0 111.334 173.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 100' ' ' ASN . . . . . 0.423 ' HA ' ' CD2' ' C' ' 103' ' ' PHE . 23.1 t-20 -57.79 -45.33 86.18 Favored 'General case' 0 C--N 1.354 0.768 0 O-C-N 121.292 -0.88 . . . . 0.0 113.226 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -57.05 -43.19 81.74 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 122.936 1.35 . . . . 0.0 113.87 174.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -68.42 -24.32 64.73 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.853 -175.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 103' ' ' PHE . . . . . 0.629 ' HE1' HG21 ' C' ' 34' ' ' ILE . 22.0 m-30 -53.67 -43.48 68.89 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 116.078 -1.915 . . . . 0.0 111.23 167.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.7 -45.73 88.69 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 121.128 1.785 . . . . 0.0 111.066 173.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -57.26 -31.41 65.55 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 106' ' ' THR . . . . . 0.69 ' HA ' ' HB2' ' C' ' 32' ' ' SER . 10.2 m -79.11 159.34 27.52 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-N 113.414 -1.721 . . . . 0.0 113.143 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 107' ' ' ASP . . . . . 0.531 ' HA ' ' HB2' ' C' ' 142' ' ' GLN . 1.8 t70 -99.98 -84.76 0.41 Allowed 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 165.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 108' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' C' ' 143' ' ' ASN . 57.2 m -79.01 111.44 15.21 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 125.307 2.48 . . . . 0.0 116.535 178.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 109' ' ' VAL . . . . . 0.774 HG11 HG21 ' C' ' 138' ' ' VAL . 21.0 t -90.3 105.61 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 112.208 -2.269 . . . . 0.0 107.857 174.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 110' ' ' LEU . . . . . 0.558 HD21 HD21 ' C' ' 27' ' ' LEU . 15.4 mt -71.55 87.79 0.91 Allowed 'General case' 0 C--O 1.25 1.125 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 173.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 111' ' ' VAL . . . . . 0.647 ' HB ' ' HA ' ' C' ' 146' ' ' VAL . 89.9 t -82.29 83.07 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 O-C-N 120.277 -1.514 . . . . 0.0 109.862 178.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 112' ' ' ILE . . . . . 0.534 ' HA ' ' HB2' ' C' ' 147' ' ' PHE . 56.0 mt -82.53 92.54 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 123.31 1.528 . . . . 0.0 110.185 -175.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 113' ' ' GLY . . . . . 0.474 ' HA3' ' HA3' ' C' ' 40' ' ' GLY . . . 57.95 29.61 62.32 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 110.513 -3.04 . . . . 0.0 113.681 175.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 114' ' ' ALA . . . . . 0.597 ' HB3' HG13 ' C' ' 111' ' ' VAL . . . -82.66 -28.84 30.41 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 118.485 -1.286 . . . . 0.0 112.322 173.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 115' ' ' ASN . . . . . 0.597 ' ND2' ' H ' ' C' ' 116' ' ' ASP . 6.2 t30 64.93 -163.26 0.26 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 116.377 -1.773 . . . . 0.0 112.564 161.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 116' ' ' ASP . . . . . 0.597 ' H ' ' ND2' ' C' ' 115' ' ' ASN . 1.9 p30 -51.99 -14.48 0.4 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 125.31 3.687 . . . . 0.0 116.881 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 117' ' ' THR . . . . . 0.414 HG22 ' CE1' ' C' ' 69' ' ' HIS . 1.3 m -63.64 -14.07 48.37 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 169.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.564 ' HB ' HG12 ' C' ' 138' ' ' VAL . 21.3 m -106.55 12.96 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 117.242 -3.411 . . . . 0.0 112.871 167.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 119' ' ' ASN . . . . . 0.519 ' HB3' ' HA ' ' C' ' 116' ' ' ASP . 0.1 OUTLIER -102.15 131.81 22.22 Favored Pre-proline 0 N--CA 1.478 0.961 0 O-C-N 118.904 -2.372 . . . . 0.0 114.392 -166.668 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 120' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -50.89 -40.01 58.22 Favored 'Trans proline' 0 C--O 1.242 0.707 0 C-N-CA 123.939 3.093 . . . . 0.0 113.869 -178.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 121' ' ' ALA . . . . . 0.758 ' HA ' ' HB3' ' C' ' 124' ' ' ASP . . . -58.87 -14.28 8.58 Favored 'General case' 0 C--O 1.208 -1.092 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 -167.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 122' ' ' ALA . . . . . 0.614 ' HB3' ' HB2' ' C' ' 133' ' ' MET . . . -58.98 -37.97 78.04 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 119.241 -2.162 . . . . 0.0 112.365 170.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -95.02 -41.38 9.17 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.369 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 124' ' ' ASP . . . . . 0.758 ' HB3' ' HA ' ' C' ' 121' ' ' ALA . 26.4 t70 -67.77 -46.88 70.77 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 124.305 1.042 . . . . 0.0 111.129 -170.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -108.55 94.85 14.74 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 120.272 1.396 . . . . 0.0 109.264 172.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -49.58 -15.43 0.96 Allowed 'Trans proline' 0 C--O 1.257 1.451 1 C-N-CA 125.677 4.251 . . . . 0.0 112.362 172.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -68.06 -32.62 73.09 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 118.654 -2.528 . . . . 0.0 109.177 176.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 128' ' ' SER . . . . . 0.426 ' HA ' ' HD2' ' C' ' 129' ' ' PRO . 44.6 m -53.44 123.01 34.59 Favored Pre-proline 0 N--CA 1.449 -0.501 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 129' ' ' PRO . . . . . 0.558 ' HG2' ' HA ' ' C' ' 156' ' ' ALA . 34.8 Cg_endo -52.18 -39.72 70.78 Favored 'Trans proline' 0 N--CA 1.435 -1.93 1 C-N-CA 125.701 4.267 . . . . 0.0 115.076 -178.858 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 130' ' ' ILE . . . . . 0.722 HG12 ' HB2' ' C' ' 156' ' ' ALA . 28.4 pt -78.11 130.6 36.0 Favored 'Isoleucine or valine' 0 C--O 1.252 1.205 0 CA-C-N 120.615 1.552 . . . . 0.0 110.931 170.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 131' ' ' ALA . . . . . 0.526 ' O ' ' HB ' ' B' 1121 ' ' ILE . . . -108.8 124.95 51.41 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-O 122.698 1.237 . . . . 0.0 113.396 -174.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.03 134.14 2.59 Favored Glycine 0 N--CA 1.474 1.225 0 CA-C-N 113.482 -1.69 . . . . 0.0 112.353 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 133' ' ' MET . . . . . 0.614 ' HB2' ' HB3' ' C' ' 122' ' ' ALA . 34.0 tpp -129.25 131.73 23.85 Favored Pre-proline 0 CA--C 1.506 -0.717 0 N-CA-C 104.932 -2.247 . . . . 0.0 104.932 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 134' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' C' ' 133' ' ' MET . 56.7 Cg_endo -57.54 149.93 63.7 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.748 2.299 . . . . 0.0 113.178 165.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 3.2 m -64.08 5.96 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.052 0 N-CA-C 119.054 2.983 . . . . 0.0 119.054 -168.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 136' ' ' LEU . . . . . 0.51 HD11 ' HA ' ' C' ' 96' ' ' MET . 27.6 mt -80.77 52.49 1.72 Allowed 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 120.193 -1.567 . . . . 0.0 110.199 171.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -82.22 96.37 7.84 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 -177.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 138' ' ' VAL . . . . . 0.774 HG21 HG11 ' C' ' 109' ' ' VAL . 13.4 p -94.12 77.89 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 113.475 -1.693 . . . . 0.0 109.294 -171.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -131.79 165.76 23.07 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 173.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 140' ' ' LYS . . . . . . . . . . . . 0.29 0.8 OUTLIER 61.9 -24.01 0.05 OUTLIER 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 126.708 2.003 . . . . 0.0 113.777 173.79 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -52.51 153.91 2.83 Favored 'General case' 0 C--O 1.252 1.234 0 CA-C-N 123.017 2.644 . . . . 0.0 116.409 163.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 142' ' ' GLN . . . . . 0.531 ' HB2' ' HA ' ' C' ' 107' ' ' ASP . 8.8 mm100 -35.67 -44.69 0.33 Allowed 'General case' 0 C--N 1.354 0.8 0 N-CA-C 120.147 3.388 . . . . 0.0 120.147 -160.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 143' ' ' ASN . . . . . 0.52 ' O ' ' HA ' ' C' ' 108' ' ' THR . 19.2 t-20 -157.56 93.79 1.32 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 122.643 1.211 . . . . 0.0 112.967 162.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 144' ' ' VAL . . . . . 0.572 ' HB ' HG23 ' C' ' 168' ' ' THR . 90.2 t -87.67 104.27 14.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 103.923 -2.621 . . . . 0.0 103.923 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 145' ' ' ILE . . . . . 0.696 HG13 ' HB2' ' C' ' 171' ' ' LEU . 3.7 tp -101.73 104.81 16.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 123.696 1.712 . . . . 0.0 111.748 -177.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 146' ' ' VAL . . . . . 0.647 ' HA ' ' HB ' ' C' ' 111' ' ' VAL . 27.2 t -91.51 98.83 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 O-C-N 119.658 -1.901 . . . . 0.0 109.453 -169.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 147' ' ' PHE . . . . . 0.534 ' HB2' ' HA ' ' C' ' 112' ' ' ILE . 9.3 m-85 -67.95 115.3 7.31 Favored 'General case' 0 C--O 1.249 1.079 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 148' ' ' LYS . . . . . 0.458 ' HB3' ' SD ' ' C' ' 170' ' ' MET . 77.1 tttt -155.5 137.09 14.2 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 149' ' ' ARG . . . . . 0.498 ' HG2' HH11 ' C' ' 149' ' ' ARG . 7.3 tpp85 -48.41 -60.65 2.51 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 110.633 -2.985 . . . . 0.0 113.924 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 8.0 m -133.7 159.75 39.6 Favored 'General case' 0 CA--C 1.552 1.022 0 O-C-N 119.977 -1.702 . . . . 0.0 112.865 -171.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 10.7 tpt -67.51 93.81 0.37 Allowed 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 168.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -155.99 160.38 40.01 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.178 0.991 . . . . 0.0 109.259 -176.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 153' ' ' THR . . . . . 0.593 HG23 ' HA3' ' C' ' 157' ' ' GLY . 8.9 m -62.86 161.33 12.93 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.94 0.896 . . . . 0.0 112.997 175.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 154' ' ' GLY . . . . . 0.574 ' HA3' ' ND2' ' C' ' 115' ' ' ASN . . . -106.8 -92.35 2.26 Favored Glycine 0 CA--C 1.508 -0.382 0 N-CA-C 105.49 -3.044 . . . . 0.0 105.49 153.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -114.92 -20.11 10.68 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 172.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 156' ' ' ALA . . . . . 0.722 ' HB2' HG12 ' C' ' 130' ' ' ILE . . . -103.32 -81.05 0.51 Allowed 'General case' 0 C--N 1.322 -0.614 0 O-C-N 119.121 -2.237 . . . . 0.0 110.703 168.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 157' ' ' GLY . . . . . 0.593 ' HA3' HG23 ' C' ' 153' ' ' THR . . . 88.71 -61.25 3.83 Favored Glycine 0 C--N 1.347 1.139 0 CA-C-N 121.594 1.997 . . . . 0.0 112.064 168.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 34.0 m -37.34 98.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-O 123.951 1.834 . . . . 0.0 115.465 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 35.72 34.62 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 120.515 3.524 . . . . 0.0 120.515 -174.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 160' ' ' ASN . . . . . 0.424 ' HA ' ' HD2' ' C' ' 161' ' ' PRO . 7.5 m120 -70.75 118.65 67.03 Favored Pre-proline 0 C--N 1.347 0.491 0 CA-C-N 113.193 -1.822 . . . . 0.0 111.075 -170.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 161' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' C' ' 160' ' ' ASN . 34.7 Cg_endo -46.64 -25.95 3.99 Favored 'Trans proline' 0 CA--C 1.509 -0.725 1 C-N-CA 126.007 4.471 . . . . 0.0 117.102 -172.66 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 162' ' ' LEU . . . . . 0.464 ' HG ' HG21 ' C' ' 146' ' ' VAL . 13.6 tp -50.71 -39.64 52.16 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 125.338 1.455 . . . . 0.0 113.529 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 163' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -84.6 -23.1 29.75 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 118.887 -1.125 . . . . 0.0 108.688 -172.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -102.67 -34.21 9.14 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 118.246 2.684 . . . . 0.0 118.246 -160.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 165' ' ' LYS . . . . . 0.718 ' HB2' ' HB ' ' C' ' 168' ' ' THR . 63.7 mmtt -57.16 157.57 5.99 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 -175.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.5 -40.14 96.29 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -99.21 -22.98 15.38 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 119.292 0.951 . . . . 0.0 111.894 173.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 168' ' ' THR . . . . . 0.718 ' HB ' ' HB2' ' C' ' 165' ' ' LYS . 89.5 m -101.24 93.91 5.68 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 175.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.91 146.87 36.21 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.07 -1.052 . . . . 0.0 108.73 -171.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 170' ' ' MET . . . . . 0.458 ' SD ' ' HB3' ' C' ' 148' ' ' LYS . 30.8 mtm -62.16 130.49 45.69 Favored 'General case' 0 C--N 1.36 1.056 0 CA-C-O 123.94 1.829 . . . . 0.0 115.123 167.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 171' ' ' LEU . . . . . 0.696 ' HB2' HG13 ' C' ' 145' ' ' ILE . 20.8 tp -92.96 104.25 16.49 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 101.338 -3.578 . . . . 0.0 101.338 167.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 172' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' C' ' 148' ' ' LYS . 97.0 m-85 -72.44 136.32 45.98 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 113.059 -1.882 . . . . 0.0 110.04 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . 128.66 166.64 12.02 Favored Glycine 0 N--CA 1.432 -1.589 0 CA-C-O 124.525 2.18 . . . . 0.0 110.113 -177.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 174' ' ' ASP . . . . . 0.603 ' HB3' ' HB3' ' C' ' 177' ' ' ALA . 16.5 t70 -62.75 149.2 44.54 Favored 'General case' 0 C--O 1.252 1.198 0 CA-C-N 112.197 -2.001 . . . . 0.0 112.902 -177.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 175' ' ' ALA . . . . . 0.493 ' O ' HG23 ' C' ' 179' ' ' VAL . . . -60.93 -53.44 57.27 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 121.421 -0.799 . . . . 0.0 113.02 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -62.49 -62.94 1.4 Allowed 'General case' 0 C--O 1.217 -0.623 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 177' ' ' ALA . . . . . 0.603 ' HB3' ' HB3' ' C' ' 174' ' ' ASP . . . -51.42 -36.38 43.53 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -176.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 14.7 m -68.6 -39.16 81.0 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 173.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 179' ' ' VAL . . . . . 0.493 HG23 ' O ' ' C' ' 175' ' ' ALA . 5.7 t -74.47 -37.23 43.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 124.041 1.877 . . . . 0.0 109.239 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 180' ' ' ASP . . . . . 0.513 ' O ' ' HG ' ' C' ' 183' ' ' LEU . 16.1 t70 -58.89 -40.77 85.46 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-N 114.299 -1.318 . . . . 0.0 110.67 176.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.04 -29.34 69.67 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.611 175.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 182' ' ' ILE . . . . . 0.624 HG22 ' HB2' ' C' ' 24' ' ' ALA . 19.9 pt -101.07 -16.2 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 -178.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 183' ' ' LEU . . . . . 0.636 ' HB2' ' HB3' ' C' ' 52' ' ' GLU 0.265 2.0 pp -48.29 -35.22 11.8 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 118.981 2.956 . . . . 0.0 118.981 -170.522 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -131.85 -21.21 2.46 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.909 171.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -88.23 60.24 5.65 Favored 'General case' 0 C--O 1.243 0.747 0 O-C-N 119.869 -1.77 . . . . 0.0 109.546 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 186' ' ' LEU . . . . . 0.467 HD23 ' H ' ' C' ' 186' ' ' LEU . 1.7 pt? . . . . . 0 N--CA 1.436 -1.16 0 CA-C-O 114.698 -2.573 . . . . 0.0 113.962 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 20.5 t-80 . . . . . 0 CA--C 1.488 -1.441 0 N-CA-C 108.418 -0.956 . . . . 65.739999999999995 108.418 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -72.05 86.71 0.48 Allowed Glycine 0 C--O 1.246 0.866 0 N-CA-C 108.839 -1.704 . . . . 48.659999999999997 108.839 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1002 ' ' ARG . . . . . 0.583 ' HD2' ' HB2' ' A' 1034 ' ' ALA . 50.4 ttp180 -118.85 131.38 56.07 Favored 'General case' 0 C--O 1.255 1.382 0 N-CA-C 105.49 -2.041 . . . . 44.560000000000002 105.49 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1003 ' ' ILE . . . . . 0.591 HD13 HD22 ' A' 1026 ' ' LEU . 96.9 mt -88.74 130.32 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 103.356 -2.831 . . . . 34.859999999999999 103.356 173.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -107.22 123.26 7.2 Favored Glycine 0 C--N 1.316 -0.579 0 N-CA-C 106.398 -2.681 . . . . 30.75 106.398 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.876 HG23 ' HB3' ' A' 1017 ' ' ALA . 39.5 mm -107.56 104.04 51.28 Favored Pre-proline 0 C--O 1.249 1.055 0 N-CA-C 102.832 -3.025 . . . . 32.210000000000001 102.832 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -83.01 161.31 15.74 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.973 2.449 . . . . 32.979999999999997 113.718 171.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1007 ' ' ARG . . . . . 0.426 ' NH2' ' HG2' ' A' 1009 ' ' ARG . 54.0 ttp85 -69.51 149.57 48.1 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 111.094 -2.776 . . . . 47.979999999999997 106.808 161.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1008 ' ' GLU . . . . . 0.477 ' HG2' ' HG2' ' A' 1013 ' ' GLU 0.297 13.9 tp10 -83.17 118.65 23.74 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 116.057 -2.257 . . . . 34.700000000000003 109.392 170.729 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 1009 ' ' ARG . . . . . 0.763 ' NH1' ' HG2' ' A' 1079 ' ' GLU . 14.5 mtp-105 -95.19 -3.91 46.89 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 109.635 -3.439 . . . . 53.369999999999997 112.371 -173.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 65.1 tp -65.24 132.61 49.53 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 105.53 -2.026 . . . . 45.07 105.53 167.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1011 ' ' THR . . . . . . . . . . . . . 5.2 m -55.41 123.01 12.5 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 125.525 1.53 . . . . 40.359999999999999 112.179 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 23.9 m120 58.41 28.92 17.5 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 118.259 2.689 . . . . 40.609999999999999 118.259 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1013 ' ' GLU . . . . . 0.477 ' HG2' ' HG2' ' A' 1008 ' ' GLU . 8.7 tp10 -89.7 147.08 24.07 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.441 -1.688 . . . . 33.759999999999998 106.441 167.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1014 ' ' THR . . . . . 0.512 HG22 ' HB3' ' A' 1320 ' ' PRO . 1.9 m -110.19 -4.54 15.7 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 113.574 0.954 . . . . 27.890000000000001 113.574 -170.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1015 ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -83.18 163.37 20.84 Favored 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 120.251 -1.53 . . . . 29.02 114.746 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1016 ' ' VAL . . . . . . . . . . . . . 12.5 p -121.49 162.06 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 103.782 -2.673 . . . . 28.129999999999999 103.782 159.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1017 ' ' ALA . . . . . 0.876 ' HB3' HG23 ' A' 1005 ' ' ILE . . . -61.09 -42.45 98.54 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 115.962 1.838 . . . . 26.870000000000001 115.962 -178.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -145.45 142.48 29.31 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 122.832 1.301 . . . . 26.77 110.255 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1019 ' ' THR . . . . . . . . . . . . . 8.2 p -84.77 161.19 54.09 Favored Pre-proline 0 N--CA 1.438 -1.071 0 O-C-N 118.877 -2.39 . . . . 27.02 108.468 171.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1020 ' ' PRO . . . . . 0.451 ' HB3' ' HB2' ' A' 1053 ' ' ALA . 0.0 OUTLIER -40.9 -45.31 4.97 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 123.706 2.937 . . . . 30.57 117.009 175.03 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -57.54 -41.05 80.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 123.753 1.739 . . . . 47.810000000000002 113.213 177.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1022 ' ' THR . . . . . 0.444 HG21 ' O ' ' A' 1325 ' ' GLN . 1.1 p -77.73 -32.5 52.85 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 114.191 1.182 . . . . 30.77 114.191 175.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1023 ' ' VAL . . . . . 0.584 ' HA ' HD12 ' A' 1026 ' ' LEU . 80.1 t -54.68 -44.96 72.44 Favored 'Isoleucine or valine' 0 C--N 1.345 0.385 0 O-C-N 121.257 -0.902 . . . . 33.590000000000003 110.815 170.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -48.62 -46.81 40.14 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.268 1.027 . . . . 53.289999999999999 111.184 172.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1025 ' ' GLN . . . . . 0.401 ' HB3' HG11 ' A' 1332 ' ' VAL . 40.6 mt-30 -64.66 -36.4 84.14 Favored 'General case' 0 N--CA 1.436 -1.144 0 O-C-N 123.563 0.54 . . . . 46.920000000000002 110.936 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1026 ' ' LEU . . . . . 0.591 HD22 HD13 ' A' 1003 ' ' ILE . 17.4 mt -66.15 -35.38 80.32 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 117.942 -1.027 . . . . 37.170000000000002 112.591 171.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.81 -43.55 98.03 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.75 1.159 . . . . 44.439999999999998 111.575 173.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 22.9 mmmt -57.7 -36.7 72.34 Favored 'General case' 0 C--O 1.217 -0.648 0 C-N-CA 123.671 0.788 . . . . 52.579999999999998 111.674 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1029 ' ' LEU . . . . . 0.547 HD12 ' HA ' ' A' 1026 ' ' LEU . 90.4 mt -58.48 -11.29 2.77 Favored 'General case' 0 C--O 1.249 1.03 0 N-CA-C 115.721 1.749 . . . . 45.689999999999998 115.721 173.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 88.21 22.91 39.41 Favored Glycine 0 CA--C 1.506 -0.516 0 O-C-N 118.115 -2.866 . . . . 42.090000000000003 112.345 170.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -113.76 162.47 16.26 Favored 'General case' 0 C--O 1.254 1.326 0 N-CA-C 105.905 -1.887 . . . . 40.719999999999999 105.905 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1032 ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -80.2 139.59 36.68 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 119.933 -1.73 . . . . 37.770000000000003 106.704 173.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1033 ' ' VAL . . . . . . . . . . . . . 11.0 t -121.54 127.18 75.57 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 O-C-N 117.803 -3.061 . . . . 33.539999999999999 108.187 -176.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1034 ' ' ALA . . . . . 0.583 ' HB2' ' HD2' ' A' 1002 ' ' ARG . . . -125.75 135.99 52.66 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 106.285 -1.746 . . . . 31.68 106.285 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1035 ' ' VAL . . . . . 0.489 HG22 ' HB ' ' A' 1005 ' ' ILE . 47.1 t -121.21 145.91 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 104.636 -2.357 . . . . 31.52 104.636 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1036 ' ' GLU . . . . . 0.696 ' HB3' ' HB2' ' A' 1039 ' ' ALA . 41.4 tt0 -58.89 154.36 15.32 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 119.52 -0.276 . . . . 41.039999999999999 111.584 173.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1037 ' ' SER . . . . . 0.465 ' OG ' ' HA ' ' A' 1059 ' ' GLU . 4.7 m -47.27 96.09 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 113.619 0.97 . . . . 31.829999999999998 113.619 173.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 61.25 38.87 96.37 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 114.674 -1.148 . . . . 29.359999999999999 112.669 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1039 ' ' ALA . . . . . 0.696 ' HB2' ' HB3' ' A' 1036 ' ' GLU . . . -52.43 -26.35 12.46 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 118.023 2.601 . . . . 27.780000000000001 118.023 -174.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1040 ' ' GLY . . . . . 0.461 ' H ' ' HE2' ' A' 1050 ' ' PHE . . . -91.69 13.0 67.85 Favored Glycine 0 N--CA 1.43 -1.731 0 CA-C-O 116.237 -2.424 . . . . 28.91 113.02 -175.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -62.67 -26.95 68.91 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 123.319 3.56 . . . . 51.18 113.482 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1042 ' ' LEU . . . . . . . . . . . . . 96.0 mt -54.94 -44.22 74.12 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 122.003 0.906 . . . . 29.91 110.915 167.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1043 ' ' ALA . . . . . 0.585 ' HA ' ' HB2' ' A' 1320 ' ' PRO . . . -104.1 35.84 2.55 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 114.303 -1.317 . . . . 28.539999999999999 109.491 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1044 ' ' SER . . . . . . . . . . . . . 3.0 m 65.8 0.36 1.5 Allowed 'General case' 0 C--O 1.239 0.548 0 N-CA-C 121.51 3.893 . . . . 33.060000000000002 121.51 172.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1045 ' ' PHE . . . . . 0.565 ' HD2' ' HB1' ' A' 1049 ' ' ALA . 86.3 m-85 -106.51 118.72 37.38 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 120.952 1.706 . . . . 30.289999999999999 114.15 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.9 -176.43 6.31 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 115.399 1.629 . . . . 48.619999999999997 115.399 178.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -43.55 -67.39 0.28 Allowed 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 125.642 1.838 . . . . 36.740000000000002 111.829 170.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 13.3 pttm -64.7 -24.15 67.48 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.347 0.976 . . . . 43.729999999999997 111.786 -172.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1049 ' ' ALA . . . . . 0.565 ' HB1' ' HD2' ' A' 1045 ' ' PHE . . . -63.48 -45.74 89.4 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.831 -1.174 . . . . 32.810000000000002 107.831 170.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1050 ' ' PHE . . . . . 0.461 ' HE2' ' H ' ' A' 1040 ' ' GLY . 87.3 m-85 -70.95 -23.03 62.15 Favored 'General case' 0 C--O 1.211 -0.931 0 O-C-N 120.275 -1.516 . . . . 31.859999999999999 110.847 173.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 78.5 t -69.39 -27.95 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 O-C-N 118.495 -2.628 . . . . 33.219999999999999 109.543 170.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -62.16 -45.63 92.55 Favored 'General case' 0 CA--C 1.509 -0.622 0 O-C-N 119.461 -2.024 . . . . 50.829999999999998 110.401 174.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1053 ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' 1020 ' ' PRO . . . -65.38 -38.07 88.9 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 115.86 -0.609 . . . . 33.119999999999997 111.705 172.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 99.16 69.21 0.91 Allowed Glycine 0 C--O 1.245 0.832 0 N-CA-C 105.485 -3.046 . . . . 35.829999999999998 105.485 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1055 ' ' ALA . . . . . 0.539 ' HB2' HG11 ' A' 1023 ' ' VAL . . . -119.7 138.03 53.55 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 113.662 -1.269 . . . . 34.82 108.059 176.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -66.13 124.63 23.14 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.474 -1.676 . . . . 49.049999999999997 106.474 171.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1057 ' ' ILE . . . . . 0.446 HG23 ' HA ' ' A' 1037 ' ' SER . 30.4 mm -90.23 98.77 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.25 0 O-C-N 117.699 -3.126 . . . . 38.530000000000001 107.792 177.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1058 ' ' VAL . . . . . 0.401 HG21 ' HA ' ' A' 1063 ' ' VAL . 2.5 m -79.81 123.23 36.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 125.44 2.543 . . . . 42.109999999999999 106.155 176.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1059 ' ' GLU . . . . . 0.465 ' HA ' ' OG ' ' A' 1037 ' ' SER . 6.4 mm-40 -76.7 82.91 3.33 Favored 'General case' 0 C--N 1.31 -1.126 1 CA-C-N 107.367 -4.469 . . . . 58.0 110.01 -174.41 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 75.51 -133.0 13.88 Favored Glycine 0 C--O 1.223 -0.589 0 N-CA-C 109.784 -1.326 . . . . 52.119999999999997 109.784 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 3.3 t30 -56.49 -25.66 51.95 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 117.427 2.38 . . . . 54.75 117.427 -161.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1062 ' ' SER . . . . . . . . . . . . . 70.5 m -55.66 -15.66 3.28 Favored 'General case' 0 C--O 1.25 1.113 0 O-C-N 120.012 -1.68 . . . . 50.340000000000003 113.125 174.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1063 ' ' VAL . . . . . 0.401 ' HA ' HG21 ' A' 1058 ' ' VAL . 14.8 p -57.17 -37.22 54.71 Favored 'Isoleucine or valine' 0 C--N 1.37 1.496 0 O-C-N 120.609 -1.307 . . . . 41.460000000000001 113.536 170.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1064 ' ' TRP . . . . . . . . . . . . . 97.9 m95 -70.2 -24.38 63.11 Favored 'General case' 0 N--CA 1.435 -1.216 0 O-C-N 125.525 1.766 . . . . 39.32 114.222 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -87.95 72.04 9.34 Favored 'General case' 0 C--O 1.246 0.883 0 N-CA-C 107.83 -1.174 . . . . 55.380000000000003 107.83 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1066 ' ' SER . . . . . . . . . . . . . 11.1 m -151.74 144.61 24.42 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-O 118.552 -0.737 . . . . 41.869999999999997 109.376 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.4 -12.28 60.22 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 119.03 2.974 . . . . 53.200000000000003 119.03 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1068 ' ' ILE . . . . . 0.43 ' HB ' ' HA ' ' A' 1003 ' ' ILE . 2.4 mp -127.06 124.66 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 104.241 -2.503 . . . . 41.899999999999999 104.241 167.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1069 ' ' ILE . . . . . 0.596 HG12 HG21 ' A' 1087 ' ' THR . 46.6 mm -119.08 111.14 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.069 0 N-CA-C 104.337 -2.468 . . . . 38.729999999999997 104.337 173.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1070 ' ' LEU . . . . . 0.668 HD13 HD13 ' A' 1331 ' ' LEU . 94.5 mt -90.22 85.17 6.17 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 105.665 -1.976 . . . . 32.439999999999998 105.665 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1071 ' ' LYS . . . . . 0.562 ' HE3' ' O ' ' A' 1073 ' ' ASN . 3.8 mmmt -81.79 145.83 30.24 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 107.049 -1.463 . . . . 34.649999999999999 107.049 -177.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1072 ' ' VAL . . . . . . . . . . . . . 2.6 t -86.89 -25.9 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-O 124.107 1.908 . . . . 31.32 111.871 -165.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1073 ' ' ASN . . . . . 0.562 ' O ' ' HE3' ' A' 1071 ' ' LYS . 61.9 m-20 -140.86 -173.82 3.82 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 105.694 -1.965 . . . . 33.939999999999998 105.694 168.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -52.0 142.7 25.72 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 116.734 2.124 . . . . 38.039999999999999 116.734 172.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1075 ' ' PRO . . . . . 0.539 ' HG2' HD21 ' A' 1089 ' ' LEU . 46.4 Cg_exo -63.77 119.21 6.18 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.652 2.902 . . . . 42.68 112.454 162.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 50.8 mt -71.31 158.45 36.32 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 113.036 -1.893 . . . . 46.740000000000002 107.098 161.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -57.88 -32.11 67.38 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 119.953 -1.717 . . . . 58.609999999999999 114.934 -172.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 14.2 t70 -44.85 -53.38 7.57 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 123.067 1.413 . . . . 59.200000000000003 111.858 164.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1079 ' ' GLU . . . . . 0.763 ' HG2' ' NH1' ' A' 1009 ' ' ARG . 18.2 mt-10 -78.2 -34.81 49.21 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.96 -1.018 . . . . 50.630000000000003 109.859 -174.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1080 ' ' ILE . . . . . . . . . . . . . 66.3 mt -49.13 -48.05 17.5 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 CA-C-O 123.169 1.461 . . . . 51.479999999999997 111.175 170.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -63.47 -38.65 91.94 Favored 'General case' 0 C--O 1.25 1.106 0 CA-C-N 113.73 -1.577 . . . . 50.280000000000001 110.332 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 87.2 mt -71.52 -24.64 61.99 Favored 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 120.922 -1.112 . . . . 50.210000000000001 113.765 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1083 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.27 161.36 29.41 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 120.211 1.369 . . . . 49.060000000000002 109.467 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -123.88 140.28 34.21 Favored Pre-proline 0 C--O 1.248 0.991 0 N-CA-C 105.399 -2.074 . . . . 51.079999999999998 105.399 -176.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1085 ' ' PRO . . . . . 0.447 ' HB3' ' HB3' ' A' 1109 ' ' ASN . 64.5 Cg_exo -56.08 155.16 24.83 Favored 'Trans proline' 0 N--CA 1.446 -1.277 1 C-N-CA 125.382 4.055 . . . . 49.729999999999997 113.64 175.437 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 81.58 -10.46 50.64 Favored Glycine 0 C--N 1.314 -0.65 0 O-C-N 121.158 -0.964 . . . . 47.710000000000001 112.296 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1087 ' ' THR . . . . . 0.596 HG21 HG12 ' A' 1069 ' ' ILE . 92.9 m -82.52 137.91 34.46 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 119.411 1.605 . . . . 45.469999999999999 110.187 -171.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1088 ' ' THR . . . . . 0.451 ' HA ' ' HB ' ' A' 1111 ' ' THR . 2.7 m -75.94 87.53 2.9 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 107.311 -1.366 . . . . 42.039999999999999 107.311 174.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1089 ' ' LEU . . . . . 0.539 HD21 ' HG2' ' A' 1075 ' ' PRO . 56.4 tp -82.62 97.08 8.32 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 122.733 1.254 . . . . 38.060000000000002 108.663 177.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1090 ' ' VAL . . . . . 0.564 HG22 ' HB2' ' A' 1113 ' ' MET . 96.7 t -97.52 116.3 39.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 102.679 -3.082 . . . . 37.399999999999999 102.679 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1091 ' ' SER . . . . . . . . . . . . . 1.9 m -153.94 160.98 42.32 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 120.325 1.42 . . . . 36.159999999999997 113.179 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1092 ' ' PHE . . . . . 0.434 ' HB2' ' HA ' ' A' 1073 ' ' ASN . 0.8 OUTLIER -58.79 97.51 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.757 0 O-C-N 119.434 -2.041 . . . . 38.939999999999998 111.305 154.281 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 1093 ' ' ILE . . . . . 0.42 HG13 ' CG1' ' A' 1112 ' ' VAL . 25.2 mm -96.47 -36.93 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 C-N-CA 123.115 0.566 . . . . 42.170000000000002 109.98 -175.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 45.8 m95 58.16 56.6 6.63 Favored Pre-proline 0 C--O 1.256 1.418 0 O-C-N 124.867 1.354 . . . . 46.509999999999998 110.98 -172.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -50.15 -39.41 51.58 Favored 'Trans proline' 0 CA--C 1.504 -1.001 0 C-N-CA 124.414 3.409 . . . . 49.759999999999998 116.364 -173.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -72.84 -24.59 60.91 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 120.004 1.275 . . . . 52.619999999999997 113.247 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -90.32 -11.76 39.76 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 122.279 1.037 . . . . 60.740000000000002 110.032 172.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1098 ' ' ASN . . . . . 0.409 ' HB3' ' HB3' ' A' 1101 ' ' LEU . 10.3 m120 -133.05 47.85 3.02 Favored Pre-proline 0 N--CA 1.451 -0.398 0 O-C-N 118.211 -2.806 . . . . 58.189999999999998 115.456 -174.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -55.31 -31.21 75.89 Favored 'Trans proline' 0 C--O 1.244 0.78 0 C-N-CA 124.664 3.576 . . . . 54.590000000000003 112.84 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1100 ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' 1104 ' ' LYS . 29.4 mp0 -61.46 -53.65 53.71 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.692 1.197 . . . . 63.280000000000001 109.971 175.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1101 ' ' LEU . . . . . 0.409 ' HB3' ' HB3' ' A' 1098 ' ' ASN . 24.2 tp -56.54 -40.64 75.43 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 124.027 0.931 . . . . 54.75 109.831 174.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1102 ' ' MET . . . . . . . . . . . . . 81.4 mmm -55.16 -50.72 68.58 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.929 1.24 . . . . 52.649999999999999 110.087 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -57.87 -39.95 79.02 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 124.96 1.304 . . . . 66.260000000000005 109.16 176.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1104 ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' 1100 ' ' GLU . 51.1 mtmt -71.72 -42.62 67.12 Favored 'General case' 0 C--N 1.313 -0.988 0 O-C-N 120.999 -1.063 . . . . 63.729999999999997 111.884 -176.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 68.3 mt -76.35 -21.28 56.32 Favored 'General case' 0 C--O 1.268 2.054 0 O-C-N 119.936 -1.728 . . . . 54.68 111.136 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -62.85 -42.54 99.79 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 120.646 -1.284 . . . . 53.640000000000001 111.759 167.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -62.47 -44.98 95.08 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 109.878 -0.415 . . . . 67.239999999999995 109.878 172.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.45 -2.79 12.07 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 117.055 -3.528 . . . . 65.760000000000005 114.347 174.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1109 ' ' ASN . . . . . 0.731 ' HA ' ' HA2' ' A' 1364 ' ' GLY . 2.1 t30 61.1 35.43 18.68 Favored 'General case' 0 C--O 1.247 0.942 0 O-C-N 118.984 -2.323 . . . . 58.710000000000001 113.717 169.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1110 ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.95 156.6 3.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 106.78 -1.563 . . . . 46.630000000000003 106.78 -171.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1111 ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' 1362 ' ' ARG . 53.9 m -81.62 97.32 7.81 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 105.878 -1.897 . . . . 44.130000000000003 105.878 165.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1112 ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' 1361 ' ' ILE . 42.7 t -95.55 111.69 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-O 123.584 1.659 . . . . 40.439999999999998 109.11 -177.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1113 ' ' MET . . . . . 0.564 ' HB2' HG22 ' A' 1090 ' ' VAL . 47.7 mtp -106.21 107.33 18.28 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 112.913 -1.948 . . . . 50.759999999999998 109.487 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1114 ' ' ALA . . . . . 0.46 ' HB3' ' HB2' ' A' 1117 ' ' SER . . . -87.64 105.44 17.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 126.338 2.97 . . . . 35.640000000000001 111.901 -177.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1115 ' ' MET . . . . . . . . . . . . . 74.2 mmm -60.19 -28.89 68.32 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 110.741 -2.936 . . . . 38.740000000000002 117.988 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -66.21 -44.17 84.65 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 113.293 -1.776 . . . . 40.140000000000001 109.737 167.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1117 ' ' SER . . . . . 0.46 ' HB2' ' HB3' ' A' 1114 ' ' ALA . 74.5 m -80.38 48.4 1.02 Allowed 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 118.509 2.781 . . . . 44.789999999999999 118.509 -175.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1118 ' ' VAL . . . . . . . . . . . . . 37.4 t -89.8 134.9 31.2 Favored Pre-proline 0 C--O 1.25 1.124 0 N-CA-C 107.112 -1.44 . . . . 43.75 107.112 173.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1119 ' ' PRO . . . . . 0.551 ' HG2' ' HA ' ' A' 1354 ' ' VAL . 0.5 OUTLIER -50.22 122.96 10.18 Favored 'Trans proline' 0 N--CA 1.459 -0.546 1 C-N-CA 125.688 4.259 . . . . 48.93 112.119 170.376 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 42.3 mmm-85 -75.31 61.1 1.17 Allowed 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 123.812 0.845 . . . . 62.899999999999999 111.905 -169.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 15.6 pt -116.78 167.65 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 O-C-N 118.042 -2.911 . . . . 57.719999999999999 110.733 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1122 ' ' SER . . . . . . . . . . . . . 4.2 p -39.0 -65.86 0.33 Allowed 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 117.592 2.442 . . . . 57.259999999999998 117.592 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -57.28 -33.29 67.48 Favored 'General case' 0 C--N 1.36 1.06 0 O-C-N 121.012 -1.055 . . . . 62.899999999999999 113.381 -176.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -82.17 -15.81 51.98 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-N 113.366 -1.743 . . . . 49.829999999999998 109.682 -169.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -56.02 -30.49 61.94 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 122.826 2.557 . . . . 52.369999999999997 114.159 -172.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1126 ' ' SER . . . . . . . . . . . . . 16.9 p -66.85 -31.73 72.54 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 122.715 1.245 . . . . 42.43 113.169 172.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1127 ' ' LEU . . . . . 0.411 HD21 HD12 ' A' 1337 ' ' LEU . 3.6 mp -83.65 -25.67 30.55 Favored 'General case' 0 C--N 1.346 0.436 0 O-C-N 121.197 -0.939 . . . . 43.740000000000002 111.971 172.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 62.0 t0 -69.84 89.32 0.57 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 123.736 1.731 . . . . 43.210000000000001 113.209 -172.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -67.92 -31.73 71.69 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 112.588 -2.096 . . . . 35.740000000000002 112.94 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 44.5 tp -54.18 -58.19 8.29 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 124.854 1.346 . . . . 38.090000000000003 108.702 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1131 ' ' SER . . . . . . . . . . . . . 7.0 m -69.77 -37.17 76.29 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 113.63 -1.623 . . . . 36.909999999999997 111.632 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1132 ' ' SER . . . . . . . . . . . . . 61.0 m -65.16 -38.27 90.04 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 123.048 2.658 . . . . 35.789999999999999 110.528 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1133 ' ' MET . . . . . . . . . . . . . 34.3 mmt -77.46 -40.16 44.11 Favored 'General case' 0 CA--C 1.489 -1.384 0 O-C-N 119.586 -1.946 . . . . 30.809999999999999 109.748 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1134 ' ' ALA . . . . . 0.604 ' HB1' ' HB2' ' A' 1176 ' ' ALA . . . -52.33 -43.16 64.41 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.094 0.557 . . . . 28.879999999999999 111.734 168.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1135 ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -63.93 -51.43 64.46 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.232 1.015 . . . . 40.759999999999998 109.796 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1136 ' ' ILE . . . . . 0.508 HD11 HD12 ' A' 1326 ' ' LEU . 94.0 mt -55.07 -42.62 65.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 114.838 -1.074 . . . . 31.539999999999999 113.343 171.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -66.54 -31.7 72.58 Favored 'General case' 0 C--O 1.219 -0.544 0 C-N-CA 124.709 1.203 . . . . 29.870000000000001 112.645 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -66.08 -50.5 51.41 Favored Glycine 0 C--O 1.216 -1.019 0 O-C-N 120.048 -1.657 . . . . 28.73 110.408 176.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 19.6 t80 -55.58 -47.11 76.97 Favored 'General case' 0 C--O 1.248 0.98 0 C-N-CA 124.187 0.995 . . . . 30.390000000000001 109.377 172.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1140 ' ' ARG . . . . . 0.476 ' HE ' ' HG2' ' A' 1144 ' ' GLU . 5.4 tpt180 -68.66 -24.45 64.53 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 114.171 1.174 . . . . 26.09 114.171 177.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1141 ' ' ALA . . . . . 0.466 ' HB2' HD21 ' A' 1284 ' ' LEU . . . -71.32 -40.35 70.84 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 121.572 1.987 . . . . 27.100000000000001 106.817 176.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 19.7 mm -63.1 -41.03 91.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.399 -0.593 . . . . 28.48 109.399 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 54.9 t -54.97 -64.85 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.607 0 C-N-CA 123.24 0.616 . . . . 23.07 111.534 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1144 ' ' GLU . . . . . 0.476 ' HG2' ' HE ' ' A' 1140 ' ' ARG . 6.1 mm-40 -68.36 -19.64 64.65 Favored 'General case' 0 C--O 1.244 0.785 0 O-C-N 120.336 -1.477 . . . . 33.399999999999999 113.253 -175.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1145 ' ' ALA . . . . . 0.735 ' HA ' HG11 ' A' 1280 ' ' VAL . . . -62.65 -56.96 12.98 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 107.154 -1.425 . . . . 24.219999999999999 107.154 164.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -59.75 -20.48 56.88 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 117.477 -3.265 . . . . 24.890000000000001 112.655 175.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 29.1 t-80 -66.73 -38.43 86.65 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 117.901 -3.0 . . . . 26.73 111.06 174.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1148 ' ' GLU . . . . . 0.753 ' HB3' ' HD2' ' A' 1308 ' ' LYS . 59.2 mm-40 -109.21 0.07 19.5 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 115.533 1.679 . . . . 39.960000000000001 115.533 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1149 ' ' PHE . . . . . 0.476 ' CZ ' ' HB3' ' A' 1250 ' ' ASP . 1.3 t80 -68.19 148.29 51.07 Favored 'General case' 0 C--O 1.246 0.888 0 O-C-N 120.988 -1.07 . . . . 25.870000000000001 108.709 -174.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1150 ' ' GLY . . . . . 0.635 ' HA2' ' HG2' ' B' 1320 ' ' PRO . . . -72.81 -40.37 52.72 Favored Glycine 0 N--CA 1.438 -1.197 0 C-N-CA 118.633 -1.746 . . . . 19.280000000000001 112.044 173.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1151 ' ' ARG . . . . . 0.803 ' HA ' ' HB2' ' B' 1322 ' ' GLN . 23.9 mtm-85 -108.21 -177.91 3.46 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.236 -1.155 . . . . 39.899999999999999 113.845 -166.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1152 ' ' PHE . . . . . 0.609 ' HB2' HG11 ' A' 1163 ' ' VAL . 2.1 m-30 -81.96 154.25 25.84 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 116.562 -2.055 . . . . 29.440000000000001 109.887 168.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1153 ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -70.47 -57.43 4.79 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 124.244 1.973 . . . . 32.600000000000001 107.177 156.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1154 ' ' THR . . . . . . . . . . . . . 3.5 m -60.16 92.24 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 110.562 -3.017 . . . . 34.640000000000001 111.425 -175.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -60.35 128.47 45.79 Favored Glycine 0 C--N 1.344 1.01 0 O-C-N 120.3 -1.5 . . . . 37.140000000000001 112.611 175.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1156 ' ' GLN . . . . . 0.449 ' H ' ' HB ' ' A' 1163 ' ' VAL . 3.7 pt20 -159.49 137.57 10.32 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 113.896 1.072 . . . . 40.57 113.896 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1157 ' ' ILE . . . . . 0.533 ' HB ' ' HB3' ' C' ' 95' ' ' GLU . 5.2 tp -80.36 125.15 39.02 Favored 'Isoleucine or valine' 0 C--O 1.257 1.491 0 N-CA-C 102.891 -3.003 . . . . 44.609999999999999 102.891 169.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1158 ' ' THR . . . . . 0.433 ' O ' ' HG3' ' C' ' 70' ' ' PRO . 56.0 p -98.44 -173.3 2.52 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 113.394 -1.73 . . . . 40.700000000000003 106.607 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -72.02 -19.0 61.92 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 121.48 1.945 . . . . 40.25 109.562 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1160 ' ' ALA . . . . . 0.448 ' HB2' ' ND2' ' B' 1330 ' ' ASN . . . -103.91 -47.81 4.09 Favored 'General case' 0 C--O 1.249 1.038 0 CA-C-N 119.972 1.26 . . . . 38.469999999999999 113.888 172.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . -148.54 162.01 28.76 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 117.723 -2.179 . . . . 37.609999999999999 114.693 -159.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 26.9 tttt -79.95 124.01 28.31 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 123.188 1.47 . . . . 48.899999999999999 113.318 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1163 ' ' VAL . . . . . 0.609 HG11 ' HB2' ' A' 1152 ' ' PHE . 79.4 t -95.29 117.0 66.81 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 105.962 -1.866 . . . . 36.520000000000003 105.962 165.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1164 ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -71.27 140.62 37.51 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.636 2.224 . . . . 35.079999999999998 112.753 172.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1165 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -59.0 125.63 18.72 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 CA-C-N 122.258 1.842 . . . . 35.329999999999998 112.861 169.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -63.85 140.57 58.88 Favored 'General case' 0 C--O 1.244 0.814 0 N-CA-C 114.773 1.398 . . . . 34.689999999999998 114.773 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1167 ' ' LYS . . . . . . . . . . . . . 79.4 mttt -88.21 113.13 23.52 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 119.845 1.202 . . . . 45.359999999999999 113.061 170.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 64.9 t -101.99 115.5 43.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.063 -1.088 . . . . 31.710000000000001 108.063 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1169 ' ' MET . . . . . 0.449 ' O ' ' HA ' ' A' 1252 ' ' ILE . 12.4 ttt -100.03 113.75 26.57 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 121.75 2.068 . . . . 42.280000000000001 109.24 170.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1170 ' ' VAL . . . . . 0.409 HG21 HG13 ' A' 1181 ' ' ILE . 68.9 t -82.92 128.69 38.48 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 N-CA-C 105.919 -1.882 . . . . 30.510000000000002 105.919 169.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 42.3 mt -119.55 136.46 56.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 O-C-N 119.63 -1.919 . . . . 31.870000000000001 106.068 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1172 ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' 1256 ' ' ALA . . . 74.91 58.26 4.12 Favored Glycine 0 CA--C 1.539 1.587 0 N-CA-C 110.043 -1.223 . . . . 34.539999999999999 110.043 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1173 ' ' ALA . . . . . . . . . . . . . . . -72.28 85.1 1.07 Allowed 'General case' 0 C--O 1.259 1.555 0 CA-C-O 122.487 1.137 . . . . 32.509999999999998 113.867 -166.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -76.16 -175.11 38.87 Favored Glycine 0 CA--C 1.554 2.498 0 N-CA-C 108.325 -1.91 . . . . 29.899999999999999 108.325 163.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1175 ' ' VAL . . . . . . . . . . . . . 79.2 t -59.42 -37.12 68.04 Favored 'Isoleucine or valine' 0 C--O 1.25 1.125 0 CA-C-N 118.49 1.145 . . . . 33.109999999999999 110.621 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1176 ' ' ALA . . . . . 0.604 ' HB2' ' HB1' ' A' 1134 ' ' ALA . . . -52.52 -42.42 64.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.322 -1.308 . . . . 28.100000000000001 114.333 169.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -64.94 -40.13 96.98 Favored Glycine 0 CA--C 1.545 1.91 0 N-CA-C 110.014 -1.234 . . . . 28.539999999999999 110.014 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1178 ' ' LEU . . . . . 0.711 HD13 ' HG2' ' A' 1203 ' ' GLN . 69.6 mt -63.31 -48.38 78.3 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.704 -0.85 . . . . 31.219999999999999 108.704 178.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -64.44 -34.18 77.59 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 120.259 -1.526 . . . . 28.98 114.937 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -57.95 -40.78 81.36 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 115.82 1.785 . . . . 27.829999999999998 115.82 171.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1181 ' ' ILE . . . . . 0.722 ' HA ' HG11 ' A' 1191 ' ' VAL . 96.7 mt -56.96 -49.15 80.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.507 -0.77 . . . . 30.25 111.672 169.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -58.08 -40.63 93.8 Favored Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 111.313 -0.715 . . . . 29.59 111.313 175.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -67.43 -52.43 39.81 Favored 'General case' 0 C--O 1.243 0.728 0 O-C-N 119.51 -2.17 . . . . 30.289999999999999 112.906 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -58.6 -40.44 83.25 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-O 122.962 1.363 . . . . 30.469999999999999 111.64 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 2.5 t30 -62.48 -43.51 98.64 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 114.932 -1.031 . . . . 42.409999999999997 112.592 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1186 ' ' SER . . . . . 0.817 ' HB3' ' HA ' ' B' 1187 ' ' LEU . 43.9 m -58.16 -50.8 72.26 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 123.985 0.914 . . . . 39.380000000000003 109.566 172.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 29.5 mt -60.48 -18.76 53.72 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 116.975 2.213 . . . . 36.18 116.975 171.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 97.34 33.33 5.99 Favored Glycine 0 C--N 1.356 1.664 0 CA-C-N 121.876 2.125 . . . . 33.780000000000001 112.418 174.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -99.92 155.82 17.47 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 123.249 0.62 . . . . 33.93 112.478 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 34.2 mt -79.26 103.29 6.05 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.462 0 N-CA-C 104.31 -2.478 . . . . 38.740000000000002 104.31 175.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1191 ' ' VAL . . . . . 0.722 HG11 ' HA ' ' A' 1181 ' ' ILE . 1.4 t -93.92 148.74 4.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 N-CA-C 106.556 -1.646 . . . . 33.090000000000003 106.556 -172.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1192 ' ' ARG . . . . . 0.59 ' HG2' ' HB2' ' A' 1210 ' ' GLU . 90.2 mtt180 -141.76 158.76 43.41 Favored 'General case' 0 C--O 1.252 1.2 0 C-N-CA 124.647 1.179 . . . . 38.920000000000002 108.39 176.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1193 ' ' ALA . . . . . 0.562 ' HB2' HD11 ' A' 1181 ' ' ILE . . . -152.24 148.3 27.41 Favored 'General case' 0 C--O 1.25 1.106 0 N-CA-C 114.405 1.261 . . . . 35.32 114.405 176.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 42.3 t80 -138.23 147.64 43.94 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 113.705 -1.589 . . . . 39.350000000000001 107.648 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 10.5 t70 -170.78 167.51 7.61 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 103.109 -2.923 . . . . 40.460000000000001 103.109 170.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1196 ' ' THR . . . . . . . . . . . . . 4.0 m -69.92 -43.16 72.25 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 125.015 1.326 . . . . 45.939999999999998 110.068 175.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1197 ' ' ARG . . . . . 0.441 ' HA ' ' HD2' ' A' 1198 ' ' PRO . 39.6 mtm180 -79.49 112.74 31.21 Favored Pre-proline 0 C--O 1.222 -0.357 0 N-CA-C 114.951 1.463 . . . . 56.020000000000003 114.951 -165.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1198 ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' 1197 ' ' ARG . 57.4 Cg_endo -58.39 -20.88 50.58 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.722 2.281 . . . . 51.270000000000003 117.666 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -55.68 -25.53 40.21 Favored 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 117.01 2.226 . . . . 59.100000000000001 117.01 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 27.7 m -87.55 -14.14 10.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 114.729 1.381 . . . . 51.060000000000002 114.729 -175.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 90.8 mttt -62.98 -38.79 92.56 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.123 -0.944 . . . . 57.380000000000003 113.443 -169.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -56.38 -48.68 76.36 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 124.638 1.211 . . . . 62.409999999999997 110.707 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1203 ' ' GLN . . . . . 0.711 ' HG2' HD13 ' A' 1178 ' ' LEU . 4.7 tp60 -65.35 -44.34 87.99 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 124.918 1.386 . . . . 57.780000000000001 110.579 175.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1204 ' ' VAL . . . . . 0.457 HG11 ' HD2' ' A' 1211 ' ' PHE . 54.1 t -55.49 -47.02 78.99 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 CA-C-N 121.083 1.765 . . . . 46.380000000000003 111.323 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -66.11 -36.09 82.25 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-N 115.008 -0.997 . . . . 50.700000000000003 110.037 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1206 ' ' SER . . . . . . . . . . . . . 59.8 m -71.2 -51.04 26.96 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 112.724 0.639 . . . . 49.979999999999997 112.724 -176.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1207 ' ' MET . . . . . . . . . . . . . 45.7 mtp -68.35 -25.78 65.26 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 123.499 0.499 . . . . 52.990000000000002 111.008 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 131.3 68.14 0.1 OUTLIER Glycine 0 N--CA 1.475 1.289 0 O-C-N 120.018 -1.677 . . . . 47.659999999999997 113.27 156.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1209 ' ' ALA . . . . . 0.474 ' HB2' HG23 ' A' 1181 ' ' ILE . . . -155.46 161.88 40.86 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 122.683 1.23 . . . . 44.770000000000003 113.173 -174.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1210 ' ' GLU . . . . . 0.59 ' HB2' ' HG2' ' A' 1192 ' ' ARG . 42.0 mt-10 -89.97 113.86 25.6 Favored 'General case' 0 C--N 1.318 -0.787 0 O-C-N 118.961 -2.337 . . . . 47.640000000000001 108.313 173.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1211 ' ' PHE . . . . . 0.457 ' HD2' HG11 ' A' 1204 ' ' VAL . 21.7 t80 -84.3 115.32 22.42 Favored 'General case' 0 N--CA 1.432 -1.375 0 C-N-CA 117.885 -1.526 . . . . 45.659999999999997 107.229 173.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 37.1 mt -71.01 116.42 11.28 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 125.955 1.702 . . . . 46.060000000000002 108.682 -176.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -69.44 144.72 53.22 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 118.444 -1.302 . . . . 60.219999999999999 112.84 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1214 ' ' LEU . . . . . 0.704 ' HG ' ' HB2' ' A' 1216 ' ' PHE . 66.6 tp -62.55 95.39 0.07 Allowed 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 113.589 -1.641 . . . . 57.25 109.72 167.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 16.3 t70 -69.45 90.67 0.54 Allowed 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 105.403 -2.073 . . . . 64.430000000000007 105.403 172.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1216 ' ' PHE . . . . . 0.704 ' HB2' ' HG ' ' A' 1214 ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.303 -1.428 0 O-C-N 126.325 2.265 . . . . 66.900000000000006 106.898 -172.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.429 -1.482 0 CA-C-O 122.174 0.988 . . . . 39.090000000000003 108.962 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -59.81 -38.66 94.31 Favored Glycine 0 CA--C 1.543 1.796 0 O-C-N 120.529 -1.357 . . . . 39.32 114.227 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 68.0 t80 -65.88 -46.35 78.72 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 117.336 0.568 . . . . 39.299999999999997 111.973 170.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -59.53 -49.46 77.68 Favored 'General case' 0 C--N 1.349 0.556 0 O-C-N 121.96 -0.463 . . . . 36.299999999999997 109.995 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -50.99 -56.98 9.81 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-O 117.432 -1.271 . . . . 37.380000000000003 111.973 168.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -51.91 -30.42 12.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 118.261 2.689 . . . . 39.109999999999999 118.261 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1230 ' ' MET . . . . . . . . . . . . . 38.7 mmt -79.21 -28.86 42.59 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 113.079 0.77 . . . . 49.590000000000003 113.079 174.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1231 ' ' SER . . . . . 0.509 ' O ' ' HB3' ' A' 1234 ' ' PHE . 23.1 m -58.21 140.43 53.09 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 117.142 2.275 . . . . 43.68 117.142 -169.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -58.96 -49.79 76.51 Favored 'General case' 0 C--O 1.214 -0.78 0 N-CA-C 116.251 1.945 . . . . 55.57 116.251 175.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -61.44 -25.44 67.22 Favored 'General case' 0 C--O 1.206 -1.19 0 N-CA-C 112.487 0.551 . . . . 44.939999999999998 112.487 174.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1234 ' ' PHE . . . . . 0.509 ' HB3' ' O ' ' A' 1231 ' ' SER . 70.7 t80 -69.22 -49.59 55.03 Favored 'General case' 0 N--CA 1.428 -1.569 0 O-C-N 124.299 0.999 . . . . 42.039999999999999 110.031 175.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 63.1 mt -62.05 -33.86 60.47 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 O-C-N 123.437 0.46 . . . . 46.280000000000001 111.982 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1236 ' ' LYS . . . . . 0.565 ' O ' ' HG3' ' A' 1240 ' ' GLU . 48.3 tttm -57.5 -53.12 61.72 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 118.085 -0.96 . . . . 47.869999999999997 111.049 164.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -60.43 -40.4 90.91 Favored 'General case' 0 C--O 1.259 1.558 0 N-CA-C 113.729 1.011 . . . . 41.609999999999999 113.729 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -57.13 -52.39 65.5 Favored 'General case' 0 C--O 1.254 1.321 0 O-C-N 121.557 -0.714 . . . . 50.649999999999999 109.567 173.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1239 ' ' MET . . . . . 0.541 ' SD ' ' HD2' ' A' 1242 ' ' PHE . 92.9 mmm -62.43 -25.14 67.81 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 113.586 0.958 . . . . 48.869999999999997 113.586 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1240 ' ' GLU . . . . . 0.565 ' HG3' ' O ' ' A' 1236 ' ' LYS . 34.7 mt-10 -71.45 -42.73 67.82 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 119.952 1.251 . . . . 54.799999999999997 111.596 168.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 2.3 mm? -59.0 -45.18 91.3 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 119.495 -2.003 . . . . 43.210000000000001 108.098 172.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1242 ' ' PHE . . . . . 0.541 ' HD2' ' SD ' ' A' 1239 ' ' MET . 12.3 m-30 -62.49 -46.17 89.7 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 125.478 1.511 . . . . 38.659999999999997 111.486 178.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -61.49 -39.83 92.39 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 123.589 1.662 . . . . 37.920000000000002 111.588 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1244 ' ' ALA . . . . . 0.442 ' HA ' ' NZ ' ' A' 1247 ' ' LYS . . . -65.11 -53.31 47.28 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 120.353 -1.467 . . . . 37.280000000000001 111.464 177.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -66.46 -31.16 71.73 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 120.825 -1.172 . . . . 43.07 112.662 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -53.37 -34.36 57.3 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 123.288 0.635 . . . . 38.299999999999997 112.099 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1247 ' ' LYS . . . . . 0.442 ' NZ ' ' HA ' ' A' 1244 ' ' ALA . 30.3 mtmm -67.42 -29.0 68.37 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.139 -0.937 . . . . 47.600000000000001 113.054 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -114.9 -37.1 4.26 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 114.195 1.183 . . . . 45.420000000000002 114.195 -168.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1249 ' ' VAL . . . . . . . . . . . . . 20.7 m -68.94 166.9 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.863 0 CA-C-O 123.624 1.678 . . . . 36.259999999999998 114.967 -166.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1250 ' ' ASP . . . . . 0.476 ' HB3' ' CZ ' ' A' 1149 ' ' PHE . 9.7 m-20 -123.68 -43.24 2.15 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 110.935 -2.848 . . . . 33.039999999999999 109.439 -172.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1251 ' ' ILE . . . . . 0.592 HD12 ' HB1' ' A' 1145 ' ' ALA . 48.4 mm -123.84 138.28 54.09 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.878 0 O-C-N 118.811 -2.43 . . . . 31.399999999999999 105.445 174.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1252 ' ' ILE . . . . . 0.737 ' HB ' HG12 ' A' 1281 ' ' ILE . 19.8 mt -114.44 130.95 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 106.351 -1.722 . . . . 29.420000000000002 106.351 162.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 13.4 t -110.22 106.49 20.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 O-C-N 121.14 -0.975 . . . . 30.370000000000001 109.222 172.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1254 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.06 108.88 20.0 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 125.022 2.344 . . . . 35.719999999999999 110.802 -178.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1255 ' ' THR . . . . . . . . . . . . . 8.5 m -109.5 -27.25 9.54 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 111.441 -2.618 . . . . 36.0 117.437 -158.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1256 ' ' ALA . . . . . 0.434 ' HB2' ' HA3' ' A' 1172 ' ' GLY . . . -70.09 77.78 0.5 Allowed 'General case' 0 C--O 1.246 0.889 0 N-CA-C 115.211 1.56 . . . . 40.93 115.211 -168.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 29.8 tp -90.8 130.27 36.79 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 124.588 1.155 . . . . 47.82 107.944 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 16.7 mm -109.57 138.61 20.64 Favored Pre-proline 0 C--O 1.246 0.91 0 N-CA-C 101.523 -3.51 . . . . 52.700000000000003 101.523 176.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -64.9 132.64 33.05 Favored 'Trans proline' 0 N--CA 1.43 -2.222 0 C-N-CA 121.589 1.526 . . . . 54.130000000000003 110.539 161.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 90.74 -69.56 2.2 Favored Glycine 0 CA--C 1.507 -0.423 0 N-CA-C 109.419 -1.472 . . . . 54.619999999999997 109.419 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 69.3 mttt -71.71 140.22 83.89 Favored Pre-proline 0 C--O 1.251 1.132 0 O-C-N 121.578 -0.954 . . . . 55.740000000000002 108.965 -176.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.36 143.95 94.39 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 123.916 3.077 . . . . 51.149999999999999 108.96 163.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -59.07 132.44 87.29 Favored Pre-proline 0 N--CA 1.446 -0.67 0 C-N-CA 126.524 1.93 . . . . 46.060000000000002 109.784 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -56.82 122.29 11.56 Favored 'Trans proline' 0 N--CA 1.445 -1.328 1 C-N-CA 125.961 4.441 . . . . 41.079999999999998 110.275 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1265 ' ' LYS . . . . . 0.596 ' HD3' ' HA ' ' A' 1293 ' ' GLU . 44.3 mttm -79.35 97.78 6.46 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 125.016 2.341 . . . . 47.420000000000002 107.721 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 48.9 mt -77.17 -63.9 1.26 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 110.931 -2.849 . . . . 39.219999999999999 109.319 -174.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 3.0 mt -87.22 111.71 22.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 CA-C-N 115.284 -0.871 . . . . 42.5 110.551 -166.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1268 ' ' THR . . . . . . . . . . . . . 63.7 m -64.39 141.95 58.59 Favored 'General case' 0 C--N 1.316 -0.85 0 O-C-N 124.728 1.267 . . . . 37.840000000000003 111.132 176.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1269 ' ' ARG . . . . . 0.424 ' HG3' ' HB2' ' A' 1293 ' ' GLU . 86.2 mtt180 -49.98 -47.77 52.67 Favored 'General case' 0 C--O 1.214 -0.812 0 N-CA-C 115.655 1.724 . . . . 54.799999999999997 115.655 -170.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -41.4 -50.46 3.83 Favored 'General case' 0 C--N 1.345 0.407 0 C-N-CA 126.392 1.877 . . . . 54.359999999999999 112.26 172.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1271 ' ' MET . . . . . . . . . . . . . 21.2 ttm -71.15 -25.0 62.37 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 122.661 1.219 . . . . 39.520000000000003 114.01 -173.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1272 ' ' VAL . . . . . 0.42 HG12 HG21 ' A' 1303 ' ' THR . 57.2 t -67.89 -41.9 85.27 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 O-C-N 121.003 -1.061 . . . . 38.25 111.273 174.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -59.1 -38.29 79.19 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 122.902 1.335 . . . . 40.770000000000003 111.95 172.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1274 ' ' SER . . . . . . . . . . . . . 11.8 m -67.64 -7.43 26.57 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 115.925 1.824 . . . . 36.579999999999998 115.925 174.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1275 ' ' MET . . . . . 0.49 ' HB3' HG21 ' A' 1307 ' ' VAL . 8.7 ttt -77.34 151.38 34.95 Favored 'General case' 0 C--O 1.247 0.969 0 O-C-N 120.664 -1.273 . . . . 36.75 108.128 -174.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1276 ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -55.22 126.67 25.86 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 114.007 -1.451 . . . . 46.109999999999999 110.698 175.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1277 ' ' ALA . . . . . 0.485 ' HB1' ' HA ' ' B' 1045 ' ' PHE . . . -72.1 170.76 13.26 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 117.012 2.227 . . . . 33.520000000000003 117.012 -175.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 68.44 30.28 73.22 Favored Glycine 0 C--O 1.25 1.102 0 C-N-CA 127.267 2.365 . . . . 31.27 111.748 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1279 ' ' SER . . . . . 0.458 ' HB2' HG22 ' A' 1307 ' ' VAL . 64.8 m -125.79 169.17 12.87 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 125.703 1.601 . . . . 32.950000000000003 111.216 -167.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1280 ' ' VAL . . . . . 0.735 HG11 ' HA ' ' A' 1145 ' ' ALA . 50.5 t -128.59 149.28 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 O-C-N 119.935 -1.728 . . . . 27.43 108.204 -176.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1281 ' ' ILE . . . . . 0.737 HG12 ' HB ' ' A' 1252 ' ' ILE . 16.4 mt -120.33 103.46 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 104.686 -2.339 . . . . 30.300000000000001 104.686 161.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.34 113.64 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 118.782 -1.167 . . . . 28.629999999999999 110.681 173.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 5.6 t0 -97.79 104.93 17.0 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 122.176 0.988 . . . . 36.270000000000003 109.094 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1284 ' ' LEU . . . . . 0.466 HD21 ' HB2' ' A' 1141 ' ' ALA . 49.1 mt -72.2 -36.31 69.16 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 112.033 -2.349 . . . . 38.57 107.602 176.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -73.38 -6.22 44.83 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 113.841 1.052 . . . . 37.560000000000002 113.841 -172.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . -43.41 -30.31 0.53 Allowed 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 127.173 2.189 . . . . 40.329999999999998 115.706 176.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1287 ' ' GLN . . . . . 0.604 ' HA ' HG23 ' A' 1313 ' ' THR . 7.8 pt20 -67.86 -2.31 7.09 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 116.017 1.858 . . . . 56.850000000000001 116.017 174.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -157.77 97.34 1.56 Allowed 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 102.983 -2.969 . . . . 45.859999999999999 102.983 159.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 90.93 -59.9 3.16 Favored Glycine 0 C--O 1.213 -1.168 0 O-C-N 119.222 -2.174 . . . . 40.310000000000002 111.931 169.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 80.1 134.97 1.33 Allowed Glycine 0 C--N 1.344 1.005 0 CA-C-N 120.14 1.97 . . . . 38.890000000000001 112.423 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1291 ' ' ASN . . . . . . . . . . . . . 33.1 m120 -84.53 -16.5 42.08 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.921 1.452 . . . . 37.229999999999997 114.921 -166.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1292 ' ' CYS . . . . . . . . . . . . . 37.2 t -88.75 150.27 23.04 Favored 'General case' 0 C--O 1.259 1.571 0 N-CA-C 105.595 -2.002 . . . . 36.5 105.595 171.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1293 ' ' GLU . . . . . 0.596 ' HA ' ' HD3' ' A' 1265 ' ' LYS . 24.7 mt-10 -78.61 -14.15 59.47 Favored 'General case' 0 C--O 1.216 -0.697 0 N-CA-C 116.877 2.177 . . . . 43.32 116.877 170.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1294 ' ' TYR . . . . . 0.447 ' CZ ' HG23 ' A' 1303 ' ' THR . 1.5 m-85 -75.34 -24.41 57.34 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 113.486 0.921 . . . . 41.32 113.486 178.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1295 ' ' THR . . . . . . . . . . . . . 24.0 m -60.96 105.35 0.46 Allowed 'General case' 0 C--O 1.249 1.036 0 C-N-CA 124.662 1.185 . . . . 35.299999999999997 113.894 -165.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 93.5 t -89.47 114.61 61.11 Favored Pre-proline 0 C--O 1.245 0.827 1 N-CA-C 99.662 -4.199 . . . . 34.840000000000003 99.662 166.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -56.85 148.89 63.98 Favored 'Trans proline' 0 CA--C 1.513 -0.546 0 C-N-CA 121.546 1.497 . . . . 33.509999999999998 111.97 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 90.35 -43.35 2.92 Favored Glycine 0 C--N 1.302 -1.343 0 CA-C-O 115.581 -2.788 . . . . 32.189999999999998 113.248 -174.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -104.91 171.39 7.34 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 121.482 2.641 . . . . 34.880000000000003 117.964 -168.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1300 ' ' ILE . . . . . 0.526 HD13 ' HG3' ' A' 1148 ' ' GLU . 50.1 mt -96.42 112.2 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 101.157 -3.645 . . . . 32.289999999999999 101.157 167.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.8 113.73 25.59 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 101.484 -3.524 . . . . 37.25 101.484 173.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1302 ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' 1308 ' ' LYS . 60.4 m -83.18 111.59 19.06 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.528 -1.656 . . . . 35.560000000000002 106.528 174.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1303 ' ' THR . . . . . 0.447 HG23 ' CZ ' ' A' 1294 ' ' TYR . 18.0 m -61.19 137.91 58.23 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 116.656 -1.64 . . . . 36.399999999999999 106.78 172.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -57.26 -10.89 1.44 Allowed 'General case' 0 C--N 1.353 0.719 0 N-CA-C 118.047 2.61 . . . . 52.32 118.047 -172.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -79.74 -37.17 36.12 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 125.056 1.473 . . . . 40.039999999999999 108.435 172.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1306 ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' B' 1044 ' ' SER . . . 123.44 31.97 0.93 Allowed Glycine 0 N--CA 1.419 -2.441 0 N-CA-C 111.161 -0.776 . . . . 36.960000000000001 111.161 -178.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1307 ' ' VAL . . . . . 0.49 HG21 ' HB3' ' A' 1275 ' ' MET . 42.1 t -102.75 109.8 27.65 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 N-CA-C 103.719 -2.697 . . . . 33.399999999999999 103.719 171.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1308 ' ' LYS . . . . . 0.753 ' HD2' ' HB3' ' A' 1148 ' ' GLU . 52.2 mttt -85.34 105.4 15.97 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 106.759 -1.571 . . . . 42.909999999999997 106.759 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 54.9 t -84.61 101.78 9.62 Favored 'Isoleucine or valine' 0 C--O 1.249 1.071 0 N-CA-C 106.043 -1.836 . . . . 32.289999999999999 106.043 176.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1310 ' ' ILE . . . . . 0.648 HD11 ' HB2' ' A' 1148 ' ' GLU . 48.5 mt -96.91 96.39 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 CA-C-N 113.058 -1.883 . . . . 30.989999999999998 108.033 -173.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -89.39 61.06 3.62 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 116.423 -0.353 . . . . 28.949999999999999 112.403 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1312 ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -80.47 98.52 7.59 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 117.564 -1.654 . . . . 31.690000000000001 110.276 -171.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1313 ' ' THR . . . . . 0.604 HG23 ' HA ' ' A' 1287 ' ' GLN . 2.8 m -59.81 -36.29 76.47 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 126.463 1.905 . . . . 34.170000000000002 108.46 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -79.54 3.9 17.42 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 114.106 1.15 . . . . 36.859999999999999 114.106 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1315 ' ' LEU . . . . . . . . . . . . . 16.6 mt -44.67 -43.83 18.87 Favored Pre-proline 0 C--O 1.22 -0.454 0 N-CA-C 119.028 2.973 . . . . 34.850000000000001 119.028 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -65.37 -21.6 60.84 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 123.653 2.902 . . . . 29.149999999999999 112.7 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -81.49 -40.29 11.27 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 110.611 -0.996 . . . . 27.289999999999999 110.611 173.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1318 ' ' ARG . . . . . . . . . . . . . 44.7 mtt-85 -50.64 -21.06 1.4 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 120.634 3.568 . . . . 41.490000000000002 120.634 -167.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1319 ' ' LEU . . . . . . . . . . . . . 14.4 tp -110.47 78.56 1.49 Allowed Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 104.557 -2.386 . . . . 27.609999999999999 104.557 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1320 ' ' PRO . . . . . 0.585 ' HB2' ' HA ' ' A' 1043 ' ' ALA . 98.8 Cg_endo -55.53 -61.45 0.36 Allowed 'Trans proline' 0 CA--C 1.514 -0.516 0 C-N-CA 123.793 2.995 . . . . 25.940000000000001 114.082 -157.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1321 ' ' THR . . . . . 0.441 HG23 ' HE1' ' A' 1045 ' ' PHE . 15.8 m -64.14 -31.86 73.21 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 120.157 1.344 . . . . 25.010000000000002 112.254 -177.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1322 ' ' GLN . . . . . 0.622 ' HB2' ' HA ' ' B' 1151 ' ' ARG . 21.6 tp60 -68.76 -52.72 27.42 Favored 'General case' 0 CA--C 1.506 -0.714 0 O-C-N 119.472 -2.017 . . . . 29.390000000000001 109.386 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1323 ' ' SER . . . . . . . . . . . . . 13.7 m -59.18 -41.14 87.76 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 125.143 1.527 . . . . 26.469999999999999 109.884 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1324 ' ' SER . . . . . . . . . . . . . 39.5 m -64.55 -42.99 95.34 Favored 'General case' 0 C--O 1.223 -0.337 0 O-C-N 123.948 0.78 . . . . 27.780000000000001 110.667 176.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1325 ' ' GLN . . . . . 0.444 ' O ' HG21 ' A' 1022 ' ' THR . 53.7 tp60 -63.57 -51.31 65.91 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.047 -1.033 . . . . 37.530000000000001 108.276 -175.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1326 ' ' LEU . . . . . 0.531 HD22 ' HB3' ' B' 1160 ' ' ALA . 96.2 mt -77.23 -35.27 55.61 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-O 116.803 -1.57 . . . . 35.710000000000001 113.309 -174.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1327 ' ' TYR . . . . . . . . . . . . . 37.1 t80 -55.94 -52.85 62.68 Favored 'General case' 0 C--N 1.362 1.139 0 CA-C-N 122.028 2.195 . . . . 31.59 108.595 168.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1328 ' ' GLY . . . . . 0.544 ' O ' HG23 ' A' 1332 ' ' VAL . . . -45.15 -46.37 10.29 Favored Glycine 0 N--CA 1.443 -0.838 0 O-C-N 126.037 2.086 . . . . 28.0 111.758 168.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1329 ' ' THR . . . . . 0.599 HG21 ' HA3' ' B' 1161 ' ' GLY . 11.9 m -69.79 -36.41 75.67 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 118.775 -2.603 . . . . 32.149999999999999 110.783 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1330 ' ' ASN . . . . . . . . . . . . . 33.7 m120 -61.73 -42.73 99.34 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 120.039 1.29 . . . . 34.359999999999999 108.918 171.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1331 ' ' LEU . . . . . 0.668 HD13 HD13 ' A' 1070 ' ' LEU . 22.4 mt -68.49 -39.14 81.43 Favored 'General case' 0 C--O 1.216 -0.663 0 O-C-N 121.439 -0.788 . . . . 33.369999999999997 112.515 -177.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1332 ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' 1328 ' ' GLY . 73.1 t -61.76 -46.38 96.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 105.403 -2.073 . . . . 35.270000000000003 105.403 175.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -55.51 -43.26 75.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 115.409 1.633 . . . . 37.659999999999997 115.409 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1334 ' ' LEU . . . . . . . . . . . . . 14.9 tp -62.92 -54.19 42.4 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 125.157 1.536 . . . . 40.270000000000003 109.831 174.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1335 ' ' LEU . . . . . 0.686 ' HA ' ' HB2' ' A' 1338 ' ' LEU . 39.6 mt -65.73 -17.31 64.52 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 118.16 -0.924 . . . . 42.5 113.391 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1336 ' ' LYS . . . . . . . . . . . . . 79.0 mttt -63.07 -49.09 75.9 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.033 -1.099 . . . . 47.810000000000002 108.033 169.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1337 ' ' LEU . . . . . 0.411 HD12 HD21 ' A' 1127 ' ' LEU . 77.4 mt -81.99 -20.28 38.81 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-O 124.212 1.958 . . . . 49.270000000000003 112.06 -176.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1338 ' ' LEU . . . . . 0.686 ' HB2' ' HA ' ' A' 1335 ' ' LEU . 9.2 mp -75.99 -24.96 55.37 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 113.546 -1.661 . . . . 50.539999999999999 112.503 169.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1339 ' ' CYS . . . . . . . . . . . . . 47.3 t -131.5 71.66 1.48 Allowed 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 102.57 -3.122 . . . . 53.670000000000002 102.57 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -67.77 -40.6 84.01 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 115.69 -0.686 . . . . 63.380000000000003 112.302 -177.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -72.06 -43.45 64.88 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 118.169 2.655 . . . . 70.950000000000003 118.169 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1342 ' ' LYS . . . . . 0.54 ' N ' ' HB3' ' A' 1343 ' ' ASP . 7.3 mtpm? 55.1 77.42 0.22 Allowed 'General case' 0 C--O 1.241 0.631 0 C-N-CA 125.505 1.522 . . . . 65.25 114.771 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1343 ' ' ASP . . . . . 0.54 ' HB3' ' N ' ' A' 1342 ' ' LYS 0.34 1.9 t70 78.3 -80.88 0.03 OUTLIER 'General case' 0 C--O 1.251 1.159 2 O-C-N 113.511 -5.743 . . . . 64.530000000000001 116.93 -6.638 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A 1344 ' ' GLY . . . . . 0.503 ' H ' ' HA ' ' A' 1342 ' ' LYS . . . 76.16 65.09 2.08 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 119.005 0.82 . . . . 59.719999999999999 112.855 -170.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 11.0 t30 -144.14 140.61 29.49 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.764 -0.458 . . . . 64.090000000000003 109.764 171.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1346 ' ' ILE . . . . . 0.504 HD12 ' H ' ' A' 1346 ' ' ILE . 3.4 mp -79.51 90.29 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 122.961 1.363 . . . . 58.82 107.628 -171.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1347 ' ' THR . . . . . . . . . . . . . 28.6 m -89.62 89.96 8.04 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-O 124.916 2.293 . . . . 54.960000000000001 109.147 175.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1348 ' ' VAL . . . . . . . . . . . . . 92.8 t -74.2 120.34 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 112.678 -2.055 . . . . 55.640000000000001 106.524 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1349 ' ' ASP . . . . . 0.441 ' H ' HG21 ' A' 1355 ' ' ILE . 1.5 t70 -94.44 148.64 22.03 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 119.544 1.065 . . . . 61.450000000000003 109.856 -176.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -109.28 -38.33 5.53 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.131 -0.941 . . . . 58.630000000000003 113.011 170.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 46.2 t0 -68.97 -29.8 68.1 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 123.463 1.601 . . . . 62.060000000000002 109.16 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 10.8 t70 -76.34 96.99 4.11 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 105.576 -2.009 . . . . 54.07 105.576 169.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1353 ' ' VAL . . . . . 0.577 ' HA ' ' HB3' ' A' 1356 ' ' ARG . 33.8 m -57.66 -29.7 35.25 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.669 0 CA-C-O 116.099 -1.905 . . . . 50.68 113.138 -174.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1354 ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' 1358 ' ' VAL . 1.5 m -69.05 -35.56 69.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 123.218 2.735 . . . . 47.68 112.633 176.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1355 ' ' ILE . . . . . 0.441 HG21 ' H ' ' A' 1349 ' ' ASP . 75.1 mt -68.93 -45.13 80.92 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 N-CA-C 107.066 -1.457 . . . . 48.490000000000002 107.066 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1356 ' ' ARG . . . . . 0.577 ' HB3' ' HA ' ' A' 1353 ' ' VAL . 46.3 tpt85 -52.1 -34.99 46.52 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 119.868 -1.77 . . . . 48.270000000000003 112.997 172.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -59.69 -62.91 5.59 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 114.685 0.634 . . . . 43.530000000000001 114.685 168.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1358 ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' 1354 ' ' VAL . 14.9 t -58.46 -37.08 62.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 O-C-N 124.848 0.97 . . . . 45.119999999999997 111.699 -177.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1359 ' ' THR . . . . . . . . . . . . . 12.7 m -72.16 78.05 0.96 Allowed 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 124.609 2.147 . . . . 42.939999999999998 109.803 175.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 29.6 m -74.56 -35.77 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 CA-C-N 113.249 -1.796 . . . . 43.259999999999998 109.719 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1361 ' ' ILE . . . . . 0.531 ' HB ' ' HB ' ' A' 1112 ' ' VAL . 60.9 mt -133.08 134.19 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 103.301 -2.852 . . . . 45.659999999999997 103.301 176.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1362 ' ' ARG . . . . . 0.494 ' HA ' ' HA ' ' A' 1111 ' ' THR . 30.2 ttt180 -123.02 121.18 35.44 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 122.689 2.495 . . . . 61.340000000000003 111.328 169.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 46.69 44.21 13.58 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 127.354 2.909 . . . . 49.759999999999998 110.322 173.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1364 ' ' GLY . . . . . 0.731 ' HA2' ' HA ' ' A' 1109 ' ' ASN . . . 115.94 -60.99 0.4 Allowed Glycine 0 C--N 1.347 1.154 0 N-CA-C 117.444 1.738 . . . . 50.0 117.444 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -82.88 130.92 35.2 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 119.619 -0.832 . . . . 56.920000000000002 110.321 -175.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1366 ' ' ILE . . . . . 0.491 HG12 HG12 ' A' 1361 ' ' ILE . 71.9 mt -64.64 118.74 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 N-CA-C 108.388 -0.967 . . . . 52.780000000000001 108.388 174.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1367 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.79 -0.13 43.22 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 112.613 -2.085 . . . . 49.439999999999998 115.975 173.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 7.2 t90 -63.45 150.08 90.6 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-O 115.312 -2.28 . . . . 52.380000000000003 112.412 173.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -78.21 -150.69 0.62 Allowed 'Cis proline' 0 CA--C 1.544 1.021 1 CA-C-N 129.259 4.342 . . . . 46.939999999999998 111.722 -8.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1370 ' ' ALA . . . . . . . . . . . . 0.264 . . -150.38 156.15 36.9 Favored Pre-proline 0 C--N 1.352 0.708 0 N-CA-C 108.328 -0.99 . . . . 45.909999999999997 108.328 -175.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1371 ' ' PRO . . . . . 0.451 ' HA ' ' HD2' ' A' 1372 ' ' PRO . 7.1 Cg_exo -43.16 117.98 1.16 Allowed 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 125.105 3.87 . . . . 46.390000000000001 114.782 169.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1372 ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' 1371 ' ' PRO . 72.1 Cg_endo -74.39 4.35 4.5 Favored 'Trans proline' 0 N--CA 1.485 0.994 0 C-N-CA 123.973 3.115 . . . . 46.719999999999999 116.93 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.217 -5.184 0 O-C-N 120.477 -1.389 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 73.9 m80 . . . . . 0 N--CA 1.427 -1.586 0 N-CA-C 105.691 -1.966 . . . . 63.439999999999998 105.691 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -123.62 43.56 2.93 Favored 'General case' 0 C--O 1.256 1.419 0 O-C-N 117.999 -2.938 . . . . 51.740000000000002 114.885 -173.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1000 ' ' HIS . . . . . 0.625 ' HA ' ' HB2' ' B' 1067 ' ' GLU . 17.1 m-70 -69.97 144.11 52.43 Favored 'General case' 0 C--O 1.258 1.533 0 CA-C-O 123.742 1.734 . . . . 54.07 108.096 167.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1001 ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' B' 1344 ' ' GLY . . . 76.98 -12.18 12.49 Favored Glycine 0 CA--C 1.534 1.259 0 O-C-N 120.967 -1.083 . . . . 39.219999999999999 112.169 -168.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1002 ' ' ARG . . . . . 0.438 ' O ' ' HB3' ' B' 1066 ' ' SER . 35.7 ttp180 -97.96 142.02 30.2 Favored 'General case' 0 CA--C 1.491 -1.299 0 CA-C-N 120.105 1.953 . . . . 38.119999999999997 109.37 174.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1003 ' ' ILE . . . . . . . . . . . . . 21.1 mt -98.74 154.77 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 N-CA-C 106.03 -1.841 . . . . 29.699999999999999 106.03 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -123.59 128.08 6.81 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 108.604 -1.799 . . . . 27.5 108.604 164.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1005 ' ' ILE . . . . . 0.783 HG23 ' HB3' ' B' 1017 ' ' ALA . 40.8 mm -116.33 112.11 41.81 Favored Pre-proline 0 C--O 1.243 0.729 0 N-CA-C 104.161 -2.533 . . . . 24.829999999999998 104.161 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1006 ' ' PRO . . . . . 0.519 ' HG2' ' HG2' ' B' 1071 ' ' LYS . 85.4 Cg_exo -74.88 154.2 42.94 Favored 'Trans proline' 0 N--CA 1.446 -1.314 1 C-N-CA 125.814 4.343 . . . . 27.190000000000001 111.189 176.37 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 63.6 ttt-85 -78.08 125.0 28.71 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 101.877 -3.379 . . . . 41.460000000000001 101.877 164.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1008 ' ' GLU . . . . . 0.607 ' HG3' ' HB ' ' B' 1072 ' ' VAL 0.411 0.3 OUTLIER -78.43 126.68 31.11 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 118.899 2.925 . . . . 26.93 118.899 -175.436 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 37.2 mtm180 -98.1 11.46 37.59 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 113.466 -1.697 . . . . 34.479999999999997 113.374 -170.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1010 ' ' LEU . . . . . . . . . . . . . 31.9 tp -66.95 143.41 56.82 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 119.803 -1.81 . . . . 44.219999999999999 109.051 175.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1011 ' ' THR . . . . . . . . . . . . . 57.9 m -67.57 147.69 52.42 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 122.304 2.32 . . . . 40.740000000000002 110.097 165.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 60.8 m-80 58.36 58.06 3.6 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-O 124.231 1.967 . . . . 44.439999999999998 110.836 -175.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1013 ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -137.75 143.89 41.38 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.87 -1.514 . . . . 29.870000000000001 109.269 -174.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1014 ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' B' 1320 ' ' PRO . 0.2 OUTLIER -137.65 3.37 2.51 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-O 124.088 1.899 . . . . 25.260000000000002 110.284 174.54 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 50.5 mtm180 -82.8 142.68 31.37 Favored 'General case' 0 C--O 1.24 0.586 0 O-C-N 119.66 -1.9 . . . . 29.539999999999999 112.559 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1016 ' ' VAL . . . . . 0.505 HG21 ' HB1' ' B' 1039 ' ' ALA . 11.1 p -106.43 162.86 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 103.137 -2.912 . . . . 23.550000000000001 103.137 154.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1017 ' ' ALA . . . . . 0.783 ' HB3' HG23 ' B' 1005 ' ' ILE . . . -68.2 -21.01 64.89 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 115.557 1.688 . . . . 23.59 115.557 177.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1018 ' ' ALA . . . . . 0.645 ' HB1' ' HB ' ' B' 1022 ' ' THR . . . -158.33 128.15 5.91 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 119.192 0.905 . . . . 24.93 109.254 175.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1019 ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.29 169.96 17.03 Favored Pre-proline 0 N--CA 1.477 0.895 0 CA-C-O 115.34 -2.267 . . . . 28.09 113.397 172.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -45.22 -50.93 8.38 Favored 'Trans proline' 0 CA--C 1.537 0.631 1 C-N-CA 125.371 4.047 . . . . 28.789999999999999 116.657 175.39 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 56.2 tttt -55.96 -39.45 71.77 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 113.486 0.921 . . . . 47.280000000000001 113.486 173.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1022 ' ' THR . . . . . 0.717 HG21 ' HA3' ' B' 1328 ' ' GLY . 0.3 OUTLIER -70.81 -34.02 71.32 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.401 -0.592 . . . . 30.120000000000001 109.401 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B 1023 ' ' VAL . . . . . 0.522 HG11 ' HB2' ' B' 1055 ' ' ALA . 39.7 t -61.93 -43.12 97.05 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 N-CA-C 108.921 -0.77 . . . . 32.240000000000002 108.921 176.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1024 ' ' GLU . . . . . 0.403 ' HG3' ' HB1' ' B' 1053 ' ' ALA . 40.9 mt-10 -61.5 -39.54 91.33 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 123.446 0.698 . . . . 49.619999999999997 112.35 174.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -55.87 -47.86 76.6 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 122.35 1.072 . . . . 44.68 111.45 174.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 86.1 mt -64.56 -32.48 74.14 Favored 'General case' 0 C--N 1.366 1.294 0 CA-C-N 113.013 -1.903 . . . . 35.710000000000001 110.694 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1027 ' ' LEU . . . . . 0.581 HD11 ' HA3' ' B' 1054 ' ' GLY . 86.5 mt -67.81 -41.22 83.42 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 122.314 1.055 . . . . 42.18 112.739 175.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 61.8 mttm -61.21 -32.8 72.57 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-N 112.918 -1.946 . . . . 48.340000000000003 111.645 176.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1029 ' ' LEU . . . . . 0.548 HD11 HG13 ' B' 1332 ' ' VAL . 93.9 mt -70.13 -3.61 17.51 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 115.637 1.718 . . . . 38.689999999999998 115.637 174.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 96.17 6.72 58.8 Favored Glycine 0 N--CA 1.471 1.007 0 N-CA-C 110.417 -1.073 . . . . 32.280000000000001 110.417 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -97.93 170.81 8.69 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.655 -1.239 . . . . 35.939999999999998 107.655 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1032 ' ' THR . . . . . . . . . . . . . 1.4 p -113.14 148.89 34.44 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 105.906 -1.887 . . . . 33.369999999999997 105.906 170.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1033 ' ' VAL . . . . . 0.444 HG11 HG22 ' B' 1023 ' ' VAL . 15.5 t -114.16 146.81 18.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 O-C-N 117.786 -3.071 . . . . 29.98 108.534 -176.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -125.1 140.84 52.52 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 107.109 -1.441 . . . . 28.18 107.109 163.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1035 ' ' VAL . . . . . 0.453 ' HB ' HD13 ' B' 1057 ' ' ILE . 21.8 t -129.31 146.61 33.96 Favored 'Isoleucine or valine' 0 C--N 1.348 0.528 0 N-CA-C 108.234 -1.024 . . . . 25.82 108.234 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1036 ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -66.11 139.91 58.19 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 121.442 0.639 . . . . 32.439999999999998 112.545 167.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1037 ' ' SER . . . . . . . . . . . . . 48.7 m -52.81 139.52 26.61 Favored 'General case' 0 C--O 1.257 1.478 0 CA-C-N 114.207 -1.36 . . . . 29.539999999999999 114.489 165.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 89.63 0.2 79.28 Favored Glycine 0 C--O 1.252 1.274 0 C-N-CA 121.322 -0.466 . . . . 27.760000000000002 113.271 176.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1039 ' ' ALA . . . . . 0.505 ' HB1' HG21 ' B' 1016 ' ' VAL . . . -64.83 -43.4 93.19 Favored 'General case' 0 CA--C 1.504 -0.796 0 O-C-N 124.502 0.766 . . . . 26.02 110.832 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -49.55 -47.85 36.12 Favored Glycine 0 N--CA 1.419 -2.458 0 C-N-CA 125.663 1.601 . . . . 26.469999999999999 111.118 173.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -53.21 -46.28 68.99 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-N 119.525 1.663 . . . . 50.979999999999997 112.514 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 94.7 mt -61.24 -57.62 11.64 Favored 'General case' 0 C--O 1.211 -0.964 0 N-CA-C 108.074 -1.084 . . . . 29.300000000000001 108.074 174.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1043 ' ' ALA . . . . . . . . . . . . . . . -72.62 11.85 0.57 Allowed 'General case' 0 C--O 1.248 0.982 0 N-CA-C 116.587 2.069 . . . . 26.739999999999998 116.587 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1044 ' ' SER . . . . . 0.435 ' O ' ' HA3' ' A' 1306 ' ' GLY . 17.3 m 46.89 25.24 0.44 Allowed 'General case' 0 C--O 1.248 0.987 0 C-N-CA 126.361 1.864 . . . . 31.260000000000002 113.717 -176.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1045 ' ' PHE . . . . . 0.485 ' HA ' ' HB1' ' A' 1277 ' ' ALA . 0.9 OUTLIER -112.86 155.93 23.82 Favored 'General case' 0 C--O 1.244 0.797 0 O-C-N 119.885 -1.76 . . . . 33.259999999999998 106.962 -177.174 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 11.3 t70 -67.96 126.04 28.22 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.869 -0.789 . . . . 46.740000000000002 108.869 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.8 -42.43 90.68 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 107.621 -1.251 . . . . 34.439999999999998 107.621 -173.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -53.03 -34.84 58.24 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 113.306 0.854 . . . . 48.670000000000002 113.306 172.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1049 ' ' ALA . . . . . 0.521 ' HA ' ' HB2' ' B' 1052 ' ' GLN . . . -62.94 -19.79 64.59 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 116.06 1.874 . . . . 35.259999999999998 116.06 176.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1050 ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -62.77 -42.72 99.82 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 123.396 1.57 . . . . 32.170000000000002 109.996 168.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 18.0 t -67.4 -50.74 59.37 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 O-C-N 119.546 -1.971 . . . . 38.369999999999997 107.061 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1052 ' ' GLN . . . . . 0.521 ' HB2' ' HA ' ' B' 1049 ' ' ALA . 21.5 mt-30 -52.17 -29.72 23.61 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.74 1.216 . . . . 45.770000000000003 114.174 175.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1053 ' ' ALA . . . . . 0.403 ' HB1' ' HG3' ' B' 1024 ' ' GLU . . . -80.55 -40.66 25.51 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 123.936 0.773 . . . . 37.829999999999998 110.584 176.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1054 ' ' GLY . . . . . 0.581 ' HA3' HD11 ' B' 1027 ' ' LEU . . . 134.81 48.73 0.08 OUTLIER Glycine 0 CA--C 1.532 1.141 0 CA-C-O 123.028 1.349 . . . . 35.82 111.657 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1055 ' ' ALA . . . . . 0.522 ' HB2' HG11 ' B' 1023 ' ' VAL . . . -128.74 140.9 51.51 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 108.206 -1.035 . . . . 33.770000000000003 108.206 177.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -76.38 106.79 8.21 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 104.513 -2.403 . . . . 51.020000000000003 104.513 166.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1057 ' ' ILE . . . . . 0.453 HD13 ' HB ' ' B' 1035 ' ' VAL . 13.6 mm -82.5 102.82 8.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 N-CA-C 102.079 -3.304 . . . . 38.469999999999999 102.079 173.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 30.1 m -86.71 159.34 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-N 109.143 -3.662 . . . . 39.399999999999999 108.29 175.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -71.48 -29.24 64.6 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.258 -1.337 . . . . 57.07 114.438 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . 172.79 -97.25 0.12 Allowed Glycine 0 CA--C 1.53 0.976 0 O-C-N 120.359 -1.463 . . . . 44.829999999999998 111.541 176.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -58.6 -32.0 68.58 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 125.632 1.573 . . . . 46.270000000000003 114.057 -170.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1062 ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -44.32 -33.87 1.76 Allowed 'General case' 0 C--O 1.24 0.578 0 N-CA-C 115.215 1.561 . . . . 43.469999999999999 115.215 171.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -54.05 -38.77 38.89 Favored 'Isoleucine or valine' 0 C--N 1.355 0.828 0 C-N-CA 124.385 1.074 . . . . 36.979999999999997 111.491 176.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 96.9 m95 -67.72 -14.38 62.9 Favored 'General case' 0 C--O 1.211 -0.949 0 N-CA-C 116.877 2.177 . . . . 37.899999999999999 116.877 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -99.83 81.58 2.47 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 104.338 -2.467 . . . . 46.189999999999998 104.338 -176.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1066 ' ' SER . . . . . 0.438 ' HB3' ' O ' ' B' 1002 ' ' ARG . 68.5 m -150.65 -178.53 6.61 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 119.006 -2.309 . . . . 37.060000000000002 108.244 -174.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1067 ' ' GLU . . . . . 0.625 ' HB2' ' HA ' ' B' 1000 ' ' HIS . 8.8 tp10 -69.8 -56.12 7.98 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 120.457 -1.402 . . . . 43.950000000000003 109.473 173.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1068 ' ' ILE . . . . . 0.562 HG23 HG13 ' B' 1346 ' ' ILE . 0.8 OUTLIER -123.07 137.88 54.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 107.411 -1.329 . . . . 33.5 107.411 -178.012 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 24.1 mm -111.28 106.81 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 N-CA-C 103.561 -2.755 . . . . 30.57 103.561 170.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1070 ' ' LEU . . . . . 0.715 HD22 HD22 ' B' 1331 ' ' LEU . 86.7 mt -97.23 118.46 33.73 Favored 'General case' 0 CA--C 1.505 -0.781 1 N-CA-C 98.117 -4.771 . . . . 27.66 98.117 -175.812 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B 1071 ' ' LYS . . . . . 0.519 ' HG2' ' HG2' ' B' 1006 ' ' PRO . 10.8 tmtt? -141.33 146.77 37.13 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 104.818 -2.29 . . . . 28.399999999999999 104.818 -164.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1072 ' ' VAL . . . . . 0.607 ' HB ' ' HG3' ' B' 1008 ' ' GLU . 61.8 t -79.93 -61.68 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-N 120.278 1.399 . . . . 23.18 112.462 -170.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1073 ' ' ASN . . . . . 0.468 ' HA ' ' HB2' ' B' 1092 ' ' PHE . 52.9 m-80 -105.95 -161.76 0.82 Allowed 'General case' 0 C--O 1.237 0.443 0 N-CA-C 106.269 -1.752 . . . . 25.469999999999999 106.269 -173.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -61.65 148.68 86.4 Favored Pre-proline 0 C--O 1.259 1.564 0 N-CA-C 112.999 0.74 . . . . 27.899999999999999 112.999 177.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -66.56 125.49 13.95 Favored 'Trans proline' 0 CA--C 1.556 1.608 0 N-CA-C 107.939 -1.6 . . . . 31.620000000000001 107.939 162.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 57.1 mt -69.14 162.18 27.55 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 107.696 -1.224 . . . . 40.490000000000002 107.696 169.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1077 ' ' ASP . . . . . 0.541 ' HA ' HD12 ' B' 1080 ' ' ILE . 1.3 m-20 -69.16 -23.63 63.97 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 118.711 2.856 . . . . 51.590000000000003 118.711 -160.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -66.27 -51.36 58.28 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 112.835 -1.984 . . . . 42.359999999999999 110.553 166.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1079 ' ' GLU . . . . . 0.419 ' HA ' HD12 ' B' 1082 ' ' LEU . 58.6 mt-10 -55.62 -37.35 68.04 Favored 'General case' 0 C--O 1.249 1.042 0 O-C-N 120.667 -1.271 . . . . 34.530000000000001 109.116 173.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1080 ' ' ILE . . . . . 0.612 HD11 HD12 ' B' 1101 ' ' LEU . 73.1 mt -59.28 -50.43 79.86 Favored 'Isoleucine or valine' 0 C--N 1.356 0.891 0 C-N-CA 123.666 0.786 . . . . 33.25 110.355 173.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -63.45 -15.14 56.82 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 118.544 -0.741 . . . . 36.469999999999999 112.837 174.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1082 ' ' LEU . . . . . 0.419 HD12 ' HA ' ' B' 1079 ' ' GLU . 41.3 mt -86.45 -24.31 25.68 Favored 'General case' 0 C--N 1.353 0.728 0 CA-C-N 120.466 1.485 . . . . 37.759999999999998 113.553 171.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1083 ' ' LEU . . . . . 0.674 ' HB3' HG11 ' B' 1110 ' ' VAL . 12.7 mt -55.2 123.99 15.51 Favored 'General case' 0 C--O 1.25 1.125 0 N-CA-C 115.629 1.714 . . . . 37.43 115.629 -178.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.09 129.35 56.37 Favored Pre-proline 0 N--CA 1.439 -0.991 0 CA-C-N 114.797 -1.092 . . . . 37.700000000000003 110.891 -172.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -58.63 123.07 12.75 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 124.55 3.5 . . . . 35.509999999999998 109.11 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 115.36 -60.49 0.4 Allowed Glycine 0 C--O 1.244 0.771 0 O-C-N 126.955 2.659 . . . . 33.869999999999997 108.097 -172.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1087 ' ' THR . . . . . . . . . . . . . 97.9 m -41.57 130.97 3.09 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 126.757 2.023 . . . . 32.5 116.059 -165.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1088 ' ' THR . . . . . 0.682 ' HA ' ' HB ' ' B' 1111 ' ' THR . 10.0 m -73.68 106.75 5.57 Favored 'General case' 0 C--O 1.216 -0.7 0 N-CA-C 107.306 -1.368 . . . . 30.219999999999999 107.306 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1089 ' ' LEU . . . . . 0.476 HD13 HD21 ' B' 1083 ' ' LEU . 20.7 tp -96.91 133.05 42.05 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 103.38 -2.822 . . . . 27.239999999999998 103.38 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1090 ' ' VAL . . . . . 0.6 HG13 ' HB2' ' B' 1113 ' ' MET . 15.1 t -134.48 109.93 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 106.889 -1.523 . . . . 25.390000000000001 106.889 -174.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1091 ' ' SER . . . . . . . . . . . . . 2.6 m -159.23 168.92 25.28 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.84 0.829 . . . . 28.809999999999999 112.127 -166.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1092 ' ' PHE . . . . . 0.536 ' CD1' ' HB3' ' B' 1116 ' ' ASP . 19.9 m-85 -66.1 107.41 1.91 Allowed 'General case' 0 C--O 1.247 0.973 0 CA-C-O 124.42 2.057 . . . . 30.780000000000001 110.933 161.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 45.3 mm -103.53 -37.84 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 O-C-N 120.172 -1.58 . . . . 30.280000000000001 110.552 -176.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1094 ' ' TRP . . . . . 0.436 ' HB2' ' OD1' ' B' 1098 ' ' ASN . 58.8 m95 53.57 54.79 12.61 Favored Pre-proline 0 C--O 1.249 1.078 0 O-C-N 124.456 1.098 . . . . 34.07 110.342 -174.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1095 ' ' PRO . . . . . 0.458 ' HG2' HG11 ' B' 1360 ' ' VAL . 71.1 Cg_exo -39.6 -60.65 0.51 Allowed 'Trans proline' 0 C--N 1.355 0.872 1 C-N-CA 126.5 4.8 . . . . 38.659999999999997 118.433 -167.046 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -62.94 -28.27 69.95 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 119.287 -2.133 . . . . 41.32 112.838 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -82.65 -22.11 34.77 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 122.543 1.163 . . . . 51.659999999999997 112.578 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1098 ' ' ASN . . . . . 0.447 ' HB3' ' HB3' ' B' 1101 ' ' LEU . 20.5 m120 -119.09 58.41 4.01 Favored Pre-proline 0 N--CA 1.447 -0.62 0 N-CA-C 115.511 1.671 . . . . 40.32 115.511 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -57.16 -43.15 55.78 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.561 3.507 . . . . 41.560000000000002 111.593 -173.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -76.51 -32.74 58.47 Favored 'General case' 0 C--O 1.208 -1.091 0 N-CA-C 113.139 0.792 . . . . 54.109999999999999 113.139 -174.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1101 ' ' LEU . . . . . 0.612 HD12 HD11 ' B' 1080 ' ' ILE . 26.6 tp -61.59 -47.99 82.98 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 107.693 -1.225 . . . . 37.880000000000003 107.693 174.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1102 ' ' MET . . . . . . . . . . . . . 69.2 mmm -47.61 -55.15 9.93 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 125.601 1.813 . . . . 37.539999999999999 111.154 173.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -55.98 -45.46 78.95 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-O 118.487 -0.768 . . . . 47.009999999999998 111.527 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1104 ' ' LYS . . . . . . . . . . . . . 88.9 mttt -61.82 -36.99 82.77 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 124.544 2.116 . . . . 48.68 114.146 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1105 ' ' LEU . . . . . . . . . . . . . 43.6 mt -74.63 -32.82 62.41 Favored 'General case' 0 C--O 1.247 0.931 0 O-C-N 119.614 -1.929 . . . . 32.210000000000001 110.03 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -67.69 -43.6 79.74 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.392 0.677 . . . . 33.729999999999997 111.177 175.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -59.45 -41.28 89.3 Favored 'General case' 0 C--O 1.25 1.101 0 N-CA-C 115.128 1.529 . . . . 51.469999999999999 115.128 169.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1108 ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -71.38 -3.83 22.93 Favored 'General case' 0 C--N 1.345 0.407 0 N-CA-C 113.693 0.997 . . . . 43.899999999999999 113.693 170.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1109 ' ' ASN . . . . . . . . . . . . . 8.1 m-80 59.03 32.57 22.35 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.835 1.791 . . . . 44.82 115.835 167.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1110 ' ' VAL . . . . . 0.674 HG11 ' HB3' ' B' 1083 ' ' LEU . 5.8 m -94.92 150.82 3.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-N 114.516 -1.22 . . . . 30.52 109.794 -174.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1111 ' ' THR . . . . . 0.682 ' HB ' ' HA ' ' B' 1088 ' ' THR . 29.9 m -83.16 86.06 7.09 Favored 'General case' 0 C--O 1.247 0.958 0 CA-C-O 122.126 0.965 . . . . 27.120000000000001 110.517 178.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1112 ' ' VAL . . . . . 0.405 ' CG2' HG23 ' B' 1110 ' ' VAL . 6.7 t -86.21 130.72 36.12 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 CA-C-O 121.986 0.898 . . . . 26.399999999999999 109.192 -169.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1113 ' ' MET . . . . . 0.6 ' HB2' HG13 ' B' 1090 ' ' VAL . 10.8 mtt -120.19 124.71 46.39 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 102.651 -3.092 . . . . 42.920000000000002 102.651 175.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -90.65 96.61 10.73 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 113.703 -1.59 . . . . 24.149999999999999 113.888 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1115 ' ' MET . . . . . 0.454 ' CG ' HG12 ' B' 1090 ' ' VAL . 78.9 mmm -56.03 -25.54 45.09 Favored 'General case' 0 C--O 1.22 -0.451 0 N-CA-C 115.479 1.659 . . . . 29.949999999999999 115.479 -178.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1116 ' ' ASP . . . . . 0.536 ' HB3' ' CD1' ' B' 1092 ' ' PHE . 10.6 p-10 -80.14 -37.14 34.12 Favored 'General case' 0 N--CA 1.439 -0.984 0 O-C-N 121.521 -0.737 . . . . 34.530000000000001 109.647 174.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1117 ' ' SER . . . . . . . . . . . . . 57.0 m -102.52 48.16 0.87 Allowed 'General case' 0 C--N 1.355 0.823 0 O-C-N 120.167 -1.583 . . . . 33.490000000000002 108.824 -168.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1118 ' ' VAL . . . . . 0.572 HG21 ' HA ' ' B' 1128 ' ' ASP . 54.5 t -81.63 124.08 80.15 Favored Pre-proline 0 N--CA 1.48 1.048 0 N-CA-C 102.357 -3.201 . . . . 34.020000000000003 102.357 176.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1119 ' ' PRO . . . . . 0.432 ' HG2' ' HA3' ' B' 1357 ' ' GLY . 90.7 Cg_exo -58.06 103.14 0.14 Allowed 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 124.904 3.736 . . . . 38.280000000000001 110.842 -173.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1120 ' ' ARG . . . . . 0.427 ' HB3' ' H4D' ' B' ' 1' ' ' NAD . 13.6 mtm-85 -72.55 71.84 0.98 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 120.338 3.459 . . . . 55.049999999999997 120.338 -159.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1121 ' ' ILE . . . . . . . . . . . . . 44.5 pt -104.48 -161.11 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.815 0 N-CA-C 104.641 -2.355 . . . . 42.090000000000003 104.641 171.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1122 ' ' SER . . . . . . . . . . . . . 31.4 m -74.56 -48.27 27.81 Favored 'General case' 0 N--CA 1.434 -1.259 0 O-C-N 118.12 -2.862 . . . . 38.020000000000003 118.226 -173.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1123 ' ' ARG . . . . . 0.732 ' HD2' HD21 ' B' 1337 ' ' LEU . 10.2 ptt180 -74.71 -21.38 59.41 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 124.305 3.23 . . . . 34.289999999999999 114.125 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1124 ' ' ALA . . . . . . . . . . . . . . . -54.46 -48.92 71.21 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 109.182 -3.644 . . . . 32.350000000000001 109.759 170.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1125 ' ' GLN . . . . . 0.418 ' HA ' ' HB3' ' B' 1128 ' ' ASP . 16.2 mm-40 -54.75 -38.12 66.78 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 114.42 1.267 . . . . 47.170000000000002 114.42 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1126 ' ' SER . . . . . . . . . . . . . 73.9 m -57.03 -36.03 69.98 Favored 'General case' 0 C--O 1.248 1.0 0 CA-C-N 121.088 1.767 . . . . 31.710000000000001 114.093 170.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1127 ' ' LEU . . . . . 0.655 HD11 HD13 ' B' 1337 ' ' LEU . 8.4 mp -87.82 -23.77 23.92 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 114.946 -1.025 . . . . 37.0 112.982 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1128 ' ' ASP . . . . . 0.572 ' HA ' HG21 ' B' 1118 ' ' VAL . 12.5 t70 -78.93 118.77 21.26 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-O 123.434 1.587 . . . . 40.399999999999999 112.549 -170.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1129 ' ' ALA . . . . . 0.435 ' HB2' ' HB3' ' B' 1115 ' ' MET . . . -62.32 -36.55 82.53 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 110.44 -3.073 . . . . 26.559999999999999 111.793 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 39.6 mt -63.09 -23.73 67.58 Favored 'General case' 0 C--O 1.248 0.976 0 CA-C-O 116.512 -1.708 . . . . 30.890000000000001 112.251 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1131 ' ' SER . . . . . . . . . . . . . 86.0 p -65.84 -57.5 7.79 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 122.611 2.46 . . . . 29.84 107.932 177.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1132 ' ' SER . . . . . . . . . . . . . 73.4 m -60.74 -43.24 98.19 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.259 -1.337 . . . . 31.91 111.223 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1133 ' ' MET . . . . . 0.509 ' HB3' ' HB3' ' B' 1316 ' ' PRO . 31.2 mmt -60.56 -37.98 83.04 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 115.504 1.668 . . . . 25.899999999999999 115.504 174.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1134 ' ' ALA . . . . . 0.76 ' HB1' ' HB2' ' B' 1176 ' ' ALA . . . -68.77 -41.75 78.39 Favored 'General case' 0 C--N 1.352 0.679 0 C-N-CA 119.929 -0.708 . . . . 26.620000000000001 109.182 174.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.27 -38.82 90.8 Favored 'General case' 0 C--O 1.206 -1.195 0 C-N-CA 125.076 1.35 . . . . 36.969999999999999 109.997 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1136 ' ' ILE . . . . . 0.602 HD13 ' HE1' ' A' 1152 ' ' PHE . 15.0 mm -58.7 -55.4 23.21 Favored 'Isoleucine or valine' 0 C--N 1.352 0.695 0 N-CA-C 106.337 -1.727 . . . . 32.109999999999999 106.337 172.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1137 ' ' ALA . . . . . 0.463 ' HA ' ' HB3' ' B' 1140 ' ' ARG . . . -61.95 -25.79 67.81 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 116.019 1.859 . . . . 24.140000000000001 116.019 178.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -65.5 -57.83 10.58 Favored Glycine 0 N--CA 1.466 0.699 0 CA-C-N 120.982 1.719 . . . . 25.129999999999999 110.28 174.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 77.9 t80 -53.55 -43.8 68.74 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 123.663 1.697 . . . . 32.729999999999997 110.534 172.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1140 ' ' ARG . . . . . 0.463 ' HB3' ' HA ' ' B' 1137 ' ' ALA . 9.1 tpt180 -70.61 -25.95 63.28 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 113.78 -1.555 . . . . 26.359999999999999 110.492 -174.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1141 ' ' ALA . . . . . 0.405 ' HA ' HG11 ' B' 1282 ' ' VAL . . . -62.89 -49.63 74.05 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 120.661 1.573 . . . . 24.120000000000001 107.978 172.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 32.5 mm -56.94 -43.89 81.46 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 CA-C-O 118.697 -0.668 . . . . 23.370000000000001 110.801 175.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 70.4 t -68.1 -59.26 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 N-CA-C 112.573 0.582 . . . . 24.960000000000001 112.573 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1144 ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' B' 1147 ' ' HIS . 67.4 mm-40 -60.1 -35.83 76.08 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 119.145 -0.455 . . . . 32.07 110.306 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1145 ' ' ALA . . . . . 0.558 ' HB1' HD12 ' B' 1251 ' ' ILE . . . -51.74 -60.32 3.3 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 119.145 0.884 . . . . 24.870000000000001 111.365 167.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1146 ' ' ALA . . . . . 0.559 ' HB2' ' HE1' ' B' 1153 ' ' PHE . . . -58.53 -22.94 57.01 Favored 'General case' 0 C--N 1.348 0.506 0 N-CA-C 114.663 1.357 . . . . 24.670000000000002 114.663 177.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1147 ' ' HIS . . . . . 0.465 ' HB3' ' O ' ' B' 1144 ' ' GLU . 26.8 t60 -63.15 -43.94 96.92 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 120.84 -1.163 . . . . 28.579999999999998 108.97 171.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1148 ' ' GLU . . . . . 0.588 ' HG3' HD13 ' B' 1300 ' ' ILE . 69.7 mm-40 -107.07 3.92 26.39 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 116.996 2.221 . . . . 36.82 116.996 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1149 ' ' PHE . . . . . 0.404 ' HE2' ' HB2' ' B' 1166 ' ' ALA . 1.1 t80 -71.53 140.69 49.99 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-O 124.733 2.206 . . . . 31.969999999999999 107.015 -178.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1150 ' ' GLY . . . . . . . . . . . . . . . -71.29 -42.17 57.84 Favored Glycine 0 N--CA 1.42 -2.423 0 CA-C-N 111.079 -2.782 . . . . 25.489999999999998 110.858 170.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1151 ' ' ARG . . . . . 0.622 ' HA ' ' HB2' ' A' 1322 ' ' GLN . 58.7 mtm-85 -110.58 179.36 4.09 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 123.961 3.881 . . . . 59.840000000000003 113.46 -168.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1152 ' ' PHE . . . . . 0.516 ' HB2' HG11 ' B' 1163 ' ' VAL . 12.1 m-30 -72.9 163.52 28.03 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 120.147 -1.596 . . . . 34.450000000000003 109.383 167.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1153 ' ' PHE . . . . . 0.559 ' HE1' ' HB2' ' B' 1146 ' ' ALA . 17.2 m-85 -82.24 -51.7 7.67 Favored 'General case' 0 C--O 1.257 1.484 0 N-CA-C 107.586 -1.265 . . . . 31.170000000000002 107.586 166.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1154 ' ' THR . . . . . . . . . . . . . 45.5 m -65.55 127.98 34.06 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 113.02 -1.9 . . . . 33.890000000000001 109.724 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -78.86 72.22 2.47 Favored Glycine 0 C--O 1.251 1.217 0 N-CA-C 109.247 -1.541 . . . . 38.950000000000003 109.247 172.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -85.03 131.75 34.42 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 103.983 -2.599 . . . . 54.229999999999997 103.983 -176.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 24.7 mm -84.16 93.54 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 N-CA-C 100.719 -3.808 . . . . 51.159999999999997 100.719 173.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1158 ' ' THR . . . . . . . . . . . . . 26.0 m -81.33 166.52 20.4 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.083 -1.08 . . . . 49.609999999999999 108.083 -170.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -51.09 -58.32 6.4 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 117.403 -1.285 . . . . 49.049999999999997 112.769 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1160 ' ' ALA . . . . . 0.531 ' HB3' HD22 ' A' 1326 ' ' LEU . . . -44.3 -53.12 7.0 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 116.984 2.216 . . . . 47.649999999999999 116.984 170.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1161 ' ' GLY . . . . . 0.599 ' HA3' HG21 ' A' 1329 ' ' THR . . . -177.96 -177.05 46.44 Favored Glycine 0 N--CA 1.426 -1.974 0 N-CA-C 109.103 -1.599 . . . . 45.609999999999999 109.103 -174.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 87.8 mttt -75.24 138.21 41.75 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.181 -1.009 . . . . 57.460000000000001 108.538 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1163 ' ' VAL . . . . . 0.516 HG11 ' HB2' ' B' 1152 ' ' PHE . 45.7 t -91.34 125.85 56.72 Favored Pre-proline 0 CA--C 1.511 -0.529 0 O-C-N 121.395 -0.816 . . . . 42.93 109.322 170.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1164 ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' B' 1165 ' ' PRO . 49.7 Cg_exo -66.22 122.06 9.49 Favored 'Trans proline' 0 C--O 1.26 1.587 0 C-N-CA 123.917 3.078 . . . . 39.289999999999999 106.029 158.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1165 ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' B' 1164 ' ' PRO . 31.3 Cg_exo -76.61 168.24 24.03 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.876 3.717 . . . . 34.170000000000002 114.091 -174.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1166 ' ' ALA . . . . . 0.426 ' HB2' ' HA ' ' B' 1153 ' ' PHE . . . -76.5 123.49 26.12 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 114.309 -1.314 . . . . 31.690000000000001 112.633 170.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1167 ' ' LYS . . . . . 0.718 ' HB2' ' HA ' ' B' 1249 ' ' VAL . 70.7 mttt -92.4 107.56 19.31 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 125.228 2.442 . . . . 44.780000000000001 110.495 165.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 40.2 t -91.76 94.68 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 113.902 -1.499 . . . . 31.23 109.314 -171.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1169 ' ' MET . . . . . 0.644 ' HB2' HG11 ' B' 1249 ' ' VAL . 40.6 ttp -88.99 96.36 10.7 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 123.415 1.579 . . . . 37.090000000000003 107.167 -177.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1170 ' ' VAL . . . . . 0.46 ' HA ' ' HB ' ' B' 1253 ' ' VAL . 38.8 t -83.75 114.78 24.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 113.242 -1.799 . . . . 30.170000000000002 107.974 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1171 ' ' ILE . . . . . 0.464 ' CD1' HD11 ' B' 1267 ' ' ILE . 78.9 mt -104.23 114.65 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 106.943 -1.502 . . . . 33.740000000000002 106.943 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 94.74 66.09 1.0 Allowed Glycine 0 N--CA 1.421 -2.313 0 N-CA-C 108.504 -1.839 . . . . 32.590000000000003 108.504 -177.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1173 ' ' ALA . . . . . 0.583 ' H ' ' HB2' ' B' 1195 ' ' ASP . . . -59.05 -9.03 1.68 Allowed 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 116.638 2.088 . . . . 32.420000000000002 116.638 -177.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -61.53 128.68 43.9 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 115.122 0.809 . . . . 31.739999999999998 115.122 173.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 22.4 t 56.19 -82.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 127.453 2.301 . . . . 31.48 111.407 170.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1176 ' ' ALA . . . . . 0.76 ' HB2' ' HB1' ' B' 1134 ' ' ALA . . . -65.53 -42.93 91.44 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.7 -1.222 . . . . 26.120000000000001 107.7 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1177 ' ' GLY . . . . . 0.502 ' O ' HG13 ' B' 1181 ' ' ILE . . . -52.71 -52.79 36.24 Favored Glycine 0 N--CA 1.43 -1.763 0 CA-C-N 118.665 0.666 . . . . 25.73 113.2 172.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1178 ' ' LEU . . . . . 0.524 ' HB3' ' HD2' ' C' ' 76' ' ' PRO . 96.6 mt -53.3 -46.67 69.44 Favored 'General case' 0 C--O 1.241 0.65 0 O-C-N 120.79 -1.418 . . . . 32.590000000000003 113.858 173.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -61.82 -40.17 94.34 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 120.23 -0.588 . . . . 27.719999999999999 111.365 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -66.34 -38.32 87.38 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 120.686 1.585 . . . . 26.030000000000001 108.907 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1181 ' ' ILE . . . . . 0.735 HG23 HG11 ' B' 1191 ' ' VAL . 70.9 mt -65.27 -47.16 88.36 Favored 'Isoleucine or valine' 0 C--N 1.36 1.033 0 O-C-N 125.347 1.654 . . . . 28.609999999999999 110.229 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -52.5 -55.24 23.47 Favored Glycine 0 N--CA 1.435 -1.374 0 C-N-CA 125.792 1.663 . . . . 25.23 111.376 174.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -61.96 -51.8 66.62 Favored 'General case' 0 C--O 1.251 1.166 0 C-N-CA 123.346 0.659 . . . . 24.09 111.425 -174.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -62.52 -41.09 98.63 Favored 'General case' 0 C--O 1.247 0.948 0 O-C-N 123.75 0.657 . . . . 26.68 111.123 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -63.31 -37.93 89.18 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 120.13 -1.606 . . . . 36.57 113.009 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1186 ' ' SER . . . . . . . . . . . . . 73.2 m -57.85 -49.83 75.37 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-O 122.804 1.287 . . . . 28.920000000000002 110.15 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1187 ' ' LEU . . . . . 0.817 ' HA ' ' HB3' ' A' 1186 ' ' SER . 12.6 mt -62.11 -21.89 65.36 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 118.192 2.664 . . . . 29.09 118.192 169.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 75.02 35.38 49.95 Favored Glycine 0 N--CA 1.433 -1.53 0 N-CA-C 109.053 -1.619 . . . . 29.260000000000002 109.053 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1189 ' ' ALA . . . . . . . . . . . . . . . -81.46 151.02 28.05 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.098 -1.816 . . . . 30.16 106.098 167.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1190 ' ' ILE . . . . . 0.458 ' HB ' ' HG2' ' B' 1167 ' ' LYS . 73.8 mt -78.74 97.49 2.35 Favored 'Isoleucine or valine' 0 C--O 1.246 0.914 0 N-CA-C 106.603 -1.629 . . . . 35.810000000000002 106.603 -174.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1191 ' ' VAL . . . . . 0.735 HG11 HG23 ' B' 1181 ' ' ILE . 57.7 t -79.94 136.75 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-N 115.408 -0.815 . . . . 31.969999999999999 109.102 -178.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1192 ' ' ARG . . . . . 0.69 ' HG2' ' HB2' ' B' 1210 ' ' GLU . 89.7 mtt180 -131.9 127.27 36.1 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 104.426 -2.435 . . . . 48.159999999999997 104.426 167.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -134.64 158.21 44.63 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 124.084 1.897 . . . . 35.890000000000001 115.618 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1194 ' ' PHE . . . . . 0.446 ' HB2' HD12 ' B' 1212 ' ' LEU . 35.5 t80 -139.28 132.98 30.63 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 114.029 -1.441 . . . . 41.880000000000003 107.167 -171.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1195 ' ' ASP . . . . . 0.829 ' HB3' HG21 ' B' 1200 ' ' VAL . 10.0 t70 -159.08 152.44 22.6 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 106.448 -1.686 . . . . 38.280000000000001 106.448 167.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1196 ' ' THR . . . . . . . . . . . . . 2.2 p -63.01 -44.3 96.37 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 113.997 1.11 . . . . 40.619999999999997 113.997 -177.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1197 ' ' ARG . . . . . 0.418 ' O ' HG22 ' B' 1200 ' ' VAL . 28.4 mtm180 -74.09 125.99 89.62 Favored Pre-proline 0 C--O 1.252 1.195 0 C-N-CA 119.67 -0.812 . . . . 53.090000000000003 111.711 -168.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -44.23 -33.79 6.32 Favored 'Trans proline' 0 C--O 1.248 0.984 1 C-N-CA 125.724 4.283 . . . . 42.560000000000002 118.219 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -54.05 -30.07 46.45 Favored 'General case' 0 C--N 1.347 0.479 0 N-CA-C 116.929 2.196 . . . . 56.310000000000002 116.929 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1200 ' ' VAL . . . . . 0.829 HG21 ' HB3' ' B' 1195 ' ' ASP . 6.4 m -71.82 -29.47 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 O-C-N 124.554 1.159 . . . . 42.909999999999997 110.196 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 34.9 tttm -54.58 -48.14 72.47 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 125.714 1.884 . . . . 48.890000000000001 113.6 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.93 -48.87 77.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 117.658 -1.163 . . . . 51.700000000000003 108.869 175.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1203 ' ' GLN . . . . . 0.846 ' HG2' ' HG3' ' C' ' 74' ' ' ARG . 54.5 mt-30 -58.89 -46.37 88.02 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 125.225 1.578 . . . . 52.57 113.978 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1204 ' ' VAL . . . . . 0.445 ' O ' ' HB3' ' B' 1209 ' ' ALA . 48.5 t -62.52 -46.48 96.29 Favored 'Isoleucine or valine' 0 C--O 1.257 1.498 0 CA-C-N 120.429 1.468 . . . . 33.789999999999999 107.744 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -54.85 -38.77 67.86 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.563 1.145 . . . . 36.579999999999998 114.025 173.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1206 ' ' SER . . . . . . . . . . . . . 12.0 m -63.38 -37.03 85.68 Favored 'General case' 0 C--N 1.347 0.482 0 O-C-N 121.171 -0.955 . . . . 39.609999999999999 110.215 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1207 ' ' MET . . . . . 0.534 ' SD ' HD22 ' C' ' 75' ' ' LEU . 4.9 mtt -87.63 28.34 1.01 Allowed 'General case' 0 C--O 1.248 1.013 0 O-C-N 117.659 -3.151 . . . . 37.450000000000003 113.906 -175.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 55.45 30.57 55.85 Favored Glycine 0 CA--C 1.538 1.516 0 O-C-N 120.589 -1.319 . . . . 31.870000000000001 113.737 -176.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1209 ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' B' 1204 ' ' VAL . . . -119.04 142.01 48.22 Favored 'General case' 0 N--CA 1.428 -1.541 0 O-C-N 119.582 -2.128 . . . . 35.399999999999999 108.87 -164.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1210 ' ' GLU . . . . . 0.69 ' HB2' ' HG2' ' B' 1192 ' ' ARG . 34.5 mt-10 -80.61 129.08 34.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 118.694 -1.202 . . . . 47.890000000000001 108.846 -176.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 45.5 t80 -90.09 132.7 35.28 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 101.473 -3.529 . . . . 45.530000000000001 101.473 178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1212 ' ' LEU . . . . . 0.446 HD12 ' HB2' ' B' 1194 ' ' PHE . 63.4 mt -84.73 121.58 27.89 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 103.689 -2.708 . . . . 46.329999999999998 103.689 173.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -68.81 147.94 51.02 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 115.496 1.665 . . . . 60.409999999999997 115.496 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 21.5 mt -66.6 140.64 57.96 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 112.588 -2.096 . . . . 57.380000000000003 107.002 167.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1215 ' ' ASP . . . . . 0.43 ' H ' ' HE1' ' B' 1234 ' ' PHE . 23.4 t70 . . . . . 0 N--CA 1.433 -1.325 0 N-CA-C 107.472 -1.307 . . . . 65.069999999999993 107.472 177.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1230 ' ' MET . . . . . 0.417 ' HB3' ' CB ' ' B' 1234 ' ' PHE . 5.4 mmm . . . . . 0 N--CA 1.433 -1.319 0 N-CA-C 104.705 -2.331 . . . . 80.319999999999993 104.705 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1231 ' ' SER . . . . . . . . . . . . . 2.6 m 78.84 -173.11 0.06 Allowed 'General case' 0 CA--C 1.539 0.542 2 O-C-N 111.99 -6.694 . . . . 79.920000000000002 118.805 -17.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1232 ' ' ASP . . . . . 0.544 ' HA ' HG12 ' B' 1235 ' ' ILE . 23.8 p-10 -43.25 154.99 0.07 Allowed 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 119.203 3.038 . . . . 77.909999999999997 119.203 -177.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 62.97 -59.19 0.15 Allowed 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 112.253 -2.248 . . . . 73.879999999999995 109.439 -159.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1234 ' ' PHE . . . . . 0.43 ' HE1' ' H ' ' B' 1215 ' ' ASP . 8.3 t80 -55.76 -44.78 77.99 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 120.044 -1.66 . . . . 68.980000000000004 113.765 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1235 ' ' ILE . . . . . 0.544 HG12 ' HA ' ' B' 1232 ' ' ASP . 8.0 pt -44.6 -38.88 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 121.772 2.078 . . . . 64.530000000000001 112.754 175.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1236 ' ' LYS . . . . . 0.489 ' HG2' HG13 ' B' 1235 ' ' ILE . 23.7 mmmt -75.83 -38.03 58.48 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 118.055 -0.974 . . . . 66.359999999999999 109.627 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -65.22 -26.22 68.03 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 120.91 1.687 . . . . 56.600000000000001 113.243 175.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -66.45 -47.99 71.4 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 106.786 -1.561 . . . . 56.789999999999999 106.786 175.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1239 ' ' MET . . . . . 0.474 ' HB2' ' O ' ' B' 1236 ' ' LYS . 19.6 mmm -49.84 -49.18 50.06 Favored 'General case' 0 C--O 1.25 1.087 0 O-C-N 124.528 1.143 . . . . 53.630000000000003 111.666 171.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.76 -37.06 85.3 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 121.243 0.544 . . . . 51.740000000000002 110.817 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1241 ' ' LEU . . . . . 0.437 HD21 ' HB3' ' B' 1212 ' ' LEU . 60.3 tp -64.78 -47.94 76.31 Favored 'General case' 0 C--N 1.342 0.25 0 O-C-N 120.555 -1.34 . . . . 44.859999999999999 107.57 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1242 ' ' PHE . . . . . 0.604 ' HE2' HD13 ' B' 1266 ' ' LEU . 14.8 m-30 -65.88 -34.06 77.26 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 124.546 1.138 . . . . 42.780000000000001 111.26 -174.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1243 ' ' ALA . . . . . 0.441 ' HA ' ' HG3' ' B' 1271 ' ' MET . . . -67.14 -51.3 55.61 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 113.929 1.085 . . . . 40.960000000000001 113.929 172.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -69.59 -28.92 66.36 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 122.492 1.139 . . . . 43.060000000000002 108.763 -173.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1245 ' ' GLN . . . . . 0.4 ' O ' HG22 ' B' 1249 ' ' VAL . 43.3 mm-40 -75.53 -37.27 60.18 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.369 -1.457 . . . . 46.450000000000003 112.608 171.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1246 ' ' ALA . . . . . 0.485 ' HA ' HG22 ' B' 1249 ' ' VAL . . . -60.67 -23.42 64.81 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 115.284 1.587 . . . . 41.780000000000001 115.284 177.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1247 ' ' LYS . . . . . 0.404 ' HD2' ' HA ' ' B' 1247 ' ' LYS . 26.0 tptt -62.44 -41.85 99.04 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.196 -0.911 . . . . 52.200000000000003 109.42 171.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1248 ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -91.26 -30.8 16.41 Favored 'General case' 0 C--O 1.244 0.808 0 O-C-N 121.586 -0.696 . . . . 53.549999999999997 112.705 -172.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1249 ' ' VAL . . . . . 0.718 ' HA ' ' HB2' ' B' 1167 ' ' LYS . 19.1 m -84.2 169.43 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 124.684 2.183 . . . . 34.409999999999997 114.808 -173.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1250 ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -111.99 -61.89 1.65 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 111.635 -2.53 . . . . 33.380000000000003 111.573 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1251 ' ' ILE . . . . . 0.582 ' HA ' ' O ' ' B' 1280 ' ' VAL . 48.5 mm -107.24 106.69 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 123.839 0.712 . . . . 29.539999999999999 109.097 -173.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1252 ' ' ILE . . . . . 0.634 ' HB ' HG12 ' B' 1281 ' ' ILE . 51.1 mt -92.41 118.5 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 N-CA-C 105.086 -2.19 . . . . 32.439999999999998 105.086 176.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1253 ' ' VAL . . . . . 0.46 ' HB ' ' HA ' ' B' 1170 ' ' VAL . 72.2 t -102.32 87.29 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.254 1.339 0 N-CA-C 104.634 -2.358 . . . . 30.57 104.634 -178.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1254 ' ' THR . . . . . . . . . . . . 0.331 1.4 t -91.3 103.53 16.18 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 127.096 3.331 . . . . 35.039999999999999 112.739 -175.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1255 ' ' THR . . . . . . . . . . . . . 17.1 m -99.7 -26.89 13.91 Favored 'General case' 0 C--N 1.318 -0.797 1 CA-C-N 106.0 -5.091 . . . . 34.619999999999997 109.451 -177.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1256 ' ' ALA . . . . . 0.495 ' HB3' ' ND2' ' B' 1291 ' ' ASN . . . -47.79 96.65 0.01 OUTLIER 'General case' 0 C--O 1.257 1.475 0 CA-C-N 123.499 2.863 . . . . 42.719999999999999 117.74 -169.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1257 ' ' LEU . . . . . 0.431 HD11 ' HB3' ' B' 1288 ' ' ASN . 3.7 tt -133.9 146.0 50.14 Favored 'General case' 0 C--O 1.251 1.156 0 N-CA-C 101.845 -3.391 . . . . 52.43 101.845 -173.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 64.4 mt -119.08 122.14 29.82 Favored Pre-proline 0 C--N 1.313 -1.002 1 N-CA-C 100.102 -4.036 . . . . 59.409999999999997 100.102 177.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -56.0 126.73 23.35 Favored 'Trans proline' 0 C--O 1.247 0.955 0 C-N-CA 123.441 2.76 . . . . 62.68 115.659 -173.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 82.26 2.0 90.5 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 112.955 -1.929 . . . . 64.159999999999997 111.366 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 85.3 mttt -120.39 145.79 41.36 Favored Pre-proline 0 N--CA 1.475 0.801 0 O-C-N 118.474 -2.78 . . . . 68.530000000000001 105.181 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -56.19 136.56 75.85 Favored 'Trans proline' 0 C--N 1.362 1.273 0 C-N-CA 123.899 3.066 . . . . 61.990000000000002 112.077 164.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1263 ' ' ALA . . . . . 0.549 ' H ' ' HA3' ' B' 1289 ' ' GLY . . . -61.3 119.83 49.66 Favored Pre-proline 0 C--O 1.242 0.671 0 CA-C-N 113.024 -1.898 . . . . 57.149999999999999 112.28 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1264 ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' B' 1263 ' ' ALA . 94.6 Cg_endo -55.08 146.49 58.53 Favored 'Trans proline' 0 CA--C 1.501 -1.157 0 C-N-CA 124.718 3.612 . . . . 51.57 112.339 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -87.91 68.31 9.25 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 122.916 1.341 . . . . 54.549999999999997 109.342 -171.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1266 ' ' LEU . . . . . 0.604 HD13 ' HE2' ' B' 1242 ' ' PHE . 91.0 mt -81.03 -30.15 34.92 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 111.51 -2.586 . . . . 46.859999999999999 111.798 -172.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1267 ' ' ILE . . . . . 0.588 ' HB ' ' HA ' ' B' 1292 ' ' CYS . 28.3 mm -96.82 100.35 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 N-CA-C 104.665 -2.346 . . . . 41.039999999999999 104.665 177.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1268 ' ' THR . . . . . . . . . . . . . 1.1 p -75.03 151.42 38.73 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 125.486 1.741 . . . . 39.579999999999998 113.222 175.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1269 ' ' ARG . . . . . . . . . . . . . 78.1 mtt85 -57.65 -40.85 80.23 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-N 119.805 1.184 . . . . 53.149999999999999 111.5 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -54.61 -43.6 72.37 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 114.759 1.392 . . . . 42.960000000000001 114.759 169.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1271 ' ' MET . . . . . 0.441 ' HG3' ' HA ' ' B' 1243 ' ' ALA . 39.4 ttm -60.8 -47.95 84.0 Favored 'General case' 0 C--O 1.241 0.613 0 O-C-N 120.945 -1.097 . . . . 43.890000000000001 111.846 176.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1272 ' ' VAL . . . . . 0.474 HG13 HD12 ' B' 1281 ' ' ILE . 15.3 t -55.26 -52.4 45.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-N 115.091 -0.959 . . . . 38.369999999999997 110.113 175.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.94 2.24 7.25 Favored 'General case' 0 C--N 1.362 1.129 0 N-CA-C 115.039 1.496 . . . . 47.460000000000001 115.039 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1274 ' ' SER . . . . . . . . . . . . . 50.3 m -97.26 -14.58 21.29 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 114.79 1.404 . . . . 38.380000000000003 114.79 172.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1275 ' ' MET . . . . . 0.487 ' SD ' HD11 ' B' 1281 ' ' ILE . 94.1 mtp -64.14 171.27 3.08 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 116.484 2.031 . . . . 37.810000000000002 116.484 -177.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -66.63 147.21 53.58 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 114.28 -1.327 . . . . 49.259999999999998 109.723 165.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -79.1 161.47 26.49 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.859 0.837 . . . . 34.460000000000001 112.931 174.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 81.3 25.22 55.32 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 112.712 -2.04 . . . . 33.530000000000001 112.926 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1279 ' ' SER . . . . . . . . . . . . . 13.0 m -126.64 165.35 19.38 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 116.439 -1.743 . . . . 31.309999999999999 111.363 -163.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1280 ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' B' 1251 ' ' ILE . 73.8 t -136.7 136.89 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 124.165 3.166 . . . . 29.32 109.856 -171.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1281 ' ' ILE . . . . . 0.634 HG12 ' HB ' ' B' 1252 ' ' ILE . 76.0 mt -113.26 113.36 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 103.735 -2.691 . . . . 31.93 103.735 171.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1282 ' ' VAL . . . . . 0.405 HG11 ' HA ' ' B' 1141 ' ' ALA . 4.0 t -99.33 123.27 51.92 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 N-CA-C 106.408 -1.701 . . . . 29.48 106.408 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 18.2 t0 -93.69 108.76 20.46 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 114.797 -1.092 . . . . 34.5 109.013 174.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1284 ' ' LEU . . . . . 0.495 ' HA ' HD12 ' B' 1315 ' ' LEU . 7.9 mp -84.27 -37.28 21.92 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 104.621 -2.363 . . . . 37.939999999999998 104.621 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -80.57 8.23 8.3 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 122.497 1.141 . . . . 40.920000000000002 113.277 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1286 ' ' ALA . . . . . 0.551 ' HA ' ' HA2' ' B' 1290 ' ' GLY . . . -43.46 -47.0 7.03 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 117.839 2.533 . . . . 44.390000000000001 117.839 175.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1287 ' ' GLN . . . . . 0.443 ' HA ' HG22 ' B' 1313 ' ' THR . 0.6 OUTLIER -75.17 -30.09 60.61 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 112.931 0.715 . . . . 51.460000000000001 112.931 -175.332 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B 1288 ' ' ASN . . . . . 0.431 ' HB3' HD11 ' B' 1257 ' ' LEU . 0.5 OUTLIER -107.52 48.1 0.86 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 122.931 1.348 . . . . 57.75 108.559 178.748 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B 1289 ' ' GLY . . . . . 0.549 ' HA3' ' H ' ' B' 1263 ' ' ALA . . . 129.21 -29.43 3.88 Favored Glycine 0 N--CA 1.428 -1.883 0 O-C-N 119.46 -2.025 . . . . 49.850000000000001 116.381 169.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1290 ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' B' 1286 ' ' ALA . . . 76.88 100.79 0.16 Allowed Glycine 0 C--O 1.245 0.804 0 CA-C-N 119.111 1.456 . . . . 45.93 109.775 -176.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1291 ' ' ASN . . . . . 0.495 ' ND2' ' HB3' ' B' 1256 ' ' ALA . 22.8 t-20 -71.48 -39.99 70.53 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 119.406 -2.232 . . . . 42.670000000000002 113.647 175.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1292 ' ' CYS . . . . . 0.588 ' HA ' ' HB ' ' B' 1267 ' ' ILE . 36.1 t -83.4 150.69 25.9 Favored 'General case' 0 C--O 1.24 0.593 0 O-C-N 119.911 -1.743 . . . . 38.82 106.821 171.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1293 ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -75.39 -49.86 17.68 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 122.58 1.181 . . . . 46.710000000000001 109.251 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1294 ' ' TYR . . . . . 0.444 ' HB3' HG11 ' B' 1309 ' ' VAL . 0.1 OUTLIER -59.13 -18.29 34.44 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 115.655 1.724 . . . . 47.229999999999997 115.655 -174.503 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B 1295 ' ' THR . . . . . 0.515 ' O ' ' HD3' ' B' 1297 ' ' PRO . 97.0 m -37.69 105.17 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 115.64 1.719 . . . . 36.020000000000003 115.64 168.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 71.4 t -88.34 106.18 11.69 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 105.785 -1.931 . . . . 37.259999999999998 105.785 170.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1297 ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' B' 1295 ' ' THR . 60.5 Cg_exo -58.89 111.42 0.89 Allowed 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 123.241 2.627 . . . . 35.090000000000003 115.811 -177.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 95.55 10.69 56.58 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 113.307 -1.77 . . . . 35.969999999999999 111.059 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -148.01 -178.03 6.06 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 124.9 2.286 . . . . 40.390000000000001 110.046 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1300 ' ' ILE . . . . . 0.588 HD13 ' HG3' ' B' 1148 ' ' GLU . 30.3 mt -110.71 162.79 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 111.006 -2.815 . . . . 37.43 105.367 172.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 61.0 t80 -150.77 130.38 13.08 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 104.052 -2.573 . . . . 44.130000000000003 104.052 170.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1302 ' ' THR . . . . . . . . . . . . . 25.7 m -95.62 136.16 36.37 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.447 -0.945 . . . . 39.780000000000001 108.447 173.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1303 ' ' THR . . . . . . . . . . . . . 46.6 p -77.25 177.22 8.07 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.287 -1.324 . . . . 43.289999999999999 113.015 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -57.63 -59.02 5.82 Favored 'General case' 0 N--CA 1.435 -1.214 0 O-C-N 121.091 -1.006 . . . . 53.07 110.805 162.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -60.5 -22.75 63.89 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 113.759 1.022 . . . . 43.969999999999999 113.759 -174.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 108.62 47.42 0.91 Allowed Glycine 0 N--CA 1.432 -1.583 0 CA-C-O 122.57 1.094 . . . . 41.119999999999997 112.713 166.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1307 ' ' VAL . . . . . 0.435 HG21 ' HB2' ' B' 1275 ' ' MET . 95.1 t -122.95 128.16 75.06 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 N-CA-C 102.226 -3.25 . . . . 38.119999999999997 102.226 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1308 ' ' LYS . . . . . 0.477 ' HB2' HG22 ' B' 1280 ' ' VAL . 43.7 mmtt -83.53 109.02 17.04 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 103.013 -2.958 . . . . 36.340000000000003 103.013 176.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1309 ' ' VAL . . . . . 0.444 HG11 ' HB3' ' B' 1294 ' ' TYR . 44.9 t -88.1 113.44 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 O-C-N 117.288 -3.382 . . . . 30.399999999999999 103.284 168.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1310 ' ' ILE . . . . . 0.49 HG12 HG23 ' B' 1300 ' ' ILE . 19.2 mt -102.41 100.16 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-N 113.617 -1.629 . . . . 30.82 107.626 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1311 ' ' GLY . . . . . 0.494 ' HA3' HG23 ' B' 1295 ' ' THR . . . -97.57 53.59 1.29 Allowed Glycine 0 C--N 1.352 1.426 0 C-N-CA 119.084 -1.531 . . . . 26.530000000000001 110.704 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1312 ' ' TYR . . . . . 0.438 ' O ' ' HG ' ' B' 1315 ' ' LEU . 0.6 OUTLIER -74.88 94.37 2.79 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 120.759 -1.436 . . . . 38.0 108.745 -171.889 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B 1313 ' ' THR . . . . . 0.443 HG22 ' HA ' ' B' 1287 ' ' GLN . 0.7 OUTLIER -54.76 -35.33 63.65 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 121.077 -1.014 . . . . 29.800000000000001 112.24 174.551 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -75.1 4.28 7.08 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 126.758 2.023 . . . . 39.039999999999999 115.376 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1315 ' ' LEU . . . . . 0.495 HD12 ' HA ' ' B' 1284 ' ' LEU . 34.6 mt -43.9 -50.99 18.52 Favored Pre-proline 0 N--CA 1.465 0.301 0 N-CA-C 118.231 2.678 . . . . 31.079999999999998 118.231 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1316 ' ' PRO . . . . . 0.509 ' HB3' ' HB3' ' B' 1133 ' ' MET . 34.3 Cg_exo -56.84 -27.5 72.31 Favored 'Trans proline' 0 CA--C 1.546 1.094 0 C-N-CA 123.628 2.886 . . . . 26.100000000000001 115.315 174.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -82.06 -35.01 22.5 Favored Glycine 0 N--CA 1.435 -1.407 0 O-C-N 120.715 -1.24 . . . . 23.170000000000002 110.139 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -52.52 3.43 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.588 1 N-CA-C 123.437 4.606 . . . . 40.399999999999999 123.437 -171.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 21.3 tp -132.75 66.54 76.71 Favored Pre-proline 0 C--O 1.243 0.741 0 O-C-N 118.746 -2.471 . . . . 23.600000000000001 108.269 -175.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1320 ' ' PRO . . . . . 0.635 ' HG2' ' HA2' ' A' 1150 ' ' GLY . 19.1 Cg_endo -26.57 -71.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.053 1 C-N-CA 126.196 4.597 . . . . 22.350000000000001 118.72 -166.323 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B 1321 ' ' THR . . . . . 0.483 HG23 ' HD2' ' B' 1045 ' ' PHE . 3.3 m -67.48 -40.62 85.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 119.952 1.251 . . . . 26.52 108.995 -169.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1322 ' ' GLN . . . . . 0.803 ' HB2' ' HA ' ' A' 1151 ' ' ARG . 32.4 tp60 -79.11 -33.14 44.6 Favored 'General case' 0 CA--C 1.488 -1.41 0 O-C-N 120.66 -1.275 . . . . 24.379999999999999 110.882 -173.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1323 ' ' SER . . . . . . . . . . . . . 71.3 m -63.07 -47.5 82.66 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 109.184 -0.673 . . . . 22.800000000000001 109.184 176.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1324 ' ' SER . . . . . . . . . . . . . 22.0 m -58.32 -37.0 74.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 122.881 1.324 . . . . 21.25 114.248 175.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1325 ' ' GLN . . . . . 0.489 ' NE2' HG23 ' B' 1022 ' ' THR . 51.6 tp60 -65.03 -54.36 31.43 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.468 -1.242 . . . . 31.34 111.804 176.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1326 ' ' LEU . . . . . . . . . . . . . 23.8 mt -73.09 -40.4 65.03 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 117.688 -1.149 . . . . 31.559999999999999 110.944 -172.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1327 ' ' TYR . . . . . . . . . . . . . 42.5 t80 -57.94 -50.95 71.62 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 106.118 -1.808 . . . . 22.73 106.118 173.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1328 ' ' GLY . . . . . 0.717 ' HA3' HG21 ' B' 1022 ' ' THR . . . -52.36 -42.63 56.91 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 114.582 0.593 . . . . 21.91 114.582 174.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1329 ' ' THR . . . . . . . . . . . . . 5.5 m -71.94 -25.45 61.89 Favored 'General case' 0 C--O 1.249 1.057 0 O-C-N 120.52 -1.577 . . . . 22.149999999999999 111.936 176.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1330 ' ' ASN . . . . . 0.448 ' ND2' ' HB2' ' A' 1160 ' ' ALA . 24.7 m120 -62.56 -37.45 86.21 Favored 'General case' 0 C--O 1.249 1.04 0 CA-C-N 120.893 1.679 . . . . 26.18 110.58 170.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1331 ' ' LEU . . . . . 0.715 HD22 HD22 ' B' 1070 ' ' LEU . 59.1 mt -68.65 -44.0 75.07 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 113.859 -1.519 . . . . 23.68 109.977 176.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1332 ' ' VAL . . . . . 0.548 HG13 HD11 ' B' 1029 ' ' LEU . 69.9 t -53.4 -55.36 13.32 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 CA-C-O 116.846 -1.55 . . . . 26.57 108.139 174.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1333 ' ' ASN . . . . . 0.693 ' HA ' ' HD2' ' B' 1336 ' ' LYS . 84.4 m-20 -55.8 -40.29 72.52 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 115.459 1.652 . . . . 28.079999999999998 115.459 175.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1334 ' ' LEU . . . . . 0.457 ' CD2' HG11 ' B' 1090 ' ' VAL . 12.9 tp -56.54 -48.24 77.7 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 124.722 1.209 . . . . 27.43 111.357 169.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1335 ' ' LEU . . . . . 0.458 ' HA ' ' HB2' ' B' 1338 ' ' LEU . 7.2 mt -71.62 -22.32 61.72 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 119.92 -0.712 . . . . 30.5 111.648 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1336 ' ' LYS . . . . . 0.693 ' HD2' ' HA ' ' B' 1333 ' ' ASN . 97.0 mttt -67.01 -47.98 69.79 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.297 -1.001 . . . . 41.649999999999999 108.297 171.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1337 ' ' LEU . . . . . 0.732 HD21 ' HD2' ' B' 1123 ' ' ARG . 6.6 mp -71.21 -35.08 71.39 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 119.591 -1.943 . . . . 42.079999999999998 112.053 176.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1338 ' ' LEU . . . . . 0.458 ' HB2' ' HA ' ' B' 1335 ' ' LEU . 35.9 mt -69.78 -68.27 0.43 Allowed 'General case' 0 N--CA 1.438 -1.048 0 O-C-N 119.638 -1.914 . . . . 35.030000000000001 110.446 176.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1339 ' ' CYS . . . . . 0.515 ' SG ' ' HA ' ' B' 1342 ' ' LYS . 52.6 t -93.32 69.86 4.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.929 1.347 . . . . 37.329999999999998 108.595 -174.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 57.3 mttp -65.88 -27.81 68.49 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 114.193 1.183 . . . . 50.509999999999998 114.193 -175.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -71.44 -21.32 61.99 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 120.998 -1.064 . . . . 54.210000000000001 112.646 168.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1342 ' ' LYS . . . . . 0.515 ' HA ' ' SG ' ' B' 1339 ' ' CYS . 7.3 mptt 52.07 50.48 18.42 Favored 'General case' 0 C--O 1.252 1.199 0 CA-C-O 124.969 2.319 . . . . 50.990000000000002 111.575 -163.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -76.55 -33.24 58.54 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 111.264 -2.698 . . . . 48.82 111.274 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1344 ' ' GLY . . . . . 0.424 ' O ' ' HA2' ' B' 1001 ' ' GLY . . . 108.34 14.45 16.35 Favored Glycine 0 C--O 1.244 0.77 0 CA-C-O 117.748 -1.585 . . . . 40.43 112.194 174.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -131.09 156.47 45.16 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 104.835 -2.283 . . . . 47.560000000000002 104.835 166.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1346 ' ' ILE . . . . . 0.562 HG13 HG23 ' B' 1068 ' ' ILE . 26.2 mm -81.95 94.23 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 O-C-N 118.955 -2.34 . . . . 42.490000000000002 112.195 -172.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1347 ' ' THR . . . . . . . . . . . . . 88.1 m -59.21 105.31 0.32 Allowed 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 106.919 -1.511 . . . . 38.119999999999997 106.919 159.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 21.7 t -90.46 96.43 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 104.761 -2.311 . . . . 37.5 104.761 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 6.6 t70 -75.39 129.03 36.67 Favored 'General case' 0 C--O 1.265 1.891 0 CA-C-N 110.995 -2.821 . . . . 43.850000000000001 110.301 -175.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1350 ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -117.24 0.82 12.37 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.934 -1.104 . . . . 39.810000000000002 111.508 175.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 7.9 t70 -81.13 -43.86 18.77 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 119.236 0.926 . . . . 51.289999999999999 109.857 -175.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.2 145.13 51.64 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-O 122.105 0.955 . . . . 39.780000000000001 110.936 174.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1353 ' ' VAL . . . . . 0.467 ' HB ' HG13 ' B' 1373 ' ' ILE . 28.7 m -68.47 -36.67 75.75 Favored 'Isoleucine or valine' 0 C--O 1.25 1.131 0 CA-C-N 114.952 -1.022 . . . . 39.280000000000001 110.726 -173.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1354 ' ' VAL . . . . . 0.629 HG21 ' HG3' ' B' 1123 ' ' ARG . 49.7 t -70.41 -47.71 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 O-C-N 121.799 -0.563 . . . . 35.700000000000003 111.19 -172.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1355 ' ' ILE . . . . . 0.717 ' HA ' HG12 ' B' 1358 ' ' VAL . 38.7 mm -70.11 -41.52 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 O-C-N 121.398 -0.813 . . . . 35.770000000000003 109.797 176.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 47.3 tpt85 -47.63 -32.54 5.67 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 115.375 1.62 . . . . 38.549999999999997 115.375 169.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1357 ' ' GLY . . . . . 0.585 ' CA ' ' HB2' ' B' 1370 ' ' ALA . . . -91.94 -40.87 5.12 Favored Glycine 0 N--CA 1.442 -0.901 0 O-C-N 121.627 -0.67 . . . . 29.579999999999998 114.011 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1358 ' ' VAL . . . . . 0.717 HG12 ' HA ' ' B' 1355 ' ' ILE . 4.0 p -66.76 -36.42 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 114.454 1.279 . . . . 32.060000000000002 114.454 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1359 ' ' THR . . . . . . . . . . . . . 4.1 m -72.35 81.16 1.03 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 123.3 1.524 . . . . 29.0 107.205 175.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1360 ' ' VAL . . . . . 0.458 HG11 ' HG2' ' B' 1095 ' ' PRO . 14.6 m -63.24 -29.23 46.73 Favored 'Isoleucine or valine' 0 C--O 1.248 1.001 0 O-C-N 121.129 -0.982 . . . . 29.68 113.392 177.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 49.1 mt -138.3 108.6 4.83 Favored 'Isoleucine or valine' 0 C--O 1.249 1.058 0 N-CA-C 104.173 -2.529 . . . . 32.049999999999997 104.173 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1362 ' ' ARG . . . . . 0.664 ' HA ' HG23 ' B' 1111 ' ' THR . 57.1 ttt180 -91.5 105.08 17.5 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 117.99 -2.944 . . . . 32.520000000000003 107.396 169.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1363 ' ' ALA . . . . . 0.654 ' H ' ' HA ' ' B' 1111 ' ' THR . . . 45.45 58.82 3.94 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 116.91 2.189 . . . . 35.68 116.91 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 91.96 -47.27 2.7 Favored Glycine 0 CA--C 1.538 1.53 0 CA-C-O 118.017 -1.435 . . . . 34.259999999999998 112.646 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -68.32 115.31 7.62 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 123.265 1.507 . . . . 51.07 109.58 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 24.4 mt -74.76 95.8 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.981 0 CA-C-O 123.427 1.584 . . . . 39.869999999999997 112.54 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1367 ' ' THR . . . . . . . . . . . . . 11.8 p -90.43 13.63 15.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 110.445 -3.071 . . . . 38.009999999999998 113.039 -174.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1368 ' ' TRP . . . . . . . . . . . . . 32.2 t90 -77.96 135.8 62.78 Favored Pre-proline 0 C--O 1.233 0.197 0 C-N-CA 125.582 1.553 . . . . 42.140000000000001 111.024 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -91.19 -167.83 3.03 Favored 'Cis proline' 0 CA--C 1.542 0.877 0 CA-C-N 123.616 2.327 . . . . 43.259999999999998 110.21 -9.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1370 ' ' ALA . . . . . 0.585 ' HB2' ' CA ' ' B' 1357 ' ' GLY . . . -72.34 167.86 28.64 Favored Pre-proline 0 C--O 1.244 0.8 0 CA-C-O 117.142 -1.408 . . . . 46.520000000000003 110.136 163.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1371 ' ' PRO . . . . . 0.514 ' O ' HG12 ' B' 1373 ' ' ILE . 29.6 Cg_endo -56.55 151.48 46.02 Favored 'Trans proline' 0 CA--C 1.548 1.191 0 CA-C-N 125.864 3.13 . . . . 51.950000000000003 109.07 164.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -64.65 100.44 0.34 Allowed 'Trans proline' 0 C--O 1.24 0.589 0 C-N-CA 122.477 2.118 . . . . 56.270000000000003 113.779 -168.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1373 ' ' ILE . . . . . 0.514 HG12 ' O ' ' B' 1371 ' ' PRO . 17.0 mm -100.63 101.33 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 102.22 -3.252 . . . . 60.829999999999998 102.22 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -62.55 120.23 10.74 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 122.78 1.276 . . . . 66.099999999999994 109.764 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 16.4 t -81.76 121.89 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 104.213 -2.514 . . . . 63.469999999999999 104.213 176.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.227 -4.724 0 O-C-N 121.92 -0.488 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.291 0 CA-C-O 120.375 0.131 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.35 -32.81 40.12 Favored 'General case' 0 C--O 1.214 -0.789 0 C-N-CA 124.74 1.216 . . . . 0.0 113.983 176.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -70.14 -63.33 1.1 Allowed 'General case' 0 C--O 1.245 0.865 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 170.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 23' ' ' THR . . . . . 0.564 ' HA ' HD22 ' C' ' 26' ' ' LEU . 0.2 OUTLIER -45.36 -34.84 3.22 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 125.748 1.619 . . . . 0.0 115.061 -174.486 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.45 -67.0 0.29 Allowed 'General case' 0 C--O 1.256 1.419 0 N-CA-C 115.238 1.569 . . . . 0.0 115.238 166.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -55.43 -38.09 68.54 Favored 'General case' 0 C--N 1.356 0.88 0 O-C-N 119.942 -1.724 . . . . 0.0 113.457 173.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.564 HD22 ' HA ' ' C' ' 23' ' ' THR . 4.8 mp -59.25 -43.4 92.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.438 176.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.555 HD11 HD12 ' C' ' 182' ' ' ILE . 13.6 mt -58.2 -53.46 58.01 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 125.139 1.375 . . . . 0.0 114.268 177.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 28' ' ' LYS . . . . . . . . . . . . . 11.9 pttm -58.58 -31.86 68.41 Favored 'General case' 0 C--O 1.242 0.708 0 O-C-N 120.004 -1.685 . . . . 0.0 113.726 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -65.62 -32.31 73.81 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 174.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.536 ' HA ' ' HB3' ' C' ' 107' ' ' ASP . 67.1 m -58.45 -34.55 70.96 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 119.609 3.188 . . . . 0.0 119.609 -158.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 59.98 -76.93 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 122.509 2.413 . . . . 0.0 107.396 -165.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 32' ' ' SER . . . . . 0.746 ' HB2' ' HA ' ' C' ' 106' ' ' THR . 15.4 m -96.32 136.2 37.12 Favored 'General case' 0 C--O 1.243 0.724 0 O-C-N 118.087 -2.883 . . . . 0.0 110.089 175.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 91.3 t -129.89 122.96 55.68 Favored 'Isoleucine or valine' 0 C--O 1.247 0.962 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.777 ' HB ' HG13 ' C' ' 109' ' ' VAL . 26.9 mm -100.12 117.99 46.13 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 168.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 27.7 mt -94.36 118.04 39.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 119.481 1.037 . . . . 0.0 109.663 170.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 36' ' ' THR . . . . . 0.501 ' HA ' ' HD3' ' C' ' 37' ' ' PRO . 3.6 m -102.96 108.28 57.98 Favored Pre-proline 0 CA--C 1.55 0.95 0 O-C-N 120.172 -1.58 . . . . 0.0 112.424 -176.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 37' ' ' PRO . . . . . 0.707 ' HG2' HG13 ' C' ' 68' ' ' ILE . 32.5 Cg_exo -74.17 37.74 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 1 C-N-CA 125.657 4.238 . . . . 0.0 118.772 -175.067 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 38' ' ' GLY . . . . . 0.499 ' HA3' ' HB2' ' C' ' 114' ' ' ALA . . . -88.24 94.35 1.98 Allowed Glycine 0 C--N 1.335 0.489 0 O-C-N 119.555 -1.966 . . . . 0.0 111.987 -166.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 39' ' ' TYR . . . . . 0.59 ' HB2' ' HA3' ' C' ' 73' ' ' GLY . 23.4 t80 68.66 -57.07 0.51 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 116.922 -1.513 . . . . 0.0 114.648 175.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -49.07 -46.87 33.29 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-N 120.39 1.45 . . . . 0.0 113.301 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 41' ' ' MET . . . . . 0.575 ' HA ' ' HB3' ' C' ' 46' ' ' ALA . 49.1 ttm -44.67 -52.07 8.58 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 173.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.86 -59.15 2.85 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.812 -175.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 8.2 p -57.84 -43.81 85.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 122.881 1.325 . . . . 0.0 109.179 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 44' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' C' ' 176' ' ' LYS . . . -85.44 6.66 25.79 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 119.801 -1.812 . . . . 0.0 113.496 -176.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 45' ' ' GLN . . . . . . . . . . . . 0.348 0.0 OUTLIER 49.52 25.87 1.53 Allowed 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 118.175 2.657 . . . . 0.0 118.175 -169.17 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.575 ' HB3' ' HA ' ' C' ' 41' ' ' MET . . . -70.2 -8.33 49.08 Favored 'General case' 0 C--O 1.255 1.359 0 O-C-N 120.352 -1.467 . . . . 0.0 111.266 -177.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 47' ' ' GLN . . . . . 0.451 ' O ' HG12 ' C' ' 50' ' ' VAL 0.365 0.0 OUTLIER -69.54 -38.22 77.41 Favored 'General case' 0 CA--C 1.51 -0.568 0 O-C-N 118.677 -2.514 . . . . 0.0 115.532 174.836 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' C' C ' 48' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -58.98 -58.45 19.43 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-O 115.292 -2.29 . . . . 0.0 111.313 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 49' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -61.71 -36.57 73.89 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 124.324 3.349 . . . . 0.0 111.711 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 50' ' ' VAL . . . . . 0.506 ' HA ' HG22 ' C' ' 53' ' ' ILE . 0.8 OUTLIER -53.16 -39.09 32.44 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-N 122.047 2.203 . . . . 0.0 112.839 177.254 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.34 -38.98 69.45 Favored 'General case' 0 C--O 1.247 0.927 0 O-C-N 121.66 -0.65 . . . . 0.0 112.007 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -75.65 -48.77 20.67 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 120.746 -1.221 . . . . 0.0 108.277 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 53' ' ' ILE . . . . . 0.556 ' HB ' HD12 ' C' ' 183' ' ' LEU . 8.1 tp -63.38 -37.4 79.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 C-N-CA 119.416 -0.914 . . . . 0.0 113.084 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 54' ' ' THR . . . . . 0.541 HG21 ' HE1' ' C' ' 66' ' ' PHE . 90.0 m -68.56 -41.99 78.96 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 119.961 -1.712 . . . . 0.0 109.49 -178.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -53.67 -42.39 67.86 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 124.626 1.17 . . . . 0.0 112.066 168.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -66.44 -39.44 88.89 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 120.927 -1.108 . . . . 0.0 111.378 173.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 57' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' C' ' 53' ' ' ILE . 97.9 mt -67.63 -33.52 75.14 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 119.862 1.21 . . . . 0.0 107.896 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 58' ' ' ARG . . . . . 0.458 ' HD2' ' HA ' ' C' ' 58' ' ' ARG . 0.8 OUTLIER -63.9 -46.51 84.49 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 121.897 0.856 . . . . 0.0 111.473 178.559 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.67 -35.97 71.28 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 124.068 1.89 . . . . 0.0 114.029 173.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -68.06 -24.07 65.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.495 -1.23 . . . . 0.0 113.53 173.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.91 79.75 1.11 Allowed Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 mt -141.94 125.97 16.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 112.89 -1.655 . . . . 0.0 107.913 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 63' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' C' ' 32' ' ' SER . 17.3 t30 -72.41 87.91 1.18 Allowed 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 125.214 1.406 . . . . 0.0 109.601 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.473 HG21 HG23 ' C' ' 54' ' ' THR . 9.2 p -93.17 139.98 17.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 CA-C-O 122.11 0.957 . . . . 0.0 111.591 -177.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 65' ' ' ARG . . . . . 0.416 ' HB2' HD13 ' C' ' 34' ' ' ILE . 84.1 mmt-85 -138.38 120.6 15.79 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 103.19 -2.892 . . . . 0.0 103.19 177.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 66' ' ' PHE . . . . . 0.541 ' HE1' HG21 ' C' ' 54' ' ' THR . 8.2 m-85 -79.87 126.13 30.6 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 165.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -100.53 86.37 0.64 Allowed Glycine 0 N--CA 1.478 1.45 0 O-C-N 119.002 -2.312 . . . . 0.0 109.509 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 68' ' ' ILE . . . . . 0.707 HG13 ' HG2' ' C' ' 37' ' ' PRO . 3.2 mp -87.09 84.93 2.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 O-C-N 118.982 -2.481 . . . . 0.0 107.857 -172.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -74.24 116.91 57.32 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-O 116.569 -1.681 . . . . 0.0 108.527 170.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 70' ' ' PRO . . . . . 0.479 ' HD3' HG12 ' A' 1157 ' ' ILE . 58.4 Cg_endo -54.62 -59.29 0.89 Allowed 'Trans proline' 0 C--N 1.333 -0.247 0 C-N-CA 124.383 3.389 . . . . 0.0 117.255 -170.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 71' ' ' VAL . . . . . 0.407 ' HA ' ' C7N' ' C' 1001 ' ' NAP . 4.4 m -68.23 95.56 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 113.303 -1.771 . . . . 0.0 108.506 169.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 72' ' ' ALA . . . . . 0.438 ' HA ' ' H3D' ' C' 1001 ' ' NAP . . . -161.17 109.91 1.58 Allowed 'General case' 0 C--O 1.242 0.66 0 CA-C-N 109.031 -3.713 . . . . 0.0 107.16 176.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 73' ' ' GLY . . . . . 0.613 ' C ' ' HD2' ' C' ' 74' ' ' ARG . . . 69.48 -90.96 0.3 Allowed Glycine 0 CA--C 1.506 -0.498 0 CA-C-O 118.285 -1.286 . . . . 0.0 112.975 172.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 74' ' ' ARG . . . . . 0.846 ' HG3' ' HG2' ' B' 1203 ' ' GLN . 1.7 mpt_? -133.17 114.06 13.41 Favored 'General case' 0 C--O 1.256 1.419 0 CA-C-N 118.196 0.998 . . . . 0.0 111.935 -167.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.534 HD22 ' SD ' ' B' 1207 ' ' MET . 1.7 mp 63.13 142.84 0.06 OUTLIER Pre-proline 0 C--O 1.236 0.344 0 C-N-CA 128.173 2.589 . . . . 0.0 117.069 169.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 76' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' B' 1178 ' ' LEU . 83.1 Cg_endo -71.47 149.9 56.91 Favored 'Trans proline' 0 C--N 1.364 1.365 0 C-N-CA 123.289 2.659 . . . . 0.0 111.093 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 70.81 -96.53 0.59 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -171.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 48.55 -84.32 0.01 OUTLIER 'General case' 0 C--O 1.24 0.602 0 C-N-CA 126.089 1.756 . . . . 0.0 111.677 173.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 79' ' ' MET . . . . . 0.548 ' HA ' ' HB2' ' C' ' 82' ' ' LEU . 0.0 OUTLIER -60.05 -25.81 65.64 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.226 1.01 . . . . 0.0 113.1 177.229 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -58.02 -55.02 40.35 Favored 'General case' 0 C--O 1.24 0.576 0 O-C-N 121.659 -0.651 . . . . 0.0 111.497 170.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 69.8 t -73.3 -38.06 53.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 O-C-N 119.664 -1.898 . . . . 0.0 108.896 177.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.548 ' HB2' ' HA ' ' C' ' 79' ' ' MET . 96.0 mt -48.73 -31.77 7.44 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 122.595 2.452 . . . . 0.0 114.234 169.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.444 HD13 ' O ' ' C' ' 79' ' ' MET . 0.7 OUTLIER -74.82 -32.06 61.86 Favored 'General case' 0 C--O 1.221 -0.399 0 O-C-N 121.429 -0.794 . . . . 0.0 111.2 173.823 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.08 -32.67 74.5 Favored 'General case' 0 CA--C 1.497 -1.078 0 O-C-N 120.007 -1.683 . . . . 0.0 113.709 170.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -64.3 -50.05 69.36 Favored 'General case' 0 C--O 1.251 1.182 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 172.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.15 -18.18 60.15 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 172.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp 63.1 62.13 1.03 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-O 124.888 2.28 . . . . 0.0 109.558 -173.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 98.2 t -103.84 127.6 29.05 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 111.337 -2.665 . . . . 0.0 105.619 168.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -56.39 126.89 23.8 Favored 'Trans proline' 0 C--O 1.219 -0.469 0 C-N-CA 122.935 2.424 . . . . 0.0 117.965 175.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 90' ' ' TYR . . . . . 0.568 ' HA ' ' HB ' ' C' ' 93' ' ' VAL . 4.2 m-85 -59.3 -12.41 5.59 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 173.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -62.45 -47.48 83.86 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 119.96 1.254 . . . . 0.0 111.555 171.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 39.5 pt -84.09 -14.42 11.46 Favored 'Isoleucine or valine' 0 C--O 1.255 1.351 0 CA-C-O 121.984 0.897 . . . . 0.0 111.521 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 93' ' ' VAL . . . . . 0.568 ' HB ' ' HA ' ' C' ' 90' ' ' TYR . 50.5 t -76.84 104.56 4.92 Favored 'Isoleucine or valine' 0 C--O 1.247 0.951 0 O-C-N 119.69 -1.881 . . . . 0.0 106.882 175.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 10.8 mp -104.29 103.44 13.19 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 124.831 2.253 . . . . 0.0 109.559 174.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 95' ' ' GLU . . . . . 0.533 ' HB3' ' HB ' ' A' 1157 ' ' ILE . 11.0 mp0 -85.36 117.16 24.12 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 119.675 -1.891 . . . . 0.0 108.28 -176.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.402 ' HB2' ' HD3' ' C' ' 70' ' ' PRO . 12.2 ttp 42.81 29.59 0.19 Allowed 'General case' 0 C--N 1.345 0.385 0 C-N-CA 127.801 2.441 . . . . 0.0 115.162 -178.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -79.92 128.63 33.68 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 103.387 -2.819 . . . . 0.0 103.387 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -87.13 79.56 8.6 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 99' ' ' ILE . . . . . 0.821 HG13 ' HB2' ' C' ' 102' ' ' ASP . 9.5 tp -85.21 58.97 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 112.482 -2.145 . . . . 0.0 108.265 -173.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 100' ' ' ASN . . . . . 0.467 ' HA ' ' CD2' ' C' ' 103' ' ' PHE . 14.3 t-20 -73.31 -38.58 65.79 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 112.837 -1.983 . . . . 0.0 111.801 -166.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.96 -39.38 79.54 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.079 -1.419 . . . . 0.0 112.437 177.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 102' ' ' ASP . . . . . 0.821 ' HB2' HG13 ' C' ' 99' ' ' ILE . 1.8 m-20 -67.74 -28.43 67.63 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 120.172 -1.58 . . . . 0.0 113.25 167.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 103' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' C' ' 100' ' ' ASN . 6.8 m-30 -56.54 -51.19 69.49 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-O 121.575 0.703 . . . . 0.0 111.95 175.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.99 -45.51 82.91 Favored 'General case' 0 C--O 1.208 -1.117 0 CA-C-N 114.524 -1.217 . . . . 0.0 112.594 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -66.31 -29.18 69.33 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 106' ' ' THR . . . . . 0.746 ' HA ' ' HB2' ' C' ' 32' ' ' SER . 69.6 m -64.92 135.52 55.79 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 177.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 107' ' ' ASP . . . . . 0.665 ' HA ' ' HB3' ' C' ' 142' ' ' GLN . 23.2 t70 -86.94 -102.68 0.07 Allowed 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 112.373 -2.194 . . . . 0.0 109.027 166.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 53.8 m -69.83 91.77 0.66 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 124.398 3.272 . . . . 0.0 113.356 -171.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 109' ' ' VAL . . . . . 0.777 HG13 ' HB ' ' C' ' 34' ' ' ILE . 21.3 t -74.27 110.6 8.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 167.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 110' ' ' LEU . . . . . 0.465 HD11 HD21 ' C' ' 27' ' ' LEU . 96.0 mt -85.6 95.44 9.34 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 111' ' ' VAL . . . . . 0.649 ' HB ' ' HA ' ' C' ' 146' ' ' VAL . 50.3 t -87.1 87.68 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 -176.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 25.3 mm -72.05 79.32 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -171.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 113' ' ' GLY . . . . . 0.429 ' H ' ' HB2' ' C' ' 147' ' ' PHE . . . 88.69 -110.26 3.64 Favored Glycine 0 C--O 1.239 0.409 0 N-CA-C 107.25 -2.34 . . . . 0.0 107.25 -171.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 114' ' ' ALA . . . . . 0.499 ' HB2' ' HA3' ' C' ' 38' ' ' GLY . . . 47.73 9.13 0.01 OUTLIER 'General case' 0 C--N 1.352 0.686 1 N-CA-C 121.817 4.006 . . . . 0.0 121.817 163.093 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.29 -41.94 51.61 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 117.258 2.318 . . . . 0.0 117.258 -175.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 116' ' ' ASP . . . . . 0.553 ' HA ' ' HB2' ' C' ' 119' ' ' ASN . 9.1 m-20 -76.51 -28.01 56.23 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 19.4 m -72.83 -13.3 61.26 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.9 -1.125 . . . . 0.0 108.642 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.701 HG12 ' HB2' ' C' ' 136' ' ' LEU . 18.3 m -120.03 16.86 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 CA-C-N 119.762 1.165 . . . . 0.0 109.873 174.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 119' ' ' ASN . . . . . 0.553 ' HB2' ' HA ' ' C' ' 116' ' ' ASP . 18.4 t30 -79.64 112.28 27.93 Favored Pre-proline 0 N--CA 1.451 -0.391 0 O-C-N 120.118 -1.614 . . . . 0.0 115.188 -171.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 120' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -58.91 -36.47 96.84 Favored 'Trans proline' 0 C--N 1.368 1.602 0 C-N-CA 123.557 2.838 . . . . 0.0 113.288 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.58 4.98 1.55 Allowed 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 122' ' ' ALA . . . . . 0.482 ' HB1' ' HB3' ' C' ' 133' ' ' MET . . . -94.2 -31.7 14.01 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 120.344 -1.472 . . . . 0.0 113.124 173.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -116.03 -52.37 2.61 Favored 'General case' 0 C--O 1.22 -0.49 0 C-N-CA 118.839 -1.144 . . . . 0.0 109.68 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -62.17 -51.01 69.53 Favored 'General case' 0 C--N 1.363 1.188 0 CA-C-O 122.735 1.255 . . . . 0.0 108.905 -173.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -95.54 132.07 28.27 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 102.869 -3.011 . . . . 0.0 102.869 164.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -78.05 46.58 2.11 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 122.223 1.949 . . . . 0.0 110.829 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -107.06 -33.2 7.54 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -152.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 128' ' ' SER . . . . . . . . . . . . . 36.3 m -79.57 144.36 60.94 Favored Pre-proline 0 C--O 1.24 0.559 0 O-C-N 124.735 1.272 . . . . 0.0 111.647 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 129' ' ' PRO . . . . . 0.638 ' HD2' ' HB2' ' C' ' 156' ' ' ALA . 4.6 Cg_exo -44.38 -40.0 12.85 Favored 'Trans proline' 0 CA--C 1.51 -0.677 0 C-N-CA 123.785 2.99 . . . . 0.0 114.69 176.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 35.4 pt -65.61 72.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.88 0 CA-C-O 124.4 2.048 . . . . 0.0 110.413 164.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.71 119.52 10.71 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.511 -1.222 . . . . 0.0 112.987 -172.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 61.71 50.38 66.75 Favored Glycine 0 N--CA 1.431 -1.648 0 CA-C-N 113.083 -1.871 . . . . 0.0 112.149 -175.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 133' ' ' MET . . . . . 0.668 ' SD ' ' HD2' ' C' ' 134' ' ' PRO . 26.5 tpp -75.98 123.79 88.27 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 119.481 1.641 . . . . 0.0 112.099 171.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 134' ' ' PRO . . . . . 0.668 ' HD2' ' SD ' ' C' ' 133' ' ' MET . 61.1 Cg_endo -71.68 82.71 1.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.969 1 C-N-CA 125.833 4.355 . . . . 0.0 107.498 177.216 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 21.7 m -80.99 151.83 4.39 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.183 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.25 -176.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.701 ' HB2' HG12 ' C' ' 118' ' ' VAL . 87.5 mt -74.59 109.27 7.93 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.696 0.76 . . . . 0.0 110.214 -178.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -72.81 80.02 1.14 Allowed 'General case' 0 N--CA 1.423 -1.789 0 CA-C-O 122.964 1.364 . . . . 0.0 112.134 -169.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 3.9 p -113.63 -1.79 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -176.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 13.1 p90 -56.56 148.71 19.0 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.131 -1.606 . . . . 0.0 111.118 174.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 140' ' ' LYS . . . . . . . . . . . . 0.378 0.0 OUTLIER 37.19 46.37 0.57 Allowed 'General case' 0 C--O 1.244 0.765 0 N-CA-C 116.55 2.056 . . . . 0.0 116.55 -160.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.5 -156.36 0.04 OUTLIER 'General case' 0 C--O 1.24 0.596 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 159.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 142' ' ' GLN . . . . . 0.665 ' HB3' ' HA ' ' C' ' 107' ' ' ASP . 0.0 OUTLIER -84.08 -32.81 24.59 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 119.754 -1.841 . . . . 0.0 113.787 170.88 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 143' ' ' ASN . . . . . 0.833 ' HA ' ' HB2' ' C' ' 167' ' ' ASN . 16.6 t30 -158.55 138.2 11.9 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 121.837 2.108 . . . . 0.0 110.239 170.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 144' ' ' VAL . . . . . 0.62 ' HB ' HG22 ' C' ' 168' ' ' THR . 21.8 t -136.46 90.43 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.598 0 O-C-N 119.051 -2.28 . . . . 0.0 105.104 -176.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 145' ' ' ILE . . . . . 0.541 HG13 ' HB2' ' C' ' 171' ' ' LEU . 10.5 tp -93.13 102.02 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 -170.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 146' ' ' VAL . . . . . 0.649 ' HA ' ' HB ' ' C' ' 111' ' ' VAL . 26.0 t -90.99 107.41 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 -170.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 147' ' ' PHE . . . . . 0.448 ' CE2' ' HB2' ' C' ' 178' ' ' SER . 2.1 m-85 -70.3 94.09 0.9 Allowed 'General case' 0 C--N 1.35 0.618 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 -177.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 148' ' ' LYS . . . . . 0.491 ' NZ ' ' OD1' ' C' ' 152' ' ' ASN . 26.1 mtpp -140.93 117.67 11.0 Favored 'General case' 0 C--O 1.253 1.254 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 173.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -70.03 -4.47 21.12 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 1.3 m -157.72 159.87 37.33 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 124.256 1.979 . . . . 0.0 108.704 175.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.44 77.72 5.99 Favored 'General case' 0 C--O 1.252 1.194 0 O-C-N 118.901 -2.374 . . . . 0.0 105.992 169.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 152' ' ' ASN . . . . . 0.491 ' OD1' ' NZ ' ' C' ' 148' ' ' LYS . 2.1 p-10 -113.85 157.95 21.67 Favored 'General case' 0 N--CA 1.438 -1.027 0 O-C-N 125.775 1.922 . . . . 0.0 108.826 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 45.7 m -67.55 125.82 27.37 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 123.848 0.717 . . . . 0.0 111.895 174.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -84.74 -108.85 0.63 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 104.7 -3.36 . . . . 0.0 104.7 173.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -91.53 -15.34 28.86 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 164.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 156' ' ' ALA . . . . . 0.638 ' HB2' ' HD2' ' C' ' 129' ' ' PRO . . . -165.54 -93.55 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 159.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 74.93 41.8 32.03 Favored Glycine 0 N--CA 1.437 -1.286 0 CA-C-N 120.876 1.671 . . . . 0.0 110.372 -165.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 15.5 m -80.81 127.94 39.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 O-C-N 120.085 -1.832 . . . . 0.0 108.941 171.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . 0.3 0.0 OUTLIER 43.2 16.31 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 120.613 3.56 . . . . 0.0 120.613 173.5 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 160' ' ' ASN . . . . . 0.734 HD22 HD12 ' C' ' 162' ' ' LEU . 16.9 p-10 -73.9 125.98 89.83 Favored Pre-proline 0 CA--C 1.532 0.269 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -178.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -49.86 -25.63 12.33 Favored 'Trans proline' 0 C--N 1.367 1.548 1 C-N-CA 126.725 4.95 . . . . 0.0 113.367 -176.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 162' ' ' LEU . . . . . 0.88 ' HA ' ' HB ' ' C' ' 168' ' ' THR . 13.2 mt -53.61 -20.14 4.8 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 173.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 163' ' ' PHE . . . . . 0.591 ' HA ' ' HG3' ' C' ' 170' ' ' MET . 9.2 m-30 -82.09 -42.16 19.56 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 123.092 1.425 . . . . 0.0 112.285 175.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -103.11 -41.23 6.16 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 113.18 -1.827 . . . . 0.0 110.099 -153.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 16.0 mttm -74.34 178.92 4.86 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 -164.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -77.43 -56.81 4.22 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-N 113.965 -1.471 . . . . 0.0 108.792 -165.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 167' ' ' ASN . . . . . 0.833 ' HB2' ' HA ' ' C' ' 143' ' ' ASN . 45.9 p30 -75.25 -45.84 37.53 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-O 117.383 -1.294 . . . . 0.0 110.591 168.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 168' ' ' THR . . . . . 0.88 ' HB ' ' HA ' ' C' ' 162' ' ' LEU . 13.6 p -87.54 94.89 9.85 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-N 121.932 2.151 . . . . 0.0 107.829 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -140.18 142.7 35.9 Favored 'General case' 0 C--N 1.353 0.743 0 O-C-N 120.419 -1.426 . . . . 0.0 110.757 -163.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 170' ' ' MET . . . . . 0.591 ' HG3' ' HA ' ' C' ' 163' ' ' PHE . 78.1 mtm -75.66 112.15 11.72 Favored 'General case' 0 CA--C 1.48 -1.72 0 CA-C-O 123.451 1.596 . . . . 0.0 115.232 174.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 171' ' ' LEU . . . . . 0.541 ' HB2' HG13 ' C' ' 145' ' ' ILE . 22.6 tp -71.95 109.81 6.03 Favored 'General case' 0 C--O 1.254 1.31 0 CA-C-N 114.146 -1.388 . . . . 0.0 107.847 169.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -83.26 68.24 9.56 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 126.194 2.902 . . . . 0.0 112.537 -173.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -153.03 163.42 30.51 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 110.161 -3.2 . . . . 0.0 109.735 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 174' ' ' ASP . . . . . 0.549 ' HA ' ' N1A' ' C' 1001 ' ' NAP . 16.7 t70 -74.41 155.32 38.21 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 111.868 -2.166 . . . . 0.0 109.146 173.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.47 -55.74 30.81 Favored 'General case' 0 CA--C 1.496 -1.121 0 CA-C-N 110.292 -3.14 . . . . 0.0 111.91 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 176' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' C' ' 44' ' ' ALA . 0.4 OUTLIER -66.3 -54.44 24.77 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 116.845 -1.55 . . . . 0.0 107.541 176.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 177' ' ' ALA . . . . . . . . . . . . . . . -51.21 -48.98 61.88 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.192 0.997 . . . . 0.0 112.619 -170.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 178' ' ' SER . . . . . 0.448 ' HB2' ' CE2' ' C' ' 147' ' ' PHE . 38.5 m -62.61 -46.46 88.18 Favored 'General case' 0 C--O 1.246 0.877 0 O-C-N 121.004 -1.06 . . . . 0.0 110.746 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 179' ' ' VAL . . . . . 0.433 ' HA ' HG12 ' C' ' 182' ' ' ILE . 22.1 t -61.09 -41.81 90.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 O-C-N 119.789 -1.819 . . . . 0.0 108.14 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 180' ' ' ASP . . . . . 0.417 ' HB2' ' HD2' ' C' ' 176' ' ' LYS . 12.2 t70 -63.97 -37.78 88.67 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.559 -174.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -70.9 -49.72 42.7 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.56 1.073 . . . . 0.0 109.769 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 182' ' ' ILE . . . . . 0.555 HD12 HD11 ' C' ' 27' ' ' LEU . 16.8 pt -63.06 -25.35 38.34 Favored 'Isoleucine or valine' 0 C--N 1.363 1.178 0 O-C-N 119.415 -2.053 . . . . 0.0 112.943 -174.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 183' ' ' LEU . . . . . 0.556 HD12 ' HB ' ' C' ' 53' ' ' ILE . 12.8 tp -49.9 -36.6 28.04 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 126.743 2.017 . . . . 0.0 112.97 170.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 18.7 tptt -112.95 -34.75 5.65 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -57.43 -63.99 1.04 Allowed 'General case' 0 C--O 1.257 1.478 0 N-CA-C 118.823 2.897 . . . . 0.0 118.823 172.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 186' ' ' LEU . . . . . . . . . . . . 0.327 1.3 pt? . . . . . 0 C--O 1.218 -0.586 0 C-N-CA 127.753 2.421 . . . . 0.0 117.349 -167.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 1' ' ' NAD . . . . . 0.427 ' H4D' ' HB3' ' B' 1120 ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C 1001 ' ' NAP . . . . . 0.549 ' N1A' ' HA ' ' C' ' 174' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 22.3 t-80 . . . . . 0 N--CA 1.436 -1.134 0 N-CA-C 104.856 -2.275 . . . . 65.739999999999995 104.856 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -69.94 82.09 0.33 Allowed Glycine 0 C--O 1.222 -0.638 0 O-C-N 117.868 -3.02 . . . . 48.659999999999997 112.313 169.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -113.44 109.47 18.72 Favored 'General case' 0 CA--C 1.478 -1.81 0 N-CA-C 103.633 -2.728 . . . . 44.560000000000002 103.633 170.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1003 ' ' ILE . . . . . . . . . . . . . 61.8 mt -80.18 110.51 15.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 112.179 -2.282 . . . . 34.859999999999999 109.187 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1004 ' ' GLY . . . . . 0.551 ' O ' ' HD3' ' A' 1006 ' ' PRO . . . -75.83 122.11 6.53 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.122 -1.191 . . . . 30.75 110.122 163.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.774 HG23 ' HB3' ' A' 1017 ' ' ALA . 16.8 mm -99.58 105.48 34.04 Favored Pre-proline 0 C--O 1.242 0.688 0 N-CA-C 102.567 -3.123 . . . . 32.210000000000001 102.567 176.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1006 ' ' PRO . . . . . 0.551 ' HD3' ' O ' ' A' 1004 ' ' GLY . 67.8 Cg_exo -85.8 158.35 10.38 Favored 'Trans proline' 0 N--CA 1.451 -1.007 1 C-N-CA 126.222 4.615 . . . . 32.979999999999997 110.468 175.46 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1007 ' ' ARG . . . . . 0.558 ' HG3' HD12 ' A' 1042 ' ' LEU . 1.8 ttp85 -84.98 138.42 32.48 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 103.181 -2.896 . . . . 47.979999999999997 103.181 153.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1008 ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -63.44 137.85 58.3 Favored 'General case' 0 N--CA 1.441 -0.89 0 O-C-N 124.41 1.068 . . . . 34.700000000000003 109.398 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1009 ' ' ARG . . . . . 0.632 HH11 ' HG2' ' A' 1079 ' ' GLU . 80.9 mtp180 -93.82 -27.53 16.4 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 114.725 -1.125 . . . . 53.369999999999997 113.558 -175.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 3.9 mp -52.81 129.2 29.25 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-O 123.018 1.39 . . . . 45.07 111.52 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1011 ' ' THR . . . . . . . . . . . . . 20.7 m -48.19 119.79 3.16 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 113.076 -1.874 . . . . 40.359999999999999 112.137 -171.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 12.5 m120 63.28 -4.67 0.28 Allowed 'General case' 0 C--O 1.243 0.753 0 N-CA-C 117.419 2.377 . . . . 40.609999999999999 117.419 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -88.1 71.97 9.22 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 104.424 -2.436 . . . . 33.759999999999998 104.424 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1014 ' ' THR . . . . . 0.627 HG23 HD13 ' A' 1042 ' ' LEU . 47.1 m -73.29 66.7 0.93 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 125.72 2.676 . . . . 27.890000000000001 111.914 -172.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1015 ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -108.51 163.29 13.36 Favored 'General case' 0 C--O 1.224 -0.262 0 O-C-N 120.002 -1.686 . . . . 29.02 108.942 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1016 ' ' VAL . . . . . 0.472 HG22 ' HA ' ' A' 1007 ' ' ARG . 39.4 t -137.05 151.59 27.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 101.505 -3.517 . . . . 28.129999999999999 101.505 171.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1017 ' ' ALA . . . . . 0.774 ' HB3' HG23 ' A' 1005 ' ' ILE . . . -55.18 -54.57 41.63 Favored 'General case' 0 C--O 1.256 1.426 0 N-CA-C 119.067 2.988 . . . . 26.870000000000001 119.067 -176.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -144.25 159.36 42.81 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 120.478 1.49 . . . . 26.77 112.566 -170.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1019 ' ' THR . . . . . . . . . . . . . 19.2 p -84.25 155.86 63.25 Favored Pre-proline 0 C--O 1.245 0.833 0 CA-C-O 117.762 -1.113 . . . . 27.02 111.423 176.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1020 ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -48.5 -40.16 36.92 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 124.059 3.172 . . . . 30.57 114.41 169.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1021 ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' 1024 ' ' GLU . 2.2 ttmp? -52.33 -48.98 65.15 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.284 1.216 . . . . 47.810000000000002 114.284 168.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1022 ' ' THR . . . . . 0.676 ' HB ' HG21 ' A' 1332 ' ' VAL . 2.6 p -75.15 -30.87 60.88 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 124.057 1.885 . . . . 30.77 109.426 -172.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1023 ' ' VAL . . . . . 0.496 HG11 ' HB2' ' A' 1055 ' ' ALA . 55.5 t -56.98 -52.23 58.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 C-N-CA 125.141 1.376 . . . . 33.590000000000003 108.691 168.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1024 ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' 1021 ' ' LYS . 26.3 mt-10 -46.2 -51.62 13.89 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 120.694 1.588 . . . . 53.289999999999999 110.755 172.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -54.38 -52.4 61.79 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.673 1.36 . . . . 46.920000000000002 114.673 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1026 ' ' LEU . . . . . 0.415 HD23 HD12 ' A' 1029 ' ' LEU . 91.7 mt -53.94 -42.79 69.23 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 115.019 1.488 . . . . 37.170000000000002 115.019 177.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 7.1 mp -54.32 -49.9 68.62 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.711 -1.131 . . . . 44.439999999999998 113.442 168.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1028 ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' 1024 ' ' GLU . 27.4 mmmt -62.08 -29.27 70.19 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 120.367 0.127 . . . . 52.579999999999998 111.094 175.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1029 ' ' LEU . . . . . 0.415 HD12 HD23 ' A' 1026 ' ' LEU . 95.3 mt -72.26 -42.33 65.73 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 119.749 -1.844 . . . . 45.689999999999998 109.784 175.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 138.06 -8.04 3.52 Favored Glycine 0 CA--C 1.507 -0.411 0 C-N-CA 120.877 -0.678 . . . . 42.090000000000003 111.949 173.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -80.15 130.68 35.41 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 118.917 -0.563 . . . . 40.719999999999999 112.301 -173.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1032 ' ' THR . . . . . . . . . . . . . 55.8 m -74.11 127.71 33.62 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.707 -1.22 . . . . 37.770000000000003 107.707 176.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1033 ' ' VAL . . . . . 0.49 HG11 HG22 ' A' 1023 ' ' VAL . 94.8 t -109.7 123.58 65.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 104.639 -2.356 . . . . 33.539999999999999 104.639 -177.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -120.1 113.12 20.01 Favored 'General case' 0 C--O 1.249 1.032 0 N-CA-C 105.966 -1.864 . . . . 31.68 105.966 175.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1035 ' ' VAL . . . . . 0.448 ' HA ' ' HB ' ' A' 1005 ' ' ILE . 17.3 t -94.34 144.3 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 O-C-N 121.553 -0.717 . . . . 31.52 109.282 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1036 ' ' GLU . . . . . 0.445 ' HB2' HG21 ' A' 1063 ' ' VAL . 50.3 tt0 -61.44 140.63 58.02 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 123.392 1.568 . . . . 41.039999999999999 111.329 170.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1037 ' ' SER . . . . . . . . . . . . . 1.4 t -61.49 126.75 28.48 Favored 'General case' 0 N--CA 1.44 -0.951 0 O-C-N 120.187 -1.571 . . . . 31.829999999999998 114.201 171.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 83.95 9.96 81.68 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 113.976 -1.465 . . . . 29.359999999999999 112.032 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -79.04 -41.05 29.76 Favored 'General case' 0 C--N 1.347 0.462 0 O-C-N 121.058 -1.26 . . . . 27.780000000000001 110.049 -176.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -52.48 -39.21 52.48 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 122.82 1.233 . . . . 28.91 113.73 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 12.6 tp-100 -46.44 -55.63 7.15 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.055 -1.072 . . . . 51.18 113.318 170.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1042 ' ' LEU . . . . . 0.627 HD13 HG23 ' A' 1014 ' ' THR . 27.0 mt -72.35 -42.28 65.49 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 120.727 -1.233 . . . . 29.91 111.213 175.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1043 ' ' ALA . . . . . . . . . . . . . . . -54.9 -22.5 15.02 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.567 0.699 . . . . 28.539999999999999 112.35 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1044 ' ' SER . . . . . 0.426 ' HB3' ' CA ' ' B' 1278 ' ' GLY . 67.4 m 63.53 42.28 6.69 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 124.746 2.212 . . . . 33.060000000000002 108.628 174.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1045 ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -172.31 92.15 0.12 Allowed 'General case' 0 N--CA 1.441 -0.914 1 N-CA-C 97.761 -4.903 . . . . 30.289999999999999 97.761 178.977 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.67 171.27 15.19 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-N 111.402 -2.635 . . . . 48.619999999999997 116.585 -147.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1047 ' ' ASP . . . . . 0.474 ' O ' HG23 ' A' 1051 ' ' VAL . 6.9 m-20 -56.77 -42.07 78.74 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 113.776 -1.556 . . . . 36.740000000000002 113.085 -176.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 21.7 pttm -69.9 -25.73 63.83 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.543 1.519 . . . . 43.729999999999997 113.661 176.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -71.07 -37.35 72.48 Favored 'General case' 0 CA--C 1.498 -1.04 0 O-C-N 119.862 -1.774 . . . . 32.810000000000002 109.801 170.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1050 ' ' PHE . . . . . 0.402 ' CD1' HG21 ' A' 1035 ' ' VAL . 26.4 m-85 -57.82 -42.22 83.86 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 120.429 1.468 . . . . 31.859999999999999 112.735 167.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1051 ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' 1047 ' ' ASP . 21.8 t -61.28 -44.9 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 114.578 -1.192 . . . . 33.219999999999999 113.081 174.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -58.17 -37.56 74.95 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.568 0.699 . . . . 50.829999999999998 112.718 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -59.46 -46.35 89.02 Favored 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 121.62 -0.675 . . . . 33.119999999999997 110.062 173.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 128.14 9.48 3.75 Favored Glycine 0 C--N 1.349 1.26 0 C-N-CA 118.905 -1.616 . . . . 35.829999999999998 112.188 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1055 ' ' ALA . . . . . 0.496 ' HB2' HG11 ' A' 1023 ' ' VAL . . . -73.49 146.72 44.69 Favored 'General case' 0 N--CA 1.436 -1.169 0 O-C-N 121.975 -0.72 . . . . 34.82 111.151 -177.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -77.52 136.79 38.35 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 101.932 -3.359 . . . . 49.049999999999997 101.932 171.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1057 ' ' ILE . . . . . . . . . . . . . 25.7 mm -102.46 134.68 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 N-CA-C 107.063 -1.458 . . . . 38.530000000000001 107.063 172.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1058 ' ' VAL . . . . . . . . . . . . . 3.1 m -129.41 143.25 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-O 123.354 1.549 . . . . 42.109999999999999 109.444 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -106.21 128.53 54.01 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 113.452 -1.704 . . . . 58.0 108.379 -165.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 66.49 -138.93 36.56 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-O 123.379 1.544 . . . . 52.119999999999997 114.019 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1061 ' ' ASN . . . . . 0.541 ' HA ' ' HD1' ' A' 1064 ' ' TRP . 8.2 t30 -64.21 -18.94 64.99 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 113.359 -1.42 . . . . 54.75 111.976 -170.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1062 ' ' SER . . . . . . . . . . . . . 49.9 m -63.05 -8.63 7.85 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 116.743 2.127 . . . . 50.340000000000003 116.743 176.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1063 ' ' VAL . . . . . 0.445 HG21 ' HB2' ' A' 1036 ' ' GLU . 9.7 p -72.52 -38.13 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-O 121.921 0.867 . . . . 41.460000000000001 110.347 167.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1064 ' ' TRP . . . . . 0.541 ' HD1' ' HA ' ' A' 1061 ' ' ASN . 86.1 m95 -73.07 -20.21 61.01 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.013 0.925 . . . . 39.32 110.389 174.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -77.21 64.57 2.65 Favored 'General case' 0 C--O 1.224 -0.272 0 O-C-N 120.31 -1.494 . . . . 55.380000000000003 111.36 171.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1066 ' ' SER . . . . . . . . . . . . . 47.8 m -152.17 129.06 10.95 Favored 'General case' 0 N--CA 1.444 -0.734 0 O-C-N 120.69 -1.256 . . . . 41.869999999999997 108.054 -174.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -74.54 4.49 6.01 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 120.093 3.368 . . . . 53.200000000000003 120.093 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1068 ' ' ILE . . . . . 0.644 HG12 ' HB ' ' A' 1088 ' ' THR . 96.9 mt -128.41 134.76 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 104.135 -2.543 . . . . 41.899999999999999 104.135 158.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1069 ' ' ILE . . . . . . . . . . . . . 34.9 mm -128.08 132.95 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 104.677 -2.342 . . . . 38.729999999999997 104.677 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1070 ' ' LEU . . . . . 0.803 HD13 HD13 ' A' 1331 ' ' LEU . 19.8 mt -108.13 79.15 1.23 Allowed 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 125.385 2.517 . . . . 32.439999999999998 112.164 172.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1071 ' ' LYS . . . . . 0.451 ' HE3' ' O ' ' A' 1073 ' ' ASN . 8.7 mmmt -65.67 127.55 32.38 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 113.302 -1.772 . . . . 34.649999999999999 111.005 169.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1072 ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -92.23 -14.32 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 CA-C-N 114.131 -1.395 . . . . 31.32 110.623 -160.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1073 ' ' ASN . . . . . 0.451 ' O ' ' HE3' ' A' 1071 ' ' LYS . 46.9 t30 -149.42 178.23 8.99 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 107.842 -1.17 . . . . 33.939999999999998 107.842 173.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1074 ' ' ALA . . . . . 0.468 ' HA ' ' HD3' ' A' 1075 ' ' PRO . . . -38.8 146.57 0.31 Allowed Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 127.547 2.339 . . . . 38.039999999999999 116.026 172.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1075 ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' 1074 ' ' ALA . 21.9 Cg_exo -80.8 157.6 21.19 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.932 3.088 . . . . 42.68 119.122 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 42.5 mt -107.77 161.27 15.04 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 105.133 -2.173 . . . . 46.740000000000002 105.133 162.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 25.5 t0 -70.27 -21.9 62.92 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.539 -0.726 . . . . 58.609999999999999 110.758 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 21.8 t0 -54.12 -56.39 18.52 Favored 'General case' 0 C--N 1.344 0.359 0 N-CA-C 108.134 -1.061 . . . . 59.200000000000003 108.134 162.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1079 ' ' GLU . . . . . 0.632 ' HG2' HH11 ' A' 1009 ' ' ARG . 33.0 mt-10 -66.67 -31.22 71.75 Favored 'General case' 0 CA--C 1.501 -0.927 0 O-C-N 121.616 -0.677 . . . . 50.630000000000003 110.543 -174.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1080 ' ' ILE . . . . . . . . . . . . . 82.8 mt -68.25 -31.56 52.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 O-C-N 120.996 -1.065 . . . . 51.479999999999997 111.704 176.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -70.61 -43.24 69.74 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 118.689 -2.507 . . . . 50.280000000000001 110.707 171.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 8.0 mp -69.07 -23.94 64.1 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 114.101 1.148 . . . . 50.210000000000001 114.101 177.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1083 ' ' LEU . . . . . 0.571 HD11 HD13 ' A' 1089 ' ' LEU . 0.1 OUTLIER -67.49 116.37 8.15 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 105.41 -2.07 . . . . 49.060000000000002 105.41 175.579 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -75.09 150.64 85.74 Favored Pre-proline 0 N--CA 1.432 -1.325 0 CA-C-O 118.561 -0.733 . . . . 51.079999999999998 110.908 171.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -55.91 165.9 3.43 Favored 'Trans proline' 0 C--O 1.249 1.053 0 C-N-CA 123.99 3.127 . . . . 49.729999999999997 113.853 167.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 81.78 -28.38 3.2 Favored Glycine 0 C--N 1.338 0.671 0 O-C-N 120.489 -1.382 . . . . 47.710000000000001 114.052 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1087 ' ' THR . . . . . . . . . . . . . 13.9 m -51.09 129.74 24.64 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 117.654 2.464 . . . . 45.469999999999999 117.654 -174.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1088 ' ' THR . . . . . 0.644 ' HB ' HG12 ' A' 1068 ' ' ILE . 30.0 m -79.6 90.39 5.14 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 106.713 -1.588 . . . . 42.039999999999999 106.713 161.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1089 ' ' LEU . . . . . 0.571 HD13 HD11 ' A' 1083 ' ' LEU . 63.5 tp -79.85 80.74 6.21 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 105.451 -2.055 . . . . 38.060000000000002 105.451 -174.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1090 ' ' VAL . . . . . 0.584 ' HA ' ' HB2' ' A' 1113 ' ' MET . 36.2 t -81.44 104.67 10.33 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 N-CA-C 101.964 -3.347 . . . . 37.399999999999999 101.964 177.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1091 ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' 1114 ' ' ALA . 60.5 m -155.05 164.76 38.42 Favored 'General case' 0 C--O 1.251 1.145 0 O-C-N 119.816 -1.803 . . . . 36.159999999999997 113.769 -167.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 17.0 t80 -92.11 90.75 7.48 Favored 'General case' 0 C--O 1.246 0.915 0 O-C-N 120.111 -1.618 . . . . 38.939999999999998 107.432 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 30.9 mm -95.15 -30.37 4.1 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 N-CA-C 113.006 0.743 . . . . 42.170000000000002 113.006 -160.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 90.7 m95 56.93 74.09 0.72 Allowed Pre-proline 0 C--O 1.236 0.346 0 C-N-CA 125.635 1.574 . . . . 46.509999999999998 111.89 -171.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -62.51 -56.24 0.71 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 123.536 2.824 . . . . 49.759999999999998 115.815 -167.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -70.34 -11.79 61.14 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 118.138 -2.851 . . . . 52.619999999999997 113.514 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -86.53 -32.11 20.9 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 105.938 -1.875 . . . . 60.740000000000002 105.938 176.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1098 ' ' ASN . . . . . 0.425 ' HB3' ' HB2' ' A' 1101 ' ' LEU . 76.7 m-20 -119.83 55.96 3.77 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 117.178 2.288 . . . . 58.189999999999998 117.178 -177.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.41 -42.77 31.89 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.767 2.978 . . . . 54.590000000000003 114.647 -174.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -60.77 -46.47 90.36 Favored 'General case' 0 C--O 1.251 1.171 0 O-C-N 119.943 -1.723 . . . . 63.280000000000001 111.918 174.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1101 ' ' LEU . . . . . 0.425 ' HB2' ' HB3' ' A' 1098 ' ' ASN . 20.6 mt -61.7 -33.37 73.9 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.602 -1.181 . . . . 54.75 111.24 176.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1102 ' ' MET . . . . . . . . . . . . . 46.4 mmm -61.58 -48.39 81.17 Favored 'General case' 0 C--O 1.245 0.861 0 O-C-N 121.662 -0.649 . . . . 52.649999999999999 111.657 175.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -60.3 -39.61 87.58 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.318 -0.856 . . . . 66.260000000000005 108.917 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 88.4 mttt -64.61 -32.51 74.2 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 118.865 0.757 . . . . 63.729999999999997 112.006 174.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 34.2 mt -76.15 -26.85 56.7 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 120.308 -1.495 . . . . 54.68 111.877 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -64.48 -47.65 78.16 Favored 'General case' 0 C--O 1.245 0.858 0 O-C-N 120.713 -1.242 . . . . 53.640000000000001 111.705 168.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -56.05 -33.69 65.21 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.397 -1.729 . . . . 67.239999999999995 114.163 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -60.5 -24.79 65.58 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 117.276 2.324 . . . . 65.760000000000005 117.276 170.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1109 ' ' ASN . . . . . 0.499 ' HA ' ' HA3' ' A' 1364 ' ' GLY . 3.7 t30 56.91 67.83 0.94 Allowed 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 123.445 1.593 . . . . 58.710000000000001 111.972 -165.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1110 ' ' VAL . . . . . 0.455 HG23 HG23 ' A' 1112 ' ' VAL . 17.0 m -133.28 151.69 34.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 113.89 -1.505 . . . . 46.630000000000003 108.299 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1111 ' ' THR . . . . . 0.55 HG21 HG21 ' A' 1348 ' ' VAL . 94.8 m -91.55 93.38 8.93 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 123.027 1.394 . . . . 44.130000000000003 110.61 171.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1112 ' ' VAL . . . . . 0.496 HG22 HD23 ' A' 1089 ' ' LEU . 41.3 t -83.55 108.44 16.08 Favored 'Isoleucine or valine' 0 C--O 1.252 1.21 0 O-C-N 119.774 -1.829 . . . . 40.439999999999998 109.806 -178.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1113 ' ' MET . . . . . 0.584 ' HB2' ' HA ' ' A' 1090 ' ' VAL . 22.8 mtp -100.97 93.07 5.32 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 111.59 -2.55 . . . . 50.759999999999998 109.122 173.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1114 ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' 1091 ' ' SER . . . -85.51 118.39 25.01 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 119.185 -1.006 . . . . 35.640000000000001 109.324 -173.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1115 ' ' MET . . . . . 0.436 ' O ' HG23 ' A' 1118 ' ' VAL . 79.5 mmm -66.04 -29.39 69.74 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 115.611 1.708 . . . . 38.740000000000002 115.611 -175.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.62 -44.48 69.53 Favored 'General case' 0 C--O 1.25 1.093 0 CA-C-O 121.682 0.753 . . . . 40.140000000000001 111.475 165.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1117 ' ' SER . . . . . . . . . . . . . 74.0 m -75.11 14.08 0.6 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 119.487 3.143 . . . . 44.789999999999999 119.487 -176.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1118 ' ' VAL . . . . . 0.785 HG22 HG22 ' A' 1358 ' ' VAL . 13.6 t -72.77 133.67 82.12 Favored Pre-proline 0 C--O 1.215 -0.751 0 O-C-N 118.432 -2.668 . . . . 43.75 107.057 177.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -60.65 152.24 70.37 Favored 'Trans proline' 0 N--CA 1.443 -1.455 1 C-N-CA 125.785 4.323 . . . . 48.93 115.451 173.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -70.1 12.88 0.19 Allowed 'General case' 0 C--O 1.255 1.39 0 N-CA-C 121.027 3.714 . . . . 62.899999999999999 121.027 -173.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1121 ' ' ILE . . . . . 0.406 HG12 ' H ' ' A' 1121 ' ' ILE . 10.5 pt -86.2 169.35 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 O-C-N 119.088 -2.257 . . . . 57.719999999999999 112.951 -170.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1122 ' ' SER . . . . . 0.422 ' HA ' ' HG2' ' A' 1125 ' ' GLN . 69.7 m -63.37 -46.19 87.66 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 124.398 1.079 . . . . 57.259999999999998 113.721 -173.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -59.24 -36.11 74.88 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 122.922 2.601 . . . . 62.899999999999999 112.128 175.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1124 ' ' ALA . . . . . 0.511 ' HB1' HG12 ' A' 1118 ' ' VAL . . . -71.16 -23.63 62.09 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 125.012 1.445 . . . . 49.829999999999998 111.904 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1125 ' ' GLN . . . . . 0.422 ' HG2' ' HA ' ' A' 1122 ' ' SER . 54.1 mm-40 -56.28 -23.69 38.16 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 118.241 2.682 . . . . 52.369999999999997 118.241 -171.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1126 ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.83 -35.12 57.77 Favored 'General case' 0 C--O 1.252 1.198 0 N-CA-C 116.463 2.023 . . . . 42.43 116.463 169.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1127 ' ' LEU . . . . . 0.473 ' O ' ' HB3' ' A' 1330 ' ' ASN . 4.5 mp -78.63 -35.82 44.93 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 113.3 -1.773 . . . . 43.740000000000002 111.504 177.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 13.3 t70 -73.64 123.04 23.27 Favored 'General case' 0 C--O 1.246 0.892 0 O-C-N 120.244 -1.535 . . . . 43.210000000000001 114.764 -165.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -75.39 -27.59 59.15 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 114.231 1.197 . . . . 35.740000000000002 114.231 175.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 69.1 mt -67.19 -11.86 58.49 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 118.679 0.672 . . . . 38.090000000000003 112.524 170.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1131 ' ' SER . . . . . 0.563 ' HA ' HG11 ' A' 1175 ' ' VAL . 6.4 m -73.86 -77.13 0.11 Allowed 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.274 -0.639 . . . . 36.909999999999997 109.274 153.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1132 ' ' SER . . . . . 0.731 ' HB3' ' HB3' ' A' 1326 ' ' LEU . 8.3 m -58.24 -55.71 31.52 Favored 'General case' 0 C--N 1.347 0.491 0 O-C-N 120.899 -1.125 . . . . 35.789999999999999 113.278 -162.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1133 ' ' MET . . . . . 0.552 ' HA ' HD12 ' A' 1136 ' ' ILE . 18.3 mtp -62.97 -34.75 78.19 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 113.067 0.766 . . . . 30.809999999999999 113.067 -177.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1134 ' ' ALA . . . . . . . . . . . . . . . -66.75 -40.79 88.41 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.536 0.607 . . . . 28.879999999999999 109.506 174.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1135 ' ' ASN . . . . . 0.404 ' HB3' ' O ' ' A' 1132 ' ' SER . 10.6 t-20 -57.32 -45.04 84.64 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 117.882 -1.056 . . . . 40.759999999999998 111.204 171.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1136 ' ' ILE . . . . . 0.552 HD12 ' HA ' ' A' 1133 ' ' MET . 83.7 mt -56.46 -44.63 80.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-O 122.51 1.147 . . . . 31.539999999999999 110.767 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -60.62 -49.2 78.49 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 112.669 -2.06 . . . . 29.870000000000001 112.15 175.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1138 ' ' GLY . . . . . 0.447 ' HA2' HD11 ' A' 1284 ' ' LEU . . . -57.44 -46.78 91.54 Favored Glycine 0 N--CA 1.468 0.819 0 O-C-N 120.806 -1.184 . . . . 28.73 111.393 -177.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 18.4 t80 -65.01 -49.29 70.78 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 118.821 -0.609 . . . . 30.390000000000001 110.391 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1140 ' ' ARG . . . . . 0.546 ' HG3' HD22 ' A' 1315 ' ' LEU . 5.7 tpt180 -70.69 -19.26 62.79 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 117.155 -1.818 . . . . 26.09 111.951 -175.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1141 ' ' ALA . . . . . 0.721 ' HB2' HD21 ' A' 1284 ' ' LEU . . . -69.76 -45.55 67.83 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 106.957 -1.497 . . . . 27.100000000000001 106.957 176.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1142 ' ' ILE . . . . . 0.419 HD13 ' HA ' ' A' 1142 ' ' ILE . 28.5 mm -50.45 -44.82 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 C-N-CA 123.588 0.755 . . . . 28.48 111.929 169.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 58.6 t -62.31 -58.94 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 112.797 0.665 . . . . 23.07 112.797 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1144 ' ' GLU . . . . . 0.468 ' CD ' HH21 ' A' 1140 ' ' ARG . 6.0 mm-40 -63.85 -31.51 72.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.839 0.828 . . . . 33.399999999999999 112.562 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1145 ' ' ALA . . . . . 0.7 ' HB1' HD12 ' A' 1251 ' ' ILE . . . -56.88 -54.5 45.85 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 115.859 -2.019 . . . . 24.219999999999999 111.554 164.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1146 ' ' ALA . . . . . 0.576 ' HA ' ' HB2' ' A' 1149 ' ' PHE . . . -58.4 -22.91 55.69 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 116.019 1.859 . . . . 24.890000000000001 116.019 174.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -70.0 -54.23 14.13 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 105.827 -1.916 . . . . 26.73 105.827 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1148 ' ' GLU . . . . . 0.828 ' HB2' HD11 ' A' 1310 ' ' ILE . 25.3 mm-40 -97.49 21.6 10.0 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 116.955 2.205 . . . . 39.960000000000001 116.955 176.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1149 ' ' PHE . . . . . 0.576 ' HB2' ' HA ' ' A' 1146 ' ' ALA . 1.0 OUTLIER -71.92 136.49 46.89 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 106.938 -1.504 . . . . 25.870000000000001 106.938 177.488 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1150 ' ' GLY . . . . . 0.452 ' HA2' ' HG2' ' B' 1320 ' ' PRO . . . -74.66 -52.75 6.99 Favored Glycine 0 CA--C 1.502 -0.73 0 O-C-N 127.262 2.851 . . . . 19.280000000000001 109.916 170.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1151 ' ' ARG . . . . . 0.72 ' NH2' ' HB2' ' A' 1164 ' ' PRO . 0.4 OUTLIER -101.17 -164.93 1.15 Allowed 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 120.8 -1.412 . . . . 39.899999999999999 113.768 -170.536 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1152 ' ' PHE . . . . . 0.521 ' HD2' ' HG2' ' B' 1322 ' ' GLN . 0.7 OUTLIER -107.23 141.21 38.9 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 120.466 -1.396 . . . . 29.440000000000001 109.129 -170.223 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1153 ' ' PHE . . . . . 0.536 ' HE2' ' HB2' ' A' 1146 ' ' ALA . 16.9 m-85 -65.22 -58.67 5.39 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 117.804 -3.06 . . . . 32.600000000000001 110.181 169.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1154 ' ' THR . . . . . . . . . . . . . 3.0 m -71.75 116.54 12.24 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 124.412 1.07 . . . . 34.640000000000001 111.234 -172.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -64.39 96.03 0.19 Allowed Glycine 0 CA--C 1.547 2.04 0 N-CA-C 106.253 -2.739 . . . . 37.140000000000001 106.253 165.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -136.1 -158.28 0.86 Allowed 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 118.935 -0.555 . . . . 40.57 112.191 -175.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1157 ' ' ILE . . . . . 0.861 HG21 ' HB2' ' C' ' 70' ' ' PRO . 3.3 tp -155.41 125.68 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 O-C-N 119.615 -1.928 . . . . 44.609999999999999 110.22 -159.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1158 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.74 -160.76 1.18 Allowed 'General case' 0 C--O 1.253 1.245 0 N-CA-C 105.436 -2.061 . . . . 40.700000000000003 105.436 176.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -48.29 -31.97 6.71 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 119.138 -2.226 . . . . 40.25 116.774 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1160 ' ' ALA . . . . . 0.51 ' HA ' ' HB ' ' B' 1329 ' ' THR . . . -64.58 -11.65 36.94 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-O 117.929 -1.034 . . . . 38.469999999999999 113.335 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . 76.8 -117.48 4.91 Favored Glycine 0 N--CA 1.432 -1.617 0 N-CA-C 107.771 -2.132 . . . . 37.609999999999999 107.771 -171.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 7.1 tttp -67.89 108.2 2.93 Favored 'General case' 0 CA--C 1.482 -1.672 0 N-CA-C 107.306 -1.368 . . . . 48.899999999999999 107.306 171.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1163 ' ' VAL . . . . . . . . . . . . . 38.8 t -82.13 106.17 5.9 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 102.843 -3.021 . . . . 36.520000000000003 102.843 163.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1164 ' ' PRO . . . . . 0.72 ' HB2' ' NH2' ' A' 1151 ' ' ARG . 10.2 Cg_endo -65.38 122.21 9.85 Favored 'Trans proline' 0 N--CA 1.443 -1.443 0 C-N-CA 124.504 3.47 . . . . 35.079999999999998 116.688 -171.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1165 ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' 1164 ' ' PRO . 95.3 Cg_endo -68.14 156.17 66.78 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 N-CA-C 118.454 2.444 . . . . 35.329999999999998 118.454 -177.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -62.92 122.68 16.59 Favored 'General case' 0 N--CA 1.417 -2.098 0 CA-C-N 113.448 -1.705 . . . . 34.689999999999998 112.779 169.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1167 ' ' LYS . . . . . 0.674 ' HB2' ' HA ' ' A' 1249 ' ' VAL . 99.0 mttt -93.84 114.35 26.58 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 104.974 -2.232 . . . . 45.359999999999999 104.974 164.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1168 ' ' VAL . . . . . 0.415 HG22 ' HB ' ' A' 1251 ' ' ILE . 59.8 t -99.89 134.53 39.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 103.967 -2.605 . . . . 31.710000000000001 103.967 -173.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1169 ' ' MET . . . . . . . . . . . . . 46.2 ttp -118.64 105.95 12.11 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 106.416 -1.698 . . . . 42.280000000000001 106.416 168.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 38.2 t -78.29 126.4 38.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 107.788 -1.19 . . . . 30.510000000000002 107.788 168.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 61.8 mt -112.41 126.16 69.77 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 108.787 -0.82 . . . . 31.870000000000001 108.787 171.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 79.6 79.65 0.82 Allowed Glycine 0 CA--C 1.536 1.346 0 N-CA-C 108.65 -1.78 . . . . 34.539999999999999 108.65 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1173 ' ' ALA . . . . . . . . . . . . . . . -85.87 89.43 7.77 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 125.568 2.604 . . . . 32.509999999999998 110.109 -172.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -113.35 -147.82 9.98 Favored Glycine 0 C--O 1.246 0.906 0 CA-C-N 110.788 -2.915 . . . . 29.899999999999999 108.882 174.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1175 ' ' VAL . . . . . 0.563 HG11 ' HA ' ' A' 1131 ' ' SER . 2.7 t -75.57 -37.35 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 119.261 1.531 . . . . 33.109999999999999 109.706 -175.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -55.77 -39.87 71.81 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 120.917 -1.115 . . . . 28.100000000000001 112.139 165.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -57.35 -49.4 73.06 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-O 118.738 -1.035 . . . . 28.539999999999999 110.572 174.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1178 ' ' LEU . . . . . . . . . . . . . 53.3 mt -56.37 -47.1 79.58 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 117.987 0.894 . . . . 31.219999999999999 110.588 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -57.28 -46.75 82.81 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 114.085 1.142 . . . . 28.98 114.085 177.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -64.02 -41.65 97.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.284 -0.871 . . . . 27.829999999999998 111.026 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1181 ' ' ILE . . . . . . . . . . . . . 92.2 mt -63.86 -46.23 94.84 Favored 'Isoleucine or valine' 0 C--N 1.361 1.085 0 CA-C-O 119.75 -0.167 . . . . 30.25 110.717 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -58.8 -54.54 37.1 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 108.64 -1.784 . . . . 29.59 108.64 -177.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -51.94 -56.1 16.25 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 118.115 0.958 . . . . 30.289999999999999 113.309 176.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -63.51 -44.49 94.15 Favored 'General case' 0 C--O 1.254 1.3 0 N-CA-C 115.274 1.583 . . . . 30.469999999999999 115.274 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -60.21 -53.25 59.93 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 124.624 1.17 . . . . 42.409999999999997 109.284 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1186 ' ' SER . . . . . 0.485 ' HB2' ' HA ' ' B' 1187 ' ' LEU . 85.2 p -57.5 -40.67 79.17 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 120.557 1.526 . . . . 39.380000000000003 115.032 175.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 5.6 mt -60.6 -21.57 62.8 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 114.71 1.374 . . . . 36.18 114.71 169.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 93.96 32.75 7.35 Favored Glycine 0 C--O 1.24 0.477 0 CA-C-O 123.085 1.38 . . . . 33.780000000000001 110.905 170.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -96.35 168.94 10.26 Favored 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 121.78 -0.836 . . . . 33.93 109.393 176.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 8.4 mt -93.9 109.11 21.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 102.511 -3.144 . . . . 38.740000000000002 102.511 -176.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 5.8 t -97.74 131.81 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 118.831 -1.148 . . . . 33.090000000000003 109.769 -170.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1192 ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -123.76 151.21 43.51 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 104.054 -2.573 . . . . 38.920000000000002 104.054 175.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -143.59 147.91 35.1 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 108.382 -0.97 . . . . 35.32 108.382 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 5.9 t80 -133.18 132.63 41.8 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.006 -1.85 . . . . 39.350000000000001 106.006 -178.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 9.0 t0 -156.74 154.5 30.09 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 105.526 -2.027 . . . . 40.460000000000001 105.526 170.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1196 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.28 -40.78 81.72 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 120.138 -0.625 . . . . 45.939999999999998 109.88 175.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1197 ' ' ARG . . . . . 0.447 ' HA ' ' HD2' ' A' 1198 ' ' PRO . 71.4 mtm180 -71.61 112.15 12.97 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 124.235 1.014 . . . . 56.020000000000003 113.516 -168.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1198 ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' 1197 ' ' ARG . 72.6 Cg_endo -60.87 -14.78 34.32 Favored 'Trans proline' 0 C--N 1.325 -0.69 0 C-N-CA 124.775 3.65 . . . . 51.270000000000003 116.411 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -69.97 -58.96 3.23 Favored 'General case' 0 C--N 1.356 0.859 0 O-C-N 120.231 -1.543 . . . . 59.100000000000001 111.561 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 17.5 m -53.29 -25.02 9.38 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.897 0 N-CA-C 113.262 0.838 . . . . 51.060000000000002 113.262 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 86.4 tttt -41.14 -38.3 1.05 Allowed 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 126.593 1.957 . . . . 57.380000000000003 114.863 169.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -66.45 -57.93 6.33 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 115.792 -2.051 . . . . 62.409999999999997 111.915 172.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -57.18 -28.62 62.98 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 123.924 3.056 . . . . 57.780000000000001 116.309 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1204 ' ' VAL . . . . . 0.597 HG11 ' HD1' ' A' 1211 ' ' PHE . 49.8 t -58.5 -60.51 2.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 O-C-N 121.555 -0.716 . . . . 46.380000000000003 109.924 168.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -69.92 -49.18 54.53 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 105.958 -1.867 . . . . 50.700000000000003 105.958 -170.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1206 ' ' SER . . . . . . . . . . . . . 45.8 m -45.75 -46.83 15.36 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.689 1.737 . . . . 49.979999999999997 115.689 169.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1207 ' ' MET . . . . . . . . . . . . . 18.2 mtp -73.21 -11.22 60.44 Favored 'General case' 0 CA--C 1.504 -0.79 0 O-C-N 119.024 -2.298 . . . . 52.990000000000002 113.06 175.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 105.27 64.95 0.66 Allowed Glycine 0 N--CA 1.439 -1.136 0 N-CA-C 109.931 -1.268 . . . . 47.659999999999997 109.931 166.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -152.81 144.52 23.53 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.099 -1.05 . . . . 44.770000000000003 110.147 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -75.49 133.19 41.11 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 105.738 -1.949 . . . . 47.640000000000001 105.738 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1211 ' ' PHE . . . . . 0.597 ' HD1' HG11 ' A' 1204 ' ' VAL . 35.1 t80 -99.22 105.93 18.02 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 117.075 -1.85 . . . . 45.659999999999997 108.974 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 55.6 mt -67.13 111.31 3.84 Favored 'General case' 0 C--O 1.252 1.229 0 CA-C-O 123.405 1.574 . . . . 46.060000000000002 109.9 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -79.18 165.37 23.37 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 113.379 -1.737 . . . . 60.219999999999999 115.318 174.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 8.4 mp -72.25 104.99 3.85 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-N 112.827 -1.988 . . . . 57.25 107.241 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1215 ' ' ASP . . . . . 0.45 ' HB3' HD21 ' A' 1241 ' ' LEU . 23.4 t70 -74.13 99.02 3.26 Favored 'General case' 0 CA--C 1.497 -1.071 0 O-C-N 118.416 -2.678 . . . . 64.430000000000007 106.617 166.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 14.5 t80 . . . . . 0 CA--C 1.54 0.558 0 CA-C-N 111.055 -2.793 . . . . 66.900000000000006 108.203 175.518 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 N--CA 1.425 -1.678 0 CA-C-O 121.843 0.83 . . . . 39.090000000000003 109.865 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -65.57 -29.38 75.03 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 126.927 2.203 . . . . 39.32 111.123 -169.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.7 -53.25 9.62 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 118.995 1.398 . . . . 39.299999999999997 107.546 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -55.6 -41.63 73.69 Favored 'General case' 0 C--O 1.211 -0.936 0 N-CA-C 113.358 0.873 . . . . 36.299999999999997 113.358 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -51.21 -64.77 0.7 Allowed 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 114.093 1.145 . . . . 37.380000000000003 114.093 162.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -63.62 -24.03 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 116.731 2.123 . . . . 39.109999999999999 116.731 -171.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1230 ' ' MET . . . . . . . . . . . . . 33.7 mmt -79.91 -23.57 41.7 Favored 'General case' 0 C--O 1.241 0.644 0 O-C-N 120.964 -1.085 . . . . 49.590000000000003 112.522 178.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1231 ' ' SER . . . . . . . . . . . . . 12.6 p -89.47 137.88 31.94 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 120.484 3.512 . . . . 43.68 120.484 -163.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -41.4 -45.58 3.14 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 117.457 2.392 . . . . 55.57 117.457 -174.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -73.01 -32.98 65.48 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 120.317 -1.489 . . . . 44.939999999999998 114.432 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -64.44 -53.9 41.03 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 106.804 -1.554 . . . . 42.039999999999999 106.804 172.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 35.9 mt -56.47 -27.5 24.93 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 N-CA-C 114.905 1.446 . . . . 46.280000000000001 114.905 173.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -59.08 -56.11 26.46 Favored 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 121.221 -0.924 . . . . 47.869999999999997 111.585 170.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -59.91 -52.92 63.35 Favored 'General case' 0 CA--C 1.496 -1.096 0 O-C-N 127.028 2.705 . . . . 41.609999999999999 111.339 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -48.68 -48.21 40.19 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 123.851 0.861 . . . . 50.649999999999999 112.316 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1239 ' ' MET . . . . . . . . . . . . . 28.4 ttm -55.02 -44.04 74.24 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 124.583 1.177 . . . . 48.869999999999997 109.149 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -72.07 -30.33 65.02 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.337 -0.945 . . . . 54.799999999999997 113.493 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1241 ' ' LEU . . . . . 0.45 HD21 ' HB3' ' A' 1215 ' ' ASP . 4.1 mm? -60.9 -43.54 98.36 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 118.833 -1.147 . . . . 43.210000000000001 113.824 169.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -62.15 -43.61 98.45 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.552 1.158 . . . . 38.659999999999997 109.37 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -57.15 -52.95 63.24 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.605 0.595 . . . . 37.920000000000002 112.605 171.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -54.35 -29.54 48.6 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 114.046 1.128 . . . . 37.280000000000001 114.046 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -85.31 -40.02 17.02 Favored 'General case' 0 C--N 1.315 -0.902 0 O-C-N 123.736 0.647 . . . . 43.07 110.588 174.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1246 ' ' ALA . . . . . 0.803 ' HB1' ' HG2' ' A' 1275 ' ' MET . . . -66.49 -15.5 63.42 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 116.742 2.127 . . . . 38.299999999999997 116.742 -158.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1247 ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -87.05 -18.46 30.52 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 113.391 -1.731 . . . . 47.600000000000001 113.792 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -105.33 -45.53 4.45 Favored 'General case' 0 C--N 1.358 0.968 0 O-C-N 120.435 -1.415 . . . . 45.420000000000002 112.839 165.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1249 ' ' VAL . . . . . 0.674 ' HA ' ' HB2' ' A' 1167 ' ' LYS . 31.4 m -64.67 148.14 12.07 Favored 'Isoleucine or valine' 0 C--N 1.345 0.382 0 CA-C-O 123.221 1.486 . . . . 36.259999999999998 114.256 -175.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1250 ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -91.37 -71.97 0.61 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.718 1.247 . . . . 33.039999999999999 111.036 -176.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1251 ' ' ILE . . . . . 0.7 HD12 ' HB1' ' A' 1145 ' ' ALA . 37.4 mm -97.68 101.29 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.946 0 C-N-CA 117.462 -1.695 . . . . 31.399999999999999 107.776 -171.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1252 ' ' ILE . . . . . . . . . . . . . 68.0 mt -77.09 94.15 1.25 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 106.563 -1.643 . . . . 29.420000000000002 106.563 166.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1253 ' ' VAL . . . . . 0.652 ' HA ' HG23 ' A' 1282 ' ' VAL . 2.0 t -81.3 98.61 4.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 104.5 -2.408 . . . . 30.370000000000001 104.5 175.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1254 ' ' THR . . . . . 0.767 HG21 ' HB2' ' A' 1291 ' ' ASN . 22.3 m -86.76 82.16 7.94 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 124.587 2.137 . . . . 35.719999999999999 105.914 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1255 ' ' THR . . . . . 0.476 HG22 HD12 ' A' 1284 ' ' LEU . 1.9 p -73.8 5.11 4.34 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 120.067 3.358 . . . . 36.0 120.067 -176.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1256 ' ' ALA . . . . . . . . . . . . . . . -85.64 63.03 7.83 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 124.105 1.907 . . . . 40.93 112.76 -170.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 57.1 tp -70.6 91.72 0.81 Allowed 'General case' 0 C--N 1.353 0.733 0 N-CA-C 103.546 -2.761 . . . . 47.82 103.546 172.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 39.5 mm -87.08 108.15 17.63 Favored Pre-proline 0 C--O 1.22 -0.489 0 N-CA-C 104.14 -2.541 . . . . 52.700000000000003 104.14 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -56.63 109.52 0.46 Allowed 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 124.398 3.399 . . . . 54.130000000000003 116.34 -170.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 78.34 16.32 79.69 Favored Glycine 0 N--CA 1.461 0.343 0 CA-C-N 112.025 -2.352 . . . . 54.619999999999997 111.945 174.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 92.1 mttt -125.78 141.72 40.11 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 119.628 1.714 . . . . 55.740000000000002 109.022 -176.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -66.46 97.85 0.38 Allowed 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 123.299 2.666 . . . . 51.149999999999999 107.031 172.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -56.58 125.02 65.8 Favored Pre-proline 0 N--CA 1.433 -1.294 0 CA-C-O 117.375 -1.298 . . . . 46.060000000000002 112.519 176.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -50.15 128.39 22.35 Favored 'Trans proline' 0 C--O 1.25 1.09 1 C-N-CA 126.622 4.881 . . . . 41.079999999999998 112.645 -166.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -61.7 97.06 0.07 Allowed 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.933 -1.03 . . . . 47.420000000000002 110.408 172.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 83.4 mt -94.77 -54.54 3.44 Favored 'General case' 0 N--CA 1.434 -1.23 0 O-C-N 120.693 -1.254 . . . . 39.219999999999999 109.68 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1267 ' ' ILE . . . . . 0.484 ' HB ' ' HA ' ' A' 1292 ' ' CYS . 12.3 mt -78.46 104.36 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 107.937 -1.135 . . . . 42.5 107.937 -172.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1268 ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.54 148.56 48.44 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 119.078 2.992 . . . . 37.840000000000003 119.078 175.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 40.6 mtt180 -52.28 -59.45 4.38 Favored 'General case' 0 C--O 1.248 0.996 0 N-CA-C 117.159 2.281 . . . . 54.799999999999997 117.159 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.55 -27.01 68.96 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 118.819 0.736 . . . . 54.359999999999999 111.919 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1271 ' ' MET . . . . . . . . . . . . . 59.5 ttm -68.45 -36.76 79.47 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.986 1.314 . . . . 39.520000000000003 111.704 175.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1272 ' ' VAL . . . . . . . . . . . . . 92.3 t -63.25 -47.94 89.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 N-CA-C 107.503 -1.295 . . . . 38.25 107.503 171.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -57.6 -26.16 61.13 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 113.731 1.012 . . . . 40.770000000000003 113.731 175.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1274 ' ' SER . . . . . . . . . . . . . 5.1 m -85.67 -8.24 58.33 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 121.261 1.846 . . . . 36.579999999999998 114.945 173.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1275 ' ' MET . . . . . 0.803 ' HG2' ' HB1' ' A' 1246 ' ' ALA . 87.1 mtp -60.76 165.19 4.11 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 116.521 2.045 . . . . 36.75 116.521 176.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1276 ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -67.47 144.47 55.69 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 122.514 1.149 . . . . 46.109999999999999 111.585 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1277 ' ' ALA . . . . . 0.494 ' HB1' ' HA ' ' B' 1045 ' ' PHE . . . -60.25 139.89 57.34 Favored 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 124.423 1.089 . . . . 33.520000000000003 109.008 176.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 76.43 -0.79 63.14 Favored Glycine 0 CA--C 1.538 1.479 0 O-C-N 119.943 -1.723 . . . . 31.27 113.267 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1279 ' ' SER . . . . . . . . . . . . . 47.0 m -74.56 160.53 30.76 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 118.771 -2.605 . . . . 32.950000000000003 109.37 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1280 ' ' VAL . . . . . 0.554 HG11 ' HA ' ' A' 1145 ' ' ALA . 82.9 t -127.49 135.88 62.05 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 O-C-N 119.776 -1.828 . . . . 27.43 108.38 -178.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1281 ' ' ILE . . . . . 0.449 HD12 HG22 ' A' 1309 ' ' VAL . 83.7 mt -108.62 98.62 7.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 103.193 -2.891 . . . . 30.300000000000001 103.193 169.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1282 ' ' VAL . . . . . 0.652 HG23 ' HA ' ' A' 1253 ' ' VAL . 0.0 OUTLIER -85.42 97.28 5.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.577 -1.268 . . . . 28.629999999999999 107.577 171.216 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1283 ' ' ASP . . . . . 0.646 ' HA ' ' HB ' ' A' 1254 ' ' THR . 19.6 t0 -87.83 109.39 19.72 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.019 -1.474 . . . . 36.270000000000003 107.019 178.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1284 ' ' LEU . . . . . 0.721 HD21 ' HB2' ' A' 1141 ' ' ALA . 25.4 mt -74.98 -28.96 60.76 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 112.909 -1.95 . . . . 38.57 115.214 173.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -65.99 -53.18 42.16 Favored 'General case' 0 C--O 1.218 -0.569 0 O-C-N 120.304 -1.497 . . . . 37.560000000000002 110.098 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1286 ' ' ALA . . . . . 0.503 ' HA ' HG21 ' A' 1295 ' ' THR . . . 38.02 -74.81 0.0 OUTLIER 'General case' 0 N--CA 1.413 -2.291 0 C-N-CA 128.511 2.724 . . . . 40.329999999999998 116.172 176.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -63.07 -47.32 83.46 Favored 'General case' 0 N--CA 1.482 1.175 0 O-C-N 120.365 -1.46 . . . . 56.850000000000001 109.634 173.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 5.5 m120 -72.83 70.1 0.97 Allowed 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 124.718 1.261 . . . . 45.859999999999999 109.43 175.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 74.26 -58.91 2.36 Favored Glycine 0 CA--C 1.538 1.524 0 N-CA-C 117.657 1.823 . . . . 40.310000000000002 117.657 -176.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 84.35 121.79 0.95 Allowed Glycine 0 C--O 1.22 -0.728 0 N-CA-C 108.835 -1.706 . . . . 38.890000000000001 108.835 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1291 ' ' ASN . . . . . 0.767 ' HB2' HG21 ' A' 1254 ' ' THR . 24.4 m120 -76.45 -20.6 56.87 Favored 'General case' 0 CA--C 1.492 -1.281 0 CA-C-N 121.26 2.53 . . . . 37.229999999999997 112.324 -176.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1292 ' ' CYS . . . . . 0.484 ' HA ' ' HB ' ' A' 1267 ' ' ILE . 36.9 t -85.44 142.99 28.84 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 120.249 -1.532 . . . . 36.5 109.638 170.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1293 ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -74.36 -13.96 60.81 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 116.218 1.932 . . . . 43.32 116.218 169.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -90.03 -4.25 57.5 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 116.018 1.858 . . . . 41.32 116.018 169.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1295 ' ' THR . . . . . 0.503 HG21 ' HA ' ' A' 1286 ' ' ALA . 52.5 m -65.96 119.22 10.96 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 119.375 -2.078 . . . . 35.299999999999997 110.971 -175.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1296 ' ' VAL . . . . . 0.577 ' HB ' ' HB2' ' A' 1299 ' ' GLU . 48.4 t -95.53 112.26 58.32 Favored Pre-proline 0 C--O 1.248 1.015 0 N-CA-C 101.575 -3.491 . . . . 34.840000000000003 101.575 171.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -55.86 104.54 0.13 Allowed 'Trans proline' 0 C--O 1.22 -0.408 0 C-N-CA 124.114 3.21 . . . . 33.509999999999998 111.902 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 112.23 9.77 19.22 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 113.561 -1.654 . . . . 32.189999999999998 111.048 172.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1299 ' ' GLU . . . . . 0.577 ' HB2' ' HB ' ' A' 1296 ' ' VAL . 8.7 mm-40 -132.89 162.34 31.85 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 121.248 2.524 . . . . 34.880000000000003 116.451 -163.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1300 ' ' ILE . . . . . 0.438 HG23 HG12 ' A' 1310 ' ' ILE . 80.2 mt -90.76 105.82 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 N-CA-C 101.671 -3.455 . . . . 32.289999999999999 101.671 163.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1301 ' ' PHE . . . . . 0.68 ' HB3' ' HB ' ' A' 1309 ' ' VAL . 35.5 t80 -81.9 110.67 17.4 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 104.73 -2.322 . . . . 37.25 104.73 166.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1302 ' ' THR . . . . . . . . . . . . . 54.0 m -93.44 119.07 32.1 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.136 -1.802 . . . . 35.560000000000002 106.136 175.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1303 ' ' THR . . . . . . . . . . . . . 2.1 m -103.18 142.6 33.88 Favored 'General case' 0 C--O 1.247 0.946 0 N-CA-C 107.643 -1.243 . . . . 36.399999999999999 107.643 -173.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -52.4 -42.6 64.17 Favored 'General case' 0 C--O 1.247 0.921 0 C-N-CA 126.285 1.834 . . . . 52.32 113.445 -168.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1305 ' ' ASN . . . . . 0.691 ' HA ' ' HB2' ' B' 1046 ' ' ASP . 38.3 p-10 -61.07 -22.0 64.19 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 115.628 1.714 . . . . 40.039999999999999 115.628 175.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 120.56 0.11 12.37 Favored Glycine 0 N--CA 1.413 -2.891 0 C-N-CA 120.333 -0.937 . . . . 36.960000000000001 111.223 177.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1307 ' ' VAL . . . . . 0.613 HG21 ' HB2' ' A' 1275 ' ' MET . 71.0 t -82.53 131.51 33.6 Favored 'Isoleucine or valine' 0 C--N 1.347 0.493 0 O-C-N 118.452 -2.793 . . . . 33.399999999999999 110.147 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1308 ' ' LYS . . . . . 0.686 ' HG3' ' HB3' ' A' 1148 ' ' GLU . 26.2 mmtp -99.15 94.91 6.76 Favored 'General case' 0 C--O 1.248 1.0 0 N-CA-C 106.226 -1.768 . . . . 42.909999999999997 106.226 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1309 ' ' VAL . . . . . 0.68 ' HB ' ' HB3' ' A' 1301 ' ' PHE . 24.0 t -76.08 85.88 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.608 0 CA-C-O 122.296 1.046 . . . . 32.289999999999999 109.803 174.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1310 ' ' ILE . . . . . 0.828 HD11 ' HB2' ' A' 1148 ' ' GLU . 55.0 mt -89.95 95.83 5.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 124.566 2.127 . . . . 30.989999999999998 106.263 -174.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -90.55 71.26 2.06 Favored Glycine 0 N--CA 1.436 -1.364 0 O-C-N 119.515 -1.991 . . . . 28.949999999999999 110.778 171.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1312 ' ' TYR . . . . . 0.482 ' HD1' ' HA ' ' A' 1312 ' ' TYR . 0.0 OUTLIER -91.65 124.52 35.86 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 119.167 1.483 . . . . 31.690000000000001 111.187 -171.105 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1313 ' ' THR . . . . . . . . . . . . . 4.5 p -103.71 -21.65 13.67 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 118.862 -1.135 . . . . 34.170000000000002 113.827 -175.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -81.85 24.53 0.61 Allowed 'General case' 0 C--O 1.256 1.432 0 CA-C-O 122.06 0.933 . . . . 36.859999999999999 112.752 -173.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1315 ' ' LEU . . . . . 0.546 HD22 ' HG3' ' A' 1140 ' ' ARG . 88.3 mt -69.84 -42.52 18.45 Favored Pre-proline 0 N--CA 1.439 -1.012 0 N-CA-C 118.075 2.62 . . . . 34.850000000000001 118.075 -168.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -59.54 -35.58 95.24 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 CA-C-N 123.672 2.347 . . . . 29.149999999999999 113.8 171.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -65.2 -35.72 91.99 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-O 122.165 0.87 . . . . 27.289999999999999 111.413 172.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1318 ' ' ARG . . . . . 0.49 ' HD2' HD23 ' A' 1315 ' ' LEU . 79.7 mtt-85 -64.38 -3.16 2.68 Favored 'General case' 0 C--O 1.24 0.563 0 O-C-N 120.438 -1.625 . . . . 41.490000000000002 114.697 168.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1319 ' ' LEU . . . . . 0.471 HD23 HG23 ' A' 1136 ' ' ILE . 8.0 tp -143.51 69.53 17.38 Favored Pre-proline 0 N--CA 1.437 -1.114 0 O-C-N 118.487 -2.633 . . . . 27.609999999999999 111.018 178.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1320 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -53.88 -62.72 0.28 Allowed 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 124.948 3.765 . . . . 25.940000000000001 116.451 -169.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1321 ' ' THR . . . . . 0.415 HG21 HH11 ' B' 1151 ' ' ARG . 0.2 OUTLIER -59.4 -22.95 62.17 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 121.361 1.891 . . . . 25.010000000000002 111.407 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1322 ' ' GLN . . . . . 0.498 ' HG3' HG12 ' A' 1136 ' ' ILE . 4.1 tp-100 -75.18 -37.57 61.17 Favored 'General case' 0 C--O 1.217 -0.617 0 O-C-N 120.192 -1.568 . . . . 29.390000000000001 109.088 176.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1323 ' ' SER . . . . . . . . . . . . . 73.6 m -60.4 -66.54 0.51 Allowed 'General case' 0 C--O 1.251 1.149 0 CA-C-O 118.185 -0.912 . . . . 26.469999999999999 109.897 166.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1324 ' ' SER . . . . . . . . . . . . . 14.5 m -45.29 -36.36 4.01 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 116.883 2.179 . . . . 27.780000000000001 116.883 177.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -77.88 -64.96 1.03 Allowed 'General case' 0 C--O 1.216 -0.701 0 O-C-N 119.805 -1.809 . . . . 37.530000000000001 114.723 170.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1326 ' ' LEU . . . . . 0.731 ' HB3' ' HB3' ' A' 1132 ' ' SER . 22.1 mt -70.39 -51.39 29.98 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 120.961 1.71 . . . . 35.710000000000001 113.544 -169.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1327 ' ' TYR . . . . . 0.468 ' HA ' ' OD1' ' A' 1330 ' ' ASN . 64.4 t80 -66.14 -46.05 78.86 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 106.779 -1.563 . . . . 31.59 106.779 174.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1328 ' ' GLY . . . . . 0.564 ' HA2' HD12 ' A' 1331 ' ' LEU . . . -40.42 -52.82 3.58 Favored Glycine 0 CA--C 1.541 1.664 0 CA-C-N 119.994 1.27 . . . . 28.0 113.829 166.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1329 ' ' THR . . . . . 0.402 ' HA ' ' HB ' ' A' 1332 ' ' VAL . 1.1 m -79.44 -18.28 52.51 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 117.328 -3.454 . . . . 32.149999999999999 108.353 -173.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1330 ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' 1127 ' ' LEU . 29.4 m120 -57.91 -53.96 52.26 Favored 'General case' 0 C--O 1.246 0.893 0 O-C-N 118.344 -2.722 . . . . 34.359999999999999 110.487 167.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1331 ' ' LEU . . . . . 0.803 HD13 HD13 ' A' 1070 ' ' LEU . 11.7 mt -57.0 -47.5 80.69 Favored 'General case' 0 C--N 1.353 0.726 0 CA-C-N 113.63 -1.623 . . . . 33.369999999999997 110.388 175.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1332 ' ' VAL . . . . . 0.676 HG21 ' HB ' ' A' 1022 ' ' THR . 59.9 t -58.86 -37.53 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 124.884 1.274 . . . . 35.270000000000003 109.98 176.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -70.59 -41.75 71.94 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-N 121.801 2.091 . . . . 37.659999999999997 112.475 -176.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1334 ' ' LEU . . . . . 0.536 HD23 HG13 ' A' 1090 ' ' VAL . 60.2 tp -58.74 -53.31 59.85 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 121.51 0.671 . . . . 40.270000000000003 109.669 170.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1335 ' ' LEU . . . . . 0.484 ' HA ' ' HB2' ' A' 1338 ' ' LEU . 13.5 mt -60.92 -21.11 63.06 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 115.511 1.671 . . . . 42.5 115.511 176.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1336 ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' 1332 ' ' VAL . 96.1 mttt -65.23 -46.83 79.01 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 118.626 0.648 . . . . 47.810000000000002 109.589 168.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1337 ' ' LEU . . . . . . . . . . . . . 36.7 mt -63.67 -41.22 98.21 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 124.03 1.871 . . . . 49.270000000000003 111.569 178.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1338 ' ' LEU . . . . . 0.484 ' HB2' ' HA ' ' A' 1335 ' ' LEU . 10.3 mp -59.74 -41.49 91.05 Favored 'General case' 0 C--N 1.355 0.823 0 CA-C-O 122.923 1.344 . . . . 50.539999999999999 112.624 175.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1339 ' ' CYS . . . . . 0.724 ' SG ' ' HA ' ' A' 1342 ' ' LYS . 18.1 t -74.93 82.01 2.18 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 123.734 1.731 . . . . 53.670000000000002 111.905 173.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -58.9 -55.23 37.76 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 112.543 -2.117 . . . . 63.380000000000003 113.229 -175.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -115.57 -0.47 13.03 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 115.351 1.611 . . . . 70.950000000000003 115.351 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1342 ' ' LYS . . . . . 0.724 ' HA ' ' SG ' ' A' 1339 ' ' CYS . 31.3 mtmm 56.3 66.41 1.2 Allowed 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 118.716 2.858 . . . . 65.25 118.716 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1343 ' ' ASP . . . . . 0.464 ' HB3' ' N ' ' A' 1342 ' ' LYS 0.462 0.0 OUTLIER 87.79 -73.96 0.01 OUTLIER 'General case' 0 C--N 1.359 0.987 3 O-C-N 113.169 -5.957 . . . . 64.530000000000001 120.278 -10.645 . . . . . . . . 5 4 . 1 . 002 nuclear build full ' A' A 1344 ' ' GLY . . . . . . . . . . . . . . . 68.55 46.6 61.53 Favored Glycine 0 C--O 1.257 1.553 0 O-C-N 120.764 -1.21 . . . . 59.719999999999999 115.562 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1345 ' ' ASN . . . . . 0.444 ' HB2' ' OD2' ' A' 1343 ' ' ASP . 9.1 t-20 -78.81 149.33 32.61 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 115.729 1.751 . . . . 64.090000000000003 115.729 176.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1346 ' ' ILE . . . . . . . . . . . . . 2.8 mp -85.04 86.69 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 N-CA-C 100.847 -3.76 . . . . 58.82 100.847 170.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1347 ' ' THR . . . . . . . . . . . . . 9.7 m -93.2 91.94 7.51 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 123.57 1.652 . . . . 54.960000000000001 113.859 172.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1348 ' ' VAL . . . . . 0.55 HG21 HG21 ' A' 1111 ' ' THR . 10.4 t -88.01 93.15 4.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 101.294 -3.595 . . . . 55.640000000000001 101.294 174.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 21.5 t70 -86.36 133.17 33.81 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-O 123.476 1.608 . . . . 61.450000000000003 107.806 169.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -99.88 -8.95 23.42 Favored 'General case' 0 N--CA 1.442 -0.838 0 O-C-N 119.991 -1.693 . . . . 58.630000000000003 113.127 176.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -73.36 -35.08 65.92 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-N 115.551 -0.75 . . . . 62.060000000000002 112.767 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 7.3 t70 -82.75 125.53 31.37 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.537 -1.283 . . . . 54.07 107.537 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 27.2 m -55.61 -30.79 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 113.53 -1.668 . . . . 50.68 114.088 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1354 ' ' VAL . . . . . 0.474 ' O ' HG23 ' A' 1358 ' ' VAL 0.251 6.0 m -71.03 -49.66 47.8 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 C-N-CA 118.955 -1.098 . . . . 47.68 112.374 178.796 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1355 ' ' ILE . . . . . . . . . . . . . 72.0 mt -71.36 -37.7 66.25 Favored 'Isoleucine or valine' 0 C--O 1.253 1.241 0 N-CA-C 108.623 -0.881 . . . . 48.490000000000002 108.623 -173.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 46.5 tpt85 -57.36 -33.38 67.73 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 113.56 0.948 . . . . 48.270000000000003 113.56 167.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -65.72 -52.54 37.7 Favored Glycine 0 N--CA 1.436 -1.357 0 C-N-CA 123.52 0.581 . . . . 43.530000000000001 112.486 172.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1358 ' ' VAL . . . . . 0.785 HG22 HG22 ' A' 1118 ' ' VAL . 3.5 t -66.18 -37.93 80.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 107.401 -1.333 . . . . 45.119999999999997 107.401 -175.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1359 ' ' THR . . . . . . . . . . . . . 30.3 m -76.43 87.74 3.19 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 119.869 -1.77 . . . . 42.939999999999998 111.228 -174.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 33.4 m -77.93 -31.43 16.89 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 O-C-N 121.025 -1.047 . . . . 43.259999999999998 110.647 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1361 ' ' ILE . . . . . 0.475 HG12 HG12 ' A' 1366 ' ' ILE . 94.8 mt -128.56 119.62 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 N-CA-C 105.844 -1.91 . . . . 45.659999999999997 105.844 176.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1362 ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -103.45 120.29 40.53 Favored 'General case' 0 C--N 1.364 1.209 0 CA-C-N 123.445 2.838 . . . . 61.340000000000003 106.365 174.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 36.01 48.5 0.52 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 112.14 -2.3 . . . . 49.759999999999998 115.999 -177.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1364 ' ' GLY . . . . . 0.499 ' HA3' ' HA ' ' A' 1109 ' ' ASN . . . 89.23 12.73 62.89 Favored Glycine 0 C--O 1.222 -0.603 0 CA-C-O 116.944 -2.031 . . . . 50.0 113.062 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -122.83 127.07 48.56 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 102.322 -3.214 . . . . 56.920000000000002 102.322 172.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1366 ' ' ILE . . . . . 0.475 HG12 HG12 ' A' 1361 ' ' ILE . 43.5 mt -73.75 92.89 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 CA-C-O 123.01 1.386 . . . . 52.780000000000001 109.184 -176.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1367 ' ' THR . . . . . . . . . . . . . 6.9 p -76.55 -5.69 48.74 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 123.55 1.643 . . . . 49.439999999999998 114.609 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 20.1 t90 -60.42 143.56 89.48 Favored Pre-proline 0 N--CA 1.44 -0.931 0 CA-C-O 116.227 -1.844 . . . . 52.380000000000003 110.365 171.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -81.37 -163.88 3.55 Favored 'Cis proline' 0 C--O 1.248 1.005 0 CA-C-N 123.417 2.256 . . . . 46.939999999999998 112.571 -6.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -129.14 158.3 73.32 Favored Pre-proline 0 N--CA 1.428 -1.561 0 CA-C-O 117.188 -1.387 . . . . 45.909999999999997 108.742 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1371 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -47.28 120.83 4.69 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 124.901 3.734 . . . . 46.390000000000001 111.216 170.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -65.66 -41.26 15.17 Favored 'Trans proline' 0 CA--C 1.557 1.64 0 C-N-CA 125.076 3.851 . . . . 46.719999999999999 112.077 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.228 -4.699 0 CA-C-N 121.508 1.958 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 20.2 m80 . . . . . 0 N--CA 1.425 -1.697 0 N-CA-C 105.958 -1.867 . . . . 63.439999999999998 105.958 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 999' ' ' HIS . . . . . 0.512 ' HB3' ' HB3' ' B' 1002 ' ' ARG . 89.7 m-70 -93.94 57.36 2.43 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 119.485 -2.009 . . . . 51.740000000000002 107.449 173.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1000 ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -81.46 118.45 22.72 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 106.792 -1.559 . . . . 54.07 106.792 -167.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 72.78 18.97 79.13 Favored Glycine 0 C--O 1.224 -0.529 0 CA-C-N 114.716 -1.129 . . . . 39.219999999999999 111.927 -168.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1002 ' ' ARG . . . . . 0.544 ' HD2' ' HB2' ' B' 1034 ' ' ALA . 33.9 ttp180 -100.6 124.93 46.85 Favored 'General case' 0 C--O 1.256 1.419 0 CA-C-N 121.387 2.594 . . . . 38.119999999999997 109.994 169.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1003 ' ' ILE . . . . . . . . . . . . . 51.6 mt -81.41 142.61 13.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 108.942 -3.753 . . . . 29.699999999999999 105.029 171.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -112.44 128.56 8.55 Favored Glycine 0 N--CA 1.436 -1.332 0 N-CA-C 106.217 -2.753 . . . . 27.5 106.217 166.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1005 ' ' ILE . . . . . 0.567 ' HB ' ' HA ' ' B' 1035 ' ' VAL . 47.6 mm -105.62 99.71 22.92 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 101.166 -3.642 . . . . 24.829999999999998 101.166 173.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -83.88 166.62 13.14 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.672 2.248 . . . . 27.190000000000001 112.148 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 30.2 ttm105 -77.17 143.61 38.95 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 103.039 -2.949 . . . . 41.460000000000001 103.039 167.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1008 ' ' GLU . . . . . 0.485 ' OE2' ' HG2' ' B' 1071 ' ' LYS . 8.6 mm-40 -63.9 129.8 41.52 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 116.83 2.159 . . . . 26.93 116.83 169.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 48.5 mmm-85 -83.73 -5.7 59.26 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 110.704 -2.953 . . . . 34.479999999999997 111.339 171.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1010 ' ' LEU . . . . . 0.401 HD23 ' HB2' ' B' 1013 ' ' GLU . 4.1 tp -60.93 126.16 26.37 Favored 'General case' 0 C--O 1.244 0.792 0 O-C-N 120.805 -1.184 . . . . 44.219999999999999 108.919 168.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1011 ' ' THR . . . . . . . . . . . . . 86.9 m -64.93 116.47 6.41 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-O 122.452 1.12 . . . . 40.740000000000002 108.95 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 21.7 t30 63.15 92.16 0.06 Allowed 'General case' 0 C--N 1.339 0.15 0 CA-C-N 112.308 -2.224 . . . . 44.439999999999998 112.546 -174.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1013 ' ' GLU . . . . . 0.401 ' HB2' HD23 ' B' 1010 ' ' LEU . 10.3 tp10 -137.88 138.72 39.36 Favored 'General case' 0 N--CA 1.415 -2.217 0 CA-C-N 111.147 -2.752 . . . . 29.870000000000001 104.385 176.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1014 ' ' THR . . . . . 0.454 HG22 ' HB3' ' B' 1320 ' ' PRO . 0.2 OUTLIER -104.38 -5.07 22.07 Favored 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 120.247 -1.533 . . . . 25.260000000000002 111.331 177.846 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B 1015 ' ' ARG . . . . . 0.701 ' HG3' ' HA2' ' B' 1317 ' ' GLY . 23.6 mtm180 -88.37 148.05 24.44 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 119.904 1.229 . . . . 29.539999999999999 113.517 177.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1016 ' ' VAL . . . . . 0.535 HG13 ' H ' ' B' 1018 ' ' ALA . 4.4 p -113.94 -173.19 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 105.643 -1.984 . . . . 23.550000000000001 105.643 151.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1017 ' ' ALA . . . . . . . . . . . . . . . -106.37 11.75 30.57 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 121.485 1.948 . . . . 23.59 115.686 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1018 ' ' ALA . . . . . 0.535 ' H ' HG13 ' B' 1016 ' ' VAL . . . -149.98 156.16 41.22 Favored 'General case' 0 C--O 1.211 -0.939 0 CA-C-O 123.018 1.389 . . . . 24.93 113.677 -176.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1019 ' ' THR . . . . . 0.524 HG22 ' HZ ' ' B' 1045 ' ' PHE . 26.1 p -135.12 163.48 50.81 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 110.812 -2.904 . . . . 28.09 103.308 176.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -49.97 -39.25 49.91 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.86 2.374 . . . . 28.789999999999999 113.541 168.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1021 ' ' LYS . . . . . 0.4 ' O ' ' HG3' ' B' 1025 ' ' GLN . 76.4 tttt -67.9 -44.7 76.38 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 112.535 0.568 . . . . 47.280000000000001 112.535 177.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1022 ' ' THR . . . . . . . . . . . . . 13.7 p -67.99 -29.61 68.66 Favored 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 120.223 -1.548 . . . . 30.120000000000001 111.956 178.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1023 ' ' VAL . . . . . . . . . . . . . 69.1 t -56.55 -53.84 35.97 Favored 'Isoleucine or valine' 0 C--N 1.351 0.637 0 N-CA-C 107.107 -1.442 . . . . 32.240000000000002 107.107 170.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1024 ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -55.96 -39.36 71.66 Favored 'General case' 0 C--O 1.215 -0.732 0 N-CA-C 114.324 1.231 . . . . 49.619999999999997 114.324 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1025 ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' B' 1021 ' ' LYS . 43.9 mt-30 -65.97 -43.26 88.4 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 122.496 1.141 . . . . 44.68 109.869 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1026 ' ' LEU . . . . . 0.404 ' CD2' HG22 ' B' 1332 ' ' VAL . 42.6 mt -67.82 -32.17 72.52 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 119.103 -2.248 . . . . 35.710000000000001 114.641 173.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1027 ' ' LEU . . . . . . . . . . . . . 98.1 mt -62.9 -39.91 95.96 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.072 -1.017 . . . . 42.18 110.493 172.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 24.8 mttm -62.17 -47.65 83.56 Favored 'General case' 0 C--O 1.251 1.154 0 N-CA-C 109.21 -0.663 . . . . 48.340000000000003 109.21 172.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1029 ' ' LEU . . . . . 0.627 HD21 ' HG2' ' B' 1336 ' ' LYS . 79.8 mt -64.84 -4.27 4.24 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 116.972 2.212 . . . . 38.689999999999998 116.972 172.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 88.95 20.95 44.37 Favored Glycine 0 N--CA 1.433 -1.551 0 CA-C-O 122.934 1.296 . . . . 32.280000000000001 114.355 166.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -99.05 143.95 28.75 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 123.163 1.459 . . . . 35.939999999999998 108.212 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1032 ' ' THR . . . . . . . . . . . . . 31.9 m -79.04 117.14 19.81 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 106.532 -1.655 . . . . 33.369999999999997 106.532 164.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1033 ' ' VAL . . . . . . . . . . . . . 2.9 t -91.89 108.62 20.27 Favored 'Isoleucine or valine' 0 C--O 1.262 1.741 0 O-C-N 120.599 -1.313 . . . . 29.98 107.708 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1034 ' ' ALA . . . . . 0.544 ' HB2' ' HD2' ' B' 1002 ' ' ARG . . . -99.84 140.17 34.44 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 107.376 -1.342 . . . . 28.18 107.376 172.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1035 ' ' VAL . . . . . 0.567 ' HA ' ' HB ' ' B' 1005 ' ' ILE . 88.3 t -124.26 145.53 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 103.652 -2.721 . . . . 25.82 103.652 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1036 ' ' GLU . . . . . 0.603 ' HB3' ' HB2' ' B' 1039 ' ' ALA . 26.9 tt0 -65.89 129.75 40.88 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.472 -1.24 . . . . 32.439999999999998 112.585 173.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1037 ' ' SER . . . . . . . . . . . . . 12.7 m -57.16 133.9 55.43 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.239 -1.346 . . . . 29.539999999999999 108.884 172.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 88.88 -43.59 3.09 Favored Glycine 0 CA--C 1.498 -0.98 0 O-C-N 117.424 -3.297 . . . . 27.760000000000002 110.886 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1039 ' ' ALA . . . . . 0.603 ' HB2' ' HB3' ' B' 1036 ' ' GLU . . . -37.52 -37.37 0.2 Allowed 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 118.304 2.705 . . . . 26.02 118.304 -175.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -62.99 -31.13 79.62 Favored Glycine 0 N--CA 1.42 -2.411 0 C-N-CA 126.029 1.776 . . . . 26.469999999999999 113.62 -175.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1041 ' ' GLN . . . . . 0.426 ' NE2' ' HA ' ' B' 1046 ' ' ASP . 3.1 mp0 -56.9 -40.62 76.6 Favored 'General case' 0 CA--C 1.518 -0.26 0 O-C-N 120.137 -1.802 . . . . 50.979999999999997 114.101 -175.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 29.9 mt -63.5 -44.19 95.04 Favored 'General case' 0 C--O 1.247 0.923 0 O-C-N 121.594 -0.691 . . . . 29.300000000000001 109.502 175.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1043 ' ' ALA . . . . . . . . . . . . . . . -87.3 17.41 4.41 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 120.732 -1.23 . . . . 26.739999999999998 113.491 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1044 ' ' SER . . . . . . . . . . . . . 10.5 m 67.83 46.24 1.29 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 123.909 1.814 . . . . 31.260000000000002 112.191 170.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1045 ' ' PHE . . . . . 0.524 ' HZ ' HG22 ' B' 1019 ' ' THR . 85.3 m-85 -130.86 162.86 28.68 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 104.79 -2.3 . . . . 33.259999999999998 104.79 175.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1046 ' ' ASP . . . . . 0.691 ' HB2' ' HA ' ' A' 1305 ' ' ASN . 22.9 t70 -104.19 161.3 14.15 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.011 -1.477 . . . . 46.740000000000002 107.011 158.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.55 -39.23 92.94 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 122.399 1.095 . . . . 34.439999999999998 111.094 -175.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.6 -22.01 63.29 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 115.443 1.646 . . . . 48.670000000000002 115.443 -176.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -62.73 -42.94 99.91 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 118.93 -2.356 . . . . 35.259999999999998 110.48 166.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1050 ' ' PHE . . . . . 0.446 ' HB2' HD11 ' B' 1057 ' ' ILE . 91.4 m-85 -69.82 -36.35 75.55 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 119.622 -1.924 . . . . 32.170000000000002 110.446 176.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 42.5 t -57.3 -43.34 81.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 116.08 -0.509 . . . . 38.369999999999997 110.585 171.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -71.26 -27.26 63.32 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 118.527 0.603 . . . . 45.770000000000003 111.504 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -73.02 -23.98 60.68 Favored 'General case' 0 N--CA 1.443 -0.775 0 O-C-N 120.723 -1.236 . . . . 37.829999999999998 112.407 174.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 95.15 39.33 4.57 Favored Glycine 0 C--O 1.221 -0.703 0 O-C-N 124.556 1.16 . . . . 35.82 112.85 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -102.21 139.13 38.23 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 124.082 0.953 . . . . 33.770000000000003 110.251 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -73.96 101.02 3.7 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.635 1.174 . . . . 51.020000000000003 107.955 -177.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1057 ' ' ILE . . . . . 0.446 HD11 ' HB2' ' B' 1050 ' ' PHE . 50.2 mm -88.86 100.4 10.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 119.442 -2.036 . . . . 38.469999999999999 106.08 -172.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1058 ' ' VAL . . . . . 0.42 HG23 ' HB ' ' B' 1063 ' ' VAL . 3.2 m -123.87 158.89 29.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 107.267 -1.383 . . . . 39.399999999999999 107.267 -173.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -72.33 167.19 20.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 118.421 -0.799 . . . . 57.07 112.732 -175.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1060 ' ' GLY . . . . . 0.411 ' O ' HG12 ' B' 1063 ' ' VAL . . . -52.5 -61.37 6.77 Favored Glycine 0 C--N 1.344 1.021 0 O-C-N 124.695 1.247 . . . . 44.829999999999998 114.129 -164.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 2.3 t30 -70.82 -32.55 69.65 Favored 'General case' 0 C--O 1.223 -0.303 0 O-C-N 119.546 -2.149 . . . . 46.270000000000003 110.486 -173.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1062 ' ' SER . . . . . . . . . . . . . 5.8 m -61.4 -41.2 96.74 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 113.125 -1.852 . . . . 43.469999999999999 113.336 171.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1063 ' ' VAL . . . . . 0.42 ' HB ' HG23 ' B' 1058 ' ' VAL . 6.4 p -72.83 -31.11 35.03 Favored 'Isoleucine or valine' 0 C--O 1.26 1.616 0 CA-C-N 121.069 1.759 . . . . 36.979999999999997 109.788 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1064 ' ' TRP . . . . . 0.591 ' HZ3' ' HG ' ' B' 1083 ' ' LEU . 0.1 OUTLIER -63.53 -31.26 72.37 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-O 122.347 1.07 . . . . 37.899999999999999 112.662 174.034 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -79.54 80.79 5.88 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 119.594 -1.941 . . . . 46.189999999999998 111.172 174.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1066 ' ' SER . . . . . 0.505 ' HB3' ' O ' ' B' 1002 ' ' ARG . 49.3 m -138.23 168.41 19.8 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 121.645 -0.659 . . . . 37.060000000000002 110.118 176.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1067 ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -79.42 -25.86 41.97 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 124.217 1.007 . . . . 43.950000000000003 109.914 176.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1068 ' ' ILE . . . . . 0.492 HG12 HD11 ' B' 1346 ' ' ILE . 3.5 mp -130.78 138.86 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 O-C-N 119.254 -2.154 . . . . 33.5 108.186 171.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1069 ' ' ILE . . . . . 0.632 HG22 ' HB2' ' B' 1071 ' ' LYS . 35.8 mm -124.31 120.72 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 104.036 -2.579 . . . . 30.57 104.036 176.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1070 ' ' LEU . . . . . 0.819 ' HB3' HD13 ' B' 1331 ' ' LEU . 56.9 mt -103.77 109.48 21.22 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 101.347 -3.575 . . . . 27.66 101.347 175.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1071 ' ' LYS . . . . . 0.632 ' HB2' HG22 ' B' 1069 ' ' ILE . 28.1 tttm -135.93 152.01 50.55 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 103.196 -2.89 . . . . 28.399999999999999 103.196 -167.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1072 ' ' VAL . . . . . 0.457 ' HA ' ' CE2' ' B' 1327 ' ' TYR . 45.4 t -80.43 -60.92 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.566 0 N-CA-C 107.717 -1.216 . . . . 23.18 107.717 -171.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 16.9 m120 -114.86 -173.97 2.4 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 120.265 -1.522 . . . . 25.469999999999999 110.803 -166.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1074 ' ' ALA . . . . . 0.407 ' HA ' ' HD2' ' B' 1075 ' ' PRO . . . -46.93 133.74 8.58 Favored Pre-proline 0 C--N 1.367 1.333 0 C-N-CA 124.602 1.161 . . . . 27.899999999999999 113.62 175.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1075 ' ' PRO . . . . . 0.544 ' HG2' HD11 ' B' 1101 ' ' LEU . 20.0 Cg_endo -65.62 139.34 57.85 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.892 2.395 . . . . 31.620000000000001 109.526 166.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 9.1 mt -80.65 164.1 23.11 Favored 'General case' 0 C--O 1.246 0.908 0 CA-C-N 113.89 -1.504 . . . . 40.490000000000002 109.672 166.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1077 ' ' ASP . . . . . 0.542 ' HA ' HD12 ' B' 1080 ' ' ILE . 0.7 OUTLIER -50.81 -34.32 27.17 Favored 'General case' 0 C--O 1.257 1.487 0 CA-C-N 119.821 1.192 . . . . 51.590000000000003 114.144 -175.254 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -73.18 -42.84 62.28 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 121.254 -0.904 . . . . 42.359999999999999 109.934 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1079 ' ' GLU . . . . . 0.429 ' HA ' HD12 ' B' 1082 ' ' LEU . 23.2 mt-10 -59.88 -35.23 74.4 Favored 'General case' 0 C--O 1.267 1.986 0 C-N-CA 123.805 0.842 . . . . 34.530000000000001 109.834 176.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1080 ' ' ILE . . . . . 0.706 ' HA ' HD12 ' B' 1083 ' ' LEU . 97.7 mt -63.33 -43.78 98.76 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 CA-C-O 123.965 1.84 . . . . 33.25 110.268 173.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -65.38 -29.77 70.52 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 118.039 -2.913 . . . . 36.469999999999999 114.852 176.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1082 ' ' LEU . . . . . 0.429 HD12 ' HA ' ' B' 1079 ' ' GLU . 41.8 mt -64.6 -40.88 96.31 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 112.836 -1.984 . . . . 37.759999999999998 113.663 168.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1083 ' ' LEU . . . . . 0.706 HD12 ' HA ' ' B' 1080 ' ' ILE . 5.6 mt -59.68 107.34 0.58 Allowed 'General case' 0 CA--C 1.495 -1.169 0 CA-C-O 123.322 1.534 . . . . 37.43 110.209 174.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -95.47 143.06 25.47 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 111.347 -2.66 . . . . 37.700000000000003 108.58 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1085 ' ' PRO . . . . . 0.633 ' HB3' ' HB2' ' B' 1109 ' ' ASN . 18.2 Cg_endo -52.62 113.86 1.43 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.937 3.092 . . . . 35.509999999999998 109.671 177.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 128.74 -32.81 3.24 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 112.357 -2.201 . . . . 33.869999999999997 112.433 -173.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1087 ' ' THR . . . . . . . . . . . . . 61.4 m -67.16 139.21 57.45 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-O 123.875 1.798 . . . . 32.5 108.682 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1088 ' ' THR . . . . . . . . . . . . . 7.8 m -98.71 110.61 23.19 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 103.498 -2.778 . . . . 30.219999999999999 103.498 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1089 ' ' LEU . . . . . 0.582 HD13 HD21 ' B' 1083 ' ' LEU . 40.1 tp -95.78 118.67 32.87 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 106.715 -1.587 . . . . 27.239999999999998 106.715 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1090 ' ' VAL . . . . . 0.459 HG13 ' HB2' ' B' 1113 ' ' MET . 4.2 t -118.22 107.1 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 107.44 -1.318 . . . . 25.390000000000001 107.44 176.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1091 ' ' SER . . . . . 0.497 ' OG ' ' HB3' ' B' 1071 ' ' LYS . 19.7 m -161.02 163.8 31.37 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.723 -0.672 . . . . 28.809999999999999 112.712 -167.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1092 ' ' PHE . . . . . 0.616 ' HZ ' ' HG3' ' B' 1133 ' ' MET . 40.8 m-85 -69.22 105.09 2.38 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-O 123.586 1.66 . . . . 30.780000000000001 106.534 166.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1093 ' ' ILE . . . . . 0.402 HG13 ' CG1' ' B' 1112 ' ' VAL . 32.9 mm -95.54 -37.56 7.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 O-C-N 119.883 -1.761 . . . . 30.280000000000001 110.968 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1094 ' ' TRP . . . . . 0.524 ' HB3' ' HB2' ' B' 1097 ' ' GLN . 96.4 m95 55.34 60.62 9.22 Favored Pre-proline 0 CA--C 1.55 0.955 0 O-C-N 124.868 1.355 . . . . 34.07 112.496 -173.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -51.68 -51.47 11.11 Favored 'Trans proline' 0 C--O 1.253 1.273 0 C-N-CA 125.207 3.938 . . . . 38.659999999999997 115.466 -171.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -62.98 -28.93 70.43 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-N 120.301 1.41 . . . . 41.32 112.147 176.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1097 ' ' GLN . . . . . 0.524 ' HB2' ' HB3' ' B' 1094 ' ' TRP . 18.6 mp0 -82.75 -22.74 34.25 Favored 'General case' 0 C--O 1.26 1.648 0 N-CA-C 108.066 -1.087 . . . . 51.659999999999997 108.066 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -127.82 57.71 27.66 Favored Pre-proline 0 C--O 1.223 -0.341 0 CA-C-N 120.754 1.615 . . . . 40.32 115.207 -175.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 0.7 OUTLIER -52.46 -37.02 72.16 Favored 'Trans proline' 0 C--O 1.248 0.993 0 C-N-CA 124.871 3.714 . . . . 41.560000000000002 115.116 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -59.66 -57.85 11.16 Favored 'General case' 0 C--O 1.217 -0.624 0 O-C-N 124.744 1.278 . . . . 54.109999999999999 107.69 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1101 ' ' LEU . . . . . 0.544 HD11 ' HG2' ' B' 1075 ' ' PRO . 9.6 tp -51.27 -44.78 61.88 Favored 'General case' 0 C--O 1.211 -0.964 0 CA-C-O 116.656 -1.64 . . . . 37.880000000000003 109.452 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1102 ' ' MET . . . . . . . . . . . . . 61.1 mmm -55.75 -49.64 72.54 Favored 'General case' 0 C--O 1.252 1.209 0 CA-C-O 123.26 1.505 . . . . 37.539999999999999 113.601 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1103 ' ' GLN . . . . . 0.406 ' O ' ' HB3' ' B' 1106 ' ' ALA . 0.0 OUTLIER -67.12 -39.97 86.73 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 114.211 -1.359 . . . . 47.009999999999998 110.73 -175.894 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B 1104 ' ' LYS . . . . . 0.444 ' HD3' HD13 ' B' 1080 ' ' ILE . 43.3 mttm -55.69 -54.42 44.44 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.395 1.078 . . . . 48.68 110.453 174.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1105 ' ' LEU . . . . . 0.625 HD13 HG21 ' B' 1112 ' ' VAL . 41.4 mt -61.57 -29.42 70.01 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 120.35 -1.469 . . . . 32.210000000000001 111.916 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1106 ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' B' 1103 ' ' GLN . . . -66.76 -39.54 87.93 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 117.278 -1.344 . . . . 33.729999999999997 111.399 173.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -64.25 -43.26 95.43 Favored 'General case' 0 C--O 1.249 1.04 0 O-C-N 124.36 1.038 . . . . 51.469999999999999 110.394 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1108 ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -67.27 -16.63 64.39 Favored 'General case' 0 C--N 1.309 -1.152 0 O-C-N 125.831 1.957 . . . . 43.899999999999999 114.031 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1109 ' ' ASN . . . . . 0.633 ' HB2' ' HB3' ' B' 1085 ' ' PRO . 13.9 m120 59.07 49.76 9.01 Favored 'General case' 0 C--N 1.348 0.533 0 CA-C-O 126.397 2.999 . . . . 44.82 115.957 178.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1110 ' ' VAL . . . . . 0.639 HG11 ' HB3' ' B' 1083 ' ' LEU . 12.8 m -107.7 163.77 5.34 Favored 'Isoleucine or valine' 0 C--O 1.248 0.992 0 O-C-N 119.517 -1.989 . . . . 30.52 111.528 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1111 ' ' THR . . . . . . . . . . . . . 18.1 m -107.04 97.5 7.27 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 123.61 1.672 . . . . 27.120000000000001 107.547 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1112 ' ' VAL . . . . . 0.67 ' HB ' ' HB ' ' B' 1361 ' ' ILE . 70.6 t -97.31 115.46 37.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 112.563 -2.108 . . . . 26.399999999999999 113.457 -170.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1113 ' ' MET . . . . . 0.463 ' HG2' HD21 ' B' 1334 ' ' LEU . 1.8 mpt? -100.13 118.45 36.5 Favored 'General case' 0 CA--C 1.504 -0.821 0 O-C-N 121.37 -0.831 . . . . 42.920000000000002 108.901 170.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -88.48 104.74 17.09 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 120.013 -0.675 . . . . 24.149999999999999 110.007 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1115 ' ' MET . . . . . 0.536 ' SD ' HD13 ' B' 1334 ' ' LEU . 72.4 mmm -65.61 -17.84 64.88 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 116.583 2.068 . . . . 29.949999999999999 116.583 -177.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1116 ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -84.73 -38.37 19.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 113.624 -1.625 . . . . 34.530000000000001 109.54 171.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1117 ' ' SER . . . . . . . . . . . . . 70.1 m -97.64 38.45 1.28 Allowed 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 123.44 1.59 . . . . 33.490000000000002 111.819 -176.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1118 ' ' VAL . . . . . 0.681 HG21 ' HA ' ' B' 1128 ' ' ASP . 12.3 t -77.59 124.52 86.62 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 102.278 -3.23 . . . . 34.020000000000003 102.278 172.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1119 ' ' PRO . . . . . 0.615 ' HB2' HG12 ' B' 1121 ' ' ILE . 75.3 Cg_exo -52.75 153.84 13.81 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.518 2.812 . . . . 38.280000000000001 115.964 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1120 ' ' ARG . . . . . 0.533 HH21 HD12 ' B' 1130 ' ' LEU . 0.0 OUTLIER -77.68 47.06 0.58 Allowed 'General case' 0 C--O 1.216 -0.679 0 O-C-N 121.757 -0.589 . . . . 55.049999999999997 110.008 178.113 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B 1121 ' ' ILE . . . . . 0.615 HG12 ' HB2' ' B' 1119 ' ' PRO . 37.3 pt -119.94 168.86 11.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 O-C-N 119.182 -2.199 . . . . 42.090000000000003 110.146 -172.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1122 ' ' SER . . . . . 0.52 ' HB3' ' HA ' ' C' ' 133' ' ' MET . 62.2 m -49.92 -80.23 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 117.618 2.451 . . . . 38.020000000000003 117.618 -161.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1123 ' ' ARG . . . . . 0.808 ' HG3' HG21 ' B' 1354 ' ' VAL . 11.2 ptt180 -66.62 -12.77 59.58 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 124.169 3.168 . . . . 34.289999999999999 114.329 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1124 ' ' ALA . . . . . 0.607 ' HB1' HG12 ' B' 1118 ' ' VAL . . . -67.16 -32.04 72.87 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 117.974 -1.012 . . . . 32.350000000000001 110.005 175.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1125 ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -58.32 -21.9 51.05 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 121.111 1.778 . . . . 47.170000000000002 114.678 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1126 ' ' SER . . . . . . . . . . . . . 10.2 m -71.6 -34.61 70.03 Favored 'General case' 0 C--O 1.246 0.885 0 O-C-N 121.119 -0.988 . . . . 31.710000000000001 111.351 173.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1127 ' ' LEU . . . . . . . . . . . . . 5.6 mp -83.9 -33.37 24.76 Favored 'General case' 0 CA--C 1.487 -1.463 0 N-CA-C 106.878 -1.527 . . . . 37.0 106.878 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1128 ' ' ASP . . . . . 0.681 ' HA ' HG21 ' B' 1118 ' ' VAL . 25.8 t70 -61.85 111.32 1.84 Allowed 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 124.303 2.001 . . . . 40.399999999999999 114.524 -168.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1129 ' ' ALA . . . . . . . . . . . . . . . -75.53 -20.62 58.59 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 113.22 -1.809 . . . . 26.559999999999999 109.52 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1130 ' ' LEU . . . . . 0.533 HD12 HH21 ' B' 1120 ' ' ARG . 17.1 mt -62.81 -40.34 97.07 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 122.294 2.315 . . . . 30.890000000000001 111.336 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1131 ' ' SER . . . . . . . . . . . . . 52.7 p -64.33 -53.78 43.47 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 118.051 -0.976 . . . . 29.84 110.782 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1132 ' ' SER . . . . . 0.451 ' HB3' ' HB3' ' B' 1326 ' ' LEU . 40.2 m -50.42 -47.23 56.66 Favored 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 124.967 1.307 . . . . 31.91 114.082 172.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1133 ' ' MET . . . . . 0.637 ' HB3' ' HB3' ' B' 1316 ' ' PRO . 37.3 mmt -70.43 -33.52 71.42 Favored 'General case' 0 CA--C 1.493 -1.221 0 O-C-N 124.37 1.044 . . . . 25.899999999999999 112.468 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1134 ' ' ALA . . . . . 0.55 ' HB1' ' HB2' ' B' 1176 ' ' ALA . . . -67.33 -41.56 85.05 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 121.17 -0.956 . . . . 26.620000000000001 111.92 171.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -56.32 -53.45 57.14 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 108.292 -1.003 . . . . 36.969999999999999 108.292 174.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1136 ' ' ILE . . . . . 0.441 HD13 ' HE2' ' A' 1152 ' ' PHE . 34.9 mm -52.37 -51.73 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 124.285 1.034 . . . . 32.109999999999999 109.95 174.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1137 ' ' ALA . . . . . 0.524 ' HB1' HD22 ' B' 1284 ' ' LEU . . . -57.13 -42.49 81.01 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 117.078 -1.439 . . . . 24.140000000000001 112.638 177.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -65.28 -45.22 91.89 Favored Glycine 0 C--O 1.253 1.328 0 CA-C-N 122.405 2.366 . . . . 25.129999999999999 111.33 -174.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1139 ' ' TYR . . . . . 0.446 ' O ' ' HB ' ' B' 1142 ' ' ILE . 16.0 t80 -63.32 -43.27 98.28 Favored 'General case' 0 C--O 1.21 -1.011 0 CA-C-N 113.241 -1.48 . . . . 32.729999999999997 112.22 171.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1140 ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -70.89 -22.4 62.27 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 119.101 -0.476 . . . . 26.359999999999999 110.0 -176.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1141 ' ' ALA . . . . . 0.774 ' HA ' HG11 ' B' 1282 ' ' VAL . . . -63.77 -43.98 94.75 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.242 -1.021 . . . . 24.120000000000001 108.242 167.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1142 ' ' ILE . . . . . 0.507 HG23 ' CE2' ' B' 1153 ' ' PHE . 16.2 mm -59.31 -47.31 90.92 Favored 'Isoleucine or valine' 0 C--N 1.359 1.004 0 CA-C-O 121.835 0.826 . . . . 23.370000000000001 111.765 177.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 71.1 t -53.51 -68.33 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.848 0 N-CA-C 113.477 0.917 . . . . 24.960000000000001 113.477 171.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -61.75 -31.14 71.3 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 113.72 1.008 . . . . 32.07 113.72 -172.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1145 ' ' ALA . . . . . 0.777 ' HB1' HD12 ' B' 1251 ' ' ILE . . . -55.11 -57.42 11.81 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.687 -0.688 . . . . 24.870000000000001 110.36 168.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1146 ' ' ALA . . . . . 0.56 ' HA ' ' HB2' ' B' 1149 ' ' PHE . . . -64.49 -19.33 65.51 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 115.895 1.813 . . . . 24.670000000000002 115.895 176.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 86.0 t60 -65.52 -26.66 68.0 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 116.986 -1.483 . . . . 28.579999999999998 112.278 169.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1148 ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -123.89 8.74 8.74 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 123.117 2.69 . . . . 36.82 115.955 170.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1149 ' ' PHE . . . . . 0.56 ' HB2' ' HA ' ' B' 1146 ' ' ALA . 0.8 OUTLIER -65.46 154.07 39.56 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-O 124.255 1.978 . . . . 31.969999999999999 111.877 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B 1150 ' ' GLY . . . . . . . . . . . . . . . -86.39 -32.09 17.39 Favored Glycine 0 N--CA 1.432 -1.613 0 CA-C-N 114.05 -1.432 . . . . 25.489999999999998 112.313 174.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1151 ' ' ARG . . . . . 0.415 HH11 HG21 ' A' 1321 ' ' THR . 64.4 mtm-85 -119.59 -174.23 2.7 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 115.981 1.845 . . . . 59.840000000000003 115.981 -166.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1152 ' ' PHE . . . . . 0.421 ' HD1' ' H ' ' B' 1154 ' ' THR . 0.8 OUTLIER -88.14 145.81 25.74 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-O 118.499 -0.762 . . . . 34.450000000000003 111.873 172.372 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B 1153 ' ' PHE . . . . . 0.507 ' CE2' HG23 ' B' 1142 ' ' ILE . 8.8 m-85 -63.16 -52.08 63.85 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 119.17 0.895 . . . . 31.170000000000002 112.294 169.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1154 ' ' THR . . . . . 0.421 ' H ' ' HD1' ' B' 1152 ' ' PHE . 7.6 m -73.88 131.08 41.12 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.896 -1.047 . . . . 33.890000000000001 110.434 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -72.34 81.84 0.58 Allowed Glycine 0 C--N 1.343 0.93 0 O-C-N 119.689 -1.882 . . . . 38.950000000000003 111.029 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -75.27 114.85 14.27 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.556 0.693 . . . . 54.229999999999997 111.794 -173.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1157 ' ' ILE . . . . . 0.416 HG23 ' HG2' ' B' 1162 ' ' LYS . 45.1 mm -92.53 104.78 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 1 N-CA-C 99.316 -4.327 . . . . 51.159999999999997 99.316 177.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B 1158 ' ' THR . . . . . . . . . . . . . 1.5 m -115.11 138.88 50.4 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 103.002 -2.962 . . . . 49.609999999999999 103.002 -172.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -52.61 -32.69 42.85 Favored 'General case' 0 C--O 1.248 1.016 0 CA-C-O 123.777 1.751 . . . . 49.049999999999997 115.009 175.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -59.16 -81.04 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 113.303 -1.771 . . . . 47.649999999999999 110.088 162.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . -146.68 155.2 26.42 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 121.366 1.894 . . . . 45.609999999999999 110.035 -174.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1162 ' ' LYS . . . . . 0.416 ' HG2' HG23 ' B' 1157 ' ' ILE . 89.0 mttt -89.39 132.12 35.13 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.648 1.213 . . . . 57.460000000000001 108.352 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1163 ' ' VAL . . . . . 0.444 ' HA ' ' HD2' ' B' 1164 ' ' PRO . 90.6 t -100.3 128.56 30.16 Favored Pre-proline 0 C--O 1.247 0.925 0 CA-C-N 113.771 -1.559 . . . . 42.93 108.484 176.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1164 ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' B' 1163 ' ' VAL . 45.9 Cg_endo -67.22 133.2 29.87 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.568 3.512 . . . . 39.289999999999999 110.689 166.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1165 ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' B' 1164 ' ' PRO . 16.9 Cg_exo -69.0 161.64 44.99 Favored 'Trans proline' 0 N--CA 1.479 0.629 0 C-N-CA 121.255 1.303 . . . . 34.170000000000002 110.04 -172.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -70.56 111.78 6.33 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 118.04 -1.464 . . . . 31.690000000000001 108.816 172.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1167 ' ' LYS . . . . . 0.644 ' HB2' ' HA ' ' B' 1249 ' ' VAL . 86.4 mttt -77.65 87.48 3.94 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.144 -1.428 . . . . 44.780000000000001 107.144 174.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1168 ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' B' 1191 ' ' VAL . 48.4 t -77.05 94.92 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 114.168 -1.378 . . . . 31.23 108.556 -174.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1169 ' ' MET . . . . . 0.575 ' HA ' ' O ' ' B' 1192 ' ' ARG . 55.5 ttp -86.19 110.37 19.54 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 122.459 1.123 . . . . 37.090000000000003 108.433 177.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 50.7 t -97.59 118.76 44.64 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 N-CA-C 107.611 -1.255 . . . . 30.170000000000002 107.611 -177.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1171 ' ' ILE . . . . . 0.487 HD13 HG23 ' B' 1252 ' ' ILE . 1.7 mp -91.94 95.97 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 103.848 -2.649 . . . . 33.740000000000002 103.848 171.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 115.4 85.18 1.23 Allowed Glycine 0 C--N 1.339 0.707 0 N-CA-C 108.657 -1.777 . . . . 32.590000000000003 108.657 170.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1173 ' ' ALA . . . . . 0.455 ' HA ' ' HA3' ' B' 1177 ' ' GLY . . . -84.16 50.33 1.83 Allowed 'General case' 0 C--O 1.255 1.346 0 CA-C-O 124.302 2.001 . . . . 32.420000000000002 110.849 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -81.15 -165.56 34.44 Favored Glycine 0 C--N 1.342 0.884 0 O-C-N 118.59 -2.569 . . . . 31.739999999999998 107.754 163.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 19.1 t -51.36 -39.96 22.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 O-C-N 119.304 -2.292 . . . . 31.48 114.352 -176.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1176 ' ' ALA . . . . . 0.55 ' HB2' ' HB1' ' B' 1134 ' ' ALA . . . -55.86 -46.82 78.15 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.934 1.087 . . . . 26.120000000000001 113.934 171.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1177 ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' B' 1173 ' ' ALA . . . -68.85 -45.8 62.8 Favored Glycine 0 C--N 1.345 1.046 0 N-CA-C 109.106 -1.598 . . . . 25.73 109.106 -176.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1178 ' ' LEU . . . . . 0.544 ' HA ' HD12 ' B' 1181 ' ' ILE . 51.4 mt -60.46 -36.36 78.07 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 118.244 -0.884 . . . . 32.590000000000003 108.9 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -68.24 -44.09 76.43 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 119.342 0.973 . . . . 27.719999999999999 110.456 176.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -58.63 -36.64 74.4 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 118.192 -0.908 . . . . 26.030000000000001 108.773 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1181 ' ' ILE . . . . . 0.544 HD12 ' HA ' ' B' 1178 ' ' LEU . 38.2 mt -61.27 -50.0 82.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 CA-C-N 120.628 1.558 . . . . 28.609999999999999 107.783 171.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -62.67 -19.95 61.14 Favored Glycine 0 CA--C 1.543 1.808 0 CA-C-O 118.363 -1.243 . . . . 25.23 114.108 -173.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -97.96 -56.64 2.43 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 117.993 0.896 . . . . 24.09 109.895 171.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -72.01 -38.5 69.6 Favored 'General case' 0 CA--C 1.509 -0.619 0 O-C-N 119.027 -2.296 . . . . 26.68 115.861 -171.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -61.61 -39.02 89.75 Favored 'General case' 0 C--O 1.247 0.966 0 O-C-N 120.589 -1.319 . . . . 36.57 111.429 174.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1186 ' ' SER . . . . . . . . . . . . . 2.0 m -62.33 -38.73 90.62 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 112.952 -1.931 . . . . 28.920000000000002 111.559 174.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1187 ' ' LEU . . . . . 0.485 ' HA ' ' HB2' ' A' 1186 ' ' SER . 4.2 mt -61.02 -31.18 70.81 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 116.038 -0.528 . . . . 29.09 110.914 172.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 111.05 -7.55 29.15 Favored Glycine 0 CA--C 1.525 0.717 0 O-C-N 121.426 -0.796 . . . . 29.260000000000002 111.25 -176.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1189 ' ' ALA . . . . . . . . . . . . . . . -62.05 134.72 56.98 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 122.234 1.016 . . . . 30.16 109.559 175.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 18.3 mt -77.19 94.97 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 104.684 -2.339 . . . . 35.810000000000002 104.684 -174.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1191 ' ' VAL . . . . . 0.488 HG11 HG12 ' B' 1181 ' ' ILE . 40.6 t -78.24 100.23 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 O-C-N 120.242 -1.536 . . . . 31.969999999999999 109.66 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1192 ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' B' 1169 ' ' MET . 98.8 mtt180 -87.07 80.84 8.24 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 124.146 1.927 . . . . 48.159999999999997 108.637 174.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -84.93 144.82 28.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 111.438 -2.619 . . . . 35.890000000000001 111.335 -172.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 82.1 t80 -134.57 145.39 48.65 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.018 -1.475 . . . . 41.880000000000003 107.018 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1195 ' ' ASP . . . . . . . . . . . . . 5.5 t70 -153.03 154.59 35.22 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 103.992 -2.596 . . . . 38.280000000000001 103.992 161.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1196 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.42 -21.19 56.28 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 114.468 -1.242 . . . . 40.619999999999997 110.59 174.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1197 ' ' ARG . . . . . 0.45 ' O ' HG22 ' B' 1200 ' ' VAL . 40.2 mtm180 -78.06 126.15 84.15 Favored Pre-proline 0 N--CA 1.435 -1.183 0 C-N-CA 120.164 -0.614 . . . . 53.090000000000003 110.978 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1198 ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' B' 1197 ' ' ARG . 37.3 Cg_endo -53.04 -46.39 34.29 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 125.273 3.982 . . . . 42.560000000000002 116.611 -176.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 10.6 pm0 -70.24 -13.98 62.41 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 115.787 1.773 . . . . 56.310000000000002 115.787 -161.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1200 ' ' VAL . . . . . 0.45 HG22 ' O ' ' B' 1197 ' ' ARG . 26.7 m -74.09 -22.17 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 116.145 -0.48 . . . . 42.909999999999997 111.24 175.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 26.0 tttm -47.83 -56.45 7.45 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 114.549 1.315 . . . . 48.890000000000001 114.549 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -55.7 -42.55 75.4 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 112.716 -2.038 . . . . 51.700000000000003 112.565 174.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1203 ' ' GLN . . . . . 0.649 ' HG2' ' HG3' ' C' ' 74' ' ' ARG . 52.1 mt-30 -64.11 -47.84 78.45 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.308 -0.86 . . . . 52.57 109.4 -174.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1204 ' ' VAL . . . . . . . . . . . . . 55.9 t -64.02 -49.84 79.8 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-O 122.677 1.227 . . . . 33.789999999999999 108.486 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -57.39 -29.78 64.36 Favored 'General case' 0 C--N 1.359 1.007 0 N-CA-C 115.812 1.782 . . . . 36.579999999999998 115.812 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1206 ' ' SER . . . . . . . . . . . . . 43.3 p -71.86 -18.26 62.07 Favored 'General case' 0 C--O 1.248 0.978 0 CA-C-N 119.423 1.011 . . . . 39.609999999999999 110.89 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1207 ' ' MET . . . . . 0.531 ' SD ' HG22 ' B' 1181 ' ' ILE . 26.1 mtp -87.39 -9.28 55.19 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 120.954 -1.091 . . . . 37.450000000000003 112.469 172.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 68.5 46.74 61.18 Favored Glycine 0 C--O 1.224 -0.484 0 O-C-N 119.319 -2.113 . . . . 31.870000000000001 109.548 -168.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -122.71 146.56 47.38 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 103.623 -2.732 . . . . 35.399999999999999 103.623 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1210 ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' B' 1192 ' ' ARG . 8.7 tt0 -85.09 116.55 23.53 Favored 'General case' 0 N--CA 1.435 -1.225 0 O-C-N 120.418 -1.426 . . . . 47.890000000000001 109.355 -164.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 70.0 t80 -89.5 120.95 31.26 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 107.982 -1.118 . . . . 45.530000000000001 107.982 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1212 ' ' LEU . . . . . 0.544 ' HB3' HD21 ' B' 1241 ' ' LEU . 57.8 mt -71.25 115.17 10.09 Favored 'General case' 0 N--CA 1.44 -0.964 0 O-C-N 121.323 -0.861 . . . . 46.329999999999998 109.271 174.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -98.38 141.4 31.3 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 124.7 2.19 . . . . 60.409999999999997 108.904 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 43.7 mt -66.32 161.33 22.64 Favored 'General case' 0 C--O 1.251 1.148 0 CA-C-N 112.2 -2.273 . . . . 57.380000000000003 114.597 168.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 27.0 t70 . . . . . 0 CA--C 1.518 -0.288 0 CA-C-N 114.264 -1.334 . . . . 65.069999999999993 110.19 -178.447 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B 1230 ' ' MET . . . . . 0.486 ' SD ' ' HB2' ' B' 1234 ' ' PHE . 13.8 mmt . . . . . 0 N--CA 1.448 -0.557 1 N-CA-C 98.674 -4.565 . . . . 80.319999999999993 98.674 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1231 ' ' SER . . . . . 0.4 ' O ' HG23 ' B' 1235 ' ' ILE 0.3 0.1 OUTLIER 63.05 173.77 0.15 Allowed 'General case' 0 C--N 1.356 0.879 2 CA-C-N 127.1 4.5 . . . . 79.920000000000002 119.458 0.628 . . . . . . . . 5 4 . 1 . 002 nuclear build full ' B' B 1232 ' ' ASP . . . . . 0.565 ' HA ' HG12 ' B' 1235 ' ' ILE . 5.6 p-10 -67.01 -166.92 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 115.719 1.748 . . . . 77.909999999999997 115.719 -172.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 71.0 -80.03 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 107.447 -1.316 . . . . 73.879999999999995 107.447 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1234 ' ' PHE . . . . . 0.486 ' HB2' ' SD ' ' B' 1230 ' ' MET . 2.2 m-85 -51.51 -33.45 31.76 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 115.651 1.723 . . . . 68.980000000000004 115.651 171.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1235 ' ' ILE . . . . . 0.565 HG12 ' HA ' ' B' 1232 ' ' ASP . 36.1 pt -47.72 -36.5 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 120.271 1.396 . . . . 64.530000000000001 113.12 169.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1236 ' ' LYS . . . . . 0.46 ' HD3' ' HA ' ' B' 1236 ' ' LYS . 69.6 mmtt -62.24 -41.62 98.58 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 120.049 -1.657 . . . . 66.359999999999999 111.011 172.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -67.34 -42.63 83.24 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 119.418 -0.913 . . . . 56.600000000000001 111.533 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -56.18 -51.74 66.94 Favored 'General case' 0 C--O 1.241 0.65 0 O-C-N 124.306 1.003 . . . . 56.789999999999999 111.966 171.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1239 ' ' MET . . . . . . . . . . . . . 10.4 tmm? -56.27 -56.74 17.27 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 118.168 -0.92 . . . . 53.630000000000003 112.976 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -55.56 -36.32 66.69 Favored 'General case' 0 C--N 1.36 1.028 0 CA-C-N 119.428 1.013 . . . . 51.740000000000002 111.111 -177.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1241 ' ' LEU . . . . . 0.544 HD21 ' HB3' ' B' 1212 ' ' LEU . 16.2 tp -57.44 -50.77 71.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 121.067 -1.021 . . . . 44.859999999999999 111.475 178.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -64.81 -39.61 93.87 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 125.99 2.056 . . . . 42.780000000000001 113.03 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1243 ' ' ALA . . . . . 0.517 ' HA ' ' HG3' ' B' 1271 ' ' MET . . . -64.94 -23.72 67.31 Favored 'General case' 0 C--N 1.36 1.048 0 N-CA-C 113.574 0.953 . . . . 40.960000000000001 113.574 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -82.01 -53.99 5.67 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 118.72 -2.488 . . . . 43.060000000000002 108.898 172.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 61.0 mm-40 -56.32 -31.99 64.23 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 124.748 1.219 . . . . 46.450000000000003 112.861 -176.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1246 ' ' ALA . . . . . 0.412 ' HA ' HG22 ' B' 1249 ' ' VAL . . . -44.46 -34.54 2.1 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 125.435 1.494 . . . . 41.780000000000001 114.885 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1247 ' ' LYS . . . . . 0.472 ' HA ' ' HD2' ' B' 1247 ' ' LYS . 34.3 tptt -63.55 -43.78 96.06 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 124.206 1.955 . . . . 52.200000000000003 111.863 -176.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1248 ' ' GLU . . . . . 0.465 ' CD ' HH12 ' B' 1192 ' ' ARG . 39.1 mt-10 -84.5 -39.91 18.29 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 113.14 -1.846 . . . . 53.549999999999997 114.283 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1249 ' ' VAL . . . . . 0.644 ' HA ' ' HB2' ' B' 1167 ' ' LYS 0.301 10.6 m -76.94 160.91 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 118.907 2.929 . . . . 34.409999999999997 118.907 -167.255 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B 1250 ' ' ASP . . . . . 0.456 ' HA ' ' HB3' ' B' 1279 ' ' SER . 16.9 m-20 -117.9 -73.09 0.66 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 124.389 2.042 . . . . 33.380000000000003 110.454 -169.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1251 ' ' ILE . . . . . 0.777 HD12 ' HB1' ' B' 1145 ' ' ALA . 23.5 mm -98.11 99.69 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 114.0 -1.455 . . . . 29.539999999999999 108.484 -169.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1252 ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' B' 1169 ' ' MET . 17.5 mt -89.54 96.13 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 105.607 -1.998 . . . . 32.439999999999998 105.607 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1253 ' ' VAL . . . . . . . . . . . . . 96.7 t -83.16 96.51 4.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 102.369 -3.197 . . . . 30.57 102.369 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1254 ' ' THR . . . . . 0.489 ' HB ' HG22 ' B' 1252 ' ' ILE . 2.4 t -104.99 138.93 40.44 Favored 'General case' 0 N--CA 1.432 -1.339 0 O-C-N 119.877 -1.764 . . . . 35.039999999999999 111.89 -175.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1255 ' ' THR . . . . . 0.403 HG22 ' HB2' ' B' 1284 ' ' LEU . 40.1 p -134.09 -83.25 0.44 Allowed 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 114.377 -1.283 . . . . 34.619999999999997 108.772 -177.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . 56.72 41.9 27.59 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.254 1.822 . . . . 42.719999999999999 114.777 -170.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 45.8 mt -89.85 93.78 9.56 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-O 123.797 1.761 . . . . 52.43 107.309 -174.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1258 ' ' ILE . . . . . 0.414 ' HB ' ' HD2' ' B' 1261 ' ' LYS . 24.7 mt -90.08 129.1 47.19 Favored Pre-proline 0 N--CA 1.438 -1.063 0 N-CA-C 107.043 -1.466 . . . . 59.409999999999997 107.043 171.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -57.03 133.31 57.08 Favored 'Trans proline' 0 N--CA 1.441 -1.577 0 C-N-CA 124.707 3.605 . . . . 62.68 114.466 -177.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 66.59 29.49 74.85 Favored Glycine 0 C--O 1.218 -0.856 0 CA-C-O 117.149 -1.917 . . . . 64.159999999999997 114.088 -174.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1261 ' ' LYS . . . . . 0.414 ' HD2' ' HB ' ' B' 1258 ' ' ILE . 59.6 mttm -138.32 148.16 58.41 Favored Pre-proline 0 CA--C 1.503 -0.827 0 CA-C-N 121.009 2.404 . . . . 68.530000000000001 111.822 172.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.63 136.96 29.27 Favored 'Trans proline' 0 C--O 1.245 0.844 0 CA-C-N 122.856 2.056 . . . . 61.990000000000002 107.486 164.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1263 ' ' ALA . . . . . 0.462 ' HA ' ' HD3' ' B' 1264 ' ' PRO . . . -51.63 116.07 7.35 Favored Pre-proline 0 C--O 1.248 1.021 0 N-CA-C 113.24 0.83 . . . . 57.149999999999999 113.24 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1264 ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' B' 1263 ' ' ALA . 87.6 Cg_exo -53.61 135.67 62.4 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 124.779 3.653 . . . . 51.57 110.5 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -78.25 84.37 4.46 Favored 'General case' 0 C--O 1.248 0.994 0 C-N-CA 123.785 0.834 . . . . 54.549999999999997 109.161 -173.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1266 ' ' LEU . . . . . 0.464 ' HB2' HD21 ' B' 1291 ' ' ASN . 94.9 mt -91.4 -41.31 10.95 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 113.185 0.809 . . . . 46.859999999999999 113.185 177.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1267 ' ' ILE . . . . . . . . . . . . . 32.1 mm -78.53 86.96 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 124.432 2.063 . . . . 41.039999999999999 111.467 171.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1268 ' ' THR . . . . . 0.597 ' HA ' ' HG3' ' B' 1293 ' ' GLU . 36.2 p -84.54 151.98 24.2 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 112.316 -2.22 . . . . 39.579999999999998 112.892 -170.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1269 ' ' ARG . . . . . 0.502 ' HG3' ' HB2' ' B' 1293 ' ' GLU . 84.2 mtt85 -52.22 -39.6 60.45 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 118.256 -2.778 . . . . 53.149999999999999 117.194 -176.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -58.27 -40.78 82.78 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-O 123.517 1.627 . . . . 42.960000000000001 112.392 173.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1271 ' ' MET . . . . . 0.517 ' HG3' ' HA ' ' B' 1243 ' ' ALA . 54.2 ttm -65.71 -42.61 90.93 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 113.048 -1.887 . . . . 43.890000000000001 110.669 -178.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1272 ' ' VAL . . . . . . . . . . . . . 10.4 t -54.78 -48.52 73.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 113.816 -1.538 . . . . 38.369999999999997 110.977 170.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 25.9 t70 -58.39 -40.71 83.08 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 114.251 1.204 . . . . 47.460000000000001 114.251 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1274 ' ' SER . . . . . . . . . . . . . 49.5 m -68.86 -22.99 64.17 Favored 'General case' 0 C--O 1.238 0.494 0 O-C-N 121.698 -0.626 . . . . 38.380000000000003 112.687 174.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1275 ' ' MET . . . . . . . . . . . . . 71.7 mtp -62.12 162.16 9.89 Favored 'General case' 0 C--O 1.252 1.197 0 CA-C-O 124.548 2.118 . . . . 37.810000000000002 114.014 -173.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 66.6 tttt -68.07 137.46 55.01 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 111.868 -2.423 . . . . 49.259999999999998 109.562 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -75.62 151.06 37.87 Favored 'General case' 0 C--O 1.246 0.874 0 O-C-N 124.121 0.888 . . . . 34.460000000000001 110.267 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1278 ' ' GLY . . . . . 0.438 ' O ' ' HD1' ' B' 1149 ' ' PHE . . . 74.55 14.51 81.06 Favored Glycine 0 N--CA 1.47 0.922 0 C-N-CA 120.514 -0.85 . . . . 33.530000000000001 112.645 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1279 ' ' SER . . . . . 0.456 ' HB3' ' HA ' ' B' 1250 ' ' ASP . 61.0 m -106.16 148.45 27.85 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 125.322 1.449 . . . . 31.309999999999999 109.67 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1280 ' ' VAL . . . . . 0.607 HG22 ' HB2' ' B' 1308 ' ' LYS . 25.9 t -127.07 119.94 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 O-C-N 120.634 -1.291 . . . . 29.32 109.886 -163.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1281 ' ' ILE . . . . . 0.44 HD12 HG22 ' B' 1309 ' ' VAL . 19.5 mt -86.8 112.26 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 102.655 -3.091 . . . . 31.93 102.655 175.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1282 ' ' VAL . . . . . 0.774 HG11 ' HA ' ' B' 1141 ' ' ALA . 21.2 t -106.5 107.71 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 N-CA-C 101.857 -3.386 . . . . 29.48 101.857 175.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 24.3 t0 -87.93 109.08 19.52 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 110.475 -3.057 . . . . 34.5 107.653 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1284 ' ' LEU . . . . . 0.703 HD21 ' HB2' ' B' 1141 ' ' ALA . 71.4 mt -79.58 -23.05 43.0 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-O 121.138 0.494 . . . . 37.939999999999998 110.467 177.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -87.52 -5.62 58.71 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 115.371 -0.831 . . . . 40.920000000000002 111.525 -175.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -18.72 -54.32 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.736 1 N-CA-C 122.173 4.138 . . . . 44.390000000000001 122.173 174.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1287 ' ' GLN . . . . . 0.578 ' HB3' HG23 ' B' 1313 ' ' THR . 0.1 OUTLIER -70.27 -43.89 69.56 Favored 'General case' 0 CA--C 1.501 -0.935 0 C-N-CA 123.431 0.692 . . . . 51.460000000000001 111.483 178.773 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 4.9 t30 -97.21 75.68 2.59 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-O 123.915 1.817 . . . . 57.75 109.378 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1289 ' ' GLY . . . . . . . . . . . . . . . 87.88 -76.72 1.95 Allowed Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 107.209 -2.356 . . . . 49.850000000000001 107.209 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 99.45 136.74 9.48 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 109.371 -1.492 . . . . 45.93 109.371 -167.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1291 ' ' ASN . . . . . 0.464 HD21 ' HB2' ' B' 1266 ' ' LEU . 24.5 t-20 -88.88 -35.17 16.68 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 120.15 1.975 . . . . 42.670000000000002 112.927 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1292 ' ' CYS . . . . . 0.515 ' HB3' ' OG1' ' B' 1295 ' ' THR . 40.4 t -77.87 143.91 37.39 Favored 'General case' 0 N--CA 1.441 -0.923 0 O-C-N 118.944 -2.348 . . . . 38.82 110.829 171.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1293 ' ' GLU . . . . . 0.597 ' HG3' ' HA ' ' B' 1268 ' ' THR . 24.2 mt-10 -69.08 -37.43 78.45 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.702 -1.135 . . . . 46.710000000000001 112.049 174.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -82.9 -8.13 59.6 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 115.564 1.691 . . . . 47.229999999999997 115.564 -173.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1295 ' ' THR . . . . . 0.67 HG23 ' HA3' ' B' 1311 ' ' GLY . 49.1 m -52.35 120.4 5.49 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 116.135 1.902 . . . . 36.020000000000003 116.135 177.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 2.9 t -88.79 108.11 21.37 Favored Pre-proline 0 N--CA 1.448 -0.559 0 CA-C-O 116.007 -1.949 . . . . 37.259999999999998 106.396 172.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -64.28 88.39 0.16 Allowed 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 124.29 3.327 . . . . 35.090000000000003 113.479 -176.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 139.46 -17.46 3.09 Favored Glycine 0 C--O 1.251 1.18 0 CA-C-N 113.243 -1.798 . . . . 35.969999999999999 110.013 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -133.71 -176.69 4.25 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 121.458 2.629 . . . . 40.390000000000001 114.554 -161.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1300 ' ' ILE . . . . . 0.491 HG23 HG12 ' B' 1310 ' ' ILE . 9.6 mt -99.8 155.58 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.045 0 N-CA-C 105.759 -1.941 . . . . 37.43 105.759 170.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 65.9 t80 -142.85 105.89 4.55 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 123.008 1.385 . . . . 44.130000000000003 107.63 167.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1302 ' ' THR . . . . . . . . . . . . . 96.5 m -75.46 118.58 18.49 Favored 'General case' 0 N--CA 1.438 -1.029 0 O-C-N 119.434 -2.041 . . . . 39.780000000000001 106.291 168.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1303 ' ' THR . . . . . . . . . . . . . 76.0 p -69.7 169.42 12.88 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 115.903 1.816 . . . . 43.289999999999999 115.903 172.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -48.37 -48.02 36.93 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 124.343 1.057 . . . . 53.07 113.02 167.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -85.8 23.52 1.42 Allowed 'General case' 0 C--O 1.244 0.81 0 N-CA-C 114.68 1.363 . . . . 43.969999999999999 114.68 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 69.38 23.5 76.4 Favored Glycine 0 C--N 1.358 1.761 0 O-C-N 119.332 -2.105 . . . . 41.119999999999997 114.961 170.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1307 ' ' VAL . . . . . . . . . . . . . 94.7 t -93.46 136.13 26.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 105.767 -1.938 . . . . 38.119999999999997 105.767 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1308 ' ' LYS . . . . . 0.607 ' HB2' HG22 ' B' 1280 ' ' VAL . 65.1 mmtt -92.77 99.54 12.19 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.757 -1.201 . . . . 36.340000000000003 107.757 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1309 ' ' VAL . . . . . 0.44 HG22 HD12 ' B' 1281 ' ' ILE . 18.0 t -90.02 92.97 4.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 105.602 -1.999 . . . . 30.399999999999999 105.602 177.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1310 ' ' ILE . . . . . 0.491 HG12 HG23 ' B' 1300 ' ' ILE . 12.1 mt -87.4 134.2 28.32 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.002 0 C-N-CA 126.02 1.728 . . . . 30.82 107.85 173.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1311 ' ' GLY . . . . . 0.67 ' HA3' HG23 ' B' 1295 ' ' THR . . . -149.09 86.95 0.15 Allowed Glycine 0 CA--C 1.493 -1.34 0 N-CA-C 108.396 -1.882 . . . . 26.530000000000001 108.396 171.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1312 ' ' TYR . . . . . 0.794 ' HB2' ' HG ' ' B' 1315 ' ' LEU . 43.6 m-85 -97.8 119.66 36.79 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 118.055 0.927 . . . . 38.0 108.848 -172.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1313 ' ' THR . . . . . 0.578 HG23 ' HB3' ' B' 1287 ' ' GLN . 39.3 m -49.83 -40.37 41.83 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 124.079 1.895 . . . . 29.800000000000001 114.355 172.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1314 ' ' ASP . . . . . 0.474 ' OD1' ' HB3' ' B' 1312 ' ' TYR . 22.8 p-10 -78.56 -2.96 41.35 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 112.834 -1.985 . . . . 39.039999999999999 116.201 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1315 ' ' LEU . . . . . 0.794 ' HG ' ' HB2' ' B' 1312 ' ' TYR . 13.4 mt -43.29 -51.35 14.45 Favored Pre-proline 0 N--CA 1.47 0.527 0 N-CA-C 119.062 2.986 . . . . 31.079999999999998 119.062 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1316 ' ' PRO . . . . . 0.637 ' HB3' ' HB3' ' B' 1133 ' ' MET . 87.7 Cg_exo -65.62 -25.06 54.86 Favored 'Trans proline' 0 C--O 1.218 -0.5 0 CA-C-N 124.606 2.681 . . . . 26.100000000000001 112.866 176.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1317 ' ' GLY . . . . . 0.701 ' HA2' ' HG3' ' B' 1015 ' ' ARG . . . -67.53 -49.23 52.17 Favored Glycine 0 N--CA 1.431 -1.688 0 O-C-N 120.496 -1.378 . . . . 23.170000000000002 109.964 169.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -39.69 -16.71 0.01 OUTLIER 'General case' 0 C--O 1.246 0.878 1 N-CA-C 125.201 5.26 . . . . 40.399999999999999 125.201 -161.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 15.9 tp -102.12 78.58 0.24 Allowed Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 121.301 1.864 . . . . 23.600000000000001 108.158 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1320 ' ' PRO . . . . . 0.454 ' HB3' HG22 ' B' 1014 ' ' THR . 48.3 Cg_endo -43.53 -64.28 0.26 Allowed 'Trans proline' 0 CA--C 1.51 -0.719 1 C-N-CA 125.416 4.077 . . . . 22.350000000000001 119.138 -156.628 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B 1321 ' ' THR . . . . . 0.417 HG23 ' CE1' ' B' 1045 ' ' PHE . 4.2 m -61.97 -44.79 96.01 Favored 'General case' 0 C--O 1.218 -0.578 0 O-C-N 121.17 -0.957 . . . . 26.52 112.293 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1322 ' ' GLN . . . . . 0.609 ' HB2' ' HA ' ' A' 1151 ' ' ARG . 11.5 tp60 -72.48 -43.44 63.67 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 118.657 -0.687 . . . . 24.379999999999999 112.471 -173.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1323 ' ' SER . . . . . 0.533 ' HB3' ' HG2' ' B' 1015 ' ' ARG . 66.6 m -48.78 -49.32 39.21 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 124.176 0.99 . . . . 22.800000000000001 110.837 164.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1324 ' ' SER . . . . . . . . . . . . . 11.4 m -61.69 -33.2 73.58 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 122.567 1.175 . . . . 21.25 113.436 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -69.43 -40.38 77.27 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 118.404 -2.685 . . . . 31.34 114.18 170.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1326 ' ' LEU . . . . . 0.451 ' HB3' ' HB3' ' B' 1132 ' ' SER . 3.6 mm? -68.89 -55.8 9.91 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.951 0.881 . . . . 31.559999999999999 112.241 -177.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1327 ' ' TYR . . . . . 0.494 ' O ' ' HB2' ' B' 1330 ' ' ASN . 31.3 t80 -56.2 -44.57 79.61 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-N 113.992 -1.458 . . . . 22.73 110.179 175.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1328 ' ' GLY . . . . . 0.672 ' HA2' HD12 ' B' 1331 ' ' LEU . . . -56.7 -60.45 8.98 Favored Glycine 0 C--N 1.343 0.929 0 O-C-N 124.153 0.908 . . . . 21.91 112.794 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1329 ' ' THR . . . . . 0.51 ' HB ' ' HA ' ' A' 1160 ' ' ALA . 9.2 m -58.44 -23.51 57.72 Favored 'General case' 0 C--O 1.252 1.185 0 CA-C-O 116.365 -1.778 . . . . 22.149999999999999 111.893 174.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1330 ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' B' 1327 ' ' TYR . 12.1 m120 -63.79 -46.72 83.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 125.4 3.727 . . . . 26.18 110.549 170.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1331 ' ' LEU . . . . . 0.819 HD13 ' HB3' ' B' 1070 ' ' LEU . 13.9 mt -61.14 -37.28 82.27 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.079 -0.964 . . . . 23.68 109.254 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1332 ' ' VAL . . . . . 0.752 HG12 ' HE3' ' B' 1336 ' ' LYS . 96.6 t -69.22 -45.21 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 106.847 -1.538 . . . . 26.57 106.847 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -58.69 -43.73 90.06 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 113.353 0.871 . . . . 28.079999999999998 113.353 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1334 ' ' LEU . . . . . 0.536 HD13 ' SD ' ' B' 1115 ' ' MET . 3.9 tt -56.95 -47.31 80.99 Favored 'General case' 0 C--O 1.247 0.929 0 C-N-CA 123.933 0.893 . . . . 27.43 109.337 170.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1335 ' ' LEU . . . . . 0.755 HD23 HD12 ' B' 1338 ' ' LEU . 68.2 mt -74.42 -12.25 60.46 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 120.924 -1.11 . . . . 30.5 113.601 -177.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1336 ' ' LYS . . . . . 0.752 ' HE3' HG12 ' B' 1332 ' ' VAL . 85.5 mttt -72.89 -49.5 29.41 Favored 'General case' 0 CA--C 1.504 -0.793 0 O-C-N 120.828 -1.17 . . . . 41.649999999999999 109.225 166.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 7.7 mp -67.51 -26.84 66.54 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 113.258 0.836 . . . . 42.079999999999998 113.258 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1338 ' ' LEU . . . . . 0.755 HD12 HD23 ' B' 1335 ' ' LEU . 95.3 mt -72.34 -67.11 0.57 Allowed 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 108.373 -0.973 . . . . 35.030000000000001 108.373 168.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 43.6 t -85.34 73.69 10.51 Favored 'General case' 0 N--CA 1.436 -1.161 0 O-C-N 118.699 -2.501 . . . . 37.329999999999998 108.185 -170.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 58.0 mttp -57.44 -33.4 67.88 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 125.323 1.449 . . . . 50.509999999999998 114.353 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -80.55 -11.61 59.64 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 114.372 1.249 . . . . 54.210000000000001 114.372 178.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 60.0 mttp 60.32 34.81 20.75 Favored 'General case' 0 C--N 1.347 0.488 0 CA-C-O 122.884 1.326 . . . . 50.990000000000002 111.608 -172.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -99.6 -34.22 10.31 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 114.959 -1.018 . . . . 48.82 111.273 -176.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 125.31 9.52 5.0 Favored Glycine 0 N--CA 1.433 -1.551 0 O-C-N 124.543 1.152 . . . . 40.43 113.407 175.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -98.67 141.17 31.84 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 125.503 1.521 . . . . 47.560000000000002 113.639 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1346 ' ' ILE . . . . . 0.492 HD11 HG12 ' B' 1068 ' ' ILE . 43.1 mm -82.79 76.18 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.63 0 CA-C-O 123.136 1.446 . . . . 42.490000000000002 108.728 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1347 ' ' THR . . . . . 0.433 ' HB ' ' O ' ' B' 1338 ' ' LEU . 2.4 m -73.82 78.92 1.59 Allowed 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.598 -1.183 . . . . 38.119999999999997 109.326 172.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 10.9 t -62.29 121.66 11.35 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 O-C-N 119.598 -1.939 . . . . 37.5 109.379 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 23.1 t0 -96.96 111.08 23.46 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 122.505 1.145 . . . . 43.850000000000001 108.565 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1350 ' ' PHE . . . . . 0.569 ' HE2' HG21 ' B' 1367 ' ' THR . 1.4 m-30 -100.52 -0.59 37.55 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 116.385 1.994 . . . . 39.810000000000002 116.385 175.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -81.41 -43.55 18.8 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 121.728 0.775 . . . . 51.289999999999999 110.776 167.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 14.4 t0 -66.75 121.8 16.23 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 124.373 2.035 . . . . 39.780000000000001 111.995 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 3.7 m -52.25 -37.21 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 CA-C-N 110.752 -2.931 . . . . 39.280000000000001 112.686 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1354 ' ' VAL . . . . . 0.808 HG21 ' HG3' ' B' 1123 ' ' ARG . 23.1 t -70.6 -54.01 19.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-N 114.894 -1.048 . . . . 35.700000000000003 112.355 -177.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1355 ' ' ILE . . . . . 0.42 ' HA ' HG12 ' B' 1358 ' ' VAL . 27.1 mm -64.68 -47.59 88.19 Favored 'Isoleucine or valine' 0 C--N 1.359 1.007 0 CA-C-O 116.95 -1.5 . . . . 35.770000000000003 112.073 176.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 42.3 tpt85 -54.1 -37.09 63.89 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 114.168 1.173 . . . . 38.549999999999997 114.168 173.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1357 ' ' GLY . . . . . 0.476 ' HA2' ' HB2' ' B' 1370 ' ' ALA . . . -62.63 -54.6 32.67 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 124.621 1.105 . . . . 29.579999999999998 115.437 171.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1358 ' ' VAL . . . . . 0.42 HG12 ' HA ' ' B' 1355 ' ' ILE . 9.1 p -69.08 -38.82 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 108.668 -0.864 . . . . 32.060000000000002 108.668 -174.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1359 ' ' THR . . . . . 0.44 ' HB ' ' HE1' ' B' 1350 ' ' PHE . 14.8 m -76.46 84.83 3.18 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-O 123.892 1.806 . . . . 29.0 107.944 -177.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1360 ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' B' 1368 ' ' TRP . 22.1 m -73.27 -19.55 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 111.692 -2.504 . . . . 29.68 111.252 -174.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1361 ' ' ILE . . . . . 0.67 ' HB ' ' HB ' ' B' 1112 ' ' VAL . 85.1 mt -139.16 116.28 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 105.76 -1.941 . . . . 32.049999999999997 105.76 177.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1362 ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -108.66 119.38 39.37 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 119.205 -2.184 . . . . 32.520000000000003 108.885 175.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 36.86 44.08 0.33 Allowed 'General case' 0 C--O 1.246 0.92 0 CA-C-O 124.454 2.073 . . . . 35.68 116.113 -172.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1364 ' ' GLY . . . . . 0.6 ' HA3' ' HA ' ' B' 1109 ' ' ASN . . . 93.36 -7.28 75.38 Favored Glycine 0 CA--C 1.54 1.647 0 CA-C-O 117.225 -1.875 . . . . 34.259999999999998 114.356 174.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1365 ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' B' 1361 ' ' ILE . 0.2 OUTLIER -88.6 132.52 34.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 104.653 -2.351 . . . . 51.07 104.653 170.718 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 59.5 mt -88.75 94.05 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 N-CA-C 107.402 -1.333 . . . . 39.869999999999997 107.402 -176.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1367 ' ' THR . . . . . 0.569 HG21 ' HE2' ' B' 1350 ' ' PHE . 3.3 p -84.77 -1.39 56.26 Favored 'General case' 0 N--CA 1.424 -1.735 0 O-C-N 126.528 2.393 . . . . 38.009999999999998 114.858 -175.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1368 ' ' TRP . . . . . 0.419 ' HB2' ' HB ' ' B' 1360 ' ' VAL . 35.0 t90 -52.05 142.26 27.29 Favored Pre-proline 0 C--O 1.241 0.635 0 C-N-CA 124.255 1.022 . . . . 42.140000000000001 111.674 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -87.91 -114.77 0.0 OUTLIER 'Cis proline' 0 N--CA 1.451 -0.996 0 CA-C-N 122.575 1.955 . . . . 43.259999999999998 113.21 -7.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1370 ' ' ALA . . . . . 0.476 ' HB2' ' HA2' ' B' 1357 ' ' GLY . . . -117.97 153.67 51.18 Favored Pre-proline 0 C--N 1.32 -0.696 0 O-C-N 120.104 -1.623 . . . . 46.520000000000003 107.297 166.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1371 ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' B' 1372 ' ' PRO . 93.1 Cg_endo -59.52 133.62 53.01 Favored 'Trans proline' 0 C--N 1.33 -0.438 0 CA-C-N 122.589 1.96 . . . . 51.950000000000003 110.954 172.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1372 ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' B' 1371 ' ' PRO . 0.1 OUTLIER -36.91 87.7 0.01 OUTLIER 'Trans proline' 0 C--O 1.25 1.091 0 C-N-CA 125.133 3.889 . . . . 56.270000000000003 118.108 -174.729 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B 1373 ' ' ILE . . . . . 0.473 HG21 HD13 ' B' 1121 ' ' ILE . 0.0 OUTLIER -104.13 140.78 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 103.099 -2.926 . . . . 60.829999999999998 103.099 177.04 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -107.48 146.64 31.52 Favored 'General case' 0 C--O 1.256 1.423 0 O-C-N 120.203 -1.561 . . . . 66.099999999999994 108.184 -174.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 96.2 t -78.95 135.86 24.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 O-C-N 125.454 1.721 . . . . 63.469999999999999 111.49 -171.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.23 -4.627 0 O-C-N 120.891 -1.13 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.274 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.6 -16.23 24.29 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.071 1.348 . . . . 0.0 114.464 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 28.7 mp0 -49.54 -42.22 43.37 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.068 -1.02 . . . . 0.0 110.531 172.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 6.6 m -56.67 -46.96 80.81 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 123.593 0.757 . . . . 0.0 111.696 173.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 24' ' ' ALA . . . . . 0.476 ' HB2' HG22 ' C' ' 182' ' ' ILE . . . -62.24 -49.81 74.23 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 123.714 0.805 . . . . 0.0 109.674 -173.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -48.82 -51.07 31.45 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 127.849 3.218 . . . . 0.0 111.409 173.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 13.5 tp -65.28 -39.41 92.53 Favored 'General case' 0 N--CA 1.44 -0.938 0 O-C-N 120.764 -1.21 . . . . 0.0 113.59 -177.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 74.1 mt -53.68 -39.62 65.26 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 118.58 2.808 . . . . 0.0 118.58 -174.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 28' ' ' LYS . . . . . . . . . . . . . 34.5 pttt -63.93 -28.65 69.97 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.082 -0.963 . . . . 0.0 113.015 175.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -82.87 -33.01 27.13 Favored 'General case' 0 C--O 1.246 0.88 0 O-C-N 125.349 1.656 . . . . 0.0 109.823 174.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.437 ' HA ' ' OD2' ' C' ' 107' ' ' ASP . 58.0 m -54.87 127.27 27.85 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -170.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -82.55 -58.37 2.94 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 113.956 -1.475 . . . . 0.0 109.041 -174.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 32' ' ' SER . . . . . 0.432 ' HB2' ' HA ' ' C' ' 106' ' ' THR . 55.5 m -116.15 143.39 45.56 Favored 'General case' 0 C--O 1.251 1.135 0 O-C-N 120.801 -1.187 . . . . 0.0 110.55 166.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 96.6 t -128.44 120.2 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.52 HD13 ' HB2' ' C' ' 65' ' ' ARG . 38.7 mm -101.69 111.41 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 101.598 -3.482 . . . . 0.0 101.598 177.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 35' ' ' ILE . . . . . 0.705 HG22 ' HD3' ' C' ' 37' ' ' PRO . 42.9 mt -83.7 122.73 38.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 169.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 13.7 m -115.97 92.94 36.65 Favored Pre-proline 0 C--O 1.246 0.919 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.129 173.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 37' ' ' PRO . . . . . 0.77 ' HD2' HG12 ' C' ' 68' ' ' ILE . 0.5 OUTLIER -56.3 116.66 3.34 Favored 'Trans proline' 0 N--CA 1.449 -1.107 1 C-N-CA 125.47 4.113 . . . . 0.0 112.347 168.926 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' C' C ' 38' ' ' GLY . . . . . 0.418 ' HA3' ' HB3' ' C' ' 114' ' ' ALA . . . -102.29 -175.23 27.52 Favored Glycine 0 N--CA 1.433 -1.558 0 O-C-N 120.869 -1.145 . . . . 0.0 110.441 167.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -38.18 -41.59 0.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.187 1.395 . . . . 0.0 114.605 168.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 40' ' ' GLY . . . . . 0.936 ' HA3' ' HA3' ' C' ' 113' ' ' GLY . . . -52.78 -47.96 57.73 Favored Glycine 0 C--O 1.249 1.08 0 CA-C-O 118.789 -1.006 . . . . 0.0 112.371 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 41' ' ' MET . . . . . 0.456 ' HG3' ' HB3' ' C' ' 46' ' ' ALA . 24.2 ttm -61.27 -31.48 71.3 Favored 'General case' 0 C--N 1.356 0.889 0 CA-C-N 119.801 1.801 . . . . 0.0 113.529 172.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 42' ' ' ALA . . . . . 0.65 ' HB2' ' HB3' ' C' ' 79' ' ' MET . . . -70.04 -33.33 71.82 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.548 -0.739 . . . . 0.0 110.816 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 43' ' ' VAL . . . . . 0.431 HG13 ' H ' ' C' ' 44' ' ' ALA . 7.4 p -90.31 -70.95 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 118.448 -0.787 . . . . 0.0 110.6 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 44' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' C' ' 175' ' ' ALA . . . -79.27 100.2 7.42 Favored 'General case' 0 C--O 1.252 1.206 0 CA-C-N 120.432 1.469 . . . . 0.0 107.658 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 45' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -69.49 82.73 0.4 Allowed 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -161.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.456 ' HB3' ' HG3' ' C' ' 41' ' ' MET . . . -81.11 -4.42 55.24 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 111.164 -2.744 . . . . 0.0 114.363 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 47' ' ' GLN . . . . . 0.447 ' HG2' ' HB3' ' C' ' 82' ' ' LEU . 0.0 OUTLIER -71.24 -46.94 59.95 Favored 'General case' 0 C--O 1.25 1.086 0 O-C-N 119.66 -1.9 . . . . 0.0 113.659 -173.481 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 48' ' ' TYR . . . . . 0.422 ' CE1' ' HA ' ' C' ' 86' ' ' ALA . 95.0 m-85 -57.8 -44.38 99.38 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 120.333 1.424 . . . . 0.0 113.401 173.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 49' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -49.92 -49.78 15.11 Favored 'Trans proline' 0 C--O 1.255 1.352 0 C-N-CA 122.391 2.061 . . . . 0.0 115.574 163.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 50' ' ' VAL . . . . . 0.439 ' HA ' HG22 ' C' ' 53' ' ' ILE . 0.8 OUTLIER -68.86 -21.47 25.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 O-C-N 120.168 -1.582 . . . . 0.0 110.356 -171.852 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.68 -49.61 74.57 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 122.031 0.919 . . . . 0.0 111.403 172.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.12 -54.92 32.91 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.937 1.295 . . . . 0.0 112.633 176.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 53' ' ' ILE . . . . . 0.439 HG22 ' HA ' ' C' ' 50' ' ' VAL . 6.7 tp -71.57 -33.5 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-N 119.171 0.896 . . . . 0.0 111.054 -176.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 89.2 m -67.01 -32.97 74.54 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 118.997 0.817 . . . . 0.0 109.659 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -56.14 -51.88 66.37 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 4.6 mppt? -65.11 -46.3 81.59 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 57' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' C' ' 53' ' ' ILE . 55.2 mt -58.8 -45.73 89.22 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 120.509 1.504 . . . . 0.0 111.899 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -70.04 -40.86 74.89 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.613 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.59 -45.26 73.55 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 121.478 1.945 . . . . 0.0 113.91 171.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 29.1 ttm-85 -65.38 -23.36 66.95 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.101 1.36 . . . . 0.0 112.346 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.07 21.25 9.66 Favored Glycine 0 CA--C 1.505 -0.545 0 CA-C-O 122.12 0.845 . . . . 0.0 114.053 174.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 59.0 mt -85.16 135.14 25.49 Favored 'Isoleucine or valine' 0 C--O 1.249 1.055 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -79.61 86.73 5.21 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 7.7 p -95.7 122.68 47.41 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 CA-C-O 122.456 1.122 . . . . 0.0 108.894 178.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 65' ' ' ARG . . . . . 0.52 ' HB2' HD13 ' C' ' 34' ' ' ILE . 9.6 mmm-85 -126.27 136.71 53.11 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 122.227 1.013 . . . . 0.0 110.102 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 66' ' ' PHE . . . . . 0.472 ' O ' HG13 ' C' ' 68' ' ' ILE . 29.8 m-85 -87.92 74.28 9.01 Favored 'General case' 0 C--O 1.243 0.715 0 O-C-N 120.082 -1.636 . . . . 0.0 109.203 177.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.65 83.14 0.91 Allowed Glycine 0 CA--C 1.529 0.965 0 N-CA-C 109.084 -1.607 . . . . 0.0 109.084 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 68' ' ' ILE . . . . . 0.77 HG12 ' HD2' ' C' ' 37' ' ' PRO . 16.5 mt -98.08 144.67 10.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 O-C-N 124.61 0.83 . . . . 0.0 111.066 -167.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -109.84 72.37 0.61 Allowed Pre-proline 0 C--O 1.242 0.69 0 N-CA-C 103.018 -2.956 . . . . 0.0 103.018 169.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 70' ' ' PRO . . . . . 0.861 ' HB2' HG21 ' A' 1157 ' ' ILE . 43.0 Cg_exo -61.47 -20.23 67.65 Favored 'Trans proline' 0 C--N 1.341 0.148 1 C-N-CA 125.335 4.024 . . . . 0.0 113.96 -167.816 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.84 81.32 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 122.949 1.357 . . . . 0.0 107.555 161.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 72' ' ' ALA . . . . . 0.759 ' HB3' ' SD ' ' C' ' 79' ' ' MET . . . -142.85 97.09 3.04 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 119.38 -2.075 . . . . 0.0 112.834 -172.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 73' ' ' GLY . . . . . 0.51 ' C ' ' HD2' ' C' ' 74' ' ' ARG . . . 74.92 -75.53 1.28 Allowed Glycine 0 N--CA 1.44 -1.08 0 O-C-N 120.388 -1.445 . . . . 0.0 114.632 170.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 74' ' ' ARG . . . . . 0.649 ' HG3' ' HG2' ' B' 1203 ' ' GLN . 1.5 mpt_? -121.63 98.9 6.17 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -174.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.469 ' HG ' HD22 ' B' 1178 ' ' LEU . 0.3 OUTLIER 75.33 132.29 0.04 OUTLIER Pre-proline 0 C--N 1.35 0.625 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 168.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.32 150.07 84.75 Favored 'Trans proline' 0 C--O 1.239 0.57 0 C-N-CA 123.287 2.658 . . . . 0.0 114.487 174.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.18 -94.16 1.46 Allowed Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 106.964 -2.454 . . . . 0.0 106.964 -169.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 2.1 t60 26.33 -80.7 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 127.83 2.452 . . . . 0.0 116.048 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 79' ' ' MET . . . . . 0.759 ' SD ' ' HB3' ' C' ' 72' ' ' ALA . 0.8 OUTLIER -59.5 -43.62 93.3 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.698 -1.251 . . . . 0.0 111.587 179.545 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -67.98 -44.95 75.46 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 121.652 -0.655 . . . . 0.0 109.643 -176.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.425 ' O ' ' HB3' ' C' ' 84' ' ' ALA . 90.1 t -52.1 -50.88 33.77 Favored 'Isoleucine or valine' 0 C--O 1.249 1.074 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 168.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.447 ' HB3' ' HG2' ' C' ' 47' ' ' GLN . 3.5 mp -53.55 -39.75 65.01 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 174.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 11.7 tp -59.99 -46.41 89.55 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 124.385 1.053 . . . . 0.0 112.667 170.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 84' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' C' ' 81' ' ' VAL . . . -57.37 -39.95 77.09 Favored 'General case' 0 C--O 1.246 0.911 0 C-N-CA 124.253 1.021 . . . . 0.0 111.25 173.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -60.87 -40.1 91.71 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.015 0.526 . . . . 0.0 111.01 172.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 86' ' ' ALA . . . . . 0.422 ' HA ' ' CE1' ' C' ' 48' ' ' TYR . . . -67.22 0.1 3.02 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 120.645 -1.285 . . . . 0.0 113.315 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp 61.8 51.77 3.72 Favored 'General case' 0 C--O 1.266 1.921 0 C-N-CA 127.873 2.469 . . . . 0.0 111.403 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 88' ' ' VAL . . . . . 0.482 ' HA ' ' HD2' ' C' ' 89' ' ' PRO . 57.8 t -100.93 130.67 24.65 Favored Pre-proline 0 N--CA 1.444 -0.739 0 CA-C-N 112.855 -1.975 . . . . 0.0 106.164 172.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 89' ' ' PRO . . . . . 0.482 ' HD2' ' HA ' ' C' ' 88' ' ' VAL . 27.7 Cg_endo -55.4 111.19 0.68 Allowed 'Trans proline' 0 CA--C 1.509 -0.744 0 C-N-CA 124.889 3.726 . . . . 0.0 116.772 177.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.16 -16.49 20.42 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 108.992 -3.731 . . . . 0.0 118.289 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -69.58 -48.76 59.1 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-O 118.081 -0.962 . . . . 0.0 111.939 174.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 22.9 pt -70.86 -15.24 18.7 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-N 120.563 1.529 . . . . 0.0 114.738 174.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 93' ' ' VAL . . . . . 0.456 ' HA ' ' HB2' ' C' ' 66' ' ' PHE . 86.4 t -69.36 98.51 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-O 124.111 1.91 . . . . 0.0 106.721 167.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 19.2 mt -105.02 87.76 2.72 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 110.258 -3.155 . . . . 0.0 108.155 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 95' ' ' GLU . . . . . 0.765 ' HB3' HD13 ' A' 1157 ' ' ILE . 34.8 mp0 -69.1 103.91 2.01 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 111.349 -2.66 . . . . 0.0 109.865 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 92.9 mtp 56.96 25.93 11.21 Favored 'General case' 0 C--O 1.25 1.106 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 171.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -81.88 155.46 25.31 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 113.64 -1.618 . . . . 0.0 109.751 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -82.97 56.27 3.4 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 120.095 1.316 . . . . 0.0 109.353 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 99' ' ' ILE . . . . . 0.606 HG13 ' HB2' ' C' ' 102' ' ' ASP . 11.1 tp -74.46 41.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 O-C-N 117.28 -3.387 . . . . 0.0 111.902 173.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -76.85 -27.19 55.0 Favored 'General case' 0 C--O 1.217 -0.607 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -162.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.12 -44.82 87.46 Favored 'General case' 0 C--O 1.24 0.599 0 O-C-N 124.519 1.137 . . . . 0.0 110.274 174.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 102' ' ' ASP . . . . . 0.606 ' HB2' HG13 ' C' ' 99' ' ' ILE . 0.9 OUTLIER -65.42 -39.5 92.21 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 117.131 -1.414 . . . . 0.0 110.729 173.896 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 103' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -47.84 -56.5 7.33 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-N 123.042 2.655 . . . . 0.0 114.021 169.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.51 -35.89 77.04 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 123.674 0.79 . . . . 0.0 113.128 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -67.52 -39.35 85.07 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 121.221 -0.925 . . . . 0.0 111.568 175.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 106' ' ' THR . . . . . 0.432 ' HA ' ' HB2' ' C' ' 32' ' ' SER . 3.8 m -52.3 133.57 34.34 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-O 126.812 3.196 . . . . 0.0 113.577 -169.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 107' ' ' ASP . . . . . 0.437 ' OD2' ' HA ' ' C' ' 30' ' ' SER . 5.0 t0 -69.26 -70.41 0.28 Allowed 'General case' 0 C--N 1.3 -1.553 1 CA-C-N 107.035 -4.62 . . . . 0.0 108.635 171.656 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 8.4 m -121.19 124.99 46.05 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 120.949 1.704 . . . . 0.0 110.662 -174.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 109' ' ' VAL . . . . . . . . . . . . . 32.5 t -99.33 119.26 47.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 174.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 16.2 mt -95.89 85.35 4.06 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 122.765 1.269 . . . . 0.0 109.854 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 111' ' ' VAL . . . . . 0.42 ' HB ' ' HA ' ' C' ' 146' ' ' VAL . 11.8 t -81.52 103.8 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 177.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 112' ' ' ILE . . . . . 0.571 ' HA ' ' HD2' ' C' ' 147' ' ' PHE . 1.8 mm -81.34 106.45 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 O-C-N 118.164 -2.835 . . . . 0.0 109.142 -171.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 113' ' ' GLY . . . . . 0.936 ' HA3' ' HA3' ' C' ' 40' ' ' GLY . . . 89.22 -78.78 1.63 Allowed Glycine 0 CA--C 1.487 -1.669 0 CA-C-O 125.422 2.679 . . . . 0.0 111.863 170.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 114' ' ' ALA . . . . . 0.418 ' HB3' ' HA3' ' C' ' 38' ' ' GLY . . . -94.43 127.23 40.2 Favored 'General case' 0 C--O 1.21 -0.983 0 O-C-N 120.077 -1.837 . . . . 0.0 111.613 -162.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 115' ' ' ASN . . . . . 0.471 ' HB2' HD23 ' C' ' 162' ' ' LEU . 5.7 p-10 -66.42 -53.79 31.67 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 113.611 -1.631 . . . . 0.0 114.803 -178.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 116' ' ' ASP . . . . . 0.646 ' HA ' ' HB2' ' C' ' 119' ' ' ASN . 61.8 m-20 -65.75 -16.03 63.4 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 117.736 2.495 . . . . 0.0 117.736 -167.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 4.7 m -41.28 -44.85 2.79 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 127.175 2.797 . . . . 0.0 110.067 168.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.468 ' HA ' ' HB ' ' C' ' 135' ' ' VAL . 3.2 m -137.55 67.64 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.507 0 O-C-N 124.339 1.024 . . . . 0.0 108.679 169.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 119' ' ' ASN . . . . . 0.646 ' HB2' ' HA ' ' C' ' 116' ' ' ASP . 28.7 t-20 -87.6 119.56 70.72 Favored Pre-proline 0 C--O 1.26 1.658 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 120' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -60.88 -45.42 20.36 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.851 3.034 . . . . 0.0 110.995 -177.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.64 -14.41 62.05 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.32 -38.1 86.91 Favored 'General case' 0 CA--C 1.552 1.049 0 O-C-N 120.663 -1.273 . . . . 0.0 110.796 170.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 123' ' ' GLN . . . . . 0.718 ' HB2' HG22 ' C' ' 135' ' ' VAL . 22.9 tp60 -75.95 -50.24 15.5 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-O 122.263 1.03 . . . . 0.0 108.739 177.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -80.76 -45.08 17.6 Favored 'General case' 0 C--O 1.247 0.947 0 N-CA-C 120.196 3.406 . . . . 0.0 120.196 -173.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 125' ' ' ASP . . . . . 0.405 ' HA ' ' HD3' ' C' ' 126' ' ' PRO . 32.3 t70 -103.1 123.44 41.92 Favored Pre-proline 0 CA--C 1.55 0.958 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -162.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 126' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' C' ' 125' ' ' ASP . 1.5 Cg_exo -46.26 -31.99 9.94 Favored 'Trans proline' 0 CA--C 1.503 -1.061 0 C-N-CA 124.534 3.49 . . . . 0.0 118.347 175.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 127' ' ' LYS . . . . . 0.462 ' HB3' ' HE2' ' C' ' 127' ' ' LYS . 25.2 ttpt -69.51 -32.8 71.88 Favored 'General case' 0 C--N 1.317 -0.829 0 O-C-N 120.904 -1.123 . . . . 0.0 110.648 -174.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 128' ' ' SER . . . . . . . . . . . . . 13.4 m -56.66 133.4 78.1 Favored Pre-proline 0 N--CA 1.467 0.42 0 C-N-CA 125.254 1.422 . . . . 0.0 107.874 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 129' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -55.14 -46.03 36.1 Favored 'Trans proline' 0 C--O 1.221 -0.368 1 C-N-CA 125.464 4.11 . . . . 0.0 114.282 175.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 130' ' ' ILE . . . . . 0.657 ' HB ' ' HB2' ' C' ' 133' ' ' MET . 4.3 pt -86.9 66.54 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.405 0 O-C-N 119.507 -1.996 . . . . 0.0 107.385 170.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -74.3 111.87 9.9 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.429 -1.26 . . . . 0.0 109.048 -174.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.73 34.87 17.82 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 122.821 1.234 . . . . 0.0 111.863 -175.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 133' ' ' MET . . . . . 0.657 ' HB2' ' HB ' ' C' ' 130' ' ' ILE . 39.0 tpp -70.09 123.03 88.0 Favored Pre-proline 0 C--O 1.243 0.722 0 CA-C-N 113.476 -1.362 . . . . 0.0 109.915 173.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 134' ' ' PRO . . . . . 0.56 ' HD2' ' SD ' ' C' ' 133' ' ' MET . 89.0 Cg_endo -68.66 88.15 0.43 Allowed 'Trans proline' 0 N--CA 1.442 -1.536 0 C-N-CA 122.625 2.217 . . . . 0.0 112.198 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 135' ' ' VAL . . . . . 0.718 HG22 ' HB2' ' C' ' 123' ' ' GLN . 28.6 m -88.31 150.09 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-N 113.424 -1.716 . . . . 0.0 106.973 168.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 27.4 mt -77.71 111.57 13.64 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 102.318 -3.215 . . . . 0.0 102.318 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 137' ' ' GLU . . . . . 0.55 ' HB3' ' NE1' ' C' ' 139' ' ' TRP . 48.5 mt-10 -70.24 96.61 1.12 Allowed 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 123.39 1.567 . . . . 0.0 113.047 -155.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 14.8 p -85.28 110.35 19.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 125.177 2.418 . . . . 0.0 109.074 169.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 139' ' ' TRP . . . . . 0.55 ' NE1' ' HB3' ' C' ' 137' ' ' GLU . 76.3 m95 -129.97 138.49 50.88 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 118.945 -2.347 . . . . 0.0 105.308 174.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 140' ' ' LYS . . . . . . . . . . . . . 24.5 pttm 38.15 20.69 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.823 1 N-CA-C 123.057 4.466 . . . . 0.0 123.057 175.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.84 150.82 36.17 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 120.369 -1.457 . . . . 0.0 107.754 163.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 142' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' C' ' 167' ' ' ASN . 16.7 mt-30 -62.89 -42.88 99.93 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 117.12 2.267 . . . . 0.0 117.12 -160.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 143' ' ' ASN . . . . . 0.402 ' HB3' HG13 ' C' ' 145' ' ' ILE . 3.8 m-80 -140.33 120.83 14.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 121.339 1.881 . . . . 0.0 108.443 167.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 144' ' ' VAL . . . . . 0.686 ' HB ' ' HA ' ' C' ' 168' ' ' THR . 44.1 t -102.02 85.39 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 101.882 -3.377 . . . . 0.0 101.882 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 145' ' ' ILE . . . . . 0.402 HG13 ' HB3' ' C' ' 143' ' ' ASN . 26.3 mt -82.57 104.37 11.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 125.84 2.733 . . . . 0.0 110.507 -178.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 146' ' ' VAL . . . . . 0.639 HG21 ' HG ' ' C' ' 162' ' ' LEU . 47.8 t -97.77 109.07 22.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 110.711 -2.949 . . . . 0.0 105.083 178.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 147' ' ' PHE . . . . . 0.571 ' HD2' ' HA ' ' C' ' 112' ' ' ILE . 82.9 m-85 -71.59 82.01 0.83 Allowed 'General case' 0 C--O 1.258 1.528 0 O-C-N 120.472 -1.393 . . . . 0.0 111.293 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 148' ' ' LYS . . . . . 0.826 ' HD3' ' SD ' ' C' ' 170' ' ' MET . 28.5 mtpt -103.05 133.09 48.75 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 120.297 -1.502 . . . . 0.0 107.764 177.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 -72.2 -29.3 63.84 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 123.056 1.408 . . . . 0.0 111.793 -175.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 16.0 m -142.04 151.32 42.31 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.337 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -73.23 102.87 3.76 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 103.077 -2.934 . . . . 0.0 103.077 167.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 152' ' ' ASN . . . . . 0.409 ' OD1' ' NZ ' ' C' ' 148' ' ' LYS . 13.0 p-10 -152.72 164.06 38.49 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 23.8 m -53.38 159.0 1.51 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 130.044 3.337 . . . . 0.0 113.741 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -136.21 -137.34 3.66 Favored Glycine 0 C--O 1.249 1.034 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -87.66 -63.75 1.25 Allowed 'General case' 0 C--O 1.238 0.468 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 171.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 156' ' ' ALA . . . . . . . . . . . . . . . -76.0 -53.63 8.08 Favored 'General case' 0 C--N 1.364 1.229 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 166.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 67.33 -89.16 0.17 Allowed Glycine 0 N--CA 1.461 0.327 0 N-CA-C 106.822 -2.511 . . . . 0.0 106.822 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 158' ' ' VAL . . . . . 0.575 HG23 ' HB3' ' C' ' 160' ' ' ASN 0.385 35.1 m 46.3 148.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 120.84 3.644 . . . . 0.0 120.84 -176.002 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.9 83.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 O-C-N 121.159 -0.963 . . . . 0.0 109.477 173.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 160' ' ' ASN . . . . . 0.575 ' HB3' HG23 ' C' ' 158' ' ' VAL . 5.5 p30 -130.77 164.27 42.93 Favored Pre-proline 0 C--O 1.242 0.673 0 CA-C-O 117.472 -1.252 . . . . 0.0 110.616 -164.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -38.33 -51.08 2.17 Favored 'Trans proline' 0 N--CA 1.445 -1.375 0 C-N-CA 124.383 3.388 . . . . 0.0 117.893 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 162' ' ' LEU . . . . . 0.639 ' HG ' HG21 ' C' ' 146' ' ' VAL . 1.4 mp -50.46 -35.41 28.76 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 176.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 163' ' ' PHE . . . . . 0.41 ' HA ' ' HE2' ' C' ' 170' ' ' MET . 12.1 m-85 -73.63 -30.79 63.17 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -107.59 -51.42 2.91 Favored 'General case' 0 C--O 1.257 1.462 0 CA-C-O 123.142 1.448 . . . . 0.0 114.494 -169.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 4.9 mmtm -61.81 153.32 29.06 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 115.983 1.845 . . . . 0.0 115.983 -171.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -85.41 -45.29 12.01 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -164.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 167' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' C' ' 142' ' ' GLN . 27.4 p-10 -89.12 -42.44 11.69 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.186 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 168' ' ' THR . . . . . 0.686 ' HA ' ' HB ' ' C' ' 144' ' ' VAL . 56.2 m -89.44 77.47 7.31 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 106.789 -1.559 . . . . 0.0 106.789 177.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -136.09 135.07 39.03 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.71 -158.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 170' ' ' MET . . . . . 0.826 ' SD ' ' HD3' ' C' ' 148' ' ' LYS . 67.6 mtm -63.99 94.57 0.1 Allowed 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.227 -1.806 . . . . 0.0 107.173 163.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 171' ' ' LEU . . . . . . . . . . . . . 10.4 tp -79.38 117.45 20.37 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 172' ' ' PHE . . . . . 0.564 ' HA ' ' O ' ' C' ' 148' ' ' LYS . 57.7 m-85 -70.65 93.21 0.91 Allowed 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 110.716 -2.947 . . . . 0.0 114.386 -168.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -166.32 159.74 33.1 Favored Glycine 0 C--O 1.248 1.029 0 O-C-N 125.222 1.576 . . . . 0.0 109.664 176.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 174' ' ' ASP . . . . . 0.615 ' HB3' ' HB3' ' C' ' 177' ' ' ALA . 31.6 t70 -69.93 151.74 45.28 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 113.582 -1.309 . . . . 0.0 108.911 177.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 175' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' C' ' 44' ' ' ALA . . . -64.52 -49.04 72.84 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.164 -175.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.53 -47.81 37.99 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -176.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 177' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' C' ' 174' ' ' ASP . . . -56.3 -47.41 78.74 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 122.113 0.959 . . . . 0.0 113.204 -175.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 49.6 m -63.62 -36.23 83.12 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 176.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 179' ' ' VAL . . . . . 0.655 ' HA ' HG12 ' C' ' 182' ' ' ILE . 44.3 t -75.04 -39.56 44.22 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -52.71 -44.5 66.36 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.845 172.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -64.79 -52.09 58.72 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 119.131 -0.461 . . . . 0.0 111.914 174.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 182' ' ' ILE . . . . . 0.655 HG12 ' HA ' ' C' ' 179' ' ' VAL . 20.4 pt -64.79 -33.15 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 O-C-N 123.796 0.685 . . . . 0.0 111.45 -169.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 183' ' ' LEU . . . . . . . . . . . . . 4.0 pp -67.64 -36.29 80.49 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 124.138 0.975 . . . . 0.0 111.66 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -77.23 -48.04 18.6 Favored 'General case' 0 C--O 1.206 -1.215 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -69.79 -71.24 0.24 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 -171.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 186' ' ' LEU . . . . . 0.421 ' HA ' ' HB1' ' C' ' 24' ' ' ALA 0.313 0.9 OUTLIER . . . . . 0 N--CA 1.476 0.873 0 N-CA-C 116.555 2.057 . . . . 0.0 116.555 -155.791 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 1' ' ' NAD . . . . . 0.415 ' H1D' ' HB3' ' B' 1120 ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C 1001 ' ' NAP . . . . . 0.628 H52N ' HA ' ' C' ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 36.6 t-80 . . . . . 0 CA--C 1.508 -0.662 0 N-CA-C 105.874 -1.898 . . . . 65.739999999999995 105.874 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -61.83 76.86 0.02 OUTLIER Glycine 0 CA--C 1.538 1.497 0 N-CA-C 116.432 1.333 . . . . 48.659999999999997 116.432 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 26.5 ttp180 -118.71 138.03 52.92 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 123.394 1.568 . . . . 44.560000000000002 108.532 175.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1003 ' ' ILE . . . . . 0.472 HG12 HD13 ' A' 1068 ' ' ILE . 36.8 mt -106.65 129.75 59.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 102.253 -3.24 . . . . 34.859999999999999 102.253 -176.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -91.88 135.76 12.92 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 106.793 -2.523 . . . . 30.75 106.793 170.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.888 HG23 ' HB3' ' A' 1017 ' ' ALA . 19.5 mm -113.5 97.69 44.42 Favored Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 105.954 -1.869 . . . . 32.210000000000001 105.954 172.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -81.05 166.28 18.85 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 123.171 2.581 . . . . 32.979999999999997 114.275 170.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1007 ' ' ARG . . . . . 0.454 ' HB2' ' HA ' ' A' 1039 ' ' ALA . 6.5 tmm_? -85.31 140.05 31.12 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 113.066 -1.879 . . . . 47.979999999999997 106.071 167.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1008 ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -68.94 157.55 36.45 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 123.76 1.743 . . . . 34.700000000000003 113.774 -175.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -138.08 132.75 32.57 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 112.324 -2.216 . . . . 53.369999999999997 108.352 -171.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 10.8 tp 170.02 -177.24 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 102.96 -2.978 . . . . 45.07 102.96 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1011 ' ' THR . . . . . . . . . . . . . 11.0 m -72.01 114.5 10.18 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 122.745 2.521 . . . . 40.359999999999999 107.718 -174.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 4.3 m-20 64.53 43.58 4.38 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 113.712 1.004 . . . . 40.609999999999999 113.712 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -87.81 137.42 32.35 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 119.42 -0.912 . . . . 33.759999999999998 110.99 -171.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1014 ' ' THR . . . . . . . . . . . . . 19.9 p -103.24 -41.7 5.97 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 122.352 1.072 . . . . 27.890000000000001 113.038 -173.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1015 ' ' ARG . . . . . 0.565 ' HG3' ' HA2' ' A' 1317 ' ' GLY . 61.9 mtm180 -48.28 167.74 0.03 OUTLIER 'General case' 0 C--N 1.356 0.88 0 N-CA-C 120.083 3.364 . . . . 29.02 120.083 -173.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1016 ' ' VAL . . . . . 0.595 HG23 ' HB1' ' A' 1039 ' ' ALA . 7.7 p -132.12 162.52 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 113.454 -1.703 . . . . 28.129999999999999 106.712 171.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1017 ' ' ALA . . . . . 0.888 ' HB3' HG23 ' A' 1005 ' ' ILE . . . -66.47 -36.5 82.92 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 119.087 -2.258 . . . . 26.870000000000001 115.2 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -154.47 144.76 22.05 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 106.277 -1.749 . . . . 26.77 106.277 -174.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1019 ' ' THR . . . . . 0.405 HG21 HG23 ' A' 1321 ' ' THR . 1.7 p -98.5 170.74 6.6 Favored Pre-proline 0 N--CA 1.447 -0.583 0 CA-C-O 116.797 -1.573 . . . . 27.02 113.422 169.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1020 ' ' PRO . . . . . 0.401 ' HD3' ' CE1' ' A' 1050 ' ' PHE . 0.0 OUTLIER -29.45 -61.66 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 125.29 3.993 . . . . 30.57 120.024 173.796 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -66.85 -28.48 68.37 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 123.216 2.734 . . . . 47.810000000000002 110.842 -175.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1022 ' ' THR . . . . . . . . . . . . . 22.4 m -64.38 -47.98 77.19 Favored 'General case' 0 CA--C 1.554 1.118 0 O-C-N 121.621 -0.674 . . . . 30.77 110.178 169.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1023 ' ' VAL . . . . . . . . . . . . . 24.8 t -61.89 -38.6 80.99 Favored 'Isoleucine or valine' 0 C--O 1.254 1.33 0 O-C-N 120.996 -1.065 . . . . 33.590000000000003 109.043 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -64.56 -45.12 88.43 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 118.801 -1.16 . . . . 53.289999999999999 110.797 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1025 ' ' GLN . . . . . 0.619 ' HB3' HG11 ' A' 1332 ' ' VAL . 78.1 mt-30 -57.37 -40.15 77.54 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 118.762 0.71 . . . . 46.920000000000002 112.262 174.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1026 ' ' LEU . . . . . . . . . . . . . 74.7 mt -65.34 -34.67 78.86 Favored 'General case' 0 C--O 1.249 1.043 0 O-C-N 120.189 -1.57 . . . . 37.170000000000002 112.322 176.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 81.0 mt -70.87 -38.63 73.11 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.605 -0.887 . . . . 44.439999999999998 108.605 174.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -57.85 -36.74 72.75 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.972 0.805 . . . . 52.579999999999998 111.989 175.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1029 ' ' LEU . . . . . 0.54 ' HA ' ' HE2' ' A' 1342 ' ' LYS . 90.3 mt -60.97 -27.51 68.32 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 114.435 1.272 . . . . 45.689999999999998 114.435 170.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 93.2 32.27 7.94 Favored Glycine 0 C--O 1.242 0.614 0 O-C-N 121.23 -0.919 . . . . 42.090000000000003 113.111 -174.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -106.14 154.62 20.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 105.756 -1.942 . . . . 40.719999999999999 105.756 165.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1032 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.38 145.85 25.27 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 123.066 1.413 . . . . 37.770000000000003 109.42 172.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1033 ' ' VAL . . . . . . . . . . . . . 20.8 t -117.01 136.07 55.34 Favored 'Isoleucine or valine' 0 C--O 1.25 1.092 0 O-C-N 119.927 -1.733 . . . . 33.539999999999999 111.756 -172.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -119.79 140.52 50.63 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 108.156 -1.053 . . . . 31.68 108.156 170.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1035 ' ' VAL . . . . . . . . . . . . . 74.0 t -121.67 146.62 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 122.654 1.216 . . . . 31.52 109.387 178.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1036 ' ' GLU . . . . . 0.529 ' HB3' ' HB2' ' A' 1039 ' ' ALA . 34.3 tt0 -71.76 136.54 47.17 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 113.552 -1.658 . . . . 41.039999999999999 111.124 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1037 ' ' SER . . . . . . . . . . . . . 49.2 m -70.56 117.8 12.55 Favored 'General case' 0 C--O 1.246 0.883 0 N-CA-C 107.4 -1.333 . . . . 31.829999999999998 107.4 175.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 103.96 -7.24 48.48 Favored Glycine 0 C--O 1.219 -0.796 0 O-C-N 120.411 -1.431 . . . . 29.359999999999999 110.42 -174.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1039 ' ' ALA . . . . . 0.595 ' HB1' HG23 ' A' 1016 ' ' VAL . . . -68.69 -27.18 65.74 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 118.961 1.381 . . . . 27.780000000000001 112.089 -177.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -79.59 -32.57 37.2 Favored Glycine 0 N--CA 1.437 -1.27 0 CA-C-O 122.189 0.883 . . . . 28.91 112.604 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -47.59 -69.17 0.13 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.002 -1.599 . . . . 51.18 114.565 -171.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1042 ' ' LEU . . . . . . . . . . . . . 13.8 mt -77.22 -20.26 55.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.913 1.339 . . . . 29.91 111.869 -174.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1043 ' ' ALA . . . . . . . . . . . . . . . -82.22 -9.62 59.43 Favored 'General case' 0 C--O 1.243 0.759 0 O-C-N 120.419 -1.426 . . . . 28.539999999999999 113.153 171.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1044 ' ' SER . . . . . . . . . . . . . 7.9 m 56.33 63.92 1.85 Allowed 'General case' 0 C--N 1.361 1.1 0 O-C-N 126.715 2.509 . . . . 33.060000000000002 112.476 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1045 ' ' PHE . . . . . 0.556 ' HD1' ' HB3' ' B' 1277 ' ' ALA . 0.0 OUTLIER -159.78 75.15 0.62 Allowed 'General case' 0 C--N 1.315 -0.931 1 N-CA-C 98.682 -4.562 . . . . 30.289999999999999 98.682 162.332 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -62.46 150.63 39.52 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.762 -1.108 . . . . 48.619999999999997 113.621 -160.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1047 ' ' ASP . . . . . 0.534 ' HA ' ' HD2' ' A' 1050 ' ' PHE . 1.3 m-20 -46.09 -29.47 1.52 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 117.612 2.449 . . . . 36.740000000000002 117.612 -156.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 21.6 pttm -53.35 -33.91 55.44 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 112.956 0.724 . . . . 43.729999999999997 112.956 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -60.49 -35.94 77.13 Favored 'General case' 0 CA--C 1.522 -0.133 0 O-C-N 120.366 -1.459 . . . . 32.810000000000002 112.917 171.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1050 ' ' PHE . . . . . 0.534 ' HD2' ' HA ' ' A' 1047 ' ' ASP . 95.1 m-85 -72.1 -24.85 61.56 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 120.187 -1.571 . . . . 31.859999999999999 111.412 175.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 61.8 t -65.41 -47.32 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 118.236 -0.888 . . . . 33.219999999999999 109.435 170.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -56.35 -34.48 66.65 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.565 1.691 . . . . 50.829999999999998 115.565 171.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -74.41 -21.78 59.46 Favored 'General case' 0 C--O 1.25 1.117 0 N-CA-C 115.093 1.516 . . . . 33.119999999999997 115.093 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 101.34 83.22 1.72 Allowed Glycine 0 CA--C 1.526 0.752 0 C-N-CA 119.453 -1.356 . . . . 35.829999999999998 110.219 -177.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -150.58 138.65 20.14 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 119.44 -2.212 . . . . 34.82 115.159 176.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -66.4 121.17 14.68 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 105.511 -2.033 . . . . 49.049999999999997 105.511 165.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1057 ' ' ILE . . . . . . . . . . . . . 43.3 mm -100.03 118.2 46.33 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 O-C-N 119.649 -1.907 . . . . 38.530000000000001 107.732 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1058 ' ' VAL . . . . . . . . . . . . . 3.2 m -133.93 172.87 15.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 125.602 1.561 . . . . 42.109999999999999 111.119 -176.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -87.84 165.36 15.35 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 122.878 2.581 . . . . 58.0 108.202 173.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1060 ' ' GLY . . . . . 0.456 ' HA2' HG12 ' A' 1063 ' ' VAL . . . -49.53 -51.42 27.55 Favored Glycine 0 C--O 1.238 0.368 0 O-C-N 120.718 -1.239 . . . . 52.119999999999997 116.044 -172.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1061 ' ' ASN . . . . . 0.443 ' O ' ' HG2' ' A' 1065 ' ' GLN . 7.8 t30 -49.5 -40.27 36.97 Favored 'General case' 0 C--O 1.251 1.159 0 CA-C-O 122.092 0.948 . . . . 54.75 112.817 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1062 ' ' SER . . . . . . . . . . . . . 16.5 m -78.08 -35.82 48.92 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 119.984 -1.697 . . . . 50.340000000000003 114.608 173.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1063 ' ' VAL . . . . . 0.456 HG12 ' HA2' ' A' 1060 ' ' GLY . 1.1 p -64.62 -28.98 46.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 119.588 -1.945 . . . . 41.460000000000001 111.027 -178.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1064 ' ' TRP . . . . . 0.415 ' HB2' HD22 ' A' 1082 ' ' LEU . 59.6 m95 -80.67 -13.87 58.64 Favored 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 121.064 -1.022 . . . . 39.32 112.736 175.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1065 ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' 1061 ' ' ASN . 92.2 mm-40 -77.34 67.4 3.28 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 119.302 -2.124 . . . . 55.380000000000003 105.979 173.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1066 ' ' SER . . . . . . . . . . . . . 60.1 m -148.69 142.87 26.04 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 119.709 -1.87 . . . . 41.869999999999997 111.227 -170.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.78 -36.55 79.26 Favored 'General case' 0 N--CA 1.437 -1.104 0 O-C-N 125.671 1.857 . . . . 53.200000000000003 112.438 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1068 ' ' ILE . . . . . 0.472 HD13 HG12 ' A' 1003 ' ' ILE . 3.7 mp -121.9 144.47 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 106.515 -1.661 . . . . 41.899999999999999 106.515 176.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1069 ' ' ILE . . . . . 0.458 HG12 HG21 ' A' 1087 ' ' THR . 49.0 mm -130.63 129.24 64.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 N-CA-C 107.416 -1.328 . . . . 38.729999999999997 107.416 169.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1070 ' ' LEU . . . . . 0.411 ' HB2' ' HB1' ' A' 1017 ' ' ALA . 44.9 mt -97.17 143.81 27.62 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.256 -2.498 . . . . 32.439999999999998 104.256 175.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1071 ' ' LYS . . . . . 0.556 ' HB2' ' OG ' ' A' 1091 ' ' SER . 16.0 mmmt -148.12 130.51 15.7 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.647 0.779 . . . . 34.649999999999999 111.534 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1072 ' ' VAL . . . . . 0.516 HG13 ' CD2' ' A' 1327 ' ' TYR . 2.1 t -89.32 -13.96 9.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-N 114.86 -1.063 . . . . 31.32 113.747 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -112.89 -176.65 2.95 Favored 'General case' 0 C--O 1.248 1.018 0 N-CA-C 106.583 -1.636 . . . . 33.939999999999998 106.583 163.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -73.2 155.12 90.25 Favored Pre-proline 0 C--O 1.259 1.567 0 N-CA-C 109.043 -0.725 . . . . 38.039999999999999 109.043 161.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1075 ' ' PRO . . . . . 0.743 ' HG2' HD21 ' A' 1089 ' ' LEU . 3.9 Cg_exo -70.83 117.31 5.08 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 123.599 2.866 . . . . 42.68 114.621 168.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 86.8 mt -71.21 162.64 29.09 Favored 'General case' 0 N--CA 1.434 -1.251 0 O-C-N 125.838 1.961 . . . . 46.740000000000002 107.868 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1077 ' ' ASP . . . . . 0.468 ' HA ' HD12 ' A' 1080 ' ' ILE . 0.5 OUTLIER -42.73 -46.3 5.06 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 117.743 2.498 . . . . 58.609999999999999 117.743 -177.233 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 38.8 t70 -64.73 -41.33 96.04 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 113.567 0.951 . . . . 59.200000000000003 113.567 174.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1079 ' ' GLU . . . . . 0.596 ' HA ' HD12 ' A' 1082 ' ' LEU . 38.2 mt-10 -66.69 -32.96 74.61 Favored 'General case' 0 C--O 1.211 -0.956 0 N-CA-C 108.347 -0.983 . . . . 50.630000000000003 108.347 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1080 ' ' ILE . . . . . 0.636 ' HA ' HD23 ' A' 1083 ' ' LEU . 95.7 mt -59.6 -41.53 85.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 123.648 1.69 . . . . 51.479999999999997 110.728 175.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -62.62 -29.35 70.55 Favored 'General case' 0 C--O 1.211 -0.969 0 O-C-N 120.876 -1.14 . . . . 50.280000000000001 111.958 175.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1082 ' ' LEU . . . . . 0.596 HD12 ' HA ' ' A' 1079 ' ' GLU . 8.0 mt -70.47 -27.26 64.09 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 114.815 1.413 . . . . 50.210000000000001 114.815 173.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1083 ' ' LEU . . . . . 0.636 HD23 ' HA ' ' A' 1080 ' ' ILE . 1.3 mm? -64.16 123.95 20.41 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 122.817 1.294 . . . . 49.060000000000002 112.099 -176.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -89.81 141.24 28.15 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 104.807 -2.294 . . . . 51.079999999999998 104.807 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -56.81 148.26 67.51 Favored 'Trans proline' 0 CA--C 1.503 -1.031 0 C-N-CA 122.745 2.297 . . . . 49.729999999999997 116.035 -177.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 84.05 -14.11 45.76 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 113.887 -1.506 . . . . 47.710000000000001 113.658 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1087 ' ' THR . . . . . 0.458 HG21 HG12 ' A' 1069 ' ' ILE . 38.6 m -59.2 127.04 30.15 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 119.868 1.834 . . . . 45.469999999999999 113.293 -175.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1088 ' ' THR . . . . . . . . . . . . . 31.0 m -75.31 96.46 3.38 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 105.66 -1.978 . . . . 42.039999999999999 105.66 173.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1089 ' ' LEU . . . . . 0.743 HD21 ' HG2' ' A' 1075 ' ' PRO . 42.7 tp -89.09 113.36 24.5 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 113.301 -1.772 . . . . 38.060000000000002 108.028 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 3.3 t -108.37 109.06 26.89 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 N-CA-C 102.265 -3.235 . . . . 37.399999999999999 102.265 -173.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1091 ' ' SER . . . . . 0.556 ' OG ' ' HB2' ' A' 1071 ' ' LYS . 19.7 m -145.67 153.87 41.49 Favored 'General case' 0 C--O 1.224 -0.285 0 O-C-N 120.686 -1.259 . . . . 36.159999999999997 112.888 -166.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 2.8 t80 -84.67 91.03 7.83 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 105.727 -1.953 . . . . 38.939999999999998 105.727 172.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 26.5 mm -83.86 -49.57 16.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 115.37 1.619 . . . . 42.170000000000002 115.37 -172.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 96.4 m95 60.42 73.0 0.67 Allowed Pre-proline 0 C--O 1.255 1.366 0 C-N-CA 125.243 1.417 . . . . 46.509999999999998 111.021 -159.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -59.76 -38.39 80.9 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 124.754 3.636 . . . . 49.759999999999998 116.566 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -55.69 -47.44 76.78 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.618 -1.628 . . . . 52.619999999999997 110.824 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -64.77 -27.49 68.93 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 113.361 -1.745 . . . . 60.740000000000002 113.577 174.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1098 ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -123.32 56.96 10.34 Favored Pre-proline 0 N--CA 1.449 -0.478 0 N-CA-C 119.363 3.097 . . . . 58.189999999999998 119.363 -164.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -59.19 -47.67 16.6 Favored 'Trans proline' 0 N--CA 1.479 0.633 0 C-N-CA 123.399 2.732 . . . . 54.590000000000003 115.257 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1100 ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' 1104 ' ' LYS . 0.0 OUTLIER -61.38 -44.52 97.02 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 113.18 0.807 . . . . 63.280000000000001 113.18 177.837 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 1101 ' ' LEU . . . . . . . . . . . . . 8.2 tp -62.5 -46.26 89.26 Favored 'General case' 0 N--CA 1.441 -0.898 0 O-C-N 124.608 1.192 . . . . 54.75 107.853 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1102 ' ' MET . . . . . . . . . . . . . 49.8 mmm -53.98 -45.56 71.42 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 123.366 0.667 . . . . 52.649999999999999 112.054 175.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -62.11 -34.41 76.28 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 118.017 -0.992 . . . . 66.260000000000005 112.364 175.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1104 ' ' LYS . . . . . 0.453 ' HB3' HG21 ' A' 1080 ' ' ILE . 86.2 mttt -66.58 -46.62 75.38 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.891 -0.781 . . . . 63.729999999999997 108.891 175.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.01 -39.08 84.59 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 121.191 -0.943 . . . . 54.68 110.513 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -69.56 -38.8 77.59 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.397 -0.814 . . . . 53.640000000000001 111.308 176.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -71.85 -18.87 62.04 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 120.292 1.405 . . . . 67.239999999999995 112.186 177.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -77.55 -4.78 47.44 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 116.124 1.898 . . . . 65.760000000000005 116.124 163.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 5.2 t30 55.17 40.8 31.85 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 126.166 1.786 . . . . 58.710000000000001 111.532 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1110 ' ' VAL . . . . . 0.419 HG23 HG23 ' A' 1112 ' ' VAL . 30.8 m -98.27 153.67 4.01 Favored 'Isoleucine or valine' 0 C--N 1.344 0.357 0 O-C-N 121.24 -0.913 . . . . 46.630000000000003 113.007 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1111 ' ' THR . . . . . 0.415 HG23 ' HA ' ' A' 1362 ' ' ARG . 53.6 m -88.89 100.22 13.01 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 104.704 -2.332 . . . . 44.130000000000003 104.704 176.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1112 ' ' VAL . . . . . 0.483 HG22 HD23 ' A' 1089 ' ' LEU . 62.2 t -93.82 115.16 31.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 O-C-N 121.111 -0.993 . . . . 40.439999999999998 109.743 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1113 ' ' MET . . . . . 0.484 ' HB3' HG12 ' A' 1358 ' ' VAL . 19.3 mtp -101.24 102.42 13.3 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.033 -1.894 . . . . 50.759999999999998 108.564 173.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1114 ' ' ALA . . . . . 0.486 ' HB3' ' HB2' ' A' 1117 ' ' SER . . . -80.08 108.07 13.37 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 122.936 1.351 . . . . 35.640000000000001 108.88 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1115 ' ' MET . . . . . 0.558 ' SD ' HD22 ' A' 1334 ' ' LEU . 69.9 mmm -71.83 -20.71 61.79 Favored 'General case' 0 C--O 1.243 0.759 0 O-C-N 119.437 -2.04 . . . . 38.740000000000002 115.308 -174.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1116 ' ' ASP . . . . . 0.464 ' O ' HD12 ' A' 1130 ' ' LEU . 8.4 p-10 -66.08 -32.63 74.2 Favored 'General case' 0 C--O 1.246 0.915 0 CA-C-O 122.238 1.018 . . . . 40.140000000000001 109.289 164.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1117 ' ' SER . . . . . 0.486 ' HB2' ' HB3' ' A' 1114 ' ' ALA . 68.9 m -91.09 34.47 0.93 Allowed 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 117.14 2.274 . . . . 44.789999999999999 117.14 -176.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1118 ' ' VAL . . . . . . . . . . . . . 3.5 t -75.56 129.03 82.81 Favored Pre-proline 0 N--CA 1.439 -1.011 0 O-C-N 121.718 -0.614 . . . . 43.75 109.547 165.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -61.19 137.97 74.55 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.714 2.276 . . . . 48.93 111.795 172.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 25.1 mmm-85 -90.16 32.86 0.9 Allowed 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.204 -1.56 . . . . 62.899999999999999 111.546 -152.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 30.8 pt -79.89 155.63 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 O-C-N 118.492 -2.63 . . . . 57.719999999999999 112.198 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1122 ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -43.27 -58.99 2.27 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 120.653 3.575 . . . . 57.259999999999998 120.653 -177.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1123 ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' 1123 ' ' ARG 0.269 0.0 OUTLIER -60.09 -16.55 32.72 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 116.565 2.061 . . . . 62.899999999999999 116.565 175.027 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A 1124 ' ' ALA . . . . . 0.806 ' HB2' HG11 ' A' 1354 ' ' VAL . . . -80.41 -15.05 57.74 Favored 'General case' 0 N--CA 1.424 -1.755 0 O-C-N 118.67 -2.519 . . . . 49.829999999999998 113.472 177.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 69.6 mm-40 -66.99 -22.04 65.93 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 116.996 2.221 . . . . 52.369999999999997 116.996 -163.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1126 ' ' SER . . . . . . . . . . . . . 13.7 m -73.31 -19.18 61.09 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 115.174 1.546 . . . . 42.43 115.174 169.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1127 ' ' LEU . . . . . . . . . . . . . 2.7 mp -95.84 -30.64 13.56 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.591 -0.892 . . . . 43.740000000000002 108.591 173.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 65.6 t0 -65.06 106.91 1.37 Allowed 'General case' 0 C--O 1.247 0.954 0 CA-C-O 125.833 2.73 . . . . 43.210000000000001 112.045 -173.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1129 ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' 1115 ' ' MET . . . -85.08 -28.72 25.43 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 109.576 -3.465 . . . . 35.740000000000002 110.12 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1130 ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' 1116 ' ' ASP . 0.5 OUTLIER -66.82 -20.26 65.9 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-N 120.866 1.666 . . . . 38.090000000000003 109.107 177.133 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 1131 ' ' SER . . . . . 0.447 ' HB3' HG21 ' A' 1175 ' ' VAL . 65.4 m -82.5 -64.37 1.19 Allowed 'General case' 0 CA--C 1.545 0.766 0 O-C-N 119.413 -2.054 . . . . 36.909999999999997 110.327 161.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1132 ' ' SER . . . . . 0.538 ' O ' ' HB3' ' A' 1135 ' ' ASN . 19.4 m -66.92 -44.51 80.51 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 117.678 2.473 . . . . 35.789999999999999 117.678 -168.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1133 ' ' MET . . . . . 0.564 ' HA ' HD12 ' A' 1136 ' ' ILE . 5.2 ttt -68.37 -35.18 77.34 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 121.784 2.084 . . . . 30.809999999999999 110.624 176.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1134 ' ' ALA . . . . . . . . . . . . . . . -60.51 -40.82 92.79 Favored 'General case' 0 C--O 1.251 1.18 0 N-CA-C 109.143 -0.688 . . . . 28.879999999999999 109.143 173.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1135 ' ' ASN . . . . . 0.882 ' HB2' HG12 ' A' 1175 ' ' VAL . 1.8 t30 -53.8 -48.06 70.22 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.235 1.414 . . . . 40.759999999999998 112.285 175.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1136 ' ' ILE . . . . . 0.631 HD13 ' HA ' ' A' 1323 ' ' SER . 69.0 mt -57.87 -47.48 86.16 Favored 'Isoleucine or valine' 0 C--O 1.247 0.934 0 CA-C-N 114.388 -1.278 . . . . 31.539999999999999 110.985 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -60.83 -34.24 74.26 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.068 -1.423 . . . . 29.870000000000001 110.495 174.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -62.59 -48.5 81.17 Favored Glycine 0 C--O 1.211 -1.327 0 CA-C-N 119.296 0.953 . . . . 28.73 112.177 176.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 28.3 t80 -59.93 -42.06 93.15 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.596 -0.802 . . . . 30.390000000000001 110.317 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1140 ' ' ARG . . . . . 0.708 ' HD3' HD13 ' A' 1319 ' ' LEU . 1.1 tpt180 -73.34 -22.6 60.27 Favored 'General case' 0 CA--C 1.497 -1.066 0 O-C-N 124.445 1.091 . . . . 26.09 113.178 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1141 ' ' ALA . . . . . . . . . . . . . . . -66.62 -48.02 70.78 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 105.545 -2.02 . . . . 27.100000000000001 105.545 171.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 25.8 mm -53.66 -43.43 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 C-N-CA 125.442 1.497 . . . . 28.48 111.541 175.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 75.4 t -58.55 -61.68 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 O-C-N 120.653 -1.279 . . . . 23.07 110.113 173.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1144 ' ' GLU . . . . . 0.428 ' CD ' HH21 ' A' 1140 ' ' ARG . 5.7 mm-40 -62.42 -28.28 69.68 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 122.126 2.239 . . . . 33.399999999999999 114.137 -177.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1145 ' ' ALA . . . . . 0.78 ' HB1' HD12 ' A' 1251 ' ' ILE . . . -57.38 -60.47 3.59 Favored 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 124.668 1.187 . . . . 24.219999999999999 109.721 169.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -65.39 -20.49 66.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.554 0.692 . . . . 24.890000000000001 111.038 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -76.61 -33.53 58.39 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-O 115.511 -2.185 . . . . 26.73 110.725 177.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1148 ' ' GLU . . . . . 0.657 ' HB2' HD11 ' A' 1310 ' ' ILE . 40.0 mm-40 -110.16 3.38 20.09 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 122.221 2.282 . . . . 39.960000000000001 115.785 175.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1149 ' ' PHE . . . . . 0.613 ' CZ ' ' HB3' ' A' 1250 ' ' ASP . 0.9 OUTLIER -67.08 145.94 54.82 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 126.063 1.745 . . . . 25.870000000000001 110.448 -178.359 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 1150 ' ' GLY . . . . . . . . . . . . . . . -69.75 -45.18 59.59 Favored Glycine 0 N--CA 1.43 -1.732 0 O-C-N 121.308 -0.87 . . . . 19.280000000000001 113.504 171.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1151 ' ' ARG . . . . . 0.703 ' HA ' ' HB2' ' B' 1322 ' ' GLN . 69.7 mtm-85 -107.42 -173.79 2.37 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 124.362 1.065 . . . . 39.899999999999999 113.347 -166.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1152 ' ' PHE . . . . . 0.539 ' CD1' ' HG2' ' B' 1322 ' ' GLN . 5.3 m-30 -84.07 149.68 26.08 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 106.218 -1.771 . . . . 29.440000000000001 106.218 172.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1153 ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -64.95 -53.31 48.39 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 124.177 1.942 . . . . 32.600000000000001 110.18 152.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1154 ' ' THR . . . . . . . . . . . . 0.255 56.3 m -65.03 110.77 2.6 Favored 'General case' 0 C--O 1.249 1.068 0 CA-C-N 111.908 -2.406 . . . . 34.640000000000001 116.427 -174.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -64.07 138.85 41.89 Favored Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 109.579 -1.409 . . . . 37.140000000000001 109.579 163.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -173.63 158.84 3.45 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 122.53 1.157 . . . . 40.57 111.507 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1157 ' ' ILE . . . . . 0.52 HD13 ' HB2' ' C' ' 95' ' ' GLU . 6.5 tp -79.03 136.81 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 O-C-N 119.995 -1.691 . . . . 44.609999999999999 109.41 163.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1158 ' ' THR . . . . . 0.565 ' O ' ' HB3' ' C' ' 70' ' ' PRO . 68.7 p -111.28 -160.12 0.7 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 105.469 -2.049 . . . . 40.700000000000003 105.469 169.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1159 ' ' ALA . . . . . 0.54 ' HB1' ' HA ' ' B' 1126 ' ' SER . . . -83.28 -20.29 34.72 Favored 'General case' 0 CA--C 1.541 0.634 1 O-C-N 116.284 -4.01 . . . . 40.25 108.92 165.526 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -96.46 43.98 1.07 Allowed 'General case' 0 C--O 1.246 0.897 0 CA-C-O 123.32 1.533 . . . . 38.469999999999999 110.238 175.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . 74.97 -171.99 53.52 Favored Glycine 0 C--O 1.244 0.762 0 O-C-N 119.943 -1.723 . . . . 37.609999999999999 116.074 170.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -72.82 135.1 45.16 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 122.812 1.292 . . . . 48.899999999999999 112.186 -174.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1163 ' ' VAL . . . . . 0.527 HG11 ' HB2' ' A' 1152 ' ' PHE . 84.0 t -93.86 127.08 46.87 Favored Pre-proline 0 C--O 1.25 1.089 0 N-CA-C 104.398 -2.445 . . . . 36.520000000000003 104.398 162.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1164 ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.09 145.86 40.22 Favored 'Trans proline' 0 N--CA 1.444 -1.403 0 C-N-CA 124.615 3.544 . . . . 35.079999999999998 109.838 173.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1165 ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -62.01 147.13 95.75 Favored 'Trans proline' 0 C--O 1.245 0.833 0 C-N-CA 123.889 3.059 . . . . 35.329999999999998 109.713 172.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -78.64 135.41 37.21 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.736 1.014 . . . . 34.689999999999998 113.736 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1167 ' ' LYS . . . . . . . . . . . . . 44.3 mttp -84.24 100.02 10.93 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 102.263 -3.236 . . . . 45.359999999999999 102.263 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 59.9 t -91.38 88.27 2.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 114.793 -1.094 . . . . 31.710000000000001 110.241 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1169 ' ' MET . . . . . 0.498 ' HA ' ' O ' ' A' 1192 ' ' ARG . 37.2 ttp -77.2 107.04 9.3 Favored 'General case' 0 CA--C 1.498 -1.037 0 O-C-N 119.49 -2.006 . . . . 42.280000000000001 107.884 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 59.4 t -92.29 121.81 43.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 117.27 -1.348 . . . . 30.510000000000002 109.612 176.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 20.8 mt -107.36 131.37 57.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 104.609 -2.367 . . . . 31.870000000000001 104.609 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 82.22 61.77 1.97 Allowed Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 108.584 -1.807 . . . . 34.539999999999999 108.584 174.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1173 ' ' ALA . . . . . 0.557 ' HA ' ' HA3' ' A' 1177 ' ' GLY . . . -77.37 76.98 3.9 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 120.373 -1.663 . . . . 32.509999999999998 115.108 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -84.81 -160.77 32.72 Favored Glycine 0 C--O 1.219 -0.796 0 CA-C-O 116.774 -2.126 . . . . 29.899999999999999 110.25 156.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1175 ' ' VAL . . . . . 0.882 HG12 ' HB2' ' A' 1135 ' ' ASN . 48.3 t -64.63 -31.09 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 1 CA-C-N 124.977 4.389 . . . . 33.109999999999999 114.32 -176.655 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 1176 ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' 1135 ' ' ASN . . . -53.58 -47.58 69.98 Favored 'General case' 0 C--O 1.218 -0.559 0 O-C-N 121.885 -0.509 . . . . 28.100000000000001 111.602 165.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1177 ' ' GLY . . . . . 0.557 ' HA3' ' HA ' ' A' 1173 ' ' ALA . . . -63.71 -42.88 98.51 Favored Glycine 0 CA--C 1.507 -0.419 0 CA-C-O 118.846 -0.974 . . . . 28.539999999999999 111.759 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1178 ' ' LEU . . . . . 0.408 HD12 HG22 ' A' 1175 ' ' VAL . 52.4 mt -62.9 -35.19 79.25 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 117.462 -1.256 . . . . 31.219999999999999 110.698 177.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -64.61 -34.88 79.3 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 121.769 2.077 . . . . 28.98 112.374 172.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -67.81 -45.78 73.79 Favored 'General case' 0 C--O 1.253 1.25 0 CA-C-N 115.249 -0.887 . . . . 27.829999999999998 112.079 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1181 ' ' ILE . . . . . 0.573 HG12 HG11 ' A' 1191 ' ' VAL . 54.7 mt -57.32 -53.9 37.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.496 0 CA-C-N 114.93 -1.032 . . . . 30.25 109.07 175.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -52.72 -58.0 12.6 Favored Glycine 0 N--CA 1.471 1.005 0 O-C-N 125.161 1.538 . . . . 29.59 109.71 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -60.37 -48.78 80.29 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 115.338 1.607 . . . . 30.289999999999999 115.338 -175.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -69.75 -33.22 72.14 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 120.116 1.325 . . . . 30.469999999999999 114.394 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -65.99 -43.78 86.76 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.689 -0.856 . . . . 42.409999999999997 108.689 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1186 ' ' SER . . . . . . . . . . . . . 68.1 m -59.38 -48.18 82.61 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 121.073 -1.017 . . . . 39.380000000000003 112.586 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1187 ' ' LEU . . . . . 0.454 ' HA ' ' HB3' ' B' 1186 ' ' SER . 10.6 mt -53.43 -34.47 57.94 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 117.207 2.299 . . . . 36.18 117.207 170.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 105.36 52.38 0.82 Allowed Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 109.124 -1.591 . . . . 33.780000000000001 109.124 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -135.54 143.93 45.99 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 107.488 -1.301 . . . . 33.93 107.488 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 7.5 mt -79.57 106.85 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 103.111 -2.922 . . . . 38.740000000000002 103.111 -170.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1191 ' ' VAL . . . . . 0.573 HG11 HG12 ' A' 1181 ' ' ILE . 44.0 t -76.21 135.26 27.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 105.974 -1.861 . . . . 33.090000000000003 105.974 173.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1192 ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' 1169 ' ' MET . 95.0 mtt180 -126.4 87.01 2.6 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 102.741 -3.059 . . . . 38.920000000000002 102.741 176.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -95.59 154.56 17.15 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 120.33 -1.481 . . . . 35.32 111.794 -170.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 35.6 t80 -155.91 164.31 38.66 Favored 'General case' 0 C--O 1.25 1.115 0 O-C-N 124.557 1.161 . . . . 39.350000000000001 108.064 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1195 ' ' ASP . . . . . 0.44 ' HB2' ' H ' ' A' 1173 ' ' ALA . 10.6 t70 -164.77 162.63 21.22 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 104.492 -2.41 . . . . 40.460000000000001 104.492 174.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1196 ' ' THR . . . . . . . . . . . . . 5.6 m -58.36 -38.63 77.62 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.836 -1.075 . . . . 45.939999999999998 111.877 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1197 ' ' ARG . . . . . 0.45 ' HA ' ' HD2' ' A' 1198 ' ' PRO . 40.5 mtm180 -90.06 113.86 58.76 Favored Pre-proline 0 N--CA 1.449 -0.498 0 C-N-CA 126.191 1.796 . . . . 56.020000000000003 108.214 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1198 ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' 1197 ' ' ARG . 39.9 Cg_endo -55.1 -22.27 30.89 Favored 'Trans proline' 0 N--CA 1.435 -1.955 0 C-N-CA 125.202 3.935 . . . . 51.270000000000003 116.361 173.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -47.86 -41.0 23.03 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 116.539 2.051 . . . . 59.100000000000001 116.539 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 32.8 m -64.16 -9.29 5.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 116.095 1.887 . . . . 51.060000000000002 116.095 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 80.6 tttt -53.74 -40.81 66.45 Favored 'General case' 0 N--CA 1.436 -1.126 0 O-C-N 123.769 0.668 . . . . 57.380000000000003 111.908 -178.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.91 -47.51 71.11 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 115.444 1.646 . . . . 62.409999999999997 115.444 174.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -61.89 -43.41 98.91 Favored 'General case' 0 C--O 1.256 1.44 0 CA-C-O 123.37 1.557 . . . . 57.780000000000001 112.538 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 42.2 t -53.68 -57.24 5.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 112.571 -2.104 . . . . 46.380000000000003 109.0 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -70.53 -31.57 68.7 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 113.106 -1.861 . . . . 50.700000000000003 112.313 -177.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1206 ' ' SER . . . . . . . . . . . . . 66.8 m -70.7 -45.02 65.74 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 119.797 1.18 . . . . 49.979999999999997 111.328 -177.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1207 ' ' MET . . . . . . . . . . . . . 59.3 mtm -68.19 -34.18 75.8 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 122.723 1.249 . . . . 52.990000000000002 112.988 175.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 123.42 96.25 1.23 Allowed Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 107.56 -2.216 . . . . 47.659999999999997 107.56 171.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -168.12 160.19 11.62 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 120.788 -0.365 . . . . 44.770000000000003 110.188 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -85.62 145.91 27.11 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 102.894 -3.002 . . . . 47.640000000000001 102.894 170.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1211 ' ' PHE . . . . . . . . . . . . . 71.6 t80 -112.93 145.28 41.04 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 103.341 -2.837 . . . . 45.659999999999997 103.341 173.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 80.0 mt -71.14 108.54 4.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 123.369 1.557 . . . . 46.060000000000002 112.233 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -87.22 123.98 32.82 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 106.238 -1.764 . . . . 60.219999999999999 106.238 174.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 8.9 mp -90.34 144.81 25.48 Favored 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 115.259 1.577 . . . . 57.25 115.259 -176.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 35.6 t70 -71.59 83.56 0.85 Allowed 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 112.976 -1.92 . . . . 64.430000000000007 109.922 165.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 83.4 t80 . . . . . 0 C--O 1.216 -0.678 0 N-CA-C 102.38 -3.193 . . . . 66.900000000000006 102.38 -177.011 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 9.2 p-10 . . . . . 0 N--CA 1.437 -1.114 0 N-CA-C 106.779 -1.563 . . . . 39.090000000000003 106.779 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -49.33 -51.11 27.51 Favored Glycine 0 N--CA 1.474 1.185 0 C-N-CA 126.956 2.217 . . . . 39.32 112.943 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 60.3 t80 -64.86 -47.56 77.46 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 119.292 1.546 . . . . 39.299999999999997 111.739 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -63.91 -43.33 96.26 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 119.625 1.102 . . . . 36.299999999999997 113.105 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -57.07 -34.52 68.35 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 124.263 0.977 . . . . 37.380000000000003 112.144 174.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -63.43 -53.99 38.36 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 CA-C-N 121.106 1.775 . . . . 39.109999999999999 111.449 166.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1230 ' ' MET . . . . . . . . . . . . . 28.9 mmt -71.13 40.57 0.06 Allowed 'General case' 0 C--O 1.242 0.709 0 N-CA-C 113.706 1.002 . . . . 49.590000000000003 113.706 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1231 ' ' SER . . . . . . . . . . . . . 61.8 p -114.12 157.02 23.15 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 118.681 -2.512 . . . . 43.68 108.131 -174.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -55.11 -46.6 75.56 Favored 'General case' 0 C--N 1.356 0.865 0 CA-C-O 123.399 1.571 . . . . 55.57 110.289 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -70.76 -35.6 72.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 117.851 -1.071 . . . . 44.939999999999998 113.579 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 31.9 t80 -72.26 -48.44 42.61 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 122.535 2.425 . . . . 42.039999999999999 109.403 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 58.9 mt -64.3 -32.17 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 CA-C-N 118.645 0.657 . . . . 46.280000000000001 111.893 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 41.1 tttm -52.88 -53.72 44.91 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.783 -1.192 . . . . 47.869999999999997 107.783 167.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -62.85 -32.2 73.38 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 114.433 1.272 . . . . 41.609999999999999 114.433 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -54.43 -50.24 68.08 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 119.054 0.843 . . . . 50.649999999999999 112.614 165.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1239 ' ' MET . . . . . . . . . . . . . 34.3 mmt -61.15 -47.52 85.84 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 123.152 1.453 . . . . 48.869999999999997 110.075 -178.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -58.83 -40.08 83.15 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 112.949 -1.932 . . . . 54.799999999999997 109.613 175.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 3.5 mm? -75.19 -33.83 61.47 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 122.376 2.353 . . . . 43.210000000000001 112.453 176.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -69.81 -40.56 75.87 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 121.788 2.086 . . . . 38.659999999999997 109.681 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -64.73 -38.65 91.7 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 125.231 1.412 . . . . 37.920000000000002 111.464 171.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -63.69 -25.15 68.08 Favored 'General case' 0 C--O 1.246 0.882 0 O-C-N 120.026 -1.671 . . . . 37.280000000000001 112.567 171.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1245 ' ' GLN . . . . . 0.438 ' HG3' ' SD ' ' A' 1169 ' ' MET . 96.5 mm-40 -84.09 -32.15 24.93 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-O 118.548 -0.739 . . . . 43.07 111.83 176.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -49.92 -45.19 50.76 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 113.443 0.905 . . . . 38.299999999999997 113.443 -158.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1247 ' ' LYS . . . . . 0.49 ' HD2' ' H ' ' A' 1247 ' ' LYS . 0.4 OUTLIER -80.38 -11.53 59.69 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 119.423 -2.048 . . . . 47.600000000000001 111.757 -172.741 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -106.88 -31.65 8.26 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 118.548 -0.739 . . . . 45.420000000000002 110.672 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1249 ' ' VAL . . . . . . . . . . . . 0.307 12.2 m -68.45 152.86 9.26 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 N-CA-C 117.658 2.466 . . . . 36.259999999999998 117.658 -172.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1250 ' ' ASP . . . . . 0.613 ' HB3' ' CZ ' ' A' 1149 ' ' PHE . 12.2 m-20 -113.74 -54.77 2.58 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 112.636 -2.074 . . . . 33.039999999999999 109.274 -171.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1251 ' ' ILE . . . . . 0.78 HD12 ' HB1' ' A' 1145 ' ' ALA . 25.8 mm -124.13 122.8 65.2 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.692 0 N-CA-C 101.644 -3.465 . . . . 31.399999999999999 101.644 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1252 ' ' ILE . . . . . 0.508 HG21 HD11 ' A' 1267 ' ' ILE . 55.5 mt -99.72 127.47 52.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 103.579 -2.749 . . . . 29.420000000000002 103.579 161.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1253 ' ' VAL . . . . . 0.567 HG12 HG23 ' A' 1255 ' ' THR . 11.2 t -110.87 104.73 17.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 1 N-CA-C 100.141 -4.022 . . . . 30.370000000000001 100.141 176.923 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 1254 ' ' THR . . . . . 0.41 HG23 HG22 ' A' 1252 ' ' ILE . 0.6 OUTLIER -88.91 84.77 6.64 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-O 125.619 2.628 . . . . 35.719999999999999 111.971 -179.658 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 1255 ' ' THR . . . . . 0.601 HG22 HD13 ' A' 1284 ' ' LEU . 14.6 p -95.09 12.68 27.76 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 110.765 -2.925 . . . . 36.0 116.748 -176.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1256 ' ' ALA . . . . . 0.418 ' HB3' HD21 ' A' 1291 ' ' ASN . . . -83.97 67.4 9.62 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 120.909 1.686 . . . . 40.93 112.011 -176.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 37.3 tp -82.24 99.27 9.2 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 106.561 -1.644 . . . . 47.82 106.561 176.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1258 ' ' ILE . . . . . 0.474 ' HA ' ' HD2' ' A' 1259 ' ' PRO . 30.8 mm -75.87 139.65 70.02 Favored Pre-proline 0 N--CA 1.433 -1.32 0 N-CA-C 108.071 -1.085 . . . . 52.700000000000003 108.071 -175.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1259 ' ' PRO . . . . . 0.474 ' HD2' ' HA ' ' A' 1258 ' ' ILE . 29.0 Cg_endo -59.78 114.04 1.9 Allowed 'Trans proline' 0 CA--C 1.512 -0.597 0 C-N-CA 122.573 2.182 . . . . 54.130000000000003 112.719 169.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 80.91 -75.47 2.27 Favored Glycine 0 C--O 1.255 1.44 0 N-CA-C 107.047 -2.421 . . . . 54.619999999999997 107.047 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 89.9 mttt -51.03 140.38 21.25 Favored Pre-proline 0 C--O 1.252 1.225 0 C-N-CA 126.064 1.746 . . . . 55.740000000000002 112.072 -177.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -56.64 136.29 75.21 Favored 'Trans proline' 0 N--CA 1.44 -1.634 1 C-N-CA 125.311 4.008 . . . . 51.149999999999999 111.043 176.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1263 ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' 1264 ' ' PRO . . . -54.98 130.81 67.49 Favored Pre-proline 0 N--CA 1.47 0.538 0 CA-C-O 121.791 0.805 . . . . 46.060000000000002 110.718 170.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1264 ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' 1263 ' ' ALA . 76.1 Cg_exo -56.5 129.2 33.46 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 124.565 3.51 . . . . 41.079999999999998 110.68 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -77.6 70.15 3.94 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 124.923 2.297 . . . . 47.420000000000002 111.874 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 61.0 mt -69.91 -58.53 3.75 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 109.572 -3.467 . . . . 39.219999999999999 110.75 -164.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1267 ' ' ILE . . . . . 0.508 HD11 HG21 ' A' 1252 ' ' ILE . 31.9 mt -83.78 106.26 14.07 Favored 'Isoleucine or valine' 0 C--O 1.246 0.918 0 N-CA-C 106.987 -1.486 . . . . 42.5 106.987 -174.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1268 ' ' THR . . . . . . . . . . . . . 38.5 p -67.55 156.15 37.43 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 115.83 -0.623 . . . . 37.840000000000003 111.562 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -55.32 -34.73 64.43 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.513 -0.551 . . . . 54.799999999999997 109.513 171.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -48.73 -54.65 14.09 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 113.403 0.89 . . . . 54.359999999999999 113.403 166.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1271 ' ' MET . . . . . . . . . . . . . 26.5 mtm -68.23 -35.52 78.08 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.833 0.679 . . . . 39.520000000000003 112.833 -177.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1272 ' ' VAL . . . . . 0.422 HG12 HG21 ' A' 1303 ' ' THR . 79.2 t -62.82 -51.89 66.33 Favored 'Isoleucine or valine' 0 C--O 1.25 1.13 0 N-CA-C 106.611 -1.626 . . . . 38.25 106.611 178.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.05 -33.48 67.28 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 117.776 2.51 . . . . 40.770000000000003 117.776 170.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1274 ' ' SER . . . . . . . . . . . . . 41.0 m -80.39 -3.06 48.23 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 113.273 0.842 . . . . 36.579999999999998 113.273 174.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1275 ' ' MET . . . . . . . . . . . . . 16.2 mtp -69.31 158.63 34.67 Favored 'General case' 0 CA--C 1.51 -0.583 0 O-C-N 118.705 -2.497 . . . . 36.75 116.706 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1276 ' ' LYS . . . . . 0.446 ' HE3' ' NH2' ' A' 1151 ' ' ARG . 39.5 ttpt -65.21 139.65 58.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 124.343 2.021 . . . . 46.109999999999999 108.006 168.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1277 ' ' ALA . . . . . 0.628 ' HB1' ' HA ' ' B' 1045 ' ' PHE 0.253 . . -75.64 157.85 33.18 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 108.588 -3.915 . . . . 33.520000000000003 109.889 -179.37 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 73.21 24.1 76.2 Favored Glycine 0 C--N 1.347 1.167 0 N-CA-C 110.917 -0.873 . . . . 31.27 110.917 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1279 ' ' SER . . . . . 0.43 ' HB3' ' O ' ' A' 1250 ' ' ASP . 22.7 m -122.22 169.65 10.69 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.734 -0.733 . . . . 32.950000000000003 110.971 -171.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1280 ' ' VAL . . . . . 0.72 HG11 ' HA ' ' A' 1145 ' ' ALA . 42.5 t -132.11 141.92 44.16 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 N-CA-C 108.347 -0.983 . . . . 27.43 108.347 -171.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1281 ' ' ILE . . . . . 0.466 HG12 HD12 ' A' 1252 ' ' ILE . 84.9 mt -114.44 102.32 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 1 N-CA-C 99.335 -4.32 . . . . 30.300000000000001 99.335 164.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -87.91 96.44 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 CA-C-O 123.21 1.481 . . . . 28.629999999999999 107.343 172.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 4.9 t70 -87.76 100.01 12.52 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 113.989 -1.459 . . . . 36.270000000000003 110.941 -175.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1284 ' ' LEU . . . . . 0.601 HD13 HG22 ' A' 1255 ' ' THR . 5.5 tt -74.27 -34.57 63.62 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 123.664 1.697 . . . . 38.57 108.42 177.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -63.42 -13.45 40.18 Favored 'General case' 0 CA--C 1.508 -0.665 0 O-C-N 120.478 -1.389 . . . . 37.560000000000002 113.84 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . -34.19 -38.39 0.06 Allowed 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 121.674 3.953 . . . . 40.329999999999998 121.674 175.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -66.63 -22.74 66.11 Favored 'General case' 0 C--N 1.345 0.4 0 C-N-CA 118.662 -1.215 . . . . 56.850000000000001 113.88 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 30.2 t30 -142.06 86.99 2.01 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.145 -1.428 . . . . 45.859999999999999 107.145 177.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 106.16 -67.84 0.24 Allowed Glycine 0 CA--C 1.492 -1.361 0 C-N-CA 120.054 -1.07 . . . . 40.310000000000002 111.494 175.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 86.08 111.27 0.8 Allowed Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 105.769 -2.933 . . . . 38.890000000000001 105.769 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1291 ' ' ASN . . . . . 0.418 HD21 ' HB3' ' A' 1256 ' ' ALA . 27.1 m120 -70.68 -22.93 62.42 Favored 'General case' 0 C--O 1.223 -0.309 0 O-C-N 120.183 -1.775 . . . . 37.229999999999997 113.393 -171.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1292 ' ' CYS . . . . . 0.54 ' HB3' ' OG1' ' A' 1295 ' ' THR . 35.6 t -89.46 143.81 26.53 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 104.335 -2.468 . . . . 36.5 104.335 171.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1293 ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -77.14 -21.21 54.49 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 123.402 1.572 . . . . 43.32 112.425 174.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.92 10.98 12.41 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 116.958 2.207 . . . . 41.32 116.958 170.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1295 ' ' THR . . . . . 0.54 ' OG1' ' HB3' ' A' 1292 ' ' CYS . 89.9 m -68.82 113.97 6.74 Favored 'General case' 0 C--O 1.25 1.092 0 O-C-N 118.282 -2.761 . . . . 35.299999999999997 110.579 -175.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 10.4 t -84.19 116.06 63.12 Favored Pre-proline 0 N--CA 1.449 -0.505 0 N-CA-C 107.28 -1.378 . . . . 34.840000000000003 107.28 169.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.87 98.66 0.71 Allowed 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 122.866 2.377 . . . . 33.509999999999998 111.944 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 115.06 13.32 9.25 Favored Glycine 0 N--CA 1.432 -1.618 0 CA-C-N 114.316 -1.311 . . . . 32.189999999999998 112.874 170.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -159.21 168.69 25.88 Favored 'General case' 0 N--CA 1.435 -1.213 0 O-C-N 120.289 -1.712 . . . . 34.880000000000003 108.958 -174.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1300 ' ' ILE . . . . . 0.578 HD13 ' HG3' ' A' 1148 ' ' GLU . 48.4 mt -89.32 115.36 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 104.284 -2.487 . . . . 32.289999999999999 104.284 175.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 52.9 t80 -85.83 150.15 24.75 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 105.777 -1.934 . . . . 37.25 105.777 162.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1302 ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' 1307 ' ' VAL . 88.5 m -135.16 122.15 21.26 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 119.294 0.952 . . . . 35.560000000000002 109.16 174.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1303 ' ' THR . . . . . 0.422 HG21 HG12 ' A' 1272 ' ' VAL . 1.2 p -74.67 160.77 30.38 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 122.289 1.043 . . . . 36.399999999999999 111.575 173.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -68.23 -22.73 64.77 Favored 'General case' 0 C--O 1.249 1.069 0 O-C-N 120.376 -1.453 . . . . 52.32 111.747 -174.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1305 ' ' ASN . . . . . 0.875 ' HA ' ' HB2' ' B' 1046 ' ' ASP . 52.8 p-10 -75.41 -10.64 59.63 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 118.402 -0.809 . . . . 40.039999999999999 110.82 175.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 94.15 43.74 3.71 Favored Glycine 0 N--CA 1.432 -1.625 0 O-C-N 124.085 0.865 . . . . 36.960000000000001 111.5 175.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1307 ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' 1302 ' ' THR . 76.8 t -108.55 123.71 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 117.746 -1.582 . . . . 33.399999999999999 107.567 168.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1308 ' ' LYS . . . . . 0.573 ' HB2' HG22 ' A' 1280 ' ' VAL . 32.1 mmtt -86.29 98.4 10.94 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 121.878 0.847 . . . . 42.909999999999997 109.144 176.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 7.7 t -84.44 86.53 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 104.73 -2.322 . . . . 32.289999999999999 104.73 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1310 ' ' ILE . . . . . 0.657 HD11 ' HB2' ' A' 1148 ' ' GLU . 33.9 mt -81.98 92.26 2.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 113.691 -1.595 . . . . 30.989999999999998 109.582 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -85.96 53.86 4.7 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 113.452 -1.704 . . . . 28.949999999999999 113.153 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1312 ' ' TYR . . . . . 0.535 ' O ' ' HG ' ' A' 1315 ' ' LEU . 1.4 m-30 -87.67 104.61 16.69 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 125.355 2.503 . . . . 31.690000000000001 107.233 -171.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1313 ' ' THR . . . . . . . . . . . . . 33.9 p -66.26 -42.56 88.35 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 110.815 -2.902 . . . . 34.170000000000002 111.113 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -68.34 8.27 0.48 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 111.79 -2.459 . . . . 36.859999999999999 116.981 -177.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1315 ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' 1312 ' ' TYR . 96.2 mt -45.4 -39.18 9.19 Favored Pre-proline 0 N--CA 1.478 0.945 0 O-C-N 118.345 -2.722 . . . . 34.850000000000001 116.498 177.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -56.14 -46.18 32.78 Favored 'Trans proline' 0 C--O 1.247 0.95 0 C-N-CA 123.064 2.509 . . . . 29.149999999999999 113.842 168.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1317 ' ' GLY . . . . . 0.565 ' HA2' ' HG3' ' A' 1015 ' ' ARG . . . -60.35 -43.74 98.31 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-N 114.058 -1.428 . . . . 27.289999999999999 110.951 178.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1318 ' ' ARG . . . . . 0.508 ' HB3' ' CZ ' ' A' 1140 ' ' ARG . 85.3 mtt-85 -62.37 -29.17 70.28 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 122.027 0.918 . . . . 41.490000000000002 113.233 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1319 ' ' LEU . . . . . 0.708 HD13 ' HD3' ' A' 1140 ' ' ARG . 3.9 tp -108.05 68.61 0.3 Allowed Pre-proline 0 N--CA 1.439 -0.982 0 O-C-N 120.002 -1.686 . . . . 27.609999999999999 111.074 168.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1320 ' ' PRO . . . . . 0.612 ' HD2' ' HA2' ' B' 1150 ' ' GLY . 95.8 Cg_endo -62.6 -58.25 0.36 Allowed 'Trans proline' 0 CA--C 1.499 -1.233 0 C-N-CA 124.553 3.502 . . . . 25.940000000000001 111.963 -163.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1321 ' ' THR . . . . . 0.405 HG23 HG21 ' A' 1019 ' ' THR . 1.8 m -60.55 -28.88 68.78 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 120.512 1.505 . . . . 25.010000000000002 110.178 -174.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1322 ' ' GLN . . . . . 0.679 ' HB2' ' HA ' ' B' 1151 ' ' ARG . 9.4 tp60 -79.79 -33.87 40.12 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 117.618 -1.182 . . . . 29.390000000000001 110.002 -176.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1323 ' ' SER . . . . . 0.631 ' HA ' HD13 ' A' 1136 ' ' ILE . 31.6 m -57.17 -56.18 25.09 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 119.902 1.228 . . . . 26.469999999999999 108.536 165.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1324 ' ' SER . . . . . . . . . . . . . 14.9 m -65.31 -21.67 66.74 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 122.136 0.969 . . . . 27.780000000000001 113.501 -172.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -93.12 -55.41 3.34 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 115.939 -1.981 . . . . 37.530000000000001 111.138 173.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1326 ' ' LEU . . . . . 0.55 ' HB2' HD11 ' A' 1136 ' ' ILE . 93.0 mt -71.6 -56.44 5.86 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 122.193 2.27 . . . . 35.710000000000001 112.552 -178.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1327 ' ' TYR . . . . . 0.516 ' CD2' HG13 ' A' 1072 ' ' VAL . 86.0 t80 -58.71 -42.45 88.68 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 119.37 0.986 . . . . 31.59 108.933 172.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1328 ' ' GLY . . . . . 0.806 ' HA2' HD12 ' A' 1331 ' ' LEU . . . -46.21 -50.51 12.82 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-N 118.44 0.564 . . . . 28.0 112.197 169.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1329 ' ' THR . . . . . . . . . . . . . 34.6 m -71.25 -20.95 62.17 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-O 117.771 -1.109 . . . . 32.149999999999999 112.258 174.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1330 ' ' ASN . . . . . 0.417 ' OD1' ' HB2' ' A' 1132 ' ' SER . 13.7 m120 -62.18 -46.17 90.13 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 124.755 3.434 . . . . 34.359999999999999 109.73 170.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1331 ' ' LEU . . . . . 0.806 HD12 ' HA2' ' A' 1328 ' ' GLY . 15.7 mt -57.01 -52.18 66.31 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-N 113.159 -1.837 . . . . 33.369999999999997 112.689 176.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1332 ' ' VAL . . . . . 0.619 HG11 ' HB3' ' A' 1025 ' ' GLN . 45.6 t -63.5 -42.25 95.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 105.388 -2.078 . . . . 35.270000000000003 105.388 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1333 ' ' ASN . . . . . 0.499 ' HA ' ' HD2' ' A' 1336 ' ' LYS . 92.1 m-20 -59.81 -37.08 78.14 Favored 'General case' 0 CA--C 1.504 -0.794 0 O-C-N 119.534 -1.979 . . . . 37.659999999999997 113.562 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1334 ' ' LEU . . . . . 0.558 HD22 ' SD ' ' A' 1115 ' ' MET . 43.1 tp -60.03 -52.96 63.14 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.289 -0.634 . . . . 40.270000000000003 109.289 165.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1335 ' ' LEU . . . . . 0.511 HD23 HD22 ' A' 1338 ' ' LEU . 19.0 mt -63.8 -18.15 63.81 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 115.308 1.596 . . . . 42.5 115.308 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1336 ' ' LYS . . . . . 0.499 ' HD2' ' HA ' ' A' 1333 ' ' ASN . 78.8 mttt -69.36 -36.38 76.79 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 120.341 -1.474 . . . . 47.810000000000002 109.198 172.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1337 ' ' LEU . . . . . . . . . . . . . 10.2 mp -70.33 -40.33 74.2 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 122.864 1.316 . . . . 49.270000000000003 111.831 170.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1338 ' ' LEU . . . . . 0.511 HD22 HD23 ' A' 1335 ' ' LEU . 3.1 mp -67.83 -47.6 68.54 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 116.793 2.146 . . . . 50.539999999999999 116.793 -177.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1339 ' ' CYS . . . . . 0.493 ' SG ' ' HA2' ' A' 1344 ' ' GLY . 41.1 t -83.21 100.31 10.5 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 102.639 -3.097 . . . . 53.670000000000002 102.639 175.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 28.5 mtpt -84.04 -70.37 0.57 Allowed 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 118.878 -2.389 . . . . 63.380000000000003 111.883 -177.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1341 ' ' GLU . . . . . 0.542 ' HB2' ' HB3' ' A' 1343 ' ' ASP . 4.3 mp0 -72.7 -15.35 61.69 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.25 0.833 . . . . 70.950000000000003 113.25 -171.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1342 ' ' LYS . . . . . 0.57 ' HA ' ' H ' ' A' 1344 ' ' GLY . 9.3 mtpm? 49.11 58.11 5.73 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 116.892 -1.528 . . . . 65.25 111.77 -173.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1343 ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' A' 1341 ' ' GLU 0.404 0.0 OUTLIER 63.72 -78.04 0.03 OUTLIER 'General case' 0 C--N 1.356 0.874 2 O-C-N 113.242 -5.911 . . . . 64.530000000000001 114.817 21.309 . . . . . . . . 5 4 . 1 . 003 nuclear build full ' A' A 1344 ' ' GLY . . . . . 0.57 ' H ' ' HA ' ' A' 1342 ' ' LYS . . . 71.58 52.04 14.05 Favored Glycine 0 C--O 1.217 -0.952 0 CA-C-N 120.908 1.685 . . . . 59.719999999999999 111.607 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 44.3 t30 -146.73 155.08 42.13 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 119.799 1.799 . . . . 64.090000000000003 106.663 172.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1346 ' ' ILE . . . . . . . . . . . . . 34.4 mt -88.94 124.05 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 CA-C-O 124.48 2.086 . . . . 58.82 112.121 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1347 ' ' THR . . . . . . . . . . . . . 33.7 m -100.63 109.54 21.61 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 110.392 -3.095 . . . . 54.960000000000001 107.683 167.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1348 ' ' VAL . . . . . . . . . . . . . 34.4 t -85.19 82.39 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 N-CA-C 106.173 -1.788 . . . . 55.640000000000001 106.173 176.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 24.2 t0 -78.36 106.25 10.16 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 112.766 -2.015 . . . . 61.450000000000003 115.449 -175.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -82.66 -13.07 57.09 Favored 'General case' 0 C--O 1.246 0.921 0 CA-C-N 112.472 -2.149 . . . . 58.630000000000003 112.751 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -65.12 -47.14 78.21 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 120.904 -1.122 . . . . 62.060000000000002 109.73 172.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 10.3 t70 -65.44 108.71 2.06 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 123.271 1.51 . . . . 54.07 108.994 174.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 22.1 m -43.82 -37.24 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.765 0 N-CA-C 117.614 2.449 . . . . 50.68 117.614 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1354 ' ' VAL . . . . . 0.806 HG11 ' HB2' ' A' 1124 ' ' ALA 0.261 5.4 m -79.72 -43.75 23.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-O 118.099 -0.953 . . . . 47.68 110.374 179.61 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 1355 ' ' ILE . . . . . . . . . . . . . 80.4 mt -60.76 -45.1 98.39 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 121.58 1.991 . . . . 48.490000000000002 109.612 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 40.7 tpt85 -43.23 -50.52 6.43 Favored 'General case' 0 C--O 1.249 1.069 0 N-CA-C 115.986 1.847 . . . . 48.270000000000003 115.986 163.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -61.15 -50.71 64.29 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.86 -0.967 . . . . 43.530000000000001 112.834 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1358 ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' 1354 ' ' VAL . 21.2 t -60.58 -49.38 84.66 Favored 'Isoleucine or valine' 0 C--O 1.249 1.059 0 N-CA-C 106.202 -1.777 . . . . 45.119999999999997 106.202 -173.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1359 ' ' THR . . . . . . . . . . . . . 6.0 m -69.01 87.84 0.38 Allowed 'General case' 0 C--N 1.313 -0.98 0 O-C-N 120.581 -1.325 . . . . 42.939999999999998 108.626 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 30.9 m -77.68 -23.74 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 CA-C-N 114.865 -1.061 . . . . 43.259999999999998 110.971 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1361 ' ' ILE . . . . . 0.494 HG12 HG12 ' A' 1366 ' ' ILE . 73.4 mt -135.58 119.02 23.91 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 N-CA-C 105.567 -2.012 . . . . 45.659999999999997 105.567 172.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1362 ' ' ARG . . . . . 0.415 ' HA ' HG23 ' A' 1111 ' ' THR . 33.3 ttt180 -100.65 110.3 22.42 Favored 'General case' 0 C--O 1.219 -0.525 0 O-C-N 119.172 -2.205 . . . . 61.340000000000003 106.584 167.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 31.87 79.0 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 O-C-N 126.388 2.305 . . . . 49.759999999999998 112.135 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 83.25 -40.54 2.84 Favored Glycine 0 CA--C 1.521 0.457 0 CA-C-O 118.59 -1.116 . . . . 50.0 112.645 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -77.05 111.0 12.16 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 105.87 -1.9 . . . . 56.920000000000002 105.87 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1366 ' ' ILE . . . . . 0.494 HG12 HG12 ' A' 1361 ' ' ILE . 66.0 mt -70.11 106.53 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 104.406 -2.442 . . . . 52.780000000000001 104.406 173.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1367 ' ' THR . . . . . . . . . . . . . 2.0 p -88.41 -4.9 58.56 Favored 'General case' 0 CA--C 1.496 -1.124 0 N-CA-C 114.901 1.445 . . . . 49.439999999999998 114.901 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 1.7 t90 -70.73 148.62 95.0 Favored Pre-proline 0 C--O 1.248 1.016 0 N-CA-C 106.701 -1.592 . . . . 52.380000000000003 106.701 166.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -65.43 156.07 77.89 Favored 'Cis proline' 0 CA--C 1.498 -1.321 0 CA-C-N 124.96 2.807 . . . . 46.939999999999998 116.32 -7.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -112.04 151.84 43.88 Favored Pre-proline 0 N--CA 1.442 -0.858 0 CA-C-N 113.342 -1.754 . . . . 45.909999999999997 110.195 -175.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1371 ' ' PRO . . . . . 0.463 ' HA ' ' HD3' ' A' 1372 ' ' PRO . 18.5 Cg_exo -57.25 145.02 89.21 Favored 'Trans proline' 0 C--O 1.248 1.007 0 C-N-CA 122.789 2.326 . . . . 46.390000000000001 117.643 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1372 ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' 1371 ' ' PRO . 51.5 Cg_exo -67.48 -20.45 47.78 Favored 'Trans proline' 0 CA--C 1.539 0.742 1 C-N-CA 125.345 4.03 . . . . 46.719999999999999 112.435 171.0 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.22 -5.055 0 CA-C-N 122.539 2.427 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 35.8 m80 . . . . . 0 N--CA 1.467 0.382 0 N-CA-C 107.738 -1.208 . . . . 63.439999999999998 107.738 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 999' ' ' HIS . . . . . 0.498 ' HB3' ' HB2' ' B' 1002 ' ' ARG . 98.8 m-70 -73.54 74.53 1.46 Allowed 'General case' 0 C--O 1.242 0.673 0 CA-C-O 124.37 2.033 . . . . 51.740000000000002 115.041 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1000 ' ' HIS . . . . . . . . . . . . . 63.9 t60 -72.62 128.45 35.6 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 114.499 -1.228 . . . . 54.07 108.573 -174.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 68.34 15.76 68.36 Favored Glycine 0 CA--C 1.506 -0.498 0 O-C-N 120.076 -1.64 . . . . 39.219999999999999 115.328 -172.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1002 ' ' ARG . . . . . 0.498 ' HB2' ' HB3' ' B' ' 999' ' ' HIS . 30.5 ttp180 -89.06 129.37 35.7 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 119.833 1.816 . . . . 38.119999999999997 108.557 176.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1003 ' ' ILE . . . . . 0.643 HG12 ' HB ' ' B' 1068 ' ' ILE . 19.6 mt -84.48 134.78 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-N 111.28 -2.691 . . . . 29.699999999999999 105.611 166.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1004 ' ' GLY . . . . . 0.417 ' O ' ' HD3' ' B' 1006 ' ' PRO . . . -114.84 125.65 6.87 Favored Glycine 0 CA--C 1.503 -0.701 0 N-CA-C 106.556 -2.617 . . . . 27.5 106.556 166.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1005 ' ' ILE . . . . . 0.476 HD12 ' HB3' ' B' 1017 ' ' ALA . 27.5 mm -99.4 105.42 33.06 Favored Pre-proline 0 N--CA 1.426 -1.646 0 N-CA-C 104.94 -2.244 . . . . 24.829999999999998 104.94 173.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1006 ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' B' 1004 ' ' GLY . 52.9 Cg_exo -74.76 145.69 32.75 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 C-N-CA 123.905 3.07 . . . . 27.190000000000001 108.977 173.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1007 ' ' ARG . . . . . 0.404 ' HD2' ' O ' ' B' 1037 ' ' SER . 73.1 ttt180 -74.47 113.16 11.39 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 109.198 -3.637 . . . . 41.460000000000001 104.127 171.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1008 ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -40.9 145.36 0.21 Allowed 'General case' 0 C--O 1.247 0.934 0 N-CA-C 120.015 3.339 . . . . 26.93 120.015 175.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1009 ' ' ARG . . . . . 0.446 HH11 ' HG3' ' B' 1009 ' ' ARG . 14.3 mmm-85 -120.27 -10.13 9.4 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-N 112.636 -2.075 . . . . 34.479999999999997 111.522 -175.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1010 ' ' LEU . . . . . . . . . . . . . 4.5 tp -64.7 143.52 57.87 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 122.098 0.951 . . . . 44.219999999999999 113.002 174.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1011 ' ' THR . . . . . . . . . . . . . 3.6 m -66.7 134.33 52.01 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 108.187 -1.042 . . . . 40.740000000000002 108.187 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 49.8 t30 51.21 53.42 12.97 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 115.948 1.832 . . . . 44.439999999999998 115.948 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1013 ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -136.67 116.48 13.11 Favored 'General case' 0 C--O 1.252 1.207 0 CA-C-N 114.245 -1.343 . . . . 29.870000000000001 108.965 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1014 ' ' THR . . . . . 0.589 ' HA ' HD22 ' B' 1042 ' ' LEU . 0.9 OUTLIER -111.99 -0.65 15.66 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.281 -0.872 . . . . 25.260000000000002 112.186 174.522 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B 1015 ' ' ARG . . . . . 0.695 ' HG3' ' HA2' ' B' 1317 ' ' GLY . 65.2 mtm180 -69.07 141.32 54.79 Favored 'General case' 0 C--O 1.248 0.995 0 N-CA-C 105.857 -1.905 . . . . 29.539999999999999 105.857 173.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1016 ' ' VAL . . . . . 0.782 HG21 ' HB1' ' B' 1039 ' ' ALA . 11.6 p -139.36 -173.62 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 104.7 -2.333 . . . . 23.550000000000001 104.7 171.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1017 ' ' ALA . . . . . 0.476 ' HB3' HD12 ' B' 1005 ' ' ILE . . . -110.0 0.67 18.6 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 118.992 -2.318 . . . . 23.59 113.636 175.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1018 ' ' ALA . . . . . . . . . . . . . . . -88.4 128.71 35.52 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 118.671 -0.681 . . . . 24.93 111.481 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1019 ' ' THR . . . . . 0.403 ' O ' ' HB ' ' B' 1022 ' ' THR . 0.0 OUTLIER -156.34 148.05 17.12 Favored Pre-proline 0 N--CA 1.442 -0.835 0 N-CA-C 105.682 -1.97 . . . . 28.09 105.682 171.055 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -61.96 -54.04 1.75 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 124.549 3.499 . . . . 28.789999999999999 112.981 -174.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1021 ' ' LYS . . . . . 0.684 ' HB3' HE22 ' B' 1325 ' ' GLN . 77.9 tttt -49.49 -48.95 47.54 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 121.289 1.859 . . . . 47.280000000000001 108.874 176.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1022 ' ' THR . . . . . 0.403 ' HB ' ' O ' ' B' 1019 ' ' THR . 39.5 m -49.86 -54.27 20.49 Favored 'General case' 0 C--O 1.203 -1.373 0 C-N-CA 125.63 1.572 . . . . 30.120000000000001 111.842 174.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1023 ' ' VAL . . . . . 0.653 HG22 HG11 ' B' 1033 ' ' VAL . 54.0 t -60.63 -37.97 77.07 Favored 'Isoleucine or valine' 0 C--N 1.352 0.691 0 CA-C-N 120.702 1.592 . . . . 32.240000000000002 108.078 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1024 ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -67.9 -44.86 75.97 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 121.205 1.821 . . . . 49.619999999999997 111.401 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1025 ' ' GLN . . . . . 0.548 ' HG3' ' O ' ' B' 1021 ' ' LYS . 52.8 mt-30 -58.43 -45.99 87.41 Favored 'General case' 0 N--CA 1.44 -0.959 0 O-C-N 125.457 1.723 . . . . 44.68 108.203 176.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 95.4 mt -63.39 -45.38 91.35 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 118.867 -0.587 . . . . 35.710000000000001 109.727 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1027 ' ' LEU . . . . . . . . . . . . . 27.2 mt -60.71 -35.19 75.69 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 118.894 0.77 . . . . 42.18 111.302 173.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 19.3 mttm -72.46 -30.11 64.28 Favored 'General case' 0 C--O 1.239 0.526 0 O-C-N 120.219 -1.551 . . . . 48.340000000000003 109.38 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1029 ' ' LEU . . . . . . . . . . . . . 87.3 mt -74.79 -21.03 59.54 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 118.249 -2.782 . . . . 38.689999999999998 109.604 169.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 101.22 18.47 19.35 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 117.935 -2.978 . . . . 32.280000000000001 110.327 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -98.08 118.48 34.79 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 106.432 -1.692 . . . . 35.939999999999998 106.432 170.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1032 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.12 139.94 57.53 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 111.598 -2.546 . . . . 33.369999999999997 111.156 171.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1033 ' ' VAL . . . . . 0.653 HG11 HG22 ' B' 1023 ' ' VAL . 6.7 t -114.0 130.92 67.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.704 0 CA-C-N 121.162 1.801 . . . . 29.98 106.931 -174.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1034 ' ' ALA . . . . . 0.493 ' HB2' ' HD2' ' B' 1002 ' ' ARG . . . -123.59 135.98 54.27 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 104.901 -2.259 . . . . 28.18 104.901 166.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1035 ' ' VAL . . . . . . . . . . . . . 46.7 t -121.72 143.43 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 103.678 -2.712 . . . . 25.82 103.678 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1036 ' ' GLU . . . . . 0.518 ' HG3' ' HA2' ' B' 1060 ' ' GLY . 78.4 tt0 -79.68 137.85 37.19 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 120.038 -1.664 . . . . 32.439999999999998 110.978 173.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1037 ' ' SER . . . . . 0.404 ' O ' ' HD2' ' B' 1007 ' ' ARG . 16.5 m -52.68 115.72 1.94 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 127.081 2.152 . . . . 29.539999999999999 109.958 177.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 115.12 -19.17 15.44 Favored Glycine 0 N--CA 1.423 -2.221 0 CA-C-O 119.382 -0.677 . . . . 27.760000000000002 113.381 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1039 ' ' ALA . . . . . 0.782 ' HB1' HG21 ' B' 1016 ' ' VAL . . . -67.0 -28.87 68.6 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 120.511 -0.475 . . . . 26.02 110.266 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -56.81 -55.18 31.43 Favored Glycine 0 C--O 1.246 0.886 0 N-CA-C 110.612 -0.995 . . . . 26.469999999999999 110.612 164.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1041 ' ' GLN . . . . . 0.511 ' NE2' ' HA ' ' B' 1046 ' ' ASP . 3.4 mp0 -53.24 -39.81 64.1 Favored 'General case' 0 C--O 1.25 1.095 0 O-C-N 120.463 -1.61 . . . . 50.979999999999997 114.32 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1042 ' ' LEU . . . . . 0.589 HD22 ' HA ' ' B' 1014 ' ' THR . 31.3 mt -52.84 -54.62 31.69 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 116.86 2.17 . . . . 29.300000000000001 116.86 163.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1043 ' ' ALA . . . . . . . . . . . . . . . -71.41 17.8 0.08 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 117.856 2.539 . . . . 26.739999999999998 117.856 172.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1044 ' ' SER . . . . . . . . . . . . . 6.7 m 52.57 41.91 31.26 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 125.187 2.422 . . . . 31.260000000000002 111.396 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1045 ' ' PHE . . . . . 0.628 ' HA ' ' HB1' ' A' 1277 ' ' ALA . 1.1 m-85 -127.96 167.3 16.85 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 111.62 -2.536 . . . . 33.259999999999998 107.124 -175.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1046 ' ' ASP . . . . . 0.875 ' HB2' ' HA ' ' A' 1305 ' ' ASN . 40.6 t0 -97.15 138.53 34.52 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 117.524 -1.671 . . . . 46.740000000000002 107.359 150.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -50.07 -36.3 28.73 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 126.887 2.617 . . . . 34.439999999999998 111.892 171.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -35.38 -44.05 0.27 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 116.323 1.972 . . . . 48.670000000000002 116.323 165.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -64.24 -27.91 69.37 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 120.205 -1.56 . . . . 35.259999999999998 112.988 177.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1050 ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -75.39 -38.75 59.77 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 117.276 -1.345 . . . . 32.170000000000002 109.196 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1051 ' ' VAL . . . . . 0.415 HG22 HG12 ' B' 1057 ' ' ILE . 8.3 t -53.44 -50.77 46.91 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 N-CA-C 107.884 -1.154 . . . . 38.369999999999997 107.884 171.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -53.53 -34.9 59.88 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 124.069 0.948 . . . . 45.770000000000003 112.736 175.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -80.31 -21.7 42.31 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.17 0.895 . . . . 37.829999999999998 111.858 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 128.26 20.78 1.56 Allowed Glycine 0 CA--C 1.519 0.304 0 O-C-N 119.658 -1.901 . . . . 35.82 109.571 170.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -100.41 140.71 34.27 Favored 'General case' 0 N--CA 1.435 -1.177 0 O-C-N 119.159 -2.377 . . . . 33.770000000000003 112.026 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -76.56 130.03 37.31 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.647 1.579 . . . . 51.020000000000003 108.545 171.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1057 ' ' ILE . . . . . 0.415 HG12 HG22 ' B' 1051 ' ' VAL . 35.7 mm -97.92 129.84 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 106.188 -1.782 . . . . 38.469999999999999 106.188 168.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 6.6 m -111.21 153.72 12.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 125.337 1.455 . . . . 39.399999999999999 108.048 169.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.13 -48.97 71.7 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 120.491 -1.381 . . . . 57.07 114.57 -175.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1060 ' ' GLY . . . . . 0.518 ' HA2' ' HG3' ' B' 1036 ' ' GLU . . . -155.83 -110.79 0.35 Allowed Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.076 -1.059 . . . . 44.829999999999998 111.018 -176.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1061 ' ' ASN . . . . . 0.573 ' HA ' ' HD1' ' B' 1064 ' ' TRP . 59.2 m-20 -58.27 -25.53 61.89 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 126.385 1.874 . . . . 46.270000000000003 115.685 -170.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1062 ' ' SER . . . . . . . . . . . . . 16.4 m -48.4 -28.19 3.08 Favored 'General case' 0 C--N 1.317 -0.81 0 O-C-N 120.731 -1.231 . . . . 43.469999999999999 112.999 165.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 1.3 p -59.04 -28.32 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 O-C-N 120.108 -1.62 . . . . 36.979999999999997 115.233 171.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1064 ' ' TRP . . . . . 0.573 ' HD1' ' HA ' ' B' 1061 ' ' ASN . 92.4 m95 -74.53 -18.65 60.57 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 122.921 0.488 . . . . 37.899999999999999 111.933 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -83.15 66.83 8.91 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 107.966 -1.124 . . . . 46.189999999999998 107.966 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1066 ' ' SER . . . . . 0.406 ' HB3' ' O ' ' B' 1002 ' ' ARG . 28.2 m -155.29 148.15 24.42 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 103.923 -2.621 . . . . 37.060000000000002 103.923 -172.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1067 ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -82.51 -15.33 52.81 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 115.844 1.794 . . . . 43.950000000000003 115.844 -172.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1068 ' ' ILE . . . . . 0.643 ' HB ' HG12 ' B' 1003 ' ' ILE . 1.4 mp -124.54 116.28 47.04 Favored 'Isoleucine or valine' 0 C--O 1.253 1.238 0 N-CA-C 103.129 -2.915 . . . . 33.5 103.129 177.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 26.0 mm -106.42 115.14 47.4 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 N-CA-C 106.733 -1.58 . . . . 30.57 106.733 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1070 ' ' LEU . . . . . 0.945 HD13 HD13 ' B' 1331 ' ' LEU . 85.3 mt -106.85 78.69 1.26 Allowed 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 115.224 -0.898 . . . . 27.66 111.229 -175.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1071 ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -80.75 166.64 20.81 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.836 -0.62 . . . . 28.399999999999999 110.749 171.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1072 ' ' VAL . . . . . 0.471 HG11 ' HB2' ' B' 1015 ' ' ARG . 8.9 t -91.51 -84.92 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 104.231 -2.507 . . . . 23.18 104.231 169.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -101.78 -170.49 1.83 Allowed 'General case' 0 C--N 1.312 -1.034 0 O-C-N 118.434 -2.666 . . . . 25.469999999999999 111.913 -170.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1074 ' ' ALA . . . . . 0.5 ' HA ' ' HD2' ' B' 1075 ' ' PRO . . . -33.93 125.51 0.47 Allowed Pre-proline 0 CA--C 1.554 1.109 0 N-CA-C 118.157 2.651 . . . . 27.899999999999999 118.157 -172.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1075 ' ' PRO . . . . . 0.5 ' HD2' ' HA ' ' B' 1074 ' ' ALA . 40.3 Cg_endo -68.48 126.89 14.79 Favored 'Trans proline' 0 N--CA 1.434 -2.009 0 C-N-CA 123.319 2.679 . . . . 31.620000000000001 111.474 166.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 45.2 mt -76.15 160.56 29.62 Favored 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 120.437 -1.414 . . . . 40.490000000000002 107.582 168.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.76 -35.5 43.88 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 117.358 2.355 . . . . 51.590000000000003 117.358 -174.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -63.97 -42.37 97.27 Favored 'General case' 0 C--O 1.208 -1.091 0 CA-C-O 118.972 -0.537 . . . . 42.359999999999999 111.004 172.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1079 ' ' GLU . . . . . 0.631 ' HA ' HD12 ' B' 1082 ' ' LEU . 20.2 mt-10 -66.57 -35.74 80.96 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 125.586 1.804 . . . . 34.530000000000001 108.917 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1080 ' ' ILE . . . . . 0.458 HG13 ' HB2' ' B' 1075 ' ' PRO . 63.3 mt -61.79 -51.8 68.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 125.983 2.052 . . . . 33.25 105.766 173.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -59.03 -29.4 67.25 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 120.969 1.713 . . . . 36.469999999999999 112.005 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1082 ' ' LEU . . . . . 0.631 HD12 ' HA ' ' B' 1079 ' ' GLU . 10.2 mt -71.74 -28.06 63.41 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.353 1.242 . . . . 37.759999999999998 114.353 177.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1083 ' ' LEU . . . . . . . . . . . . . 33.9 mt -64.45 112.97 3.36 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 118.594 -1.242 . . . . 37.43 109.204 -175.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -71.12 139.42 84.98 Favored Pre-proline 0 C--O 1.254 1.306 0 CA-C-N 115.149 -0.932 . . . . 37.700000000000003 109.435 167.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1085 ' ' PRO . . . . . 0.729 ' HB3' ' HB2' ' B' 1109 ' ' ASN . 35.1 Cg_exo -55.47 151.92 35.42 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.878 2.385 . . . . 35.509999999999998 116.379 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 74.79 -8.72 13.62 Favored Glycine 0 N--CA 1.445 -0.754 0 O-C-N 120.16 -1.587 . . . . 33.869999999999997 115.981 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1087 ' ' THR . . . . . . . . . . . . . 89.2 m -71.89 139.55 48.85 Favored 'General case' 0 C--O 1.261 1.688 0 O-C-N 119.608 -2.113 . . . . 32.5 108.062 178.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1088 ' ' THR . . . . . 0.545 ' HA ' ' HB ' ' B' 1111 ' ' THR . 0.2 OUTLIER -81.53 97.09 7.66 Favored 'General case' 0 C--O 1.255 1.387 0 N-CA-C 106.591 -1.633 . . . . 30.219999999999999 106.591 -173.613 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B 1089 ' ' LEU . . . . . . . . . . . . . 31.3 tp -91.77 101.21 13.81 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 122.167 0.984 . . . . 27.239999999999998 111.214 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1090 ' ' VAL . . . . . 0.644 HG13 ' HB2' ' B' 1113 ' ' MET . 11.7 t -104.11 107.35 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 111.089 -2.778 . . . . 25.390000000000001 109.795 -175.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1091 ' ' SER . . . . . . . . . . . . . 13.1 m -163.48 168.14 20.58 Favored 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 117.087 -3.508 . . . . 28.809999999999999 113.308 -170.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1092 ' ' PHE . . . . . 0.662 ' HD1' ' HB3' ' B' 1116 ' ' ASP . 68.6 m-85 -65.22 91.71 0.11 Allowed 'General case' 0 C--O 1.278 2.602 0 CA-C-O 124.212 1.958 . . . . 30.780000000000001 110.183 168.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 36.8 mm -89.9 -32.25 5.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 O-C-N 120.631 -1.293 . . . . 30.280000000000001 111.178 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1094 ' ' TRP . . . . . 0.555 ' HB2' ' ND2' ' B' 1098 ' ' ASN . 67.6 m95 57.92 55.83 6.77 Favored Pre-proline 0 C--O 1.247 0.965 0 CA-C-N 114.823 -1.08 . . . . 34.07 112.021 -175.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -49.97 -34.89 39.18 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 124.952 3.768 . . . . 38.659999999999997 113.409 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -56.37 -56.15 24.73 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 120.841 -1.162 . . . . 41.32 110.776 169.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -78.94 -22.68 45.39 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 113.951 1.093 . . . . 51.659999999999997 113.951 -174.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1098 ' ' ASN . . . . . 0.555 ' ND2' ' HB2' ' B' 1094 ' ' TRP . 75.9 m-20 -130.22 81.1 69.34 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 119.934 1.243 . . . . 40.32 111.02 -164.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -64.17 -48.93 4.19 Favored 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 120.987 1.124 . . . . 41.560000000000002 114.561 176.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -61.93 -35.87 79.7 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.399 -0.964 . . . . 54.109999999999999 108.399 -175.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1101 ' ' LEU . . . . . . . . . . . . . 17.0 tp -60.43 -47.17 87.27 Favored 'General case' 0 CA--C 1.515 -0.386 0 O-C-N 120.703 -1.248 . . . . 37.880000000000003 110.116 175.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1102 ' ' MET . . . . . . . . . . . . . 73.2 mmm -57.82 -38.62 75.91 Favored 'General case' 0 C--O 1.238 0.45 0 O-C-N 121.116 -0.99 . . . . 37.539999999999999 113.196 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -64.21 -45.77 86.82 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.869 -1.06 . . . . 47.009999999999998 113.398 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1104 ' ' LYS . . . . . 0.478 ' O ' ' HG2' ' B' 1108 ' ' ARG . 54.1 mttm -65.98 -35.26 80.1 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.506 -0.77 . . . . 48.68 110.264 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1105 ' ' LEU . . . . . . . . . . . . . 50.2 mt -72.86 -29.5 63.25 Favored 'General case' 0 C--O 1.269 2.127 0 O-C-N 120.546 -1.346 . . . . 32.210000000000001 112.583 177.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -61.63 -49.55 76.1 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 124.648 1.179 . . . . 33.729999999999997 108.098 172.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -54.1 -40.56 67.41 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 122.753 0.421 . . . . 51.469999999999999 111.702 172.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1108 ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' B' 1104 ' ' LYS . 20.6 mmm180 -72.97 -9.92 59.25 Favored 'General case' 0 C--O 1.213 -0.847 0 O-C-N 120.241 -1.537 . . . . 43.899999999999999 113.617 177.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1109 ' ' ASN . . . . . 0.729 ' HB2' ' HB3' ' B' 1085 ' ' PRO . 8.9 m120 62.93 30.83 16.46 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.556 1.142 . . . . 44.82 110.637 172.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1110 ' ' VAL . . . . . . . . . . . . . 2.7 m -92.76 155.0 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 O-C-N 120.557 -1.34 . . . . 30.52 112.404 -172.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1111 ' ' THR . . . . . 0.545 ' HB ' ' HA ' ' B' 1088 ' ' THR . 1.2 m -82.75 92.26 7.18 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 105.883 -1.895 . . . . 27.120000000000001 105.883 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1112 ' ' VAL . . . . . 0.441 ' HB ' ' HB ' ' B' 1361 ' ' ILE . 39.9 t -88.27 121.72 38.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 O-C-N 120.322 -1.486 . . . . 26.399999999999999 110.58 -173.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1113 ' ' MET . . . . . 0.644 ' HB2' HG13 ' B' 1090 ' ' VAL . 21.0 mtp -115.95 116.72 28.44 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 104.904 -2.258 . . . . 42.920000000000002 104.904 177.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -96.19 107.83 20.22 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 117.34 -1.744 . . . . 24.149999999999999 110.893 -172.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1115 ' ' MET . . . . . 0.476 ' HB3' ' HB2' ' B' 1129 ' ' ALA . 83.5 mmm -55.16 -26.88 41.64 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 116.543 2.053 . . . . 29.949999999999999 116.543 -176.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1116 ' ' ASP . . . . . 0.662 ' HB3' ' HD1' ' B' 1092 ' ' PHE . 6.9 p-10 -86.54 -39.84 15.82 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.117 -1.856 . . . . 34.530000000000001 110.946 177.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1117 ' ' SER . . . . . . . . . . . . . 49.9 m -99.16 31.8 2.93 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-O 123.966 1.841 . . . . 33.490000000000002 111.409 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1118 ' ' VAL . . . . . 0.766 HG22 HG23 ' B' 1358 ' ' VAL . 22.0 t -64.16 119.33 54.79 Favored Pre-proline 0 C--O 1.243 0.727 0 N-CA-C 102.402 -3.185 . . . . 34.020000000000003 102.402 151.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1119 ' ' PRO . . . . . 0.574 ' HB2' HG12 ' B' 1121 ' ' ILE . 73.1 Cg_exo -62.67 159.64 36.11 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 123.0 2.467 . . . . 38.280000000000001 113.047 -176.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1120 ' ' ARG . . . . . 0.787 ' HB2' HG13 ' B' 1375 ' ' VAL . 1.9 mmp_? -77.37 50.53 0.79 Allowed 'General case' 0 C--N 1.354 0.776 0 CA-C-O 122.099 0.952 . . . . 55.049999999999997 109.826 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1121 ' ' ILE . . . . . 0.574 HG12 ' HB2' ' B' 1119 ' ' PRO . 39.0 pt -119.21 143.96 28.98 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.844 0 O-C-N 121.232 -0.918 . . . . 42.090000000000003 110.042 -169.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1122 ' ' SER . . . . . . . . . . . . . 53.6 p -9.08 -88.82 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 120.479 3.511 . . . . 38.020000000000003 120.479 -176.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1123 ' ' ARG . . . . . 0.643 ' HA ' ' HD3' ' C' ' 134' ' ' PRO 0.254 18.7 ptt180 -71.5 -30.12 65.58 Favored 'General case' 0 C--N 1.357 0.892 0 CA-C-N 121.194 1.815 . . . . 34.289999999999999 114.502 178.669 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B 1124 ' ' ALA . . . . . 0.562 ' HB2' HG13 ' B' 1354 ' ' VAL . . . -58.83 -34.4 71.51 Favored 'General case' 0 C--O 1.219 -0.525 0 O-C-N 124.056 0.847 . . . . 32.350000000000001 109.851 -177.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1125 ' ' GLN . . . . . 0.401 ' NE2' ' HB3' ' B' 1131 ' ' SER . 0.0 OUTLIER -59.2 -9.06 1.86 Allowed 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 117.473 2.397 . . . . 47.170000000000002 117.473 176.909 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B 1126 ' ' SER . . . . . 0.54 ' HA ' ' HB1' ' A' 1159 ' ' ALA . 22.9 p -90.9 -32.95 15.81 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.863 1.211 . . . . 31.710000000000001 112.687 169.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1127 ' ' LEU . . . . . 0.601 ' HG ' ' HA ' ' B' 1334 ' ' LEU . 4.1 mp -71.36 -30.06 65.71 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 111.726 -2.488 . . . . 37.0 110.71 175.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1128 ' ' ASP . . . . . 0.402 ' CG ' HH12 ' B' 1120 ' ' ARG . 9.9 t70 -62.56 127.36 30.92 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 115.694 1.738 . . . . 40.399999999999999 115.694 -176.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1129 ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' B' 1115 ' ' MET . . . -70.06 -38.02 75.65 Favored 'General case' 0 C--O 1.212 -0.869 0 CA-C-N 113.746 -1.57 . . . . 26.559999999999999 108.1 177.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 36.2 mt -66.79 -13.85 61.96 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 115.039 1.496 . . . . 30.890000000000001 115.039 -174.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1131 ' ' SER . . . . . 0.401 ' HB3' ' NE2' ' B' 1125 ' ' GLN . 66.5 p -69.24 -56.17 8.37 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 105.507 -2.035 . . . . 29.84 105.507 167.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1132 ' ' SER . . . . . . . . . . . . . 67.5 m -55.05 -55.64 28.74 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 124.332 1.053 . . . . 31.91 113.616 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1133 ' ' MET . . . . . . . . . . . . . 32.2 mmt -54.32 -45.1 72.54 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.463 0.705 . . . . 25.899999999999999 111.757 176.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1134 ' ' ALA . . . . . 0.436 ' HB1' ' N ' ' B' 1176 ' ' ALA . . . -56.64 -52.57 64.38 Favored 'General case' 0 C--O 1.209 -1.049 0 C-N-CA 119.477 -0.889 . . . . 26.620000000000001 112.898 170.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1135 ' ' ASN . . . . . 0.484 ' HA ' ' HB2' ' B' 1179 ' ' ALA . 0.1 OUTLIER -53.66 -33.41 55.18 Favored 'General case' 0 C--O 1.22 -0.491 0 O-C-N 120.807 -1.183 . . . . 36.969999999999999 113.809 174.162 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B 1136 ' ' ILE . . . . . 0.464 HG21 ' HA ' ' B' 1316 ' ' PRO . 37.2 mm -68.96 -54.66 19.07 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 N-CA-C 107.255 -1.387 . . . . 32.109999999999999 107.255 175.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -59.53 -30.09 68.35 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 117.087 -1.435 . . . . 24.140000000000001 111.95 -171.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -66.49 -58.05 9.21 Favored Glycine 0 N--CA 1.47 0.912 0 CA-C-N 119.27 0.941 . . . . 25.129999999999999 111.562 174.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 21.0 t80 -58.88 -49.32 78.2 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.232 -1.025 . . . . 32.729999999999997 108.232 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1140 ' ' ARG . . . . . 0.4 ' HA ' ' HB ' ' B' 1143 ' ' VAL . 12.6 tpt180 -63.49 -28.95 70.31 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-O 117.806 -1.092 . . . . 26.359999999999999 108.94 -178.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1141 ' ' ALA . . . . . 0.462 ' HA ' HG11 ' B' 1282 ' ' VAL . . . -62.2 -47.92 82.32 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 122.412 2.369 . . . . 24.120000000000001 108.809 173.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 45.7 mm -60.92 -39.36 81.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.281 1.432 . . . . 23.370000000000001 109.298 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1143 ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' B' 1140 ' ' ARG . 40.6 t -63.84 -57.72 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 124.728 1.211 . . . . 24.960000000000001 111.931 176.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -63.6 -37.94 89.25 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 119.819 -1.801 . . . . 32.07 110.991 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1145 ' ' ALA . . . . . 0.772 ' HB1' HD12 ' B' 1251 ' ' ILE . . . -53.35 -51.63 61.84 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 122.432 1.111 . . . . 24.870000000000001 113.743 170.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1146 ' ' ALA . . . . . 0.685 ' HB2' ' HE1' ' B' 1153 ' ' PHE . . . -59.15 -37.14 76.6 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 113.835 -1.53 . . . . 24.670000000000002 114.677 177.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 42.5 t60 -60.79 -22.9 64.58 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.867 1.267 . . . . 28.579999999999998 111.692 177.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1148 ' ' GLU . . . . . 0.784 ' HB3' ' HD2' ' B' 1308 ' ' LYS . 60.9 mm-40 -127.81 16.24 6.89 Favored 'General case' 0 N--CA 1.442 -0.867 0 O-C-N 119.666 -1.896 . . . . 36.82 113.625 173.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1149 ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -77.65 155.93 31.08 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 122.563 1.173 . . . . 31.969999999999999 108.621 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1150 ' ' GLY . . . . . 0.612 ' HA2' ' HD2' ' A' 1320 ' ' PRO . . . -88.72 -23.72 35.16 Favored Glycine 0 C--O 1.208 -1.507 0 O-C-N 120.146 -1.596 . . . . 25.489999999999998 111.668 176.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1151 ' ' ARG . . . . . 0.679 ' HA ' ' HB2' ' A' 1322 ' ' GLN . 71.3 mtm-85 -131.62 179.98 5.73 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.614 1.166 . . . . 59.840000000000003 112.644 -162.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1152 ' ' PHE . . . . . 0.713 ' HB2' HG11 ' B' 1163 ' ' VAL . 5.9 m-30 -83.14 163.16 21.02 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 120.941 1.7 . . . . 34.450000000000003 111.177 171.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1153 ' ' PHE . . . . . 0.685 ' HE1' ' HB2' ' B' 1146 ' ' ALA . 46.1 m-85 -85.6 -48.68 8.67 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 112.46 -2.154 . . . . 31.170000000000002 109.271 166.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1154 ' ' THR . . . . . . . . . . . . . 6.3 m -72.1 135.57 46.29 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 114.636 -1.166 . . . . 33.890000000000001 108.162 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -80.6 73.67 2.49 Favored Glycine 0 CA--C 1.543 1.843 0 N-CA-C 106.47 -2.652 . . . . 38.950000000000003 106.47 171.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -75.17 124.17 26.57 Favored 'General case' 0 C--O 1.242 0.668 0 O-C-N 120.796 -1.414 . . . . 54.229999999999997 108.065 -174.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1157 ' ' ILE . . . . . 0.411 HD12 ' HG2' ' B' 1162 ' ' LYS . 26.8 mm -73.5 100.54 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 105.07 -2.196 . . . . 51.159999999999997 105.07 169.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1158 ' ' THR . . . . . . . . . . . . . 5.6 m -99.72 151.43 21.24 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 103.591 -2.744 . . . . 49.609999999999999 103.591 -172.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -57.92 -37.44 74.07 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 121.398 1.908 . . . . 49.049999999999997 113.707 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -53.52 -35.21 60.42 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 115.854 1.798 . . . . 47.649999999999999 115.854 169.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . 157.88 175.45 28.82 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 108.813 -1.715 . . . . 45.609999999999999 108.813 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1162 ' ' LYS . . . . . 0.411 ' HG2' HD12 ' B' 1157 ' ' ILE . 82.7 mttt -83.35 145.27 29.13 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 112.932 0.715 . . . . 57.460000000000001 112.932 -177.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1163 ' ' VAL . . . . . 0.713 HG11 ' HB2' ' B' 1152 ' ' PHE . 94.5 t -94.25 142.84 25.44 Favored Pre-proline 0 N--CA 1.433 -1.296 0 N-CA-C 106.385 -1.709 . . . . 42.93 106.385 170.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1164 ' ' PRO . . . . . 0.425 ' HA ' ' HD2' ' B' 1165 ' ' PRO . 98.6 Cg_endo -81.23 133.95 8.92 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 124.989 3.793 . . . . 39.289999999999999 104.74 168.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1165 ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' B' 1164 ' ' PRO . 50.3 Cg_endo -62.55 148.46 93.3 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 125.293 3.995 . . . . 34.170000000000002 108.199 176.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -75.17 134.7 41.17 Favored 'General case' 0 C--O 1.208 -1.124 0 CA-C-N 115.213 -0.903 . . . . 31.690000000000001 111.014 172.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1167 ' ' LYS . . . . . 0.59 ' HB2' ' HA ' ' B' 1249 ' ' VAL . 98.4 mttt -91.6 113.59 25.9 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 124.05 1.881 . . . . 44.780000000000001 107.189 167.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 87.6 t -98.25 99.43 8.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 113.099 -1.864 . . . . 31.23 107.212 -174.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1169 ' ' MET . . . . . 0.781 ' HB2' HG11 ' B' 1249 ' ' VAL . 36.5 ttp -83.42 100.85 10.97 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 119.14 -1.024 . . . . 37.090000000000003 108.313 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1170 ' ' VAL . . . . . 0.519 HG22 ' HB ' ' B' 1253 ' ' VAL . 45.2 t -91.07 111.76 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 106.948 -1.501 . . . . 30.170000000000002 106.948 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1171 ' ' ILE . . . . . . . . . . . . . 2.7 mt -97.84 135.43 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 107.303 -1.369 . . . . 33.740000000000002 107.303 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 71.76 71.94 0.99 Allowed Glycine 0 C--O 1.247 0.911 0 N-CA-C 108.564 -1.815 . . . . 32.590000000000003 108.564 -177.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1173 ' ' ALA . . . . . 0.483 ' H ' ' HB2' ' B' 1195 ' ' ASP . . . -76.25 74.31 3.06 Favored 'General case' 0 N--CA 1.44 -0.956 0 O-C-N 121.176 -1.191 . . . . 32.420000000000002 112.693 -174.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -81.0 -155.68 12.87 Favored Glycine 0 N--CA 1.44 -1.073 0 N-CA-C 109.652 -1.379 . . . . 31.739999999999998 109.652 169.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 47.9 t -65.11 -38.94 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.416 0 O-C-N 122.016 -0.696 . . . . 31.48 109.146 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1176 ' ' ALA . . . . . 0.436 ' N ' ' HB1' ' B' 1134 ' ' ALA . . . -65.65 -39.81 91.79 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 122.66 1.219 . . . . 26.120000000000001 110.186 174.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1177 ' ' GLY . . . . . 0.415 ' HA2' HG11 ' B' 1170 ' ' VAL . . . -52.29 -54.68 25.54 Favored Glycine 0 CA--C 1.527 0.82 0 O-C-N 120.499 -1.376 . . . . 25.73 111.05 171.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1178 ' ' LEU . . . . . 0.676 ' HA ' HD12 ' B' 1181 ' ' ILE . 65.5 mt -57.78 -39.21 76.93 Favored 'General case' 0 C--N 1.351 0.65 0 N-CA-C 112.863 0.69 . . . . 32.590000000000003 112.863 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1179 ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' B' 1135 ' ' ASN . . . -60.67 -46.15 91.42 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 124.664 1.227 . . . . 27.719999999999999 111.777 170.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -64.71 -39.35 93.51 Favored 'General case' 0 C--O 1.249 1.075 0 O-C-N 119.884 -1.76 . . . . 26.030000000000001 111.764 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1181 ' ' ILE . . . . . 0.676 HD12 ' HA ' ' B' 1178 ' ' LEU . 37.7 mt -56.61 -60.7 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 N-CA-C 104.137 -2.542 . . . . 28.609999999999999 104.137 171.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -43.32 -49.7 6.72 Favored Glycine 0 C--O 1.214 -1.099 0 N-CA-C 116.05 1.18 . . . . 25.23 116.05 177.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1183 ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' B' 1186 ' ' SER . . . -72.59 -57.02 4.46 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 112.115 0.413 . . . . 24.09 112.115 -174.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -60.59 -41.42 94.7 Favored 'General case' 0 C--O 1.246 0.892 0 O-C-N 121.518 -0.739 . . . . 26.68 112.689 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -65.7 -32.81 74.57 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-O 118.255 -0.878 . . . . 36.57 109.946 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1186 ' ' SER . . . . . 0.471 ' HB2' ' O ' ' B' 1183 ' ' ALA . 64.8 m -57.33 -49.27 76.67 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 122.48 2.4 . . . . 28.920000000000002 108.486 167.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1187 ' ' LEU . . . . . . . . . . . . . 19.6 mt -67.88 -6.51 22.13 Favored 'General case' 0 C--N 1.365 1.267 0 N-CA-C 115.511 1.671 . . . . 29.09 115.511 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 82.39 16.11 72.22 Favored Glycine 0 N--CA 1.447 -0.584 0 O-C-N 120.285 -1.509 . . . . 29.260000000000002 113.819 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1189 ' ' ALA . . . . . . . . . . . . . . . -86.81 139.74 30.39 Favored 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 120.514 -1.58 . . . . 30.16 108.407 175.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 8.3 mt -87.08 110.33 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 105.916 -1.883 . . . . 35.810000000000002 105.916 -164.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1191 ' ' VAL . . . . . 0.491 HG21 ' HA ' ' B' 1181 ' ' ILE . 43.8 t -81.02 123.5 37.7 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 O-C-N 121.093 -1.004 . . . . 31.969999999999999 111.351 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1192 ' ' ARG . . . . . 0.737 ' HG2' ' HB2' ' B' 1210 ' ' GLU . 91.2 mtt180 -105.91 105.13 15.02 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 108.202 -1.036 . . . . 48.159999999999997 108.202 170.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -103.04 155.01 18.68 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 115.823 -2.351 . . . . 35.890000000000001 110.339 -176.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1194 ' ' PHE . . . . . 0.534 ' HB2' ' HB2' ' B' 1212 ' ' LEU . 39.5 t80 -141.42 136.84 31.75 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 106.318 -1.734 . . . . 41.880000000000003 106.318 170.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1195 ' ' ASP . . . . . 0.483 ' HB2' ' H ' ' B' 1173 ' ' ALA . 9.9 t0 -149.84 159.78 44.09 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 100.948 -3.723 . . . . 38.280000000000001 100.948 165.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1196 ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.75 -9.85 59.77 Favored 'General case' 0 N--CA 1.435 -1.206 0 O-C-N 120.892 -1.13 . . . . 40.619999999999997 112.593 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1197 ' ' ARG . . . . . 0.402 HH11 ' HD2' ' B' 1197 ' ' ARG . 31.9 mtm105 -90.53 134.3 31.18 Favored Pre-proline 0 C--O 1.25 1.115 0 O-C-N 119.992 -1.692 . . . . 53.090000000000003 107.815 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -61.81 -34.39 82.66 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 123.417 2.745 . . . . 42.560000000000002 116.378 -165.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1199 ' ' GLU . . . . . 0.574 ' O ' ' HG2' ' B' 1203 ' ' GLN . 2.8 pm0 -68.57 -17.9 64.23 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 115.018 1.488 . . . . 56.310000000000002 115.018 -165.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1200 ' ' VAL . . . . . . . . . . . . . 14.1 m -58.72 -29.05 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-N 115.137 -0.938 . . . . 42.909999999999997 113.335 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 37.9 tttm -60.3 -62.31 1.96 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.685 -1.228 . . . . 48.890000000000001 107.685 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -60.16 -26.77 66.56 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 114.909 1.448 . . . . 51.700000000000003 114.909 176.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1203 ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' B' 1199 ' ' GLU . 67.6 mm-40 -62.04 -47.82 83.0 Favored 'General case' 0 C--O 1.253 1.283 0 CA-C-N 121.104 1.775 . . . . 52.57 111.449 171.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1204 ' ' VAL . . . . . 0.56 ' HB ' ' HB3' ' B' 1209 ' ' ALA 0.257 34.5 m -67.23 -43.97 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 O-C-N 120.619 -1.3 . . . . 33.789999999999999 113.736 175.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -56.61 -52.08 66.23 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 117.068 -1.444 . . . . 36.579999999999998 110.876 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1206 ' ' SER . . . . . . . . . . . . . 90.3 p -61.46 -40.88 96.12 Favored 'General case' 0 C--O 1.253 1.288 0 CA-C-N 120.125 1.33 . . . . 39.609999999999999 112.196 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1207 ' ' MET . . . . . . . . . . . . . 11.7 ttm -72.78 -18.78 61.45 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 119.738 -1.851 . . . . 37.450000000000003 112.808 174.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 84.83 73.36 1.27 Allowed Glycine 0 C--O 1.248 0.995 0 O-C-N 119.368 -2.083 . . . . 31.870000000000001 109.933 -176.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1209 ' ' ALA . . . . . 0.56 ' HB3' ' HB ' ' B' 1204 ' ' VAL . . . -163.17 155.51 18.29 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 106.742 -1.577 . . . . 35.399999999999999 106.742 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1210 ' ' GLU . . . . . 0.737 ' HB2' ' HG2' ' B' 1192 ' ' ARG . 50.1 mt-10 -86.56 148.48 25.48 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 112.088 -2.324 . . . . 47.890000000000001 111.59 -171.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 30.7 t80 -113.92 125.3 53.88 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 120.198 -1.564 . . . . 45.530000000000001 108.14 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1212 ' ' LEU . . . . . 0.534 ' HB2' ' HB2' ' B' 1194 ' ' PHE . 44.6 mt -74.36 108.49 7.17 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 103.832 -2.655 . . . . 46.329999999999998 103.832 170.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.41 159.64 21.75 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 113.357 -1.747 . . . . 60.409999999999997 112.313 -172.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.56 145.38 54.96 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 115.19 1.552 . . . . 57.380000000000003 115.19 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 34.4 t70 . . . . . 0 C--O 1.222 -0.349 0 CA-C-N 112.911 -1.95 . . . . 65.069999999999993 107.512 173.044 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B 1230 ' ' MET . . . . . . . . . . . . . 28.2 mmt . . . . . 0 N--CA 1.445 -0.696 0 N-CA-C 107.556 -1.275 . . . . 80.319999999999993 107.556 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B 1231 ' ' SER . . . . . . . . . . . . . 18.6 m -160.25 157.63 28.49 Favored 'General case' 0 C--O 1.224 -0.286 1 O-C-N 114.94 -4.85 . . . . 79.920000000000002 104.658 -10.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.93 -175.06 3.78 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-N 121.968 2.167 . . . . 77.909999999999997 105.685 155.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 60.9 -56.48 0.09 Allowed 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 117.032 2.234 . . . . 73.879999999999995 117.032 -170.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 4.9 t80 -38.87 -33.1 0.1 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.313 1.445 . . . . 68.980000000000004 113.703 169.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1235 ' ' ILE . . . . . 0.514 ' O ' ' HG2' ' B' 1239 ' ' MET . 35.9 pt -36.48 -39.63 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.384 0 N-CA-C 116.967 2.21 . . . . 64.530000000000001 116.967 167.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1236 ' ' LYS . . . . . 0.487 ' HA ' ' HD3' ' B' 1236 ' ' LYS . 71.2 mmtt -62.52 -51.03 69.04 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 122.903 0.481 . . . . 66.359999999999999 110.986 175.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -67.26 -33.72 75.91 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 125.29 1.619 . . . . 56.600000000000001 109.15 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -56.71 -52.77 63.68 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 120.637 1.562 . . . . 56.789999999999999 109.805 171.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1239 ' ' MET . . . . . 0.514 ' HG2' ' O ' ' B' 1235 ' ' ILE . 31.1 mmt -56.44 -47.2 79.6 Favored 'General case' 0 C--O 1.238 0.471 0 O-C-N 124.558 1.161 . . . . 53.630000000000003 113.38 176.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -63.63 -25.63 68.31 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 115.211 1.56 . . . . 51.740000000000002 115.211 175.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 13.1 tp -67.06 -46.25 74.91 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 105.483 -2.043 . . . . 44.859999999999999 105.483 174.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 8.4 m-30 -70.48 -45.13 66.3 Favored 'General case' 0 C--O 1.216 -0.701 0 O-C-N 120.268 -1.52 . . . . 42.780000000000001 106.999 -173.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -52.82 -43.08 65.71 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.343 1.238 . . . . 40.960000000000001 114.343 171.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -62.78 -29.74 70.94 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 115.813 1.782 . . . . 43.060000000000002 115.813 170.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -79.72 -24.76 41.42 Favored 'General case' 0 C--O 1.202 -1.445 0 CA-C-O 117.013 -1.47 . . . . 46.450000000000003 113.03 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -35.2 -40.45 0.13 Allowed 'General case' 0 C--O 1.241 0.636 1 N-CA-C 121.959 4.059 . . . . 41.780000000000001 121.959 -174.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1247 ' ' LYS . . . . . 0.491 ' HA ' ' HB2' ' B' 1276 ' ' LYS . 7.9 mptt -101.74 -4.9 25.65 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-N 120.379 1.445 . . . . 52.200000000000003 113.866 175.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1248 ' ' GLU . . . . . 0.483 ' HB3' ' HD2' ' B' 1167 ' ' LYS . 36.2 mt-10 -81.74 -63.23 1.43 Allowed 'General case' 0 C--O 1.25 1.125 0 N-CA-C 108.006 -1.109 . . . . 53.549999999999997 108.006 167.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1249 ' ' VAL . . . . . 0.781 HG11 ' HB2' ' B' 1169 ' ' MET . 21.7 m -65.69 154.41 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 123.963 1.84 . . . . 34.409999999999997 115.146 -168.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1250 ' ' ASP . . . . . 0.441 ' O ' ' HB3' ' B' 1279 ' ' SER . 2.8 m-20 -118.1 -56.56 2.16 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 105.271 -2.122 . . . . 33.380000000000003 105.271 -177.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1251 ' ' ILE . . . . . 0.772 HD12 ' HB1' ' B' 1145 ' ' ALA . 32.5 mm -110.73 109.02 26.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 O-C-N 119.782 -1.824 . . . . 29.539999999999999 106.881 -169.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1252 ' ' ILE . . . . . 0.435 HD11 ' SD ' ' B' 1275 ' ' MET . 47.1 mt -88.59 117.86 32.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 119.833 -1.792 . . . . 32.439999999999998 108.545 171.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1253 ' ' VAL . . . . . 0.519 ' HB ' HG22 ' B' 1170 ' ' VAL . 74.0 t -104.28 94.34 3.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 100.286 -3.968 . . . . 30.57 100.286 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1254 ' ' THR . . . . . . . . . . . . 0.294 6.5 t -94.78 101.56 13.39 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 125.681 2.658 . . . . 35.039999999999999 109.257 -176.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1255 ' ' THR . . . . . 0.446 HG23 HD22 ' B' 1284 ' ' LEU . 33.3 m -100.72 -21.11 15.31 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 109.192 -3.64 . . . . 34.619999999999997 113.933 -163.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . -62.17 139.25 58.48 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-O 122.877 1.323 . . . . 42.719999999999999 113.051 -162.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 5.6 tt -153.61 126.8 8.47 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 111.165 -2.743 . . . . 52.43 104.945 175.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1258 ' ' ILE . . . . . 0.692 ' HB ' ' HB2' ' B' 1261 ' ' LYS . 58.3 mt -85.69 118.21 70.19 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 101.34 -3.578 . . . . 59.409999999999997 101.34 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -51.37 92.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 124.877 3.718 . . . . 62.68 114.974 -175.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 130.46 -64.27 0.61 Allowed Glycine 0 N--CA 1.425 -2.061 0 N-CA-C 107.008 -2.437 . . . . 64.159999999999997 107.008 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1261 ' ' LYS . . . . . 0.692 ' HB2' ' HB ' ' B' 1258 ' ' ILE . 79.7 mttt -59.1 166.52 2.66 Favored Pre-proline 0 CA--C 1.51 -0.58 0 C-N-CA 125.992 1.717 . . . . 68.530000000000001 115.582 171.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -67.67 166.45 24.09 Favored 'Trans proline' 0 C--O 1.249 1.034 0 C-N-CA 122.659 2.239 . . . . 61.990000000000002 114.459 169.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1263 ' ' ALA . . . . . 0.427 ' HB1' ' ND2' ' B' 1291 ' ' ASN . . . -54.71 126.92 59.02 Favored Pre-proline 0 C--O 1.25 1.091 0 CA-C-N 111.819 -2.446 . . . . 57.149999999999999 111.52 166.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -60.95 141.49 94.68 Favored 'Trans proline' 0 C--N 1.324 -0.745 0 C-N-CA 123.998 3.132 . . . . 51.57 109.57 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -77.22 73.34 3.8 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-N 114.998 -1.001 . . . . 54.549999999999997 112.724 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 43.1 mt -76.02 -40.18 54.1 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 115.217 1.562 . . . . 46.859999999999999 115.217 -170.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1267 ' ' ILE . . . . . 0.48 HG21 HD13 ' B' 1281 ' ' ILE . 40.1 mm -110.72 119.75 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 106.432 -1.692 . . . . 41.039999999999999 106.432 -173.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1268 ' ' THR . . . . . 0.437 ' O ' HG23 ' B' 1272 ' ' VAL . 19.0 p -84.13 159.0 21.18 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 113.03 -1.895 . . . . 39.579999999999998 110.108 177.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1269 ' ' ARG . . . . . 0.494 ' HG3' ' HB2' ' B' 1293 ' ' GLU . 64.8 mtt85 -63.62 -33.6 75.98 Favored 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 120.689 -1.257 . . . . 53.149999999999999 111.03 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -64.4 -43.91 92.93 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 109.046 -0.724 . . . . 42.960000000000001 109.046 176.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1271 ' ' MET . . . . . . . . . . . . . 5.8 ttm -62.18 -40.45 96.06 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 114.516 1.302 . . . . 43.890000000000001 114.516 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1272 ' ' VAL . . . . . 0.545 HG21 ' HD2' ' B' 1294 ' ' TYR . 53.7 t -56.62 -59.12 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 120.339 -0.544 . . . . 38.369999999999997 111.53 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -66.84 -25.15 66.29 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 122.779 1.275 . . . . 47.460000000000001 114.02 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1274 ' ' SER . . . . . . . . . . . . . 33.2 m -74.71 -17.13 60.71 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 118.262 -2.774 . . . . 38.380000000000003 114.131 170.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1275 ' ' MET . . . . . 0.435 ' SD ' HD11 ' B' 1252 ' ' ILE . 34.0 mtp -69.12 163.64 24.35 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 121.388 1.904 . . . . 37.810000000000002 112.808 -174.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1276 ' ' LYS . . . . . 0.491 ' HB2' ' HA ' ' B' 1247 ' ' LYS . 87.8 tttt -56.04 126.32 25.41 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 113.131 -1.85 . . . . 49.259999999999998 108.778 167.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1277 ' ' ALA . . . . . 0.556 ' HB3' ' HD1' ' A' 1045 ' ' PHE . . . -83.47 169.85 15.07 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 120.559 1.527 . . . . 34.460000000000001 114.003 -167.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 62.32 41.64 99.74 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-O 122.995 1.331 . . . . 33.530000000000001 110.639 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1279 ' ' SER . . . . . 0.441 ' HB3' ' O ' ' B' 1250 ' ' ASP . 70.4 m -134.59 158.98 42.62 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 110.204 -2.998 . . . . 31.309999999999999 104.224 -172.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1280 ' ' VAL . . . . . 0.662 HG11 ' HA ' ' B' 1145 ' ' ALA . 41.4 t -128.66 142.1 44.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 106.708 -1.59 . . . . 29.32 106.708 -169.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1281 ' ' ILE . . . . . 0.48 HD13 HG21 ' B' 1267 ' ' ILE . 43.4 mt -113.31 113.22 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 103.002 -2.962 . . . . 31.93 103.002 167.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1282 ' ' VAL . . . . . 0.462 HG11 ' HA ' ' B' 1141 ' ' ALA . 5.1 t -97.09 127.57 49.17 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 N-CA-C 105.873 -1.899 . . . . 29.48 105.873 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1283 ' ' ASP . . . . . 0.566 ' HB3' ' HA2' ' B' 1311 ' ' GLY . 12.8 t0 -100.12 115.37 29.65 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 104.387 -2.449 . . . . 34.5 104.387 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1284 ' ' LEU . . . . . 0.542 ' HA ' HD12 ' B' 1315 ' ' LEU . 6.9 mp -82.01 -22.74 36.35 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.727 1.01 . . . . 37.939999999999998 113.727 -178.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -118.45 30.72 7.05 Favored 'General case' 0 N--CA 1.428 -1.551 0 O-C-N 119.374 -2.079 . . . . 40.920000000000002 111.115 -165.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -51.72 -38.2 54.24 Favored 'General case' 0 C--O 1.248 0.987 0 N-CA-C 117.647 2.462 . . . . 44.390000000000001 117.647 -169.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1287 ' ' GLN . . . . . 0.78 ' HB3' HG23 ' B' 1313 ' ' THR . 3.7 pm0 -65.31 -22.98 66.9 Favored 'General case' 0 C--O 1.268 2.049 0 N-CA-C 117.226 2.306 . . . . 51.460000000000001 117.226 176.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 20.7 m120 -110.31 73.31 0.83 Allowed 'General case' 0 C--N 1.35 0.604 0 N-CA-C 105.65 -1.981 . . . . 57.75 105.65 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1289 ' ' GLY . . . . . . . . . . . . . . . 87.08 -64.05 3.93 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-O 116.443 -2.31 . . . . 49.850000000000001 112.484 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 106.26 120.61 4.68 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 118.903 1.352 . . . . 45.93 112.03 -167.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1291 ' ' ASN . . . . . 0.427 ' ND2' ' HB1' ' B' 1263 ' ' ALA . 2.1 m-80 -69.6 -36.95 76.66 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.37 1.468 . . . . 42.670000000000002 112.368 176.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1292 ' ' CYS . . . . . . . . . . . . . 31.5 t -99.16 145.37 27.27 Favored 'General case' 0 C--O 1.253 1.257 0 CA-C-N 123.216 2.735 . . . . 38.82 108.401 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1293 ' ' GLU . . . . . 0.494 ' HB2' ' HG3' ' B' 1269 ' ' ARG . 67.6 mt-10 -60.47 -29.94 69.36 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 114.93 1.456 . . . . 46.710000000000001 114.93 175.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1294 ' ' TYR . . . . . 0.545 ' HD2' HG21 ' B' 1272 ' ' VAL . 21.3 m-85 -72.09 -16.7 62.02 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 116.396 1.998 . . . . 47.229999999999997 116.396 176.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1295 ' ' THR . . . . . 0.579 HG23 ' HA3' ' B' 1311 ' ' GLY . 85.9 m -56.19 122.35 11.55 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 123.854 1.788 . . . . 36.020000000000003 115.756 -165.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 7.2 t -107.03 124.18 36.11 Favored Pre-proline 0 N--CA 1.438 -1.054 1 N-CA-C 100.147 -4.02 . . . . 37.259999999999998 100.147 175.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -62.67 107.74 0.64 Allowed 'Trans proline' 0 C--O 1.243 0.752 0 C-N-CA 123.906 3.07 . . . . 35.090000000000003 112.459 -172.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 83.01 50.93 4.39 Favored Glycine 0 C--O 1.252 1.265 0 N-CA-C 108.035 -2.026 . . . . 35.969999999999999 108.035 173.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -151.74 145.25 24.87 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-O 122.181 0.991 . . . . 40.390000000000001 109.706 175.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1300 ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' B' 1310 ' ' ILE . 77.1 mt -80.49 130.07 36.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 103.877 -2.638 . . . . 37.43 103.877 156.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 4.5 t80 -121.94 120.79 35.47 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 104.758 -2.312 . . . . 44.130000000000003 104.758 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1302 ' ' THR . . . . . . . . . . . . . 59.6 m -83.51 133.97 34.86 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.325 -1.307 . . . . 39.780000000000001 108.264 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1303 ' ' THR . . . . . 0.519 HG21 HG11 ' B' 1272 ' ' VAL . 14.0 p -97.75 179.74 4.72 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 121.105 -0.997 . . . . 43.289999999999999 112.155 175.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -60.19 -51.69 68.51 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.64 0.733 . . . . 53.07 111.457 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 43.9 p-10 -74.57 -17.18 60.77 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 116.351 1.982 . . . . 43.969999999999999 116.351 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 85.25 33.69 16.6 Favored Glycine 0 N--CA 1.468 0.799 0 CA-C-N 114.626 -1.17 . . . . 41.119999999999997 113.994 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1307 ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' B' 1279 ' ' SER . 99.8 t -92.08 94.1 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 N-CA-C 105.374 -2.084 . . . . 38.119999999999997 105.374 163.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1308 ' ' LYS . . . . . 0.784 ' HD2' ' HB3' ' B' 1148 ' ' GLU . 80.7 mttt -78.59 119.72 22.27 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.649 -1.614 . . . . 36.340000000000003 109.662 -165.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1309 ' ' VAL . . . . . 0.412 HG22 HD12 ' B' 1281 ' ' ILE . 59.4 t -90.01 97.18 6.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 125.084 2.373 . . . . 30.399999999999999 109.195 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1310 ' ' ILE . . . . . 0.502 HD11 ' HB2' ' B' 1148 ' ' GLU . 14.1 mt -87.39 80.21 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.891 0 CA-C-N 112.239 -2.255 . . . . 30.82 105.314 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1311 ' ' GLY . . . . . 0.579 ' HA3' HG23 ' B' 1295 ' ' THR . . . -81.41 109.42 3.0 Favored Glycine 0 CA--C 1.503 -0.71 0 O-C-N 119.897 -1.752 . . . . 26.530000000000001 109.847 -179.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1312 ' ' TYR . . . . . 0.426 ' HB2' ' HG ' ' B' 1315 ' ' LEU . 9.8 m-30 -120.23 124.99 47.03 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 119.741 3.237 . . . . 38.0 119.741 -176.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1313 ' ' THR . . . . . 0.78 HG23 ' HB3' ' B' 1287 ' ' GLN . 4.0 m -69.65 -33.02 72.02 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.3 -1.773 . . . . 29.800000000000001 110.419 164.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -118.74 24.14 11.05 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 114.145 -1.389 . . . . 39.039999999999999 114.001 -157.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1315 ' ' LEU . . . . . 0.542 HD12 ' HA ' ' B' 1284 ' ' LEU . 18.7 mt -52.1 -41.93 83.08 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 114.728 1.381 . . . . 31.079999999999998 114.728 176.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1316 ' ' PRO . . . . . 0.464 ' HA ' HG21 ' B' 1136 ' ' ILE . 96.2 Cg_exo -67.17 -36.84 20.19 Favored 'Trans proline' 0 CA--C 1.499 -1.252 0 CA-C-N 123.831 2.404 . . . . 26.100000000000001 113.094 168.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1317 ' ' GLY . . . . . 0.695 ' HA2' ' HG3' ' B' 1015 ' ' ARG . . . -60.29 -44.96 96.96 Favored Glycine 0 CA--C 1.503 -0.685 0 CA-C-N 120.512 1.506 . . . . 23.170000000000002 110.606 -177.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 56.1 mtt-85 -66.95 -0.21 2.96 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 116.149 1.907 . . . . 40.399999999999999 116.149 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 22.6 tp -120.37 78.79 27.73 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 105.325 -2.102 . . . . 23.600000000000001 105.325 172.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1320 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -58.41 -64.78 0.1 Allowed 'Trans proline' 0 CA--C 1.552 1.397 0 C-N-CA 125.158 3.905 . . . . 22.350000000000001 113.956 -161.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1321 ' ' THR . . . . . . . . . . . . . 6.3 m -66.16 -40.96 90.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 121.149 1.795 . . . . 26.52 112.874 -175.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1322 ' ' GLN . . . . . 0.703 ' HB2' ' HA ' ' A' 1151 ' ' ARG . 60.0 tp60 -69.67 -43.57 72.27 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 120.262 1.392 . . . . 24.379999999999999 110.83 -174.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1323 ' ' SER . . . . . . . . . . . . . 21.0 m -56.13 -50.22 71.72 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 119.217 -0.993 . . . . 22.800000000000001 111.091 170.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1324 ' ' SER . . . . . . . . . . . . . 15.1 m -57.57 -34.56 69.34 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 123.242 1.496 . . . . 21.25 112.731 176.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1325 ' ' GLN . . . . . 0.684 HE22 ' HB3' ' B' 1021 ' ' LYS . 9.3 tp-100 -67.23 -55.73 12.8 Favored 'General case' 0 N--CA 1.438 -1.036 0 O-C-N 119.594 -1.941 . . . . 31.34 111.387 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1326 ' ' LEU . . . . . 0.448 ' HG ' HE21 ' B' 1322 ' ' GLN . 45.0 mt -69.32 -40.41 77.63 Favored 'General case' 0 N--CA 1.435 -1.19 0 O-C-N 120.886 -1.134 . . . . 31.559999999999999 111.764 -173.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1327 ' ' TYR . . . . . 0.406 ' O ' ' HG ' ' B' 1331 ' ' LEU . 27.4 t80 -53.42 -53.31 53.15 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.428 -1.323 . . . . 22.73 107.428 171.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1328 ' ' GLY . . . . . . . . . . . . . . . -44.84 -56.89 5.6 Favored Glycine 0 C--O 1.254 1.381 0 C-N-CA 124.539 1.066 . . . . 21.91 114.335 172.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1329 ' ' THR . . . . . . . . . . . . . 19.3 m -69.84 -23.64 63.32 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 121.428 -1.042 . . . . 22.149999999999999 110.421 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1330 ' ' ASN . . . . . . . . . . . . . 31.6 m120 -66.3 -42.66 87.99 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.076 -1.64 . . . . 26.18 107.004 172.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1331 ' ' LEU . . . . . 0.945 HD13 HD13 ' B' 1070 ' ' LEU . 41.5 mt -66.6 -39.13 88.23 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.569 -0.9 . . . . 23.68 108.569 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1332 ' ' VAL . . . . . 0.531 HG12 ' HE3' ' B' 1336 ' ' LYS . 70.3 t -58.69 -46.73 90.35 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-O 116.958 -1.496 . . . . 26.57 108.622 171.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -56.53 -43.11 79.53 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 121.018 1.736 . . . . 28.079999999999998 113.592 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1334 ' ' LEU . . . . . 0.601 ' HA ' ' HG ' ' B' 1127 ' ' LEU . 46.9 tp -59.6 -50.76 72.64 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 113.82 -1.536 . . . . 27.43 107.855 175.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1335 ' ' LEU . . . . . 0.507 HD23 HD12 ' B' 1338 ' ' LEU . 65.1 mt -69.77 -23.99 63.44 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 119.011 -2.306 . . . . 30.5 111.841 -177.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1336 ' ' LYS . . . . . 0.531 ' HE3' HG12 ' B' 1332 ' ' VAL . 90.9 mttt -64.42 -40.28 95.46 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 122.81 2.55 . . . . 41.649999999999999 109.891 169.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 12.4 tp -77.75 -31.09 51.91 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 113.472 0.916 . . . . 42.079999999999998 113.472 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1338 ' ' LEU . . . . . 0.507 HD12 HD23 ' B' 1335 ' ' LEU . 95.1 mt -78.64 -69.77 0.54 Allowed 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 122.281 1.039 . . . . 35.030000000000001 109.61 173.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 42.4 t -81.1 72.35 8.12 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 124.397 2.046 . . . . 37.329999999999998 107.584 -174.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 58.9 mttp -70.18 -19.25 63.2 Favored 'General case' 0 CA--C 1.5 -0.952 0 O-C-N 118.376 -2.703 . . . . 50.509999999999998 114.929 -178.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -78.14 -9.18 59.06 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 113.169 0.803 . . . . 54.210000000000001 113.169 168.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 44.9 mttt 48.11 56.23 7.61 Favored 'General case' 0 C--N 1.364 1.224 0 C-N-CA 124.96 1.304 . . . . 50.990000000000002 113.359 -173.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 26.6 p-10 -122.38 -47.87 2.1 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.857 -0.737 . . . . 48.82 111.17 -172.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 150.37 -3.71 0.56 Allowed Glycine 0 CA--C 1.54 1.623 0 CA-C-O 123.369 1.538 . . . . 40.43 111.195 172.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 22.9 t30 -79.64 116.4 19.81 Favored 'General case' 0 N--CA 1.428 -1.53 0 O-C-N 119.463 -2.198 . . . . 47.560000000000002 114.292 175.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1346 ' ' ILE . . . . . . . . . . . . . 40.4 mm -59.74 97.62 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.246 0.902 0 CA-C-O 123.204 1.478 . . . . 42.490000000000002 112.234 169.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1347 ' ' THR . . . . . . . . . . . . . 48.2 m -101.38 93.99 5.69 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 113.394 -1.73 . . . . 38.119999999999997 107.504 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 85.5 t -87.0 94.84 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 O-C-N 119.309 -2.119 . . . . 37.5 107.802 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 16.2 t70 -75.12 101.97 4.75 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 107.228 -1.397 . . . . 43.850000000000001 107.228 170.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1350 ' ' PHE . . . . . 0.715 ' HE1' ' HB ' ' B' 1359 ' ' THR . 0.1 OUTLIER -75.98 -5.24 45.39 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 113.244 -1.798 . . . . 39.810000000000002 113.168 -179.284 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 24.2 t70 -79.81 -42.65 23.95 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 120.341 -1.474 . . . . 51.289999999999999 107.706 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 20.1 t0 -57.11 113.54 1.76 Allowed 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 122.756 1.265 . . . . 39.780000000000001 109.865 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 15.1 m -46.27 -35.24 2.31 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 CA-C-N 113.502 -1.681 . . . . 39.280000000000001 114.443 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1354 ' ' VAL . . . . . 0.562 HG13 ' HB2' ' B' 1124 ' ' ALA . 47.4 t -67.72 -50.53 59.69 Favored 'Isoleucine or valine' 0 C--O 1.263 1.794 0 O-C-N 124.72 1.262 . . . . 35.700000000000003 110.751 177.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1355 ' ' ILE . . . . . 0.575 ' HA ' HG12 ' B' 1358 ' ' VAL . 34.7 mm -69.0 -40.2 80.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 CA-C-N 120.046 1.294 . . . . 35.770000000000003 108.902 178.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 43.8 tpt85 -52.52 -32.18 39.16 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 125.44 1.496 . . . . 38.549999999999997 111.662 168.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -74.14 -59.64 3.86 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 110.229 -1.149 . . . . 29.579999999999998 110.229 176.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1358 ' ' VAL . . . . . 0.766 HG23 HG22 ' B' 1118 ' ' VAL . 11.6 p -60.32 -38.55 77.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-N 118.393 1.096 . . . . 32.060000000000002 111.634 -172.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1359 ' ' THR . . . . . 0.715 ' HB ' ' HE1' ' B' 1350 ' ' PHE . 5.6 m -81.78 92.17 6.61 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 123.049 1.404 . . . . 29.0 107.695 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1360 ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' B' 1368 ' ' TRP . 31.2 m -82.27 -17.88 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 110.771 -2.922 . . . . 29.68 113.903 -176.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1361 ' ' ILE . . . . . 0.461 HG12 ' HA ' ' B' 1366 ' ' ILE . 48.6 mt -133.7 106.88 9.68 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 N-CA-C 101.274 -3.602 . . . . 32.049999999999997 101.274 168.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1362 ' ' ARG . . . . . 0.53 HH11 ' HB2' ' B' 1350 ' ' PHE . 46.8 ttt180 -87.62 78.04 8.59 Favored 'General case' 0 C--O 1.243 0.727 0 O-C-N 118.341 -2.725 . . . . 32.520000000000003 109.182 174.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 58.62 89.1 0.06 Allowed 'General case' 0 C--O 1.246 0.912 0 CA-C-N 112.488 -2.142 . . . . 35.68 114.161 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 88.56 -72.68 2.3 Favored Glycine 0 N--CA 1.477 1.43 0 CA-C-N 114.733 -1.122 . . . . 34.259999999999998 111.253 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.03 117.64 6.73 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.182 0.993 . . . . 51.07 110.46 176.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1366 ' ' ILE . . . . . 0.461 ' HA ' HG12 ' B' 1361 ' ' ILE . 95.9 mt -74.24 104.13 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 104.93 -2.248 . . . . 39.869999999999997 104.93 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1367 ' ' THR . . . . . . . . . . . . . 7.2 p -94.2 -1.08 54.68 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.1 -1.409 . . . . 38.009999999999998 111.985 -174.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1368 ' ' TRP . . . . . 0.467 ' HB2' ' HB ' ' B' 1360 ' ' VAL . 24.5 t90 -74.23 137.67 75.34 Favored Pre-proline 0 CA--C 1.548 0.876 0 O-C-N 120.236 -1.54 . . . . 42.140000000000001 108.009 162.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -72.94 161.22 94.17 Favored 'Cis proline' 0 CA--C 1.512 -0.624 0 CA-C-N 123.171 2.168 . . . . 43.259999999999998 116.785 -11.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1370 ' ' ALA . . . . . . . . . . . . . . . -87.38 170.42 11.99 Favored Pre-proline 0 N--CA 1.469 0.505 0 CA-C-O 117.12 -1.419 . . . . 46.520000000000003 111.072 176.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -47.93 144.26 12.1 Favored 'Trans proline' 0 CA--C 1.555 1.557 0 C-N-CA 123.43 2.753 . . . . 51.950000000000003 112.671 165.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.96 75.76 2.17 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.568 2.845 . . . . 56.270000000000003 114.85 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1373 ' ' ILE . . . . . 0.523 HG23 HG21 ' B' 1121 ' ' ILE . 0.0 OUTLIER -82.92 128.76 38.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 104.895 -2.261 . . . . 60.829999999999998 104.895 173.618 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -68.25 123.23 20.15 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 115.707 1.743 . . . . 66.099999999999994 115.707 -173.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1375 ' ' VAL . . . . . 0.787 HG13 ' HB2' ' B' 1120 ' ' ARG . 14.4 t -60.88 123.23 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 1 O-C-N 129.208 4.068 . . . . 63.469999999999999 110.922 175.835 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.23 -4.627 0 O-C-N 119.795 -1.816 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 20' ' ' ALA . . . . . 0.814 ' HA ' HD21 ' C' ' 171' ' ' LEU . . . . . . . . 0 C--O 1.242 0.702 0 CA-C-O 118.828 -0.606 . . . . 0.0 111.508 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -45.33 -30.25 1.25 Allowed 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 117.454 2.39 . . . . 0.0 117.454 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -46.57 -40.19 12.34 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.991 1.716 . . . . 0.0 109.436 177.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 23' ' ' THR . . . . . 0.501 ' HA ' HD22 ' C' ' 26' ' ' LEU . 22.4 m -55.97 -29.23 59.9 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -178.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.55 -47.28 86.25 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.276 -1.515 . . . . 0.0 111.104 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -66.56 -34.36 77.73 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.327 1.051 . . . . 0.0 108.284 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.501 HD22 ' HA ' ' C' ' 23' ' ' THR . 2.2 mp -70.06 -31.31 68.86 Favored 'General case' 0 N--CA 1.426 -1.663 0 C-N-CA 123.825 0.85 . . . . 0.0 110.827 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 63.0 mt -61.14 -48.08 83.24 Favored 'General case' 0 CA--C 1.518 -0.282 0 O-C-N 119.431 -2.043 . . . . 0.0 115.334 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 28' ' ' LYS . . . . . . . . . . . . . 10.2 pttm -63.98 -28.2 69.65 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 119.063 -1.055 . . . . 0.0 113.213 172.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -73.87 -35.3 64.72 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 118.632 -0.699 . . . . 0.0 112.053 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.77 ' HA ' ' HB3' ' C' ' 107' ' ' ASP . 39.6 m -56.42 -17.79 9.15 Favored 'General case' 0 C--O 1.239 0.531 1 N-CA-C 124.137 4.865 . . . . 0.0 124.137 -163.677 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 44.2 m-70 66.67 -77.31 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 125.336 1.455 . . . . 0.0 109.726 -174.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 74.2 m -97.5 160.01 14.58 Favored 'General case' 0 C--O 1.242 0.661 0 O-C-N 120.158 -1.589 . . . . 0.0 108.318 168.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 12.8 t -132.23 118.01 34.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 O-C-N 119.01 -2.306 . . . . 0.0 105.658 174.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.629 HD11 ' HB3' ' C' ' 102' ' ' ASP . 27.3 mm -104.29 124.12 58.56 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 N-CA-C 105.882 -1.895 . . . . 0.0 105.882 175.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 35' ' ' ILE . . . . . 0.583 HG12 HD12 ' C' ' 110' ' ' LEU . 92.3 mt -107.03 125.61 63.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 176.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 82.8 m -106.86 98.79 22.51 Favored Pre-proline 0 N--CA 1.44 -0.962 0 O-C-N 119.316 -2.115 . . . . 0.0 112.249 171.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 37' ' ' PRO . . . . . 0.804 ' HD2' HG12 ' C' ' 68' ' ' ILE . 84.2 Cg_exo -75.95 56.32 4.75 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.421 2.747 . . . . 0.0 114.526 175.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.92 89.03 1.42 Allowed Glycine 0 N--CA 1.443 -0.894 0 O-C-N 119.78 -1.825 . . . . 0.0 111.137 -170.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 40.1 t80 65.76 -72.71 0.07 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.895 1.278 . . . . 0.0 108.916 -177.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -28.46 -64.09 0.11 Allowed Glycine 0 C--N 1.349 1.285 0 N-CA-C 117.985 1.954 . . . . 0.0 117.985 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 9.2 ttm -49.83 -39.84 40.15 Favored 'General case' 0 C--O 1.25 1.126 0 N-CA-C 118.265 2.691 . . . . 0.0 118.265 173.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -85.35 -22.92 28.25 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 9.0 p -84.13 -38.09 13.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 O-C-N 119.078 -2.264 . . . . 0.0 110.945 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.67 9.57 2.71 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 117.4 2.37 . . . . 0.0 117.4 175.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 45' ' ' GLN . . . . . . . . . . . . 0.388 1.0 OUTLIER 41.75 48.1 3.64 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 119.124 3.009 . . . . 0.0 119.124 -159.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.51 -1.31 57.05 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.887 169.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 47' ' ' GLN . . . . . 0.526 ' O ' HG12 ' C' ' 50' ' ' VAL . 0.0 OUTLIER -50.56 -48.84 57.3 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 118.335 -0.841 . . . . 0.0 111.455 177.424 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 48' ' ' TYR . . . . . 0.645 ' HB2' ' HD3' ' C' ' 49' ' ' PRO . 18.7 m-85 -71.42 -58.01 4.09 Favored Pre-proline 0 C--O 1.247 0.964 0 CA-C-O 116.87 -1.538 . . . . 0.0 113.922 177.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 49' ' ' PRO . . . . . 0.645 ' HD3' ' HB2' ' C' ' 48' ' ' TYR . 88.5 Cg_exo -50.9 -15.05 1.55 Allowed 'Trans proline' 0 C--N 1.367 1.53 0 N-CA-C 120.412 3.197 . . . . 0.0 120.412 172.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 50' ' ' VAL . . . . . 0.526 HG12 ' O ' ' C' ' 47' ' ' GLN . 5.5 p -63.6 -29.82 48.25 Favored 'Isoleucine or valine' 0 C--O 1.246 0.87 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.294 172.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.23 93.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 117.951 -2.968 . . . . 0.0 111.148 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 52' ' ' GLU . . . . . 0.519 ' HB3' ' HB2' ' C' ' 183' ' ' LEU . 3.1 mm-40 -47.42 -48.87 26.12 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 171.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 53' ' ' ILE . . . . . . . . . . . . 0.253 8.4 tp -72.99 -46.26 52.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.902 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 60.5 m -53.13 -36.77 61.15 Favored 'General case' 0 C--O 1.256 1.419 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -52.67 -64.22 0.89 Allowed 'General case' 0 C--O 1.238 0.485 0 C-N-CA 127.045 2.138 . . . . 0.0 111.311 173.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 56' ' ' LYS . . . . . 0.411 ' HE2' ' HB2' ' C' ' 56' ' ' LYS . 3.1 mppt? -66.12 -33.09 74.99 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 117.373 -1.298 . . . . 0.0 109.732 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 50.4 mt -60.54 -45.89 92.2 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 122.372 2.351 . . . . 0.0 108.845 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 58' ' ' ARG . . . . . 0.487 ' HD2' ' HA ' ' C' ' 58' ' ' ARG . 2.3 tpt180 -66.36 -43.99 84.45 Favored 'General case' 0 C--O 1.255 1.369 0 O-C-N 121.3 -0.875 . . . . 0.0 111.747 -178.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.63 -12.56 61.09 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 121.872 0.844 . . . . 0.0 112.67 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 60' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' C' ' 60' ' ' ARG . 1.8 tpm_? -76.87 -31.82 57.06 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-O 123.822 1.772 . . . . 0.0 110.045 171.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.47 42.01 2.62 Favored Glycine 0 N--CA 1.431 -1.638 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.654 -173.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 95.3 mt -109.11 132.1 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 121.568 0.699 . . . . 0.0 109.68 -177.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -68.94 91.74 0.48 Allowed 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 122.684 1.23 . . . . 0.0 108.255 169.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 8.9 p -96.98 122.43 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-O 122.525 1.155 . . . . 0.0 109.687 176.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 65' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' C' ' 34' ' ' ILE . 17.8 mmt-85 -129.27 153.43 47.8 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 175.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 66' ' ' PHE . . . . . 0.757 ' HB2' ' HA ' ' C' ' 93' ' ' VAL . 6.1 m-85 -112.93 141.67 46.49 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -126.74 99.54 0.54 Allowed Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 107.596 -2.202 . . . . 0.0 107.596 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 68' ' ' ILE . . . . . 0.804 HG12 ' HD2' ' C' ' 37' ' ' PRO . 1.1 mt -102.92 -154.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 O-C-N 124.411 0.712 . . . . 0.0 111.384 174.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -165.2 135.2 2.9 Favored Pre-proline 0 N--CA 1.473 0.68 0 O-C-N 119.243 -2.161 . . . . 0.0 105.61 -169.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 70' ' ' PRO . . . . . 0.565 ' HB3' ' O ' ' A' 1158 ' ' THR . 14.0 Cg_endo -45.4 -61.51 0.58 Allowed 'Trans proline' 0 C--N 1.352 0.716 1 C-N-CA 126.428 4.752 . . . . 0.0 117.526 -179.351 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 71' ' ' VAL . . . . . 0.422 ' HB ' ' H2N' ' C' 1001 ' ' NAP . 14.5 m -94.42 133.41 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.93 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 174.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.57 9.34 8.99 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 117.786 2.513 . . . . 0.0 117.786 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.88 -52.28 0.65 Allowed Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 -169.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 74' ' ' ARG . . . . . 0.453 ' HA ' ' OE1' ' B' 1203 ' ' GLN . 3.3 mpt_? -147.94 177.64 9.18 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 175.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 7.0 mt 53.71 44.39 1.87 Allowed Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 119.557 3.169 . . . . 0.0 119.557 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -63.31 133.74 41.89 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.691 2.927 . . . . 0.0 113.195 -174.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.22 -70.6 1.84 Allowed Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.385 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 78' ' ' HIS . . . . . . . . . . . . 0.258 0.8 OUTLIER -36.91 -34.2 0.07 Allowed 'General case' 0 C--O 1.25 1.124 0 N-CA-C 121.648 3.944 . . . . 0.0 121.648 177.115 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -54.36 -34.13 60.54 Favored 'General case' 0 C--N 1.347 0.46 0 O-C-N 118.942 -2.348 . . . . 0.0 113.926 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -77.0 -30.38 55.89 Favored 'General case' 0 CA--C 1.501 -0.912 0 O-C-N 120.822 -1.174 . . . . 0.0 112.107 175.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 6.5 t -67.06 -39.77 84.02 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 O-C-N 120.678 -1.264 . . . . 0.0 110.689 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 95.3 mt -54.97 -36.24 65.16 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.111 0.964 . . . . 0.0 112.381 171.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.514 HD21 ' HG2' ' C' ' 37' ' ' PRO . 8.1 mp -71.72 -31.23 66.49 Favored 'General case' 0 C--O 1.249 1.04 0 CA-C-N 119.997 1.272 . . . . 0.0 112.077 176.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.13 -30.15 64.76 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.681 173.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.25 -48.37 78.52 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-O 122.024 0.916 . . . . 0.0 109.146 166.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.03 -1.38 2.05 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 119.171 -2.205 . . . . 0.0 115.827 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp 55.29 53.11 10.42 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -171.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 88' ' ' VAL . . . . . 0.501 HG21 HG13 ' C' ' 50' ' ' VAL . 14.5 t -111.27 125.55 30.33 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 101.483 -3.525 . . . . 0.0 101.483 169.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 89' ' ' PRO . . . . . 0.568 ' HG2' HG12 ' C' ' 92' ' ' ILE . 92.8 Cg_endo -61.66 120.97 8.86 Favored 'Trans proline' 0 C--O 1.241 0.653 1 C-N-CA 126.49 4.793 . . . . 0.0 115.949 -171.005 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.58 -26.73 45.32 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 126.66 1.984 . . . . 0.0 113.008 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -58.46 -51.3 70.43 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 119.965 1.257 . . . . 0.0 112.148 174.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 92' ' ' ILE . . . . . 0.568 HG12 ' HG2' ' C' ' 89' ' ' PRO . 45.2 pt -77.73 -23.11 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 119.655 -1.903 . . . . 0.0 110.575 -175.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 93' ' ' VAL . . . . . 0.757 ' HA ' ' HB2' ' C' ' 66' ' ' PHE . 67.9 t -68.35 83.55 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 174.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 20.7 mt -89.84 151.85 21.56 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 173.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 95' ' ' GLU . . . . . 0.52 ' HB2' HD13 ' A' 1157 ' ' ILE . 9.6 mp0 -138.53 127.96 24.59 Favored 'General case' 0 C--O 1.249 1.066 0 O-C-N 118.597 -2.565 . . . . 0.0 108.44 176.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 50.3 ttp 45.11 75.17 0.11 Allowed 'General case' 0 C--N 1.354 0.8 0 CA-C-O 124.872 2.272 . . . . 0.0 113.732 -177.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -145.5 164.01 32.93 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 109.994 -3.275 . . . . 0.0 106.809 -162.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -79.97 13.41 2.24 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 112.934 -1.939 . . . . 0.0 111.66 -178.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 4.2 tt -45.42 -16.35 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 124.614 1.166 . . . . 0.0 111.652 153.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 100' ' ' ASN . . . . . 0.457 ' ND2' ' HB2' ' C' ' 137' ' ' GLU . 1.7 t-20 -33.91 -35.85 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 117.108 2.262 . . . . 0.0 117.108 162.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -65.45 -62.1 1.72 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 119.336 -0.945 . . . . 0.0 111.232 172.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 102' ' ' ASP . . . . . 0.629 ' HB3' HD11 ' C' ' 34' ' ' ILE . 5.1 m-20 -51.0 -32.79 22.3 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 175.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 103' ' ' PHE . . . . . 0.448 ' HB3' ' HB ' ' C' ' 138' ' ' VAL . 3.6 m-85 -55.71 -47.97 75.95 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 125.705 1.602 . . . . 0.0 109.958 170.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -79.97 -18.33 50.62 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 119.01 0.823 . . . . 0.0 111.774 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -73.08 -47.13 47.11 Favored 'General case' 0 C--O 1.239 0.501 0 O-C-N 120.459 -1.401 . . . . 0.0 111.548 171.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 106' ' ' THR . . . . . 0.53 HG21 ' H ' ' C' ' 34' ' ' ILE . 77.0 m -54.14 133.8 44.19 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 122.342 0.257 . . . . 0.0 111.599 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 107' ' ' ASP . . . . . 0.77 ' HB3' ' HA ' ' C' ' 30' ' ' SER . 11.0 t70 -67.07 -65.59 0.66 Allowed 'General case' 0 C--O 1.234 0.252 0 O-C-N 124.076 0.86 . . . . 0.0 112.292 169.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 108' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' C' ' 143' ' ' ASN . 68.0 m -103.42 105.91 16.29 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 123.978 0.911 . . . . 0.0 109.64 -178.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 109' ' ' VAL . . . . . 0.612 HG13 ' HB ' ' C' ' 34' ' ' ILE . 16.4 t -89.54 110.97 22.35 Favored 'Isoleucine or valine' 0 C--N 1.349 0.578 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -176.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 110' ' ' LEU . . . . . 0.583 HD12 HG12 ' C' ' 35' ' ' ILE . 28.5 mt -77.96 84.26 4.25 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 123.219 1.485 . . . . 0.0 110.791 -175.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 111' ' ' VAL . . . . . 0.568 HG11 HG21 ' C' ' 118' ' ' VAL . 93.1 t -90.65 96.3 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 CA-C-O 123.154 1.454 . . . . 0.0 108.622 -177.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 112' ' ' ILE . . . . . 0.427 HD11 HG23 ' C' ' 35' ' ' ILE . 1.3 mm -83.67 89.52 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-O 124.001 1.858 . . . . 0.0 108.586 -171.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.55 -103.91 2.47 Favored Glycine 0 CA--C 1.496 -1.116 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.669 -172.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . 56.47 -57.11 0.02 OUTLIER 'General case' 0 C--O 1.249 1.063 0 N-CA-C 120.463 3.505 . . . . 0.0 120.463 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 115' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 59.67 -93.03 0.04 OUTLIER 'General case' 0 C--O 1.241 0.644 0 CA-C-N 122.553 2.433 . . . . 0.0 112.438 173.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 116' ' ' ASP . . . . . 0.765 ' HA ' ' HB2' ' C' ' 119' ' ' ASN . 34.4 m-20 -82.72 -19.38 38.11 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.123 -0.986 . . . . 0.0 111.977 -176.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 117' ' ' THR . . . . . . . . . . . . 0.254 1.0 OUTLIER -67.22 -15.28 63.61 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 176.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.568 HG21 HG11 ' C' ' 111' ' ' VAL . 16.5 m -122.81 30.66 2.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 124.612 1.165 . . . . 0.0 108.327 171.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 119' ' ' ASN . . . . . 0.765 ' HB2' ' HA ' ' C' ' 116' ' ' ASP . 46.7 t-20 -86.78 119.62 71.31 Favored Pre-proline 0 CA--C 1.506 -0.714 0 O-C-N 119.212 -2.18 . . . . 0.0 114.146 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 120' ' ' PRO . . . . . 0.425 ' HG3' ' CE3' ' C' ' 139' ' ' TRP . 40.7 Cg_exo -53.24 -53.22 7.05 Favored 'Trans proline' 0 C--O 1.243 0.733 0 C-N-CA 124.878 3.718 . . . . 0.0 113.127 175.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 121' ' ' ALA . . . . . 0.457 ' HA ' ' HB3' ' C' ' 124' ' ' ASP . . . -61.9 -28.09 69.27 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -174.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 122' ' ' ALA . . . . . 0.42 ' HB1' ' HB3' ' C' ' 133' ' ' MET . . . -54.51 -41.05 69.19 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-O 121.609 0.719 . . . . 0.0 111.622 172.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -92.57 -16.62 25.45 Favored 'General case' 0 C--O 1.245 0.846 0 O-C-N 118.499 -2.625 . . . . 0.0 114.074 173.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 124' ' ' ASP . . . . . 0.457 ' HB3' ' HA ' ' C' ' 121' ' ' ALA . 12.4 t70 -98.77 -35.52 10.12 Favored 'General case' 0 C--O 1.241 0.647 0 O-C-N 121.242 -0.911 . . . . 0.0 112.846 -165.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 125' ' ' ASP . . . . . 0.422 ' OD2' ' HB3' ' C' ' 127' ' ' LYS . 25.4 t70 -117.54 126.94 26.99 Favored Pre-proline 0 C--N 1.321 -0.639 0 C-N-CA 124.516 1.126 . . . . 0.0 113.112 -157.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -62.36 -38.03 56.53 Favored 'Trans proline' 0 CA--C 1.548 1.196 0 C-N-CA 124.971 3.781 . . . . 0.0 114.57 176.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 127' ' ' LYS . . . . . 0.422 ' HB3' ' OD2' ' C' ' 125' ' ' ASP . 4.2 ttpm? -63.75 -29.57 70.77 Favored 'General case' 0 C--N 1.314 -0.941 0 O-C-N 119.291 -2.131 . . . . 0.0 111.267 -178.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 128' ' ' SER . . . . . 0.471 ' HA ' HG11 ' C' ' 158' ' ' VAL . 18.4 m -58.6 127.94 82.74 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 118.074 -0.965 . . . . 0.0 111.044 172.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 129' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -56.23 -31.36 83.74 Favored 'Trans proline' 0 C--O 1.257 1.428 0 CA-C-N 122.506 1.931 . . . . 0.0 116.17 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 10.5 pt -105.78 53.53 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-O 123.246 1.498 . . . . 0.0 109.278 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.85 120.8 14.17 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 123.3 1.524 . . . . 0.0 111.811 -171.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.61 38.97 10.02 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 133' ' ' MET . . . . . 0.682 ' SD ' ' HD2' ' C' ' 134' ' ' PRO . 42.8 tpp -73.72 134.98 78.23 Favored Pre-proline 0 N--CA 1.45 -0.444 0 O-C-N 119.819 -1.989 . . . . 0.0 110.535 172.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 134' ' ' PRO . . . . . 0.682 ' HD2' ' SD ' ' C' ' 133' ' ' MET . 92.8 Cg_endo -68.25 90.24 0.39 Allowed 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 124.011 3.141 . . . . 0.0 110.418 173.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 135' ' ' VAL . . . . . 0.402 HG22 ' O ' ' C' ' 133' ' ' MET . 1.5 m -110.95 150.8 13.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -175.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.456 ' HB2' HG12 ' C' ' 118' ' ' VAL . 28.7 mt -73.9 104.51 4.79 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.934 0.873 . . . . 0.0 112.589 -165.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 137' ' ' GLU . . . . . 0.457 ' HB2' ' ND2' ' C' ' 100' ' ' ASN . 20.4 mt-10 -64.63 110.97 2.53 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -172.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 138' ' ' VAL . . . . . 0.448 ' HB ' ' HB3' ' C' ' 103' ' ' PHE . 4.9 p -151.71 61.4 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 164.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 139' ' ' TRP . . . . . 0.425 ' CE3' ' HG3' ' C' ' 120' ' ' PRO . 4.5 m95 -81.63 136.67 35.53 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.909 -1.496 . . . . 0.0 112.837 -166.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 41.65 45.54 2.97 Favored 'General case' 0 C--O 1.243 0.755 0 O-C-N 126.886 2.616 . . . . 0.0 116.603 175.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -166.3 162.48 17.29 Favored 'General case' 0 C--N 1.345 0.402 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -170.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 59.91 163.29 0.05 Allowed 'General case' 0 C--O 1.242 0.681 0 N-CA-C 117.77 2.507 . . . . 0.0 117.77 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 143' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' C' ' 108' ' ' THR . 20.6 t-20 -82.3 68.91 8.91 Favored 'General case' 0 C--O 1.248 1.01 0 O-C-N 120.979 -1.076 . . . . 0.0 109.269 176.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 144' ' ' VAL . . . . . . . . . . . . . 26.0 t -74.88 96.56 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 113.598 -1.637 . . . . 0.0 108.627 -177.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 145' ' ' ILE . . . . . 0.461 HD11 HD13 ' C' ' 171' ' ' LEU 0.266 7.9 tp -92.1 87.31 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-O 126.416 3.008 . . . . 0.0 113.3 -170.018 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 146' ' ' VAL . . . . . 0.506 ' HA ' ' HB ' ' C' ' 111' ' ' VAL . 26.7 t -77.73 97.42 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 CA-C-N 108.761 -3.836 . . . . 0.0 111.087 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 147' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -67.1 96.24 0.44 Allowed 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 148' ' ' LYS . . . . . 0.599 ' O ' ' HA ' ' C' ' 172' ' ' PHE . 48.2 tptt -123.38 131.01 53.52 Favored 'General case' 0 C--O 1.211 -0.938 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -174.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 9.8 tpp85 -63.65 -49.26 73.92 Favored 'General case' 0 C--O 1.256 1.437 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -171.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 150' ' ' SER . . . . . 0.508 ' O ' ' HE3' ' C' ' 148' ' ' LYS . 1.5 m -143.45 170.47 15.73 Favored 'General case' 0 C--O 1.249 1.073 0 O-C-N 120.86 -1.15 . . . . 0.0 108.966 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 10.5 tpt -79.17 99.11 6.84 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 176.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -155.29 157.51 37.33 Favored 'General case' 0 N--CA 1.426 -1.671 0 C-N-CA 118.131 -1.428 . . . . 0.0 109.973 -176.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 4.8 m -62.75 130.29 44.26 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 125.548 1.78 . . . . 0.0 106.639 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 154' ' ' GLY . . . . . 0.433 ' HA2' ' O3B' ' C' 1001 ' ' NAP . . . -72.32 -120.83 0.06 OUTLIER Glycine 0 N--CA 1.415 -2.732 0 O-C-N 120.745 -1.222 . . . . 0.0 113.387 171.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -86.41 -66.83 0.86 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 170.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 156' ' ' ALA . . . . . . . . . . . . . . . -85.18 -39.65 17.6 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 170.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 54.89 33.41 56.52 Favored Glycine 0 C--N 1.352 1.423 0 C-N-CA 124.692 1.139 . . . . 0.0 114.335 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 158' ' ' VAL . . . . . 0.471 HG11 ' HA ' ' C' ' 128' ' ' SER . 3.3 m -76.42 144.52 11.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 O-C-N 121.441 -1.035 . . . . 0.0 111.265 -173.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.58 136.43 57.98 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 -174.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 160' ' ' ASN . . . . . 0.405 ' OD1' ' HB3' ' C' ' 162' ' ' LEU . 13.8 p30 -169.72 156.54 6.19 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -171.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -54.31 -31.42 67.08 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 124.642 3.561 . . . . 0.0 115.223 177.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 162' ' ' LEU . . . . . 0.405 ' HB3' ' OD1' ' C' ' 160' ' ' ASN . 4.1 tt -68.04 -24.12 65.05 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 118.665 -2.522 . . . . 0.0 111.516 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 163' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -79.16 -10.78 59.91 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 172.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -127.57 -30.93 2.52 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 -169.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 35.8 mmtt -74.83 161.78 29.26 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.25 -170.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -89.84 -38.26 13.88 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.843 -173.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -74.25 -57.27 4.06 Favored 'General case' 0 C--O 1.243 0.716 0 O-C-N 117.329 -3.357 . . . . 0.0 106.93 172.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 168' ' ' THR . . . . . . . . . . . . 0.258 4.2 m -82.53 85.0 7.04 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 103.183 -2.895 . . . . 0.0 103.183 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -129.75 132.03 46.45 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-O 122.953 1.358 . . . . 0.0 113.607 -162.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 170' ' ' MET . . . . . 0.47 ' HA ' ' HB ' ' C' ' 146' ' ' VAL . 51.4 mtm -73.18 99.65 2.89 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 110.337 -3.119 . . . . 0.0 110.069 165.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 171' ' ' LEU . . . . . 0.814 HD21 ' HA ' ' C' ' 20' ' ' ALA . 17.4 tp -76.71 122.49 24.78 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 104.247 -2.501 . . . . 0.0 104.247 177.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 172' ' ' PHE . . . . . 0.599 ' HA ' ' O ' ' C' ' 148' ' ' LYS . 46.3 m-85 -89.26 77.93 7.37 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 120.24 -1.537 . . . . 0.0 111.792 -166.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -149.99 162.78 29.27 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-N 113.46 -1.7 . . . . 0.0 112.295 -172.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 174' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -75.0 144.91 42.88 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 -177.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.06 -39.73 93.37 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 125.367 1.667 . . . . 0.0 112.795 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.92 -51.45 18.49 Favored 'General case' 0 C--N 1.359 1.005 0 C-N-CA 117.759 -1.576 . . . . 0.0 108.511 174.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 177' ' ' ALA . . . . . . . . . . . . . . . -53.7 -55.94 21.73 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 125.939 1.696 . . . . 0.0 114.379 -168.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 4.5 m -57.99 -38.3 75.85 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-N 114.678 -1.146 . . . . 0.0 113.83 175.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 179' ' ' VAL . . . . . 0.458 ' HA ' HG12 ' C' ' 182' ' ' ILE . 40.0 t -72.24 -38.38 61.83 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -57.6 -40.71 79.68 Favored 'General case' 0 C--N 1.351 0.66 0 O-C-N 118.45 -2.656 . . . . 0.0 112.461 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -58.97 -53.37 59.15 Favored 'General case' 0 CA--C 1.552 1.022 0 O-C-N 121.506 -0.746 . . . . 0.0 111.812 170.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 182' ' ' ILE . . . . . 0.458 HG12 ' HA ' ' C' ' 179' ' ' VAL . 30.9 pt -78.15 -24.41 13.87 Favored 'Isoleucine or valine' 0 C--O 1.249 1.077 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -168.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 183' ' ' LEU . . . . . 0.519 ' HB2' ' HB3' ' C' ' 52' ' ' GLU . 4.7 pp -59.0 -24.78 63.08 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 118.831 -2.418 . . . . 0.0 114.815 171.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 28.6 tptt -96.71 -60.18 1.65 Allowed 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 175.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -88.88 107.25 18.89 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 123.172 1.463 . . . . 0.0 108.265 -171.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 186' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--O 1.218 -0.567 0 CA-C-N 114.519 -1.219 . . . . 0.0 112.352 160.851 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' NAD . . . . . 0.604 ' O1N' ' H3D' ' B' ' 1' ' ' NAD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C 1001 ' ' NAP . . . . . 0.433 ' O3B' ' HA2' ' C' ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 48.6 t-80 . . . . . 0 CA--C 1.506 -0.723 0 N-CA-C 108.811 -0.811 . . . . 65.739999999999995 108.811 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -67.47 81.28 0.15 Allowed Glycine 0 N--CA 1.424 -2.122 0 CA-C-O 125.576 2.764 . . . . 48.659999999999997 114.539 176.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1002 ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' 1032 ' ' THR . 30.6 ttp180 -100.85 118.7 37.43 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 111.07 -2.565 . . . . 44.560000000000002 104.154 172.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1003 ' ' ILE . . . . . 0.594 HD13 HD13 ' A' 1335 ' ' LEU . 54.9 mt -101.46 101.91 12.76 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 103.332 -2.84 . . . . 34.859999999999999 103.332 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -76.41 122.25 6.37 Favored Glycine 0 C--O 1.256 1.477 0 CA-C-N 109.644 -3.434 . . . . 30.75 110.41 174.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.587 HG23 ' HB3' ' A' 1017 ' ' ALA . 49.0 mm -105.01 98.02 14.55 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 105.912 -1.884 . . . . 32.210000000000001 105.912 177.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1006 ' ' PRO . . . . . 0.444 ' HA ' ' HB2' ' A' 1036 ' ' GLU . 80.0 Cg_exo -73.81 155.16 48.92 Favored 'Trans proline' 0 CA--C 1.508 -0.8 0 C-N-CA 123.305 2.67 . . . . 32.979999999999997 112.133 167.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1007 ' ' ARG . . . . . 0.448 ' O ' ' HG3' ' A' 1009 ' ' ARG . 33.9 ttp85 -71.85 146.14 48.14 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 110.564 -3.016 . . . . 47.979999999999997 105.316 162.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1008 ' ' GLU . . . . . 0.42 ' CD ' ' HZ2' ' A' 1071 ' ' LYS . 4.2 tp10 -75.31 119.49 19.49 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 123.603 1.668 . . . . 34.700000000000003 108.254 172.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1009 ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' 1007 ' ' ARG . 25.7 mtp-105 -104.43 7.65 35.54 Favored 'General case' 0 N--CA 1.423 -1.778 0 CA-C-N 109.734 -3.394 . . . . 53.369999999999997 108.052 -172.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 19.9 tp -62.88 127.11 29.7 Favored 'General case' 0 CA--C 1.505 -0.774 0 O-C-N 118.376 -2.702 . . . . 45.07 108.171 152.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1011 ' ' THR . . . . . . . . . . . . . 7.9 m -52.95 144.42 14.89 Favored 'General case' 0 C--O 1.255 1.365 0 C-N-CA 125.06 1.344 . . . . 40.359999999999999 112.067 -173.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 57.8 t30 70.19 -35.37 0.32 Allowed 'General case' 0 C--O 1.269 2.1 0 N-CA-C 114.728 1.381 . . . . 40.609999999999999 114.728 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -74.25 99.59 3.48 Favored 'General case' 0 C--O 1.254 1.331 0 CA-C-N 120.95 1.705 . . . . 33.759999999999998 110.647 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1014 ' ' THR . . . . . 0.453 HG22 ' HB3' ' A' 1042 ' ' LEU . 5.3 p -75.81 94.83 3.37 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 112.186 -2.279 . . . . 27.890000000000001 106.314 174.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1015 ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -145.63 147.19 31.75 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 104.472 -2.418 . . . . 29.02 104.472 173.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1016 ' ' VAL . . . . . 0.539 HG11 ' HZ ' ' A' 1050 ' ' PHE . 11.7 p -110.85 160.83 9.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 O-C-N 118.791 -2.443 . . . . 28.129999999999999 106.245 168.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1017 ' ' ALA . . . . . 0.587 ' HB3' HG23 ' A' 1005 ' ' ILE . . . -69.77 -23.34 63.34 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 118.583 -2.573 . . . . 26.870000000000001 114.673 -176.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1018 ' ' ALA . . . . . 0.85 ' HB1' ' HB ' ' A' 1022 ' ' THR . . . -156.72 136.29 12.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.454 -0.943 . . . . 26.77 108.454 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1019 ' ' THR . . . . . 0.422 HG23 ' HB2' ' A' 1324 ' ' SER . 41.6 p -72.58 172.7 7.03 Favored Pre-proline 0 C--O 1.249 1.045 0 CA-C-N 119.822 1.192 . . . . 27.02 114.207 174.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1020 ' ' PRO . . . . . 0.524 ' HD2' ' CD2' ' A' 1045 ' ' PHE . 0.1 OUTLIER -49.96 -38.98 49.9 Favored 'Trans proline' 0 C--O 1.245 0.832 0 C-N-CA 123.216 2.611 . . . . 30.57 113.813 166.262 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -63.78 -39.41 94.2 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 113.029 0.752 . . . . 47.810000000000002 113.029 173.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1022 ' ' THR . . . . . 0.85 ' HB ' ' HB1' ' A' 1018 ' ' ALA . 0.2 OUTLIER -71.66 -29.48 64.67 Favored 'General case' 0 C--N 1.312 -1.039 0 O-C-N 121.124 -0.985 . . . . 30.77 113.245 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1023 ' ' VAL . . . . . 0.689 HG22 HG11 ' A' 1033 ' ' VAL . 48.7 t -61.52 -48.49 88.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.862 0 C-N-CA 125.909 1.684 . . . . 33.590000000000003 107.416 171.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -55.94 -34.37 65.6 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 120.327 -1.483 . . . . 53.289999999999999 112.616 175.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -64.7 -47.76 77.15 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 119.792 1.178 . . . . 46.920000000000002 110.596 174.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1026 ' ' LEU . . . . . 0.711 HD21 HG22 ' A' 1332 ' ' VAL . 60.3 mt -59.14 -32.57 69.98 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.574 1.324 . . . . 37.170000000000002 114.574 177.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 1.9 tp -65.19 -34.86 79.39 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.874 -1.057 . . . . 44.439999999999998 111.689 168.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -67.49 -32.78 73.83 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 122.402 1.096 . . . . 52.579999999999998 112.22 175.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1029 ' ' LEU . . . . . 0.605 ' HA ' ' HE2' ' A' 1342 ' ' LYS . 45.2 mt -76.23 -26.11 55.72 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.446 -1.252 . . . . 45.689999999999998 110.269 171.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 84.62 43.51 6.84 Favored Glycine 0 N--CA 1.431 -1.698 0 CA-C-O 124.117 1.954 . . . . 42.090000000000003 112.679 175.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -118.53 137.71 53.03 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 104.688 -2.338 . . . . 40.719999999999999 104.688 -176.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1032 ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' 1002 ' ' ARG . 0.1 OUTLIER -78.5 113.06 16.18 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.187 -1.412 . . . . 37.770000000000003 107.187 -172.577 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1033 ' ' VAL . . . . . 0.689 HG11 HG22 ' A' 1023 ' ' VAL . 3.1 t -85.15 134.37 27.23 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 N-CA-C 107.318 -1.364 . . . . 33.539999999999999 107.318 -174.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1034 ' ' ALA . . . . . 0.637 ' HA ' ' HB3' ' A' 1056 ' ' GLU . . . -124.86 129.57 50.67 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 116.753 -1.594 . . . . 31.68 106.742 174.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1035 ' ' VAL . . . . . 0.491 HG22 ' HB ' ' A' 1005 ' ' ILE . 90.5 t -122.16 145.84 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 123.589 2.904 . . . . 31.52 108.331 -178.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1036 ' ' GLU . . . . . 0.6 ' HG2' HG11 ' A' 1063 ' ' VAL . 0.1 OUTLIER -64.66 134.66 54.72 Favored 'General case' 0 N--CA 1.436 -1.158 0 O-C-N 125.249 1.593 . . . . 41.039999999999999 108.373 178.509 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1037 ' ' SER . . . . . . . . . . . . . 25.5 m -75.22 122.51 23.78 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-N 115.093 -0.958 . . . . 31.829999999999998 110.422 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 91.36 21.76 33.99 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 114.764 -1.107 . . . . 29.359999999999999 112.236 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1039 ' ' ALA . . . . . 0.438 ' HA ' ' HD3' ' A' 1007 ' ' ARG . . . -87.06 -46.01 10.19 Favored 'General case' 0 CA--C 1.495 -1.172 0 O-C-N 119.952 -1.911 . . . . 27.780000000000001 109.847 -178.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -70.44 -24.73 76.55 Favored Glycine 0 C--O 1.242 0.596 0 C-N-CA 120.182 -1.008 . . . . 28.91 113.047 -170.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -61.59 -38.11 86.35 Favored 'General case' 0 CA--C 1.505 -0.756 0 O-C-N 124.314 0.655 . . . . 51.18 111.401 175.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1042 ' ' LEU . . . . . 0.453 ' HB3' HG22 ' A' 1014 ' ' THR . 16.8 mt -70.59 -58.2 3.93 Favored 'General case' 0 CA--C 1.513 -0.459 0 O-C-N 121.468 -0.77 . . . . 29.91 110.118 169.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1043 ' ' ALA . . . . . . . . . . . . . . . -65.5 3.8 0.65 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.375 1.62 . . . . 28.539999999999999 115.375 -173.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1044 ' ' SER . . . . . . . . . . . . . 49.5 m 65.73 28.77 10.96 Favored 'General case' 0 C--O 1.244 0.791 0 O-C-N 120.259 -1.526 . . . . 33.060000000000002 114.95 172.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1045 ' ' PHE . . . . . 0.524 ' CD2' ' HD2' ' A' 1020 ' ' PRO . 0.8 OUTLIER -155.81 101.33 2.12 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 101.86 -3.385 . . . . 30.289999999999999 101.86 174.069 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 4.2 p30 -73.36 161.31 30.61 Favored 'General case' 0 C--O 1.248 0.984 0 N-CA-C 117.676 2.472 . . . . 48.619999999999997 117.676 -153.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1047 ' ' ASP . . . . . 0.677 ' HA ' ' HD2' ' A' 1050 ' ' PHE . 5.5 m-20 -57.54 -23.4 50.19 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-N 112.493 -2.139 . . . . 36.740000000000002 114.993 177.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.9 -32.12 40.25 Favored 'General case' 0 C--O 1.24 0.605 0 O-C-N 121.156 -0.965 . . . . 43.729999999999997 111.298 174.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -72.09 -29.79 64.45 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.967 -0.753 . . . . 32.810000000000002 108.967 172.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1050 ' ' PHE . . . . . 0.677 ' HD2' ' HA ' ' A' 1047 ' ' ASP . 48.3 m-85 -58.42 -49.07 78.59 Favored 'General case' 0 C--N 1.346 0.442 0 N-CA-C 114.45 1.278 . . . . 31.859999999999999 114.45 165.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 6.9 t -59.16 -39.55 78.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 O-C-N 119.881 -1.762 . . . . 33.219999999999999 111.891 174.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -61.15 -40.65 94.64 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 123.244 0.617 . . . . 50.829999999999998 111.99 172.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -72.06 -23.8 61.42 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 118.98 -2.325 . . . . 33.119999999999997 110.822 173.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 101.8 49.31 1.28 Allowed Glycine 0 N--CA 1.439 -1.118 0 C-N-CA 118.247 -1.93 . . . . 35.829999999999998 112.443 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1055 ' ' ALA . . . . . 0.436 ' HB1' HG23 ' A' 1035 ' ' VAL . . . -101.98 135.89 42.76 Favored 'General case' 0 N--CA 1.423 -1.775 0 O-C-N 125.0 1.059 . . . . 34.82 111.369 175.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1056 ' ' GLU . . . . . 0.637 ' HB3' ' HA ' ' A' 1034 ' ' ALA . 46.9 tt0 -77.65 99.04 5.65 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 104.968 -2.234 . . . . 49.049999999999997 104.968 -177.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1057 ' ' ILE . . . . . 0.427 HD13 ' HB ' ' A' 1035 ' ' VAL . 32.0 mm -75.18 102.96 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 N-CA-C 108.535 -0.913 . . . . 38.530000000000001 108.535 -177.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1058 ' ' VAL . . . . . 0.403 HG23 ' HB ' ' A' 1063 ' ' VAL . 2.8 m -127.08 166.5 23.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 122.512 1.149 . . . . 42.109999999999999 108.287 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -114.47 141.34 47.81 Favored 'General case' 0 C--O 1.258 1.513 0 O-C-N 120.602 -1.311 . . . . 58.0 109.832 -161.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 44.25 -116.49 1.62 Allowed Glycine 0 N--CA 1.477 1.411 0 N-CA-C 115.736 1.055 . . . . 52.119999999999997 115.736 163.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 6.8 m120 -60.28 -38.44 83.59 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 120.153 -0.619 . . . . 54.75 110.046 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1062 ' ' SER . . . . . . . . . . . . . 14.6 m -74.66 -11.67 60.24 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 120.037 -1.664 . . . . 50.340000000000003 110.267 -173.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1063 ' ' VAL . . . . . 0.6 HG11 ' HG2' ' A' 1036 ' ' GLU . 11.6 p -88.79 -41.14 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 O-C-N 119.107 -2.246 . . . . 41.460000000000001 106.291 166.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1064 ' ' TRP . . . . . 0.513 ' CH2' ' HB3' ' A' 1079 ' ' GLU . 24.9 m95 -64.44 -24.61 67.69 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 115.283 1.586 . . . . 39.32 115.283 -174.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -87.04 79.58 8.65 Favored 'General case' 0 C--O 1.247 0.94 0 O-C-N 120.943 -1.098 . . . . 55.380000000000003 109.729 174.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1066 ' ' SER . . . . . 0.43 ' HB3' ' O ' ' A' 1002 ' ' ARG . 69.2 m -135.41 166.06 24.03 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 120.264 -0.575 . . . . 41.869999999999997 111.032 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -68.24 -35.67 78.28 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-O 121.593 0.711 . . . . 53.200000000000003 110.241 -177.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1068 ' ' ILE . . . . . 0.447 ' HB ' HG12 ' A' 1003 ' ' ILE . 4.9 mp -124.55 141.24 45.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 O-C-N 119.193 -2.192 . . . . 41.899999999999999 107.825 173.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1069 ' ' ILE . . . . . . . . . . . . . 19.5 mm -126.34 118.76 52.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 104.139 -2.541 . . . . 38.729999999999997 104.139 171.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1070 ' ' LEU . . . . . 0.756 HD21 HD11 ' A' 1335 ' ' LEU . 64.3 mt -93.02 135.74 33.92 Favored 'General case' 0 C--N 1.316 -0.859 0 O-C-N 124.419 1.075 . . . . 32.439999999999998 108.553 172.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1071 ' ' LYS . . . . . 0.42 ' HZ2' ' CD ' ' A' 1008 ' ' GLU . 14.1 mmmt -137.21 147.16 45.65 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-O 123.528 1.632 . . . . 34.649999999999999 112.714 -175.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1072 ' ' VAL . . . . . 0.581 ' HA ' ' HE2' ' A' 1327 ' ' TYR . 0.0 OUTLIER -86.75 -35.43 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 CA-C-N 110.088 -3.233 . . . . 31.32 111.094 -163.199 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -127.32 -175.96 3.59 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 106.83 -1.545 . . . . 33.939999999999998 106.83 165.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1074 ' ' ALA . . . . . 0.558 ' HB1' HD21 ' A' 1101 ' ' LEU . . . -53.97 132.68 58.46 Favored Pre-proline 0 N--CA 1.465 0.31 0 CA-C-N 113.984 -1.462 . . . . 38.039999999999999 108.247 166.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1075 ' ' PRO . . . . . 0.497 ' HG2' HD21 ' A' 1089 ' ' LEU . 92.6 Cg_exo -65.88 145.88 81.49 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 123.677 2.918 . . . . 42.68 111.551 175.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 15.3 mt -71.65 159.63 34.06 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 106.49 -1.67 . . . . 46.740000000000002 106.49 173.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -50.45 -32.45 17.95 Favored 'General case' 0 C--O 1.242 0.687 0 O-C-N 119.744 -1.848 . . . . 58.609999999999999 113.683 171.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 12.4 t0 -51.98 -60.89 2.67 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 124.294 1.038 . . . . 59.200000000000003 109.887 167.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1079 ' ' GLU . . . . . 0.513 ' HB3' ' CH2' ' A' 1064 ' ' TRP . 55.6 mt-10 -65.04 -36.83 85.62 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.047 -1.433 . . . . 50.630000000000003 114.016 -173.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1080 ' ' ILE . . . . . 0.661 ' HA ' HD23 ' A' 1083 ' ' LEU . 66.3 mt -48.0 -52.46 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.125 1.77 . . . . 51.479999999999997 109.275 171.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -66.44 -25.85 66.94 Favored 'General case' 0 CA--C 1.512 -0.518 0 O-C-N 119.323 -2.111 . . . . 50.280000000000001 113.743 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 25.8 mt -77.81 -17.76 57.1 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 115.649 -0.705 . . . . 50.210000000000001 112.207 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1083 ' ' LEU . . . . . 0.661 HD23 ' HA ' ' A' 1080 ' ' ILE . 1.2 mm? -58.84 134.1 56.59 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 119.305 -2.122 . . . . 49.060000000000002 111.329 168.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.72 152.02 42.03 Favored Pre-proline 0 N--CA 1.473 0.705 0 CA-C-O 117.832 -1.08 . . . . 51.079999999999998 109.874 -175.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -54.34 116.39 3.03 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 124.707 3.605 . . . . 49.729999999999997 110.052 172.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 110.45 -5.8 29.92 Favored Glycine 0 CA--C 1.489 -1.587 0 N-CA-C 112.3 -0.32 . . . . 47.710000000000001 112.3 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1087 ' ' THR . . . . . . . . . . . . . 84.0 m -83.54 132.84 34.9 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 118.097 -3.002 . . . . 45.469999999999999 109.905 -174.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1088 ' ' THR . . . . . . . . . . . . . 1.6 m -89.09 94.65 10.01 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.333 -1.729 . . . . 42.039999999999999 106.333 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1089 ' ' LEU . . . . . 0.56 HD13 HD11 ' A' 1083 ' ' LEU . 54.2 tp -81.36 102.35 10.4 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.182 -0.949 . . . . 38.060000000000002 109.376 176.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1090 ' ' VAL . . . . . 0.752 HG13 ' HB2' ' A' 1113 ' ' MET . 3.2 t -99.75 123.05 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 104.822 -2.288 . . . . 37.399999999999999 104.822 174.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1091 ' ' SER . . . . . 0.415 ' OG ' ' HB2' ' A' 1071 ' ' LYS . 4.9 m -153.8 165.48 35.91 Favored 'General case' 0 CA--C 1.549 0.915 0 O-C-N 120.103 -1.623 . . . . 36.159999999999997 111.319 -175.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 15.2 t80 -86.66 101.97 13.76 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 106.048 -1.834 . . . . 38.939999999999998 106.048 166.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 40.3 mm -91.56 -65.34 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 123.046 1.403 . . . . 42.170000000000002 113.256 -170.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1094 ' ' TRP . . . . . 0.454 ' CZ2' HD21 ' A' 1130 ' ' LEU . 29.7 m95 69.69 74.63 0.27 Allowed Pre-proline 0 C--N 1.354 0.773 0 CA-C-N 112.185 -2.28 . . . . 46.509999999999998 113.947 -159.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -59.03 -32.6 97.8 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 122.803 2.336 . . . . 49.759999999999998 115.301 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -63.23 -43.63 97.53 Favored 'General case' 0 C--N 1.356 0.889 0 CA-C-N 120.846 1.657 . . . . 52.619999999999997 110.834 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -66.33 -52.72 44.27 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-N 114.257 -1.338 . . . . 60.740000000000002 112.621 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1098 ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -120.48 80.43 30.2 Favored Pre-proline 0 C--O 1.239 0.528 0 O-C-N 118.111 -2.868 . . . . 58.189999999999998 115.525 -174.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.95 -28.37 58.12 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 124.667 3.578 . . . . 54.590000000000003 111.404 175.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -54.97 -48.39 73.3 Favored 'General case' 0 CA--C 1.504 -0.813 0 O-C-N 120.171 -1.58 . . . . 63.280000000000001 109.321 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1101 ' ' LEU . . . . . 0.558 HD21 ' HB1' ' A' 1074 ' ' ALA . 1.3 mp -46.98 -52.62 14.24 Favored 'General case' 0 CA--C 1.513 -0.463 0 O-C-N 125.62 1.825 . . . . 54.75 113.685 172.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1102 ' ' MET . . . . . . . . . . . . . 72.8 mmm -57.8 -49.24 77.3 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 113.497 -1.683 . . . . 52.649999999999999 109.864 -176.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1103 ' ' GLN . . . . . 0.481 ' O ' ' HG2' ' A' 1107 ' ' GLU . 33.6 mt-30 -58.66 -51.62 69.15 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 123.192 1.472 . . . . 66.260000000000005 109.025 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1104 ' ' LYS . . . . . 0.492 ' HB3' HG21 ' A' 1080 ' ' ILE . 98.7 mttt -64.47 -40.75 96.29 Favored 'General case' 0 C--O 1.239 0.539 0 O-C-N 118.599 -2.563 . . . . 63.729999999999997 110.884 -176.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 63.3 mt -69.16 -34.46 75.01 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.095 0.558 . . . . 54.68 111.117 176.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -65.3 -42.65 92.86 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 106.766 -1.568 . . . . 53.640000000000001 106.766 177.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1107 ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' 1103 ' ' GLN . 47.4 mm-40 -55.85 -40.84 73.45 Favored 'General case' 0 CA--C 1.501 -0.919 0 O-C-N 125.296 1.623 . . . . 67.239999999999995 112.826 170.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1108 ' ' ARG . . . . . 0.405 ' HA ' ' NE ' ' A' 1108 ' ' ARG . 3.4 mmp_? -65.86 -23.02 66.58 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 116.945 -1.503 . . . . 65.760000000000005 112.685 175.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 30.8 t30 61.43 60.81 1.62 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 126.895 3.236 . . . . 58.710000000000001 113.446 -175.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1110 ' ' VAL . . . . . 0.508 HG11 ' HB3' ' A' 1083 ' ' LEU . 19.3 m -122.1 157.9 26.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 111.543 -2.572 . . . . 46.630000000000003 108.558 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1111 ' ' THR . . . . . . . . . . . . . 51.6 m -94.81 109.32 21.3 Favored 'General case' 0 N--CA 1.44 -0.961 0 O-C-N 120.999 -1.063 . . . . 44.130000000000003 111.426 171.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1112 ' ' VAL . . . . . . . . . . . . . 49.8 t -99.83 119.52 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-O 122.902 1.334 . . . . 40.439999999999998 109.366 -175.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1113 ' ' MET . . . . . 0.752 ' HB2' HG13 ' A' 1090 ' ' VAL . 10.7 mtp -108.17 120.52 42.57 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 104.793 -2.299 . . . . 50.759999999999998 104.793 177.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1114 ' ' ALA . . . . . 0.497 ' HB3' ' HB2' ' A' 1117 ' ' SER . . . -107.89 108.84 20.18 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 118.204 -2.81 . . . . 35.640000000000001 108.363 -175.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1115 ' ' MET . . . . . . . . . . . . . 62.1 mmm -65.92 -19.12 65.76 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 117.947 2.573 . . . . 38.740000000000002 117.947 -173.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -71.88 -36.73 70.15 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 122.553 1.168 . . . . 40.140000000000001 108.582 166.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1117 ' ' SER . . . . . 0.497 ' HB2' ' HB3' ' A' 1114 ' ' ALA . 58.3 m -86.35 28.63 0.82 Allowed 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 115.085 1.513 . . . . 44.789999999999999 115.085 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1118 ' ' VAL . . . . . 0.533 ' HA ' HG22 ' A' 1358 ' ' VAL . 88.0 t -74.05 132.95 79.09 Favored Pre-proline 0 N--CA 1.471 0.611 0 N-CA-C 106.296 -1.742 . . . . 43.75 106.296 171.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -65.95 132.22 29.58 Favored 'Trans proline' 0 C--N 1.323 -0.777 0 C-N-CA 123.752 2.968 . . . . 48.93 108.211 175.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 30.9 mmm-85 -77.26 32.11 0.15 Allowed 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 116.667 2.099 . . . . 62.899999999999999 116.667 -164.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 31.8 pt -89.2 170.78 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 120.599 -1.313 . . . . 57.719999999999999 111.754 -169.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1122 ' ' SER . . . . . . . . . . . . . 11.4 p -57.2 -58.65 7.28 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 120.04 1.291 . . . . 57.259999999999998 114.286 -172.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 31.5 ptt85 -62.03 -19.1 62.52 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 116.576 2.065 . . . . 62.899999999999999 116.576 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -77.92 -15.99 58.56 Favored 'General case' 0 C--O 1.214 -0.77 0 O-C-N 120.254 -1.529 . . . . 49.829999999999998 113.965 172.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -56.78 -35.9 69.22 Favored 'General case' 0 C--O 1.258 1.521 0 CA-C-N 121.068 1.758 . . . . 52.369999999999997 115.019 -171.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1126 ' ' SER . . . . . . . . . . . . . 38.3 m -67.38 -23.55 65.6 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 119.51 -1.994 . . . . 42.43 111.226 176.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1127 ' ' LEU . . . . . . . . . . . . . 6.8 mp -89.79 -29.3 18.75 Favored 'General case' 0 C--O 1.221 -0.423 0 O-C-N 119.297 -2.127 . . . . 43.740000000000002 111.645 172.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 51.2 t0 -61.57 107.78 0.86 Allowed 'General case' 0 C--O 1.247 0.942 0 C-N-CA 125.358 1.463 . . . . 43.210000000000001 111.994 -170.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -71.62 -37.49 70.9 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 115.277 -0.874 . . . . 35.740000000000002 111.336 174.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1130 ' ' LEU . . . . . 0.454 HD21 ' CZ2' ' A' 1094 ' ' TRP . 45.7 mt -66.47 -16.19 63.93 Favored 'General case' 0 C--O 1.244 0.799 0 O-C-N 119.97 -1.706 . . . . 38.090000000000003 112.047 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1131 ' ' SER . . . . . 0.417 ' HA ' ' HB ' ' A' 1175 ' ' VAL . 70.6 m -86.63 -64.25 1.18 Allowed 'General case' 0 CA--C 1.55 0.959 0 O-C-N 120.656 -1.278 . . . . 36.909999999999997 109.194 163.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1132 ' ' SER . . . . . 0.566 ' HB2' ' OD1' ' A' 1330 ' ' ASN . 1.6 m -76.6 -45.27 30.92 Favored 'General case' 0 C--O 1.244 0.802 0 O-C-N 117.789 -3.069 . . . . 35.789999999999999 114.594 -166.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1133 ' ' MET . . . . . 0.833 ' HA ' HD12 ' A' 1136 ' ' ILE . 5.0 ttp -66.38 -42.81 87.39 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 122.08 2.218 . . . . 30.809999999999999 108.996 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1134 ' ' ALA . . . . . 0.635 ' HB1' ' HB2' ' A' 1176 ' ' ALA . . . -50.71 -46.57 59.02 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.627 0.973 . . . . 28.879999999999999 113.627 166.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1135 ' ' ASN . . . . . 0.553 ' ND2' ' HB2' ' A' 1179 ' ' ALA . 11.3 t-20 -62.47 -36.62 83.04 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 119.762 1.164 . . . . 40.759999999999998 111.354 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1136 ' ' ILE . . . . . 0.833 HD12 ' HA ' ' A' 1133 ' ' MET . 57.3 mt -53.02 -57.1 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 O-C-N 121.597 -0.689 . . . . 31.539999999999999 110.274 170.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -60.07 -29.71 68.74 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.57 -0.741 . . . . 29.870000000000001 112.486 175.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -64.52 -44.53 95.03 Favored Glycine 0 CA--C 1.533 1.174 0 O-C-N 120.649 -1.282 . . . . 28.73 113.757 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 43.2 t80 -60.64 -50.53 73.14 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 123.587 1.66 . . . . 30.390000000000001 107.677 173.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1140 ' ' ARG . . . . . 0.704 ' HG3' HD22 ' A' 1315 ' ' LEU . 4.0 tpt180 -61.68 -24.61 66.87 Favored 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 111.81 -2.45 . . . . 26.09 113.107 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1141 ' ' ALA . . . . . 0.627 ' HB2' HD21 ' A' 1284 ' ' LEU . . . -60.1 -38.83 84.13 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 122.136 0.97 . . . . 27.100000000000001 113.584 171.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 40.9 mm -66.43 -46.15 87.4 Favored 'Isoleucine or valine' 0 C--O 1.246 0.894 0 O-C-N 121.222 -0.924 . . . . 28.48 109.777 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 94.4 t -57.38 -60.12 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 114.394 -1.275 . . . . 23.07 110.207 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1144 ' ' GLU . . . . . 0.451 ' HG2' ' HE ' ' A' 1140 ' ' ARG . 5.4 mm-40 -72.93 -21.28 60.91 Favored 'General case' 0 CA--C 1.502 -0.879 0 O-C-N 124.262 0.976 . . . . 33.399999999999999 113.322 -175.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1145 ' ' ALA . . . . . 0.842 ' HB1' HD12 ' A' 1251 ' ' ILE . . . -55.48 -57.65 11.03 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 124.013 0.821 . . . . 24.219999999999999 108.96 163.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1146 ' ' ALA . . . . . 0.565 ' HB2' ' HE2' ' A' 1153 ' ' PHE . . . -67.43 -16.18 64.08 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 124.522 1.139 . . . . 24.890000000000001 111.96 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 66.2 t-80 -72.34 -49.3 35.32 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 117.911 -1.042 . . . . 26.73 108.397 175.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1148 ' ' GLU . . . . . 0.825 ' HB3' ' HD2' ' A' 1308 ' ' LYS . 13.1 mm-40 -81.63 -15.05 55.84 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 121.493 1.951 . . . . 39.960000000000001 115.139 175.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1149 ' ' PHE . . . . . 0.557 ' HB2' ' HA ' ' A' 1146 ' ' ALA . 0.6 OUTLIER -59.18 140.03 56.32 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 125.226 2.441 . . . . 25.870000000000001 109.767 -170.499 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1150 ' ' GLY . . . . . . . . . . . . . . . -79.99 -35.51 27.41 Favored Glycine 0 N--CA 1.426 -2.019 0 CA-C-N 109.823 -3.353 . . . . 19.280000000000001 109.248 170.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1151 ' ' ARG . . . . . 0.568 ' HA ' ' HB2' ' B' 1322 ' ' GLN . 10.9 mtt-85 -108.48 -169.94 1.59 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.789 0.804 . . . . 39.899999999999999 112.756 -159.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1152 ' ' PHE . . . . . 0.551 ' HB2' ' HG2' ' B' 1322 ' ' GLN . 1.7 t80 -110.98 145.92 37.57 Favored 'General case' 0 C--O 1.248 0.978 0 CA-C-O 118.178 -0.915 . . . . 29.440000000000001 109.078 178.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1153 ' ' PHE . . . . . 0.565 ' HE2' ' HB2' ' A' 1146 ' ' ALA . 25.5 m-85 -66.94 -50.74 61.41 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 120.924 1.693 . . . . 32.600000000000001 114.269 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1154 ' ' THR . . . . . 0.438 HG21 HG22 ' C' ' 81' ' ' VAL . 51.6 m -93.59 134.84 35.47 Favored 'General case' 0 CA--C 1.549 0.923 0 O-C-N 120.665 -1.272 . . . . 34.640000000000001 110.653 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -76.67 69.77 2.32 Favored Glycine 0 C--N 1.338 0.651 0 O-C-N 121.53 -0.731 . . . . 37.140000000000001 112.023 176.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -81.28 151.73 27.94 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 116.107 1.891 . . . . 40.57 116.107 -175.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1157 ' ' ILE . . . . . 0.443 HG23 ' H ' ' C' ' 77' ' ' GLY . 6.9 tp -79.25 119.21 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 123.068 1.413 . . . . 44.609999999999999 110.58 165.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1158 ' ' THR . . . . . . . . . . . . . 37.7 p -92.15 -168.27 1.96 Allowed 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.489 -1.232 . . . . 40.700000000000003 109.59 174.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -76.13 -23.18 54.84 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 124.091 3.132 . . . . 40.25 108.596 173.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -85.37 -60.8 1.92 Allowed 'General case' 0 C--O 1.251 1.175 0 CA-C-N 115.804 -0.635 . . . . 38.469999999999999 110.012 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1161 ' ' GLY . . . . . 0.628 ' HA3' HG21 ' B' 1329 ' ' THR . . . 175.66 -157.55 23.98 Favored Glycine 0 CA--C 1.505 -0.575 0 O-C-N 118.625 -2.547 . . . . 37.609999999999999 110.471 -174.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1162 ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' 1163 ' ' VAL . 32.3 tttt -92.84 138.99 31.0 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 125.332 2.491 . . . . 48.899999999999999 113.335 -163.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1163 ' ' VAL . . . . . 0.527 HG11 ' HB3' ' A' 1152 ' ' PHE . 24.9 t -83.9 147.11 50.61 Favored Pre-proline 0 C--N 1.305 -1.338 0 CA-C-N 109.202 -3.636 . . . . 36.520000000000003 109.241 167.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1164 ' ' PRO . . . . . 0.435 ' HD2' ' HG2' ' B' 1325 ' ' GLN . 45.5 Cg_endo -69.58 119.75 6.66 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 124.756 3.637 . . . . 35.079999999999998 116.106 162.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1165 ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' 1164 ' ' PRO . 97.5 Cg_endo -66.16 142.96 69.5 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.612 2.208 . . . . 35.329999999999998 115.17 176.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -82.36 126.63 32.39 Favored 'General case' 0 C--N 1.343 0.295 0 O-C-N 120.389 -1.444 . . . . 34.689999999999998 112.955 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1167 ' ' LYS . . . . . 0.583 ' HB2' ' HA ' ' A' 1249 ' ' VAL . 61.7 mttp -86.52 102.07 13.77 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 106.293 -1.743 . . . . 45.359999999999999 106.293 168.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 16.2 t -88.58 86.36 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 112.567 -2.106 . . . . 31.710000000000001 110.006 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1169 ' ' MET . . . . . 0.65 ' HA ' ' O ' ' A' 1192 ' ' ARG . 62.4 ttp -79.34 103.53 9.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 123.933 1.825 . . . . 42.280000000000001 110.73 176.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 21.6 t -92.26 119.27 39.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 106.699 -1.593 . . . . 30.510000000000002 106.699 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 63.9 mt -108.92 126.84 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 104.898 -2.26 . . . . 31.870000000000001 104.898 -173.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1172 ' ' GLY . . . . . 0.584 ' O ' ' HB ' ' A' 1255 ' ' THR . . . 70.83 71.64 1.0 Allowed Glycine 0 C--N 1.352 1.449 0 C-N-CA 119.719 -1.229 . . . . 34.539999999999999 110.3 -175.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1173 ' ' ALA . . . . . . . . . . . . . . . -76.97 68.66 3.16 Favored 'General case' 0 C--O 1.243 0.752 0 O-C-N 121.188 -1.183 . . . . 32.509999999999998 111.854 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -78.7 -173.03 42.35 Favored Glycine 0 C--N 1.342 0.871 0 N-CA-C 107.667 -2.173 . . . . 29.899999999999999 107.667 164.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1175 ' ' VAL . . . . . 0.488 HG12 ' HB2' ' A' 1135 ' ' ASN . 48.8 t -62.83 -31.22 51.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 121.58 2.69 . . . . 33.109999999999999 113.995 -172.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1176 ' ' ALA . . . . . 0.635 ' HB2' ' HB1' ' A' 1134 ' ' ALA . . . -58.7 -52.44 65.67 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 118.102 0.41 . . . . 28.100000000000001 110.621 168.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -56.72 -36.13 70.64 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.27 0.938 . . . . 28.539999999999999 112.653 173.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1178 ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' 1175 ' ' VAL . 56.6 mt -65.64 -37.85 87.73 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 118.244 1.022 . . . . 31.219999999999999 110.702 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1179 ' ' ALA . . . . . 0.553 ' HB2' ' ND2' ' A' 1135 ' ' ASN . . . -64.11 -42.7 96.79 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 112.406 0.521 . . . . 28.98 112.406 173.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -58.98 -44.91 91.66 Favored 'General case' 0 C--N 1.352 0.683 0 O-C-N 125.012 1.445 . . . . 27.829999999999998 113.995 173.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1181 ' ' ILE . . . . . 0.571 HD13 HG22 ' A' 1204 ' ' VAL . 47.1 mt -60.61 -51.08 77.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 O-C-N 122.045 -0.409 . . . . 30.25 111.232 178.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -60.67 -57.42 19.02 Favored Glycine 0 CA--C 1.525 0.665 0 O-C-N 126.523 2.389 . . . . 29.59 111.56 -174.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -55.09 -50.1 70.03 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 119.057 1.428 . . . . 30.289999999999999 111.534 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1184 ' ' ALA . . . . . 0.579 ' HA ' HD12 ' A' 1187 ' ' LEU . . . -70.31 -27.14 64.15 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 114.988 1.477 . . . . 30.469999999999999 114.988 -175.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -71.86 -40.31 69.06 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-O 116.144 -1.884 . . . . 42.409999999999997 110.181 172.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1186 ' ' SER . . . . . . . . . . . . . 1.5 m -64.52 -31.05 72.1 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-N 119.752 1.16 . . . . 39.380000000000003 110.617 172.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1187 ' ' LEU . . . . . 0.846 ' HA ' ' HB3' ' B' 1186 ' ' SER . 58.9 mt -65.75 -33.36 75.7 Favored 'General case' 0 C--N 1.345 0.393 0 O-C-N 119.187 -2.196 . . . . 36.18 111.404 168.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 84.8 60.35 1.88 Allowed Glycine 0 N--CA 1.433 -1.542 0 CA-C-O 123.366 1.537 . . . . 33.780000000000001 110.076 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -119.11 160.22 22.48 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 113.751 -1.224 . . . . 33.93 108.722 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 79.0 mt -79.33 81.57 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.825 0 C-N-CA 118.841 -1.144 . . . . 38.740000000000002 108.915 -173.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 12.1 t -81.56 131.86 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.792 -1.188 . . . . 33.090000000000003 107.792 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1192 ' ' ARG . . . . . 0.65 ' O ' ' HA ' ' A' 1169 ' ' MET . 1.2 ptp180 -139.58 103.29 4.66 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 104.926 -2.25 . . . . 38.920000000000002 104.926 177.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -95.46 131.96 41.05 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 110.883 -2.871 . . . . 35.32 110.983 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1194 ' ' PHE . . . . . 0.47 ' HD1' ' O ' ' A' 1212 ' ' LEU . 71.5 t80 -111.93 140.12 46.86 Favored 'General case' 0 C--O 1.248 1.002 0 O-C-N 119.236 -2.165 . . . . 39.350000000000001 106.537 168.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 8.9 t0 -141.51 150.12 41.76 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 105.197 -2.149 . . . . 40.460000000000001 105.197 163.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1196 ' ' THR . . . . . . . . . . . . . 1.3 m -60.19 -32.33 70.97 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 111.816 -2.447 . . . . 45.939999999999998 110.064 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1197 ' ' ARG . . . . . 0.432 ' HA ' ' HD2' ' A' 1198 ' ' PRO . 59.9 mtm180 -83.13 117.81 69.74 Favored Pre-proline 0 N--CA 1.447 -0.624 0 C-N-CA 124.99 1.316 . . . . 56.020000000000003 108.739 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1198 ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' 1197 ' ' ARG . 74.5 Cg_endo -67.45 -19.06 49.53 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.891 2.394 . . . . 51.270000000000003 110.058 176.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -58.17 -37.97 75.74 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 124.248 1.019 . . . . 59.100000000000001 113.146 -174.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 16.1 m -83.96 5.2 2.36 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.583 0 N-CA-C 116.949 2.204 . . . . 51.060000000000002 116.949 -172.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1201 ' ' LYS . . . . . 0.403 ' HA ' ' CD1' ' A' 1211 ' ' PHE . 81.2 tttt -62.61 -55.47 26.83 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 126.194 1.798 . . . . 57.380000000000003 111.736 -172.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -54.9 -44.36 74.08 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 113.034 -1.894 . . . . 62.409999999999997 112.698 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -61.83 -47.87 83.12 Favored 'General case' 0 C--N 1.344 0.349 0 O-C-N 124.166 0.916 . . . . 57.780000000000001 112.794 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1204 ' ' VAL . . . . . 0.571 HG22 HD13 ' A' 1181 ' ' ILE . 82.6 t -49.39 -46.76 19.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 122.29 1.043 . . . . 46.380000000000003 113.428 176.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -69.61 -30.21 67.91 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 113.432 -1.713 . . . . 50.700000000000003 111.592 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1206 ' ' SER . . . . . . . . . . . . . 24.6 m -70.93 -22.1 62.27 Favored 'General case' 0 N--CA 1.435 -1.225 0 O-C-N 120.345 -1.472 . . . . 49.979999999999997 113.375 172.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1207 ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -76.58 -49.91 15.18 Favored 'General case' 0 C--N 1.362 1.131 0 O-C-N 118.974 -2.329 . . . . 52.990000000000002 108.341 164.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 126.67 58.1 0.14 Allowed Glycine 0 C--N 1.304 -1.233 0 N-CA-C 109.292 -1.523 . . . . 47.659999999999997 109.292 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -144.73 150.84 37.95 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 106.407 -1.701 . . . . 44.770000000000003 106.407 -177.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -65.98 137.99 57.51 Favored 'General case' 0 C--O 1.252 1.232 0 O-C-N 125.936 2.023 . . . . 47.640000000000001 106.587 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1211 ' ' PHE . . . . . 0.403 ' CD1' ' HA ' ' A' 1201 ' ' LYS . 44.6 t80 -104.13 116.92 33.08 Favored 'General case' 0 C--N 1.31 -1.109 1 N-CA-C 99.786 -4.153 . . . . 45.659999999999997 99.786 166.796 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1212 ' ' LEU . . . . . 0.47 ' O ' ' HD1' ' A' 1194 ' ' PHE . 97.1 mt -71.2 119.63 15.62 Favored 'General case' 0 C--O 1.201 -1.486 0 N-CA-C 106.627 -1.62 . . . . 46.060000000000002 106.627 -177.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -82.62 140.47 33.17 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 127.45 2.969 . . . . 60.219999999999999 110.107 171.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 29.4 tp -81.21 125.81 30.75 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 127.328 3.442 . . . . 57.25 107.886 -166.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 24.6 t70 -74.59 87.66 2.14 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 111.729 -2.487 . . . . 64.430000000000007 109.613 165.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 47.8 t80 . . . . . 0 N--CA 1.432 -1.366 0 CA-C-N 113.178 -1.828 . . . . 66.900000000000006 107.394 -178.475 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 3.6 p-10 . . . . . 0 N--CA 1.442 -0.867 0 N-CA-C 107.655 -1.239 . . . . 39.090000000000003 107.655 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -54.33 -57.14 18.31 Favored Glycine 0 C--O 1.224 -0.474 0 O-C-N 127.301 2.876 . . . . 39.32 115.346 -174.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 24.7 t80 -72.76 -39.82 66.51 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-N 118.294 1.047 . . . . 39.299999999999997 111.277 -169.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -68.35 -42.38 79.31 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.675 -1.602 . . . . 36.299999999999997 106.675 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -58.9 -44.43 91.21 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 116.211 -1.852 . . . . 37.380000000000003 111.293 175.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -59.3 -51.79 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 125.036 1.46 . . . . 39.109999999999999 112.665 174.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1230 ' ' MET . . . . . . . . . . . . . 26.8 mmt -84.27 70.46 10.6 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 123.135 1.445 . . . . 49.590000000000003 110.211 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1231 ' ' SER . . . . . . . . . . . . . 61.5 m -138.93 154.62 48.36 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.556 -1.202 . . . . 43.68 109.152 176.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -58.63 -66.8 0.44 Allowed 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.311 1.045 . . . . 55.57 111.672 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1233 ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' 1236 ' ' LYS . . . -62.41 -23.83 67.06 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.092 -0.958 . . . . 44.939999999999998 113.006 -174.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 15.1 t80 -66.75 -51.89 50.59 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-O 117.522 -1.227 . . . . 42.039999999999999 109.383 171.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 13.3 mt -68.57 -26.0 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 123.554 2.888 . . . . 46.280000000000001 109.054 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1236 ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' 1233 ' ' ALA . 33.3 tttm -61.75 -46.14 90.9 Favored 'General case' 0 C--O 1.237 0.43 0 O-C-N 119.705 -1.872 . . . . 47.869999999999997 109.308 169.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -67.52 -36.52 81.18 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-N 115.816 -0.629 . . . . 41.609999999999999 111.81 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -58.5 -56.36 23.11 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.076 0.55 . . . . 50.649999999999999 110.142 173.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1239 ' ' MET . . . . . . . . . . . . . 3.2 mtm -52.66 -45.71 66.85 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 114.044 1.127 . . . . 48.869999999999997 114.044 173.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -68.91 -33.43 73.74 Favored 'General case' 0 C--N 1.315 -0.907 0 O-C-N 121.618 -0.676 . . . . 54.799999999999997 110.998 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.42 -45.12 85.14 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 105.334 -2.099 . . . . 43.210000000000001 105.334 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -67.17 -36.92 82.81 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.08 1.352 . . . . 38.659999999999997 113.202 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1243 ' ' ALA . . . . . 0.568 ' HA ' ' HG3' ' A' 1271 ' ' MET . . . -62.26 -45.76 91.88 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 123.015 0.526 . . . . 37.920000000000002 112.289 175.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -67.16 -36.93 82.87 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 121.445 -0.784 . . . . 37.280000000000001 110.99 176.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -65.75 -30.38 71.03 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 112.971 0.73 . . . . 43.07 112.971 172.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -59.09 -34.18 71.69 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 112.565 0.58 . . . . 38.299999999999997 112.565 -175.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1247 ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.1 -15.55 63.46 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 119.521 -0.872 . . . . 47.600000000000001 112.869 178.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -114.2 -25.39 8.5 Favored 'General case' 0 N--CA 1.441 -0.924 0 O-C-N 119.077 -2.264 . . . . 45.420000000000002 115.988 176.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1249 ' ' VAL . . . . . 0.583 ' HA ' ' HB2' ' A' 1167 ' ' LYS . 34.7 m -74.93 163.68 3.92 Favored 'Isoleucine or valine' 0 C--O 1.247 0.944 0 CA-C-N 121.74 2.064 . . . . 36.259999999999998 116.541 -173.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1250 ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' 1279 ' ' SER . 2.4 m-20 -124.81 -57.45 1.53 Allowed 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 113.448 -1.705 . . . . 33.039999999999999 108.432 -170.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1251 ' ' ILE . . . . . 0.842 HD12 ' HB1' ' A' 1145 ' ' ALA . 34.6 mm -110.91 131.67 61.49 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.977 0 N-CA-C 106.613 -1.625 . . . . 31.399999999999999 106.613 175.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1252 ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' 1169 ' ' MET . 52.3 mt -122.43 134.97 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 N-CA-C 103.912 -2.625 . . . . 29.420000000000002 103.912 170.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 9.2 t -117.45 92.31 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 103.102 -2.925 . . . . 30.370000000000001 103.102 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1254 ' ' THR . . . . . 0.514 ' HB ' ' HB2' ' A' 1291 ' ' ASN . 0.7 OUTLIER -79.35 98.02 6.55 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 123.189 1.471 . . . . 35.719999999999999 113.213 179.421 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1255 ' ' THR . . . . . 0.584 ' HB ' ' O ' ' A' 1172 ' ' GLY . 4.0 m -111.5 0.16 16.4 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.09 -1.414 . . . . 36.0 114.466 -168.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1256 ' ' ALA . . . . . . . . . . . . . . . -84.3 79.32 9.58 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 125.607 2.622 . . . . 40.93 113.553 -170.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 41.7 tp -94.36 109.53 21.37 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 112.024 -2.353 . . . . 47.82 106.777 172.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 28.1 mm -66.37 119.05 59.37 Favored Pre-proline 0 CA--C 1.554 1.116 0 N-CA-C 103.651 -2.722 . . . . 52.700000000000003 103.651 168.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -53.25 125.32 18.02 Favored 'Trans proline' 0 C--N 1.35 0.637 1 C-N-CA 126.002 4.468 . . . . 54.130000000000003 112.313 -173.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 76.2 6.12 82.55 Favored Glycine 0 CA--C 1.489 -1.576 0 CA-C-O 119.907 -0.385 . . . . 54.619999999999997 112.947 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 89.2 mttt -128.78 155.84 78.64 Favored Pre-proline 0 C--O 1.252 1.198 0 O-C-N 119.492 -2.181 . . . . 55.740000000000002 109.337 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -61.36 117.8 4.63 Favored 'Trans proline' 0 N--CA 1.44 -1.63 0 C-N-CA 121.905 1.737 . . . . 51.149999999999999 113.083 168.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -51.26 132.47 32.61 Favored Pre-proline 0 N--CA 1.473 0.695 0 CA-C-N 113.094 -1.866 . . . . 46.060000000000002 111.953 176.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1264 ' ' PRO . . . . . 0.46 ' O ' ' HA ' ' A' 1291 ' ' ASN . 57.4 Cg_endo -55.62 138.86 82.09 Favored 'Trans proline' 0 C--O 1.249 1.051 0 C-N-CA 124.974 3.782 . . . . 41.079999999999998 112.283 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -78.13 99.59 6.23 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 104.22 -2.511 . . . . 47.420000000000002 104.22 171.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 94.6 mt -98.89 -21.09 16.47 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 113.189 -1.823 . . . . 39.219999999999999 111.299 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1267 ' ' ILE . . . . . 0.664 HG23 ' SD ' ' A' 1271 ' ' MET . 86.4 mt -117.55 114.23 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 O-C-N 118.298 -2.751 . . . . 42.5 106.718 172.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1268 ' ' THR . . . . . 0.401 ' H ' ' HE3' ' A' 1271 ' ' MET . 5.0 p -80.31 162.49 24.54 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 115.665 1.728 . . . . 37.840000000000003 115.665 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -60.6 -41.87 95.61 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-O 116.381 -1.771 . . . . 54.799999999999997 112.764 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -53.06 -51.07 62.97 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 125.243 1.417 . . . . 54.359999999999999 110.825 171.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1271 ' ' MET . . . . . 0.664 ' SD ' HG23 ' A' 1267 ' ' ILE . 43.0 ttm -55.49 -44.11 76.21 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 125.483 1.739 . . . . 39.520000000000003 112.485 -178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1272 ' ' VAL . . . . . 0.408 ' CG1' HG21 ' A' 1303 ' ' THR . 2.4 t -68.05 -45.57 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 120.781 1.628 . . . . 38.25 110.588 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -59.77 -28.27 67.25 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 114.64 1.348 . . . . 40.770000000000003 114.64 173.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1274 ' ' SER . . . . . . . . . . . . . 20.4 m -89.02 13.37 13.08 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 113.591 0.96 . . . . 36.579999999999998 113.591 172.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1275 ' ' MET . . . . . 0.583 ' HB3' HG21 ' A' 1307 ' ' VAL . 36.0 ttm -85.69 164.53 17.6 Favored 'General case' 0 C--O 1.246 0.87 0 O-C-N 120.899 -1.125 . . . . 36.75 109.573 -175.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1276 ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -76.8 130.62 37.92 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 105.527 -2.027 . . . . 46.109999999999999 105.527 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1277 ' ' ALA . . . . . 0.451 ' HB3' ' CD1' ' B' 1045 ' ' PHE . . . -86.01 172.17 10.85 Favored 'General case' 0 CA--C 1.504 -0.796 0 O-C-N 120.181 -1.574 . . . . 33.520000000000003 115.14 -168.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 86.26 14.99 65.32 Favored Glycine 0 C--O 1.217 -0.939 0 O-C-N 120.648 -1.283 . . . . 31.27 111.799 -171.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1279 ' ' SER . . . . . 0.468 ' HB3' ' O ' ' A' 1250 ' ' ASP . 36.9 m -130.45 163.88 26.01 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 124.108 0.963 . . . . 32.950000000000003 111.006 -156.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1280 ' ' VAL . . . . . . . . . . . . . 65.4 t -134.93 131.65 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 O-C-N 119.959 -1.713 . . . . 27.43 111.466 -170.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1281 ' ' ILE . . . . . 0.553 HD11 ' SD ' ' A' 1275 ' ' MET . 46.3 mt -106.36 104.35 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 106.213 -1.773 . . . . 30.300000000000001 106.213 171.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 43.9 t -88.9 109.74 20.52 Favored 'Isoleucine or valine' 0 C--O 1.252 1.215 0 O-C-N 119.189 -2.195 . . . . 28.629999999999999 106.773 175.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 5.0 t70 -86.15 96.64 9.97 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 123.277 1.513 . . . . 36.270000000000003 108.14 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1284 ' ' LEU . . . . . 0.627 HD21 ' HB2' ' A' 1141 ' ' ALA . 21.1 mt -73.69 -12.73 60.82 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 112.604 -2.089 . . . . 38.57 112.889 172.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -77.24 -34.58 55.84 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 120.922 1.692 . . . . 37.560000000000002 110.179 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1286 ' ' ALA . . . . . 0.572 ' HB1' HG23 ' A' 1313 ' ' THR . . . 33.54 -74.33 0.0 OUTLIER 'General case' 0 C--O 1.246 0.883 1 N-CA-C 123.423 4.601 . . . . 40.329999999999998 123.423 171.191 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -55.15 -40.54 70.73 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 116.966 2.21 . . . . 56.850000000000001 116.966 -166.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 18.0 m120 -125.59 116.89 22.44 Favored 'General case' 0 CA--C 1.491 -1.317 0 O-C-N 119.688 -1.883 . . . . 45.859999999999999 107.211 177.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 73.82 -74.6 1.14 Allowed Glycine 0 C--N 1.345 1.033 0 N-CA-C 110.859 -0.896 . . . . 40.310000000000002 110.859 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 86.03 134.26 3.52 Favored Glycine 0 C--O 1.237 0.335 0 N-CA-C 109.493 -1.443 . . . . 38.890000000000001 109.493 -173.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1291 ' ' ASN . . . . . 0.514 ' HB2' ' HB ' ' A' 1254 ' ' THR . 25.6 m120 -70.93 -24.91 62.54 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-N 118.009 0.905 . . . . 37.229999999999997 112.391 -167.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1292 ' ' CYS . . . . . 0.426 ' HB3' ' OG1' ' A' 1295 ' ' THR . 53.7 t -91.58 155.65 18.21 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 120.835 -1.166 . . . . 36.5 111.853 177.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1293 ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -83.46 6.51 19.98 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 119.729 -1.857 . . . . 43.32 115.343 173.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -113.47 8.5 17.84 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-O 123.053 1.406 . . . . 41.32 111.99 171.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1295 ' ' THR . . . . . 0.426 ' OG1' ' HB3' ' A' 1292 ' ' CYS . 33.5 m -75.84 95.14 3.43 Favored 'General case' 0 CA--C 1.501 -0.938 0 O-C-N 118.744 -2.472 . . . . 35.299999999999997 112.098 -176.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 60.1 t -92.07 115.94 65.57 Favored Pre-proline 0 N--CA 1.437 -1.124 0 CA-C-N 109.583 -3.462 . . . . 34.840000000000003 105.562 169.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -54.51 107.78 0.25 Allowed 'Trans proline' 0 C--O 1.247 0.975 0 C-N-CA 124.969 3.779 . . . . 33.509999999999998 115.202 174.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 85.65 28.12 30.39 Favored Glycine 0 N--CA 1.442 -0.9 0 CA-C-N 111.761 -2.472 . . . . 32.189999999999998 113.793 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -140.36 158.0 44.68 Favored 'General case' 0 C--O 1.242 0.685 0 O-C-N 118.935 -2.509 . . . . 34.880000000000003 111.475 177.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1300 ' ' ILE . . . . . . . . . . . . . 31.4 mt -94.88 124.46 47.39 Favored 'Isoleucine or valine' 0 C--O 1.254 1.315 0 N-CA-C 105.152 -2.166 . . . . 32.289999999999999 105.152 169.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -128.4 108.03 10.23 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 105.385 -2.08 . . . . 37.25 105.385 175.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1302 ' ' THR . . . . . . . . . . . . . 55.9 m -75.53 135.26 40.62 Favored 'General case' 0 C--O 1.243 0.736 0 O-C-N 120.847 -1.158 . . . . 35.560000000000002 108.529 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1303 ' ' THR . . . . . 0.408 HG21 ' CG1' ' A' 1272 ' ' VAL . 35.8 p -85.07 172.36 11.32 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 119.581 -1.95 . . . . 36.399999999999999 109.981 176.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -61.97 -42.67 99.38 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 118.647 0.658 . . . . 52.32 111.914 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -64.56 -35.77 82.06 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.628 0.728 . . . . 40.039999999999999 112.644 176.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 117.17 44.79 0.55 Allowed Glycine 0 C--O 1.217 -0.912 0 O-C-N 120.063 -1.648 . . . . 36.960000000000001 110.157 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1307 ' ' VAL . . . . . 0.583 HG21 ' HB3' ' A' 1275 ' ' MET . 74.3 t -113.51 124.5 70.21 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.233 0 N-CA-C 104.273 -2.491 . . . . 33.399999999999999 104.273 171.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1308 ' ' LYS . . . . . 0.825 ' HD2' ' HB3' ' A' 1148 ' ' GLU . 88.3 mttt -84.6 119.26 25.01 Favored 'General case' 0 CA--C 1.496 -1.127 0 C-N-CA 119.411 -0.916 . . . . 42.909999999999997 109.465 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 57.3 t -96.52 130.73 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.082 0 N-CA-C 106.919 -1.511 . . . . 32.289999999999999 106.919 172.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1310 ' ' ILE . . . . . . . . . . . . . 1.5 mt -125.06 111.27 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.369 0 O-C-N 120.512 -1.367 . . . . 30.989999999999998 108.125 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -83.31 59.3 4.99 Favored Glycine 0 N--CA 1.466 0.686 0 O-C-N 120.448 -1.408 . . . . 28.949999999999999 109.885 174.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1312 ' ' TYR . . . . . 0.437 ' HD1' ' HA ' ' A' 1312 ' ' TYR 0.252 0.5 OUTLIER -73.98 85.77 1.79 Allowed 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 121.189 2.495 . . . . 31.690000000000001 116.952 -172.301 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A 1313 ' ' THR . . . . . 0.572 HG23 ' HB1' ' A' 1286 ' ' ALA . 0.8 OUTLIER -54.57 -53.44 54.58 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 113.906 -1.497 . . . . 34.170000000000002 112.823 168.414 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -65.42 5.9 0.36 Allowed 'General case' 0 C--O 1.248 1.021 0 N-CA-C 116.849 2.166 . . . . 36.859999999999999 116.849 -172.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1315 ' ' LEU . . . . . 0.704 HD22 ' HG3' ' A' 1140 ' ' ARG . 58.5 mt -47.09 -39.92 20.48 Favored Pre-proline 0 CA--C 1.547 0.86 0 CA-C-N 121.544 1.975 . . . . 34.850000000000001 116.123 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -57.19 -43.12 55.94 Favored 'Trans proline' 0 CA--C 1.505 -0.953 0 CA-C-N 123.311 2.218 . . . . 29.149999999999999 116.542 168.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -66.04 -39.19 94.66 Favored Glycine 0 C--N 1.313 -0.709 0 O-C-N 119.918 -1.738 . . . . 27.289999999999999 111.859 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1318 ' ' ARG . . . . . 0.488 ' HB3' ' NH2' ' A' 1140 ' ' ARG . 92.7 mtt-85 -62.97 -25.03 68.18 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 124.747 1.219 . . . . 41.490000000000002 113.796 174.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1319 ' ' LEU . . . . . 0.482 HD23 HG23 ' A' 1136 ' ' ILE . 12.7 tp -115.91 70.26 3.68 Favored Pre-proline 0 C--O 1.251 1.132 0 N-CA-C 107.748 -1.205 . . . . 27.609999999999999 107.748 172.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1320 ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -59.5 -59.68 0.4 Allowed 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 122.722 2.281 . . . . 25.940000000000001 115.057 -163.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1321 ' ' THR . . . . . . . . . . . . . 7.6 m -65.0 -36.45 84.45 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 108.735 -0.839 . . . . 25.010000000000002 108.735 -171.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1322 ' ' GLN . . . . . 0.461 ' HB2' ' HA ' ' B' 1151 ' ' ARG . 31.6 tp60 -72.97 -32.31 65.13 Favored 'General case' 0 CA--C 1.502 -0.866 0 O-C-N 120.988 -1.07 . . . . 29.390000000000001 112.18 -172.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1323 ' ' SER . . . . . 0.586 ' HA ' HD13 ' A' 1136 ' ' ILE . 40.2 m -65.68 -50.66 64.12 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 107.098 -1.445 . . . . 26.469999999999999 107.098 172.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1324 ' ' SER . . . . . 0.422 ' HB2' HG23 ' A' 1019 ' ' THR . 3.4 m -60.8 -23.62 65.18 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.962 0.905 . . . . 27.780000000000001 112.22 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 19.4 tm0? -86.43 -76.29 0.35 Allowed 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.782 -1.562 . . . . 37.530000000000001 106.782 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1326 ' ' LEU . . . . . 0.55 ' HB2' HD11 ' A' 1136 ' ' ILE . 92.8 mt -54.76 -62.27 1.77 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 115.446 1.647 . . . . 35.710000000000001 115.446 -175.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1327 ' ' TYR . . . . . 0.581 ' HE2' ' HA ' ' A' 1072 ' ' VAL . 30.3 t80 -63.85 -35.49 80.81 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 107.613 -1.254 . . . . 31.59 107.613 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1328 ' ' GLY . . . . . 0.547 ' HA2' HD12 ' A' 1331 ' ' LEU . . . -54.06 -46.18 70.5 Favored Glycine 0 C--N 1.359 1.818 0 O-C-N 124.156 0.91 . . . . 28.0 111.699 171.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1329 ' ' THR . . . . . 0.507 ' HA ' ' HB ' ' A' 1332 ' ' VAL . 28.5 m -71.29 -24.46 62.15 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 123.241 0.616 . . . . 32.149999999999999 110.922 175.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1330 ' ' ASN . . . . . 0.566 ' OD1' ' HB2' ' A' 1132 ' ' SER . 3.1 m120 -61.78 -54.07 47.41 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 116.911 -3.618 . . . . 34.359999999999999 107.246 174.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1331 ' ' LEU . . . . . 0.657 HD13 ' HB3' ' A' 1070 ' ' LEU . 12.9 mt -47.01 -54.51 10.04 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 126.548 1.939 . . . . 33.369999999999997 111.155 170.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1332 ' ' VAL . . . . . 0.711 HG22 HD21 ' A' 1026 ' ' LEU . 70.0 t -63.98 -32.71 58.27 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.729 0 CA-C-O 117.179 -1.391 . . . . 35.270000000000003 114.073 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -73.67 -31.19 63.34 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 124.191 3.178 . . . . 37.659999999999997 110.737 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1334 ' ' LEU . . . . . . . . . . . . . 43.3 tp -60.71 -51.11 70.74 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-N 118.687 0.676 . . . . 40.270000000000003 110.592 164.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1335 ' ' LEU . . . . . 0.756 HD11 HD21 ' A' 1070 ' ' LEU . 55.2 mt -54.5 -34.96 62.58 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 114.793 1.405 . . . . 42.5 114.793 168.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1336 ' ' LYS . . . . . 0.597 ' HG2' HD21 ' A' 1029 ' ' LEU . 90.0 mttt -60.69 -46.17 91.38 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 123.18 2.718 . . . . 47.810000000000002 112.977 174.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1337 ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.85 -36.99 78.0 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 124.365 1.041 . . . . 49.270000000000003 113.251 173.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1338 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.8 -32.51 70.99 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 124.628 1.171 . . . . 50.539999999999999 111.16 172.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1339 ' ' CYS . . . . . 0.591 ' HB3' ' HG2' ' A' 1342 ' ' LYS . 64.8 m -79.48 88.78 5.04 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 124.052 1.882 . . . . 53.670000000000002 107.958 172.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -76.01 -66.26 0.81 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 113.67 -1.605 . . . . 63.380000000000003 106.734 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -85.69 -18.88 31.87 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.384 -0.826 . . . . 70.950000000000003 110.626 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1342 ' ' LYS . . . . . 0.605 ' HE2' ' HA ' ' A' 1029 ' ' LEU . 5.8 mtpm? 68.41 56.91 0.47 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.129 -1.396 . . . . 65.25 114.437 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1343 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 172.84 -38.49 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.389 2 O-C-N 112.345 -6.472 . . . . 64.530000000000001 107.714 -17.335 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1344 ' ' GLY . . . . . . . . . . . . . . . 84.34 -62.45 4.57 Favored Glycine 0 C--N 1.346 1.118 0 O-C-N 117.491 -3.255 . . . . 59.719999999999999 111.129 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 4.6 t30 -116.62 132.23 56.74 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 103.666 -2.716 . . . . 64.090000000000003 103.666 169.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1346 ' ' ILE . . . . . . . . . . . . . 20.8 pt -62.92 164.47 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.256 1.409 0 O-C-N 123.891 0.744 . . . . 58.82 112.785 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1347 ' ' THR . . . . . . . . . . . . . 1.8 m -124.97 92.98 3.76 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 104.834 -2.284 . . . . 54.960000000000001 104.834 -176.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1348 ' ' VAL . . . . . . . . . . . . . 60.2 t -77.29 84.78 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 N-CA-C 105.201 -2.148 . . . . 55.640000000000001 105.201 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.67 126.63 30.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 124.113 1.911 . . . . 61.450000000000003 112.752 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -96.32 -5.48 39.95 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 118.182 2.66 . . . . 58.630000000000003 118.182 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -73.72 -39.89 63.98 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 118.351 -1.34 . . . . 62.060000000000002 110.095 172.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 17.3 t70 -70.57 112.5 6.87 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.038 -0.983 . . . . 54.07 112.144 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 15.8 m -59.51 -20.43 18.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 N-CA-C 116.33 1.974 . . . . 50.68 116.33 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1354 ' ' VAL . . . . . 0.576 ' O ' HG23 ' A' 1358 ' ' VAL . 0.9 OUTLIER -79.77 -47.39 21.83 Favored 'Isoleucine or valine' 0 C--N 1.343 0.317 0 CA-C-N 121.485 1.948 . . . . 47.68 105.778 177.749 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1355 ' ' ILE . . . . . . . . . . . . . 89.9 mt -64.65 -55.14 22.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 108.476 -0.935 . . . . 48.490000000000002 108.476 -177.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 34.0 tpt85 -45.36 -46.77 13.28 Favored 'General case' 0 C--O 1.255 1.379 0 O-C-N 124.123 0.889 . . . . 48.270000000000003 113.362 167.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -59.39 -51.03 61.57 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-O 117.563 -1.687 . . . . 43.530000000000001 111.882 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1358 ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' 1354 ' ' VAL . 17.5 t -63.37 -35.08 70.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 CA-C-N 118.808 1.304 . . . . 45.119999999999997 108.544 -175.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1359 ' ' THR . . . . . . . . . . . . . 18.1 m -75.84 93.84 3.24 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 123.959 1.838 . . . . 42.939999999999998 109.889 -176.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 16.6 m -80.02 -22.84 11.75 Favored 'Isoleucine or valine' 0 C--O 1.248 1.011 0 CA-C-N 110.998 -2.819 . . . . 43.259999999999998 113.858 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1361 ' ' ILE . . . . . . . . . . . . . 43.7 mt -137.11 119.39 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 N-CA-C 104.055 -2.572 . . . . 45.659999999999997 104.055 175.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1362 ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -106.92 113.28 26.67 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 104.311 -2.477 . . . . 61.340000000000003 104.311 170.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 32.95 77.38 0.03 OUTLIER 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 117.204 2.298 . . . . 49.759999999999998 117.204 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 86.52 -50.26 4.19 Favored Glycine 0 N--CA 1.481 1.685 0 CA-C-N 113.645 -1.616 . . . . 50.0 111.628 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -70.37 116.43 10.7 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 106.953 -1.499 . . . . 56.920000000000002 106.953 -176.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1366 ' ' ILE . . . . . . . . . . . . . 67.5 mt -72.83 101.57 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.066 0 CA-C-O 123.408 1.575 . . . . 52.780000000000001 109.006 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1367 ' ' THR . . . . . . . . . . . . . 10.9 p -92.94 10.49 31.02 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 112.857 -1.974 . . . . 49.439999999999998 116.16 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1368 ' ' TRP . . . . . 0.518 ' CD1' ' HA ' ' A' 1369 ' ' PRO . 1.9 t90 -58.82 145.77 77.66 Favored Pre-proline 0 C--O 1.254 1.333 0 O-C-N 117.972 -2.955 . . . . 52.380000000000003 105.683 163.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1369 ' ' PRO . . . . . 0.518 ' HA ' ' CD1' ' A' 1368 ' ' TRP . 42.0 Cg_endo -85.76 -175.0 11.55 Favored 'Cis proline' 0 C--O 1.211 -0.829 0 CA-C-N 123.983 2.458 . . . . 46.939999999999998 113.553 4.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -83.19 138.66 42.21 Favored Pre-proline 0 CA--C 1.545 0.756 0 O-C-N 124.065 0.853 . . . . 45.909999999999997 108.84 164.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1371 ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -58.3 135.29 67.1 Favored 'Trans proline' 0 C--N 1.351 0.678 1 C-N-CA 125.777 4.318 . . . . 46.390000000000001 111.509 177.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -59.03 -35.35 98.57 Favored 'Trans proline' 0 CA--C 1.549 1.241 1 C-N-CA 125.36 4.04 . . . . 46.719999999999999 116.653 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.233 -4.489 0 O-C-N 118.331 -2.731 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 15.9 m80 . . . . . 0 N--CA 1.432 -1.347 0 N-CA-C 108.174 -1.047 . . . . 63.439999999999998 108.174 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -77.44 76.65 3.98 Favored 'General case' 0 C--O 1.254 1.304 0 O-C-N 121.093 -1.005 . . . . 51.740000000000002 112.402 -177.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1000 ' ' HIS . . . . . 0.456 ' HA ' ' OE2' ' B' 1067 ' ' GLU . 12.0 t60 -72.55 118.38 15.38 Favored 'General case' 0 C--O 1.247 0.964 0 CA-C-O 122.694 1.235 . . . . 54.07 111.618 -166.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 64.27 27.11 71.11 Favored Glycine 0 C--O 1.209 -1.434 0 CA-C-O 123.46 1.589 . . . . 39.219999999999999 111.889 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1002 ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -97.21 134.52 40.42 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 105.515 -2.031 . . . . 38.119999999999997 105.515 173.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1003 ' ' ILE . . . . . 0.536 HD12 HG22 ' B' 1033 ' ' VAL . 57.1 mt -84.92 149.97 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 CA-C-N 112.023 -2.353 . . . . 29.699999999999999 105.89 170.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -118.71 131.39 9.12 Favored Glycine 0 CA--C 1.492 -1.404 0 N-CA-C 108.351 -1.9 . . . . 27.5 108.351 164.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1005 ' ' ILE . . . . . 0.683 HG23 ' HB3' ' B' 1017 ' ' ALA . 45.4 mm -102.69 110.08 62.4 Favored Pre-proline 0 C--N 1.313 -1.002 0 N-CA-C 104.852 -2.277 . . . . 24.829999999999998 104.852 172.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -83.83 155.0 13.4 Favored 'Trans proline' 0 C--O 1.238 0.514 0 C-N-CA 121.743 1.629 . . . . 27.190000000000001 111.966 173.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -77.39 114.97 16.77 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 112.031 -2.349 . . . . 41.460000000000001 106.013 169.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1008 ' ' GLU . . . . . 0.503 ' OE2' ' HG2' ' B' 1071 ' ' LYS . 25.4 mm-40 -51.43 164.77 0.18 Allowed 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 116.463 2.023 . . . . 26.93 116.463 -178.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1009 ' ' ARG . . . . . 0.428 ' NH2' ' HG2' ' B' 1079 ' ' GLU . 14.4 mtm180 -146.15 59.06 1.23 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 123.314 1.531 . . . . 34.479999999999997 108.566 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1010 ' ' LEU . . . . . 0.564 ' HB3' ' HB2' ' B' 1013 ' ' GLU . 17.9 tp -104.37 152.94 21.67 Favored 'General case' 0 N--CA 1.469 0.511 1 O-C-N 116.287 -4.008 . . . . 44.219999999999999 107.743 174.246 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B 1011 ' ' THR . . . . . . . . . . . . . 24.3 m -58.99 114.42 2.57 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 123.779 0.832 . . . . 40.740000000000002 109.107 167.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 47.6 t30 54.62 80.08 0.13 Allowed 'General case' 0 C--N 1.35 0.624 0 C-N-CA 125.271 1.428 . . . . 44.439999999999998 111.861 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1013 ' ' GLU . . . . . 0.564 ' HB2' ' HB3' ' B' 1010 ' ' LEU . 9.5 tp10 -147.29 141.54 26.21 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 123.817 1.77 . . . . 29.870000000000001 109.857 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1014 ' ' THR . . . . . 0.617 ' HB ' ' HB3' ' B' 1320 ' ' PRO . 0.2 OUTLIER -128.43 2.96 5.64 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 113.173 -1.83 . . . . 25.260000000000002 111.535 -178.756 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 65.4 mtm180 -76.95 145.29 38.23 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 123.925 1.821 . . . . 29.539999999999999 110.631 174.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1016 ' ' VAL . . . . . 0.633 HG21 ' HB1' ' B' 1039 ' ' ALA . 2.2 p -126.64 -175.96 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-N 114.45 -1.25 . . . . 23.550000000000001 109.161 161.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1017 ' ' ALA . . . . . 0.683 ' HB3' HG23 ' B' 1005 ' ' ILE . . . -93.64 7.95 42.76 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 115.339 1.607 . . . . 23.59 115.339 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1018 ' ' ALA . . . . . 0.487 ' H ' HG13 ' B' 1016 ' ' VAL . . . -164.75 147.55 8.58 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 114.608 1.336 . . . . 24.93 114.608 -177.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1019 ' ' THR . . . . . . . . . . . . . 68.7 p -98.91 172.77 4.4 Favored Pre-proline 0 C--O 1.242 0.688 0 N-CA-C 106.839 -1.541 . . . . 28.09 106.839 159.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -49.56 -51.28 11.05 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.404 3.402 . . . . 28.789999999999999 110.959 166.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 37.9 tttp -46.88 -48.29 21.19 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 123.533 2.879 . . . . 47.280000000000001 112.728 170.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1022 ' ' THR . . . . . 0.41 HG21 ' HA3' ' B' 1328 ' ' GLY . 3.4 m -62.45 -32.39 73.26 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 117.715 0.234 . . . . 30.120000000000001 111.071 -177.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1023 ' ' VAL . . . . . 0.5 HG13 ' HB ' ' B' 1033 ' ' VAL . 91.6 t -64.21 -48.82 83.96 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 O-C-N 120.514 -1.367 . . . . 32.240000000000002 108.109 176.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1024 ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' B' 1028 ' ' LYS . 31.3 mt-10 -60.36 -29.15 68.73 Favored 'General case' 0 C--O 1.246 0.921 0 O-C-N 121.937 -0.477 . . . . 49.619999999999997 111.305 176.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -66.44 -42.06 88.24 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-O 123.805 1.764 . . . . 44.68 113.034 176.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 34.2 mt -70.38 -37.8 74.62 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 113.71 -1.586 . . . . 35.710000000000001 109.392 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1027 ' ' LEU . . . . . 0.461 HD12 ' HA ' ' B' 1024 ' ' GLU . 63.4 mt -67.47 -26.8 66.55 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 115.599 -0.728 . . . . 42.18 111.179 174.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1028 ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' B' 1024 ' ' GLU . 65.1 mttm -61.01 -33.82 73.86 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.273 0.942 . . . . 48.340000000000003 111.99 169.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1029 ' ' LEU . . . . . 0.503 ' HB2' ' HD2' ' B' 1031 ' ' PHE . 7.8 mt -88.61 10.39 20.69 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 120.984 -1.072 . . . . 38.689999999999998 111.326 176.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 85.09 -10.45 63.24 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 116.169 1.228 . . . . 32.280000000000001 116.169 -175.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1031 ' ' PHE . . . . . 0.503 ' HD2' ' HB2' ' B' 1029 ' ' LEU . 66.4 m-85 -78.19 120.21 22.67 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 119.447 1.624 . . . . 35.939999999999998 112.659 -170.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1032 ' ' THR . . . . . . . . . . . . . 34.8 m -73.74 132.51 42.72 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 106.596 -1.631 . . . . 33.369999999999997 106.596 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1033 ' ' VAL . . . . . 0.536 HG22 HD12 ' B' 1003 ' ' ILE . 16.9 t -117.63 128.93 74.76 Favored 'Isoleucine or valine' 0 C--O 1.249 1.028 0 O-C-N 119.489 -2.007 . . . . 29.98 108.662 -171.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -108.56 143.61 37.36 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.31 -0.859 . . . . 28.18 110.228 166.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1035 ' ' VAL . . . . . 0.432 HG23 ' HB1' ' B' 1055 ' ' ALA . 57.6 t -125.57 131.35 72.2 Favored 'Isoleucine or valine' 0 C--N 1.372 1.552 0 N-CA-C 108.107 -1.071 . . . . 25.82 108.107 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1036 ' ' GLU . . . . . 0.449 ' HB2' HG11 ' B' 1063 ' ' VAL . 30.5 tt0 -73.3 143.16 47.08 Favored 'General case' 0 C--O 1.252 1.223 0 O-C-N 120.455 -1.403 . . . . 32.439999999999998 108.996 177.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1037 ' ' SER . . . . . 0.586 ' H ' ' HG3' ' B' 1059 ' ' GLU . 1.2 m -65.95 137.98 57.51 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 119.612 -1.93 . . . . 29.539999999999999 111.64 174.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 103.09 -22.08 37.85 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 124.844 1.34 . . . . 27.760000000000002 111.165 -175.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1039 ' ' ALA . . . . . 0.633 ' HB1' HG21 ' B' 1016 ' ' VAL . . . -65.46 -40.14 92.84 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 123.089 0.555 . . . . 26.02 110.428 174.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -55.05 -51.71 51.96 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 124.445 1.091 . . . . 26.469999999999999 112.093 169.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.19 -28.71 68.18 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 113.745 1.017 . . . . 50.979999999999997 113.745 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1042 ' ' LEU . . . . . 0.584 HD22 ' HA ' ' B' 1014 ' ' THR . 76.9 mt -67.63 -52.68 35.38 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 119.951 1.251 . . . . 29.300000000000001 109.092 168.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1043 ' ' ALA . . . . . 0.51 ' HB2' HG12 ' B' 1016 ' ' VAL . . . -72.26 29.81 0.05 Allowed 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 118.014 2.598 . . . . 26.739999999999998 118.014 174.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1044 ' ' SER . . . . . . . . . . . . . 28.4 m 47.66 36.51 5.6 Favored 'General case' 0 C--N 1.358 0.951 0 N-CA-C 117.713 2.486 . . . . 31.260000000000002 117.713 -173.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1045 ' ' PHE . . . . . 0.451 ' CD1' ' HB3' ' A' 1277 ' ' ALA . 0.8 OUTLIER -130.06 163.5 26.39 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 124.112 1.91 . . . . 33.259999999999998 112.626 -173.834 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 3.3 t70 -67.84 139.84 56.56 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 114.548 -1.205 . . . . 46.740000000000002 109.525 158.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -68.42 -36.59 79.3 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 121.057 1.753 . . . . 34.439999999999998 111.259 174.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1048 ' ' LYS . . . . . 0.427 ' O ' HG12 ' B' 1051 ' ' VAL . 0.1 OUTLIER -70.97 -15.08 62.56 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.463 0.649 . . . . 48.670000000000002 112.652 -175.011 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -58.56 -37.04 74.9 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 119.234 -2.166 . . . . 35.259999999999998 111.122 165.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1050 ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -65.29 -33.57 76.28 Favored 'General case' 0 CA--C 1.563 1.451 0 CA-C-O 117.843 -1.075 . . . . 32.170000000000002 111.725 170.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1051 ' ' VAL . . . . . 0.427 HG12 ' O ' ' B' 1048 ' ' LYS . 0.3 OUTLIER -68.1 -30.28 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 121.404 1.911 . . . . 38.369999999999997 108.702 176.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -63.59 -38.46 91.22 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.222 0.919 . . . . 45.770000000000003 109.883 173.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -76.97 -21.66 54.39 Favored 'General case' 0 C--N 1.36 1.065 0 CA-C-O 121.557 0.694 . . . . 37.829999999999998 112.685 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 118.73 31.12 1.52 Allowed Glycine 0 C--O 1.215 -1.07 0 O-C-N 120.515 -1.366 . . . . 35.82 113.346 176.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1055 ' ' ALA . . . . . 0.432 ' HB1' HG23 ' B' 1035 ' ' VAL . . . -102.05 135.73 43.12 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 123.175 1.464 . . . . 33.770000000000003 109.558 178.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -75.4 105.5 6.46 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 106.374 -1.713 . . . . 51.020000000000003 106.374 174.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1057 ' ' ILE . . . . . . . . . . . . . 37.5 mm -77.64 85.62 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 O-C-N 120.476 -1.39 . . . . 38.469999999999999 107.597 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1058 ' ' VAL . . . . . 0.469 ' O ' ' HB ' ' B' 1063 ' ' VAL . 3.5 m -117.98 123.7 72.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 125.038 1.461 . . . . 39.399999999999999 110.712 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1059 ' ' GLU . . . . . 0.586 ' HG3' ' H ' ' B' 1037 ' ' SER . 5.4 mp0 -90.58 155.77 18.63 Favored 'General case' 0 C--O 1.248 1.01 0 O-C-N 120.758 -1.214 . . . . 57.07 110.274 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1060 ' ' GLY . . . . . 0.408 ' O ' HG12 ' B' 1063 ' ' VAL . . . 65.23 -145.61 49.2 Favored Glycine 0 C--O 1.21 -1.375 0 CA-C-N 113.405 -1.725 . . . . 44.829999999999998 114.23 169.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 5.4 m120 -55.31 -20.26 10.93 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 115.586 1.699 . . . . 46.270000000000003 115.586 -177.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1062 ' ' SER . . . . . . . . . . . . . 28.9 m -59.54 -50.73 72.78 Favored 'General case' 0 CA--C 1.489 -1.395 0 O-C-N 120.166 -1.584 . . . . 43.469999999999999 111.9 164.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1063 ' ' VAL . . . . . 0.469 ' HB ' ' O ' ' B' 1058 ' ' VAL . 0.8 OUTLIER -65.41 -38.42 82.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 120.61 1.55 . . . . 36.979999999999997 109.91 177.55 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 98.9 m95 -66.48 -21.47 66.19 Favored 'General case' 0 C--O 1.269 2.108 0 N-CA-C 114.936 1.458 . . . . 37.899999999999999 114.936 178.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -83.74 90.25 7.29 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 104.687 -2.338 . . . . 46.189999999999998 104.687 169.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1066 ' ' SER . . . . . . . . . . . . . 73.4 m -154.36 150.88 28.41 Favored 'General case' 0 CA--C 1.49 -1.335 0 CA-C-N 113.213 -1.812 . . . . 37.060000000000002 108.512 176.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1067 ' ' GLU . . . . . 0.456 ' OE2' ' HA ' ' B' 1000 ' ' HIS . 78.4 mt-10 -79.3 -17.87 53.78 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 120.799 -1.188 . . . . 43.950000000000003 113.783 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1068 ' ' ILE . . . . . . . . . . . . . 3.1 mp -126.67 143.99 38.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 103.233 -2.877 . . . . 33.5 103.233 173.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 16.5 mm -122.9 105.59 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 102.245 -3.243 . . . . 30.57 102.245 165.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1070 ' ' LEU . . . . . 0.805 ' HB3' HD13 ' B' 1331 ' ' LEU . 81.5 mt -86.7 122.27 30.37 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 101.975 -3.343 . . . . 27.66 101.975 176.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1071 ' ' LYS . . . . . 0.503 ' HG2' ' OE2' ' B' 1008 ' ' GLU . 34.0 tttm -146.58 158.21 43.86 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 108.255 -1.017 . . . . 28.399999999999999 108.255 -169.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1072 ' ' VAL . . . . . 0.471 ' HA ' ' CZ ' ' B' 1327 ' ' TYR . 58.7 t -90.82 -77.0 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 108.481 -0.933 . . . . 23.18 108.481 -176.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1073 ' ' ASN . . . . . 0.441 HD21 ' HG2' ' B' 1013 ' ' GLU . 62.8 m-80 -93.89 146.07 24.17 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 108.178 -1.045 . . . . 25.469999999999999 108.178 -165.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1074 ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' B' 1092 ' ' PHE . . . -50.11 115.38 5.28 Favored Pre-proline 0 C--O 1.249 1.028 0 N-CA-C 114.386 1.254 . . . . 27.899999999999999 114.386 -174.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1075 ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' B' 1074 ' ' ALA . 35.8 Cg_endo -43.57 136.67 6.32 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.26 3.307 . . . . 31.620000000000001 115.587 -173.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1076 ' ' LEU . . . . . 0.41 ' O ' HG13 ' B' 1080 ' ' ILE . 13.3 mt -69.75 166.79 18.51 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 112.047 -2.342 . . . . 40.490000000000002 107.905 173.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1077 ' ' ASP . . . . . 0.598 ' HA ' HD12 ' B' 1080 ' ' ILE . 27.7 t70 -58.76 -35.83 73.4 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 119.315 -0.954 . . . . 51.590000000000003 110.065 -174.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.39 -39.47 81.69 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 122.307 1.051 . . . . 42.359999999999999 109.549 -178.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1079 ' ' GLU . . . . . 0.468 ' HA ' HD12 ' B' 1082 ' ' LEU . 27.9 mt-10 -68.11 -27.25 66.3 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 113.678 -1.601 . . . . 34.530000000000001 109.636 175.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1080 ' ' ILE . . . . . 0.598 HD12 ' HA ' ' B' 1077 ' ' ASP . 88.3 mt -70.84 -37.75 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 120.461 1.482 . . . . 33.25 108.071 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -64.84 -46.99 79.58 Favored 'General case' 0 C--O 1.247 0.959 0 N-CA-C 109.822 -0.436 . . . . 36.469999999999999 109.822 174.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1082 ' ' LEU . . . . . 0.468 HD12 ' HA ' ' B' 1079 ' ' GLU . 33.0 mt -53.96 -44.96 71.18 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 125.119 1.368 . . . . 37.759999999999998 113.314 177.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1083 ' ' LEU . . . . . 0.583 ' HB3' HG11 ' B' 1110 ' ' VAL . 9.6 mt -57.89 125.09 21.55 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 122.396 1.093 . . . . 37.43 109.9 175.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -96.17 147.09 32.43 Favored Pre-proline 0 N--CA 1.438 -1.073 0 CA-C-N 114.279 -1.328 . . . . 37.700000000000003 108.522 -172.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -51.93 122.6 10.77 Favored 'Trans proline' 0 N--CA 1.451 -0.996 1 C-N-CA 126.114 4.543 . . . . 35.509999999999998 114.319 -178.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 98.22 -15.16 61.74 Favored Glycine 0 N--CA 1.466 0.678 0 CA-C-N 113.123 -1.853 . . . . 33.869999999999997 113.003 176.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1087 ' ' THR . . . . . . . . . . . . . 29.3 m -63.02 133.14 54.1 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 124.515 2.103 . . . . 32.5 111.299 174.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1088 ' ' THR . . . . . 0.677 ' HA ' ' HB ' ' B' 1111 ' ' THR . 4.8 m -74.42 92.53 2.33 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 113.233 -1.803 . . . . 30.219999999999999 111.059 176.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1089 ' ' LEU . . . . . 0.475 HD13 HD11 ' B' 1083 ' ' LEU . 14.2 tp -76.89 119.69 20.99 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 122.374 1.083 . . . . 27.239999999999998 108.721 171.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 24.8 t -112.95 122.61 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 107.304 -1.369 . . . . 25.390000000000001 107.304 171.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1091 ' ' SER . . . . . 0.42 ' OG ' ' HB3' ' B' 1071 ' ' LYS . 69.0 m -157.58 165.38 35.69 Favored 'General case' 0 CA--C 1.504 -0.799 0 O-C-N 120.122 -1.611 . . . . 28.809999999999999 109.995 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1092 ' ' PHE . . . . . 0.449 ' O ' ' HB2' ' B' 1074 ' ' ALA . 2.2 m-85 -62.53 96.35 0.08 Allowed 'General case' 0 N--CA 1.466 0.351 0 O-C-N 119.374 -2.078 . . . . 30.780000000000001 107.978 159.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1093 ' ' ILE . . . . . 0.407 ' CD1' ' HB2' ' B' 1091 ' ' SER . 44.0 mm -88.63 -27.7 5.4 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.184 0 O-C-N 121.087 -1.008 . . . . 30.280000000000001 112.683 -174.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1094 ' ' TRP . . . . . . . . . . . . . 76.1 m95 50.37 54.7 15.98 Favored Pre-proline 0 C--N 1.321 -0.654 0 O-C-N 124.486 1.116 . . . . 34.07 113.957 -177.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -41.5 -56.26 1.9 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 1 C-N-CA 125.776 4.317 . . . . 38.659999999999997 117.607 -164.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -66.99 -38.56 86.26 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 121.015 1.734 . . . . 41.32 111.826 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -68.61 -22.46 64.43 Favored 'General case' 0 C--O 1.209 -1.051 0 CA-C-N 113.644 -1.616 . . . . 51.659999999999997 111.199 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1098 ' ' ASN . . . . . 0.567 ' HB3' ' HB2' ' B' 1101 ' ' LEU . 96.0 m-20 -126.25 68.84 66.69 Favored Pre-proline 0 N--CA 1.439 -0.987 0 O-C-N 120.364 -1.46 . . . . 40.32 109.94 -174.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -64.94 -62.18 0.09 OUTLIER 'Trans proline' 0 CA--C 1.559 1.756 0 C-N-CA 124.112 3.208 . . . . 41.560000000000002 109.85 -174.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -51.87 -44.0 63.5 Favored 'General case' 0 C--N 1.374 1.664 0 N-CA-C 114.101 1.149 . . . . 54.109999999999999 114.101 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1101 ' ' LEU . . . . . 0.567 ' HB2' ' HB3' ' B' 1098 ' ' ASN . 9.1 mp -58.36 -48.16 81.46 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.472 -0.767 . . . . 37.880000000000003 110.034 175.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1102 ' ' MET . . . . . . . . . . . . . 39.6 mmm -57.19 -43.1 82.39 Favored 'General case' 0 C--O 1.241 0.607 0 O-C-N 121.459 -0.775 . . . . 37.539999999999999 112.446 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -71.62 -41.8 68.45 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 107.798 -1.186 . . . . 47.009999999999998 107.798 -171.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1104 ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -61.94 -40.73 96.51 Favored 'General case' 0 C--O 1.262 1.759 0 N-CA-C 114.849 1.425 . . . . 48.68 114.849 175.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1105 ' ' LEU . . . . . 0.479 ' HB3' HG21 ' B' 1112 ' ' VAL . 61.6 mt -64.98 -37.79 88.83 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.779 1.231 . . . . 32.210000000000001 111.16 173.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -60.72 -45.78 92.91 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 117.524 -1.226 . . . . 33.729999999999997 113.138 172.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -55.98 -44.6 78.71 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 122.379 1.085 . . . . 51.469999999999999 112.296 171.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1108 ' ' ARG . . . . . 0.426 ' HG3' HG22 ' B' 1080 ' ' ILE . 24.1 mmm180 -69.51 -6.49 30.99 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 120.747 -1.221 . . . . 43.899999999999999 113.205 178.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1109 ' ' ASN . . . . . 0.463 ' HA ' ' HA2' ' B' 1364 ' ' GLY . 13.7 m-80 62.15 27.6 16.61 Favored 'General case' 0 CA--C 1.486 -1.493 0 N-CA-C 114.084 1.142 . . . . 44.82 114.084 170.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1110 ' ' VAL . . . . . 0.583 HG11 ' HB3' ' B' 1083 ' ' LEU . 11.1 m -84.06 154.18 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 113.516 0.932 . . . . 30.52 113.516 174.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1111 ' ' THR . . . . . 0.677 ' HB ' ' HA ' ' B' 1088 ' ' THR . 4.1 m -86.59 90.85 8.38 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 120.749 -1.219 . . . . 27.120000000000001 109.22 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1112 ' ' VAL . . . . . 0.479 HG21 ' HB3' ' B' 1105 ' ' LEU . 41.0 t -91.51 125.02 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 124.738 1.274 . . . . 26.399999999999999 112.644 -168.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1113 ' ' MET . . . . . 0.679 ' SD ' HD21 ' B' 1334 ' ' LEU . 59.2 mtp -123.18 127.62 48.91 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 104.301 -2.481 . . . . 42.920000000000002 104.301 -176.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -101.56 113.1 25.93 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 122.918 1.342 . . . . 24.149999999999999 112.2 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1115 ' ' MET . . . . . 0.479 ' HB3' ' HB2' ' B' 1129 ' ' ALA . 24.0 mmm -66.81 -21.16 66.05 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 113.395 -1.729 . . . . 29.949999999999999 115.318 -173.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1116 ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -81.02 -52.65 7.19 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 111.253 -2.703 . . . . 34.530000000000001 112.793 172.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1117 ' ' SER . . . . . . . . . . . . . 57.8 m -90.11 68.22 7.09 Favored 'General case' 0 C--O 1.242 0.684 0 O-C-N 118.826 -2.421 . . . . 33.490000000000002 112.021 -171.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1118 ' ' VAL . . . . . . . . . . . . . 1.8 t -94.87 131.18 30.94 Favored Pre-proline 0 N--CA 1.467 0.376 0 CA-C-N 112.967 -1.924 . . . . 34.020000000000003 106.3 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1119 ' ' PRO . . . . . 0.552 ' HG2' ' HA3' ' B' 1357 ' ' GLY . 86.8 Cg_exo -62.34 115.41 2.85 Favored 'Trans proline' 0 C--O 1.249 1.038 1 C-N-CA 125.711 4.274 . . . . 38.280000000000001 112.321 175.204 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B 1120 ' ' ARG . . . . . 0.42 HH12 ' CG ' ' B' 1128 ' ' ASP . 7.8 mmt180 -82.19 86.81 6.58 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 122.367 1.079 . . . . 55.049999999999997 112.74 -166.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1121 ' ' ILE . . . . . 0.519 HG12 HD11 ' B' 1373 ' ' ILE . 11.1 pt -123.16 142.73 38.71 Favored 'Isoleucine or valine' 0 C--O 1.256 1.41 0 N-CA-C 101.351 -3.574 . . . . 42.090000000000003 101.351 151.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1122 ' ' SER . . . . . 0.679 ' HB2' ' HA ' ' C' ' 133' ' ' MET . 2.5 m -37.05 -43.55 0.48 Allowed 'General case' 0 C--O 1.243 0.761 0 N-CA-C 121.466 3.876 . . . . 38.020000000000003 121.466 -161.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1123 ' ' ARG . . . . . 0.515 ' HG3' HG21 ' B' 1354 ' ' VAL . 20.8 ptt-85 -47.9 -31.26 4.93 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 121.364 1.893 . . . . 34.289999999999999 115.549 175.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1124 ' ' ALA . . . . . . . . . . . . . . . -43.13 -47.53 6.15 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 114.623 1.342 . . . . 32.350000000000001 114.623 169.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1125 ' ' GLN . . . . . 0.454 ' HA ' ' HB3' ' B' 1128 ' ' ASP . 30.1 mm100 -52.5 -26.56 13.35 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 116.511 2.041 . . . . 47.170000000000002 116.511 -178.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1126 ' ' SER . . . . . . . . . . . . . 47.3 p -71.27 -32.25 68.48 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 124.135 1.922 . . . . 31.710000000000001 110.968 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1127 ' ' LEU . . . . . . . . . . . . . 4.3 mp -88.12 -32.02 18.89 Favored 'General case' 0 C--N 1.356 0.888 0 CA-C-N 113.949 -1.478 . . . . 37.0 110.268 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1128 ' ' ASP . . . . . 0.454 ' HB3' ' HA ' ' B' 1125 ' ' GLN . 14.7 t0 -58.73 103.87 0.19 Allowed 'General case' 0 CA--C 1.505 -0.773 0 O-C-N 120.291 -1.506 . . . . 40.399999999999999 113.114 -173.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1129 ' ' ALA . . . . . 0.479 ' HB2' ' HB3' ' B' 1115 ' ' MET . . . -63.86 -29.13 70.35 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 111.911 -2.404 . . . . 26.559999999999999 113.862 175.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 53.8 mt -67.95 -31.47 71.24 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-O 117.295 -1.336 . . . . 30.890000000000001 110.66 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1131 ' ' SER . . . . . 0.42 ' HB3' ' NE2' ' B' 1125 ' ' GLN . 84.0 p -60.16 -53.14 61.21 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 122.301 2.319 . . . . 29.84 110.608 175.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1132 ' ' SER . . . . . 0.454 ' HB3' ' HB3' ' B' 1326 ' ' LEU . 51.7 m -57.93 -49.46 76.68 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 113.451 0.908 . . . . 31.91 113.451 176.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1133 ' ' MET . . . . . . . . . . . . . 32.7 mmt -63.84 -37.63 88.09 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 122.678 1.227 . . . . 25.899999999999999 110.667 -175.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1134 ' ' ALA . . . . . 0.864 ' HB1' ' HB2' ' B' 1176 ' ' ALA . . . -62.98 -48.12 80.24 Favored 'General case' 0 N--CA 1.426 -1.64 0 O-C-N 121.139 -0.976 . . . . 26.620000000000001 110.097 171.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -51.23 -51.28 55.46 Favored 'General case' 0 C--N 1.35 0.607 0 C-N-CA 125.287 1.435 . . . . 36.969999999999999 112.247 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1136 ' ' ILE . . . . . 0.536 HG21 ' HA ' ' B' 1316 ' ' PRO . 29.7 mm -50.25 -58.62 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 C-N-CA 124.938 1.295 . . . . 32.109999999999999 108.893 169.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -58.92 -30.14 67.61 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 119.077 -0.487 . . . . 24.140000000000001 110.053 -175.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1138 ' ' GLY . . . . . 0.423 ' HA2' HD21 ' B' 1284 ' ' LEU . . . -66.3 -57.38 10.51 Favored Glycine 0 N--CA 1.479 1.555 0 N-CA-C 109.777 -1.329 . . . . 25.129999999999999 109.777 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 53.4 t80 -55.65 -47.21 77.06 Favored 'General case' 0 C--O 1.204 -1.32 0 CA-C-N 117.9 0.85 . . . . 32.729999999999997 111.706 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1140 ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -67.65 -23.43 65.34 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 116.975 -1.488 . . . . 26.359999999999999 110.848 -178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1141 ' ' ALA . . . . . 0.43 ' HB1' HG21 ' B' 1282 ' ' VAL . . . -64.22 -45.33 88.74 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 122.126 2.239 . . . . 24.120000000000001 111.152 171.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1142 ' ' ILE . . . . . 0.584 HG13 ' HB3' ' B' 1183 ' ' ALA . 49.4 mm -60.49 -44.76 97.1 Favored 'Isoleucine or valine' 0 C--O 1.247 0.937 0 CA-C-N 115.718 -0.674 . . . . 23.370000000000001 110.323 176.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 98.0 t -53.83 -69.99 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 114.607 1.336 . . . . 24.960000000000001 114.607 171.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1144 ' ' GLU . . . . . 0.48 ' HG3' ' HE2' ' B' 1312 ' ' TYR . 43.9 mm-40 -59.12 -27.78 65.92 Favored 'General case' 0 C--O 1.243 0.736 0 O-C-N 121.724 -0.61 . . . . 32.07 111.922 -176.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1145 ' ' ALA . . . . . 0.881 ' HB1' HD12 ' B' 1251 ' ' ILE . . . -58.95 -63.89 1.14 Allowed 'General case' 0 C--O 1.246 0.883 0 CA-C-O 117.459 -1.258 . . . . 24.870000000000001 108.202 169.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1146 ' ' ALA . . . . . . . . . . . . . . . -58.68 -20.33 47.53 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 121.474 1.943 . . . . 24.670000000000002 115.326 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1147 ' ' HIS . . . . . 0.471 ' HB3' ' O ' ' B' 1144 ' ' GLU . 74.9 t60 -62.39 -63.72 1.15 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.254 1.421 . . . . 28.579999999999998 107.674 170.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1148 ' ' GLU . . . . . 0.565 ' HB2' HD11 ' B' 1310 ' ' ILE . 59.2 mm-40 -87.83 -1.65 58.11 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 118.663 2.838 . . . . 36.82 118.663 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1149 ' ' PHE . . . . . 0.441 ' HE1' ' NH2' ' B' 1151 ' ' ARG . 2.7 t80 -69.22 141.65 54.43 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 122.801 1.286 . . . . 31.969999999999999 110.77 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1150 ' ' GLY . . . . . . . . . . . . . . . -66.79 -34.72 88.15 Favored Glycine 0 CA--C 1.536 1.36 0 CA-C-O 118.599 -1.111 . . . . 25.489999999999998 112.461 175.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1151 ' ' ARG . . . . . 0.461 ' HA ' ' HB2' ' A' 1322 ' ' GLN . 71.6 mtm-85 -122.77 177.46 5.46 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 120.773 2.287 . . . . 59.840000000000003 109.6 -157.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1152 ' ' PHE . . . . . 0.968 ' HB2' HG11 ' B' 1163 ' ' VAL . 7.7 m-30 -78.67 156.8 28.82 Favored 'General case' 0 C--O 1.25 1.111 0 CA-C-N 119.79 1.177 . . . . 34.450000000000003 108.69 167.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1153 ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -68.03 -50.8 53.16 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.441 1.591 . . . . 31.170000000000002 108.865 163.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1154 ' ' THR . . . . . . . . . . . . . 2.8 m -61.74 124.32 20.41 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 113.264 -1.789 . . . . 33.890000000000001 115.618 -175.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -74.08 69.78 1.58 Allowed Glycine 0 N--CA 1.442 -0.948 0 O-C-N 120.942 -1.098 . . . . 38.950000000000003 110.738 175.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1156 ' ' GLN . . . . . 0.483 ' H ' ' HB ' ' B' 1163 ' ' VAL . 18.1 tt0 -99.57 133.02 44.5 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-O 123.436 1.589 . . . . 54.229999999999997 112.291 -168.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 20.6 mm -85.77 99.92 8.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 101.191 -3.633 . . . . 51.159999999999997 101.191 173.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1158 ' ' THR . . . . . . . . . . . . . 6.4 m -110.63 101.58 10.22 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.592 -1.186 . . . . 49.609999999999999 108.809 -171.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . 27.31 -71.41 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 120.28 3.437 . . . . 49.049999999999997 120.28 -175.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1160 ' ' ALA . . . . . 0.539 ' HB2' ' ND2' ' A' 1330 ' ' ASN . . . -69.13 -48.87 61.26 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 125.272 1.429 . . . . 47.649999999999999 112.926 175.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . -137.05 -171.56 12.23 Favored Glycine 0 C--O 1.243 0.663 0 CA-C-N 121.856 2.116 . . . . 45.609999999999999 111.283 -170.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 92.0 mttt -111.58 139.22 47.2 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 111.595 -2.303 . . . . 57.460000000000001 109.052 175.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1163 ' ' VAL . . . . . 0.968 HG11 ' HB2' ' B' 1152 ' ' PHE . 74.4 t -98.96 130.91 26.48 Favored Pre-proline 0 N--CA 1.426 -1.662 0 CA-C-O 116.691 -1.623 . . . . 42.93 108.05 170.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1164 ' ' PRO . . . . . 0.506 ' HA ' ' HD3' ' B' 1165 ' ' PRO . 73.0 Cg_endo -69.78 140.2 42.02 Favored 'Trans proline' 0 N--CA 1.441 -1.609 0 C-N-CA 123.715 2.943 . . . . 39.289999999999999 110.432 171.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1165 ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' B' 1164 ' ' PRO . 70.4 Cg_exo -66.78 115.51 3.62 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 123.185 2.59 . . . . 34.170000000000002 111.72 178.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -64.49 125.59 25.16 Favored 'General case' 0 C--N 1.355 0.837 0 CA-C-N 119.496 1.044 . . . . 31.690000000000001 112.875 -177.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1167 ' ' LYS . . . . . 0.625 ' HB2' ' HA ' ' B' 1249 ' ' VAL . 77.4 mttt -90.94 115.12 27.72 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 104.205 -2.517 . . . . 44.780000000000001 104.205 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 85.4 t -104.41 96.25 4.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 O-C-N 120.507 -1.371 . . . . 31.23 108.627 -174.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1169 ' ' MET . . . . . 0.833 ' HB2' HG11 ' B' 1249 ' ' VAL . 57.1 ttp -77.36 94.85 4.28 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 122.63 1.205 . . . . 37.090000000000003 110.697 177.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1170 ' ' VAL . . . . . 0.471 HG22 ' HB ' ' B' 1253 ' ' VAL . 92.8 t -81.26 115.88 24.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 N-CA-C 107.075 -1.454 . . . . 30.170000000000002 107.075 175.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1171 ' ' ILE . . . . . 0.519 HG22 ' HB2' ' B' 1256 ' ' ALA . 84.0 mt -98.85 112.76 31.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 104.456 -2.424 . . . . 33.740000000000002 104.456 174.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 98.19 91.39 1.95 Allowed Glycine 0 CA--C 1.486 -1.78 0 CA-C-N 113.547 -1.66 . . . . 32.590000000000003 109.166 175.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1173 ' ' ALA . . . . . 0.474 ' H ' ' HB2' ' B' 1195 ' ' ASP . . . -75.68 61.28 1.35 Allowed 'General case' 0 C--O 1.253 1.251 0 CA-C-O 123.46 1.6 . . . . 32.420000000000002 112.095 174.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -78.48 -170.06 36.54 Favored Glycine 0 C--O 1.224 -0.502 0 O-C-N 120.745 -1.222 . . . . 31.739999999999998 110.063 170.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 36.5 t -56.44 -44.98 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-N 119.224 1.512 . . . . 31.48 111.031 174.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1176 ' ' ALA . . . . . 0.864 ' HB2' ' HB1' ' B' 1134 ' ' ALA . . . -55.19 -50.25 69.85 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 123.856 0.862 . . . . 26.120000000000001 112.136 172.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1177 ' ' GLY . . . . . . . . . . . . . . . -54.56 -47.39 70.3 Favored Glycine 0 C--N 1.344 1.01 0 O-C-N 125.008 1.442 . . . . 25.73 109.574 178.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1178 ' ' LEU . . . . . 0.478 ' HA ' HD12 ' B' 1181 ' ' ILE . 81.3 mt -66.57 -34.94 79.01 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.778 -1.424 . . . . 32.590000000000003 112.684 -173.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -71.73 -33.93 69.13 Favored 'General case' 0 C--N 1.351 0.674 0 O-C-N 120.452 -1.405 . . . . 27.719999999999999 112.26 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -67.16 -42.58 84.08 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 123.044 1.402 . . . . 26.030000000000001 110.348 172.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1181 ' ' ILE . . . . . 0.752 HG22 ' HG2' ' B' 1207 ' ' MET . 60.0 mt -58.71 -45.82 90.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 O-C-N 119.6 -1.937 . . . . 28.609999999999999 112.314 174.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -53.94 -55.08 27.62 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-N 115.105 -0.952 . . . . 25.23 111.942 172.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1183 ' ' ALA . . . . . 0.584 ' HB3' HG13 ' B' 1142 ' ' ILE . . . -60.31 -50.05 75.18 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.985 1.393 . . . . 24.09 113.265 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -69.58 -33.78 73.2 Favored 'General case' 0 C--O 1.241 0.636 0 O-C-N 121.401 -0.812 . . . . 26.68 110.404 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -68.71 -41.11 79.55 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 120.379 -1.45 . . . . 36.57 111.027 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1186 ' ' SER . . . . . 0.846 ' HB3' ' HA ' ' A' 1187 ' ' LEU . 70.7 m -51.62 -44.36 62.87 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 122.211 1.005 . . . . 28.920000000000002 113.497 163.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1187 ' ' LEU . . . . . . . . . . . . . 74.7 mt -78.92 -1.76 36.71 Favored 'General case' 0 N--CA 1.433 -1.298 0 O-C-N 119.893 -1.754 . . . . 29.09 113.92 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 71.17 42.19 58.63 Favored Glycine 0 C--O 1.219 -0.817 0 O-C-N 120.746 -1.221 . . . . 29.260000000000002 111.961 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1189 ' ' ALA . . . . . . . . . . . . 0.251 . . -104.59 154.06 20.41 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.491 -0.559 . . . . 30.16 109.491 172.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1190 ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' B' 1167 ' ' LYS . 65.1 mt -81.11 93.37 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 O-C-N 119.726 -1.859 . . . . 35.810000000000002 108.389 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1191 ' ' VAL . . . . . 0.437 HG11 HG12 ' B' 1181 ' ' ILE . 4.4 t -78.4 125.57 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.289 -1.004 . . . . 31.969999999999999 108.289 -178.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1192 ' ' ARG . . . . . 0.512 HH12 ' CD ' ' B' 1248 ' ' GLU . 27.0 mmt85 -112.33 94.44 4.93 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 106.081 -1.822 . . . . 48.159999999999997 106.081 177.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -103.78 133.34 48.93 Favored 'General case' 0 C--N 1.355 0.845 0 O-C-N 119.223 -2.173 . . . . 35.890000000000001 115.044 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 38.4 t80 -108.16 156.46 19.29 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 105.02 -2.215 . . . . 41.880000000000003 105.02 176.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1195 ' ' ASP . . . . . 0.474 ' HB2' ' H ' ' B' 1173 ' ' ALA . 7.5 t70 -167.23 146.69 5.22 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 113.371 -1.741 . . . . 38.280000000000001 107.949 163.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1196 ' ' THR . . . . . . . . . . . . . 2.7 p -68.27 -31.49 70.98 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 115.474 1.657 . . . . 40.619999999999997 115.474 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1197 ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -79.02 139.85 57.29 Favored Pre-proline 0 C--N 1.304 -1.391 0 CA-C-O 122.341 1.067 . . . . 53.090000000000003 110.928 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -69.09 -37.33 10.94 Favored 'Trans proline' 0 C--O 1.236 0.414 0 N-CA-C 117.991 2.266 . . . . 42.560000000000002 117.991 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -30.28 71.47 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 122.286 2.312 . . . . 56.310000000000002 116.514 -170.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1200 ' ' VAL . . . . . 0.537 ' HA ' ' HG2' ' B' 1203 ' ' GLN . 2.1 m -63.99 -29.07 46.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 114.654 -1.157 . . . . 42.909999999999997 113.201 174.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 41.6 tttm -43.03 -56.57 3.27 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 115.711 1.745 . . . . 48.890000000000001 115.711 175.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -56.75 -37.99 71.8 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.604 -1.18 . . . . 51.700000000000003 112.824 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1203 ' ' GLN . . . . . 0.604 ' OE1' ' HA ' ' C' ' 74' ' ' ARG . 47.3 mm-40 -60.19 -52.07 66.88 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 109.187 -0.671 . . . . 52.57 109.187 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1204 ' ' VAL . . . . . 0.488 HG22 HD13 ' B' 1181 ' ' ILE . 99.7 t -61.79 -47.57 92.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 O-C-N 125.561 1.788 . . . . 33.789999999999999 110.671 -174.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -53.41 -49.34 67.5 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 125.366 1.466 . . . . 36.579999999999998 111.025 175.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1206 ' ' SER . . . . . . . . . . . . . 18.8 m -80.01 -3.38 48.2 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 114.149 1.166 . . . . 39.609999999999999 114.149 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1207 ' ' MET . . . . . 0.752 ' HG2' HG22 ' B' 1181 ' ' ILE . 9.1 tpt -79.21 -22.38 44.95 Favored 'General case' 0 CA--C 1.511 -0.523 0 O-C-N 120.911 -1.118 . . . . 37.450000000000003 111.019 163.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 96.23 41.59 3.69 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 119.777 -1.827 . . . . 31.870000000000001 109.522 -173.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -144.95 142.79 30.13 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 123.759 0.824 . . . . 35.399999999999999 111.831 -171.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -80.74 130.69 35.22 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.981 -0.748 . . . . 47.890000000000001 108.981 -173.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 53.2 t80 -96.77 110.84 23.23 Favored 'General case' 0 C--O 1.247 0.925 0 N-CA-C 105.967 -1.864 . . . . 45.530000000000001 105.967 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1212 ' ' LEU . . . . . . . . . . . . . 78.6 mt -70.66 129.68 39.8 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 105.107 -2.182 . . . . 46.329999999999998 105.107 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -115.28 164.55 14.07 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 114.603 -1.18 . . . . 60.409999999999997 111.246 -170.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 4.9 mp -70.57 137.69 50.29 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-O 121.228 0.537 . . . . 57.380000000000003 109.875 -167.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1215 ' ' ASP . . . . . 0.885 ' HB3' ' HB1' ' B' 1237 ' ' ALA . 19.5 t70 . . . . . 0 N--CA 1.476 0.84 0 O-C-N 120.697 -1.252 . . . . 65.069999999999993 111.066 -169.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1230 ' ' MET . . . . . 0.493 ' HA ' ' HB2' ' B' 1231 ' ' SER . 28.5 mmt . . . . . 0 N--CA 1.422 -1.865 0 N-CA-C 109.654 -0.499 . . . . 80.319999999999993 109.654 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1231 ' ' SER . . . . . 0.493 ' HB2' ' HA ' ' B' 1230 ' ' MET . 40.0 m 70.05 174.51 0.29 Allowed 'General case' 0 N--CA 1.476 0.853 2 O-C-N 112.163 -6.586 . . . . 79.920000000000002 117.433 -1.584 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -114.3 -117.37 0.32 Allowed 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 105.254 -2.128 . . . . 77.909999999999997 105.254 175.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 57.99 -60.51 0.03 OUTLIER 'General case' 0 C--O 1.241 0.649 0 CA-C-N 123.073 2.669 . . . . 73.879999999999995 116.132 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.41 -26.3 66.59 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 120.218 1.372 . . . . 68.980000000000004 112.0 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 37.3 pt -31.27 -44.91 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.247 0.931 0 N-CA-C 116.056 1.873 . . . . 64.530000000000001 116.056 164.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -63.69 -39.17 93.65 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-O 121.336 0.589 . . . . 66.359999999999999 109.656 -177.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1237 ' ' ALA . . . . . 0.885 ' HB1' ' HB3' ' B' 1215 ' ' ASP . . . -68.02 -52.3 37.21 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.507 -0.77 . . . . 56.600000000000001 111.888 176.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1238 ' ' GLU . . . . . 0.414 ' HB3' ' CE2' ' B' 1242 ' ' PHE . 75.1 mt-10 -50.39 -66.2 0.43 Allowed 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 125.06 1.344 . . . . 56.789999999999999 110.405 176.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1239 ' ' MET . . . . . . . . . . . . . 82.7 mtp -50.49 -40.57 51.54 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 115.929 1.826 . . . . 53.630000000000003 115.929 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -57.27 -49.78 75.0 Favored 'General case' 0 C--O 1.259 1.601 0 O-C-N 124.511 1.132 . . . . 51.740000000000002 110.742 173.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 4.2 tt -66.34 -37.36 85.16 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 116.214 -0.448 . . . . 44.859999999999999 110.525 -174.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1242 ' ' PHE . . . . . 0.414 ' CE2' ' HB3' ' B' 1238 ' ' GLU . 23.1 m-30 -67.17 -42.49 84.21 Favored 'General case' 0 N--CA 1.438 -1.041 0 O-C-N 126.257 2.223 . . . . 42.780000000000001 109.597 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1243 ' ' ALA . . . . . 0.509 ' HA ' ' HG3' ' B' 1271 ' ' MET . . . -63.65 -40.84 97.86 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 120.294 -1.504 . . . . 40.960000000000001 108.607 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -67.41 -34.43 77.23 Favored 'General case' 0 C--O 1.246 0.907 0 O-C-N 120.58 -1.325 . . . . 43.060000000000002 110.798 175.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1245 ' ' GLN . . . . . 0.432 ' O ' HG22 ' B' 1249 ' ' VAL . 25.5 mm-40 -70.03 -27.58 64.78 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.378 0.881 . . . . 46.450000000000003 113.378 168.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -57.43 -45.38 84.72 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 119.953 -1.717 . . . . 41.780000000000001 111.598 -176.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 21.1 tptt -62.26 -31.69 72.3 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.33 0.863 . . . . 52.200000000000003 113.33 173.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1248 ' ' GLU . . . . . 0.512 ' CD ' HH12 ' B' 1192 ' ' ARG . 0.5 OUTLIER -77.35 -43.64 32.23 Favored 'General case' 0 C--O 1.248 0.986 0 O-C-N 121.394 -0.816 . . . . 53.549999999999997 113.019 177.646 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B 1249 ' ' VAL . . . . . 0.833 HG11 ' HB2' ' B' 1169 ' ' MET . 30.0 m -81.49 -179.26 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.031 0 O-C-N 120.575 -1.328 . . . . 34.409999999999997 114.457 -160.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1250 ' ' ASP . . . . . 0.42 ' O ' ' HB3' ' B' 1279 ' ' SER . 6.2 m-20 -132.94 -37.94 0.99 Allowed 'General case' 0 C--O 1.247 0.948 0 CA-C-N 113.087 -1.869 . . . . 33.380000000000003 109.616 -172.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1251 ' ' ILE . . . . . 0.881 HD12 ' HB1' ' B' 1145 ' ' ALA . 41.1 mm -129.8 138.11 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 N-CA-C 104.469 -2.419 . . . . 29.539999999999999 104.469 175.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1252 ' ' ILE . . . . . 0.489 HG22 ' HB ' ' B' 1254 ' ' THR . 78.7 mt -112.84 116.36 52.4 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 N-CA-C 103.641 -2.726 . . . . 32.439999999999998 103.641 166.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1253 ' ' VAL . . . . . 0.484 HG13 HD11 ' B' 1284 ' ' LEU . 42.8 t -97.57 87.56 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.258 1.52 0 N-CA-C 102.139 -3.282 . . . . 30.57 102.139 176.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1254 ' ' THR . . . . . 0.489 ' HB ' HG22 ' B' 1252 ' ' ILE 0.286 1.3 t -89.7 104.63 17.17 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 126.245 2.926 . . . . 35.039999999999999 109.141 -174.274 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B 1255 ' ' THR . . . . . 0.433 ' CG2' ' HB3' ' B' 1176 ' ' ALA . 21.9 m -110.99 -5.26 14.86 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 109.021 -3.718 . . . . 34.619999999999997 113.099 -169.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1256 ' ' ALA . . . . . 0.519 ' HB2' HG22 ' B' 1171 ' ' ILE . . . -71.08 79.7 0.68 Allowed 'General case' 0 C--O 1.247 0.921 0 CA-C-O 124.026 1.869 . . . . 42.719999999999999 112.45 -162.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1257 ' ' LEU . . . . . 0.583 HD23 ' HB2' ' B' 1263 ' ' ALA . 29.2 mt -92.56 120.9 33.47 Favored 'General case' 0 C--O 1.249 1.077 0 N-CA-C 106.912 -1.514 . . . . 52.43 106.912 169.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 70.1 mt -81.68 113.6 43.65 Favored Pre-proline 0 N--CA 1.449 -0.486 0 N-CA-C 102.055 -3.313 . . . . 59.409999999999997 102.055 176.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -57.02 94.44 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 124.077 3.185 . . . . 62.68 115.746 -171.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 135.56 -44.91 1.13 Allowed Glycine 0 CA--C 1.493 -1.285 0 CA-C-N 112.065 -2.334 . . . . 64.159999999999997 108.479 174.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 82.5 mttt -68.98 161.78 69.85 Favored Pre-proline 0 N--CA 1.446 -0.626 0 O-C-N 120.215 -1.756 . . . . 68.530000000000001 114.335 172.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -61.07 157.48 39.07 Favored 'Trans proline' 0 N--CA 1.44 -1.64 0 C-N-CA 122.235 1.957 . . . . 61.990000000000002 111.504 157.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1263 ' ' ALA . . . . . 0.583 ' HB2' HD23 ' B' 1257 ' ' LEU . . . -66.14 128.23 93.7 Favored Pre-proline 0 N--CA 1.416 -2.142 0 O-C-N 120.761 -1.212 . . . . 57.149999999999999 112.811 174.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1264 ' ' PRO . . . . . 0.462 ' HD2' ' O ' ' B' 1256 ' ' ALA . 73.1 Cg_endo -68.15 137.94 42.04 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 123.787 2.991 . . . . 51.57 110.24 -176.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -76.9 71.15 3.4 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 123.358 1.552 . . . . 54.549999999999997 111.248 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 63.4 mt -70.1 -42.58 72.51 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 124.086 1.898 . . . . 46.859999999999999 110.7 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1267 ' ' ILE . . . . . 0.742 ' HB ' ' HA ' ' B' 1292 ' ' CYS . 44.4 mm -80.07 93.44 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 O-C-N 119.207 -2.183 . . . . 41.039999999999999 107.129 -177.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1268 ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.81 152.63 31.0 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 113.429 -1.714 . . . . 39.579999999999998 112.8 170.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1269 ' ' ARG . . . . . . . . . . . . . 73.1 mtt85 -56.4 -37.97 70.86 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 120.782 -1.199 . . . . 53.149999999999999 111.675 172.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -43.85 -54.54 5.17 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 125.888 1.675 . . . . 42.960000000000001 114.376 168.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1271 ' ' MET . . . . . 0.509 ' HG3' ' HA ' ' B' 1243 ' ' ALA . 48.7 ttm -64.37 -33.91 76.95 Favored 'General case' 0 C--N 1.353 0.758 0 CA-C-N 114.648 -1.16 . . . . 43.890000000000001 109.551 -174.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1272 ' ' VAL . . . . . 0.656 HG11 HG21 ' B' 1303 ' ' THR . 21.5 t -65.89 -48.58 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 123.315 1.531 . . . . 38.369999999999997 108.087 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -67.47 -14.63 63.1 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 120.802 -1.187 . . . . 47.460000000000001 114.155 173.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1274 ' ' SER . . . . . . . . . . . . . 48.6 m -86.73 0.2 55.14 Favored 'General case' 0 N--CA 1.44 -0.926 0 O-C-N 119.2 -2.187 . . . . 38.380000000000003 114.367 168.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1275 ' ' MET . . . . . 0.653 ' HB2' HG21 ' B' 1307 ' ' VAL . 55.6 mtp -82.24 156.98 24.08 Favored 'General case' 0 CA--C 1.486 -1.499 0 O-C-N 118.502 -2.624 . . . . 37.810000000000002 112.946 173.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -62.39 146.59 50.9 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 112.743 -2.026 . . . . 49.259999999999998 107.25 167.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -73.62 150.43 41.37 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 114.319 1.229 . . . . 34.460000000000001 114.319 -176.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 62.18 51.6 55.57 Favored Glycine 0 N--CA 1.479 1.521 0 CA-C-O 124.859 2.366 . . . . 33.530000000000001 111.698 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1279 ' ' SER . . . . . 0.42 ' HB3' ' O ' ' B' 1250 ' ' ASP . 45.4 m -134.49 154.27 51.51 Favored 'General case' 0 C--O 1.26 1.607 0 CA-C-N 111.543 -2.328 . . . . 31.309999999999999 105.348 -173.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1280 ' ' VAL . . . . . . . . . . . . . 63.3 t -120.65 138.99 49.33 Favored 'Isoleucine or valine' 0 C--O 1.247 0.961 0 O-C-N 119.459 -2.026 . . . . 29.32 109.108 -170.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1281 ' ' ILE . . . . . . . . . . . . . 40.7 mt -106.81 101.48 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 105.874 -1.899 . . . . 31.93 105.874 168.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1282 ' ' VAL . . . . . 0.472 HG23 ' HA ' ' B' 1253 ' ' VAL . 0.0 OUTLIER -89.81 114.65 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.179 0 CA-C-O 124.414 2.054 . . . . 29.48 107.498 176.719 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B 1283 ' ' ASP . . . . . 0.408 ' HA ' HG22 ' B' 1254 ' ' THR . 22.5 t0 -94.51 108.48 20.42 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 113.192 -1.822 . . . . 34.5 106.439 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1284 ' ' LEU . . . . . 0.484 HD11 HG13 ' B' 1253 ' ' VAL . 5.9 mp -84.78 -33.43 22.99 Favored 'General case' 0 C--O 1.255 1.354 0 CA-C-N 112.448 -2.16 . . . . 37.939999999999998 108.779 174.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1285 ' ' ALA . . . . . 0.519 ' HB1' ' CB ' ' B' 1263 ' ' ALA . . . -75.23 -9.67 58.76 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 113.298 -1.774 . . . . 40.920000000000002 110.881 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -42.65 -30.02 0.34 Allowed 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 118.709 2.855 . . . . 44.390000000000001 118.709 169.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1287 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.96 -36.56 83.68 Favored 'General case' 0 C--N 1.363 1.157 0 CA-C-N 121.385 1.902 . . . . 51.460000000000001 110.566 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 20.9 t30 -122.92 100.09 6.71 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 122.996 1.379 . . . . 57.75 109.328 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1289 ' ' GLY . . . . . . . . . . . . . . . 82.9 -60.85 4.85 Favored Glycine 0 C--O 1.259 1.693 0 O-C-N 119.858 -1.776 . . . . 49.850000000000001 114.274 177.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 90.61 128.35 3.84 Favored Glycine 0 C--O 1.252 1.234 0 O-C-N 120.674 -1.486 . . . . 45.93 111.535 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1291 ' ' ASN . . . . . . . . . . . . . 7.7 m120 -80.83 -31.57 35.46 Favored 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 124.298 0.646 . . . . 42.670000000000002 110.667 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1292 ' ' CYS . . . . . 0.742 ' HA ' ' HB ' ' B' 1267 ' ' ILE . 52.5 t -92.1 140.49 29.59 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.285 -1.005 . . . . 38.82 108.285 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1293 ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -65.57 -45.28 83.89 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 113.376 0.88 . . . . 46.710000000000001 113.376 171.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1294 ' ' TYR . . . . . 0.513 ' HD2' HG21 ' B' 1272 ' ' VAL . 26.2 m-85 -63.78 -15.57 59.03 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 117.458 2.392 . . . . 47.229999999999997 117.458 -178.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1295 ' ' THR . . . . . 0.589 ' OG1' ' HB3' ' B' 1292 ' ' CYS . 33.2 m -59.98 119.02 6.98 Favored 'General case' 0 C--O 1.262 1.755 0 O-C-N 120.986 -1.071 . . . . 36.020000000000003 111.41 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 60.8 t -79.49 121.42 82.69 Favored Pre-proline 0 N--CA 1.473 0.694 0 N-CA-C 102.767 -3.049 . . . . 37.259999999999998 102.767 163.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -62.45 92.63 0.13 Allowed 'Trans proline' 0 C--O 1.249 1.036 0 C-N-CA 124.592 3.528 . . . . 35.090000000000003 110.542 -177.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1298 ' ' GLY . . . . . 0.656 ' HA2' ' HA ' ' B' 1312 ' ' TYR . . . 114.66 27.02 3.43 Favored Glycine 0 N--CA 1.443 -0.886 0 O-C-N 120.861 -1.15 . . . . 35.969999999999999 112.237 175.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -153.04 171.4 18.44 Favored 'General case' 0 C--N 1.356 0.861 0 CA-C-N 121.001 2.401 . . . . 40.390000000000001 116.079 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1300 ' ' ILE . . . . . 0.681 HG23 HG12 ' B' 1310 ' ' ILE . 18.9 mt -87.82 160.08 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 O-C-N 122.103 -0.373 . . . . 37.43 110.086 165.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 51.6 t80 -150.44 161.71 41.98 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 106.116 -1.809 . . . . 44.130000000000003 106.116 169.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1302 ' ' THR . . . . . . . . . . . . . 9.2 m -136.16 138.39 41.9 Favored 'General case' 0 C--O 1.253 1.249 0 O-C-N 120.519 -1.363 . . . . 39.780000000000001 109.483 173.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1303 ' ' THR . . . . . 0.656 HG21 HG11 ' B' 1272 ' ' VAL . 41.4 p -98.37 168.49 10.18 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 126.004 2.065 . . . . 43.289999999999999 114.095 -167.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -47.74 -49.4 28.38 Favored 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 124.721 1.208 . . . . 53.07 113.161 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 32.9 p-10 -67.69 -39.95 84.39 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 115.226 1.565 . . . . 43.969999999999999 115.226 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 127.62 29.03 0.85 Allowed Glycine 0 CA--C 1.527 0.783 0 N-CA-C 109.547 -1.421 . . . . 41.119999999999997 109.547 177.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1307 ' ' VAL . . . . . 0.653 HG21 ' HB2' ' B' 1275 ' ' MET . 47.3 t -98.61 148.25 6.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 107.409 -1.33 . . . . 38.119999999999997 107.409 173.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1308 ' ' LYS . . . . . 0.454 ' CD ' ' HB3' ' B' 1148 ' ' GLU . 90.6 mttt -113.27 128.51 56.49 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 118.718 -2.489 . . . . 36.340000000000003 105.482 -175.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1309 ' ' VAL . . . . . . . . . . . . . 42.7 t -110.06 130.41 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 103.294 -2.854 . . . . 30.399999999999999 103.294 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1310 ' ' ILE . . . . . 0.681 HG12 HG23 ' B' 1300 ' ' ILE . 52.9 mt -127.14 113.01 30.48 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.411 0 N-CA-C 105.108 -2.182 . . . . 30.82 105.108 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1311 ' ' GLY . . . . . 0.585 ' HA3' HG23 ' B' 1295 ' ' THR . . . -132.98 117.54 1.97 Allowed Glycine 0 C--O 1.214 -1.134 0 N-CA-C 104.789 -3.324 . . . . 26.530000000000001 104.789 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1312 ' ' TYR . . . . . 0.666 ' HB2' ' HG ' ' B' 1315 ' ' LEU . 36.0 m-85 -117.59 128.03 54.55 Favored 'General case' 0 CA--C 1.493 -1.235 0 CA-C-N 118.345 1.073 . . . . 38.0 110.667 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1313 ' ' THR . . . . . . . . . . . . . 26.3 m -68.11 -28.42 67.31 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.511 -1.677 . . . . 29.800000000000001 107.601 167.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -89.4 18.61 5.09 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 124.835 1.254 . . . . 39.039999999999999 113.592 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1315 ' ' LEU . . . . . 0.666 ' HG ' ' HB2' ' B' 1312 ' ' TYR . 6.9 mt -48.24 -40.21 34.34 Favored Pre-proline 0 CA--C 1.509 -0.633 0 N-CA-C 117.25 2.315 . . . . 31.079999999999998 117.25 177.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1316 ' ' PRO . . . . . 0.536 ' HA ' HG21 ' B' 1136 ' ' ILE . 17.9 Cg_exo -64.19 -44.56 11.92 Favored 'Trans proline' 0 CA--C 1.513 -0.548 0 C-N-CA 123.911 3.074 . . . . 26.100000000000001 111.968 169.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -56.02 -33.05 60.15 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 115.524 0.969 . . . . 23.170000000000002 115.524 172.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -54.9 -23.92 21.03 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 113.623 0.971 . . . . 40.399999999999999 113.623 171.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 12.6 tp -126.76 79.73 71.59 Favored Pre-proline 0 N--CA 1.442 -0.874 0 O-C-N 119.08 -2.263 . . . . 23.600000000000001 107.194 176.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1320 ' ' PRO . . . . . 0.617 ' HB3' ' HB ' ' B' 1014 ' ' THR . 51.6 Cg_endo -58.65 -63.04 0.15 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.801 3.001 . . . . 22.350000000000001 119.246 -171.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1321 ' ' THR . . . . . . . . . . . . . 2.3 m -57.02 -43.82 82.23 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 119.666 1.121 . . . . 26.52 109.779 -175.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1322 ' ' GLN . . . . . 0.568 ' HB2' ' HA ' ' A' 1151 ' ' ARG . 34.4 tp60 -74.13 -35.79 64.14 Favored 'General case' 0 CA--C 1.493 -1.218 0 O-C-N 121.626 -0.671 . . . . 24.379999999999999 112.442 -172.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1323 ' ' SER . . . . . . . . . . . . . 68.6 m -61.01 -45.28 95.46 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 113.905 1.076 . . . . 22.800000000000001 113.905 168.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1324 ' ' SER . . . . . . . . . . . . . 14.5 m -59.01 -37.94 78.07 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.89 0.476 . . . . 21.25 111.015 175.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1325 ' ' GLN . . . . . 0.435 ' HG2' ' HD2' ' A' 1164 ' ' PRO . 43.6 tp60 -63.05 -49.18 75.59 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 113.12 0.785 . . . . 31.34 113.12 171.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1326 ' ' LEU . . . . . 0.471 ' HA ' HD23 ' B' 1326 ' ' LEU . 35.7 mt -78.57 -48.1 15.87 Favored 'General case' 0 CA--C 1.488 -1.439 0 O-C-N 120.092 -1.63 . . . . 31.559999999999999 113.02 -170.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1327 ' ' TYR . . . . . 0.471 ' CZ ' ' HA ' ' B' 1072 ' ' VAL . 38.7 t80 -57.26 -42.81 82.27 Favored 'General case' 0 C--N 1.359 1.003 0 N-CA-C 107.536 -1.283 . . . . 22.73 107.536 170.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1328 ' ' GLY . . . . . 0.803 ' HA2' HD12 ' B' 1331 ' ' LEU . . . -52.37 -50.87 45.52 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 123.472 0.558 . . . . 21.91 112.438 171.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1329 ' ' THR . . . . . 0.628 HG21 ' HA3' ' A' 1161 ' ' GLY . 34.6 m -65.39 -29.46 70.16 Favored 'General case' 0 C--O 1.245 0.84 0 O-C-N 119.004 -2.468 . . . . 22.149999999999999 111.265 177.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1330 ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' B' 1327 ' ' TYR . 20.3 m120 -60.59 -49.19 78.53 Favored 'General case' 0 C--O 1.25 1.12 0 CA-C-O 122.446 1.117 . . . . 26.18 110.889 173.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1331 ' ' LEU . . . . . 0.805 HD13 ' HB3' ' B' 1070 ' ' LEU . 36.4 mt -53.21 -46.16 68.95 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 113.278 -1.783 . . . . 23.68 113.16 171.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1332 ' ' VAL . . . . . 0.574 HG12 ' HE3' ' B' 1336 ' ' LYS . 39.0 t -53.79 -50.0 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 115.754 -0.657 . . . . 26.57 110.643 171.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1333 ' ' ASN . . . . . 0.59 ' HA ' ' HD2' ' B' 1336 ' ' LYS . 76.3 m-20 -69.55 -27.37 65.09 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 119.875 -1.766 . . . . 28.079999999999998 113.303 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1334 ' ' LEU . . . . . 0.679 HD21 ' SD ' ' B' 1113 ' ' MET . 1.2 tt -66.96 -51.62 52.88 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 106.206 -1.775 . . . . 27.43 106.206 175.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1335 ' ' LEU . . . . . . . . . . . . . 86.3 mt -62.4 -29.75 70.71 Favored 'General case' 0 C--N 1.355 0.844 0 CA-C-N 115.162 -0.926 . . . . 30.5 111.255 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1336 ' ' LYS . . . . . 0.59 ' HD2' ' HA ' ' B' 1333 ' ' ASN . 95.0 mttt -64.8 -45.73 85.05 Favored 'General case' 0 C--O 1.245 0.843 0 O-C-N 120.418 -1.426 . . . . 41.649999999999999 110.052 169.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 29.5 tp -76.04 -18.27 59.3 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 119.454 1.024 . . . . 42.079999999999998 112.227 -174.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1338 ' ' LEU . . . . . 0.539 HD13 HD12 ' B' 1346 ' ' ILE . 26.8 mt -79.09 -67.92 0.71 Allowed 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 119.637 -1.914 . . . . 35.030000000000001 108.194 167.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1339 ' ' CYS . . . . . 0.506 ' SG ' ' HA ' ' B' 1342 ' ' LYS . 43.0 t -76.45 80.46 3.16 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 124.283 1.992 . . . . 37.329999999999998 108.282 -173.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1340 ' ' LYS . . . . . 0.422 ' HD2' ' O ' ' B' 1338 ' ' LEU . 2.6 mptp? -62.22 -27.64 69.13 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.531 -1.356 . . . . 50.509999999999998 111.984 174.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -84.63 -6.24 59.35 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 114.245 1.202 . . . . 54.210000000000001 114.245 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1342 ' ' LYS . . . . . 0.506 ' HA ' ' SG ' ' B' 1339 ' ' CYS . 90.7 mttt 39.07 39.8 0.42 Allowed 'General case' 0 C--O 1.257 1.477 0 N-CA-C 116.717 2.117 . . . . 50.990000000000002 116.717 -172.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -89.69 -14.52 34.6 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 113.885 -1.507 . . . . 48.82 107.542 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 89.98 27.99 19.58 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.052 -1.071 . . . . 40.43 112.351 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -136.68 160.84 37.62 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 120.289 2.044 . . . . 47.560000000000002 109.012 164.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1346 ' ' ILE . . . . . 0.539 HD12 HD13 ' B' 1338 ' ' LEU . 45.0 mm -68.1 101.13 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 C-N-CA 119.612 -0.835 . . . . 42.490000000000002 108.898 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1347 ' ' THR . . . . . . . . . . . . . 17.6 m -71.91 105.56 3.88 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 103.412 -2.81 . . . . 38.119999999999997 103.412 163.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 47.3 t -69.03 84.97 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.144 -1.389 . . . . 37.5 109.292 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1349 ' ' ASP . . . . . 0.442 ' HB3' HG21 ' B' 1355 ' ' ILE . 24.5 t70 -81.29 164.13 22.44 Favored 'General case' 0 C--O 1.243 0.761 0 O-C-N 121.298 -0.876 . . . . 43.850000000000001 110.701 171.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1350 ' ' PHE . . . . . 0.521 ' HE1' ' HB ' ' B' 1359 ' ' THR . 0.0 OUTLIER -155.0 3.09 0.2 Allowed 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 126.925 2.09 . . . . 39.810000000000002 111.17 158.302 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 10.6 t70 -72.94 -32.68 65.43 Favored 'General case' 0 C--O 1.247 0.939 0 CA-C-O 121.761 0.791 . . . . 51.289999999999999 112.234 -163.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.39 142.34 31.07 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.31 -0.859 . . . . 39.780000000000001 111.904 170.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1353 ' ' VAL . . . . . 0.436 ' HA ' ' HB3' ' B' 1356 ' ' ARG . 22.5 m -62.84 -26.47 40.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 114.956 1.465 . . . . 39.280000000000001 114.956 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1354 ' ' VAL . . . . . 0.515 HG21 ' HG3' ' B' 1123 ' ' ARG . 81.1 t -71.06 -49.94 45.73 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.195 0 N-CA-C 106.389 -1.708 . . . . 35.700000000000003 106.389 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1355 ' ' ILE . . . . . 0.442 HG21 ' HB3' ' B' 1349 ' ' ASP . 25.6 mm -62.49 -46.63 95.95 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 119.458 1.026 . . . . 35.770000000000003 111.766 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1356 ' ' ARG . . . . . 0.436 ' HB3' ' HA ' ' B' 1353 ' ' VAL . 45.1 tpt85 -46.15 -32.2 2.82 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 124.331 1.019 . . . . 38.549999999999997 113.091 172.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1357 ' ' GLY . . . . . 0.552 ' HA3' ' HG2' ' B' 1119 ' ' PRO . . . -97.28 -46.37 2.39 Favored Glycine 0 CA--C 1.497 -1.061 0 O-C-N 120.682 -1.261 . . . . 29.579999999999998 114.125 -176.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1358 ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' B' 1113 ' ' MET . 10.9 p -65.52 -35.73 75.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 117.035 0.417 . . . . 32.060000000000002 111.848 -176.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1359 ' ' THR . . . . . 0.521 ' HB ' ' HE1' ' B' 1350 ' ' PHE . 2.8 m -75.6 80.93 2.59 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.519 -1.66 . . . . 29.0 106.519 172.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1360 ' ' VAL . . . . . . . . . . . . . 15.6 m -68.39 -24.35 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 O-C-N 121.123 -0.986 . . . . 29.68 113.161 -172.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1361 ' ' ILE . . . . . 0.612 HG12 HG12 ' B' 1366 ' ' ILE . 74.7 mt -132.88 97.39 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 103.842 -2.651 . . . . 32.049999999999997 103.842 176.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1362 ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -79.71 92.63 5.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 124.442 3.292 . . . . 32.520000000000003 109.81 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1363 ' ' ALA . . . . . 0.48 ' H ' ' HA ' ' B' 1111 ' ' THR . . . 57.09 30.68 18.67 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 115.922 1.823 . . . . 35.68 115.922 168.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1364 ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' B' 1109 ' ' ASN . . . 147.97 -73.39 0.29 Allowed Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.26 -0.972 . . . . 34.259999999999998 110.887 177.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -69.28 141.45 54.34 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 113.565 0.95 . . . . 51.07 113.565 173.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1366 ' ' ILE . . . . . 0.612 HG12 HG12 ' B' 1361 ' ' ILE . 88.8 mt -86.66 113.33 24.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 125.198 2.428 . . . . 39.869999999999997 111.436 -175.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1367 ' ' THR . . . . . . . . . . . . . 1.1 p -98.45 3.14 48.31 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 111.344 -2.662 . . . . 38.009999999999998 112.698 -172.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1368 ' ' TRP . . . . . 0.411 ' HA ' ' HA ' ' B' 1369 ' ' PRO . 57.7 t90 -73.07 137.45 79.13 Favored Pre-proline 0 N--CA 1.447 -0.599 0 N-CA-C 107.757 -1.201 . . . . 42.140000000000001 107.757 167.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1369 ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' B' 1368 ' ' TRP . 31.5 Cg_exo -94.49 -178.84 8.06 Favored 'Cis proline' 0 N--CA 1.452 -0.939 0 C-N-CA 124.695 -0.96 . . . . 43.259999999999998 111.464 -5.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1370 ' ' ALA . . . . . 0.51 ' HB2' ' HA3' ' B' 1357 ' ' GLY . . . -76.08 163.54 65.95 Favored Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 124.718 1.207 . . . . 46.520000000000003 108.19 169.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -54.04 126.89 23.55 Favored 'Trans proline' 0 CA--C 1.553 1.46 0 C-N-CA 125.149 3.899 . . . . 51.950000000000003 111.003 166.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -37.88 109.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.365 1.442 1 C-N-CA 126.99 5.127 . . . . 56.270000000000003 113.375 -173.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1373 ' ' ILE . . . . . 0.519 HD11 HG12 ' B' 1121 ' ' ILE . 8.3 tp -82.44 137.33 21.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 C-N-CA 126.655 1.982 . . . . 60.829999999999998 113.094 -174.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 16.1 mp0 -87.49 101.09 13.26 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-O 122.979 1.371 . . . . 66.099999999999994 110.188 175.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 43.1 t -73.97 118.34 19.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 112.396 -2.184 . . . . 63.469999999999999 108.12 176.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.217 -5.174 0 O-C-N 118.206 -2.809 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.541 0 CA-C-O 116.792 -1.575 . . . . 0.0 111.416 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -58.11 -23.24 54.17 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 122.655 2.479 . . . . 0.0 115.676 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 52.9 mp0 -52.49 -53.07 50.71 Favored 'General case' 0 C--O 1.215 -0.715 0 CA-C-O 122.027 0.918 . . . . 0.0 109.25 171.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 23' ' ' THR . . . . . 0.551 HG21 ' HZ ' ' C' ' 147' ' ' PHE . 16.8 m -67.3 -43.53 81.48 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 114.561 -1.199 . . . . 0.0 109.791 -176.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 24' ' ' ALA . . . . . 0.521 ' HB2' HG22 ' C' ' 182' ' ' ILE . . . -55.87 -36.38 67.52 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 123.993 0.917 . . . . 0.0 111.26 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.12 -57.87 3.62 Favored 'General case' 0 C--O 1.24 0.605 0 O-C-N 120.082 -1.636 . . . . 0.0 112.706 171.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 mp -46.82 -44.94 19.76 Favored 'General case' 0 C--O 1.21 -1.025 0 C-N-CA 125.664 1.585 . . . . 0.0 114.284 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.426 HD11 HD11 ' C' ' 110' ' ' LEU . 27.6 mt -62.77 -49.52 74.68 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 28' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -67.6 -30.33 69.89 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 119.241 -0.983 . . . . 0.0 111.795 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -62.52 -43.2 99.4 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 124.06 0.944 . . . . 0.0 111.937 168.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.778 ' HA ' ' HB3' ' C' ' 107' ' ' ASP . 51.7 m -44.87 -31.7 1.34 Allowed 'General case' 0 CA--C 1.498 -1.028 1 N-CA-C 122.175 4.139 . . . . 0.0 122.175 -164.22 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 31' ' ' HIS . . . . . 0.538 ' O ' HG23 ' C' ' 62' ' ' ILE . 5.6 m-70 70.85 -62.67 0.44 Allowed 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.499 1.12 . . . . 0.0 111.607 -175.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 32' ' ' SER . . . . . 0.454 ' HB2' ' HA ' ' C' ' 106' ' ' THR . 71.7 m -108.52 139.67 42.95 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 162.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 92.2 t -124.05 134.98 65.08 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 103.738 -2.69 . . . . 0.0 103.738 174.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 42.5 mm -109.95 123.73 66.09 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.305 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 165.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 35' ' ' ILE . . . . . 0.417 ' O ' ' HD3' ' C' ' 37' ' ' PRO . 66.9 mt -108.51 124.8 65.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 172.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 89.2 m -108.1 100.22 35.39 Favored Pre-proline 0 C--O 1.245 0.825 0 CA-C-N 113.359 -1.746 . . . . 0.0 109.147 173.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 37' ' ' PRO . . . . . 0.687 ' HD2' HG12 ' C' ' 68' ' ' ILE . 66.4 Cg_exo -61.76 82.47 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.482 3.455 . . . . 0.0 110.391 174.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.18 -132.91 3.65 Favored Glycine 0 N--CA 1.432 -1.61 0 CA-C-O 123.3 1.5 . . . . 0.0 110.503 169.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 39' ' ' TYR . . . . . 0.78 ' HB2' ' HB2' ' C' ' 114' ' ' ALA . 4.2 t80 -59.28 -57.4 13.19 Favored 'General case' 0 CA--C 1.5 -0.966 0 O-C-N 121.306 -1.114 . . . . 0.0 110.834 -157.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -55.24 -34.92 59.41 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-O 118.392 -1.227 . . . . 0.0 112.328 -173.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 41' ' ' MET . . . . . 0.44 ' SD ' ' HB3' ' C' ' 37' ' ' PRO . 31.3 ttm -88.15 -37.55 16.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 118.539 1.169 . . . . 0.0 110.421 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.36 -2.37 37.86 Favored 'General case' 0 C--O 1.246 0.887 0 C-N-CA 122.416 0.287 . . . . 0.0 111.525 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 p -111.39 -43.53 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 166.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -135.9 179.03 6.59 Favored 'General case' 0 CA--C 1.507 -0.709 0 O-C-N 119.412 -2.055 . . . . 0.0 110.255 -167.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 45' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -63.64 16.02 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 120.583 3.549 . . . . 0.0 120.583 -169.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.417 ' HA ' ' HG2' ' C' ' 176' ' ' LYS . . . -59.9 -17.01 33.98 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 123.68 2.945 . . . . 0.0 115.048 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 47' ' ' GLN . . . . . 0.834 ' HG2' ' HB3' ' C' ' 82' ' ' LEU . 0.0 OUTLIER -62.46 -44.22 96.92 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.157 0.983 . . . . 0.0 111.106 174.516 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 48' ' ' TYR . . . . . 0.568 ' HB2' ' HD3' ' C' ' 49' ' ' PRO . 28.1 m-85 -62.74 -47.26 88.01 Favored Pre-proline 0 C--O 1.253 1.265 0 CA-C-N 121.99 2.177 . . . . 0.0 110.011 177.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 49' ' ' PRO . . . . . 0.568 ' HD3' ' HB2' ' C' ' 48' ' ' TYR . 0.1 OUTLIER -53.95 -42.64 65.04 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 124.642 3.561 . . . . 0.0 114.884 169.714 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 50' ' ' VAL . . . . . 0.415 ' HA ' HG22 ' C' ' 53' ' ' ILE . 1.4 p -65.95 -34.98 73.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 119.203 0.91 . . . . 0.0 111.09 -174.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.3 -50.07 70.53 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.175 0.99 . . . . 0.0 112.419 169.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 52' ' ' GLU . . . . . 0.417 ' HB3' ' HB2' ' C' ' 183' ' ' LEU . 1.5 tm-20 -68.82 -29.41 67.74 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -178.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 53' ' ' ILE . . . . . 0.415 HG22 ' HA ' ' C' ' 50' ' ' VAL . 9.4 tp -76.53 -46.05 32.35 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 N-CA-C 115.597 1.702 . . . . 0.0 115.597 166.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 96.9 m -57.63 -27.93 63.23 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 113.421 0.896 . . . . 0.0 113.421 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -47.43 -57.45 5.32 Favored 'General case' 0 N--CA 1.427 -1.618 0 C-N-CA 125.608 1.563 . . . . 0.0 114.017 167.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -81.17 -25.31 36.92 Favored 'General case' 0 N--CA 1.434 -1.244 0 O-C-N 120.76 -1.213 . . . . 0.0 112.271 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.77 -38.35 90.26 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 123.083 1.421 . . . . 0.0 111.488 171.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 58' ' ' ARG . . . . . 0.425 ' HA ' ' HD2' ' C' ' 58' ' ' ARG . 8.6 tpt180 -73.42 -32.9 64.66 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.536 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.18 -23.08 66.39 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 167.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -81.71 -6.29 58.89 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 119.157 0.89 . . . . 0.0 110.97 168.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.01 41.74 80.43 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 120.52 -1.363 . . . . 0.0 114.465 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 62' ' ' ILE . . . . . 0.538 HG23 ' O ' ' C' ' 31' ' ' HIS . 25.2 mt -96.04 134.54 33.22 Favored 'Isoleucine or valine' 0 C--O 1.253 1.253 0 CA-C-O 123.756 1.741 . . . . 0.0 111.081 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -68.99 83.07 0.32 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 124.629 2.156 . . . . 0.0 110.182 168.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.642 HG13 HD12 ' C' ' 92' ' ' ILE . 1.9 p -100.39 92.0 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 113.748 -1.569 . . . . 0.0 107.749 -176.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -91.62 128.08 37.32 Favored 'General case' 0 N--CA 1.442 -0.836 0 O-C-N 120.117 -1.614 . . . . 0.0 111.929 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 66' ' ' PHE . . . . . 0.517 ' HB2' ' HA ' ' C' ' 93' ' ' VAL . 25.6 m-85 -83.1 78.69 9.56 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 122.639 1.209 . . . . 0.0 109.047 176.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.48 89.06 0.35 Allowed Glycine 0 C--O 1.219 -0.804 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 68' ' ' ILE . . . . . 0.687 HG12 ' HD2' ' C' ' 37' ' ' PRO . 20.6 mt -88.72 132.62 33.13 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.902 0 CA-C-O 120.953 0.406 . . . . 0.0 111.845 -176.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -83.39 128.99 62.15 Favored Pre-proline 0 N--CA 1.472 0.654 0 CA-C-O 117.583 -1.199 . . . . 0.0 109.45 169.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 70' ' ' PRO . . . . . 0.792 ' HD3' ' HB2' ' C' ' 96' ' ' MET . 57.8 Cg_endo -61.11 -66.36 0.06 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.526 0 C-N-CA 124.582 3.521 . . . . 0.0 117.934 -175.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 45.8 t -76.16 107.54 7.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 170.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -168.15 142.71 3.48 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-N 121.315 1.871 . . . . 0.0 111.901 -171.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 61.77 -113.75 6.05 Favored Glycine 0 C--N 1.346 1.103 0 O-C-N 121.208 -0.932 . . . . 0.0 111.493 171.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 74' ' ' ARG . . . . . 0.604 ' HA ' ' OE1' ' B' 1203 ' ' GLN . 1.0 OUTLIER -128.72 105.88 8.56 Favored 'General case' 0 C--O 1.242 0.681 0 O-C-N 121.163 -1.199 . . . . 0.0 109.914 177.326 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.512 ' HB2' ' HB2' ' C' ' 78' ' ' HIS 0.25 2.0 mp 68.63 132.35 0.04 OUTLIER Pre-proline 0 CA--C 1.553 1.058 0 O-C-N 127.605 3.065 . . . . 0.0 116.269 -177.071 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.42 158.29 57.77 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 124.346 3.364 . . . . 0.0 107.784 167.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 77' ' ' GLY . . . . . 0.443 ' H ' HG23 ' A' 1157 ' ' ILE . . . 73.04 -63.92 1.62 Allowed Glycine 0 C--O 1.212 -1.244 0 CA-C-O 116.802 -2.11 . . . . 0.0 111.856 -168.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 78' ' ' HIS . . . . . 0.512 ' HB2' ' HB2' ' C' ' 75' ' ' LEU . 10.2 t-80 -33.23 -50.25 0.29 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -172.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.37 -45.03 85.7 Favored 'General case' 0 C--O 1.245 0.819 0 O-C-N 124.294 0.996 . . . . 0.0 113.207 -178.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.16 -26.07 42.77 Favored 'General case' 0 C--O 1.246 0.908 0 O-C-N 120.266 -1.521 . . . . 0.0 109.409 -175.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.438 HG22 HG21 ' A' 1154 ' ' THR . 46.5 t -58.48 -52.87 54.24 Favored 'Isoleucine or valine' 0 C--N 1.347 0.477 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 166.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.834 ' HB3' ' HG2' ' C' ' 47' ' ' GLN . 63.0 mt -56.95 -29.5 63.21 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 11.1 mp -63.96 -44.98 91.14 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 121.756 -0.59 . . . . 0.0 111.12 167.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.53 -38.08 86.39 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 120.223 -1.548 . . . . 0.0 112.334 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -50.39 -53.79 26.59 Favored 'General case' 0 C--N 1.349 0.572 0 O-C-N 124.654 1.221 . . . . 0.0 113.167 163.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.51 10.31 3.27 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp 58.68 30.29 19.73 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.867 2.067 . . . . 0.0 112.243 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 65.9 t -70.16 127.36 92.33 Favored Pre-proline 0 C--O 1.242 0.697 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 -174.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -50.56 107.41 0.16 Allowed 'Trans proline' 0 C--O 1.243 0.758 1 C-N-CA 125.313 4.009 . . . . 0.0 112.513 -176.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.75 -26.67 64.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.107 -1.406 . . . . 0.0 112.462 -165.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -40.15 -44.11 1.76 Allowed 'General case' 0 C--O 1.245 0.844 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 174.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 92' ' ' ILE . . . . . 0.642 HD12 HG13 ' C' ' 64' ' ' VAL . 0.5 OUTLIER -90.87 -1.42 9.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 -173.437 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 93' ' ' VAL . . . . . 0.517 ' HA ' ' HB2' ' C' ' 66' ' ' PHE . 10.6 t -83.36 121.73 36.59 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 O-C-N 120.686 -1.258 . . . . 0.0 114.38 -174.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 45.0 mt -125.59 81.78 2.01 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -170.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 95' ' ' GLU . . . . . 0.446 ' HA ' ' HB ' ' C' ' 68' ' ' ILE . 27.7 mp0 -75.76 104.38 6.28 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 121.677 -0.64 . . . . 0.0 110.433 -174.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.792 ' HB2' ' HD3' ' C' ' 70' ' ' PRO . 41.5 ttp 49.31 59.65 4.33 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.35 -171.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -103.84 135.74 44.82 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 167.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -85.73 75.64 10.05 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 -172.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 8.3 tp -92.97 62.27 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-O 124.777 2.227 . . . . 0.0 110.585 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -60.04 -32.97 71.42 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 112.397 -2.183 . . . . 0.0 109.354 -170.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.83 -59.65 4.57 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 118.155 -0.926 . . . . 0.0 112.23 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.01 -28.66 69.73 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 128.266 3.479 . . . . 0.0 113.239 176.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 103' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -64.52 -39.92 94.67 Favored 'General case' 0 C--O 1.224 -0.269 0 O-C-N 120.415 -1.428 . . . . 0.0 111.231 174.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -103.32 60.76 0.77 Allowed 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 123.263 1.506 . . . . 0.0 109.453 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -168.79 -37.02 0.02 OUTLIER 'General case' 0 C--O 1.241 0.655 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 106' ' ' THR . . . . . 0.454 ' HA ' ' HB2' ' C' ' 32' ' ' SER . 2.7 m -51.12 132.46 28.0 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 121.256 -0.902 . . . . 0.0 113.282 170.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 107' ' ' ASP . . . . . 0.778 ' HB3' ' HA ' ' C' ' 30' ' ' SER . 1.7 t70 -85.84 -60.49 2.0 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 34.6 m -109.22 130.67 55.49 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 118.572 -1.251 . . . . 0.0 112.563 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 109' ' ' VAL . . . . . 0.668 ' HB ' ' HA ' ' C' ' 144' ' ' VAL . 47.9 t -102.17 132.73 47.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 O-C-N 124.647 1.217 . . . . 0.0 108.225 173.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 110' ' ' LEU . . . . . 0.426 HD11 HD11 ' C' ' 27' ' ' LEU . 15.3 mt -98.58 84.24 3.13 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 124.57 1.169 . . . . 0.0 109.679 176.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 61.8 t -78.55 104.74 6.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 124.461 2.077 . . . . 0.0 107.494 170.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 36.3 mm -72.62 76.47 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.185 0 CA-C-O 124.424 2.059 . . . . 0.0 113.779 -175.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.11 -58.21 3.57 Favored Glycine 0 C--N 1.346 1.128 0 O-C-N 118.18 -2.825 . . . . 0.0 114.568 171.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 114' ' ' ALA . . . . . 0.78 ' HB2' ' HB2' ' C' ' 39' ' ' TYR . . . -82.75 95.05 7.75 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 123.153 1.454 . . . . 0.0 111.557 -171.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 115' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -52.25 -57.56 9.33 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 111.098 -2.774 . . . . 0.0 112.127 165.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 116' ' ' ASP . . . . . 0.589 ' HA ' ' HB2' ' C' ' 119' ' ' ASN . 15.1 m-20 -56.95 -34.03 67.63 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -169.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 20.7 m -43.46 -38.36 2.8 Favored 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 169.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 16.8 m -127.22 26.15 2.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 125.22 1.408 . . . . 0.0 110.826 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 119' ' ' ASN . . . . . 0.589 ' HB2' ' HA ' ' C' ' 116' ' ' ASP . 33.6 t-20 -75.54 120.71 82.93 Favored Pre-proline 0 CA--C 1.505 -0.775 0 CA-C-O 117.524 -1.227 . . . . 0.0 109.513 -177.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 120' ' ' PRO . . . . . 1.039 ' HG2' ' HB2' ' C' ' 160' ' ' ASN . 10.1 Cg_endo -53.25 -45.25 42.44 Favored 'Trans proline' 0 CA--C 1.51 -0.696 0 C-N-CA 124.639 3.559 . . . . 0.0 115.419 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 121' ' ' ALA . . . . . 0.47 ' HB2' ' HB3' ' C' ' 160' ' ' ASN . . . -55.4 -32.88 63.02 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 120.675 1.579 . . . . 0.0 112.897 -176.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 122' ' ' ALA . . . . . 0.535 ' HB1' ' HB3' ' C' ' 133' ' ' MET . . . -56.06 -20.15 15.81 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 120.774 -1.203 . . . . 0.0 113.121 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -119.11 -27.42 5.7 Favored 'General case' 0 C--O 1.221 -0.432 0 O-C-N 119.982 -1.699 . . . . 0.0 111.612 166.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -84.07 -11.08 57.26 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.26 -169.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -128.49 99.42 23.77 Favored Pre-proline 0 C--O 1.247 0.967 0 C-N-CA 119.314 -0.954 . . . . 0.0 111.096 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -64.19 69.25 0.21 Allowed 'Trans proline' 0 N--CA 1.441 -1.582 1 C-N-CA 125.62 4.213 . . . . 0.0 114.642 170.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 127' ' ' LYS . . . . . 0.499 ' HB3' ' HZ3' ' C' ' 127' ' ' LYS . 5.6 ttpm? -177.66 -28.11 0.01 OUTLIER 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 -174.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 128' ' ' SER . . . . . . . . . . . . . 66.2 m -59.46 129.39 86.94 Favored Pre-proline 0 C--O 1.222 -0.355 0 O-C-N 117.532 -3.23 . . . . 0.0 110.6 168.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 129' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -57.29 -46.82 25.54 Favored 'Trans proline' 0 N--CA 1.459 -0.522 1 C-N-CA 126.189 4.592 . . . . 0.0 115.738 -173.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 9.1 pt -84.11 63.7 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.842 0 CA-C-N 121.721 2.055 . . . . 0.0 111.038 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.75 153.44 43.36 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 118.111 2.634 . . . . 0.0 118.111 -168.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.15 22.83 77.46 Favored Glycine 0 C--O 1.213 -1.193 0 CA-C-N 110.232 -3.167 . . . . 0.0 111.553 177.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 133' ' ' MET . . . . . 0.755 ' SD ' ' HD2' ' C' ' 134' ' ' PRO . 34.0 tpp -74.15 119.32 75.76 Favored Pre-proline 0 C--O 1.238 0.481 0 CA-C-N 120.444 2.122 . . . . 0.0 107.956 -175.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 134' ' ' PRO . . . . . 0.755 ' HD2' ' SD ' ' C' ' 133' ' ' MET . 71.6 Cg_endo -67.89 105.17 1.1 Allowed 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 121.112 1.208 . . . . 0.0 108.99 -175.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 4.5 m -117.93 103.71 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 103.503 -2.777 . . . . 0.0 103.503 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 42.2 mt -73.81 90.73 1.9 Allowed 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 110.777 -2.92 . . . . 0.0 113.123 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 51.68 -12.48 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 120.96 3.689 . . . . 0.0 120.96 163.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 8.4 p -80.8 82.88 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-N 125.177 3.626 . . . . 0.0 113.182 -171.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 139' ' ' TRP . . . . . 0.517 ' HA ' HG21 ' C' ' 144' ' ' VAL . 44.6 p90 -163.71 173.12 13.27 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 111.799 -2.455 . . . . 0.0 106.754 173.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 140' ' ' LYS . . . . . . . . . . . . 0.398 25.2 pttm 68.31 -62.81 0.36 Allowed 'General case' 0 C--O 1.242 0.667 0 C-N-CA 128.233 2.613 . . . . 0.0 116.078 171.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.25 110.45 4.05 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-O 121.661 0.743 . . . . 0.0 111.961 169.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 142' ' ' GLN . . . . . 0.427 ' HB3' ' H ' ' C' ' 143' ' ' ASN 0.261 18.3 mm100 74.75 -163.27 0.08 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 172.189 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 143' ' ' ASN . . . . . 0.427 ' H ' ' HB3' ' C' ' 142' ' ' GLN . 2.1 m-20 -91.03 69.37 6.26 Favored 'General case' 0 C--O 1.248 1.018 0 CA-C-O 124.605 2.145 . . . . 0.0 107.288 -159.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 144' ' ' VAL . . . . . 0.668 ' HA ' ' HB ' ' C' ' 109' ' ' VAL . 20.5 t -75.24 82.69 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 114.145 -1.389 . . . . 0.0 107.384 178.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 145' ' ' ILE . . . . . . . . . . . . . 1.3 mp -80.17 120.71 32.16 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -176.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 146' ' ' VAL . . . . . . . . . . . . . 92.9 t -98.6 115.53 39.19 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 N-CA-C 102.919 -2.993 . . . . 0.0 102.919 172.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 147' ' ' PHE . . . . . 0.551 ' HZ ' HG21 ' C' ' 23' ' ' THR . 37.9 m-85 -64.82 123.96 20.73 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.611 0.719 . . . . 0.0 111.739 173.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 148' ' ' LYS . . . . . 0.61 ' HE3' ' SD ' ' C' ' 151' ' ' MET . 62.6 mmtt -126.54 146.41 50.14 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 2.1 tpp85 -89.02 -55.21 3.78 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 100.513 -3.884 . . . . 0.0 100.513 162.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 150' ' ' SER . . . . . 0.514 ' O ' ' HD2' ' C' ' 148' ' ' LYS . 3.4 m -152.82 -179.82 7.98 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 167.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 151' ' ' MET . . . . . 0.61 ' SD ' ' HE3' ' C' ' 148' ' ' LYS . 10.6 tpt -115.61 111.83 21.23 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 171.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -84.13 -144.1 0.08 Allowed 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 111.802 -2.453 . . . . 0.0 107.371 167.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 91.8 m -97.01 133.9 41.08 Favored 'General case' 0 C--O 1.24 0.577 0 O-C-N 117.243 -3.411 . . . . 0.0 107.43 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -84.57 151.91 27.07 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 113.256 -1.793 . . . . 0.0 110.292 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 16.1 m-30 -59.93 -39.03 84.11 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 117.917 -3.107 . . . . 0.0 114.523 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 156' ' ' ALA . . . . . . . . . . . . . . . -85.17 -54.6 4.51 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 119.199 -2.188 . . . . 0.0 107.548 166.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 80.84 -77.25 2.03 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.302 -0.863 . . . . 0.0 114.56 171.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 20.2 m -63.57 159.93 3.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 117.73 2.493 . . . . 0.0 117.73 -162.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . 0.258 0.0 OUTLIER -2.48 104.56 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.527 1 N-CA-C 122.043 4.09 . . . . 0.0 122.043 -176.071 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' C' C ' 160' ' ' ASN . . . . . 1.039 ' HB2' ' HG2' ' C' ' 120' ' ' PRO . 12.3 p30 -165.89 140.25 3.77 Favored Pre-proline 0 N--CA 1.434 -1.257 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.598 -173.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 161' ' ' PRO . . . . . 0.566 ' HG2' ' HG3' ' C' ' 120' ' ' PRO . 3.4 Cg_endo -45.56 -33.78 10.13 Favored 'Trans proline' 0 CA--C 1.512 -0.599 0 C-N-CA 123.521 2.814 . . . . 0.0 118.638 170.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 162' ' ' LEU . . . . . 0.588 ' HA ' HG22 ' C' ' 168' ' ' THR . 6.6 tp -68.28 -25.75 65.31 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 121.575 -0.703 . . . . 0.0 111.608 -173.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 163' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -87.66 -39.15 15.26 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 120.483 -1.385 . . . . 0.0 113.553 165.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -74.78 -53.26 9.5 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 115.802 1.778 . . . . 0.0 115.802 -169.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 165' ' ' LYS . . . . . 0.449 ' HB2' ' HB ' ' C' ' 168' ' ' THR . 5.4 mtpt -69.8 165.49 21.35 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 117.876 2.547 . . . . 0.0 117.876 -160.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 166' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' C' ' 169' ' ' HIS . 0.0 OUTLIER -73.09 -39.84 65.49 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 127.106 2.162 . . . . 0.0 113.109 174.179 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 167' ' ' ASN . . . . . 0.408 ' O ' ' HA ' ' C' ' 143' ' ' ASN . 42.1 p-10 -102.86 -46.19 4.76 Favored 'General case' 0 CA--C 1.498 -1.047 0 O-C-N 120.25 -1.531 . . . . 0.0 109.887 -174.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 168' ' ' THR . . . . . 0.599 HG23 ' HB ' ' C' ' 144' ' ' VAL . 54.4 m -74.27 91.84 2.2 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 102.92 -2.993 . . . . 0.0 102.92 161.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 169' ' ' HIS . . . . . 0.438 ' HB2' ' O ' ' C' ' 166' ' ' GLU . 16.6 t-80 -132.08 135.38 46.41 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 -164.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 170' ' ' MET . . . . . . . . . . . . . 75.7 mtm -74.1 102.28 4.18 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 113.397 -1.729 . . . . 0.0 108.399 169.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 171' ' ' LEU . . . . . . . . . . . . . 54.6 tp -100.01 129.29 46.05 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 -173.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -76.4 96.29 3.99 Favored 'General case' 0 C--O 1.248 0.976 0 CA-C-O 123.969 1.842 . . . . 0.0 112.839 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -156.88 134.65 4.1 Favored Glycine 0 CA--C 1.503 -0.671 0 N-CA-C 106.323 -2.711 . . . . 0.0 106.323 168.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 174' ' ' ASP . . . . . 0.803 ' HB3' ' HB3' ' C' ' 177' ' ' ALA . 22.5 t70 -60.17 143.12 53.17 Favored 'General case' 0 C--O 1.217 -0.631 0 O-C-N 121.734 -0.863 . . . . 0.0 111.296 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.48 -31.16 72.09 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -173.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 176' ' ' LYS . . . . . 0.516 ' HD3' ' HG2' ' C' ' 49' ' ' PRO . 0.1 OUTLIER -87.42 -61.53 1.7 Allowed 'General case' 0 C--O 1.236 0.357 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 168.507 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 177' ' ' ALA . . . . . 0.803 ' HB3' ' HB3' ' C' ' 174' ' ' ASP . . . -49.35 -44.76 44.88 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 -164.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 3.3 m -65.2 -42.59 93.38 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.58 177.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 179' ' ' VAL . . . . . 0.606 ' HA ' HG12 ' C' ' 182' ' ' ILE . 45.8 t -68.19 -40.95 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 119.451 1.023 . . . . 0.0 108.705 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -61.04 -28.98 69.45 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 114.996 -1.002 . . . . 0.0 113.184 174.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -77.69 -51.55 10.41 Favored 'General case' 0 N--CA 1.445 -0.688 0 O-C-N 117.366 -3.334 . . . . 0.0 112.323 171.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 182' ' ' ILE . . . . . 0.606 HG12 ' HA ' ' C' ' 179' ' ' VAL . 29.1 pt -62.68 -27.01 42.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 117.791 -1.1 . . . . 0.0 110.748 -174.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 183' ' ' LEU . . . . . 0.417 ' HB2' ' HB3' ' C' ' 52' ' ' GLU . 3.5 pp -58.42 -27.8 64.66 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 120.555 1.525 . . . . 0.0 114.315 174.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -94.38 -51.05 4.96 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -68.13 -72.57 0.17 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -175.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 186' ' ' LEU . . . . . . . . . . . . 0.293 0.5 OUTLIER . . . . . 0 CA--C 1.538 0.517 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -158.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 1' ' ' NAD . . . . . 0.443 ' O4B' ' HA ' ' B' 1256 ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C 1001 ' ' NAP . . . . . 0.414 ' O2N' ' HD2' ' C' ' 39' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 57.9 t-80 . . . . . 0 N--CA 1.44 -0.946 0 N-CA-C 106.322 -1.733 . . . . 65.739999999999995 106.322 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -52.48 88.01 0.01 OUTLIER Glycine 0 CA--C 1.526 0.753 0 O-C-N 119.562 -1.961 . . . . 48.659999999999997 110.462 160.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -130.1 131.39 45.71 Favored 'General case' 0 N--CA 1.431 -1.403 1 N-CA-C 97.445 -5.02 . . . . 44.560000000000002 97.445 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1003 ' ' ILE . . . . . 0.487 HD12 ' HB3' ' A' 1026 ' ' LEU . 42.2 mt -100.46 112.18 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 N-CA-C 105.266 -2.124 . . . . 34.859999999999999 105.266 176.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -77.73 132.06 11.6 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 112.646 -2.07 . . . . 30.75 110.259 169.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.623 HG23 ' HB3' ' A' 1017 ' ' ALA . 28.0 mm -119.18 91.05 43.07 Favored Pre-proline 0 CA--C 1.508 -0.642 0 N-CA-C 103.857 -2.645 . . . . 32.210000000000001 103.857 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -71.82 164.21 36.4 Favored 'Trans proline' 0 C--O 1.245 0.862 0 C-N-CA 123.421 2.747 . . . . 32.979999999999997 111.856 172.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1007 ' ' ARG . . . . . 0.56 ' HD2' HD12 ' A' 1042 ' ' LEU . 40.0 ttp85 -87.22 141.83 28.36 Favored 'General case' 0 C--O 1.267 1.998 0 N-CA-C 103.401 -2.814 . . . . 47.979999999999997 103.401 161.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1008 ' ' GLU . . . . . . . . . . . . 0.267 22.3 mm-40 -63.95 150.26 45.49 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 114.298 1.222 . . . . 34.700000000000003 114.298 177.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 24.4 mtp-105 -121.01 37.81 4.23 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 115.356 1.613 . . . . 53.369999999999997 115.356 -175.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1010 ' ' LEU . . . . . 0.639 HD12 HD11 ' A' 1076 ' ' LEU . 11.1 tp -96.63 179.18 5.08 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.144 -1.058 . . . . 45.07 108.144 -176.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1011 ' ' THR . . . . . . . . . . . . . 10.3 m -63.2 140.1 58.84 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 107.419 -1.326 . . . . 40.359999999999999 107.419 171.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 23.8 m120 63.17 33.89 13.98 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 122.924 1.345 . . . . 40.609999999999999 114.501 169.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -98.4 151.02 21.01 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 116.898 2.185 . . . . 33.759999999999998 116.898 -158.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1014 ' ' THR . . . . . 0.451 ' HB ' ' O ' ' A' 1317 ' ' GLY . 5.0 m -136.13 -16.2 1.67 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 118.301 -0.857 . . . . 27.890000000000001 112.541 -177.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1015 ' ' ARG . . . . . 0.495 HH11 HG12 ' A' 1072 ' ' VAL . 69.7 mtm180 -70.01 150.68 46.39 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 117.081 2.252 . . . . 29.02 117.081 -173.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1016 ' ' VAL . . . . . 0.473 ' HB ' ' HB2' ' A' 1043 ' ' ALA . 4.3 p -113.96 166.76 7.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 103.976 -2.602 . . . . 28.129999999999999 103.976 159.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1017 ' ' ALA . . . . . 0.623 ' HB3' HG23 ' A' 1005 ' ' ILE . . . -67.51 -47.88 68.67 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.099 -1.041 . . . . 26.870000000000001 113.205 177.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -146.68 133.44 20.03 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 118.635 -2.54 . . . . 26.77 109.071 -176.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1019 ' ' THR . . . . . 0.685 HG21 HG23 ' A' 1321 ' ' THR . 0.7 OUTLIER -90.51 172.87 6.29 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-O 117.3 -1.333 . . . . 27.02 110.652 -177.89 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 1020 ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -25.45 -71.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.006 1 C-N-CA 127.496 5.464 . . . . 30.57 119.573 178.41 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 14.3 mptt -54.58 -44.0 72.62 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 120.371 1.441 . . . . 47.810000000000002 114.082 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1022 ' ' THR . . . . . 0.536 ' O ' ' HG ' ' A' 1026 ' ' LEU . 0.5 OUTLIER -65.8 -37.33 85.97 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 120.017 1.281 . . . . 30.77 112.217 175.83 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 1023 ' ' VAL . . . . . . . . . . . . . 25.5 t -59.52 -46.5 92.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 119.015 0.825 . . . . 33.590000000000003 110.3 170.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -59.95 -34.22 72.96 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 113.562 0.949 . . . . 53.289999999999999 113.562 172.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1025 ' ' GLN . . . . . 0.518 ' HB3' HG11 ' A' 1332 ' ' VAL . 37.4 mt-30 -64.36 -38.47 91.16 Favored 'General case' 0 N--CA 1.441 -0.883 0 O-C-N 120.73 -1.231 . . . . 46.920000000000002 112.122 171.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1026 ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' 1022 ' ' THR . 14.5 mt -68.37 -34.84 76.79 Favored 'General case' 0 C--O 1.249 1.078 0 O-C-N 121.082 -1.011 . . . . 37.170000000000002 110.195 175.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1027 ' ' LEU . . . . . 0.467 HD21 ' HA3' ' A' 1054 ' ' GLY . 10.8 mp -59.29 -42.58 91.61 Favored 'General case' 0 C--O 1.246 0.876 0 O-C-N 121.062 -1.024 . . . . 44.439999999999998 111.349 169.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -49.61 -51.21 39.03 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 124.361 1.038 . . . . 52.579999999999998 111.811 169.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1029 ' ' LEU . . . . . 0.664 ' HA ' ' HE2' ' A' 1342 ' ' LYS . 59.7 mt -65.9 -11.64 48.55 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 114.279 1.214 . . . . 45.689999999999998 114.279 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 90.12 28.24 18.41 Favored Glycine 0 C--O 1.25 1.148 0 O-C-N 121.223 -0.923 . . . . 42.090000000000003 112.646 174.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -119.34 127.63 53.35 Favored 'General case' 0 CA--C 1.488 -1.413 0 CA-C-O 117.854 -1.069 . . . . 40.719999999999999 108.255 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1032 ' ' THR . . . . . . . . . . . . . 97.4 m -67.27 135.53 53.51 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 108.683 -0.858 . . . . 37.770000000000003 108.683 176.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1033 ' ' VAL . . . . . . . . . . . . . 57.9 t -103.53 134.41 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 O-C-N 119.365 -2.084 . . . . 33.539999999999999 108.353 -172.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -121.68 105.26 10.25 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 105.907 -1.886 . . . . 31.68 105.907 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1035 ' ' VAL . . . . . . . . . . . . . 21.9 t -99.16 138.69 22.84 Favored 'Isoleucine or valine' 0 C--O 1.246 0.917 0 CA-C-N 114.944 -1.026 . . . . 31.52 108.737 -173.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1036 ' ' GLU . . . . . 0.443 ' HB3' ' HB2' ' A' 1039 ' ' ALA . 25.4 tt0 -57.76 130.88 48.43 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 123.867 1.794 . . . . 41.039999999999999 113.277 173.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1037 ' ' SER . . . . . . . . . . . . . 7.1 t -60.89 132.67 54.59 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 113.176 -1.829 . . . . 31.829999999999998 112.746 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 77.02 -4.92 52.43 Favored Glycine 0 CA--C 1.525 0.696 0 O-C-N 119.876 -1.765 . . . . 29.359999999999999 111.54 173.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1039 ' ' ALA . . . . . 0.443 ' HB2' ' HB3' ' A' 1036 ' ' GLU . . . -62.61 -40.14 96.03 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 119.04 -2.447 . . . . 27.780000000000001 113.667 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1040 ' ' GLY . . . . . 0.643 ' HA2' ' HB3' ' A' 1043 ' ' ALA . . . -62.52 -18.73 59.21 Favored Glycine 0 C--O 1.25 1.121 0 N-CA-C 114.652 0.621 . . . . 28.91 114.652 -177.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -62.38 -47.53 83.74 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.099 -1.236 . . . . 51.18 110.957 173.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1042 ' ' LEU . . . . . 0.56 HD12 ' HD2' ' A' 1007 ' ' ARG . 36.2 mt -64.39 -57.59 8.89 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.969 0.89 . . . . 29.91 112.528 167.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1043 ' ' ALA . . . . . 0.643 ' HB3' ' HA2' ' A' 1040 ' ' GLY . . . -60.38 -7.57 2.12 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 115.241 1.571 . . . . 28.539999999999999 115.241 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1044 ' ' SER . . . . . . . . . . . . . 62.9 m 69.81 31.47 3.48 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 125.393 1.477 . . . . 33.060000000000002 111.2 169.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1045 ' ' PHE . . . . . 0.695 ' HD1' ' HB3' ' B' 1277 ' ' ALA . 0.1 OUTLIER -157.95 107.06 2.06 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 102.44 -3.17 . . . . 30.289999999999999 102.44 169.671 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 1046 ' ' ASP . . . . . 0.471 ' OD2' ' HG2' ' A' 1048 ' ' LYS . 0.3 OUTLIER -79.74 174.22 11.81 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 117.372 2.36 . . . . 48.619999999999997 117.372 -148.094 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 28.9 t70 -47.7 -49.64 27.26 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 112.659 -2.064 . . . . 36.740000000000002 113.355 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1048 ' ' LYS . . . . . 0.471 ' HG2' ' OD2' ' A' 1046 ' ' ASP . 24.8 pttm -75.27 -26.72 59.01 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 120.947 -1.096 . . . . 43.729999999999997 110.206 176.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -62.35 -29.98 70.84 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 118.162 -2.837 . . . . 32.810000000000002 110.874 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1050 ' ' PHE . . . . . 0.481 ' HB2' HD11 ' A' 1057 ' ' ILE . 64.4 m-85 -62.46 -41.13 98.54 Favored 'General case' 0 C--O 1.219 -0.536 0 O-C-N 121.72 -0.613 . . . . 31.859999999999999 111.345 171.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 25.6 t -66.26 -40.81 87.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 119.889 -0.724 . . . . 33.219999999999999 111.771 172.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -56.68 -40.85 76.27 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 122.243 1.021 . . . . 50.829999999999998 111.163 176.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -61.98 -50.38 72.33 Favored 'General case' 0 C--O 1.263 1.815 0 N-CA-C 113.596 0.961 . . . . 33.119999999999997 113.596 168.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1054 ' ' GLY . . . . . 0.467 ' HA3' HD21 ' A' 1027 ' ' LEU . . . 131.65 47.63 0.12 Allowed Glycine 0 N--CA 1.443 -0.886 0 CA-C-O 119.337 -0.702 . . . . 35.829999999999998 113.617 175.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -126.82 150.53 49.14 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 114.698 1.37 . . . . 34.82 114.698 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -73.51 125.64 28.4 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 105.732 -1.951 . . . . 49.049999999999997 105.732 174.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1057 ' ' ILE . . . . . 0.481 HD11 ' HB2' ' A' 1050 ' ' PHE . 6.9 mm -89.52 125.46 42.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 106.203 -1.777 . . . . 38.530000000000001 106.203 173.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1058 ' ' VAL . . . . . 0.686 ' HB ' ' HB2' ' A' 1062 ' ' SER . 29.8 m -115.99 135.15 57.06 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 107.609 -1.256 . . . . 42.109999999999999 107.609 -177.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -75.74 79.13 2.69 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-O 122.696 1.236 . . . . 58.0 114.169 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 76.2 -123.77 7.01 Favored Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 107.739 -2.145 . . . . 52.119999999999997 107.739 171.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 39.7 t30 -47.92 -23.65 0.83 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 118.476 2.769 . . . . 54.75 118.476 -172.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1062 ' ' SER . . . . . 0.686 ' HB2' ' HB ' ' A' 1058 ' ' VAL . 1.3 m -53.26 -24.38 11.29 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 116.212 1.93 . . . . 50.340000000000003 116.212 171.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 6.1 p -44.71 -35.24 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 116.423 2.008 . . . . 41.460000000000001 116.423 172.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1064 ' ' TRP . . . . . . . . . . . . . 46.0 m95 -73.25 -22.41 60.41 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-N 119.64 1.109 . . . . 39.32 111.941 -169.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -69.22 70.39 0.24 Allowed 'General case' 0 CA--C 1.547 0.859 0 O-C-N 119.414 -2.054 . . . . 55.380000000000003 110.676 172.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1066 ' ' SER . . . . . . . . . . . . . 72.3 m -160.17 123.17 3.44 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 101.457 -3.535 . . . . 41.869999999999997 101.457 -171.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -74.56 2.08 10.54 Favored 'General case' 0 CA--C 1.508 -0.646 0 O-C-N 120.924 -1.11 . . . . 53.200000000000003 112.285 -178.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1068 ' ' ILE . . . . . 0.43 ' HB ' HG12 ' A' 1003 ' ' ILE . 4.9 mp -130.19 129.11 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 104.05 -2.574 . . . . 41.899999999999999 104.05 167.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1069 ' ' ILE . . . . . . . . . . . . . 25.7 mm -125.58 120.57 58.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 104.972 -2.233 . . . . 38.729999999999997 104.972 171.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1070 ' ' LEU . . . . . 0.851 HD13 HD13 ' A' 1331 ' ' LEU . 80.1 mt -101.75 133.95 45.68 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.061 -2.2 . . . . 32.439999999999998 105.061 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1071 ' ' LYS . . . . . 0.508 ' HB2' ' OG ' ' A' 1091 ' ' SER . 2.5 mmmp? -133.68 141.78 47.73 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.134 -1.432 . . . . 34.649999999999999 107.134 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1072 ' ' VAL . . . . . 0.495 HG12 HH11 ' A' 1015 ' ' ARG . 2.4 t -92.16 -4.1 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.016 0 O-C-N 119.87 -1.769 . . . . 31.32 111.031 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -142.09 159.41 42.28 Favored 'General case' 0 C--O 1.256 1.396 0 N-CA-C 102.393 -3.188 . . . . 33.939999999999998 102.393 173.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -42.1 140.89 1.47 Allowed Pre-proline 0 C--O 1.239 0.515 0 C-N-CA 124.872 1.269 . . . . 38.039999999999999 113.25 171.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1075 ' ' PRO . . . . . 0.741 ' HG2' HD21 ' A' 1089 ' ' LEU . 44.9 Cg_exo -67.36 99.67 0.52 Allowed 'Trans proline' 0 CA--C 1.492 -1.589 0 C-N-CA 122.18 1.92 . . . . 42.68 107.595 165.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1076 ' ' LEU . . . . . 0.639 HD11 HD12 ' A' 1010 ' ' LEU . 38.9 mt -73.02 167.35 21.28 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 112.219 -2.264 . . . . 46.740000000000002 108.61 -173.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1077 ' ' ASP . . . . . 0.449 ' HA ' HD12 ' A' 1080 ' ' ILE . 10.8 m-20 -43.15 -32.94 0.8 Allowed 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 120.46 3.504 . . . . 58.609999999999999 120.46 -175.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 16.0 t70 -75.09 -44.08 49.44 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 118.412 -0.804 . . . . 59.200000000000003 109.772 176.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1079 ' ' GLU . . . . . 0.434 ' HG2' ' HE2' ' A' 1071 ' ' LYS . 1.8 mp0 -59.73 -40.63 88.65 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 119.525 -0.87 . . . . 50.630000000000003 112.378 173.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1080 ' ' ILE . . . . . 0.716 HD11 ' HG ' ' A' 1101 ' ' LEU . 74.5 mt -54.15 -49.56 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 O-C-N 124.443 1.09 . . . . 51.479999999999997 108.36 176.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -57.15 -33.82 67.79 Favored 'General case' 0 C--O 1.249 1.075 0 N-CA-C 112.864 0.69 . . . . 50.280000000000001 112.864 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 42.0 mt -87.4 -16.75 34.03 Favored 'General case' 0 C--N 1.334 -0.078 0 O-C-N 120.29 -1.506 . . . . 50.210000000000001 114.239 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1083 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.81 132.88 48.23 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 118.841 -2.412 . . . . 49.060000000000002 116.476 -162.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 31.7 t30 -76.86 123.77 87.48 Favored Pre-proline 0 N--CA 1.452 -0.339 0 CA-C-N 114.293 -1.321 . . . . 51.079999999999998 113.651 174.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -61.27 155.59 50.74 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 124.249 3.3 . . . . 49.729999999999997 115.939 173.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 68.45 66.16 2.4 Favored Glycine 0 C--O 1.215 -1.058 0 CA-C-O 124.63 2.239 . . . . 47.710000000000001 109.539 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1087 ' ' THR . . . . . . . . . . . . . 33.0 m -146.22 137.75 24.74 Favored 'General case' 0 C--O 1.252 1.23 0 O-C-N 119.631 -2.1 . . . . 45.469999999999999 107.519 -171.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1088 ' ' THR . . . . . . . . . . . . . 3.0 m -80.21 94.98 6.15 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 104.169 -2.53 . . . . 42.039999999999999 104.169 165.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1089 ' ' LEU . . . . . 0.741 HD21 ' HG2' ' A' 1075 ' ' PRO . 27.7 tp -94.35 87.71 5.29 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 106.469 -1.678 . . . . 38.060000000000002 106.469 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1090 ' ' VAL . . . . . 0.408 ' HB ' HD23 ' A' 1070 ' ' LEU . 33.8 t -92.95 121.1 43.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 104.544 -2.391 . . . . 37.399999999999999 104.544 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1091 ' ' SER . . . . . 0.508 ' OG ' ' HB2' ' A' 1071 ' ' LYS . 26.7 m -153.37 151.83 30.38 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.857 -1.152 . . . . 36.159999999999997 112.673 -169.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 5.2 t80 -77.92 109.73 12.21 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 118.748 -2.47 . . . . 38.939999999999998 105.561 169.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 29.9 mm -90.56 -45.46 14.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 113.295 0.85 . . . . 42.170000000000002 113.295 -168.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 86.3 m95 54.61 66.36 4.21 Favored Pre-proline 0 C--O 1.245 0.827 0 O-C-N 124.485 1.115 . . . . 46.509999999999998 111.423 -157.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -52.0 -36.08 63.51 Favored 'Trans proline' 0 N--CA 1.449 -1.124 1 C-N-CA 125.801 4.334 . . . . 49.759999999999998 116.268 -175.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -72.35 -31.88 66.0 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-N 119.334 0.97 . . . . 52.619999999999997 108.84 -177.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 10.2 mp0 -77.95 -20.65 52.33 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 118.858 0.754 . . . . 60.740000000000002 112.243 172.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1098 ' ' ASN . . . . . 0.619 ' HB3' ' HB3' ' A' 1101 ' ' LEU . 69.4 m-80 -118.99 38.85 0.29 Allowed Pre-proline 0 N--CA 1.44 -0.958 0 N-CA-C 117.945 2.572 . . . . 58.189999999999998 117.945 -172.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -66.87 -24.59 46.24 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 124.569 3.513 . . . . 54.590000000000003 113.04 -168.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.99 -39.0 18.58 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 113.05 0.759 . . . . 63.280000000000001 113.05 175.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1101 ' ' LEU . . . . . 0.716 ' HG ' HD11 ' A' 1080 ' ' ILE . 10.2 tt -54.97 -39.78 69.32 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 109.765 -0.458 . . . . 54.75 109.765 166.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1102 ' ' MET . . . . . 0.417 ' HG2' ' O ' ' A' 1098 ' ' ASN . 49.2 mmm -57.74 -45.05 86.36 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.677 -1.264 . . . . 52.649999999999999 114.156 175.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -54.78 -43.35 72.75 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 112.536 0.569 . . . . 66.260000000000005 112.536 174.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1104 ' ' LYS . . . . . 0.632 ' HB3' HG21 ' A' 1080 ' ' ILE . 82.5 mttt -71.09 -41.67 70.32 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.435 0.636 . . . . 63.729999999999997 112.102 -175.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 71.8 mt -68.53 -32.38 72.29 Favored 'General case' 0 C--O 1.241 0.618 0 O-C-N 120.572 -1.33 . . . . 54.68 112.874 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -57.72 -51.52 69.2 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 120.455 1.479 . . . . 53.640000000000001 108.203 167.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -57.08 -25.68 59.14 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 122.14 2.246 . . . . 67.239999999999995 115.001 169.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -80.01 -3.85 50.15 Favored 'General case' 0 C--N 1.361 1.085 0 CA-C-N 121.177 1.808 . . . . 65.760000000000005 111.191 171.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 24.9 t-20 62.7 47.67 4.62 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 122.744 1.259 . . . . 58.710000000000001 109.578 168.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1110 ' ' VAL . . . . . . . . . . . . . 17.3 m -118.06 145.71 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 O-C-N 121.558 -0.714 . . . . 46.630000000000003 111.607 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1111 ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' 1361 ' ' ILE . 49.2 m -83.62 94.63 8.14 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-O 123.156 1.455 . . . . 44.130000000000003 107.681 174.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1112 ' ' VAL . . . . . 0.556 HG22 HD23 ' A' 1089 ' ' LEU . 82.8 t -89.94 118.93 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.008 0 CA-C-N 113.624 -1.625 . . . . 40.439999999999998 109.414 -174.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1113 ' ' MET . . . . . 0.696 ' HB3' HG12 ' A' 1358 ' ' VAL . 63.6 mtp -109.75 108.59 19.0 Favored 'General case' 0 C--O 1.252 1.229 0 N-CA-C 107.547 -1.279 . . . . 50.759999999999998 107.547 -177.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1114 ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' 1091 ' ' SER . . . -85.12 108.42 17.67 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-O 123.736 1.731 . . . . 35.640000000000001 110.653 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1115 ' ' MET . . . . . 0.489 ' HB3' ' CB ' ' A' 1129 ' ' ALA . 61.8 mmm -69.39 -14.35 62.86 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 112.049 -2.342 . . . . 38.740000000000002 115.467 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1116 ' ' ASP . . . . . 0.595 ' HA ' ' HB2' ' A' 1130 ' ' LEU . 3.6 p30 -71.14 -36.25 72.01 Favored 'General case' 0 C--N 1.352 0.674 0 CA-C-N 120.189 1.359 . . . . 40.140000000000001 111.122 162.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1117 ' ' SER . . . . . . . . . . . . . 49.2 m -80.97 23.33 0.56 Allowed 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 125.121 1.513 . . . . 44.789999999999999 114.551 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1118 ' ' VAL . . . . . 0.583 HG12 ' HB1' ' A' 1124 ' ' ALA . 16.5 t -70.3 131.41 88.55 Favored Pre-proline 0 N--CA 1.445 -0.681 0 N-CA-C 104.576 -2.379 . . . . 43.75 104.576 166.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1119 ' ' PRO . . . . . 0.487 ' HB2' HG12 ' A' 1121 ' ' ILE . 91.6 Cg_exo -58.36 146.25 90.48 Favored 'Trans proline' 0 C--O 1.252 1.216 0 C-N-CA 122.63 2.22 . . . . 48.93 113.556 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -66.6 -10.31 44.41 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 120.691 -1.255 . . . . 62.899999999999999 113.0 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1121 ' ' ILE . . . . . 0.487 HG12 ' HB2' ' A' 1119 ' ' PRO . 50.0 pt -62.19 152.19 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 N-CA-C 114.003 1.112 . . . . 57.719999999999999 114.003 -177.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1122 ' ' SER . . . . . . . . . . . . . 6.5 m -48.52 -52.63 21.61 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 118.304 2.705 . . . . 57.259999999999998 118.304 -177.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -56.64 -22.62 35.69 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 118.386 -2.696 . . . . 62.899999999999999 113.423 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1124 ' ' ALA . . . . . 0.583 ' HB1' HG12 ' A' 1118 ' ' VAL . . . -90.04 -21.52 22.31 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 117.025 -1.464 . . . . 49.829999999999998 111.773 -172.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -61.67 -26.73 68.2 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 116.444 2.016 . . . . 52.369999999999997 116.444 -163.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1126 ' ' SER . . . . . . . . . . . . . 5.8 p -66.83 -37.77 85.13 Favored 'General case' 0 C--O 1.245 0.821 0 O-C-N 119.058 -2.276 . . . . 42.43 111.999 170.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1127 ' ' LEU . . . . . . . . . . . . . 3.5 mp -77.23 -31.16 54.94 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 122.95 1.357 . . . . 43.740000000000002 110.739 176.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1128 ' ' ASP . . . . . 0.406 ' HA ' HG21 ' A' 1118 ' ' VAL . 6.1 t70 -53.82 109.78 0.5 Allowed 'General case' 0 C--O 1.252 1.227 0 CA-C-O 123.965 1.84 . . . . 43.210000000000001 113.649 -176.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1129 ' ' ALA . . . . . 0.489 ' CB ' ' HB3' ' A' 1115 ' ' MET . . . -80.06 -31.65 39.39 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 111.62 -2.536 . . . . 35.740000000000002 112.687 177.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1130 ' ' LEU . . . . . 0.595 ' HB2' ' HA ' ' A' 1116 ' ' ASP . 36.0 tp -54.45 -51.64 64.35 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.775 0.716 . . . . 38.090000000000003 110.538 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1131 ' ' SER . . . . . 0.464 ' HB3' HG21 ' A' 1175 ' ' VAL . 7.3 m -50.47 -49.26 55.69 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.715 1.206 . . . . 36.909999999999997 111.347 174.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1132 ' ' SER . . . . . . . . . . . . . 1.4 m -73.28 -42.29 62.61 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 115.676 -0.693 . . . . 35.789999999999999 111.123 -171.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1133 ' ' MET . . . . . 0.517 ' HA ' HD12 ' A' 1136 ' ' ILE . 28.6 mtp -63.2 -43.09 99.15 Favored 'General case' 0 N--CA 1.433 -1.308 0 O-C-N 120.479 -1.388 . . . . 30.809999999999999 110.564 177.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1134 ' ' ALA . . . . . 0.651 ' HB1' ' HB2' ' A' 1176 ' ' ALA . . . -52.09 -47.17 65.38 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 122.99 1.376 . . . . 28.879999999999999 112.903 168.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1135 ' ' ASN . . . . . 0.774 ' HB2' HG12 ' A' 1175 ' ' VAL . 25.0 t-20 -59.01 -48.21 82.4 Favored 'General case' 0 C--N 1.347 0.463 0 O-C-N 120.832 -1.168 . . . . 40.759999999999998 112.18 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1136 ' ' ILE . . . . . 0.575 HD13 ' HA ' ' A' 1323 ' ' SER . 61.3 mt -59.18 -46.48 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 108.782 -0.821 . . . . 31.539999999999999 108.782 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -61.39 -30.46 70.56 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 115.905 -1.998 . . . . 29.870000000000001 112.771 175.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -75.14 -39.8 36.18 Favored Glycine 0 CA--C 1.499 -0.932 0 CA-C-N 121.472 1.942 . . . . 28.73 109.814 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 25.5 t80 -65.62 -45.68 82.18 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.21 -1.033 . . . . 30.390000000000001 108.21 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1140 ' ' ARG . . . . . 0.459 ' HG3' HD22 ' A' 1315 ' ' LEU . 8.7 tpt180 -69.19 -24.82 64.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.906 0.86 . . . . 26.09 112.536 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1141 ' ' ALA . . . . . 0.604 ' HB2' HD21 ' A' 1284 ' ' LEU . . . -62.13 -45.14 94.77 Favored 'General case' 0 C--O 1.245 0.858 0 O-C-N 120.353 -1.467 . . . . 27.100000000000001 109.409 168.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 46.7 mm -58.52 -44.48 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 120.444 1.475 . . . . 28.48 114.538 172.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 28.8 t -53.1 -59.62 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 114.72 -1.127 . . . . 23.07 111.266 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1144 ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -75.27 -23.9 57.51 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.982 -0.377 . . . . 33.399999999999999 109.982 -171.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1145 ' ' ALA . . . . . 0.531 ' HA ' HG11 ' A' 1280 ' ' VAL . . . -62.12 -51.55 67.44 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.334 -0.987 . . . . 24.219999999999999 108.334 171.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -64.07 -28.06 69.53 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 123.8 0.84 . . . . 24.890000000000001 112.348 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -65.51 -40.28 92.82 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 118.763 -0.637 . . . . 26.73 110.832 171.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1148 ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -101.68 5.78 41.6 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 119.009 -2.307 . . . . 39.960000000000001 113.043 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1149 ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -76.15 144.9 40.29 Favored 'General case' 0 CA--C 1.514 -0.427 0 O-C-N 120.067 -1.645 . . . . 25.870000000000001 112.816 -169.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1150 ' ' GLY . . . . . 0.653 ' HA2' ' HG2' ' B' 1320 ' ' PRO . . . -71.21 -48.97 28.8 Favored Glycine 0 C--O 1.218 -0.9 0 N-CA-C 109.799 -1.32 . . . . 19.280000000000001 109.799 172.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1151 ' ' ARG . . . . . 0.866 ' HA ' ' HB2' ' B' 1322 ' ' GLN . 74.2 mtm-85 -99.57 -172.17 2.2 Favored 'General case' 0 C--N 1.318 -0.795 0 O-C-N 120.906 -1.35 . . . . 39.899999999999999 114.071 -172.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1152 ' ' PHE . . . . . 0.44 ' HD2' ' HG2' ' B' 1322 ' ' GLN . 0.4 OUTLIER -96.51 144.69 26.36 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 103.856 -2.646 . . . . 29.440000000000001 103.856 177.282 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 1153 ' ' PHE . . . . . 0.421 ' CZ ' HG13 ' A' 1251 ' ' ILE . 8.7 m-85 -64.21 -57.19 10.2 Favored 'General case' 0 C--N 1.341 0.224 0 O-C-N 121.211 -0.931 . . . . 32.600000000000001 110.039 168.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1154 ' ' THR . . . . . 0.519 HG22 ' HB3' ' A' 1156 ' ' GLN . 90.8 m -61.8 123.95 19.41 Favored 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 126.431 1.893 . . . . 34.640000000000001 116.015 -177.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -71.78 73.43 0.81 Allowed Glycine 0 N--CA 1.439 -1.158 0 CA-C-O 126.052 3.029 . . . . 37.140000000000001 111.259 175.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1156 ' ' GLN . . . . . 0.519 ' HB3' HG22 ' A' 1154 ' ' THR . 4.2 pp0? -108.93 136.2 48.86 Favored 'General case' 0 N--CA 1.434 -1.232 0 O-C-N 118.588 -2.713 . . . . 40.57 115.876 -177.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1157 ' ' ILE . . . . . 0.773 HG13 ' HB3' ' C' ' 70' ' ' PRO . 4.5 tp -90.87 110.2 21.97 Favored 'Isoleucine or valine' 0 C--O 1.256 1.431 0 CA-C-N 113.361 -1.745 . . . . 44.609999999999999 106.673 171.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1158 ' ' THR . . . . . . . . . . . . . 17.5 m -78.15 177.11 8.62 Favored 'General case' 0 C--O 1.252 1.202 0 O-C-N 120.87 -1.144 . . . . 40.700000000000003 110.563 169.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -65.09 -23.24 67.1 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 116.97 -3.581 . . . . 40.25 111.171 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1160 ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' B' 1126 ' ' SER . . . -134.35 131.01 37.8 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 104.828 -2.286 . . . . 38.469999999999999 104.828 159.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . 111.93 115.05 3.42 Favored Glycine 0 C--O 1.247 0.93 0 C-N-CA 119.572 -1.299 . . . . 37.609999999999999 112.095 170.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 15.8 tttp -85.7 130.87 34.45 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 104.456 -2.424 . . . . 48.899999999999999 104.456 169.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1163 ' ' VAL . . . . . 0.496 HG22 ' NE2' ' B' 1322 ' ' GLN . 69.7 t -85.98 128.19 59.09 Favored Pre-proline 0 N--CA 1.42 -1.933 0 O-C-N 120.01 -1.681 . . . . 36.520000000000003 107.896 164.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1164 ' ' PRO . . . . . 0.508 ' HA ' ' HD2' ' A' 1165 ' ' PRO . 28.6 Cg_endo -72.26 108.23 2.44 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.516 2.144 . . . . 35.079999999999998 108.904 155.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1165 ' ' PRO . . . . . 0.508 ' HD2' ' HA ' ' A' 1164 ' ' PRO . 30.4 Cg_endo -56.34 148.25 62.67 Favored 'Trans proline' 0 N--CA 1.444 -1.394 1 C-N-CA 126.314 4.676 . . . . 35.329999999999998 115.289 -176.524 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 1166 ' ' ALA . . . . . 0.443 ' O ' ' HB1' ' A' 1189 ' ' ALA . . . -66.12 129.02 38.39 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 125.159 1.537 . . . . 34.689999999999998 110.962 177.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1167 ' ' LYS . . . . . 0.611 ' HB2' ' HA ' ' A' 1249 ' ' VAL . 64.4 mttp -92.41 106.99 18.88 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 105.17 -2.159 . . . . 45.359999999999999 105.17 172.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 60.6 t -91.58 91.57 3.57 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 106.967 -1.494 . . . . 31.710000000000001 106.967 -175.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1169 ' ' MET . . . . . 0.465 ' HA ' ' O ' ' A' 1192 ' ' ARG . 25.1 ttp -79.29 92.11 5.1 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 124.593 2.14 . . . . 42.280000000000001 108.717 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1170 ' ' VAL . . . . . 0.438 HG13 ' OG1' ' A' 1255 ' ' THR . 13.8 t -75.29 115.14 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 112.128 -2.305 . . . . 30.510000000000002 106.629 176.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 64.5 mt -104.07 123.59 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 104.528 -2.397 . . . . 31.870000000000001 104.528 176.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 79.32 79.25 0.83 Allowed Glycine 0 CA--C 1.493 -1.332 0 CA-C-O 123.796 1.776 . . . . 34.539999999999999 109.81 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1173 ' ' ALA . . . . . 0.613 ' HB3' HG21 ' A' 1200 ' ' VAL . . . -75.7 179.86 5.15 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 123.417 1.58 . . . . 32.509999999999998 109.669 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . 138.92 -157.69 24.89 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 106.182 -2.767 . . . . 29.899999999999999 106.182 -175.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1175 ' ' VAL . . . . . 0.774 HG12 ' HB2' ' A' 1135 ' ' ASN . 34.3 t -70.49 -30.06 41.19 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 CA-C-N 122.188 2.994 . . . . 33.109999999999999 110.66 -170.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1176 ' ' ALA . . . . . 0.651 ' HB2' ' HB1' ' A' 1134 ' ' ALA . . . -65.35 -41.73 93.57 Favored 'General case' 0 C--N 1.348 0.517 0 CA-C-O 122.343 1.068 . . . . 28.100000000000001 108.832 171.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -60.67 -42.45 99.32 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 124.478 2.154 . . . . 28.539999999999999 109.997 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1178 ' ' LEU . . . . . 0.534 ' HA ' HD12 ' A' 1181 ' ' ILE . 72.8 mt -67.83 -35.69 79.05 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 113.403 -1.399 . . . . 31.219999999999999 111.052 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1179 ' ' ALA . . . . . 0.485 ' HB2' ' ND2' ' A' 1135 ' ' ASN . . . -64.99 -44.59 88.79 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-N 122.832 2.56 . . . . 28.98 108.822 175.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -55.25 -45.46 76.08 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 126.317 2.26 . . . . 27.829999999999998 113.085 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1181 ' ' ILE . . . . . 0.534 HD12 ' HA ' ' A' 1178 ' ' LEU . 33.5 mt -63.62 -54.28 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 O-C-N 120.237 -1.54 . . . . 30.25 108.819 175.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -52.29 -26.02 20.52 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 112.668 -2.06 . . . . 29.59 112.761 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -85.24 -60.25 2.09 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 115.323 1.601 . . . . 30.289999999999999 115.323 165.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -74.8 -39.73 61.52 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 115.386 1.624 . . . . 30.469999999999999 115.386 -167.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -60.22 -43.49 95.96 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 119.759 -1.838 . . . . 42.409999999999997 109.685 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1186 ' ' SER . . . . . 0.492 ' O ' ' HB3' ' B' 1186 ' ' SER . 21.4 m -58.39 -46.11 87.03 Favored 'General case' 0 C--O 1.213 -0.827 0 CA-C-O 121.957 0.885 . . . . 39.380000000000003 111.078 175.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 44.0 mt -62.47 -30.44 71.26 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 114.909 1.448 . . . . 36.18 114.909 174.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 103.36 42.38 2.04 Favored Glycine 0 N--CA 1.428 -1.879 0 CA-C-N 114.839 -1.073 . . . . 33.780000000000001 111.015 176.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1189 ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' 1166 ' ' ALA . . . -115.9 144.2 44.38 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 106.915 -1.513 . . . . 33.93 106.915 174.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 45.7 mt -72.07 102.63 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 O-C-N 120.226 -1.546 . . . . 38.740000000000002 110.375 -174.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1191 ' ' VAL . . . . . 0.451 HG21 ' HA ' ' A' 1181 ' ' ILE . 17.0 t -86.84 121.27 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 O-C-N 119.817 -1.802 . . . . 33.090000000000003 106.854 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1192 ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' 1169 ' ' MET . 73.8 mtt180 -115.68 105.33 12.63 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 105.321 -2.103 . . . . 38.920000000000002 105.321 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1193 ' ' ALA . . . . . 0.463 ' HB3' HG11 ' A' 1204 ' ' VAL . . . -102.73 124.67 48.69 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 118.928 -1.109 . . . . 35.32 110.482 -176.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1194 ' ' PHE . . . . . 0.54 ' HB2' HD12 ' A' 1212 ' ' LEU . 69.7 t80 -110.59 140.74 44.63 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 122.133 0.968 . . . . 39.350000000000001 109.419 175.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 7.1 t0 -157.52 150.12 22.95 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.182 -1.044 . . . . 40.460000000000001 108.182 174.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1196 ' ' THR . . . . . 0.541 HG23 ' CE2' ' A' 1234 ' ' PHE . 8.7 m -58.31 -38.98 78.16 Favored 'General case' 0 N--CA 1.445 -0.698 0 O-C-N 128.391 3.557 . . . . 45.939999999999998 109.493 171.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1197 ' ' ARG . . . . . 0.417 ' HA ' ' HD2' ' A' 1198 ' ' PRO . 86.5 mtm180 -87.73 110.92 38.6 Favored Pre-proline 0 C--N 1.318 -0.776 0 C-N-CA 126.67 1.988 . . . . 56.020000000000003 109.777 -172.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1198 ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' 1197 ' ' ARG . 72.6 Cg_endo -66.32 -13.32 39.38 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 121.457 1.438 . . . . 51.270000000000003 112.072 166.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -52.8 -30.49 33.54 Favored 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 118.66 -2.525 . . . . 59.100000000000001 115.1 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1200 ' ' VAL . . . . . 0.613 HG21 ' HB3' ' A' 1173 ' ' ALA . 35.6 m -93.92 -9.84 9.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 114.235 1.198 . . . . 51.060000000000002 114.235 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 86.4 tttt -52.17 -61.52 2.21 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 114.991 1.478 . . . . 57.380000000000003 114.991 -174.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1202 ' ' GLU . . . . . 0.4 ' HA ' ' HB2' ' A' 1205 ' ' GLN . 23.7 mp0 -69.37 -22.27 63.74 Favored 'General case' 0 C--O 1.211 -0.955 0 CA-C-N 119.934 1.243 . . . . 62.409999999999997 112.567 -177.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -63.84 -50.79 67.51 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 113.174 0.805 . . . . 57.780000000000001 113.174 170.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1204 ' ' VAL . . . . . 0.463 HG11 ' HB3' ' A' 1193 ' ' ALA . 47.4 t -58.98 -41.01 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 113.751 -1.568 . . . . 46.380000000000003 110.634 173.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1205 ' ' GLN . . . . . 0.4 ' HB2' ' HA ' ' A' 1202 ' ' GLU . 97.7 mt-30 -68.19 -29.37 68.21 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 115.401 1.63 . . . . 50.700000000000003 115.401 173.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1206 ' ' SER . . . . . . . . . . . . . 64.0 m -74.59 -31.37 62.01 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 121.062 -1.024 . . . . 49.979999999999997 110.872 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1207 ' ' MET . . . . . 0.413 ' SD ' ' HB3' ' A' 1178 ' ' LEU . 36.8 mtp -79.68 -15.2 58.0 Favored 'General case' 0 C--O 1.249 1.045 0 O-C-N 120.745 -1.222 . . . . 52.990000000000002 113.469 170.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 97.53 83.83 1.72 Allowed Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 109.009 -1.636 . . . . 47.659999999999997 109.009 173.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1209 ' ' ALA . . . . . 0.448 ' HB3' ' CG1' ' A' 1204 ' ' VAL . . . -161.27 145.82 13.49 Favored 'General case' 0 C--N 1.289 -2.03 0 O-C-N 119.093 -2.416 . . . . 44.770000000000003 107.311 176.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -76.76 123.04 25.59 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 103.74 -2.689 . . . . 47.640000000000001 103.74 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1211 ' ' PHE . . . . . . . . . . . . . 11.9 t80 -89.01 136.52 32.97 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 106.606 -1.627 . . . . 45.659999999999997 106.606 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1212 ' ' LEU . . . . . 0.54 HD12 ' HB2' ' A' 1194 ' ' PHE . 68.4 mt -94.51 119.22 32.87 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 107.521 -1.288 . . . . 46.060000000000002 107.521 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -71.76 144.25 49.28 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 112.79 -2.004 . . . . 60.219999999999999 111.875 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1214 ' ' LEU . . . . . 0.537 HD21 ' HZ ' ' A' 1234 ' ' PHE . 17.2 tp -73.66 89.13 1.74 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 109.504 -3.498 . . . . 57.25 112.421 -171.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1215 ' ' ASP . . . . . 0.481 ' O ' ' HB1' ' A' 1237 ' ' ALA . 23.6 t0 -71.53 87.09 0.89 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 114.086 1.143 . . . . 64.430000000000007 114.086 -174.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 85.4 t80 . . . . . 0 C--O 1.202 -1.413 0 O-C-N 124.794 1.309 . . . . 66.900000000000006 107.814 -170.507 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 30.9 t70 . . . . . 0 N--CA 1.447 -0.578 0 N-CA-C 107.071 -1.455 . . . . 39.090000000000003 107.071 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -67.34 -41.87 90.75 Favored Glycine 0 C--N 1.347 1.17 0 CA-C-N 114.484 -1.235 . . . . 39.32 111.598 -173.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 51.0 t80 -73.4 -42.09 62.53 Favored 'General case' 0 CA--C 1.504 -0.788 0 CA-C-O 118.151 -0.928 . . . . 39.299999999999997 108.696 -177.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -62.04 -38.51 89.01 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-N 119.539 1.063 . . . . 36.299999999999997 109.226 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -57.11 -45.94 83.02 Favored 'General case' 0 C--O 1.207 -1.159 0 CA-C-O 117.903 -1.046 . . . . 37.380000000000003 111.241 172.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -53.79 -31.12 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 113.15 0.796 . . . . 39.109999999999999 113.15 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1230 ' ' MET . . . . . . . . . . . . . 38.1 mmt -81.36 -23.97 37.37 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 116.394 1.998 . . . . 49.590000000000003 116.394 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1231 ' ' SER . . . . . . . . . . . . . 54.0 p -67.77 133.69 49.68 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.194 0.812 . . . . 43.68 113.194 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -50.23 -40.52 47.82 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 116.282 1.956 . . . . 55.57 116.282 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -64.72 -33.12 75.21 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 122.16 0.981 . . . . 44.939999999999998 110.271 178.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1234 ' ' PHE . . . . . 0.541 ' CE2' HG23 ' A' 1196 ' ' THR . 26.0 t80 -76.16 -46.48 28.37 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.365 -0.834 . . . . 42.039999999999999 109.041 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 12.2 mt -59.26 -31.43 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 122.344 -0.222 . . . . 46.280000000000001 111.377 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 53.3 tttm -62.48 -48.46 79.51 Favored 'General case' 0 C--O 1.245 0.867 0 O-C-N 119.531 -1.981 . . . . 47.869999999999997 109.0 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1237 ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' A' 1215 ' ' ASP . . . -58.83 -51.68 68.98 Favored 'General case' 0 C--O 1.247 0.931 0 N-CA-C 113.859 1.059 . . . . 41.609999999999999 113.859 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -54.79 -53.67 52.16 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 114.615 -1.175 . . . . 50.649999999999999 109.629 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1239 ' ' MET . . . . . . . . . . . . . 43.1 ttm -57.95 -41.36 82.66 Favored 'General case' 0 C--O 1.22 -0.484 0 O-C-N 123.694 0.621 . . . . 48.869999999999997 110.582 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -76.48 -22.5 54.44 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 120.119 -1.613 . . . . 54.799999999999997 111.725 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 1.3 tm? -66.9 -47.35 72.08 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.512 -1.662 . . . . 43.210000000000001 106.512 169.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -60.05 -36.51 77.47 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-O 118.701 -0.666 . . . . 38.659999999999997 110.283 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -67.19 -47.96 69.37 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 121.003 1.729 . . . . 37.920000000000002 111.353 -177.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -56.97 -55.19 37.88 Favored 'General case' 0 C--O 1.249 1.047 0 O-C-N 121.357 -0.839 . . . . 37.280000000000001 110.769 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -55.95 -36.33 67.66 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.743 1.217 . . . . 43.07 113.943 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1246 ' ' ALA . . . . . 0.458 ' HA ' HG22 ' A' 1249 ' ' VAL . . . -56.46 -30.4 62.85 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.996 1.11 . . . . 38.299999999999997 113.996 -176.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1247 ' ' LYS . . . . . . . . . . . . . 16.4 mtmt -78.89 -10.63 59.87 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 114.94 1.459 . . . . 47.600000000000001 114.94 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -121.18 -16.53 7.95 Favored 'General case' 0 C--O 1.246 0.899 0 O-C-N 119.0 -2.313 . . . . 45.420000000000002 114.858 173.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1249 ' ' VAL . . . . . 0.611 ' HA ' ' HB2' ' A' 1167 ' ' LYS . 27.7 m -85.33 175.21 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 O-C-N 119.199 -2.188 . . . . 36.259999999999998 111.193 -175.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1250 ' ' ASP . . . . . 0.427 ' O ' ' HB3' ' A' 1279 ' ' SER . 10.4 m-20 -134.27 -61.83 0.77 Allowed 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 112.818 -1.992 . . . . 33.039999999999999 109.371 -169.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1251 ' ' ILE . . . . . 0.523 HD12 ' HB1' ' A' 1145 ' ' ALA . 39.3 mm -108.61 94.99 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 107.002 -1.481 . . . . 31.399999999999999 107.002 -173.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1252 ' ' ILE . . . . . 0.436 ' HB ' HG23 ' A' 1281 ' ' ILE . 44.2 mt -77.7 107.65 9.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 106.13 -1.804 . . . . 29.420000000000002 106.13 171.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 5.5 t -99.28 105.19 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 104.635 -2.357 . . . . 30.370000000000001 104.635 173.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1254 ' ' THR . . . . . 0.667 HG21 ' HB2' ' A' 1291 ' ' ASN . 29.1 m -74.37 84.58 1.95 Allowed 'General case' 0 C--O 1.248 1.004 0 CA-C-O 122.732 1.253 . . . . 35.719999999999999 109.561 171.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1255 ' ' THR . . . . . 0.438 ' OG1' HG13 ' A' 1170 ' ' VAL . 1.1 p -75.89 -4.28 39.98 Favored 'General case' 0 C--O 1.25 1.093 0 N-CA-C 115.067 1.506 . . . . 36.0 115.067 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1256 ' ' ALA . . . . . . . . . . . . . . . -69.34 86.94 0.43 Allowed 'General case' 0 C--O 1.246 0.878 0 CA-C-O 121.65 0.738 . . . . 40.93 109.41 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1257 ' ' LEU . . . . . 0.553 HD22 ' HB2' ' A' 1134 ' ' ALA . 8.8 tp -73.13 91.96 1.67 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 105.653 -1.98 . . . . 47.82 105.653 178.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1258 ' ' ILE . . . . . 0.41 ' HA ' ' HD3' ' A' 1259 ' ' PRO . 41.8 mm -69.49 131.46 89.96 Favored Pre-proline 0 C--O 1.213 -0.865 0 CA-C-N 112.838 -1.983 . . . . 52.700000000000003 109.048 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1259 ' ' PRO . . . . . 0.433 ' O ' ' HG2' ' A' 1261 ' ' LYS . 6.8 Cg_exo -99.41 124.74 0.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.816 2.344 . . . . 54.130000000000003 114.387 177.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 78.2 -83.63 1.19 Allowed Glycine 0 C--N 1.343 0.962 0 CA-C-O 124.698 2.277 . . . . 54.619999999999997 114.786 173.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1261 ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' 1259 ' ' PRO . 55.2 pttt -42.84 146.91 0.7 Allowed Pre-proline 0 C--O 1.257 1.474 0 N-CA-C 117.711 2.486 . . . . 55.740000000000002 117.711 171.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -57.22 142.65 94.63 Favored 'Trans proline' 0 N--CA 1.451 -0.999 1 C-N-CA 125.336 4.024 . . . . 51.149999999999999 112.579 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1263 ' ' ALA . . . . . 0.414 ' HA ' ' HD2' ' A' 1264 ' ' PRO . . . -66.93 123.51 86.32 Favored Pre-proline 0 C--N 1.343 0.307 0 CA-C-N 113.446 -1.706 . . . . 46.060000000000002 111.169 174.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1264 ' ' PRO . . . . . 0.59 ' HG2' HD21 ' A' 1291 ' ' ASN . 43.7 Cg_endo -58.43 115.58 2.64 Favored 'Trans proline' 0 CA--C 1.509 -0.743 0 C-N-CA 123.792 2.995 . . . . 41.079999999999998 115.769 175.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1265 ' ' LYS . . . . . 0.435 ' HB3' ' HG2' ' A' 1293 ' ' GLU . 72.7 mmtt -75.6 89.58 2.76 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 122.495 1.141 . . . . 47.420000000000002 108.83 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 37.7 mt -97.67 -45.87 6.21 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.243 -1.391 . . . . 39.219999999999999 107.243 -177.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 7.9 mt -87.37 93.99 4.35 Favored 'Isoleucine or valine' 0 C--O 1.252 1.224 0 CA-C-O 126.19 2.9 . . . . 42.5 107.739 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1268 ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.75 143.68 30.01 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 111.97 -2.377 . . . . 37.840000000000003 112.383 175.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1269 ' ' ARG . . . . . 0.569 ' HG3' ' HB2' ' A' 1293 ' ' GLU . 56.3 mtt-85 -47.51 -39.18 15.54 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.072 0.949 . . . . 54.799999999999997 112.199 175.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -56.72 -50.09 73.24 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.388 -1.445 . . . . 54.359999999999999 109.154 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1271 ' ' MET . . . . . . . . . . . . . 10.0 mtt -68.78 -25.36 64.67 Favored 'General case' 0 CA--C 1.497 -1.09 0 O-C-N 123.789 0.68 . . . . 39.520000000000003 111.189 -170.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1272 ' ' VAL . . . . . 0.476 HG12 HG21 ' A' 1303 ' ' THR . 59.1 t -66.56 -49.62 73.5 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 O-C-N 126.179 2.174 . . . . 38.25 110.473 175.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -68.58 -26.43 65.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 119.985 -1.697 . . . . 40.770000000000003 112.445 174.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1274 ' ' SER . . . . . . . . . . . . . 7.2 m -68.76 -11.84 60.79 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 120.527 1.512 . . . . 36.579999999999998 114.442 169.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1275 ' ' MET . . . . . . . . . . . . . 62.7 mtp -62.52 145.69 53.63 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-O 124.478 2.085 . . . . 36.75 111.005 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1276 ' ' LYS . . . . . . . . . . . . . 74.1 tttt -50.64 137.38 19.88 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 110.967 -2.833 . . . . 46.109999999999999 106.468 165.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1277 ' ' ALA . . . . . 0.418 ' HB3' ' CD1' ' B' 1045 ' ' PHE . . . -90.94 176.85 6.46 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 117.9 -1.52 . . . . 33.520000000000003 110.472 -169.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 63.42 31.01 79.31 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 111.404 -0.679 . . . . 31.27 111.404 -170.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1279 ' ' SER . . . . . 0.427 ' HB3' ' O ' ' A' 1250 ' ' ASP . 15.2 m -122.32 171.93 8.68 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 120.587 -1.537 . . . . 32.950000000000003 110.528 -171.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1280 ' ' VAL . . . . . 0.531 HG11 ' HA ' ' A' 1145 ' ' ALA . 41.7 t -134.45 136.27 53.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 O-C-N 120.822 -1.174 . . . . 27.43 110.425 -173.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1281 ' ' ILE . . . . . 0.436 HG23 ' HB ' ' A' 1252 ' ' ILE . 66.0 mt -113.37 109.02 27.01 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 N-CA-C 103.122 -2.918 . . . . 30.300000000000001 103.122 170.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1282 ' ' VAL . . . . . 0.448 HG21 ' HB2' ' A' 1145 ' ' ALA . 2.4 t -101.15 97.86 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 105.104 -2.184 . . . . 28.629999999999999 105.104 176.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1283 ' ' ASP . . . . . 0.621 ' HA ' ' HB ' ' A' 1254 ' ' THR . 9.4 t70 -95.63 101.18 12.86 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 113.568 -1.651 . . . . 36.270000000000003 107.155 -171.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1284 ' ' LEU . . . . . 0.604 HD21 ' HB2' ' A' 1141 ' ' ALA . 31.2 mt -64.38 -37.69 88.41 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 119.608 -0.837 . . . . 38.57 110.688 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -59.23 -1.86 0.23 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 116.523 2.046 . . . . 37.560000000000002 116.523 173.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . -36.7 -42.52 0.37 Allowed 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 116.687 2.106 . . . . 40.329999999999998 116.687 161.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -51.33 -28.19 11.61 Favored 'General case' 0 C--N 1.348 0.534 0 N-CA-C 115.714 1.746 . . . . 56.850000000000001 115.714 174.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 11.4 m120 -113.97 22.88 13.49 Favored 'General case' 0 N--CA 1.433 -1.281 0 O-C-N 121.4 -0.813 . . . . 45.859999999999999 108.866 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 109.68 -23.11 22.75 Favored Glycine 0 N--CA 1.43 -1.731 0 O-C-N 118.196 -2.815 . . . . 40.310000000000002 114.338 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1290 ' ' GLY . . . . . 0.491 ' HA3' ' HB ' ' A' 1295 ' ' THR . . . 87.62 127.92 2.63 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 120.853 2.327 . . . . 38.890000000000001 112.2 -177.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1291 ' ' ASN . . . . . 0.667 ' HB2' HG21 ' A' 1254 ' ' THR . 2.8 m120 -71.27 -26.22 62.79 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 113.345 -1.427 . . . . 37.229999999999997 113.804 175.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1292 ' ' CYS . . . . . 0.425 ' SG ' HG21 ' A' 1272 ' ' VAL . 1.6 t -82.51 138.86 34.19 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.757 -1.11 . . . . 36.5 108.951 165.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1293 ' ' GLU . . . . . 0.569 ' HB2' ' HG3' ' A' 1269 ' ' ARG . 78.5 mt-10 -68.8 -6.56 27.52 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 115.371 1.619 . . . . 43.32 115.371 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -102.81 -2.09 28.59 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 119.688 -1.883 . . . . 41.32 112.706 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1295 ' ' THR . . . . . 0.491 ' HB ' ' HA3' ' A' 1290 ' ' GLY . 31.5 m -78.04 103.13 7.79 Favored 'General case' 0 C--N 1.355 0.832 0 O-C-N 120.845 -1.16 . . . . 35.299999999999997 112.827 -168.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 47.8 t -82.6 121.59 78.1 Favored Pre-proline 0 C--N 1.31 -1.131 0 O-C-N 125.292 1.62 . . . . 34.840000000000003 107.4 174.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -63.51 143.46 88.0 Favored 'Trans proline' 0 C--O 1.25 1.118 0 C-N-CA 122.984 2.456 . . . . 33.509999999999998 108.884 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 69.69 13.56 68.87 Favored Glycine 0 CA--C 1.544 1.9 0 CA-C-O 116.682 -2.177 . . . . 32.189999999999998 115.425 -175.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -147.37 169.98 18.32 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-N 123.988 3.894 . . . . 34.880000000000003 112.823 -172.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1300 ' ' ILE . . . . . 0.452 HG12 HG12 ' A' 1310 ' ' ILE . 74.3 mt -107.92 141.44 23.16 Favored 'Isoleucine or valine' 0 C--O 1.248 0.992 0 N-CA-C 106.555 -1.646 . . . . 32.289999999999999 106.555 166.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 78.8 t80 -119.74 114.28 21.92 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 104.194 -2.521 . . . . 37.25 104.194 164.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1302 ' ' THR . . . . . . . . . . . . . 46.0 m -93.66 118.9 31.99 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 103.614 -2.735 . . . . 35.560000000000002 103.614 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1303 ' ' THR . . . . . 0.476 HG21 HG12 ' A' 1272 ' ' VAL . 8.5 p -70.74 170.92 11.41 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 113.525 -1.671 . . . . 36.399999999999999 114.284 -171.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -75.23 -9.65 58.75 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 113.963 1.097 . . . . 52.32 113.963 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 37.3 p-10 -83.84 -46.14 12.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.363 0.601 . . . . 40.039999999999999 111.356 166.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 127.45 52.0 0.14 Allowed Glycine 0 N--CA 1.427 -1.903 0 CA-C-N 114.466 -1.243 . . . . 36.960000000000001 112.808 -177.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1307 ' ' VAL . . . . . . . . . . . . . 82.0 t -118.77 124.02 72.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 N-CA-C 104.943 -2.243 . . . . 33.399999999999999 104.943 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1308 ' ' LYS . . . . . 0.44 ' HB2' HG22 ' A' 1280 ' ' VAL . 53.7 mmtt -80.21 95.11 6.18 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 106.116 -1.809 . . . . 42.909999999999997 106.116 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 38.4 t -84.22 92.68 3.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 106.357 -1.72 . . . . 32.289999999999999 106.357 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1310 ' ' ILE . . . . . 0.452 HG12 HG12 ' A' 1300 ' ' ILE . 82.6 mt -82.44 103.41 9.62 Favored 'Isoleucine or valine' 0 C--N 1.351 0.642 0 CA-C-N 112.782 -2.008 . . . . 30.989999999999998 109.166 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -103.21 60.69 0.48 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 108.936 -1.666 . . . . 28.949999999999999 108.936 168.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1312 ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -83.25 95.73 8.24 Favored 'General case' 0 C--O 1.252 1.189 0 CA-C-O 125.278 2.466 . . . . 31.690000000000001 111.483 177.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1313 ' ' THR . . . . . . . . . . . . . 2.8 m -51.91 -37.92 54.35 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 112.46 -2.155 . . . . 34.170000000000002 111.567 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -84.77 10.38 11.58 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 113.381 -1.736 . . . . 36.859999999999999 111.679 -169.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1315 ' ' LEU . . . . . 0.459 HD22 ' HG3' ' A' 1140 ' ' ARG . 96.9 mt -44.05 -44.36 17.0 Favored Pre-proline 0 N--CA 1.474 0.743 0 N-CA-C 119.356 3.095 . . . . 34.850000000000001 119.356 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -53.6 -33.46 68.88 Favored 'Trans proline' 0 C--O 1.258 1.518 0 C-N-CA 124.53 3.486 . . . . 29.149999999999999 115.025 170.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1317 ' ' GLY . . . . . 0.451 ' O ' ' HB ' ' A' 1014 ' ' THR . . . -76.32 -40.66 28.02 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 109.496 -1.442 . . . . 27.289999999999999 109.496 177.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1318 ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' 1318 ' ' ARG . 58.1 mtt-85 -58.05 -26.62 62.73 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 115.641 1.719 . . . . 41.490000000000002 115.641 177.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1319 ' ' LEU . . . . . 0.459 HD23 HG23 ' A' 1136 ' ' ILE . 13.1 tp -103.97 71.88 0.17 Allowed Pre-proline 0 C--O 1.238 0.486 0 O-C-N 119.587 -1.946 . . . . 27.609999999999999 109.141 168.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1320 ' ' PRO . . . . . 0.706 ' HD2' ' HA2' ' B' 1150 ' ' GLY . 86.1 Cg_endo -58.12 -54.87 2.67 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.854 3.036 . . . . 25.940000000000001 113.985 -166.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1321 ' ' THR . . . . . 0.685 HG23 HG21 ' A' 1019 ' ' THR . 4.3 m -63.7 -43.53 96.35 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.937 0.895 . . . . 25.010000000000002 109.621 -171.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1322 ' ' GLN . . . . . 0.504 HE21 ' HG ' ' A' 1326 ' ' LEU . 9.3 tp60 -67.56 -26.76 66.46 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 117.451 -1.261 . . . . 29.390000000000001 112.803 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1323 ' ' SER . . . . . 0.575 ' HA ' HD13 ' A' 1136 ' ' ILE . 36.9 m -66.81 -51.29 57.34 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 120.346 1.43 . . . . 26.469999999999999 111.131 162.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1324 ' ' SER . . . . . . . . . . . . . 4.3 m -63.39 -17.83 63.04 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 116.296 1.962 . . . . 27.780000000000001 116.296 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -104.44 -54.87 2.45 Favored 'General case' 0 C--O 1.247 0.937 0 CA-C-N 114.787 -1.097 . . . . 37.530000000000001 110.811 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1326 ' ' LEU . . . . . 0.504 ' HG ' HE21 ' A' 1322 ' ' GLN . 33.6 mt -69.3 -59.5 2.96 Favored 'General case' 0 CA--C 1.505 -0.761 0 O-C-N 118.015 -2.928 . . . . 35.710000000000001 112.274 175.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1327 ' ' TYR . . . . . 0.531 ' HB3' ' O ' ' A' 1323 ' ' SER . 31.3 t80 -57.16 -37.5 72.18 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-O 122.31 1.052 . . . . 31.59 108.218 177.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1328 ' ' GLY . . . . . 0.463 ' HA2' HD12 ' A' 1331 ' ' LEU . . . -46.77 -58.4 6.13 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.95 1.262 . . . . 28.0 113.226 168.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1329 ' ' THR . . . . . . . . . . . . . 17.3 m -70.14 -25.45 63.47 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.371 1.586 . . . . 32.149999999999999 110.619 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1330 ' ' ASN . . . . . . . . . . . . . 26.4 m120 -59.3 -49.97 75.79 Favored 'General case' 0 C--O 1.244 0.792 0 O-C-N 119.807 -1.808 . . . . 34.359999999999999 111.361 168.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1331 ' ' LEU . . . . . 0.851 HD13 HD13 ' A' 1070 ' ' LEU . 13.2 mt -55.55 -48.96 73.91 Favored 'General case' 0 C--N 1.357 0.907 0 O-C-N 127.226 2.829 . . . . 33.369999999999997 108.747 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1332 ' ' VAL . . . . . 0.518 HG11 ' HB3' ' A' 1025 ' ' GLN . 44.1 t -56.9 -42.66 78.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 O-C-N 124.782 1.301 . . . . 35.270000000000003 110.783 175.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -57.55 -49.33 76.71 Favored 'General case' 0 C--O 1.242 0.706 0 O-C-N 119.844 -1.785 . . . . 37.659999999999997 112.677 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1334 ' ' LEU . . . . . 0.405 HD22 ' SD ' ' A' 1115 ' ' MET . 53.6 tp -57.06 -54.02 51.52 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 124.736 1.273 . . . . 40.270000000000003 108.43 176.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1335 ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' 1331 ' ' LEU . 46.6 mt -62.98 -23.81 67.61 Favored 'General case' 0 N--CA 1.436 -1.154 0 O-C-N 126.369 2.293 . . . . 42.5 111.146 -176.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1336 ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -69.02 -35.19 76.37 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 123.284 2.766 . . . . 47.810000000000002 111.944 173.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1337 ' ' LEU . . . . . 0.443 ' O ' ' HG2' ' A' 1340 ' ' LYS . 58.5 mt -67.84 -43.94 78.32 Favored 'General case' 0 CA--C 1.507 -0.709 0 O-C-N 120.84 -1.163 . . . . 49.270000000000003 108.297 172.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1338 ' ' LEU . . . . . 0.642 HD23 HG23 ' A' 1346 ' ' ILE . 6.9 mp -66.91 -38.93 87.15 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 116.724 2.12 . . . . 50.539999999999999 116.724 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1339 ' ' CYS . . . . . . . . . . . . . 49.1 t -104.82 81.32 1.74 Allowed 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 104.761 -2.311 . . . . 53.670000000000002 104.761 -175.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1340 ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' 1337 ' ' LEU . 75.3 mttt -74.31 -52.13 13.16 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 124.312 2.006 . . . . 63.380000000000003 113.096 -165.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1341 ' ' GLU . . . . . 0.412 ' HB2' ' HB3' ' A' 1343 ' ' ASP . 15.8 mt-10 -76.48 -44.16 36.61 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 110.077 -3.238 . . . . 70.950000000000003 111.85 -166.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1342 ' ' LYS . . . . . 0.664 ' HE2' ' HA ' ' A' 1029 ' ' LEU . 7.6 mtpm? 59.84 67.5 0.87 Allowed 'General case' 0 C--N 1.356 0.881 0 C-N-CA 127.043 2.137 . . . . 65.25 113.216 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1343 ' ' ASP . . . . . 0.412 ' HB3' ' HB2' ' A' 1341 ' ' GLU 0.468 0.0 OUTLIER 68.38 -72.14 0.1 Allowed 'General case' 0 C--N 1.375 1.712 1 O-C-N 115.001 -4.812 . . . . 64.530000000000001 118.904 8.507 . . . . . . . . 5 4 . 1 . 005 nuclear build full ' A' A 1344 ' ' GLY . . . . . 0.658 ' H ' ' HA ' ' A' 1342 ' ' LYS . . . 79.71 46.69 7.71 Favored Glycine 0 C--O 1.244 0.755 0 CA-C-N 121.238 1.835 . . . . 59.719999999999999 110.462 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -130.03 122.8 29.1 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 121.792 0.806 . . . . 64.090000000000003 111.081 166.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1346 ' ' ILE . . . . . 0.642 HG23 HD23 ' A' 1338 ' ' LEU . 13.4 mt -79.99 109.9 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 CA-C-O 123.513 1.625 . . . . 58.82 109.382 170.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1347 ' ' THR . . . . . . . . . . . . . 28.6 m -96.84 107.2 19.65 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 110.275 -3.148 . . . . 54.960000000000001 104.533 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1348 ' ' VAL . . . . . 0.417 ' HB ' ' NH2' ' A' 1362 ' ' ARG . 42.2 t -84.16 87.78 2.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 103.608 -2.738 . . . . 55.640000000000001 103.608 -178.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 29.8 t70 -73.16 111.54 8.37 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.539 -1.21 . . . . 61.450000000000003 112.605 178.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1350 ' ' PHE . . . . . 0.454 ' HE2' HG21 ' A' 1367 ' ' THR . 3.1 m-85 -79.79 4.51 16.21 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 114.946 1.461 . . . . 58.630000000000003 114.946 171.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -78.45 -33.04 48.71 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 117.12 -1.832 . . . . 62.060000000000002 112.377 173.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 5.1 t70 -84.31 123.96 30.73 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 124.703 2.192 . . . . 54.07 108.8 171.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 32.2 m -61.46 -29.83 46.83 Favored 'Isoleucine or valine' 0 C--O 1.247 0.973 0 CA-C-N 109.902 -3.317 . . . . 50.68 113.089 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1354 ' ' VAL . . . . . 0.638 ' O ' HG23 ' A' 1358 ' ' VAL . 5.8 m -69.45 -40.92 80.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 119.908 1.231 . . . . 47.68 109.7 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1355 ' ' ILE . . . . . 0.501 HG23 HD11 ' A' 1338 ' ' LEU . 54.7 mt -68.11 -48.4 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.872 -1.159 . . . . 48.490000000000002 107.872 -176.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1356 ' ' ARG . . . . . 0.465 ' HG3' ' HG2' ' A' 1371 ' ' PRO . 22.5 tpt85 -52.08 -40.52 61.34 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.687 1.195 . . . . 48.270000000000003 113.145 168.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -58.65 -53.43 46.17 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 125.67 1.605 . . . . 43.530000000000001 112.623 174.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1358 ' ' VAL . . . . . 0.696 HG12 ' HB3' ' A' 1113 ' ' MET . 10.9 t -62.92 -39.9 86.86 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.5 0 O-C-N 124.982 1.048 . . . . 45.119999999999997 109.079 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1359 ' ' THR . . . . . . . . . . . . . 21.4 m -74.16 88.68 1.97 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 123.278 1.513 . . . . 42.939999999999998 109.835 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1360 ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' 1368 ' ' TRP . 29.7 m -78.62 -23.0 13.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 113.874 1.065 . . . . 43.259999999999998 113.874 178.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1361 ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' 1111 ' ' THR . 57.7 mt -133.36 120.5 39.11 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.003 0 O-C-N 118.119 -2.863 . . . . 45.659999999999997 106.604 170.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1362 ' ' ARG . . . . . 0.417 ' NH2' ' HB ' ' A' 1348 ' ' VAL . 12.9 ttt180 -102.09 109.78 21.57 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 118.474 -2.641 . . . . 61.340000000000003 106.358 170.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 43.16 39.92 2.16 Favored 'General case' 0 C--O 1.249 1.044 0 N-CA-C 117.278 2.325 . . . . 49.759999999999998 117.278 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1364 ' ' GLY . . . . . 0.44 ' H ' HG22 ' A' 1361 ' ' ILE . . . 119.6 -34.75 4.12 Favored Glycine 0 C--N 1.349 1.283 0 C-N-CA 119.392 -1.385 . . . . 50.0 111.758 177.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -82.4 123.12 28.83 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.002 -1.481 . . . . 56.920000000000002 107.002 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1366 ' ' ILE . . . . . 0.42 HG12 HG12 ' A' 1361 ' ' ILE . 93.4 mt -84.85 87.31 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 107.851 -1.166 . . . . 52.780000000000001 107.851 -177.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1367 ' ' THR . . . . . 0.454 HG21 ' HE2' ' A' 1350 ' ' PHE . 1.3 p -66.25 -6.76 14.92 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 116.031 1.863 . . . . 49.439999999999998 116.031 175.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1368 ' ' TRP . . . . . 0.571 ' CD1' ' HA ' ' A' 1369 ' ' PRO . 20.7 t90 -59.45 141.14 88.16 Favored Pre-proline 0 N--CA 1.442 -0.872 0 CA-C-O 116.13 -1.89 . . . . 52.380000000000003 108.128 164.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1369 ' ' PRO . . . . . 0.571 ' HA ' ' CD1' ' A' 1368 ' ' TRP . 72.6 Cg_exo -67.06 160.32 78.85 Favored 'Cis proline' 0 C--N 1.362 1.258 0 N-CA-C 119.733 2.936 . . . . 46.939999999999998 119.733 -0.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -89.68 142.53 29.35 Favored Pre-proline 0 C--O 1.24 0.6 0 CA-C-N 114.862 -1.063 . . . . 45.909999999999997 113.208 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1371 ' ' PRO . . . . . 0.465 ' HG2' ' HG3' ' A' 1356 ' ' ARG . 0.4 OUTLIER -51.59 124.1 13.63 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 124.366 3.377 . . . . 46.390000000000001 114.77 169.295 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 1372 ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' 1371 ' ' PRO . 56.0 Cg_exo -72.29 -59.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.357 1.005 1 C-N-CA 126.839 5.026 . . . . 46.719999999999999 109.225 173.381 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.223 -4.904 0 CA-C-N 119.741 1.155 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 79.4 m80 . . . . . 0 CA--C 1.548 0.884 0 N-CA-C 102.436 -3.172 . . . . 63.439999999999998 102.436 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 999' ' ' HIS . . . . . 0.552 ' HB3' ' HB3' ' B' 1002 ' ' ARG . 28.4 m170 -124.02 50.72 1.62 Allowed 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 121.875 2.125 . . . . 51.740000000000002 111.849 170.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1000 ' ' HIS . . . . . . . . . . . . . 33.2 t60 -71.53 119.45 15.7 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 111.868 -2.424 . . . . 54.07 107.552 174.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 82.13 15.19 75.22 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 123.773 0.701 . . . . 39.219999999999999 111.442 -174.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1002 ' ' ARG . . . . . 0.552 ' HB3' ' HB3' ' B' ' 999' ' ' HIS . 30.6 ttp180 -107.59 128.05 54.19 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 124.534 2.112 . . . . 38.119999999999997 108.765 167.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1003 ' ' ILE . . . . . 0.678 HG12 ' HB ' ' B' 1068 ' ' ILE . 14.9 mt -81.79 150.52 4.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 110.191 -3.186 . . . . 29.699999999999999 107.229 174.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -129.34 120.42 3.2 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 105.167 -3.173 . . . . 27.5 105.167 171.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1005 ' ' ILE . . . . . 0.639 HG23 ' HB3' ' B' 1017 ' ' ALA . 45.8 mm -100.06 110.4 59.39 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 116.514 -1.708 . . . . 24.829999999999998 107.505 173.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -78.77 152.44 25.41 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 124.117 3.211 . . . . 27.190000000000001 110.757 175.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1007 ' ' ARG . . . . . 0.449 ' HB3' ' OE1' ' B' 1036 ' ' GLU . 18.2 ttt180 -79.97 110.27 15.19 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 102.938 -2.986 . . . . 41.460000000000001 102.938 160.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1008 ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -55.36 131.26 45.29 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 124.176 1.941 . . . . 26.93 115.757 -165.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 36.7 mmm-85 -84.95 -12.28 53.67 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 111.71 -2.496 . . . . 34.479999999999997 111.033 -169.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1010 ' ' LEU . . . . . 0.429 ' HB3' ' HB2' ' B' 1013 ' ' GLU . 13.1 tp -55.74 133.67 51.02 Favored 'General case' 0 C--O 1.243 0.728 0 O-C-N 120.776 -1.203 . . . . 44.219999999999999 109.609 172.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1011 ' ' THR . . . . . . . . . . . . . 28.7 m -60.46 111.65 1.66 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 114.365 1.246 . . . . 40.740000000000002 114.365 -168.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 42.3 t30 54.69 55.73 7.56 Favored 'General case' 0 C--O 1.222 -0.368 0 O-C-N 124.51 1.131 . . . . 44.439999999999998 114.047 -170.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1013 ' ' GLU . . . . . 0.429 ' HB2' ' HB3' ' B' 1010 ' ' LEU . 10.7 tp10 -88.49 136.75 32.84 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 115.054 -0.976 . . . . 29.870000000000001 108.988 166.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1014 ' ' THR . . . . . 0.523 HG22 ' HB3' ' B' 1320 ' ' PRO . 96.2 m -96.97 -26.18 15.13 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 111.422 -2.626 . . . . 25.260000000000002 109.906 -173.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1015 ' ' ARG . . . . . 0.676 ' HG3' ' HA2' ' B' 1317 ' ' GLY . 85.0 mtm180 -70.96 141.81 51.05 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 123.985 1.85 . . . . 29.539999999999999 112.218 175.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1016 ' ' VAL . . . . . 0.648 HG12 ' HB2' ' B' 1043 ' ' ALA . 9.9 p -102.47 169.5 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 N-CA-C 105.586 -2.005 . . . . 23.550000000000001 105.586 151.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1017 ' ' ALA . . . . . 0.639 ' HB3' HG23 ' B' 1005 ' ' ILE . . . -72.24 -35.93 68.97 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.294 1.22 . . . . 23.59 114.294 -174.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1018 ' ' ALA . . . . . . . . . . . . . . . -147.16 153.08 39.45 Favored 'General case' 0 CA--C 1.509 -0.612 0 O-C-N 124.001 0.813 . . . . 24.93 111.71 -172.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1019 ' ' THR . . . . . . . . . . . . . 12.7 p -91.57 163.75 27.09 Favored Pre-proline 0 C--O 1.25 1.11 0 CA-C-O 117.742 -1.123 . . . . 28.09 110.343 171.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -48.27 -41.76 34.54 Favored 'Trans proline' 0 CA--C 1.501 -1.166 1 C-N-CA 125.664 4.242 . . . . 28.789999999999999 111.966 173.672 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B 1021 ' ' LYS . . . . . 0.567 ' HD2' HE22 ' B' 1325 ' ' GLN . 0.5 OUTLIER -51.4 -47.57 62.9 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 122.638 1.209 . . . . 47.280000000000001 112.182 174.502 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B 1022 ' ' THR . . . . . 0.513 ' O ' ' HG ' ' B' 1026 ' ' LEU . 9.6 p -78.41 -22.34 47.93 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 118.835 -1.146 . . . . 30.120000000000001 112.038 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1023 ' ' VAL . . . . . . . . . . . . . 51.6 t -66.24 -42.3 90.72 Favored 'Isoleucine or valine' 0 C--N 1.349 0.548 0 O-C-N 120.84 -1.162 . . . . 32.240000000000002 110.421 169.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1024 ' ' GLU . . . . . 0.513 ' HA ' HD12 ' B' 1027 ' ' LEU . 43.6 mt-10 -54.57 -48.59 71.88 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 120.451 -1.405 . . . . 49.619999999999997 112.42 171.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -49.49 -48.36 47.93 Favored 'General case' 0 C--O 1.21 -0.975 0 N-CA-C 114.31 1.226 . . . . 44.68 114.31 169.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1026 ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' B' 1022 ' ' THR . 70.8 mt -58.07 -41.09 82.63 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 120.063 -1.648 . . . . 35.710000000000001 111.432 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1027 ' ' LEU . . . . . 0.513 HD12 ' HA ' ' B' 1024 ' ' GLU . 12.3 mt -70.05 -27.64 64.81 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.894 1.278 . . . . 42.18 114.247 177.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 51.5 mttm -66.11 -47.21 74.91 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 105.877 -1.898 . . . . 48.340000000000003 105.877 169.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1029 ' ' LEU . . . . . . . . . . . . . 74.1 mt -69.42 -10.99 60.4 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 120.426 -1.421 . . . . 38.689999999999998 113.714 175.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 97.05 10.52 54.79 Favored Glycine 0 C--N 1.353 1.522 0 C-N-CA 125.722 1.63 . . . . 32.280000000000001 113.015 166.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -77.12 140.59 40.28 Favored 'General case' 0 N--CA 1.44 -0.974 0 O-C-N 120.735 -1.45 . . . . 35.939999999999998 110.913 173.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1032 ' ' THR . . . . . . . . . . . . . 5.9 m -83.95 138.95 32.88 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 104.788 -2.301 . . . . 33.369999999999997 104.788 174.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1033 ' ' VAL . . . . . . . . . . . . . 10.0 t -122.34 144.39 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 124.045 3.111 . . . . 29.98 111.769 -172.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -129.57 144.93 51.49 Favored 'General case' 0 C--O 1.249 1.036 0 C-N-CA 125.791 1.636 . . . . 28.18 108.537 169.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1035 ' ' VAL . . . . . . . . . . . . . 47.0 t -136.84 142.47 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 105.831 -1.914 . . . . 25.82 105.831 -174.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1036 ' ' GLU . . . . . 0.595 ' HB2' HG11 ' B' 1063 ' ' VAL . 27.7 tt0 -76.95 141.33 40.5 Favored 'General case' 0 C--O 1.258 1.535 0 C-N-CA 118.886 -1.126 . . . . 32.439999999999998 113.968 -174.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1037 ' ' SER . . . . . . . . . . . . . 49.6 m -52.24 128.06 23.92 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.117 0.961 . . . . 29.539999999999999 113.178 171.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 92.34 -13.2 67.81 Favored Glycine 0 CA--C 1.542 1.779 0 CA-C-N 115.292 -0.867 . . . . 27.760000000000002 113.475 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1039 ' ' ALA . . . . . 0.624 ' HB1' HG21 ' B' 1016 ' ' VAL . . . -62.71 -39.37 93.81 Favored 'General case' 0 N--CA 1.438 -1.062 0 O-C-N 120.553 -1.557 . . . . 26.02 112.062 178.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -61.08 -45.81 95.83 Favored Glycine 0 C--N 1.304 -1.232 0 C-N-CA 119.315 -1.422 . . . . 26.469999999999999 110.962 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -68.17 -28.18 67.06 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 118.421 -2.811 . . . . 50.979999999999997 111.972 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 15.3 mt -58.91 -51.23 70.95 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 117.955 -2.965 . . . . 29.300000000000001 109.97 166.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1043 ' ' ALA . . . . . 0.648 ' HB2' HG12 ' B' 1016 ' ' VAL . . . -68.2 17.13 0.04 OUTLIER 'General case' 0 C--O 1.213 -0.823 0 O-C-N 119.0 -2.313 . . . . 26.739999999999998 116.564 167.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1044 ' ' SER . . . . . . . . . . . . . 15.1 m 54.12 34.47 20.13 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 123.707 1.717 . . . . 31.260000000000002 114.792 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1045 ' ' PHE . . . . . 0.418 ' CD1' ' HB3' ' A' 1277 ' ' ALA . 0.1 OUTLIER -127.94 158.59 37.41 Favored 'General case' 0 C--O 1.241 0.65 0 O-C-N 121.172 -0.955 . . . . 33.259999999999998 108.712 -177.528 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 29.1 t0 -72.71 139.05 46.97 Favored 'General case' 0 C--O 1.245 0.835 0 O-C-N 120.755 -1.215 . . . . 46.740000000000002 108.824 170.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.54 -40.57 72.03 Favored 'General case' 0 C--O 1.214 -0.816 0 CA-C-O 122.572 1.177 . . . . 34.439999999999998 110.858 175.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.65 -2.41 17.14 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 120.635 -1.291 . . . . 48.670000000000002 113.134 -174.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -72.08 -35.68 69.3 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 118.302 -2.749 . . . . 35.259999999999998 108.365 167.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1050 ' ' PHE . . . . . 0.661 ' HB2' HD11 ' B' 1057 ' ' ILE . 64.2 m-85 -65.32 -41.63 93.81 Favored 'General case' 0 C--O 1.219 -0.524 0 O-C-N 120.335 -1.478 . . . . 32.170000000000002 108.438 176.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1051 ' ' VAL . . . . . 0.629 HG23 HG12 ' B' 1057 ' ' ILE . 17.5 t -50.8 -57.98 2.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 123.757 0.66 . . . . 38.369999999999997 111.98 168.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -42.77 -54.28 4.17 Favored 'General case' 0 C--O 1.213 -0.845 0 N-CA-C 113.511 0.93 . . . . 45.770000000000003 113.511 172.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -54.25 -38.4 65.75 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.376 1.251 . . . . 37.829999999999998 114.376 173.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 126.89 34.53 0.59 Allowed Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.845 -0.902 . . . . 35.82 110.845 174.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -112.23 147.21 36.71 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 107.985 -1.117 . . . . 33.770000000000003 107.985 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -76.85 132.82 39.37 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 107.19 -1.411 . . . . 51.020000000000003 107.19 168.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1057 ' ' ILE . . . . . 0.661 HD11 ' HB2' ' B' 1050 ' ' PHE . 27.8 mm -100.96 124.68 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-O 122.92 1.343 . . . . 38.469999999999999 108.06 169.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1058 ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' B' 1036 ' ' GLU . 0.0 OUTLIER -143.52 142.34 25.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 C-N-CA 124.942 1.297 . . . . 39.399999999999999 113.235 -171.553 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -82.17 123.13 28.72 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.998 -1.112 . . . . 57.07 107.998 -171.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1060 ' ' GLY . . . . . 0.495 ' O ' HG12 ' B' 1063 ' ' VAL . . . 57.0 -133.82 52.53 Favored Glycine 0 N--CA 1.432 -1.596 0 CA-C-O 122.605 1.114 . . . . 44.829999999999998 114.404 165.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -38.92 -40.52 0.65 Allowed 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 111.084 -2.558 . . . . 46.270000000000003 115.403 -172.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1062 ' ' SER . . . . . . . . . . . . . 5.5 m -45.71 -51.31 12.67 Favored 'General case' 0 C--N 1.349 0.586 0 N-CA-C 113.98 1.104 . . . . 43.469999999999999 113.98 173.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1063 ' ' VAL . . . . . 0.595 HG11 ' HB2' ' B' 1036 ' ' GLU . 3.6 p -69.3 -35.32 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 C-N-CA 123.371 0.668 . . . . 36.979999999999997 110.15 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -64.22 -28.57 69.83 Favored 'General case' 0 N--CA 1.422 -1.844 0 O-C-N 123.813 0.696 . . . . 37.899999999999999 111.908 175.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -82.29 82.91 7.61 Favored 'General case' 0 C--O 1.243 0.748 0 O-C-N 118.798 -2.439 . . . . 46.189999999999998 110.802 171.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1066 ' ' SER . . . . . . . . . . . . . 44.7 m -150.35 162.36 40.69 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.412 -1.267 . . . . 37.060000000000002 108.299 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1067 ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -72.02 -58.3 3.55 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 117.821 -1.551 . . . . 43.950000000000003 111.951 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1068 ' ' ILE . . . . . 0.678 ' HB ' HG12 ' B' 1003 ' ' ILE . 4.4 mp -96.22 107.15 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 103.165 -2.902 . . . . 33.5 103.165 -169.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 48.9 mm -97.54 109.22 23.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 107.208 -1.404 . . . . 30.57 107.208 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1070 ' ' LEU . . . . . 0.681 HD22 HD22 ' B' 1331 ' ' LEU . 83.6 mt -95.74 91.86 6.29 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 124.377 2.037 . . . . 27.66 107.174 177.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1071 ' ' LYS . . . . . . . . . . . . . 10.9 mtpt -90.69 161.27 15.44 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-N 112.59 -2.095 . . . . 28.399999999999999 109.491 176.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1072 ' ' VAL . . . . . . . . . . . . . 2.7 t -83.91 -56.91 4.97 Favored 'Isoleucine or valine' 0 C--N 1.351 0.637 0 N-CA-C 104.733 -2.321 . . . . 23.18 104.733 -177.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -113.46 173.88 6.19 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 113.808 -1.542 . . . . 25.469999999999999 107.448 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -49.41 146.93 6.08 Favored Pre-proline 0 C--O 1.264 1.832 0 C-N-CA 124.899 1.28 . . . . 27.899999999999999 113.66 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1075 ' ' PRO . . . . . 0.525 ' HG3' HD21 ' B' 1105 ' ' LEU . 59.7 Cg_endo -60.52 151.89 72.06 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.455 2.77 . . . . 31.620000000000001 110.574 166.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 7.4 mp -89.7 165.74 14.01 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 113.828 -1.533 . . . . 40.490000000000002 107.171 166.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1077 ' ' ASP . . . . . 0.582 ' HA ' HD12 ' B' 1080 ' ' ILE . 10.1 t70 -58.71 -40.63 84.24 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 116.448 2.018 . . . . 51.590000000000003 116.448 -173.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -57.3 -43.43 83.22 Favored 'General case' 0 C--O 1.244 0.773 0 O-C-N 121.489 -0.757 . . . . 42.359999999999999 111.202 169.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1079 ' ' GLU . . . . . 0.438 ' OE1' ' HA ' ' B' 1075 ' ' PRO . 43.2 mt-10 -64.8 -28.65 69.71 Favored 'General case' 0 C--O 1.221 -0.426 0 O-C-N 121.404 -0.81 . . . . 34.530000000000001 109.868 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1080 ' ' ILE . . . . . 0.843 ' HA ' HD12 ' B' 1083 ' ' LEU . 69.5 mt -64.13 -41.21 91.73 Favored 'Isoleucine or valine' 0 C--N 1.36 1.053 0 O-C-N 119.926 -1.734 . . . . 33.25 110.231 171.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -62.73 -30.01 71.1 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.442 -1.411 . . . . 36.469999999999999 114.365 172.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1082 ' ' LEU . . . . . 0.42 HD12 ' HA ' ' B' 1079 ' ' GLU . 65.4 mt -75.16 -28.34 60.05 Favored 'General case' 0 C--N 1.348 0.532 0 O-C-N 121.584 -0.698 . . . . 37.759999999999998 110.852 175.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1083 ' ' LEU . . . . . 0.843 HD12 ' HA ' ' B' 1080 ' ' ILE . 34.1 mt -52.78 114.8 1.53 Allowed 'General case' 0 C--O 1.247 0.953 0 N-CA-C 114.928 1.455 . . . . 37.43 114.928 174.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.34 143.83 52.65 Favored Pre-proline 0 N--CA 1.453 -0.314 0 CA-C-N 111.289 -2.687 . . . . 37.700000000000003 107.587 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -54.67 123.69 14.33 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.176 3.251 . . . . 35.509999999999998 109.434 175.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 83.61 17.16 66.66 Favored Glycine 0 C--N 1.316 -0.565 0 CA-C-O 119.608 -0.551 . . . . 33.869999999999997 112.076 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1087 ' ' THR . . . . . . . . . . . . . 52.5 m -69.76 134.44 48.58 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 121.707 2.753 . . . . 32.5 108.72 163.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1088 ' ' THR . . . . . . . . . . . . . 38.9 m -92.93 97.94 11.05 Favored 'General case' 0 C--O 1.254 1.321 0 N-CA-C 105.528 -2.027 . . . . 30.219999999999999 105.528 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1089 ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' B' 1112 ' ' VAL . 22.1 tp -96.17 130.19 43.29 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 120.829 -1.169 . . . . 27.239999999999998 108.639 -176.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 95.8 t -125.6 128.01 72.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 102.247 -3.242 . . . . 25.390000000000001 102.247 -175.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1091 ' ' SER . . . . . . . . . . . . . 3.9 m -160.23 168.38 25.51 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 121.893 2.133 . . . . 28.809999999999999 111.925 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1092 ' ' PHE . . . . . 0.421 ' CD2' ' HB3' ' B' 1116 ' ' ASP . 25.2 m-85 -66.71 108.25 2.42 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.549 -1.278 . . . . 30.780000000000001 107.549 155.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 26.2 mm -104.31 -36.67 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 O-C-N 118.837 -2.414 . . . . 30.280000000000001 114.267 -176.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1094 ' ' TRP . . . . . . . . . . . . . 61.9 m95 54.53 65.49 5.06 Favored Pre-proline 0 CA--C 1.548 0.886 0 O-C-N 124.319 1.012 . . . . 34.07 110.582 -175.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -47.99 -58.39 1.78 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 1 C-N-CA 127.375 5.383 . . . . 38.659999999999997 118.91 -166.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1096 ' ' ALA . . . . . 0.512 ' HB2' ' HZ3' ' B' 1368 ' ' TRP . . . -82.29 -14.89 54.7 Favored 'General case' 0 N--CA 1.436 -1.163 0 O-C-N 119.734 -1.854 . . . . 41.32 110.437 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -76.58 -21.96 54.91 Favored 'General case' 0 C--O 1.246 0.895 0 N-CA-C 108.579 -0.897 . . . . 51.659999999999997 108.579 166.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 9.5 m120 -121.36 42.39 0.56 Allowed Pre-proline 0 C--N 1.309 -1.168 0 N-CA-C 117.391 2.367 . . . . 40.32 117.391 -172.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -56.49 -42.54 64.47 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 123.633 2.889 . . . . 41.560000000000002 117.188 -167.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -61.25 -39.84 91.83 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.714 1.143 . . . . 54.109999999999999 113.316 175.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1101 ' ' LEU . . . . . 0.403 ' O ' ' HG ' ' B' 1105 ' ' LEU . 6.2 tp -62.78 -49.44 74.97 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 108.521 -0.918 . . . . 37.880000000000003 108.521 176.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1102 ' ' MET . . . . . . . . . . . . . 91.6 mmm -51.25 -55.73 16.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.712 -0.676 . . . . 37.539999999999999 110.381 177.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -49.34 -49.74 42.86 Favored 'General case' 0 C--O 1.244 0.775 0 O-C-N 121.694 -0.629 . . . . 47.009999999999998 112.483 176.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1104 ' ' LYS . . . . . 0.405 ' HB3' HG21 ' B' 1080 ' ' ILE . 83.4 mttt -60.46 -38.25 83.6 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 114.991 1.478 . . . . 48.68 114.991 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1105 ' ' LEU . . . . . 0.622 HD13 HG21 ' B' 1112 ' ' VAL . 31.3 mt -66.96 -36.82 83.07 Favored 'General case' 0 C--O 1.245 0.837 0 O-C-N 121.009 -1.057 . . . . 32.210000000000001 109.198 177.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1106 ' ' ALA . . . . . 0.501 ' HA ' ' HA2' ' B' 1364 ' ' GLY . . . -67.87 -28.24 67.36 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 108.871 -0.788 . . . . 33.729999999999997 108.871 177.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -68.44 -39.62 81.45 Favored 'General case' 0 CA--C 1.494 -1.197 0 O-C-N 119.412 -2.055 . . . . 51.469999999999999 110.207 175.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1108 ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -72.85 -4.05 29.38 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 115.026 1.491 . . . . 43.899999999999999 115.026 -178.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1109 ' ' ASN . . . . . 0.584 ' HA ' ' HA3' ' B' 1364 ' ' GLY . 9.9 m120 58.6 32.81 22.55 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 124.027 1.87 . . . . 44.82 113.436 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1110 ' ' VAL . . . . . 0.754 HG11 HD22 ' B' 1083 ' ' LEU . 33.6 m -93.14 166.27 1.8 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.662 0 CA-C-N 114.351 -1.295 . . . . 30.52 111.454 177.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1111 ' ' THR . . . . . 0.597 HG23 ' HA ' ' B' 1362 ' ' ARG . 87.2 m -109.65 103.26 12.09 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 105.532 -2.025 . . . . 27.120000000000001 105.532 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1112 ' ' VAL . . . . . 0.622 HG21 HD13 ' B' 1105 ' ' LEU . 40.7 t -99.36 129.11 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-O 122.418 1.104 . . . . 26.399999999999999 109.496 -174.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1113 ' ' MET . . . . . 0.572 ' SD ' HD11 ' B' 1338 ' ' LEU . 31.2 mtp -109.65 124.33 50.99 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.921 0.889 . . . . 42.920000000000002 110.128 171.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -102.51 106.18 16.85 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 119.716 1.144 . . . . 24.149999999999999 109.17 -174.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1115 ' ' MET . . . . . . . . . . . . . 80.2 mmm -71.29 -2.33 15.83 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 113.072 -1.876 . . . . 29.949999999999999 112.168 -169.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1116 ' ' ASP . . . . . 0.509 ' HA ' ' HB2' ' B' 1130 ' ' LEU . 7.5 p-10 -93.44 -52.07 4.68 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.745 1.218 . . . . 34.530000000000001 112.428 169.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1117 ' ' SER . . . . . . . . . . . . . 51.1 m -86.71 60.94 6.52 Favored 'General case' 0 C--N 1.343 0.298 0 O-C-N 120.401 -1.437 . . . . 33.490000000000002 111.118 -175.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1118 ' ' VAL . . . . . . . . . . . . . 17.9 t -95.62 146.56 31.54 Favored Pre-proline 0 C--O 1.245 0.868 0 N-CA-C 105.171 -2.159 . . . . 34.020000000000003 105.171 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -60.97 146.02 98.3 Favored 'Trans proline' 0 C--N 1.354 0.82 0 CA-C-N 124.661 2.7 . . . . 38.280000000000001 113.308 174.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1120 ' ' ARG . . . . . 0.518 HH12 ' CG ' ' B' 1128 ' ' ASP . 5.3 mmt180 -85.82 56.82 4.14 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 120.685 -1.259 . . . . 55.049999999999997 111.481 -167.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1121 ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' C' ' 131' ' ' ALA . 6.7 pt -132.26 164.28 35.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 CA-C-N 114.53 -1.213 . . . . 42.090000000000003 112.585 -176.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1122 ' ' SER . . . . . . . . . . . . . 8.9 m -48.75 -63.94 0.95 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 119.12 3.008 . . . . 38.020000000000003 119.12 -162.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1123 ' ' ARG . . . . . 0.465 ' HD2' HD21 ' B' 1337 ' ' LEU . 21.4 ptt-85 -70.53 -29.06 65.44 Favored 'General case' 0 C--N 1.354 0.804 1 O-C-N 116.114 -4.116 . . . . 34.289999999999999 110.924 -179.288 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B 1124 ' ' ALA . . . . . 0.72 ' HB2' HG22 ' B' 1354 ' ' VAL . . . -60.51 -40.62 92.08 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 113.282 -1.781 . . . . 32.350000000000001 108.151 176.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1125 ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -60.75 -24.67 65.91 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 115.744 1.757 . . . . 47.170000000000002 115.744 173.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1126 ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' 1160 ' ' ALA . 57.1 m -68.59 -36.66 79.01 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 119.05 -2.281 . . . . 31.710000000000001 114.667 165.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1127 ' ' LEU . . . . . 0.717 HD23 HD12 ' B' 1334 ' ' LEU . 6.9 mp -72.84 -30.15 63.79 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.181 -0.949 . . . . 37.0 111.472 172.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1128 ' ' ASP . . . . . 0.518 ' CG ' HH12 ' B' 1120 ' ' ARG . 37.9 t70 -64.54 101.02 0.41 Allowed 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 115.59 -0.732 . . . . 40.399999999999999 110.977 -169.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1129 ' ' ALA . . . . . . . . . . . . . . . -72.52 -21.42 61.18 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 118.411 -1.316 . . . . 26.559999999999999 110.506 174.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1130 ' ' LEU . . . . . 0.509 ' HB2' ' HA ' ' B' 1116 ' ' ASP . 7.8 tt -55.13 -26.37 37.98 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.378 1.251 . . . . 30.890000000000001 114.378 168.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1131 ' ' SER . . . . . . . . . . . . . 13.6 p -77.59 -51.91 9.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 122.68 1.228 . . . . 29.84 113.118 172.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1132 ' ' SER . . . . . 0.423 ' HB3' ' HB3' ' B' 1326 ' ' LEU . 16.6 m -58.23 -49.51 76.83 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.279 -1.513 . . . . 31.91 114.663 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1133 ' ' MET . . . . . 0.645 ' HB3' ' HB3' ' B' 1316 ' ' PRO . 38.1 mmt -68.74 -36.58 78.56 Favored 'General case' 0 CA--C 1.509 -0.598 0 O-C-N 120.776 -1.202 . . . . 25.899999999999999 110.765 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1134 ' ' ALA . . . . . 0.809 ' HB1' ' HB2' ' B' 1176 ' ' ALA . . . -55.62 -44.55 77.18 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 119.137 0.881 . . . . 26.620000000000001 113.289 164.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -58.03 -48.08 81.15 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 122.272 1.034 . . . . 36.969999999999999 112.096 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1136 ' ' ILE . . . . . . . . . . . . . 42.9 mm -52.3 -58.07 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-N 113.294 -1.775 . . . . 32.109999999999999 111.48 173.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -57.27 -30.36 64.62 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.888 1.069 . . . . 24.140000000000001 113.888 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -68.58 -49.28 44.96 Favored Glycine 0 N--CA 1.484 1.9 0 N-CA-C 110.202 -1.159 . . . . 25.129999999999999 110.202 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 55.3 t80 -63.72 -44.47 93.46 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 123.417 1.579 . . . . 32.729999999999997 112.748 173.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1140 ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -62.57 -33.94 75.96 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 114.041 -1.436 . . . . 26.359999999999999 110.914 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1141 ' ' ALA . . . . . . . . . . . . . . . -55.71 -49.38 73.16 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 123.232 0.613 . . . . 24.120000000000001 112.42 168.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 50.1 mm -58.78 -35.97 58.54 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 O-C-N 120.873 -1.142 . . . . 23.370000000000001 109.927 174.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 14.3 t -71.24 -46.19 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 O-C-N 119.555 -1.966 . . . . 24.960000000000001 111.837 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -72.0 -41.82 67.15 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 106.661 -1.607 . . . . 32.07 106.661 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1145 ' ' ALA . . . . . 0.693 ' HA ' HG11 ' B' 1280 ' ' VAL . . . -53.38 -45.86 69.42 Favored 'General case' 0 C--O 1.206 -1.209 0 O-C-N 121.318 -0.864 . . . . 24.870000000000001 111.655 170.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1146 ' ' ALA . . . . . . . . . . . . . . . -63.99 -39.08 93.32 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 123.016 0.527 . . . . 24.670000000000002 109.658 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 16.5 t60 -59.06 -34.33 71.82 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 119.746 -1.846 . . . . 28.579999999999998 109.177 172.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1148 ' ' GLU . . . . . 0.418 ' HB3' ' CD ' ' B' 1308 ' ' LYS . 44.0 mm-40 -93.93 -10.38 33.96 Favored 'General case' 0 C--O 1.25 1.088 0 O-C-N 120.118 -1.614 . . . . 36.82 113.8 178.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1149 ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -78.9 144.09 35.24 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-O 123.488 1.613 . . . . 31.969999999999999 109.257 -171.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1150 ' ' GLY . . . . . 0.706 ' HA2' ' HD2' ' A' 1320 ' ' PRO . . . -93.93 -19.64 33.38 Favored Glycine 0 C--O 1.242 0.644 0 CA-C-N 114.313 -1.312 . . . . 25.489999999999998 113.239 174.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1151 ' ' ARG . . . . . . . . . . . . . 81.1 mtm-85 -112.65 166.75 11.06 Favored 'General case' 0 C--O 1.242 0.709 0 O-C-N 121.537 -0.978 . . . . 59.840000000000003 111.067 -169.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1152 ' ' PHE . . . . . 0.717 ' HB2' HG11 ' B' 1163 ' ' VAL . 3.3 m-30 -78.85 156.81 28.52 Favored 'General case' 0 C--O 1.239 0.543 0 O-C-N 119.803 -1.811 . . . . 34.450000000000003 108.647 174.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1153 ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -84.59 -43.74 14.17 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 123.837 1.78 . . . . 31.170000000000002 108.655 166.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1154 ' ' THR . . . . . . . . . . . . . 48.2 m -68.01 128.17 35.56 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 112.934 -1.939 . . . . 33.890000000000001 111.367 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -75.94 65.47 2.58 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 109.161 -1.576 . . . . 38.950000000000003 109.161 174.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1156 ' ' GLN . . . . . 0.463 ' H ' ' HB ' ' B' 1163 ' ' VAL . 15.4 tt0 -85.17 121.37 27.83 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 119.461 1.631 . . . . 54.229999999999997 109.476 -160.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 29.8 mm -70.82 95.09 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.883 0 O-C-N 119.906 -1.746 . . . . 51.159999999999997 106.406 173.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1158 ' ' THR . . . . . . . . . . . . . 1.7 m -109.22 138.8 45.02 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 107.783 -1.191 . . . . 49.609999999999999 107.783 -175.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -56.62 -30.57 63.42 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 121.034 1.743 . . . . 49.049999999999997 115.51 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -52.34 -53.09 48.94 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.245 0.545 . . . . 47.649999999999999 111.127 167.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . -179.02 156.14 17.86 Favored Glycine 0 C--O 1.215 -1.062 0 N-CA-C 108.071 -2.012 . . . . 45.609999999999999 108.071 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 79.9 mttt -76.91 128.15 34.03 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 120.197 1.998 . . . . 57.460000000000001 111.966 177.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1163 ' ' VAL . . . . . 0.717 HG11 ' HB2' ' B' 1152 ' ' PHE . 23.3 t -80.18 129.6 69.18 Favored Pre-proline 0 CA--C 1.514 -0.425 0 CA-C-N 118.923 0.783 . . . . 42.93 110.08 177.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1164 ' ' PRO . . . . . 0.435 ' O ' HG12 ' B' 1163 ' ' VAL . 58.4 Cg_endo -66.74 142.67 64.51 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.618 2.212 . . . . 39.289999999999999 110.667 164.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1165 ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -59.85 153.77 54.56 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 C-N-CA 122.898 2.399 . . . . 34.170000000000002 114.943 170.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -83.25 159.85 21.87 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 113.088 -1.869 . . . . 31.690000000000001 108.383 168.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1167 ' ' LYS . . . . . 0.8 ' HB2' ' HA ' ' B' 1249 ' ' VAL . 67.2 mttt -123.56 118.04 26.45 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 105.466 -2.05 . . . . 44.780000000000001 105.466 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1168 ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' B' 1251 ' ' ILE . 60.3 t -104.31 104.83 17.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 O-C-N 121.827 -0.546 . . . . 31.23 111.122 -174.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1169 ' ' MET . . . . . 0.676 ' HB2' HG11 ' B' 1249 ' ' VAL . 42.7 ttp -82.82 98.11 8.97 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.088 -0.708 . . . . 37.090000000000003 109.088 -178.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 53.1 t -89.74 119.35 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 N-CA-C 109.029 -0.73 . . . . 30.170000000000002 109.029 -177.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1171 ' ' ILE . . . . . . . . . . . . . 9.7 mt -113.52 132.76 61.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 CA-C-N 120.307 1.412 . . . . 33.740000000000002 107.578 -175.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 69.56 63.86 3.2 Favored Glycine 0 CA--C 1.502 -0.72 0 N-CA-C 110.046 -1.221 . . . . 32.590000000000003 110.046 -176.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1173 ' ' ALA . . . . . 0.539 ' HA ' ' HA3' ' B' 1177 ' ' GLY . . . -79.89 75.6 6.6 Favored 'General case' 0 C--O 1.252 1.233 0 CA-C-O 124.17 1.938 . . . . 32.420000000000002 114.018 -174.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -86.52 -165.3 40.86 Favored Glycine 0 C--O 1.216 -0.982 0 N-CA-C 107.367 -2.293 . . . . 31.739999999999998 107.367 166.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 46.1 t -48.54 -38.14 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 122.11 2.955 . . . . 31.48 114.279 -176.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1176 ' ' ALA . . . . . 0.809 ' HB2' ' HB1' ' B' 1134 ' ' ALA . . . -58.06 -51.67 68.73 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 113.462 -1.699 . . . . 26.120000000000001 114.063 171.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1177 ' ' GLY . . . . . 0.539 ' HA3' ' HA ' ' B' 1173 ' ' ALA . . . -60.46 -48.61 85.35 Favored Glycine 0 CA--C 1.49 -1.473 0 N-CA-C 111.321 -0.712 . . . . 25.73 111.321 176.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1178 ' ' LEU . . . . . 0.669 HD22 ' HG ' ' C' ' 75' ' ' LEU . 91.5 mt -53.75 -38.26 64.2 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 114.899 1.444 . . . . 32.590000000000003 114.899 174.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -70.67 -38.68 73.8 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 119.298 0.953 . . . . 27.719999999999999 111.734 175.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -60.9 -46.7 89.59 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 114.602 1.334 . . . . 26.030000000000001 114.602 175.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1181 ' ' ILE . . . . . 0.779 HG12 HG11 ' B' 1191 ' ' VAL . 79.0 mt -58.32 -48.04 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 123.707 0.803 . . . . 28.609999999999999 109.095 173.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1182 ' ' GLY . . . . . 0.413 ' HA2' ' HE1' ' B' 1207 ' ' MET . . . -51.09 -53.11 28.61 Favored Glycine 0 C--N 1.373 2.611 0 CA-C-N 114.827 -1.079 . . . . 25.23 110.721 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -63.26 -50.78 68.83 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 114.419 1.266 . . . . 24.09 114.419 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -69.42 -42.81 74.52 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 121.195 -0.94 . . . . 26.68 112.579 -172.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -57.49 -47.11 82.78 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 115.713 -0.676 . . . . 36.57 111.271 174.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1186 ' ' SER . . . . . 0.492 ' HB3' ' O ' ' A' 1186 ' ' SER . 75.4 m -58.81 -39.87 82.44 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-O 121.81 0.814 . . . . 28.920000000000002 112.338 177.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1187 ' ' LEU . . . . . . . . . . . . . 66.1 mt -61.78 -35.13 77.26 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 121.041 -1.037 . . . . 29.09 112.997 172.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 120.3 -7.07 11.65 Favored Glycine 0 CA--C 1.539 1.591 0 N-CA-C 111.113 -0.795 . . . . 29.260000000000002 111.113 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1189 ' ' ALA . . . . . . . . . . . . . . . -68.46 121.7 16.89 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 121.666 0.746 . . . . 30.16 112.272 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 37.2 mt -67.31 112.07 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-O 123.594 1.664 . . . . 35.810000000000002 109.718 -172.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1191 ' ' VAL . . . . . 0.779 HG11 HG12 ' B' 1181 ' ' ILE . 93.2 t -82.46 128.75 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 107.706 -1.22 . . . . 31.969999999999999 107.706 -177.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1192 ' ' ARG . . . . . 0.492 ' O ' ' HA ' ' B' 1169 ' ' MET . 22.9 mmt85 -118.89 90.39 3.32 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 102.903 -2.999 . . . . 48.159999999999997 102.903 174.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1193 ' ' ALA . . . . . 0.65 ' HB3' HG21 ' B' 1204 ' ' VAL . . . -103.07 159.69 15.3 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 120.712 -1.242 . . . . 35.890000000000001 114.281 -172.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 35.2 t80 -150.13 152.41 34.68 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 123.041 1.4 . . . . 41.880000000000003 107.224 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1195 ' ' ASP . . . . . 0.445 ' HB3' HG11 ' B' 1200 ' ' VAL . 10.0 t0 -158.55 155.61 28.68 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 103.666 -2.716 . . . . 38.280000000000001 103.666 168.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1196 ' ' THR . . . . . 0.433 HG23 ' HB2' ' B' 1230 ' ' MET . 43.0 m -59.23 -24.15 62.92 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 124.956 1.302 . . . . 40.619999999999997 110.53 172.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1197 ' ' ARG . . . . . 0.429 HH11 ' HD2' ' B' 1197 ' ' ARG . 33.1 mtm105 -91.97 144.33 29.06 Favored Pre-proline 0 C--O 1.249 1.066 0 O-C-N 119.925 -1.735 . . . . 53.090000000000003 111.026 -174.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -71.95 -42.58 1.53 Allowed 'Trans proline' 0 CA--C 1.548 1.188 1 C-N-CA 125.637 4.225 . . . . 42.560000000000002 117.418 -174.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -29.4 70.55 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 121.269 1.85 . . . . 56.310000000000002 114.462 -168.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1200 ' ' VAL . . . . . 0.504 ' O ' HG23 ' B' 1204 ' ' VAL . 10.8 p -58.56 -28.65 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 115.133 -0.94 . . . . 42.909999999999997 112.596 177.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 35.1 tttm -45.05 -58.66 3.04 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 124.581 1.153 . . . . 48.890000000000001 113.535 168.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 16.0 mp0 -63.39 -28.37 69.94 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 114.265 1.209 . . . . 51.700000000000003 114.265 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1203 ' ' GLN . . . . . 0.816 ' HG2' ' HG3' ' C' ' 74' ' ' ARG . 51.4 mt-30 -66.13 -46.63 76.83 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.586 -0.734 . . . . 52.57 109.442 176.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1204 ' ' VAL . . . . . 0.65 HG21 ' HB3' ' B' 1193 ' ' ALA . 40.0 t -72.69 -40.67 62.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.255 -1.017 . . . . 33.789999999999999 108.255 -173.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -60.98 -29.36 69.62 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 113.57 0.952 . . . . 36.579999999999998 113.57 176.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1206 ' ' SER . . . . . . . . . . . . . 44.7 m -68.67 -10.85 58.71 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 120.254 -1.529 . . . . 39.609999999999999 114.246 174.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1207 ' ' MET . . . . . 0.413 ' HE1' ' HA2' ' B' 1182 ' ' GLY . 46.1 mmm -97.22 5.21 50.47 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.587 0.708 . . . . 37.450000000000003 109.579 174.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 60.5 32.28 77.34 Favored Glycine 0 N--CA 1.471 0.984 0 O-C-N 120.133 -1.604 . . . . 31.870000000000001 111.829 -165.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1209 ' ' ALA . . . . . 0.502 ' HB1' ' HB ' ' B' 1191 ' ' VAL . . . -119.6 163.23 17.66 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 105.328 -2.101 . . . . 35.399999999999999 105.328 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1210 ' ' GLU . . . . . 0.478 ' HB3' ' HD3' ' B' 1192 ' ' ARG . 36.0 tt0 -108.62 137.23 46.9 Favored 'General case' 0 C--N 1.313 -1.014 0 O-C-N 119.859 -1.776 . . . . 47.890000000000001 111.999 -166.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 75.7 t80 -84.97 141.39 30.38 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 106.416 -1.698 . . . . 45.530000000000001 106.416 172.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1212 ' ' LEU . . . . . 0.549 ' HB3' HD21 ' B' 1241 ' ' LEU . 73.8 mt -73.74 99.64 3.2 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 125.11 2.386 . . . . 46.329999999999998 116.641 -176.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -77.08 122.75 25.4 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 112.101 -2.318 . . . . 60.409999999999997 108.147 172.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1214 ' ' LEU . . . . . 0.798 ' HG ' HD22 ' B' 1241 ' ' LEU . 1.0 OUTLIER -99.03 176.38 5.59 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 104.5 -2.407 . . . . 57.380000000000003 104.5 -178.173 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 14.0 t70 . . . . . 0 CA--C 1.499 -0.994 0 CA-C-O 117.665 -1.159 . . . . 65.069999999999993 108.613 177.149 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B 1230 ' ' MET . . . . . 0.433 ' HB2' HG23 ' B' 1196 ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.429 -1.48 0 N-CA-C 104.147 -2.538 . . . . 80.319999999999993 104.147 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1231 ' ' SER . . . . . 0.414 ' HB2' ' HA ' ' B' 1230 ' ' MET . 1.6 m 78.26 156.71 0.17 Allowed 'General case' 0 C--O 1.251 1.174 2 CA-C-N 127.914 4.87 . . . . 79.920000000000002 119.591 -8.597 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -88.7 -157.62 0.44 Allowed 'General case' 0 C--O 1.248 0.991 0 CA-C-N 112.584 -2.098 . . . . 77.909999999999997 111.872 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 66.38 -68.2 0.14 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 121.383 1.902 . . . . 73.879999999999995 111.036 -170.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 11.4 t80 -55.81 -33.18 64.2 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.75 1.22 . . . . 68.980000000000004 110.802 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1235 ' ' ILE . . . . . 0.595 ' O ' ' HG2' ' B' 1239 ' ' MET . 32.6 pt -42.94 -39.24 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 114.858 1.429 . . . . 64.530000000000001 114.858 170.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1236 ' ' LYS . . . . . 0.45 ' HA ' ' HD2' ' B' 1236 ' ' LYS . 28.6 mmmt -58.95 -45.81 89.54 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 121.306 1.866 . . . . 66.359999999999999 111.306 176.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -67.01 -30.54 70.67 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 114.609 1.337 . . . . 56.600000000000001 114.609 170.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.9 -46.4 85.02 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 120.302 1.41 . . . . 56.789999999999999 108.643 171.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1239 ' ' MET . . . . . 0.595 ' HG2' ' O ' ' B' 1235 ' ' ILE . 31.0 mmt -67.79 -36.53 80.6 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 120.848 -1.157 . . . . 53.630000000000003 108.711 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -70.11 -39.63 75.37 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 119.52 -0.872 . . . . 51.740000000000002 109.347 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1241 ' ' LEU . . . . . 0.798 HD22 ' HG ' ' B' 1214 ' ' LEU . 17.4 tp -53.14 -53.59 48.25 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-O 118.17 -0.919 . . . . 44.859999999999999 110.116 170.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -64.27 -40.57 96.24 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 112.509 0.559 . . . . 42.780000000000001 112.509 -177.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -61.02 -49.41 77.54 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 124.522 1.129 . . . . 40.960000000000001 108.138 -178.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -59.35 -43.84 92.76 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.608 1.549 . . . . 43.060000000000002 112.215 175.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1245 ' ' GLN . . . . . 0.472 ' O ' HG22 ' B' 1249 ' ' VAL . 46.5 mm-40 -62.01 -28.39 69.54 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.127 -1.397 . . . . 46.450000000000003 114.392 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -57.27 -27.44 62.11 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 123.263 1.506 . . . . 41.780000000000001 112.171 -174.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 10.5 tptt -77.98 -41.93 34.4 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 114.094 -1.412 . . . . 52.200000000000003 110.901 175.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1248 ' ' GLU . . . . . 0.436 ' CD ' HH12 ' B' 1192 ' ' ARG . 26.0 mt-10 -70.26 -41.45 73.46 Favored 'General case' 0 C--O 1.244 0.813 0 O-C-N 120.604 -1.31 . . . . 53.549999999999997 111.952 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1249 ' ' VAL . . . . . 0.8 ' HA ' ' HB2' ' B' 1167 ' ' LYS 0.259 32.8 m -84.88 164.3 2.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 124.336 2.017 . . . . 34.409999999999997 113.504 -166.203 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B 1250 ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' B' 1279 ' ' SER . 2.6 m-20 -122.63 -50.07 1.98 Allowed 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 113.663 -1.608 . . . . 33.380000000000003 107.602 -176.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1251 ' ' ILE . . . . . 0.514 HD12 ' HB1' ' B' 1145 ' ' ALA . 24.5 mm -119.94 114.98 45.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 108.035 -1.098 . . . . 29.539999999999999 108.035 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1252 ' ' ILE . . . . . . . . . . . . . 82.3 mt -91.62 119.79 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 N-CA-C 104.477 -2.416 . . . . 32.439999999999998 104.477 169.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1253 ' ' VAL . . . . . 0.617 HG12 HG23 ' B' 1255 ' ' THR . 55.9 t -112.81 100.91 11.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 104.665 -2.346 . . . . 30.57 104.665 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1254 ' ' THR . . . . . . . . . . . . . 7.4 t -103.08 98.6 8.51 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 125.982 2.801 . . . . 35.039999999999999 108.894 -175.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1255 ' ' THR . . . . . 0.617 HG23 HG12 ' B' 1253 ' ' VAL . 3.2 p -84.74 8.7 16.2 Favored 'General case' 0 N--CA 1.421 -1.888 1 CA-C-N 107.26 -4.518 . . . . 34.619999999999997 117.662 -176.618 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . -72.98 92.06 1.61 Allowed 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 114.115 1.154 . . . . 42.719999999999999 114.115 -174.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 13.7 mt -109.0 101.34 10.43 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 102.936 -2.987 . . . . 52.43 102.936 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 2.3 mp -93.99 128.87 39.58 Favored Pre-proline 0 N--CA 1.481 1.123 0 C-N-CA 118.962 -1.095 . . . . 59.409999999999997 110.014 -177.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -58.68 126.43 21.23 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.779 2.32 . . . . 62.68 107.831 170.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 81.8 -75.24 2.35 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 117.033 -1.982 . . . . 64.159999999999997 108.46 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 91.5 mttt -58.13 149.73 55.44 Favored Pre-proline 0 C--O 1.242 0.676 0 CA-C-N 121.838 2.819 . . . . 68.530000000000001 115.715 -174.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.76 118.49 3.47 Favored 'Trans proline' 0 C--O 1.246 0.9 0 C-N-CA 123.544 2.829 . . . . 61.990000000000002 113.178 167.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1263 ' ' ALA . . . . . 0.501 ' HB1' ' ND2' ' B' 1291 ' ' ASN . . . -35.78 122.95 0.68 Allowed Pre-proline 0 C--O 1.245 0.831 0 C-N-CA 124.858 1.263 . . . . 57.149999999999999 111.052 164.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1264 ' ' PRO . . . . . 0.574 ' O ' ' HA ' ' B' 1291 ' ' ASN . 97.1 Cg_endo -77.13 158.6 33.85 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.292 1.995 . . . . 51.57 111.633 -172.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1265 ' ' LYS . . . . . 0.438 ' NZ ' ' O ' ' B' 1289 ' ' GLY . 46.6 mmtm -78.76 76.09 5.26 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 125.566 2.603 . . . . 54.549999999999997 110.751 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 40.3 mt -67.27 -52.99 34.03 Favored 'General case' 0 N--CA 1.438 -1.069 0 O-C-N 118.317 -2.739 . . . . 46.859999999999999 111.615 -177.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1267 ' ' ILE . . . . . 0.537 HG21 HD13 ' B' 1281 ' ' ILE . 38.0 mm -89.15 99.19 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 107.13 -1.433 . . . . 41.039999999999999 107.13 -176.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1268 ' ' THR . . . . . 0.691 ' HA ' ' HG3' ' B' 1293 ' ' GLU . 7.8 p -73.64 156.82 37.61 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 111.057 -2.792 . . . . 39.579999999999998 113.301 -175.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1269 ' ' ARG . . . . . 0.416 ' HG3' ' HB3' ' B' 1293 ' ' GLU . 78.3 mtt85 -55.81 -41.08 73.65 Favored 'General case' 0 C--O 1.206 -1.21 0 N-CA-C 113.371 0.878 . . . . 53.149999999999999 113.371 -175.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -59.38 -46.52 88.46 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 124.64 1.212 . . . . 42.960000000000001 110.481 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1271 ' ' MET . . . . . . . . . . . . . 48.6 ttm -58.48 -48.08 81.96 Favored 'General case' 0 C--O 1.242 0.66 0 O-C-N 124.096 0.873 . . . . 43.890000000000001 110.252 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1272 ' ' VAL . . . . . 0.413 HG23 ' O ' ' B' 1268 ' ' THR . 33.2 t -57.2 -50.26 77.16 Favored 'Isoleucine or valine' 0 C--O 1.257 1.45 0 O-C-N 125.637 1.836 . . . . 38.369999999999997 111.521 176.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.83 -29.59 67.03 Favored 'General case' 0 C--N 1.357 0.919 0 N-CA-C 115.364 1.616 . . . . 47.460000000000001 115.364 176.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1274 ' ' SER . . . . . . . . . . . . . 50.4 m -84.49 -7.35 59.3 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 126.022 1.729 . . . . 38.380000000000003 114.5 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1275 ' ' MET . . . . . 0.563 ' HB2' HG21 ' B' 1307 ' ' VAL . 49.5 mtp -66.5 164.77 15.79 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 113.576 0.954 . . . . 37.810000000000002 113.576 -175.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -55.85 137.1 50.87 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 124.645 1.178 . . . . 49.259999999999998 108.506 169.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1277 ' ' ALA . . . . . 0.695 ' HB3' ' HD1' ' A' 1045 ' ' PHE . . . -67.96 140.99 56.43 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 121.55 -0.719 . . . . 34.460000000000001 111.136 -177.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 72.93 55.15 6.58 Favored Glycine 0 N--CA 1.434 -1.495 0 CA-C-O 122.669 1.149 . . . . 33.530000000000001 113.824 175.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1279 ' ' SER . . . . . 0.555 ' O ' ' HA ' ' B' 1307 ' ' VAL . 70.9 m -141.37 160.87 39.23 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 107.7 -1.222 . . . . 31.309999999999999 107.7 -167.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1280 ' ' VAL . . . . . 0.693 HG11 ' HA ' ' B' 1145 ' ' ALA . 69.0 t -123.53 141.57 43.32 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 CA-C-N 120.039 1.29 . . . . 29.32 109.547 -169.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1281 ' ' ILE . . . . . 0.537 HD13 HG21 ' B' 1267 ' ' ILE . 74.8 mt -118.2 98.95 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 105.367 -2.086 . . . . 31.93 105.367 170.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1282 ' ' VAL . . . . . . . . . . . . . 5.3 t -86.85 109.84 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 106.77 -1.567 . . . . 29.48 106.77 174.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 58.4 t0 -93.64 111.76 23.5 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 103.236 -2.876 . . . . 34.5 103.236 171.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1284 ' ' LEU . . . . . 0.438 HD22 ' HA ' ' B' 1255 ' ' THR . 7.2 mp -74.15 -40.44 62.59 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 113.686 -1.597 . . . . 37.939999999999998 106.718 172.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -76.03 11.52 1.43 Allowed 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 120.285 -1.509 . . . . 40.920000000000002 114.898 -160.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -47.73 -45.05 28.42 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 118.486 2.773 . . . . 44.390000000000001 118.486 176.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1287 ' ' GLN . . . . . 0.838 ' HB3' HG23 ' B' 1313 ' ' THR . 0.0 OUTLIER -66.87 -28.94 68.74 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 122.588 1.185 . . . . 51.460000000000001 112.196 172.623 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -82.57 -33.9 27.91 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 114.671 1.36 . . . . 57.75 114.671 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1289 ' ' GLY . . . . . 0.438 ' O ' ' NZ ' ' B' 1265 ' ' LYS . . . 164.65 -21.95 0.14 Allowed Glycine 0 CA--C 1.536 1.4 0 C-N-CA 120.138 -1.029 . . . . 49.850000000000001 113.258 -172.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 80.48 112.01 0.29 Allowed Glycine 0 N--CA 1.464 0.535 0 CA-C-O 118.25 -1.305 . . . . 45.93 112.844 175.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1291 ' ' ASN . . . . . 0.574 ' HA ' ' O ' ' B' 1264 ' ' PRO . 29.2 m120 -89.93 -15.28 32.37 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 119.152 1.476 . . . . 42.670000000000002 114.711 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1292 ' ' CYS . . . . . . . . . . . . . 48.5 t -105.88 144.06 33.13 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.287 0.847 . . . . 38.82 113.287 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1293 ' ' GLU . . . . . 0.691 ' HG3' ' HA ' ' B' 1268 ' ' THR . 6.8 mt-10 -69.5 -16.38 63.44 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 119.189 3.033 . . . . 46.710000000000001 119.189 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1294 ' ' TYR . . . . . 0.43 ' HB2' HG21 ' B' 1309 ' ' VAL . 58.5 m-85 -107.39 0.36 22.91 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 120.211 -1.555 . . . . 47.229999999999997 113.023 -178.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1295 ' ' THR . . . . . 0.712 HG23 ' HA3' ' B' 1311 ' ' GLY . 91.2 m -53.79 115.58 2.07 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 116.148 1.907 . . . . 36.020000000000003 116.148 -178.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1296 ' ' VAL . . . . . 0.466 ' HB ' ' HB3' ' B' 1299 ' ' GLU . 46.5 t -97.13 121.03 60.08 Favored Pre-proline 0 N--CA 1.435 -1.199 0 N-CA-C 102.551 -3.129 . . . . 37.259999999999998 102.551 169.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -51.59 114.29 1.51 Allowed 'Trans proline' 0 C--O 1.238 0.475 0 C-N-CA 124.827 3.684 . . . . 35.090000000000003 116.612 -177.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1298 ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' B' 1312 ' ' TYR . . . 66.18 42.56 94.25 Favored Glycine 0 C--O 1.245 0.793 0 CA-C-O 116.342 -2.365 . . . . 35.969999999999999 114.016 -173.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1299 ' ' GLU . . . . . 0.466 ' HB3' ' HB ' ' B' 1296 ' ' VAL . 18.2 tt0 -151.87 175.48 12.43 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 118.484 1.142 . . . . 40.390000000000001 111.17 175.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1300 ' ' ILE . . . . . 0.485 HG12 HG12 ' B' 1310 ' ' ILE . 58.6 mt -110.19 133.49 55.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 107.536 -1.283 . . . . 37.43 107.536 170.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 69.3 t80 -107.8 124.78 50.57 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.509 -0.876 . . . . 44.130000000000003 110.347 163.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1302 ' ' THR . . . . . . . . . . . . . 96.0 m -92.84 126.79 38.09 Favored 'General case' 0 C--O 1.248 0.985 0 O-C-N 120.238 -1.539 . . . . 39.780000000000001 107.95 176.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1303 ' ' THR . . . . . . . . . . . . . 67.5 p -82.56 175.08 10.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 120.851 1.66 . . . . 43.289999999999999 113.249 166.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -69.81 -30.6 68.16 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 122.222 1.01 . . . . 53.07 109.882 -174.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -82.98 14.45 3.31 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 114.5 1.296 . . . . 43.969999999999999 114.5 173.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 70.31 32.23 68.59 Favored Glycine 0 C--O 1.211 -1.339 0 O-C-N 120.569 -1.332 . . . . 41.119999999999997 110.909 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1307 ' ' VAL . . . . . 0.563 HG21 ' HB2' ' B' 1275 ' ' MET . 73.6 t -98.67 109.45 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 105.075 -2.194 . . . . 38.119999999999997 105.075 173.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1308 ' ' LYS . . . . . 0.418 ' CD ' ' HB3' ' B' 1148 ' ' GLU . 78.5 mttt -86.44 98.04 10.8 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 113.321 -1.763 . . . . 36.340000000000003 107.562 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1309 ' ' VAL . . . . . 0.43 HG21 ' HB2' ' B' 1294 ' ' TYR . 44.4 t -71.34 90.96 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 CA-C-N 114.608 -1.178 . . . . 30.399999999999999 108.93 172.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1310 ' ' ILE . . . . . 0.485 HG12 HG12 ' B' 1300 ' ' ILE . 37.0 mt -83.46 101.96 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 O-C-N 120.564 -1.335 . . . . 30.82 110.225 176.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1311 ' ' GLY . . . . . 0.712 ' HA3' HG23 ' B' 1295 ' ' THR . . . -99.5 63.38 0.7 Allowed Glycine 0 CA--C 1.499 -0.936 0 CA-C-N 114.137 -1.392 . . . . 26.530000000000001 111.317 178.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1312 ' ' TYR . . . . . 0.519 ' HB2' ' HG ' ' B' 1315 ' ' LEU . 8.4 m-30 -82.08 100.44 9.77 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 119.635 -2.097 . . . . 38.0 113.995 -175.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1313 ' ' THR . . . . . 0.838 HG23 ' HB3' ' B' 1287 ' ' GLN . 98.3 m -51.42 -38.0 51.39 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 114.082 -1.417 . . . . 29.800000000000001 109.733 168.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -95.59 14.86 21.52 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.965 2.106 . . . . 39.039999999999999 112.576 -166.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1315 ' ' LEU . . . . . 0.519 ' HG ' ' HB2' ' B' 1312 ' ' TYR . 41.9 mt -50.58 -50.36 72.84 Favored Pre-proline 0 C--O 1.21 -1.019 0 CA-C-O 113.274 -3.25 . . . . 31.079999999999998 116.425 176.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1316 ' ' PRO . . . . . 0.645 ' HB3' ' HB3' ' B' 1133 ' ' MET . 68.2 Cg_exo -51.73 -34.69 55.14 Favored 'Trans proline' 0 CA--C 1.536 0.581 1 C-N-CA 125.955 4.437 . . . . 26.100000000000001 113.646 174.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B 1317 ' ' GLY . . . . . 0.676 ' HA2' ' HG3' ' B' 1015 ' ' ARG . . . -66.16 -48.47 64.57 Favored Glycine 0 C--N 1.344 0.98 0 O-C-N 120.378 -1.451 . . . . 23.170000000000002 113.228 176.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1318 ' ' ARG . . . . . 0.424 ' HD2' HD23 ' B' 1315 ' ' LEU . 75.6 mtt-85 -50.34 -0.55 0.01 OUTLIER 'General case' 0 C--O 1.237 0.405 1 N-CA-C 124.683 5.068 . . . . 40.399999999999999 124.683 -169.733 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 13.5 tp -126.92 72.67 75.95 Favored Pre-proline 0 C--O 1.245 0.843 0 N-CA-C 104.872 -2.27 . . . . 23.600000000000001 104.872 176.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1320 ' ' PRO . . . . . 0.653 ' HG2' ' HA2' ' A' 1150 ' ' GLY . 95.7 Cg_endo -43.49 -72.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 124.882 3.721 . . . . 22.350000000000001 119.847 -160.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1321 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.9 -37.66 66.61 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 113.349 0.87 . . . . 26.52 113.349 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1322 ' ' GLN . . . . . 0.866 ' HB2' ' HA ' ' A' 1151 ' ' ARG . 55.5 tp60 -74.23 -41.96 60.5 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 118.653 -1.219 . . . . 24.379999999999999 110.066 -173.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1323 ' ' SER . . . . . 0.445 ' HB2' ' HG2' ' B' 1015 ' ' ARG . 14.8 m -59.43 -40.81 87.93 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.601 -0.84 . . . . 22.800000000000001 112.284 170.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1324 ' ' SER . . . . . . . . . . . . . 13.7 m -64.22 -25.04 67.89 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 115.481 1.66 . . . . 21.25 115.481 170.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1325 ' ' GLN . . . . . 0.567 HE22 ' HD2' ' B' 1021 ' ' LYS . 67.5 tp60 -74.05 -50.17 20.88 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.767 -0.583 . . . . 31.34 109.551 175.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1326 ' ' LEU . . . . . 0.423 ' HB3' ' HB3' ' B' 1132 ' ' SER . 13.7 mt -72.33 -51.84 18.85 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 108.125 -1.065 . . . . 31.559999999999999 108.125 -174.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1327 ' ' TYR . . . . . 0.439 ' O ' ' HG ' ' B' 1331 ' ' LEU . 18.7 t80 -51.19 -46.63 62.22 Favored 'General case' 0 C--N 1.377 1.774 0 O-C-N 118.984 -2.322 . . . . 22.73 111.613 172.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1328 ' ' GLY . . . . . 0.461 ' O ' HG23 ' B' 1332 ' ' VAL . . . -51.16 -52.91 29.69 Favored Glycine 0 C--O 1.244 0.763 0 CA-C-O 123.654 1.697 . . . . 21.91 112.115 175.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1329 ' ' THR . . . . . . . . . . . . . 20.1 m -65.69 -36.41 83.56 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.099 -1.074 . . . . 22.149999999999999 108.099 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1330 ' ' ASN . . . . . . . . . . . . . 23.7 m120 -60.56 -47.72 84.92 Favored 'General case' 0 N--CA 1.437 -1.082 0 O-C-N 118.673 -2.517 . . . . 26.18 110.275 178.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1331 ' ' LEU . . . . . 0.681 HD22 HD22 ' B' 1070 ' ' LEU . 20.1 mt -57.61 -42.57 83.52 Favored 'General case' 0 N--CA 1.435 -1.179 0 O-C-N 125.853 1.97 . . . . 23.68 111.842 172.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1332 ' ' VAL . . . . . 0.598 HG12 ' HE3' ' B' 1336 ' ' LYS . 97.9 t -59.56 -44.91 94.2 Favored 'Isoleucine or valine' 0 C--N 1.349 0.552 0 CA-C-O 121.436 0.636 . . . . 26.57 110.581 178.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1333 ' ' ASN . . . . . 0.622 ' HA ' ' HD2' ' B' 1336 ' ' LYS . 82.4 m-20 -62.67 -45.72 91.5 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.953 0.901 . . . . 28.079999999999998 110.109 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1334 ' ' LEU . . . . . 0.717 HD12 HD23 ' B' 1127 ' ' LEU . 4.3 tp -52.0 -52.17 52.43 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 124.733 1.27 . . . . 27.43 109.616 174.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1335 ' ' LEU . . . . . 0.749 HD23 HD12 ' B' 1338 ' ' LEU . 75.3 mt -72.7 -19.29 61.43 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 114.234 -1.348 . . . . 30.5 113.356 -178.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1336 ' ' LYS . . . . . 0.622 ' HD2' ' HA ' ' B' 1333 ' ' ASN . 88.5 mttt -65.63 -48.17 73.11 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-N 122.9 2.591 . . . . 41.649999999999999 107.526 169.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1337 ' ' LEU . . . . . 0.465 HD21 ' HD2' ' B' 1123 ' ' ARG . 10.6 mp -75.1 -30.55 60.93 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.362 0.665 . . . . 42.079999999999998 110.663 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1338 ' ' LEU . . . . . 0.749 HD12 HD23 ' B' 1335 ' ' LEU . 79.0 mt -71.11 -51.53 24.55 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 119.697 -1.877 . . . . 35.030000000000001 111.052 172.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 49.8 t -96.5 71.67 2.7 Favored 'General case' 0 C--O 1.254 1.298 0 CA-C-O 124.849 2.261 . . . . 37.329999999999998 107.462 -173.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 12.8 mttp -54.35 -39.08 66.78 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 111.827 -2.442 . . . . 50.509999999999998 112.472 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -98.93 20.06 13.9 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 112.998 0.74 . . . . 54.210000000000001 112.998 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 97.1 mttt 42.6 38.35 1.26 Allowed 'General case' 0 C--O 1.248 0.974 0 C-N-CA 127.758 2.423 . . . . 50.990000000000002 117.081 159.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -111.76 -2.95 15.12 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 112.456 -2.156 . . . . 48.82 109.808 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 89.08 26.1 27.19 Favored Glycine 0 C--O 1.214 -1.1 0 CA-C-O 116.849 -2.084 . . . . 40.43 111.711 -171.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -116.78 122.76 45.37 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-N 122.277 3.038 . . . . 47.560000000000002 113.013 174.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1346 ' ' ILE . . . . . . . . . . . . . 37.6 mm -68.28 113.18 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 124.265 1.026 . . . . 42.490000000000002 111.343 -174.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1347 ' ' THR . . . . . . . . . . . . . 11.2 m -106.13 106.28 16.72 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 104.84 -2.281 . . . . 38.119999999999997 104.84 170.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 98.9 t -81.04 100.97 5.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 106.573 -1.64 . . . . 37.5 106.573 -174.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 61.0 t0 -72.91 113.2 9.67 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.712 -1.131 . . . . 43.850000000000001 111.544 -174.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1350 ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.32 -6.54 25.7 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.567 -1.333 . . . . 39.810000000000002 110.909 176.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -76.51 -29.31 56.75 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.809 -0.632 . . . . 51.289999999999999 110.827 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 42.6 t0 -88.04 127.47 35.4 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 104.147 -2.538 . . . . 39.780000000000001 104.147 -176.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 15.5 m -63.44 -27.26 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 123.766 0.826 . . . . 39.280000000000001 111.519 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1354 ' ' VAL . . . . . 0.72 HG22 ' HB2' ' B' 1124 ' ' ALA . 50.6 t -65.16 -56.01 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.796 0.838 . . . . 35.700000000000003 112.931 175.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1355 ' ' ILE . . . . . 0.406 ' HA ' HG12 ' B' 1358 ' ' VAL . 27.5 mm -68.86 -45.62 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-O 117.284 -1.341 . . . . 35.770000000000003 109.263 178.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 52.3 tpt85 -49.1 -32.1 9.23 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 120.158 1.344 . . . . 38.549999999999997 114.577 172.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1357 ' ' GLY . . . . . 0.538 ' HA2' ' HB2' ' B' 1370 ' ' ALA . . . -76.14 -61.33 2.86 Favored Glycine 0 CA--C 1.492 -1.402 0 CA-C-N 116.027 -0.533 . . . . 29.579999999999998 113.101 175.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1358 ' ' VAL . . . . . 0.462 HG13 ' HE2' ' B' 1113 ' ' MET . 13.1 p -64.97 -32.65 59.19 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 O-C-N 122.079 -0.659 . . . . 32.060000000000002 111.053 -172.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1359 ' ' THR . . . . . . . . . . . . . 4.2 m -71.92 81.78 0.92 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 122.85 1.309 . . . . 29.0 108.274 175.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1360 ' ' VAL . . . . . 0.442 HG12 ' CD1' ' B' 1368 ' ' TRP . 34.8 m -71.13 -26.03 26.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 113.004 -1.907 . . . . 29.68 111.34 -175.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1361 ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' B' 1365 ' ' GLU . 83.9 mt -132.25 119.22 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 107.118 -1.438 . . . . 32.049999999999997 107.118 170.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1362 ' ' ARG . . . . . 0.597 ' HA ' HG23 ' B' 1111 ' ' THR . 27.1 ttt180 -106.8 125.34 50.87 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 105.571 -2.011 . . . . 32.520000000000003 105.571 172.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 45.62 37.3 3.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 117.542 2.423 . . . . 35.68 117.542 176.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1364 ' ' GLY . . . . . 0.584 ' HA3' ' HA ' ' B' 1109 ' ' ASN . . . 85.84 14.88 66.51 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 113.926 -1.488 . . . . 34.259999999999998 116.057 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1365 ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' B' 1361 ' ' ILE . 20.8 mm-40 -108.41 135.48 49.64 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.465 -0.939 . . . . 51.07 108.465 164.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1366 ' ' ILE . . . . . 0.439 ' HA ' HG12 ' B' 1361 ' ' ILE . 61.4 mt -69.6 90.71 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 106.57 -1.641 . . . . 39.869999999999997 106.57 173.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1367 ' ' THR . . . . . . . . . . . . 0.252 23.8 p -85.7 10.88 12.21 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 116.698 2.11 . . . . 38.009999999999998 116.698 176.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1368 ' ' TRP . . . . . 0.512 ' HZ3' ' HB2' ' B' 1096 ' ' ALA . 1.7 t90 -78.07 138.8 60.78 Favored Pre-proline 0 C--O 1.252 1.232 0 N-CA-C 107.586 -1.264 . . . . 42.140000000000001 107.586 166.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1369 ' ' PRO . . . . . 0.403 ' HA ' ' CD1' ' B' 1368 ' ' TRP . 7.9 Cg_exo -94.3 179.77 9.28 Favored 'Cis proline' 0 C--N 1.35 0.627 0 N-CA-C 115.958 1.484 . . . . 43.259999999999998 115.958 -3.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1370 ' ' ALA . . . . . 0.538 ' HB2' ' HA2' ' B' 1357 ' ' GLY . . . -81.97 149.99 64.28 Favored Pre-proline 0 C--O 1.242 0.686 0 CA-C-O 116.77 -1.586 . . . . 46.520000000000003 108.486 163.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -49.01 120.24 5.26 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 124.44 3.427 . . . . 51.950000000000003 110.734 175.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -48.83 100.95 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 125.121 3.88 . . . . 56.270000000000003 117.503 -172.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1373 ' ' ILE . . . . . . . . . . . . . 19.1 tt -76.37 126.16 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 106.34 -1.726 . . . . 60.829999999999998 106.34 172.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -72.02 106.57 4.34 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-O 125.566 2.603 . . . . 66.099999999999994 109.634 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 71.2 t -98.24 121.56 48.92 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 CA-C-N 111.45 -2.614 . . . . 63.469999999999999 106.279 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.218 -5.11 0 O-C-N 120.004 -1.685 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.414 -2.236 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.26 -31.82 71.63 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 124.789 1.235 . . . . 0.0 110.026 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -36.15 83.42 Favored 'General case' 0 C--O 1.252 1.19 0 CA-C-N 119.398 0.999 . . . . 0.0 109.787 175.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 84.8 m -67.04 -33.03 74.65 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 118.622 0.646 . . . . 0.0 109.91 171.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 24' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' C' ' 27' ' ' LEU . . . -68.65 -50.35 51.91 Favored 'General case' 0 C--O 1.246 0.87 0 O-C-N 119.41 -2.056 . . . . 0.0 110.973 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 25' ' ' GLU . . . . . 0.587 ' HA ' ' HE2' ' C' ' 28' ' ' LYS . 0.7 OUTLIER -41.72 -57.28 2.37 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.728 -1.233 . . . . 0.0 113.557 162.281 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.618 ' HA ' ' HB3' ' C' ' 29' ' ' ASN . 84.7 mt -60.96 -25.42 66.81 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 175.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.608 HD21 HD21 ' C' ' 110' ' ' LEU . 44.4 mt -58.37 -56.46 21.81 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 116.613 -1.66 . . . . 0.0 110.868 172.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 28' ' ' LYS . . . . . 0.587 ' HE2' ' HA ' ' C' ' 25' ' ' GLU . 12.3 pttt -67.9 -31.33 71.04 Favored 'General case' 0 C--O 1.257 1.459 0 CA-C-O 123.556 1.646 . . . . 0.0 110.272 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 29' ' ' ASN . . . . . 0.618 ' HB3' ' HA ' ' C' ' 26' ' ' LEU . 22.6 t-20 -64.46 -27.33 68.91 Favored 'General case' 0 C--O 1.212 -0.886 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 169.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.647 ' HA ' ' HB3' ' C' ' 107' ' ' ASP . 35.4 m -65.69 -31.85 73.08 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 116.582 2.068 . . . . 0.0 116.582 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 31' ' ' HIS . . . . . 0.482 ' O ' HG23 ' C' ' 62' ' ' ILE . 19.7 m-70 61.08 -60.79 0.08 Allowed 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.289 -178.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 32' ' ' SER . . . . . 0.544 ' O ' ' HB3' ' C' ' 30' ' ' SER . 42.0 m -85.74 137.04 33.09 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 117.072 -3.518 . . . . 0.0 106.948 156.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 33' ' ' VAL . . . . . 0.413 ' HA ' HG23 ' C' ' 106' ' ' THR . 60.7 t -127.99 94.33 2.48 Favored 'Isoleucine or valine' 0 C--O 1.246 0.892 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 174.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.646 HG13 ' HA ' ' C' ' 103' ' ' PHE . 23.6 mm -74.11 110.25 7.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 O-C-N 118.607 -2.558 . . . . 0.0 107.666 168.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 35' ' ' ILE . . . . . 0.521 HG12 HD12 ' C' ' 110' ' ' LEU . 33.6 mt -85.88 114.59 25.85 Favored 'Isoleucine or valine' 0 C--O 1.254 1.303 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 169.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 36.2 m -93.67 107.88 30.3 Favored Pre-proline 0 C--O 1.246 0.914 0 O-C-N 121.08 -1.013 . . . . 0.0 110.382 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 37' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' C' ' 35' ' ' ILE . 80.2 Cg_exo -61.18 91.35 0.1 OUTLIER 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 123.294 2.663 . . . . 0.0 113.382 177.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.56 168.92 40.5 Favored Glycine 0 N--CA 1.432 -1.569 0 CA-C-N 113.086 -1.87 . . . . 0.0 108.624 169.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 39' ' ' TYR . . . . . 0.436 ' HB3' ' HB2' ' C' ' 114' ' ' ALA . 46.9 t80 -57.43 -28.04 62.96 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -177.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 40' ' ' GLY . . . . . 0.465 ' HA2' HG12 ' C' ' 43' ' ' VAL . . . -58.45 -32.71 69.06 Favored Glycine 0 C--O 1.244 0.758 0 O-C-N 120.83 -1.169 . . . . 0.0 112.536 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 41' ' ' MET . . . . . 0.833 ' HA ' ' HB3' ' C' ' 46' ' ' ALA . 16.1 ttm -55.64 -44.54 77.26 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.557 -0.822 . . . . 0.0 111.454 177.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.89 -51.97 10.29 Favored 'General case' 0 C--O 1.214 -0.777 0 O-C-N 124.967 1.417 . . . . 0.0 111.627 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 43' ' ' VAL . . . . . 0.465 HG12 ' HA2' ' C' ' 40' ' ' GLY . 11.3 p -67.43 -41.47 86.17 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 C-N-CA 119.333 -0.947 . . . . 0.0 113.358 -168.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 44' ' ' ALA . . . . . 0.43 ' HB1' ' HB2' ' C' ' 176' ' ' LYS . . . -92.47 19.71 6.97 Favored 'General case' 0 N--CA 1.424 -1.731 0 O-C-N 120.899 -1.125 . . . . 0.0 110.597 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 45' ' ' GLN . . . . . . . . . . . . 0.353 0.0 OUTLIER 30.31 56.65 0.19 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 117.819 2.525 . . . . 0.0 117.819 -167.669 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.833 ' HB3' ' HA ' ' C' ' 41' ' ' MET . . . -78.26 -14.19 59.54 Favored 'General case' 0 C--O 1.202 -1.44 0 CA-C-N 111.891 -2.413 . . . . 0.0 114.094 -178.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 47' ' ' GLN . . . . . 0.486 ' HA ' ' HB ' ' C' ' 50' ' ' VAL . 0.0 OUTLIER -66.89 -26.38 66.85 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 179.386 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 48' ' ' TYR . . . . . 0.592 ' HB2' ' HD3' ' C' ' 49' ' ' PRO . 47.0 m-85 -62.58 -52.2 66.95 Favored Pre-proline 0 N--CA 1.443 -0.787 0 CA-C-O 117.636 -1.174 . . . . 0.0 111.767 170.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 49' ' ' PRO . . . . . 0.592 ' HD3' ' HB2' ' C' ' 48' ' ' TYR . 8.2 Cg_exo -63.58 -39.34 36.12 Favored 'Trans proline' 0 CA--C 1.551 1.359 0 C-N-CA 122.846 2.364 . . . . 0.0 114.231 170.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 50' ' ' VAL . . . . . 0.577 ' HA ' HG22 ' C' ' 53' ' ' ILE . 54.2 t -59.81 -37.4 71.39 Favored 'Isoleucine or valine' 0 C--N 1.346 0.442 0 CA-C-O 116.126 -1.892 . . . . 0.0 111.191 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.02 -46.8 89.26 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 122.971 2.623 . . . . 0.0 108.993 -176.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 52' ' ' GLU . . . . . 0.54 ' HB3' HD11 ' C' ' 183' ' ' LEU . 3.6 tm-20 -69.57 -41.18 76.19 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.332 -1.304 . . . . 0.0 113.721 -178.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 53' ' ' ILE . . . . . 0.643 HD13 ' HA ' ' C' ' 183' ' ' LEU . 10.2 tp -60.45 -39.72 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 120.309 1.413 . . . . 0.0 113.002 172.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 95.0 m -60.68 -46.82 88.91 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.166 173.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -55.15 -50.82 68.33 Favored 'General case' 0 C--O 1.252 1.184 0 C-N-CA 127.178 2.191 . . . . 0.0 110.231 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 56' ' ' LYS . . . . . 0.431 ' HG2' HD12 ' C' ' 186' ' ' LEU . 4.3 ttpt -57.57 -50.73 72.14 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 116.59 2.071 . . . . 0.0 116.59 175.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 57' ' ' LEU . . . . . 0.479 ' O ' ' HB3' ' C' ' 60' ' ' ARG . 29.6 mt -63.06 -40.33 97.38 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.803 -0.561 . . . . 0.0 111.787 175.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 58' ' ' ARG . . . . . 0.516 ' NH1' ' HA ' ' C' ' 63' ' ' ASN . 2.5 tpt180 -67.7 -46.04 73.41 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 118.787 -0.625 . . . . 0.0 109.882 -175.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.74 -31.72 72.98 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 120.231 1.378 . . . . 0.0 112.502 175.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 60' ' ' ARG . . . . . 0.479 ' HB3' ' O ' ' C' ' 57' ' ' LEU . 1.7 tpm_? -61.36 -28.52 69.29 Favored 'General case' 0 C--N 1.346 0.45 0 O-C-N 119.913 -1.742 . . . . 0.0 110.89 171.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.4 1.84 40.91 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -177.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 62' ' ' ILE . . . . . 0.482 HG23 ' O ' ' C' ' 31' ' ' HIS . 64.5 mt -73.28 137.18 23.88 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 CA-C-O 126.096 2.855 . . . . 0.0 107.131 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 63' ' ' ASN . . . . . 0.516 ' HA ' ' NH1' ' C' ' 58' ' ' ARG . 59.3 t30 -81.52 67.01 7.31 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 112.275 -2.239 . . . . 0.0 111.754 -177.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 2.8 p -78.51 128.64 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 173.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 30.2 mmm-85 -137.42 148.78 46.42 Favored 'General case' 0 C--N 1.349 0.546 0 N-CA-C 103.468 -2.79 . . . . 0.0 103.468 -174.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 66' ' ' PHE . . . . . 0.73 ' HB2' ' HA ' ' C' ' 93' ' ' VAL . 22.4 m-85 -106.09 118.89 37.8 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 122.798 1.285 . . . . 0.0 111.048 -176.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -97.29 83.05 0.72 Allowed Glycine 0 C--O 1.25 1.107 0 N-CA-C 107.919 -2.072 . . . . 0.0 107.919 -177.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 68' ' ' ILE . . . . . 0.76 ' HB ' ' HA ' ' C' ' 95' ' ' GLU . 1.7 mp -73.03 126.38 33.59 Favored 'Isoleucine or valine' 0 C--N 1.348 0.518 0 CA-C-N 119.918 1.859 . . . . 0.0 110.191 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 69' ' ' HIS . . . . . 0.503 ' NE2' ' HG2' ' C' ' 134' ' ' PRO . 18.1 t-80 -118.16 91.98 41.59 Favored Pre-proline 0 CA--C 1.5 -0.945 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.911 -178.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 70' ' ' PRO . . . . . 0.773 ' HB3' HG13 ' A' 1157 ' ' ILE . 98.3 Cg_endo -54.39 -39.29 88.07 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 124.733 3.622 . . . . 0.0 118.307 -168.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 42.2 t -71.03 95.57 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 171.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -161.49 106.58 1.31 Allowed 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.445 1.117 . . . . 0.0 110.762 -172.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 73' ' ' GLY . . . . . 0.466 ' C ' ' HD2' ' C' ' 74' ' ' ARG . . . 72.31 -90.95 0.53 Allowed Glycine 0 N--CA 1.467 0.719 0 O-C-N 118.34 -2.725 . . . . 0.0 113.984 156.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 74' ' ' ARG . . . . . 0.816 ' HG3' ' HG2' ' B' 1203 ' ' GLN . 2.4 mpt_? -145.91 114.09 6.61 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -169.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.669 ' HG ' HD22 ' B' 1178 ' ' LEU . 4.0 mp 60.36 119.89 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.416 0 O-C-N 127.079 2.737 . . . . 0.0 116.808 175.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 76' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' C' ' 75' ' ' LEU . 73.0 Cg_endo -66.69 165.14 26.54 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 124.244 3.296 . . . . 0.0 109.423 167.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.39 -115.94 5.01 Favored Glycine 0 CA--C 1.505 -0.535 0 O-C-N 120.21 -1.556 . . . . 0.0 110.338 -169.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 49.56 -79.95 0.01 OUTLIER 'General case' 0 C--O 1.248 0.979 0 C-N-CA 124.819 1.248 . . . . 0.0 114.166 155.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -67.65 -35.43 78.87 Favored 'General case' 0 C--O 1.241 0.652 0 O-C-N 118.962 -2.336 . . . . 0.0 110.209 -177.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -64.13 -34.1 77.29 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 74.8 t -65.71 -41.03 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 122.139 -0.351 . . . . 0.0 111.351 176.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 45.9 mt -66.63 -30.27 70.5 Favored 'General case' 0 C--O 1.252 1.194 0 CA-C-O 123.361 1.553 . . . . 0.0 109.904 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.793 HD11 ' SD ' ' C' ' 41' ' ' MET . 6.0 mp -66.89 -48.34 69.05 Favored 'General case' 0 C--O 1.24 0.568 0 O-C-N 120.869 -1.144 . . . . 0.0 110.162 172.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.18 -49.42 77.1 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 177.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -58.59 -55.04 40.18 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-O 117.873 -1.061 . . . . 0.0 109.075 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.77 9.08 0.3 Allowed 'General case' 0 C--O 1.246 0.874 0 CA-C-N 121.158 1.799 . . . . 0.0 114.05 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp 64.14 30.87 13.64 Favored 'General case' 0 C--O 1.257 1.5 0 CA-C-N 122.017 2.19 . . . . 0.0 115.012 172.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 60.7 t -72.34 120.24 79.33 Favored Pre-proline 0 C--O 1.262 1.722 0 N-CA-C 104.462 -2.421 . . . . 0.0 104.462 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -56.71 115.94 2.84 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.854 3.036 . . . . 0.0 116.37 -171.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 90' ' ' TYR . . . . . 0.753 ' HA ' ' HB ' ' C' ' 93' ' ' VAL . 16.4 m-85 -60.69 -22.37 63.85 Favored 'General case' 0 C--O 1.246 0.885 0 CA-C-O 123.381 1.562 . . . . 0.0 114.125 173.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -43.19 -56.75 3.28 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 124.87 1.268 . . . . 0.0 112.758 164.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 1.9 pt -96.43 -10.38 8.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.577 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 93' ' ' VAL . . . . . 0.753 ' HB ' ' HA ' ' C' ' 90' ' ' TYR . 41.5 t -74.13 108.43 5.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-O 123.749 1.738 . . . . 0.0 110.656 175.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 6.0 mt -106.25 95.61 5.89 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 120.624 -1.297 . . . . 0.0 110.975 176.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 95' ' ' GLU . . . . . 0.76 ' HA ' ' HB ' ' C' ' 68' ' ' ILE . 3.1 mp0 -71.19 91.53 0.95 Allowed 'General case' 0 C--O 1.255 1.352 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.056 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 39.3 ttp 50.52 97.8 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 124.503 2.097 . . . . 0.0 116.445 -175.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -157.94 163.51 37.77 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 113.396 -1.729 . . . . 0.0 107.53 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -84.8 94.92 8.82 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 124.975 2.322 . . . . 0.0 111.471 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 10.3 tp -100.03 41.02 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 CA-C-N 109.079 -3.691 . . . . 0.0 107.386 164.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -76.91 -31.12 56.47 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 119.984 -1.698 . . . . 0.0 108.153 -161.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -63.45 -61.22 2.48 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 124.576 1.15 . . . . 0.0 113.93 170.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 102' ' ' ASP . . . . . 0.438 ' HA ' ' HB3' ' C' ' 105' ' ' ASP . 1.4 m-20 -65.83 -21.08 66.45 Favored 'General case' 0 C--N 1.355 0.818 0 O-C-N 123.852 0.72 . . . . 0.0 111.626 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 103' ' ' PHE . . . . . 0.646 ' HA ' HG13 ' C' ' 34' ' ' ILE . 0.1 OUTLIER -56.62 -60.17 3.94 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 123.304 0.642 . . . . 0.0 110.768 170.608 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.25 -31.35 72.48 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 173.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 105' ' ' ASP . . . . . 0.438 ' HB3' ' HA ' ' C' ' 102' ' ' ASP . 8.6 t70 -66.24 -26.45 67.37 Favored 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 120.509 -1.369 . . . . 0.0 111.837 175.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 106' ' ' THR . . . . . 0.557 ' OG1' HG12 ' C' ' 34' ' ' ILE . 53.6 m -73.02 125.75 28.35 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 121.842 2.11 . . . . 0.0 108.946 177.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 107' ' ' ASP . . . . . 0.647 ' HB3' ' HA ' ' C' ' 30' ' ' SER . 11.7 t70 -72.36 -43.37 64.13 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 113.006 -1.906 . . . . 0.0 110.621 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 108' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' C' ' 143' ' ' ASN . 80.0 m -125.62 104.53 8.44 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 119.015 0.825 . . . . 0.0 111.622 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 109' ' ' VAL . . . . . 0.445 HG11 HG21 ' C' ' 138' ' ' VAL . 8.1 t -87.0 120.95 37.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -171.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 110' ' ' LEU . . . . . 0.608 HD21 HD21 ' C' ' 27' ' ' LEU . 20.8 mt -90.32 93.77 9.47 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -171.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 19.1 t -84.81 109.31 17.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.037 170.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 112' ' ' ILE . . . . . 0.52 HD11 HG23 ' C' ' 35' ' ' ILE . 6.5 mm -78.06 90.02 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.919 0 CA-C-O 121.888 0.851 . . . . 0.0 110.652 -174.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 113' ' ' GLY . . . . . 0.558 ' HA2' ' O ' ' C' ' 147' ' ' PHE . . . 86.79 -72.95 2.54 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-O 124.106 1.948 . . . . 0.0 113.969 168.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 114' ' ' ALA . . . . . 0.436 ' HB2' ' HB3' ' C' ' 39' ' ' TYR . . . -75.77 108.29 8.52 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 120.773 -1.428 . . . . 0.0 112.819 -168.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 115' ' ' ASN . . . . . 0.511 ' OD1' ' H4B' ' C' 1001 ' ' NAP . 4.6 p-10 -65.75 -58.46 5.62 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 113.106 -1.861 . . . . 0.0 115.213 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 116' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' C' ' 119' ' ' ASN . 81.8 m-20 -57.62 -19.38 25.77 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 116.713 2.116 . . . . 0.0 116.713 -168.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 3.1 m -44.54 -43.47 8.03 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.658 1.983 . . . . 0.0 110.624 173.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.523 HG23 HD21 ' C' ' 162' ' ' LEU . 13.7 m -125.07 37.75 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.624 0 CA-C-O 122.952 1.358 . . . . 0.0 110.83 -177.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 119' ' ' ASN . . . . . 0.506 ' HB2' ' HA ' ' C' ' 116' ' ' ASP . 40.7 t-20 -77.82 114.22 39.55 Favored Pre-proline 0 C--O 1.243 0.73 0 O-C-N 120.463 -1.398 . . . . 0.0 110.832 -176.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 120' ' ' PRO . . . . . 0.416 ' HG2' ' HB2' ' C' ' 160' ' ' ASN . 71.7 Cg_endo -64.6 -34.0 53.69 Favored 'Trans proline' 0 CA--C 1.495 -1.471 0 C-N-CA 125.045 3.83 . . . . 0.0 114.183 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 121' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' C' ' 125' ' ' ASP . . . -64.23 -30.27 71.33 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 118.614 -1.235 . . . . 0.0 110.429 174.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 122' ' ' ALA . . . . . 0.555 ' HA ' ' CB ' ' C' ' 128' ' ' SER . . . -68.72 -19.83 64.37 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 174.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 123' ' ' GLN . . . . . 0.48 ' HB3' ' O ' ' C' ' 133' ' ' MET . 3.9 pt20 -86.7 -59.78 2.17 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 118.039 -2.913 . . . . 0.0 114.621 161.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -65.44 -45.05 85.33 Favored 'General case' 0 N--CA 1.438 -1.067 0 O-C-N 127.431 2.957 . . . . 0.0 115.042 -168.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 125' ' ' ASP . . . . . 0.459 ' HA ' ' HD3' ' C' ' 126' ' ' PRO . 0.9 OUTLIER -80.59 119.98 77.84 Favored Pre-proline 0 C--O 1.243 0.735 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -170.639 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 126' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' C' ' 125' ' ' ASP . 33.1 Cg_exo -75.49 76.01 3.73 Favored 'Trans proline' 0 N--CA 1.436 -1.878 1 C-N-CA 125.843 4.362 . . . . 0.0 109.413 175.114 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 127' ' ' LYS . . . . . 0.41 ' HB3' ' OD2' ' C' ' 125' ' ' ASP . 6.0 ttpm? 174.98 -25.5 0.0 OUTLIER 'General case' 0 C--O 1.248 0.981 0 C-N-CA 125.98 1.712 . . . . 0.0 108.378 -173.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 128' ' ' SER . . . . . 0.558 ' OG ' HG21 ' C' ' 158' ' ' VAL . 73.8 m -68.17 126.62 92.87 Favored Pre-proline 0 N--CA 1.446 -0.658 0 CA-C-N 120.961 1.709 . . . . 0.0 112.024 175.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 129' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' C' ' 128' ' ' SER . 17.0 Cg_endo -56.72 -58.39 0.98 Allowed 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 123.836 3.024 . . . . 0.0 114.091 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 13.3 pt -73.21 66.32 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 C-N-CA 123.977 0.911 . . . . 0.0 112.308 171.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 131' ' ' ALA . . . . . 0.474 ' O ' ' HB ' ' B' 1121 ' ' ILE . . . -72.93 150.9 42.15 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 122.695 1.236 . . . . 0.0 113.409 -170.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.03 53.36 27.0 Favored Glycine 0 CA--C 1.497 -1.045 0 CA-C-N 111.846 -2.434 . . . . 0.0 107.679 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 133' ' ' MET . . . . . 0.48 ' O ' ' HB3' ' C' ' 123' ' ' GLN . 24.5 tpp -76.62 129.45 79.4 Favored Pre-proline 0 C--O 1.252 1.185 0 CA-C-N 118.69 1.245 . . . . 0.0 110.715 175.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 134' ' ' PRO . . . . . 0.503 ' HG2' ' NE2' ' C' ' 69' ' ' HIS . 40.7 Cg_endo -62.78 101.93 0.28 Allowed 'Trans proline' 0 CA--C 1.517 -0.341 0 C-N-CA 125.22 3.947 . . . . 0.0 110.981 171.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 15.7 t -120.45 93.88 2.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 1 N-CA-C 99.743 -4.169 . . . . 0.0 99.743 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 5.1 mt -73.5 78.84 1.43 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.451 0.643 . . . . 0.0 112.196 -170.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 48.68 5.05 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 120.243 3.423 . . . . 0.0 120.243 -167.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 138' ' ' VAL . . . . . 0.445 HG21 HG11 ' C' ' 109' ' ' VAL 0.291 13.0 p -76.22 61.9 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 117.457 2.391 . . . . 0.0 117.457 -173.435 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 17.7 p90 -158.2 178.18 10.47 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 123.302 0.641 . . . . 0.0 109.618 171.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 140' ' ' LYS . . . . . . . . . . . . . 15.4 pttm 63.58 -58.16 0.19 Allowed 'General case' 0 C--O 1.247 0.933 0 C-N-CA 126.998 2.119 . . . . 0.0 115.681 174.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -90.76 174.28 7.56 Favored 'General case' 0 C--N 1.319 -0.746 0 O-C-N 120.122 -1.611 . . . . 0.0 107.346 170.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 63.97 157.51 0.08 Allowed 'General case' 0 C--N 1.345 0.383 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 172.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 143' ' ' ASN . . . . . 0.46 ' O ' ' HA ' ' C' ' 108' ' ' THR . 52.9 m-80 -80.14 79.26 6.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 125.167 2.413 . . . . 0.0 107.075 177.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 144' ' ' VAL . . . . . 0.647 ' HB ' HG23 ' C' ' 168' ' ' THR . 58.0 t -85.94 83.97 2.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 O-C-N 118.598 -2.564 . . . . 0.0 106.001 -178.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 145' ' ' ILE . . . . . 0.721 HG23 ' HB2' ' C' ' 171' ' ' LEU . 35.7 mt -88.91 109.18 19.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 125.501 2.572 . . . . 0.0 114.823 -170.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 146' ' ' VAL . . . . . . . . . . . . . 27.1 t -96.05 108.58 21.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 109.444 -3.525 . . . . 0.0 107.142 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 147' ' ' PHE . . . . . 0.558 ' O ' ' HA2' ' C' ' 113' ' ' GLY . 13.8 m-85 -70.75 102.58 2.35 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 148' ' ' LYS . . . . . 0.771 ' HE3' ' HA ' ' C' ' 151' ' ' MET . 60.2 tttp -131.28 133.77 45.73 Favored 'General case' 0 C--O 1.244 0.797 0 O-C-N 118.973 -2.329 . . . . 0.0 109.512 -175.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 149' ' ' ARG . . . . . 0.564 ' HE ' ' HB2' ' C' ' 174' ' ' ASP . 19.6 ttm105 -83.37 -92.27 0.07 Allowed 'General case' 0 C--O 1.24 0.565 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 176.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 1.1 m -70.52 131.46 44.05 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 121.475 1.943 . . . . 0.0 111.056 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 151' ' ' MET . . . . . 0.771 ' HA ' ' HE3' ' C' ' 148' ' ' LYS . 5.7 tpt -75.58 92.86 2.96 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-O 125.823 2.725 . . . . 0.0 107.713 163.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -133.85 152.02 51.73 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-N 110.698 -2.956 . . . . 0.0 109.523 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 153' ' ' THR . . . . . 0.436 ' HA ' ' HA3' ' C' ' 157' ' ' GLY . 73.2 m -63.46 150.63 43.27 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.396 172.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -111.2 -81.32 1.17 Allowed Glycine 0 C--N 1.353 1.527 0 N-CA-C 107.27 -2.332 . . . . 0.0 107.27 165.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -112.0 -46.94 3.17 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 117.51 -1.233 . . . . 0.0 110.876 174.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 156' ' ' ALA . . . . . 0.408 ' HB1' HG22 ' C' ' 158' ' ' VAL . . . -87.4 -69.18 0.7 Allowed 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 119.614 1.097 . . . . 0.0 110.403 166.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 157' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' C' ' 153' ' ' THR . . . 50.15 32.08 20.17 Favored Glycine 0 C--N 1.34 0.802 0 N-CA-C 115.218 0.847 . . . . 0.0 115.218 -170.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 158' ' ' VAL . . . . . 0.558 HG21 ' OG ' ' C' ' 128' ' ' SER . 14.6 m -92.26 153.69 3.26 Favored 'Isoleucine or valine' 0 C--O 1.253 1.27 0 C-N-CA 123.41 0.684 . . . . 0.0 110.007 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -41.76 112.05 0.29 Allowed 'General case' 0 C--N 1.345 0.394 0 N-CA-C 119.75 3.241 . . . . 0.0 119.75 176.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 160' ' ' ASN . . . . . 0.416 ' HB2' ' HG2' ' C' ' 120' ' ' PRO . 3.4 p30 -157.54 159.09 30.9 Favored Pre-proline 0 N--CA 1.436 -1.147 0 O-C-N 120.486 -1.384 . . . . 0.0 110.511 -173.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -38.38 -57.7 0.82 Allowed 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 124.43 3.42 . . . . 0.0 112.313 176.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 162' ' ' LEU . . . . . 0.523 HD21 HG23 ' C' ' 118' ' ' VAL . 9.6 mp -43.21 -31.34 0.59 Allowed 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 163' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -88.11 -59.57 2.2 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.729 -1.578 . . . . 0.0 107.382 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -91.44 -10.16 42.0 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 116.579 2.066 . . . . 0.0 116.579 -161.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -84.58 152.62 23.74 Favored 'General case' 0 C--O 1.243 0.713 0 O-C-N 120.614 -1.304 . . . . 0.0 110.639 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -78.87 -34.08 45.25 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-N 112.936 -1.938 . . . . 0.0 110.546 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 40.3 p-10 -91.78 -63.16 1.28 Allowed 'General case' 0 C--O 1.245 0.848 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 168' ' ' THR . . . . . 0.647 HG23 ' HB ' ' C' ' 144' ' ' VAL . 25.1 m -72.02 102.71 3.03 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 117.091 -3.505 . . . . 0.0 103.328 172.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -143.72 136.57 27.42 Favored 'General case' 0 CA--C 1.5 -0.962 0 O-C-N 119.254 -2.154 . . . . 0.0 112.692 -153.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 170' ' ' MET . . . . . 0.52 ' SD ' ' HD3' ' C' ' 148' ' ' LYS . 76.9 mtm -67.12 119.97 12.93 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 120.526 -1.359 . . . . 0.0 109.057 163.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 171' ' ' LEU . . . . . 0.721 ' HB2' HG23 ' C' ' 145' ' ' ILE . 13.1 tp -83.92 144.65 29.06 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 168.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -89.22 99.27 12.3 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 -167.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . 154.79 166.4 15.18 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-O 124.466 2.148 . . . . 0.0 109.992 167.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 174' ' ' ASP . . . . . 0.564 ' HB2' ' HE ' ' C' ' 149' ' ' ARG . 21.2 t70 -50.68 153.13 1.78 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.339 1.856 . . . . 0.0 112.648 169.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.9 -56.0 27.16 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.886 1.274 . . . . 0.0 110.842 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 176' ' ' LYS . . . . . 0.448 ' HD3' ' HG2' ' C' ' 49' ' ' PRO . 0.1 OUTLIER -69.81 -39.88 76.25 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 121.272 -0.892 . . . . 0.0 112.61 -177.131 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 177' ' ' ALA . . . . . . . . . . . . . . . -53.73 -44.1 69.62 Favored 'General case' 0 C--O 1.256 1.395 0 C-N-CA 125.249 1.42 . . . . 0.0 110.642 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 20.0 m -74.81 -42.5 57.93 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.0 -1.454 . . . . 0.0 111.456 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 179' ' ' VAL . . . . . 0.449 ' HA ' HG12 ' C' ' 182' ' ' ILE . 58.1 t -62.17 -55.01 26.82 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-N 120.223 1.374 . . . . 0.0 112.335 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -55.87 -39.12 71.05 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 119.001 -2.312 . . . . 0.0 112.672 178.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -54.46 -56.59 17.23 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 117.479 -1.248 . . . . 0.0 111.172 169.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 182' ' ' ILE . . . . . 0.449 HG12 ' HA ' ' C' ' 179' ' ' VAL . 19.0 pt -66.59 -32.32 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 121.058 1.754 . . . . 0.0 114.583 -175.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 183' ' ' LEU . . . . . 0.643 ' HA ' HD13 ' C' ' 53' ' ' ILE . 59.3 tp -48.27 -57.14 6.38 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 127.002 2.121 . . . . 0.0 112.581 170.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 184' ' ' LYS . . . . . 0.459 ' HA ' ' HD2' ' C' ' 184' ' ' LYS . 24.6 tptt -75.15 -33.48 61.52 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 124.83 1.332 . . . . 0.0 112.648 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -67.78 -91.61 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.17 0 O-C-N 126.502 2.376 . . . . 0.0 110.972 177.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 186' ' ' LEU . . . . . 0.431 HD12 ' HG2' ' C' ' 56' ' ' LYS 0.25 8.8 mt . . . . . 0 C--O 1.205 -1.255 0 O-C-N 120.237 -1.54 . . . . 0.0 112.505 -152.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 1' ' ' NAD . . . . . 0.497 H51N ' HD2' ' B' 1120 ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C 1001 ' ' NAP . . . . . 0.511 ' H4B' ' OD1' ' C' ' 115' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 42.2 t-80 . . . . . 0 N--CA 1.419 -1.999 0 N-CA-C 105.757 -1.942 . . . . 65.739999999999995 105.757 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -69.1 66.88 0.5 Allowed Glycine 0 C--N 1.348 1.236 0 C-N-CA 123.937 0.779 . . . . 48.659999999999997 111.622 172.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -80.18 124.86 29.16 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 120.002 -0.679 . . . . 44.560000000000002 109.388 173.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1003 ' ' ILE . . . . . 0.84 HG12 ' HB ' ' A' 1068 ' ' ILE . 34.8 mt -95.65 132.71 39.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 120.554 -1.341 . . . . 34.859999999999999 107.668 171.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -105.11 127.76 9.17 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 108.438 -1.865 . . . . 30.75 108.438 172.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.496 HG23 ' HB3' ' A' 1017 ' ' ALA . 23.0 mm -103.01 108.63 59.29 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 102.903 -2.999 . . . . 32.210000000000001 102.903 172.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -74.09 167.09 28.03 Favored 'Trans proline' 0 N--CA 1.439 -1.68 0 C-N-CA 122.474 2.116 . . . . 32.979999999999997 111.104 171.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1007 ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -84.77 131.78 34.51 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 102.438 -3.171 . . . . 47.979999999999997 102.438 157.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1008 ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -55.81 134.19 51.58 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 117.157 2.28 . . . . 34.700000000000003 117.157 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 21.7 mtp-105 -101.18 0.44 37.61 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 113.658 -1.61 . . . . 53.369999999999997 110.796 -171.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 52.7 tp -70.57 136.78 49.53 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 106.314 -1.735 . . . . 45.07 106.314 169.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1011 ' ' THR . . . . . . . . . . . . . 45.8 m -57.27 135.39 56.46 Favored 'General case' 0 C--O 1.243 0.76 0 O-C-N 120.461 -1.4 . . . . 40.359999999999999 109.81 -174.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 84.3 m-20 60.34 27.92 17.51 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 116.412 2.004 . . . . 40.609999999999999 116.412 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -87.74 147.93 24.97 Favored 'General case' 0 CA--C 1.504 -0.811 0 C-N-CA 118.616 -1.234 . . . . 33.759999999999998 109.797 -174.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1014 ' ' THR . . . . . 0.488 HG22 ' HB3' ' A' 1320 ' ' PRO . 1.9 m -117.06 -14.41 10.58 Favored 'General case' 0 C--O 1.257 1.483 0 CA-C-O 124.199 1.952 . . . . 27.890000000000001 110.81 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1015 ' ' ARG . . . . . 0.612 ' HG3' ' HA2' ' A' 1317 ' ' GLY . 12.9 mtm180 -66.12 125.76 26.52 Favored 'General case' 0 C--O 1.214 -0.775 0 O-C-N 119.468 -2.02 . . . . 29.02 114.054 173.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1016 ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' 1043 ' ' ALA . 3.4 t -120.52 150.81 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 106.721 -1.585 . . . . 28.129999999999999 106.721 165.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1017 ' ' ALA . . . . . 0.496 ' HB3' HG23 ' A' 1005 ' ' ILE . . . -59.19 -53.24 60.6 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 117.311 2.337 . . . . 26.870000000000001 117.311 -177.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -129.52 143.05 50.67 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 112.22 0.452 . . . . 26.77 112.22 -167.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1019 ' ' THR . . . . . 0.577 HG23 ' HB2' ' A' 1324 ' ' SER . 1.0 OUTLIER -80.5 174.06 6.74 Favored Pre-proline 0 C--N 1.347 0.475 0 C-N-CA 124.176 0.99 . . . . 27.02 110.887 168.178 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 1020 ' ' PRO . . . . . 0.482 ' HB3' ' HB2' ' A' 1053 ' ' ALA . 0.1 OUTLIER -54.18 -34.96 81.03 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.33 2.687 . . . . 30.57 111.455 168.457 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -55.24 -58.02 9.4 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 114.055 -1.43 . . . . 47.810000000000002 112.461 173.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1022 ' ' THR . . . . . . . . . . . . 0.281 3.2 p -77.13 -21.75 53.67 Favored 'General case' 0 C--N 1.309 -1.17 0 O-C-N 120.312 -1.492 . . . . 30.77 112.892 -174.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1023 ' ' VAL . . . . . 0.569 HG22 HG11 ' A' 1033 ' ' VAL . 8.9 t -56.89 -51.29 69.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 N-CA-C 108.594 -0.891 . . . . 33.590000000000003 108.594 164.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -65.8 -32.73 74.42 Favored 'General case' 0 C--N 1.35 0.617 0 N-CA-C 114.284 1.216 . . . . 53.289999999999999 114.284 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1025 ' ' GLN . . . . . 0.662 ' HB3' HG11 ' A' 1332 ' ' VAL . 68.2 mt-30 -58.2 -49.71 76.09 Favored 'General case' 0 C--O 1.254 1.336 0 CA-C-N 119.286 0.948 . . . . 46.920000000000002 112.125 170.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1026 ' ' LEU . . . . . 0.583 ' HA ' HD12 ' A' 1029 ' ' LEU . 14.9 mt -59.75 -38.56 82.1 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 118.527 -2.608 . . . . 37.170000000000002 114.006 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 29.3 tp -59.11 -40.59 85.83 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 113.848 -1.523 . . . . 44.439999999999998 112.404 171.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1028 ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' 1028 ' ' LYS . 12.3 mmmm -70.06 -26.29 63.94 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 119.526 -1.983 . . . . 52.579999999999998 113.71 173.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1029 ' ' LEU . . . . . 0.583 HD12 ' HA ' ' A' 1026 ' ' LEU . 25.5 mt -65.51 -39.88 92.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.609 0.719 . . . . 45.689999999999998 111.019 162.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 115.55 15.57 7.47 Favored Glycine 0 CA--C 1.503 -0.715 0 O-C-N 118.708 -2.495 . . . . 42.090000000000003 110.97 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -92.82 147.54 22.77 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 107.299 -1.371 . . . . 40.719999999999999 107.299 168.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1032 ' ' THR . . . . . . . . . . . . . 10.7 m -99.17 118.68 36.44 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.056 -1.091 . . . . 37.770000000000003 108.056 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1033 ' ' VAL . . . . . 0.569 HG11 HG22 ' A' 1023 ' ' VAL . 3.5 t -89.49 141.96 13.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.134 -0.939 . . . . 33.539999999999999 111.761 -171.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -128.58 135.01 48.77 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 104.445 -2.428 . . . . 31.68 104.445 176.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1035 ' ' VAL . . . . . . . . . . . . . 69.2 t -119.71 144.5 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 O-C-N 120.697 -1.252 . . . . 31.52 110.718 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1036 ' ' GLU . . . . . 0.462 ' HB2' HG11 ' A' 1063 ' ' VAL . 35.5 tt0 -72.7 130.2 39.99 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 124.155 0.91 . . . . 41.039999999999999 110.778 176.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1037 ' ' SER . . . . . . . . . . . . . 65.9 m -60.1 111.2 1.42 Allowed 'General case' 0 C--O 1.262 1.714 0 N-CA-C 107.293 -1.373 . . . . 31.829999999999998 107.293 165.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 130.01 -32.41 3.14 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.573 -0.822 . . . . 29.359999999999999 111.127 -172.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -64.08 -39.89 95.06 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 117.594 -1.193 . . . . 27.780000000000001 108.842 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -52.08 -47.32 55.03 Favored Glycine 0 C--N 1.359 1.809 0 CA-C-O 121.817 0.676 . . . . 28.91 112.325 169.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -66.24 -32.37 73.75 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.771 -0.841 . . . . 51.18 110.894 -175.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1042 ' ' LEU . . . . . . . . . . . . . 14.0 mt -69.93 -56.3 7.39 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 121.16 1.8 . . . . 29.91 111.528 165.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1043 ' ' ALA . . . . . 0.497 ' HA ' ' HB2' ' A' 1320 ' ' PRO . . . -69.9 12.31 0.22 Allowed 'General case' 0 CA--C 1.556 1.2 0 O-C-N 119.334 -2.104 . . . . 28.539999999999999 112.636 -174.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1044 ' ' SER . . . . . . . . . . . . . 13.8 m 63.27 59.54 1.26 Allowed 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 124.454 2.073 . . . . 33.060000000000002 113.863 174.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1045 ' ' PHE . . . . . 0.406 ' HA ' ' HB1' ' B' 1277 ' ' ALA . 97.0 m-85 -150.58 167.15 28.1 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 111.088 -2.778 . . . . 30.289999999999999 106.52 177.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -97.25 151.34 19.95 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 106.624 -1.621 . . . . 48.619999999999997 106.624 151.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -59.84 -16.99 32.97 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 114.199 1.185 . . . . 36.740000000000002 114.199 -166.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 20.5 pttm -55.05 -26.36 36.99 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 121.987 2.176 . . . . 43.729999999999997 110.91 174.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -52.73 -53.63 45.17 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 120.661 -1.274 . . . . 32.810000000000002 112.576 171.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1050 ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -63.09 -33.38 75.32 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.909 -1.041 . . . . 31.859999999999999 113.657 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 25.5 t -63.98 -41.27 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 O-C-N 121.157 -0.964 . . . . 33.219999999999999 109.313 173.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -64.41 -41.99 96.31 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 122.468 1.128 . . . . 50.829999999999998 111.586 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1053 ' ' ALA . . . . . 0.482 ' HB2' ' HB3' ' A' 1020 ' ' PRO . . . -60.48 -52.76 63.82 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 114.333 -1.303 . . . . 33.119999999999997 110.64 170.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 122.34 75.03 0.33 Allowed Glycine 0 CA--C 1.489 -1.555 0 CA-C-O 123.523 1.624 . . . . 35.829999999999998 110.057 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -143.26 127.22 17.34 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 105.809 -1.923 . . . . 34.82 105.809 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -62.28 118.57 7.61 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.283 -0.871 . . . . 49.049999999999997 111.718 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1057 ' ' ILE . . . . . . . . . . . . . 17.3 mm -89.04 124.62 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 124.538 2.113 . . . . 38.530000000000001 110.953 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1058 ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' 1036 ' ' GLU . 0.0 OUTLIER -144.11 158.55 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 110.877 -2.874 . . . . 42.109999999999999 107.133 -175.612 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -88.22 167.8 13.28 Favored 'General case' 0 C--O 1.259 1.592 0 N-CA-C 113.925 1.083 . . . . 58.0 113.925 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . -31.05 -69.66 0.09 OUTLIER Glycine 0 C--N 1.348 1.235 0 N-CA-C 117.881 1.912 . . . . 52.119999999999997 117.881 -172.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 5.4 m120 -64.37 -33.59 76.2 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 119.912 1.856 . . . . 54.75 112.215 -169.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1062 ' ' SER . . . . . . . . . . . . . 16.8 m -73.91 -40.33 63.22 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 125.972 2.045 . . . . 50.340000000000003 108.009 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1063 ' ' VAL . . . . . 0.462 HG11 ' HB2' ' A' 1036 ' ' GLU . 4.1 p -68.88 -25.95 31.46 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 CA-C-N 122.473 2.397 . . . . 41.460000000000001 111.415 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1064 ' ' TRP . . . . . 0.402 ' HA ' HD11 ' A' 1069 ' ' ILE . 11.4 m95 -66.21 -29.56 69.84 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-N 115.303 -0.862 . . . . 39.32 112.837 173.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -81.31 79.44 7.94 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 123.423 1.582 . . . . 55.380000000000003 107.847 -174.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1066 ' ' SER . . . . . . . . . . . . . 58.7 m -147.63 161.4 41.23 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 120.553 -1.342 . . . . 41.869999999999997 108.771 -171.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1067 ' ' GLU . . . . . 0.591 ' HB3' HD12 ' A' 1068 ' ' ILE . 1.5 tp10 -69.62 -44.78 69.98 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 107.009 -1.478 . . . . 53.200000000000003 107.009 -176.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1068 ' ' ILE . . . . . 0.84 ' HB ' HG12 ' A' 1003 ' ' ILE . 5.2 mp -120.12 139.44 47.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 103.605 -2.739 . . . . 41.899999999999999 103.605 -178.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1069 ' ' ILE . . . . . 0.437 HD13 ' HA ' ' A' 1069 ' ' ILE . 9.7 mm -119.23 126.9 75.76 Favored 'Isoleucine or valine' 0 C--O 1.248 0.989 0 N-CA-C 105.292 -2.114 . . . . 38.729999999999997 105.292 170.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1070 ' ' LEU . . . . . 0.629 HD22 HD22 ' A' 1331 ' ' LEU . 71.4 mt -107.47 87.6 2.54 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-O 122.618 1.199 . . . . 32.439999999999998 108.233 173.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1071 ' ' LYS . . . . . . . . . . . . . 3.5 mmmt -87.32 171.67 10.43 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 107.429 -1.322 . . . . 34.649999999999999 107.429 166.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1072 ' ' VAL . . . . . 0.579 HG21 ' HB3' ' A' 1015 ' ' ARG . 8.0 t -100.37 -78.05 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 107.043 -1.465 . . . . 31.32 107.043 171.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -101.26 140.25 35.82 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 108.038 -1.097 . . . . 33.939999999999998 108.038 -161.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . 27.58 103.03 0.01 OUTLIER Pre-proline 0 C--O 1.247 0.933 0 N-CA-C 119.642 3.201 . . . . 38.039999999999999 119.642 171.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1075 ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' 1093 ' ' ILE . 34.8 Cg_exo -76.39 91.04 1.15 Allowed 'Trans proline' 0 CA--C 1.509 -0.77 0 C-N-CA 123.678 2.918 . . . . 42.68 109.541 177.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 65.3 mt -71.36 -179.75 2.59 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 114.425 -1.262 . . . . 46.740000000000002 114.043 -171.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.38 -35.6 67.9 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 116.907 2.188 . . . . 58.609999999999999 116.907 -173.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 16.4 t70 -67.2 -47.86 69.63 Favored 'General case' 0 C--O 1.26 1.641 0 C-N-CA 124.094 0.957 . . . . 59.200000000000003 110.388 173.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1079 ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -53.78 -37.35 63.36 Favored 'General case' 0 C--N 1.363 1.173 0 CA-C-O 117.108 -1.425 . . . . 50.630000000000003 110.753 174.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1080 ' ' ILE . . . . . 0.531 ' HA ' HD23 ' A' 1083 ' ' LEU . 55.6 mt -54.4 -47.3 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-N 119.433 1.015 . . . . 51.479999999999997 111.05 175.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -64.19 -33.77 76.56 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.54 1.518 . . . . 50.280000000000001 109.843 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 34.6 mt -71.82 -27.04 62.64 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 114.044 1.127 . . . . 50.210000000000001 114.044 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1083 ' ' LEU . . . . . 0.531 HD23 ' HA ' ' A' 1080 ' ' ILE . 0.4 OUTLIER -55.44 133.15 49.79 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-O 122.656 1.217 . . . . 49.060000000000002 112.205 174.428 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.02 125.96 62.65 Favored Pre-proline 0 N--CA 1.472 0.627 0 N-CA-C 101.431 -3.544 . . . . 51.079999999999998 101.431 177.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.87 63.92 0.03 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 124.165 3.243 . . . . 49.729999999999997 119.729 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1086 ' ' GLY . . . . . 0.537 ' H ' HG12 ' A' 1110 ' ' VAL . . . 173.44 -33.68 0.11 Allowed Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.111 -1.195 . . . . 47.710000000000001 110.111 -168.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1087 ' ' THR . . . . . . . . . . . . . 98.0 m -44.78 130.13 7.12 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 117.42 2.378 . . . . 45.469999999999999 117.42 -175.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1088 ' ' THR . . . . . . . . . . . . . 1.4 m -75.53 93.82 3.06 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 113.427 -1.715 . . . . 42.039999999999999 108.956 170.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1089 ' ' LEU . . . . . 0.483 HD22 HD21 ' A' 1083 ' ' LEU . 54.8 tp -90.67 92.83 9.0 Favored 'General case' 0 C--N 1.348 0.535 0 O-C-N 121.074 -1.016 . . . . 38.060000000000002 108.398 -178.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 89.1 t -99.65 99.03 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 102.559 -3.126 . . . . 37.399999999999999 102.559 -172.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1091 ' ' SER . . . . . . . . . . . . . 49.5 m -152.55 166.31 32.44 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 115.51 1.67 . . . . 36.159999999999997 115.51 -174.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1092 ' ' PHE . . . . . 0.417 ' HE1' ' HB1' ' A' 1129 ' ' ALA . 2.6 m-85 -66.42 88.28 0.13 Allowed 'General case' 0 C--O 1.253 1.274 0 O-C-N 118.118 -2.864 . . . . 38.939999999999998 109.822 161.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1093 ' ' ILE . . . . . 0.478 HG12 ' HA ' ' A' 1114 ' ' ALA . 26.2 mm -81.22 -32.43 12.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 122.935 1.35 . . . . 42.170000000000002 110.981 -173.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1094 ' ' TRP . . . . . 0.431 ' HH2' HD21 ' A' 1257 ' ' LEU . 77.8 m95 60.5 48.53 1.71 Allowed Pre-proline 0 C--O 1.243 0.717 0 C-N-CA 125.306 1.442 . . . . 46.509999999999998 111.108 -170.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1095 ' ' PRO . . . . . 0.441 ' HD3' ' HB ' ' A' 1093 ' ' ILE . 92.2 Cg_endo -54.68 -44.62 47.91 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 124.691 3.594 . . . . 49.759999999999998 116.468 -169.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1096 ' ' ALA . . . . . 0.589 ' HB3' ' NE2' ' A' 1097 ' ' GLN . . . -67.41 -33.98 76.29 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 122.529 1.157 . . . . 52.619999999999997 110.724 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1097 ' ' GLN . . . . . 0.589 ' NE2' ' HB3' ' A' 1096 ' ' ALA . 7.8 mp0 -85.2 -5.39 59.33 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 114.67 -1.15 . . . . 60.740000000000002 110.657 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1098 ' ' ASN . . . . . 0.515 ' HB3' ' HB3' ' A' 1101 ' ' LEU . 18.5 m120 -130.94 64.17 72.83 Favored Pre-proline 0 N--CA 1.439 -0.975 0 N-CA-C 114.082 1.141 . . . . 58.189999999999998 114.082 -178.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -61.11 -42.97 32.28 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.759 2.973 . . . . 54.590000000000003 114.8 -174.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 52.2 mp0 -70.5 -42.73 70.96 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.541 -0.911 . . . . 63.280000000000001 108.541 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1101 ' ' LEU . . . . . 0.515 ' HB3' ' HB3' ' A' 1098 ' ' ASN . 5.7 tp -57.39 -41.14 79.67 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.859 0.864 . . . . 54.75 109.309 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1102 ' ' MET . . . . . . . . . . . . . 43.1 mmm -54.93 -48.37 73.22 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 120.599 -1.313 . . . . 52.649999999999999 112.46 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -61.25 -41.11 96.35 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 124.305 1.042 . . . . 66.260000000000005 110.479 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -74.23 -34.1 63.57 Favored 'General case' 0 C--O 1.247 0.946 0 O-C-N 121.373 -0.829 . . . . 63.729999999999997 110.947 -177.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 79.3 mt -68.51 -35.13 77.06 Favored 'General case' 0 C--O 1.253 1.281 0 CA-C-O 121.218 0.532 . . . . 54.68 109.826 174.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -66.83 -40.37 87.97 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.59 0.709 . . . . 53.640000000000001 112.089 172.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -54.91 -33.13 61.76 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.607 2.363 . . . . 67.239999999999995 113.981 168.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1108 ' ' ARG . . . . . 0.4 ' O ' HG13 ' A' 1110 ' ' VAL . 0.1 OUTLIER -78.43 10.49 3.08 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 116.121 -1.895 . . . . 65.760000000000005 115.343 172.141 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 20.1 t30 53.65 21.17 2.47 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 123.136 2.698 . . . . 58.710000000000001 114.602 173.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1110 ' ' VAL . . . . . 0.688 HG23 HG23 ' A' 1112 ' ' VAL . 17.9 m -90.67 175.08 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 O-C-N 118.412 -2.68 . . . . 46.630000000000003 114.422 -173.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1111 ' ' THR . . . . . . . . . . . . . 22.0 m -112.91 90.84 3.45 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 106.788 -1.56 . . . . 44.130000000000003 106.788 174.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1112 ' ' VAL . . . . . 0.688 HG23 HG23 ' A' 1110 ' ' VAL . 53.0 t -92.14 109.98 22.15 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 CA-C-N 114.653 -1.158 . . . . 40.439999999999998 110.446 -173.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1113 ' ' MET . . . . . 0.507 ' HB3' HG12 ' A' 1358 ' ' VAL . 64.6 mtp -102.93 115.52 30.76 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 112.326 -2.216 . . . . 50.759999999999998 110.489 178.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1114 ' ' ALA . . . . . 0.478 ' HA ' HG12 ' A' 1093 ' ' ILE . . . -94.44 94.08 8.03 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-N 114.435 -1.257 . . . . 35.640000000000001 109.511 -169.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1115 ' ' MET . . . . . 0.541 ' SD ' HD22 ' A' 1334 ' ' LEU . 83.8 mmm -57.7 -34.49 69.5 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 114.951 1.463 . . . . 38.740000000000002 114.951 -178.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1116 ' ' ASP . . . . . 0.424 ' OD2' ' HD2' ' A' 1095 ' ' PRO . 9.4 p-10 -61.04 -38.69 87.04 Favored 'General case' 0 C--O 1.219 -0.525 0 O-C-N 121.694 -0.629 . . . . 40.140000000000001 110.533 174.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1117 ' ' SER . . . . . . . . . . . . . 47.9 m -94.68 27.88 2.87 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 115.058 1.503 . . . . 44.789999999999999 115.058 -176.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1118 ' ' VAL . . . . . . . . . . . . . 10.3 m -53.96 140.93 50.25 Favored Pre-proline 0 N--CA 1.436 -1.166 0 CA-C-O 117.49 -1.243 . . . . 43.75 112.072 168.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -66.2 125.71 14.51 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.373 2.716 . . . . 48.93 109.684 168.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 34.1 mmm-85 -78.81 20.31 0.47 Allowed 'General case' 0 C--O 1.249 1.041 0 N-CA-C 117.082 2.253 . . . . 62.899999999999999 117.082 -160.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 38.9 pt -72.86 167.99 2.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 114.538 1.31 . . . . 57.719999999999999 114.538 -167.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1122 ' ' SER . . . . . . . . . . . . . 6.7 m -59.73 -40.35 87.76 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-O 118.066 -0.968 . . . . 57.259999999999998 111.435 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -56.45 -36.23 68.79 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 121.443 1.929 . . . . 62.899999999999999 108.762 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -73.75 -24.34 59.86 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-O 116.114 -1.898 . . . . 49.829999999999998 115.68 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1125 ' ' GLN . . . . . . . . . . . . 0.28 73.4 mm-40 -46.8 -21.96 0.26 Allowed 'General case' 0 N--CA 1.474 0.754 1 N-CA-C 122.352 4.205 . . . . 52.369999999999997 122.352 -169.238 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A 1126 ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' B' 1160 ' ' ALA . 11.9 p -85.07 -35.66 21.7 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 119.199 -2.188 . . . . 42.43 109.971 172.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1127 ' ' LEU . . . . . 0.663 HD21 HD22 ' A' 1337 ' ' LEU . 4.6 mp -84.78 -18.79 33.92 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.354 1.862 . . . . 43.740000000000002 112.394 176.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 53.8 t0 -70.97 92.92 0.95 Allowed 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 125.423 2.535 . . . . 43.210000000000001 110.645 -173.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1129 ' ' ALA . . . . . 0.417 ' HB1' ' HE1' ' A' 1092 ' ' PHE . . . -61.02 -40.98 95.67 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 110.024 -3.262 . . . . 35.740000000000002 111.273 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.95 -28.63 68.44 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 119.043 -2.286 . . . . 38.090000000000003 108.737 -176.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1131 ' ' SER . . . . . . . . . . . . . 75.0 m -67.71 -55.47 13.05 Favored 'General case' 0 CA--C 1.501 -0.935 0 O-C-N 119.487 -2.008 . . . . 36.909999999999997 113.634 172.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1132 ' ' SER . . . . . 0.477 ' HB3' ' HB3' ' A' 1326 ' ' LEU . 4.1 m -61.99 -43.85 97.97 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 119.159 0.89 . . . . 35.789999999999999 113.203 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1133 ' ' MET . . . . . 0.422 ' HA ' HD12 ' A' 1136 ' ' ILE . 13.9 mmm -59.58 -41.56 90.5 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 121.005 1.73 . . . . 30.809999999999999 109.897 176.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1134 ' ' ALA . . . . . 0.652 ' HB1' ' HB2' ' A' 1176 ' ' ALA . . . -63.45 -45.03 92.74 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 123.636 0.775 . . . . 28.879999999999999 109.157 175.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1135 ' ' ASN . . . . . 0.646 ' HB2' HG12 ' A' 1175 ' ' VAL . 16.3 t-20 -59.5 -46.25 89.37 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.532 0.682 . . . . 40.759999999999998 112.237 -177.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1136 ' ' ILE . . . . . 0.682 HD13 ' HA ' ' A' 1323 ' ' SER . 68.6 mt -55.9 -50.3 69.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 125.038 1.335 . . . . 31.539999999999999 109.4 173.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1137 ' ' ALA . . . . . 0.423 ' HB2' ' HG3' ' A' 1316 ' ' PRO . . . -62.55 -32.1 73.01 Favored 'General case' 0 C--N 1.344 0.352 0 N-CA-C 114.193 1.183 . . . . 29.870000000000001 114.193 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -70.53 -44.02 59.33 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 118.914 0.779 . . . . 28.73 112.412 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 20.1 t80 -66.76 -48.5 68.89 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 107.321 -1.363 . . . . 30.390000000000001 107.321 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1140 ' ' ARG . . . . . 0.548 ' HE ' ' HG2' ' A' 1144 ' ' GLU . 6.0 tpt180 -65.19 -26.22 68.05 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 113.577 0.954 . . . . 26.09 113.577 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1141 ' ' ALA . . . . . 0.69 ' HB2' HD21 ' A' 1284 ' ' LEU . . . -58.84 -53.5 57.68 Favored 'General case' 0 C--N 1.359 1.0 0 CA-C-O 118.521 -0.752 . . . . 27.100000000000001 109.914 167.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 32.8 mm -51.8 -43.58 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 O-C-N 124.238 0.961 . . . . 28.48 112.219 172.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 76.2 t -58.98 -62.02 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-N 119.655 1.116 . . . . 23.07 112.687 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1144 ' ' GLU . . . . . 0.548 ' HG2' ' HE ' ' A' 1140 ' ' ARG . 5.6 mm-40 -64.73 -29.1 70.07 Favored 'General case' 0 C--N 1.343 0.296 0 O-C-N 120.703 -1.248 . . . . 33.399999999999999 111.551 -177.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1145 ' ' ALA . . . . . 0.591 ' HA ' HG11 ' A' 1280 ' ' VAL . . . -54.61 -63.95 0.99 Allowed 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 117.784 -1.103 . . . . 24.219999999999999 112.601 165.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -54.35 -23.17 14.35 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 122.881 1.324 . . . . 24.890000000000001 113.908 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -66.63 -69.03 0.33 Allowed 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 120.272 -1.518 . . . . 26.73 110.13 169.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1148 ' ' GLU . . . . . 0.721 ' HB2' HD11 ' A' 1310 ' ' ILE . 68.5 mm-40 -73.72 -9.46 58.68 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 116.684 2.105 . . . . 39.960000000000001 116.684 -176.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1149 ' ' PHE . . . . . 0.471 ' HB2' ' O ' ' A' 1145 ' ' ALA . 1.2 t80 -59.99 146.18 43.53 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 123.272 1.511 . . . . 25.870000000000001 111.678 176.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1150 ' ' GLY . . . . . . . . . . . . . . . -80.63 -38.92 15.42 Favored Glycine 0 N--CA 1.429 -1.816 0 CA-C-N 113.374 -1.739 . . . . 19.280000000000001 109.617 173.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1151 ' ' ARG . . . . . 0.92 ' HA ' ' HB2' ' B' 1322 ' ' GLN . 66.6 mtm-85 -113.84 -170.83 1.78 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 121.157 2.479 . . . . 39.899999999999999 114.774 -163.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1152 ' ' PHE . . . . . 0.575 ' CD1' ' HG2' ' B' 1322 ' ' GLN . 2.8 m-85 -83.49 152.97 24.67 Favored 'General case' 0 C--O 1.218 -0.557 0 O-C-N 119.369 -2.082 . . . . 29.440000000000001 113.637 165.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1153 ' ' PHE . . . . . 0.419 ' CZ ' HG13 ' A' 1251 ' ' ILE . 10.0 m-85 -70.64 -49.75 44.2 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 113.232 -1.804 . . . . 32.600000000000001 107.509 157.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1154 ' ' THR . . . . . . . . . . . . . 1.8 m -76.47 115.57 16.34 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 125.236 1.414 . . . . 34.640000000000001 113.955 -165.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -69.47 109.06 2.71 Favored Glycine 0 C--O 1.251 1.176 0 N-CA-C 105.838 -2.905 . . . . 37.140000000000001 105.838 170.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -158.9 -169.3 2.64 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-N 117.918 0.859 . . . . 40.57 111.99 -174.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1157 ' ' ILE . . . . . 0.708 HD13 ' HB3' ' C' ' 95' ' ' GLU . 1.5 tp -137.02 142.51 37.43 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.201 0 C-N-CA 125.426 1.49 . . . . 44.609999999999999 111.298 -171.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1158 ' ' THR . . . . . 0.404 ' HB ' ' H ' ' A' 1159 ' ' ALA . 1.1 p -93.33 -143.07 0.22 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.592 -1.64 . . . . 40.700000000000003 109.03 177.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1159 ' ' ALA . . . . . 0.404 ' H ' ' HB ' ' A' 1158 ' ' THR . . . -103.09 -14.3 16.47 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.423 -1.695 . . . . 40.25 106.423 157.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1160 ' ' ALA . . . . . 0.433 ' HB2' ' ND2' ' B' 1330 ' ' ASN . . . -76.09 -58.19 3.43 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 117.198 2.296 . . . . 38.469999999999999 117.198 173.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . 175.92 -165.27 35.81 Favored Glycine 0 CA--C 1.505 -0.556 0 CA-C-O 124.58 2.211 . . . . 37.609999999999999 111.128 -170.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 8.8 tttp -64.29 130.55 44.29 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 111.823 -2.188 . . . . 48.899999999999999 111.327 -171.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1163 ' ' VAL . . . . . 0.608 HG22 HD21 ' B' 1326 ' ' LEU . 10.1 t -100.93 114.69 65.82 Favored Pre-proline 0 N--CA 1.426 -1.661 0 CA-C-N 110.589 -3.005 . . . . 36.520000000000003 104.401 165.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1164 ' ' PRO . . . . . 0.46 ' HD2' HE22 ' B' 1322 ' ' GLN . 74.9 Cg_endo -73.05 137.05 25.81 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 124.938 3.759 . . . . 35.079999999999998 116.827 -176.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1165 ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.01 138.69 28.71 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 124.003 3.135 . . . . 35.329999999999998 116.312 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -79.63 141.96 36.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.212 -1.358 . . . . 34.689999999999998 112.415 174.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1167 ' ' LYS . . . . . 0.552 ' HB2' ' HA ' ' A' 1249 ' ' VAL . 44.1 mttp -100.69 115.14 29.55 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 113.099 -1.864 . . . . 45.359999999999999 107.298 172.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 49.9 t -100.38 91.38 2.15 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 CA-C-N 113.745 -1.571 . . . . 31.710000000000001 108.825 -174.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1169 ' ' MET . . . . . 0.426 ' HA ' ' O ' ' A' 1192 ' ' ARG . 35.3 ttp -76.85 92.67 3.64 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 123.749 1.737 . . . . 42.280000000000001 111.981 175.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 42.9 t -81.0 110.58 16.64 Favored 'Isoleucine or valine' 0 C--O 1.246 0.919 0 O-C-N 121.104 -0.997 . . . . 30.510000000000002 110.067 174.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 66.7 mt -88.84 119.63 36.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.194 -1.039 . . . . 31.870000000000001 108.194 176.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 87.13 87.23 1.09 Allowed Glycine 0 CA--C 1.537 1.428 0 N-CA-C 106.74 -2.544 . . . . 34.539999999999999 106.74 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1173 ' ' ALA . . . . . 0.531 ' HA ' ' HA3' ' A' 1177 ' ' GLY . . . -85.05 57.3 4.37 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 120.45 2.125 . . . . 32.509999999999998 111.612 176.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1174 ' ' GLY . . . . . 0.458 ' HA2' HH22 ' A' 1197 ' ' ARG . . . -73.85 -163.73 9.27 Favored Glycine 0 N--CA 1.448 -0.566 0 O-C-N 120.224 -1.548 . . . . 29.899999999999999 109.439 160.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1175 ' ' VAL . . . . . 0.646 HG12 ' HB2' ' A' 1135 ' ' ASN . 3.5 t -62.25 -36.6 75.34 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 O-C-N 121.342 -1.093 . . . . 33.109999999999999 111.651 -174.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1176 ' ' ALA . . . . . 0.652 ' HB2' ' HB1' ' A' 1134 ' ' ALA . . . -61.48 -43.12 99.42 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 113.626 -1.625 . . . . 28.100000000000001 114.363 170.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1177 ' ' GLY . . . . . 0.531 ' HA3' ' HA ' ' A' 1173 ' ' ALA . . . -63.32 -49.94 66.59 Favored Glycine 0 C--N 1.312 -0.752 0 N-CA-C 110.322 -1.111 . . . . 28.539999999999999 110.322 176.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1178 ' ' LEU . . . . . 0.58 ' HB3' ' SD ' ' A' 1207 ' ' MET . 70.3 mt -53.56 -51.6 62.4 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 117.693 0.747 . . . . 31.219999999999999 112.387 177.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -51.21 -46.34 62.19 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.624 0.972 . . . . 28.98 113.624 175.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -60.13 -41.1 91.96 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 116.664 2.098 . . . . 27.829999999999998 116.664 174.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1181 ' ' ILE . . . . . 0.471 HD12 ' HA ' ' A' 1178 ' ' LEU . 55.8 mt -64.8 -50.47 75.19 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 O-C-N 121.252 -0.905 . . . . 30.25 109.678 174.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -50.36 -54.77 18.79 Favored Glycine 0 C--O 1.241 0.579 0 O-C-N 120.54 -1.35 . . . . 29.59 110.289 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -59.88 -48.0 83.46 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 116.243 1.942 . . . . 30.289999999999999 116.243 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1184 ' ' ALA . . . . . 0.485 ' HB1' ' HB3' ' A' 1189 ' ' ALA . . . -68.77 -43.94 74.73 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.478 -1.389 . . . . 30.469999999999999 112.537 178.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -60.18 -43.68 95.67 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 118.482 0.583 . . . . 42.409999999999997 110.906 176.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1186 ' ' SER . . . . . 0.557 ' O ' ' HB3' ' B' 1186 ' ' SER . 72.4 m -48.65 -40.44 27.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.719 1.007 . . . . 39.380000000000003 113.719 164.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 27.2 mt -91.02 24.83 2.65 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 115.154 1.538 . . . . 36.18 115.154 173.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 69.38 8.9 60.19 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 115.535 0.974 . . . . 33.780000000000001 115.535 171.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1189 ' ' ALA . . . . . 0.485 ' HB3' ' HB1' ' A' 1184 ' ' ALA . . . -79.24 145.14 33.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 118.464 1.132 . . . . 33.93 111.63 -177.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 9.5 mt -77.26 88.48 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 105.459 -2.052 . . . . 38.740000000000002 105.459 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 14.0 t -76.21 125.59 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 106.828 -1.545 . . . . 33.090000000000003 106.828 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1192 ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' 1169 ' ' MET . 94.0 mtt180 -114.39 99.75 7.81 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 105.045 -2.206 . . . . 38.920000000000002 105.045 170.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1193 ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' A' 1211 ' ' PHE . . . -92.91 144.35 25.35 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 119.58 -1.95 . . . . 35.32 111.126 177.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1194 ' ' PHE . . . . . 0.646 ' HB2' HD12 ' A' 1212 ' ' LEU . 37.6 t80 -128.76 157.05 42.5 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 106.904 -1.517 . . . . 39.350000000000001 106.904 171.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1195 ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' 1173 ' ' ALA . 8.0 t0 -163.1 148.09 11.49 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 105.983 -1.858 . . . . 40.460000000000001 105.983 168.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1196 ' ' THR . . . . . . . . . . . . . 1.1 p -77.38 -12.52 59.96 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 114.837 -1.074 . . . . 45.939999999999998 112.359 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1197 ' ' ARG . . . . . 0.458 HH22 ' HA2' ' A' 1174 ' ' GLY . 74.4 mtm180 -94.06 115.74 65.56 Favored Pre-proline 0 N--CA 1.471 0.619 0 N-CA-C 106.146 -1.798 . . . . 56.020000000000003 106.146 172.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1198 ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -66.3 -14.71 45.38 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.305 2.003 . . . . 51.270000000000003 114.473 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -51.72 -54.41 28.7 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 122.328 1.061 . . . . 59.100000000000001 112.342 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 26.8 m -71.95 -2.91 3.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 115.402 1.63 . . . . 51.060000000000002 115.402 -169.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 83.5 tttt -55.36 -36.08 65.94 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 119.758 -1.839 . . . . 57.380000000000003 113.074 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -71.38 -37.73 71.58 Favored 'General case' 0 C--O 1.247 0.922 0 CA-C-N 118.552 0.614 . . . . 62.409999999999997 110.657 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -62.84 -37.79 88.2 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 120.739 -1.226 . . . . 57.780000000000001 112.719 171.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1204 ' ' VAL . . . . . 0.675 HG13 ' HB3' ' A' 1209 ' ' ALA . 25.4 t -58.49 -47.48 88.15 Favored 'Isoleucine or valine' 0 C--N 1.343 0.297 0 O-C-N 124.006 0.816 . . . . 46.380000000000003 111.432 173.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -54.09 -54.08 44.36 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.261 1.024 . . . . 50.700000000000003 113.349 171.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1206 ' ' SER . . . . . . . . . . . . . 6.4 m -62.32 -42.85 99.72 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 113.323 0.86 . . . . 49.979999999999997 113.323 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1207 ' ' MET . . . . . 0.58 ' SD ' ' HB3' ' A' 1178 ' ' LEU . 29.0 mtp -77.49 -13.31 59.95 Favored 'General case' 0 C--O 1.242 0.692 0 O-C-N 117.635 -3.166 . . . . 52.990000000000002 114.107 176.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 97.7 59.64 0.96 Allowed Glycine 0 N--CA 1.429 -1.802 0 O-C-N 121.427 -0.795 . . . . 47.659999999999997 111.151 166.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1209 ' ' ALA . . . . . 0.675 ' HB3' HG13 ' A' 1204 ' ' VAL . . . -134.26 151.22 51.17 Favored 'General case' 0 N--CA 1.457 -0.087 0 O-C-N 120.126 -1.808 . . . . 44.770000000000003 110.709 167.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1210 ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' 1192 ' ' ARG . 56.3 tt0 -76.15 145.73 39.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.805 -1.089 . . . . 47.640000000000001 108.763 165.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1211 ' ' PHE . . . . . 0.582 ' HD1' HG11 ' A' 1204 ' ' VAL . 9.9 t80 -93.97 160.06 14.89 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 106.947 -1.501 . . . . 45.659999999999997 106.947 -178.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1212 ' ' LEU . . . . . 0.646 HD12 ' HB2' ' A' 1194 ' ' PHE . 77.7 mt -85.39 106.4 16.73 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 104.613 -2.366 . . . . 46.060000000000002 104.613 171.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -73.86 97.59 2.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.314 -0.857 . . . . 60.219999999999999 108.793 168.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1214 ' ' LEU . . . . . 0.663 HD11 ' HA ' ' A' 1238 ' ' GLU . 5.8 tp -65.68 101.54 0.64 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.472 -0.785 . . . . 57.25 109.653 -174.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 19.7 t0 -61.08 100.27 0.11 Allowed 'General case' 0 C--O 1.247 0.925 0 O-C-N 124.73 1.268 . . . . 64.430000000000007 108.483 175.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 3.8 t80 . . . . . 0 C--O 1.212 -0.91 0 N-CA-C 102.556 -3.127 . . . . 66.900000000000006 102.556 179.27 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 2.8 p30 . . . . . 0 N--CA 1.426 -1.659 0 CA-C-O 118.765 -0.636 . . . . 39.090000000000003 109.569 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -57.35 -36.88 78.5 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 118.66 0.663 . . . . 39.32 113.565 -170.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 76.8 t80 -74.96 -43.67 52.74 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-O 116.901 -1.523 . . . . 39.299999999999997 110.287 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -58.14 -46.35 85.79 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.617 1.099 . . . . 36.299999999999997 111.057 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -62.54 -72.09 0.14 Allowed 'General case' 0 C--N 1.346 0.415 0 CA-C-O 117.332 -1.318 . . . . 37.380000000000003 110.326 173.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1229 ' ' VAL . . . . . 0.425 ' HA ' ' CD2' ' A' 1234 ' ' PHE . . . -50.18 -42.04 19.47 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 N-CA-C 117.468 2.396 . . . . 39.109999999999999 117.468 -172.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1230 ' ' MET . . . . . . . . . . . . . 21.0 mmt -86.23 1.67 49.94 Favored 'General case' 0 C--O 1.25 1.13 0 O-C-N 119.532 -1.98 . . . . 49.590000000000003 113.576 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1231 ' ' SER . . . . . . . . . . . . . 22.1 p -76.89 143.38 39.66 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 122.304 2.32 . . . . 43.68 110.52 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -49.08 -47.57 44.92 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.727 1.211 . . . . 55.57 112.961 -174.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -60.18 -34.04 73.05 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 113.333 0.864 . . . . 44.939999999999998 113.333 172.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1234 ' ' PHE . . . . . 0.425 ' CD2' ' HA ' ' A' 1229 ' ' VAL . 13.3 t80 -69.27 -49.82 52.57 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 120.46 1.482 . . . . 42.039999999999999 108.363 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1235 ' ' ILE . . . . . 0.522 ' O ' ' HG2' ' A' 1239 ' ' MET . 63.4 mt -58.53 -34.6 51.52 Favored 'Isoleucine or valine' 0 C--O 1.249 1.048 0 CA-C-O 118.325 -0.845 . . . . 46.280000000000001 110.026 175.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 25.8 tttm -62.43 -44.75 95.69 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 119.743 1.156 . . . . 47.869999999999997 108.844 171.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -60.71 -33.77 73.38 Favored 'General case' 0 C--O 1.25 1.104 0 O-C-N 119.406 -2.059 . . . . 41.609999999999999 112.755 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1238 ' ' GLU . . . . . 0.663 ' HA ' HD11 ' A' 1214 ' ' LEU . 38.3 mt-10 -56.22 -51.65 67.29 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 113.723 1.008 . . . . 50.649999999999999 113.723 168.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1239 ' ' MET . . . . . 0.522 ' HG2' ' O ' ' A' 1235 ' ' ILE . 8.3 mmm -57.55 -47.94 80.66 Favored 'General case' 0 C--O 1.247 0.972 0 C-N-CA 124.745 1.218 . . . . 48.869999999999997 112.018 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -58.65 -45.31 89.6 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 118.864 -0.588 . . . . 54.799999999999997 112.239 177.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 1.8 mm? -63.07 -39.09 93.68 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 123.672 0.608 . . . . 43.210000000000001 112.453 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -70.64 -39.34 73.73 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 125.492 1.745 . . . . 38.659999999999997 111.214 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -63.68 -29.49 70.71 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.131 1.772 . . . . 37.920000000000002 114.743 174.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -74.22 -66.23 0.75 Allowed 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 113.593 -1.64 . . . . 37.280000000000001 110.236 173.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -52.79 -31.48 38.82 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 124.699 1.2 . . . . 43.07 113.619 -177.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1246 ' ' ALA . . . . . 0.424 ' HB1' ' HG2' ' A' 1275 ' ' MET . . . -45.17 -46.2 11.97 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.814 1.246 . . . . 38.299999999999997 111.857 175.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1247 ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' 1276 ' ' LYS . 22.4 mtmm -68.77 -18.21 64.16 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 116.682 -1.628 . . . . 47.600000000000001 113.736 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -113.29 -30.45 6.92 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 121.322 1.874 . . . . 45.420000000000002 114.896 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1249 ' ' VAL . . . . . 0.552 ' HA ' ' HB2' ' A' 1167 ' ' LYS . 29.6 m -78.41 172.35 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 O-C-N 119.954 -1.716 . . . . 36.259999999999998 113.607 -171.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1250 ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' 1279 ' ' SER . 4.5 m-20 -121.71 -64.48 1.21 Allowed 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 124.018 0.824 . . . . 33.039999999999999 111.245 -173.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1251 ' ' ILE . . . . . 0.484 HD12 ' HB1' ' A' 1145 ' ' ALA . 32.3 mm -102.73 123.21 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 N-CA-C 105.629 -1.989 . . . . 31.399999999999999 105.629 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1252 ' ' ILE . . . . . . . . . . . . . 68.3 mt -105.85 136.41 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 O-C-N 124.764 1.29 . . . . 29.420000000000002 107.83 165.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 65.3 t -119.23 108.69 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.008 0 N-CA-C 104.265 -2.495 . . . . 30.370000000000001 104.265 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1254 ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.53 95.82 7.56 Favored 'General case' 0 C--O 1.246 0.89 0 CA-C-N 121.828 2.103 . . . . 35.719999999999999 113.188 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1255 ' ' THR . . . . . 0.535 HG22 HD12 ' A' 1284 ' ' LEU . 36.6 p -72.23 -24.99 61.47 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 119.068 2.988 . . . . 36.0 119.068 -166.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1256 ' ' ALA . . . . . . . . . . . . . . . -70.89 74.81 0.62 Allowed 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 117.571 2.434 . . . . 40.93 117.571 -151.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1257 ' ' LEU . . . . . 0.431 HD21 ' HH2' ' A' 1094 ' ' TRP . 14.0 tp -71.0 81.34 0.66 Allowed 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.174 -1.417 . . . . 47.82 107.174 167.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 42.6 mm -75.44 134.95 72.71 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 104.503 -2.406 . . . . 52.700000000000003 104.503 173.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -64.86 92.93 0.21 Allowed 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 122.131 1.887 . . . . 54.130000000000003 114.545 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1260 ' ' GLY . . . . . 0.437 ' HA2' ' HG3' ' A' 1097 ' ' GLN . . . 93.99 -57.51 2.14 Favored Glycine 0 CA--C 1.489 -1.57 0 O-C-N 121.019 -1.051 . . . . 54.619999999999997 112.754 166.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1261 ' ' LYS . . . . . 0.431 ' HB2' ' HE3' ' A' 1261 ' ' LYS . 25.1 mtmt -63.86 119.93 59.1 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-O 116.567 -1.682 . . . . 55.740000000000002 107.652 174.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -56.98 134.44 64.53 Favored 'Trans proline' 0 CA--C 1.5 -1.201 0 C-N-CA 124.131 3.221 . . . . 51.149999999999999 114.808 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -62.15 122.96 76.04 Favored Pre-proline 0 C--O 1.247 0.943 0 O-C-N 124.089 0.868 . . . . 46.060000000000002 110.114 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -49.59 133.26 31.87 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 125.282 3.988 . . . . 41.079999999999998 117.494 -175.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -68.07 83.36 0.22 Allowed 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.528 -0.916 . . . . 47.420000000000002 108.528 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1266 ' ' LEU . . . . . 0.456 ' HA ' ' SD ' ' A' 1239 ' ' MET . 98.0 mt -79.42 -41.55 27.4 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 122.476 1.131 . . . . 39.219999999999999 108.473 -177.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 21.7 mt -97.65 91.41 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 N-CA-C 105.013 -2.217 . . . . 42.5 105.013 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1268 ' ' THR . . . . . 0.601 ' HA ' ' HG3' ' A' 1293 ' ' GLU . 39.6 p -71.16 153.84 42.18 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.589 -1.187 . . . . 37.840000000000003 111.233 176.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1269 ' ' ARG . . . . . 0.549 ' HG3' ' HB2' ' A' 1293 ' ' GLU . 95.5 mtt180 -47.0 -50.67 18.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.354 1.462 . . . . 54.799999999999997 111.136 -177.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -42.89 -46.6 5.39 Favored 'General case' 0 C--O 1.249 1.072 0 C-N-CA 124.123 0.969 . . . . 54.359999999999999 113.426 172.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1271 ' ' MET . . . . . . . . . . . . . 26.6 mtt -68.83 -41.57 78.38 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 118.522 -0.752 . . . . 39.520000000000003 112.213 177.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1272 ' ' VAL . . . . . 0.489 HG21 ' SG ' ' A' 1292 ' ' CYS . 14.0 t -65.95 -44.53 92.37 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 CA-C-O 121.811 0.815 . . . . 38.25 109.648 -177.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -54.66 -44.02 72.91 Favored 'General case' 0 C--O 1.249 1.048 0 C-N-CA 124.466 1.107 . . . . 40.770000000000003 111.793 171.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1274 ' ' SER . . . . . . . . . . . . . 76.5 p -86.05 12.3 9.83 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 119.579 -1.951 . . . . 36.579999999999998 115.072 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1275 ' ' MET . . . . . 0.442 ' HG3' ' HA ' ' A' 1272 ' ' VAL . 52.5 mtp -70.89 160.92 31.93 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 123.521 1.629 . . . . 36.75 110.751 173.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1276 ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' 1247 ' ' LYS . 36.4 ttpt -68.61 134.84 50.53 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 112.999 -1.909 . . . . 46.109999999999999 106.007 166.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1277 ' ' ALA . . . . . . . . . . . . . . . -85.69 -179.73 6.92 Favored 'General case' 0 C--O 1.261 1.677 0 N-CA-C 115.365 1.617 . . . . 33.520000000000003 115.365 -176.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 67.99 29.05 73.3 Favored Glycine 0 CA--C 1.538 1.515 0 O-C-N 120.315 -1.491 . . . . 31.27 109.697 -171.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1279 ' ' SER . . . . . 0.525 ' HB3' ' O ' ' A' 1250 ' ' ASP . 16.7 m -131.33 173.21 11.29 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.692 1.746 . . . . 32.950000000000003 110.833 -165.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1280 ' ' VAL . . . . . 0.591 HG11 ' HA ' ' A' 1145 ' ' ALA . 98.5 t -140.77 144.63 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 O-C-N 118.623 -2.548 . . . . 27.43 104.783 -169.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1281 ' ' ILE . . . . . . . . . . . . . 59.9 mt -119.08 107.18 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.646 0 N-CA-C 101.813 -3.402 . . . . 30.300000000000001 101.813 164.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -92.36 104.2 15.39 Favored 'Isoleucine or valine' 0 C--O 1.25 1.102 0 N-CA-C 107.019 -1.474 . . . . 28.629999999999999 107.019 171.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 7.1 t70 -96.03 115.38 27.34 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 111.472 -2.604 . . . . 36.270000000000003 109.396 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1284 ' ' LEU . . . . . 0.69 HD21 ' HB2' ' A' 1141 ' ' ALA . 90.9 mt -87.2 -29.19 21.91 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 112.237 -2.256 . . . . 38.57 111.194 -173.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -62.51 -41.67 98.99 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 114.711 -1.132 . . . . 37.560000000000002 111.293 176.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . 22.84 -75.97 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 120.158 3.392 . . . . 40.329999999999998 120.158 174.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -59.92 -42.73 94.57 Favored 'General case' 0 C--O 1.212 -0.875 0 CA-C-O 121.538 0.685 . . . . 56.850000000000001 111.44 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 29.9 t30 -85.34 65.29 9.12 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.094 -1.412 . . . . 45.859999999999999 108.633 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 84.34 -57.61 5.02 Favored Glycine 0 C--O 1.246 0.858 0 O-C-N 120.63 -1.294 . . . . 40.310000000000002 113.682 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 84.51 128.62 1.75 Allowed Glycine 0 CA--C 1.538 1.515 0 N-CA-C 108.531 -1.828 . . . . 38.890000000000001 108.531 -171.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1291 ' ' ASN . . . . . . . . . . . . . 33.8 m120 -74.9 -21.6 59.12 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.743 1.771 . . . . 37.229999999999997 111.545 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1292 ' ' CYS . . . . . 0.489 ' SG ' HG21 ' A' 1272 ' ' VAL . 18.0 t -96.79 148.24 23.11 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.417 -1.427 . . . . 36.5 107.851 175.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1293 ' ' GLU . . . . . 0.601 ' HG3' ' HA ' ' A' 1268 ' ' THR . 27.7 mt-10 -75.13 -39.98 60.12 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 120.556 -1.34 . . . . 43.32 111.94 177.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -65.11 -5.88 7.69 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 115.291 1.589 . . . . 41.32 115.291 174.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1295 ' ' THR . . . . . 0.417 ' OG1' ' HB3' ' A' 1292 ' ' CYS . 86.5 m -58.48 115.18 2.84 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 119.262 0.937 . . . . 35.299999999999997 110.514 174.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 35.4 t -96.77 114.28 64.27 Favored Pre-proline 0 C--N 1.313 -1.004 0 N-CA-C 102.126 -3.287 . . . . 34.840000000000003 102.126 169.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -54.34 118.01 4.56 Favored 'Trans proline' 0 CA--C 1.537 0.669 1 C-N-CA 125.787 4.324 . . . . 33.509999999999998 111.757 176.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 99.19 -16.06 59.65 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 113.144 -1.844 . . . . 32.189999999999998 113.063 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -135.61 162.91 31.38 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 125.009 2.338 . . . . 34.880000000000003 115.541 -167.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1300 ' ' ILE . . . . . 0.799 HG12 HG12 ' A' 1310 ' ' ILE . 50.1 mt -75.58 140.59 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 CA-C-N 112.635 -2.075 . . . . 32.289999999999999 110.539 167.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 54.5 t80 -129.38 120.02 24.86 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 120.113 1.324 . . . . 37.25 108.194 159.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1302 ' ' THR . . . . . . . . . . . . . 34.8 m -79.14 125.05 28.92 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 104.198 -2.519 . . . . 35.560000000000002 104.198 172.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1303 ' ' THR . . . . . . . . . . . . . 76.3 p -85.45 -179.63 6.97 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 113.991 1.108 . . . . 36.399999999999999 113.991 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -67.84 -34.36 76.56 Favored 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 120.131 -1.606 . . . . 52.32 112.33 -170.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -74.99 -41.85 58.69 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.09 -1.414 . . . . 40.039999999999999 111.001 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 118.38 57.72 0.28 Allowed Glycine 0 N--CA 1.448 -0.512 0 O-C-N 119.901 -1.749 . . . . 36.960000000000001 109.207 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1307 ' ' VAL . . . . . . . . . . . . . 73.5 t -124.32 121.12 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.898 0 N-CA-C 101.336 -3.579 . . . . 33.399999999999999 101.336 174.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1308 ' ' LYS . . . . . 0.431 ' HB2' HG22 ' A' 1280 ' ' VAL . 20.8 mmtp -81.81 95.68 7.37 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 113.4 -1.727 . . . . 42.909999999999997 108.507 -178.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 44.0 t -85.83 93.44 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 O-C-N 121.125 -0.984 . . . . 32.289999999999999 108.618 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1310 ' ' ILE . . . . . 0.799 HG12 HG12 ' A' 1300 ' ' ILE . 61.0 mt -89.52 95.33 5.36 Favored 'Isoleucine or valine' 0 C--O 1.256 1.419 0 N-CA-C 105.378 -2.082 . . . . 30.989999999999998 105.378 -174.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1311 ' ' GLY . . . . . 0.417 ' HA3' HG23 ' A' 1295 ' ' THR . . . -91.37 56.75 3.15 Favored Glycine 0 N--CA 1.431 -1.641 0 N-CA-C 110.877 -0.889 . . . . 28.949999999999999 110.877 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1312 ' ' TYR . . . . . 0.613 ' HB2' ' HG ' ' A' 1315 ' ' LEU . 9.1 m-30 -78.66 113.54 16.81 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 120.602 2.201 . . . . 31.690000000000001 116.808 -170.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1313 ' ' THR . . . . . . . . . . . . . 4.6 p -71.8 -40.38 69.23 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 125.889 2.757 . . . . 34.170000000000002 109.841 -177.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -69.81 -0.88 7.91 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 110.072 -3.24 . . . . 36.859999999999999 115.802 176.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1315 ' ' LEU . . . . . 0.613 ' HG ' ' HB2' ' A' 1312 ' ' TYR 0.342 42.0 mt -40.65 -45.9 5.9 Favored Pre-proline 0 N--CA 1.487 1.404 0 N-CA-C 121.241 3.793 . . . . 34.850000000000001 121.241 178.512 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 1316 ' ' PRO . . . . . 0.509 ' HB2' ' HD3' ' A' 1015 ' ' ARG . 46.1 Cg_exo -56.55 -47.26 24.71 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.916 2.411 . . . . 29.149999999999999 110.529 168.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1317 ' ' GLY . . . . . 0.612 ' HA2' ' HG3' ' A' 1015 ' ' ARG . . . -61.18 -44.81 97.65 Favored Glycine 0 CA--C 1.483 -1.936 0 CA-C-O 118.545 -1.142 . . . . 27.289999999999999 111.578 -177.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1318 ' ' ARG . . . . . 0.447 ' HB3' ' NH2' ' A' 1140 ' ' ARG . 59.2 mtt-85 -60.21 -15.72 26.96 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 114.204 1.187 . . . . 41.490000000000002 114.204 174.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1319 ' ' LEU . . . . . 0.525 HD22 ' HB2' ' A' 1140 ' ' ARG . 14.0 tp -110.95 73.2 0.86 Allowed Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-N 123.258 2.754 . . . . 27.609999999999999 103.779 166.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1320 ' ' PRO . . . . . 0.615 ' HD2' ' HA2' ' B' 1150 ' ' GLY . 57.4 Cg_endo -59.06 -58.93 0.53 Allowed 'Trans proline' 0 C--O 1.213 -0.769 0 C-N-CA 122.85 2.367 . . . . 25.940000000000001 112.567 -159.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1321 ' ' THR . . . . . 0.414 ' H ' ' HG2' ' A' 1320 ' ' PRO . 3.1 m -58.37 -30.37 66.73 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 112.797 -2.001 . . . . 25.010000000000002 113.704 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1322 ' ' GLN . . . . . 0.409 HE22 HG13 ' B' 1163 ' ' VAL . 55.0 tp60 -74.23 -39.87 62.79 Favored 'General case' 0 N--CA 1.436 -1.166 0 O-C-N 120.589 -1.32 . . . . 29.390000000000001 110.852 176.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1323 ' ' SER . . . . . 0.682 ' HA ' HD13 ' A' 1136 ' ' ILE . 75.0 m -52.7 -53.18 51.1 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 118.912 0.778 . . . . 26.469999999999999 109.449 168.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1324 ' ' SER . . . . . 0.577 ' HB2' HG23 ' A' 1019 ' ' THR . 2.3 m -61.0 -26.12 67.37 Favored 'General case' 0 C--O 1.25 1.121 0 N-CA-C 114.335 1.235 . . . . 27.780000000000001 114.335 175.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -75.37 -63.15 1.34 Allowed 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 117.739 -3.1 . . . . 37.530000000000001 110.228 172.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1326 ' ' LEU . . . . . 0.562 ' HB2' HD11 ' A' 1136 ' ' ILE . 18.2 mt -77.98 -47.86 17.56 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 116.973 -1.489 . . . . 35.710000000000001 114.357 -170.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1327 ' ' TYR . . . . . . . . . . . . . 32.1 t80 -59.29 -47.29 85.92 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 105.877 -1.897 . . . . 31.59 105.877 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1328 ' ' GLY . . . . . 0.698 ' HA2' HD12 ' A' 1331 ' ' LEU . . . -40.78 -54.47 3.51 Favored Glycine 0 CA--C 1.544 1.847 0 C-N-CA 124.668 1.127 . . . . 28.0 114.778 167.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1329 ' ' THR . . . . . . . . . . . . . 28.7 m -67.57 -35.09 78.36 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-O 118.106 -0.95 . . . . 32.149999999999999 109.449 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1330 ' ' ASN . . . . . . . . . . . . . 29.2 m120 -62.47 -43.86 97.79 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.579 -0.897 . . . . 34.359999999999999 108.579 174.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1331 ' ' LEU . . . . . 0.698 HD12 ' HA2' ' A' 1328 ' ' GLY . 13.9 mt -59.96 -50.16 74.84 Favored 'General case' 0 C--O 1.213 -0.85 0 N-CA-C 109.367 -0.605 . . . . 33.369999999999997 109.367 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1332 ' ' VAL . . . . . 0.662 HG11 ' HB3' ' A' 1025 ' ' GLN . 44.2 t -57.04 -40.17 71.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 118.787 -0.625 . . . . 35.270000000000003 111.181 174.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -68.02 -38.45 82.6 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 114.602 1.334 . . . . 37.659999999999997 114.602 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1334 ' ' LEU . . . . . 0.541 HD22 ' SD ' ' A' 1115 ' ' MET . 28.9 tp -60.97 -48.61 81.03 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 106.916 -1.513 . . . . 40.270000000000003 106.916 172.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1335 ' ' LEU . . . . . 0.552 ' HA ' ' HB2' ' A' 1338 ' ' LEU . 20.5 mt -71.66 -4.4 27.11 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 114.625 1.343 . . . . 42.5 114.625 175.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1336 ' ' LYS . . . . . 0.515 ' HE3' HG12 ' A' 1332 ' ' VAL . 82.6 mttt -74.76 -44.91 47.22 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 121.81 2.095 . . . . 47.810000000000002 111.774 161.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1337 ' ' LEU . . . . . 0.663 HD22 HD21 ' A' 1127 ' ' LEU . 10.4 mp -62.34 -41.02 98.24 Favored 'General case' 0 C--O 1.216 -0.672 0 C-N-CA 118.555 -1.258 . . . . 49.270000000000003 113.8 172.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1338 ' ' LEU . . . . . 0.552 ' HB2' ' HA ' ' A' 1335 ' ' LEU . 10.2 mp -70.8 -69.38 0.37 Allowed 'General case' 0 CA--C 1.51 -0.577 0 O-C-N 124.695 1.247 . . . . 50.539999999999999 113.054 172.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1339 ' ' CYS . . . . . 0.603 ' SG ' ' HA2' ' A' 1344 ' ' GLY . 51.5 t -69.71 91.95 0.64 Allowed 'General case' 0 CA--C 1.503 -0.835 0 O-C-N 118.396 -2.69 . . . . 53.670000000000002 107.571 172.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 72.3 tttt -83.73 -62.56 1.54 Allowed 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.121 -1.4 . . . . 63.380000000000003 108.052 -165.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -74.88 -35.89 62.3 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 124.82 1.248 . . . . 70.950000000000003 114.057 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1342 ' ' LYS . . . . . 0.428 ' HE2' ' HA ' ' A' 1029 ' ' LEU . 3.2 mtpm? 62.22 83.88 0.15 Allowed 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 125.537 1.535 . . . . 65.25 113.484 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1343 ' ' ASP . . . . . . . . . . . . 0.38 0.0 OUTLIER 79.21 -78.81 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.775 2 O-C-N 112.593 -6.317 . . . . 64.530000000000001 120.076 -19.347 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A 1344 ' ' GLY . . . . . 0.603 ' HA2' ' SG ' ' A' 1339 ' ' CYS . . . 104.39 10.73 33.02 Favored Glycine 0 CA--C 1.545 1.94 0 O-C-N 117.536 -3.227 . . . . 59.719999999999999 111.379 178.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1345 ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' 1339 ' ' CYS . 19.0 t30 -72.05 131.24 42.61 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 121.932 2.866 . . . . 64.090000000000003 112.929 174.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1346 ' ' ILE . . . . . . . . . . . . . 24.7 mt -80.31 79.37 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.83 0 O-C-N 120.018 -1.676 . . . . 58.82 109.063 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1347 ' ' THR . . . . . . . . . . . . . 5.3 m -66.43 85.14 0.1 Allowed 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 119.867 -1.771 . . . . 54.960000000000001 112.711 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1348 ' ' VAL . . . . . 0.518 ' HB ' ' NH2' ' A' 1362 ' ' ARG . 40.0 t -76.46 98.45 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.803 0 N-CA-C 102.915 -2.994 . . . . 55.640000000000001 102.915 178.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 8.8 t70 -87.79 138.14 31.72 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 111.735 -2.484 . . . . 61.450000000000003 110.906 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1350 ' ' PHE . . . . . 0.401 ' CE1' ' HD2' ' A' 1362 ' ' ARG . 1.0 OUTLIER -107.22 -12.39 15.38 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 117.443 2.386 . . . . 58.630000000000003 117.443 176.692 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -76.69 -48.47 18.83 Favored 'General case' 0 C--O 1.246 0.904 0 O-C-N 124.028 0.83 . . . . 62.060000000000002 109.073 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 28.0 t70 -65.76 118.82 10.17 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.651 0.738 . . . . 54.07 112.621 -177.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 13.7 m -40.23 -46.87 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 116.545 2.054 . . . . 50.68 116.545 173.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1354 ' ' VAL . . . . . 0.547 ' O ' HG23 ' A' 1358 ' ' VAL . 3.2 m -77.52 -41.85 29.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 122.426 2.375 . . . . 47.68 109.466 -174.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1355 ' ' ILE . . . . . 0.47 HD11 HD23 ' A' 1337 ' ' LEU . 53.6 mt -64.88 -49.26 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.718 1.207 . . . . 48.490000000000002 107.791 -177.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1356 ' ' ARG . . . . . 0.41 ' NH1' ' O ' ' A' 1367 ' ' THR . 31.4 tpt85 -57.17 -40.71 77.86 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.592 0.96 . . . . 48.270000000000003 113.592 172.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -67.21 -39.9 92.37 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-O 119.018 -0.879 . . . . 43.530000000000001 111.911 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1358 ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' 1354 ' ' VAL . 5.7 t -72.06 -36.35 56.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 CA-C-O 118.554 -0.736 . . . . 45.119999999999997 112.045 176.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1359 ' ' THR . . . . . . . . . . . . . 10.6 m -72.21 88.11 1.13 Allowed 'General case' 0 C--O 1.239 0.517 0 CA-C-N 119.346 0.975 . . . . 42.939999999999998 110.492 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 27.6 m -85.77 -25.51 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 CA-C-O 121.794 0.807 . . . . 43.259999999999998 110.805 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1361 ' ' ILE . . . . . 0.618 ' HB ' ' HB ' ' A' 1112 ' ' VAL . 23.6 mm -126.55 114.71 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 117.705 -3.122 . . . . 45.659999999999997 102.994 171.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1362 ' ' ARG . . . . . 0.518 ' NH2' ' HB ' ' A' 1348 ' ' VAL . 32.4 ttt180 -100.93 104.13 15.31 Favored 'General case' 0 CA--C 1.511 -0.548 0 O-C-N 119.128 -2.232 . . . . 61.340000000000003 109.687 172.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 54.54 51.34 14.21 Favored 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 114.367 1.247 . . . . 49.759999999999998 114.367 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 86.68 -27.38 5.89 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 117.997 1.959 . . . . 50.0 117.997 -175.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -81.71 138.19 35.28 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 120.476 2.138 . . . . 56.920000000000002 106.951 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1366 ' ' ILE . . . . . . . . . . . . . 70.1 mt -83.18 100.56 6.89 Favored 'Isoleucine or valine' 0 C--O 1.263 1.811 0 N-CA-C 105.629 -1.989 . . . . 52.780000000000001 105.629 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1367 ' ' THR . . . . . 0.41 ' O ' ' NH1' ' A' 1356 ' ' ARG . 10.8 p -94.22 10.92 32.05 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 112.916 -1.947 . . . . 49.439999999999998 110.199 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 6.7 t90 -73.32 150.39 89.5 Favored Pre-proline 0 C--O 1.251 1.141 0 N-CA-C 106.479 -1.674 . . . . 52.380000000000003 106.479 162.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -68.48 169.58 56.62 Favored 'Cis proline' 0 C--O 1.249 1.057 0 N-CA-C 121.017 3.43 . . . . 46.939999999999998 121.017 -0.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1370 ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' 1371 ' ' PRO . . . -86.99 124.89 68.08 Favored Pre-proline 0 CA--C 1.506 -0.728 0 CA-C-O 122.366 1.079 . . . . 45.909999999999997 109.404 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1371 ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' 1370 ' ' ALA . 85.3 Cg_exo -70.81 126.84 13.03 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 122.849 2.366 . . . . 46.390000000000001 111.974 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -77.31 -57.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 123.538 2.825 . . . . 46.719999999999999 108.332 169.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.221 -5.008 0 O-C-N 119.552 -1.968 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 15.4 m80 . . . . . 0 N--CA 1.432 -1.353 0 N-CA-C 104.361 -2.459 . . . . 63.439999999999998 104.361 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 999' ' ' HIS . . . . . 0.568 ' HB2' ' HA ' ' B' 1066 ' ' SER . 96.8 m-70 -126.03 56.03 1.44 Allowed 'General case' 0 C--N 1.352 0.698 0 CA-C-N 121.292 1.86 . . . . 51.740000000000002 109.792 175.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1000 ' ' HIS . . . . . 0.454 ' HA ' ' HB2' ' B' 1067 ' ' GLU . 20.0 m-70 -71.87 145.71 48.38 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 114.162 -1.381 . . . . 54.07 110.936 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 64.56 5.87 19.58 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 122.435 1.02 . . . . 39.219999999999999 112.675 -173.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1002 ' ' ARG . . . . . 0.658 ' HG3' ' HB ' ' B' 1032 ' ' THR . 28.0 ttp180 -104.62 141.41 36.48 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 119.523 -2.163 . . . . 38.119999999999997 106.8 -173.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1003 ' ' ILE . . . . . 0.489 HG12 ' HB ' ' B' 1068 ' ' ILE . 87.4 mt -100.79 134.47 40.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 105.827 -1.916 . . . . 29.699999999999999 105.827 174.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -94.56 135.13 12.31 Favored Glycine 0 N--CA 1.419 -2.448 0 C-N-CA 119.914 -1.136 . . . . 27.5 111.136 156.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1005 ' ' ILE . . . . . . . . . . . . . 40.6 mm -104.61 104.86 47.76 Favored Pre-proline 0 CA--C 1.553 1.064 0 N-CA-C 102.244 -3.243 . . . . 24.829999999999998 102.244 171.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -66.25 157.47 59.84 Favored 'Trans proline' 0 C--N 1.361 1.214 1 C-N-CA 125.818 4.345 . . . . 27.190000000000001 114.811 172.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 44.1 ttt180 -86.26 101.78 13.36 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 113.765 -1.561 . . . . 41.460000000000001 107.874 173.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1008 ' ' GLU . . . . . 0.423 ' HG3' ' HB ' ' B' 1072 ' ' VAL . 5.4 mm-40 -49.35 134.23 18.89 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 117.342 2.349 . . . . 26.93 117.342 -175.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 32.3 mmm-85 -107.52 -11.32 15.51 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 111.935 -2.393 . . . . 34.479999999999997 114.129 -163.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1010 ' ' LEU . . . . . 0.675 ' HB3' ' HB2' ' B' 1013 ' ' GLU . 13.0 tp -63.31 145.5 55.43 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-N 119.796 1.18 . . . . 44.219999999999999 112.514 -174.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1011 ' ' THR . . . . . . . . . . . . . 33.1 m -32.95 106.65 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 115.75 1.759 . . . . 40.740000000000002 115.75 172.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 53.9 t30 46.25 49.69 12.6 Favored 'General case' 0 C--O 1.254 1.302 0 C-N-CA 125.552 1.541 . . . . 44.439999999999998 112.737 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1013 ' ' GLU . . . . . 0.675 ' HB2' ' HB3' ' B' 1010 ' ' LEU . 7.9 tp10 -79.97 133.57 36.19 Favored 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 118.292 -1.363 . . . . 29.870000000000001 108.102 177.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1014 ' ' THR . . . . . 0.479 ' HB ' ' O ' ' B' 1317 ' ' GLY . 3.4 m -112.76 -9.01 13.73 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 107.353 -1.351 . . . . 25.260000000000002 107.353 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1015 ' ' ARG . . . . . 0.626 ' HG3' ' HA2' ' B' 1317 ' ' GLY . 67.9 mtm180 -77.92 129.42 35.33 Favored 'General case' 0 CA--C 1.503 -0.854 0 O-C-N 120.359 -1.463 . . . . 29.539999999999999 110.694 174.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1016 ' ' VAL . . . . . 0.678 HG21 ' HB1' ' B' 1039 ' ' ALA . 5.0 p -97.65 177.64 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 120.388 -1.445 . . . . 23.550000000000001 107.452 155.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1017 ' ' ALA . . . . . 0.591 ' H ' HG22 ' B' 1016 ' ' VAL . . . -79.89 -19.37 48.35 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.154 -1.591 . . . . 23.59 113.604 -177.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1018 ' ' ALA . . . . . 0.532 ' HB1' ' HB ' ' B' 1022 ' ' THR . . . -153.43 146.87 24.9 Favored 'General case' 0 N--CA 1.442 -0.825 0 O-C-N 119.908 -1.745 . . . . 24.93 114.143 -167.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1019 ' ' THR . . . . . . . . . . . . . 76.7 p -88.75 172.29 7.79 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 118.594 0.634 . . . . 28.09 112.509 169.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1020 ' ' PRO . . . . . 0.475 ' O ' ' HB ' ' B' 1023 ' ' VAL . 42.7 Cg_exo -55.25 -36.1 92.67 Favored 'Trans proline' 0 C--O 1.249 1.046 0 C-N-CA 122.448 2.098 . . . . 28.789999999999999 116.631 165.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 51.4 tttt -54.13 -51.12 65.25 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 119.013 -2.304 . . . . 47.280000000000001 113.325 161.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1022 ' ' THR . . . . . 0.532 ' HB ' ' HB1' ' B' 1018 ' ' ALA . 22.8 m -52.77 -38.68 61.38 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 118.471 0.578 . . . . 30.120000000000001 109.873 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1023 ' ' VAL . . . . . 0.521 ' HA ' HG21 ' B' 1033 ' ' VAL . 73.5 t -53.41 -53.37 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 O-C-N 121.254 -0.904 . . . . 32.240000000000002 109.156 174.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1024 ' ' GLU . . . . . 0.545 ' O ' ' HG3' ' B' 1028 ' ' LYS . 15.1 mt-10 -57.42 -41.94 81.38 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.906 0.86 . . . . 49.619999999999997 113.193 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -58.39 -47.77 82.79 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 123.044 1.402 . . . . 44.68 111.735 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 41.5 mt -72.13 -34.37 68.52 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.528 -1.215 . . . . 35.710000000000001 110.487 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1027 ' ' LEU . . . . . 0.51 HD23 ' O ' ' B' 1031 ' ' PHE . 50.5 mt -57.64 -40.52 79.41 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 122.927 1.346 . . . . 42.18 110.636 175.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1028 ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' B' 1024 ' ' GLU . 58.2 mttm -58.34 -36.45 73.43 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 115.211 -0.904 . . . . 48.340000000000003 111.425 173.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1029 ' ' LEU . . . . . 0.724 HD21 ' HG2' ' B' 1336 ' ' LYS . 20.7 mt -77.33 -1.87 32.07 Favored 'General case' 0 C--O 1.259 1.56 0 N-CA-C 116.414 2.005 . . . . 38.689999999999998 116.414 175.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 90.03 25.0 28.04 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 125.877 1.703 . . . . 32.280000000000001 111.189 176.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1031 ' ' PHE . . . . . 0.51 ' O ' HD23 ' B' 1027 ' ' LEU . 55.0 m-85 -103.89 127.96 51.39 Favored 'General case' 0 C--O 1.252 1.236 0 N-CA-C 107.78 -1.193 . . . . 35.939999999999998 107.78 -177.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1032 ' ' THR . . . . . 0.658 ' HB ' ' HG3' ' B' 1002 ' ' ARG . 11.9 m -72.22 122.2 20.65 Favored 'General case' 0 C--O 1.251 1.166 0 N-CA-C 103.165 -2.902 . . . . 33.369999999999997 103.165 167.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1033 ' ' VAL . . . . . 0.521 HG21 ' HA ' ' B' 1023 ' ' VAL . 48.8 t -93.32 134.92 29.48 Favored 'Isoleucine or valine' 0 C--O 1.258 1.508 0 N-CA-C 104.681 -2.34 . . . . 29.98 104.681 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -123.0 140.11 53.38 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 104.063 -2.569 . . . . 28.18 104.063 172.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1035 ' ' VAL . . . . . 0.442 HG21 ' CD2' ' B' 1050 ' ' PHE . 89.3 t -131.5 135.14 59.79 Favored 'Isoleucine or valine' 0 C--O 1.255 1.373 0 N-CA-C 104.29 -2.485 . . . . 25.82 104.29 -170.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1036 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.91 151.23 43.49 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-O 123.123 1.44 . . . . 32.439999999999998 109.755 177.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1037 ' ' SER . . . . . . . . . . . . . 47.1 p -65.99 130.09 42.06 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 111.839 -2.437 . . . . 29.539999999999999 112.413 177.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 92.96 -15.57 62.5 Favored Glycine 0 CA--C 1.504 -0.645 0 O-C-N 118.366 -2.709 . . . . 27.760000000000002 111.62 -177.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1039 ' ' ALA . . . . . 0.678 ' HB1' HG21 ' B' 1016 ' ' VAL . . . -73.52 -33.93 64.99 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-O 122.29 1.043 . . . . 26.02 112.874 -171.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -59.86 -53.78 43.06 Favored Glycine 0 C--O 1.249 1.076 0 N-CA-C 110.477 -1.049 . . . . 26.469999999999999 110.477 167.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.07 -26.79 64.93 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 117.154 -1.403 . . . . 50.979999999999997 112.154 -177.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 58.3 mt -54.47 -48.84 71.31 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 120.944 1.702 . . . . 29.300000000000001 112.091 167.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1043 ' ' ALA . . . . . 0.507 ' HA ' ' HB2' ' B' 1320 ' ' PRO . . . -88.27 36.37 0.78 Allowed 'General case' 0 C--O 1.238 0.486 0 CA-C-O 116.166 -1.873 . . . . 26.739999999999998 111.341 -177.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1044 ' ' SER . . . . . . . . . . . . . 18.9 m 47.72 31.3 2.12 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 116.038 1.866 . . . . 31.260000000000002 116.038 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1045 ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.77 147.93 48.4 Favored 'General case' 0 C--N 1.36 1.051 0 CA-C-O 122.585 1.183 . . . . 33.259999999999998 109.366 177.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 11.3 t0 -71.2 123.75 22.92 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.153 -1.054 . . . . 46.740000000000002 108.153 173.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.75 -29.3 64.68 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 124.993 1.317 . . . . 34.439999999999998 112.1 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1048 ' ' LYS . . . . . 0.506 ' HA ' HG22 ' B' 1051 ' ' VAL . 0.8 OUTLIER -64.32 -22.45 66.95 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 119.624 -1.923 . . . . 48.670000000000002 113.12 172.327 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -64.69 -26.5 68.4 Favored 'General case' 0 C--N 1.365 1.262 0 O-C-N 119.311 -2.118 . . . . 35.259999999999998 112.692 169.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1050 ' ' PHE . . . . . 0.442 ' CD2' HG21 ' B' 1035 ' ' VAL . 64.4 m-85 -69.1 -40.38 78.42 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 118.474 -0.774 . . . . 32.170000000000002 111.952 168.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1051 ' ' VAL . . . . . 0.506 HG22 ' HA ' ' B' 1048 ' ' LYS . 20.6 m -70.93 -29.25 36.47 Favored 'Isoleucine or valine' 0 C--N 1.347 0.477 0 CA-C-N 120.668 1.576 . . . . 38.369999999999997 111.155 175.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -60.18 -48.05 83.36 Favored 'General case' 0 C--O 1.205 -1.257 0 O-C-N 119.013 -2.304 . . . . 45.770000000000003 111.405 167.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -64.62 -16.56 62.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 115.29 1.589 . . . . 37.829999999999998 115.29 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 99.39 31.53 6.1 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.632 -0.987 . . . . 35.82 110.632 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -110.77 143.45 41.29 Favored 'General case' 0 C--N 1.356 0.858 0 O-C-N 120.859 -1.377 . . . . 33.770000000000003 108.448 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -90.81 115.88 28.22 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 120.113 -1.617 . . . . 51.020000000000003 109.46 -172.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1057 ' ' ILE . . . . . . . . . . . . . 11.8 mm -76.15 109.59 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 106.494 -1.669 . . . . 38.469999999999999 106.494 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 6.5 m -126.03 126.26 69.39 Favored 'Isoleucine or valine' 0 C--O 1.247 0.969 0 CA-C-O 123.613 1.673 . . . . 39.399999999999999 111.576 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -86.52 125.49 33.8 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.977 -1.011 . . . . 57.07 111.195 -162.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . 71.31 -124.66 11.24 Favored Glycine 0 CA--C 1.517 0.206 0 O-C-N 125.785 1.928 . . . . 44.829999999999998 112.795 167.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -57.84 -31.36 66.58 Favored 'General case' 0 CA--C 1.481 -1.709 0 CA-C-N 118.566 1.183 . . . . 46.270000000000003 113.946 -175.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1062 ' ' SER . . . . . . . . . . . . . 4.8 m -52.47 -51.17 60.68 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 116.727 -1.606 . . . . 43.469999999999999 107.407 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.21 -39.81 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 121.313 1.87 . . . . 36.979999999999997 110.59 -177.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 93.2 m95 -60.41 -38.46 84.11 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 117.072 2.249 . . . . 37.899999999999999 117.072 174.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1065 ' ' GLN . . . . . 0.417 ' O ' ' NH2' ' B' 1002 ' ' ARG . 6.0 mm-40 -74.0 106.92 5.91 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 122.875 2.58 . . . . 46.189999999999998 104.952 172.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1066 ' ' SER . . . . . 0.568 ' HA ' ' HB2' ' B' ' 999' ' ' HIS . 51.1 m -164.76 166.49 19.81 Favored 'General case' 0 C--O 1.25 1.121 0 N-CA-C 109.304 -0.628 . . . . 37.060000000000002 109.304 -178.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1067 ' ' GLU . . . . . 0.454 ' HB2' ' HA ' ' B' 1000 ' ' HIS . 1.0 OUTLIER -65.55 -53.36 43.08 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 125.662 1.851 . . . . 43.950000000000003 111.993 169.586 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B 1068 ' ' ILE . . . . . 0.489 ' HB ' HG12 ' B' 1003 ' ' ILE . 4.5 mp -120.33 145.47 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 102.907 -2.997 . . . . 33.5 102.907 -173.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 16.8 mm -127.52 117.77 47.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 103.452 -2.796 . . . . 30.57 103.452 170.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1070 ' ' LEU . . . . . 0.741 HD22 HD22 ' B' 1331 ' ' LEU . 96.8 mt -106.42 114.46 28.59 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 103.934 -2.617 . . . . 27.66 103.934 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1071 ' ' LYS . . . . . 0.503 ' HB3' ' OG ' ' B' 1091 ' ' SER . 43.6 tttm -133.99 153.71 51.6 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 106.848 -1.538 . . . . 28.399999999999999 106.848 -168.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1072 ' ' VAL . . . . . 0.423 ' HB ' ' HG3' ' B' 1008 ' ' GLU . 61.5 t -85.03 -65.62 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 CA-C-N 119.517 1.053 . . . . 23.18 108.507 -174.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -107.02 165.34 11.42 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 105.865 -1.902 . . . . 25.469999999999999 105.865 -168.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -51.58 135.91 33.87 Favored Pre-proline 0 C--O 1.206 -1.22 0 CA-C-N 111.841 -2.436 . . . . 27.899999999999999 113.468 -171.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -60.22 123.49 13.26 Favored 'Trans proline' 0 N--CA 1.429 -2.279 0 C-N-CA 123.491 2.794 . . . . 31.620000000000001 113.425 171.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 91.6 mt -70.78 161.96 29.98 Favored 'General case' 0 C--O 1.244 0.802 0 O-C-N 125.61 1.818 . . . . 40.490000000000002 107.453 174.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1077 ' ' ASP . . . . . 0.471 ' HA ' HD12 ' B' 1080 ' ' ILE . 33.6 t70 -44.79 -42.28 7.68 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 120.072 3.36 . . . . 51.590000000000003 120.072 -173.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -68.09 -44.38 76.38 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 113.535 -1.666 . . . . 42.359999999999999 112.059 173.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1079 ' ' GLU . . . . . 0.431 ' HA ' HD12 ' B' 1082 ' ' LEU . 36.3 mt-10 -61.63 -35.7 78.66 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.109 -1.071 . . . . 34.530000000000001 108.109 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1080 ' ' ILE . . . . . 0.601 HG21 ' HB3' ' B' 1104 ' ' LYS . 76.5 mt -56.42 -50.91 70.15 Favored 'Isoleucine or valine' 0 C--O 1.25 1.082 0 O-C-N 119.936 -1.728 . . . . 33.25 108.524 172.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -63.59 -33.85 76.51 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 119.579 -1.95 . . . . 36.469999999999999 112.74 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1082 ' ' LEU . . . . . 0.431 HD12 ' HA ' ' B' 1079 ' ' GLU . 67.5 mt -61.05 -38.43 86.13 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.873 -0.603 . . . . 37.759999999999998 112.119 174.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1083 ' ' LEU . . . . . 0.448 ' HB3' HG11 ' B' 1110 ' ' VAL . 14.2 mt -58.66 154.31 14.74 Favored 'General case' 0 C--O 1.261 1.667 0 CA-C-O 123.594 1.664 . . . . 37.43 110.851 172.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1084 ' ' ASN . . . . . 0.407 ' HB2' ' OG1' ' B' 1087 ' ' THR . 3.0 m-80 -124.1 154.73 68.31 Favored Pre-proline 0 C--O 1.237 0.429 0 N-CA-C 106.747 -1.575 . . . . 37.700000000000003 106.747 -158.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -50.42 129.87 27.52 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 124.515 3.477 . . . . 35.509999999999998 110.667 171.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 93.58 -46.37 2.34 Favored Glycine 0 CA--C 1.542 1.738 0 CA-C-O 117.041 -1.977 . . . . 33.869999999999997 113.306 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1087 ' ' THR . . . . . 0.407 ' OG1' ' HB2' ' B' 1084 ' ' ASN . 59.1 m -46.28 118.13 1.82 Allowed 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 114.906 1.446 . . . . 32.5 114.906 -164.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1088 ' ' THR . . . . . . . . . . . . . 54.6 m -69.17 101.27 1.42 Allowed 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 106.782 -1.562 . . . . 30.219999999999999 106.782 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1089 ' ' LEU . . . . . 0.443 HD13 HD21 ' B' 1083 ' ' LEU . 13.2 tp -95.6 128.74 42.72 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-O 123.691 1.71 . . . . 27.239999999999998 110.245 174.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1090 ' ' VAL . . . . . 0.465 HG13 ' HB2' ' B' 1113 ' ' MET . 19.2 t -123.53 115.59 45.8 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 N-CA-C 105.677 -1.972 . . . . 25.390000000000001 105.677 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1091 ' ' SER . . . . . 0.503 ' OG ' ' HB3' ' B' 1071 ' ' LYS . 14.8 m -155.76 165.39 36.65 Favored 'General case' 0 C--N 1.352 0.685 0 O-C-N 120.654 -1.278 . . . . 28.809999999999999 110.123 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1092 ' ' PHE . . . . . 0.651 ' HZ ' ' HG3' ' B' 1133 ' ' MET . 88.4 m-85 -64.53 103.86 0.72 Allowed 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 107.119 -1.437 . . . . 30.780000000000001 107.119 158.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 26.9 mm -94.79 -37.92 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.221 0 CA-C-N 114.561 -1.2 . . . . 30.280000000000001 111.632 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1094 ' ' TRP . . . . . 0.469 ' HB3' ' HB2' ' B' 1097 ' ' GLN . 82.6 m95 60.25 71.83 0.82 Allowed Pre-proline 0 C--O 1.242 0.659 0 N-CA-C 107.057 -1.461 . . . . 34.07 107.057 -178.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -55.95 -58.06 1.24 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 125.24 3.96 . . . . 38.659999999999997 115.416 -170.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -66.22 -21.34 66.3 Favored 'General case' 0 CA--C 1.505 -0.762 0 O-C-N 120.627 -1.296 . . . . 41.32 112.321 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1097 ' ' GLN . . . . . 0.469 ' HB2' ' HB3' ' B' 1094 ' ' TRP . 12.6 mp0 -89.07 -20.89 23.77 Favored 'General case' 0 C--O 1.25 1.118 0 N-CA-C 107.23 -1.396 . . . . 51.659999999999997 107.23 -176.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1098 ' ' ASN . . . . . 0.416 ' HB3' ' HB3' ' B' 1101 ' ' LEU . 73.6 m-20 -135.57 54.92 11.36 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-N 120.7 1.591 . . . . 40.32 110.387 -176.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1099 ' ' PRO . . . . . 0.452 ' O ' ' HB2' ' B' 1102 ' ' MET . 58.8 Cg_endo -55.51 -49.01 17.45 Favored 'Trans proline' 0 CA--C 1.54 0.819 1 C-N-CA 125.314 4.009 . . . . 41.560000000000002 119.478 -175.343 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.85 -40.38 88.4 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.538 0.94 . . . . 54.109999999999999 113.538 173.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1101 ' ' LEU . . . . . 0.416 ' HB3' ' HB3' ' B' 1098 ' ' ASN . 9.3 tt -58.51 -49.51 77.13 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 125.194 1.398 . . . . 37.880000000000003 107.374 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1102 ' ' MET . . . . . 0.452 ' HB2' ' O ' ' B' 1099 ' ' PRO . 69.7 mmm -49.74 -45.64 49.59 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 113.934 1.087 . . . . 37.539999999999999 113.934 165.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -65.26 -44.14 89.08 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 121.288 1.858 . . . . 47.009999999999998 110.367 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1104 ' ' LYS . . . . . 0.601 ' HB3' HG21 ' B' 1080 ' ' ILE . 74.1 mttt -60.36 -38.49 84.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 119.423 -2.048 . . . . 48.68 110.652 -178.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1105 ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.04 -41.44 99.5 Favored 'General case' 0 C--O 1.25 1.081 0 CA-C-O 122.888 1.327 . . . . 32.210000000000001 113.977 171.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -63.91 -44.59 92.48 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.26 1.824 . . . . 33.729999999999997 108.93 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -54.11 -49.33 69.4 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 121.406 -0.809 . . . . 51.469999999999999 110.056 170.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1108 ' ' ARG . . . . . 0.589 ' HG2' ' O ' ' B' 1104 ' ' LYS . 13.9 mmm180 -67.86 -16.46 64.1 Favored 'General case' 0 C--O 1.207 -1.179 0 CA-C-N 120.221 1.373 . . . . 43.899999999999999 110.92 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1109 ' ' ASN . . . . . . . . . . . . . 4.6 m-80 69.41 28.84 4.62 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 123.73 1.728 . . . . 44.82 113.158 174.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1110 ' ' VAL . . . . . 0.448 HG11 ' HB3' ' B' 1083 ' ' LEU . 17.4 m -72.87 151.19 7.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 CA-C-N 114.179 -1.373 . . . . 30.52 109.45 174.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1111 ' ' THR . . . . . 0.431 ' HA ' ' H ' ' B' 1363 ' ' ALA . 6.4 m -94.77 107.3 19.31 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 106.524 -1.658 . . . . 27.120000000000001 106.524 176.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1112 ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' B' 1089 ' ' LEU . 4.0 t -101.29 126.14 55.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 115.237 1.569 . . . . 26.399999999999999 115.237 -169.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1113 ' ' MET . . . . . 0.465 ' HB2' HG13 ' B' 1090 ' ' VAL . 0.0 OUTLIER -107.43 127.57 53.71 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 106.08 -1.822 . . . . 42.920000000000002 106.08 165.209 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -100.74 105.74 17.09 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 113.362 -1.745 . . . . 24.149999999999999 108.044 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1115 ' ' MET . . . . . 0.491 ' HB3' ' HB2' ' B' 1129 ' ' ALA . 56.8 mmm -60.51 -23.33 64.45 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 112.896 -1.956 . . . . 29.949999999999999 116.24 -173.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1116 ' ' ASP . . . . . 0.603 ' HB3' ' HD1' ' B' 1092 ' ' PHE . 9.2 p-10 -78.46 -33.3 48.45 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 113.249 -1.796 . . . . 34.530000000000001 112.076 176.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1117 ' ' SER . . . . . . . . . . . . . 51.2 m -111.36 48.77 0.92 Allowed 'General case' 0 N--CA 1.435 -1.207 0 O-C-N 120.483 -1.386 . . . . 33.490000000000002 109.691 -178.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1118 ' ' VAL . . . . . 0.503 HG21 ' HA ' ' B' 1128 ' ' ASP . 55.3 t -76.73 139.91 67.08 Favored Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 104.81 -2.293 . . . . 34.020000000000003 104.81 167.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -50.35 141.06 33.22 Favored 'Trans proline' 0 C--O 1.245 0.871 0 C-N-CA 123.021 2.481 . . . . 38.280000000000001 117.395 175.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1120 ' ' ARG . . . . . 0.431 ' NH2' HD12 ' B' 1130 ' ' LEU . 9.7 mmt-85 -74.69 36.35 0.11 Allowed 'General case' 0 C--O 1.242 0.694 0 N-CA-C 116.714 2.116 . . . . 55.049999999999997 116.714 177.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1121 ' ' ILE . . . . . 0.411 ' HB ' ' O ' ' C' ' 131' ' ' ALA . 17.3 pt -118.8 142.75 32.29 Favored 'Isoleucine or valine' 0 C--N 1.347 0.466 0 O-C-N 117.702 -3.124 . . . . 42.090000000000003 106.695 -176.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1122 ' ' SER . . . . . . . . . . . . . 62.0 m -35.88 -47.96 0.54 Allowed 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 117.91 2.559 . . . . 38.020000000000003 117.91 -175.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1123 ' ' ARG . . . . . 0.462 ' HG3' HG21 ' B' 1354 ' ' VAL . 37.9 ptt85 -74.86 -35.92 62.34 Favored 'General case' 0 C--O 1.208 -1.122 0 CA-C-N 123.581 2.9 . . . . 34.289999999999999 113.416 177.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1124 ' ' ALA . . . . . 0.598 ' HA ' HD13 ' B' 1127 ' ' LEU . . . -68.51 -26.54 65.5 Favored 'General case' 0 C--O 1.218 -0.57 0 O-C-N 120.314 -1.491 . . . . 32.350000000000001 109.823 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1125 ' ' GLN . . . . . 0.406 ' HA ' ' HB3' ' B' 1128 ' ' ASP . 13.1 mm100 -60.01 -15.07 19.52 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 115.42 1.637 . . . . 47.170000000000002 115.42 171.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1126 ' ' SER . . . . . . . . . . . . . 97.1 p -77.47 -30.54 53.2 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 114.568 1.321 . . . . 31.710000000000001 114.568 170.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1127 ' ' LEU . . . . . 0.598 HD13 ' HA ' ' B' 1124 ' ' ALA . 3.4 mp -83.58 -25.22 31.11 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 112.395 -2.184 . . . . 37.0 109.212 175.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1128 ' ' ASP . . . . . 0.503 ' HA ' HG21 ' B' 1118 ' ' VAL . 33.9 t70 -69.76 118.86 13.14 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 115.421 1.637 . . . . 40.399999999999999 115.421 -174.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1129 ' ' ALA . . . . . 0.491 ' HB2' ' HB3' ' B' 1115 ' ' MET . . . -62.93 -46.09 89.43 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 109.851 -3.34 . . . . 26.559999999999999 111.095 177.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1130 ' ' LEU . . . . . 0.431 HD12 ' NH2' ' B' 1120 ' ' ARG . 35.2 mt -53.95 -41.83 68.2 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 117.071 -1.442 . . . . 30.890000000000001 114.452 -173.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1131 ' ' SER . . . . . . . . . . . . . 16.3 p -62.09 -46.97 86.73 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 124.473 1.108 . . . . 29.84 113.271 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1132 ' ' SER . . . . . 0.654 ' HB3' ' HB3' ' B' 1326 ' ' LEU . 14.6 m -65.13 -46.64 80.11 Favored 'General case' 0 N--CA 1.421 -1.881 0 O-C-N 119.421 -2.049 . . . . 31.91 111.17 174.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1133 ' ' MET . . . . . 0.651 ' HG3' ' HZ ' ' B' 1092 ' ' PHE . 38.8 mmt -59.32 -32.17 69.83 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 120.555 -1.341 . . . . 25.899999999999999 114.182 175.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1134 ' ' ALA . . . . . 0.611 ' HB1' ' HB2' ' B' 1176 ' ' ALA . . . -75.07 -35.66 61.82 Favored 'General case' 0 C--O 1.203 -1.369 0 O-C-N 120.393 -1.442 . . . . 26.620000000000001 108.542 173.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 40.7 t30 -61.23 -41.71 97.34 Favored 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 119.092 -2.255 . . . . 36.969999999999999 110.527 176.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1136 ' ' ILE . . . . . 0.62 HG21 ' HA ' ' B' 1316 ' ' PRO . 48.5 mm -59.33 -56.7 15.38 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 O-C-N 125.406 1.691 . . . . 32.109999999999999 108.47 171.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -55.69 -42.25 74.91 Favored 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 126.128 1.771 . . . . 24.140000000000001 114.682 -174.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -64.75 -45.47 92.64 Favored Glycine 0 C--N 1.316 -0.549 0 CA-C-N 122.031 2.196 . . . . 25.129999999999999 111.577 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 16.1 t80 -67.14 -43.21 82.94 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 122.683 1.23 . . . . 32.729999999999997 108.917 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1140 ' ' ARG . . . . . 0.584 HH11 HD13 ' B' 1319 ' ' LEU . 8.6 tpt180 -68.0 -32.54 73.01 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.709 -0.849 . . . . 26.359999999999999 108.709 -175.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1141 ' ' ALA . . . . . . . . . . . . . . . -55.98 -53.9 51.34 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 113.015 0.746 . . . . 24.120000000000001 113.015 170.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 36.5 mm -52.38 -45.51 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 124.052 0.941 . . . . 23.370000000000001 110.163 174.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 75.5 t -60.05 -62.8 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 117.537 -1.22 . . . . 24.960000000000001 114.274 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1144 ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' B' 1147 ' ' HIS . 59.5 mm-40 -61.87 -36.13 80.35 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-N 120.764 1.62 . . . . 32.07 111.138 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1145 ' ' ALA . . . . . 0.741 ' HA ' HG11 ' B' 1280 ' ' VAL . . . -54.28 -49.66 69.07 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 117.476 -1.25 . . . . 24.870000000000001 109.987 169.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1146 ' ' ALA . . . . . . . . . . . . . . . -67.26 -27.13 66.95 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 119.105 0.866 . . . . 24.670000000000002 110.792 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1147 ' ' HIS . . . . . 0.416 ' CD2' ' HG2' ' B' 1148 ' ' GLU . 51.9 t60 -57.85 -47.04 83.85 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 119.056 -0.497 . . . . 28.579999999999998 111.053 169.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1148 ' ' GLU . . . . . 0.416 ' HG2' ' CD2' ' B' 1147 ' ' HIS . 68.3 mm-40 -94.53 -5.09 46.78 Favored 'General case' 0 CA--C 1.501 -0.912 0 O-C-N 120.102 -1.624 . . . . 36.82 113.462 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1149 ' ' PHE . . . . . . . . . . . . . 3.3 t80 -67.73 137.52 55.54 Favored 'General case' 0 C--O 1.254 1.313 0 C-N-CA 124.827 1.251 . . . . 31.969999999999999 108.945 -177.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1150 ' ' GLY . . . . . 0.615 ' HA2' ' HD2' ' A' 1320 ' ' PRO . . . -75.31 -19.07 79.81 Favored Glycine 0 N--CA 1.44 -1.081 0 CA-C-O 118.135 -1.37 . . . . 25.489999999999998 114.083 174.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1151 ' ' ARG . . . . . . . . . . . . . 71.1 mtm-85 -130.34 177.59 7.22 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 122.811 3.305 . . . . 59.840000000000003 114.306 -158.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1152 ' ' PHE . . . . . 0.59 ' HB2' HG11 ' B' 1163 ' ' VAL . 7.1 m-30 -81.36 162.21 23.49 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 123.111 1.434 . . . . 34.450000000000003 109.238 170.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1153 ' ' PHE . . . . . 0.484 ' HB3' ' HB2' ' B' 1189 ' ' ALA . 77.4 m-85 -82.14 -50.15 9.36 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 112.949 -1.932 . . . . 31.170000000000002 108.834 165.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1154 ' ' THR . . . . . . . . . . . . . 3.5 m -77.19 126.68 31.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 112.273 -2.239 . . . . 33.890000000000001 108.666 -168.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -81.37 65.91 3.91 Favored Glycine 0 N--CA 1.433 -1.535 0 N-CA-C 110.132 -1.187 . . . . 38.950000000000003 110.132 -176.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -67.05 146.99 53.74 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.587 1.955 . . . . 54.229999999999997 115.786 -170.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 12.7 mm -90.87 125.89 43.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 102.012 -3.329 . . . . 51.159999999999997 102.012 173.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1158 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.75 138.08 51.91 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 102.327 -3.212 . . . . 49.609999999999999 102.327 172.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -58.65 -29.2 66.38 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.744 1.156 . . . . 49.049999999999997 110.817 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1160 ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' 1126 ' ' SER . . . -55.0 -58.92 5.67 Favored 'General case' 0 C--N 1.363 1.171 0 N-CA-C 112.993 0.738 . . . . 47.649999999999999 112.993 165.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . -171.52 143.27 7.47 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 107.766 -2.133 . . . . 45.609999999999999 107.766 -165.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 92.7 mttt -78.25 138.56 38.69 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 118.584 1.192 . . . . 57.460000000000001 109.55 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1163 ' ' VAL . . . . . 0.59 HG11 ' HB2' ' B' 1152 ' ' PHE . 48.0 t -88.01 133.34 37.49 Favored Pre-proline 0 C--O 1.251 1.144 0 N-CA-C 105.533 -2.025 . . . . 42.93 105.533 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1164 ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' B' 1165 ' ' PRO . 48.2 Cg_endo -67.48 145.06 69.56 Favored 'Trans proline' 0 C--N 1.323 -0.815 0 C-N-CA 123.265 2.643 . . . . 39.289999999999999 113.655 170.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1165 ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' B' 1164 ' ' PRO . 75.7 Cg_exo -65.54 152.77 80.84 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 CA-C-N 124.016 2.47 . . . . 34.170000000000002 113.836 176.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -88.42 143.65 26.86 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.57 -1.27 . . . . 31.690000000000001 107.57 167.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1167 ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -107.7 117.35 33.89 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 106.945 -1.502 . . . . 44.780000000000001 106.945 173.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1168 ' ' VAL . . . . . 0.529 HG22 ' HB ' ' B' 1251 ' ' ILE . 61.8 t -102.59 113.83 40.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 106.418 -1.697 . . . . 31.23 106.418 -174.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1169 ' ' MET . . . . . 0.628 ' HB2' HG11 ' B' 1249 ' ' VAL . 43.0 ttp -95.94 97.52 9.68 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 120.892 0.377 . . . . 37.090000000000003 110.967 178.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1170 ' ' VAL . . . . . 0.448 HG22 ' HB ' ' B' 1253 ' ' VAL . 61.4 t -88.78 122.0 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.851 -1.166 . . . . 30.170000000000002 107.851 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1171 ' ' ILE . . . . . 0.409 HG22 ' HB2' ' B' 1256 ' ' ALA . 44.4 mt -112.07 131.94 62.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 104.097 -2.557 . . . . 33.740000000000002 104.097 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 81.29 64.6 1.76 Allowed Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 108.11 -1.996 . . . . 32.590000000000003 108.11 -174.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1173 ' ' ALA . . . . . 0.469 ' H ' ' HB2' ' B' 1195 ' ' ASP . . . -62.93 -7.01 4.37 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 120.842 -1.387 . . . . 32.420000000000002 114.683 -177.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -58.11 129.19 49.2 Favored Glycine 0 C--O 1.245 0.799 0 CA-C-O 122.8 1.222 . . . . 31.739999999999998 112.23 175.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 1.5 t 48.81 -82.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 112.612 -1.794 . . . . 31.48 114.441 173.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1176 ' ' ALA . . . . . 0.611 ' HB2' ' HB1' ' B' 1134 ' ' ALA . . . -65.34 -42.38 92.95 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.548 0.69 . . . . 26.120000000000001 112.609 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1177 ' ' GLY . . . . . . . . . . . . . . . -56.72 -45.22 91.11 Favored Glycine 0 N--CA 1.464 0.563 0 CA-C-N 113.123 -1.853 . . . . 25.73 108.781 174.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1178 ' ' LEU . . . . . 0.592 ' HA ' HD12 ' B' 1181 ' ' ILE . 5.5 tp -58.62 -48.89 79.48 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 126.288 1.835 . . . . 32.590000000000003 108.336 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -58.74 -38.81 79.22 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 114.347 1.24 . . . . 27.719999999999999 114.347 175.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -65.82 -43.21 89.28 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.884 0.874 . . . . 26.030000000000001 112.034 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1181 ' ' ILE . . . . . 0.599 HD13 HG22 ' B' 1204 ' ' VAL . 9.5 mt -56.12 -48.29 79.33 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 O-C-N 120.299 -1.5 . . . . 28.609999999999999 108.633 170.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -57.68 -49.88 70.17 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 117.749 -1.584 . . . . 25.23 112.986 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -63.48 -49.57 73.1 Favored 'General case' 0 C--O 1.249 1.063 0 CA-C-N 120.78 2.29 . . . . 24.09 113.253 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -68.02 -38.44 82.58 Favored 'General case' 0 C--O 1.24 0.605 0 O-C-N 121.497 -0.752 . . . . 26.68 109.323 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 45.5 t30 -62.32 -33.65 75.09 Favored 'General case' 0 C--O 1.249 1.042 0 O-C-N 118.075 -2.891 . . . . 36.57 111.004 174.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1186 ' ' SER . . . . . 0.557 ' HB3' ' O ' ' A' 1186 ' ' SER . 61.4 m -67.42 -45.85 74.9 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 111.941 0.348 . . . . 28.920000000000002 111.941 174.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1187 ' ' LEU . . . . . 0.513 ' HA ' ' HB3' ' A' 1186 ' ' SER . 5.6 mt -60.49 -24.64 65.45 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.093 0.957 . . . . 29.09 111.477 169.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 93.75 34.74 6.42 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 121.559 1.981 . . . . 29.260000000000002 112.224 175.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1189 ' ' ALA . . . . . 0.484 ' HB2' ' HB3' ' B' 1153 ' ' PHE . . . -104.3 146.02 29.4 Favored 'General case' 0 C--O 1.252 1.192 0 N-CA-C 107.772 -1.196 . . . . 30.16 107.772 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 69.9 mt -77.18 110.76 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 102.776 -3.046 . . . . 35.810000000000002 102.776 -173.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1191 ' ' VAL . . . . . . . . . . . . . 17.4 t -91.93 128.28 43.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 C-N-CA 118.485 -1.286 . . . . 31.969999999999999 108.024 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1192 ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' B' 1169 ' ' MET . 87.6 mtt180 -113.83 107.76 16.16 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 106.868 -1.53 . . . . 48.159999999999997 106.868 168.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -114.92 147.39 40.03 Favored 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 120.381 -1.449 . . . . 35.890000000000001 110.74 -173.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1194 ' ' PHE . . . . . 0.537 ' HB2' ' HB2' ' B' 1212 ' ' LEU . 42.0 t80 -135.9 146.96 47.92 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.304 -1.369 . . . . 41.880000000000003 107.304 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1195 ' ' ASP . . . . . 0.871 ' HB3' HG21 ' B' 1200 ' ' VAL . 23.7 t0 -154.46 154.06 32.57 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 102.051 -3.314 . . . . 38.280000000000001 102.051 172.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1196 ' ' THR . . . . . 0.459 ' HB ' ' HG2' ' B' 1230 ' ' MET . 1.8 p -85.76 37.92 0.72 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 117.695 -1.145 . . . . 40.619999999999997 110.811 -170.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1197 ' ' ARG . . . . . . . . . . . . . 75.4 mtm180 -140.24 166.2 25.13 Favored Pre-proline 0 C--O 1.246 0.878 0 CA-C-N 121.955 2.161 . . . . 53.090000000000003 112.386 -166.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -72.35 -64.33 0.03 OUTLIER 'Trans proline' 0 C--O 1.254 1.299 0 N-CA-C 119.149 2.711 . . . . 42.560000000000002 119.149 168.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.02 -34.26 63.33 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 115.574 1.694 . . . . 56.310000000000002 115.574 -167.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1200 ' ' VAL . . . . . 0.871 HG21 ' HB3' ' B' 1195 ' ' ASP . 0.3 OUTLIER -43.96 -42.18 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 N-CA-C 116.102 1.89 . . . . 42.909999999999997 116.102 172.417 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 43.5 tttm -58.2 -51.79 68.27 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 120.038 -1.664 . . . . 48.890000000000001 110.216 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -61.34 -28.05 68.94 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 122.36 1.076 . . . . 51.700000000000003 112.847 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1203 ' ' GLN . . . . . 0.551 ' HG2' ' HA ' ' B' 1200 ' ' VAL . 34.7 mm-40 -68.16 -46.55 70.45 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 107.641 -1.244 . . . . 52.57 107.641 173.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1204 ' ' VAL . . . . . 0.599 HG22 HD13 ' B' 1181 ' ' ILE . 25.5 t -63.99 -34.34 67.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 120.383 1.447 . . . . 33.789999999999999 111.292 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -61.97 -34.92 77.03 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.806 0.843 . . . . 36.579999999999998 109.972 171.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1206 ' ' SER . . . . . . . . . . . . . 14.9 m -72.78 -1.64 17.35 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 115.359 1.615 . . . . 39.609999999999999 115.359 173.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1207 ' ' MET . . . . . 0.469 ' SD ' HD11 ' C' ' 75' ' ' LEU . 2.8 mpp? -98.42 -18.68 18.13 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 113.258 0.836 . . . . 37.450000000000003 113.258 165.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 72.04 43.97 46.98 Favored Glycine 0 N--CA 1.484 1.843 0 O-C-N 119.624 -1.923 . . . . 31.870000000000001 110.868 -167.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -126.38 166.96 16.21 Favored 'General case' 0 CA--C 1.505 -0.772 0 O-C-N 120.471 -1.605 . . . . 35.399999999999999 111.899 -176.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -81.0 125.56 30.32 Favored 'General case' 0 C--O 1.216 -0.663 0 O-C-N 120.529 -1.357 . . . . 47.890000000000001 108.989 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 70.9 t80 -92.1 130.7 37.77 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 104.33 -2.47 . . . . 45.530000000000001 104.33 165.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1212 ' ' LEU . . . . . 0.537 ' HB2' ' HB2' ' B' 1194 ' ' PHE . 53.0 mt -76.25 106.89 8.12 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 105.2 -2.148 . . . . 46.329999999999998 105.2 167.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.17 150.79 37.09 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 124.07 1.89 . . . . 60.409999999999997 111.577 -173.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1214 ' ' LEU . . . . . 0.566 ' HB3' ' HE2' ' B' 1234 ' ' PHE . 8.0 mp -60.97 127.41 31.45 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 111.847 -2.433 . . . . 57.380000000000003 112.895 176.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 30.9 t0 . . . . . 0 N--CA 1.45 -0.465 0 C-N-CA 127.154 2.182 . . . . 65.069999999999993 110.46 -169.088 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B 1230 ' ' MET . . . . . 0.459 ' HG2' ' HB ' ' B' 1196 ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.417 -2.123 0 N-CA-C 102.489 -3.152 . . . . 80.319999999999993 102.489 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1231 ' ' SER . . . . . . . . . . . . 0.298 2.6 p 58.75 169.15 0.06 Allowed 'General case' 0 N--CA 1.444 -0.762 2 CA-C-N 130.094 5.861 . . . . 79.920000000000002 116.365 2.152 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -61.04 -49.76 76.06 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.274 -1.517 . . . . 77.909999999999997 108.304 175.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 34.22 -77.56 0.0 OUTLIER 'General case' 0 C--O 1.248 1.012 0 N-CA-C 119.657 3.206 . . . . 73.879999999999995 119.657 175.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1234 ' ' PHE . . . . . 0.566 ' HE2' ' HB3' ' B' 1214 ' ' LEU . 8.3 m-30 -93.59 -0.25 56.29 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 120.98 1.718 . . . . 68.980000000000004 110.365 -168.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 13.5 pt -33.16 -33.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 119.213 3.042 . . . . 64.530000000000001 119.213 -174.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -80.27 -38.57 30.63 Favored 'General case' 0 C--O 1.245 0.859 0 O-C-N 120.74 -1.225 . . . . 66.359999999999999 113.79 173.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -63.89 -47.65 79.78 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-O 117.45 -1.262 . . . . 56.600000000000001 109.154 170.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1238 ' ' GLU . . . . . 0.48 ' HG2' ' HE2' ' B' 1194 ' ' PHE . 47.7 mt-10 -47.96 -61.14 2.11 Favored 'General case' 0 C--N 1.36 1.06 0 O-C-N 124.347 1.029 . . . . 56.789999999999999 112.284 174.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1239 ' ' MET . . . . . . . . . . . . . 14.1 ttm -54.28 -50.15 67.92 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 124.853 1.261 . . . . 53.630000000000003 111.029 -175.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -72.41 -27.9 62.64 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 117.432 2.382 . . . . 51.740000000000002 117.432 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 28.2 tp -63.48 -50.46 69.6 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 106.498 -1.667 . . . . 44.859999999999999 106.498 169.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1242 ' ' PHE . . . . . 0.453 ' HE2' HD13 ' B' 1266 ' ' LEU . 18.3 m-30 -58.62 -41.91 86.99 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.998 1.436 . . . . 42.780000000000001 111.375 176.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -59.46 -44.77 92.91 Favored 'General case' 0 C--O 1.25 1.088 0 CA-C-N 120.577 1.535 . . . . 40.960000000000001 114.876 173.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -61.43 -51.84 67.07 Favored 'General case' 0 C--O 1.25 1.085 0 C-N-CA 120.169 -0.612 . . . . 43.060000000000002 110.063 174.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 -58.84 -28.64 66.26 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 116.203 1.927 . . . . 46.450000000000003 116.203 173.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -52.34 -33.09 41.21 Favored 'General case' 0 C--O 1.254 1.323 0 CA-C-N 119.291 0.95 . . . . 41.780000000000001 113.143 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1247 ' ' LYS . . . . . 0.438 ' HA ' ' HD2' ' B' 1247 ' ' LYS . 22.0 tptt -76.61 -31.56 57.52 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 120.932 -1.105 . . . . 52.200000000000003 112.322 177.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1248 ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -84.49 -42.12 15.87 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 120.818 -1.176 . . . . 53.549999999999997 112.697 178.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1249 ' ' VAL . . . . . 0.628 HG11 ' HB2' ' B' 1169 ' ' MET . 36.0 m -82.03 160.11 3.82 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.788 0 CA-C-O 123.154 1.454 . . . . 34.409999999999997 113.713 -162.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1250 ' ' ASP . . . . . 0.603 ' O ' ' HB3' ' B' 1279 ' ' SER . 3.7 m-20 -107.48 -69.72 0.83 Allowed 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 111.832 -2.44 . . . . 33.380000000000003 113.748 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1251 ' ' ILE . . . . . 0.714 HD12 ' HB1' ' B' 1145 ' ' ALA . 44.2 mm -101.6 102.5 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 N-CA-C 108.04 -1.096 . . . . 29.539999999999999 108.04 -175.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1252 ' ' ILE . . . . . 0.56 HD12 HG12 ' B' 1281 ' ' ILE . 75.0 mt -83.29 116.41 27.34 Favored 'Isoleucine or valine' 0 C--O 1.25 1.127 0 N-CA-C 107.082 -1.451 . . . . 32.439999999999998 107.082 168.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1253 ' ' VAL . . . . . 0.545 HG13 HD11 ' B' 1284 ' ' LEU . 39.0 t -101.16 87.9 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 105.644 -1.984 . . . . 30.57 105.644 174.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1254 ' ' THR . . . . . . . . . . . . . 1.2 t -92.85 115.02 27.73 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-O 125.462 2.553 . . . . 35.039999999999999 111.331 -174.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1255 ' ' THR . . . . . . . . . . . . . 7.1 m -135.83 10.16 3.35 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 110.606 -2.997 . . . . 34.619999999999997 108.987 -161.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1256 ' ' ALA . . . . . 0.409 ' HB2' HG22 ' B' 1171 ' ' ILE . . . -70.37 84.86 0.58 Allowed 'General case' 0 C--N 1.35 0.628 0 O-C-N 121.086 -1.009 . . . . 42.719999999999999 113.552 -172.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 41.1 mt -105.89 126.63 52.41 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 125.387 1.475 . . . . 52.43 110.103 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1258 ' ' ILE . . . . . 0.407 ' HA ' ' HD2' ' B' 1259 ' ' PRO . 2.6 mp -77.14 132.1 71.2 Favored Pre-proline 0 N--CA 1.438 -1.057 0 N-CA-C 103.151 -2.907 . . . . 59.409999999999997 103.151 168.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1259 ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' B' 1258 ' ' ILE . 67.7 Cg_endo -65.22 69.87 0.29 Allowed 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 124.217 3.278 . . . . 62.68 111.967 169.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 153.19 -81.12 0.18 Allowed Glycine 0 CA--C 1.534 1.266 0 O-C-N 118.653 -2.53 . . . . 64.159999999999997 108.43 -171.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 38.3 tttt -64.69 138.45 97.46 Favored Pre-proline 0 N--CA 1.44 -0.968 0 N-CA-C 114.755 1.391 . . . . 68.530000000000001 114.755 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -55.31 132.08 50.07 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 124.703 3.602 . . . . 61.990000000000002 111.392 166.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1263 ' ' ALA . . . . . . . . . . . . . . . -59.53 128.18 85.73 Favored Pre-proline 0 C--O 1.239 0.544 0 CA-C-N 111.675 -2.511 . . . . 57.149999999999999 111.407 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1264 ' ' PRO . . . . . 0.475 ' O ' ' HA ' ' B' 1291 ' ' ASN . 97.1 Cg_endo -64.19 146.08 89.95 Favored 'Trans proline' 0 C--O 1.25 1.077 0 C-N-CA 124.69 3.594 . . . . 51.57 113.815 177.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1265 ' ' LYS . . . . . 0.463 ' NZ ' ' O ' ' B' 1289 ' ' GLY . 38.5 mmtm -71.7 97.44 1.75 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 123.56 1.647 . . . . 54.549999999999997 108.309 167.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1266 ' ' LEU . . . . . 0.453 HD13 ' HE2' ' B' 1242 ' ' PHE . 91.3 mt -94.14 -47.85 6.47 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 123.223 1.487 . . . . 46.859999999999999 112.134 172.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1267 ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' B' 1292 ' ' CYS . 20.7 mm -84.06 82.36 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 104.651 -2.351 . . . . 41.039999999999999 104.651 -175.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1268 ' ' THR . . . . . 0.643 ' HA ' ' HG3' ' B' 1293 ' ' GLU . 23.2 p -82.36 175.45 10.24 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 111.068 -2.787 . . . . 39.579999999999998 108.729 -175.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1269 ' ' ARG . . . . . 0.457 ' HG2' ' CE2' ' B' 1294 ' ' TYR . 64.8 mtt85 -52.56 -41.28 63.42 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.019 0.927 . . . . 53.149999999999999 111.765 175.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -60.57 -21.06 62.18 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 115.727 1.751 . . . . 42.960000000000001 115.727 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1271 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.42 -51.51 6.89 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 120.338 1.426 . . . . 43.890000000000001 110.725 162.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1272 ' ' VAL . . . . . 0.41 HG23 ' O ' ' B' 1268 ' ' THR . 96.4 t -57.72 -60.68 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 CA-C-N 115.187 -0.915 . . . . 38.369999999999997 112.203 -168.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.26 -34.93 77.49 Favored 'General case' 0 C--O 1.247 0.97 0 O-C-N 119.541 -1.974 . . . . 47.460000000000001 112.708 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1274 ' ' SER . . . . . . . . . . . . . 5.2 m -74.32 -17.03 60.9 Favored 'General case' 0 C--O 1.244 0.786 0 O-C-N 120.044 -1.66 . . . . 38.380000000000003 111.16 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1275 ' ' MET . . . . . 0.581 ' SD ' HD11 ' B' 1281 ' ' ILE . 38.3 mtp -53.75 145.07 16.53 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 118.747 2.869 . . . . 37.810000000000002 118.747 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -61.39 130.76 47.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.547 -1.206 . . . . 49.259999999999998 109.101 171.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1277 ' ' ALA . . . . . 0.406 ' HB1' ' HA ' ' A' 1045 ' ' PHE . . . -64.03 165.35 9.12 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 118.5 2.778 . . . . 34.460000000000001 118.5 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 67.34 26.47 73.52 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-O 124.711 2.284 . . . . 33.530000000000001 115.363 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1279 ' ' SER . . . . . 0.603 ' HB3' ' O ' ' B' 1250 ' ' ASP . 36.6 m -127.89 159.75 33.95 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 111.243 -2.478 . . . . 31.309999999999999 106.139 -168.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1280 ' ' VAL . . . . . 0.741 HG11 ' HA ' ' B' 1145 ' ' ALA . 94.8 t -128.28 129.31 69.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.537 -0.912 . . . . 29.32 108.537 -165.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1281 ' ' ILE . . . . . 0.581 HD11 ' SD ' ' B' 1275 ' ' MET . 58.5 mt -99.49 96.28 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 N-CA-C 107.304 -1.369 . . . . 31.93 107.304 170.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1282 ' ' VAL . . . . . . . . . . . . . 14.2 t -80.63 110.99 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 O-C-N 120.383 -1.448 . . . . 29.48 110.793 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 33.6 t0 -90.57 95.81 10.34 Favored 'General case' 0 N--CA 1.417 -2.115 0 O-C-N 120.289 -1.507 . . . . 34.5 107.189 173.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1284 ' ' LEU . . . . . 0.545 HD11 HG13 ' B' 1253 ' ' VAL . 5.0 mp -76.65 -21.97 54.72 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-N 113.18 -1.827 . . . . 37.939999999999998 111.207 173.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -87.0 8.01 25.2 Favored 'General case' 0 C--N 1.35 0.589 0 N-CA-C 115.656 1.724 . . . . 40.920000000000002 115.656 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -50.29 -42.66 52.79 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 119.524 3.157 . . . . 44.390000000000001 119.524 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1287 ' ' GLN . . . . . 0.452 ' HB3' HG22 ' B' 1313 ' ' THR . 1.7 pm0 -64.03 -28.86 70.09 Favored 'General case' 0 C--O 1.257 1.495 0 O-C-N 119.322 -2.111 . . . . 51.460000000000001 114.137 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 38.9 t30 -121.91 76.78 1.31 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.243 -1.021 . . . . 57.75 108.243 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1289 ' ' GLY . . . . . 0.463 ' O ' ' NZ ' ' B' 1265 ' ' LYS . . . 98.45 -60.68 0.9 Allowed Glycine 0 C--N 1.336 0.531 0 O-C-N 120.102 -1.624 . . . . 49.850000000000001 114.902 176.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 80.99 119.48 0.44 Allowed Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 121.247 2.523 . . . . 45.93 112.128 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1291 ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' B' 1264 ' ' PRO . 27.0 m120 -81.5 -25.84 35.66 Favored 'General case' 0 C--N 1.346 0.429 0 N-CA-C 114.457 1.28 . . . . 42.670000000000002 114.457 -175.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1292 ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' B' 1267 ' ' ILE . 48.2 t -95.14 144.44 25.77 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 120.399 -1.438 . . . . 38.82 111.754 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1293 ' ' GLU . . . . . 0.643 ' HG3' ' HA ' ' B' 1268 ' ' THR . 22.7 mt-10 -68.82 -34.25 75.2 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 113.784 1.031 . . . . 46.710000000000001 113.784 178.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1294 ' ' TYR . . . . . 0.457 ' CE2' ' HG2' ' B' 1269 ' ' ARG . 52.7 m-85 -80.91 7.76 9.86 Favored 'General case' 0 C--O 1.248 0.982 0 N-CA-C 116.766 2.135 . . . . 47.229999999999997 116.766 -176.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1295 ' ' THR . . . . . 0.455 ' OG1' ' HB3' ' B' 1292 ' ' CYS . 26.4 m -71.79 107.73 4.74 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 114.007 1.114 . . . . 36.020000000000003 114.007 -173.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 36.7 t -93.57 123.42 60.14 Favored Pre-proline 0 C--N 1.304 -1.394 0 N-CA-C 103.448 -2.797 . . . . 37.259999999999998 103.448 155.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -61.16 136.8 67.14 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.649 2.233 . . . . 35.090000000000003 114.268 177.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 71.69 40.73 58.16 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 113.699 -1.591 . . . . 35.969999999999999 112.691 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -148.91 152.75 36.94 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-O 124.882 2.277 . . . . 40.390000000000001 114.671 -172.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1300 ' ' ILE . . . . . . . . . . . . . 55.3 mt -99.84 107.61 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 101.422 -3.547 . . . . 37.43 101.422 166.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 15.2 t80 -104.78 103.12 12.68 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.07 -1.085 . . . . 44.130000000000003 108.07 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1302 ' ' THR . . . . . . . . . . . . . 17.7 m -82.98 120.42 25.69 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-O 123.337 1.541 . . . . 39.780000000000001 111.012 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1303 ' ' THR . . . . . . . . . . . . . 3.2 p -79.84 139.35 37.22 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 112.929 -1.941 . . . . 43.289999999999999 109.398 175.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -48.25 -31.22 5.59 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 117.352 2.352 . . . . 53.07 117.352 -175.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -59.88 -21.93 61.68 Favored 'General case' 0 C--O 1.262 1.713 0 C-N-CA 126.496 1.918 . . . . 43.969999999999999 116.062 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 113.35 1.09 24.94 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 110.987 -0.845 . . . . 41.119999999999997 110.987 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1307 ' ' VAL . . . . . . . . . . . . . 45.6 t -88.95 148.28 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-N 118.653 1.227 . . . . 38.119999999999997 109.437 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1308 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.09 114.87 27.97 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 107.726 -1.212 . . . . 36.340000000000003 107.726 177.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1309 ' ' VAL . . . . . 0.405 HG21 ' HB2' ' B' 1294 ' ' TYR . 85.2 t -84.05 97.04 4.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 107.108 -1.441 . . . . 30.399999999999999 107.108 172.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1310 ' ' ILE . . . . . . . . . . . . . 19.0 mt -88.32 91.58 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 CA-C-O 122.912 1.339 . . . . 30.82 108.228 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1311 ' ' GLY . . . . . 0.415 ' HA3' HG23 ' B' 1295 ' ' THR . . . -88.97 93.32 1.88 Allowed Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 109.65 -1.38 . . . . 26.530000000000001 109.65 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1312 ' ' TYR . . . . . . . . . . . . . 13.9 m-30 -116.56 128.18 55.19 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 117.755 2.502 . . . . 38.0 117.755 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1313 ' ' THR . . . . . 0.452 HG22 ' HB3' ' B' 1287 ' ' GLN . 24.0 p -81.83 -56.25 4.1 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 112.668 -2.06 . . . . 29.800000000000001 108.64 173.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -70.05 21.26 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 117.991 2.589 . . . . 39.039999999999999 117.991 -173.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1315 ' ' LEU . . . . . . . . . . . . . 63.8 mt -50.78 -34.29 11.57 Favored Pre-proline 0 CA--C 1.545 0.777 0 O-C-N 118.013 -2.93 . . . . 31.079999999999998 117.128 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1316 ' ' PRO . . . . . 0.62 ' HA ' HG21 ' B' 1136 ' ' ILE . 51.3 Cg_exo -61.87 -54.23 1.67 Allowed 'Trans proline' 0 C--O 1.24 0.589 0 C-N-CA 123.213 2.608 . . . . 26.100000000000001 112.173 166.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1317 ' ' GLY . . . . . 0.626 ' HA2' ' HG3' ' B' 1015 ' ' ARG . . . -58.1 -32.99 68.07 Favored Glycine 0 C--O 1.213 -1.168 0 O-C-N 121.548 -0.72 . . . . 23.170000000000002 113.004 -177.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 74.7 mtt-85 -60.24 -27.44 67.21 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 113.584 0.957 . . . . 40.399999999999999 113.584 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1319 ' ' LEU . . . . . 0.584 HD13 HH11 ' B' 1140 ' ' ARG . 14.1 tp -111.86 77.98 2.1 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 105.397 -2.075 . . . . 23.600000000000001 105.397 171.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1320 ' ' PRO . . . . . 0.507 ' HB2' ' HA ' ' B' 1043 ' ' ALA . 81.2 Cg_endo -59.71 -64.66 0.1 OUTLIER 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.309 2.673 . . . . 22.350000000000001 115.414 -163.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1321 ' ' THR . . . . . . . . . . . . . 1.5 m -60.6 -38.07 83.48 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 120.552 -1.342 . . . . 26.52 111.404 -172.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1322 ' ' GLN . . . . . 0.92 ' HB2' ' HA ' ' A' 1151 ' ' ARG . 43.1 tp60 -72.34 -35.37 68.54 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 120.288 -1.508 . . . . 24.379999999999999 109.342 -175.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1323 ' ' SER . . . . . . . . . . . . . 68.8 m -61.56 -47.6 84.77 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 124.633 1.208 . . . . 22.800000000000001 111.433 171.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1324 ' ' SER . . . . . . . . . . . . . 7.6 m -60.71 -28.86 68.97 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 119.612 -1.93 . . . . 21.25 112.915 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -74.61 -47.27 33.25 Favored 'General case' 0 C--O 1.252 1.211 0 O-C-N 119.82 -1.8 . . . . 31.34 109.973 176.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1326 ' ' LEU . . . . . 0.654 ' HB3' ' HB3' ' B' 1132 ' ' SER . 86.1 mt -74.85 -47.35 30.76 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 120.343 1.429 . . . . 31.559999999999999 109.527 -173.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1327 ' ' TYR . . . . . 0.409 ' O ' ' HG ' ' B' 1331 ' ' LEU . 55.9 t80 -58.35 -45.1 88.81 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 109.547 -0.538 . . . . 22.73 109.547 174.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1328 ' ' GLY . . . . . 0.632 ' HA2' HD12 ' B' 1331 ' ' LEU . . . -55.4 -46.49 80.15 Favored Glycine 0 C--N 1.357 1.719 0 N-CA-C 111.253 -0.739 . . . . 21.91 111.253 173.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1329 ' ' THR . . . . . . . . . . . . . 48.2 m -67.98 -25.24 65.32 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 120.323 -1.692 . . . . 22.149999999999999 111.217 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1330 ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' B' 1127 ' ' LEU . 31.7 m120 -69.25 -48.47 61.75 Favored 'General case' 0 C--N 1.314 -0.941 0 O-C-N 119.637 -1.914 . . . . 26.18 107.252 173.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1331 ' ' LEU . . . . . 0.741 HD22 HD22 ' B' 1070 ' ' LEU . 33.8 mt -56.7 -38.9 72.93 Favored 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 123.003 0.521 . . . . 23.68 110.663 176.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1332 ' ' VAL . . . . . 0.489 HG23 ' O ' ' B' 1328 ' ' GLY . 71.0 t -54.3 -53.76 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 CA-C-N 120.157 1.344 . . . . 26.57 111.897 171.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -61.9 -44.24 97.2 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 122.37 1.081 . . . . 28.079999999999998 111.387 -177.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1334 ' ' LEU . . . . . . . . . . . . . 5.0 tt -53.92 -47.84 70.78 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 123.745 1.735 . . . . 27.43 113.016 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1335 ' ' LEU . . . . . 0.526 HD11 HD21 ' B' 1070 ' ' LEU . 39.1 mt -78.9 -15.29 58.52 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 119.844 -1.785 . . . . 30.5 109.606 -177.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1336 ' ' LYS . . . . . 0.724 ' HG2' HD21 ' B' 1029 ' ' LEU . 89.7 mttt -72.08 -36.68 69.6 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-N 119.583 1.083 . . . . 41.649999999999999 109.771 167.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1337 ' ' LEU . . . . . 0.592 HD22 HD21 ' B' 1127 ' ' LEU . 10.4 mp -67.33 -34.12 76.68 Favored 'General case' 0 N--CA 1.434 -1.251 0 O-C-N 120.086 -1.634 . . . . 42.079999999999998 113.749 169.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1338 ' ' LEU . . . . . 0.605 ' HB3' HG23 ' B' 1346 ' ' ILE . 85.6 mt -81.78 -43.71 17.98 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 118.878 -2.389 . . . . 35.030000000000001 113.774 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 41.5 t -105.23 60.3 0.68 Allowed 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 105.462 -2.051 . . . . 37.329999999999998 105.462 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 56.7 mttp -57.83 -21.15 40.88 Favored 'General case' 0 N--CA 1.432 -1.339 0 O-C-N 118.964 -2.335 . . . . 50.509999999999998 115.906 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -85.52 -5.42 59.29 Favored 'General case' 0 C--O 1.249 1.053 0 N-CA-C 114.856 1.428 . . . . 54.210000000000001 114.856 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1342 ' ' LYS . . . . . 0.534 ' HG2' HD23 ' B' 1029 ' ' LEU . 45.7 mttp 56.85 56.57 5.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 123.826 1.774 . . . . 50.990000000000002 111.16 -176.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -133.04 -1.97 3.25 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 113.344 -1.753 . . . . 48.82 113.809 -168.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 88.95 -30.72 5.32 Favored Glycine 0 CA--C 1.541 1.657 0 N-CA-C 117.509 1.764 . . . . 40.43 117.509 -170.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -86.4 124.22 32.5 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 117.839 -1.545 . . . . 47.560000000000002 110.369 -171.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1346 ' ' ILE . . . . . 0.605 HG23 ' HB3' ' B' 1338 ' ' LEU . 39.4 mm -80.51 117.11 25.86 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.416 0 N-CA-C 107.12 -1.437 . . . . 42.490000000000002 107.12 -177.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1347 ' ' THR . . . . . . . . . . . . . 35.6 m -82.73 106.44 14.58 Favored 'General case' 0 C--N 1.352 0.708 0 CA-C-O 123.748 1.737 . . . . 38.119999999999997 108.935 164.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 18.8 t -84.0 93.14 3.14 Favored 'Isoleucine or valine' 0 C--O 1.257 1.457 0 N-CA-C 107.259 -1.386 . . . . 37.5 107.259 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 4.4 t70 -68.86 167.09 16.33 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.179 -1.373 . . . . 43.850000000000001 109.296 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1350 ' ' PHE . . . . . . . . . . . . . 13.5 t80 -131.61 -42.32 1.04 Allowed 'General case' 0 C--N 1.314 -0.945 0 O-C-N 121.023 -1.048 . . . . 39.810000000000002 110.391 169.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -64.51 -39.86 94.57 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 114.607 1.336 . . . . 51.289999999999999 114.607 -174.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 34.4 t70 -62.42 112.95 2.66 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 121.523 -0.736 . . . . 39.780000000000001 111.991 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 27.0 m -47.99 -37.88 6.97 Favored 'Isoleucine or valine' 0 C--N 1.35 0.628 0 N-CA-C 114.101 1.149 . . . . 39.280000000000001 114.101 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1354 ' ' VAL . . . . . 0.499 HG13 ' HB2' ' B' 1124 ' ' ALA . 99.5 t -67.79 -53.96 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 O-C-N 120.311 -1.493 . . . . 35.700000000000003 111.392 -178.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1355 ' ' ILE . . . . . . . . . . . . . 25.0 mm -56.11 -51.79 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 114.153 1.168 . . . . 35.770000000000003 114.153 174.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 43.0 tpt85 -55.43 -31.47 61.92 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 115.725 1.75 . . . . 38.549999999999997 115.725 176.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1357 ' ' GLY . . . . . 0.451 ' HA2' ' HB1' ' B' 1370 ' ' ALA . . . -68.96 -58.84 6.39 Favored Glycine 0 C--N 1.341 0.857 0 C-N-CA 125.855 1.693 . . . . 29.579999999999998 109.934 172.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1358 ' ' VAL . . . . . 0.426 HG22 ' HB3' ' B' 1113 ' ' MET . 13.0 p -71.65 -36.67 60.32 Favored 'Isoleucine or valine' 0 C--O 1.249 1.072 0 O-C-N 120.763 -1.433 . . . . 32.060000000000002 112.152 -171.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1359 ' ' THR . . . . . 0.42 HG23 ' HE3' ' B' 1113 ' ' MET . 54.1 m -78.29 93.22 4.61 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 103.575 -2.75 . . . . 29.0 103.575 -176.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1360 ' ' VAL . . . . . . . . . . . . . 18.6 m -80.17 -27.88 12.08 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 CA-C-N 111.467 -2.606 . . . . 29.68 110.394 -175.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 97.7 mt -128.31 106.64 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.644 -1.243 . . . . 32.049999999999997 107.644 172.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1362 ' ' ARG . . . . . . . . . . . . . 46.1 ttt85 -83.08 90.45 7.05 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 105.643 -1.984 . . . . 32.520000000000003 105.643 172.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1363 ' ' ALA . . . . . 0.431 ' H ' ' HA ' ' B' 1111 ' ' THR . . . 47.35 71.66 0.31 Allowed 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 123.809 1.766 . . . . 35.68 112.786 170.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 85.85 -41.41 3.07 Favored Glycine 0 C--N 1.344 1.026 0 N-CA-C 116.311 1.284 . . . . 34.259999999999998 116.311 -173.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -78.87 112.24 15.84 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 106.508 -1.664 . . . . 51.07 106.508 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 65.5 mt -67.98 93.71 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 O-C-N 120.152 -1.593 . . . . 39.869999999999997 108.167 176.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1367 ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.02 -4.13 54.12 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 126.063 1.745 . . . . 38.009999999999998 113.247 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1368 ' ' TRP . . . . . . . . . . . . . 49.3 t90 -86.52 134.3 38.24 Favored Pre-proline 0 C--O 1.242 0.671 0 N-CA-C 103.248 -2.871 . . . . 42.140000000000001 103.248 168.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -64.6 140.89 43.49 Favored 'Cis proline' 0 N--CA 1.489 1.243 0 N-CA-C 121.457 3.599 . . . . 43.259999999999998 121.457 9.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1370 ' ' ALA . . . . . 0.451 ' HB1' ' HA2' ' B' 1357 ' ' GLY . . . -87.57 160.97 46.57 Favored Pre-proline 0 C--N 1.307 -1.261 0 CA-C-N 113.527 -1.67 . . . . 46.520000000000003 107.243 -174.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -56.25 153.28 34.26 Favored 'Trans proline' 0 C--O 1.245 0.866 0 C-N-CA 125.212 3.941 . . . . 51.950000000000003 111.838 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -63.9 114.13 2.47 Favored 'Trans proline' 0 C--O 1.251 1.146 0 C-N-CA 122.804 2.336 . . . . 56.270000000000003 114.544 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1373 ' ' ILE . . . . . 0.414 HG21 ' H ' ' B' 1120 ' ' ARG . 37.2 mm -93.81 129.85 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 114.588 -1.187 . . . . 60.829999999999998 108.558 -171.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -70.03 121.57 17.69 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-O 123.642 1.687 . . . . 66.099999999999994 109.035 166.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 59.7 t -109.96 127.25 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 113.827 -1.533 . . . . 63.469999999999999 108.545 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.226 -4.764 0 CA-C-N 120.254 1.388 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.209 -1.044 0 CA-C-O 118.445 -0.788 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -47.53 -36.86 11.05 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 123.769 1.747 . . . . 0.0 113.915 168.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 35.4 mp0 -56.14 -42.0 76.27 Favored 'General case' 0 C--O 1.249 1.075 0 C-N-CA 126.308 1.843 . . . . 0.0 108.904 176.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 14.6 m -66.05 -32.62 74.2 Favored 'General case' 0 C--O 1.24 0.583 0 O-C-N 120.026 -1.671 . . . . 0.0 111.122 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 24' ' ' ALA . . . . . 0.498 ' HB1' ' HA ' ' C' ' 186' ' ' LEU . . . -64.31 -46.81 81.92 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 121.438 1.926 . . . . 0.0 111.249 175.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 25' ' ' GLU . . . . . 0.442 ' HA ' ' HE2' ' C' ' 28' ' ' LYS . 24.2 mm-40 -57.38 -35.17 69.65 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 126.356 2.285 . . . . 0.0 113.62 174.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 14.6 tp -68.12 -60.81 2.2 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.31 -1.314 . . . . 0.0 111.219 177.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 7.9 mt -48.4 -43.46 33.98 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 115.931 -1.985 . . . . 0.0 113.746 -169.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 28' ' ' LYS . . . . . 0.442 ' HE2' ' HA ' ' C' ' 25' ' ' GLU . 34.4 pttt -58.05 -30.48 66.21 Favored 'General case' 0 C--O 1.244 0.783 0 O-C-N 125.076 1.485 . . . . 0.0 114.813 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -93.12 -23.76 18.5 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 174.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 53.2 m -57.85 -16.91 13.26 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 120.201 3.408 . . . . 0.0 120.201 -168.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . 0.45 1.3 p-80 53.9 -55.4 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 117.373 2.36 . . . . 0.0 117.373 -174.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 32' ' ' SER . . . . . 0.564 ' HB2' ' HA ' ' C' ' 106' ' ' THR . 68.0 m -108.53 133.88 52.06 Favored 'General case' 0 CA--C 1.476 -1.902 0 O-C-N 118.419 -2.676 . . . . 0.0 110.426 167.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 33' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' C' ' 64' ' ' VAL . 42.6 t -134.38 115.01 19.46 Favored 'Isoleucine or valine' 0 C--N 1.355 0.833 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 174.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 42.5 mt -106.22 100.76 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 35' ' ' ILE . . . . . 0.643 ' O ' ' HD3' ' C' ' 37' ' ' PRO . 84.4 mt -81.59 108.36 14.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 103.719 -2.697 . . . . 0.0 103.719 -177.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 89.2 m -103.56 95.31 7.1 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -171.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 37' ' ' PRO . . . . . 0.643 ' HD3' ' O ' ' C' ' 35' ' ' ILE . 37.6 Cg_exo -63.29 114.1 2.35 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.091 2.528 . . . . 0.0 113.21 176.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.85 -166.44 33.16 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 158.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 39' ' ' TYR . . . . . 0.61 ' HB3' ' HB2' ' C' ' 114' ' ' ALA . 41.0 t80 -50.08 -21.18 1.17 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 175.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 40' ' ' GLY . . . . . 0.569 ' HA3' ' HA3' ' C' ' 113' ' ' GLY . . . -60.24 -38.46 94.57 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-N 121.154 1.797 . . . . 0.0 111.365 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 41' ' ' MET . . . . . 0.614 ' SD ' HD11 ' C' ' 83' ' ' LEU . 26.4 ttm -74.98 -6.73 50.89 Favored 'General case' 0 C--O 1.248 1.018 0 O-C-N 121.271 -1.135 . . . . 0.0 113.887 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.78 -52.26 3.5 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 121.147 1.794 . . . . 0.0 109.16 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.09 -45.57 90.14 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.557 0 O-C-N 123.734 0.646 . . . . 0.0 110.691 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 44' ' ' ALA . . . . . 0.491 ' HB1' ' HB2' ' C' ' 176' ' ' LYS . . . -95.23 144.62 25.67 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 174.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.7 55.58 0.52 Allowed 'General case' 0 CA--C 1.552 1.022 0 CA-C-O 123.118 1.437 . . . . 0.0 112.475 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' C' ' 41' ' ' MET . . . -75.26 -16.13 60.47 Favored 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 120.617 -1.302 . . . . 0.0 111.047 -171.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 47' ' ' GLN . . . . . 0.549 ' HB2' ' HB2' ' C' ' 86' ' ' ALA . 0.0 OUTLIER -69.97 -38.04 75.95 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 117.68 2.474 . . . . 0.0 117.68 177.615 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 48' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -62.22 -36.66 30.33 Favored Pre-proline 0 CA--C 1.517 -0.308 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -175.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 49' ' ' PRO . . . . . 0.586 ' O ' HD11 ' C' ' 183' ' ' LEU . 98.0 Cg_endo -75.19 -28.98 8.4 Favored 'Trans proline' 0 C--N 1.318 -1.026 0 C-N-CA 122.34 2.026 . . . . 0.0 115.223 164.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.93 -35.54 61.4 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 O-C-N 118.38 -2.7 . . . . 0.0 115.318 -170.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.17 -27.12 67.76 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.45 -30.49 66.09 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.2 176.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 53' ' ' ILE . . . . . 0.607 ' HB ' HD12 ' C' ' 183' ' ' LEU . 10.9 tp -76.76 -41.5 33.19 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 O-C-N 120.056 -1.653 . . . . 0.0 107.664 170.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 27.5 m -53.77 -27.26 27.79 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 121.256 1.844 . . . . 0.0 113.662 172.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -57.32 -57.18 13.74 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 121.014 -1.053 . . . . 0.0 108.963 172.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -74.89 -27.87 60.41 Favored 'General case' 0 C--O 1.253 1.266 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 57' ' ' LEU . . . . . 0.422 ' HA ' HD12 ' C' ' 62' ' ' ILE . 95.9 mt -66.16 -47.68 73.23 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 58' ' ' ARG . . . . . 0.462 ' HA ' ' HD2' ' C' ' 58' ' ' ARG . 1.8 tpt180 -66.5 -44.22 83.16 Favored 'General case' 0 C--N 1.359 0.988 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.583 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.72 -30.18 55.39 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 171.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 60' ' ' ARG . . . . . 0.409 ' HD3' HH11 ' C' ' 60' ' ' ARG . 3.9 ttm180 -89.83 8.14 33.51 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 175.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.97 36.75 91.46 Favored Glycine 0 N--CA 1.432 -1.589 0 O-C-N 119.896 -1.753 . . . . 0.0 110.418 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 62' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' C' ' 57' ' ' LEU . 64.1 mt -94.66 126.61 47.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -62.99 91.5 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.326 171.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 7.1 p -107.71 129.68 61.32 Favored 'Isoleucine or valine' 0 C--O 1.258 1.522 0 C-N-CA 119.629 -0.828 . . . . 0.0 108.811 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 23.1 mmm-85 -127.01 156.35 41.77 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 175.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 66' ' ' PHE . . . . . 0.559 ' HB2' ' HA ' ' C' ' 93' ' ' VAL . 33.5 m-85 -117.71 105.4 11.97 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-O 122.65 1.215 . . . . 0.0 108.434 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.92 80.14 1.85 Allowed Glycine 0 C--O 1.24 0.477 0 CA-C-O 117.347 -1.807 . . . . 0.0 109.593 -174.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 68' ' ' ILE . . . . . 0.577 HD13 HG13 ' C' ' 93' ' ' VAL . 1.8 mp -72.06 126.25 32.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 121.447 2.624 . . . . 0.0 109.639 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -94.67 126.43 47.54 Favored Pre-proline 0 N--CA 1.437 -1.082 0 C-N-CA 117.626 -1.63 . . . . 0.0 108.728 -177.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 70' ' ' PRO . . . . . 0.439 ' O ' ' HA ' ' C' ' 76' ' ' PRO . 28.3 Cg_endo -57.92 -62.74 0.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.967 2.444 . . . . 0.0 112.806 175.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 71' ' ' VAL . . . . . 0.408 ' O ' HG23 ' C' ' 117' ' ' THR . 42.4 t -64.01 92.33 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.211 -0.927 0 CA-C-O 123.252 1.501 . . . . 0.0 107.096 166.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 72' ' ' ALA . . . . . 0.406 ' HB2' ' HA2' ' C' ' 77' ' ' GLY . . . -84.19 -32.79 24.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 113.451 -1.704 . . . . 0.0 114.134 -174.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 129.97 -51.23 0.86 Allowed Glycine 0 CA--C 1.504 -0.63 0 CA-C-N 113.302 -1.772 . . . . 0.0 109.26 -171.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 74' ' ' ARG . . . . . 0.506 ' HD3' ' CZ ' ' C' ' 39' ' ' TYR . 2.4 mpt_? -130.86 129.2 42.0 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 101.625 -3.472 . . . . 0.0 101.625 163.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.469 HD11 ' SD ' ' B' 1207 ' ' MET . 1.9 mp 68.59 153.38 0.14 Allowed Pre-proline 0 N--CA 1.441 -0.892 0 C-N-CA 127.034 2.133 . . . . 0.0 115.8 177.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 76' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' C' ' 70' ' ' PRO . 14.9 Cg_endo -57.46 88.31 0.05 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 123.689 2.926 . . . . 0.0 110.659 158.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 77' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' C' ' 72' ' ' ALA . . . 46.17 48.47 15.11 Favored Glycine 0 C--O 1.216 -1.001 0 N-CA-C 118.139 2.016 . . . . 0.0 118.139 175.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -49.91 -24.19 2.37 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 122.032 2.916 . . . . 0.0 116.346 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -63.81 -25.89 68.38 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -69.14 -22.52 63.94 Favored 'General case' 0 CA--C 1.561 1.369 0 O-C-N 124.102 0.876 . . . . 0.0 111.751 -176.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 40.7 t -66.13 -52.97 42.09 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 169.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.462 ' HB3' ' HG2' ' C' ' 47' ' ' GLN . 6.9 mp -57.64 -30.32 65.29 Favored 'General case' 0 CA--C 1.512 -0.499 0 O-C-N 119.944 -1.723 . . . . 0.0 114.319 178.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.614 HD11 ' SD ' ' C' ' 41' ' ' MET . 5.3 mp -64.46 -22.22 66.9 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 117.836 -1.078 . . . . 0.0 113.063 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.99 -34.89 76.02 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 120.338 1.426 . . . . 0.0 113.178 173.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -69.07 -42.3 76.4 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 172.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 86' ' ' ALA . . . . . 0.549 ' HB2' ' HB2' ' C' ' 47' ' ' GLN . . . -66.37 -21.69 66.24 Favored 'General case' 0 C--O 1.213 -0.833 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 177.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp 70.73 45.49 0.57 Allowed 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 128.165 2.586 . . . . 0.0 108.436 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 45.6 t -81.58 130.8 60.1 Favored Pre-proline 0 C--N 1.351 0.672 0 CA-C-O 117.664 -1.16 . . . . 0.0 108.259 174.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -61.81 115.4 2.78 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 124.025 3.15 . . . . 0.0 114.143 176.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 90' ' ' TYR . . . . . 0.582 ' HA ' ' HB ' ' C' ' 93' ' ' VAL . 35.4 m-85 -60.76 -13.09 12.92 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-N 114.765 -1.107 . . . . 0.0 113.481 -177.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -59.16 -51.73 68.76 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 166.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 26.3 pt -82.64 -15.71 11.77 Favored 'Isoleucine or valine' 0 C--O 1.249 1.047 0 CA-C-N 119.169 0.895 . . . . 0.0 110.447 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 93' ' ' VAL . . . . . 0.582 ' HB ' ' HA ' ' C' ' 90' ' ' TYR . 73.5 t -75.59 99.99 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 123.026 1.394 . . . . 0.0 109.453 175.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 94' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' C' ' 97' ' ' ASP . 53.0 mt -103.7 100.44 10.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 113.707 -1.588 . . . . 0.0 112.621 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 95' ' ' GLU . . . . . 0.708 ' HB3' HD13 ' A' 1157 ' ' ILE . 40.9 mp0 -81.06 91.8 6.15 Favored 'General case' 0 C--O 1.267 1.989 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 -178.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.643 ' SD ' ' HB2' ' C' ' 134' ' ' PRO . 31.8 ttp 47.94 73.47 0.21 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 123.892 1.806 . . . . 0.0 115.606 -171.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 97' ' ' ASP . . . . . 0.496 ' HB2' ' HB3' ' C' ' 94' ' ' LEU . 4.2 t70 -91.74 144.42 25.52 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 168.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -92.82 51.9 1.77 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 123.844 1.783 . . . . 0.0 112.247 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 99' ' ' ILE . . . . . 0.557 HG12 ' HB2' ' C' ' 102' ' ' ASP 0.286 10.2 tt -87.22 70.0 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-O 126.978 3.275 . . . . 0.0 108.852 -166.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -54.73 -52.49 62.33 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 108.834 -3.803 . . . . 0.0 114.935 -174.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -62.49 -42.98 99.86 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 118.368 -0.825 . . . . 0.0 112.861 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 102' ' ' ASP . . . . . 0.557 ' HB2' HG12 ' C' ' 99' ' ' ILE . 0.5 OUTLIER -68.54 -39.32 81.18 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-N 119.974 1.261 . . . . 0.0 108.785 -174.257 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 103' ' ' PHE . . . . . 0.458 ' HB3' ' HB2' ' C' ' 137' ' ' GLU . 4.6 m-85 -55.34 -52.5 63.29 Favored 'General case' 0 C--O 1.251 1.173 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 168.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.85 -26.02 67.06 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -75.62 -39.53 57.73 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 106' ' ' THR . . . . . 0.564 ' HA ' ' HB2' ' C' ' 32' ' ' SER . 96.0 m -61.34 141.52 57.53 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 -162.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 107' ' ' ASP . . . . . 0.87 ' HA ' ' HB2' ' C' ' 142' ' ' GLN . 9.9 t0 -71.53 -87.8 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 124.019 0.928 . . . . 0.0 108.714 161.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 108' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' C' ' 143' ' ' ASN . 0.3 OUTLIER -89.09 112.35 23.31 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 122.448 1.118 . . . . 0.0 112.395 -165.362 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 109' ' ' VAL . . . . . 0.682 HG11 HG23 ' C' ' 138' ' ' VAL . 4.4 t -102.92 104.2 16.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 174.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 110' ' ' LEU . . . . . 0.589 HD12 HG12 ' C' ' 35' ' ' ILE . 95.9 mt -88.3 90.6 8.46 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.521 -172.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 28.2 t -81.19 104.84 10.33 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 CA-C-O 124.338 2.018 . . . . 0.0 107.771 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 112' ' ' ILE . . . . . 0.421 ' HB ' ' HA ' ' C' ' 37' ' ' PRO . 45.1 mm -78.24 97.79 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 CA-C-O 122.635 1.207 . . . . 0.0 108.45 -171.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 113' ' ' GLY . . . . . 0.569 ' HA3' ' HA3' ' C' ' 40' ' ' GLY . . . 85.21 -70.45 3.1 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-N 111.275 -2.693 . . . . 0.0 113.738 165.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 114' ' ' ALA . . . . . 0.61 ' HB2' ' HB3' ' C' ' 39' ' ' TYR . . . -87.57 121.84 30.51 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 120.775 -1.427 . . . . 0.0 112.441 -163.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 115' ' ' ASN . . . . . 0.481 ' HB2' ' HE1' ' C' ' 163' ' ' PHE . 10.2 p-10 -85.09 -55.1 4.22 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 118.156 -0.926 . . . . 0.0 113.192 -173.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 116' ' ' ASP . . . . . 0.64 ' HB2' H51N ' C' 1001 ' ' NAP . 0.9 OUTLIER -54.19 -38.89 66.12 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 121.298 1.863 . . . . 0.0 109.915 -175.084 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 117' ' ' THR . . . . . 0.408 HG23 ' O ' ' C' ' 71' ' ' VAL . 67.6 m -33.61 -36.31 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 118.751 2.871 . . . . 0.0 118.751 166.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.46 ' HB ' HG11 ' C' ' 138' ' ' VAL . 26.7 m -119.58 2.53 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-O 117.646 -1.168 . . . . 0.0 110.459 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 119' ' ' ASN . . . . . 0.551 HD21 ' HB3' ' C' ' 121' ' ' ALA . 23.1 t30 -52.09 117.77 10.81 Favored Pre-proline 0 C--O 1.257 1.454 0 CA-C-N 122.472 2.396 . . . . 0.0 115.708 -164.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 120' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' C' ' 119' ' ' ASN . 0.8 OUTLIER -45.1 -59.92 1.0 Allowed 'Trans proline' 0 C--N 1.363 1.339 1 C-N-CA 127.954 5.77 . . . . 0.0 110.706 174.293 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' C' C ' 121' ' ' ALA . . . . . 0.551 ' HB3' HD21 ' C' ' 119' ' ' ASN . . . -48.28 -38.75 19.56 Favored 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 176.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.92 -16.54 63.42 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 118.618 -1.233 . . . . 0.0 114.256 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 123' ' ' GLN . . . . . 0.602 ' HG2' HG23 ' C' ' 135' ' ' VAL . 0.0 OUTLIER -101.25 -41.68 6.61 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 117.359 -1.736 . . . . 0.0 110.892 165.692 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.68 -60.95 2.98 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 126.297 1.839 . . . . 0.0 114.27 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -82.09 117.04 66.92 Favored Pre-proline 0 C--O 1.246 0.918 0 O-C-N 124.851 1.345 . . . . 0.0 111.222 173.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -67.52 -26.53 40.19 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.732 3.621 . . . . 0.0 112.157 176.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 127' ' ' LYS . . . . . 0.49 ' HB3' ' HZ3' ' C' ' 127' ' ' LYS . 6.0 ttpm? -64.96 -28.34 69.45 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 122.445 1.117 . . . . 0.0 113.934 -175.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 128' ' ' SER . . . . . 0.423 ' HA ' ' HD2' ' C' ' 129' ' ' PRO . 70.3 m -32.9 116.66 0.42 Allowed Pre-proline 0 C--N 1.357 0.92 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 166.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 129' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' C' ' 128' ' ' SER . 16.1 Cg_endo -50.03 -48.84 18.03 Favored 'Trans proline' 0 C--O 1.241 0.67 0 C-N-CA 124.042 3.162 . . . . 0.0 111.58 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 130' ' ' ILE . . . . . 0.474 HG21 ' O3D' ' C' 1001 ' ' NAP . 13.1 pt -73.97 84.07 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 O-C-N 119.732 -1.855 . . . . 0.0 108.669 168.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 131' ' ' ALA . . . . . 0.411 ' O ' ' HB ' ' B' 1121 ' ' ILE . . . -75.93 119.17 19.54 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -172.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 73.76 78.36 0.57 Allowed Glycine 0 N--CA 1.48 1.57 0 CA-C-N 114.715 -1.13 . . . . 0.0 113.113 177.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 133' ' ' MET . . . . . 0.417 ' SD ' ' HD2' ' C' ' 134' ' ' PRO . 41.6 tpp -76.01 124.06 88.32 Favored Pre-proline 0 C--N 1.313 -0.999 0 O-C-N 118.965 -2.491 . . . . 0.0 109.638 171.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 134' ' ' PRO . . . . . 0.643 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 49.2 Cg_endo -70.62 85.52 0.74 Allowed 'Trans proline' 0 CA--C 1.5 -1.188 0 C-N-CA 123.562 2.841 . . . . 0.0 113.734 176.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 135' ' ' VAL . . . . . 0.602 HG23 ' HG2' ' C' ' 123' ' ' GLN . 0.5 OUTLIER -134.93 137.54 50.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 124.889 2.28 . . . . 0.0 111.233 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -105.17 137.59 42.7 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 111.839 -2.437 . . . . 0.0 107.134 167.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 137' ' ' GLU . . . . . 0.458 ' HB2' ' HB3' ' C' ' 103' ' ' PHE 0.258 6.3 mm-40 23.23 40.68 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.964 1 N-CA-C 122.531 4.271 . . . . 0.0 122.531 166.429 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' C' C ' 138' ' ' VAL . . . . . 0.682 HG23 HG11 ' C' ' 109' ' ' VAL . 13.7 p -88.01 48.35 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 126.228 2.918 . . . . 0.0 109.386 174.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -159.0 148.54 18.92 Favored 'General case' 0 C--O 1.256 1.434 0 CA-C-N 111.185 -2.734 . . . . 0.0 104.597 -172.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 140' ' ' LYS . . . . . . . . . . . . 0.356 23.6 pttm 65.63 -26.57 0.1 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 118.017 2.599 . . . . 0.0 118.017 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -45.4 146.71 0.93 Allowed 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 125.665 1.586 . . . . 0.0 113.614 161.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 142' ' ' GLN . . . . . 0.87 ' HB2' ' HA ' ' C' ' 107' ' ' ASP . 21.0 mt-30 -58.62 -28.88 66.05 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 120.136 3.384 . . . . 0.0 120.136 -151.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 143' ' ' ASN . . . . . 0.511 ' O ' ' HA ' ' C' ' 108' ' ' THR . 2.5 t-20 -153.57 87.51 1.24 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 172.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 144' ' ' VAL . . . . . 0.684 ' HB ' ' HA ' ' C' ' 168' ' ' THR . 37.4 t -81.24 89.76 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.146 0 O-C-N 119.803 -1.811 . . . . 0.0 107.358 177.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 145' ' ' ILE . . . . . . . . . . . . . 21.7 mt -92.28 104.63 15.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 125.545 2.593 . . . . 0.0 107.977 -173.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 146' ' ' VAL . . . . . 0.652 ' HB ' ' HA ' ' C' ' 170' ' ' MET . 10.0 t -86.25 102.7 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 CA-C-N 111.38 -2.645 . . . . 0.0 107.552 176.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 147' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -64.34 94.48 0.11 Allowed 'General case' 0 C--O 1.242 0.7 0 CA-C-O 122.372 1.082 . . . . 0.0 112.105 177.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 148' ' ' LYS . . . . . 0.642 ' O ' ' HA ' ' C' ' 172' ' ' PHE . 20.9 mmmt -128.22 111.59 13.59 Favored 'General case' 0 CA--C 1.485 -1.541 0 C-N-CA 123.98 0.912 . . . . 0.0 109.352 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 10.7 ptp85 -54.0 -31.96 52.59 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 174.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 19.4 m -153.0 155.47 36.98 Favored 'General case' 0 C--O 1.249 1.067 0 O-C-N 118.682 -2.511 . . . . 0.0 106.185 -170.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 151' ' ' MET . . . . . 0.608 ' SD ' ' SD ' ' C' ' 170' ' ' MET . 6.8 tpt -88.03 67.17 8.87 Favored 'General case' 0 C--O 1.254 1.329 0 CA-C-O 125.865 2.745 . . . . 0.0 108.074 177.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -94.93 117.32 29.93 Favored 'General case' 0 N--CA 1.44 -0.958 0 O-C-N 119.636 -1.915 . . . . 0.0 106.109 170.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 7.4 m -64.18 138.99 58.72 Favored 'General case' 0 C--O 1.249 1.074 0 CA-C-N 113.286 -1.779 . . . . 0.0 107.696 171.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 154' ' ' GLY . . . . . 0.416 ' HA3' H52A ' C' 1001 ' ' NAP . . . -86.85 -53.42 2.87 Favored Glycine 0 C--O 1.214 -1.105 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -132.17 -78.3 0.5 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 118.002 0.901 . . . . 0.0 108.901 164.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 156' ' ' ALA . . . . . . . . . . . . . . . -86.71 -61.44 1.73 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -170.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.81 28.85 5.69 Favored Glycine 0 C--N 1.353 1.475 0 C-N-CA 127.387 2.422 . . . . 0.0 114.654 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 6.1 m -54.76 138.97 14.26 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 N-CA-C 119.414 3.116 . . . . 0.0 119.414 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . 0.263 0.0 OUTLIER 6.76 92.53 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.974 1 N-CA-C 122.811 4.375 . . . . 0.0 122.811 173.663 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' C' C ' 160' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -150.1 152.16 33.25 Favored Pre-proline 0 N--CA 1.469 0.493 0 CA-C-O 117.602 -1.19 . . . . 0.0 112.952 -174.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.76 -27.85 37.41 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 124.551 3.501 . . . . 0.0 114.025 167.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 162' ' ' LEU . . . . . 0.583 ' HA ' HG22 ' C' ' 168' ' ' THR . 16.3 tp -43.8 -31.5 0.84 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 119.415 3.117 . . . . 0.0 119.415 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 163' ' ' PHE . . . . . 0.532 ' HA ' ' HG3' ' C' ' 170' ' ' MET . 14.0 m-30 -85.7 -60.62 1.97 Allowed 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 124.611 2.148 . . . . 0.0 109.749 171.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -82.8 -7.43 59.66 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-N 111.752 -2.476 . . . . 0.0 113.97 -158.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -91.71 177.16 6.28 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 122.0 0.905 . . . . 0.0 110.611 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.77 -51.98 4.66 Favored 'General case' 0 C--O 1.254 1.316 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -174.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 167' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' C' ' 142' ' ' GLN . 20.7 p-10 -78.88 -45.55 20.44 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 120.552 -1.342 . . . . 0.0 111.344 177.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 168' ' ' THR . . . . . 0.684 ' HA ' ' HB ' ' C' ' 144' ' ' VAL . 3.0 m -89.75 95.15 10.12 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 101.495 -3.52 . . . . 0.0 101.495 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -150.26 132.3 15.27 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 123.662 1.696 . . . . 0.0 112.302 -162.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 170' ' ' MET . . . . . 0.652 ' HA ' ' HB ' ' C' ' 146' ' ' VAL . 33.7 mtm -64.88 110.78 2.55 Favored 'General case' 0 C--O 1.253 1.288 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 165.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 171' ' ' LEU . . . . . . . . . . . . . 15.2 tp -91.16 124.01 35.05 Favored 'General case' 0 C--O 1.256 1.401 0 N-CA-C 103.545 -2.761 . . . . 0.0 103.545 172.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 172' ' ' PHE . . . . . 0.642 ' HA ' ' O ' ' C' ' 148' ' ' LYS . 3.6 m-85 -70.76 82.74 0.63 Allowed 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 111.774 -2.466 . . . . 0.0 115.317 -175.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -157.97 147.5 15.52 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 106.611 -2.595 . . . . 0.0 106.611 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 174' ' ' ASP . . . . . 0.641 ' HB3' ' HB3' ' C' ' 177' ' ' ALA . 14.1 t70 -63.69 147.69 50.99 Favored 'General case' 0 N--CA 1.431 -1.378 0 O-C-N 121.706 -0.879 . . . . 0.0 112.609 172.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -52.24 -60.22 3.47 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 176' ' ' LYS . . . . . 0.491 ' HB2' ' HB1' ' C' ' 44' ' ' ALA . 0.0 OUTLIER -69.01 -48.8 62.14 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 -171.892 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 177' ' ' ALA . . . . . 0.641 ' HB3' ' HB3' ' C' ' 174' ' ' ASP . . . -55.25 -50.55 69.18 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 127.03 2.706 . . . . 0.0 109.978 -176.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 44.2 m -68.26 -32.87 73.35 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.941 -1.1 . . . . 0.0 110.697 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 179' ' ' VAL . . . . . . . . . . . . . 86.9 t -62.87 -45.51 98.68 Favored 'Isoleucine or valine' 0 C--N 1.343 0.287 0 CA-C-N 119.642 1.11 . . . . 0.0 108.421 176.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -68.06 -28.9 67.77 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 119.966 -1.709 . . . . 0.0 111.471 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -64.99 -56.27 14.12 Favored 'General case' 0 C--N 1.348 0.536 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 182' ' ' ILE . . . . . 0.432 ' HA ' ' HB2' ' C' ' 24' ' ' ALA . 23.8 pt -64.29 -33.47 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 183' ' ' LEU . . . . . 0.607 HD12 ' HB ' ' C' ' 53' ' ' ILE . 5.9 tp -32.02 -50.62 0.22 Allowed 'General case' 0 C--O 1.248 1.012 0 C-N-CA 128.934 2.894 . . . . 0.0 118.565 -171.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -123.79 -7.11 7.92 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.633 169.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -62.39 -44.12 97.2 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -170.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 186' ' ' LEU . . . . . 0.498 ' HA ' ' HB1' ' C' ' 24' ' ' ALA 0.331 88.1 mt . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 121.588 3.922 . . . . 0.0 121.588 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 1' ' ' NAD . . . . . 0.423 ' O3 ' ' H3B' ' B' ' 1' ' ' NAD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C 1001 ' ' NAP . . . . . 0.64 H51N ' HB2' ' C' ' 116' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 9.8 t-80 . . . . . 0 N--CA 1.444 -0.738 0 N-CA-C 103.958 -2.608 . . . . 65.739999999999995 103.958 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -75.04 78.28 1.09 Allowed Glycine 0 C--O 1.256 1.487 0 CA-C-O 119.067 -0.852 . . . . 48.659999999999997 112.326 -174.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 24.2 ttp180 -86.81 131.98 33.97 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 120.045 1.922 . . . . 44.560000000000002 106.289 153.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1003 ' ' ILE . . . . . 0.522 ' HA ' ' O ' ' A' 1068 ' ' ILE . 39.9 mt -101.4 124.74 55.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 102.471 -3.159 . . . . 34.859999999999999 102.471 177.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1004 ' ' GLY . . . . . 0.663 ' O ' ' HD3' ' A' 1006 ' ' PRO . . . -88.1 129.25 9.47 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 107.486 -2.245 . . . . 30.75 107.486 165.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.746 HG23 ' HB3' ' A' 1017 ' ' ALA . 48.2 mm -98.63 99.55 7.77 Favored Pre-proline 0 C--O 1.249 1.027 0 N-CA-C 105.647 -1.982 . . . . 32.210000000000001 105.647 174.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1006 ' ' PRO . . . . . 0.663 ' HD3' ' O ' ' A' 1004 ' ' GLY . 99.5 Cg_exo -71.51 131.03 18.1 Favored 'Trans proline' 0 CA--C 1.499 -1.24 0 C-N-CA 123.779 2.986 . . . . 32.979999999999997 109.317 174.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1007 ' ' ARG . . . . . 0.481 ' HG2' HD12 ' A' 1042 ' ' LEU . 7.1 ttp85 -73.86 121.34 20.75 Favored 'General case' 0 C--O 1.255 1.347 0 CA-C-N 110.284 -3.144 . . . . 47.979999999999997 106.734 155.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1008 ' ' GLU . . . . . 0.428 ' CD ' ' HZ2' ' A' 1071 ' ' LYS . 6.4 tp10 -73.33 133.33 43.81 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 123.306 1.527 . . . . 34.700000000000003 112.956 -165.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -97.86 9.43 42.7 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 112.805 -1.998 . . . . 53.369999999999997 111.456 -174.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 17.7 tp -70.28 146.54 50.53 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 117.211 -1.796 . . . . 45.07 106.396 168.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1011 ' ' THR . . . . . . . . . . . . . 5.7 m -54.58 146.42 16.51 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-O 117.7 -1.143 . . . . 40.359999999999999 110.698 174.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 76.8 m-20 61.81 -10.67 0.07 Allowed 'General case' 0 C--O 1.258 1.508 0 N-CA-C 119.089 2.996 . . . . 40.609999999999999 119.089 -175.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1013 ' ' GLU . . . . . 0.544 ' HG3' ' H ' ' A' 1015 ' ' ARG . 8.6 tp10 -68.99 114.93 7.73 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 124.35 2.024 . . . . 33.759999999999998 113.838 -160.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1014 ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.56 -26.95 68.93 Favored 'General case' 0 N--CA 1.427 -1.597 1 CA-C-N 108.27 -4.059 . . . . 27.890000000000001 114.86 174.518 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 1015 ' ' ARG . . . . . 0.676 ' HB3' HG11 ' A' 1072 ' ' VAL . 57.8 mtm180 -79.81 151.32 30.35 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 126.65 3.119 . . . . 29.02 116.621 -171.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1016 ' ' VAL . . . . . . . . . . . . . 2.6 p -115.8 169.02 6.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 1 CA-C-N 107.745 -4.298 . . . . 28.129999999999999 106.655 160.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1017 ' ' ALA . . . . . 0.746 ' HB3' HG23 ' A' 1005 ' ' ILE . . . -60.98 -46.92 88.81 Favored 'General case' 0 C--O 1.217 -0.617 0 O-C-N 119.296 -2.128 . . . . 26.870000000000001 113.45 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -155.82 133.55 11.15 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 120.838 -1.164 . . . . 26.77 108.516 -175.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1019 ' ' THR . . . . . 0.471 HG21 HG23 ' A' 1321 ' ' THR . 0.6 OUTLIER -85.41 167.39 25.6 Favored Pre-proline 0 C--O 1.239 0.517 0 O-C-N 120.36 -1.462 . . . . 27.02 114.539 177.173 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 1020 ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -42.87 -53.57 3.87 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 124.667 3.578 . . . . 30.57 119.546 -174.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 9.5 tttp -58.28 -39.26 78.81 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 124.111 1.91 . . . . 47.810000000000002 112.853 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1022 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.57 -40.38 92.71 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 113.188 -1.824 . . . . 30.77 109.833 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1023 ' ' VAL . . . . . 0.518 HG13 HG11 ' A' 1033 ' ' VAL . 8.9 t -59.75 -42.61 89.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 118.953 -0.546 . . . . 33.590000000000003 110.475 176.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -49.32 -46.44 46.68 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 124.165 0.915 . . . . 53.289999999999999 112.05 172.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -68.04 -32.74 73.32 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.97 0.89 . . . . 46.920000000000002 111.383 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1026 ' ' LEU . . . . . 0.419 ' CD2' HG22 ' A' 1332 ' ' VAL . 99.0 mt -68.61 -41.53 79.41 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.166 -1.584 . . . . 37.170000000000002 112.434 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1027 ' ' LEU . . . . . 0.44 HD22 ' HA3' ' A' 1054 ' ' GLY . 36.0 tp -61.67 -50.69 71.47 Favored 'General case' 0 C--O 1.254 1.294 0 CA-C-N 111.928 -2.396 . . . . 44.439999999999998 107.039 173.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -48.79 -41.62 33.15 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 116.762 2.134 . . . . 52.579999999999998 116.762 171.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1029 ' ' LEU . . . . . . . . . . . . . 77.0 mt -71.78 -11.32 60.76 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 121.467 1.939 . . . . 45.689999999999998 110.21 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 110.84 33.28 2.45 Favored Glycine 0 C--O 1.244 0.756 0 CA-C-O 122.971 1.317 . . . . 42.090000000000003 111.641 166.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1031 ' ' PHE . . . . . 0.646 ' HZ ' ' SG ' ' A' 1339 ' ' CYS . 50.1 m-85 -117.19 155.14 29.9 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 118.584 -2.715 . . . . 40.719999999999999 109.785 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1032 ' ' THR . . . . . . . . . . . . . 40.1 m -86.62 114.93 23.74 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 104.225 -2.509 . . . . 37.770000000000003 104.225 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1033 ' ' VAL . . . . . 0.518 HG11 HG13 ' A' 1023 ' ' VAL . 19.3 t -88.77 125.78 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 105.837 -1.912 . . . . 33.539999999999999 105.837 -177.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -117.26 126.37 52.63 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 104.446 -2.428 . . . . 31.68 104.446 173.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1035 ' ' VAL . . . . . 0.541 ' HA ' ' HB ' ' A' 1005 ' ' ILE . 59.4 t -116.01 145.69 21.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 105.1 -2.185 . . . . 31.52 105.1 -177.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1036 ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -69.38 133.47 47.84 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 122.971 0.509 . . . . 41.039999999999999 111.915 174.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1037 ' ' SER . . . . . . . . . . . . . 54.4 m -54.89 123.33 13.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 123.926 1.822 . . . . 31.829999999999998 114.414 168.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 99.83 -8.14 59.5 Favored Glycine 0 N--CA 1.444 -0.806 0 O-C-N 119.035 -2.29 . . . . 29.359999999999999 112.159 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -64.53 -34.19 77.67 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 113.898 1.073 . . . . 27.780000000000001 113.898 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1040 ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' 1046 ' ' ASP . . . -59.76 -19.48 49.49 Favored Glycine 0 N--CA 1.427 -1.963 0 CA-C-N 112.14 -2.3 . . . . 28.91 114.648 175.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -76.24 -44.94 35.26 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 120.076 1.938 . . . . 51.18 110.646 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1042 ' ' LEU . . . . . 0.481 HD12 ' HG2' ' A' 1007 ' ' ARG . 20.6 mt -64.32 -50.01 69.5 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.949 0.881 . . . . 29.91 111.39 173.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1043 ' ' ALA . . . . . 0.411 ' HB3' ' HA2' ' A' 1040 ' ' GLY 0.267 . . -53.5 -22.65 8.46 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 112.807 -1.997 . . . . 28.539999999999999 114.477 172.853 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 1044 ' ' SER . . . . . . . . . . . . . 15.5 m 53.98 44.93 28.65 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 124.688 2.185 . . . . 33.060000000000002 110.281 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1045 ' ' PHE . . . . . 0.437 ' HA ' ' HB3' ' B' 1277 ' ' ALA . 0.1 OUTLIER -167.59 102.82 0.5 Allowed 'General case' 0 C--O 1.249 1.066 0 N-CA-C 100.292 -3.966 . . . . 30.289999999999999 100.292 178.105 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 1046 ' ' ASP . . . . . 0.5 ' HA ' ' HA3' ' A' 1040 ' ' GLY . 2.9 p-10 -84.51 168.85 15.05 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 123.479 1.609 . . . . 48.619999999999997 114.464 -151.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1047 ' ' ASP . . . . . 0.479 ' HA ' ' HD2' ' A' 1050 ' ' PHE . 2.8 m-20 -46.01 -45.85 16.16 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 112.499 -2.137 . . . . 36.740000000000002 115.609 -172.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 22.5 pttm -54.21 -40.71 67.88 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 115.191 1.552 . . . . 43.729999999999997 115.191 169.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -65.02 -31.52 72.8 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 119.752 1.16 . . . . 32.810000000000002 112.275 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1050 ' ' PHE . . . . . 0.479 ' HD2' ' HA ' ' A' 1047 ' ' ASP . 58.4 m-85 -64.01 -42.37 97.16 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 111.612 0.227 . . . . 31.859999999999999 111.612 169.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 41.3 t -61.68 -46.61 96.18 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 N-CA-C 106.774 -1.565 . . . . 33.219999999999999 106.774 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -55.15 -37.06 66.47 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 123.914 0.885 . . . . 50.829999999999998 112.521 174.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -62.56 -41.45 98.93 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 120.065 1.302 . . . . 33.119999999999997 112.578 172.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1054 ' ' GLY . . . . . 0.44 ' HA3' HD22 ' A' 1027 ' ' LEU . . . 120.31 81.36 0.67 Allowed Glycine 0 C--O 1.21 -1.399 0 N-CA-C 106.039 -2.824 . . . . 35.829999999999998 106.039 -177.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -161.06 132.22 5.45 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 125.162 1.154 . . . . 34.82 109.204 -173.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -71.19 135.3 47.48 Favored 'General case' 0 N--CA 1.44 -0.945 0 O-C-N 126.727 2.517 . . . . 49.049999999999997 107.201 166.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1057 ' ' ILE . . . . . . . . . . . . . 36.1 mm -104.43 125.95 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 101.951 -3.351 . . . . 38.530000000000001 101.951 169.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1058 ' ' VAL . . . . . 0.556 ' HB ' ' HB ' ' A' 1063 ' ' VAL . 44.1 t -102.29 135.72 37.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 103.566 -2.753 . . . . 42.109999999999999 103.566 174.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -69.38 76.08 0.38 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 114.13 1.159 . . . . 58.0 114.13 178.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1060 ' ' GLY . . . . . 0.466 ' O ' HG12 ' A' 1063 ' ' VAL . . . 80.08 -129.83 9.38 Favored Glycine 0 N--CA 1.422 -2.253 0 C-N-CA 121.092 -0.575 . . . . 52.119999999999997 113.187 177.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 29.4 t30 -46.79 -40.14 13.13 Favored 'General case' 0 C--O 1.217 -0.612 0 N-CA-C 117.963 2.579 . . . . 54.75 117.963 -156.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1062 ' ' SER . . . . . . . . . . . . . 15.3 m -67.79 -9.36 43.58 Favored 'General case' 0 C--O 1.247 0.932 0 O-C-N 118.23 -2.794 . . . . 50.340000000000003 116.468 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1063 ' ' VAL . . . . . 0.556 ' HB ' ' HB ' ' A' 1058 ' ' VAL . 8.3 p -64.08 -26.57 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 O-C-N 120.763 -1.211 . . . . 41.460000000000001 111.444 169.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1064 ' ' TRP . . . . . . . . . . . . . 76.8 m95 -72.42 -23.01 61.02 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.941 1.296 . . . . 39.32 112.312 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -83.49 73.58 10.18 Favored 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 120.743 -1.223 . . . . 55.380000000000003 109.058 175.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1066 ' ' SER . . . . . . . . . . . . . 70.5 m -146.34 164.7 31.56 Favored 'General case' 0 C--O 1.257 1.468 0 CA-C-O 121.661 0.743 . . . . 41.869999999999997 109.983 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.11 -66.84 0.63 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.04 -0.982 . . . . 53.200000000000003 109.571 -176.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1068 ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' 1003 ' ' ILE . 31.4 mt -88.63 110.48 21.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 O-C-N 118.236 -2.79 . . . . 41.899999999999999 104.97 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1069 ' ' ILE . . . . . . . . . . . . . 28.1 mm -102.12 119.42 50.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 107.046 -1.465 . . . . 38.729999999999997 107.046 168.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1070 ' ' LEU . . . . . 0.681 ' HB3' HD13 ' A' 1331 ' ' LEU . 81.6 mt -88.02 74.83 8.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.736 -1.12 . . . . 32.439999999999998 110.126 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1071 ' ' LYS . . . . . 0.576 ' HE2' ' HA ' ' A' 1075 ' ' PRO . 5.1 mmmt -71.54 128.65 36.53 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 121.98 0.895 . . . . 34.649999999999999 111.111 -176.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1072 ' ' VAL . . . . . 0.676 HG11 ' HB3' ' A' 1015 ' ' ARG . 0.8 OUTLIER -82.04 -30.7 10.08 Favored 'Isoleucine or valine' 0 C--O 1.251 1.17 0 N-CA-C 109.167 -0.679 . . . . 31.32 109.167 -163.083 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 1073 ' ' ASN . . . . . 0.448 ' O ' ' HE3' ' A' 1071 ' ' LYS . 73.1 m-20 -128.61 -171.1 2.38 Favored 'General case' 0 C--O 1.246 0.902 0 N-CA-C 108.305 -0.998 . . . . 33.939999999999998 108.305 171.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -54.5 141.89 52.85 Favored Pre-proline 0 N--CA 1.47 0.556 0 CA-C-N 119.783 1.174 . . . . 38.039999999999999 112.069 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1075 ' ' PRO . . . . . 0.69 ' HG2' HD21 ' A' 1089 ' ' LEU . 82.2 Cg_exo -72.76 130.56 15.93 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.37 2.047 . . . . 42.68 112.892 173.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 17.8 mt -105.98 165.13 11.43 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 103.969 -2.604 . . . . 46.740000000000002 103.969 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1077 ' ' ASP . . . . . 0.422 ' O ' ' HB ' ' A' 1080 ' ' ILE . 75.3 m-20 -31.01 -58.7 0.22 Allowed 'General case' 0 C--N 1.357 0.909 0 N-CA-C 117.057 2.243 . . . . 58.609999999999999 117.057 -173.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 13.8 t70 -62.79 -43.63 98.28 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 113.496 0.924 . . . . 59.200000000000003 113.496 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1079 ' ' GLU . . . . . 0.433 ' CD ' ' HZ3' ' A' 1071 ' ' LYS . 33.4 mt-10 -64.93 -37.88 89.1 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 113.581 0.956 . . . . 50.630000000000003 113.581 176.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1080 ' ' ILE . . . . . 0.522 HG12 HD21 ' A' 1105 ' ' LEU . 25.0 mt -54.01 -54.03 23.48 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.88 0 CA-C-N 112.906 -1.952 . . . . 51.479999999999997 108.882 175.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -59.34 -25.69 64.41 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 123.812 1.768 . . . . 50.280000000000001 114.315 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 61.5 mt -77.92 -41.88 34.98 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 120.48 -1.387 . . . . 50.210000000000001 111.424 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1083 ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' 1080 ' ' ILE . 0.0 OUTLIER -55.27 139.92 40.88 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 123.93 1.824 . . . . 49.060000000000002 112.936 -178.119 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -101.8 152.69 38.17 Favored Pre-proline 0 N--CA 1.435 -1.185 0 CA-C-N 112.197 -2.274 . . . . 51.079999999999998 108.543 -156.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -64.07 109.67 1.18 Allowed 'Trans proline' 0 C--N 1.322 -0.824 0 CA-C-N 121.446 1.552 . . . . 49.729999999999997 114.006 170.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 110.94 -7.04 29.3 Favored Glycine 0 C--N 1.316 -0.539 0 C-N-CA 119.103 -1.522 . . . . 47.710000000000001 113.424 -171.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1087 ' ' THR . . . . . 0.6 ' HB ' HG12 ' A' 1110 ' ' VAL . 2.8 m -64.18 118.35 8.46 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 117.487 0.643 . . . . 45.469999999999999 110.921 176.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1088 ' ' THR . . . . . . . . . . . . . 99.2 m -83.86 93.51 8.02 Favored 'General case' 0 N--CA 1.411 -2.4 0 N-CA-C 104.491 -2.411 . . . . 42.039999999999999 104.491 172.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1089 ' ' LEU . . . . . 0.69 HD21 ' HG2' ' A' 1075 ' ' PRO . 55.0 tp -84.88 87.31 7.33 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 110.321 -3.127 . . . . 38.060000000000002 108.796 -174.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 15.8 t -83.11 120.16 33.91 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.813 0 N-CA-C 105.2 -2.148 . . . . 37.399999999999999 105.2 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1091 ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' 1071 ' ' LYS . 13.7 p -154.46 143.38 20.99 Favored 'General case' 0 C--O 1.247 0.974 0 O-C-N 119.454 -2.029 . . . . 36.159999999999997 114.897 -168.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 45.5 t80 -84.26 82.48 8.36 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-O 124.138 1.923 . . . . 38.939999999999998 109.694 168.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.28 -31.39 3.7 Favored 'Isoleucine or valine' 0 C--O 1.254 1.294 0 N-CA-C 116.865 2.172 . . . . 42.170000000000002 116.865 -169.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 99.0 m95 58.5 75.08 0.55 Allowed Pre-proline 0 C--O 1.247 0.932 0 CA-C-O 122.782 1.277 . . . . 46.509999999999998 113.039 -168.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1095 ' ' PRO . . . . . 0.563 ' HG3' HG11 ' A' 1360 ' ' VAL . 46.7 Cg_endo -60.04 -40.81 58.05 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 124.613 3.542 . . . . 49.759999999999998 115.687 -172.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1096 ' ' ALA . . . . . 0.457 ' HA ' ' HZ2' ' A' 1368 ' ' TRP . . . -61.15 -29.31 69.71 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.633 1.206 . . . . 52.619999999999997 113.84 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1097 ' ' GLN . . . . . 0.537 ' NE2' ' HA2' ' A' 1260 ' ' GLY . 28.0 mp0 -83.84 -24.27 30.99 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 106.276 -1.75 . . . . 60.740000000000002 106.276 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1098 ' ' ASN . . . . . 0.487 ' HB3' ' HB3' ' A' 1101 ' ' LEU . 61.1 m-80 -122.15 55.05 5.9 Favored Pre-proline 0 C--O 1.239 0.514 0 O-C-N 119.817 -1.802 . . . . 58.189999999999998 115.426 -168.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.01 -41.57 73.64 Favored 'Trans proline' 0 N--CA 1.476 0.478 1 C-N-CA 125.891 4.394 . . . . 54.590000000000003 114.218 -176.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -47.69 77.2 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.027 -0.988 . . . . 63.280000000000001 111.845 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1101 ' ' LEU . . . . . 0.487 ' HB3' ' HB3' ' A' 1098 ' ' ASN . 7.6 tp -56.89 -41.43 78.07 Favored 'General case' 0 C--O 1.254 1.307 0 CA-C-N 113.304 -1.771 . . . . 54.75 112.288 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1102 ' ' MET . . . . . 0.46 ' HE1' ' HB ' ' A' 1360 ' ' VAL . 75.0 mmm -57.09 -49.0 77.22 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 126.204 2.19 . . . . 52.649999999999999 109.598 174.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -65.01 -35.34 80.89 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.41 1.005 . . . . 66.260000000000005 111.116 -175.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -64.87 -43.88 91.53 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 109.136 -0.69 . . . . 63.729999999999997 109.136 177.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1105 ' ' LEU . . . . . 0.522 HD21 HG12 ' A' 1080 ' ' ILE . 49.0 mt -69.51 -30.57 68.45 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.926 0.869 . . . . 54.68 112.593 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -55.63 -48.92 74.13 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.482 0.919 . . . . 53.640000000000001 113.482 165.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -52.57 -46.58 66.92 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 114.479 1.289 . . . . 67.239999999999995 114.479 173.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -58.39 -22.16 52.87 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.702 -0.681 . . . . 65.760000000000005 111.95 174.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 45.2 t30 68.58 44.33 1.23 Allowed 'General case' 0 C--O 1.239 0.552 0 CA-C-O 124.322 2.011 . . . . 58.710000000000001 112.075 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1110 ' ' VAL . . . . . 0.6 HG12 ' HB ' ' A' 1087 ' ' THR . 28.3 m -93.11 165.7 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 O-C-N 119.288 -2.132 . . . . 46.630000000000003 112.109 175.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1111 ' ' THR . . . . . 0.485 HG21 HG21 ' A' 1348 ' ' VAL . 58.7 m -102.32 101.4 11.65 Favored 'General case' 0 C--O 1.214 -0.794 0 O-C-N 119.281 -2.137 . . . . 44.130000000000003 110.078 165.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1112 ' ' VAL . . . . . 0.679 HG22 HD23 ' A' 1089 ' ' LEU . 48.6 t -90.96 117.58 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 109.513 -0.551 . . . . 40.439999999999998 109.513 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1113 ' ' MET . . . . . 0.744 ' SD ' HD21 ' A' 1338 ' ' LEU . 58.3 mtp -112.61 108.16 17.13 Favored 'General case' 0 N--CA 1.422 -1.842 0 C-N-CA 124.105 0.962 . . . . 50.759999999999998 108.788 178.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1114 ' ' ALA . . . . . 0.603 ' HB3' ' HB2' ' A' 1117 ' ' SER . . . -81.37 115.42 20.71 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 116.065 -0.516 . . . . 35.640000000000001 111.575 -172.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1115 ' ' MET . . . . . 0.502 ' SD ' HD22 ' A' 1334 ' ' LEU . 93.5 mmm -76.0 -21.0 57.37 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 123.616 1.674 . . . . 38.740000000000002 114.877 -176.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -62.73 -50.38 71.33 Favored 'General case' 0 CA--C 1.482 -1.643 0 CA-C-N 112.767 -2.015 . . . . 40.140000000000001 111.692 163.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1117 ' ' SER . . . . . 0.603 ' HB2' ' HB3' ' A' 1114 ' ' ALA . 75.8 m -76.12 22.22 0.16 Allowed 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 118.866 2.913 . . . . 44.789999999999999 118.866 -175.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1118 ' ' VAL . . . . . 0.499 ' HA ' HG22 ' A' 1358 ' ' VAL . 59.9 t -66.12 130.75 94.36 Favored Pre-proline 0 C--O 1.249 1.063 0 N-CA-C 107.322 -1.362 . . . . 43.75 107.322 175.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -61.63 133.64 46.53 Favored 'Trans proline' 0 N--CA 1.428 -2.33 0 N-CA-C 107.903 -1.614 . . . . 48.93 107.903 175.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1120 ' ' ARG . . . . . 0.456 ' HD2' ' O ' ' A' 1118 ' ' VAL . 23.4 mmm-85 -79.5 41.02 0.46 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 113.861 -1.518 . . . . 62.899999999999999 114.665 -161.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 18.1 pt -116.56 155.15 18.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 O-C-N 119.978 -1.701 . . . . 57.719999999999999 113.132 -167.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1122 ' ' SER . . . . . . . . . . . . . 2.8 m -27.23 -64.73 0.08 Allowed 'General case' 0 C--N 1.312 -1.024 0 O-C-N 127.07 2.731 . . . . 57.259999999999998 116.637 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 39.9 ptt85 -68.53 -22.36 64.52 Favored 'General case' 0 C--N 1.353 0.726 0 O-C-N 119.655 -1.903 . . . . 62.899999999999999 112.428 -172.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1124 ' ' ALA . . . . . 0.409 ' HA ' HD13 ' A' 1127 ' ' LEU . . . -77.68 -13.66 59.84 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 115.108 1.521 . . . . 49.829999999999998 115.108 174.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 42.0 mm-40 -59.85 -29.22 68.14 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 119.04 2.978 . . . . 52.369999999999997 119.04 -165.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1126 ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' B' 1160 ' ' ALA . 15.8 m -69.96 -22.28 63.17 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 115.43 1.641 . . . . 42.43 115.43 168.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1127 ' ' LEU . . . . . 0.566 HD23 HD12 ' A' 1334 ' ' LEU . 3.3 mp -88.22 -45.48 10.05 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.179 -2.156 . . . . 43.740000000000002 105.179 177.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 30.3 t0 -50.45 109.23 0.29 Allowed 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 116.238 1.94 . . . . 43.210000000000001 116.238 -176.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -79.04 -30.06 43.9 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.68 -1.6 . . . . 35.740000000000002 113.134 176.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 80.8 mt -72.7 -6.52 45.01 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 119.545 -1.972 . . . . 38.090000000000003 111.945 175.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1131 ' ' SER . . . . . 0.556 ' HB3' HG11 ' A' 1175 ' ' VAL . 32.9 m -94.73 -57.66 2.4 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 107.801 -1.185 . . . . 36.909999999999997 107.801 161.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1132 ' ' SER . . . . . . . . . . . . . 22.2 m -77.28 -51.9 10.1 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 117.094 -1.431 . . . . 35.789999999999999 113.848 -169.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1133 ' ' MET . . . . . 0.582 ' HA ' HD12 ' A' 1136 ' ' ILE . 81.6 mtp -58.25 -37.81 75.67 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 124.274 3.215 . . . . 30.809999999999999 110.045 173.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1134 ' ' ALA . . . . . 0.514 ' HB1' ' HB2' ' A' 1176 ' ' ALA . . . -65.98 -34.19 77.53 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 120.538 -0.465 . . . . 28.879999999999999 110.333 177.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1135 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.79 -46.21 91.4 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 120.704 -1.248 . . . . 40.759999999999998 108.938 173.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1136 ' ' ILE . . . . . 0.893 HD13 ' HA ' ' A' 1323 ' ' SER . 16.8 mt -56.78 -50.65 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 117.631 -1.176 . . . . 31.539999999999999 111.745 172.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1137 ' ' ALA . . . . . 0.526 ' HB2' ' HG3' ' A' 1316 ' ' PRO . . . -53.56 -38.41 63.85 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 114.672 1.36 . . . . 29.870000000000001 114.672 169.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -63.9 -41.41 98.73 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-O 123.41 1.561 . . . . 28.73 111.652 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 17.0 t80 -71.68 -46.37 59.03 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-N 114.16 -1.02 . . . . 30.390000000000001 110.428 176.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1140 ' ' ARG . . . . . 0.513 HH11 HD13 ' A' 1319 ' ' LEU . 14.9 tpt180 -67.94 -19.97 65.03 Favored 'General case' 0 C--N 1.356 0.884 0 N-CA-C 107.949 -1.13 . . . . 26.09 107.949 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1141 ' ' ALA . . . . . 0.445 ' HB1' HG21 ' A' 1282 ' ' VAL . . . -62.89 -48.66 78.04 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 106.833 -1.543 . . . . 27.100000000000001 106.833 172.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 36.3 mm -64.53 -42.68 95.9 Favored 'Isoleucine or valine' 0 C--N 1.346 0.44 0 CA-C-N 119.343 0.974 . . . . 28.48 109.792 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1143 ' ' VAL . . . . . 0.408 ' HB ' ' HA ' ' A' 1140 ' ' ARG . 21.8 t -54.86 -60.04 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 113.533 0.938 . . . . 23.07 113.533 175.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1144 ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -71.7 -27.98 63.4 Favored 'General case' 0 C--O 1.248 0.989 0 O-C-N 119.561 -1.962 . . . . 33.399999999999999 112.456 -174.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1145 ' ' ALA . . . . . 0.701 ' HB1' HD12 ' A' 1251 ' ' ILE . . . -62.18 -49.04 77.38 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 106.54 -1.652 . . . . 24.219999999999999 106.54 175.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1146 ' ' ALA . . . . . 0.557 ' HA ' ' HB2' ' A' 1149 ' ' PHE . . . -58.76 -33.74 70.62 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 115.375 1.62 . . . . 24.890000000000001 115.375 171.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -61.96 -31.62 71.98 Favored 'General case' 0 C--N 1.372 1.569 0 CA-C-O 117.925 -1.036 . . . . 26.73 111.628 175.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1148 ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -109.77 1.63 19.5 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 115.706 1.743 . . . . 39.960000000000001 115.706 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1149 ' ' PHE . . . . . 0.557 ' HB2' ' HA ' ' A' 1146 ' ' ALA . 0.6 OUTLIER -64.47 138.38 58.38 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 126.06 1.744 . . . . 25.870000000000001 110.516 -170.125 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 1150 ' ' GLY . . . . . 0.566 ' HA2' ' HG2' ' B' 1320 ' ' PRO . . . -73.01 -55.46 6.34 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 110.259 -1.136 . . . . 19.280000000000001 110.259 171.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1151 ' ' ARG . . . . . 0.759 ' HA ' ' HB2' ' B' 1322 ' ' GLN . 33.4 mtm-85 -94.37 -178.8 4.7 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 113.025 0.75 . . . . 39.899999999999999 113.025 -174.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1152 ' ' PHE . . . . . 0.821 ' HB2' HG11 ' A' 1163 ' ' VAL . 19.3 m-30 -85.68 160.6 19.52 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 116.578 -2.049 . . . . 29.440000000000001 111.716 171.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1153 ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -73.27 -58.45 3.31 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 122.45 1.119 . . . . 32.600000000000001 108.523 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1154 ' ' THR . . . . . . . . . . . . . 20.9 m -62.86 123.93 19.74 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 125.536 1.534 . . . . 34.640000000000001 110.379 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -80.48 71.26 2.85 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 109.957 -1.257 . . . . 37.140000000000001 109.957 174.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -90.75 139.36 30.8 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 120.848 -0.341 . . . . 40.57 111.113 -166.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1157 ' ' ILE . . . . . 0.659 HG13 ' HB3' ' C' ' 70' ' ' PRO . 2.6 tp -73.77 112.28 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 107.86 -1.163 . . . . 44.609999999999999 107.86 168.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1158 ' ' THR . . . . . . . . . . . . . 42.6 p -91.21 174.53 7.35 Favored 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 109.013 -0.736 . . . . 40.700000000000003 109.013 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -49.06 -39.97 29.64 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 115.469 1.655 . . . . 40.25 115.469 167.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -86.55 -46.69 9.91 Favored 'General case' 0 C--O 1.253 1.255 0 N-CA-C 116.194 1.924 . . . . 38.469999999999999 116.194 178.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1161 ' ' GLY . . . . . 0.533 ' HA3' HG21 ' B' 1329 ' ' THR . . . -172.24 179.07 44.08 Favored Glycine 0 N--CA 1.475 1.259 0 CA-C-O 124.456 2.142 . . . . 37.609999999999999 116.493 -170.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1162 ' ' LYS . . . . . 0.486 ' HB2' ' HB2' ' C' ' 95' ' ' GLU . 17.1 tttt -76.27 115.06 15.65 Favored 'General case' 0 C--O 1.251 1.168 0 CA-C-N 111.995 -2.103 . . . . 48.899999999999999 108.788 -178.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1163 ' ' VAL . . . . . 0.821 HG11 ' HB2' ' A' 1152 ' ' PHE . 38.8 t -69.36 128.97 92.11 Favored Pre-proline 0 C--O 1.243 0.747 0 CA-C-O 116.662 -1.637 . . . . 36.520000000000003 108.977 171.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1164 ' ' PRO . . . . . 0.502 ' HA ' ' HD2' ' A' 1165 ' ' PRO . 42.6 Cg_exo -77.29 103.79 1.79 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 124.047 3.165 . . . . 35.079999999999998 112.151 177.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1165 ' ' PRO . . . . . 0.502 ' HD2' ' HA ' ' A' 1164 ' ' PRO . 55.5 Cg_endo -46.86 151.37 2.18 Favored 'Trans proline' 0 N--CA 1.455 -0.762 1 C-N-CA 125.46 4.107 . . . . 35.329999999999998 117.67 -173.072 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -79.27 137.47 37.39 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.948 1.356 . . . . 34.689999999999998 109.284 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1167 ' ' LYS . . . . . 0.606 ' HB2' ' HA ' ' A' 1249 ' ' VAL . 6.7 mptt -99.91 105.86 17.62 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 103.972 -2.603 . . . . 45.359999999999999 103.972 171.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 58.8 t -90.57 90.2 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 N-CA-C 105.039 -2.208 . . . . 31.710000000000001 105.039 -176.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1169 ' ' MET . . . . . 0.456 ' O ' ' HA ' ' A' 1252 ' ' ILE . 6.2 ttp -80.5 116.81 20.74 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.449 -1.315 . . . . 42.280000000000001 107.449 172.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 86.0 t -91.08 136.06 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 105.574 -2.01 . . . . 30.510000000000002 105.574 176.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 15.8 mt -109.92 120.5 61.12 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 N-CA-C 104.46 -2.422 . . . . 31.870000000000001 104.46 170.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1172 ' ' GLY . . . . . 0.457 ' HA3' ' HB2' ' A' 1256 ' ' ALA . . . 87.3 80.73 1.22 Allowed Glycine 0 C--O 1.256 1.489 0 N-CA-C 109.63 -1.388 . . . . 34.539999999999999 109.63 175.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1173 ' ' ALA . . . . . . . . . . . . . . . -87.34 118.83 27.04 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 122.726 1.25 . . . . 32.509999999999998 109.819 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1174 ' ' GLY . . . . . 0.587 ' HA2' HG11 ' A' 1200 ' ' VAL . . . -148.34 -149.8 5.06 Favored Glycine 0 N--CA 1.437 -1.249 0 N-CA-C 106.513 -2.635 . . . . 29.899999999999999 106.513 164.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1175 ' ' VAL . . . . . 0.556 HG11 ' HB3' ' A' 1131 ' ' SER . 54.1 t -57.21 -41.67 78.45 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 CA-C-N 121.101 2.45 . . . . 33.109999999999999 111.382 -175.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1176 ' ' ALA . . . . . 0.514 ' HB2' ' HB1' ' A' 1134 ' ' ALA . . . -60.02 -49.5 77.42 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-N 114.301 -1.318 . . . . 28.100000000000001 111.659 176.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -59.52 -46.96 93.1 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 108.458 -1.857 . . . . 28.539999999999999 108.458 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1178 ' ' LEU . . . . . . . . . . . . . 47.9 mt -58.77 -29.72 67.0 Favored 'General case' 0 C--O 1.241 0.62 0 O-C-N 119.129 -2.395 . . . . 31.219999999999999 113.447 175.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -58.68 -55.74 31.24 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-O 122.356 1.074 . . . . 28.98 110.88 168.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -55.85 -43.43 77.06 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 113.886 -1.507 . . . . 27.829999999999998 114.446 177.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1181 ' ' ILE . . . . . . . . . . . . . 74.8 mt -62.05 -49.52 83.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 107.89 -1.152 . . . . 30.25 107.89 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -54.47 -34.54 55.08 Favored Glycine 0 C--N 1.343 0.928 0 O-C-N 126.744 2.527 . . . . 29.59 113.512 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -74.92 -61.77 1.77 Allowed 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 117.503 0.652 . . . . 30.289999999999999 112.52 170.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1184 ' ' ALA . . . . . 0.427 ' HA ' HD12 ' A' 1187 ' ' LEU . . . -59.69 -32.21 70.29 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-O 121.752 0.787 . . . . 30.469999999999999 113.088 -166.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1185 ' ' ASN . . . . . 0.439 ' OD1' ' HA3' ' A' 1208 ' ' GLY . 10.2 t30 -56.49 -53.3 59.04 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.622 1.169 . . . . 42.409999999999997 112.206 173.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1186 ' ' SER . . . . . . . . . . . . . 3.6 m -64.41 -39.66 94.28 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.765 -1.107 . . . . 39.380000000000003 109.295 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1187 ' ' LEU . . . . . 0.942 ' HA ' ' HB3' ' B' 1186 ' ' SER . 25.8 mt -55.87 -34.71 65.73 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 115.826 1.787 . . . . 36.18 115.826 173.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 93.27 48.37 2.84 Favored Glycine 0 CA--C 1.534 1.259 0 O-C-N 124.108 0.88 . . . . 33.780000000000001 112.317 -177.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -113.98 162.02 16.94 Favored 'General case' 0 C--O 1.247 0.958 0 O-C-N 126.114 1.714 . . . . 33.93 108.756 172.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 66.1 mt -84.8 103.02 11.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 104.55 -2.389 . . . . 38.740000000000002 104.55 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 3.5 t -94.48 142.5 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 O-C-N 120.958 -1.089 . . . . 33.090000000000003 108.847 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1192 ' ' ARG . . . . . 0.498 ' HB3' ' HG ' ' A' 1212 ' ' LEU . 98.6 mtt180 -143.76 108.78 4.97 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.06 -1.089 . . . . 38.920000000000002 108.06 177.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -96.42 120.16 36.22 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 120.335 -1.478 . . . . 35.32 113.988 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 87.4 t80 -80.34 131.13 35.59 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 114.984 -1.007 . . . . 39.350000000000001 109.501 166.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 8.0 t70 -150.74 178.56 9.0 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 105.397 -2.075 . . . . 40.460000000000001 105.397 153.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1196 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.08 -31.98 9.91 Favored 'General case' 0 N--CA 1.428 -1.556 0 O-C-N 119.569 -1.957 . . . . 45.939999999999998 108.875 175.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1197 ' ' ARG . . . . . . . . . . . . . 53.0 mtm180 -69.63 133.44 88.73 Favored Pre-proline 0 N--CA 1.445 -0.684 0 O-C-N 120.832 -1.167 . . . . 56.020000000000003 109.916 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1198 ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -67.08 -28.29 41.31 Favored 'Trans proline' 0 C--O 1.242 0.719 0 C-N-CA 124.537 3.491 . . . . 51.270000000000003 118.276 173.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -55.71 -55.14 35.8 Favored 'General case' 0 C--O 1.254 1.334 0 O-C-N 119.925 -1.734 . . . . 59.100000000000001 114.037 -168.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1200 ' ' VAL . . . . . 0.587 HG11 ' HA2' ' A' 1174 ' ' GLY . 18.5 m -53.8 -25.35 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 116.749 2.129 . . . . 51.060000000000002 116.749 176.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 98.9 mttt -47.36 -43.45 23.13 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 115.774 1.768 . . . . 57.380000000000003 115.774 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -54.17 -51.29 64.8 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 122.942 1.353 . . . . 62.409999999999997 113.542 -175.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -70.87 -41.72 71.02 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 111.31 -2.677 . . . . 57.780000000000001 112.97 177.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1204 ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' 1209 ' ' ALA . 4.8 t -45.29 -49.88 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.448 1.499 . . . . 46.380000000000003 112.429 174.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -68.22 -52.82 29.85 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 113.639 -1.618 . . . . 50.700000000000003 112.435 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1206 ' ' SER . . . . . . . . . . . . . 41.0 p -66.87 -28.39 68.3 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.65 -0.705 . . . . 49.979999999999997 112.37 -172.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1207 ' ' MET . . . . . . . . . . . . . 12.3 mtt -66.55 -67.79 0.42 Allowed 'General case' 0 C--O 1.249 1.055 0 N-CA-C 106.562 -1.644 . . . . 52.990000000000002 106.562 166.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1208 ' ' GLY . . . . . 0.439 ' HA3' ' OD1' ' A' 1185 ' ' ASN . . . 154.9 60.25 0.01 OUTLIER Glycine 0 CA--C 1.522 0.522 0 CA-C-O 123.217 1.454 . . . . 47.659999999999997 112.955 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1209 ' ' ALA . . . . . 0.421 ' HB3' HG13 ' A' 1204 ' ' VAL . . . -141.44 145.5 35.36 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 112.347 -1.926 . . . . 44.770000000000003 111.32 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1210 ' ' GLU . . . . . 0.407 ' HB2' ' HG2' ' A' 1192 ' ' ARG . 37.3 mt-10 -74.01 155.51 38.51 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 104.068 -2.568 . . . . 47.640000000000001 104.068 163.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1211 ' ' PHE . . . . . . . . . . . . . 44.0 t80 -94.61 131.58 40.24 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 105.772 -1.936 . . . . 45.659999999999997 105.772 163.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1212 ' ' LEU . . . . . 0.498 ' HG ' ' HB3' ' A' 1192 ' ' ARG . 72.7 mt -88.33 108.42 19.33 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 106.993 -1.484 . . . . 46.060000000000002 106.993 174.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -82.19 133.26 35.25 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 111.801 -2.454 . . . . 60.219999999999999 109.012 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 4.9 tp -41.72 133.51 2.72 Favored 'General case' 0 C--O 1.241 0.609 0 O-C-N 127.858 3.224 . . . . 57.25 110.69 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 27.8 t0 -76.58 75.16 3.29 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 123.509 1.623 . . . . 64.430000000000007 114.013 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 3.2 t80 . . . . . 0 C--O 1.213 -0.853 0 N-CA-C 102.801 -3.037 . . . . 66.900000000000006 102.801 -171.806 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 N--CA 1.421 -1.886 0 N-CA-C 107.917 -1.142 . . . . 39.090000000000003 107.917 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -61.62 -45.26 96.68 Favored Glycine 0 CA--C 1.535 1.285 0 N-CA-C 115.988 1.155 . . . . 39.32 115.988 -174.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 91.5 t80 -72.98 -43.53 62.11 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 120.455 2.128 . . . . 39.299999999999997 112.639 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -69.31 -27.17 65.15 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 118.311 -2.743 . . . . 36.299999999999997 112.4 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -61.89 -60.44 3.64 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 120.089 -1.632 . . . . 37.380000000000003 106.988 163.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -52.42 -61.13 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.581 0 N-CA-C 116.769 2.137 . . . . 39.109999999999999 116.769 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1230 ' ' MET . . . . . 0.507 ' SD ' HD11 ' A' 1235 ' ' ILE . 34.7 mmt -89.94 49.38 1.71 Allowed 'General case' 0 C--O 1.251 1.166 0 O-C-N 118.197 -2.814 . . . . 49.590000000000003 116.202 -174.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1231 ' ' SER . . . . . . . . . . . . . 67.7 p -98.57 163.85 12.5 Favored 'General case' 0 C--O 1.253 1.286 0 CA-C-N 113.972 -1.467 . . . . 43.68 108.999 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.43 -36.85 83.84 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 116.172 -0.467 . . . . 55.57 110.928 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1233 ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' A' 1236 ' ' LYS . . . -60.31 -54.79 41.53 Favored 'General case' 0 C--O 1.215 -0.748 0 C-N-CA 125.403 1.481 . . . . 44.939999999999998 112.157 173.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -60.63 -52.49 64.91 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 115.23 1.566 . . . . 42.039999999999999 115.23 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1235 ' ' ILE . . . . . 0.507 HD11 ' SD ' ' A' 1230 ' ' MET . 94.8 mt -57.28 -32.26 40.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-O 123.491 1.615 . . . . 46.280000000000001 113.65 173.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1236 ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' 1233 ' ' ALA . 47.9 tttm -58.12 -57.67 11.81 Favored 'General case' 0 C--O 1.252 1.21 0 CA-C-O 124.525 2.107 . . . . 47.869999999999997 111.323 170.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1237 ' ' ALA . . . . . 0.422 ' HA ' ' HB2' ' A' 1240 ' ' GLU . . . -70.92 -11.89 61.23 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 115.731 1.752 . . . . 41.609999999999999 115.731 -175.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -67.73 -62.94 1.17 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.714 -1.587 . . . . 50.649999999999999 106.714 170.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1239 ' ' MET . . . . . . . . . . . . . 2.4 mtm -58.44 -35.42 72.1 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 121.158 -0.964 . . . . 48.869999999999997 113.249 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1240 ' ' GLU . . . . . 0.422 ' HB2' ' HA ' ' A' 1237 ' ' ALA . 91.0 mt-10 -68.73 -26.64 65.36 Favored 'General case' 0 C--O 1.25 1.11 0 C-N-CA 120.79 -0.364 . . . . 54.799999999999997 111.379 176.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 2.3 tm? -69.83 -56.99 5.64 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.962 -0.755 . . . . 43.210000000000001 108.962 166.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1242 ' ' PHE . . . . . 0.573 ' HE2' HD13 ' A' 1266 ' ' LEU . 22.9 m-30 -57.95 -41.79 83.58 Favored 'General case' 0 C--O 1.221 -0.409 0 O-C-N 124.76 1.287 . . . . 38.659999999999997 111.749 -166.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -68.84 -38.07 79.55 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.402 1.001 . . . . 37.920000000000002 111.764 -175.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -63.38 -51.0 67.69 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 120.266 -1.521 . . . . 37.280000000000001 109.994 174.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 -59.2 -34.36 72.06 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.232 1.413 . . . . 43.07 109.897 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1246 ' ' ALA . . . . . 0.438 ' HB1' ' HG3' ' A' 1275 ' ' MET . . . -62.77 -17.95 61.86 Favored 'General case' 0 N--CA 1.439 -1.021 0 O-C-N 119.314 -2.116 . . . . 38.299999999999997 116.272 176.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1247 ' ' LYS . . . . . . . . . . . . . 16.5 mtmm -81.83 -1.93 49.18 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 122.532 1.158 . . . . 47.600000000000001 112.929 174.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1248 ' ' GLU . . . . . 0.448 ' CD ' HH12 ' A' 1192 ' ' ARG . 14.6 pt-20 -129.35 -35.69 1.75 Allowed 'General case' 0 C--O 1.239 0.537 0 CA-C-O 116.117 -1.897 . . . . 45.420000000000002 113.6 177.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1249 ' ' VAL . . . . . 0.606 ' HA ' ' HB2' ' A' 1167 ' ' LYS . 33.0 m -75.71 161.77 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 121.635 2.016 . . . . 36.259999999999998 114.614 -168.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1250 ' ' ASP . . . . . 0.506 ' O ' ' HB3' ' A' 1279 ' ' SER . 4.7 m-20 -108.84 -60.32 1.76 Allowed 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.129 -1.396 . . . . 33.039999999999999 109.647 -175.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1251 ' ' ILE . . . . . 0.701 HD12 ' HB1' ' A' 1145 ' ' ALA . 51.5 mm -110.91 112.89 42.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 107.436 -1.32 . . . . 31.399999999999999 107.436 -168.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1252 ' ' ILE . . . . . 0.652 HD12 HG12 ' A' 1281 ' ' ILE . 64.2 mt -100.6 102.8 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 104.249 -2.5 . . . . 29.420000000000002 104.249 176.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1253 ' ' VAL . . . . . 0.586 ' HA ' HG23 ' A' 1282 ' ' VAL . 89.9 t -84.78 97.74 5.56 Favored 'Isoleucine or valine' 0 C--O 1.251 1.173 0 N-CA-C 104.296 -2.483 . . . . 30.370000000000001 104.296 175.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1254 ' ' THR . . . . . 0.479 ' CG2' ' HB2' ' A' 1291 ' ' ASN . 3.8 m -93.58 70.48 4.22 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 104.449 -2.426 . . . . 35.719999999999999 104.449 -167.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1255 ' ' THR . . . . . 0.663 ' HA ' ' HB2' ' A' 1284 ' ' LEU . 0.8 OUTLIER -78.48 0.88 24.23 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 119.443 -2.036 . . . . 36.0 115.844 -175.235 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 1256 ' ' ALA . . . . . 0.457 ' HB2' ' HA3' ' A' 1172 ' ' GLY . . . -64.77 68.83 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 118.297 2.702 . . . . 40.93 118.297 176.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 60.4 tp -77.8 91.81 4.15 Favored 'General case' 0 C--O 1.246 0.909 0 N-CA-C 106.456 -1.683 . . . . 47.82 106.456 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1258 ' ' ILE . . . . . 0.527 ' HA ' ' HD3' ' A' 1259 ' ' PRO . 39.3 mm -64.53 128.85 93.86 Favored Pre-proline 0 C--O 1.241 0.608 0 N-CA-C 108.275 -1.009 . . . . 52.700000000000003 108.275 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1259 ' ' PRO . . . . . 0.527 ' HD3' ' HA ' ' A' 1258 ' ' ILE . 51.0 Cg_exo -62.05 108.49 0.67 Allowed 'Trans proline' 0 N--CA 1.439 -1.701 0 C-N-CA 123.933 3.089 . . . . 54.130000000000003 109.786 -175.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1260 ' ' GLY . . . . . 0.537 ' HA2' ' NE2' ' A' 1097 ' ' GLN . . . 82.44 -64.95 4.19 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-O 118.186 -1.341 . . . . 54.619999999999997 113.589 168.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 13.5 mttp -65.9 137.03 95.87 Favored Pre-proline 0 C--O 1.216 -0.677 0 C-N-CA 125.468 1.507 . . . . 55.740000000000002 110.728 173.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -52.81 144.79 42.56 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.636 2.891 . . . . 51.149999999999999 116.371 176.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -67.28 133.72 93.31 Favored Pre-proline 0 CA--C 1.529 0.157 0 O-C-N 121.996 -0.44 . . . . 46.060000000000002 110.933 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -63.51 145.38 91.95 Favored 'Trans proline' 0 C--N 1.344 0.308 1 C-N-CA 125.914 4.409 . . . . 41.079999999999998 111.596 -178.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1265 ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' 1265 ' ' LYS . 67.8 mmtt -78.14 78.92 4.61 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 122.147 0.975 . . . . 47.420000000000002 109.785 -178.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1266 ' ' LEU . . . . . 0.573 HD13 ' HE2' ' A' 1242 ' ' PHE . 62.4 mt -83.82 -37.08 22.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.034 -1.439 . . . . 39.219999999999999 110.109 -171.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 15.4 mt -94.5 97.41 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 103.783 -2.673 . . . . 42.5 103.783 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1268 ' ' THR . . . . . 0.571 ' O ' HG23 ' A' 1272 ' ' VAL . 16.5 p -70.51 157.01 38.63 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 114.631 -1.168 . . . . 37.840000000000003 111.309 -176.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1269 ' ' ARG . . . . . 0.585 ' HG3' ' HB3' ' A' 1293 ' ' GLU . 97.5 mtt180 -52.09 -41.4 62.38 Favored 'General case' 0 CA--C 1.512 -0.499 0 O-C-N 120.994 -1.066 . . . . 54.799999999999997 111.833 168.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -44.37 -62.57 1.12 Allowed 'General case' 0 N--CA 1.476 0.836 0 O-C-N 125.362 1.664 . . . . 54.359999999999999 111.547 164.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1271 ' ' MET . . . . . . . . . . . . . 34.0 ttm -58.52 -44.36 89.48 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 120.726 1.603 . . . . 39.520000000000003 111.36 -173.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1272 ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' 1268 ' ' THR . 20.0 t -66.77 -46.58 85.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 115.793 -0.64 . . . . 38.25 111.553 -175.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.44 -3.84 26.65 Favored 'General case' 0 CA--C 1.506 -0.713 0 O-C-N 119.943 -1.723 . . . . 40.770000000000003 115.583 172.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1274 ' ' SER . . . . . . . . . . . . . 8.6 m -113.03 14.75 19.67 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 116.085 1.883 . . . . 36.579999999999998 116.085 164.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1275 ' ' MET . . . . . 0.633 ' HB3' HG21 ' A' 1307 ' ' VAL . 4.8 ttt -85.35 162.44 19.06 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.362 -0.977 . . . . 36.75 108.362 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1276 ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -63.07 132.48 52.05 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 124.198 1.951 . . . . 46.109999999999999 109.536 174.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1277 ' ' ALA . . . . . 0.68 ' HB1' ' HA ' ' B' 1045 ' ' PHE . . . -70.56 162.22 29.26 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 111.736 -2.484 . . . . 33.520000000000003 113.713 -172.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 67.28 27.54 73.52 Favored Glycine 0 N--CA 1.479 1.535 0 O-C-N 119.485 -2.01 . . . . 31.27 113.449 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1279 ' ' SER . . . . . 0.506 ' HB3' ' O ' ' A' 1250 ' ' ASP . 14.0 m -132.0 154.21 49.57 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 113.671 -1.265 . . . . 32.950000000000003 107.912 -168.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1280 ' ' VAL . . . . . 0.432 HG11 ' HA ' ' A' 1145 ' ' ALA . 18.5 t -126.52 123.88 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 122.082 0.944 . . . . 27.43 112.988 -171.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1281 ' ' ILE . . . . . 0.652 HG12 HD12 ' A' 1252 ' ' ILE . 52.1 mt -91.66 108.37 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 105.973 -1.862 . . . . 30.300000000000001 105.973 166.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1282 ' ' VAL . . . . . 0.586 HG23 ' HA ' ' A' 1253 ' ' VAL . 0.1 OUTLIER -89.13 124.0 41.66 Favored 'Isoleucine or valine' 0 C--O 1.25 1.108 0 O-C-N 120.813 -1.179 . . . . 28.629999999999999 108.729 170.575 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 1283 ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' 1286 ' ' ALA . 14.5 t0 -96.42 121.72 38.54 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 120.595 1.543 . . . . 36.270000000000003 110.482 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1284 ' ' LEU . . . . . 0.663 ' HB2' ' HA ' ' A' 1255 ' ' THR . 2.1 mm? -107.01 -9.08 16.33 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-O 122.968 1.366 . . . . 38.57 112.149 -176.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1285 ' ' ALA . . . . . 0.56 ' HB3' ' HA2' ' A' 1290 ' ' GLY . . . -76.99 -29.85 55.68 Favored 'General case' 0 C--O 1.243 0.736 0 O-C-N 120.691 -1.256 . . . . 37.560000000000002 108.092 164.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1286 ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' 1283 ' ' ASP . . . 28.06 -82.79 0.0 OUTLIER 'General case' 0 C--N 1.361 1.094 0 N-CA-C 118.545 2.795 . . . . 40.329999999999998 118.545 173.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -66.33 -41.93 88.92 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 113.905 1.076 . . . . 56.850000000000001 113.905 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 46.9 t30 -85.7 82.32 8.26 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 122.65 1.214 . . . . 45.859999999999999 111.824 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 73.52 -67.14 1.59 Allowed Glycine 0 CA--C 1.538 1.524 0 O-C-N 119.498 -2.001 . . . . 40.310000000000002 111.724 -175.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1290 ' ' GLY . . . . . 0.56 ' HA2' ' HB3' ' A' 1285 ' ' ALA . . . 89.26 129.49 3.62 Favored Glycine 0 CA--C 1.536 1.356 0 N-CA-C 110.357 -1.097 . . . . 38.890000000000001 110.357 -177.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1291 ' ' ASN . . . . . 0.479 ' HB2' ' CG2' ' A' 1254 ' ' THR . 32.2 m120 -73.47 -17.06 61.28 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.469 1.634 . . . . 37.229999999999997 115.3 -172.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1292 ' ' CYS . . . . . 0.476 ' SG ' HG11 ' A' 1309 ' ' VAL . 49.1 t -91.75 146.33 23.85 Favored 'General case' 0 C--O 1.248 1.016 0 CA-C-O 125.36 2.505 . . . . 36.5 110.359 173.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1293 ' ' GLU . . . . . 0.585 ' HB3' ' HG3' ' A' 1269 ' ' ARG . 6.5 mt-10 -75.67 -7.99 55.7 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 119.259 -2.151 . . . . 43.32 115.782 172.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -109.05 26.56 10.48 Favored 'General case' 0 C--O 1.215 -0.735 0 O-C-N 120.124 -1.61 . . . . 41.32 113.629 175.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1295 ' ' THR . . . . . . . . . . . . . 54.6 m -81.3 81.15 7.55 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 125.868 2.747 . . . . 35.299999999999997 108.925 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1296 ' ' VAL . . . . . 0.467 ' HA ' ' HD3' ' A' 1297 ' ' PRO . 72.5 t -76.58 124.11 87.79 Favored Pre-proline 0 N--CA 1.424 -1.733 0 O-C-N 119.794 -1.817 . . . . 34.840000000000003 108.389 -176.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1297 ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' 1296 ' ' VAL . 50.4 Cg_exo -56.47 99.21 0.08 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.684 0 C-N-CA 124.362 3.375 . . . . 33.509999999999998 115.291 -167.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 81.83 37.8 15.43 Favored Glycine 0 N--CA 1.437 -1.266 0 CA-C-N 112.565 -2.107 . . . . 32.189999999999998 111.575 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -145.3 153.6 41.45 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 124.234 1.969 . . . . 34.880000000000003 110.151 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1300 ' ' ILE . . . . . 0.54 HG12 HG12 ' A' 1310 ' ' ILE . 77.2 mt -83.75 157.6 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 CA-C-N 111.203 -2.726 . . . . 32.289999999999999 105.328 161.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 58.3 t80 -137.47 147.31 45.21 Favored 'General case' 0 C--O 1.253 1.262 0 N-CA-C 104.948 -2.241 . . . . 37.25 104.948 176.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1302 ' ' THR . . . . . . . . . . . . . 8.3 m -126.65 134.68 50.69 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 106.098 -1.816 . . . . 35.560000000000002 106.098 170.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1303 ' ' THR . . . . . 0.424 HG21 HG12 ' A' 1272 ' ' VAL . 24.9 p -79.78 174.71 11.31 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 112.705 0.631 . . . . 36.399999999999999 112.705 176.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -53.32 -56.34 17.46 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 121.335 -0.853 . . . . 52.32 111.218 171.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -68.46 10.01 0.29 Allowed 'General case' 0 C--N 1.352 0.684 0 N-CA-C 117.189 2.292 . . . . 40.039999999999999 117.189 176.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 70.67 38.12 67.4 Favored Glycine 0 C--O 1.244 0.753 0 O-C-N 121.909 -0.494 . . . . 36.960000000000001 112.9 169.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1307 ' ' VAL . . . . . 0.633 HG21 ' HB3' ' A' 1275 ' ' MET . 87.5 t -99.83 133.9 41.13 Favored 'Isoleucine or valine' 0 C--O 1.262 1.715 0 N-CA-C 101.412 -3.551 . . . . 33.399999999999999 101.412 170.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1308 ' ' LYS . . . . . 0.426 ' HB2' HG22 ' A' 1280 ' ' VAL . 67.2 mmtt -94.93 136.41 35.27 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 111.659 -2.519 . . . . 42.909999999999997 108.809 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1309 ' ' VAL . . . . . 0.476 HG11 ' SG ' ' A' 1292 ' ' CYS . 21.8 t -118.13 116.75 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 N-CA-C 106.581 -1.637 . . . . 32.289999999999999 106.581 171.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1310 ' ' ILE . . . . . 0.54 HG12 HG12 ' A' 1300 ' ' ILE . 27.3 mt -102.61 98.09 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 105.423 -2.066 . . . . 30.989999999999998 105.423 -178.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -103.68 51.29 0.83 Allowed Glycine 0 CA--C 1.529 0.962 0 N-CA-C 106.353 -2.699 . . . . 28.949999999999999 106.353 175.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1312 ' ' TYR . . . . . 0.594 ' HB2' ' HG ' ' A' 1315 ' ' LEU . 5.0 m-85 -72.64 101.82 3.14 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 105.037 -2.209 . . . . 31.690000000000001 105.037 171.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1313 ' ' THR . . . . . 0.409 ' HA ' ' HB1' ' A' 1286 ' ' ALA . 1.6 p -53.3 -31.79 45.67 Favored 'General case' 0 C--O 1.243 0.719 0 O-C-N 121.022 -1.049 . . . . 34.170000000000002 111.426 177.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -81.46 7.74 11.12 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 118.695 2.85 . . . . 36.859999999999999 118.695 174.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1315 ' ' LEU . . . . . 0.594 ' HG ' ' HB2' ' A' 1312 ' ' TYR . 26.7 mt -47.69 -39.35 22.47 Favored Pre-proline 0 C--O 1.252 1.223 0 CA-C-N 123.798 2.999 . . . . 34.850000000000001 118.511 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1316 ' ' PRO . . . . . 0.526 ' HG3' ' HB2' ' A' 1137 ' ' ALA . 73.0 Cg_exo -59.15 -35.83 96.98 Favored 'Trans proline' 0 C--O 1.205 -1.17 0 C-N-CA 123.143 2.562 . . . . 29.149999999999999 112.961 173.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1317 ' ' GLY . . . . . 0.42 ' HA3' ' HE ' ' A' 1015 ' ' ARG . . . -94.74 -12.87 55.09 Favored Glycine 0 CA--C 1.495 -1.209 0 O-C-N 120.5 -1.375 . . . . 27.289999999999999 116.173 -177.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1318 ' ' ARG . . . . . . . . . . . . . 8.2 ttt-85 -64.76 6.1 0.25 Allowed 'General case' 0 C--O 1.244 0.777 0 N-CA-C 117.057 2.243 . . . . 41.490000000000002 117.057 -175.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1319 ' ' LEU . . . . . 0.513 HD13 HH11 ' A' 1140 ' ' ARG . 15.4 tp -116.6 78.96 9.11 Favored Pre-proline 0 N--CA 1.439 -1.008 0 CA-C-N 123.23 2.741 . . . . 27.609999999999999 107.011 173.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1320 ' ' PRO . . . . . 0.561 ' HG2' ' HA2' ' B' 1150 ' ' GLY . 20.4 Cg_endo -40.89 -57.87 1.19 Allowed 'Trans proline' 0 CA--C 1.504 -0.988 0 C-N-CA 124.476 3.45 . . . . 25.940000000000001 118.126 -155.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1321 ' ' THR . . . . . 0.471 HG23 HG21 ' A' 1019 ' ' THR . 3.0 m -72.04 -33.65 68.16 Favored 'General case' 0 N--CA 1.437 -1.125 0 O-C-N 118.597 -2.564 . . . . 25.010000000000002 109.678 -174.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1322 ' ' GLN . . . . . 0.843 ' HB2' ' HA ' ' B' 1151 ' ' ARG . 61.3 tp60 -84.88 -39.08 18.66 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 120.26 1.391 . . . . 29.390000000000001 110.575 -171.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1323 ' ' SER . . . . . 0.893 ' HA ' HD13 ' A' 1136 ' ' ILE . 17.6 m -47.5 -56.69 6.54 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.963 1.098 . . . . 26.469999999999999 113.963 158.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1324 ' ' SER . . . . . . . . . . . . . 14.4 m -68.93 -17.28 63.93 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.274 0.842 . . . . 27.780000000000001 113.274 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -75.62 -67.91 0.62 Allowed 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 103.856 -2.646 . . . . 37.530000000000001 103.856 174.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1326 ' ' LEU . . . . . 0.758 ' HB2' HD11 ' A' 1136 ' ' ILE . 89.8 mt -72.42 -43.83 63.3 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 115.042 -2.409 . . . . 35.710000000000001 112.921 -168.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1327 ' ' TYR . . . . . 0.415 ' HE2' ' HA ' ' A' 1072 ' ' VAL . 73.8 t80 -58.02 -43.63 86.84 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-N 122.501 2.41 . . . . 31.59 107.703 169.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1328 ' ' GLY . . . . . 0.656 ' HA2' HD12 ' A' 1331 ' ' LEU . . . -58.17 -37.28 85.92 Favored Glycine 0 C--N 1.345 1.058 0 N-CA-C 110.884 -0.886 . . . . 28.0 110.884 176.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1329 ' ' THR . . . . . 0.418 HG21 ' HA3' ' B' 1161 ' ' GLY . 36.5 m -77.8 -28.7 50.49 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 118.938 1.369 . . . . 32.149999999999999 111.415 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1330 ' ' ASN . . . . . 0.4 ' HA ' ' O ' ' A' 1126 ' ' SER . 16.2 m120 -55.31 -48.31 74.31 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 120.693 1.588 . . . . 34.359999999999999 111.611 164.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1331 ' ' LEU . . . . . 0.681 HD13 ' HB3' ' A' 1070 ' ' LEU . 19.6 mt -56.1 -53.35 58.08 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 124.507 1.123 . . . . 33.369999999999997 111.241 175.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1332 ' ' VAL . . . . . 0.58 HG12 ' HE3' ' A' 1336 ' ' LYS . 59.8 t -49.13 -47.45 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 C-N-CA 125.898 1.679 . . . . 35.270000000000003 111.125 175.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -70.19 -30.35 67.45 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-O 117.243 -1.361 . . . . 37.659999999999997 113.85 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1334 ' ' LEU . . . . . 0.566 HD12 HD23 ' A' 1127 ' ' LEU . 18.3 tp -62.76 -48.67 78.15 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 122.887 1.327 . . . . 40.270000000000003 108.451 169.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1335 ' ' LEU . . . . . . . . . . . . . 82.0 mt -66.12 -23.65 66.53 Favored 'General case' 0 C--O 1.246 0.899 0 O-C-N 120.252 -1.53 . . . . 42.5 110.096 -175.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1336 ' ' LYS . . . . . 0.58 ' HE3' HG12 ' A' 1332 ' ' VAL . 96.9 mttt -60.24 -45.31 93.67 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.445 -1.41 . . . . 47.810000000000002 112.836 168.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1337 ' ' LEU . . . . . 0.486 HD22 HD21 ' A' 1127 ' ' LEU . 8.1 mp -75.03 -38.97 61.33 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 113.218 -1.81 . . . . 49.270000000000003 113.049 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1338 ' ' LEU . . . . . 0.744 HD21 ' SD ' ' A' 1113 ' ' MET . 6.3 mp -72.56 -58.37 3.43 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 125.818 1.647 . . . . 50.539999999999999 111.204 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1339 ' ' CYS . . . . . 0.675 ' HB3' ' HA2' ' A' 1344 ' ' GLY . 58.7 m -92.38 68.45 4.95 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-O 124.408 2.051 . . . . 53.670000000000002 106.35 -177.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 75.3 tttt -76.02 -47.93 22.95 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 111.526 -2.579 . . . . 63.380000000000003 109.016 -158.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -70.08 -25.64 63.62 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 113.425 0.898 . . . . 70.950000000000003 113.425 -175.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1342 ' ' LYS . . . . . 0.487 ' N ' ' HB3' ' A' 1343 ' ' ASP . 46.5 mtpt 52.12 68.27 0.84 Allowed 'General case' 0 C--O 1.253 1.26 0 N-CA-C 118.106 2.632 . . . . 65.25 118.106 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1343 ' ' ASP . . . . . 0.487 ' HB3' ' N ' ' A' 1342 ' ' LYS 0.278 10.9 t70 67.04 -88.14 0.03 OUTLIER 'General case' 0 C--O 1.236 0.387 2 O-C-N 110.921 -7.362 . . . . 64.530000000000001 119.784 -0.177 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A 1344 ' ' GLY . . . . . 0.675 ' HA2' ' HB3' ' A' 1339 ' ' CYS . . . 86.29 17.85 60.02 Favored Glycine 0 N--CA 1.425 -2.036 0 O-C-N 119.98 -1.7 . . . . 59.719999999999999 115.963 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 19.5 t30 -80.4 143.24 33.63 Favored 'General case' 0 N--CA 1.434 -1.226 0 O-C-N 120.469 -1.607 . . . . 64.090000000000003 108.767 160.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1346 ' ' ILE . . . . . 0.414 ' HA ' ' SG ' ' A' 1339 ' ' CYS . 14.7 mt -91.6 100.18 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 104.49 -2.411 . . . . 58.82 104.49 -167.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1347 ' ' THR . . . . . . . . . . . . . 6.9 m -84.08 98.8 10.07 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 104.339 -2.467 . . . . 54.960000000000001 104.339 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1348 ' ' VAL . . . . . 0.485 HG21 HG21 ' A' 1111 ' ' THR . 19.5 t -93.4 80.02 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.257 1.475 0 N-CA-C 105.448 -2.056 . . . . 55.640000000000001 105.448 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 12.9 t70 -76.68 135.17 39.09 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 115.238 1.57 . . . . 61.450000000000003 115.238 -167.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -80.89 -28.28 35.99 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-N 114.864 -1.062 . . . . 58.630000000000003 111.882 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -85.82 -31.82 22.08 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 119.977 -1.702 . . . . 62.060000000000002 114.747 -170.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 9.9 t70 -64.07 123.08 18.11 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 125.046 1.466 . . . . 54.07 109.238 169.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 18.6 m -57.44 -45.66 85.66 Favored 'Isoleucine or valine' 0 C--O 1.253 1.268 0 N-CA-C 113.508 0.929 . . . . 50.68 113.508 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1354 ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' 1358 ' ' VAL . 12.9 m -77.45 -38.53 26.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 119.971 -0.692 . . . . 47.68 110.188 -172.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1355 ' ' ILE . . . . . . . . . . . . . 90.3 mt -62.39 -54.05 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-N 121.141 1.791 . . . . 48.490000000000002 108.589 174.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1356 ' ' ARG . . . . . 0.451 ' HG3' ' HD2' ' A' 1371 ' ' PRO . 45.3 tpt85 -55.92 -37.92 69.58 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 112.107 0.41 . . . . 48.270000000000003 112.107 178.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -59.72 -46.92 93.22 Favored Glycine 0 N--CA 1.469 0.846 0 O-C-N 125.41 1.694 . . . . 43.530000000000001 112.466 174.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1358 ' ' VAL . . . . . 0.499 HG22 ' HA ' ' A' 1118 ' ' VAL . 30.2 t -75.08 -28.69 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 O-C-N 118.428 -2.807 . . . . 45.119999999999997 109.726 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1359 ' ' THR . . . . . 0.466 ' CG2' ' HB2' ' A' 1362 ' ' ARG . 26.2 m -64.71 96.16 0.17 Allowed 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 118.082 -2.886 . . . . 42.939999999999998 114.706 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1360 ' ' VAL . . . . . 0.563 HG11 ' HG3' ' A' 1095 ' ' PRO . 17.5 m -96.55 -30.62 3.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 112.214 0.449 . . . . 43.259999999999998 112.214 -177.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1361 ' ' ILE . . . . . . . . . . . . . 95.7 mt -131.49 136.22 57.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 101.919 -3.363 . . . . 45.659999999999997 101.919 163.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1362 ' ' ARG . . . . . 0.466 ' HB2' ' CG2' ' A' 1359 ' ' THR . 50.4 ttt180 -124.62 125.77 44.67 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 104.428 -2.434 . . . . 61.340000000000003 104.428 165.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 48.89 55.7 8.83 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 125.507 1.754 . . . . 49.759999999999998 113.996 172.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 82.08 -42.33 2.85 Favored Glycine 0 C--O 1.218 -0.871 0 CA-C-N 113.021 -1.899 . . . . 50.0 112.569 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -69.9 126.47 29.81 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 119.953 1.876 . . . . 56.920000000000002 107.071 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1366 ' ' ILE . . . . . . . . . . . . . 96.5 mt -74.59 96.18 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.391 0 N-CA-C 107.19 -1.411 . . . . 52.780000000000001 107.19 178.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1367 ' ' THR . . . . . . . . . . . . . 17.6 p -82.75 1.52 38.39 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 115.932 1.827 . . . . 49.439999999999998 115.932 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1368 ' ' TRP . . . . . 0.457 ' HZ2' ' HA ' ' A' 1096 ' ' ALA . 29.6 t90 -78.66 133.71 62.35 Favored Pre-proline 0 N--CA 1.442 -0.872 0 N-CA-C 105.313 -2.106 . . . . 52.380000000000003 105.313 161.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -58.28 130.09 4.53 Favored 'Cis proline' 0 C--N 1.329 -0.47 0 N-CA-C 119.687 2.918 . . . . 46.939999999999998 119.687 5.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1370 ' ' ALA . . . . . 0.461 ' HA ' ' HD3' ' A' 1371 ' ' PRO . . . -72.84 112.53 15.65 Favored Pre-proline 0 C--O 1.245 0.838 0 C-N-CA 124.567 1.147 . . . . 45.909999999999997 110.837 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1371 ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' 1370 ' ' ALA . 32.3 Cg_exo -67.61 120.65 7.68 Favored 'Trans proline' 0 N--CA 1.433 -2.082 0 C-N-CA 124.636 3.558 . . . . 46.390000000000001 118.104 -173.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -71.89 -62.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 123.179 2.586 . . . . 46.719999999999999 109.968 164.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.239 -4.238 0 CA-C-N 120.642 1.564 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 23.1 m80 . . . . . 0 C--O 1.245 0.826 0 N-CA-C 107.24 -1.393 . . . . 63.439999999999998 107.24 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 999' ' ' HIS . . . . . 0.475 ' HB3' ' HB3' ' B' 1002 ' ' ARG . 23.2 m-70 -120.75 59.74 0.91 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.857 -0.794 . . . . 51.740000000000002 108.857 164.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1000 ' ' HIS . . . . . 0.599 ' HA ' ' HB2' ' B' 1067 ' ' GLU . 10.1 t60 -77.18 139.53 39.93 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 102.795 -3.039 . . . . 54.07 102.795 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 81.88 -0.46 88.37 Favored Glycine 0 C--O 1.26 1.721 0 CA-C-N 113.728 -1.578 . . . . 39.219999999999999 111.814 -171.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1002 ' ' ARG . . . . . 0.475 ' HB3' ' HB3' ' B' ' 999' ' ' HIS . 34.1 ttp180 -108.52 148.36 30.38 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 119.59 1.695 . . . . 38.119999999999997 106.677 177.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1003 ' ' ILE . . . . . 0.714 HG12 HD12 ' B' 1068 ' ' ILE . 24.3 mt -102.61 147.27 9.38 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 N-CA-C 105.724 -1.954 . . . . 29.699999999999999 105.724 172.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -107.38 121.72 6.58 Favored Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 108.492 -1.843 . . . . 27.5 108.492 167.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1005 ' ' ILE . . . . . 0.515 HG23 ' HB3' ' B' 1017 ' ' ALA . 40.7 mm -105.77 106.51 56.8 Favored Pre-proline 0 N--CA 1.439 -1.006 0 N-CA-C 106.689 -1.597 . . . . 24.829999999999998 106.689 171.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1006 ' ' PRO . . . . . 0.58 ' HA ' ' HG3' ' B' 1036 ' ' GLU . 26.4 Cg_exo -80.12 176.82 8.93 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 124.687 3.591 . . . . 27.190000000000001 108.35 -175.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 22.9 ttm105 -84.82 131.51 34.52 Favored 'General case' 0 C--N 1.318 -0.773 0 O-C-N 120.128 -1.608 . . . . 41.460000000000001 108.124 165.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1008 ' ' GLU . . . . . 0.649 ' HG3' ' HB ' ' B' 1072 ' ' VAL 0.311 25.2 mm-40 -68.93 136.18 52.16 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 119.612 3.19 . . . . 26.93 119.612 173.71 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 47.6 mmm-85 -99.08 -3.76 33.95 Favored 'General case' 0 C--O 1.253 1.285 0 CA-C-N 111.512 -2.585 . . . . 34.479999999999997 116.068 -165.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1010 ' ' LEU . . . . . . . . . . . . . 65.6 tp -58.21 138.6 56.14 Favored 'General case' 0 N--CA 1.441 -0.875 0 O-C-N 121.177 -0.952 . . . . 44.219999999999999 112.108 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1011 ' ' THR . . . . . . . . . . . . . 1.3 m -59.72 111.93 1.63 Allowed 'General case' 0 C--N 1.319 -0.759 0 O-C-N 124.573 1.171 . . . . 40.740000000000002 108.187 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 38.8 t30 60.63 92.75 0.05 OUTLIER 'General case' 0 C--O 1.252 1.199 0 O-C-N 126.657 2.473 . . . . 44.439999999999998 107.894 -171.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1013 ' ' GLU . . . . . 0.539 ' HG2' ' HB3' ' B' 1008 ' ' GLU . 9.3 tp10 -130.99 132.72 45.2 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 124.88 2.276 . . . . 29.870000000000001 109.609 -177.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1014 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.16 -32.49 50.27 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-N 108.816 -3.811 . . . . 25.260000000000002 117.642 176.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 43.5 mtm180 -95.64 159.86 14.78 Favored 'General case' 0 C--O 1.252 1.201 0 CA-C-O 124.021 1.867 . . . . 29.539999999999999 115.179 -161.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1016 ' ' VAL . . . . . 0.553 HG13 ' H ' ' B' 1018 ' ' ALA . 4.7 p -128.86 -176.5 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 102.936 -2.987 . . . . 23.550000000000001 102.936 159.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1017 ' ' ALA . . . . . 0.515 ' HB3' HG23 ' B' 1005 ' ' ILE . . . -90.34 -8.81 49.84 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 116.854 2.168 . . . . 23.59 116.854 -178.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1018 ' ' ALA . . . . . 0.553 ' H ' HG13 ' B' 1016 ' ' VAL . . . -159.75 145.72 15.86 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-O 121.528 0.68 . . . . 24.93 110.313 -177.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1019 ' ' THR . . . . . 0.516 HG21 HG23 ' B' 1321 ' ' THR . 0.7 OUTLIER -108.8 165.45 12.64 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-O 116.682 -1.628 . . . . 28.09 111.924 172.297 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B 1020 ' ' PRO . . . . . 0.482 ' HB3' ' HB2' ' B' 1053 ' ' ALA . 0.2 OUTLIER -47.88 -43.2 30.15 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 124.331 3.354 . . . . 28.789999999999999 116.652 175.251 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 47.7 tptt -50.71 -41.53 56.16 Favored 'General case' 0 C--O 1.256 1.446 0 N-CA-C 113.358 0.873 . . . . 47.280000000000001 113.358 168.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1022 ' ' THR . . . . . 0.539 HG21 ' HA3' ' B' 1328 ' ' GLY . 0.2 OUTLIER -72.63 -38.49 67.73 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 118.83 -0.605 . . . . 30.120000000000001 111.63 177.679 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B 1023 ' ' VAL . . . . . 0.427 HG22 HG11 ' B' 1033 ' ' VAL . 79.8 t -49.23 -48.63 17.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-O 122.61 1.195 . . . . 32.240000000000002 113.156 -178.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1024 ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -53.25 -48.16 68.45 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 112.684 -2.053 . . . . 49.619999999999997 110.492 174.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -61.71 -43.24 99.24 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 120.831 -1.168 . . . . 44.68 110.316 -174.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 51.1 mt -64.93 -39.03 92.89 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 115.069 1.507 . . . . 35.710000000000001 115.069 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1027 ' ' LEU . . . . . . . . . . . . . 58.1 mt -64.78 -41.58 95.74 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 125.581 1.552 . . . . 42.18 109.006 174.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 31.4 mttm -63.5 -35.9 81.97 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 123.731 0.644 . . . . 48.340000000000003 110.652 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1029 ' ' LEU . . . . . . . . . . . . . 82.0 mt -59.47 -62.36 1.93 Allowed 'General case' 0 CA--C 1.504 -0.808 0 C-N-CA 123.618 0.767 . . . . 38.689999999999998 109.212 170.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 143.35 45.02 0.05 OUTLIER Glycine 0 C--N 1.312 -0.758 0 N-CA-C 110.309 -1.116 . . . . 32.280000000000001 110.309 168.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -133.17 122.7 24.39 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 123.038 1.399 . . . . 35.939999999999998 108.733 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1032 ' ' THR . . . . . . . . . . . . . 28.0 m -66.3 133.2 50.06 Favored 'General case' 0 C--O 1.25 1.098 0 CA-C-N 114.121 -1.399 . . . . 33.369999999999997 108.414 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1033 ' ' VAL . . . . . 0.427 HG11 HG22 ' B' 1023 ' ' VAL . 22.2 t -107.38 126.88 63.57 Favored 'Isoleucine or valine' 0 C--O 1.251 1.169 0 O-C-N 120.068 -1.645 . . . . 29.98 107.271 -169.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -122.45 139.15 54.2 Favored 'General case' 0 C--O 1.243 0.714 0 O-C-N 124.134 0.896 . . . . 28.18 111.553 168.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1035 ' ' VAL . . . . . 0.605 ' HB ' HD13 ' B' 1057 ' ' ILE . 21.2 t -127.35 149.33 32.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 105.866 -1.901 . . . . 25.82 105.866 -175.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1036 ' ' GLU . . . . . 0.58 ' HG3' ' HA ' ' B' 1006 ' ' PRO . 13.3 mt-10 -62.67 145.61 54.22 Favored 'General case' 0 C--O 1.257 1.473 0 N-CA-C 113.7 1.0 . . . . 32.439999999999998 113.7 171.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1037 ' ' SER . . . . . . . . . . . . . 13.0 m -70.54 148.13 48.54 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 106.038 -1.838 . . . . 29.539999999999999 106.038 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 82.11 -53.2 4.73 Favored Glycine 0 CA--C 1.534 1.27 0 O-C-N 119.205 -2.184 . . . . 27.760000000000002 110.401 -172.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1039 ' ' ALA . . . . . . . . . . . . . . . -51.61 -40.99 60.91 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-N 119.434 1.617 . . . . 26.02 112.547 172.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -57.59 -49.08 76.68 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 120.465 -0.874 . . . . 26.469999999999999 112.288 171.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1041 ' ' GLN . . . . . 0.517 ' OE1' ' HA ' ' B' 1046 ' ' ASP . 1.1 tp-100 -59.12 -40.62 85.98 Favored 'General case' 0 C--O 1.246 0.877 0 C-N-CA 123.233 0.613 . . . . 50.979999999999997 110.429 178.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 46.2 mt -66.5 -26.51 67.2 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.771 1.026 . . . . 29.300000000000001 113.771 -171.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1043 ' ' ALA . . . . . . . . . . . . . . . -83.88 40.48 0.75 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 119.521 1.055 . . . . 26.739999999999998 111.926 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1044 ' ' SER . . . . . . . . . . . . . 38.6 m 44.3 54.62 6.07 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 126.284 1.833 . . . . 31.260000000000002 110.899 -166.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1045 ' ' PHE . . . . . 0.68 ' HA ' ' HB1' ' A' 1277 ' ' ALA . 0.2 OUTLIER -144.68 -167.39 2.64 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.439 -1.255 . . . . 33.259999999999998 109.775 -174.526 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B 1046 ' ' ASP . . . . . 0.517 ' HA ' ' OE1' ' B' 1041 ' ' GLN . 22.3 t70 -131.06 140.22 50.02 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 105.805 -1.924 . . . . 46.740000000000002 105.805 174.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -68.06 -37.47 81.31 Favored 'General case' 0 CA--C 1.502 -0.866 0 O-C-N 125.954 2.034 . . . . 34.439999999999998 111.407 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -77.85 -23.95 48.75 Favored 'General case' 0 N--CA 1.435 -1.2 0 O-C-N 119.279 -2.138 . . . . 48.670000000000002 109.955 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1049 ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' B' 1046 ' ' ASP . . . -58.45 -43.42 88.8 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 118.762 -0.637 . . . . 35.259999999999998 111.896 163.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1050 ' ' PHE . . . . . 0.461 ' HD1' ' O ' ' B' 1046 ' ' ASP . 31.1 m-85 -60.87 -37.85 83.57 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 120.889 1.677 . . . . 32.170000000000002 112.167 170.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 98.0 t -59.67 -45.74 94.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 O-C-N 119.585 -1.947 . . . . 38.369999999999997 108.503 174.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -63.76 -23.36 67.33 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 116.261 1.949 . . . . 45.770000000000003 116.261 174.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1053 ' ' ALA . . . . . 0.482 ' HB2' ' HB3' ' B' 1020 ' ' PRO . . . -78.35 -4.67 49.26 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 124.91 1.284 . . . . 37.829999999999998 112.269 170.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 87.75 34.57 9.99 Favored Glycine 0 CA--C 1.5 -0.866 0 CA-C-N 120.29 1.404 . . . . 35.82 110.681 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -114.62 138.1 51.09 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-O 124.151 1.929 . . . . 33.770000000000003 107.401 174.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -77.45 134.77 38.29 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 104.487 -2.412 . . . . 51.020000000000003 104.487 173.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1057 ' ' ILE . . . . . 0.605 HD13 ' HB ' ' B' 1035 ' ' VAL . 19.5 mm -108.46 107.16 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 106.259 -1.756 . . . . 38.469999999999999 106.259 175.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 88.1 t -86.29 132.77 31.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 CA-C-N 113.163 -1.835 . . . . 39.399999999999999 108.045 -173.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -72.5 95.82 1.85 Allowed 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 123.291 1.519 . . . . 57.07 110.576 168.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . 82.27 -151.16 29.54 Favored Glycine 0 C--O 1.248 1.026 0 CA-C-O 125.093 2.496 . . . . 44.829999999999998 116.191 166.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -58.64 -21.28 53.44 Favored 'General case' 0 C--O 1.212 -0.869 0 N-CA-C 118.91 2.93 . . . . 46.270000000000003 118.91 -167.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1062 ' ' SER . . . . . . . . . . . . . 4.2 m -53.65 -22.12 8.2 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.188 -1.57 . . . . 43.469999999999999 112.677 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 1.5 p -53.28 -35.31 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 O-C-N 120.983 -1.073 . . . . 36.979999999999997 111.181 176.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1064 ' ' TRP . . . . . 0.549 ' HA ' HD11 ' B' 1069 ' ' ILE . 55.2 m95 -63.16 -23.35 67.39 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 116.155 1.909 . . . . 37.899999999999999 116.155 177.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -83.44 93.58 7.82 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 124.475 2.083 . . . . 46.189999999999998 108.923 173.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1066 ' ' SER . . . . . 0.427 ' HB3' ' O ' ' B' 1002 ' ' ARG . 71.4 m -149.77 179.7 7.81 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 111.206 -2.725 . . . . 37.060000000000002 107.211 -174.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1067 ' ' GLU . . . . . 0.599 ' HB2' ' HA ' ' B' 1000 ' ' HIS . 35.2 tt0 -83.37 -51.3 7.52 Favored 'General case' 0 N--CA 1.437 -1.103 0 O-C-N 123.792 0.683 . . . . 43.950000000000003 109.952 166.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1068 ' ' ILE . . . . . 0.714 HD12 HG12 ' B' 1003 ' ' ILE . 1.3 mt -108.99 145.15 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 N-CA-C 107.061 -1.459 . . . . 33.5 107.061 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1069 ' ' ILE . . . . . 0.549 HD11 ' HA ' ' B' 1064 ' ' TRP . 46.0 mm -109.0 118.26 56.15 Favored 'Isoleucine or valine' 0 C--O 1.254 1.299 0 N-CA-C 104.33 -2.47 . . . . 30.57 104.33 158.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1070 ' ' LEU . . . . . 0.83 HD22 HD22 ' B' 1331 ' ' LEU . 94.5 mt -101.8 117.75 35.51 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 106.674 -1.602 . . . . 27.66 106.674 170.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1071 ' ' LYS . . . . . 0.54 ' HG2' ' OE2' ' B' 1008 ' ' GLU 0.279 13.6 tttm -140.83 160.16 40.64 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 125.994 2.059 . . . . 28.399999999999999 111.042 -170.025 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B 1072 ' ' VAL . . . . . 0.649 ' HB ' ' HG3' ' B' 1008 ' ' GLU . 99.7 t -94.63 -70.76 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.429 0 O-C-N 120.629 -1.294 . . . . 23.18 108.155 -173.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -97.4 152.68 18.69 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.893 -1.129 . . . . 25.469999999999999 108.011 -170.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -53.3 133.05 52.35 Favored Pre-proline 0 C--O 1.243 0.725 0 C-N-CA 126.29 1.836 . . . . 27.899999999999999 111.907 -173.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -60.32 129.75 31.13 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 122.752 2.301 . . . . 31.620000000000001 114.949 -173.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 49.2 mt -72.65 158.56 35.41 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.202 -1.036 . . . . 40.490000000000002 108.202 173.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.23 -29.7 10.04 Favored 'General case' 0 C--O 1.214 -0.768 0 O-C-N 118.937 -2.352 . . . . 51.590000000000003 117.014 -171.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -67.28 -46.21 74.3 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-N 114.986 -1.006 . . . . 42.359999999999999 110.017 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1079 ' ' GLU . . . . . 0.472 ' HA ' HD12 ' B' 1082 ' ' LEU . 31.8 mt-10 -63.07 -40.49 97.83 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 123.162 1.458 . . . . 34.530000000000001 109.029 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1080 ' ' ILE . . . . . 0.487 HG21 ' HB3' ' B' 1104 ' ' LYS . 84.3 mt -59.1 -48.81 85.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 108.333 -0.988 . . . . 33.25 108.333 175.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -56.84 -39.7 74.73 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 119.143 0.883 . . . . 36.469999999999999 112.874 175.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1082 ' ' LEU . . . . . 0.472 HD12 ' HA ' ' B' 1079 ' ' GLU . 28.6 mt -61.12 -38.51 86.61 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 125.762 1.625 . . . . 37.759999999999998 111.08 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1083 ' ' LEU . . . . . 0.447 HD11 HD22 ' B' 1089 ' ' LEU . 21.8 mt -56.73 121.11 9.02 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 123.17 0.588 . . . . 37.43 110.679 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -78.07 148.7 75.45 Favored Pre-proline 0 CA--C 1.558 1.271 0 N-CA-C 106.953 -1.499 . . . . 37.700000000000003 106.953 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1085 ' ' PRO . . . . . 0.647 ' HA ' ' O ' ' B' 1108 ' ' ARG . 0.1 OUTLIER -40.3 102.37 0.04 OUTLIER 'Trans proline' 0 C--O 1.239 0.562 0 C-N-CA 122.826 2.35 . . . . 35.509999999999998 115.564 169.674 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B 1086 ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' B' 1110 ' ' VAL . . . 84.49 26.38 39.46 Favored Glycine 0 C--N 1.345 1.04 0 CA-C-N 112.652 -2.067 . . . . 33.869999999999997 114.532 177.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1087 ' ' THR . . . . . . . . . . . . . 16.8 m -66.67 155.79 37.03 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 120.956 2.378 . . . . 32.5 108.491 166.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1088 ' ' THR . . . . . 0.655 ' HB ' ' HA ' ' B' 1068 ' ' ILE . 4.1 m -87.49 131.37 34.38 Favored 'General case' 0 C--O 1.205 -1.245 0 N-CA-C 105.088 -2.189 . . . . 30.219999999999999 105.088 174.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1089 ' ' LEU . . . . . 0.447 HD22 HD11 ' B' 1083 ' ' LEU . 39.3 tp -122.87 127.65 49.28 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 107.926 -1.139 . . . . 27.239999999999998 107.926 173.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 44.2 t -120.2 120.1 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 N-CA-C 103.326 -2.842 . . . . 25.390000000000001 103.326 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1091 ' ' SER . . . . . 0.549 ' O ' ' HA ' ' B' 1114 ' ' ALA . 2.6 m -164.53 160.31 20.2 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.528 1.513 . . . . 28.809999999999999 108.857 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1092 ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -59.48 99.43 0.06 Allowed 'General case' 0 C--O 1.247 0.971 0 O-C-N 121.088 -1.008 . . . . 30.780000000000001 111.204 158.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 32.2 mm -95.73 -28.53 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 109.199 -0.667 . . . . 30.280000000000001 109.199 -171.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1094 ' ' TRP . . . . . 0.441 ' HB2' HD22 ' B' 1098 ' ' ASN . 68.5 m95 52.06 56.08 15.48 Favored Pre-proline 0 N--CA 1.472 0.659 0 O-C-N 121.129 -0.982 . . . . 34.07 112.551 -175.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -53.43 -51.05 11.82 Favored 'Trans proline' 0 CA--C 1.505 -0.952 1 C-N-CA 126.541 4.828 . . . . 38.659999999999997 115.999 -162.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -69.17 -28.77 66.71 Favored 'General case' 0 C--O 1.247 0.929 0 O-C-N 120.714 -1.241 . . . . 41.32 110.684 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.04 -17.82 48.87 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 120.71 -1.244 . . . . 51.659999999999997 111.197 172.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1098 ' ' ASN . . . . . 0.534 ' HB3' ' HB3' ' B' 1101 ' ' LEU . 70.7 m-20 -125.73 61.19 36.82 Favored Pre-proline 0 C--O 1.243 0.728 0 N-CA-C 114.719 1.377 . . . . 40.32 114.719 176.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -60.45 -38.68 72.18 Favored 'Trans proline' 0 CA--C 1.506 -0.887 0 C-N-CA 123.743 2.962 . . . . 41.560000000000002 113.13 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -69.52 -45.24 69.32 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 106.863 -1.532 . . . . 54.109999999999999 106.863 -174.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1101 ' ' LEU . . . . . 0.534 ' HB3' ' HB3' ' B' 1098 ' ' ASN . 7.0 tt -60.64 -48.77 80.29 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.645 -1.243 . . . . 37.880000000000003 107.645 177.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1102 ' ' MET . . . . . . . . . . . . . 43.2 mmm -50.86 -46.76 60.37 Favored 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 120.616 -1.302 . . . . 37.539999999999999 114.341 173.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -64.55 -39.0 92.96 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 123.173 1.463 . . . . 47.009999999999998 112.794 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1104 ' ' LYS . . . . . 0.487 ' HB3' HG21 ' B' 1080 ' ' ILE . 52.5 mttm -60.98 -45.47 94.68 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 118.928 -2.358 . . . . 48.68 111.77 175.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1105 ' ' LEU . . . . . 0.673 HD13 HG21 ' B' 1112 ' ' VAL . 52.2 mt -62.05 -39.25 91.74 Favored 'General case' 0 C--O 1.252 1.235 0 O-C-N 120.668 -1.27 . . . . 32.210000000000001 109.604 177.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -57.36 -37.05 71.99 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 112.968 0.729 . . . . 33.729999999999997 112.968 171.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -67.63 -45.92 73.97 Favored 'General case' 0 CA--C 1.504 -0.824 0 O-C-N 118.888 -2.383 . . . . 51.469999999999999 112.105 172.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1108 ' ' ARG . . . . . 0.647 ' O ' ' HA ' ' B' 1085 ' ' PRO . 21.9 mmm180 -61.42 -11.64 11.24 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 120.577 -1.327 . . . . 43.899999999999999 112.013 169.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1109 ' ' ASN . . . . . 0.407 ' HA ' ' HA2' ' B' 1364 ' ' GLY . 27.0 m-80 63.04 24.86 14.73 Favored 'General case' 0 C--N 1.358 0.96 0 O-C-N 120.024 -1.673 . . . . 44.82 114.253 172.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1110 ' ' VAL . . . . . 0.478 ' HA ' ' HA2' ' B' 1086 ' ' GLY . 18.4 m -83.59 167.87 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 N-CA-C 112.563 0.579 . . . . 30.52 112.563 -171.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1111 ' ' THR . . . . . 0.702 HG23 ' HA ' ' B' 1362 ' ' ARG . 95.9 m -109.74 111.14 22.41 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.439 -1.689 . . . . 27.120000000000001 106.439 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1112 ' ' VAL . . . . . 0.673 HG21 HD13 ' B' 1105 ' ' LEU . 63.6 t -113.27 120.3 62.86 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.621 0 N-CA-C 108.178 -1.045 . . . . 26.399999999999999 108.178 -165.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1113 ' ' MET . . . . . 0.453 ' SD ' HD11 ' B' 1338 ' ' LEU . 0.8 OUTLIER -94.79 105.92 17.88 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-O 123.596 1.665 . . . . 42.920000000000002 109.376 164.274 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B 1114 ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' B' 1091 ' ' SER . . . -86.4 108.55 18.52 Favored 'General case' 0 CA--C 1.5 -0.958 0 O-C-N 119.302 -2.124 . . . . 24.149999999999999 108.444 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1115 ' ' MET . . . . . 0.565 ' HB3' ' CB ' ' B' 1129 ' ' ALA . 82.1 mmm -67.98 -16.93 64.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 111.971 -2.377 . . . . 29.949999999999999 113.32 -173.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1116 ' ' ASP . . . . . 0.573 ' HA ' ' HG ' ' B' 1130 ' ' LEU . 9.8 p-10 -79.6 -35.01 40.25 Favored 'General case' 0 C--O 1.253 1.244 0 O-C-N 120.018 -1.676 . . . . 34.530000000000001 109.481 171.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1117 ' ' SER . . . . . . . . . . . . . 69.1 m -87.62 31.13 0.77 Allowed 'General case' 0 C--O 1.247 0.97 0 C-N-CA 126.293 1.837 . . . . 33.490000000000002 114.451 -166.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1118 ' ' VAL . . . . . 0.624 HG12 ' HB1' ' B' 1124 ' ' ALA . 15.1 t -77.98 136.96 61.7 Favored Pre-proline 0 C--O 1.259 1.555 0 N-CA-C 107.887 -1.153 . . . . 34.020000000000003 107.887 -177.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1119 ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' B' 1118 ' ' VAL . 55.4 Cg_exo -62.06 132.31 38.7 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 124.226 3.284 . . . . 38.280000000000001 108.232 174.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1120 ' ' ARG . . . . . 0.552 ' HB2' HG11 ' B' 1375 ' ' VAL . 2.0 mmt180 -73.27 29.36 0.07 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 119.158 3.022 . . . . 55.049999999999997 119.158 -160.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1121 ' ' ILE . . . . . 0.54 HG21 HD12 ' B' 1373 ' ' ILE . 23.8 pt -90.51 162.74 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 CA-C-N 119.176 0.898 . . . . 42.090000000000003 110.582 -169.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1122 ' ' SER . . . . . 0.648 ' HB2' ' HA ' ' C' ' 133' ' ' MET . 1.1 m -51.29 -40.91 59.98 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 112.954 -1.93 . . . . 38.020000000000003 115.576 -175.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1123 ' ' ARG . . . . . . . . . . . . . 24.1 ptt-85 -72.37 -41.48 66.32 Favored 'General case' 0 C--N 1.361 1.084 0 O-C-N 119.921 -1.737 . . . . 34.289999999999999 112.632 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1124 ' ' ALA . . . . . 0.624 ' HB1' HG12 ' B' 1118 ' ' VAL . . . -53.49 -35.3 60.46 Favored 'General case' 0 N--CA 1.434 -1.232 0 O-C-N 124.957 1.411 . . . . 32.350000000000001 114.766 175.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1125 ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -58.71 -20.77 51.77 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 117.964 2.579 . . . . 47.170000000000002 117.964 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1126 ' ' SER . . . . . 0.525 ' OG ' HD12 ' B' 1127 ' ' LEU . 73.3 p -70.72 -35.89 72.93 Favored 'General case' 0 C--O 1.251 1.178 0 O-C-N 120.05 -1.656 . . . . 31.710000000000001 112.099 170.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1127 ' ' LEU . . . . . 0.604 HD22 HG11 ' B' 1354 ' ' VAL . 4.5 mp -86.56 -16.85 35.57 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.884 -1.053 . . . . 37.0 112.35 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1128 ' ' ASP . . . . . . . . . . . . . 24.3 t70 -75.09 117.38 16.87 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 126.49 3.043 . . . . 40.399999999999999 117.06 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1129 ' ' ALA . . . . . 0.565 ' CB ' ' HB3' ' B' 1115 ' ' MET . . . -70.13 -33.83 72.31 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-N 109.924 -3.307 . . . . 26.559999999999999 107.419 -176.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1130 ' ' LEU . . . . . 0.573 ' HG ' ' HA ' ' B' 1116 ' ' ASP . 32.0 mt -61.98 -35.34 78.19 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 124.045 0.938 . . . . 30.890000000000001 110.664 177.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1131 ' ' SER . . . . . . . . . . . . . 61.4 m -71.39 -51.43 24.06 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 120.937 1.699 . . . . 29.84 109.164 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1132 ' ' SER . . . . . . . . . . . . . 55.5 m -55.85 -44.45 78.02 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.51 1.505 . . . . 31.91 112.47 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1133 ' ' MET . . . . . 0.607 ' HB3' ' HB3' ' B' 1316 ' ' PRO . 36.7 mmt -71.56 -33.66 69.3 Favored 'General case' 0 CA--C 1.51 -0.57 0 O-C-N 121.175 -0.953 . . . . 25.899999999999999 111.101 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1134 ' ' ALA . . . . . 0.609 ' HB1' ' HB2' ' B' 1176 ' ' ALA . . . -66.72 -38.15 86.12 Favored 'General case' 0 C--O 1.201 -1.483 0 O-C-N 119.767 -1.833 . . . . 26.620000000000001 110.558 170.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.45 -30.75 71.17 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 120.126 1.33 . . . . 36.969999999999999 113.064 176.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1136 ' ' ILE . . . . . . . . . . . . . 39.3 mm -58.37 -56.96 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 CA-C-O 117.492 -1.242 . . . . 32.109999999999999 110.231 164.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1137 ' ' ALA . . . . . 0.427 ' HB2' ' HG3' ' B' 1316 ' ' PRO . . . -53.76 -37.96 63.92 Favored 'General case' 0 CA--C 1.508 -0.64 0 O-C-N 124.901 1.376 . . . . 24.140000000000001 112.985 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -71.74 -40.71 57.91 Favored Glycine 0 N--CA 1.441 -1.033 0 CA-C-O 122.22 0.9 . . . . 25.129999999999999 111.492 -176.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 4.5 t80 -68.25 -41.86 80.52 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 120.847 -1.384 . . . . 32.729999999999997 108.405 174.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1140 ' ' ARG . . . . . 0.495 ' HA ' ' HB ' ' B' 1143 ' ' VAL . 11.5 tpt180 -71.2 -19.68 62.36 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 118.51 -0.757 . . . . 26.359999999999999 110.901 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1141 ' ' ALA . . . . . 0.74 ' HB2' HD21 ' B' 1284 ' ' LEU . . . -60.34 -52.72 64.07 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 119.721 1.146 . . . . 24.120000000000001 108.682 171.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 42.6 mm -64.98 -36.08 76.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 O-C-N 124.219 0.949 . . . . 23.370000000000001 111.623 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1143 ' ' VAL . . . . . 0.495 ' HB ' ' HA ' ' B' 1140 ' ' ARG . 57.2 t -65.58 -67.39 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 C-N-CA 124.018 0.927 . . . . 24.960000000000001 112.112 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -55.56 -31.95 62.59 Favored 'General case' 0 C--N 1.354 0.783 0 O-C-N 120.103 -1.623 . . . . 32.07 114.116 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1145 ' ' ALA . . . . . 0.634 ' HB1' HD12 ' B' 1251 ' ' ILE . . . -58.21 -57.2 13.92 Favored 'General case' 0 C--O 1.203 -1.388 0 CA-C-N 115.817 -0.629 . . . . 24.870000000000001 109.589 170.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1146 ' ' ALA . . . . . . . . . . . . . . . -58.04 -38.95 77.21 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.831 0.824 . . . . 24.670000000000002 113.051 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 83.4 t60 -51.7 -56.96 10.68 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.699 -1.137 . . . . 28.579999999999998 111.152 170.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1148 ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -90.13 1.76 56.04 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 115.557 1.688 . . . . 36.82 115.557 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1149 ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' B' 1145 ' ' ALA . 0.7 OUTLIER -72.23 153.06 41.79 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.886 1.674 . . . . 31.969999999999999 109.277 -174.386 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B 1150 ' ' GLY . . . . . 0.561 ' HA2' ' HG2' ' A' 1320 ' ' PRO . . . -86.24 -36.06 10.25 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 117.211 -1.883 . . . . 25.489999999999998 112.685 169.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1151 ' ' ARG . . . . . 0.843 ' HA ' ' HB2' ' A' 1322 ' ' GLN . 25.8 mtm-85 -119.05 -177.95 3.45 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 122.717 3.258 . . . . 59.840000000000003 115.893 -168.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1152 ' ' PHE . . . . . 0.723 ' HB2' HG11 ' B' 1163 ' ' VAL . 18.2 m-30 -81.75 165.66 20.74 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 124.124 1.916 . . . . 34.450000000000003 110.092 175.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1153 ' ' PHE . . . . . 0.523 ' HB3' ' HB2' ' B' 1189 ' ' ALA . 56.7 m-85 -82.31 -49.89 9.55 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.415 -1.266 . . . . 31.170000000000002 111.605 166.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1154 ' ' THR . . . . . . . . . . . . . 3.1 m -65.31 142.42 58.26 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.684 1.193 . . . . 33.890000000000001 111.31 -176.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -80.52 72.35 2.68 Favored Glycine 0 C--N 1.34 0.786 0 O-C-N 117.871 -3.018 . . . . 38.950000000000003 108.754 169.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1156 ' ' GLN . . . . . 0.439 ' H ' ' HB ' ' B' 1163 ' ' VAL . 39.0 tt0 -89.82 114.53 26.27 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 123.169 1.461 . . . . 54.229999999999997 110.77 -163.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 6.9 mm -67.87 95.07 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 113.441 -1.709 . . . . 51.159999999999997 106.426 166.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1158 ' ' THR . . . . . 0.561 HG21 HD13 ' A' 1326 ' ' LEU . 10.3 m -95.9 157.24 15.99 Favored 'General case' 0 C--O 1.249 1.069 0 N-CA-C 108.03 -1.1 . . . . 49.609999999999999 108.03 -172.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -46.92 -51.56 16.56 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.024 0.75 . . . . 49.049999999999997 113.024 174.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1160 ' ' ALA . . . . . 0.535 ' HA ' ' HA ' ' A' 1126 ' ' SER . . . -63.65 -58.27 7.44 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 114.659 1.355 . . . . 47.649999999999999 114.659 173.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1161 ' ' GLY . . . . . 0.418 ' HA3' HG21 ' A' 1329 ' ' THR . . . -159.87 179.18 35.6 Favored Glycine 0 C--O 1.25 1.119 0 CA-C-O 118.079 -1.401 . . . . 45.609999999999999 110.864 -168.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 95.6 mttt -94.46 140.14 30.21 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.169 -1.048 . . . . 57.460000000000001 108.169 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1163 ' ' VAL . . . . . 0.723 HG11 ' HB2' ' B' 1152 ' ' PHE . 59.2 t -97.41 128.57 34.32 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-N 114.59 -1.186 . . . . 42.93 112.573 176.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1164 ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' B' 1165 ' ' PRO . 92.7 Cg_endo -71.21 130.42 17.54 Favored 'Trans proline' 0 N--CA 1.483 0.911 0 C-N-CA 122.84 2.36 . . . . 39.289999999999999 108.322 174.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1165 ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' B' 1164 ' ' PRO . 39.4 Cg_exo -68.27 146.1 68.25 Favored 'Trans proline' 0 C--O 1.245 0.829 0 C-N-CA 123.251 2.634 . . . . 34.170000000000002 111.02 -172.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1166 ' ' ALA . . . . . 0.417 ' CB ' ' HA ' ' B' 1153 ' ' PHE . . . -68.98 119.41 13.23 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-O 123.731 1.729 . . . . 31.690000000000001 111.438 170.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1167 ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' B' 1190 ' ' ILE . 87.9 mttt -89.41 98.04 11.54 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 125.42 2.533 . . . . 44.780000000000001 107.566 171.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1168 ' ' VAL . . . . . 0.446 HG12 HG23 ' B' 1170 ' ' VAL . 60.5 t -89.03 100.48 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 109.739 -3.391 . . . . 31.23 108.867 -178.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1169 ' ' MET . . . . . 0.468 ' HA ' ' O ' ' B' 1192 ' ' ARG . 42.6 ttp -85.02 89.93 7.72 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.29 -0.868 . . . . 37.090000000000003 108.908 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1170 ' ' VAL . . . . . 0.446 HG23 HG12 ' B' 1168 ' ' VAL . 62.8 t -83.22 105.45 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-O 122.728 1.252 . . . . 30.170000000000002 108.415 177.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1171 ' ' ILE . . . . . 0.566 ' HB ' ' HA ' ' B' 1254 ' ' THR . 97.3 mt -88.93 87.86 2.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 105.285 -2.117 . . . . 33.740000000000002 105.285 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1172 ' ' GLY . . . . . 0.477 ' O ' ' HA3' ' B' 1177 ' ' GLY . . . 134.37 95.85 0.54 Allowed Glycine 0 N--CA 1.437 -1.298 0 CA-C-N 113.499 -1.682 . . . . 32.590000000000003 109.962 178.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1173 ' ' ALA . . . . . . . . . . . . . . . -92.99 46.09 1.21 Allowed 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 119.911 1.856 . . . . 32.420000000000002 112.978 -175.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -134.22 151.94 20.44 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 108.241 -1.944 . . . . 31.739999999999998 108.241 -174.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 23.4 t 24.97 -84.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 127.324 2.249 . . . . 31.48 115.242 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1176 ' ' ALA . . . . . 0.609 ' HB2' ' HB1' ' B' 1134 ' ' ALA . . . -62.61 -41.36 98.95 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 123.418 1.58 . . . . 26.120000000000001 111.137 -175.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1177 ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' B' 1172 ' ' GLY . . . -68.95 -31.37 72.52 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 113.093 -1.867 . . . . 25.73 111.284 177.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1178 ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.0 -48.41 81.67 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 121.445 2.622 . . . . 32.590000000000003 108.126 175.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -61.43 -46.78 88.69 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 112.764 0.653 . . . . 27.719999999999999 112.764 176.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -56.86 -46.52 81.72 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 121.993 0.902 . . . . 26.030000000000001 112.875 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1181 ' ' ILE . . . . . 0.605 HG22 ' SD ' ' B' 1207 ' ' MET . 72.5 mt -60.11 -50.55 79.74 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.435 0 C-N-CA 126.559 1.944 . . . . 28.609999999999999 107.784 174.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -48.07 -55.78 9.78 Favored Glycine 0 N--CA 1.44 -1.042 0 O-C-N 124.228 0.955 . . . . 25.23 113.151 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -63.9 -51.09 66.12 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 117.754 -1.117 . . . . 24.09 110.882 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -62.23 -43.77 98.08 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-O 123.549 1.642 . . . . 26.68 113.963 -175.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -67.24 -40.35 86.29 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 119.346 -2.096 . . . . 36.57 109.02 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1186 ' ' SER . . . . . 0.942 ' HB3' ' HA ' ' A' 1187 ' ' LEU . 61.0 m -66.44 -23.63 66.32 Favored 'General case' 0 C--O 1.25 1.088 0 CA-C-N 119.914 1.234 . . . . 28.920000000000002 113.226 173.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1187 ' ' LEU . . . . . 0.405 ' HG ' HD21 ' A' 1187 ' ' LEU . 19.5 mt -84.32 6.8 21.61 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 119.871 -1.768 . . . . 29.09 112.997 165.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 83.62 14.05 74.27 Favored Glycine 0 CA--C 1.538 1.524 0 O-C-N 118.546 -2.596 . . . . 29.260000000000002 114.33 172.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1189 ' ' ALA . . . . . 0.523 ' HB2' ' HB3' ' B' 1153 ' ' PHE . . . -88.98 143.76 26.63 Favored 'General case' 0 N--CA 1.433 -1.276 0 O-C-N 120.843 -1.386 . . . . 30.16 112.396 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1190 ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' B' 1167 ' ' LYS . 97.0 mt -76.77 97.43 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 105.13 -2.174 . . . . 35.810000000000002 105.13 174.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1191 ' ' VAL . . . . . 0.441 HG11 HG12 ' B' 1181 ' ' ILE . 47.7 t -74.35 115.95 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 104.955 -2.239 . . . . 31.969999999999999 104.955 176.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1192 ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' B' 1169 ' ' MET . 83.3 mtt180 -103.3 77.91 1.57 Allowed 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 106.438 -1.69 . . . . 48.159999999999997 106.438 174.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1193 ' ' ALA . . . . . 0.625 ' HB3' HG21 ' B' 1204 ' ' VAL . . . -87.07 155.64 20.06 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 114.719 1.377 . . . . 35.890000000000001 114.719 -172.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 44.7 t80 -138.87 139.25 38.05 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 104.872 -2.27 . . . . 41.880000000000003 104.872 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1195 ' ' ASP . . . . . . . . . . . . . 8.8 t0 -146.1 150.07 35.23 Favored 'General case' 0 C--O 1.245 0.857 0 N-CA-C 102.289 -3.226 . . . . 38.280000000000001 102.289 165.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1196 ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -72.15 -27.47 62.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 120.383 -1.448 . . . . 40.619999999999997 111.605 176.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1197 ' ' ARG . . . . . . . . . . . . . 36.5 mtm180 -84.4 132.09 48.34 Favored Pre-proline 0 N--CA 1.444 -0.759 0 N-CA-C 115.876 1.806 . . . . 53.090000000000003 115.876 -171.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -69.31 -30.32 24.58 Favored 'Trans proline' 0 CA--C 1.498 -1.291 0 C-N-CA 122.906 2.404 . . . . 42.560000000000002 117.35 -176.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -54.89 -26.74 37.83 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 113.199 0.814 . . . . 56.310000000000002 113.199 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1200 ' ' VAL . . . . . 0.56 ' HB ' ' NE2' ' B' 1203 ' ' GLN . 3.5 m -114.5 20.34 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 CA-C-O 123.59 1.662 . . . . 42.909999999999997 114.717 -173.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 58.0 tttm -69.94 -56.12 7.86 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 122.53 1.157 . . . . 48.890000000000001 110.931 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -55.66 -43.51 76.36 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 115.957 1.836 . . . . 51.700000000000003 115.957 -165.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1203 ' ' GLN . . . . . 0.56 ' NE2' ' HB ' ' B' 1200 ' ' VAL . 9.6 pt20 -43.37 -38.51 2.76 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 119.307 3.077 . . . . 52.57 119.307 -175.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1204 ' ' VAL . . . . . 0.625 HG21 ' HB3' ' B' 1193 ' ' ALA . 43.7 t -71.91 -47.05 57.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 106.058 -1.83 . . . . 33.789999999999999 106.058 -177.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -62.65 -44.58 95.9 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.773 -0.455 . . . . 36.579999999999998 109.773 175.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1206 ' ' SER . . . . . . . . . . . . . 16.8 m -60.87 -22.24 64.06 Favored 'General case' 0 CA--C 1.504 -0.808 0 C-N-CA 127.186 2.194 . . . . 39.609999999999999 115.333 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1207 ' ' MET . . . . . 0.694 ' SD ' ' HG ' ' C' ' 75' ' ' LEU . 27.0 mtp -87.59 -23.59 24.25 Favored 'General case' 0 C--O 1.253 1.249 0 CA-C-O 123.98 1.848 . . . . 37.450000000000003 111.523 175.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 95.32 73.58 1.19 Allowed Glycine 0 CA--C 1.5 -0.858 0 O-C-N 118.274 -2.766 . . . . 31.870000000000001 107.158 -175.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1209 ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' B' 1191 ' ' VAL . . . -169.67 -170.96 1.12 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 109.842 -3.179 . . . . 35.399999999999999 106.448 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -125.45 147.55 49.16 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 121.581 1.992 . . . . 47.890000000000001 111.885 -172.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 14.9 t80 -105.92 138.95 41.22 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 105.673 -1.973 . . . . 45.530000000000001 105.673 173.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1212 ' ' LEU . . . . . . . . . . . . . 78.9 mt -86.86 128.06 35.04 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 122.449 1.119 . . . . 46.329999999999998 111.344 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -94.44 145.2 24.94 Favored 'General case' 0 C--O 1.254 1.317 0 CA-C-N 112.299 -2.228 . . . . 60.409999999999997 111.72 177.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.62 153.51 17.68 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 114.184 -1.371 . . . . 57.380000000000003 108.775 -175.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 18.2 t70 . . . . . 0 CA--C 1.506 -0.738 0 N-CA-C 112.72 0.637 . . . . 65.069999999999993 112.72 -178.329 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B 1230 ' ' MET . . . . . 0.645 ' N ' ' HG ' ' B' 1231 ' ' SER . 16.3 mmt . . . . . 0 N--CA 1.432 -1.372 1 N-CA-C 99.374 -4.306 . . . . 80.319999999999993 99.374 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1231 ' ' SER . . . . . 0.645 ' HG ' ' N ' ' B' 1230 ' ' MET . 67.1 m 127.5 147.28 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.348 3 O-C-N 110.924 -7.36 . . . . 79.920000000000002 107.109 -10.319 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -63.79 150.54 44.43 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 120.618 1.554 . . . . 77.909999999999997 110.338 -172.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 65.92 -43.11 0.38 Allowed 'General case' 0 C--N 1.356 0.888 0 C-N-CA 125.065 1.346 . . . . 73.879999999999995 114.08 -170.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 12.0 t80 -56.35 -50.91 70.14 Favored 'General case' 0 CA--C 1.507 -0.707 0 O-C-N 118.935 -2.353 . . . . 68.980000000000004 109.996 172.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 30.3 pt -54.77 -31.87 24.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 112.57 -2.104 . . . . 64.530000000000001 113.048 172.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -74.43 -30.45 61.91 Favored 'General case' 0 C--O 1.218 -0.598 0 O-C-N 117.947 -2.971 . . . . 66.359999999999999 111.632 172.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -64.61 -41.75 96.01 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-N 119.629 1.104 . . . . 56.600000000000001 110.645 170.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -55.85 -52.66 63.27 Favored 'General case' 0 C--O 1.249 1.065 0 O-C-N 121.606 -0.684 . . . . 56.789999999999999 111.368 169.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1239 ' ' MET . . . . . 0.403 ' HG2' ' O ' ' B' 1266 ' ' LEU . 14.2 mtm -49.05 -45.05 42.34 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 114.589 1.329 . . . . 53.630000000000003 114.589 174.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -65.59 -37.1 85.67 Favored 'General case' 0 C--O 1.247 0.971 0 CA-C-O 123.042 1.401 . . . . 51.740000000000002 109.995 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 31.4 tp -63.17 -44.75 94.55 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 118.319 -2.738 . . . . 44.859999999999999 107.474 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 11.4 m-30 -68.85 -37.57 79.22 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.362 -1.29 . . . . 42.780000000000001 109.772 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -62.48 -33.73 75.45 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 121.123 1.783 . . . . 40.960000000000001 109.58 175.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -66.23 -47.52 73.53 Favored 'General case' 0 C--N 1.345 0.413 0 CA-C-O 122.253 1.025 . . . . 43.060000000000002 110.278 173.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -63.97 -25.54 68.18 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.588 -1.642 . . . . 46.450000000000003 113.241 176.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -31.85 -51.16 0.22 Allowed 'General case' 0 N--CA 1.472 0.671 1 N-CA-C 122.109 4.114 . . . . 41.780000000000001 122.109 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 6.2 tptt -86.08 -18.28 32.84 Favored 'General case' 0 C--N 1.347 0.49 0 O-C-N 120.438 -1.414 . . . . 52.200000000000003 111.874 176.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1248 ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -80.96 -48.15 12.68 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 118.745 -2.472 . . . . 53.549999999999997 112.618 172.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1249 ' ' VAL . . . . . . . . . . . . 0.255 26.8 m -71.02 137.38 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 CA-C-O 126.54 3.067 . . . . 34.409999999999997 114.933 -168.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1250 ' ' ASP . . . . . 0.435 ' HB3' ' CZ ' ' B' 1149 ' ' PHE . 3.8 m-20 -98.29 -51.43 3.99 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 108.62 -3.9 . . . . 33.380000000000003 111.225 -176.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1251 ' ' ILE . . . . . 0.634 HD12 ' HB1' ' B' 1145 ' ' ALA . 40.4 mm -126.39 111.7 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 O-C-N 118.439 -2.663 . . . . 29.539999999999999 106.543 -174.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1252 ' ' ILE . . . . . 0.468 HG22 ' HB ' ' B' 1254 ' ' THR . 61.8 mt -98.28 108.62 22.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 105.947 -1.871 . . . . 32.439999999999998 105.947 176.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1253 ' ' VAL . . . . . 0.441 ' HB ' ' HA ' ' B' 1170 ' ' VAL . 39.9 t -90.71 87.13 2.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 N-CA-C 102.342 -3.207 . . . . 30.57 102.342 176.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1254 ' ' THR . . . . . 0.568 HG23 ' HB2' ' B' 1291 ' ' ASN 0.275 2.0 t -88.33 96.17 10.47 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 103.452 -2.795 . . . . 35.039999999999999 103.452 -176.361 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B 1255 ' ' THR . . . . . 0.582 ' HA ' ' HB2' ' B' 1284 ' ' LEU . 21.6 m -90.11 -73.56 0.52 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 109.795 -3.366 . . . . 34.619999999999997 108.515 -175.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1256 ' ' ALA . . . . . 0.539 ' HB3' ' OD1' ' B' 1291 ' ' ASN . . . 45.3 1.51 0.0 OUTLIER 'General case' 0 C--O 1.242 0.671 1 N-CA-C 123.175 4.509 . . . . 42.719999999999999 123.175 -178.778 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B 1257 ' ' LEU . . . . . 0.467 ' HB2' ' O2A' ' B' ' 1' ' ' NAD . 2.6 mp -65.64 92.79 0.15 Allowed 'General case' 0 C--O 1.242 0.68 0 CA-C-N 123.173 2.715 . . . . 52.43 113.863 -177.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1258 ' ' ILE . . . . . 0.6 HG23 ' H8A' ' B' ' 1' ' ' NAD . 0.3 OUTLIER -76.0 137.59 69.21 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 112.319 -2.218 . . . . 59.409999999999997 108.7 171.612 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -55.22 113.3 1.35 Allowed 'Trans proline' 0 N--CA 1.444 -1.411 0 C-N-CA 124.499 3.466 . . . . 62.68 116.391 -165.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 89.77 -36.4 3.54 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 109.772 -1.331 . . . . 64.159999999999997 109.772 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1261 ' ' LYS . . . . . 0.499 ' HB2' HG13 ' B' 1258 ' ' ILE . 70.6 mttt -75.16 135.69 73.12 Favored Pre-proline 0 C--O 1.247 0.95 0 CA-C-N 120.886 2.343 . . . . 68.530000000000001 107.63 -175.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.58 145.49 98.72 Favored 'Trans proline' 0 CA--C 1.5 -1.205 0 C-N-CA 123.895 3.064 . . . . 61.990000000000002 113.097 161.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1263 ' ' ALA . . . . . . . . . . . . . . . -81.92 128.81 67.14 Favored Pre-proline 0 C--O 1.24 0.561 0 O-C-N 120.618 -1.301 . . . . 57.149999999999999 112.833 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -64.32 153.03 78.93 Favored 'Trans proline' 0 C--O 1.247 0.969 0 C-N-CA 122.416 2.077 . . . . 51.57 116.101 169.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1265 ' ' LYS . . . . . 0.416 ' NZ ' ' O ' ' B' 1289 ' ' GLY . 41.9 mmtm -77.22 88.59 3.67 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 122.603 1.192 . . . . 54.549999999999997 110.065 -174.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1266 ' ' LEU . . . . . 0.403 ' O ' ' HG2' ' B' 1239 ' ' MET . 68.6 mt -80.35 -43.49 21.06 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 115.102 1.519 . . . . 46.859999999999999 115.102 178.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1267 ' ' ILE . . . . . 0.591 HG21 HD13 ' B' 1281 ' ' ILE . 35.1 mm -87.7 101.94 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 105.809 -1.923 . . . . 41.039999999999999 105.809 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1268 ' ' THR . . . . . 0.482 ' O ' HG23 ' B' 1272 ' ' VAL . 24.4 p -73.96 159.16 33.15 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-N 113.858 -1.519 . . . . 39.579999999999998 112.484 -178.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1269 ' ' ARG . . . . . . . . . . . . . 79.1 mtt85 -55.45 -43.42 75.42 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 115.997 -0.547 . . . . 53.149999999999999 110.471 172.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -56.37 -41.33 76.01 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 113.816 1.043 . . . . 42.960000000000001 113.816 175.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1271 ' ' MET . . . . . 0.44 ' SD ' HG23 ' B' 1267 ' ' ILE . 43.4 ttm -65.94 -47.79 73.48 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.704 -0.68 . . . . 43.890000000000001 110.189 -177.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1272 ' ' VAL . . . . . 0.482 HG23 ' O ' ' B' 1268 ' ' THR . 38.5 t -65.68 -41.97 91.67 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.671 0 CA-C-O 121.467 0.651 . . . . 38.369999999999997 110.922 -177.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -63.13 -35.78 81.43 Favored 'General case' 0 C--O 1.239 0.541 0 O-C-N 118.53 -2.606 . . . . 47.460000000000001 112.664 173.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1274 ' ' SER . . . . . . . . . . . . . 72.8 m -70.14 -25.34 63.43 Favored 'General case' 0 N--CA 1.441 -0.917 0 O-C-N 120.845 -1.16 . . . . 38.380000000000003 113.868 173.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1275 ' ' MET . . . . . 0.491 ' SD ' HD11 ' B' 1281 ' ' ILE . 40.2 mtp -60.79 163.53 5.57 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 117.95 2.574 . . . . 37.810000000000002 117.95 -174.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 81.8 tttt -62.95 131.79 49.88 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 110.242 -3.163 . . . . 49.259999999999998 108.97 166.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1277 ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' 1045 ' ' PHE . . . -84.24 166.37 17.58 Favored 'General case' 0 CA--C 1.51 -0.594 0 O-C-N 124.83 1.331 . . . . 34.460000000000001 110.023 -177.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 63.2 30.53 77.81 Favored Glycine 0 C--N 1.334 0.467 0 O-C-N 120.886 -1.134 . . . . 33.530000000000001 111.861 -172.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1279 ' ' SER . . . . . . . . . . . . . 42.3 m -126.5 146.81 49.97 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 106.062 -1.829 . . . . 31.309999999999999 106.062 -176.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1280 ' ' VAL . . . . . 0.412 HG11 ' HA ' ' B' 1145 ' ' ALA . 58.1 t -117.66 135.36 58.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 122.592 1.187 . . . . 29.32 109.278 -171.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1281 ' ' ILE . . . . . 0.591 HD13 HG21 ' B' 1267 ' ' ILE . 67.4 mt -110.62 104.09 16.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 103.601 -2.74 . . . . 31.93 103.601 178.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1282 ' ' VAL . . . . . 0.698 HG11 ' HA ' ' B' 1141 ' ' ALA . 31.7 t -95.78 111.72 26.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 N-CA-C 101.681 -3.451 . . . . 29.48 101.681 -175.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 36.8 t0 -87.67 107.01 18.42 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.231 -1.349 . . . . 34.5 108.544 175.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1284 ' ' LEU . . . . . 0.74 HD21 ' HB2' ' B' 1141 ' ' ALA . 19.6 mt -79.02 -17.21 55.72 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 118.609 -1.236 . . . . 37.939999999999998 111.045 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -102.12 29.23 5.22 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.664 0.745 . . . . 40.920000000000002 111.868 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -51.83 -36.59 48.63 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.64 1.976 . . . . 44.390000000000001 115.797 177.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1287 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.19 -38.86 21.74 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.497 1.119 . . . . 51.460000000000001 110.347 171.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 11.3 t30 -98.37 71.95 2.07 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-O 121.482 0.658 . . . . 57.75 111.574 -171.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1289 ' ' GLY . . . . . 0.416 ' O ' ' NZ ' ' B' 1265 ' ' LYS . . . 86.61 -40.74 3.07 Favored Glycine 0 N--CA 1.47 0.948 0 CA-C-O 117.949 -1.473 . . . . 49.850000000000001 113.614 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 72.57 119.73 0.06 OUTLIER Glycine 0 CA--C 1.541 1.672 0 CA-C-N 121.42 2.61 . . . . 45.93 112.195 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1291 ' ' ASN . . . . . 0.568 ' HB2' HG23 ' B' 1254 ' ' THR . 54.8 m-80 -85.52 -21.75 28.46 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.625 1.17 . . . . 42.670000000000002 110.034 -175.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1292 ' ' CYS . . . . . 0.486 ' HB3' ' OG1' ' B' 1295 ' ' THR . 27.1 t -110.83 132.19 54.41 Favored 'General case' 0 CA--C 1.51 -0.582 0 O-C-N 118.503 -2.623 . . . . 38.82 111.608 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1293 ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -58.17 -41.79 84.62 Favored 'General case' 0 C--O 1.245 0.856 0 CA-C-O 121.399 0.619 . . . . 46.710000000000001 111.928 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -75.56 -7.71 54.91 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 115.37 1.618 . . . . 47.229999999999997 115.37 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1295 ' ' THR . . . . . 0.563 HG23 ' HA3' ' B' 1311 ' ' GLY . 38.6 m -53.89 122.3 9.75 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.239 0.616 . . . . 36.020000000000003 112.551 172.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1296 ' ' VAL . . . . . 0.558 HG23 ' HB2' ' B' 1301 ' ' PHE . 26.3 t -89.0 106.31 12.84 Favored Pre-proline 0 N--CA 1.488 1.452 0 N-CA-C 101.993 -3.336 . . . . 37.259999999999998 101.993 161.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -59.97 76.15 0.06 OUTLIER 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 125.227 3.951 . . . . 35.090000000000003 115.536 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1298 ' ' GLY . . . . . 0.567 ' HA2' ' H ' ' B' 1313 ' ' THR . . . 149.24 -14.92 1.12 Allowed Glycine 0 CA--C 1.528 0.887 0 CA-C-N 113.218 -1.81 . . . . 35.969999999999999 111.679 -178.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -139.48 -174.31 3.85 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 123.487 3.643 . . . . 40.390000000000001 112.262 -174.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1300 ' ' ILE . . . . . 0.756 HG12 HG12 ' B' 1310 ' ' ILE . 30.7 mt -88.44 133.91 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-N 113.917 -1.492 . . . . 37.43 109.374 166.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1301 ' ' PHE . . . . . 0.558 ' HB2' HG23 ' B' 1296 ' ' VAL . 61.8 t80 -108.66 116.84 32.74 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 107.223 -1.399 . . . . 44.130000000000003 107.223 159.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1302 ' ' THR . . . . . 0.659 HG23 ' HG2' ' B' 1308 ' ' LYS . 13.9 m -84.82 112.38 20.48 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.632 -1.618 . . . . 39.780000000000001 106.632 172.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1303 ' ' THR . . . . . . . . . . . . . 34.5 p -74.36 162.32 28.99 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 120.879 -1.138 . . . . 43.289999999999999 111.628 175.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -49.96 -47.72 52.49 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 125.192 1.397 . . . . 53.07 114.313 -168.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1305 ' ' ASN . . . . . 0.537 ' OD1' HG23 ' B' 1307 ' ' VAL . 47.7 p30 -70.51 -23.96 62.74 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 115.531 1.678 . . . . 43.969999999999999 115.531 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 114.38 21.13 5.62 Favored Glycine 0 CA--C 1.529 0.932 0 O-C-N 121.177 -0.952 . . . . 41.119999999999997 111.885 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1307 ' ' VAL . . . . . 0.537 HG23 ' OD1' ' B' 1305 ' ' ASN . 47.6 t -80.08 128.56 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 O-C-N 119.6 -2.118 . . . . 38.119999999999997 106.439 163.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1308 ' ' LYS . . . . . 0.659 ' HG2' HG23 ' B' 1302 ' ' THR . 92.6 mttt -109.76 114.67 28.43 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-N 120.58 1.536 . . . . 36.340000000000003 109.285 -176.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1309 ' ' VAL . . . . . . . . . . . . . 44.0 t -89.88 103.26 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 O-C-N 120.589 -1.32 . . . . 30.399999999999999 110.059 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1310 ' ' ILE . . . . . 0.756 HG12 HG12 ' B' 1300 ' ' ILE . 40.4 mt -92.93 104.4 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.98 0 N-CA-C 104.921 -2.252 . . . . 30.82 104.921 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1311 ' ' GLY . . . . . 0.563 ' HA3' HG23 ' B' 1295 ' ' THR . . . -124.09 81.59 0.35 Allowed Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 104.246 -3.542 . . . . 26.530000000000001 104.246 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1312 ' ' TYR . . . . . 0.692 ' HB2' ' HG ' ' B' 1315 ' ' LEU . 16.9 m-85 -92.4 137.82 32.04 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 120.452 -1.617 . . . . 38.0 111.849 176.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1313 ' ' THR . . . . . 0.567 ' H ' ' HA2' ' B' 1298 ' ' GLY . 3.4 p -61.72 -36.37 80.76 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.79 -1.189 . . . . 29.800000000000001 107.79 168.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -83.49 12.13 6.04 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 118.143 2.645 . . . . 39.039999999999999 118.143 -175.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1315 ' ' LEU . . . . . 0.692 ' HG ' ' HB2' ' B' 1312 ' ' TYR . 12.2 mt -58.37 -42.76 96.45 Favored Pre-proline 0 C--O 1.245 0.831 0 O-C-N 118.671 -2.518 . . . . 31.079999999999998 114.992 170.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1316 ' ' PRO . . . . . 0.607 ' HB3' ' HB3' ' B' 1133 ' ' MET . 83.4 Cg_exo -67.22 -3.45 9.9 Favored 'Trans proline' 0 C--O 1.24 0.602 0 C-N-CA 122.509 2.139 . . . . 26.100000000000001 113.361 169.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -89.12 -57.26 1.81 Allowed Glycine 0 CA--C 1.536 1.373 0 O-C-N 119.243 -2.16 . . . . 23.170000000000002 110.409 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1318 ' ' ARG . . . . . 0.431 ' HB2' ' HG2' ' B' 1140 ' ' ARG . 79.0 mtt180 -68.89 52.65 0.09 Allowed 'General case' 0 CA--C 1.529 0.139 1 N-CA-C 122.582 4.29 . . . . 40.399999999999999 122.582 -158.088 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -133.66 76.47 66.33 Favored Pre-proline 0 C--O 1.236 0.394 0 O-C-N 118.579 -2.576 . . . . 23.600000000000001 104.94 151.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1320 ' ' PRO . . . . . 0.566 ' HG2' ' HA2' ' A' 1150 ' ' GLY . 18.1 Cg_endo -35.32 -70.78 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.199 3.266 . . . . 22.350000000000001 120.553 -166.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1321 ' ' THR . . . . . 0.516 HG23 HG21 ' B' 1019 ' ' THR . 2.8 m -55.69 -43.45 76.43 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 114.858 1.429 . . . . 26.52 114.858 173.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1322 ' ' GLN . . . . . 0.759 ' HB2' ' HA ' ' A' 1151 ' ' ARG . 42.3 tp60 -72.94 -37.59 67.1 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 118.144 -2.847 . . . . 24.379999999999999 109.296 -173.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1323 ' ' SER . . . . . . . . . . . . . 49.7 m -61.13 -54.37 45.4 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 116.925 -1.512 . . . . 22.800000000000001 107.653 174.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1324 ' ' SER . . . . . . . . . . . . . 15.2 m -54.16 -35.88 62.75 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 114.417 1.266 . . . . 21.25 114.417 173.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -67.44 -57.41 6.61 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 120.921 -1.112 . . . . 31.34 110.783 173.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1326 ' ' LEU . . . . . 0.539 ' HG ' HE21 ' B' 1322 ' ' GLN . 97.3 mt -73.3 -32.6 64.71 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-N 121.765 2.075 . . . . 31.559999999999999 108.349 -166.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1327 ' ' TYR . . . . . 0.403 ' CZ ' ' HA ' ' B' 1072 ' ' VAL . 24.7 t80 -60.94 -56.97 14.83 Favored 'General case' 0 C--O 1.257 1.471 0 N-CA-C 105.421 -2.066 . . . . 22.73 105.421 169.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1328 ' ' GLY . . . . . 0.694 ' HA2' HD12 ' B' 1331 ' ' LEU . . . -48.24 -41.55 23.58 Favored Glycine 0 N--CA 1.467 0.725 0 CA-C-O 119.786 -0.452 . . . . 21.91 114.162 173.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1329 ' ' THR . . . . . 0.533 HG21 ' HA3' ' A' 1161 ' ' GLY . 16.5 m -72.0 -31.17 65.97 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 118.709 1.255 . . . . 22.149999999999999 110.598 -175.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1330 ' ' ASN . . . . . . . . . . . . . 33.0 m120 -63.6 -46.46 85.69 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.291 -0.881 . . . . 26.18 109.885 170.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1331 ' ' LEU . . . . . 0.83 HD22 HD22 ' B' 1070 ' ' LEU . 73.1 mt -53.72 -48.13 69.9 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.77 0.828 . . . . 23.68 112.224 176.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1332 ' ' VAL . . . . . 0.432 HG12 ' HE3' ' B' 1336 ' ' LYS . 90.8 t -51.92 -57.49 3.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 O-C-N 124.638 1.212 . . . . 26.57 110.804 169.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -55.06 -37.49 66.81 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.79 1.177 . . . . 28.079999999999998 112.165 -177.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1334 ' ' LEU . . . . . . . . . . . . . 32.4 tp -64.78 -49.29 71.28 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 124.779 1.3 . . . . 27.43 111.39 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1335 ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' B' 1331 ' ' LEU . 64.4 mt -62.13 -35.43 78.72 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 114.68 -1.146 . . . . 30.5 109.616 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1336 ' ' LYS . . . . . 0.473 ' NZ ' ' HG3' ' C' ' 98' ' ' GLU . 83.2 mttt -57.87 -42.04 83.71 Favored 'General case' 0 CA--C 1.512 -0.498 0 O-C-N 121.486 -0.758 . . . . 41.649999999999999 112.555 171.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 8.2 mp -72.74 -34.85 67.31 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 113.164 0.801 . . . . 42.079999999999998 113.164 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1338 ' ' LEU . . . . . 0.453 HD11 ' SD ' ' B' 1113 ' ' MET . 47.0 mt -74.59 -72.81 0.27 Allowed 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 122.804 1.288 . . . . 35.030000000000001 107.967 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1339 ' ' CYS . . . . . 0.509 ' SG ' HD13 ' B' 1346 ' ' ILE . 50.0 m -81.02 69.93 7.73 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-O 123.442 1.591 . . . . 37.329999999999998 113.982 -175.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 55.4 mttp -67.69 -6.28 19.91 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 113.65 -1.613 . . . . 50.509999999999998 115.262 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -95.07 -24.62 16.8 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.508 0.723 . . . . 54.210000000000001 110.753 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.23 34.85 21.25 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.957 1.703 . . . . 50.990000000000002 111.501 -174.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -82.7 -30.11 29.4 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 114.177 -1.374 . . . . 48.82 111.658 -172.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 116.16 22.61 4.47 Favored Glycine 0 N--CA 1.473 1.141 0 CA-C-O 118.335 -1.258 . . . . 40.43 110.319 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -134.32 140.14 46.17 Favored 'General case' 0 C--O 1.25 1.102 0 CA-C-N 120.955 2.378 . . . . 47.560000000000002 108.149 173.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1346 ' ' ILE . . . . . 0.509 HD13 ' SG ' ' B' 1339 ' ' CYS . 22.6 mm -63.9 92.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 CA-C-O 126.284 2.945 . . . . 42.490000000000002 108.807 171.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1347 ' ' THR . . . . . . . . . . . . . 61.1 m -80.19 99.36 7.75 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 100.778 -3.786 . . . . 38.119999999999997 100.778 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1348 ' ' VAL . . . . . 0.466 HG22 HG22 ' B' 1346 ' ' ILE . 6.7 t -82.32 102.42 8.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 106.515 -1.661 . . . . 37.5 106.515 -176.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1349 ' ' ASP . . . . . 0.765 ' HB3' HG21 ' B' 1355 ' ' ILE . 29.0 t70 -67.14 164.61 17.68 Favored 'General case' 0 C--O 1.214 -0.767 0 O-C-N 125.645 1.841 . . . . 43.850000000000001 110.264 178.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1350 ' ' PHE . . . . . 0.401 ' HD1' ' HA ' ' B' 1350 ' ' PHE . 0.1 OUTLIER -148.7 5.42 0.69 Allowed 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.769 -0.826 . . . . 39.810000000000002 108.769 177.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 32.4 t70 -92.18 -56.59 3.0 Favored 'General case' 0 C--O 1.247 0.946 0 N-CA-C 114.26 1.207 . . . . 51.289999999999999 114.26 -174.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 7.7 t0 -65.06 134.68 54.35 Favored 'General case' 0 C--O 1.258 1.513 0 CA-C-O 121.703 0.764 . . . . 39.780000000000001 110.381 -174.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1353 ' ' VAL . . . . . 0.487 HG21 HG13 ' B' 1373 ' ' ILE . 30.6 m -48.71 -38.52 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 116.813 2.153 . . . . 39.280000000000001 116.813 175.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1354 ' ' VAL . . . . . 0.604 HG11 HD22 ' B' 1127 ' ' LEU . 95.0 t -58.84 -59.34 3.87 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 CA-C-N 114.805 -1.089 . . . . 35.700000000000003 109.306 173.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1355 ' ' ILE . . . . . 0.765 HG21 ' HB3' ' B' 1349 ' ' ASP . 43.6 mm -61.06 -42.95 95.11 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.93 0 O-C-N 124.319 1.012 . . . . 35.770000000000003 109.557 -173.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1356 ' ' ARG . . . . . 0.636 ' HG3' ' HD3' ' B' 1371 ' ' PRO . 39.9 tpt85 -58.98 -25.01 63.22 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 120.002 -1.686 . . . . 38.549999999999997 113.865 175.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -82.33 -67.03 1.52 Allowed Glycine 0 CA--C 1.535 1.316 0 N-CA-C 110.1 -1.2 . . . . 29.579999999999998 110.1 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1358 ' ' VAL . . . . . 0.44 HG12 ' HA ' ' B' 1355 ' ' ILE . 10.0 p -54.42 -35.34 30.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 116.025 1.861 . . . . 32.060000000000002 116.025 -177.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1359 ' ' THR . . . . . . . . . . . . . 8.0 m -85.09 83.21 8.11 Favored 'General case' 0 CA--C 1.513 -0.464 0 O-C-N 118.413 -2.679 . . . . 29.0 108.173 178.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1360 ' ' VAL . . . . . 0.499 ' HB ' ' HB2' ' B' 1368 ' ' TRP . 36.0 m -76.06 -21.99 15.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 109.905 -3.316 . . . . 29.68 112.478 -168.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 60.6 mt -133.17 129.45 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 101.832 -3.396 . . . . 32.049999999999997 101.832 172.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1362 ' ' ARG . . . . . 0.702 ' HA ' HG23 ' B' 1111 ' ' THR . 11.7 mtp180 -112.45 104.83 12.97 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 123.484 1.611 . . . . 32.520000000000003 108.327 168.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 50.9 60.03 4.18 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 122.711 1.243 . . . . 35.68 111.706 171.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1364 ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' B' 1109 ' ' ASN . . . 94.46 -43.69 2.33 Favored Glycine 0 CA--C 1.529 0.911 0 O-C-N 119.019 -2.301 . . . . 34.259999999999998 110.743 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -72.45 117.59 14.3 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-O 117.711 -1.138 . . . . 51.07 109.769 -174.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 54.1 mt -73.92 94.87 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.34 0 CA-C-O 123.39 1.567 . . . . 39.869999999999997 108.368 174.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1367 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.14 -14.08 59.33 Favored 'General case' 0 C--O 1.25 1.092 0 CA-C-N 111.903 -2.408 . . . . 38.009999999999998 114.701 -173.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1368 ' ' TRP . . . . . 0.499 ' HB2' ' HB ' ' B' 1360 ' ' VAL . 73.8 t90 -59.81 140.05 89.93 Favored Pre-proline 0 N--CA 1.47 0.529 0 CA-C-N 110.941 -2.845 . . . . 42.140000000000001 106.362 170.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -78.77 178.07 35.85 Favored 'Cis proline' 0 N--CA 1.446 -1.31 0 CA-C-N 124.811 2.754 . . . . 43.259999999999998 118.12 4.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1370 ' ' ALA . . . . . . . . . . . . . . . -76.84 149.03 80.0 Favored Pre-proline 0 C--O 1.248 1.021 0 CA-C-N 110.897 -2.865 . . . . 46.520000000000003 110.718 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1371 ' ' PRO . . . . . 0.636 ' HD3' ' HG3' ' B' 1356 ' ' ARG . 92.6 Cg_endo -62.71 142.63 90.03 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.573 2.182 . . . . 51.950000000000003 113.702 170.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.0 72.57 1.55 Allowed 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 124.853 3.702 . . . . 56.270000000000003 113.648 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1373 ' ' ILE . . . . . 0.54 HD12 HG21 ' B' 1121 ' ' ILE 0.26 0.1 OUTLIER -79.71 135.12 26.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 O-C-N 119.627 -1.921 . . . . 60.829999999999998 106.929 173.957 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -75.31 116.62 16.23 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.032 -1.47 . . . . 66.099999999999994 107.032 -176.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1375 ' ' VAL . . . . . 0.552 HG11 ' HB2' ' B' 1120 ' ' ARG . 49.1 t -104.06 109.1 26.25 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 CA-C-N 113.061 -1.882 . . . . 63.469999999999999 106.712 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.223 -4.929 0 O-C-N 118.967 -2.333 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.818 0 CA-C-O 121.723 0.773 . . . . 0.0 111.997 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.66 -42.86 65.08 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 175.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.93 -43.73 77.67 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 122.572 2.442 . . . . 0.0 108.456 177.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 85.6 m -64.11 -37.91 89.15 Favored 'General case' 0 C--O 1.249 1.077 0 CA-C-O 117.924 -1.036 . . . . 0.0 111.846 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 24' ' ' ALA . . . . . 0.84 ' HB1' ' HA ' ' C' ' 186' ' ' LEU . . . -59.2 -51.58 69.37 Favored 'General case' 0 CA--C 1.559 1.326 0 CA-C-N 120.016 1.28 . . . . 0.0 110.625 173.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 25' ' ' GLU . . . . . 0.763 ' HA ' ' HE2' ' C' ' 28' ' ' LYS . 0.8 OUTLIER -54.99 -33.09 62.22 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.515 1.126 . . . . 0.0 110.897 174.637 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.7 -54.33 33.31 Favored 'General case' 0 C--O 1.214 -0.78 0 O-C-N 119.608 -1.933 . . . . 0.0 111.556 171.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.626 HD21 HD21 ' C' ' 110' ' ' LEU . 2.3 mm? -47.81 -59.02 3.62 Favored 'General case' 0 C--O 1.247 0.949 0 C-N-CA 127.187 2.195 . . . . 0.0 113.382 -175.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 28' ' ' LYS . . . . . 0.763 ' HE2' ' HA ' ' C' ' 25' ' ' GLU . 27.2 pttt -59.32 -35.91 74.68 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.328 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -79.05 -30.37 44.01 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.434 ' HB3' ' HB3' ' C' ' 107' ' ' ASP . 69.7 m -43.25 -35.99 1.64 Allowed 'General case' 0 CA--C 1.508 -0.659 1 N-CA-C 122.869 4.396 . . . . 0.0 122.869 -167.385 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 67.73 -41.62 0.43 Allowed 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.887 1.675 . . . . 0.0 112.309 -171.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 12.0 m -121.15 139.42 53.37 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 120.028 1.285 . . . . 0.0 109.533 162.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 33' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' C' ' 64' ' ' VAL . 89.0 t -130.08 125.88 60.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 175.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.597 ' HB ' HG22 ' C' ' 109' ' ' VAL . 41.5 mm -104.74 123.56 58.82 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 O-C-N 118.93 -2.356 . . . . 0.0 106.071 169.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 35' ' ' ILE . . . . . 0.417 HD12 ' CZ ' ' C' ' 66' ' ' PHE . 29.7 mt -100.97 128.22 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 172.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 52.7 m -113.91 107.85 51.83 Favored Pre-proline 0 N--CA 1.426 -1.643 0 C-N-CA 125.565 1.546 . . . . 0.0 108.721 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 37' ' ' PRO . . . . . 0.481 ' HG3' ' SD ' ' C' ' 41' ' ' MET . 32.5 Cg_exo -64.69 117.59 4.65 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.311 3.341 . . . . 0.0 110.16 170.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 38' ' ' GLY . . . . . 0.645 ' HA3' ' HB2' ' C' ' 114' ' ' ALA . . . -115.39 -155.63 10.87 Favored Glycine 0 N--CA 1.416 -2.634 0 CA-C-N 111.906 -2.406 . . . . 0.0 110.465 164.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -66.82 -42.57 85.62 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.512 -0.993 . . . . 0.0 111.202 -173.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 40' ' ' GLY . . . . . 0.625 ' HA3' ' HA3' ' C' ' 113' ' ' GLY . . . -60.52 -39.84 96.95 Favored Glycine 0 N--CA 1.437 -1.247 0 CA-C-O 117.483 -1.732 . . . . 0.0 110.781 -178.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 41' ' ' MET . . . . . 0.587 ' HA ' ' HB3' ' C' ' 46' ' ' ALA . 9.1 ttm -56.66 -43.47 80.41 Favored 'General case' 0 C--N 1.36 1.036 0 CA-C-N 122.221 3.01 . . . . 0.0 111.284 177.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.36 -36.72 26.55 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 121.617 -0.677 . . . . 0.0 112.47 -171.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 85.6 t -77.79 -64.09 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.965 1.306 . . . . 0.0 110.533 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.95 65.81 2.97 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.535 1.159 . . . . 0.0 109.626 -172.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 45' ' ' GLN . . . . . 0.592 ' HG3' ' HG3' ' C' ' 176' ' ' LYS . 8.9 pt20 17.71 36.18 0.0 OUTLIER 'General case' 0 C--O 1.245 0.863 1 N-CA-C 123.805 4.743 . . . . 0.0 123.805 175.006 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.587 ' HB3' ' HA ' ' C' ' 41' ' ' MET . . . -73.81 -14.94 61.18 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 119.033 2.975 . . . . 0.0 119.033 -176.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . 0.251 0.0 OUTLIER -65.83 -46.85 77.03 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 114.721 -2.561 . . . . 0.0 114.762 -178.358 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 48' ' ' TYR . . . . . 0.525 ' CD1' ' HD3' ' C' ' 49' ' ' PRO 0.37 2.8 p90 -65.88 -32.59 6.0 Favored Pre-proline 0 N--CA 1.474 0.771 0 CA-C-N 125.389 3.722 . . . . 0.0 115.294 174.124 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 49' ' ' PRO . . . . . 0.525 ' HD3' ' CD1' ' C' ' 48' ' ' TYR . 8.8 Cg_exo -58.96 -44.85 32.04 Favored 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 123.042 2.494 . . . . 0.0 111.293 164.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 50' ' ' VAL . . . . . 0.447 ' HA ' HG22 ' C' ' 53' ' ' ILE . 23.2 t -55.55 -40.64 60.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 119.59 1.086 . . . . 0.0 109.655 173.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.33 -42.04 77.03 Favored 'General case' 0 C--N 1.367 1.334 0 CA-C-N 121.004 1.729 . . . . 0.0 112.763 175.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -60.81 -40.03 91.18 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 173.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 53' ' ' ILE . . . . . 0.73 HD13 ' HA ' ' C' ' 183' ' ' LEU . 8.2 tp -75.93 -31.53 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 120.368 1.44 . . . . 0.0 109.659 177.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 89.6 m -68.89 -29.34 67.6 Favored 'General case' 0 CA--C 1.498 -1.028 0 O-C-N 119.833 -1.792 . . . . 0.0 112.458 -174.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -48.93 -67.82 0.23 Allowed 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 163.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -57.59 -41.4 81.08 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -172.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 57' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' C' ' 53' ' ' ILE . 58.0 mt -61.91 -52.25 64.84 Favored 'General case' 0 N--CA 1.434 -1.249 0 O-C-N 124.779 1.3 . . . . 0.0 109.443 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 58' ' ' ARG . . . . . 0.446 ' HD2' ' HA ' ' C' ' 58' ' ' ARG . 10.1 tpt180 -70.07 -36.1 74.71 Favored 'General case' 0 C--O 1.245 0.865 0 O-C-N 120.27 -1.519 . . . . 0.0 108.74 -174.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.54 -27.55 64.65 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 173.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 30.3 ttm-85 -87.8 2.34 51.58 Favored 'General case' 0 CA--C 1.543 0.712 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 175.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.22 3.36 84.89 Favored Glycine 0 C--N 1.343 0.962 0 O-C-N 118.557 -2.589 . . . . 0.0 111.782 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 88.2 mt -66.87 130.05 31.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 CA-C-N 118.732 1.266 . . . . 0.0 109.676 -177.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -70.11 75.67 0.5 Allowed 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 122.844 1.307 . . . . 0.0 109.111 169.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 2.9 p -86.64 103.28 12.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-O 123.096 1.427 . . . . 0.0 107.76 173.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 65' ' ' ARG . . . . . 0.532 ' NH2' HD22 ' C' ' 94' ' ' LEU . 50.0 mmm-85 -108.74 151.4 26.25 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 124.833 2.254 . . . . 0.0 109.573 173.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 66' ' ' PHE . . . . . 0.869 ' HB2' ' HA ' ' C' ' 93' ' ' VAL . 19.8 m-85 -106.94 114.5 28.62 Favored 'General case' 0 C--O 1.251 1.142 0 C-N-CA 117.664 -1.614 . . . . 0.0 108.049 -176.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 67' ' ' GLY . . . . . 0.473 ' HA3' ' HE2' ' C' ' 103' ' ' PHE . . . -98.99 98.57 2.01 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 106.79 -2.524 . . . . 0.0 106.79 176.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 68' ' ' ILE . . . . . 0.636 HD11 HG13 ' C' ' 93' ' ' VAL . 3.2 mp -89.93 140.25 16.2 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -114.21 121.74 35.84 Favored Pre-proline 0 CA--C 1.506 -0.747 0 CA-C-O 116.034 -1.936 . . . . 0.0 106.029 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 70' ' ' PRO . . . . . 0.659 ' HB3' HG13 ' A' 1157 ' ' ILE . 32.1 Cg_endo -61.56 -50.52 5.42 Favored 'Trans proline' 0 N--CA 1.482 0.823 0 C-N-CA 124.237 3.291 . . . . 0.0 112.214 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 73.0 t -72.86 96.71 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.256 1.397 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 168.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -158.54 128.58 5.92 Favored 'General case' 0 C--O 1.259 1.585 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 176.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.23 -102.79 0.83 Allowed Glycine 0 C--N 1.319 -0.397 0 O-C-N 121.535 -0.728 . . . . 0.0 111.454 167.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.14 122.34 5.05 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -172.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.694 ' HG ' ' SD ' ' B' 1207 ' ' MET . 0.2 OUTLIER 67.09 115.76 0.03 OUTLIER Pre-proline 0 N--CA 1.444 -0.734 0 C-N-CA 125.73 1.612 . . . . 0.0 111.598 -177.313 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 76' ' ' PRO . . . . . 0.47 ' HD3' ' O7N' ' C' 1001 ' ' NAP . 72.0 Cg_endo -69.09 172.48 11.91 Favored 'Trans proline' 0 C--O 1.26 1.614 0 C-N-CA 123.508 2.805 . . . . 0.0 114.386 169.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.63 -104.69 1.35 Allowed Glycine 0 N--CA 1.441 -0.971 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 -166.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 34.02 -78.07 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 127.256 2.222 . . . . 0.0 116.018 160.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -61.86 -41.44 97.84 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 119.404 1.002 . . . . 0.0 113.078 -175.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -85.82 -23.46 27.15 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 113.944 -1.48 . . . . 0.0 112.249 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 98.7 t -62.37 -51.78 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 171.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 11.1 mt -57.95 -29.78 65.44 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 170.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.568 ' HG ' ' HB ' ' C' ' 88' ' ' VAL . 11.8 tp -62.0 -37.26 84.18 Favored 'General case' 0 C--O 1.239 0.517 0 O-C-N 119.673 -1.892 . . . . 0.0 111.498 167.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.4 -43.16 74.03 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 120.542 -1.349 . . . . 0.0 109.704 173.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -60.05 -31.05 69.62 Favored 'General case' 0 C--N 1.348 0.5 0 O-C-N 120.089 -1.632 . . . . 0.0 113.391 173.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 86' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' C' ' 83' ' ' LEU 0.261 . . -73.24 -5.93 42.65 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 120.245 -1.534 . . . . 0.0 112.236 171.752 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 65.49 29.44 11.19 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 118.515 -2.616 . . . . 0.0 116.735 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 88' ' ' VAL . . . . . 0.568 ' HB ' ' HG ' ' C' ' 83' ' ' LEU . 78.0 t -82.83 123.0 78.45 Favored Pre-proline 0 N--CA 1.438 -1.031 0 CA-C-N 112.711 -2.041 . . . . 0.0 106.281 172.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -60.12 103.59 0.21 Allowed 'Trans proline' 0 CA--C 1.545 1.037 1 C-N-CA 125.69 4.26 . . . . 0.0 116.681 -176.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 90' ' ' TYR . . . . . 0.747 ' HA ' ' HB ' ' C' ' 93' ' ' VAL . 1.4 m-30 -50.41 -16.99 0.4 Allowed 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -61.62 -59.82 4.62 Favored 'General case' 0 C--N 1.344 0.349 0 O-C-N 121.383 -0.823 . . . . 0.0 110.554 165.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 5.6 pt -74.94 -18.13 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 118.392 -2.693 . . . . 0.0 111.736 -175.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 93' ' ' VAL . . . . . 0.869 ' HA ' ' HB2' ' C' ' 66' ' ' PHE . 51.7 t -70.05 135.56 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 127.186 2.195 . . . . 0.0 106.574 170.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 94' ' ' LEU . . . . . 0.532 HD22 ' NH2' ' C' ' 65' ' ' ARG . 16.4 tp -138.2 101.72 4.47 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 124.361 2.029 . . . . 0.0 108.353 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 95' ' ' GLU . . . . . 0.618 ' HB3' HD13 ' A' 1157 ' ' ILE . 4.0 mp0 -74.91 84.08 2.21 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 112.004 -2.362 . . . . 0.0 111.06 -177.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.485 ' SD ' ' HD2' ' C' ' 70' ' ' PRO . 24.8 ttp 43.73 60.58 2.61 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 119.548 3.166 . . . . 0.0 119.548 176.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -119.13 -152.02 0.5 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 111.275 -2.693 . . . . 0.0 105.824 -175.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 98' ' ' GLU . . . . . 0.473 ' HG3' ' NZ ' ' B' 1336 ' ' LYS . 8.6 mt-10 -77.1 54.34 1.05 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 125.098 3.59 . . . . 0.0 113.512 -177.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 9.6 tp -79.11 3.01 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 O-C-N 120.753 -1.217 . . . . 0.0 111.334 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -44.48 -52.49 7.86 Favored 'General case' 0 C--N 1.362 1.121 0 C-N-CA 125.58 1.552 . . . . 0.0 114.144 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -57.05 -55.09 39.27 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 124.778 1.299 . . . . 0.0 110.681 -174.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.0 -41.78 77.33 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 113.724 -1.58 . . . . 0.0 107.832 -174.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 103' ' ' PHE . . . . . 0.473 ' HE2' ' HA3' ' C' ' 67' ' ' GLY . 0.2 OUTLIER -59.53 -57.41 13.08 Favored 'General case' 0 C--N 1.358 0.962 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -172.088 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.44 -15.42 63.28 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 118.979 0.809 . . . . 0.0 112.465 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -73.33 -39.2 65.42 Favored 'General case' 0 CA--C 1.568 1.66 0 O-C-N 119.755 -1.84 . . . . 0.0 110.499 174.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 106' ' ' THR . . . . . 0.41 HG21 HG12 ' C' ' 34' ' ' ILE . 19.9 m -52.28 146.16 9.76 Favored 'General case' 0 C--O 1.247 0.948 0 O-C-N 126.984 2.678 . . . . 0.0 116.087 -165.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 107' ' ' ASP . . . . . 0.72 ' HA ' ' HB2' ' C' ' 142' ' ' GLN . 9.5 t70 -81.06 -83.06 0.11 Allowed 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 111.907 -2.406 . . . . 0.0 108.386 165.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 108' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' C' ' 143' ' ' ASN . 31.4 m -89.82 118.35 29.35 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 120.565 1.529 . . . . 0.0 112.866 -174.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 109' ' ' VAL . . . . . 0.667 HG21 HG23 ' C' ' 138' ' ' VAL . 84.2 t -101.49 100.05 9.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 C-N-CA 124.266 1.026 . . . . 0.0 109.76 169.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 110' ' ' LEU . . . . . 0.626 HD21 HD21 ' C' ' 27' ' ' LEU . 29.2 mt -72.12 93.29 1.41 Allowed 'General case' 0 C--O 1.236 0.356 0 O-C-N 124.286 0.992 . . . . 0.0 108.776 177.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 111' ' ' VAL . . . . . 0.656 ' HB ' ' HA ' ' C' ' 146' ' ' VAL . 38.3 t -85.51 94.14 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 177.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 8.5 mm -81.13 92.52 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-O 122.697 1.236 . . . . 0.0 111.096 -171.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 113' ' ' GLY . . . . . 0.625 ' HA3' ' HA3' ' C' ' 40' ' ' GLY . . . 75.69 65.81 1.99 Allowed Glycine 0 C--N 1.315 -0.598 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 168.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 114' ' ' ALA . . . . . 0.645 ' HB2' ' HA3' ' C' ' 38' ' ' GLY . . . -170.98 -166.71 0.5 Allowed 'General case' 0 CA--C 1.504 -0.803 0 O-C-N 122.048 -0.677 . . . . 0.0 110.895 -174.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 115' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -174.01 -53.74 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 166.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 116' ' ' ASP . . . . . 0.577 ' HB2' H51N ' C' 1001 ' ' NAP . 4.0 m-20 -61.26 -25.32 67.01 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 123.58 1.657 . . . . 0.0 112.575 -172.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.6 -43.49 62.52 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 176.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 3.6 m -124.49 13.32 4.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 112.276 -2.238 . . . . 0.0 112.26 -176.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 119' ' ' ASN . . . . . 0.424 ' HA ' ' HD2' ' C' ' 120' ' ' PRO . 25.3 t30 -68.26 112.49 11.07 Favored Pre-proline 0 C--N 1.364 1.201 0 O-C-N 118.372 -2.705 . . . . 0.0 111.814 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 120' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' C' ' 119' ' ' ASN . 10.7 Cg_endo -45.17 -45.38 14.79 Favored 'Trans proline' 0 N--CA 1.444 -1.394 1 C-N-CA 125.353 4.035 . . . . 0.0 115.584 -176.215 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 121' ' ' ALA . . . . . 0.571 ' HA ' ' HB3' ' C' ' 124' ' ' ASP . . . -57.06 -31.72 65.49 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 124.93 1.292 . . . . 0.0 111.864 -177.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 122' ' ' ALA . . . . . 0.773 ' HB1' ' HB3' ' C' ' 133' ' ' MET . . . -67.69 -12.77 61.22 Favored 'General case' 0 N--CA 1.438 -1.035 0 O-C-N 120.325 -1.484 . . . . 0.0 112.883 -174.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -106.97 -35.19 6.97 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 120.662 -1.274 . . . . 0.0 110.341 159.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 124' ' ' ASP . . . . . 0.571 ' HB3' ' HA ' ' C' ' 121' ' ' ALA . 11.3 t70 -65.32 -65.2 0.7 Allowed 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 123.251 1.5 . . . . 0.0 111.253 -172.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 125' ' ' ASP . . . . . 0.489 ' HA ' ' HD3' ' C' ' 126' ' ' PRO . 14.6 t70 -84.07 119.16 72.96 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-N 112.783 -2.008 . . . . 0.0 112.469 -173.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 126' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' C' ' 125' ' ' ASP . 34.6 Cg_exo -70.83 -11.54 29.59 Favored 'Trans proline' 0 N--CA 1.449 -1.145 1 C-N-CA 125.534 4.156 . . . . 0.0 111.984 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 127' ' ' LYS . . . . . 0.603 ' HB3' ' HZ3' ' C' ' 127' ' ' LYS . 6.4 ttpm? -77.09 -0.63 25.46 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 119.337 0.971 . . . . 0.0 112.646 176.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 128' ' ' SER . . . . . 0.438 ' HA ' ' HD2' ' C' ' 129' ' ' PRO . 70.0 m -59.07 121.19 53.52 Favored Pre-proline 0 C--N 1.355 0.824 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 172.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 129' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' C' ' 128' ' ' SER . 42.9 Cg_endo -58.82 -45.36 29.39 Favored 'Trans proline' 0 C--N 1.353 0.774 1 C-N-CA 126.181 4.587 . . . . 0.0 116.816 173.567 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 130' ' ' ILE . . . . . 0.617 HG12 ' HB2' ' C' ' 156' ' ' ALA . 15.0 pt -69.54 92.62 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.716 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 165.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.91 110.2 1.27 Allowed 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 125.801 2.715 . . . . 0.0 112.151 -169.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.89 72.57 0.48 Allowed Glycine 0 N--CA 1.462 0.428 0 CA-C-N 109.11 -3.677 . . . . 0.0 113.411 -176.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 133' ' ' MET . . . . . 0.773 ' HB3' ' HB1' ' C' ' 122' ' ' ALA . 62.0 tpp -82.69 127.6 69.56 Favored Pre-proline 0 C--O 1.249 1.053 0 CA-C-N 118.207 1.004 . . . . 0.0 110.291 -177.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 134' ' ' PRO . . . . . 0.584 ' HD2' ' SD ' ' C' ' 133' ' ' MET . 40.2 Cg_endo -78.95 67.37 8.58 Favored 'Trans proline' 0 C--O 1.243 0.746 0 C-N-CA 124.777 3.651 . . . . 0.0 113.275 -174.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 135' ' ' VAL . . . . . 0.539 HG23 ' HH2' ' C' ' 139' ' ' TRP . 27.7 m -68.96 136.5 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-N 113.414 -1.721 . . . . 0.0 112.464 -177.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 97.4 mt -77.54 153.23 33.57 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.288 -1.778 . . . . 0.0 108.68 -174.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -67.63 59.5 0.06 Allowed 'General case' 0 C--O 1.211 -0.967 0 N-CA-C 118.218 2.673 . . . . 0.0 118.218 -162.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 138' ' ' VAL . . . . . 0.667 HG23 HG21 ' C' ' 109' ' ' VAL . 4.5 p -82.25 20.16 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.254 1.331 0 CA-C-O 123.864 1.792 . . . . 0.0 112.826 -173.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 139' ' ' TRP . . . . . 0.539 ' HH2' HG23 ' C' ' 135' ' ' VAL . 2.2 m95 -70.73 133.12 46.32 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.831 -162.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 140' ' ' LYS . . . . . . . . . . . . . 20.3 pttm 36.62 42.32 0.2 Allowed 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 -169.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 141' ' ' ALA . . . . . 0.469 ' HB3' HG22 ' C' ' 144' ' ' VAL . . . -73.13 152.02 41.34 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 120.574 -1.329 . . . . 0.0 112.154 174.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 142' ' ' GLN . . . . . 0.72 ' HB2' ' HA ' ' C' ' 107' ' ' ASP . 85.7 mm-40 -77.23 -9.21 58.65 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -159.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 143' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' C' ' 108' ' ' THR . 14.4 t30 -164.49 95.29 0.73 Allowed 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.636 1.574 . . . . 0.0 108.672 169.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 144' ' ' VAL . . . . . 0.522 ' HB ' ' HA ' ' C' ' 168' ' ' THR . 21.9 t -89.8 101.0 11.74 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 145' ' ' ILE . . . . . 0.691 HG13 ' HB2' ' C' ' 171' ' ' LEU . 10.1 tp -110.8 102.34 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.352 0 CA-C-O 125.333 2.492 . . . . 0.0 107.359 -166.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 146' ' ' VAL . . . . . 0.921 HG21 ' HB3' ' C' ' 162' ' ' LEU . 28.8 t -95.82 100.67 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 111.728 -2.487 . . . . 0.0 110.998 -168.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 147' ' ' PHE . . . . . 0.554 ' HB2' ' H ' ' C' ' 113' ' ' GLY . 0.7 OUTLIER -60.61 115.07 3.35 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 119.752 -1.842 . . . . 0.0 109.845 178.756 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 148' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -141.1 138.57 33.62 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 166.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 8.4 tpp85 -59.37 -38.98 81.84 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 117.528 -1.225 . . . . 0.0 111.513 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 20.2 m -148.16 164.49 33.76 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 120.936 1.698 . . . . 0.0 108.816 173.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 8.0 tpt -54.88 108.87 0.44 Allowed 'General case' 0 CA--C 1.502 -0.876 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.239 171.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -155.42 124.18 6.07 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.567 -173.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 153' ' ' THR . . . . . 0.655 HG23 ' HA3' ' C' ' 157' ' ' GLY . 46.2 m -62.16 136.52 57.98 Favored 'General case' 0 N--CA 1.434 -1.232 0 O-C-N 125.767 1.917 . . . . 0.0 107.889 175.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -76.08 -146.3 1.79 Allowed Glycine 0 N--CA 1.443 -0.855 0 O-C-N 119.641 -1.912 . . . . 0.0 110.371 172.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -60.97 -63.25 1.36 Allowed 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 120.955 -1.321 . . . . 0.0 109.438 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 156' ' ' ALA . . . . . 0.617 ' HB2' HG12 ' C' ' 130' ' ' ILE . . . -83.24 -52.36 6.65 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.899 -176.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 157' ' ' GLY . . . . . 0.655 ' HA3' HG23 ' C' ' 153' ' ' THR . . . 65.31 -85.31 0.08 OUTLIER Glycine 0 CA--C 1.531 1.038 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -165.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 158' ' ' VAL . . . . . 0.473 HG22 ' HB1' ' C' ' 156' ' ' ALA 0.293 17.3 m 30.91 104.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 -179.172 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 50.45 12.67 0.1 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -171.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 160' ' ' ASN . . . . . 0.63 ' HB2' ' O ' ' C' ' 157' ' ' GLY . 1.4 t30 -53.05 94.73 0.06 OUTLIER Pre-proline 0 C--N 1.35 0.629 0 N-CA-C 117.338 2.348 . . . . 0.0 117.338 -159.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 161' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' C' ' 160' ' ' ASN . 84.8 Cg_exo -57.81 -34.42 98.23 Favored 'Trans proline' 0 N--CA 1.482 0.795 0 C-N-CA 123.361 2.708 . . . . 0.0 109.974 -169.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 162' ' ' LEU . . . . . 0.921 ' HB3' HG21 ' C' ' 146' ' ' VAL . 13.3 mt -54.29 -17.99 3.52 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 116.966 2.21 . . . . 0.0 116.966 -176.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 163' ' ' PHE . . . . . 0.604 ' HA ' ' HG3' ' C' ' 170' ' ' MET . 20.9 m-30 -91.74 -45.14 8.59 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 123.022 1.392 . . . . 0.0 107.756 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -86.47 -51.8 5.97 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 111.446 -2.615 . . . . 0.0 112.732 -158.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 165' ' ' LYS . . . . . 0.664 ' HB2' ' HB ' ' C' ' 168' ' ' THR . 17.1 mmmt -73.2 -176.16 2.08 Favored 'General case' 0 C--O 1.246 0.871 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -157.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -69.5 -70.0 0.31 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.362 1.065 . . . . 0.0 108.168 -165.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -86.45 -19.04 30.21 Favored 'General case' 0 C--N 1.347 0.478 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 175.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 168' ' ' THR . . . . . 0.697 HG22 ' HA ' ' C' ' 162' ' ' LEU 0.275 37.6 m -93.67 86.33 5.13 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.207 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -150.47 155.74 40.1 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 123.075 1.417 . . . . 0.0 107.877 -164.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 170' ' ' MET . . . . . 0.604 ' HG3' ' HA ' ' C' ' 163' ' ' PHE . 76.7 mtm -73.33 140.38 46.68 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 176.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 171' ' ' LEU . . . . . 0.691 ' HB2' HG13 ' C' ' 145' ' ' ILE . 40.8 tp -92.18 107.51 19.27 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 103.448 -2.797 . . . . 0.0 103.448 167.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -78.4 102.79 7.95 Favored 'General case' 0 C--O 1.253 1.253 0 CA-C-N 111.902 -2.408 . . . . 0.0 111.279 -174.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . 167.97 175.36 37.65 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.203 175.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 174' ' ' ASP . . . . . 0.517 ' HB3' ' HB3' ' C' ' 177' ' ' ALA . 20.6 t70 -62.67 149.13 44.39 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 114.422 -0.889 . . . . 0.0 111.4 173.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 175' ' ' ALA . . . . . 0.411 ' O ' HG23 ' C' ' 179' ' ' VAL . . . -58.57 -59.78 4.84 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 120.088 -1.632 . . . . 0.0 113.651 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 176' ' ' LYS . . . . . 0.592 ' HG3' ' HG3' ' C' ' 45' ' ' GLN . 0.5 OUTLIER -54.59 -66.47 0.39 Allowed 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 124.579 1.175 . . . . 0.0 108.133 176.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 177' ' ' ALA . . . . . 0.517 ' HB3' ' HB3' ' C' ' 174' ' ' ASP . . . -48.16 -39.23 20.1 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 117.781 2.511 . . . . 0.0 117.781 -177.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 56.2 m -67.82 -43.34 79.81 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 120.545 1.52 . . . . 0.0 111.301 173.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 179' ' ' VAL . . . . . 0.411 HG23 ' O ' ' C' ' 175' ' ' ALA . 3.1 t -64.5 -39.68 86.44 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 CA-C-N 121.028 1.74 . . . . 0.0 108.175 175.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -56.78 -45.75 81.94 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 122.786 1.279 . . . . 0.0 112.55 176.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -56.58 -31.22 64.03 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 182' ' ' ILE . . . . . 0.437 HG22 ' HB2' ' C' ' 24' ' ' ALA . 42.9 pt -98.21 -25.81 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -178.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 183' ' ' LEU . . . . . 0.73 ' HA ' HD13 ' C' ' 53' ' ' ILE . 2.9 pp -59.44 -20.16 52.93 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 120.287 3.44 . . . . 0.0 120.287 -164.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -126.65 -34.75 2.4 Favored 'General case' 0 CA--C 1.492 -1.28 0 O-C-N 125.371 1.669 . . . . 0.0 107.118 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -73.06 -14.94 61.5 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 120.299 -1.5 . . . . 0.0 114.151 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 186' ' ' LEU . . . . . 0.84 ' HA ' ' HB1' ' C' ' 24' ' ' ALA . 2.6 pt? . . . . . 0 C--O 1.219 -0.547 0 N-CA-C 119.796 3.258 . . . . 0.0 119.796 -167.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 1' ' ' NAD . . . . . 0.6 ' H8A' HG23 ' B' 1258 ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C 1001 ' ' NAP . . . . . 0.577 H51N ' HB2' ' C' ' 116' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 19.6 t-80 . . . . . 0 C--O 1.236 0.346 0 N-CA-C 102.441 -3.17 . . . . 65.739999999999995 102.441 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -67.64 81.47 0.16 Allowed Glycine 0 CA--C 1.544 1.864 0 CA-C-O 123.33 1.516 . . . . 48.659999999999997 111.332 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -116.06 122.92 46.6 Favored 'General case' 0 N--CA 1.419 -1.982 1 N-CA-C 100.1 -4.037 . . . . 44.560000000000002 100.1 175.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1003 ' ' ILE . . . . . 0.455 HG12 ' HB ' ' A' 1068 ' ' ILE . 30.4 mt -99.13 121.51 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.163 0 N-CA-C 106.024 -1.843 . . . . 34.859999999999999 106.024 177.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1004 ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' 1034 ' ' ALA . . . -79.47 135.15 14.76 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 108.35 -1.9 . . . . 30.75 108.35 165.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.637 HG23 ' HB3' ' A' 1017 ' ' ALA . 32.8 mm -110.82 96.25 27.94 Favored Pre-proline 0 C--O 1.242 0.696 0 N-CA-C 101.564 -3.495 . . . . 32.210000000000001 101.564 170.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -71.6 171.59 16.03 Favored 'Trans proline' 0 CA--C 1.504 -0.992 0 C-N-CA 122.529 2.153 . . . . 32.979999999999997 111.312 170.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1007 ' ' ARG . . . . . 0.433 ' HA ' HG22 ' A' 1016 ' ' VAL . 19.0 ttp85 -104.32 141.36 36.44 Favored 'General case' 0 C--O 1.258 1.549 0 CA-C-N 110.976 -2.829 . . . . 47.979999999999997 106.726 169.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1008 ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -65.25 143.32 57.88 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 123.456 1.598 . . . . 34.700000000000003 112.699 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1009 ' ' ARG . . . . . 0.479 HH11 ' HD3' ' A' 1009 ' ' ARG . 37.7 mtp180 -108.74 22.29 16.12 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-O 123.473 1.606 . . . . 53.369999999999997 113.553 176.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 30.0 tp -77.96 149.65 34.11 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.588 -1.264 . . . . 45.07 107.588 170.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1011 ' ' THR . . . . . . . . . . . . . 23.5 m -74.77 143.99 43.78 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 122.378 2.354 . . . . 40.359999999999999 110.023 -174.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 32.4 t30 41.64 64.4 1.06 Allowed 'General case' 0 N--CA 1.439 -0.997 0 CA-C-O 125.178 2.418 . . . . 40.609999999999999 113.283 -176.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1013 ' ' GLU . . . . . 0.435 ' O ' HD13 ' A' 1042 ' ' LEU . 8.3 tp10 -134.04 147.61 50.96 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 109.932 -3.304 . . . . 33.759999999999998 104.424 -169.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1014 ' ' THR . . . . . 0.823 ' HB ' ' HB3' ' A' 1320 ' ' PRO . 0.0 OUTLIER -124.15 1.1 8.51 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 112.935 0.717 . . . . 27.890000000000001 112.935 177.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 1015 ' ' ARG . . . . . 0.932 ' HD2' HG11 ' A' 1072 ' ' VAL . 21.0 mtm180 -68.13 130.57 43.34 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 119.884 -1.76 . . . . 29.02 112.161 -176.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1016 ' ' VAL . . . . . 0.554 ' HB ' ' HB2' ' A' 1043 ' ' ALA . 83.9 t -132.17 141.73 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 110.644 -2.98 . . . . 28.129999999999999 103.862 168.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1017 ' ' ALA . . . . . 0.637 ' HB3' HG23 ' A' 1005 ' ' ILE . . . -56.54 -37.23 70.22 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 118.024 2.601 . . . . 26.870000000000001 118.024 -171.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -136.08 143.01 44.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 120.077 1.308 . . . . 26.77 110.64 -165.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1019 ' ' THR . . . . . . . . . . . . . 75.5 p -77.67 173.4 7.64 Favored Pre-proline 0 C--N 1.346 0.444 0 O-C-N 120.104 -1.622 . . . . 27.02 108.25 163.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1020 ' ' PRO . . . . . 0.478 ' HB3' ' HB2' ' A' 1053 ' ' ALA . 2.5 Cg_exo -55.39 -35.3 91.53 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 123.837 3.025 . . . . 30.57 111.741 164.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -62.49 -49.55 74.94 Favored 'General case' 0 C--N 1.358 0.957 0 CA-C-N 118.98 0.809 . . . . 47.810000000000002 110.826 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1022 ' ' THR . . . . . . . . . . . . . 6.7 p -65.74 -29.16 69.63 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.573 0.953 . . . . 30.77 113.573 176.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1023 ' ' VAL . . . . . 0.892 HG22 HG11 ' A' 1033 ' ' VAL . 3.4 t -62.74 -44.83 99.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 107.65 -1.241 . . . . 33.590000000000003 107.65 175.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1024 ' ' GLU . . . . . 0.625 ' O ' ' HG2' ' A' 1028 ' ' LYS . 48.6 mt-10 -59.75 -44.22 93.91 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 117.609 -1.186 . . . . 53.289999999999999 111.847 173.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -54.71 -38.69 67.36 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-N 119.998 1.272 . . . . 46.920000000000002 114.333 170.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1026 ' ' LEU . . . . . . . . . . . . . 91.2 mt -68.75 -38.63 80.27 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 119.141 0.882 . . . . 37.170000000000002 109.278 177.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 12.7 tp -63.83 -43.29 96.62 Favored 'General case' 0 CA--C 1.556 1.183 0 O-C-N 124.074 0.859 . . . . 44.439999999999998 109.064 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1028 ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' 1024 ' ' GLU . 28.0 mmmt -59.67 -41.21 90.13 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 123.292 0.637 . . . . 52.579999999999998 109.698 175.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1029 ' ' LEU . . . . . 0.478 ' HA ' ' HE3' ' A' 1342 ' ' LYS . 61.9 mt -72.44 7.23 1.9 Allowed 'General case' 0 C--O 1.253 1.247 0 N-CA-C 116.654 2.094 . . . . 45.689999999999998 116.654 174.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 94.74 -5.19 69.45 Favored Glycine 0 CA--C 1.494 -1.272 0 O-C-N 121.004 -1.06 . . . . 42.090000000000003 112.303 171.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -86.66 137.07 32.76 Favored 'General case' 0 N--CA 1.443 -0.803 0 O-C-N 119.352 -2.264 . . . . 40.719999999999999 106.86 -171.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1032 ' ' THR . . . . . . . . . . . . . 37.8 m -76.69 127.38 32.67 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 104.915 -2.254 . . . . 37.770000000000003 104.915 162.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1033 ' ' VAL . . . . . 0.892 HG11 HG22 ' A' 1023 ' ' VAL . 4.1 t -94.06 133.71 34.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 103.225 -2.88 . . . . 33.539999999999999 103.225 177.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1034 ' ' ALA . . . . . 0.414 ' O ' ' HA2' ' A' 1004 ' ' GLY . . . -126.84 116.61 21.12 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 104.803 -2.295 . . . . 31.68 104.803 172.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1035 ' ' VAL . . . . . . . . . . . . . 21.2 t -109.29 142.34 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 O-C-N 120.91 -1.119 . . . . 31.52 109.765 -174.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1036 ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -65.17 139.14 58.64 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.32 -1.363 . . . . 41.039999999999999 107.32 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1037 ' ' SER . . . . . . . . . . . . . 8.6 t -73.56 132.7 43.12 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 106.176 -1.787 . . . . 31.829999999999998 106.176 176.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1038 ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' 1041 ' ' GLN . . . 100.04 -20.91 47.01 Favored Glycine 0 C--O 1.22 -0.773 0 N-CA-C 109.278 -1.529 . . . . 29.359999999999999 109.278 -175.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -67.73 -34.91 77.79 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 121.484 -1.009 . . . . 27.780000000000001 110.649 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1040 ' ' GLY . . . . . 0.583 ' HA2' ' HE2' ' A' 1050 ' ' PHE . . . -59.98 -43.18 98.4 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-O 123.429 1.571 . . . . 28.91 110.622 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1041 ' ' GLN . . . . . 0.418 ' HB3' ' O ' ' A' 1038 ' ' GLY . 8.5 tp60 -52.15 -49.12 64.36 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 112.218 -1.991 . . . . 51.18 113.652 172.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1042 ' ' LEU . . . . . 0.435 HD13 ' O ' ' A' 1013 ' ' GLU . 10.7 mt -78.54 -38.47 40.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.541 -1.974 . . . . 29.91 114.119 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1043 ' ' ALA . . . . . 0.554 ' HB2' ' HB ' ' A' 1016 ' ' VAL . . . -61.26 -14.95 30.06 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 113.719 1.007 . . . . 28.539999999999999 113.719 169.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1044 ' ' SER . . . . . . . . . . . . . 51.1 m 68.27 34.56 3.81 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 120.246 -1.534 . . . . 33.060000000000002 108.596 173.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1045 ' ' PHE . . . . . 0.439 ' HD2' ' HD2' ' A' 1020 ' ' PRO . 0.0 OUTLIER -161.58 97.74 1.09 Allowed 'General case' 0 C--O 1.247 0.96 0 N-CA-C 101.092 -3.669 . . . . 30.289999999999999 101.092 -178.988 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -71.92 165.77 23.49 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 120.854 3.65 . . . . 48.619999999999997 120.854 -149.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.42 -53.97 12.58 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 112.35 -2.205 . . . . 36.740000000000002 111.438 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 3.4 pttm -65.02 -39.02 92.79 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-N 121.76 2.073 . . . . 43.729999999999997 111.132 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -62.25 -29.86 70.7 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.398 -1.439 . . . . 32.810000000000002 112.198 175.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1050 ' ' PHE . . . . . 0.583 ' HE2' ' HA2' ' A' 1040 ' ' GLY . 21.9 m-85 -62.52 -50.01 73.08 Favored 'General case' 0 C--O 1.255 1.352 0 C-N-CA 120.246 -0.581 . . . . 31.859999999999999 112.494 169.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1051 ' ' VAL . . . . . 0.517 HG22 HG12 ' A' 1057 ' ' ILE . 11.0 t -62.95 -42.45 96.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 O-C-N 121.101 -0.999 . . . . 33.219999999999999 109.289 -176.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -51.01 -44.87 61.04 Favored 'General case' 0 C--O 1.256 1.434 0 C-N-CA 125.212 1.405 . . . . 50.829999999999998 110.599 172.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1053 ' ' ALA . . . . . 0.478 ' HB2' ' HB3' ' A' 1020 ' ' PRO . . . -65.87 -44.82 84.27 Favored 'General case' 0 C--O 1.246 0.91 0 CA-C-O 124.819 2.247 . . . . 33.119999999999997 113.016 -176.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 147.56 33.88 0.06 OUTLIER Glycine 0 N--CA 1.464 0.511 0 CA-C-N 113.141 -1.845 . . . . 35.829999999999998 114.553 -177.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -111.04 139.37 46.46 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-N 118.66 1.23 . . . . 34.82 110.138 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -84.09 121.56 27.59 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 103.297 -2.853 . . . . 49.049999999999997 103.297 167.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1057 ' ' ILE . . . . . 0.517 HG12 HG22 ' A' 1051 ' ' VAL . 26.2 mm -85.32 122.49 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 O-C-N 118.105 -2.872 . . . . 38.530000000000001 108.807 177.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1058 ' ' VAL . . . . . . . . . . . . . 12.0 m -122.31 147.05 26.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 105.4 -2.074 . . . . 42.109999999999999 105.4 -173.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -121.4 135.01 55.11 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 126.026 2.822 . . . . 58.0 111.632 -171.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 57.3 -141.9 43.32 Favored Glycine 0 N--CA 1.465 0.616 0 CA-C-N 110.451 -3.068 . . . . 52.119999999999997 113.444 -176.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1061 ' ' ASN . . . . . 0.878 ' HA ' ' HD1' ' A' 1064 ' ' TRP . 1.4 t30 -48.12 -25.34 1.42 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 116.527 2.047 . . . . 54.75 116.527 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1062 ' ' SER . . . . . . . . . . . . . 15.2 m -60.22 -20.73 60.09 Favored 'General case' 0 CA--C 1.552 1.048 0 N-CA-C 114.028 1.122 . . . . 50.340000000000003 114.028 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1063 ' ' VAL . . . . . 0.493 ' O ' HD11 ' A' 1069 ' ' ILE . 14.9 p -70.03 -48.36 63.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 107.309 -1.367 . . . . 41.460000000000001 107.309 169.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1064 ' ' TRP . . . . . 0.878 ' HD1' ' HA ' ' A' 1061 ' ' ASN . 75.4 m95 -65.34 -30.73 71.6 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 124.397 1.079 . . . . 39.32 110.907 -172.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.43 81.05 4.79 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 113.489 -1.687 . . . . 55.380000000000003 109.427 172.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1066 ' ' SER . . . . . . . . . . . . . 68.5 m -145.72 -178.91 6.34 Favored 'General case' 0 C--O 1.242 0.67 0 O-C-N 120.431 -1.418 . . . . 41.869999999999997 111.128 172.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1067 ' ' GLU . . . . . 0.447 ' HB3' HD12 ' A' 1068 ' ' ILE . 22.0 tp10 -69.77 -62.81 1.23 Allowed 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.183 -1.414 . . . . 53.200000000000003 107.183 174.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1068 ' ' ILE . . . . . 0.455 ' HB ' HG12 ' A' 1003 ' ' ILE . 5.3 mp -107.56 142.17 20.94 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 N-CA-C 105.482 -2.044 . . . . 41.899999999999999 105.482 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1069 ' ' ILE . . . . . 0.493 HD11 ' O ' ' A' 1063 ' ' VAL . 5.4 mm -124.38 121.28 61.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 104.177 -2.527 . . . . 38.729999999999997 104.177 168.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1070 ' ' LEU . . . . . 0.674 HD22 HD22 ' A' 1331 ' ' LEU . 77.2 mt -98.74 87.05 3.67 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 104.302 -2.481 . . . . 32.439999999999998 104.302 172.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1071 ' ' LYS . . . . . 0.407 ' HB3' ' HE3' ' A' 1071 ' ' LYS . 1.1 mmmt -83.59 162.09 20.94 Favored 'General case' 0 C--O 1.257 1.48 0 N-CA-C 105.403 -2.073 . . . . 34.649999999999999 105.403 167.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1072 ' ' VAL . . . . . 0.932 HG11 ' HD2' ' A' 1015 ' ' ARG . 18.8 t -88.18 -86.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.705 0 C-N-CA 119.588 -0.845 . . . . 31.32 110.844 175.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -84.4 151.89 24.39 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.133 -1.432 . . . . 33.939999999999998 107.133 -170.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1074 ' ' ALA . . . . . 0.448 ' HA ' ' HD2' ' A' 1075 ' ' PRO . . . -33.92 120.29 0.5 Allowed Pre-proline 0 C--O 1.253 1.271 0 C-N-CA 125.084 1.353 . . . . 38.039999999999999 114.646 170.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1075 ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' 1074 ' ' ALA . 72.6 Cg_endo -56.81 128.2 28.97 Favored 'Trans proline' 0 N--CA 1.441 -1.579 0 C-N-CA 125.074 3.85 . . . . 42.68 114.887 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 33.0 mt -72.88 158.25 35.87 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 120.712 -1.242 . . . . 46.740000000000002 108.295 170.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1077 ' ' ASP . . . . . 0.497 ' HA ' HD12 ' A' 1080 ' ' ILE . 7.4 m-20 -45.98 -39.63 9.25 Favored 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 118.515 2.783 . . . . 58.609999999999999 118.515 -176.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 15.7 t70 -61.98 -48.71 79.12 Favored 'General case' 0 C--N 1.352 0.686 0 CA-C-N 119.144 0.884 . . . . 59.200000000000003 109.706 173.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1079 ' ' GLU . . . . . 0.427 ' HG2' HH11 ' A' 1009 ' ' ARG . 35.5 mt-10 -62.88 -32.42 73.66 Favored 'General case' 0 C--O 1.259 1.559 0 CA-C-N 114.024 -1.444 . . . . 50.630000000000003 109.109 -178.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1080 ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' 1077 ' ' ASP . 73.7 mt -62.88 -44.51 99.64 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-N 118.899 0.772 . . . . 51.479999999999997 109.59 173.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -62.53 -26.22 68.44 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 119.789 -1.82 . . . . 50.280000000000001 112.321 175.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 15.7 mt -80.96 -24.33 38.16 Favored 'General case' 0 C--O 1.25 1.102 0 O-C-N 119.339 -2.1 . . . . 50.210000000000001 112.206 174.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1083 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.22 120.26 10.01 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 124.477 2.084 . . . . 49.060000000000002 111.501 176.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -82.99 134.81 45.82 Favored Pre-proline 0 CA--C 1.515 -0.385 0 CA-C-N 112.483 -2.144 . . . . 51.079999999999998 111.756 -167.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -48.96 113.18 0.81 Allowed 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 125.106 3.871 . . . . 49.729999999999997 119.159 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 104.31 -27.16 20.41 Favored Glycine 0 N--CA 1.436 -1.309 0 O-C-N 124.9 1.375 . . . . 47.710000000000001 114.021 177.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1087 ' ' THR . . . . . . . . . . . . . 39.4 m -49.92 128.87 19.45 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 118.316 2.71 . . . . 45.469999999999999 118.316 -174.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1088 ' ' THR . . . . . . . . . . . . . 41.2 m -68.77 88.86 0.38 Allowed 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 123.354 1.549 . . . . 42.039999999999999 113.047 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1089 ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' 1112 ' ' VAL . 57.2 tp -83.43 98.32 9.44 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 104.291 -2.485 . . . . 38.060000000000002 104.291 -176.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1090 ' ' VAL . . . . . 0.625 ' HB ' HD23 ' A' 1070 ' ' LEU . 45.5 t -96.49 109.37 22.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 104.719 -2.326 . . . . 37.399999999999999 104.719 175.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1091 ' ' SER . . . . . 0.46 ' HA ' ' OH ' ' A' 1327 ' ' TYR . 13.4 m -152.26 162.91 40.45 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 116.537 2.051 . . . . 36.159999999999997 116.537 -175.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1092 ' ' PHE . . . . . 0.438 ' CD1' ' HB3' ' A' 1116 ' ' ASP . 51.4 t80 -74.33 79.42 1.85 Allowed 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 123.133 1.444 . . . . 38.939999999999998 107.652 170.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 21.8 mm -82.27 -42.72 18.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 126.571 1.948 . . . . 42.170000000000002 114.966 -168.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 2.9 m95 66.67 60.57 0.94 Allowed Pre-proline 0 N--CA 1.436 -1.175 0 C-N-CA 125.113 1.365 . . . . 46.509999999999998 114.625 -174.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1095 ' ' PRO . . . . . 0.404 ' HG2' HG11 ' A' 1360 ' ' VAL . 52.4 Cg_exo -56.43 -33.44 92.1 Favored 'Trans proline' 0 C--O 1.253 1.269 0 C-N-CA 124.87 3.713 . . . . 49.759999999999998 114.319 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -60.65 -51.8 67.86 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.118 -1.401 . . . . 52.619999999999997 111.61 174.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -78.96 -14.4 59.23 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 115.32 1.6 . . . . 60.740000000000002 115.32 177.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1098 ' ' ASN . . . . . 0.463 ' HB3' ' HB3' ' A' 1101 ' ' LEU . 43.6 m-20 -125.36 65.91 51.85 Favored Pre-proline 0 N--CA 1.441 -0.901 0 N-CA-C 115.765 1.765 . . . . 58.189999999999998 115.765 -173.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -66.24 -41.6 12.28 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.715 2.944 . . . . 54.590000000000003 113.308 -175.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.23 -42.09 85.54 Favored 'General case' 0 C--O 1.253 1.237 0 CA-C-O 123.335 1.54 . . . . 63.280000000000001 112.696 176.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1101 ' ' LEU . . . . . 0.463 ' HB3' ' HB3' ' A' 1098 ' ' ASN . 21.3 tp -55.78 -37.03 68.03 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 113.162 -1.835 . . . . 54.75 109.928 -178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1102 ' ' MET . . . . . . . . . . . . . 82.3 mmm -61.06 -45.3 95.34 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 108.667 -0.864 . . . . 52.649999999999999 108.667 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -64.8 -45.0 88.11 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-N 114.642 -1.163 . . . . 66.260000000000005 112.197 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 95.0 mttt -61.62 -41.84 98.04 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 123.132 1.444 . . . . 63.729999999999997 110.352 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1105 ' ' LEU . . . . . 0.424 HD13 HG21 ' A' 1112 ' ' VAL . 95.8 mt -74.83 -35.5 62.41 Favored 'General case' 0 C--O 1.246 0.884 0 O-C-N 118.485 -2.635 . . . . 54.68 109.227 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -62.84 -38.87 92.51 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 117.427 -1.273 . . . . 53.640000000000001 109.953 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -60.67 -41.19 94.57 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 124.277 0.985 . . . . 67.239999999999995 110.671 169.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1108 ' ' ARG . . . . . 0.482 ' HA ' ' HD3' ' A' 1108 ' ' ARG . 12.0 mmt85 -76.28 -0.05 21.02 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 114.281 1.215 . . . . 65.760000000000005 114.281 173.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1109 ' ' ASN . . . . . 0.588 ' HA ' ' HA2' ' A' 1364 ' ' GLY . 35.7 t30 61.22 15.22 6.2 Favored 'General case' 0 C--N 1.346 0.422 0 N-CA-C 114.431 1.271 . . . . 58.710000000000001 114.431 175.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1110 ' ' VAL . . . . . . . . . . . . . 29.8 m -79.39 132.97 30.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 O-C-N 120.111 -1.618 . . . . 46.630000000000003 108.623 -169.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1111 ' ' THR . . . . . 0.652 HG21 HG21 ' A' 1348 ' ' VAL . 56.5 m -74.72 93.91 2.64 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.509 0.671 . . . . 44.130000000000003 110.02 -176.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1112 ' ' VAL . . . . . 0.424 HG21 HD13 ' A' 1105 ' ' LEU . 38.9 t -92.84 115.97 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 123.874 1.797 . . . . 40.439999999999998 111.376 -170.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1113 ' ' MET . . . . . 0.565 ' SD ' HG13 ' A' 1348 ' ' VAL . 73.9 mtp -107.86 105.93 15.97 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 104.525 -2.398 . . . . 50.759999999999998 104.525 173.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1114 ' ' ALA . . . . . . . . . . . . . . . -86.63 109.07 18.91 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.399 -0.819 . . . . 35.640000000000001 111.608 -177.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1115 ' ' MET . . . . . 0.639 ' SD ' HD22 ' A' 1334 ' ' LEU . 90.9 mmm -66.19 -21.59 66.32 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 115.929 1.826 . . . . 38.740000000000002 115.929 -175.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1116 ' ' ASP . . . . . 0.438 ' HB3' ' CD1' ' A' 1092 ' ' PHE . 6.5 p-10 -73.09 -32.84 65.23 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 114.234 -1.348 . . . . 40.140000000000001 109.948 169.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1117 ' ' SER . . . . . . . . . . . . . 29.5 m -82.97 13.19 4.13 Favored 'General case' 0 C--O 1.244 0.772 0 O-C-N 119.777 -1.827 . . . . 44.789999999999999 114.937 -175.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1118 ' ' VAL . . . . . 0.676 HG22 HG22 ' A' 1358 ' ' VAL . 12.0 t -64.14 124.3 85.0 Favored Pre-proline 0 N--CA 1.484 1.26 0 CA-C-O 117.246 -1.359 . . . . 43.75 107.426 169.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1119 ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' 1354 ' ' VAL . 47.8 Cg_exo -55.88 134.64 65.31 Favored 'Trans proline' 0 C--O 1.242 0.698 0 C-N-CA 124.93 3.753 . . . . 48.93 110.745 173.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1120 ' ' ARG . . . . . 0.649 ' HD3' HD13 ' A' 1130 ' ' LEU . 41.8 mmm-85 -69.12 17.56 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 120.018 3.34 . . . . 62.899999999999999 120.018 -163.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 26.9 pt -85.67 171.46 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 C-N-CA 123.344 0.658 . . . . 57.719999999999999 112.562 -165.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1122 ' ' SER . . . . . . . . . . . . . 1.1 p -51.48 -53.79 33.68 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 118.822 -2.424 . . . . 57.259999999999998 114.743 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -64.58 -2.19 2.24 Favored 'General case' 0 C--O 1.248 0.997 0 CA-C-N 121.359 1.89 . . . . 62.899999999999999 115.875 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1124 ' ' ALA . . . . . 0.454 ' HB2' HG11 ' A' 1354 ' ' VAL . . . -106.41 -11.68 15.88 Favored 'General case' 0 C--O 1.2 -1.521 0 CA-C-O 116.381 -1.771 . . . . 49.829999999999998 114.198 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -57.99 -29.36 65.19 Favored 'General case' 0 CA--C 1.488 -1.415 0 N-CA-C 115.628 1.714 . . . . 52.369999999999997 115.628 -170.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1126 ' ' SER . . . . . . . . . . . . . 64.0 p -65.16 -41.14 94.98 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 115.102 1.519 . . . . 42.43 115.102 169.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1127 ' ' LEU . . . . . . . . . . . . . 1.6 mp -81.43 -28.44 34.24 Favored 'General case' 0 C--O 1.208 -1.096 0 CA-C-N 115.492 -0.777 . . . . 43.740000000000002 111.013 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 61.3 t0 -67.88 101.11 1.03 Allowed 'General case' 0 N--CA 1.439 -0.985 0 O-C-N 119.699 -1.876 . . . . 43.210000000000001 110.063 -164.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -74.2 -34.23 63.66 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.963 -0.562 . . . . 35.740000000000002 109.977 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1130 ' ' LEU . . . . . 0.649 HD13 ' HD3' ' A' 1120 ' ' ARG . 0.7 OUTLIER -60.16 -26.81 66.6 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 119.029 -2.294 . . . . 38.090000000000003 108.627 177.282 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 1131 ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' 1134 ' ' ALA . 61.9 m -84.92 -56.34 3.62 Favored 'General case' 0 C--O 1.216 -0.677 0 O-C-N 120.928 -1.107 . . . . 36.909999999999997 110.441 168.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1132 ' ' SER . . . . . 0.489 ' O ' ' HB3' ' A' 1135 ' ' ASN . 13.8 m -73.17 -43.72 61.04 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 116.854 2.168 . . . . 35.789999999999999 116.854 -168.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1133 ' ' MET . . . . . 0.891 ' HA ' HD12 ' A' 1136 ' ' ILE . 53.1 mtp -57.55 -45.45 85.08 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 122.463 1.125 . . . . 30.809999999999999 113.103 169.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1134 ' ' ALA . . . . . 0.978 ' HB1' ' HB2' ' A' 1176 ' ' ALA . . . -57.03 -39.17 74.27 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 112.91 -1.95 . . . . 28.879999999999999 111.144 170.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1135 ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' 1132 ' ' SER . 1.6 t30 -58.54 -51.59 69.25 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 120.389 -1.444 . . . . 40.759999999999998 113.743 175.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1136 ' ' ILE . . . . . 0.891 HD12 ' HA ' ' A' 1133 ' ' MET . 14.6 mt -52.34 -46.68 46.35 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 CA-C-O 118.163 -0.923 . . . . 31.539999999999999 108.977 172.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1137 ' ' ALA . . . . . 0.731 ' HB2' ' HG3' ' A' 1316 ' ' PRO . . . -67.02 -27.11 67.14 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 124.925 1.29 . . . . 29.870000000000001 113.6 176.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -74.61 -44.2 27.11 Favored Glycine 0 C--N 1.313 -0.713 0 O-C-N 120.865 -1.147 . . . . 28.73 110.812 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 16.1 t80 -61.85 -46.34 89.88 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.206 -1.173 . . . . 30.390000000000001 108.506 171.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1140 ' ' ARG . . . . . 0.679 ' HD3' ' HB2' ' A' 1319 ' ' LEU . 5.6 tpt180 -63.33 -29.75 71.0 Favored 'General case' 0 CA--C 1.493 -1.229 0 O-C-N 121.339 -0.851 . . . . 26.09 112.427 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1141 ' ' ALA . . . . . . . . . . . . . . . -63.29 -43.68 97.19 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 119.905 -1.747 . . . . 27.100000000000001 110.674 173.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 47.1 mm -54.3 -45.64 68.3 Favored 'Isoleucine or valine' 0 C--N 1.347 0.488 0 O-C-N 120.693 -1.255 . . . . 28.48 111.77 168.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 25.1 t -62.38 -55.26 25.1 Favored 'Isoleucine or valine' 0 C--O 1.252 1.223 0 CA-C-O 115.88 -2.01 . . . . 23.07 114.243 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1144 ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -70.19 -22.36 62.95 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 123.563 2.892 . . . . 33.399999999999999 110.159 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1145 ' ' ALA . . . . . 0.737 ' HA ' HG11 ' A' 1280 ' ' VAL . . . -63.61 -56.33 16.71 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 119.458 -0.897 . . . . 24.219999999999999 109.708 167.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -59.28 -21.33 59.49 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-O 117.871 -1.061 . . . . 24.890000000000001 112.496 174.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1147 ' ' HIS . . . . . 0.419 ' HA ' ' CG1' ' B' 1143 ' ' VAL . 49.2 t-80 -66.35 -41.51 89.44 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 120.59 1.541 . . . . 26.73 111.691 169.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1148 ' ' GLU . . . . . 0.799 ' HB3' ' HD2' ' A' 1308 ' ' LYS . 77.6 mm-40 -105.98 -2.62 22.63 Favored 'General case' 0 C--O 1.252 1.207 0 N-CA-C 114.991 1.478 . . . . 39.960000000000001 114.991 -176.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1149 ' ' PHE . . . . . . . . . . . . . 1.3 t80 -70.18 149.03 47.95 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 116.167 -0.469 . . . . 25.870000000000001 111.546 -178.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1150 ' ' GLY . . . . . 0.614 ' HA2' ' HG2' ' B' 1320 ' ' PRO . . . -75.71 -49.9 8.51 Favored Glycine 0 N--CA 1.43 -1.702 0 CA-C-N 114.479 -1.237 . . . . 19.280000000000001 113.616 172.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1151 ' ' ARG . . . . . 0.489 ' HG3' ' HB ' ' B' 1321 ' ' THR . 29.1 mtm-85 -97.94 170.68 8.78 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-O 123.308 1.527 . . . . 39.899999999999999 113.865 -168.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1152 ' ' PHE . . . . . 0.491 ' HA ' ' CZ ' ' B' 1139 ' ' TYR . 0.3 OUTLIER -72.97 142.63 47.79 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.46 -0.941 . . . . 29.440000000000001 108.46 166.011 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 1153 ' ' PHE . . . . . 0.428 ' HD1' ' OH ' ' B' 1139 ' ' TYR . 25.0 m-85 -58.03 -46.87 84.63 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 114.528 1.307 . . . . 32.600000000000001 114.528 168.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1154 ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -72.29 145.92 47.53 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 125.068 1.347 . . . . 34.640000000000001 109.215 -178.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -77.88 65.99 3.15 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 119.214 -2.179 . . . . 37.140000000000001 108.272 169.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -92.1 136.38 33.22 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 107.772 -1.196 . . . . 40.57 107.772 -167.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1157 ' ' ILE . . . . . 0.462 HG12 ' HB3' ' C' ' 95' ' ' GLU . 3.8 tp -96.16 135.58 29.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 105.075 -2.194 . . . . 44.609999999999999 105.075 163.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1158 ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.65 -123.72 0.1 Allowed 'General case' 0 C--O 1.242 0.696 0 CA-C-O 117.171 -1.395 . . . . 40.700000000000003 112.435 173.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -84.18 -45.71 12.65 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 122.034 2.197 . . . . 40.25 106.94 160.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -126.13 153.53 44.42 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 113.261 -1.791 . . . . 38.469999999999999 107.704 170.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1161 ' ' GLY . . . . . 0.683 ' HA3' ' HA ' ' B' 1326 ' ' LEU . . . 87.26 103.95 0.85 Allowed Glycine 0 CA--C 1.496 -1.099 0 C-N-CA 119.632 -1.27 . . . . 37.609999999999999 113.559 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1162 ' ' LYS . . . . . 0.428 ' HG3' ' CD ' ' C' ' 95' ' ' GLU . 1.5 tmtp? -102.53 122.05 43.58 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 126.642 2.025 . . . . 48.899999999999999 106.026 171.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1163 ' ' VAL . . . . . . . . . . . . . 45.8 t -82.0 133.67 51.0 Favored Pre-proline 0 C--O 1.247 0.943 0 CA-C-O 117.451 -1.262 . . . . 36.520000000000003 109.438 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1164 ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -73.3 109.49 2.85 Favored 'Trans proline' 0 N--CA 1.43 -2.248 0 CA-C-N 124.326 2.581 . . . . 35.079999999999998 109.739 160.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1165 ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -50.96 161.74 1.34 Allowed 'Trans proline' 0 N--CA 1.483 0.865 1 C-N-CA 125.957 4.438 . . . . 35.329999999999998 118.696 -169.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -74.54 122.04 22.48 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.863 -1.162 . . . . 34.689999999999998 107.863 -176.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1167 ' ' LYS . . . . . 0.426 ' HB2' ' HA ' ' A' 1249 ' ' VAL . 76.6 mttt -88.2 104.99 17.23 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-O 124.007 1.86 . . . . 45.359999999999999 106.628 166.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 58.7 t -94.58 89.99 2.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 113.681 -1.6 . . . . 31.710000000000001 108.259 -175.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1169 ' ' MET . . . . . 0.482 ' SD ' ' HB3' ' A' 1245 ' ' GLN . 5.6 ttp -77.9 92.1 4.24 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 113.407 -1.724 . . . . 42.280000000000001 111.828 177.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 81.0 t -88.79 112.5 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 106.146 -1.798 . . . . 30.510000000000002 106.146 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 57.7 mt -98.24 123.1 50.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 109.631 -0.507 . . . . 31.870000000000001 109.631 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1172 ' ' GLY . . . . . 0.444 ' HA3' ' HB2' ' A' 1256 ' ' ALA . . . 77.13 81.58 0.6 Allowed Glycine 0 N--CA 1.436 -1.346 0 CA-C-O 122.77 1.206 . . . . 34.539999999999999 113.716 -178.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1173 ' ' ALA . . . . . 0.446 ' HA ' ' HA3' ' A' 1177 ' ' GLY . . . -82.07 80.05 8.42 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 111.773 -2.214 . . . . 32.509999999999998 109.212 -172.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -85.09 -157.0 27.14 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 108.056 -2.018 . . . . 29.899999999999999 108.056 163.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1175 ' ' VAL . . . . . . . . . . . . . 67.2 t -74.02 -26.9 21.54 Favored 'Isoleucine or valine' 0 C--O 1.259 1.598 0 CA-C-N 120.378 2.089 . . . . 33.109999999999999 108.765 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1176 ' ' ALA . . . . . 0.978 ' HB2' ' HB1' ' A' 1134 ' ' ALA . . . -50.22 -47.27 54.95 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.596 0.712 . . . . 28.100000000000001 112.623 162.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1177 ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' A' 1173 ' ' ALA . . . -61.25 -52.21 53.18 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 113.475 -1.693 . . . . 28.539999999999999 110.115 176.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1178 ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' 1181 ' ' ILE . 94.3 mt -53.14 -43.89 67.33 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 118.923 1.361 . . . . 31.219999999999999 113.177 178.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -66.47 -34.75 78.62 Favored 'General case' 0 C--O 1.245 0.822 0 O-C-N 118.088 -2.883 . . . . 28.98 114.115 174.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -65.62 -45.74 81.96 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.069 0.85 . . . . 27.829999999999998 109.498 176.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1181 ' ' ILE . . . . . 0.562 ' HA ' HG11 ' A' 1191 ' ' VAL . 55.6 mt -59.33 -52.68 58.04 Favored 'Isoleucine or valine' 0 C--N 1.349 0.561 0 C-N-CA 124.571 1.148 . . . . 30.25 109.89 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -51.67 -54.88 22.85 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 125.735 1.636 . . . . 29.59 110.53 176.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -65.26 -43.23 91.94 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 114.176 1.176 . . . . 30.289999999999999 114.176 -175.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -68.96 -43.56 74.76 Favored 'General case' 0 N--CA 1.425 -1.699 0 C-N-CA 123.771 0.828 . . . . 30.469999999999999 109.404 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -64.76 -35.61 81.63 Favored 'General case' 0 C--O 1.243 0.755 0 O-C-N 120.693 -1.254 . . . . 42.409999999999997 109.376 173.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1186 ' ' SER . . . . . 1.075 ' HB3' ' HA ' ' B' 1187 ' ' LEU . 72.9 m -60.25 -36.95 78.95 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 121.509 1.959 . . . . 39.380000000000003 112.354 169.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 89.4 mt -82.18 18.68 1.33 Allowed 'General case' 0 C--O 1.244 0.791 0 CA-C-N 120.361 1.437 . . . . 36.18 114.001 169.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 78.93 2.35 86.46 Favored Glycine 0 N--CA 1.47 0.952 0 CA-C-N 119.876 1.217 . . . . 33.780000000000001 115.003 170.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -73.34 151.14 41.38 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 124.106 0.962 . . . . 33.93 113.009 -175.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 18.5 mt -86.36 101.67 10.89 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 N-CA-C 103.153 -2.906 . . . . 38.740000000000002 103.153 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1191 ' ' VAL . . . . . 0.562 HG11 ' HA ' ' A' 1181 ' ' ILE . 3.0 t -86.99 127.78 40.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 112.921 -1.945 . . . . 33.090000000000003 107.231 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1192 ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -119.85 107.33 13.02 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 106.761 -1.57 . . . . 38.920000000000002 106.761 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -108.39 121.75 45.57 Favored 'General case' 0 C--O 1.248 0.982 0 O-C-N 120.626 -1.297 . . . . 35.32 109.571 -174.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 75.5 t80 -93.85 147.73 22.8 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 105.517 -2.031 . . . . 39.350000000000001 105.517 169.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 7.2 t70 -149.29 157.41 43.32 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 105.874 -1.899 . . . . 40.460000000000001 105.874 154.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1196 ' ' THR . . . . . . . . . . . . . 2.7 m -67.08 -43.39 82.71 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 104.962 -2.236 . . . . 45.939999999999998 104.962 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1197 ' ' ARG . . . . . . . . . . . . . 72.4 mtm180 -72.48 116.69 52.06 Favored Pre-proline 0 N--CA 1.453 -0.322 0 O-C-N 120.966 -1.084 . . . . 56.020000000000003 111.721 -175.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1198 ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -62.05 -26.94 78.78 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 125.244 3.963 . . . . 51.270000000000003 116.826 175.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -54.23 -34.65 61.18 Favored 'General case' 0 C--O 1.248 1.023 0 CA-C-N 114.557 -1.201 . . . . 59.100000000000001 112.598 -176.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 34.6 m -75.35 -10.7 13.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 117.23 2.307 . . . . 51.060000000000002 117.23 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 83.3 tttt -51.2 -46.21 62.1 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 124.709 1.204 . . . . 57.380000000000003 111.852 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -72.99 -29.79 63.31 Favored 'General case' 0 CA--C 1.512 -0.482 0 O-C-N 120.472 -1.393 . . . . 62.409999999999997 109.845 -173.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -66.3 -42.46 88.27 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.294 -1.373 . . . . 57.780000000000001 107.294 173.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1204 ' ' VAL . . . . . 0.61 HG13 ' HB3' ' A' 1209 ' ' ALA . 5.3 t -60.93 -50.23 81.41 Favored 'Isoleucine or valine' 0 C--N 1.344 0.357 0 C-N-CA 124.928 1.291 . . . . 46.380000000000003 109.141 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -56.54 -44.59 81.02 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 114.421 1.267 . . . . 50.700000000000003 114.421 173.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1206 ' ' SER . . . . . . . . . . . . . 48.7 m -58.44 -34.91 71.34 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.028 1.492 . . . . 49.979999999999997 115.028 174.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1207 ' ' MET . . . . . . . . . . . . . 61.4 mtp -92.54 11.02 27.83 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 119.759 -1.838 . . . . 52.990000000000002 111.08 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 78.28 51.19 5.81 Favored Glycine 0 CA--C 1.549 2.218 0 CA-C-O 124.39 2.106 . . . . 47.659999999999997 111.481 168.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1209 ' ' ALA . . . . . 0.61 ' HB3' HG13 ' A' 1204 ' ' VAL . . . -129.67 143.3 50.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 113.059 -1.57 . . . . 44.770000000000003 114.19 171.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -69.84 132.5 46.12 Favored 'General case' 0 C--N 1.347 0.468 0 N-CA-C 105.957 -1.868 . . . . 47.640000000000001 105.957 167.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1211 ' ' PHE . . . . . 0.526 ' HD1' HG11 ' A' 1204 ' ' VAL . 26.5 t80 -86.76 134.32 33.58 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 104.739 -2.319 . . . . 45.659999999999997 104.739 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 51.7 mt -84.93 109.09 17.9 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 123.719 1.724 . . . . 46.060000000000002 108.41 165.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -79.32 145.23 33.57 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 113.703 -1.589 . . . . 60.219999999999999 109.414 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 9.2 tp -79.94 85.36 5.57 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 124.369 2.033 . . . . 57.25 108.953 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1215 ' ' ASP . . . . . 0.644 ' H ' HD21 ' A' 1241 ' ' LEU . 12.3 t70 -76.71 111.89 12.71 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 110.978 -2.828 . . . . 64.430000000000007 104.696 -176.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1216 ' ' PHE . . . . . 0.642 ' HE1' ' HB1' ' A' 1233 ' ' ALA . 33.4 t80 . . . . . 0 CA--C 1.516 -0.362 0 N-CA-C 107.765 -1.198 . . . . 66.900000000000006 107.765 -175.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 2.2 p-10 . . . . . 0 N--CA 1.446 -0.663 0 CA-C-O 120.954 0.407 . . . . 39.090000000000003 110.978 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -42.26 -57.07 3.81 Favored Glycine 0 C--O 1.208 -1.492 0 O-C-N 126.427 2.329 . . . . 39.32 113.912 175.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 79.0 t80 -60.9 -47.89 84.34 Favored 'General case' 0 N--CA 1.44 -0.955 0 O-C-N 120.98 -1.306 . . . . 39.299999999999997 110.739 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -63.07 -35.98 82.05 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 120.645 -1.284 . . . . 36.299999999999997 114.42 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -65.4 -59.83 3.61 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 117.695 -1.145 . . . . 37.380000000000003 110.476 176.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -54.23 -47.78 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 121.065 1.757 . . . . 39.109999999999999 114.047 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1230 ' ' MET . . . . . . . . . . . . . 20.3 mmt -90.21 68.61 7.06 Favored 'General case' 0 C--O 1.247 0.933 0 CA-C-O 123.094 1.426 . . . . 49.590000000000003 112.708 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1231 ' ' SER . . . . . . . . . . . . . 1.9 p -142.43 132.69 24.79 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.222 -1.399 . . . . 43.68 107.222 165.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -49.08 -42.37 38.6 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 116.426 2.01 . . . . 55.57 116.426 -172.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1233 ' ' ALA . . . . . 0.642 ' HB1' ' HE1' ' A' 1216 ' ' PHE . . . -59.57 -39.02 82.72 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 119.109 0.868 . . . . 44.939999999999998 113.158 174.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -55.0 -60.59 3.16 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 114.435 1.272 . . . . 42.039999999999999 114.435 170.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 59.3 mt -57.89 -42.41 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 124.425 2.059 . . . . 46.280000000000001 109.854 -176.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 45.2 tttm -50.86 -53.12 35.07 Favored 'General case' 0 C--O 1.25 1.095 0 CA-C-N 113.289 -1.778 . . . . 47.869999999999997 114.15 166.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -63.47 -33.41 75.51 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 120.419 1.463 . . . . 41.609999999999999 110.703 -176.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -55.13 -59.66 4.46 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 124.883 1.273 . . . . 50.649999999999999 107.708 169.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1239 ' ' MET . . . . . . . . . . . . . 32.7 mtm -56.31 -31.69 63.93 Favored 'General case' 0 C--O 1.238 0.498 0 O-C-N 120.135 -1.603 . . . . 48.869999999999997 113.368 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -64.54 -39.72 94.28 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 112.166 0.432 . . . . 54.799999999999997 112.166 175.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1241 ' ' LEU . . . . . 0.644 HD21 ' H ' ' A' 1215 ' ' ASP . 1.6 mm? -65.6 -46.24 80.12 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 120.598 -1.314 . . . . 43.210000000000001 108.738 177.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -64.0 -34.38 77.86 Favored 'General case' 0 CA--C 1.508 -0.666 0 O-C-N 126.922 2.639 . . . . 38.659999999999997 112.635 -168.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -59.19 -54.12 50.54 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 120.403 1.456 . . . . 37.920000000000002 113.394 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -67.23 -42.94 83.18 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 119.803 1.183 . . . . 37.280000000000001 110.242 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1245 ' ' GLN . . . . . 0.482 ' HB3' ' SD ' ' A' 1169 ' ' MET . 96.7 mm-40 -54.19 -40.97 68.07 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 121.383 -0.823 . . . . 43.07 112.297 177.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -55.49 -37.08 67.37 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.076 0.95 . . . . 38.299999999999997 112.172 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1247 ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' A' 1276 ' ' LYS . 12.8 ttmm -54.9 -35.93 64.64 Favored 'General case' 0 C--O 1.258 1.517 0 C-N-CA 125.115 1.366 . . . . 47.600000000000001 110.905 177.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -111.24 -20.29 12.37 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.477 1.288 . . . . 45.420000000000002 114.477 -175.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1249 ' ' VAL . . . . . 0.437 HG11 ' HB2' ' A' 1169 ' ' MET . 31.2 m -78.27 162.63 4.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 115.303 1.594 . . . . 36.259999999999998 115.303 -173.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1250 ' ' ASP . . . . . 0.581 ' O ' ' HB3' ' A' 1279 ' ' SER . 3.6 m-20 -109.42 -60.47 1.77 Allowed 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 115.076 -0.965 . . . . 33.039999999999999 111.381 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1251 ' ' ILE . . . . . 0.449 HD12 ' HB1' ' A' 1145 ' ' ALA . 36.1 mm -112.76 102.08 13.43 Favored 'Isoleucine or valine' 0 C--O 1.247 0.934 0 N-CA-C 105.709 -1.96 . . . . 31.399999999999999 105.709 -170.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1252 ' ' ILE . . . . . 0.436 ' HB ' HG12 ' A' 1281 ' ' ILE . 64.9 mt -80.63 117.15 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 104.354 -2.462 . . . . 29.420000000000002 104.354 167.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1253 ' ' VAL . . . . . 0.598 HG12 HG23 ' A' 1255 ' ' THR . 18.2 t -103.92 109.75 28.14 Favored 'Isoleucine or valine' 0 C--O 1.248 0.985 0 N-CA-C 100.694 -3.817 . . . . 30.370000000000001 100.694 175.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1254 ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.53 82.4 5.34 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 124.904 2.287 . . . . 35.719999999999999 110.65 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1255 ' ' THR . . . . . 0.742 HG22 HD13 ' A' 1284 ' ' LEU . 1.1 p -86.29 -16.95 35.93 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 112.09 -2.323 . . . . 36.0 115.112 -174.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1256 ' ' ALA . . . . . 0.444 ' HB2' ' HA3' ' A' 1172 ' ' GLY . . . -57.81 64.45 0.0 OUTLIER 'General case' 0 C--O 1.261 1.675 0 N-CA-C 116.927 2.195 . . . . 40.93 116.927 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 44.4 tp -83.67 101.14 11.32 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 124.356 2.027 . . . . 47.82 110.369 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 32.8 mm -82.51 120.99 77.87 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-N 111.883 -2.417 . . . . 52.700000000000003 108.24 173.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -72.79 148.7 46.81 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 124.887 3.724 . . . . 54.130000000000003 111.366 175.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 74.69 -88.8 0.74 Allowed Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.699 -0.96 . . . . 54.619999999999997 110.699 176.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 41.1 mttt -56.78 124.93 66.63 Favored Pre-proline 0 CA--C 1.55 0.946 0 O-C-N 121.288 -1.125 . . . . 55.740000000000002 108.194 173.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -57.76 135.31 68.4 Favored 'Trans proline' 0 CA--C 1.521 -0.142 0 C-N-CA 123.306 2.671 . . . . 51.149999999999999 109.483 177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1263 ' ' ALA . . . . . 0.557 ' HB1' ' ND2' ' A' 1291 ' ' ASN . . . -57.53 130.59 81.44 Favored Pre-proline 0 N--CA 1.482 1.14 0 O-C-N 124.049 0.843 . . . . 46.060000000000002 110.042 -178.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -60.01 143.74 99.54 Favored 'Trans proline' 0 C--O 1.242 0.679 0 C-N-CA 124.187 3.258 . . . . 41.079999999999998 117.17 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1265 ' ' LYS . . . . . 0.589 ' HD2' ' HA ' ' A' 1293 ' ' GLU . 69.7 mmtt -79.65 85.54 5.36 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-O 124.423 2.058 . . . . 47.420000000000002 106.684 177.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 74.0 mt -84.43 -42.17 15.9 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 109.378 -3.555 . . . . 39.219999999999999 108.848 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 4.0 mp -99.07 108.76 22.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.842 0 N-CA-C 102.242 -3.244 . . . . 42.5 102.242 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1268 ' ' THR . . . . . 0.531 ' O ' HG23 ' A' 1272 ' ' VAL . 27.1 p -80.2 163.23 24.2 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 113.931 -1.486 . . . . 37.840000000000003 114.31 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 59.2 mtt-85 -58.27 -39.72 79.98 Favored 'General case' 0 C--O 1.212 -0.921 0 CA-C-N 115.883 -0.599 . . . . 54.799999999999997 110.487 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -60.15 -53.72 54.33 Favored 'General case' 0 N--CA 1.426 -1.654 0 O-C-N 124.851 1.344 . . . . 54.359999999999999 109.443 174.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1271 ' ' MET . . . . . . . . . . . . . 42.1 ttm -58.04 -37.46 74.4 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.087 0.955 . . . . 39.520000000000003 113.423 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1272 ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' 1268 ' ' THR . 13.5 t -67.45 -48.48 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 108.72 -0.844 . . . . 38.25 108.72 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.89 -29.18 70.03 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.491 0.922 . . . . 40.770000000000003 113.491 175.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1274 ' ' SER . . . . . . . . . . . . . 28.6 m -73.94 -12.43 60.65 Favored 'General case' 0 C--O 1.256 1.395 0 O-C-N 120.863 -1.148 . . . . 36.579999999999998 113.81 173.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1275 ' ' MET . . . . . 0.475 ' SD ' HD11 ' A' 1281 ' ' ILE . 70.3 mtp -63.16 155.77 27.11 Favored 'General case' 0 C--O 1.245 0.854 0 O-C-N 119.084 -2.26 . . . . 36.75 113.601 -177.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1276 ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' 1247 ' ' LYS . 36.1 ttpt -61.21 133.52 56.03 Favored 'General case' 0 C--N 1.347 0.471 0 N-CA-C 106.596 -1.631 . . . . 46.109999999999999 106.596 171.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1277 ' ' ALA . . . . . . . . . . . . . . . -71.29 175.15 5.6 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 122.441 1.115 . . . . 33.520000000000003 112.978 -172.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 67.34 28.16 73.62 Favored Glycine 0 C--O 1.22 -0.76 0 O-C-N 120.907 -1.12 . . . . 31.27 111.932 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1279 ' ' SER . . . . . 0.581 ' HB3' ' O ' ' A' 1250 ' ' ASP . 50.4 m -125.75 170.2 11.81 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.389 -1.065 . . . . 32.950000000000003 112.097 -165.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1280 ' ' VAL . . . . . 0.737 HG11 ' HA ' ' A' 1145 ' ' ALA . 65.2 t -130.82 133.45 63.16 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 O-C-N 119.472 -2.017 . . . . 27.43 108.66 -167.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1281 ' ' ILE . . . . . 0.475 HD11 ' SD ' ' A' 1275 ' ' MET . 48.4 mt -110.98 100.75 11.41 Favored 'Isoleucine or valine' 0 C--O 1.251 1.179 0 N-CA-C 103.624 -2.732 . . . . 30.300000000000001 103.624 166.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1282 ' ' VAL . . . . . 0.483 HG23 ' HA ' ' A' 1253 ' ' VAL . 0.0 OUTLIER -91.64 97.82 7.67 Favored 'Isoleucine or valine' 0 C--O 1.249 1.065 0 N-CA-C 107.108 -1.441 . . . . 28.629999999999999 107.108 176.929 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 4.4 t70 -86.95 108.72 18.94 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 106.819 -1.549 . . . . 36.270000000000003 106.819 -173.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1284 ' ' LEU . . . . . 0.742 HD13 HG22 ' A' 1255 ' ' THR . 9.6 tt -80.14 -35.62 36.4 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.88 0.847 . . . . 38.57 109.207 171.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -63.57 -12.71 35.02 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.497 -0.774 . . . . 37.560000000000002 112.765 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . -41.04 -29.51 0.11 Allowed 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 117.011 2.226 . . . . 40.329999999999998 117.011 162.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -51.19 -40.55 58.91 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-O 117.978 -1.01 . . . . 56.850000000000001 110.8 171.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 48.4 t30 -141.45 96.25 2.95 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 118.976 0.807 . . . . 45.859999999999999 110.1 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 92.28 -59.8 2.64 Favored Glycine 0 C--N 1.348 1.196 0 O-C-N 120.305 -1.497 . . . . 40.310000000000002 112.607 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 81.63 128.93 1.03 Allowed Glycine 0 N--CA 1.471 0.975 0 CA-C-N 120.485 2.143 . . . . 38.890000000000001 114.053 -171.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1291 ' ' ASN . . . . . 0.557 ' ND2' ' HB1' ' A' 1263 ' ' ALA . 20.3 m120 -82.02 -22.51 36.43 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 116.311 1.967 . . . . 37.229999999999997 116.311 -170.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1292 ' ' CYS . . . . . 0.565 ' HB3' ' OG1' ' A' 1295 ' ' THR . 29.6 t -94.29 144.36 25.59 Favored 'General case' 0 C--O 1.252 1.228 0 N-CA-C 102.461 -3.163 . . . . 36.5 102.461 174.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1293 ' ' GLU . . . . . 0.589 ' HA ' ' HD2' ' A' 1265 ' ' LYS . 30.5 mt-10 -64.96 -51.46 61.69 Favored 'General case' 0 CA--C 1.56 1.336 0 CA-C-O 122.811 1.291 . . . . 43.32 107.868 172.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -54.78 -18.68 5.06 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 119.916 3.302 . . . . 41.32 119.916 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1295 ' ' THR . . . . . 0.565 ' OG1' ' HB3' ' A' 1292 ' ' CYS . 58.4 m -49.75 103.97 0.06 Allowed 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 122.423 1.106 . . . . 35.299999999999997 112.77 167.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 94.6 t -86.1 121.29 72.8 Favored Pre-proline 0 C--O 1.246 0.887 0 N-CA-C 100.913 -3.736 . . . . 34.840000000000003 100.913 164.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -65.49 125.09 13.82 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.855 2.37 . . . . 33.509999999999998 107.597 -176.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 93.42 -3.23 71.84 Favored Glycine 0 N--CA 1.433 -1.556 0 CA-C-O 117.777 -1.568 . . . . 32.189999999999998 113.699 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -130.46 172.28 12.06 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 123.656 3.728 . . . . 34.880000000000003 117.206 -177.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1300 ' ' ILE . . . . . 0.576 HG23 HG12 ' A' 1310 ' ' ILE . 59.3 mt -98.72 98.17 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 101.744 -3.428 . . . . 32.289999999999999 101.744 170.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1301 ' ' PHE . . . . . 0.533 ' HB3' ' HB ' ' A' 1309 ' ' VAL . 61.9 t80 -71.99 148.56 45.82 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 103.905 -2.628 . . . . 37.25 103.905 161.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1302 ' ' THR . . . . . 0.486 HG22 ' O ' ' A' 1303 ' ' THR . 86.4 m -132.46 141.67 48.92 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 105.644 -1.984 . . . . 35.560000000000002 105.644 169.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1303 ' ' THR . . . . . 0.486 ' O ' HG22 ' A' 1302 ' ' THR . 16.8 p -81.23 163.71 22.81 Favored 'General case' 0 N--CA 1.425 -1.693 0 C-N-CA 125.333 1.453 . . . . 36.399999999999999 109.795 168.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -55.84 -49.66 72.7 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 124.924 1.29 . . . . 52.32 109.568 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 39.4 p-10 -66.44 -19.56 65.83 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.854 1.057 . . . . 40.039999999999999 113.854 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 97.94 63.12 0.88 Allowed Glycine 0 N--CA 1.426 -2.025 0 CA-C-N 113.865 -1.516 . . . . 36.960000000000001 112.036 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1307 ' ' VAL . . . . . 0.462 HG11 ' SD ' ' A' 1275 ' ' MET . 45.6 t -118.18 114.5 45.38 Favored 'Isoleucine or valine' 0 C--O 1.251 1.158 0 N-CA-C 108.221 -1.029 . . . . 33.399999999999999 108.221 163.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1308 ' ' LYS . . . . . 0.799 ' HD2' ' HB3' ' A' 1148 ' ' GLU . 78.2 mttt -92.75 108.19 19.8 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.943 0.878 . . . . 42.909999999999997 112.686 -171.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1309 ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' 1301 ' ' PHE . 14.0 t -94.62 83.43 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 106.025 -1.842 . . . . 32.289999999999999 106.025 -174.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1310 ' ' ILE . . . . . 0.576 HG12 HG23 ' A' 1300 ' ' ILE . 47.8 mt -80.83 91.33 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.35 0 CA-C-N 110.737 -2.938 . . . . 30.989999999999998 108.648 -173.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1311 ' ' GLY . . . . . 0.408 ' HA3' HG23 ' A' 1295 ' ' THR . . . -87.47 71.17 2.7 Favored Glycine 0 CA--C 1.537 1.442 0 O-C-N 118.284 -2.76 . . . . 28.949999999999999 112.318 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1312 ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -90.63 93.9 9.46 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 118.815 -1.154 . . . . 31.690000000000001 112.529 -172.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1313 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.53 -36.81 62.18 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 112.985 -1.916 . . . . 34.170000000000002 109.756 172.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 29.1 p-10 -84.74 3.87 35.41 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 118.192 2.664 . . . . 36.859999999999999 118.192 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1315 ' ' LEU . . . . . . . . . . . . . 28.7 mt -37.11 -50.85 2.26 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 118.322 2.712 . . . . 34.850000000000001 118.322 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1316 ' ' PRO . . . . . 0.731 ' HG3' ' HB2' ' A' 1137 ' ' ALA . 82.5 Cg_exo -53.35 -46.82 31.1 Favored 'Trans proline' 0 C--N 1.355 0.9 0 CA-C-N 125.655 3.056 . . . . 29.149999999999999 112.791 171.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1317 ' ' GLY . . . . . 0.615 ' HA2' ' HG3' ' A' 1015 ' ' ARG . . . -63.41 -29.89 75.93 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 115.097 0.799 . . . . 27.289999999999999 115.097 -175.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1318 ' ' ARG . . . . . 0.479 ' HB3' ' NH2' ' A' 1140 ' ' ARG . 52.3 mtt-85 -65.88 -19.94 66.05 Favored 'General case' 0 C--O 1.255 1.376 0 O-C-N 126.348 1.852 . . . . 41.490000000000002 115.345 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1319 ' ' LEU . . . . . 0.679 ' HB2' ' HD3' ' A' 1140 ' ' ARG . 13.3 tp -118.2 72.09 9.23 Favored Pre-proline 0 N--CA 1.438 -1.031 0 N-CA-C 105.232 -2.136 . . . . 27.609999999999999 105.232 178.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1320 ' ' PRO . . . . . 0.823 ' HB3' ' HB ' ' A' 1014 ' ' THR . 38.3 Cg_endo -56.04 -53.82 4.91 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.571 2.847 . . . . 25.940000000000001 114.698 -164.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1321 ' ' THR . . . . . . . . . . . . . 1.8 m -67.64 -39.52 84.63 Favored 'General case' 0 CA--C 1.499 -0.995 0 O-C-N 119.485 -2.009 . . . . 25.010000000000002 110.41 -168.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1322 ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -68.77 -26.57 65.29 Favored 'General case' 0 CA--C 1.511 -0.519 0 O-C-N 118.19 -2.819 . . . . 29.390000000000001 110.838 176.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1323 ' ' SER . . . . . 0.767 ' HA ' HD13 ' A' 1136 ' ' ILE . 70.6 m -64.59 -53.11 52.9 Favored 'General case' 0 CA--C 1.501 -0.913 0 O-C-N 119.569 -1.957 . . . . 26.469999999999999 109.91 167.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1324 ' ' SER . . . . . . . . . . . . . 4.6 m -55.66 -27.5 50.28 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.96 0.886 . . . . 27.780000000000001 113.001 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -86.54 -51.68 6.03 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 118.319 -1.352 . . . . 37.530000000000001 110.81 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1326 ' ' LEU . . . . . 0.407 ' HB2' HD11 ' A' 1136 ' ' ILE . 92.9 mt -79.94 -52.2 8.15 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 118.182 -0.913 . . . . 35.710000000000001 111.261 -172.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1327 ' ' TYR . . . . . 0.46 ' OH ' ' HA ' ' A' 1091 ' ' SER . 66.8 t80 -57.47 -43.39 84.02 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.799 0.809 . . . . 31.59 110.99 170.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1328 ' ' GLY . . . . . 0.564 ' HA2' HD12 ' A' 1331 ' ' LEU . . . -49.72 -50.11 32.4 Favored Glycine 0 N--CA 1.468 0.798 0 CA-C-O 118.149 -1.362 . . . . 28.0 110.816 171.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1329 ' ' THR . . . . . . . . . . . . . 52.4 m -72.5 -27.7 62.43 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 118.76 -1.176 . . . . 32.149999999999999 112.484 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1330 ' ' ASN . . . . . . . . . . . . . 28.5 m120 -60.1 -43.73 95.34 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 118.007 -2.933 . . . . 34.359999999999999 108.957 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1331 ' ' LEU . . . . . 0.674 HD22 HD22 ' A' 1070 ' ' LEU . 27.7 mt -59.79 -48.8 80.21 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 112.774 -2.012 . . . . 33.369999999999997 108.027 177.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1332 ' ' VAL . . . . . 0.497 HG12 ' HE3' ' A' 1336 ' ' LYS . 77.5 t -54.0 -47.75 64.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 C-N-CA 124.712 1.205 . . . . 35.270000000000003 111.682 175.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1333 ' ' ASN . . . . . 0.424 ' HA ' ' HD2' ' A' 1336 ' ' LYS . 82.9 m-20 -61.3 -34.09 74.65 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 115.343 1.608 . . . . 37.659999999999997 115.343 -177.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1334 ' ' LEU . . . . . 0.639 HD22 ' SD ' ' A' 1115 ' ' MET . 44.2 tp -72.09 -47.3 52.39 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 106.35 -1.722 . . . . 40.270000000000003 106.35 173.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1335 ' ' LEU . . . . . 0.615 ' HA ' ' HB2' ' A' 1338 ' ' LEU . 20.2 mt -64.94 -21.05 66.76 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 115.512 1.671 . . . . 42.5 115.512 -176.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1336 ' ' LYS . . . . . 0.497 ' HE3' HG12 ' A' 1332 ' ' VAL . 94.4 mttt -56.33 -42.93 78.46 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 119.617 -1.927 . . . . 47.810000000000002 112.145 164.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1337 ' ' LEU . . . . . 0.636 HD13 HD11 ' A' 1355 ' ' ILE . 96.0 mt -79.01 -33.69 44.68 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.044 -0.98 . . . . 49.270000000000003 111.318 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1338 ' ' LEU . . . . . 0.615 ' HB2' ' HA ' ' A' 1335 ' ' LEU . 8.3 mp -65.86 -37.52 86.39 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 114.075 1.139 . . . . 50.539999999999999 114.075 174.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1339 ' ' CYS . . . . . . . . . . . . . 27.0 m -116.73 87.19 2.64 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 124.301 2.001 . . . . 53.670000000000002 112.538 169.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1340 ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' 1337 ' ' LEU . 96.7 mttt -76.46 -52.8 9.13 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 112.2 -2.273 . . . . 63.380000000000003 108.954 -176.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -74.61 -44.87 48.56 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-O 122.707 1.241 . . . . 70.950000000000003 110.837 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1342 ' ' LYS . . . . . 0.478 ' HE3' ' HA ' ' A' 1029 ' ' LEU . 2.8 mtpt 61.41 90.44 0.07 Allowed 'General case' 0 C--O 1.214 -0.766 0 C-N-CA 126.122 1.769 . . . . 65.25 113.336 -173.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1343 ' ' ASP . . . . . 0.4 ' HB3' ' N ' ' A' 1342 ' ' LYS . 24.8 t70 70.27 160.75 0.21 Allowed 'General case' 0 C--O 1.247 0.928 2 O-C-N 111.146 -7.221 . . . . 64.530000000000001 115.526 -6.082 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 1344 ' ' GLY . . . . . . . . . . . . . . . -140.61 2.18 2.18 Favored Glycine 0 N--CA 1.433 -1.501 0 CA-C-O 122.267 0.926 . . . . 59.719999999999999 112.013 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 10.2 t30 -80.03 85.59 5.61 Favored 'General case' 0 C--O 1.247 0.933 0 O-C-N 119.218 -2.342 . . . . 64.090000000000003 106.88 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1346 ' ' ILE . . . . . 0.441 ' H ' HG13 ' A' 1346 ' ' ILE . 1.2 pp -54.26 117.18 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 109.877 -3.329 . . . . 58.82 111.176 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1347 ' ' THR . . . . . . . . . . . . . 4.0 m -78.47 96.04 5.29 Favored 'General case' 0 C--N 1.348 0.52 0 N-CA-C 103.779 -2.674 . . . . 54.960000000000001 103.779 -177.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1348 ' ' VAL . . . . . 0.652 HG21 HG21 ' A' 1111 ' ' THR . 3.5 t -75.96 85.27 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 N-CA-C 104.511 -2.403 . . . . 55.640000000000001 104.511 170.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 33.4 t70 -73.39 150.6 41.63 Favored 'General case' 0 C--O 1.254 1.296 0 CA-C-N 112.065 -2.334 . . . . 61.450000000000003 112.805 -169.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1350 ' ' PHE . . . . . 0.434 ' O ' ' HB2' ' A' 1356 ' ' ARG . 49.8 m-85 -111.79 -30.16 7.41 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 113.12 -1.855 . . . . 58.630000000000003 108.527 171.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -69.58 -23.47 63.55 Favored 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 120.381 -1.449 . . . . 62.060000000000002 114.21 -159.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 10.1 t70 -91.53 136.66 32.96 Favored 'General case' 0 C--O 1.253 1.254 0 N-CA-C 106.429 -1.693 . . . . 54.07 106.429 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 4.6 m -50.42 -41.47 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 123.671 0.788 . . . . 50.68 112.151 177.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1354 ' ' VAL . . . . . 0.525 ' O ' HG23 ' A' 1358 ' ' VAL . 15.2 m -71.83 -41.74 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 C-N-CA 117.137 -1.825 . . . . 47.68 109.143 -175.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1355 ' ' ILE . . . . . 0.636 HD11 HD13 ' A' 1337 ' ' LEU . 26.6 mt -74.13 -29.05 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 120.167 -0.613 . . . . 48.490000000000002 111.697 -176.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1356 ' ' ARG . . . . . 0.471 ' HA ' ' HD2' ' A' 1356 ' ' ARG . 32.6 tpt85 -60.96 -24.75 66.32 Favored 'General case' 0 C--O 1.248 0.983 0 O-C-N 120.047 -1.658 . . . . 48.270000000000003 112.352 170.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1357 ' ' GLY . . . . . 0.409 ' HA3' ' HD3' ' A' 1119 ' ' PRO . . . -82.97 -32.58 26.05 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-O 123.839 1.8 . . . . 43.530000000000001 110.945 175.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1358 ' ' VAL . . . . . 0.676 HG22 HG22 ' A' 1118 ' ' VAL . 21.7 t -76.1 -46.04 34.87 Favored 'Isoleucine or valine' 0 C--O 1.256 1.433 0 O-C-N 121.636 -0.92 . . . . 45.119999999999997 108.701 -176.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1359 ' ' THR . . . . . . . . . . . . . 22.1 m -64.82 84.83 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 123.788 1.756 . . . . 42.939999999999998 110.474 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1360 ' ' VAL . . . . . 0.404 HG11 ' HG2' ' A' 1095 ' ' PRO . 27.2 m -92.22 -34.95 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 114.828 -1.078 . . . . 43.259999999999998 111.883 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1361 ' ' ILE . . . . . 0.417 ' HB ' ' HB ' ' A' 1112 ' ' VAL . 79.6 mt -130.86 109.54 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 106.308 -1.738 . . . . 45.659999999999997 106.308 171.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1362 ' ' ARG . . . . . 0.549 ' HA ' HG23 ' A' 1111 ' ' THR . 61.0 ttt180 -94.82 121.58 36.57 Favored 'General case' 0 C--O 1.207 -1.134 0 O-C-N 118.258 -2.776 . . . . 61.340000000000003 107.826 169.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 45.25 61.15 2.68 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.184 1.179 . . . . 49.759999999999998 114.184 166.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1364 ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' 1109 ' ' ASN . . . 88.3 -47.52 3.5 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 114.016 -1.447 . . . . 50.0 112.042 -178.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -77.83 130.8 37.12 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 118.12 0.96 . . . . 56.920000000000002 109.293 -173.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1366 ' ' ILE . . . . . . . . . . . . . 31.2 mt -81.34 93.88 2.4 Favored 'Isoleucine or valine' 0 C--O 1.249 1.053 0 N-CA-C 105.02 -2.215 . . . . 52.780000000000001 105.02 177.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1367 ' ' THR . . . . . . . . . . . . . 26.0 p -72.12 -9.91 59.07 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 112.832 -1.985 . . . . 49.439999999999998 113.836 176.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 1.4 t90 -65.28 143.96 98.89 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 106.615 -1.624 . . . . 52.380000000000003 106.615 164.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -67.93 167.7 61.82 Favored 'Cis proline' 0 C--O 1.244 0.82 0 CA-C-N 124.811 2.754 . . . . 46.939999999999998 118.616 2.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -111.3 121.71 39.63 Favored Pre-proline 0 N--CA 1.437 -1.086 0 N-CA-C 106.076 -1.824 . . . . 45.909999999999997 106.076 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1371 ' ' PRO . . . . . 0.441 ' HD2' ' HG3' ' A' 1356 ' ' ARG . 17.5 Cg_exo -51.05 139.52 42.02 Favored 'Trans proline' 0 C--O 1.247 0.959 0 C-N-CA 123.67 2.913 . . . . 46.390000000000001 110.379 174.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -57.44 -31.09 90.33 Favored 'Trans proline' 0 N--CA 1.44 -1.621 0 C-N-CA 124.761 3.641 . . . . 46.719999999999999 112.719 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.231 -4.556 0 O-C-N 119.731 -1.856 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.441 -0.893 0 CA-C-O 117.6 -1.191 . . . . 63.439999999999998 110.644 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -79.68 55.6 2.05 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 123.652 2.933 . . . . 51.740000000000002 111.034 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1000 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.84 125.34 28.61 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 124.488 1.115 . . . . 54.07 111.407 -172.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 65.76 17.77 65.37 Favored Glycine 0 CA--C 1.531 1.079 0 O-C-N 121.688 -0.633 . . . . 39.219999999999999 112.7 -169.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1002 ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' B' 1066 ' ' SER . 13.7 ttp180 -90.19 118.66 29.88 Favored 'General case' 0 C--O 1.211 -0.939 0 CA-C-N 120.327 2.063 . . . . 38.119999999999997 111.381 177.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1003 ' ' ILE . . . . . 0.52 HD13 HD11 ' B' 1070 ' ' LEU . 21.8 mt -75.63 150.04 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 112.25 -2.25 . . . . 29.699999999999999 110.36 169.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -123.36 118.39 3.51 Favored Glycine 0 C--O 1.241 0.582 0 N-CA-C 110.472 -1.051 . . . . 27.5 110.472 165.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1005 ' ' ILE . . . . . 0.525 HG23 ' HB3' ' B' 1017 ' ' ALA . 23.3 mm -97.55 116.81 65.86 Favored Pre-proline 0 CA--C 1.558 1.278 0 N-CA-C 105.915 -1.883 . . . . 24.829999999999998 105.915 173.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -86.81 162.7 9.1 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.709 2.94 . . . . 27.190000000000001 112.446 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1007 ' ' ARG . . . . . 0.53 ' HG3' ' HB3' ' B' 1036 ' ' GLU . 19.7 mtp180 -77.59 101.3 6.48 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 102.028 -3.323 . . . . 41.460000000000001 102.028 163.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1008 ' ' GLU . . . . . 0.611 ' HG3' ' HB ' ' B' 1072 ' ' VAL . 3.2 mm-40 -58.71 140.62 54.5 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-O 122.369 1.081 . . . . 26.93 113.663 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 43.0 mmm-85 -86.89 -25.46 24.43 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.226 -1.352 . . . . 34.479999999999997 109.787 -162.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1010 ' ' LEU . . . . . 0.446 ' HB3' ' HB2' ' B' 1013 ' ' GLU . 4.8 tp -59.42 155.64 14.52 Favored 'General case' 0 C--O 1.25 1.093 0 N-CA-C 115.175 1.546 . . . . 44.219999999999999 115.175 -157.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1011 ' ' THR . . . . . . . . . . . . . 28.7 m -61.17 120.06 9.6 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.885 -0.598 . . . . 40.740000000000002 111.155 174.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 67.37 41.53 2.42 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 123.523 1.63 . . . . 44.439999999999998 112.151 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1013 ' ' GLU . . . . . 0.446 ' HB2' ' HB3' ' B' 1010 ' ' LEU . 8.5 tp10 -102.16 128.4 48.68 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.596 -1.184 . . . . 29.870000000000001 111.687 -175.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1014 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.01 -11.35 7.09 Favored 'General case' 0 C--O 1.247 0.934 0 O-C-N 125.456 1.723 . . . . 25.260000000000002 110.286 176.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -76.97 98.32 4.9 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 120.174 -1.579 . . . . 29.539999999999999 112.633 -175.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1016 ' ' VAL . . . . . 0.989 ' HB ' ' HB2' ' B' 1043 ' ' ALA . 44.0 t -96.56 141.95 14.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 105.02 -2.215 . . . . 23.550000000000001 105.02 168.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1017 ' ' ALA . . . . . 0.525 ' HB3' HG23 ' B' 1005 ' ' ILE . . . -62.42 -39.32 92.93 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 118.307 2.706 . . . . 23.59 118.307 -155.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1018 ' ' ALA . . . . . . . . . . . . . . . -128.12 149.95 50.19 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 119.255 -2.153 . . . . 24.93 111.76 -168.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1019 ' ' THR . . . . . 0.409 ' O ' HG23 ' B' 1023 ' ' VAL . 13.2 p -84.9 166.16 33.33 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-O 117.361 -1.304 . . . . 28.09 111.101 165.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1020 ' ' PRO . . . . . 0.471 ' HB3' ' HB2' ' B' 1053 ' ' ALA . 41.0 Cg_exo -55.02 -39.75 89.35 Favored 'Trans proline' 0 CA--C 1.549 1.241 0 C-N-CA 123.163 2.576 . . . . 28.789999999999999 112.838 165.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 70.7 tttt -57.49 -49.1 77.38 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 120.17 -1.581 . . . . 47.280000000000001 111.144 175.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1022 ' ' THR . . . . . . . . . . . . . 11.8 p -73.64 -27.33 61.2 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 117.068 -1.444 . . . . 30.120000000000001 110.275 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1023 ' ' VAL . . . . . 0.438 HG11 ' HB2' ' B' 1055 ' ' ALA . 46.0 t -53.2 -50.32 47.1 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 CA-C-N 120.624 1.556 . . . . 32.240000000000002 108.638 165.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1024 ' ' GLU . . . . . 0.462 ' HA ' HD12 ' B' 1027 ' ' LEU . 48.6 mt-10 -63.4 -35.61 80.99 Favored 'General case' 0 CA--C 1.511 -0.553 0 O-C-N 120.42 -1.425 . . . . 49.619999999999997 113.038 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -63.74 -43.23 97.08 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.438 -0.789 . . . . 44.68 109.849 172.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1026 ' ' LEU . . . . . 0.584 ' HG ' HG22 ' B' 1332 ' ' VAL . 19.2 mt -63.79 -35.41 80.49 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 115.651 1.722 . . . . 35.710000000000001 115.651 176.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1027 ' ' LEU . . . . . 0.462 HD12 ' HA ' ' B' 1024 ' ' GLU . 68.1 mt -62.4 -45.2 94.19 Favored 'General case' 0 C--O 1.237 0.445 0 O-C-N 124.254 0.971 . . . . 42.18 109.937 170.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 62.9 mttm -61.12 -30.06 70.15 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.205 1.187 . . . . 48.340000000000003 114.205 172.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1029 ' ' LEU . . . . . 0.446 HD12 HD23 ' B' 1026 ' ' LEU . 85.6 mt -69.27 -30.98 69.21 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-O 122.978 1.37 . . . . 38.689999999999998 112.832 165.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 113.34 31.6 2.36 Favored Glycine 0 N--CA 1.465 0.576 0 O-C-N 118.518 -2.614 . . . . 32.280000000000001 108.749 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -126.64 112.7 15.78 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 120.551 -1.558 . . . . 35.939999999999998 109.158 -177.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1032 ' ' THR . . . . . . . . . . . . . 15.0 m -71.5 137.55 48.25 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 106.942 -1.503 . . . . 33.369999999999997 106.942 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1033 ' ' VAL . . . . . 0.428 ' HB ' HG13 ' B' 1023 ' ' VAL . 61.0 t -106.17 119.47 55.6 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 CA-C-N 120.272 1.396 . . . . 29.98 112.774 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -96.07 140.31 30.98 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 106.802 -1.555 . . . . 28.18 106.802 169.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1035 ' ' VAL . . . . . 0.59 ' HB ' HD13 ' B' 1057 ' ' ILE . 39.8 t -133.36 140.56 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 119.02 -2.3 . . . . 25.82 105.923 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1036 ' ' GLU . . . . . 0.53 ' HB3' ' HG3' ' B' 1007 ' ' ARG . 10.5 mt-10 -65.63 142.51 58.03 Favored 'General case' 0 C--O 1.247 0.971 0 O-C-N 121.004 -1.06 . . . . 32.439999999999998 112.956 175.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1037 ' ' SER . . . . . 0.411 ' O ' ' HD2' ' B' 1007 ' ' ARG . 24.0 m -59.15 124.35 19.68 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 121.587 -0.695 . . . . 29.539999999999999 111.268 170.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 93.65 -18.08 57.24 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.04 -0.824 . . . . 27.760000000000002 111.04 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1039 ' ' ALA . . . . . . . . . . . . . . . -66.48 -40.4 89.3 Favored 'General case' 0 C--O 1.243 0.759 0 O-C-N 120.778 -1.425 . . . . 26.02 111.495 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -56.09 -51.36 56.22 Favored Glycine 0 CA--C 1.5 -0.891 0 N-CA-C 110.077 -1.209 . . . . 26.469999999999999 110.077 171.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -58.42 -29.49 66.15 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 120.661 -1.494 . . . . 50.979999999999997 113.033 173.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 65.0 mt -70.55 -48.27 56.26 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 123.045 2.657 . . . . 29.300000000000001 110.631 176.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1043 ' ' ALA . . . . . 0.989 ' HB2' ' HB ' ' B' 1016 ' ' VAL . . . -63.68 -17.96 63.49 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 114.928 -1.033 . . . . 26.739999999999998 111.834 174.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1044 ' ' SER . . . . . . . . . . . . . 29.0 m 69.11 47.47 0.74 Allowed 'General case' 0 C--N 1.352 0.694 0 CA-C-O 127.408 3.48 . . . . 31.260000000000002 109.813 175.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1045 ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -146.9 105.25 3.78 Favored 'General case' 0 N--CA 1.442 -0.866 1 N-CA-C 97.413 -5.032 . . . . 33.259999999999998 97.413 171.464 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 26.7 t0 -57.46 146.86 28.19 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 123.614 1.673 . . . . 46.740000000000002 115.465 -164.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -49.4 -43.17 44.12 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 110.803 -2.908 . . . . 34.439999999999998 110.091 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1048 ' ' LYS . . . . . 0.405 ' O ' ' HB ' ' B' 1051 ' ' VAL . 1.1 mptm? -66.14 -28.52 68.86 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.228 -0.92 . . . . 48.670000000000002 113.218 177.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -66.4 -32.29 73.58 Favored 'General case' 0 C--O 1.246 0.889 0 O-C-N 120.618 -1.301 . . . . 35.259999999999998 111.272 167.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1050 ' ' PHE . . . . . 0.631 ' HB2' HD11 ' B' 1057 ' ' ILE . 77.6 m-85 -70.98 -33.46 70.45 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 119.334 0.97 . . . . 32.170000000000002 109.005 170.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1051 ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' B' 1048 ' ' LYS . 76.7 t -58.98 -40.19 79.98 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 O-C-N 119.706 -1.871 . . . . 38.369999999999997 112.726 170.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -61.16 -38.94 88.26 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-O 118.427 -0.797 . . . . 45.770000000000003 112.19 171.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1053 ' ' ALA . . . . . 0.471 ' HB2' ' HB3' ' B' 1020 ' ' PRO . . . -68.15 -22.92 64.83 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 124.281 0.988 . . . . 37.829999999999998 113.064 172.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 76.34 59.04 3.44 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 109.782 -1.327 . . . . 35.82 109.782 -175.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1055 ' ' ALA . . . . . 0.438 ' HB2' HG11 ' B' 1023 ' ' VAL . . . -109.99 140.63 43.78 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 122.186 0.993 . . . . 33.770000000000003 108.49 166.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -78.34 96.51 5.33 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 118.207 -2.808 . . . . 51.020000000000003 108.887 -175.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1057 ' ' ILE . . . . . 0.631 HD11 ' HB2' ' B' 1050 ' ' PHE . 34.4 mm -72.97 110.13 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 106.712 -1.588 . . . . 38.469999999999999 106.712 176.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1058 ' ' VAL . . . . . 0.677 ' HB ' ' HB2' ' B' 1062 ' ' SER . 2.9 m -127.1 143.78 39.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 112.195 -2.275 . . . . 39.399999999999999 110.988 -174.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -77.44 124.16 27.52 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 122.181 0.991 . . . . 57.07 110.454 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . 50.3 -107.78 0.4 Allowed Glycine 0 CA--C 1.497 -1.074 0 N-CA-C 117.423 1.729 . . . . 44.829999999999998 117.423 164.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -63.73 -27.85 69.48 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.911 0.862 . . . . 46.270000000000003 111.934 -164.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1062 ' ' SER . . . . . 0.677 ' HB2' ' HB ' ' B' 1058 ' ' VAL . 3.1 m -55.48 -39.96 71.07 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 113.848 -1.524 . . . . 43.469999999999999 111.822 175.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.71 -27.13 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 O-C-N 119.992 -1.692 . . . . 36.979999999999997 113.645 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 96.5 m95 -71.42 -27.49 63.33 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 124.042 1.877 . . . . 37.899999999999999 111.993 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -79.12 80.24 5.48 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 118.744 -2.473 . . . . 46.189999999999998 108.869 176.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1066 ' ' SER . . . . . 0.45 ' HB3' ' O ' ' B' 1002 ' ' ARG . 72.9 m -156.39 165.05 37.46 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.093 -0.958 . . . . 37.060000000000002 109.786 -172.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1067 ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' 1068 ' ' ILE . 0.5 OUTLIER -81.31 -39.15 25.62 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 114.504 -1.225 . . . . 43.950000000000003 109.236 -178.683 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B 1068 ' ' ILE . . . . . 0.409 HD12 ' HB3' ' B' 1067 ' ' GLU . 4.1 mp -123.93 140.45 47.34 Favored 'Isoleucine or valine' 0 C--O 1.251 1.142 0 N-CA-C 104.034 -2.58 . . . . 33.5 104.034 -179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 43.8 mm -112.31 135.65 51.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 N-CA-C 103.599 -2.741 . . . . 30.57 103.599 165.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1070 ' ' LEU . . . . . 0.552 HD13 HD13 ' B' 1331 ' ' LEU . 84.9 mt -114.27 75.67 0.94 Allowed 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 121.391 1.905 . . . . 27.66 105.913 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1071 ' ' LYS . . . . . . . . . . . . . 4.6 mttm -73.34 152.93 40.72 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 124.371 1.068 . . . . 28.399999999999999 111.656 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1072 ' ' VAL . . . . . 0.611 ' HB ' ' HG3' ' B' 1008 ' ' GLU . 15.6 t -94.01 -31.93 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-O 118.967 -0.539 . . . . 23.18 110.729 176.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -111.85 -167.84 1.23 Allowed 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 124.242 1.017 . . . . 25.469999999999999 111.303 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -71.38 162.36 73.21 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 119.166 0.894 . . . . 27.899999999999999 111.902 165.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1075 ' ' PRO . . . . . 0.412 ' O ' HD11 ' B' 1101 ' ' LEU . 38.2 Cg_endo -76.8 143.77 23.89 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.605 2.203 . . . . 31.620000000000001 113.727 164.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 31.9 mt -88.86 178.14 6.51 Favored 'General case' 0 CA--C 1.555 1.166 0 O-C-N 120.916 -1.115 . . . . 40.490000000000002 109.305 170.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 28.3 t70 -62.16 -31.68 72.2 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 122.418 2.372 . . . . 51.590000000000003 114.691 -172.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -68.7 -39.58 80.43 Favored 'General case' 0 N--CA 1.439 -0.991 0 O-C-N 120.844 -1.16 . . . . 42.359999999999999 112.112 175.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1079 ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -69.58 -35.95 75.83 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.985 -1.007 . . . . 34.530000000000001 109.049 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1080 ' ' ILE . . . . . 0.538 ' HA ' HD12 ' B' 1083 ' ' LEU . 86.5 mt -59.49 -45.28 93.92 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 C-N-CA 124.447 1.099 . . . . 33.25 110.78 171.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -61.23 -39.6 90.9 Favored 'General case' 0 C--O 1.251 1.166 0 N-CA-C 113.095 0.776 . . . . 36.469999999999999 113.095 173.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1082 ' ' LEU . . . . . . . . . . . . . 51.7 mt -67.25 -34.04 76.6 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 115.365 1.616 . . . . 37.759999999999998 115.365 173.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1083 ' ' LEU . . . . . 0.85 HD21 HD13 ' B' 1089 ' ' LEU . 16.6 mt -56.74 112.01 1.18 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 123.467 1.603 . . . . 37.43 111.045 175.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -69.67 136.07 88.07 Favored Pre-proline 0 C--O 1.219 -0.509 0 CA-C-N 111.754 -2.476 . . . . 37.700000000000003 113.267 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -51.69 109.92 0.37 Allowed 'Trans proline' 0 C--O 1.246 0.896 0 C-N-CA 124.383 3.389 . . . . 35.509999999999998 116.982 171.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 101.72 3.83 52.36 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 113.726 -1.579 . . . . 33.869999999999997 115.253 -172.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1087 ' ' THR . . . . . . . . . . . . . 52.0 m -74.23 127.72 33.69 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-N 119.523 1.661 . . . . 32.5 109.266 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1088 ' ' THR . . . . . 0.549 ' HA ' ' HB ' ' B' 1111 ' ' THR . 1.2 m -62.87 101.23 0.25 Allowed 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 105.312 -2.107 . . . . 30.219999999999999 105.312 170.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1089 ' ' LEU . . . . . 0.85 HD13 HD21 ' B' 1083 ' ' LEU . 43.3 tp -96.85 109.69 22.34 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 104.719 -2.326 . . . . 27.239999999999998 104.719 -176.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1090 ' ' VAL . . . . . 0.533 HG22 ' HB2' ' B' 1113 ' ' MET . 70.3 t -94.05 123.51 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 105.835 -1.913 . . . . 25.390000000000001 105.835 169.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1091 ' ' SER . . . . . . . . . . . . . 58.0 m -156.15 164.62 38.16 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 123.613 1.673 . . . . 28.809999999999999 110.544 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1092 ' ' PHE . . . . . . . . . . . . . 10.8 t80 -93.12 95.85 9.68 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 101.557 -3.498 . . . . 30.780000000000001 101.557 174.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 37.3 mm -83.43 -52.77 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-O 117.349 -1.31 . . . . 30.280000000000001 113.036 -172.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1094 ' ' TRP . . . . . 0.508 ' HB3' ' HB2' ' B' 1097 ' ' GLN . 20.9 m95 52.96 75.9 0.59 Allowed Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 118.631 0.65 . . . . 34.07 109.657 -154.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -57.15 -49.51 13.92 Favored 'Trans proline' 0 CA--C 1.511 -0.638 1 C-N-CA 125.707 4.271 . . . . 38.659999999999997 113.502 -171.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -71.52 -14.38 62.09 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 118.643 0.656 . . . . 41.32 111.302 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1097 ' ' GLN . . . . . 0.508 ' HB2' ' HB3' ' B' 1094 ' ' TRP . 15.3 mp0 -103.86 -4.89 22.92 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.794 1.238 . . . . 51.659999999999997 109.59 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1098 ' ' ASN . . . . . 0.445 ' N ' ' HD3' ' B' 1099 ' ' PRO . 57.8 m-80 -137.53 62.65 37.34 Favored Pre-proline 0 C--O 1.24 0.573 0 O-C-N 120.456 -1.402 . . . . 40.32 109.087 167.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1099 ' ' PRO . . . . . 0.445 ' HD3' ' N ' ' B' 1098 ' ' ASN . 52.2 Cg_exo -63.07 -45.94 11.46 Favored 'Trans proline' 0 CA--C 1.536 0.604 1 C-N-CA 128.191 5.927 . . . . 41.560000000000002 113.92 -171.881 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B 1100 ' ' GLU . . . . . 0.495 ' H ' ' CD ' ' B' 1100 ' ' GLU . 0.6 OUTLIER -66.14 -38.86 89.17 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 123.945 0.898 . . . . 54.109999999999999 108.84 176.663 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B 1101 ' ' LEU . . . . . 0.44 ' O ' ' HG ' ' B' 1105 ' ' LEU . 6.3 tt -60.31 -48.76 80.35 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.727 0.775 . . . . 37.880000000000003 109.006 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1102 ' ' MET . . . . . . . . . . . . . 62.1 mmm -53.44 -45.14 69.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.086 -0.961 . . . . 37.539999999999999 112.994 171.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -62.6 -33.1 74.31 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.92 1.082 . . . . 47.009999999999998 113.92 175.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1104 ' ' LYS . . . . . 0.403 ' HB3' HG21 ' B' 1080 ' ' ILE . 82.0 mttt -73.02 -32.07 64.88 Favored 'General case' 0 C--O 1.213 -0.827 0 O-C-N 119.994 -1.691 . . . . 48.68 111.539 173.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1105 ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' B' 1101 ' ' LEU . 66.6 mt -66.11 -34.51 78.23 Favored 'General case' 0 C--O 1.256 1.447 0 O-C-N 121.609 -0.682 . . . . 32.210000000000001 110.244 174.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -61.18 -46.89 88.64 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 123.209 0.604 . . . . 33.729999999999997 111.541 168.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -58.22 -47.75 82.53 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 125.783 2.706 . . . . 51.469999999999999 117.016 174.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1108 ' ' ARG . . . . . . . . . . . . . 31.6 mmm180 -69.17 -10.54 58.2 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 112.728 -2.033 . . . . 43.899999999999999 111.218 171.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1109 ' ' ASN . . . . . 0.409 ' HA ' ' CA ' ' B' 1364 ' ' GLY . 0.6 OUTLIER 59.19 42.82 18.02 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 123.504 1.621 . . . . 44.82 111.586 170.84 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B 1110 ' ' VAL . . . . . 0.432 HG11 ' HB3' ' B' 1083 ' ' LEU . 12.4 m -93.32 149.89 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 115.032 -0.986 . . . . 30.52 109.124 -177.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1111 ' ' THR . . . . . 0.549 ' HB ' ' HA ' ' B' 1088 ' ' THR . 88.5 m -86.33 92.39 8.79 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.963 -0.754 . . . . 27.120000000000001 108.963 177.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1112 ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' B' 1089 ' ' LEU . 4.1 t -94.99 124.88 47.68 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 120.297 1.408 . . . . 26.399999999999999 110.781 -168.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1113 ' ' MET . . . . . 0.533 ' HB2' HG22 ' B' 1090 ' ' VAL . 1.3 mpt? -102.33 115.7 31.11 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 124.388 2.042 . . . . 42.920000000000002 107.932 163.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -93.75 106.93 18.87 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 120.55 -1.344 . . . . 24.149999999999999 110.216 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1115 ' ' MET . . . . . 0.517 ' HB3' ' HB2' ' B' 1129 ' ' ALA . 14.2 mmm -63.94 -11.14 25.64 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 117.303 2.334 . . . . 29.949999999999999 117.303 -176.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1116 ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -84.81 -41.86 15.69 Favored 'General case' 0 C--O 1.218 -0.58 0 C-N-CA 123.721 0.809 . . . . 34.530000000000001 109.323 169.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1117 ' ' SER . . . . . . . . . . . . . 25.0 m -91.45 37.49 0.95 Allowed 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 120.066 -1.646 . . . . 33.490000000000002 109.666 -173.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1118 ' ' VAL . . . . . 0.749 HG12 ' HB1' ' B' 1124 ' ' ALA . 1.8 t -78.38 147.67 72.59 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 103.988 -2.597 . . . . 34.020000000000003 103.988 166.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 1.6 Cg_exo -58.13 165.56 6.87 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.971 2.447 . . . . 38.280000000000001 114.192 169.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1120 ' ' ARG . . . . . 0.718 ' HB2' HG21 ' B' 1375 ' ' VAL . 5.0 mmp_? -92.27 -0.07 57.42 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 120.924 -1.11 . . . . 55.049999999999997 112.186 -178.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1121 ' ' ILE . . . . . 0.722 HG22 ' HB1' ' C' ' 131' ' ' ALA . 30.3 pt -68.76 141.82 16.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 119.964 1.256 . . . . 42.090000000000003 108.65 175.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1122 ' ' SER . . . . . 0.68 ' HB2' ' HA ' ' C' ' 133' ' ' MET . 5.0 m -58.73 -28.45 65.86 Favored 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 116.982 2.216 . . . . 38.020000000000003 116.982 -158.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1123 ' ' ARG . . . . . 0.621 ' HG3' HG21 ' B' 1354 ' ' VAL . 19.4 ptt-85 -66.45 -39.59 88.94 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 121.359 1.891 . . . . 34.289999999999999 107.849 174.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1124 ' ' ALA . . . . . 0.749 ' HB1' HG12 ' B' 1118 ' ' VAL . . . -68.03 -38.44 82.53 Favored 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 106.764 -1.569 . . . . 32.350000000000001 106.764 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1125 ' ' GLN . . . . . 0.622 ' NE2' ' HB3' ' B' 1131 ' ' SER . 17.9 mm100 -51.15 -38.97 55.15 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 118.197 2.666 . . . . 47.170000000000002 118.197 170.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1126 ' ' SER . . . . . . . . . . . . . 3.9 p -69.18 -19.68 63.99 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 122.107 0.956 . . . . 31.710000000000001 113.549 175.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1127 ' ' LEU . . . . . 0.739 ' HG ' ' HA ' ' B' 1334 ' ' LEU . 5.2 mp -90.26 -36.06 14.94 Favored 'General case' 0 C--N 1.347 0.48 0 N-CA-C 107.911 -1.144 . . . . 37.0 107.911 173.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1128 ' ' ASP . . . . . 0.506 ' HB3' ' HA ' ' B' 1125 ' ' GLN . 4.6 t70 -62.88 130.08 43.27 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 125.958 1.703 . . . . 40.399999999999999 115.107 -164.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1129 ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' B' 1115 ' ' MET . . . -72.14 -36.93 69.49 Favored 'General case' 0 C--O 1.255 1.393 0 N-CA-C 106.713 -1.588 . . . . 26.559999999999999 106.713 -176.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 56.9 mt -59.83 -24.63 64.35 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 121.191 1.814 . . . . 30.890000000000001 112.494 -172.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1131 ' ' SER . . . . . 0.622 ' HB3' ' NE2' ' B' 1125 ' ' GLN . 93.9 p -69.23 -60.48 2.32 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 106.035 -1.839 . . . . 29.84 106.035 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1132 ' ' SER . . . . . 0.557 ' O ' HG12 ' B' 1136 ' ' ILE . 16.0 m -62.64 -34.86 77.91 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 115.438 1.644 . . . . 31.91 115.438 -178.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1133 ' ' MET . . . . . . . . . . . . . 35.3 mmt -72.68 -36.53 67.91 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.872 0.844 . . . . 25.899999999999999 111.596 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1134 ' ' ALA . . . . . 0.851 ' HB1' ' HB2' ' B' 1176 ' ' ALA . . . -60.84 -39.44 89.08 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 115.259 -0.882 . . . . 26.620000000000001 109.959 167.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -60.37 -50.09 74.98 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 117.782 -1.104 . . . . 36.969999999999999 113.738 173.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1136 ' ' ILE . . . . . 0.557 HG12 ' O ' ' B' 1132 ' ' SER . 16.4 mm -53.48 -52.02 36.49 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 O-C-N 124.686 1.241 . . . . 32.109999999999999 108.416 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1137 ' ' ALA . . . . . 0.45 ' HB2' ' HG3' ' B' 1316 ' ' PRO . . . -61.87 -35.88 79.6 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 114.132 1.16 . . . . 24.140000000000001 114.132 176.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -71.53 -41.55 57.47 Favored Glycine 0 CA--C 1.503 -0.713 0 N-CA-C 109.262 -1.535 . . . . 25.129999999999999 109.262 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1139 ' ' TYR . . . . . 0.698 ' HD2' HD21 ' B' 1319 ' ' LEU . 17.8 t80 -61.74 -55.6 28.54 Favored 'General case' 0 C--O 1.211 -0.958 0 O-C-N 120.928 -1.337 . . . . 32.729999999999997 109.689 169.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1140 ' ' ARG . . . . . 0.464 ' HA ' ' HB ' ' B' 1143 ' ' VAL . 18.3 tpt180 -59.36 -25.18 64.01 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 119.15 0.886 . . . . 26.359999999999999 111.75 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1141 ' ' ALA . . . . . 0.663 ' HA ' HG11 ' B' 1282 ' ' VAL . . . -62.91 -55.65 24.2 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.466 1.106 . . . . 24.120000000000001 109.971 170.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 21.4 mm -57.94 -40.7 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 107.839 -1.171 . . . . 23.370000000000001 107.839 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1143 ' ' VAL . . . . . 0.464 ' HB ' ' HA ' ' B' 1140 ' ' ARG . 19.4 t -59.29 -66.49 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.662 0 CA-C-O 117.8 -1.095 . . . . 24.960000000000001 112.356 177.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -61.1 -33.2 72.97 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.518 1.127 . . . . 32.07 112.09 -175.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1145 ' ' ALA . . . . . 0.659 ' HA ' HG11 ' B' 1280 ' ' VAL . . . -60.54 -59.37 5.5 Favored 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 106.386 -1.709 . . . . 24.870000000000001 106.386 174.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1146 ' ' ALA . . . . . 0.463 ' HB2' ' HE1' ' B' 1153 ' ' PHE . . . -58.27 -33.64 69.62 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 120.577 1.535 . . . . 24.670000000000002 111.727 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1147 ' ' HIS . . . . . 0.413 ' O ' ' NH2' ' A' 1140 ' ' ARG . 73.8 t60 -59.72 -44.63 93.65 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.052 1.341 . . . . 28.579999999999998 111.282 174.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1148 ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -96.8 -6.81 35.22 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 122.614 1.197 . . . . 36.82 113.933 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1149 ' ' PHE . . . . . 0.525 ' CZ ' ' HB3' ' B' 1250 ' ' ASP . 1.0 OUTLIER -76.26 148.84 37.32 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 113.235 -1.802 . . . . 31.969999999999999 110.263 -176.65 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B 1150 ' ' GLY . . . . . 0.408 ' HA2' ' HD2' ' A' 1320 ' ' PRO . . . -92.73 -19.34 37.72 Favored Glycine 0 N--CA 1.427 -1.964 0 CA-C-N 113.474 -1.694 . . . . 25.489999999999998 115.42 173.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1151 ' ' ARG . . . . . . . . . . . . . 86.5 mtm-85 -121.17 177.22 5.23 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 119.738 1.769 . . . . 59.840000000000003 110.97 -169.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1152 ' ' PHE . . . . . 0.574 ' HB2' HG11 ' B' 1163 ' ' VAL . 15.7 m-30 -84.99 155.04 21.75 Favored 'General case' 0 C--N 1.352 0.691 0 CA-C-N 121.544 1.975 . . . . 34.450000000000003 108.857 175.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1153 ' ' PHE . . . . . 0.463 ' HE1' ' HB2' ' B' 1146 ' ' ALA . 33.0 m-85 -74.93 -46.82 33.22 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.529 -1.214 . . . . 31.170000000000002 109.794 164.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1154 ' ' THR . . . . . . . . . . . . . 22.4 m -71.58 122.64 20.87 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 113.379 -1.737 . . . . 33.890000000000001 109.362 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1155 ' ' GLY . . . . . 0.681 ' HA3' ' HG3' ' B' 1165 ' ' PRO . . . -75.18 103.47 1.59 Allowed Glycine 0 C--O 1.269 2.287 0 N-CA-C 106.837 -2.505 . . . . 38.950000000000003 106.837 172.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1156 ' ' GLN . . . . . 0.685 ' H ' ' HB ' ' B' 1163 ' ' VAL . 49.5 tt0 -112.09 112.39 23.97 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 105.638 -1.986 . . . . 54.229999999999997 105.638 -169.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1157 ' ' ILE . . . . . 0.854 HG23 ' HG2' ' B' 1162 ' ' LYS . 29.6 mm -81.53 96.88 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 102.954 -2.98 . . . . 51.159999999999997 102.954 172.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1158 ' ' THR . . . . . . . . . . . . . 34.9 m -95.13 153.93 17.42 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 112.841 -1.981 . . . . 49.609999999999999 107.382 -163.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -36.95 -51.35 0.91 Allowed 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 116.64 2.089 . . . . 49.049999999999997 116.64 175.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -55.74 -56.15 23.83 Favored 'General case' 0 C--N 1.349 0.577 0 N-CA-C 114.833 1.42 . . . . 47.649999999999999 114.833 169.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . 177.53 -165.79 35.77 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 108.773 -1.731 . . . . 45.609999999999999 108.773 -175.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1162 ' ' LYS . . . . . 0.854 ' HG2' HG23 ' B' 1157 ' ' ILE . 89.3 mttt -95.49 149.46 21.38 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 122.38 1.086 . . . . 57.460000000000001 112.968 -166.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1163 ' ' VAL . . . . . 0.685 ' HB ' ' H ' ' B' 1156 ' ' GLN . 99.1 t -116.69 121.59 32.79 Favored Pre-proline 0 CA--C 1.499 -0.994 0 CA-C-N 113.067 -1.878 . . . . 42.93 106.279 166.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1164 ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' B' 1163 ' ' VAL . 36.5 Cg_endo -68.82 137.55 38.61 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.478 2.118 . . . . 39.289999999999999 109.66 168.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1165 ' ' PRO . . . . . 0.681 ' HG3' ' HA3' ' B' 1155 ' ' GLY . 64.2 Cg_exo -62.93 149.08 92.59 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.548 2.832 . . . . 34.170000000000002 113.193 -177.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -73.47 122.1 21.6 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 124.837 1.336 . . . . 31.690000000000001 109.11 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1167 ' ' LYS . . . . . 0.437 ' HD3' ' HB3' ' B' 1248 ' ' GLU . 80.4 mttt -79.59 104.05 9.92 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 105.63 -1.989 . . . . 44.780000000000001 105.63 171.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 62.0 t -102.02 99.59 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 N-CA-C 106.69 -1.596 . . . . 31.23 106.69 -170.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1169 ' ' MET . . . . . 0.499 ' HA ' ' O ' ' B' 1192 ' ' ARG . 30.2 ttp -82.29 112.2 19.06 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 119.419 -0.913 . . . . 37.090000000000003 109.132 178.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 60.0 t -104.03 107.21 21.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 N-CA-C 105.511 -2.033 . . . . 30.170000000000002 105.511 -177.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1171 ' ' ILE . . . . . . . . . . . . . 70.4 mt -97.49 127.17 50.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 108.222 -1.029 . . . . 33.740000000000002 108.222 -177.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 88.72 67.21 1.27 Allowed Glycine 0 C--N 1.318 -0.44 0 CA-C-O 124.502 2.168 . . . . 32.590000000000003 108.458 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1173 ' ' ALA . . . . . 0.681 ' HA ' ' HA3' ' B' 1177 ' ' GLY . . . -74.42 42.25 0.16 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 117.975 2.583 . . . . 32.420000000000002 117.975 178.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1174 ' ' GLY . . . . . 0.438 ' HA3' ' O3B' ' B' ' 1' ' ' NAD . . . -79.78 -155.26 10.03 Favored Glycine 0 CA--C 1.524 0.601 0 O-C-N 117.573 -3.204 . . . . 31.739999999999998 110.397 164.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 86.7 t -48.58 -50.8 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-N 120.762 2.281 . . . . 31.48 115.289 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1176 ' ' ALA . . . . . 0.851 ' HB2' ' HB1' ' B' 1134 ' ' ALA . . . -49.46 -50.83 39.42 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 123.591 1.663 . . . . 26.120000000000001 113.324 172.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1177 ' ' GLY . . . . . 0.681 ' HA3' ' HA ' ' B' 1173 ' ' ALA . . . -63.73 -49.79 66.16 Favored Glycine 0 C--O 1.211 -1.3 0 CA-C-N 112.748 -2.024 . . . . 25.73 110.765 -178.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1178 ' ' LEU . . . . . 0.421 HD23 HD12 ' B' 1181 ' ' ILE . 46.3 mt -56.59 -33.38 66.14 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 123.94 0.896 . . . . 32.590000000000003 112.718 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -62.34 -57.96 9.42 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.893 -1.049 . . . . 27.719999999999999 110.602 172.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -57.78 -39.78 78.29 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 114.137 1.162 . . . . 26.030000000000001 114.137 177.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1181 ' ' ILE . . . . . 0.72 HG22 ' SD ' ' B' 1207 ' ' MET . 96.4 mt -57.06 -45.84 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 108.413 -0.958 . . . . 28.609999999999999 108.413 172.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -55.25 -54.39 34.46 Favored Glycine 0 N--CA 1.465 0.583 0 N-CA-C 110.4 -1.08 . . . . 25.23 110.4 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -56.93 -61.42 2.45 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.276 1.213 . . . . 24.09 114.276 174.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -67.3 -35.73 80.06 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-O 119.178 -0.439 . . . . 26.68 111.504 -169.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -66.91 -45.32 78.28 Favored 'General case' 0 CA--C 1.502 -0.873 0 O-C-N 120.554 -1.341 . . . . 36.57 110.071 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1186 ' ' SER . . . . . . . . . . . . . 61.3 m -66.04 -32.31 73.71 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 119.923 -0.711 . . . . 28.920000000000002 112.823 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1187 ' ' LEU . . . . . 1.075 ' HA ' ' HB3' ' A' 1186 ' ' SER . 25.8 mt -57.87 -23.68 54.13 Favored 'General case' 0 C--O 1.247 0.941 0 N-CA-C 113.4 0.889 . . . . 29.09 113.4 165.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 89.68 20.91 42.04 Favored Glycine 0 CA--C 1.534 1.247 0 N-CA-C 108.593 -1.803 . . . . 29.260000000000002 108.593 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1189 ' ' ALA . . . . . . . . . . . . . . . -82.29 149.64 27.69 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 118.385 -0.817 . . . . 30.16 109.461 174.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 74.8 mt -80.51 90.93 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 120.094 1.315 . . . . 35.810000000000002 108.32 -176.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1191 ' ' VAL . . . . . 0.43 HG11 HG23 ' B' 1181 ' ' ILE . 67.1 t -77.3 109.24 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 105.421 -2.066 . . . . 31.969999999999999 105.421 -172.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1192 ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' B' 1169 ' ' MET . 47.5 mtt180 -101.21 85.58 2.84 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-O 123.776 1.75 . . . . 48.159999999999997 106.911 172.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1193 ' ' ALA . . . . . 0.787 ' HB3' HG11 ' B' 1204 ' ' VAL . . . -93.62 152.91 18.69 Favored 'General case' 0 C--O 1.259 1.598 0 CA-C-N 112.223 -2.262 . . . . 35.890000000000001 112.227 -171.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 87.7 t80 -144.75 148.72 34.45 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 124.567 2.127 . . . . 41.880000000000003 105.592 -176.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1195 ' ' ASP . . . . . 0.479 ' HB2' ' H ' ' B' 1173 ' ' ALA . 22.4 t0 -159.77 154.04 23.65 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 101.513 -3.514 . . . . 38.280000000000001 101.513 163.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1196 ' ' THR . . . . . . . . . . . . . 1.1 m -73.53 -27.16 61.2 Favored 'General case' 0 C--O 1.247 0.942 0 C-N-CA 119.654 -0.818 . . . . 40.619999999999997 111.469 -176.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1197 ' ' ARG . . . . . . . . . . . . . 22.9 mtm105 -73.41 103.37 0.79 Allowed Pre-proline 0 CA--C 1.565 1.542 0 O-C-N 121.079 -1.013 . . . . 53.090000000000003 108.832 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -56.34 -26.2 60.93 Favored 'Trans proline' 0 C--N 1.347 0.481 1 C-N-CA 125.775 4.316 . . . . 42.560000000000002 119.25 -162.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.91 -12.74 19.53 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 119.726 -1.859 . . . . 56.310000000000002 113.828 -177.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1200 ' ' VAL . . . . . 0.537 ' HA ' ' HG3' ' B' 1203 ' ' GLN . 23.3 m -57.98 -20.88 15.79 Favored 'Isoleucine or valine' 0 C--O 1.25 1.106 0 O-C-N 119.873 -1.767 . . . . 42.909999999999997 112.298 172.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1201 ' ' LYS . . . . . 0.467 ' HA ' ' HB2' ' B' 1211 ' ' PHE . 46.2 tttm -50.55 -55.9 14.1 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 122.901 0.48 . . . . 48.890000000000001 111.712 166.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1202 ' ' GLU . . . . . 0.572 ' HA ' ' HB2' ' B' 1205 ' ' GLN . 18.2 mp0 -70.07 -34.0 72.62 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 120.727 -1.233 . . . . 51.700000000000003 110.488 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1203 ' ' GLN . . . . . 0.589 ' OE1' ' HA ' ' C' ' 74' ' ' ARG . 13.6 mm100 -50.47 -52.09 41.24 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 120.999 -1.063 . . . . 52.57 111.815 176.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1204 ' ' VAL . . . . . 0.787 HG11 ' HB3' ' B' 1193 ' ' ALA . 18.6 m -73.42 -36.95 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 O-C-N 121.247 -0.908 . . . . 33.789999999999999 112.16 175.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1205 ' ' GLN . . . . . 0.572 ' HB2' ' HA ' ' B' 1202 ' ' GLU . 39.3 mt-30 -53.6 -39.63 65.03 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 114.957 1.465 . . . . 36.579999999999998 114.957 174.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1206 ' ' SER . . . . . . . . . . . . . 84.4 p -60.62 -45.84 92.51 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.45 -1.406 . . . . 39.609999999999999 109.096 175.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1207 ' ' MET . . . . . 0.72 ' SD ' HG22 ' B' 1181 ' ' ILE . 5.0 mtp -68.6 -18.14 64.26 Favored 'General case' 0 N--CA 1.44 -0.959 0 O-C-N 119.519 -1.988 . . . . 37.450000000000003 113.632 177.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 77.62 56.6 3.82 Favored Glycine 0 N--CA 1.475 1.238 0 N-CA-C 108.686 -1.766 . . . . 31.870000000000001 108.686 -172.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1209 ' ' ALA . . . . . 0.595 ' HB3' ' HB ' ' B' 1204 ' ' VAL . . . -139.87 159.52 41.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.886 1.274 . . . . 35.399999999999999 111.131 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -90.46 136.21 33.2 Favored 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 120.559 -1.338 . . . . 47.890000000000001 110.038 -165.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1211 ' ' PHE . . . . . 0.467 ' HB2' ' HA ' ' B' 1201 ' ' LYS . 29.1 t80 -86.94 141.7 28.53 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.743 -1.206 . . . . 45.530000000000001 107.743 167.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1212 ' ' LEU . . . . . 0.873 ' HB3' HD21 ' B' 1241 ' ' LEU . 32.2 mt -81.85 102.92 11.15 Favored 'General case' 0 N--CA 1.433 -1.32 0 O-C-N 121.396 -0.815 . . . . 46.329999999999998 111.02 167.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -83.51 124.48 30.78 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 103.864 -2.643 . . . . 60.409999999999997 103.864 -176.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1214 ' ' LEU . . . . . 0.459 ' H ' HD12 ' B' 1214 ' ' LEU . 4.6 mp -68.32 164.52 20.59 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 114.075 -1.42 . . . . 57.380000000000003 110.108 -177.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 28.0 t70 . . . . . 0 N--CA 1.444 -0.752 0 CA-C-O 116.326 -1.797 . . . . 65.069999999999993 107.083 168.932 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B 1230 ' ' MET . . . . . 0.677 ' N ' ' HG ' ' B' 1231 ' ' SER . 3.7 mmt . . . . . 0 N--CA 1.435 -1.217 0 N-CA-C 101.725 -3.435 . . . . 80.319999999999993 101.725 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1231 ' ' SER . . . . . 0.677 ' HG ' ' N ' ' B' 1230 ' ' MET 0.275 19.4 m 112.66 155.47 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 3 CA-C-N 130.408 6.003 . . . . 79.920000000000002 115.221 -9.924 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 28.6 t70 -43.12 140.24 1.55 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 116.203 1.927 . . . . 77.909999999999997 116.203 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 67.46 -54.38 0.48 Allowed 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 115.846 1.795 . . . . 73.879999999999995 115.846 -166.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1234 ' ' PHE . . . . . 0.435 ' HE2' HD22 ' B' 1214 ' ' LEU . 1.5 t80 -61.23 -21.68 64.09 Favored 'General case' 0 C--O 1.254 1.293 0 CA-C-N 120.096 1.316 . . . . 68.980000000000004 112.92 176.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 1.9 pp -42.05 -38.71 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 O-C-N 120.795 -1.191 . . . . 64.530000000000001 113.361 159.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -69.29 -29.26 67.09 Favored 'General case' 0 CA--C 1.501 -0.919 0 O-C-N 120.124 -1.61 . . . . 66.359999999999999 112.89 174.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -62.4 -31.11 71.74 Favored 'General case' 0 N--CA 1.438 -1.061 0 O-C-N 117.575 -3.203 . . . . 56.600000000000001 111.333 171.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1238 ' ' GLU . . . . . 0.475 ' O ' ' HB3' ' B' 1241 ' ' LEU . 39.0 mt-10 -68.97 -61.41 1.81 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.86 0.864 . . . . 56.789999999999999 111.289 170.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1239 ' ' MET . . . . . . . . . . . . . 14.4 mtt -59.01 -44.79 91.75 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 114.842 1.423 . . . . 53.630000000000003 114.842 -177.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -68.53 -35.38 77.37 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 120.497 1.499 . . . . 51.740000000000002 112.828 -176.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1241 ' ' LEU . . . . . 0.873 HD21 ' HB3' ' B' 1212 ' ' LEU . 46.3 tp -54.27 -49.18 70.14 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.983 -1.008 . . . . 44.859999999999999 110.856 166.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 13.0 m-30 -62.68 -38.59 90.99 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 114.096 1.147 . . . . 42.780000000000001 114.096 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -59.3 -41.47 89.08 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 114.685 -1.143 . . . . 40.960000000000001 110.935 170.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -77.55 -8.66 58.15 Favored 'General case' 0 C--O 1.249 1.049 0 O-C-N 120.385 -1.447 . . . . 43.060000000000002 112.361 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1245 ' ' GLN . . . . . 0.433 ' OE1' ' HD3' ' B' 1192 ' ' ARG . 92.6 mm-40 -82.23 -26.4 33.28 Favored 'General case' 0 C--O 1.207 -1.14 0 N-CA-C 114.407 1.262 . . . . 46.450000000000003 114.407 164.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -54.69 -38.18 66.7 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 118.941 2.941 . . . . 41.780000000000001 118.941 -167.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 11.9 mptt -68.97 -30.22 68.61 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 115.011 1.485 . . . . 52.200000000000003 115.011 174.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1248 ' ' GLU . . . . . 0.474 ' CD ' HH12 ' B' 1192 ' ' ARG . 33.5 mt-10 -85.09 -39.91 17.4 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 115.055 1.502 . . . . 53.549999999999997 115.055 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1249 ' ' VAL . . . . . . . . . . . . 0.266 18.4 m -68.94 135.4 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 124.165 1.936 . . . . 34.409999999999997 115.575 -163.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1250 ' ' ASP . . . . . 0.525 ' HB3' ' CZ ' ' B' 1149 ' ' PHE . 2.7 m-20 -97.57 -48.91 5.07 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 111.969 -2.378 . . . . 33.380000000000003 110.387 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1251 ' ' ILE . . . . . 0.631 HD12 ' HB1' ' B' 1145 ' ' ALA . 30.1 mm -128.23 126.3 65.77 Favored 'Isoleucine or valine' 0 C--O 1.248 0.988 0 N-CA-C 103.434 -2.802 . . . . 29.539999999999999 103.434 177.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1252 ' ' ILE . . . . . . . . . . . . . 53.6 mt -90.49 97.91 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 107.013 -1.477 . . . . 32.439999999999998 107.013 159.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1253 ' ' VAL . . . . . 0.676 HG12 HG23 ' B' 1255 ' ' THR . 4.0 t -83.99 93.05 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 103.181 -2.896 . . . . 30.57 103.181 175.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1254 ' ' THR . . . . . 0.698 HG23 ' HA ' ' B' 1283 ' ' ASP 0.353 8.8 t -90.42 84.63 6.01 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 124.207 1.956 . . . . 35.039999999999999 107.158 -178.027 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B 1255 ' ' THR . . . . . 0.676 HG23 HG12 ' B' 1253 ' ' VAL . 2.7 p -69.73 -16.5 63.33 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 110.927 -2.851 . . . . 34.619999999999997 114.305 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1256 ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' B' 1285 ' ' ALA . . . -57.46 82.84 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 124.172 0.989 . . . . 42.719999999999999 112.773 176.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 3.4 tt -90.82 85.5 6.04 Favored 'General case' 0 CA--C 1.54 0.562 1 N-CA-C 99.175 -4.379 . . . . 52.43 99.175 173.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 2.6 mp -55.5 125.54 60.26 Favored Pre-proline 0 C--N 1.353 0.759 0 O-C-N 120.996 -1.065 . . . . 59.409999999999997 111.144 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -57.31 110.45 0.61 Allowed 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 125.119 3.879 . . . . 62.68 111.928 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 77.73 -79.01 1.45 Allowed Glycine 0 CA--C 1.55 2.238 0 O-C-N 119.846 -1.784 . . . . 64.159999999999997 113.229 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 37.2 mttm -46.44 125.79 7.68 Favored Pre-proline 0 C--O 1.239 0.549 0 CA-C-O 116.535 -1.698 . . . . 68.530000000000001 113.667 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -55.16 120.93 9.0 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 124.027 3.151 . . . . 61.990000000000002 111.068 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1263 ' ' ALA . . . . . . . . . . . . . . . -48.73 122.78 11.19 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 117.402 2.371 . . . . 57.149999999999999 117.402 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -58.26 141.67 96.91 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 124.477 3.451 . . . . 51.57 111.903 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1265 ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' B' 1265 ' ' LYS . 35.2 mmtm -75.89 82.37 2.8 Favored 'General case' 0 C--O 1.21 -1.026 0 O-C-N 121.13 -0.981 . . . . 54.549999999999997 110.977 -178.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 49.7 mt -74.96 -56.34 4.84 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.352 -1.295 . . . . 46.859999999999999 109.567 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1267 ' ' ILE . . . . . 0.581 HG22 HG22 ' B' 1272 ' ' VAL . 32.1 mm -84.43 89.35 2.56 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 N-CA-C 103.655 -2.72 . . . . 41.039999999999999 103.655 -175.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1268 ' ' THR . . . . . 0.497 ' HA ' ' HG3' ' B' 1293 ' ' GLU . 1.1 p -80.63 160.09 25.17 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 113.001 -1.909 . . . . 39.579999999999998 112.286 -176.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1269 ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -53.31 -54.87 30.11 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 117.467 2.395 . . . . 53.149999999999999 117.467 -168.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -55.46 -40.35 71.51 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 125.1 1.5 . . . . 42.960000000000001 113.892 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1271 ' ' MET . . . . . 0.406 ' HB3' ' O ' ' B' 1268 ' ' THR . 41.6 ttm -56.89 -58.27 8.87 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 117.673 -1.156 . . . . 43.890000000000001 108.394 168.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1272 ' ' VAL . . . . . 0.581 HG22 HG22 ' B' 1267 ' ' ILE . 24.6 t -52.7 -59.83 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.808 0 CA-C-N 120.001 1.273 . . . . 38.369999999999997 111.877 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1273 ' ' ASP . . . . . . . . . . . . 0.265 1.2 m-20 -68.28 14.31 0.07 Allowed 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 120.358 3.466 . . . . 47.460000000000001 120.358 176.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1274 ' ' SER . . . . . . . . . . . . . 54.7 p -124.36 -2.28 8.04 Favored 'General case' 0 C--O 1.247 0.93 0 O-C-N 119.956 -1.715 . . . . 38.380000000000003 110.432 170.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1275 ' ' MET . . . . . 0.653 ' HB2' HG21 ' B' 1307 ' ' VAL . 40.6 mtp -63.88 162.99 12.69 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 114.093 1.145 . . . . 37.810000000000002 114.093 177.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.06 134.67 52.76 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.182 -0.949 . . . . 49.259999999999998 112.721 175.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -64.84 141.43 58.78 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 123.311 1.529 . . . . 34.460000000000001 113.332 -173.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 70.38 24.23 76.88 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 114.922 -1.035 . . . . 33.530000000000001 112.165 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1279 ' ' SER . . . . . . . . . . . . . 59.0 m -95.7 153.72 17.59 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 122.91 0.484 . . . . 31.309999999999999 109.736 176.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1280 ' ' VAL . . . . . 0.659 HG11 ' HA ' ' B' 1145 ' ' ALA . 84.4 t -118.01 144.29 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 O-C-N 119.307 -2.12 . . . . 29.32 106.815 -170.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1281 ' ' ILE . . . . . 0.452 HD13 HG21 ' B' 1267 ' ' ILE . 75.8 mt -121.5 120.22 61.21 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 N-CA-C 101.054 -3.684 . . . . 31.93 101.054 170.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1282 ' ' VAL . . . . . 0.663 HG11 ' HA ' ' B' 1141 ' ' ALA . 12.3 t -108.22 113.58 44.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 105.983 -1.858 . . . . 29.48 105.983 175.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1283 ' ' ASP . . . . . 0.698 ' HA ' HG23 ' B' 1254 ' ' THR . 5.6 t0 -87.33 102.73 14.79 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-N 113.826 -1.534 . . . . 34.5 110.885 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1284 ' ' LEU . . . . . 0.62 HD22 ' HA ' ' B' 1255 ' ' THR . 8.5 mp -69.46 -23.72 63.7 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 113.977 1.103 . . . . 37.939999999999998 113.977 172.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1285 ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' B' 1256 ' ' ALA . . . -88.38 16.09 6.89 Favored 'General case' 0 C--N 1.364 1.216 0 O-C-N 121.548 -0.72 . . . . 40.920000000000002 111.454 176.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1286 ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' B' 1297 ' ' PRO . . . -45.42 -37.5 5.16 Favored 'General case' 0 C--O 1.214 -0.786 0 N-CA-C 115.986 1.847 . . . . 44.390000000000001 115.986 174.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1287 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.43 -24.54 39.53 Favored 'General case' 0 C--N 1.313 -1.014 0 O-C-N 119.527 -1.983 . . . . 51.460000000000001 112.047 176.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 1.5 t30 -114.06 64.7 0.66 Allowed 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 125.101 1.361 . . . . 57.75 109.13 -170.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1289 ' ' GLY . . . . . . . . . . . . . . . 92.34 -39.62 2.98 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-O 117.056 -1.969 . . . . 49.850000000000001 114.663 170.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 87.02 117.2 1.1 Allowed Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 120.531 2.166 . . . . 45.93 112.292 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1291 ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -77.25 -29.63 54.08 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 119.761 1.78 . . . . 42.670000000000002 111.03 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1292 ' ' CYS . . . . . 0.612 ' HB3' ' OG1' ' B' 1295 ' ' THR . 40.9 t -95.84 146.03 24.88 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 118.704 -2.497 . . . . 38.82 108.442 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1293 ' ' GLU . . . . . 0.497 ' HG3' ' HA ' ' B' 1268 ' ' THR . 25.0 mt-10 -69.74 -38.64 76.9 Favored 'General case' 0 CA--C 1.502 -0.882 0 O-C-N 119.927 -1.733 . . . . 46.710000000000001 114.564 172.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -74.33 -3.84 32.68 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.273 0.842 . . . . 47.229999999999997 113.273 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1295 ' ' THR . . . . . 0.62 HG23 ' HA3' ' B' 1311 ' ' GLY . 88.2 m -59.6 110.77 1.2 Allowed 'General case' 0 C--O 1.243 0.759 0 CA-C-N 120.077 1.308 . . . . 36.020000000000003 111.238 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 51.2 t -78.34 100.25 0.5 Allowed Pre-proline 0 N--CA 1.44 -0.933 0 CA-C-N 112.604 -2.089 . . . . 37.259999999999998 105.437 163.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1297 ' ' PRO . . . . . 0.412 ' HB3' ' O ' ' B' 1286 ' ' ALA . 37.2 Cg_exo -65.46 78.22 0.25 Allowed 'Trans proline' 0 N--CA 1.44 -1.672 0 C-N-CA 125.024 3.816 . . . . 35.090000000000003 112.464 -177.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 169.09 -43.52 0.22 Allowed Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 109.045 -1.622 . . . . 35.969999999999999 109.045 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -134.35 -179.27 5.47 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 115.406 1.632 . . . . 40.390000000000001 115.406 -165.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1300 ' ' ILE . . . . . 0.547 HG12 HG12 ' B' 1310 ' ' ILE . 21.2 mt -82.63 140.6 16.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 107.563 -1.273 . . . . 37.43 107.563 172.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 58.6 t80 -119.96 112.66 19.45 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 104.706 -2.331 . . . . 44.130000000000003 104.706 163.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1302 ' ' THR . . . . . . . . . . . . . 29.4 m -79.72 137.03 36.92 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 119.92 -1.737 . . . . 39.780000000000001 109.623 167.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1303 ' ' THR . . . . . . . . . . . . . 35.7 p -93.32 -179.72 5.15 Favored 'General case' 0 C--O 1.251 1.184 0 N-CA-C 114.54 1.311 . . . . 43.289999999999999 114.54 177.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -75.97 -27.34 57.45 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 120.323 -1.486 . . . . 53.07 109.692 -169.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -84.55 2.55 40.7 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 124.519 2.104 . . . . 43.969999999999999 110.008 173.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 78.63 38.99 22.83 Favored Glycine 0 CA--C 1.539 1.533 0 O-C-N 118.217 -2.802 . . . . 41.119999999999997 113.495 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1307 ' ' VAL . . . . . 0.653 HG21 ' HB2' ' B' 1275 ' ' MET . 18.0 t -100.72 127.4 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-O 122.252 1.025 . . . . 38.119999999999997 109.705 172.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1308 ' ' LYS . . . . . . . . . . . . . 98.1 mttt -97.59 99.86 11.26 Favored 'General case' 0 N--CA 1.437 -1.093 0 O-C-N 119.01 -2.306 . . . . 36.340000000000003 109.782 -171.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1309 ' ' VAL . . . . . 0.419 HG22 HD12 ' B' 1281 ' ' ILE . 23.9 t -82.53 99.67 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 106.941 -1.503 . . . . 30.399999999999999 106.941 175.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1310 ' ' ILE . . . . . 0.547 HG12 HG12 ' B' 1300 ' ' ILE . 72.4 mt -82.82 107.64 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 N-CA-C 106.425 -1.695 . . . . 30.82 106.425 175.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1311 ' ' GLY . . . . . 0.62 ' HA3' HG23 ' B' 1295 ' ' THR . . . -116.0 61.52 0.39 Allowed Glycine 0 C--N 1.354 1.535 0 C-N-CA 118.567 -1.778 . . . . 26.530000000000001 111.6 176.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1312 ' ' TYR . . . . . 0.586 ' HB2' ' HG ' ' B' 1315 ' ' LEU . 14.9 m-85 -81.52 123.3 28.52 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 118.526 1.163 . . . . 38.0 108.984 -176.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1313 ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.1 -48.87 70.25 Favored 'General case' 0 C--O 1.256 1.428 0 CA-C-O 123.839 1.78 . . . . 29.800000000000001 108.56 167.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -72.41 16.66 0.13 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 116.453 2.02 . . . . 39.039999999999999 116.453 -176.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1315 ' ' LEU . . . . . 0.586 ' HG ' ' HB2' ' B' 1312 ' ' TYR . 25.4 mt -53.72 -43.63 96.48 Favored Pre-proline 0 C--O 1.224 -0.272 0 O-C-N 119.549 -1.969 . . . . 31.079999999999998 113.995 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1316 ' ' PRO . . . . . 0.45 ' HG3' ' HB2' ' B' 1137 ' ' ALA . 66.8 Cg_exo -63.97 -50.97 2.53 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.909 3.073 . . . . 26.100000000000001 112.475 168.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -50.76 -35.39 30.85 Favored Glycine 0 C--N 1.343 0.962 0 C-N-CA 125.867 1.698 . . . . 23.170000000000002 115.015 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 53.3 mtt180 -66.52 -7.22 18.39 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 117.492 2.404 . . . . 40.399999999999999 117.492 177.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1319 ' ' LEU . . . . . 0.698 HD21 ' HD2' ' B' 1139 ' ' TYR . 38.4 tp -127.48 117.64 21.39 Favored Pre-proline 0 C--N 1.347 0.488 0 O-C-N 119.395 -2.065 . . . . 23.600000000000001 110.24 -173.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1320 ' ' PRO . . . . . 0.614 ' HG2' ' HA2' ' A' 1150 ' ' GLY . 87.3 Cg_endo -73.62 -95.48 0.01 OUTLIER 'Trans proline' 0 N--CA 1.481 0.774 0 N-CA-C 121.428 3.588 . . . . 22.350000000000001 121.428 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1321 ' ' THR . . . . . 0.489 ' HB ' ' HG3' ' A' 1151 ' ' ARG . 0.2 OUTLIER -55.49 -31.25 61.86 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 116.125 1.898 . . . . 26.52 116.125 -162.614 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B 1322 ' ' GLN . . . . . . . . . . . . . 35.8 tp60 -52.86 -51.3 61.54 Favored 'General case' 0 C--O 1.248 1.018 0 CA-C-N 113.13 -1.85 . . . . 24.379999999999999 109.67 173.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1323 ' ' SER . . . . . . . . . . . . . 8.1 m -62.77 -48.35 79.56 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 118.121 -0.942 . . . . 22.800000000000001 112.578 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1324 ' ' SER . . . . . . . . . . . . . 3.0 m -49.49 -35.7 20.67 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 123.797 1.761 . . . . 21.25 115.263 174.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 45.8 tp60 -78.15 -60.82 2.21 Favored 'General case' 0 CA--C 1.505 -0.788 0 O-C-N 119.587 -1.946 . . . . 31.34 110.571 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1326 ' ' LEU . . . . . 0.683 ' HA ' ' HA3' ' A' 1161 ' ' GLY . 12.5 mt -62.7 -59.07 5.41 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 117.182 -1.39 . . . . 31.559999999999999 110.372 -174.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1327 ' ' TYR . . . . . . . . . . . . . 57.9 t80 -63.06 -40.32 97.35 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 119.033 0.833 . . . . 22.73 109.798 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1328 ' ' GLY . . . . . 0.463 ' HA2' HD12 ' B' 1331 ' ' LEU . . . -42.8 -49.01 6.14 Favored Glycine 0 C--N 1.308 -1.006 0 O-C-N 124.716 1.26 . . . . 21.91 115.122 165.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1329 ' ' THR . . . . . . . . . . . . . 8.7 m -72.56 -35.28 67.95 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 117.669 0.734 . . . . 22.149999999999999 109.631 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1330 ' ' ASN . . . . . . . . . . . . . 9.5 m120 -55.1 -46.07 75.5 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 123.765 0.666 . . . . 26.18 110.362 172.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1331 ' ' LEU . . . . . 0.552 HD13 HD13 ' B' 1070 ' ' LEU . 14.6 mt -66.54 -41.22 89.04 Favored 'General case' 0 C--O 1.253 1.246 0 O-C-N 119.729 -1.857 . . . . 23.68 110.339 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1332 ' ' VAL . . . . . 0.584 HG22 ' HG ' ' B' 1026 ' ' LEU . 69.7 t -55.09 -48.77 75.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 O-C-N 123.493 0.495 . . . . 26.57 109.807 174.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -62.09 -35.18 77.91 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 124.327 1.051 . . . . 28.079999999999998 112.13 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1334 ' ' LEU . . . . . 0.739 ' HA ' ' HG ' ' B' 1127 ' ' LEU . 32.3 tp -64.85 -58.9 4.96 Favored 'General case' 0 CA--C 1.492 -1.256 0 C-N-CA 124.446 1.099 . . . . 27.43 109.818 178.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1335 ' ' LEU . . . . . 0.469 HD21 HD21 ' B' 1070 ' ' LEU . 3.8 mm? -60.11 -39.46 86.26 Favored 'General case' 0 C--O 1.242 0.694 0 O-C-N 124.708 1.255 . . . . 30.5 112.977 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1336 ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' B' 1332 ' ' VAL . 31.9 ttmt -54.64 -44.98 73.68 Favored 'General case' 0 CA--C 1.495 -1.17 0 C-N-CA 124.483 1.113 . . . . 41.649999999999999 113.16 171.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 13.5 tp -85.75 -25.39 26.45 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.26 -0.9 . . . . 42.079999999999998 113.267 -174.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1338 ' ' LEU . . . . . 0.555 ' O ' ' HB ' ' B' 1347 ' ' THR . 7.3 mt -73.08 -67.97 0.53 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.45 -1.315 . . . . 35.030000000000001 107.45 170.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 43.8 t -85.43 73.23 10.55 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 107.187 -1.412 . . . . 37.329999999999998 107.187 -174.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 61.7 mttp -68.18 -22.28 64.83 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 119.471 -2.018 . . . . 50.509999999999998 111.743 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -78.11 -10.51 59.66 Favored 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 120.271 -1.518 . . . . 54.210000000000001 113.021 174.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 91.3 mttt 52.31 41.99 30.74 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-O 125.793 2.711 . . . . 50.990000000000002 111.787 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -105.73 -43.98 4.77 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 126.196 1.798 . . . . 48.82 109.548 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 132.69 -9.29 5.24 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 109.069 -1.612 . . . . 40.43 109.069 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -82.49 120.8 25.95 Favored 'General case' 0 C--O 1.242 0.665 0 O-C-N 119.256 -2.32 . . . . 47.560000000000002 109.453 175.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1346 ' ' ILE . . . . . . . . . . . . . 31.4 mm -68.11 90.5 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-N 114.171 -1.377 . . . . 42.490000000000002 110.413 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1347 ' ' THR . . . . . 0.555 ' HB ' ' O ' ' B' 1338 ' ' LEU . 92.5 m -74.47 90.88 2.22 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 123.869 1.795 . . . . 38.119999999999997 109.555 -177.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 39.4 t -84.17 90.53 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 106.697 -1.594 . . . . 37.5 106.697 171.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 10.5 t70 -77.7 147.21 35.56 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 109.067 -3.697 . . . . 43.850000000000001 108.409 175.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1350 ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -109.5 -16.83 13.9 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 118.599 -1.24 . . . . 39.810000000000002 113.689 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -91.35 -16.23 27.77 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 114.094 1.146 . . . . 51.289999999999999 114.094 -175.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 54.6 t0 -83.92 116.32 22.73 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 105.027 -2.212 . . . . 39.780000000000001 105.027 158.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 11.1 m -55.5 -25.33 17.51 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 C-N-CA 125.186 1.394 . . . . 39.280000000000001 109.822 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1354 ' ' VAL . . . . . 0.621 HG21 ' HG3' ' B' 1123 ' ' ARG . 73.9 t -64.48 -50.75 74.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 117.68 -1.152 . . . . 35.700000000000003 110.907 175.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1355 ' ' ILE . . . . . 0.52 HD12 HD23 ' B' 1338 ' ' LEU . 23.1 mm -70.95 -42.39 77.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 119.634 -0.826 . . . . 35.770000000000003 110.563 -177.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 48.5 tpt85 -52.37 -36.91 54.99 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 112.849 -1.978 . . . . 38.549999999999997 113.059 169.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -80.8 -51.05 4.97 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 121.88 2.127 . . . . 29.579999999999998 112.525 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1358 ' ' VAL . . . . . 0.521 HG23 HG22 ' B' 1118 ' ' VAL . 10.6 p -63.27 -35.68 73.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 118.917 1.358 . . . . 32.060000000000002 112.132 -171.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1359 ' ' THR . . . . . . . . . . . . . 14.0 m -84.21 88.22 7.21 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 103.268 -2.864 . . . . 29.0 103.268 -178.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1360 ' ' VAL . . . . . 0.455 HG12 ' HD1' ' B' 1368 ' ' TRP . 35.7 m -70.83 -25.42 26.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 114.816 -1.083 . . . . 29.68 112.428 -176.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 75.7 mt -139.79 136.92 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 103.121 -2.918 . . . . 32.049999999999997 103.121 175.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1362 ' ' ARG . . . . . 0.485 ' HA ' HG23 ' B' 1111 ' ' THR . 64.5 ttt180 -120.66 108.82 14.47 Favored 'General case' 0 C--O 1.254 1.318 0 N-CA-C 105.392 -2.077 . . . . 32.520000000000003 105.392 171.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 35.87 77.36 0.04 OUTLIER 'General case' 0 C--O 1.241 0.617 0 N-CA-C 116.335 1.976 . . . . 35.68 116.335 -170.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1364 ' ' GLY . . . . . 0.409 ' CA ' ' HA ' ' B' 1109 ' ' ASN . . . 80.65 -43.74 2.83 Favored Glycine 0 C--N 1.308 -1.013 0 CA-C-N 114.005 -1.452 . . . . 34.259999999999998 115.005 176.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -68.01 116.05 8.21 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 119.609 1.704 . . . . 51.07 112.04 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 83.5 mt -68.91 110.55 2.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 121.166 -0.959 . . . . 39.869999999999997 109.299 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1367 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.55 -20.14 25.44 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 115.474 1.657 . . . . 38.009999999999998 115.474 168.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1368 ' ' TRP . . . . . 0.455 ' HD1' HG12 ' B' 1360 ' ' VAL . 15.2 t90 -57.71 146.07 67.65 Favored Pre-proline 0 C--O 1.244 0.774 0 C-N-CA 123.281 0.632 . . . . 42.140000000000001 110.767 176.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1369 ' ' PRO . . . . . 0.417 ' HA ' ' CD1' ' B' 1368 ' ' TRP . 25.1 Cg_endo -78.1 -172.21 10.94 Favored 'Cis proline' 0 C--N 1.369 1.644 0 CA-C-N 121.362 1.522 . . . . 43.259999999999998 115.046 -5.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1370 ' ' ALA . . . . . . . . . . . . . . . -78.8 162.01 66.77 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 114.624 -1.171 . . . . 46.520000000000003 108.72 166.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -59.59 153.01 58.15 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 123.918 3.078 . . . . 51.950000000000003 108.995 162.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -57.53 113.61 1.58 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 1 C-N-CA 126.662 4.908 . . . . 56.270000000000003 115.056 -177.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1373 ' ' ILE . . . . . . . . . . . . . 50.7 mm -92.49 120.28 41.5 Favored 'Isoleucine or valine' 0 C--O 1.255 1.377 0 O-C-N 120.715 -1.24 . . . . 60.829999999999998 110.927 -174.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -92.46 127.88 38.11 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.961 -1.126 . . . . 66.099999999999994 107.961 174.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1375 ' ' VAL . . . . . 0.718 HG21 ' HB2' ' B' 1120 ' ' ARG . 19.9 t -124.72 118.57 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 113.401 -1.727 . . . . 63.469999999999999 107.693 -170.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.223 -4.906 0 O-C-N 117.774 -3.079 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.582 0 CA-C-O 118.926 -0.559 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -23.76 67.37 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 121.18 1.809 . . . . 0.0 113.323 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 32.7 mp0 -53.91 -50.68 65.84 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 123.107 1.432 . . . . 0.0 110.734 165.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 3.3 m -65.0 -38.21 90.19 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 113.579 -1.646 . . . . 0.0 109.362 -171.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.95 76.13 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-O 124.193 1.949 . . . . 0.0 114.682 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -70.25 -52.22 24.71 Favored 'General case' 0 C--O 1.249 1.076 0 CA-C-N 114.044 -1.434 . . . . 0.0 112.343 172.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.511 ' HB3' ' OG1' ' C' ' 108' ' ' THR . 74.8 mt -62.58 -43.08 99.7 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-O 116.965 -1.493 . . . . 0.0 113.368 -175.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.521 HD11 HD12 ' C' ' 182' ' ' ILE . 43.7 mt -52.39 -51.32 59.61 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -177.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 28' ' ' LYS . . . . . . . . . . . . . 13.3 pttm -65.93 -26.49 67.62 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -72.32 -35.67 68.68 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.304 1.041 . . . . 0.0 110.178 170.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 58.2 m -54.28 -43.99 71.5 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 120.941 3.682 . . . . 0.0 120.941 -167.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . 0.27 56.3 p-80 43.58 -18.22 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 123.418 2.827 . . . . 0.0 117.288 -160.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 32' ' ' SER . . . . . 0.535 ' HB2' ' HA ' ' C' ' 106' ' ' THR . 19.3 m -136.17 127.32 28.04 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.652 -3.78 . . . . 0.0 104.936 169.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 33' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' C' ' 64' ' ' VAL . 77.3 t -137.03 126.88 38.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 104.104 -2.554 . . . . 0.0 104.104 -174.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.489 HD12 HD11 ' C' ' 99' ' ' ILE . 21.8 mm -109.26 132.91 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 172.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 35' ' ' ILE . . . . . 0.699 HG12 ' HB2' ' C' ' 110' ' ' LEU . 55.5 mt -98.64 117.06 43.06 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 170.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 89.8 m -113.47 99.78 50.29 Favored Pre-proline 0 N--CA 1.44 -0.971 0 CA-C-O 122.597 1.189 . . . . 0.0 110.779 175.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -81.84 147.26 15.12 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 124.573 3.516 . . . . 0.0 114.973 178.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -159.95 120.29 0.95 Allowed Glycine 0 N--CA 1.415 -2.718 0 N-CA-C 108.014 -2.035 . . . . 0.0 108.014 166.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 39' ' ' TYR . . . . . 0.542 ' HB2' ' HA3' ' C' ' 73' ' ' GLY . 4.3 t80 61.45 -67.35 0.06 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.212 1.405 . . . . 0.0 113.839 -175.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -47.85 -43.3 23.12 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-N 121.394 1.906 . . . . 0.0 116.117 -170.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 41' ' ' MET . . . . . 0.822 ' HA ' ' HB3' ' C' ' 46' ' ' ALA . 5.6 ttm -47.24 -46.98 24.79 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 123.097 1.427 . . . . 0.0 113.49 178.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.16 -56.27 4.34 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.68 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 p -62.81 -30.46 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 N-CA-C 117.392 2.367 . . . . 0.0 117.392 -168.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.18 18.75 17.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.366 -0.833 . . . . 0.0 108.857 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 45' ' ' GLN . . . . . . . . . . . . 0.255 0.1 OUTLIER 35.31 46.73 0.27 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 124.95 2.31 . . . . 0.0 112.899 -158.347 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.822 ' HB3' ' HA ' ' C' ' 41' ' ' MET . . . -69.81 -20.16 63.46 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 114.203 -1.362 . . . . 0.0 113.523 -175.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 47' ' ' GLN . . . . . 0.526 ' HB2' ' HB2' ' C' ' 86' ' ' ALA . 0.0 OUTLIER -57.95 -39.13 77.34 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 176.577 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 48' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -59.2 -41.2 86.45 Favored Pre-proline 0 CA--C 1.553 1.07 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 49' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -67.32 -39.76 12.3 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 123.267 2.645 . . . . 0.0 111.671 164.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 50' ' ' VAL . . . . . 0.452 ' HA ' HG22 ' C' ' 53' ' ' ILE . 64.2 t -58.93 -33.67 50.48 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 O-C-N 121.57 -0.706 . . . . 0.0 110.304 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.35 -54.07 50.97 Favored 'General case' 0 C--O 1.243 0.739 0 O-C-N 120.308 -1.495 . . . . 0.0 107.386 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 52' ' ' GLU . . . . . 0.728 ' HB3' ' HB2' ' C' ' 183' ' ' LEU . 2.5 mm-40 -54.94 -37.64 66.7 Favored 'General case' 0 C--O 1.249 1.037 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -178.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 53' ' ' ILE . . . . . 0.452 HG22 ' HA ' ' C' ' 50' ' ' VAL . 9.0 tp -78.05 -44.47 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 O-C-N 121.466 -0.771 . . . . 0.0 111.493 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 88.3 m -59.87 -34.67 73.45 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -58.98 -52.95 63.57 Favored 'General case' 0 C--O 1.266 1.944 0 C-N-CA 124.658 1.183 . . . . 0.0 107.936 -175.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -74.85 -32.96 62.05 Favored 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 120.753 -1.217 . . . . 0.0 112.597 -177.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 93.6 mt -60.87 -42.08 97.21 Favored 'General case' 0 C--O 1.211 -0.93 0 O-C-N 120.659 -1.275 . . . . 0.0 110.566 174.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 58' ' ' ARG . . . . . 0.485 ' HD3' HG12 ' C' ' 64' ' ' VAL . 12.9 tpt180 -78.01 -27.78 49.01 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 119.743 -1.848 . . . . 0.0 110.934 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.05 -34.27 77.69 Favored 'General case' 0 C--N 1.349 0.548 0 O-C-N 121.587 -0.696 . . . . 0.0 109.89 173.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 9.2 ttm-85 -79.61 3.34 19.27 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 118.877 0.762 . . . . 0.0 111.182 174.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.44 36.92 78.46 Favored Glycine 0 C--O 1.251 1.185 0 O-C-N 120.395 -1.441 . . . . 0.0 111.067 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 7.0 mt -85.31 140.15 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -68.3 75.87 0.25 Allowed 'General case' 0 C--O 1.239 0.53 0 O-C-N 121.149 -0.969 . . . . 0.0 109.069 166.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 8.1 p -97.06 118.72 44.03 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 175.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 31.7 mmm-85 -126.2 144.35 50.8 Favored 'General case' 0 C--N 1.312 -1.036 0 O-C-N 124.842 1.339 . . . . 0.0 109.004 -173.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 66' ' ' PHE . . . . . 0.533 ' HB3' HD13 ' C' ' 68' ' ' ILE . 5.5 m-85 -100.08 98.11 8.87 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 123.666 1.698 . . . . 0.0 112.618 -176.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.88 83.11 1.63 Allowed Glycine 0 C--N 1.34 0.786 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 68' ' ' ILE . . . . . 0.533 HD13 ' HB3' ' C' ' 66' ' ' PHE 0.273 1.7 mp -77.89 112.89 16.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 122.006 0.908 . . . . 0.0 110.989 178.742 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -86.13 86.54 0.09 OUTLIER Pre-proline 0 N--CA 1.449 -0.477 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 165.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 70' ' ' PRO . . . . . 0.413 ' HG2' ' H ' ' C' ' 71' ' ' VAL . 94.6 Cg_endo -48.25 -52.87 7.61 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 125.211 3.94 . . . . 0.0 118.055 -165.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 71' ' ' VAL . . . . . 0.688 HG22 ' HB3' ' C' ' 76' ' ' PRO . 21.8 t -80.6 92.07 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 N-CA-C 102.13 -3.285 . . . . 0.0 102.13 178.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 72' ' ' ALA . . . . . 0.505 ' HA ' H52N ' C' 1001 ' ' NAP . . . -153.68 104.84 2.74 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 123.224 1.487 . . . . 0.0 113.387 178.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 73' ' ' GLY . . . . . 0.542 ' HA3' ' HB2' ' C' ' 39' ' ' TYR . . . 86.94 -98.32 2.35 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 111.723 -2.489 . . . . 0.0 108.149 177.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 74' ' ' ARG . . . . . 0.589 ' HA ' ' OE1' ' B' 1203 ' ' GLN . 0.8 OUTLIER -128.15 111.89 13.96 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 125.184 1.167 . . . . 0.0 112.549 -170.47 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.634 ' HB2' ' HB2' ' C' ' 78' ' ' HIS . 6.7 mp 71.62 134.04 0.04 OUTLIER Pre-proline 0 C--O 1.254 1.322 0 O-C-N 125.766 1.916 . . . . 0.0 112.481 -170.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 76' ' ' PRO . . . . . 0.688 ' HB3' HG22 ' C' ' 71' ' ' VAL . 56.6 Cg_endo -66.35 124.64 12.78 Favored 'Trans proline' 0 N--CA 1.432 -2.091 0 C-N-CA 121.951 1.767 . . . . 0.0 107.708 167.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 78.26 3.94 86.12 Favored Glycine 0 CA--C 1.54 1.626 0 CA-C-N 114.053 -1.431 . . . . 0.0 114.051 169.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 78' ' ' HIS . . . . . 0.634 ' HB2' ' HB2' ' C' ' 75' ' ' LEU . 21.3 t-160 -54.49 -31.46 55.93 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 79' ' ' MET . . . . . 0.619 ' HB2' ' SD ' ' C' ' 41' ' ' MET . 0.0 OUTLIER -62.18 -44.15 97.24 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 172.384 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -65.81 -36.49 83.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 122.413 1.102 . . . . 0.0 109.638 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 51.1 t -61.08 -43.65 96.67 Favored 'Isoleucine or valine' 0 C--N 1.357 0.903 0 CA-C-O 116.815 -1.564 . . . . 0.0 108.594 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 10.9 mp -82.61 -16.97 46.39 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 120.658 1.572 . . . . 0.0 112.104 174.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 15.0 tp -63.42 -32.15 73.51 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 117.492 -3.255 . . . . 0.0 110.576 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.75 -33.73 64.57 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 169.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -67.27 -45.21 77.31 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 120.274 -1.516 . . . . 0.0 113.598 166.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 86' ' ' ALA . . . . . 0.526 ' HB2' ' HB2' ' C' ' 47' ' ' GLN . . . -65.52 -11.22 41.66 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 176.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt 64.78 22.8 12.61 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 169.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 88' ' ' VAL . . . . . 0.435 ' HA ' ' HD2' ' C' ' 89' ' ' PRO . 74.9 t -84.55 121.75 74.93 Favored Pre-proline 0 C--O 1.249 1.034 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 173.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 89' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' C' ' 88' ' ' VAL . 37.1 Cg_endo -50.39 124.81 13.84 Favored 'Trans proline' 0 N--CA 1.442 -1.541 1 C-N-CA 126.392 4.728 . . . . 0.0 114.339 177.28 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -63.18 -16.34 59.82 Favored 'General case' 0 C--N 1.363 1.168 0 O-C-N 120.144 -1.598 . . . . 0.0 115.052 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -61.75 -40.04 93.74 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 123.345 0.658 . . . . 0.0 111.485 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 22.5 pt -75.44 -8.29 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 O-C-N 118.023 -2.923 . . . . 0.0 117.387 173.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 93' ' ' VAL . . . . . 0.519 HG13 HD13 ' C' ' 68' ' ' ILE . 16.8 t -88.06 121.47 38.5 Favored 'Isoleucine or valine' 0 C--O 1.248 1.02 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 -177.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 94' ' ' LEU . . . . . 0.553 ' HB3' ' HB3' ' C' ' 97' ' ' ASP . 6.2 mp -104.27 97.26 7.23 Favored 'General case' 0 C--O 1.25 1.107 0 CA-C-N 113.335 -1.757 . . . . 0.0 108.564 168.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 95' ' ' GLU . . . . . 0.462 ' HB3' HG12 ' A' 1157 ' ' ILE . 53.7 mp0 -81.84 93.45 6.87 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 4.0 tpp 56.55 29.57 15.74 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.451 1.9 . . . . 0.0 112.271 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 97' ' ' ASP . . . . . 0.553 ' HB3' ' HB3' ' C' ' 94' ' ' LEU . 18.7 t70 -92.11 172.7 8.25 Favored 'General case' 0 C--O 1.251 1.163 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 173.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -67.7 87.67 0.23 Allowed 'General case' 0 C--N 1.347 0.491 0 CA-C-O 123.724 1.726 . . . . 0.0 113.464 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 99' ' ' ILE . . . . . 0.489 HD11 HD12 ' C' ' 34' ' ' ILE . 6.5 tp -101.29 7.31 9.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-N 110.712 -2.949 . . . . 0.0 110.543 174.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -58.94 -49.11 79.08 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 119.765 -1.834 . . . . 0.0 112.168 -171.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -79.42 -29.54 41.95 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.839 0.828 . . . . 0.0 110.833 -174.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 102' ' ' ASP . . . . . 0.414 ' HB3' HD11 ' C' ' 34' ' ' ILE . 0.8 OUTLIER -63.73 -32.12 73.51 Favored 'General case' 0 N--CA 1.433 -1.319 0 O-C-N 121.051 -1.031 . . . . 0.0 112.826 169.213 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 103' ' ' PHE . . . . . 0.468 ' CE2' HG23 ' C' ' 99' ' ' ILE . 35.1 m-85 -63.22 -48.54 77.86 Favored 'General case' 0 N--CA 1.426 -1.657 0 O-C-N 119.606 -1.934 . . . . 0.0 111.617 169.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.15 -27.67 69.11 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 124.319 1.012 . . . . 0.0 112.959 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -72.16 -40.57 67.89 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.799 1.285 . . . . 0.0 112.179 174.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 106' ' ' THR . . . . . 0.535 ' HA ' ' HB2' ' C' ' 32' ' ' SER . 3.1 m -60.6 143.58 53.6 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 112.901 -1.954 . . . . 0.0 114.856 -174.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 107' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -92.56 -62.87 1.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 112.337 -2.21 . . . . 0.0 107.948 175.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 108' ' ' THR . . . . . 0.511 ' OG1' ' HB3' ' C' ' 26' ' ' LEU . 97.0 m -108.44 126.19 52.61 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-O 123.789 1.757 . . . . 0.0 111.134 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 109' ' ' VAL . . . . . 0.594 HG11 HG21 ' C' ' 138' ' ' VAL . 3.2 t -108.96 119.93 59.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.985 0 CA-C-N 113.191 -1.822 . . . . 0.0 106.73 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 110' ' ' LEU . . . . . 0.699 ' HB2' HG12 ' C' ' 35' ' ' ILE . 34.7 mt -91.14 91.54 8.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 123.745 1.736 . . . . 0.0 110.019 177.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 111' ' ' VAL . . . . . 0.806 ' HB ' ' HA ' ' C' ' 146' ' ' VAL . 12.0 t -90.87 99.87 10.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 -175.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 26.4 mm -78.86 97.9 2.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 CA-C-N 112.314 -2.221 . . . . 0.0 110.394 -171.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.04 -100.76 1.16 Allowed Glycine 0 C--N 1.334 0.467 0 N-CA-C 107.233 -2.347 . . . . 0.0 107.233 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 114' ' ' ALA . . . . . 0.544 ' HB3' HG12 ' C' ' 111' ' ' VAL . . . 57.41 -56.55 0.03 OUTLIER 'General case' 0 C--O 1.25 1.113 1 N-CA-C 126.336 5.68 . . . . 0.0 126.336 162.818 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 115' ' ' ASN . . . . . 0.406 ' HB2' ' CE1' ' C' ' 163' ' ' PHE 0.344 2.7 p-10 24.48 -80.44 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 120.391 3.478 . . . . 0.0 120.391 -169.392 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 116' ' ' ASP . . . . . 0.514 ' HA ' ' HB2' ' C' ' 119' ' ' ASN . 69.7 m-20 -64.35 -18.38 64.6 Favored 'General case' 0 C--O 1.241 0.648 0 O-C-N 118.067 -2.896 . . . . 0.0 114.36 -177.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 117' ' ' THR . . . . . 0.509 ' HB ' ' HB1' ' C' ' 114' ' ' ALA . 30.8 m -45.66 -35.96 4.52 Favored 'General case' 0 C--O 1.248 0.993 0 C-N-CA 125.627 1.571 . . . . 0.0 111.792 169.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.481 ' HA ' ' HB ' ' C' ' 135' ' ' VAL . 4.3 m -127.44 20.45 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 O-C-N 120.28 -1.512 . . . . 0.0 113.184 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 119' ' ' ASN . . . . . 0.514 ' HB2' ' HA ' ' C' ' 116' ' ' ASP . 61.0 t-20 -73.12 108.36 4.47 Favored Pre-proline 0 C--N 1.32 -0.688 0 O-C-N 119.656 -1.902 . . . . 0.0 111.025 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 120' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -56.3 -27.19 65.65 Favored 'Trans proline' 0 N--CA 1.441 -1.601 0 C-N-CA 125.041 3.827 . . . . 0.0 115.868 -172.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -55.88 -39.16 71.15 Favored 'General case' 0 C--O 1.204 -1.324 0 O-C-N 125.719 1.887 . . . . 0.0 111.874 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 122' ' ' ALA . . . . . 0.51 ' HB1' ' HB3' ' C' ' 133' ' ' MET . . . -57.35 -21.86 38.5 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 117.998 2.592 . . . . 0.0 117.998 177.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -102.45 -43.92 5.51 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 117.859 -1.536 . . . . 0.0 112.591 169.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 124' ' ' ASP . . . . . 0.405 ' O ' ' HD3' ' C' ' 126' ' ' PRO . 38.7 t70 -78.37 -30.13 47.78 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 122.98 1.372 . . . . 0.0 111.66 -171.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -107.94 101.7 42.18 Favored Pre-proline 0 N--CA 1.429 -1.477 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 -169.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 126' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' C' ' 124' ' ' ASP . 27.5 Cg_exo -55.13 -39.06 92.92 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 124.009 3.139 . . . . 0.0 114.26 171.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -53.4 -21.09 5.35 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 128' ' ' SER . . . . . 0.509 ' HA ' ' HD2' ' C' ' 129' ' ' PRO . 22.3 m -48.1 134.49 11.95 Favored Pre-proline 0 N--CA 1.434 -1.227 0 O-C-N 120.685 -1.26 . . . . 0.0 113.822 172.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 129' ' ' PRO . . . . . 0.565 ' HG2' ' HA ' ' C' ' 156' ' ' ALA . 36.5 Cg_endo -55.39 -38.0 94.26 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 124.912 3.742 . . . . 0.0 117.777 172.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 130' ' ' ILE . . . . . 0.954 HG12 ' HB2' ' C' ' 156' ' ' ALA 0.291 39.3 pt -77.19 104.64 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.367 168.198 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 131' ' ' ALA . . . . . 0.722 ' HB1' HG22 ' B' 1121 ' ' ILE . . . -63.7 115.02 4.37 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 113.125 -1.852 . . . . 0.0 111.363 -168.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 29.56 69.18 0.08 OUTLIER Glycine 0 N--CA 1.473 1.108 0 CA-C-O 116.525 -2.264 . . . . 0.0 114.192 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 133' ' ' MET . . . . . 0.68 ' HA ' ' HB2' ' B' 1122 ' ' SER . 5.9 tpp -96.2 126.22 45.0 Favored Pre-proline 0 N--CA 1.434 -1.247 0 CA-C-N 119.638 1.719 . . . . 0.0 113.344 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 134' ' ' PRO . . . . . 0.516 ' HD2' ' SD ' ' C' ' 133' ' ' MET . 72.8 Cg_endo -66.54 81.05 0.32 Allowed 'Trans proline' 0 C--O 1.262 1.707 1 C-N-CA 125.696 4.264 . . . . 0.0 107.247 168.889 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 135' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' C' ' 118' ' ' VAL . 6.3 m -69.38 137.0 25.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.363 171.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 7.8 tp -78.53 83.42 4.73 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.301 -1.318 . . . . 0.0 113.564 -166.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . 0.28 34.2 mm-40 42.04 -26.44 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.329 1 N-CA-C 128.213 6.375 . . . . 0.0 128.213 160.092 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' C' C ' 138' ' ' VAL . . . . . 0.594 HG21 HG11 ' C' ' 109' ' ' VAL . 4.4 p -73.96 14.78 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.491 0 O-C-N 117.144 -3.472 . . . . 0.0 117.152 -160.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 5.3 p90 -69.19 142.67 54.22 Favored 'General case' 0 C--O 1.244 0.772 0 O-C-N 119.45 -2.031 . . . . 0.0 109.006 176.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.77 24.46 0.34 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 127.055 2.142 . . . . 0.0 116.588 -166.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -101.12 70.47 1.34 Allowed 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 123.154 1.454 . . . . 0.0 110.112 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 142' ' ' GLN . . . . . 0.43 ' HB3' ' H ' ' C' ' 143' ' ' ASN . 0.2 OUTLIER 64.75 -135.66 0.26 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 112.271 -2.241 . . . . 0.0 114.487 171.771 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 143' ' ' ASN . . . . . 0.439 ' HB2' ' HA ' ' C' ' 108' ' ' THR . 53.8 m-20 -85.57 84.87 7.48 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 118.986 -1.086 . . . . 0.0 109.102 -168.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 144' ' ' VAL . . . . . 0.481 ' HA ' ' HB ' ' C' ' 109' ' ' VAL . 58.2 t -88.51 88.25 2.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 102.617 -3.105 . . . . 0.0 102.617 -173.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 145' ' ' ILE . . . . . 0.46 HD12 HG23 ' C' ' 108' ' ' THR . 97.4 mt -88.92 97.79 7.31 Favored 'Isoleucine or valine' 0 C--O 1.251 1.171 0 CA-C-O 123.308 1.528 . . . . 0.0 107.802 -173.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 146' ' ' VAL . . . . . 0.806 ' HA ' ' HB ' ' C' ' 111' ' ' VAL . 48.7 t -85.44 104.22 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 113.298 -1.774 . . . . 0.0 106.967 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 147' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -67.55 91.64 0.29 Allowed 'General case' 0 C--O 1.242 0.661 0 O-C-N 120.625 -1.297 . . . . 0.0 109.646 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 148' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' C' ' 172' ' ' PHE . 15.7 mmmt -118.62 110.45 17.34 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.171 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -64.35 -36.0 82.7 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.046 1.338 . . . . 0.0 109.683 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 150' ' ' SER . . . . . 0.424 ' O ' ' HE3' ' C' ' 148' ' ' LYS . 10.7 m -139.5 137.41 35.48 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 151' ' ' MET . . . . . 0.466 ' SD ' ' HE1' ' C' ' 170' ' ' MET . 5.2 tpt -77.35 98.31 5.19 Favored 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 118.791 -2.443 . . . . 0.0 109.007 170.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 152' ' ' ASN . . . . . 0.416 ' OD1' ' NZ ' ' C' ' 148' ' ' LYS . 38.5 p30 -140.68 152.17 45.15 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 110.837 -2.892 . . . . 0.0 108.952 177.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 153' ' ' THR . . . . . 0.646 HG23 ' HA3' ' C' ' 157' ' ' GLY . 98.6 m -65.17 120.39 12.62 Favored 'General case' 0 C--N 1.358 0.977 0 O-C-N 125.073 1.483 . . . . 0.0 107.797 176.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -78.58 -115.76 0.21 Allowed Glycine 0 N--CA 1.424 -2.118 0 CA-C-N 112.358 -2.201 . . . . 0.0 108.272 167.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 155' ' ' TYR . . . . . 0.57 ' HB3' HG21 ' C' ' 130' ' ' ILE . 0.6 OUTLIER -79.7 -53.65 6.61 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 179.157 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 156' ' ' ALA . . . . . 0.954 ' HB2' HG12 ' C' ' 130' ' ' ILE . . . -92.57 -60.32 1.86 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.362 0.983 . . . . 0.0 108.37 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 157' ' ' GLY . . . . . 0.646 ' HA3' HG23 ' C' ' 153' ' ' THR . . . 57.46 44.5 93.66 Favored Glycine 0 CA--C 1.492 -1.368 0 CA-C-N 113.544 -1.662 . . . . 0.0 112.257 -176.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 158' ' ' VAL . . . . . 0.472 HG22 ' HB1' ' C' ' 156' ' ' ALA . 28.4 m -123.37 157.56 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-O 122.309 1.052 . . . . 0.0 112.503 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -30.59 123.67 0.19 Allowed 'General case' 0 C--O 1.242 0.679 1 N-CA-C 122.008 4.077 . . . . 0.0 122.008 178.491 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 160' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -168.22 163.59 8.66 Favored Pre-proline 0 C--O 1.268 2.052 0 C-N-CA 126.088 1.755 . . . . 0.0 109.99 -176.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.74 -36.23 1.66 Allowed 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 124.106 3.204 . . . . 0.0 115.212 169.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 162' ' ' LEU . . . . . . . . . . . . . 8.1 tt -58.07 -35.66 71.7 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -166.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 163' ' ' PHE . . . . . 0.406 ' CE1' ' HB2' ' C' ' 115' ' ' ASN . 12.9 m-30 -70.39 -29.0 65.52 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 118.298 -2.751 . . . . 0.0 113.361 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -102.94 -17.9 15.27 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.169 -1.378 . . . . 0.0 114.206 -162.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 165' ' ' LYS . . . . . 0.448 ' HB2' ' HB ' ' C' ' 168' ' ' THR . 20.5 mmmt -73.64 -177.26 2.65 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.698 1.237 . . . . 0.0 111.986 -170.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -88.63 -63.17 1.34 Allowed 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 120.361 -1.462 . . . . 0.0 109.616 -164.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.94 -26.15 24.01 Favored 'General case' 0 C--O 1.243 0.753 0 O-C-N 120.329 -1.482 . . . . 0.0 112.442 170.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 168' ' ' THR . . . . . 0.448 ' HB ' ' HB2' ' C' ' 165' ' ' LYS . 96.3 m -88.81 91.11 8.69 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 124.45 2.072 . . . . 0.0 105.467 165.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -146.89 137.79 23.91 Favored 'General case' 0 N--CA 1.432 -1.34 0 O-C-N 118.682 -2.511 . . . . 0.0 111.585 -160.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 170' ' ' MET . . . . . 0.649 ' HA ' ' HB ' ' C' ' 146' ' ' VAL . 54.3 mtm -69.97 107.58 3.66 Favored 'General case' 0 N--CA 1.418 -2.044 0 O-C-N 121.507 -0.746 . . . . 0.0 110.077 162.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 171' ' ' LEU . . . . . 0.401 ' HB2' HG23 ' C' ' 145' ' ' ILE . 7.5 mp -79.22 130.56 35.6 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 172.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 172' ' ' PHE . . . . . 0.543 ' HA ' ' O ' ' C' ' 148' ' ' LYS . 68.9 m-85 -82.5 85.73 6.89 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 125.675 1.86 . . . . 0.0 110.853 -167.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -162.68 150.14 18.86 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 124.561 1.077 . . . . 0.0 111.388 -173.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 174' ' ' ASP . . . . . 0.638 ' HB3' ' HB3' ' C' ' 177' ' ' ALA . 9.7 t70 -68.07 149.42 49.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.607 -0.796 . . . . 0.0 112.01 176.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.82 -51.67 45.96 Favored 'General case' 0 C--O 1.241 0.653 0 O-C-N 121.329 -0.857 . . . . 0.0 108.879 -175.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.66 -54.5 19.08 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 116.39 -1.767 . . . . 0.0 106.277 178.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 177' ' ' ALA . . . . . 0.638 ' HB3' ' HB3' ' C' ' 174' ' ' ASP . . . -53.47 -55.99 20.69 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 -174.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 6.4 m -60.71 -37.52 81.98 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 121.622 -0.674 . . . . 0.0 110.869 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 179' ' ' VAL . . . . . 0.522 ' HA ' HG12 ' C' ' 182' ' ' ILE . 50.9 t -67.56 -36.99 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 120.617 -1.302 . . . . 0.0 110.366 175.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -59.39 -39.17 82.5 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 125.934 1.694 . . . . 0.0 109.661 174.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.34 -52.98 62.41 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 120.926 0.393 . . . . 0.0 110.075 173.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 182' ' ' ILE . . . . . 0.522 HG12 ' HA ' ' C' ' 179' ' ' VAL . 20.8 pt -75.53 -19.77 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 O-C-N 119.592 -1.943 . . . . 0.0 114.106 -175.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 183' ' ' LEU . . . . . 0.728 ' HB2' ' HB3' ' C' ' 52' ' ' GLU . 4.2 pp -58.57 -44.85 89.87 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 122.106 2.23 . . . . 0.0 115.271 -167.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 184' ' ' LYS . . . . . 0.483 ' N ' HD12 ' C' ' 183' ' ' LEU . 13.5 tttp -96.12 -14.4 22.87 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.575 168.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 185' ' ' ALA . . . . . 0.447 ' HB3' ' HA ' ' C' ' 182' ' ' ILE . . . -80.19 -74.47 0.31 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 119.251 -0.98 . . . . 0.0 111.607 -176.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 186' ' ' LEU . . . . . . . . . . . . 0.301 1.9 pt? . . . . . 0 C--N 1.363 1.158 0 N-CA-C 117.582 2.438 . . . . 0.0 117.582 -171.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 1' ' ' NAD . . . . . 0.471 ' H3D' ' O3 ' ' B' ' 1' ' ' NAD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C 1001 ' ' NAP . . . . . 0.54 ' O3D' ' HG2' ' C' ' 133' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1000 ' ' HIS . . . . . 0.426 ' O ' ' HB2' ' A' 1067 ' ' GLU . 26.4 t-80 . . . . . 0 CA--C 1.512 -0.505 0 N-CA-C 102.757 -3.053 . . . . 65.739999999999995 102.757 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1001 ' ' GLY . . . . . 0.41 ' HA2' ' HB2' ' A' 1067 ' ' GLU . . . -69.17 78.13 0.3 Allowed Glycine 0 CA--C 1.533 1.176 0 CA-C-O 122.337 0.965 . . . . 48.659999999999997 112.565 -167.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1002 ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' 1032 ' ' THR . 21.1 ttp180 -125.55 141.06 52.24 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 103.323 -2.843 . . . . 44.560000000000002 103.323 177.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1003 ' ' ILE . . . . . 0.496 HG12 ' HB ' ' A' 1068 ' ' ILE . 96.0 mt -105.88 127.07 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 O-C-N 117.995 -2.941 . . . . 34.859999999999999 104.787 169.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -92.89 136.71 13.3 Favored Glycine 0 N--CA 1.434 -1.487 0 CA-C-N 115.463 -0.79 . . . . 30.75 111.419 170.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.729 HG23 ' HB3' ' A' 1017 ' ' ALA . 37.5 mm -109.87 99.31 38.05 Favored Pre-proline 0 C--O 1.248 0.99 0 N-CA-C 103.75 -2.685 . . . . 32.210000000000001 103.75 173.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -80.57 144.68 15.95 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 124.536 3.491 . . . . 32.979999999999997 112.636 174.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1007 ' ' ARG . . . . . . . . . . . . . 10.0 ttp85 -75.42 155.11 36.68 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 113.25 -1.795 . . . . 47.979999999999997 107.878 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1008 ' ' GLU . . . . . 0.486 ' CD ' ' HZ3' ' A' 1071 ' ' LYS . 4.7 mm-40 -83.9 146.23 28.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 118.409 2.744 . . . . 34.700000000000003 118.409 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -83.45 -30.28 27.37 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 111.704 -2.498 . . . . 53.369999999999997 110.792 166.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1010 ' ' LEU . . . . . 0.441 HD22 ' ND2' ' A' 1073 ' ' ASN . 2.5 mp -49.32 135.64 16.96 Favored 'General case' 0 C--O 1.251 1.175 0 C-N-CA 125.024 1.33 . . . . 45.07 113.389 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1011 ' ' THR . . . . . . . . . . . . . 2.3 m -68.95 147.17 52.03 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 123.289 1.518 . . . . 40.359999999999999 107.205 -177.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 10.7 t30 65.06 -17.01 0.09 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 112.795 -2.002 . . . . 40.609999999999999 114.354 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -69.53 112.92 6.37 Favored 'General case' 0 C--O 1.243 0.713 0 O-C-N 119.398 -2.064 . . . . 33.759999999999998 111.049 -165.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1014 ' ' THR . . . . . 0.57 ' HB ' ' HB3' ' A' 1320 ' ' PRO . 0.0 OUTLIER -96.36 -13.19 23.43 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 112.727 0.64 . . . . 27.890000000000001 112.727 173.914 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 1015 ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.02 136.88 39.96 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 118.988 -2.32 . . . . 29.02 106.555 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1016 ' ' VAL . . . . . 0.568 HG12 ' HB2' ' A' 1043 ' ' ALA . 4.2 p -109.72 -178.51 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.101 0 N-CA-C 106.42 -1.696 . . . . 28.129999999999999 106.42 168.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1017 ' ' ALA . . . . . 0.729 ' HB3' HG23 ' A' 1005 ' ' ILE . . . -68.99 -53.65 19.45 Favored 'General case' 0 C--N 1.309 -1.18 0 O-C-N 120.538 -1.351 . . . . 26.870000000000001 111.817 -176.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -136.03 140.76 44.1 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.675 0.75 . . . . 26.77 112.404 -173.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1019 ' ' THR . . . . . 0.477 HG23 ' HB2' ' A' 1324 ' ' SER . 3.4 p -79.6 166.66 39.69 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 124.311 1.044 . . . . 27.02 111.494 172.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1020 ' ' PRO . . . . . 0.472 ' O ' ' HB2' ' A' 1024 ' ' GLU . 0.2 OUTLIER -51.07 -38.94 60.81 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.614 2.876 . . . . 30.57 114.585 171.262 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 52.2 mttp -56.1 -48.89 75.29 Favored 'General case' 0 C--O 1.219 -0.541 0 O-C-N 123.965 0.791 . . . . 47.810000000000002 111.802 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1022 ' ' THR . . . . . . . . . . . . . 1.9 p -74.44 -40.08 62.16 Favored 'General case' 0 C--N 1.348 0.505 0 C-N-CA 119.354 -0.938 . . . . 30.77 111.11 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1023 ' ' VAL . . . . . 0.567 ' HA ' HD12 ' A' 1026 ' ' LEU . 3.3 t -51.65 -42.46 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 113.091 0.775 . . . . 33.590000000000003 113.091 170.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1024 ' ' GLU . . . . . 0.583 ' HA ' HD12 ' A' 1027 ' ' LEU . 23.2 tt0 -59.4 -43.77 92.94 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 124.278 1.031 . . . . 53.289999999999999 109.545 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -69.06 -40.38 78.56 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 125.294 1.438 . . . . 46.920000000000002 110.014 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1026 ' ' LEU . . . . . 0.567 HD12 ' HA ' ' A' 1023 ' ' VAL . 91.0 mt -54.51 -46.49 73.51 Favored 'General case' 0 C--O 1.248 0.974 0 C-N-CA 124.036 0.934 . . . . 37.170000000000002 112.364 171.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1027 ' ' LEU . . . . . 0.583 HD12 ' HA ' ' A' 1024 ' ' GLU . 14.3 mt -57.85 -43.0 85.6 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-O 118.177 -0.916 . . . . 44.439999999999998 111.922 170.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 55.7 mmtt -60.38 -20.29 58.98 Favored 'General case' 0 C--O 1.257 1.493 0 C-N-CA 124.296 1.039 . . . . 52.579999999999998 113.714 174.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1029 ' ' LEU . . . . . 0.502 HD23 ' HE3' ' A' 1342 ' ' LYS . 32.3 mt -78.35 24.31 0.27 Allowed 'General case' 0 N--CA 1.472 0.67 0 O-C-N 119.617 -1.927 . . . . 45.689999999999998 114.791 164.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 68.94 13.75 66.99 Favored Glycine 0 C--N 1.343 0.933 0 O-C-N 119.899 -1.75 . . . . 42.090000000000003 113.546 -176.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -93.29 159.44 15.27 Favored 'General case' 0 C--O 1.251 1.176 0 CA-C-N 121.91 2.855 . . . . 40.719999999999999 110.928 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1032 ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' 1002 ' ' ARG . 0.6 OUTLIER -87.95 155.2 19.96 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 103.707 -2.701 . . . . 37.770000000000003 103.707 158.562 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 1033 ' ' VAL . . . . . . . . . . . . . 87.2 t -135.51 131.3 51.11 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 O-C-N 120.037 -1.665 . . . . 33.539999999999999 108.511 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -116.07 143.59 45.26 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 119.217 0.917 . . . . 31.68 109.46 171.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1035 ' ' VAL . . . . . 0.503 HG21 ' CD1' ' A' 1050 ' ' PHE . 80.0 t -128.77 137.0 58.46 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.52 0 O-C-N 119.452 -2.03 . . . . 31.52 108.273 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1036 ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -73.3 119.43 17.52 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 119.542 -1.974 . . . . 41.039999999999999 108.419 174.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1037 ' ' SER . . . . . 0.538 ' HB2' HG23 ' A' 1057 ' ' ILE . 19.7 t -63.49 144.18 57.2 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.853 0.835 . . . . 31.829999999999998 110.072 -171.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 110.27 -31.61 7.29 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 107.378 -2.289 . . . . 29.359999999999999 107.378 -169.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -52.44 -34.03 46.77 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.456 1.28 . . . . 27.780000000000001 114.456 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -60.6 -48.85 84.14 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 120.306 1.412 . . . . 28.91 112.25 172.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -65.05 -31.72 73.09 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 114.507 -0.847 . . . . 51.18 112.518 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1042 ' ' LEU . . . . . . . . . . . . . 8.9 mp -67.91 -66.9 0.51 Allowed 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.587 0.708 . . . . 29.91 109.407 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1043 ' ' ALA . . . . . 0.568 ' HB2' HG12 ' A' 1016 ' ' VAL . . . -66.36 -5.54 11.11 Favored 'General case' 0 N--CA 1.439 -1.0 0 O-C-N 121.239 -0.913 . . . . 28.539999999999999 111.496 -171.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1044 ' ' SER . . . . . 0.446 ' HB3' ' HA2' ' B' 1278 ' ' GLY . 16.6 m 62.45 72.59 0.49 Allowed 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 126.967 3.27 . . . . 33.060000000000002 110.077 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1045 ' ' PHE . . . . . . . . . . . . . 1.9 t80 -157.57 155.03 29.49 Favored 'General case' 0 N--CA 1.423 -1.784 1 CA-C-N 108.063 -4.153 . . . . 30.289999999999999 101.896 -172.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 10.7 t0 -68.18 123.83 21.77 Favored 'General case' 0 N--CA 1.439 -0.999 0 O-C-N 120.394 -1.441 . . . . 48.619999999999997 109.688 171.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.65 -49.34 77.93 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 122.811 1.291 . . . . 36.740000000000002 111.69 176.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.01 -13.71 62.35 Favored 'General case' 0 N--CA 1.434 -1.273 0 O-C-N 119.031 -2.293 . . . . 43.729999999999997 112.081 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -65.19 -15.63 62.65 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 116.957 -1.497 . . . . 32.810000000000002 113.904 168.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1050 ' ' PHE . . . . . 0.503 ' CD1' HG21 ' A' 1035 ' ' VAL . 62.9 m-85 -65.82 -47.0 76.51 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 106.464 -1.68 . . . . 31.859999999999999 106.464 167.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 76.6 t -60.71 -38.55 78.99 Favored 'Isoleucine or valine' 0 C--O 1.254 1.318 0 CA-C-O 118.266 -0.873 . . . . 33.219999999999999 111.242 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -52.91 -50.58 63.66 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 119.398 0.999 . . . . 50.829999999999998 113.009 171.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -61.37 -33.89 74.39 Favored 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 124.339 1.056 . . . . 33.119999999999997 112.213 173.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 114.24 15.96 8.05 Favored Glycine 0 C--O 1.257 1.552 0 O-C-N 120.436 -1.415 . . . . 35.829999999999998 111.326 175.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1055 ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' A' 1050 ' ' PHE . . . -84.42 140.15 31.73 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 107.374 -1.343 . . . . 34.82 107.374 177.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -70.09 121.3 17.21 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 117.534 -1.222 . . . . 49.049999999999997 111.101 172.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1057 ' ' ILE . . . . . 0.538 HG23 ' HB2' ' A' 1037 ' ' SER . 3.6 mm -90.11 103.16 13.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 104.9 -2.259 . . . . 38.530000000000001 104.9 177.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1058 ' ' VAL . . . . . 0.474 ' HB ' ' HB2' ' A' 1062 ' ' SER . 34.6 m -110.98 172.15 2.78 Favored 'Isoleucine or valine' 0 C--O 1.252 1.236 0 CA-C-N 113.309 -1.769 . . . . 42.109999999999999 108.432 -170.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -119.35 131.99 55.79 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 106.666 -1.605 . . . . 58.0 106.666 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1060 ' ' GLY . . . . . 0.542 ' O ' HG12 ' A' 1063 ' ' VAL . . . 54.86 -129.14 44.7 Favored Glycine 0 CA--C 1.526 0.736 0 O-C-N 125.375 1.672 . . . . 52.119999999999997 112.918 169.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 1.4 t30 -57.0 -26.43 60.22 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 112.807 -1.697 . . . . 54.75 112.643 -168.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1062 ' ' SER . . . . . 0.474 ' HB2' ' HB ' ' A' 1058 ' ' VAL . 3.0 m -55.83 -37.31 68.53 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-O 122.56 1.172 . . . . 50.340000000000003 111.863 -179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1063 ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' 1060 ' ' GLY . 9.3 p -62.26 -33.43 58.83 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.186 0 O-C-N 119.19 -2.194 . . . . 41.460000000000001 116.183 176.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1064 ' ' TRP . . . . . 0.435 ' HA ' HD11 ' A' 1069 ' ' ILE . 93.2 m95 -74.0 -15.86 61.08 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 113.551 0.945 . . . . 39.32 113.551 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -82.63 83.02 7.77 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.408 1.099 . . . . 55.380000000000003 108.427 170.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1066 ' ' SER . . . . . . . . . . . . . 66.1 m -153.65 173.9 15.19 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 113.769 -1.56 . . . . 41.869999999999997 110.549 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1067 ' ' GLU . . . . . 0.731 ' HB3' HD12 ' A' 1068 ' ' ILE . 0.3 OUTLIER -77.74 -57.16 3.96 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 106.976 -1.49 . . . . 53.200000000000003 106.976 173.341 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 1068 ' ' ILE . . . . . 0.731 HD12 ' HB3' ' A' 1067 ' ' GLU . 5.4 mp -109.68 149.22 12.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 105.45 -2.056 . . . . 41.899999999999999 105.45 -176.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1069 ' ' ILE . . . . . 0.435 HD11 ' HA ' ' A' 1064 ' ' TRP . 20.6 mm -128.78 120.16 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 N-CA-C 104.39 -2.448 . . . . 38.729999999999997 104.39 172.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1070 ' ' LEU . . . . . 0.591 HD22 HD22 ' A' 1331 ' ' LEU . 33.9 mt -97.69 97.93 9.44 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 104.908 -2.256 . . . . 32.439999999999998 104.908 175.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1071 ' ' LYS . . . . . 0.486 ' HZ3' ' CD ' ' A' 1008 ' ' GLU . 7.5 tmtt? -90.36 141.51 28.66 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 125.608 2.623 . . . . 34.649999999999999 109.074 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1072 ' ' VAL . . . . . 0.434 ' HA ' ' HE2' ' A' 1327 ' ' TYR . 15.1 t -62.86 -46.34 96.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 111.531 -2.577 . . . . 31.32 109.888 -168.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1073 ' ' ASN . . . . . 0.489 ' HA ' ' HB2' ' A' 1092 ' ' PHE . 63.3 m-80 -127.42 -160.11 0.98 Allowed 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.082 -1.081 . . . . 33.939999999999998 108.082 172.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -67.96 147.56 98.46 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 121.869 2.122 . . . . 38.039999999999999 111.481 173.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1075 ' ' PRO . . . . . 0.605 ' HG2' HD21 ' A' 1089 ' ' LEU . 22.9 Cg_exo -63.38 132.46 36.02 Favored 'Trans proline' 0 C--O 1.266 1.89 0 C-N-CA 123.332 2.688 . . . . 42.68 111.065 163.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 11.8 mt -90.81 175.98 6.8 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 105.51 -2.033 . . . . 46.740000000000002 105.51 170.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.71 -31.82 49.56 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.655 1.724 . . . . 58.609999999999999 115.655 -171.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 13.1 t70 -65.9 -52.06 53.35 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.037 -0.727 . . . . 59.200000000000003 109.037 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1079 ' ' GLU . . . . . 0.578 ' HA ' HD12 ' A' 1082 ' ' LEU . 1.9 mp0 -62.92 -31.03 72.02 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 114.294 1.22 . . . . 50.630000000000003 114.294 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1080 ' ' ILE . . . . . 0.447 HD13 ' HB2' ' A' 1104 ' ' LYS . 57.5 mt -61.97 -44.88 99.52 Favored 'Isoleucine or valine' 0 C--N 1.346 0.418 0 CA-C-N 115.948 -0.569 . . . . 51.479999999999997 111.109 170.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -59.49 -33.23 71.07 Favored 'General case' 0 C--O 1.25 1.112 0 CA-C-O 122.755 1.264 . . . . 50.280000000000001 113.646 170.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1082 ' ' LEU . . . . . 0.578 HD12 ' HA ' ' A' 1079 ' ' GLU . 66.2 mt -72.33 -26.77 62.06 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.228 -1.351 . . . . 50.210000000000001 112.49 173.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1083 ' ' LEU . . . . . 0.627 HD12 HG11 ' A' 1110 ' ' VAL . 3.6 mm? -60.81 149.73 34.97 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 125.73 2.681 . . . . 49.060000000000002 113.574 172.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 4.9 m120 -113.3 136.84 21.86 Favored Pre-proline 0 N--CA 1.437 -1.106 0 CA-C-N 111.361 -2.654 . . . . 51.079999999999998 107.097 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -60.2 124.59 15.53 Favored 'Trans proline' 0 N--CA 1.435 -1.914 0 C-N-CA 121.4 1.4 . . . . 49.729999999999997 115.014 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 91.7 8.43 63.77 Favored Glycine 0 C--O 1.259 1.709 0 N-CA-C 111.158 -0.777 . . . . 47.710000000000001 111.158 -177.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1087 ' ' THR . . . . . 0.406 HG21 HG12 ' A' 1069 ' ' ILE . 72.7 m -84.66 145.64 27.87 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 123.208 1.48 . . . . 45.469999999999999 110.652 167.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1088 ' ' THR . . . . . . . . . . . . . 52.3 m -91.98 121.53 33.65 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 118.19 -2.819 . . . . 42.039999999999999 104.295 173.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1089 ' ' LEU . . . . . 0.605 HD21 ' HG2' ' A' 1075 ' ' PRO . 55.6 tp -106.84 116.66 32.3 Favored 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 123.961 0.904 . . . . 38.060000000000002 109.029 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 38.5 t -114.62 124.49 71.32 Favored 'Isoleucine or valine' 0 C--O 1.25 1.081 0 N-CA-C 105.184 -2.154 . . . . 37.399999999999999 105.184 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1091 ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' 1073 ' ' ASN . 3.5 m -158.46 168.56 26.62 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 122.424 1.107 . . . . 36.159999999999997 113.049 -174.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1092 ' ' PHE . . . . . 0.489 ' HB2' ' HA ' ' A' 1073 ' ' ASN . 14.9 m-85 -82.23 94.85 7.38 Favored 'General case' 0 C--O 1.25 1.087 0 O-C-N 119.579 -1.951 . . . . 38.939999999999998 108.486 165.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 26.6 mm -84.76 -34.63 9.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 113.864 1.061 . . . . 42.170000000000002 113.864 -172.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 84.0 m95 57.99 60.06 6.29 Favored Pre-proline 0 C--N 1.357 0.921 0 C-N-CA 123.086 0.554 . . . . 46.509999999999998 111.56 -169.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -62.78 -34.22 73.59 Favored 'Trans proline' 0 C--O 1.241 0.646 0 C-N-CA 124.185 3.257 . . . . 49.759999999999998 117.013 -165.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -69.2 -35.99 76.82 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 124.643 1.215 . . . . 52.619999999999997 108.784 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -76.78 -30.28 56.42 Favored 'General case' 0 C--O 1.216 -0.669 0 CA-C-N 115.151 -0.931 . . . . 60.740000000000002 109.34 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1098 ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -109.84 36.03 0.11 Allowed Pre-proline 0 CA--C 1.557 1.215 1 N-CA-C 124.96 5.17 . . . . 58.189999999999998 124.96 -169.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -52.09 -24.08 18.96 Favored 'Trans proline' 0 C--N 1.366 1.493 0 C-N-CA 124.655 3.57 . . . . 54.590000000000003 113.961 175.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -57.84 -59.53 5.09 Favored 'General case' 0 C--O 1.253 1.287 0 CA-C-O 124.396 2.046 . . . . 63.280000000000001 110.019 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1101 ' ' LEU . . . . . . . . . . . . . 5.4 mp -70.55 -42.07 71.66 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 111.526 -2.579 . . . . 54.75 107.587 -175.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1102 ' ' MET . . . . . . . . . . . . . 72.0 mtm -56.74 -39.22 73.56 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 114.757 1.391 . . . . 52.649999999999999 114.757 174.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -62.78 -38.33 90.2 Favored 'General case' 0 C--N 1.35 0.608 0 O-C-N 119.968 -1.707 . . . . 66.260000000000005 110.329 -178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1104 ' ' LYS . . . . . 0.447 ' HB2' HD13 ' A' 1080 ' ' ILE . 87.7 mttt -74.18 -36.76 64.07 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 114.262 -1.335 . . . . 63.729999999999997 110.49 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 22.6 mt -63.64 -35.1 79.41 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 120.652 -1.28 . . . . 54.68 112.699 169.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -65.97 -41.45 91.17 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 106.907 -1.516 . . . . 53.640000000000001 106.907 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -51.46 -46.01 62.91 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 113.94 1.089 . . . . 67.239999999999995 113.94 168.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -67.18 1.12 2.24 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 115.848 1.796 . . . . 65.760000000000005 115.848 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 12.6 t-20 49.81 44.55 25.03 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 125.088 2.375 . . . . 58.710000000000001 113.925 177.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1110 ' ' VAL . . . . . 0.627 HG11 HD12 ' A' 1083 ' ' LEU . 3.7 m -110.75 152.6 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 113.944 -1.48 . . . . 46.630000000000003 109.421 -178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1111 ' ' THR . . . . . . . . . . . . . 89.4 m -89.14 99.85 12.75 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 106.881 -1.526 . . . . 44.130000000000003 106.881 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1112 ' ' VAL . . . . . 0.57 ' HB ' ' HB ' ' A' 1361 ' ' ILE . 91.6 t -91.56 128.01 43.55 Favored 'Isoleucine or valine' 0 C--O 1.253 1.25 0 CA-C-O 123.829 1.776 . . . . 40.439999999999998 110.366 -176.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1113 ' ' MET . . . . . 0.648 ' SD ' HD21 ' A' 1334 ' ' LEU . 35.2 mtp -119.27 123.18 43.63 Favored 'General case' 0 C--O 1.255 1.367 0 N-CA-C 105.79 -1.93 . . . . 50.759999999999998 105.79 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1114 ' ' ALA . . . . . . . . . . . . . . . -99.42 96.62 7.82 Favored 'General case' 0 N--CA 1.428 -1.575 0 O-C-N 124.106 0.879 . . . . 35.640000000000001 111.896 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1115 ' ' MET . . . . . 0.563 ' HB3' ' HB3' ' A' 1129 ' ' ALA . 36.0 mmm -65.33 -17.77 64.78 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 116.765 2.135 . . . . 38.740000000000002 116.765 -173.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1116 ' ' ASP . . . . . 0.462 ' HA ' ' HB2' ' A' 1130 ' ' LEU . 7.5 p-10 -73.67 -36.52 65.35 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 118.179 -0.915 . . . . 40.140000000000001 108.561 168.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1117 ' ' SER . . . . . . . . . . . . . 63.6 m -102.37 62.3 0.86 Allowed 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 125.05 2.357 . . . . 44.789999999999999 109.801 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1118 ' ' VAL . . . . . . . . . . . . . 87.4 t -90.94 134.31 30.5 Favored Pre-proline 0 C--O 1.243 0.739 0 N-CA-C 106.55 -1.648 . . . . 43.75 106.55 174.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -46.13 120.9 3.96 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.732 3.622 . . . . 48.93 111.299 171.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -63.3 -4.56 2.66 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 117.502 2.408 . . . . 62.899999999999999 117.502 -169.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 45.1 pt -66.77 158.14 5.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 115.172 1.545 . . . . 57.719999999999999 115.172 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1122 ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.66 -49.19 68.48 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 125.499 1.75 . . . . 57.259999999999998 114.242 -173.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 21.4 ptt85 -63.21 -13.34 36.43 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 118.36 -2.712 . . . . 62.899999999999999 115.286 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -89.65 -21.37 22.81 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 120.394 -1.441 . . . . 49.829999999999998 108.573 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -61.27 -20.51 62.96 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 115.532 1.679 . . . . 52.369999999999997 115.532 -163.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1126 ' ' SER . . . . . . . . . . . . . 6.0 p -68.52 -39.0 81.36 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.184 0.902 . . . . 42.43 112.341 168.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1127 ' ' LEU . . . . . 0.438 ' O ' ' HB3' ' A' 1330 ' ' ASN . 5.1 mp -82.56 -23.68 34.36 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.277 -0.874 . . . . 43.740000000000002 110.977 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 10.1 t0 -68.04 105.03 1.91 Allowed 'General case' 0 C--O 1.246 0.908 0 CA-C-O 124.658 2.17 . . . . 43.210000000000001 112.361 -167.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1129 ' ' ALA . . . . . 0.563 ' HB3' ' HB3' ' A' 1115 ' ' MET . . . -72.37 -41.22 66.63 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 111.159 -2.746 . . . . 35.740000000000002 111.502 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1130 ' ' LEU . . . . . 0.462 ' HB2' ' HA ' ' A' 1116 ' ' ASP . 9.0 tp -54.94 -40.94 70.47 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 118.889 0.768 . . . . 38.090000000000003 112.009 175.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1131 ' ' SER . . . . . 0.651 ' HA ' HG21 ' A' 1175 ' ' VAL . 68.1 m -54.8 -53.01 60.82 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-N 119.979 1.263 . . . . 36.909999999999997 112.732 176.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1132 ' ' SER . . . . . . . . . . . . . 4.6 m -65.2 -37.49 87.48 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 119.312 0.96 . . . . 35.789999999999999 113.303 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1133 ' ' MET . . . . . 0.478 ' HE2' HD12 ' A' 1136 ' ' ILE . 24.8 mmt -59.46 -45.46 91.56 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 121.893 2.133 . . . . 30.809999999999999 115.69 171.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1134 ' ' ALA . . . . . 0.439 ' HB1' ' HB2' ' A' 1176 ' ' ALA . . . -69.29 -39.75 78.13 Favored 'General case' 0 CA--C 1.504 -0.803 0 O-C-N 124.275 0.984 . . . . 28.879999999999999 109.936 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1135 ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -53.27 -47.76 68.86 Favored 'General case' 0 C--O 1.245 0.86 0 O-C-N 123.972 0.795 . . . . 40.759999999999998 112.518 169.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1136 ' ' ILE . . . . . 0.744 HG23 HD23 ' A' 1319 ' ' LEU . 71.4 mt -59.95 -44.71 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 107.951 -1.129 . . . . 31.539999999999999 107.951 177.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -60.06 -44.01 95.02 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-O 117.251 -1.357 . . . . 29.870000000000001 111.109 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -62.3 -46.79 93.17 Favored Glycine 0 N--CA 1.439 -1.155 0 CA-C-N 123.074 2.67 . . . . 28.73 112.478 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 36.5 t80 -59.87 -48.97 79.52 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 122.353 1.073 . . . . 30.390000000000001 109.226 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1140 ' ' ARG . . . . . 0.66 HH11 HD13 ' A' 1319 ' ' LEU . 3.7 tpt180 -65.58 -24.46 67.08 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 112.895 0.702 . . . . 26.09 112.895 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1141 ' ' ALA . . . . . 0.839 ' HB2' HD21 ' A' 1284 ' ' LEU . . . -65.73 -44.83 84.82 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 109.655 -0.498 . . . . 27.100000000000001 109.655 173.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1142 ' ' ILE . . . . . 0.461 HG13 ' HB3' ' A' 1183 ' ' ALA . 42.2 mm -57.36 -38.67 63.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 123.984 0.914 . . . . 28.48 109.664 175.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 97.7 t -68.05 -59.89 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-O 121.242 0.544 . . . . 23.07 111.804 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1144 ' ' GLU . . . . . 0.421 ' CD ' HH21 ' A' 1140 ' ' ARG . 4.4 mm-40 -61.05 -28.56 69.16 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 120.637 -1.289 . . . . 33.399999999999999 111.642 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1145 ' ' ALA . . . . . 0.525 ' HB1' HD12 ' A' 1251 ' ' ILE . . . -65.73 -60.71 2.62 Favored 'General case' 0 C--O 1.206 -1.209 0 CA-C-O 115.256 -2.307 . . . . 24.219999999999999 107.227 171.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -55.17 -18.62 6.11 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 121.922 2.146 . . . . 24.890000000000001 115.881 176.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -68.21 -56.36 8.97 Favored 'General case' 0 N--CA 1.439 -1.011 0 O-C-N 120.438 -1.413 . . . . 26.73 111.267 169.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1148 ' ' GLU . . . . . 0.666 ' HB2' HD11 ' A' 1310 ' ' ILE . 54.3 mm-40 -90.35 -12.67 36.96 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 118.025 2.602 . . . . 39.960000000000001 118.025 -174.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1149 ' ' PHE . . . . . . . . . . . . . 2.9 t80 -67.92 152.24 45.86 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 124.086 1.898 . . . . 25.870000000000001 108.186 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1150 ' ' GLY . . . . . . . . . . . . . . . -74.01 -48.62 15.31 Favored Glycine 0 N--CA 1.41 -3.058 0 CA-C-N 111.554 -2.566 . . . . 19.280000000000001 113.075 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1151 ' ' ARG . . . . . 0.765 ' HA ' ' HB2' ' B' 1322 ' ' GLN . 61.8 mtm-85 -103.56 176.25 5.21 Favored 'General case' 0 C--O 1.25 1.1 0 N-CA-C 109.241 -0.652 . . . . 39.899999999999999 109.241 -164.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1152 ' ' PHE . . . . . 0.7 ' HB2' HG11 ' A' 1163 ' ' VAL . 12.0 m-30 -76.24 161.11 29.04 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 120.87 -1.144 . . . . 29.440000000000001 108.122 169.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1153 ' ' PHE . . . . . 0.606 ' HB3' ' HB2' ' A' 1189 ' ' ALA . 7.8 m-85 -78.78 -48.61 14.51 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 122.891 1.329 . . . . 32.600000000000001 108.662 168.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1154 ' ' THR . . . . . . . . . . . . . 9.7 m -64.45 116.62 6.3 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 115.252 1.575 . . . . 34.640000000000001 115.252 -170.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -66.49 88.67 0.13 Allowed Glycine 0 C--O 1.24 0.486 0 N-CA-C 110.666 -0.973 . . . . 37.140000000000001 110.666 173.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -139.45 178.89 6.88 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 124.883 2.278 . . . . 40.57 111.137 -173.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1157 ' ' ILE . . . . . 0.693 ' HB ' ' HG2' ' C' ' 95' ' ' GLU . 3.1 tp -107.53 153.44 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 112.928 -1.942 . . . . 44.609999999999999 107.548 167.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1158 ' ' THR . . . . . 0.501 ' O ' HG13 ' A' 1157 ' ' ILE . 24.5 p -103.76 -143.63 0.36 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.539 -1.282 . . . . 40.700000000000003 107.539 169.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -94.45 -25.15 17.02 Favored 'General case' 0 C--O 1.246 0.869 0 O-C-N 119.301 -2.124 . . . . 40.25 110.233 167.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -82.78 -56.53 3.78 Favored 'General case' 0 C--O 1.249 1.059 0 O-C-N 121.914 -0.491 . . . . 38.469999999999999 111.952 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1161 ' ' GLY . . . . . 0.623 ' HA3' HG21 ' B' 1329 ' ' THR . . . -169.02 -173.42 36.71 Favored Glycine 0 N--CA 1.476 1.333 0 N-CA-C 111.894 -0.483 . . . . 37.609999999999999 111.894 -164.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 15.6 tttp -78.35 151.8 32.68 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 126.057 1.743 . . . . 48.899999999999999 111.772 -170.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1163 ' ' VAL . . . . . 0.7 HG11 ' HB2' ' A' 1152 ' ' PHE . 92.5 t -102.07 123.86 42.04 Favored Pre-proline 0 N--CA 1.44 -0.942 0 CA-C-N 113.197 -1.82 . . . . 36.520000000000003 108.019 161.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1164 ' ' PRO . . . . . 0.502 ' HD2' ' HA ' ' A' 1163 ' ' VAL . 47.2 Cg_endo -62.82 114.47 2.43 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 123.897 3.064 . . . . 35.079999999999998 115.046 162.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1165 ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' 1164 ' ' PRO . 61.8 Cg_exo -61.91 130.8 32.34 Favored 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 124.142 3.228 . . . . 35.329999999999998 113.42 -171.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1166 ' ' ALA . . . . . 0.427 ' HB2' ' HA ' ' A' 1153 ' ' PHE . . . -66.8 123.39 20.01 Favored 'General case' 0 CA--C 1.501 -0.925 0 O-C-N 125.043 1.464 . . . . 34.689999999999998 112.055 172.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1167 ' ' LYS . . . . . 0.522 ' HA ' ' HB ' ' A' 1190 ' ' ILE . 7.1 mttp -96.89 94.32 7.16 Favored 'General case' 0 CA--C 1.486 -1.494 0 N-CA-C 105.227 -2.138 . . . . 45.359999999999999 105.227 176.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 20.2 t -82.19 97.83 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 C-N-CA 124.479 1.111 . . . . 31.710000000000001 108.215 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1169 ' ' MET . . . . . 0.483 ' O ' ' HA ' ' A' 1252 ' ' ILE . 59.2 ttp -77.96 125.78 29.85 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.037 -1.468 . . . . 42.280000000000001 107.037 166.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 94.6 t -111.86 112.04 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 106.828 -1.545 . . . . 30.510000000000002 106.828 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1171 ' ' ILE . . . . . 0.535 HD12 HG23 ' A' 1254 ' ' THR . 75.8 mt -88.69 116.29 30.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 119.979 -1.701 . . . . 31.870000000000001 109.412 173.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 93.61 89.51 1.61 Allowed Glycine 0 C--O 1.215 -1.043 0 N-CA-C 109.215 -1.554 . . . . 34.539999999999999 109.215 171.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1173 ' ' ALA . . . . . 0.489 ' HA ' ' HA3' ' A' 1177 ' ' GLY . . . -80.95 67.73 6.96 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 123.05 1.405 . . . . 32.509999999999998 110.19 176.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -100.98 -153.73 26.5 Favored Glycine 0 C--O 1.217 -0.95 0 CA-C-O 117.101 -1.944 . . . . 29.899999999999999 108.369 167.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1175 ' ' VAL . . . . . 0.651 HG21 ' HA ' ' A' 1131 ' ' SER . 0.0 OUTLIER -58.45 -49.03 83.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 CA-C-N 121.438 2.619 . . . . 33.109999999999999 111.931 -178.542 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 1176 ' ' ALA . . . . . 0.439 ' HB2' ' HB1' ' A' 1134 ' ' ALA 0.26 . . -59.89 -36.98 78.11 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 121.984 0.897 . . . . 28.100000000000001 110.538 174.91 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 1177 ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' 1173 ' ' ALA . . . -63.96 -55.05 26.57 Favored Glycine 0 C--O 1.215 -1.057 0 N-CA-C 109.63 -1.388 . . . . 28.539999999999999 109.63 -175.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1178 ' ' LEU . . . . . 0.673 HD23 HD12 ' A' 1181 ' ' ILE . 29.5 mt -65.7 -30.76 71.49 Favored 'General case' 0 C--O 1.254 1.303 0 CA-C-N 114.231 -0.984 . . . . 31.219999999999999 110.869 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -66.28 -40.34 90.03 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.022 -1.674 . . . . 28.98 112.391 173.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -65.03 -42.18 94.59 Favored 'General case' 0 C--O 1.221 -0.433 0 O-C-N 119.23 -2.169 . . . . 27.829999999999998 112.261 173.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1181 ' ' ILE . . . . . 0.673 HD12 HD23 ' A' 1178 ' ' LEU . 71.1 mt -54.07 -55.09 15.94 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 CA-C-O 118.46 -0.781 . . . . 30.25 110.055 172.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -59.3 -53.27 47.64 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-O 122.957 1.309 . . . . 29.59 111.633 -175.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1183 ' ' ALA . . . . . 0.461 ' HB3' HG13 ' A' 1142 ' ' ILE . . . -50.39 -64.22 0.88 Allowed 'General case' 0 C--N 1.348 0.535 0 O-C-N 120.022 -1.869 . . . . 30.289999999999999 113.535 173.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -60.8 -37.86 83.4 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 115.86 1.8 . . . . 30.469999999999999 115.86 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -60.11 -45.91 91.4 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 107.923 -1.14 . . . . 42.409999999999997 107.923 174.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1186 ' ' SER . . . . . . . . . . . . . 67.4 m -62.77 -44.33 96.47 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 123.458 1.599 . . . . 39.380000000000003 113.026 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 25.2 tp -63.87 -30.94 71.98 Favored 'General case' 0 C--O 1.244 0.796 0 O-C-N 119.765 -1.834 . . . . 36.18 110.36 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 108.89 40.14 1.61 Allowed Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 125.722 1.629 . . . . 33.780000000000001 114.114 170.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1189 ' ' ALA . . . . . 0.606 ' HB2' ' HB3' ' A' 1153 ' ' PHE . . . -108.75 161.18 15.34 Favored 'General case' 0 CA--C 1.49 -1.332 0 O-C-N 121.164 -1.198 . . . . 33.93 110.745 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1190 ' ' ILE . . . . . 0.522 ' HB ' ' HA ' ' A' 1167 ' ' LYS . 67.8 mt -72.56 120.29 20.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 104.996 -2.224 . . . . 38.740000000000002 104.996 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1191 ' ' VAL . . . . . 0.507 HG11 ' HA ' ' A' 1181 ' ' ILE . 10.1 t -110.65 129.2 66.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.15 -1.426 . . . . 33.090000000000003 107.15 175.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1192 ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' 1210 ' ' GLU . 71.9 mtt180 -127.59 101.89 6.6 Favored 'General case' 0 N--CA 1.438 -1.027 0 O-C-N 125.399 1.687 . . . . 38.920000000000002 108.022 173.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -100.47 152.3 20.54 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.619 0.723 . . . . 35.32 112.536 -175.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1194 ' ' PHE . . . . . 0.455 ' HZ ' ' HG2' ' A' 1238 ' ' GLU . 79.1 t80 -128.67 148.35 50.81 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 127.751 2.42 . . . . 39.350000000000001 105.231 -172.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 7.9 t70 -166.59 161.89 16.22 Favored 'General case' 0 C--O 1.243 0.714 0 O-C-N 124.483 1.114 . . . . 40.460000000000001 109.966 170.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1196 ' ' THR . . . . . 0.441 HG23 ' CE2' ' A' 1234 ' ' PHE . 0.8 OUTLIER -67.86 -42.41 81.36 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 113.625 -1.625 . . . . 45.939999999999998 107.734 179.684 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 1197 ' ' ARG . . . . . . . . . . . . . 47.7 mtm180 -94.26 117.67 67.08 Favored Pre-proline 0 C--O 1.212 -0.892 0 C-N-CA 123.97 0.908 . . . . 56.020000000000003 109.65 -162.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1198 ' ' PRO . . . . . 0.47 ' O ' ' HB3' ' A' 1201 ' ' LYS . 74.5 Cg_endo -68.12 -8.82 23.89 Favored 'Trans proline' 0 C--N 1.36 1.142 0 C-N-CA 124.125 3.217 . . . . 51.270000000000003 114.555 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.44 -35.63 34.73 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 120.299 -1.501 . . . . 59.100000000000001 108.485 -177.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 15.0 m -71.36 -26.39 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 113.662 0.986 . . . . 51.060000000000002 113.662 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1201 ' ' LYS . . . . . 0.47 ' HB3' ' O ' ' A' 1198 ' ' PRO . 74.9 tttt -39.39 -42.41 1.07 Allowed 'General case' 0 C--O 1.239 0.512 0 N-CA-C 115.878 1.807 . . . . 57.380000000000003 115.878 166.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -57.37 -47.85 80.59 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 114.814 -1.085 . . . . 62.409999999999997 111.114 177.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -69.46 -41.61 75.97 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 118.752 -0.642 . . . . 57.780000000000001 109.634 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1204 ' ' VAL . . . . . 0.404 HG11 ' HD1' ' A' 1211 ' ' PHE . 99.9 t -51.95 -54.65 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 120.276 1.398 . . . . 46.380000000000003 114.529 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -53.42 -51.22 63.29 Favored 'General case' 0 N--CA 1.427 -1.585 0 C-N-CA 125.208 1.403 . . . . 50.700000000000003 112.452 169.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1206 ' ' SER . . . . . . . . . . . . . 7.1 m -78.41 4.15 13.86 Favored 'General case' 0 C--O 1.261 1.663 0 O-C-N 119.429 -2.044 . . . . 49.979999999999997 115.531 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1207 ' ' MET . . . . . . . . . . . . . 75.6 mtp -99.69 -1.86 36.83 Favored 'General case' 0 C--O 1.244 0.784 0 O-C-N 119.87 -1.769 . . . . 52.990000000000002 111.828 169.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 86.79 48.93 4.26 Favored Glycine 0 C--N 1.346 1.13 0 C-N-CA 120.304 -0.95 . . . . 47.659999999999997 111.112 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -137.62 153.67 49.86 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 124.532 2.11 . . . . 44.770000000000003 108.353 170.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1210 ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' 1192 ' ' ARG . 20.9 tt0 -85.44 134.17 34.07 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 113.094 -1.866 . . . . 47.640000000000001 106.351 172.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1211 ' ' PHE . . . . . 0.404 ' HD1' HG11 ' A' 1204 ' ' VAL . 39.2 t80 -86.09 128.06 34.8 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 120.42 -1.425 . . . . 45.659999999999997 109.174 175.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 32.5 mt -99.44 115.02 28.32 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 106.072 -1.825 . . . . 46.060000000000002 106.072 171.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -88.02 167.88 13.31 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-O 122.708 1.242 . . . . 60.219999999999999 109.876 167.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1214 ' ' LEU . . . . . 0.464 HD23 ' HB3' ' A' 1237 ' ' ALA . 4.9 mp -74.22 136.41 42.76 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 106.471 -1.677 . . . . 57.25 106.471 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.75 92.46 1.57 Allowed 'General case' 0 C--O 1.243 0.734 0 N-CA-C 107.411 -1.329 . . . . 64.430000000000007 107.411 166.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 5.1 t80 . . . . . 0 CA--C 1.506 -0.734 0 CA-C-N 114.326 -1.306 . . . . 66.900000000000006 111.277 -167.368 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 6.1 p-10 . . . . . 0 N--CA 1.443 -0.816 0 N-CA-C 103.313 -2.847 . . . . 39.090000000000003 103.313 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -55.09 -37.36 63.28 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.61 -0.723 . . . . 39.32 113.089 -175.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 84.2 t80 -69.3 -54.26 15.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 117.759 0.78 . . . . 39.299999999999997 111.11 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -67.05 -34.01 76.75 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 119.277 0.944 . . . . 36.299999999999997 112.917 -177.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -62.01 -37.41 84.75 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 113.122 0.786 . . . . 37.380000000000003 113.122 168.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -70.87 -36.1 62.8 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 CA-C-N 121.429 1.922 . . . . 39.109999999999999 110.579 169.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1230 ' ' MET . . . . . . . . . . . . . 33.2 mmt -90.22 63.5 5.78 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 124.101 1.905 . . . . 49.590000000000003 110.97 -177.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1231 ' ' SER . . . . . . . . . . . . . 67.0 m -151.68 126.64 9.73 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 110.847 -2.888 . . . . 43.68 107.141 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -56.78 -18.27 12.1 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 114.136 1.162 . . . . 55.57 114.136 -176.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -56.75 -49.02 76.49 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 114.238 1.199 . . . . 44.939999999999998 114.238 167.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1234 ' ' PHE . . . . . 0.441 ' CE2' HG23 ' A' 1196 ' ' THR . 19.5 t80 -63.07 -56.6 15.49 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 124.835 1.254 . . . . 42.039999999999999 108.151 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1235 ' ' ILE . . . . . 0.415 ' O ' ' HG2' ' A' 1239 ' ' MET . 93.0 mt -51.72 -45.32 37.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 114.532 -1.213 . . . . 46.280000000000001 110.173 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1236 ' ' LYS . . . . . 0.624 ' O ' ' HG3' ' A' 1240 ' ' GLU . 26.7 tttm -66.16 -39.9 90.12 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 115.69 -2.1 . . . . 47.869999999999997 111.791 175.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1237 ' ' ALA . . . . . 0.464 ' HB3' HD23 ' A' 1214 ' ' LEU . . . -64.08 -37.5 87.68 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-N 121.98 2.173 . . . . 41.609999999999999 112.629 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1238 ' ' GLU . . . . . 0.455 ' HG2' ' HZ ' ' A' 1194 ' ' PHE . 48.5 mt-10 -55.59 -56.87 15.24 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 106.524 -1.658 . . . . 50.649999999999999 106.524 170.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1239 ' ' MET . . . . . 0.415 ' HG2' ' O ' ' A' 1235 ' ' ILE . 97.7 mmm -50.0 -48.91 52.17 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.713 1.005 . . . . 48.869999999999997 113.713 178.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1240 ' ' GLU . . . . . 0.624 ' HG3' ' O ' ' A' 1236 ' ' LYS . 29.5 mt-10 -62.72 -40.17 96.36 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 119.462 -2.024 . . . . 54.799999999999997 110.749 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.32 -46.56 79.81 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.455 0.702 . . . . 43.210000000000001 111.855 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -64.33 -47.34 79.77 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 106.659 -1.608 . . . . 38.659999999999997 106.659 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -62.63 -32.9 74.02 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 122.761 1.267 . . . . 37.920000000000002 114.14 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1244 ' ' ALA . . . . . 0.45 ' O ' ' HE2' ' A' 1247 ' ' LYS . . . -70.02 -51.94 28.13 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.634 -0.876 . . . . 37.280000000000001 108.634 174.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -61.31 -29.05 69.64 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 113.593 0.96 . . . . 43.07 113.593 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -51.1 -34.24 29.64 Favored 'General case' 0 C--O 1.248 1.01 0 C-N-CA 126.249 1.82 . . . . 38.299999999999997 112.612 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1247 ' ' LYS . . . . . 0.45 ' HE2' ' O ' ' A' 1244 ' ' ALA . 11.3 mtmm -57.7 -22.3 45.49 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 118.505 2.78 . . . . 47.600000000000001 118.505 174.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.78 -30.73 0.81 Allowed 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 117.383 2.364 . . . . 45.420000000000002 117.383 -171.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1249 ' ' VAL . . . . . . . . . . . . . 34.6 m -70.06 158.6 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 123.661 1.696 . . . . 36.259999999999998 111.386 -173.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1250 ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -103.04 -50.78 3.41 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 113.884 -1.507 . . . . 33.039999999999999 111.641 -172.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1251 ' ' ILE . . . . . 0.525 HD12 ' HB1' ' A' 1145 ' ' ALA . 51.7 mm -121.05 138.33 51.82 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 N-CA-C 103.938 -2.616 . . . . 31.399999999999999 103.938 -177.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1252 ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' 1169 ' ' MET . 39.5 mt -120.87 113.68 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 105.798 -1.927 . . . . 29.420000000000002 105.798 166.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 27.7 t -97.0 111.46 26.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 104.504 -2.406 . . . . 30.370000000000001 104.504 176.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1254 ' ' THR . . . . . 0.535 HG23 HD12 ' A' 1171 ' ' ILE . 0.2 OUTLIER -108.58 112.01 24.13 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 102.468 -3.16 . . . . 35.719999999999999 102.468 -173.532 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 1255 ' ' THR . . . . . 0.522 HG22 HD12 ' A' 1284 ' ' LEU . 66.1 p -98.89 -27.55 13.85 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 120.004 3.335 . . . . 36.0 120.004 -159.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1256 ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' 1263 ' ' ALA . . . -71.19 82.31 0.72 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 118.579 2.807 . . . . 40.93 118.579 -140.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 52.9 tp -84.39 84.18 7.73 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 104.897 -2.26 . . . . 47.82 104.897 175.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 26.0 mm -70.26 131.14 88.77 Favored Pre-proline 0 N--CA 1.431 -1.417 0 CA-C-N 112.701 -2.045 . . . . 52.700000000000003 107.83 172.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -59.78 133.75 52.99 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.3 2.667 . . . . 54.130000000000003 111.144 176.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 76.64 -67.44 2.6 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 122.581 1.101 . . . . 54.619999999999997 115.418 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1261 ' ' LYS . . . . . 0.422 ' HA ' ' HD2' ' A' 1262 ' ' PRO . 85.3 mttt -80.8 129.05 69.58 Favored Pre-proline 0 C--O 1.24 0.575 0 N-CA-C 114.839 1.422 . . . . 55.740000000000002 114.839 -173.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1262 ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' 1261 ' ' LYS . 11.0 Cg_endo -46.0 134.02 14.58 Favored 'Trans proline' 0 N--CA 1.451 -0.976 1 C-N-CA 127.395 5.397 . . . . 51.149999999999999 112.14 167.396 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 1263 ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' 1256 ' ' ALA . . . -64.94 131.88 95.32 Favored Pre-proline 0 C--O 1.246 0.881 0 CA-C-O 117.194 -1.384 . . . . 46.060000000000002 111.95 171.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -66.66 148.56 83.3 Favored 'Trans proline' 0 C--O 1.255 1.352 0 C-N-CA 123.379 2.719 . . . . 41.079999999999998 111.581 -177.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1265 ' ' LYS . . . . . 0.512 ' HD3' ' HA ' ' A' 1293 ' ' GLU . 61.8 mttm -85.75 79.09 9.42 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 124.356 2.026 . . . . 47.420000000000002 112.347 -175.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1266 ' ' LEU . . . . . 0.415 ' O ' ' SD ' ' A' 1239 ' ' MET . 93.5 mt -74.19 -59.01 2.92 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 110.737 -2.938 . . . . 39.219999999999999 113.125 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 63.8 mt -75.29 112.43 12.83 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 CA-C-N 120.884 1.675 . . . . 42.5 107.801 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1268 ' ' THR . . . . . . . . . . . . . 1.1 p -76.92 163.04 27.11 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.005 -1.452 . . . . 37.840000000000003 113.202 -176.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1269 ' ' ARG . . . . . 0.476 ' HG3' ' HB2' ' A' 1293 ' ' GLU . 58.7 mtt-85 -62.5 -40.46 96.78 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-O 121.793 0.806 . . . . 54.799999999999997 112.836 172.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -50.38 -51.86 42.36 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 124.874 1.27 . . . . 54.359999999999999 113.1 167.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1271 ' ' MET . . . . . . . . . . . . . 30.0 ttm -60.43 -48.04 83.47 Favored 'General case' 0 C--O 1.253 1.249 0 C-N-CA 124.831 1.252 . . . . 39.520000000000003 112.136 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1272 ' ' VAL . . . . . . . . . . . . . 60.0 t -57.33 -50.02 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 C-N-CA 123.69 0.796 . . . . 38.25 111.895 176.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -54.05 -43.89 70.61 Favored 'General case' 0 C--O 1.262 1.761 0 O-C-N 119.666 -1.896 . . . . 40.770000000000003 114.432 171.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1274 ' ' SER . . . . . . . . . . . . . 10.5 p -73.02 3.18 5.69 Favored 'General case' 0 CA--C 1.556 1.203 0 O-C-N 120.219 -1.55 . . . . 36.579999999999998 113.646 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1275 ' ' MET . . . . . 0.629 ' HB3' HG21 ' A' 1307 ' ' VAL . 0.3 OUTLIER -78.63 151.65 32.19 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 118.641 -2.537 . . . . 36.75 108.245 -179.071 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 1276 ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -66.4 142.0 57.75 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.056 1.742 . . . . 46.109999999999999 113.007 177.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1277 ' ' ALA . . . . . . . . . . . . . . . -72.69 153.06 41.37 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 115.327 1.603 . . . . 33.520000000000003 115.327 -169.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 80.02 37.66 21.41 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 108.694 -1.762 . . . . 31.27 108.694 174.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1279 ' ' SER . . . . . . . . . . . . . 19.7 m -139.56 163.27 32.99 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 119.27 1.535 . . . . 32.950000000000003 111.065 -160.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1280 ' ' VAL . . . . . 0.629 HG22 ' HB2' ' A' 1308 ' ' LYS . 92.7 t -123.78 148.78 27.76 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 O-C-N 118.496 -2.628 . . . . 27.43 111.175 -173.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1281 ' ' ILE . . . . . 0.406 HG12 ' HB ' ' A' 1252 ' ' ILE . 60.9 mt -121.83 112.18 33.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 103.872 -2.64 . . . . 30.300000000000001 103.872 164.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 4.1 t -98.5 134.59 36.55 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 104.984 -2.228 . . . . 28.629999999999999 104.984 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 6.1 t0 -111.55 121.32 44.86 Favored 'General case' 0 C--O 1.254 1.32 0 CA-C-N 114.692 -1.14 . . . . 36.270000000000003 108.956 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1284 ' ' LEU . . . . . 0.839 HD21 ' HB2' ' A' 1141 ' ' ALA . 72.4 mt -105.96 14.5 27.86 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.678 -0.692 . . . . 38.57 109.814 -175.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1285 ' ' ALA . . . . . 0.459 ' HB3' ' HA2' ' A' 1290 ' ' GLY . . . -104.95 -40.3 5.97 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 122.862 1.315 . . . . 37.560000000000002 109.015 169.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1286 ' ' ALA . . . . . 0.471 ' HA ' HG21 ' A' 1295 ' ' THR . . . 49.32 -81.0 0.01 OUTLIER 'General case' 0 C--O 1.263 1.809 0 N-CA-C 117.992 2.59 . . . . 40.329999999999998 117.992 173.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -76.61 -36.13 57.66 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 123.938 0.895 . . . . 56.850000000000001 111.865 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 52.4 t30 -80.13 77.98 6.81 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 104.802 -2.296 . . . . 45.859999999999999 104.802 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 72.16 -72.51 0.93 Allowed Glycine 0 CA--C 1.5 -0.854 0 N-CA-C 109.444 -1.462 . . . . 40.310000000000002 109.444 -176.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1290 ' ' GLY . . . . . 0.459 ' HA2' ' HB3' ' A' 1285 ' ' ALA . . . 87.16 117.32 1.13 Allowed Glycine 0 C--O 1.22 -0.722 0 N-CA-C 106.755 -2.538 . . . . 38.890000000000001 106.755 -175.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1291 ' ' ASN . . . . . 0.457 ' ND2' ' HB1' ' A' 1263 ' ' ALA . 12.4 m120 -65.46 -16.78 63.99 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 115.633 1.716 . . . . 37.229999999999997 115.633 -172.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1292 ' ' CYS . . . . . . . . . . . . . 36.0 t -103.34 157.08 17.27 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 119.45 1.023 . . . . 36.5 109.497 173.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1293 ' ' GLU . . . . . 0.512 ' HA ' ' HD3' ' A' 1265 ' ' LYS . 57.0 mt-10 -82.53 -9.17 59.52 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 115.331 1.604 . . . . 43.32 115.331 173.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -96.38 9.02 42.54 Favored 'General case' 0 C--O 1.244 0.778 0 O-C-N 117.55 -3.219 . . . . 41.32 111.699 172.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1295 ' ' THR . . . . . 0.483 HG23 ' HA3' ' A' 1311 ' ' GLY . 85.3 m -75.61 98.8 4.12 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.871 0.843 . . . . 35.299999999999997 111.072 -173.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1296 ' ' VAL . . . . . 0.819 ' HB ' ' HB2' ' A' 1299 ' ' GLU . 2.3 t -81.94 128.25 69.12 Favored Pre-proline 0 C--O 1.251 1.166 0 N-CA-C 102.622 -3.103 . . . . 34.840000000000003 102.622 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -51.42 105.34 0.11 Allowed 'Trans proline' 0 C--O 1.251 1.137 0 C-N-CA 124.773 3.649 . . . . 33.509999999999998 113.04 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1298 ' ' GLY . . . . . 0.482 ' HA2' ' H ' ' A' 1313 ' ' THR . . . 76.98 23.43 69.12 Favored Glycine 0 CA--C 1.504 -0.635 0 CA-C-N 113.328 -1.76 . . . . 32.189999999999998 113.937 175.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1299 ' ' GLU . . . . . 0.819 ' HB2' ' HB ' ' A' 1296 ' ' VAL . 45.5 mt-10 -131.6 170.58 14.56 Favored 'General case' 0 C--O 1.246 0.916 0 CA-C-N 118.86 1.33 . . . . 34.880000000000003 112.905 -175.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1300 ' ' ILE . . . . . 0.586 HG12 HG12 ' A' 1310 ' ' ILE . 43.3 mt -108.58 121.84 62.23 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.198 0 N-CA-C 106.044 -1.835 . . . . 32.289999999999999 106.044 169.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 16.0 t80 -97.96 126.5 43.4 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 103.624 -2.732 . . . . 37.25 103.624 169.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1302 ' ' THR . . . . . . . . . . . . . 8.2 m -106.41 123.91 48.8 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 119.735 1.152 . . . . 35.560000000000002 108.628 174.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1303 ' ' THR . . . . . . . . . . . . . 2.6 p -86.7 165.17 16.3 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 118.37 -0.824 . . . . 36.399999999999999 113.191 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -53.96 -41.1 67.44 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 121.254 1.843 . . . . 52.32 115.704 -176.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1305 ' ' ASN . . . . . 0.532 ' HA ' ' HB2' ' B' 1046 ' ' ASP . 53.2 p-10 -62.18 -24.05 66.97 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.369 -1.287 . . . . 40.039999999999999 111.741 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 98.23 44.51 2.56 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.294 -1.122 . . . . 36.960000000000001 110.294 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1307 ' ' VAL . . . . . 0.629 HG21 ' HB3' ' A' 1275 ' ' MET . 59.7 t -107.08 120.11 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 123.617 1.675 . . . . 33.399999999999999 108.584 168.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1308 ' ' LYS . . . . . 0.629 ' HB2' HG22 ' A' 1280 ' ' VAL . 61.2 mmtt -87.3 102.78 14.83 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 110.541 -3.027 . . . . 42.909999999999997 106.986 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 39.3 t -88.98 95.22 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.676 0 O-C-N 119.469 -2.019 . . . . 32.289999999999999 108.212 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1310 ' ' ILE . . . . . 0.666 HD11 ' HB2' ' A' 1148 ' ' GLU . 91.1 mt -89.54 95.17 5.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 O-C-N 120.76 -1.212 . . . . 30.989999999999998 110.093 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1311 ' ' GLY . . . . . 0.483 ' HA3' HG23 ' A' 1295 ' ' THR . . . -97.33 57.9 1.17 Allowed Glycine 0 N--CA 1.441 -1.012 0 O-C-N 120.483 -1.386 . . . . 28.949999999999999 113.798 178.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1312 ' ' TYR . . . . . . . . . . . . . 7.0 m-30 -77.36 131.82 38.26 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 122.914 1.34 . . . . 31.690000000000001 113.374 -169.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1313 ' ' THR . . . . . 0.482 ' H ' ' HA2' ' A' 1298 ' ' GLY . 8.8 p -86.6 -49.79 7.28 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 120.965 -1.084 . . . . 34.170000000000002 110.596 174.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -72.29 14.27 0.25 Allowed 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 117.367 2.358 . . . . 36.859999999999999 117.367 -167.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1315 ' ' LEU . . . . . . . . . . . . . 28.5 mt -51.04 -39.45 56.12 Favored Pre-proline 0 C--N 1.347 0.495 0 O-C-N 119.827 -1.796 . . . . 34.850000000000001 114.256 -173.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.74 -43.98 40.02 Favored 'Trans proline' 0 C--O 1.257 1.431 0 CA-C-N 124.408 2.61 . . . . 29.149999999999999 113.207 170.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -58.25 -45.12 94.55 Favored Glycine 0 CA--C 1.543 1.807 0 N-CA-C 109.124 -1.59 . . . . 27.289999999999999 109.124 174.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1318 ' ' ARG . . . . . 0.435 ' HB3' ' NH2' ' A' 1140 ' ' ARG . 90.2 mtt-85 -58.35 -23.38 56.6 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 116.47 2.026 . . . . 41.490000000000002 116.47 177.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1319 ' ' LEU . . . . . 0.744 HD23 HG23 ' A' 1136 ' ' ILE . 12.3 tp -123.07 67.27 32.9 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 104.018 -2.586 . . . . 27.609999999999999 104.018 175.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1320 ' ' PRO . . . . . 0.57 ' HB3' ' HB ' ' A' 1014 ' ' THR . 64.9 Cg_endo -58.14 -53.05 4.67 Favored 'Trans proline' 0 C--O 1.257 1.456 1 C-N-CA 125.396 4.064 . . . . 25.940000000000001 114.67 -163.243 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 1321 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.86 -39.79 91.05 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 109.868 -0.419 . . . . 25.010000000000002 109.868 -173.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1322 ' ' GLN . . . . . 0.699 ' HB2' ' HA ' ' B' 1151 ' ' ARG . 24.1 tp60 -64.83 -43.82 91.84 Favored 'General case' 0 CA--C 1.51 -0.563 0 O-C-N 123.968 0.792 . . . . 29.390000000000001 109.78 -175.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1323 ' ' SER . . . . . . . . . . . . . 49.6 m -58.47 -53.52 57.41 Favored 'General case' 0 CA--C 1.486 -1.514 0 CA-C-N 114.16 -1.382 . . . . 26.469999999999999 113.166 173.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1324 ' ' SER . . . . . 0.477 ' HB2' HG23 ' A' 1019 ' ' THR . 5.0 m -65.01 -29.37 70.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.324 -0.86 . . . . 27.780000000000001 110.002 -178.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -68.81 -59.66 2.93 Favored 'General case' 0 C--N 1.348 0.519 0 O-C-N 121.653 -0.654 . . . . 37.530000000000001 110.783 172.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1326 ' ' LEU . . . . . 0.506 HD12 HD11 ' A' 1136 ' ' ILE . 59.5 mt -72.29 -51.79 19.23 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 115.838 -2.03 . . . . 35.710000000000001 111.102 -170.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1327 ' ' TYR . . . . . 0.434 ' HE2' ' HA ' ' A' 1072 ' ' VAL . 7.3 t80 -48.83 -48.26 41.84 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 121.364 1.893 . . . . 31.59 110.96 170.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1328 ' ' GLY . . . . . 0.509 ' O ' HG23 ' A' 1332 ' ' VAL . . . -47.46 -52.52 14.06 Favored Glycine 0 N--CA 1.465 0.61 0 C-N-CA 124.229 0.918 . . . . 28.0 112.49 170.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1329 ' ' THR . . . . . 0.654 ' HB ' ' HB1' ' B' 1160 ' ' ALA . 77.2 m -70.4 -34.81 72.97 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 120.344 -1.68 . . . . 32.149999999999999 110.188 -173.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1330 ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' 1127 ' ' LEU . 29.4 m120 -64.65 -43.6 93.13 Favored 'General case' 0 C--O 1.21 -0.997 0 C-N-CA 119.521 -0.871 . . . . 34.359999999999999 111.28 173.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1331 ' ' LEU . . . . . 0.591 HD22 HD22 ' A' 1070 ' ' LEU . 80.6 mt -53.09 -44.83 67.88 Favored 'General case' 0 C--O 1.219 -0.534 0 O-C-N 124.71 1.256 . . . . 33.369999999999997 111.527 173.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1332 ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' 1328 ' ' GLY . 6.8 t -70.62 -37.12 68.37 Favored 'Isoleucine or valine' 0 C--O 1.245 0.842 0 CA-C-N 114.849 -1.069 . . . . 35.270000000000003 110.125 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1333 ' ' ASN . . . . . 0.629 ' HA ' ' HD2' ' A' 1336 ' ' LYS . 76.9 m-20 -69.89 -28.69 65.84 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 121.414 0.626 . . . . 37.659999999999997 111.227 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1334 ' ' LEU . . . . . 0.648 HD21 ' SD ' ' A' 1113 ' ' MET . 0.4 OUTLIER -71.52 -51.99 20.62 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 108.805 -0.813 . . . . 40.270000000000003 108.805 171.331 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 1335 ' ' LEU . . . . . 0.484 HD11 HD21 ' A' 1070 ' ' LEU . 37.1 mt -68.41 -5.91 21.7 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 115.564 1.69 . . . . 42.5 115.564 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1336 ' ' LYS . . . . . 0.629 ' HD2' ' HA ' ' A' 1333 ' ' ASN . 74.8 mttt -66.96 -35.75 80.68 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 119.85 -1.781 . . . . 47.810000000000002 111.823 162.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1337 ' ' LEU . . . . . 0.472 ' O ' ' HG3' ' A' 1340 ' ' LYS . 4.8 mp -78.08 -46.74 19.99 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 120.9 -1.125 . . . . 49.270000000000003 109.995 169.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1338 ' ' LEU . . . . . 0.466 ' HB2' ' HA ' ' A' 1335 ' ' LEU . 6.0 mp -76.81 16.96 0.46 Allowed 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 115.786 1.773 . . . . 50.539999999999999 115.786 176.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1339 ' ' CYS . . . . . . . . . . . . . 36.5 t -156.98 80.34 0.92 Allowed 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 126.042 2.829 . . . . 53.670000000000002 104.768 164.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1340 ' ' LYS . . . . . 0.604 ' HD2' HG21 ' A' 1347 ' ' THR . 82.6 mttt -79.08 -40.66 30.61 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 113.431 -1.713 . . . . 63.380000000000003 111.139 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -69.69 -51.26 36.1 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 113.706 1.002 . . . . 70.950000000000003 113.706 -166.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1342 ' ' LYS . . . . . 0.502 ' HE3' HD23 ' A' 1029 ' ' LEU . 36.3 mtpt 52.77 67.08 1.05 Allowed 'General case' 0 C--O 1.239 0.535 0 N-CA-C 117.499 2.407 . . . . 65.25 117.499 171.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1343 ' ' ASP . . . . . . . . . . . . 0.262 7.8 t70 59.82 -94.19 0.05 OUTLIER 'General case' 0 CA--C 1.502 -0.869 2 O-C-N 110.915 -7.365 . . . . 64.530000000000001 117.847 4.486 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A 1344 ' ' GLY . . . . . . . . . . . . . . . 117.86 70.15 0.38 Allowed Glycine 0 C--N 1.348 1.212 0 N-CA-C 107.764 -2.134 . . . . 59.719999999999999 107.764 172.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -167.78 149.56 5.52 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 113.683 -1.259 . . . . 64.090000000000003 108.12 -177.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1346 ' ' ILE . . . . . 0.442 HG23 HD11 ' A' 1068 ' ' ILE . 8.4 pt -55.38 125.22 10.03 Favored 'Isoleucine or valine' 0 C--O 1.247 0.95 0 N-CA-C 115.211 1.56 . . . . 58.82 115.211 178.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1347 ' ' THR . . . . . 0.604 HG21 ' HD2' ' A' 1340 ' ' LYS . 7.8 m -97.91 100.12 11.45 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 103.309 -2.848 . . . . 54.960000000000001 103.309 163.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1348 ' ' VAL . . . . . . . . . . . . . 15.1 t -90.87 113.08 26.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 106.663 -1.606 . . . . 55.640000000000001 106.663 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 27.9 t70 -112.55 145.22 40.69 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 122.194 0.997 . . . . 61.450000000000003 110.094 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 60.2 t80 -116.23 4.19 13.51 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.509 1.124 . . . . 58.630000000000003 109.238 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.77 -62.71 1.25 Allowed 'General case' 0 N--CA 1.477 0.893 0 O-C-N 119.723 -1.861 . . . . 62.060000000000002 110.469 -169.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 7.3 t70 -69.83 143.95 52.73 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 114.571 1.322 . . . . 54.07 114.571 -170.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 20.3 m -65.49 -29.73 48.01 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 CA-C-N 119.541 1.064 . . . . 50.68 111.114 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1354 ' ' VAL . . . . . . . . . . . . . 4.3 m -76.53 -17.26 14.97 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 O-C-N 120.284 -1.51 . . . . 47.68 110.404 -176.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1355 ' ' ILE . . . . . 0.406 HG23 HD11 ' A' 1338 ' ' LEU . 74.8 mt -100.34 -69.79 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.867 0 N-CA-C 106.636 -1.616 . . . . 48.490000000000002 106.636 171.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 40.4 tpt85 -55.73 -31.99 62.98 Favored 'General case' 0 C--N 1.349 0.548 0 O-C-N 120.653 -1.28 . . . . 48.270000000000003 114.286 -175.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -62.27 -46.18 94.45 Favored Glycine 0 CA--C 1.525 0.662 0 O-C-N 120.025 -1.672 . . . . 43.530000000000001 111.749 171.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1358 ' ' VAL . . . . . . . . . . . . . 42.4 t -72.18 -35.27 52.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 122.042 0.925 . . . . 45.119999999999997 111.025 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1359 ' ' THR . . . . . . . . . . . . . 25.6 m -69.07 88.43 0.41 Allowed 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 122.817 1.294 . . . . 42.939999999999998 109.162 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 16.1 m -76.83 -22.82 14.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-O 122.317 1.056 . . . . 43.259999999999998 113.122 176.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1361 ' ' ILE . . . . . 0.57 ' HB ' ' HB ' ' A' 1112 ' ' VAL . 30.5 mt -133.29 135.52 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 103.563 -2.754 . . . . 45.659999999999997 103.563 169.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1362 ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -117.68 113.11 21.4 Favored 'General case' 0 C--O 1.252 1.228 0 N-CA-C 104.879 -2.267 . . . . 61.340000000000003 104.879 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 26.53 73.6 0.03 OUTLIER 'General case' 0 C--O 1.231 0.115 0 C-N-CA 127.047 2.139 . . . . 49.759999999999998 113.186 -166.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 88.9 -38.1 3.24 Favored Glycine 0 CA--C 1.529 0.911 0 O-C-N 119.902 -1.749 . . . . 50.0 112.443 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -74.46 124.0 25.75 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 119.416 1.608 . . . . 56.920000000000002 109.168 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1366 ' ' ILE . . . . . 0.463 HG22 ' HB3' ' A' 1368 ' ' TRP . 10.2 mt -77.13 86.3 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.256 1.401 0 CA-C-O 123.07 1.414 . . . . 52.780000000000001 111.748 -178.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1367 ' ' THR . . . . . . . . . . . . . 16.6 p -70.95 -11.88 61.22 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 111.728 -2.487 . . . . 49.439999999999998 114.624 -174.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1368 ' ' TRP . . . . . 0.463 ' HB3' HG22 ' A' 1366 ' ' ILE . 26.3 t90 -47.44 133.81 10.05 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 127.362 2.265 . . . . 52.380000000000003 110.157 170.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -81.79 -166.61 5.19 Favored 'Cis proline' 0 C--O 1.238 0.497 0 N-CA-C 117.443 2.055 . . . . 46.939999999999998 117.443 4.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -73.63 140.69 78.65 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 117.113 -1.422 . . . . 45.909999999999997 110.925 164.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1371 ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -70.43 139.74 38.58 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.691 2.927 . . . . 46.390000000000001 107.052 164.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -65.64 -35.86 35.69 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.778 2.319 . . . . 46.719999999999999 117.073 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.235 -4.412 0 CA-C-N 120.726 1.603 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 7.1 m80 . . . . . 0 N--CA 1.438 -1.043 0 N-CA-C 104.143 -2.54 . . . . 63.439999999999998 104.143 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -106.14 65.49 0.69 Allowed 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 102.939 -2.985 . . . . 51.740000000000002 102.939 159.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1000 ' ' HIS . . . . . 0.478 ' HA ' ' CG ' ' B' 1067 ' ' GLU . 5.3 t-80 -76.1 128.03 34.16 Favored 'General case' 0 C--N 1.36 1.054 0 O-C-N 120.584 -1.322 . . . . 54.07 109.986 -173.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1001 ' ' GLY . . . . . 0.486 ' H ' ' HG3' ' B' 1067 ' ' GLU . . . 86.23 -6.47 81.6 Favored Glycine 0 C--O 1.218 -0.885 0 CA-C-O 121.656 0.587 . . . . 39.219999999999999 113.696 -169.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1002 ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -93.12 138.85 31.18 Favored 'General case' 0 C--O 1.252 1.185 0 CA-C-O 124.854 2.264 . . . . 38.119999999999997 109.482 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1003 ' ' ILE . . . . . 0.415 HG12 ' HB ' ' B' 1068 ' ' ILE . 49.0 mt -98.25 141.63 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 110.835 -2.893 . . . . 29.699999999999999 105.201 169.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1004 ' ' GLY . . . . . 0.421 ' CA ' HG22 ' B' 1063 ' ' VAL . . . -111.0 123.79 6.67 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 108.659 -1.776 . . . . 27.5 108.659 172.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1005 ' ' ILE . . . . . . . . . . . . . 41.1 mm -109.8 111.77 58.64 Favored Pre-proline 0 N--CA 1.447 -0.582 0 N-CA-C 106.515 -1.661 . . . . 24.829999999999998 106.515 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -74.7 156.36 44.36 Favored 'Trans proline' 0 N--CA 1.44 -1.626 0 C-N-CA 123.473 2.782 . . . . 27.190000000000001 115.944 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1007 ' ' ARG . . . . . 0.553 ' NH1' ' HA3' ' B' 1038 ' ' GLY . 37.3 ttt180 -79.0 96.65 5.82 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 118.782 -2.449 . . . . 41.460000000000001 106.468 162.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1008 ' ' GLU . . . . . 0.57 ' HG3' ' HB ' ' B' 1072 ' ' VAL . 2.8 mm-40 -51.94 151.5 3.55 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 118.734 2.864 . . . . 26.93 118.734 -170.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 45.1 mmm-85 -92.97 -20.72 20.32 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 112.528 -2.124 . . . . 34.479999999999997 115.535 -164.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1010 ' ' LEU . . . . . 0.545 ' HB3' ' HB2' ' B' 1013 ' ' GLU . 4.7 tp -67.74 160.21 28.59 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 119.386 0.994 . . . . 44.219999999999999 113.678 -173.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1011 ' ' THR . . . . . . . . . . . . . 63.3 m -68.25 132.61 47.44 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 106.018 -1.845 . . . . 40.740000000000002 106.018 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 12.5 m120 62.22 22.22 13.01 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 113.984 -1.462 . . . . 44.439999999999998 112.119 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1013 ' ' GLU . . . . . 0.545 ' HB2' ' HB3' ' B' 1010 ' ' LEU . 4.7 tp10 -78.1 118.7 20.6 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 117.748 -1.581 . . . . 29.870000000000001 111.85 -173.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1014 ' ' THR . . . . . . . . . . . . . 1.6 p -105.17 -9.62 17.63 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 111.514 -2.585 . . . . 25.260000000000002 112.413 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1015 ' ' ARG . . . . . 0.501 ' HD3' ' SD ' ' B' 1133 ' ' MET . 77.4 mtm180 -77.01 110.3 11.53 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 123.546 1.641 . . . . 29.539999999999999 113.188 -176.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1016 ' ' VAL . . . . . 0.431 HG12 ' HB2' ' B' 1043 ' ' ALA . 7.2 p -87.69 120.54 36.98 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 N-CA-C 104.153 -2.536 . . . . 23.550000000000001 104.153 164.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1017 ' ' ALA . . . . . . . . . . . . . . . -62.71 -5.96 3.18 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 116.29 1.959 . . . . 23.59 116.29 -177.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1018 ' ' ALA . . . . . . . . . . . . . . . -150.34 111.95 4.48 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 123.996 1.855 . . . . 24.93 107.059 170.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1019 ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.43 164.38 40.81 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 115.14 -2.362 . . . . 28.09 111.696 172.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 0.7 OUTLIER -38.93 -46.35 2.74 Favored 'Trans proline' 0 C--N 1.362 1.245 1 C-N-CA 125.669 4.246 . . . . 28.789999999999999 117.717 -176.528 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 77.3 tttt -63.67 -49.21 74.09 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 120.086 1.312 . . . . 47.280000000000001 107.743 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1022 ' ' THR . . . . . . . . . . . . . 39.0 m -61.39 -34.98 76.26 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 114.001 1.111 . . . . 30.120000000000001 114.001 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1023 ' ' VAL . . . . . . . . . . . . . 75.4 t -51.11 -52.96 16.44 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 CA-C-N 121.239 1.836 . . . . 32.240000000000002 110.381 167.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1024 ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' B' 1028 ' ' LYS . 45.6 mt-10 -64.04 -37.1 86.2 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 113.973 1.101 . . . . 49.619999999999997 113.973 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1025 ' ' GLN . . . . . 0.473 ' O ' ' HG ' ' B' 1029 ' ' LEU . 39.2 mt-30 -56.5 -46.4 80.55 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 114.373 -1.285 . . . . 44.68 109.871 177.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 14.4 mt -72.49 -35.86 68.26 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 114.341 1.238 . . . . 35.710000000000001 114.341 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1027 ' ' LEU . . . . . . . . . . . . . 75.8 mt -63.51 -41.51 98.51 Favored 'General case' 0 C--N 1.346 0.436 0 N-CA-C 109.896 -0.409 . . . . 42.18 109.896 176.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1028 ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' B' 1024 ' ' GLU . 55.1 mttm -57.96 -40.87 81.66 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 115.897 1.814 . . . . 48.340000000000003 115.897 169.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1029 ' ' LEU . . . . . 0.518 HD11 HG13 ' B' 1332 ' ' VAL . 65.4 mt -69.67 -10.51 58.57 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 121.442 -0.787 . . . . 38.689999999999998 110.719 173.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 106.12 3.51 38.81 Favored Glycine 0 C--N 1.321 -0.294 0 O-C-N 119.861 -1.774 . . . . 32.280000000000001 112.407 166.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -90.77 158.61 16.76 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 119.957 -1.908 . . . . 35.939999999999998 108.879 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1032 ' ' THR . . . . . . . . . . . . . 5.9 m -101.06 137.33 39.56 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 103.834 -2.654 . . . . 33.369999999999997 103.834 172.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1033 ' ' VAL . . . . . . . . . . . . . 5.1 t -107.88 137.65 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 0 O-C-N 118.222 -2.799 . . . . 29.98 106.701 -172.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -128.21 131.62 48.84 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.243 -1.391 . . . . 28.18 107.243 168.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1035 ' ' VAL . . . . . 0.423 ' HB ' HD13 ' B' 1057 ' ' ILE . 87.5 t -115.79 137.34 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.286 0 CA-C-N 113.225 -1.807 . . . . 25.82 110.216 177.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1036 ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -74.13 125.98 29.55 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 107.425 -1.324 . . . . 32.439999999999998 107.425 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1037 ' ' SER . . . . . . . . . . . . . 2.8 t -58.08 121.89 11.73 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 124.313 2.006 . . . . 29.539999999999999 113.309 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1038 ' ' GLY . . . . . 0.553 ' HA3' ' NH1' ' B' 1007 ' ' ARG . . . 119.45 -26.72 7.22 Favored Glycine 0 C--O 1.259 1.678 0 CA-C-N 113.187 -1.824 . . . . 27.760000000000002 109.413 -175.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1039 ' ' ALA . . . . . . . . . . . . . . . -59.43 -32.21 69.99 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.243 1.02 . . . . 26.02 113.057 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -57.99 -51.63 57.15 Favored Glycine 0 N--CA 1.466 0.686 0 CA-C-N 113.148 -1.842 . . . . 26.469999999999999 111.918 165.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -59.46 -30.19 68.34 Favored 'General case' 0 C--O 1.251 1.149 0 CA-C-N 118.254 1.027 . . . . 50.979999999999997 112.272 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 75.2 mt -64.65 -58.01 7.47 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-N 115.784 -0.644 . . . . 29.300000000000001 110.598 167.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1043 ' ' ALA . . . . . 0.431 ' HB2' HG12 ' B' 1016 ' ' VAL . . . -74.66 14.73 0.44 Allowed 'General case' 0 C--O 1.215 -0.737 0 O-C-N 119.776 -1.828 . . . . 26.739999999999998 112.611 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1044 ' ' SER . . . . . . . . . . . . . 72.7 m 63.61 49.3 3.08 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 127.321 3.439 . . . . 31.260000000000002 112.646 174.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1045 ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.59 155.25 44.22 Favored 'General case' 0 N--CA 1.432 -1.352 0 O-C-N 119.314 -2.116 . . . . 33.259999999999998 107.056 -168.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1046 ' ' ASP . . . . . 0.532 ' HB2' ' HA ' ' A' 1305 ' ' ASN . 14.2 t70 -82.88 127.32 33.39 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 107.385 -1.339 . . . . 46.740000000000002 107.385 168.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -57.45 -32.32 66.81 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 124.439 1.096 . . . . 34.439999999999998 112.47 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1048 ' ' LYS . . . . . 0.572 ' HD3' ' H ' ' B' 1048 ' ' LYS . 0.0 OUTLIER -68.67 -14.28 62.92 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 121.024 -1.048 . . . . 48.670000000000002 111.316 178.918 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -68.32 -28.9 67.56 Favored 'General case' 0 C--O 1.216 -0.662 0 O-C-N 120.241 -1.537 . . . . 35.259999999999998 110.851 169.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1050 ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -69.47 -31.14 69.25 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 108.142 -1.059 . . . . 32.170000000000002 108.142 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 83.9 t -70.16 -41.55 78.95 Favored 'Isoleucine or valine' 0 C--O 1.25 1.123 0 N-CA-C 106.305 -1.739 . . . . 38.369999999999997 106.305 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -60.49 -29.59 69.17 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 123.133 1.444 . . . . 45.770000000000003 110.118 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1053 ' ' ALA . . . . . 0.405 ' HB1' ' HG3' ' B' 1024 ' ' GLU . . . -77.48 -40.17 43.92 Favored 'General case' 0 CA--C 1.5 -0.957 0 O-C-N 120.421 -1.425 . . . . 37.829999999999998 112.905 168.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 137.03 18.89 0.64 Allowed Glycine 0 C--N 1.334 0.468 0 O-C-N 120.178 -1.576 . . . . 35.82 113.834 172.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -88.93 144.32 26.26 Favored 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 120.512 2.156 . . . . 33.770000000000003 112.724 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -73.83 124.6 26.4 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 103.844 -2.65 . . . . 51.020000000000003 103.844 168.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1057 ' ' ILE . . . . . 0.423 HD13 ' HB ' ' B' 1035 ' ' VAL . 39.0 mm -89.42 116.75 31.45 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 O-C-N 120.155 -1.591 . . . . 38.469999999999999 107.752 168.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 2.8 m -112.56 139.37 37.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 O-C-N 125.785 1.928 . . . . 39.399999999999999 106.345 174.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -100.65 100.54 11.26 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 123.729 0.812 . . . . 57.07 110.012 -172.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . 102.78 -178.95 26.27 Favored Glycine 0 C--O 1.248 0.983 0 CA-C-O 123.005 1.336 . . . . 44.829999999999998 112.353 -175.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 30.2 m120 -64.47 2.59 0.6 Allowed 'General case' 0 C--O 1.239 0.523 0 N-CA-C 118.229 2.677 . . . . 46.270000000000003 118.229 -168.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1062 ' ' SER . . . . . . . . . . . . . 13.3 m -41.07 -40.77 1.55 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 127.75 2.42 . . . . 43.469999999999999 107.325 156.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1063 ' ' VAL . . . . . 0.421 HG22 ' CA ' ' B' 1004 ' ' GLY . 0.3 OUTLIER -52.62 -30.34 14.77 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 O-C-N 119.125 -2.235 . . . . 36.979999999999997 114.566 176.051 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 52.1 m95 -76.41 -22.08 55.19 Favored 'General case' 0 N--CA 1.439 -0.99 0 O-C-N 120.867 -1.145 . . . . 37.899999999999999 110.68 -174.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -85.65 84.46 7.58 Favored 'General case' 0 C--O 1.205 -1.283 0 N-CA-C 103.482 -2.785 . . . . 46.189999999999998 103.482 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1066 ' ' SER . . . . . . . . . . . . . 56.6 m -151.08 173.41 14.39 Favored 'General case' 0 C--O 1.261 1.685 0 C-N-CA 126.117 1.767 . . . . 37.060000000000002 107.523 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1067 ' ' GLU . . . . . 0.676 ' HB2' HD12 ' B' 1068 ' ' ILE . 70.9 mm-40 -82.61 -40.55 20.65 Favored 'General case' 0 N--CA 1.433 -1.298 0 O-C-N 120.428 -1.42 . . . . 43.950000000000003 111.512 174.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1068 ' ' ILE . . . . . 0.676 HD12 ' HB2' ' B' 1067 ' ' GLU . 1.2 mp -120.8 135.09 62.13 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 N-CA-C 103.777 -2.675 . . . . 33.5 103.777 -175.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1069 ' ' ILE . . . . . 0.483 HG22 ' HB2' ' B' 1071 ' ' LYS . 37.1 mm -120.21 116.06 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 101.208 -3.627 . . . . 30.57 101.208 172.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1070 ' ' LEU . . . . . 0.624 ' HB3' HD13 ' B' 1331 ' ' LEU . 30.1 mt -102.8 105.62 16.06 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 102.845 -3.02 . . . . 27.66 102.845 172.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1071 ' ' LYS . . . . . 0.483 ' HB2' HG22 ' B' 1069 ' ' ILE . 3.2 tmtm? -127.77 147.17 50.41 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 103.873 -2.64 . . . . 28.399999999999999 103.873 -168.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1072 ' ' VAL . . . . . 0.57 ' HB ' ' HG3' ' B' 1008 ' ' GLU . 25.5 t -81.4 -65.07 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.85 0 CA-C-O 117.723 -1.132 . . . . 23.18 112.201 -171.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -106.45 -159.42 0.7 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 120.843 1.656 . . . . 25.469999999999999 111.817 -161.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -64.28 142.28 98.29 Favored Pre-proline 0 CA--C 1.517 -0.317 0 CA-C-N 120.691 1.587 . . . . 27.899999999999999 111.222 -177.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -70.94 118.71 5.84 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.024 3.149 . . . . 31.620000000000001 117.116 164.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 5.3 mp -74.48 170.75 15.07 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 124.652 2.168 . . . . 40.490000000000002 107.47 166.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 36.6 t70 -56.22 -39.26 72.22 Favored 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 125.222 1.409 . . . . 51.590000000000003 113.707 -175.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -67.89 -39.12 83.69 Favored 'General case' 0 C--N 1.348 0.5 0 O-C-N 120.626 -1.296 . . . . 42.359999999999999 108.19 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1079 ' ' GLU . . . . . 0.661 ' HA ' HD12 ' B' 1082 ' ' LEU . 32.8 mt-10 -63.5 -45.54 90.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 123.501 1.619 . . . . 34.530000000000001 108.94 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1080 ' ' ILE . . . . . 0.646 HG22 ' HG3' ' B' 1108 ' ' ARG . 61.3 mt -60.67 -37.07 74.67 Favored 'Isoleucine or valine' 0 C--O 1.261 1.694 0 CA-C-N 113.354 -1.748 . . . . 33.25 110.959 176.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -74.13 -28.92 61.56 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 115.614 1.709 . . . . 36.469999999999999 115.614 172.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1082 ' ' LEU . . . . . 0.661 HD12 ' HA ' ' B' 1079 ' ' GLU . 23.3 mt -71.36 -28.26 63.93 Favored 'General case' 0 C--N 1.317 -0.821 0 O-C-N 119.933 -1.729 . . . . 37.759999999999998 110.644 173.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1083 ' ' LEU . . . . . 0.767 HD11 HD22 ' B' 1089 ' ' LEU . 28.7 mt -58.77 127.79 33.96 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 123.037 1.398 . . . . 37.43 111.997 171.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.38 133.55 42.17 Favored Pre-proline 0 C--O 1.243 0.759 0 CA-C-N 112.892 -1.958 . . . . 37.700000000000003 107.572 177.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -44.42 111.42 0.27 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 123.996 3.131 . . . . 35.509999999999998 113.68 169.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 130.2 -48.96 0.94 Allowed Glycine 0 C--N 1.31 -0.911 0 CA-C-N 110.954 -2.839 . . . . 33.869999999999997 109.645 175.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1087 ' ' THR . . . . . . . . . . . . . 72.5 m -43.74 126.84 4.82 Favored 'General case' 0 C--O 1.252 1.21 0 C-N-CA 126.051 1.74 . . . . 32.5 114.504 -165.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1088 ' ' THR . . . . . 0.432 ' HA ' ' O ' ' B' 1111 ' ' THR . 50.1 m -78.97 91.71 4.86 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-O 124.037 1.875 . . . . 30.219999999999999 109.843 -176.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1089 ' ' LEU . . . . . 0.767 HD22 HD11 ' B' 1083 ' ' LEU . 36.0 tp -76.15 137.39 40.04 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 113.112 -1.858 . . . . 27.239999999999998 111.084 170.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 56.7 t -133.95 112.12 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 103.589 -2.745 . . . . 25.390000000000001 103.589 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1091 ' ' SER . . . . . 0.405 ' OG ' ' HB3' ' B' 1071 ' ' LYS . 48.7 m -160.45 163.84 32.71 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 120.43 -1.419 . . . . 28.809999999999999 111.201 -171.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1092 ' ' PHE . . . . . 0.56 ' HD1' ' HB3' ' B' 1116 ' ' ASP . 84.5 m-85 -71.18 102.88 2.62 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.005 -1.059 . . . . 30.780000000000001 110.606 165.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 29.7 mm -85.29 -45.21 17.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 120.261 1.391 . . . . 30.280000000000001 111.807 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1094 ' ' TRP . . . . . . . . . . . . . 93.1 m95 56.21 73.52 0.82 Allowed Pre-proline 0 C--O 1.244 0.809 0 O-C-N 125.091 1.495 . . . . 34.07 110.403 -157.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -55.28 -50.16 13.88 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 123.819 3.013 . . . . 38.659999999999997 115.951 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -64.67 -33.05 75.03 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-O 123.057 1.408 . . . . 41.32 110.096 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 8.4 mp0 -80.25 -17.58 51.8 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 116.711 -1.614 . . . . 51.659999999999997 110.378 175.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -142.46 59.89 9.33 Favored Pre-proline 0 N--CA 1.481 1.092 0 CA-C-N 122.588 2.449 . . . . 40.32 111.591 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -59.55 -32.72 96.59 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 123.621 2.881 . . . . 41.560000000000002 112.955 177.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -63.46 -47.71 80.72 Favored 'General case' 0 C--O 1.206 -1.196 0 CA-C-O 123.001 1.381 . . . . 54.109999999999999 109.217 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1101 ' ' LEU . . . . . . . . . . . . . 5.1 tp -62.95 -45.71 91.18 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 113.313 -1.767 . . . . 37.880000000000003 108.547 -176.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1102 ' ' MET . . . . . . . . . . . . . 67.9 mmm -49.77 -51.31 40.2 Favored 'General case' 0 CA--C 1.498 -1.03 0 C-N-CA 124.122 0.969 . . . . 37.539999999999999 109.994 169.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -62.83 -36.13 82.22 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 118.772 -1.171 . . . . 47.009999999999998 113.922 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1104 ' ' LYS . . . . . . . . . . . . . 93.2 mttt -60.95 -45.8 93.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 120.139 -0.624 . . . . 48.68 112.352 173.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1105 ' ' LEU . . . . . 0.64 HD13 HG21 ' B' 1112 ' ' VAL . 73.9 mt -57.89 -43.35 86.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 124.839 2.257 . . . . 32.210000000000001 114.95 175.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -56.24 -55.59 31.45 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 112.089 -2.323 . . . . 33.729999999999997 111.717 172.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.51 -20.69 66.45 Favored 'General case' 0 C--N 1.359 1.01 0 O-C-N 118.811 -2.431 . . . . 51.469999999999999 114.159 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1108 ' ' ARG . . . . . 0.646 ' HG3' HG22 ' B' 1080 ' ' ILE . 26.4 mmm180 -82.96 -1.51 52.65 Favored 'General case' 0 C--N 1.348 0.543 0 N-CA-C 114.249 1.204 . . . . 43.899999999999999 114.249 170.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1109 ' ' ASN . . . . . . . . . . . . . 12.1 m-80 61.93 28.87 17.6 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 118.813 2.894 . . . . 44.82 118.813 171.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1110 ' ' VAL . . . . . 0.664 HG11 ' HB3' ' B' 1083 ' ' LEU . 30.0 m -89.77 170.04 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.28 0 CA-C-N 113.486 -1.688 . . . . 30.52 111.921 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1111 ' ' THR . . . . . 0.432 ' O ' ' HA ' ' B' 1088 ' ' THR . 59.1 m -111.21 119.02 37.55 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 104.417 -2.438 . . . . 27.120000000000001 104.417 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1112 ' ' VAL . . . . . 0.64 HG21 HD13 ' B' 1105 ' ' LEU . 34.3 t -119.15 126.5 75.41 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 CA-C-O 118.726 -0.654 . . . . 26.399999999999999 110.129 -171.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1113 ' ' MET . . . . . 0.53 ' HA ' ' O ' ' B' 1358 ' ' VAL . 0.9 OUTLIER -101.01 115.41 30.43 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 106.011 -1.848 . . . . 42.920000000000002 106.011 168.048 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B 1114 ' ' ALA . . . . . 0.452 ' HB3' ' HB2' ' B' 1117 ' ' SER . . . -85.91 104.11 15.26 Favored 'General case' 0 N--CA 1.426 -1.631 0 C-N-CA 119.118 -1.033 . . . . 24.149999999999999 109.909 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1115 ' ' MET . . . . . . . . . . . . . 44.2 mmm -59.35 -14.86 13.24 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 116.326 1.972 . . . . 29.949999999999999 116.326 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1116 ' ' ASP . . . . . 0.56 ' HB3' ' HD1' ' B' 1092 ' ' PHE . 7.5 p-10 -86.42 -37.95 17.85 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 108.246 -1.02 . . . . 34.530000000000001 108.246 172.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1117 ' ' SER . . . . . 0.452 ' HB2' ' HB3' ' B' 1114 ' ' ALA . 68.4 m -95.05 38.51 1.13 Allowed 'General case' 0 C--N 1.316 -0.863 0 O-C-N 118.605 -2.56 . . . . 33.490000000000002 110.066 -173.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1118 ' ' VAL . . . . . 0.648 HG12 ' HB1' ' B' 1124 ' ' ALA . 2.2 t -78.47 133.22 63.78 Favored Pre-proline 0 N--CA 1.468 0.453 0 N-CA-C 105.8 -1.926 . . . . 34.020000000000003 105.8 169.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -47.21 142.16 12.34 Favored 'Trans proline' 0 C--N 1.328 -0.507 1 C-N-CA 126.321 4.681 . . . . 38.280000000000001 115.224 -176.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1120 ' ' ARG . . . . . 0.477 HH12 ' CG ' ' B' 1128 ' ' ASP . 0.4 OUTLIER -81.58 56.62 3.04 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 114.226 1.195 . . . . 55.049999999999997 114.226 -175.528 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B 1121 ' ' ILE . . . . . 0.609 HD12 ' HB3' ' B' 1123 ' ' ARG . 13.1 pt -129.4 149.22 33.45 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 107.969 -1.123 . . . . 42.090000000000003 107.969 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1122 ' ' SER . . . . . . . . . . . . . 48.6 m -51.14 -32.48 23.16 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 116.894 2.183 . . . . 38.020000000000003 116.894 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1123 ' ' ARG . . . . . 0.609 ' HB3' HD12 ' B' 1121 ' ' ILE . 6.9 tpt180 -58.02 -39.05 77.37 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.642 1.577 . . . . 34.289999999999999 109.219 174.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1124 ' ' ALA . . . . . 0.648 ' HB1' HG12 ' B' 1118 ' ' VAL . . . -84.19 -30.82 25.48 Favored 'General case' 0 C--O 1.206 -1.191 0 O-C-N 121.241 -0.912 . . . . 32.350000000000001 111.419 175.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1125 ' ' GLN . . . . . 0.466 ' HA ' ' HB3' ' B' 1128 ' ' ASP . 13.9 mm100 -58.85 -26.84 64.57 Favored 'General case' 0 C--N 1.348 0.534 0 N-CA-C 118.304 2.705 . . . . 47.170000000000002 118.304 -165.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1126 ' ' SER . . . . . . . . . . . . . 1.4 p -72.04 -34.49 68.81 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 124.183 1.944 . . . . 31.710000000000001 110.805 173.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1127 ' ' LEU . . . . . 0.656 HD23 HD12 ' B' 1334 ' ' LEU . 2.5 mp -80.64 -30.84 36.6 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 113.304 -1.771 . . . . 37.0 110.363 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1128 ' ' ASP . . . . . 0.579 ' HA ' HG21 ' B' 1118 ' ' VAL . 10.1 t70 -62.74 123.43 18.42 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 114.554 1.316 . . . . 40.399999999999999 114.554 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1129 ' ' ALA . . . . . . . . . . . . . . . -70.12 -35.17 73.91 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 115.671 -0.695 . . . . 26.559999999999999 112.359 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 46.7 mt -57.48 -33.53 68.09 Favored 'General case' 0 CA--C 1.557 1.248 0 CA-C-O 115.635 -2.126 . . . . 30.890000000000001 111.751 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1131 ' ' SER . . . . . . . . . . . . . 59.7 p -57.15 -56.99 14.58 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 119.825 1.193 . . . . 29.84 113.047 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1132 ' ' SER . . . . . 0.414 ' HB3' ' HB3' ' B' 1326 ' ' LEU . 24.9 m -64.93 -39.29 93.28 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 126.121 2.138 . . . . 31.91 111.862 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1133 ' ' MET . . . . . 0.614 ' HB3' ' HB3' ' B' 1316 ' ' PRO . 36.4 mmt -69.73 -30.61 68.26 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 113.102 0.779 . . . . 25.899999999999999 113.102 178.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1134 ' ' ALA . . . . . . . . . . . . . . . -72.52 -39.04 67.89 Favored 'General case' 0 N--CA 1.415 -2.222 0 CA-C-N 114.447 -1.251 . . . . 26.620000000000001 107.95 174.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.85 -35.22 79.54 Favored 'General case' 0 C--O 1.215 -0.763 0 CA-C-N 119.506 1.048 . . . . 36.969999999999999 110.902 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1136 ' ' ILE . . . . . 0.428 HG21 ' O ' ' B' 1316 ' ' PRO . 39.5 mm -64.09 -53.67 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 102.457 -3.164 . . . . 32.109999999999999 102.457 174.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -55.25 -37.16 66.86 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 114.23 1.196 . . . . 24.140000000000001 114.23 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -71.64 -43.28 52.53 Favored Glycine 0 C--N 1.308 -1.018 0 CA-C-N 118.273 0.488 . . . . 25.129999999999999 114.291 178.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 34.6 t80 -71.01 -41.59 70.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 123.316 1.531 . . . . 32.729999999999997 112.535 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1140 ' ' ARG . . . . . 0.61 HH11 HD13 ' B' 1319 ' ' LEU . 13.2 tpt180 -67.98 -28.59 67.58 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 113.463 -1.699 . . . . 26.359999999999999 110.552 175.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1141 ' ' ALA . . . . . . . . . . . . . . . -58.95 -51.46 69.96 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 105.931 -1.877 . . . . 24.120000000000001 105.931 174.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 20.6 mm -59.03 -42.29 85.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-O 117.84 -1.076 . . . . 23.370000000000001 109.686 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 76.4 t -58.97 -62.41 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 119.528 1.058 . . . . 24.960000000000001 113.454 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -62.85 -35.58 80.43 Favored 'General case' 0 C--O 1.267 1.983 0 O-C-N 124.384 1.053 . . . . 32.07 110.258 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1145 ' ' ALA . . . . . 0.655 ' HB1' HD12 ' B' 1251 ' ' ILE . . . -54.65 -61.58 2.22 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.124 0.57 . . . . 24.870000000000001 112.085 167.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1146 ' ' ALA . . . . . 0.402 ' HB2' ' CE1' ' B' 1153 ' ' PHE . . . -58.85 -27.5 65.2 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 118.965 -2.334 . . . . 24.670000000000002 114.893 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 62.1 t60 -63.57 -45.87 88.51 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 114.374 -1.285 . . . . 28.579999999999998 109.973 170.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1148 ' ' GLU . . . . . 0.689 ' HB3' ' HD2' ' B' 1308 ' ' LYS . 71.5 mm-40 -100.59 4.89 43.76 Favored 'General case' 0 C--O 1.255 1.343 0 N-CA-C 114.628 1.344 . . . . 36.82 114.628 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1149 ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' B' 1145 ' ' ALA . 1.4 t80 -76.45 146.09 38.83 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 123.719 1.723 . . . . 31.969999999999999 108.099 -174.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1150 ' ' GLY . . . . . . . . . . . . . . . -66.29 -43.82 92.05 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 113.355 -1.748 . . . . 25.489999999999998 109.682 170.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1151 ' ' ARG . . . . . 0.699 ' HA ' ' HB2' ' A' 1322 ' ' GLN . 75.2 mtm-85 -119.89 -171.58 2.17 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 117.983 0.892 . . . . 59.840000000000003 113.374 -163.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1152 ' ' PHE . . . . . 0.574 ' HB2' HG11 ' B' 1163 ' ' VAL . 17.4 m-30 -88.65 159.11 18.0 Favored 'General case' 0 C--O 1.238 0.486 0 O-C-N 120.264 -1.522 . . . . 34.450000000000003 111.759 169.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1153 ' ' PHE . . . . . 0.431 ' CZ ' HG13 ' B' 1251 ' ' ILE . 14.5 m-85 -77.02 -56.59 4.45 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 114.205 -1.361 . . . . 31.170000000000002 112.809 171.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1154 ' ' THR . . . . . . . . . . . . . 12.1 m -65.05 142.07 58.53 Favored 'General case' 0 C--O 1.25 1.131 0 CA-C-O 121.899 0.857 . . . . 33.890000000000001 109.956 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1155 ' ' GLY . . . . . 0.496 ' HA3' ' HG3' ' B' 1165 ' ' PRO . . . -73.06 59.0 1.83 Allowed Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 110.515 -1.034 . . . . 38.950000000000003 110.515 170.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -77.24 134.6 38.54 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 124.938 1.295 . . . . 54.229999999999997 110.646 -160.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 15.0 mm -80.68 116.58 25.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 101.454 -3.535 . . . . 51.159999999999997 101.454 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1158 ' ' THR . . . . . . . . . . . . . 31.5 m -122.22 155.07 36.6 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.305 1.05 . . . . 49.609999999999999 108.396 -175.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -26.36 -61.2 0.08 Allowed 'General case' 0 C--O 1.212 -0.907 0 N-CA-C 119.422 3.119 . . . . 49.049999999999997 119.422 172.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1160 ' ' ALA . . . . . 0.654 ' HB1' ' HB ' ' A' 1329 ' ' THR . . . -57.94 -51.03 71.32 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 114.299 1.222 . . . . 47.649999999999999 114.299 170.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . 179.6 178.59 48.5 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-O 122.225 0.903 . . . . 45.609999999999999 113.717 -165.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 84.4 mttt -79.3 140.61 37.52 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 123.083 1.42 . . . . 57.460000000000001 109.764 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1163 ' ' VAL . . . . . 0.574 HG11 ' HB2' ' B' 1152 ' ' PHE . 48.6 t -90.99 130.11 41.62 Favored Pre-proline 0 C--N 1.299 -1.624 0 CA-C-O 116.5 -1.714 . . . . 42.93 107.603 173.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1164 ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' B' 1165 ' ' PRO . 37.9 Cg_endo -59.33 135.83 68.0 Favored 'Trans proline' 0 N--CA 1.479 0.667 0 C-N-CA 123.906 3.071 . . . . 39.289999999999999 111.865 167.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1165 ' ' PRO . . . . . 0.496 ' HG3' ' HA3' ' B' 1155 ' ' GLY . 27.9 Cg_exo -67.31 141.46 56.68 Favored 'Trans proline' 0 C--O 1.255 1.327 0 C-N-CA 123.287 2.658 . . . . 34.170000000000002 114.254 177.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -73.09 127.68 33.29 Favored 'General case' 0 C--O 1.253 1.266 0 N-CA-C 105.826 -1.916 . . . . 31.690000000000001 105.826 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1167 ' ' LYS . . . . . 0.658 ' HB2' ' HA ' ' B' 1249 ' ' VAL . 93.6 mttt -93.81 108.27 20.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 123.201 1.477 . . . . 44.780000000000001 107.949 168.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 87.7 t -94.24 95.44 5.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 113.766 -1.561 . . . . 31.23 108.153 -172.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1169 ' ' MET . . . . . 0.563 ' HB2' HG11 ' B' 1249 ' ' VAL . 54.8 ttp -79.83 95.69 6.11 Favored 'General case' 0 C--O 1.245 0.831 0 O-C-N 120.534 -1.354 . . . . 37.090000000000003 108.759 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 24.3 t -93.22 99.2 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 N-CA-C 106.435 -1.691 . . . . 30.170000000000002 106.435 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1171 ' ' ILE . . . . . 0.401 HG23 ' HD2' ' B' 1194 ' ' PHE . 35.4 mt -93.38 119.75 41.66 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 N-CA-C 105.677 -1.972 . . . . 33.740000000000002 105.677 -175.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 98.68 62.52 0.86 Allowed Glycine 0 C--N 1.346 1.131 0 N-CA-C 108.44 -1.864 . . . . 32.590000000000003 108.44 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1173 ' ' ALA . . . . . 0.809 ' HA ' ' HA3' ' B' 1177 ' ' GLY . . . -74.44 60.34 0.86 Allowed 'General case' 0 C--O 1.247 0.944 0 N-CA-C 114.89 1.441 . . . . 32.420000000000002 114.89 176.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -87.95 -158.76 33.64 Favored Glycine 0 C--O 1.213 -1.203 0 N-CA-C 105.642 -2.983 . . . . 31.739999999999998 105.642 160.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 3.7 t -54.42 -39.1 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-N 120.432 2.116 . . . . 31.48 112.439 -172.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1176 ' ' ALA . . . . . 0.614 ' HB3' HG21 ' B' 1255 ' ' THR . . . -67.14 -38.24 85.17 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 120.689 -1.257 . . . . 26.120000000000001 110.977 178.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1177 ' ' GLY . . . . . 0.809 ' HA3' ' HA ' ' B' 1173 ' ' ALA . . . -55.29 -54.12 36.34 Favored Glycine 0 C--O 1.208 -1.519 0 C-N-CA 124.534 1.064 . . . . 25.73 110.759 174.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1178 ' ' LEU . . . . . 0.447 ' HA ' HD12 ' B' 1181 ' ' ILE . 15.6 mt -65.39 -30.03 70.8 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 113.285 -1.457 . . . . 32.590000000000003 110.846 -177.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -68.82 -42.19 77.58 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.765 -0.584 . . . . 27.719999999999999 109.782 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -70.25 -37.57 74.96 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 107.498 -1.297 . . . . 26.030000000000001 107.498 -174.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1181 ' ' ILE . . . . . 0.748 HG12 HG11 ' B' 1191 ' ' VAL . 13.3 mt -63.06 -48.8 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 107.342 -1.355 . . . . 28.609999999999999 107.342 171.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -58.38 -26.7 59.66 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-O 118.724 -1.042 . . . . 25.23 115.203 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -90.11 -60.78 1.84 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 118.683 1.241 . . . . 24.09 111.308 174.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -61.05 -44.92 96.67 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 116.097 1.888 . . . . 26.68 116.097 -175.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 5.0 t30 -66.14 -45.91 79.37 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 118.099 -0.953 . . . . 36.57 109.344 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1186 ' ' SER . . . . . . . . . . . . . 16.1 m -56.21 -45.61 79.8 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 120.577 1.535 . . . . 28.920000000000002 112.876 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1187 ' ' LEU . . . . . . . . . . . . . 58.6 mt -45.1 -52.35 9.23 Favored 'General case' 0 C--O 1.246 0.879 0 O-C-N 123.934 0.771 . . . . 29.09 112.788 165.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 128.41 27.24 0.91 Allowed Glycine 0 N--CA 1.438 -1.175 0 O-C-N 121.26 -0.9 . . . . 29.260000000000002 112.969 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1189 ' ' ALA . . . . . 0.428 ' HB2' ' HB3' ' B' 1153 ' ' PHE 0.259 . . -102.48 146.11 28.59 Favored 'General case' 0 C--O 1.251 1.176 0 N-CA-C 107.747 -1.205 . . . . 30.16 107.747 -179.115 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B 1190 ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' B' 1167 ' ' LYS . 74.0 mt -83.82 103.94 11.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 103.178 -2.897 . . . . 35.810000000000002 103.178 -171.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1191 ' ' VAL . . . . . 0.748 HG11 HG12 ' B' 1181 ' ' ILE . 53.0 t -81.26 131.85 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.646 0 N-CA-C 104.903 -2.258 . . . . 31.969999999999999 104.903 176.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1192 ' ' ARG . . . . . 0.454 ' HG2' ' HB3' ' B' 1210 ' ' GLU . 33.2 mtt180 -120.57 89.85 3.21 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 109.827 -3.351 . . . . 48.159999999999997 104.946 171.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -90.31 130.29 36.43 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.401 -1.272 . . . . 35.890000000000001 113.151 -176.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1194 ' ' PHE . . . . . 0.401 ' HD2' HG23 ' B' 1171 ' ' ILE . 35.2 t80 -106.31 144.12 33.45 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.72 -1.215 . . . . 41.880000000000003 107.72 175.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1195 ' ' ASP . . . . . . . . . . . . . 8.9 t70 -157.98 153.26 25.82 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 104.417 -2.438 . . . . 38.280000000000001 104.417 160.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1196 ' ' THR . . . . . . . . . . . . . 13.4 p -84.25 -10.04 58.0 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.114 0.783 . . . . 40.619999999999997 113.114 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1197 ' ' ARG . . . . . 0.403 ' HA ' ' HD2' ' B' 1198 ' ' PRO . 39.9 mtm180 -91.43 126.6 53.93 Favored Pre-proline 0 C--O 1.247 0.969 0 C-N-CA 124.294 1.038 . . . . 53.090000000000003 108.353 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1198 ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' B' 1197 ' ' ARG . 13.9 Cg_endo -52.6 -45.7 38.37 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 N-CA-C 121.264 3.525 . . . . 42.560000000000002 121.264 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1199 ' ' GLU . . . . . 0.862 ' HB2' ' HE1' ' C' ' 155' ' ' TYR . 0.0 OUTLIER -72.66 -8.42 55.21 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 118.351 -2.718 . . . . 56.310000000000002 114.094 -157.493 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B 1200 ' ' VAL . . . . . 0.541 ' HA ' ' HG2' ' B' 1203 ' ' GLN . 34.5 m -85.06 -17.46 9.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 120.799 -1.188 . . . . 42.909999999999997 111.257 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1201 ' ' LYS . . . . . 0.494 ' HG3' ' CD2' ' B' 1211 ' ' PHE . 49.1 tttm -50.39 -54.26 23.12 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 121.428 1.922 . . . . 48.890000000000001 112.252 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 20.6 mp0 -64.64 -21.96 66.85 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 116.715 2.117 . . . . 51.700000000000003 116.715 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1203 ' ' GLN . . . . . 0.581 ' OE1' ' HA ' ' C' ' 74' ' ' ARG . 29.9 mm-40 -64.98 -48.16 74.98 Favored 'General case' 0 C--O 1.248 1.0 0 O-C-N 118.647 -2.533 . . . . 52.57 110.197 172.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1204 ' ' VAL . . . . . 0.444 HG22 HD13 ' B' 1181 ' ' ILE . 12.1 t -59.97 -54.2 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 112.144 -2.298 . . . . 33.789999999999999 108.504 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -51.08 -51.73 50.4 Favored 'General case' 0 C--O 1.203 -1.362 0 C-N-CA 124.579 1.152 . . . . 36.579999999999998 112.88 177.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1206 ' ' SER . . . . . . . . . . . . . 16.5 m -71.41 -7.58 48.23 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 115.634 1.716 . . . . 39.609999999999999 115.634 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1207 ' ' MET . . . . . 0.495 ' SD ' HG22 ' B' 1181 ' ' ILE . 27.5 mtp -80.21 -38.71 30.58 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 123.118 1.437 . . . . 37.450000000000003 112.012 167.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 121.58 46.87 0.31 Allowed Glycine 0 CA--C 1.519 0.297 0 CA-C-N 112.035 -2.348 . . . . 31.870000000000001 108.031 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -142.36 150.28 40.51 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 114.033 -1.083 . . . . 35.399999999999999 110.233 -168.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1210 ' ' GLU . . . . . 0.454 ' HB3' ' HG2' ' B' 1192 ' ' ARG . 10.4 tt0 -81.58 139.51 35.02 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 125.677 1.861 . . . . 47.890000000000001 107.421 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1211 ' ' PHE . . . . . 0.494 ' CD2' ' HG3' ' B' 1201 ' ' LYS . 87.7 t80 -107.21 114.24 28.16 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 106.244 -1.761 . . . . 45.530000000000001 106.244 170.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1212 ' ' LEU . . . . . . . . . . . . . 62.7 mt -65.94 116.65 7.31 Favored 'General case' 0 N--CA 1.441 -0.913 0 O-C-N 120.616 -1.303 . . . . 46.329999999999998 108.075 170.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -80.99 175.81 10.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 122.964 1.364 . . . . 60.409999999999997 111.932 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 25.4 mt -56.92 132.0 51.33 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 112.705 -2.043 . . . . 57.380000000000003 108.998 168.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 15.1 t70 . . . . . 0 N--CA 1.443 -0.777 0 C-N-CA 124.354 1.062 . . . . 65.069999999999993 108.848 -177.102 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B 1230 ' ' MET . . . . . 0.62 ' N ' ' HG ' ' B' 1231 ' ' SER . 3.0 mmt . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 105.121 -2.178 . . . . 80.319999999999993 105.121 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1231 ' ' SER . . . . . 0.62 ' HG ' ' N ' ' B' 1230 ' ' MET . 4.8 m 103.83 159.49 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.085 2 O-C-N 114.398 -5.189 . . . . 79.920000000000002 114.175 -18.343 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -56.06 154.0 8.22 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 116.579 2.066 . . . . 77.909999999999997 116.579 -172.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 66.39 -53.79 0.41 Allowed 'General case' 0 C--N 1.356 0.873 0 C-N-CA 126.273 1.829 . . . . 73.879999999999995 112.688 -172.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 32.2 t80 -60.5 -35.7 76.59 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-N 121.025 1.739 . . . . 68.980000000000004 109.227 171.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1235 ' ' ILE . . . . . 0.472 ' O ' ' HG2' ' B' 1239 ' ' MET . 15.4 pt -47.46 -32.69 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 120.22 1.373 . . . . 64.530000000000001 114.175 169.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -60.17 -46.02 91.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 117.994 -2.941 . . . . 66.359999999999999 111.75 169.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -69.5 -29.94 67.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 123.229 1.49 . . . . 56.600000000000001 111.527 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -63.79 -48.38 77.13 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 114.16 -1.382 . . . . 56.789999999999999 109.196 175.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1239 ' ' MET . . . . . 0.472 ' HG2' ' O ' ' B' 1235 ' ' ILE . 29.6 mmt -57.47 -55.98 27.73 Favored 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 125.359 1.464 . . . . 53.630000000000003 107.343 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -53.9 -29.44 41.91 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 114.643 1.349 . . . . 51.740000000000002 114.643 176.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 58.3 tp -70.02 -43.46 71.29 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 108.978 -0.749 . . . . 44.859999999999999 108.978 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1242 ' ' PHE . . . . . 0.408 ' HB3' ' HE3' ' B' 1169 ' ' MET . 8.9 m-30 -74.08 -39.94 63.1 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 124.722 1.264 . . . . 42.780000000000001 111.408 -178.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.97 93.77 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.373 -0.831 . . . . 40.960000000000001 109.86 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -60.25 -49.13 78.81 Favored 'General case' 0 C--N 1.316 -0.879 0 O-C-N 121.195 -0.941 . . . . 43.060000000000002 110.368 172.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -65.38 -24.19 67.16 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 113.052 -1.885 . . . . 46.450000000000003 110.842 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1246 ' ' ALA . . . . . 0.547 ' HB1' ' HA ' ' B' 1275 ' ' MET . . . -48.84 -39.75 26.8 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 119.589 3.181 . . . . 41.780000000000001 119.589 -174.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 12.3 mptt -67.91 -31.7 71.65 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.224 -1.548 . . . . 52.200000000000003 112.324 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1248 ' ' GLU . . . . . 0.498 ' HB3' ' HD2' ' B' 1167 ' ' LYS . 33.5 mt-10 -80.97 -44.17 18.57 Favored 'General case' 0 C--O 1.251 1.158 0 CA-C-N 114.168 -1.378 . . . . 53.549999999999997 111.885 -177.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1249 ' ' VAL . . . . . 0.658 ' HA ' ' HB2' ' B' 1167 ' ' LYS . 35.2 m -85.72 150.36 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 124.454 2.073 . . . . 34.409999999999997 111.135 -165.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1250 ' ' ASP . . . . . 0.578 ' O ' ' HB3' ' B' 1279 ' ' SER . 1.5 m-20 -108.08 -47.59 3.53 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 110.749 -2.932 . . . . 33.380000000000003 111.328 -176.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1251 ' ' ILE . . . . . 0.655 HD12 ' HB1' ' B' 1145 ' ' ALA . 33.0 mm -119.21 125.15 74.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 105.978 -1.86 . . . . 29.539999999999999 105.978 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1252 ' ' ILE . . . . . 0.517 HD12 HG12 ' B' 1281 ' ' ILE . 79.8 mt -103.68 118.56 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 104.583 -2.377 . . . . 32.439999999999998 104.583 172.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1253 ' ' VAL . . . . . 0.426 HG23 HG22 ' B' 1251 ' ' ILE . 52.9 t -111.39 89.99 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.072 0 N-CA-C 104.433 -2.432 . . . . 30.57 104.433 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1254 ' ' THR . . . . . . . . . . . . . 14.1 t -101.44 131.94 47.3 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 113.736 -1.575 . . . . 35.039999999999999 109.027 -169.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1255 ' ' THR . . . . . 0.614 HG21 ' HB3' ' B' 1176 ' ' ALA . 2.6 m -146.93 31.43 0.94 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.875 -1.057 . . . . 34.619999999999997 113.14 -157.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . -73.7 75.62 1.55 Allowed 'General case' 0 C--O 1.244 0.804 0 O-C-N 117.842 -3.036 . . . . 42.719999999999999 111.483 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 32.7 mt -83.83 79.18 9.56 Favored 'General case' 0 C--O 1.248 0.976 0 CA-C-O 123.677 1.703 . . . . 52.43 108.084 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1258 ' ' ILE . . . . . 0.461 HG13 ' HB2' ' B' 1261 ' ' LYS . 27.2 pt -81.86 132.91 52.88 Favored Pre-proline 0 N--CA 1.448 -0.568 0 CA-C-N 113.357 -1.747 . . . . 59.409999999999997 109.985 -173.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -49.59 99.33 0.04 OUTLIER 'Trans proline' 0 CA--C 1.495 -1.451 0 N-CA-C 120.113 3.082 . . . . 62.68 120.113 -166.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 74.09 3.81 65.93 Favored Glycine 0 N--CA 1.432 -1.574 0 CA-C-N 112.604 -2.089 . . . . 64.159999999999997 112.698 173.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1261 ' ' LYS . . . . . 0.461 ' HB2' HG13 ' B' 1258 ' ' ILE . 95.0 mttt -105.53 164.7 14.51 Favored Pre-proline 0 C--O 1.211 -0.946 0 CA-C-O 115.919 -1.991 . . . . 68.530000000000001 110.991 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -70.92 142.24 42.36 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 CA-C-N 126.654 3.412 . . . . 61.990000000000002 111.957 167.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1263 ' ' ALA . . . . . 0.545 ' H ' ' HA3' ' B' 1289 ' ' GLY . . . -62.68 135.91 95.96 Favored Pre-proline 0 C--O 1.249 1.073 0 N-CA-C 113.851 1.056 . . . . 57.149999999999999 113.851 173.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -64.91 154.26 73.98 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 121.991 1.794 . . . . 51.57 114.647 173.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -81.96 82.69 7.49 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 118.649 -1.221 . . . . 54.549999999999997 109.019 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 62.5 mt -64.98 -48.19 74.87 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-O 123.125 1.441 . . . . 46.859999999999999 113.399 175.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1267 ' ' ILE . . . . . 0.827 HG21 HD13 ' B' 1281 ' ' ILE . 22.9 mm -96.0 97.56 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 122.088 0.947 . . . . 41.039999999999999 108.896 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1268 ' ' THR . . . . . 0.424 ' O ' HG23 ' B' 1272 ' ' VAL . 18.1 p -76.5 162.04 28.14 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 113.732 -1.576 . . . . 39.579999999999998 113.197 177.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1269 ' ' ARG . . . . . 0.547 ' HG3' ' HB2' ' B' 1293 ' ' GLU . 82.4 mtt85 -59.24 -36.05 74.78 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 124.376 1.07 . . . . 53.149999999999999 111.296 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -50.65 -58.65 5.34 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 114.57 -1.196 . . . . 42.960000000000001 111.638 167.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1271 ' ' MET . . . . . . . . . . . . . 28.6 ttm -60.08 -33.55 72.22 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.637 1.347 . . . . 43.890000000000001 114.637 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1272 ' ' VAL . . . . . 0.424 HG23 ' O ' ' B' 1268 ' ' THR . 58.1 t -66.27 -48.05 82.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 109.048 -0.723 . . . . 38.369999999999997 109.048 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 4.7 t70 -77.25 -27.43 53.28 Favored 'General case' 0 C--O 1.244 0.776 0 O-C-N 121.617 -0.677 . . . . 47.460000000000001 110.059 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1274 ' ' SER . . . . . . . . . . . . . 67.3 m -74.13 -24.27 59.4 Favored 'General case' 0 C--O 1.246 0.878 0 CA-C-N 115.962 -0.563 . . . . 38.380000000000003 111.814 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1275 ' ' MET . . . . . 0.547 ' HA ' ' HB1' ' B' 1246 ' ' ALA . 1.0 OUTLIER -60.51 163.19 5.53 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 115.553 1.686 . . . . 37.810000000000002 115.553 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -56.12 130.04 42.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 113.742 -1.572 . . . . 49.259999999999998 110.219 169.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -60.59 159.63 10.34 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.732 -1.576 . . . . 34.460000000000001 111.141 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1278 ' ' GLY . . . . . 0.446 ' HA2' ' HB3' ' A' 1044 ' ' SER . . . 64.78 33.54 87.51 Favored Glycine 0 CA--C 1.521 0.421 0 O-C-N 121.427 -0.795 . . . . 33.530000000000001 113.526 172.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1279 ' ' SER . . . . . 0.578 ' HB3' ' O ' ' B' 1250 ' ' ASP . 15.2 m -133.94 167.28 20.89 Favored 'General case' 0 C--O 1.262 1.763 0 C-N-CA 123.481 0.712 . . . . 31.309999999999999 111.598 -164.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1280 ' ' VAL . . . . . 0.466 HG11 ' HA ' ' B' 1145 ' ' ALA . 66.9 t -127.01 131.06 71.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 O-C-N 119.868 -1.77 . . . . 29.32 111.118 -173.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1281 ' ' ILE . . . . . 0.827 HD13 HG21 ' B' 1267 ' ' ILE . 91.3 mt -103.25 99.37 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 102.505 -3.146 . . . . 31.93 102.505 169.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1282 ' ' VAL . . . . . . . . . . . . . 17.4 t -82.52 115.04 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 105.121 -2.177 . . . . 29.48 105.121 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1283 ' ' ASP . . . . . 0.453 ' HB3' ' HA2' ' B' 1311 ' ' GLY . 42.8 t0 -97.99 112.64 24.5 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 123.819 1.771 . . . . 34.5 106.76 174.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1284 ' ' LEU . . . . . 0.58 ' HG ' HD13 ' B' 1315 ' ' LEU . 7.3 mp -90.6 -21.28 21.8 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 113.64 -1.618 . . . . 37.939999999999998 110.215 -176.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -96.87 16.68 18.64 Favored 'General case' 0 C--O 1.25 1.115 0 CA-C-O 121.503 0.668 . . . . 40.920000000000002 111.784 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1286 ' ' ALA . . . . . 0.707 ' HA ' ' HA2' ' B' 1290 ' ' GLY . . . -63.5 -34.89 78.76 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 122.756 1.265 . . . . 44.390000000000001 112.399 -167.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1287 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -45.99 74.36 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 115.237 -0.892 . . . . 51.460000000000001 109.656 174.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.4 37.75 1.62 Allowed 'General case' 0 C--O 1.245 0.843 0 CA-C-O 125.214 2.435 . . . . 57.75 108.856 -167.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1289 ' ' GLY . . . . . 0.545 ' HA3' ' H ' ' B' 1263 ' ' ALA . . . 139.57 -61.75 0.56 Allowed Glycine 0 N--CA 1.433 -1.532 0 O-C-N 119.147 -2.221 . . . . 49.850000000000001 111.869 175.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1290 ' ' GLY . . . . . 0.707 ' HA2' ' HA ' ' B' 1286 ' ' ALA . . . 96.19 114.39 2.98 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 107.519 -2.232 . . . . 45.93 107.519 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1291 ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -72.86 -16.26 61.59 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.314 -0.995 . . . . 42.670000000000002 108.314 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1292 ' ' CYS . . . . . 0.52 ' HB3' ' OG1' ' B' 1295 ' ' THR . 25.3 t -118.93 139.09 52.24 Favored 'General case' 0 N--CA 1.432 -1.33 0 O-C-N 118.748 -2.47 . . . . 38.82 113.265 -175.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1293 ' ' GLU . . . . . 0.547 ' HB2' ' HG3' ' B' 1269 ' ' ARG . 51.2 mt-10 -66.81 -40.84 88.21 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 118.745 -0.645 . . . . 46.710000000000001 112.441 177.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.08 -6.41 50.99 Favored 'General case' 0 C--O 1.239 0.531 0 O-C-N 125.866 1.979 . . . . 47.229999999999997 113.124 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1295 ' ' THR . . . . . 0.713 HG23 ' HA3' ' B' 1311 ' ' GLY . 74.1 m -52.67 137.76 30.24 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 124.955 2.312 . . . . 36.020000000000003 112.025 172.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1296 ' ' VAL . . . . . 0.476 ' HB ' ' HB2' ' B' 1299 ' ' GLU . 3.7 t -117.42 105.14 48.94 Favored Pre-proline 0 C--N 1.321 -0.643 1 N-CA-C 96.65 -5.315 . . . . 37.259999999999998 96.65 168.382 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -56.7 128.42 29.93 Favored 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 124.968 3.779 . . . . 35.090000000000003 111.311 177.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 96.12 -17.46 59.24 Favored Glycine 0 C--N 1.315 -0.615 0 CA-C-O 122.288 0.938 . . . . 35.969999999999999 112.296 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1299 ' ' GLU . . . . . 0.476 ' HB2' ' HB ' ' B' 1296 ' ' VAL . 28.6 mt-10 -123.44 173.64 7.88 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 123.822 1.772 . . . . 40.390000000000001 110.751 -171.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1300 ' ' ILE . . . . . 0.6 HD13 ' HG3' ' B' 1148 ' ' GLU . 96.4 mt -113.55 105.96 19.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 110.744 -2.935 . . . . 37.43 103.088 177.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1301 ' ' PHE . . . . . 0.507 ' HB3' ' HB ' ' B' 1309 ' ' VAL . 76.6 t80 -73.1 148.5 43.92 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.347 -1.353 . . . . 44.130000000000003 107.347 171.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1302 ' ' THR . . . . . . . . . . . . . 40.7 m -140.46 119.41 12.65 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 122.773 2.533 . . . . 39.780000000000001 106.538 175.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1303 ' ' THR . . . . . 0.454 HG23 ' HE2' ' B' 1301 ' ' PHE . 2.7 p -74.21 175.15 7.82 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.854 0.835 . . . . 43.289999999999999 109.801 171.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -74.66 -25.39 59.15 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-O 121.849 0.833 . . . . 53.07 109.801 -174.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -80.47 -7.99 59.38 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.342 -0.984 . . . . 43.969999999999999 108.342 173.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 90.3 37.46 6.64 Favored Glycine 0 N--CA 1.462 0.382 0 O-C-N 119.752 -1.842 . . . . 41.119999999999997 111.382 174.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1307 ' ' VAL . . . . . . . . . . . . . 43.2 t -97.69 108.79 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-O 125.837 2.732 . . . . 38.119999999999997 104.019 170.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1308 ' ' LYS . . . . . 0.689 ' HD2' ' HB3' ' B' 1148 ' ' GLU . 83.9 mttt -84.67 102.56 13.05 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 108.783 -3.826 . . . . 36.340000000000003 109.498 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1309 ' ' VAL . . . . . 0.507 ' HB ' ' HB3' ' B' 1301 ' ' PHE . 22.0 t -85.02 100.17 7.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 105.483 -2.043 . . . . 30.399999999999999 105.483 177.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1310 ' ' ILE . . . . . 0.647 HD11 ' HB2' ' B' 1148 ' ' GLU . 27.1 mt -81.8 90.53 2.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 107.032 -1.47 . . . . 30.82 107.032 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1311 ' ' GLY . . . . . 0.713 ' HA3' HG23 ' B' 1295 ' ' THR . . . -89.57 83.02 1.41 Allowed Glycine 0 C--N 1.301 -1.411 0 N-CA-C 108.751 -1.739 . . . . 26.530000000000001 108.751 -172.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1312 ' ' TYR . . . . . 0.504 ' CB ' ' HG ' ' B' 1315 ' ' LEU . 6.6 m-30 -98.57 133.05 43.47 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 119.306 3.076 . . . . 38.0 119.306 -170.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1313 ' ' THR . . . . . . . . . . . . . 2.6 p -76.87 -63.86 1.26 Allowed 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 109.222 -3.626 . . . . 29.800000000000001 108.509 166.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 4.3 p30 -69.62 6.85 0.98 Allowed 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 120.405 3.483 . . . . 39.039999999999999 120.405 -171.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1315 ' ' LEU . . . . . 0.58 HD13 ' HG ' ' B' 1284 ' ' LEU . 28.4 mt -46.6 -50.42 41.87 Favored Pre-proline 0 C--N 1.352 0.703 0 N-CA-C 118.952 2.945 . . . . 31.079999999999998 118.952 175.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1316 ' ' PRO . . . . . 0.614 ' HB3' ' HB3' ' B' 1133 ' ' MET . 92.6 Cg_exo -55.45 -33.39 85.81 Favored 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 123.956 3.104 . . . . 26.100000000000001 112.072 174.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -82.56 -53.73 3.5 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 120.424 -1.423 . . . . 23.170000000000002 111.247 -175.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1318 ' ' ARG . . . . . 0.4 HH11 ' HD3' ' B' 1318 ' ' ARG . 71.3 mtt-85 -36.95 -16.5 0.0 OUTLIER 'General case' 0 C--O 1.235 0.318 1 N-CA-C 124.077 4.843 . . . . 40.399999999999999 124.077 -170.256 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B 1319 ' ' LEU . . . . . 0.61 HD13 HH11 ' B' 1140 ' ' ARG . 1.3 tp -105.52 77.35 0.38 Allowed Pre-proline 0 C--O 1.252 1.232 0 CA-C-N 124.031 3.105 . . . . 23.600000000000001 106.684 -176.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1320 ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -39.79 -72.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 124.79 3.66 . . . . 22.350000000000001 117.926 -151.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1321 ' ' THR . . . . . . . . . . . . . 2.0 m -66.64 -31.83 72.77 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 112.904 0.705 . . . . 26.52 112.904 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1322 ' ' GLN . . . . . 0.765 ' HB2' ' HA ' ' A' 1151 ' ' ARG . 45.8 tp60 -75.81 -44.66 40.07 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 119.097 -2.252 . . . . 24.379999999999999 110.267 -178.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1323 ' ' SER . . . . . . . . . . . . . 50.6 m -46.97 -52.1 15.47 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 120.272 -1.517 . . . . 22.800000000000001 110.394 169.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1324 ' ' SER . . . . . . . . . . . . . 29.0 m -57.1 -59.58 4.88 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 113.495 -1.684 . . . . 21.25 113.457 173.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 66.3 tp60 -52.84 -40.58 63.46 Favored 'General case' 0 C--N 1.344 0.346 0 O-C-N 120.303 -1.498 . . . . 31.34 113.957 -177.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1326 ' ' LEU . . . . . 0.428 ' CD1' HG21 ' A' 1158 ' ' THR . 63.4 mt -73.54 -46.94 44.55 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 113.665 0.987 . . . . 31.559999999999999 113.665 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1327 ' ' TYR . . . . . 0.428 ' O ' ' HG ' ' B' 1331 ' ' LEU . 47.2 t80 -54.22 -51.68 63.66 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-O 122.947 1.356 . . . . 22.73 108.6 173.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1328 ' ' GLY . . . . . 0.535 ' HA2' HD12 ' B' 1331 ' ' LEU . . . -41.06 -57.22 3.04 Favored Glycine 0 CA--C 1.496 -1.151 0 CA-C-N 112.614 -2.085 . . . . 21.91 115.793 168.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1329 ' ' THR . . . . . 0.623 HG21 ' HA3' ' A' 1161 ' ' GLY . 62.4 m -66.92 -28.96 68.73 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 114.605 1.335 . . . . 22.149999999999999 114.605 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1330 ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' B' 1127 ' ' LEU . 30.5 m120 -53.45 -51.42 62.72 Favored 'General case' 0 C--O 1.24 0.573 0 O-C-N 121.365 -0.834 . . . . 26.18 109.952 167.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1331 ' ' LEU . . . . . 0.624 HD13 ' HB3' ' B' 1070 ' ' LEU . 20.2 mt -65.95 -39.0 90.07 Favored 'General case' 0 CA--C 1.508 -0.653 0 O-C-N 125.413 1.696 . . . . 23.68 110.404 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1332 ' ' VAL . . . . . 0.671 HG12 ' HE3' ' B' 1336 ' ' LYS . 59.6 t -55.49 -51.31 58.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 120.073 1.306 . . . . 26.57 109.545 171.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -61.33 -39.86 92.1 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 114.371 -1.286 . . . . 28.079999999999998 109.771 -173.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1334 ' ' LEU . . . . . 0.656 HD12 HD23 ' B' 1127 ' ' LEU . 15.2 tp -70.95 -42.78 69.33 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 126.315 1.846 . . . . 27.43 107.482 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1335 ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' B' 1331 ' ' LEU . 79.7 mt -69.6 -24.19 63.63 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 121.195 1.816 . . . . 30.5 111.495 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1336 ' ' LYS . . . . . 0.671 ' HE3' HG12 ' B' 1332 ' ' VAL . 76.1 mttt -67.94 -40.57 83.25 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 120.166 1.348 . . . . 41.649999999999999 109.649 169.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 11.5 tp -81.31 -25.88 36.1 Favored 'General case' 0 C--O 1.244 0.802 0 O-C-N 119.266 -2.146 . . . . 42.079999999999998 110.985 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1338 ' ' LEU . . . . . 0.477 HD22 HG23 ' B' 1346 ' ' ILE . 12.8 mt -68.81 -78.94 0.06 Allowed 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 122.753 1.263 . . . . 35.030000000000001 109.946 164.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 18.0 t -78.75 76.5 5.24 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.278 -1.379 . . . . 37.329999999999998 107.278 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 58.2 mttp -65.47 -24.76 67.24 Favored 'General case' 0 C--N 1.35 0.595 0 N-CA-C 113.901 1.074 . . . . 50.509999999999998 113.901 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -73.83 -3.3 27.86 Favored 'General case' 0 C--O 1.25 1.097 0 N-CA-C 115.41 1.633 . . . . 54.210000000000001 115.41 169.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1342 ' ' LYS . . . . . 0.404 ' HD2' HD22 ' B' 1029 ' ' LEU . 9.3 mtmp? 33.43 66.58 0.22 Allowed 'General case' 0 C--N 1.357 0.923 0 CA-C-O 125.141 2.4 . . . . 50.990000000000002 116.891 -173.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -134.76 -37.01 0.83 Allowed 'General case' 0 C--O 1.248 0.981 0 CA-C-N 112.975 -1.92 . . . . 48.82 111.315 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 148.23 -31.37 1.3 Allowed Glycine 0 N--CA 1.434 -1.483 0 CA-C-N 122.64 2.473 . . . . 40.43 109.583 -178.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -75.82 113.96 13.88 Favored 'General case' 0 C--N 1.361 1.087 0 CA-C-N 119.442 1.621 . . . . 47.560000000000002 109.758 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1346 ' ' ILE . . . . . 0.477 HG23 HD22 ' B' 1338 ' ' LEU . 46.1 mm -69.4 107.05 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 CA-C-O 125.715 2.674 . . . . 42.490000000000002 107.589 177.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1347 ' ' THR . . . . . . . . . . . . . 9.2 m -83.11 108.24 16.24 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 103.154 -2.906 . . . . 38.119999999999997 103.154 176.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 11.7 t -84.16 84.78 2.01 Favored 'Isoleucine or valine' 0 C--O 1.257 1.478 0 N-CA-C 108.049 -1.093 . . . . 37.5 108.049 -175.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 50.5 t0 -80.86 129.78 34.71 Favored 'General case' 0 CA--C 1.5 -0.951 0 O-C-N 124.053 0.846 . . . . 43.850000000000001 111.244 -169.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1350 ' ' PHE . . . . . 0.478 ' HD1' ' HD2' ' B' 1356 ' ' ARG . 46.2 m-85 -114.67 -8.89 12.65 Favored 'General case' 0 C--O 1.251 1.147 0 O-C-N 118.668 -2.52 . . . . 39.810000000000002 110.3 175.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 34.3 t70 -72.78 -49.07 32.98 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 120.306 -1.496 . . . . 51.289999999999999 110.075 177.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 2.6 t70 -64.1 135.63 56.54 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 122.098 2.226 . . . . 39.780000000000001 109.787 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 7.4 m -57.48 -34.32 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 114.507 -1.224 . . . . 39.280000000000001 113.266 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1354 ' ' VAL . . . . . 0.562 HG21 ' HG3' ' B' 1123 ' ' ARG . 35.8 t -76.02 -48.37 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.408 0 CA-C-N 120.124 1.329 . . . . 35.700000000000003 109.353 -174.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1355 ' ' ILE . . . . . 0.736 ' HA ' HG12 ' B' 1358 ' ' VAL 0.257 24.1 mm -69.58 -32.86 54.26 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 CA-C-O 116.825 -1.56 . . . . 35.770000000000003 112.917 176.516 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B 1356 ' ' ARG . . . . . 0.478 ' HD2' ' HD1' ' B' 1350 ' ' PHE . 39.5 tpt85 -54.79 -49.16 71.63 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 120.488 1.495 . . . . 38.549999999999997 109.287 166.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -64.39 -55.96 20.3 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 119.62 1.1 . . . . 29.579999999999998 112.91 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1358 ' ' VAL . . . . . 0.736 HG12 ' HA ' ' B' 1355 ' ' ILE . 5.0 p -67.85 -34.19 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 124.334 1.054 . . . . 32.060000000000002 112.704 -174.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1359 ' ' THR . . . . . . . . . . . . . 6.2 m -78.34 92.16 4.52 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-O 125.264 2.459 . . . . 29.0 108.733 177.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1360 ' ' VAL . . . . . . . . . . . . . 18.9 m -78.51 -31.68 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.978 0 CA-C-N 108.898 -3.774 . . . . 29.68 108.257 -175.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 70.0 mt -128.97 119.95 50.7 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 N-CA-C 107.027 -1.471 . . . . 32.049999999999997 107.027 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1362 ' ' ARG . . . . . 0.454 ' HB2' ' CZ ' ' B' 1350 ' ' PHE . 19.8 ttt180 -97.67 113.13 24.82 Favored 'General case' 0 C--O 1.249 1.035 0 O-C-N 119.171 -2.205 . . . . 32.520000000000003 105.187 171.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 26.04 70.75 0.04 OUTLIER 'General case' 0 C--O 1.256 1.432 0 N-CA-C 118.028 2.603 . . . . 35.68 118.028 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 95.06 -50.1 1.94 Allowed Glycine 0 N--CA 1.428 -1.886 0 O-C-N 120.437 -1.414 . . . . 34.259999999999998 114.126 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -66.18 126.41 28.58 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.231 -0.655 . . . . 51.07 109.231 -175.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 49.7 mt -76.44 103.38 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.819 0 O-C-N 119.046 -2.284 . . . . 39.869999999999997 107.885 169.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1367 ' ' THR . . . . . . . . . . . . . 7.3 p -90.79 1.0 57.28 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 116.167 1.914 . . . . 38.009999999999998 116.167 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1368 ' ' TRP . . . . . . . . . . . . . 62.2 t90 -65.26 140.92 98.01 Favored Pre-proline 0 N--CA 1.432 -1.359 0 N-CA-C 105.017 -2.216 . . . . 42.140000000000001 105.017 160.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -70.22 157.69 93.1 Favored 'Cis proline' 0 C--O 1.252 1.184 0 N-CA-C 119.223 2.74 . . . . 43.259999999999998 119.223 10.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1370 ' ' ALA . . . . . . . . . . . . . . . -82.86 113.0 42.35 Favored Pre-proline 0 C--O 1.247 0.95 0 N-CA-C 104.427 -2.435 . . . . 46.520000000000003 104.427 168.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1371 ' ' PRO . . . . . 0.425 ' HA ' ' HD3' ' B' 1372 ' ' PRO . 83.8 Cg_endo -49.46 132.91 30.67 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.796 2.997 . . . . 51.950000000000003 116.411 -173.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1372 ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' B' 1371 ' ' PRO . 8.1 Cg_exo -55.83 83.48 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.838 1 C-N-CA 126.144 4.563 . . . . 56.270000000000003 113.604 176.871 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B 1373 ' ' ILE . . . . . . . . . . . . . 12.8 tt -75.46 140.78 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-N 114.335 -1.302 . . . . 60.829999999999998 110.552 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -67.4 108.47 2.8 Favored 'General case' 0 C--O 1.249 1.064 0 N-CA-C 107.27 -1.381 . . . . 66.099999999999994 107.27 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 60.8 t -102.97 113.64 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 106.437 -1.69 . . . . 63.469999999999999 106.437 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.206 -5.637 0 O-C-N 120.889 -1.132 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 20' ' ' ALA . . . . . 0.468 ' HA ' HD11 ' C' ' 171' ' ' LEU . . . . . . . . 0 N--CA 1.431 -1.422 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -52.96 -36.65 60.27 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 116.739 2.126 . . . . 0.0 116.739 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 22' ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' C' ' 22' ' ' GLU . 1.9 mp0 -37.96 -43.68 0.73 Allowed 'General case' 0 C--O 1.242 0.676 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 174.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 22.0 m -42.47 -30.04 0.32 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.678 1.591 . . . . 0.0 114.056 176.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.1 -46.93 86.88 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 123.919 1.819 . . . . 0.0 114.508 171.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 25' ' ' GLU . . . . . 0.822 ' HA ' ' HE2' ' C' ' 28' ' ' LYS . 2.5 mp0 -67.23 -46.11 74.79 Favored 'General case' 0 C--O 1.252 1.202 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.105 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 10.9 mp -52.68 -48.66 66.37 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.638 173.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.579 HD21 HD11 ' C' ' 110' ' ' LEU . 1.3 mm? -60.85 -40.36 92.57 Favored 'General case' 0 C--O 1.223 -0.297 0 O-C-N 119.654 -1.904 . . . . 0.0 115.187 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 28' ' ' LYS . . . . . 0.822 ' HE2' ' HA ' ' C' ' 25' ' ' GLU . 3.0 pttm -67.09 -29.29 69.01 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 118.496 -1.282 . . . . 0.0 113.729 168.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -79.28 -20.12 48.85 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -53.38 -21.34 5.71 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 118.467 2.766 . . . . 0.0 118.467 -160.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 31' ' ' HIS . . . . . 0.413 ' O ' HG23 ' C' ' 62' ' ' ILE . 48.4 m-70 71.63 -69.3 0.19 Allowed 'General case' 0 C--N 1.352 0.682 0 CA-C-N 122.925 2.602 . . . . 0.0 109.137 -176.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 32' ' ' SER . . . . . 0.503 ' HB2' ' OG1' ' C' ' 106' ' ' THR . 48.7 m -120.12 158.62 26.51 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 159.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 33' ' ' VAL . . . . . 0.442 ' HB ' HG23 ' C' ' 64' ' ' VAL . 32.7 t -123.06 114.56 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.155 0 N-CA-C 101.946 -3.353 . . . . 0.0 101.946 -178.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.494 HD12 HD11 ' C' ' 99' ' ' ILE . 18.5 mm -99.32 113.69 35.12 Favored 'Isoleucine or valine' 0 C--O 1.249 1.055 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 175.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 35' ' ' ILE . . . . . 0.52 HG12 HD12 ' C' ' 110' ' ' LEU . 75.9 mt -97.03 116.34 39.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 174.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 36' ' ' THR . . . . . 0.429 ' HB ' ' HA ' ' C' ' 111' ' ' VAL . 93.2 m -99.68 100.74 11.59 Favored Pre-proline 0 C--O 1.239 0.552 0 CA-C-N 114.867 -1.06 . . . . 0.0 113.22 174.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 37' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' C' ' 35' ' ' ILE . 15.4 Cg_exo -62.48 149.1 92.11 Favored 'Trans proline' 0 C--O 1.238 0.519 1 C-N-CA 125.879 4.386 . . . . 0.0 109.615 176.154 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.18 -153.8 7.92 Favored Glycine 0 C--O 1.217 -0.959 0 CA-C-N 109.694 -3.412 . . . . 0.0 108.62 174.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 39' ' ' TYR . . . . . 0.517 ' CD1' ' HD3' ' C' ' 74' ' ' ARG . 6.8 t80 -65.59 -41.35 92.92 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 110.127 -3.037 . . . . 0.0 108.165 -170.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 40' ' ' GLY . . . . . 0.478 ' H ' ' HA3' ' C' ' 113' ' ' GLY . . . -51.74 -54.76 23.6 Favored Glycine 0 C--N 1.347 1.19 0 O-C-N 120.543 -1.348 . . . . 0.0 113.972 174.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 30.4 ttm -58.97 -35.47 73.24 Favored 'General case' 0 C--O 1.215 -0.722 0 C-N-CA 124.484 1.114 . . . . 0.0 110.307 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.94 -60.59 2.15 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 2.9 p -75.03 -35.49 35.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 CA-C-N 118.422 0.555 . . . . 0.0 111.1 -168.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 44' ' ' ALA . . . . . 0.419 ' HB3' ' HB3' ' C' ' 175' ' ' ALA . . . -112.5 100.16 8.53 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 103.933 -2.617 . . . . 0.0 103.933 166.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 45' ' ' GLN . . . . . . . . . . . . . 16.3 pm0 -46.97 72.64 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 117.955 2.576 . . . . 0.0 117.955 -175.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.21 -22.69 54.97 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.914 -1.741 . . . . 0.0 111.507 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 47' ' ' GLN . . . . . 0.434 ' HA ' ' HB ' ' C' ' 50' ' ' VAL . 0.0 OUTLIER -56.24 -33.38 65.35 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 -176.185 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 48' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -65.3 -57.78 14.11 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 120.803 1.638 . . . . 0.0 110.59 172.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 49' ' ' PRO . . . . . 0.513 ' HB3' HD13 ' C' ' 183' ' ' LEU . 12.1 Cg_endo -58.47 -29.09 87.55 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 CA-C-N 125.526 3.009 . . . . 0.0 116.619 171.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 50' ' ' VAL . . . . . 0.503 HG23 HG11 ' C' ' 179' ' ' VAL . 20.3 t -58.16 -51.44 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 120.478 -1.389 . . . . 0.0 108.016 168.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.18 -36.39 79.72 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.324 0.965 . . . . 0.0 112.656 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 52' ' ' GLU . . . . . 0.52 ' O ' ' HE2' ' C' ' 56' ' ' LYS . 0.6 OUTLIER -64.28 -53.98 40.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 117.424 -1.274 . . . . 0.0 112.758 173.407 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 9.6 tp -62.83 -36.48 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 121.991 2.178 . . . . 0.0 110.398 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 74.2 m -47.89 -39.29 18.4 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 176.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -59.9 -42.54 94.08 Favored 'General case' 0 N--CA 1.437 -1.12 0 O-C-N 121.874 -0.517 . . . . 0.0 111.7 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 56' ' ' LYS . . . . . 0.52 ' HE2' ' O ' ' C' ' 52' ' ' GLU . 0.0 OUTLIER -75.41 -39.27 59.21 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -176.719 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 57' ' ' LEU . . . . . 0.558 HD21 HD12 ' C' ' 27' ' ' LEU . 72.9 mt -65.59 -33.23 75.42 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.658 1.183 . . . . 0.0 108.72 -176.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 58' ' ' ARG . . . . . 0.412 ' HD2' ' HA ' ' C' ' 58' ' ' ARG . 0.2 OUTLIER -77.58 -32.49 53.76 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 120.231 -1.543 . . . . 0.0 108.882 177.822 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.89 -46.93 61.71 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-N 121.005 1.73 . . . . 0.0 109.388 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -42.93 -42.42 3.72 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.329 1.452 . . . . 0.0 112.844 162.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.44 54.72 2.61 Favored Glycine 0 N--CA 1.437 -1.271 0 O-C-N 126.016 2.072 . . . . 0.0 112.154 176.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 62' ' ' ILE . . . . . 0.413 HG23 ' O ' ' C' ' 31' ' ' HIS . 93.8 mt -103.35 142.7 16.67 Favored 'Isoleucine or valine' 0 C--O 1.248 1.006 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 63' ' ' ASN . . . . . 0.403 ' OD1' ' HD3' ' C' ' 65' ' ' ARG . 31.0 t30 -71.41 74.52 0.75 Allowed 'General case' 0 C--O 1.257 1.466 0 CA-C-O 123.418 1.58 . . . . 0.0 109.418 174.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.442 HG23 ' HB ' ' C' ' 33' ' ' VAL . 3.5 p -88.14 115.34 28.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 117.551 -1.659 . . . . 0.0 108.211 -176.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 65' ' ' ARG . . . . . 0.483 HH21 HD11 ' C' ' 94' ' ' LEU . 14.3 mmm-85 -114.84 134.25 55.29 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.273 -177.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 66' ' ' PHE . . . . . 0.713 ' HB2' ' HA ' ' C' ' 93' ' ' VAL . 36.9 m-85 -93.5 79.48 4.35 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 123.01 1.386 . . . . 0.0 109.857 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.95 78.04 0.4 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-N 110.316 -3.129 . . . . 0.0 111.809 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 68' ' ' ILE . . . . . 0.512 HD11 HD22 ' C' ' 83' ' ' LEU . 12.9 mt -77.72 148.62 6.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 69' ' ' HIS . . . . . 0.478 ' HB3' ' HB2' ' C' ' 72' ' ' ALA . 32.0 t-80 -103.15 134.39 19.81 Favored Pre-proline 0 C--O 1.242 0.699 0 N-CA-C 104.152 -2.536 . . . . 0.0 104.152 168.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 70' ' ' PRO . . . . . 0.537 ' HB3' HD11 ' A' 1157 ' ' ILE . 27.6 Cg_endo -59.6 -72.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.123 0 C-N-CA 123.862 3.041 . . . . 0.0 114.887 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 23.0 t -70.87 95.53 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 170.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 72' ' ' ALA . . . . . 0.478 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . . . -165.26 161.34 19.16 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 123.252 1.501 . . . . 0.0 108.608 175.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 73' ' ' GLY . . . . . 0.47 ' O ' ' HD2' ' C' ' 74' ' ' ARG . . . 54.15 -110.55 1.58 Allowed Glycine 0 CA--C 1.535 1.296 0 CA-C-N 112.934 -1.939 . . . . 0.0 109.824 171.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 74' ' ' ARG . . . . . 0.581 ' HA ' ' OE1' ' B' 1203 ' ' GLN . 1.5 mpt_? -130.85 108.28 9.73 Favored 'General case' 0 C--O 1.259 1.605 0 O-C-N 121.959 -0.73 . . . . 0.0 111.234 -177.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.455 ' HA ' ' HD2' ' C' ' 76' ' ' PRO . 4.5 tt 63.83 114.67 0.02 OUTLIER Pre-proline 0 N--CA 1.445 -0.682 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 174.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 76' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' C' ' 75' ' ' LEU . 71.8 Cg_endo -56.89 104.28 0.14 Allowed 'Trans proline' 0 C--N 1.32 -0.925 1 C-N-CA 126.037 4.491 . . . . 0.0 107.805 175.469 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 132.01 -68.34 0.55 Allowed Glycine 0 N--CA 1.435 -1.395 0 N-CA-C 106.818 -2.513 . . . . 0.0 106.818 -171.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 78' ' ' HIS . . . . . 0.4 ' HB2' HD22 ' C' ' 75' ' ' LEU . 19.2 t-80 -63.37 -29.19 70.53 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -159.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -42.43 94.67 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 119.406 1.003 . . . . 0.0 110.493 175.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -72.83 -32.16 65.3 Favored 'General case' 0 C--N 1.368 1.377 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.562 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 48.7 t -73.01 -26.22 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 123.893 1.806 . . . . 0.0 110.303 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.9 tp -75.11 -31.92 61.26 Favored 'General case' 0 C--N 1.312 -1.03 0 O-C-N 120.55 -1.343 . . . . 0.0 108.397 166.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.512 HD22 HD11 ' C' ' 68' ' ' ILE . 9.0 mp -63.86 -30.52 71.6 Favored 'General case' 0 C--O 1.241 0.653 0 O-C-N 116.976 -3.577 . . . . 0.0 112.872 166.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 84' ' ' ALA . . . . . 0.479 ' HB2' ' OH ' ' C' ' 90' ' ' TYR . . . -62.21 -49.24 76.54 Favored 'General case' 0 N--CA 1.442 -0.849 0 O-C-N 124.57 1.169 . . . . 0.0 111.877 168.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -55.55 -40.02 71.36 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.225 1.01 . . . . 0.0 111.845 171.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.43 -21.27 53.27 Favored 'General case' 0 C--O 1.254 1.324 0 O-C-N 121.069 -1.019 . . . . 0.0 112.274 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp 77.36 50.82 0.04 OUTLIER 'General case' 0 C--O 1.242 0.682 0 CA-C-O 125.627 2.632 . . . . 0.0 112.95 -177.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 66.5 t -91.56 131.58 35.69 Favored Pre-proline 0 C--N 1.319 -0.751 0 O-C-N 118.885 -2.385 . . . . 0.0 112.146 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -61.28 99.57 0.16 Allowed 'Trans proline' 0 C--O 1.242 0.703 0 C-N-CA 124.471 3.447 . . . . 0.0 116.264 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 90' ' ' TYR . . . . . 0.479 ' OH ' ' HB2' ' C' ' 84' ' ' ALA . 82.2 m-85 -54.49 -26.07 29.15 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -174.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.97 -47.78 77.04 Favored 'General case' 0 C--O 1.248 1.004 0 O-C-N 120.116 -1.615 . . . . 0.0 112.024 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 5.0 pt -88.47 -8.54 10.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 93' ' ' VAL . . . . . 0.713 ' HA ' ' HB2' ' C' ' 66' ' ' PHE . 84.8 t -71.19 119.77 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 165.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 94' ' ' LEU . . . . . 0.523 HD12 HD13 ' C' ' 99' ' ' ILE . 65.0 mt -123.77 99.72 6.42 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.711 -1.132 . . . . 0.0 109.129 -175.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 95' ' ' GLU . . . . . 0.693 ' HG2' ' HB ' ' A' 1157 ' ' ILE . 12.9 mp0 -91.79 74.47 5.74 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 -171.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 6.2 ttp 62.83 124.5 0.01 OUTLIER 'General case' 0 CA--C 1.497 -1.089 0 CA-C-N 111.322 -2.672 . . . . 0.0 111.602 -167.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -159.34 -172.35 3.7 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-N 112.657 -2.065 . . . . 0.0 106.973 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -76.49 61.19 1.71 Allowed 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 121.082 -1.012 . . . . 0.0 111.223 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 99' ' ' ILE . . . . . 0.523 HD13 HD12 ' C' ' 94' ' ' LEU . 6.2 tp -92.64 27.66 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.778 0 CA-C-O 124.851 2.262 . . . . 0.0 109.92 -168.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 100' ' ' ASN . . . . . 0.447 ' O ' ' HB2' ' C' ' 103' ' ' PHE . 2.2 t-20 -71.64 -60.82 2.03 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.602 -1.311 . . . . 0.0 114.115 -166.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -70.3 -32.49 70.28 Favored 'General case' 0 C--O 1.215 -0.753 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -56.97 -41.44 78.36 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 117.11 -1.424 . . . . 0.0 110.697 173.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 103' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' C' ' 100' ' ' ASN . 3.4 m-85 -54.98 -45.08 74.98 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 120.185 1.357 . . . . 0.0 113.153 169.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.21 -33.19 73.96 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 122.411 1.101 . . . . 0.0 108.722 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -68.03 -33.13 74.01 Favored 'General case' 0 C--O 1.243 0.711 0 O-C-N 118.87 -2.394 . . . . 0.0 111.367 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 106' ' ' THR . . . . . 0.503 ' OG1' ' HB2' ' C' ' 32' ' ' SER . 51.7 m -76.11 122.42 24.26 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.745 1.26 . . . . 0.0 109.183 -175.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.26 -57.97 3.98 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.594 169.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 4.3 m -104.05 104.99 15.02 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -169.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 109' ' ' VAL . . . . . 0.559 ' HB ' ' HA ' ' C' ' 144' ' ' VAL . 24.4 t -94.95 107.95 20.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 172.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 110' ' ' LEU . . . . . 0.579 HD11 HD21 ' C' ' 27' ' ' LEU . 80.2 mt -78.23 86.37 4.35 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.901 -0.499 . . . . 0.0 111.827 178.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 111' ' ' VAL . . . . . 0.543 HG13 ' HB3' ' C' ' 114' ' ' ALA . 98.8 t -79.93 83.1 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-O 124.315 2.007 . . . . 0.0 108.237 177.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 7.4 mt -78.05 77.22 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.747 0 CA-C-O 123.321 1.534 . . . . 0.0 113.03 -172.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 113' ' ' GLY . . . . . 0.478 ' HA3' ' H ' ' C' ' 40' ' ' GLY . . . 71.19 42.07 58.71 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.054 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 114' ' ' ALA . . . . . 0.543 ' HB3' HG13 ' C' ' 111' ' ' VAL . . . -107.83 -24.8 11.52 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 120.84 -1.388 . . . . 0.0 110.321 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 115' ' ' ASN . . . . . 0.541 ' HB3' ' O1N' ' C' 1001 ' ' NAP . 0.2 OUTLIER 56.94 -85.79 0.02 OUTLIER 'General case' 0 C--N 1.352 0.709 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 162.163 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 116' ' ' ASP . . . . . 0.615 ' HB3' HD13 ' C' ' 130' ' ' ILE . 45.9 m-20 -83.61 -22.74 32.16 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -174.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 117' ' ' THR . . . . . 0.497 HG23 H51N ' C' 1001 ' ' NAP . 2.7 p -80.01 9.99 4.82 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 117.303 2.335 . . . . 0.0 117.303 -175.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.569 HG12 ' HB2' ' C' ' 136' ' ' LEU . 3.0 m -124.66 13.06 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 112.947 -1.933 . . . . 0.0 109.645 169.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 119' ' ' ASN . . . . . 0.481 ' HA ' ' HD2' ' C' ' 120' ' ' PRO . 37.4 t30 -90.08 121.02 69.19 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-O 118.475 -0.774 . . . . 0.0 111.17 -169.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 120' ' ' PRO . . . . . 0.481 ' HD2' ' HA ' ' C' ' 119' ' ' ASN . 36.9 Cg_endo -52.75 -28.33 37.66 Favored 'Trans proline' 0 C--O 1.251 1.153 0 C-N-CA 123.401 2.734 . . . . 0.0 113.701 175.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 121' ' ' ALA . . . . . 0.871 ' HA ' ' HB3' ' C' ' 125' ' ' ASP . . . -64.97 12.48 0.04 OUTLIER 'General case' 0 C--N 1.354 0.784 0 N-CA-C 116.644 2.091 . . . . 0.0 116.644 174.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 122' ' ' ALA . . . . . 0.659 ' HB1' ' HB3' ' C' ' 133' ' ' MET . . . -109.61 -2.34 17.58 Favored 'General case' 0 N--CA 1.426 -1.653 0 O-C-N 120.628 -1.295 . . . . 0.0 113.993 171.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.9 -39.85 0.09 Allowed 'General case' 0 C--N 1.351 0.671 0 CA-C-O 125.021 2.344 . . . . 0.0 115.969 169.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -66.12 -38.6 88.6 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 119.351 -2.093 . . . . 0.0 111.818 173.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 125' ' ' ASP . . . . . 0.871 ' HB3' ' HA ' ' C' ' 121' ' ' ALA . 22.7 t70 -102.63 121.08 50.91 Favored Pre-proline 0 C--N 1.347 0.457 0 O-C-N 124.19 0.931 . . . . 0.0 110.707 171.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 126' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' C' ' 125' ' ' ASP . 9.4 Cg_exo -77.6 -18.28 13.73 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 124.461 3.441 . . . . 0.0 115.677 174.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -62.95 -58.93 5.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 122.061 0.934 . . . . 0.0 112.47 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 128' ' ' SER . . . . . 0.571 ' HB3' HG21 ' C' ' 158' ' ' VAL . 66.6 m -57.36 149.52 48.3 Favored Pre-proline 0 C--O 1.24 0.595 0 N-CA-C 116.496 2.036 . . . . 0.0 116.496 -163.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 129' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -55.18 -17.73 15.98 Favored 'Trans proline' 0 CA--C 1.564 2.012 1 C-N-CA 126.003 4.469 . . . . 0.0 115.296 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 130' ' ' ILE . . . . . 0.615 HD13 ' HB3' ' C' ' 116' ' ' ASP . 8.8 pt -101.67 12.8 6.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 120.004 1.275 . . . . 0.0 114.283 173.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 131' ' ' ALA . . . . . 0.571 ' HA ' ' HA ' ' C' ' 122' ' ' ALA . . . -71.77 86.04 0.94 Allowed 'General case' 0 C--O 1.239 0.549 0 CA-C-O 124.353 2.025 . . . . 0.0 109.147 -172.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 149.5 53.83 0.02 OUTLIER Glycine 0 N--CA 1.423 -2.17 0 CA-C-N 111.963 -2.381 . . . . 0.0 108.777 -175.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 133' ' ' MET . . . . . 0.705 ' SD ' ' HD2' ' C' ' 134' ' ' PRO . 6.6 tpp -147.54 125.3 5.88 Favored Pre-proline 0 CA--C 1.548 0.865 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 134' ' ' PRO . . . . . 0.705 ' HD2' ' SD ' ' C' ' 133' ' ' MET . 22.4 Cg_endo -78.1 83.6 2.17 Favored 'Trans proline' 0 C--O 1.238 0.492 1 C-N-CA 125.612 4.208 . . . . 0.0 107.479 -175.954 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 135' ' ' VAL . . . . . 0.427 HG23 ' CZ3' ' C' ' 139' ' ' TRP . 8.3 m -64.7 154.02 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 CA-C-N 113.681 -1.6 . . . . 0.0 113.288 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.569 ' HB2' HG12 ' C' ' 118' ' ' VAL . 88.3 mt -74.87 120.51 20.52 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -177.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 137' ' ' GLU . . . . . 0.428 ' HA ' ' CZ3' ' C' ' 139' ' ' TRP . 42.9 mm-40 -21.29 -28.02 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.159 1 N-CA-C 123.738 4.718 . . . . 0.0 123.738 179.162 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 138' ' ' VAL . . . . . 0.521 HG21 HG21 ' C' ' 109' ' ' VAL . 8.3 p -79.6 83.35 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -175.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 139' ' ' TRP . . . . . 0.428 ' CZ3' ' HA ' ' C' ' 137' ' ' GLU . 34.7 p90 -125.91 171.01 11.09 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-N 112.206 -2.27 . . . . 0.0 109.008 165.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 140' ' ' LYS . . . . . . . . . . . . . 21.0 pttm 56.55 -0.55 0.06 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 117.598 2.444 . . . . 0.0 117.598 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -141.76 165.62 26.97 Favored 'General case' 0 C--O 1.256 1.423 0 CA-C-O 116.015 -1.945 . . . . 0.0 109.731 -175.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 64.35 168.1 0.17 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 161.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 143' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -84.24 73.49 10.43 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 124.52 2.105 . . . . 0.0 109.667 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 144' ' ' VAL . . . . . 0.559 ' HA ' ' HB ' ' C' ' 109' ' ' VAL . 3.2 t -81.34 100.58 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 103.393 -2.818 . . . . 0.0 103.393 175.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 145' ' ' ILE . . . . . 0.804 HG12 ' HB2' ' C' ' 171' ' ' LEU 0.287 13.0 tt -98.87 99.27 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 112.31 -2.223 . . . . 0.0 112.062 -173.636 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 146' ' ' VAL . . . . . 0.608 HG21 ' HB3' ' C' ' 162' ' ' LEU . 39.5 t -84.11 113.38 22.85 Favored 'Isoleucine or valine' 0 C--N 1.343 0.298 0 CA-C-N 112.702 -2.044 . . . . 0.0 107.013 -171.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 147' ' ' PHE . . . . . 0.449 ' HD2' ' HA ' ' C' ' 175' ' ' ALA . 1.3 m-85 -66.41 112.73 4.2 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 122.647 1.213 . . . . 0.0 110.427 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 148' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -146.26 108.76 4.48 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 105.909 -1.885 . . . . 0.0 105.909 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -64.97 -40.7 95.38 Favored 'General case' 0 C--N 1.344 0.333 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.78 145.13 51.88 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 103.988 -2.597 . . . . 0.0 103.988 -174.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 151' ' ' MET . . . . . 0.526 ' HG2' ' SD ' ' C' ' 170' ' ' MET . 0.3 OUTLIER -84.02 68.94 10.24 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 170.909 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -87.16 168.06 13.59 Favored 'General case' 0 C--O 1.258 1.536 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.294 173.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 13.3 m -71.43 119.52 15.7 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -72.94 -133.16 0.18 Allowed Glycine 0 N--CA 1.478 1.441 0 O-C-N 118.797 -2.439 . . . . 0.0 108.75 172.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 155' ' ' TYR . . . . . 0.862 ' HE1' ' HB2' ' B' 1199 ' ' GLU . 2.8 m-85 -77.03 -50.86 12.15 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 117.135 -1.826 . . . . 0.0 109.881 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 156' ' ' ALA . . . . . 0.631 ' HB1' HG22 ' C' ' 158' ' ' VAL . . . -94.83 -53.32 3.89 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 161.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 65.96 14.68 61.48 Favored Glycine 0 C--O 1.254 1.349 0 CA-C-O 122.504 1.058 . . . . 0.0 114.253 -173.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 158' ' ' VAL . . . . . 0.631 HG22 ' HB1' ' C' ' 156' ' ' ALA . 13.5 m -89.6 124.84 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -162.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . 0.301 0.0 OUTLIER 37.0 24.61 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 118.266 2.691 . . . . 0.0 118.266 172.981 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 160' ' ' ASN . . . . . 0.71 ' HB3' HD12 ' C' ' 162' ' ' LEU . 3.7 m120 -62.57 111.63 5.1 Favored Pre-proline 0 C--O 1.239 0.535 0 O-C-N 120.461 -1.399 . . . . 0.0 110.22 -171.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -56.18 -41.94 71.46 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.885 2.39 . . . . 0.0 112.48 -177.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 162' ' ' LEU . . . . . 1.003 ' HA ' HG22 ' C' ' 168' ' ' THR . 16.0 mt -17.48 -40.91 0.0 OUTLIER 'General case' 0 C--O 1.244 0.794 0 N-CA-C 120.62 3.563 . . . . 0.0 120.62 155.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 163' ' ' PHE . . . . . 0.409 ' HA ' ' HG3' ' C' ' 170' ' ' MET . 12.9 m-30 -82.02 -48.33 11.55 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-O 124.385 2.041 . . . . 0.0 111.777 176.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -91.06 -17.04 26.88 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 111.963 -2.38 . . . . 0.0 113.611 -158.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -87.88 172.43 9.62 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 121.818 2.099 . . . . 0.0 110.863 -168.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -55.75 10.62 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 120.406 -1.434 . . . . 0.0 114.479 177.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -82.53 -49.97 9.31 Favored 'General case' 0 C--O 1.239 0.538 0 O-C-N 124.848 1.342 . . . . 0.0 108.115 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 168' ' ' THR . . . . . 1.003 HG22 ' HA ' ' C' ' 162' ' ' LEU . 4.8 m -82.84 91.9 7.17 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 123.328 1.537 . . . . 0.0 107.443 177.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -142.41 142.82 32.44 Favored 'General case' 0 N--CA 1.439 -1.013 0 O-C-N 120.88 -1.137 . . . . 0.0 111.686 -154.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 170' ' ' MET . . . . . 0.526 ' SD ' ' HG2' ' C' ' 151' ' ' MET . 54.1 mtm -58.41 126.83 29.21 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 121.169 -0.957 . . . . 0.0 108.878 166.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 171' ' ' LEU . . . . . 0.804 ' HB2' HG12 ' C' ' 145' ' ' ILE . 39.4 tp -89.06 108.78 19.78 Favored 'General case' 0 C--O 1.254 1.329 0 N-CA-C 104.103 -2.554 . . . . 0.0 104.103 166.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -82.22 91.51 6.74 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -174.69 168.19 40.74 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 106.139 -2.784 . . . . 0.0 106.139 175.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 174' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -72.57 151.7 42.23 Favored 'General case' 0 C--O 1.252 1.225 0 O-C-N 119.026 -2.455 . . . . 0.0 111.528 170.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 175' ' ' ALA . . . . . 0.449 ' HA ' ' HD2' ' C' ' 147' ' ' PHE . . . -59.85 -50.79 72.42 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 126.251 1.82 . . . . 0.0 111.676 -170.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.67 -55.9 6.84 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 177' ' ' ALA . . . . . . . . . . . . . . . -41.35 -44.83 2.88 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 117.851 2.537 . . . . 0.0 117.851 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 9.3 m -64.48 -41.34 96.53 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 175.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 179' ' ' VAL . . . . . 0.503 HG11 HG23 ' C' ' 50' ' ' VAL . 5.2 t -72.45 -32.05 40.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 119.278 -2.138 . . . . 0.0 107.615 177.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -67.67 -33.17 74.39 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 117.912 -2.992 . . . . 0.0 111.321 176.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.69 -30.61 70.86 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.202 173.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 182' ' ' ILE . . . . . 0.459 HD12 ' HG ' ' C' ' 27' ' ' LEU . 31.0 pt -87.22 -39.14 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 CA-C-O 122.668 1.223 . . . . 0.0 113.672 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 183' ' ' LEU . . . . . 0.513 HD13 ' HB3' ' C' ' 49' ' ' PRO . 12.9 tp -11.42 -66.9 0.01 OUTLIER 'General case' 0 C--N 1.355 0.838 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -107.7 -19.76 13.44 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 118.365 -1.334 . . . . 0.0 114.486 176.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -70.07 -65.28 0.74 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.941 -1.027 . . . . 0.0 113.743 -172.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 186' ' ' LEU . . . . . . . . . . . . 0.345 2.2 pt? . . . . . 0 N--CA 1.43 -1.433 0 N-CA-C 118.969 2.951 . . . . 0.0 118.969 -165.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 1' ' ' NAD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C 1001 ' ' NAP . . . . . 0.541 ' O1N' ' HB3' ' C' ' 115' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 47.7 t60 . . . . . 0 N--CA 1.418 -2.064 0 N-CA-C 106.906 -1.516 . . . . 65.739999999999995 106.906 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -54.63 77.17 0.01 OUTLIER Glycine 0 C--O 1.223 -0.574 0 C-N-CA 125.581 1.562 . . . . 48.659999999999997 114.438 164.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 26.1 ttp180 -110.0 134.79 51.75 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.128 -1.536 . . . . 44.560000000000002 107.299 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1003 ' ' ILE . . . . . 0.597 HG12 ' HB ' ' A' 1068 ' ' ILE . 30.2 mt -99.75 139.22 21.86 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.757 0 O-C-N 124.482 1.114 . . . . 34.859999999999999 110.0 176.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -109.7 135.17 12.68 Favored Glycine 0 C--O 1.25 1.146 0 N-CA-C 107.376 -2.29 . . . . 30.75 107.376 172.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.441 HG21 ' HB2' ' A' 1018 ' ' ALA . 43.6 mm -106.76 112.05 63.63 Favored Pre-proline 0 N--CA 1.427 -1.578 0 N-CA-C 102.008 -3.33 . . . . 32.210000000000001 102.008 175.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -71.45 143.86 43.96 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 123.137 2.558 . . . . 32.979999999999997 111.438 168.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1007 ' ' ARG . . . . . 0.493 ' HG3' HD11 ' A' 1042 ' ' LEU . 25.3 ttp85 -67.8 126.61 29.95 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 104.248 -2.501 . . . . 47.979999999999997 104.248 162.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1008 ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -62.81 130.96 47.18 Favored 'General case' 0 CA--C 1.513 -0.478 0 O-C-N 120.247 -1.533 . . . . 34.700000000000003 113.219 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -86.68 -11.48 51.13 Favored 'General case' 0 C--O 1.252 1.191 0 O-C-N 121.125 -0.984 . . . . 53.369999999999997 113.579 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 5.9 mp -63.17 148.45 47.99 Favored 'General case' 0 C--O 1.214 -0.786 0 CA-C-O 123.034 1.397 . . . . 45.07 112.529 -176.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1011 ' ' THR . . . . . . . . . . . . . 7.3 m -64.23 107.59 1.35 Allowed 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 114.048 -1.433 . . . . 40.359999999999999 111.89 -167.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 33.8 t30 68.31 69.07 0.32 Allowed 'General case' 0 C--O 1.215 -0.73 0 CA-C-N 113.173 -1.831 . . . . 40.609999999999999 110.264 176.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1013 ' ' GLU . . . . . 0.616 ' HG3' ' H ' ' A' 1015 ' ' ARG . 8.3 tp10 -104.08 146.1 29.21 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 120.034 -0.666 . . . . 33.759999999999998 112.207 -168.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1014 ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' 1043 ' ' ALA . 0.6 OUTLIER -103.93 -6.23 21.5 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 122.758 1.266 . . . . 27.890000000000001 112.664 178.517 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 1015 ' ' ARG . . . . . 0.802 ' HD2' HG11 ' A' 1072 ' ' VAL . 69.5 mtm180 -106.19 147.3 29.21 Favored 'General case' 0 N--CA 1.44 -0.932 0 O-C-N 120.691 -1.255 . . . . 29.02 113.413 -172.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1016 ' ' VAL . . . . . 0.699 HG21 ' HB1' ' A' 1039 ' ' ALA . 8.6 p -148.48 138.93 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 N-CA-C 104.033 -2.58 . . . . 28.129999999999999 104.033 159.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1017 ' ' ALA . . . . . . . . . . . . . . . -63.44 -12.94 35.24 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 117.742 -3.098 . . . . 26.870000000000001 116.749 -176.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1018 ' ' ALA . . . . . 0.441 ' HB2' HG21 ' A' 1005 ' ' ILE . . . -84.11 112.1 19.93 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 123.734 1.73 . . . . 26.77 111.204 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1019 ' ' THR . . . . . 0.672 HG21 ' HA ' ' A' 1325 ' ' GLN . 67.8 p -118.26 167.74 10.85 Favored Pre-proline 0 N--CA 1.416 -2.138 0 N-CA-C 106.297 -1.742 . . . . 27.02 106.297 158.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1020 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -48.0 -57.48 2.31 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 124.767 3.645 . . . . 30.57 109.782 163.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1021 ' ' LYS . . . . . 0.415 ' HB2' ' OE1' ' A' 1325 ' ' GLN . 21.0 mttp -53.7 -31.12 46.73 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.856 1.662 . . . . 47.810000000000002 113.966 178.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1022 ' ' THR . . . . . . . . . . . . . 5.0 m -62.67 -65.57 0.67 Allowed 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 120.435 1.47 . . . . 30.77 108.758 169.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1023 ' ' VAL . . . . . 0.513 HG13 ' HB ' ' A' 1033 ' ' VAL . 59.0 t -56.75 -55.91 17.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 O-C-N 126.611 2.444 . . . . 33.590000000000003 113.11 -171.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -49.66 -52.24 32.3 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.036 1.334 . . . . 53.289999999999999 114.568 -176.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1025 ' ' GLN . . . . . 0.582 ' OE1' ' HE2' ' A' 1336 ' ' LYS . 8.2 tt0 -75.44 -34.46 60.98 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 114.389 -1.278 . . . . 46.920000000000002 113.122 -173.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1026 ' ' LEU . . . . . 0.571 HD21 ' HA ' ' A' 1332 ' ' VAL . 95.9 mt -66.87 -39.38 87.51 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.219 -0.901 . . . . 37.170000000000002 110.025 177.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1027 ' ' LEU . . . . . 0.501 HD23 ' HA ' ' A' 1032 ' ' THR . 96.5 mt -54.53 -50.03 68.84 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 118.241 -0.885 . . . . 44.439999999999998 110.673 172.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 42.5 mttm -57.61 -37.86 73.97 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.94 1.296 . . . . 52.579999999999998 112.051 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1029 ' ' LEU . . . . . 0.643 ' HA ' ' HE3' ' A' 1342 ' ' LYS . 98.6 mt -66.97 -40.23 87.4 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 119.015 0.825 . . . . 45.689999999999998 110.625 173.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 148.88 -30.31 1.24 Allowed Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.832 -0.699 . . . . 42.090000000000003 111.46 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -74.85 109.36 8.25 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 124.72 2.2 . . . . 40.719999999999999 108.884 -172.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1032 ' ' THR . . . . . 0.501 ' HA ' HD23 ' A' 1027 ' ' LEU . 18.6 m -74.51 131.14 40.76 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 105.611 -1.996 . . . . 37.770000000000003 105.611 176.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1033 ' ' VAL . . . . . 0.513 ' HB ' HG13 ' A' 1023 ' ' VAL . 61.1 t -109.83 136.78 44.73 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.784 0 CA-C-O 121.536 0.684 . . . . 33.539999999999999 109.66 -171.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -119.37 130.94 55.58 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 126.789 2.556 . . . . 31.68 109.456 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1035 ' ' VAL . . . . . 0.402 HG11 ' CD2' ' A' 1050 ' ' PHE . 77.6 t -115.34 135.87 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 105.765 -1.939 . . . . 31.52 105.765 -175.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1036 ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -62.31 141.67 58.15 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 123.703 1.716 . . . . 41.039999999999999 110.626 169.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1037 ' ' SER . . . . . . . . . . . . . 19.5 m -70.05 151.16 45.83 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.46 -1.245 . . . . 31.829999999999998 108.736 174.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 91.71 -29.27 7.49 Favored Glycine 0 C--O 1.213 -1.192 0 C-N-CA 120.057 -1.068 . . . . 29.359999999999999 110.561 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1039 ' ' ALA . . . . . 0.699 ' HB1' HG21 ' A' 1016 ' ' VAL . . . -62.37 -21.11 65.07 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 116.825 2.158 . . . . 27.780000000000001 116.825 -169.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -61.78 -43.2 99.55 Favored Glycine 0 CA--C 1.538 1.492 0 O-C-N 119.795 -1.816 . . . . 28.91 114.342 -175.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.79 -28.31 68.91 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 116.35 1.982 . . . . 51.18 116.35 -174.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1042 ' ' LEU . . . . . 0.493 HD11 ' HG3' ' A' 1007 ' ' ARG . 19.5 mt -52.82 -60.79 2.83 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 123.615 1.674 . . . . 29.91 107.898 171.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1043 ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' 1014 ' ' THR . . . -84.88 17.8 2.7 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.854 -1.066 . . . . 28.539999999999999 112.792 -173.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1044 ' ' SER . . . . . 0.619 ' HB3' ' HA2' ' B' 1278 ' ' GLY . 60.8 m 52.56 63.79 2.1 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-O 124.13 1.919 . . . . 33.060000000000002 112.959 -174.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1045 ' ' PHE . . . . . 0.62 ' HA ' ' HB1' ' B' 1277 ' ' ALA . 22.4 m-85 -128.66 157.08 42.34 Favored 'General case' 0 C--O 1.245 0.842 0 O-C-N 120.849 -1.157 . . . . 30.289999999999999 110.675 176.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 2.4 t70 -85.26 127.65 34.39 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 111.125 -2.762 . . . . 48.619999999999997 104.506 164.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -65.17 -39.34 92.8 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 123.068 1.413 . . . . 36.740000000000002 112.342 -174.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 25.5 pttm -66.84 -12.53 59.45 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 120.059 -1.651 . . . . 43.729999999999997 113.918 173.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -71.64 -21.65 61.8 Favored 'General case' 0 C--O 1.247 0.964 0 CA-C-O 122.776 1.274 . . . . 32.810000000000002 110.819 168.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1050 ' ' PHE . . . . . 0.402 ' CD2' HG11 ' A' 1035 ' ' VAL . 22.3 m-30 -78.84 -32.21 46.05 Favored 'General case' 0 CA--C 1.505 -0.773 0 O-C-N 119.492 -2.005 . . . . 31.859999999999999 110.056 169.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1051 ' ' VAL . . . . . 0.485 HG22 HG13 ' A' 1057 ' ' ILE . 62.2 t -62.87 -50.66 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-O 122.452 1.12 . . . . 33.219999999999999 109.095 173.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -43.65 -53.38 5.78 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.038 1.735 . . . . 50.829999999999998 112.676 165.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -56.75 -29.99 63.13 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-O 118.298 -0.858 . . . . 33.119999999999997 111.389 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 104.32 31.28 4.7 Favored Glycine 0 C--N 1.343 0.96 0 N-CA-C 111.896 -0.482 . . . . 35.829999999999998 111.896 176.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -90.59 149.51 22.1 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 121.783 -0.834 . . . . 34.82 109.92 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -83.04 122.21 28.02 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 106.295 -1.743 . . . . 49.049999999999997 106.295 167.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1057 ' ' ILE . . . . . 0.485 HG13 HG22 ' A' 1051 ' ' VAL . 27.3 mm -98.41 83.71 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.879 0 N-CA-C 106.389 -1.708 . . . . 38.530000000000001 106.389 -165.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1058 ' ' VAL . . . . . . . . . . . . . 48.7 t -80.11 130.11 36.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 O-C-N 124.312 1.008 . . . . 42.109999999999999 111.976 -173.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -79.62 78.55 6.17 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 123.994 1.854 . . . . 58.0 111.537 177.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 101.84 -142.49 15.68 Favored Glycine 0 CA--C 1.49 -1.531 0 CA-C-N 113.599 -1.637 . . . . 52.119999999999997 110.631 167.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -58.19 -26.4 62.74 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 111.33 -2.435 . . . . 54.75 114.12 -156.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1062 ' ' SER . . . . . . . . . . . . . 49.0 m -63.18 -14.3 47.36 Favored 'General case' 0 N--CA 1.427 -1.617 0 O-C-N 119.4 -2.062 . . . . 50.340000000000003 111.194 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -61.47 -29.29 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 O-C-N 119.839 -1.788 . . . . 41.460000000000001 109.634 172.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1064 ' ' TRP . . . . . 0.479 ' CH2' ' HB3' ' A' 1079 ' ' GLU . 87.7 m95 -65.28 -26.31 68.03 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 114.791 1.404 . . . . 39.32 114.791 171.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -79.49 75.34 6.11 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 122.508 1.147 . . . . 55.380000000000003 109.125 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1066 ' ' SER . . . . . . . . . . . . . 69.6 m -152.32 151.4 30.84 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 107.118 -1.438 . . . . 41.869999999999997 107.118 -172.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -66.74 -29.55 69.55 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-O 123.519 1.628 . . . . 53.200000000000003 112.324 -174.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1068 ' ' ILE . . . . . 0.597 ' HB ' HG12 ' A' 1003 ' ' ILE . 60.4 mt -131.04 143.21 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 102.868 -3.012 . . . . 41.899999999999999 102.868 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1069 ' ' ILE . . . . . 0.439 HG12 HG21 ' A' 1087 ' ' THR . 23.2 mm -123.97 114.29 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 N-CA-C 103.221 -2.881 . . . . 38.729999999999997 103.221 175.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1070 ' ' LEU . . . . . 0.599 HD22 HD22 ' A' 1331 ' ' LEU . 95.9 mt -90.05 94.27 9.72 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-N 116.144 -0.48 . . . . 32.439999999999998 112.07 172.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1071 ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -91.81 154.3 19.0 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 106.675 -1.602 . . . . 34.649999999999999 106.675 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1072 ' ' VAL . . . . . 0.802 HG11 ' HD2' ' A' 1015 ' ' ARG . 12.2 t -90.73 -67.32 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.964 0 N-CA-C 105.038 -2.208 . . . . 31.32 105.038 172.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -88.04 179.24 6.45 Favored 'General case' 0 CA--C 1.508 -0.658 0 O-C-N 120.39 -1.444 . . . . 33.939999999999998 110.571 -170.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -52.61 128.89 44.36 Favored Pre-proline 0 N--CA 1.441 -0.894 0 N-CA-C 114.079 1.141 . . . . 38.039999999999999 114.079 165.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1075 ' ' PRO . . . . . 0.491 ' HG2' HD21 ' A' 1089 ' ' LEU . 77.9 Cg_exo -67.13 128.39 18.48 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.089 2.526 . . . . 42.68 109.048 174.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 53.4 mt -78.16 158.06 29.19 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 112.557 -2.111 . . . . 46.740000000000002 106.068 175.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1077 ' ' ASP . . . . . 0.587 ' HA ' HD12 ' A' 1080 ' ' ILE . 4.1 m-20 -45.39 -35.82 3.88 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 118.054 2.613 . . . . 58.609999999999999 118.054 -169.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -68.6 -47.47 66.63 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 125.027 1.454 . . . . 59.200000000000003 110.729 173.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1079 ' ' GLU . . . . . 0.479 ' HB3' ' CH2' ' A' 1064 ' ' TRP . 33.0 mt-10 -60.44 -37.77 82.0 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 109.361 -0.607 . . . . 50.630000000000003 109.361 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1080 ' ' ILE . . . . . 0.587 HD12 ' HA ' ' A' 1077 ' ' ASP . 96.6 mt -56.5 -56.79 11.86 Favored 'Isoleucine or valine' 0 C--N 1.355 0.836 0 O-C-N 120.942 -1.099 . . . . 51.479999999999997 108.077 176.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -62.59 -20.91 65.2 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.712 -1.243 . . . . 50.280000000000001 113.028 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 75.2 mt -79.17 -16.22 56.92 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 114.954 1.465 . . . . 50.210000000000001 114.954 175.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1083 ' ' LEU . . . . . 0.62 HD11 HD13 ' A' 1089 ' ' LEU . 2.3 mm? -59.68 141.04 55.91 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.02 1.282 . . . . 49.060000000000002 109.549 172.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -86.61 142.61 35.0 Favored Pre-proline 0 C--O 1.217 -0.626 0 N-CA-C 103.413 -2.81 . . . . 51.079999999999998 103.413 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -54.39 120.96 8.88 Favored 'Trans proline' 0 N--CA 1.42 -2.829 0 C-N-CA 124.306 3.337 . . . . 49.729999999999997 109.83 168.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 98.67 -3.68 59.27 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-O 117.925 -1.486 . . . . 47.710000000000001 112.757 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1087 ' ' THR . . . . . 0.439 HG21 HG12 ' A' 1069 ' ' ILE . 87.1 m -68.09 129.43 39.89 Favored 'General case' 0 C--O 1.251 1.134 0 CA-C-N 119.139 1.47 . . . . 45.469999999999999 111.819 173.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1088 ' ' THR . . . . . 0.434 ' HA ' ' HB ' ' A' 1111 ' ' THR . 2.8 m -68.75 110.51 4.35 Favored 'General case' 0 C--O 1.244 0.803 0 O-C-N 119.324 -2.11 . . . . 42.039999999999999 108.739 165.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1089 ' ' LEU . . . . . 0.62 HD13 HD11 ' A' 1083 ' ' LEU . 33.1 tp -98.89 118.88 36.66 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 105.741 -1.948 . . . . 38.060000000000002 105.741 173.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 24.4 t -113.26 126.43 70.68 Favored 'Isoleucine or valine' 0 C--O 1.256 1.433 0 N-CA-C 104.642 -2.355 . . . . 37.399999999999999 104.642 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1091 ' ' SER . . . . . . . . . . . . . 5.1 m -162.17 168.98 21.61 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 121.172 1.805 . . . . 36.159999999999997 111.05 -176.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1092 ' ' PHE . . . . . 0.4 ' CE2' ' HG3' ' A' 1133 ' ' MET . 6.5 m-85 -69.46 99.82 1.3 Allowed 'General case' 0 C--N 1.349 0.562 0 O-C-N 120.962 -1.086 . . . . 38.939999999999998 109.672 159.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 40.7 mm -90.21 -46.93 14.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 113.316 0.858 . . . . 42.170000000000002 113.316 175.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1094 ' ' TRP . . . . . 0.446 ' HB3' ' NE2' ' A' 1097 ' ' GLN . 23.8 m95 61.52 63.35 2.32 Favored Pre-proline 0 N--CA 1.469 0.499 0 C-N-CA 124.02 0.928 . . . . 46.509999999999998 112.037 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -55.96 -27.85 65.81 Favored 'Trans proline' 0 C--N 1.346 0.423 0 N-CA-C 120.494 3.229 . . . . 49.759999999999998 120.494 -166.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -77.2 -29.57 54.35 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 121.546 1.975 . . . . 52.619999999999997 112.538 175.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1097 ' ' GLN . . . . . 0.446 ' NE2' ' HB3' ' A' 1094 ' ' TRP . 1.5 mp0 -86.75 -24.16 25.22 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 124.456 2.074 . . . . 60.740000000000002 111.233 173.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1098 ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -127.33 74.24 77.48 Favored Pre-proline 0 N--CA 1.431 -1.422 0 O-C-N 120.024 -1.672 . . . . 58.189999999999998 112.81 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1099 ' ' PRO . . . . . 0.546 ' HG2' ' HG3' ' A' 1100 ' ' GLU . 94.5 Cg_endo -70.96 -29.42 18.17 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.947 2.431 . . . . 54.590000000000003 113.508 177.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1100 ' ' GLU . . . . . 0.546 ' HG3' ' HG2' ' A' 1099 ' ' PRO . 27.2 mt-10 -80.89 -28.02 36.09 Favored 'General case' 0 N--CA 1.434 -1.225 0 O-C-N 119.424 -2.047 . . . . 63.280000000000001 106.067 -163.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1101 ' ' LEU . . . . . 0.406 HD23 HD11 ' A' 1080 ' ' ILE . 15.1 mt -50.72 -41.97 56.73 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 124.917 1.287 . . . . 54.75 110.31 171.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1102 ' ' MET . . . . . 0.423 ' SD ' HD11 ' A' 1361 ' ' ILE . 18.6 mmm -66.77 -47.44 72.17 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 118.676 0.671 . . . . 52.649999999999999 111.533 -168.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -64.16 -38.02 89.57 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 120.735 -1.228 . . . . 66.260000000000005 112.673 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 86.1 mttt -67.42 -42.33 83.41 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 123.037 1.399 . . . . 63.729999999999997 112.926 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 47.8 mt -71.83 -28.41 63.56 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.834 -1.075 . . . . 54.68 112.63 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -65.12 -41.95 94.39 Favored 'General case' 0 C--O 1.243 0.751 0 O-C-N 120.694 -1.254 . . . . 53.640000000000001 110.473 170.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -56.28 -39.25 72.36 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.074 0.95 . . . . 67.239999999999995 109.696 169.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -69.82 -20.93 63.43 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 115.446 1.647 . . . . 65.760000000000005 115.446 173.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 53.7 t30 68.83 38.69 2.06 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 124.594 2.14 . . . . 58.710000000000001 109.106 177.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1110 ' ' VAL . . . . . 0.552 HG11 ' HB3' ' A' 1083 ' ' LEU . 27.1 m -97.92 161.05 2.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 N-CA-C 115.41 1.633 . . . . 46.630000000000003 115.41 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1111 ' ' THR . . . . . 0.628 HG23 ' HG3' ' A' 1362 ' ' ARG . 95.0 m -97.68 95.22 7.43 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 106.446 -1.687 . . . . 44.130000000000003 106.446 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1112 ' ' VAL . . . . . 0.605 ' HB ' ' HB ' ' A' 1361 ' ' ILE . 49.1 t -86.57 110.7 20.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 O-C-N 121.147 -0.971 . . . . 40.439999999999998 112.306 -176.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1113 ' ' MET . . . . . 0.685 ' HB3' HG12 ' A' 1358 ' ' VAL . 46.8 mtp -101.74 110.65 22.68 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 106.344 -1.724 . . . . 50.759999999999998 106.344 174.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1114 ' ' ALA . . . . . 0.478 ' HB3' ' HB2' ' A' 1117 ' ' SER . . . -83.99 116.52 22.86 Favored 'General case' 0 C--O 1.253 1.244 0 O-C-N 121.369 -0.832 . . . . 35.640000000000001 108.989 -176.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1115 ' ' MET . . . . . 0.441 ' O ' HG23 ' A' 1118 ' ' VAL . 32.7 mmm -70.62 -30.65 67.36 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 113.369 0.877 . . . . 38.740000000000002 113.369 -176.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -60.33 -35.19 75.07 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 124.486 1.114 . . . . 40.140000000000001 112.141 164.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1117 ' ' SER . . . . . 0.478 ' HB2' ' HB3' ' A' 1114 ' ' ALA . 48.5 m -87.58 11.88 13.88 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 118.466 2.765 . . . . 44.789999999999999 118.466 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1118 ' ' VAL . . . . . 0.509 ' HA ' HG22 ' A' 1358 ' ' VAL . 40.8 t -60.96 128.39 89.06 Favored Pre-proline 0 N--CA 1.473 0.685 0 N-CA-C 103.755 -2.683 . . . . 43.75 103.755 168.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -46.6 140.78 11.8 Favored 'Trans proline' 0 CA--C 1.543 0.928 1 C-N-CA 127.7 5.6 . . . . 48.93 117.762 179.279 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -64.32 -0.3 1.23 Allowed 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 116.798 2.147 . . . . 62.899999999999999 116.798 -174.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 14.5 pt -83.26 148.98 4.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 114.281 1.215 . . . . 57.719999999999999 114.281 -170.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1122 ' ' SER . . . . . . . . . . . . . 8.5 m -45.54 -51.56 11.67 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 126.512 1.925 . . . . 57.259999999999998 114.432 -176.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.62 -24.19 66.53 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 120.676 -1.265 . . . . 62.899999999999999 112.258 -178.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -87.41 -19.0 28.69 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-O 116.642 -1.647 . . . . 49.829999999999998 111.097 -176.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1125 ' ' GLN . . . . . 0.607 ' HA ' ' HB3' ' A' 1128 ' ' ASP . 5.4 mm-40 -61.31 -21.34 63.88 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 115.941 1.83 . . . . 52.369999999999997 115.941 -167.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1126 ' ' SER . . . . . . . . . . . . . 31.9 m -68.47 -38.77 81.35 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 122.587 1.184 . . . . 42.43 111.117 172.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1127 ' ' LEU . . . . . 0.606 HD21 HD22 ' A' 1337 ' ' LEU . 4.6 mp -77.64 -35.81 52.18 Favored 'General case' 0 C--N 1.35 0.609 0 CA-C-N 115.009 -0.996 . . . . 43.740000000000002 110.986 172.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1128 ' ' ASP . . . . . 0.607 ' HB3' ' HA ' ' A' 1125 ' ' GLN . 37.0 t70 -59.71 108.15 0.7 Allowed 'General case' 0 C--N 1.352 0.709 0 CA-C-O 125.892 2.758 . . . . 43.210000000000001 115.953 -177.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1129 ' ' ALA . . . . . 0.409 ' CB ' ' HB3' ' A' 1115 ' ' MET . . . -68.09 -29.06 67.9 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 110.459 -3.064 . . . . 35.740000000000002 112.293 -176.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 43.3 mt -60.36 -37.09 79.62 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 114.934 -1.03 . . . . 38.090000000000003 112.854 172.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1131 ' ' SER . . . . . 0.45 ' HA ' HG11 ' A' 1175 ' ' VAL . 16.5 m -58.95 -48.32 81.92 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 119.255 0.934 . . . . 36.909999999999997 111.367 173.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1132 ' ' SER . . . . . . . . . . . . . 73.9 m -59.82 -58.3 9.18 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 119.098 0.863 . . . . 35.789999999999999 111.757 175.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1133 ' ' MET . . . . . 0.4 ' HG3' ' CE2' ' A' 1092 ' ' PHE . 27.1 mmt -61.24 -31.17 70.97 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 117.635 2.457 . . . . 30.809999999999999 117.635 -176.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1134 ' ' ALA . . . . . . . . . . . . . . . -68.81 -57.06 6.12 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.029 -0.987 . . . . 28.879999999999999 112.467 169.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1135 ' ' ASN . . . . . . . . . . . . . 1.4 t30 -54.8 -48.87 72.22 Favored 'General case' 0 C--O 1.245 0.864 0 C-N-CA 124.379 1.071 . . . . 40.759999999999998 110.604 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1136 ' ' ILE . . . . . 0.719 HD13 ' HA ' ' A' 1323 ' ' SER . 42.4 mt -56.31 -50.63 70.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 113.02 0.748 . . . . 31.539999999999999 113.02 174.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1137 ' ' ALA . . . . . 0.699 ' HB2' ' HG3' ' A' 1316 ' ' PRO . . . -57.83 -31.55 66.74 Favored 'General case' 0 C--O 1.213 -0.867 0 N-CA-C 114.208 1.188 . . . . 29.870000000000001 114.208 174.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -68.07 -51.09 35.74 Favored Glycine 0 N--CA 1.443 -0.863 0 O-C-N 120.54 -1.35 . . . . 28.73 111.287 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 15.7 t80 -62.21 -38.76 90.4 Favored 'General case' 0 C--O 1.217 -0.607 0 O-C-N 122.208 -0.583 . . . . 30.390000000000001 110.634 175.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1140 ' ' ARG . . . . . 0.638 ' HG3' HD22 ' A' 1315 ' ' LEU . 7.6 tpt180 -74.54 -24.43 58.95 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.864 1.266 . . . . 26.09 112.521 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1141 ' ' ALA . . . . . 0.551 ' HB2' HD21 ' A' 1284 ' ' LEU . . . -68.15 -40.14 82.44 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.16 -1.422 . . . . 27.100000000000001 107.16 170.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1142 ' ' ILE . . . . . 0.443 HG13 ' HB3' ' A' 1183 ' ' ALA . 35.3 mm -64.03 -39.74 86.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 108.259 -1.015 . . . . 28.48 108.259 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 54.4 t -59.97 -64.54 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-O 118.694 -0.67 . . . . 23.07 110.792 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1144 ' ' GLU . . . . . 0.453 ' HG3' HD21 ' A' 1315 ' ' LEU . 6.0 mm-40 -71.88 -23.72 61.55 Favored 'General case' 0 C--O 1.247 0.959 0 CA-C-N 121.257 1.844 . . . . 33.399999999999999 114.015 -168.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1145 ' ' ALA . . . . . 0.857 ' HB1' HD12 ' A' 1251 ' ' ILE . . . -58.36 -59.06 5.93 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 115.951 -1.976 . . . . 24.219999999999999 108.657 164.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -60.87 -28.21 68.7 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.285 0.991 . . . . 24.890000000000001 110.528 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -64.5 -37.23 86.82 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 112.865 0.691 . . . . 26.73 112.865 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1148 ' ' GLU . . . . . 0.461 ' HB2' HD11 ' A' 1310 ' ' ILE . 29.0 mm-40 -107.74 -3.63 18.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 117.981 -1.488 . . . . 39.960000000000001 112.41 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1149 ' ' PHE . . . . . 0.611 ' CZ ' ' HB3' ' A' 1250 ' ' ASP . 0.8 OUTLIER -64.67 134.72 54.85 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 107.976 -1.12 . . . . 25.870000000000001 107.976 178.045 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 1150 ' ' GLY . . . . . 0.507 ' HA2' ' HD2' ' B' 1320 ' ' PRO . . . -74.12 -38.74 46.76 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 110.638 -0.985 . . . . 19.280000000000001 110.638 173.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1151 ' ' ARG . . . . . 0.962 ' HA ' ' HB2' ' B' 1322 ' ' GLN . 46.1 mtm-85 -94.97 177.09 6.0 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 120.67 -1.488 . . . . 39.899999999999999 111.48 -178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1152 ' ' PHE . . . . . 0.945 ' HB2' HG11 ' A' 1163 ' ' VAL . 2.6 m-30 -79.48 157.46 27.47 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 120.021 1.282 . . . . 29.440000000000001 109.288 169.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1153 ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -66.46 -56.05 12.77 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 105.819 -1.919 . . . . 32.600000000000001 105.819 155.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1154 ' ' THR . . . . . . . . . . . . . 25.9 m -51.57 89.24 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 128.352 2.661 . . . . 34.640000000000001 116.433 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1155 ' ' GLY . . . . . 0.497 ' HA3' ' HG3' ' A' 1165 ' ' PRO . . . -69.05 83.95 0.23 Allowed Glycine 0 C--O 1.215 -1.05 0 CA-C-O 122.291 0.939 . . . . 37.140000000000001 111.328 174.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -117.23 -170.68 1.89 Allowed 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 112.365 -1.917 . . . . 40.57 108.931 168.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1157 ' ' ILE . . . . . 0.718 HG12 ' HG2' ' C' ' 70' ' ' PRO . 1.1 tp -141.83 148.7 20.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 103.404 -2.813 . . . . 44.609999999999999 103.404 -175.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1158 ' ' THR . . . . . . . . . . . . . 16.7 p -98.8 -144.23 0.32 Allowed 'General case' 0 C--O 1.249 1.075 0 CA-C-O 116.628 -1.653 . . . . 40.700000000000003 110.349 175.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1159 ' ' ALA . . . . . 0.417 ' HB2' HG21 ' C' ' 71' ' ' VAL . . . -95.39 -29.47 14.42 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 121.866 2.121 . . . . 40.25 106.932 163.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1160 ' ' ALA . . . . . 0.439 ' HB2' ' ND2' ' B' 1330 ' ' ASN . . . -76.27 -83.5 0.07 Allowed 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 109.713 -0.477 . . . . 38.469999999999999 109.713 173.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . -122.3 169.43 14.93 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-O 123.85 1.806 . . . . 37.609999999999999 113.574 -160.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 23.2 tttp -102.01 140.98 35.56 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-N 109.908 -3.146 . . . . 48.899999999999999 108.667 -172.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1163 ' ' VAL . . . . . 0.945 HG11 ' HB2' ' A' 1152 ' ' PHE . 47.0 t -98.27 114.98 65.84 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-N 113.658 -1.61 . . . . 36.520000000000003 106.8 167.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1164 ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -54.92 123.53 14.0 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.97 2.447 . . . . 35.079999999999998 112.103 165.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1165 ' ' PRO . . . . . 0.497 ' HG3' ' HA3' ' A' 1155 ' ' GLY . 91.8 Cg_exo -60.39 119.9 7.35 Favored 'Trans proline' 0 N--CA 1.432 -2.138 0 C-N-CA 125.091 3.86 . . . . 35.329999999999998 109.532 176.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1166 ' ' ALA . . . . . 0.435 ' O ' ' HB1' ' A' 1189 ' ' ALA . . . -67.87 126.11 28.4 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 113.838 -1.528 . . . . 34.689999999999998 114.615 -167.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1167 ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' A' 1190 ' ' ILE . 9.4 mptt -73.53 90.67 1.76 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 124.662 1.226 . . . . 45.359999999999999 109.535 172.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 34.3 t -83.7 89.85 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-O 124.439 2.066 . . . . 31.710000000000001 105.823 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1169 ' ' MET . . . . . 0.602 ' HG3' HD11 ' A' 1212 ' ' LEU . 25.7 ttp -74.98 134.09 41.56 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 113.917 -1.492 . . . . 42.280000000000001 108.888 174.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 99.1 t -125.26 136.99 59.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 104.442 -2.429 . . . . 30.510000000000002 104.442 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1171 ' ' ILE . . . . . 0.46 HG22 ' HB2' ' A' 1256 ' ' ALA . 61.3 mt -121.69 127.57 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 103.979 -2.6 . . . . 31.870000000000001 103.979 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 73.82 70.51 1.23 Allowed Glycine 0 CA--C 1.535 1.304 0 N-CA-C 107.557 -2.217 . . . . 34.539999999999999 107.557 -170.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1173 ' ' ALA . . . . . 0.669 ' HA ' ' HA3' ' A' 1177 ' ' GLY . . . -72.95 59.96 0.52 Allowed 'General case' 0 N--CA 1.445 -0.725 0 O-C-N 120.311 -1.699 . . . . 32.509999999999998 109.577 173.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1174 ' ' GLY . . . . . 0.605 ' HA2' ' NH2' ' A' 1197 ' ' ARG . . . -86.95 -148.98 13.78 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 107.987 -2.045 . . . . 29.899999999999999 107.987 -177.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1175 ' ' VAL . . . . . 0.45 HG11 ' HA ' ' A' 1131 ' ' SER . 57.7 t -60.03 -40.43 83.15 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 O-C-N 119.329 -2.277 . . . . 33.109999999999999 108.832 176.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1176 ' ' ALA . . . . . 0.641 ' HB3' HG21 ' A' 1255 ' ' THR . . . -69.62 -52.75 23.13 Favored 'General case' 0 C--O 1.224 -0.277 0 O-C-N 121.858 -0.526 . . . . 28.100000000000001 110.712 177.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1177 ' ' GLY . . . . . 0.669 ' HA3' ' HA ' ' A' 1173 ' ' ALA . . . -56.27 -48.02 77.94 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 110.892 -0.883 . . . . 28.539999999999999 110.892 -176.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1178 ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' 1181 ' ' ILE . 51.4 mt -58.57 -39.4 80.17 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.939 1.459 . . . . 31.219999999999999 114.939 177.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -68.84 -36.49 78.23 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.708 -0.62 . . . . 28.98 112.355 173.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -63.92 -37.31 86.93 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.399 0.518 . . . . 27.829999999999998 112.399 171.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1181 ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' 1178 ' ' LEU . 90.0 mt -62.46 -53.28 49.33 Favored 'Isoleucine or valine' 0 C--O 1.246 0.904 0 C-N-CA 125.622 1.569 . . . . 30.25 108.775 175.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -50.25 -52.3 28.02 Favored Glycine 0 N--CA 1.435 -1.399 0 O-C-N 125.481 1.738 . . . . 29.59 114.134 175.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1183 ' ' ALA . . . . . 0.443 ' HB3' HG13 ' A' 1142 ' ' ILE . . . -61.42 -45.24 95.13 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.982 0.734 . . . . 30.289999999999999 112.982 178.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -74.15 -36.82 64.14 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 113.457 0.91 . . . . 30.469999999999999 113.457 -173.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -57.73 -48.77 78.67 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 108.369 -0.974 . . . . 42.409999999999997 108.369 167.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1186 ' ' SER . . . . . 0.632 ' HB3' ' HA ' ' B' 1187 ' ' LEU . 74.1 m -56.68 -37.23 70.56 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 123.153 1.454 . . . . 39.380000000000003 112.546 176.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1187 ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' 1187 ' ' LEU . 13.5 mt -69.39 -34.84 75.12 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 118.141 -2.849 . . . . 36.18 114.548 173.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 105.11 76.08 1.05 Allowed Glycine 0 C--N 1.308 -0.995 0 O-C-N 119.929 -1.732 . . . . 33.780000000000001 112.057 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1189 ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' A' 1166 ' ' ALA . . . -151.64 168.41 25.06 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 113.635 -1.282 . . . . 33.93 109.362 -168.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1190 ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' 1167 ' ' LYS . 86.3 mt -90.67 95.38 5.48 Favored 'Isoleucine or valine' 0 C--O 1.253 1.288 0 N-CA-C 107.122 -1.436 . . . . 38.740000000000002 107.122 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 10.8 t -86.93 133.47 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 106.806 -1.553 . . . . 33.090000000000003 106.806 -178.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1192 ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' 1169 ' ' MET . 99.0 mtt180 -133.02 121.52 22.85 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 105.295 -2.113 . . . . 38.920000000000002 105.295 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -127.39 149.41 50.09 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 115.089 1.514 . . . . 35.32 115.089 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1194 ' ' PHE . . . . . 0.515 ' HB2' HD12 ' A' 1212 ' ' LEU . 47.5 t80 -137.39 154.0 50.08 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.425 -2.065 . . . . 39.350000000000001 105.425 176.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 13.4 t0 -146.91 159.16 43.88 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 103.352 -2.833 . . . . 40.460000000000001 103.352 173.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1196 ' ' THR . . . . . . . . . . . . . 53.5 m -63.7 -30.7 71.77 Favored 'General case' 0 C--O 1.254 1.32 0 CA-C-N 111.574 -2.557 . . . . 45.939999999999998 108.692 171.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1197 ' ' ARG . . . . . 0.605 ' NH2' ' HA2' ' A' 1174 ' ' GLY . 58.2 mtm180 -101.47 100.69 14.56 Favored Pre-proline 0 CA--C 1.509 -0.629 0 N-CA-C 105.391 -2.078 . . . . 56.020000000000003 105.391 176.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1198 ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -59.59 -12.57 17.99 Favored 'Trans proline' 0 C--O 1.257 1.44 0 C-N-CA 122.621 2.214 . . . . 51.270000000000003 114.914 175.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -48.37 -16.61 0.11 Allowed 'General case' 0 C--O 1.234 0.257 0 N-CA-C 121.219 3.785 . . . . 59.100000000000001 121.219 167.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1200 ' ' VAL . . . . . 0.637 HG21 ' HB3' ' A' 1173 ' ' ALA . 33.8 m -80.65 -10.26 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 116.273 1.953 . . . . 51.060000000000002 116.273 169.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 75.0 tttt -50.59 -54.4 22.97 Favored 'General case' 0 C--N 1.348 0.516 0 N-CA-C 117.431 2.382 . . . . 57.380000000000003 117.431 -167.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.65 -30.78 63.14 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 115.368 -0.833 . . . . 62.409999999999997 108.776 -176.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -66.82 -33.2 75.09 Favored 'General case' 0 CA--C 1.501 -0.914 0 O-C-N 119.795 -1.815 . . . . 57.780000000000001 111.976 173.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 25.1 t -64.41 -47.9 87.5 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 C-N-CA 124.571 1.148 . . . . 46.380000000000003 109.3 172.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1205 ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' 1209 ' ' ALA . 21.6 mm100 -60.3 -45.62 92.74 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 122.006 -0.434 . . . . 50.700000000000003 111.403 177.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1206 ' ' SER . . . . . . . . . . . . . 47.5 m -69.54 -24.38 63.71 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 113.098 0.777 . . . . 49.979999999999997 113.098 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1207 ' ' MET . . . . . . . . . . . . . 36.6 mtp -86.67 9.77 17.73 Favored 'General case' 0 N--CA 1.443 -0.824 0 O-C-N 120.9 -1.125 . . . . 52.990000000000002 113.834 173.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 89.18 49.31 3.54 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 118.565 0.621 . . . . 47.659999999999997 112.648 170.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1209 ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' 1205 ' ' GLN . . . -158.28 160.88 37.55 Favored 'General case' 0 C--O 1.246 0.91 0 C-N-CA 124.116 0.966 . . . . 44.770000000000003 112.814 -174.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -96.4 147.52 23.73 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 105.476 -2.046 . . . . 47.640000000000001 105.476 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1211 ' ' PHE . . . . . . . . . . . . . 44.8 t80 -95.48 130.78 42.19 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.792 -1.188 . . . . 45.659999999999997 107.792 166.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1212 ' ' LEU . . . . . 0.602 HD11 ' HG3' ' A' 1169 ' ' MET . 84.6 mt -65.43 105.6 1.2 Allowed 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 113.508 0.929 . . . . 46.060000000000002 113.508 -177.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -79.11 124.33 28.21 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 122.58 1.181 . . . . 60.219999999999999 110.024 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1214 ' ' LEU . . . . . 0.548 ' HA ' ' HG ' ' A' 1241 ' ' LEU . 9.6 mp -76.5 133.8 39.67 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 112.736 -2.029 . . . . 57.25 108.321 174.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 28.6 t70 -85.56 81.01 8.85 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 104.801 -2.296 . . . . 64.430000000000007 104.801 177.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 14.8 t80 . . . . . 0 CA--C 1.503 -0.836 0 CA-C-N 113.483 -1.69 . . . . 66.900000000000006 112.66 -167.278 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 CA--C 1.561 1.394 0 CA-C-O 116.809 -1.567 . . . . 39.090000000000003 108.576 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -52.12 -49.67 48.79 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 120.689 1.586 . . . . 39.32 114.242 173.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 74.3 t80 -64.25 -41.47 96.94 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.878 0.847 . . . . 39.299999999999997 109.738 -175.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -62.05 -41.89 98.61 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 114.479 -1.237 . . . . 36.299999999999997 111.466 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -58.14 -49.8 75.72 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 124.078 0.861 . . . . 37.380000000000003 109.364 170.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -65.99 -11.17 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 114.77 1.396 . . . . 39.109999999999999 114.77 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1230 ' ' MET . . . . . . . . . . . . . 26.4 mmt -107.93 -7.39 16.23 Favored 'General case' 0 C--O 1.244 0.789 0 O-C-N 121.103 -0.998 . . . . 49.590000000000003 110.235 175.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1231 ' ' SER . . . . . 0.495 ' O ' HG13 ' A' 1235 ' ' ILE . 69.4 m -87.12 132.74 33.75 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 118.919 0.781 . . . . 43.68 109.06 176.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -49.46 -58.34 5.34 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 114.462 1.282 . . . . 55.57 114.462 -167.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -64.94 -30.13 71.1 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 113.86 1.059 . . . . 44.939999999999998 113.86 -173.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 32.5 t80 -66.29 -48.74 69.43 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 115.483 -2.199 . . . . 42.039999999999999 107.994 172.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1235 ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' 1231 ' ' SER . 2.9 mt -59.2 -30.92 44.94 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 CA-C-O 123.627 1.679 . . . . 46.280000000000001 112.8 177.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 33.3 tttm -74.49 -42.15 59.49 Favored 'General case' 0 C--O 1.215 -0.761 0 O-C-N 119.156 -2.215 . . . . 47.869999999999997 105.585 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -61.18 -31.03 70.78 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 119.551 1.069 . . . . 41.609999999999999 112.012 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -62.14 -59.1 5.54 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.741 -1.207 . . . . 50.649999999999999 107.741 168.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1239 ' ' MET . . . . . . . . . . . . . 38.6 mtt -55.33 -40.15 70.84 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 121.688 0.756 . . . . 48.869999999999997 112.667 -178.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -61.43 -51.46 68.65 Favored 'General case' 0 C--O 1.254 1.291 0 O-C-N 120.267 -1.521 . . . . 54.799999999999997 108.984 176.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1241 ' ' LEU . . . . . 0.548 ' HG ' ' HA ' ' A' 1214 ' ' LEU . 1.5 tm? -65.43 -37.39 86.77 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.703 -0.851 . . . . 43.210000000000001 108.703 -172.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -66.94 -43.06 84.2 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.685 -1.143 . . . . 38.659999999999997 112.256 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1243 ' ' ALA . . . . . 0.504 ' HA ' ' HG3' ' A' 1271 ' ' MET . . . -58.41 -45.09 89.08 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 120.799 1.636 . . . . 37.920000000000002 111.288 175.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -60.8 -48.57 81.18 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 114.337 -1.301 . . . . 37.280000000000001 110.28 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -63.93 -43.45 95.82 Favored 'General case' 0 C--O 1.214 -0.783 0 CA-C-O 115.413 -2.232 . . . . 43.07 112.496 170.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1246 ' ' ALA . . . . . 0.626 ' HB1' ' HG2' ' A' 1275 ' ' MET . . . -57.59 -38.75 75.4 Favored 'General case' 0 C--O 1.212 -0.892 0 CA-C-N 122.471 2.396 . . . . 38.299999999999997 110.186 -170.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1247 ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' 1274 ' ' SER . 38.2 mtmt -62.71 -22.1 66.26 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 115.658 1.725 . . . . 47.600000000000001 115.658 176.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -118.56 -14.36 9.65 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-O 117.914 -1.041 . . . . 45.420000000000002 112.444 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1249 ' ' VAL . . . . . 0.544 HG22 ' HA ' ' A' 1246 ' ' ALA 0.277 34.7 m -78.79 175.66 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 120.801 1.637 . . . . 36.259999999999998 113.304 -178.48 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 1250 ' ' ASP . . . . . 0.611 ' HB3' ' CZ ' ' A' 1149 ' ' PHE . 13.1 m-20 -124.28 -47.4 1.88 Allowed 'General case' 0 N--CA 1.432 -1.339 0 O-C-N 124.586 1.179 . . . . 33.039999999999999 112.823 -171.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1251 ' ' ILE . . . . . 0.857 HD12 ' HB1' ' A' 1145 ' ' ALA . 38.0 mm -127.04 137.61 57.34 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 N-CA-C 105.147 -2.168 . . . . 31.399999999999999 105.147 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1252 ' ' ILE . . . . . 0.685 HD12 HG12 ' A' 1281 ' ' ILE . 33.0 mt -125.14 113.14 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 C-N-CA 119.282 -0.967 . . . . 29.420000000000002 108.526 167.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 48.5 t -90.65 102.93 13.87 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 CA-C-O 124.394 2.045 . . . . 30.370000000000001 106.728 176.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1254 ' ' THR . . . . . 0.86 ' HB ' ' HA ' ' A' 1283 ' ' ASP . 21.8 m -100.36 99.17 9.77 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 110.473 -3.058 . . . . 35.719999999999999 104.04 -158.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1255 ' ' THR . . . . . 0.641 HG21 ' HB3' ' A' 1176 ' ' ALA . 0.2 OUTLIER -137.4 22.75 2.96 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.758 -1.565 . . . . 36.0 113.845 -168.216 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 1256 ' ' ALA . . . . . 0.46 ' HB2' HG22 ' A' 1171 ' ' ILE . . . -78.48 85.84 4.54 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 118.166 -2.834 . . . . 40.93 110.223 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 10.2 tp -142.55 124.2 14.99 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 111.514 -2.585 . . . . 47.82 109.311 -168.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 8.4 mm -78.13 120.71 82.24 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 100.916 -3.735 . . . . 52.700000000000003 100.916 160.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 1.3 Cg_exo -44.18 113.33 0.42 Allowed 'Trans proline' 0 C--N 1.319 -0.982 1 C-N-CA 125.551 4.167 . . . . 54.130000000000003 116.373 -167.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 78.71 3.96 87.55 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 112.243 -2.253 . . . . 54.619999999999997 115.727 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -111.22 145.16 31.92 Favored Pre-proline 0 C--O 1.219 -0.539 0 CA-C-N 121.561 2.68 . . . . 55.740000000000002 105.581 -174.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -48.16 108.27 0.17 Allowed 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 125.08 3.853 . . . . 51.149999999999999 116.055 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1263 ' ' ALA . . . . . 0.46 ' HB1' ' ND2' ' A' 1291 ' ' ASN . . . -65.12 154.85 85.99 Favored Pre-proline 0 C--O 1.222 -0.358 0 CA-C-N 112.579 -2.1 . . . . 46.060000000000002 112.725 -176.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.44 126.26 15.27 Favored 'Trans proline' 0 C--O 1.248 0.983 0 C-N-CA 123.737 2.958 . . . . 41.079999999999998 109.826 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 50.1 mmtt -77.56 105.63 8.83 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 106.385 -1.709 . . . . 47.420000000000002 106.385 176.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 52.4 mt -107.59 -52.35 2.78 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 113.112 -1.858 . . . . 39.219999999999999 110.246 -174.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1267 ' ' ILE . . . . . 0.623 ' HA ' ' SD ' ' A' 1271 ' ' MET . 61.1 mt -88.03 100.46 10.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 104.882 -2.266 . . . . 42.5 104.882 -169.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1268 ' ' THR . . . . . 0.545 ' O ' HG23 ' A' 1272 ' ' VAL . 12.3 p -68.05 157.6 34.81 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 126.146 1.778 . . . . 37.840000000000003 113.934 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -57.49 -34.15 68.76 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 115.223 1.564 . . . . 54.799999999999997 115.223 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -67.37 -47.24 70.97 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 114.355 -1.293 . . . . 54.359999999999999 110.889 172.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1271 ' ' MET . . . . . 0.623 ' SD ' ' HA ' ' A' 1267 ' ' ILE . 54.6 ttm -58.33 -45.41 88.15 Favored 'General case' 0 C--O 1.251 1.18 0 C-N-CA 124.297 1.039 . . . . 39.520000000000003 109.862 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1272 ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' 1268 ' ' THR . 21.2 t -57.4 -54.44 30.88 Favored 'Isoleucine or valine' 0 C--O 1.249 1.069 0 CA-C-N 115.843 -0.617 . . . . 38.25 110.379 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.41 -11.91 60.14 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 114.096 1.147 . . . . 40.770000000000003 114.096 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1274 ' ' SER . . . . . 0.474 ' O ' ' HG2' ' A' 1247 ' ' LYS . 70.7 m -78.28 -18.96 54.58 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 116.631 -1.652 . . . . 36.579999999999998 112.875 172.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1275 ' ' MET . . . . . 0.626 ' HG2' ' HB1' ' A' 1246 ' ' ALA . 85.0 mtp -53.4 155.03 3.05 Favored 'General case' 0 CA--C 1.51 -0.571 0 O-C-N 125.222 1.576 . . . . 36.75 115.156 -176.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1276 ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' 1247 ' ' LYS . 39.8 ttpt -60.93 139.99 57.87 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 105.532 -2.025 . . . . 46.109999999999999 105.532 166.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1277 ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' B' 1044 ' ' SER . . . -85.57 165.37 17.12 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 123.182 1.468 . . . . 33.520000000000003 110.304 -171.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 74.02 36.5 51.64 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.697 1.141 . . . . 31.27 111.977 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1279 ' ' SER . . . . . 0.48 ' HB2' HG22 ' A' 1307 ' ' VAL . 37.3 m -134.42 166.27 23.24 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 114.2 -1.0 . . . . 32.950000000000003 108.539 -165.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1280 ' ' VAL . . . . . 0.782 HG22 ' HB2' ' A' 1308 ' ' LYS . 48.4 t -133.65 142.94 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 O-C-N 118.939 -2.35 . . . . 27.43 111.474 -176.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1281 ' ' ILE . . . . . 0.685 HG12 HD12 ' A' 1252 ' ' ILE . 74.7 mt -110.49 103.23 15.15 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 N-CA-C 102.167 -3.272 . . . . 30.300000000000001 102.167 164.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -86.85 95.86 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 N-CA-C 107.291 -1.374 . . . . 28.629999999999999 107.291 174.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1283 ' ' ASP . . . . . 0.86 ' HA ' ' HB ' ' A' 1254 ' ' THR . 19.7 t0 -85.96 106.92 17.48 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 105.547 -2.019 . . . . 36.270000000000003 105.547 -173.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1284 ' ' LEU . . . . . 0.551 HD21 ' HB2' ' A' 1141 ' ' ALA . 91.0 mt -89.59 -31.9 17.36 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 114.924 -1.035 . . . . 38.57 108.584 175.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -66.43 -11.25 50.86 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 122.449 1.119 . . . . 37.560000000000002 110.861 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . -42.48 -20.36 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 126.509 1.924 . . . . 40.329999999999998 115.304 163.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -47.92 -41.25 24.22 Favored 'General case' 0 CA--C 1.553 1.071 0 O-C-N 121.378 -0.826 . . . . 56.850000000000001 110.675 173.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 1.4 t30 -137.07 99.26 3.95 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 119.787 -0.765 . . . . 45.859999999999999 109.509 170.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 82.18 -50.34 4.29 Favored Glycine 0 N--CA 1.476 1.317 0 O-C-N 119.693 -1.879 . . . . 40.310000000000002 113.863 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 101.39 164.47 27.41 Favored Glycine 0 N--CA 1.477 1.373 0 CA-C-N 119.749 1.775 . . . . 38.890000000000001 113.241 -176.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1291 ' ' ASN . . . . . 0.565 ' HB2' HG22 ' A' 1254 ' ' THR . 33.5 m120 -93.14 -35.84 12.96 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 117.954 0.877 . . . . 37.229999999999997 109.1 171.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1292 ' ' CYS . . . . . 0.598 ' HB3' ' OG1' ' A' 1295 ' ' THR . 20.5 t -78.49 153.67 31.16 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 122.885 1.326 . . . . 36.5 109.265 173.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1293 ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -82.89 -50.5 8.55 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 113.104 -1.862 . . . . 43.32 109.666 174.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.64 -24.94 59.19 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 117.454 2.39 . . . . 41.32 117.454 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1295 ' ' THR . . . . . 0.598 ' OG1' ' HB3' ' A' 1292 ' ' CYS . 98.0 m -38.48 112.52 0.23 Allowed 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 124.915 1.286 . . . . 35.299999999999997 113.585 167.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 29.6 t -87.65 111.65 43.34 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 102.921 -2.992 . . . . 34.840000000000003 102.921 163.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -64.92 86.44 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.697 1 C-N-CA 125.327 4.018 . . . . 33.509999999999998 107.056 174.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 154.77 -27.94 0.66 Allowed Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 107.722 -2.151 . . . . 32.189999999999998 107.722 178.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -130.94 164.63 24.9 Favored 'General case' 0 C--O 1.251 1.135 0 CA-C-N 122.067 2.934 . . . . 34.880000000000003 113.975 -168.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1300 ' ' ILE . . . . . 0.681 HG12 HG12 ' A' 1310 ' ' ILE . 84.1 mt -77.13 124.45 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 104.563 -2.384 . . . . 32.289999999999999 104.563 156.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 50.9 t80 -108.0 113.14 26.11 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 102.387 -3.19 . . . . 37.25 102.387 170.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1302 ' ' THR . . . . . . . . . . . . . 5.5 m -94.08 108.42 20.25 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 120.067 -1.646 . . . . 35.560000000000002 107.066 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1303 ' ' THR . . . . . . . . . . . . . 8.8 p -74.96 166.32 23.85 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 115.517 1.673 . . . . 36.399999999999999 115.517 -174.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.41 -26.53 65.58 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 120.561 -1.337 . . . . 52.32 112.039 -164.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1305 ' ' ASN . . . . . 0.455 HD21 ' HB2' ' A' 1275 ' ' MET . 49.1 p-10 -66.75 -42.99 85.29 Favored 'General case' 0 C--O 1.239 0.552 0 O-C-N 121.116 -0.99 . . . . 40.039999999999999 112.116 171.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 123.61 43.15 0.35 Allowed Glycine 0 N--CA 1.414 -2.785 0 CA-C-O 123.244 1.469 . . . . 36.960000000000001 111.663 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1307 ' ' VAL . . . . . 0.48 HG22 ' HB2' ' A' 1279 ' ' SER . 41.5 t -113.52 140.89 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-N 113.728 -1.236 . . . . 33.399999999999999 109.253 176.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1308 ' ' LYS . . . . . 0.782 ' HB2' HG22 ' A' 1280 ' ' VAL . 34.6 mmtt -97.81 110.73 23.24 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 112.658 -2.064 . . . . 42.909999999999997 107.902 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 5.3 t -99.62 87.42 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.817 0 N-CA-C 104.73 -2.322 . . . . 32.289999999999999 104.73 -176.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1310 ' ' ILE . . . . . 0.681 HG12 HG12 ' A' 1300 ' ' ILE . 75.2 mt -88.57 83.09 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 113.979 -1.464 . . . . 30.989999999999998 109.232 -171.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -82.11 54.83 4.9 Favored Glycine 0 N--CA 1.437 -1.282 0 CA-C-O 123.415 1.564 . . . . 28.949999999999999 112.249 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1312 ' ' TYR . . . . . 0.545 ' CB ' ' HG ' ' A' 1315 ' ' LEU . 11.1 m-30 -82.58 98.73 9.13 Favored 'General case' 0 CA--C 1.502 -0.881 0 O-C-N 118.242 -2.916 . . . . 31.690000000000001 114.314 -173.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1313 ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -52.05 -44.26 64.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 112.041 -2.345 . . . . 34.170000000000002 111.806 170.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -64.9 -10.12 26.3 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 117.827 2.529 . . . . 36.859999999999999 117.827 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1315 ' ' LEU . . . . . 0.638 HD22 ' HG3' ' A' 1140 ' ' ARG . 45.9 mt -62.55 -29.24 4.45 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 118.713 2.857 . . . . 34.850000000000001 118.713 -175.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1316 ' ' PRO . . . . . 0.699 ' HG3' ' HB2' ' A' 1137 ' ' ALA . 0.7 OUTLIER -59.92 -27.61 85.3 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.446 2.764 . . . . 29.149999999999999 114.267 165.223 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -79.98 -48.97 6.23 Favored Glycine 0 CA--C 1.502 -0.764 0 N-CA-C 107.55 -2.22 . . . . 27.289999999999999 107.55 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1318 ' ' ARG . . . . . . . . . . . . . 4.7 ttm180 -87.05 57.1 4.31 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 113.627 0.973 . . . . 41.490000000000002 113.627 -159.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1319 ' ' LEU . . . . . . . . . . . . . 15.1 tp -135.89 73.31 60.11 Favored Pre-proline 0 C--N 1.32 -0.715 1 N-CA-C 99.327 -4.323 . . . . 27.609999999999999 99.327 156.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1320 ' ' PRO . . . . . 0.613 ' HG2' ' HA2' ' B' 1150 ' ' GLY . 60.7 Cg_endo -42.25 -64.18 0.27 Allowed 'Trans proline' 0 N--CA 1.442 -1.531 1 C-N-CA 126.171 4.581 . . . . 25.940000000000001 117.999 -158.934 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 1321 ' ' THR . . . . . 0.528 HG23 ' CZ ' ' A' 1045 ' ' PHE . 6.7 m -58.07 -45.58 86.89 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 119.803 -0.759 . . . . 25.010000000000002 111.016 176.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1322 ' ' GLN . . . . . 0.652 ' HB2' ' HA ' ' B' 1151 ' ' ARG . 33.8 tp60 -67.38 -48.07 68.48 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 123.767 0.667 . . . . 29.390000000000001 109.76 -169.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1323 ' ' SER . . . . . 0.719 ' HA ' HD13 ' A' 1136 ' ' ILE . 20.4 m -56.08 -48.67 75.66 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 118.391 -0.814 . . . . 26.469999999999999 112.946 174.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1324 ' ' SER . . . . . . . . . . . . . 36.0 m -65.03 -29.76 70.69 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 123.069 1.414 . . . . 27.780000000000001 112.581 175.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1325 ' ' GLN . . . . . 0.672 ' HA ' HG21 ' A' 1019 ' ' THR . 5.3 tp-100 -72.6 -58.84 3.06 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 106.641 -1.614 . . . . 37.530000000000001 106.641 -174.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1326 ' ' LEU . . . . . 0.458 ' HG ' HE21 ' A' 1322 ' ' GLN . 37.9 mt -71.21 -42.01 69.51 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 118.385 -0.817 . . . . 35.710000000000001 109.151 -172.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1327 ' ' TYR . . . . . 0.496 ' O ' ' HB2' ' A' 1330 ' ' ASN . 53.0 t80 -60.55 -41.32 94.29 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 119.636 1.107 . . . . 31.59 110.857 173.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1328 ' ' GLY . . . . . 0.511 ' HA2' HD12 ' A' 1331 ' ' LEU . . . -61.71 -47.01 93.0 Favored Glycine 0 C--O 1.256 1.487 0 O-C-N 121.336 -0.852 . . . . 28.0 111.653 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1329 ' ' THR . . . . . . . . . . . . . 6.5 m -71.99 -24.05 61.52 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 113.964 -1.118 . . . . 32.149999999999999 109.251 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1330 ' ' ASN . . . . . 0.496 ' HB2' ' O ' ' A' 1327 ' ' TYR . 17.6 m120 -60.74 -49.28 78.15 Favored 'General case' 0 C--O 1.24 0.595 0 O-C-N 119.067 -2.27 . . . . 34.359999999999999 111.851 168.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1331 ' ' LEU . . . . . 0.599 HD22 HD22 ' A' 1070 ' ' LEU . 16.4 mt -62.41 -37.81 87.22 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 114.758 -1.11 . . . . 33.369999999999997 111.136 178.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1332 ' ' VAL . . . . . 0.571 ' HA ' HD21 ' A' 1026 ' ' LEU . 64.1 t -63.76 -45.64 96.69 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 N-CA-C 108.634 -0.876 . . . . 35.270000000000003 108.634 173.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1333 ' ' ASN . . . . . 0.402 ' HA ' ' HD2' ' A' 1336 ' ' LYS . 37.0 m-80 -57.8 -44.82 86.58 Favored 'General case' 0 C--O 1.241 0.613 0 O-C-N 118.979 -2.325 . . . . 37.659999999999997 112.679 -178.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1334 ' ' LEU . . . . . . . . . . . . . 41.3 tp -53.64 -59.22 4.88 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.886 -1.052 . . . . 40.270000000000003 110.443 169.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1335 ' ' LEU . . . . . 0.528 ' HA ' ' HB2' ' A' 1338 ' ' LEU . 32.0 mt -62.9 -14.23 44.05 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 117.472 2.397 . . . . 42.5 117.472 174.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1336 ' ' LYS . . . . . 0.582 ' HE2' ' OE1' ' A' 1025 ' ' GLN . 94.5 mttt -66.52 -46.21 76.93 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 121.749 2.068 . . . . 47.810000000000002 107.123 169.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1337 ' ' LEU . . . . . 0.606 HD22 HD21 ' A' 1127 ' ' LEU . 10.9 mp -72.51 -39.68 67.41 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 114.657 -1.156 . . . . 49.270000000000003 112.792 177.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1338 ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' 1347 ' ' THR . 9.4 mp -66.85 -32.73 74.19 Favored 'General case' 0 C--O 1.246 0.877 0 O-C-N 120.457 -1.402 . . . . 50.539999999999999 112.821 175.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1339 ' ' CYS . . . . . 0.575 ' SG ' ' HA2' ' A' 1344 ' ' GLY . 50.2 t -116.38 68.47 0.73 Allowed 'General case' 0 C--O 1.25 1.079 0 O-C-N 118.711 -2.493 . . . . 53.670000000000002 105.532 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1340 ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' 1337 ' ' LEU . 40.2 mtmt -75.02 -42.71 56.74 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.354 1.073 . . . . 63.380000000000003 111.132 174.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -68.44 -44.94 73.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 123.63 1.681 . . . . 70.950000000000003 114.069 -177.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1342 ' ' LYS . . . . . 0.643 ' HE3' ' HA ' ' A' 1029 ' ' LEU . 18.3 mtpt 59.77 67.61 0.86 Allowed 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 128.072 2.549 . . . . 65.25 112.859 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1343 ' ' ASP . . . . . 0.489 ' HB3' ' N ' ' A' 1342 ' ' LYS 0.269 37.5 t70 60.42 -122.11 0.96 Allowed 'General case' 0 N--CA 1.426 -1.66 2 O-C-N 111.602 -6.936 . . . . 64.530000000000001 111.795 9.594 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A 1344 ' ' GLY . . . . . 0.575 ' HA2' ' SG ' ' A' 1339 ' ' CYS . . . 109.97 31.25 3.18 Favored Glycine 0 C--O 1.252 1.225 0 O-C-N 117.289 -3.382 . . . . 59.719999999999999 111.461 -174.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 28.5 t30 -84.21 149.0 26.42 Favored 'General case' 0 N--CA 1.436 -1.156 0 O-C-N 120.492 -1.593 . . . . 64.090000000000003 107.105 164.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1346 ' ' ILE . . . . . 0.435 HD12 ' H ' ' A' 1346 ' ' ILE . 2.6 mp -81.36 83.56 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 103.198 -2.89 . . . . 58.82 103.198 176.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1347 ' ' THR . . . . . 0.533 ' O ' ' HG ' ' A' 1338 ' ' LEU . 3.3 m -76.91 83.43 3.46 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 105.798 -1.926 . . . . 54.960000000000001 105.798 -177.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1348 ' ' VAL . . . . . 0.456 HG21 HG21 ' A' 1111 ' ' THR . 21.8 t -78.33 76.13 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 124.406 2.051 . . . . 55.640000000000001 106.508 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 27.0 t70 -75.13 138.38 42.0 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 112.113 -2.312 . . . . 61.450000000000003 112.518 -165.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1350 ' ' PHE . . . . . 0.451 ' CZ ' ' HD3' ' A' 1362 ' ' ARG . 11.4 m-30 -103.49 -6.35 21.89 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 112.082 -2.326 . . . . 58.630000000000003 112.898 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 15.1 t70 -71.71 -48.24 48.49 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 118.797 0.726 . . . . 62.060000000000002 110.072 177.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 18.2 t0 -66.25 130.57 43.67 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.538 -0.756 . . . . 54.07 109.397 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 31.8 m -67.95 -28.31 40.81 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 N-CA-C 113.077 0.769 . . . . 50.68 113.077 -176.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1354 ' ' VAL . . . . . 0.66 ' O ' HG23 ' A' 1358 ' ' VAL . 3.1 m -80.23 -43.65 22.14 Favored 'Isoleucine or valine' 0 C--O 1.246 0.876 0 N-CA-C 105.471 -2.048 . . . . 47.68 105.471 -174.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1355 ' ' ILE . . . . . 0.543 HD11 ' HB3' ' A' 1337 ' ' LEU . 62.2 mt -65.77 -44.08 93.2 Favored 'Isoleucine or valine' 0 C--O 1.25 1.115 0 C-N-CA 119.423 -0.911 . . . . 48.490000000000002 109.731 -177.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 35.2 tpt85 -53.61 -48.04 69.67 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 115.269 -2.3 . . . . 48.270000000000003 113.329 168.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -57.9 -45.58 93.47 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 122.124 2.238 . . . . 43.530000000000001 114.995 174.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1358 ' ' VAL . . . . . 0.685 HG12 ' HB3' ' A' 1113 ' ' MET . 11.6 t -59.44 -49.82 82.18 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 C-N-CA 125.041 1.337 . . . . 45.119999999999997 110.913 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1359 ' ' THR . . . . . . . . . . . . . 18.5 m -70.74 87.73 0.7 Allowed 'General case' 0 C--O 1.244 0.774 0 CA-C-O 125.011 2.338 . . . . 42.939999999999998 112.479 -177.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 16.5 m -78.13 -28.83 15.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 112.642 -2.072 . . . . 43.259999999999998 111.461 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1361 ' ' ILE . . . . . 0.605 ' HB ' ' HB ' ' A' 1112 ' ' VAL . 96.5 mt -131.98 119.83 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 102.972 -2.973 . . . . 45.659999999999997 102.972 175.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1362 ' ' ARG . . . . . 0.628 ' HG3' HG23 ' A' 1111 ' ' THR . 2.0 ttp180 -106.41 124.42 49.57 Favored 'General case' 0 C--O 1.253 1.241 1 CA-C-N 126.254 4.116 . . . . 61.340000000000003 106.762 168.489 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 43.81 54.6 5.58 Favored 'General case' 0 C--O 1.241 0.627 0 O-C-N 126.447 2.342 . . . . 49.759999999999998 115.192 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 86.04 -24.08 8.49 Favored Glycine 0 CA--C 1.526 0.74 0 O-C-N 120.014 -1.678 . . . . 50.0 114.301 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -88.78 124.93 34.62 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 103.692 -2.707 . . . . 56.920000000000002 103.692 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1366 ' ' ILE . . . . . 0.518 HG22 ' HB3' ' A' 1368 ' ' TRP . 92.4 mt -75.18 89.32 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.753 0 CA-C-O 123.073 1.416 . . . . 52.780000000000001 108.065 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1367 ' ' THR . . . . . . . . . . . . . 17.1 p -75.76 53.05 0.71 Allowed 'General case' 0 C--O 1.252 1.211 0 CA-C-O 125.951 2.786 . . . . 49.439999999999998 113.767 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1368 ' ' TRP . . . . . 0.518 ' HB3' HG22 ' A' 1366 ' ' ILE . 57.1 t90 -132.37 144.07 51.49 Favored Pre-proline 0 CA--C 1.545 0.787 0 O-C-N 119.525 -1.984 . . . . 52.380000000000003 108.491 -170.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1369 ' ' PRO . . . . . 0.435 ' HA ' ' CD1' ' A' 1368 ' ' TRP . 60.9 Cg_endo -75.39 170.81 70.84 Favored 'Cis proline' 0 C--O 1.25 1.11 0 CA-C-N 123.101 2.143 . . . . 46.939999999999998 114.164 -4.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -128.75 117.98 19.7 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 108.5 -0.926 . . . . 45.909999999999997 108.5 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1371 ' ' PRO . . . . . 0.469 ' HA ' ' HD2' ' A' 1372 ' ' PRO . 51.6 Cg_exo -61.22 137.62 72.12 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 125.198 3.932 . . . . 46.390000000000001 112.823 -174.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1372 ' ' PRO . . . . . 0.469 ' HD2' ' HA ' ' A' 1371 ' ' PRO . 86.9 Cg_endo -78.35 8.61 3.51 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 121.105 1.204 . . . . 46.719999999999999 113.797 160.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.214 -5.31 0 O-C-N 119.541 -1.974 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 998' ' ' HIS . . . . . 0.729 ' HB2' ' HB2' ' B' 1000 ' ' HIS . 60.3 m80 . . . . . 0 N--CA 1.436 -1.16 0 N-CA-C 102.989 -2.967 . . . . 63.439999999999998 102.989 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -111.05 43.53 1.44 Allowed 'General case' 0 C--O 1.243 0.739 0 CA-C-O 123.21 1.481 . . . . 51.740000000000002 109.045 148.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1000 ' ' HIS . . . . . 0.729 ' HB2' ' HB2' ' B' ' 998' ' ' HIS . 18.7 t60 -84.61 135.61 34.11 Favored 'General case' 0 C--O 1.247 0.96 0 N-CA-C 104.924 -2.25 . . . . 54.07 104.924 -166.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 67.01 13.22 61.49 Favored Glycine 0 N--CA 1.451 -0.341 0 O-C-N 119.304 -2.122 . . . . 39.219999999999999 111.806 -172.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1002 ' ' ARG . . . . . 0.434 ' NH2' ' O ' ' B' 1065 ' ' GLN . 16.6 ttp180 -97.74 121.93 40.24 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.049 -1.463 . . . . 38.119999999999997 107.049 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1003 ' ' ILE . . . . . 0.463 HD13 HD13 ' B' 1026 ' ' LEU 0.279 46.6 mt -78.79 149.94 5.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 106.378 -1.712 . . . . 29.699999999999999 106.378 172.054 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -121.18 130.09 8.05 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 108.568 -1.813 . . . . 27.5 108.568 162.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1005 ' ' ILE . . . . . 0.483 ' HB ' ' HA ' ' B' 1035 ' ' VAL . 38.4 mm -104.91 103.14 39.63 Favored Pre-proline 0 C--O 1.243 0.748 0 N-CA-C 105.371 -2.085 . . . . 24.829999999999998 105.371 170.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -74.15 162.47 38.71 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 124.399 3.399 . . . . 27.190000000000001 108.993 171.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1007 ' ' ARG . . . . . 0.693 ' HB2' ' HA ' ' B' 1039 ' ' ALA . 29.2 ttp180 -80.52 137.33 36.42 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 104.449 -2.426 . . . . 41.460000000000001 104.449 157.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1008 ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -68.82 158.84 33.6 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-N 115.076 -0.965 . . . . 26.93 110.779 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1009 ' ' ARG . . . . . 0.416 HH22 ' CG ' ' B' 1078 ' ' ASP . 35.0 mmm-85 -113.91 -35.16 5.2 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 111.975 -2.375 . . . . 34.479999999999997 112.848 -171.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1010 ' ' LEU . . . . . 0.476 HD13 ' HB2' ' B' 1073 ' ' ASN . 7.3 mp -61.04 153.31 25.72 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 115.713 1.746 . . . . 44.219999999999999 115.713 -169.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1011 ' ' THR . . . . . . . . . . . . . 20.1 m -62.82 131.82 50.09 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 113.74 -1.573 . . . . 40.740000000000002 110.781 -173.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 5.2 t30 38.64 47.65 1.17 Allowed 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 129.492 3.117 . . . . 44.439999999999998 116.042 -166.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1013 ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -105.19 118.58 36.9 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 112.217 -2.265 . . . . 29.870000000000001 106.809 175.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1014 ' ' THR . . . . . 0.407 ' HA ' ' HB3' ' B' 1042 ' ' LEU . 1.0 OUTLIER -106.0 0.51 25.73 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 115.14 1.533 . . . . 25.260000000000002 115.14 176.577 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -80.6 144.42 32.4 Favored 'General case' 0 C--O 1.241 0.62 0 O-C-N 119.53 -1.981 . . . . 29.539999999999999 112.957 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1016 ' ' VAL . . . . . . . . . . . . . 4.7 p -111.42 175.63 1.8 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 103.992 -2.596 . . . . 23.550000000000001 103.992 165.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1017 ' ' ALA . . . . . 0.42 ' HB3' HD12 ' B' 1005 ' ' ILE . . . -75.91 -40.33 54.49 Favored 'General case' 0 C--N 1.344 0.356 0 O-C-N 117.939 -2.976 . . . . 23.59 115.042 -176.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1018 ' ' ALA . . . . . 0.65 ' HB1' ' HB ' ' B' 1022 ' ' THR . . . -152.19 145.47 24.71 Favored 'General case' 0 C--O 1.247 0.935 0 N-CA-C 105.28 -2.118 . . . . 24.93 105.28 -176.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1019 ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.14 172.6 5.02 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 115.725 -2.083 . . . . 28.09 111.521 -178.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1020 ' ' PRO . . . . . 0.462 ' HB3' ' HB2' ' B' 1053 ' ' ALA . 82.8 Cg_exo -51.61 -42.65 55.14 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 CA-C-N 127.155 3.591 . . . . 28.789999999999999 118.161 -172.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 83.6 tttt -54.96 -48.76 72.79 Favored 'General case' 0 CA--C 1.502 -0.89 0 O-C-N 121.236 -0.915 . . . . 47.280000000000001 112.617 169.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1022 ' ' THR . . . . . 0.65 ' HB ' ' HB1' ' B' 1018 ' ' ALA . 0.0 OUTLIER -67.77 -24.22 65.3 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 120.755 -1.215 . . . . 30.120000000000001 113.253 177.611 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B 1023 ' ' VAL . . . . . 0.487 HG21 ' HD2' ' B' 1050 ' ' PHE . 43.0 t -67.41 -47.57 80.42 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.711 0 O-C-N 120.244 -1.535 . . . . 32.240000000000002 107.713 171.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1024 ' ' GLU . . . . . 0.631 ' HA ' HD12 ' B' 1027 ' ' LEU . 27.6 mt-10 -62.73 -36.09 81.87 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 118.776 -0.63 . . . . 49.619999999999997 112.684 176.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -58.68 -43.78 90.06 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 124.305 1.003 . . . . 44.68 113.271 169.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1026 ' ' LEU . . . . . 0.478 HD12 ' HA ' ' B' 1023 ' ' VAL . 35.1 mt -62.14 -43.45 98.8 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 119.895 -1.753 . . . . 35.710000000000001 113.217 171.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1027 ' ' LEU . . . . . 0.631 HD12 ' HA ' ' B' 1024 ' ' GLU . 24.7 mt -58.24 -27.16 63.71 Favored 'General case' 0 C--N 1.348 0.542 0 O-C-N 119.808 -1.807 . . . . 42.18 112.332 174.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 62.7 mttm -61.75 -21.48 64.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 121.097 1.772 . . . . 48.340000000000003 112.38 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1029 ' ' LEU . . . . . 0.489 HD23 ' HG2' ' B' 1342 ' ' LYS . 49.6 mt -86.45 -4.16 59.13 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 114.233 1.197 . . . . 38.689999999999998 114.233 175.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 78.58 21.98 68.08 Favored Glycine 0 N--CA 1.446 -0.693 0 O-C-N 120.314 -1.491 . . . . 32.280000000000001 113.301 -174.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1031 ' ' PHE . . . . . 0.433 ' HE2' ' HB3' ' B' 1335 ' ' LEU . 22.5 m-85 -99.35 132.44 44.67 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 105.419 -2.067 . . . . 35.939999999999998 105.419 176.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1032 ' ' THR . . . . . . . . . . . . . 3.6 m -89.35 123.97 34.01 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 107.971 -1.122 . . . . 33.369999999999997 107.971 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1033 ' ' VAL . . . . . . . . . . . . . 22.8 t -95.34 134.12 33.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.637 -1.616 . . . . 29.98 106.637 -171.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -111.77 145.83 38.68 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.911 -1.144 . . . . 28.18 107.911 159.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1035 ' ' VAL . . . . . 0.526 ' HB ' HD13 ' B' 1057 ' ' ILE . 97.1 t -122.5 149.73 26.06 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 N-CA-C 103.713 -2.699 . . . . 25.82 103.713 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1036 ' ' GLU . . . . . 0.625 ' HB3' ' HB2' ' B' 1039 ' ' ALA . 19.1 tt0 -73.3 147.27 44.65 Favored 'General case' 0 C--O 1.213 -0.835 0 C-N-CA 123.252 0.621 . . . . 32.439999999999998 111.293 176.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1037 ' ' SER . . . . . . . . . . . . . 44.0 m -60.25 112.72 2.03 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.347 -1.297 . . . . 29.539999999999999 111.015 172.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 77.92 20.4 73.39 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 111.695 -2.502 . . . . 27.760000000000002 113.941 -175.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1039 ' ' ALA . . . . . 0.693 ' HA ' ' HB2' ' B' 1007 ' ' ARG . . . -64.81 -57.8 7.93 Favored 'General case' 0 C--O 1.25 1.12 0 N-CA-C 115.69 1.737 . . . . 26.02 115.69 -176.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -67.58 -15.1 65.83 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 114.201 -1.363 . . . . 26.469999999999999 113.543 -173.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -53.36 -35.72 60.59 Favored 'General case' 0 C--O 1.255 1.347 0 O-C-N 119.615 -2.109 . . . . 50.979999999999997 113.133 172.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1042 ' ' LEU . . . . . 0.407 ' HB3' ' HA ' ' B' 1014 ' ' THR . 60.8 mt -53.03 -54.47 34.79 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 123.028 2.649 . . . . 29.300000000000001 110.03 167.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1043 ' ' ALA . . . . . 0.775 ' HA ' ' HB2' ' B' 1320 ' ' PRO . . . -66.67 2.81 1.19 Allowed 'General case' 0 C--O 1.241 0.641 0 N-CA-C 115.706 1.743 . . . . 26.739999999999998 115.706 174.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1044 ' ' SER . . . . . 0.47 ' O ' ' HB1' ' A' 1277 ' ' ALA . 24.3 m 62.28 35.67 15.12 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 123.702 1.715 . . . . 31.260000000000002 114.668 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1045 ' ' PHE . . . . . 0.405 ' HA ' ' CB ' ' A' 1277 ' ' ALA . 0.3 OUTLIER -132.5 108.81 9.36 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 105.005 -2.221 . . . . 33.259999999999998 105.005 177.066 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 8.5 t70 -61.52 144.31 54.5 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 114.975 1.472 . . . . 46.740000000000002 114.975 -177.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1047 ' ' ASP . . . . . 0.515 ' HA ' ' HD1' ' B' 1050 ' ' PHE . 43.0 p-10 -65.13 -20.4 66.44 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 114.146 1.165 . . . . 34.439999999999998 114.146 -175.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -56.72 -23.47 42.62 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 117.371 2.36 . . . . 48.670000000000002 117.371 165.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -83.81 -24.21 31.08 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 123.672 0.789 . . . . 35.259999999999998 110.371 172.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1050 ' ' PHE . . . . . 0.515 ' HD1' ' HA ' ' B' 1047 ' ' ASP . 75.3 m-85 -74.22 -28.33 61.2 Favored 'General case' 0 C--O 1.251 1.184 0 O-C-N 119.156 -2.215 . . . . 32.170000000000002 110.262 171.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 91.6 t -62.43 -50.29 80.46 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 N-CA-C 105.918 -1.882 . . . . 38.369999999999997 105.918 167.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -51.6 -41.52 61.29 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.135 1.531 . . . . 45.770000000000003 115.135 172.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1053 ' ' ALA . . . . . 0.462 ' HB2' ' HB3' ' B' 1020 ' ' PRO . . . -65.42 -41.69 93.3 Favored 'General case' 0 C--O 1.218 -0.558 0 O-C-N 123.618 0.574 . . . . 37.829999999999998 111.78 173.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 111.61 53.21 0.53 Allowed Glycine 0 C--N 1.35 1.317 0 N-CA-C 110.704 -0.959 . . . . 35.82 110.704 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -120.69 150.26 41.22 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-O 123.854 1.788 . . . . 33.770000000000003 109.365 171.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -63.76 142.83 58.26 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 112.227 -2.261 . . . . 51.020000000000003 108.493 167.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1057 ' ' ILE . . . . . 0.526 HD13 ' HB ' ' B' 1035 ' ' VAL . 46.2 mm -120.17 112.74 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 N-CA-C 106.17 -1.789 . . . . 38.469999999999999 106.17 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 1.8 m -133.74 142.23 42.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 115.445 1.646 . . . . 39.399999999999999 115.445 -171.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -72.82 105.01 4.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 113.479 -1.691 . . . . 57.07 114.762 -169.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1060 ' ' GLY . . . . . 0.422 ' O ' HG12 ' B' 1063 ' ' VAL . . . 59.96 -113.7 5.61 Favored Glycine 0 N--CA 1.433 -1.558 0 CA-C-N 114.425 -1.261 . . . . 44.829999999999998 112.554 165.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1061 ' ' ASN . . . . . 0.416 ' O ' ' HG2' ' B' 1065 ' ' GLN . 13.8 m-20 -61.96 -25.1 67.41 Favored 'General case' 0 C--O 1.241 0.632 0 O-C-N 120.459 -1.613 . . . . 46.270000000000003 111.922 -171.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1062 ' ' SER . . . . . . . . . . . . . 66.5 m -59.08 -41.89 89.1 Favored 'General case' 0 N--CA 1.426 -1.642 0 C-N-CA 124.349 1.06 . . . . 43.469999999999999 111.21 173.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1063 ' ' VAL . . . . . 0.422 HG12 ' O ' ' B' 1060 ' ' GLY . 2.0 p -66.91 -31.53 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 O-C-N 118.593 -2.567 . . . . 36.979999999999997 109.347 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 38.8 m95 -68.87 -30.55 69.09 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 113.994 1.109 . . . . 37.899999999999999 113.994 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1065 ' ' GLN . . . . . 0.434 ' O ' ' NH2' ' B' 1002 ' ' ARG . 47.1 mm-40 -77.47 92.88 4.04 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.03 -1.1 . . . . 46.189999999999998 108.03 175.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1066 ' ' SER . . . . . . . . . . . . . 53.5 m -159.94 165.79 31.39 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 119.929 -1.732 . . . . 37.060000000000002 110.906 -169.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1067 ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -65.47 -52.52 52.35 Favored 'General case' 0 C--O 1.22 -0.468 0 O-C-N 124.643 1.214 . . . . 43.950000000000003 111.277 170.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1068 ' ' ILE . . . . . 0.6 HD11 HD11 ' B' 1346 ' ' ILE . 23.9 mt -123.74 131.81 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 104.888 -2.264 . . . . 33.5 104.888 -173.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1069 ' ' ILE . . . . . 0.433 HD13 ' HA ' ' B' 1069 ' ' ILE . 26.4 mm -111.4 116.92 53.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 104.779 -2.304 . . . . 30.57 104.779 171.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1070 ' ' LEU . . . . . 0.706 HD22 HD22 ' B' 1331 ' ' LEU . 73.7 mt -102.27 114.96 29.57 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 101.72 -3.437 . . . . 27.66 101.72 178.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1071 ' ' LYS . . . . . . . . . . . . . 18.9 tttm -140.14 157.73 45.16 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 106.182 -1.784 . . . . 28.399999999999999 106.182 -169.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1072 ' ' VAL . . . . . . . . . . . . . 67.6 t -83.27 -81.14 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.828 0 C-N-CA 117.547 -1.661 . . . . 23.18 110.188 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1073 ' ' ASN . . . . . 0.476 ' HB2' HD13 ' B' 1010 ' ' LEU . 24.9 m120 -87.04 156.89 19.56 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 114.174 1.176 . . . . 25.469999999999999 114.174 -167.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -46.65 117.14 4.21 Favored Pre-proline 0 C--O 1.249 1.075 0 C-N-CA 124.129 0.972 . . . . 27.899999999999999 113.049 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -54.48 136.14 68.69 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.903 2.402 . . . . 31.620000000000001 114.074 -173.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 38.3 mt -71.33 160.28 33.07 Favored 'General case' 0 CA--C 1.506 -0.74 0 O-C-N 126.51 2.381 . . . . 40.490000000000002 106.776 173.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.49 -38.68 63.91 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 115.923 1.823 . . . . 51.590000000000003 115.923 -168.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1078 ' ' ASP . . . . . 0.416 ' CG ' HH22 ' B' 1009 ' ' ARG . 9.8 p-10 -68.69 -36.13 78.1 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-O 120.84 0.352 . . . . 42.359999999999999 111.751 175.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1079 ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -64.07 -36.02 82.64 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-O 123.551 1.643 . . . . 34.530000000000001 111.37 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1080 ' ' ILE . . . . . 0.442 ' O ' ' HG3' ' B' 1108 ' ' ARG . 57.6 mt -60.45 -50.78 78.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 113.119 -1.855 . . . . 33.25 109.64 174.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -57.15 -34.01 67.99 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 115.486 1.661 . . . . 36.469999999999999 115.486 173.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1082 ' ' LEU . . . . . . . . . . . . . 86.0 mt -62.94 -26.88 69.03 Favored 'General case' 0 CA--C 1.491 -1.31 0 O-C-N 125.391 1.682 . . . . 37.759999999999998 114.303 173.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1083 ' ' LEU . . . . . 0.755 HD11 HD22 ' B' 1089 ' ' LEU . 68.8 mt -55.28 156.63 4.11 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 113.865 1.061 . . . . 37.43 113.865 167.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1084 ' ' ASN . . . . . . . . . . . . 0.252 1.5 m-80 -130.56 148.53 70.36 Favored Pre-proline 0 C--N 1.319 -0.753 0 N-CA-C 103.673 -2.714 . . . . 37.700000000000003 103.673 -167.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -55.82 114.0 1.69 Allowed 'Trans proline' 0 C--O 1.25 1.11 0 C-N-CA 125.004 3.803 . . . . 35.509999999999998 109.673 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 120.71 -37.65 2.96 Favored Glycine 0 N--CA 1.437 -1.246 0 CA-C-N 111.624 -2.535 . . . . 33.869999999999997 114.332 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1087 ' ' THR . . . . . . . . . . . . . 26.4 m -56.2 122.24 11.3 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 114.513 1.301 . . . . 32.5 114.513 -164.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1088 ' ' THR . . . . . 0.408 ' HA ' ' HB ' ' B' 1111 ' ' THR . 13.5 m -70.49 94.72 0.99 Allowed 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 113.633 -1.621 . . . . 30.219999999999999 107.268 174.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1089 ' ' LEU . . . . . 0.755 HD22 HD11 ' B' 1083 ' ' LEU . 42.4 tp -85.77 111.36 20.08 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 118.951 0.796 . . . . 27.239999999999998 110.05 174.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 6.0 t -112.76 104.53 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 104.037 -2.579 . . . . 25.390000000000001 104.037 -175.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1091 ' ' SER . . . . . . . . . . . . . 45.5 m -154.86 163.4 40.34 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.043 -1.435 . . . . 28.809999999999999 113.282 -171.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1092 ' ' PHE . . . . . 0.483 ' HZ ' ' HG3' ' B' 1133 ' ' MET . 53.2 m-85 -73.64 99.77 3.18 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 104.233 -2.506 . . . . 30.780000000000001 104.233 171.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1093 ' ' ILE . . . . . 0.467 HG13 ' CG1' ' B' 1112 ' ' VAL . 37.6 mm -85.38 -33.71 8.04 Favored 'Isoleucine or valine' 0 C--N 1.355 0.843 0 CA-C-O 118.254 -0.879 . . . . 30.280000000000001 111.909 -175.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1094 ' ' TRP . . . . . . . . . . . . . 70.6 m95 53.59 62.23 9.57 Favored Pre-proline 0 C--O 1.248 0.994 0 C-N-CA 124.811 1.245 . . . . 34.07 113.274 -167.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -50.1 -49.2 16.89 Favored 'Trans proline' 0 C--O 1.248 0.992 0 C-N-CA 125.104 3.87 . . . . 38.659999999999997 114.089 -170.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -75.18 -19.7 59.7 Favored 'General case' 0 C--O 1.241 0.621 0 O-C-N 120.617 -1.302 . . . . 41.32 110.142 -175.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -85.43 -22.9 28.11 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 122.272 1.034 . . . . 51.659999999999997 111.279 173.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1098 ' ' ASN . . . . . 0.405 ' N ' ' HD3' ' B' 1099 ' ' PRO . 27.7 m-20 -127.84 48.87 3.74 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 113.869 1.063 . . . . 40.32 113.869 -170.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1099 ' ' PRO . . . . . 0.405 ' HD3' ' N ' ' B' 1098 ' ' ASN . 77.5 Cg_exo -60.98 -40.26 53.79 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 124.044 3.163 . . . . 41.560000000000002 118.051 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -64.11 -39.13 93.37 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 109.206 -0.664 . . . . 54.109999999999999 109.206 175.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1101 ' ' LEU . . . . . 0.461 ' O ' ' HG ' ' B' 1105 ' ' LEU . 9.9 mp -61.89 -45.21 94.75 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 118.17 0.441 . . . . 37.880000000000003 111.873 172.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1102 ' ' MET . . . . . 0.642 ' HA ' HD12 ' B' 1105 ' ' LEU . 75.1 mmm -55.42 -42.63 74.42 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 123.214 0.605 . . . . 37.539999999999999 112.432 173.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -66.55 -40.77 89.23 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-O 122.407 1.098 . . . . 47.009999999999998 108.434 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1104 ' ' LYS . . . . . . . . . . . . . 37.8 mtmt -65.65 -27.72 68.57 Favored 'General case' 0 CA--C 1.481 -1.681 0 O-C-N 118.101 -2.875 . . . . 48.68 116.043 170.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1105 ' ' LEU . . . . . 0.642 HD12 ' HA ' ' B' 1102 ' ' MET . 31.3 mt -70.82 -38.81 73.29 Favored 'General case' 0 C--O 1.265 1.869 0 O-C-N 120.385 -1.447 . . . . 32.210000000000001 110.374 173.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -61.77 -42.21 98.7 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 109.019 -0.734 . . . . 33.729999999999997 109.019 175.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -60.14 -44.92 94.58 Favored 'General case' 0 CA--C 1.497 -1.075 0 O-C-N 121.039 -1.038 . . . . 51.469999999999999 113.773 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1108 ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' B' 1080 ' ' ILE . 16.4 mmm180 -62.2 -24.5 67.25 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.649 -1.282 . . . . 43.899999999999999 114.332 173.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1109 ' ' ASN . . . . . . . . . . . . . 14.9 m-80 72.01 47.12 0.32 Allowed 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 125.12 2.391 . . . . 44.82 110.94 173.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1110 ' ' VAL . . . . . 0.579 HG11 ' HB3' ' B' 1083 ' ' LEU . 16.5 m -96.46 169.38 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-N 110.081 -3.236 . . . . 30.52 113.826 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1111 ' ' THR . . . . . 0.408 ' HB ' ' HA ' ' B' 1088 ' ' THR . 8.1 m -104.65 97.87 7.7 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 107.548 -1.278 . . . . 27.120000000000001 107.548 171.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1112 ' ' VAL . . . . . 0.467 ' CG1' HG13 ' B' 1093 ' ' ILE . 93.4 t -92.8 123.85 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 O-C-N 119.556 -1.965 . . . . 26.399999999999999 108.736 -173.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1113 ' ' MET . . . . . 0.691 ' SD ' HD21 ' B' 1334 ' ' LEU . 21.0 mtp -116.87 103.12 9.98 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.986 -1.487 . . . . 42.920000000000002 106.986 174.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -79.75 88.04 5.23 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 113.457 -1.701 . . . . 24.149999999999999 113.782 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1115 ' ' MET . . . . . 0.48 ' SD ' HD13 ' B' 1334 ' ' LEU . 95.0 mmm -54.71 -19.23 5.79 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 117.073 2.249 . . . . 29.949999999999999 117.073 -173.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1116 ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -72.7 -46.23 54.79 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.115 -1.402 . . . . 34.530000000000001 114.503 168.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1117 ' ' SER . . . . . . . . . . . . . 66.1 m -93.8 52.87 1.73 Allowed 'General case' 0 C--O 1.255 1.347 0 O-C-N 119.181 -2.199 . . . . 33.490000000000002 112.028 -167.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1118 ' ' VAL . . . . . . . . . . . . . 40.5 t -89.53 137.38 28.86 Favored Pre-proline 0 N--CA 1.445 -0.718 0 N-CA-C 106.565 -1.643 . . . . 34.020000000000003 106.565 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -63.63 131.07 30.04 Favored 'Trans proline' 0 CA--C 1.512 -0.602 0 C-N-CA 123.765 2.976 . . . . 38.280000000000001 108.336 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1120 ' ' ARG . . . . . 0.752 ' HB2' HG11 ' B' 1375 ' ' VAL . 1.8 mmt180 -74.77 50.2 0.44 Allowed 'General case' 0 C--O 1.247 0.97 0 N-CA-C 115.09 1.515 . . . . 55.049999999999997 115.09 -163.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1121 ' ' ILE . . . . . 0.526 ' HB ' ' O ' ' C' ' 131' ' ' ALA . 36.1 pt -102.08 172.51 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.912 0 O-C-N 117.082 -3.511 . . . . 42.090000000000003 115.969 -177.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1122 ' ' SER . . . . . . . . . . . . . 2.9 m -62.29 -32.73 73.5 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 117.718 2.488 . . . . 38.020000000000003 117.718 -172.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1123 ' ' ARG . . . . . 0.416 ' HA ' ' HD3' ' C' ' 134' ' ' PRO . 11.3 ptt-85 -67.25 -35.76 80.21 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 119.378 -0.929 . . . . 34.289999999999999 113.407 162.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1124 ' ' ALA . . . . . . . . . . . . . . . -62.22 -36.08 80.88 Favored 'General case' 0 C--N 1.359 0.98 0 N-CA-C 116.877 2.177 . . . . 32.350000000000001 116.877 -158.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1125 ' ' GLN . . . . . 0.803 ' HA ' ' HB3' ' B' 1128 ' ' ASP . 2.3 mp0 -64.94 -8.73 16.88 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 115.415 1.635 . . . . 47.170000000000002 115.415 -172.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1126 ' ' SER . . . . . . . . . . . . . 21.1 p -75.05 -41.82 58.29 Favored 'General case' 0 C--O 1.24 0.585 0 O-C-N 120.414 -1.429 . . . . 31.710000000000001 109.074 173.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1127 ' ' LEU . . . . . . . . . . . . . 3.5 mp -80.13 -40.85 26.58 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-N 113.248 -1.796 . . . . 37.0 111.159 174.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1128 ' ' ASP . . . . . 0.803 ' HB3' ' HA ' ' B' 1125 ' ' GLN . 9.3 t70 -61.6 119.89 9.52 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 123.743 1.735 . . . . 40.399999999999999 115.001 -173.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1129 ' ' ALA . . . . . . . . . . . . . . . -68.63 -34.98 76.68 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 111.629 -2.532 . . . . 26.559999999999999 109.277 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 58.8 mt -67.8 -28.93 68.01 Favored 'General case' 0 C--N 1.31 -1.111 0 O-C-N 118.957 -2.339 . . . . 30.890000000000001 112.451 -169.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1131 ' ' SER . . . . . 0.632 ' HB3' ' HG3' ' B' 1125 ' ' GLN . 57.9 p -65.5 -56.11 14.15 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 107.685 -1.228 . . . . 29.84 107.685 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1132 ' ' SER . . . . . 0.66 ' HB3' ' HB3' ' B' 1326 ' ' LEU . 5.8 m -55.54 -47.69 75.92 Favored 'General case' 0 CA--C 1.507 -0.675 0 O-C-N 125.727 1.892 . . . . 31.91 110.174 178.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1133 ' ' MET . . . . . 0.483 ' HG3' ' HZ ' ' B' 1092 ' ' PHE . 33.2 mmt -65.87 -31.35 72.24 Favored 'General case' 0 C--N 1.361 1.073 0 N-CA-C 115.72 1.748 . . . . 25.899999999999999 115.72 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1134 ' ' ALA . . . . . . . . . . . . . . . -67.06 -43.62 82.18 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 107.602 -1.258 . . . . 26.620000000000001 107.602 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -67.97 -35.59 78.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 121.501 1.955 . . . . 36.969999999999999 110.466 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1136 ' ' ILE . . . . . 0.691 HD13 ' HE1' ' A' 1152 ' ' PHE . 23.5 mm -52.02 -56.81 4.97 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 O-C-N 121.393 -0.817 . . . . 32.109999999999999 110.313 167.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -69.75 -20.32 63.51 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 116.968 -1.491 . . . . 24.140000000000001 110.551 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -69.15 -48.16 48.46 Favored Glycine 0 N--CA 1.471 1.002 0 CA-C-N 120.909 1.686 . . . . 25.129999999999999 110.545 173.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 81.9 t80 -66.33 -51.85 53.03 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 105.595 -2.002 . . . . 32.729999999999997 105.595 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1140 ' ' ARG . . . . . 0.43 ' HA ' ' HB ' ' B' 1143 ' ' VAL . 7.1 tpt180 -54.63 -25.78 28.81 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-O 115.538 -2.172 . . . . 26.359999999999999 113.4 173.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1141 ' ' ALA . . . . . 0.557 ' HA ' HG11 ' B' 1282 ' ' VAL . . . -62.17 -54.28 43.26 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 121.381 1.901 . . . . 24.120000000000001 109.055 173.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 45.7 mm -57.69 -43.37 83.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 CA-C-O 122.734 1.254 . . . . 23.370000000000001 110.96 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1143 ' ' VAL . . . . . 0.43 ' HB ' ' HA ' ' B' 1140 ' ' ARG . 75.3 t -63.46 -56.76 15.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 114.523 1.305 . . . . 24.960000000000001 114.523 177.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1144 ' ' GLU . . . . . 0.415 ' OE2' ' HD3' ' B' 1318 ' ' ARG . 20.3 mm-40 -70.16 -29.74 66.72 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 120.47 -1.394 . . . . 32.07 111.639 -178.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1145 ' ' ALA . . . . . 0.825 ' HB1' HD12 ' B' 1251 ' ' ILE . . . -55.99 -60.3 3.67 Favored 'General case' 0 C--N 1.346 0.418 0 N-CA-C 107.68 -1.23 . . . . 24.870000000000001 107.68 168.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1146 ' ' ALA . . . . . 0.648 ' HB2' ' HE1' ' B' 1153 ' ' PHE . . . -48.4 -32.48 7.68 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.248 1.573 . . . . 24.670000000000002 115.248 175.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 80.7 t60 -53.59 -50.53 65.41 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 119.76 1.164 . . . . 28.579999999999998 111.988 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1148 ' ' GLU . . . . . 0.733 ' HB2' HD11 ' B' 1310 ' ' ILE . 28.7 mm-40 -108.14 -5.38 16.97 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 119.561 -1.962 . . . . 36.82 114.377 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1149 ' ' PHE . . . . . . . . . . . . . 2.8 t80 -54.09 138.94 36.55 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 126.029 2.823 . . . . 31.969999999999999 109.141 177.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1150 ' ' GLY . . . . . 0.613 ' HA2' ' HG2' ' A' 1320 ' ' PRO . . . -68.6 -35.35 80.71 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 109.784 -3.371 . . . . 25.489999999999998 113.816 175.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1151 ' ' ARG . . . . . 0.652 ' HA ' ' HB2' ' A' 1322 ' ' GLN . 55.3 mtm-85 -128.37 -170.56 2.27 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 123.048 3.424 . . . . 59.840000000000003 110.022 -162.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1152 ' ' PHE . . . . . 0.804 ' HB2' HG11 ' B' 1163 ' ' VAL . 19.0 m-30 -81.7 161.29 23.43 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 107.734 -1.21 . . . . 34.450000000000003 107.734 168.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1153 ' ' PHE . . . . . 0.648 ' HE1' ' HB2' ' B' 1146 ' ' ALA . 53.2 m-85 -79.91 -47.91 14.3 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.102 -1.814 . . . . 31.170000000000002 106.102 166.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1154 ' ' THR . . . . . . . . . . . . . 57.5 m -54.77 134.82 47.82 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 112.28 -2.237 . . . . 33.890000000000001 112.411 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -78.02 62.64 3.63 Favored Glycine 0 N--CA 1.44 -1.094 0 O-C-N 123.881 0.738 . . . . 38.950000000000003 112.86 169.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -83.79 125.04 31.53 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 122.984 1.373 . . . . 54.229999999999997 111.767 -166.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1157 ' ' ILE . . . . . 0.545 HG23 ' HE2' ' B' 1162 ' ' LYS . 18.8 mm -78.09 89.39 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 105.375 -2.083 . . . . 51.159999999999997 105.375 172.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1158 ' ' THR . . . . . . . . . . . . . 6.2 m -97.79 146.46 25.37 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 107.157 -1.423 . . . . 49.609999999999999 107.157 -177.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -44.15 -57.3 3.49 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 115.09 1.515 . . . . 49.049999999999997 115.09 -171.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -60.43 -37.27 80.38 Favored 'General case' 0 C--O 1.207 -1.144 0 C-N-CA 125.175 1.39 . . . . 47.649999999999999 112.011 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . 179.87 157.52 20.23 Favored Glycine 0 CA--C 1.498 -1.026 0 N-CA-C 109.421 -1.472 . . . . 45.609999999999999 109.421 -177.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1162 ' ' LYS . . . . . 0.545 ' HE2' HG23 ' B' 1157 ' ' ILE . 85.6 mttt -75.1 125.63 29.34 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.044 -1.078 . . . . 57.460000000000001 110.605 -177.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1163 ' ' VAL . . . . . 0.804 HG11 ' HB2' ' B' 1152 ' ' PHE . 57.1 t -75.81 128.0 84.41 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-O 118.332 -0.842 . . . . 42.93 108.864 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1164 ' ' PRO . . . . . 0.526 ' HA ' ' HD3' ' B' 1165 ' ' PRO . 74.0 Cg_endo -66.92 122.46 9.81 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 124.826 3.684 . . . . 39.289999999999999 108.442 172.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1165 ' ' PRO . . . . . 0.526 ' HD3' ' HA ' ' B' 1164 ' ' PRO . 81.1 Cg_exo -64.88 142.48 75.8 Favored 'Trans proline' 0 C--O 1.248 1.013 0 O-C-N 124.289 1.678 . . . . 34.170000000000002 109.452 -171.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1166 ' ' ALA . . . . . 0.442 ' HB2' ' HA ' ' B' 1153 ' ' PHE . . . -76.89 120.77 22.49 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 123.833 1.778 . . . . 31.690000000000001 108.898 -173.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1167 ' ' LYS . . . . . 0.629 ' HB2' ' HA ' ' B' 1249 ' ' VAL . 87.4 mttt -86.54 101.86 13.59 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 103.085 -2.931 . . . . 44.780000000000001 103.085 174.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 35.7 t -97.31 91.59 2.65 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 CA-C-N 112.805 -1.998 . . . . 31.23 109.46 -175.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1169 ' ' MET . . . . . 0.811 ' HB2' HG11 ' B' 1249 ' ' VAL . 48.3 ttp -77.48 99.68 5.75 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 105.442 -2.058 . . . . 37.090000000000003 105.442 -177.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 93.3 t -87.6 96.42 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 106.668 -1.605 . . . . 30.170000000000002 106.668 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1171 ' ' ILE . . . . . . . . . . . . . 61.3 mt -90.03 113.08 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 N-CA-C 107.132 -1.433 . . . . 33.740000000000002 107.132 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 94.91 73.85 1.21 Allowed Glycine 0 CA--C 1.5 -0.895 0 C-N-CA 119.561 -1.304 . . . . 32.590000000000003 110.455 170.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1173 ' ' ALA . . . . . 0.677 ' HA ' ' HA3' ' B' 1177 ' ' GLY . . . -78.47 57.16 1.9 Allowed 'General case' 0 C--N 1.329 -0.295 0 O-C-N 126.465 1.921 . . . . 32.420000000000002 113.79 -175.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -86.83 -162.52 37.54 Favored Glycine 0 C--O 1.211 -1.3 0 N-CA-C 108.185 -1.966 . . . . 31.739999999999998 108.185 164.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 41.4 t -47.37 -46.9 10.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 CA-C-N 121.538 2.669 . . . . 31.48 116.521 -171.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1176 ' ' ALA . . . . . . . . . . . . . . . -53.97 -56.15 20.5 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 115.665 1.728 . . . . 26.120000000000001 115.665 169.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1177 ' ' GLY . . . . . 0.677 ' HA3' ' HA ' ' B' 1173 ' ' ALA . . . -51.3 -52.19 33.31 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-N 113.474 -1.694 . . . . 25.73 111.185 176.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1178 ' ' LEU . . . . . 0.494 HD21 HG12 ' B' 1200 ' ' VAL . 37.8 mt -62.13 -44.34 96.84 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 126.02 1.728 . . . . 32.590000000000003 113.158 -174.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -59.9 -39.36 85.13 Favored 'General case' 0 C--N 1.348 0.517 0 N-CA-C 113.762 1.023 . . . . 27.719999999999999 113.762 171.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -66.53 -39.53 88.66 Favored 'General case' 0 C--O 1.244 0.767 0 O-C-N 124.0 0.813 . . . . 26.030000000000001 111.784 178.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1181 ' ' ILE . . . . . 0.672 HG23 HG11 ' B' 1191 ' ' VAL . 62.9 mt -57.03 -52.85 50.74 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 118.375 -0.821 . . . . 28.609999999999999 111.3 171.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -46.8 -61.85 4.07 Favored Glycine 0 C--N 1.346 1.106 0 O-C-N 126.148 2.155 . . . . 25.23 109.495 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -64.45 -47.27 79.67 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 121.799 0.809 . . . . 24.09 112.921 -171.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -64.67 -37.78 88.77 Favored 'General case' 0 CA--C 1.509 -0.632 0 O-C-N 121.04 -1.038 . . . . 26.68 112.483 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -66.38 -45.52 79.8 Favored 'General case' 0 C--O 1.252 1.208 0 C-N-CA 124.155 0.982 . . . . 36.57 110.009 176.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1186 ' ' SER . . . . . . . . . . . . . 69.1 m -58.29 -37.3 74.76 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 113.138 0.792 . . . . 28.920000000000002 113.138 173.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1187 ' ' LEU . . . . . 0.632 ' HA ' ' HB3' ' A' 1186 ' ' SER . 19.1 mt -69.49 -16.54 63.48 Favored 'General case' 0 C--O 1.249 1.03 0 N-CA-C 114.853 1.427 . . . . 29.09 114.853 173.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 80.42 52.38 4.52 Favored Glycine 0 C--O 1.251 1.187 0 O-C-N 119.151 -2.218 . . . . 29.260000000000002 109.168 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1189 ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' B' 1153 ' ' PHE . . . -115.52 155.34 27.72 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 113.325 -1.438 . . . . 30.16 108.597 170.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 80.2 mt -81.48 94.89 2.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 103.413 -2.81 . . . . 35.810000000000002 103.413 -175.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1191 ' ' VAL . . . . . 0.672 HG11 HG23 ' B' 1181 ' ' ILE . 23.8 t -71.0 121.8 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 C-N-CA 118.228 -1.389 . . . . 31.969999999999999 108.223 170.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1192 ' ' ARG . . . . . 0.516 ' HD2' HD21 ' B' 1212 ' ' LEU . 26.6 mmt85 -104.85 85.12 2.24 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 113.279 -1.782 . . . . 48.159999999999997 106.197 173.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -96.3 149.94 21.12 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 118.368 -2.708 . . . . 35.890000000000001 114.257 -165.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 20.2 t80 -147.54 153.4 39.43 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 120.397 -1.439 . . . . 41.880000000000003 108.615 -177.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1195 ' ' ASP . . . . . . . . . . . . . 8.9 t0 -162.97 159.9 24.06 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 103.409 -2.812 . . . . 38.280000000000001 103.409 167.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1196 ' ' THR . . . . . . . . . . . . . 4.7 m -65.48 -47.17 76.97 Favored 'General case' 0 N--CA 1.427 -1.611 0 C-N-CA 125.38 1.472 . . . . 40.619999999999997 108.203 171.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1197 ' ' ARG . . . . . 0.421 HH11 ' HD2' ' B' 1197 ' ' ARG . 12.2 mtm180 -75.43 130.56 79.45 Favored Pre-proline 0 C--N 1.345 0.387 0 C-N-CA 124.14 0.976 . . . . 53.090000000000003 109.929 -171.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -58.01 -34.58 98.57 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.892 2.395 . . . . 42.560000000000002 117.522 -172.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1199 ' ' GLU . . . . . 0.706 ' HB2' ' NH2' ' C' ' 74' ' ' ARG . 0.0 OUTLIER -66.19 -35.83 81.48 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.539 -1.351 . . . . 56.310000000000002 113.252 -150.331 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B 1200 ' ' VAL . . . . . 0.494 HG12 HD21 ' B' 1178 ' ' LEU . 17.0 m -59.48 -22.36 22.81 Favored 'Isoleucine or valine' 0 C--O 1.249 1.076 0 CA-C-N 112.699 -2.046 . . . . 42.909999999999997 113.44 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 51.8 tttm -52.66 -45.94 66.95 Favored 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 124.665 1.186 . . . . 48.890000000000001 113.744 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -65.94 -31.17 71.93 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.823 0.82 . . . . 51.700000000000003 112.815 -176.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1203 ' ' GLN . . . . . 0.431 ' OE1' HD22 ' B' 1178 ' ' LEU . 23.8 tt0 -61.37 -48.76 79.8 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.945 -1.131 . . . . 52.57 107.945 172.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1204 ' ' VAL . . . . . 0.453 HG23 ' O ' ' B' 1200 ' ' VAL . 18.9 t -72.87 -33.91 44.96 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.222 0 CA-C-O 125.358 2.504 . . . . 33.789999999999999 110.606 -167.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -57.38 -52.25 66.11 Favored 'General case' 0 C--O 1.256 1.435 0 CA-C-N 112.997 -1.911 . . . . 36.579999999999998 110.47 168.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1206 ' ' SER . . . . . . . . . . . . . 17.7 m -62.62 -25.39 68.08 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 121.864 2.12 . . . . 39.609999999999999 112.135 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1207 ' ' MET . . . . . . . . . . . . . 20.4 mtp -75.04 -21.21 59.2 Favored 'General case' 0 C--N 1.359 0.988 0 N-CA-C 116.348 1.981 . . . . 37.450000000000003 116.348 172.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 74.7 52.76 6.94 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-O 125.354 2.641 . . . . 31.870000000000001 110.54 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -148.22 151.74 36.01 Favored 'General case' 0 C--O 1.25 1.118 0 N-CA-C 103.382 -2.821 . . . . 35.399999999999999 103.382 -173.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -89.61 126.71 35.72 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 119.602 1.092 . . . . 47.890000000000001 113.548 -169.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 59.4 t80 -85.52 115.96 23.54 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 103.501 -2.777 . . . . 45.530000000000001 103.501 169.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1212 ' ' LEU . . . . . 0.516 HD21 ' HD2' ' B' 1192 ' ' ARG . 97.3 mt -70.27 93.31 0.83 Allowed 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 114.57 -1.196 . . . . 46.329999999999998 108.163 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -76.31 150.85 36.87 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 122.61 1.195 . . . . 60.409999999999997 111.23 172.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1214 ' ' LEU . . . . . 0.409 HD11 ' HE1' ' B' 1234 ' ' PHE . 97.2 mt -70.7 144.64 50.94 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 110.53 -3.032 . . . . 57.380000000000003 112.548 174.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 36.3 t0 . . . . . 0 N--CA 1.425 -1.68 0 O-C-N 125.445 1.716 . . . . 65.069999999999993 107.678 173.934 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B 1230 ' ' MET . . . . . . . . . . . . . 15.2 mmt . . . . . 0 N--CA 1.442 -0.836 0 N-CA-C 103.197 -2.89 . . . . 80.319999999999993 103.197 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B 1231 ' ' SER . . . . . . . . . . . . 0.324 66.8 m 75.53 132.8 0.05 OUTLIER 'General case' 0 C--O 1.212 -0.912 2 CA-C-N 129.98 5.809 . . . . 79.920000000000002 121.428 -0.032 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -70.29 -158.81 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.188 0 O-C-N 125.307 1.63 . . . . 77.909999999999997 111.096 -176.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 68.71 -52.9 0.56 Allowed 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 126.043 1.737 . . . . 73.879999999999995 110.969 -160.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1234 ' ' PHE . . . . . 0.409 ' HE1' HD11 ' B' 1214 ' ' LEU . 10.9 t80 -39.77 -51.57 2.36 Favored 'General case' 0 CA--C 1.5 -0.965 0 C-N-CA 127.96 2.504 . . . . 68.980000000000004 110.937 162.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 46.9 pt -52.4 -25.8 8.16 Favored 'Isoleucine or valine' 0 C--O 1.248 1.01 0 N-CA-C 115.84 1.793 . . . . 64.530000000000001 115.84 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -77.97 -48.31 16.54 Favored 'General case' 0 CA--C 1.511 -0.529 0 O-C-N 119.883 -1.761 . . . . 66.359999999999999 110.064 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -60.09 -36.15 76.76 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 123.978 0.911 . . . . 56.600000000000001 109.832 177.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -59.08 -62.11 2.13 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.259 -1.015 . . . . 56.789999999999999 108.259 171.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1239 ' ' MET . . . . . . . . . . . . . 20.3 mmt -59.26 -34.3 72.07 Favored 'General case' 0 C--O 1.222 -0.392 0 O-C-N 119.41 -2.056 . . . . 53.630000000000003 114.356 -173.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -46.33 -54.34 9.16 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 113.871 1.063 . . . . 51.740000000000002 113.871 168.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 48.8 tp -68.24 -49.16 62.56 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 112.488 -2.142 . . . . 44.859999999999999 106.38 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -64.95 -44.22 90.12 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 119.494 -2.004 . . . . 42.780000000000001 111.644 -172.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -65.73 -24.05 66.88 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 114.688 1.366 . . . . 40.960000000000001 114.688 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -76.63 -58.04 3.51 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 104.834 -2.284 . . . . 43.060000000000002 104.834 171.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 75.7 mm-40 -53.45 -30.32 40.05 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.901 1.281 . . . . 46.450000000000003 112.195 -173.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -57.67 -35.98 71.29 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.946 1.248 . . . . 41.780000000000001 113.003 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 31.4 tptt -67.04 -23.76 65.92 Favored 'General case' 0 C--O 1.241 0.637 0 O-C-N 119.369 -2.082 . . . . 52.200000000000003 113.6 176.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1248 ' ' GLU . . . . . 0.422 ' CD ' HH12 ' B' 1192 ' ' ARG . 20.8 mt-10 -95.12 -44.84 7.47 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 114.179 -1.373 . . . . 53.549999999999997 113.76 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1249 ' ' VAL . . . . . 0.811 HG11 ' HB2' ' B' 1169 ' ' MET . 29.0 m -77.99 143.13 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-O 126.352 2.977 . . . . 34.409999999999997 114.21 -162.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1250 ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -100.05 -37.35 9.02 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 109.066 -3.697 . . . . 33.380000000000003 107.247 -177.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1251 ' ' ILE . . . . . 0.825 HD12 ' HB1' ' B' 1145 ' ' ALA . 37.0 mm -128.98 125.64 63.2 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.755 0 O-C-N 119.789 -1.82 . . . . 29.539999999999999 107.083 176.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1252 ' ' ILE . . . . . 0.484 HG22 ' HB ' ' B' 1254 ' ' THR . 64.8 mt -103.34 109.2 26.27 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.734 0 N-CA-C 103.927 -2.62 . . . . 32.439999999999998 103.927 166.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1253 ' ' VAL . . . . . . . . . . . . . 95.4 t -84.76 82.31 1.86 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.976 0 N-CA-C 103.924 -2.621 . . . . 30.57 103.924 169.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1254 ' ' THR . . . . . 0.484 ' HB ' HG22 ' B' 1252 ' ' ILE 0.283 2.8 t -84.13 91.16 7.62 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-O 127.243 3.402 . . . . 35.039999999999999 110.037 -179.618 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B 1255 ' ' THR . . . . . 0.596 ' HA ' ' HB2' ' B' 1284 ' ' LEU . 27.1 m -85.45 -71.24 0.54 Allowed 'General case' 0 C--O 1.242 0.703 0 CA-C-N 110.001 -3.272 . . . . 34.619999999999997 108.136 -175.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . 44.1 24.74 0.09 Allowed 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 120.973 3.694 . . . . 42.719999999999999 120.973 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 39.3 mt -66.2 112.25 3.85 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-O 123.255 1.502 . . . . 52.43 110.576 -172.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 55.6 mt -91.92 109.01 34.28 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 105.066 -2.198 . . . . 59.409999999999997 105.066 175.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -56.3 97.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 123.441 2.761 . . . . 62.68 114.864 -175.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 68.61 47.92 53.46 Favored Glycine 0 N--CA 1.466 0.652 0 N-CA-C 109.353 -1.499 . . . . 64.159999999999997 109.353 174.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 55.5 tttt -155.76 149.1 18.56 Favored Pre-proline 0 C--O 1.248 1.019 0 N-CA-C 102.258 -3.238 . . . . 68.530000000000001 102.258 168.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.53 132.22 37.09 Favored 'Trans proline' 0 C--N 1.364 1.376 0 C-N-CA 124.746 3.631 . . . . 61.990000000000002 112.765 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1263 ' ' ALA . . . . . . . . . . . . . . . -71.69 143.08 86.72 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-N 112.933 -1.94 . . . . 57.149999999999999 112.201 175.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -73.08 147.87 43.71 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 124.156 3.237 . . . . 51.57 116.003 -176.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -71.46 82.63 0.8 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 118.567 -2.583 . . . . 54.549999999999997 109.58 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 84.9 mt -71.3 -64.4 0.92 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.103 -1.408 . . . . 46.859999999999999 113.946 178.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1267 ' ' ILE . . . . . 0.704 HG21 HD13 ' B' 1281 ' ' ILE . 26.5 mm -87.66 89.66 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 107.389 -1.337 . . . . 41.039999999999999 107.389 -170.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1268 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.86 150.64 47.56 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 111.504 -2.589 . . . . 39.579999999999998 116.51 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1269 ' ' ARG . . . . . 0.513 ' HG3' ' HB2' ' B' 1293 ' ' GLU . 44.3 mtt85 -54.28 -44.27 71.76 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 114.516 1.302 . . . . 53.149999999999999 114.516 -169.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -57.53 -44.6 85.23 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.261 0.624 . . . . 42.960000000000001 112.551 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1271 ' ' MET . . . . . . . . . . . . . 30.1 ttm -58.91 -52.2 66.78 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 125.687 1.867 . . . . 43.890000000000001 109.966 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1272 ' ' VAL . . . . . 0.416 HG22 HG22 ' B' 1267 ' ' ILE . 40.2 t -54.95 -47.09 76.67 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 C-N-CA 124.176 0.99 . . . . 38.369999999999997 108.618 -177.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.99 -26.7 67.78 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 115.634 1.716 . . . . 47.460000000000001 115.634 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1274 ' ' SER . . . . . . . . . . . . . 3.2 p -92.42 -6.39 50.08 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 114.53 1.307 . . . . 38.380000000000003 114.53 174.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1275 ' ' MET . . . . . . . . . . . . . 11.2 ttt -67.02 159.72 28.06 Favored 'General case' 0 C--O 1.24 0.586 0 O-C-N 121.22 -0.925 . . . . 37.810000000000002 112.56 -176.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 83.1 tttt -55.62 147.98 17.01 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 124.627 1.171 . . . . 49.259999999999998 113.059 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1277 ' ' ALA . . . . . 0.62 ' HB1' ' HA ' ' A' 1045 ' ' PHE . . . -76.35 150.15 36.89 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 108.195 -1.039 . . . . 34.460000000000001 108.195 -176.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1278 ' ' GLY . . . . . 0.619 ' HA2' ' HB3' ' A' 1044 ' ' SER . . . 68.28 26.59 74.12 Favored Glycine 0 N--CA 1.466 0.657 0 C-N-CA 125.006 1.289 . . . . 33.530000000000001 112.118 173.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1279 ' ' SER . . . . . . . . . . . . . 36.6 m -113.17 156.49 23.14 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 106.198 -1.779 . . . . 31.309999999999999 106.198 -171.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1280 ' ' VAL . . . . . 0.771 HG11 ' HA ' ' B' 1145 ' ' ALA . 52.9 t -115.62 140.04 39.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 O-C-N 119.535 -1.978 . . . . 29.32 109.314 -171.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1281 ' ' ILE . . . . . 0.704 HD13 HG21 ' B' 1267 ' ' ILE . 19.5 mt -109.27 105.18 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 104.953 -2.24 . . . . 31.93 104.953 165.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1282 ' ' VAL . . . . . 0.557 HG11 ' HA ' ' B' 1141 ' ' ALA . 15.8 t -84.35 114.92 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 N-CA-C 101.078 -3.675 . . . . 29.48 101.078 176.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 45.7 t0 -97.98 96.62 8.29 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.208 -1.405 . . . . 34.5 107.208 175.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1284 ' ' LEU . . . . . 0.596 ' HB2' ' HA ' ' B' 1255 ' ' THR . 6.6 mp -68.48 -32.84 73.12 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 113.548 -1.66 . . . . 37.939999999999998 110.727 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -89.03 20.23 3.74 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 125.54 1.775 . . . . 40.920000000000002 112.35 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -48.48 -34.23 10.8 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 120.917 1.69 . . . . 44.390000000000001 115.062 177.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1287 ' ' GLN . . . . . 0.895 ' HB3' HG23 ' B' 1313 ' ' THR . 0.0 OUTLIER -90.56 -20.51 22.54 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 113.165 0.802 . . . . 51.460000000000001 113.165 175.886 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -91.21 -17.16 26.49 Favored 'General case' 0 C--O 1.215 -0.727 0 O-C-N 120.515 -1.366 . . . . 57.75 113.575 -177.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1289 ' ' GLY . . . . . . . . . . . . . . . 173.17 -19.55 0.06 OUTLIER Glycine 0 C--O 1.243 0.699 0 CA-C-O 116.82 -2.1 . . . . 49.850000000000001 112.97 177.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 74.89 88.3 0.23 Allowed Glycine 0 CA--C 1.524 0.65 0 CA-C-N 122.12 2.96 . . . . 45.93 108.806 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1291 ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -71.41 -30.58 66.27 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 123.015 1.388 . . . . 42.670000000000002 113.616 -173.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1292 ' ' CYS . . . . . 0.503 ' HB3' ' OG1' ' B' 1295 ' ' THR . 33.2 t -98.57 145.83 26.43 Favored 'General case' 0 C--O 1.241 0.619 0 O-C-N 121.445 -0.785 . . . . 38.82 109.134 175.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1293 ' ' GLU . . . . . 0.513 ' HB2' ' HG3' ' B' 1269 ' ' ARG . 37.2 mt-10 -73.57 -35.85 65.52 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.463 -0.495 . . . . 46.710000000000001 111.07 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -72.94 -13.64 61.29 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.188 0.81 . . . . 47.229999999999997 113.188 -178.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1295 ' ' THR . . . . . 0.808 HG23 ' HA3' ' B' 1311 ' ' GLY . 98.1 m -53.39 102.39 0.06 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.992 0.738 . . . . 36.020000000000003 112.992 173.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 82.8 t -73.24 113.97 26.99 Favored Pre-proline 0 N--CA 1.429 -1.503 0 N-CA-C 104.298 -2.482 . . . . 37.259999999999998 104.298 158.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -62.01 131.06 33.13 Favored 'Trans proline' 0 CA--C 1.507 -0.868 0 C-N-CA 122.773 2.315 . . . . 35.090000000000003 114.125 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 81.07 8.78 86.99 Favored Glycine 0 CA--C 1.543 1.826 0 CA-C-O 118.174 -1.348 . . . . 35.969999999999999 110.692 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -143.61 172.5 12.72 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 120.82 2.31 . . . . 40.390000000000001 112.075 -173.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1300 ' ' ILE . . . . . 0.493 HG12 HG12 ' B' 1310 ' ' ILE . 67.4 mt -101.11 148.1 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 103.848 -2.649 . . . . 37.43 103.848 170.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 65.3 t80 -123.7 125.21 44.36 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 101.561 -3.496 . . . . 44.130000000000003 101.561 164.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1302 ' ' THR . . . . . . . . . . . . . 90.8 m -98.03 110.72 23.24 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.476 -1.305 . . . . 39.780000000000001 107.476 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1303 ' ' THR . . . . . . . . . . . . . 40.5 p -72.62 162.48 29.43 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 113.515 0.932 . . . . 43.289999999999999 113.515 -174.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -53.7 -37.1 62.91 Favored 'General case' 0 C--N 1.354 0.789 0 O-C-N 120.338 -1.476 . . . . 53.07 112.085 173.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -77.81 12.71 1.6 Allowed 'General case' 0 C--N 1.349 0.555 0 O-C-N 120.192 -1.567 . . . . 43.969999999999999 114.437 174.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 72.13 34.89 61.14 Favored Glycine 0 CA--C 1.546 1.997 0 C-N-CA 119.078 -1.534 . . . . 41.119999999999997 111.879 173.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1307 ' ' VAL . . . . . . . . . . . . . 68.0 t -104.87 133.68 48.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 116.723 -3.81 . . . . 38.119999999999997 102.381 175.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1308 ' ' LYS . . . . . 0.651 ' HB2' HG22 ' B' 1280 ' ' VAL . 41.7 mmtt -97.68 97.71 9.25 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 105.938 -1.875 . . . . 36.340000000000003 105.938 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1309 ' ' VAL . . . . . 0.414 HG22 HD12 ' B' 1281 ' ' ILE . 21.8 t -85.62 92.22 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 N-CA-C 106.68 -1.6 . . . . 30.399999999999999 106.68 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1310 ' ' ILE . . . . . 0.733 HD11 ' HB2' ' B' 1148 ' ' GLU . 56.8 mt -89.45 87.51 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 C-N-CA 124.615 1.166 . . . . 30.82 111.378 -177.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1311 ' ' GLY . . . . . 0.808 ' HA3' HG23 ' B' 1295 ' ' THR . . . -94.48 62.44 1.71 Allowed Glycine 0 C--O 1.245 0.839 0 N-CA-C 110.825 -0.91 . . . . 26.530000000000001 110.825 -178.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1312 ' ' TYR . . . . . 0.497 ' O ' ' HG ' ' B' 1315 ' ' LEU . 5.5 m-85 -83.0 99.27 9.73 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 124.02 1.866 . . . . 38.0 111.732 -176.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1313 ' ' THR . . . . . 0.895 HG23 ' HB3' ' B' 1287 ' ' GLN . 26.9 m -51.76 -37.87 53.1 Favored 'General case' 0 C--O 1.255 1.365 0 C-N-CA 126.006 1.722 . . . . 29.800000000000001 113.226 170.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -81.09 17.57 1.22 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 116.292 1.96 . . . . 39.039999999999999 116.292 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1315 ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' B' 1312 ' ' TYR . 42.9 mt -45.51 -46.76 36.27 Favored Pre-proline 0 C--O 1.254 1.323 0 N-CA-C 117.214 2.301 . . . . 31.079999999999998 117.214 174.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1316 ' ' PRO . . . . . 0.417 ' HA ' ' CG2' ' B' 1136 ' ' ILE . 52.5 Cg_exo -61.5 -33.03 88.55 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.244 2.629 . . . . 26.100000000000001 115.19 167.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -70.51 -40.69 67.49 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 118.447 -1.835 . . . . 23.170000000000002 112.608 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1318 ' ' ARG . . . . . 0.415 ' HD3' ' OE2' ' B' 1144 ' ' GLU . 94.0 mtt-85 -60.84 -2.74 0.6 Allowed 'General case' 0 C--O 1.246 0.894 0 N-CA-C 118.384 2.735 . . . . 40.399999999999999 118.384 -174.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1319 ' ' LEU . . . . . 0.468 HD23 HG23 ' B' 1136 ' ' ILE . 3.3 tp -120.52 58.41 6.26 Favored Pre-proline 0 C--N 1.327 -0.38 0 O-C-N 118.843 -2.411 . . . . 23.600000000000001 107.003 -176.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1320 ' ' PRO . . . . . 0.775 ' HB2' ' HA ' ' B' 1043 ' ' ALA . 84.9 Cg_endo -54.19 -60.93 0.49 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 124.429 3.419 . . . . 22.350000000000001 117.588 -152.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1321 ' ' THR . . . . . 0.479 ' OG1' ' HA3' ' A' 1150 ' ' GLY . 1.3 m -57.03 -49.81 74.67 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.504 1.502 . . . . 26.52 111.375 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1322 ' ' GLN . . . . . 0.962 ' HB2' ' HA ' ' A' 1151 ' ' ARG . 39.1 tp60 -73.26 -33.81 65.47 Favored 'General case' 0 N--CA 1.435 -1.223 0 O-C-N 122.15 -0.344 . . . . 24.379999999999999 110.903 -172.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1323 ' ' SER . . . . . . . . . . . . . 68.3 m -57.84 -46.57 84.56 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 123.702 0.801 . . . . 22.800000000000001 112.488 165.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1324 ' ' SER . . . . . . . . . . . . . 15.7 m -69.48 -30.74 68.69 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 120.24 -1.538 . . . . 21.25 110.416 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -73.64 -36.54 65.43 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 121.093 1.77 . . . . 31.34 108.692 176.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1326 ' ' LEU . . . . . 0.66 ' HB3' ' HB3' ' B' 1132 ' ' SER . 11.3 mt -70.92 -58.21 3.81 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.871 1.669 . . . . 31.559999999999999 108.346 -175.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1327 ' ' TYR . . . . . 0.493 ' O ' ' HB2' ' B' 1330 ' ' ASN . 12.4 t80 -52.63 -45.25 66.55 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 125.44 1.496 . . . . 22.73 110.747 173.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1328 ' ' GLY . . . . . 0.563 ' O ' HG23 ' B' 1332 ' ' VAL . . . -51.87 -50.98 41.97 Favored Glycine 0 C--O 1.249 1.08 0 CA-C-O 118.951 -0.916 . . . . 21.91 111.552 170.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1329 ' ' THR . . . . . . . . . . . . . 8.5 m -66.87 -28.62 68.48 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 121.4 2.6 . . . . 22.149999999999999 109.377 -177.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1330 ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' B' 1327 ' ' TYR . 10.1 m120 -60.86 -50.17 74.5 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.312 -0.868 . . . . 26.18 110.649 174.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1331 ' ' LEU . . . . . 0.706 HD22 HD22 ' B' 1070 ' ' LEU . 18.7 mt -60.22 -36.76 78.42 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 126.904 2.081 . . . . 23.68 112.123 174.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1332 ' ' VAL . . . . . 0.563 HG23 ' O ' ' B' 1328 ' ' GLY . 20.9 t -65.15 -48.7 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 N-CA-C 107.301 -1.37 . . . . 26.57 107.301 175.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1333 ' ' ASN . . . . . 0.676 ' HA ' ' HD2' ' B' 1336 ' ' LYS . 62.8 m-20 -59.63 -47.75 84.38 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 109.641 -0.503 . . . . 28.079999999999998 109.641 -174.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1334 ' ' LEU . . . . . 0.691 HD21 ' SD ' ' B' 1113 ' ' MET . 6.1 tt -56.25 -50.82 70.24 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 113.486 0.921 . . . . 27.43 113.486 170.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1335 ' ' LEU . . . . . 0.443 HD11 HD21 ' B' 1070 ' ' LEU . 93.0 mt -64.88 -16.89 63.78 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 114.96 1.466 . . . . 30.5 114.96 177.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1336 ' ' LYS . . . . . 0.676 ' HD2' ' HA ' ' B' 1333 ' ' ASN . 86.8 mttt -72.6 -46.28 55.01 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 120.256 1.389 . . . . 41.649999999999999 107.292 170.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 11.6 tp -64.63 -32.88 74.74 Favored 'General case' 0 N--CA 1.441 -0.91 0 O-C-N 120.329 -1.482 . . . . 42.079999999999998 110.731 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1338 ' ' LEU . . . . . 0.683 HD13 HG23 ' B' 1346 ' ' ILE . 24.2 mt -73.2 -47.01 47.07 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 118.896 -0.573 . . . . 35.030000000000001 110.289 168.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1339 ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' B' 1344 ' ' GLY . 0.5 OUTLIER -88.3 81.95 7.17 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 121.522 1.964 . . . . 37.329999999999998 109.328 -175.171 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -27.56 66.85 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.7 -1.136 . . . . 50.509999999999998 112.207 -160.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -117.14 18.18 14.62 Favored 'General case' 0 C--O 1.242 0.703 0 O-C-N 123.949 0.781 . . . . 54.210000000000001 110.831 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1342 ' ' LYS . . . . . 0.489 ' HG2' HD23 ' B' 1029 ' ' LEU . 49.0 mttp 49.09 59.42 4.47 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 124.572 2.129 . . . . 50.990000000000002 109.303 -166.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -127.67 31.58 5.13 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 111.683 -2.508 . . . . 48.82 111.083 -165.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1344 ' ' GLY . . . . . 0.528 ' N ' ' SG ' ' B' 1339 ' ' CYS . . . 47.3 24.07 2.19 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 116.912 1.525 . . . . 40.43 116.912 175.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 40.0 t30 -127.28 151.12 49.15 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.775 -1.194 . . . . 47.560000000000002 107.775 -169.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1346 ' ' ILE . . . . . 0.683 HG23 HD13 ' B' 1338 ' ' LEU . 32.9 mm -100.24 86.65 1.26 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 105.012 -2.218 . . . . 42.490000000000002 105.012 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1347 ' ' THR . . . . . . . . . . . . . 33.2 p -87.34 102.48 14.56 Favored 'General case' 0 C--O 1.241 0.632 0 O-C-N 118.157 -2.839 . . . . 38.119999999999997 109.839 164.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1348 ' ' VAL . . . . . 0.595 HG23 HG22 ' B' 1346 ' ' ILE . 61.0 t -90.84 111.89 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 107.094 -1.447 . . . . 37.5 107.094 -177.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 23.6 t70 -97.69 127.92 44.0 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 106.051 -1.833 . . . . 43.850000000000001 106.051 172.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1350 ' ' PHE . . . . . 0.434 ' CE1' ' HB ' ' B' 1359 ' ' THR . 0.3 OUTLIER -97.62 -0.12 46.27 Favored 'General case' 0 C--O 1.257 1.476 0 O-C-N 119.92 -1.737 . . . . 39.810000000000002 114.016 175.356 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -73.17 -37.21 66.63 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 121.441 1.928 . . . . 51.289999999999999 109.122 176.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 22.1 t0 -54.66 118.3 4.09 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 119.754 -0.779 . . . . 39.780000000000001 110.754 167.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1353 ' ' VAL . . . . . 0.41 ' HA ' ' HB3' ' B' 1356 ' ' ARG . 33.9 m -55.93 -31.18 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 O-C-N 123.868 0.73 . . . . 39.280000000000001 112.843 176.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1354 ' ' VAL . . . . . 0.462 ' O ' HG12 ' B' 1358 ' ' VAL . 83.7 t -70.37 -51.73 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 N-CA-C 106.637 -1.616 . . . . 35.700000000000003 106.637 -177.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1355 ' ' ILE . . . . . 0.6 ' HA ' HG12 ' B' 1358 ' ' VAL . 50.4 mm -62.27 -46.02 97.4 Favored 'Isoleucine or valine' 0 C--N 1.359 0.99 0 CA-C-N 121.82 2.1 . . . . 35.770000000000003 113.464 173.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1356 ' ' ARG . . . . . 0.41 ' HB3' ' HA ' ' B' 1353 ' ' VAL . 49.5 tpt85 -49.73 -33.63 16.7 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 114.505 1.298 . . . . 38.549999999999997 114.505 171.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -83.71 -54.16 3.17 Favored Glycine 0 C--N 1.343 0.963 0 N-CA-C 109.454 -1.458 . . . . 29.579999999999998 109.454 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1358 ' ' VAL . . . . . 0.6 HG12 ' HA ' ' B' 1355 ' ' ILE . 14.8 p -62.95 -42.54 96.98 Favored 'Isoleucine or valine' 0 C--O 1.256 1.413 0 CA-C-O 121.916 0.865 . . . . 32.060000000000002 112.531 -173.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1359 ' ' THR . . . . . 0.434 ' HB ' ' CE1' ' B' 1350 ' ' PHE . 3.6 m -83.83 81.96 8.54 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 124.13 1.919 . . . . 29.0 109.42 -174.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1360 ' ' VAL . . . . . . . . . . . . . 10.0 m -71.23 -16.98 19.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 113.022 -1.899 . . . . 29.68 113.907 -173.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 57.7 mt -134.98 110.22 12.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 N-CA-C 107.041 -1.466 . . . . 32.049999999999997 107.041 170.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1362 ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -98.74 110.43 23.03 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 104.99 -2.226 . . . . 32.520000000000003 104.99 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 48.26 60.77 3.39 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 112.922 -1.944 . . . . 35.68 113.528 172.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 83.58 -46.24 3.61 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 115.495 0.958 . . . . 34.259999999999998 115.495 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -64.62 124.56 22.21 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 119.277 -0.969 . . . . 51.07 111.802 172.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 69.7 mt -78.47 118.08 25.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 N-CA-C 103.265 -2.865 . . . . 39.869999999999997 103.265 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1367 ' ' THR . . . . . . . . . . . . . 1.4 p -107.03 11.57 29.56 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 113.883 -1.508 . . . . 38.009999999999998 112.039 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1368 ' ' TRP . . . . . . . . . . . . . 20.7 t90 -82.74 131.96 53.08 Favored Pre-proline 0 C--O 1.241 0.657 0 N-CA-C 103.531 -2.766 . . . . 42.140000000000001 103.531 164.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -82.23 171.89 53.15 Favored 'Cis proline' 0 C--N 1.353 0.812 0 N-CA-C 116.805 1.81 . . . . 43.259999999999998 116.805 -2.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1370 ' ' ALA . . . . . 0.408 ' HA ' ' HD2' ' B' 1371 ' ' PRO . . . -113.74 130.14 24.07 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 105.712 -1.958 . . . . 46.520000000000003 105.712 173.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1371 ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' B' 1370 ' ' ALA . 37.8 Cg_endo -62.73 106.36 0.51 Allowed 'Trans proline' 0 CA--C 1.552 1.419 0 C-N-CA 123.384 2.723 . . . . 51.950000000000003 108.671 173.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -65.66 140.56 62.68 Favored 'Trans proline' 0 N--CA 1.441 -1.579 0 C-N-CA 123.584 2.856 . . . . 56.270000000000003 119.118 -170.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1373 ' ' ILE . . . . . 0.466 HD13 HD13 ' B' 1121 ' ' ILE . 14.9 tt -74.61 145.67 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 113.902 -1.499 . . . . 60.829999999999998 108.02 170.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -65.83 108.9 2.29 Favored 'General case' 0 C--N 1.317 -0.845 0 O-C-N 120.91 -1.119 . . . . 66.099999999999994 110.054 176.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1375 ' ' VAL . . . . . 0.752 HG11 ' HB2' ' B' 1120 ' ' ARG . 76.9 t -102.01 108.86 24.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 106.082 -1.822 . . . . 63.469999999999999 106.082 -169.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.23 -4.619 0 O-C-N 120.601 -1.312 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 20' ' ' ALA . . . . . 0.585 ' HA ' HD21 ' C' ' 171' ' ' LEU . . . . . . . . 0 C--O 1.253 1.274 0 CA-C-O 121.637 0.732 . . . . 0.0 112.4 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -58.09 -28.01 64.21 Favored 'General case' 0 C--O 1.251 1.162 0 O-C-N 119.141 -2.225 . . . . 0.0 114.1 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -66.08 -53.25 40.47 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 176.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 23' ' ' THR . . . . . 0.464 ' HA ' ' HB2' ' C' ' 26' ' ' LEU . 29.2 m -56.33 -34.11 66.27 Favored 'General case' 0 C--O 1.209 -1.064 0 C-N-CA 126.043 1.737 . . . . 0.0 112.516 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 24' ' ' ALA . . . . . 0.624 ' HB2' HG22 ' C' ' 182' ' ' ILE . . . -62.32 -36.82 83.35 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.59 0.756 . . . . 0.0 112.089 174.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.78 -50.12 16.15 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.917 171.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.464 ' HB2' ' HA ' ' C' ' 23' ' ' THR . 0.2 OUTLIER -52.3 -43.62 64.58 Favored 'General case' 0 C--O 1.213 -0.867 0 C-N-CA 126.239 1.816 . . . . 0.0 113.175 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.558 HD21 HD21 ' C' ' 110' ' ' LEU . 81.1 mt -60.16 -51.23 70.49 Favored 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 118.63 -2.544 . . . . 0.0 115.315 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 28' ' ' LYS . . . . . 0.435 ' HZ2' ' C ' ' C' ' 186' ' ' LEU . 18.5 pttm -67.66 -17.41 64.58 Favored 'General case' 0 CA--C 1.555 1.169 0 O-C-N 121.113 -0.992 . . . . 0.0 110.022 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -75.21 -46.85 31.31 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 119.746 1.157 . . . . 0.0 111.048 164.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 38.9 m -50.28 -35.52 27.53 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 121.229 3.788 . . . . 0.0 121.229 -163.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 31' ' ' HIS . . . . . 0.488 ' HA ' HG12 ' C' ' 62' ' ' ILE 0.4 3.7 p-80 54.32 -38.86 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 119.121 3.008 . . . . 0.0 119.121 -170.477 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 32' ' ' SER . . . . . 0.69 ' HB2' ' HA ' ' C' ' 106' ' ' THR . 17.7 m -123.99 133.61 53.65 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 103.019 -2.956 . . . . 0.0 103.019 169.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 64.3 t -131.7 125.17 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 -174.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.629 HG21 ' HE1' ' C' ' 103' ' ' PHE . 34.4 mm -102.97 128.94 55.43 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 N-CA-C 103.467 -2.79 . . . . 0.0 103.467 172.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 31.8 mt -103.59 117.5 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 172.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 36' ' ' THR . . . . . 0.423 HG21 HG11 ' C' ' 118' ' ' VAL . 93.2 m -111.24 92.42 15.71 Favored Pre-proline 0 C--N 1.347 0.485 0 C-N-CA 124.255 1.022 . . . . 0.0 109.294 176.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 37' ' ' PRO . . . . . 0.853 ' HD2' HG12 ' C' ' 68' ' ' ILE . 90.2 Cg_exo -78.7 154.88 27.09 Favored 'Trans proline' 0 C--O 1.246 0.911 0 C-N-CA 123.614 2.876 . . . . 0.0 112.856 169.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 38' ' ' GLY . . . . . 0.557 ' HA3' ' HA ' ' C' ' 114' ' ' ALA . . . -150.77 -143.78 3.79 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 109.766 -3.379 . . . . 0.0 105.096 174.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -61.34 -34.49 75.36 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 117.393 -1.289 . . . . 0.0 113.449 -168.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 40' ' ' GLY . . . . . 0.474 ' HA3' ' HA3' ' C' ' 113' ' ' GLY . . . -57.08 -32.55 63.01 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-O 116.528 -2.262 . . . . 0.0 112.474 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 32.8 ttm -75.82 -26.13 56.94 Favored 'General case' 0 C--O 1.253 1.266 0 CA-C-N 119.556 1.678 . . . . 0.0 111.294 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.68 -38.82 58.39 Favored 'General case' 0 C--O 1.221 -0.443 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.274 175.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 59.9 t -74.95 -66.08 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 O-C-N 121.215 -0.928 . . . . 0.0 110.495 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 44' ' ' ALA . . . . . 0.597 ' HB2' H62A ' C' 1001 ' ' NAP . . . -91.04 113.51 25.79 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 174.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 45' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -72.0 79.5 0.92 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 124.514 2.102 . . . . 0.0 110.265 -169.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.41 -6.13 22.92 Favored 'General case' 0 C--O 1.239 0.534 0 O-C-N 120.332 -1.48 . . . . 0.0 112.974 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 47' ' ' GLN . . . . . 0.656 ' HG2' ' HB3' ' C' ' 82' ' ' LEU . 0.0 OUTLIER -76.21 -41.81 48.19 Favored 'General case' 0 C--O 1.249 1.05 0 O-C-N 120.155 -1.591 . . . . 0.0 114.235 -159.766 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 48' ' ' TYR . . . . . 0.524 ' CZ ' ' HA ' ' C' ' 86' ' ' ALA . 61.6 m-85 -61.34 -43.74 90.63 Favored Pre-proline 0 CA--C 1.55 0.971 0 O-C-N 119.964 -1.71 . . . . 0.0 113.352 168.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 49' ' ' PRO . . . . . 0.42 ' HA ' ' HB2' ' C' ' 52' ' ' GLU . 11.6 Cg_exo -54.34 -41.44 76.44 Favored 'Trans proline' 0 C--N 1.351 0.696 0 CA-C-N 124.069 2.489 . . . . 0.0 116.536 165.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 48.6 t -60.87 -41.58 89.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 O-C-N 119.971 -1.706 . . . . 0.0 112.509 175.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 51' ' ' ALA . . . . . 0.449 ' HB2' HG22 ' C' ' 88' ' ' VAL . . . -63.08 -33.72 76.05 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 171.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 52' ' ' GLU . . . . . 0.636 ' HB3' ' HB2' ' C' ' 183' ' ' LEU . 1.5 mm-40 -67.09 -39.41 86.76 Favored 'General case' 0 C--N 1.351 0.638 0 CA-C-O 118.284 -0.865 . . . . 0.0 113.277 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 10.2 tp -76.04 -37.27 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.718 0 CA-C-N 119.775 1.171 . . . . 0.0 110.429 175.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 26.1 m -64.78 -37.53 87.91 Favored 'General case' 0 C--O 1.244 0.814 0 O-C-N 120.219 -1.55 . . . . 0.0 112.889 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 55' ' ' GLU . . . . . 0.447 ' HB3' ' O ' ' C' ' 52' ' ' GLU . 8.1 tp10 -34.12 -43.36 0.15 Allowed 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 126.808 2.043 . . . . 0.0 112.858 159.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -87.95 -44.57 10.93 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 120.254 1.388 . . . . 0.0 109.92 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 74.8 mt -62.91 -48.74 77.65 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 121.017 -1.052 . . . . 0.0 111.309 -167.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -72.38 -34.51 68.0 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 121.334 1.879 . . . . 0.0 108.901 -171.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.28 -19.42 54.87 Favored 'General case' 0 C--N 1.345 0.384 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 166.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 60' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' C' ' 60' ' ' ARG . 28.8 ttm-85 -94.35 14.14 21.4 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-O 120.96 0.409 . . . . 0.0 110.557 173.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.48 22.89 66.2 Favored Glycine 0 C--O 1.24 0.52 0 O-C-N 120.647 -1.283 . . . . 0.0 114.425 -177.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 62' ' ' ILE . . . . . 0.488 HG12 ' HA ' ' C' ' 31' ' ' HIS . 15.0 mt -76.66 119.93 25.9 Favored 'Isoleucine or valine' 0 C--O 1.254 1.298 0 CA-C-O 122.062 0.934 . . . . 0.0 113.191 177.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 63' ' ' ASN . . . . . 0.433 ' O ' ' HA ' ' C' ' 32' ' ' SER . 12.0 t30 -63.23 84.66 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.561 0 CA-C-O 123.935 1.826 . . . . 0.0 106.285 171.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.478 ' O ' HD12 ' C' ' 92' ' ' ILE . 9.2 p -100.51 135.08 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 5.1 mmm-85 -137.84 140.06 40.26 Favored 'General case' 0 C--O 1.253 1.281 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 66' ' ' PHE . . . . . 0.601 ' HB2' HG22 ' C' ' 93' ' ' VAL . 33.4 m-85 -101.44 84.05 2.54 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -176.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.95 69.42 2.68 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.399 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 68' ' ' ILE . . . . . 0.853 HG12 ' HD2' ' C' ' 37' ' ' PRO . 10.1 mt -70.07 142.3 16.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 120.763 -1.433 . . . . 0.0 112.772 -174.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 69' ' ' HIS . . . . . 0.426 ' HA ' ' HD3' ' C' ' 70' ' ' PRO . 20.5 t-80 -114.66 89.59 19.17 Favored Pre-proline 0 N--CA 1.475 0.794 0 O-C-N 120.277 -1.514 . . . . 0.0 107.054 176.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 70' ' ' PRO . . . . . 0.718 ' HG2' HG12 ' A' 1157 ' ' ILE . 51.2 Cg_exo -61.84 -53.09 2.36 Favored 'Trans proline' 0 CA--C 1.513 -0.575 1 C-N-CA 125.504 4.136 . . . . 0.0 117.919 -163.126 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 71' ' ' VAL . . . . . 0.417 HG21 ' HB2' ' A' 1159 ' ' ALA . 51.8 t -67.26 104.79 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 168.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -171.89 119.26 0.43 Allowed 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 113.121 -1.854 . . . . 0.0 106.374 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.87 -97.82 2.08 Favored Glycine 0 C--O 1.213 -1.161 0 O-C-N 120.209 -1.557 . . . . 0.0 112.115 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 74' ' ' ARG . . . . . 0.706 ' NH2' ' HB2' ' B' 1199 ' ' GLU . 1.9 mpt_? -149.17 171.22 16.8 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 103.384 -2.821 . . . . 0.0 103.384 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.513 ' HA ' ' HD2' ' C' ' 76' ' ' PRO 0.268 33.0 mt 60.43 103.59 0.03 OUTLIER Pre-proline 0 C--O 1.236 0.385 0 N-CA-C 117.21 2.3 . . . . 0.0 117.21 -175.769 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 76' ' ' PRO . . . . . 0.513 ' HD2' ' HA ' ' C' ' 75' ' ' LEU . 72.9 Cg_endo -63.53 90.16 0.15 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.891 2.394 . . . . 0.0 112.137 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.08 -7.64 62.87 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-O 116.125 -2.486 . . . . 0.0 115.507 175.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -51.29 -28.01 10.88 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 123.733 3.766 . . . . 0.0 119.592 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 79' ' ' MET . . . . . 0.716 ' HA ' HD12 ' C' ' 82' ' ' LEU . 0.7 OUTLIER -58.52 -32.27 68.69 Favored 'General case' 0 C--O 1.243 0.757 0 O-C-N 118.925 -2.359 . . . . 0.0 113.748 169.63 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -66.88 -37.79 85.07 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 122.586 0.354 . . . . 0.0 111.054 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' 1155 ' ' GLY . 92.9 t -68.74 -42.76 83.12 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.718 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.383 -175.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.716 HD12 ' HA ' ' C' ' 79' ' ' MET . 34.9 mt -53.56 -41.55 66.59 Favored 'General case' 0 C--N 1.35 0.619 0 C-N-CA 125.319 1.448 . . . . 0.0 113.144 170.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 21.4 tp -65.24 -46.4 80.74 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.181 0.991 . . . . 0.0 110.379 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.44 -35.26 77.08 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-O 118.107 -0.949 . . . . 0.0 112.38 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -64.51 -43.88 92.67 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.597 0.561 . . . . 0.0 112.283 173.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 86' ' ' ALA . . . . . 0.524 ' HA ' ' CZ ' ' C' ' 48' ' ' TYR . . . -54.35 -3.31 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 119.131 3.011 . . . . 0.0 119.131 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 87' ' ' LYS . . . . . 0.429 ' HD3' ' HA ' ' C' ' 87' ' ' LYS . 31.7 mmtp 60.3 65.9 1.02 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 125.278 2.466 . . . . 0.0 112.184 -175.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 88' ' ' VAL . . . . . 0.449 HG22 ' HB2' ' C' ' 51' ' ' ALA . 87.0 t -115.29 149.96 43.65 Favored Pre-proline 0 N--CA 1.481 1.1 0 CA-C-N 108.748 -3.842 . . . . 0.0 104.208 -178.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -55.94 76.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.476 0.47 1 C-N-CA 127.178 5.252 . . . . 0.0 113.823 164.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -60.4 -30.24 69.47 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 113.062 -1.881 . . . . 0.0 107.004 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -39.02 -39.76 0.59 Allowed 'General case' 0 C--N 1.354 0.763 0 CA-C-O 116.359 -1.781 . . . . 0.0 115.436 168.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 92' ' ' ILE . . . . . 0.478 HD12 ' O ' ' C' ' 64' ' ' VAL . 2.3 pt -107.52 24.92 2.59 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 CA-C-O 124.034 1.873 . . . . 0.0 111.881 -176.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 93' ' ' VAL . . . . . 0.601 HG22 ' HB2' ' C' ' 66' ' ' PHE . 53.4 t -87.52 128.68 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 O-C-N 120.623 -1.298 . . . . 0.0 109.304 174.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 94' ' ' LEU . . . . . 0.59 HD23 ' HB3' ' C' ' 97' ' ' ASP . 4.7 mp -117.36 83.45 1.99 Allowed 'General case' 0 C--O 1.259 1.58 0 CA-C-O 123.644 1.688 . . . . 0.0 110.495 172.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -75.94 111.8 11.7 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 119.876 -1.765 . . . . 0.0 106.729 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.51 ' HA ' HD11 ' C' ' 136' ' ' LEU . 0.9 OUTLIER 68.35 -9.08 0.54 Allowed 'General case' 0 C--O 1.251 1.182 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 173.038 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 97' ' ' ASP . . . . . 0.59 ' HB3' HD23 ' C' ' 94' ' ' LEU . 3.3 t70 -68.09 -177.01 0.78 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 118.109 -0.948 . . . . 0.0 113.089 175.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -77.22 57.84 1.51 Allowed 'General case' 0 C--O 1.24 0.603 0 CA-C-O 125.627 2.632 . . . . 0.0 117.168 -171.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 8.6 tp -77.75 -2.52 4.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 O-C-N 119.174 -2.204 . . . . 0.0 111.334 173.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 100' ' ' ASN . . . . . 0.423 ' HA ' ' CD2' ' C' ' 103' ' ' PHE . 23.1 t-20 -57.79 -45.33 86.18 Favored 'General case' 0 C--N 1.354 0.768 0 O-C-N 121.292 -0.88 . . . . 0.0 113.226 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -57.05 -43.19 81.74 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 122.936 1.35 . . . . 0.0 113.87 174.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -68.42 -24.32 64.73 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.853 -175.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 103' ' ' PHE . . . . . 0.629 ' HE1' HG21 ' C' ' 34' ' ' ILE . 22.0 m-30 -53.67 -43.48 68.89 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 116.078 -1.915 . . . . 0.0 111.23 167.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.7 -45.73 88.69 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 121.128 1.785 . . . . 0.0 111.066 173.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -57.26 -31.41 65.55 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 106' ' ' THR . . . . . 0.69 ' HA ' ' HB2' ' C' ' 32' ' ' SER . 10.2 m -79.11 159.34 27.52 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-N 113.414 -1.721 . . . . 0.0 113.143 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 107' ' ' ASP . . . . . 0.531 ' HA ' ' HB2' ' C' ' 142' ' ' GLN . 1.8 t70 -99.98 -84.76 0.41 Allowed 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 165.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 108' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' C' ' 143' ' ' ASN . 57.2 m -79.01 111.44 15.21 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 125.307 2.48 . . . . 0.0 116.535 178.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 109' ' ' VAL . . . . . 0.774 HG11 HG21 ' C' ' 138' ' ' VAL . 21.0 t -90.3 105.61 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 112.208 -2.269 . . . . 0.0 107.857 174.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 110' ' ' LEU . . . . . 0.558 HD21 HD21 ' C' ' 27' ' ' LEU . 15.4 mt -71.55 87.79 0.91 Allowed 'General case' 0 C--O 1.25 1.125 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 173.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 111' ' ' VAL . . . . . 0.647 ' HB ' ' HA ' ' C' ' 146' ' ' VAL . 89.9 t -82.29 83.07 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 O-C-N 120.277 -1.514 . . . . 0.0 109.862 178.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 112' ' ' ILE . . . . . 0.534 ' HA ' ' HB2' ' C' ' 147' ' ' PHE . 56.0 mt -82.53 92.54 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 123.31 1.528 . . . . 0.0 110.185 -175.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 113' ' ' GLY . . . . . 0.474 ' HA3' ' HA3' ' C' ' 40' ' ' GLY . . . 57.95 29.61 62.32 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 110.513 -3.04 . . . . 0.0 113.681 175.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 114' ' ' ALA . . . . . 0.597 ' HB3' HG13 ' C' ' 111' ' ' VAL . . . -82.66 -28.84 30.41 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 118.485 -1.286 . . . . 0.0 112.322 173.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 115' ' ' ASN . . . . . 0.597 ' ND2' ' H ' ' C' ' 116' ' ' ASP . 6.2 t30 64.93 -163.26 0.26 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 116.377 -1.773 . . . . 0.0 112.564 161.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 116' ' ' ASP . . . . . 0.597 ' H ' ' ND2' ' C' ' 115' ' ' ASN . 1.9 p30 -51.99 -14.48 0.4 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 125.31 3.687 . . . . 0.0 116.881 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 117' ' ' THR . . . . . 0.414 HG22 ' CE1' ' C' ' 69' ' ' HIS . 1.3 m -63.64 -14.07 48.37 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 169.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.564 ' HB ' HG12 ' C' ' 138' ' ' VAL . 21.3 m -106.55 12.96 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 117.242 -3.411 . . . . 0.0 112.871 167.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 119' ' ' ASN . . . . . 0.519 ' HB3' ' HA ' ' C' ' 116' ' ' ASP . 0.1 OUTLIER -102.15 131.81 22.22 Favored Pre-proline 0 N--CA 1.478 0.961 0 O-C-N 118.904 -2.372 . . . . 0.0 114.392 -166.668 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 120' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -50.89 -40.01 58.22 Favored 'Trans proline' 0 C--O 1.242 0.707 0 C-N-CA 123.939 3.093 . . . . 0.0 113.869 -178.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 121' ' ' ALA . . . . . 0.758 ' HA ' ' HB3' ' C' ' 124' ' ' ASP . . . -58.87 -14.28 8.58 Favored 'General case' 0 C--O 1.208 -1.092 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 -167.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 122' ' ' ALA . . . . . 0.614 ' HB3' ' HB2' ' C' ' 133' ' ' MET . . . -58.98 -37.97 78.04 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 119.241 -2.162 . . . . 0.0 112.365 170.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -95.02 -41.38 9.17 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.369 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 124' ' ' ASP . . . . . 0.758 ' HB3' ' HA ' ' C' ' 121' ' ' ALA . 26.4 t70 -67.77 -46.88 70.77 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 124.305 1.042 . . . . 0.0 111.129 -170.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -108.55 94.85 14.74 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 120.272 1.396 . . . . 0.0 109.264 172.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -49.58 -15.43 0.96 Allowed 'Trans proline' 0 C--O 1.257 1.451 1 C-N-CA 125.677 4.251 . . . . 0.0 112.362 172.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -68.06 -32.62 73.09 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 118.654 -2.528 . . . . 0.0 109.177 176.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 128' ' ' SER . . . . . 0.426 ' HA ' ' HD2' ' C' ' 129' ' ' PRO . 44.6 m -53.44 123.01 34.59 Favored Pre-proline 0 N--CA 1.449 -0.501 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 129' ' ' PRO . . . . . 0.558 ' HG2' ' HA ' ' C' ' 156' ' ' ALA . 34.8 Cg_endo -52.18 -39.72 70.78 Favored 'Trans proline' 0 N--CA 1.435 -1.93 1 C-N-CA 125.701 4.267 . . . . 0.0 115.076 -178.858 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 130' ' ' ILE . . . . . 0.722 HG12 ' HB2' ' C' ' 156' ' ' ALA . 28.4 pt -78.11 130.6 36.0 Favored 'Isoleucine or valine' 0 C--O 1.252 1.205 0 CA-C-N 120.615 1.552 . . . . 0.0 110.931 170.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 131' ' ' ALA . . . . . 0.526 ' O ' ' HB ' ' B' 1121 ' ' ILE . . . -108.8 124.95 51.41 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-O 122.698 1.237 . . . . 0.0 113.396 -174.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.03 134.14 2.59 Favored Glycine 0 N--CA 1.474 1.225 0 CA-C-N 113.482 -1.69 . . . . 0.0 112.353 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 133' ' ' MET . . . . . 0.614 ' HB2' ' HB3' ' C' ' 122' ' ' ALA . 34.0 tpp -129.25 131.73 23.85 Favored Pre-proline 0 CA--C 1.506 -0.717 0 N-CA-C 104.932 -2.247 . . . . 0.0 104.932 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 134' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' C' ' 133' ' ' MET . 56.7 Cg_endo -57.54 149.93 63.7 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.748 2.299 . . . . 0.0 113.178 165.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 3.2 m -64.08 5.96 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.052 0 N-CA-C 119.054 2.983 . . . . 0.0 119.054 -168.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.51 HD11 ' HA ' ' C' ' 96' ' ' MET . 27.6 mt -80.77 52.49 1.72 Allowed 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 120.193 -1.567 . . . . 0.0 110.199 171.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -82.22 96.37 7.84 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 -177.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 138' ' ' VAL . . . . . 0.774 HG21 HG11 ' C' ' 109' ' ' VAL . 13.4 p -94.12 77.89 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 113.475 -1.693 . . . . 0.0 109.294 -171.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -131.79 165.76 23.07 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 173.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 140' ' ' LYS . . . . . . . . . . . . 0.29 0.8 OUTLIER 61.9 -24.01 0.05 OUTLIER 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 126.708 2.003 . . . . 0.0 113.777 173.79 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -52.51 153.91 2.83 Favored 'General case' 0 C--O 1.252 1.234 0 CA-C-N 123.017 2.644 . . . . 0.0 116.409 163.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 142' ' ' GLN . . . . . 0.531 ' HB2' ' HA ' ' C' ' 107' ' ' ASP . 8.8 mm100 -35.67 -44.69 0.33 Allowed 'General case' 0 C--N 1.354 0.8 0 N-CA-C 120.147 3.388 . . . . 0.0 120.147 -160.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 143' ' ' ASN . . . . . 0.52 ' O ' ' HA ' ' C' ' 108' ' ' THR . 19.2 t-20 -157.56 93.79 1.32 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 122.643 1.211 . . . . 0.0 112.967 162.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 144' ' ' VAL . . . . . 0.572 ' HB ' HG23 ' C' ' 168' ' ' THR . 90.2 t -87.67 104.27 14.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 103.923 -2.621 . . . . 0.0 103.923 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 145' ' ' ILE . . . . . 0.696 HG13 ' HB2' ' C' ' 171' ' ' LEU . 3.7 tp -101.73 104.81 16.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 123.696 1.712 . . . . 0.0 111.748 -177.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 146' ' ' VAL . . . . . 0.647 ' HA ' ' HB ' ' C' ' 111' ' ' VAL . 27.2 t -91.51 98.83 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 O-C-N 119.658 -1.901 . . . . 0.0 109.453 -169.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 147' ' ' PHE . . . . . 0.534 ' HB2' ' HA ' ' C' ' 112' ' ' ILE . 9.3 m-85 -67.95 115.3 7.31 Favored 'General case' 0 C--O 1.249 1.079 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 148' ' ' LYS . . . . . 0.591 ' HE3' ' O2B' ' C' 1001 ' ' NAP . 77.1 tttt -155.5 137.09 14.2 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 149' ' ' ARG . . . . . 0.498 ' HG2' HH11 ' C' ' 149' ' ' ARG . 7.3 tpp85 -48.41 -60.65 2.51 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 110.633 -2.985 . . . . 0.0 113.924 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 8.0 m -133.7 159.75 39.6 Favored 'General case' 0 CA--C 1.552 1.022 0 O-C-N 119.977 -1.702 . . . . 0.0 112.865 -171.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 10.7 tpt -67.51 93.81 0.37 Allowed 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 168.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -155.99 160.38 40.01 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.178 0.991 . . . . 0.0 109.259 -176.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 153' ' ' THR . . . . . 0.593 HG23 ' HA3' ' C' ' 157' ' ' GLY . 8.9 m -62.86 161.33 12.93 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.94 0.896 . . . . 0.0 112.997 175.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 154' ' ' GLY . . . . . 0.574 ' HA3' ' ND2' ' C' ' 115' ' ' ASN . . . -106.8 -92.35 2.26 Favored Glycine 0 CA--C 1.508 -0.382 0 N-CA-C 105.49 -3.044 . . . . 0.0 105.49 153.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -114.92 -20.11 10.68 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 172.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 156' ' ' ALA . . . . . 0.722 ' HB2' HG12 ' C' ' 130' ' ' ILE . . . -103.32 -81.05 0.51 Allowed 'General case' 0 C--N 1.322 -0.614 0 O-C-N 119.121 -2.237 . . . . 0.0 110.703 168.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 157' ' ' GLY . . . . . 0.593 ' HA3' HG23 ' C' ' 153' ' ' THR . . . 88.71 -61.25 3.83 Favored Glycine 0 C--N 1.347 1.139 0 CA-C-N 121.594 1.997 . . . . 0.0 112.064 168.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 34.0 m -37.34 98.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-O 123.951 1.834 . . . . 0.0 115.465 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 35.72 34.62 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 120.515 3.524 . . . . 0.0 120.515 -174.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 160' ' ' ASN . . . . . 0.424 ' HA ' ' HD2' ' C' ' 161' ' ' PRO . 7.5 m120 -70.75 118.65 67.03 Favored Pre-proline 0 C--N 1.347 0.491 0 CA-C-N 113.193 -1.822 . . . . 0.0 111.075 -170.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 161' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' C' ' 160' ' ' ASN . 34.7 Cg_endo -46.64 -25.95 3.99 Favored 'Trans proline' 0 CA--C 1.509 -0.725 1 C-N-CA 126.007 4.471 . . . . 0.0 117.102 -172.66 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 162' ' ' LEU . . . . . 0.464 ' HG ' HG21 ' C' ' 146' ' ' VAL . 13.6 tp -50.71 -39.64 52.16 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 125.338 1.455 . . . . 0.0 113.529 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 163' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -84.6 -23.1 29.75 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 118.887 -1.125 . . . . 0.0 108.688 -172.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -102.67 -34.21 9.14 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 118.246 2.684 . . . . 0.0 118.246 -160.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 165' ' ' LYS . . . . . 0.718 ' HB2' ' HB ' ' C' ' 168' ' ' THR . 63.7 mmtt -57.16 157.57 5.99 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 -175.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.5 -40.14 96.29 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -99.21 -22.98 15.38 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 119.292 0.951 . . . . 0.0 111.894 173.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 168' ' ' THR . . . . . 0.718 ' HB ' ' HB2' ' C' ' 165' ' ' LYS . 89.5 m -101.24 93.91 5.68 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 175.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.91 146.87 36.21 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.07 -1.052 . . . . 0.0 108.73 -171.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 170' ' ' MET . . . . . 0.458 ' SD ' ' HB3' ' C' ' 148' ' ' LYS . 30.8 mtm -62.16 130.49 45.69 Favored 'General case' 0 C--N 1.36 1.056 0 CA-C-O 123.94 1.829 . . . . 0.0 115.123 167.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 171' ' ' LEU . . . . . 0.696 ' HB2' HG13 ' C' ' 145' ' ' ILE . 20.8 tp -92.96 104.25 16.49 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 101.338 -3.578 . . . . 0.0 101.338 167.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 172' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' C' ' 148' ' ' LYS . 97.0 m-85 -72.44 136.32 45.98 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 113.059 -1.882 . . . . 0.0 110.04 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . 128.66 166.64 12.02 Favored Glycine 0 N--CA 1.432 -1.589 0 CA-C-O 124.525 2.18 . . . . 0.0 110.113 -177.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 174' ' ' ASP . . . . . 0.603 ' HB3' ' HB3' ' C' ' 177' ' ' ALA . 16.5 t70 -62.75 149.2 44.54 Favored 'General case' 0 C--O 1.252 1.198 0 CA-C-N 112.197 -2.001 . . . . 0.0 112.902 -177.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 175' ' ' ALA . . . . . 0.493 ' O ' HG23 ' C' ' 179' ' ' VAL . . . -60.93 -53.44 57.27 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 121.421 -0.799 . . . . 0.0 113.02 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -62.49 -62.94 1.4 Allowed 'General case' 0 C--O 1.217 -0.623 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 177' ' ' ALA . . . . . 0.603 ' HB3' ' HB3' ' C' ' 174' ' ' ASP . . . -51.42 -36.38 43.53 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -176.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 14.7 m -68.6 -39.16 81.0 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 173.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 179' ' ' VAL . . . . . 0.493 HG23 ' O ' ' C' ' 175' ' ' ALA . 5.7 t -74.47 -37.23 43.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 124.041 1.877 . . . . 0.0 109.239 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 180' ' ' ASP . . . . . 0.513 ' O ' ' HG ' ' C' ' 183' ' ' LEU . 16.1 t70 -58.89 -40.77 85.46 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-N 114.299 -1.318 . . . . 0.0 110.67 176.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.04 -29.34 69.67 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.611 175.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 182' ' ' ILE . . . . . 0.624 HG22 ' HB2' ' C' ' 24' ' ' ALA . 19.9 pt -101.07 -16.2 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 -178.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 183' ' ' LEU . . . . . 0.636 ' HB2' ' HB3' ' C' ' 52' ' ' GLU 0.265 2.0 pp -48.29 -35.22 11.8 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 118.981 2.956 . . . . 0.0 118.981 -170.522 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -131.85 -21.21 2.46 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.909 171.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -88.23 60.24 5.65 Favored 'General case' 0 C--O 1.243 0.747 0 O-C-N 119.869 -1.77 . . . . 0.0 109.546 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 186' ' ' LEU . . . . . 0.467 HD23 ' H ' ' C' ' 186' ' ' LEU . 1.7 pt? . . . . . 0 N--CA 1.436 -1.16 0 CA-C-O 114.698 -2.573 . . . . 0.0 113.962 176.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 1' ' ' NAD . . . . . 0.624 ' H1D' ' HB3' ' B' 1120 ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C 1001 ' ' NAP . . . . . 0.597 H62A ' HB2' ' C' ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 20.5 t-80 . . . . . 0 CA--C 1.488 -1.441 0 N-CA-C 108.418 -0.956 . . . . 65.74 108.418 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -72.05 86.71 0.48 Allowed Glycine 0 C--O 1.246 0.866 0 N-CA-C 108.839 -1.704 . . . . 48.66 108.839 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1002 ' ' ARG . . . . . 0.583 ' HD2' ' HB2' ' A' 1034 ' ' ALA . 50.4 ttp180 -118.85 131.38 56.07 Favored 'General case' 0 C--O 1.255 1.382 0 N-CA-C 105.49 -2.041 . . . . 44.56 105.49 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1003 ' ' ILE . . . . . 0.591 HD13 HD22 ' A' 1026 ' ' LEU . 96.9 mt -88.74 130.32 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 103.356 -2.831 . . . . 34.86 103.356 173.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -107.22 123.26 7.2 Favored Glycine 0 C--N 1.316 -0.579 0 N-CA-C 106.398 -2.681 . . . . 30.75 106.398 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.876 HG23 ' HB3' ' A' 1017 ' ' ALA . 39.5 mm -107.56 104.04 51.28 Favored Pre-proline 0 C--O 1.249 1.055 0 N-CA-C 102.832 -3.025 . . . . 32.21 102.832 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -83.01 161.31 15.74 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.973 2.449 . . . . 32.98 113.718 171.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1007 ' ' ARG . . . . . 0.426 ' NH2' ' HG2' ' A' 1009 ' ' ARG . 54.0 ttp85 -69.51 149.57 48.1 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 111.094 -2.776 . . . . 47.98 106.808 161.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1008 ' ' GLU . . . . . 0.477 ' HG2' ' HG2' ' A' 1013 ' ' GLU 0.297 13.9 tp10 -83.17 118.65 23.74 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 116.057 -2.257 . . . . 34.7 109.392 170.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 1009 ' ' ARG . . . . . 0.763 ' NH1' ' HG2' ' A' 1079 ' ' GLU . 14.5 mtp-105 -95.19 -3.91 46.89 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 109.635 -3.439 . . . . 53.37 112.371 -173.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 65.1 tp -65.24 132.61 49.53 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 105.53 -2.026 . . . . 45.07 105.53 167.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1011 ' ' THR . . . . . . . . . . . . . 5.2 m -55.41 123.01 12.5 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 125.525 1.53 . . . . 40.36 112.179 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 66.9 m-80 58.41 28.92 17.5 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 118.259 2.689 . . . . 40.61 118.259 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1013 ' ' GLU . . . . . 0.477 ' HG2' ' HG2' ' A' 1008 ' ' GLU . 8.7 tp10 -89.7 147.08 24.07 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.441 -1.688 . . . . 33.76 106.441 167.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1014 ' ' THR . . . . . 0.512 HG22 ' HB3' ' A' 1320 ' ' PRO . 1.9 m -110.19 -4.54 15.7 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 113.574 0.954 . . . . 27.89 113.574 -170.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1015 ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -83.18 163.37 20.84 Favored 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 120.251 -1.53 . . . . 29.02 114.746 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1016 ' ' VAL . . . . . . . . . . . . . 12.5 p -121.49 162.06 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 103.782 -2.673 . . . . 28.13 103.782 159.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1017 ' ' ALA . . . . . 0.876 ' HB3' HG23 ' A' 1005 ' ' ILE . . . -61.09 -42.45 98.54 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 115.962 1.838 . . . . 26.87 115.962 -178.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -145.45 142.48 29.31 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 122.832 1.301 . . . . 26.77 110.255 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1019 ' ' THR . . . . . . . . . . . . . 8.2 p -84.77 161.19 54.09 Favored Pre-proline 0 N--CA 1.438 -1.071 0 O-C-N 118.877 -2.39 . . . . 27.02 108.468 171.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1020 ' ' PRO . . . . . 0.451 ' HB3' ' HB2' ' A' 1053 ' ' ALA . 0.0 OUTLIER -40.9 -45.31 4.97 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 123.706 2.937 . . . . 30.57 117.009 175.03 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -57.54 -41.05 80.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 123.753 1.739 . . . . 47.81 113.213 177.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1022 ' ' THR . . . . . 0.444 HG21 ' O ' ' A' 1325 ' ' GLN . 1.1 p -77.73 -32.5 52.85 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 114.191 1.182 . . . . 30.77 114.191 175.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1023 ' ' VAL . . . . . 0.584 ' HA ' HD12 ' A' 1026 ' ' LEU . 80.1 t -54.68 -44.96 72.44 Favored 'Isoleucine or valine' 0 C--N 1.345 0.385 0 O-C-N 121.257 -0.902 . . . . 33.59 110.815 170.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -48.62 -46.81 40.14 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.268 1.027 . . . . 53.29 111.184 172.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1025 ' ' GLN . . . . . 0.401 ' HB3' HG11 ' A' 1332 ' ' VAL . 40.6 mt-30 -64.66 -36.4 84.14 Favored 'General case' 0 N--CA 1.436 -1.144 0 O-C-N 123.563 0.54 . . . . 46.92 110.936 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1026 ' ' LEU . . . . . 0.591 HD22 HD13 ' A' 1003 ' ' ILE . 17.4 mt -66.15 -35.38 80.32 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 117.942 -1.027 . . . . 37.17 112.591 171.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.81 -43.55 98.03 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.75 1.159 . . . . 44.44 111.575 173.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 22.9 mmmt -57.7 -36.7 72.34 Favored 'General case' 0 C--O 1.217 -0.648 0 C-N-CA 123.671 0.788 . . . . 52.58 111.674 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1029 ' ' LEU . . . . . 0.547 HD12 ' HA ' ' A' 1026 ' ' LEU . 90.4 mt -58.48 -11.29 2.77 Favored 'General case' 0 C--O 1.249 1.03 0 N-CA-C 115.721 1.749 . . . . 45.69 115.721 173.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 88.21 22.91 39.41 Favored Glycine 0 CA--C 1.506 -0.516 0 O-C-N 118.115 -2.866 . . . . 42.09 112.345 170.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -113.76 162.47 16.26 Favored 'General case' 0 C--O 1.254 1.326 0 N-CA-C 105.905 -1.887 . . . . 40.72 105.905 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1032 ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -80.2 139.59 36.68 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 119.933 -1.73 . . . . 37.77 106.704 173.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1033 ' ' VAL . . . . . . . . . . . . . 11.0 t -121.54 127.18 75.57 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 O-C-N 117.803 -3.061 . . . . 33.54 108.187 -176.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1034 ' ' ALA . . . . . 0.583 ' HB2' ' HD2' ' A' 1002 ' ' ARG . . . -125.75 135.99 52.66 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 106.285 -1.746 . . . . 31.68 106.285 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1035 ' ' VAL . . . . . 0.489 HG22 ' HB ' ' A' 1005 ' ' ILE . 47.1 t -121.21 145.91 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 104.636 -2.357 . . . . 31.52 104.636 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1036 ' ' GLU . . . . . 0.696 ' HB3' ' HB2' ' A' 1039 ' ' ALA . 41.4 tt0 -58.89 154.36 15.32 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 119.52 -0.276 . . . . 41.04 111.584 173.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1037 ' ' SER . . . . . 0.465 ' OG ' ' HA ' ' A' 1059 ' ' GLU . 4.7 m -47.27 96.09 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 113.619 0.97 . . . . 31.83 113.619 173.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 61.25 38.87 96.37 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 114.674 -1.148 . . . . 29.36 112.669 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1039 ' ' ALA . . . . . 0.696 ' HB2' ' HB3' ' A' 1036 ' ' GLU . . . -52.43 -26.35 12.46 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 118.023 2.601 . . . . 27.78 118.023 -174.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1040 ' ' GLY . . . . . 0.461 ' H ' ' HE2' ' A' 1050 ' ' PHE . . . -91.69 13.0 67.85 Favored Glycine 0 N--CA 1.43 -1.731 0 CA-C-O 116.237 -2.424 . . . . 28.91 113.02 -175.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -62.67 -26.95 68.91 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 123.319 3.56 . . . . 51.18 113.482 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1042 ' ' LEU . . . . . . . . . . . . . 96.0 mt -54.94 -44.22 74.12 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 122.003 0.906 . . . . 29.91 110.915 167.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1043 ' ' ALA . . . . . 0.585 ' HA ' ' HB2' ' A' 1320 ' ' PRO . . . -104.1 35.84 2.55 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 114.303 -1.317 . . . . 28.54 109.491 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1044 ' ' SER . . . . . . . . . . . . . 3.0 m 65.8 0.36 1.5 Allowed 'General case' 0 C--O 1.239 0.548 0 N-CA-C 121.51 3.893 . . . . 33.06 121.51 172.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1045 ' ' PHE . . . . . 0.565 ' HD2' ' HB1' ' A' 1049 ' ' ALA . 86.3 m-85 -106.51 118.72 37.38 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 120.952 1.706 . . . . 30.29 114.15 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.9 -176.43 6.31 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 115.399 1.629 . . . . 48.62 115.399 178.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -43.55 -67.39 0.28 Allowed 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 125.642 1.838 . . . . 36.74 111.829 170.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 13.3 pttm -64.7 -24.15 67.48 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.347 0.976 . . . . 43.73 111.786 -172.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1049 ' ' ALA . . . . . 0.565 ' HB1' ' HD2' ' A' 1045 ' ' PHE . . . -63.48 -45.74 89.4 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.831 -1.174 . . . . 32.81 107.831 170.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1050 ' ' PHE . . . . . 0.461 ' HE2' ' H ' ' A' 1040 ' ' GLY . 87.3 m-85 -70.95 -23.03 62.15 Favored 'General case' 0 C--O 1.211 -0.931 0 O-C-N 120.275 -1.516 . . . . 31.86 110.847 173.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 78.5 t -69.39 -27.95 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 O-C-N 118.495 -2.628 . . . . 33.22 109.543 170.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -62.16 -45.63 92.55 Favored 'General case' 0 CA--C 1.509 -0.622 0 O-C-N 119.461 -2.024 . . . . 50.83 110.401 174.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1053 ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' 1020 ' ' PRO . . . -65.38 -38.07 88.9 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 115.86 -0.609 . . . . 33.12 111.705 172.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 99.16 69.21 0.91 Allowed Glycine 0 C--O 1.245 0.832 0 N-CA-C 105.485 -3.046 . . . . 35.83 105.485 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1055 ' ' ALA . . . . . 0.539 ' HB2' HG11 ' A' 1023 ' ' VAL . . . -119.7 138.03 53.55 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 113.662 -1.269 . . . . 34.82 108.059 176.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -66.13 124.63 23.14 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.474 -1.676 . . . . 49.05 106.474 171.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1057 ' ' ILE . . . . . 0.446 HG23 ' HA ' ' A' 1037 ' ' SER . 30.4 mm -90.23 98.77 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.25 0 O-C-N 117.699 -3.126 . . . . 38.53 107.792 177.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1058 ' ' VAL . . . . . 0.401 HG21 ' HA ' ' A' 1063 ' ' VAL . 2.5 m -79.81 123.23 36.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 125.44 2.543 . . . . 42.11 106.155 176.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1059 ' ' GLU . . . . . 0.465 ' HA ' ' OG ' ' A' 1037 ' ' SER . 6.4 mm-40 -76.7 82.91 3.33 Favored 'General case' 0 C--N 1.31 -1.126 1 CA-C-N 107.367 -4.469 . . . . 58.0 110.01 -174.41 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 75.51 -133.0 13.88 Favored Glycine 0 C--O 1.223 -0.589 0 N-CA-C 109.784 -1.326 . . . . 52.12 109.784 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 3.3 t30 -56.49 -25.66 51.95 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 117.427 2.38 . . . . 54.75 117.427 -161.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1062 ' ' SER . . . . . . . . . . . . . 70.5 m -55.66 -15.66 3.28 Favored 'General case' 0 C--O 1.25 1.113 0 O-C-N 120.012 -1.68 . . . . 50.34 113.125 174.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1063 ' ' VAL . . . . . 0.401 ' HA ' HG21 ' A' 1058 ' ' VAL . 14.8 p -57.17 -37.22 54.71 Favored 'Isoleucine or valine' 0 C--N 1.37 1.496 0 O-C-N 120.609 -1.307 . . . . 41.46 113.536 170.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1064 ' ' TRP . . . . . . . . . . . . . 97.9 m95 -70.2 -24.38 63.11 Favored 'General case' 0 N--CA 1.435 -1.216 0 O-C-N 125.525 1.766 . . . . 39.32 114.222 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -87.95 72.04 9.34 Favored 'General case' 0 C--O 1.246 0.883 0 N-CA-C 107.83 -1.174 . . . . 55.38 107.83 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1066 ' ' SER . . . . . . . . . . . . . 11.1 m -151.74 144.61 24.42 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-O 118.552 -0.737 . . . . 41.87 109.376 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.4 -12.28 60.22 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 119.03 2.974 . . . . 53.2 119.03 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1068 ' ' ILE . . . . . 0.43 ' HB ' ' HA ' ' A' 1003 ' ' ILE . 2.4 mp -127.06 124.66 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 104.241 -2.503 . . . . 41.9 104.241 167.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1069 ' ' ILE . . . . . 0.596 HG12 HG21 ' A' 1087 ' ' THR . 46.6 mm -119.08 111.14 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.069 0 N-CA-C 104.337 -2.468 . . . . 38.73 104.337 173.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1070 ' ' LEU . . . . . 0.668 HD13 HD13 ' A' 1331 ' ' LEU . 94.5 mt -90.22 85.17 6.17 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 105.665 -1.976 . . . . 32.44 105.665 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1071 ' ' LYS . . . . . 0.562 ' HE3' ' O ' ' A' 1073 ' ' ASN . 3.8 mmmt -81.79 145.83 30.24 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 107.049 -1.463 . . . . 34.65 107.049 -177.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1072 ' ' VAL . . . . . . . . . . . . . 2.6 t -86.89 -25.9 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-O 124.107 1.908 . . . . 31.32 111.871 -165.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1073 ' ' ASN . . . . . 0.562 ' O ' ' HE3' ' A' 1071 ' ' LYS . 61.9 m-20 -140.86 -173.82 3.82 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 105.694 -1.965 . . . . 33.94 105.694 168.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -52.0 142.7 25.72 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 116.734 2.124 . . . . 38.04 116.734 172.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1075 ' ' PRO . . . . . 0.539 ' HG2' HD21 ' A' 1089 ' ' LEU . 46.4 Cg_exo -63.77 119.21 6.18 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.652 2.902 . . . . 42.68 112.454 162.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 50.8 mt -71.31 158.45 36.32 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 113.036 -1.893 . . . . 46.74 107.098 161.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -57.88 -32.11 67.38 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 119.953 -1.717 . . . . 58.61 114.934 -172.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 14.2 t70 -44.85 -53.38 7.57 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 123.067 1.413 . . . . 59.2 111.858 164.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1079 ' ' GLU . . . . . 0.763 ' HG2' ' NH1' ' A' 1009 ' ' ARG . 18.2 mt-10 -78.2 -34.81 49.21 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.96 -1.018 . . . . 50.63 109.859 -174.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1080 ' ' ILE . . . . . . . . . . . . . 66.3 mt -49.13 -48.05 17.5 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 CA-C-O 123.169 1.461 . . . . 51.48 111.175 170.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -63.47 -38.65 91.94 Favored 'General case' 0 C--O 1.25 1.106 0 CA-C-N 113.73 -1.577 . . . . 50.28 110.332 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 87.2 mt -71.52 -24.64 61.99 Favored 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 120.922 -1.112 . . . . 50.21 113.765 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1083 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.27 161.36 29.41 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 120.211 1.369 . . . . 49.06 109.467 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -123.88 140.28 34.21 Favored Pre-proline 0 C--O 1.248 0.991 0 N-CA-C 105.399 -2.074 . . . . 51.08 105.399 -176.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1085 ' ' PRO . . . . . 0.447 ' HB3' ' HB3' ' A' 1109 ' ' ASN . 64.5 Cg_exo -56.08 155.16 24.83 Favored 'Trans proline' 0 N--CA 1.446 -1.277 1 C-N-CA 125.382 4.055 . . . . 49.73 113.64 175.437 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 81.58 -10.46 50.64 Favored Glycine 0 C--N 1.314 -0.65 0 O-C-N 121.158 -0.964 . . . . 47.71 112.296 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1087 ' ' THR . . . . . 0.596 HG21 HG12 ' A' 1069 ' ' ILE . 92.9 m -82.52 137.91 34.46 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 119.411 1.605 . . . . 45.47 110.187 -171.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1088 ' ' THR . . . . . 0.451 ' HA ' ' HB ' ' A' 1111 ' ' THR . 2.7 m -75.94 87.53 2.9 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 107.311 -1.366 . . . . 42.04 107.311 174.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1089 ' ' LEU . . . . . 0.539 HD21 ' HG2' ' A' 1075 ' ' PRO . 56.4 tp -82.62 97.08 8.32 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 122.733 1.254 . . . . 38.06 108.663 177.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1090 ' ' VAL . . . . . 0.564 HG22 ' HB2' ' A' 1113 ' ' MET . 96.7 t -97.52 116.3 39.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 102.679 -3.082 . . . . 37.4 102.679 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1091 ' ' SER . . . . . . . . . . . . . 1.9 m -153.94 160.98 42.32 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 120.325 1.42 . . . . 36.16 113.179 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1092 ' ' PHE . . . . . 0.434 ' HB2' ' HA ' ' A' 1073 ' ' ASN . 0.8 OUTLIER -58.79 97.51 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.757 0 O-C-N 119.434 -2.041 . . . . 38.94 111.305 154.281 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 1093 ' ' ILE . . . . . 0.42 HG13 ' CG1' ' A' 1112 ' ' VAL . 25.2 mm -96.47 -36.93 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 C-N-CA 123.115 0.566 . . . . 42.17 109.98 -175.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1094 ' ' TRP . . . . . 0.601 ' HB2' HD22 ' A' 1098 ' ' ASN . 45.8 m95 58.16 56.6 6.63 Favored Pre-proline 0 C--O 1.256 1.418 0 O-C-N 124.867 1.354 . . . . 46.51 110.98 -172.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -50.15 -39.41 51.58 Favored 'Trans proline' 0 CA--C 1.504 -1.001 0 C-N-CA 124.414 3.409 . . . . 49.76 116.364 -173.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -72.84 -24.59 60.91 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 120.004 1.275 . . . . 52.62 113.247 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -90.32 -11.76 39.76 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 122.279 1.037 . . . . 60.74 110.032 172.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1098 ' ' ASN . . . . . 0.601 HD22 ' HB2' ' A' 1094 ' ' TRP . 36.4 m-80 -133.05 47.85 3.02 Favored Pre-proline 0 N--CA 1.451 -0.398 0 O-C-N 118.211 -2.806 . . . . 58.19 115.456 -174.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -55.31 -31.21 75.89 Favored 'Trans proline' 0 C--O 1.244 0.78 0 C-N-CA 124.664 3.576 . . . . 54.59 112.84 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1100 ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' 1104 ' ' LYS . 29.4 mp0 -61.46 -53.65 53.71 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.692 1.197 . . . . 63.28 109.971 175.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1101 ' ' LEU . . . . . 0.409 ' HB3' ' HB3' ' A' 1098 ' ' ASN . 24.2 tp -56.54 -40.64 75.43 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 124.027 0.931 . . . . 54.75 109.831 174.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1102 ' ' MET . . . . . . . . . . . . . 81.4 mmm -55.16 -50.72 68.58 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.929 1.24 . . . . 52.65 110.087 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -57.87 -39.95 79.02 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 124.96 1.304 . . . . 66.26 109.16 176.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1104 ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' 1100 ' ' GLU . 51.1 mtmt -71.72 -42.62 67.12 Favored 'General case' 0 C--N 1.313 -0.988 0 O-C-N 120.999 -1.063 . . . . 63.73 111.884 -176.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 68.3 mt -76.35 -21.28 56.32 Favored 'General case' 0 C--O 1.268 2.054 0 O-C-N 119.936 -1.728 . . . . 54.68 111.136 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -62.85 -42.54 99.79 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 120.646 -1.284 . . . . 53.64 111.759 167.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -62.47 -44.98 95.08 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 109.878 -0.415 . . . . 67.24 109.878 172.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.45 -2.79 12.07 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 117.055 -3.528 . . . . 65.76 114.347 174.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1109 ' ' ASN . . . . . 0.731 ' HA ' ' HA2' ' A' 1364 ' ' GLY . 2.1 t30 61.1 35.43 18.68 Favored 'General case' 0 C--O 1.247 0.942 0 O-C-N 118.984 -2.323 . . . . 58.71 113.717 169.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1110 ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.95 156.6 3.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 106.78 -1.563 . . . . 46.63 106.78 -171.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1111 ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' 1362 ' ' ARG . 53.9 m -81.62 97.32 7.81 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 105.878 -1.897 . . . . 44.13 105.878 165.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1112 ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' 1361 ' ' ILE . 42.7 t -95.55 111.69 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-O 123.584 1.659 . . . . 40.44 109.11 -177.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1113 ' ' MET . . . . . 0.564 ' HB2' HG22 ' A' 1090 ' ' VAL . 47.7 mtp -106.21 107.33 18.28 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 112.913 -1.948 . . . . 50.76 109.487 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1114 ' ' ALA . . . . . 0.46 ' HB3' ' HB2' ' A' 1117 ' ' SER . . . -87.64 105.44 17.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 126.338 2.97 . . . . 35.64 111.901 -177.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1115 ' ' MET . . . . . . . . . . . . . 74.2 mmm -60.19 -28.89 68.32 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 110.741 -2.936 . . . . 38.74 117.988 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -66.21 -44.17 84.65 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 113.293 -1.776 . . . . 40.14 109.737 167.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1117 ' ' SER . . . . . 0.46 ' HB2' ' HB3' ' A' 1114 ' ' ALA . 74.5 m -80.38 48.4 1.02 Allowed 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 118.509 2.781 . . . . 44.79 118.509 -175.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1118 ' ' VAL . . . . . . . . . . . . . 37.4 t -89.8 134.9 31.2 Favored Pre-proline 0 C--O 1.25 1.124 0 N-CA-C 107.112 -1.44 . . . . 43.75 107.112 173.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1119 ' ' PRO . . . . . 0.551 ' HG2' ' HA ' ' A' 1354 ' ' VAL . 0.5 OUTLIER -50.22 122.96 10.18 Favored 'Trans proline' 0 N--CA 1.459 -0.546 1 C-N-CA 125.688 4.259 . . . . 48.93 112.119 170.376 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 42.3 mmm-85 -75.31 61.1 1.17 Allowed 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 123.812 0.845 . . . . 62.9 111.905 -169.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 15.6 pt -116.78 167.65 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 O-C-N 118.042 -2.911 . . . . 57.72 110.733 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1122 ' ' SER . . . . . . . . . . . . . 4.2 p -39.0 -65.86 0.33 Allowed 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 117.592 2.442 . . . . 57.26 117.592 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -57.28 -33.29 67.48 Favored 'General case' 0 C--N 1.36 1.06 0 O-C-N 121.012 -1.055 . . . . 62.9 113.381 -176.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -82.17 -15.81 51.98 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-N 113.366 -1.743 . . . . 49.83 109.682 -169.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -56.02 -30.49 61.94 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 122.826 2.557 . . . . 52.37 114.159 -172.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1126 ' ' SER . . . . . . . . . . . . . 16.9 p -66.85 -31.73 72.54 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 122.715 1.245 . . . . 42.43 113.169 172.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1127 ' ' LEU . . . . . 0.411 HD21 HD12 ' A' 1337 ' ' LEU . 3.6 mp -83.65 -25.67 30.55 Favored 'General case' 0 C--N 1.346 0.436 0 O-C-N 121.197 -0.939 . . . . 43.74 111.971 172.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 62.0 t0 -69.84 89.32 0.57 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 123.736 1.731 . . . . 43.21 113.209 -172.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -67.92 -31.73 71.69 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 112.588 -2.096 . . . . 35.74 112.94 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 44.5 tp -54.18 -58.19 8.29 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 124.854 1.346 . . . . 38.09 108.702 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1131 ' ' SER . . . . . . . . . . . . . 7.0 m -69.77 -37.17 76.29 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 113.63 -1.623 . . . . 36.91 111.632 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1132 ' ' SER . . . . . . . . . . . . . 61.0 m -65.16 -38.27 90.04 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 123.048 2.658 . . . . 35.79 110.528 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1133 ' ' MET . . . . . . . . . . . . . 34.3 mmt -77.46 -40.16 44.11 Favored 'General case' 0 CA--C 1.489 -1.384 0 O-C-N 119.586 -1.946 . . . . 30.81 109.748 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1134 ' ' ALA . . . . . 0.604 ' HB1' ' HB2' ' A' 1176 ' ' ALA . . . -52.33 -43.16 64.41 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.094 0.557 . . . . 28.88 111.734 168.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1135 ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -63.93 -51.43 64.46 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.232 1.015 . . . . 40.76 109.796 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1136 ' ' ILE . . . . . 0.508 HD11 HD12 ' A' 1326 ' ' LEU . 94.0 mt -55.07 -42.62 65.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 114.838 -1.074 . . . . 31.54 113.343 171.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -66.54 -31.7 72.58 Favored 'General case' 0 C--O 1.219 -0.544 0 C-N-CA 124.709 1.203 . . . . 29.87 112.645 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -66.08 -50.5 51.41 Favored Glycine 0 C--O 1.216 -1.019 0 O-C-N 120.048 -1.657 . . . . 28.73 110.408 176.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 19.6 t80 -55.58 -47.11 76.97 Favored 'General case' 0 C--O 1.248 0.98 0 C-N-CA 124.187 0.995 . . . . 30.39 109.377 172.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1140 ' ' ARG . . . . . 0.476 ' HE ' ' HG2' ' A' 1144 ' ' GLU . 5.4 tpt180 -68.66 -24.45 64.53 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 114.171 1.174 . . . . 26.09 114.171 177.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1141 ' ' ALA . . . . . 0.466 ' HB2' HD21 ' A' 1284 ' ' LEU . . . -71.32 -40.35 70.84 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 121.572 1.987 . . . . 27.1 106.817 176.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 19.7 mm -63.1 -41.03 91.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.399 -0.593 . . . . 28.48 109.399 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 54.9 t -54.97 -64.85 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.607 0 C-N-CA 123.24 0.616 . . . . 23.07 111.534 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1144 ' ' GLU . . . . . 0.476 ' HG2' ' HE ' ' A' 1140 ' ' ARG . 6.1 mm-40 -68.36 -19.64 64.65 Favored 'General case' 0 C--O 1.244 0.785 0 O-C-N 120.336 -1.477 . . . . 33.4 113.253 -175.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1145 ' ' ALA . . . . . 0.735 ' HA ' HG11 ' A' 1280 ' ' VAL . . . -62.65 -56.96 12.98 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 107.154 -1.425 . . . . 24.22 107.154 164.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -59.75 -20.48 56.88 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 117.477 -3.265 . . . . 24.89 112.655 175.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 29.1 t-80 -66.73 -38.43 86.65 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 117.901 -3.0 . . . . 26.73 111.06 174.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1148 ' ' GLU . . . . . 0.753 ' HB3' ' HD2' ' A' 1308 ' ' LYS . 59.2 mm-40 -109.21 0.07 19.5 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 115.533 1.679 . . . . 39.96 115.533 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1149 ' ' PHE . . . . . 0.476 ' CZ ' ' HB3' ' A' 1250 ' ' ASP . 1.3 t80 -68.19 148.29 51.07 Favored 'General case' 0 C--O 1.246 0.888 0 O-C-N 120.988 -1.07 . . . . 25.87 108.709 -174.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1150 ' ' GLY . . . . . 0.635 ' HA2' ' HG2' ' B' 1320 ' ' PRO . . . -72.81 -40.37 52.72 Favored Glycine 0 N--CA 1.438 -1.197 0 C-N-CA 118.633 -1.746 . . . . 19.28 112.044 173.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1151 ' ' ARG . . . . . 0.803 ' HA ' ' HB2' ' B' 1322 ' ' GLN . 23.9 mtm-85 -108.21 -177.91 3.46 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.236 -1.155 . . . . 39.9 113.845 -166.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1152 ' ' PHE . . . . . 0.609 ' HB2' HG11 ' A' 1163 ' ' VAL . 2.1 m-30 -81.96 154.25 25.84 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 116.562 -2.055 . . . . 29.44 109.887 168.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1153 ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -70.47 -57.43 4.79 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 124.244 1.973 . . . . 32.6 107.177 156.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1154 ' ' THR . . . . . . . . . . . . . 3.5 m -60.16 92.24 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 110.562 -3.017 . . . . 34.64 111.425 -175.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -60.35 128.47 45.79 Favored Glycine 0 C--N 1.344 1.01 0 O-C-N 120.3 -1.5 . . . . 37.14 112.611 175.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1156 ' ' GLN . . . . . 0.449 ' H ' ' HB ' ' A' 1163 ' ' VAL . 3.7 pt20 -159.49 137.57 10.32 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 113.896 1.072 . . . . 40.57 113.896 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1157 ' ' ILE . . . . . 0.533 ' HB ' ' HB3' ' C' ' 95' ' ' GLU . 5.2 tp -80.36 125.15 39.02 Favored 'Isoleucine or valine' 0 C--O 1.257 1.491 0 N-CA-C 102.891 -3.003 . . . . 44.61 102.891 169.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1158 ' ' THR . . . . . 0.433 ' O ' ' HG3' ' C' ' 70' ' ' PRO . 56.0 p -98.44 -173.3 2.52 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 113.394 -1.73 . . . . 40.7 106.607 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -72.02 -19.0 61.92 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 121.48 1.945 . . . . 40.25 109.562 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1160 ' ' ALA . . . . . 0.448 ' HB2' ' ND2' ' B' 1330 ' ' ASN . . . -103.91 -47.81 4.09 Favored 'General case' 0 C--O 1.249 1.038 0 CA-C-N 119.972 1.26 . . . . 38.47 113.888 172.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . -148.54 162.01 28.76 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 117.723 -2.179 . . . . 37.61 114.693 -159.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 26.9 tttt -79.95 124.01 28.31 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 123.188 1.47 . . . . 48.9 113.318 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1163 ' ' VAL . . . . . 0.609 HG11 ' HB2' ' A' 1152 ' ' PHE . 79.4 t -95.29 117.0 66.81 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 105.962 -1.866 . . . . 36.52 105.962 165.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1164 ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -71.27 140.62 37.51 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.636 2.224 . . . . 35.08 112.753 172.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1165 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -59.0 125.63 18.72 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 CA-C-N 122.258 1.842 . . . . 35.33 112.861 169.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -63.85 140.57 58.88 Favored 'General case' 0 C--O 1.244 0.814 0 N-CA-C 114.773 1.398 . . . . 34.69 114.773 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1167 ' ' LYS . . . . . . . . . . . . . 79.4 mttt -88.21 113.13 23.52 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 119.845 1.202 . . . . 45.36 113.061 170.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 64.9 t -101.99 115.5 43.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.063 -1.088 . . . . 31.71 108.063 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1169 ' ' MET . . . . . 0.449 ' O ' ' HA ' ' A' 1252 ' ' ILE . 12.4 ttt -100.03 113.75 26.57 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 121.75 2.068 . . . . 42.28 109.24 170.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1170 ' ' VAL . . . . . 0.409 HG21 HG13 ' A' 1181 ' ' ILE . 68.9 t -82.92 128.69 38.48 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 N-CA-C 105.919 -1.882 . . . . 30.51 105.919 169.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 42.3 mt -119.55 136.46 56.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 O-C-N 119.63 -1.919 . . . . 31.87 106.068 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1172 ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' 1256 ' ' ALA . . . 74.91 58.26 4.12 Favored Glycine 0 CA--C 1.539 1.587 0 N-CA-C 110.043 -1.223 . . . . 34.54 110.043 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1173 ' ' ALA . . . . . . . . . . . . . . . -72.28 85.1 1.07 Allowed 'General case' 0 C--O 1.259 1.555 0 CA-C-O 122.487 1.137 . . . . 32.51 113.867 -166.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -76.16 -175.11 38.87 Favored Glycine 0 CA--C 1.554 2.498 0 N-CA-C 108.325 -1.91 . . . . 29.9 108.325 163.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1175 ' ' VAL . . . . . . . . . . . . . 79.2 t -59.42 -37.12 68.04 Favored 'Isoleucine or valine' 0 C--O 1.25 1.125 0 CA-C-N 118.49 1.145 . . . . 33.11 110.621 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1176 ' ' ALA . . . . . 0.604 ' HB2' ' HB1' ' A' 1134 ' ' ALA . . . -52.52 -42.42 64.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.322 -1.308 . . . . 28.1 114.333 169.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -64.94 -40.13 96.98 Favored Glycine 0 CA--C 1.545 1.91 0 N-CA-C 110.014 -1.234 . . . . 28.54 110.014 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1178 ' ' LEU . . . . . 0.711 HD13 ' HG2' ' A' 1203 ' ' GLN . 69.6 mt -63.31 -48.38 78.3 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.704 -0.85 . . . . 31.22 108.704 178.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -64.44 -34.18 77.59 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 120.259 -1.526 . . . . 28.98 114.937 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -57.95 -40.78 81.36 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 115.82 1.785 . . . . 27.83 115.82 171.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1181 ' ' ILE . . . . . 0.722 ' HA ' HG11 ' A' 1191 ' ' VAL . 96.7 mt -56.96 -49.15 80.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.507 -0.77 . . . . 30.25 111.672 169.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -58.08 -40.63 93.8 Favored Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 111.313 -0.715 . . . . 29.59 111.313 175.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -67.43 -52.43 39.81 Favored 'General case' 0 C--O 1.243 0.728 0 O-C-N 119.51 -2.17 . . . . 30.29 112.906 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -58.6 -40.44 83.25 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-O 122.962 1.363 . . . . 30.47 111.64 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1185 ' ' ASN . . . . . 0.473 ' ND2' ' HA3' ' A' 1208 ' ' GLY . 23.3 t-20 -62.48 -43.51 98.64 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 114.932 -1.031 . . . . 42.41 112.592 177.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1186 ' ' SER . . . . . 0.817 ' HB3' ' HA ' ' B' 1187 ' ' LEU . 43.9 m -58.16 -50.8 72.26 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 123.985 0.914 . . . . 39.38 109.566 172.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 29.5 mt -60.48 -18.76 53.72 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 116.975 2.213 . . . . 36.18 116.975 171.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 97.34 33.33 5.99 Favored Glycine 0 C--N 1.356 1.664 0 CA-C-N 121.876 2.125 . . . . 33.78 112.418 174.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -99.92 155.82 17.47 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 123.249 0.62 . . . . 33.93 112.478 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 34.2 mt -79.26 103.29 6.05 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.462 0 N-CA-C 104.31 -2.478 . . . . 38.74 104.31 175.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1191 ' ' VAL . . . . . 0.722 HG11 ' HA ' ' A' 1181 ' ' ILE . 1.4 t -93.92 148.74 4.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 N-CA-C 106.556 -1.646 . . . . 33.09 106.556 -172.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1192 ' ' ARG . . . . . 0.59 ' HG2' ' HB2' ' A' 1210 ' ' GLU . 90.2 mtt180 -141.76 158.76 43.41 Favored 'General case' 0 C--O 1.252 1.2 0 C-N-CA 124.647 1.179 . . . . 38.92 108.39 176.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1193 ' ' ALA . . . . . 0.562 ' HB2' HD11 ' A' 1181 ' ' ILE . . . -152.24 148.3 27.41 Favored 'General case' 0 C--O 1.25 1.106 0 N-CA-C 114.405 1.261 . . . . 35.32 114.405 176.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 42.3 t80 -138.23 147.64 43.94 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 113.705 -1.589 . . . . 39.35 107.648 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 10.5 t70 -170.78 167.51 7.61 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 103.109 -2.923 . . . . 40.46 103.109 170.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1196 ' ' THR . . . . . . . . . . . . . 4.0 m -69.92 -43.16 72.25 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 125.015 1.326 . . . . 45.94 110.068 175.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1197 ' ' ARG . . . . . 0.441 ' HA ' ' HD2' ' A' 1198 ' ' PRO . 39.6 mtm180 -79.49 112.74 31.21 Favored Pre-proline 0 C--O 1.222 -0.357 0 N-CA-C 114.951 1.463 . . . . 56.02 114.951 -165.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1198 ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' 1197 ' ' ARG . 57.4 Cg_endo -58.39 -20.88 50.58 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.722 2.281 . . . . 51.27 117.666 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -55.68 -25.53 40.21 Favored 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 117.01 2.226 . . . . 59.1 117.01 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 27.7 m -87.55 -14.14 10.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 114.729 1.381 . . . . 51.06 114.729 -175.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 90.8 mttt -62.98 -38.79 92.56 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.123 -0.944 . . . . 57.38 113.443 -169.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -56.38 -48.68 76.36 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 124.638 1.211 . . . . 62.41 110.707 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1203 ' ' GLN . . . . . 0.711 ' HG2' HD13 ' A' 1178 ' ' LEU . 0.0 OUTLIER -65.35 -44.34 87.99 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 124.918 1.386 . . . . 57.78 110.579 175.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 1204 ' ' VAL . . . . . 0.457 HG11 ' HD2' ' A' 1211 ' ' PHE . 54.1 t -55.49 -47.02 78.99 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 CA-C-N 121.083 1.765 . . . . 46.38 111.323 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -66.11 -36.09 82.25 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-N 115.008 -0.997 . . . . 50.7 110.037 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1206 ' ' SER . . . . . . . . . . . . . 59.8 m -71.2 -51.04 26.96 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 112.724 0.639 . . . . 49.98 112.724 -176.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1207 ' ' MET . . . . . . . . . . . . . 45.7 mtp -68.35 -25.78 65.26 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 123.499 0.499 . . . . 52.99 111.008 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1208 ' ' GLY . . . . . 0.473 ' HA3' ' ND2' ' A' 1185 ' ' ASN . . . 131.3 68.14 0.1 OUTLIER Glycine 0 N--CA 1.475 1.289 0 O-C-N 120.018 -1.677 . . . . 47.66 113.27 156.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1209 ' ' ALA . . . . . 0.474 ' HB2' HG23 ' A' 1181 ' ' ILE . . . -155.46 161.88 40.86 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 122.683 1.23 . . . . 44.77 113.173 -174.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1210 ' ' GLU . . . . . 0.59 ' HB2' ' HG2' ' A' 1192 ' ' ARG . 42.0 mt-10 -89.97 113.86 25.6 Favored 'General case' 0 C--N 1.318 -0.787 0 O-C-N 118.961 -2.337 . . . . 47.64 108.313 173.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1211 ' ' PHE . . . . . 0.457 ' HD2' HG11 ' A' 1204 ' ' VAL . 21.7 t80 -84.3 115.32 22.42 Favored 'General case' 0 N--CA 1.432 -1.375 0 C-N-CA 117.885 -1.526 . . . . 45.66 107.229 173.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 37.1 mt -71.01 116.42 11.28 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 125.955 1.702 . . . . 46.06 108.682 -176.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -69.44 144.72 53.22 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 118.444 -1.302 . . . . 60.22 112.84 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1214 ' ' LEU . . . . . 0.704 ' HG ' ' HB2' ' A' 1216 ' ' PHE . 66.6 tp -62.55 95.39 0.07 Allowed 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 113.589 -1.641 . . . . 57.25 109.72 167.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 16.3 t70 -69.45 90.67 0.54 Allowed 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 105.403 -2.073 . . . . 64.43 105.403 172.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1216 ' ' PHE . . . . . 0.704 ' HB2' ' HG ' ' A' 1214 ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.303 -1.428 0 O-C-N 126.325 2.265 . . . . 66.9 106.898 -172.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.429 -1.482 0 CA-C-O 122.174 0.988 . . . . 39.09 108.962 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -59.81 -38.66 94.31 Favored Glycine 0 CA--C 1.543 1.796 0 O-C-N 120.529 -1.357 . . . . 39.32 114.227 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 68.0 t80 -65.88 -46.35 78.72 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 117.336 0.568 . . . . 39.3 111.973 170.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -59.53 -49.46 77.68 Favored 'General case' 0 C--N 1.349 0.556 0 O-C-N 121.96 -0.463 . . . . 36.3 109.995 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -50.99 -56.98 9.81 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-O 117.432 -1.271 . . . . 37.38 111.973 168.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -51.91 -30.42 12.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 118.261 2.689 . . . . 39.11 118.261 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1230 ' ' MET . . . . . . . . . . . . . 38.7 mmt -79.21 -28.86 42.59 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 113.079 0.77 . . . . 49.59 113.079 174.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1231 ' ' SER . . . . . 0.509 ' O ' ' HB3' ' A' 1234 ' ' PHE . 23.1 m -58.21 140.43 53.09 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 117.142 2.275 . . . . 43.68 117.142 -169.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -58.96 -49.79 76.51 Favored 'General case' 0 C--O 1.214 -0.78 0 N-CA-C 116.251 1.945 . . . . 55.57 116.251 175.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -61.44 -25.44 67.22 Favored 'General case' 0 C--O 1.206 -1.19 0 N-CA-C 112.487 0.551 . . . . 44.94 112.487 174.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1234 ' ' PHE . . . . . 0.509 ' HB3' ' O ' ' A' 1231 ' ' SER . 70.7 t80 -69.22 -49.59 55.03 Favored 'General case' 0 N--CA 1.428 -1.569 0 O-C-N 124.299 0.999 . . . . 42.04 110.031 175.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 63.1 mt -62.05 -33.86 60.47 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 O-C-N 123.437 0.46 . . . . 46.28 111.982 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1236 ' ' LYS . . . . . 0.565 ' O ' ' HG3' ' A' 1240 ' ' GLU . 48.3 tttm -57.5 -53.12 61.72 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 118.085 -0.96 . . . . 47.87 111.049 164.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -60.43 -40.4 90.91 Favored 'General case' 0 C--O 1.259 1.558 0 N-CA-C 113.729 1.011 . . . . 41.61 113.729 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -57.13 -52.39 65.5 Favored 'General case' 0 C--O 1.254 1.321 0 O-C-N 121.557 -0.714 . . . . 50.65 109.567 173.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1239 ' ' MET . . . . . 0.541 ' SD ' ' HD2' ' A' 1242 ' ' PHE . 92.9 mmm -62.43 -25.14 67.81 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 113.586 0.958 . . . . 48.87 113.586 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1240 ' ' GLU . . . . . 0.565 ' HG3' ' O ' ' A' 1236 ' ' LYS . 34.7 mt-10 -71.45 -42.73 67.82 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 119.952 1.251 . . . . 54.8 111.596 168.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 2.3 mm? -59.0 -45.18 91.3 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 119.495 -2.003 . . . . 43.21 108.098 172.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1242 ' ' PHE . . . . . 0.541 ' HD2' ' SD ' ' A' 1239 ' ' MET . 12.3 m-30 -62.49 -46.17 89.7 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 125.478 1.511 . . . . 38.66 111.486 178.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -61.49 -39.83 92.39 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 123.589 1.662 . . . . 37.92 111.588 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1244 ' ' ALA . . . . . 0.442 ' HA ' ' NZ ' ' A' 1247 ' ' LYS . . . -65.11 -53.31 47.28 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 120.353 -1.467 . . . . 37.28 111.464 177.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -66.46 -31.16 71.73 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 120.825 -1.172 . . . . 43.07 112.662 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -53.37 -34.36 57.3 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 123.288 0.635 . . . . 38.3 112.099 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1247 ' ' LYS . . . . . 0.442 ' NZ ' ' HA ' ' A' 1244 ' ' ALA . 30.3 mtmm -67.42 -29.0 68.37 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.139 -0.937 . . . . 47.6 113.054 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -114.9 -37.1 4.26 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 114.195 1.183 . . . . 45.42 114.195 -168.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1249 ' ' VAL . . . . . . . . . . . . . 20.7 m -68.94 166.9 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.863 0 CA-C-O 123.624 1.678 . . . . 36.26 114.967 -166.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1250 ' ' ASP . . . . . 0.476 ' HB3' ' CZ ' ' A' 1149 ' ' PHE . 9.7 m-20 -123.68 -43.24 2.15 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 110.935 -2.848 . . . . 33.04 109.439 -172.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1251 ' ' ILE . . . . . 0.592 HD12 ' HB1' ' A' 1145 ' ' ALA . 48.4 mm -123.84 138.28 54.09 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.878 0 O-C-N 118.811 -2.43 . . . . 31.4 105.445 174.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1252 ' ' ILE . . . . . 0.737 ' HB ' HG12 ' A' 1281 ' ' ILE . 19.8 mt -114.44 130.95 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 106.351 -1.722 . . . . 29.42 106.351 162.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 13.4 t -110.22 106.49 20.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 O-C-N 121.14 -0.975 . . . . 30.37 109.222 172.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1254 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.06 108.88 20.0 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 125.022 2.344 . . . . 35.72 110.802 -178.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1255 ' ' THR . . . . . . . . . . . . . 8.5 m -109.5 -27.25 9.54 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 111.441 -2.618 . . . . 36.0 117.437 -158.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1256 ' ' ALA . . . . . 0.434 ' HB2' ' HA3' ' A' 1172 ' ' GLY . . . -70.09 77.78 0.5 Allowed 'General case' 0 C--O 1.246 0.889 0 N-CA-C 115.211 1.56 . . . . 40.93 115.211 -168.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 29.8 tp -90.8 130.27 36.79 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 124.588 1.155 . . . . 47.82 107.944 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 16.7 mm -109.57 138.61 20.64 Favored Pre-proline 0 C--O 1.246 0.91 0 N-CA-C 101.523 -3.51 . . . . 52.7 101.523 176.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -64.9 132.64 33.05 Favored 'Trans proline' 0 N--CA 1.43 -2.222 0 C-N-CA 121.589 1.526 . . . . 54.13 110.539 161.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 90.74 -69.56 2.2 Favored Glycine 0 CA--C 1.507 -0.423 0 N-CA-C 109.419 -1.472 . . . . 54.62 109.419 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 69.3 mttt -71.71 140.22 83.89 Favored Pre-proline 0 C--O 1.251 1.132 0 O-C-N 121.578 -0.954 . . . . 55.74 108.965 -176.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.36 143.95 94.39 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 123.916 3.077 . . . . 51.15 108.96 163.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -59.07 132.44 87.29 Favored Pre-proline 0 N--CA 1.446 -0.67 0 C-N-CA 126.524 1.93 . . . . 46.06 109.784 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -56.82 122.29 11.56 Favored 'Trans proline' 0 N--CA 1.445 -1.328 1 C-N-CA 125.961 4.441 . . . . 41.08 110.275 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1265 ' ' LYS . . . . . 0.596 ' HD3' ' HA ' ' A' 1293 ' ' GLU . 44.3 mttm -79.35 97.78 6.46 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 125.016 2.341 . . . . 47.42 107.721 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 48.9 mt -77.17 -63.9 1.26 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 110.931 -2.849 . . . . 39.22 109.319 -174.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 3.0 mt -87.22 111.71 22.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 CA-C-N 115.284 -0.871 . . . . 42.5 110.551 -166.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1268 ' ' THR . . . . . . . . . . . . . 63.7 m -64.39 141.95 58.59 Favored 'General case' 0 C--N 1.316 -0.85 0 O-C-N 124.728 1.267 . . . . 37.84 111.132 176.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1269 ' ' ARG . . . . . 0.424 ' HG3' ' HB2' ' A' 1293 ' ' GLU . 86.2 mtt180 -49.98 -47.77 52.67 Favored 'General case' 0 C--O 1.214 -0.812 0 N-CA-C 115.655 1.724 . . . . 54.8 115.655 -170.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -41.4 -50.46 3.83 Favored 'General case' 0 C--N 1.345 0.407 0 C-N-CA 126.392 1.877 . . . . 54.36 112.26 172.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1271 ' ' MET . . . . . . . . . . . . . 21.2 ttm -71.15 -25.0 62.37 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 122.661 1.219 . . . . 39.52 114.01 -173.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1272 ' ' VAL . . . . . 0.42 HG12 HG21 ' A' 1303 ' ' THR . 57.2 t -67.89 -41.9 85.27 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 O-C-N 121.003 -1.061 . . . . 38.25 111.273 174.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -59.1 -38.29 79.19 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 122.902 1.335 . . . . 40.77 111.95 172.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1274 ' ' SER . . . . . . . . . . . . . 11.8 m -67.64 -7.43 26.57 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 115.925 1.824 . . . . 36.58 115.925 174.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1275 ' ' MET . . . . . 0.49 ' HB3' HG21 ' A' 1307 ' ' VAL . 8.7 ttt -77.34 151.38 34.95 Favored 'General case' 0 C--O 1.247 0.969 0 O-C-N 120.664 -1.273 . . . . 36.75 108.128 -174.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1276 ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -55.22 126.67 25.86 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 114.007 -1.451 . . . . 46.11 110.698 175.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1277 ' ' ALA . . . . . 0.485 ' HB1' ' HA ' ' B' 1045 ' ' PHE . . . -72.1 170.76 13.26 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 117.012 2.227 . . . . 33.52 117.012 -175.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 68.44 30.28 73.22 Favored Glycine 0 C--O 1.25 1.102 0 C-N-CA 127.267 2.365 . . . . 31.27 111.748 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1279 ' ' SER . . . . . 0.458 ' HB2' HG22 ' A' 1307 ' ' VAL . 64.8 m -125.79 169.17 12.87 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 125.703 1.601 . . . . 32.95 111.216 -167.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1280 ' ' VAL . . . . . 0.735 HG11 ' HA ' ' A' 1145 ' ' ALA . 50.5 t -128.59 149.28 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 O-C-N 119.935 -1.728 . . . . 27.43 108.204 -176.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1281 ' ' ILE . . . . . 0.737 HG12 ' HB ' ' A' 1252 ' ' ILE . 16.4 mt -120.33 103.46 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 104.686 -2.339 . . . . 30.3 104.686 161.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.34 113.64 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 118.782 -1.167 . . . . 28.63 110.681 173.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 5.6 t0 -97.79 104.93 17.0 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 122.176 0.988 . . . . 36.27 109.094 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1284 ' ' LEU . . . . . 0.466 HD21 ' HB2' ' A' 1141 ' ' ALA . 49.1 mt -72.2 -36.31 69.16 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 112.033 -2.349 . . . . 38.57 107.602 176.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -73.38 -6.22 44.83 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 113.841 1.052 . . . . 37.56 113.841 -172.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . -43.41 -30.31 0.53 Allowed 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 127.173 2.189 . . . . 40.33 115.706 176.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1287 ' ' GLN . . . . . 0.604 ' HA ' HG23 ' A' 1313 ' ' THR . 7.8 pt20 -67.86 -2.31 7.09 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 116.017 1.858 . . . . 56.85 116.017 174.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -157.77 97.34 1.56 Allowed 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 102.983 -2.969 . . . . 45.86 102.983 159.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 90.93 -59.9 3.16 Favored Glycine 0 C--O 1.213 -1.168 0 O-C-N 119.222 -2.174 . . . . 40.31 111.931 169.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 80.1 134.97 1.33 Allowed Glycine 0 C--N 1.344 1.005 0 CA-C-N 120.14 1.97 . . . . 38.89 112.423 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1291 ' ' ASN . . . . . . . . . . . . . 33.1 m120 -84.53 -16.5 42.08 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.921 1.452 . . . . 37.23 114.921 -166.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1292 ' ' CYS . . . . . . . . . . . . . 37.2 t -88.75 150.27 23.04 Favored 'General case' 0 C--O 1.259 1.571 0 N-CA-C 105.595 -2.002 . . . . 36.5 105.595 171.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1293 ' ' GLU . . . . . 0.596 ' HA ' ' HD3' ' A' 1265 ' ' LYS . 24.7 mt-10 -78.61 -14.15 59.47 Favored 'General case' 0 C--O 1.216 -0.697 0 N-CA-C 116.877 2.177 . . . . 43.32 116.877 170.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1294 ' ' TYR . . . . . 0.447 ' CZ ' HG23 ' A' 1303 ' ' THR . 1.5 m-85 -75.34 -24.41 57.34 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 113.486 0.921 . . . . 41.32 113.486 178.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1295 ' ' THR . . . . . . . . . . . . . 24.0 m -60.96 105.35 0.46 Allowed 'General case' 0 C--O 1.249 1.036 0 C-N-CA 124.662 1.185 . . . . 35.3 113.894 -165.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 93.5 t -89.47 114.61 61.11 Favored Pre-proline 0 C--O 1.245 0.827 1 N-CA-C 99.662 -4.199 . . . . 34.84 99.662 166.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -56.85 148.89 63.98 Favored 'Trans proline' 0 CA--C 1.513 -0.546 0 C-N-CA 121.546 1.497 . . . . 33.51 111.97 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 90.35 -43.35 2.92 Favored Glycine 0 C--N 1.302 -1.343 0 CA-C-O 115.581 -2.788 . . . . 32.19 113.248 -174.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -104.91 171.39 7.34 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 121.482 2.641 . . . . 34.88 117.964 -168.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1300 ' ' ILE . . . . . 0.526 HD13 ' HG3' ' A' 1148 ' ' GLU . 50.1 mt -96.42 112.2 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 101.157 -3.645 . . . . 32.29 101.157 167.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.8 113.73 25.59 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 101.484 -3.524 . . . . 37.25 101.484 173.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1302 ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' 1308 ' ' LYS . 60.4 m -83.18 111.59 19.06 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.528 -1.656 . . . . 35.56 106.528 174.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1303 ' ' THR . . . . . 0.447 HG23 ' CZ ' ' A' 1294 ' ' TYR . 18.0 m -61.19 137.91 58.23 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 116.656 -1.64 . . . . 36.4 106.78 172.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -57.26 -10.89 1.44 Allowed 'General case' 0 C--N 1.353 0.719 0 N-CA-C 118.047 2.61 . . . . 52.32 118.047 -172.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -79.74 -37.17 36.12 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 125.056 1.473 . . . . 40.04 108.435 172.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1306 ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' B' 1044 ' ' SER . . . 123.44 31.97 0.93 Allowed Glycine 0 N--CA 1.419 -2.441 0 N-CA-C 111.161 -0.776 . . . . 36.96 111.161 -178.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1307 ' ' VAL . . . . . 0.49 HG21 ' HB3' ' A' 1275 ' ' MET . 42.1 t -102.75 109.8 27.65 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 N-CA-C 103.719 -2.697 . . . . 33.4 103.719 171.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1308 ' ' LYS . . . . . 0.753 ' HD2' ' HB3' ' A' 1148 ' ' GLU . 52.2 mttt -85.34 105.4 15.97 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 106.759 -1.571 . . . . 42.91 106.759 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 54.9 t -84.61 101.78 9.62 Favored 'Isoleucine or valine' 0 C--O 1.249 1.071 0 N-CA-C 106.043 -1.836 . . . . 32.29 106.043 176.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1310 ' ' ILE . . . . . 0.648 HD11 ' HB2' ' A' 1148 ' ' GLU . 48.5 mt -96.91 96.39 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 CA-C-N 113.058 -1.883 . . . . 30.99 108.033 -173.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -89.39 61.06 3.62 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 116.423 -0.353 . . . . 28.95 112.403 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1312 ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -80.47 98.52 7.59 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 117.564 -1.654 . . . . 31.69 110.276 -171.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1313 ' ' THR . . . . . 0.604 HG23 ' HA ' ' A' 1287 ' ' GLN . 2.8 m -59.81 -36.29 76.47 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 126.463 1.905 . . . . 34.17 108.46 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -79.54 3.9 17.42 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 114.106 1.15 . . . . 36.86 114.106 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1315 ' ' LEU . . . . . . . . . . . . . 16.6 mt -44.67 -43.83 18.87 Favored Pre-proline 0 C--O 1.22 -0.454 0 N-CA-C 119.028 2.973 . . . . 34.85 119.028 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -65.37 -21.6 60.84 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 123.653 2.902 . . . . 29.15 112.7 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -81.49 -40.29 11.27 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 110.611 -0.996 . . . . 27.29 110.611 173.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1318 ' ' ARG . . . . . . . . . . . . . 44.7 mtt-85 -50.64 -21.06 1.4 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 120.634 3.568 . . . . 41.49 120.634 -167.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1319 ' ' LEU . . . . . . . . . . . . . 14.4 tp -110.47 78.56 1.49 Allowed Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 104.557 -2.386 . . . . 27.61 104.557 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1320 ' ' PRO . . . . . 0.585 ' HB2' ' HA ' ' A' 1043 ' ' ALA . 98.8 Cg_endo -55.53 -61.45 0.36 Allowed 'Trans proline' 0 CA--C 1.514 -0.516 0 C-N-CA 123.793 2.995 . . . . 25.94 114.082 -157.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1321 ' ' THR . . . . . 0.441 HG23 ' HE1' ' A' 1045 ' ' PHE . 15.8 m -64.14 -31.86 73.21 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 120.157 1.344 . . . . 25.01 112.254 -177.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1322 ' ' GLN . . . . . 0.622 ' HB2' ' HA ' ' B' 1151 ' ' ARG . 21.6 tp60 -68.76 -52.72 27.42 Favored 'General case' 0 CA--C 1.506 -0.714 0 O-C-N 119.472 -2.017 . . . . 29.39 109.386 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1323 ' ' SER . . . . . . . . . . . . . 13.7 m -59.18 -41.14 87.76 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 125.143 1.527 . . . . 26.47 109.884 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1324 ' ' SER . . . . . . . . . . . . . 39.5 m -64.55 -42.99 95.34 Favored 'General case' 0 C--O 1.223 -0.337 0 O-C-N 123.948 0.78 . . . . 27.78 110.667 176.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1325 ' ' GLN . . . . . 0.444 ' O ' HG21 ' A' 1022 ' ' THR . 53.7 tp60 -63.57 -51.31 65.91 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.047 -1.033 . . . . 37.53 108.276 -175.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1326 ' ' LEU . . . . . 0.531 HD22 ' HB3' ' B' 1160 ' ' ALA . 96.2 mt -77.23 -35.27 55.61 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-O 116.803 -1.57 . . . . 35.71 113.309 -174.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1327 ' ' TYR . . . . . . . . . . . . . 37.1 t80 -55.94 -52.85 62.68 Favored 'General case' 0 C--N 1.362 1.139 0 CA-C-N 122.028 2.195 . . . . 31.59 108.595 168.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1328 ' ' GLY . . . . . 0.544 ' O ' HG23 ' A' 1332 ' ' VAL . . . -45.15 -46.37 10.29 Favored Glycine 0 N--CA 1.443 -0.838 0 O-C-N 126.037 2.086 . . . . 28.0 111.758 168.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1329 ' ' THR . . . . . 0.599 HG21 ' HA3' ' B' 1161 ' ' GLY . 11.9 m -69.79 -36.41 75.67 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 118.775 -2.603 . . . . 32.15 110.783 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1330 ' ' ASN . . . . . . . . . . . . . 33.7 m120 -61.73 -42.73 99.34 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 120.039 1.29 . . . . 34.36 108.918 171.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1331 ' ' LEU . . . . . 0.668 HD13 HD13 ' A' 1070 ' ' LEU . 22.4 mt -68.49 -39.14 81.43 Favored 'General case' 0 C--O 1.216 -0.663 0 O-C-N 121.439 -0.788 . . . . 33.37 112.515 -177.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1332 ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' 1328 ' ' GLY . 73.1 t -61.76 -46.38 96.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 105.403 -2.073 . . . . 35.27 105.403 175.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -55.51 -43.26 75.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 115.409 1.633 . . . . 37.66 115.409 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1334 ' ' LEU . . . . . . . . . . . . . 14.9 tp -62.92 -54.19 42.4 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 125.157 1.536 . . . . 40.27 109.831 174.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1335 ' ' LEU . . . . . 0.686 ' HA ' ' HB2' ' A' 1338 ' ' LEU . 39.6 mt -65.73 -17.31 64.52 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 118.16 -0.924 . . . . 42.5 113.391 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1336 ' ' LYS . . . . . . . . . . . . . 79.0 mttt -63.07 -49.09 75.9 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.033 -1.099 . . . . 47.81 108.033 169.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1337 ' ' LEU . . . . . 0.411 HD12 HD21 ' A' 1127 ' ' LEU . 77.4 mt -81.99 -20.28 38.81 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-O 124.212 1.958 . . . . 49.27 112.06 -176.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1338 ' ' LEU . . . . . 0.686 ' HB2' ' HA ' ' A' 1335 ' ' LEU . 9.2 mp -75.99 -24.96 55.37 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 113.546 -1.661 . . . . 50.54 112.503 169.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1339 ' ' CYS . . . . . . . . . . . . . 47.3 t -131.5 71.66 1.48 Allowed 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 102.57 -3.122 . . . . 53.67 102.57 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -67.77 -40.6 84.01 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 115.69 -0.686 . . . . 63.38 112.302 -177.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -72.06 -43.45 64.88 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 118.169 2.655 . . . . 70.95 118.169 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1342 ' ' LYS . . . . . 0.54 ' N ' ' HB3' ' A' 1343 ' ' ASP . 7.3 mtpm? 55.1 77.42 0.22 Allowed 'General case' 0 C--O 1.241 0.631 0 C-N-CA 125.505 1.522 . . . . 65.25 114.771 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1343 ' ' ASP . . . . . 0.54 ' HB3' ' N ' ' A' 1342 ' ' LYS 0.34 1.9 t70 78.3 -80.88 0.03 OUTLIER 'General case' 0 C--O 1.251 1.159 2 O-C-N 113.511 -5.743 . . . . 64.53 116.93 -6.638 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A 1344 ' ' GLY . . . . . 0.503 ' H ' ' HA ' ' A' 1342 ' ' LYS . . . 76.16 65.09 2.08 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 119.005 0.82 . . . . 59.72 112.855 -170.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 11.0 t30 -144.14 140.61 29.49 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.764 -0.458 . . . . 64.09 109.764 171.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1346 ' ' ILE . . . . . 0.504 HD12 ' H ' ' A' 1346 ' ' ILE . 3.4 mp -79.51 90.29 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 122.961 1.363 . . . . 58.82 107.628 -171.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1347 ' ' THR . . . . . . . . . . . . . 28.6 m -89.62 89.96 8.04 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-O 124.916 2.293 . . . . 54.96 109.147 175.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1348 ' ' VAL . . . . . . . . . . . . . 92.8 t -74.2 120.34 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 112.678 -2.055 . . . . 55.64 106.524 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1349 ' ' ASP . . . . . 0.441 ' H ' HG21 ' A' 1355 ' ' ILE . 1.5 t70 -94.44 148.64 22.03 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 119.544 1.065 . . . . 61.45 109.856 -176.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -109.28 -38.33 5.53 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.131 -0.941 . . . . 58.63 113.011 170.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 46.2 t0 -68.97 -29.8 68.1 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 123.463 1.601 . . . . 62.06 109.16 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 10.8 t70 -76.34 96.99 4.11 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 105.576 -2.009 . . . . 54.07 105.576 169.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1353 ' ' VAL . . . . . 0.577 ' HA ' ' HB3' ' A' 1356 ' ' ARG . 33.8 m -57.66 -29.7 35.25 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.669 0 CA-C-O 116.099 -1.905 . . . . 50.68 113.138 -174.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1354 ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' 1358 ' ' VAL . 1.5 m -69.05 -35.56 69.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 123.218 2.735 . . . . 47.68 112.633 176.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1355 ' ' ILE . . . . . 0.441 HG21 ' H ' ' A' 1349 ' ' ASP . 75.1 mt -68.93 -45.13 80.92 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 N-CA-C 107.066 -1.457 . . . . 48.49 107.066 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1356 ' ' ARG . . . . . 0.577 ' HB3' ' HA ' ' A' 1353 ' ' VAL . 46.3 tpt85 -52.1 -34.99 46.52 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 119.868 -1.77 . . . . 48.27 112.997 172.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -59.69 -62.91 5.59 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 114.685 0.634 . . . . 43.53 114.685 168.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1358 ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' 1354 ' ' VAL . 14.9 t -58.46 -37.08 62.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 O-C-N 124.848 0.97 . . . . 45.12 111.699 -177.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1359 ' ' THR . . . . . . . . . . . . . 12.7 m -72.16 78.05 0.96 Allowed 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 124.609 2.147 . . . . 42.94 109.803 175.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 29.6 m -74.56 -35.77 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 CA-C-N 113.249 -1.796 . . . . 43.26 109.719 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1361 ' ' ILE . . . . . 0.531 ' HB ' ' HB ' ' A' 1112 ' ' VAL . 60.9 mt -133.08 134.19 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 103.301 -2.852 . . . . 45.66 103.301 176.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1362 ' ' ARG . . . . . 0.494 ' HA ' ' HA ' ' A' 1111 ' ' THR . 30.2 ttt180 -123.02 121.18 35.44 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 122.689 2.495 . . . . 61.34 111.328 169.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 46.69 44.21 13.58 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 127.354 2.909 . . . . 49.76 110.322 173.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1364 ' ' GLY . . . . . 0.731 ' HA2' ' HA ' ' A' 1109 ' ' ASN . . . 115.94 -60.99 0.4 Allowed Glycine 0 C--N 1.347 1.154 0 N-CA-C 117.444 1.738 . . . . 50.0 117.444 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -82.88 130.92 35.2 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 119.619 -0.832 . . . . 56.92 110.321 -175.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1366 ' ' ILE . . . . . 0.491 HG12 HG12 ' A' 1361 ' ' ILE . 71.9 mt -64.64 118.74 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 N-CA-C 108.388 -0.967 . . . . 52.78 108.388 174.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1367 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.79 -0.13 43.22 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 112.613 -2.085 . . . . 49.44 115.975 173.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 7.2 t90 -63.45 150.08 90.6 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-O 115.312 -2.28 . . . . 52.38 112.412 173.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -78.21 -150.69 0.62 Allowed 'Cis proline' 0 CA--C 1.544 1.021 1 CA-C-N 129.259 4.342 . . . . 46.94 111.722 -8.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1370 ' ' ALA . . . . . . . . . . . . 0.264 . . -150.38 156.15 36.9 Favored Pre-proline 0 C--N 1.352 0.708 0 N-CA-C 108.328 -0.99 . . . . 45.91 108.328 -175.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1371 ' ' PRO . . . . . 0.451 ' HA ' ' HD2' ' A' 1372 ' ' PRO . 7.1 Cg_exo -43.16 117.98 1.16 Allowed 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 125.105 3.87 . . . . 46.39 114.782 169.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1372 ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' 1371 ' ' PRO . 72.1 Cg_endo -74.39 4.35 4.5 Favored 'Trans proline' 0 N--CA 1.485 0.994 0 C-N-CA 123.973 3.115 . . . . 46.72 116.93 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.217 -5.184 0 O-C-N 120.477 -1.389 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 73.9 m80 . . . . . 0 N--CA 1.427 -1.586 0 N-CA-C 105.691 -1.966 . . . . 63.44 105.691 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -123.62 43.56 2.93 Favored 'General case' 0 C--O 1.256 1.419 0 O-C-N 117.999 -2.938 . . . . 51.74 114.885 -173.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1000 ' ' HIS . . . . . 0.625 ' HA ' ' HB2' ' B' 1067 ' ' GLU . 17.1 m-70 -69.97 144.11 52.43 Favored 'General case' 0 C--O 1.258 1.533 0 CA-C-O 123.742 1.734 . . . . 54.07 108.096 167.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1001 ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' B' 1344 ' ' GLY . . . 76.98 -12.18 12.49 Favored Glycine 0 CA--C 1.534 1.259 0 O-C-N 120.967 -1.083 . . . . 39.22 112.169 -168.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1002 ' ' ARG . . . . . 0.438 ' O ' ' HB3' ' B' 1066 ' ' SER . 35.7 ttp180 -97.96 142.02 30.2 Favored 'General case' 0 CA--C 1.491 -1.299 0 CA-C-N 120.105 1.953 . . . . 38.12 109.37 174.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1003 ' ' ILE . . . . . . . . . . . . . 21.1 mt -98.74 154.77 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 N-CA-C 106.03 -1.841 . . . . 29.7 106.03 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -123.59 128.08 6.81 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 108.604 -1.799 . . . . 27.5 108.604 164.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1005 ' ' ILE . . . . . 0.783 HG23 ' HB3' ' B' 1017 ' ' ALA . 40.8 mm -116.33 112.11 41.81 Favored Pre-proline 0 C--O 1.243 0.729 0 N-CA-C 104.161 -2.533 . . . . 24.83 104.161 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1006 ' ' PRO . . . . . 0.519 ' HG2' ' HG2' ' B' 1071 ' ' LYS . 85.4 Cg_exo -74.88 154.2 42.94 Favored 'Trans proline' 0 N--CA 1.446 -1.314 1 C-N-CA 125.814 4.343 . . . . 27.19 111.189 176.37 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 63.6 ttt-85 -78.08 125.0 28.71 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 101.877 -3.379 . . . . 41.46 101.877 164.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1008 ' ' GLU . . . . . 0.607 ' HG3' ' HB ' ' B' 1072 ' ' VAL 0.411 0.3 OUTLIER -78.43 126.68 31.11 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 118.899 2.925 . . . . 26.93 118.899 -175.436 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 37.2 mtm180 -98.1 11.46 37.59 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 113.466 -1.697 . . . . 34.48 113.374 -170.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1010 ' ' LEU . . . . . . . . . . . . . 31.9 tp -66.95 143.41 56.82 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 119.803 -1.81 . . . . 44.22 109.051 175.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1011 ' ' THR . . . . . . . . . . . . . 57.9 m -67.57 147.69 52.42 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 122.304 2.32 . . . . 40.74 110.097 165.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 60.8 m-80 58.36 58.06 3.6 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-O 124.231 1.967 . . . . 44.44 110.836 -175.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1013 ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -137.75 143.89 41.38 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.87 -1.514 . . . . 29.87 109.269 -174.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1014 ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' B' 1320 ' ' PRO . 0.2 OUTLIER -137.65 3.37 2.51 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-O 124.088 1.899 . . . . 25.26 110.284 174.54 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 50.5 mtm180 -82.8 142.68 31.37 Favored 'General case' 0 C--O 1.24 0.586 0 O-C-N 119.66 -1.9 . . . . 29.54 112.559 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1016 ' ' VAL . . . . . 0.505 HG21 ' HB1' ' B' 1039 ' ' ALA . 11.1 p -106.43 162.86 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 103.137 -2.912 . . . . 23.55 103.137 154.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1017 ' ' ALA . . . . . 0.783 ' HB3' HG23 ' B' 1005 ' ' ILE . . . -68.2 -21.01 64.89 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 115.557 1.688 . . . . 23.59 115.557 177.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1018 ' ' ALA . . . . . 0.645 ' HB1' ' HB ' ' B' 1022 ' ' THR . . . -158.33 128.15 5.91 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 119.192 0.905 . . . . 24.93 109.254 175.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1019 ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.29 169.96 17.03 Favored Pre-proline 0 N--CA 1.477 0.895 0 CA-C-O 115.34 -2.267 . . . . 28.09 113.397 172.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -45.22 -50.93 8.38 Favored 'Trans proline' 0 CA--C 1.537 0.631 1 C-N-CA 125.371 4.047 . . . . 28.79 116.657 175.39 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 56.2 tttt -55.96 -39.45 71.77 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 113.486 0.921 . . . . 47.28 113.486 173.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1022 ' ' THR . . . . . 0.717 HG21 ' HA3' ' B' 1328 ' ' GLY . 0.3 OUTLIER -70.81 -34.02 71.32 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.401 -0.592 . . . . 30.12 109.401 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B 1023 ' ' VAL . . . . . 0.522 HG11 ' HB2' ' B' 1055 ' ' ALA . 39.7 t -61.93 -43.12 97.05 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 N-CA-C 108.921 -0.77 . . . . 32.24 108.921 176.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1024 ' ' GLU . . . . . 0.403 ' HG3' ' HB1' ' B' 1053 ' ' ALA . 40.9 mt-10 -61.5 -39.54 91.33 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 123.446 0.698 . . . . 49.62 112.35 174.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -55.87 -47.86 76.6 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 122.35 1.072 . . . . 44.68 111.45 174.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 86.1 mt -64.56 -32.48 74.14 Favored 'General case' 0 C--N 1.366 1.294 0 CA-C-N 113.013 -1.903 . . . . 35.71 110.694 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1027 ' ' LEU . . . . . 0.581 HD11 ' HA3' ' B' 1054 ' ' GLY . 86.5 mt -67.81 -41.22 83.42 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 122.314 1.055 . . . . 42.18 112.739 175.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 61.8 mttm -61.21 -32.8 72.57 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-N 112.918 -1.946 . . . . 48.34 111.645 176.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1029 ' ' LEU . . . . . 0.548 HD11 HG13 ' B' 1332 ' ' VAL . 93.9 mt -70.13 -3.61 17.51 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 115.637 1.718 . . . . 38.69 115.637 174.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 96.17 6.72 58.8 Favored Glycine 0 N--CA 1.471 1.007 0 N-CA-C 110.417 -1.073 . . . . 32.28 110.417 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -97.93 170.81 8.69 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.655 -1.239 . . . . 35.94 107.655 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1032 ' ' THR . . . . . . . . . . . . . 1.4 p -113.14 148.89 34.44 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 105.906 -1.887 . . . . 33.37 105.906 170.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1033 ' ' VAL . . . . . 0.444 HG11 HG22 ' B' 1023 ' ' VAL . 15.5 t -114.16 146.81 18.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 O-C-N 117.786 -3.071 . . . . 29.98 108.534 -176.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -125.1 140.84 52.52 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 107.109 -1.441 . . . . 28.18 107.109 163.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1035 ' ' VAL . . . . . 0.453 ' HB ' HD13 ' B' 1057 ' ' ILE . 21.8 t -129.31 146.61 33.96 Favored 'Isoleucine or valine' 0 C--N 1.348 0.528 0 N-CA-C 108.234 -1.024 . . . . 25.82 108.234 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1036 ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -66.11 139.91 58.19 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 121.442 0.639 . . . . 32.44 112.545 167.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1037 ' ' SER . . . . . . . . . . . . . 48.7 m -52.81 139.52 26.61 Favored 'General case' 0 C--O 1.257 1.478 0 CA-C-N 114.207 -1.36 . . . . 29.54 114.489 165.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 89.63 0.2 79.28 Favored Glycine 0 C--O 1.252 1.274 0 C-N-CA 121.322 -0.466 . . . . 27.76 113.271 176.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1039 ' ' ALA . . . . . 0.505 ' HB1' HG21 ' B' 1016 ' ' VAL . . . -64.83 -43.4 93.19 Favored 'General case' 0 CA--C 1.504 -0.796 0 O-C-N 124.502 0.766 . . . . 26.02 110.832 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -49.55 -47.85 36.12 Favored Glycine 0 N--CA 1.419 -2.458 0 C-N-CA 125.663 1.601 . . . . 26.47 111.118 173.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -53.21 -46.28 68.99 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-N 119.525 1.663 . . . . 50.98 112.514 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 94.7 mt -61.24 -57.62 11.64 Favored 'General case' 0 C--O 1.211 -0.964 0 N-CA-C 108.074 -1.084 . . . . 29.3 108.074 174.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1043 ' ' ALA . . . . . . . . . . . . . . . -72.62 11.85 0.57 Allowed 'General case' 0 C--O 1.248 0.982 0 N-CA-C 116.587 2.069 . . . . 26.74 116.587 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1044 ' ' SER . . . . . 0.435 ' O ' ' HA3' ' A' 1306 ' ' GLY . 17.3 m 46.89 25.24 0.44 Allowed 'General case' 0 C--O 1.248 0.987 0 C-N-CA 126.361 1.864 . . . . 31.26 113.717 -176.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1045 ' ' PHE . . . . . 0.485 ' HA ' ' HB1' ' A' 1277 ' ' ALA . 0.9 OUTLIER -112.86 155.93 23.82 Favored 'General case' 0 C--O 1.244 0.797 0 O-C-N 119.885 -1.76 . . . . 33.26 106.962 -177.174 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 11.3 t70 -67.96 126.04 28.22 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.869 -0.789 . . . . 46.74 108.869 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.8 -42.43 90.68 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 107.621 -1.251 . . . . 34.44 107.621 -173.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -53.03 -34.84 58.24 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 113.306 0.854 . . . . 48.67 113.306 172.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1049 ' ' ALA . . . . . 0.521 ' HA ' ' HB2' ' B' 1052 ' ' GLN . . . -62.94 -19.79 64.59 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 116.06 1.874 . . . . 35.26 116.06 176.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1050 ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -62.77 -42.72 99.82 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 123.396 1.57 . . . . 32.17 109.996 168.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 18.0 t -67.4 -50.74 59.37 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 O-C-N 119.546 -1.971 . . . . 38.37 107.061 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1052 ' ' GLN . . . . . 0.521 ' HB2' ' HA ' ' B' 1049 ' ' ALA . 52.9 mt-30 -52.17 -29.72 23.61 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.74 1.216 . . . . 45.77 114.174 175.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1053 ' ' ALA . . . . . 0.403 ' HB1' ' HG3' ' B' 1024 ' ' GLU . . . -80.55 -40.66 25.51 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 123.936 0.773 . . . . 37.83 110.584 176.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1054 ' ' GLY . . . . . 0.581 ' HA3' HD11 ' B' 1027 ' ' LEU . . . 134.81 48.73 0.08 OUTLIER Glycine 0 CA--C 1.532 1.141 0 CA-C-O 123.028 1.349 . . . . 35.82 111.657 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1055 ' ' ALA . . . . . 0.522 ' HB2' HG11 ' B' 1023 ' ' VAL . . . -128.74 140.9 51.51 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 108.206 -1.035 . . . . 33.77 108.206 177.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -76.38 106.79 8.21 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 104.513 -2.403 . . . . 51.02 104.513 166.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1057 ' ' ILE . . . . . 0.453 HD13 ' HB ' ' B' 1035 ' ' VAL . 13.6 mm -82.5 102.82 8.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 N-CA-C 102.079 -3.304 . . . . 38.47 102.079 173.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 30.1 m -86.71 159.34 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-N 109.143 -3.662 . . . . 39.4 108.29 175.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -71.48 -29.24 64.6 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.258 -1.337 . . . . 57.07 114.438 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . 172.79 -97.25 0.12 Allowed Glycine 0 CA--C 1.53 0.976 0 O-C-N 120.359 -1.463 . . . . 44.83 111.541 176.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -58.6 -32.0 68.58 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 125.632 1.573 . . . . 46.27 114.057 -170.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1062 ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -44.32 -33.87 1.76 Allowed 'General case' 0 C--O 1.24 0.578 0 N-CA-C 115.215 1.561 . . . . 43.47 115.215 171.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -54.05 -38.77 38.89 Favored 'Isoleucine or valine' 0 C--N 1.355 0.828 0 C-N-CA 124.385 1.074 . . . . 36.98 111.491 176.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 96.9 m95 -67.72 -14.38 62.9 Favored 'General case' 0 C--O 1.211 -0.949 0 N-CA-C 116.877 2.177 . . . . 37.9 116.877 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -99.83 81.58 2.47 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 104.338 -2.467 . . . . 46.19 104.338 -176.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1066 ' ' SER . . . . . 0.438 ' HB3' ' O ' ' B' 1002 ' ' ARG . 68.5 m -150.65 -178.53 6.61 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 119.006 -2.309 . . . . 37.06 108.244 -174.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1067 ' ' GLU . . . . . 0.625 ' HB2' ' HA ' ' B' 1000 ' ' HIS . 8.8 tp10 -69.8 -56.12 7.98 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 120.457 -1.402 . . . . 43.95 109.473 173.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1068 ' ' ILE . . . . . 0.562 HG23 HG13 ' B' 1346 ' ' ILE . 0.8 OUTLIER -123.07 137.88 54.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 107.411 -1.329 . . . . 33.5 107.411 -178.012 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 24.1 mm -111.28 106.81 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 N-CA-C 103.561 -2.755 . . . . 30.57 103.561 170.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1070 ' ' LEU . . . . . 0.715 HD22 HD22 ' B' 1331 ' ' LEU . 86.7 mt -97.23 118.46 33.73 Favored 'General case' 0 CA--C 1.505 -0.781 1 N-CA-C 98.117 -4.771 . . . . 27.66 98.117 -175.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B 1071 ' ' LYS . . . . . 0.519 ' HG2' ' HG2' ' B' 1006 ' ' PRO . 10.8 tmtt? -141.33 146.77 37.13 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 104.818 -2.29 . . . . 28.4 104.818 -164.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1072 ' ' VAL . . . . . 0.607 ' HB ' ' HG3' ' B' 1008 ' ' GLU . 61.8 t -79.93 -61.68 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-N 120.278 1.399 . . . . 23.18 112.462 -170.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1073 ' ' ASN . . . . . 0.468 ' HA ' ' HB2' ' B' 1092 ' ' PHE . 52.9 m-80 -105.95 -161.76 0.82 Allowed 'General case' 0 C--O 1.237 0.443 0 N-CA-C 106.269 -1.752 . . . . 25.47 106.269 -173.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -61.65 148.68 86.4 Favored Pre-proline 0 C--O 1.259 1.564 0 N-CA-C 112.999 0.74 . . . . 27.9 112.999 177.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -66.56 125.49 13.95 Favored 'Trans proline' 0 CA--C 1.556 1.608 0 N-CA-C 107.939 -1.6 . . . . 31.62 107.939 162.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 57.1 mt -69.14 162.18 27.55 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 107.696 -1.224 . . . . 40.49 107.696 169.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1077 ' ' ASP . . . . . 0.541 ' HA ' HD12 ' B' 1080 ' ' ILE . 1.3 m-20 -69.16 -23.63 63.97 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 118.711 2.856 . . . . 51.59 118.711 -160.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -66.27 -51.36 58.28 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 112.835 -1.984 . . . . 42.36 110.553 166.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1079 ' ' GLU . . . . . 0.419 ' HA ' HD12 ' B' 1082 ' ' LEU . 58.6 mt-10 -55.62 -37.35 68.04 Favored 'General case' 0 C--O 1.249 1.042 0 O-C-N 120.667 -1.271 . . . . 34.53 109.116 173.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1080 ' ' ILE . . . . . 0.612 HD11 HD12 ' B' 1101 ' ' LEU . 73.1 mt -59.28 -50.43 79.86 Favored 'Isoleucine or valine' 0 C--N 1.356 0.891 0 C-N-CA 123.666 0.786 . . . . 33.25 110.355 173.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -63.45 -15.14 56.82 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 118.544 -0.741 . . . . 36.47 112.837 174.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1082 ' ' LEU . . . . . 0.419 HD12 ' HA ' ' B' 1079 ' ' GLU . 41.3 mt -86.45 -24.31 25.68 Favored 'General case' 0 C--N 1.353 0.728 0 CA-C-N 120.466 1.485 . . . . 37.76 113.553 171.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1083 ' ' LEU . . . . . 0.674 ' HB3' HG11 ' B' 1110 ' ' VAL . 12.7 mt -55.2 123.99 15.51 Favored 'General case' 0 C--O 1.25 1.125 0 N-CA-C 115.629 1.714 . . . . 37.43 115.629 -178.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.09 129.35 56.37 Favored Pre-proline 0 N--CA 1.439 -0.991 0 CA-C-N 114.797 -1.092 . . . . 37.7 110.891 -172.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -58.63 123.07 12.75 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 124.55 3.5 . . . . 35.51 109.11 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 115.36 -60.49 0.4 Allowed Glycine 0 C--O 1.244 0.771 0 O-C-N 126.955 2.659 . . . . 33.87 108.097 -172.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1087 ' ' THR . . . . . . . . . . . . . 97.9 m -41.57 130.97 3.09 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 126.757 2.023 . . . . 32.5 116.059 -165.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1088 ' ' THR . . . . . 0.682 ' HA ' ' HB ' ' B' 1111 ' ' THR . 10.0 m -73.68 106.75 5.57 Favored 'General case' 0 C--O 1.216 -0.7 0 N-CA-C 107.306 -1.368 . . . . 30.22 107.306 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1089 ' ' LEU . . . . . 0.476 HD13 HD21 ' B' 1083 ' ' LEU . 20.7 tp -96.91 133.05 42.05 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 103.38 -2.822 . . . . 27.24 103.38 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1090 ' ' VAL . . . . . 0.6 HG13 ' HB2' ' B' 1113 ' ' MET . 15.1 t -134.48 109.93 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 106.889 -1.523 . . . . 25.39 106.889 -174.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1091 ' ' SER . . . . . . . . . . . . . 2.6 m -159.23 168.92 25.28 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.84 0.829 . . . . 28.81 112.127 -166.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1092 ' ' PHE . . . . . 0.536 ' CD1' ' HB3' ' B' 1116 ' ' ASP . 19.9 m-85 -66.1 107.41 1.91 Allowed 'General case' 0 C--O 1.247 0.973 0 CA-C-O 124.42 2.057 . . . . 30.78 110.933 161.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 45.3 mm -103.53 -37.84 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 O-C-N 120.172 -1.58 . . . . 30.28 110.552 -176.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1094 ' ' TRP . . . . . 0.589 ' HB2' ' ND2' ' B' 1098 ' ' ASN . 58.8 m95 53.57 54.79 12.61 Favored Pre-proline 0 C--O 1.249 1.078 0 O-C-N 124.456 1.098 . . . . 34.07 110.342 -174.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1095 ' ' PRO . . . . . 0.458 ' HG2' HG11 ' B' 1360 ' ' VAL . 71.1 Cg_exo -39.6 -60.65 0.51 Allowed 'Trans proline' 0 C--N 1.355 0.872 1 C-N-CA 126.5 4.8 . . . . 38.66 118.433 -167.046 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -62.94 -28.27 69.95 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 119.287 -2.133 . . . . 41.32 112.838 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -82.65 -22.11 34.77 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 122.543 1.163 . . . . 51.66 112.578 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1098 ' ' ASN . . . . . 0.589 ' ND2' ' HB2' ' B' 1094 ' ' TRP . 48.4 m-80 -119.09 58.41 4.01 Favored Pre-proline 0 N--CA 1.447 -0.62 0 N-CA-C 115.511 1.671 . . . . 40.32 115.511 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -57.16 -43.15 55.78 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.561 3.507 . . . . 41.56 111.593 -173.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -76.51 -32.74 58.47 Favored 'General case' 0 C--O 1.208 -1.091 0 N-CA-C 113.139 0.792 . . . . 54.11 113.139 -174.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1101 ' ' LEU . . . . . 0.612 HD12 HD11 ' B' 1080 ' ' ILE . 26.6 tp -61.59 -47.99 82.98 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 107.693 -1.225 . . . . 37.88 107.693 174.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1102 ' ' MET . . . . . . . . . . . . . 69.2 mmm -47.61 -55.15 9.93 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 125.601 1.813 . . . . 37.54 111.154 173.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -55.98 -45.46 78.95 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-O 118.487 -0.768 . . . . 47.01 111.527 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1104 ' ' LYS . . . . . . . . . . . . . 88.9 mttt -61.82 -36.99 82.77 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 124.544 2.116 . . . . 48.68 114.146 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1105 ' ' LEU . . . . . . . . . . . . . 43.6 mt -74.63 -32.82 62.41 Favored 'General case' 0 C--O 1.247 0.931 0 O-C-N 119.614 -1.929 . . . . 32.21 110.03 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -67.69 -43.6 79.74 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.392 0.677 . . . . 33.73 111.177 175.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -59.45 -41.28 89.3 Favored 'General case' 0 C--O 1.25 1.101 0 N-CA-C 115.128 1.529 . . . . 51.47 115.128 169.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1108 ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -71.38 -3.83 22.93 Favored 'General case' 0 C--N 1.345 0.407 0 N-CA-C 113.693 0.997 . . . . 43.9 113.693 170.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1109 ' ' ASN . . . . . . . . . . . . . 8.1 m-80 59.03 32.57 22.35 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.835 1.791 . . . . 44.82 115.835 167.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1110 ' ' VAL . . . . . 0.674 HG11 ' HB3' ' B' 1083 ' ' LEU . 5.8 m -94.92 150.82 3.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-N 114.516 -1.22 . . . . 30.52 109.794 -174.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1111 ' ' THR . . . . . 0.682 ' HB ' ' HA ' ' B' 1088 ' ' THR . 29.9 m -83.16 86.06 7.09 Favored 'General case' 0 C--O 1.247 0.958 0 CA-C-O 122.126 0.965 . . . . 27.12 110.517 178.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1112 ' ' VAL . . . . . 0.405 ' CG2' HG23 ' B' 1110 ' ' VAL . 6.7 t -86.21 130.72 36.12 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 CA-C-O 121.986 0.898 . . . . 26.4 109.192 -169.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1113 ' ' MET . . . . . 0.6 ' HB2' HG13 ' B' 1090 ' ' VAL . 10.8 mtt -120.19 124.71 46.39 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 102.651 -3.092 . . . . 42.92 102.651 175.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -90.65 96.61 10.73 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 113.703 -1.59 . . . . 24.15 113.888 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1115 ' ' MET . . . . . 0.454 ' CG ' HG12 ' B' 1090 ' ' VAL . 78.9 mmm -56.03 -25.54 45.09 Favored 'General case' 0 C--O 1.22 -0.451 0 N-CA-C 115.479 1.659 . . . . 29.95 115.479 -178.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1116 ' ' ASP . . . . . 0.536 ' HB3' ' CD1' ' B' 1092 ' ' PHE . 10.6 p-10 -80.14 -37.14 34.12 Favored 'General case' 0 N--CA 1.439 -0.984 0 O-C-N 121.521 -0.737 . . . . 34.53 109.647 174.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1117 ' ' SER . . . . . . . . . . . . . 57.0 m -102.52 48.16 0.87 Allowed 'General case' 0 C--N 1.355 0.823 0 O-C-N 120.167 -1.583 . . . . 33.49 108.824 -168.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1118 ' ' VAL . . . . . 0.572 HG21 ' HA ' ' B' 1128 ' ' ASP . 54.5 t -81.63 124.08 80.15 Favored Pre-proline 0 N--CA 1.48 1.048 0 N-CA-C 102.357 -3.201 . . . . 34.02 102.357 176.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1119 ' ' PRO . . . . . 0.432 ' HG2' ' HA3' ' B' 1357 ' ' GLY . 90.7 Cg_exo -58.06 103.14 0.14 Allowed 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 124.904 3.736 . . . . 38.28 110.842 -173.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1120 ' ' ARG . . . . . . . . . . . . . 13.6 mtm-85 -72.55 71.84 0.98 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 120.338 3.459 . . . . 55.05 120.338 -159.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1121 ' ' ILE . . . . . . . . . . . . . 44.5 pt -104.48 -161.11 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.815 0 N-CA-C 104.641 -2.355 . . . . 42.09 104.641 171.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1122 ' ' SER . . . . . . . . . . . . . 31.4 m -74.56 -48.27 27.81 Favored 'General case' 0 N--CA 1.434 -1.259 0 O-C-N 118.12 -2.862 . . . . 38.02 118.226 -173.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1123 ' ' ARG . . . . . 0.732 ' HD2' HD21 ' B' 1337 ' ' LEU . 10.2 ptt180 -74.71 -21.38 59.41 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 124.305 3.23 . . . . 34.29 114.125 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1124 ' ' ALA . . . . . . . . . . . . . . . -54.46 -48.92 71.21 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 109.182 -3.644 . . . . 32.35 109.759 170.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1125 ' ' GLN . . . . . 0.418 ' HA ' ' HB3' ' B' 1128 ' ' ASP . 16.2 mm-40 -54.75 -38.12 66.78 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 114.42 1.267 . . . . 47.17 114.42 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1126 ' ' SER . . . . . . . . . . . . . 73.9 m -57.03 -36.03 69.98 Favored 'General case' 0 C--O 1.248 1.0 0 CA-C-N 121.088 1.767 . . . . 31.71 114.093 170.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1127 ' ' LEU . . . . . 0.655 HD11 HD13 ' B' 1337 ' ' LEU . 8.4 mp -87.82 -23.77 23.92 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 114.946 -1.025 . . . . 37.0 112.982 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1128 ' ' ASP . . . . . 0.572 ' HA ' HG21 ' B' 1118 ' ' VAL . 12.5 t70 -78.93 118.77 21.26 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-O 123.434 1.587 . . . . 40.4 112.549 -170.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1129 ' ' ALA . . . . . 0.435 ' HB2' ' HB3' ' B' 1115 ' ' MET . . . -62.32 -36.55 82.53 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 110.44 -3.073 . . . . 26.56 111.793 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 39.6 mt -63.09 -23.73 67.58 Favored 'General case' 0 C--O 1.248 0.976 0 CA-C-O 116.512 -1.708 . . . . 30.89 112.251 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1131 ' ' SER . . . . . . . . . . . . . 86.0 p -65.84 -57.5 7.79 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 122.611 2.46 . . . . 29.84 107.932 177.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1132 ' ' SER . . . . . . . . . . . . . 73.4 m -60.74 -43.24 98.19 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.259 -1.337 . . . . 31.91 111.223 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1133 ' ' MET . . . . . 0.509 ' HB3' ' HB3' ' B' 1316 ' ' PRO . 31.2 mmt -60.56 -37.98 83.04 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 115.504 1.668 . . . . 25.9 115.504 174.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1134 ' ' ALA . . . . . 0.76 ' HB1' ' HB2' ' B' 1176 ' ' ALA . . . -68.77 -41.75 78.39 Favored 'General case' 0 C--N 1.352 0.679 0 C-N-CA 119.929 -0.708 . . . . 26.62 109.182 174.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.27 -38.82 90.8 Favored 'General case' 0 C--O 1.206 -1.195 0 C-N-CA 125.076 1.35 . . . . 36.97 109.997 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1136 ' ' ILE . . . . . 0.602 HD13 ' HE1' ' A' 1152 ' ' PHE . 15.0 mm -58.7 -55.4 23.21 Favored 'Isoleucine or valine' 0 C--N 1.352 0.695 0 N-CA-C 106.337 -1.727 . . . . 32.11 106.337 172.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1137 ' ' ALA . . . . . 0.463 ' HA ' ' HB3' ' B' 1140 ' ' ARG . . . -61.95 -25.79 67.81 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 116.019 1.859 . . . . 24.14 116.019 178.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -65.5 -57.83 10.58 Favored Glycine 0 N--CA 1.466 0.699 0 CA-C-N 120.982 1.719 . . . . 25.13 110.28 174.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 77.9 t80 -53.55 -43.8 68.74 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 123.663 1.697 . . . . 32.73 110.534 172.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1140 ' ' ARG . . . . . 0.463 ' HB3' ' HA ' ' B' 1137 ' ' ALA . 9.1 tpt180 -70.61 -25.95 63.28 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 113.78 -1.555 . . . . 26.36 110.492 -174.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1141 ' ' ALA . . . . . 0.405 ' HA ' HG11 ' B' 1282 ' ' VAL . . . -62.89 -49.63 74.05 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 120.661 1.573 . . . . 24.12 107.978 172.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 32.5 mm -56.94 -43.89 81.46 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 CA-C-O 118.697 -0.668 . . . . 23.37 110.801 175.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 70.4 t -68.1 -59.26 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 N-CA-C 112.573 0.582 . . . . 24.96 112.573 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1144 ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' B' 1147 ' ' HIS . 67.4 mm-40 -60.1 -35.83 76.08 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 119.145 -0.455 . . . . 32.07 110.306 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1145 ' ' ALA . . . . . 0.558 ' HB1' HD12 ' B' 1251 ' ' ILE . . . -51.74 -60.32 3.3 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 119.145 0.884 . . . . 24.87 111.365 167.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1146 ' ' ALA . . . . . 0.559 ' HB2' ' HE1' ' B' 1153 ' ' PHE . . . -58.53 -22.94 57.01 Favored 'General case' 0 C--N 1.348 0.506 0 N-CA-C 114.663 1.357 . . . . 24.67 114.663 177.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1147 ' ' HIS . . . . . 0.465 ' HB3' ' O ' ' B' 1144 ' ' GLU . 26.8 t60 -63.15 -43.94 96.92 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 120.84 -1.163 . . . . 28.58 108.97 171.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1148 ' ' GLU . . . . . 0.588 ' HG3' HD13 ' B' 1300 ' ' ILE . 69.7 mm-40 -107.07 3.92 26.39 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 116.996 2.221 . . . . 36.82 116.996 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1149 ' ' PHE . . . . . 0.404 ' HE2' ' HB2' ' B' 1166 ' ' ALA . 1.1 t80 -71.53 140.69 49.99 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-O 124.733 2.206 . . . . 31.97 107.015 -178.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1150 ' ' GLY . . . . . . . . . . . . . . . -71.29 -42.17 57.84 Favored Glycine 0 N--CA 1.42 -2.423 0 CA-C-N 111.079 -2.782 . . . . 25.49 110.858 170.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1151 ' ' ARG . . . . . 0.622 ' HA ' ' HB2' ' A' 1322 ' ' GLN . 58.7 mtm-85 -110.58 179.36 4.09 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 123.961 3.881 . . . . 59.84 113.46 -168.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1152 ' ' PHE . . . . . 0.516 ' HB2' HG11 ' B' 1163 ' ' VAL . 12.1 m-30 -72.9 163.52 28.03 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 120.147 -1.596 . . . . 34.45 109.383 167.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1153 ' ' PHE . . . . . 0.559 ' HE1' ' HB2' ' B' 1146 ' ' ALA . 17.2 m-85 -82.24 -51.7 7.67 Favored 'General case' 0 C--O 1.257 1.484 0 N-CA-C 107.586 -1.265 . . . . 31.17 107.586 166.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1154 ' ' THR . . . . . . . . . . . . . 45.5 m -65.55 127.98 34.06 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 113.02 -1.9 . . . . 33.89 109.724 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -78.86 72.22 2.47 Favored Glycine 0 C--O 1.251 1.217 0 N-CA-C 109.247 -1.541 . . . . 38.95 109.247 172.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -85.03 131.75 34.42 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 103.983 -2.599 . . . . 54.23 103.983 -176.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 24.7 mm -84.16 93.54 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 N-CA-C 100.719 -3.808 . . . . 51.16 100.719 173.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1158 ' ' THR . . . . . . . . . . . . . 26.0 m -81.33 166.52 20.4 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.083 -1.08 . . . . 49.61 108.083 -170.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -51.09 -58.32 6.4 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 117.403 -1.285 . . . . 49.05 112.769 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1160 ' ' ALA . . . . . 0.531 ' HB3' HD22 ' A' 1326 ' ' LEU . . . -44.3 -53.12 7.0 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 116.984 2.216 . . . . 47.65 116.984 170.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1161 ' ' GLY . . . . . 0.599 ' HA3' HG21 ' A' 1329 ' ' THR . . . -177.96 -177.05 46.44 Favored Glycine 0 N--CA 1.426 -1.974 0 N-CA-C 109.103 -1.599 . . . . 45.61 109.103 -174.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 87.8 mttt -75.24 138.21 41.75 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.181 -1.009 . . . . 57.46 108.538 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1163 ' ' VAL . . . . . 0.516 HG11 ' HB2' ' B' 1152 ' ' PHE . 45.7 t -91.34 125.85 56.72 Favored Pre-proline 0 CA--C 1.511 -0.529 0 O-C-N 121.395 -0.816 . . . . 42.93 109.322 170.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1164 ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' B' 1165 ' ' PRO . 49.7 Cg_exo -66.22 122.06 9.49 Favored 'Trans proline' 0 C--O 1.26 1.587 0 C-N-CA 123.917 3.078 . . . . 39.29 106.029 158.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1165 ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' B' 1164 ' ' PRO . 31.3 Cg_exo -76.61 168.24 24.03 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.876 3.717 . . . . 34.17 114.091 -174.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1166 ' ' ALA . . . . . 0.426 ' HB2' ' HA ' ' B' 1153 ' ' PHE . . . -76.5 123.49 26.12 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 114.309 -1.314 . . . . 31.69 112.633 170.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1167 ' ' LYS . . . . . 0.718 ' HB2' ' HA ' ' B' 1249 ' ' VAL . 70.7 mttt -92.4 107.56 19.31 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 125.228 2.442 . . . . 44.78 110.495 165.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 40.2 t -91.76 94.68 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 113.902 -1.499 . . . . 31.23 109.314 -171.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1169 ' ' MET . . . . . 0.644 ' HB2' HG11 ' B' 1249 ' ' VAL . 40.6 ttp -88.99 96.36 10.7 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 123.415 1.579 . . . . 37.09 107.167 -177.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1170 ' ' VAL . . . . . 0.46 ' HA ' ' HB ' ' B' 1253 ' ' VAL . 38.8 t -83.75 114.78 24.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 113.242 -1.799 . . . . 30.17 107.974 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1171 ' ' ILE . . . . . 0.464 ' CD1' HD11 ' B' 1267 ' ' ILE . 78.9 mt -104.23 114.65 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 106.943 -1.502 . . . . 33.74 106.943 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 94.74 66.09 1.0 Allowed Glycine 0 N--CA 1.421 -2.313 0 N-CA-C 108.504 -1.839 . . . . 32.59 108.504 -177.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1173 ' ' ALA . . . . . 0.583 ' H ' ' HB2' ' B' 1195 ' ' ASP . . . -59.05 -9.03 1.68 Allowed 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 116.638 2.088 . . . . 32.42 116.638 -177.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -61.53 128.68 43.9 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 115.122 0.809 . . . . 31.74 115.122 173.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 22.4 t 56.19 -82.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 127.453 2.301 . . . . 31.48 111.407 170.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1176 ' ' ALA . . . . . 0.76 ' HB2' ' HB1' ' B' 1134 ' ' ALA . . . -65.53 -42.93 91.44 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.7 -1.222 . . . . 26.12 107.7 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1177 ' ' GLY . . . . . 0.502 ' O ' HG13 ' B' 1181 ' ' ILE . . . -52.71 -52.79 36.24 Favored Glycine 0 N--CA 1.43 -1.763 0 CA-C-N 118.665 0.666 . . . . 25.73 113.2 172.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1178 ' ' LEU . . . . . 0.524 ' HB3' ' HD2' ' C' ' 76' ' ' PRO . 96.6 mt -53.3 -46.67 69.44 Favored 'General case' 0 C--O 1.241 0.65 0 O-C-N 120.79 -1.418 . . . . 32.59 113.858 173.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -61.82 -40.17 94.34 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 120.23 -0.588 . . . . 27.72 111.365 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -66.34 -38.32 87.38 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 120.686 1.585 . . . . 26.03 108.907 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1181 ' ' ILE . . . . . 0.735 HG23 HG11 ' B' 1191 ' ' VAL . 70.9 mt -65.27 -47.16 88.36 Favored 'Isoleucine or valine' 0 C--N 1.36 1.033 0 O-C-N 125.347 1.654 . . . . 28.61 110.229 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -52.5 -55.24 23.47 Favored Glycine 0 N--CA 1.435 -1.374 0 C-N-CA 125.792 1.663 . . . . 25.23 111.376 174.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -61.96 -51.8 66.62 Favored 'General case' 0 C--O 1.251 1.166 0 C-N-CA 123.346 0.659 . . . . 24.09 111.425 -174.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -62.52 -41.09 98.63 Favored 'General case' 0 C--O 1.247 0.948 0 O-C-N 123.75 0.657 . . . . 26.68 111.123 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -63.31 -37.93 89.18 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 120.13 -1.606 . . . . 36.57 113.009 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1186 ' ' SER . . . . . . . . . . . . . 73.2 m -57.85 -49.83 75.37 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-O 122.804 1.287 . . . . 28.92 110.15 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1187 ' ' LEU . . . . . 0.817 ' HA ' ' HB3' ' A' 1186 ' ' SER . 12.6 mt -62.11 -21.89 65.36 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 118.192 2.664 . . . . 29.09 118.192 169.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 75.02 35.38 49.95 Favored Glycine 0 N--CA 1.433 -1.53 0 N-CA-C 109.053 -1.619 . . . . 29.26 109.053 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1189 ' ' ALA . . . . . . . . . . . . . . . -81.46 151.02 28.05 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.098 -1.816 . . . . 30.16 106.098 167.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1190 ' ' ILE . . . . . 0.458 ' HB ' ' HG2' ' B' 1167 ' ' LYS . 73.8 mt -78.74 97.49 2.35 Favored 'Isoleucine or valine' 0 C--O 1.246 0.914 0 N-CA-C 106.603 -1.629 . . . . 35.81 106.603 -174.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1191 ' ' VAL . . . . . 0.735 HG11 HG23 ' B' 1181 ' ' ILE . 57.7 t -79.94 136.75 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-N 115.408 -0.815 . . . . 31.97 109.102 -178.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1192 ' ' ARG . . . . . 0.69 ' HG2' ' HB2' ' B' 1210 ' ' GLU . 89.7 mtt180 -131.9 127.27 36.1 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 104.426 -2.435 . . . . 48.16 104.426 167.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -134.64 158.21 44.63 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 124.084 1.897 . . . . 35.89 115.618 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1194 ' ' PHE . . . . . 0.446 ' HB2' HD12 ' B' 1212 ' ' LEU . 35.5 t80 -139.28 132.98 30.63 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 114.029 -1.441 . . . . 41.88 107.167 -171.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1195 ' ' ASP . . . . . 0.829 ' HB3' HG21 ' B' 1200 ' ' VAL . 10.0 t70 -159.08 152.44 22.6 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 106.448 -1.686 . . . . 38.28 106.448 167.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1196 ' ' THR . . . . . . . . . . . . . 2.2 p -63.01 -44.3 96.37 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 113.997 1.11 . . . . 40.62 113.997 -177.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1197 ' ' ARG . . . . . 0.418 ' O ' HG22 ' B' 1200 ' ' VAL . 28.4 mtm180 -74.09 125.99 89.62 Favored Pre-proline 0 C--O 1.252 1.195 0 C-N-CA 119.67 -0.812 . . . . 53.09 111.711 -168.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -44.23 -33.79 6.32 Favored 'Trans proline' 0 C--O 1.248 0.984 1 C-N-CA 125.724 4.283 . . . . 42.56 118.219 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -54.05 -30.07 46.45 Favored 'General case' 0 C--N 1.347 0.479 0 N-CA-C 116.929 2.196 . . . . 56.31 116.929 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1200 ' ' VAL . . . . . 0.829 HG21 ' HB3' ' B' 1195 ' ' ASP . 6.4 m -71.82 -29.47 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 O-C-N 124.554 1.159 . . . . 42.91 110.196 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 34.9 tttm -54.58 -48.14 72.47 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 125.714 1.884 . . . . 48.89 113.6 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.93 -48.87 77.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 117.658 -1.163 . . . . 51.7 108.869 175.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1203 ' ' GLN . . . . . 0.846 ' HG2' ' HG3' ' C' ' 74' ' ' ARG . 54.5 mt-30 -58.89 -46.37 88.02 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 125.225 1.578 . . . . 52.57 113.978 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1204 ' ' VAL . . . . . 0.445 ' O ' ' HB3' ' B' 1209 ' ' ALA . 48.5 t -62.52 -46.48 96.29 Favored 'Isoleucine or valine' 0 C--O 1.257 1.498 0 CA-C-N 120.429 1.468 . . . . 33.79 107.744 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -54.85 -38.77 67.86 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.563 1.145 . . . . 36.58 114.025 173.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1206 ' ' SER . . . . . . . . . . . . . 12.0 m -63.38 -37.03 85.68 Favored 'General case' 0 C--N 1.347 0.482 0 O-C-N 121.171 -0.955 . . . . 39.61 110.215 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1207 ' ' MET . . . . . 0.534 ' SD ' HD22 ' C' ' 75' ' ' LEU . 4.9 mtt -87.63 28.34 1.01 Allowed 'General case' 0 C--O 1.248 1.013 0 O-C-N 117.659 -3.151 . . . . 37.45 113.906 -175.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 55.45 30.57 55.85 Favored Glycine 0 CA--C 1.538 1.516 0 O-C-N 120.589 -1.319 . . . . 31.87 113.737 -176.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1209 ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' B' 1204 ' ' VAL . . . -119.04 142.01 48.22 Favored 'General case' 0 N--CA 1.428 -1.541 0 O-C-N 119.582 -2.128 . . . . 35.4 108.87 -164.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1210 ' ' GLU . . . . . 0.69 ' HB2' ' HG2' ' B' 1192 ' ' ARG . 34.5 mt-10 -80.61 129.08 34.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 118.694 -1.202 . . . . 47.89 108.846 -176.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 45.5 t80 -90.09 132.7 35.28 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 101.473 -3.529 . . . . 45.53 101.473 178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1212 ' ' LEU . . . . . 0.446 HD12 ' HB2' ' B' 1194 ' ' PHE . 63.4 mt -84.73 121.58 27.89 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 103.689 -2.708 . . . . 46.33 103.689 173.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -68.81 147.94 51.02 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 115.496 1.665 . . . . 60.41 115.496 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 21.5 mt -66.6 140.64 57.96 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 112.588 -2.096 . . . . 57.38 107.002 167.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1215 ' ' ASP . . . . . 0.43 ' H ' ' HE1' ' B' 1234 ' ' PHE . 23.4 t70 . . . . . 0 N--CA 1.433 -1.325 0 N-CA-C 107.472 -1.307 . . . . 65.07 107.472 177.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1230 ' ' MET . . . . . 0.417 ' HB3' ' CB ' ' B' 1234 ' ' PHE . 5.4 mmm . . . . . 0 N--CA 1.433 -1.319 0 N-CA-C 104.705 -2.331 . . . . 80.32 104.705 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1231 ' ' SER . . . . . . . . . . . . . 2.6 m 78.84 -173.11 0.06 Allowed 'General case' 0 CA--C 1.539 0.542 2 O-C-N 111.99 -6.694 . . . . 79.92 118.805 -17.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1232 ' ' ASP . . . . . 0.544 ' HA ' HG12 ' B' 1235 ' ' ILE . 23.8 p-10 -43.25 154.99 0.07 Allowed 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 119.203 3.038 . . . . 77.91 119.203 -177.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 62.97 -59.19 0.15 Allowed 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 112.253 -2.248 . . . . 73.88 109.439 -159.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1234 ' ' PHE . . . . . 0.43 ' HE1' ' H ' ' B' 1215 ' ' ASP . 8.3 t80 -55.76 -44.78 77.99 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 120.044 -1.66 . . . . 68.98 113.765 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1235 ' ' ILE . . . . . 0.544 HG12 ' HA ' ' B' 1232 ' ' ASP . 8.0 pt -44.6 -38.88 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 121.772 2.078 . . . . 64.53 112.754 175.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1236 ' ' LYS . . . . . 0.489 ' HG2' HG13 ' B' 1235 ' ' ILE . 23.7 mmmt -75.83 -38.03 58.48 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 118.055 -0.974 . . . . 66.36 109.627 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -65.22 -26.22 68.03 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 120.91 1.687 . . . . 56.6 113.243 175.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -66.45 -47.99 71.4 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 106.786 -1.561 . . . . 56.79 106.786 175.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1239 ' ' MET . . . . . 0.474 ' HB2' ' O ' ' B' 1236 ' ' LYS . 19.6 mmm -49.84 -49.18 50.06 Favored 'General case' 0 C--O 1.25 1.087 0 O-C-N 124.528 1.143 . . . . 53.63 111.666 171.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.76 -37.06 85.3 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 121.243 0.544 . . . . 51.74 110.817 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1241 ' ' LEU . . . . . 0.437 HD21 ' HB3' ' B' 1212 ' ' LEU . 60.3 tp -64.78 -47.94 76.31 Favored 'General case' 0 C--N 1.342 0.25 0 O-C-N 120.555 -1.34 . . . . 44.86 107.57 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1242 ' ' PHE . . . . . 0.604 ' HE2' HD13 ' B' 1266 ' ' LEU . 14.8 m-30 -65.88 -34.06 77.26 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 124.546 1.138 . . . . 42.78 111.26 -174.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1243 ' ' ALA . . . . . 0.441 ' HA ' ' HG3' ' B' 1271 ' ' MET . . . -67.14 -51.3 55.61 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 113.929 1.085 . . . . 40.96 113.929 172.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -69.59 -28.92 66.36 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 122.492 1.139 . . . . 43.06 108.763 -173.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1245 ' ' GLN . . . . . 0.4 ' O ' HG22 ' B' 1249 ' ' VAL . 43.3 mm-40 -75.53 -37.27 60.18 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.369 -1.457 . . . . 46.45 112.608 171.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1246 ' ' ALA . . . . . 0.485 ' HA ' HG22 ' B' 1249 ' ' VAL . . . -60.67 -23.42 64.81 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 115.284 1.587 . . . . 41.78 115.284 177.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1247 ' ' LYS . . . . . 0.404 ' HD2' ' HA ' ' B' 1247 ' ' LYS . 26.0 tptt -62.44 -41.85 99.04 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.196 -0.911 . . . . 52.2 109.42 171.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1248 ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -91.26 -30.8 16.41 Favored 'General case' 0 C--O 1.244 0.808 0 O-C-N 121.586 -0.696 . . . . 53.55 112.705 -172.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1249 ' ' VAL . . . . . 0.718 ' HA ' ' HB2' ' B' 1167 ' ' LYS . 19.1 m -84.2 169.43 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 124.684 2.183 . . . . 34.41 114.808 -173.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1250 ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -111.99 -61.89 1.65 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 111.635 -2.53 . . . . 33.38 111.573 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1251 ' ' ILE . . . . . 0.582 ' HA ' ' O ' ' B' 1280 ' ' VAL . 48.5 mm -107.24 106.69 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 123.839 0.712 . . . . 29.54 109.097 -173.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1252 ' ' ILE . . . . . 0.634 ' HB ' HG12 ' B' 1281 ' ' ILE . 51.1 mt -92.41 118.5 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 N-CA-C 105.086 -2.19 . . . . 32.44 105.086 176.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1253 ' ' VAL . . . . . 0.46 ' HB ' ' HA ' ' B' 1170 ' ' VAL . 72.2 t -102.32 87.29 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.254 1.339 0 N-CA-C 104.634 -2.358 . . . . 30.57 104.634 -178.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1254 ' ' THR . . . . . . . . . . . . 0.331 1.4 t -91.3 103.53 16.18 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 127.096 3.331 . . . . 35.04 112.739 -175.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1255 ' ' THR . . . . . . . . . . . . . 17.1 m -99.7 -26.89 13.91 Favored 'General case' 0 C--N 1.318 -0.797 1 CA-C-N 106.0 -5.091 . . . . 34.62 109.451 -177.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1256 ' ' ALA . . . . . 0.495 ' HB3' ' ND2' ' B' 1291 ' ' ASN . . . -47.79 96.65 0.01 OUTLIER 'General case' 0 C--O 1.257 1.475 0 CA-C-N 123.499 2.863 . . . . 42.72 117.74 -169.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1257 ' ' LEU . . . . . 0.431 HD11 ' HB3' ' B' 1288 ' ' ASN . 3.7 tt -133.9 146.0 50.14 Favored 'General case' 0 C--O 1.251 1.156 0 N-CA-C 101.845 -3.391 . . . . 52.43 101.845 -173.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 64.4 mt -119.08 122.14 29.82 Favored Pre-proline 0 C--N 1.313 -1.002 1 N-CA-C 100.102 -4.036 . . . . 59.41 100.102 177.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -56.0 126.73 23.35 Favored 'Trans proline' 0 C--O 1.247 0.955 0 C-N-CA 123.441 2.76 . . . . 62.68 115.659 -173.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 82.26 2.0 90.5 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 112.955 -1.929 . . . . 64.16 111.366 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 85.3 mttt -120.39 145.79 41.36 Favored Pre-proline 0 N--CA 1.475 0.801 0 O-C-N 118.474 -2.78 . . . . 68.53 105.181 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -56.19 136.56 75.85 Favored 'Trans proline' 0 C--N 1.362 1.273 0 C-N-CA 123.899 3.066 . . . . 61.99 112.077 164.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1263 ' ' ALA . . . . . 0.549 ' H ' ' HA3' ' B' 1289 ' ' GLY . . . -61.3 119.83 49.66 Favored Pre-proline 0 C--O 1.242 0.671 0 CA-C-N 113.024 -1.898 . . . . 57.15 112.28 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1264 ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' B' 1263 ' ' ALA . 94.6 Cg_endo -55.08 146.49 58.53 Favored 'Trans proline' 0 CA--C 1.501 -1.157 0 C-N-CA 124.718 3.612 . . . . 51.57 112.339 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -87.91 68.31 9.25 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 122.916 1.341 . . . . 54.55 109.342 -171.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1266 ' ' LEU . . . . . 0.604 HD13 ' HE2' ' B' 1242 ' ' PHE . 91.0 mt -81.03 -30.15 34.92 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 111.51 -2.586 . . . . 46.86 111.798 -172.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1267 ' ' ILE . . . . . 0.588 ' HB ' ' HA ' ' B' 1292 ' ' CYS . 28.3 mm -96.82 100.35 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 N-CA-C 104.665 -2.346 . . . . 41.04 104.665 177.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1268 ' ' THR . . . . . . . . . . . . . 1.1 p -75.03 151.42 38.73 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 125.486 1.741 . . . . 39.58 113.222 175.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1269 ' ' ARG . . . . . . . . . . . . . 78.1 mtt85 -57.65 -40.85 80.23 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-N 119.805 1.184 . . . . 53.15 111.5 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -54.61 -43.6 72.37 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 114.759 1.392 . . . . 42.96 114.759 169.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1271 ' ' MET . . . . . 0.441 ' HG3' ' HA ' ' B' 1243 ' ' ALA . 39.4 ttm -60.8 -47.95 84.0 Favored 'General case' 0 C--O 1.241 0.613 0 O-C-N 120.945 -1.097 . . . . 43.89 111.846 176.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1272 ' ' VAL . . . . . 0.474 HG13 HD12 ' B' 1281 ' ' ILE . 15.3 t -55.26 -52.4 45.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-N 115.091 -0.959 . . . . 38.37 110.113 175.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.94 2.24 7.25 Favored 'General case' 0 C--N 1.362 1.129 0 N-CA-C 115.039 1.496 . . . . 47.46 115.039 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1274 ' ' SER . . . . . . . . . . . . . 50.3 m -97.26 -14.58 21.29 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 114.79 1.404 . . . . 38.38 114.79 172.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1275 ' ' MET . . . . . 0.487 ' SD ' HD11 ' B' 1281 ' ' ILE . 94.1 mtp -64.14 171.27 3.08 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 116.484 2.031 . . . . 37.81 116.484 -177.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -66.63 147.21 53.58 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 114.28 -1.327 . . . . 49.26 109.723 165.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -79.1 161.47 26.49 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.859 0.837 . . . . 34.46 112.931 174.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 81.3 25.22 55.32 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 112.712 -2.04 . . . . 33.53 112.926 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1279 ' ' SER . . . . . . . . . . . . . 13.0 m -126.64 165.35 19.38 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 116.439 -1.743 . . . . 31.31 111.363 -163.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1280 ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' B' 1251 ' ' ILE . 73.8 t -136.7 136.89 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 124.165 3.166 . . . . 29.32 109.856 -171.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1281 ' ' ILE . . . . . 0.634 HG12 ' HB ' ' B' 1252 ' ' ILE . 76.0 mt -113.26 113.36 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 103.735 -2.691 . . . . 31.93 103.735 171.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1282 ' ' VAL . . . . . 0.405 HG11 ' HA ' ' B' 1141 ' ' ALA . 4.0 t -99.33 123.27 51.92 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 N-CA-C 106.408 -1.701 . . . . 29.48 106.408 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 18.2 t0 -93.69 108.76 20.46 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 114.797 -1.092 . . . . 34.5 109.013 174.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1284 ' ' LEU . . . . . 0.495 ' HA ' HD12 ' B' 1315 ' ' LEU . 7.9 mp -84.27 -37.28 21.92 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 104.621 -2.363 . . . . 37.94 104.621 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -80.57 8.23 8.3 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 122.497 1.141 . . . . 40.92 113.277 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1286 ' ' ALA . . . . . 0.551 ' HA ' ' HA2' ' B' 1290 ' ' GLY . . . -43.46 -47.0 7.03 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 117.839 2.533 . . . . 44.39 117.839 175.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1287 ' ' GLN . . . . . 0.443 ' HA ' HG22 ' B' 1313 ' ' THR . 0.6 OUTLIER -75.17 -30.09 60.61 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 112.931 0.715 . . . . 51.46 112.931 -175.332 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B 1288 ' ' ASN . . . . . 0.431 ' HB3' HD11 ' B' 1257 ' ' LEU . 0.5 OUTLIER -107.52 48.1 0.86 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 122.931 1.348 . . . . 57.75 108.559 178.748 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B 1289 ' ' GLY . . . . . 0.549 ' HA3' ' H ' ' B' 1263 ' ' ALA . . . 129.21 -29.43 3.88 Favored Glycine 0 N--CA 1.428 -1.883 0 O-C-N 119.46 -2.025 . . . . 49.85 116.381 169.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1290 ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' B' 1286 ' ' ALA . . . 76.88 100.79 0.16 Allowed Glycine 0 C--O 1.245 0.804 0 CA-C-N 119.111 1.456 . . . . 45.93 109.775 -176.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1291 ' ' ASN . . . . . 0.495 ' ND2' ' HB3' ' B' 1256 ' ' ALA . 22.8 t-20 -71.48 -39.99 70.53 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 119.406 -2.232 . . . . 42.67 113.647 175.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1292 ' ' CYS . . . . . 0.588 ' HA ' ' HB ' ' B' 1267 ' ' ILE . 36.1 t -83.4 150.69 25.9 Favored 'General case' 0 C--O 1.24 0.593 0 O-C-N 119.911 -1.743 . . . . 38.82 106.821 171.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1293 ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -75.39 -49.86 17.68 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 122.58 1.181 . . . . 46.71 109.251 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1294 ' ' TYR . . . . . 0.444 ' HB3' HG11 ' B' 1309 ' ' VAL . 0.1 OUTLIER -59.13 -18.29 34.44 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 115.655 1.724 . . . . 47.23 115.655 -174.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B 1295 ' ' THR . . . . . 0.515 ' O ' ' HD3' ' B' 1297 ' ' PRO . 97.0 m -37.69 105.17 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 115.64 1.719 . . . . 36.02 115.64 168.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 71.4 t -88.34 106.18 11.69 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 105.785 -1.931 . . . . 37.26 105.785 170.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1297 ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' B' 1295 ' ' THR . 60.5 Cg_exo -58.89 111.42 0.89 Allowed 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 123.241 2.627 . . . . 35.09 115.811 -177.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 95.55 10.69 56.58 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 113.307 -1.77 . . . . 35.97 111.059 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -148.01 -178.03 6.06 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 124.9 2.286 . . . . 40.39 110.046 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1300 ' ' ILE . . . . . 0.588 HD13 ' HG3' ' B' 1148 ' ' GLU . 30.3 mt -110.71 162.79 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 111.006 -2.815 . . . . 37.43 105.367 172.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 61.0 t80 -150.77 130.38 13.08 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 104.052 -2.573 . . . . 44.13 104.052 170.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1302 ' ' THR . . . . . . . . . . . . . 25.7 m -95.62 136.16 36.37 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.447 -0.945 . . . . 39.78 108.447 173.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1303 ' ' THR . . . . . . . . . . . . . 46.6 p -77.25 177.22 8.07 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.287 -1.324 . . . . 43.29 113.015 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -57.63 -59.02 5.82 Favored 'General case' 0 N--CA 1.435 -1.214 0 O-C-N 121.091 -1.006 . . . . 53.07 110.805 162.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -60.5 -22.75 63.89 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 113.759 1.022 . . . . 43.97 113.759 -174.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 108.62 47.42 0.91 Allowed Glycine 0 N--CA 1.432 -1.583 0 CA-C-O 122.57 1.094 . . . . 41.12 112.713 166.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1307 ' ' VAL . . . . . 0.435 HG21 ' HB2' ' B' 1275 ' ' MET . 95.1 t -122.95 128.16 75.06 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 N-CA-C 102.226 -3.25 . . . . 38.12 102.226 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1308 ' ' LYS . . . . . 0.477 ' HB2' HG22 ' B' 1280 ' ' VAL . 43.7 mmtt -83.53 109.02 17.04 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 103.013 -2.958 . . . . 36.34 103.013 176.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1309 ' ' VAL . . . . . 0.444 HG11 ' HB3' ' B' 1294 ' ' TYR . 44.9 t -88.1 113.44 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 O-C-N 117.288 -3.382 . . . . 30.4 103.284 168.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1310 ' ' ILE . . . . . 0.49 HG12 HG23 ' B' 1300 ' ' ILE . 19.2 mt -102.41 100.16 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-N 113.617 -1.629 . . . . 30.82 107.626 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1311 ' ' GLY . . . . . 0.494 ' HA3' HG23 ' B' 1295 ' ' THR . . . -97.57 53.59 1.29 Allowed Glycine 0 C--N 1.352 1.426 0 C-N-CA 119.084 -1.531 . . . . 26.53 110.704 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1312 ' ' TYR . . . . . 0.438 ' O ' ' HG ' ' B' 1315 ' ' LEU . 0.6 OUTLIER -74.88 94.37 2.79 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 120.759 -1.436 . . . . 38.0 108.745 -171.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B 1313 ' ' THR . . . . . 0.443 HG22 ' HA ' ' B' 1287 ' ' GLN . 0.7 OUTLIER -54.76 -35.33 63.65 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 121.077 -1.014 . . . . 29.8 112.24 174.551 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -75.1 4.28 7.08 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 126.758 2.023 . . . . 39.04 115.376 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1315 ' ' LEU . . . . . 0.495 HD12 ' HA ' ' B' 1284 ' ' LEU . 34.6 mt -43.9 -50.99 18.52 Favored Pre-proline 0 N--CA 1.465 0.301 0 N-CA-C 118.231 2.678 . . . . 31.08 118.231 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1316 ' ' PRO . . . . . 0.509 ' HB3' ' HB3' ' B' 1133 ' ' MET . 34.3 Cg_exo -56.84 -27.5 72.31 Favored 'Trans proline' 0 CA--C 1.546 1.094 0 C-N-CA 123.628 2.886 . . . . 26.1 115.315 174.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -82.06 -35.01 22.5 Favored Glycine 0 N--CA 1.435 -1.407 0 O-C-N 120.715 -1.24 . . . . 23.17 110.139 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -52.52 3.43 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.588 1 N-CA-C 123.437 4.606 . . . . 40.4 123.437 -171.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 21.3 tp -132.75 66.54 76.71 Favored Pre-proline 0 C--O 1.243 0.741 0 O-C-N 118.746 -2.471 . . . . 23.6 108.269 -175.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1320 ' ' PRO . . . . . 0.635 ' HG2' ' HA2' ' A' 1150 ' ' GLY . 19.1 Cg_endo -26.57 -71.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.053 1 C-N-CA 126.196 4.597 . . . . 22.35 118.72 -166.323 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B 1321 ' ' THR . . . . . 0.483 HG23 ' HD2' ' B' 1045 ' ' PHE . 3.3 m -67.48 -40.62 85.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 119.952 1.251 . . . . 26.52 108.995 -169.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1322 ' ' GLN . . . . . 0.803 ' HB2' ' HA ' ' A' 1151 ' ' ARG . 32.4 tp60 -79.11 -33.14 44.6 Favored 'General case' 0 CA--C 1.488 -1.41 0 O-C-N 120.66 -1.275 . . . . 24.38 110.882 -173.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1323 ' ' SER . . . . . . . . . . . . . 71.3 m -63.07 -47.5 82.66 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 109.184 -0.673 . . . . 22.8 109.184 176.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1324 ' ' SER . . . . . . . . . . . . . 22.0 m -58.32 -37.0 74.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 122.881 1.324 . . . . 21.25 114.248 175.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1325 ' ' GLN . . . . . 0.489 ' NE2' HG23 ' B' 1022 ' ' THR . 51.6 tp60 -65.03 -54.36 31.43 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.468 -1.242 . . . . 31.34 111.804 176.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1326 ' ' LEU . . . . . . . . . . . . . 23.8 mt -73.09 -40.4 65.03 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 117.688 -1.149 . . . . 31.56 110.944 -172.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1327 ' ' TYR . . . . . . . . . . . . . 42.5 t80 -57.94 -50.95 71.62 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 106.118 -1.808 . . . . 22.73 106.118 173.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1328 ' ' GLY . . . . . 0.717 ' HA3' HG21 ' B' 1022 ' ' THR . . . -52.36 -42.63 56.91 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 114.582 0.593 . . . . 21.91 114.582 174.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1329 ' ' THR . . . . . . . . . . . . . 5.5 m -71.94 -25.45 61.89 Favored 'General case' 0 C--O 1.249 1.057 0 O-C-N 120.52 -1.577 . . . . 22.15 111.936 176.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1330 ' ' ASN . . . . . 0.448 ' ND2' ' HB2' ' A' 1160 ' ' ALA . 24.7 m120 -62.56 -37.45 86.21 Favored 'General case' 0 C--O 1.249 1.04 0 CA-C-N 120.893 1.679 . . . . 26.18 110.58 170.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1331 ' ' LEU . . . . . 0.715 HD22 HD22 ' B' 1070 ' ' LEU . 59.1 mt -68.65 -44.0 75.07 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 113.859 -1.519 . . . . 23.68 109.977 176.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1332 ' ' VAL . . . . . 0.548 HG13 HD11 ' B' 1029 ' ' LEU . 69.9 t -53.4 -55.36 13.32 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 CA-C-O 116.846 -1.55 . . . . 26.57 108.139 174.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1333 ' ' ASN . . . . . 0.693 ' HA ' ' HD2' ' B' 1336 ' ' LYS . 84.4 m-20 -55.8 -40.29 72.52 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 115.459 1.652 . . . . 28.08 115.459 175.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1334 ' ' LEU . . . . . 0.457 ' CD2' HG11 ' B' 1090 ' ' VAL . 12.9 tp -56.54 -48.24 77.7 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 124.722 1.209 . . . . 27.43 111.357 169.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1335 ' ' LEU . . . . . 0.458 ' HA ' ' HB2' ' B' 1338 ' ' LEU . 7.2 mt -71.62 -22.32 61.72 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 119.92 -0.712 . . . . 30.5 111.648 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1336 ' ' LYS . . . . . 0.693 ' HD2' ' HA ' ' B' 1333 ' ' ASN . 97.0 mttt -67.01 -47.98 69.79 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.297 -1.001 . . . . 41.65 108.297 171.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1337 ' ' LEU . . . . . 0.732 HD21 ' HD2' ' B' 1123 ' ' ARG . 6.6 mp -71.21 -35.08 71.39 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 119.591 -1.943 . . . . 42.08 112.053 176.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1338 ' ' LEU . . . . . 0.458 ' HB2' ' HA ' ' B' 1335 ' ' LEU . 35.9 mt -69.78 -68.27 0.43 Allowed 'General case' 0 N--CA 1.438 -1.048 0 O-C-N 119.638 -1.914 . . . . 35.03 110.446 176.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1339 ' ' CYS . . . . . 0.515 ' SG ' ' HA ' ' B' 1342 ' ' LYS . 52.6 t -93.32 69.86 4.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.929 1.347 . . . . 37.33 108.595 -174.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 57.3 mttp -65.88 -27.81 68.49 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 114.193 1.183 . . . . 50.51 114.193 -175.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -71.44 -21.32 61.99 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 120.998 -1.064 . . . . 54.21 112.646 168.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1342 ' ' LYS . . . . . 0.515 ' HA ' ' SG ' ' B' 1339 ' ' CYS . 7.3 mptt 52.07 50.48 18.42 Favored 'General case' 0 C--O 1.252 1.199 0 CA-C-O 124.969 2.319 . . . . 50.99 111.575 -163.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -76.55 -33.24 58.54 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 111.264 -2.698 . . . . 48.82 111.274 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1344 ' ' GLY . . . . . 0.424 ' O ' ' HA2' ' B' 1001 ' ' GLY . . . 108.34 14.45 16.35 Favored Glycine 0 C--O 1.244 0.77 0 CA-C-O 117.748 -1.585 . . . . 40.43 112.194 174.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -131.09 156.47 45.16 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 104.835 -2.283 . . . . 47.56 104.835 166.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1346 ' ' ILE . . . . . 0.562 HG13 HG23 ' B' 1068 ' ' ILE . 26.2 mm -81.95 94.23 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 O-C-N 118.955 -2.34 . . . . 42.49 112.195 -172.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1347 ' ' THR . . . . . . . . . . . . . 88.1 m -59.21 105.31 0.32 Allowed 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 106.919 -1.511 . . . . 38.12 106.919 159.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 21.7 t -90.46 96.43 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 104.761 -2.311 . . . . 37.5 104.761 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 6.6 t70 -75.39 129.03 36.67 Favored 'General case' 0 C--O 1.265 1.891 0 CA-C-N 110.995 -2.821 . . . . 43.85 110.301 -175.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1350 ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -117.24 0.82 12.37 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.934 -1.104 . . . . 39.81 111.508 175.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 7.9 t70 -81.13 -43.86 18.77 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 119.236 0.926 . . . . 51.29 109.857 -175.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.2 145.13 51.64 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-O 122.105 0.955 . . . . 39.78 110.936 174.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1353 ' ' VAL . . . . . 0.467 ' HB ' HG13 ' B' 1373 ' ' ILE . 28.7 m -68.47 -36.67 75.75 Favored 'Isoleucine or valine' 0 C--O 1.25 1.131 0 CA-C-N 114.952 -1.022 . . . . 39.28 110.726 -173.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1354 ' ' VAL . . . . . 0.629 HG21 ' HG3' ' B' 1123 ' ' ARG . 49.7 t -70.41 -47.71 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 O-C-N 121.799 -0.563 . . . . 35.7 111.19 -172.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1355 ' ' ILE . . . . . 0.717 ' HA ' HG12 ' B' 1358 ' ' VAL . 38.7 mm -70.11 -41.52 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 O-C-N 121.398 -0.813 . . . . 35.77 109.797 176.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 47.3 tpt85 -47.63 -32.54 5.67 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 115.375 1.62 . . . . 38.55 115.375 169.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1357 ' ' GLY . . . . . 0.585 ' CA ' ' HB2' ' B' 1370 ' ' ALA . . . -91.94 -40.87 5.12 Favored Glycine 0 N--CA 1.442 -0.901 0 O-C-N 121.627 -0.67 . . . . 29.58 114.011 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1358 ' ' VAL . . . . . 0.717 HG12 ' HA ' ' B' 1355 ' ' ILE . 4.0 p -66.76 -36.42 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 114.454 1.279 . . . . 32.06 114.454 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1359 ' ' THR . . . . . . . . . . . . . 4.1 m -72.35 81.16 1.03 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 123.3 1.524 . . . . 29.0 107.205 175.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1360 ' ' VAL . . . . . 0.458 HG11 ' HG2' ' B' 1095 ' ' PRO . 14.6 m -63.24 -29.23 46.73 Favored 'Isoleucine or valine' 0 C--O 1.248 1.001 0 O-C-N 121.129 -0.982 . . . . 29.68 113.392 177.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 49.1 mt -138.3 108.6 4.83 Favored 'Isoleucine or valine' 0 C--O 1.249 1.058 0 N-CA-C 104.173 -2.529 . . . . 32.05 104.173 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1362 ' ' ARG . . . . . 0.664 ' HA ' HG23 ' B' 1111 ' ' THR . 57.1 ttt180 -91.5 105.08 17.5 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 117.99 -2.944 . . . . 32.52 107.396 169.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1363 ' ' ALA . . . . . 0.654 ' H ' ' HA ' ' B' 1111 ' ' THR . . . 45.45 58.82 3.94 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 116.91 2.189 . . . . 35.68 116.91 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 91.96 -47.27 2.7 Favored Glycine 0 CA--C 1.538 1.53 0 CA-C-O 118.017 -1.435 . . . . 34.26 112.646 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -68.32 115.31 7.62 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 123.265 1.507 . . . . 51.07 109.58 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 24.4 mt -74.76 95.8 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.981 0 CA-C-O 123.427 1.584 . . . . 39.87 112.54 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1367 ' ' THR . . . . . . . . . . . . . 11.8 p -90.43 13.63 15.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 110.445 -3.071 . . . . 38.01 113.039 -174.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1368 ' ' TRP . . . . . . . . . . . . . 32.2 t90 -77.96 135.8 62.78 Favored Pre-proline 0 C--O 1.233 0.197 0 C-N-CA 125.582 1.553 . . . . 42.14 111.024 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -91.19 -167.83 3.03 Favored 'Cis proline' 0 CA--C 1.542 0.877 0 CA-C-N 123.616 2.327 . . . . 43.26 110.21 -9.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1370 ' ' ALA . . . . . 0.585 ' HB2' ' CA ' ' B' 1357 ' ' GLY . . . -72.34 167.86 28.64 Favored Pre-proline 0 C--O 1.244 0.8 0 CA-C-O 117.142 -1.408 . . . . 46.52 110.136 163.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1371 ' ' PRO . . . . . 0.514 ' O ' HG12 ' B' 1373 ' ' ILE . 29.6 Cg_endo -56.55 151.48 46.02 Favored 'Trans proline' 0 CA--C 1.548 1.191 0 CA-C-N 125.864 3.13 . . . . 51.95 109.07 164.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1372 ' ' PRO . . . . . 0.473 ' HB2' ' NE2' ' B' 1374 ' ' GLN . 64.7 Cg_endo -64.65 100.44 0.34 Allowed 'Trans proline' 0 C--O 1.24 0.589 0 C-N-CA 122.477 2.118 . . . . 56.27 113.779 -168.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1373 ' ' ILE . . . . . 0.514 HG12 ' O ' ' B' 1371 ' ' PRO . 17.0 mm -100.63 101.33 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 102.22 -3.252 . . . . 60.83 102.22 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1374 ' ' GLN . . . . . 0.473 ' NE2' ' HB2' ' B' 1372 ' ' PRO . 17.3 mp0 -62.55 120.23 10.74 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 122.78 1.276 . . . . 66.1 109.764 -177.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 16.4 t -81.76 121.89 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 104.213 -2.514 . . . . 63.47 104.213 176.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.227 -4.724 0 O-C-N 121.92 -0.488 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.291 0 CA-C-O 120.375 0.131 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.35 -32.81 40.12 Favored 'General case' 0 C--O 1.214 -0.789 0 C-N-CA 124.74 1.216 . . . . 0.0 113.983 176.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -70.14 -63.33 1.1 Allowed 'General case' 0 C--O 1.245 0.865 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 170.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 23' ' ' THR . . . . . 0.564 ' HA ' HD22 ' C' ' 26' ' ' LEU . 0.2 OUTLIER -45.36 -34.84 3.22 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 125.748 1.619 . . . . 0.0 115.061 -174.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.45 -67.0 0.29 Allowed 'General case' 0 C--O 1.256 1.419 0 N-CA-C 115.238 1.569 . . . . 0.0 115.238 166.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -55.43 -38.09 68.54 Favored 'General case' 0 C--N 1.356 0.88 0 O-C-N 119.942 -1.724 . . . . 0.0 113.457 173.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.564 HD22 ' HA ' ' C' ' 23' ' ' THR . 4.8 mp -59.25 -43.4 92.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.438 176.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.555 HD11 HD12 ' C' ' 182' ' ' ILE . 13.6 mt -58.2 -53.46 58.01 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 125.139 1.375 . . . . 0.0 114.268 177.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 28' ' ' LYS . . . . . . . . . . . . . 11.9 pttm -58.58 -31.86 68.41 Favored 'General case' 0 C--O 1.242 0.708 0 O-C-N 120.004 -1.685 . . . . 0.0 113.726 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -65.62 -32.31 73.81 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 174.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.536 ' HA ' ' HB3' ' C' ' 107' ' ' ASP . 67.1 m -58.45 -34.55 70.96 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 119.609 3.188 . . . . 0.0 119.609 -158.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 59.98 -76.93 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 122.509 2.413 . . . . 0.0 107.396 -165.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 32' ' ' SER . . . . . 0.746 ' HB2' ' HA ' ' C' ' 106' ' ' THR . 15.4 m -96.32 136.2 37.12 Favored 'General case' 0 C--O 1.243 0.724 0 O-C-N 118.087 -2.883 . . . . 0.0 110.089 175.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 91.3 t -129.89 122.96 55.68 Favored 'Isoleucine or valine' 0 C--O 1.247 0.962 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.777 ' HB ' HG13 ' C' ' 109' ' ' VAL . 26.9 mm -100.12 117.99 46.13 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 168.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 27.7 mt -94.36 118.04 39.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 119.481 1.037 . . . . 0.0 109.663 170.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 36' ' ' THR . . . . . 0.501 ' HA ' ' HD3' ' C' ' 37' ' ' PRO . 3.6 m -102.96 108.28 57.98 Favored Pre-proline 0 CA--C 1.55 0.95 0 O-C-N 120.172 -1.58 . . . . 0.0 112.424 -176.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . 0.707 ' HG2' HG13 ' C' ' 68' ' ' ILE . 32.5 Cg_exo -74.17 37.74 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 1 C-N-CA 125.657 4.238 . . . . 0.0 118.772 -175.067 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 38' ' ' GLY . . . . . 0.499 ' HA3' ' HB2' ' C' ' 114' ' ' ALA . . . -88.24 94.35 1.98 Allowed Glycine 0 C--N 1.335 0.489 0 O-C-N 119.555 -1.966 . . . . 0.0 111.987 -166.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 39' ' ' TYR . . . . . 0.59 ' HB2' ' HA3' ' C' ' 73' ' ' GLY . 23.4 t80 68.66 -57.07 0.51 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 116.922 -1.513 . . . . 0.0 114.648 175.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -49.07 -46.87 33.29 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-N 120.39 1.45 . . . . 0.0 113.301 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 41' ' ' MET . . . . . 0.575 ' HA ' ' HB3' ' C' ' 46' ' ' ALA . 49.1 ttm -44.67 -52.07 8.58 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 173.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.86 -59.15 2.85 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.812 -175.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 8.2 p -57.84 -43.81 85.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 122.881 1.325 . . . . 0.0 109.179 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' C' ' 176' ' ' LYS . . . -85.44 6.66 25.79 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 119.801 -1.812 . . . . 0.0 113.496 -176.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 45' ' ' GLN . . . . . . . . . . . . 0.348 0.0 OUTLIER 49.52 25.87 1.53 Allowed 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 118.175 2.657 . . . . 0.0 118.175 -169.17 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.575 ' HB3' ' HA ' ' C' ' 41' ' ' MET . . . -70.2 -8.33 49.08 Favored 'General case' 0 C--O 1.255 1.359 0 O-C-N 120.352 -1.467 . . . . 0.0 111.266 -177.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 47' ' ' GLN . . . . . 0.451 ' O ' HG12 ' C' ' 50' ' ' VAL 0.365 0.0 OUTLIER -69.54 -38.22 77.41 Favored 'General case' 0 CA--C 1.51 -0.568 0 O-C-N 118.677 -2.514 . . . . 0.0 115.532 174.836 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' C' C ' 48' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -58.98 -58.45 19.43 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-O 115.292 -2.29 . . . . 0.0 111.313 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 49' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -61.71 -36.57 73.89 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 124.324 3.349 . . . . 0.0 111.711 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . 0.506 ' HA ' HG22 ' C' ' 53' ' ' ILE . 0.8 OUTLIER -53.16 -39.09 32.44 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-N 122.047 2.203 . . . . 0.0 112.839 177.254 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.34 -38.98 69.45 Favored 'General case' 0 C--O 1.247 0.927 0 O-C-N 121.66 -0.65 . . . . 0.0 112.007 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -75.65 -48.77 20.67 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 120.746 -1.221 . . . . 0.0 108.277 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 53' ' ' ILE . . . . . 0.556 ' HB ' HD12 ' C' ' 183' ' ' LEU . 8.1 tp -63.38 -37.4 79.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 C-N-CA 119.416 -0.914 . . . . 0.0 113.084 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . 0.541 HG21 ' HE1' ' C' ' 66' ' ' PHE . 90.0 m -68.56 -41.99 78.96 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 119.961 -1.712 . . . . 0.0 109.49 -178.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -53.67 -42.39 67.86 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 124.626 1.17 . . . . 0.0 112.066 168.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -66.44 -39.44 88.89 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 120.927 -1.108 . . . . 0.0 111.378 173.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 57' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' C' ' 53' ' ' ILE . 97.9 mt -67.63 -33.52 75.14 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 119.862 1.21 . . . . 0.0 107.896 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . 0.458 ' HD2' ' HA ' ' C' ' 58' ' ' ARG . 0.8 OUTLIER -63.9 -46.51 84.49 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 121.897 0.856 . . . . 0.0 111.473 178.559 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.67 -35.97 71.28 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 124.068 1.89 . . . . 0.0 114.029 173.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -68.06 -24.07 65.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.495 -1.23 . . . . 0.0 113.53 173.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.91 79.75 1.11 Allowed Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 mt -141.94 125.97 16.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 112.89 -1.655 . . . . 0.0 107.913 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 63' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' C' ' 32' ' ' SER . 17.3 t30 -72.41 87.91 1.18 Allowed 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 125.214 1.406 . . . . 0.0 109.601 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.473 HG21 HG23 ' C' ' 54' ' ' THR . 9.2 p -93.17 139.98 17.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 CA-C-O 122.11 0.957 . . . . 0.0 111.591 -177.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 65' ' ' ARG . . . . . 0.416 ' HB2' HD13 ' C' ' 34' ' ' ILE . 84.1 mmt-85 -138.38 120.6 15.79 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 103.19 -2.892 . . . . 0.0 103.19 177.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . 0.541 ' HE1' HG21 ' C' ' 54' ' ' THR . 8.2 m-85 -79.87 126.13 30.6 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 165.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -100.53 86.37 0.64 Allowed Glycine 0 N--CA 1.478 1.45 0 O-C-N 119.002 -2.312 . . . . 0.0 109.509 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 68' ' ' ILE . . . . . 0.707 HG13 ' HG2' ' C' ' 37' ' ' PRO . 3.2 mp -87.09 84.93 2.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 O-C-N 118.982 -2.481 . . . . 0.0 107.857 -172.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -74.24 116.91 57.32 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-O 116.569 -1.681 . . . . 0.0 108.527 170.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 70' ' ' PRO . . . . . 0.479 ' HD3' HG12 ' A' 1157 ' ' ILE . 58.4 Cg_endo -54.62 -59.29 0.89 Allowed 'Trans proline' 0 C--N 1.333 -0.247 0 C-N-CA 124.383 3.389 . . . . 0.0 117.255 -170.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 4.4 m -68.23 95.56 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 113.303 -1.771 . . . . 0.0 108.506 169.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -161.17 109.91 1.58 Allowed 'General case' 0 C--O 1.242 0.66 0 CA-C-N 109.031 -3.713 . . . . 0.0 107.16 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 73' ' ' GLY . . . . . 0.613 ' C ' ' HD2' ' C' ' 74' ' ' ARG . . . 69.48 -90.96 0.3 Allowed Glycine 0 CA--C 1.506 -0.498 0 CA-C-O 118.285 -1.286 . . . . 0.0 112.975 172.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 74' ' ' ARG . . . . . 0.846 ' HG3' ' HG2' ' B' 1203 ' ' GLN . 1.7 mpt_? -133.17 114.06 13.41 Favored 'General case' 0 C--O 1.256 1.419 0 CA-C-N 118.196 0.998 . . . . 0.0 111.935 -167.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.534 HD22 ' SD ' ' B' 1207 ' ' MET . 1.7 mp 63.13 142.84 0.06 OUTLIER Pre-proline 0 C--O 1.236 0.344 0 C-N-CA 128.173 2.589 . . . . 0.0 117.069 169.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 76' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' B' 1178 ' ' LEU . 83.1 Cg_endo -71.47 149.9 56.91 Favored 'Trans proline' 0 C--N 1.364 1.365 0 C-N-CA 123.289 2.659 . . . . 0.0 111.093 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 70.81 -96.53 0.59 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -171.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 48.55 -84.32 0.01 OUTLIER 'General case' 0 C--O 1.24 0.602 0 C-N-CA 126.089 1.756 . . . . 0.0 111.677 173.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 79' ' ' MET . . . . . 0.548 ' HA ' ' HB2' ' C' ' 82' ' ' LEU . 0.0 OUTLIER -60.05 -25.81 65.64 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.226 1.01 . . . . 0.0 113.1 177.229 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -58.02 -55.02 40.35 Favored 'General case' 0 C--O 1.24 0.576 0 O-C-N 121.659 -0.651 . . . . 0.0 111.497 170.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 69.8 t -73.3 -38.06 53.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 O-C-N 119.664 -1.898 . . . . 0.0 108.896 177.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.548 ' HB2' ' HA ' ' C' ' 79' ' ' MET . 96.0 mt -48.73 -31.77 7.44 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 122.595 2.452 . . . . 0.0 114.234 169.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.444 HD13 ' O ' ' C' ' 79' ' ' MET . 0.7 OUTLIER -74.82 -32.06 61.86 Favored 'General case' 0 C--O 1.221 -0.399 0 O-C-N 121.429 -0.794 . . . . 0.0 111.2 173.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.08 -32.67 74.5 Favored 'General case' 0 CA--C 1.497 -1.078 0 O-C-N 120.007 -1.683 . . . . 0.0 113.709 170.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -64.3 -50.05 69.36 Favored 'General case' 0 C--O 1.251 1.182 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 172.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.15 -18.18 60.15 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 172.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp 63.1 62.13 1.03 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-O 124.888 2.28 . . . . 0.0 109.558 -173.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 98.2 t -103.84 127.6 29.05 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 111.337 -2.665 . . . . 0.0 105.619 168.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -56.39 126.89 23.8 Favored 'Trans proline' 0 C--O 1.219 -0.469 0 C-N-CA 122.935 2.424 . . . . 0.0 117.965 175.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 90' ' ' TYR . . . . . 0.568 ' HA ' ' HB ' ' C' ' 93' ' ' VAL . 4.2 m-85 -59.3 -12.41 5.59 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 173.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -62.45 -47.48 83.86 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 119.96 1.254 . . . . 0.0 111.555 171.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 39.5 pt -84.09 -14.42 11.46 Favored 'Isoleucine or valine' 0 C--O 1.255 1.351 0 CA-C-O 121.984 0.897 . . . . 0.0 111.521 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 93' ' ' VAL . . . . . 0.568 ' HB ' ' HA ' ' C' ' 90' ' ' TYR . 50.5 t -76.84 104.56 4.92 Favored 'Isoleucine or valine' 0 C--O 1.247 0.951 0 O-C-N 119.69 -1.881 . . . . 0.0 106.882 175.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 10.8 mp -104.29 103.44 13.19 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 124.831 2.253 . . . . 0.0 109.559 174.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 95' ' ' GLU . . . . . 0.533 ' HB3' ' HB ' ' A' 1157 ' ' ILE . 11.0 mp0 -85.36 117.16 24.12 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 119.675 -1.891 . . . . 0.0 108.28 -176.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.402 ' HB2' ' HD3' ' C' ' 70' ' ' PRO . 12.2 ttp 42.81 29.59 0.19 Allowed 'General case' 0 C--N 1.345 0.385 0 C-N-CA 127.801 2.441 . . . . 0.0 115.162 -178.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -79.92 128.63 33.68 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 103.387 -2.819 . . . . 0.0 103.387 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -87.13 79.56 8.6 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 99' ' ' ILE . . . . . 0.821 HG13 ' HB2' ' C' ' 102' ' ' ASP . 9.5 tp -85.21 58.97 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 112.482 -2.145 . . . . 0.0 108.265 -173.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . 0.467 ' HA ' ' CD2' ' C' ' 103' ' ' PHE . 14.3 t-20 -73.31 -38.58 65.79 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 112.837 -1.983 . . . . 0.0 111.801 -166.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.96 -39.38 79.54 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.079 -1.419 . . . . 0.0 112.437 177.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 102' ' ' ASP . . . . . 0.821 ' HB2' HG13 ' C' ' 99' ' ' ILE . 1.8 m-20 -67.74 -28.43 67.63 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 120.172 -1.58 . . . . 0.0 113.25 167.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 103' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' C' ' 100' ' ' ASN . 6.8 m-30 -56.54 -51.19 69.49 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-O 121.575 0.703 . . . . 0.0 111.95 175.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.99 -45.51 82.91 Favored 'General case' 0 C--O 1.208 -1.117 0 CA-C-N 114.524 -1.217 . . . . 0.0 112.594 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -66.31 -29.18 69.33 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 106' ' ' THR . . . . . 0.746 ' HA ' ' HB2' ' C' ' 32' ' ' SER . 69.6 m -64.92 135.52 55.79 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 177.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 107' ' ' ASP . . . . . 0.665 ' HA ' ' HB3' ' C' ' 142' ' ' GLN . 23.2 t70 -86.94 -102.68 0.07 Allowed 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 112.373 -2.194 . . . . 0.0 109.027 166.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 53.8 m -69.83 91.77 0.66 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 124.398 3.272 . . . . 0.0 113.356 -171.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 109' ' ' VAL . . . . . 0.777 HG13 ' HB ' ' C' ' 34' ' ' ILE . 21.3 t -74.27 110.6 8.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 167.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 110' ' ' LEU . . . . . 0.465 HD11 HD21 ' C' ' 27' ' ' LEU . 96.0 mt -85.6 95.44 9.34 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 111' ' ' VAL . . . . . 0.649 ' HB ' ' HA ' ' C' ' 146' ' ' VAL . 50.3 t -87.1 87.68 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 -176.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 25.3 mm -72.05 79.32 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -171.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 113' ' ' GLY . . . . . 0.429 ' H ' ' HB2' ' C' ' 147' ' ' PHE . . . 88.69 -110.26 3.64 Favored Glycine 0 C--O 1.239 0.409 0 N-CA-C 107.25 -2.34 . . . . 0.0 107.25 -171.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 114' ' ' ALA . . . . . 0.499 ' HB2' ' HA3' ' C' ' 38' ' ' GLY . . . 47.73 9.13 0.01 OUTLIER 'General case' 0 C--N 1.352 0.686 1 N-CA-C 121.817 4.006 . . . . 0.0 121.817 163.093 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.29 -41.94 51.61 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 117.258 2.318 . . . . 0.0 117.258 -175.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 116' ' ' ASP . . . . . 0.553 ' HA ' ' HB2' ' C' ' 119' ' ' ASN . 9.1 m-20 -76.51 -28.01 56.23 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 19.4 m -72.83 -13.3 61.26 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.9 -1.125 . . . . 0.0 108.642 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.701 HG12 ' HB2' ' C' ' 136' ' ' LEU . 18.3 m -120.03 16.86 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 CA-C-N 119.762 1.165 . . . . 0.0 109.873 174.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 119' ' ' ASN . . . . . 0.553 ' HB2' ' HA ' ' C' ' 116' ' ' ASP . 18.4 t30 -79.64 112.28 27.93 Favored Pre-proline 0 N--CA 1.451 -0.391 0 O-C-N 120.118 -1.614 . . . . 0.0 115.188 -171.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 120' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -58.91 -36.47 96.84 Favored 'Trans proline' 0 C--N 1.368 1.602 0 C-N-CA 123.557 2.838 . . . . 0.0 113.288 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.58 4.98 1.55 Allowed 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 122' ' ' ALA . . . . . 0.482 ' HB1' ' HB3' ' C' ' 133' ' ' MET . . . -94.2 -31.7 14.01 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 120.344 -1.472 . . . . 0.0 113.124 173.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -116.03 -52.37 2.61 Favored 'General case' 0 C--O 1.22 -0.49 0 C-N-CA 118.839 -1.144 . . . . 0.0 109.68 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -62.17 -51.01 69.53 Favored 'General case' 0 C--N 1.363 1.188 0 CA-C-O 122.735 1.255 . . . . 0.0 108.905 -173.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -95.54 132.07 28.27 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 102.869 -3.011 . . . . 0.0 102.869 164.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -78.05 46.58 2.11 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 122.223 1.949 . . . . 0.0 110.829 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -107.06 -33.2 7.54 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -152.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 128' ' ' SER . . . . . . . . . . . . . 36.3 m -79.57 144.36 60.94 Favored Pre-proline 0 C--O 1.24 0.559 0 O-C-N 124.735 1.272 . . . . 0.0 111.647 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 129' ' ' PRO . . . . . 0.638 ' HD2' ' HB2' ' C' ' 156' ' ' ALA . 4.6 Cg_exo -44.38 -40.0 12.85 Favored 'Trans proline' 0 CA--C 1.51 -0.677 0 C-N-CA 123.785 2.99 . . . . 0.0 114.69 176.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 35.4 pt -65.61 72.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.88 0 CA-C-O 124.4 2.048 . . . . 0.0 110.413 164.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.71 119.52 10.71 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.511 -1.222 . . . . 0.0 112.987 -172.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 61.71 50.38 66.75 Favored Glycine 0 N--CA 1.431 -1.648 0 CA-C-N 113.083 -1.871 . . . . 0.0 112.149 -175.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 133' ' ' MET . . . . . 0.668 ' SD ' ' HD2' ' C' ' 134' ' ' PRO . 26.5 tpp -75.98 123.79 88.27 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 119.481 1.641 . . . . 0.0 112.099 171.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 134' ' ' PRO . . . . . 0.668 ' HD2' ' SD ' ' C' ' 133' ' ' MET . 61.1 Cg_endo -71.68 82.71 1.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.969 1 C-N-CA 125.833 4.355 . . . . 0.0 107.498 177.216 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 21.7 m -80.99 151.83 4.39 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.183 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.25 -176.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . 0.701 ' HB2' HG12 ' C' ' 118' ' ' VAL . 87.5 mt -74.59 109.27 7.93 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.696 0.76 . . . . 0.0 110.214 -178.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -72.81 80.02 1.14 Allowed 'General case' 0 N--CA 1.423 -1.789 0 CA-C-O 122.964 1.364 . . . . 0.0 112.134 -169.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 3.9 p -113.63 -1.79 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -176.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 13.1 p90 -56.56 148.71 19.0 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.131 -1.606 . . . . 0.0 111.118 174.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 140' ' ' LYS . . . . . . . . . . . . 0.378 0.0 OUTLIER 37.19 46.37 0.57 Allowed 'General case' 0 C--O 1.244 0.765 0 N-CA-C 116.55 2.056 . . . . 0.0 116.55 -160.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.5 -156.36 0.04 OUTLIER 'General case' 0 C--O 1.24 0.596 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 159.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 142' ' ' GLN . . . . . 0.665 ' HB3' ' HA ' ' C' ' 107' ' ' ASP . 0.0 OUTLIER -84.08 -32.81 24.59 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 119.754 -1.841 . . . . 0.0 113.787 170.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 143' ' ' ASN . . . . . 0.833 ' HA ' ' HB2' ' C' ' 167' ' ' ASN . 16.6 t30 -158.55 138.2 11.9 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 121.837 2.108 . . . . 0.0 110.239 170.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 144' ' ' VAL . . . . . 0.62 ' HB ' HG22 ' C' ' 168' ' ' THR . 21.8 t -136.46 90.43 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.598 0 O-C-N 119.051 -2.28 . . . . 0.0 105.104 -176.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 145' ' ' ILE . . . . . 0.541 HG13 ' HB2' ' C' ' 171' ' ' LEU . 10.5 tp -93.13 102.02 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 -170.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 146' ' ' VAL . . . . . 0.649 ' HA ' ' HB ' ' C' ' 111' ' ' VAL . 26.0 t -90.99 107.41 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 -170.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 147' ' ' PHE . . . . . 0.448 ' CE2' ' HB2' ' C' ' 178' ' ' SER . 2.1 m-85 -70.3 94.09 0.9 Allowed 'General case' 0 C--N 1.35 0.618 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 -177.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 148' ' ' LYS . . . . . 0.467 ' NZ ' ' OD1' ' C' ' 152' ' ' ASN . 26.1 mtpp -140.93 117.67 11.0 Favored 'General case' 0 C--O 1.253 1.254 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 173.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -70.03 -4.47 21.12 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 1.3 m -157.72 159.87 37.33 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 124.256 1.979 . . . . 0.0 108.704 175.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.44 77.72 5.99 Favored 'General case' 0 C--O 1.252 1.194 0 O-C-N 118.901 -2.374 . . . . 0.0 105.992 169.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 152' ' ' ASN . . . . . 0.467 ' OD1' ' NZ ' ' C' ' 148' ' ' LYS . 2.1 p-10 -113.85 157.95 21.67 Favored 'General case' 0 N--CA 1.438 -1.027 0 O-C-N 125.775 1.922 . . . . 0.0 108.826 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 45.7 m -67.55 125.82 27.37 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 123.848 0.717 . . . . 0.0 111.895 174.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -84.74 -108.85 0.63 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 104.7 -3.36 . . . . 0.0 104.7 173.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -91.53 -15.34 28.86 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 164.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 156' ' ' ALA . . . . . 0.638 ' HB2' ' HD2' ' C' ' 129' ' ' PRO . . . -165.54 -93.55 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 159.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 74.93 41.8 32.03 Favored Glycine 0 N--CA 1.437 -1.286 0 CA-C-N 120.876 1.671 . . . . 0.0 110.372 -165.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 15.5 m -80.81 127.94 39.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 O-C-N 120.085 -1.832 . . . . 0.0 108.941 171.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . 0.3 0.0 OUTLIER 43.2 16.31 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 120.613 3.56 . . . . 0.0 120.613 173.5 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 160' ' ' ASN . . . . . 0.734 HD22 HD12 ' C' ' 162' ' ' LEU . 16.9 p-10 -73.9 125.98 89.83 Favored Pre-proline 0 CA--C 1.532 0.269 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -178.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -49.86 -25.63 12.33 Favored 'Trans proline' 0 C--N 1.367 1.548 1 C-N-CA 126.725 4.95 . . . . 0.0 113.367 -176.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 162' ' ' LEU . . . . . 0.88 ' HA ' ' HB ' ' C' ' 168' ' ' THR . 13.2 mt -53.61 -20.14 4.8 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 173.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 163' ' ' PHE . . . . . 0.591 ' HA ' ' HG3' ' C' ' 170' ' ' MET . 9.2 m-30 -82.09 -42.16 19.56 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 123.092 1.425 . . . . 0.0 112.285 175.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -103.11 -41.23 6.16 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 113.18 -1.827 . . . . 0.0 110.099 -153.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 16.0 mttm -74.34 178.92 4.86 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 -164.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -77.43 -56.81 4.22 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-N 113.965 -1.471 . . . . 0.0 108.792 -165.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 167' ' ' ASN . . . . . 0.833 ' HB2' ' HA ' ' C' ' 143' ' ' ASN . 45.9 p30 -75.25 -45.84 37.53 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-O 117.383 -1.294 . . . . 0.0 110.591 168.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 168' ' ' THR . . . . . 0.88 ' HB ' ' HA ' ' C' ' 162' ' ' LEU . 13.6 p -87.54 94.89 9.85 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-N 121.932 2.151 . . . . 0.0 107.829 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -140.18 142.7 35.9 Favored 'General case' 0 C--N 1.353 0.743 0 O-C-N 120.419 -1.426 . . . . 0.0 110.757 -163.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 170' ' ' MET . . . . . 0.591 ' HG3' ' HA ' ' C' ' 163' ' ' PHE . 78.1 mtm -75.66 112.15 11.72 Favored 'General case' 0 CA--C 1.48 -1.72 0 CA-C-O 123.451 1.596 . . . . 0.0 115.232 174.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 171' ' ' LEU . . . . . 0.541 ' HB2' HG13 ' C' ' 145' ' ' ILE . 22.6 tp -71.95 109.81 6.03 Favored 'General case' 0 C--O 1.254 1.31 0 CA-C-N 114.146 -1.388 . . . . 0.0 107.847 169.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -83.26 68.24 9.56 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 126.194 2.902 . . . . 0.0 112.537 -173.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -153.03 163.42 30.51 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 110.161 -3.2 . . . . 0.0 109.735 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 174' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -74.41 155.32 38.21 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 111.868 -2.166 . . . . 0.0 109.146 173.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.47 -55.74 30.81 Favored 'General case' 0 CA--C 1.496 -1.121 0 CA-C-N 110.292 -3.14 . . . . 0.0 111.91 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 176' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' C' ' 44' ' ' ALA . 0.4 OUTLIER -66.3 -54.44 24.77 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 116.845 -1.55 . . . . 0.0 107.541 176.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 177' ' ' ALA . . . . . . . . . . . . . . . -51.21 -48.98 61.88 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.192 0.997 . . . . 0.0 112.619 -170.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 178' ' ' SER . . . . . 0.448 ' HB2' ' CE2' ' C' ' 147' ' ' PHE . 38.5 m -62.61 -46.46 88.18 Favored 'General case' 0 C--O 1.246 0.877 0 O-C-N 121.004 -1.06 . . . . 0.0 110.746 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 179' ' ' VAL . . . . . 0.433 ' HA ' HG12 ' C' ' 182' ' ' ILE . 22.1 t -61.09 -41.81 90.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 O-C-N 119.789 -1.819 . . . . 0.0 108.14 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 180' ' ' ASP . . . . . 0.417 ' HB2' ' HD2' ' C' ' 176' ' ' LYS . 12.2 t70 -63.97 -37.78 88.67 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.559 -174.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -70.9 -49.72 42.7 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.56 1.073 . . . . 0.0 109.769 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 182' ' ' ILE . . . . . 0.555 HD12 HD11 ' C' ' 27' ' ' LEU . 16.8 pt -63.06 -25.35 38.34 Favored 'Isoleucine or valine' 0 C--N 1.363 1.178 0 O-C-N 119.415 -2.053 . . . . 0.0 112.943 -174.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 183' ' ' LEU . . . . . 0.556 HD12 ' HB ' ' C' ' 53' ' ' ILE . 12.8 tp -49.9 -36.6 28.04 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 126.743 2.017 . . . . 0.0 112.97 170.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 18.7 tptt -112.95 -34.75 5.65 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -57.43 -63.99 1.04 Allowed 'General case' 0 C--O 1.257 1.478 0 N-CA-C 118.823 2.897 . . . . 0.0 118.823 172.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 186' ' ' LEU . . . . . . . . . . . . 0.327 1.3 pt? . . . . . 0 C--O 1.218 -0.586 0 C-N-CA 127.753 2.421 . . . . 0.0 117.349 -167.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 22.3 t-80 . . . . . 0 N--CA 1.436 -1.134 0 N-CA-C 104.856 -2.275 . . . . 65.74 104.856 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -69.94 82.09 0.33 Allowed Glycine 0 C--O 1.222 -0.638 0 O-C-N 117.868 -3.02 . . . . 48.66 112.313 169.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -113.44 109.47 18.72 Favored 'General case' 0 CA--C 1.478 -1.81 0 N-CA-C 103.633 -2.728 . . . . 44.56 103.633 170.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1003 ' ' ILE . . . . . . . . . . . . . 61.8 mt -80.18 110.51 15.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 112.179 -2.282 . . . . 34.86 109.187 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1004 ' ' GLY . . . . . 0.551 ' O ' ' HD3' ' A' 1006 ' ' PRO . . . -75.83 122.11 6.53 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.122 -1.191 . . . . 30.75 110.122 163.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.774 HG23 ' HB3' ' A' 1017 ' ' ALA . 16.8 mm -99.58 105.48 34.04 Favored Pre-proline 0 C--O 1.242 0.688 0 N-CA-C 102.567 -3.123 . . . . 32.21 102.567 176.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1006 ' ' PRO . . . . . 0.551 ' HD3' ' O ' ' A' 1004 ' ' GLY . 67.8 Cg_exo -85.8 158.35 10.38 Favored 'Trans proline' 0 N--CA 1.451 -1.007 1 C-N-CA 126.222 4.615 . . . . 32.98 110.468 175.46 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1007 ' ' ARG . . . . . 0.558 ' HG3' HD12 ' A' 1042 ' ' LEU . 1.8 ttp85 -84.98 138.42 32.48 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 103.181 -2.896 . . . . 47.98 103.181 153.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1008 ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -63.44 137.85 58.3 Favored 'General case' 0 N--CA 1.441 -0.89 0 O-C-N 124.41 1.068 . . . . 34.7 109.398 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1009 ' ' ARG . . . . . 0.632 HH11 ' HG2' ' A' 1079 ' ' GLU . 80.9 mtp180 -93.82 -27.53 16.4 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 114.725 -1.125 . . . . 53.37 113.558 -175.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 3.9 mp -52.81 129.2 29.25 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-O 123.018 1.39 . . . . 45.07 111.52 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1011 ' ' THR . . . . . . . . . . . . . 20.7 m -48.19 119.79 3.16 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 113.076 -1.874 . . . . 40.36 112.137 -171.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 12.5 m120 63.28 -4.67 0.28 Allowed 'General case' 0 C--O 1.243 0.753 0 N-CA-C 117.419 2.377 . . . . 40.61 117.419 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -88.1 71.97 9.22 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 104.424 -2.436 . . . . 33.76 104.424 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1014 ' ' THR . . . . . 0.627 HG23 HD13 ' A' 1042 ' ' LEU . 47.1 m -73.29 66.7 0.93 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 125.72 2.676 . . . . 27.89 111.914 -172.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1015 ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -108.51 163.29 13.36 Favored 'General case' 0 C--O 1.224 -0.262 0 O-C-N 120.002 -1.686 . . . . 29.02 108.942 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1016 ' ' VAL . . . . . 0.472 HG22 ' HA ' ' A' 1007 ' ' ARG . 39.4 t -137.05 151.59 27.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 101.505 -3.517 . . . . 28.13 101.505 171.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1017 ' ' ALA . . . . . 0.774 ' HB3' HG23 ' A' 1005 ' ' ILE . . . -55.18 -54.57 41.63 Favored 'General case' 0 C--O 1.256 1.426 0 N-CA-C 119.067 2.988 . . . . 26.87 119.067 -176.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -144.25 159.36 42.81 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 120.478 1.49 . . . . 26.77 112.566 -170.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1019 ' ' THR . . . . . . . . . . . . . 19.2 p -84.25 155.86 63.25 Favored Pre-proline 0 C--O 1.245 0.833 0 CA-C-O 117.762 -1.113 . . . . 27.02 111.423 176.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1020 ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -48.5 -40.16 36.92 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 124.059 3.172 . . . . 30.57 114.41 169.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1021 ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' 1024 ' ' GLU . 2.2 ttmp? -52.33 -48.98 65.15 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.284 1.216 . . . . 47.81 114.284 168.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1022 ' ' THR . . . . . 0.676 ' HB ' HG21 ' A' 1332 ' ' VAL . 2.6 p -75.15 -30.87 60.88 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 124.057 1.885 . . . . 30.77 109.426 -172.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1023 ' ' VAL . . . . . 0.496 HG11 ' HB2' ' A' 1055 ' ' ALA . 55.5 t -56.98 -52.23 58.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 C-N-CA 125.141 1.376 . . . . 33.59 108.691 168.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1024 ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' 1021 ' ' LYS . 26.3 mt-10 -46.2 -51.62 13.89 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 120.694 1.588 . . . . 53.29 110.755 172.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -54.38 -52.4 61.79 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.673 1.36 . . . . 46.92 114.673 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1026 ' ' LEU . . . . . 0.415 HD23 HD12 ' A' 1029 ' ' LEU . 91.7 mt -53.94 -42.79 69.23 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 115.019 1.488 . . . . 37.17 115.019 177.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 7.1 mp -54.32 -49.9 68.62 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.711 -1.131 . . . . 44.44 113.442 168.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1028 ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' 1024 ' ' GLU . 27.4 mmmt -62.08 -29.27 70.19 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 120.367 0.127 . . . . 52.58 111.094 175.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1029 ' ' LEU . . . . . 0.415 HD12 HD23 ' A' 1026 ' ' LEU . 95.3 mt -72.26 -42.33 65.73 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 119.749 -1.844 . . . . 45.69 109.784 175.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 138.06 -8.04 3.52 Favored Glycine 0 CA--C 1.507 -0.411 0 C-N-CA 120.877 -0.678 . . . . 42.09 111.949 173.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -80.15 130.68 35.41 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 118.917 -0.563 . . . . 40.72 112.301 -173.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1032 ' ' THR . . . . . . . . . . . . . 55.8 m -74.11 127.71 33.62 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.707 -1.22 . . . . 37.77 107.707 176.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1033 ' ' VAL . . . . . 0.49 HG11 HG22 ' A' 1023 ' ' VAL . 94.8 t -109.7 123.58 65.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 104.639 -2.356 . . . . 33.54 104.639 -177.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -120.1 113.12 20.01 Favored 'General case' 0 C--O 1.249 1.032 0 N-CA-C 105.966 -1.864 . . . . 31.68 105.966 175.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1035 ' ' VAL . . . . . 0.448 ' HA ' ' HB ' ' A' 1005 ' ' ILE . 17.3 t -94.34 144.3 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 O-C-N 121.553 -0.717 . . . . 31.52 109.282 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1036 ' ' GLU . . . . . 0.445 ' HB2' HG21 ' A' 1063 ' ' VAL . 50.3 tt0 -61.44 140.63 58.02 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 123.392 1.568 . . . . 41.04 111.329 170.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1037 ' ' SER . . . . . . . . . . . . . 1.4 t -61.49 126.75 28.48 Favored 'General case' 0 N--CA 1.44 -0.951 0 O-C-N 120.187 -1.571 . . . . 31.83 114.201 171.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 83.95 9.96 81.68 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 113.976 -1.465 . . . . 29.36 112.032 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -79.04 -41.05 29.76 Favored 'General case' 0 C--N 1.347 0.462 0 O-C-N 121.058 -1.26 . . . . 27.78 110.049 -176.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -52.48 -39.21 52.48 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 122.82 1.233 . . . . 28.91 113.73 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 73.1 tp60 -46.44 -55.63 7.15 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.055 -1.072 . . . . 51.18 113.318 170.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1042 ' ' LEU . . . . . 0.627 HD13 HG23 ' A' 1014 ' ' THR . 27.0 mt -72.35 -42.28 65.49 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 120.727 -1.233 . . . . 29.91 111.213 175.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1043 ' ' ALA . . . . . . . . . . . . . . . -54.9 -22.5 15.02 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.567 0.699 . . . . 28.54 112.35 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1044 ' ' SER . . . . . 0.426 ' HB3' ' CA ' ' B' 1278 ' ' GLY . 67.4 m 63.53 42.28 6.69 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 124.746 2.212 . . . . 33.06 108.628 174.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1045 ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -172.31 92.15 0.12 Allowed 'General case' 0 N--CA 1.441 -0.914 1 N-CA-C 97.761 -4.903 . . . . 30.29 97.761 178.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.67 171.27 15.19 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-N 111.402 -2.635 . . . . 48.62 116.585 -147.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1047 ' ' ASP . . . . . 0.474 ' O ' HG23 ' A' 1051 ' ' VAL . 6.9 m-20 -56.77 -42.07 78.74 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 113.776 -1.556 . . . . 36.74 113.085 -176.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 21.7 pttm -69.9 -25.73 63.83 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.543 1.519 . . . . 43.73 113.661 176.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -71.07 -37.35 72.48 Favored 'General case' 0 CA--C 1.498 -1.04 0 O-C-N 119.862 -1.774 . . . . 32.81 109.801 170.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1050 ' ' PHE . . . . . 0.402 ' CD1' HG21 ' A' 1035 ' ' VAL . 26.4 m-85 -57.82 -42.22 83.86 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 120.429 1.468 . . . . 31.86 112.735 167.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1051 ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' 1047 ' ' ASP . 21.8 t -61.28 -44.9 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 114.578 -1.192 . . . . 33.22 113.081 174.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -58.17 -37.56 74.95 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.568 0.699 . . . . 50.83 112.718 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -59.46 -46.35 89.02 Favored 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 121.62 -0.675 . . . . 33.12 110.062 173.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 128.14 9.48 3.75 Favored Glycine 0 C--N 1.349 1.26 0 C-N-CA 118.905 -1.616 . . . . 35.83 112.188 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1055 ' ' ALA . . . . . 0.496 ' HB2' HG11 ' A' 1023 ' ' VAL . . . -73.49 146.72 44.69 Favored 'General case' 0 N--CA 1.436 -1.169 0 O-C-N 121.975 -0.72 . . . . 34.82 111.151 -177.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -77.52 136.79 38.35 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 101.932 -3.359 . . . . 49.05 101.932 171.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1057 ' ' ILE . . . . . . . . . . . . . 25.7 mm -102.46 134.68 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 N-CA-C 107.063 -1.458 . . . . 38.53 107.063 172.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1058 ' ' VAL . . . . . . . . . . . . . 3.1 m -129.41 143.25 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-O 123.354 1.549 . . . . 42.11 109.444 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -106.21 128.53 54.01 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 113.452 -1.704 . . . . 58.0 108.379 -165.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 66.49 -138.93 36.56 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-O 123.379 1.544 . . . . 52.12 114.019 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1061 ' ' ASN . . . . . 0.541 ' HA ' ' HD1' ' A' 1064 ' ' TRP . 8.2 t30 -64.21 -18.94 64.99 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 113.359 -1.42 . . . . 54.75 111.976 -170.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1062 ' ' SER . . . . . . . . . . . . . 49.9 m -63.05 -8.63 7.85 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 116.743 2.127 . . . . 50.34 116.743 176.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1063 ' ' VAL . . . . . 0.445 HG21 ' HB2' ' A' 1036 ' ' GLU . 9.7 p -72.52 -38.13 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-O 121.921 0.867 . . . . 41.46 110.347 167.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1064 ' ' TRP . . . . . 0.541 ' HD1' ' HA ' ' A' 1061 ' ' ASN . 86.1 m95 -73.07 -20.21 61.01 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.013 0.925 . . . . 39.32 110.389 174.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1065 ' ' GLN . . . . . 0.537 ' NE2' HD21 ' A' 1084 ' ' ASN . 92.3 mm-40 -77.21 64.57 2.65 Favored 'General case' 0 C--O 1.224 -0.272 0 O-C-N 120.31 -1.494 . . . . 55.38 111.36 171.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1066 ' ' SER . . . . . . . . . . . . . 47.8 m -152.17 129.06 10.95 Favored 'General case' 0 N--CA 1.444 -0.734 0 O-C-N 120.69 -1.256 . . . . 41.87 108.054 -174.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -74.54 4.49 6.01 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 120.093 3.368 . . . . 53.2 120.093 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1068 ' ' ILE . . . . . 0.644 HG12 ' HB ' ' A' 1088 ' ' THR . 96.9 mt -128.41 134.76 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 104.135 -2.543 . . . . 41.9 104.135 158.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1069 ' ' ILE . . . . . . . . . . . . . 34.9 mm -128.08 132.95 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 104.677 -2.342 . . . . 38.73 104.677 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1070 ' ' LEU . . . . . 0.803 HD13 HD13 ' A' 1331 ' ' LEU . 19.8 mt -108.13 79.15 1.23 Allowed 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 125.385 2.517 . . . . 32.44 112.164 172.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1071 ' ' LYS . . . . . 0.451 ' HE3' ' O ' ' A' 1073 ' ' ASN . 8.7 mmmt -65.67 127.55 32.38 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 113.302 -1.772 . . . . 34.65 111.005 169.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1072 ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -92.23 -14.32 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 CA-C-N 114.131 -1.395 . . . . 31.32 110.623 -160.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1073 ' ' ASN . . . . . 0.451 ' O ' ' HE3' ' A' 1071 ' ' LYS . 46.9 t30 -149.42 178.23 8.99 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 107.842 -1.17 . . . . 33.94 107.842 173.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1074 ' ' ALA . . . . . 0.468 ' HA ' ' HD3' ' A' 1075 ' ' PRO . . . -38.8 146.57 0.31 Allowed Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 127.547 2.339 . . . . 38.04 116.026 172.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1075 ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' 1074 ' ' ALA . 21.9 Cg_exo -80.8 157.6 21.19 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.932 3.088 . . . . 42.68 119.122 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 42.5 mt -107.77 161.27 15.04 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 105.133 -2.173 . . . . 46.74 105.133 162.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 25.5 t0 -70.27 -21.9 62.92 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.539 -0.726 . . . . 58.61 110.758 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 21.8 t0 -54.12 -56.39 18.52 Favored 'General case' 0 C--N 1.344 0.359 0 N-CA-C 108.134 -1.061 . . . . 59.2 108.134 162.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1079 ' ' GLU . . . . . 0.632 ' HG2' HH11 ' A' 1009 ' ' ARG . 33.0 mt-10 -66.67 -31.22 71.75 Favored 'General case' 0 CA--C 1.501 -0.927 0 O-C-N 121.616 -0.677 . . . . 50.63 110.543 -174.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1080 ' ' ILE . . . . . . . . . . . . . 82.8 mt -68.25 -31.56 52.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 O-C-N 120.996 -1.065 . . . . 51.48 111.704 176.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -70.61 -43.24 69.74 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 118.689 -2.507 . . . . 50.28 110.707 171.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 8.0 mp -69.07 -23.94 64.1 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 114.101 1.148 . . . . 50.21 114.101 177.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1083 ' ' LEU . . . . . 0.571 HD11 HD13 ' A' 1089 ' ' LEU . 0.1 OUTLIER -67.49 116.37 8.15 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 105.41 -2.07 . . . . 49.06 105.41 175.579 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1084 ' ' ASN . . . . . 0.537 HD21 ' NE2' ' A' 1065 ' ' GLN . 13.1 m-80 -75.09 150.64 85.74 Favored Pre-proline 0 N--CA 1.432 -1.325 0 CA-C-O 118.561 -0.733 . . . . 51.08 110.908 171.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -55.91 165.9 3.43 Favored 'Trans proline' 0 C--O 1.249 1.053 0 C-N-CA 123.99 3.127 . . . . 49.73 113.853 167.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 81.78 -28.38 3.2 Favored Glycine 0 C--N 1.338 0.671 0 O-C-N 120.489 -1.382 . . . . 47.71 114.052 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1087 ' ' THR . . . . . . . . . . . . . 13.9 m -51.09 129.74 24.64 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 117.654 2.464 . . . . 45.47 117.654 -174.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1088 ' ' THR . . . . . 0.644 ' HB ' HG12 ' A' 1068 ' ' ILE . 30.0 m -79.6 90.39 5.14 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 106.713 -1.588 . . . . 42.04 106.713 161.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1089 ' ' LEU . . . . . 0.571 HD13 HD11 ' A' 1083 ' ' LEU . 63.5 tp -79.85 80.74 6.21 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 105.451 -2.055 . . . . 38.06 105.451 -174.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1090 ' ' VAL . . . . . 0.584 ' HA ' ' HB2' ' A' 1113 ' ' MET . 36.2 t -81.44 104.67 10.33 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 N-CA-C 101.964 -3.347 . . . . 37.4 101.964 177.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1091 ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' 1114 ' ' ALA . 60.5 m -155.05 164.76 38.42 Favored 'General case' 0 C--O 1.251 1.145 0 O-C-N 119.816 -1.803 . . . . 36.16 113.769 -167.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 17.0 t80 -92.11 90.75 7.48 Favored 'General case' 0 C--O 1.246 0.915 0 O-C-N 120.111 -1.618 . . . . 38.94 107.432 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 30.9 mm -95.15 -30.37 4.1 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 N-CA-C 113.006 0.743 . . . . 42.17 113.006 -160.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 90.7 m95 56.93 74.09 0.72 Allowed Pre-proline 0 C--O 1.236 0.346 0 C-N-CA 125.635 1.574 . . . . 46.51 111.89 -171.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -62.51 -56.24 0.71 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 123.536 2.824 . . . . 49.76 115.815 -167.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -70.34 -11.79 61.14 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 118.138 -2.851 . . . . 52.62 113.514 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -86.53 -32.11 20.9 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 105.938 -1.875 . . . . 60.74 105.938 176.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1098 ' ' ASN . . . . . 0.425 ' HB3' ' HB2' ' A' 1101 ' ' LEU . 76.7 m-20 -119.83 55.96 3.77 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 117.178 2.288 . . . . 58.19 117.178 -177.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.41 -42.77 31.89 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.767 2.978 . . . . 54.59 114.647 -174.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -60.77 -46.47 90.36 Favored 'General case' 0 C--O 1.251 1.171 0 O-C-N 119.943 -1.723 . . . . 63.28 111.918 174.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1101 ' ' LEU . . . . . 0.425 ' HB2' ' HB3' ' A' 1098 ' ' ASN . 20.6 mt -61.7 -33.37 73.9 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.602 -1.181 . . . . 54.75 111.24 176.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1102 ' ' MET . . . . . . . . . . . . . 46.4 mmm -61.58 -48.39 81.17 Favored 'General case' 0 C--O 1.245 0.861 0 O-C-N 121.662 -0.649 . . . . 52.65 111.657 175.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -60.3 -39.61 87.58 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.318 -0.856 . . . . 66.26 108.917 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 88.4 mttt -64.61 -32.51 74.2 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 118.865 0.757 . . . . 63.73 112.006 174.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 34.2 mt -76.15 -26.85 56.7 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 120.308 -1.495 . . . . 54.68 111.877 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -64.48 -47.65 78.16 Favored 'General case' 0 C--O 1.245 0.858 0 O-C-N 120.713 -1.242 . . . . 53.64 111.705 168.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -56.05 -33.69 65.21 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.397 -1.729 . . . . 67.24 114.163 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -60.5 -24.79 65.58 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 117.276 2.324 . . . . 65.76 117.276 170.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1109 ' ' ASN . . . . . 0.499 ' HA ' ' HA3' ' A' 1364 ' ' GLY . 3.7 t30 56.91 67.83 0.94 Allowed 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 123.445 1.593 . . . . 58.71 111.972 -165.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1110 ' ' VAL . . . . . 0.455 HG23 HG23 ' A' 1112 ' ' VAL . 17.0 m -133.28 151.69 34.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 113.89 -1.505 . . . . 46.63 108.299 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1111 ' ' THR . . . . . 0.55 HG21 HG21 ' A' 1348 ' ' VAL . 94.8 m -91.55 93.38 8.93 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 123.027 1.394 . . . . 44.13 110.61 171.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1112 ' ' VAL . . . . . 0.496 HG22 HD23 ' A' 1089 ' ' LEU . 41.3 t -83.55 108.44 16.08 Favored 'Isoleucine or valine' 0 C--O 1.252 1.21 0 O-C-N 119.774 -1.829 . . . . 40.44 109.806 -178.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1113 ' ' MET . . . . . 0.584 ' HB2' ' HA ' ' A' 1090 ' ' VAL . 22.8 mtp -100.97 93.07 5.32 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 111.59 -2.55 . . . . 50.76 109.122 173.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1114 ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' 1091 ' ' SER . . . -85.51 118.39 25.01 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 119.185 -1.006 . . . . 35.64 109.324 -173.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1115 ' ' MET . . . . . 0.436 ' O ' HG23 ' A' 1118 ' ' VAL . 79.5 mmm -66.04 -29.39 69.74 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 115.611 1.708 . . . . 38.74 115.611 -175.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.62 -44.48 69.53 Favored 'General case' 0 C--O 1.25 1.093 0 CA-C-O 121.682 0.753 . . . . 40.14 111.475 165.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1117 ' ' SER . . . . . . . . . . . . . 74.0 m -75.11 14.08 0.6 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 119.487 3.143 . . . . 44.79 119.487 -176.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1118 ' ' VAL . . . . . 0.785 HG22 HG22 ' A' 1358 ' ' VAL . 13.6 t -72.77 133.67 82.12 Favored Pre-proline 0 C--O 1.215 -0.751 0 O-C-N 118.432 -2.668 . . . . 43.75 107.057 177.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -60.65 152.24 70.37 Favored 'Trans proline' 0 N--CA 1.443 -1.455 1 C-N-CA 125.785 4.323 . . . . 48.93 115.451 173.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -70.1 12.88 0.19 Allowed 'General case' 0 C--O 1.255 1.39 0 N-CA-C 121.027 3.714 . . . . 62.9 121.027 -173.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1121 ' ' ILE . . . . . 0.406 HG12 ' H ' ' A' 1121 ' ' ILE . 10.5 pt -86.2 169.35 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 O-C-N 119.088 -2.257 . . . . 57.72 112.951 -170.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1122 ' ' SER . . . . . 0.422 ' HA ' ' HG2' ' A' 1125 ' ' GLN . 69.7 m -63.37 -46.19 87.66 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 124.398 1.079 . . . . 57.26 113.721 -173.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -59.24 -36.11 74.88 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 122.922 2.601 . . . . 62.9 112.128 175.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1124 ' ' ALA . . . . . 0.511 ' HB1' HG12 ' A' 1118 ' ' VAL . . . -71.16 -23.63 62.09 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 125.012 1.445 . . . . 49.83 111.904 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1125 ' ' GLN . . . . . 0.422 ' HG2' ' HA ' ' A' 1122 ' ' SER . 54.1 mm-40 -56.28 -23.69 38.16 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 118.241 2.682 . . . . 52.37 118.241 -171.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1126 ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.83 -35.12 57.77 Favored 'General case' 0 C--O 1.252 1.198 0 N-CA-C 116.463 2.023 . . . . 42.43 116.463 169.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1127 ' ' LEU . . . . . 0.473 ' O ' ' HB3' ' A' 1330 ' ' ASN . 4.5 mp -78.63 -35.82 44.93 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 113.3 -1.773 . . . . 43.74 111.504 177.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 13.3 t70 -73.64 123.04 23.27 Favored 'General case' 0 C--O 1.246 0.892 0 O-C-N 120.244 -1.535 . . . . 43.21 114.764 -165.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -75.39 -27.59 59.15 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 114.231 1.197 . . . . 35.74 114.231 175.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 69.1 mt -67.19 -11.86 58.49 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 118.679 0.672 . . . . 38.09 112.524 170.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1131 ' ' SER . . . . . 0.563 ' HA ' HG11 ' A' 1175 ' ' VAL . 6.4 m -73.86 -77.13 0.11 Allowed 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.274 -0.639 . . . . 36.91 109.274 153.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1132 ' ' SER . . . . . 0.731 ' HB3' ' HB3' ' A' 1326 ' ' LEU . 8.3 m -58.24 -55.71 31.52 Favored 'General case' 0 C--N 1.347 0.491 0 O-C-N 120.899 -1.125 . . . . 35.79 113.278 -162.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1133 ' ' MET . . . . . 0.552 ' HA ' HD12 ' A' 1136 ' ' ILE . 18.3 mtp -62.97 -34.75 78.19 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 113.067 0.766 . . . . 30.81 113.067 -177.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1134 ' ' ALA . . . . . . . . . . . . . . . -66.75 -40.79 88.41 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.536 0.607 . . . . 28.88 109.506 174.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1135 ' ' ASN . . . . . 0.404 ' HB3' ' O ' ' A' 1132 ' ' SER . 10.6 t-20 -57.32 -45.04 84.64 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 117.882 -1.056 . . . . 40.76 111.204 171.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1136 ' ' ILE . . . . . 0.552 HD12 ' HA ' ' A' 1133 ' ' MET . 83.7 mt -56.46 -44.63 80.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-O 122.51 1.147 . . . . 31.54 110.767 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -60.62 -49.2 78.49 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 112.669 -2.06 . . . . 29.87 112.15 175.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1138 ' ' GLY . . . . . 0.447 ' HA2' HD11 ' A' 1284 ' ' LEU . . . -57.44 -46.78 91.54 Favored Glycine 0 N--CA 1.468 0.819 0 O-C-N 120.806 -1.184 . . . . 28.73 111.393 -177.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 18.4 t80 -65.01 -49.29 70.78 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 118.821 -0.609 . . . . 30.39 110.391 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1140 ' ' ARG . . . . . 0.546 ' HG3' HD22 ' A' 1315 ' ' LEU . 5.7 tpt180 -70.69 -19.26 62.79 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 117.155 -1.818 . . . . 26.09 111.951 -175.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1141 ' ' ALA . . . . . 0.721 ' HB2' HD21 ' A' 1284 ' ' LEU . . . -69.76 -45.55 67.83 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 106.957 -1.497 . . . . 27.1 106.957 176.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1142 ' ' ILE . . . . . 0.419 HD13 ' HA ' ' A' 1142 ' ' ILE . 28.5 mm -50.45 -44.82 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 C-N-CA 123.588 0.755 . . . . 28.48 111.929 169.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 58.6 t -62.31 -58.94 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 112.797 0.665 . . . . 23.07 112.797 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1144 ' ' GLU . . . . . 0.468 ' CD ' HH21 ' A' 1140 ' ' ARG . 6.0 mm-40 -63.85 -31.51 72.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.839 0.828 . . . . 33.4 112.562 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1145 ' ' ALA . . . . . 0.7 ' HB1' HD12 ' A' 1251 ' ' ILE . . . -56.88 -54.5 45.85 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 115.859 -2.019 . . . . 24.22 111.554 164.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1146 ' ' ALA . . . . . 0.576 ' HA ' ' HB2' ' A' 1149 ' ' PHE . . . -58.4 -22.91 55.69 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 116.019 1.859 . . . . 24.89 116.019 174.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -70.0 -54.23 14.13 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 105.827 -1.916 . . . . 26.73 105.827 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1148 ' ' GLU . . . . . 0.828 ' HB2' HD11 ' A' 1310 ' ' ILE . 25.3 mm-40 -97.49 21.6 10.0 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 116.955 2.205 . . . . 39.96 116.955 176.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1149 ' ' PHE . . . . . 0.576 ' HB2' ' HA ' ' A' 1146 ' ' ALA . 1.0 OUTLIER -71.92 136.49 46.89 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 106.938 -1.504 . . . . 25.87 106.938 177.488 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1150 ' ' GLY . . . . . 0.452 ' HA2' ' HG2' ' B' 1320 ' ' PRO . . . -74.66 -52.75 6.99 Favored Glycine 0 CA--C 1.502 -0.73 0 O-C-N 127.262 2.851 . . . . 19.28 109.916 170.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1151 ' ' ARG . . . . . 0.72 ' NH2' ' HB2' ' A' 1164 ' ' PRO . 0.4 OUTLIER -101.17 -164.93 1.15 Allowed 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 120.8 -1.412 . . . . 39.9 113.768 -170.536 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1152 ' ' PHE . . . . . 0.521 ' HD2' ' HG2' ' B' 1322 ' ' GLN . 0.7 OUTLIER -107.23 141.21 38.9 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 120.466 -1.396 . . . . 29.44 109.129 -170.223 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1153 ' ' PHE . . . . . 0.536 ' HE2' ' HB2' ' A' 1146 ' ' ALA . 16.9 m-85 -65.22 -58.67 5.39 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 117.804 -3.06 . . . . 32.6 110.181 169.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1154 ' ' THR . . . . . . . . . . . . . 3.0 m -71.75 116.54 12.24 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 124.412 1.07 . . . . 34.64 111.234 -172.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -64.39 96.03 0.19 Allowed Glycine 0 CA--C 1.547 2.04 0 N-CA-C 106.253 -2.739 . . . . 37.14 106.253 165.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -136.1 -158.28 0.86 Allowed 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 118.935 -0.555 . . . . 40.57 112.191 -175.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1157 ' ' ILE . . . . . 0.861 HG21 ' HB2' ' C' ' 70' ' ' PRO . 3.3 tp -155.41 125.68 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 O-C-N 119.615 -1.928 . . . . 44.61 110.22 -159.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1158 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.74 -160.76 1.18 Allowed 'General case' 0 C--O 1.253 1.245 0 N-CA-C 105.436 -2.061 . . . . 40.7 105.436 176.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -48.29 -31.97 6.71 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 119.138 -2.226 . . . . 40.25 116.774 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1160 ' ' ALA . . . . . 0.51 ' HA ' ' HB ' ' B' 1329 ' ' THR . . . -64.58 -11.65 36.94 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-O 117.929 -1.034 . . . . 38.47 113.335 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . 76.8 -117.48 4.91 Favored Glycine 0 N--CA 1.432 -1.617 0 N-CA-C 107.771 -2.132 . . . . 37.61 107.771 -171.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 7.1 tttp -67.89 108.2 2.93 Favored 'General case' 0 CA--C 1.482 -1.672 0 N-CA-C 107.306 -1.368 . . . . 48.9 107.306 171.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1163 ' ' VAL . . . . . . . . . . . . . 38.8 t -82.13 106.17 5.9 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 102.843 -3.021 . . . . 36.52 102.843 163.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1164 ' ' PRO . . . . . 0.72 ' HB2' ' NH2' ' A' 1151 ' ' ARG . 10.2 Cg_endo -65.38 122.21 9.85 Favored 'Trans proline' 0 N--CA 1.443 -1.443 0 C-N-CA 124.504 3.47 . . . . 35.08 116.688 -171.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1165 ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' 1164 ' ' PRO . 95.3 Cg_endo -68.14 156.17 66.78 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 N-CA-C 118.454 2.444 . . . . 35.33 118.454 -177.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -62.92 122.68 16.59 Favored 'General case' 0 N--CA 1.417 -2.098 0 CA-C-N 113.448 -1.705 . . . . 34.69 112.779 169.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1167 ' ' LYS . . . . . 0.674 ' HB2' ' HA ' ' A' 1249 ' ' VAL . 99.0 mttt -93.84 114.35 26.58 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 104.974 -2.232 . . . . 45.36 104.974 164.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1168 ' ' VAL . . . . . 0.415 HG22 ' HB ' ' A' 1251 ' ' ILE . 59.8 t -99.89 134.53 39.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 103.967 -2.605 . . . . 31.71 103.967 -173.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1169 ' ' MET . . . . . . . . . . . . . 46.2 ttp -118.64 105.95 12.11 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 106.416 -1.698 . . . . 42.28 106.416 168.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 38.2 t -78.29 126.4 38.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 107.788 -1.19 . . . . 30.51 107.788 168.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 61.8 mt -112.41 126.16 69.77 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 108.787 -0.82 . . . . 31.87 108.787 171.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 79.6 79.65 0.82 Allowed Glycine 0 CA--C 1.536 1.346 0 N-CA-C 108.65 -1.78 . . . . 34.54 108.65 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1173 ' ' ALA . . . . . . . . . . . . . . . -85.87 89.43 7.77 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 125.568 2.604 . . . . 32.51 110.109 -172.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -113.35 -147.82 9.98 Favored Glycine 0 C--O 1.246 0.906 0 CA-C-N 110.788 -2.915 . . . . 29.9 108.882 174.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1175 ' ' VAL . . . . . 0.563 HG11 ' HA ' ' A' 1131 ' ' SER . 2.7 t -75.57 -37.35 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 119.261 1.531 . . . . 33.11 109.706 -175.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -55.77 -39.87 71.81 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 120.917 -1.115 . . . . 28.1 112.139 165.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -57.35 -49.4 73.06 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-O 118.738 -1.035 . . . . 28.54 110.572 174.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1178 ' ' LEU . . . . . . . . . . . . . 53.3 mt -56.37 -47.1 79.58 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 117.987 0.894 . . . . 31.22 110.588 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -57.28 -46.75 82.81 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 114.085 1.142 . . . . 28.98 114.085 177.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -64.02 -41.65 97.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.284 -0.871 . . . . 27.83 111.026 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1181 ' ' ILE . . . . . . . . . . . . . 92.2 mt -63.86 -46.23 94.84 Favored 'Isoleucine or valine' 0 C--N 1.361 1.085 0 CA-C-O 119.75 -0.167 . . . . 30.25 110.717 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -58.8 -54.54 37.1 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 108.64 -1.784 . . . . 29.59 108.64 -177.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -51.94 -56.1 16.25 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 118.115 0.958 . . . . 30.29 113.309 176.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -63.51 -44.49 94.15 Favored 'General case' 0 C--O 1.254 1.3 0 N-CA-C 115.274 1.583 . . . . 30.47 115.274 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -60.21 -53.25 59.93 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 124.624 1.17 . . . . 42.41 109.284 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1186 ' ' SER . . . . . 0.485 ' HB2' ' HA ' ' B' 1187 ' ' LEU . 85.2 p -57.5 -40.67 79.17 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 120.557 1.526 . . . . 39.38 115.032 175.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 5.6 mt -60.6 -21.57 62.8 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 114.71 1.374 . . . . 36.18 114.71 169.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 93.96 32.75 7.35 Favored Glycine 0 C--O 1.24 0.477 0 CA-C-O 123.085 1.38 . . . . 33.78 110.905 170.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -96.35 168.94 10.26 Favored 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 121.78 -0.836 . . . . 33.93 109.393 176.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 8.4 mt -93.9 109.11 21.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 102.511 -3.144 . . . . 38.74 102.511 -176.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 5.8 t -97.74 131.81 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 118.831 -1.148 . . . . 33.09 109.769 -170.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1192 ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -123.76 151.21 43.51 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 104.054 -2.573 . . . . 38.92 104.054 175.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -143.59 147.91 35.1 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 108.382 -0.97 . . . . 35.32 108.382 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 5.9 t80 -133.18 132.63 41.8 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.006 -1.85 . . . . 39.35 106.006 -178.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 9.0 t0 -156.74 154.5 30.09 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 105.526 -2.027 . . . . 40.46 105.526 170.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1196 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.28 -40.78 81.72 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 120.138 -0.625 . . . . 45.94 109.88 175.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1197 ' ' ARG . . . . . 0.447 ' HA ' ' HD2' ' A' 1198 ' ' PRO . 71.4 mtm180 -71.61 112.15 12.97 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 124.235 1.014 . . . . 56.02 113.516 -168.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1198 ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' 1197 ' ' ARG . 72.6 Cg_endo -60.87 -14.78 34.32 Favored 'Trans proline' 0 C--N 1.325 -0.69 0 C-N-CA 124.775 3.65 . . . . 51.27 116.411 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -69.97 -58.96 3.23 Favored 'General case' 0 C--N 1.356 0.859 0 O-C-N 120.231 -1.543 . . . . 59.1 111.561 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 17.5 m -53.29 -25.02 9.38 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.897 0 N-CA-C 113.262 0.838 . . . . 51.06 113.262 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 86.4 tttt -41.14 -38.3 1.05 Allowed 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 126.593 1.957 . . . . 57.38 114.863 169.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -66.45 -57.93 6.33 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 115.792 -2.051 . . . . 62.41 111.915 172.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -57.18 -28.62 62.98 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 123.924 3.056 . . . . 57.78 116.309 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1204 ' ' VAL . . . . . 0.597 HG11 ' HD1' ' A' 1211 ' ' PHE . 49.8 t -58.5 -60.51 2.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 O-C-N 121.555 -0.716 . . . . 46.38 109.924 168.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -69.92 -49.18 54.53 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 105.958 -1.867 . . . . 50.7 105.958 -170.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1206 ' ' SER . . . . . . . . . . . . . 45.8 m -45.75 -46.83 15.36 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.689 1.737 . . . . 49.98 115.689 169.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1207 ' ' MET . . . . . . . . . . . . . 18.2 mtp -73.21 -11.22 60.44 Favored 'General case' 0 CA--C 1.504 -0.79 0 O-C-N 119.024 -2.298 . . . . 52.99 113.06 175.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 105.27 64.95 0.66 Allowed Glycine 0 N--CA 1.439 -1.136 0 N-CA-C 109.931 -1.268 . . . . 47.66 109.931 166.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -152.81 144.52 23.53 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.099 -1.05 . . . . 44.77 110.147 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -75.49 133.19 41.11 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 105.738 -1.949 . . . . 47.64 105.738 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1211 ' ' PHE . . . . . 0.597 ' HD1' HG11 ' A' 1204 ' ' VAL . 35.1 t80 -99.22 105.93 18.02 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 117.075 -1.85 . . . . 45.66 108.974 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 55.6 mt -67.13 111.31 3.84 Favored 'General case' 0 C--O 1.252 1.229 0 CA-C-O 123.405 1.574 . . . . 46.06 109.9 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -79.18 165.37 23.37 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 113.379 -1.737 . . . . 60.22 115.318 174.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 8.4 mp -72.25 104.99 3.85 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-N 112.827 -1.988 . . . . 57.25 107.241 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1215 ' ' ASP . . . . . 0.45 ' HB3' HD21 ' A' 1241 ' ' LEU . 23.4 t70 -74.13 99.02 3.26 Favored 'General case' 0 CA--C 1.497 -1.071 0 O-C-N 118.416 -2.678 . . . . 64.43 106.617 166.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 14.5 t80 . . . . . 0 CA--C 1.54 0.558 0 CA-C-N 111.055 -2.793 . . . . 66.9 108.203 175.518 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 N--CA 1.425 -1.678 0 CA-C-O 121.843 0.83 . . . . 39.09 109.865 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -65.57 -29.38 75.03 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 126.927 2.203 . . . . 39.32 111.123 -169.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.7 -53.25 9.62 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 118.995 1.398 . . . . 39.3 107.546 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -55.6 -41.63 73.69 Favored 'General case' 0 C--O 1.211 -0.936 0 N-CA-C 113.358 0.873 . . . . 36.3 113.358 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -51.21 -64.77 0.7 Allowed 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 114.093 1.145 . . . . 37.38 114.093 162.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -63.62 -24.03 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 116.731 2.123 . . . . 39.11 116.731 -171.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1230 ' ' MET . . . . . . . . . . . . . 33.7 mmt -79.91 -23.57 41.7 Favored 'General case' 0 C--O 1.241 0.644 0 O-C-N 120.964 -1.085 . . . . 49.59 112.522 178.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1231 ' ' SER . . . . . . . . . . . . . 12.6 p -89.47 137.88 31.94 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 120.484 3.512 . . . . 43.68 120.484 -163.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -41.4 -45.58 3.14 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 117.457 2.392 . . . . 55.57 117.457 -174.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -73.01 -32.98 65.48 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 120.317 -1.489 . . . . 44.94 114.432 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -64.44 -53.9 41.03 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 106.804 -1.554 . . . . 42.04 106.804 172.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 35.9 mt -56.47 -27.5 24.93 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 N-CA-C 114.905 1.446 . . . . 46.28 114.905 173.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -59.08 -56.11 26.46 Favored 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 121.221 -0.924 . . . . 47.87 111.585 170.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -59.91 -52.92 63.35 Favored 'General case' 0 CA--C 1.496 -1.096 0 O-C-N 127.028 2.705 . . . . 41.61 111.339 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -48.68 -48.21 40.19 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 123.851 0.861 . . . . 50.65 112.316 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1239 ' ' MET . . . . . . . . . . . . . 28.4 ttm -55.02 -44.04 74.24 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 124.583 1.177 . . . . 48.87 109.149 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -72.07 -30.33 65.02 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.337 -0.945 . . . . 54.8 113.493 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1241 ' ' LEU . . . . . 0.45 HD21 ' HB3' ' A' 1215 ' ' ASP . 4.1 mm? -60.9 -43.54 98.36 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 118.833 -1.147 . . . . 43.21 113.824 169.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -62.15 -43.61 98.45 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.552 1.158 . . . . 38.66 109.37 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -57.15 -52.95 63.24 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.605 0.595 . . . . 37.92 112.605 171.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -54.35 -29.54 48.6 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 114.046 1.128 . . . . 37.28 114.046 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -85.31 -40.02 17.02 Favored 'General case' 0 C--N 1.315 -0.902 0 O-C-N 123.736 0.647 . . . . 43.07 110.588 174.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1246 ' ' ALA . . . . . 0.803 ' HB1' ' HG2' ' A' 1275 ' ' MET . . . -66.49 -15.5 63.42 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 116.742 2.127 . . . . 38.3 116.742 -158.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1247 ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -87.05 -18.46 30.52 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 113.391 -1.731 . . . . 47.6 113.792 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -105.33 -45.53 4.45 Favored 'General case' 0 C--N 1.358 0.968 0 O-C-N 120.435 -1.415 . . . . 45.42 112.839 165.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1249 ' ' VAL . . . . . 0.674 ' HA ' ' HB2' ' A' 1167 ' ' LYS . 31.4 m -64.67 148.14 12.07 Favored 'Isoleucine or valine' 0 C--N 1.345 0.382 0 CA-C-O 123.221 1.486 . . . . 36.26 114.256 -175.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1250 ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -91.37 -71.97 0.61 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.718 1.247 . . . . 33.04 111.036 -176.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1251 ' ' ILE . . . . . 0.7 HD12 ' HB1' ' A' 1145 ' ' ALA . 37.4 mm -97.68 101.29 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.946 0 C-N-CA 117.462 -1.695 . . . . 31.4 107.776 -171.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1252 ' ' ILE . . . . . . . . . . . . . 68.0 mt -77.09 94.15 1.25 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 106.563 -1.643 . . . . 29.42 106.563 166.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1253 ' ' VAL . . . . . 0.652 ' HA ' HG23 ' A' 1282 ' ' VAL . 2.0 t -81.3 98.61 4.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 104.5 -2.408 . . . . 30.37 104.5 175.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1254 ' ' THR . . . . . 0.767 HG21 ' HB2' ' A' 1291 ' ' ASN . 22.3 m -86.76 82.16 7.94 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 124.587 2.137 . . . . 35.72 105.914 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1255 ' ' THR . . . . . 0.476 HG22 HD12 ' A' 1284 ' ' LEU . 1.9 p -73.8 5.11 4.34 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 120.067 3.358 . . . . 36.0 120.067 -176.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1256 ' ' ALA . . . . . . . . . . . . . . . -85.64 63.03 7.83 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 124.105 1.907 . . . . 40.93 112.76 -170.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 57.1 tp -70.6 91.72 0.81 Allowed 'General case' 0 C--N 1.353 0.733 0 N-CA-C 103.546 -2.761 . . . . 47.82 103.546 172.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 39.5 mm -87.08 108.15 17.63 Favored Pre-proline 0 C--O 1.22 -0.489 0 N-CA-C 104.14 -2.541 . . . . 52.7 104.14 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -56.63 109.52 0.46 Allowed 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 124.398 3.399 . . . . 54.13 116.34 -170.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 78.34 16.32 79.69 Favored Glycine 0 N--CA 1.461 0.343 0 CA-C-N 112.025 -2.352 . . . . 54.62 111.945 174.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 92.1 mttt -125.78 141.72 40.11 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 119.628 1.714 . . . . 55.74 109.022 -176.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -66.46 97.85 0.38 Allowed 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 123.299 2.666 . . . . 51.15 107.031 172.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -56.58 125.02 65.8 Favored Pre-proline 0 N--CA 1.433 -1.294 0 CA-C-O 117.375 -1.298 . . . . 46.06 112.519 176.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -50.15 128.39 22.35 Favored 'Trans proline' 0 C--O 1.25 1.09 1 C-N-CA 126.622 4.881 . . . . 41.08 112.645 -166.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -61.7 97.06 0.07 Allowed 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.933 -1.03 . . . . 47.42 110.408 172.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 83.4 mt -94.77 -54.54 3.44 Favored 'General case' 0 N--CA 1.434 -1.23 0 O-C-N 120.693 -1.254 . . . . 39.22 109.68 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1267 ' ' ILE . . . . . 0.484 ' HB ' ' HA ' ' A' 1292 ' ' CYS . 12.3 mt -78.46 104.36 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 107.937 -1.135 . . . . 42.5 107.937 -172.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1268 ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.54 148.56 48.44 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 119.078 2.992 . . . . 37.84 119.078 175.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 40.6 mtt180 -52.28 -59.45 4.38 Favored 'General case' 0 C--O 1.248 0.996 0 N-CA-C 117.159 2.281 . . . . 54.8 117.159 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.55 -27.01 68.96 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 118.819 0.736 . . . . 54.36 111.919 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1271 ' ' MET . . . . . . . . . . . . . 59.5 ttm -68.45 -36.76 79.47 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.986 1.314 . . . . 39.52 111.704 175.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1272 ' ' VAL . . . . . . . . . . . . . 92.3 t -63.25 -47.94 89.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 N-CA-C 107.503 -1.295 . . . . 38.25 107.503 171.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -57.6 -26.16 61.13 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 113.731 1.012 . . . . 40.77 113.731 175.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1274 ' ' SER . . . . . . . . . . . . . 5.1 m -85.67 -8.24 58.33 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 121.261 1.846 . . . . 36.58 114.945 173.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1275 ' ' MET . . . . . 0.803 ' HG2' ' HB1' ' A' 1246 ' ' ALA . 87.1 mtp -60.76 165.19 4.11 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 116.521 2.045 . . . . 36.75 116.521 176.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1276 ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -67.47 144.47 55.69 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 122.514 1.149 . . . . 46.11 111.585 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1277 ' ' ALA . . . . . 0.494 ' HB1' ' HA ' ' B' 1045 ' ' PHE . . . -60.25 139.89 57.34 Favored 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 124.423 1.089 . . . . 33.52 109.008 176.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 76.43 -0.79 63.14 Favored Glycine 0 CA--C 1.538 1.479 0 O-C-N 119.943 -1.723 . . . . 31.27 113.267 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1279 ' ' SER . . . . . . . . . . . . . 47.0 m -74.56 160.53 30.76 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 118.771 -2.605 . . . . 32.95 109.37 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1280 ' ' VAL . . . . . 0.554 HG11 ' HA ' ' A' 1145 ' ' ALA . 82.9 t -127.49 135.88 62.05 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 O-C-N 119.776 -1.828 . . . . 27.43 108.38 -178.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1281 ' ' ILE . . . . . 0.449 HD12 HG22 ' A' 1309 ' ' VAL . 83.7 mt -108.62 98.62 7.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 103.193 -2.891 . . . . 30.3 103.193 169.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1282 ' ' VAL . . . . . 0.652 HG23 ' HA ' ' A' 1253 ' ' VAL . 0.0 OUTLIER -85.42 97.28 5.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.577 -1.268 . . . . 28.63 107.577 171.216 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1283 ' ' ASP . . . . . 0.646 ' HA ' ' HB ' ' A' 1254 ' ' THR . 19.6 t0 -87.83 109.39 19.72 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.019 -1.474 . . . . 36.27 107.019 178.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1284 ' ' LEU . . . . . 0.721 HD21 ' HB2' ' A' 1141 ' ' ALA . 25.4 mt -74.98 -28.96 60.76 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 112.909 -1.95 . . . . 38.57 115.214 173.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -65.99 -53.18 42.16 Favored 'General case' 0 C--O 1.218 -0.569 0 O-C-N 120.304 -1.497 . . . . 37.56 110.098 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1286 ' ' ALA . . . . . 0.503 ' HA ' HG21 ' A' 1295 ' ' THR . . . 38.02 -74.81 0.0 OUTLIER 'General case' 0 N--CA 1.413 -2.291 0 C-N-CA 128.511 2.724 . . . . 40.33 116.172 176.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -63.07 -47.32 83.46 Favored 'General case' 0 N--CA 1.482 1.175 0 O-C-N 120.365 -1.46 . . . . 56.85 109.634 173.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 5.5 m120 -72.83 70.1 0.97 Allowed 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 124.718 1.261 . . . . 45.86 109.43 175.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 74.26 -58.91 2.36 Favored Glycine 0 CA--C 1.538 1.524 0 N-CA-C 117.657 1.823 . . . . 40.31 117.657 -176.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 84.35 121.79 0.95 Allowed Glycine 0 C--O 1.22 -0.728 0 N-CA-C 108.835 -1.706 . . . . 38.89 108.835 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1291 ' ' ASN . . . . . 0.767 ' HB2' HG21 ' A' 1254 ' ' THR . 24.4 m120 -76.45 -20.6 56.87 Favored 'General case' 0 CA--C 1.492 -1.281 0 CA-C-N 121.26 2.53 . . . . 37.23 112.324 -176.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1292 ' ' CYS . . . . . 0.484 ' HA ' ' HB ' ' A' 1267 ' ' ILE . 36.9 t -85.44 142.99 28.84 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 120.249 -1.532 . . . . 36.5 109.638 170.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1293 ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -74.36 -13.96 60.81 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 116.218 1.932 . . . . 43.32 116.218 169.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -90.03 -4.25 57.5 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 116.018 1.858 . . . . 41.32 116.018 169.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1295 ' ' THR . . . . . 0.503 HG21 ' HA ' ' A' 1286 ' ' ALA . 52.5 m -65.96 119.22 10.96 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 119.375 -2.078 . . . . 35.3 110.971 -175.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1296 ' ' VAL . . . . . 0.577 ' HB ' ' HB2' ' A' 1299 ' ' GLU . 48.4 t -95.53 112.26 58.32 Favored Pre-proline 0 C--O 1.248 1.015 0 N-CA-C 101.575 -3.491 . . . . 34.84 101.575 171.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -55.86 104.54 0.13 Allowed 'Trans proline' 0 C--O 1.22 -0.408 0 C-N-CA 124.114 3.21 . . . . 33.51 111.902 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 112.23 9.77 19.22 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 113.561 -1.654 . . . . 32.19 111.048 172.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1299 ' ' GLU . . . . . 0.577 ' HB2' ' HB ' ' A' 1296 ' ' VAL . 8.7 mm-40 -132.89 162.34 31.85 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 121.248 2.524 . . . . 34.88 116.451 -163.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1300 ' ' ILE . . . . . 0.438 HG23 HG12 ' A' 1310 ' ' ILE . 80.2 mt -90.76 105.82 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 N-CA-C 101.671 -3.455 . . . . 32.29 101.671 163.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1301 ' ' PHE . . . . . 0.68 ' HB3' ' HB ' ' A' 1309 ' ' VAL . 35.5 t80 -81.9 110.67 17.4 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 104.73 -2.322 . . . . 37.25 104.73 166.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1302 ' ' THR . . . . . . . . . . . . . 54.0 m -93.44 119.07 32.1 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.136 -1.802 . . . . 35.56 106.136 175.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1303 ' ' THR . . . . . . . . . . . . . 2.1 m -103.18 142.6 33.88 Favored 'General case' 0 C--O 1.247 0.946 0 N-CA-C 107.643 -1.243 . . . . 36.4 107.643 -173.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -52.4 -42.6 64.17 Favored 'General case' 0 C--O 1.247 0.921 0 C-N-CA 126.285 1.834 . . . . 52.32 113.445 -168.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1305 ' ' ASN . . . . . 0.691 ' HA ' ' HB2' ' B' 1046 ' ' ASP . 38.3 p-10 -61.07 -22.0 64.19 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 115.628 1.714 . . . . 40.04 115.628 175.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 120.56 0.11 12.37 Favored Glycine 0 N--CA 1.413 -2.891 0 C-N-CA 120.333 -0.937 . . . . 36.96 111.223 177.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1307 ' ' VAL . . . . . 0.613 HG21 ' HB2' ' A' 1275 ' ' MET . 71.0 t -82.53 131.51 33.6 Favored 'Isoleucine or valine' 0 C--N 1.347 0.493 0 O-C-N 118.452 -2.793 . . . . 33.4 110.147 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1308 ' ' LYS . . . . . 0.686 ' HG3' ' HB3' ' A' 1148 ' ' GLU . 26.2 mmtp -99.15 94.91 6.76 Favored 'General case' 0 C--O 1.248 1.0 0 N-CA-C 106.226 -1.768 . . . . 42.91 106.226 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1309 ' ' VAL . . . . . 0.68 ' HB ' ' HB3' ' A' 1301 ' ' PHE . 24.0 t -76.08 85.88 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.608 0 CA-C-O 122.296 1.046 . . . . 32.29 109.803 174.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1310 ' ' ILE . . . . . 0.828 HD11 ' HB2' ' A' 1148 ' ' GLU . 55.0 mt -89.95 95.83 5.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 124.566 2.127 . . . . 30.99 106.263 -174.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -90.55 71.26 2.06 Favored Glycine 0 N--CA 1.436 -1.364 0 O-C-N 119.515 -1.991 . . . . 28.95 110.778 171.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1312 ' ' TYR . . . . . 0.482 ' HD1' ' HA ' ' A' 1312 ' ' TYR . 0.0 OUTLIER -91.65 124.52 35.86 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 119.167 1.483 . . . . 31.69 111.187 -171.105 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1313 ' ' THR . . . . . . . . . . . . . 4.5 p -103.71 -21.65 13.67 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 118.862 -1.135 . . . . 34.17 113.827 -175.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -81.85 24.53 0.61 Allowed 'General case' 0 C--O 1.256 1.432 0 CA-C-O 122.06 0.933 . . . . 36.86 112.752 -173.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1315 ' ' LEU . . . . . 0.546 HD22 ' HG3' ' A' 1140 ' ' ARG . 88.3 mt -69.84 -42.52 18.45 Favored Pre-proline 0 N--CA 1.439 -1.012 0 N-CA-C 118.075 2.62 . . . . 34.85 118.075 -168.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -59.54 -35.58 95.24 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 CA-C-N 123.672 2.347 . . . . 29.15 113.8 171.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -65.2 -35.72 91.99 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-O 122.165 0.87 . . . . 27.29 111.413 172.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1318 ' ' ARG . . . . . 0.49 ' HD2' HD23 ' A' 1315 ' ' LEU . 79.7 mtt-85 -64.38 -3.16 2.68 Favored 'General case' 0 C--O 1.24 0.563 0 O-C-N 120.438 -1.625 . . . . 41.49 114.697 168.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1319 ' ' LEU . . . . . 0.471 HD23 HG23 ' A' 1136 ' ' ILE . 8.0 tp -143.51 69.53 17.38 Favored Pre-proline 0 N--CA 1.437 -1.114 0 O-C-N 118.487 -2.633 . . . . 27.61 111.018 178.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1320 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -53.88 -62.72 0.28 Allowed 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 124.948 3.765 . . . . 25.94 116.451 -169.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1321 ' ' THR . . . . . 0.415 HG21 HH11 ' B' 1151 ' ' ARG . 0.2 OUTLIER -59.4 -22.95 62.17 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 121.361 1.891 . . . . 25.01 111.407 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1322 ' ' GLN . . . . . 0.502 HE22 HG21 ' B' 1163 ' ' VAL . 29.7 tp60 -75.18 -37.57 61.17 Favored 'General case' 0 C--O 1.217 -0.617 0 O-C-N 120.192 -1.568 . . . . 29.39 109.088 176.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1323 ' ' SER . . . . . . . . . . . . . 73.6 m -60.4 -66.54 0.51 Allowed 'General case' 0 C--O 1.251 1.149 0 CA-C-O 118.185 -0.912 . . . . 26.47 109.897 166.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1324 ' ' SER . . . . . . . . . . . . . 14.5 m -45.29 -36.36 4.01 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 116.883 2.179 . . . . 27.78 116.883 177.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -77.88 -64.96 1.03 Allowed 'General case' 0 C--O 1.216 -0.701 0 O-C-N 119.805 -1.809 . . . . 37.53 114.723 170.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1326 ' ' LEU . . . . . 0.731 ' HB3' ' HB3' ' A' 1132 ' ' SER . 22.1 mt -70.39 -51.39 29.98 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 120.961 1.71 . . . . 35.71 113.544 -169.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1327 ' ' TYR . . . . . 0.468 ' HA ' ' OD1' ' A' 1330 ' ' ASN . 64.4 t80 -66.14 -46.05 78.86 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 106.779 -1.563 . . . . 31.59 106.779 174.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1328 ' ' GLY . . . . . 0.564 ' HA2' HD12 ' A' 1331 ' ' LEU . . . -40.42 -52.82 3.58 Favored Glycine 0 CA--C 1.541 1.664 0 CA-C-N 119.994 1.27 . . . . 28.0 113.829 166.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1329 ' ' THR . . . . . 0.402 ' HA ' ' HB ' ' A' 1332 ' ' VAL . 1.1 m -79.44 -18.28 52.51 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 117.328 -3.454 . . . . 32.15 108.353 -173.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1330 ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' 1127 ' ' LEU . 29.4 m120 -57.91 -53.96 52.26 Favored 'General case' 0 C--O 1.246 0.893 0 O-C-N 118.344 -2.722 . . . . 34.36 110.487 167.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1331 ' ' LEU . . . . . 0.803 HD13 HD13 ' A' 1070 ' ' LEU . 11.7 mt -57.0 -47.5 80.69 Favored 'General case' 0 C--N 1.353 0.726 0 CA-C-N 113.63 -1.623 . . . . 33.37 110.388 175.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1332 ' ' VAL . . . . . 0.676 HG21 ' HB ' ' A' 1022 ' ' THR . 59.9 t -58.86 -37.53 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 124.884 1.274 . . . . 35.27 109.98 176.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -70.59 -41.75 71.94 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-N 121.801 2.091 . . . . 37.66 112.475 -176.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1334 ' ' LEU . . . . . 0.536 HD23 HG13 ' A' 1090 ' ' VAL . 60.2 tp -58.74 -53.31 59.85 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 121.51 0.671 . . . . 40.27 109.669 170.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1335 ' ' LEU . . . . . 0.484 ' HA ' ' HB2' ' A' 1338 ' ' LEU . 13.5 mt -60.92 -21.11 63.06 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 115.511 1.671 . . . . 42.5 115.511 176.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1336 ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' 1332 ' ' VAL . 96.1 mttt -65.23 -46.83 79.01 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 118.626 0.648 . . . . 47.81 109.589 168.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1337 ' ' LEU . . . . . . . . . . . . . 36.7 mt -63.67 -41.22 98.21 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 124.03 1.871 . . . . 49.27 111.569 178.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1338 ' ' LEU . . . . . 0.484 ' HB2' ' HA ' ' A' 1335 ' ' LEU . 10.3 mp -59.74 -41.49 91.05 Favored 'General case' 0 C--N 1.355 0.823 0 CA-C-O 122.923 1.344 . . . . 50.54 112.624 175.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1339 ' ' CYS . . . . . 0.724 ' SG ' ' HA ' ' A' 1342 ' ' LYS . 18.1 t -74.93 82.01 2.18 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 123.734 1.731 . . . . 53.67 111.905 173.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -58.9 -55.23 37.76 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 112.543 -2.117 . . . . 63.38 113.229 -175.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -115.57 -0.47 13.03 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 115.351 1.611 . . . . 70.95 115.351 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1342 ' ' LYS . . . . . 0.724 ' HA ' ' SG ' ' A' 1339 ' ' CYS . 31.3 mtmm 56.3 66.41 1.2 Allowed 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 118.716 2.858 . . . . 65.25 118.716 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1343 ' ' ASP . . . . . 0.464 ' HB3' ' N ' ' A' 1342 ' ' LYS 0.462 0.0 OUTLIER 87.79 -73.96 0.01 OUTLIER 'General case' 0 C--N 1.359 0.987 3 O-C-N 113.169 -5.957 . . . . 64.53 120.278 -10.645 . . . . . . . . 5 4 . 1 . 002 nuclear nobuild core ' A' A 1344 ' ' GLY . . . . . . . . . . . . . . . 68.55 46.6 61.53 Favored Glycine 0 C--O 1.257 1.553 0 O-C-N 120.764 -1.21 . . . . 59.72 115.562 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1345 ' ' ASN . . . . . 0.444 ' HB2' ' OD2' ' A' 1343 ' ' ASP . 9.1 t-20 -78.81 149.33 32.61 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 115.729 1.751 . . . . 64.09 115.729 176.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1346 ' ' ILE . . . . . . . . . . . . . 2.8 mp -85.04 86.69 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 N-CA-C 100.847 -3.76 . . . . 58.82 100.847 170.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1347 ' ' THR . . . . . . . . . . . . . 9.7 m -93.2 91.94 7.51 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 123.57 1.652 . . . . 54.96 113.859 172.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1348 ' ' VAL . . . . . 0.55 HG21 HG21 ' A' 1111 ' ' THR . 10.4 t -88.01 93.15 4.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 101.294 -3.595 . . . . 55.64 101.294 174.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 21.5 t70 -86.36 133.17 33.81 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-O 123.476 1.608 . . . . 61.45 107.806 169.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -99.88 -8.95 23.42 Favored 'General case' 0 N--CA 1.442 -0.838 0 O-C-N 119.991 -1.693 . . . . 58.63 113.127 176.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -73.36 -35.08 65.92 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-N 115.551 -0.75 . . . . 62.06 112.767 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 7.3 t70 -82.75 125.53 31.37 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.537 -1.283 . . . . 54.07 107.537 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 27.2 m -55.61 -30.79 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 113.53 -1.668 . . . . 50.68 114.088 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1354 ' ' VAL . . . . . 0.474 ' O ' HG23 ' A' 1358 ' ' VAL 0.251 6.0 m -71.03 -49.66 47.8 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 C-N-CA 118.955 -1.098 . . . . 47.68 112.374 178.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1355 ' ' ILE . . . . . . . . . . . . . 72.0 mt -71.36 -37.7 66.25 Favored 'Isoleucine or valine' 0 C--O 1.253 1.241 0 N-CA-C 108.623 -0.881 . . . . 48.49 108.623 -173.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 46.5 tpt85 -57.36 -33.38 67.73 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 113.56 0.948 . . . . 48.27 113.56 167.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -65.72 -52.54 37.7 Favored Glycine 0 N--CA 1.436 -1.357 0 C-N-CA 123.52 0.581 . . . . 43.53 112.486 172.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1358 ' ' VAL . . . . . 0.785 HG22 HG22 ' A' 1118 ' ' VAL . 3.5 t -66.18 -37.93 80.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 107.401 -1.333 . . . . 45.12 107.401 -175.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1359 ' ' THR . . . . . . . . . . . . . 30.3 m -76.43 87.74 3.19 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 119.869 -1.77 . . . . 42.94 111.228 -174.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 33.4 m -77.93 -31.43 16.89 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 O-C-N 121.025 -1.047 . . . . 43.26 110.647 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1361 ' ' ILE . . . . . 0.475 HG12 HG12 ' A' 1366 ' ' ILE . 94.8 mt -128.56 119.62 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 N-CA-C 105.844 -1.91 . . . . 45.66 105.844 176.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1362 ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -103.45 120.29 40.53 Favored 'General case' 0 C--N 1.364 1.209 0 CA-C-N 123.445 2.838 . . . . 61.34 106.365 174.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 36.01 48.5 0.52 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 112.14 -2.3 . . . . 49.76 115.999 -177.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1364 ' ' GLY . . . . . 0.499 ' HA3' ' HA ' ' A' 1109 ' ' ASN . . . 89.23 12.73 62.89 Favored Glycine 0 C--O 1.222 -0.603 0 CA-C-O 116.944 -2.031 . . . . 50.0 113.062 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -122.83 127.07 48.56 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 102.322 -3.214 . . . . 56.92 102.322 172.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1366 ' ' ILE . . . . . 0.475 HG12 HG12 ' A' 1361 ' ' ILE . 43.5 mt -73.75 92.89 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 CA-C-O 123.01 1.386 . . . . 52.78 109.184 -176.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1367 ' ' THR . . . . . . . . . . . . . 6.9 p -76.55 -5.69 48.74 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 123.55 1.643 . . . . 49.44 114.609 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 20.1 t90 -60.42 143.56 89.48 Favored Pre-proline 0 N--CA 1.44 -0.931 0 CA-C-O 116.227 -1.844 . . . . 52.38 110.365 171.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -81.37 -163.88 3.55 Favored 'Cis proline' 0 C--O 1.248 1.005 0 CA-C-N 123.417 2.256 . . . . 46.94 112.571 -6.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -129.14 158.3 73.32 Favored Pre-proline 0 N--CA 1.428 -1.561 0 CA-C-O 117.188 -1.387 . . . . 45.91 108.742 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1371 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -47.28 120.83 4.69 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 124.901 3.734 . . . . 46.39 111.216 170.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -65.66 -41.26 15.17 Favored 'Trans proline' 0 CA--C 1.557 1.64 0 C-N-CA 125.076 3.851 . . . . 46.72 112.077 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.228 -4.699 0 CA-C-N 121.508 1.958 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 20.2 m80 . . . . . 0 N--CA 1.425 -1.697 0 N-CA-C 105.958 -1.867 . . . . 63.44 105.958 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 999' ' ' HIS . . . . . 0.512 ' HB3' ' HB3' ' B' 1002 ' ' ARG . 89.7 m-70 -93.94 57.36 2.43 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 119.485 -2.009 . . . . 51.74 107.449 173.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1000 ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -81.46 118.45 22.72 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 106.792 -1.559 . . . . 54.07 106.792 -167.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 72.78 18.97 79.13 Favored Glycine 0 C--O 1.224 -0.529 0 CA-C-N 114.716 -1.129 . . . . 39.22 111.927 -168.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1002 ' ' ARG . . . . . 0.544 ' HD2' ' HB2' ' B' 1034 ' ' ALA . 33.9 ttp180 -100.6 124.93 46.85 Favored 'General case' 0 C--O 1.256 1.419 0 CA-C-N 121.387 2.594 . . . . 38.12 109.994 169.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1003 ' ' ILE . . . . . . . . . . . . . 51.6 mt -81.41 142.61 13.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 108.942 -3.753 . . . . 29.7 105.029 171.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -112.44 128.56 8.55 Favored Glycine 0 N--CA 1.436 -1.332 0 N-CA-C 106.217 -2.753 . . . . 27.5 106.217 166.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1005 ' ' ILE . . . . . 0.567 ' HB ' ' HA ' ' B' 1035 ' ' VAL . 47.6 mm -105.62 99.71 22.92 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 101.166 -3.642 . . . . 24.83 101.166 173.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -83.88 166.62 13.14 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.672 2.248 . . . . 27.19 112.148 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 30.2 ttm105 -77.17 143.61 38.95 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 103.039 -2.949 . . . . 41.46 103.039 167.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1008 ' ' GLU . . . . . 0.485 ' OE2' ' HG2' ' B' 1071 ' ' LYS . 8.6 mm-40 -63.9 129.8 41.52 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 116.83 2.159 . . . . 26.93 116.83 169.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 48.5 mmm-85 -83.73 -5.7 59.26 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 110.704 -2.953 . . . . 34.48 111.339 171.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1010 ' ' LEU . . . . . 0.401 HD23 ' HB2' ' B' 1013 ' ' GLU . 4.1 tp -60.93 126.16 26.37 Favored 'General case' 0 C--O 1.244 0.792 0 O-C-N 120.805 -1.184 . . . . 44.22 108.919 168.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1011 ' ' THR . . . . . . . . . . . . . 86.9 m -64.93 116.47 6.41 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-O 122.452 1.12 . . . . 40.74 108.95 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 21.7 t30 63.15 92.16 0.06 Allowed 'General case' 0 C--N 1.339 0.15 0 CA-C-N 112.308 -2.224 . . . . 44.44 112.546 -174.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1013 ' ' GLU . . . . . 0.401 ' HB2' HD23 ' B' 1010 ' ' LEU . 10.3 tp10 -137.88 138.72 39.36 Favored 'General case' 0 N--CA 1.415 -2.217 0 CA-C-N 111.147 -2.752 . . . . 29.87 104.385 176.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1014 ' ' THR . . . . . 0.454 HG22 ' HB3' ' B' 1320 ' ' PRO . 0.2 OUTLIER -104.38 -5.07 22.07 Favored 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 120.247 -1.533 . . . . 25.26 111.331 177.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B 1015 ' ' ARG . . . . . 0.701 ' HG3' ' HA2' ' B' 1317 ' ' GLY . 23.6 mtm180 -88.37 148.05 24.44 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 119.904 1.229 . . . . 29.54 113.517 177.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1016 ' ' VAL . . . . . 0.535 HG13 ' H ' ' B' 1018 ' ' ALA . 4.4 p -113.94 -173.19 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 105.643 -1.984 . . . . 23.55 105.643 151.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1017 ' ' ALA . . . . . . . . . . . . . . . -106.37 11.75 30.57 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 121.485 1.948 . . . . 23.59 115.686 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1018 ' ' ALA . . . . . 0.535 ' H ' HG13 ' B' 1016 ' ' VAL . . . -149.98 156.16 41.22 Favored 'General case' 0 C--O 1.211 -0.939 0 CA-C-O 123.018 1.389 . . . . 24.93 113.677 -176.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1019 ' ' THR . . . . . 0.524 HG22 ' HZ ' ' B' 1045 ' ' PHE . 26.1 p -135.12 163.48 50.81 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 110.812 -2.904 . . . . 28.09 103.308 176.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -49.97 -39.25 49.91 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.86 2.374 . . . . 28.79 113.541 168.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1021 ' ' LYS . . . . . 0.4 ' O ' ' HG3' ' B' 1025 ' ' GLN . 76.4 tttt -67.9 -44.7 76.38 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 112.535 0.568 . . . . 47.28 112.535 177.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1022 ' ' THR . . . . . . . . . . . . . 13.7 p -67.99 -29.61 68.66 Favored 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 120.223 -1.548 . . . . 30.12 111.956 178.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1023 ' ' VAL . . . . . . . . . . . . . 69.1 t -56.55 -53.84 35.97 Favored 'Isoleucine or valine' 0 C--N 1.351 0.637 0 N-CA-C 107.107 -1.442 . . . . 32.24 107.107 170.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1024 ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -55.96 -39.36 71.66 Favored 'General case' 0 C--O 1.215 -0.732 0 N-CA-C 114.324 1.231 . . . . 49.62 114.324 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1025 ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' B' 1021 ' ' LYS . 43.9 mt-30 -65.97 -43.26 88.4 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 122.496 1.141 . . . . 44.68 109.869 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1026 ' ' LEU . . . . . 0.404 ' CD2' HG22 ' B' 1332 ' ' VAL . 42.6 mt -67.82 -32.17 72.52 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 119.103 -2.248 . . . . 35.71 114.641 173.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1027 ' ' LEU . . . . . . . . . . . . . 98.1 mt -62.9 -39.91 95.96 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.072 -1.017 . . . . 42.18 110.493 172.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 24.8 mttm -62.17 -47.65 83.56 Favored 'General case' 0 C--O 1.251 1.154 0 N-CA-C 109.21 -0.663 . . . . 48.34 109.21 172.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1029 ' ' LEU . . . . . 0.627 HD21 ' HG2' ' B' 1336 ' ' LYS . 79.8 mt -64.84 -4.27 4.24 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 116.972 2.212 . . . . 38.69 116.972 172.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 88.95 20.95 44.37 Favored Glycine 0 N--CA 1.433 -1.551 0 CA-C-O 122.934 1.296 . . . . 32.28 114.355 166.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -99.05 143.95 28.75 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 123.163 1.459 . . . . 35.94 108.212 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1032 ' ' THR . . . . . . . . . . . . . 31.9 m -79.04 117.14 19.81 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 106.532 -1.655 . . . . 33.37 106.532 164.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1033 ' ' VAL . . . . . . . . . . . . . 2.9 t -91.89 108.62 20.27 Favored 'Isoleucine or valine' 0 C--O 1.262 1.741 0 O-C-N 120.599 -1.313 . . . . 29.98 107.708 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1034 ' ' ALA . . . . . 0.544 ' HB2' ' HD2' ' B' 1002 ' ' ARG . . . -99.84 140.17 34.44 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 107.376 -1.342 . . . . 28.18 107.376 172.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1035 ' ' VAL . . . . . 0.567 ' HA ' ' HB ' ' B' 1005 ' ' ILE . 88.3 t -124.26 145.53 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 103.652 -2.721 . . . . 25.82 103.652 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1036 ' ' GLU . . . . . 0.603 ' HB3' ' HB2' ' B' 1039 ' ' ALA . 26.9 tt0 -65.89 129.75 40.88 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.472 -1.24 . . . . 32.44 112.585 173.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1037 ' ' SER . . . . . . . . . . . . . 12.7 m -57.16 133.9 55.43 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.239 -1.346 . . . . 29.54 108.884 172.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 88.88 -43.59 3.09 Favored Glycine 0 CA--C 1.498 -0.98 0 O-C-N 117.424 -3.297 . . . . 27.76 110.886 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1039 ' ' ALA . . . . . 0.603 ' HB2' ' HB3' ' B' 1036 ' ' GLU . . . -37.52 -37.37 0.2 Allowed 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 118.304 2.705 . . . . 26.02 118.304 -175.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -62.99 -31.13 79.62 Favored Glycine 0 N--CA 1.42 -2.411 0 C-N-CA 126.029 1.776 . . . . 26.47 113.62 -175.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1041 ' ' GLN . . . . . 0.426 ' NE2' ' HA ' ' B' 1046 ' ' ASP . 3.1 mp0 -56.9 -40.62 76.6 Favored 'General case' 0 CA--C 1.518 -0.26 0 O-C-N 120.137 -1.802 . . . . 50.98 114.101 -175.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 29.9 mt -63.5 -44.19 95.04 Favored 'General case' 0 C--O 1.247 0.923 0 O-C-N 121.594 -0.691 . . . . 29.3 109.502 175.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1043 ' ' ALA . . . . . . . . . . . . . . . -87.3 17.41 4.41 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 120.732 -1.23 . . . . 26.74 113.491 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1044 ' ' SER . . . . . . . . . . . . . 10.5 m 67.83 46.24 1.29 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 123.909 1.814 . . . . 31.26 112.191 170.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1045 ' ' PHE . . . . . 0.524 ' HZ ' HG22 ' B' 1019 ' ' THR . 85.3 m-85 -130.86 162.86 28.68 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 104.79 -2.3 . . . . 33.26 104.79 175.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1046 ' ' ASP . . . . . 0.691 ' HB2' ' HA ' ' A' 1305 ' ' ASN . 22.9 t70 -104.19 161.3 14.15 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.011 -1.477 . . . . 46.74 107.011 158.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.55 -39.23 92.94 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 122.399 1.095 . . . . 34.44 111.094 -175.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.6 -22.01 63.29 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 115.443 1.646 . . . . 48.67 115.443 -176.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -62.73 -42.94 99.91 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 118.93 -2.356 . . . . 35.26 110.48 166.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1050 ' ' PHE . . . . . 0.446 ' HB2' HD11 ' B' 1057 ' ' ILE . 91.4 m-85 -69.82 -36.35 75.55 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 119.622 -1.924 . . . . 32.17 110.446 176.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 42.5 t -57.3 -43.34 81.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 116.08 -0.509 . . . . 38.37 110.585 171.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -71.26 -27.26 63.32 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 118.527 0.603 . . . . 45.77 111.504 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -73.02 -23.98 60.68 Favored 'General case' 0 N--CA 1.443 -0.775 0 O-C-N 120.723 -1.236 . . . . 37.83 112.407 174.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 95.15 39.33 4.57 Favored Glycine 0 C--O 1.221 -0.703 0 O-C-N 124.556 1.16 . . . . 35.82 112.85 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -102.21 139.13 38.23 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 124.082 0.953 . . . . 33.77 110.251 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -73.96 101.02 3.7 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.635 1.174 . . . . 51.02 107.955 -177.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1057 ' ' ILE . . . . . 0.446 HD11 ' HB2' ' B' 1050 ' ' PHE . 50.2 mm -88.86 100.4 10.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 119.442 -2.036 . . . . 38.47 106.08 -172.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1058 ' ' VAL . . . . . 0.42 HG23 ' HB ' ' B' 1063 ' ' VAL . 3.2 m -123.87 158.89 29.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 107.267 -1.383 . . . . 39.4 107.267 -173.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -72.33 167.19 20.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 118.421 -0.799 . . . . 57.07 112.732 -175.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1060 ' ' GLY . . . . . 0.411 ' O ' HG12 ' B' 1063 ' ' VAL . . . -52.5 -61.37 6.77 Favored Glycine 0 C--N 1.344 1.021 0 O-C-N 124.695 1.247 . . . . 44.83 114.129 -164.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 2.3 t30 -70.82 -32.55 69.65 Favored 'General case' 0 C--O 1.223 -0.303 0 O-C-N 119.546 -2.149 . . . . 46.27 110.486 -173.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1062 ' ' SER . . . . . . . . . . . . . 5.8 m -61.4 -41.2 96.74 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 113.125 -1.852 . . . . 43.47 113.336 171.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1063 ' ' VAL . . . . . 0.42 ' HB ' HG23 ' B' 1058 ' ' VAL . 6.4 p -72.83 -31.11 35.03 Favored 'Isoleucine or valine' 0 C--O 1.26 1.616 0 CA-C-N 121.069 1.759 . . . . 36.98 109.788 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1064 ' ' TRP . . . . . 0.591 ' HZ3' ' HG ' ' B' 1083 ' ' LEU . 0.1 OUTLIER -63.53 -31.26 72.37 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-O 122.347 1.07 . . . . 37.9 112.662 174.034 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -79.54 80.79 5.88 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 119.594 -1.941 . . . . 46.19 111.172 174.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1066 ' ' SER . . . . . 0.505 ' HB3' ' O ' ' B' 1002 ' ' ARG . 49.3 m -138.23 168.41 19.8 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 121.645 -0.659 . . . . 37.06 110.118 176.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1067 ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -79.42 -25.86 41.97 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 124.217 1.007 . . . . 43.95 109.914 176.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1068 ' ' ILE . . . . . 0.492 HG12 HD11 ' B' 1346 ' ' ILE . 3.5 mp -130.78 138.86 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 O-C-N 119.254 -2.154 . . . . 33.5 108.186 171.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1069 ' ' ILE . . . . . 0.632 HG22 ' HB2' ' B' 1071 ' ' LYS . 35.8 mm -124.31 120.72 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 104.036 -2.579 . . . . 30.57 104.036 176.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1070 ' ' LEU . . . . . 0.819 ' HB3' HD13 ' B' 1331 ' ' LEU . 56.9 mt -103.77 109.48 21.22 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 101.347 -3.575 . . . . 27.66 101.347 175.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1071 ' ' LYS . . . . . 0.632 ' HB2' HG22 ' B' 1069 ' ' ILE . 28.1 tttm -135.93 152.01 50.55 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 103.196 -2.89 . . . . 28.4 103.196 -167.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1072 ' ' VAL . . . . . 0.457 ' HA ' ' CE2' ' B' 1327 ' ' TYR . 45.4 t -80.43 -60.92 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.566 0 N-CA-C 107.717 -1.216 . . . . 23.18 107.717 -171.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -114.86 -173.97 2.4 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 120.265 -1.522 . . . . 25.47 110.803 -166.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1074 ' ' ALA . . . . . 0.407 ' HA ' ' HD2' ' B' 1075 ' ' PRO . . . -46.93 133.74 8.58 Favored Pre-proline 0 C--N 1.367 1.333 0 C-N-CA 124.602 1.161 . . . . 27.9 113.62 175.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1075 ' ' PRO . . . . . 0.544 ' HG2' HD11 ' B' 1101 ' ' LEU . 20.0 Cg_endo -65.62 139.34 57.85 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.892 2.395 . . . . 31.62 109.526 166.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 9.1 mt -80.65 164.1 23.11 Favored 'General case' 0 C--O 1.246 0.908 0 CA-C-N 113.89 -1.504 . . . . 40.49 109.672 166.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1077 ' ' ASP . . . . . 0.542 ' HA ' HD12 ' B' 1080 ' ' ILE . 0.7 OUTLIER -50.81 -34.32 27.17 Favored 'General case' 0 C--O 1.257 1.487 0 CA-C-N 119.821 1.192 . . . . 51.59 114.144 -175.254 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -73.18 -42.84 62.28 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 121.254 -0.904 . . . . 42.36 109.934 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1079 ' ' GLU . . . . . 0.429 ' HA ' HD12 ' B' 1082 ' ' LEU . 23.2 mt-10 -59.88 -35.23 74.4 Favored 'General case' 0 C--O 1.267 1.986 0 C-N-CA 123.805 0.842 . . . . 34.53 109.834 176.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1080 ' ' ILE . . . . . 0.706 ' HA ' HD12 ' B' 1083 ' ' LEU . 97.7 mt -63.33 -43.78 98.76 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 CA-C-O 123.965 1.84 . . . . 33.25 110.268 173.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -65.38 -29.77 70.52 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 118.039 -2.913 . . . . 36.47 114.852 176.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1082 ' ' LEU . . . . . 0.429 HD12 ' HA ' ' B' 1079 ' ' GLU . 41.8 mt -64.6 -40.88 96.31 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 112.836 -1.984 . . . . 37.76 113.663 168.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1083 ' ' LEU . . . . . 0.706 HD12 ' HA ' ' B' 1080 ' ' ILE . 5.6 mt -59.68 107.34 0.58 Allowed 'General case' 0 CA--C 1.495 -1.169 0 CA-C-O 123.322 1.534 . . . . 37.43 110.209 174.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -95.47 143.06 25.47 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 111.347 -2.66 . . . . 37.7 108.58 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1085 ' ' PRO . . . . . 0.633 ' HB3' ' HB2' ' B' 1109 ' ' ASN . 18.2 Cg_endo -52.62 113.86 1.43 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.937 3.092 . . . . 35.51 109.671 177.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 128.74 -32.81 3.24 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 112.357 -2.201 . . . . 33.87 112.433 -173.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1087 ' ' THR . . . . . . . . . . . . . 61.4 m -67.16 139.21 57.45 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-O 123.875 1.798 . . . . 32.5 108.682 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1088 ' ' THR . . . . . . . . . . . . . 7.8 m -98.71 110.61 23.19 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 103.498 -2.778 . . . . 30.22 103.498 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1089 ' ' LEU . . . . . 0.582 HD13 HD21 ' B' 1083 ' ' LEU . 40.1 tp -95.78 118.67 32.87 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 106.715 -1.587 . . . . 27.24 106.715 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1090 ' ' VAL . . . . . 0.459 HG13 ' HB2' ' B' 1113 ' ' MET . 4.2 t -118.22 107.1 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 107.44 -1.318 . . . . 25.39 107.44 176.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1091 ' ' SER . . . . . 0.497 ' OG ' ' HB3' ' B' 1071 ' ' LYS . 19.7 m -161.02 163.8 31.37 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.723 -0.672 . . . . 28.81 112.712 -167.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1092 ' ' PHE . . . . . 0.616 ' HZ ' ' HG3' ' B' 1133 ' ' MET . 40.8 m-85 -69.22 105.09 2.38 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-O 123.586 1.66 . . . . 30.78 106.534 166.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1093 ' ' ILE . . . . . 0.402 HG13 ' CG1' ' B' 1112 ' ' VAL . 32.9 mm -95.54 -37.56 7.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 O-C-N 119.883 -1.761 . . . . 30.28 110.968 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1094 ' ' TRP . . . . . 0.524 ' HB3' ' HB2' ' B' 1097 ' ' GLN . 96.4 m95 55.34 60.62 9.22 Favored Pre-proline 0 CA--C 1.55 0.955 0 O-C-N 124.868 1.355 . . . . 34.07 112.496 -173.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -51.68 -51.47 11.11 Favored 'Trans proline' 0 C--O 1.253 1.273 0 C-N-CA 125.207 3.938 . . . . 38.66 115.466 -171.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -62.98 -28.93 70.43 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-N 120.301 1.41 . . . . 41.32 112.147 176.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1097 ' ' GLN . . . . . 0.524 ' HB2' ' HB3' ' B' 1094 ' ' TRP . 18.6 mp0 -82.75 -22.74 34.25 Favored 'General case' 0 C--O 1.26 1.648 0 N-CA-C 108.066 -1.087 . . . . 51.66 108.066 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -127.82 57.71 27.66 Favored Pre-proline 0 C--O 1.223 -0.341 0 CA-C-N 120.754 1.615 . . . . 40.32 115.207 -175.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 0.7 OUTLIER -52.46 -37.02 72.16 Favored 'Trans proline' 0 C--O 1.248 0.993 0 C-N-CA 124.871 3.714 . . . . 41.56 115.116 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -59.66 -57.85 11.16 Favored 'General case' 0 C--O 1.217 -0.624 0 O-C-N 124.744 1.278 . . . . 54.11 107.69 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1101 ' ' LEU . . . . . 0.544 HD11 ' HG2' ' B' 1075 ' ' PRO . 9.6 tp -51.27 -44.78 61.88 Favored 'General case' 0 C--O 1.211 -0.964 0 CA-C-O 116.656 -1.64 . . . . 37.88 109.452 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1102 ' ' MET . . . . . . . . . . . . . 61.1 mmm -55.75 -49.64 72.54 Favored 'General case' 0 C--O 1.252 1.209 0 CA-C-O 123.26 1.505 . . . . 37.54 113.601 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1103 ' ' GLN . . . . . 0.406 ' O ' ' HB3' ' B' 1106 ' ' ALA . 0.0 OUTLIER -67.12 -39.97 86.73 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 114.211 -1.359 . . . . 47.01 110.73 -175.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B 1104 ' ' LYS . . . . . 0.444 ' HD3' HD13 ' B' 1080 ' ' ILE . 43.3 mttm -55.69 -54.42 44.44 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.395 1.078 . . . . 48.68 110.453 174.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1105 ' ' LEU . . . . . 0.625 HD13 HG21 ' B' 1112 ' ' VAL . 41.4 mt -61.57 -29.42 70.01 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 120.35 -1.469 . . . . 32.21 111.916 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1106 ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' B' 1103 ' ' GLN . . . -66.76 -39.54 87.93 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 117.278 -1.344 . . . . 33.73 111.399 173.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -64.25 -43.26 95.43 Favored 'General case' 0 C--O 1.249 1.04 0 O-C-N 124.36 1.038 . . . . 51.47 110.394 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1108 ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -67.27 -16.63 64.39 Favored 'General case' 0 C--N 1.309 -1.152 0 O-C-N 125.831 1.957 . . . . 43.9 114.031 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1109 ' ' ASN . . . . . 0.633 ' HB2' ' HB3' ' B' 1085 ' ' PRO . 13.9 m120 59.07 49.76 9.01 Favored 'General case' 0 C--N 1.348 0.533 0 CA-C-O 126.397 2.999 . . . . 44.82 115.957 178.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1110 ' ' VAL . . . . . 0.639 HG11 ' HB3' ' B' 1083 ' ' LEU . 12.8 m -107.7 163.77 5.34 Favored 'Isoleucine or valine' 0 C--O 1.248 0.992 0 O-C-N 119.517 -1.989 . . . . 30.52 111.528 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1111 ' ' THR . . . . . . . . . . . . . 18.1 m -107.04 97.5 7.27 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 123.61 1.672 . . . . 27.12 107.547 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1112 ' ' VAL . . . . . 0.67 ' HB ' ' HB ' ' B' 1361 ' ' ILE . 70.6 t -97.31 115.46 37.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 112.563 -2.108 . . . . 26.4 113.457 -170.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1113 ' ' MET . . . . . 0.463 ' HG2' HD21 ' B' 1334 ' ' LEU . 1.8 mpt? -100.13 118.45 36.5 Favored 'General case' 0 CA--C 1.504 -0.821 0 O-C-N 121.37 -0.831 . . . . 42.92 108.901 170.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -88.48 104.74 17.09 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 120.013 -0.675 . . . . 24.15 110.007 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1115 ' ' MET . . . . . 0.536 ' SD ' HD13 ' B' 1334 ' ' LEU . 72.4 mmm -65.61 -17.84 64.88 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 116.583 2.068 . . . . 29.95 116.583 -177.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1116 ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -84.73 -38.37 19.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 113.624 -1.625 . . . . 34.53 109.54 171.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1117 ' ' SER . . . . . . . . . . . . . 70.1 m -97.64 38.45 1.28 Allowed 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 123.44 1.59 . . . . 33.49 111.819 -176.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1118 ' ' VAL . . . . . 0.681 HG21 ' HA ' ' B' 1128 ' ' ASP . 12.3 t -77.59 124.52 86.62 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 102.278 -3.23 . . . . 34.02 102.278 172.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1119 ' ' PRO . . . . . 0.615 ' HB2' HG12 ' B' 1121 ' ' ILE . 75.3 Cg_exo -52.75 153.84 13.81 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.518 2.812 . . . . 38.28 115.964 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1120 ' ' ARG . . . . . 0.533 HH21 HD12 ' B' 1130 ' ' LEU . 0.0 OUTLIER -77.68 47.06 0.58 Allowed 'General case' 0 C--O 1.216 -0.679 0 O-C-N 121.757 -0.589 . . . . 55.05 110.008 178.113 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B 1121 ' ' ILE . . . . . 0.615 HG12 ' HB2' ' B' 1119 ' ' PRO . 37.3 pt -119.94 168.86 11.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 O-C-N 119.182 -2.199 . . . . 42.09 110.146 -172.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1122 ' ' SER . . . . . 0.52 ' HB3' ' HA ' ' C' ' 133' ' ' MET . 62.2 m -49.92 -80.23 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 117.618 2.451 . . . . 38.02 117.618 -161.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1123 ' ' ARG . . . . . 0.808 ' HG3' HG21 ' B' 1354 ' ' VAL . 11.2 ptt180 -66.62 -12.77 59.58 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 124.169 3.168 . . . . 34.29 114.329 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1124 ' ' ALA . . . . . 0.607 ' HB1' HG12 ' B' 1118 ' ' VAL . . . -67.16 -32.04 72.87 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 117.974 -1.012 . . . . 32.35 110.005 175.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1125 ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -58.32 -21.9 51.05 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 121.111 1.778 . . . . 47.17 114.678 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1126 ' ' SER . . . . . . . . . . . . . 10.2 m -71.6 -34.61 70.03 Favored 'General case' 0 C--O 1.246 0.885 0 O-C-N 121.119 -0.988 . . . . 31.71 111.351 173.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1127 ' ' LEU . . . . . . . . . . . . . 5.6 mp -83.9 -33.37 24.76 Favored 'General case' 0 CA--C 1.487 -1.463 0 N-CA-C 106.878 -1.527 . . . . 37.0 106.878 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1128 ' ' ASP . . . . . 0.681 ' HA ' HG21 ' B' 1118 ' ' VAL . 25.8 t70 -61.85 111.32 1.84 Allowed 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 124.303 2.001 . . . . 40.4 114.524 -168.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1129 ' ' ALA . . . . . . . . . . . . . . . -75.53 -20.62 58.59 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 113.22 -1.809 . . . . 26.56 109.52 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1130 ' ' LEU . . . . . 0.533 HD12 HH21 ' B' 1120 ' ' ARG . 17.1 mt -62.81 -40.34 97.07 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 122.294 2.315 . . . . 30.89 111.336 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1131 ' ' SER . . . . . . . . . . . . . 52.7 p -64.33 -53.78 43.47 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 118.051 -0.976 . . . . 29.84 110.782 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1132 ' ' SER . . . . . 0.451 ' HB3' ' HB3' ' B' 1326 ' ' LEU . 40.2 m -50.42 -47.23 56.66 Favored 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 124.967 1.307 . . . . 31.91 114.082 172.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1133 ' ' MET . . . . . 0.637 ' HB3' ' HB3' ' B' 1316 ' ' PRO . 37.3 mmt -70.43 -33.52 71.42 Favored 'General case' 0 CA--C 1.493 -1.221 0 O-C-N 124.37 1.044 . . . . 25.9 112.468 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1134 ' ' ALA . . . . . 0.55 ' HB1' ' HB2' ' B' 1176 ' ' ALA . . . -67.33 -41.56 85.05 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 121.17 -0.956 . . . . 26.62 111.92 171.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -56.32 -53.45 57.14 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 108.292 -1.003 . . . . 36.97 108.292 174.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1136 ' ' ILE . . . . . 0.441 HD13 ' HE2' ' A' 1152 ' ' PHE . 34.9 mm -52.37 -51.73 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 124.285 1.034 . . . . 32.11 109.95 174.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1137 ' ' ALA . . . . . 0.524 ' HB1' HD22 ' B' 1284 ' ' LEU . . . -57.13 -42.49 81.01 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 117.078 -1.439 . . . . 24.14 112.638 177.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -65.28 -45.22 91.89 Favored Glycine 0 C--O 1.253 1.328 0 CA-C-N 122.405 2.366 . . . . 25.13 111.33 -174.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1139 ' ' TYR . . . . . 0.446 ' O ' ' HB ' ' B' 1142 ' ' ILE . 16.0 t80 -63.32 -43.27 98.28 Favored 'General case' 0 C--O 1.21 -1.011 0 CA-C-N 113.241 -1.48 . . . . 32.73 112.22 171.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1140 ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -70.89 -22.4 62.27 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 119.101 -0.476 . . . . 26.36 110.0 -176.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1141 ' ' ALA . . . . . 0.774 ' HA ' HG11 ' B' 1282 ' ' VAL . . . -63.77 -43.98 94.75 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.242 -1.021 . . . . 24.12 108.242 167.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1142 ' ' ILE . . . . . 0.507 HG23 ' CE2' ' B' 1153 ' ' PHE . 16.2 mm -59.31 -47.31 90.92 Favored 'Isoleucine or valine' 0 C--N 1.359 1.004 0 CA-C-O 121.835 0.826 . . . . 23.37 111.765 177.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 71.1 t -53.51 -68.33 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.848 0 N-CA-C 113.477 0.917 . . . . 24.96 113.477 171.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -61.75 -31.14 71.3 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 113.72 1.008 . . . . 32.07 113.72 -172.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1145 ' ' ALA . . . . . 0.777 ' HB1' HD12 ' B' 1251 ' ' ILE . . . -55.11 -57.42 11.81 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.687 -0.688 . . . . 24.87 110.36 168.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1146 ' ' ALA . . . . . 0.56 ' HA ' ' HB2' ' B' 1149 ' ' PHE . . . -64.49 -19.33 65.51 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 115.895 1.813 . . . . 24.67 115.895 176.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 86.0 t60 -65.52 -26.66 68.0 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 116.986 -1.483 . . . . 28.58 112.278 169.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1148 ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -123.89 8.74 8.74 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 123.117 2.69 . . . . 36.82 115.955 170.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1149 ' ' PHE . . . . . 0.56 ' HB2' ' HA ' ' B' 1146 ' ' ALA . 0.8 OUTLIER -65.46 154.07 39.56 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-O 124.255 1.978 . . . . 31.97 111.877 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B 1150 ' ' GLY . . . . . . . . . . . . . . . -86.39 -32.09 17.39 Favored Glycine 0 N--CA 1.432 -1.613 0 CA-C-N 114.05 -1.432 . . . . 25.49 112.313 174.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1151 ' ' ARG . . . . . 0.415 HH11 HG21 ' A' 1321 ' ' THR . 64.4 mtm-85 -119.59 -174.23 2.7 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 115.981 1.845 . . . . 59.84 115.981 -166.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1152 ' ' PHE . . . . . 0.421 ' HD1' ' H ' ' B' 1154 ' ' THR . 0.8 OUTLIER -88.14 145.81 25.74 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-O 118.499 -0.762 . . . . 34.45 111.873 172.372 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B 1153 ' ' PHE . . . . . 0.507 ' CE2' HG23 ' B' 1142 ' ' ILE . 8.8 m-85 -63.16 -52.08 63.85 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 119.17 0.895 . . . . 31.17 112.294 169.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1154 ' ' THR . . . . . 0.421 ' H ' ' HD1' ' B' 1152 ' ' PHE . 7.6 m -73.88 131.08 41.12 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.896 -1.047 . . . . 33.89 110.434 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -72.34 81.84 0.58 Allowed Glycine 0 C--N 1.343 0.93 0 O-C-N 119.689 -1.882 . . . . 38.95 111.029 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -75.27 114.85 14.27 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.556 0.693 . . . . 54.23 111.794 -173.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1157 ' ' ILE . . . . . 0.416 HG23 ' HG2' ' B' 1162 ' ' LYS . 45.1 mm -92.53 104.78 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 1 N-CA-C 99.316 -4.327 . . . . 51.16 99.316 177.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B 1158 ' ' THR . . . . . . . . . . . . . 1.5 m -115.11 138.88 50.4 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 103.002 -2.962 . . . . 49.61 103.002 -172.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -52.61 -32.69 42.85 Favored 'General case' 0 C--O 1.248 1.016 0 CA-C-O 123.777 1.751 . . . . 49.05 115.009 175.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -59.16 -81.04 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 113.303 -1.771 . . . . 47.65 110.088 162.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . -146.68 155.2 26.42 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 121.366 1.894 . . . . 45.61 110.035 -174.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1162 ' ' LYS . . . . . 0.416 ' HG2' HG23 ' B' 1157 ' ' ILE . 89.0 mttt -89.39 132.12 35.13 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.648 1.213 . . . . 57.46 108.352 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1163 ' ' VAL . . . . . 0.502 HG21 HE22 ' A' 1322 ' ' GLN . 90.6 t -100.3 128.56 30.16 Favored Pre-proline 0 C--O 1.247 0.925 0 CA-C-N 113.771 -1.559 . . . . 42.93 108.484 176.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1164 ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' B' 1163 ' ' VAL . 45.9 Cg_endo -67.22 133.2 29.87 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.568 3.512 . . . . 39.29 110.689 166.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1165 ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' B' 1164 ' ' PRO . 16.9 Cg_exo -69.0 161.64 44.99 Favored 'Trans proline' 0 N--CA 1.479 0.629 0 C-N-CA 121.255 1.303 . . . . 34.17 110.04 -172.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -70.56 111.78 6.33 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 118.04 -1.464 . . . . 31.69 108.816 172.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1167 ' ' LYS . . . . . 0.644 ' HB2' ' HA ' ' B' 1249 ' ' VAL . 86.4 mttt -77.65 87.48 3.94 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.144 -1.428 . . . . 44.78 107.144 174.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1168 ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' B' 1191 ' ' VAL . 48.4 t -77.05 94.92 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 114.168 -1.378 . . . . 31.23 108.556 -174.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1169 ' ' MET . . . . . 0.575 ' HA ' ' O ' ' B' 1192 ' ' ARG . 55.5 ttp -86.19 110.37 19.54 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 122.459 1.123 . . . . 37.09 108.433 177.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 50.7 t -97.59 118.76 44.64 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 N-CA-C 107.611 -1.255 . . . . 30.17 107.611 -177.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1171 ' ' ILE . . . . . 0.487 HD13 HG23 ' B' 1252 ' ' ILE . 1.7 mp -91.94 95.97 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 103.848 -2.649 . . . . 33.74 103.848 171.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 115.4 85.18 1.23 Allowed Glycine 0 C--N 1.339 0.707 0 N-CA-C 108.657 -1.777 . . . . 32.59 108.657 170.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1173 ' ' ALA . . . . . 0.455 ' HA ' ' HA3' ' B' 1177 ' ' GLY . . . -84.16 50.33 1.83 Allowed 'General case' 0 C--O 1.255 1.346 0 CA-C-O 124.302 2.001 . . . . 32.42 110.849 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -81.15 -165.56 34.44 Favored Glycine 0 C--N 1.342 0.884 0 O-C-N 118.59 -2.569 . . . . 31.74 107.754 163.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 19.1 t -51.36 -39.96 22.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 O-C-N 119.304 -2.292 . . . . 31.48 114.352 -176.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1176 ' ' ALA . . . . . 0.55 ' HB2' ' HB1' ' B' 1134 ' ' ALA . . . -55.86 -46.82 78.15 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.934 1.087 . . . . 26.12 113.934 171.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1177 ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' B' 1173 ' ' ALA . . . -68.85 -45.8 62.8 Favored Glycine 0 C--N 1.345 1.046 0 N-CA-C 109.106 -1.598 . . . . 25.73 109.106 -176.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1178 ' ' LEU . . . . . 0.544 ' HA ' HD12 ' B' 1181 ' ' ILE . 51.4 mt -60.46 -36.36 78.07 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 118.244 -0.884 . . . . 32.59 108.9 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -68.24 -44.09 76.43 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 119.342 0.973 . . . . 27.72 110.456 176.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -58.63 -36.64 74.4 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 118.192 -0.908 . . . . 26.03 108.773 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1181 ' ' ILE . . . . . 0.544 HD12 ' HA ' ' B' 1178 ' ' LEU . 38.2 mt -61.27 -50.0 82.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 CA-C-N 120.628 1.558 . . . . 28.61 107.783 171.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -62.67 -19.95 61.14 Favored Glycine 0 CA--C 1.543 1.808 0 CA-C-O 118.363 -1.243 . . . . 25.23 114.108 -173.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -97.96 -56.64 2.43 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 117.993 0.896 . . . . 24.09 109.895 171.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -72.01 -38.5 69.6 Favored 'General case' 0 CA--C 1.509 -0.619 0 O-C-N 119.027 -2.296 . . . . 26.68 115.861 -171.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1185 ' ' ASN . . . . . 0.418 ' HB3' ' HE1' ' B' 1207 ' ' MET . 22.1 t30 -61.61 -39.02 89.75 Favored 'General case' 0 C--O 1.247 0.966 0 O-C-N 120.589 -1.319 . . . . 36.57 111.429 174.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1186 ' ' SER . . . . . . . . . . . . . 2.0 m -62.33 -38.73 90.62 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 112.952 -1.931 . . . . 28.92 111.559 174.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1187 ' ' LEU . . . . . 0.485 ' HA ' ' HB2' ' A' 1186 ' ' SER . 4.2 mt -61.02 -31.18 70.81 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 116.038 -0.528 . . . . 29.09 110.914 172.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 111.05 -7.55 29.15 Favored Glycine 0 CA--C 1.525 0.717 0 O-C-N 121.426 -0.796 . . . . 29.26 111.25 -176.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1189 ' ' ALA . . . . . . . . . . . . . . . -62.05 134.72 56.98 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 122.234 1.016 . . . . 30.16 109.559 175.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 18.3 mt -77.19 94.97 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 104.684 -2.339 . . . . 35.81 104.684 -174.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1191 ' ' VAL . . . . . 0.488 HG11 HG12 ' B' 1181 ' ' ILE . 40.6 t -78.24 100.23 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 O-C-N 120.242 -1.536 . . . . 31.97 109.66 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1192 ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' B' 1169 ' ' MET . 98.8 mtt180 -87.07 80.84 8.24 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 124.146 1.927 . . . . 48.16 108.637 174.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -84.93 144.82 28.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 111.438 -2.619 . . . . 35.89 111.335 -172.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 82.1 t80 -134.57 145.39 48.65 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.018 -1.475 . . . . 41.88 107.018 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1195 ' ' ASP . . . . . . . . . . . . . 5.5 t70 -153.03 154.59 35.22 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 103.992 -2.596 . . . . 38.28 103.992 161.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1196 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.42 -21.19 56.28 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 114.468 -1.242 . . . . 40.62 110.59 174.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1197 ' ' ARG . . . . . 0.45 ' O ' HG22 ' B' 1200 ' ' VAL . 40.2 mtm180 -78.06 126.15 84.15 Favored Pre-proline 0 N--CA 1.435 -1.183 0 C-N-CA 120.164 -0.614 . . . . 53.09 110.978 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1198 ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' B' 1197 ' ' ARG . 37.3 Cg_endo -53.04 -46.39 34.29 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 125.273 3.982 . . . . 42.56 116.611 -176.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 10.6 pm0 -70.24 -13.98 62.41 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 115.787 1.773 . . . . 56.31 115.787 -161.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1200 ' ' VAL . . . . . 0.45 HG22 ' O ' ' B' 1197 ' ' ARG . 26.7 m -74.09 -22.17 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 116.145 -0.48 . . . . 42.91 111.24 175.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 26.0 tttm -47.83 -56.45 7.45 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 114.549 1.315 . . . . 48.89 114.549 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -55.7 -42.55 75.4 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 112.716 -2.038 . . . . 51.7 112.565 174.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1203 ' ' GLN . . . . . 0.649 ' HG2' ' HG3' ' C' ' 74' ' ' ARG . 52.1 mt-30 -64.11 -47.84 78.45 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.308 -0.86 . . . . 52.57 109.4 -174.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1204 ' ' VAL . . . . . . . . . . . . . 55.9 t -64.02 -49.84 79.8 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-O 122.677 1.227 . . . . 33.79 108.486 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -57.39 -29.78 64.36 Favored 'General case' 0 C--N 1.359 1.007 0 N-CA-C 115.812 1.782 . . . . 36.58 115.812 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1206 ' ' SER . . . . . . . . . . . . . 43.3 p -71.86 -18.26 62.07 Favored 'General case' 0 C--O 1.248 0.978 0 CA-C-N 119.423 1.011 . . . . 39.61 110.89 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1207 ' ' MET . . . . . 0.531 ' SD ' HG22 ' B' 1181 ' ' ILE . 26.1 mtp -87.39 -9.28 55.19 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 120.954 -1.091 . . . . 37.45 112.469 172.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 68.5 46.74 61.18 Favored Glycine 0 C--O 1.224 -0.484 0 O-C-N 119.319 -2.113 . . . . 31.87 109.548 -168.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -122.71 146.56 47.38 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 103.623 -2.732 . . . . 35.4 103.623 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1210 ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' B' 1192 ' ' ARG . 8.7 tt0 -85.09 116.55 23.53 Favored 'General case' 0 N--CA 1.435 -1.225 0 O-C-N 120.418 -1.426 . . . . 47.89 109.355 -164.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 70.0 t80 -89.5 120.95 31.26 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 107.982 -1.118 . . . . 45.53 107.982 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1212 ' ' LEU . . . . . 0.544 ' HB3' HD21 ' B' 1241 ' ' LEU . 57.8 mt -71.25 115.17 10.09 Favored 'General case' 0 N--CA 1.44 -0.964 0 O-C-N 121.323 -0.861 . . . . 46.33 109.271 174.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -98.38 141.4 31.3 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 124.7 2.19 . . . . 60.41 108.904 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 43.7 mt -66.32 161.33 22.64 Favored 'General case' 0 C--O 1.251 1.148 0 CA-C-N 112.2 -2.273 . . . . 57.38 114.597 168.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 27.0 t70 . . . . . 0 CA--C 1.518 -0.288 0 CA-C-N 114.264 -1.334 . . . . 65.07 110.19 -178.447 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B 1230 ' ' MET . . . . . 0.486 ' SD ' ' HB2' ' B' 1234 ' ' PHE . 13.8 mmt . . . . . 0 N--CA 1.448 -0.557 1 N-CA-C 98.674 -4.565 . . . . 80.32 98.674 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1231 ' ' SER . . . . . 0.4 ' O ' HG23 ' B' 1235 ' ' ILE 0.3 0.1 OUTLIER 63.05 173.77 0.15 Allowed 'General case' 0 C--N 1.356 0.879 2 CA-C-N 127.1 4.5 . . . . 79.92 119.458 0.628 . . . . . . . . 5 4 . 1 . 002 nuclear nobuild core ' B' B 1232 ' ' ASP . . . . . 0.565 ' HA ' HG12 ' B' 1235 ' ' ILE . 5.6 p-10 -67.01 -166.92 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 115.719 1.748 . . . . 77.91 115.719 -172.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 71.0 -80.03 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 107.447 -1.316 . . . . 73.88 107.447 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1234 ' ' PHE . . . . . 0.486 ' HB2' ' SD ' ' B' 1230 ' ' MET . 2.2 m-85 -51.51 -33.45 31.76 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 115.651 1.723 . . . . 68.98 115.651 171.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1235 ' ' ILE . . . . . 0.565 HG12 ' HA ' ' B' 1232 ' ' ASP . 36.1 pt -47.72 -36.5 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 120.271 1.396 . . . . 64.53 113.12 169.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1236 ' ' LYS . . . . . 0.46 ' HD3' ' HA ' ' B' 1236 ' ' LYS . 69.6 mmtt -62.24 -41.62 98.58 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 120.049 -1.657 . . . . 66.36 111.011 172.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -67.34 -42.63 83.24 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 119.418 -0.913 . . . . 56.6 111.533 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -56.18 -51.74 66.94 Favored 'General case' 0 C--O 1.241 0.65 0 O-C-N 124.306 1.003 . . . . 56.79 111.966 171.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1239 ' ' MET . . . . . . . . . . . . . 10.4 tmm? -56.27 -56.74 17.27 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 118.168 -0.92 . . . . 53.63 112.976 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -55.56 -36.32 66.69 Favored 'General case' 0 C--N 1.36 1.028 0 CA-C-N 119.428 1.013 . . . . 51.74 111.111 -177.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1241 ' ' LEU . . . . . 0.544 HD21 ' HB3' ' B' 1212 ' ' LEU . 16.2 tp -57.44 -50.77 71.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 121.067 -1.021 . . . . 44.86 111.475 178.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -64.81 -39.61 93.87 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 125.99 2.056 . . . . 42.78 113.03 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1243 ' ' ALA . . . . . 0.517 ' HA ' ' HG3' ' B' 1271 ' ' MET . . . -64.94 -23.72 67.31 Favored 'General case' 0 C--N 1.36 1.048 0 N-CA-C 113.574 0.953 . . . . 40.96 113.574 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -82.01 -53.99 5.67 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 118.72 -2.488 . . . . 43.06 108.898 172.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 61.0 mm-40 -56.32 -31.99 64.23 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 124.748 1.219 . . . . 46.45 112.861 -176.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1246 ' ' ALA . . . . . 0.412 ' HA ' HG22 ' B' 1249 ' ' VAL . . . -44.46 -34.54 2.1 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 125.435 1.494 . . . . 41.78 114.885 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1247 ' ' LYS . . . . . 0.472 ' HD2' ' HA ' ' B' 1247 ' ' LYS . 34.3 tptt -63.55 -43.78 96.06 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 124.206 1.955 . . . . 52.2 111.863 -176.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1248 ' ' GLU . . . . . 0.465 ' CD ' HH12 ' B' 1192 ' ' ARG . 39.1 mt-10 -84.5 -39.91 18.29 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 113.14 -1.846 . . . . 53.55 114.283 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1249 ' ' VAL . . . . . 0.644 ' HA ' ' HB2' ' B' 1167 ' ' LYS 0.301 10.6 m -76.94 160.91 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 118.907 2.929 . . . . 34.41 118.907 -167.255 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B 1250 ' ' ASP . . . . . 0.456 ' HA ' ' HB3' ' B' 1279 ' ' SER . 16.9 m-20 -117.9 -73.09 0.66 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 124.389 2.042 . . . . 33.38 110.454 -169.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1251 ' ' ILE . . . . . 0.777 HD12 ' HB1' ' B' 1145 ' ' ALA . 23.5 mm -98.11 99.69 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 114.0 -1.455 . . . . 29.54 108.484 -169.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1252 ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' B' 1169 ' ' MET . 17.5 mt -89.54 96.13 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 105.607 -1.998 . . . . 32.44 105.607 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1253 ' ' VAL . . . . . . . . . . . . . 96.7 t -83.16 96.51 4.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 102.369 -3.197 . . . . 30.57 102.369 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1254 ' ' THR . . . . . 0.489 ' HB ' HG22 ' B' 1252 ' ' ILE . 2.4 t -104.99 138.93 40.44 Favored 'General case' 0 N--CA 1.432 -1.339 0 O-C-N 119.877 -1.764 . . . . 35.04 111.89 -175.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1255 ' ' THR . . . . . 0.403 HG22 ' HB2' ' B' 1284 ' ' LEU . 40.1 p -134.09 -83.25 0.44 Allowed 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 114.377 -1.283 . . . . 34.62 108.772 -177.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . 56.72 41.9 27.59 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.254 1.822 . . . . 42.72 114.777 -170.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 45.8 mt -89.85 93.78 9.56 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-O 123.797 1.761 . . . . 52.43 107.309 -174.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1258 ' ' ILE . . . . . 0.414 ' HB ' ' HD2' ' B' 1261 ' ' LYS . 24.7 mt -90.08 129.1 47.19 Favored Pre-proline 0 N--CA 1.438 -1.063 0 N-CA-C 107.043 -1.466 . . . . 59.41 107.043 171.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -57.03 133.31 57.08 Favored 'Trans proline' 0 N--CA 1.441 -1.577 0 C-N-CA 124.707 3.605 . . . . 62.68 114.466 -177.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 66.59 29.49 74.85 Favored Glycine 0 C--O 1.218 -0.856 0 CA-C-O 117.149 -1.917 . . . . 64.16 114.088 -174.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1261 ' ' LYS . . . . . 0.414 ' HD2' ' HB ' ' B' 1258 ' ' ILE . 59.6 mttm -138.32 148.16 58.41 Favored Pre-proline 0 CA--C 1.503 -0.827 0 CA-C-N 121.009 2.404 . . . . 68.53 111.822 172.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.63 136.96 29.27 Favored 'Trans proline' 0 C--O 1.245 0.844 0 CA-C-N 122.856 2.056 . . . . 61.99 107.486 164.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1263 ' ' ALA . . . . . 0.462 ' HA ' ' HD3' ' B' 1264 ' ' PRO . . . -51.63 116.07 7.35 Favored Pre-proline 0 C--O 1.248 1.021 0 N-CA-C 113.24 0.83 . . . . 57.15 113.24 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1264 ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' B' 1263 ' ' ALA . 87.6 Cg_exo -53.61 135.67 62.4 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 124.779 3.653 . . . . 51.57 110.5 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -78.25 84.37 4.46 Favored 'General case' 0 C--O 1.248 0.994 0 C-N-CA 123.785 0.834 . . . . 54.55 109.161 -173.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1266 ' ' LEU . . . . . 0.464 ' HB2' HD21 ' B' 1291 ' ' ASN . 94.9 mt -91.4 -41.31 10.95 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 113.185 0.809 . . . . 46.86 113.185 177.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1267 ' ' ILE . . . . . . . . . . . . . 32.1 mm -78.53 86.96 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 124.432 2.063 . . . . 41.04 111.467 171.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1268 ' ' THR . . . . . 0.597 ' HA ' ' HG3' ' B' 1293 ' ' GLU . 36.2 p -84.54 151.98 24.2 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 112.316 -2.22 . . . . 39.58 112.892 -170.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1269 ' ' ARG . . . . . 0.502 ' HG3' ' HB2' ' B' 1293 ' ' GLU . 84.2 mtt85 -52.22 -39.6 60.45 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 118.256 -2.778 . . . . 53.15 117.194 -176.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -58.27 -40.78 82.78 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-O 123.517 1.627 . . . . 42.96 112.392 173.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1271 ' ' MET . . . . . 0.517 ' HG3' ' HA ' ' B' 1243 ' ' ALA . 54.2 ttm -65.71 -42.61 90.93 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 113.048 -1.887 . . . . 43.89 110.669 -178.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1272 ' ' VAL . . . . . . . . . . . . . 10.4 t -54.78 -48.52 73.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 113.816 -1.538 . . . . 38.37 110.977 170.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 25.9 t70 -58.39 -40.71 83.08 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 114.251 1.204 . . . . 47.46 114.251 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1274 ' ' SER . . . . . . . . . . . . . 49.5 m -68.86 -22.99 64.17 Favored 'General case' 0 C--O 1.238 0.494 0 O-C-N 121.698 -0.626 . . . . 38.38 112.687 174.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1275 ' ' MET . . . . . . . . . . . . . 71.7 mtp -62.12 162.16 9.89 Favored 'General case' 0 C--O 1.252 1.197 0 CA-C-O 124.548 2.118 . . . . 37.81 114.014 -173.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 66.6 tttt -68.07 137.46 55.01 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 111.868 -2.423 . . . . 49.26 109.562 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -75.62 151.06 37.87 Favored 'General case' 0 C--O 1.246 0.874 0 O-C-N 124.121 0.888 . . . . 34.46 110.267 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1278 ' ' GLY . . . . . 0.438 ' O ' ' HD1' ' B' 1149 ' ' PHE . . . 74.55 14.51 81.06 Favored Glycine 0 N--CA 1.47 0.922 0 C-N-CA 120.514 -0.85 . . . . 33.53 112.645 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1279 ' ' SER . . . . . 0.456 ' HB3' ' HA ' ' B' 1250 ' ' ASP . 61.0 m -106.16 148.45 27.85 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 125.322 1.449 . . . . 31.31 109.67 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1280 ' ' VAL . . . . . 0.607 HG22 ' HB2' ' B' 1308 ' ' LYS . 25.9 t -127.07 119.94 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 O-C-N 120.634 -1.291 . . . . 29.32 109.886 -163.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1281 ' ' ILE . . . . . 0.44 HD12 HG22 ' B' 1309 ' ' VAL . 19.5 mt -86.8 112.26 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 102.655 -3.091 . . . . 31.93 102.655 175.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1282 ' ' VAL . . . . . 0.774 HG11 ' HA ' ' B' 1141 ' ' ALA . 21.2 t -106.5 107.71 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 N-CA-C 101.857 -3.386 . . . . 29.48 101.857 175.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 24.3 t0 -87.93 109.08 19.52 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 110.475 -3.057 . . . . 34.5 107.653 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1284 ' ' LEU . . . . . 0.703 HD21 ' HB2' ' B' 1141 ' ' ALA . 71.4 mt -79.58 -23.05 43.0 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-O 121.138 0.494 . . . . 37.94 110.467 177.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -87.52 -5.62 58.71 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 115.371 -0.831 . . . . 40.92 111.525 -175.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -18.72 -54.32 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.736 1 N-CA-C 122.173 4.138 . . . . 44.39 122.173 174.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1287 ' ' GLN . . . . . 0.578 ' HB3' HG23 ' B' 1313 ' ' THR . 0.1 OUTLIER -70.27 -43.89 69.56 Favored 'General case' 0 CA--C 1.501 -0.935 0 C-N-CA 123.431 0.692 . . . . 51.46 111.483 178.773 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 4.9 t30 -97.21 75.68 2.59 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-O 123.915 1.817 . . . . 57.75 109.378 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1289 ' ' GLY . . . . . . . . . . . . . . . 87.88 -76.72 1.95 Allowed Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 107.209 -2.356 . . . . 49.85 107.209 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 99.45 136.74 9.48 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 109.371 -1.492 . . . . 45.93 109.371 -167.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1291 ' ' ASN . . . . . 0.464 HD21 ' HB2' ' B' 1266 ' ' LEU . 24.5 t-20 -88.88 -35.17 16.68 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 120.15 1.975 . . . . 42.67 112.927 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1292 ' ' CYS . . . . . 0.515 ' HB3' ' OG1' ' B' 1295 ' ' THR . 40.4 t -77.87 143.91 37.39 Favored 'General case' 0 N--CA 1.441 -0.923 0 O-C-N 118.944 -2.348 . . . . 38.82 110.829 171.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1293 ' ' GLU . . . . . 0.597 ' HG3' ' HA ' ' B' 1268 ' ' THR . 24.2 mt-10 -69.08 -37.43 78.45 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.702 -1.135 . . . . 46.71 112.049 174.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -82.9 -8.13 59.6 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 115.564 1.691 . . . . 47.23 115.564 -173.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1295 ' ' THR . . . . . 0.67 HG23 ' HA3' ' B' 1311 ' ' GLY . 49.1 m -52.35 120.4 5.49 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 116.135 1.902 . . . . 36.02 116.135 177.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 2.9 t -88.79 108.11 21.37 Favored Pre-proline 0 N--CA 1.448 -0.559 0 CA-C-O 116.007 -1.949 . . . . 37.26 106.396 172.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -64.28 88.39 0.16 Allowed 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 124.29 3.327 . . . . 35.09 113.479 -176.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 139.46 -17.46 3.09 Favored Glycine 0 C--O 1.251 1.18 0 CA-C-N 113.243 -1.798 . . . . 35.97 110.013 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -133.71 -176.69 4.25 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 121.458 2.629 . . . . 40.39 114.554 -161.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1300 ' ' ILE . . . . . 0.491 HG23 HG12 ' B' 1310 ' ' ILE . 9.6 mt -99.8 155.58 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.045 0 N-CA-C 105.759 -1.941 . . . . 37.43 105.759 170.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 65.9 t80 -142.85 105.89 4.55 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 123.008 1.385 . . . . 44.13 107.63 167.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1302 ' ' THR . . . . . . . . . . . . . 96.5 m -75.46 118.58 18.49 Favored 'General case' 0 N--CA 1.438 -1.029 0 O-C-N 119.434 -2.041 . . . . 39.78 106.291 168.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1303 ' ' THR . . . . . . . . . . . . . 76.0 p -69.7 169.42 12.88 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 115.903 1.816 . . . . 43.29 115.903 172.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -48.37 -48.02 36.93 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 124.343 1.057 . . . . 53.07 113.02 167.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -85.8 23.52 1.42 Allowed 'General case' 0 C--O 1.244 0.81 0 N-CA-C 114.68 1.363 . . . . 43.97 114.68 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 69.38 23.5 76.4 Favored Glycine 0 C--N 1.358 1.761 0 O-C-N 119.332 -2.105 . . . . 41.12 114.961 170.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1307 ' ' VAL . . . . . . . . . . . . . 94.7 t -93.46 136.13 26.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 105.767 -1.938 . . . . 38.12 105.767 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1308 ' ' LYS . . . . . 0.607 ' HB2' HG22 ' B' 1280 ' ' VAL . 65.1 mmtt -92.77 99.54 12.19 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.757 -1.201 . . . . 36.34 107.757 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1309 ' ' VAL . . . . . 0.44 HG22 HD12 ' B' 1281 ' ' ILE . 18.0 t -90.02 92.97 4.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 105.602 -1.999 . . . . 30.4 105.602 177.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1310 ' ' ILE . . . . . 0.491 HG12 HG23 ' B' 1300 ' ' ILE . 12.1 mt -87.4 134.2 28.32 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.002 0 C-N-CA 126.02 1.728 . . . . 30.82 107.85 173.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1311 ' ' GLY . . . . . 0.67 ' HA3' HG23 ' B' 1295 ' ' THR . . . -149.09 86.95 0.15 Allowed Glycine 0 CA--C 1.493 -1.34 0 N-CA-C 108.396 -1.882 . . . . 26.53 108.396 171.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1312 ' ' TYR . . . . . 0.794 ' HB2' ' HG ' ' B' 1315 ' ' LEU . 43.6 m-85 -97.8 119.66 36.79 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 118.055 0.927 . . . . 38.0 108.848 -172.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1313 ' ' THR . . . . . 0.578 HG23 ' HB3' ' B' 1287 ' ' GLN . 39.3 m -49.83 -40.37 41.83 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 124.079 1.895 . . . . 29.8 114.355 172.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1314 ' ' ASP . . . . . 0.474 ' OD1' ' HB3' ' B' 1312 ' ' TYR . 22.8 p-10 -78.56 -2.96 41.35 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 112.834 -1.985 . . . . 39.04 116.201 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1315 ' ' LEU . . . . . 0.794 ' HG ' ' HB2' ' B' 1312 ' ' TYR . 13.4 mt -43.29 -51.35 14.45 Favored Pre-proline 0 N--CA 1.47 0.527 0 N-CA-C 119.062 2.986 . . . . 31.08 119.062 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1316 ' ' PRO . . . . . 0.637 ' HB3' ' HB3' ' B' 1133 ' ' MET . 87.7 Cg_exo -65.62 -25.06 54.86 Favored 'Trans proline' 0 C--O 1.218 -0.5 0 CA-C-N 124.606 2.681 . . . . 26.1 112.866 176.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1317 ' ' GLY . . . . . 0.701 ' HA2' ' HG3' ' B' 1015 ' ' ARG . . . -67.53 -49.23 52.17 Favored Glycine 0 N--CA 1.431 -1.688 0 O-C-N 120.496 -1.378 . . . . 23.17 109.964 169.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -39.69 -16.71 0.01 OUTLIER 'General case' 0 C--O 1.246 0.878 1 N-CA-C 125.201 5.26 . . . . 40.4 125.201 -161.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 15.9 tp -102.12 78.58 0.24 Allowed Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 121.301 1.864 . . . . 23.6 108.158 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1320 ' ' PRO . . . . . 0.454 ' HB3' HG22 ' B' 1014 ' ' THR . 48.3 Cg_endo -43.53 -64.28 0.26 Allowed 'Trans proline' 0 CA--C 1.51 -0.719 1 C-N-CA 125.416 4.077 . . . . 22.35 119.138 -156.628 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B 1321 ' ' THR . . . . . 0.417 HG23 ' CE1' ' B' 1045 ' ' PHE . 4.2 m -61.97 -44.79 96.01 Favored 'General case' 0 C--O 1.218 -0.578 0 O-C-N 121.17 -0.957 . . . . 26.52 112.293 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1322 ' ' GLN . . . . . 0.609 ' HB2' ' HA ' ' A' 1151 ' ' ARG . 11.5 tp60 -72.48 -43.44 63.67 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 118.657 -0.687 . . . . 24.38 112.471 -173.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1323 ' ' SER . . . . . 0.533 ' HB3' ' HG2' ' B' 1015 ' ' ARG . 66.6 m -48.78 -49.32 39.21 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 124.176 0.99 . . . . 22.8 110.837 164.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1324 ' ' SER . . . . . . . . . . . . . 11.4 m -61.69 -33.2 73.58 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 122.567 1.175 . . . . 21.25 113.436 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -69.43 -40.38 77.27 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 118.404 -2.685 . . . . 31.34 114.18 170.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1326 ' ' LEU . . . . . 0.451 ' HB3' ' HB3' ' B' 1132 ' ' SER . 3.6 mm? -68.89 -55.8 9.91 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.951 0.881 . . . . 31.56 112.241 -177.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1327 ' ' TYR . . . . . 0.494 ' O ' ' HB2' ' B' 1330 ' ' ASN . 31.3 t80 -56.2 -44.57 79.61 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-N 113.992 -1.458 . . . . 22.73 110.179 175.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1328 ' ' GLY . . . . . 0.672 ' HA2' HD12 ' B' 1331 ' ' LEU . . . -56.7 -60.45 8.98 Favored Glycine 0 C--N 1.343 0.929 0 O-C-N 124.153 0.908 . . . . 21.91 112.794 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1329 ' ' THR . . . . . 0.51 ' HB ' ' HA ' ' A' 1160 ' ' ALA . 9.2 m -58.44 -23.51 57.72 Favored 'General case' 0 C--O 1.252 1.185 0 CA-C-O 116.365 -1.778 . . . . 22.15 111.893 174.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1330 ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' B' 1327 ' ' TYR . 12.1 m120 -63.79 -46.72 83.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 125.4 3.727 . . . . 26.18 110.549 170.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1331 ' ' LEU . . . . . 0.819 HD13 ' HB3' ' B' 1070 ' ' LEU . 13.9 mt -61.14 -37.28 82.27 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.079 -0.964 . . . . 23.68 109.254 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1332 ' ' VAL . . . . . 0.752 HG12 ' HE3' ' B' 1336 ' ' LYS . 96.6 t -69.22 -45.21 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 106.847 -1.538 . . . . 26.57 106.847 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -58.69 -43.73 90.06 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 113.353 0.871 . . . . 28.08 113.353 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1334 ' ' LEU . . . . . 0.536 HD13 ' SD ' ' B' 1115 ' ' MET . 3.9 tt -56.95 -47.31 80.99 Favored 'General case' 0 C--O 1.247 0.929 0 C-N-CA 123.933 0.893 . . . . 27.43 109.337 170.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1335 ' ' LEU . . . . . 0.755 HD23 HD12 ' B' 1338 ' ' LEU . 68.2 mt -74.42 -12.25 60.46 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 120.924 -1.11 . . . . 30.5 113.601 -177.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1336 ' ' LYS . . . . . 0.752 ' HE3' HG12 ' B' 1332 ' ' VAL . 85.5 mttt -72.89 -49.5 29.41 Favored 'General case' 0 CA--C 1.504 -0.793 0 O-C-N 120.828 -1.17 . . . . 41.65 109.225 166.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 7.7 mp -67.51 -26.84 66.54 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 113.258 0.836 . . . . 42.08 113.258 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1338 ' ' LEU . . . . . 0.755 HD12 HD23 ' B' 1335 ' ' LEU . 95.3 mt -72.34 -67.11 0.57 Allowed 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 108.373 -0.973 . . . . 35.03 108.373 168.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 43.6 t -85.34 73.69 10.51 Favored 'General case' 0 N--CA 1.436 -1.161 0 O-C-N 118.699 -2.501 . . . . 37.33 108.185 -170.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 58.0 mttp -57.44 -33.4 67.88 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 125.323 1.449 . . . . 50.51 114.353 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -80.55 -11.61 59.64 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 114.372 1.249 . . . . 54.21 114.372 178.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 60.0 mttp 60.32 34.81 20.75 Favored 'General case' 0 C--N 1.347 0.488 0 CA-C-O 122.884 1.326 . . . . 50.99 111.608 -172.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -99.6 -34.22 10.31 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 114.959 -1.018 . . . . 48.82 111.273 -176.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 125.31 9.52 5.0 Favored Glycine 0 N--CA 1.433 -1.551 0 O-C-N 124.543 1.152 . . . . 40.43 113.407 175.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -98.67 141.17 31.84 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 125.503 1.521 . . . . 47.56 113.639 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1346 ' ' ILE . . . . . 0.492 HD11 HG12 ' B' 1068 ' ' ILE . 43.1 mm -82.79 76.18 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.63 0 CA-C-O 123.136 1.446 . . . . 42.49 108.728 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1347 ' ' THR . . . . . 0.433 ' HB ' ' O ' ' B' 1338 ' ' LEU . 2.4 m -73.82 78.92 1.59 Allowed 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.598 -1.183 . . . . 38.12 109.326 172.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 10.9 t -62.29 121.66 11.35 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 O-C-N 119.598 -1.939 . . . . 37.5 109.379 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 23.1 t0 -96.96 111.08 23.46 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 122.505 1.145 . . . . 43.85 108.565 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1350 ' ' PHE . . . . . 0.569 ' HE2' HG21 ' B' 1367 ' ' THR . 1.4 m-30 -100.52 -0.59 37.55 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 116.385 1.994 . . . . 39.81 116.385 175.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -81.41 -43.55 18.8 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 121.728 0.775 . . . . 51.29 110.776 167.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 14.4 t0 -66.75 121.8 16.23 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 124.373 2.035 . . . . 39.78 111.995 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 3.7 m -52.25 -37.21 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 CA-C-N 110.752 -2.931 . . . . 39.28 112.686 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1354 ' ' VAL . . . . . 0.808 HG21 ' HG3' ' B' 1123 ' ' ARG . 23.1 t -70.6 -54.01 19.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-N 114.894 -1.048 . . . . 35.7 112.355 -177.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1355 ' ' ILE . . . . . 0.42 ' HA ' HG12 ' B' 1358 ' ' VAL . 27.1 mm -64.68 -47.59 88.19 Favored 'Isoleucine or valine' 0 C--N 1.359 1.007 0 CA-C-O 116.95 -1.5 . . . . 35.77 112.073 176.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 42.3 tpt85 -54.1 -37.09 63.89 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 114.168 1.173 . . . . 38.55 114.168 173.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1357 ' ' GLY . . . . . 0.476 ' HA2' ' HB2' ' B' 1370 ' ' ALA . . . -62.63 -54.6 32.67 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 124.621 1.105 . . . . 29.58 115.437 171.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1358 ' ' VAL . . . . . 0.42 HG12 ' HA ' ' B' 1355 ' ' ILE . 9.1 p -69.08 -38.82 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 108.668 -0.864 . . . . 32.06 108.668 -174.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1359 ' ' THR . . . . . 0.44 ' HB ' ' HE1' ' B' 1350 ' ' PHE . 14.8 m -76.46 84.83 3.18 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-O 123.892 1.806 . . . . 29.0 107.944 -177.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1360 ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' B' 1368 ' ' TRP . 22.1 m -73.27 -19.55 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 111.692 -2.504 . . . . 29.68 111.252 -174.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1361 ' ' ILE . . . . . 0.67 ' HB ' ' HB ' ' B' 1112 ' ' VAL . 85.1 mt -139.16 116.28 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 105.76 -1.941 . . . . 32.05 105.76 177.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1362 ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -108.66 119.38 39.37 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 119.205 -2.184 . . . . 32.52 108.885 175.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 36.86 44.08 0.33 Allowed 'General case' 0 C--O 1.246 0.92 0 CA-C-O 124.454 2.073 . . . . 35.68 116.113 -172.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1364 ' ' GLY . . . . . 0.6 ' HA3' ' HA ' ' B' 1109 ' ' ASN . . . 93.36 -7.28 75.38 Favored Glycine 0 CA--C 1.54 1.647 0 CA-C-O 117.225 -1.875 . . . . 34.26 114.356 174.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1365 ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' B' 1361 ' ' ILE . 0.2 OUTLIER -88.6 132.52 34.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 104.653 -2.351 . . . . 51.07 104.653 170.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 59.5 mt -88.75 94.05 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 N-CA-C 107.402 -1.333 . . . . 39.87 107.402 -176.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1367 ' ' THR . . . . . 0.569 HG21 ' HE2' ' B' 1350 ' ' PHE . 3.3 p -84.77 -1.39 56.26 Favored 'General case' 0 N--CA 1.424 -1.735 0 O-C-N 126.528 2.393 . . . . 38.01 114.858 -175.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1368 ' ' TRP . . . . . 0.419 ' HB2' ' HB ' ' B' 1360 ' ' VAL . 35.0 t90 -52.05 142.26 27.29 Favored Pre-proline 0 C--O 1.241 0.635 0 C-N-CA 124.255 1.022 . . . . 42.14 111.674 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -87.91 -114.77 0.0 OUTLIER 'Cis proline' 0 N--CA 1.451 -0.996 0 CA-C-N 122.575 1.955 . . . . 43.26 113.21 -7.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1370 ' ' ALA . . . . . 0.476 ' HB2' ' HA2' ' B' 1357 ' ' GLY . . . -117.97 153.67 51.18 Favored Pre-proline 0 C--N 1.32 -0.696 0 O-C-N 120.104 -1.623 . . . . 46.52 107.297 166.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1371 ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' B' 1372 ' ' PRO . 93.1 Cg_endo -59.52 133.62 53.01 Favored 'Trans proline' 0 C--N 1.33 -0.438 0 CA-C-N 122.589 1.96 . . . . 51.95 110.954 172.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1372 ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' B' 1371 ' ' PRO . 0.1 OUTLIER -36.91 87.7 0.01 OUTLIER 'Trans proline' 0 C--O 1.25 1.091 0 C-N-CA 125.133 3.889 . . . . 56.27 118.108 -174.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B 1373 ' ' ILE . . . . . 0.473 HG21 HD13 ' B' 1121 ' ' ILE . 0.0 OUTLIER -104.13 140.78 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 103.099 -2.926 . . . . 60.83 103.099 177.04 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -107.48 146.64 31.52 Favored 'General case' 0 C--O 1.256 1.423 0 O-C-N 120.203 -1.561 . . . . 66.1 108.184 -174.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 96.2 t -78.95 135.86 24.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 O-C-N 125.454 1.721 . . . . 63.47 111.49 -171.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.23 -4.627 0 O-C-N 120.891 -1.13 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.274 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.6 -16.23 24.29 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.071 1.348 . . . . 0.0 114.464 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 28.7 mp0 -49.54 -42.22 43.37 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.068 -1.02 . . . . 0.0 110.531 172.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 6.6 m -56.67 -46.96 80.81 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 123.593 0.757 . . . . 0.0 111.696 173.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 24' ' ' ALA . . . . . 0.476 ' HB2' HG22 ' C' ' 182' ' ' ILE . . . -62.24 -49.81 74.23 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 123.714 0.805 . . . . 0.0 109.674 -173.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -48.82 -51.07 31.45 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 127.849 3.218 . . . . 0.0 111.409 173.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 13.5 tp -65.28 -39.41 92.53 Favored 'General case' 0 N--CA 1.44 -0.938 0 O-C-N 120.764 -1.21 . . . . 0.0 113.59 -177.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 74.1 mt -53.68 -39.62 65.26 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 118.58 2.808 . . . . 0.0 118.58 -174.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 28' ' ' LYS . . . . . . . . . . . . . 34.5 pttt -63.93 -28.65 69.97 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.082 -0.963 . . . . 0.0 113.015 175.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -82.87 -33.01 27.13 Favored 'General case' 0 C--O 1.246 0.88 0 O-C-N 125.349 1.656 . . . . 0.0 109.823 174.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.437 ' HA ' ' OD2' ' C' ' 107' ' ' ASP . 58.0 m -54.87 127.27 27.85 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -170.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -82.55 -58.37 2.94 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 113.956 -1.475 . . . . 0.0 109.041 -174.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 32' ' ' SER . . . . . 0.432 ' HB2' ' HA ' ' C' ' 106' ' ' THR . 55.5 m -116.15 143.39 45.56 Favored 'General case' 0 C--O 1.251 1.135 0 O-C-N 120.801 -1.187 . . . . 0.0 110.55 166.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 96.6 t -128.44 120.2 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.52 HD13 ' HB2' ' C' ' 65' ' ' ARG . 38.7 mm -101.69 111.41 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 101.598 -3.482 . . . . 0.0 101.598 177.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . 0.705 HG22 ' HD3' ' C' ' 37' ' ' PRO . 42.9 mt -83.7 122.73 38.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 169.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 13.7 m -115.97 92.94 36.65 Favored Pre-proline 0 C--O 1.246 0.919 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.129 173.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . 0.77 ' HD2' HG12 ' C' ' 68' ' ' ILE . 0.5 OUTLIER -56.3 116.66 3.34 Favored 'Trans proline' 0 N--CA 1.449 -1.107 1 C-N-CA 125.47 4.113 . . . . 0.0 112.347 168.926 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' C' C ' 38' ' ' GLY . . . . . 0.418 ' HA3' ' HB3' ' C' ' 114' ' ' ALA . . . -102.29 -175.23 27.52 Favored Glycine 0 N--CA 1.433 -1.558 0 O-C-N 120.869 -1.145 . . . . 0.0 110.441 167.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -38.18 -41.59 0.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.187 1.395 . . . . 0.0 114.605 168.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 40' ' ' GLY . . . . . 0.936 ' HA3' ' HA3' ' C' ' 113' ' ' GLY . . . -52.78 -47.96 57.73 Favored Glycine 0 C--O 1.249 1.08 0 CA-C-O 118.789 -1.006 . . . . 0.0 112.371 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 41' ' ' MET . . . . . 0.456 ' HG3' ' HB3' ' C' ' 46' ' ' ALA . 24.2 ttm -61.27 -31.48 71.3 Favored 'General case' 0 C--N 1.356 0.889 0 CA-C-N 119.801 1.801 . . . . 0.0 113.529 172.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . 0.65 ' HB2' ' HB3' ' C' ' 79' ' ' MET . . . -70.04 -33.33 71.82 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.548 -0.739 . . . . 0.0 110.816 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . 0.431 HG13 ' H ' ' C' ' 44' ' ' ALA . 7.4 p -90.31 -70.95 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 118.448 -0.787 . . . . 0.0 110.6 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' C' ' 175' ' ' ALA . . . -79.27 100.2 7.42 Favored 'General case' 0 C--O 1.252 1.206 0 CA-C-N 120.432 1.469 . . . . 0.0 107.658 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 45' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -69.49 82.73 0.4 Allowed 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -161.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.456 ' HB3' ' HG3' ' C' ' 41' ' ' MET . . . -81.11 -4.42 55.24 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 111.164 -2.744 . . . . 0.0 114.363 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 47' ' ' GLN . . . . . 0.447 ' HG2' ' HB3' ' C' ' 82' ' ' LEU . 0.0 OUTLIER -71.24 -46.94 59.95 Favored 'General case' 0 C--O 1.25 1.086 0 O-C-N 119.66 -1.9 . . . . 0.0 113.659 -173.481 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 48' ' ' TYR . . . . . 0.422 ' CE1' ' HA ' ' C' ' 86' ' ' ALA . 95.0 m-85 -57.8 -44.38 99.38 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 120.333 1.424 . . . . 0.0 113.401 173.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 49' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -49.92 -49.78 15.11 Favored 'Trans proline' 0 C--O 1.255 1.352 0 C-N-CA 122.391 2.061 . . . . 0.0 115.574 163.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . 0.439 ' HA ' HG22 ' C' ' 53' ' ' ILE . 0.8 OUTLIER -68.86 -21.47 25.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 O-C-N 120.168 -1.582 . . . . 0.0 110.356 -171.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.68 -49.61 74.57 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 122.031 0.919 . . . . 0.0 111.403 172.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.12 -54.92 32.91 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.937 1.295 . . . . 0.0 112.633 176.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 53' ' ' ILE . . . . . 0.439 HG22 ' HA ' ' C' ' 50' ' ' VAL . 6.7 tp -71.57 -33.5 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-N 119.171 0.896 . . . . 0.0 111.054 -176.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 89.2 m -67.01 -32.97 74.54 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 118.997 0.817 . . . . 0.0 109.659 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -56.14 -51.88 66.37 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 4.6 mppt? -65.11 -46.3 81.59 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 57' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' C' ' 53' ' ' ILE . 55.2 mt -58.8 -45.73 89.22 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 120.509 1.504 . . . . 0.0 111.899 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -70.04 -40.86 74.89 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.613 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.59 -45.26 73.55 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 121.478 1.945 . . . . 0.0 113.91 171.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 29.1 ttm-85 -65.38 -23.36 66.95 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.101 1.36 . . . . 0.0 112.346 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.07 21.25 9.66 Favored Glycine 0 CA--C 1.505 -0.545 0 CA-C-O 122.12 0.845 . . . . 0.0 114.053 174.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 59.0 mt -85.16 135.14 25.49 Favored 'Isoleucine or valine' 0 C--O 1.249 1.055 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -79.61 86.73 5.21 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 7.7 p -95.7 122.68 47.41 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 CA-C-O 122.456 1.122 . . . . 0.0 108.894 178.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 65' ' ' ARG . . . . . 0.52 ' HB2' HD13 ' C' ' 34' ' ' ILE . 9.6 mmm-85 -126.27 136.71 53.11 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 122.227 1.013 . . . . 0.0 110.102 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . 0.472 ' O ' HG13 ' C' ' 68' ' ' ILE . 29.8 m-85 -87.92 74.28 9.01 Favored 'General case' 0 C--O 1.243 0.715 0 O-C-N 120.082 -1.636 . . . . 0.0 109.203 177.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.65 83.14 0.91 Allowed Glycine 0 CA--C 1.529 0.965 0 N-CA-C 109.084 -1.607 . . . . 0.0 109.084 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 68' ' ' ILE . . . . . 0.77 HG12 ' HD2' ' C' ' 37' ' ' PRO . 16.5 mt -98.08 144.67 10.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 O-C-N 124.61 0.83 . . . . 0.0 111.066 -167.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -109.84 72.37 0.61 Allowed Pre-proline 0 C--O 1.242 0.69 0 N-CA-C 103.018 -2.956 . . . . 0.0 103.018 169.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 70' ' ' PRO . . . . . 0.861 ' HB2' HG21 ' A' 1157 ' ' ILE . 43.0 Cg_exo -61.47 -20.23 67.65 Favored 'Trans proline' 0 C--N 1.341 0.148 1 C-N-CA 125.335 4.024 . . . . 0.0 113.96 -167.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.84 81.32 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 122.949 1.357 . . . . 0.0 107.555 161.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 72' ' ' ALA . . . . . 0.759 ' HB3' ' SD ' ' C' ' 79' ' ' MET . . . -142.85 97.09 3.04 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 119.38 -2.075 . . . . 0.0 112.834 -172.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 73' ' ' GLY . . . . . 0.51 ' C ' ' HD2' ' C' ' 74' ' ' ARG . . . 74.92 -75.53 1.28 Allowed Glycine 0 N--CA 1.44 -1.08 0 O-C-N 120.388 -1.445 . . . . 0.0 114.632 170.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 74' ' ' ARG . . . . . 0.649 ' HG3' ' HG2' ' B' 1203 ' ' GLN . 1.5 mpt_? -121.63 98.9 6.17 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -174.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.469 ' HG ' HD22 ' B' 1178 ' ' LEU . 0.3 OUTLIER 75.33 132.29 0.04 OUTLIER Pre-proline 0 C--N 1.35 0.625 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 168.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.32 150.07 84.75 Favored 'Trans proline' 0 C--O 1.239 0.57 0 C-N-CA 123.287 2.658 . . . . 0.0 114.487 174.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.18 -94.16 1.46 Allowed Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 106.964 -2.454 . . . . 0.0 106.964 -169.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 2.1 t60 26.33 -80.7 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 127.83 2.452 . . . . 0.0 116.048 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 79' ' ' MET . . . . . 0.759 ' SD ' ' HB3' ' C' ' 72' ' ' ALA . 0.8 OUTLIER -59.5 -43.62 93.3 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.698 -1.251 . . . . 0.0 111.587 179.545 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -67.98 -44.95 75.46 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 121.652 -0.655 . . . . 0.0 109.643 -176.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.425 ' O ' ' HB3' ' C' ' 84' ' ' ALA . 90.1 t -52.1 -50.88 33.77 Favored 'Isoleucine or valine' 0 C--O 1.249 1.074 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 168.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.447 ' HB3' ' HG2' ' C' ' 47' ' ' GLN . 3.5 mp -53.55 -39.75 65.01 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 174.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 11.7 tp -59.99 -46.41 89.55 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 124.385 1.053 . . . . 0.0 112.667 170.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 84' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' C' ' 81' ' ' VAL . . . -57.37 -39.95 77.09 Favored 'General case' 0 C--O 1.246 0.911 0 C-N-CA 124.253 1.021 . . . . 0.0 111.25 173.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -60.87 -40.1 91.71 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.015 0.526 . . . . 0.0 111.01 172.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . 0.422 ' HA ' ' CE1' ' C' ' 48' ' ' TYR . . . -67.22 0.1 3.02 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 120.645 -1.285 . . . . 0.0 113.315 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp 61.8 51.77 3.72 Favored 'General case' 0 C--O 1.266 1.921 0 C-N-CA 127.873 2.469 . . . . 0.0 111.403 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 88' ' ' VAL . . . . . 0.482 ' HA ' ' HD2' ' C' ' 89' ' ' PRO . 57.8 t -100.93 130.67 24.65 Favored Pre-proline 0 N--CA 1.444 -0.739 0 CA-C-N 112.855 -1.975 . . . . 0.0 106.164 172.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 89' ' ' PRO . . . . . 0.482 ' HD2' ' HA ' ' C' ' 88' ' ' VAL . 27.7 Cg_endo -55.4 111.19 0.68 Allowed 'Trans proline' 0 CA--C 1.509 -0.744 0 C-N-CA 124.889 3.726 . . . . 0.0 116.772 177.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.16 -16.49 20.42 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 108.992 -3.731 . . . . 0.0 118.289 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -69.58 -48.76 59.1 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-O 118.081 -0.962 . . . . 0.0 111.939 174.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 22.9 pt -70.86 -15.24 18.7 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-N 120.563 1.529 . . . . 0.0 114.738 174.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 93' ' ' VAL . . . . . 0.456 ' HA ' ' HB2' ' C' ' 66' ' ' PHE . 86.4 t -69.36 98.51 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-O 124.111 1.91 . . . . 0.0 106.721 167.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 19.2 mt -105.02 87.76 2.72 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 110.258 -3.155 . . . . 0.0 108.155 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 95' ' ' GLU . . . . . 0.765 ' HB3' HD13 ' A' 1157 ' ' ILE . 34.8 mp0 -69.1 103.91 2.01 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 111.349 -2.66 . . . . 0.0 109.865 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 92.9 mtp 56.96 25.93 11.21 Favored 'General case' 0 C--O 1.25 1.106 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 171.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -81.88 155.46 25.31 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 113.64 -1.618 . . . . 0.0 109.751 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -82.97 56.27 3.4 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 120.095 1.316 . . . . 0.0 109.353 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 99' ' ' ILE . . . . . 0.606 HG13 ' HB2' ' C' ' 102' ' ' ASP . 11.1 tp -74.46 41.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 O-C-N 117.28 -3.387 . . . . 0.0 111.902 173.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -76.85 -27.19 55.0 Favored 'General case' 0 C--O 1.217 -0.607 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -162.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.12 -44.82 87.46 Favored 'General case' 0 C--O 1.24 0.599 0 O-C-N 124.519 1.137 . . . . 0.0 110.274 174.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 102' ' ' ASP . . . . . 0.606 ' HB2' HG13 ' C' ' 99' ' ' ILE . 0.9 OUTLIER -65.42 -39.5 92.21 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 117.131 -1.414 . . . . 0.0 110.729 173.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 103' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -47.84 -56.5 7.33 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-N 123.042 2.655 . . . . 0.0 114.021 169.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.51 -35.89 77.04 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 123.674 0.79 . . . . 0.0 113.128 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -67.52 -39.35 85.07 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 121.221 -0.925 . . . . 0.0 111.568 175.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 106' ' ' THR . . . . . 0.432 ' HA ' ' HB2' ' C' ' 32' ' ' SER . 3.8 m -52.3 133.57 34.34 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-O 126.812 3.196 . . . . 0.0 113.577 -169.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 107' ' ' ASP . . . . . 0.437 ' OD2' ' HA ' ' C' ' 30' ' ' SER . 5.0 t0 -69.26 -70.41 0.28 Allowed 'General case' 0 C--N 1.3 -1.553 1 CA-C-N 107.035 -4.62 . . . . 0.0 108.635 171.656 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 8.4 m -121.19 124.99 46.05 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 120.949 1.704 . . . . 0.0 110.662 -174.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 109' ' ' VAL . . . . . . . . . . . . . 32.5 t -99.33 119.26 47.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 174.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 16.2 mt -95.89 85.35 4.06 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 122.765 1.269 . . . . 0.0 109.854 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 111' ' ' VAL . . . . . 0.42 ' HB ' ' HA ' ' C' ' 146' ' ' VAL . 11.8 t -81.52 103.8 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 177.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 112' ' ' ILE . . . . . 0.571 ' HA ' ' HD2' ' C' ' 147' ' ' PHE . 1.8 mm -81.34 106.45 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 O-C-N 118.164 -2.835 . . . . 0.0 109.142 -171.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 113' ' ' GLY . . . . . 0.936 ' HA3' ' HA3' ' C' ' 40' ' ' GLY . . . 89.22 -78.78 1.63 Allowed Glycine 0 CA--C 1.487 -1.669 0 CA-C-O 125.422 2.679 . . . . 0.0 111.863 170.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 114' ' ' ALA . . . . . 0.418 ' HB3' ' HA3' ' C' ' 38' ' ' GLY . . . -94.43 127.23 40.2 Favored 'General case' 0 C--O 1.21 -0.983 0 O-C-N 120.077 -1.837 . . . . 0.0 111.613 -162.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 115' ' ' ASN . . . . . 0.471 ' HB2' HD23 ' C' ' 162' ' ' LEU . 5.7 p-10 -66.42 -53.79 31.67 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 113.611 -1.631 . . . . 0.0 114.803 -178.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 116' ' ' ASP . . . . . 0.646 ' HA ' ' HB2' ' C' ' 119' ' ' ASN . 61.8 m-20 -65.75 -16.03 63.4 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 117.736 2.495 . . . . 0.0 117.736 -167.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 4.7 m -41.28 -44.85 2.79 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 127.175 2.797 . . . . 0.0 110.067 168.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.468 ' HA ' ' HB ' ' C' ' 135' ' ' VAL . 3.2 m -137.55 67.64 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.507 0 O-C-N 124.339 1.024 . . . . 0.0 108.679 169.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 119' ' ' ASN . . . . . 0.646 ' HB2' ' HA ' ' C' ' 116' ' ' ASP . 28.7 t-20 -87.6 119.56 70.72 Favored Pre-proline 0 C--O 1.26 1.658 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 120' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -60.88 -45.42 20.36 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.851 3.034 . . . . 0.0 110.995 -177.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.64 -14.41 62.05 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.32 -38.1 86.91 Favored 'General case' 0 CA--C 1.552 1.049 0 O-C-N 120.663 -1.273 . . . . 0.0 110.796 170.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 123' ' ' GLN . . . . . 0.718 ' HB2' HG22 ' C' ' 135' ' ' VAL . 3.4 tp-100 -75.95 -50.24 15.5 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-O 122.263 1.03 . . . . 0.0 108.739 177.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -80.76 -45.08 17.6 Favored 'General case' 0 C--O 1.247 0.947 0 N-CA-C 120.196 3.406 . . . . 0.0 120.196 -173.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 125' ' ' ASP . . . . . 0.405 ' HA ' ' HD3' ' C' ' 126' ' ' PRO . 32.3 t70 -103.1 123.44 41.92 Favored Pre-proline 0 CA--C 1.55 0.958 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -162.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 126' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' C' ' 125' ' ' ASP . 1.5 Cg_exo -46.26 -31.99 9.94 Favored 'Trans proline' 0 CA--C 1.503 -1.061 0 C-N-CA 124.534 3.49 . . . . 0.0 118.347 175.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 127' ' ' LYS . . . . . 0.462 ' HE2' ' HB3' ' C' ' 127' ' ' LYS . 25.2 ttpt -69.51 -32.8 71.88 Favored 'General case' 0 C--N 1.317 -0.829 0 O-C-N 120.904 -1.123 . . . . 0.0 110.648 -174.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 128' ' ' SER . . . . . . . . . . . . . 13.4 m -56.66 133.4 78.1 Favored Pre-proline 0 N--CA 1.467 0.42 0 C-N-CA 125.254 1.422 . . . . 0.0 107.874 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 129' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -55.14 -46.03 36.1 Favored 'Trans proline' 0 C--O 1.221 -0.368 1 C-N-CA 125.464 4.11 . . . . 0.0 114.282 175.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 130' ' ' ILE . . . . . 0.657 ' HB ' ' HB2' ' C' ' 133' ' ' MET . 4.3 pt -86.9 66.54 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.405 0 O-C-N 119.507 -1.996 . . . . 0.0 107.385 170.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -74.3 111.87 9.9 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.429 -1.26 . . . . 0.0 109.048 -174.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.73 34.87 17.82 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 122.821 1.234 . . . . 0.0 111.863 -175.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 133' ' ' MET . . . . . 0.657 ' HB2' ' HB ' ' C' ' 130' ' ' ILE . 39.0 tpp -70.09 123.03 88.0 Favored Pre-proline 0 C--O 1.243 0.722 0 CA-C-N 113.476 -1.362 . . . . 0.0 109.915 173.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 134' ' ' PRO . . . . . 0.56 ' HD2' ' SD ' ' C' ' 133' ' ' MET . 89.0 Cg_endo -68.66 88.15 0.43 Allowed 'Trans proline' 0 N--CA 1.442 -1.536 0 C-N-CA 122.625 2.217 . . . . 0.0 112.198 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 135' ' ' VAL . . . . . 0.718 HG22 ' HB2' ' C' ' 123' ' ' GLN . 28.6 m -88.31 150.09 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-N 113.424 -1.716 . . . . 0.0 106.973 168.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 27.4 mt -77.71 111.57 13.64 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 102.318 -3.215 . . . . 0.0 102.318 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 137' ' ' GLU . . . . . 0.55 ' HB3' ' NE1' ' C' ' 139' ' ' TRP . 48.5 mt-10 -70.24 96.61 1.12 Allowed 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 123.39 1.567 . . . . 0.0 113.047 -155.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 14.8 p -85.28 110.35 19.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 125.177 2.418 . . . . 0.0 109.074 169.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 139' ' ' TRP . . . . . 0.55 ' NE1' ' HB3' ' C' ' 137' ' ' GLU . 76.3 m95 -129.97 138.49 50.88 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 118.945 -2.347 . . . . 0.0 105.308 174.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 140' ' ' LYS . . . . . . . . . . . . . 24.5 pttm 38.15 20.69 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.823 1 N-CA-C 123.057 4.466 . . . . 0.0 123.057 175.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.84 150.82 36.17 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 120.369 -1.457 . . . . 0.0 107.754 163.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 142' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' C' ' 167' ' ' ASN . 16.7 mt-30 -62.89 -42.88 99.93 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 117.12 2.267 . . . . 0.0 117.12 -160.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 143' ' ' ASN . . . . . 0.402 ' HB3' HG13 ' C' ' 145' ' ' ILE . 3.8 m-80 -140.33 120.83 14.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 121.339 1.881 . . . . 0.0 108.443 167.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 144' ' ' VAL . . . . . 0.686 ' HB ' ' HA ' ' C' ' 168' ' ' THR . 44.1 t -102.02 85.39 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 101.882 -3.377 . . . . 0.0 101.882 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 145' ' ' ILE . . . . . 0.402 HG13 ' HB3' ' C' ' 143' ' ' ASN . 26.3 mt -82.57 104.37 11.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 125.84 2.733 . . . . 0.0 110.507 -178.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 146' ' ' VAL . . . . . 0.639 HG21 ' HG ' ' C' ' 162' ' ' LEU . 47.8 t -97.77 109.07 22.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 110.711 -2.949 . . . . 0.0 105.083 178.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 147' ' ' PHE . . . . . 0.571 ' HD2' ' HA ' ' C' ' 112' ' ' ILE . 82.9 m-85 -71.59 82.01 0.83 Allowed 'General case' 0 C--O 1.258 1.528 0 O-C-N 120.472 -1.393 . . . . 0.0 111.293 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 148' ' ' LYS . . . . . 0.826 ' HD3' ' SD ' ' C' ' 170' ' ' MET . 28.5 mtpt -103.05 133.09 48.75 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 120.297 -1.502 . . . . 0.0 107.764 177.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 -72.2 -29.3 63.84 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 123.056 1.408 . . . . 0.0 111.793 -175.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 16.0 m -142.04 151.32 42.31 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.337 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -73.23 102.87 3.76 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 103.077 -2.934 . . . . 0.0 103.077 167.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -152.72 164.06 38.49 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 23.8 m -53.38 159.0 1.51 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 130.044 3.337 . . . . 0.0 113.741 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -136.21 -137.34 3.66 Favored Glycine 0 C--O 1.249 1.034 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -87.66 -63.75 1.25 Allowed 'General case' 0 C--O 1.238 0.468 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 171.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 156' ' ' ALA . . . . . . . . . . . . . . . -76.0 -53.63 8.08 Favored 'General case' 0 C--N 1.364 1.229 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 166.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 67.33 -89.16 0.17 Allowed Glycine 0 N--CA 1.461 0.327 0 N-CA-C 106.822 -2.511 . . . . 0.0 106.822 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 158' ' ' VAL . . . . . 0.575 HG23 ' HB3' ' C' ' 160' ' ' ASN 0.385 35.1 m 46.3 148.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 120.84 3.644 . . . . 0.0 120.84 -176.002 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.9 83.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 O-C-N 121.159 -0.963 . . . . 0.0 109.477 173.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 160' ' ' ASN . . . . . 0.575 ' HB3' HG23 ' C' ' 158' ' ' VAL . 5.5 p30 -130.77 164.27 42.93 Favored Pre-proline 0 C--O 1.242 0.673 0 CA-C-O 117.472 -1.252 . . . . 0.0 110.616 -164.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -38.33 -51.08 2.17 Favored 'Trans proline' 0 N--CA 1.445 -1.375 0 C-N-CA 124.383 3.388 . . . . 0.0 117.893 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 162' ' ' LEU . . . . . 0.639 ' HG ' HG21 ' C' ' 146' ' ' VAL . 1.4 mp -50.46 -35.41 28.76 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 176.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 163' ' ' PHE . . . . . 0.41 ' HA ' ' HE2' ' C' ' 170' ' ' MET . 12.1 m-85 -73.63 -30.79 63.17 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -107.59 -51.42 2.91 Favored 'General case' 0 C--O 1.257 1.462 0 CA-C-O 123.142 1.448 . . . . 0.0 114.494 -169.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 4.9 mmtm -61.81 153.32 29.06 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 115.983 1.845 . . . . 0.0 115.983 -171.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -85.41 -45.29 12.01 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -164.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 167' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' C' ' 142' ' ' GLN . 27.4 p-10 -89.12 -42.44 11.69 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.186 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 168' ' ' THR . . . . . 0.686 ' HA ' ' HB ' ' C' ' 144' ' ' VAL . 56.2 m -89.44 77.47 7.31 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 106.789 -1.559 . . . . 0.0 106.789 177.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -136.09 135.07 39.03 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.71 -158.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 170' ' ' MET . . . . . 0.826 ' SD ' ' HD3' ' C' ' 148' ' ' LYS . 67.6 mtm -63.99 94.57 0.1 Allowed 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.227 -1.806 . . . . 0.0 107.173 163.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 171' ' ' LEU . . . . . . . . . . . . . 10.4 tp -79.38 117.45 20.37 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 172' ' ' PHE . . . . . 0.564 ' HA ' ' O ' ' C' ' 148' ' ' LYS . 57.7 m-85 -70.65 93.21 0.91 Allowed 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 110.716 -2.947 . . . . 0.0 114.386 -168.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -166.32 159.74 33.1 Favored Glycine 0 C--O 1.248 1.029 0 O-C-N 125.222 1.576 . . . . 0.0 109.664 176.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 174' ' ' ASP . . . . . 0.615 ' HB3' ' HB3' ' C' ' 177' ' ' ALA . 31.6 t70 -69.93 151.74 45.28 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 113.582 -1.309 . . . . 0.0 108.911 177.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 175' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' C' ' 44' ' ' ALA . . . -64.52 -49.04 72.84 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.164 -175.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.53 -47.81 37.99 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -176.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 177' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' C' ' 174' ' ' ASP . . . -56.3 -47.41 78.74 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 122.113 0.959 . . . . 0.0 113.204 -175.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 49.6 m -63.62 -36.23 83.12 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 176.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 179' ' ' VAL . . . . . 0.655 ' HA ' HG12 ' C' ' 182' ' ' ILE . 44.3 t -75.04 -39.56 44.22 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -52.71 -44.5 66.36 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.845 172.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -64.79 -52.09 58.72 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 119.131 -0.461 . . . . 0.0 111.914 174.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 182' ' ' ILE . . . . . 0.655 HG12 ' HA ' ' C' ' 179' ' ' VAL . 20.4 pt -64.79 -33.15 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 O-C-N 123.796 0.685 . . . . 0.0 111.45 -169.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 183' ' ' LEU . . . . . . . . . . . . . 4.0 pp -67.64 -36.29 80.49 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 124.138 0.975 . . . . 0.0 111.66 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -77.23 -48.04 18.6 Favored 'General case' 0 C--O 1.206 -1.215 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -69.79 -71.24 0.24 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 -171.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 186' ' ' LEU . . . . . 0.421 ' HA ' ' HB1' ' C' ' 24' ' ' ALA 0.313 0.9 OUTLIER . . . . . 0 N--CA 1.476 0.873 0 N-CA-C 116.555 2.057 . . . . 0.0 116.555 -155.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 36.6 t-80 . . . . . 0 CA--C 1.508 -0.662 0 N-CA-C 105.874 -1.898 . . . . 65.74 105.874 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -61.83 76.86 0.02 OUTLIER Glycine 0 CA--C 1.538 1.497 0 N-CA-C 116.432 1.333 . . . . 48.66 116.432 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 26.5 ttp180 -118.71 138.03 52.92 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 123.394 1.568 . . . . 44.56 108.532 175.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1003 ' ' ILE . . . . . 0.472 HG12 HD13 ' A' 1068 ' ' ILE . 36.8 mt -106.65 129.75 59.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 102.253 -3.24 . . . . 34.86 102.253 -176.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -91.88 135.76 12.92 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 106.793 -2.523 . . . . 30.75 106.793 170.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.888 HG23 ' HB3' ' A' 1017 ' ' ALA . 19.5 mm -113.5 97.69 44.42 Favored Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 105.954 -1.869 . . . . 32.21 105.954 172.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -81.05 166.28 18.85 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 123.171 2.581 . . . . 32.98 114.275 170.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1007 ' ' ARG . . . . . 0.454 ' HB2' ' HA ' ' A' 1039 ' ' ALA . 6.5 tmm_? -85.31 140.05 31.12 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 113.066 -1.879 . . . . 47.98 106.071 167.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1008 ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -68.94 157.55 36.45 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 123.76 1.743 . . . . 34.7 113.774 -175.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -138.08 132.75 32.57 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 112.324 -2.216 . . . . 53.37 108.352 -171.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 10.8 tp 170.02 -177.24 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 102.96 -2.978 . . . . 45.07 102.96 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1011 ' ' THR . . . . . . . . . . . . . 11.0 m -72.01 114.5 10.18 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 122.745 2.521 . . . . 40.36 107.718 -174.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 4.3 m-20 64.53 43.58 4.38 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 113.712 1.004 . . . . 40.61 113.712 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -87.81 137.42 32.35 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 119.42 -0.912 . . . . 33.76 110.99 -171.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1014 ' ' THR . . . . . . . . . . . . . 19.9 p -103.24 -41.7 5.97 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 122.352 1.072 . . . . 27.89 113.038 -173.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1015 ' ' ARG . . . . . 0.565 ' HG3' ' HA2' ' A' 1317 ' ' GLY . 61.9 mtm180 -48.28 167.74 0.03 OUTLIER 'General case' 0 C--N 1.356 0.88 0 N-CA-C 120.083 3.364 . . . . 29.02 120.083 -173.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1016 ' ' VAL . . . . . 0.595 HG23 ' HB1' ' A' 1039 ' ' ALA . 7.7 p -132.12 162.52 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 113.454 -1.703 . . . . 28.13 106.712 171.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1017 ' ' ALA . . . . . 0.888 ' HB3' HG23 ' A' 1005 ' ' ILE . . . -66.47 -36.5 82.92 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 119.087 -2.258 . . . . 26.87 115.2 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -154.47 144.76 22.05 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 106.277 -1.749 . . . . 26.77 106.277 -174.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1019 ' ' THR . . . . . 0.405 HG21 HG23 ' A' 1321 ' ' THR . 1.7 p -98.5 170.74 6.6 Favored Pre-proline 0 N--CA 1.447 -0.583 0 CA-C-O 116.797 -1.573 . . . . 27.02 113.422 169.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1020 ' ' PRO . . . . . 0.401 ' HD3' ' CE1' ' A' 1050 ' ' PHE . 0.0 OUTLIER -29.45 -61.66 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 125.29 3.993 . . . . 30.57 120.024 173.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -66.85 -28.48 68.37 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 123.216 2.734 . . . . 47.81 110.842 -175.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1022 ' ' THR . . . . . . . . . . . . . 22.4 m -64.38 -47.98 77.19 Favored 'General case' 0 CA--C 1.554 1.118 0 O-C-N 121.621 -0.674 . . . . 30.77 110.178 169.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1023 ' ' VAL . . . . . . . . . . . . . 24.8 t -61.89 -38.6 80.99 Favored 'Isoleucine or valine' 0 C--O 1.254 1.33 0 O-C-N 120.996 -1.065 . . . . 33.59 109.043 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -64.56 -45.12 88.43 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 118.801 -1.16 . . . . 53.29 110.797 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1025 ' ' GLN . . . . . 0.619 ' HB3' HG11 ' A' 1332 ' ' VAL . 78.1 mt-30 -57.37 -40.15 77.54 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 118.762 0.71 . . . . 46.92 112.262 174.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1026 ' ' LEU . . . . . . . . . . . . . 74.7 mt -65.34 -34.67 78.86 Favored 'General case' 0 C--O 1.249 1.043 0 O-C-N 120.189 -1.57 . . . . 37.17 112.322 176.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 81.0 mt -70.87 -38.63 73.11 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.605 -0.887 . . . . 44.44 108.605 174.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -57.85 -36.74 72.75 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.972 0.805 . . . . 52.58 111.989 175.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1029 ' ' LEU . . . . . 0.54 ' HA ' ' HE2' ' A' 1342 ' ' LYS . 90.3 mt -60.97 -27.51 68.32 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 114.435 1.272 . . . . 45.69 114.435 170.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 93.2 32.27 7.94 Favored Glycine 0 C--O 1.242 0.614 0 O-C-N 121.23 -0.919 . . . . 42.09 113.111 -174.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -106.14 154.62 20.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 105.756 -1.942 . . . . 40.72 105.756 165.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1032 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.38 145.85 25.27 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 123.066 1.413 . . . . 37.77 109.42 172.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1033 ' ' VAL . . . . . . . . . . . . . 20.8 t -117.01 136.07 55.34 Favored 'Isoleucine or valine' 0 C--O 1.25 1.092 0 O-C-N 119.927 -1.733 . . . . 33.54 111.756 -172.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -119.79 140.52 50.63 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 108.156 -1.053 . . . . 31.68 108.156 170.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1035 ' ' VAL . . . . . . . . . . . . . 74.0 t -121.67 146.62 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 122.654 1.216 . . . . 31.52 109.387 178.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1036 ' ' GLU . . . . . 0.529 ' HB3' ' HB2' ' A' 1039 ' ' ALA . 34.3 tt0 -71.76 136.54 47.17 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 113.552 -1.658 . . . . 41.04 111.124 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1037 ' ' SER . . . . . . . . . . . . . 49.2 m -70.56 117.8 12.55 Favored 'General case' 0 C--O 1.246 0.883 0 N-CA-C 107.4 -1.333 . . . . 31.83 107.4 175.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 103.96 -7.24 48.48 Favored Glycine 0 C--O 1.219 -0.796 0 O-C-N 120.411 -1.431 . . . . 29.36 110.42 -174.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1039 ' ' ALA . . . . . 0.595 ' HB1' HG23 ' A' 1016 ' ' VAL . . . -68.69 -27.18 65.74 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 118.961 1.381 . . . . 27.78 112.089 -177.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -79.59 -32.57 37.2 Favored Glycine 0 N--CA 1.437 -1.27 0 CA-C-O 122.189 0.883 . . . . 28.91 112.604 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -47.59 -69.17 0.13 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.002 -1.599 . . . . 51.18 114.565 -171.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1042 ' ' LEU . . . . . . . . . . . . . 13.8 mt -77.22 -20.26 55.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.913 1.339 . . . . 29.91 111.869 -174.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1043 ' ' ALA . . . . . . . . . . . . . . . -82.22 -9.62 59.43 Favored 'General case' 0 C--O 1.243 0.759 0 O-C-N 120.419 -1.426 . . . . 28.54 113.153 171.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1044 ' ' SER . . . . . . . . . . . . . 7.9 m 56.33 63.92 1.85 Allowed 'General case' 0 C--N 1.361 1.1 0 O-C-N 126.715 2.509 . . . . 33.06 112.476 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1045 ' ' PHE . . . . . 0.556 ' HD1' ' HB3' ' B' 1277 ' ' ALA . 0.0 OUTLIER -159.78 75.15 0.62 Allowed 'General case' 0 C--N 1.315 -0.931 1 N-CA-C 98.682 -4.562 . . . . 30.29 98.682 162.332 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -62.46 150.63 39.52 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.762 -1.108 . . . . 48.62 113.621 -160.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1047 ' ' ASP . . . . . 0.534 ' HA ' ' HD2' ' A' 1050 ' ' PHE . 1.3 m-20 -46.09 -29.47 1.52 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 117.612 2.449 . . . . 36.74 117.612 -156.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 21.6 pttm -53.35 -33.91 55.44 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 112.956 0.724 . . . . 43.73 112.956 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -60.49 -35.94 77.13 Favored 'General case' 0 CA--C 1.522 -0.133 0 O-C-N 120.366 -1.459 . . . . 32.81 112.917 171.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1050 ' ' PHE . . . . . 0.534 ' HD2' ' HA ' ' A' 1047 ' ' ASP . 95.1 m-85 -72.1 -24.85 61.56 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 120.187 -1.571 . . . . 31.86 111.412 175.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 61.8 t -65.41 -47.32 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 118.236 -0.888 . . . . 33.22 109.435 170.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -56.35 -34.48 66.65 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.565 1.691 . . . . 50.83 115.565 171.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -74.41 -21.78 59.46 Favored 'General case' 0 C--O 1.25 1.117 0 N-CA-C 115.093 1.516 . . . . 33.12 115.093 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 101.34 83.22 1.72 Allowed Glycine 0 CA--C 1.526 0.752 0 C-N-CA 119.453 -1.356 . . . . 35.83 110.219 -177.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -150.58 138.65 20.14 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 119.44 -2.212 . . . . 34.82 115.159 176.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -66.4 121.17 14.68 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 105.511 -2.033 . . . . 49.05 105.511 165.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1057 ' ' ILE . . . . . . . . . . . . . 43.3 mm -100.03 118.2 46.33 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 O-C-N 119.649 -1.907 . . . . 38.53 107.732 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1058 ' ' VAL . . . . . . . . . . . . . 3.2 m -133.93 172.87 15.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 125.602 1.561 . . . . 42.11 111.119 -176.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -87.84 165.36 15.35 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 122.878 2.581 . . . . 58.0 108.202 173.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1060 ' ' GLY . . . . . 0.456 ' HA2' HG12 ' A' 1063 ' ' VAL . . . -49.53 -51.42 27.55 Favored Glycine 0 C--O 1.238 0.368 0 O-C-N 120.718 -1.239 . . . . 52.12 116.044 -172.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1061 ' ' ASN . . . . . 0.443 ' O ' ' HG2' ' A' 1065 ' ' GLN . 7.8 t30 -49.5 -40.27 36.97 Favored 'General case' 0 C--O 1.251 1.159 0 CA-C-O 122.092 0.948 . . . . 54.75 112.817 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1062 ' ' SER . . . . . . . . . . . . . 16.5 m -78.08 -35.82 48.92 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 119.984 -1.697 . . . . 50.34 114.608 173.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1063 ' ' VAL . . . . . 0.456 HG12 ' HA2' ' A' 1060 ' ' GLY . 1.1 p -64.62 -28.98 46.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 119.588 -1.945 . . . . 41.46 111.027 -178.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1064 ' ' TRP . . . . . 0.415 ' HB2' HD22 ' A' 1082 ' ' LEU . 59.6 m95 -80.67 -13.87 58.64 Favored 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 121.064 -1.022 . . . . 39.32 112.736 175.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1065 ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' 1061 ' ' ASN . 92.2 mm-40 -77.34 67.4 3.28 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 119.302 -2.124 . . . . 55.38 105.979 173.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1066 ' ' SER . . . . . . . . . . . . . 60.1 m -148.69 142.87 26.04 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 119.709 -1.87 . . . . 41.87 111.227 -170.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.78 -36.55 79.26 Favored 'General case' 0 N--CA 1.437 -1.104 0 O-C-N 125.671 1.857 . . . . 53.2 112.438 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1068 ' ' ILE . . . . . 0.472 HD13 HG12 ' A' 1003 ' ' ILE . 3.7 mp -121.9 144.47 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 106.515 -1.661 . . . . 41.9 106.515 176.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1069 ' ' ILE . . . . . 0.458 HG12 HG21 ' A' 1087 ' ' THR . 49.0 mm -130.63 129.24 64.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 N-CA-C 107.416 -1.328 . . . . 38.73 107.416 169.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1070 ' ' LEU . . . . . 0.411 ' HB2' ' HB1' ' A' 1017 ' ' ALA . 44.9 mt -97.17 143.81 27.62 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.256 -2.498 . . . . 32.44 104.256 175.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1071 ' ' LYS . . . . . 0.556 ' HB2' ' OG ' ' A' 1091 ' ' SER . 16.0 mmmt -148.12 130.51 15.7 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.647 0.779 . . . . 34.65 111.534 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1072 ' ' VAL . . . . . 0.516 HG13 ' CD2' ' A' 1327 ' ' TYR . 2.1 t -89.32 -13.96 9.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-N 114.86 -1.063 . . . . 31.32 113.747 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -112.89 -176.65 2.95 Favored 'General case' 0 C--O 1.248 1.018 0 N-CA-C 106.583 -1.636 . . . . 33.94 106.583 163.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -73.2 155.12 90.25 Favored Pre-proline 0 C--O 1.259 1.567 0 N-CA-C 109.043 -0.725 . . . . 38.04 109.043 161.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1075 ' ' PRO . . . . . 0.743 ' HG2' HD21 ' A' 1089 ' ' LEU . 3.9 Cg_exo -70.83 117.31 5.08 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 123.599 2.866 . . . . 42.68 114.621 168.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 86.8 mt -71.21 162.64 29.09 Favored 'General case' 0 N--CA 1.434 -1.251 0 O-C-N 125.838 1.961 . . . . 46.74 107.868 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1077 ' ' ASP . . . . . 0.468 ' HA ' HD12 ' A' 1080 ' ' ILE . 0.5 OUTLIER -42.73 -46.3 5.06 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 117.743 2.498 . . . . 58.61 117.743 -177.233 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 38.8 t70 -64.73 -41.33 96.04 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 113.567 0.951 . . . . 59.2 113.567 174.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1079 ' ' GLU . . . . . 0.596 ' HA ' HD12 ' A' 1082 ' ' LEU . 38.2 mt-10 -66.69 -32.96 74.61 Favored 'General case' 0 C--O 1.211 -0.956 0 N-CA-C 108.347 -0.983 . . . . 50.63 108.347 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1080 ' ' ILE . . . . . 0.636 ' HA ' HD23 ' A' 1083 ' ' LEU . 95.7 mt -59.6 -41.53 85.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 123.648 1.69 . . . . 51.48 110.728 175.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -62.62 -29.35 70.55 Favored 'General case' 0 C--O 1.211 -0.969 0 O-C-N 120.876 -1.14 . . . . 50.28 111.958 175.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1082 ' ' LEU . . . . . 0.596 HD12 ' HA ' ' A' 1079 ' ' GLU . 8.0 mt -70.47 -27.26 64.09 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 114.815 1.413 . . . . 50.21 114.815 173.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1083 ' ' LEU . . . . . 0.636 HD23 ' HA ' ' A' 1080 ' ' ILE . 1.3 mm? -64.16 123.95 20.41 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 122.817 1.294 . . . . 49.06 112.099 -176.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -89.81 141.24 28.15 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 104.807 -2.294 . . . . 51.08 104.807 175.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -56.81 148.26 67.51 Favored 'Trans proline' 0 CA--C 1.503 -1.031 0 C-N-CA 122.745 2.297 . . . . 49.73 116.035 -177.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 84.05 -14.11 45.76 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 113.887 -1.506 . . . . 47.71 113.658 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1087 ' ' THR . . . . . 0.458 HG21 HG12 ' A' 1069 ' ' ILE . 38.6 m -59.2 127.04 30.15 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 119.868 1.834 . . . . 45.47 113.293 -175.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1088 ' ' THR . . . . . . . . . . . . . 31.0 m -75.31 96.46 3.38 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 105.66 -1.978 . . . . 42.04 105.66 173.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1089 ' ' LEU . . . . . 0.743 HD21 ' HG2' ' A' 1075 ' ' PRO . 42.7 tp -89.09 113.36 24.5 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 113.301 -1.772 . . . . 38.06 108.028 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 3.3 t -108.37 109.06 26.89 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 N-CA-C 102.265 -3.235 . . . . 37.4 102.265 -173.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1091 ' ' SER . . . . . 0.556 ' OG ' ' HB2' ' A' 1071 ' ' LYS . 19.7 m -145.67 153.87 41.49 Favored 'General case' 0 C--O 1.224 -0.285 0 O-C-N 120.686 -1.259 . . . . 36.16 112.888 -166.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 2.8 t80 -84.67 91.03 7.83 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 105.727 -1.953 . . . . 38.94 105.727 172.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 26.5 mm -83.86 -49.57 16.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 115.37 1.619 . . . . 42.17 115.37 -172.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 96.4 m95 60.42 73.0 0.67 Allowed Pre-proline 0 C--O 1.255 1.366 0 C-N-CA 125.243 1.417 . . . . 46.51 111.021 -159.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -59.76 -38.39 80.9 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 124.754 3.636 . . . . 49.76 116.566 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -55.69 -47.44 76.78 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.618 -1.628 . . . . 52.62 110.824 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -64.77 -27.49 68.93 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 113.361 -1.745 . . . . 60.74 113.577 174.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1098 ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -123.32 56.96 10.34 Favored Pre-proline 0 N--CA 1.449 -0.478 0 N-CA-C 119.363 3.097 . . . . 58.19 119.363 -164.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -59.19 -47.67 16.6 Favored 'Trans proline' 0 N--CA 1.479 0.633 0 C-N-CA 123.399 2.732 . . . . 54.59 115.257 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1100 ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' 1104 ' ' LYS . 0.0 OUTLIER -61.38 -44.52 97.02 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 113.18 0.807 . . . . 63.28 113.18 177.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 1101 ' ' LEU . . . . . . . . . . . . . 8.2 tp -62.5 -46.26 89.26 Favored 'General case' 0 N--CA 1.441 -0.898 0 O-C-N 124.608 1.192 . . . . 54.75 107.853 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1102 ' ' MET . . . . . . . . . . . . . 49.8 mmm -53.98 -45.56 71.42 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 123.366 0.667 . . . . 52.65 112.054 175.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -62.11 -34.41 76.28 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 118.017 -0.992 . . . . 66.26 112.364 175.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1104 ' ' LYS . . . . . 0.453 ' HB3' HG21 ' A' 1080 ' ' ILE . 86.2 mttt -66.58 -46.62 75.38 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.891 -0.781 . . . . 63.73 108.891 175.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.01 -39.08 84.59 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 121.191 -0.943 . . . . 54.68 110.513 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -69.56 -38.8 77.59 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.397 -0.814 . . . . 53.64 111.308 176.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -71.85 -18.87 62.04 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 120.292 1.405 . . . . 67.24 112.186 177.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -77.55 -4.78 47.44 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 116.124 1.898 . . . . 65.76 116.124 163.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 5.2 t30 55.17 40.8 31.85 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 126.166 1.786 . . . . 58.71 111.532 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1110 ' ' VAL . . . . . 0.419 HG23 HG23 ' A' 1112 ' ' VAL . 30.8 m -98.27 153.67 4.01 Favored 'Isoleucine or valine' 0 C--N 1.344 0.357 0 O-C-N 121.24 -0.913 . . . . 46.63 113.007 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1111 ' ' THR . . . . . 0.415 HG23 ' HA ' ' A' 1362 ' ' ARG . 53.6 m -88.89 100.22 13.01 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 104.704 -2.332 . . . . 44.13 104.704 176.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1112 ' ' VAL . . . . . 0.483 HG22 HD23 ' A' 1089 ' ' LEU . 62.2 t -93.82 115.16 31.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 O-C-N 121.111 -0.993 . . . . 40.44 109.743 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1113 ' ' MET . . . . . 0.484 ' HB3' HG12 ' A' 1358 ' ' VAL . 19.3 mtp -101.24 102.42 13.3 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.033 -1.894 . . . . 50.76 108.564 173.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1114 ' ' ALA . . . . . 0.486 ' HB3' ' HB2' ' A' 1117 ' ' SER . . . -80.08 108.07 13.37 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 122.936 1.351 . . . . 35.64 108.88 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1115 ' ' MET . . . . . 0.558 ' SD ' HD22 ' A' 1334 ' ' LEU . 69.9 mmm -71.83 -20.71 61.79 Favored 'General case' 0 C--O 1.243 0.759 0 O-C-N 119.437 -2.04 . . . . 38.74 115.308 -174.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1116 ' ' ASP . . . . . 0.464 ' O ' HD12 ' A' 1130 ' ' LEU . 8.4 p-10 -66.08 -32.63 74.2 Favored 'General case' 0 C--O 1.246 0.915 0 CA-C-O 122.238 1.018 . . . . 40.14 109.289 164.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1117 ' ' SER . . . . . 0.486 ' HB2' ' HB3' ' A' 1114 ' ' ALA . 68.9 m -91.09 34.47 0.93 Allowed 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 117.14 2.274 . . . . 44.79 117.14 -176.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1118 ' ' VAL . . . . . . . . . . . . . 3.5 t -75.56 129.03 82.81 Favored Pre-proline 0 N--CA 1.439 -1.011 0 O-C-N 121.718 -0.614 . . . . 43.75 109.547 165.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -61.19 137.97 74.55 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.714 2.276 . . . . 48.93 111.795 172.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 25.1 mmm-85 -90.16 32.86 0.9 Allowed 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.204 -1.56 . . . . 62.9 111.546 -152.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 30.8 pt -79.89 155.63 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 O-C-N 118.492 -2.63 . . . . 57.72 112.198 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1122 ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -43.27 -58.99 2.27 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 120.653 3.575 . . . . 57.26 120.653 -177.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1123 ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' 1123 ' ' ARG 0.269 0.0 OUTLIER -60.09 -16.55 32.72 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 116.565 2.061 . . . . 62.9 116.565 175.027 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A 1124 ' ' ALA . . . . . 0.806 ' HB2' HG11 ' A' 1354 ' ' VAL . . . -80.41 -15.05 57.74 Favored 'General case' 0 N--CA 1.424 -1.755 0 O-C-N 118.67 -2.519 . . . . 49.83 113.472 177.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 69.6 mm-40 -66.99 -22.04 65.93 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 116.996 2.221 . . . . 52.37 116.996 -163.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1126 ' ' SER . . . . . . . . . . . . . 13.7 m -73.31 -19.18 61.09 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 115.174 1.546 . . . . 42.43 115.174 169.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1127 ' ' LEU . . . . . . . . . . . . . 2.7 mp -95.84 -30.64 13.56 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.591 -0.892 . . . . 43.74 108.591 173.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 65.6 t0 -65.06 106.91 1.37 Allowed 'General case' 0 C--O 1.247 0.954 0 CA-C-O 125.833 2.73 . . . . 43.21 112.045 -173.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1129 ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' 1115 ' ' MET . . . -85.08 -28.72 25.43 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 109.576 -3.465 . . . . 35.74 110.12 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1130 ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' 1116 ' ' ASP . 0.5 OUTLIER -66.82 -20.26 65.9 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-N 120.866 1.666 . . . . 38.09 109.107 177.133 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 1131 ' ' SER . . . . . 0.447 ' HB3' HG21 ' A' 1175 ' ' VAL . 65.4 m -82.5 -64.37 1.19 Allowed 'General case' 0 CA--C 1.545 0.766 0 O-C-N 119.413 -2.054 . . . . 36.91 110.327 161.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1132 ' ' SER . . . . . 0.538 ' O ' ' HB3' ' A' 1135 ' ' ASN . 19.4 m -66.92 -44.51 80.51 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 117.678 2.473 . . . . 35.79 117.678 -168.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1133 ' ' MET . . . . . 0.564 ' HA ' HD12 ' A' 1136 ' ' ILE . 5.2 ttt -68.37 -35.18 77.34 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 121.784 2.084 . . . . 30.81 110.624 176.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1134 ' ' ALA . . . . . . . . . . . . . . . -60.51 -40.82 92.79 Favored 'General case' 0 C--O 1.251 1.18 0 N-CA-C 109.143 -0.688 . . . . 28.88 109.143 173.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1135 ' ' ASN . . . . . 0.882 ' HB2' HG12 ' A' 1175 ' ' VAL . 10.4 t-20 -53.8 -48.06 70.22 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.235 1.414 . . . . 40.76 112.285 175.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1136 ' ' ILE . . . . . 0.631 HD13 ' HA ' ' A' 1323 ' ' SER . 69.0 mt -57.87 -47.48 86.16 Favored 'Isoleucine or valine' 0 C--O 1.247 0.934 0 CA-C-N 114.388 -1.278 . . . . 31.54 110.985 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -60.83 -34.24 74.26 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.068 -1.423 . . . . 29.87 110.495 174.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -62.59 -48.5 81.17 Favored Glycine 0 C--O 1.211 -1.327 0 CA-C-N 119.296 0.953 . . . . 28.73 112.177 176.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 28.3 t80 -59.93 -42.06 93.15 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.596 -0.802 . . . . 30.39 110.317 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1140 ' ' ARG . . . . . 0.708 ' HD3' HD13 ' A' 1319 ' ' LEU . 1.1 tpt180 -73.34 -22.6 60.27 Favored 'General case' 0 CA--C 1.497 -1.066 0 O-C-N 124.445 1.091 . . . . 26.09 113.178 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1141 ' ' ALA . . . . . . . . . . . . . . . -66.62 -48.02 70.78 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 105.545 -2.02 . . . . 27.1 105.545 171.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 25.8 mm -53.66 -43.43 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 C-N-CA 125.442 1.497 . . . . 28.48 111.541 175.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 75.4 t -58.55 -61.68 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 O-C-N 120.653 -1.279 . . . . 23.07 110.113 173.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1144 ' ' GLU . . . . . 0.428 ' CD ' HH21 ' A' 1140 ' ' ARG . 5.7 mm-40 -62.42 -28.28 69.68 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 122.126 2.239 . . . . 33.4 114.137 -177.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1145 ' ' ALA . . . . . 0.78 ' HB1' HD12 ' A' 1251 ' ' ILE . . . -57.38 -60.47 3.59 Favored 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 124.668 1.187 . . . . 24.22 109.721 169.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -65.39 -20.49 66.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.554 0.692 . . . . 24.89 111.038 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -76.61 -33.53 58.39 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-O 115.511 -2.185 . . . . 26.73 110.725 177.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1148 ' ' GLU . . . . . 0.657 ' HB2' HD11 ' A' 1310 ' ' ILE . 40.0 mm-40 -110.16 3.38 20.09 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 122.221 2.282 . . . . 39.96 115.785 175.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1149 ' ' PHE . . . . . 0.613 ' CZ ' ' HB3' ' A' 1250 ' ' ASP . 0.9 OUTLIER -67.08 145.94 54.82 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 126.063 1.745 . . . . 25.87 110.448 -178.359 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 1150 ' ' GLY . . . . . . . . . . . . . . . -69.75 -45.18 59.59 Favored Glycine 0 N--CA 1.43 -1.732 0 O-C-N 121.308 -0.87 . . . . 19.28 113.504 171.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1151 ' ' ARG . . . . . 0.703 ' HA ' ' HB2' ' B' 1322 ' ' GLN . 69.7 mtm-85 -107.42 -173.79 2.37 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 124.362 1.065 . . . . 39.9 113.347 -166.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1152 ' ' PHE . . . . . 0.539 ' CD1' ' HG2' ' B' 1322 ' ' GLN . 5.3 m-30 -84.07 149.68 26.08 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 106.218 -1.771 . . . . 29.44 106.218 172.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1153 ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -64.95 -53.31 48.39 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 124.177 1.942 . . . . 32.6 110.18 152.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1154 ' ' THR . . . . . . . . . . . . 0.255 56.3 m -65.03 110.77 2.6 Favored 'General case' 0 C--O 1.249 1.068 0 CA-C-N 111.908 -2.406 . . . . 34.64 116.427 -174.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -64.07 138.85 41.89 Favored Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 109.579 -1.409 . . . . 37.14 109.579 163.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -173.63 158.84 3.45 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 122.53 1.157 . . . . 40.57 111.507 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1157 ' ' ILE . . . . . 0.52 HD13 ' HB2' ' C' ' 95' ' ' GLU . 6.5 tp -79.03 136.81 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 O-C-N 119.995 -1.691 . . . . 44.61 109.41 163.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1158 ' ' THR . . . . . 0.565 ' O ' ' HB3' ' C' ' 70' ' ' PRO . 68.7 p -111.28 -160.12 0.7 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 105.469 -2.049 . . . . 40.7 105.469 169.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1159 ' ' ALA . . . . . 0.54 ' HB1' ' HA ' ' B' 1126 ' ' SER . . . -83.28 -20.29 34.72 Favored 'General case' 0 CA--C 1.541 0.634 1 O-C-N 116.284 -4.01 . . . . 40.25 108.92 165.526 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -96.46 43.98 1.07 Allowed 'General case' 0 C--O 1.246 0.897 0 CA-C-O 123.32 1.533 . . . . 38.47 110.238 175.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . 74.97 -171.99 53.52 Favored Glycine 0 C--O 1.244 0.762 0 O-C-N 119.943 -1.723 . . . . 37.61 116.074 170.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -72.82 135.1 45.16 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 122.812 1.292 . . . . 48.9 112.186 -174.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1163 ' ' VAL . . . . . 0.527 HG11 ' HB2' ' A' 1152 ' ' PHE . 84.0 t -93.86 127.08 46.87 Favored Pre-proline 0 C--O 1.25 1.089 0 N-CA-C 104.398 -2.445 . . . . 36.52 104.398 162.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1164 ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.09 145.86 40.22 Favored 'Trans proline' 0 N--CA 1.444 -1.403 0 C-N-CA 124.615 3.544 . . . . 35.08 109.838 173.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1165 ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -62.01 147.13 95.75 Favored 'Trans proline' 0 C--O 1.245 0.833 0 C-N-CA 123.889 3.059 . . . . 35.33 109.713 172.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -78.64 135.41 37.21 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.736 1.014 . . . . 34.69 113.736 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1167 ' ' LYS . . . . . . . . . . . . . 44.3 mttp -84.24 100.02 10.93 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 102.263 -3.236 . . . . 45.36 102.263 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 59.9 t -91.38 88.27 2.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 114.793 -1.094 . . . . 31.71 110.241 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1169 ' ' MET . . . . . 0.498 ' HA ' ' O ' ' A' 1192 ' ' ARG . 37.2 ttp -77.2 107.04 9.3 Favored 'General case' 0 CA--C 1.498 -1.037 0 O-C-N 119.49 -2.006 . . . . 42.28 107.884 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 59.4 t -92.29 121.81 43.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 117.27 -1.348 . . . . 30.51 109.612 176.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 20.8 mt -107.36 131.37 57.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 104.609 -2.367 . . . . 31.87 104.609 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 82.22 61.77 1.97 Allowed Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 108.584 -1.807 . . . . 34.54 108.584 174.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1173 ' ' ALA . . . . . 0.557 ' HA ' ' HA3' ' A' 1177 ' ' GLY . . . -77.37 76.98 3.9 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 120.373 -1.663 . . . . 32.51 115.108 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -84.81 -160.77 32.72 Favored Glycine 0 C--O 1.219 -0.796 0 CA-C-O 116.774 -2.126 . . . . 29.9 110.25 156.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1175 ' ' VAL . . . . . 0.882 HG12 ' HB2' ' A' 1135 ' ' ASN . 48.3 t -64.63 -31.09 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 1 CA-C-N 124.977 4.389 . . . . 33.11 114.32 -176.655 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 1176 ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' 1135 ' ' ASN . . . -53.58 -47.58 69.98 Favored 'General case' 0 C--O 1.218 -0.559 0 O-C-N 121.885 -0.509 . . . . 28.1 111.602 165.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1177 ' ' GLY . . . . . 0.557 ' HA3' ' HA ' ' A' 1173 ' ' ALA . . . -63.71 -42.88 98.51 Favored Glycine 0 CA--C 1.507 -0.419 0 CA-C-O 118.846 -0.974 . . . . 28.54 111.759 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1178 ' ' LEU . . . . . 0.408 HD12 HG22 ' A' 1175 ' ' VAL . 52.4 mt -62.9 -35.19 79.25 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 117.462 -1.256 . . . . 31.22 110.698 177.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1179 ' ' ALA . . . . . 0.457 ' HB2' ' ND2' ' A' 1135 ' ' ASN . . . -64.61 -34.88 79.3 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 121.769 2.077 . . . . 28.98 112.374 172.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -67.81 -45.78 73.79 Favored 'General case' 0 C--O 1.253 1.25 0 CA-C-N 115.249 -0.887 . . . . 27.83 112.079 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1181 ' ' ILE . . . . . 0.573 HG12 HG11 ' A' 1191 ' ' VAL . 54.7 mt -57.32 -53.9 37.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.496 0 CA-C-N 114.93 -1.032 . . . . 30.25 109.07 175.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -52.72 -58.0 12.6 Favored Glycine 0 N--CA 1.471 1.005 0 O-C-N 125.161 1.538 . . . . 29.59 109.71 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -60.37 -48.78 80.29 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 115.338 1.607 . . . . 30.29 115.338 -175.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -69.75 -33.22 72.14 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 120.116 1.325 . . . . 30.47 114.394 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -65.99 -43.78 86.76 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.689 -0.856 . . . . 42.41 108.689 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1186 ' ' SER . . . . . . . . . . . . . 68.1 m -59.38 -48.18 82.61 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 121.073 -1.017 . . . . 39.38 112.586 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1187 ' ' LEU . . . . . 0.454 ' HA ' ' HB3' ' B' 1186 ' ' SER . 10.6 mt -53.43 -34.47 57.94 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 117.207 2.299 . . . . 36.18 117.207 170.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 105.36 52.38 0.82 Allowed Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 109.124 -1.591 . . . . 33.78 109.124 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -135.54 143.93 45.99 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 107.488 -1.301 . . . . 33.93 107.488 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 7.5 mt -79.57 106.85 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 103.111 -2.922 . . . . 38.74 103.111 -170.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1191 ' ' VAL . . . . . 0.573 HG11 HG12 ' A' 1181 ' ' ILE . 44.0 t -76.21 135.26 27.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 105.974 -1.861 . . . . 33.09 105.974 173.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1192 ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' 1169 ' ' MET . 95.0 mtt180 -126.4 87.01 2.6 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 102.741 -3.059 . . . . 38.92 102.741 176.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -95.59 154.56 17.15 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 120.33 -1.481 . . . . 35.32 111.794 -170.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 35.6 t80 -155.91 164.31 38.66 Favored 'General case' 0 C--O 1.25 1.115 0 O-C-N 124.557 1.161 . . . . 39.35 108.064 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1195 ' ' ASP . . . . . 0.44 ' HB2' ' H ' ' A' 1173 ' ' ALA . 10.6 t70 -164.77 162.63 21.22 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 104.492 -2.41 . . . . 40.46 104.492 174.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1196 ' ' THR . . . . . . . . . . . . . 5.6 m -58.36 -38.63 77.62 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.836 -1.075 . . . . 45.94 111.877 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1197 ' ' ARG . . . . . 0.45 ' HA ' ' HD2' ' A' 1198 ' ' PRO . 40.5 mtm180 -90.06 113.86 58.76 Favored Pre-proline 0 N--CA 1.449 -0.498 0 C-N-CA 126.191 1.796 . . . . 56.02 108.214 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1198 ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' 1197 ' ' ARG . 39.9 Cg_endo -55.1 -22.27 30.89 Favored 'Trans proline' 0 N--CA 1.435 -1.955 0 C-N-CA 125.202 3.935 . . . . 51.27 116.361 173.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -47.86 -41.0 23.03 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 116.539 2.051 . . . . 59.1 116.539 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 32.8 m -64.16 -9.29 5.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 116.095 1.887 . . . . 51.06 116.095 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 80.6 tttt -53.74 -40.81 66.45 Favored 'General case' 0 N--CA 1.436 -1.126 0 O-C-N 123.769 0.668 . . . . 57.38 111.908 -178.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.91 -47.51 71.11 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 115.444 1.646 . . . . 62.41 115.444 174.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -61.89 -43.41 98.91 Favored 'General case' 0 C--O 1.256 1.44 0 CA-C-O 123.37 1.557 . . . . 57.78 112.538 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 42.2 t -53.68 -57.24 5.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 112.571 -2.104 . . . . 46.38 109.0 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -70.53 -31.57 68.7 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 113.106 -1.861 . . . . 50.7 112.313 -177.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1206 ' ' SER . . . . . . . . . . . . . 66.8 m -70.7 -45.02 65.74 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 119.797 1.18 . . . . 49.98 111.328 -177.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1207 ' ' MET . . . . . . . . . . . . . 59.3 mtm -68.19 -34.18 75.8 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 122.723 1.249 . . . . 52.99 112.988 175.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 123.42 96.25 1.23 Allowed Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 107.56 -2.216 . . . . 47.66 107.56 171.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -168.12 160.19 11.62 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 120.788 -0.365 . . . . 44.77 110.188 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -85.62 145.91 27.11 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 102.894 -3.002 . . . . 47.64 102.894 170.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1211 ' ' PHE . . . . . . . . . . . . . 71.6 t80 -112.93 145.28 41.04 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 103.341 -2.837 . . . . 45.66 103.341 173.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 80.0 mt -71.14 108.54 4.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 123.369 1.557 . . . . 46.06 112.233 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -87.22 123.98 32.82 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 106.238 -1.764 . . . . 60.22 106.238 174.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 8.9 mp -90.34 144.81 25.48 Favored 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 115.259 1.577 . . . . 57.25 115.259 -176.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 35.6 t70 -71.59 83.56 0.85 Allowed 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 112.976 -1.92 . . . . 64.43 109.922 165.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 83.4 t80 . . . . . 0 C--O 1.216 -0.678 0 N-CA-C 102.38 -3.193 . . . . 66.9 102.38 -177.011 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 9.2 p-10 . . . . . 0 N--CA 1.437 -1.114 0 N-CA-C 106.779 -1.563 . . . . 39.09 106.779 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -49.33 -51.11 27.51 Favored Glycine 0 N--CA 1.474 1.185 0 C-N-CA 126.956 2.217 . . . . 39.32 112.943 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 60.3 t80 -64.86 -47.56 77.46 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 119.292 1.546 . . . . 39.3 111.739 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -63.91 -43.33 96.26 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 119.625 1.102 . . . . 36.3 113.105 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -57.07 -34.52 68.35 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 124.263 0.977 . . . . 37.38 112.144 174.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -63.43 -53.99 38.36 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 CA-C-N 121.106 1.775 . . . . 39.11 111.449 166.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1230 ' ' MET . . . . . . . . . . . . . 28.9 mmt -71.13 40.57 0.06 Allowed 'General case' 0 C--O 1.242 0.709 0 N-CA-C 113.706 1.002 . . . . 49.59 113.706 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1231 ' ' SER . . . . . . . . . . . . . 61.8 p -114.12 157.02 23.15 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 118.681 -2.512 . . . . 43.68 108.131 -174.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -55.11 -46.6 75.56 Favored 'General case' 0 C--N 1.356 0.865 0 CA-C-O 123.399 1.571 . . . . 55.57 110.289 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -70.76 -35.6 72.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 117.851 -1.071 . . . . 44.94 113.579 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 31.9 t80 -72.26 -48.44 42.61 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 122.535 2.425 . . . . 42.04 109.403 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 58.9 mt -64.3 -32.17 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 CA-C-N 118.645 0.657 . . . . 46.28 111.893 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 41.1 tttm -52.88 -53.72 44.91 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.783 -1.192 . . . . 47.87 107.783 167.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -62.85 -32.2 73.38 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 114.433 1.272 . . . . 41.61 114.433 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -54.43 -50.24 68.08 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 119.054 0.843 . . . . 50.65 112.614 165.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1239 ' ' MET . . . . . . . . . . . . . 34.3 mmt -61.15 -47.52 85.84 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 123.152 1.453 . . . . 48.87 110.075 -178.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -58.83 -40.08 83.15 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 112.949 -1.932 . . . . 54.8 109.613 175.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 3.5 mm? -75.19 -33.83 61.47 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 122.376 2.353 . . . . 43.21 112.453 176.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -69.81 -40.56 75.87 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 121.788 2.086 . . . . 38.66 109.681 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -64.73 -38.65 91.7 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 125.231 1.412 . . . . 37.92 111.464 171.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -63.69 -25.15 68.08 Favored 'General case' 0 C--O 1.246 0.882 0 O-C-N 120.026 -1.671 . . . . 37.28 112.567 171.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1245 ' ' GLN . . . . . 0.438 ' HG3' ' SD ' ' A' 1169 ' ' MET . 96.5 mm-40 -84.09 -32.15 24.93 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-O 118.548 -0.739 . . . . 43.07 111.83 176.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -49.92 -45.19 50.76 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 113.443 0.905 . . . . 38.3 113.443 -158.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1247 ' ' LYS . . . . . 0.49 ' H ' ' HD2' ' A' 1247 ' ' LYS . 0.4 OUTLIER -80.38 -11.53 59.69 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 119.423 -2.048 . . . . 47.6 111.757 -172.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -106.88 -31.65 8.26 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 118.548 -0.739 . . . . 45.42 110.672 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1249 ' ' VAL . . . . . . . . . . . . 0.307 12.2 m -68.45 152.86 9.26 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 N-CA-C 117.658 2.466 . . . . 36.26 117.658 -172.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1250 ' ' ASP . . . . . 0.613 ' HB3' ' CZ ' ' A' 1149 ' ' PHE . 12.2 m-20 -113.74 -54.77 2.58 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 112.636 -2.074 . . . . 33.04 109.274 -171.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1251 ' ' ILE . . . . . 0.78 HD12 ' HB1' ' A' 1145 ' ' ALA . 25.8 mm -124.13 122.8 65.2 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.692 0 N-CA-C 101.644 -3.465 . . . . 31.4 101.644 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1252 ' ' ILE . . . . . 0.508 HG21 HD11 ' A' 1267 ' ' ILE . 55.5 mt -99.72 127.47 52.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 103.579 -2.749 . . . . 29.42 103.579 161.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1253 ' ' VAL . . . . . 0.567 HG12 HG23 ' A' 1255 ' ' THR . 11.2 t -110.87 104.73 17.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 1 N-CA-C 100.141 -4.022 . . . . 30.37 100.141 176.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 1254 ' ' THR . . . . . 0.41 HG23 HG22 ' A' 1252 ' ' ILE . 0.6 OUTLIER -88.91 84.77 6.64 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-O 125.619 2.628 . . . . 35.72 111.971 -179.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 1255 ' ' THR . . . . . 0.601 HG22 HD13 ' A' 1284 ' ' LEU . 14.6 p -95.09 12.68 27.76 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 110.765 -2.925 . . . . 36.0 116.748 -176.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1256 ' ' ALA . . . . . 0.418 ' HB3' HD21 ' A' 1291 ' ' ASN . . . -83.97 67.4 9.62 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 120.909 1.686 . . . . 40.93 112.011 -176.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 37.3 tp -82.24 99.27 9.2 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 106.561 -1.644 . . . . 47.82 106.561 176.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1258 ' ' ILE . . . . . 0.474 ' HA ' ' HD2' ' A' 1259 ' ' PRO . 30.8 mm -75.87 139.65 70.02 Favored Pre-proline 0 N--CA 1.433 -1.32 0 N-CA-C 108.071 -1.085 . . . . 52.7 108.071 -175.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1259 ' ' PRO . . . . . 0.474 ' HD2' ' HA ' ' A' 1258 ' ' ILE . 29.0 Cg_endo -59.78 114.04 1.9 Allowed 'Trans proline' 0 CA--C 1.512 -0.597 0 C-N-CA 122.573 2.182 . . . . 54.13 112.719 169.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 80.91 -75.47 2.27 Favored Glycine 0 C--O 1.255 1.44 0 N-CA-C 107.047 -2.421 . . . . 54.62 107.047 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 89.9 mttt -51.03 140.38 21.25 Favored Pre-proline 0 C--O 1.252 1.225 0 C-N-CA 126.064 1.746 . . . . 55.74 112.072 -177.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -56.64 136.29 75.21 Favored 'Trans proline' 0 N--CA 1.44 -1.634 1 C-N-CA 125.311 4.008 . . . . 51.15 111.043 176.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1263 ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' 1264 ' ' PRO . . . -54.98 130.81 67.49 Favored Pre-proline 0 N--CA 1.47 0.538 0 CA-C-O 121.791 0.805 . . . . 46.06 110.718 170.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1264 ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' 1263 ' ' ALA . 76.1 Cg_exo -56.5 129.2 33.46 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 124.565 3.51 . . . . 41.08 110.68 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -77.6 70.15 3.94 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 124.923 2.297 . . . . 47.42 111.874 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 61.0 mt -69.91 -58.53 3.75 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 109.572 -3.467 . . . . 39.22 110.75 -164.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1267 ' ' ILE . . . . . 0.508 HD11 HG21 ' A' 1252 ' ' ILE . 31.9 mt -83.78 106.26 14.07 Favored 'Isoleucine or valine' 0 C--O 1.246 0.918 0 N-CA-C 106.987 -1.486 . . . . 42.5 106.987 -174.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1268 ' ' THR . . . . . . . . . . . . . 38.5 p -67.55 156.15 37.43 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 115.83 -0.623 . . . . 37.84 111.562 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -55.32 -34.73 64.43 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.513 -0.551 . . . . 54.8 109.513 171.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -48.73 -54.65 14.09 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 113.403 0.89 . . . . 54.36 113.403 166.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1271 ' ' MET . . . . . . . . . . . . . 26.5 mtm -68.23 -35.52 78.08 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.833 0.679 . . . . 39.52 112.833 -177.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1272 ' ' VAL . . . . . 0.422 HG12 HG21 ' A' 1303 ' ' THR . 79.2 t -62.82 -51.89 66.33 Favored 'Isoleucine or valine' 0 C--O 1.25 1.13 0 N-CA-C 106.611 -1.626 . . . . 38.25 106.611 178.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.05 -33.48 67.28 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 117.776 2.51 . . . . 40.77 117.776 170.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1274 ' ' SER . . . . . . . . . . . . . 41.0 m -80.39 -3.06 48.23 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 113.273 0.842 . . . . 36.58 113.273 174.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1275 ' ' MET . . . . . . . . . . . . . 16.2 mtp -69.31 158.63 34.67 Favored 'General case' 0 CA--C 1.51 -0.583 0 O-C-N 118.705 -2.497 . . . . 36.75 116.706 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1276 ' ' LYS . . . . . 0.446 ' HE3' ' NH2' ' A' 1151 ' ' ARG . 39.5 ttpt -65.21 139.65 58.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 124.343 2.021 . . . . 46.11 108.006 168.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1277 ' ' ALA . . . . . 0.628 ' HB1' ' HA ' ' B' 1045 ' ' PHE 0.253 . . -75.64 157.85 33.18 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 108.588 -3.915 . . . . 33.52 109.889 -179.37 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 73.21 24.1 76.2 Favored Glycine 0 C--N 1.347 1.167 0 N-CA-C 110.917 -0.873 . . . . 31.27 110.917 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1279 ' ' SER . . . . . 0.43 ' HB3' ' O ' ' A' 1250 ' ' ASP . 22.7 m -122.22 169.65 10.69 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.734 -0.733 . . . . 32.95 110.971 -171.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1280 ' ' VAL . . . . . 0.72 HG11 ' HA ' ' A' 1145 ' ' ALA . 42.5 t -132.11 141.92 44.16 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 N-CA-C 108.347 -0.983 . . . . 27.43 108.347 -171.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1281 ' ' ILE . . . . . 0.466 HG12 HD12 ' A' 1252 ' ' ILE . 84.9 mt -114.44 102.32 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 1 N-CA-C 99.335 -4.32 . . . . 30.3 99.335 164.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -87.91 96.44 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 CA-C-O 123.21 1.481 . . . . 28.63 107.343 172.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 4.9 t70 -87.76 100.01 12.52 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 113.989 -1.459 . . . . 36.27 110.941 -175.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1284 ' ' LEU . . . . . 0.601 HD13 HG22 ' A' 1255 ' ' THR . 5.5 tt -74.27 -34.57 63.62 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 123.664 1.697 . . . . 38.57 108.42 177.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -63.42 -13.45 40.18 Favored 'General case' 0 CA--C 1.508 -0.665 0 O-C-N 120.478 -1.389 . . . . 37.56 113.84 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . -34.19 -38.39 0.06 Allowed 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 121.674 3.953 . . . . 40.33 121.674 175.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -66.63 -22.74 66.11 Favored 'General case' 0 C--N 1.345 0.4 0 C-N-CA 118.662 -1.215 . . . . 56.85 113.88 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 30.2 t30 -142.06 86.99 2.01 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.145 -1.428 . . . . 45.86 107.145 177.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 106.16 -67.84 0.24 Allowed Glycine 0 CA--C 1.492 -1.361 0 C-N-CA 120.054 -1.07 . . . . 40.31 111.494 175.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 86.08 111.27 0.8 Allowed Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 105.769 -2.933 . . . . 38.89 105.769 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1291 ' ' ASN . . . . . 0.418 HD21 ' HB3' ' A' 1256 ' ' ALA . 27.1 m120 -70.68 -22.93 62.42 Favored 'General case' 0 C--O 1.223 -0.309 0 O-C-N 120.183 -1.775 . . . . 37.23 113.393 -171.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1292 ' ' CYS . . . . . 0.54 ' HB3' ' OG1' ' A' 1295 ' ' THR . 35.6 t -89.46 143.81 26.53 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 104.335 -2.468 . . . . 36.5 104.335 171.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1293 ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -77.14 -21.21 54.49 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 123.402 1.572 . . . . 43.32 112.425 174.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.92 10.98 12.41 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 116.958 2.207 . . . . 41.32 116.958 170.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1295 ' ' THR . . . . . 0.54 ' OG1' ' HB3' ' A' 1292 ' ' CYS . 89.9 m -68.82 113.97 6.74 Favored 'General case' 0 C--O 1.25 1.092 0 O-C-N 118.282 -2.761 . . . . 35.3 110.579 -175.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 10.4 t -84.19 116.06 63.12 Favored Pre-proline 0 N--CA 1.449 -0.505 0 N-CA-C 107.28 -1.378 . . . . 34.84 107.28 169.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.87 98.66 0.71 Allowed 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 122.866 2.377 . . . . 33.51 111.944 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 115.06 13.32 9.25 Favored Glycine 0 N--CA 1.432 -1.618 0 CA-C-N 114.316 -1.311 . . . . 32.19 112.874 170.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -159.21 168.69 25.88 Favored 'General case' 0 N--CA 1.435 -1.213 0 O-C-N 120.289 -1.712 . . . . 34.88 108.958 -174.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1300 ' ' ILE . . . . . 0.578 HD13 ' HG3' ' A' 1148 ' ' GLU . 48.4 mt -89.32 115.36 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 104.284 -2.487 . . . . 32.29 104.284 175.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 52.9 t80 -85.83 150.15 24.75 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 105.777 -1.934 . . . . 37.25 105.777 162.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1302 ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' 1307 ' ' VAL . 88.5 m -135.16 122.15 21.26 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 119.294 0.952 . . . . 35.56 109.16 174.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1303 ' ' THR . . . . . 0.422 HG21 HG12 ' A' 1272 ' ' VAL . 1.2 p -74.67 160.77 30.38 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 122.289 1.043 . . . . 36.4 111.575 173.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -68.23 -22.73 64.77 Favored 'General case' 0 C--O 1.249 1.069 0 O-C-N 120.376 -1.453 . . . . 52.32 111.747 -174.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1305 ' ' ASN . . . . . 0.875 ' HA ' ' HB2' ' B' 1046 ' ' ASP . 52.8 p-10 -75.41 -10.64 59.63 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 118.402 -0.809 . . . . 40.04 110.82 175.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 94.15 43.74 3.71 Favored Glycine 0 N--CA 1.432 -1.625 0 O-C-N 124.085 0.865 . . . . 36.96 111.5 175.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1307 ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' 1302 ' ' THR . 76.8 t -108.55 123.71 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 117.746 -1.582 . . . . 33.4 107.567 168.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1308 ' ' LYS . . . . . 0.573 ' HB2' HG22 ' A' 1280 ' ' VAL . 32.1 mmtt -86.29 98.4 10.94 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 121.878 0.847 . . . . 42.91 109.144 176.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 7.7 t -84.44 86.53 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 104.73 -2.322 . . . . 32.29 104.73 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1310 ' ' ILE . . . . . 0.657 HD11 ' HB2' ' A' 1148 ' ' GLU . 33.9 mt -81.98 92.26 2.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 113.691 -1.595 . . . . 30.99 109.582 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -85.96 53.86 4.7 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 113.452 -1.704 . . . . 28.95 113.153 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1312 ' ' TYR . . . . . 0.535 ' O ' ' HG ' ' A' 1315 ' ' LEU . 1.4 m-30 -87.67 104.61 16.69 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 125.355 2.503 . . . . 31.69 107.233 -171.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1313 ' ' THR . . . . . . . . . . . . . 33.9 p -66.26 -42.56 88.35 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 110.815 -2.902 . . . . 34.17 111.113 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -68.34 8.27 0.48 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 111.79 -2.459 . . . . 36.86 116.981 -177.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1315 ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' 1312 ' ' TYR . 96.2 mt -45.4 -39.18 9.19 Favored Pre-proline 0 N--CA 1.478 0.945 0 O-C-N 118.345 -2.722 . . . . 34.85 116.498 177.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -56.14 -46.18 32.78 Favored 'Trans proline' 0 C--O 1.247 0.95 0 C-N-CA 123.064 2.509 . . . . 29.15 113.842 168.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1317 ' ' GLY . . . . . 0.565 ' HA2' ' HG3' ' A' 1015 ' ' ARG . . . -60.35 -43.74 98.31 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-N 114.058 -1.428 . . . . 27.29 110.951 178.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1318 ' ' ARG . . . . . 0.508 ' HB3' ' CZ ' ' A' 1140 ' ' ARG . 85.3 mtt-85 -62.37 -29.17 70.28 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 122.027 0.918 . . . . 41.49 113.233 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1319 ' ' LEU . . . . . 0.708 HD13 ' HD3' ' A' 1140 ' ' ARG . 3.9 tp -108.05 68.61 0.3 Allowed Pre-proline 0 N--CA 1.439 -0.982 0 O-C-N 120.002 -1.686 . . . . 27.61 111.074 168.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1320 ' ' PRO . . . . . 0.612 ' HD2' ' HA2' ' B' 1150 ' ' GLY . 95.8 Cg_endo -62.6 -58.25 0.36 Allowed 'Trans proline' 0 CA--C 1.499 -1.233 0 C-N-CA 124.553 3.502 . . . . 25.94 111.963 -163.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1321 ' ' THR . . . . . 0.405 HG23 HG21 ' A' 1019 ' ' THR . 1.8 m -60.55 -28.88 68.78 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 120.512 1.505 . . . . 25.01 110.178 -174.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1322 ' ' GLN . . . . . 0.679 ' HB2' ' HA ' ' B' 1151 ' ' ARG . 9.4 tp60 -79.79 -33.87 40.12 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 117.618 -1.182 . . . . 29.39 110.002 -176.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1323 ' ' SER . . . . . 0.631 ' HA ' HD13 ' A' 1136 ' ' ILE . 31.6 m -57.17 -56.18 25.09 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 119.902 1.228 . . . . 26.47 108.536 165.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1324 ' ' SER . . . . . . . . . . . . . 14.9 m -65.31 -21.67 66.74 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 122.136 0.969 . . . . 27.78 113.501 -172.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -93.12 -55.41 3.34 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 115.939 -1.981 . . . . 37.53 111.138 173.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1326 ' ' LEU . . . . . 0.55 ' HB2' HD11 ' A' 1136 ' ' ILE . 93.0 mt -71.6 -56.44 5.86 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 122.193 2.27 . . . . 35.71 112.552 -178.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1327 ' ' TYR . . . . . 0.516 ' CD2' HG13 ' A' 1072 ' ' VAL . 86.0 t80 -58.71 -42.45 88.68 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 119.37 0.986 . . . . 31.59 108.933 172.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1328 ' ' GLY . . . . . 0.806 ' HA2' HD12 ' A' 1331 ' ' LEU . . . -46.21 -50.51 12.82 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-N 118.44 0.564 . . . . 28.0 112.197 169.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1329 ' ' THR . . . . . . . . . . . . . 34.6 m -71.25 -20.95 62.17 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-O 117.771 -1.109 . . . . 32.15 112.258 174.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1330 ' ' ASN . . . . . 0.417 ' OD1' ' HB2' ' A' 1132 ' ' SER . 13.7 m120 -62.18 -46.17 90.13 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 124.755 3.434 . . . . 34.36 109.73 170.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1331 ' ' LEU . . . . . 0.806 HD12 ' HA2' ' A' 1328 ' ' GLY . 15.7 mt -57.01 -52.18 66.31 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-N 113.159 -1.837 . . . . 33.37 112.689 176.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1332 ' ' VAL . . . . . 0.619 HG11 ' HB3' ' A' 1025 ' ' GLN . 45.6 t -63.5 -42.25 95.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 105.388 -2.078 . . . . 35.27 105.388 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1333 ' ' ASN . . . . . 0.499 ' HA ' ' HD2' ' A' 1336 ' ' LYS . 92.1 m-20 -59.81 -37.08 78.14 Favored 'General case' 0 CA--C 1.504 -0.794 0 O-C-N 119.534 -1.979 . . . . 37.66 113.562 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1334 ' ' LEU . . . . . 0.558 HD22 ' SD ' ' A' 1115 ' ' MET . 43.1 tp -60.03 -52.96 63.14 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.289 -0.634 . . . . 40.27 109.289 165.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1335 ' ' LEU . . . . . 0.511 HD23 HD22 ' A' 1338 ' ' LEU . 19.0 mt -63.8 -18.15 63.81 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 115.308 1.596 . . . . 42.5 115.308 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1336 ' ' LYS . . . . . 0.499 ' HD2' ' HA ' ' A' 1333 ' ' ASN . 78.8 mttt -69.36 -36.38 76.79 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 120.341 -1.474 . . . . 47.81 109.198 172.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1337 ' ' LEU . . . . . . . . . . . . . 10.2 mp -70.33 -40.33 74.2 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 122.864 1.316 . . . . 49.27 111.831 170.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1338 ' ' LEU . . . . . 0.511 HD22 HD23 ' A' 1335 ' ' LEU . 3.1 mp -67.83 -47.6 68.54 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 116.793 2.146 . . . . 50.54 116.793 -177.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1339 ' ' CYS . . . . . 0.493 ' SG ' ' HA2' ' A' 1344 ' ' GLY . 41.1 t -83.21 100.31 10.5 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 102.639 -3.097 . . . . 53.67 102.639 175.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 28.5 mtpt -84.04 -70.37 0.57 Allowed 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 118.878 -2.389 . . . . 63.38 111.883 -177.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1341 ' ' GLU . . . . . 0.542 ' HB2' ' HB3' ' A' 1343 ' ' ASP . 4.3 mp0 -72.7 -15.35 61.69 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.25 0.833 . . . . 70.95 113.25 -171.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1342 ' ' LYS . . . . . 0.57 ' HA ' ' H ' ' A' 1344 ' ' GLY . 9.3 mtpm? 49.11 58.11 5.73 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 116.892 -1.528 . . . . 65.25 111.77 -173.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1343 ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' A' 1341 ' ' GLU 0.404 0.0 OUTLIER 63.72 -78.04 0.03 OUTLIER 'General case' 0 C--N 1.356 0.874 2 O-C-N 113.242 -5.911 . . . . 64.53 114.817 21.309 . . . . . . . . 5 4 . 1 . 003 nuclear nobuild core ' A' A 1344 ' ' GLY . . . . . 0.57 ' H ' ' HA ' ' A' 1342 ' ' LYS . . . 71.58 52.04 14.05 Favored Glycine 0 C--O 1.217 -0.952 0 CA-C-N 120.908 1.685 . . . . 59.72 111.607 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 44.3 t30 -146.73 155.08 42.13 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 119.799 1.799 . . . . 64.09 106.663 172.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1346 ' ' ILE . . . . . . . . . . . . . 34.4 mt -88.94 124.05 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 CA-C-O 124.48 2.086 . . . . 58.82 112.121 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1347 ' ' THR . . . . . . . . . . . . . 33.7 m -100.63 109.54 21.61 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 110.392 -3.095 . . . . 54.96 107.683 167.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1348 ' ' VAL . . . . . . . . . . . . . 34.4 t -85.19 82.39 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 N-CA-C 106.173 -1.788 . . . . 55.64 106.173 176.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 24.2 t0 -78.36 106.25 10.16 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 112.766 -2.015 . . . . 61.45 115.449 -175.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -82.66 -13.07 57.09 Favored 'General case' 0 C--O 1.246 0.921 0 CA-C-N 112.472 -2.149 . . . . 58.63 112.751 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -65.12 -47.14 78.21 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 120.904 -1.122 . . . . 62.06 109.73 172.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 10.3 t70 -65.44 108.71 2.06 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 123.271 1.51 . . . . 54.07 108.994 174.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 22.1 m -43.82 -37.24 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.765 0 N-CA-C 117.614 2.449 . . . . 50.68 117.614 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1354 ' ' VAL . . . . . 0.806 HG11 ' HB2' ' A' 1124 ' ' ALA 0.261 5.4 m -79.72 -43.75 23.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-O 118.099 -0.953 . . . . 47.68 110.374 179.61 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 1355 ' ' ILE . . . . . . . . . . . . . 80.4 mt -60.76 -45.1 98.39 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 121.58 1.991 . . . . 48.49 109.612 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 40.7 tpt85 -43.23 -50.52 6.43 Favored 'General case' 0 C--O 1.249 1.069 0 N-CA-C 115.986 1.847 . . . . 48.27 115.986 163.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -61.15 -50.71 64.29 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.86 -0.967 . . . . 43.53 112.834 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1358 ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' 1354 ' ' VAL . 21.2 t -60.58 -49.38 84.66 Favored 'Isoleucine or valine' 0 C--O 1.249 1.059 0 N-CA-C 106.202 -1.777 . . . . 45.12 106.202 -173.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1359 ' ' THR . . . . . . . . . . . . . 6.0 m -69.01 87.84 0.38 Allowed 'General case' 0 C--N 1.313 -0.98 0 O-C-N 120.581 -1.325 . . . . 42.94 108.626 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 30.9 m -77.68 -23.74 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 CA-C-N 114.865 -1.061 . . . . 43.26 110.971 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1361 ' ' ILE . . . . . 0.494 HG12 HG12 ' A' 1366 ' ' ILE . 73.4 mt -135.58 119.02 23.91 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 N-CA-C 105.567 -2.012 . . . . 45.66 105.567 172.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1362 ' ' ARG . . . . . 0.415 ' HA ' HG23 ' A' 1111 ' ' THR . 33.3 ttt180 -100.65 110.3 22.42 Favored 'General case' 0 C--O 1.219 -0.525 0 O-C-N 119.172 -2.205 . . . . 61.34 106.584 167.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 31.87 79.0 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 O-C-N 126.388 2.305 . . . . 49.76 112.135 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 83.25 -40.54 2.84 Favored Glycine 0 CA--C 1.521 0.457 0 CA-C-O 118.59 -1.116 . . . . 50.0 112.645 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -77.05 111.0 12.16 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 105.87 -1.9 . . . . 56.92 105.87 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1366 ' ' ILE . . . . . 0.494 HG12 HG12 ' A' 1361 ' ' ILE . 66.0 mt -70.11 106.53 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 104.406 -2.442 . . . . 52.78 104.406 173.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1367 ' ' THR . . . . . . . . . . . . . 2.0 p -88.41 -4.9 58.56 Favored 'General case' 0 CA--C 1.496 -1.124 0 N-CA-C 114.901 1.445 . . . . 49.44 114.901 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 1.7 t90 -70.73 148.62 95.0 Favored Pre-proline 0 C--O 1.248 1.016 0 N-CA-C 106.701 -1.592 . . . . 52.38 106.701 166.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -65.43 156.07 77.89 Favored 'Cis proline' 0 CA--C 1.498 -1.321 0 CA-C-N 124.96 2.807 . . . . 46.94 116.32 -7.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -112.04 151.84 43.88 Favored Pre-proline 0 N--CA 1.442 -0.858 0 CA-C-N 113.342 -1.754 . . . . 45.91 110.195 -175.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1371 ' ' PRO . . . . . 0.463 ' HA ' ' HD3' ' A' 1372 ' ' PRO . 18.5 Cg_exo -57.25 145.02 89.21 Favored 'Trans proline' 0 C--O 1.248 1.007 0 C-N-CA 122.789 2.326 . . . . 46.39 117.643 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1372 ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' 1371 ' ' PRO . 51.5 Cg_exo -67.48 -20.45 47.78 Favored 'Trans proline' 0 CA--C 1.539 0.742 1 C-N-CA 125.345 4.03 . . . . 46.72 112.435 171.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.22 -5.055 0 CA-C-N 122.539 2.427 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 35.8 m80 . . . . . 0 N--CA 1.467 0.382 0 N-CA-C 107.738 -1.208 . . . . 63.44 107.738 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 999' ' ' HIS . . . . . 0.498 ' HB3' ' HB2' ' B' 1002 ' ' ARG . 98.8 m-70 -73.54 74.53 1.46 Allowed 'General case' 0 C--O 1.242 0.673 0 CA-C-O 124.37 2.033 . . . . 51.74 115.041 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1000 ' ' HIS . . . . . . . . . . . . . 63.9 t60 -72.62 128.45 35.6 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 114.499 -1.228 . . . . 54.07 108.573 -174.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 68.34 15.76 68.36 Favored Glycine 0 CA--C 1.506 -0.498 0 O-C-N 120.076 -1.64 . . . . 39.22 115.328 -172.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1002 ' ' ARG . . . . . 0.498 ' HB2' ' HB3' ' B' ' 999' ' ' HIS . 30.5 ttp180 -89.06 129.37 35.7 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 119.833 1.816 . . . . 38.12 108.557 176.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1003 ' ' ILE . . . . . 0.643 HG12 ' HB ' ' B' 1068 ' ' ILE . 19.6 mt -84.48 134.78 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-N 111.28 -2.691 . . . . 29.7 105.611 166.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1004 ' ' GLY . . . . . 0.417 ' O ' ' HD3' ' B' 1006 ' ' PRO . . . -114.84 125.65 6.87 Favored Glycine 0 CA--C 1.503 -0.701 0 N-CA-C 106.556 -2.617 . . . . 27.5 106.556 166.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1005 ' ' ILE . . . . . 0.476 HD12 ' HB3' ' B' 1017 ' ' ALA . 27.5 mm -99.4 105.42 33.06 Favored Pre-proline 0 N--CA 1.426 -1.646 0 N-CA-C 104.94 -2.244 . . . . 24.83 104.94 173.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1006 ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' B' 1004 ' ' GLY . 52.9 Cg_exo -74.76 145.69 32.75 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 C-N-CA 123.905 3.07 . . . . 27.19 108.977 173.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1007 ' ' ARG . . . . . 0.404 ' HD2' ' O ' ' B' 1037 ' ' SER . 73.1 ttt180 -74.47 113.16 11.39 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 109.198 -3.637 . . . . 41.46 104.127 171.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1008 ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -40.9 145.36 0.21 Allowed 'General case' 0 C--O 1.247 0.934 0 N-CA-C 120.015 3.339 . . . . 26.93 120.015 175.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1009 ' ' ARG . . . . . 0.446 ' HG3' HH11 ' B' 1009 ' ' ARG . 14.3 mmm-85 -120.27 -10.13 9.4 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-N 112.636 -2.075 . . . . 34.48 111.522 -175.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1010 ' ' LEU . . . . . . . . . . . . . 4.5 tp -64.7 143.52 57.87 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 122.098 0.951 . . . . 44.22 113.002 174.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1011 ' ' THR . . . . . . . . . . . . . 3.6 m -66.7 134.33 52.01 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 108.187 -1.042 . . . . 40.74 108.187 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 49.8 t30 51.21 53.42 12.97 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 115.948 1.832 . . . . 44.44 115.948 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1013 ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -136.67 116.48 13.11 Favored 'General case' 0 C--O 1.252 1.207 0 CA-C-N 114.245 -1.343 . . . . 29.87 108.965 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1014 ' ' THR . . . . . 0.589 ' HA ' HD22 ' B' 1042 ' ' LEU . 0.9 OUTLIER -111.99 -0.65 15.66 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.281 -0.872 . . . . 25.26 112.186 174.522 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B 1015 ' ' ARG . . . . . 0.695 ' HG3' ' HA2' ' B' 1317 ' ' GLY . 65.2 mtm180 -69.07 141.32 54.79 Favored 'General case' 0 C--O 1.248 0.995 0 N-CA-C 105.857 -1.905 . . . . 29.54 105.857 173.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1016 ' ' VAL . . . . . 0.782 HG21 ' HB1' ' B' 1039 ' ' ALA . 11.6 p -139.36 -173.62 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 104.7 -2.333 . . . . 23.55 104.7 171.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1017 ' ' ALA . . . . . 0.476 ' HB3' HD12 ' B' 1005 ' ' ILE . . . -110.0 0.67 18.6 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 118.992 -2.318 . . . . 23.59 113.636 175.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1018 ' ' ALA . . . . . . . . . . . . . . . -88.4 128.71 35.52 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 118.671 -0.681 . . . . 24.93 111.481 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1019 ' ' THR . . . . . 0.403 ' O ' ' HB ' ' B' 1022 ' ' THR . 0.0 OUTLIER -156.34 148.05 17.12 Favored Pre-proline 0 N--CA 1.442 -0.835 0 N-CA-C 105.682 -1.97 . . . . 28.09 105.682 171.055 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -61.96 -54.04 1.75 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 124.549 3.499 . . . . 28.79 112.981 -174.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1021 ' ' LYS . . . . . 0.548 ' O ' ' HG3' ' B' 1025 ' ' GLN . 77.9 tttt -49.49 -48.95 47.54 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 121.289 1.859 . . . . 47.28 108.874 176.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1022 ' ' THR . . . . . 0.403 ' HB ' ' O ' ' B' 1019 ' ' THR . 39.5 m -49.86 -54.27 20.49 Favored 'General case' 0 C--O 1.203 -1.373 0 C-N-CA 125.63 1.572 . . . . 30.12 111.842 174.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1023 ' ' VAL . . . . . 0.653 HG22 HG11 ' B' 1033 ' ' VAL . 54.0 t -60.63 -37.97 77.07 Favored 'Isoleucine or valine' 0 C--N 1.352 0.691 0 CA-C-N 120.702 1.592 . . . . 32.24 108.078 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1024 ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -67.9 -44.86 75.97 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 121.205 1.821 . . . . 49.62 111.401 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1025 ' ' GLN . . . . . 0.737 HE22 HG23 ' B' 1329 ' ' THR . 46.2 mt-30 -58.43 -45.99 87.41 Favored 'General case' 0 N--CA 1.44 -0.959 0 O-C-N 125.457 1.723 . . . . 44.68 108.203 176.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 95.4 mt -63.39 -45.38 91.35 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 118.867 -0.587 . . . . 35.71 109.727 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1027 ' ' LEU . . . . . . . . . . . . . 27.2 mt -60.71 -35.19 75.69 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 118.894 0.77 . . . . 42.18 111.302 173.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 19.3 mttm -72.46 -30.11 64.28 Favored 'General case' 0 C--O 1.239 0.526 0 O-C-N 120.219 -1.551 . . . . 48.34 109.38 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1029 ' ' LEU . . . . . . . . . . . . . 87.3 mt -74.79 -21.03 59.54 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 118.249 -2.782 . . . . 38.69 109.604 169.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 101.22 18.47 19.35 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 117.935 -2.978 . . . . 32.28 110.327 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -98.08 118.48 34.79 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 106.432 -1.692 . . . . 35.94 106.432 170.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1032 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.12 139.94 57.53 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 111.598 -2.546 . . . . 33.37 111.156 171.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1033 ' ' VAL . . . . . 0.653 HG11 HG22 ' B' 1023 ' ' VAL . 6.7 t -114.0 130.92 67.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.704 0 CA-C-N 121.162 1.801 . . . . 29.98 106.931 -174.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1034 ' ' ALA . . . . . 0.493 ' HB2' ' HD2' ' B' 1002 ' ' ARG . . . -123.59 135.98 54.27 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 104.901 -2.259 . . . . 28.18 104.901 166.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1035 ' ' VAL . . . . . . . . . . . . . 46.7 t -121.72 143.43 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 103.678 -2.712 . . . . 25.82 103.678 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1036 ' ' GLU . . . . . 0.518 ' HG3' ' HA2' ' B' 1060 ' ' GLY . 78.4 tt0 -79.68 137.85 37.19 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 120.038 -1.664 . . . . 32.44 110.978 173.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1037 ' ' SER . . . . . 0.404 ' O ' ' HD2' ' B' 1007 ' ' ARG . 16.5 m -52.68 115.72 1.94 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 127.081 2.152 . . . . 29.54 109.958 177.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 115.12 -19.17 15.44 Favored Glycine 0 N--CA 1.423 -2.221 0 CA-C-O 119.382 -0.677 . . . . 27.76 113.381 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1039 ' ' ALA . . . . . 0.782 ' HB1' HG21 ' B' 1016 ' ' VAL . . . -67.0 -28.87 68.6 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 120.511 -0.475 . . . . 26.02 110.266 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -56.81 -55.18 31.43 Favored Glycine 0 C--O 1.246 0.886 0 N-CA-C 110.612 -0.995 . . . . 26.47 110.612 164.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1041 ' ' GLN . . . . . 0.511 ' NE2' ' HA ' ' B' 1046 ' ' ASP . 3.4 mp0 -53.24 -39.81 64.1 Favored 'General case' 0 C--O 1.25 1.095 0 O-C-N 120.463 -1.61 . . . . 50.98 114.32 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1042 ' ' LEU . . . . . 0.589 HD22 ' HA ' ' B' 1014 ' ' THR . 31.3 mt -52.84 -54.62 31.69 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 116.86 2.17 . . . . 29.3 116.86 163.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1043 ' ' ALA . . . . . . . . . . . . . . . -71.41 17.8 0.08 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 117.856 2.539 . . . . 26.74 117.856 172.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1044 ' ' SER . . . . . . . . . . . . . 6.7 m 52.57 41.91 31.26 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 125.187 2.422 . . . . 31.26 111.396 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1045 ' ' PHE . . . . . 0.628 ' HA ' ' HB1' ' A' 1277 ' ' ALA . 1.1 m-85 -127.96 167.3 16.85 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 111.62 -2.536 . . . . 33.26 107.124 -175.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1046 ' ' ASP . . . . . 0.875 ' HB2' ' HA ' ' A' 1305 ' ' ASN . 40.6 t0 -97.15 138.53 34.52 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 117.524 -1.671 . . . . 46.74 107.359 150.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -50.07 -36.3 28.73 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 126.887 2.617 . . . . 34.44 111.892 171.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -35.38 -44.05 0.27 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 116.323 1.972 . . . . 48.67 116.323 165.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -64.24 -27.91 69.37 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 120.205 -1.56 . . . . 35.26 112.988 177.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1050 ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -75.39 -38.75 59.77 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 117.276 -1.345 . . . . 32.17 109.196 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1051 ' ' VAL . . . . . 0.415 HG22 HG12 ' B' 1057 ' ' ILE . 8.3 t -53.44 -50.77 46.91 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 N-CA-C 107.884 -1.154 . . . . 38.37 107.884 171.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -53.53 -34.9 59.88 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 124.069 0.948 . . . . 45.77 112.736 175.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -80.31 -21.7 42.31 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.17 0.895 . . . . 37.83 111.858 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 128.26 20.78 1.56 Allowed Glycine 0 CA--C 1.519 0.304 0 O-C-N 119.658 -1.901 . . . . 35.82 109.571 170.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -100.41 140.71 34.27 Favored 'General case' 0 N--CA 1.435 -1.177 0 O-C-N 119.159 -2.377 . . . . 33.77 112.026 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -76.56 130.03 37.31 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.647 1.579 . . . . 51.02 108.545 171.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1057 ' ' ILE . . . . . 0.415 HG12 HG22 ' B' 1051 ' ' VAL . 35.7 mm -97.92 129.84 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 106.188 -1.782 . . . . 38.47 106.188 168.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 6.6 m -111.21 153.72 12.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 125.337 1.455 . . . . 39.4 108.048 169.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.13 -48.97 71.7 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 120.491 -1.381 . . . . 57.07 114.57 -175.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1060 ' ' GLY . . . . . 0.518 ' HA2' ' HG3' ' B' 1036 ' ' GLU . . . -155.83 -110.79 0.35 Allowed Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.076 -1.059 . . . . 44.83 111.018 -176.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1061 ' ' ASN . . . . . 0.573 ' HA ' ' HD1' ' B' 1064 ' ' TRP . 2.5 m120 -58.27 -25.53 61.89 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 126.385 1.874 . . . . 46.27 115.685 -170.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1062 ' ' SER . . . . . . . . . . . . . 16.4 m -48.4 -28.19 3.08 Favored 'General case' 0 C--N 1.317 -0.81 0 O-C-N 120.731 -1.231 . . . . 43.47 112.999 165.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 1.3 p -59.04 -28.32 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 O-C-N 120.108 -1.62 . . . . 36.98 115.233 171.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1064 ' ' TRP . . . . . 0.573 ' HD1' ' HA ' ' B' 1061 ' ' ASN . 92.4 m95 -74.53 -18.65 60.57 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 122.921 0.488 . . . . 37.9 111.933 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -83.15 66.83 8.91 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 107.966 -1.124 . . . . 46.19 107.966 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1066 ' ' SER . . . . . 0.406 ' HB3' ' O ' ' B' 1002 ' ' ARG . 28.2 m -155.29 148.15 24.42 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 103.923 -2.621 . . . . 37.06 103.923 -172.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1067 ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -82.51 -15.33 52.81 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 115.844 1.794 . . . . 43.95 115.844 -172.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1068 ' ' ILE . . . . . 0.643 ' HB ' HG12 ' B' 1003 ' ' ILE . 1.4 mp -124.54 116.28 47.04 Favored 'Isoleucine or valine' 0 C--O 1.253 1.238 0 N-CA-C 103.129 -2.915 . . . . 33.5 103.129 177.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 26.0 mm -106.42 115.14 47.4 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 N-CA-C 106.733 -1.58 . . . . 30.57 106.733 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1070 ' ' LEU . . . . . 0.945 HD13 HD13 ' B' 1331 ' ' LEU . 85.3 mt -106.85 78.69 1.26 Allowed 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 115.224 -0.898 . . . . 27.66 111.229 -175.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1071 ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -80.75 166.64 20.81 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.836 -0.62 . . . . 28.4 110.749 171.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1072 ' ' VAL . . . . . 0.471 HG11 ' HB2' ' B' 1015 ' ' ARG . 8.9 t -91.51 -84.92 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 104.231 -2.507 . . . . 23.18 104.231 169.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -101.78 -170.49 1.83 Allowed 'General case' 0 C--N 1.312 -1.034 0 O-C-N 118.434 -2.666 . . . . 25.47 111.913 -170.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1074 ' ' ALA . . . . . 0.5 ' HA ' ' HD2' ' B' 1075 ' ' PRO . . . -33.93 125.51 0.47 Allowed Pre-proline 0 CA--C 1.554 1.109 0 N-CA-C 118.157 2.651 . . . . 27.9 118.157 -172.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1075 ' ' PRO . . . . . 0.5 ' HD2' ' HA ' ' B' 1074 ' ' ALA . 40.3 Cg_endo -68.48 126.89 14.79 Favored 'Trans proline' 0 N--CA 1.434 -2.009 0 C-N-CA 123.319 2.679 . . . . 31.62 111.474 166.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 45.2 mt -76.15 160.56 29.62 Favored 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 120.437 -1.414 . . . . 40.49 107.582 168.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.76 -35.5 43.88 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 117.358 2.355 . . . . 51.59 117.358 -174.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -63.97 -42.37 97.27 Favored 'General case' 0 C--O 1.208 -1.091 0 CA-C-O 118.972 -0.537 . . . . 42.36 111.004 172.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1079 ' ' GLU . . . . . 0.631 ' HA ' HD12 ' B' 1082 ' ' LEU . 20.2 mt-10 -66.57 -35.74 80.96 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 125.586 1.804 . . . . 34.53 108.917 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1080 ' ' ILE . . . . . 0.458 HG13 ' HB2' ' B' 1075 ' ' PRO . 63.3 mt -61.79 -51.8 68.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 125.983 2.052 . . . . 33.25 105.766 173.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -59.03 -29.4 67.25 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 120.969 1.713 . . . . 36.47 112.005 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1082 ' ' LEU . . . . . 0.631 HD12 ' HA ' ' B' 1079 ' ' GLU . 10.2 mt -71.74 -28.06 63.41 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.353 1.242 . . . . 37.76 114.353 177.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1083 ' ' LEU . . . . . . . . . . . . . 33.9 mt -64.45 112.97 3.36 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 118.594 -1.242 . . . . 37.43 109.204 -175.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -71.12 139.42 84.98 Favored Pre-proline 0 C--O 1.254 1.306 0 CA-C-N 115.149 -0.932 . . . . 37.7 109.435 167.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1085 ' ' PRO . . . . . 0.729 ' HB3' ' HB2' ' B' 1109 ' ' ASN . 35.1 Cg_exo -55.47 151.92 35.42 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.878 2.385 . . . . 35.51 116.379 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 74.79 -8.72 13.62 Favored Glycine 0 N--CA 1.445 -0.754 0 O-C-N 120.16 -1.587 . . . . 33.87 115.981 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1087 ' ' THR . . . . . . . . . . . . . 89.2 m -71.89 139.55 48.85 Favored 'General case' 0 C--O 1.261 1.688 0 O-C-N 119.608 -2.113 . . . . 32.5 108.062 178.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1088 ' ' THR . . . . . 0.545 ' HA ' ' HB ' ' B' 1111 ' ' THR . 0.2 OUTLIER -81.53 97.09 7.66 Favored 'General case' 0 C--O 1.255 1.387 0 N-CA-C 106.591 -1.633 . . . . 30.22 106.591 -173.613 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B 1089 ' ' LEU . . . . . . . . . . . . . 31.3 tp -91.77 101.21 13.81 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 122.167 0.984 . . . . 27.24 111.214 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1090 ' ' VAL . . . . . 0.644 HG13 ' HB2' ' B' 1113 ' ' MET . 11.7 t -104.11 107.35 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 111.089 -2.778 . . . . 25.39 109.795 -175.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1091 ' ' SER . . . . . . . . . . . . . 13.1 m -163.48 168.14 20.58 Favored 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 117.087 -3.508 . . . . 28.81 113.308 -170.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1092 ' ' PHE . . . . . 0.662 ' HD1' ' HB3' ' B' 1116 ' ' ASP . 68.6 m-85 -65.22 91.71 0.11 Allowed 'General case' 0 C--O 1.278 2.602 0 CA-C-O 124.212 1.958 . . . . 30.78 110.183 168.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 36.8 mm -89.9 -32.25 5.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 O-C-N 120.631 -1.293 . . . . 30.28 111.178 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1094 ' ' TRP . . . . . 0.555 ' HB2' ' ND2' ' B' 1098 ' ' ASN . 67.6 m95 57.92 55.83 6.77 Favored Pre-proline 0 C--O 1.247 0.965 0 CA-C-N 114.823 -1.08 . . . . 34.07 112.021 -175.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -49.97 -34.89 39.18 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 124.952 3.768 . . . . 38.66 113.409 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -56.37 -56.15 24.73 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 120.841 -1.162 . . . . 41.32 110.776 169.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -78.94 -22.68 45.39 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 113.951 1.093 . . . . 51.66 113.951 -174.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1098 ' ' ASN . . . . . 0.555 ' ND2' ' HB2' ' B' 1094 ' ' TRP . 75.9 m-20 -130.22 81.1 69.34 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 119.934 1.243 . . . . 40.32 111.02 -164.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -64.17 -48.93 4.19 Favored 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 120.987 1.124 . . . . 41.56 114.561 176.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -61.93 -35.87 79.7 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.399 -0.964 . . . . 54.11 108.399 -175.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1101 ' ' LEU . . . . . . . . . . . . . 17.0 tp -60.43 -47.17 87.27 Favored 'General case' 0 CA--C 1.515 -0.386 0 O-C-N 120.703 -1.248 . . . . 37.88 110.116 175.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1102 ' ' MET . . . . . . . . . . . . . 73.2 mmm -57.82 -38.62 75.91 Favored 'General case' 0 C--O 1.238 0.45 0 O-C-N 121.116 -0.99 . . . . 37.54 113.196 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -64.21 -45.77 86.82 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.869 -1.06 . . . . 47.01 113.398 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1104 ' ' LYS . . . . . 0.478 ' O ' ' HG2' ' B' 1108 ' ' ARG . 54.1 mttm -65.98 -35.26 80.1 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.506 -0.77 . . . . 48.68 110.264 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1105 ' ' LEU . . . . . . . . . . . . . 50.2 mt -72.86 -29.5 63.25 Favored 'General case' 0 C--O 1.269 2.127 0 O-C-N 120.546 -1.346 . . . . 32.21 112.583 177.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -61.63 -49.55 76.1 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 124.648 1.179 . . . . 33.73 108.098 172.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -54.1 -40.56 67.41 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 122.753 0.421 . . . . 51.47 111.702 172.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1108 ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' B' 1104 ' ' LYS . 20.6 mmm180 -72.97 -9.92 59.25 Favored 'General case' 0 C--O 1.213 -0.847 0 O-C-N 120.241 -1.537 . . . . 43.9 113.617 177.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1109 ' ' ASN . . . . . 0.729 ' HB2' ' HB3' ' B' 1085 ' ' PRO . 8.9 m120 62.93 30.83 16.46 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.556 1.142 . . . . 44.82 110.637 172.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1110 ' ' VAL . . . . . . . . . . . . . 2.7 m -92.76 155.0 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 O-C-N 120.557 -1.34 . . . . 30.52 112.404 -172.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1111 ' ' THR . . . . . 0.545 ' HB ' ' HA ' ' B' 1088 ' ' THR . 1.2 m -82.75 92.26 7.18 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 105.883 -1.895 . . . . 27.12 105.883 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1112 ' ' VAL . . . . . 0.441 ' HB ' ' HB ' ' B' 1361 ' ' ILE . 39.9 t -88.27 121.72 38.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 O-C-N 120.322 -1.486 . . . . 26.4 110.58 -173.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1113 ' ' MET . . . . . 0.644 ' HB2' HG13 ' B' 1090 ' ' VAL . 21.0 mtp -115.95 116.72 28.44 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 104.904 -2.258 . . . . 42.92 104.904 177.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -96.19 107.83 20.22 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 117.34 -1.744 . . . . 24.15 110.893 -172.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1115 ' ' MET . . . . . 0.476 ' HB3' ' HB2' ' B' 1129 ' ' ALA . 83.5 mmm -55.16 -26.88 41.64 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 116.543 2.053 . . . . 29.95 116.543 -176.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1116 ' ' ASP . . . . . 0.662 ' HB3' ' HD1' ' B' 1092 ' ' PHE . 6.9 p-10 -86.54 -39.84 15.82 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.117 -1.856 . . . . 34.53 110.946 177.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1117 ' ' SER . . . . . . . . . . . . . 49.9 m -99.16 31.8 2.93 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-O 123.966 1.841 . . . . 33.49 111.409 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1118 ' ' VAL . . . . . 0.766 HG22 HG23 ' B' 1358 ' ' VAL . 22.0 t -64.16 119.33 54.79 Favored Pre-proline 0 C--O 1.243 0.727 0 N-CA-C 102.402 -3.185 . . . . 34.02 102.402 151.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1119 ' ' PRO . . . . . 0.574 ' HB2' HG12 ' B' 1121 ' ' ILE . 73.1 Cg_exo -62.67 159.64 36.11 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 123.0 2.467 . . . . 38.28 113.047 -176.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1120 ' ' ARG . . . . . 0.787 ' HB2' HG13 ' B' 1375 ' ' VAL . 1.9 mmp_? -77.37 50.53 0.79 Allowed 'General case' 0 C--N 1.354 0.776 0 CA-C-O 122.099 0.952 . . . . 55.05 109.826 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1121 ' ' ILE . . . . . 0.574 HG12 ' HB2' ' B' 1119 ' ' PRO . 39.0 pt -119.21 143.96 28.98 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.844 0 O-C-N 121.232 -0.918 . . . . 42.09 110.042 -169.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1122 ' ' SER . . . . . . . . . . . . . 53.6 p -9.08 -88.82 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 120.479 3.511 . . . . 38.02 120.479 -176.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1123 ' ' ARG . . . . . 0.643 ' HA ' ' HD3' ' C' ' 134' ' ' PRO 0.254 18.7 ptt180 -71.5 -30.12 65.58 Favored 'General case' 0 C--N 1.357 0.892 0 CA-C-N 121.194 1.815 . . . . 34.29 114.502 178.669 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B 1124 ' ' ALA . . . . . 0.562 ' HB2' HG13 ' B' 1354 ' ' VAL . . . -58.83 -34.4 71.51 Favored 'General case' 0 C--O 1.219 -0.525 0 O-C-N 124.056 0.847 . . . . 32.35 109.851 -177.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1125 ' ' GLN . . . . . 0.401 ' NE2' ' HB3' ' B' 1131 ' ' SER . 0.0 OUTLIER -59.2 -9.06 1.86 Allowed 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 117.473 2.397 . . . . 47.17 117.473 176.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B 1126 ' ' SER . . . . . 0.54 ' HA ' ' HB1' ' A' 1159 ' ' ALA . 22.9 p -90.9 -32.95 15.81 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.863 1.211 . . . . 31.71 112.687 169.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1127 ' ' LEU . . . . . 0.601 ' HG ' ' HA ' ' B' 1334 ' ' LEU . 4.1 mp -71.36 -30.06 65.71 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 111.726 -2.488 . . . . 37.0 110.71 175.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1128 ' ' ASP . . . . . 0.402 ' CG ' HH12 ' B' 1120 ' ' ARG . 9.9 t70 -62.56 127.36 30.92 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 115.694 1.738 . . . . 40.4 115.694 -176.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1129 ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' B' 1115 ' ' MET . . . -70.06 -38.02 75.65 Favored 'General case' 0 C--O 1.212 -0.869 0 CA-C-N 113.746 -1.57 . . . . 26.56 108.1 177.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 36.2 mt -66.79 -13.85 61.96 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 115.039 1.496 . . . . 30.89 115.039 -174.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1131 ' ' SER . . . . . 0.401 ' HB3' ' NE2' ' B' 1125 ' ' GLN . 66.5 p -69.24 -56.17 8.37 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 105.507 -2.035 . . . . 29.84 105.507 167.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1132 ' ' SER . . . . . . . . . . . . . 67.5 m -55.05 -55.64 28.74 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 124.332 1.053 . . . . 31.91 113.616 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1133 ' ' MET . . . . . . . . . . . . . 32.2 mmt -54.32 -45.1 72.54 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.463 0.705 . . . . 25.9 111.757 176.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1134 ' ' ALA . . . . . 0.436 ' HB1' ' N ' ' B' 1176 ' ' ALA . . . -56.64 -52.57 64.38 Favored 'General case' 0 C--O 1.209 -1.049 0 C-N-CA 119.477 -0.889 . . . . 26.62 112.898 170.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1135 ' ' ASN . . . . . 0.484 ' HA ' ' HB2' ' B' 1179 ' ' ALA . 0.1 OUTLIER -53.66 -33.41 55.18 Favored 'General case' 0 C--O 1.22 -0.491 0 O-C-N 120.807 -1.183 . . . . 36.97 113.809 174.162 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B 1136 ' ' ILE . . . . . 0.464 HG21 ' HA ' ' B' 1316 ' ' PRO . 37.2 mm -68.96 -54.66 19.07 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 N-CA-C 107.255 -1.387 . . . . 32.11 107.255 175.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -59.53 -30.09 68.35 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 117.087 -1.435 . . . . 24.14 111.95 -171.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -66.49 -58.05 9.21 Favored Glycine 0 N--CA 1.47 0.912 0 CA-C-N 119.27 0.941 . . . . 25.13 111.562 174.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 21.0 t80 -58.88 -49.32 78.2 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.232 -1.025 . . . . 32.73 108.232 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1140 ' ' ARG . . . . . 0.4 ' HA ' ' HB ' ' B' 1143 ' ' VAL . 12.6 tpt180 -63.49 -28.95 70.31 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-O 117.806 -1.092 . . . . 26.36 108.94 -178.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1141 ' ' ALA . . . . . 0.462 ' HA ' HG11 ' B' 1282 ' ' VAL . . . -62.2 -47.92 82.32 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 122.412 2.369 . . . . 24.12 108.809 173.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 45.7 mm -60.92 -39.36 81.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.281 1.432 . . . . 23.37 109.298 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1143 ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' B' 1140 ' ' ARG . 40.6 t -63.84 -57.72 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 124.728 1.211 . . . . 24.96 111.931 176.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -63.6 -37.94 89.25 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 119.819 -1.801 . . . . 32.07 110.991 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1145 ' ' ALA . . . . . 0.772 ' HB1' HD12 ' B' 1251 ' ' ILE . . . -53.35 -51.63 61.84 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 122.432 1.111 . . . . 24.87 113.743 170.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1146 ' ' ALA . . . . . 0.685 ' HB2' ' HE1' ' B' 1153 ' ' PHE . . . -59.15 -37.14 76.6 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 113.835 -1.53 . . . . 24.67 114.677 177.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 42.5 t60 -60.79 -22.9 64.58 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.867 1.267 . . . . 28.58 111.692 177.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1148 ' ' GLU . . . . . 0.784 ' HB3' ' HD2' ' B' 1308 ' ' LYS . 60.9 mm-40 -127.81 16.24 6.89 Favored 'General case' 0 N--CA 1.442 -0.867 0 O-C-N 119.666 -1.896 . . . . 36.82 113.625 173.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1149 ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -77.65 155.93 31.08 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 122.563 1.173 . . . . 31.97 108.621 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1150 ' ' GLY . . . . . 0.612 ' HA2' ' HD2' ' A' 1320 ' ' PRO . . . -88.72 -23.72 35.16 Favored Glycine 0 C--O 1.208 -1.507 0 O-C-N 120.146 -1.596 . . . . 25.49 111.668 176.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1151 ' ' ARG . . . . . 0.679 ' HA ' ' HB2' ' A' 1322 ' ' GLN . 71.3 mtm-85 -131.62 179.98 5.73 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.614 1.166 . . . . 59.84 112.644 -162.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1152 ' ' PHE . . . . . 0.713 ' HB2' HG11 ' B' 1163 ' ' VAL . 5.9 m-30 -83.14 163.16 21.02 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 120.941 1.7 . . . . 34.45 111.177 171.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1153 ' ' PHE . . . . . 0.685 ' HE1' ' HB2' ' B' 1146 ' ' ALA . 46.1 m-85 -85.6 -48.68 8.67 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 112.46 -2.154 . . . . 31.17 109.271 166.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1154 ' ' THR . . . . . . . . . . . . . 6.3 m -72.1 135.57 46.29 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 114.636 -1.166 . . . . 33.89 108.162 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -80.6 73.67 2.49 Favored Glycine 0 CA--C 1.543 1.843 0 N-CA-C 106.47 -2.652 . . . . 38.95 106.47 171.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1156 ' ' GLN . . . . . 0.545 ' NE2' ' HE2' ' B' 1152 ' ' PHE . 6.7 tt0 -75.17 124.17 26.57 Favored 'General case' 0 C--O 1.242 0.668 0 O-C-N 120.796 -1.414 . . . . 54.23 108.065 -174.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1157 ' ' ILE . . . . . 0.411 HD12 ' HG2' ' B' 1162 ' ' LYS . 26.8 mm -73.5 100.54 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 105.07 -2.196 . . . . 51.16 105.07 169.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1158 ' ' THR . . . . . . . . . . . . . 5.6 m -99.72 151.43 21.24 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 103.591 -2.744 . . . . 49.61 103.591 -172.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -57.92 -37.44 74.07 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 121.398 1.908 . . . . 49.05 113.707 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -53.52 -35.21 60.42 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 115.854 1.798 . . . . 47.65 115.854 169.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . 157.88 175.45 28.82 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 108.813 -1.715 . . . . 45.61 108.813 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1162 ' ' LYS . . . . . 0.411 ' HG2' HD12 ' B' 1157 ' ' ILE . 82.7 mttt -83.35 145.27 29.13 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 112.932 0.715 . . . . 57.46 112.932 -177.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1163 ' ' VAL . . . . . 0.713 HG11 ' HB2' ' B' 1152 ' ' PHE . 94.5 t -94.25 142.84 25.44 Favored Pre-proline 0 N--CA 1.433 -1.296 0 N-CA-C 106.385 -1.709 . . . . 42.93 106.385 170.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1164 ' ' PRO . . . . . 0.425 ' HA ' ' HD2' ' B' 1165 ' ' PRO . 98.6 Cg_endo -81.23 133.95 8.92 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 124.989 3.793 . . . . 39.29 104.74 168.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1165 ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' B' 1164 ' ' PRO . 50.3 Cg_endo -62.55 148.46 93.3 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 125.293 3.995 . . . . 34.17 108.199 176.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -75.17 134.7 41.17 Favored 'General case' 0 C--O 1.208 -1.124 0 CA-C-N 115.213 -0.903 . . . . 31.69 111.014 172.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1167 ' ' LYS . . . . . 0.59 ' HB2' ' HA ' ' B' 1249 ' ' VAL . 98.4 mttt -91.6 113.59 25.9 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 124.05 1.881 . . . . 44.78 107.189 167.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 87.6 t -98.25 99.43 8.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 113.099 -1.864 . . . . 31.23 107.212 -174.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1169 ' ' MET . . . . . 0.781 ' HB2' HG11 ' B' 1249 ' ' VAL . 36.5 ttp -83.42 100.85 10.97 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 119.14 -1.024 . . . . 37.09 108.313 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1170 ' ' VAL . . . . . 0.519 HG22 ' HB ' ' B' 1253 ' ' VAL . 45.2 t -91.07 111.76 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 106.948 -1.501 . . . . 30.17 106.948 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1171 ' ' ILE . . . . . . . . . . . . . 2.7 mt -97.84 135.43 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 107.303 -1.369 . . . . 33.74 107.303 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 71.76 71.94 0.99 Allowed Glycine 0 C--O 1.247 0.911 0 N-CA-C 108.564 -1.815 . . . . 32.59 108.564 -177.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1173 ' ' ALA . . . . . 0.483 ' H ' ' HB2' ' B' 1195 ' ' ASP . . . -76.25 74.31 3.06 Favored 'General case' 0 N--CA 1.44 -0.956 0 O-C-N 121.176 -1.191 . . . . 32.42 112.693 -174.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -81.0 -155.68 12.87 Favored Glycine 0 N--CA 1.44 -1.073 0 N-CA-C 109.652 -1.379 . . . . 31.74 109.652 169.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 47.9 t -65.11 -38.94 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.416 0 O-C-N 122.016 -0.696 . . . . 31.48 109.146 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1176 ' ' ALA . . . . . 0.436 ' N ' ' HB1' ' B' 1134 ' ' ALA . . . -65.65 -39.81 91.79 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 122.66 1.219 . . . . 26.12 110.186 174.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1177 ' ' GLY . . . . . 0.415 ' HA2' HG11 ' B' 1170 ' ' VAL . . . -52.29 -54.68 25.54 Favored Glycine 0 CA--C 1.527 0.82 0 O-C-N 120.499 -1.376 . . . . 25.73 111.05 171.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1178 ' ' LEU . . . . . 0.676 ' HA ' HD12 ' B' 1181 ' ' ILE . 65.5 mt -57.78 -39.21 76.93 Favored 'General case' 0 C--N 1.351 0.65 0 N-CA-C 112.863 0.69 . . . . 32.59 112.863 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1179 ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' B' 1135 ' ' ASN . . . -60.67 -46.15 91.42 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 124.664 1.227 . . . . 27.72 111.777 170.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -64.71 -39.35 93.51 Favored 'General case' 0 C--O 1.249 1.075 0 O-C-N 119.884 -1.76 . . . . 26.03 111.764 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1181 ' ' ILE . . . . . 0.676 HD12 ' HA ' ' B' 1178 ' ' LEU . 37.7 mt -56.61 -60.7 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 N-CA-C 104.137 -2.542 . . . . 28.61 104.137 171.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -43.32 -49.7 6.72 Favored Glycine 0 C--O 1.214 -1.099 0 N-CA-C 116.05 1.18 . . . . 25.23 116.05 177.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1183 ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' B' 1186 ' ' SER . . . -72.59 -57.02 4.46 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 112.115 0.413 . . . . 24.09 112.115 -174.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -60.59 -41.42 94.7 Favored 'General case' 0 C--O 1.246 0.892 0 O-C-N 121.518 -0.739 . . . . 26.68 112.689 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -65.7 -32.81 74.57 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-O 118.255 -0.878 . . . . 36.57 109.946 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1186 ' ' SER . . . . . 0.471 ' HB2' ' O ' ' B' 1183 ' ' ALA . 64.8 m -57.33 -49.27 76.67 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 122.48 2.4 . . . . 28.92 108.486 167.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1187 ' ' LEU . . . . . . . . . . . . . 19.6 mt -67.88 -6.51 22.13 Favored 'General case' 0 C--N 1.365 1.267 0 N-CA-C 115.511 1.671 . . . . 29.09 115.511 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 82.39 16.11 72.22 Favored Glycine 0 N--CA 1.447 -0.584 0 O-C-N 120.285 -1.509 . . . . 29.26 113.819 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1189 ' ' ALA . . . . . . . . . . . . . . . -86.81 139.74 30.39 Favored 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 120.514 -1.58 . . . . 30.16 108.407 175.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 8.3 mt -87.08 110.33 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 105.916 -1.883 . . . . 35.81 105.916 -164.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1191 ' ' VAL . . . . . 0.491 HG21 ' HA ' ' B' 1181 ' ' ILE . 43.8 t -81.02 123.5 37.7 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 O-C-N 121.093 -1.004 . . . . 31.97 111.351 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1192 ' ' ARG . . . . . 0.737 ' HG2' ' HB2' ' B' 1210 ' ' GLU . 91.2 mtt180 -105.91 105.13 15.02 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 108.202 -1.036 . . . . 48.16 108.202 170.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -103.04 155.01 18.68 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 115.823 -2.351 . . . . 35.89 110.339 -176.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1194 ' ' PHE . . . . . 0.534 ' HB2' ' HB2' ' B' 1212 ' ' LEU . 39.5 t80 -141.42 136.84 31.75 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 106.318 -1.734 . . . . 41.88 106.318 170.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1195 ' ' ASP . . . . . 0.483 ' HB2' ' H ' ' B' 1173 ' ' ALA . 9.9 t0 -149.84 159.78 44.09 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 100.948 -3.723 . . . . 38.28 100.948 165.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1196 ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.75 -9.85 59.77 Favored 'General case' 0 N--CA 1.435 -1.206 0 O-C-N 120.892 -1.13 . . . . 40.62 112.593 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1197 ' ' ARG . . . . . 0.402 HH11 ' HD2' ' B' 1197 ' ' ARG . 31.9 mtm105 -90.53 134.3 31.18 Favored Pre-proline 0 C--O 1.25 1.115 0 O-C-N 119.992 -1.692 . . . . 53.09 107.815 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -61.81 -34.39 82.66 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 123.417 2.745 . . . . 42.56 116.378 -165.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1199 ' ' GLU . . . . . 0.574 ' O ' ' HG2' ' B' 1203 ' ' GLN . 2.8 pm0 -68.57 -17.9 64.23 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 115.018 1.488 . . . . 56.31 115.018 -165.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1200 ' ' VAL . . . . . . . . . . . . . 14.1 m -58.72 -29.05 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-N 115.137 -0.938 . . . . 42.91 113.335 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 37.9 tttm -60.3 -62.31 1.96 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.685 -1.228 . . . . 48.89 107.685 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -60.16 -26.77 66.56 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 114.909 1.448 . . . . 51.7 114.909 176.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1203 ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' B' 1199 ' ' GLU . 67.6 mm-40 -62.04 -47.82 83.0 Favored 'General case' 0 C--O 1.253 1.283 0 CA-C-N 121.104 1.775 . . . . 52.57 111.449 171.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1204 ' ' VAL . . . . . 0.56 ' HB ' ' HB3' ' B' 1209 ' ' ALA 0.257 34.5 m -67.23 -43.97 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 O-C-N 120.619 -1.3 . . . . 33.79 113.736 175.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -56.61 -52.08 66.23 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 117.068 -1.444 . . . . 36.58 110.876 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1206 ' ' SER . . . . . . . . . . . . . 90.3 p -61.46 -40.88 96.12 Favored 'General case' 0 C--O 1.253 1.288 0 CA-C-N 120.125 1.33 . . . . 39.61 112.196 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1207 ' ' MET . . . . . . . . . . . . . 11.7 ttm -72.78 -18.78 61.45 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 119.738 -1.851 . . . . 37.45 112.808 174.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 84.83 73.36 1.27 Allowed Glycine 0 C--O 1.248 0.995 0 O-C-N 119.368 -2.083 . . . . 31.87 109.933 -176.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1209 ' ' ALA . . . . . 0.56 ' HB3' ' HB ' ' B' 1204 ' ' VAL . . . -163.17 155.51 18.29 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 106.742 -1.577 . . . . 35.4 106.742 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1210 ' ' GLU . . . . . 0.737 ' HB2' ' HG2' ' B' 1192 ' ' ARG . 50.1 mt-10 -86.56 148.48 25.48 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 112.088 -2.324 . . . . 47.89 111.59 -171.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 30.7 t80 -113.92 125.3 53.88 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 120.198 -1.564 . . . . 45.53 108.14 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1212 ' ' LEU . . . . . 0.534 ' HB2' ' HB2' ' B' 1194 ' ' PHE . 44.6 mt -74.36 108.49 7.17 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 103.832 -2.655 . . . . 46.33 103.832 170.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.41 159.64 21.75 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 113.357 -1.747 . . . . 60.41 112.313 -172.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.56 145.38 54.96 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 115.19 1.552 . . . . 57.38 115.19 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 34.4 t70 . . . . . 0 C--O 1.222 -0.349 0 CA-C-N 112.911 -1.95 . . . . 65.07 107.512 173.044 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B 1230 ' ' MET . . . . . . . . . . . . . 28.2 mmt . . . . . 0 N--CA 1.445 -0.696 0 N-CA-C 107.556 -1.275 . . . . 80.32 107.556 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B 1231 ' ' SER . . . . . . . . . . . . . 18.6 m -160.25 157.63 28.49 Favored 'General case' 0 C--O 1.224 -0.286 1 O-C-N 114.94 -4.85 . . . . 79.92 104.658 -10.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.93 -175.06 3.78 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-N 121.968 2.167 . . . . 77.91 105.685 155.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 60.9 -56.48 0.09 Allowed 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 117.032 2.234 . . . . 73.88 117.032 -170.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 4.9 t80 -38.87 -33.1 0.1 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.313 1.445 . . . . 68.98 113.703 169.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1235 ' ' ILE . . . . . 0.514 ' O ' ' HG2' ' B' 1239 ' ' MET . 35.9 pt -36.48 -39.63 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.384 0 N-CA-C 116.967 2.21 . . . . 64.53 116.967 167.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1236 ' ' LYS . . . . . 0.487 ' HA ' ' HD3' ' B' 1236 ' ' LYS . 71.2 mmtt -62.52 -51.03 69.04 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 122.903 0.481 . . . . 66.36 110.986 175.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -67.26 -33.72 75.91 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 125.29 1.619 . . . . 56.6 109.15 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -56.71 -52.77 63.68 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 120.637 1.562 . . . . 56.79 109.805 171.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1239 ' ' MET . . . . . 0.514 ' HG2' ' O ' ' B' 1235 ' ' ILE . 31.1 mmt -56.44 -47.2 79.6 Favored 'General case' 0 C--O 1.238 0.471 0 O-C-N 124.558 1.161 . . . . 53.63 113.38 176.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -63.63 -25.63 68.31 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 115.211 1.56 . . . . 51.74 115.211 175.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 13.1 tp -67.06 -46.25 74.91 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 105.483 -2.043 . . . . 44.86 105.483 174.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 8.4 m-30 -70.48 -45.13 66.3 Favored 'General case' 0 C--O 1.216 -0.701 0 O-C-N 120.268 -1.52 . . . . 42.78 106.999 -173.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -52.82 -43.08 65.71 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.343 1.238 . . . . 40.96 114.343 171.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -62.78 -29.74 70.94 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 115.813 1.782 . . . . 43.06 115.813 170.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -79.72 -24.76 41.42 Favored 'General case' 0 C--O 1.202 -1.445 0 CA-C-O 117.013 -1.47 . . . . 46.45 113.03 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -35.2 -40.45 0.13 Allowed 'General case' 0 C--O 1.241 0.636 1 N-CA-C 121.959 4.059 . . . . 41.78 121.959 -174.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1247 ' ' LYS . . . . . 0.491 ' HA ' ' HB2' ' B' 1276 ' ' LYS . 7.9 mptt -101.74 -4.9 25.65 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-N 120.379 1.445 . . . . 52.2 113.866 175.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1248 ' ' GLU . . . . . 0.483 ' HB3' ' HD2' ' B' 1167 ' ' LYS . 36.2 mt-10 -81.74 -63.23 1.43 Allowed 'General case' 0 C--O 1.25 1.125 0 N-CA-C 108.006 -1.109 . . . . 53.55 108.006 167.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1249 ' ' VAL . . . . . 0.781 HG11 ' HB2' ' B' 1169 ' ' MET . 21.7 m -65.69 154.41 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 123.963 1.84 . . . . 34.41 115.146 -168.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1250 ' ' ASP . . . . . 0.441 ' O ' ' HB3' ' B' 1279 ' ' SER . 2.8 m-20 -118.1 -56.56 2.16 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 105.271 -2.122 . . . . 33.38 105.271 -177.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1251 ' ' ILE . . . . . 0.772 HD12 ' HB1' ' B' 1145 ' ' ALA . 32.5 mm -110.73 109.02 26.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 O-C-N 119.782 -1.824 . . . . 29.54 106.881 -169.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1252 ' ' ILE . . . . . 0.435 HD11 ' SD ' ' B' 1275 ' ' MET . 47.1 mt -88.59 117.86 32.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 119.833 -1.792 . . . . 32.44 108.545 171.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1253 ' ' VAL . . . . . 0.519 ' HB ' HG22 ' B' 1170 ' ' VAL . 74.0 t -104.28 94.34 3.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 100.286 -3.968 . . . . 30.57 100.286 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1254 ' ' THR . . . . . . . . . . . . 0.294 6.5 t -94.78 101.56 13.39 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 125.681 2.658 . . . . 35.04 109.257 -176.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1255 ' ' THR . . . . . 0.446 HG23 HD22 ' B' 1284 ' ' LEU . 33.3 m -100.72 -21.11 15.31 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 109.192 -3.64 . . . . 34.62 113.933 -163.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . -62.17 139.25 58.48 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-O 122.877 1.323 . . . . 42.72 113.051 -162.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 5.6 tt -153.61 126.8 8.47 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 111.165 -2.743 . . . . 52.43 104.945 175.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1258 ' ' ILE . . . . . 0.692 ' HB ' ' HB2' ' B' 1261 ' ' LYS . 58.3 mt -85.69 118.21 70.19 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 101.34 -3.578 . . . . 59.41 101.34 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -51.37 92.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 124.877 3.718 . . . . 62.68 114.974 -175.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 130.46 -64.27 0.61 Allowed Glycine 0 N--CA 1.425 -2.061 0 N-CA-C 107.008 -2.437 . . . . 64.16 107.008 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1261 ' ' LYS . . . . . 0.692 ' HB2' ' HB ' ' B' 1258 ' ' ILE . 79.7 mttt -59.1 166.52 2.66 Favored Pre-proline 0 CA--C 1.51 -0.58 0 C-N-CA 125.992 1.717 . . . . 68.53 115.582 171.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -67.67 166.45 24.09 Favored 'Trans proline' 0 C--O 1.249 1.034 0 C-N-CA 122.659 2.239 . . . . 61.99 114.459 169.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1263 ' ' ALA . . . . . 0.427 ' HB1' ' ND2' ' B' 1291 ' ' ASN . . . -54.71 126.92 59.02 Favored Pre-proline 0 C--O 1.25 1.091 0 CA-C-N 111.819 -2.446 . . . . 57.15 111.52 166.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -60.95 141.49 94.68 Favored 'Trans proline' 0 C--N 1.324 -0.745 0 C-N-CA 123.998 3.132 . . . . 51.57 109.57 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -77.22 73.34 3.8 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-N 114.998 -1.001 . . . . 54.55 112.724 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 43.1 mt -76.02 -40.18 54.1 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 115.217 1.562 . . . . 46.86 115.217 -170.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1267 ' ' ILE . . . . . 0.48 HG21 HD13 ' B' 1281 ' ' ILE . 40.1 mm -110.72 119.75 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 106.432 -1.692 . . . . 41.04 106.432 -173.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1268 ' ' THR . . . . . 0.437 ' O ' HG23 ' B' 1272 ' ' VAL . 19.0 p -84.13 159.0 21.18 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 113.03 -1.895 . . . . 39.58 110.108 177.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1269 ' ' ARG . . . . . 0.494 ' HG3' ' HB2' ' B' 1293 ' ' GLU . 64.8 mtt85 -63.62 -33.6 75.98 Favored 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 120.689 -1.257 . . . . 53.15 111.03 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -64.4 -43.91 92.93 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 109.046 -0.724 . . . . 42.96 109.046 176.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1271 ' ' MET . . . . . . . . . . . . . 5.8 ttm -62.18 -40.45 96.06 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 114.516 1.302 . . . . 43.89 114.516 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1272 ' ' VAL . . . . . 0.545 HG21 ' HD2' ' B' 1294 ' ' TYR . 53.7 t -56.62 -59.12 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 120.339 -0.544 . . . . 38.37 111.53 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -66.84 -25.15 66.29 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 122.779 1.275 . . . . 47.46 114.02 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1274 ' ' SER . . . . . . . . . . . . . 33.2 m -74.71 -17.13 60.71 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 118.262 -2.774 . . . . 38.38 114.131 170.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1275 ' ' MET . . . . . 0.435 ' SD ' HD11 ' B' 1252 ' ' ILE . 34.0 mtp -69.12 163.64 24.35 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 121.388 1.904 . . . . 37.81 112.808 -174.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1276 ' ' LYS . . . . . 0.491 ' HB2' ' HA ' ' B' 1247 ' ' LYS . 87.8 tttt -56.04 126.32 25.41 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 113.131 -1.85 . . . . 49.26 108.778 167.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1277 ' ' ALA . . . . . 0.556 ' HB3' ' HD1' ' A' 1045 ' ' PHE . . . -83.47 169.85 15.07 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 120.559 1.527 . . . . 34.46 114.003 -167.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 62.32 41.64 99.74 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-O 122.995 1.331 . . . . 33.53 110.639 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1279 ' ' SER . . . . . 0.441 ' HB3' ' O ' ' B' 1250 ' ' ASP . 70.4 m -134.59 158.98 42.62 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 110.204 -2.998 . . . . 31.31 104.224 -172.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1280 ' ' VAL . . . . . 0.662 HG11 ' HA ' ' B' 1145 ' ' ALA . 41.4 t -128.66 142.1 44.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 106.708 -1.59 . . . . 29.32 106.708 -169.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1281 ' ' ILE . . . . . 0.48 HD13 HG21 ' B' 1267 ' ' ILE . 43.4 mt -113.31 113.22 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 103.002 -2.962 . . . . 31.93 103.002 167.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1282 ' ' VAL . . . . . 0.462 HG11 ' HA ' ' B' 1141 ' ' ALA . 5.1 t -97.09 127.57 49.17 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 N-CA-C 105.873 -1.899 . . . . 29.48 105.873 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1283 ' ' ASP . . . . . 0.566 ' HB3' ' HA2' ' B' 1311 ' ' GLY . 12.8 t0 -100.12 115.37 29.65 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 104.387 -2.449 . . . . 34.5 104.387 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1284 ' ' LEU . . . . . 0.542 ' HA ' HD12 ' B' 1315 ' ' LEU . 6.9 mp -82.01 -22.74 36.35 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.727 1.01 . . . . 37.94 113.727 -178.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -118.45 30.72 7.05 Favored 'General case' 0 N--CA 1.428 -1.551 0 O-C-N 119.374 -2.079 . . . . 40.92 111.115 -165.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -51.72 -38.2 54.24 Favored 'General case' 0 C--O 1.248 0.987 0 N-CA-C 117.647 2.462 . . . . 44.39 117.647 -169.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1287 ' ' GLN . . . . . 0.78 ' HB3' HG23 ' B' 1313 ' ' THR . 3.7 pm0 -65.31 -22.98 66.9 Favored 'General case' 0 C--O 1.268 2.049 0 N-CA-C 117.226 2.306 . . . . 51.46 117.226 176.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 20.7 m120 -110.31 73.31 0.83 Allowed 'General case' 0 C--N 1.35 0.604 0 N-CA-C 105.65 -1.981 . . . . 57.75 105.65 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1289 ' ' GLY . . . . . . . . . . . . . . . 87.08 -64.05 3.93 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-O 116.443 -2.31 . . . . 49.85 112.484 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 106.26 120.61 4.68 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 118.903 1.352 . . . . 45.93 112.03 -167.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1291 ' ' ASN . . . . . 0.427 ' ND2' ' HB1' ' B' 1263 ' ' ALA . 2.1 m-80 -69.6 -36.95 76.66 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.37 1.468 . . . . 42.67 112.368 176.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1292 ' ' CYS . . . . . . . . . . . . . 31.5 t -99.16 145.37 27.27 Favored 'General case' 0 C--O 1.253 1.257 0 CA-C-N 123.216 2.735 . . . . 38.82 108.401 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1293 ' ' GLU . . . . . 0.494 ' HB2' ' HG3' ' B' 1269 ' ' ARG . 67.6 mt-10 -60.47 -29.94 69.36 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 114.93 1.456 . . . . 46.71 114.93 175.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1294 ' ' TYR . . . . . 0.545 ' HD2' HG21 ' B' 1272 ' ' VAL . 21.3 m-85 -72.09 -16.7 62.02 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 116.396 1.998 . . . . 47.23 116.396 176.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1295 ' ' THR . . . . . 0.579 HG23 ' HA3' ' B' 1311 ' ' GLY . 85.9 m -56.19 122.35 11.55 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 123.854 1.788 . . . . 36.02 115.756 -165.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 7.2 t -107.03 124.18 36.11 Favored Pre-proline 0 N--CA 1.438 -1.054 1 N-CA-C 100.147 -4.02 . . . . 37.26 100.147 175.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -62.67 107.74 0.64 Allowed 'Trans proline' 0 C--O 1.243 0.752 0 C-N-CA 123.906 3.07 . . . . 35.09 112.459 -172.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 83.01 50.93 4.39 Favored Glycine 0 C--O 1.252 1.265 0 N-CA-C 108.035 -2.026 . . . . 35.97 108.035 173.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -151.74 145.25 24.87 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-O 122.181 0.991 . . . . 40.39 109.706 175.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1300 ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' B' 1310 ' ' ILE . 77.1 mt -80.49 130.07 36.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 103.877 -2.638 . . . . 37.43 103.877 156.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 4.5 t80 -121.94 120.79 35.47 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 104.758 -2.312 . . . . 44.13 104.758 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1302 ' ' THR . . . . . . . . . . . . . 59.6 m -83.51 133.97 34.86 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.325 -1.307 . . . . 39.78 108.264 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1303 ' ' THR . . . . . 0.519 HG21 HG11 ' B' 1272 ' ' VAL . 14.0 p -97.75 179.74 4.72 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 121.105 -0.997 . . . . 43.29 112.155 175.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -60.19 -51.69 68.51 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.64 0.733 . . . . 53.07 111.457 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 43.9 p-10 -74.57 -17.18 60.77 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 116.351 1.982 . . . . 43.97 116.351 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 85.25 33.69 16.6 Favored Glycine 0 N--CA 1.468 0.799 0 CA-C-N 114.626 -1.17 . . . . 41.12 113.994 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1307 ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' B' 1279 ' ' SER . 99.8 t -92.08 94.1 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 N-CA-C 105.374 -2.084 . . . . 38.12 105.374 163.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1308 ' ' LYS . . . . . 0.784 ' HD2' ' HB3' ' B' 1148 ' ' GLU . 80.7 mttt -78.59 119.72 22.27 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.649 -1.614 . . . . 36.34 109.662 -165.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1309 ' ' VAL . . . . . 0.412 HG22 HD12 ' B' 1281 ' ' ILE . 59.4 t -90.01 97.18 6.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 125.084 2.373 . . . . 30.4 109.195 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1310 ' ' ILE . . . . . 0.502 HD11 ' HB2' ' B' 1148 ' ' GLU . 14.1 mt -87.39 80.21 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.891 0 CA-C-N 112.239 -2.255 . . . . 30.82 105.314 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1311 ' ' GLY . . . . . 0.579 ' HA3' HG23 ' B' 1295 ' ' THR . . . -81.41 109.42 3.0 Favored Glycine 0 CA--C 1.503 -0.71 0 O-C-N 119.897 -1.752 . . . . 26.53 109.847 -179.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1312 ' ' TYR . . . . . 0.426 ' HB2' ' HG ' ' B' 1315 ' ' LEU . 9.8 m-30 -120.23 124.99 47.03 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 119.741 3.237 . . . . 38.0 119.741 -176.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1313 ' ' THR . . . . . 0.78 HG23 ' HB3' ' B' 1287 ' ' GLN . 4.0 m -69.65 -33.02 72.02 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.3 -1.773 . . . . 29.8 110.419 164.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -118.74 24.14 11.05 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 114.145 -1.389 . . . . 39.04 114.001 -157.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1315 ' ' LEU . . . . . 0.542 HD12 ' HA ' ' B' 1284 ' ' LEU . 18.7 mt -52.1 -41.93 83.08 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 114.728 1.381 . . . . 31.08 114.728 176.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1316 ' ' PRO . . . . . 0.464 ' HA ' HG21 ' B' 1136 ' ' ILE . 96.2 Cg_exo -67.17 -36.84 20.19 Favored 'Trans proline' 0 CA--C 1.499 -1.252 0 CA-C-N 123.831 2.404 . . . . 26.1 113.094 168.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1317 ' ' GLY . . . . . 0.695 ' HA2' ' HG3' ' B' 1015 ' ' ARG . . . -60.29 -44.96 96.96 Favored Glycine 0 CA--C 1.503 -0.685 0 CA-C-N 120.512 1.506 . . . . 23.17 110.606 -177.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 56.1 mtt-85 -66.95 -0.21 2.96 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 116.149 1.907 . . . . 40.4 116.149 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 22.6 tp -120.37 78.79 27.73 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 105.325 -2.102 . . . . 23.6 105.325 172.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1320 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -58.41 -64.78 0.1 Allowed 'Trans proline' 0 CA--C 1.552 1.397 0 C-N-CA 125.158 3.905 . . . . 22.35 113.956 -161.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1321 ' ' THR . . . . . . . . . . . . . 6.3 m -66.16 -40.96 90.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 121.149 1.795 . . . . 26.52 112.874 -175.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1322 ' ' GLN . . . . . 0.703 ' HB2' ' HA ' ' A' 1151 ' ' ARG . 60.0 tp60 -69.67 -43.57 72.27 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 120.262 1.392 . . . . 24.38 110.83 -174.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1323 ' ' SER . . . . . . . . . . . . . 21.0 m -56.13 -50.22 71.72 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 119.217 -0.993 . . . . 22.8 111.091 170.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1324 ' ' SER . . . . . . . . . . . . . 15.1 m -57.57 -34.56 69.34 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 123.242 1.496 . . . . 21.25 112.731 176.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1325 ' ' GLN . . . . . 0.446 ' OE1' ' HB3' ' B' 1021 ' ' LYS . 37.6 tp60 -67.23 -55.73 12.8 Favored 'General case' 0 N--CA 1.438 -1.036 0 O-C-N 119.594 -1.941 . . . . 31.34 111.387 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1326 ' ' LEU . . . . . 0.448 ' HG ' HE21 ' B' 1322 ' ' GLN . 45.0 mt -69.32 -40.41 77.63 Favored 'General case' 0 N--CA 1.435 -1.19 0 O-C-N 120.886 -1.134 . . . . 31.56 111.764 -173.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1327 ' ' TYR . . . . . 0.406 ' O ' ' HG ' ' B' 1331 ' ' LEU . 27.4 t80 -53.42 -53.31 53.15 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.428 -1.323 . . . . 22.73 107.428 171.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1328 ' ' GLY . . . . . . . . . . . . . . . -44.84 -56.89 5.6 Favored Glycine 0 C--O 1.254 1.381 0 C-N-CA 124.539 1.066 . . . . 21.91 114.335 172.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1329 ' ' THR . . . . . 0.737 HG23 HE22 ' B' 1025 ' ' GLN . 19.3 m -69.84 -23.64 63.32 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 121.428 -1.042 . . . . 22.15 110.421 -178.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1330 ' ' ASN . . . . . . . . . . . . . 31.6 m120 -66.3 -42.66 87.99 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.076 -1.64 . . . . 26.18 107.004 172.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1331 ' ' LEU . . . . . 0.945 HD13 HD13 ' B' 1070 ' ' LEU . 41.5 mt -66.6 -39.13 88.23 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.569 -0.9 . . . . 23.68 108.569 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1332 ' ' VAL . . . . . 0.531 HG12 ' HE3' ' B' 1336 ' ' LYS . 70.3 t -58.69 -46.73 90.35 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-O 116.958 -1.496 . . . . 26.57 108.622 171.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -56.53 -43.11 79.53 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 121.018 1.736 . . . . 28.08 113.592 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1334 ' ' LEU . . . . . 0.601 ' HA ' ' HG ' ' B' 1127 ' ' LEU . 46.9 tp -59.6 -50.76 72.64 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 113.82 -1.536 . . . . 27.43 107.855 175.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1335 ' ' LEU . . . . . 0.507 HD23 HD12 ' B' 1338 ' ' LEU . 65.1 mt -69.77 -23.99 63.44 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 119.011 -2.306 . . . . 30.5 111.841 -177.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1336 ' ' LYS . . . . . 0.531 ' HE3' HG12 ' B' 1332 ' ' VAL . 90.9 mttt -64.42 -40.28 95.46 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 122.81 2.55 . . . . 41.65 109.891 169.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 12.4 tp -77.75 -31.09 51.91 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 113.472 0.916 . . . . 42.08 113.472 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1338 ' ' LEU . . . . . 0.507 HD12 HD23 ' B' 1335 ' ' LEU . 95.1 mt -78.64 -69.77 0.54 Allowed 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 122.281 1.039 . . . . 35.03 109.61 173.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 42.4 t -81.1 72.35 8.12 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 124.397 2.046 . . . . 37.33 107.584 -174.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 58.9 mttp -70.18 -19.25 63.2 Favored 'General case' 0 CA--C 1.5 -0.952 0 O-C-N 118.376 -2.703 . . . . 50.51 114.929 -178.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -78.14 -9.18 59.06 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 113.169 0.803 . . . . 54.21 113.169 168.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 44.9 mttt 48.11 56.23 7.61 Favored 'General case' 0 C--N 1.364 1.224 0 C-N-CA 124.96 1.304 . . . . 50.99 113.359 -173.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 26.6 p-10 -122.38 -47.87 2.1 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.857 -0.737 . . . . 48.82 111.17 -172.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 150.37 -3.71 0.56 Allowed Glycine 0 CA--C 1.54 1.623 0 CA-C-O 123.369 1.538 . . . . 40.43 111.195 172.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 22.9 t30 -79.64 116.4 19.81 Favored 'General case' 0 N--CA 1.428 -1.53 0 O-C-N 119.463 -2.198 . . . . 47.56 114.292 175.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1346 ' ' ILE . . . . . . . . . . . . . 40.4 mm -59.74 97.62 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.246 0.902 0 CA-C-O 123.204 1.478 . . . . 42.49 112.234 169.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1347 ' ' THR . . . . . . . . . . . . . 48.2 m -101.38 93.99 5.69 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 113.394 -1.73 . . . . 38.12 107.504 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 85.5 t -87.0 94.84 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 O-C-N 119.309 -2.119 . . . . 37.5 107.802 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 16.2 t70 -75.12 101.97 4.75 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 107.228 -1.397 . . . . 43.85 107.228 170.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1350 ' ' PHE . . . . . 0.715 ' HE1' ' HB ' ' B' 1359 ' ' THR . 0.1 OUTLIER -75.98 -5.24 45.39 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 113.244 -1.798 . . . . 39.81 113.168 -179.284 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 24.2 t70 -79.81 -42.65 23.95 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 120.341 -1.474 . . . . 51.29 107.706 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 20.1 t0 -57.11 113.54 1.76 Allowed 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 122.756 1.265 . . . . 39.78 109.865 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 15.1 m -46.27 -35.24 2.31 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 CA-C-N 113.502 -1.681 . . . . 39.28 114.443 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1354 ' ' VAL . . . . . 0.562 HG13 ' HB2' ' B' 1124 ' ' ALA . 47.4 t -67.72 -50.53 59.69 Favored 'Isoleucine or valine' 0 C--O 1.263 1.794 0 O-C-N 124.72 1.262 . . . . 35.7 110.751 177.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1355 ' ' ILE . . . . . 0.575 ' HA ' HG12 ' B' 1358 ' ' VAL . 34.7 mm -69.0 -40.2 80.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 CA-C-N 120.046 1.294 . . . . 35.77 108.902 178.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 43.8 tpt85 -52.52 -32.18 39.16 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 125.44 1.496 . . . . 38.55 111.662 168.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -74.14 -59.64 3.86 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 110.229 -1.149 . . . . 29.58 110.229 176.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1358 ' ' VAL . . . . . 0.766 HG23 HG22 ' B' 1118 ' ' VAL . 11.6 p -60.32 -38.55 77.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-N 118.393 1.096 . . . . 32.06 111.634 -172.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1359 ' ' THR . . . . . 0.715 ' HB ' ' HE1' ' B' 1350 ' ' PHE . 5.6 m -81.78 92.17 6.61 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 123.049 1.404 . . . . 29.0 107.695 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1360 ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' B' 1368 ' ' TRP . 31.2 m -82.27 -17.88 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 110.771 -2.922 . . . . 29.68 113.903 -176.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1361 ' ' ILE . . . . . 0.461 HG12 ' HA ' ' B' 1366 ' ' ILE . 48.6 mt -133.7 106.88 9.68 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 N-CA-C 101.274 -3.602 . . . . 32.05 101.274 168.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1362 ' ' ARG . . . . . 0.53 HH11 ' HB2' ' B' 1350 ' ' PHE . 46.8 ttt180 -87.62 78.04 8.59 Favored 'General case' 0 C--O 1.243 0.727 0 O-C-N 118.341 -2.725 . . . . 32.52 109.182 174.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 58.62 89.1 0.06 Allowed 'General case' 0 C--O 1.246 0.912 0 CA-C-N 112.488 -2.142 . . . . 35.68 114.161 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 88.56 -72.68 2.3 Favored Glycine 0 N--CA 1.477 1.43 0 CA-C-N 114.733 -1.122 . . . . 34.26 111.253 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.03 117.64 6.73 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.182 0.993 . . . . 51.07 110.46 176.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1366 ' ' ILE . . . . . 0.461 ' HA ' HG12 ' B' 1361 ' ' ILE . 95.9 mt -74.24 104.13 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 104.93 -2.248 . . . . 39.87 104.93 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1367 ' ' THR . . . . . . . . . . . . . 7.2 p -94.2 -1.08 54.68 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.1 -1.409 . . . . 38.01 111.985 -174.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1368 ' ' TRP . . . . . 0.467 ' HB2' ' HB ' ' B' 1360 ' ' VAL . 24.5 t90 -74.23 137.67 75.34 Favored Pre-proline 0 CA--C 1.548 0.876 0 O-C-N 120.236 -1.54 . . . . 42.14 108.009 162.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -72.94 161.22 94.17 Favored 'Cis proline' 0 CA--C 1.512 -0.624 0 CA-C-N 123.171 2.168 . . . . 43.26 116.785 -11.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1370 ' ' ALA . . . . . . . . . . . . . . . -87.38 170.42 11.99 Favored Pre-proline 0 N--CA 1.469 0.505 0 CA-C-O 117.12 -1.419 . . . . 46.52 111.072 176.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -47.93 144.26 12.1 Favored 'Trans proline' 0 CA--C 1.555 1.557 0 C-N-CA 123.43 2.753 . . . . 51.95 112.671 165.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.96 75.76 2.17 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.568 2.845 . . . . 56.27 114.85 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1373 ' ' ILE . . . . . 0.523 HG23 HG21 ' B' 1121 ' ' ILE . 0.0 OUTLIER -82.92 128.76 38.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 104.895 -2.261 . . . . 60.83 104.895 173.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -68.25 123.23 20.15 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 115.707 1.743 . . . . 66.1 115.707 -173.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1375 ' ' VAL . . . . . 0.787 HG13 ' HB2' ' B' 1120 ' ' ARG . 14.4 t -60.88 123.23 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 1 O-C-N 129.208 4.068 . . . . 63.47 110.922 175.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.23 -4.627 0 O-C-N 119.795 -1.816 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 20' ' ' ALA . . . . . 0.814 ' HA ' HD21 ' C' ' 171' ' ' LEU . . . . . . . . 0 C--O 1.242 0.702 0 CA-C-O 118.828 -0.606 . . . . 0.0 111.508 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -45.33 -30.25 1.25 Allowed 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 117.454 2.39 . . . . 0.0 117.454 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -46.57 -40.19 12.34 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.991 1.716 . . . . 0.0 109.436 177.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 23' ' ' THR . . . . . 0.501 ' HA ' HD22 ' C' ' 26' ' ' LEU . 22.4 m -55.97 -29.23 59.9 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -178.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.55 -47.28 86.25 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.276 -1.515 . . . . 0.0 111.104 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -66.56 -34.36 77.73 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.327 1.051 . . . . 0.0 108.284 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.501 HD22 ' HA ' ' C' ' 23' ' ' THR . 2.2 mp -70.06 -31.31 68.86 Favored 'General case' 0 N--CA 1.426 -1.663 0 C-N-CA 123.825 0.85 . . . . 0.0 110.827 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 63.0 mt -61.14 -48.08 83.24 Favored 'General case' 0 CA--C 1.518 -0.282 0 O-C-N 119.431 -2.043 . . . . 0.0 115.334 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 28' ' ' LYS . . . . . . . . . . . . . 10.2 pttm -63.98 -28.2 69.65 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 119.063 -1.055 . . . . 0.0 113.213 172.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -73.87 -35.3 64.72 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 118.632 -0.699 . . . . 0.0 112.053 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.77 ' HA ' ' HB3' ' C' ' 107' ' ' ASP . 39.6 m -56.42 -17.79 9.15 Favored 'General case' 0 C--O 1.239 0.531 1 N-CA-C 124.137 4.865 . . . . 0.0 124.137 -163.677 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 44.2 m-70 66.67 -77.31 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 125.336 1.455 . . . . 0.0 109.726 -174.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 74.2 m -97.5 160.01 14.58 Favored 'General case' 0 C--O 1.242 0.661 0 O-C-N 120.158 -1.589 . . . . 0.0 108.318 168.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 12.8 t -132.23 118.01 34.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 O-C-N 119.01 -2.306 . . . . 0.0 105.658 174.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.629 HD11 ' HB3' ' C' ' 102' ' ' ASP . 27.3 mm -104.29 124.12 58.56 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 N-CA-C 105.882 -1.895 . . . . 0.0 105.882 175.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . 0.583 HG12 HD12 ' C' ' 110' ' ' LEU . 92.3 mt -107.03 125.61 63.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 176.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 82.8 m -106.86 98.79 22.51 Favored Pre-proline 0 N--CA 1.44 -0.962 0 O-C-N 119.316 -2.115 . . . . 0.0 112.249 171.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . 0.804 ' HD2' HG12 ' C' ' 68' ' ' ILE . 84.2 Cg_exo -75.95 56.32 4.75 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.421 2.747 . . . . 0.0 114.526 175.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.92 89.03 1.42 Allowed Glycine 0 N--CA 1.443 -0.894 0 O-C-N 119.78 -1.825 . . . . 0.0 111.137 -170.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 40.1 t80 65.76 -72.71 0.07 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.895 1.278 . . . . 0.0 108.916 -177.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -28.46 -64.09 0.11 Allowed Glycine 0 C--N 1.349 1.285 0 N-CA-C 117.985 1.954 . . . . 0.0 117.985 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 9.2 ttm -49.83 -39.84 40.15 Favored 'General case' 0 C--O 1.25 1.126 0 N-CA-C 118.265 2.691 . . . . 0.0 118.265 173.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -85.35 -22.92 28.25 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 9.0 p -84.13 -38.09 13.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 O-C-N 119.078 -2.264 . . . . 0.0 110.945 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.67 9.57 2.71 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 117.4 2.37 . . . . 0.0 117.4 175.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 45' ' ' GLN . . . . . . . . . . . . 0.388 1.0 OUTLIER 41.75 48.1 3.64 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 119.124 3.009 . . . . 0.0 119.124 -159.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.51 -1.31 57.05 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.887 169.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 47' ' ' GLN . . . . . 0.526 ' O ' HG12 ' C' ' 50' ' ' VAL . 0.0 OUTLIER -50.56 -48.84 57.3 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 118.335 -0.841 . . . . 0.0 111.455 177.424 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 48' ' ' TYR . . . . . 0.645 ' HB2' ' HD3' ' C' ' 49' ' ' PRO . 18.7 m-85 -71.42 -58.01 4.09 Favored Pre-proline 0 C--O 1.247 0.964 0 CA-C-O 116.87 -1.538 . . . . 0.0 113.922 177.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 49' ' ' PRO . . . . . 0.645 ' HD3' ' HB2' ' C' ' 48' ' ' TYR . 88.5 Cg_exo -50.9 -15.05 1.55 Allowed 'Trans proline' 0 C--N 1.367 1.53 0 N-CA-C 120.412 3.197 . . . . 0.0 120.412 172.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . 0.526 HG12 ' O ' ' C' ' 47' ' ' GLN . 5.5 p -63.6 -29.82 48.25 Favored 'Isoleucine or valine' 0 C--O 1.246 0.87 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.294 172.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.23 93.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 117.951 -2.968 . . . . 0.0 111.148 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 52' ' ' GLU . . . . . 0.519 ' HB3' ' HB2' ' C' ' 183' ' ' LEU . 3.1 mm-40 -47.42 -48.87 26.12 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 171.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 53' ' ' ILE . . . . . . . . . . . . 0.253 8.4 tp -72.99 -46.26 52.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.902 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 60.5 m -53.13 -36.77 61.15 Favored 'General case' 0 C--O 1.256 1.419 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -52.67 -64.22 0.89 Allowed 'General case' 0 C--O 1.238 0.485 0 C-N-CA 127.045 2.138 . . . . 0.0 111.311 173.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . 0.411 ' HE2' ' HB2' ' C' ' 56' ' ' LYS . 3.1 mppt? -66.12 -33.09 74.99 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 117.373 -1.298 . . . . 0.0 109.732 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 50.4 mt -60.54 -45.89 92.2 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 122.372 2.351 . . . . 0.0 108.845 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . 0.487 ' HD2' ' HA ' ' C' ' 58' ' ' ARG . 2.3 tpt180 -66.36 -43.99 84.45 Favored 'General case' 0 C--O 1.255 1.369 0 O-C-N 121.3 -0.875 . . . . 0.0 111.747 -178.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.63 -12.56 61.09 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 121.872 0.844 . . . . 0.0 112.67 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' C' ' 60' ' ' ARG . 1.8 tpm_? -76.87 -31.82 57.06 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-O 123.822 1.772 . . . . 0.0 110.045 171.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.47 42.01 2.62 Favored Glycine 0 N--CA 1.431 -1.638 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.654 -173.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 95.3 mt -109.11 132.1 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 121.568 0.699 . . . . 0.0 109.68 -177.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -68.94 91.74 0.48 Allowed 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 122.684 1.23 . . . . 0.0 108.255 169.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 8.9 p -96.98 122.43 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-O 122.525 1.155 . . . . 0.0 109.687 176.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 65' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' C' ' 34' ' ' ILE . 17.8 mmt-85 -129.27 153.43 47.8 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 175.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . 0.757 ' HB2' ' HA ' ' C' ' 93' ' ' VAL . 6.1 m-85 -112.93 141.67 46.49 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -126.74 99.54 0.54 Allowed Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 107.596 -2.202 . . . . 0.0 107.596 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 68' ' ' ILE . . . . . 0.804 HG12 ' HD2' ' C' ' 37' ' ' PRO . 1.1 mt -102.92 -154.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 O-C-N 124.411 0.712 . . . . 0.0 111.384 174.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -165.2 135.2 2.9 Favored Pre-proline 0 N--CA 1.473 0.68 0 O-C-N 119.243 -2.161 . . . . 0.0 105.61 -169.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 70' ' ' PRO . . . . . 0.565 ' HB3' ' O ' ' A' 1158 ' ' THR . 14.0 Cg_endo -45.4 -61.51 0.58 Allowed 'Trans proline' 0 C--N 1.352 0.716 1 C-N-CA 126.428 4.752 . . . . 0.0 117.526 -179.351 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 14.5 m -94.42 133.41 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.93 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 174.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.57 9.34 8.99 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 117.786 2.513 . . . . 0.0 117.786 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.88 -52.28 0.65 Allowed Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 -169.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 74' ' ' ARG . . . . . 0.453 ' HA ' ' OE1' ' B' 1203 ' ' GLN . 3.3 mpt_? -147.94 177.64 9.18 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 175.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 7.0 mt 53.71 44.39 1.87 Allowed Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 119.557 3.169 . . . . 0.0 119.557 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -63.31 133.74 41.89 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.691 2.927 . . . . 0.0 113.195 -174.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.22 -70.6 1.84 Allowed Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.385 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 78' ' ' HIS . . . . . . . . . . . . 0.258 0.2 OUTLIER -36.91 -34.2 0.07 Allowed 'General case' 0 C--O 1.25 1.124 0 N-CA-C 121.648 3.944 . . . . 0.0 121.648 177.115 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -54.36 -34.13 60.54 Favored 'General case' 0 C--N 1.347 0.46 0 O-C-N 118.942 -2.348 . . . . 0.0 113.926 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -77.0 -30.38 55.89 Favored 'General case' 0 CA--C 1.501 -0.912 0 O-C-N 120.822 -1.174 . . . . 0.0 112.107 175.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 6.5 t -67.06 -39.77 84.02 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 O-C-N 120.678 -1.264 . . . . 0.0 110.689 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 95.3 mt -54.97 -36.24 65.16 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.111 0.964 . . . . 0.0 112.381 171.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.514 HD21 ' HG2' ' C' ' 37' ' ' PRO . 8.1 mp -71.72 -31.23 66.49 Favored 'General case' 0 C--O 1.249 1.04 0 CA-C-N 119.997 1.272 . . . . 0.0 112.077 176.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.13 -30.15 64.76 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.681 173.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.25 -48.37 78.52 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-O 122.024 0.916 . . . . 0.0 109.146 166.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.03 -1.38 2.05 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 119.171 -2.205 . . . . 0.0 115.827 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp 55.29 53.11 10.42 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -171.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 88' ' ' VAL . . . . . 0.501 HG21 HG13 ' C' ' 50' ' ' VAL . 14.5 t -111.27 125.55 30.33 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 101.483 -3.525 . . . . 0.0 101.483 169.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 89' ' ' PRO . . . . . 0.568 ' HG2' HG12 ' C' ' 92' ' ' ILE . 92.8 Cg_endo -61.66 120.97 8.86 Favored 'Trans proline' 0 C--O 1.241 0.653 1 C-N-CA 126.49 4.793 . . . . 0.0 115.949 -171.005 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.58 -26.73 45.32 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 126.66 1.984 . . . . 0.0 113.008 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -58.46 -51.3 70.43 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 119.965 1.257 . . . . 0.0 112.148 174.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 92' ' ' ILE . . . . . 0.568 HG12 ' HG2' ' C' ' 89' ' ' PRO . 45.2 pt -77.73 -23.11 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 119.655 -1.903 . . . . 0.0 110.575 -175.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 93' ' ' VAL . . . . . 0.757 ' HA ' ' HB2' ' C' ' 66' ' ' PHE . 67.9 t -68.35 83.55 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 174.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 20.7 mt -89.84 151.85 21.56 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 173.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 95' ' ' GLU . . . . . 0.52 ' HB2' HD13 ' A' 1157 ' ' ILE . 9.6 mp0 -138.53 127.96 24.59 Favored 'General case' 0 C--O 1.249 1.066 0 O-C-N 118.597 -2.565 . . . . 0.0 108.44 176.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 50.3 ttp 45.11 75.17 0.11 Allowed 'General case' 0 C--N 1.354 0.8 0 CA-C-O 124.872 2.272 . . . . 0.0 113.732 -177.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -145.5 164.01 32.93 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 109.994 -3.275 . . . . 0.0 106.809 -162.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -79.97 13.41 2.24 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 112.934 -1.939 . . . . 0.0 111.66 -178.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 4.2 tt -45.42 -16.35 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 124.614 1.166 . . . . 0.0 111.652 153.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . 0.457 ' ND2' ' HB2' ' C' ' 137' ' ' GLU . 1.7 t-20 -33.91 -35.85 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 117.108 2.262 . . . . 0.0 117.108 162.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -65.45 -62.1 1.72 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 119.336 -0.945 . . . . 0.0 111.232 172.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 102' ' ' ASP . . . . . 0.629 ' HB3' HD11 ' C' ' 34' ' ' ILE . 5.1 m-20 -51.0 -32.79 22.3 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 175.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 103' ' ' PHE . . . . . 0.448 ' HB3' ' HB ' ' C' ' 138' ' ' VAL . 3.6 m-85 -55.71 -47.97 75.95 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 125.705 1.602 . . . . 0.0 109.958 170.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -79.97 -18.33 50.62 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 119.01 0.823 . . . . 0.0 111.774 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -73.08 -47.13 47.11 Favored 'General case' 0 C--O 1.239 0.501 0 O-C-N 120.459 -1.401 . . . . 0.0 111.548 171.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 106' ' ' THR . . . . . 0.53 HG21 ' H ' ' C' ' 34' ' ' ILE . 77.0 m -54.14 133.8 44.19 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 122.342 0.257 . . . . 0.0 111.599 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 107' ' ' ASP . . . . . 0.77 ' HB3' ' HA ' ' C' ' 30' ' ' SER . 11.0 t70 -67.07 -65.59 0.66 Allowed 'General case' 0 C--O 1.234 0.252 0 O-C-N 124.076 0.86 . . . . 0.0 112.292 169.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' C' ' 143' ' ' ASN . 68.0 m -103.42 105.91 16.29 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 123.978 0.911 . . . . 0.0 109.64 -178.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 109' ' ' VAL . . . . . 0.612 HG13 ' HB ' ' C' ' 34' ' ' ILE . 16.4 t -89.54 110.97 22.35 Favored 'Isoleucine or valine' 0 C--N 1.349 0.578 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -176.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 110' ' ' LEU . . . . . 0.583 HD12 HG12 ' C' ' 35' ' ' ILE . 28.5 mt -77.96 84.26 4.25 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 123.219 1.485 . . . . 0.0 110.791 -175.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 111' ' ' VAL . . . . . 0.568 HG11 HG21 ' C' ' 118' ' ' VAL . 93.1 t -90.65 96.3 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 CA-C-O 123.154 1.454 . . . . 0.0 108.622 -177.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 112' ' ' ILE . . . . . 0.427 HD11 HG23 ' C' ' 35' ' ' ILE . 1.3 mm -83.67 89.52 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-O 124.001 1.858 . . . . 0.0 108.586 -171.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.55 -103.91 2.47 Favored Glycine 0 CA--C 1.496 -1.116 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.669 -172.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . 56.47 -57.11 0.02 OUTLIER 'General case' 0 C--O 1.249 1.063 0 N-CA-C 120.463 3.505 . . . . 0.0 120.463 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 115' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 59.67 -93.03 0.04 OUTLIER 'General case' 0 C--O 1.241 0.644 0 CA-C-N 122.553 2.433 . . . . 0.0 112.438 173.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 116' ' ' ASP . . . . . 0.765 ' HA ' ' HB2' ' C' ' 119' ' ' ASN . 34.4 m-20 -82.72 -19.38 38.11 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.123 -0.986 . . . . 0.0 111.977 -176.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 117' ' ' THR . . . . . . . . . . . . 0.254 1.0 OUTLIER -67.22 -15.28 63.61 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 176.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.568 HG21 HG11 ' C' ' 111' ' ' VAL . 16.5 m -122.81 30.66 2.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 124.612 1.165 . . . . 0.0 108.327 171.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 119' ' ' ASN . . . . . 0.765 ' HB2' ' HA ' ' C' ' 116' ' ' ASP . 46.7 t-20 -86.78 119.62 71.31 Favored Pre-proline 0 CA--C 1.506 -0.714 0 O-C-N 119.212 -2.18 . . . . 0.0 114.146 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 120' ' ' PRO . . . . . 0.425 ' HG3' ' CE3' ' C' ' 139' ' ' TRP . 40.7 Cg_exo -53.24 -53.22 7.05 Favored 'Trans proline' 0 C--O 1.243 0.733 0 C-N-CA 124.878 3.718 . . . . 0.0 113.127 175.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 121' ' ' ALA . . . . . 0.457 ' HA ' ' HB3' ' C' ' 124' ' ' ASP . . . -61.9 -28.09 69.27 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -174.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 122' ' ' ALA . . . . . 0.42 ' HB1' ' HB3' ' C' ' 133' ' ' MET . . . -54.51 -41.05 69.19 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-O 121.609 0.719 . . . . 0.0 111.622 172.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -92.57 -16.62 25.45 Favored 'General case' 0 C--O 1.245 0.846 0 O-C-N 118.499 -2.625 . . . . 0.0 114.074 173.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 124' ' ' ASP . . . . . 0.457 ' HB3' ' HA ' ' C' ' 121' ' ' ALA . 12.4 t70 -98.77 -35.52 10.12 Favored 'General case' 0 C--O 1.241 0.647 0 O-C-N 121.242 -0.911 . . . . 0.0 112.846 -165.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 125' ' ' ASP . . . . . 0.422 ' OD2' ' HB3' ' C' ' 127' ' ' LYS . 25.4 t70 -117.54 126.94 26.99 Favored Pre-proline 0 C--N 1.321 -0.639 0 C-N-CA 124.516 1.126 . . . . 0.0 113.112 -157.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -62.36 -38.03 56.53 Favored 'Trans proline' 0 CA--C 1.548 1.196 0 C-N-CA 124.971 3.781 . . . . 0.0 114.57 176.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 127' ' ' LYS . . . . . 0.422 ' HB3' ' OD2' ' C' ' 125' ' ' ASP . 4.2 ttpm? -63.75 -29.57 70.77 Favored 'General case' 0 C--N 1.314 -0.941 0 O-C-N 119.291 -2.131 . . . . 0.0 111.267 -178.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 128' ' ' SER . . . . . 0.471 ' HA ' HG11 ' C' ' 158' ' ' VAL . 18.4 m -58.6 127.94 82.74 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 118.074 -0.965 . . . . 0.0 111.044 172.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 129' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -56.23 -31.36 83.74 Favored 'Trans proline' 0 C--O 1.257 1.428 0 CA-C-N 122.506 1.931 . . . . 0.0 116.17 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 10.5 pt -105.78 53.53 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-O 123.246 1.498 . . . . 0.0 109.278 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.85 120.8 14.17 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 123.3 1.524 . . . . 0.0 111.811 -171.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.61 38.97 10.02 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 133' ' ' MET . . . . . 0.682 ' SD ' ' HD2' ' C' ' 134' ' ' PRO . 42.8 tpp -73.72 134.98 78.23 Favored Pre-proline 0 N--CA 1.45 -0.444 0 O-C-N 119.819 -1.989 . . . . 0.0 110.535 172.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 134' ' ' PRO . . . . . 0.682 ' HD2' ' SD ' ' C' ' 133' ' ' MET . 92.8 Cg_endo -68.25 90.24 0.39 Allowed 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 124.011 3.141 . . . . 0.0 110.418 173.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 135' ' ' VAL . . . . . 0.402 HG22 ' O ' ' C' ' 133' ' ' MET . 1.5 m -110.95 150.8 13.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -175.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . 0.456 ' HB2' HG12 ' C' ' 118' ' ' VAL . 28.7 mt -73.9 104.51 4.79 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.934 0.873 . . . . 0.0 112.589 -165.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 137' ' ' GLU . . . . . 0.457 ' HB2' ' ND2' ' C' ' 100' ' ' ASN . 20.4 mt-10 -64.63 110.97 2.53 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -172.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 138' ' ' VAL . . . . . 0.448 ' HB ' ' HB3' ' C' ' 103' ' ' PHE . 4.9 p -151.71 61.4 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 164.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 139' ' ' TRP . . . . . 0.425 ' CE3' ' HG3' ' C' ' 120' ' ' PRO . 4.5 m95 -81.63 136.67 35.53 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.909 -1.496 . . . . 0.0 112.837 -166.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 41.65 45.54 2.97 Favored 'General case' 0 C--O 1.243 0.755 0 O-C-N 126.886 2.616 . . . . 0.0 116.603 175.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -166.3 162.48 17.29 Favored 'General case' 0 C--N 1.345 0.402 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -170.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 59.91 163.29 0.05 Allowed 'General case' 0 C--O 1.242 0.681 0 N-CA-C 117.77 2.507 . . . . 0.0 117.77 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 143' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' C' ' 108' ' ' THR . 35.9 t30 -82.3 68.91 8.91 Favored 'General case' 0 C--O 1.248 1.01 0 O-C-N 120.979 -1.076 . . . . 0.0 109.269 176.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 144' ' ' VAL . . . . . . . . . . . . . 26.0 t -74.88 96.56 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 113.598 -1.637 . . . . 0.0 108.627 -177.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 145' ' ' ILE . . . . . 0.461 HD11 HD13 ' C' ' 171' ' ' LEU 0.266 7.9 tp -92.1 87.31 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-O 126.416 3.008 . . . . 0.0 113.3 -170.018 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 146' ' ' VAL . . . . . 0.506 ' HA ' ' HB ' ' C' ' 111' ' ' VAL . 26.7 t -77.73 97.42 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 CA-C-N 108.761 -3.836 . . . . 0.0 111.087 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 147' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -67.1 96.24 0.44 Allowed 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 148' ' ' LYS . . . . . 0.599 ' O ' ' HA ' ' C' ' 172' ' ' PHE . 48.2 tptt -123.38 131.01 53.52 Favored 'General case' 0 C--O 1.211 -0.938 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -174.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 9.8 tpp85 -63.65 -49.26 73.92 Favored 'General case' 0 C--O 1.256 1.437 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -171.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 150' ' ' SER . . . . . 0.508 ' O ' ' HE3' ' C' ' 148' ' ' LYS . 1.5 m -143.45 170.47 15.73 Favored 'General case' 0 C--O 1.249 1.073 0 O-C-N 120.86 -1.15 . . . . 0.0 108.966 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 10.5 tpt -79.17 99.11 6.84 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 176.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -155.29 157.51 37.33 Favored 'General case' 0 N--CA 1.426 -1.671 0 C-N-CA 118.131 -1.428 . . . . 0.0 109.973 -176.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 4.8 m -62.75 130.29 44.26 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 125.548 1.78 . . . . 0.0 106.639 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -72.32 -120.83 0.06 OUTLIER Glycine 0 N--CA 1.415 -2.732 0 O-C-N 120.745 -1.222 . . . . 0.0 113.387 171.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -86.41 -66.83 0.86 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 170.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 156' ' ' ALA . . . . . . . . . . . . . . . -85.18 -39.65 17.6 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 170.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 54.89 33.41 56.52 Favored Glycine 0 C--N 1.352 1.423 0 C-N-CA 124.692 1.139 . . . . 0.0 114.335 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 158' ' ' VAL . . . . . 0.471 HG11 ' HA ' ' C' ' 128' ' ' SER . 3.3 m -76.42 144.52 11.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 O-C-N 121.441 -1.035 . . . . 0.0 111.265 -173.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.58 136.43 57.98 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 -174.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 160' ' ' ASN . . . . . 0.405 ' OD1' ' HB3' ' C' ' 162' ' ' LEU . 13.8 p30 -169.72 156.54 6.19 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -171.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -54.31 -31.42 67.08 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 124.642 3.561 . . . . 0.0 115.223 177.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 162' ' ' LEU . . . . . 0.405 ' HB3' ' OD1' ' C' ' 160' ' ' ASN . 4.1 tt -68.04 -24.12 65.05 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 118.665 -2.522 . . . . 0.0 111.516 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 163' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -79.16 -10.78 59.91 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 172.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -127.57 -30.93 2.52 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 -169.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 35.8 mmtt -74.83 161.78 29.26 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.25 -170.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -89.84 -38.26 13.88 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.843 -173.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -74.25 -57.27 4.06 Favored 'General case' 0 C--O 1.243 0.716 0 O-C-N 117.329 -3.357 . . . . 0.0 106.93 172.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 168' ' ' THR . . . . . . . . . . . . 0.258 4.2 m -82.53 85.0 7.04 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 103.183 -2.895 . . . . 0.0 103.183 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -129.75 132.03 46.45 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-O 122.953 1.358 . . . . 0.0 113.607 -162.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 170' ' ' MET . . . . . 0.47 ' HA ' ' HB ' ' C' ' 146' ' ' VAL . 51.4 mtm -73.18 99.65 2.89 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 110.337 -3.119 . . . . 0.0 110.069 165.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 171' ' ' LEU . . . . . 0.814 HD21 ' HA ' ' C' ' 20' ' ' ALA . 17.4 tp -76.71 122.49 24.78 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 104.247 -2.501 . . . . 0.0 104.247 177.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 172' ' ' PHE . . . . . 0.599 ' HA ' ' O ' ' C' ' 148' ' ' LYS . 46.3 m-85 -89.26 77.93 7.37 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 120.24 -1.537 . . . . 0.0 111.792 -166.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -149.99 162.78 29.27 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-N 113.46 -1.7 . . . . 0.0 112.295 -172.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 174' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -75.0 144.91 42.88 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 -177.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.06 -39.73 93.37 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 125.367 1.667 . . . . 0.0 112.795 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.92 -51.45 18.49 Favored 'General case' 0 C--N 1.359 1.005 0 C-N-CA 117.759 -1.576 . . . . 0.0 108.511 174.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 177' ' ' ALA . . . . . . . . . . . . . . . -53.7 -55.94 21.73 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 125.939 1.696 . . . . 0.0 114.379 -168.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 4.5 m -57.99 -38.3 75.85 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-N 114.678 -1.146 . . . . 0.0 113.83 175.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 179' ' ' VAL . . . . . 0.458 ' HA ' HG12 ' C' ' 182' ' ' ILE . 40.0 t -72.24 -38.38 61.83 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -57.6 -40.71 79.68 Favored 'General case' 0 C--N 1.351 0.66 0 O-C-N 118.45 -2.656 . . . . 0.0 112.461 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -58.97 -53.37 59.15 Favored 'General case' 0 CA--C 1.552 1.022 0 O-C-N 121.506 -0.746 . . . . 0.0 111.812 170.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 182' ' ' ILE . . . . . 0.458 HG12 ' HA ' ' C' ' 179' ' ' VAL . 30.9 pt -78.15 -24.41 13.87 Favored 'Isoleucine or valine' 0 C--O 1.249 1.077 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -168.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 183' ' ' LEU . . . . . 0.519 ' HB2' ' HB3' ' C' ' 52' ' ' GLU . 4.7 pp -59.0 -24.78 63.08 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 118.831 -2.418 . . . . 0.0 114.815 171.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 28.6 tptt -96.71 -60.18 1.65 Allowed 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 175.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -88.88 107.25 18.89 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 123.172 1.463 . . . . 0.0 108.265 -171.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 186' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--O 1.218 -0.567 0 CA-C-N 114.519 -1.219 . . . . 0.0 112.352 160.851 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 48.6 t-80 . . . . . 0 CA--C 1.506 -0.723 0 N-CA-C 108.811 -0.811 . . . . 65.74 108.811 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -67.47 81.28 0.15 Allowed Glycine 0 N--CA 1.424 -2.122 0 CA-C-O 125.576 2.764 . . . . 48.66 114.539 176.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1002 ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' 1032 ' ' THR . 30.6 ttp180 -100.85 118.7 37.43 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 111.07 -2.565 . . . . 44.56 104.154 172.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1003 ' ' ILE . . . . . 0.594 HD13 HD13 ' A' 1335 ' ' LEU . 54.9 mt -101.46 101.91 12.76 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 103.332 -2.84 . . . . 34.86 103.332 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -76.41 122.25 6.37 Favored Glycine 0 C--O 1.256 1.477 0 CA-C-N 109.644 -3.434 . . . . 30.75 110.41 174.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.587 HG23 ' HB3' ' A' 1017 ' ' ALA . 49.0 mm -105.01 98.02 14.55 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 105.912 -1.884 . . . . 32.21 105.912 177.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1006 ' ' PRO . . . . . 0.444 ' HA ' ' HB2' ' A' 1036 ' ' GLU . 80.0 Cg_exo -73.81 155.16 48.92 Favored 'Trans proline' 0 CA--C 1.508 -0.8 0 C-N-CA 123.305 2.67 . . . . 32.98 112.133 167.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1007 ' ' ARG . . . . . 0.448 ' O ' ' HG3' ' A' 1009 ' ' ARG . 33.9 ttp85 -71.85 146.14 48.14 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 110.564 -3.016 . . . . 47.98 105.316 162.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1008 ' ' GLU . . . . . 0.42 ' CD ' ' HZ2' ' A' 1071 ' ' LYS . 4.2 tp10 -75.31 119.49 19.49 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 123.603 1.668 . . . . 34.7 108.254 172.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1009 ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' 1007 ' ' ARG . 25.7 mtp-105 -104.43 7.65 35.54 Favored 'General case' 0 N--CA 1.423 -1.778 0 CA-C-N 109.734 -3.394 . . . . 53.37 108.052 -172.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 19.9 tp -62.88 127.11 29.7 Favored 'General case' 0 CA--C 1.505 -0.774 0 O-C-N 118.376 -2.702 . . . . 45.07 108.171 152.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1011 ' ' THR . . . . . . . . . . . . . 7.9 m -52.95 144.42 14.89 Favored 'General case' 0 C--O 1.255 1.365 0 C-N-CA 125.06 1.344 . . . . 40.36 112.067 -173.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 57.8 t30 70.19 -35.37 0.32 Allowed 'General case' 0 C--O 1.269 2.1 0 N-CA-C 114.728 1.381 . . . . 40.61 114.728 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -74.25 99.59 3.48 Favored 'General case' 0 C--O 1.254 1.331 0 CA-C-N 120.95 1.705 . . . . 33.76 110.647 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1014 ' ' THR . . . . . 0.453 HG22 ' HB3' ' A' 1042 ' ' LEU . 5.3 p -75.81 94.83 3.37 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 112.186 -2.279 . . . . 27.89 106.314 174.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1015 ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -145.63 147.19 31.75 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 104.472 -2.418 . . . . 29.02 104.472 173.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1016 ' ' VAL . . . . . 0.539 HG11 ' HZ ' ' A' 1050 ' ' PHE . 11.7 p -110.85 160.83 9.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 O-C-N 118.791 -2.443 . . . . 28.13 106.245 168.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1017 ' ' ALA . . . . . 0.587 ' HB3' HG23 ' A' 1005 ' ' ILE . . . -69.77 -23.34 63.34 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 118.583 -2.573 . . . . 26.87 114.673 -176.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1018 ' ' ALA . . . . . 0.85 ' HB1' ' HB ' ' A' 1022 ' ' THR . . . -156.72 136.29 12.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.454 -0.943 . . . . 26.77 108.454 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1019 ' ' THR . . . . . 0.422 HG23 ' HB2' ' A' 1324 ' ' SER . 41.6 p -72.58 172.7 7.03 Favored Pre-proline 0 C--O 1.249 1.045 0 CA-C-N 119.822 1.192 . . . . 27.02 114.207 174.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1020 ' ' PRO . . . . . 0.524 ' HD2' ' CD2' ' A' 1045 ' ' PHE . 0.1 OUTLIER -49.96 -38.98 49.9 Favored 'Trans proline' 0 C--O 1.245 0.832 0 C-N-CA 123.216 2.611 . . . . 30.57 113.813 166.262 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -63.78 -39.41 94.2 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 113.029 0.752 . . . . 47.81 113.029 173.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1022 ' ' THR . . . . . 0.85 ' HB ' ' HB1' ' A' 1018 ' ' ALA . 0.2 OUTLIER -71.66 -29.48 64.67 Favored 'General case' 0 C--N 1.312 -1.039 0 O-C-N 121.124 -0.985 . . . . 30.77 113.245 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 1023 ' ' VAL . . . . . 0.689 HG22 HG11 ' A' 1033 ' ' VAL . 48.7 t -61.52 -48.49 88.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.862 0 C-N-CA 125.909 1.684 . . . . 33.59 107.416 171.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -55.94 -34.37 65.6 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 120.327 -1.483 . . . . 53.29 112.616 175.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -64.7 -47.76 77.15 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 119.792 1.178 . . . . 46.92 110.596 174.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1026 ' ' LEU . . . . . 0.711 HD21 HG22 ' A' 1332 ' ' VAL . 60.3 mt -59.14 -32.57 69.98 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.574 1.324 . . . . 37.17 114.574 177.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 1.9 tp -65.19 -34.86 79.39 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.874 -1.057 . . . . 44.44 111.689 168.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -67.49 -32.78 73.83 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 122.402 1.096 . . . . 52.58 112.22 175.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1029 ' ' LEU . . . . . 0.605 ' HA ' ' HE2' ' A' 1342 ' ' LYS . 45.2 mt -76.23 -26.11 55.72 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.446 -1.252 . . . . 45.69 110.269 171.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 84.62 43.51 6.84 Favored Glycine 0 N--CA 1.431 -1.698 0 CA-C-O 124.117 1.954 . . . . 42.09 112.679 175.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -118.53 137.71 53.03 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 104.688 -2.338 . . . . 40.72 104.688 -176.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1032 ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' 1002 ' ' ARG . 0.1 OUTLIER -78.5 113.06 16.18 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.187 -1.412 . . . . 37.77 107.187 -172.577 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 1033 ' ' VAL . . . . . 0.689 HG11 HG22 ' A' 1023 ' ' VAL . 3.1 t -85.15 134.37 27.23 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 N-CA-C 107.318 -1.364 . . . . 33.54 107.318 -174.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1034 ' ' ALA . . . . . 0.637 ' HA ' ' HB3' ' A' 1056 ' ' GLU . . . -124.86 129.57 50.67 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 116.753 -1.594 . . . . 31.68 106.742 174.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1035 ' ' VAL . . . . . 0.491 HG22 ' HB ' ' A' 1005 ' ' ILE . 90.5 t -122.16 145.84 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 123.589 2.904 . . . . 31.52 108.331 -178.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1036 ' ' GLU . . . . . 0.6 ' HG2' HG11 ' A' 1063 ' ' VAL . 0.1 OUTLIER -64.66 134.66 54.72 Favored 'General case' 0 N--CA 1.436 -1.158 0 O-C-N 125.249 1.593 . . . . 41.04 108.373 178.509 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 1037 ' ' SER . . . . . . . . . . . . . 25.5 m -75.22 122.51 23.78 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-N 115.093 -0.958 . . . . 31.83 110.422 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 91.36 21.76 33.99 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 114.764 -1.107 . . . . 29.36 112.236 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1039 ' ' ALA . . . . . 0.438 ' HA ' ' HD3' ' A' 1007 ' ' ARG . . . -87.06 -46.01 10.19 Favored 'General case' 0 CA--C 1.495 -1.172 0 O-C-N 119.952 -1.911 . . . . 27.78 109.847 -178.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -70.44 -24.73 76.55 Favored Glycine 0 C--O 1.242 0.596 0 C-N-CA 120.182 -1.008 . . . . 28.91 113.047 -170.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -61.59 -38.11 86.35 Favored 'General case' 0 CA--C 1.505 -0.756 0 O-C-N 124.314 0.655 . . . . 51.18 111.401 175.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1042 ' ' LEU . . . . . 0.453 ' HB3' HG22 ' A' 1014 ' ' THR . 16.8 mt -70.59 -58.2 3.93 Favored 'General case' 0 CA--C 1.513 -0.459 0 O-C-N 121.468 -0.77 . . . . 29.91 110.118 169.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1043 ' ' ALA . . . . . . . . . . . . . . . -65.5 3.8 0.65 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.375 1.62 . . . . 28.54 115.375 -173.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1044 ' ' SER . . . . . . . . . . . . . 49.5 m 65.73 28.77 10.96 Favored 'General case' 0 C--O 1.244 0.791 0 O-C-N 120.259 -1.526 . . . . 33.06 114.95 172.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1045 ' ' PHE . . . . . 0.524 ' CD2' ' HD2' ' A' 1020 ' ' PRO . 0.8 OUTLIER -155.81 101.33 2.12 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 101.86 -3.385 . . . . 30.29 101.86 174.069 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 4.2 p30 -73.36 161.31 30.61 Favored 'General case' 0 C--O 1.248 0.984 0 N-CA-C 117.676 2.472 . . . . 48.62 117.676 -153.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1047 ' ' ASP . . . . . 0.677 ' HA ' ' HD2' ' A' 1050 ' ' PHE . 5.5 m-20 -57.54 -23.4 50.19 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-N 112.493 -2.139 . . . . 36.74 114.993 177.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.9 -32.12 40.25 Favored 'General case' 0 C--O 1.24 0.605 0 O-C-N 121.156 -0.965 . . . . 43.73 111.298 174.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -72.09 -29.79 64.45 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.967 -0.753 . . . . 32.81 108.967 172.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1050 ' ' PHE . . . . . 0.677 ' HD2' ' HA ' ' A' 1047 ' ' ASP . 48.3 m-85 -58.42 -49.07 78.59 Favored 'General case' 0 C--N 1.346 0.442 0 N-CA-C 114.45 1.278 . . . . 31.86 114.45 165.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 6.9 t -59.16 -39.55 78.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 O-C-N 119.881 -1.762 . . . . 33.22 111.891 174.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -61.15 -40.65 94.64 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 123.244 0.617 . . . . 50.83 111.99 172.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -72.06 -23.8 61.42 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 118.98 -2.325 . . . . 33.12 110.822 173.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 101.8 49.31 1.28 Allowed Glycine 0 N--CA 1.439 -1.118 0 C-N-CA 118.247 -1.93 . . . . 35.83 112.443 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1055 ' ' ALA . . . . . 0.436 ' HB1' HG23 ' A' 1035 ' ' VAL . . . -101.98 135.89 42.76 Favored 'General case' 0 N--CA 1.423 -1.775 0 O-C-N 125.0 1.059 . . . . 34.82 111.369 175.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1056 ' ' GLU . . . . . 0.637 ' HB3' ' HA ' ' A' 1034 ' ' ALA . 46.9 tt0 -77.65 99.04 5.65 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 104.968 -2.234 . . . . 49.05 104.968 -177.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1057 ' ' ILE . . . . . 0.427 HD13 ' HB ' ' A' 1035 ' ' VAL . 32.0 mm -75.18 102.96 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 N-CA-C 108.535 -0.913 . . . . 38.53 108.535 -177.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1058 ' ' VAL . . . . . 0.403 HG23 ' HB ' ' A' 1063 ' ' VAL . 2.8 m -127.08 166.5 23.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 122.512 1.149 . . . . 42.11 108.287 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -114.47 141.34 47.81 Favored 'General case' 0 C--O 1.258 1.513 0 O-C-N 120.602 -1.311 . . . . 58.0 109.832 -161.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 44.25 -116.49 1.62 Allowed Glycine 0 N--CA 1.477 1.411 0 N-CA-C 115.736 1.055 . . . . 52.12 115.736 163.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 6.8 m120 -60.28 -38.44 83.59 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 120.153 -0.619 . . . . 54.75 110.046 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1062 ' ' SER . . . . . . . . . . . . . 14.6 m -74.66 -11.67 60.24 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 120.037 -1.664 . . . . 50.34 110.267 -173.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1063 ' ' VAL . . . . . 0.6 HG11 ' HG2' ' A' 1036 ' ' GLU . 11.6 p -88.79 -41.14 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 O-C-N 119.107 -2.246 . . . . 41.46 106.291 166.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1064 ' ' TRP . . . . . 0.513 ' CH2' ' HB3' ' A' 1079 ' ' GLU . 24.9 m95 -64.44 -24.61 67.69 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 115.283 1.586 . . . . 39.32 115.283 -174.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -87.04 79.58 8.65 Favored 'General case' 0 C--O 1.247 0.94 0 O-C-N 120.943 -1.098 . . . . 55.38 109.729 174.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1066 ' ' SER . . . . . 0.43 ' HB3' ' O ' ' A' 1002 ' ' ARG . 69.2 m -135.41 166.06 24.03 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 120.264 -0.575 . . . . 41.87 111.032 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -68.24 -35.67 78.28 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-O 121.593 0.711 . . . . 53.2 110.241 -177.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1068 ' ' ILE . . . . . 0.447 ' HB ' HG12 ' A' 1003 ' ' ILE . 4.9 mp -124.55 141.24 45.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 O-C-N 119.193 -2.192 . . . . 41.9 107.825 173.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1069 ' ' ILE . . . . . . . . . . . . . 19.5 mm -126.34 118.76 52.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 104.139 -2.541 . . . . 38.73 104.139 171.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1070 ' ' LEU . . . . . 0.756 HD21 HD11 ' A' 1335 ' ' LEU . 64.3 mt -93.02 135.74 33.92 Favored 'General case' 0 C--N 1.316 -0.859 0 O-C-N 124.419 1.075 . . . . 32.44 108.553 172.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1071 ' ' LYS . . . . . 0.42 ' HZ2' ' CD ' ' A' 1008 ' ' GLU . 14.1 mmmt -137.21 147.16 45.65 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-O 123.528 1.632 . . . . 34.65 112.714 -175.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1072 ' ' VAL . . . . . 0.581 ' HA ' ' HE2' ' A' 1327 ' ' TYR . 0.0 OUTLIER -86.75 -35.43 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 CA-C-N 110.088 -3.233 . . . . 31.32 111.094 -163.199 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -127.32 -175.96 3.59 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 106.83 -1.545 . . . . 33.94 106.83 165.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1074 ' ' ALA . . . . . 0.558 ' HB1' HD21 ' A' 1101 ' ' LEU . . . -53.97 132.68 58.46 Favored Pre-proline 0 N--CA 1.465 0.31 0 CA-C-N 113.984 -1.462 . . . . 38.04 108.247 166.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1075 ' ' PRO . . . . . 0.497 ' HG2' HD21 ' A' 1089 ' ' LEU . 92.6 Cg_exo -65.88 145.88 81.49 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 123.677 2.918 . . . . 42.68 111.551 175.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 15.3 mt -71.65 159.63 34.06 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 106.49 -1.67 . . . . 46.74 106.49 173.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -50.45 -32.45 17.95 Favored 'General case' 0 C--O 1.242 0.687 0 O-C-N 119.744 -1.848 . . . . 58.61 113.683 171.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 12.4 t0 -51.98 -60.89 2.67 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 124.294 1.038 . . . . 59.2 109.887 167.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1079 ' ' GLU . . . . . 0.513 ' HB3' ' CH2' ' A' 1064 ' ' TRP . 55.6 mt-10 -65.04 -36.83 85.62 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.047 -1.433 . . . . 50.63 114.016 -173.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1080 ' ' ILE . . . . . 0.661 ' HA ' HD23 ' A' 1083 ' ' LEU . 66.3 mt -48.0 -52.46 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.125 1.77 . . . . 51.48 109.275 171.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -66.44 -25.85 66.94 Favored 'General case' 0 CA--C 1.512 -0.518 0 O-C-N 119.323 -2.111 . . . . 50.28 113.743 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 25.8 mt -77.81 -17.76 57.1 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 115.649 -0.705 . . . . 50.21 112.207 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1083 ' ' LEU . . . . . 0.661 HD23 ' HA ' ' A' 1080 ' ' ILE . 1.2 mm? -58.84 134.1 56.59 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 119.305 -2.122 . . . . 49.06 111.329 168.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.72 152.02 42.03 Favored Pre-proline 0 N--CA 1.473 0.705 0 CA-C-O 117.832 -1.08 . . . . 51.08 109.874 -175.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -54.34 116.39 3.03 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 124.707 3.605 . . . . 49.73 110.052 172.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 110.45 -5.8 29.92 Favored Glycine 0 CA--C 1.489 -1.587 0 N-CA-C 112.3 -0.32 . . . . 47.71 112.3 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1087 ' ' THR . . . . . . . . . . . . . 84.0 m -83.54 132.84 34.9 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 118.097 -3.002 . . . . 45.47 109.905 -174.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1088 ' ' THR . . . . . . . . . . . . . 1.6 m -89.09 94.65 10.01 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.333 -1.729 . . . . 42.04 106.333 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1089 ' ' LEU . . . . . 0.56 HD13 HD11 ' A' 1083 ' ' LEU . 54.2 tp -81.36 102.35 10.4 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.182 -0.949 . . . . 38.06 109.376 176.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1090 ' ' VAL . . . . . 0.752 HG13 ' HB2' ' A' 1113 ' ' MET . 3.2 t -99.75 123.05 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 104.822 -2.288 . . . . 37.4 104.822 174.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1091 ' ' SER . . . . . 0.415 ' OG ' ' HB2' ' A' 1071 ' ' LYS . 4.9 m -153.8 165.48 35.91 Favored 'General case' 0 CA--C 1.549 0.915 0 O-C-N 120.103 -1.623 . . . . 36.16 111.319 -175.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 15.2 t80 -86.66 101.97 13.76 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 106.048 -1.834 . . . . 38.94 106.048 166.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 40.3 mm -91.56 -65.34 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 123.046 1.403 . . . . 42.17 113.256 -170.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1094 ' ' TRP . . . . . 0.454 ' CZ2' HD21 ' A' 1130 ' ' LEU . 29.7 m95 69.69 74.63 0.27 Allowed Pre-proline 0 C--N 1.354 0.773 0 CA-C-N 112.185 -2.28 . . . . 46.51 113.947 -159.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -59.03 -32.6 97.8 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 122.803 2.336 . . . . 49.76 115.301 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -63.23 -43.63 97.53 Favored 'General case' 0 C--N 1.356 0.889 0 CA-C-N 120.846 1.657 . . . . 52.62 110.834 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -66.33 -52.72 44.27 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-N 114.257 -1.338 . . . . 60.74 112.621 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1098 ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -120.48 80.43 30.2 Favored Pre-proline 0 C--O 1.239 0.528 0 O-C-N 118.111 -2.868 . . . . 58.19 115.525 -174.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.95 -28.37 58.12 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 124.667 3.578 . . . . 54.59 111.404 175.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -54.97 -48.39 73.3 Favored 'General case' 0 CA--C 1.504 -0.813 0 O-C-N 120.171 -1.58 . . . . 63.28 109.321 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1101 ' ' LEU . . . . . 0.558 HD21 ' HB1' ' A' 1074 ' ' ALA . 1.3 mp -46.98 -52.62 14.24 Favored 'General case' 0 CA--C 1.513 -0.463 0 O-C-N 125.62 1.825 . . . . 54.75 113.685 172.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1102 ' ' MET . . . . . . . . . . . . . 72.8 mmm -57.8 -49.24 77.3 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 113.497 -1.683 . . . . 52.65 109.864 -176.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1103 ' ' GLN . . . . . 0.481 ' O ' ' HG2' ' A' 1107 ' ' GLU . 33.6 mt-30 -58.66 -51.62 69.15 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 123.192 1.472 . . . . 66.26 109.025 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1104 ' ' LYS . . . . . 0.492 ' HB3' HG21 ' A' 1080 ' ' ILE . 98.7 mttt -64.47 -40.75 96.29 Favored 'General case' 0 C--O 1.239 0.539 0 O-C-N 118.599 -2.563 . . . . 63.73 110.884 -176.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 63.3 mt -69.16 -34.46 75.01 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.095 0.558 . . . . 54.68 111.117 176.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -65.3 -42.65 92.86 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 106.766 -1.568 . . . . 53.64 106.766 177.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1107 ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' 1103 ' ' GLN . 47.4 mm-40 -55.85 -40.84 73.45 Favored 'General case' 0 CA--C 1.501 -0.919 0 O-C-N 125.296 1.623 . . . . 67.24 112.826 170.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1108 ' ' ARG . . . . . 0.405 ' HA ' ' NE ' ' A' 1108 ' ' ARG . 3.4 mmp_? -65.86 -23.02 66.58 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 116.945 -1.503 . . . . 65.76 112.685 175.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 30.8 t30 61.43 60.81 1.62 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 126.895 3.236 . . . . 58.71 113.446 -175.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1110 ' ' VAL . . . . . 0.508 HG11 ' HB3' ' A' 1083 ' ' LEU . 19.3 m -122.1 157.9 26.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 111.543 -2.572 . . . . 46.63 108.558 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1111 ' ' THR . . . . . . . . . . . . . 51.6 m -94.81 109.32 21.3 Favored 'General case' 0 N--CA 1.44 -0.961 0 O-C-N 120.999 -1.063 . . . . 44.13 111.426 171.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1112 ' ' VAL . . . . . . . . . . . . . 49.8 t -99.83 119.52 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-O 122.902 1.334 . . . . 40.44 109.366 -175.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1113 ' ' MET . . . . . 0.752 ' HB2' HG13 ' A' 1090 ' ' VAL . 10.7 mtp -108.17 120.52 42.57 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 104.793 -2.299 . . . . 50.76 104.793 177.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1114 ' ' ALA . . . . . 0.497 ' HB3' ' HB2' ' A' 1117 ' ' SER . . . -107.89 108.84 20.18 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 118.204 -2.81 . . . . 35.64 108.363 -175.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1115 ' ' MET . . . . . . . . . . . . . 62.1 mmm -65.92 -19.12 65.76 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 117.947 2.573 . . . . 38.74 117.947 -173.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -71.88 -36.73 70.15 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 122.553 1.168 . . . . 40.14 108.582 166.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1117 ' ' SER . . . . . 0.497 ' HB2' ' HB3' ' A' 1114 ' ' ALA . 58.3 m -86.35 28.63 0.82 Allowed 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 115.085 1.513 . . . . 44.79 115.085 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1118 ' ' VAL . . . . . 0.533 ' HA ' HG22 ' A' 1358 ' ' VAL . 88.0 t -74.05 132.95 79.09 Favored Pre-proline 0 N--CA 1.471 0.611 0 N-CA-C 106.296 -1.742 . . . . 43.75 106.296 171.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -65.95 132.22 29.58 Favored 'Trans proline' 0 C--N 1.323 -0.777 0 C-N-CA 123.752 2.968 . . . . 48.93 108.211 175.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 30.9 mmm-85 -77.26 32.11 0.15 Allowed 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 116.667 2.099 . . . . 62.9 116.667 -164.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 31.8 pt -89.2 170.78 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 120.599 -1.313 . . . . 57.72 111.754 -169.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1122 ' ' SER . . . . . . . . . . . . . 11.4 p -57.2 -58.65 7.28 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 120.04 1.291 . . . . 57.26 114.286 -172.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 31.5 ptt85 -62.03 -19.1 62.52 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 116.576 2.065 . . . . 62.9 116.576 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -77.92 -15.99 58.56 Favored 'General case' 0 C--O 1.214 -0.77 0 O-C-N 120.254 -1.529 . . . . 49.83 113.965 172.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -56.78 -35.9 69.22 Favored 'General case' 0 C--O 1.258 1.521 0 CA-C-N 121.068 1.758 . . . . 52.37 115.019 -171.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1126 ' ' SER . . . . . . . . . . . . . 38.3 m -67.38 -23.55 65.6 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 119.51 -1.994 . . . . 42.43 111.226 176.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1127 ' ' LEU . . . . . . . . . . . . . 6.8 mp -89.79 -29.3 18.75 Favored 'General case' 0 C--O 1.221 -0.423 0 O-C-N 119.297 -2.127 . . . . 43.74 111.645 172.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 51.2 t0 -61.57 107.78 0.86 Allowed 'General case' 0 C--O 1.247 0.942 0 C-N-CA 125.358 1.463 . . . . 43.21 111.994 -170.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -71.62 -37.49 70.9 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 115.277 -0.874 . . . . 35.74 111.336 174.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1130 ' ' LEU . . . . . 0.454 HD21 ' CZ2' ' A' 1094 ' ' TRP . 45.7 mt -66.47 -16.19 63.93 Favored 'General case' 0 C--O 1.244 0.799 0 O-C-N 119.97 -1.706 . . . . 38.09 112.047 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1131 ' ' SER . . . . . 0.417 ' HA ' ' HB ' ' A' 1175 ' ' VAL . 70.6 m -86.63 -64.25 1.18 Allowed 'General case' 0 CA--C 1.55 0.959 0 O-C-N 120.656 -1.278 . . . . 36.91 109.194 163.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1132 ' ' SER . . . . . 0.566 ' HB2' ' OD1' ' A' 1330 ' ' ASN . 1.6 m -76.6 -45.27 30.92 Favored 'General case' 0 C--O 1.244 0.802 0 O-C-N 117.789 -3.069 . . . . 35.79 114.594 -166.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1133 ' ' MET . . . . . 0.833 ' HA ' HD12 ' A' 1136 ' ' ILE . 5.0 ttp -66.38 -42.81 87.39 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 122.08 2.218 . . . . 30.81 108.996 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1134 ' ' ALA . . . . . 0.635 ' HB1' ' HB2' ' A' 1176 ' ' ALA . . . -50.71 -46.57 59.02 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.627 0.973 . . . . 28.88 113.627 166.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1135 ' ' ASN . . . . . 0.553 ' ND2' ' HB2' ' A' 1179 ' ' ALA . 11.3 t-20 -62.47 -36.62 83.04 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 119.762 1.164 . . . . 40.76 111.354 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1136 ' ' ILE . . . . . 0.833 HD12 ' HA ' ' A' 1133 ' ' MET . 57.3 mt -53.02 -57.1 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 O-C-N 121.597 -0.689 . . . . 31.54 110.274 170.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -60.07 -29.71 68.74 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.57 -0.741 . . . . 29.87 112.486 175.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -64.52 -44.53 95.03 Favored Glycine 0 CA--C 1.533 1.174 0 O-C-N 120.649 -1.282 . . . . 28.73 113.757 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 43.2 t80 -60.64 -50.53 73.14 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 123.587 1.66 . . . . 30.39 107.677 173.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1140 ' ' ARG . . . . . 0.704 ' HG3' HD22 ' A' 1315 ' ' LEU . 4.0 tpt180 -61.68 -24.61 66.87 Favored 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 111.81 -2.45 . . . . 26.09 113.107 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1141 ' ' ALA . . . . . 0.627 ' HB2' HD21 ' A' 1284 ' ' LEU . . . -60.1 -38.83 84.13 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 122.136 0.97 . . . . 27.1 113.584 171.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 40.9 mm -66.43 -46.15 87.4 Favored 'Isoleucine or valine' 0 C--O 1.246 0.894 0 O-C-N 121.222 -0.924 . . . . 28.48 109.777 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 94.4 t -57.38 -60.12 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 114.394 -1.275 . . . . 23.07 110.207 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1144 ' ' GLU . . . . . 0.451 ' HG2' ' HE ' ' A' 1140 ' ' ARG . 5.4 mm-40 -72.93 -21.28 60.91 Favored 'General case' 0 CA--C 1.502 -0.879 0 O-C-N 124.262 0.976 . . . . 33.4 113.322 -175.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1145 ' ' ALA . . . . . 0.842 ' HB1' HD12 ' A' 1251 ' ' ILE . . . -55.48 -57.65 11.03 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 124.013 0.821 . . . . 24.22 108.96 163.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1146 ' ' ALA . . . . . 0.565 ' HB2' ' HE2' ' A' 1153 ' ' PHE . . . -67.43 -16.18 64.08 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 124.522 1.139 . . . . 24.89 111.96 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 66.2 t-80 -72.34 -49.3 35.32 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 117.911 -1.042 . . . . 26.73 108.397 175.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1148 ' ' GLU . . . . . 0.825 ' HB3' ' HD2' ' A' 1308 ' ' LYS . 13.1 mm-40 -81.63 -15.05 55.84 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 121.493 1.951 . . . . 39.96 115.139 175.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1149 ' ' PHE . . . . . 0.557 ' HB2' ' HA ' ' A' 1146 ' ' ALA . 0.6 OUTLIER -59.18 140.03 56.32 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 125.226 2.441 . . . . 25.87 109.767 -170.499 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 1150 ' ' GLY . . . . . . . . . . . . . . . -79.99 -35.51 27.41 Favored Glycine 0 N--CA 1.426 -2.019 0 CA-C-N 109.823 -3.353 . . . . 19.28 109.248 170.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1151 ' ' ARG . . . . . 0.568 ' HA ' ' HB2' ' B' 1322 ' ' GLN . 10.9 mtt-85 -108.48 -169.94 1.59 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.789 0.804 . . . . 39.9 112.756 -159.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1152 ' ' PHE . . . . . 0.551 ' HB2' ' HG2' ' B' 1322 ' ' GLN . 1.7 t80 -110.98 145.92 37.57 Favored 'General case' 0 C--O 1.248 0.978 0 CA-C-O 118.178 -0.915 . . . . 29.44 109.078 178.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1153 ' ' PHE . . . . . 0.565 ' HE2' ' HB2' ' A' 1146 ' ' ALA . 25.5 m-85 -66.94 -50.74 61.41 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 120.924 1.693 . . . . 32.6 114.269 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1154 ' ' THR . . . . . 0.438 HG21 HG22 ' C' ' 81' ' ' VAL . 51.6 m -93.59 134.84 35.47 Favored 'General case' 0 CA--C 1.549 0.923 0 O-C-N 120.665 -1.272 . . . . 34.64 110.653 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -76.67 69.77 2.32 Favored Glycine 0 C--N 1.338 0.651 0 O-C-N 121.53 -0.731 . . . . 37.14 112.023 176.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -81.28 151.73 27.94 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 116.107 1.891 . . . . 40.57 116.107 -175.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1157 ' ' ILE . . . . . 0.443 HG23 ' H ' ' C' ' 77' ' ' GLY . 6.9 tp -79.25 119.21 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 123.068 1.413 . . . . 44.61 110.58 165.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1158 ' ' THR . . . . . . . . . . . . . 37.7 p -92.15 -168.27 1.96 Allowed 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.489 -1.232 . . . . 40.7 109.59 174.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -76.13 -23.18 54.84 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 124.091 3.132 . . . . 40.25 108.596 173.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -85.37 -60.8 1.92 Allowed 'General case' 0 C--O 1.251 1.175 0 CA-C-N 115.804 -0.635 . . . . 38.47 110.012 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1161 ' ' GLY . . . . . 0.628 ' HA3' HG21 ' B' 1329 ' ' THR . . . 175.66 -157.55 23.98 Favored Glycine 0 CA--C 1.505 -0.575 0 O-C-N 118.625 -2.547 . . . . 37.61 110.471 -174.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1162 ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' 1163 ' ' VAL . 32.3 tttt -92.84 138.99 31.0 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 125.332 2.491 . . . . 48.9 113.335 -163.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1163 ' ' VAL . . . . . 0.527 HG11 ' HB3' ' A' 1152 ' ' PHE . 24.9 t -83.9 147.11 50.61 Favored Pre-proline 0 C--N 1.305 -1.338 0 CA-C-N 109.202 -3.636 . . . . 36.52 109.241 167.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1164 ' ' PRO . . . . . 0.435 ' HA ' ' HD2' ' A' 1165 ' ' PRO . 45.5 Cg_endo -69.58 119.75 6.66 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 124.756 3.637 . . . . 35.08 116.106 162.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1165 ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' 1164 ' ' PRO . 97.5 Cg_endo -66.16 142.96 69.5 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.612 2.208 . . . . 35.33 115.17 176.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -82.36 126.63 32.39 Favored 'General case' 0 C--N 1.343 0.295 0 O-C-N 120.389 -1.444 . . . . 34.69 112.955 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1167 ' ' LYS . . . . . 0.583 ' HB2' ' HA ' ' A' 1249 ' ' VAL . 61.7 mttp -86.52 102.07 13.77 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 106.293 -1.743 . . . . 45.36 106.293 168.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 16.2 t -88.58 86.36 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 112.567 -2.106 . . . . 31.71 110.006 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1169 ' ' MET . . . . . 0.65 ' HA ' ' O ' ' A' 1192 ' ' ARG . 62.4 ttp -79.34 103.53 9.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 123.933 1.825 . . . . 42.28 110.73 176.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 21.6 t -92.26 119.27 39.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 106.699 -1.593 . . . . 30.51 106.699 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 63.9 mt -108.92 126.84 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 104.898 -2.26 . . . . 31.87 104.898 -173.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1172 ' ' GLY . . . . . 0.584 ' O ' ' HB ' ' A' 1255 ' ' THR . . . 70.83 71.64 1.0 Allowed Glycine 0 C--N 1.352 1.449 0 C-N-CA 119.719 -1.229 . . . . 34.54 110.3 -175.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1173 ' ' ALA . . . . . . . . . . . . . . . -76.97 68.66 3.16 Favored 'General case' 0 C--O 1.243 0.752 0 O-C-N 121.188 -1.183 . . . . 32.51 111.854 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -78.7 -173.03 42.35 Favored Glycine 0 C--N 1.342 0.871 0 N-CA-C 107.667 -2.173 . . . . 29.9 107.667 164.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1175 ' ' VAL . . . . . 0.488 HG12 ' HB2' ' A' 1135 ' ' ASN . 48.8 t -62.83 -31.22 51.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 121.58 2.69 . . . . 33.11 113.995 -172.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1176 ' ' ALA . . . . . 0.635 ' HB2' ' HB1' ' A' 1134 ' ' ALA . . . -58.7 -52.44 65.67 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 118.102 0.41 . . . . 28.1 110.621 168.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -56.72 -36.13 70.64 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.27 0.938 . . . . 28.54 112.653 173.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1178 ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' 1175 ' ' VAL . 56.6 mt -65.64 -37.85 87.73 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 118.244 1.022 . . . . 31.22 110.702 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1179 ' ' ALA . . . . . 0.553 ' HB2' ' ND2' ' A' 1135 ' ' ASN . . . -64.11 -42.7 96.79 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 112.406 0.521 . . . . 28.98 112.406 173.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -58.98 -44.91 91.66 Favored 'General case' 0 C--N 1.352 0.683 0 O-C-N 125.012 1.445 . . . . 27.83 113.995 173.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1181 ' ' ILE . . . . . 0.571 HD13 HG22 ' A' 1204 ' ' VAL . 47.1 mt -60.61 -51.08 77.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 O-C-N 122.045 -0.409 . . . . 30.25 111.232 178.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -60.67 -57.42 19.02 Favored Glycine 0 CA--C 1.525 0.665 0 O-C-N 126.523 2.389 . . . . 29.59 111.56 -174.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -55.09 -50.1 70.03 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 119.057 1.428 . . . . 30.29 111.534 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1184 ' ' ALA . . . . . 0.579 ' HA ' HD12 ' A' 1187 ' ' LEU . . . -70.31 -27.14 64.15 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 114.988 1.477 . . . . 30.47 114.988 -175.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -71.86 -40.31 69.06 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-O 116.144 -1.884 . . . . 42.41 110.181 172.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1186 ' ' SER . . . . . . . . . . . . . 1.5 m -64.52 -31.05 72.1 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-N 119.752 1.16 . . . . 39.38 110.617 172.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1187 ' ' LEU . . . . . 0.846 ' HA ' ' HB3' ' B' 1186 ' ' SER . 58.9 mt -65.75 -33.36 75.7 Favored 'General case' 0 C--N 1.345 0.393 0 O-C-N 119.187 -2.196 . . . . 36.18 111.404 168.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 84.8 60.35 1.88 Allowed Glycine 0 N--CA 1.433 -1.542 0 CA-C-O 123.366 1.537 . . . . 33.78 110.076 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -119.11 160.22 22.48 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 113.751 -1.224 . . . . 33.93 108.722 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 79.0 mt -79.33 81.57 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.825 0 C-N-CA 118.841 -1.144 . . . . 38.74 108.915 -173.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 12.1 t -81.56 131.86 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.792 -1.188 . . . . 33.09 107.792 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1192 ' ' ARG . . . . . 0.65 ' O ' ' HA ' ' A' 1169 ' ' MET . 1.2 ptp180 -139.58 103.29 4.66 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 104.926 -2.25 . . . . 38.92 104.926 177.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -95.46 131.96 41.05 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 110.883 -2.871 . . . . 35.32 110.983 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1194 ' ' PHE . . . . . 0.47 ' HD1' ' O ' ' A' 1212 ' ' LEU . 71.5 t80 -111.93 140.12 46.86 Favored 'General case' 0 C--O 1.248 1.002 0 O-C-N 119.236 -2.165 . . . . 39.35 106.537 168.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 8.9 t0 -141.51 150.12 41.76 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 105.197 -2.149 . . . . 40.46 105.197 163.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1196 ' ' THR . . . . . . . . . . . . . 1.3 m -60.19 -32.33 70.97 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 111.816 -2.447 . . . . 45.94 110.064 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1197 ' ' ARG . . . . . 0.432 ' HA ' ' HD2' ' A' 1198 ' ' PRO . 59.9 mtm180 -83.13 117.81 69.74 Favored Pre-proline 0 N--CA 1.447 -0.624 0 C-N-CA 124.99 1.316 . . . . 56.02 108.739 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1198 ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' 1197 ' ' ARG . 74.5 Cg_endo -67.45 -19.06 49.53 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.891 2.394 . . . . 51.27 110.058 176.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -58.17 -37.97 75.74 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 124.248 1.019 . . . . 59.1 113.146 -174.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 16.1 m -83.96 5.2 2.36 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.583 0 N-CA-C 116.949 2.204 . . . . 51.06 116.949 -172.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1201 ' ' LYS . . . . . 0.403 ' HA ' ' CD1' ' A' 1211 ' ' PHE . 81.2 tttt -62.61 -55.47 26.83 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 126.194 1.798 . . . . 57.38 111.736 -172.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -54.9 -44.36 74.08 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 113.034 -1.894 . . . . 62.41 112.698 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -61.83 -47.87 83.12 Favored 'General case' 0 C--N 1.344 0.349 0 O-C-N 124.166 0.916 . . . . 57.78 112.794 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1204 ' ' VAL . . . . . 0.571 HG22 HD13 ' A' 1181 ' ' ILE . 82.6 t -49.39 -46.76 19.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 122.29 1.043 . . . . 46.38 113.428 176.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -69.61 -30.21 67.91 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 113.432 -1.713 . . . . 50.7 111.592 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1206 ' ' SER . . . . . . . . . . . . . 24.6 m -70.93 -22.1 62.27 Favored 'General case' 0 N--CA 1.435 -1.225 0 O-C-N 120.345 -1.472 . . . . 49.98 113.375 172.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1207 ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -76.58 -49.91 15.18 Favored 'General case' 0 C--N 1.362 1.131 0 O-C-N 118.974 -2.329 . . . . 52.99 108.341 164.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 126.67 58.1 0.14 Allowed Glycine 0 C--N 1.304 -1.233 0 N-CA-C 109.292 -1.523 . . . . 47.66 109.292 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -144.73 150.84 37.95 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 106.407 -1.701 . . . . 44.77 106.407 -177.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -65.98 137.99 57.51 Favored 'General case' 0 C--O 1.252 1.232 0 O-C-N 125.936 2.023 . . . . 47.64 106.587 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1211 ' ' PHE . . . . . 0.403 ' CD1' ' HA ' ' A' 1201 ' ' LYS . 44.6 t80 -104.13 116.92 33.08 Favored 'General case' 0 C--N 1.31 -1.109 1 N-CA-C 99.786 -4.153 . . . . 45.66 99.786 166.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 1212 ' ' LEU . . . . . 0.47 ' O ' ' HD1' ' A' 1194 ' ' PHE . 97.1 mt -71.2 119.63 15.62 Favored 'General case' 0 C--O 1.201 -1.486 0 N-CA-C 106.627 -1.62 . . . . 46.06 106.627 -177.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -82.62 140.47 33.17 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 127.45 2.969 . . . . 60.22 110.107 171.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 29.4 tp -81.21 125.81 30.75 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 127.328 3.442 . . . . 57.25 107.886 -166.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 24.6 t70 -74.59 87.66 2.14 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 111.729 -2.487 . . . . 64.43 109.613 165.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 47.8 t80 . . . . . 0 N--CA 1.432 -1.366 0 CA-C-N 113.178 -1.828 . . . . 66.9 107.394 -178.475 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 3.6 p-10 . . . . . 0 N--CA 1.442 -0.867 0 N-CA-C 107.655 -1.239 . . . . 39.09 107.655 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -54.33 -57.14 18.31 Favored Glycine 0 C--O 1.224 -0.474 0 O-C-N 127.301 2.876 . . . . 39.32 115.346 -174.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 24.7 t80 -72.76 -39.82 66.51 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-N 118.294 1.047 . . . . 39.3 111.277 -169.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -68.35 -42.38 79.31 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.675 -1.602 . . . . 36.3 106.675 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -58.9 -44.43 91.21 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 116.211 -1.852 . . . . 37.38 111.293 175.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -59.3 -51.79 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 125.036 1.46 . . . . 39.11 112.665 174.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1230 ' ' MET . . . . . . . . . . . . . 26.8 mmt -84.27 70.46 10.6 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 123.135 1.445 . . . . 49.59 110.211 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1231 ' ' SER . . . . . . . . . . . . . 61.5 m -138.93 154.62 48.36 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.556 -1.202 . . . . 43.68 109.152 176.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -58.63 -66.8 0.44 Allowed 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.311 1.045 . . . . 55.57 111.672 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1233 ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' 1236 ' ' LYS . . . -62.41 -23.83 67.06 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.092 -0.958 . . . . 44.94 113.006 -174.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 15.1 t80 -66.75 -51.89 50.59 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-O 117.522 -1.227 . . . . 42.04 109.383 171.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 13.3 mt -68.57 -26.0 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 123.554 2.888 . . . . 46.28 109.054 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1236 ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' 1233 ' ' ALA . 33.3 tttm -61.75 -46.14 90.9 Favored 'General case' 0 C--O 1.237 0.43 0 O-C-N 119.705 -1.872 . . . . 47.87 109.308 169.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -67.52 -36.52 81.18 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-N 115.816 -0.629 . . . . 41.61 111.81 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -58.5 -56.36 23.11 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.076 0.55 . . . . 50.65 110.142 173.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1239 ' ' MET . . . . . . . . . . . . . 3.2 mtm -52.66 -45.71 66.85 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 114.044 1.127 . . . . 48.87 114.044 173.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -68.91 -33.43 73.74 Favored 'General case' 0 C--N 1.315 -0.907 0 O-C-N 121.618 -0.676 . . . . 54.8 110.998 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.42 -45.12 85.14 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 105.334 -2.099 . . . . 43.21 105.334 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -67.17 -36.92 82.81 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.08 1.352 . . . . 38.66 113.202 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1243 ' ' ALA . . . . . 0.568 ' HA ' ' HG3' ' A' 1271 ' ' MET . . . -62.26 -45.76 91.88 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 123.015 0.526 . . . . 37.92 112.289 175.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -67.16 -36.93 82.87 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 121.445 -0.784 . . . . 37.28 110.99 176.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -65.75 -30.38 71.03 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 112.971 0.73 . . . . 43.07 112.971 172.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -59.09 -34.18 71.69 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 112.565 0.58 . . . . 38.3 112.565 -175.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1247 ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.1 -15.55 63.46 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 119.521 -0.872 . . . . 47.6 112.869 178.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -114.2 -25.39 8.5 Favored 'General case' 0 N--CA 1.441 -0.924 0 O-C-N 119.077 -2.264 . . . . 45.42 115.988 176.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1249 ' ' VAL . . . . . 0.583 ' HA ' ' HB2' ' A' 1167 ' ' LYS . 34.7 m -74.93 163.68 3.92 Favored 'Isoleucine or valine' 0 C--O 1.247 0.944 0 CA-C-N 121.74 2.064 . . . . 36.26 116.541 -173.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1250 ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' 1279 ' ' SER . 2.4 m-20 -124.81 -57.45 1.53 Allowed 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 113.448 -1.705 . . . . 33.04 108.432 -170.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1251 ' ' ILE . . . . . 0.842 HD12 ' HB1' ' A' 1145 ' ' ALA . 34.6 mm -110.91 131.67 61.49 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.977 0 N-CA-C 106.613 -1.625 . . . . 31.4 106.613 175.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1252 ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' 1169 ' ' MET . 52.3 mt -122.43 134.97 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 N-CA-C 103.912 -2.625 . . . . 29.42 103.912 170.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 9.2 t -117.45 92.31 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 103.102 -2.925 . . . . 30.37 103.102 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1254 ' ' THR . . . . . 0.514 ' HB ' ' HB2' ' A' 1291 ' ' ASN . 0.7 OUTLIER -79.35 98.02 6.55 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 123.189 1.471 . . . . 35.72 113.213 179.421 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 1255 ' ' THR . . . . . 0.584 ' HB ' ' O ' ' A' 1172 ' ' GLY . 4.0 m -111.5 0.16 16.4 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.09 -1.414 . . . . 36.0 114.466 -168.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1256 ' ' ALA . . . . . . . . . . . . . . . -84.3 79.32 9.58 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 125.607 2.622 . . . . 40.93 113.553 -170.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 41.7 tp -94.36 109.53 21.37 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 112.024 -2.353 . . . . 47.82 106.777 172.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 28.1 mm -66.37 119.05 59.37 Favored Pre-proline 0 CA--C 1.554 1.116 0 N-CA-C 103.651 -2.722 . . . . 52.7 103.651 168.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -53.25 125.32 18.02 Favored 'Trans proline' 0 C--N 1.35 0.637 1 C-N-CA 126.002 4.468 . . . . 54.13 112.313 -173.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 76.2 6.12 82.55 Favored Glycine 0 CA--C 1.489 -1.576 0 CA-C-O 119.907 -0.385 . . . . 54.62 112.947 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 89.2 mttt -128.78 155.84 78.64 Favored Pre-proline 0 C--O 1.252 1.198 0 O-C-N 119.492 -2.181 . . . . 55.74 109.337 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -61.36 117.8 4.63 Favored 'Trans proline' 0 N--CA 1.44 -1.63 0 C-N-CA 121.905 1.737 . . . . 51.15 113.083 168.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -51.26 132.47 32.61 Favored Pre-proline 0 N--CA 1.473 0.695 0 CA-C-N 113.094 -1.866 . . . . 46.06 111.953 176.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1264 ' ' PRO . . . . . 0.46 ' O ' ' HA ' ' A' 1291 ' ' ASN . 57.4 Cg_endo -55.62 138.86 82.09 Favored 'Trans proline' 0 C--O 1.249 1.051 0 C-N-CA 124.974 3.782 . . . . 41.08 112.283 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -78.13 99.59 6.23 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 104.22 -2.511 . . . . 47.42 104.22 171.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 94.6 mt -98.89 -21.09 16.47 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 113.189 -1.823 . . . . 39.22 111.299 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1267 ' ' ILE . . . . . 0.664 HG23 ' SD ' ' A' 1271 ' ' MET . 86.4 mt -117.55 114.23 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 O-C-N 118.298 -2.751 . . . . 42.5 106.718 172.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1268 ' ' THR . . . . . 0.401 ' H ' ' HE3' ' A' 1271 ' ' MET . 5.0 p -80.31 162.49 24.54 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 115.665 1.728 . . . . 37.84 115.665 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -60.6 -41.87 95.61 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-O 116.381 -1.771 . . . . 54.8 112.764 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -53.06 -51.07 62.97 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 125.243 1.417 . . . . 54.36 110.825 171.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1271 ' ' MET . . . . . 0.664 ' SD ' HG23 ' A' 1267 ' ' ILE . 43.0 ttm -55.49 -44.11 76.21 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 125.483 1.739 . . . . 39.52 112.485 -178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1272 ' ' VAL . . . . . 0.408 ' CG1' HG21 ' A' 1303 ' ' THR . 2.4 t -68.05 -45.57 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 120.781 1.628 . . . . 38.25 110.588 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -59.77 -28.27 67.25 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 114.64 1.348 . . . . 40.77 114.64 173.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1274 ' ' SER . . . . . . . . . . . . . 20.4 m -89.02 13.37 13.08 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 113.591 0.96 . . . . 36.58 113.591 172.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1275 ' ' MET . . . . . 0.583 ' HB3' HG21 ' A' 1307 ' ' VAL . 36.0 ttm -85.69 164.53 17.6 Favored 'General case' 0 C--O 1.246 0.87 0 O-C-N 120.899 -1.125 . . . . 36.75 109.573 -175.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1276 ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -76.8 130.62 37.92 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 105.527 -2.027 . . . . 46.11 105.527 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1277 ' ' ALA . . . . . 0.451 ' HB3' ' CD1' ' B' 1045 ' ' PHE . . . -86.01 172.17 10.85 Favored 'General case' 0 CA--C 1.504 -0.796 0 O-C-N 120.181 -1.574 . . . . 33.52 115.14 -168.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 86.26 14.99 65.32 Favored Glycine 0 C--O 1.217 -0.939 0 O-C-N 120.648 -1.283 . . . . 31.27 111.799 -171.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1279 ' ' SER . . . . . 0.468 ' HB3' ' O ' ' A' 1250 ' ' ASP . 36.9 m -130.45 163.88 26.01 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 124.108 0.963 . . . . 32.95 111.006 -156.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1280 ' ' VAL . . . . . . . . . . . . . 65.4 t -134.93 131.65 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 O-C-N 119.959 -1.713 . . . . 27.43 111.466 -170.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1281 ' ' ILE . . . . . 0.553 HD11 ' SD ' ' A' 1275 ' ' MET . 46.3 mt -106.36 104.35 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 106.213 -1.773 . . . . 30.3 106.213 171.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 43.9 t -88.9 109.74 20.52 Favored 'Isoleucine or valine' 0 C--O 1.252 1.215 0 O-C-N 119.189 -2.195 . . . . 28.63 106.773 175.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 5.0 t70 -86.15 96.64 9.97 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 123.277 1.513 . . . . 36.27 108.14 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1284 ' ' LEU . . . . . 0.627 HD21 ' HB2' ' A' 1141 ' ' ALA . 21.1 mt -73.69 -12.73 60.82 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 112.604 -2.089 . . . . 38.57 112.889 172.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -77.24 -34.58 55.84 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 120.922 1.692 . . . . 37.56 110.179 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1286 ' ' ALA . . . . . 0.572 ' HB1' HG23 ' A' 1313 ' ' THR . . . 33.54 -74.33 0.0 OUTLIER 'General case' 0 C--O 1.246 0.883 1 N-CA-C 123.423 4.601 . . . . 40.33 123.423 171.191 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -55.15 -40.54 70.73 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 116.966 2.21 . . . . 56.85 116.966 -166.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 18.0 m120 -125.59 116.89 22.44 Favored 'General case' 0 CA--C 1.491 -1.317 0 O-C-N 119.688 -1.883 . . . . 45.86 107.211 177.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 73.82 -74.6 1.14 Allowed Glycine 0 C--N 1.345 1.033 0 N-CA-C 110.859 -0.896 . . . . 40.31 110.859 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 86.03 134.26 3.52 Favored Glycine 0 C--O 1.237 0.335 0 N-CA-C 109.493 -1.443 . . . . 38.89 109.493 -173.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1291 ' ' ASN . . . . . 0.514 ' HB2' ' HB ' ' A' 1254 ' ' THR . 25.6 m120 -70.93 -24.91 62.54 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-N 118.009 0.905 . . . . 37.23 112.391 -167.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1292 ' ' CYS . . . . . 0.426 ' HB3' ' OG1' ' A' 1295 ' ' THR . 53.7 t -91.58 155.65 18.21 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 120.835 -1.166 . . . . 36.5 111.853 177.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1293 ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -83.46 6.51 19.98 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 119.729 -1.857 . . . . 43.32 115.343 173.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -113.47 8.5 17.84 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-O 123.053 1.406 . . . . 41.32 111.99 171.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1295 ' ' THR . . . . . 0.426 ' OG1' ' HB3' ' A' 1292 ' ' CYS . 33.5 m -75.84 95.14 3.43 Favored 'General case' 0 CA--C 1.501 -0.938 0 O-C-N 118.744 -2.472 . . . . 35.3 112.098 -176.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 60.1 t -92.07 115.94 65.57 Favored Pre-proline 0 N--CA 1.437 -1.124 0 CA-C-N 109.583 -3.462 . . . . 34.84 105.562 169.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -54.51 107.78 0.25 Allowed 'Trans proline' 0 C--O 1.247 0.975 0 C-N-CA 124.969 3.779 . . . . 33.51 115.202 174.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 85.65 28.12 30.39 Favored Glycine 0 N--CA 1.442 -0.9 0 CA-C-N 111.761 -2.472 . . . . 32.19 113.793 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -140.36 158.0 44.68 Favored 'General case' 0 C--O 1.242 0.685 0 O-C-N 118.935 -2.509 . . . . 34.88 111.475 177.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1300 ' ' ILE . . . . . . . . . . . . . 31.4 mt -94.88 124.46 47.39 Favored 'Isoleucine or valine' 0 C--O 1.254 1.315 0 N-CA-C 105.152 -2.166 . . . . 32.29 105.152 169.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -128.4 108.03 10.23 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 105.385 -2.08 . . . . 37.25 105.385 175.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1302 ' ' THR . . . . . . . . . . . . . 55.9 m -75.53 135.26 40.62 Favored 'General case' 0 C--O 1.243 0.736 0 O-C-N 120.847 -1.158 . . . . 35.56 108.529 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1303 ' ' THR . . . . . 0.408 HG21 ' CG1' ' A' 1272 ' ' VAL . 35.8 p -85.07 172.36 11.32 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 119.581 -1.95 . . . . 36.4 109.981 176.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -61.97 -42.67 99.38 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 118.647 0.658 . . . . 52.32 111.914 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -64.56 -35.77 82.06 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.628 0.728 . . . . 40.04 112.644 176.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 117.17 44.79 0.55 Allowed Glycine 0 C--O 1.217 -0.912 0 O-C-N 120.063 -1.648 . . . . 36.96 110.157 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1307 ' ' VAL . . . . . 0.583 HG21 ' HB3' ' A' 1275 ' ' MET . 74.3 t -113.51 124.5 70.21 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.233 0 N-CA-C 104.273 -2.491 . . . . 33.4 104.273 171.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1308 ' ' LYS . . . . . 0.825 ' HD2' ' HB3' ' A' 1148 ' ' GLU . 88.3 mttt -84.6 119.26 25.01 Favored 'General case' 0 CA--C 1.496 -1.127 0 C-N-CA 119.411 -0.916 . . . . 42.91 109.465 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 57.3 t -96.52 130.73 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.082 0 N-CA-C 106.919 -1.511 . . . . 32.29 106.919 172.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1310 ' ' ILE . . . . . . . . . . . . . 1.5 mt -125.06 111.27 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.369 0 O-C-N 120.512 -1.367 . . . . 30.99 108.125 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -83.31 59.3 4.99 Favored Glycine 0 N--CA 1.466 0.686 0 O-C-N 120.448 -1.408 . . . . 28.95 109.885 174.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1312 ' ' TYR . . . . . 0.437 ' HD1' ' HA ' ' A' 1312 ' ' TYR 0.252 0.5 OUTLIER -73.98 85.77 1.79 Allowed 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 121.189 2.495 . . . . 31.69 116.952 -172.301 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A 1313 ' ' THR . . . . . 0.572 HG23 ' HB1' ' A' 1286 ' ' ALA . 0.8 OUTLIER -54.57 -53.44 54.58 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 113.906 -1.497 . . . . 34.17 112.823 168.414 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -65.42 5.9 0.36 Allowed 'General case' 0 C--O 1.248 1.021 0 N-CA-C 116.849 2.166 . . . . 36.86 116.849 -172.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1315 ' ' LEU . . . . . 0.704 HD22 ' HG3' ' A' 1140 ' ' ARG . 58.5 mt -47.09 -39.92 20.48 Favored Pre-proline 0 CA--C 1.547 0.86 0 CA-C-N 121.544 1.975 . . . . 34.85 116.123 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -57.19 -43.12 55.94 Favored 'Trans proline' 0 CA--C 1.505 -0.953 0 CA-C-N 123.311 2.218 . . . . 29.15 116.542 168.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -66.04 -39.19 94.66 Favored Glycine 0 C--N 1.313 -0.709 0 O-C-N 119.918 -1.738 . . . . 27.29 111.859 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1318 ' ' ARG . . . . . 0.488 ' HB3' ' NH2' ' A' 1140 ' ' ARG . 92.7 mtt-85 -62.97 -25.03 68.18 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 124.747 1.219 . . . . 41.49 113.796 174.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1319 ' ' LEU . . . . . 0.482 HD23 HG23 ' A' 1136 ' ' ILE . 12.7 tp -115.91 70.26 3.68 Favored Pre-proline 0 C--O 1.251 1.132 0 N-CA-C 107.748 -1.205 . . . . 27.61 107.748 172.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1320 ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -59.5 -59.68 0.4 Allowed 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 122.722 2.281 . . . . 25.94 115.057 -163.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1321 ' ' THR . . . . . . . . . . . . . 7.6 m -65.0 -36.45 84.45 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 108.735 -0.839 . . . . 25.01 108.735 -171.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1322 ' ' GLN . . . . . 0.461 ' HB2' ' HA ' ' B' 1151 ' ' ARG . 31.6 tp60 -72.97 -32.31 65.13 Favored 'General case' 0 CA--C 1.502 -0.866 0 O-C-N 120.988 -1.07 . . . . 29.39 112.18 -172.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1323 ' ' SER . . . . . 0.586 ' HA ' HD13 ' A' 1136 ' ' ILE . 40.2 m -65.68 -50.66 64.12 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 107.098 -1.445 . . . . 26.47 107.098 172.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1324 ' ' SER . . . . . 0.422 ' HB2' HG23 ' A' 1019 ' ' THR . 3.4 m -60.8 -23.62 65.18 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.962 0.905 . . . . 27.78 112.22 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 19.4 tm0? -86.43 -76.29 0.35 Allowed 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.782 -1.562 . . . . 37.53 106.782 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1326 ' ' LEU . . . . . 0.55 ' HB2' HD11 ' A' 1136 ' ' ILE . 92.8 mt -54.76 -62.27 1.77 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 115.446 1.647 . . . . 35.71 115.446 -175.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1327 ' ' TYR . . . . . 0.581 ' HE2' ' HA ' ' A' 1072 ' ' VAL . 30.3 t80 -63.85 -35.49 80.81 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 107.613 -1.254 . . . . 31.59 107.613 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1328 ' ' GLY . . . . . 0.547 ' HA2' HD12 ' A' 1331 ' ' LEU . . . -54.06 -46.18 70.5 Favored Glycine 0 C--N 1.359 1.818 0 O-C-N 124.156 0.91 . . . . 28.0 111.699 171.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1329 ' ' THR . . . . . 0.507 ' HA ' ' HB ' ' A' 1332 ' ' VAL . 28.5 m -71.29 -24.46 62.15 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 123.241 0.616 . . . . 32.15 110.922 175.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1330 ' ' ASN . . . . . 0.566 ' OD1' ' HB2' ' A' 1132 ' ' SER . 3.1 m120 -61.78 -54.07 47.41 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 116.911 -3.618 . . . . 34.36 107.246 174.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1331 ' ' LEU . . . . . 0.657 HD13 ' HB3' ' A' 1070 ' ' LEU . 12.9 mt -47.01 -54.51 10.04 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 126.548 1.939 . . . . 33.37 111.155 170.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1332 ' ' VAL . . . . . 0.711 HG22 HD21 ' A' 1026 ' ' LEU . 70.0 t -63.98 -32.71 58.27 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.729 0 CA-C-O 117.179 -1.391 . . . . 35.27 114.073 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -73.67 -31.19 63.34 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 124.191 3.178 . . . . 37.66 110.737 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1334 ' ' LEU . . . . . . . . . . . . . 43.3 tp -60.71 -51.11 70.74 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-N 118.687 0.676 . . . . 40.27 110.592 164.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1335 ' ' LEU . . . . . 0.756 HD11 HD21 ' A' 1070 ' ' LEU . 55.2 mt -54.5 -34.96 62.58 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 114.793 1.405 . . . . 42.5 114.793 168.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1336 ' ' LYS . . . . . 0.597 ' HG2' HD21 ' A' 1029 ' ' LEU . 90.0 mttt -60.69 -46.17 91.38 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 123.18 2.718 . . . . 47.81 112.977 174.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1337 ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.85 -36.99 78.0 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 124.365 1.041 . . . . 49.27 113.251 173.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1338 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.8 -32.51 70.99 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 124.628 1.171 . . . . 50.54 111.16 172.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1339 ' ' CYS . . . . . 0.591 ' HB3' ' HG2' ' A' 1342 ' ' LYS . 64.8 m -79.48 88.78 5.04 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 124.052 1.882 . . . . 53.67 107.958 172.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -76.01 -66.26 0.81 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 113.67 -1.605 . . . . 63.38 106.734 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -85.69 -18.88 31.87 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.384 -0.826 . . . . 70.95 110.626 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1342 ' ' LYS . . . . . 0.605 ' HE2' ' HA ' ' A' 1029 ' ' LEU . 5.8 mtpm? 68.41 56.91 0.47 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.129 -1.396 . . . . 65.25 114.437 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1343 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 172.84 -38.49 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.389 2 O-C-N 112.345 -6.472 . . . . 64.53 107.714 -17.335 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 1344 ' ' GLY . . . . . . . . . . . . . . . 84.34 -62.45 4.57 Favored Glycine 0 C--N 1.346 1.118 0 O-C-N 117.491 -3.255 . . . . 59.72 111.129 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 4.6 t30 -116.62 132.23 56.74 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 103.666 -2.716 . . . . 64.09 103.666 169.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1346 ' ' ILE . . . . . . . . . . . . . 20.8 pt -62.92 164.47 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.256 1.409 0 O-C-N 123.891 0.744 . . . . 58.82 112.785 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1347 ' ' THR . . . . . . . . . . . . . 1.8 m -124.97 92.98 3.76 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 104.834 -2.284 . . . . 54.96 104.834 -176.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1348 ' ' VAL . . . . . . . . . . . . . 60.2 t -77.29 84.78 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 N-CA-C 105.201 -2.148 . . . . 55.64 105.201 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.67 126.63 30.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 124.113 1.911 . . . . 61.45 112.752 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -96.32 -5.48 39.95 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 118.182 2.66 . . . . 58.63 118.182 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -73.72 -39.89 63.98 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 118.351 -1.34 . . . . 62.06 110.095 172.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 17.3 t70 -70.57 112.5 6.87 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.038 -0.983 . . . . 54.07 112.144 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 15.8 m -59.51 -20.43 18.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 N-CA-C 116.33 1.974 . . . . 50.68 116.33 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1354 ' ' VAL . . . . . 0.576 ' O ' HG23 ' A' 1358 ' ' VAL . 0.9 OUTLIER -79.77 -47.39 21.83 Favored 'Isoleucine or valine' 0 C--N 1.343 0.317 0 CA-C-N 121.485 1.948 . . . . 47.68 105.778 177.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 1355 ' ' ILE . . . . . . . . . . . . . 89.9 mt -64.65 -55.14 22.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 108.476 -0.935 . . . . 48.49 108.476 -177.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 34.0 tpt85 -45.36 -46.77 13.28 Favored 'General case' 0 C--O 1.255 1.379 0 O-C-N 124.123 0.889 . . . . 48.27 113.362 167.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -59.39 -51.03 61.57 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-O 117.563 -1.687 . . . . 43.53 111.882 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1358 ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' 1354 ' ' VAL . 17.5 t -63.37 -35.08 70.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 CA-C-N 118.808 1.304 . . . . 45.12 108.544 -175.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1359 ' ' THR . . . . . . . . . . . . . 18.1 m -75.84 93.84 3.24 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 123.959 1.838 . . . . 42.94 109.889 -176.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 16.6 m -80.02 -22.84 11.75 Favored 'Isoleucine or valine' 0 C--O 1.248 1.011 0 CA-C-N 110.998 -2.819 . . . . 43.26 113.858 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1361 ' ' ILE . . . . . . . . . . . . . 43.7 mt -137.11 119.39 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 N-CA-C 104.055 -2.572 . . . . 45.66 104.055 175.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1362 ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -106.92 113.28 26.67 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 104.311 -2.477 . . . . 61.34 104.311 170.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 32.95 77.38 0.03 OUTLIER 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 117.204 2.298 . . . . 49.76 117.204 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 86.52 -50.26 4.19 Favored Glycine 0 N--CA 1.481 1.685 0 CA-C-N 113.645 -1.616 . . . . 50.0 111.628 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -70.37 116.43 10.7 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 106.953 -1.499 . . . . 56.92 106.953 -176.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1366 ' ' ILE . . . . . . . . . . . . . 67.5 mt -72.83 101.57 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.066 0 CA-C-O 123.408 1.575 . . . . 52.78 109.006 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1367 ' ' THR . . . . . . . . . . . . . 10.9 p -92.94 10.49 31.02 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 112.857 -1.974 . . . . 49.44 116.16 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1368 ' ' TRP . . . . . 0.518 ' CD1' ' HA ' ' A' 1369 ' ' PRO . 1.9 t90 -58.82 145.77 77.66 Favored Pre-proline 0 C--O 1.254 1.333 0 O-C-N 117.972 -2.955 . . . . 52.38 105.683 163.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1369 ' ' PRO . . . . . 0.518 ' HA ' ' CD1' ' A' 1368 ' ' TRP . 42.0 Cg_endo -85.76 -175.0 11.55 Favored 'Cis proline' 0 C--O 1.211 -0.829 0 CA-C-N 123.983 2.458 . . . . 46.94 113.553 4.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -83.19 138.66 42.21 Favored Pre-proline 0 CA--C 1.545 0.756 0 O-C-N 124.065 0.853 . . . . 45.91 108.84 164.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1371 ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -58.3 135.29 67.1 Favored 'Trans proline' 0 C--N 1.351 0.678 1 C-N-CA 125.777 4.318 . . . . 46.39 111.509 177.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -59.03 -35.35 98.57 Favored 'Trans proline' 0 CA--C 1.549 1.241 1 C-N-CA 125.36 4.04 . . . . 46.72 116.653 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.233 -4.489 0 O-C-N 118.331 -2.731 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 15.9 m80 . . . . . 0 N--CA 1.432 -1.347 0 N-CA-C 108.174 -1.047 . . . . 63.44 108.174 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -77.44 76.65 3.98 Favored 'General case' 0 C--O 1.254 1.304 0 O-C-N 121.093 -1.005 . . . . 51.74 112.402 -177.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1000 ' ' HIS . . . . . 0.456 ' HA ' ' OE2' ' B' 1067 ' ' GLU . 12.0 t60 -72.55 118.38 15.38 Favored 'General case' 0 C--O 1.247 0.964 0 CA-C-O 122.694 1.235 . . . . 54.07 111.618 -166.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 64.27 27.11 71.11 Favored Glycine 0 C--O 1.209 -1.434 0 CA-C-O 123.46 1.589 . . . . 39.22 111.889 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1002 ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -97.21 134.52 40.42 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 105.515 -2.031 . . . . 38.12 105.515 173.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1003 ' ' ILE . . . . . 0.536 HD12 HG22 ' B' 1033 ' ' VAL . 57.1 mt -84.92 149.97 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 CA-C-N 112.023 -2.353 . . . . 29.7 105.89 170.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -118.71 131.39 9.12 Favored Glycine 0 CA--C 1.492 -1.404 0 N-CA-C 108.351 -1.9 . . . . 27.5 108.351 164.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1005 ' ' ILE . . . . . 0.683 HG23 ' HB3' ' B' 1017 ' ' ALA . 45.4 mm -102.69 110.08 62.4 Favored Pre-proline 0 C--N 1.313 -1.002 0 N-CA-C 104.852 -2.277 . . . . 24.83 104.852 172.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -83.83 155.0 13.4 Favored 'Trans proline' 0 C--O 1.238 0.514 0 C-N-CA 121.743 1.629 . . . . 27.19 111.966 173.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -77.39 114.97 16.77 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 112.031 -2.349 . . . . 41.46 106.013 169.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1008 ' ' GLU . . . . . 0.503 ' OE2' ' HG2' ' B' 1071 ' ' LYS . 25.4 mm-40 -51.43 164.77 0.18 Allowed 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 116.463 2.023 . . . . 26.93 116.463 -178.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1009 ' ' ARG . . . . . 0.428 ' NH2' ' HG2' ' B' 1079 ' ' GLU . 14.4 mtm180 -146.15 59.06 1.23 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 123.314 1.531 . . . . 34.48 108.566 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1010 ' ' LEU . . . . . 0.564 ' HB3' ' HB2' ' B' 1013 ' ' GLU . 17.9 tp -104.37 152.94 21.67 Favored 'General case' 0 N--CA 1.469 0.511 1 O-C-N 116.287 -4.008 . . . . 44.22 107.743 174.246 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B 1011 ' ' THR . . . . . . . . . . . . . 24.3 m -58.99 114.42 2.57 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 123.779 0.832 . . . . 40.74 109.107 167.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 47.6 t30 54.62 80.08 0.13 Allowed 'General case' 0 C--N 1.35 0.624 0 C-N-CA 125.271 1.428 . . . . 44.44 111.861 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1013 ' ' GLU . . . . . 0.564 ' HB2' ' HB3' ' B' 1010 ' ' LEU . 9.5 tp10 -147.29 141.54 26.21 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 123.817 1.77 . . . . 29.87 109.857 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1014 ' ' THR . . . . . 0.617 ' HB ' ' HB3' ' B' 1320 ' ' PRO . 0.2 OUTLIER -128.43 2.96 5.64 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 113.173 -1.83 . . . . 25.26 111.535 -178.756 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 65.4 mtm180 -76.95 145.29 38.23 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 123.925 1.821 . . . . 29.54 110.631 174.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1016 ' ' VAL . . . . . 0.633 HG21 ' HB1' ' B' 1039 ' ' ALA . 2.2 p -126.64 -175.96 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-N 114.45 -1.25 . . . . 23.55 109.161 161.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1017 ' ' ALA . . . . . 0.683 ' HB3' HG23 ' B' 1005 ' ' ILE . . . -93.64 7.95 42.76 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 115.339 1.607 . . . . 23.59 115.339 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1018 ' ' ALA . . . . . 0.487 ' H ' HG13 ' B' 1016 ' ' VAL . . . -164.75 147.55 8.58 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 114.608 1.336 . . . . 24.93 114.608 -177.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1019 ' ' THR . . . . . . . . . . . . . 68.7 p -98.91 172.77 4.4 Favored Pre-proline 0 C--O 1.242 0.688 0 N-CA-C 106.839 -1.541 . . . . 28.09 106.839 159.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -49.56 -51.28 11.05 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.404 3.402 . . . . 28.79 110.959 166.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 37.9 tttp -46.88 -48.29 21.19 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 123.533 2.879 . . . . 47.28 112.728 170.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1022 ' ' THR . . . . . 0.41 HG21 ' HA3' ' B' 1328 ' ' GLY . 3.4 m -62.45 -32.39 73.26 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 117.715 0.234 . . . . 30.12 111.071 -177.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1023 ' ' VAL . . . . . 0.5 HG13 ' HB ' ' B' 1033 ' ' VAL . 91.6 t -64.21 -48.82 83.96 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 O-C-N 120.514 -1.367 . . . . 32.24 108.109 176.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1024 ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' B' 1028 ' ' LYS . 31.3 mt-10 -60.36 -29.15 68.73 Favored 'General case' 0 C--O 1.246 0.921 0 O-C-N 121.937 -0.477 . . . . 49.62 111.305 176.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -66.44 -42.06 88.24 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-O 123.805 1.764 . . . . 44.68 113.034 176.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 34.2 mt -70.38 -37.8 74.62 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 113.71 -1.586 . . . . 35.71 109.392 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1027 ' ' LEU . . . . . 0.461 HD12 ' HA ' ' B' 1024 ' ' GLU . 63.4 mt -67.47 -26.8 66.55 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 115.599 -0.728 . . . . 42.18 111.179 174.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1028 ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' B' 1024 ' ' GLU . 65.1 mttm -61.01 -33.82 73.86 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.273 0.942 . . . . 48.34 111.99 169.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1029 ' ' LEU . . . . . 0.503 ' HB2' ' HD2' ' B' 1031 ' ' PHE . 7.8 mt -88.61 10.39 20.69 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 120.984 -1.072 . . . . 38.69 111.326 176.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 85.09 -10.45 63.24 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 116.169 1.228 . . . . 32.28 116.169 -175.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1031 ' ' PHE . . . . . 0.503 ' HD2' ' HB2' ' B' 1029 ' ' LEU . 66.4 m-85 -78.19 120.21 22.67 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 119.447 1.624 . . . . 35.94 112.659 -170.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1032 ' ' THR . . . . . . . . . . . . . 34.8 m -73.74 132.51 42.72 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 106.596 -1.631 . . . . 33.37 106.596 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1033 ' ' VAL . . . . . 0.536 HG22 HD12 ' B' 1003 ' ' ILE . 16.9 t -117.63 128.93 74.76 Favored 'Isoleucine or valine' 0 C--O 1.249 1.028 0 O-C-N 119.489 -2.007 . . . . 29.98 108.662 -171.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -108.56 143.61 37.36 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.31 -0.859 . . . . 28.18 110.228 166.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1035 ' ' VAL . . . . . 0.432 HG23 ' HB1' ' B' 1055 ' ' ALA . 57.6 t -125.57 131.35 72.2 Favored 'Isoleucine or valine' 0 C--N 1.372 1.552 0 N-CA-C 108.107 -1.071 . . . . 25.82 108.107 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1036 ' ' GLU . . . . . 0.449 ' HB2' HG11 ' B' 1063 ' ' VAL . 30.5 tt0 -73.3 143.16 47.08 Favored 'General case' 0 C--O 1.252 1.223 0 O-C-N 120.455 -1.403 . . . . 32.44 108.996 177.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1037 ' ' SER . . . . . 0.586 ' H ' ' HG3' ' B' 1059 ' ' GLU . 1.2 m -65.95 137.98 57.51 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 119.612 -1.93 . . . . 29.54 111.64 174.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 103.09 -22.08 37.85 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 124.844 1.34 . . . . 27.76 111.165 -175.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1039 ' ' ALA . . . . . 0.633 ' HB1' HG21 ' B' 1016 ' ' VAL . . . -65.46 -40.14 92.84 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 123.089 0.555 . . . . 26.02 110.428 174.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -55.05 -51.71 51.96 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 124.445 1.091 . . . . 26.47 112.093 169.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.19 -28.71 68.18 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 113.745 1.017 . . . . 50.98 113.745 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1042 ' ' LEU . . . . . 0.584 HD22 ' HA ' ' B' 1014 ' ' THR . 76.9 mt -67.63 -52.68 35.38 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 119.951 1.251 . . . . 29.3 109.092 168.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1043 ' ' ALA . . . . . 0.51 ' HB2' HG12 ' B' 1016 ' ' VAL . . . -72.26 29.81 0.05 Allowed 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 118.014 2.598 . . . . 26.74 118.014 174.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1044 ' ' SER . . . . . . . . . . . . . 28.4 m 47.66 36.51 5.6 Favored 'General case' 0 C--N 1.358 0.951 0 N-CA-C 117.713 2.486 . . . . 31.26 117.713 -173.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1045 ' ' PHE . . . . . 0.451 ' CD1' ' HB3' ' A' 1277 ' ' ALA . 0.8 OUTLIER -130.06 163.5 26.39 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 124.112 1.91 . . . . 33.26 112.626 -173.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 3.3 t70 -67.84 139.84 56.56 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 114.548 -1.205 . . . . 46.74 109.525 158.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -68.42 -36.59 79.3 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 121.057 1.753 . . . . 34.44 111.259 174.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1048 ' ' LYS . . . . . 0.427 ' O ' HG12 ' B' 1051 ' ' VAL . 0.1 OUTLIER -70.97 -15.08 62.56 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.463 0.649 . . . . 48.67 112.652 -175.011 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -58.56 -37.04 74.9 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 119.234 -2.166 . . . . 35.26 111.122 165.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1050 ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -65.29 -33.57 76.28 Favored 'General case' 0 CA--C 1.563 1.451 0 CA-C-O 117.843 -1.075 . . . . 32.17 111.725 170.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1051 ' ' VAL . . . . . 0.427 HG12 ' O ' ' B' 1048 ' ' LYS . 0.3 OUTLIER -68.1 -30.28 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 121.404 1.911 . . . . 38.37 108.702 176.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -63.59 -38.46 91.22 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.222 0.919 . . . . 45.77 109.883 173.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -76.97 -21.66 54.39 Favored 'General case' 0 C--N 1.36 1.065 0 CA-C-O 121.557 0.694 . . . . 37.83 112.685 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 118.73 31.12 1.52 Allowed Glycine 0 C--O 1.215 -1.07 0 O-C-N 120.515 -1.366 . . . . 35.82 113.346 176.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1055 ' ' ALA . . . . . 0.432 ' HB1' HG23 ' B' 1035 ' ' VAL . . . -102.05 135.73 43.12 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 123.175 1.464 . . . . 33.77 109.558 178.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -75.4 105.5 6.46 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 106.374 -1.713 . . . . 51.02 106.374 174.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1057 ' ' ILE . . . . . . . . . . . . . 37.5 mm -77.64 85.62 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 O-C-N 120.476 -1.39 . . . . 38.47 107.597 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1058 ' ' VAL . . . . . 0.469 ' O ' ' HB ' ' B' 1063 ' ' VAL . 3.5 m -117.98 123.7 72.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 125.038 1.461 . . . . 39.4 110.712 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1059 ' ' GLU . . . . . 0.586 ' HG3' ' H ' ' B' 1037 ' ' SER . 5.4 mp0 -90.58 155.77 18.63 Favored 'General case' 0 C--O 1.248 1.01 0 O-C-N 120.758 -1.214 . . . . 57.07 110.274 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1060 ' ' GLY . . . . . 0.408 ' O ' HG12 ' B' 1063 ' ' VAL . . . 65.23 -145.61 49.2 Favored Glycine 0 C--O 1.21 -1.375 0 CA-C-N 113.405 -1.725 . . . . 44.83 114.23 169.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 5.4 m120 -55.31 -20.26 10.93 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 115.586 1.699 . . . . 46.27 115.586 -177.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1062 ' ' SER . . . . . . . . . . . . . 28.9 m -59.54 -50.73 72.78 Favored 'General case' 0 CA--C 1.489 -1.395 0 O-C-N 120.166 -1.584 . . . . 43.47 111.9 164.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1063 ' ' VAL . . . . . 0.469 ' HB ' ' O ' ' B' 1058 ' ' VAL . 0.8 OUTLIER -65.41 -38.42 82.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 120.61 1.55 . . . . 36.98 109.91 177.55 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 98.9 m95 -66.48 -21.47 66.19 Favored 'General case' 0 C--O 1.269 2.108 0 N-CA-C 114.936 1.458 . . . . 37.9 114.936 178.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -83.74 90.25 7.29 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 104.687 -2.338 . . . . 46.19 104.687 169.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1066 ' ' SER . . . . . . . . . . . . . 73.4 m -154.36 150.88 28.41 Favored 'General case' 0 CA--C 1.49 -1.335 0 CA-C-N 113.213 -1.812 . . . . 37.06 108.512 176.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1067 ' ' GLU . . . . . 0.456 ' OE2' ' HA ' ' B' 1000 ' ' HIS . 78.4 mt-10 -79.3 -17.87 53.78 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 120.799 -1.188 . . . . 43.95 113.783 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1068 ' ' ILE . . . . . . . . . . . . . 3.1 mp -126.67 143.99 38.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 103.233 -2.877 . . . . 33.5 103.233 173.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 16.5 mm -122.9 105.59 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 102.245 -3.243 . . . . 30.57 102.245 165.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1070 ' ' LEU . . . . . 0.805 ' HB3' HD13 ' B' 1331 ' ' LEU . 81.5 mt -86.7 122.27 30.37 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 101.975 -3.343 . . . . 27.66 101.975 176.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1071 ' ' LYS . . . . . 0.503 ' HG2' ' OE2' ' B' 1008 ' ' GLU . 34.0 tttm -146.58 158.21 43.86 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 108.255 -1.017 . . . . 28.4 108.255 -169.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1072 ' ' VAL . . . . . 0.471 ' HA ' ' CZ ' ' B' 1327 ' ' TYR . 58.7 t -90.82 -77.0 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 108.481 -0.933 . . . . 23.18 108.481 -176.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1073 ' ' ASN . . . . . 0.441 HD21 ' HG2' ' B' 1013 ' ' GLU . 62.8 m-80 -93.89 146.07 24.17 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 108.178 -1.045 . . . . 25.47 108.178 -165.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1074 ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' B' 1092 ' ' PHE . . . -50.11 115.38 5.28 Favored Pre-proline 0 C--O 1.249 1.028 0 N-CA-C 114.386 1.254 . . . . 27.9 114.386 -174.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1075 ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' B' 1074 ' ' ALA . 35.8 Cg_endo -43.57 136.67 6.32 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.26 3.307 . . . . 31.62 115.587 -173.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1076 ' ' LEU . . . . . 0.41 ' O ' HG13 ' B' 1080 ' ' ILE . 13.3 mt -69.75 166.79 18.51 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 112.047 -2.342 . . . . 40.49 107.905 173.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1077 ' ' ASP . . . . . 0.598 ' HA ' HD12 ' B' 1080 ' ' ILE . 27.7 t70 -58.76 -35.83 73.4 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 119.315 -0.954 . . . . 51.59 110.065 -174.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.39 -39.47 81.69 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 122.307 1.051 . . . . 42.36 109.549 -178.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1079 ' ' GLU . . . . . 0.468 ' HA ' HD12 ' B' 1082 ' ' LEU . 27.9 mt-10 -68.11 -27.25 66.3 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 113.678 -1.601 . . . . 34.53 109.636 175.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1080 ' ' ILE . . . . . 0.598 HD12 ' HA ' ' B' 1077 ' ' ASP . 88.3 mt -70.84 -37.75 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 120.461 1.482 . . . . 33.25 108.071 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -64.84 -46.99 79.58 Favored 'General case' 0 C--O 1.247 0.959 0 N-CA-C 109.822 -0.436 . . . . 36.47 109.822 174.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1082 ' ' LEU . . . . . 0.468 HD12 ' HA ' ' B' 1079 ' ' GLU . 33.0 mt -53.96 -44.96 71.18 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 125.119 1.368 . . . . 37.76 113.314 177.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1083 ' ' LEU . . . . . 0.583 ' HB3' HG11 ' B' 1110 ' ' VAL . 9.6 mt -57.89 125.09 21.55 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 122.396 1.093 . . . . 37.43 109.9 175.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -96.17 147.09 32.43 Favored Pre-proline 0 N--CA 1.438 -1.073 0 CA-C-N 114.279 -1.328 . . . . 37.7 108.522 -172.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -51.93 122.6 10.77 Favored 'Trans proline' 0 N--CA 1.451 -0.996 1 C-N-CA 126.114 4.543 . . . . 35.51 114.319 -178.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 98.22 -15.16 61.74 Favored Glycine 0 N--CA 1.466 0.678 0 CA-C-N 113.123 -1.853 . . . . 33.87 113.003 176.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1087 ' ' THR . . . . . . . . . . . . . 29.3 m -63.02 133.14 54.1 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 124.515 2.103 . . . . 32.5 111.299 174.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1088 ' ' THR . . . . . 0.677 ' HA ' ' HB ' ' B' 1111 ' ' THR . 4.8 m -74.42 92.53 2.33 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 113.233 -1.803 . . . . 30.22 111.059 176.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1089 ' ' LEU . . . . . 0.475 HD13 HD11 ' B' 1083 ' ' LEU . 14.2 tp -76.89 119.69 20.99 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 122.374 1.083 . . . . 27.24 108.721 171.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 24.8 t -112.95 122.61 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 107.304 -1.369 . . . . 25.39 107.304 171.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1091 ' ' SER . . . . . 0.42 ' OG ' ' HB3' ' B' 1071 ' ' LYS . 69.0 m -157.58 165.38 35.69 Favored 'General case' 0 CA--C 1.504 -0.799 0 O-C-N 120.122 -1.611 . . . . 28.81 109.995 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1092 ' ' PHE . . . . . 0.449 ' O ' ' HB2' ' B' 1074 ' ' ALA . 2.2 m-85 -62.53 96.35 0.08 Allowed 'General case' 0 N--CA 1.466 0.351 0 O-C-N 119.374 -2.078 . . . . 30.78 107.978 159.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1093 ' ' ILE . . . . . 0.407 ' CD1' ' HB2' ' B' 1091 ' ' SER . 44.0 mm -88.63 -27.7 5.4 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.184 0 O-C-N 121.087 -1.008 . . . . 30.28 112.683 -174.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1094 ' ' TRP . . . . . . . . . . . . . 76.1 m95 50.37 54.7 15.98 Favored Pre-proline 0 C--N 1.321 -0.654 0 O-C-N 124.486 1.116 . . . . 34.07 113.957 -177.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -41.5 -56.26 1.9 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 1 C-N-CA 125.776 4.317 . . . . 38.66 117.607 -164.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -66.99 -38.56 86.26 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 121.015 1.734 . . . . 41.32 111.826 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -68.61 -22.46 64.43 Favored 'General case' 0 C--O 1.209 -1.051 0 CA-C-N 113.644 -1.616 . . . . 51.66 111.199 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1098 ' ' ASN . . . . . 0.567 ' HB3' ' HB2' ' B' 1101 ' ' LEU . 96.0 m-20 -126.25 68.84 66.69 Favored Pre-proline 0 N--CA 1.439 -0.987 0 O-C-N 120.364 -1.46 . . . . 40.32 109.94 -174.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -64.94 -62.18 0.09 OUTLIER 'Trans proline' 0 CA--C 1.559 1.756 0 C-N-CA 124.112 3.208 . . . . 41.56 109.85 -174.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -51.87 -44.0 63.5 Favored 'General case' 0 C--N 1.374 1.664 0 N-CA-C 114.101 1.149 . . . . 54.11 114.101 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1101 ' ' LEU . . . . . 0.567 ' HB2' ' HB3' ' B' 1098 ' ' ASN . 9.1 mp -58.36 -48.16 81.46 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.472 -0.767 . . . . 37.88 110.034 175.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1102 ' ' MET . . . . . . . . . . . . . 39.6 mmm -57.19 -43.1 82.39 Favored 'General case' 0 C--O 1.241 0.607 0 O-C-N 121.459 -0.775 . . . . 37.54 112.446 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -71.62 -41.8 68.45 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 107.798 -1.186 . . . . 47.01 107.798 -171.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1104 ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -61.94 -40.73 96.51 Favored 'General case' 0 C--O 1.262 1.759 0 N-CA-C 114.849 1.425 . . . . 48.68 114.849 175.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1105 ' ' LEU . . . . . 0.479 ' HB3' HG21 ' B' 1112 ' ' VAL . 61.6 mt -64.98 -37.79 88.83 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.779 1.231 . . . . 32.21 111.16 173.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -60.72 -45.78 92.91 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 117.524 -1.226 . . . . 33.73 113.138 172.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -55.98 -44.6 78.71 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 122.379 1.085 . . . . 51.47 112.296 171.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1108 ' ' ARG . . . . . 0.426 ' HG3' HG22 ' B' 1080 ' ' ILE . 24.1 mmm180 -69.51 -6.49 30.99 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 120.747 -1.221 . . . . 43.9 113.205 178.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1109 ' ' ASN . . . . . 0.463 ' HA ' ' HA2' ' B' 1364 ' ' GLY . 13.7 m-80 62.15 27.6 16.61 Favored 'General case' 0 CA--C 1.486 -1.493 0 N-CA-C 114.084 1.142 . . . . 44.82 114.084 170.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1110 ' ' VAL . . . . . 0.583 HG11 ' HB3' ' B' 1083 ' ' LEU . 11.1 m -84.06 154.18 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 113.516 0.932 . . . . 30.52 113.516 174.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1111 ' ' THR . . . . . 0.677 ' HB ' ' HA ' ' B' 1088 ' ' THR . 4.1 m -86.59 90.85 8.38 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 120.749 -1.219 . . . . 27.12 109.22 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1112 ' ' VAL . . . . . 0.479 HG21 ' HB3' ' B' 1105 ' ' LEU . 41.0 t -91.51 125.02 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 124.738 1.274 . . . . 26.4 112.644 -168.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1113 ' ' MET . . . . . 0.679 ' SD ' HD21 ' B' 1334 ' ' LEU . 59.2 mtp -123.18 127.62 48.91 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 104.301 -2.481 . . . . 42.92 104.301 -176.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -101.56 113.1 25.93 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 122.918 1.342 . . . . 24.15 112.2 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1115 ' ' MET . . . . . 0.479 ' HB3' ' HB2' ' B' 1129 ' ' ALA . 24.0 mmm -66.81 -21.16 66.05 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 113.395 -1.729 . . . . 29.95 115.318 -173.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1116 ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -81.02 -52.65 7.19 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 111.253 -2.703 . . . . 34.53 112.793 172.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1117 ' ' SER . . . . . . . . . . . . . 57.8 m -90.11 68.22 7.09 Favored 'General case' 0 C--O 1.242 0.684 0 O-C-N 118.826 -2.421 . . . . 33.49 112.021 -171.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1118 ' ' VAL . . . . . . . . . . . . . 1.8 t -94.87 131.18 30.94 Favored Pre-proline 0 N--CA 1.467 0.376 0 CA-C-N 112.967 -1.924 . . . . 34.02 106.3 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1119 ' ' PRO . . . . . 0.552 ' HG2' ' HA3' ' B' 1357 ' ' GLY . 86.8 Cg_exo -62.34 115.41 2.85 Favored 'Trans proline' 0 C--O 1.249 1.038 1 C-N-CA 125.711 4.274 . . . . 38.28 112.321 175.204 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B 1120 ' ' ARG . . . . . 0.42 HH12 ' CG ' ' B' 1128 ' ' ASP . 7.8 mmt180 -82.19 86.81 6.58 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 122.367 1.079 . . . . 55.05 112.74 -166.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1121 ' ' ILE . . . . . 0.519 HG12 HD11 ' B' 1373 ' ' ILE . 11.1 pt -123.16 142.73 38.71 Favored 'Isoleucine or valine' 0 C--O 1.256 1.41 0 N-CA-C 101.351 -3.574 . . . . 42.09 101.351 151.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1122 ' ' SER . . . . . 0.679 ' HB2' ' HA ' ' C' ' 133' ' ' MET . 2.5 m -37.05 -43.55 0.48 Allowed 'General case' 0 C--O 1.243 0.761 0 N-CA-C 121.466 3.876 . . . . 38.02 121.466 -161.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1123 ' ' ARG . . . . . 0.515 ' HG3' HG21 ' B' 1354 ' ' VAL . 20.8 ptt-85 -47.9 -31.26 4.93 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 121.364 1.893 . . . . 34.29 115.549 175.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1124 ' ' ALA . . . . . . . . . . . . . . . -43.13 -47.53 6.15 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 114.623 1.342 . . . . 32.35 114.623 169.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1125 ' ' GLN . . . . . 0.454 ' HA ' ' HB3' ' B' 1128 ' ' ASP . 30.1 mm100 -52.5 -26.56 13.35 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 116.511 2.041 . . . . 47.17 116.511 -178.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1126 ' ' SER . . . . . . . . . . . . . 47.3 p -71.27 -32.25 68.48 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 124.135 1.922 . . . . 31.71 110.968 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1127 ' ' LEU . . . . . . . . . . . . . 4.3 mp -88.12 -32.02 18.89 Favored 'General case' 0 C--N 1.356 0.888 0 CA-C-N 113.949 -1.478 . . . . 37.0 110.268 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1128 ' ' ASP . . . . . 0.454 ' HB3' ' HA ' ' B' 1125 ' ' GLN . 14.7 t0 -58.73 103.87 0.19 Allowed 'General case' 0 CA--C 1.505 -0.773 0 O-C-N 120.291 -1.506 . . . . 40.4 113.114 -173.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1129 ' ' ALA . . . . . 0.479 ' HB2' ' HB3' ' B' 1115 ' ' MET . . . -63.86 -29.13 70.35 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 111.911 -2.404 . . . . 26.56 113.862 175.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 53.8 mt -67.95 -31.47 71.24 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-O 117.295 -1.336 . . . . 30.89 110.66 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1131 ' ' SER . . . . . 0.42 ' HB3' ' NE2' ' B' 1125 ' ' GLN . 84.0 p -60.16 -53.14 61.21 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 122.301 2.319 . . . . 29.84 110.608 175.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1132 ' ' SER . . . . . 0.454 ' HB3' ' HB3' ' B' 1326 ' ' LEU . 51.7 m -57.93 -49.46 76.68 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 113.451 0.908 . . . . 31.91 113.451 176.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1133 ' ' MET . . . . . . . . . . . . . 32.7 mmt -63.84 -37.63 88.09 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 122.678 1.227 . . . . 25.9 110.667 -175.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1134 ' ' ALA . . . . . 0.864 ' HB1' ' HB2' ' B' 1176 ' ' ALA . . . -62.98 -48.12 80.24 Favored 'General case' 0 N--CA 1.426 -1.64 0 O-C-N 121.139 -0.976 . . . . 26.62 110.097 171.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -51.23 -51.28 55.46 Favored 'General case' 0 C--N 1.35 0.607 0 C-N-CA 125.287 1.435 . . . . 36.97 112.247 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1136 ' ' ILE . . . . . 0.536 HG21 ' HA ' ' B' 1316 ' ' PRO . 29.7 mm -50.25 -58.62 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 C-N-CA 124.938 1.295 . . . . 32.11 108.893 169.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -58.92 -30.14 67.61 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 119.077 -0.487 . . . . 24.14 110.053 -175.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1138 ' ' GLY . . . . . 0.423 ' HA2' HD21 ' B' 1284 ' ' LEU . . . -66.3 -57.38 10.51 Favored Glycine 0 N--CA 1.479 1.555 0 N-CA-C 109.777 -1.329 . . . . 25.13 109.777 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 53.4 t80 -55.65 -47.21 77.06 Favored 'General case' 0 C--O 1.204 -1.32 0 CA-C-N 117.9 0.85 . . . . 32.73 111.706 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1140 ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -67.65 -23.43 65.34 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 116.975 -1.488 . . . . 26.36 110.848 -178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1141 ' ' ALA . . . . . 0.43 ' HB1' HG21 ' B' 1282 ' ' VAL . . . -64.22 -45.33 88.74 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 122.126 2.239 . . . . 24.12 111.152 171.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1142 ' ' ILE . . . . . 0.584 HG13 ' HB3' ' B' 1183 ' ' ALA . 49.4 mm -60.49 -44.76 97.1 Favored 'Isoleucine or valine' 0 C--O 1.247 0.937 0 CA-C-N 115.718 -0.674 . . . . 23.37 110.323 176.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 98.0 t -53.83 -69.99 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 114.607 1.336 . . . . 24.96 114.607 171.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1144 ' ' GLU . . . . . 0.48 ' HG3' ' HE2' ' B' 1312 ' ' TYR . 43.9 mm-40 -59.12 -27.78 65.92 Favored 'General case' 0 C--O 1.243 0.736 0 O-C-N 121.724 -0.61 . . . . 32.07 111.922 -176.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1145 ' ' ALA . . . . . 0.881 ' HB1' HD12 ' B' 1251 ' ' ILE . . . -58.95 -63.89 1.14 Allowed 'General case' 0 C--O 1.246 0.883 0 CA-C-O 117.459 -1.258 . . . . 24.87 108.202 169.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1146 ' ' ALA . . . . . . . . . . . . . . . -58.68 -20.33 47.53 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 121.474 1.943 . . . . 24.67 115.326 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1147 ' ' HIS . . . . . 0.471 ' HB3' ' O ' ' B' 1144 ' ' GLU . 74.9 t60 -62.39 -63.72 1.15 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.254 1.421 . . . . 28.58 107.674 170.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1148 ' ' GLU . . . . . 0.565 ' HB2' HD11 ' B' 1310 ' ' ILE . 59.2 mm-40 -87.83 -1.65 58.11 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 118.663 2.838 . . . . 36.82 118.663 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1149 ' ' PHE . . . . . 0.441 ' HE1' ' NH2' ' B' 1151 ' ' ARG . 2.7 t80 -69.22 141.65 54.43 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 122.801 1.286 . . . . 31.97 110.77 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1150 ' ' GLY . . . . . . . . . . . . . . . -66.79 -34.72 88.15 Favored Glycine 0 CA--C 1.536 1.36 0 CA-C-O 118.599 -1.111 . . . . 25.49 112.461 175.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1151 ' ' ARG . . . . . 0.461 ' HA ' ' HB2' ' A' 1322 ' ' GLN . 71.6 mtm-85 -122.77 177.46 5.46 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 120.773 2.287 . . . . 59.84 109.6 -157.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1152 ' ' PHE . . . . . 0.968 ' HB2' HG11 ' B' 1163 ' ' VAL . 7.7 m-30 -78.67 156.8 28.82 Favored 'General case' 0 C--O 1.25 1.111 0 CA-C-N 119.79 1.177 . . . . 34.45 108.69 167.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1153 ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -68.03 -50.8 53.16 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.441 1.591 . . . . 31.17 108.865 163.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1154 ' ' THR . . . . . . . . . . . . . 2.8 m -61.74 124.32 20.41 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 113.264 -1.789 . . . . 33.89 115.618 -175.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -74.08 69.78 1.58 Allowed Glycine 0 N--CA 1.442 -0.948 0 O-C-N 120.942 -1.098 . . . . 38.95 110.738 175.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1156 ' ' GLN . . . . . 0.483 ' H ' ' HB ' ' B' 1163 ' ' VAL . 18.1 tt0 -99.57 133.02 44.5 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-O 123.436 1.589 . . . . 54.23 112.291 -168.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 20.6 mm -85.77 99.92 8.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 101.191 -3.633 . . . . 51.16 101.191 173.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1158 ' ' THR . . . . . . . . . . . . . 6.4 m -110.63 101.58 10.22 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.592 -1.186 . . . . 49.61 108.809 -171.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . 27.31 -71.41 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 120.28 3.437 . . . . 49.05 120.28 -175.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1160 ' ' ALA . . . . . 0.539 ' HB2' ' ND2' ' A' 1330 ' ' ASN . . . -69.13 -48.87 61.26 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 125.272 1.429 . . . . 47.65 112.926 175.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . -137.05 -171.56 12.23 Favored Glycine 0 C--O 1.243 0.663 0 CA-C-N 121.856 2.116 . . . . 45.61 111.283 -170.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 92.0 mttt -111.58 139.22 47.2 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 111.595 -2.303 . . . . 57.46 109.052 175.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1163 ' ' VAL . . . . . 0.968 HG11 ' HB2' ' B' 1152 ' ' PHE . 74.4 t -98.96 130.91 26.48 Favored Pre-proline 0 N--CA 1.426 -1.662 0 CA-C-O 116.691 -1.623 . . . . 42.93 108.05 170.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1164 ' ' PRO . . . . . 0.506 ' HA ' ' HD3' ' B' 1165 ' ' PRO . 73.0 Cg_endo -69.78 140.2 42.02 Favored 'Trans proline' 0 N--CA 1.441 -1.609 0 C-N-CA 123.715 2.943 . . . . 39.29 110.432 171.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1165 ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' B' 1164 ' ' PRO . 70.4 Cg_exo -66.78 115.51 3.62 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 123.185 2.59 . . . . 34.17 111.72 178.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -64.49 125.59 25.16 Favored 'General case' 0 C--N 1.355 0.837 0 CA-C-N 119.496 1.044 . . . . 31.69 112.875 -177.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1167 ' ' LYS . . . . . 0.625 ' HB2' ' HA ' ' B' 1249 ' ' VAL . 77.4 mttt -90.94 115.12 27.72 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 104.205 -2.517 . . . . 44.78 104.205 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 85.4 t -104.41 96.25 4.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 O-C-N 120.507 -1.371 . . . . 31.23 108.627 -174.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1169 ' ' MET . . . . . 0.833 ' HB2' HG11 ' B' 1249 ' ' VAL . 57.1 ttp -77.36 94.85 4.28 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 122.63 1.205 . . . . 37.09 110.697 177.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1170 ' ' VAL . . . . . 0.471 HG22 ' HB ' ' B' 1253 ' ' VAL . 92.8 t -81.26 115.88 24.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 N-CA-C 107.075 -1.454 . . . . 30.17 107.075 175.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1171 ' ' ILE . . . . . 0.519 HG22 ' HB2' ' B' 1256 ' ' ALA . 84.0 mt -98.85 112.76 31.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 104.456 -2.424 . . . . 33.74 104.456 174.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 98.19 91.39 1.95 Allowed Glycine 0 CA--C 1.486 -1.78 0 CA-C-N 113.547 -1.66 . . . . 32.59 109.166 175.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1173 ' ' ALA . . . . . 0.474 ' H ' ' HB2' ' B' 1195 ' ' ASP . . . -75.68 61.28 1.35 Allowed 'General case' 0 C--O 1.253 1.251 0 CA-C-O 123.46 1.6 . . . . 32.42 112.095 174.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -78.48 -170.06 36.54 Favored Glycine 0 C--O 1.224 -0.502 0 O-C-N 120.745 -1.222 . . . . 31.74 110.063 170.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 36.5 t -56.44 -44.98 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-N 119.224 1.512 . . . . 31.48 111.031 174.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1176 ' ' ALA . . . . . 0.864 ' HB2' ' HB1' ' B' 1134 ' ' ALA . . . -55.19 -50.25 69.85 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 123.856 0.862 . . . . 26.12 112.136 172.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1177 ' ' GLY . . . . . . . . . . . . . . . -54.56 -47.39 70.3 Favored Glycine 0 C--N 1.344 1.01 0 O-C-N 125.008 1.442 . . . . 25.73 109.574 178.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1178 ' ' LEU . . . . . 0.478 ' HA ' HD12 ' B' 1181 ' ' ILE . 81.3 mt -66.57 -34.94 79.01 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.778 -1.424 . . . . 32.59 112.684 -173.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -71.73 -33.93 69.13 Favored 'General case' 0 C--N 1.351 0.674 0 O-C-N 120.452 -1.405 . . . . 27.72 112.26 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -67.16 -42.58 84.08 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 123.044 1.402 . . . . 26.03 110.348 172.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1181 ' ' ILE . . . . . 0.752 HG22 ' HG2' ' B' 1207 ' ' MET . 60.0 mt -58.71 -45.82 90.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 O-C-N 119.6 -1.937 . . . . 28.61 112.314 174.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -53.94 -55.08 27.62 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-N 115.105 -0.952 . . . . 25.23 111.942 172.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1183 ' ' ALA . . . . . 0.584 ' HB3' HG13 ' B' 1142 ' ' ILE . . . -60.31 -50.05 75.18 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.985 1.393 . . . . 24.09 113.265 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -69.58 -33.78 73.2 Favored 'General case' 0 C--O 1.241 0.636 0 O-C-N 121.401 -0.812 . . . . 26.68 110.404 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -68.71 -41.11 79.55 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 120.379 -1.45 . . . . 36.57 111.027 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1186 ' ' SER . . . . . 0.846 ' HB3' ' HA ' ' A' 1187 ' ' LEU . 70.7 m -51.62 -44.36 62.87 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 122.211 1.005 . . . . 28.92 113.497 163.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1187 ' ' LEU . . . . . . . . . . . . . 74.7 mt -78.92 -1.76 36.71 Favored 'General case' 0 N--CA 1.433 -1.298 0 O-C-N 119.893 -1.754 . . . . 29.09 113.92 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 71.17 42.19 58.63 Favored Glycine 0 C--O 1.219 -0.817 0 O-C-N 120.746 -1.221 . . . . 29.26 111.961 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1189 ' ' ALA . . . . . . . . . . . . 0.251 . . -104.59 154.06 20.41 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.491 -0.559 . . . . 30.16 109.491 172.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1190 ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' B' 1167 ' ' LYS . 65.1 mt -81.11 93.37 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 O-C-N 119.726 -1.859 . . . . 35.81 108.389 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1191 ' ' VAL . . . . . 0.437 HG11 HG12 ' B' 1181 ' ' ILE . 4.4 t -78.4 125.57 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.289 -1.004 . . . . 31.97 108.289 -178.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1192 ' ' ARG . . . . . 0.512 HH12 ' CD ' ' B' 1248 ' ' GLU . 27.0 mmt85 -112.33 94.44 4.93 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 106.081 -1.822 . . . . 48.16 106.081 177.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -103.78 133.34 48.93 Favored 'General case' 0 C--N 1.355 0.845 0 O-C-N 119.223 -2.173 . . . . 35.89 115.044 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 38.4 t80 -108.16 156.46 19.29 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 105.02 -2.215 . . . . 41.88 105.02 176.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1195 ' ' ASP . . . . . 0.474 ' HB2' ' H ' ' B' 1173 ' ' ALA . 7.5 t70 -167.23 146.69 5.22 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 113.371 -1.741 . . . . 38.28 107.949 163.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1196 ' ' THR . . . . . . . . . . . . . 2.7 p -68.27 -31.49 70.98 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 115.474 1.657 . . . . 40.62 115.474 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1197 ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -79.02 139.85 57.29 Favored Pre-proline 0 C--N 1.304 -1.391 0 CA-C-O 122.341 1.067 . . . . 53.09 110.928 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -69.09 -37.33 10.94 Favored 'Trans proline' 0 C--O 1.236 0.414 0 N-CA-C 117.991 2.266 . . . . 42.56 117.991 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -30.28 71.47 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 122.286 2.312 . . . . 56.31 116.514 -170.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1200 ' ' VAL . . . . . 0.537 ' HA ' ' HG2' ' B' 1203 ' ' GLN . 2.1 m -63.99 -29.07 46.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 114.654 -1.157 . . . . 42.91 113.201 174.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 41.6 tttm -43.03 -56.57 3.27 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 115.711 1.745 . . . . 48.89 115.711 175.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -56.75 -37.99 71.8 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.604 -1.18 . . . . 51.7 112.824 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1203 ' ' GLN . . . . . 0.604 ' OE1' ' HA ' ' C' ' 74' ' ' ARG . 47.3 mm-40 -60.19 -52.07 66.88 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 109.187 -0.671 . . . . 52.57 109.187 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1204 ' ' VAL . . . . . 0.488 HG22 HD13 ' B' 1181 ' ' ILE . 99.7 t -61.79 -47.57 92.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 O-C-N 125.561 1.788 . . . . 33.79 110.671 -174.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -53.41 -49.34 67.5 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 125.366 1.466 . . . . 36.58 111.025 175.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1206 ' ' SER . . . . . . . . . . . . . 18.8 m -80.01 -3.38 48.2 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 114.149 1.166 . . . . 39.61 114.149 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1207 ' ' MET . . . . . 0.752 ' HG2' HG22 ' B' 1181 ' ' ILE . 9.1 tpt -79.21 -22.38 44.95 Favored 'General case' 0 CA--C 1.511 -0.523 0 O-C-N 120.911 -1.118 . . . . 37.45 111.019 163.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 96.23 41.59 3.69 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 119.777 -1.827 . . . . 31.87 109.522 -173.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -144.95 142.79 30.13 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 123.759 0.824 . . . . 35.4 111.831 -171.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -80.74 130.69 35.22 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.981 -0.748 . . . . 47.89 108.981 -173.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 53.2 t80 -96.77 110.84 23.23 Favored 'General case' 0 C--O 1.247 0.925 0 N-CA-C 105.967 -1.864 . . . . 45.53 105.967 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1212 ' ' LEU . . . . . . . . . . . . . 78.6 mt -70.66 129.68 39.8 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 105.107 -2.182 . . . . 46.33 105.107 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -115.28 164.55 14.07 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 114.603 -1.18 . . . . 60.41 111.246 -170.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 4.9 mp -70.57 137.69 50.29 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-O 121.228 0.537 . . . . 57.38 109.875 -167.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1215 ' ' ASP . . . . . 0.885 ' HB3' ' HB1' ' B' 1237 ' ' ALA . 19.5 t70 . . . . . 0 N--CA 1.476 0.84 0 O-C-N 120.697 -1.252 . . . . 65.07 111.066 -169.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1230 ' ' MET . . . . . 0.493 ' HA ' ' HB2' ' B' 1231 ' ' SER . 28.5 mmt . . . . . 0 N--CA 1.422 -1.865 0 N-CA-C 109.654 -0.499 . . . . 80.32 109.654 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1231 ' ' SER . . . . . 0.493 ' HB2' ' HA ' ' B' 1230 ' ' MET . 40.0 m 70.05 174.51 0.29 Allowed 'General case' 0 N--CA 1.476 0.853 2 O-C-N 112.163 -6.586 . . . . 79.92 117.433 -1.584 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -114.3 -117.37 0.32 Allowed 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 105.254 -2.128 . . . . 77.91 105.254 175.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 57.99 -60.51 0.03 OUTLIER 'General case' 0 C--O 1.241 0.649 0 CA-C-N 123.073 2.669 . . . . 73.88 116.132 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.41 -26.3 66.59 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 120.218 1.372 . . . . 68.98 112.0 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 37.3 pt -31.27 -44.91 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.247 0.931 0 N-CA-C 116.056 1.873 . . . . 64.53 116.056 164.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -63.69 -39.17 93.65 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-O 121.336 0.589 . . . . 66.36 109.656 -177.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1237 ' ' ALA . . . . . 0.885 ' HB1' ' HB3' ' B' 1215 ' ' ASP . . . -68.02 -52.3 37.21 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.507 -0.77 . . . . 56.6 111.888 176.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1238 ' ' GLU . . . . . 0.414 ' HB3' ' CE2' ' B' 1242 ' ' PHE . 75.1 mt-10 -50.39 -66.2 0.43 Allowed 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 125.06 1.344 . . . . 56.79 110.405 176.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1239 ' ' MET . . . . . . . . . . . . . 82.7 mtp -50.49 -40.57 51.54 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 115.929 1.826 . . . . 53.63 115.929 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -57.27 -49.78 75.0 Favored 'General case' 0 C--O 1.259 1.601 0 O-C-N 124.511 1.132 . . . . 51.74 110.742 173.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 4.2 tt -66.34 -37.36 85.16 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 116.214 -0.448 . . . . 44.86 110.525 -174.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1242 ' ' PHE . . . . . 0.414 ' CE2' ' HB3' ' B' 1238 ' ' GLU . 23.1 m-30 -67.17 -42.49 84.21 Favored 'General case' 0 N--CA 1.438 -1.041 0 O-C-N 126.257 2.223 . . . . 42.78 109.597 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1243 ' ' ALA . . . . . 0.509 ' HA ' ' HG3' ' B' 1271 ' ' MET . . . -63.65 -40.84 97.86 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 120.294 -1.504 . . . . 40.96 108.607 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -67.41 -34.43 77.23 Favored 'General case' 0 C--O 1.246 0.907 0 O-C-N 120.58 -1.325 . . . . 43.06 110.798 175.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1245 ' ' GLN . . . . . 0.432 ' O ' HG22 ' B' 1249 ' ' VAL . 25.5 mm-40 -70.03 -27.58 64.78 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.378 0.881 . . . . 46.45 113.378 168.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -57.43 -45.38 84.72 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 119.953 -1.717 . . . . 41.78 111.598 -176.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 21.1 tptt -62.26 -31.69 72.3 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.33 0.863 . . . . 52.2 113.33 173.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1248 ' ' GLU . . . . . 0.512 ' CD ' HH12 ' B' 1192 ' ' ARG . 0.5 OUTLIER -77.35 -43.64 32.23 Favored 'General case' 0 C--O 1.248 0.986 0 O-C-N 121.394 -0.816 . . . . 53.55 113.019 177.646 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B 1249 ' ' VAL . . . . . 0.833 HG11 ' HB2' ' B' 1169 ' ' MET . 30.0 m -81.49 -179.26 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.031 0 O-C-N 120.575 -1.328 . . . . 34.41 114.457 -160.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1250 ' ' ASP . . . . . 0.42 ' O ' ' HB3' ' B' 1279 ' ' SER . 6.2 m-20 -132.94 -37.94 0.99 Allowed 'General case' 0 C--O 1.247 0.948 0 CA-C-N 113.087 -1.869 . . . . 33.38 109.616 -172.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1251 ' ' ILE . . . . . 0.881 HD12 ' HB1' ' B' 1145 ' ' ALA . 41.1 mm -129.8 138.11 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 N-CA-C 104.469 -2.419 . . . . 29.54 104.469 175.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1252 ' ' ILE . . . . . 0.489 HG22 ' HB ' ' B' 1254 ' ' THR . 78.7 mt -112.84 116.36 52.4 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 N-CA-C 103.641 -2.726 . . . . 32.44 103.641 166.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1253 ' ' VAL . . . . . 0.484 HG13 HD11 ' B' 1284 ' ' LEU . 42.8 t -97.57 87.56 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.258 1.52 0 N-CA-C 102.139 -3.282 . . . . 30.57 102.139 176.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1254 ' ' THR . . . . . 0.489 ' HB ' HG22 ' B' 1252 ' ' ILE 0.286 1.3 t -89.7 104.63 17.17 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 126.245 2.926 . . . . 35.04 109.141 -174.274 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B 1255 ' ' THR . . . . . 0.433 ' CG2' ' HB3' ' B' 1176 ' ' ALA . 21.9 m -110.99 -5.26 14.86 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 109.021 -3.718 . . . . 34.62 113.099 -169.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1256 ' ' ALA . . . . . 0.519 ' HB2' HG22 ' B' 1171 ' ' ILE . . . -71.08 79.7 0.68 Allowed 'General case' 0 C--O 1.247 0.921 0 CA-C-O 124.026 1.869 . . . . 42.72 112.45 -162.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1257 ' ' LEU . . . . . 0.583 HD23 ' HB2' ' B' 1263 ' ' ALA . 29.2 mt -92.56 120.9 33.47 Favored 'General case' 0 C--O 1.249 1.077 0 N-CA-C 106.912 -1.514 . . . . 52.43 106.912 169.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 70.1 mt -81.68 113.6 43.65 Favored Pre-proline 0 N--CA 1.449 -0.486 0 N-CA-C 102.055 -3.313 . . . . 59.41 102.055 176.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -57.02 94.44 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 124.077 3.185 . . . . 62.68 115.746 -171.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 135.56 -44.91 1.13 Allowed Glycine 0 CA--C 1.493 -1.285 0 CA-C-N 112.065 -2.334 . . . . 64.16 108.479 174.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 82.5 mttt -68.98 161.78 69.85 Favored Pre-proline 0 N--CA 1.446 -0.626 0 O-C-N 120.215 -1.756 . . . . 68.53 114.335 172.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -61.07 157.48 39.07 Favored 'Trans proline' 0 N--CA 1.44 -1.64 0 C-N-CA 122.235 1.957 . . . . 61.99 111.504 157.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1263 ' ' ALA . . . . . 0.583 ' HB2' HD23 ' B' 1257 ' ' LEU . . . -66.14 128.23 93.7 Favored Pre-proline 0 N--CA 1.416 -2.142 0 O-C-N 120.761 -1.212 . . . . 57.15 112.811 174.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1264 ' ' PRO . . . . . 0.462 ' HD2' ' O ' ' B' 1256 ' ' ALA . 73.1 Cg_endo -68.15 137.94 42.04 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 123.787 2.991 . . . . 51.57 110.24 -176.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -76.9 71.15 3.4 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 123.358 1.552 . . . . 54.55 111.248 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 63.4 mt -70.1 -42.58 72.51 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 124.086 1.898 . . . . 46.86 110.7 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1267 ' ' ILE . . . . . 0.742 ' HB ' ' HA ' ' B' 1292 ' ' CYS . 44.4 mm -80.07 93.44 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 O-C-N 119.207 -2.183 . . . . 41.04 107.129 -177.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1268 ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.81 152.63 31.0 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 113.429 -1.714 . . . . 39.58 112.8 170.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1269 ' ' ARG . . . . . . . . . . . . . 73.1 mtt85 -56.4 -37.97 70.86 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 120.782 -1.199 . . . . 53.15 111.675 172.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -43.85 -54.54 5.17 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 125.888 1.675 . . . . 42.96 114.376 168.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1271 ' ' MET . . . . . 0.509 ' HG3' ' HA ' ' B' 1243 ' ' ALA . 48.7 ttm -64.37 -33.91 76.95 Favored 'General case' 0 C--N 1.353 0.758 0 CA-C-N 114.648 -1.16 . . . . 43.89 109.551 -174.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1272 ' ' VAL . . . . . 0.656 HG11 HG21 ' B' 1303 ' ' THR . 21.5 t -65.89 -48.58 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 123.315 1.531 . . . . 38.37 108.087 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -67.47 -14.63 63.1 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 120.802 -1.187 . . . . 47.46 114.155 173.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1274 ' ' SER . . . . . . . . . . . . . 48.6 m -86.73 0.2 55.14 Favored 'General case' 0 N--CA 1.44 -0.926 0 O-C-N 119.2 -2.187 . . . . 38.38 114.367 168.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1275 ' ' MET . . . . . 0.653 ' HB2' HG21 ' B' 1307 ' ' VAL . 55.6 mtp -82.24 156.98 24.08 Favored 'General case' 0 CA--C 1.486 -1.499 0 O-C-N 118.502 -2.624 . . . . 37.81 112.946 173.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -62.39 146.59 50.9 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 112.743 -2.026 . . . . 49.26 107.25 167.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -73.62 150.43 41.37 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 114.319 1.229 . . . . 34.46 114.319 -176.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 62.18 51.6 55.57 Favored Glycine 0 N--CA 1.479 1.521 0 CA-C-O 124.859 2.366 . . . . 33.53 111.698 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1279 ' ' SER . . . . . 0.42 ' HB3' ' O ' ' B' 1250 ' ' ASP . 45.4 m -134.49 154.27 51.51 Favored 'General case' 0 C--O 1.26 1.607 0 CA-C-N 111.543 -2.328 . . . . 31.31 105.348 -173.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1280 ' ' VAL . . . . . . . . . . . . . 63.3 t -120.65 138.99 49.33 Favored 'Isoleucine or valine' 0 C--O 1.247 0.961 0 O-C-N 119.459 -2.026 . . . . 29.32 109.108 -170.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1281 ' ' ILE . . . . . . . . . . . . . 40.7 mt -106.81 101.48 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 105.874 -1.899 . . . . 31.93 105.874 168.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1282 ' ' VAL . . . . . 0.472 HG23 ' HA ' ' B' 1253 ' ' VAL . 0.0 OUTLIER -89.81 114.65 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.179 0 CA-C-O 124.414 2.054 . . . . 29.48 107.498 176.719 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B 1283 ' ' ASP . . . . . 0.408 ' HA ' HG22 ' B' 1254 ' ' THR . 22.5 t0 -94.51 108.48 20.42 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 113.192 -1.822 . . . . 34.5 106.439 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1284 ' ' LEU . . . . . 0.484 HD11 HG13 ' B' 1253 ' ' VAL . 5.9 mp -84.78 -33.43 22.99 Favored 'General case' 0 C--O 1.255 1.354 0 CA-C-N 112.448 -2.16 . . . . 37.94 108.779 174.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1285 ' ' ALA . . . . . 0.519 ' HB1' ' CB ' ' B' 1263 ' ' ALA . . . -75.23 -9.67 58.76 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 113.298 -1.774 . . . . 40.92 110.881 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -42.65 -30.02 0.34 Allowed 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 118.709 2.855 . . . . 44.39 118.709 169.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1287 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.96 -36.56 83.68 Favored 'General case' 0 C--N 1.363 1.157 0 CA-C-N 121.385 1.902 . . . . 51.46 110.566 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 20.9 t30 -122.92 100.09 6.71 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 122.996 1.379 . . . . 57.75 109.328 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1289 ' ' GLY . . . . . . . . . . . . . . . 82.9 -60.85 4.85 Favored Glycine 0 C--O 1.259 1.693 0 O-C-N 119.858 -1.776 . . . . 49.85 114.274 177.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 90.61 128.35 3.84 Favored Glycine 0 C--O 1.252 1.234 0 O-C-N 120.674 -1.486 . . . . 45.93 111.535 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1291 ' ' ASN . . . . . . . . . . . . . 7.7 m120 -80.83 -31.57 35.46 Favored 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 124.298 0.646 . . . . 42.67 110.667 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1292 ' ' CYS . . . . . 0.742 ' HA ' ' HB ' ' B' 1267 ' ' ILE . 52.5 t -92.1 140.49 29.59 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.285 -1.005 . . . . 38.82 108.285 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1293 ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -65.57 -45.28 83.89 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 113.376 0.88 . . . . 46.71 113.376 171.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1294 ' ' TYR . . . . . 0.513 ' HD2' HG21 ' B' 1272 ' ' VAL . 26.2 m-85 -63.78 -15.57 59.03 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 117.458 2.392 . . . . 47.23 117.458 -178.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1295 ' ' THR . . . . . 0.589 ' OG1' ' HB3' ' B' 1292 ' ' CYS . 33.2 m -59.98 119.02 6.98 Favored 'General case' 0 C--O 1.262 1.755 0 O-C-N 120.986 -1.071 . . . . 36.02 111.41 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 60.8 t -79.49 121.42 82.69 Favored Pre-proline 0 N--CA 1.473 0.694 0 N-CA-C 102.767 -3.049 . . . . 37.26 102.767 163.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -62.45 92.63 0.13 Allowed 'Trans proline' 0 C--O 1.249 1.036 0 C-N-CA 124.592 3.528 . . . . 35.09 110.542 -177.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1298 ' ' GLY . . . . . 0.656 ' HA2' ' HA ' ' B' 1312 ' ' TYR . . . 114.66 27.02 3.43 Favored Glycine 0 N--CA 1.443 -0.886 0 O-C-N 120.861 -1.15 . . . . 35.97 112.237 175.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -153.04 171.4 18.44 Favored 'General case' 0 C--N 1.356 0.861 0 CA-C-N 121.001 2.401 . . . . 40.39 116.079 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1300 ' ' ILE . . . . . 0.681 HG23 HG12 ' B' 1310 ' ' ILE . 18.9 mt -87.82 160.08 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 O-C-N 122.103 -0.373 . . . . 37.43 110.086 165.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 51.6 t80 -150.44 161.71 41.98 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 106.116 -1.809 . . . . 44.13 106.116 169.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1302 ' ' THR . . . . . . . . . . . . . 9.2 m -136.16 138.39 41.9 Favored 'General case' 0 C--O 1.253 1.249 0 O-C-N 120.519 -1.363 . . . . 39.78 109.483 173.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1303 ' ' THR . . . . . 0.656 HG21 HG11 ' B' 1272 ' ' VAL . 41.4 p -98.37 168.49 10.18 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 126.004 2.065 . . . . 43.29 114.095 -167.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -47.74 -49.4 28.38 Favored 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 124.721 1.208 . . . . 53.07 113.161 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 32.9 p-10 -67.69 -39.95 84.39 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 115.226 1.565 . . . . 43.97 115.226 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 127.62 29.03 0.85 Allowed Glycine 0 CA--C 1.527 0.783 0 N-CA-C 109.547 -1.421 . . . . 41.12 109.547 177.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1307 ' ' VAL . . . . . 0.653 HG21 ' HB2' ' B' 1275 ' ' MET . 47.3 t -98.61 148.25 6.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 107.409 -1.33 . . . . 38.12 107.409 173.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1308 ' ' LYS . . . . . 0.454 ' CD ' ' HB3' ' B' 1148 ' ' GLU . 90.6 mttt -113.27 128.51 56.49 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 118.718 -2.489 . . . . 36.34 105.482 -175.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1309 ' ' VAL . . . . . . . . . . . . . 42.7 t -110.06 130.41 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 103.294 -2.854 . . . . 30.4 103.294 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1310 ' ' ILE . . . . . 0.681 HG12 HG23 ' B' 1300 ' ' ILE . 52.9 mt -127.14 113.01 30.48 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.411 0 N-CA-C 105.108 -2.182 . . . . 30.82 105.108 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1311 ' ' GLY . . . . . 0.585 ' HA3' HG23 ' B' 1295 ' ' THR . . . -132.98 117.54 1.97 Allowed Glycine 0 C--O 1.214 -1.134 0 N-CA-C 104.789 -3.324 . . . . 26.53 104.789 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1312 ' ' TYR . . . . . 0.666 ' HB2' ' HG ' ' B' 1315 ' ' LEU . 36.0 m-85 -117.59 128.03 54.55 Favored 'General case' 0 CA--C 1.493 -1.235 0 CA-C-N 118.345 1.073 . . . . 38.0 110.667 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1313 ' ' THR . . . . . . . . . . . . . 26.3 m -68.11 -28.42 67.31 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.511 -1.677 . . . . 29.8 107.601 167.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -89.4 18.61 5.09 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 124.835 1.254 . . . . 39.04 113.592 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1315 ' ' LEU . . . . . 0.666 ' HG ' ' HB2' ' B' 1312 ' ' TYR . 6.9 mt -48.24 -40.21 34.34 Favored Pre-proline 0 CA--C 1.509 -0.633 0 N-CA-C 117.25 2.315 . . . . 31.08 117.25 177.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1316 ' ' PRO . . . . . 0.536 ' HA ' HG21 ' B' 1136 ' ' ILE . 17.9 Cg_exo -64.19 -44.56 11.92 Favored 'Trans proline' 0 CA--C 1.513 -0.548 0 C-N-CA 123.911 3.074 . . . . 26.1 111.968 169.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -56.02 -33.05 60.15 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 115.524 0.969 . . . . 23.17 115.524 172.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -54.9 -23.92 21.03 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 113.623 0.971 . . . . 40.4 113.623 171.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 12.6 tp -126.76 79.73 71.59 Favored Pre-proline 0 N--CA 1.442 -0.874 0 O-C-N 119.08 -2.263 . . . . 23.6 107.194 176.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1320 ' ' PRO . . . . . 0.617 ' HB3' ' HB ' ' B' 1014 ' ' THR . 51.6 Cg_endo -58.65 -63.04 0.15 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.801 3.001 . . . . 22.35 119.246 -171.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1321 ' ' THR . . . . . . . . . . . . . 2.3 m -57.02 -43.82 82.23 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 119.666 1.121 . . . . 26.52 109.779 -175.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1322 ' ' GLN . . . . . 0.568 ' HB2' ' HA ' ' A' 1151 ' ' ARG . 34.4 tp60 -74.13 -35.79 64.14 Favored 'General case' 0 CA--C 1.493 -1.218 0 O-C-N 121.626 -0.671 . . . . 24.38 112.442 -172.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1323 ' ' SER . . . . . . . . . . . . . 68.6 m -61.01 -45.28 95.46 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 113.905 1.076 . . . . 22.8 113.905 168.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1324 ' ' SER . . . . . . . . . . . . . 14.5 m -59.01 -37.94 78.07 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.89 0.476 . . . . 21.25 111.015 175.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1325 ' ' GLN . . . . . 0.435 ' HG2' ' HD2' ' A' 1164 ' ' PRO . 43.6 tp60 -63.05 -49.18 75.59 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 113.12 0.785 . . . . 31.34 113.12 171.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1326 ' ' LEU . . . . . 0.471 ' HA ' HD23 ' B' 1326 ' ' LEU . 35.7 mt -78.57 -48.1 15.87 Favored 'General case' 0 CA--C 1.488 -1.439 0 O-C-N 120.092 -1.63 . . . . 31.56 113.02 -170.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1327 ' ' TYR . . . . . 0.471 ' CZ ' ' HA ' ' B' 1072 ' ' VAL . 38.7 t80 -57.26 -42.81 82.27 Favored 'General case' 0 C--N 1.359 1.003 0 N-CA-C 107.536 -1.283 . . . . 22.73 107.536 170.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1328 ' ' GLY . . . . . 0.803 ' HA2' HD12 ' B' 1331 ' ' LEU . . . -52.37 -50.87 45.52 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 123.472 0.558 . . . . 21.91 112.438 171.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1329 ' ' THR . . . . . 0.628 HG21 ' HA3' ' A' 1161 ' ' GLY . 34.6 m -65.39 -29.46 70.16 Favored 'General case' 0 C--O 1.245 0.84 0 O-C-N 119.004 -2.468 . . . . 22.15 111.265 177.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1330 ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' B' 1327 ' ' TYR . 20.3 m120 -60.59 -49.19 78.53 Favored 'General case' 0 C--O 1.25 1.12 0 CA-C-O 122.446 1.117 . . . . 26.18 110.889 173.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1331 ' ' LEU . . . . . 0.805 HD13 ' HB3' ' B' 1070 ' ' LEU . 36.4 mt -53.21 -46.16 68.95 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 113.278 -1.783 . . . . 23.68 113.16 171.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1332 ' ' VAL . . . . . 0.574 HG12 ' HE3' ' B' 1336 ' ' LYS . 39.0 t -53.79 -50.0 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 115.754 -0.657 . . . . 26.57 110.643 171.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1333 ' ' ASN . . . . . 0.59 ' HA ' ' HD2' ' B' 1336 ' ' LYS . 76.3 m-20 -69.55 -27.37 65.09 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 119.875 -1.766 . . . . 28.08 113.303 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1334 ' ' LEU . . . . . 0.679 HD21 ' SD ' ' B' 1113 ' ' MET . 1.2 tt -66.96 -51.62 52.88 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 106.206 -1.775 . . . . 27.43 106.206 175.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1335 ' ' LEU . . . . . . . . . . . . . 86.3 mt -62.4 -29.75 70.71 Favored 'General case' 0 C--N 1.355 0.844 0 CA-C-N 115.162 -0.926 . . . . 30.5 111.255 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1336 ' ' LYS . . . . . 0.59 ' HD2' ' HA ' ' B' 1333 ' ' ASN . 95.0 mttt -64.8 -45.73 85.05 Favored 'General case' 0 C--O 1.245 0.843 0 O-C-N 120.418 -1.426 . . . . 41.65 110.052 169.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 29.5 tp -76.04 -18.27 59.3 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 119.454 1.024 . . . . 42.08 112.227 -174.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1338 ' ' LEU . . . . . 0.539 HD13 HD12 ' B' 1346 ' ' ILE . 26.8 mt -79.09 -67.92 0.71 Allowed 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 119.637 -1.914 . . . . 35.03 108.194 167.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1339 ' ' CYS . . . . . 0.506 ' SG ' ' HA ' ' B' 1342 ' ' LYS . 43.0 t -76.45 80.46 3.16 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 124.283 1.992 . . . . 37.33 108.282 -173.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1340 ' ' LYS . . . . . 0.422 ' HD2' ' O ' ' B' 1338 ' ' LEU . 2.6 mptp? -62.22 -27.64 69.13 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.531 -1.356 . . . . 50.51 111.984 174.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -84.63 -6.24 59.35 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 114.245 1.202 . . . . 54.21 114.245 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1342 ' ' LYS . . . . . 0.506 ' HA ' ' SG ' ' B' 1339 ' ' CYS . 90.7 mttt 39.07 39.8 0.42 Allowed 'General case' 0 C--O 1.257 1.477 0 N-CA-C 116.717 2.117 . . . . 50.99 116.717 -172.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -89.69 -14.52 34.6 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 113.885 -1.507 . . . . 48.82 107.542 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 89.98 27.99 19.58 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.052 -1.071 . . . . 40.43 112.351 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -136.68 160.84 37.62 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 120.289 2.044 . . . . 47.56 109.012 164.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1346 ' ' ILE . . . . . 0.539 HD12 HD13 ' B' 1338 ' ' LEU . 45.0 mm -68.1 101.13 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 C-N-CA 119.612 -0.835 . . . . 42.49 108.898 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1347 ' ' THR . . . . . . . . . . . . . 17.6 m -71.91 105.56 3.88 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 103.412 -2.81 . . . . 38.12 103.412 163.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 47.3 t -69.03 84.97 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.144 -1.389 . . . . 37.5 109.292 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1349 ' ' ASP . . . . . 0.442 ' HB3' HG21 ' B' 1355 ' ' ILE . 24.5 t70 -81.29 164.13 22.44 Favored 'General case' 0 C--O 1.243 0.761 0 O-C-N 121.298 -0.876 . . . . 43.85 110.701 171.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1350 ' ' PHE . . . . . 0.521 ' HE1' ' HB ' ' B' 1359 ' ' THR . 0.0 OUTLIER -155.0 3.09 0.2 Allowed 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 126.925 2.09 . . . . 39.81 111.17 158.302 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 10.6 t70 -72.94 -32.68 65.43 Favored 'General case' 0 C--O 1.247 0.939 0 CA-C-O 121.761 0.791 . . . . 51.29 112.234 -163.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.39 142.34 31.07 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.31 -0.859 . . . . 39.78 111.904 170.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1353 ' ' VAL . . . . . 0.436 ' HA ' ' HB3' ' B' 1356 ' ' ARG . 22.5 m -62.84 -26.47 40.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 114.956 1.465 . . . . 39.28 114.956 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1354 ' ' VAL . . . . . 0.515 HG21 ' HG3' ' B' 1123 ' ' ARG . 81.1 t -71.06 -49.94 45.73 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.195 0 N-CA-C 106.389 -1.708 . . . . 35.7 106.389 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1355 ' ' ILE . . . . . 0.442 HG21 ' HB3' ' B' 1349 ' ' ASP . 25.6 mm -62.49 -46.63 95.95 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 119.458 1.026 . . . . 35.77 111.766 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1356 ' ' ARG . . . . . 0.436 ' HB3' ' HA ' ' B' 1353 ' ' VAL . 45.1 tpt85 -46.15 -32.2 2.82 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 124.331 1.019 . . . . 38.55 113.091 172.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1357 ' ' GLY . . . . . 0.552 ' HA3' ' HG2' ' B' 1119 ' ' PRO . . . -97.28 -46.37 2.39 Favored Glycine 0 CA--C 1.497 -1.061 0 O-C-N 120.682 -1.261 . . . . 29.58 114.125 -176.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1358 ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' B' 1113 ' ' MET . 10.9 p -65.52 -35.73 75.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 117.035 0.417 . . . . 32.06 111.848 -176.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1359 ' ' THR . . . . . 0.521 ' HB ' ' HE1' ' B' 1350 ' ' PHE . 2.8 m -75.6 80.93 2.59 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.519 -1.66 . . . . 29.0 106.519 172.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1360 ' ' VAL . . . . . . . . . . . . . 15.6 m -68.39 -24.35 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 O-C-N 121.123 -0.986 . . . . 29.68 113.161 -172.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1361 ' ' ILE . . . . . 0.612 HG12 HG12 ' B' 1366 ' ' ILE . 74.7 mt -132.88 97.39 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 103.842 -2.651 . . . . 32.05 103.842 176.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1362 ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -79.71 92.63 5.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 124.442 3.292 . . . . 32.52 109.81 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1363 ' ' ALA . . . . . 0.48 ' H ' ' HA ' ' B' 1111 ' ' THR . . . 57.09 30.68 18.67 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 115.922 1.823 . . . . 35.68 115.922 168.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1364 ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' B' 1109 ' ' ASN . . . 147.97 -73.39 0.29 Allowed Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.26 -0.972 . . . . 34.26 110.887 177.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -69.28 141.45 54.34 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 113.565 0.95 . . . . 51.07 113.565 173.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1366 ' ' ILE . . . . . 0.612 HG12 HG12 ' B' 1361 ' ' ILE . 88.8 mt -86.66 113.33 24.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 125.198 2.428 . . . . 39.87 111.436 -175.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1367 ' ' THR . . . . . . . . . . . . . 1.1 p -98.45 3.14 48.31 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 111.344 -2.662 . . . . 38.01 112.698 -172.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1368 ' ' TRP . . . . . 0.411 ' HA ' ' HA ' ' B' 1369 ' ' PRO . 57.7 t90 -73.07 137.45 79.13 Favored Pre-proline 0 N--CA 1.447 -0.599 0 N-CA-C 107.757 -1.201 . . . . 42.14 107.757 167.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1369 ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' B' 1368 ' ' TRP . 31.5 Cg_exo -94.49 -178.84 8.06 Favored 'Cis proline' 0 N--CA 1.452 -0.939 0 C-N-CA 124.695 -0.96 . . . . 43.26 111.464 -5.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1370 ' ' ALA . . . . . 0.51 ' HB2' ' HA3' ' B' 1357 ' ' GLY . . . -76.08 163.54 65.95 Favored Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 124.718 1.207 . . . . 46.52 108.19 169.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -54.04 126.89 23.55 Favored 'Trans proline' 0 CA--C 1.553 1.46 0 C-N-CA 125.149 3.899 . . . . 51.95 111.003 166.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -37.88 109.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.365 1.442 1 C-N-CA 126.99 5.127 . . . . 56.27 113.375 -173.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1373 ' ' ILE . . . . . 0.519 HD11 HG12 ' B' 1121 ' ' ILE . 8.3 tp -82.44 137.33 21.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 C-N-CA 126.655 1.982 . . . . 60.83 113.094 -174.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 16.1 mp0 -87.49 101.09 13.26 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-O 122.979 1.371 . . . . 66.1 110.188 175.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 43.1 t -73.97 118.34 19.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 112.396 -2.184 . . . . 63.47 108.12 176.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.217 -5.174 0 O-C-N 118.206 -2.809 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.541 0 CA-C-O 116.792 -1.575 . . . . 0.0 111.416 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -58.11 -23.24 54.17 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 122.655 2.479 . . . . 0.0 115.676 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 52.9 mp0 -52.49 -53.07 50.71 Favored 'General case' 0 C--O 1.215 -0.715 0 CA-C-O 122.027 0.918 . . . . 0.0 109.25 171.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 23' ' ' THR . . . . . 0.551 HG21 ' HZ ' ' C' ' 147' ' ' PHE . 16.8 m -67.3 -43.53 81.48 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 114.561 -1.199 . . . . 0.0 109.791 -176.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 24' ' ' ALA . . . . . 0.521 ' HB2' HG22 ' C' ' 182' ' ' ILE . . . -55.87 -36.38 67.52 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 123.993 0.917 . . . . 0.0 111.26 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.12 -57.87 3.62 Favored 'General case' 0 C--O 1.24 0.605 0 O-C-N 120.082 -1.636 . . . . 0.0 112.706 171.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 mp -46.82 -44.94 19.76 Favored 'General case' 0 C--O 1.21 -1.025 0 C-N-CA 125.664 1.585 . . . . 0.0 114.284 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.426 HD11 HD11 ' C' ' 110' ' ' LEU . 27.6 mt -62.77 -49.52 74.68 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 28' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -67.6 -30.33 69.89 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 119.241 -0.983 . . . . 0.0 111.795 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -62.52 -43.2 99.4 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 124.06 0.944 . . . . 0.0 111.937 168.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.778 ' HA ' ' HB3' ' C' ' 107' ' ' ASP . 51.7 m -44.87 -31.7 1.34 Allowed 'General case' 0 CA--C 1.498 -1.028 1 N-CA-C 122.175 4.139 . . . . 0.0 122.175 -164.22 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 31' ' ' HIS . . . . . 0.538 ' O ' HG23 ' C' ' 62' ' ' ILE . 5.6 m-70 70.85 -62.67 0.44 Allowed 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.499 1.12 . . . . 0.0 111.607 -175.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 32' ' ' SER . . . . . 0.454 ' HB2' ' HA ' ' C' ' 106' ' ' THR . 71.7 m -108.52 139.67 42.95 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 162.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 92.2 t -124.05 134.98 65.08 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 103.738 -2.69 . . . . 0.0 103.738 174.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 42.5 mm -109.95 123.73 66.09 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.305 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 165.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . 0.417 ' O ' ' HD3' ' C' ' 37' ' ' PRO . 66.9 mt -108.51 124.8 65.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 172.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 89.2 m -108.1 100.22 35.39 Favored Pre-proline 0 C--O 1.245 0.825 0 CA-C-N 113.359 -1.746 . . . . 0.0 109.147 173.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . 0.687 ' HD2' HG12 ' C' ' 68' ' ' ILE . 66.4 Cg_exo -61.76 82.47 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.482 3.455 . . . . 0.0 110.391 174.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.18 -132.91 3.65 Favored Glycine 0 N--CA 1.432 -1.61 0 CA-C-O 123.3 1.5 . . . . 0.0 110.503 169.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 39' ' ' TYR . . . . . 0.78 ' HB2' ' HB2' ' C' ' 114' ' ' ALA . 4.2 t80 -59.28 -57.4 13.19 Favored 'General case' 0 CA--C 1.5 -0.966 0 O-C-N 121.306 -1.114 . . . . 0.0 110.834 -157.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -55.24 -34.92 59.41 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-O 118.392 -1.227 . . . . 0.0 112.328 -173.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 41' ' ' MET . . . . . 0.44 ' SD ' ' HB3' ' C' ' 37' ' ' PRO . 31.3 ttm -88.15 -37.55 16.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 118.539 1.169 . . . . 0.0 110.421 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.36 -2.37 37.86 Favored 'General case' 0 C--O 1.246 0.887 0 C-N-CA 122.416 0.287 . . . . 0.0 111.525 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 p -111.39 -43.53 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 166.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -135.9 179.03 6.59 Favored 'General case' 0 CA--C 1.507 -0.709 0 O-C-N 119.412 -2.055 . . . . 0.0 110.255 -167.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 45' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -63.64 16.02 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 120.583 3.549 . . . . 0.0 120.583 -169.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.417 ' HA ' ' HG2' ' C' ' 176' ' ' LYS . . . -59.9 -17.01 33.98 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 123.68 2.945 . . . . 0.0 115.048 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 47' ' ' GLN . . . . . 0.834 ' HG2' ' HB3' ' C' ' 82' ' ' LEU . 0.0 OUTLIER -62.46 -44.22 96.92 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.157 0.983 . . . . 0.0 111.106 174.516 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 48' ' ' TYR . . . . . 0.568 ' HB2' ' HD3' ' C' ' 49' ' ' PRO . 28.1 m-85 -62.74 -47.26 88.01 Favored Pre-proline 0 C--O 1.253 1.265 0 CA-C-N 121.99 2.177 . . . . 0.0 110.011 177.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 49' ' ' PRO . . . . . 0.568 ' HD3' ' HB2' ' C' ' 48' ' ' TYR . 0.1 OUTLIER -53.95 -42.64 65.04 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 124.642 3.561 . . . . 0.0 114.884 169.714 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . 0.415 ' HA ' HG22 ' C' ' 53' ' ' ILE . 1.4 p -65.95 -34.98 73.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 119.203 0.91 . . . . 0.0 111.09 -174.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.3 -50.07 70.53 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.175 0.99 . . . . 0.0 112.419 169.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 52' ' ' GLU . . . . . 0.417 ' HB3' ' HB2' ' C' ' 183' ' ' LEU . 1.5 tm-20 -68.82 -29.41 67.74 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -178.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 53' ' ' ILE . . . . . 0.415 HG22 ' HA ' ' C' ' 50' ' ' VAL . 9.4 tp -76.53 -46.05 32.35 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 N-CA-C 115.597 1.702 . . . . 0.0 115.597 166.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 96.9 m -57.63 -27.93 63.23 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 113.421 0.896 . . . . 0.0 113.421 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -47.43 -57.45 5.32 Favored 'General case' 0 N--CA 1.427 -1.618 0 C-N-CA 125.608 1.563 . . . . 0.0 114.017 167.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -81.17 -25.31 36.92 Favored 'General case' 0 N--CA 1.434 -1.244 0 O-C-N 120.76 -1.213 . . . . 0.0 112.271 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.77 -38.35 90.26 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 123.083 1.421 . . . . 0.0 111.488 171.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . 0.425 ' HA ' ' HD2' ' C' ' 58' ' ' ARG . 8.6 tpt180 -73.42 -32.9 64.66 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.536 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.18 -23.08 66.39 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 167.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -81.71 -6.29 58.89 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 119.157 0.89 . . . . 0.0 110.97 168.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.01 41.74 80.43 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 120.52 -1.363 . . . . 0.0 114.465 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . 0.538 HG23 ' O ' ' C' ' 31' ' ' HIS . 25.2 mt -96.04 134.54 33.22 Favored 'Isoleucine or valine' 0 C--O 1.253 1.253 0 CA-C-O 123.756 1.741 . . . . 0.0 111.081 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -68.99 83.07 0.32 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 124.629 2.156 . . . . 0.0 110.182 168.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.642 HG13 HD12 ' C' ' 92' ' ' ILE . 1.9 p -100.39 92.0 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 113.748 -1.569 . . . . 0.0 107.749 -176.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -91.62 128.08 37.32 Favored 'General case' 0 N--CA 1.442 -0.836 0 O-C-N 120.117 -1.614 . . . . 0.0 111.929 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . 0.517 ' HB2' ' HA ' ' C' ' 93' ' ' VAL . 25.6 m-85 -83.1 78.69 9.56 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 122.639 1.209 . . . . 0.0 109.047 176.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.48 89.06 0.35 Allowed Glycine 0 C--O 1.219 -0.804 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 68' ' ' ILE . . . . . 0.687 HG12 ' HD2' ' C' ' 37' ' ' PRO . 20.6 mt -88.72 132.62 33.13 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.902 0 CA-C-O 120.953 0.406 . . . . 0.0 111.845 -176.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -83.39 128.99 62.15 Favored Pre-proline 0 N--CA 1.472 0.654 0 CA-C-O 117.583 -1.199 . . . . 0.0 109.45 169.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 70' ' ' PRO . . . . . 0.792 ' HD3' ' HB2' ' C' ' 96' ' ' MET . 57.8 Cg_endo -61.11 -66.36 0.06 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.526 0 C-N-CA 124.582 3.521 . . . . 0.0 117.934 -175.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 45.8 t -76.16 107.54 7.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 170.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -168.15 142.71 3.48 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-N 121.315 1.871 . . . . 0.0 111.901 -171.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 61.77 -113.75 6.05 Favored Glycine 0 C--N 1.346 1.103 0 O-C-N 121.208 -0.932 . . . . 0.0 111.493 171.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 74' ' ' ARG . . . . . 0.604 ' HA ' ' OE1' ' B' 1203 ' ' GLN . 1.0 OUTLIER -128.72 105.88 8.56 Favored 'General case' 0 C--O 1.242 0.681 0 O-C-N 121.163 -1.199 . . . . 0.0 109.914 177.326 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.512 ' HB2' ' HB2' ' C' ' 78' ' ' HIS 0.25 2.0 mp 68.63 132.35 0.04 OUTLIER Pre-proline 0 CA--C 1.553 1.058 0 O-C-N 127.605 3.065 . . . . 0.0 116.269 -177.071 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.42 158.29 57.77 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 124.346 3.364 . . . . 0.0 107.784 167.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 77' ' ' GLY . . . . . 0.443 ' H ' HG23 ' A' 1157 ' ' ILE . . . 73.04 -63.92 1.62 Allowed Glycine 0 C--O 1.212 -1.244 0 CA-C-O 116.802 -2.11 . . . . 0.0 111.856 -168.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 78' ' ' HIS . . . . . 0.512 ' HB2' ' HB2' ' C' ' 75' ' ' LEU . 10.2 t-80 -33.23 -50.25 0.29 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -172.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.37 -45.03 85.7 Favored 'General case' 0 C--O 1.245 0.819 0 O-C-N 124.294 0.996 . . . . 0.0 113.207 -178.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.16 -26.07 42.77 Favored 'General case' 0 C--O 1.246 0.908 0 O-C-N 120.266 -1.521 . . . . 0.0 109.409 -175.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.438 HG22 HG21 ' A' 1154 ' ' THR . 46.5 t -58.48 -52.87 54.24 Favored 'Isoleucine or valine' 0 C--N 1.347 0.477 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 166.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.834 ' HB3' ' HG2' ' C' ' 47' ' ' GLN . 63.0 mt -56.95 -29.5 63.21 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 11.1 mp -63.96 -44.98 91.14 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 121.756 -0.59 . . . . 0.0 111.12 167.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.53 -38.08 86.39 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 120.223 -1.548 . . . . 0.0 112.334 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -50.39 -53.79 26.59 Favored 'General case' 0 C--N 1.349 0.572 0 O-C-N 124.654 1.221 . . . . 0.0 113.167 163.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.51 10.31 3.27 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp 58.68 30.29 19.73 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.867 2.067 . . . . 0.0 112.243 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 65.9 t -70.16 127.36 92.33 Favored Pre-proline 0 C--O 1.242 0.697 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 -174.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -50.56 107.41 0.16 Allowed 'Trans proline' 0 C--O 1.243 0.758 1 C-N-CA 125.313 4.009 . . . . 0.0 112.513 -176.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.75 -26.67 64.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.107 -1.406 . . . . 0.0 112.462 -165.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -40.15 -44.11 1.76 Allowed 'General case' 0 C--O 1.245 0.844 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 174.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 92' ' ' ILE . . . . . 0.642 HD12 HG13 ' C' ' 64' ' ' VAL . 0.5 OUTLIER -90.87 -1.42 9.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 -173.437 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 93' ' ' VAL . . . . . 0.517 ' HA ' ' HB2' ' C' ' 66' ' ' PHE . 10.6 t -83.36 121.73 36.59 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 O-C-N 120.686 -1.258 . . . . 0.0 114.38 -174.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 45.0 mt -125.59 81.78 2.01 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -170.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 95' ' ' GLU . . . . . 0.446 ' HA ' ' HB ' ' C' ' 68' ' ' ILE . 27.7 mp0 -75.76 104.38 6.28 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 121.677 -0.64 . . . . 0.0 110.433 -174.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.792 ' HB2' ' HD3' ' C' ' 70' ' ' PRO . 41.5 ttp 49.31 59.65 4.33 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.35 -171.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -103.84 135.74 44.82 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 167.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -85.73 75.64 10.05 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 -172.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 8.3 tp -92.97 62.27 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-O 124.777 2.227 . . . . 0.0 110.585 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -60.04 -32.97 71.42 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 112.397 -2.183 . . . . 0.0 109.354 -170.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.83 -59.65 4.57 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 118.155 -0.926 . . . . 0.0 112.23 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.01 -28.66 69.73 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 128.266 3.479 . . . . 0.0 113.239 176.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 103' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -64.52 -39.92 94.67 Favored 'General case' 0 C--O 1.224 -0.269 0 O-C-N 120.415 -1.428 . . . . 0.0 111.231 174.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -103.32 60.76 0.77 Allowed 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 123.263 1.506 . . . . 0.0 109.453 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -168.79 -37.02 0.02 OUTLIER 'General case' 0 C--O 1.241 0.655 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 106' ' ' THR . . . . . 0.454 ' HA ' ' HB2' ' C' ' 32' ' ' SER . 2.7 m -51.12 132.46 28.0 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 121.256 -0.902 . . . . 0.0 113.282 170.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 107' ' ' ASP . . . . . 0.778 ' HB3' ' HA ' ' C' ' 30' ' ' SER . 1.7 t70 -85.84 -60.49 2.0 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 34.6 m -109.22 130.67 55.49 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 118.572 -1.251 . . . . 0.0 112.563 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 109' ' ' VAL . . . . . 0.668 ' HB ' ' HA ' ' C' ' 144' ' ' VAL . 47.9 t -102.17 132.73 47.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 O-C-N 124.647 1.217 . . . . 0.0 108.225 173.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 110' ' ' LEU . . . . . 0.426 HD11 HD11 ' C' ' 27' ' ' LEU . 15.3 mt -98.58 84.24 3.13 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 124.57 1.169 . . . . 0.0 109.679 176.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 61.8 t -78.55 104.74 6.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 124.461 2.077 . . . . 0.0 107.494 170.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 36.3 mm -72.62 76.47 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.185 0 CA-C-O 124.424 2.059 . . . . 0.0 113.779 -175.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.11 -58.21 3.57 Favored Glycine 0 C--N 1.346 1.128 0 O-C-N 118.18 -2.825 . . . . 0.0 114.568 171.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 114' ' ' ALA . . . . . 0.78 ' HB2' ' HB2' ' C' ' 39' ' ' TYR . . . -82.75 95.05 7.75 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 123.153 1.454 . . . . 0.0 111.557 -171.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 115' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -52.25 -57.56 9.33 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 111.098 -2.774 . . . . 0.0 112.127 165.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 116' ' ' ASP . . . . . 0.589 ' HA ' ' HB2' ' C' ' 119' ' ' ASN . 15.1 m-20 -56.95 -34.03 67.63 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -169.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 20.7 m -43.46 -38.36 2.8 Favored 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 169.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 16.8 m -127.22 26.15 2.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 125.22 1.408 . . . . 0.0 110.826 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 119' ' ' ASN . . . . . 0.589 ' HB2' ' HA ' ' C' ' 116' ' ' ASP . 33.6 t-20 -75.54 120.71 82.93 Favored Pre-proline 0 CA--C 1.505 -0.775 0 CA-C-O 117.524 -1.227 . . . . 0.0 109.513 -177.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 120' ' ' PRO . . . . . 1.039 ' HG2' ' HB2' ' C' ' 160' ' ' ASN . 10.1 Cg_endo -53.25 -45.25 42.44 Favored 'Trans proline' 0 CA--C 1.51 -0.696 0 C-N-CA 124.639 3.559 . . . . 0.0 115.419 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 121' ' ' ALA . . . . . 0.47 ' HB2' ' HB3' ' C' ' 160' ' ' ASN . . . -55.4 -32.88 63.02 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 120.675 1.579 . . . . 0.0 112.897 -176.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 122' ' ' ALA . . . . . 0.535 ' HB1' ' HB3' ' C' ' 133' ' ' MET . . . -56.06 -20.15 15.81 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 120.774 -1.203 . . . . 0.0 113.121 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -119.11 -27.42 5.7 Favored 'General case' 0 C--O 1.221 -0.432 0 O-C-N 119.982 -1.699 . . . . 0.0 111.612 166.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -84.07 -11.08 57.26 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.26 -169.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -128.49 99.42 23.77 Favored Pre-proline 0 C--O 1.247 0.967 0 C-N-CA 119.314 -0.954 . . . . 0.0 111.096 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -64.19 69.25 0.21 Allowed 'Trans proline' 0 N--CA 1.441 -1.582 1 C-N-CA 125.62 4.213 . . . . 0.0 114.642 170.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 127' ' ' LYS . . . . . 0.499 ' HB3' ' HZ3' ' C' ' 127' ' ' LYS . 5.6 ttpm? -177.66 -28.11 0.01 OUTLIER 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 -174.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 128' ' ' SER . . . . . . . . . . . . . 66.2 m -59.46 129.39 86.94 Favored Pre-proline 0 C--O 1.222 -0.355 0 O-C-N 117.532 -3.23 . . . . 0.0 110.6 168.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 129' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -57.29 -46.82 25.54 Favored 'Trans proline' 0 N--CA 1.459 -0.522 1 C-N-CA 126.189 4.592 . . . . 0.0 115.738 -173.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 9.1 pt -84.11 63.7 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.842 0 CA-C-N 121.721 2.055 . . . . 0.0 111.038 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.75 153.44 43.36 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 118.111 2.634 . . . . 0.0 118.111 -168.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.15 22.83 77.46 Favored Glycine 0 C--O 1.213 -1.193 0 CA-C-N 110.232 -3.167 . . . . 0.0 111.553 177.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 133' ' ' MET . . . . . 0.755 ' SD ' ' HD2' ' C' ' 134' ' ' PRO . 34.0 tpp -74.15 119.32 75.76 Favored Pre-proline 0 C--O 1.238 0.481 0 CA-C-N 120.444 2.122 . . . . 0.0 107.956 -175.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 134' ' ' PRO . . . . . 0.755 ' HD2' ' SD ' ' C' ' 133' ' ' MET . 71.6 Cg_endo -67.89 105.17 1.1 Allowed 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 121.112 1.208 . . . . 0.0 108.99 -175.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 4.5 m -117.93 103.71 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 103.503 -2.777 . . . . 0.0 103.503 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 42.2 mt -73.81 90.73 1.9 Allowed 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 110.777 -2.92 . . . . 0.0 113.123 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 51.68 -12.48 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 120.96 3.689 . . . . 0.0 120.96 163.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 8.4 p -80.8 82.88 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-N 125.177 3.626 . . . . 0.0 113.182 -171.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 139' ' ' TRP . . . . . 0.517 ' HA ' HG21 ' C' ' 144' ' ' VAL . 44.6 p90 -163.71 173.12 13.27 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 111.799 -2.455 . . . . 0.0 106.754 173.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 140' ' ' LYS . . . . . . . . . . . . 0.398 25.2 pttm 68.31 -62.81 0.36 Allowed 'General case' 0 C--O 1.242 0.667 0 C-N-CA 128.233 2.613 . . . . 0.0 116.078 171.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.25 110.45 4.05 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-O 121.661 0.743 . . . . 0.0 111.961 169.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 142' ' ' GLN . . . . . 0.427 ' HB3' ' H ' ' C' ' 143' ' ' ASN 0.261 18.3 mm100 74.75 -163.27 0.08 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 172.189 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 143' ' ' ASN . . . . . 0.427 ' H ' ' HB3' ' C' ' 142' ' ' GLN . 2.1 m-20 -91.03 69.37 6.26 Favored 'General case' 0 C--O 1.248 1.018 0 CA-C-O 124.605 2.145 . . . . 0.0 107.288 -159.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 144' ' ' VAL . . . . . 0.668 ' HA ' ' HB ' ' C' ' 109' ' ' VAL . 20.5 t -75.24 82.69 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 114.145 -1.389 . . . . 0.0 107.384 178.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 145' ' ' ILE . . . . . . . . . . . . . 1.3 mp -80.17 120.71 32.16 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -176.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 146' ' ' VAL . . . . . . . . . . . . . 92.9 t -98.6 115.53 39.19 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 N-CA-C 102.919 -2.993 . . . . 0.0 102.919 172.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 147' ' ' PHE . . . . . 0.551 ' HZ ' HG21 ' C' ' 23' ' ' THR . 37.9 m-85 -64.82 123.96 20.73 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.611 0.719 . . . . 0.0 111.739 173.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 148' ' ' LYS . . . . . 0.61 ' HE3' ' SD ' ' C' ' 151' ' ' MET . 62.6 mmtt -126.54 146.41 50.14 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 2.1 tpp85 -89.02 -55.21 3.78 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 100.513 -3.884 . . . . 0.0 100.513 162.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 150' ' ' SER . . . . . 0.514 ' O ' ' HD2' ' C' ' 148' ' ' LYS . 3.4 m -152.82 -179.82 7.98 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 167.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 151' ' ' MET . . . . . 0.61 ' SD ' ' HE3' ' C' ' 148' ' ' LYS . 10.6 tpt -115.61 111.83 21.23 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 171.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -84.13 -144.1 0.08 Allowed 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 111.802 -2.453 . . . . 0.0 107.371 167.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 91.8 m -97.01 133.9 41.08 Favored 'General case' 0 C--O 1.24 0.577 0 O-C-N 117.243 -3.411 . . . . 0.0 107.43 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -84.57 151.91 27.07 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 113.256 -1.793 . . . . 0.0 110.292 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 16.1 m-30 -59.93 -39.03 84.11 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 117.917 -3.107 . . . . 0.0 114.523 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 156' ' ' ALA . . . . . . . . . . . . . . . -85.17 -54.6 4.51 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 119.199 -2.188 . . . . 0.0 107.548 166.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 80.84 -77.25 2.03 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.302 -0.863 . . . . 0.0 114.56 171.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 20.2 m -63.57 159.93 3.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 117.73 2.493 . . . . 0.0 117.73 -162.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . 0.258 0.0 OUTLIER -2.48 104.56 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.527 1 N-CA-C 122.043 4.09 . . . . 0.0 122.043 -176.071 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' C' C ' 160' ' ' ASN . . . . . 1.039 ' HB2' ' HG2' ' C' ' 120' ' ' PRO . 12.3 p30 -165.89 140.25 3.77 Favored Pre-proline 0 N--CA 1.434 -1.257 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.598 -173.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 161' ' ' PRO . . . . . 0.566 ' HG2' ' HG3' ' C' ' 120' ' ' PRO . 3.4 Cg_endo -45.56 -33.78 10.13 Favored 'Trans proline' 0 CA--C 1.512 -0.599 0 C-N-CA 123.521 2.814 . . . . 0.0 118.638 170.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 162' ' ' LEU . . . . . 0.588 ' HA ' HG22 ' C' ' 168' ' ' THR . 6.6 tp -68.28 -25.75 65.31 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 121.575 -0.703 . . . . 0.0 111.608 -173.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 163' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -87.66 -39.15 15.26 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 120.483 -1.385 . . . . 0.0 113.553 165.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -74.78 -53.26 9.5 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 115.802 1.778 . . . . 0.0 115.802 -169.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 165' ' ' LYS . . . . . 0.449 ' HB2' ' HB ' ' C' ' 168' ' ' THR . 5.4 mtpt -69.8 165.49 21.35 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 117.876 2.547 . . . . 0.0 117.876 -160.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 166' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' C' ' 169' ' ' HIS . 0.0 OUTLIER -73.09 -39.84 65.49 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 127.106 2.162 . . . . 0.0 113.109 174.179 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 167' ' ' ASN . . . . . 0.408 ' O ' ' HA ' ' C' ' 143' ' ' ASN . 42.1 p-10 -102.86 -46.19 4.76 Favored 'General case' 0 CA--C 1.498 -1.047 0 O-C-N 120.25 -1.531 . . . . 0.0 109.887 -174.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 168' ' ' THR . . . . . 0.599 HG23 ' HB ' ' C' ' 144' ' ' VAL . 54.4 m -74.27 91.84 2.2 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 102.92 -2.993 . . . . 0.0 102.92 161.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 169' ' ' HIS . . . . . 0.438 ' HB2' ' O ' ' C' ' 166' ' ' GLU . 16.6 t-80 -132.08 135.38 46.41 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 -164.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 170' ' ' MET . . . . . . . . . . . . . 75.7 mtm -74.1 102.28 4.18 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 113.397 -1.729 . . . . 0.0 108.399 169.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 171' ' ' LEU . . . . . . . . . . . . . 54.6 tp -100.01 129.29 46.05 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 -173.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -76.4 96.29 3.99 Favored 'General case' 0 C--O 1.248 0.976 0 CA-C-O 123.969 1.842 . . . . 0.0 112.839 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -156.88 134.65 4.1 Favored Glycine 0 CA--C 1.503 -0.671 0 N-CA-C 106.323 -2.711 . . . . 0.0 106.323 168.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 174' ' ' ASP . . . . . 0.803 ' HB3' ' HB3' ' C' ' 177' ' ' ALA . 22.5 t70 -60.17 143.12 53.17 Favored 'General case' 0 C--O 1.217 -0.631 0 O-C-N 121.734 -0.863 . . . . 0.0 111.296 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.48 -31.16 72.09 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -173.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 176' ' ' LYS . . . . . 0.516 ' HD3' ' HG2' ' C' ' 49' ' ' PRO . 0.1 OUTLIER -87.42 -61.53 1.7 Allowed 'General case' 0 C--O 1.236 0.357 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 168.507 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 177' ' ' ALA . . . . . 0.803 ' HB3' ' HB3' ' C' ' 174' ' ' ASP . . . -49.35 -44.76 44.88 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 -164.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 3.3 m -65.2 -42.59 93.38 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.58 177.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 179' ' ' VAL . . . . . 0.606 ' HA ' HG12 ' C' ' 182' ' ' ILE . 45.8 t -68.19 -40.95 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 119.451 1.023 . . . . 0.0 108.705 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -61.04 -28.98 69.45 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 114.996 -1.002 . . . . 0.0 113.184 174.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -77.69 -51.55 10.41 Favored 'General case' 0 N--CA 1.445 -0.688 0 O-C-N 117.366 -3.334 . . . . 0.0 112.323 171.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 182' ' ' ILE . . . . . 0.606 HG12 ' HA ' ' C' ' 179' ' ' VAL . 29.1 pt -62.68 -27.01 42.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 117.791 -1.1 . . . . 0.0 110.748 -174.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 183' ' ' LEU . . . . . 0.417 ' HB2' ' HB3' ' C' ' 52' ' ' GLU . 3.5 pp -58.42 -27.8 64.66 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 120.555 1.525 . . . . 0.0 114.315 174.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -94.38 -51.05 4.96 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -68.13 -72.57 0.17 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -175.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 186' ' ' LEU . . . . . . . . . . . . 0.293 0.5 OUTLIER . . . . . 0 CA--C 1.538 0.517 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -158.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 57.9 t-80 . . . . . 0 N--CA 1.44 -0.946 0 N-CA-C 106.322 -1.733 . . . . 65.74 106.322 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -52.48 88.01 0.01 OUTLIER Glycine 0 CA--C 1.526 0.753 0 O-C-N 119.562 -1.961 . . . . 48.66 110.462 160.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -130.1 131.39 45.71 Favored 'General case' 0 N--CA 1.431 -1.403 1 N-CA-C 97.445 -5.02 . . . . 44.56 97.445 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1003 ' ' ILE . . . . . 0.487 HD12 ' HB3' ' A' 1026 ' ' LEU . 42.2 mt -100.46 112.18 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 N-CA-C 105.266 -2.124 . . . . 34.86 105.266 176.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -77.73 132.06 11.6 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 112.646 -2.07 . . . . 30.75 110.259 169.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.623 HG23 ' HB3' ' A' 1017 ' ' ALA . 28.0 mm -119.18 91.05 43.07 Favored Pre-proline 0 CA--C 1.508 -0.642 0 N-CA-C 103.857 -2.645 . . . . 32.21 103.857 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -71.82 164.21 36.4 Favored 'Trans proline' 0 C--O 1.245 0.862 0 C-N-CA 123.421 2.747 . . . . 32.98 111.856 172.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1007 ' ' ARG . . . . . 0.56 ' HD2' HD12 ' A' 1042 ' ' LEU . 40.0 ttp85 -87.22 141.83 28.36 Favored 'General case' 0 C--O 1.267 1.998 0 N-CA-C 103.401 -2.814 . . . . 47.98 103.401 161.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1008 ' ' GLU . . . . . . . . . . . . 0.267 22.3 mm-40 -63.95 150.26 45.49 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 114.298 1.222 . . . . 34.7 114.298 177.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 24.4 mtp-105 -121.01 37.81 4.23 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 115.356 1.613 . . . . 53.37 115.356 -175.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1010 ' ' LEU . . . . . 0.639 HD12 HD11 ' A' 1076 ' ' LEU . 11.1 tp -96.63 179.18 5.08 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.144 -1.058 . . . . 45.07 108.144 -176.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1011 ' ' THR . . . . . 0.419 HG22 ' ND2' ' A' 1012 ' ' ASN . 10.3 m -63.2 140.1 58.84 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 107.419 -1.326 . . . . 40.36 107.419 171.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1012 ' ' ASN . . . . . 0.419 ' ND2' HG22 ' A' 1011 ' ' THR . 60.4 m-80 63.17 33.89 13.98 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 122.924 1.345 . . . . 40.61 114.501 169.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -98.4 151.02 21.01 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 116.898 2.185 . . . . 33.76 116.898 -158.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1014 ' ' THR . . . . . 0.451 ' HB ' ' O ' ' A' 1317 ' ' GLY . 5.0 m -136.13 -16.2 1.67 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 118.301 -0.857 . . . . 27.89 112.541 -177.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1015 ' ' ARG . . . . . 0.495 HH11 HG12 ' A' 1072 ' ' VAL . 69.7 mtm180 -70.01 150.68 46.39 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 117.081 2.252 . . . . 29.02 117.081 -173.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1016 ' ' VAL . . . . . 0.473 ' HB ' ' HB2' ' A' 1043 ' ' ALA . 4.3 p -113.96 166.76 7.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 103.976 -2.602 . . . . 28.13 103.976 159.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1017 ' ' ALA . . . . . 0.623 ' HB3' HG23 ' A' 1005 ' ' ILE . . . -67.51 -47.88 68.67 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.099 -1.041 . . . . 26.87 113.205 177.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -146.68 133.44 20.03 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 118.635 -2.54 . . . . 26.77 109.071 -176.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1019 ' ' THR . . . . . 0.685 HG21 HG23 ' A' 1321 ' ' THR . 0.7 OUTLIER -90.51 172.87 6.29 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-O 117.3 -1.333 . . . . 27.02 110.652 -177.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 1020 ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -25.45 -71.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.006 1 C-N-CA 127.496 5.464 . . . . 30.57 119.573 178.41 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 14.3 mptt -54.58 -44.0 72.62 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 120.371 1.441 . . . . 47.81 114.082 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1022 ' ' THR . . . . . 0.536 ' O ' ' HG ' ' A' 1026 ' ' LEU . 0.5 OUTLIER -65.8 -37.33 85.97 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 120.017 1.281 . . . . 30.77 112.217 175.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 1023 ' ' VAL . . . . . . . . . . . . . 25.5 t -59.52 -46.5 92.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 119.015 0.825 . . . . 33.59 110.3 170.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -59.95 -34.22 72.96 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 113.562 0.949 . . . . 53.29 113.562 172.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1025 ' ' GLN . . . . . 0.518 ' HB3' HG11 ' A' 1332 ' ' VAL . 39.2 mt-30 -64.36 -38.47 91.16 Favored 'General case' 0 N--CA 1.441 -0.883 0 O-C-N 120.73 -1.231 . . . . 46.92 112.122 171.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1026 ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' 1022 ' ' THR . 14.5 mt -68.37 -34.84 76.79 Favored 'General case' 0 C--O 1.249 1.078 0 O-C-N 121.082 -1.011 . . . . 37.17 110.195 175.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1027 ' ' LEU . . . . . 0.467 HD21 ' HA3' ' A' 1054 ' ' GLY . 10.8 mp -59.29 -42.58 91.61 Favored 'General case' 0 C--O 1.246 0.876 0 O-C-N 121.062 -1.024 . . . . 44.44 111.349 169.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -49.61 -51.21 39.03 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 124.361 1.038 . . . . 52.58 111.811 169.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1029 ' ' LEU . . . . . 0.664 ' HA ' ' HE2' ' A' 1342 ' ' LYS . 59.7 mt -65.9 -11.64 48.55 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 114.279 1.214 . . . . 45.69 114.279 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 90.12 28.24 18.41 Favored Glycine 0 C--O 1.25 1.148 0 O-C-N 121.223 -0.923 . . . . 42.09 112.646 174.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -119.34 127.63 53.35 Favored 'General case' 0 CA--C 1.488 -1.413 0 CA-C-O 117.854 -1.069 . . . . 40.72 108.255 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1032 ' ' THR . . . . . . . . . . . . . 97.4 m -67.27 135.53 53.51 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 108.683 -0.858 . . . . 37.77 108.683 176.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1033 ' ' VAL . . . . . . . . . . . . . 57.9 t -103.53 134.41 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 O-C-N 119.365 -2.084 . . . . 33.54 108.353 -172.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -121.68 105.26 10.25 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 105.907 -1.886 . . . . 31.68 105.907 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1035 ' ' VAL . . . . . . . . . . . . . 21.9 t -99.16 138.69 22.84 Favored 'Isoleucine or valine' 0 C--O 1.246 0.917 0 CA-C-N 114.944 -1.026 . . . . 31.52 108.737 -173.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1036 ' ' GLU . . . . . 0.443 ' HB3' ' HB2' ' A' 1039 ' ' ALA . 25.4 tt0 -57.76 130.88 48.43 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 123.867 1.794 . . . . 41.04 113.277 173.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1037 ' ' SER . . . . . . . . . . . . . 7.1 t -60.89 132.67 54.59 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 113.176 -1.829 . . . . 31.83 112.746 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 77.02 -4.92 52.43 Favored Glycine 0 CA--C 1.525 0.696 0 O-C-N 119.876 -1.765 . . . . 29.36 111.54 173.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1039 ' ' ALA . . . . . 0.443 ' HB2' ' HB3' ' A' 1036 ' ' GLU . . . -62.61 -40.14 96.03 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 119.04 -2.447 . . . . 27.78 113.667 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1040 ' ' GLY . . . . . 0.643 ' HA2' ' HB3' ' A' 1043 ' ' ALA . . . -62.52 -18.73 59.21 Favored Glycine 0 C--O 1.25 1.121 0 N-CA-C 114.652 0.621 . . . . 28.91 114.652 -177.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -62.38 -47.53 83.74 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.099 -1.236 . . . . 51.18 110.957 173.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1042 ' ' LEU . . . . . 0.56 HD12 ' HD2' ' A' 1007 ' ' ARG . 36.2 mt -64.39 -57.59 8.89 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.969 0.89 . . . . 29.91 112.528 167.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1043 ' ' ALA . . . . . 0.643 ' HB3' ' HA2' ' A' 1040 ' ' GLY . . . -60.38 -7.57 2.12 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 115.241 1.571 . . . . 28.54 115.241 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1044 ' ' SER . . . . . . . . . . . . . 62.9 m 69.81 31.47 3.48 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 125.393 1.477 . . . . 33.06 111.2 169.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1045 ' ' PHE . . . . . 0.695 ' HD1' ' HB3' ' B' 1277 ' ' ALA . 0.1 OUTLIER -157.95 107.06 2.06 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 102.44 -3.17 . . . . 30.29 102.44 169.671 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 1046 ' ' ASP . . . . . 0.471 ' OD2' ' HG2' ' A' 1048 ' ' LYS . 0.3 OUTLIER -79.74 174.22 11.81 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 117.372 2.36 . . . . 48.62 117.372 -148.094 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 28.9 t70 -47.7 -49.64 27.26 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 112.659 -2.064 . . . . 36.74 113.355 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1048 ' ' LYS . . . . . 0.471 ' HG2' ' OD2' ' A' 1046 ' ' ASP . 24.8 pttm -75.27 -26.72 59.01 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 120.947 -1.096 . . . . 43.73 110.206 176.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -62.35 -29.98 70.84 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 118.162 -2.837 . . . . 32.81 110.874 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1050 ' ' PHE . . . . . 0.481 ' HB2' HD11 ' A' 1057 ' ' ILE . 64.4 m-85 -62.46 -41.13 98.54 Favored 'General case' 0 C--O 1.219 -0.536 0 O-C-N 121.72 -0.613 . . . . 31.86 111.345 171.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 25.6 t -66.26 -40.81 87.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 119.889 -0.724 . . . . 33.22 111.771 172.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -56.68 -40.85 76.27 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 122.243 1.021 . . . . 50.83 111.163 176.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -61.98 -50.38 72.33 Favored 'General case' 0 C--O 1.263 1.815 0 N-CA-C 113.596 0.961 . . . . 33.12 113.596 168.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1054 ' ' GLY . . . . . 0.467 ' HA3' HD21 ' A' 1027 ' ' LEU . . . 131.65 47.63 0.12 Allowed Glycine 0 N--CA 1.443 -0.886 0 CA-C-O 119.337 -0.702 . . . . 35.83 113.617 175.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -126.82 150.53 49.14 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 114.698 1.37 . . . . 34.82 114.698 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -73.51 125.64 28.4 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 105.732 -1.951 . . . . 49.05 105.732 174.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1057 ' ' ILE . . . . . 0.481 HD11 ' HB2' ' A' 1050 ' ' PHE . 6.9 mm -89.52 125.46 42.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 106.203 -1.777 . . . . 38.53 106.203 173.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1058 ' ' VAL . . . . . 0.686 ' HB ' ' HB2' ' A' 1062 ' ' SER . 29.8 m -115.99 135.15 57.06 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 107.609 -1.256 . . . . 42.11 107.609 -177.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -75.74 79.13 2.69 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-O 122.696 1.236 . . . . 58.0 114.169 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 76.2 -123.77 7.01 Favored Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 107.739 -2.145 . . . . 52.12 107.739 171.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 39.7 t30 -47.92 -23.65 0.83 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 118.476 2.769 . . . . 54.75 118.476 -172.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1062 ' ' SER . . . . . 0.686 ' HB2' ' HB ' ' A' 1058 ' ' VAL . 1.3 m -53.26 -24.38 11.29 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 116.212 1.93 . . . . 50.34 116.212 171.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 6.1 p -44.71 -35.24 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 116.423 2.008 . . . . 41.46 116.423 172.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1064 ' ' TRP . . . . . . . . . . . . . 46.0 m95 -73.25 -22.41 60.41 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-N 119.64 1.109 . . . . 39.32 111.941 -169.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -69.22 70.39 0.24 Allowed 'General case' 0 CA--C 1.547 0.859 0 O-C-N 119.414 -2.054 . . . . 55.38 110.676 172.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1066 ' ' SER . . . . . . . . . . . . . 72.3 m -160.17 123.17 3.44 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 101.457 -3.535 . . . . 41.87 101.457 -171.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -74.56 2.08 10.54 Favored 'General case' 0 CA--C 1.508 -0.646 0 O-C-N 120.924 -1.11 . . . . 53.2 112.285 -178.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1068 ' ' ILE . . . . . 0.43 ' HB ' HG12 ' A' 1003 ' ' ILE . 4.9 mp -130.19 129.11 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 104.05 -2.574 . . . . 41.9 104.05 167.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1069 ' ' ILE . . . . . . . . . . . . . 25.7 mm -125.58 120.57 58.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 104.972 -2.233 . . . . 38.73 104.972 171.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1070 ' ' LEU . . . . . 0.851 HD13 HD13 ' A' 1331 ' ' LEU . 80.1 mt -101.75 133.95 45.68 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.061 -2.2 . . . . 32.44 105.061 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1071 ' ' LYS . . . . . 0.508 ' HB2' ' OG ' ' A' 1091 ' ' SER . 2.5 mmmp? -133.68 141.78 47.73 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.134 -1.432 . . . . 34.65 107.134 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1072 ' ' VAL . . . . . 0.495 HG12 HH11 ' A' 1015 ' ' ARG . 2.4 t -92.16 -4.1 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.016 0 O-C-N 119.87 -1.769 . . . . 31.32 111.031 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -142.09 159.41 42.28 Favored 'General case' 0 C--O 1.256 1.396 0 N-CA-C 102.393 -3.188 . . . . 33.94 102.393 173.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -42.1 140.89 1.47 Allowed Pre-proline 0 C--O 1.239 0.515 0 C-N-CA 124.872 1.269 . . . . 38.04 113.25 171.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1075 ' ' PRO . . . . . 0.741 ' HG2' HD21 ' A' 1089 ' ' LEU . 44.9 Cg_exo -67.36 99.67 0.52 Allowed 'Trans proline' 0 CA--C 1.492 -1.589 0 C-N-CA 122.18 1.92 . . . . 42.68 107.595 165.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1076 ' ' LEU . . . . . 0.639 HD11 HD12 ' A' 1010 ' ' LEU . 38.9 mt -73.02 167.35 21.28 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 112.219 -2.264 . . . . 46.74 108.61 -173.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1077 ' ' ASP . . . . . 0.449 ' HA ' HD12 ' A' 1080 ' ' ILE . 10.8 m-20 -43.15 -32.94 0.8 Allowed 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 120.46 3.504 . . . . 58.61 120.46 -175.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 16.0 t70 -75.09 -44.08 49.44 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 118.412 -0.804 . . . . 59.2 109.772 176.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1079 ' ' GLU . . . . . 0.434 ' HG2' ' HE2' ' A' 1071 ' ' LYS . 1.8 mp0 -59.73 -40.63 88.65 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 119.525 -0.87 . . . . 50.63 112.378 173.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1080 ' ' ILE . . . . . 0.716 HD11 ' HG ' ' A' 1101 ' ' LEU . 74.5 mt -54.15 -49.56 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 O-C-N 124.443 1.09 . . . . 51.48 108.36 176.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -57.15 -33.82 67.79 Favored 'General case' 0 C--O 1.249 1.075 0 N-CA-C 112.864 0.69 . . . . 50.28 112.864 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 42.0 mt -87.4 -16.75 34.03 Favored 'General case' 0 C--N 1.334 -0.078 0 O-C-N 120.29 -1.506 . . . . 50.21 114.239 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1083 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.81 132.88 48.23 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 118.841 -2.412 . . . . 49.06 116.476 -162.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 31.7 t30 -76.86 123.77 87.48 Favored Pre-proline 0 N--CA 1.452 -0.339 0 CA-C-N 114.293 -1.321 . . . . 51.08 113.651 174.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -61.27 155.59 50.74 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 124.249 3.3 . . . . 49.73 115.939 173.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 68.45 66.16 2.4 Favored Glycine 0 C--O 1.215 -1.058 0 CA-C-O 124.63 2.239 . . . . 47.71 109.539 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1087 ' ' THR . . . . . . . . . . . . . 33.0 m -146.22 137.75 24.74 Favored 'General case' 0 C--O 1.252 1.23 0 O-C-N 119.631 -2.1 . . . . 45.47 107.519 -171.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1088 ' ' THR . . . . . . . . . . . . . 3.0 m -80.21 94.98 6.15 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 104.169 -2.53 . . . . 42.04 104.169 165.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1089 ' ' LEU . . . . . 0.741 HD21 ' HG2' ' A' 1075 ' ' PRO . 27.7 tp -94.35 87.71 5.29 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 106.469 -1.678 . . . . 38.06 106.469 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1090 ' ' VAL . . . . . 0.408 ' HB ' HD23 ' A' 1070 ' ' LEU . 33.8 t -92.95 121.1 43.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 104.544 -2.391 . . . . 37.4 104.544 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1091 ' ' SER . . . . . 0.508 ' OG ' ' HB2' ' A' 1071 ' ' LYS . 26.7 m -153.37 151.83 30.38 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.857 -1.152 . . . . 36.16 112.673 -169.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 5.2 t80 -77.92 109.73 12.21 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 118.748 -2.47 . . . . 38.94 105.561 169.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 29.9 mm -90.56 -45.46 14.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 113.295 0.85 . . . . 42.17 113.295 -168.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 86.3 m95 54.61 66.36 4.21 Favored Pre-proline 0 C--O 1.245 0.827 0 O-C-N 124.485 1.115 . . . . 46.51 111.423 -157.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -52.0 -36.08 63.51 Favored 'Trans proline' 0 N--CA 1.449 -1.124 1 C-N-CA 125.801 4.334 . . . . 49.76 116.268 -175.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -72.35 -31.88 66.0 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-N 119.334 0.97 . . . . 52.62 108.84 -177.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 10.2 mp0 -77.95 -20.65 52.33 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 118.858 0.754 . . . . 60.74 112.243 172.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1098 ' ' ASN . . . . . 0.619 ' HB3' ' HB3' ' A' 1101 ' ' LEU . 69.4 m-80 -118.99 38.85 0.29 Allowed Pre-proline 0 N--CA 1.44 -0.958 0 N-CA-C 117.945 2.572 . . . . 58.19 117.945 -172.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -66.87 -24.59 46.24 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 124.569 3.513 . . . . 54.59 113.04 -168.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.99 -39.0 18.58 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 113.05 0.759 . . . . 63.28 113.05 175.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1101 ' ' LEU . . . . . 0.716 ' HG ' HD11 ' A' 1080 ' ' ILE . 10.2 tt -54.97 -39.78 69.32 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 109.765 -0.458 . . . . 54.75 109.765 166.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1102 ' ' MET . . . . . 0.417 ' HG2' ' O ' ' A' 1098 ' ' ASN . 49.2 mmm -57.74 -45.05 86.36 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.677 -1.264 . . . . 52.65 114.156 175.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -54.78 -43.35 72.75 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 112.536 0.569 . . . . 66.26 112.536 174.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1104 ' ' LYS . . . . . 0.632 ' HB3' HG21 ' A' 1080 ' ' ILE . 82.5 mttt -71.09 -41.67 70.32 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.435 0.636 . . . . 63.73 112.102 -175.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 71.8 mt -68.53 -32.38 72.29 Favored 'General case' 0 C--O 1.241 0.618 0 O-C-N 120.572 -1.33 . . . . 54.68 112.874 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -57.72 -51.52 69.2 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 120.455 1.479 . . . . 53.64 108.203 167.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -57.08 -25.68 59.14 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 122.14 2.246 . . . . 67.24 115.001 169.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -80.01 -3.85 50.15 Favored 'General case' 0 C--N 1.361 1.085 0 CA-C-N 121.177 1.808 . . . . 65.76 111.191 171.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 24.9 t-20 62.7 47.67 4.62 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 122.744 1.259 . . . . 58.71 109.578 168.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1110 ' ' VAL . . . . . . . . . . . . . 17.3 m -118.06 145.71 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 O-C-N 121.558 -0.714 . . . . 46.63 111.607 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1111 ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' 1361 ' ' ILE . 49.2 m -83.62 94.63 8.14 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-O 123.156 1.455 . . . . 44.13 107.681 174.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1112 ' ' VAL . . . . . 0.556 HG22 HD23 ' A' 1089 ' ' LEU . 82.8 t -89.94 118.93 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.008 0 CA-C-N 113.624 -1.625 . . . . 40.44 109.414 -174.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1113 ' ' MET . . . . . 0.696 ' HB3' HG12 ' A' 1358 ' ' VAL . 63.6 mtp -109.75 108.59 19.0 Favored 'General case' 0 C--O 1.252 1.229 0 N-CA-C 107.547 -1.279 . . . . 50.76 107.547 -177.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1114 ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' 1091 ' ' SER . . . -85.12 108.42 17.67 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-O 123.736 1.731 . . . . 35.64 110.653 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1115 ' ' MET . . . . . 0.489 ' HB3' ' CB ' ' A' 1129 ' ' ALA . 61.8 mmm -69.39 -14.35 62.86 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 112.049 -2.342 . . . . 38.74 115.467 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1116 ' ' ASP . . . . . 0.595 ' HA ' ' HB2' ' A' 1130 ' ' LEU . 3.6 p30 -71.14 -36.25 72.01 Favored 'General case' 0 C--N 1.352 0.674 0 CA-C-N 120.189 1.359 . . . . 40.14 111.122 162.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1117 ' ' SER . . . . . . . . . . . . . 49.2 m -80.97 23.33 0.56 Allowed 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 125.121 1.513 . . . . 44.79 114.551 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1118 ' ' VAL . . . . . 0.583 HG12 ' HB1' ' A' 1124 ' ' ALA . 16.5 t -70.3 131.41 88.55 Favored Pre-proline 0 N--CA 1.445 -0.681 0 N-CA-C 104.576 -2.379 . . . . 43.75 104.576 166.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1119 ' ' PRO . . . . . 0.487 ' HB2' HG12 ' A' 1121 ' ' ILE . 91.6 Cg_exo -58.36 146.25 90.48 Favored 'Trans proline' 0 C--O 1.252 1.216 0 C-N-CA 122.63 2.22 . . . . 48.93 113.556 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -66.6 -10.31 44.41 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 120.691 -1.255 . . . . 62.9 113.0 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1121 ' ' ILE . . . . . 0.487 HG12 ' HB2' ' A' 1119 ' ' PRO . 50.0 pt -62.19 152.19 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 N-CA-C 114.003 1.112 . . . . 57.72 114.003 -177.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1122 ' ' SER . . . . . . . . . . . . . 6.5 m -48.52 -52.63 21.61 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 118.304 2.705 . . . . 57.26 118.304 -177.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -56.64 -22.62 35.69 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 118.386 -2.696 . . . . 62.9 113.423 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1124 ' ' ALA . . . . . 0.583 ' HB1' HG12 ' A' 1118 ' ' VAL . . . -90.04 -21.52 22.31 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 117.025 -1.464 . . . . 49.83 111.773 -172.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -61.67 -26.73 68.2 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 116.444 2.016 . . . . 52.37 116.444 -163.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1126 ' ' SER . . . . . . . . . . . . . 5.8 p -66.83 -37.77 85.13 Favored 'General case' 0 C--O 1.245 0.821 0 O-C-N 119.058 -2.276 . . . . 42.43 111.999 170.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1127 ' ' LEU . . . . . . . . . . . . . 3.5 mp -77.23 -31.16 54.94 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 122.95 1.357 . . . . 43.74 110.739 176.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1128 ' ' ASP . . . . . 0.406 ' HA ' HG21 ' A' 1118 ' ' VAL . 6.1 t70 -53.82 109.78 0.5 Allowed 'General case' 0 C--O 1.252 1.227 0 CA-C-O 123.965 1.84 . . . . 43.21 113.649 -176.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1129 ' ' ALA . . . . . 0.489 ' CB ' ' HB3' ' A' 1115 ' ' MET . . . -80.06 -31.65 39.39 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 111.62 -2.536 . . . . 35.74 112.687 177.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1130 ' ' LEU . . . . . 0.595 ' HB2' ' HA ' ' A' 1116 ' ' ASP . 36.0 tp -54.45 -51.64 64.35 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.775 0.716 . . . . 38.09 110.538 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1131 ' ' SER . . . . . 0.464 ' HB3' HG21 ' A' 1175 ' ' VAL . 7.3 m -50.47 -49.26 55.69 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.715 1.206 . . . . 36.91 111.347 174.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1132 ' ' SER . . . . . . . . . . . . . 1.4 m -73.28 -42.29 62.61 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 115.676 -0.693 . . . . 35.79 111.123 -171.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1133 ' ' MET . . . . . 0.517 ' HA ' HD12 ' A' 1136 ' ' ILE . 28.6 mtp -63.2 -43.09 99.15 Favored 'General case' 0 N--CA 1.433 -1.308 0 O-C-N 120.479 -1.388 . . . . 30.81 110.564 177.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1134 ' ' ALA . . . . . 0.651 ' HB1' ' HB2' ' A' 1176 ' ' ALA . . . -52.09 -47.17 65.38 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 122.99 1.376 . . . . 28.88 112.903 168.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1135 ' ' ASN . . . . . 0.774 ' HB2' HG12 ' A' 1175 ' ' VAL . 25.0 t-20 -59.01 -48.21 82.4 Favored 'General case' 0 C--N 1.347 0.463 0 O-C-N 120.832 -1.168 . . . . 40.76 112.18 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1136 ' ' ILE . . . . . 0.575 HD13 ' HA ' ' A' 1323 ' ' SER . 61.3 mt -59.18 -46.48 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 108.782 -0.821 . . . . 31.54 108.782 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -61.39 -30.46 70.56 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 115.905 -1.998 . . . . 29.87 112.771 175.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -75.14 -39.8 36.18 Favored Glycine 0 CA--C 1.499 -0.932 0 CA-C-N 121.472 1.942 . . . . 28.73 109.814 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 25.5 t80 -65.62 -45.68 82.18 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.21 -1.033 . . . . 30.39 108.21 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1140 ' ' ARG . . . . . 0.459 ' HG3' HD22 ' A' 1315 ' ' LEU . 8.7 tpt180 -69.19 -24.82 64.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.906 0.86 . . . . 26.09 112.536 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1141 ' ' ALA . . . . . 0.604 ' HB2' HD21 ' A' 1284 ' ' LEU . . . -62.13 -45.14 94.77 Favored 'General case' 0 C--O 1.245 0.858 0 O-C-N 120.353 -1.467 . . . . 27.1 109.409 168.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 46.7 mm -58.52 -44.48 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 120.444 1.475 . . . . 28.48 114.538 172.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 28.8 t -53.1 -59.62 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 114.72 -1.127 . . . . 23.07 111.266 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1144 ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -75.27 -23.9 57.51 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.982 -0.377 . . . . 33.4 109.982 -171.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1145 ' ' ALA . . . . . 0.531 ' HA ' HG11 ' A' 1280 ' ' VAL . . . -62.12 -51.55 67.44 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.334 -0.987 . . . . 24.22 108.334 171.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -64.07 -28.06 69.53 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 123.8 0.84 . . . . 24.89 112.348 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -65.51 -40.28 92.82 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 118.763 -0.637 . . . . 26.73 110.832 171.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1148 ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -101.68 5.78 41.6 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 119.009 -2.307 . . . . 39.96 113.043 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1149 ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -76.15 144.9 40.29 Favored 'General case' 0 CA--C 1.514 -0.427 0 O-C-N 120.067 -1.645 . . . . 25.87 112.816 -169.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1150 ' ' GLY . . . . . 0.653 ' HA2' ' HG2' ' B' 1320 ' ' PRO . . . -71.21 -48.97 28.8 Favored Glycine 0 C--O 1.218 -0.9 0 N-CA-C 109.799 -1.32 . . . . 19.28 109.799 172.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1151 ' ' ARG . . . . . 0.866 ' HA ' ' HB2' ' B' 1322 ' ' GLN . 74.2 mtm-85 -99.57 -172.17 2.2 Favored 'General case' 0 C--N 1.318 -0.795 0 O-C-N 120.906 -1.35 . . . . 39.9 114.071 -172.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1152 ' ' PHE . . . . . 0.44 ' HD2' ' HG2' ' B' 1322 ' ' GLN . 0.4 OUTLIER -96.51 144.69 26.36 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 103.856 -2.646 . . . . 29.44 103.856 177.282 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 1153 ' ' PHE . . . . . 0.421 ' CZ ' HG13 ' A' 1251 ' ' ILE . 8.7 m-85 -64.21 -57.19 10.2 Favored 'General case' 0 C--N 1.341 0.224 0 O-C-N 121.211 -0.931 . . . . 32.6 110.039 168.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1154 ' ' THR . . . . . 0.519 HG22 ' HB3' ' A' 1156 ' ' GLN . 90.8 m -61.8 123.95 19.41 Favored 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 126.431 1.893 . . . . 34.64 116.015 -177.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -71.78 73.43 0.81 Allowed Glycine 0 N--CA 1.439 -1.158 0 CA-C-O 126.052 3.029 . . . . 37.14 111.259 175.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1156 ' ' GLN . . . . . 0.519 ' HB3' HG22 ' A' 1154 ' ' THR . 4.2 pp0? -108.93 136.2 48.86 Favored 'General case' 0 N--CA 1.434 -1.232 0 O-C-N 118.588 -2.713 . . . . 40.57 115.876 -177.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1157 ' ' ILE . . . . . 0.773 HG13 ' HB3' ' C' ' 70' ' ' PRO . 4.5 tp -90.87 110.2 21.97 Favored 'Isoleucine or valine' 0 C--O 1.256 1.431 0 CA-C-N 113.361 -1.745 . . . . 44.61 106.673 171.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1158 ' ' THR . . . . . . . . . . . . . 17.5 m -78.15 177.11 8.62 Favored 'General case' 0 C--O 1.252 1.202 0 O-C-N 120.87 -1.144 . . . . 40.7 110.563 169.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -65.09 -23.24 67.1 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 116.97 -3.581 . . . . 40.25 111.171 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1160 ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' B' 1126 ' ' SER . . . -134.35 131.01 37.8 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 104.828 -2.286 . . . . 38.47 104.828 159.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . 111.93 115.05 3.42 Favored Glycine 0 C--O 1.247 0.93 0 C-N-CA 119.572 -1.299 . . . . 37.61 112.095 170.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 15.8 tttp -85.7 130.87 34.45 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 104.456 -2.424 . . . . 48.9 104.456 169.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1163 ' ' VAL . . . . . 0.496 HG22 ' NE2' ' B' 1322 ' ' GLN . 69.7 t -85.98 128.19 59.09 Favored Pre-proline 0 N--CA 1.42 -1.933 0 O-C-N 120.01 -1.681 . . . . 36.52 107.896 164.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1164 ' ' PRO . . . . . 0.508 ' HA ' ' HD2' ' A' 1165 ' ' PRO . 28.6 Cg_endo -72.26 108.23 2.44 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.516 2.144 . . . . 35.08 108.904 155.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1165 ' ' PRO . . . . . 0.508 ' HD2' ' HA ' ' A' 1164 ' ' PRO . 30.4 Cg_endo -56.34 148.25 62.67 Favored 'Trans proline' 0 N--CA 1.444 -1.394 1 C-N-CA 126.314 4.676 . . . . 35.33 115.289 -176.524 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 1166 ' ' ALA . . . . . 0.443 ' O ' ' HB1' ' A' 1189 ' ' ALA . . . -66.12 129.02 38.39 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 125.159 1.537 . . . . 34.69 110.962 177.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1167 ' ' LYS . . . . . 0.611 ' HB2' ' HA ' ' A' 1249 ' ' VAL . 64.4 mttp -92.41 106.99 18.88 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 105.17 -2.159 . . . . 45.36 105.17 172.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 60.6 t -91.58 91.57 3.57 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 106.967 -1.494 . . . . 31.71 106.967 -175.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1169 ' ' MET . . . . . 0.465 ' HA ' ' O ' ' A' 1192 ' ' ARG . 25.1 ttp -79.29 92.11 5.1 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 124.593 2.14 . . . . 42.28 108.717 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1170 ' ' VAL . . . . . 0.438 HG13 ' OG1' ' A' 1255 ' ' THR . 13.8 t -75.29 115.14 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 112.128 -2.305 . . . . 30.51 106.629 176.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 64.5 mt -104.07 123.59 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 104.528 -2.397 . . . . 31.87 104.528 176.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 79.32 79.25 0.83 Allowed Glycine 0 CA--C 1.493 -1.332 0 CA-C-O 123.796 1.776 . . . . 34.54 109.81 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1173 ' ' ALA . . . . . 0.613 ' HB3' HG21 ' A' 1200 ' ' VAL . . . -75.7 179.86 5.15 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 123.417 1.58 . . . . 32.51 109.669 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . 138.92 -157.69 24.89 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 106.182 -2.767 . . . . 29.9 106.182 -175.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1175 ' ' VAL . . . . . 0.774 HG12 ' HB2' ' A' 1135 ' ' ASN . 34.3 t -70.49 -30.06 41.19 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 CA-C-N 122.188 2.994 . . . . 33.11 110.66 -170.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1176 ' ' ALA . . . . . 0.651 ' HB2' ' HB1' ' A' 1134 ' ' ALA . . . -65.35 -41.73 93.57 Favored 'General case' 0 C--N 1.348 0.517 0 CA-C-O 122.343 1.068 . . . . 28.1 108.832 171.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -60.67 -42.45 99.32 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 124.478 2.154 . . . . 28.54 109.997 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1178 ' ' LEU . . . . . 0.534 ' HA ' HD12 ' A' 1181 ' ' ILE . 72.8 mt -67.83 -35.69 79.05 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 113.403 -1.399 . . . . 31.22 111.052 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1179 ' ' ALA . . . . . 0.485 ' HB2' ' ND2' ' A' 1135 ' ' ASN . . . -64.99 -44.59 88.79 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-N 122.832 2.56 . . . . 28.98 108.822 175.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -55.25 -45.46 76.08 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 126.317 2.26 . . . . 27.83 113.085 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1181 ' ' ILE . . . . . 0.534 HD12 ' HA ' ' A' 1178 ' ' LEU . 33.5 mt -63.62 -54.28 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 O-C-N 120.237 -1.54 . . . . 30.25 108.819 175.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -52.29 -26.02 20.52 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 112.668 -2.06 . . . . 29.59 112.761 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -85.24 -60.25 2.09 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 115.323 1.601 . . . . 30.29 115.323 165.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -74.8 -39.73 61.52 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 115.386 1.624 . . . . 30.47 115.386 -167.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -60.22 -43.49 95.96 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 119.759 -1.838 . . . . 42.41 109.685 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1186 ' ' SER . . . . . 0.492 ' O ' ' HB3' ' B' 1186 ' ' SER . 21.4 m -58.39 -46.11 87.03 Favored 'General case' 0 C--O 1.213 -0.827 0 CA-C-O 121.957 0.885 . . . . 39.38 111.078 175.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 44.0 mt -62.47 -30.44 71.26 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 114.909 1.448 . . . . 36.18 114.909 174.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 103.36 42.38 2.04 Favored Glycine 0 N--CA 1.428 -1.879 0 CA-C-N 114.839 -1.073 . . . . 33.78 111.015 176.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1189 ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' 1166 ' ' ALA . . . -115.9 144.2 44.38 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 106.915 -1.513 . . . . 33.93 106.915 174.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 45.7 mt -72.07 102.63 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 O-C-N 120.226 -1.546 . . . . 38.74 110.375 -174.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1191 ' ' VAL . . . . . 0.451 HG21 ' HA ' ' A' 1181 ' ' ILE . 17.0 t -86.84 121.27 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 O-C-N 119.817 -1.802 . . . . 33.09 106.854 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1192 ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' 1169 ' ' MET . 73.8 mtt180 -115.68 105.33 12.63 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 105.321 -2.103 . . . . 38.92 105.321 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1193 ' ' ALA . . . . . 0.463 ' HB3' HG11 ' A' 1204 ' ' VAL . . . -102.73 124.67 48.69 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 118.928 -1.109 . . . . 35.32 110.482 -176.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1194 ' ' PHE . . . . . 0.54 ' HB2' HD12 ' A' 1212 ' ' LEU . 69.7 t80 -110.59 140.74 44.63 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 122.133 0.968 . . . . 39.35 109.419 175.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 7.1 t0 -157.52 150.12 22.95 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.182 -1.044 . . . . 40.46 108.182 174.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1196 ' ' THR . . . . . 0.541 HG23 ' CE2' ' A' 1234 ' ' PHE . 8.7 m -58.31 -38.98 78.16 Favored 'General case' 0 N--CA 1.445 -0.698 0 O-C-N 128.391 3.557 . . . . 45.94 109.493 171.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1197 ' ' ARG . . . . . 0.417 ' HA ' ' HD2' ' A' 1198 ' ' PRO . 86.5 mtm180 -87.73 110.92 38.6 Favored Pre-proline 0 C--N 1.318 -0.776 0 C-N-CA 126.67 1.988 . . . . 56.02 109.777 -172.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1198 ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' 1197 ' ' ARG . 72.6 Cg_endo -66.32 -13.32 39.38 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 121.457 1.438 . . . . 51.27 112.072 166.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -52.8 -30.49 33.54 Favored 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 118.66 -2.525 . . . . 59.1 115.1 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1200 ' ' VAL . . . . . 0.613 HG21 ' HB3' ' A' 1173 ' ' ALA . 35.6 m -93.92 -9.84 9.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 114.235 1.198 . . . . 51.06 114.235 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 86.4 tttt -52.17 -61.52 2.21 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 114.991 1.478 . . . . 57.38 114.991 -174.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1202 ' ' GLU . . . . . 0.4 ' HA ' ' HB2' ' A' 1205 ' ' GLN . 23.7 mp0 -69.37 -22.27 63.74 Favored 'General case' 0 C--O 1.211 -0.955 0 CA-C-N 119.934 1.243 . . . . 62.41 112.567 -177.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -63.84 -50.79 67.51 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 113.174 0.805 . . . . 57.78 113.174 170.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1204 ' ' VAL . . . . . 0.463 HG11 ' HB3' ' A' 1193 ' ' ALA . 47.4 t -58.98 -41.01 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 113.751 -1.568 . . . . 46.38 110.634 173.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1205 ' ' GLN . . . . . 0.4 ' HB2' ' HA ' ' A' 1202 ' ' GLU . 97.7 mt-30 -68.19 -29.37 68.21 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 115.401 1.63 . . . . 50.7 115.401 173.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1206 ' ' SER . . . . . . . . . . . . . 64.0 m -74.59 -31.37 62.01 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 121.062 -1.024 . . . . 49.98 110.872 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1207 ' ' MET . . . . . 0.413 ' SD ' ' HB3' ' A' 1178 ' ' LEU . 36.8 mtp -79.68 -15.2 58.0 Favored 'General case' 0 C--O 1.249 1.045 0 O-C-N 120.745 -1.222 . . . . 52.99 113.469 170.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 97.53 83.83 1.72 Allowed Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 109.009 -1.636 . . . . 47.66 109.009 173.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1209 ' ' ALA . . . . . 0.448 ' HB3' ' CG1' ' A' 1204 ' ' VAL . . . -161.27 145.82 13.49 Favored 'General case' 0 C--N 1.289 -2.03 0 O-C-N 119.093 -2.416 . . . . 44.77 107.311 176.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -76.76 123.04 25.59 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 103.74 -2.689 . . . . 47.64 103.74 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1211 ' ' PHE . . . . . . . . . . . . . 11.9 t80 -89.01 136.52 32.97 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 106.606 -1.627 . . . . 45.66 106.606 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1212 ' ' LEU . . . . . 0.54 HD12 ' HB2' ' A' 1194 ' ' PHE . 68.4 mt -94.51 119.22 32.87 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 107.521 -1.288 . . . . 46.06 107.521 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -71.76 144.25 49.28 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 112.79 -2.004 . . . . 60.22 111.875 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1214 ' ' LEU . . . . . 0.537 HD21 ' HZ ' ' A' 1234 ' ' PHE . 17.2 tp -73.66 89.13 1.74 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 109.504 -3.498 . . . . 57.25 112.421 -171.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1215 ' ' ASP . . . . . 0.481 ' O ' ' HB1' ' A' 1237 ' ' ALA . 23.6 t0 -71.53 87.09 0.89 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 114.086 1.143 . . . . 64.43 114.086 -174.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 85.4 t80 . . . . . 0 C--O 1.202 -1.413 0 O-C-N 124.794 1.309 . . . . 66.9 107.814 -170.507 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 30.9 t70 . . . . . 0 N--CA 1.447 -0.578 0 N-CA-C 107.071 -1.455 . . . . 39.09 107.071 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -67.34 -41.87 90.75 Favored Glycine 0 C--N 1.347 1.17 0 CA-C-N 114.484 -1.235 . . . . 39.32 111.598 -173.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 51.0 t80 -73.4 -42.09 62.53 Favored 'General case' 0 CA--C 1.504 -0.788 0 CA-C-O 118.151 -0.928 . . . . 39.3 108.696 -177.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -62.04 -38.51 89.01 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-N 119.539 1.063 . . . . 36.3 109.226 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -57.11 -45.94 83.02 Favored 'General case' 0 C--O 1.207 -1.159 0 CA-C-O 117.903 -1.046 . . . . 37.38 111.241 172.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -53.79 -31.12 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 113.15 0.796 . . . . 39.11 113.15 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1230 ' ' MET . . . . . . . . . . . . . 38.1 mmt -81.36 -23.97 37.37 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 116.394 1.998 . . . . 49.59 116.394 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1231 ' ' SER . . . . . . . . . . . . . 54.0 p -67.77 133.69 49.68 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.194 0.812 . . . . 43.68 113.194 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -50.23 -40.52 47.82 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 116.282 1.956 . . . . 55.57 116.282 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -64.72 -33.12 75.21 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 122.16 0.981 . . . . 44.94 110.271 178.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1234 ' ' PHE . . . . . 0.541 ' CE2' HG23 ' A' 1196 ' ' THR . 26.0 t80 -76.16 -46.48 28.37 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.365 -0.834 . . . . 42.04 109.041 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 12.2 mt -59.26 -31.43 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 122.344 -0.222 . . . . 46.28 111.377 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 53.3 tttm -62.48 -48.46 79.51 Favored 'General case' 0 C--O 1.245 0.867 0 O-C-N 119.531 -1.981 . . . . 47.87 109.0 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1237 ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' A' 1215 ' ' ASP . . . -58.83 -51.68 68.98 Favored 'General case' 0 C--O 1.247 0.931 0 N-CA-C 113.859 1.059 . . . . 41.61 113.859 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -54.79 -53.67 52.16 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 114.615 -1.175 . . . . 50.65 109.629 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1239 ' ' MET . . . . . . . . . . . . . 43.1 ttm -57.95 -41.36 82.66 Favored 'General case' 0 C--O 1.22 -0.484 0 O-C-N 123.694 0.621 . . . . 48.87 110.582 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -76.48 -22.5 54.44 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 120.119 -1.613 . . . . 54.8 111.725 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 1.3 tm? -66.9 -47.35 72.08 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.512 -1.662 . . . . 43.21 106.512 169.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -60.05 -36.51 77.47 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-O 118.701 -0.666 . . . . 38.66 110.283 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -67.19 -47.96 69.37 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 121.003 1.729 . . . . 37.92 111.353 -177.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -56.97 -55.19 37.88 Favored 'General case' 0 C--O 1.249 1.047 0 O-C-N 121.357 -0.839 . . . . 37.28 110.769 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -55.95 -36.33 67.66 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.743 1.217 . . . . 43.07 113.943 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1246 ' ' ALA . . . . . 0.458 ' HA ' HG22 ' A' 1249 ' ' VAL . . . -56.46 -30.4 62.85 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.996 1.11 . . . . 38.3 113.996 -176.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1247 ' ' LYS . . . . . . . . . . . . . 16.4 mtmt -78.89 -10.63 59.87 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 114.94 1.459 . . . . 47.6 114.94 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -121.18 -16.53 7.95 Favored 'General case' 0 C--O 1.246 0.899 0 O-C-N 119.0 -2.313 . . . . 45.42 114.858 173.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1249 ' ' VAL . . . . . 0.611 ' HA ' ' HB2' ' A' 1167 ' ' LYS . 27.7 m -85.33 175.21 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 O-C-N 119.199 -2.188 . . . . 36.26 111.193 -175.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1250 ' ' ASP . . . . . 0.427 ' O ' ' HB3' ' A' 1279 ' ' SER . 10.4 m-20 -134.27 -61.83 0.77 Allowed 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 112.818 -1.992 . . . . 33.04 109.371 -169.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1251 ' ' ILE . . . . . 0.523 HD12 ' HB1' ' A' 1145 ' ' ALA . 39.3 mm -108.61 94.99 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 107.002 -1.481 . . . . 31.4 107.002 -173.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1252 ' ' ILE . . . . . 0.436 ' HB ' HG23 ' A' 1281 ' ' ILE . 44.2 mt -77.7 107.65 9.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 106.13 -1.804 . . . . 29.42 106.13 171.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 5.5 t -99.28 105.19 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 104.635 -2.357 . . . . 30.37 104.635 173.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1254 ' ' THR . . . . . 0.667 HG21 ' HB2' ' A' 1291 ' ' ASN . 29.1 m -74.37 84.58 1.95 Allowed 'General case' 0 C--O 1.248 1.004 0 CA-C-O 122.732 1.253 . . . . 35.72 109.561 171.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1255 ' ' THR . . . . . 0.438 ' OG1' HG13 ' A' 1170 ' ' VAL . 1.1 p -75.89 -4.28 39.98 Favored 'General case' 0 C--O 1.25 1.093 0 N-CA-C 115.067 1.506 . . . . 36.0 115.067 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1256 ' ' ALA . . . . . . . . . . . . . . . -69.34 86.94 0.43 Allowed 'General case' 0 C--O 1.246 0.878 0 CA-C-O 121.65 0.738 . . . . 40.93 109.41 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1257 ' ' LEU . . . . . 0.553 HD22 ' HB2' ' A' 1134 ' ' ALA . 8.8 tp -73.13 91.96 1.67 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 105.653 -1.98 . . . . 47.82 105.653 178.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1258 ' ' ILE . . . . . 0.41 ' HA ' ' HD3' ' A' 1259 ' ' PRO . 41.8 mm -69.49 131.46 89.96 Favored Pre-proline 0 C--O 1.213 -0.865 0 CA-C-N 112.838 -1.983 . . . . 52.7 109.048 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1259 ' ' PRO . . . . . 0.433 ' O ' ' HG2' ' A' 1261 ' ' LYS . 6.8 Cg_exo -99.41 124.74 0.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.816 2.344 . . . . 54.13 114.387 177.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 78.2 -83.63 1.19 Allowed Glycine 0 C--N 1.343 0.962 0 CA-C-O 124.698 2.277 . . . . 54.62 114.786 173.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1261 ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' 1259 ' ' PRO . 55.2 pttt -42.84 146.91 0.7 Allowed Pre-proline 0 C--O 1.257 1.474 0 N-CA-C 117.711 2.486 . . . . 55.74 117.711 171.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -57.22 142.65 94.63 Favored 'Trans proline' 0 N--CA 1.451 -0.999 1 C-N-CA 125.336 4.024 . . . . 51.15 112.579 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1263 ' ' ALA . . . . . 0.414 ' HA ' ' HD2' ' A' 1264 ' ' PRO . . . -66.93 123.51 86.32 Favored Pre-proline 0 C--N 1.343 0.307 0 CA-C-N 113.446 -1.706 . . . . 46.06 111.169 174.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1264 ' ' PRO . . . . . 0.59 ' HG2' HD21 ' A' 1291 ' ' ASN . 43.7 Cg_endo -58.43 115.58 2.64 Favored 'Trans proline' 0 CA--C 1.509 -0.743 0 C-N-CA 123.792 2.995 . . . . 41.08 115.769 175.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1265 ' ' LYS . . . . . 0.435 ' HB3' ' HG2' ' A' 1293 ' ' GLU . 72.7 mmtt -75.6 89.58 2.76 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 122.495 1.141 . . . . 47.42 108.83 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 37.7 mt -97.67 -45.87 6.21 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.243 -1.391 . . . . 39.22 107.243 -177.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 7.9 mt -87.37 93.99 4.35 Favored 'Isoleucine or valine' 0 C--O 1.252 1.224 0 CA-C-O 126.19 2.9 . . . . 42.5 107.739 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1268 ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.75 143.68 30.01 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 111.97 -2.377 . . . . 37.84 112.383 175.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1269 ' ' ARG . . . . . 0.569 ' HG3' ' HB2' ' A' 1293 ' ' GLU . 56.3 mtt-85 -47.51 -39.18 15.54 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.072 0.949 . . . . 54.8 112.199 175.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -56.72 -50.09 73.24 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.388 -1.445 . . . . 54.36 109.154 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1271 ' ' MET . . . . . . . . . . . . . 10.0 mtt -68.78 -25.36 64.67 Favored 'General case' 0 CA--C 1.497 -1.09 0 O-C-N 123.789 0.68 . . . . 39.52 111.189 -170.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1272 ' ' VAL . . . . . 0.476 HG12 HG21 ' A' 1303 ' ' THR . 59.1 t -66.56 -49.62 73.5 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 O-C-N 126.179 2.174 . . . . 38.25 110.473 175.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -68.58 -26.43 65.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 119.985 -1.697 . . . . 40.77 112.445 174.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1274 ' ' SER . . . . . . . . . . . . . 7.2 m -68.76 -11.84 60.79 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 120.527 1.512 . . . . 36.58 114.442 169.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1275 ' ' MET . . . . . . . . . . . . . 62.7 mtp -62.52 145.69 53.63 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-O 124.478 2.085 . . . . 36.75 111.005 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1276 ' ' LYS . . . . . . . . . . . . . 74.1 tttt -50.64 137.38 19.88 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 110.967 -2.833 . . . . 46.11 106.468 165.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1277 ' ' ALA . . . . . 0.418 ' HB3' ' CD1' ' B' 1045 ' ' PHE . . . -90.94 176.85 6.46 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 117.9 -1.52 . . . . 33.52 110.472 -169.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 63.42 31.01 79.31 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 111.404 -0.679 . . . . 31.27 111.404 -170.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1279 ' ' SER . . . . . 0.427 ' HB3' ' O ' ' A' 1250 ' ' ASP . 15.2 m -122.32 171.93 8.68 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 120.587 -1.537 . . . . 32.95 110.528 -171.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1280 ' ' VAL . . . . . 0.531 HG11 ' HA ' ' A' 1145 ' ' ALA . 41.7 t -134.45 136.27 53.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 O-C-N 120.822 -1.174 . . . . 27.43 110.425 -173.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1281 ' ' ILE . . . . . 0.436 HG23 ' HB ' ' A' 1252 ' ' ILE . 66.0 mt -113.37 109.02 27.01 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 N-CA-C 103.122 -2.918 . . . . 30.3 103.122 170.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1282 ' ' VAL . . . . . 0.448 HG21 ' HB2' ' A' 1145 ' ' ALA . 2.4 t -101.15 97.86 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 105.104 -2.184 . . . . 28.63 105.104 176.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1283 ' ' ASP . . . . . 0.621 ' HA ' ' HB ' ' A' 1254 ' ' THR . 9.4 t70 -95.63 101.18 12.86 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 113.568 -1.651 . . . . 36.27 107.155 -171.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1284 ' ' LEU . . . . . 0.604 HD21 ' HB2' ' A' 1141 ' ' ALA . 31.2 mt -64.38 -37.69 88.41 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 119.608 -0.837 . . . . 38.57 110.688 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -59.23 -1.86 0.23 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 116.523 2.046 . . . . 37.56 116.523 173.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . -36.7 -42.52 0.37 Allowed 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 116.687 2.106 . . . . 40.33 116.687 161.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -51.33 -28.19 11.61 Favored 'General case' 0 C--N 1.348 0.534 0 N-CA-C 115.714 1.746 . . . . 56.85 115.714 174.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 11.4 m120 -113.97 22.88 13.49 Favored 'General case' 0 N--CA 1.433 -1.281 0 O-C-N 121.4 -0.813 . . . . 45.86 108.866 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 109.68 -23.11 22.75 Favored Glycine 0 N--CA 1.43 -1.731 0 O-C-N 118.196 -2.815 . . . . 40.31 114.338 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1290 ' ' GLY . . . . . 0.491 ' HA3' ' HB ' ' A' 1295 ' ' THR . . . 87.62 127.92 2.63 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 120.853 2.327 . . . . 38.89 112.2 -177.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1291 ' ' ASN . . . . . 0.667 ' HB2' HG21 ' A' 1254 ' ' THR . 2.8 m120 -71.27 -26.22 62.79 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 113.345 -1.427 . . . . 37.23 113.804 175.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1292 ' ' CYS . . . . . 0.425 ' SG ' HG21 ' A' 1272 ' ' VAL . 1.6 t -82.51 138.86 34.19 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.757 -1.11 . . . . 36.5 108.951 165.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1293 ' ' GLU . . . . . 0.569 ' HB2' ' HG3' ' A' 1269 ' ' ARG . 78.5 mt-10 -68.8 -6.56 27.52 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 115.371 1.619 . . . . 43.32 115.371 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -102.81 -2.09 28.59 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 119.688 -1.883 . . . . 41.32 112.706 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1295 ' ' THR . . . . . 0.491 ' HB ' ' HA3' ' A' 1290 ' ' GLY . 31.5 m -78.04 103.13 7.79 Favored 'General case' 0 C--N 1.355 0.832 0 O-C-N 120.845 -1.16 . . . . 35.3 112.827 -168.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 47.8 t -82.6 121.59 78.1 Favored Pre-proline 0 C--N 1.31 -1.131 0 O-C-N 125.292 1.62 . . . . 34.84 107.4 174.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -63.51 143.46 88.0 Favored 'Trans proline' 0 C--O 1.25 1.118 0 C-N-CA 122.984 2.456 . . . . 33.51 108.884 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 69.69 13.56 68.87 Favored Glycine 0 CA--C 1.544 1.9 0 CA-C-O 116.682 -2.177 . . . . 32.19 115.425 -175.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -147.37 169.98 18.32 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-N 123.988 3.894 . . . . 34.88 112.823 -172.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1300 ' ' ILE . . . . . 0.452 HG12 HG12 ' A' 1310 ' ' ILE . 74.3 mt -107.92 141.44 23.16 Favored 'Isoleucine or valine' 0 C--O 1.248 0.992 0 N-CA-C 106.555 -1.646 . . . . 32.29 106.555 166.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 78.8 t80 -119.74 114.28 21.92 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 104.194 -2.521 . . . . 37.25 104.194 164.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1302 ' ' THR . . . . . . . . . . . . . 46.0 m -93.66 118.9 31.99 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 103.614 -2.735 . . . . 35.56 103.614 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1303 ' ' THR . . . . . 0.476 HG21 HG12 ' A' 1272 ' ' VAL . 8.5 p -70.74 170.92 11.41 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 113.525 -1.671 . . . . 36.4 114.284 -171.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -75.23 -9.65 58.75 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 113.963 1.097 . . . . 52.32 113.963 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 37.3 p-10 -83.84 -46.14 12.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.363 0.601 . . . . 40.04 111.356 166.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 127.45 52.0 0.14 Allowed Glycine 0 N--CA 1.427 -1.903 0 CA-C-N 114.466 -1.243 . . . . 36.96 112.808 -177.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1307 ' ' VAL . . . . . . . . . . . . . 82.0 t -118.77 124.02 72.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 N-CA-C 104.943 -2.243 . . . . 33.4 104.943 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1308 ' ' LYS . . . . . 0.44 ' HB2' HG22 ' A' 1280 ' ' VAL . 53.7 mmtt -80.21 95.11 6.18 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 106.116 -1.809 . . . . 42.91 106.116 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 38.4 t -84.22 92.68 3.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 106.357 -1.72 . . . . 32.29 106.357 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1310 ' ' ILE . . . . . 0.452 HG12 HG12 ' A' 1300 ' ' ILE . 82.6 mt -82.44 103.41 9.62 Favored 'Isoleucine or valine' 0 C--N 1.351 0.642 0 CA-C-N 112.782 -2.008 . . . . 30.99 109.166 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -103.21 60.69 0.48 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 108.936 -1.666 . . . . 28.95 108.936 168.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1312 ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -83.25 95.73 8.24 Favored 'General case' 0 C--O 1.252 1.189 0 CA-C-O 125.278 2.466 . . . . 31.69 111.483 177.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1313 ' ' THR . . . . . . . . . . . . . 2.8 m -51.91 -37.92 54.35 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 112.46 -2.155 . . . . 34.17 111.567 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -84.77 10.38 11.58 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 113.381 -1.736 . . . . 36.86 111.679 -169.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1315 ' ' LEU . . . . . 0.459 HD22 ' HG3' ' A' 1140 ' ' ARG . 96.9 mt -44.05 -44.36 17.0 Favored Pre-proline 0 N--CA 1.474 0.743 0 N-CA-C 119.356 3.095 . . . . 34.85 119.356 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -53.6 -33.46 68.88 Favored 'Trans proline' 0 C--O 1.258 1.518 0 C-N-CA 124.53 3.486 . . . . 29.15 115.025 170.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1317 ' ' GLY . . . . . 0.451 ' O ' ' HB ' ' A' 1014 ' ' THR . . . -76.32 -40.66 28.02 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 109.496 -1.442 . . . . 27.29 109.496 177.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1318 ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' 1318 ' ' ARG . 58.1 mtt-85 -58.05 -26.62 62.73 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 115.641 1.719 . . . . 41.49 115.641 177.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1319 ' ' LEU . . . . . 0.459 HD23 HG23 ' A' 1136 ' ' ILE . 13.1 tp -103.97 71.88 0.17 Allowed Pre-proline 0 C--O 1.238 0.486 0 O-C-N 119.587 -1.946 . . . . 27.61 109.141 168.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1320 ' ' PRO . . . . . 0.706 ' HD2' ' HA2' ' B' 1150 ' ' GLY . 86.1 Cg_endo -58.12 -54.87 2.67 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.854 3.036 . . . . 25.94 113.985 -166.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1321 ' ' THR . . . . . 0.685 HG23 HG21 ' A' 1019 ' ' THR . 4.3 m -63.7 -43.53 96.35 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.937 0.895 . . . . 25.01 109.621 -171.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1322 ' ' GLN . . . . . 0.504 HE21 ' HG ' ' A' 1326 ' ' LEU . 9.3 tp60 -67.56 -26.76 66.46 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 117.451 -1.261 . . . . 29.39 112.803 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1323 ' ' SER . . . . . 0.575 ' HA ' HD13 ' A' 1136 ' ' ILE . 36.9 m -66.81 -51.29 57.34 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 120.346 1.43 . . . . 26.47 111.131 162.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1324 ' ' SER . . . . . . . . . . . . . 4.3 m -63.39 -17.83 63.04 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 116.296 1.962 . . . . 27.78 116.296 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -104.44 -54.87 2.45 Favored 'General case' 0 C--O 1.247 0.937 0 CA-C-N 114.787 -1.097 . . . . 37.53 110.811 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1326 ' ' LEU . . . . . 0.504 ' HG ' HE21 ' A' 1322 ' ' GLN . 33.6 mt -69.3 -59.5 2.96 Favored 'General case' 0 CA--C 1.505 -0.761 0 O-C-N 118.015 -2.928 . . . . 35.71 112.274 175.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1327 ' ' TYR . . . . . 0.531 ' HB3' ' O ' ' A' 1323 ' ' SER . 31.3 t80 -57.16 -37.5 72.18 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-O 122.31 1.052 . . . . 31.59 108.218 177.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1328 ' ' GLY . . . . . 0.463 ' HA2' HD12 ' A' 1331 ' ' LEU . . . -46.77 -58.4 6.13 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.95 1.262 . . . . 28.0 113.226 168.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1329 ' ' THR . . . . . 0.476 HG23 HE22 ' A' 1025 ' ' GLN . 17.3 m -70.14 -25.45 63.47 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.371 1.586 . . . . 32.15 110.619 -177.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1330 ' ' ASN . . . . . . . . . . . . . 26.4 m120 -59.3 -49.97 75.79 Favored 'General case' 0 C--O 1.244 0.792 0 O-C-N 119.807 -1.808 . . . . 34.36 111.361 168.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1331 ' ' LEU . . . . . 0.851 HD13 HD13 ' A' 1070 ' ' LEU . 13.2 mt -55.55 -48.96 73.91 Favored 'General case' 0 C--N 1.357 0.907 0 O-C-N 127.226 2.829 . . . . 33.37 108.747 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1332 ' ' VAL . . . . . 0.518 HG11 ' HB3' ' A' 1025 ' ' GLN . 44.1 t -56.9 -42.66 78.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 O-C-N 124.782 1.301 . . . . 35.27 110.783 175.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -57.55 -49.33 76.71 Favored 'General case' 0 C--O 1.242 0.706 0 O-C-N 119.844 -1.785 . . . . 37.66 112.677 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1334 ' ' LEU . . . . . 0.405 HD22 ' SD ' ' A' 1115 ' ' MET . 53.6 tp -57.06 -54.02 51.52 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 124.736 1.273 . . . . 40.27 108.43 176.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1335 ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' 1331 ' ' LEU . 46.6 mt -62.98 -23.81 67.61 Favored 'General case' 0 N--CA 1.436 -1.154 0 O-C-N 126.369 2.293 . . . . 42.5 111.146 -176.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1336 ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -69.02 -35.19 76.37 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 123.284 2.766 . . . . 47.81 111.944 173.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1337 ' ' LEU . . . . . 0.443 ' O ' ' HG2' ' A' 1340 ' ' LYS . 58.5 mt -67.84 -43.94 78.32 Favored 'General case' 0 CA--C 1.507 -0.709 0 O-C-N 120.84 -1.163 . . . . 49.27 108.297 172.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1338 ' ' LEU . . . . . 0.642 HD23 HG23 ' A' 1346 ' ' ILE . 6.9 mp -66.91 -38.93 87.15 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 116.724 2.12 . . . . 50.54 116.724 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1339 ' ' CYS . . . . . . . . . . . . . 49.1 t -104.82 81.32 1.74 Allowed 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 104.761 -2.311 . . . . 53.67 104.761 -175.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1340 ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' 1337 ' ' LEU . 75.3 mttt -74.31 -52.13 13.16 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 124.312 2.006 . . . . 63.38 113.096 -165.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1341 ' ' GLU . . . . . 0.412 ' HB2' ' HB3' ' A' 1343 ' ' ASP . 15.8 mt-10 -76.48 -44.16 36.61 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 110.077 -3.238 . . . . 70.95 111.85 -166.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1342 ' ' LYS . . . . . 0.664 ' HE2' ' HA ' ' A' 1029 ' ' LEU . 7.6 mtpm? 59.84 67.5 0.87 Allowed 'General case' 0 C--N 1.356 0.881 0 C-N-CA 127.043 2.137 . . . . 65.25 113.216 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1343 ' ' ASP . . . . . 0.412 ' HB3' ' HB2' ' A' 1341 ' ' GLU 0.468 0.0 OUTLIER 68.38 -72.14 0.1 Allowed 'General case' 0 C--N 1.375 1.712 1 O-C-N 115.001 -4.812 . . . . 64.53 118.904 8.507 . . . . . . . . 5 4 . 1 . 005 nuclear nobuild core ' A' A 1344 ' ' GLY . . . . . 0.658 ' H ' ' HA ' ' A' 1342 ' ' LYS . . . 79.71 46.69 7.71 Favored Glycine 0 C--O 1.244 0.755 0 CA-C-N 121.238 1.835 . . . . 59.72 110.462 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 28.8 t30 -130.03 122.8 29.1 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 121.792 0.806 . . . . 64.09 111.081 166.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1346 ' ' ILE . . . . . 0.642 HG23 HD23 ' A' 1338 ' ' LEU . 13.4 mt -79.99 109.9 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 CA-C-O 123.513 1.625 . . . . 58.82 109.382 170.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1347 ' ' THR . . . . . . . . . . . . . 28.6 m -96.84 107.2 19.65 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 110.275 -3.148 . . . . 54.96 104.533 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1348 ' ' VAL . . . . . 0.417 ' HB ' ' NH2' ' A' 1362 ' ' ARG . 42.2 t -84.16 87.78 2.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 103.608 -2.738 . . . . 55.64 103.608 -178.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 29.8 t70 -73.16 111.54 8.37 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.539 -1.21 . . . . 61.45 112.605 178.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1350 ' ' PHE . . . . . 0.454 ' HE2' HG21 ' A' 1367 ' ' THR . 3.1 m-85 -79.79 4.51 16.21 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 114.946 1.461 . . . . 58.63 114.946 171.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -78.45 -33.04 48.71 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 117.12 -1.832 . . . . 62.06 112.377 173.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 5.1 t70 -84.31 123.96 30.73 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 124.703 2.192 . . . . 54.07 108.8 171.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 32.2 m -61.46 -29.83 46.83 Favored 'Isoleucine or valine' 0 C--O 1.247 0.973 0 CA-C-N 109.902 -3.317 . . . . 50.68 113.089 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1354 ' ' VAL . . . . . 0.638 ' O ' HG23 ' A' 1358 ' ' VAL . 5.8 m -69.45 -40.92 80.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 119.908 1.231 . . . . 47.68 109.7 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1355 ' ' ILE . . . . . 0.501 HG23 HD11 ' A' 1338 ' ' LEU . 54.7 mt -68.11 -48.4 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.872 -1.159 . . . . 48.49 107.872 -176.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1356 ' ' ARG . . . . . 0.465 ' HG3' ' HG2' ' A' 1371 ' ' PRO . 22.5 tpt85 -52.08 -40.52 61.34 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.687 1.195 . . . . 48.27 113.145 168.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -58.65 -53.43 46.17 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 125.67 1.605 . . . . 43.53 112.623 174.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1358 ' ' VAL . . . . . 0.696 HG12 ' HB3' ' A' 1113 ' ' MET . 10.9 t -62.92 -39.9 86.86 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.5 0 O-C-N 124.982 1.048 . . . . 45.12 109.079 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1359 ' ' THR . . . . . . . . . . . . . 21.4 m -74.16 88.68 1.97 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 123.278 1.513 . . . . 42.94 109.835 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1360 ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' 1368 ' ' TRP . 29.7 m -78.62 -23.0 13.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 113.874 1.065 . . . . 43.26 113.874 178.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1361 ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' 1111 ' ' THR . 57.7 mt -133.36 120.5 39.11 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.003 0 O-C-N 118.119 -2.863 . . . . 45.66 106.604 170.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1362 ' ' ARG . . . . . 0.417 ' NH2' ' HB ' ' A' 1348 ' ' VAL . 12.9 ttt180 -102.09 109.78 21.57 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 118.474 -2.641 . . . . 61.34 106.358 170.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 43.16 39.92 2.16 Favored 'General case' 0 C--O 1.249 1.044 0 N-CA-C 117.278 2.325 . . . . 49.76 117.278 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1364 ' ' GLY . . . . . 0.44 ' H ' HG22 ' A' 1361 ' ' ILE . . . 119.6 -34.75 4.12 Favored Glycine 0 C--N 1.349 1.283 0 C-N-CA 119.392 -1.385 . . . . 50.0 111.758 177.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -82.4 123.12 28.83 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.002 -1.481 . . . . 56.92 107.002 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1366 ' ' ILE . . . . . 0.42 HG12 HG12 ' A' 1361 ' ' ILE . 93.4 mt -84.85 87.31 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 107.851 -1.166 . . . . 52.78 107.851 -177.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1367 ' ' THR . . . . . 0.454 HG21 ' HE2' ' A' 1350 ' ' PHE . 1.3 p -66.25 -6.76 14.92 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 116.031 1.863 . . . . 49.44 116.031 175.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1368 ' ' TRP . . . . . 0.571 ' CD1' ' HA ' ' A' 1369 ' ' PRO . 20.7 t90 -59.45 141.14 88.16 Favored Pre-proline 0 N--CA 1.442 -0.872 0 CA-C-O 116.13 -1.89 . . . . 52.38 108.128 164.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1369 ' ' PRO . . . . . 0.571 ' HA ' ' CD1' ' A' 1368 ' ' TRP . 72.6 Cg_exo -67.06 160.32 78.85 Favored 'Cis proline' 0 C--N 1.362 1.258 0 N-CA-C 119.733 2.936 . . . . 46.94 119.733 -0.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -89.68 142.53 29.35 Favored Pre-proline 0 C--O 1.24 0.6 0 CA-C-N 114.862 -1.063 . . . . 45.91 113.208 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1371 ' ' PRO . . . . . 0.465 ' HG2' ' HG3' ' A' 1356 ' ' ARG . 0.4 OUTLIER -51.59 124.1 13.63 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 124.366 3.377 . . . . 46.39 114.77 169.295 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 1372 ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' 1371 ' ' PRO . 56.0 Cg_exo -72.29 -59.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.357 1.005 1 C-N-CA 126.839 5.026 . . . . 46.72 109.225 173.381 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.223 -4.904 0 CA-C-N 119.741 1.155 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 79.4 m80 . . . . . 0 CA--C 1.548 0.884 0 N-CA-C 102.436 -3.172 . . . . 63.44 102.436 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 999' ' ' HIS . . . . . 0.552 ' HB3' ' HB3' ' B' 1002 ' ' ARG . 66.3 m-70 -124.02 50.72 1.62 Allowed 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 121.875 2.125 . . . . 51.74 111.849 170.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1000 ' ' HIS . . . . . . . . . . . . . 33.2 t60 -71.53 119.45 15.7 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 111.868 -2.424 . . . . 54.07 107.552 174.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 82.13 15.19 75.22 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 123.773 0.701 . . . . 39.22 111.442 -174.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1002 ' ' ARG . . . . . 0.552 ' HB3' ' HB3' ' B' ' 999' ' ' HIS . 30.6 ttp180 -107.59 128.05 54.19 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 124.534 2.112 . . . . 38.12 108.765 167.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1003 ' ' ILE . . . . . 0.678 HG12 ' HB ' ' B' 1068 ' ' ILE . 14.9 mt -81.79 150.52 4.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 110.191 -3.186 . . . . 29.7 107.229 174.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -129.34 120.42 3.2 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 105.167 -3.173 . . . . 27.5 105.167 171.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1005 ' ' ILE . . . . . 0.639 HG23 ' HB3' ' B' 1017 ' ' ALA . 45.8 mm -100.06 110.4 59.39 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 116.514 -1.708 . . . . 24.83 107.505 173.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -78.77 152.44 25.41 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 124.117 3.211 . . . . 27.19 110.757 175.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1007 ' ' ARG . . . . . 0.449 ' HB3' ' OE1' ' B' 1036 ' ' GLU . 18.2 ttt180 -79.97 110.27 15.19 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 102.938 -2.986 . . . . 41.46 102.938 160.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1008 ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -55.36 131.26 45.29 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 124.176 1.941 . . . . 26.93 115.757 -165.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 36.7 mmm-85 -84.95 -12.28 53.67 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 111.71 -2.496 . . . . 34.48 111.033 -169.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1010 ' ' LEU . . . . . 0.429 ' HB3' ' HB2' ' B' 1013 ' ' GLU . 13.1 tp -55.74 133.67 51.02 Favored 'General case' 0 C--O 1.243 0.728 0 O-C-N 120.776 -1.203 . . . . 44.22 109.609 172.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1011 ' ' THR . . . . . . . . . . . . . 28.7 m -60.46 111.65 1.66 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 114.365 1.246 . . . . 40.74 114.365 -168.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 42.3 t30 54.69 55.73 7.56 Favored 'General case' 0 C--O 1.222 -0.368 0 O-C-N 124.51 1.131 . . . . 44.44 114.047 -170.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1013 ' ' GLU . . . . . 0.429 ' HB2' ' HB3' ' B' 1010 ' ' LEU . 10.7 tp10 -88.49 136.75 32.84 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 115.054 -0.976 . . . . 29.87 108.988 166.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1014 ' ' THR . . . . . 0.523 HG22 ' HB3' ' B' 1320 ' ' PRO . 96.2 m -96.97 -26.18 15.13 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 111.422 -2.626 . . . . 25.26 109.906 -173.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1015 ' ' ARG . . . . . 0.676 ' HG3' ' HA2' ' B' 1317 ' ' GLY . 85.0 mtm180 -70.96 141.81 51.05 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 123.985 1.85 . . . . 29.54 112.218 175.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1016 ' ' VAL . . . . . 0.648 HG12 ' HB2' ' B' 1043 ' ' ALA . 9.9 p -102.47 169.5 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 N-CA-C 105.586 -2.005 . . . . 23.55 105.586 151.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1017 ' ' ALA . . . . . 0.639 ' HB3' HG23 ' B' 1005 ' ' ILE . . . -72.24 -35.93 68.97 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.294 1.22 . . . . 23.59 114.294 -174.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1018 ' ' ALA . . . . . . . . . . . . . . . -147.16 153.08 39.45 Favored 'General case' 0 CA--C 1.509 -0.612 0 O-C-N 124.001 0.813 . . . . 24.93 111.71 -172.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1019 ' ' THR . . . . . . . . . . . . . 12.7 p -91.57 163.75 27.09 Favored Pre-proline 0 C--O 1.25 1.11 0 CA-C-O 117.742 -1.123 . . . . 28.09 110.343 171.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -48.27 -41.76 34.54 Favored 'Trans proline' 0 CA--C 1.501 -1.166 1 C-N-CA 125.664 4.242 . . . . 28.79 111.966 173.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B 1021 ' ' LYS . . . . . 0.567 ' HD2' HE22 ' B' 1325 ' ' GLN . 0.5 OUTLIER -51.4 -47.57 62.9 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 122.638 1.209 . . . . 47.28 112.182 174.502 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B 1022 ' ' THR . . . . . 0.513 ' O ' ' HG ' ' B' 1026 ' ' LEU . 9.6 p -78.41 -22.34 47.93 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 118.835 -1.146 . . . . 30.12 112.038 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1023 ' ' VAL . . . . . . . . . . . . . 51.6 t -66.24 -42.3 90.72 Favored 'Isoleucine or valine' 0 C--N 1.349 0.548 0 O-C-N 120.84 -1.162 . . . . 32.24 110.421 169.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1024 ' ' GLU . . . . . 0.513 ' HA ' HD12 ' B' 1027 ' ' LEU . 43.6 mt-10 -54.57 -48.59 71.88 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 120.451 -1.405 . . . . 49.62 112.42 171.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -49.49 -48.36 47.93 Favored 'General case' 0 C--O 1.21 -0.975 0 N-CA-C 114.31 1.226 . . . . 44.68 114.31 169.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1026 ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' B' 1022 ' ' THR . 70.8 mt -58.07 -41.09 82.63 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 120.063 -1.648 . . . . 35.71 111.432 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1027 ' ' LEU . . . . . 0.513 HD12 ' HA ' ' B' 1024 ' ' GLU . 12.3 mt -70.05 -27.64 64.81 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.894 1.278 . . . . 42.18 114.247 177.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 51.5 mttm -66.11 -47.21 74.91 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 105.877 -1.898 . . . . 48.34 105.877 169.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1029 ' ' LEU . . . . . . . . . . . . . 74.1 mt -69.42 -10.99 60.4 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 120.426 -1.421 . . . . 38.69 113.714 175.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 97.05 10.52 54.79 Favored Glycine 0 C--N 1.353 1.522 0 C-N-CA 125.722 1.63 . . . . 32.28 113.015 166.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -77.12 140.59 40.28 Favored 'General case' 0 N--CA 1.44 -0.974 0 O-C-N 120.735 -1.45 . . . . 35.94 110.913 173.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1032 ' ' THR . . . . . . . . . . . . . 5.9 m -83.95 138.95 32.88 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 104.788 -2.301 . . . . 33.37 104.788 174.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1033 ' ' VAL . . . . . . . . . . . . . 10.0 t -122.34 144.39 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 124.045 3.111 . . . . 29.98 111.769 -172.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -129.57 144.93 51.49 Favored 'General case' 0 C--O 1.249 1.036 0 C-N-CA 125.791 1.636 . . . . 28.18 108.537 169.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1035 ' ' VAL . . . . . . . . . . . . . 47.0 t -136.84 142.47 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 105.831 -1.914 . . . . 25.82 105.831 -174.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1036 ' ' GLU . . . . . 0.595 ' HB2' HG11 ' B' 1063 ' ' VAL . 27.7 tt0 -76.95 141.33 40.5 Favored 'General case' 0 C--O 1.258 1.535 0 C-N-CA 118.886 -1.126 . . . . 32.44 113.968 -174.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1037 ' ' SER . . . . . . . . . . . . . 49.6 m -52.24 128.06 23.92 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.117 0.961 . . . . 29.54 113.178 171.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 92.34 -13.2 67.81 Favored Glycine 0 CA--C 1.542 1.779 0 CA-C-N 115.292 -0.867 . . . . 27.76 113.475 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1039 ' ' ALA . . . . . 0.624 ' HB1' HG21 ' B' 1016 ' ' VAL . . . -62.71 -39.37 93.81 Favored 'General case' 0 N--CA 1.438 -1.062 0 O-C-N 120.553 -1.557 . . . . 26.02 112.062 178.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -61.08 -45.81 95.83 Favored Glycine 0 C--N 1.304 -1.232 0 C-N-CA 119.315 -1.422 . . . . 26.47 110.962 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -68.17 -28.18 67.06 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 118.421 -2.811 . . . . 50.98 111.972 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 15.3 mt -58.91 -51.23 70.95 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 117.955 -2.965 . . . . 29.3 109.97 166.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1043 ' ' ALA . . . . . 0.648 ' HB2' HG12 ' B' 1016 ' ' VAL . . . -68.2 17.13 0.04 OUTLIER 'General case' 0 C--O 1.213 -0.823 0 O-C-N 119.0 -2.313 . . . . 26.74 116.564 167.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1044 ' ' SER . . . . . . . . . . . . . 15.1 m 54.12 34.47 20.13 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 123.707 1.717 . . . . 31.26 114.792 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1045 ' ' PHE . . . . . 0.418 ' CD1' ' HB3' ' A' 1277 ' ' ALA . 0.1 OUTLIER -127.94 158.59 37.41 Favored 'General case' 0 C--O 1.241 0.65 0 O-C-N 121.172 -0.955 . . . . 33.26 108.712 -177.528 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 29.1 t0 -72.71 139.05 46.97 Favored 'General case' 0 C--O 1.245 0.835 0 O-C-N 120.755 -1.215 . . . . 46.74 108.824 170.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.54 -40.57 72.03 Favored 'General case' 0 C--O 1.214 -0.816 0 CA-C-O 122.572 1.177 . . . . 34.44 110.858 175.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.65 -2.41 17.14 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 120.635 -1.291 . . . . 48.67 113.134 -174.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -72.08 -35.68 69.3 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 118.302 -2.749 . . . . 35.26 108.365 167.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1050 ' ' PHE . . . . . 0.661 ' HB2' HD11 ' B' 1057 ' ' ILE . 64.2 m-85 -65.32 -41.63 93.81 Favored 'General case' 0 C--O 1.219 -0.524 0 O-C-N 120.335 -1.478 . . . . 32.17 108.438 176.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1051 ' ' VAL . . . . . 0.629 HG23 HG12 ' B' 1057 ' ' ILE . 17.5 t -50.8 -57.98 2.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 123.757 0.66 . . . . 38.37 111.98 168.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -42.77 -54.28 4.17 Favored 'General case' 0 C--O 1.213 -0.845 0 N-CA-C 113.511 0.93 . . . . 45.77 113.511 172.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -54.25 -38.4 65.75 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.376 1.251 . . . . 37.83 114.376 173.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 126.89 34.53 0.59 Allowed Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.845 -0.902 . . . . 35.82 110.845 174.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -112.23 147.21 36.71 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 107.985 -1.117 . . . . 33.77 107.985 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -76.85 132.82 39.37 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 107.19 -1.411 . . . . 51.02 107.19 168.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1057 ' ' ILE . . . . . 0.661 HD11 ' HB2' ' B' 1050 ' ' PHE . 27.8 mm -100.96 124.68 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-O 122.92 1.343 . . . . 38.47 108.06 169.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1058 ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' B' 1036 ' ' GLU . 0.0 OUTLIER -143.52 142.34 25.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 C-N-CA 124.942 1.297 . . . . 39.4 113.235 -171.553 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -82.17 123.13 28.72 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.998 -1.112 . . . . 57.07 107.998 -171.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1060 ' ' GLY . . . . . 0.495 ' O ' HG12 ' B' 1063 ' ' VAL . . . 57.0 -133.82 52.53 Favored Glycine 0 N--CA 1.432 -1.596 0 CA-C-O 122.605 1.114 . . . . 44.83 114.404 165.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -38.92 -40.52 0.65 Allowed 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 111.084 -2.558 . . . . 46.27 115.403 -172.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1062 ' ' SER . . . . . . . . . . . . . 5.5 m -45.71 -51.31 12.67 Favored 'General case' 0 C--N 1.349 0.586 0 N-CA-C 113.98 1.104 . . . . 43.47 113.98 173.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1063 ' ' VAL . . . . . 0.595 HG11 ' HB2' ' B' 1036 ' ' GLU . 3.6 p -69.3 -35.32 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 C-N-CA 123.371 0.668 . . . . 36.98 110.15 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -64.22 -28.57 69.83 Favored 'General case' 0 N--CA 1.422 -1.844 0 O-C-N 123.813 0.696 . . . . 37.9 111.908 175.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -82.29 82.91 7.61 Favored 'General case' 0 C--O 1.243 0.748 0 O-C-N 118.798 -2.439 . . . . 46.19 110.802 171.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1066 ' ' SER . . . . . . . . . . . . . 44.7 m -150.35 162.36 40.69 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.412 -1.267 . . . . 37.06 108.299 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1067 ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -72.02 -58.3 3.55 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 117.821 -1.551 . . . . 43.95 111.951 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1068 ' ' ILE . . . . . 0.678 ' HB ' HG12 ' B' 1003 ' ' ILE . 4.4 mp -96.22 107.15 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 103.165 -2.902 . . . . 33.5 103.165 -169.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 48.9 mm -97.54 109.22 23.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 107.208 -1.404 . . . . 30.57 107.208 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1070 ' ' LEU . . . . . 0.681 HD22 HD22 ' B' 1331 ' ' LEU . 83.6 mt -95.74 91.86 6.29 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 124.377 2.037 . . . . 27.66 107.174 177.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1071 ' ' LYS . . . . . . . . . . . . . 10.9 mtpt -90.69 161.27 15.44 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-N 112.59 -2.095 . . . . 28.4 109.491 176.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1072 ' ' VAL . . . . . . . . . . . . . 2.7 t -83.91 -56.91 4.97 Favored 'Isoleucine or valine' 0 C--N 1.351 0.637 0 N-CA-C 104.733 -2.321 . . . . 23.18 104.733 -177.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -113.46 173.88 6.19 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 113.808 -1.542 . . . . 25.47 107.448 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -49.41 146.93 6.08 Favored Pre-proline 0 C--O 1.264 1.832 0 C-N-CA 124.899 1.28 . . . . 27.9 113.66 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1075 ' ' PRO . . . . . 0.525 ' HG3' HD21 ' B' 1105 ' ' LEU . 59.7 Cg_endo -60.52 151.89 72.06 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.455 2.77 . . . . 31.62 110.574 166.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 7.4 mp -89.7 165.74 14.01 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 113.828 -1.533 . . . . 40.49 107.171 166.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1077 ' ' ASP . . . . . 0.582 ' HA ' HD12 ' B' 1080 ' ' ILE . 10.1 t70 -58.71 -40.63 84.24 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 116.448 2.018 . . . . 51.59 116.448 -173.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -57.3 -43.43 83.22 Favored 'General case' 0 C--O 1.244 0.773 0 O-C-N 121.489 -0.757 . . . . 42.36 111.202 169.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1079 ' ' GLU . . . . . 0.438 ' OE1' ' HA ' ' B' 1075 ' ' PRO . 43.2 mt-10 -64.8 -28.65 69.71 Favored 'General case' 0 C--O 1.221 -0.426 0 O-C-N 121.404 -0.81 . . . . 34.53 109.868 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1080 ' ' ILE . . . . . 0.843 ' HA ' HD12 ' B' 1083 ' ' LEU . 69.5 mt -64.13 -41.21 91.73 Favored 'Isoleucine or valine' 0 C--N 1.36 1.053 0 O-C-N 119.926 -1.734 . . . . 33.25 110.231 171.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -62.73 -30.01 71.1 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.442 -1.411 . . . . 36.47 114.365 172.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1082 ' ' LEU . . . . . 0.42 HD12 ' HA ' ' B' 1079 ' ' GLU . 65.4 mt -75.16 -28.34 60.05 Favored 'General case' 0 C--N 1.348 0.532 0 O-C-N 121.584 -0.698 . . . . 37.76 110.852 175.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1083 ' ' LEU . . . . . 0.843 HD12 ' HA ' ' B' 1080 ' ' ILE . 34.1 mt -52.78 114.8 1.53 Allowed 'General case' 0 C--O 1.247 0.953 0 N-CA-C 114.928 1.455 . . . . 37.43 114.928 174.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.34 143.83 52.65 Favored Pre-proline 0 N--CA 1.453 -0.314 0 CA-C-N 111.289 -2.687 . . . . 37.7 107.587 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -54.67 123.69 14.33 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.176 3.251 . . . . 35.51 109.434 175.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 83.61 17.16 66.66 Favored Glycine 0 C--N 1.316 -0.565 0 CA-C-O 119.608 -0.551 . . . . 33.87 112.076 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1087 ' ' THR . . . . . . . . . . . . . 52.5 m -69.76 134.44 48.58 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 121.707 2.753 . . . . 32.5 108.72 163.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1088 ' ' THR . . . . . . . . . . . . . 38.9 m -92.93 97.94 11.05 Favored 'General case' 0 C--O 1.254 1.321 0 N-CA-C 105.528 -2.027 . . . . 30.22 105.528 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1089 ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' B' 1112 ' ' VAL . 22.1 tp -96.17 130.19 43.29 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 120.829 -1.169 . . . . 27.24 108.639 -176.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 95.8 t -125.6 128.01 72.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 102.247 -3.242 . . . . 25.39 102.247 -175.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1091 ' ' SER . . . . . . . . . . . . . 3.9 m -160.23 168.38 25.51 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 121.893 2.133 . . . . 28.81 111.925 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1092 ' ' PHE . . . . . 0.421 ' CD2' ' HB3' ' B' 1116 ' ' ASP . 25.2 m-85 -66.71 108.25 2.42 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.549 -1.278 . . . . 30.78 107.549 155.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 26.2 mm -104.31 -36.67 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 O-C-N 118.837 -2.414 . . . . 30.28 114.267 -176.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1094 ' ' TRP . . . . . 0.504 ' HB2' ' ND2' ' B' 1098 ' ' ASN . 61.9 m95 54.53 65.49 5.06 Favored Pre-proline 0 CA--C 1.548 0.886 0 O-C-N 124.319 1.012 . . . . 34.07 110.582 -175.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -47.99 -58.39 1.78 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 1 C-N-CA 127.375 5.383 . . . . 38.66 118.91 -166.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1096 ' ' ALA . . . . . 0.512 ' HB2' ' HZ3' ' B' 1368 ' ' TRP . . . -82.29 -14.89 54.7 Favored 'General case' 0 N--CA 1.436 -1.163 0 O-C-N 119.734 -1.854 . . . . 41.32 110.437 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -76.58 -21.96 54.91 Favored 'General case' 0 C--O 1.246 0.895 0 N-CA-C 108.579 -0.897 . . . . 51.66 108.579 166.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1098 ' ' ASN . . . . . 0.504 ' ND2' ' HB2' ' B' 1094 ' ' TRP . 14.1 m-80 -121.36 42.39 0.56 Allowed Pre-proline 0 C--N 1.309 -1.168 0 N-CA-C 117.391 2.367 . . . . 40.32 117.391 -172.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -56.49 -42.54 64.47 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 123.633 2.889 . . . . 41.56 117.188 -167.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -61.25 -39.84 91.83 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.714 1.143 . . . . 54.11 113.316 175.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1101 ' ' LEU . . . . . 0.403 ' O ' ' HG ' ' B' 1105 ' ' LEU . 6.2 tp -62.78 -49.44 74.97 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 108.521 -0.918 . . . . 37.88 108.521 176.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1102 ' ' MET . . . . . . . . . . . . . 91.6 mmm -51.25 -55.73 16.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.712 -0.676 . . . . 37.54 110.381 177.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -49.34 -49.74 42.86 Favored 'General case' 0 C--O 1.244 0.775 0 O-C-N 121.694 -0.629 . . . . 47.01 112.483 176.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1104 ' ' LYS . . . . . 0.405 ' HB3' HG21 ' B' 1080 ' ' ILE . 83.4 mttt -60.46 -38.25 83.6 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 114.991 1.478 . . . . 48.68 114.991 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1105 ' ' LEU . . . . . 0.622 HD13 HG21 ' B' 1112 ' ' VAL . 31.3 mt -66.96 -36.82 83.07 Favored 'General case' 0 C--O 1.245 0.837 0 O-C-N 121.009 -1.057 . . . . 32.21 109.198 177.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1106 ' ' ALA . . . . . 0.501 ' HA ' ' HA2' ' B' 1364 ' ' GLY . . . -67.87 -28.24 67.36 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 108.871 -0.788 . . . . 33.73 108.871 177.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -68.44 -39.62 81.45 Favored 'General case' 0 CA--C 1.494 -1.197 0 O-C-N 119.412 -2.055 . . . . 51.47 110.207 175.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1108 ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -72.85 -4.05 29.38 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 115.026 1.491 . . . . 43.9 115.026 -178.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1109 ' ' ASN . . . . . 0.584 ' HA ' ' HA3' ' B' 1364 ' ' GLY . 9.9 m120 58.6 32.81 22.55 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 124.027 1.87 . . . . 44.82 113.436 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1110 ' ' VAL . . . . . 0.754 HG11 HD22 ' B' 1083 ' ' LEU . 33.6 m -93.14 166.27 1.8 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.662 0 CA-C-N 114.351 -1.295 . . . . 30.52 111.454 177.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1111 ' ' THR . . . . . 0.597 HG23 ' HA ' ' B' 1362 ' ' ARG . 87.2 m -109.65 103.26 12.09 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 105.532 -2.025 . . . . 27.12 105.532 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1112 ' ' VAL . . . . . 0.622 HG21 HD13 ' B' 1105 ' ' LEU . 40.7 t -99.36 129.11 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-O 122.418 1.104 . . . . 26.4 109.496 -174.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1113 ' ' MET . . . . . 0.572 ' SD ' HD11 ' B' 1338 ' ' LEU . 31.2 mtp -109.65 124.33 50.99 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.921 0.889 . . . . 42.92 110.128 171.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -102.51 106.18 16.85 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 119.716 1.144 . . . . 24.15 109.17 -174.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1115 ' ' MET . . . . . . . . . . . . . 80.2 mmm -71.29 -2.33 15.83 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 113.072 -1.876 . . . . 29.95 112.168 -169.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1116 ' ' ASP . . . . . 0.509 ' HA ' ' HB2' ' B' 1130 ' ' LEU . 7.5 p-10 -93.44 -52.07 4.68 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.745 1.218 . . . . 34.53 112.428 169.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1117 ' ' SER . . . . . . . . . . . . . 51.1 m -86.71 60.94 6.52 Favored 'General case' 0 C--N 1.343 0.298 0 O-C-N 120.401 -1.437 . . . . 33.49 111.118 -175.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1118 ' ' VAL . . . . . . . . . . . . . 17.9 t -95.62 146.56 31.54 Favored Pre-proline 0 C--O 1.245 0.868 0 N-CA-C 105.171 -2.159 . . . . 34.02 105.171 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -60.97 146.02 98.3 Favored 'Trans proline' 0 C--N 1.354 0.82 0 CA-C-N 124.661 2.7 . . . . 38.28 113.308 174.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1120 ' ' ARG . . . . . 0.518 HH12 ' CG ' ' B' 1128 ' ' ASP . 5.3 mmt180 -85.82 56.82 4.14 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 120.685 -1.259 . . . . 55.05 111.481 -167.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1121 ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' C' ' 131' ' ' ALA . 6.7 pt -132.26 164.28 35.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 CA-C-N 114.53 -1.213 . . . . 42.09 112.585 -176.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1122 ' ' SER . . . . . . . . . . . . . 8.9 m -48.75 -63.94 0.95 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 119.12 3.008 . . . . 38.02 119.12 -162.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1123 ' ' ARG . . . . . 0.465 ' HD2' HD21 ' B' 1337 ' ' LEU . 21.4 ptt-85 -70.53 -29.06 65.44 Favored 'General case' 0 C--N 1.354 0.804 1 O-C-N 116.114 -4.116 . . . . 34.29 110.924 -179.288 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B 1124 ' ' ALA . . . . . 0.72 ' HB2' HG22 ' B' 1354 ' ' VAL . . . -60.51 -40.62 92.08 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 113.282 -1.781 . . . . 32.35 108.151 176.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1125 ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -60.75 -24.67 65.91 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 115.744 1.757 . . . . 47.17 115.744 173.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1126 ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' 1160 ' ' ALA . 57.1 m -68.59 -36.66 79.01 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 119.05 -2.281 . . . . 31.71 114.667 165.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1127 ' ' LEU . . . . . 0.717 HD23 HD12 ' B' 1334 ' ' LEU . 6.9 mp -72.84 -30.15 63.79 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.181 -0.949 . . . . 37.0 111.472 172.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1128 ' ' ASP . . . . . 0.518 ' CG ' HH12 ' B' 1120 ' ' ARG . 37.9 t70 -64.54 101.02 0.41 Allowed 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 115.59 -0.732 . . . . 40.4 110.977 -169.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1129 ' ' ALA . . . . . . . . . . . . . . . -72.52 -21.42 61.18 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 118.411 -1.316 . . . . 26.56 110.506 174.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1130 ' ' LEU . . . . . 0.509 ' HB2' ' HA ' ' B' 1116 ' ' ASP . 7.8 tt -55.13 -26.37 37.98 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.378 1.251 . . . . 30.89 114.378 168.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1131 ' ' SER . . . . . . . . . . . . . 13.6 p -77.59 -51.91 9.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 122.68 1.228 . . . . 29.84 113.118 172.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1132 ' ' SER . . . . . 0.423 ' HB3' ' HB3' ' B' 1326 ' ' LEU . 16.6 m -58.23 -49.51 76.83 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.279 -1.513 . . . . 31.91 114.663 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1133 ' ' MET . . . . . 0.645 ' HB3' ' HB3' ' B' 1316 ' ' PRO . 38.1 mmt -68.74 -36.58 78.56 Favored 'General case' 0 CA--C 1.509 -0.598 0 O-C-N 120.776 -1.202 . . . . 25.9 110.765 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1134 ' ' ALA . . . . . 0.809 ' HB1' ' HB2' ' B' 1176 ' ' ALA . . . -55.62 -44.55 77.18 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 119.137 0.881 . . . . 26.62 113.289 164.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -58.03 -48.08 81.15 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 122.272 1.034 . . . . 36.97 112.096 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1136 ' ' ILE . . . . . . . . . . . . . 42.9 mm -52.3 -58.07 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-N 113.294 -1.775 . . . . 32.11 111.48 173.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -57.27 -30.36 64.62 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.888 1.069 . . . . 24.14 113.888 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -68.58 -49.28 44.96 Favored Glycine 0 N--CA 1.484 1.9 0 N-CA-C 110.202 -1.159 . . . . 25.13 110.202 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 55.3 t80 -63.72 -44.47 93.46 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 123.417 1.579 . . . . 32.73 112.748 173.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1140 ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -62.57 -33.94 75.96 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 114.041 -1.436 . . . . 26.36 110.914 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1141 ' ' ALA . . . . . . . . . . . . . . . -55.71 -49.38 73.16 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 123.232 0.613 . . . . 24.12 112.42 168.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 50.1 mm -58.78 -35.97 58.54 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 O-C-N 120.873 -1.142 . . . . 23.37 109.927 174.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 14.3 t -71.24 -46.19 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 O-C-N 119.555 -1.966 . . . . 24.96 111.837 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -72.0 -41.82 67.15 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 106.661 -1.607 . . . . 32.07 106.661 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1145 ' ' ALA . . . . . 0.693 ' HA ' HG11 ' B' 1280 ' ' VAL . . . -53.38 -45.86 69.42 Favored 'General case' 0 C--O 1.206 -1.209 0 O-C-N 121.318 -0.864 . . . . 24.87 111.655 170.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1146 ' ' ALA . . . . . . . . . . . . . . . -63.99 -39.08 93.32 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 123.016 0.527 . . . . 24.67 109.658 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 16.5 t60 -59.06 -34.33 71.82 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 119.746 -1.846 . . . . 28.58 109.177 172.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1148 ' ' GLU . . . . . 0.418 ' HB3' ' CD ' ' B' 1308 ' ' LYS . 44.0 mm-40 -93.93 -10.38 33.96 Favored 'General case' 0 C--O 1.25 1.088 0 O-C-N 120.118 -1.614 . . . . 36.82 113.8 178.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1149 ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -78.9 144.09 35.24 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-O 123.488 1.613 . . . . 31.97 109.257 -171.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1150 ' ' GLY . . . . . 0.706 ' HA2' ' HD2' ' A' 1320 ' ' PRO . . . -93.93 -19.64 33.38 Favored Glycine 0 C--O 1.242 0.644 0 CA-C-N 114.313 -1.312 . . . . 25.49 113.239 174.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1151 ' ' ARG . . . . . . . . . . . . . 81.1 mtm-85 -112.65 166.75 11.06 Favored 'General case' 0 C--O 1.242 0.709 0 O-C-N 121.537 -0.978 . . . . 59.84 111.067 -169.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1152 ' ' PHE . . . . . 0.717 ' HB2' HG11 ' B' 1163 ' ' VAL . 3.3 m-30 -78.85 156.81 28.52 Favored 'General case' 0 C--O 1.239 0.543 0 O-C-N 119.803 -1.811 . . . . 34.45 108.647 174.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1153 ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -84.59 -43.74 14.17 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 123.837 1.78 . . . . 31.17 108.655 166.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1154 ' ' THR . . . . . . . . . . . . . 48.2 m -68.01 128.17 35.56 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 112.934 -1.939 . . . . 33.89 111.367 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -75.94 65.47 2.58 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 109.161 -1.576 . . . . 38.95 109.161 174.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1156 ' ' GLN . . . . . 0.463 ' H ' ' HB ' ' B' 1163 ' ' VAL . 15.4 tt0 -85.17 121.37 27.83 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 119.461 1.631 . . . . 54.23 109.476 -160.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 29.8 mm -70.82 95.09 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.883 0 O-C-N 119.906 -1.746 . . . . 51.16 106.406 173.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1158 ' ' THR . . . . . . . . . . . . . 1.7 m -109.22 138.8 45.02 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 107.783 -1.191 . . . . 49.61 107.783 -175.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -56.62 -30.57 63.42 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 121.034 1.743 . . . . 49.05 115.51 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -52.34 -53.09 48.94 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.245 0.545 . . . . 47.65 111.127 167.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . -179.02 156.14 17.86 Favored Glycine 0 C--O 1.215 -1.062 0 N-CA-C 108.071 -2.012 . . . . 45.61 108.071 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 79.9 mttt -76.91 128.15 34.03 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 120.197 1.998 . . . . 57.46 111.966 177.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1163 ' ' VAL . . . . . 0.717 HG11 ' HB2' ' B' 1152 ' ' PHE . 23.3 t -80.18 129.6 69.18 Favored Pre-proline 0 CA--C 1.514 -0.425 0 CA-C-N 118.923 0.783 . . . . 42.93 110.08 177.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1164 ' ' PRO . . . . . 0.435 ' O ' HG12 ' B' 1163 ' ' VAL . 58.4 Cg_endo -66.74 142.67 64.51 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.618 2.212 . . . . 39.29 110.667 164.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1165 ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -59.85 153.77 54.56 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 C-N-CA 122.898 2.399 . . . . 34.17 114.943 170.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -83.25 159.85 21.87 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 113.088 -1.869 . . . . 31.69 108.383 168.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1167 ' ' LYS . . . . . 0.8 ' HB2' ' HA ' ' B' 1249 ' ' VAL . 67.2 mttt -123.56 118.04 26.45 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 105.466 -2.05 . . . . 44.78 105.466 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1168 ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' B' 1251 ' ' ILE . 60.3 t -104.31 104.83 17.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 O-C-N 121.827 -0.546 . . . . 31.23 111.122 -174.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1169 ' ' MET . . . . . 0.676 ' HB2' HG11 ' B' 1249 ' ' VAL . 42.7 ttp -82.82 98.11 8.97 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.088 -0.708 . . . . 37.09 109.088 -178.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 53.1 t -89.74 119.35 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 N-CA-C 109.029 -0.73 . . . . 30.17 109.029 -177.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1171 ' ' ILE . . . . . . . . . . . . . 9.7 mt -113.52 132.76 61.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 CA-C-N 120.307 1.412 . . . . 33.74 107.578 -175.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 69.56 63.86 3.2 Favored Glycine 0 CA--C 1.502 -0.72 0 N-CA-C 110.046 -1.221 . . . . 32.59 110.046 -176.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1173 ' ' ALA . . . . . 0.539 ' HA ' ' HA3' ' B' 1177 ' ' GLY . . . -79.89 75.6 6.6 Favored 'General case' 0 C--O 1.252 1.233 0 CA-C-O 124.17 1.938 . . . . 32.42 114.018 -174.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -86.52 -165.3 40.86 Favored Glycine 0 C--O 1.216 -0.982 0 N-CA-C 107.367 -2.293 . . . . 31.74 107.367 166.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 46.1 t -48.54 -38.14 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 122.11 2.955 . . . . 31.48 114.279 -176.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1176 ' ' ALA . . . . . 0.809 ' HB2' ' HB1' ' B' 1134 ' ' ALA . . . -58.06 -51.67 68.73 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 113.462 -1.699 . . . . 26.12 114.063 171.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1177 ' ' GLY . . . . . 0.539 ' HA3' ' HA ' ' B' 1173 ' ' ALA . . . -60.46 -48.61 85.35 Favored Glycine 0 CA--C 1.49 -1.473 0 N-CA-C 111.321 -0.712 . . . . 25.73 111.321 176.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1178 ' ' LEU . . . . . 0.669 HD22 ' HG ' ' C' ' 75' ' ' LEU . 91.5 mt -53.75 -38.26 64.2 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 114.899 1.444 . . . . 32.59 114.899 174.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -70.67 -38.68 73.8 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 119.298 0.953 . . . . 27.72 111.734 175.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -60.9 -46.7 89.59 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 114.602 1.334 . . . . 26.03 114.602 175.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1181 ' ' ILE . . . . . 0.779 HG12 HG11 ' B' 1191 ' ' VAL . 79.0 mt -58.32 -48.04 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 123.707 0.803 . . . . 28.61 109.095 173.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1182 ' ' GLY . . . . . 0.413 ' HA2' ' HE1' ' B' 1207 ' ' MET . . . -51.09 -53.11 28.61 Favored Glycine 0 C--N 1.373 2.611 0 CA-C-N 114.827 -1.079 . . . . 25.23 110.721 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -63.26 -50.78 68.83 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 114.419 1.266 . . . . 24.09 114.419 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -69.42 -42.81 74.52 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 121.195 -0.94 . . . . 26.68 112.579 -172.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -57.49 -47.11 82.78 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 115.713 -0.676 . . . . 36.57 111.271 174.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1186 ' ' SER . . . . . 0.492 ' HB3' ' O ' ' A' 1186 ' ' SER . 75.4 m -58.81 -39.87 82.44 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-O 121.81 0.814 . . . . 28.92 112.338 177.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1187 ' ' LEU . . . . . . . . . . . . . 66.1 mt -61.78 -35.13 77.26 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 121.041 -1.037 . . . . 29.09 112.997 172.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 120.3 -7.07 11.65 Favored Glycine 0 CA--C 1.539 1.591 0 N-CA-C 111.113 -0.795 . . . . 29.26 111.113 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1189 ' ' ALA . . . . . . . . . . . . . . . -68.46 121.7 16.89 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 121.666 0.746 . . . . 30.16 112.272 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 37.2 mt -67.31 112.07 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-O 123.594 1.664 . . . . 35.81 109.718 -172.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1191 ' ' VAL . . . . . 0.779 HG11 HG12 ' B' 1181 ' ' ILE . 93.2 t -82.46 128.75 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 107.706 -1.22 . . . . 31.97 107.706 -177.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1192 ' ' ARG . . . . . 0.492 ' O ' ' HA ' ' B' 1169 ' ' MET . 22.9 mmt85 -118.89 90.39 3.32 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 102.903 -2.999 . . . . 48.16 102.903 174.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1193 ' ' ALA . . . . . 0.65 ' HB3' HG21 ' B' 1204 ' ' VAL . . . -103.07 159.69 15.3 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 120.712 -1.242 . . . . 35.89 114.281 -172.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 35.2 t80 -150.13 152.41 34.68 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 123.041 1.4 . . . . 41.88 107.224 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1195 ' ' ASP . . . . . 0.445 ' HB3' HG11 ' B' 1200 ' ' VAL . 10.0 t0 -158.55 155.61 28.68 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 103.666 -2.716 . . . . 38.28 103.666 168.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1196 ' ' THR . . . . . 0.433 HG23 ' HB2' ' B' 1230 ' ' MET . 43.0 m -59.23 -24.15 62.92 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 124.956 1.302 . . . . 40.62 110.53 172.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1197 ' ' ARG . . . . . 0.429 HH11 ' HD2' ' B' 1197 ' ' ARG . 33.1 mtm105 -91.97 144.33 29.06 Favored Pre-proline 0 C--O 1.249 1.066 0 O-C-N 119.925 -1.735 . . . . 53.09 111.026 -174.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -71.95 -42.58 1.53 Allowed 'Trans proline' 0 CA--C 1.548 1.188 1 C-N-CA 125.637 4.225 . . . . 42.56 117.418 -174.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -29.4 70.55 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 121.269 1.85 . . . . 56.31 114.462 -168.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1200 ' ' VAL . . . . . 0.504 ' O ' HG23 ' B' 1204 ' ' VAL . 10.8 p -58.56 -28.65 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 115.133 -0.94 . . . . 42.91 112.596 177.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 35.1 tttm -45.05 -58.66 3.04 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 124.581 1.153 . . . . 48.89 113.535 168.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 16.0 mp0 -63.39 -28.37 69.94 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 114.265 1.209 . . . . 51.7 114.265 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1203 ' ' GLN . . . . . 0.816 ' HG2' ' HG3' ' C' ' 74' ' ' ARG . 51.4 mt-30 -66.13 -46.63 76.83 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.586 -0.734 . . . . 52.57 109.442 176.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1204 ' ' VAL . . . . . 0.65 HG21 ' HB3' ' B' 1193 ' ' ALA . 40.0 t -72.69 -40.67 62.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.255 -1.017 . . . . 33.79 108.255 -173.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -60.98 -29.36 69.62 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 113.57 0.952 . . . . 36.58 113.57 176.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1206 ' ' SER . . . . . . . . . . . . . 44.7 m -68.67 -10.85 58.71 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 120.254 -1.529 . . . . 39.61 114.246 174.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1207 ' ' MET . . . . . 0.413 ' HE1' ' HA2' ' B' 1182 ' ' GLY . 46.1 mmm -97.22 5.21 50.47 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.587 0.708 . . . . 37.45 109.579 174.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 60.5 32.28 77.34 Favored Glycine 0 N--CA 1.471 0.984 0 O-C-N 120.133 -1.604 . . . . 31.87 111.829 -165.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1209 ' ' ALA . . . . . 0.502 ' HB1' ' HB ' ' B' 1191 ' ' VAL . . . -119.6 163.23 17.66 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 105.328 -2.101 . . . . 35.4 105.328 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1210 ' ' GLU . . . . . 0.478 ' HB3' ' HD3' ' B' 1192 ' ' ARG . 36.0 tt0 -108.62 137.23 46.9 Favored 'General case' 0 C--N 1.313 -1.014 0 O-C-N 119.859 -1.776 . . . . 47.89 111.999 -166.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 75.7 t80 -84.97 141.39 30.38 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 106.416 -1.698 . . . . 45.53 106.416 172.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1212 ' ' LEU . . . . . 0.549 ' HB3' HD21 ' B' 1241 ' ' LEU . 73.8 mt -73.74 99.64 3.2 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 125.11 2.386 . . . . 46.33 116.641 -176.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -77.08 122.75 25.4 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 112.101 -2.318 . . . . 60.41 108.147 172.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1214 ' ' LEU . . . . . 0.798 ' HG ' HD22 ' B' 1241 ' ' LEU . 1.0 OUTLIER -99.03 176.38 5.59 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 104.5 -2.407 . . . . 57.38 104.5 -178.173 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 14.0 t70 . . . . . 0 CA--C 1.499 -0.994 0 CA-C-O 117.665 -1.159 . . . . 65.07 108.613 177.149 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B 1230 ' ' MET . . . . . 0.433 ' HB2' HG23 ' B' 1196 ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.429 -1.48 0 N-CA-C 104.147 -2.538 . . . . 80.32 104.147 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1231 ' ' SER . . . . . 0.414 ' HB2' ' HA ' ' B' 1230 ' ' MET . 1.6 m 78.26 156.71 0.17 Allowed 'General case' 0 C--O 1.251 1.174 2 CA-C-N 127.914 4.87 . . . . 79.92 119.591 -8.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -88.7 -157.62 0.44 Allowed 'General case' 0 C--O 1.248 0.991 0 CA-C-N 112.584 -2.098 . . . . 77.91 111.872 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 66.38 -68.2 0.14 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 121.383 1.902 . . . . 73.88 111.036 -170.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 11.4 t80 -55.81 -33.18 64.2 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.75 1.22 . . . . 68.98 110.802 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1235 ' ' ILE . . . . . 0.595 ' O ' ' HG2' ' B' 1239 ' ' MET . 32.6 pt -42.94 -39.24 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 114.858 1.429 . . . . 64.53 114.858 170.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1236 ' ' LYS . . . . . 0.45 ' HD2' ' HA ' ' B' 1236 ' ' LYS . 28.6 mmmt -58.95 -45.81 89.54 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 121.306 1.866 . . . . 66.36 111.306 176.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -67.01 -30.54 70.67 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 114.609 1.337 . . . . 56.6 114.609 170.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.9 -46.4 85.02 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 120.302 1.41 . . . . 56.79 108.643 171.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1239 ' ' MET . . . . . 0.595 ' HG2' ' O ' ' B' 1235 ' ' ILE . 31.0 mmt -67.79 -36.53 80.6 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 120.848 -1.157 . . . . 53.63 108.711 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -70.11 -39.63 75.37 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 119.52 -0.872 . . . . 51.74 109.347 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1241 ' ' LEU . . . . . 0.798 HD22 ' HG ' ' B' 1214 ' ' LEU . 17.4 tp -53.14 -53.59 48.25 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-O 118.17 -0.919 . . . . 44.86 110.116 170.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -64.27 -40.57 96.24 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 112.509 0.559 . . . . 42.78 112.509 -177.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -61.02 -49.41 77.54 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 124.522 1.129 . . . . 40.96 108.138 -178.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -59.35 -43.84 92.76 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.608 1.549 . . . . 43.06 112.215 175.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1245 ' ' GLN . . . . . 0.472 ' O ' HG22 ' B' 1249 ' ' VAL . 46.5 mm-40 -62.01 -28.39 69.54 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.127 -1.397 . . . . 46.45 114.392 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -57.27 -27.44 62.11 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 123.263 1.506 . . . . 41.78 112.171 -174.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 10.5 tptt -77.98 -41.93 34.4 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 114.094 -1.412 . . . . 52.2 110.901 175.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1248 ' ' GLU . . . . . 0.436 ' CD ' HH12 ' B' 1192 ' ' ARG . 26.0 mt-10 -70.26 -41.45 73.46 Favored 'General case' 0 C--O 1.244 0.813 0 O-C-N 120.604 -1.31 . . . . 53.55 111.952 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1249 ' ' VAL . . . . . 0.8 ' HA ' ' HB2' ' B' 1167 ' ' LYS 0.259 32.8 m -84.88 164.3 2.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 124.336 2.017 . . . . 34.41 113.504 -166.203 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B 1250 ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' B' 1279 ' ' SER . 2.6 m-20 -122.63 -50.07 1.98 Allowed 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 113.663 -1.608 . . . . 33.38 107.602 -176.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1251 ' ' ILE . . . . . 0.514 HD12 ' HB1' ' B' 1145 ' ' ALA . 24.5 mm -119.94 114.98 45.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 108.035 -1.098 . . . . 29.54 108.035 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1252 ' ' ILE . . . . . . . . . . . . . 82.3 mt -91.62 119.79 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 N-CA-C 104.477 -2.416 . . . . 32.44 104.477 169.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1253 ' ' VAL . . . . . 0.617 HG12 HG23 ' B' 1255 ' ' THR . 55.9 t -112.81 100.91 11.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 104.665 -2.346 . . . . 30.57 104.665 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1254 ' ' THR . . . . . . . . . . . . . 7.4 t -103.08 98.6 8.51 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 125.982 2.801 . . . . 35.04 108.894 -175.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1255 ' ' THR . . . . . 0.617 HG23 HG12 ' B' 1253 ' ' VAL . 3.2 p -84.74 8.7 16.2 Favored 'General case' 0 N--CA 1.421 -1.888 1 CA-C-N 107.26 -4.518 . . . . 34.62 117.662 -176.618 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B 1256 ' ' ALA . . . . . 0.465 ' HB3' HD21 ' B' 1291 ' ' ASN . . . -72.98 92.06 1.61 Allowed 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 114.115 1.154 . . . . 42.72 114.115 -174.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 13.7 mt -109.0 101.34 10.43 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 102.936 -2.987 . . . . 52.43 102.936 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 2.3 mp -93.99 128.87 39.58 Favored Pre-proline 0 N--CA 1.481 1.123 0 C-N-CA 118.962 -1.095 . . . . 59.41 110.014 -177.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -58.68 126.43 21.23 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.779 2.32 . . . . 62.68 107.831 170.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 81.8 -75.24 2.35 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 117.033 -1.982 . . . . 64.16 108.46 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 91.5 mttt -58.13 149.73 55.44 Favored Pre-proline 0 C--O 1.242 0.676 0 CA-C-N 121.838 2.819 . . . . 68.53 115.715 -174.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.76 118.49 3.47 Favored 'Trans proline' 0 C--O 1.246 0.9 0 C-N-CA 123.544 2.829 . . . . 61.99 113.178 167.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1263 ' ' ALA . . . . . 0.412 ' HB1' ' CG ' ' B' 1291 ' ' ASN . . . -35.78 122.95 0.68 Allowed Pre-proline 0 C--O 1.245 0.831 0 C-N-CA 124.858 1.263 . . . . 57.15 111.052 164.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1264 ' ' PRO . . . . . 0.574 ' O ' ' HA ' ' B' 1291 ' ' ASN . 97.1 Cg_endo -77.13 158.6 33.85 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.292 1.995 . . . . 51.57 111.633 -172.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1265 ' ' LYS . . . . . 0.438 ' NZ ' ' O ' ' B' 1289 ' ' GLY . 46.6 mmtm -78.76 76.09 5.26 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 125.566 2.603 . . . . 54.55 110.751 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 40.3 mt -67.27 -52.99 34.03 Favored 'General case' 0 N--CA 1.438 -1.069 0 O-C-N 118.317 -2.739 . . . . 46.86 111.615 -177.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1267 ' ' ILE . . . . . 0.537 HG21 HD13 ' B' 1281 ' ' ILE . 38.0 mm -89.15 99.19 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 107.13 -1.433 . . . . 41.04 107.13 -176.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1268 ' ' THR . . . . . 0.691 ' HA ' ' HG3' ' B' 1293 ' ' GLU . 7.8 p -73.64 156.82 37.61 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 111.057 -2.792 . . . . 39.58 113.301 -175.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1269 ' ' ARG . . . . . 0.416 ' HG3' ' HB3' ' B' 1293 ' ' GLU . 78.3 mtt85 -55.81 -41.08 73.65 Favored 'General case' 0 C--O 1.206 -1.21 0 N-CA-C 113.371 0.878 . . . . 53.15 113.371 -175.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -59.38 -46.52 88.46 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 124.64 1.212 . . . . 42.96 110.481 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1271 ' ' MET . . . . . . . . . . . . . 48.6 ttm -58.48 -48.08 81.96 Favored 'General case' 0 C--O 1.242 0.66 0 O-C-N 124.096 0.873 . . . . 43.89 110.252 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1272 ' ' VAL . . . . . 0.413 HG23 ' O ' ' B' 1268 ' ' THR . 33.2 t -57.2 -50.26 77.16 Favored 'Isoleucine or valine' 0 C--O 1.257 1.45 0 O-C-N 125.637 1.836 . . . . 38.37 111.521 176.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.83 -29.59 67.03 Favored 'General case' 0 C--N 1.357 0.919 0 N-CA-C 115.364 1.616 . . . . 47.46 115.364 176.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1274 ' ' SER . . . . . . . . . . . . . 50.4 m -84.49 -7.35 59.3 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 126.022 1.729 . . . . 38.38 114.5 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1275 ' ' MET . . . . . 0.563 ' HB2' HG21 ' B' 1307 ' ' VAL . 49.5 mtp -66.5 164.77 15.79 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 113.576 0.954 . . . . 37.81 113.576 -175.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -55.85 137.1 50.87 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 124.645 1.178 . . . . 49.26 108.506 169.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1277 ' ' ALA . . . . . 0.695 ' HB3' ' HD1' ' A' 1045 ' ' PHE . . . -67.96 140.99 56.43 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 121.55 -0.719 . . . . 34.46 111.136 -177.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 72.93 55.15 6.58 Favored Glycine 0 N--CA 1.434 -1.495 0 CA-C-O 122.669 1.149 . . . . 33.53 113.824 175.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1279 ' ' SER . . . . . 0.555 ' O ' ' HA ' ' B' 1307 ' ' VAL . 70.9 m -141.37 160.87 39.23 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 107.7 -1.222 . . . . 31.31 107.7 -167.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1280 ' ' VAL . . . . . 0.693 HG11 ' HA ' ' B' 1145 ' ' ALA . 69.0 t -123.53 141.57 43.32 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 CA-C-N 120.039 1.29 . . . . 29.32 109.547 -169.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1281 ' ' ILE . . . . . 0.537 HD13 HG21 ' B' 1267 ' ' ILE . 74.8 mt -118.2 98.95 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 105.367 -2.086 . . . . 31.93 105.367 170.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1282 ' ' VAL . . . . . . . . . . . . . 5.3 t -86.85 109.84 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 106.77 -1.567 . . . . 29.48 106.77 174.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 58.4 t0 -93.64 111.76 23.5 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 103.236 -2.876 . . . . 34.5 103.236 171.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1284 ' ' LEU . . . . . 0.438 HD22 ' HA ' ' B' 1255 ' ' THR . 7.2 mp -74.15 -40.44 62.59 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 113.686 -1.597 . . . . 37.94 106.718 172.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -76.03 11.52 1.43 Allowed 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 120.285 -1.509 . . . . 40.92 114.898 -160.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -47.73 -45.05 28.42 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 118.486 2.773 . . . . 44.39 118.486 176.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1287 ' ' GLN . . . . . 0.838 ' HB3' HG23 ' B' 1313 ' ' THR . 0.0 OUTLIER -66.87 -28.94 68.74 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 122.588 1.185 . . . . 51.46 112.196 172.623 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -82.57 -33.9 27.91 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 114.671 1.36 . . . . 57.75 114.671 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1289 ' ' GLY . . . . . 0.438 ' O ' ' NZ ' ' B' 1265 ' ' LYS . . . 164.65 -21.95 0.14 Allowed Glycine 0 CA--C 1.536 1.4 0 C-N-CA 120.138 -1.029 . . . . 49.85 113.258 -172.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 80.48 112.01 0.29 Allowed Glycine 0 N--CA 1.464 0.535 0 CA-C-O 118.25 -1.305 . . . . 45.93 112.844 175.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1291 ' ' ASN . . . . . 0.574 ' HA ' ' O ' ' B' 1264 ' ' PRO . 69.2 m-80 -89.93 -15.28 32.37 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 119.152 1.476 . . . . 42.67 114.711 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1292 ' ' CYS . . . . . . . . . . . . . 48.5 t -105.88 144.06 33.13 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.287 0.847 . . . . 38.82 113.287 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1293 ' ' GLU . . . . . 0.691 ' HG3' ' HA ' ' B' 1268 ' ' THR . 6.8 mt-10 -69.5 -16.38 63.44 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 119.189 3.033 . . . . 46.71 119.189 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1294 ' ' TYR . . . . . 0.43 ' HB2' HG21 ' B' 1309 ' ' VAL . 58.5 m-85 -107.39 0.36 22.91 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 120.211 -1.555 . . . . 47.23 113.023 -178.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1295 ' ' THR . . . . . 0.712 HG23 ' HA3' ' B' 1311 ' ' GLY . 91.2 m -53.79 115.58 2.07 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 116.148 1.907 . . . . 36.02 116.148 -178.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1296 ' ' VAL . . . . . 0.466 ' HB ' ' HB3' ' B' 1299 ' ' GLU . 46.5 t -97.13 121.03 60.08 Favored Pre-proline 0 N--CA 1.435 -1.199 0 N-CA-C 102.551 -3.129 . . . . 37.26 102.551 169.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -51.59 114.29 1.51 Allowed 'Trans proline' 0 C--O 1.238 0.475 0 C-N-CA 124.827 3.684 . . . . 35.09 116.612 -177.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1298 ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' B' 1312 ' ' TYR . . . 66.18 42.56 94.25 Favored Glycine 0 C--O 1.245 0.793 0 CA-C-O 116.342 -2.365 . . . . 35.97 114.016 -173.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1299 ' ' GLU . . . . . 0.466 ' HB3' ' HB ' ' B' 1296 ' ' VAL . 18.2 tt0 -151.87 175.48 12.43 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 118.484 1.142 . . . . 40.39 111.17 175.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1300 ' ' ILE . . . . . 0.485 HG12 HG12 ' B' 1310 ' ' ILE . 58.6 mt -110.19 133.49 55.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 107.536 -1.283 . . . . 37.43 107.536 170.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 69.3 t80 -107.8 124.78 50.57 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.509 -0.876 . . . . 44.13 110.347 163.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1302 ' ' THR . . . . . . . . . . . . . 96.0 m -92.84 126.79 38.09 Favored 'General case' 0 C--O 1.248 0.985 0 O-C-N 120.238 -1.539 . . . . 39.78 107.95 176.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1303 ' ' THR . . . . . . . . . . . . . 67.5 p -82.56 175.08 10.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 120.851 1.66 . . . . 43.29 113.249 166.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -69.81 -30.6 68.16 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 122.222 1.01 . . . . 53.07 109.882 -174.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -82.98 14.45 3.31 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 114.5 1.296 . . . . 43.97 114.5 173.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 70.31 32.23 68.59 Favored Glycine 0 C--O 1.211 -1.339 0 O-C-N 120.569 -1.332 . . . . 41.12 110.909 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1307 ' ' VAL . . . . . 0.563 HG21 ' HB2' ' B' 1275 ' ' MET . 73.6 t -98.67 109.45 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 105.075 -2.194 . . . . 38.12 105.075 173.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1308 ' ' LYS . . . . . 0.418 ' CD ' ' HB3' ' B' 1148 ' ' GLU . 78.5 mttt -86.44 98.04 10.8 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 113.321 -1.763 . . . . 36.34 107.562 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1309 ' ' VAL . . . . . 0.43 HG21 ' HB2' ' B' 1294 ' ' TYR . 44.4 t -71.34 90.96 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 CA-C-N 114.608 -1.178 . . . . 30.4 108.93 172.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1310 ' ' ILE . . . . . 0.485 HG12 HG12 ' B' 1300 ' ' ILE . 37.0 mt -83.46 101.96 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 O-C-N 120.564 -1.335 . . . . 30.82 110.225 176.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1311 ' ' GLY . . . . . 0.712 ' HA3' HG23 ' B' 1295 ' ' THR . . . -99.5 63.38 0.7 Allowed Glycine 0 CA--C 1.499 -0.936 0 CA-C-N 114.137 -1.392 . . . . 26.53 111.317 178.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1312 ' ' TYR . . . . . 0.519 ' HB2' ' HG ' ' B' 1315 ' ' LEU . 8.4 m-30 -82.08 100.44 9.77 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 119.635 -2.097 . . . . 38.0 113.995 -175.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1313 ' ' THR . . . . . 0.838 HG23 ' HB3' ' B' 1287 ' ' GLN . 98.3 m -51.42 -38.0 51.39 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 114.082 -1.417 . . . . 29.8 109.733 168.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -95.59 14.86 21.52 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.965 2.106 . . . . 39.04 112.576 -166.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1315 ' ' LEU . . . . . 0.519 ' HG ' ' HB2' ' B' 1312 ' ' TYR . 41.9 mt -50.58 -50.36 72.84 Favored Pre-proline 0 C--O 1.21 -1.019 0 CA-C-O 113.274 -3.25 . . . . 31.08 116.425 176.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1316 ' ' PRO . . . . . 0.645 ' HB3' ' HB3' ' B' 1133 ' ' MET . 68.2 Cg_exo -51.73 -34.69 55.14 Favored 'Trans proline' 0 CA--C 1.536 0.581 1 C-N-CA 125.955 4.437 . . . . 26.1 113.646 174.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B 1317 ' ' GLY . . . . . 0.676 ' HA2' ' HG3' ' B' 1015 ' ' ARG . . . -66.16 -48.47 64.57 Favored Glycine 0 C--N 1.344 0.98 0 O-C-N 120.378 -1.451 . . . . 23.17 113.228 176.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1318 ' ' ARG . . . . . 0.424 ' HD2' HD23 ' B' 1315 ' ' LEU . 75.6 mtt-85 -50.34 -0.55 0.01 OUTLIER 'General case' 0 C--O 1.237 0.405 1 N-CA-C 124.683 5.068 . . . . 40.4 124.683 -169.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 13.5 tp -126.92 72.67 75.95 Favored Pre-proline 0 C--O 1.245 0.843 0 N-CA-C 104.872 -2.27 . . . . 23.6 104.872 176.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1320 ' ' PRO . . . . . 0.653 ' HG2' ' HA2' ' A' 1150 ' ' GLY . 95.7 Cg_endo -43.49 -72.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 124.882 3.721 . . . . 22.35 119.847 -160.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1321 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.9 -37.66 66.61 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 113.349 0.87 . . . . 26.52 113.349 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1322 ' ' GLN . . . . . 0.866 ' HB2' ' HA ' ' A' 1151 ' ' ARG . 55.5 tp60 -74.23 -41.96 60.5 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 118.653 -1.219 . . . . 24.38 110.066 -173.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1323 ' ' SER . . . . . 0.445 ' HB2' ' HG2' ' B' 1015 ' ' ARG . 14.8 m -59.43 -40.81 87.93 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.601 -0.84 . . . . 22.8 112.284 170.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1324 ' ' SER . . . . . . . . . . . . . 13.7 m -64.22 -25.04 67.89 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 115.481 1.66 . . . . 21.25 115.481 170.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1325 ' ' GLN . . . . . 0.567 HE22 ' HD2' ' B' 1021 ' ' LYS . 67.5 tp60 -74.05 -50.17 20.88 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.767 -0.583 . . . . 31.34 109.551 175.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1326 ' ' LEU . . . . . 0.423 ' HB3' ' HB3' ' B' 1132 ' ' SER . 13.7 mt -72.33 -51.84 18.85 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 108.125 -1.065 . . . . 31.56 108.125 -174.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1327 ' ' TYR . . . . . 0.439 ' O ' ' HG ' ' B' 1331 ' ' LEU . 18.7 t80 -51.19 -46.63 62.22 Favored 'General case' 0 C--N 1.377 1.774 0 O-C-N 118.984 -2.322 . . . . 22.73 111.613 172.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1328 ' ' GLY . . . . . 0.461 ' O ' HG23 ' B' 1332 ' ' VAL . . . -51.16 -52.91 29.69 Favored Glycine 0 C--O 1.244 0.763 0 CA-C-O 123.654 1.697 . . . . 21.91 112.115 175.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1329 ' ' THR . . . . . . . . . . . . . 20.1 m -65.69 -36.41 83.56 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.099 -1.074 . . . . 22.15 108.099 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1330 ' ' ASN . . . . . . . . . . . . . 23.7 m120 -60.56 -47.72 84.92 Favored 'General case' 0 N--CA 1.437 -1.082 0 O-C-N 118.673 -2.517 . . . . 26.18 110.275 178.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1331 ' ' LEU . . . . . 0.681 HD22 HD22 ' B' 1070 ' ' LEU . 20.1 mt -57.61 -42.57 83.52 Favored 'General case' 0 N--CA 1.435 -1.179 0 O-C-N 125.853 1.97 . . . . 23.68 111.842 172.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1332 ' ' VAL . . . . . 0.598 HG12 ' HE3' ' B' 1336 ' ' LYS . 97.9 t -59.56 -44.91 94.2 Favored 'Isoleucine or valine' 0 C--N 1.349 0.552 0 CA-C-O 121.436 0.636 . . . . 26.57 110.581 178.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1333 ' ' ASN . . . . . 0.622 ' HA ' ' HD2' ' B' 1336 ' ' LYS . 82.4 m-20 -62.67 -45.72 91.5 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.953 0.901 . . . . 28.08 110.109 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1334 ' ' LEU . . . . . 0.717 HD12 HD23 ' B' 1127 ' ' LEU . 4.3 tp -52.0 -52.17 52.43 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 124.733 1.27 . . . . 27.43 109.616 174.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1335 ' ' LEU . . . . . 0.749 HD23 HD12 ' B' 1338 ' ' LEU . 75.3 mt -72.7 -19.29 61.43 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 114.234 -1.348 . . . . 30.5 113.356 -178.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1336 ' ' LYS . . . . . 0.622 ' HD2' ' HA ' ' B' 1333 ' ' ASN . 88.5 mttt -65.63 -48.17 73.11 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-N 122.9 2.591 . . . . 41.65 107.526 169.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1337 ' ' LEU . . . . . 0.465 HD21 ' HD2' ' B' 1123 ' ' ARG . 10.6 mp -75.1 -30.55 60.93 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.362 0.665 . . . . 42.08 110.663 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1338 ' ' LEU . . . . . 0.749 HD12 HD23 ' B' 1335 ' ' LEU . 79.0 mt -71.11 -51.53 24.55 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 119.697 -1.877 . . . . 35.03 111.052 172.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 49.8 t -96.5 71.67 2.7 Favored 'General case' 0 C--O 1.254 1.298 0 CA-C-O 124.849 2.261 . . . . 37.33 107.462 -173.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 12.8 mttp -54.35 -39.08 66.78 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 111.827 -2.442 . . . . 50.51 112.472 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -98.93 20.06 13.9 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 112.998 0.74 . . . . 54.21 112.998 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 97.1 mttt 42.6 38.35 1.26 Allowed 'General case' 0 C--O 1.248 0.974 0 C-N-CA 127.758 2.423 . . . . 50.99 117.081 159.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -111.76 -2.95 15.12 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 112.456 -2.156 . . . . 48.82 109.808 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 89.08 26.1 27.19 Favored Glycine 0 C--O 1.214 -1.1 0 CA-C-O 116.849 -2.084 . . . . 40.43 111.711 -171.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -116.78 122.76 45.37 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-N 122.277 3.038 . . . . 47.56 113.013 174.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1346 ' ' ILE . . . . . . . . . . . . . 37.6 mm -68.28 113.18 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 124.265 1.026 . . . . 42.49 111.343 -174.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1347 ' ' THR . . . . . . . . . . . . . 11.2 m -106.13 106.28 16.72 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 104.84 -2.281 . . . . 38.12 104.84 170.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 98.9 t -81.04 100.97 5.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 106.573 -1.64 . . . . 37.5 106.573 -174.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 61.0 t0 -72.91 113.2 9.67 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.712 -1.131 . . . . 43.85 111.544 -174.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1350 ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.32 -6.54 25.7 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.567 -1.333 . . . . 39.81 110.909 176.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -76.51 -29.31 56.75 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.809 -0.632 . . . . 51.29 110.827 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 42.6 t0 -88.04 127.47 35.4 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 104.147 -2.538 . . . . 39.78 104.147 -176.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 15.5 m -63.44 -27.26 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 123.766 0.826 . . . . 39.28 111.519 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1354 ' ' VAL . . . . . 0.72 HG22 ' HB2' ' B' 1124 ' ' ALA . 50.6 t -65.16 -56.01 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.796 0.838 . . . . 35.7 112.931 175.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1355 ' ' ILE . . . . . 0.406 ' HA ' HG12 ' B' 1358 ' ' VAL . 27.5 mm -68.86 -45.62 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-O 117.284 -1.341 . . . . 35.77 109.263 178.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 52.3 tpt85 -49.1 -32.1 9.23 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 120.158 1.344 . . . . 38.55 114.577 172.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1357 ' ' GLY . . . . . 0.538 ' HA2' ' HB2' ' B' 1370 ' ' ALA . . . -76.14 -61.33 2.86 Favored Glycine 0 CA--C 1.492 -1.402 0 CA-C-N 116.027 -0.533 . . . . 29.58 113.101 175.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1358 ' ' VAL . . . . . 0.462 HG13 ' HE2' ' B' 1113 ' ' MET . 13.1 p -64.97 -32.65 59.19 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 O-C-N 122.079 -0.659 . . . . 32.06 111.053 -172.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1359 ' ' THR . . . . . . . . . . . . . 4.2 m -71.92 81.78 0.92 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 122.85 1.309 . . . . 29.0 108.274 175.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1360 ' ' VAL . . . . . 0.442 HG12 ' CD1' ' B' 1368 ' ' TRP . 34.8 m -71.13 -26.03 26.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 113.004 -1.907 . . . . 29.68 111.34 -175.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1361 ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' B' 1365 ' ' GLU . 83.9 mt -132.25 119.22 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 107.118 -1.438 . . . . 32.05 107.118 170.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1362 ' ' ARG . . . . . 0.597 ' HA ' HG23 ' B' 1111 ' ' THR . 27.1 ttt180 -106.8 125.34 50.87 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 105.571 -2.011 . . . . 32.52 105.571 172.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 45.62 37.3 3.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 117.542 2.423 . . . . 35.68 117.542 176.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1364 ' ' GLY . . . . . 0.584 ' HA3' ' HA ' ' B' 1109 ' ' ASN . . . 85.84 14.88 66.51 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 113.926 -1.488 . . . . 34.26 116.057 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1365 ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' B' 1361 ' ' ILE . 20.8 mm-40 -108.41 135.48 49.64 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.465 -0.939 . . . . 51.07 108.465 164.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1366 ' ' ILE . . . . . 0.439 ' HA ' HG12 ' B' 1361 ' ' ILE . 61.4 mt -69.6 90.71 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 106.57 -1.641 . . . . 39.87 106.57 173.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1367 ' ' THR . . . . . . . . . . . . 0.252 23.8 p -85.7 10.88 12.21 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 116.698 2.11 . . . . 38.01 116.698 176.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1368 ' ' TRP . . . . . 0.512 ' HZ3' ' HB2' ' B' 1096 ' ' ALA . 1.7 t90 -78.07 138.8 60.78 Favored Pre-proline 0 C--O 1.252 1.232 0 N-CA-C 107.586 -1.264 . . . . 42.14 107.586 166.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1369 ' ' PRO . . . . . 0.403 ' HA ' ' CD1' ' B' 1368 ' ' TRP . 7.9 Cg_exo -94.3 179.77 9.28 Favored 'Cis proline' 0 C--N 1.35 0.627 0 N-CA-C 115.958 1.484 . . . . 43.26 115.958 -3.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1370 ' ' ALA . . . . . 0.538 ' HB2' ' HA2' ' B' 1357 ' ' GLY . . . -81.97 149.99 64.28 Favored Pre-proline 0 C--O 1.242 0.686 0 CA-C-O 116.77 -1.586 . . . . 46.52 108.486 163.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -49.01 120.24 5.26 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 124.44 3.427 . . . . 51.95 110.734 175.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -48.83 100.95 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 125.121 3.88 . . . . 56.27 117.503 -172.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1373 ' ' ILE . . . . . . . . . . . . . 19.1 tt -76.37 126.16 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 106.34 -1.726 . . . . 60.83 106.34 172.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -72.02 106.57 4.34 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-O 125.566 2.603 . . . . 66.1 109.634 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 71.2 t -98.24 121.56 48.92 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 CA-C-N 111.45 -2.614 . . . . 63.47 106.279 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.218 -5.11 0 O-C-N 120.004 -1.685 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.414 -2.236 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.26 -31.82 71.63 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 124.789 1.235 . . . . 0.0 110.026 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -36.15 83.42 Favored 'General case' 0 C--O 1.252 1.19 0 CA-C-N 119.398 0.999 . . . . 0.0 109.787 175.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 84.8 m -67.04 -33.03 74.65 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 118.622 0.646 . . . . 0.0 109.91 171.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 24' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' C' ' 27' ' ' LEU . . . -68.65 -50.35 51.91 Favored 'General case' 0 C--O 1.246 0.87 0 O-C-N 119.41 -2.056 . . . . 0.0 110.973 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 25' ' ' GLU . . . . . 0.587 ' HA ' ' HE2' ' C' ' 28' ' ' LYS . 0.7 OUTLIER -41.72 -57.28 2.37 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.728 -1.233 . . . . 0.0 113.557 162.281 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.618 ' HA ' ' HB3' ' C' ' 29' ' ' ASN . 84.7 mt -60.96 -25.42 66.81 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 175.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.608 HD21 HD21 ' C' ' 110' ' ' LEU . 44.4 mt -58.37 -56.46 21.81 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 116.613 -1.66 . . . . 0.0 110.868 172.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 28' ' ' LYS . . . . . 0.587 ' HE2' ' HA ' ' C' ' 25' ' ' GLU . 12.3 pttt -67.9 -31.33 71.04 Favored 'General case' 0 C--O 1.257 1.459 0 CA-C-O 123.556 1.646 . . . . 0.0 110.272 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 29' ' ' ASN . . . . . 0.618 ' HB3' ' HA ' ' C' ' 26' ' ' LEU . 6.0 t30 -64.46 -27.33 68.91 Favored 'General case' 0 C--O 1.212 -0.886 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 169.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.647 ' HA ' ' HB3' ' C' ' 107' ' ' ASP . 35.4 m -65.69 -31.85 73.08 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 116.582 2.068 . . . . 0.0 116.582 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 31' ' ' HIS . . . . . 0.482 ' O ' HG23 ' C' ' 62' ' ' ILE . 19.7 m-70 61.08 -60.79 0.08 Allowed 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.289 -178.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 32' ' ' SER . . . . . 0.544 ' O ' ' HB3' ' C' ' 30' ' ' SER . 42.0 m -85.74 137.04 33.09 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 117.072 -3.518 . . . . 0.0 106.948 156.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . 0.413 ' HA ' HG23 ' C' ' 106' ' ' THR . 60.7 t -127.99 94.33 2.48 Favored 'Isoleucine or valine' 0 C--O 1.246 0.892 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 174.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.646 HG13 ' HA ' ' C' ' 103' ' ' PHE . 23.6 mm -74.11 110.25 7.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 O-C-N 118.607 -2.558 . . . . 0.0 107.666 168.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . 0.521 HG12 HD12 ' C' ' 110' ' ' LEU . 33.6 mt -85.88 114.59 25.85 Favored 'Isoleucine or valine' 0 C--O 1.254 1.303 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 169.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 36.2 m -93.67 107.88 30.3 Favored Pre-proline 0 C--O 1.246 0.914 0 O-C-N 121.08 -1.013 . . . . 0.0 110.382 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' C' ' 35' ' ' ILE . 80.2 Cg_exo -61.18 91.35 0.1 OUTLIER 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 123.294 2.663 . . . . 0.0 113.382 177.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.56 168.92 40.5 Favored Glycine 0 N--CA 1.432 -1.569 0 CA-C-N 113.086 -1.87 . . . . 0.0 108.624 169.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 39' ' ' TYR . . . . . 0.436 ' HB3' ' HB2' ' C' ' 114' ' ' ALA . 46.9 t80 -57.43 -28.04 62.96 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -177.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 40' ' ' GLY . . . . . 0.465 ' HA2' HG12 ' C' ' 43' ' ' VAL . . . -58.45 -32.71 69.06 Favored Glycine 0 C--O 1.244 0.758 0 O-C-N 120.83 -1.169 . . . . 0.0 112.536 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 41' ' ' MET . . . . . 0.833 ' HA ' ' HB3' ' C' ' 46' ' ' ALA . 16.1 ttm -55.64 -44.54 77.26 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.557 -0.822 . . . . 0.0 111.454 177.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.89 -51.97 10.29 Favored 'General case' 0 C--O 1.214 -0.777 0 O-C-N 124.967 1.417 . . . . 0.0 111.627 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . 0.465 HG12 ' HA2' ' C' ' 40' ' ' GLY . 11.3 p -67.43 -41.47 86.17 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 C-N-CA 119.333 -0.947 . . . . 0.0 113.358 -168.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . 0.43 ' HB1' ' HB2' ' C' ' 176' ' ' LYS . . . -92.47 19.71 6.97 Favored 'General case' 0 N--CA 1.424 -1.731 0 O-C-N 120.899 -1.125 . . . . 0.0 110.597 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 45' ' ' GLN . . . . . . . . . . . . 0.353 0.0 OUTLIER 30.31 56.65 0.19 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 117.819 2.525 . . . . 0.0 117.819 -167.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.833 ' HB3' ' HA ' ' C' ' 41' ' ' MET . . . -78.26 -14.19 59.54 Favored 'General case' 0 C--O 1.202 -1.44 0 CA-C-N 111.891 -2.413 . . . . 0.0 114.094 -178.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 47' ' ' GLN . . . . . 0.486 ' HA ' ' HB ' ' C' ' 50' ' ' VAL . 0.0 OUTLIER -66.89 -26.38 66.85 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 179.386 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 48' ' ' TYR . . . . . 0.592 ' HB2' ' HD3' ' C' ' 49' ' ' PRO . 47.0 m-85 -62.58 -52.2 66.95 Favored Pre-proline 0 N--CA 1.443 -0.787 0 CA-C-O 117.636 -1.174 . . . . 0.0 111.767 170.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 49' ' ' PRO . . . . . 0.592 ' HD3' ' HB2' ' C' ' 48' ' ' TYR . 8.2 Cg_exo -63.58 -39.34 36.12 Favored 'Trans proline' 0 CA--C 1.551 1.359 0 C-N-CA 122.846 2.364 . . . . 0.0 114.231 170.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . 0.577 ' HA ' HG22 ' C' ' 53' ' ' ILE . 54.2 t -59.81 -37.4 71.39 Favored 'Isoleucine or valine' 0 C--N 1.346 0.442 0 CA-C-O 116.126 -1.892 . . . . 0.0 111.191 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.02 -46.8 89.26 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 122.971 2.623 . . . . 0.0 108.993 -176.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 52' ' ' GLU . . . . . 0.54 ' HB3' HD11 ' C' ' 183' ' ' LEU . 3.6 tm-20 -69.57 -41.18 76.19 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.332 -1.304 . . . . 0.0 113.721 -178.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 53' ' ' ILE . . . . . 0.643 HD13 ' HA ' ' C' ' 183' ' ' LEU . 10.2 tp -60.45 -39.72 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 120.309 1.413 . . . . 0.0 113.002 172.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 95.0 m -60.68 -46.82 88.91 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.166 173.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -55.15 -50.82 68.33 Favored 'General case' 0 C--O 1.252 1.184 0 C-N-CA 127.178 2.191 . . . . 0.0 110.231 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . 0.431 ' HG2' HD12 ' C' ' 186' ' ' LEU . 4.3 ttpt -57.57 -50.73 72.14 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 116.59 2.071 . . . . 0.0 116.59 175.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 57' ' ' LEU . . . . . 0.479 ' O ' ' HB3' ' C' ' 60' ' ' ARG . 29.6 mt -63.06 -40.33 97.38 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.803 -0.561 . . . . 0.0 111.787 175.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . 0.516 ' NH1' ' HA ' ' C' ' 63' ' ' ASN . 2.5 tpt180 -67.7 -46.04 73.41 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 118.787 -0.625 . . . . 0.0 109.882 -175.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.74 -31.72 72.98 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 120.231 1.378 . . . . 0.0 112.502 175.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . 0.479 ' HB3' ' O ' ' C' ' 57' ' ' LEU . 1.7 tpm_? -61.36 -28.52 69.29 Favored 'General case' 0 C--N 1.346 0.45 0 O-C-N 119.913 -1.742 . . . . 0.0 110.89 171.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.4 1.84 40.91 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -177.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . 0.482 HG23 ' O ' ' C' ' 31' ' ' HIS . 64.5 mt -73.28 137.18 23.88 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 CA-C-O 126.096 2.855 . . . . 0.0 107.131 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 63' ' ' ASN . . . . . 0.516 ' HA ' ' NH1' ' C' ' 58' ' ' ARG . 59.3 t30 -81.52 67.01 7.31 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 112.275 -2.239 . . . . 0.0 111.754 -177.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 2.8 p -78.51 128.64 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 173.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 30.2 mmm-85 -137.42 148.78 46.42 Favored 'General case' 0 C--N 1.349 0.546 0 N-CA-C 103.468 -2.79 . . . . 0.0 103.468 -174.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . 0.73 ' HB2' ' HA ' ' C' ' 93' ' ' VAL . 22.4 m-85 -106.09 118.89 37.8 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 122.798 1.285 . . . . 0.0 111.048 -176.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -97.29 83.05 0.72 Allowed Glycine 0 C--O 1.25 1.107 0 N-CA-C 107.919 -2.072 . . . . 0.0 107.919 -177.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 68' ' ' ILE . . . . . 0.76 ' HB ' ' HA ' ' C' ' 95' ' ' GLU . 1.7 mp -73.03 126.38 33.59 Favored 'Isoleucine or valine' 0 C--N 1.348 0.518 0 CA-C-N 119.918 1.859 . . . . 0.0 110.191 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 69' ' ' HIS . . . . . 0.503 ' NE2' ' HG2' ' C' ' 134' ' ' PRO . 18.1 t-80 -118.16 91.98 41.59 Favored Pre-proline 0 CA--C 1.5 -0.945 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.911 -178.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 70' ' ' PRO . . . . . 0.773 ' HB3' HG13 ' A' 1157 ' ' ILE . 98.3 Cg_endo -54.39 -39.29 88.07 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 124.733 3.622 . . . . 0.0 118.307 -168.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 42.2 t -71.03 95.57 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 171.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -161.49 106.58 1.31 Allowed 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.445 1.117 . . . . 0.0 110.762 -172.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 73' ' ' GLY . . . . . 0.466 ' C ' ' HD2' ' C' ' 74' ' ' ARG . . . 72.31 -90.95 0.53 Allowed Glycine 0 N--CA 1.467 0.719 0 O-C-N 118.34 -2.725 . . . . 0.0 113.984 156.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 74' ' ' ARG . . . . . 0.816 ' HG3' ' HG2' ' B' 1203 ' ' GLN . 2.4 mpt_? -145.91 114.09 6.61 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -169.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.669 ' HG ' HD22 ' B' 1178 ' ' LEU . 4.0 mp 60.36 119.89 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.416 0 O-C-N 127.079 2.737 . . . . 0.0 116.808 175.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 76' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' C' ' 75' ' ' LEU . 73.0 Cg_endo -66.69 165.14 26.54 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 124.244 3.296 . . . . 0.0 109.423 167.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.39 -115.94 5.01 Favored Glycine 0 CA--C 1.505 -0.535 0 O-C-N 120.21 -1.556 . . . . 0.0 110.338 -169.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 49.56 -79.95 0.01 OUTLIER 'General case' 0 C--O 1.248 0.979 0 C-N-CA 124.819 1.248 . . . . 0.0 114.166 155.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -67.65 -35.43 78.87 Favored 'General case' 0 C--O 1.241 0.652 0 O-C-N 118.962 -2.336 . . . . 0.0 110.209 -177.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -64.13 -34.1 77.29 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 74.8 t -65.71 -41.03 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 122.139 -0.351 . . . . 0.0 111.351 176.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 45.9 mt -66.63 -30.27 70.5 Favored 'General case' 0 C--O 1.252 1.194 0 CA-C-O 123.361 1.553 . . . . 0.0 109.904 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.793 HD11 ' SD ' ' C' ' 41' ' ' MET . 6.0 mp -66.89 -48.34 69.05 Favored 'General case' 0 C--O 1.24 0.568 0 O-C-N 120.869 -1.144 . . . . 0.0 110.162 172.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.18 -49.42 77.1 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 177.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -58.59 -55.04 40.18 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-O 117.873 -1.061 . . . . 0.0 109.075 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.77 9.08 0.3 Allowed 'General case' 0 C--O 1.246 0.874 0 CA-C-N 121.158 1.799 . . . . 0.0 114.05 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp 64.14 30.87 13.64 Favored 'General case' 0 C--O 1.257 1.5 0 CA-C-N 122.017 2.19 . . . . 0.0 115.012 172.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 60.7 t -72.34 120.24 79.33 Favored Pre-proline 0 C--O 1.262 1.722 0 N-CA-C 104.462 -2.421 . . . . 0.0 104.462 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -56.71 115.94 2.84 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.854 3.036 . . . . 0.0 116.37 -171.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 90' ' ' TYR . . . . . 0.753 ' HA ' ' HB ' ' C' ' 93' ' ' VAL . 16.4 m-85 -60.69 -22.37 63.85 Favored 'General case' 0 C--O 1.246 0.885 0 CA-C-O 123.381 1.562 . . . . 0.0 114.125 173.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -43.19 -56.75 3.28 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 124.87 1.268 . . . . 0.0 112.758 164.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 1.9 pt -96.43 -10.38 8.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.577 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 93' ' ' VAL . . . . . 0.753 ' HB ' ' HA ' ' C' ' 90' ' ' TYR . 41.5 t -74.13 108.43 5.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-O 123.749 1.738 . . . . 0.0 110.656 175.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 6.0 mt -106.25 95.61 5.89 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 120.624 -1.297 . . . . 0.0 110.975 176.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 95' ' ' GLU . . . . . 0.76 ' HA ' ' HB ' ' C' ' 68' ' ' ILE . 3.1 mp0 -71.19 91.53 0.95 Allowed 'General case' 0 C--O 1.255 1.352 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.056 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 39.3 ttp 50.52 97.8 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 124.503 2.097 . . . . 0.0 116.445 -175.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -157.94 163.51 37.77 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 113.396 -1.729 . . . . 0.0 107.53 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -84.8 94.92 8.82 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 124.975 2.322 . . . . 0.0 111.471 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 10.3 tp -100.03 41.02 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 CA-C-N 109.079 -3.691 . . . . 0.0 107.386 164.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -76.91 -31.12 56.47 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 119.984 -1.698 . . . . 0.0 108.153 -161.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -63.45 -61.22 2.48 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 124.576 1.15 . . . . 0.0 113.93 170.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 102' ' ' ASP . . . . . 0.438 ' HA ' ' HB3' ' C' ' 105' ' ' ASP . 1.4 m-20 -65.83 -21.08 66.45 Favored 'General case' 0 C--N 1.355 0.818 0 O-C-N 123.852 0.72 . . . . 0.0 111.626 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 103' ' ' PHE . . . . . 0.646 ' HA ' HG13 ' C' ' 34' ' ' ILE . 0.1 OUTLIER -56.62 -60.17 3.94 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 123.304 0.642 . . . . 0.0 110.768 170.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.25 -31.35 72.48 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 173.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . 0.438 ' HB3' ' HA ' ' C' ' 102' ' ' ASP . 8.6 t70 -66.24 -26.45 67.37 Favored 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 120.509 -1.369 . . . . 0.0 111.837 175.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 106' ' ' THR . . . . . 0.557 ' OG1' HG12 ' C' ' 34' ' ' ILE . 53.6 m -73.02 125.75 28.35 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 121.842 2.11 . . . . 0.0 108.946 177.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 107' ' ' ASP . . . . . 0.647 ' HB3' ' HA ' ' C' ' 30' ' ' SER . 11.7 t70 -72.36 -43.37 64.13 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 113.006 -1.906 . . . . 0.0 110.621 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' C' ' 143' ' ' ASN . 80.0 m -125.62 104.53 8.44 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 119.015 0.825 . . . . 0.0 111.622 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 109' ' ' VAL . . . . . 0.445 HG11 HG21 ' C' ' 138' ' ' VAL . 8.1 t -87.0 120.95 37.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -171.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 110' ' ' LEU . . . . . 0.608 HD21 HD21 ' C' ' 27' ' ' LEU . 20.8 mt -90.32 93.77 9.47 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -171.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 19.1 t -84.81 109.31 17.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.037 170.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 112' ' ' ILE . . . . . 0.52 HD11 HG23 ' C' ' 35' ' ' ILE . 6.5 mm -78.06 90.02 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.919 0 CA-C-O 121.888 0.851 . . . . 0.0 110.652 -174.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 113' ' ' GLY . . . . . 0.558 ' HA2' ' O ' ' C' ' 147' ' ' PHE . . . 86.79 -72.95 2.54 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-O 124.106 1.948 . . . . 0.0 113.969 168.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 114' ' ' ALA . . . . . 0.436 ' HB2' ' HB3' ' C' ' 39' ' ' TYR . . . -75.77 108.29 8.52 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 120.773 -1.428 . . . . 0.0 112.819 -168.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 115' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -65.75 -58.46 5.62 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 113.106 -1.861 . . . . 0.0 115.213 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 116' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' C' ' 119' ' ' ASN . 81.8 m-20 -57.62 -19.38 25.77 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 116.713 2.116 . . . . 0.0 116.713 -168.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 3.1 m -44.54 -43.47 8.03 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.658 1.983 . . . . 0.0 110.624 173.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.523 HG23 HD21 ' C' ' 162' ' ' LEU . 13.7 m -125.07 37.75 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.624 0 CA-C-O 122.952 1.358 . . . . 0.0 110.83 -177.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 119' ' ' ASN . . . . . 0.506 ' HB2' ' HA ' ' C' ' 116' ' ' ASP . 40.7 t-20 -77.82 114.22 39.55 Favored Pre-proline 0 C--O 1.243 0.73 0 O-C-N 120.463 -1.398 . . . . 0.0 110.832 -176.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 120' ' ' PRO . . . . . 0.416 ' HG2' ' HB2' ' C' ' 160' ' ' ASN . 71.7 Cg_endo -64.6 -34.0 53.69 Favored 'Trans proline' 0 CA--C 1.495 -1.471 0 C-N-CA 125.045 3.83 . . . . 0.0 114.183 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 121' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' C' ' 125' ' ' ASP . . . -64.23 -30.27 71.33 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 118.614 -1.235 . . . . 0.0 110.429 174.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 122' ' ' ALA . . . . . 0.555 ' HA ' ' CB ' ' C' ' 128' ' ' SER . . . -68.72 -19.83 64.37 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 174.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 123' ' ' GLN . . . . . 0.48 ' HB3' ' O ' ' C' ' 133' ' ' MET . 3.9 pt20 -86.7 -59.78 2.17 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 118.039 -2.913 . . . . 0.0 114.621 161.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -65.44 -45.05 85.33 Favored 'General case' 0 N--CA 1.438 -1.067 0 O-C-N 127.431 2.957 . . . . 0.0 115.042 -168.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 125' ' ' ASP . . . . . 0.459 ' HA ' ' HD3' ' C' ' 126' ' ' PRO . 0.9 OUTLIER -80.59 119.98 77.84 Favored Pre-proline 0 C--O 1.243 0.735 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -170.639 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 126' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' C' ' 125' ' ' ASP . 33.1 Cg_exo -75.49 76.01 3.73 Favored 'Trans proline' 0 N--CA 1.436 -1.878 1 C-N-CA 125.843 4.362 . . . . 0.0 109.413 175.114 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 127' ' ' LYS . . . . . 0.41 ' HB3' ' OD2' ' C' ' 125' ' ' ASP . 6.0 ttpm? 174.98 -25.5 0.0 OUTLIER 'General case' 0 C--O 1.248 0.981 0 C-N-CA 125.98 1.712 . . . . 0.0 108.378 -173.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 128' ' ' SER . . . . . 0.558 ' OG ' HG21 ' C' ' 158' ' ' VAL . 73.8 m -68.17 126.62 92.87 Favored Pre-proline 0 N--CA 1.446 -0.658 0 CA-C-N 120.961 1.709 . . . . 0.0 112.024 175.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 129' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' C' ' 128' ' ' SER . 17.0 Cg_endo -56.72 -58.39 0.98 Allowed 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 123.836 3.024 . . . . 0.0 114.091 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 13.3 pt -73.21 66.32 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 C-N-CA 123.977 0.911 . . . . 0.0 112.308 171.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 131' ' ' ALA . . . . . 0.474 ' O ' ' HB ' ' B' 1121 ' ' ILE . . . -72.93 150.9 42.15 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 122.695 1.236 . . . . 0.0 113.409 -170.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.03 53.36 27.0 Favored Glycine 0 CA--C 1.497 -1.045 0 CA-C-N 111.846 -2.434 . . . . 0.0 107.679 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 133' ' ' MET . . . . . 0.48 ' O ' ' HB3' ' C' ' 123' ' ' GLN . 24.5 tpp -76.62 129.45 79.4 Favored Pre-proline 0 C--O 1.252 1.185 0 CA-C-N 118.69 1.245 . . . . 0.0 110.715 175.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 134' ' ' PRO . . . . . 0.503 ' HG2' ' NE2' ' C' ' 69' ' ' HIS . 40.7 Cg_endo -62.78 101.93 0.28 Allowed 'Trans proline' 0 CA--C 1.517 -0.341 0 C-N-CA 125.22 3.947 . . . . 0.0 110.981 171.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 15.7 t -120.45 93.88 2.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 1 N-CA-C 99.743 -4.169 . . . . 0.0 99.743 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 5.1 mt -73.5 78.84 1.43 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.451 0.643 . . . . 0.0 112.196 -170.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 48.68 5.05 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 120.243 3.423 . . . . 0.0 120.243 -167.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 138' ' ' VAL . . . . . 0.445 HG21 HG11 ' C' ' 109' ' ' VAL 0.291 13.0 p -76.22 61.9 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 117.457 2.391 . . . . 0.0 117.457 -173.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 17.7 p90 -158.2 178.18 10.47 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 123.302 0.641 . . . . 0.0 109.618 171.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 140' ' ' LYS . . . . . . . . . . . . . 15.4 pttm 63.58 -58.16 0.19 Allowed 'General case' 0 C--O 1.247 0.933 0 C-N-CA 126.998 2.119 . . . . 0.0 115.681 174.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -90.76 174.28 7.56 Favored 'General case' 0 C--N 1.319 -0.746 0 O-C-N 120.122 -1.611 . . . . 0.0 107.346 170.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 63.97 157.51 0.08 Allowed 'General case' 0 C--N 1.345 0.383 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 172.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 143' ' ' ASN . . . . . 0.46 ' O ' ' HA ' ' C' ' 108' ' ' THR . 52.9 m-80 -80.14 79.26 6.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 125.167 2.413 . . . . 0.0 107.075 177.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 144' ' ' VAL . . . . . 0.647 ' HB ' HG23 ' C' ' 168' ' ' THR . 58.0 t -85.94 83.97 2.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 O-C-N 118.598 -2.564 . . . . 0.0 106.001 -178.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 145' ' ' ILE . . . . . 0.721 HG23 ' HB2' ' C' ' 171' ' ' LEU . 35.7 mt -88.91 109.18 19.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 125.501 2.572 . . . . 0.0 114.823 -170.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 146' ' ' VAL . . . . . . . . . . . . . 27.1 t -96.05 108.58 21.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 109.444 -3.525 . . . . 0.0 107.142 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 147' ' ' PHE . . . . . 0.558 ' O ' ' HA2' ' C' ' 113' ' ' GLY . 13.8 m-85 -70.75 102.58 2.35 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 148' ' ' LYS . . . . . 0.771 ' HE3' ' HA ' ' C' ' 151' ' ' MET . 60.2 tttp -131.28 133.77 45.73 Favored 'General case' 0 C--O 1.244 0.797 0 O-C-N 118.973 -2.329 . . . . 0.0 109.512 -175.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 149' ' ' ARG . . . . . 0.564 ' HE ' ' HB2' ' C' ' 174' ' ' ASP . 19.6 ttm105 -83.37 -92.27 0.07 Allowed 'General case' 0 C--O 1.24 0.565 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 176.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 1.1 m -70.52 131.46 44.05 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 121.475 1.943 . . . . 0.0 111.056 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 151' ' ' MET . . . . . 0.771 ' HA ' ' HE3' ' C' ' 148' ' ' LYS . 5.7 tpt -75.58 92.86 2.96 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-O 125.823 2.725 . . . . 0.0 107.713 163.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -133.85 152.02 51.73 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-N 110.698 -2.956 . . . . 0.0 109.523 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 153' ' ' THR . . . . . 0.436 ' HA ' ' HA3' ' C' ' 157' ' ' GLY . 73.2 m -63.46 150.63 43.27 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.396 172.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -111.2 -81.32 1.17 Allowed Glycine 0 C--N 1.353 1.527 0 N-CA-C 107.27 -2.332 . . . . 0.0 107.27 165.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -112.0 -46.94 3.17 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 117.51 -1.233 . . . . 0.0 110.876 174.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 156' ' ' ALA . . . . . 0.408 ' HB1' HG22 ' C' ' 158' ' ' VAL . . . -87.4 -69.18 0.7 Allowed 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 119.614 1.097 . . . . 0.0 110.403 166.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 157' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' C' ' 153' ' ' THR . . . 50.15 32.08 20.17 Favored Glycine 0 C--N 1.34 0.802 0 N-CA-C 115.218 0.847 . . . . 0.0 115.218 -170.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 158' ' ' VAL . . . . . 0.558 HG21 ' OG ' ' C' ' 128' ' ' SER . 14.6 m -92.26 153.69 3.26 Favored 'Isoleucine or valine' 0 C--O 1.253 1.27 0 C-N-CA 123.41 0.684 . . . . 0.0 110.007 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -41.76 112.05 0.29 Allowed 'General case' 0 C--N 1.345 0.394 0 N-CA-C 119.75 3.241 . . . . 0.0 119.75 176.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 160' ' ' ASN . . . . . 0.416 ' HB2' ' HG2' ' C' ' 120' ' ' PRO . 3.4 p30 -157.54 159.09 30.9 Favored Pre-proline 0 N--CA 1.436 -1.147 0 O-C-N 120.486 -1.384 . . . . 0.0 110.511 -173.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -38.38 -57.7 0.82 Allowed 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 124.43 3.42 . . . . 0.0 112.313 176.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 162' ' ' LEU . . . . . 0.523 HD21 HG23 ' C' ' 118' ' ' VAL . 9.6 mp -43.21 -31.34 0.59 Allowed 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 163' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -88.11 -59.57 2.2 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.729 -1.578 . . . . 0.0 107.382 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -91.44 -10.16 42.0 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 116.579 2.066 . . . . 0.0 116.579 -161.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -84.58 152.62 23.74 Favored 'General case' 0 C--O 1.243 0.713 0 O-C-N 120.614 -1.304 . . . . 0.0 110.639 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -78.87 -34.08 45.25 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-N 112.936 -1.938 . . . . 0.0 110.546 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 40.3 p-10 -91.78 -63.16 1.28 Allowed 'General case' 0 C--O 1.245 0.848 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 168' ' ' THR . . . . . 0.647 HG23 ' HB ' ' C' ' 144' ' ' VAL . 25.1 m -72.02 102.71 3.03 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 117.091 -3.505 . . . . 0.0 103.328 172.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -143.72 136.57 27.42 Favored 'General case' 0 CA--C 1.5 -0.962 0 O-C-N 119.254 -2.154 . . . . 0.0 112.692 -153.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 170' ' ' MET . . . . . 0.52 ' SD ' ' HD3' ' C' ' 148' ' ' LYS . 76.9 mtm -67.12 119.97 12.93 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 120.526 -1.359 . . . . 0.0 109.057 163.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 171' ' ' LEU . . . . . 0.721 ' HB2' HG23 ' C' ' 145' ' ' ILE . 13.1 tp -83.92 144.65 29.06 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 168.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -89.22 99.27 12.3 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 -167.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . 154.79 166.4 15.18 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-O 124.466 2.148 . . . . 0.0 109.992 167.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 174' ' ' ASP . . . . . 0.564 ' HB2' ' HE ' ' C' ' 149' ' ' ARG . 21.2 t70 -50.68 153.13 1.78 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.339 1.856 . . . . 0.0 112.648 169.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.9 -56.0 27.16 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.886 1.274 . . . . 0.0 110.842 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 176' ' ' LYS . . . . . 0.448 ' HD3' ' HG2' ' C' ' 49' ' ' PRO . 0.1 OUTLIER -69.81 -39.88 76.25 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 121.272 -0.892 . . . . 0.0 112.61 -177.131 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 177' ' ' ALA . . . . . . . . . . . . . . . -53.73 -44.1 69.62 Favored 'General case' 0 C--O 1.256 1.395 0 C-N-CA 125.249 1.42 . . . . 0.0 110.642 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 20.0 m -74.81 -42.5 57.93 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.0 -1.454 . . . . 0.0 111.456 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 179' ' ' VAL . . . . . 0.449 ' HA ' HG12 ' C' ' 182' ' ' ILE . 58.1 t -62.17 -55.01 26.82 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-N 120.223 1.374 . . . . 0.0 112.335 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -55.87 -39.12 71.05 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 119.001 -2.312 . . . . 0.0 112.672 178.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -54.46 -56.59 17.23 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 117.479 -1.248 . . . . 0.0 111.172 169.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 182' ' ' ILE . . . . . 0.449 HG12 ' HA ' ' C' ' 179' ' ' VAL . 19.0 pt -66.59 -32.32 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 121.058 1.754 . . . . 0.0 114.583 -175.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 183' ' ' LEU . . . . . 0.643 ' HA ' HD13 ' C' ' 53' ' ' ILE . 59.3 tp -48.27 -57.14 6.38 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 127.002 2.121 . . . . 0.0 112.581 170.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 184' ' ' LYS . . . . . 0.459 ' HD2' ' HA ' ' C' ' 184' ' ' LYS . 24.6 tptt -75.15 -33.48 61.52 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 124.83 1.332 . . . . 0.0 112.648 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -67.78 -91.61 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.17 0 O-C-N 126.502 2.376 . . . . 0.0 110.972 177.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 186' ' ' LEU . . . . . 0.431 HD12 ' HG2' ' C' ' 56' ' ' LYS 0.25 8.8 mt . . . . . 0 C--O 1.205 -1.255 0 O-C-N 120.237 -1.54 . . . . 0.0 112.505 -152.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 42.2 t-80 . . . . . 0 N--CA 1.419 -1.999 0 N-CA-C 105.757 -1.942 . . . . 65.74 105.757 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -69.1 66.88 0.5 Allowed Glycine 0 C--N 1.348 1.236 0 C-N-CA 123.937 0.779 . . . . 48.66 111.622 172.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -80.18 124.86 29.16 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 120.002 -0.679 . . . . 44.56 109.388 173.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1003 ' ' ILE . . . . . 0.84 HG12 ' HB ' ' A' 1068 ' ' ILE . 34.8 mt -95.65 132.71 39.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 120.554 -1.341 . . . . 34.86 107.668 171.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -105.11 127.76 9.17 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 108.438 -1.865 . . . . 30.75 108.438 172.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.496 HG23 ' HB3' ' A' 1017 ' ' ALA . 23.0 mm -103.01 108.63 59.29 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 102.903 -2.999 . . . . 32.21 102.903 172.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -74.09 167.09 28.03 Favored 'Trans proline' 0 N--CA 1.439 -1.68 0 C-N-CA 122.474 2.116 . . . . 32.98 111.104 171.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1007 ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -84.77 131.78 34.51 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 102.438 -3.171 . . . . 47.98 102.438 157.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1008 ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -55.81 134.19 51.58 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 117.157 2.28 . . . . 34.7 117.157 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 21.7 mtp-105 -101.18 0.44 37.61 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 113.658 -1.61 . . . . 53.37 110.796 -171.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 52.7 tp -70.57 136.78 49.53 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 106.314 -1.735 . . . . 45.07 106.314 169.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1011 ' ' THR . . . . . . . . . . . . . 45.8 m -57.27 135.39 56.46 Favored 'General case' 0 C--O 1.243 0.76 0 O-C-N 120.461 -1.4 . . . . 40.36 109.81 -174.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 84.3 m-20 60.34 27.92 17.51 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 116.412 2.004 . . . . 40.61 116.412 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -87.74 147.93 24.97 Favored 'General case' 0 CA--C 1.504 -0.811 0 C-N-CA 118.616 -1.234 . . . . 33.76 109.797 -174.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1014 ' ' THR . . . . . 0.488 HG22 ' HB3' ' A' 1320 ' ' PRO . 1.9 m -117.06 -14.41 10.58 Favored 'General case' 0 C--O 1.257 1.483 0 CA-C-O 124.199 1.952 . . . . 27.89 110.81 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1015 ' ' ARG . . . . . 0.612 ' HG3' ' HA2' ' A' 1317 ' ' GLY . 12.9 mtm180 -66.12 125.76 26.52 Favored 'General case' 0 C--O 1.214 -0.775 0 O-C-N 119.468 -2.02 . . . . 29.02 114.054 173.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1016 ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' 1043 ' ' ALA . 3.4 t -120.52 150.81 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 106.721 -1.585 . . . . 28.13 106.721 165.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1017 ' ' ALA . . . . . 0.496 ' HB3' HG23 ' A' 1005 ' ' ILE . . . -59.19 -53.24 60.6 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 117.311 2.337 . . . . 26.87 117.311 -177.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -129.52 143.05 50.67 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 112.22 0.452 . . . . 26.77 112.22 -167.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1019 ' ' THR . . . . . 0.577 HG23 ' HB2' ' A' 1324 ' ' SER . 1.0 OUTLIER -80.5 174.06 6.74 Favored Pre-proline 0 C--N 1.347 0.475 0 C-N-CA 124.176 0.99 . . . . 27.02 110.887 168.178 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 1020 ' ' PRO . . . . . 0.482 ' HB3' ' HB2' ' A' 1053 ' ' ALA . 0.1 OUTLIER -54.18 -34.96 81.03 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.33 2.687 . . . . 30.57 111.455 168.457 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -55.24 -58.02 9.4 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 114.055 -1.43 . . . . 47.81 112.461 173.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1022 ' ' THR . . . . . . . . . . . . 0.281 3.2 p -77.13 -21.75 53.67 Favored 'General case' 0 C--N 1.309 -1.17 0 O-C-N 120.312 -1.492 . . . . 30.77 112.892 -174.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1023 ' ' VAL . . . . . 0.569 HG22 HG11 ' A' 1033 ' ' VAL . 8.9 t -56.89 -51.29 69.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 N-CA-C 108.594 -0.891 . . . . 33.59 108.594 164.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -65.8 -32.73 74.42 Favored 'General case' 0 C--N 1.35 0.617 0 N-CA-C 114.284 1.216 . . . . 53.29 114.284 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1025 ' ' GLN . . . . . 0.662 ' HB3' HG11 ' A' 1332 ' ' VAL . 68.2 mt-30 -58.2 -49.71 76.09 Favored 'General case' 0 C--O 1.254 1.336 0 CA-C-N 119.286 0.948 . . . . 46.92 112.125 170.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1026 ' ' LEU . . . . . 0.583 ' HA ' HD12 ' A' 1029 ' ' LEU . 14.9 mt -59.75 -38.56 82.1 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 118.527 -2.608 . . . . 37.17 114.006 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 29.3 tp -59.11 -40.59 85.83 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 113.848 -1.523 . . . . 44.44 112.404 171.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1028 ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' 1028 ' ' LYS . 12.3 mmmm -70.06 -26.29 63.94 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 119.526 -1.983 . . . . 52.58 113.71 173.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1029 ' ' LEU . . . . . 0.583 HD12 ' HA ' ' A' 1026 ' ' LEU . 25.5 mt -65.51 -39.88 92.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.609 0.719 . . . . 45.69 111.019 162.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 115.55 15.57 7.47 Favored Glycine 0 CA--C 1.503 -0.715 0 O-C-N 118.708 -2.495 . . . . 42.09 110.97 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -92.82 147.54 22.77 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 107.299 -1.371 . . . . 40.72 107.299 168.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1032 ' ' THR . . . . . . . . . . . . . 10.7 m -99.17 118.68 36.44 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.056 -1.091 . . . . 37.77 108.056 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1033 ' ' VAL . . . . . 0.569 HG11 HG22 ' A' 1023 ' ' VAL . 3.5 t -89.49 141.96 13.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.134 -0.939 . . . . 33.54 111.761 -171.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -128.58 135.01 48.77 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 104.445 -2.428 . . . . 31.68 104.445 176.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1035 ' ' VAL . . . . . . . . . . . . . 69.2 t -119.71 144.5 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 O-C-N 120.697 -1.252 . . . . 31.52 110.718 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1036 ' ' GLU . . . . . 0.462 ' HB2' HG11 ' A' 1063 ' ' VAL . 35.5 tt0 -72.7 130.2 39.99 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 124.155 0.91 . . . . 41.04 110.778 176.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1037 ' ' SER . . . . . . . . . . . . . 65.9 m -60.1 111.2 1.42 Allowed 'General case' 0 C--O 1.262 1.714 0 N-CA-C 107.293 -1.373 . . . . 31.83 107.293 165.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 130.01 -32.41 3.14 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.573 -0.822 . . . . 29.36 111.127 -172.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -64.08 -39.89 95.06 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 117.594 -1.193 . . . . 27.78 108.842 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -52.08 -47.32 55.03 Favored Glycine 0 C--N 1.359 1.809 0 CA-C-O 121.817 0.676 . . . . 28.91 112.325 169.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -66.24 -32.37 73.75 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.771 -0.841 . . . . 51.18 110.894 -175.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1042 ' ' LEU . . . . . . . . . . . . . 14.0 mt -69.93 -56.3 7.39 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 121.16 1.8 . . . . 29.91 111.528 165.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1043 ' ' ALA . . . . . 0.497 ' HA ' ' HB2' ' A' 1320 ' ' PRO . . . -69.9 12.31 0.22 Allowed 'General case' 0 CA--C 1.556 1.2 0 O-C-N 119.334 -2.104 . . . . 28.54 112.636 -174.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1044 ' ' SER . . . . . . . . . . . . . 13.8 m 63.27 59.54 1.26 Allowed 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 124.454 2.073 . . . . 33.06 113.863 174.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1045 ' ' PHE . . . . . 0.406 ' HA ' ' HB1' ' B' 1277 ' ' ALA . 97.0 m-85 -150.58 167.15 28.1 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 111.088 -2.778 . . . . 30.29 106.52 177.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -97.25 151.34 19.95 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 106.624 -1.621 . . . . 48.62 106.624 151.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -59.84 -16.99 32.97 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 114.199 1.185 . . . . 36.74 114.199 -166.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 20.5 pttm -55.05 -26.36 36.99 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 121.987 2.176 . . . . 43.73 110.91 174.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -52.73 -53.63 45.17 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 120.661 -1.274 . . . . 32.81 112.576 171.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1050 ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -63.09 -33.38 75.32 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.909 -1.041 . . . . 31.86 113.657 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 25.5 t -63.98 -41.27 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 O-C-N 121.157 -0.964 . . . . 33.22 109.313 173.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -64.41 -41.99 96.31 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 122.468 1.128 . . . . 50.83 111.586 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1053 ' ' ALA . . . . . 0.482 ' HB2' ' HB3' ' A' 1020 ' ' PRO . . . -60.48 -52.76 63.82 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 114.333 -1.303 . . . . 33.12 110.64 170.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 122.34 75.03 0.33 Allowed Glycine 0 CA--C 1.489 -1.555 0 CA-C-O 123.523 1.624 . . . . 35.83 110.057 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -143.26 127.22 17.34 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 105.809 -1.923 . . . . 34.82 105.809 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -62.28 118.57 7.61 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.283 -0.871 . . . . 49.05 111.718 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1057 ' ' ILE . . . . . . . . . . . . . 17.3 mm -89.04 124.62 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 124.538 2.113 . . . . 38.53 110.953 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1058 ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' 1036 ' ' GLU . 0.0 OUTLIER -144.11 158.55 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 110.877 -2.874 . . . . 42.11 107.133 -175.612 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -88.22 167.8 13.28 Favored 'General case' 0 C--O 1.259 1.592 0 N-CA-C 113.925 1.083 . . . . 58.0 113.925 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . -31.05 -69.66 0.09 OUTLIER Glycine 0 C--N 1.348 1.235 0 N-CA-C 117.881 1.912 . . . . 52.12 117.881 -172.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 5.4 m120 -64.37 -33.59 76.2 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 119.912 1.856 . . . . 54.75 112.215 -169.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1062 ' ' SER . . . . . . . . . . . . . 16.8 m -73.91 -40.33 63.22 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 125.972 2.045 . . . . 50.34 108.009 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1063 ' ' VAL . . . . . 0.462 HG11 ' HB2' ' A' 1036 ' ' GLU . 4.1 p -68.88 -25.95 31.46 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 CA-C-N 122.473 2.397 . . . . 41.46 111.415 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1064 ' ' TRP . . . . . 0.402 ' HA ' HD11 ' A' 1069 ' ' ILE . 11.4 m95 -66.21 -29.56 69.84 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-N 115.303 -0.862 . . . . 39.32 112.837 173.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -81.31 79.44 7.94 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 123.423 1.582 . . . . 55.38 107.847 -174.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1066 ' ' SER . . . . . . . . . . . . . 58.7 m -147.63 161.4 41.23 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 120.553 -1.342 . . . . 41.87 108.771 -171.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1067 ' ' GLU . . . . . 0.591 ' HB3' HD12 ' A' 1068 ' ' ILE . 1.5 tp10 -69.62 -44.78 69.98 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 107.009 -1.478 . . . . 53.2 107.009 -176.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1068 ' ' ILE . . . . . 0.84 ' HB ' HG12 ' A' 1003 ' ' ILE . 5.2 mp -120.12 139.44 47.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 103.605 -2.739 . . . . 41.9 103.605 -178.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1069 ' ' ILE . . . . . 0.437 HD13 ' HA ' ' A' 1069 ' ' ILE . 9.7 mm -119.23 126.9 75.76 Favored 'Isoleucine or valine' 0 C--O 1.248 0.989 0 N-CA-C 105.292 -2.114 . . . . 38.73 105.292 170.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1070 ' ' LEU . . . . . 0.629 HD22 HD22 ' A' 1331 ' ' LEU . 71.4 mt -107.47 87.6 2.54 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-O 122.618 1.199 . . . . 32.44 108.233 173.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1071 ' ' LYS . . . . . . . . . . . . . 3.5 mmmt -87.32 171.67 10.43 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 107.429 -1.322 . . . . 34.65 107.429 166.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1072 ' ' VAL . . . . . 0.579 HG21 ' HB3' ' A' 1015 ' ' ARG . 8.0 t -100.37 -78.05 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 107.043 -1.465 . . . . 31.32 107.043 171.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -101.26 140.25 35.82 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 108.038 -1.097 . . . . 33.94 108.038 -161.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . 27.58 103.03 0.01 OUTLIER Pre-proline 0 C--O 1.247 0.933 0 N-CA-C 119.642 3.201 . . . . 38.04 119.642 171.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1075 ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' 1093 ' ' ILE . 34.8 Cg_exo -76.39 91.04 1.15 Allowed 'Trans proline' 0 CA--C 1.509 -0.77 0 C-N-CA 123.678 2.918 . . . . 42.68 109.541 177.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 65.3 mt -71.36 -179.75 2.59 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 114.425 -1.262 . . . . 46.74 114.043 -171.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.38 -35.6 67.9 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 116.907 2.188 . . . . 58.61 116.907 -173.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 16.4 t70 -67.2 -47.86 69.63 Favored 'General case' 0 C--O 1.26 1.641 0 C-N-CA 124.094 0.957 . . . . 59.2 110.388 173.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1079 ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -53.78 -37.35 63.36 Favored 'General case' 0 C--N 1.363 1.173 0 CA-C-O 117.108 -1.425 . . . . 50.63 110.753 174.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1080 ' ' ILE . . . . . 0.531 ' HA ' HD23 ' A' 1083 ' ' LEU . 55.6 mt -54.4 -47.3 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-N 119.433 1.015 . . . . 51.48 111.05 175.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -64.19 -33.77 76.56 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.54 1.518 . . . . 50.28 109.843 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 34.6 mt -71.82 -27.04 62.64 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 114.044 1.127 . . . . 50.21 114.044 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1083 ' ' LEU . . . . . 0.531 HD23 ' HA ' ' A' 1080 ' ' ILE . 0.4 OUTLIER -55.44 133.15 49.79 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-O 122.656 1.217 . . . . 49.06 112.205 174.428 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.02 125.96 62.65 Favored Pre-proline 0 N--CA 1.472 0.627 0 N-CA-C 101.431 -3.544 . . . . 51.08 101.431 177.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.87 63.92 0.03 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 124.165 3.243 . . . . 49.73 119.729 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1086 ' ' GLY . . . . . 0.537 ' H ' HG12 ' A' 1110 ' ' VAL . . . 173.44 -33.68 0.11 Allowed Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.111 -1.195 . . . . 47.71 110.111 -168.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1087 ' ' THR . . . . . . . . . . . . . 98.0 m -44.78 130.13 7.12 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 117.42 2.378 . . . . 45.47 117.42 -175.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1088 ' ' THR . . . . . . . . . . . . . 1.4 m -75.53 93.82 3.06 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 113.427 -1.715 . . . . 42.04 108.956 170.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1089 ' ' LEU . . . . . 0.483 HD22 HD21 ' A' 1083 ' ' LEU . 54.8 tp -90.67 92.83 9.0 Favored 'General case' 0 C--N 1.348 0.535 0 O-C-N 121.074 -1.016 . . . . 38.06 108.398 -178.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 89.1 t -99.65 99.03 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 102.559 -3.126 . . . . 37.4 102.559 -172.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1091 ' ' SER . . . . . . . . . . . . . 49.5 m -152.55 166.31 32.44 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 115.51 1.67 . . . . 36.16 115.51 -174.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1092 ' ' PHE . . . . . 0.417 ' HE1' ' HB1' ' A' 1129 ' ' ALA . 2.6 m-85 -66.42 88.28 0.13 Allowed 'General case' 0 C--O 1.253 1.274 0 O-C-N 118.118 -2.864 . . . . 38.94 109.822 161.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1093 ' ' ILE . . . . . 0.478 HG12 ' HA ' ' A' 1114 ' ' ALA . 26.2 mm -81.22 -32.43 12.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 122.935 1.35 . . . . 42.17 110.981 -173.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1094 ' ' TRP . . . . . 0.431 ' HH2' HD21 ' A' 1257 ' ' LEU . 77.8 m95 60.5 48.53 1.71 Allowed Pre-proline 0 C--O 1.243 0.717 0 C-N-CA 125.306 1.442 . . . . 46.51 111.108 -170.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1095 ' ' PRO . . . . . 0.441 ' HD3' ' HB ' ' A' 1093 ' ' ILE . 92.2 Cg_endo -54.68 -44.62 47.91 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 124.691 3.594 . . . . 49.76 116.468 -169.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1096 ' ' ALA . . . . . 0.589 ' HB3' ' NE2' ' A' 1097 ' ' GLN . . . -67.41 -33.98 76.29 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 122.529 1.157 . . . . 52.62 110.724 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1097 ' ' GLN . . . . . 0.589 ' NE2' ' HB3' ' A' 1096 ' ' ALA . 7.8 mp0 -85.2 -5.39 59.33 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 114.67 -1.15 . . . . 60.74 110.657 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1098 ' ' ASN . . . . . 0.515 ' HB3' ' HB3' ' A' 1101 ' ' LEU . 71.7 m-20 -130.94 64.17 72.83 Favored Pre-proline 0 N--CA 1.439 -0.975 0 N-CA-C 114.082 1.141 . . . . 58.19 114.082 -178.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -61.11 -42.97 32.28 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.759 2.973 . . . . 54.59 114.8 -174.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 52.2 mp0 -70.5 -42.73 70.96 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.541 -0.911 . . . . 63.28 108.541 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1101 ' ' LEU . . . . . 0.515 ' HB3' ' HB3' ' A' 1098 ' ' ASN . 5.7 tp -57.39 -41.14 79.67 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.859 0.864 . . . . 54.75 109.309 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1102 ' ' MET . . . . . . . . . . . . . 43.1 mmm -54.93 -48.37 73.22 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 120.599 -1.313 . . . . 52.65 112.46 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -61.25 -41.11 96.35 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 124.305 1.042 . . . . 66.26 110.479 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -74.23 -34.1 63.57 Favored 'General case' 0 C--O 1.247 0.946 0 O-C-N 121.373 -0.829 . . . . 63.73 110.947 -177.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 79.3 mt -68.51 -35.13 77.06 Favored 'General case' 0 C--O 1.253 1.281 0 CA-C-O 121.218 0.532 . . . . 54.68 109.826 174.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -66.83 -40.37 87.97 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.59 0.709 . . . . 53.64 112.089 172.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -54.91 -33.13 61.76 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.607 2.363 . . . . 67.24 113.981 168.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1108 ' ' ARG . . . . . 0.4 ' O ' HG13 ' A' 1110 ' ' VAL . 0.1 OUTLIER -78.43 10.49 3.08 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 116.121 -1.895 . . . . 65.76 115.343 172.141 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 20.1 t30 53.65 21.17 2.47 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 123.136 2.698 . . . . 58.71 114.602 173.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1110 ' ' VAL . . . . . 0.688 HG23 HG23 ' A' 1112 ' ' VAL . 17.9 m -90.67 175.08 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 O-C-N 118.412 -2.68 . . . . 46.63 114.422 -173.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1111 ' ' THR . . . . . . . . . . . . . 22.0 m -112.91 90.84 3.45 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 106.788 -1.56 . . . . 44.13 106.788 174.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1112 ' ' VAL . . . . . 0.688 HG23 HG23 ' A' 1110 ' ' VAL . 53.0 t -92.14 109.98 22.15 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 CA-C-N 114.653 -1.158 . . . . 40.44 110.446 -173.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1113 ' ' MET . . . . . 0.507 ' HB3' HG12 ' A' 1358 ' ' VAL . 64.6 mtp -102.93 115.52 30.76 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 112.326 -2.216 . . . . 50.76 110.489 178.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1114 ' ' ALA . . . . . 0.478 ' HA ' HG12 ' A' 1093 ' ' ILE . . . -94.44 94.08 8.03 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-N 114.435 -1.257 . . . . 35.64 109.511 -169.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1115 ' ' MET . . . . . 0.541 ' SD ' HD22 ' A' 1334 ' ' LEU . 83.8 mmm -57.7 -34.49 69.5 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 114.951 1.463 . . . . 38.74 114.951 -178.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1116 ' ' ASP . . . . . 0.424 ' OD2' ' HD2' ' A' 1095 ' ' PRO . 9.4 p-10 -61.04 -38.69 87.04 Favored 'General case' 0 C--O 1.219 -0.525 0 O-C-N 121.694 -0.629 . . . . 40.14 110.533 174.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1117 ' ' SER . . . . . . . . . . . . . 47.9 m -94.68 27.88 2.87 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 115.058 1.503 . . . . 44.79 115.058 -176.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1118 ' ' VAL . . . . . . . . . . . . . 10.3 m -53.96 140.93 50.25 Favored Pre-proline 0 N--CA 1.436 -1.166 0 CA-C-O 117.49 -1.243 . . . . 43.75 112.072 168.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -66.2 125.71 14.51 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.373 2.716 . . . . 48.93 109.684 168.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 34.1 mmm-85 -78.81 20.31 0.47 Allowed 'General case' 0 C--O 1.249 1.041 0 N-CA-C 117.082 2.253 . . . . 62.9 117.082 -160.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 38.9 pt -72.86 167.99 2.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 114.538 1.31 . . . . 57.72 114.538 -167.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1122 ' ' SER . . . . . . . . . . . . . 6.7 m -59.73 -40.35 87.76 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-O 118.066 -0.968 . . . . 57.26 111.435 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -56.45 -36.23 68.79 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 121.443 1.929 . . . . 62.9 108.762 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -73.75 -24.34 59.86 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-O 116.114 -1.898 . . . . 49.83 115.68 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1125 ' ' GLN . . . . . . . . . . . . 0.28 73.4 mm-40 -46.8 -21.96 0.26 Allowed 'General case' 0 N--CA 1.474 0.754 1 N-CA-C 122.352 4.205 . . . . 52.37 122.352 -169.238 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A 1126 ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' B' 1160 ' ' ALA . 11.9 p -85.07 -35.66 21.7 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 119.199 -2.188 . . . . 42.43 109.971 172.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1127 ' ' LEU . . . . . 0.663 HD21 HD22 ' A' 1337 ' ' LEU . 4.6 mp -84.78 -18.79 33.92 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.354 1.862 . . . . 43.74 112.394 176.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 53.8 t0 -70.97 92.92 0.95 Allowed 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 125.423 2.535 . . . . 43.21 110.645 -173.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1129 ' ' ALA . . . . . 0.417 ' HB1' ' HE1' ' A' 1092 ' ' PHE . . . -61.02 -40.98 95.67 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 110.024 -3.262 . . . . 35.74 111.273 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.95 -28.63 68.44 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 119.043 -2.286 . . . . 38.09 108.737 -176.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1131 ' ' SER . . . . . . . . . . . . . 75.0 m -67.71 -55.47 13.05 Favored 'General case' 0 CA--C 1.501 -0.935 0 O-C-N 119.487 -2.008 . . . . 36.91 113.634 172.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1132 ' ' SER . . . . . 0.477 ' HB3' ' HB3' ' A' 1326 ' ' LEU . 4.1 m -61.99 -43.85 97.97 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 119.159 0.89 . . . . 35.79 113.203 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1133 ' ' MET . . . . . 0.422 ' HA ' HD12 ' A' 1136 ' ' ILE . 13.9 mmm -59.58 -41.56 90.5 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 121.005 1.73 . . . . 30.81 109.897 176.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1134 ' ' ALA . . . . . 0.652 ' HB1' ' HB2' ' A' 1176 ' ' ALA . . . -63.45 -45.03 92.74 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 123.636 0.775 . . . . 28.88 109.157 175.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1135 ' ' ASN . . . . . 0.646 ' HB2' HG12 ' A' 1175 ' ' VAL . 16.3 t-20 -59.5 -46.25 89.37 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.532 0.682 . . . . 40.76 112.237 -177.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1136 ' ' ILE . . . . . 0.682 HD13 ' HA ' ' A' 1323 ' ' SER . 68.6 mt -55.9 -50.3 69.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 125.038 1.335 . . . . 31.54 109.4 173.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1137 ' ' ALA . . . . . 0.423 ' HB2' ' HG3' ' A' 1316 ' ' PRO . . . -62.55 -32.1 73.01 Favored 'General case' 0 C--N 1.344 0.352 0 N-CA-C 114.193 1.183 . . . . 29.87 114.193 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -70.53 -44.02 59.33 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 118.914 0.779 . . . . 28.73 112.412 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 20.1 t80 -66.76 -48.5 68.89 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 107.321 -1.363 . . . . 30.39 107.321 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1140 ' ' ARG . . . . . 0.548 ' HE ' ' HG2' ' A' 1144 ' ' GLU . 6.0 tpt180 -65.19 -26.22 68.05 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 113.577 0.954 . . . . 26.09 113.577 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1141 ' ' ALA . . . . . 0.69 ' HB2' HD21 ' A' 1284 ' ' LEU . . . -58.84 -53.5 57.68 Favored 'General case' 0 C--N 1.359 1.0 0 CA-C-O 118.521 -0.752 . . . . 27.1 109.914 167.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 32.8 mm -51.8 -43.58 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 O-C-N 124.238 0.961 . . . . 28.48 112.219 172.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 76.2 t -58.98 -62.02 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-N 119.655 1.116 . . . . 23.07 112.687 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1144 ' ' GLU . . . . . 0.548 ' HG2' ' HE ' ' A' 1140 ' ' ARG . 5.6 mm-40 -64.73 -29.1 70.07 Favored 'General case' 0 C--N 1.343 0.296 0 O-C-N 120.703 -1.248 . . . . 33.4 111.551 -177.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1145 ' ' ALA . . . . . 0.591 ' HA ' HG11 ' A' 1280 ' ' VAL . . . -54.61 -63.95 0.99 Allowed 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 117.784 -1.103 . . . . 24.22 112.601 165.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -54.35 -23.17 14.35 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 122.881 1.324 . . . . 24.89 113.908 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -66.63 -69.03 0.33 Allowed 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 120.272 -1.518 . . . . 26.73 110.13 169.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1148 ' ' GLU . . . . . 0.721 ' HB2' HD11 ' A' 1310 ' ' ILE . 68.5 mm-40 -73.72 -9.46 58.68 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 116.684 2.105 . . . . 39.96 116.684 -176.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1149 ' ' PHE . . . . . 0.471 ' HB2' ' O ' ' A' 1145 ' ' ALA . 1.2 t80 -59.99 146.18 43.53 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 123.272 1.511 . . . . 25.87 111.678 176.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1150 ' ' GLY . . . . . . . . . . . . . . . -80.63 -38.92 15.42 Favored Glycine 0 N--CA 1.429 -1.816 0 CA-C-N 113.374 -1.739 . . . . 19.28 109.617 173.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1151 ' ' ARG . . . . . 0.92 ' HA ' ' HB2' ' B' 1322 ' ' GLN . 66.6 mtm-85 -113.84 -170.83 1.78 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 121.157 2.479 . . . . 39.9 114.774 -163.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1152 ' ' PHE . . . . . 0.575 ' CD1' ' HG2' ' B' 1322 ' ' GLN . 2.8 m-85 -83.49 152.97 24.67 Favored 'General case' 0 C--O 1.218 -0.557 0 O-C-N 119.369 -2.082 . . . . 29.44 113.637 165.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1153 ' ' PHE . . . . . 0.419 ' CZ ' HG13 ' A' 1251 ' ' ILE . 10.0 m-85 -70.64 -49.75 44.2 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 113.232 -1.804 . . . . 32.6 107.509 157.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1154 ' ' THR . . . . . 0.507 ' HB ' HE21 ' A' 1156 ' ' GLN . 1.8 m -76.47 115.57 16.34 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 125.236 1.414 . . . . 34.64 113.955 -165.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -69.47 109.06 2.71 Favored Glycine 0 C--O 1.251 1.176 0 N-CA-C 105.838 -2.905 . . . . 37.14 105.838 170.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1156 ' ' GLN . . . . . 0.507 HE21 ' HB ' ' A' 1154 ' ' THR . 11.3 pt20 -158.9 -169.3 2.64 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-N 117.918 0.859 . . . . 40.57 111.99 -174.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1157 ' ' ILE . . . . . 0.708 HD13 ' HB3' ' C' ' 95' ' ' GLU . 1.5 tp -137.02 142.51 37.43 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.201 0 C-N-CA 125.426 1.49 . . . . 44.61 111.298 -171.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1158 ' ' THR . . . . . 0.404 ' HB ' ' H ' ' A' 1159 ' ' ALA . 1.1 p -93.33 -143.07 0.22 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.592 -1.64 . . . . 40.7 109.03 177.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1159 ' ' ALA . . . . . 0.404 ' H ' ' HB ' ' A' 1158 ' ' THR . . . -103.09 -14.3 16.47 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.423 -1.695 . . . . 40.25 106.423 157.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1160 ' ' ALA . . . . . 0.433 ' HB2' ' ND2' ' B' 1330 ' ' ASN . . . -76.09 -58.19 3.43 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 117.198 2.296 . . . . 38.47 117.198 173.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . 175.92 -165.27 35.81 Favored Glycine 0 CA--C 1.505 -0.556 0 CA-C-O 124.58 2.211 . . . . 37.61 111.128 -170.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 8.8 tttp -64.29 130.55 44.29 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 111.823 -2.188 . . . . 48.9 111.327 -171.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1163 ' ' VAL . . . . . 0.608 HG22 HD21 ' B' 1326 ' ' LEU . 10.1 t -100.93 114.69 65.82 Favored Pre-proline 0 N--CA 1.426 -1.661 0 CA-C-N 110.589 -3.005 . . . . 36.52 104.401 165.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1164 ' ' PRO . . . . . 0.46 ' HD2' HE22 ' B' 1322 ' ' GLN . 74.9 Cg_endo -73.05 137.05 25.81 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 124.938 3.759 . . . . 35.08 116.827 -176.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1165 ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.01 138.69 28.71 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 124.003 3.135 . . . . 35.33 116.312 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -79.63 141.96 36.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.212 -1.358 . . . . 34.69 112.415 174.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1167 ' ' LYS . . . . . 0.552 ' HB2' ' HA ' ' A' 1249 ' ' VAL . 44.1 mttp -100.69 115.14 29.55 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 113.099 -1.864 . . . . 45.36 107.298 172.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 49.9 t -100.38 91.38 2.15 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 CA-C-N 113.745 -1.571 . . . . 31.71 108.825 -174.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1169 ' ' MET . . . . . 0.426 ' HA ' ' O ' ' A' 1192 ' ' ARG . 35.3 ttp -76.85 92.67 3.64 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 123.749 1.737 . . . . 42.28 111.981 175.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 42.9 t -81.0 110.58 16.64 Favored 'Isoleucine or valine' 0 C--O 1.246 0.919 0 O-C-N 121.104 -0.997 . . . . 30.51 110.067 174.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 66.7 mt -88.84 119.63 36.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.194 -1.039 . . . . 31.87 108.194 176.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 87.13 87.23 1.09 Allowed Glycine 0 CA--C 1.537 1.428 0 N-CA-C 106.74 -2.544 . . . . 34.54 106.74 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1173 ' ' ALA . . . . . 0.531 ' HA ' ' HA3' ' A' 1177 ' ' GLY . . . -85.05 57.3 4.37 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 120.45 2.125 . . . . 32.51 111.612 176.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1174 ' ' GLY . . . . . 0.458 ' HA2' HH22 ' A' 1197 ' ' ARG . . . -73.85 -163.73 9.27 Favored Glycine 0 N--CA 1.448 -0.566 0 O-C-N 120.224 -1.548 . . . . 29.9 109.439 160.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1175 ' ' VAL . . . . . 0.646 HG12 ' HB2' ' A' 1135 ' ' ASN . 3.5 t -62.25 -36.6 75.34 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 O-C-N 121.342 -1.093 . . . . 33.11 111.651 -174.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1176 ' ' ALA . . . . . 0.652 ' HB2' ' HB1' ' A' 1134 ' ' ALA . . . -61.48 -43.12 99.42 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 113.626 -1.625 . . . . 28.1 114.363 170.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1177 ' ' GLY . . . . . 0.531 ' HA3' ' HA ' ' A' 1173 ' ' ALA . . . -63.32 -49.94 66.59 Favored Glycine 0 C--N 1.312 -0.752 0 N-CA-C 110.322 -1.111 . . . . 28.54 110.322 176.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1178 ' ' LEU . . . . . 0.58 ' HB3' ' SD ' ' A' 1207 ' ' MET . 70.3 mt -53.56 -51.6 62.4 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 117.693 0.747 . . . . 31.22 112.387 177.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -51.21 -46.34 62.19 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.624 0.972 . . . . 28.98 113.624 175.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -60.13 -41.1 91.96 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 116.664 2.098 . . . . 27.83 116.664 174.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1181 ' ' ILE . . . . . 0.471 HD12 ' HA ' ' A' 1178 ' ' LEU . 55.8 mt -64.8 -50.47 75.19 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 O-C-N 121.252 -0.905 . . . . 30.25 109.678 174.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -50.36 -54.77 18.79 Favored Glycine 0 C--O 1.241 0.579 0 O-C-N 120.54 -1.35 . . . . 29.59 110.289 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -59.88 -48.0 83.46 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 116.243 1.942 . . . . 30.29 116.243 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1184 ' ' ALA . . . . . 0.485 ' HB1' ' HB3' ' A' 1189 ' ' ALA . . . -68.77 -43.94 74.73 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.478 -1.389 . . . . 30.47 112.537 178.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -60.18 -43.68 95.67 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 118.482 0.583 . . . . 42.41 110.906 176.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1186 ' ' SER . . . . . 0.557 ' O ' ' HB3' ' B' 1186 ' ' SER . 72.4 m -48.65 -40.44 27.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.719 1.007 . . . . 39.38 113.719 164.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 27.2 mt -91.02 24.83 2.65 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 115.154 1.538 . . . . 36.18 115.154 173.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 69.38 8.9 60.19 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 115.535 0.974 . . . . 33.78 115.535 171.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1189 ' ' ALA . . . . . 0.485 ' HB3' ' HB1' ' A' 1184 ' ' ALA . . . -79.24 145.14 33.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 118.464 1.132 . . . . 33.93 111.63 -177.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 9.5 mt -77.26 88.48 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 105.459 -2.052 . . . . 38.74 105.459 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 14.0 t -76.21 125.59 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 106.828 -1.545 . . . . 33.09 106.828 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1192 ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' 1169 ' ' MET . 94.0 mtt180 -114.39 99.75 7.81 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 105.045 -2.206 . . . . 38.92 105.045 170.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1193 ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' A' 1211 ' ' PHE . . . -92.91 144.35 25.35 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 119.58 -1.95 . . . . 35.32 111.126 177.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1194 ' ' PHE . . . . . 0.646 ' HB2' HD12 ' A' 1212 ' ' LEU . 37.6 t80 -128.76 157.05 42.5 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 106.904 -1.517 . . . . 39.35 106.904 171.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1195 ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' 1173 ' ' ALA . 8.0 t0 -163.1 148.09 11.49 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 105.983 -1.858 . . . . 40.46 105.983 168.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1196 ' ' THR . . . . . . . . . . . . . 1.1 p -77.38 -12.52 59.96 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 114.837 -1.074 . . . . 45.94 112.359 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1197 ' ' ARG . . . . . 0.458 HH22 ' HA2' ' A' 1174 ' ' GLY . 74.4 mtm180 -94.06 115.74 65.56 Favored Pre-proline 0 N--CA 1.471 0.619 0 N-CA-C 106.146 -1.798 . . . . 56.02 106.146 172.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1198 ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -66.3 -14.71 45.38 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.305 2.003 . . . . 51.27 114.473 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -51.72 -54.41 28.7 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 122.328 1.061 . . . . 59.1 112.342 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 26.8 m -71.95 -2.91 3.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 115.402 1.63 . . . . 51.06 115.402 -169.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 83.5 tttt -55.36 -36.08 65.94 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 119.758 -1.839 . . . . 57.38 113.074 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -71.38 -37.73 71.58 Favored 'General case' 0 C--O 1.247 0.922 0 CA-C-N 118.552 0.614 . . . . 62.41 110.657 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -62.84 -37.79 88.2 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 120.739 -1.226 . . . . 57.78 112.719 171.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1204 ' ' VAL . . . . . 0.675 HG13 ' HB3' ' A' 1209 ' ' ALA . 25.4 t -58.49 -47.48 88.15 Favored 'Isoleucine or valine' 0 C--N 1.343 0.297 0 O-C-N 124.006 0.816 . . . . 46.38 111.432 173.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -54.09 -54.08 44.36 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.261 1.024 . . . . 50.7 113.349 171.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1206 ' ' SER . . . . . . . . . . . . . 6.4 m -62.32 -42.85 99.72 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 113.323 0.86 . . . . 49.98 113.323 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1207 ' ' MET . . . . . 0.58 ' SD ' ' HB3' ' A' 1178 ' ' LEU . 29.0 mtp -77.49 -13.31 59.95 Favored 'General case' 0 C--O 1.242 0.692 0 O-C-N 117.635 -3.166 . . . . 52.99 114.107 176.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 97.7 59.64 0.96 Allowed Glycine 0 N--CA 1.429 -1.802 0 O-C-N 121.427 -0.795 . . . . 47.66 111.151 166.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1209 ' ' ALA . . . . . 0.675 ' HB3' HG13 ' A' 1204 ' ' VAL . . . -134.26 151.22 51.17 Favored 'General case' 0 N--CA 1.457 -0.087 0 O-C-N 120.126 -1.808 . . . . 44.77 110.709 167.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1210 ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' 1192 ' ' ARG . 56.3 tt0 -76.15 145.73 39.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.805 -1.089 . . . . 47.64 108.763 165.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1211 ' ' PHE . . . . . 0.582 ' HD1' HG11 ' A' 1204 ' ' VAL . 9.9 t80 -93.97 160.06 14.89 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 106.947 -1.501 . . . . 45.66 106.947 -178.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1212 ' ' LEU . . . . . 0.646 HD12 ' HB2' ' A' 1194 ' ' PHE . 77.7 mt -85.39 106.4 16.73 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 104.613 -2.366 . . . . 46.06 104.613 171.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -73.86 97.59 2.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.314 -0.857 . . . . 60.22 108.793 168.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1214 ' ' LEU . . . . . 0.663 HD11 ' HA ' ' A' 1238 ' ' GLU . 5.8 tp -65.68 101.54 0.64 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.472 -0.785 . . . . 57.25 109.653 -174.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 19.7 t0 -61.08 100.27 0.11 Allowed 'General case' 0 C--O 1.247 0.925 0 O-C-N 124.73 1.268 . . . . 64.43 108.483 175.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 3.8 t80 . . . . . 0 C--O 1.212 -0.91 0 N-CA-C 102.556 -3.127 . . . . 66.9 102.556 179.27 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 2.8 p30 . . . . . 0 N--CA 1.426 -1.659 0 CA-C-O 118.765 -0.636 . . . . 39.09 109.569 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -57.35 -36.88 78.5 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 118.66 0.663 . . . . 39.32 113.565 -170.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 76.8 t80 -74.96 -43.67 52.74 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-O 116.901 -1.523 . . . . 39.3 110.287 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -58.14 -46.35 85.79 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.617 1.099 . . . . 36.3 111.057 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -62.54 -72.09 0.14 Allowed 'General case' 0 C--N 1.346 0.415 0 CA-C-O 117.332 -1.318 . . . . 37.38 110.326 173.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1229 ' ' VAL . . . . . 0.425 ' HA ' ' CD2' ' A' 1234 ' ' PHE . . . -50.18 -42.04 19.47 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 N-CA-C 117.468 2.396 . . . . 39.11 117.468 -172.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1230 ' ' MET . . . . . . . . . . . . . 21.0 mmt -86.23 1.67 49.94 Favored 'General case' 0 C--O 1.25 1.13 0 O-C-N 119.532 -1.98 . . . . 49.59 113.576 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1231 ' ' SER . . . . . . . . . . . . . 22.1 p -76.89 143.38 39.66 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 122.304 2.32 . . . . 43.68 110.52 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -49.08 -47.57 44.92 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.727 1.211 . . . . 55.57 112.961 -174.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -60.18 -34.04 73.05 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 113.333 0.864 . . . . 44.94 113.333 172.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1234 ' ' PHE . . . . . 0.425 ' CD2' ' HA ' ' A' 1229 ' ' VAL . 13.3 t80 -69.27 -49.82 52.57 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 120.46 1.482 . . . . 42.04 108.363 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1235 ' ' ILE . . . . . 0.522 ' O ' ' HG2' ' A' 1239 ' ' MET . 63.4 mt -58.53 -34.6 51.52 Favored 'Isoleucine or valine' 0 C--O 1.249 1.048 0 CA-C-O 118.325 -0.845 . . . . 46.28 110.026 175.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 25.8 tttm -62.43 -44.75 95.69 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 119.743 1.156 . . . . 47.87 108.844 171.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -60.71 -33.77 73.38 Favored 'General case' 0 C--O 1.25 1.104 0 O-C-N 119.406 -2.059 . . . . 41.61 112.755 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1238 ' ' GLU . . . . . 0.663 ' HA ' HD11 ' A' 1214 ' ' LEU . 38.3 mt-10 -56.22 -51.65 67.29 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 113.723 1.008 . . . . 50.65 113.723 168.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1239 ' ' MET . . . . . 0.522 ' HG2' ' O ' ' A' 1235 ' ' ILE . 8.3 mmm -57.55 -47.94 80.66 Favored 'General case' 0 C--O 1.247 0.972 0 C-N-CA 124.745 1.218 . . . . 48.87 112.018 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -58.65 -45.31 89.6 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 118.864 -0.588 . . . . 54.8 112.239 177.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 1.8 mm? -63.07 -39.09 93.68 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 123.672 0.608 . . . . 43.21 112.453 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -70.64 -39.34 73.73 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 125.492 1.745 . . . . 38.66 111.214 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -63.68 -29.49 70.71 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.131 1.772 . . . . 37.92 114.743 174.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -74.22 -66.23 0.75 Allowed 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 113.593 -1.64 . . . . 37.28 110.236 173.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -52.79 -31.48 38.82 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 124.699 1.2 . . . . 43.07 113.619 -177.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1246 ' ' ALA . . . . . 0.424 ' HB1' ' HG2' ' A' 1275 ' ' MET . . . -45.17 -46.2 11.97 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.814 1.246 . . . . 38.3 111.857 175.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1247 ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' 1276 ' ' LYS . 22.4 mtmm -68.77 -18.21 64.16 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 116.682 -1.628 . . . . 47.6 113.736 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -113.29 -30.45 6.92 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 121.322 1.874 . . . . 45.42 114.896 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1249 ' ' VAL . . . . . 0.552 ' HA ' ' HB2' ' A' 1167 ' ' LYS . 29.6 m -78.41 172.35 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 O-C-N 119.954 -1.716 . . . . 36.26 113.607 -171.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1250 ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' 1279 ' ' SER . 4.5 m-20 -121.71 -64.48 1.21 Allowed 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 124.018 0.824 . . . . 33.04 111.245 -173.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1251 ' ' ILE . . . . . 0.484 HD12 ' HB1' ' A' 1145 ' ' ALA . 32.3 mm -102.73 123.21 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 N-CA-C 105.629 -1.989 . . . . 31.4 105.629 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1252 ' ' ILE . . . . . . . . . . . . . 68.3 mt -105.85 136.41 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 O-C-N 124.764 1.29 . . . . 29.42 107.83 165.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 65.3 t -119.23 108.69 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.008 0 N-CA-C 104.265 -2.495 . . . . 30.37 104.265 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1254 ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.53 95.82 7.56 Favored 'General case' 0 C--O 1.246 0.89 0 CA-C-N 121.828 2.103 . . . . 35.72 113.188 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1255 ' ' THR . . . . . 0.535 HG22 HD12 ' A' 1284 ' ' LEU . 36.6 p -72.23 -24.99 61.47 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 119.068 2.988 . . . . 36.0 119.068 -166.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1256 ' ' ALA . . . . . . . . . . . . . . . -70.89 74.81 0.62 Allowed 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 117.571 2.434 . . . . 40.93 117.571 -151.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1257 ' ' LEU . . . . . 0.431 HD21 ' HH2' ' A' 1094 ' ' TRP . 14.0 tp -71.0 81.34 0.66 Allowed 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.174 -1.417 . . . . 47.82 107.174 167.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 42.6 mm -75.44 134.95 72.71 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 104.503 -2.406 . . . . 52.7 104.503 173.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -64.86 92.93 0.21 Allowed 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 122.131 1.887 . . . . 54.13 114.545 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1260 ' ' GLY . . . . . 0.437 ' HA2' ' HG3' ' A' 1097 ' ' GLN . . . 93.99 -57.51 2.14 Favored Glycine 0 CA--C 1.489 -1.57 0 O-C-N 121.019 -1.051 . . . . 54.62 112.754 166.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1261 ' ' LYS . . . . . 0.431 ' HE3' ' HB2' ' A' 1261 ' ' LYS . 25.1 mtmt -63.86 119.93 59.1 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-O 116.567 -1.682 . . . . 55.74 107.652 174.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -56.98 134.44 64.53 Favored 'Trans proline' 0 CA--C 1.5 -1.201 0 C-N-CA 124.131 3.221 . . . . 51.15 114.808 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -62.15 122.96 76.04 Favored Pre-proline 0 C--O 1.247 0.943 0 O-C-N 124.089 0.868 . . . . 46.06 110.114 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -49.59 133.26 31.87 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 125.282 3.988 . . . . 41.08 117.494 -175.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -68.07 83.36 0.22 Allowed 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.528 -0.916 . . . . 47.42 108.528 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1266 ' ' LEU . . . . . 0.456 ' HA ' ' SD ' ' A' 1239 ' ' MET . 98.0 mt -79.42 -41.55 27.4 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 122.476 1.131 . . . . 39.22 108.473 -177.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 21.7 mt -97.65 91.41 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 N-CA-C 105.013 -2.217 . . . . 42.5 105.013 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1268 ' ' THR . . . . . 0.601 ' HA ' ' HG3' ' A' 1293 ' ' GLU . 39.6 p -71.16 153.84 42.18 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.589 -1.187 . . . . 37.84 111.233 176.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1269 ' ' ARG . . . . . 0.549 ' HG3' ' HB2' ' A' 1293 ' ' GLU . 95.5 mtt180 -47.0 -50.67 18.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.354 1.462 . . . . 54.8 111.136 -177.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -42.89 -46.6 5.39 Favored 'General case' 0 C--O 1.249 1.072 0 C-N-CA 124.123 0.969 . . . . 54.36 113.426 172.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1271 ' ' MET . . . . . . . . . . . . . 26.6 mtt -68.83 -41.57 78.38 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 118.522 -0.752 . . . . 39.52 112.213 177.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1272 ' ' VAL . . . . . 0.489 HG21 ' SG ' ' A' 1292 ' ' CYS . 14.0 t -65.95 -44.53 92.37 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 CA-C-O 121.811 0.815 . . . . 38.25 109.648 -177.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -54.66 -44.02 72.91 Favored 'General case' 0 C--O 1.249 1.048 0 C-N-CA 124.466 1.107 . . . . 40.77 111.793 171.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1274 ' ' SER . . . . . . . . . . . . . 76.5 p -86.05 12.3 9.83 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 119.579 -1.951 . . . . 36.58 115.072 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1275 ' ' MET . . . . . 0.442 ' HG3' ' HA ' ' A' 1272 ' ' VAL . 52.5 mtp -70.89 160.92 31.93 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 123.521 1.629 . . . . 36.75 110.751 173.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1276 ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' 1247 ' ' LYS . 36.4 ttpt -68.61 134.84 50.53 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 112.999 -1.909 . . . . 46.11 106.007 166.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1277 ' ' ALA . . . . . . . . . . . . . . . -85.69 -179.73 6.92 Favored 'General case' 0 C--O 1.261 1.677 0 N-CA-C 115.365 1.617 . . . . 33.52 115.365 -176.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 67.99 29.05 73.3 Favored Glycine 0 CA--C 1.538 1.515 0 O-C-N 120.315 -1.491 . . . . 31.27 109.697 -171.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1279 ' ' SER . . . . . 0.525 ' HB3' ' O ' ' A' 1250 ' ' ASP . 16.7 m -131.33 173.21 11.29 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.692 1.746 . . . . 32.95 110.833 -165.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1280 ' ' VAL . . . . . 0.591 HG11 ' HA ' ' A' 1145 ' ' ALA . 98.5 t -140.77 144.63 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 O-C-N 118.623 -2.548 . . . . 27.43 104.783 -169.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1281 ' ' ILE . . . . . . . . . . . . . 59.9 mt -119.08 107.18 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.646 0 N-CA-C 101.813 -3.402 . . . . 30.3 101.813 164.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -92.36 104.2 15.39 Favored 'Isoleucine or valine' 0 C--O 1.25 1.102 0 N-CA-C 107.019 -1.474 . . . . 28.63 107.019 171.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 7.1 t70 -96.03 115.38 27.34 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 111.472 -2.604 . . . . 36.27 109.396 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1284 ' ' LEU . . . . . 0.69 HD21 ' HB2' ' A' 1141 ' ' ALA . 90.9 mt -87.2 -29.19 21.91 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 112.237 -2.256 . . . . 38.57 111.194 -173.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -62.51 -41.67 98.99 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 114.711 -1.132 . . . . 37.56 111.293 176.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . 22.84 -75.97 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 120.158 3.392 . . . . 40.33 120.158 174.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -59.92 -42.73 94.57 Favored 'General case' 0 C--O 1.212 -0.875 0 CA-C-O 121.538 0.685 . . . . 56.85 111.44 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 29.9 t30 -85.34 65.29 9.12 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.094 -1.412 . . . . 45.86 108.633 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 84.34 -57.61 5.02 Favored Glycine 0 C--O 1.246 0.858 0 O-C-N 120.63 -1.294 . . . . 40.31 113.682 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 84.51 128.62 1.75 Allowed Glycine 0 CA--C 1.538 1.515 0 N-CA-C 108.531 -1.828 . . . . 38.89 108.531 -171.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1291 ' ' ASN . . . . . . . . . . . . . 33.8 m120 -74.9 -21.6 59.12 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.743 1.771 . . . . 37.23 111.545 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1292 ' ' CYS . . . . . 0.489 ' SG ' HG21 ' A' 1272 ' ' VAL . 18.0 t -96.79 148.24 23.11 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.417 -1.427 . . . . 36.5 107.851 175.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1293 ' ' GLU . . . . . 0.601 ' HG3' ' HA ' ' A' 1268 ' ' THR . 27.7 mt-10 -75.13 -39.98 60.12 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 120.556 -1.34 . . . . 43.32 111.94 177.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -65.11 -5.88 7.69 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 115.291 1.589 . . . . 41.32 115.291 174.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1295 ' ' THR . . . . . 0.417 ' OG1' ' HB3' ' A' 1292 ' ' CYS . 86.5 m -58.48 115.18 2.84 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 119.262 0.937 . . . . 35.3 110.514 174.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 35.4 t -96.77 114.28 64.27 Favored Pre-proline 0 C--N 1.313 -1.004 0 N-CA-C 102.126 -3.287 . . . . 34.84 102.126 169.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -54.34 118.01 4.56 Favored 'Trans proline' 0 CA--C 1.537 0.669 1 C-N-CA 125.787 4.324 . . . . 33.51 111.757 176.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 99.19 -16.06 59.65 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 113.144 -1.844 . . . . 32.19 113.063 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -135.61 162.91 31.38 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 125.009 2.338 . . . . 34.88 115.541 -167.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1300 ' ' ILE . . . . . 0.799 HG12 HG12 ' A' 1310 ' ' ILE . 50.1 mt -75.58 140.59 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 CA-C-N 112.635 -2.075 . . . . 32.29 110.539 167.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 54.5 t80 -129.38 120.02 24.86 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 120.113 1.324 . . . . 37.25 108.194 159.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1302 ' ' THR . . . . . . . . . . . . . 34.8 m -79.14 125.05 28.92 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 104.198 -2.519 . . . . 35.56 104.198 172.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1303 ' ' THR . . . . . . . . . . . . . 76.3 p -85.45 -179.63 6.97 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 113.991 1.108 . . . . 36.4 113.991 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -67.84 -34.36 76.56 Favored 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 120.131 -1.606 . . . . 52.32 112.33 -170.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -74.99 -41.85 58.69 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.09 -1.414 . . . . 40.04 111.001 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 118.38 57.72 0.28 Allowed Glycine 0 N--CA 1.448 -0.512 0 O-C-N 119.901 -1.749 . . . . 36.96 109.207 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1307 ' ' VAL . . . . . . . . . . . . . 73.5 t -124.32 121.12 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.898 0 N-CA-C 101.336 -3.579 . . . . 33.4 101.336 174.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1308 ' ' LYS . . . . . 0.431 ' HB2' HG22 ' A' 1280 ' ' VAL . 20.8 mmtp -81.81 95.68 7.37 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 113.4 -1.727 . . . . 42.91 108.507 -178.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 44.0 t -85.83 93.44 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 O-C-N 121.125 -0.984 . . . . 32.29 108.618 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1310 ' ' ILE . . . . . 0.799 HG12 HG12 ' A' 1300 ' ' ILE . 61.0 mt -89.52 95.33 5.36 Favored 'Isoleucine or valine' 0 C--O 1.256 1.419 0 N-CA-C 105.378 -2.082 . . . . 30.99 105.378 -174.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1311 ' ' GLY . . . . . 0.417 ' HA3' HG23 ' A' 1295 ' ' THR . . . -91.37 56.75 3.15 Favored Glycine 0 N--CA 1.431 -1.641 0 N-CA-C 110.877 -0.889 . . . . 28.95 110.877 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1312 ' ' TYR . . . . . 0.613 ' HB2' ' HG ' ' A' 1315 ' ' LEU . 9.1 m-30 -78.66 113.54 16.81 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 120.602 2.201 . . . . 31.69 116.808 -170.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1313 ' ' THR . . . . . . . . . . . . . 4.6 p -71.8 -40.38 69.23 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 125.889 2.757 . . . . 34.17 109.841 -177.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -69.81 -0.88 7.91 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 110.072 -3.24 . . . . 36.86 115.802 176.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1315 ' ' LEU . . . . . 0.613 ' HG ' ' HB2' ' A' 1312 ' ' TYR 0.342 42.0 mt -40.65 -45.9 5.9 Favored Pre-proline 0 N--CA 1.487 1.404 0 N-CA-C 121.241 3.793 . . . . 34.85 121.241 178.512 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 1316 ' ' PRO . . . . . 0.509 ' HB2' ' HD3' ' A' 1015 ' ' ARG . 46.1 Cg_exo -56.55 -47.26 24.71 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.916 2.411 . . . . 29.15 110.529 168.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1317 ' ' GLY . . . . . 0.612 ' HA2' ' HG3' ' A' 1015 ' ' ARG . . . -61.18 -44.81 97.65 Favored Glycine 0 CA--C 1.483 -1.936 0 CA-C-O 118.545 -1.142 . . . . 27.29 111.578 -177.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1318 ' ' ARG . . . . . 0.447 ' HB3' ' NH2' ' A' 1140 ' ' ARG . 59.2 mtt-85 -60.21 -15.72 26.96 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 114.204 1.187 . . . . 41.49 114.204 174.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1319 ' ' LEU . . . . . 0.525 HD22 ' HB2' ' A' 1140 ' ' ARG . 14.0 tp -110.95 73.2 0.86 Allowed Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-N 123.258 2.754 . . . . 27.61 103.779 166.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1320 ' ' PRO . . . . . 0.615 ' HD2' ' HA2' ' B' 1150 ' ' GLY . 57.4 Cg_endo -59.06 -58.93 0.53 Allowed 'Trans proline' 0 C--O 1.213 -0.769 0 C-N-CA 122.85 2.367 . . . . 25.94 112.567 -159.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1321 ' ' THR . . . . . 0.414 ' H ' ' HG2' ' A' 1320 ' ' PRO . 3.1 m -58.37 -30.37 66.73 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 112.797 -2.001 . . . . 25.01 113.704 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1322 ' ' GLN . . . . . 0.409 HE22 HG13 ' B' 1163 ' ' VAL . 55.0 tp60 -74.23 -39.87 62.79 Favored 'General case' 0 N--CA 1.436 -1.166 0 O-C-N 120.589 -1.32 . . . . 29.39 110.852 176.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1323 ' ' SER . . . . . 0.682 ' HA ' HD13 ' A' 1136 ' ' ILE . 75.0 m -52.7 -53.18 51.1 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 118.912 0.778 . . . . 26.47 109.449 168.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1324 ' ' SER . . . . . 0.577 ' HB2' HG23 ' A' 1019 ' ' THR . 2.3 m -61.0 -26.12 67.37 Favored 'General case' 0 C--O 1.25 1.121 0 N-CA-C 114.335 1.235 . . . . 27.78 114.335 175.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -75.37 -63.15 1.34 Allowed 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 117.739 -3.1 . . . . 37.53 110.228 172.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1326 ' ' LEU . . . . . 0.562 ' HB2' HD11 ' A' 1136 ' ' ILE . 18.2 mt -77.98 -47.86 17.56 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 116.973 -1.489 . . . . 35.71 114.357 -170.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1327 ' ' TYR . . . . . . . . . . . . . 32.1 t80 -59.29 -47.29 85.92 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 105.877 -1.897 . . . . 31.59 105.877 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1328 ' ' GLY . . . . . 0.698 ' HA2' HD12 ' A' 1331 ' ' LEU . . . -40.78 -54.47 3.51 Favored Glycine 0 CA--C 1.544 1.847 0 C-N-CA 124.668 1.127 . . . . 28.0 114.778 167.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1329 ' ' THR . . . . . . . . . . . . . 28.7 m -67.57 -35.09 78.36 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-O 118.106 -0.95 . . . . 32.15 109.449 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1330 ' ' ASN . . . . . . . . . . . . . 29.2 m120 -62.47 -43.86 97.79 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.579 -0.897 . . . . 34.36 108.579 174.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1331 ' ' LEU . . . . . 0.698 HD12 ' HA2' ' A' 1328 ' ' GLY . 13.9 mt -59.96 -50.16 74.84 Favored 'General case' 0 C--O 1.213 -0.85 0 N-CA-C 109.367 -0.605 . . . . 33.37 109.367 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1332 ' ' VAL . . . . . 0.662 HG11 ' HB3' ' A' 1025 ' ' GLN . 44.2 t -57.04 -40.17 71.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 118.787 -0.625 . . . . 35.27 111.181 174.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -68.02 -38.45 82.6 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 114.602 1.334 . . . . 37.66 114.602 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1334 ' ' LEU . . . . . 0.541 HD22 ' SD ' ' A' 1115 ' ' MET . 28.9 tp -60.97 -48.61 81.03 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 106.916 -1.513 . . . . 40.27 106.916 172.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1335 ' ' LEU . . . . . 0.552 ' HA ' ' HB2' ' A' 1338 ' ' LEU . 20.5 mt -71.66 -4.4 27.11 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 114.625 1.343 . . . . 42.5 114.625 175.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1336 ' ' LYS . . . . . 0.515 ' HE3' HG12 ' A' 1332 ' ' VAL . 82.6 mttt -74.76 -44.91 47.22 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 121.81 2.095 . . . . 47.81 111.774 161.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1337 ' ' LEU . . . . . 0.663 HD22 HD21 ' A' 1127 ' ' LEU . 10.4 mp -62.34 -41.02 98.24 Favored 'General case' 0 C--O 1.216 -0.672 0 C-N-CA 118.555 -1.258 . . . . 49.27 113.8 172.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1338 ' ' LEU . . . . . 0.552 ' HB2' ' HA ' ' A' 1335 ' ' LEU . 10.2 mp -70.8 -69.38 0.37 Allowed 'General case' 0 CA--C 1.51 -0.577 0 O-C-N 124.695 1.247 . . . . 50.54 113.054 172.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1339 ' ' CYS . . . . . 0.603 ' SG ' ' HA2' ' A' 1344 ' ' GLY . 51.5 t -69.71 91.95 0.64 Allowed 'General case' 0 CA--C 1.503 -0.835 0 O-C-N 118.396 -2.69 . . . . 53.67 107.571 172.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 72.3 tttt -83.73 -62.56 1.54 Allowed 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.121 -1.4 . . . . 63.38 108.052 -165.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -74.88 -35.89 62.3 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 124.82 1.248 . . . . 70.95 114.057 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1342 ' ' LYS . . . . . 0.428 ' HE2' ' HA ' ' A' 1029 ' ' LEU . 3.2 mtpm? 62.22 83.88 0.15 Allowed 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 125.537 1.535 . . . . 65.25 113.484 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1343 ' ' ASP . . . . . . . . . . . . 0.38 0.0 OUTLIER 79.21 -78.81 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.775 2 O-C-N 112.593 -6.317 . . . . 64.53 120.076 -19.347 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A 1344 ' ' GLY . . . . . 0.603 ' HA2' ' SG ' ' A' 1339 ' ' CYS . . . 104.39 10.73 33.02 Favored Glycine 0 CA--C 1.545 1.94 0 O-C-N 117.536 -3.227 . . . . 59.72 111.379 178.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1345 ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' 1339 ' ' CYS . 19.0 t30 -72.05 131.24 42.61 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 121.932 2.866 . . . . 64.09 112.929 174.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1346 ' ' ILE . . . . . . . . . . . . . 24.7 mt -80.31 79.37 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.83 0 O-C-N 120.018 -1.676 . . . . 58.82 109.063 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1347 ' ' THR . . . . . . . . . . . . . 5.3 m -66.43 85.14 0.1 Allowed 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 119.867 -1.771 . . . . 54.96 112.711 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1348 ' ' VAL . . . . . 0.518 ' HB ' ' NH2' ' A' 1362 ' ' ARG . 40.0 t -76.46 98.45 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.803 0 N-CA-C 102.915 -2.994 . . . . 55.64 102.915 178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 8.8 t70 -87.79 138.14 31.72 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 111.735 -2.484 . . . . 61.45 110.906 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1350 ' ' PHE . . . . . 0.401 ' CE1' ' HD2' ' A' 1362 ' ' ARG . 1.0 OUTLIER -107.22 -12.39 15.38 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 117.443 2.386 . . . . 58.63 117.443 176.692 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -76.69 -48.47 18.83 Favored 'General case' 0 C--O 1.246 0.904 0 O-C-N 124.028 0.83 . . . . 62.06 109.073 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 28.0 t70 -65.76 118.82 10.17 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.651 0.738 . . . . 54.07 112.621 -177.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 13.7 m -40.23 -46.87 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 116.545 2.054 . . . . 50.68 116.545 173.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1354 ' ' VAL . . . . . 0.547 ' O ' HG23 ' A' 1358 ' ' VAL . 3.2 m -77.52 -41.85 29.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 122.426 2.375 . . . . 47.68 109.466 -174.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1355 ' ' ILE . . . . . 0.47 HD11 HD23 ' A' 1337 ' ' LEU . 53.6 mt -64.88 -49.26 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.718 1.207 . . . . 48.49 107.791 -177.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1356 ' ' ARG . . . . . 0.41 ' NH1' ' O ' ' A' 1367 ' ' THR . 31.4 tpt85 -57.17 -40.71 77.86 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.592 0.96 . . . . 48.27 113.592 172.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -67.21 -39.9 92.37 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-O 119.018 -0.879 . . . . 43.53 111.911 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1358 ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' 1354 ' ' VAL . 5.7 t -72.06 -36.35 56.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 CA-C-O 118.554 -0.736 . . . . 45.12 112.045 176.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1359 ' ' THR . . . . . . . . . . . . . 10.6 m -72.21 88.11 1.13 Allowed 'General case' 0 C--O 1.239 0.517 0 CA-C-N 119.346 0.975 . . . . 42.94 110.492 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 27.6 m -85.77 -25.51 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 CA-C-O 121.794 0.807 . . . . 43.26 110.805 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1361 ' ' ILE . . . . . 0.618 ' HB ' ' HB ' ' A' 1112 ' ' VAL . 23.6 mm -126.55 114.71 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 117.705 -3.122 . . . . 45.66 102.994 171.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1362 ' ' ARG . . . . . 0.518 ' NH2' ' HB ' ' A' 1348 ' ' VAL . 32.4 ttt180 -100.93 104.13 15.31 Favored 'General case' 0 CA--C 1.511 -0.548 0 O-C-N 119.128 -2.232 . . . . 61.34 109.687 172.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 54.54 51.34 14.21 Favored 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 114.367 1.247 . . . . 49.76 114.367 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 86.68 -27.38 5.89 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 117.997 1.959 . . . . 50.0 117.997 -175.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -81.71 138.19 35.28 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 120.476 2.138 . . . . 56.92 106.951 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1366 ' ' ILE . . . . . . . . . . . . . 70.1 mt -83.18 100.56 6.89 Favored 'Isoleucine or valine' 0 C--O 1.263 1.811 0 N-CA-C 105.629 -1.989 . . . . 52.78 105.629 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1367 ' ' THR . . . . . 0.41 ' O ' ' NH1' ' A' 1356 ' ' ARG . 10.8 p -94.22 10.92 32.05 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 112.916 -1.947 . . . . 49.44 110.199 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 6.7 t90 -73.32 150.39 89.5 Favored Pre-proline 0 C--O 1.251 1.141 0 N-CA-C 106.479 -1.674 . . . . 52.38 106.479 162.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -68.48 169.58 56.62 Favored 'Cis proline' 0 C--O 1.249 1.057 0 N-CA-C 121.017 3.43 . . . . 46.94 121.017 -0.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1370 ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' 1371 ' ' PRO . . . -86.99 124.89 68.08 Favored Pre-proline 0 CA--C 1.506 -0.728 0 CA-C-O 122.366 1.079 . . . . 45.91 109.404 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1371 ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' 1370 ' ' ALA . 85.3 Cg_exo -70.81 126.84 13.03 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 122.849 2.366 . . . . 46.39 111.974 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -77.31 -57.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 123.538 2.825 . . . . 46.72 108.332 169.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.221 -5.008 0 O-C-N 119.552 -1.968 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 15.4 m80 . . . . . 0 N--CA 1.432 -1.353 0 N-CA-C 104.361 -2.459 . . . . 63.44 104.361 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 999' ' ' HIS . . . . . 0.568 ' HB2' ' HA ' ' B' 1066 ' ' SER . 96.8 m-70 -126.03 56.03 1.44 Allowed 'General case' 0 C--N 1.352 0.698 0 CA-C-N 121.292 1.86 . . . . 51.74 109.792 175.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1000 ' ' HIS . . . . . 0.454 ' HA ' ' HB2' ' B' 1067 ' ' GLU . 20.0 m-70 -71.87 145.71 48.38 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 114.162 -1.381 . . . . 54.07 110.936 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 64.56 5.87 19.58 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 122.435 1.02 . . . . 39.22 112.675 -173.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1002 ' ' ARG . . . . . 0.658 ' HG3' ' HB ' ' B' 1032 ' ' THR . 28.0 ttp180 -104.62 141.41 36.48 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 119.523 -2.163 . . . . 38.12 106.8 -173.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1003 ' ' ILE . . . . . 0.489 HG12 ' HB ' ' B' 1068 ' ' ILE . 87.4 mt -100.79 134.47 40.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 105.827 -1.916 . . . . 29.7 105.827 174.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -94.56 135.13 12.31 Favored Glycine 0 N--CA 1.419 -2.448 0 C-N-CA 119.914 -1.136 . . . . 27.5 111.136 156.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1005 ' ' ILE . . . . . . . . . . . . . 40.6 mm -104.61 104.86 47.76 Favored Pre-proline 0 CA--C 1.553 1.064 0 N-CA-C 102.244 -3.243 . . . . 24.83 102.244 171.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -66.25 157.47 59.84 Favored 'Trans proline' 0 C--N 1.361 1.214 1 C-N-CA 125.818 4.345 . . . . 27.19 114.811 172.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 44.1 ttt180 -86.26 101.78 13.36 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 113.765 -1.561 . . . . 41.46 107.874 173.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1008 ' ' GLU . . . . . 0.423 ' HG3' ' HB ' ' B' 1072 ' ' VAL . 5.4 mm-40 -49.35 134.23 18.89 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 117.342 2.349 . . . . 26.93 117.342 -175.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 32.3 mmm-85 -107.52 -11.32 15.51 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 111.935 -2.393 . . . . 34.48 114.129 -163.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1010 ' ' LEU . . . . . 0.675 ' HB3' ' HB2' ' B' 1013 ' ' GLU . 13.0 tp -63.31 145.5 55.43 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-N 119.796 1.18 . . . . 44.22 112.514 -174.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1011 ' ' THR . . . . . . . . . . . . . 33.1 m -32.95 106.65 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 115.75 1.759 . . . . 40.74 115.75 172.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 53.9 t30 46.25 49.69 12.6 Favored 'General case' 0 C--O 1.254 1.302 0 C-N-CA 125.552 1.541 . . . . 44.44 112.737 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1013 ' ' GLU . . . . . 0.675 ' HB2' ' HB3' ' B' 1010 ' ' LEU . 7.9 tp10 -79.97 133.57 36.19 Favored 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 118.292 -1.363 . . . . 29.87 108.102 177.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1014 ' ' THR . . . . . 0.479 ' HB ' ' O ' ' B' 1317 ' ' GLY . 3.4 m -112.76 -9.01 13.73 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 107.353 -1.351 . . . . 25.26 107.353 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1015 ' ' ARG . . . . . 0.626 ' HG3' ' HA2' ' B' 1317 ' ' GLY . 67.9 mtm180 -77.92 129.42 35.33 Favored 'General case' 0 CA--C 1.503 -0.854 0 O-C-N 120.359 -1.463 . . . . 29.54 110.694 174.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1016 ' ' VAL . . . . . 0.678 HG21 ' HB1' ' B' 1039 ' ' ALA . 5.0 p -97.65 177.64 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 120.388 -1.445 . . . . 23.55 107.452 155.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1017 ' ' ALA . . . . . 0.591 ' H ' HG22 ' B' 1016 ' ' VAL . . . -79.89 -19.37 48.35 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.154 -1.591 . . . . 23.59 113.604 -177.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1018 ' ' ALA . . . . . 0.532 ' HB1' ' HB ' ' B' 1022 ' ' THR . . . -153.43 146.87 24.9 Favored 'General case' 0 N--CA 1.442 -0.825 0 O-C-N 119.908 -1.745 . . . . 24.93 114.143 -167.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1019 ' ' THR . . . . . . . . . . . . . 76.7 p -88.75 172.29 7.79 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 118.594 0.634 . . . . 28.09 112.509 169.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1020 ' ' PRO . . . . . 0.475 ' O ' ' HB ' ' B' 1023 ' ' VAL . 42.7 Cg_exo -55.25 -36.1 92.67 Favored 'Trans proline' 0 C--O 1.249 1.046 0 C-N-CA 122.448 2.098 . . . . 28.79 116.631 165.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 51.4 tttt -54.13 -51.12 65.25 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 119.013 -2.304 . . . . 47.28 113.325 161.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1022 ' ' THR . . . . . 0.532 ' HB ' ' HB1' ' B' 1018 ' ' ALA . 22.8 m -52.77 -38.68 61.38 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 118.471 0.578 . . . . 30.12 109.873 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1023 ' ' VAL . . . . . 0.521 ' HA ' HG21 ' B' 1033 ' ' VAL . 73.5 t -53.41 -53.37 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 O-C-N 121.254 -0.904 . . . . 32.24 109.156 174.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1024 ' ' GLU . . . . . 0.545 ' O ' ' HG3' ' B' 1028 ' ' LYS . 15.1 mt-10 -57.42 -41.94 81.38 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.906 0.86 . . . . 49.62 113.193 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -58.39 -47.77 82.79 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 123.044 1.402 . . . . 44.68 111.735 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 41.5 mt -72.13 -34.37 68.52 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.528 -1.215 . . . . 35.71 110.487 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1027 ' ' LEU . . . . . 0.51 HD23 ' O ' ' B' 1031 ' ' PHE . 50.5 mt -57.64 -40.52 79.41 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 122.927 1.346 . . . . 42.18 110.636 175.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1028 ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' B' 1024 ' ' GLU . 58.2 mttm -58.34 -36.45 73.43 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 115.211 -0.904 . . . . 48.34 111.425 173.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1029 ' ' LEU . . . . . 0.724 HD21 ' HG2' ' B' 1336 ' ' LYS . 20.7 mt -77.33 -1.87 32.07 Favored 'General case' 0 C--O 1.259 1.56 0 N-CA-C 116.414 2.005 . . . . 38.69 116.414 175.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 90.03 25.0 28.04 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 125.877 1.703 . . . . 32.28 111.189 176.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1031 ' ' PHE . . . . . 0.51 ' O ' HD23 ' B' 1027 ' ' LEU . 55.0 m-85 -103.89 127.96 51.39 Favored 'General case' 0 C--O 1.252 1.236 0 N-CA-C 107.78 -1.193 . . . . 35.94 107.78 -177.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1032 ' ' THR . . . . . 0.658 ' HB ' ' HG3' ' B' 1002 ' ' ARG . 11.9 m -72.22 122.2 20.65 Favored 'General case' 0 C--O 1.251 1.166 0 N-CA-C 103.165 -2.902 . . . . 33.37 103.165 167.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1033 ' ' VAL . . . . . 0.521 HG21 ' HA ' ' B' 1023 ' ' VAL . 48.8 t -93.32 134.92 29.48 Favored 'Isoleucine or valine' 0 C--O 1.258 1.508 0 N-CA-C 104.681 -2.34 . . . . 29.98 104.681 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -123.0 140.11 53.38 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 104.063 -2.569 . . . . 28.18 104.063 172.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1035 ' ' VAL . . . . . 0.442 HG21 ' CD2' ' B' 1050 ' ' PHE . 89.3 t -131.5 135.14 59.79 Favored 'Isoleucine or valine' 0 C--O 1.255 1.373 0 N-CA-C 104.29 -2.485 . . . . 25.82 104.29 -170.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1036 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.91 151.23 43.49 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-O 123.123 1.44 . . . . 32.44 109.755 177.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1037 ' ' SER . . . . . . . . . . . . . 47.1 p -65.99 130.09 42.06 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 111.839 -2.437 . . . . 29.54 112.413 177.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 92.96 -15.57 62.5 Favored Glycine 0 CA--C 1.504 -0.645 0 O-C-N 118.366 -2.709 . . . . 27.76 111.62 -177.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1039 ' ' ALA . . . . . 0.678 ' HB1' HG21 ' B' 1016 ' ' VAL . . . -73.52 -33.93 64.99 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-O 122.29 1.043 . . . . 26.02 112.874 -171.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -59.86 -53.78 43.06 Favored Glycine 0 C--O 1.249 1.076 0 N-CA-C 110.477 -1.049 . . . . 26.47 110.477 167.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.07 -26.79 64.93 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 117.154 -1.403 . . . . 50.98 112.154 -177.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 58.3 mt -54.47 -48.84 71.31 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 120.944 1.702 . . . . 29.3 112.091 167.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1043 ' ' ALA . . . . . 0.507 ' HA ' ' HB2' ' B' 1320 ' ' PRO . . . -88.27 36.37 0.78 Allowed 'General case' 0 C--O 1.238 0.486 0 CA-C-O 116.166 -1.873 . . . . 26.74 111.341 -177.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1044 ' ' SER . . . . . . . . . . . . . 18.9 m 47.72 31.3 2.12 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 116.038 1.866 . . . . 31.26 116.038 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1045 ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.77 147.93 48.4 Favored 'General case' 0 C--N 1.36 1.051 0 CA-C-O 122.585 1.183 . . . . 33.26 109.366 177.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 11.3 t0 -71.2 123.75 22.92 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.153 -1.054 . . . . 46.74 108.153 173.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.75 -29.3 64.68 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 124.993 1.317 . . . . 34.44 112.1 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1048 ' ' LYS . . . . . 0.506 ' HA ' HG22 ' B' 1051 ' ' VAL . 0.8 OUTLIER -64.32 -22.45 66.95 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 119.624 -1.923 . . . . 48.67 113.12 172.327 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -64.69 -26.5 68.4 Favored 'General case' 0 C--N 1.365 1.262 0 O-C-N 119.311 -2.118 . . . . 35.26 112.692 169.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1050 ' ' PHE . . . . . 0.442 ' CD2' HG21 ' B' 1035 ' ' VAL . 64.4 m-85 -69.1 -40.38 78.42 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 118.474 -0.774 . . . . 32.17 111.952 168.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1051 ' ' VAL . . . . . 0.506 HG22 ' HA ' ' B' 1048 ' ' LYS . 20.6 m -70.93 -29.25 36.47 Favored 'Isoleucine or valine' 0 C--N 1.347 0.477 0 CA-C-N 120.668 1.576 . . . . 38.37 111.155 175.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -60.18 -48.05 83.36 Favored 'General case' 0 C--O 1.205 -1.257 0 O-C-N 119.013 -2.304 . . . . 45.77 111.405 167.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -64.62 -16.56 62.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 115.29 1.589 . . . . 37.83 115.29 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 99.39 31.53 6.1 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.632 -0.987 . . . . 35.82 110.632 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -110.77 143.45 41.29 Favored 'General case' 0 C--N 1.356 0.858 0 O-C-N 120.859 -1.377 . . . . 33.77 108.448 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -90.81 115.88 28.22 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 120.113 -1.617 . . . . 51.02 109.46 -172.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1057 ' ' ILE . . . . . . . . . . . . . 11.8 mm -76.15 109.59 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 106.494 -1.669 . . . . 38.47 106.494 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 6.5 m -126.03 126.26 69.39 Favored 'Isoleucine or valine' 0 C--O 1.247 0.969 0 CA-C-O 123.613 1.673 . . . . 39.4 111.576 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -86.52 125.49 33.8 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.977 -1.011 . . . . 57.07 111.195 -162.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . 71.31 -124.66 11.24 Favored Glycine 0 CA--C 1.517 0.206 0 O-C-N 125.785 1.928 . . . . 44.83 112.795 167.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 5.8 m120 -57.84 -31.36 66.58 Favored 'General case' 0 CA--C 1.481 -1.709 0 CA-C-N 118.566 1.183 . . . . 46.27 113.946 -175.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1062 ' ' SER . . . . . . . . . . . . . 4.8 m -52.47 -51.17 60.68 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 116.727 -1.606 . . . . 43.47 107.407 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.21 -39.81 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 121.313 1.87 . . . . 36.98 110.59 -177.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 93.2 m95 -60.41 -38.46 84.11 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 117.072 2.249 . . . . 37.9 117.072 174.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1065 ' ' GLN . . . . . 0.417 ' O ' ' NH2' ' B' 1002 ' ' ARG . 6.0 mm-40 -74.0 106.92 5.91 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 122.875 2.58 . . . . 46.19 104.952 172.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1066 ' ' SER . . . . . 0.568 ' HA ' ' HB2' ' B' ' 999' ' ' HIS . 51.1 m -164.76 166.49 19.81 Favored 'General case' 0 C--O 1.25 1.121 0 N-CA-C 109.304 -0.628 . . . . 37.06 109.304 -178.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1067 ' ' GLU . . . . . 0.454 ' HB2' ' HA ' ' B' 1000 ' ' HIS . 1.0 OUTLIER -65.55 -53.36 43.08 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 125.662 1.851 . . . . 43.95 111.993 169.586 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B 1068 ' ' ILE . . . . . 0.489 ' HB ' HG12 ' B' 1003 ' ' ILE . 4.5 mp -120.33 145.47 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 102.907 -2.997 . . . . 33.5 102.907 -173.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 16.8 mm -127.52 117.77 47.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 103.452 -2.796 . . . . 30.57 103.452 170.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1070 ' ' LEU . . . . . 0.741 HD22 HD22 ' B' 1331 ' ' LEU . 96.8 mt -106.42 114.46 28.59 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 103.934 -2.617 . . . . 27.66 103.934 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1071 ' ' LYS . . . . . 0.503 ' HB3' ' OG ' ' B' 1091 ' ' SER . 43.6 tttm -133.99 153.71 51.6 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 106.848 -1.538 . . . . 28.4 106.848 -168.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1072 ' ' VAL . . . . . 0.423 ' HB ' ' HG3' ' B' 1008 ' ' GLU . 61.5 t -85.03 -65.62 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 CA-C-N 119.517 1.053 . . . . 23.18 108.507 -174.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -107.02 165.34 11.42 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 105.865 -1.902 . . . . 25.47 105.865 -168.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -51.58 135.91 33.87 Favored Pre-proline 0 C--O 1.206 -1.22 0 CA-C-N 111.841 -2.436 . . . . 27.9 113.468 -171.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -60.22 123.49 13.26 Favored 'Trans proline' 0 N--CA 1.429 -2.279 0 C-N-CA 123.491 2.794 . . . . 31.62 113.425 171.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 91.6 mt -70.78 161.96 29.98 Favored 'General case' 0 C--O 1.244 0.802 0 O-C-N 125.61 1.818 . . . . 40.49 107.453 174.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1077 ' ' ASP . . . . . 0.471 ' HA ' HD12 ' B' 1080 ' ' ILE . 33.6 t70 -44.79 -42.28 7.68 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 120.072 3.36 . . . . 51.59 120.072 -173.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -68.09 -44.38 76.38 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 113.535 -1.666 . . . . 42.36 112.059 173.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1079 ' ' GLU . . . . . 0.431 ' HA ' HD12 ' B' 1082 ' ' LEU . 36.3 mt-10 -61.63 -35.7 78.66 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.109 -1.071 . . . . 34.53 108.109 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1080 ' ' ILE . . . . . 0.601 HG21 ' HB3' ' B' 1104 ' ' LYS . 76.5 mt -56.42 -50.91 70.15 Favored 'Isoleucine or valine' 0 C--O 1.25 1.082 0 O-C-N 119.936 -1.728 . . . . 33.25 108.524 172.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -63.59 -33.85 76.51 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 119.579 -1.95 . . . . 36.47 112.74 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1082 ' ' LEU . . . . . 0.431 HD12 ' HA ' ' B' 1079 ' ' GLU . 67.5 mt -61.05 -38.43 86.13 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.873 -0.603 . . . . 37.76 112.119 174.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1083 ' ' LEU . . . . . 0.448 ' HB3' HG11 ' B' 1110 ' ' VAL . 14.2 mt -58.66 154.31 14.74 Favored 'General case' 0 C--O 1.261 1.667 0 CA-C-O 123.594 1.664 . . . . 37.43 110.851 172.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1084 ' ' ASN . . . . . 0.407 ' HB2' ' OG1' ' B' 1087 ' ' THR . 3.0 m-80 -124.1 154.73 68.31 Favored Pre-proline 0 C--O 1.237 0.429 0 N-CA-C 106.747 -1.575 . . . . 37.7 106.747 -158.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -50.42 129.87 27.52 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 124.515 3.477 . . . . 35.51 110.667 171.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 93.58 -46.37 2.34 Favored Glycine 0 CA--C 1.542 1.738 0 CA-C-O 117.041 -1.977 . . . . 33.87 113.306 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1087 ' ' THR . . . . . 0.407 ' OG1' ' HB2' ' B' 1084 ' ' ASN . 59.1 m -46.28 118.13 1.82 Allowed 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 114.906 1.446 . . . . 32.5 114.906 -164.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1088 ' ' THR . . . . . . . . . . . . . 54.6 m -69.17 101.27 1.42 Allowed 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 106.782 -1.562 . . . . 30.22 106.782 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1089 ' ' LEU . . . . . 0.443 HD13 HD21 ' B' 1083 ' ' LEU . 13.2 tp -95.6 128.74 42.72 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-O 123.691 1.71 . . . . 27.24 110.245 174.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1090 ' ' VAL . . . . . 0.465 HG13 ' HB2' ' B' 1113 ' ' MET . 19.2 t -123.53 115.59 45.8 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 N-CA-C 105.677 -1.972 . . . . 25.39 105.677 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1091 ' ' SER . . . . . 0.503 ' OG ' ' HB3' ' B' 1071 ' ' LYS . 14.8 m -155.76 165.39 36.65 Favored 'General case' 0 C--N 1.352 0.685 0 O-C-N 120.654 -1.278 . . . . 28.81 110.123 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1092 ' ' PHE . . . . . 0.651 ' HZ ' ' HG3' ' B' 1133 ' ' MET . 88.4 m-85 -64.53 103.86 0.72 Allowed 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 107.119 -1.437 . . . . 30.78 107.119 158.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 26.9 mm -94.79 -37.92 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.221 0 CA-C-N 114.561 -1.2 . . . . 30.28 111.632 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1094 ' ' TRP . . . . . 0.469 ' HB3' ' HB2' ' B' 1097 ' ' GLN . 82.6 m95 60.25 71.83 0.82 Allowed Pre-proline 0 C--O 1.242 0.659 0 N-CA-C 107.057 -1.461 . . . . 34.07 107.057 -178.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -55.95 -58.06 1.24 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 125.24 3.96 . . . . 38.66 115.416 -170.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -66.22 -21.34 66.3 Favored 'General case' 0 CA--C 1.505 -0.762 0 O-C-N 120.627 -1.296 . . . . 41.32 112.321 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1097 ' ' GLN . . . . . 0.469 ' HB2' ' HB3' ' B' 1094 ' ' TRP . 12.6 mp0 -89.07 -20.89 23.77 Favored 'General case' 0 C--O 1.25 1.118 0 N-CA-C 107.23 -1.396 . . . . 51.66 107.23 -176.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1098 ' ' ASN . . . . . 0.416 ' HB3' ' HB3' ' B' 1101 ' ' LEU . 73.6 m-20 -135.57 54.92 11.36 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-N 120.7 1.591 . . . . 40.32 110.387 -176.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1099 ' ' PRO . . . . . 0.452 ' O ' ' HB2' ' B' 1102 ' ' MET . 58.8 Cg_endo -55.51 -49.01 17.45 Favored 'Trans proline' 0 CA--C 1.54 0.819 1 C-N-CA 125.314 4.009 . . . . 41.56 119.478 -175.343 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.85 -40.38 88.4 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.538 0.94 . . . . 54.11 113.538 173.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1101 ' ' LEU . . . . . 0.416 ' HB3' ' HB3' ' B' 1098 ' ' ASN . 9.3 tt -58.51 -49.51 77.13 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 125.194 1.398 . . . . 37.88 107.374 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1102 ' ' MET . . . . . 0.452 ' HB2' ' O ' ' B' 1099 ' ' PRO . 69.7 mmm -49.74 -45.64 49.59 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 113.934 1.087 . . . . 37.54 113.934 165.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -65.26 -44.14 89.08 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 121.288 1.858 . . . . 47.01 110.367 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1104 ' ' LYS . . . . . 0.601 ' HB3' HG21 ' B' 1080 ' ' ILE . 74.1 mttt -60.36 -38.49 84.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 119.423 -2.048 . . . . 48.68 110.652 -178.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1105 ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.04 -41.44 99.5 Favored 'General case' 0 C--O 1.25 1.081 0 CA-C-O 122.888 1.327 . . . . 32.21 113.977 171.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -63.91 -44.59 92.48 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.26 1.824 . . . . 33.73 108.93 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -54.11 -49.33 69.4 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 121.406 -0.809 . . . . 51.47 110.056 170.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1108 ' ' ARG . . . . . 0.589 ' HG2' ' O ' ' B' 1104 ' ' LYS . 13.9 mmm180 -67.86 -16.46 64.1 Favored 'General case' 0 C--O 1.207 -1.179 0 CA-C-N 120.221 1.373 . . . . 43.9 110.92 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1109 ' ' ASN . . . . . . . . . . . . . 4.6 m-80 69.41 28.84 4.62 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 123.73 1.728 . . . . 44.82 113.158 174.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1110 ' ' VAL . . . . . 0.448 HG11 ' HB3' ' B' 1083 ' ' LEU . 17.4 m -72.87 151.19 7.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 CA-C-N 114.179 -1.373 . . . . 30.52 109.45 174.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1111 ' ' THR . . . . . 0.431 ' HA ' ' H ' ' B' 1363 ' ' ALA . 6.4 m -94.77 107.3 19.31 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 106.524 -1.658 . . . . 27.12 106.524 176.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1112 ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' B' 1089 ' ' LEU . 4.0 t -101.29 126.14 55.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 115.237 1.569 . . . . 26.4 115.237 -169.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1113 ' ' MET . . . . . 0.465 ' HB2' HG13 ' B' 1090 ' ' VAL . 0.0 OUTLIER -107.43 127.57 53.71 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 106.08 -1.822 . . . . 42.92 106.08 165.209 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -100.74 105.74 17.09 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 113.362 -1.745 . . . . 24.15 108.044 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1115 ' ' MET . . . . . 0.491 ' HB3' ' HB2' ' B' 1129 ' ' ALA . 56.8 mmm -60.51 -23.33 64.45 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 112.896 -1.956 . . . . 29.95 116.24 -173.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1116 ' ' ASP . . . . . 0.603 ' HB3' ' HD1' ' B' 1092 ' ' PHE . 9.2 p-10 -78.46 -33.3 48.45 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 113.249 -1.796 . . . . 34.53 112.076 176.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1117 ' ' SER . . . . . . . . . . . . . 51.2 m -111.36 48.77 0.92 Allowed 'General case' 0 N--CA 1.435 -1.207 0 O-C-N 120.483 -1.386 . . . . 33.49 109.691 -178.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1118 ' ' VAL . . . . . 0.503 HG21 ' HA ' ' B' 1128 ' ' ASP . 55.3 t -76.73 139.91 67.08 Favored Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 104.81 -2.293 . . . . 34.02 104.81 167.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -50.35 141.06 33.22 Favored 'Trans proline' 0 C--O 1.245 0.871 0 C-N-CA 123.021 2.481 . . . . 38.28 117.395 175.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1120 ' ' ARG . . . . . 0.431 ' NH2' HD12 ' B' 1130 ' ' LEU . 9.7 mmt-85 -74.69 36.35 0.11 Allowed 'General case' 0 C--O 1.242 0.694 0 N-CA-C 116.714 2.116 . . . . 55.05 116.714 177.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1121 ' ' ILE . . . . . 0.411 ' HB ' ' O ' ' C' ' 131' ' ' ALA . 17.3 pt -118.8 142.75 32.29 Favored 'Isoleucine or valine' 0 C--N 1.347 0.466 0 O-C-N 117.702 -3.124 . . . . 42.09 106.695 -176.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1122 ' ' SER . . . . . . . . . . . . . 62.0 m -35.88 -47.96 0.54 Allowed 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 117.91 2.559 . . . . 38.02 117.91 -175.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1123 ' ' ARG . . . . . 0.462 ' HG3' HG21 ' B' 1354 ' ' VAL . 37.9 ptt85 -74.86 -35.92 62.34 Favored 'General case' 0 C--O 1.208 -1.122 0 CA-C-N 123.581 2.9 . . . . 34.29 113.416 177.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1124 ' ' ALA . . . . . 0.598 ' HA ' HD13 ' B' 1127 ' ' LEU . . . -68.51 -26.54 65.5 Favored 'General case' 0 C--O 1.218 -0.57 0 O-C-N 120.314 -1.491 . . . . 32.35 109.823 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1125 ' ' GLN . . . . . 0.406 ' HA ' ' HB3' ' B' 1128 ' ' ASP . 13.1 mm100 -60.01 -15.07 19.52 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 115.42 1.637 . . . . 47.17 115.42 171.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1126 ' ' SER . . . . . . . . . . . . . 97.1 p -77.47 -30.54 53.2 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 114.568 1.321 . . . . 31.71 114.568 170.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1127 ' ' LEU . . . . . 0.598 HD13 ' HA ' ' B' 1124 ' ' ALA . 3.4 mp -83.58 -25.22 31.11 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 112.395 -2.184 . . . . 37.0 109.212 175.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1128 ' ' ASP . . . . . 0.503 ' HA ' HG21 ' B' 1118 ' ' VAL . 33.9 t70 -69.76 118.86 13.14 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 115.421 1.637 . . . . 40.4 115.421 -174.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1129 ' ' ALA . . . . . 0.491 ' HB2' ' HB3' ' B' 1115 ' ' MET . . . -62.93 -46.09 89.43 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 109.851 -3.34 . . . . 26.56 111.095 177.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1130 ' ' LEU . . . . . 0.431 HD12 ' NH2' ' B' 1120 ' ' ARG . 35.2 mt -53.95 -41.83 68.2 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 117.071 -1.442 . . . . 30.89 114.452 -173.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1131 ' ' SER . . . . . . . . . . . . . 16.3 p -62.09 -46.97 86.73 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 124.473 1.108 . . . . 29.84 113.271 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1132 ' ' SER . . . . . 0.654 ' HB3' ' HB3' ' B' 1326 ' ' LEU . 14.6 m -65.13 -46.64 80.11 Favored 'General case' 0 N--CA 1.421 -1.881 0 O-C-N 119.421 -2.049 . . . . 31.91 111.17 174.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1133 ' ' MET . . . . . 0.651 ' HG3' ' HZ ' ' B' 1092 ' ' PHE . 38.8 mmt -59.32 -32.17 69.83 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 120.555 -1.341 . . . . 25.9 114.182 175.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1134 ' ' ALA . . . . . 0.611 ' HB1' ' HB2' ' B' 1176 ' ' ALA . . . -75.07 -35.66 61.82 Favored 'General case' 0 C--O 1.203 -1.369 0 O-C-N 120.393 -1.442 . . . . 26.62 108.542 173.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -61.23 -41.71 97.34 Favored 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 119.092 -2.255 . . . . 36.97 110.527 176.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1136 ' ' ILE . . . . . 0.62 HG21 ' HA ' ' B' 1316 ' ' PRO . 48.5 mm -59.33 -56.7 15.38 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 O-C-N 125.406 1.691 . . . . 32.11 108.47 171.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -55.69 -42.25 74.91 Favored 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 126.128 1.771 . . . . 24.14 114.682 -174.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -64.75 -45.47 92.64 Favored Glycine 0 C--N 1.316 -0.549 0 CA-C-N 122.031 2.196 . . . . 25.13 111.577 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 16.1 t80 -67.14 -43.21 82.94 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 122.683 1.23 . . . . 32.73 108.917 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1140 ' ' ARG . . . . . 0.584 HH11 HD13 ' B' 1319 ' ' LEU . 8.6 tpt180 -68.0 -32.54 73.01 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.709 -0.849 . . . . 26.36 108.709 -175.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1141 ' ' ALA . . . . . . . . . . . . . . . -55.98 -53.9 51.34 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 113.015 0.746 . . . . 24.12 113.015 170.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 36.5 mm -52.38 -45.51 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 124.052 0.941 . . . . 23.37 110.163 174.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 75.5 t -60.05 -62.8 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 117.537 -1.22 . . . . 24.96 114.274 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1144 ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' B' 1147 ' ' HIS . 59.5 mm-40 -61.87 -36.13 80.35 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-N 120.764 1.62 . . . . 32.07 111.138 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1145 ' ' ALA . . . . . 0.741 ' HA ' HG11 ' B' 1280 ' ' VAL . . . -54.28 -49.66 69.07 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 117.476 -1.25 . . . . 24.87 109.987 169.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1146 ' ' ALA . . . . . . . . . . . . . . . -67.26 -27.13 66.95 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 119.105 0.866 . . . . 24.67 110.792 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1147 ' ' HIS . . . . . 0.416 ' CD2' ' HG2' ' B' 1148 ' ' GLU . 51.9 t60 -57.85 -47.04 83.85 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 119.056 -0.497 . . . . 28.58 111.053 169.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1148 ' ' GLU . . . . . 0.416 ' HG2' ' CD2' ' B' 1147 ' ' HIS . 68.3 mm-40 -94.53 -5.09 46.78 Favored 'General case' 0 CA--C 1.501 -0.912 0 O-C-N 120.102 -1.624 . . . . 36.82 113.462 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1149 ' ' PHE . . . . . . . . . . . . . 3.3 t80 -67.73 137.52 55.54 Favored 'General case' 0 C--O 1.254 1.313 0 C-N-CA 124.827 1.251 . . . . 31.97 108.945 -177.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1150 ' ' GLY . . . . . 0.615 ' HA2' ' HD2' ' A' 1320 ' ' PRO . . . -75.31 -19.07 79.81 Favored Glycine 0 N--CA 1.44 -1.081 0 CA-C-O 118.135 -1.37 . . . . 25.49 114.083 174.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1151 ' ' ARG . . . . . . . . . . . . . 71.1 mtm-85 -130.34 177.59 7.22 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 122.811 3.305 . . . . 59.84 114.306 -158.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1152 ' ' PHE . . . . . 0.59 ' HB2' HG11 ' B' 1163 ' ' VAL . 7.1 m-30 -81.36 162.21 23.49 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 123.111 1.434 . . . . 34.45 109.238 170.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1153 ' ' PHE . . . . . 0.484 ' HB3' ' HB2' ' B' 1189 ' ' ALA . 77.4 m-85 -82.14 -50.15 9.36 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 112.949 -1.932 . . . . 31.17 108.834 165.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1154 ' ' THR . . . . . . . . . . . . . 3.5 m -77.19 126.68 31.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 112.273 -2.239 . . . . 33.89 108.666 -168.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -81.37 65.91 3.91 Favored Glycine 0 N--CA 1.433 -1.535 0 N-CA-C 110.132 -1.187 . . . . 38.95 110.132 -176.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -67.05 146.99 53.74 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.587 1.955 . . . . 54.23 115.786 -170.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 12.7 mm -90.87 125.89 43.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 102.012 -3.329 . . . . 51.16 102.012 173.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1158 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.75 138.08 51.91 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 102.327 -3.212 . . . . 49.61 102.327 172.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -58.65 -29.2 66.38 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.744 1.156 . . . . 49.05 110.817 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1160 ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' 1126 ' ' SER . . . -55.0 -58.92 5.67 Favored 'General case' 0 C--N 1.363 1.171 0 N-CA-C 112.993 0.738 . . . . 47.65 112.993 165.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . -171.52 143.27 7.47 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 107.766 -2.133 . . . . 45.61 107.766 -165.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 92.7 mttt -78.25 138.56 38.69 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 118.584 1.192 . . . . 57.46 109.55 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1163 ' ' VAL . . . . . 0.59 HG11 ' HB2' ' B' 1152 ' ' PHE . 48.0 t -88.01 133.34 37.49 Favored Pre-proline 0 C--O 1.251 1.144 0 N-CA-C 105.533 -2.025 . . . . 42.93 105.533 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1164 ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' B' 1165 ' ' PRO . 48.2 Cg_endo -67.48 145.06 69.56 Favored 'Trans proline' 0 C--N 1.323 -0.815 0 C-N-CA 123.265 2.643 . . . . 39.29 113.655 170.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1165 ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' B' 1164 ' ' PRO . 75.7 Cg_exo -65.54 152.77 80.84 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 CA-C-N 124.016 2.47 . . . . 34.17 113.836 176.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -88.42 143.65 26.86 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.57 -1.27 . . . . 31.69 107.57 167.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1167 ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -107.7 117.35 33.89 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 106.945 -1.502 . . . . 44.78 106.945 173.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1168 ' ' VAL . . . . . 0.529 HG22 ' HB ' ' B' 1251 ' ' ILE . 61.8 t -102.59 113.83 40.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 106.418 -1.697 . . . . 31.23 106.418 -174.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1169 ' ' MET . . . . . 0.628 ' HB2' HG11 ' B' 1249 ' ' VAL . 43.0 ttp -95.94 97.52 9.68 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 120.892 0.377 . . . . 37.09 110.967 178.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1170 ' ' VAL . . . . . 0.448 HG22 ' HB ' ' B' 1253 ' ' VAL . 61.4 t -88.78 122.0 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.851 -1.166 . . . . 30.17 107.851 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1171 ' ' ILE . . . . . 0.409 HG22 ' HB2' ' B' 1256 ' ' ALA . 44.4 mt -112.07 131.94 62.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 104.097 -2.557 . . . . 33.74 104.097 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 81.29 64.6 1.76 Allowed Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 108.11 -1.996 . . . . 32.59 108.11 -174.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1173 ' ' ALA . . . . . 0.469 ' H ' ' HB2' ' B' 1195 ' ' ASP . . . -62.93 -7.01 4.37 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 120.842 -1.387 . . . . 32.42 114.683 -177.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -58.11 129.19 49.2 Favored Glycine 0 C--O 1.245 0.799 0 CA-C-O 122.8 1.222 . . . . 31.74 112.23 175.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 1.5 t 48.81 -82.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 112.612 -1.794 . . . . 31.48 114.441 173.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1176 ' ' ALA . . . . . 0.611 ' HB2' ' HB1' ' B' 1134 ' ' ALA . . . -65.34 -42.38 92.95 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.548 0.69 . . . . 26.12 112.609 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1177 ' ' GLY . . . . . . . . . . . . . . . -56.72 -45.22 91.11 Favored Glycine 0 N--CA 1.464 0.563 0 CA-C-N 113.123 -1.853 . . . . 25.73 108.781 174.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1178 ' ' LEU . . . . . 0.592 ' HA ' HD12 ' B' 1181 ' ' ILE . 5.5 tp -58.62 -48.89 79.48 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 126.288 1.835 . . . . 32.59 108.336 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -58.74 -38.81 79.22 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 114.347 1.24 . . . . 27.72 114.347 175.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -65.82 -43.21 89.28 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.884 0.874 . . . . 26.03 112.034 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1181 ' ' ILE . . . . . 0.599 HD13 HG22 ' B' 1204 ' ' VAL . 9.5 mt -56.12 -48.29 79.33 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 O-C-N 120.299 -1.5 . . . . 28.61 108.633 170.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -57.68 -49.88 70.17 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 117.749 -1.584 . . . . 25.23 112.986 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -63.48 -49.57 73.1 Favored 'General case' 0 C--O 1.249 1.063 0 CA-C-N 120.78 2.29 . . . . 24.09 113.253 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -68.02 -38.44 82.58 Favored 'General case' 0 C--O 1.24 0.605 0 O-C-N 121.497 -0.752 . . . . 26.68 109.323 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 45.5 t30 -62.32 -33.65 75.09 Favored 'General case' 0 C--O 1.249 1.042 0 O-C-N 118.075 -2.891 . . . . 36.57 111.004 174.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1186 ' ' SER . . . . . 0.557 ' HB3' ' O ' ' A' 1186 ' ' SER . 61.4 m -67.42 -45.85 74.9 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 111.941 0.348 . . . . 28.92 111.941 174.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1187 ' ' LEU . . . . . 0.513 ' HA ' ' HB3' ' A' 1186 ' ' SER . 5.6 mt -60.49 -24.64 65.45 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.093 0.957 . . . . 29.09 111.477 169.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 93.75 34.74 6.42 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 121.559 1.981 . . . . 29.26 112.224 175.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1189 ' ' ALA . . . . . 0.484 ' HB2' ' HB3' ' B' 1153 ' ' PHE . . . -104.3 146.02 29.4 Favored 'General case' 0 C--O 1.252 1.192 0 N-CA-C 107.772 -1.196 . . . . 30.16 107.772 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 69.9 mt -77.18 110.76 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 102.776 -3.046 . . . . 35.81 102.776 -173.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1191 ' ' VAL . . . . . . . . . . . . . 17.4 t -91.93 128.28 43.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 C-N-CA 118.485 -1.286 . . . . 31.97 108.024 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1192 ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' B' 1169 ' ' MET . 87.6 mtt180 -113.83 107.76 16.16 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 106.868 -1.53 . . . . 48.16 106.868 168.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -114.92 147.39 40.03 Favored 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 120.381 -1.449 . . . . 35.89 110.74 -173.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1194 ' ' PHE . . . . . 0.537 ' HB2' ' HB2' ' B' 1212 ' ' LEU . 42.0 t80 -135.9 146.96 47.92 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.304 -1.369 . . . . 41.88 107.304 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1195 ' ' ASP . . . . . 0.871 ' HB3' HG21 ' B' 1200 ' ' VAL . 23.7 t0 -154.46 154.06 32.57 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 102.051 -3.314 . . . . 38.28 102.051 172.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1196 ' ' THR . . . . . 0.459 ' HB ' ' HG2' ' B' 1230 ' ' MET . 1.8 p -85.76 37.92 0.72 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 117.695 -1.145 . . . . 40.62 110.811 -170.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1197 ' ' ARG . . . . . . . . . . . . . 75.4 mtm180 -140.24 166.2 25.13 Favored Pre-proline 0 C--O 1.246 0.878 0 CA-C-N 121.955 2.161 . . . . 53.09 112.386 -166.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -72.35 -64.33 0.03 OUTLIER 'Trans proline' 0 C--O 1.254 1.299 0 N-CA-C 119.149 2.711 . . . . 42.56 119.149 168.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.02 -34.26 63.33 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 115.574 1.694 . . . . 56.31 115.574 -167.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1200 ' ' VAL . . . . . 0.871 HG21 ' HB3' ' B' 1195 ' ' ASP . 0.3 OUTLIER -43.96 -42.18 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 N-CA-C 116.102 1.89 . . . . 42.91 116.102 172.417 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 43.5 tttm -58.2 -51.79 68.27 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 120.038 -1.664 . . . . 48.89 110.216 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -61.34 -28.05 68.94 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 122.36 1.076 . . . . 51.7 112.847 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1203 ' ' GLN . . . . . 0.551 ' HG2' ' HA ' ' B' 1200 ' ' VAL . 34.7 mm-40 -68.16 -46.55 70.45 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 107.641 -1.244 . . . . 52.57 107.641 173.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1204 ' ' VAL . . . . . 0.599 HG22 HD13 ' B' 1181 ' ' ILE . 25.5 t -63.99 -34.34 67.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 120.383 1.447 . . . . 33.79 111.292 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -61.97 -34.92 77.03 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.806 0.843 . . . . 36.58 109.972 171.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1206 ' ' SER . . . . . . . . . . . . . 14.9 m -72.78 -1.64 17.35 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 115.359 1.615 . . . . 39.61 115.359 173.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1207 ' ' MET . . . . . 0.469 ' SD ' HD11 ' C' ' 75' ' ' LEU . 2.8 mpp? -98.42 -18.68 18.13 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 113.258 0.836 . . . . 37.45 113.258 165.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 72.04 43.97 46.98 Favored Glycine 0 N--CA 1.484 1.843 0 O-C-N 119.624 -1.923 . . . . 31.87 110.868 -167.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -126.38 166.96 16.21 Favored 'General case' 0 CA--C 1.505 -0.772 0 O-C-N 120.471 -1.605 . . . . 35.4 111.899 -176.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -81.0 125.56 30.32 Favored 'General case' 0 C--O 1.216 -0.663 0 O-C-N 120.529 -1.357 . . . . 47.89 108.989 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 70.9 t80 -92.1 130.7 37.77 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 104.33 -2.47 . . . . 45.53 104.33 165.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1212 ' ' LEU . . . . . 0.537 ' HB2' ' HB2' ' B' 1194 ' ' PHE . 53.0 mt -76.25 106.89 8.12 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 105.2 -2.148 . . . . 46.33 105.2 167.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.17 150.79 37.09 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 124.07 1.89 . . . . 60.41 111.577 -173.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1214 ' ' LEU . . . . . 0.566 ' HB3' ' HE2' ' B' 1234 ' ' PHE . 8.0 mp -60.97 127.41 31.45 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 111.847 -2.433 . . . . 57.38 112.895 176.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 30.9 t0 . . . . . 0 N--CA 1.45 -0.465 0 C-N-CA 127.154 2.182 . . . . 65.07 110.46 -169.088 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B 1230 ' ' MET . . . . . 0.459 ' HG2' ' HB ' ' B' 1196 ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.417 -2.123 0 N-CA-C 102.489 -3.152 . . . . 80.32 102.489 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1231 ' ' SER . . . . . . . . . . . . 0.298 2.6 p 58.75 169.15 0.06 Allowed 'General case' 0 N--CA 1.444 -0.762 2 CA-C-N 130.094 5.861 . . . . 79.92 116.365 2.152 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -61.04 -49.76 76.06 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.274 -1.517 . . . . 77.91 108.304 175.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 34.22 -77.56 0.0 OUTLIER 'General case' 0 C--O 1.248 1.012 0 N-CA-C 119.657 3.206 . . . . 73.88 119.657 175.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1234 ' ' PHE . . . . . 0.566 ' HE2' ' HB3' ' B' 1214 ' ' LEU . 8.3 m-30 -93.59 -0.25 56.29 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 120.98 1.718 . . . . 68.98 110.365 -168.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 13.5 pt -33.16 -33.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 119.213 3.042 . . . . 64.53 119.213 -174.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -80.27 -38.57 30.63 Favored 'General case' 0 C--O 1.245 0.859 0 O-C-N 120.74 -1.225 . . . . 66.36 113.79 173.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -63.89 -47.65 79.78 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-O 117.45 -1.262 . . . . 56.6 109.154 170.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1238 ' ' GLU . . . . . 0.48 ' HG2' ' HE2' ' B' 1194 ' ' PHE . 47.7 mt-10 -47.96 -61.14 2.11 Favored 'General case' 0 C--N 1.36 1.06 0 O-C-N 124.347 1.029 . . . . 56.79 112.284 174.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1239 ' ' MET . . . . . . . . . . . . . 14.1 ttm -54.28 -50.15 67.92 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 124.853 1.261 . . . . 53.63 111.029 -175.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -72.41 -27.9 62.64 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 117.432 2.382 . . . . 51.74 117.432 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 28.2 tp -63.48 -50.46 69.6 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 106.498 -1.667 . . . . 44.86 106.498 169.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1242 ' ' PHE . . . . . 0.453 ' HE2' HD13 ' B' 1266 ' ' LEU . 18.3 m-30 -58.62 -41.91 86.99 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.998 1.436 . . . . 42.78 111.375 176.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -59.46 -44.77 92.91 Favored 'General case' 0 C--O 1.25 1.088 0 CA-C-N 120.577 1.535 . . . . 40.96 114.876 173.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -61.43 -51.84 67.07 Favored 'General case' 0 C--O 1.25 1.085 0 C-N-CA 120.169 -0.612 . . . . 43.06 110.063 174.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 -58.84 -28.64 66.26 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 116.203 1.927 . . . . 46.45 116.203 173.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -52.34 -33.09 41.21 Favored 'General case' 0 C--O 1.254 1.323 0 CA-C-N 119.291 0.95 . . . . 41.78 113.143 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1247 ' ' LYS . . . . . 0.438 ' HD2' ' HA ' ' B' 1247 ' ' LYS . 22.0 tptt -76.61 -31.56 57.52 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 120.932 -1.105 . . . . 52.2 112.322 177.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1248 ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -84.49 -42.12 15.87 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 120.818 -1.176 . . . . 53.55 112.697 178.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1249 ' ' VAL . . . . . 0.628 HG11 ' HB2' ' B' 1169 ' ' MET . 36.0 m -82.03 160.11 3.82 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.788 0 CA-C-O 123.154 1.454 . . . . 34.41 113.713 -162.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1250 ' ' ASP . . . . . 0.603 ' O ' ' HB3' ' B' 1279 ' ' SER . 3.7 m-20 -107.48 -69.72 0.83 Allowed 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 111.832 -2.44 . . . . 33.38 113.748 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1251 ' ' ILE . . . . . 0.714 HD12 ' HB1' ' B' 1145 ' ' ALA . 44.2 mm -101.6 102.5 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 N-CA-C 108.04 -1.096 . . . . 29.54 108.04 -175.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1252 ' ' ILE . . . . . 0.56 HD12 HG12 ' B' 1281 ' ' ILE . 75.0 mt -83.29 116.41 27.34 Favored 'Isoleucine or valine' 0 C--O 1.25 1.127 0 N-CA-C 107.082 -1.451 . . . . 32.44 107.082 168.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1253 ' ' VAL . . . . . 0.545 HG13 HD11 ' B' 1284 ' ' LEU . 39.0 t -101.16 87.9 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 105.644 -1.984 . . . . 30.57 105.644 174.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1254 ' ' THR . . . . . . . . . . . . . 1.2 t -92.85 115.02 27.73 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-O 125.462 2.553 . . . . 35.04 111.331 -174.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1255 ' ' THR . . . . . . . . . . . . . 7.1 m -135.83 10.16 3.35 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 110.606 -2.997 . . . . 34.62 108.987 -161.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1256 ' ' ALA . . . . . 0.409 ' HB2' HG22 ' B' 1171 ' ' ILE . . . -70.37 84.86 0.58 Allowed 'General case' 0 C--N 1.35 0.628 0 O-C-N 121.086 -1.009 . . . . 42.72 113.552 -172.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 41.1 mt -105.89 126.63 52.41 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 125.387 1.475 . . . . 52.43 110.103 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1258 ' ' ILE . . . . . 0.407 ' HA ' ' HD2' ' B' 1259 ' ' PRO . 2.6 mp -77.14 132.1 71.2 Favored Pre-proline 0 N--CA 1.438 -1.057 0 N-CA-C 103.151 -2.907 . . . . 59.41 103.151 168.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1259 ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' B' 1258 ' ' ILE . 67.7 Cg_endo -65.22 69.87 0.29 Allowed 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 124.217 3.278 . . . . 62.68 111.967 169.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 153.19 -81.12 0.18 Allowed Glycine 0 CA--C 1.534 1.266 0 O-C-N 118.653 -2.53 . . . . 64.16 108.43 -171.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 38.3 tttt -64.69 138.45 97.46 Favored Pre-proline 0 N--CA 1.44 -0.968 0 N-CA-C 114.755 1.391 . . . . 68.53 114.755 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -55.31 132.08 50.07 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 124.703 3.602 . . . . 61.99 111.392 166.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1263 ' ' ALA . . . . . . . . . . . . . . . -59.53 128.18 85.73 Favored Pre-proline 0 C--O 1.239 0.544 0 CA-C-N 111.675 -2.511 . . . . 57.15 111.407 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1264 ' ' PRO . . . . . 0.475 ' O ' ' HA ' ' B' 1291 ' ' ASN . 97.1 Cg_endo -64.19 146.08 89.95 Favored 'Trans proline' 0 C--O 1.25 1.077 0 C-N-CA 124.69 3.594 . . . . 51.57 113.815 177.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1265 ' ' LYS . . . . . 0.463 ' NZ ' ' O ' ' B' 1289 ' ' GLY . 38.5 mmtm -71.7 97.44 1.75 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 123.56 1.647 . . . . 54.55 108.309 167.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1266 ' ' LEU . . . . . 0.453 HD13 ' HE2' ' B' 1242 ' ' PHE . 91.3 mt -94.14 -47.85 6.47 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 123.223 1.487 . . . . 46.86 112.134 172.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1267 ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' B' 1292 ' ' CYS . 20.7 mm -84.06 82.36 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 104.651 -2.351 . . . . 41.04 104.651 -175.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1268 ' ' THR . . . . . 0.643 ' HA ' ' HG3' ' B' 1293 ' ' GLU . 23.2 p -82.36 175.45 10.24 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 111.068 -2.787 . . . . 39.58 108.729 -175.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1269 ' ' ARG . . . . . 0.457 ' HG2' ' CE2' ' B' 1294 ' ' TYR . 64.8 mtt85 -52.56 -41.28 63.42 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.019 0.927 . . . . 53.15 111.765 175.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -60.57 -21.06 62.18 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 115.727 1.751 . . . . 42.96 115.727 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1271 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.42 -51.51 6.89 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 120.338 1.426 . . . . 43.89 110.725 162.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1272 ' ' VAL . . . . . 0.41 HG23 ' O ' ' B' 1268 ' ' THR . 96.4 t -57.72 -60.68 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 CA-C-N 115.187 -0.915 . . . . 38.37 112.203 -168.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.26 -34.93 77.49 Favored 'General case' 0 C--O 1.247 0.97 0 O-C-N 119.541 -1.974 . . . . 47.46 112.708 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1274 ' ' SER . . . . . . . . . . . . . 5.2 m -74.32 -17.03 60.9 Favored 'General case' 0 C--O 1.244 0.786 0 O-C-N 120.044 -1.66 . . . . 38.38 111.16 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1275 ' ' MET . . . . . 0.581 ' SD ' HD11 ' B' 1281 ' ' ILE . 38.3 mtp -53.75 145.07 16.53 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 118.747 2.869 . . . . 37.81 118.747 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -61.39 130.76 47.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.547 -1.206 . . . . 49.26 109.101 171.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1277 ' ' ALA . . . . . 0.406 ' HB1' ' HA ' ' A' 1045 ' ' PHE . . . -64.03 165.35 9.12 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 118.5 2.778 . . . . 34.46 118.5 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 67.34 26.47 73.52 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-O 124.711 2.284 . . . . 33.53 115.363 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1279 ' ' SER . . . . . 0.603 ' HB3' ' O ' ' B' 1250 ' ' ASP . 36.6 m -127.89 159.75 33.95 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 111.243 -2.478 . . . . 31.31 106.139 -168.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1280 ' ' VAL . . . . . 0.741 HG11 ' HA ' ' B' 1145 ' ' ALA . 94.8 t -128.28 129.31 69.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.537 -0.912 . . . . 29.32 108.537 -165.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1281 ' ' ILE . . . . . 0.581 HD11 ' SD ' ' B' 1275 ' ' MET . 58.5 mt -99.49 96.28 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 N-CA-C 107.304 -1.369 . . . . 31.93 107.304 170.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1282 ' ' VAL . . . . . . . . . . . . . 14.2 t -80.63 110.99 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 O-C-N 120.383 -1.448 . . . . 29.48 110.793 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 33.6 t0 -90.57 95.81 10.34 Favored 'General case' 0 N--CA 1.417 -2.115 0 O-C-N 120.289 -1.507 . . . . 34.5 107.189 173.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1284 ' ' LEU . . . . . 0.545 HD11 HG13 ' B' 1253 ' ' VAL . 5.0 mp -76.65 -21.97 54.72 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-N 113.18 -1.827 . . . . 37.94 111.207 173.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -87.0 8.01 25.2 Favored 'General case' 0 C--N 1.35 0.589 0 N-CA-C 115.656 1.724 . . . . 40.92 115.656 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -50.29 -42.66 52.79 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 119.524 3.157 . . . . 44.39 119.524 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1287 ' ' GLN . . . . . 0.452 ' HB3' HG22 ' B' 1313 ' ' THR . 0.1 OUTLIER -64.03 -28.86 70.09 Favored 'General case' 0 C--O 1.257 1.495 0 O-C-N 119.322 -2.111 . . . . 51.46 114.137 178.497 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 38.9 t30 -121.91 76.78 1.31 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.243 -1.021 . . . . 57.75 108.243 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1289 ' ' GLY . . . . . 0.463 ' O ' ' NZ ' ' B' 1265 ' ' LYS . . . 98.45 -60.68 0.9 Allowed Glycine 0 C--N 1.336 0.531 0 O-C-N 120.102 -1.624 . . . . 49.85 114.902 176.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 80.99 119.48 0.44 Allowed Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 121.247 2.523 . . . . 45.93 112.128 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1291 ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' B' 1264 ' ' PRO . 27.0 m120 -81.5 -25.84 35.66 Favored 'General case' 0 C--N 1.346 0.429 0 N-CA-C 114.457 1.28 . . . . 42.67 114.457 -175.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1292 ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' B' 1267 ' ' ILE . 48.2 t -95.14 144.44 25.77 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 120.399 -1.438 . . . . 38.82 111.754 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1293 ' ' GLU . . . . . 0.643 ' HG3' ' HA ' ' B' 1268 ' ' THR . 22.7 mt-10 -68.82 -34.25 75.2 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 113.784 1.031 . . . . 46.71 113.784 178.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1294 ' ' TYR . . . . . 0.457 ' CE2' ' HG2' ' B' 1269 ' ' ARG . 52.7 m-85 -80.91 7.76 9.86 Favored 'General case' 0 C--O 1.248 0.982 0 N-CA-C 116.766 2.135 . . . . 47.23 116.766 -176.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1295 ' ' THR . . . . . 0.455 ' OG1' ' HB3' ' B' 1292 ' ' CYS . 26.4 m -71.79 107.73 4.74 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 114.007 1.114 . . . . 36.02 114.007 -173.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 36.7 t -93.57 123.42 60.14 Favored Pre-proline 0 C--N 1.304 -1.394 0 N-CA-C 103.448 -2.797 . . . . 37.26 103.448 155.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -61.16 136.8 67.14 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.649 2.233 . . . . 35.09 114.268 177.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 71.69 40.73 58.16 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 113.699 -1.591 . . . . 35.97 112.691 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -148.91 152.75 36.94 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-O 124.882 2.277 . . . . 40.39 114.671 -172.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1300 ' ' ILE . . . . . . . . . . . . . 55.3 mt -99.84 107.61 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 101.422 -3.547 . . . . 37.43 101.422 166.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 15.2 t80 -104.78 103.12 12.68 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.07 -1.085 . . . . 44.13 108.07 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1302 ' ' THR . . . . . . . . . . . . . 17.7 m -82.98 120.42 25.69 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-O 123.337 1.541 . . . . 39.78 111.012 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1303 ' ' THR . . . . . . . . . . . . . 3.2 p -79.84 139.35 37.22 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 112.929 -1.941 . . . . 43.29 109.398 175.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -48.25 -31.22 5.59 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 117.352 2.352 . . . . 53.07 117.352 -175.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -59.88 -21.93 61.68 Favored 'General case' 0 C--O 1.262 1.713 0 C-N-CA 126.496 1.918 . . . . 43.97 116.062 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 113.35 1.09 24.94 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 110.987 -0.845 . . . . 41.12 110.987 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1307 ' ' VAL . . . . . . . . . . . . . 45.6 t -88.95 148.28 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-N 118.653 1.227 . . . . 38.12 109.437 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1308 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.09 114.87 27.97 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 107.726 -1.212 . . . . 36.34 107.726 177.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1309 ' ' VAL . . . . . 0.405 HG21 ' HB2' ' B' 1294 ' ' TYR . 85.2 t -84.05 97.04 4.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 107.108 -1.441 . . . . 30.4 107.108 172.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1310 ' ' ILE . . . . . . . . . . . . . 19.0 mt -88.32 91.58 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 CA-C-O 122.912 1.339 . . . . 30.82 108.228 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1311 ' ' GLY . . . . . 0.415 ' HA3' HG23 ' B' 1295 ' ' THR . . . -88.97 93.32 1.88 Allowed Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 109.65 -1.38 . . . . 26.53 109.65 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1312 ' ' TYR . . . . . . . . . . . . . 13.9 m-30 -116.56 128.18 55.19 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 117.755 2.502 . . . . 38.0 117.755 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1313 ' ' THR . . . . . 0.452 HG22 ' HB3' ' B' 1287 ' ' GLN . 24.0 p -81.83 -56.25 4.1 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 112.668 -2.06 . . . . 29.8 108.64 173.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -70.05 21.26 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 117.991 2.589 . . . . 39.04 117.991 -173.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1315 ' ' LEU . . . . . . . . . . . . . 63.8 mt -50.78 -34.29 11.57 Favored Pre-proline 0 CA--C 1.545 0.777 0 O-C-N 118.013 -2.93 . . . . 31.08 117.128 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1316 ' ' PRO . . . . . 0.62 ' HA ' HG21 ' B' 1136 ' ' ILE . 51.3 Cg_exo -61.87 -54.23 1.67 Allowed 'Trans proline' 0 C--O 1.24 0.589 0 C-N-CA 123.213 2.608 . . . . 26.1 112.173 166.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1317 ' ' GLY . . . . . 0.626 ' HA2' ' HG3' ' B' 1015 ' ' ARG . . . -58.1 -32.99 68.07 Favored Glycine 0 C--O 1.213 -1.168 0 O-C-N 121.548 -0.72 . . . . 23.17 113.004 -177.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 74.7 mtt-85 -60.24 -27.44 67.21 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 113.584 0.957 . . . . 40.4 113.584 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1319 ' ' LEU . . . . . 0.584 HD13 HH11 ' B' 1140 ' ' ARG . 14.1 tp -111.86 77.98 2.1 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 105.397 -2.075 . . . . 23.6 105.397 171.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1320 ' ' PRO . . . . . 0.507 ' HB2' ' HA ' ' B' 1043 ' ' ALA . 81.2 Cg_endo -59.71 -64.66 0.1 OUTLIER 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.309 2.673 . . . . 22.35 115.414 -163.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1321 ' ' THR . . . . . . . . . . . . . 1.5 m -60.6 -38.07 83.48 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 120.552 -1.342 . . . . 26.52 111.404 -172.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1322 ' ' GLN . . . . . 0.92 ' HB2' ' HA ' ' A' 1151 ' ' ARG . 43.1 tp60 -72.34 -35.37 68.54 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 120.288 -1.508 . . . . 24.38 109.342 -175.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1323 ' ' SER . . . . . . . . . . . . . 68.8 m -61.56 -47.6 84.77 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 124.633 1.208 . . . . 22.8 111.433 171.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1324 ' ' SER . . . . . . . . . . . . . 7.6 m -60.71 -28.86 68.97 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 119.612 -1.93 . . . . 21.25 112.915 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -74.61 -47.27 33.25 Favored 'General case' 0 C--O 1.252 1.211 0 O-C-N 119.82 -1.8 . . . . 31.34 109.973 176.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1326 ' ' LEU . . . . . 0.654 ' HB3' ' HB3' ' B' 1132 ' ' SER . 86.1 mt -74.85 -47.35 30.76 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 120.343 1.429 . . . . 31.56 109.527 -173.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1327 ' ' TYR . . . . . 0.409 ' O ' ' HG ' ' B' 1331 ' ' LEU . 55.9 t80 -58.35 -45.1 88.81 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 109.547 -0.538 . . . . 22.73 109.547 174.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1328 ' ' GLY . . . . . 0.632 ' HA2' HD12 ' B' 1331 ' ' LEU . . . -55.4 -46.49 80.15 Favored Glycine 0 C--N 1.357 1.719 0 N-CA-C 111.253 -0.739 . . . . 21.91 111.253 173.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1329 ' ' THR . . . . . . . . . . . . . 48.2 m -67.98 -25.24 65.32 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 120.323 -1.692 . . . . 22.15 111.217 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1330 ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' B' 1127 ' ' LEU . 31.7 m120 -69.25 -48.47 61.75 Favored 'General case' 0 C--N 1.314 -0.941 0 O-C-N 119.637 -1.914 . . . . 26.18 107.252 173.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1331 ' ' LEU . . . . . 0.741 HD22 HD22 ' B' 1070 ' ' LEU . 33.8 mt -56.7 -38.9 72.93 Favored 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 123.003 0.521 . . . . 23.68 110.663 176.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1332 ' ' VAL . . . . . 0.489 HG23 ' O ' ' B' 1328 ' ' GLY . 71.0 t -54.3 -53.76 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 CA-C-N 120.157 1.344 . . . . 26.57 111.897 171.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -61.9 -44.24 97.2 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 122.37 1.081 . . . . 28.08 111.387 -177.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1334 ' ' LEU . . . . . . . . . . . . . 5.0 tt -53.92 -47.84 70.78 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 123.745 1.735 . . . . 27.43 113.016 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1335 ' ' LEU . . . . . 0.526 HD11 HD21 ' B' 1070 ' ' LEU . 39.1 mt -78.9 -15.29 58.52 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 119.844 -1.785 . . . . 30.5 109.606 -177.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1336 ' ' LYS . . . . . 0.724 ' HG2' HD21 ' B' 1029 ' ' LEU . 89.7 mttt -72.08 -36.68 69.6 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-N 119.583 1.083 . . . . 41.65 109.771 167.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1337 ' ' LEU . . . . . 0.592 HD22 HD21 ' B' 1127 ' ' LEU . 10.4 mp -67.33 -34.12 76.68 Favored 'General case' 0 N--CA 1.434 -1.251 0 O-C-N 120.086 -1.634 . . . . 42.08 113.749 169.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1338 ' ' LEU . . . . . 0.605 ' HB3' HG23 ' B' 1346 ' ' ILE . 85.6 mt -81.78 -43.71 17.98 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 118.878 -2.389 . . . . 35.03 113.774 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 41.5 t -105.23 60.3 0.68 Allowed 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 105.462 -2.051 . . . . 37.33 105.462 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 56.7 mttp -57.83 -21.15 40.88 Favored 'General case' 0 N--CA 1.432 -1.339 0 O-C-N 118.964 -2.335 . . . . 50.51 115.906 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -85.52 -5.42 59.29 Favored 'General case' 0 C--O 1.249 1.053 0 N-CA-C 114.856 1.428 . . . . 54.21 114.856 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1342 ' ' LYS . . . . . 0.534 ' HG2' HD23 ' B' 1029 ' ' LEU . 45.7 mttp 56.85 56.57 5.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 123.826 1.774 . . . . 50.99 111.16 -176.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -133.04 -1.97 3.25 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 113.344 -1.753 . . . . 48.82 113.809 -168.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 88.95 -30.72 5.32 Favored Glycine 0 CA--C 1.541 1.657 0 N-CA-C 117.509 1.764 . . . . 40.43 117.509 -170.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -86.4 124.22 32.5 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 117.839 -1.545 . . . . 47.56 110.369 -171.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1346 ' ' ILE . . . . . 0.605 HG23 ' HB3' ' B' 1338 ' ' LEU . 39.4 mm -80.51 117.11 25.86 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.416 0 N-CA-C 107.12 -1.437 . . . . 42.49 107.12 -177.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1347 ' ' THR . . . . . . . . . . . . . 35.6 m -82.73 106.44 14.58 Favored 'General case' 0 C--N 1.352 0.708 0 CA-C-O 123.748 1.737 . . . . 38.12 108.935 164.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 18.8 t -84.0 93.14 3.14 Favored 'Isoleucine or valine' 0 C--O 1.257 1.457 0 N-CA-C 107.259 -1.386 . . . . 37.5 107.259 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 4.4 t70 -68.86 167.09 16.33 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.179 -1.373 . . . . 43.85 109.296 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1350 ' ' PHE . . . . . . . . . . . . . 13.5 t80 -131.61 -42.32 1.04 Allowed 'General case' 0 C--N 1.314 -0.945 0 O-C-N 121.023 -1.048 . . . . 39.81 110.391 169.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -64.51 -39.86 94.57 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 114.607 1.336 . . . . 51.29 114.607 -174.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 34.4 t70 -62.42 112.95 2.66 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 121.523 -0.736 . . . . 39.78 111.991 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 27.0 m -47.99 -37.88 6.97 Favored 'Isoleucine or valine' 0 C--N 1.35 0.628 0 N-CA-C 114.101 1.149 . . . . 39.28 114.101 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1354 ' ' VAL . . . . . 0.499 HG13 ' HB2' ' B' 1124 ' ' ALA . 99.5 t -67.79 -53.96 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 O-C-N 120.311 -1.493 . . . . 35.7 111.392 -178.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1355 ' ' ILE . . . . . . . . . . . . . 25.0 mm -56.11 -51.79 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 114.153 1.168 . . . . 35.77 114.153 174.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 43.0 tpt85 -55.43 -31.47 61.92 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 115.725 1.75 . . . . 38.55 115.725 176.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1357 ' ' GLY . . . . . 0.451 ' HA2' ' HB1' ' B' 1370 ' ' ALA . . . -68.96 -58.84 6.39 Favored Glycine 0 C--N 1.341 0.857 0 C-N-CA 125.855 1.693 . . . . 29.58 109.934 172.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1358 ' ' VAL . . . . . 0.426 HG22 ' HB3' ' B' 1113 ' ' MET . 13.0 p -71.65 -36.67 60.32 Favored 'Isoleucine or valine' 0 C--O 1.249 1.072 0 O-C-N 120.763 -1.433 . . . . 32.06 112.152 -171.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1359 ' ' THR . . . . . 0.42 HG23 ' HE3' ' B' 1113 ' ' MET . 54.1 m -78.29 93.22 4.61 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 103.575 -2.75 . . . . 29.0 103.575 -176.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1360 ' ' VAL . . . . . . . . . . . . . 18.6 m -80.17 -27.88 12.08 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 CA-C-N 111.467 -2.606 . . . . 29.68 110.394 -175.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 97.7 mt -128.31 106.64 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.644 -1.243 . . . . 32.05 107.644 172.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1362 ' ' ARG . . . . . . . . . . . . . 46.1 ttt85 -83.08 90.45 7.05 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 105.643 -1.984 . . . . 32.52 105.643 172.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1363 ' ' ALA . . . . . 0.431 ' H ' ' HA ' ' B' 1111 ' ' THR . . . 47.35 71.66 0.31 Allowed 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 123.809 1.766 . . . . 35.68 112.786 170.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 85.85 -41.41 3.07 Favored Glycine 0 C--N 1.344 1.026 0 N-CA-C 116.311 1.284 . . . . 34.26 116.311 -173.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -78.87 112.24 15.84 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 106.508 -1.664 . . . . 51.07 106.508 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 65.5 mt -67.98 93.71 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 O-C-N 120.152 -1.593 . . . . 39.87 108.167 176.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1367 ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.02 -4.13 54.12 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 126.063 1.745 . . . . 38.01 113.247 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1368 ' ' TRP . . . . . . . . . . . . . 49.3 t90 -86.52 134.3 38.24 Favored Pre-proline 0 C--O 1.242 0.671 0 N-CA-C 103.248 -2.871 . . . . 42.14 103.248 168.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -64.6 140.89 43.49 Favored 'Cis proline' 0 N--CA 1.489 1.243 0 N-CA-C 121.457 3.599 . . . . 43.26 121.457 9.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1370 ' ' ALA . . . . . 0.451 ' HB1' ' HA2' ' B' 1357 ' ' GLY . . . -87.57 160.97 46.57 Favored Pre-proline 0 C--N 1.307 -1.261 0 CA-C-N 113.527 -1.67 . . . . 46.52 107.243 -174.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -56.25 153.28 34.26 Favored 'Trans proline' 0 C--O 1.245 0.866 0 C-N-CA 125.212 3.941 . . . . 51.95 111.838 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -63.9 114.13 2.47 Favored 'Trans proline' 0 C--O 1.251 1.146 0 C-N-CA 122.804 2.336 . . . . 56.27 114.544 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1373 ' ' ILE . . . . . 0.414 HG21 ' H ' ' B' 1120 ' ' ARG . 37.2 mm -93.81 129.85 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 114.588 -1.187 . . . . 60.83 108.558 -171.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -70.03 121.57 17.69 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-O 123.642 1.687 . . . . 66.1 109.035 166.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 59.7 t -109.96 127.25 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 113.827 -1.533 . . . . 63.47 108.545 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.226 -4.764 0 CA-C-N 120.254 1.388 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.209 -1.044 0 CA-C-O 118.445 -0.788 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -47.53 -36.86 11.05 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 123.769 1.747 . . . . 0.0 113.915 168.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 35.4 mp0 -56.14 -42.0 76.27 Favored 'General case' 0 C--O 1.249 1.075 0 C-N-CA 126.308 1.843 . . . . 0.0 108.904 176.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 14.6 m -66.05 -32.62 74.2 Favored 'General case' 0 C--O 1.24 0.583 0 O-C-N 120.026 -1.671 . . . . 0.0 111.122 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 24' ' ' ALA . . . . . 0.498 ' HB1' ' HA ' ' C' ' 186' ' ' LEU . . . -64.31 -46.81 81.92 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 121.438 1.926 . . . . 0.0 111.249 175.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 25' ' ' GLU . . . . . 0.442 ' HA ' ' HE2' ' C' ' 28' ' ' LYS . 24.2 mm-40 -57.38 -35.17 69.65 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 126.356 2.285 . . . . 0.0 113.62 174.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 14.6 tp -68.12 -60.81 2.2 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.31 -1.314 . . . . 0.0 111.219 177.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 7.9 mt -48.4 -43.46 33.98 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 115.931 -1.985 . . . . 0.0 113.746 -169.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 28' ' ' LYS . . . . . 0.442 ' HE2' ' HA ' ' C' ' 25' ' ' GLU . 34.4 pttt -58.05 -30.48 66.21 Favored 'General case' 0 C--O 1.244 0.783 0 O-C-N 125.076 1.485 . . . . 0.0 114.813 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -93.12 -23.76 18.5 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 174.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 53.2 m -57.85 -16.91 13.26 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 120.201 3.408 . . . . 0.0 120.201 -168.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 31' ' ' HIS . . . . . . . . . . . . 0.45 1.3 p-80 53.9 -55.4 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 117.373 2.36 . . . . 0.0 117.373 -174.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 32' ' ' SER . . . . . 0.564 ' HB2' ' HA ' ' C' ' 106' ' ' THR . 68.0 m -108.53 133.88 52.06 Favored 'General case' 0 CA--C 1.476 -1.902 0 O-C-N 118.419 -2.676 . . . . 0.0 110.426 167.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' C' ' 64' ' ' VAL . 42.6 t -134.38 115.01 19.46 Favored 'Isoleucine or valine' 0 C--N 1.355 0.833 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 174.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 42.5 mt -106.22 100.76 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . 0.643 ' O ' ' HD3' ' C' ' 37' ' ' PRO . 84.4 mt -81.59 108.36 14.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 103.719 -2.697 . . . . 0.0 103.719 -177.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 89.2 m -103.56 95.31 7.1 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -171.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . 0.643 ' HD3' ' O ' ' C' ' 35' ' ' ILE . 37.6 Cg_exo -63.29 114.1 2.35 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.091 2.528 . . . . 0.0 113.21 176.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.85 -166.44 33.16 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 158.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 39' ' ' TYR . . . . . 0.61 ' HB3' ' HB2' ' C' ' 114' ' ' ALA . 41.0 t80 -50.08 -21.18 1.17 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 175.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 40' ' ' GLY . . . . . 0.569 ' HA3' ' HA3' ' C' ' 113' ' ' GLY . . . -60.24 -38.46 94.57 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-N 121.154 1.797 . . . . 0.0 111.365 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 41' ' ' MET . . . . . 0.614 ' SD ' HD11 ' C' ' 83' ' ' LEU . 26.4 ttm -74.98 -6.73 50.89 Favored 'General case' 0 C--O 1.248 1.018 0 O-C-N 121.271 -1.135 . . . . 0.0 113.887 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.78 -52.26 3.5 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 121.147 1.794 . . . . 0.0 109.16 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.09 -45.57 90.14 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.557 0 O-C-N 123.734 0.646 . . . . 0.0 110.691 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . 0.491 ' HB1' ' HB2' ' C' ' 176' ' ' LYS . . . -95.23 144.62 25.67 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 174.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.7 55.58 0.52 Allowed 'General case' 0 CA--C 1.552 1.022 0 CA-C-O 123.118 1.437 . . . . 0.0 112.475 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' C' ' 41' ' ' MET . . . -75.26 -16.13 60.47 Favored 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 120.617 -1.302 . . . . 0.0 111.047 -171.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 47' ' ' GLN . . . . . 0.549 ' HB2' ' HB2' ' C' ' 86' ' ' ALA . 0.0 OUTLIER -69.97 -38.04 75.95 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 117.68 2.474 . . . . 0.0 117.68 177.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 48' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -62.22 -36.66 30.33 Favored Pre-proline 0 CA--C 1.517 -0.308 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -175.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 49' ' ' PRO . . . . . 0.586 ' O ' HD11 ' C' ' 183' ' ' LEU . 98.0 Cg_endo -75.19 -28.98 8.4 Favored 'Trans proline' 0 C--N 1.318 -1.026 0 C-N-CA 122.34 2.026 . . . . 0.0 115.223 164.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.93 -35.54 61.4 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 O-C-N 118.38 -2.7 . . . . 0.0 115.318 -170.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.17 -27.12 67.76 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.45 -30.49 66.09 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.2 176.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 53' ' ' ILE . . . . . 0.607 ' HB ' HD12 ' C' ' 183' ' ' LEU . 10.9 tp -76.76 -41.5 33.19 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 O-C-N 120.056 -1.653 . . . . 0.0 107.664 170.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 27.5 m -53.77 -27.26 27.79 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 121.256 1.844 . . . . 0.0 113.662 172.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -57.32 -57.18 13.74 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 121.014 -1.053 . . . . 0.0 108.963 172.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -74.89 -27.87 60.41 Favored 'General case' 0 C--O 1.253 1.266 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 57' ' ' LEU . . . . . 0.422 ' HA ' HD12 ' C' ' 62' ' ' ILE . 95.9 mt -66.16 -47.68 73.23 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . 0.462 ' HD2' ' HA ' ' C' ' 58' ' ' ARG . 1.8 tpt180 -66.5 -44.22 83.16 Favored 'General case' 0 C--N 1.359 0.988 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.583 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.72 -30.18 55.39 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 171.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . 0.409 ' HD3' HH11 ' C' ' 60' ' ' ARG . 3.9 ttm180 -89.83 8.14 33.51 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 175.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.97 36.75 91.46 Favored Glycine 0 N--CA 1.432 -1.589 0 O-C-N 119.896 -1.753 . . . . 0.0 110.418 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' C' ' 57' ' ' LEU . 64.1 mt -94.66 126.61 47.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -62.99 91.5 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.326 171.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 7.1 p -107.71 129.68 61.32 Favored 'Isoleucine or valine' 0 C--O 1.258 1.522 0 C-N-CA 119.629 -0.828 . . . . 0.0 108.811 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 23.1 mmm-85 -127.01 156.35 41.77 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 175.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . 0.559 ' HB2' ' HA ' ' C' ' 93' ' ' VAL . 33.5 m-85 -117.71 105.4 11.97 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-O 122.65 1.215 . . . . 0.0 108.434 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.92 80.14 1.85 Allowed Glycine 0 C--O 1.24 0.477 0 CA-C-O 117.347 -1.807 . . . . 0.0 109.593 -174.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 68' ' ' ILE . . . . . 0.577 HD13 HG13 ' C' ' 93' ' ' VAL . 1.8 mp -72.06 126.25 32.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 121.447 2.624 . . . . 0.0 109.639 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -94.67 126.43 47.54 Favored Pre-proline 0 N--CA 1.437 -1.082 0 C-N-CA 117.626 -1.63 . . . . 0.0 108.728 -177.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 70' ' ' PRO . . . . . 0.439 ' O ' ' HA ' ' C' ' 76' ' ' PRO . 28.3 Cg_endo -57.92 -62.74 0.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.967 2.444 . . . . 0.0 112.806 175.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 71' ' ' VAL . . . . . 0.408 ' O ' HG23 ' C' ' 117' ' ' THR . 42.4 t -64.01 92.33 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.211 -0.927 0 CA-C-O 123.252 1.501 . . . . 0.0 107.096 166.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 72' ' ' ALA . . . . . 0.406 ' HB2' ' HA2' ' C' ' 77' ' ' GLY . . . -84.19 -32.79 24.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 113.451 -1.704 . . . . 0.0 114.134 -174.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 129.97 -51.23 0.86 Allowed Glycine 0 CA--C 1.504 -0.63 0 CA-C-N 113.302 -1.772 . . . . 0.0 109.26 -171.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 74' ' ' ARG . . . . . 0.506 ' HD3' ' CZ ' ' C' ' 39' ' ' TYR . 2.4 mpt_? -130.86 129.2 42.0 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 101.625 -3.472 . . . . 0.0 101.625 163.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.469 HD11 ' SD ' ' B' 1207 ' ' MET . 1.9 mp 68.59 153.38 0.14 Allowed Pre-proline 0 N--CA 1.441 -0.892 0 C-N-CA 127.034 2.133 . . . . 0.0 115.8 177.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 76' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' C' ' 70' ' ' PRO . 14.9 Cg_endo -57.46 88.31 0.05 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 123.689 2.926 . . . . 0.0 110.659 158.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 77' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' C' ' 72' ' ' ALA . . . 46.17 48.47 15.11 Favored Glycine 0 C--O 1.216 -1.001 0 N-CA-C 118.139 2.016 . . . . 0.0 118.139 175.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -49.91 -24.19 2.37 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 122.032 2.916 . . . . 0.0 116.346 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -63.81 -25.89 68.38 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -69.14 -22.52 63.94 Favored 'General case' 0 CA--C 1.561 1.369 0 O-C-N 124.102 0.876 . . . . 0.0 111.751 -176.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 40.7 t -66.13 -52.97 42.09 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 169.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.462 ' HB3' ' HG2' ' C' ' 47' ' ' GLN . 6.9 mp -57.64 -30.32 65.29 Favored 'General case' 0 CA--C 1.512 -0.499 0 O-C-N 119.944 -1.723 . . . . 0.0 114.319 178.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.614 HD11 ' SD ' ' C' ' 41' ' ' MET . 5.3 mp -64.46 -22.22 66.9 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 117.836 -1.078 . . . . 0.0 113.063 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.99 -34.89 76.02 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 120.338 1.426 . . . . 0.0 113.178 173.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -69.07 -42.3 76.4 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 172.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . 0.549 ' HB2' ' HB2' ' C' ' 47' ' ' GLN . . . -66.37 -21.69 66.24 Favored 'General case' 0 C--O 1.213 -0.833 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 177.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp 70.73 45.49 0.57 Allowed 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 128.165 2.586 . . . . 0.0 108.436 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 45.6 t -81.58 130.8 60.1 Favored Pre-proline 0 C--N 1.351 0.672 0 CA-C-O 117.664 -1.16 . . . . 0.0 108.259 174.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -61.81 115.4 2.78 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 124.025 3.15 . . . . 0.0 114.143 176.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 90' ' ' TYR . . . . . 0.582 ' HA ' ' HB ' ' C' ' 93' ' ' VAL . 35.4 m-85 -60.76 -13.09 12.92 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-N 114.765 -1.107 . . . . 0.0 113.481 -177.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -59.16 -51.73 68.76 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 166.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 26.3 pt -82.64 -15.71 11.77 Favored 'Isoleucine or valine' 0 C--O 1.249 1.047 0 CA-C-N 119.169 0.895 . . . . 0.0 110.447 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 93' ' ' VAL . . . . . 0.582 ' HB ' ' HA ' ' C' ' 90' ' ' TYR . 73.5 t -75.59 99.99 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 123.026 1.394 . . . . 0.0 109.453 175.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 94' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' C' ' 97' ' ' ASP . 53.0 mt -103.7 100.44 10.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 113.707 -1.588 . . . . 0.0 112.621 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 95' ' ' GLU . . . . . 0.708 ' HB3' HD13 ' A' 1157 ' ' ILE . 40.9 mp0 -81.06 91.8 6.15 Favored 'General case' 0 C--O 1.267 1.989 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 -178.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.643 ' SD ' ' HB2' ' C' ' 134' ' ' PRO . 31.8 ttp 47.94 73.47 0.21 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 123.892 1.806 . . . . 0.0 115.606 -171.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 97' ' ' ASP . . . . . 0.496 ' HB2' ' HB3' ' C' ' 94' ' ' LEU . 4.2 t70 -91.74 144.42 25.52 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 168.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -92.82 51.9 1.77 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 123.844 1.783 . . . . 0.0 112.247 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 99' ' ' ILE . . . . . 0.557 HG12 ' HB2' ' C' ' 102' ' ' ASP 0.286 10.2 tt -87.22 70.0 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-O 126.978 3.275 . . . . 0.0 108.852 -166.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -54.73 -52.49 62.33 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 108.834 -3.803 . . . . 0.0 114.935 -174.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -62.49 -42.98 99.86 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 118.368 -0.825 . . . . 0.0 112.861 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 102' ' ' ASP . . . . . 0.557 ' HB2' HG12 ' C' ' 99' ' ' ILE . 0.5 OUTLIER -68.54 -39.32 81.18 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-N 119.974 1.261 . . . . 0.0 108.785 -174.257 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 103' ' ' PHE . . . . . 0.458 ' HB3' ' HB2' ' C' ' 137' ' ' GLU . 4.6 m-85 -55.34 -52.5 63.29 Favored 'General case' 0 C--O 1.251 1.173 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 168.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.85 -26.02 67.06 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -75.62 -39.53 57.73 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 106' ' ' THR . . . . . 0.564 ' HA ' ' HB2' ' C' ' 32' ' ' SER . 96.0 m -61.34 141.52 57.53 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 -162.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 107' ' ' ASP . . . . . 0.87 ' HA ' ' HB2' ' C' ' 142' ' ' GLN . 9.9 t0 -71.53 -87.8 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 124.019 0.928 . . . . 0.0 108.714 161.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' C' ' 143' ' ' ASN . 0.3 OUTLIER -89.09 112.35 23.31 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 122.448 1.118 . . . . 0.0 112.395 -165.362 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 109' ' ' VAL . . . . . 0.682 HG11 HG23 ' C' ' 138' ' ' VAL . 4.4 t -102.92 104.2 16.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 174.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 110' ' ' LEU . . . . . 0.589 HD12 HG12 ' C' ' 35' ' ' ILE . 95.9 mt -88.3 90.6 8.46 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.521 -172.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 28.2 t -81.19 104.84 10.33 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 CA-C-O 124.338 2.018 . . . . 0.0 107.771 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 112' ' ' ILE . . . . . 0.421 ' HB ' ' HA ' ' C' ' 37' ' ' PRO . 45.1 mm -78.24 97.79 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 CA-C-O 122.635 1.207 . . . . 0.0 108.45 -171.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 113' ' ' GLY . . . . . 0.569 ' HA3' ' HA3' ' C' ' 40' ' ' GLY . . . 85.21 -70.45 3.1 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-N 111.275 -2.693 . . . . 0.0 113.738 165.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 114' ' ' ALA . . . . . 0.61 ' HB2' ' HB3' ' C' ' 39' ' ' TYR . . . -87.57 121.84 30.51 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 120.775 -1.427 . . . . 0.0 112.441 -163.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 115' ' ' ASN . . . . . 0.481 ' HB2' ' HE1' ' C' ' 163' ' ' PHE . 10.2 p-10 -85.09 -55.1 4.22 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 118.156 -0.926 . . . . 0.0 113.192 -173.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.19 -38.89 66.12 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 121.298 1.863 . . . . 0.0 109.915 -175.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 117' ' ' THR . . . . . 0.408 HG23 ' O ' ' C' ' 71' ' ' VAL . 67.6 m -33.61 -36.31 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 118.751 2.871 . . . . 0.0 118.751 166.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.46 ' HB ' HG11 ' C' ' 138' ' ' VAL . 26.7 m -119.58 2.53 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-O 117.646 -1.168 . . . . 0.0 110.459 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 119' ' ' ASN . . . . . 0.551 HD21 ' HB3' ' C' ' 121' ' ' ALA . 23.1 t30 -52.09 117.77 10.81 Favored Pre-proline 0 C--O 1.257 1.454 0 CA-C-N 122.472 2.396 . . . . 0.0 115.708 -164.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 120' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' C' ' 119' ' ' ASN . 0.8 OUTLIER -45.1 -59.92 1.0 Allowed 'Trans proline' 0 C--N 1.363 1.339 1 C-N-CA 127.954 5.77 . . . . 0.0 110.706 174.293 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' C' C ' 121' ' ' ALA . . . . . 0.551 ' HB3' HD21 ' C' ' 119' ' ' ASN . . . -48.28 -38.75 19.56 Favored 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 176.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.92 -16.54 63.42 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 118.618 -1.233 . . . . 0.0 114.256 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 123' ' ' GLN . . . . . 0.602 ' HG2' HG23 ' C' ' 135' ' ' VAL . 0.0 OUTLIER -101.25 -41.68 6.61 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 117.359 -1.736 . . . . 0.0 110.892 165.692 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.68 -60.95 2.98 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 126.297 1.839 . . . . 0.0 114.27 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -82.09 117.04 66.92 Favored Pre-proline 0 C--O 1.246 0.918 0 O-C-N 124.851 1.345 . . . . 0.0 111.222 173.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -67.52 -26.53 40.19 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.732 3.621 . . . . 0.0 112.157 176.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 127' ' ' LYS . . . . . 0.49 ' HB3' ' HZ3' ' C' ' 127' ' ' LYS . 6.0 ttpm? -64.96 -28.34 69.45 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 122.445 1.117 . . . . 0.0 113.934 -175.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 128' ' ' SER . . . . . 0.423 ' HA ' ' HD2' ' C' ' 129' ' ' PRO . 70.3 m -32.9 116.66 0.42 Allowed Pre-proline 0 C--N 1.357 0.92 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 166.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 129' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' C' ' 128' ' ' SER . 16.1 Cg_endo -50.03 -48.84 18.03 Favored 'Trans proline' 0 C--O 1.241 0.67 0 C-N-CA 124.042 3.162 . . . . 0.0 111.58 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 13.1 pt -73.97 84.07 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 O-C-N 119.732 -1.855 . . . . 0.0 108.669 168.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 131' ' ' ALA . . . . . 0.411 ' O ' ' HB ' ' B' 1121 ' ' ILE . . . -75.93 119.17 19.54 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -172.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 73.76 78.36 0.57 Allowed Glycine 0 N--CA 1.48 1.57 0 CA-C-N 114.715 -1.13 . . . . 0.0 113.113 177.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 133' ' ' MET . . . . . 0.417 ' SD ' ' HD2' ' C' ' 134' ' ' PRO . 41.6 tpp -76.01 124.06 88.32 Favored Pre-proline 0 C--N 1.313 -0.999 0 O-C-N 118.965 -2.491 . . . . 0.0 109.638 171.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 134' ' ' PRO . . . . . 0.643 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 49.2 Cg_endo -70.62 85.52 0.74 Allowed 'Trans proline' 0 CA--C 1.5 -1.188 0 C-N-CA 123.562 2.841 . . . . 0.0 113.734 176.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 135' ' ' VAL . . . . . 0.602 HG23 ' HG2' ' C' ' 123' ' ' GLN . 0.5 OUTLIER -134.93 137.54 50.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 124.889 2.28 . . . . 0.0 111.233 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -105.17 137.59 42.7 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 111.839 -2.437 . . . . 0.0 107.134 167.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 137' ' ' GLU . . . . . 0.458 ' HB2' ' HB3' ' C' ' 103' ' ' PHE 0.258 6.3 mm-40 23.23 40.68 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.964 1 N-CA-C 122.531 4.271 . . . . 0.0 122.531 166.429 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' C' C ' 138' ' ' VAL . . . . . 0.682 HG23 HG11 ' C' ' 109' ' ' VAL . 13.7 p -88.01 48.35 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 126.228 2.918 . . . . 0.0 109.386 174.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -159.0 148.54 18.92 Favored 'General case' 0 C--O 1.256 1.434 0 CA-C-N 111.185 -2.734 . . . . 0.0 104.597 -172.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 140' ' ' LYS . . . . . . . . . . . . 0.356 23.6 pttm 65.63 -26.57 0.1 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 118.017 2.599 . . . . 0.0 118.017 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -45.4 146.71 0.93 Allowed 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 125.665 1.586 . . . . 0.0 113.614 161.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 142' ' ' GLN . . . . . 0.87 ' HB2' ' HA ' ' C' ' 107' ' ' ASP . 21.0 mt-30 -58.62 -28.88 66.05 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 120.136 3.384 . . . . 0.0 120.136 -151.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 143' ' ' ASN . . . . . 0.511 ' O ' ' HA ' ' C' ' 108' ' ' THR . 2.5 t-20 -153.57 87.51 1.24 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 172.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 144' ' ' VAL . . . . . 0.684 ' HB ' ' HA ' ' C' ' 168' ' ' THR . 37.4 t -81.24 89.76 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.146 0 O-C-N 119.803 -1.811 . . . . 0.0 107.358 177.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 145' ' ' ILE . . . . . . . . . . . . . 21.7 mt -92.28 104.63 15.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 125.545 2.593 . . . . 0.0 107.977 -173.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 146' ' ' VAL . . . . . 0.652 ' HB ' ' HA ' ' C' ' 170' ' ' MET . 10.0 t -86.25 102.7 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 CA-C-N 111.38 -2.645 . . . . 0.0 107.552 176.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 147' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -64.34 94.48 0.11 Allowed 'General case' 0 C--O 1.242 0.7 0 CA-C-O 122.372 1.082 . . . . 0.0 112.105 177.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 148' ' ' LYS . . . . . 0.642 ' O ' ' HA ' ' C' ' 172' ' ' PHE . 20.9 mmmt -128.22 111.59 13.59 Favored 'General case' 0 CA--C 1.485 -1.541 0 C-N-CA 123.98 0.912 . . . . 0.0 109.352 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 10.7 ptp85 -54.0 -31.96 52.59 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 174.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 19.4 m -153.0 155.47 36.98 Favored 'General case' 0 C--O 1.249 1.067 0 O-C-N 118.682 -2.511 . . . . 0.0 106.185 -170.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 151' ' ' MET . . . . . 0.608 ' SD ' ' SD ' ' C' ' 170' ' ' MET . 6.8 tpt -88.03 67.17 8.87 Favored 'General case' 0 C--O 1.254 1.329 0 CA-C-O 125.865 2.745 . . . . 0.0 108.074 177.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -94.93 117.32 29.93 Favored 'General case' 0 N--CA 1.44 -0.958 0 O-C-N 119.636 -1.915 . . . . 0.0 106.109 170.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 7.4 m -64.18 138.99 58.72 Favored 'General case' 0 C--O 1.249 1.074 0 CA-C-N 113.286 -1.779 . . . . 0.0 107.696 171.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -86.85 -53.42 2.87 Favored Glycine 0 C--O 1.214 -1.105 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -132.17 -78.3 0.5 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 118.002 0.901 . . . . 0.0 108.901 164.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 156' ' ' ALA . . . . . . . . . . . . . . . -86.71 -61.44 1.73 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -170.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.81 28.85 5.69 Favored Glycine 0 C--N 1.353 1.475 0 C-N-CA 127.387 2.422 . . . . 0.0 114.654 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 6.1 m -54.76 138.97 14.26 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 N-CA-C 119.414 3.116 . . . . 0.0 119.414 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . 0.263 0.0 OUTLIER 6.76 92.53 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.974 1 N-CA-C 122.811 4.375 . . . . 0.0 122.811 173.663 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' C' C ' 160' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -150.1 152.16 33.25 Favored Pre-proline 0 N--CA 1.469 0.493 0 CA-C-O 117.602 -1.19 . . . . 0.0 112.952 -174.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.76 -27.85 37.41 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 124.551 3.501 . . . . 0.0 114.025 167.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 162' ' ' LEU . . . . . 0.583 ' HA ' HG22 ' C' ' 168' ' ' THR . 16.3 tp -43.8 -31.5 0.84 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 119.415 3.117 . . . . 0.0 119.415 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 163' ' ' PHE . . . . . 0.532 ' HA ' ' HG3' ' C' ' 170' ' ' MET . 14.0 m-30 -85.7 -60.62 1.97 Allowed 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 124.611 2.148 . . . . 0.0 109.749 171.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -82.8 -7.43 59.66 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-N 111.752 -2.476 . . . . 0.0 113.97 -158.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -91.71 177.16 6.28 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 122.0 0.905 . . . . 0.0 110.611 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.77 -51.98 4.66 Favored 'General case' 0 C--O 1.254 1.316 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -174.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 167' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' C' ' 142' ' ' GLN . 20.7 p-10 -78.88 -45.55 20.44 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 120.552 -1.342 . . . . 0.0 111.344 177.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 168' ' ' THR . . . . . 0.684 ' HA ' ' HB ' ' C' ' 144' ' ' VAL . 3.0 m -89.75 95.15 10.12 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 101.495 -3.52 . . . . 0.0 101.495 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -150.26 132.3 15.27 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 123.662 1.696 . . . . 0.0 112.302 -162.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 170' ' ' MET . . . . . 0.652 ' HA ' ' HB ' ' C' ' 146' ' ' VAL . 33.7 mtm -64.88 110.78 2.55 Favored 'General case' 0 C--O 1.253 1.288 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 165.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 171' ' ' LEU . . . . . . . . . . . . . 15.2 tp -91.16 124.01 35.05 Favored 'General case' 0 C--O 1.256 1.401 0 N-CA-C 103.545 -2.761 . . . . 0.0 103.545 172.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 172' ' ' PHE . . . . . 0.642 ' HA ' ' O ' ' C' ' 148' ' ' LYS . 3.6 m-85 -70.76 82.74 0.63 Allowed 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 111.774 -2.466 . . . . 0.0 115.317 -175.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -157.97 147.5 15.52 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 106.611 -2.595 . . . . 0.0 106.611 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 174' ' ' ASP . . . . . 0.641 ' HB3' ' HB3' ' C' ' 177' ' ' ALA . 14.1 t70 -63.69 147.69 50.99 Favored 'General case' 0 N--CA 1.431 -1.378 0 O-C-N 121.706 -0.879 . . . . 0.0 112.609 172.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -52.24 -60.22 3.47 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 176' ' ' LYS . . . . . 0.491 ' HB2' ' HB1' ' C' ' 44' ' ' ALA . 0.0 OUTLIER -69.01 -48.8 62.14 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 -171.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 177' ' ' ALA . . . . . 0.641 ' HB3' ' HB3' ' C' ' 174' ' ' ASP . . . -55.25 -50.55 69.18 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 127.03 2.706 . . . . 0.0 109.978 -176.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 44.2 m -68.26 -32.87 73.35 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.941 -1.1 . . . . 0.0 110.697 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 179' ' ' VAL . . . . . . . . . . . . . 86.9 t -62.87 -45.51 98.68 Favored 'Isoleucine or valine' 0 C--N 1.343 0.287 0 CA-C-N 119.642 1.11 . . . . 0.0 108.421 176.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -68.06 -28.9 67.77 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 119.966 -1.709 . . . . 0.0 111.471 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -64.99 -56.27 14.12 Favored 'General case' 0 C--N 1.348 0.536 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 182' ' ' ILE . . . . . 0.432 ' HA ' ' HB2' ' C' ' 24' ' ' ALA . 23.8 pt -64.29 -33.47 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 183' ' ' LEU . . . . . 0.607 HD12 ' HB ' ' C' ' 53' ' ' ILE . 5.9 tp -32.02 -50.62 0.22 Allowed 'General case' 0 C--O 1.248 1.012 0 C-N-CA 128.934 2.894 . . . . 0.0 118.565 -171.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -123.79 -7.11 7.92 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.633 169.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -62.39 -44.12 97.2 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -170.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 186' ' ' LEU . . . . . 0.498 ' HA ' ' HB1' ' C' ' 24' ' ' ALA 0.331 88.1 mt . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 121.588 3.922 . . . . 0.0 121.588 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 9.8 t-80 . . . . . 0 N--CA 1.444 -0.738 0 N-CA-C 103.958 -2.608 . . . . 65.74 103.958 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -75.04 78.28 1.09 Allowed Glycine 0 C--O 1.256 1.487 0 CA-C-O 119.067 -0.852 . . . . 48.66 112.326 -174.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 24.2 ttp180 -86.81 131.98 33.97 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 120.045 1.922 . . . . 44.56 106.289 153.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1003 ' ' ILE . . . . . 0.522 ' HA ' ' O ' ' A' 1068 ' ' ILE . 39.9 mt -101.4 124.74 55.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 102.471 -3.159 . . . . 34.86 102.471 177.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1004 ' ' GLY . . . . . 0.663 ' O ' ' HD3' ' A' 1006 ' ' PRO . . . -88.1 129.25 9.47 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 107.486 -2.245 . . . . 30.75 107.486 165.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.746 HG23 ' HB3' ' A' 1017 ' ' ALA . 48.2 mm -98.63 99.55 7.77 Favored Pre-proline 0 C--O 1.249 1.027 0 N-CA-C 105.647 -1.982 . . . . 32.21 105.647 174.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1006 ' ' PRO . . . . . 0.663 ' HD3' ' O ' ' A' 1004 ' ' GLY . 99.5 Cg_exo -71.51 131.03 18.1 Favored 'Trans proline' 0 CA--C 1.499 -1.24 0 C-N-CA 123.779 2.986 . . . . 32.98 109.317 174.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1007 ' ' ARG . . . . . 0.481 ' HG2' HD12 ' A' 1042 ' ' LEU . 7.1 ttp85 -73.86 121.34 20.75 Favored 'General case' 0 C--O 1.255 1.347 0 CA-C-N 110.284 -3.144 . . . . 47.98 106.734 155.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1008 ' ' GLU . . . . . 0.428 ' CD ' ' HZ2' ' A' 1071 ' ' LYS . 6.4 tp10 -73.33 133.33 43.81 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 123.306 1.527 . . . . 34.7 112.956 -165.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -97.86 9.43 42.7 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 112.805 -1.998 . . . . 53.37 111.456 -174.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 17.7 tp -70.28 146.54 50.53 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 117.211 -1.796 . . . . 45.07 106.396 168.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1011 ' ' THR . . . . . . . . . . . . . 5.7 m -54.58 146.42 16.51 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-O 117.7 -1.143 . . . . 40.36 110.698 174.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 76.8 m-20 61.81 -10.67 0.07 Allowed 'General case' 0 C--O 1.258 1.508 0 N-CA-C 119.089 2.996 . . . . 40.61 119.089 -175.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1013 ' ' GLU . . . . . 0.544 ' HG3' ' H ' ' A' 1015 ' ' ARG . 8.6 tp10 -68.99 114.93 7.73 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 124.35 2.024 . . . . 33.76 113.838 -160.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1014 ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.56 -26.95 68.93 Favored 'General case' 0 N--CA 1.427 -1.597 1 CA-C-N 108.27 -4.059 . . . . 27.89 114.86 174.518 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 1015 ' ' ARG . . . . . 0.676 ' HB3' HG11 ' A' 1072 ' ' VAL . 57.8 mtm180 -79.81 151.32 30.35 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 126.65 3.119 . . . . 29.02 116.621 -171.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1016 ' ' VAL . . . . . . . . . . . . . 2.6 p -115.8 169.02 6.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 1 CA-C-N 107.745 -4.298 . . . . 28.13 106.655 160.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1017 ' ' ALA . . . . . 0.746 ' HB3' HG23 ' A' 1005 ' ' ILE . . . -60.98 -46.92 88.81 Favored 'General case' 0 C--O 1.217 -0.617 0 O-C-N 119.296 -2.128 . . . . 26.87 113.45 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -155.82 133.55 11.15 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 120.838 -1.164 . . . . 26.77 108.516 -175.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1019 ' ' THR . . . . . 0.471 HG21 HG23 ' A' 1321 ' ' THR . 0.6 OUTLIER -85.41 167.39 25.6 Favored Pre-proline 0 C--O 1.239 0.517 0 O-C-N 120.36 -1.462 . . . . 27.02 114.539 177.173 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 1020 ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -42.87 -53.57 3.87 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 124.667 3.578 . . . . 30.57 119.546 -174.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 9.5 tttp -58.28 -39.26 78.81 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 124.111 1.91 . . . . 47.81 112.853 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1022 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.57 -40.38 92.71 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 113.188 -1.824 . . . . 30.77 109.833 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1023 ' ' VAL . . . . . 0.518 HG13 HG11 ' A' 1033 ' ' VAL . 8.9 t -59.75 -42.61 89.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 118.953 -0.546 . . . . 33.59 110.475 176.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -49.32 -46.44 46.68 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 124.165 0.915 . . . . 53.29 112.05 172.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -68.04 -32.74 73.32 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.97 0.89 . . . . 46.92 111.383 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1026 ' ' LEU . . . . . 0.419 ' CD2' HG22 ' A' 1332 ' ' VAL . 99.0 mt -68.61 -41.53 79.41 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.166 -1.584 . . . . 37.17 112.434 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1027 ' ' LEU . . . . . 0.44 HD22 ' HA3' ' A' 1054 ' ' GLY . 36.0 tp -61.67 -50.69 71.47 Favored 'General case' 0 C--O 1.254 1.294 0 CA-C-N 111.928 -2.396 . . . . 44.44 107.039 173.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -48.79 -41.62 33.15 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 116.762 2.134 . . . . 52.58 116.762 171.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1029 ' ' LEU . . . . . . . . . . . . . 77.0 mt -71.78 -11.32 60.76 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 121.467 1.939 . . . . 45.69 110.21 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 110.84 33.28 2.45 Favored Glycine 0 C--O 1.244 0.756 0 CA-C-O 122.971 1.317 . . . . 42.09 111.641 166.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1031 ' ' PHE . . . . . 0.646 ' HZ ' ' SG ' ' A' 1339 ' ' CYS . 50.1 m-85 -117.19 155.14 29.9 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 118.584 -2.715 . . . . 40.72 109.785 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1032 ' ' THR . . . . . . . . . . . . . 40.1 m -86.62 114.93 23.74 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 104.225 -2.509 . . . . 37.77 104.225 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1033 ' ' VAL . . . . . 0.518 HG11 HG13 ' A' 1023 ' ' VAL . 19.3 t -88.77 125.78 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 105.837 -1.912 . . . . 33.54 105.837 -177.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -117.26 126.37 52.63 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 104.446 -2.428 . . . . 31.68 104.446 173.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1035 ' ' VAL . . . . . 0.541 ' HA ' ' HB ' ' A' 1005 ' ' ILE . 59.4 t -116.01 145.69 21.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 105.1 -2.185 . . . . 31.52 105.1 -177.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1036 ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -69.38 133.47 47.84 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 122.971 0.509 . . . . 41.04 111.915 174.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1037 ' ' SER . . . . . . . . . . . . . 54.4 m -54.89 123.33 13.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 123.926 1.822 . . . . 31.83 114.414 168.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 99.83 -8.14 59.5 Favored Glycine 0 N--CA 1.444 -0.806 0 O-C-N 119.035 -2.29 . . . . 29.36 112.159 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -64.53 -34.19 77.67 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 113.898 1.073 . . . . 27.78 113.898 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1040 ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' 1046 ' ' ASP . . . -59.76 -19.48 49.49 Favored Glycine 0 N--CA 1.427 -1.963 0 CA-C-N 112.14 -2.3 . . . . 28.91 114.648 175.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -76.24 -44.94 35.26 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 120.076 1.938 . . . . 51.18 110.646 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1042 ' ' LEU . . . . . 0.481 HD12 ' HG2' ' A' 1007 ' ' ARG . 20.6 mt -64.32 -50.01 69.5 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.949 0.881 . . . . 29.91 111.39 173.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1043 ' ' ALA . . . . . 0.411 ' HB3' ' HA2' ' A' 1040 ' ' GLY 0.267 . . -53.5 -22.65 8.46 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 112.807 -1.997 . . . . 28.54 114.477 172.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 1044 ' ' SER . . . . . . . . . . . . . 15.5 m 53.98 44.93 28.65 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 124.688 2.185 . . . . 33.06 110.281 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1045 ' ' PHE . . . . . 0.437 ' HA ' ' HB3' ' B' 1277 ' ' ALA . 0.1 OUTLIER -167.59 102.82 0.5 Allowed 'General case' 0 C--O 1.249 1.066 0 N-CA-C 100.292 -3.966 . . . . 30.29 100.292 178.105 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 1046 ' ' ASP . . . . . 0.5 ' HA ' ' HA3' ' A' 1040 ' ' GLY . 2.9 p-10 -84.51 168.85 15.05 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 123.479 1.609 . . . . 48.62 114.464 -151.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1047 ' ' ASP . . . . . 0.479 ' HA ' ' HD2' ' A' 1050 ' ' PHE . 2.8 m-20 -46.01 -45.85 16.16 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 112.499 -2.137 . . . . 36.74 115.609 -172.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 22.5 pttm -54.21 -40.71 67.88 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 115.191 1.552 . . . . 43.73 115.191 169.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -65.02 -31.52 72.8 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 119.752 1.16 . . . . 32.81 112.275 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1050 ' ' PHE . . . . . 0.479 ' HD2' ' HA ' ' A' 1047 ' ' ASP . 58.4 m-85 -64.01 -42.37 97.16 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 111.612 0.227 . . . . 31.86 111.612 169.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 41.3 t -61.68 -46.61 96.18 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 N-CA-C 106.774 -1.565 . . . . 33.22 106.774 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -55.15 -37.06 66.47 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 123.914 0.885 . . . . 50.83 112.521 174.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -62.56 -41.45 98.93 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 120.065 1.302 . . . . 33.12 112.578 172.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1054 ' ' GLY . . . . . 0.44 ' HA3' HD22 ' A' 1027 ' ' LEU . . . 120.31 81.36 0.67 Allowed Glycine 0 C--O 1.21 -1.399 0 N-CA-C 106.039 -2.824 . . . . 35.83 106.039 -177.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -161.06 132.22 5.45 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 125.162 1.154 . . . . 34.82 109.204 -173.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -71.19 135.3 47.48 Favored 'General case' 0 N--CA 1.44 -0.945 0 O-C-N 126.727 2.517 . . . . 49.05 107.201 166.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1057 ' ' ILE . . . . . . . . . . . . . 36.1 mm -104.43 125.95 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 101.951 -3.351 . . . . 38.53 101.951 169.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1058 ' ' VAL . . . . . 0.556 ' HB ' ' HB ' ' A' 1063 ' ' VAL . 44.1 t -102.29 135.72 37.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 103.566 -2.753 . . . . 42.11 103.566 174.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -69.38 76.08 0.38 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 114.13 1.159 . . . . 58.0 114.13 178.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1060 ' ' GLY . . . . . 0.466 ' O ' HG12 ' A' 1063 ' ' VAL . . . 80.08 -129.83 9.38 Favored Glycine 0 N--CA 1.422 -2.253 0 C-N-CA 121.092 -0.575 . . . . 52.12 113.187 177.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 29.4 t30 -46.79 -40.14 13.13 Favored 'General case' 0 C--O 1.217 -0.612 0 N-CA-C 117.963 2.579 . . . . 54.75 117.963 -156.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1062 ' ' SER . . . . . . . . . . . . . 15.3 m -67.79 -9.36 43.58 Favored 'General case' 0 C--O 1.247 0.932 0 O-C-N 118.23 -2.794 . . . . 50.34 116.468 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1063 ' ' VAL . . . . . 0.556 ' HB ' ' HB ' ' A' 1058 ' ' VAL . 8.3 p -64.08 -26.57 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 O-C-N 120.763 -1.211 . . . . 41.46 111.444 169.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1064 ' ' TRP . . . . . . . . . . . . . 76.8 m95 -72.42 -23.01 61.02 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.941 1.296 . . . . 39.32 112.312 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -83.49 73.58 10.18 Favored 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 120.743 -1.223 . . . . 55.38 109.058 175.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1066 ' ' SER . . . . . . . . . . . . . 70.5 m -146.34 164.7 31.56 Favored 'General case' 0 C--O 1.257 1.468 0 CA-C-O 121.661 0.743 . . . . 41.87 109.983 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.11 -66.84 0.63 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.04 -0.982 . . . . 53.2 109.571 -176.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1068 ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' 1003 ' ' ILE . 31.4 mt -88.63 110.48 21.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 O-C-N 118.236 -2.79 . . . . 41.9 104.97 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1069 ' ' ILE . . . . . . . . . . . . . 28.1 mm -102.12 119.42 50.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 107.046 -1.465 . . . . 38.73 107.046 168.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1070 ' ' LEU . . . . . 0.681 ' HB3' HD13 ' A' 1331 ' ' LEU . 81.6 mt -88.02 74.83 8.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.736 -1.12 . . . . 32.44 110.126 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1071 ' ' LYS . . . . . 0.576 ' HE2' ' HA ' ' A' 1075 ' ' PRO . 5.1 mmmt -71.54 128.65 36.53 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 121.98 0.895 . . . . 34.65 111.111 -176.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1072 ' ' VAL . . . . . 0.676 HG11 ' HB3' ' A' 1015 ' ' ARG . 0.8 OUTLIER -82.04 -30.7 10.08 Favored 'Isoleucine or valine' 0 C--O 1.251 1.17 0 N-CA-C 109.167 -0.679 . . . . 31.32 109.167 -163.083 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 1073 ' ' ASN . . . . . 0.448 ' O ' ' HE3' ' A' 1071 ' ' LYS . 73.1 m-20 -128.61 -171.1 2.38 Favored 'General case' 0 C--O 1.246 0.902 0 N-CA-C 108.305 -0.998 . . . . 33.94 108.305 171.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -54.5 141.89 52.85 Favored Pre-proline 0 N--CA 1.47 0.556 0 CA-C-N 119.783 1.174 . . . . 38.04 112.069 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1075 ' ' PRO . . . . . 0.69 ' HG2' HD21 ' A' 1089 ' ' LEU . 82.2 Cg_exo -72.76 130.56 15.93 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.37 2.047 . . . . 42.68 112.892 173.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 17.8 mt -105.98 165.13 11.43 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 103.969 -2.604 . . . . 46.74 103.969 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1077 ' ' ASP . . . . . 0.422 ' O ' ' HB ' ' A' 1080 ' ' ILE . 75.3 m-20 -31.01 -58.7 0.22 Allowed 'General case' 0 C--N 1.357 0.909 0 N-CA-C 117.057 2.243 . . . . 58.61 117.057 -173.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 13.8 t70 -62.79 -43.63 98.28 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 113.496 0.924 . . . . 59.2 113.496 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1079 ' ' GLU . . . . . 0.433 ' CD ' ' HZ3' ' A' 1071 ' ' LYS . 33.4 mt-10 -64.93 -37.88 89.1 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 113.581 0.956 . . . . 50.63 113.581 176.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1080 ' ' ILE . . . . . 0.522 HG12 HD21 ' A' 1105 ' ' LEU . 25.0 mt -54.01 -54.03 23.48 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.88 0 CA-C-N 112.906 -1.952 . . . . 51.48 108.882 175.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -59.34 -25.69 64.41 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 123.812 1.768 . . . . 50.28 114.315 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 61.5 mt -77.92 -41.88 34.98 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 120.48 -1.387 . . . . 50.21 111.424 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1083 ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' 1080 ' ' ILE . 0.0 OUTLIER -55.27 139.92 40.88 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 123.93 1.824 . . . . 49.06 112.936 -178.119 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -101.8 152.69 38.17 Favored Pre-proline 0 N--CA 1.435 -1.185 0 CA-C-N 112.197 -2.274 . . . . 51.08 108.543 -156.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -64.07 109.67 1.18 Allowed 'Trans proline' 0 C--N 1.322 -0.824 0 CA-C-N 121.446 1.552 . . . . 49.73 114.006 170.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 110.94 -7.04 29.3 Favored Glycine 0 C--N 1.316 -0.539 0 C-N-CA 119.103 -1.522 . . . . 47.71 113.424 -171.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1087 ' ' THR . . . . . 0.6 ' HB ' HG12 ' A' 1110 ' ' VAL . 2.8 m -64.18 118.35 8.46 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 117.487 0.643 . . . . 45.47 110.921 176.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1088 ' ' THR . . . . . . . . . . . . . 99.2 m -83.86 93.51 8.02 Favored 'General case' 0 N--CA 1.411 -2.4 0 N-CA-C 104.491 -2.411 . . . . 42.04 104.491 172.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1089 ' ' LEU . . . . . 0.69 HD21 ' HG2' ' A' 1075 ' ' PRO . 55.0 tp -84.88 87.31 7.33 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 110.321 -3.127 . . . . 38.06 108.796 -174.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 15.8 t -83.11 120.16 33.91 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.813 0 N-CA-C 105.2 -2.148 . . . . 37.4 105.2 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1091 ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' 1071 ' ' LYS . 13.7 p -154.46 143.38 20.99 Favored 'General case' 0 C--O 1.247 0.974 0 O-C-N 119.454 -2.029 . . . . 36.16 114.897 -168.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 45.5 t80 -84.26 82.48 8.36 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-O 124.138 1.923 . . . . 38.94 109.694 168.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.28 -31.39 3.7 Favored 'Isoleucine or valine' 0 C--O 1.254 1.294 0 N-CA-C 116.865 2.172 . . . . 42.17 116.865 -169.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 99.0 m95 58.5 75.08 0.55 Allowed Pre-proline 0 C--O 1.247 0.932 0 CA-C-O 122.782 1.277 . . . . 46.51 113.039 -168.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1095 ' ' PRO . . . . . 0.563 ' HG3' HG11 ' A' 1360 ' ' VAL . 46.7 Cg_endo -60.04 -40.81 58.05 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 124.613 3.542 . . . . 49.76 115.687 -172.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1096 ' ' ALA . . . . . 0.457 ' HA ' ' HZ2' ' A' 1368 ' ' TRP . . . -61.15 -29.31 69.71 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.633 1.206 . . . . 52.62 113.84 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1097 ' ' GLN . . . . . 0.537 ' NE2' ' HA2' ' A' 1260 ' ' GLY . 28.0 mp0 -83.84 -24.27 30.99 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 106.276 -1.75 . . . . 60.74 106.276 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1098 ' ' ASN . . . . . 0.487 ' HB3' ' HB3' ' A' 1101 ' ' LEU . 61.1 m-80 -122.15 55.05 5.9 Favored Pre-proline 0 C--O 1.239 0.514 0 O-C-N 119.817 -1.802 . . . . 58.19 115.426 -168.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.01 -41.57 73.64 Favored 'Trans proline' 0 N--CA 1.476 0.478 1 C-N-CA 125.891 4.394 . . . . 54.59 114.218 -176.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -47.69 77.2 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.027 -0.988 . . . . 63.28 111.845 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1101 ' ' LEU . . . . . 0.487 ' HB3' ' HB3' ' A' 1098 ' ' ASN . 7.6 tp -56.89 -41.43 78.07 Favored 'General case' 0 C--O 1.254 1.307 0 CA-C-N 113.304 -1.771 . . . . 54.75 112.288 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1102 ' ' MET . . . . . 0.46 ' HE1' ' HB ' ' A' 1360 ' ' VAL . 75.0 mmm -57.09 -49.0 77.22 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 126.204 2.19 . . . . 52.65 109.598 174.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -65.01 -35.34 80.89 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.41 1.005 . . . . 66.26 111.116 -175.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -64.87 -43.88 91.53 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 109.136 -0.69 . . . . 63.73 109.136 177.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1105 ' ' LEU . . . . . 0.522 HD21 HG12 ' A' 1080 ' ' ILE . 49.0 mt -69.51 -30.57 68.45 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.926 0.869 . . . . 54.68 112.593 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -55.63 -48.92 74.13 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.482 0.919 . . . . 53.64 113.482 165.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -52.57 -46.58 66.92 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 114.479 1.289 . . . . 67.24 114.479 173.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -58.39 -22.16 52.87 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.702 -0.681 . . . . 65.76 111.95 174.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 45.2 t30 68.58 44.33 1.23 Allowed 'General case' 0 C--O 1.239 0.552 0 CA-C-O 124.322 2.011 . . . . 58.71 112.075 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1110 ' ' VAL . . . . . 0.6 HG12 ' HB ' ' A' 1087 ' ' THR . 28.3 m -93.11 165.7 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 O-C-N 119.288 -2.132 . . . . 46.63 112.109 175.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1111 ' ' THR . . . . . 0.485 HG21 HG21 ' A' 1348 ' ' VAL . 58.7 m -102.32 101.4 11.65 Favored 'General case' 0 C--O 1.214 -0.794 0 O-C-N 119.281 -2.137 . . . . 44.13 110.078 165.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1112 ' ' VAL . . . . . 0.679 HG22 HD23 ' A' 1089 ' ' LEU . 48.6 t -90.96 117.58 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 109.513 -0.551 . . . . 40.44 109.513 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1113 ' ' MET . . . . . 0.744 ' SD ' HD21 ' A' 1338 ' ' LEU . 58.3 mtp -112.61 108.16 17.13 Favored 'General case' 0 N--CA 1.422 -1.842 0 C-N-CA 124.105 0.962 . . . . 50.76 108.788 178.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1114 ' ' ALA . . . . . 0.603 ' HB3' ' HB2' ' A' 1117 ' ' SER . . . -81.37 115.42 20.71 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 116.065 -0.516 . . . . 35.64 111.575 -172.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1115 ' ' MET . . . . . 0.502 ' SD ' HD22 ' A' 1334 ' ' LEU . 93.5 mmm -76.0 -21.0 57.37 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 123.616 1.674 . . . . 38.74 114.877 -176.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -62.73 -50.38 71.33 Favored 'General case' 0 CA--C 1.482 -1.643 0 CA-C-N 112.767 -2.015 . . . . 40.14 111.692 163.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1117 ' ' SER . . . . . 0.603 ' HB2' ' HB3' ' A' 1114 ' ' ALA . 75.8 m -76.12 22.22 0.16 Allowed 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 118.866 2.913 . . . . 44.79 118.866 -175.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1118 ' ' VAL . . . . . 0.499 ' HA ' HG22 ' A' 1358 ' ' VAL . 59.9 t -66.12 130.75 94.36 Favored Pre-proline 0 C--O 1.249 1.063 0 N-CA-C 107.322 -1.362 . . . . 43.75 107.322 175.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -61.63 133.64 46.53 Favored 'Trans proline' 0 N--CA 1.428 -2.33 0 N-CA-C 107.903 -1.614 . . . . 48.93 107.903 175.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1120 ' ' ARG . . . . . 0.456 ' HD2' ' O ' ' A' 1118 ' ' VAL . 23.4 mmm-85 -79.5 41.02 0.46 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 113.861 -1.518 . . . . 62.9 114.665 -161.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 18.1 pt -116.56 155.15 18.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 O-C-N 119.978 -1.701 . . . . 57.72 113.132 -167.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1122 ' ' SER . . . . . . . . . . . . . 2.8 m -27.23 -64.73 0.08 Allowed 'General case' 0 C--N 1.312 -1.024 0 O-C-N 127.07 2.731 . . . . 57.26 116.637 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 39.9 ptt85 -68.53 -22.36 64.52 Favored 'General case' 0 C--N 1.353 0.726 0 O-C-N 119.655 -1.903 . . . . 62.9 112.428 -172.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1124 ' ' ALA . . . . . 0.409 ' HA ' HD13 ' A' 1127 ' ' LEU . . . -77.68 -13.66 59.84 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 115.108 1.521 . . . . 49.83 115.108 174.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 42.0 mm-40 -59.85 -29.22 68.14 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 119.04 2.978 . . . . 52.37 119.04 -165.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1126 ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' B' 1160 ' ' ALA . 15.8 m -69.96 -22.28 63.17 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 115.43 1.641 . . . . 42.43 115.43 168.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1127 ' ' LEU . . . . . 0.566 HD23 HD12 ' A' 1334 ' ' LEU . 3.3 mp -88.22 -45.48 10.05 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.179 -2.156 . . . . 43.74 105.179 177.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 30.3 t0 -50.45 109.23 0.29 Allowed 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 116.238 1.94 . . . . 43.21 116.238 -176.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -79.04 -30.06 43.9 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.68 -1.6 . . . . 35.74 113.134 176.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 80.8 mt -72.7 -6.52 45.01 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 119.545 -1.972 . . . . 38.09 111.945 175.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1131 ' ' SER . . . . . 0.556 ' HB3' HG11 ' A' 1175 ' ' VAL . 32.9 m -94.73 -57.66 2.4 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 107.801 -1.185 . . . . 36.91 107.801 161.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1132 ' ' SER . . . . . . . . . . . . . 22.2 m -77.28 -51.9 10.1 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 117.094 -1.431 . . . . 35.79 113.848 -169.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1133 ' ' MET . . . . . 0.582 ' HA ' HD12 ' A' 1136 ' ' ILE . 81.6 mtp -58.25 -37.81 75.67 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 124.274 3.215 . . . . 30.81 110.045 173.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1134 ' ' ALA . . . . . 0.514 ' HB1' ' HB2' ' A' 1176 ' ' ALA . . . -65.98 -34.19 77.53 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 120.538 -0.465 . . . . 28.88 110.333 177.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1135 ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -60.79 -46.21 91.4 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 120.704 -1.248 . . . . 40.76 108.938 173.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1136 ' ' ILE . . . . . 0.893 HD13 ' HA ' ' A' 1323 ' ' SER . 16.8 mt -56.78 -50.65 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 117.631 -1.176 . . . . 31.54 111.745 172.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1137 ' ' ALA . . . . . 0.526 ' HB2' ' HG3' ' A' 1316 ' ' PRO . . . -53.56 -38.41 63.85 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 114.672 1.36 . . . . 29.87 114.672 169.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -63.9 -41.41 98.73 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-O 123.41 1.561 . . . . 28.73 111.652 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 17.0 t80 -71.68 -46.37 59.03 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-N 114.16 -1.02 . . . . 30.39 110.428 176.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1140 ' ' ARG . . . . . 0.513 HH11 HD13 ' A' 1319 ' ' LEU . 14.9 tpt180 -67.94 -19.97 65.03 Favored 'General case' 0 C--N 1.356 0.884 0 N-CA-C 107.949 -1.13 . . . . 26.09 107.949 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1141 ' ' ALA . . . . . 0.445 ' HB1' HG21 ' A' 1282 ' ' VAL . . . -62.89 -48.66 78.04 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 106.833 -1.543 . . . . 27.1 106.833 172.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 36.3 mm -64.53 -42.68 95.9 Favored 'Isoleucine or valine' 0 C--N 1.346 0.44 0 CA-C-N 119.343 0.974 . . . . 28.48 109.792 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1143 ' ' VAL . . . . . 0.408 ' HB ' ' HA ' ' A' 1140 ' ' ARG . 21.8 t -54.86 -60.04 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 113.533 0.938 . . . . 23.07 113.533 175.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1144 ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -71.7 -27.98 63.4 Favored 'General case' 0 C--O 1.248 0.989 0 O-C-N 119.561 -1.962 . . . . 33.4 112.456 -174.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1145 ' ' ALA . . . . . 0.701 ' HB1' HD12 ' A' 1251 ' ' ILE . . . -62.18 -49.04 77.38 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 106.54 -1.652 . . . . 24.22 106.54 175.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1146 ' ' ALA . . . . . 0.557 ' HA ' ' HB2' ' A' 1149 ' ' PHE . . . -58.76 -33.74 70.62 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 115.375 1.62 . . . . 24.89 115.375 171.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -61.96 -31.62 71.98 Favored 'General case' 0 C--N 1.372 1.569 0 CA-C-O 117.925 -1.036 . . . . 26.73 111.628 175.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1148 ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -109.77 1.63 19.5 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 115.706 1.743 . . . . 39.96 115.706 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1149 ' ' PHE . . . . . 0.557 ' HB2' ' HA ' ' A' 1146 ' ' ALA . 0.6 OUTLIER -64.47 138.38 58.38 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 126.06 1.744 . . . . 25.87 110.516 -170.125 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 1150 ' ' GLY . . . . . 0.566 ' HA2' ' HG2' ' B' 1320 ' ' PRO . . . -73.01 -55.46 6.34 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 110.259 -1.136 . . . . 19.28 110.259 171.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1151 ' ' ARG . . . . . 0.759 ' HA ' ' HB2' ' B' 1322 ' ' GLN . 33.4 mtm-85 -94.37 -178.8 4.7 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 113.025 0.75 . . . . 39.9 113.025 -174.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1152 ' ' PHE . . . . . 0.821 ' HB2' HG11 ' A' 1163 ' ' VAL . 19.3 m-30 -85.68 160.6 19.52 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 116.578 -2.049 . . . . 29.44 111.716 171.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1153 ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -73.27 -58.45 3.31 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 122.45 1.119 . . . . 32.6 108.523 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1154 ' ' THR . . . . . . . . . . . . . 20.9 m -62.86 123.93 19.74 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 125.536 1.534 . . . . 34.64 110.379 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -80.48 71.26 2.85 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 109.957 -1.257 . . . . 37.14 109.957 174.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -90.75 139.36 30.8 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 120.848 -0.341 . . . . 40.57 111.113 -166.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1157 ' ' ILE . . . . . 0.659 HG13 ' HB3' ' C' ' 70' ' ' PRO . 2.6 tp -73.77 112.28 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 107.86 -1.163 . . . . 44.61 107.86 168.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1158 ' ' THR . . . . . . . . . . . . . 42.6 p -91.21 174.53 7.35 Favored 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 109.013 -0.736 . . . . 40.7 109.013 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -49.06 -39.97 29.64 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 115.469 1.655 . . . . 40.25 115.469 167.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -86.55 -46.69 9.91 Favored 'General case' 0 C--O 1.253 1.255 0 N-CA-C 116.194 1.924 . . . . 38.47 116.194 178.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1161 ' ' GLY . . . . . 0.533 ' HA3' HG21 ' B' 1329 ' ' THR . . . -172.24 179.07 44.08 Favored Glycine 0 N--CA 1.475 1.259 0 CA-C-O 124.456 2.142 . . . . 37.61 116.493 -170.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1162 ' ' LYS . . . . . 0.486 ' HB2' ' HB2' ' C' ' 95' ' ' GLU . 17.1 tttt -76.27 115.06 15.65 Favored 'General case' 0 C--O 1.251 1.168 0 CA-C-N 111.995 -2.103 . . . . 48.9 108.788 -178.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1163 ' ' VAL . . . . . 0.821 HG11 ' HB2' ' A' 1152 ' ' PHE . 38.8 t -69.36 128.97 92.11 Favored Pre-proline 0 C--O 1.243 0.747 0 CA-C-O 116.662 -1.637 . . . . 36.52 108.977 171.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1164 ' ' PRO . . . . . 0.502 ' HA ' ' HD2' ' A' 1165 ' ' PRO . 42.6 Cg_exo -77.29 103.79 1.79 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 124.047 3.165 . . . . 35.08 112.151 177.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1165 ' ' PRO . . . . . 0.502 ' HD2' ' HA ' ' A' 1164 ' ' PRO . 55.5 Cg_endo -46.86 151.37 2.18 Favored 'Trans proline' 0 N--CA 1.455 -0.762 1 C-N-CA 125.46 4.107 . . . . 35.33 117.67 -173.072 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -79.27 137.47 37.39 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.948 1.356 . . . . 34.69 109.284 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1167 ' ' LYS . . . . . 0.606 ' HB2' ' HA ' ' A' 1249 ' ' VAL . 6.7 mptt -99.91 105.86 17.62 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 103.972 -2.603 . . . . 45.36 103.972 171.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 58.8 t -90.57 90.2 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 N-CA-C 105.039 -2.208 . . . . 31.71 105.039 -176.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1169 ' ' MET . . . . . 0.456 ' O ' ' HA ' ' A' 1252 ' ' ILE . 6.2 ttp -80.5 116.81 20.74 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.449 -1.315 . . . . 42.28 107.449 172.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 86.0 t -91.08 136.06 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 105.574 -2.01 . . . . 30.51 105.574 176.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 15.8 mt -109.92 120.5 61.12 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 N-CA-C 104.46 -2.422 . . . . 31.87 104.46 170.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1172 ' ' GLY . . . . . 0.457 ' HA3' ' HB2' ' A' 1256 ' ' ALA . . . 87.3 80.73 1.22 Allowed Glycine 0 C--O 1.256 1.489 0 N-CA-C 109.63 -1.388 . . . . 34.54 109.63 175.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1173 ' ' ALA . . . . . . . . . . . . . . . -87.34 118.83 27.04 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 122.726 1.25 . . . . 32.51 109.819 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1174 ' ' GLY . . . . . 0.587 ' HA2' HG11 ' A' 1200 ' ' VAL . . . -148.34 -149.8 5.06 Favored Glycine 0 N--CA 1.437 -1.249 0 N-CA-C 106.513 -2.635 . . . . 29.9 106.513 164.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1175 ' ' VAL . . . . . 0.556 HG11 ' HB3' ' A' 1131 ' ' SER . 54.1 t -57.21 -41.67 78.45 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 CA-C-N 121.101 2.45 . . . . 33.11 111.382 -175.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1176 ' ' ALA . . . . . 0.514 ' HB2' ' HB1' ' A' 1134 ' ' ALA . . . -60.02 -49.5 77.42 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-N 114.301 -1.318 . . . . 28.1 111.659 176.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -59.52 -46.96 93.1 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 108.458 -1.857 . . . . 28.54 108.458 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1178 ' ' LEU . . . . . . . . . . . . . 47.9 mt -58.77 -29.72 67.0 Favored 'General case' 0 C--O 1.241 0.62 0 O-C-N 119.129 -2.395 . . . . 31.22 113.447 175.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -58.68 -55.74 31.24 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-O 122.356 1.074 . . . . 28.98 110.88 168.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -55.85 -43.43 77.06 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 113.886 -1.507 . . . . 27.83 114.446 177.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1181 ' ' ILE . . . . . . . . . . . . . 74.8 mt -62.05 -49.52 83.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 107.89 -1.152 . . . . 30.25 107.89 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -54.47 -34.54 55.08 Favored Glycine 0 C--N 1.343 0.928 0 O-C-N 126.744 2.527 . . . . 29.59 113.512 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -74.92 -61.77 1.77 Allowed 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 117.503 0.652 . . . . 30.29 112.52 170.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1184 ' ' ALA . . . . . 0.427 ' HA ' HD12 ' A' 1187 ' ' LEU . . . -59.69 -32.21 70.29 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-O 121.752 0.787 . . . . 30.47 113.088 -166.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1185 ' ' ASN . . . . . 0.589 ' ND2' ' HA3' ' A' 1208 ' ' GLY . 14.5 t-20 -56.49 -53.3 59.04 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.622 1.169 . . . . 42.41 112.206 173.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1186 ' ' SER . . . . . . . . . . . . . 3.6 m -64.41 -39.66 94.28 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.765 -1.107 . . . . 39.38 109.295 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1187 ' ' LEU . . . . . 0.942 ' HA ' ' HB3' ' B' 1186 ' ' SER . 25.8 mt -55.87 -34.71 65.73 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 115.826 1.787 . . . . 36.18 115.826 173.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 93.27 48.37 2.84 Favored Glycine 0 CA--C 1.534 1.259 0 O-C-N 124.108 0.88 . . . . 33.78 112.317 -177.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -113.98 162.02 16.94 Favored 'General case' 0 C--O 1.247 0.958 0 O-C-N 126.114 1.714 . . . . 33.93 108.756 172.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 66.1 mt -84.8 103.02 11.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 104.55 -2.389 . . . . 38.74 104.55 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 3.5 t -94.48 142.5 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 O-C-N 120.958 -1.089 . . . . 33.09 108.847 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1192 ' ' ARG . . . . . 0.498 ' HB3' ' HG ' ' A' 1212 ' ' LEU . 98.6 mtt180 -143.76 108.78 4.97 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.06 -1.089 . . . . 38.92 108.06 177.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -96.42 120.16 36.22 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 120.335 -1.478 . . . . 35.32 113.988 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 87.4 t80 -80.34 131.13 35.59 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 114.984 -1.007 . . . . 39.35 109.501 166.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 8.0 t70 -150.74 178.56 9.0 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 105.397 -2.075 . . . . 40.46 105.397 153.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1196 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.08 -31.98 9.91 Favored 'General case' 0 N--CA 1.428 -1.556 0 O-C-N 119.569 -1.957 . . . . 45.94 108.875 175.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1197 ' ' ARG . . . . . . . . . . . . . 53.0 mtm180 -69.63 133.44 88.73 Favored Pre-proline 0 N--CA 1.445 -0.684 0 O-C-N 120.832 -1.167 . . . . 56.02 109.916 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1198 ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -67.08 -28.29 41.31 Favored 'Trans proline' 0 C--O 1.242 0.719 0 C-N-CA 124.537 3.491 . . . . 51.27 118.276 173.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -55.71 -55.14 35.8 Favored 'General case' 0 C--O 1.254 1.334 0 O-C-N 119.925 -1.734 . . . . 59.1 114.037 -168.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1200 ' ' VAL . . . . . 0.587 HG11 ' HA2' ' A' 1174 ' ' GLY . 18.5 m -53.8 -25.35 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 116.749 2.129 . . . . 51.06 116.749 176.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 98.9 mttt -47.36 -43.45 23.13 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 115.774 1.768 . . . . 57.38 115.774 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -54.17 -51.29 64.8 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 122.942 1.353 . . . . 62.41 113.542 -175.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -70.87 -41.72 71.02 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 111.31 -2.677 . . . . 57.78 112.97 177.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1204 ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' 1209 ' ' ALA . 4.8 t -45.29 -49.88 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.448 1.499 . . . . 46.38 112.429 174.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -68.22 -52.82 29.85 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 113.639 -1.618 . . . . 50.7 112.435 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1206 ' ' SER . . . . . . . . . . . . . 41.0 p -66.87 -28.39 68.3 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.65 -0.705 . . . . 49.98 112.37 -172.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1207 ' ' MET . . . . . . . . . . . . . 12.3 mtt -66.55 -67.79 0.42 Allowed 'General case' 0 C--O 1.249 1.055 0 N-CA-C 106.562 -1.644 . . . . 52.99 106.562 166.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1208 ' ' GLY . . . . . 0.589 ' HA3' ' ND2' ' A' 1185 ' ' ASN . . . 154.9 60.25 0.01 OUTLIER Glycine 0 CA--C 1.522 0.522 0 CA-C-O 123.217 1.454 . . . . 47.66 112.955 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1209 ' ' ALA . . . . . 0.421 ' HB3' HG13 ' A' 1204 ' ' VAL . . . -141.44 145.5 35.36 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 112.347 -1.926 . . . . 44.77 111.32 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1210 ' ' GLU . . . . . 0.407 ' HB2' ' HG2' ' A' 1192 ' ' ARG . 37.3 mt-10 -74.01 155.51 38.51 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 104.068 -2.568 . . . . 47.64 104.068 163.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1211 ' ' PHE . . . . . . . . . . . . . 44.0 t80 -94.61 131.58 40.24 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 105.772 -1.936 . . . . 45.66 105.772 163.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1212 ' ' LEU . . . . . 0.498 ' HG ' ' HB3' ' A' 1192 ' ' ARG . 72.7 mt -88.33 108.42 19.33 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 106.993 -1.484 . . . . 46.06 106.993 174.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -82.19 133.26 35.25 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 111.801 -2.454 . . . . 60.22 109.012 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 4.9 tp -41.72 133.51 2.72 Favored 'General case' 0 C--O 1.241 0.609 0 O-C-N 127.858 3.224 . . . . 57.25 110.69 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 27.8 t0 -76.58 75.16 3.29 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 123.509 1.623 . . . . 64.43 114.013 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 3.2 t80 . . . . . 0 C--O 1.213 -0.853 0 N-CA-C 102.801 -3.037 . . . . 66.9 102.801 -171.806 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 N--CA 1.421 -1.886 0 N-CA-C 107.917 -1.142 . . . . 39.09 107.917 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -61.62 -45.26 96.68 Favored Glycine 0 CA--C 1.535 1.285 0 N-CA-C 115.988 1.155 . . . . 39.32 115.988 -174.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 91.5 t80 -72.98 -43.53 62.11 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 120.455 2.128 . . . . 39.3 112.639 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -69.31 -27.17 65.15 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 118.311 -2.743 . . . . 36.3 112.4 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -61.89 -60.44 3.64 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 120.089 -1.632 . . . . 37.38 106.988 163.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -52.42 -61.13 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.581 0 N-CA-C 116.769 2.137 . . . . 39.11 116.769 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1230 ' ' MET . . . . . 0.507 ' SD ' HD11 ' A' 1235 ' ' ILE . 34.7 mmt -89.94 49.38 1.71 Allowed 'General case' 0 C--O 1.251 1.166 0 O-C-N 118.197 -2.814 . . . . 49.59 116.202 -174.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1231 ' ' SER . . . . . . . . . . . . . 67.7 p -98.57 163.85 12.5 Favored 'General case' 0 C--O 1.253 1.286 0 CA-C-N 113.972 -1.467 . . . . 43.68 108.999 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.43 -36.85 83.84 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 116.172 -0.467 . . . . 55.57 110.928 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1233 ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' A' 1236 ' ' LYS . . . -60.31 -54.79 41.53 Favored 'General case' 0 C--O 1.215 -0.748 0 C-N-CA 125.403 1.481 . . . . 44.94 112.157 173.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -60.63 -52.49 64.91 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 115.23 1.566 . . . . 42.04 115.23 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1235 ' ' ILE . . . . . 0.507 HD11 ' SD ' ' A' 1230 ' ' MET . 94.8 mt -57.28 -32.26 40.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-O 123.491 1.615 . . . . 46.28 113.65 173.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1236 ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' 1233 ' ' ALA . 47.9 tttm -58.12 -57.67 11.81 Favored 'General case' 0 C--O 1.252 1.21 0 CA-C-O 124.525 2.107 . . . . 47.87 111.323 170.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1237 ' ' ALA . . . . . 0.422 ' HA ' ' HB2' ' A' 1240 ' ' GLU . . . -70.92 -11.89 61.23 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 115.731 1.752 . . . . 41.61 115.731 -175.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -67.73 -62.94 1.17 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.714 -1.587 . . . . 50.65 106.714 170.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1239 ' ' MET . . . . . . . . . . . . . 2.4 mtm -58.44 -35.42 72.1 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 121.158 -0.964 . . . . 48.87 113.249 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1240 ' ' GLU . . . . . 0.422 ' HB2' ' HA ' ' A' 1237 ' ' ALA . 91.0 mt-10 -68.73 -26.64 65.36 Favored 'General case' 0 C--O 1.25 1.11 0 C-N-CA 120.79 -0.364 . . . . 54.8 111.379 176.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 2.3 tm? -69.83 -56.99 5.64 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.962 -0.755 . . . . 43.21 108.962 166.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1242 ' ' PHE . . . . . 0.573 ' HE2' HD13 ' A' 1266 ' ' LEU . 22.9 m-30 -57.95 -41.79 83.58 Favored 'General case' 0 C--O 1.221 -0.409 0 O-C-N 124.76 1.287 . . . . 38.66 111.749 -166.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -68.84 -38.07 79.55 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.402 1.001 . . . . 37.92 111.764 -175.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -63.38 -51.0 67.69 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 120.266 -1.521 . . . . 37.28 109.994 174.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 -59.2 -34.36 72.06 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.232 1.413 . . . . 43.07 109.897 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1246 ' ' ALA . . . . . 0.438 ' HB1' ' HG3' ' A' 1275 ' ' MET . . . -62.77 -17.95 61.86 Favored 'General case' 0 N--CA 1.439 -1.021 0 O-C-N 119.314 -2.116 . . . . 38.3 116.272 176.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1247 ' ' LYS . . . . . . . . . . . . . 16.5 mtmm -81.83 -1.93 49.18 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 122.532 1.158 . . . . 47.6 112.929 174.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1248 ' ' GLU . . . . . 0.448 ' CD ' HH12 ' A' 1192 ' ' ARG . 14.6 pt-20 -129.35 -35.69 1.75 Allowed 'General case' 0 C--O 1.239 0.537 0 CA-C-O 116.117 -1.897 . . . . 45.42 113.6 177.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1249 ' ' VAL . . . . . 0.606 ' HA ' ' HB2' ' A' 1167 ' ' LYS . 33.0 m -75.71 161.77 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 121.635 2.016 . . . . 36.26 114.614 -168.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1250 ' ' ASP . . . . . 0.506 ' O ' ' HB3' ' A' 1279 ' ' SER . 4.7 m-20 -108.84 -60.32 1.76 Allowed 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.129 -1.396 . . . . 33.04 109.647 -175.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1251 ' ' ILE . . . . . 0.701 HD12 ' HB1' ' A' 1145 ' ' ALA . 51.5 mm -110.91 112.89 42.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 107.436 -1.32 . . . . 31.4 107.436 -168.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1252 ' ' ILE . . . . . 0.652 HD12 HG12 ' A' 1281 ' ' ILE . 64.2 mt -100.6 102.8 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 104.249 -2.5 . . . . 29.42 104.249 176.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1253 ' ' VAL . . . . . 0.586 ' HA ' HG23 ' A' 1282 ' ' VAL . 89.9 t -84.78 97.74 5.56 Favored 'Isoleucine or valine' 0 C--O 1.251 1.173 0 N-CA-C 104.296 -2.483 . . . . 30.37 104.296 175.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1254 ' ' THR . . . . . 0.479 ' CG2' ' HB2' ' A' 1291 ' ' ASN . 3.8 m -93.58 70.48 4.22 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 104.449 -2.426 . . . . 35.72 104.449 -167.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1255 ' ' THR . . . . . 0.663 ' HA ' ' HB2' ' A' 1284 ' ' LEU . 0.8 OUTLIER -78.48 0.88 24.23 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 119.443 -2.036 . . . . 36.0 115.844 -175.235 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 1256 ' ' ALA . . . . . 0.457 ' HB2' ' HA3' ' A' 1172 ' ' GLY . . . -64.77 68.83 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 118.297 2.702 . . . . 40.93 118.297 176.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 60.4 tp -77.8 91.81 4.15 Favored 'General case' 0 C--O 1.246 0.909 0 N-CA-C 106.456 -1.683 . . . . 47.82 106.456 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1258 ' ' ILE . . . . . 0.527 ' HA ' ' HD3' ' A' 1259 ' ' PRO . 39.3 mm -64.53 128.85 93.86 Favored Pre-proline 0 C--O 1.241 0.608 0 N-CA-C 108.275 -1.009 . . . . 52.7 108.275 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1259 ' ' PRO . . . . . 0.527 ' HD3' ' HA ' ' A' 1258 ' ' ILE . 51.0 Cg_exo -62.05 108.49 0.67 Allowed 'Trans proline' 0 N--CA 1.439 -1.701 0 C-N-CA 123.933 3.089 . . . . 54.13 109.786 -175.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1260 ' ' GLY . . . . . 0.537 ' HA2' ' NE2' ' A' 1097 ' ' GLN . . . 82.44 -64.95 4.19 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-O 118.186 -1.341 . . . . 54.62 113.589 168.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 13.5 mttp -65.9 137.03 95.87 Favored Pre-proline 0 C--O 1.216 -0.677 0 C-N-CA 125.468 1.507 . . . . 55.74 110.728 173.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -52.81 144.79 42.56 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.636 2.891 . . . . 51.15 116.371 176.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -67.28 133.72 93.31 Favored Pre-proline 0 CA--C 1.529 0.157 0 O-C-N 121.996 -0.44 . . . . 46.06 110.933 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -63.51 145.38 91.95 Favored 'Trans proline' 0 C--N 1.344 0.308 1 C-N-CA 125.914 4.409 . . . . 41.08 111.596 -178.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1265 ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' 1265 ' ' LYS . 67.8 mmtt -78.14 78.92 4.61 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 122.147 0.975 . . . . 47.42 109.785 -178.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1266 ' ' LEU . . . . . 0.573 HD13 ' HE2' ' A' 1242 ' ' PHE . 62.4 mt -83.82 -37.08 22.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.034 -1.439 . . . . 39.22 110.109 -171.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 15.4 mt -94.5 97.41 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 103.783 -2.673 . . . . 42.5 103.783 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1268 ' ' THR . . . . . 0.571 ' O ' HG23 ' A' 1272 ' ' VAL . 16.5 p -70.51 157.01 38.63 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 114.631 -1.168 . . . . 37.84 111.309 -176.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1269 ' ' ARG . . . . . 0.585 ' HG3' ' HB3' ' A' 1293 ' ' GLU . 97.5 mtt180 -52.09 -41.4 62.38 Favored 'General case' 0 CA--C 1.512 -0.499 0 O-C-N 120.994 -1.066 . . . . 54.8 111.833 168.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -44.37 -62.57 1.12 Allowed 'General case' 0 N--CA 1.476 0.836 0 O-C-N 125.362 1.664 . . . . 54.36 111.547 164.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1271 ' ' MET . . . . . . . . . . . . . 34.0 ttm -58.52 -44.36 89.48 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 120.726 1.603 . . . . 39.52 111.36 -173.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1272 ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' 1268 ' ' THR . 20.0 t -66.77 -46.58 85.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 115.793 -0.64 . . . . 38.25 111.553 -175.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.44 -3.84 26.65 Favored 'General case' 0 CA--C 1.506 -0.713 0 O-C-N 119.943 -1.723 . . . . 40.77 115.583 172.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1274 ' ' SER . . . . . . . . . . . . . 8.6 m -113.03 14.75 19.67 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 116.085 1.883 . . . . 36.58 116.085 164.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1275 ' ' MET . . . . . 0.633 ' HB3' HG21 ' A' 1307 ' ' VAL . 4.8 ttt -85.35 162.44 19.06 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.362 -0.977 . . . . 36.75 108.362 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1276 ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -63.07 132.48 52.05 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 124.198 1.951 . . . . 46.11 109.536 174.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1277 ' ' ALA . . . . . 0.68 ' HB1' ' HA ' ' B' 1045 ' ' PHE . . . -70.56 162.22 29.26 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 111.736 -2.484 . . . . 33.52 113.713 -172.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 67.28 27.54 73.52 Favored Glycine 0 N--CA 1.479 1.535 0 O-C-N 119.485 -2.01 . . . . 31.27 113.449 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1279 ' ' SER . . . . . 0.506 ' HB3' ' O ' ' A' 1250 ' ' ASP . 14.0 m -132.0 154.21 49.57 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 113.671 -1.265 . . . . 32.95 107.912 -168.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1280 ' ' VAL . . . . . 0.432 HG11 ' HA ' ' A' 1145 ' ' ALA . 18.5 t -126.52 123.88 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 122.082 0.944 . . . . 27.43 112.988 -171.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1281 ' ' ILE . . . . . 0.652 HG12 HD12 ' A' 1252 ' ' ILE . 52.1 mt -91.66 108.37 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 105.973 -1.862 . . . . 30.3 105.973 166.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1282 ' ' VAL . . . . . 0.586 HG23 ' HA ' ' A' 1253 ' ' VAL . 0.1 OUTLIER -89.13 124.0 41.66 Favored 'Isoleucine or valine' 0 C--O 1.25 1.108 0 O-C-N 120.813 -1.179 . . . . 28.63 108.729 170.575 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 1283 ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' 1286 ' ' ALA . 14.5 t0 -96.42 121.72 38.54 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 120.595 1.543 . . . . 36.27 110.482 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1284 ' ' LEU . . . . . 0.663 ' HB2' ' HA ' ' A' 1255 ' ' THR . 2.1 mm? -107.01 -9.08 16.33 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-O 122.968 1.366 . . . . 38.57 112.149 -176.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1285 ' ' ALA . . . . . 0.56 ' HB3' ' HA2' ' A' 1290 ' ' GLY . . . -76.99 -29.85 55.68 Favored 'General case' 0 C--O 1.243 0.736 0 O-C-N 120.691 -1.256 . . . . 37.56 108.092 164.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1286 ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' 1283 ' ' ASP . . . 28.06 -82.79 0.0 OUTLIER 'General case' 0 C--N 1.361 1.094 0 N-CA-C 118.545 2.795 . . . . 40.33 118.545 173.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -66.33 -41.93 88.92 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 113.905 1.076 . . . . 56.85 113.905 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 46.9 t30 -85.7 82.32 8.26 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 122.65 1.214 . . . . 45.86 111.824 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 73.52 -67.14 1.59 Allowed Glycine 0 CA--C 1.538 1.524 0 O-C-N 119.498 -2.001 . . . . 40.31 111.724 -175.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1290 ' ' GLY . . . . . 0.56 ' HA2' ' HB3' ' A' 1285 ' ' ALA . . . 89.26 129.49 3.62 Favored Glycine 0 CA--C 1.536 1.356 0 N-CA-C 110.357 -1.097 . . . . 38.89 110.357 -177.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1291 ' ' ASN . . . . . 0.479 ' HB2' ' CG2' ' A' 1254 ' ' THR . 32.2 m120 -73.47 -17.06 61.28 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.469 1.634 . . . . 37.23 115.3 -172.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1292 ' ' CYS . . . . . 0.476 ' SG ' HG11 ' A' 1309 ' ' VAL . 49.1 t -91.75 146.33 23.85 Favored 'General case' 0 C--O 1.248 1.016 0 CA-C-O 125.36 2.505 . . . . 36.5 110.359 173.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1293 ' ' GLU . . . . . 0.585 ' HB3' ' HG3' ' A' 1269 ' ' ARG . 6.5 mt-10 -75.67 -7.99 55.7 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 119.259 -2.151 . . . . 43.32 115.782 172.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -109.05 26.56 10.48 Favored 'General case' 0 C--O 1.215 -0.735 0 O-C-N 120.124 -1.61 . . . . 41.32 113.629 175.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1295 ' ' THR . . . . . . . . . . . . . 54.6 m -81.3 81.15 7.55 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 125.868 2.747 . . . . 35.3 108.925 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1296 ' ' VAL . . . . . 0.467 ' HA ' ' HD3' ' A' 1297 ' ' PRO . 72.5 t -76.58 124.11 87.79 Favored Pre-proline 0 N--CA 1.424 -1.733 0 O-C-N 119.794 -1.817 . . . . 34.84 108.389 -176.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1297 ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' 1296 ' ' VAL . 50.4 Cg_exo -56.47 99.21 0.08 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.684 0 C-N-CA 124.362 3.375 . . . . 33.51 115.291 -167.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 81.83 37.8 15.43 Favored Glycine 0 N--CA 1.437 -1.266 0 CA-C-N 112.565 -2.107 . . . . 32.19 111.575 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -145.3 153.6 41.45 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 124.234 1.969 . . . . 34.88 110.151 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1300 ' ' ILE . . . . . 0.54 HG12 HG12 ' A' 1310 ' ' ILE . 77.2 mt -83.75 157.6 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 CA-C-N 111.203 -2.726 . . . . 32.29 105.328 161.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 58.3 t80 -137.47 147.31 45.21 Favored 'General case' 0 C--O 1.253 1.262 0 N-CA-C 104.948 -2.241 . . . . 37.25 104.948 176.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1302 ' ' THR . . . . . . . . . . . . . 8.3 m -126.65 134.68 50.69 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 106.098 -1.816 . . . . 35.56 106.098 170.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1303 ' ' THR . . . . . 0.424 HG21 HG12 ' A' 1272 ' ' VAL . 24.9 p -79.78 174.71 11.31 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 112.705 0.631 . . . . 36.4 112.705 176.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -53.32 -56.34 17.46 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 121.335 -0.853 . . . . 52.32 111.218 171.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -68.46 10.01 0.29 Allowed 'General case' 0 C--N 1.352 0.684 0 N-CA-C 117.189 2.292 . . . . 40.04 117.189 176.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 70.67 38.12 67.4 Favored Glycine 0 C--O 1.244 0.753 0 O-C-N 121.909 -0.494 . . . . 36.96 112.9 169.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1307 ' ' VAL . . . . . 0.633 HG21 ' HB3' ' A' 1275 ' ' MET . 87.5 t -99.83 133.9 41.13 Favored 'Isoleucine or valine' 0 C--O 1.262 1.715 0 N-CA-C 101.412 -3.551 . . . . 33.4 101.412 170.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1308 ' ' LYS . . . . . 0.426 ' HB2' HG22 ' A' 1280 ' ' VAL . 67.2 mmtt -94.93 136.41 35.27 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 111.659 -2.519 . . . . 42.91 108.809 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1309 ' ' VAL . . . . . 0.476 HG11 ' SG ' ' A' 1292 ' ' CYS . 21.8 t -118.13 116.75 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 N-CA-C 106.581 -1.637 . . . . 32.29 106.581 171.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1310 ' ' ILE . . . . . 0.54 HG12 HG12 ' A' 1300 ' ' ILE . 27.3 mt -102.61 98.09 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 105.423 -2.066 . . . . 30.99 105.423 -178.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -103.68 51.29 0.83 Allowed Glycine 0 CA--C 1.529 0.962 0 N-CA-C 106.353 -2.699 . . . . 28.95 106.353 175.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1312 ' ' TYR . . . . . 0.594 ' HB2' ' HG ' ' A' 1315 ' ' LEU . 5.0 m-85 -72.64 101.82 3.14 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 105.037 -2.209 . . . . 31.69 105.037 171.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1313 ' ' THR . . . . . 0.409 ' HA ' ' HB1' ' A' 1286 ' ' ALA . 1.6 p -53.3 -31.79 45.67 Favored 'General case' 0 C--O 1.243 0.719 0 O-C-N 121.022 -1.049 . . . . 34.17 111.426 177.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -81.46 7.74 11.12 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 118.695 2.85 . . . . 36.86 118.695 174.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1315 ' ' LEU . . . . . 0.594 ' HG ' ' HB2' ' A' 1312 ' ' TYR . 26.7 mt -47.69 -39.35 22.47 Favored Pre-proline 0 C--O 1.252 1.223 0 CA-C-N 123.798 2.999 . . . . 34.85 118.511 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1316 ' ' PRO . . . . . 0.526 ' HG3' ' HB2' ' A' 1137 ' ' ALA . 73.0 Cg_exo -59.15 -35.83 96.98 Favored 'Trans proline' 0 C--O 1.205 -1.17 0 C-N-CA 123.143 2.562 . . . . 29.15 112.961 173.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1317 ' ' GLY . . . . . 0.42 ' HA3' ' HE ' ' A' 1015 ' ' ARG . . . -94.74 -12.87 55.09 Favored Glycine 0 CA--C 1.495 -1.209 0 O-C-N 120.5 -1.375 . . . . 27.29 116.173 -177.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1318 ' ' ARG . . . . . . . . . . . . . 8.2 ttt-85 -64.76 6.1 0.25 Allowed 'General case' 0 C--O 1.244 0.777 0 N-CA-C 117.057 2.243 . . . . 41.49 117.057 -175.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1319 ' ' LEU . . . . . 0.513 HD13 HH11 ' A' 1140 ' ' ARG . 15.4 tp -116.6 78.96 9.11 Favored Pre-proline 0 N--CA 1.439 -1.008 0 CA-C-N 123.23 2.741 . . . . 27.61 107.011 173.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1320 ' ' PRO . . . . . 0.561 ' HG2' ' HA2' ' B' 1150 ' ' GLY . 20.4 Cg_endo -40.89 -57.87 1.19 Allowed 'Trans proline' 0 CA--C 1.504 -0.988 0 C-N-CA 124.476 3.45 . . . . 25.94 118.126 -155.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1321 ' ' THR . . . . . 0.471 HG23 HG21 ' A' 1019 ' ' THR . 3.0 m -72.04 -33.65 68.16 Favored 'General case' 0 N--CA 1.437 -1.125 0 O-C-N 118.597 -2.564 . . . . 25.01 109.678 -174.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1322 ' ' GLN . . . . . 0.843 ' HB2' ' HA ' ' B' 1151 ' ' ARG . 61.3 tp60 -84.88 -39.08 18.66 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 120.26 1.391 . . . . 29.39 110.575 -171.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1323 ' ' SER . . . . . 0.893 ' HA ' HD13 ' A' 1136 ' ' ILE . 17.6 m -47.5 -56.69 6.54 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.963 1.098 . . . . 26.47 113.963 158.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1324 ' ' SER . . . . . . . . . . . . . 14.4 m -68.93 -17.28 63.93 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.274 0.842 . . . . 27.78 113.274 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -75.62 -67.91 0.62 Allowed 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 103.856 -2.646 . . . . 37.53 103.856 174.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1326 ' ' LEU . . . . . 0.758 ' HB2' HD11 ' A' 1136 ' ' ILE . 89.8 mt -72.42 -43.83 63.3 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 115.042 -2.409 . . . . 35.71 112.921 -168.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1327 ' ' TYR . . . . . 0.415 ' HE2' ' HA ' ' A' 1072 ' ' VAL . 73.8 t80 -58.02 -43.63 86.84 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-N 122.501 2.41 . . . . 31.59 107.703 169.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1328 ' ' GLY . . . . . 0.656 ' HA2' HD12 ' A' 1331 ' ' LEU . . . -58.17 -37.28 85.92 Favored Glycine 0 C--N 1.345 1.058 0 N-CA-C 110.884 -0.886 . . . . 28.0 110.884 176.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1329 ' ' THR . . . . . 0.418 HG21 ' HA3' ' B' 1161 ' ' GLY . 36.5 m -77.8 -28.7 50.49 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 118.938 1.369 . . . . 32.15 111.415 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1330 ' ' ASN . . . . . 0.4 ' HA ' ' O ' ' A' 1126 ' ' SER . 16.2 m120 -55.31 -48.31 74.31 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 120.693 1.588 . . . . 34.36 111.611 164.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1331 ' ' LEU . . . . . 0.681 HD13 ' HB3' ' A' 1070 ' ' LEU . 19.6 mt -56.1 -53.35 58.08 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 124.507 1.123 . . . . 33.37 111.241 175.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1332 ' ' VAL . . . . . 0.58 HG12 ' HE3' ' A' 1336 ' ' LYS . 59.8 t -49.13 -47.45 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 C-N-CA 125.898 1.679 . . . . 35.27 111.125 175.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -70.19 -30.35 67.45 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-O 117.243 -1.361 . . . . 37.66 113.85 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1334 ' ' LEU . . . . . 0.566 HD12 HD23 ' A' 1127 ' ' LEU . 18.3 tp -62.76 -48.67 78.15 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 122.887 1.327 . . . . 40.27 108.451 169.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1335 ' ' LEU . . . . . . . . . . . . . 82.0 mt -66.12 -23.65 66.53 Favored 'General case' 0 C--O 1.246 0.899 0 O-C-N 120.252 -1.53 . . . . 42.5 110.096 -175.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1336 ' ' LYS . . . . . 0.58 ' HE3' HG12 ' A' 1332 ' ' VAL . 96.9 mttt -60.24 -45.31 93.67 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.445 -1.41 . . . . 47.81 112.836 168.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1337 ' ' LEU . . . . . 0.486 HD22 HD21 ' A' 1127 ' ' LEU . 8.1 mp -75.03 -38.97 61.33 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 113.218 -1.81 . . . . 49.27 113.049 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1338 ' ' LEU . . . . . 0.744 HD21 ' SD ' ' A' 1113 ' ' MET . 6.3 mp -72.56 -58.37 3.43 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 125.818 1.647 . . . . 50.54 111.204 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1339 ' ' CYS . . . . . 0.675 ' HB3' ' HA2' ' A' 1344 ' ' GLY . 58.7 m -92.38 68.45 4.95 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-O 124.408 2.051 . . . . 53.67 106.35 -177.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 75.3 tttt -76.02 -47.93 22.95 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 111.526 -2.579 . . . . 63.38 109.016 -158.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -70.08 -25.64 63.62 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 113.425 0.898 . . . . 70.95 113.425 -175.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1342 ' ' LYS . . . . . 0.487 ' N ' ' HB3' ' A' 1343 ' ' ASP . 46.5 mtpt 52.12 68.27 0.84 Allowed 'General case' 0 C--O 1.253 1.26 0 N-CA-C 118.106 2.632 . . . . 65.25 118.106 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1343 ' ' ASP . . . . . 0.487 ' HB3' ' N ' ' A' 1342 ' ' LYS 0.278 10.9 t70 67.04 -88.14 0.03 OUTLIER 'General case' 0 C--O 1.236 0.387 2 O-C-N 110.921 -7.362 . . . . 64.53 119.784 -0.177 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A 1344 ' ' GLY . . . . . 0.675 ' HA2' ' HB3' ' A' 1339 ' ' CYS . . . 86.29 17.85 60.02 Favored Glycine 0 N--CA 1.425 -2.036 0 O-C-N 119.98 -1.7 . . . . 59.72 115.963 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 19.5 t30 -80.4 143.24 33.63 Favored 'General case' 0 N--CA 1.434 -1.226 0 O-C-N 120.469 -1.607 . . . . 64.09 108.767 160.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1346 ' ' ILE . . . . . 0.414 ' HA ' ' SG ' ' A' 1339 ' ' CYS . 14.7 mt -91.6 100.18 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 104.49 -2.411 . . . . 58.82 104.49 -167.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1347 ' ' THR . . . . . . . . . . . . . 6.9 m -84.08 98.8 10.07 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 104.339 -2.467 . . . . 54.96 104.339 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1348 ' ' VAL . . . . . 0.485 HG21 HG21 ' A' 1111 ' ' THR . 19.5 t -93.4 80.02 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.257 1.475 0 N-CA-C 105.448 -2.056 . . . . 55.64 105.448 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 12.9 t70 -76.68 135.17 39.09 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 115.238 1.57 . . . . 61.45 115.238 -167.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -80.89 -28.28 35.99 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-N 114.864 -1.062 . . . . 58.63 111.882 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -85.82 -31.82 22.08 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 119.977 -1.702 . . . . 62.06 114.747 -170.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 9.9 t70 -64.07 123.08 18.11 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 125.046 1.466 . . . . 54.07 109.238 169.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 18.6 m -57.44 -45.66 85.66 Favored 'Isoleucine or valine' 0 C--O 1.253 1.268 0 N-CA-C 113.508 0.929 . . . . 50.68 113.508 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1354 ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' 1358 ' ' VAL . 12.9 m -77.45 -38.53 26.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 119.971 -0.692 . . . . 47.68 110.188 -172.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1355 ' ' ILE . . . . . . . . . . . . . 90.3 mt -62.39 -54.05 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-N 121.141 1.791 . . . . 48.49 108.589 174.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1356 ' ' ARG . . . . . 0.451 ' HG3' ' HD2' ' A' 1371 ' ' PRO . 45.3 tpt85 -55.92 -37.92 69.58 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 112.107 0.41 . . . . 48.27 112.107 178.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -59.72 -46.92 93.22 Favored Glycine 0 N--CA 1.469 0.846 0 O-C-N 125.41 1.694 . . . . 43.53 112.466 174.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1358 ' ' VAL . . . . . 0.499 HG22 ' HA ' ' A' 1118 ' ' VAL . 30.2 t -75.08 -28.69 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 O-C-N 118.428 -2.807 . . . . 45.12 109.726 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1359 ' ' THR . . . . . 0.466 ' CG2' ' HB2' ' A' 1362 ' ' ARG . 26.2 m -64.71 96.16 0.17 Allowed 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 118.082 -2.886 . . . . 42.94 114.706 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1360 ' ' VAL . . . . . 0.563 HG11 ' HG3' ' A' 1095 ' ' PRO . 17.5 m -96.55 -30.62 3.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 112.214 0.449 . . . . 43.26 112.214 -177.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1361 ' ' ILE . . . . . . . . . . . . . 95.7 mt -131.49 136.22 57.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 101.919 -3.363 . . . . 45.66 101.919 163.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1362 ' ' ARG . . . . . 0.466 ' HB2' ' CG2' ' A' 1359 ' ' THR . 50.4 ttt180 -124.62 125.77 44.67 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 104.428 -2.434 . . . . 61.34 104.428 165.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 48.89 55.7 8.83 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 125.507 1.754 . . . . 49.76 113.996 172.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 82.08 -42.33 2.85 Favored Glycine 0 C--O 1.218 -0.871 0 CA-C-N 113.021 -1.899 . . . . 50.0 112.569 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -69.9 126.47 29.81 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 119.953 1.876 . . . . 56.92 107.071 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1366 ' ' ILE . . . . . . . . . . . . . 96.5 mt -74.59 96.18 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.391 0 N-CA-C 107.19 -1.411 . . . . 52.78 107.19 178.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1367 ' ' THR . . . . . . . . . . . . . 17.6 p -82.75 1.52 38.39 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 115.932 1.827 . . . . 49.44 115.932 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1368 ' ' TRP . . . . . 0.457 ' HZ2' ' HA ' ' A' 1096 ' ' ALA . 29.6 t90 -78.66 133.71 62.35 Favored Pre-proline 0 N--CA 1.442 -0.872 0 N-CA-C 105.313 -2.106 . . . . 52.38 105.313 161.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -58.28 130.09 4.53 Favored 'Cis proline' 0 C--N 1.329 -0.47 0 N-CA-C 119.687 2.918 . . . . 46.94 119.687 5.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1370 ' ' ALA . . . . . 0.461 ' HA ' ' HD3' ' A' 1371 ' ' PRO . . . -72.84 112.53 15.65 Favored Pre-proline 0 C--O 1.245 0.838 0 C-N-CA 124.567 1.147 . . . . 45.91 110.837 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1371 ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' 1370 ' ' ALA . 32.3 Cg_exo -67.61 120.65 7.68 Favored 'Trans proline' 0 N--CA 1.433 -2.082 0 C-N-CA 124.636 3.558 . . . . 46.39 118.104 -173.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -71.89 -62.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 123.179 2.586 . . . . 46.72 109.968 164.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.239 -4.238 0 CA-C-N 120.642 1.564 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 23.1 m80 . . . . . 0 C--O 1.245 0.826 0 N-CA-C 107.24 -1.393 . . . . 63.44 107.24 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 999' ' ' HIS . . . . . 0.475 ' HB3' ' HB3' ' B' 1002 ' ' ARG . 23.2 m-70 -120.75 59.74 0.91 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.857 -0.794 . . . . 51.74 108.857 164.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1000 ' ' HIS . . . . . 0.599 ' HA ' ' HB2' ' B' 1067 ' ' GLU . 1.8 t-80 -77.18 139.53 39.93 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 102.795 -3.039 . . . . 54.07 102.795 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 81.88 -0.46 88.37 Favored Glycine 0 C--O 1.26 1.721 0 CA-C-N 113.728 -1.578 . . . . 39.22 111.814 -171.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1002 ' ' ARG . . . . . 0.475 ' HB3' ' HB3' ' B' ' 999' ' ' HIS . 34.1 ttp180 -108.52 148.36 30.38 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 119.59 1.695 . . . . 38.12 106.677 177.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1003 ' ' ILE . . . . . 0.714 HG12 HD12 ' B' 1068 ' ' ILE . 24.3 mt -102.61 147.27 9.38 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 N-CA-C 105.724 -1.954 . . . . 29.7 105.724 172.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -107.38 121.72 6.58 Favored Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 108.492 -1.843 . . . . 27.5 108.492 167.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1005 ' ' ILE . . . . . 0.515 HG23 ' HB3' ' B' 1017 ' ' ALA . 40.7 mm -105.77 106.51 56.8 Favored Pre-proline 0 N--CA 1.439 -1.006 0 N-CA-C 106.689 -1.597 . . . . 24.83 106.689 171.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1006 ' ' PRO . . . . . 0.58 ' HA ' ' HG3' ' B' 1036 ' ' GLU . 26.4 Cg_exo -80.12 176.82 8.93 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 124.687 3.591 . . . . 27.19 108.35 -175.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 22.9 ttm105 -84.82 131.51 34.52 Favored 'General case' 0 C--N 1.318 -0.773 0 O-C-N 120.128 -1.608 . . . . 41.46 108.124 165.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1008 ' ' GLU . . . . . 0.649 ' HG3' ' HB ' ' B' 1072 ' ' VAL 0.311 25.2 mm-40 -68.93 136.18 52.16 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 119.612 3.19 . . . . 26.93 119.612 173.71 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 47.6 mmm-85 -99.08 -3.76 33.95 Favored 'General case' 0 C--O 1.253 1.285 0 CA-C-N 111.512 -2.585 . . . . 34.48 116.068 -165.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1010 ' ' LEU . . . . . . . . . . . . . 65.6 tp -58.21 138.6 56.14 Favored 'General case' 0 N--CA 1.441 -0.875 0 O-C-N 121.177 -0.952 . . . . 44.22 112.108 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1011 ' ' THR . . . . . . . . . . . . . 1.3 m -59.72 111.93 1.63 Allowed 'General case' 0 C--N 1.319 -0.759 0 O-C-N 124.573 1.171 . . . . 40.74 108.187 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 38.8 t30 60.63 92.75 0.05 OUTLIER 'General case' 0 C--O 1.252 1.199 0 O-C-N 126.657 2.473 . . . . 44.44 107.894 -171.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1013 ' ' GLU . . . . . 0.539 ' HG2' ' HB3' ' B' 1008 ' ' GLU . 9.3 tp10 -130.99 132.72 45.2 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 124.88 2.276 . . . . 29.87 109.609 -177.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1014 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.16 -32.49 50.27 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-N 108.816 -3.811 . . . . 25.26 117.642 176.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 43.5 mtm180 -95.64 159.86 14.78 Favored 'General case' 0 C--O 1.252 1.201 0 CA-C-O 124.021 1.867 . . . . 29.54 115.179 -161.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1016 ' ' VAL . . . . . 0.553 HG13 ' H ' ' B' 1018 ' ' ALA . 4.7 p -128.86 -176.5 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 102.936 -2.987 . . . . 23.55 102.936 159.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1017 ' ' ALA . . . . . 0.515 ' HB3' HG23 ' B' 1005 ' ' ILE . . . -90.34 -8.81 49.84 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 116.854 2.168 . . . . 23.59 116.854 -178.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1018 ' ' ALA . . . . . 0.553 ' H ' HG13 ' B' 1016 ' ' VAL . . . -159.75 145.72 15.86 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-O 121.528 0.68 . . . . 24.93 110.313 -177.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1019 ' ' THR . . . . . 0.516 HG21 HG23 ' B' 1321 ' ' THR . 0.7 OUTLIER -108.8 165.45 12.64 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-O 116.682 -1.628 . . . . 28.09 111.924 172.297 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B 1020 ' ' PRO . . . . . 0.482 ' HB3' ' HB2' ' B' 1053 ' ' ALA . 0.2 OUTLIER -47.88 -43.2 30.15 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 124.331 3.354 . . . . 28.79 116.652 175.251 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 47.7 tptt -50.71 -41.53 56.16 Favored 'General case' 0 C--O 1.256 1.446 0 N-CA-C 113.358 0.873 . . . . 47.28 113.358 168.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1022 ' ' THR . . . . . 0.539 HG21 ' HA3' ' B' 1328 ' ' GLY . 0.2 OUTLIER -72.63 -38.49 67.73 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 118.83 -0.605 . . . . 30.12 111.63 177.679 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B 1023 ' ' VAL . . . . . 0.427 HG22 HG11 ' B' 1033 ' ' VAL . 79.8 t -49.23 -48.63 17.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-O 122.61 1.195 . . . . 32.24 113.156 -178.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1024 ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -53.25 -48.16 68.45 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 112.684 -2.053 . . . . 49.62 110.492 174.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -61.71 -43.24 99.24 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 120.831 -1.168 . . . . 44.68 110.316 -174.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 51.1 mt -64.93 -39.03 92.89 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 115.069 1.507 . . . . 35.71 115.069 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1027 ' ' LEU . . . . . . . . . . . . . 58.1 mt -64.78 -41.58 95.74 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 125.581 1.552 . . . . 42.18 109.006 174.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 31.4 mttm -63.5 -35.9 81.97 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 123.731 0.644 . . . . 48.34 110.652 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1029 ' ' LEU . . . . . . . . . . . . . 82.0 mt -59.47 -62.36 1.93 Allowed 'General case' 0 CA--C 1.504 -0.808 0 C-N-CA 123.618 0.767 . . . . 38.69 109.212 170.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 143.35 45.02 0.05 OUTLIER Glycine 0 C--N 1.312 -0.758 0 N-CA-C 110.309 -1.116 . . . . 32.28 110.309 168.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -133.17 122.7 24.39 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 123.038 1.399 . . . . 35.94 108.733 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1032 ' ' THR . . . . . . . . . . . . . 28.0 m -66.3 133.2 50.06 Favored 'General case' 0 C--O 1.25 1.098 0 CA-C-N 114.121 -1.399 . . . . 33.37 108.414 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1033 ' ' VAL . . . . . 0.427 HG11 HG22 ' B' 1023 ' ' VAL . 22.2 t -107.38 126.88 63.57 Favored 'Isoleucine or valine' 0 C--O 1.251 1.169 0 O-C-N 120.068 -1.645 . . . . 29.98 107.271 -169.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -122.45 139.15 54.2 Favored 'General case' 0 C--O 1.243 0.714 0 O-C-N 124.134 0.896 . . . . 28.18 111.553 168.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1035 ' ' VAL . . . . . 0.605 ' HB ' HD13 ' B' 1057 ' ' ILE . 21.2 t -127.35 149.33 32.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 105.866 -1.901 . . . . 25.82 105.866 -175.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1036 ' ' GLU . . . . . 0.58 ' HG3' ' HA ' ' B' 1006 ' ' PRO . 13.3 mt-10 -62.67 145.61 54.22 Favored 'General case' 0 C--O 1.257 1.473 0 N-CA-C 113.7 1.0 . . . . 32.44 113.7 171.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1037 ' ' SER . . . . . . . . . . . . . 13.0 m -70.54 148.13 48.54 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 106.038 -1.838 . . . . 29.54 106.038 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 82.11 -53.2 4.73 Favored Glycine 0 CA--C 1.534 1.27 0 O-C-N 119.205 -2.184 . . . . 27.76 110.401 -172.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1039 ' ' ALA . . . . . . . . . . . . . . . -51.61 -40.99 60.91 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-N 119.434 1.617 . . . . 26.02 112.547 172.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -57.59 -49.08 76.68 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 120.465 -0.874 . . . . 26.47 112.288 171.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1041 ' ' GLN . . . . . 0.667 ' NE2' ' HA ' ' B' 1046 ' ' ASP . 2.6 tp60 -59.12 -40.62 85.98 Favored 'General case' 0 C--O 1.246 0.877 0 C-N-CA 123.233 0.613 . . . . 50.98 110.429 178.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 46.2 mt -66.5 -26.51 67.2 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.771 1.026 . . . . 29.3 113.771 -171.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1043 ' ' ALA . . . . . . . . . . . . . . . -83.88 40.48 0.75 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 119.521 1.055 . . . . 26.74 111.926 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1044 ' ' SER . . . . . . . . . . . . . 38.6 m 44.3 54.62 6.07 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 126.284 1.833 . . . . 31.26 110.899 -166.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1045 ' ' PHE . . . . . 0.68 ' HA ' ' HB1' ' A' 1277 ' ' ALA . 0.2 OUTLIER -144.68 -167.39 2.64 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.439 -1.255 . . . . 33.26 109.775 -174.526 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B 1046 ' ' ASP . . . . . 0.667 ' HA ' ' NE2' ' B' 1041 ' ' GLN . 22.3 t70 -131.06 140.22 50.02 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 105.805 -1.924 . . . . 46.74 105.805 174.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -68.06 -37.47 81.31 Favored 'General case' 0 CA--C 1.502 -0.866 0 O-C-N 125.954 2.034 . . . . 34.44 111.407 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -77.85 -23.95 48.75 Favored 'General case' 0 N--CA 1.435 -1.2 0 O-C-N 119.279 -2.138 . . . . 48.67 109.955 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1049 ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' B' 1046 ' ' ASP . . . -58.45 -43.42 88.8 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 118.762 -0.637 . . . . 35.26 111.896 163.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1050 ' ' PHE . . . . . 0.461 ' HD1' ' O ' ' B' 1046 ' ' ASP . 31.1 m-85 -60.87 -37.85 83.57 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 120.889 1.677 . . . . 32.17 112.167 170.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 98.0 t -59.67 -45.74 94.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 O-C-N 119.585 -1.947 . . . . 38.37 108.503 174.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -63.76 -23.36 67.33 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 116.261 1.949 . . . . 45.77 116.261 174.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1053 ' ' ALA . . . . . 0.482 ' HB2' ' HB3' ' B' 1020 ' ' PRO . . . -78.35 -4.67 49.26 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 124.91 1.284 . . . . 37.83 112.269 170.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 87.75 34.57 9.99 Favored Glycine 0 CA--C 1.5 -0.866 0 CA-C-N 120.29 1.404 . . . . 35.82 110.681 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -114.62 138.1 51.09 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-O 124.151 1.929 . . . . 33.77 107.401 174.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -77.45 134.77 38.29 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 104.487 -2.412 . . . . 51.02 104.487 173.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1057 ' ' ILE . . . . . 0.605 HD13 ' HB ' ' B' 1035 ' ' VAL . 19.5 mm -108.46 107.16 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 106.259 -1.756 . . . . 38.47 106.259 175.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 88.1 t -86.29 132.77 31.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 CA-C-N 113.163 -1.835 . . . . 39.4 108.045 -173.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -72.5 95.82 1.85 Allowed 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 123.291 1.519 . . . . 57.07 110.576 168.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . 82.27 -151.16 29.54 Favored Glycine 0 C--O 1.248 1.026 0 CA-C-O 125.093 2.496 . . . . 44.83 116.191 166.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 5.0 m120 -58.64 -21.28 53.44 Favored 'General case' 0 C--O 1.212 -0.869 0 N-CA-C 118.91 2.93 . . . . 46.27 118.91 -167.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1062 ' ' SER . . . . . . . . . . . . . 4.2 m -53.65 -22.12 8.2 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.188 -1.57 . . . . 43.47 112.677 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 1.5 p -53.28 -35.31 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 O-C-N 120.983 -1.073 . . . . 36.98 111.181 176.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1064 ' ' TRP . . . . . 0.549 ' HA ' HD11 ' B' 1069 ' ' ILE . 55.2 m95 -63.16 -23.35 67.39 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 116.155 1.909 . . . . 37.9 116.155 177.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -83.44 93.58 7.82 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 124.475 2.083 . . . . 46.19 108.923 173.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1066 ' ' SER . . . . . 0.427 ' HB3' ' O ' ' B' 1002 ' ' ARG . 71.4 m -149.77 179.7 7.81 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 111.206 -2.725 . . . . 37.06 107.211 -174.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1067 ' ' GLU . . . . . 0.599 ' HB2' ' HA ' ' B' 1000 ' ' HIS . 35.2 tt0 -83.37 -51.3 7.52 Favored 'General case' 0 N--CA 1.437 -1.103 0 O-C-N 123.792 0.683 . . . . 43.95 109.952 166.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1068 ' ' ILE . . . . . 0.714 HD12 HG12 ' B' 1003 ' ' ILE . 1.3 mt -108.99 145.15 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 N-CA-C 107.061 -1.459 . . . . 33.5 107.061 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1069 ' ' ILE . . . . . 0.549 HD11 ' HA ' ' B' 1064 ' ' TRP . 46.0 mm -109.0 118.26 56.15 Favored 'Isoleucine or valine' 0 C--O 1.254 1.299 0 N-CA-C 104.33 -2.47 . . . . 30.57 104.33 158.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1070 ' ' LEU . . . . . 0.83 HD22 HD22 ' B' 1331 ' ' LEU . 94.5 mt -101.8 117.75 35.51 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 106.674 -1.602 . . . . 27.66 106.674 170.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1071 ' ' LYS . . . . . 0.54 ' HG2' ' OE2' ' B' 1008 ' ' GLU 0.279 13.6 tttm -140.83 160.16 40.64 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 125.994 2.059 . . . . 28.4 111.042 -170.025 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B 1072 ' ' VAL . . . . . 0.649 ' HB ' ' HG3' ' B' 1008 ' ' GLU . 99.7 t -94.63 -70.76 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.429 0 O-C-N 120.629 -1.294 . . . . 23.18 108.155 -173.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -97.4 152.68 18.69 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.893 -1.129 . . . . 25.47 108.011 -170.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -53.3 133.05 52.35 Favored Pre-proline 0 C--O 1.243 0.725 0 C-N-CA 126.29 1.836 . . . . 27.9 111.907 -173.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -60.32 129.75 31.13 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 122.752 2.301 . . . . 31.62 114.949 -173.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 49.2 mt -72.65 158.56 35.41 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.202 -1.036 . . . . 40.49 108.202 173.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.23 -29.7 10.04 Favored 'General case' 0 C--O 1.214 -0.768 0 O-C-N 118.937 -2.352 . . . . 51.59 117.014 -171.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -67.28 -46.21 74.3 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-N 114.986 -1.006 . . . . 42.36 110.017 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1079 ' ' GLU . . . . . 0.472 ' HA ' HD12 ' B' 1082 ' ' LEU . 31.8 mt-10 -63.07 -40.49 97.83 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 123.162 1.458 . . . . 34.53 109.029 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1080 ' ' ILE . . . . . 0.487 HG21 ' HB3' ' B' 1104 ' ' LYS . 84.3 mt -59.1 -48.81 85.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 108.333 -0.988 . . . . 33.25 108.333 175.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -56.84 -39.7 74.73 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 119.143 0.883 . . . . 36.47 112.874 175.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1082 ' ' LEU . . . . . 0.472 HD12 ' HA ' ' B' 1079 ' ' GLU . 28.6 mt -61.12 -38.51 86.61 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 125.762 1.625 . . . . 37.76 111.08 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1083 ' ' LEU . . . . . 0.447 HD11 HD22 ' B' 1089 ' ' LEU . 21.8 mt -56.73 121.11 9.02 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 123.17 0.588 . . . . 37.43 110.679 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -78.07 148.7 75.45 Favored Pre-proline 0 CA--C 1.558 1.271 0 N-CA-C 106.953 -1.499 . . . . 37.7 106.953 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1085 ' ' PRO . . . . . 0.647 ' HA ' ' O ' ' B' 1108 ' ' ARG . 0.1 OUTLIER -40.3 102.37 0.04 OUTLIER 'Trans proline' 0 C--O 1.239 0.562 0 C-N-CA 122.826 2.35 . . . . 35.51 115.564 169.674 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B 1086 ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' B' 1110 ' ' VAL . . . 84.49 26.38 39.46 Favored Glycine 0 C--N 1.345 1.04 0 CA-C-N 112.652 -2.067 . . . . 33.87 114.532 177.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1087 ' ' THR . . . . . . . . . . . . . 16.8 m -66.67 155.79 37.03 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 120.956 2.378 . . . . 32.5 108.491 166.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1088 ' ' THR . . . . . 0.655 ' HB ' ' HA ' ' B' 1068 ' ' ILE . 4.1 m -87.49 131.37 34.38 Favored 'General case' 0 C--O 1.205 -1.245 0 N-CA-C 105.088 -2.189 . . . . 30.22 105.088 174.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1089 ' ' LEU . . . . . 0.447 HD22 HD11 ' B' 1083 ' ' LEU . 39.3 tp -122.87 127.65 49.28 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 107.926 -1.139 . . . . 27.24 107.926 173.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 44.2 t -120.2 120.1 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 N-CA-C 103.326 -2.842 . . . . 25.39 103.326 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1091 ' ' SER . . . . . 0.549 ' O ' ' HA ' ' B' 1114 ' ' ALA . 2.6 m -164.53 160.31 20.2 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.528 1.513 . . . . 28.81 108.857 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1092 ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -59.48 99.43 0.06 Allowed 'General case' 0 C--O 1.247 0.971 0 O-C-N 121.088 -1.008 . . . . 30.78 111.204 158.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 32.2 mm -95.73 -28.53 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 109.199 -0.667 . . . . 30.28 109.199 -171.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1094 ' ' TRP . . . . . 0.441 ' HB2' HD22 ' B' 1098 ' ' ASN . 68.5 m95 52.06 56.08 15.48 Favored Pre-proline 0 N--CA 1.472 0.659 0 O-C-N 121.129 -0.982 . . . . 34.07 112.551 -175.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -53.43 -51.05 11.82 Favored 'Trans proline' 0 CA--C 1.505 -0.952 1 C-N-CA 126.541 4.828 . . . . 38.66 115.999 -162.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -69.17 -28.77 66.71 Favored 'General case' 0 C--O 1.247 0.929 0 O-C-N 120.714 -1.241 . . . . 41.32 110.684 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.04 -17.82 48.87 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 120.71 -1.244 . . . . 51.66 111.197 172.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1098 ' ' ASN . . . . . 0.534 ' HB3' ' HB3' ' B' 1101 ' ' LEU . 70.7 m-20 -125.73 61.19 36.82 Favored Pre-proline 0 C--O 1.243 0.728 0 N-CA-C 114.719 1.377 . . . . 40.32 114.719 176.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -60.45 -38.68 72.18 Favored 'Trans proline' 0 CA--C 1.506 -0.887 0 C-N-CA 123.743 2.962 . . . . 41.56 113.13 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -69.52 -45.24 69.32 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 106.863 -1.532 . . . . 54.11 106.863 -174.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1101 ' ' LEU . . . . . 0.534 ' HB3' ' HB3' ' B' 1098 ' ' ASN . 7.0 tt -60.64 -48.77 80.29 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.645 -1.243 . . . . 37.88 107.645 177.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1102 ' ' MET . . . . . . . . . . . . . 43.2 mmm -50.86 -46.76 60.37 Favored 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 120.616 -1.302 . . . . 37.54 114.341 173.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -64.55 -39.0 92.96 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 123.173 1.463 . . . . 47.01 112.794 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1104 ' ' LYS . . . . . 0.487 ' HB3' HG21 ' B' 1080 ' ' ILE . 52.5 mttm -60.98 -45.47 94.68 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 118.928 -2.358 . . . . 48.68 111.77 175.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1105 ' ' LEU . . . . . 0.673 HD13 HG21 ' B' 1112 ' ' VAL . 52.2 mt -62.05 -39.25 91.74 Favored 'General case' 0 C--O 1.252 1.235 0 O-C-N 120.668 -1.27 . . . . 32.21 109.604 177.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -57.36 -37.05 71.99 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 112.968 0.729 . . . . 33.73 112.968 171.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -67.63 -45.92 73.97 Favored 'General case' 0 CA--C 1.504 -0.824 0 O-C-N 118.888 -2.383 . . . . 51.47 112.105 172.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1108 ' ' ARG . . . . . 0.647 ' O ' ' HA ' ' B' 1085 ' ' PRO . 21.9 mmm180 -61.42 -11.64 11.24 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 120.577 -1.327 . . . . 43.9 112.013 169.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1109 ' ' ASN . . . . . 0.407 ' HA ' ' HA2' ' B' 1364 ' ' GLY . 27.0 m-80 63.04 24.86 14.73 Favored 'General case' 0 C--N 1.358 0.96 0 O-C-N 120.024 -1.673 . . . . 44.82 114.253 172.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1110 ' ' VAL . . . . . 0.478 ' HA ' ' HA2' ' B' 1086 ' ' GLY . 18.4 m -83.59 167.87 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 N-CA-C 112.563 0.579 . . . . 30.52 112.563 -171.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1111 ' ' THR . . . . . 0.702 HG23 ' HA ' ' B' 1362 ' ' ARG . 95.9 m -109.74 111.14 22.41 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.439 -1.689 . . . . 27.12 106.439 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1112 ' ' VAL . . . . . 0.673 HG21 HD13 ' B' 1105 ' ' LEU . 63.6 t -113.27 120.3 62.86 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.621 0 N-CA-C 108.178 -1.045 . . . . 26.4 108.178 -165.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1113 ' ' MET . . . . . 0.453 ' SD ' HD11 ' B' 1338 ' ' LEU . 0.8 OUTLIER -94.79 105.92 17.88 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-O 123.596 1.665 . . . . 42.92 109.376 164.274 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B 1114 ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' B' 1091 ' ' SER . . . -86.4 108.55 18.52 Favored 'General case' 0 CA--C 1.5 -0.958 0 O-C-N 119.302 -2.124 . . . . 24.15 108.444 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1115 ' ' MET . . . . . 0.565 ' HB3' ' CB ' ' B' 1129 ' ' ALA . 82.1 mmm -67.98 -16.93 64.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 111.971 -2.377 . . . . 29.95 113.32 -173.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1116 ' ' ASP . . . . . 0.573 ' HA ' ' HG ' ' B' 1130 ' ' LEU . 9.8 p-10 -79.6 -35.01 40.25 Favored 'General case' 0 C--O 1.253 1.244 0 O-C-N 120.018 -1.676 . . . . 34.53 109.481 171.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1117 ' ' SER . . . . . . . . . . . . . 69.1 m -87.62 31.13 0.77 Allowed 'General case' 0 C--O 1.247 0.97 0 C-N-CA 126.293 1.837 . . . . 33.49 114.451 -166.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1118 ' ' VAL . . . . . 0.624 HG12 ' HB1' ' B' 1124 ' ' ALA . 15.1 t -77.98 136.96 61.7 Favored Pre-proline 0 C--O 1.259 1.555 0 N-CA-C 107.887 -1.153 . . . . 34.02 107.887 -177.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1119 ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' B' 1118 ' ' VAL . 55.4 Cg_exo -62.06 132.31 38.7 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 124.226 3.284 . . . . 38.28 108.232 174.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1120 ' ' ARG . . . . . 0.552 ' HB2' HG11 ' B' 1375 ' ' VAL . 2.0 mmt180 -73.27 29.36 0.07 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 119.158 3.022 . . . . 55.05 119.158 -160.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1121 ' ' ILE . . . . . 0.54 HG21 HD12 ' B' 1373 ' ' ILE . 23.8 pt -90.51 162.74 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 CA-C-N 119.176 0.898 . . . . 42.09 110.582 -169.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1122 ' ' SER . . . . . 0.648 ' HB2' ' HA ' ' C' ' 133' ' ' MET . 1.1 m -51.29 -40.91 59.98 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 112.954 -1.93 . . . . 38.02 115.576 -175.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1123 ' ' ARG . . . . . . . . . . . . . 24.1 ptt-85 -72.37 -41.48 66.32 Favored 'General case' 0 C--N 1.361 1.084 0 O-C-N 119.921 -1.737 . . . . 34.29 112.632 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1124 ' ' ALA . . . . . 0.624 ' HB1' HG12 ' B' 1118 ' ' VAL . . . -53.49 -35.3 60.46 Favored 'General case' 0 N--CA 1.434 -1.232 0 O-C-N 124.957 1.411 . . . . 32.35 114.766 175.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1125 ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -58.71 -20.77 51.77 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 117.964 2.579 . . . . 47.17 117.964 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1126 ' ' SER . . . . . 0.525 ' OG ' HD12 ' B' 1127 ' ' LEU . 73.3 p -70.72 -35.89 72.93 Favored 'General case' 0 C--O 1.251 1.178 0 O-C-N 120.05 -1.656 . . . . 31.71 112.099 170.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1127 ' ' LEU . . . . . 0.604 HD22 HG11 ' B' 1354 ' ' VAL . 4.5 mp -86.56 -16.85 35.57 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.884 -1.053 . . . . 37.0 112.35 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1128 ' ' ASP . . . . . . . . . . . . . 24.3 t70 -75.09 117.38 16.87 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 126.49 3.043 . . . . 40.4 117.06 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1129 ' ' ALA . . . . . 0.565 ' CB ' ' HB3' ' B' 1115 ' ' MET . . . -70.13 -33.83 72.31 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-N 109.924 -3.307 . . . . 26.56 107.419 -176.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1130 ' ' LEU . . . . . 0.573 ' HG ' ' HA ' ' B' 1116 ' ' ASP . 32.0 mt -61.98 -35.34 78.19 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 124.045 0.938 . . . . 30.89 110.664 177.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1131 ' ' SER . . . . . . . . . . . . . 61.4 m -71.39 -51.43 24.06 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 120.937 1.699 . . . . 29.84 109.164 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1132 ' ' SER . . . . . . . . . . . . . 55.5 m -55.85 -44.45 78.02 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.51 1.505 . . . . 31.91 112.47 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1133 ' ' MET . . . . . 0.607 ' HB3' ' HB3' ' B' 1316 ' ' PRO . 36.7 mmt -71.56 -33.66 69.3 Favored 'General case' 0 CA--C 1.51 -0.57 0 O-C-N 121.175 -0.953 . . . . 25.9 111.101 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1134 ' ' ALA . . . . . 0.609 ' HB1' ' HB2' ' B' 1176 ' ' ALA . . . -66.72 -38.15 86.12 Favored 'General case' 0 C--O 1.201 -1.483 0 O-C-N 119.767 -1.833 . . . . 26.62 110.558 170.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.45 -30.75 71.17 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 120.126 1.33 . . . . 36.97 113.064 176.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1136 ' ' ILE . . . . . . . . . . . . . 39.3 mm -58.37 -56.96 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 CA-C-O 117.492 -1.242 . . . . 32.11 110.231 164.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1137 ' ' ALA . . . . . 0.427 ' HB2' ' HG3' ' B' 1316 ' ' PRO . . . -53.76 -37.96 63.92 Favored 'General case' 0 CA--C 1.508 -0.64 0 O-C-N 124.901 1.376 . . . . 24.14 112.985 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -71.74 -40.71 57.91 Favored Glycine 0 N--CA 1.441 -1.033 0 CA-C-O 122.22 0.9 . . . . 25.13 111.492 -176.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 4.5 t80 -68.25 -41.86 80.52 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 120.847 -1.384 . . . . 32.73 108.405 174.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1140 ' ' ARG . . . . . 0.495 ' HA ' ' HB ' ' B' 1143 ' ' VAL . 11.5 tpt180 -71.2 -19.68 62.36 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 118.51 -0.757 . . . . 26.36 110.901 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1141 ' ' ALA . . . . . 0.74 ' HB2' HD21 ' B' 1284 ' ' LEU . . . -60.34 -52.72 64.07 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 119.721 1.146 . . . . 24.12 108.682 171.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 42.6 mm -64.98 -36.08 76.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 O-C-N 124.219 0.949 . . . . 23.37 111.623 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1143 ' ' VAL . . . . . 0.495 ' HB ' ' HA ' ' B' 1140 ' ' ARG . 57.2 t -65.58 -67.39 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 C-N-CA 124.018 0.927 . . . . 24.96 112.112 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -55.56 -31.95 62.59 Favored 'General case' 0 C--N 1.354 0.783 0 O-C-N 120.103 -1.623 . . . . 32.07 114.116 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1145 ' ' ALA . . . . . 0.634 ' HB1' HD12 ' B' 1251 ' ' ILE . . . -58.21 -57.2 13.92 Favored 'General case' 0 C--O 1.203 -1.388 0 CA-C-N 115.817 -0.629 . . . . 24.87 109.589 170.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1146 ' ' ALA . . . . . . . . . . . . . . . -58.04 -38.95 77.21 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.831 0.824 . . . . 24.67 113.051 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 83.4 t60 -51.7 -56.96 10.68 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.699 -1.137 . . . . 28.58 111.152 170.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1148 ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -90.13 1.76 56.04 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 115.557 1.688 . . . . 36.82 115.557 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1149 ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' B' 1145 ' ' ALA . 0.7 OUTLIER -72.23 153.06 41.79 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.886 1.674 . . . . 31.97 109.277 -174.386 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B 1150 ' ' GLY . . . . . 0.561 ' HA2' ' HG2' ' A' 1320 ' ' PRO . . . -86.24 -36.06 10.25 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 117.211 -1.883 . . . . 25.49 112.685 169.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1151 ' ' ARG . . . . . 0.843 ' HA ' ' HB2' ' A' 1322 ' ' GLN . 25.8 mtm-85 -119.05 -177.95 3.45 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 122.717 3.258 . . . . 59.84 115.893 -168.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1152 ' ' PHE . . . . . 0.723 ' HB2' HG11 ' B' 1163 ' ' VAL . 18.2 m-30 -81.75 165.66 20.74 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 124.124 1.916 . . . . 34.45 110.092 175.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1153 ' ' PHE . . . . . 0.523 ' HB3' ' HB2' ' B' 1189 ' ' ALA . 56.7 m-85 -82.31 -49.89 9.55 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.415 -1.266 . . . . 31.17 111.605 166.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1154 ' ' THR . . . . . . . . . . . . . 3.1 m -65.31 142.42 58.26 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.684 1.193 . . . . 33.89 111.31 -176.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -80.52 72.35 2.68 Favored Glycine 0 C--N 1.34 0.786 0 O-C-N 117.871 -3.018 . . . . 38.95 108.754 169.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1156 ' ' GLN . . . . . 0.439 ' H ' ' HB ' ' B' 1163 ' ' VAL . 12.7 tt0 -89.82 114.53 26.27 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 123.169 1.461 . . . . 54.23 110.77 -163.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 6.9 mm -67.87 95.07 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 113.441 -1.709 . . . . 51.16 106.426 166.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1158 ' ' THR . . . . . 0.561 HG21 HD13 ' A' 1326 ' ' LEU . 10.3 m -95.9 157.24 15.99 Favored 'General case' 0 C--O 1.249 1.069 0 N-CA-C 108.03 -1.1 . . . . 49.61 108.03 -172.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -46.92 -51.56 16.56 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.024 0.75 . . . . 49.05 113.024 174.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1160 ' ' ALA . . . . . 0.535 ' HA ' ' HA ' ' A' 1126 ' ' SER . . . -63.65 -58.27 7.44 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 114.659 1.355 . . . . 47.65 114.659 173.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1161 ' ' GLY . . . . . 0.418 ' HA3' HG21 ' A' 1329 ' ' THR . . . -159.87 179.18 35.6 Favored Glycine 0 C--O 1.25 1.119 0 CA-C-O 118.079 -1.401 . . . . 45.61 110.864 -168.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 95.6 mttt -94.46 140.14 30.21 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.169 -1.048 . . . . 57.46 108.169 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1163 ' ' VAL . . . . . 0.723 HG11 ' HB2' ' B' 1152 ' ' PHE . 59.2 t -97.41 128.57 34.32 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-N 114.59 -1.186 . . . . 42.93 112.573 176.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1164 ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' B' 1165 ' ' PRO . 92.7 Cg_endo -71.21 130.42 17.54 Favored 'Trans proline' 0 N--CA 1.483 0.911 0 C-N-CA 122.84 2.36 . . . . 39.29 108.322 174.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1165 ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' B' 1164 ' ' PRO . 39.4 Cg_exo -68.27 146.1 68.25 Favored 'Trans proline' 0 C--O 1.245 0.829 0 C-N-CA 123.251 2.634 . . . . 34.17 111.02 -172.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1166 ' ' ALA . . . . . 0.417 ' CB ' ' HA ' ' B' 1153 ' ' PHE . . . -68.98 119.41 13.23 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-O 123.731 1.729 . . . . 31.69 111.438 170.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1167 ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' B' 1190 ' ' ILE . 87.9 mttt -89.41 98.04 11.54 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 125.42 2.533 . . . . 44.78 107.566 171.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1168 ' ' VAL . . . . . 0.446 HG12 HG23 ' B' 1170 ' ' VAL . 60.5 t -89.03 100.48 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 109.739 -3.391 . . . . 31.23 108.867 -178.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1169 ' ' MET . . . . . 0.468 ' HA ' ' O ' ' B' 1192 ' ' ARG . 42.6 ttp -85.02 89.93 7.72 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.29 -0.868 . . . . 37.09 108.908 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1170 ' ' VAL . . . . . 0.446 HG23 HG12 ' B' 1168 ' ' VAL . 62.8 t -83.22 105.45 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-O 122.728 1.252 . . . . 30.17 108.415 177.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1171 ' ' ILE . . . . . 0.566 ' HB ' ' HA ' ' B' 1254 ' ' THR . 97.3 mt -88.93 87.86 2.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 105.285 -2.117 . . . . 33.74 105.285 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1172 ' ' GLY . . . . . 0.477 ' O ' ' HA3' ' B' 1177 ' ' GLY . . . 134.37 95.85 0.54 Allowed Glycine 0 N--CA 1.437 -1.298 0 CA-C-N 113.499 -1.682 . . . . 32.59 109.962 178.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1173 ' ' ALA . . . . . . . . . . . . . . . -92.99 46.09 1.21 Allowed 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 119.911 1.856 . . . . 32.42 112.978 -175.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -134.22 151.94 20.44 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 108.241 -1.944 . . . . 31.74 108.241 -174.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 23.4 t 24.97 -84.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 127.324 2.249 . . . . 31.48 115.242 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1176 ' ' ALA . . . . . 0.609 ' HB2' ' HB1' ' B' 1134 ' ' ALA . . . -62.61 -41.36 98.95 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 123.418 1.58 . . . . 26.12 111.137 -175.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1177 ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' B' 1172 ' ' GLY . . . -68.95 -31.37 72.52 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 113.093 -1.867 . . . . 25.73 111.284 177.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1178 ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.0 -48.41 81.67 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 121.445 2.622 . . . . 32.59 108.126 175.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -61.43 -46.78 88.69 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 112.764 0.653 . . . . 27.72 112.764 176.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -56.86 -46.52 81.72 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 121.993 0.902 . . . . 26.03 112.875 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1181 ' ' ILE . . . . . 0.605 HG22 ' SD ' ' B' 1207 ' ' MET . 72.5 mt -60.11 -50.55 79.74 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.435 0 C-N-CA 126.559 1.944 . . . . 28.61 107.784 174.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -48.07 -55.78 9.78 Favored Glycine 0 N--CA 1.44 -1.042 0 O-C-N 124.228 0.955 . . . . 25.23 113.151 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -63.9 -51.09 66.12 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 117.754 -1.117 . . . . 24.09 110.882 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -62.23 -43.77 98.08 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-O 123.549 1.642 . . . . 26.68 113.963 -175.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -67.24 -40.35 86.29 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 119.346 -2.096 . . . . 36.57 109.02 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1186 ' ' SER . . . . . 0.942 ' HB3' ' HA ' ' A' 1187 ' ' LEU . 61.0 m -66.44 -23.63 66.32 Favored 'General case' 0 C--O 1.25 1.088 0 CA-C-N 119.914 1.234 . . . . 28.92 113.226 173.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1187 ' ' LEU . . . . . 0.405 ' HG ' HD21 ' A' 1187 ' ' LEU . 19.5 mt -84.32 6.8 21.61 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 119.871 -1.768 . . . . 29.09 112.997 165.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 83.62 14.05 74.27 Favored Glycine 0 CA--C 1.538 1.524 0 O-C-N 118.546 -2.596 . . . . 29.26 114.33 172.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1189 ' ' ALA . . . . . 0.523 ' HB2' ' HB3' ' B' 1153 ' ' PHE . . . -88.98 143.76 26.63 Favored 'General case' 0 N--CA 1.433 -1.276 0 O-C-N 120.843 -1.386 . . . . 30.16 112.396 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1190 ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' B' 1167 ' ' LYS . 97.0 mt -76.77 97.43 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 105.13 -2.174 . . . . 35.81 105.13 174.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1191 ' ' VAL . . . . . 0.441 HG11 HG12 ' B' 1181 ' ' ILE . 47.7 t -74.35 115.95 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 104.955 -2.239 . . . . 31.97 104.955 176.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1192 ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' B' 1169 ' ' MET . 83.3 mtt180 -103.3 77.91 1.57 Allowed 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 106.438 -1.69 . . . . 48.16 106.438 174.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1193 ' ' ALA . . . . . 0.625 ' HB3' HG21 ' B' 1204 ' ' VAL . . . -87.07 155.64 20.06 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 114.719 1.377 . . . . 35.89 114.719 -172.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 44.7 t80 -138.87 139.25 38.05 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 104.872 -2.27 . . . . 41.88 104.872 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1195 ' ' ASP . . . . . . . . . . . . . 8.8 t0 -146.1 150.07 35.23 Favored 'General case' 0 C--O 1.245 0.857 0 N-CA-C 102.289 -3.226 . . . . 38.28 102.289 165.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1196 ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -72.15 -27.47 62.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 120.383 -1.448 . . . . 40.62 111.605 176.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1197 ' ' ARG . . . . . . . . . . . . . 36.5 mtm180 -84.4 132.09 48.34 Favored Pre-proline 0 N--CA 1.444 -0.759 0 N-CA-C 115.876 1.806 . . . . 53.09 115.876 -171.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -69.31 -30.32 24.58 Favored 'Trans proline' 0 CA--C 1.498 -1.291 0 C-N-CA 122.906 2.404 . . . . 42.56 117.35 -176.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -54.89 -26.74 37.83 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 113.199 0.814 . . . . 56.31 113.199 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1200 ' ' VAL . . . . . 0.56 ' HB ' ' NE2' ' B' 1203 ' ' GLN . 3.5 m -114.5 20.34 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 CA-C-O 123.59 1.662 . . . . 42.91 114.717 -173.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 58.0 tttm -69.94 -56.12 7.86 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 122.53 1.157 . . . . 48.89 110.931 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -55.66 -43.51 76.36 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 115.957 1.836 . . . . 51.7 115.957 -165.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1203 ' ' GLN . . . . . 0.56 ' NE2' ' HB ' ' B' 1200 ' ' VAL . 9.6 pt20 -43.37 -38.51 2.76 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 119.307 3.077 . . . . 52.57 119.307 -175.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1204 ' ' VAL . . . . . 0.625 HG21 ' HB3' ' B' 1193 ' ' ALA . 43.7 t -71.91 -47.05 57.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 106.058 -1.83 . . . . 33.79 106.058 -177.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -62.65 -44.58 95.9 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.773 -0.455 . . . . 36.58 109.773 175.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1206 ' ' SER . . . . . . . . . . . . . 16.8 m -60.87 -22.24 64.06 Favored 'General case' 0 CA--C 1.504 -0.808 0 C-N-CA 127.186 2.194 . . . . 39.61 115.333 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1207 ' ' MET . . . . . 0.694 ' SD ' ' HG ' ' C' ' 75' ' ' LEU . 27.0 mtp -87.59 -23.59 24.25 Favored 'General case' 0 C--O 1.253 1.249 0 CA-C-O 123.98 1.848 . . . . 37.45 111.523 175.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 95.32 73.58 1.19 Allowed Glycine 0 CA--C 1.5 -0.858 0 O-C-N 118.274 -2.766 . . . . 31.87 107.158 -175.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1209 ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' B' 1191 ' ' VAL . . . -169.67 -170.96 1.12 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 109.842 -3.179 . . . . 35.4 106.448 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -125.45 147.55 49.16 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 121.581 1.992 . . . . 47.89 111.885 -172.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 14.9 t80 -105.92 138.95 41.22 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 105.673 -1.973 . . . . 45.53 105.673 173.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1212 ' ' LEU . . . . . . . . . . . . . 78.9 mt -86.86 128.06 35.04 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 122.449 1.119 . . . . 46.33 111.344 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -94.44 145.2 24.94 Favored 'General case' 0 C--O 1.254 1.317 0 CA-C-N 112.299 -2.228 . . . . 60.41 111.72 177.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.62 153.51 17.68 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 114.184 -1.371 . . . . 57.38 108.775 -175.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 18.2 t70 . . . . . 0 CA--C 1.506 -0.738 0 N-CA-C 112.72 0.637 . . . . 65.07 112.72 -178.329 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B 1230 ' ' MET . . . . . 0.645 ' N ' ' HG ' ' B' 1231 ' ' SER . 16.3 mmt . . . . . 0 N--CA 1.432 -1.372 1 N-CA-C 99.374 -4.306 . . . . 80.32 99.374 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1231 ' ' SER . . . . . 0.645 ' HG ' ' N ' ' B' 1230 ' ' MET . 67.1 m 127.5 147.28 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.348 3 O-C-N 110.924 -7.36 . . . . 79.92 107.109 -10.319 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -63.79 150.54 44.43 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 120.618 1.554 . . . . 77.91 110.338 -172.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 65.92 -43.11 0.38 Allowed 'General case' 0 C--N 1.356 0.888 0 C-N-CA 125.065 1.346 . . . . 73.88 114.08 -170.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 12.0 t80 -56.35 -50.91 70.14 Favored 'General case' 0 CA--C 1.507 -0.707 0 O-C-N 118.935 -2.353 . . . . 68.98 109.996 172.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 30.3 pt -54.77 -31.87 24.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 112.57 -2.104 . . . . 64.53 113.048 172.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -74.43 -30.45 61.91 Favored 'General case' 0 C--O 1.218 -0.598 0 O-C-N 117.947 -2.971 . . . . 66.36 111.632 172.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -64.61 -41.75 96.01 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-N 119.629 1.104 . . . . 56.6 110.645 170.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -55.85 -52.66 63.27 Favored 'General case' 0 C--O 1.249 1.065 0 O-C-N 121.606 -0.684 . . . . 56.79 111.368 169.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1239 ' ' MET . . . . . 0.403 ' HG2' ' O ' ' B' 1266 ' ' LEU . 14.2 mtm -49.05 -45.05 42.34 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 114.589 1.329 . . . . 53.63 114.589 174.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -65.59 -37.1 85.67 Favored 'General case' 0 C--O 1.247 0.971 0 CA-C-O 123.042 1.401 . . . . 51.74 109.995 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 31.4 tp -63.17 -44.75 94.55 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 118.319 -2.738 . . . . 44.86 107.474 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 11.4 m-30 -68.85 -37.57 79.22 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.362 -1.29 . . . . 42.78 109.772 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -62.48 -33.73 75.45 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 121.123 1.783 . . . . 40.96 109.58 175.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -66.23 -47.52 73.53 Favored 'General case' 0 C--N 1.345 0.413 0 CA-C-O 122.253 1.025 . . . . 43.06 110.278 173.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -63.97 -25.54 68.18 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.588 -1.642 . . . . 46.45 113.241 176.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -31.85 -51.16 0.22 Allowed 'General case' 0 N--CA 1.472 0.671 1 N-CA-C 122.109 4.114 . . . . 41.78 122.109 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 6.2 tptt -86.08 -18.28 32.84 Favored 'General case' 0 C--N 1.347 0.49 0 O-C-N 120.438 -1.414 . . . . 52.2 111.874 176.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1248 ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -80.96 -48.15 12.68 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 118.745 -2.472 . . . . 53.55 112.618 172.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1249 ' ' VAL . . . . . . . . . . . . 0.255 26.8 m -71.02 137.38 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 CA-C-O 126.54 3.067 . . . . 34.41 114.933 -168.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1250 ' ' ASP . . . . . 0.435 ' HB3' ' CZ ' ' B' 1149 ' ' PHE . 3.8 m-20 -98.29 -51.43 3.99 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 108.62 -3.9 . . . . 33.38 111.225 -176.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1251 ' ' ILE . . . . . 0.634 HD12 ' HB1' ' B' 1145 ' ' ALA . 40.4 mm -126.39 111.7 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 O-C-N 118.439 -2.663 . . . . 29.54 106.543 -174.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1252 ' ' ILE . . . . . 0.468 HG22 ' HB ' ' B' 1254 ' ' THR . 61.8 mt -98.28 108.62 22.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 105.947 -1.871 . . . . 32.44 105.947 176.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1253 ' ' VAL . . . . . 0.441 ' HB ' ' HA ' ' B' 1170 ' ' VAL . 39.9 t -90.71 87.13 2.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 N-CA-C 102.342 -3.207 . . . . 30.57 102.342 176.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1254 ' ' THR . . . . . 0.568 HG23 ' HB2' ' B' 1291 ' ' ASN 0.275 2.0 t -88.33 96.17 10.47 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 103.452 -2.795 . . . . 35.04 103.452 -176.361 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B 1255 ' ' THR . . . . . 0.582 ' HA ' ' HB2' ' B' 1284 ' ' LEU . 21.6 m -90.11 -73.56 0.52 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 109.795 -3.366 . . . . 34.62 108.515 -175.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1256 ' ' ALA . . . . . 0.539 ' HB3' ' OD1' ' B' 1291 ' ' ASN . . . 45.3 1.51 0.0 OUTLIER 'General case' 0 C--O 1.242 0.671 1 N-CA-C 123.175 4.509 . . . . 42.72 123.175 -178.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 2.6 mp -65.64 92.79 0.15 Allowed 'General case' 0 C--O 1.242 0.68 0 CA-C-N 123.173 2.715 . . . . 52.43 113.863 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1258 ' ' ILE . . . . . 0.499 HG13 ' HB2' ' B' 1261 ' ' LYS . 0.3 OUTLIER -76.0 137.59 69.21 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 112.319 -2.218 . . . . 59.41 108.7 171.612 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -55.22 113.3 1.35 Allowed 'Trans proline' 0 N--CA 1.444 -1.411 0 C-N-CA 124.499 3.466 . . . . 62.68 116.391 -165.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 89.77 -36.4 3.54 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 109.772 -1.331 . . . . 64.16 109.772 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1261 ' ' LYS . . . . . 0.499 ' HB2' HG13 ' B' 1258 ' ' ILE . 70.6 mttt -75.16 135.69 73.12 Favored Pre-proline 0 C--O 1.247 0.95 0 CA-C-N 120.886 2.343 . . . . 68.53 107.63 -175.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.58 145.49 98.72 Favored 'Trans proline' 0 CA--C 1.5 -1.205 0 C-N-CA 123.895 3.064 . . . . 61.99 113.097 161.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1263 ' ' ALA . . . . . . . . . . . . . . . -81.92 128.81 67.14 Favored Pre-proline 0 C--O 1.24 0.561 0 O-C-N 120.618 -1.301 . . . . 57.15 112.833 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -64.32 153.03 78.93 Favored 'Trans proline' 0 C--O 1.247 0.969 0 C-N-CA 122.416 2.077 . . . . 51.57 116.101 169.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1265 ' ' LYS . . . . . 0.416 ' NZ ' ' O ' ' B' 1289 ' ' GLY . 41.9 mmtm -77.22 88.59 3.67 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 122.603 1.192 . . . . 54.55 110.065 -174.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1266 ' ' LEU . . . . . 0.403 ' O ' ' HG2' ' B' 1239 ' ' MET . 68.6 mt -80.35 -43.49 21.06 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 115.102 1.519 . . . . 46.86 115.102 178.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1267 ' ' ILE . . . . . 0.591 HG21 HD13 ' B' 1281 ' ' ILE . 35.1 mm -87.7 101.94 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 105.809 -1.923 . . . . 41.04 105.809 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1268 ' ' THR . . . . . 0.482 ' O ' HG23 ' B' 1272 ' ' VAL . 24.4 p -73.96 159.16 33.15 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-N 113.858 -1.519 . . . . 39.58 112.484 -178.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1269 ' ' ARG . . . . . . . . . . . . . 79.1 mtt85 -55.45 -43.42 75.42 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 115.997 -0.547 . . . . 53.15 110.471 172.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -56.37 -41.33 76.01 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 113.816 1.043 . . . . 42.96 113.816 175.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1271 ' ' MET . . . . . 0.44 ' SD ' HG23 ' B' 1267 ' ' ILE . 43.4 ttm -65.94 -47.79 73.48 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.704 -0.68 . . . . 43.89 110.189 -177.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1272 ' ' VAL . . . . . 0.482 HG23 ' O ' ' B' 1268 ' ' THR . 38.5 t -65.68 -41.97 91.67 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.671 0 CA-C-O 121.467 0.651 . . . . 38.37 110.922 -177.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -63.13 -35.78 81.43 Favored 'General case' 0 C--O 1.239 0.541 0 O-C-N 118.53 -2.606 . . . . 47.46 112.664 173.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1274 ' ' SER . . . . . . . . . . . . . 72.8 m -70.14 -25.34 63.43 Favored 'General case' 0 N--CA 1.441 -0.917 0 O-C-N 120.845 -1.16 . . . . 38.38 113.868 173.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1275 ' ' MET . . . . . 0.491 ' SD ' HD11 ' B' 1281 ' ' ILE . 40.2 mtp -60.79 163.53 5.57 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 117.95 2.574 . . . . 37.81 117.95 -174.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 81.8 tttt -62.95 131.79 49.88 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 110.242 -3.163 . . . . 49.26 108.97 166.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1277 ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' 1045 ' ' PHE . . . -84.24 166.37 17.58 Favored 'General case' 0 CA--C 1.51 -0.594 0 O-C-N 124.83 1.331 . . . . 34.46 110.023 -177.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 63.2 30.53 77.81 Favored Glycine 0 C--N 1.334 0.467 0 O-C-N 120.886 -1.134 . . . . 33.53 111.861 -172.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1279 ' ' SER . . . . . . . . . . . . . 42.3 m -126.5 146.81 49.97 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 106.062 -1.829 . . . . 31.31 106.062 -176.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1280 ' ' VAL . . . . . 0.412 HG11 ' HA ' ' B' 1145 ' ' ALA . 58.1 t -117.66 135.36 58.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 122.592 1.187 . . . . 29.32 109.278 -171.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1281 ' ' ILE . . . . . 0.591 HD13 HG21 ' B' 1267 ' ' ILE . 67.4 mt -110.62 104.09 16.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 103.601 -2.74 . . . . 31.93 103.601 178.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1282 ' ' VAL . . . . . 0.698 HG11 ' HA ' ' B' 1141 ' ' ALA . 31.7 t -95.78 111.72 26.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 N-CA-C 101.681 -3.451 . . . . 29.48 101.681 -175.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 36.8 t0 -87.67 107.01 18.42 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.231 -1.349 . . . . 34.5 108.544 175.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1284 ' ' LEU . . . . . 0.74 HD21 ' HB2' ' B' 1141 ' ' ALA . 19.6 mt -79.02 -17.21 55.72 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 118.609 -1.236 . . . . 37.94 111.045 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -102.12 29.23 5.22 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.664 0.745 . . . . 40.92 111.868 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -51.83 -36.59 48.63 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.64 1.976 . . . . 44.39 115.797 177.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1287 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.19 -38.86 21.74 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.497 1.119 . . . . 51.46 110.347 171.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 11.3 t30 -98.37 71.95 2.07 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-O 121.482 0.658 . . . . 57.75 111.574 -171.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1289 ' ' GLY . . . . . 0.416 ' O ' ' NZ ' ' B' 1265 ' ' LYS . . . 86.61 -40.74 3.07 Favored Glycine 0 N--CA 1.47 0.948 0 CA-C-O 117.949 -1.473 . . . . 49.85 113.614 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 72.57 119.73 0.06 OUTLIER Glycine 0 CA--C 1.541 1.672 0 CA-C-N 121.42 2.61 . . . . 45.93 112.195 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1291 ' ' ASN . . . . . 0.568 ' HB2' HG23 ' B' 1254 ' ' THR . 54.8 m-80 -85.52 -21.75 28.46 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.625 1.17 . . . . 42.67 110.034 -175.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1292 ' ' CYS . . . . . 0.486 ' HB3' ' OG1' ' B' 1295 ' ' THR . 27.1 t -110.83 132.19 54.41 Favored 'General case' 0 CA--C 1.51 -0.582 0 O-C-N 118.503 -2.623 . . . . 38.82 111.608 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1293 ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -58.17 -41.79 84.62 Favored 'General case' 0 C--O 1.245 0.856 0 CA-C-O 121.399 0.619 . . . . 46.71 111.928 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -75.56 -7.71 54.91 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 115.37 1.618 . . . . 47.23 115.37 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1295 ' ' THR . . . . . 0.563 HG23 ' HA3' ' B' 1311 ' ' GLY . 38.6 m -53.89 122.3 9.75 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.239 0.616 . . . . 36.02 112.551 172.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1296 ' ' VAL . . . . . 0.558 HG23 ' HB2' ' B' 1301 ' ' PHE . 26.3 t -89.0 106.31 12.84 Favored Pre-proline 0 N--CA 1.488 1.452 0 N-CA-C 101.993 -3.336 . . . . 37.26 101.993 161.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -59.97 76.15 0.06 OUTLIER 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 125.227 3.951 . . . . 35.09 115.536 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1298 ' ' GLY . . . . . 0.567 ' HA2' ' H ' ' B' 1313 ' ' THR . . . 149.24 -14.92 1.12 Allowed Glycine 0 CA--C 1.528 0.887 0 CA-C-N 113.218 -1.81 . . . . 35.97 111.679 -178.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -139.48 -174.31 3.85 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 123.487 3.643 . . . . 40.39 112.262 -174.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1300 ' ' ILE . . . . . 0.756 HG12 HG12 ' B' 1310 ' ' ILE . 30.7 mt -88.44 133.91 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-N 113.917 -1.492 . . . . 37.43 109.374 166.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1301 ' ' PHE . . . . . 0.558 ' HB2' HG23 ' B' 1296 ' ' VAL . 61.8 t80 -108.66 116.84 32.74 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 107.223 -1.399 . . . . 44.13 107.223 159.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1302 ' ' THR . . . . . 0.659 HG23 ' HG2' ' B' 1308 ' ' LYS . 13.9 m -84.82 112.38 20.48 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.632 -1.618 . . . . 39.78 106.632 172.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1303 ' ' THR . . . . . . . . . . . . . 34.5 p -74.36 162.32 28.99 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 120.879 -1.138 . . . . 43.29 111.628 175.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -49.96 -47.72 52.49 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 125.192 1.397 . . . . 53.07 114.313 -168.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1305 ' ' ASN . . . . . 0.537 ' OD1' HG23 ' B' 1307 ' ' VAL . 47.7 p30 -70.51 -23.96 62.74 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 115.531 1.678 . . . . 43.97 115.531 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 114.38 21.13 5.62 Favored Glycine 0 CA--C 1.529 0.932 0 O-C-N 121.177 -0.952 . . . . 41.12 111.885 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1307 ' ' VAL . . . . . 0.537 HG23 ' OD1' ' B' 1305 ' ' ASN . 47.6 t -80.08 128.56 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 O-C-N 119.6 -2.118 . . . . 38.12 106.439 163.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1308 ' ' LYS . . . . . 0.659 ' HG2' HG23 ' B' 1302 ' ' THR . 92.6 mttt -109.76 114.67 28.43 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-N 120.58 1.536 . . . . 36.34 109.285 -176.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1309 ' ' VAL . . . . . . . . . . . . . 44.0 t -89.88 103.26 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 O-C-N 120.589 -1.32 . . . . 30.4 110.059 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1310 ' ' ILE . . . . . 0.756 HG12 HG12 ' B' 1300 ' ' ILE . 40.4 mt -92.93 104.4 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.98 0 N-CA-C 104.921 -2.252 . . . . 30.82 104.921 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1311 ' ' GLY . . . . . 0.563 ' HA3' HG23 ' B' 1295 ' ' THR . . . -124.09 81.59 0.35 Allowed Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 104.246 -3.542 . . . . 26.53 104.246 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1312 ' ' TYR . . . . . 0.692 ' HB2' ' HG ' ' B' 1315 ' ' LEU . 16.9 m-85 -92.4 137.82 32.04 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 120.452 -1.617 . . . . 38.0 111.849 176.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1313 ' ' THR . . . . . 0.567 ' H ' ' HA2' ' B' 1298 ' ' GLY . 3.4 p -61.72 -36.37 80.76 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.79 -1.189 . . . . 29.8 107.79 168.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -83.49 12.13 6.04 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 118.143 2.645 . . . . 39.04 118.143 -175.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1315 ' ' LEU . . . . . 0.692 ' HG ' ' HB2' ' B' 1312 ' ' TYR . 12.2 mt -58.37 -42.76 96.45 Favored Pre-proline 0 C--O 1.245 0.831 0 O-C-N 118.671 -2.518 . . . . 31.08 114.992 170.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1316 ' ' PRO . . . . . 0.607 ' HB3' ' HB3' ' B' 1133 ' ' MET . 83.4 Cg_exo -67.22 -3.45 9.9 Favored 'Trans proline' 0 C--O 1.24 0.602 0 C-N-CA 122.509 2.139 . . . . 26.1 113.361 169.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -89.12 -57.26 1.81 Allowed Glycine 0 CA--C 1.536 1.373 0 O-C-N 119.243 -2.16 . . . . 23.17 110.409 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1318 ' ' ARG . . . . . 0.431 ' HB2' ' HG2' ' B' 1140 ' ' ARG . 79.0 mtt180 -68.89 52.65 0.09 Allowed 'General case' 0 CA--C 1.529 0.139 1 N-CA-C 122.582 4.29 . . . . 40.4 122.582 -158.088 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -133.66 76.47 66.33 Favored Pre-proline 0 C--O 1.236 0.394 0 O-C-N 118.579 -2.576 . . . . 23.6 104.94 151.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1320 ' ' PRO . . . . . 0.566 ' HG2' ' HA2' ' A' 1150 ' ' GLY . 18.1 Cg_endo -35.32 -70.78 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.199 3.266 . . . . 22.35 120.553 -166.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1321 ' ' THR . . . . . 0.516 HG23 HG21 ' B' 1019 ' ' THR . 2.8 m -55.69 -43.45 76.43 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 114.858 1.429 . . . . 26.52 114.858 173.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1322 ' ' GLN . . . . . 0.759 ' HB2' ' HA ' ' A' 1151 ' ' ARG . 42.3 tp60 -72.94 -37.59 67.1 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 118.144 -2.847 . . . . 24.38 109.296 -173.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1323 ' ' SER . . . . . . . . . . . . . 49.7 m -61.13 -54.37 45.4 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 116.925 -1.512 . . . . 22.8 107.653 174.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1324 ' ' SER . . . . . . . . . . . . . 15.2 m -54.16 -35.88 62.75 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 114.417 1.266 . . . . 21.25 114.417 173.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -67.44 -57.41 6.61 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 120.921 -1.112 . . . . 31.34 110.783 173.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1326 ' ' LEU . . . . . 0.539 ' HG ' HE21 ' B' 1322 ' ' GLN . 97.3 mt -73.3 -32.6 64.71 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-N 121.765 2.075 . . . . 31.56 108.349 -166.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1327 ' ' TYR . . . . . 0.403 ' CZ ' ' HA ' ' B' 1072 ' ' VAL . 24.7 t80 -60.94 -56.97 14.83 Favored 'General case' 0 C--O 1.257 1.471 0 N-CA-C 105.421 -2.066 . . . . 22.73 105.421 169.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1328 ' ' GLY . . . . . 0.694 ' HA2' HD12 ' B' 1331 ' ' LEU . . . -48.24 -41.55 23.58 Favored Glycine 0 N--CA 1.467 0.725 0 CA-C-O 119.786 -0.452 . . . . 21.91 114.162 173.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1329 ' ' THR . . . . . 0.533 HG21 ' HA3' ' A' 1161 ' ' GLY . 16.5 m -72.0 -31.17 65.97 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 118.709 1.255 . . . . 22.15 110.598 -175.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1330 ' ' ASN . . . . . . . . . . . . . 33.0 m120 -63.6 -46.46 85.69 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.291 -0.881 . . . . 26.18 109.885 170.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1331 ' ' LEU . . . . . 0.83 HD22 HD22 ' B' 1070 ' ' LEU . 73.1 mt -53.72 -48.13 69.9 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.77 0.828 . . . . 23.68 112.224 176.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1332 ' ' VAL . . . . . 0.432 HG12 ' HE3' ' B' 1336 ' ' LYS . 90.8 t -51.92 -57.49 3.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 O-C-N 124.638 1.212 . . . . 26.57 110.804 169.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -55.06 -37.49 66.81 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.79 1.177 . . . . 28.08 112.165 -177.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1334 ' ' LEU . . . . . . . . . . . . . 32.4 tp -64.78 -49.29 71.28 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 124.779 1.3 . . . . 27.43 111.39 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1335 ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' B' 1331 ' ' LEU . 64.4 mt -62.13 -35.43 78.72 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 114.68 -1.146 . . . . 30.5 109.616 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1336 ' ' LYS . . . . . 0.473 ' NZ ' ' HG3' ' C' ' 98' ' ' GLU . 83.2 mttt -57.87 -42.04 83.71 Favored 'General case' 0 CA--C 1.512 -0.498 0 O-C-N 121.486 -0.758 . . . . 41.65 112.555 171.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 8.2 mp -72.74 -34.85 67.31 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 113.164 0.801 . . . . 42.08 113.164 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1338 ' ' LEU . . . . . 0.453 HD11 ' SD ' ' B' 1113 ' ' MET . 47.0 mt -74.59 -72.81 0.27 Allowed 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 122.804 1.288 . . . . 35.03 107.967 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1339 ' ' CYS . . . . . 0.509 ' SG ' HD13 ' B' 1346 ' ' ILE . 50.0 m -81.02 69.93 7.73 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-O 123.442 1.591 . . . . 37.33 113.982 -175.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 55.4 mttp -67.69 -6.28 19.91 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 113.65 -1.613 . . . . 50.51 115.262 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -95.07 -24.62 16.8 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.508 0.723 . . . . 54.21 110.753 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.23 34.85 21.25 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.957 1.703 . . . . 50.99 111.501 -174.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -82.7 -30.11 29.4 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 114.177 -1.374 . . . . 48.82 111.658 -172.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 116.16 22.61 4.47 Favored Glycine 0 N--CA 1.473 1.141 0 CA-C-O 118.335 -1.258 . . . . 40.43 110.319 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -134.32 140.14 46.17 Favored 'General case' 0 C--O 1.25 1.102 0 CA-C-N 120.955 2.378 . . . . 47.56 108.149 173.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1346 ' ' ILE . . . . . 0.509 HD13 ' SG ' ' B' 1339 ' ' CYS . 22.6 mm -63.9 92.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 CA-C-O 126.284 2.945 . . . . 42.49 108.807 171.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1347 ' ' THR . . . . . . . . . . . . . 61.1 m -80.19 99.36 7.75 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 100.778 -3.786 . . . . 38.12 100.778 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1348 ' ' VAL . . . . . 0.466 HG22 HG22 ' B' 1346 ' ' ILE . 6.7 t -82.32 102.42 8.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 106.515 -1.661 . . . . 37.5 106.515 -176.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1349 ' ' ASP . . . . . 0.765 ' HB3' HG21 ' B' 1355 ' ' ILE . 29.0 t70 -67.14 164.61 17.68 Favored 'General case' 0 C--O 1.214 -0.767 0 O-C-N 125.645 1.841 . . . . 43.85 110.264 178.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1350 ' ' PHE . . . . . 0.401 ' HD1' ' HA ' ' B' 1350 ' ' PHE . 0.1 OUTLIER -148.7 5.42 0.69 Allowed 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.769 -0.826 . . . . 39.81 108.769 177.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 32.4 t70 -92.18 -56.59 3.0 Favored 'General case' 0 C--O 1.247 0.946 0 N-CA-C 114.26 1.207 . . . . 51.29 114.26 -174.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 7.7 t0 -65.06 134.68 54.35 Favored 'General case' 0 C--O 1.258 1.513 0 CA-C-O 121.703 0.764 . . . . 39.78 110.381 -174.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1353 ' ' VAL . . . . . 0.487 HG21 HG13 ' B' 1373 ' ' ILE . 30.6 m -48.71 -38.52 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 116.813 2.153 . . . . 39.28 116.813 175.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1354 ' ' VAL . . . . . 0.604 HG11 HD22 ' B' 1127 ' ' LEU . 95.0 t -58.84 -59.34 3.87 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 CA-C-N 114.805 -1.089 . . . . 35.7 109.306 173.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1355 ' ' ILE . . . . . 0.765 HG21 ' HB3' ' B' 1349 ' ' ASP . 43.6 mm -61.06 -42.95 95.11 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.93 0 O-C-N 124.319 1.012 . . . . 35.77 109.557 -173.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1356 ' ' ARG . . . . . 0.636 ' HG3' ' HD3' ' B' 1371 ' ' PRO . 39.9 tpt85 -58.98 -25.01 63.22 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 120.002 -1.686 . . . . 38.55 113.865 175.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -82.33 -67.03 1.52 Allowed Glycine 0 CA--C 1.535 1.316 0 N-CA-C 110.1 -1.2 . . . . 29.58 110.1 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1358 ' ' VAL . . . . . 0.44 HG12 ' HA ' ' B' 1355 ' ' ILE . 10.0 p -54.42 -35.34 30.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 116.025 1.861 . . . . 32.06 116.025 -177.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1359 ' ' THR . . . . . . . . . . . . . 8.0 m -85.09 83.21 8.11 Favored 'General case' 0 CA--C 1.513 -0.464 0 O-C-N 118.413 -2.679 . . . . 29.0 108.173 178.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1360 ' ' VAL . . . . . 0.499 ' HB ' ' HB2' ' B' 1368 ' ' TRP . 36.0 m -76.06 -21.99 15.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 109.905 -3.316 . . . . 29.68 112.478 -168.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 60.6 mt -133.17 129.45 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 101.832 -3.396 . . . . 32.05 101.832 172.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1362 ' ' ARG . . . . . 0.702 ' HA ' HG23 ' B' 1111 ' ' THR . 11.7 mtp180 -112.45 104.83 12.97 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 123.484 1.611 . . . . 32.52 108.327 168.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 50.9 60.03 4.18 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 122.711 1.243 . . . . 35.68 111.706 171.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1364 ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' B' 1109 ' ' ASN . . . 94.46 -43.69 2.33 Favored Glycine 0 CA--C 1.529 0.911 0 O-C-N 119.019 -2.301 . . . . 34.26 110.743 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -72.45 117.59 14.3 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-O 117.711 -1.138 . . . . 51.07 109.769 -174.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 54.1 mt -73.92 94.87 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.34 0 CA-C-O 123.39 1.567 . . . . 39.87 108.368 174.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1367 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.14 -14.08 59.33 Favored 'General case' 0 C--O 1.25 1.092 0 CA-C-N 111.903 -2.408 . . . . 38.01 114.701 -173.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1368 ' ' TRP . . . . . 0.499 ' HB2' ' HB ' ' B' 1360 ' ' VAL . 73.8 t90 -59.81 140.05 89.93 Favored Pre-proline 0 N--CA 1.47 0.529 0 CA-C-N 110.941 -2.845 . . . . 42.14 106.362 170.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -78.77 178.07 35.85 Favored 'Cis proline' 0 N--CA 1.446 -1.31 0 CA-C-N 124.811 2.754 . . . . 43.26 118.12 4.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1370 ' ' ALA . . . . . . . . . . . . . . . -76.84 149.03 80.0 Favored Pre-proline 0 C--O 1.248 1.021 0 CA-C-N 110.897 -2.865 . . . . 46.52 110.718 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1371 ' ' PRO . . . . . 0.636 ' HD3' ' HG3' ' B' 1356 ' ' ARG . 92.6 Cg_endo -62.71 142.63 90.03 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.573 2.182 . . . . 51.95 113.702 170.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.0 72.57 1.55 Allowed 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 124.853 3.702 . . . . 56.27 113.648 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1373 ' ' ILE . . . . . 0.54 HD12 HG21 ' B' 1121 ' ' ILE 0.26 0.1 OUTLIER -79.71 135.12 26.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 O-C-N 119.627 -1.921 . . . . 60.83 106.929 173.957 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -75.31 116.62 16.23 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.032 -1.47 . . . . 66.1 107.032 -176.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1375 ' ' VAL . . . . . 0.552 HG11 ' HB2' ' B' 1120 ' ' ARG . 49.1 t -104.06 109.1 26.25 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 CA-C-N 113.061 -1.882 . . . . 63.47 106.712 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.223 -4.929 0 O-C-N 118.967 -2.333 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.818 0 CA-C-O 121.723 0.773 . . . . 0.0 111.997 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.66 -42.86 65.08 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 175.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.93 -43.73 77.67 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 122.572 2.442 . . . . 0.0 108.456 177.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 85.6 m -64.11 -37.91 89.15 Favored 'General case' 0 C--O 1.249 1.077 0 CA-C-O 117.924 -1.036 . . . . 0.0 111.846 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 24' ' ' ALA . . . . . 0.84 ' HB1' ' HA ' ' C' ' 186' ' ' LEU . . . -59.2 -51.58 69.37 Favored 'General case' 0 CA--C 1.559 1.326 0 CA-C-N 120.016 1.28 . . . . 0.0 110.625 173.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 25' ' ' GLU . . . . . 0.763 ' HA ' ' HE2' ' C' ' 28' ' ' LYS . 0.8 OUTLIER -54.99 -33.09 62.22 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.515 1.126 . . . . 0.0 110.897 174.637 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.7 -54.33 33.31 Favored 'General case' 0 C--O 1.214 -0.78 0 O-C-N 119.608 -1.933 . . . . 0.0 111.556 171.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.626 HD21 HD21 ' C' ' 110' ' ' LEU . 2.3 mm? -47.81 -59.02 3.62 Favored 'General case' 0 C--O 1.247 0.949 0 C-N-CA 127.187 2.195 . . . . 0.0 113.382 -175.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 28' ' ' LYS . . . . . 0.763 ' HE2' ' HA ' ' C' ' 25' ' ' GLU . 27.2 pttt -59.32 -35.91 74.68 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.328 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -79.05 -30.37 44.01 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.434 ' HB3' ' HB3' ' C' ' 107' ' ' ASP . 69.7 m -43.25 -35.99 1.64 Allowed 'General case' 0 CA--C 1.508 -0.659 1 N-CA-C 122.869 4.396 . . . . 0.0 122.869 -167.385 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 67.73 -41.62 0.43 Allowed 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.887 1.675 . . . . 0.0 112.309 -171.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 12.0 m -121.15 139.42 53.37 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 120.028 1.285 . . . . 0.0 109.533 162.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' C' ' 64' ' ' VAL . 89.0 t -130.08 125.88 60.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 175.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.597 ' HB ' HG22 ' C' ' 109' ' ' VAL . 41.5 mm -104.74 123.56 58.82 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 O-C-N 118.93 -2.356 . . . . 0.0 106.071 169.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . 0.417 HD12 ' CZ ' ' C' ' 66' ' ' PHE . 29.7 mt -100.97 128.22 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 172.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 52.7 m -113.91 107.85 51.83 Favored Pre-proline 0 N--CA 1.426 -1.643 0 C-N-CA 125.565 1.546 . . . . 0.0 108.721 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . 0.481 ' HG3' ' SD ' ' C' ' 41' ' ' MET . 32.5 Cg_exo -64.69 117.59 4.65 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.311 3.341 . . . . 0.0 110.16 170.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 38' ' ' GLY . . . . . 0.645 ' HA3' ' HB2' ' C' ' 114' ' ' ALA . . . -115.39 -155.63 10.87 Favored Glycine 0 N--CA 1.416 -2.634 0 CA-C-N 111.906 -2.406 . . . . 0.0 110.465 164.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -66.82 -42.57 85.62 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.512 -0.993 . . . . 0.0 111.202 -173.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 40' ' ' GLY . . . . . 0.625 ' HA3' ' HA3' ' C' ' 113' ' ' GLY . . . -60.52 -39.84 96.95 Favored Glycine 0 N--CA 1.437 -1.247 0 CA-C-O 117.483 -1.732 . . . . 0.0 110.781 -178.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 41' ' ' MET . . . . . 0.587 ' HA ' ' HB3' ' C' ' 46' ' ' ALA . 9.1 ttm -56.66 -43.47 80.41 Favored 'General case' 0 C--N 1.36 1.036 0 CA-C-N 122.221 3.01 . . . . 0.0 111.284 177.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.36 -36.72 26.55 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 121.617 -0.677 . . . . 0.0 112.47 -171.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 85.6 t -77.79 -64.09 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.965 1.306 . . . . 0.0 110.533 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.95 65.81 2.97 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.535 1.159 . . . . 0.0 109.626 -172.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 45' ' ' GLN . . . . . 0.592 ' HG3' ' HG3' ' C' ' 176' ' ' LYS . 8.9 pt20 17.71 36.18 0.0 OUTLIER 'General case' 0 C--O 1.245 0.863 1 N-CA-C 123.805 4.743 . . . . 0.0 123.805 175.006 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.587 ' HB3' ' HA ' ' C' ' 41' ' ' MET . . . -73.81 -14.94 61.18 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 119.033 2.975 . . . . 0.0 119.033 -176.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 47' ' ' GLN . . . . . . . . . . . . 0.251 0.0 OUTLIER -65.83 -46.85 77.03 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 114.721 -2.561 . . . . 0.0 114.762 -178.358 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 48' ' ' TYR . . . . . 0.525 ' CD1' ' HD3' ' C' ' 49' ' ' PRO 0.37 2.8 p90 -65.88 -32.59 6.0 Favored Pre-proline 0 N--CA 1.474 0.771 0 CA-C-N 125.389 3.722 . . . . 0.0 115.294 174.124 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 49' ' ' PRO . . . . . 0.525 ' HD3' ' CD1' ' C' ' 48' ' ' TYR . 8.8 Cg_exo -58.96 -44.85 32.04 Favored 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 123.042 2.494 . . . . 0.0 111.293 164.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . 0.447 ' HA ' HG22 ' C' ' 53' ' ' ILE . 23.2 t -55.55 -40.64 60.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 119.59 1.086 . . . . 0.0 109.655 173.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.33 -42.04 77.03 Favored 'General case' 0 C--N 1.367 1.334 0 CA-C-N 121.004 1.729 . . . . 0.0 112.763 175.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -60.81 -40.03 91.18 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 173.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 53' ' ' ILE . . . . . 0.73 HD13 ' HA ' ' C' ' 183' ' ' LEU . 8.2 tp -75.93 -31.53 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 120.368 1.44 . . . . 0.0 109.659 177.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 89.6 m -68.89 -29.34 67.6 Favored 'General case' 0 CA--C 1.498 -1.028 0 O-C-N 119.833 -1.792 . . . . 0.0 112.458 -174.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -48.93 -67.82 0.23 Allowed 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 163.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -57.59 -41.4 81.08 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -172.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 57' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' C' ' 53' ' ' ILE . 58.0 mt -61.91 -52.25 64.84 Favored 'General case' 0 N--CA 1.434 -1.249 0 O-C-N 124.779 1.3 . . . . 0.0 109.443 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . 0.446 ' HD2' ' HA ' ' C' ' 58' ' ' ARG . 10.1 tpt180 -70.07 -36.1 74.71 Favored 'General case' 0 C--O 1.245 0.865 0 O-C-N 120.27 -1.519 . . . . 0.0 108.74 -174.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.54 -27.55 64.65 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 173.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 30.3 ttm-85 -87.8 2.34 51.58 Favored 'General case' 0 CA--C 1.543 0.712 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 175.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.22 3.36 84.89 Favored Glycine 0 C--N 1.343 0.962 0 O-C-N 118.557 -2.589 . . . . 0.0 111.782 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 88.2 mt -66.87 130.05 31.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 CA-C-N 118.732 1.266 . . . . 0.0 109.676 -177.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -70.11 75.67 0.5 Allowed 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 122.844 1.307 . . . . 0.0 109.111 169.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 2.9 p -86.64 103.28 12.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-O 123.096 1.427 . . . . 0.0 107.76 173.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 65' ' ' ARG . . . . . 0.532 ' NH2' HD22 ' C' ' 94' ' ' LEU . 50.0 mmm-85 -108.74 151.4 26.25 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 124.833 2.254 . . . . 0.0 109.573 173.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . 0.869 ' HB2' ' HA ' ' C' ' 93' ' ' VAL . 19.8 m-85 -106.94 114.5 28.62 Favored 'General case' 0 C--O 1.251 1.142 0 C-N-CA 117.664 -1.614 . . . . 0.0 108.049 -176.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . 0.473 ' HA3' ' HE2' ' C' ' 103' ' ' PHE . . . -98.99 98.57 2.01 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 106.79 -2.524 . . . . 0.0 106.79 176.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 68' ' ' ILE . . . . . 0.636 HD11 HG13 ' C' ' 93' ' ' VAL . 3.2 mp -89.93 140.25 16.2 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -114.21 121.74 35.84 Favored Pre-proline 0 CA--C 1.506 -0.747 0 CA-C-O 116.034 -1.936 . . . . 0.0 106.029 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 70' ' ' PRO . . . . . 0.659 ' HB3' HG13 ' A' 1157 ' ' ILE . 32.1 Cg_endo -61.56 -50.52 5.42 Favored 'Trans proline' 0 N--CA 1.482 0.823 0 C-N-CA 124.237 3.291 . . . . 0.0 112.214 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 73.0 t -72.86 96.71 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.256 1.397 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 168.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -158.54 128.58 5.92 Favored 'General case' 0 C--O 1.259 1.585 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 176.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.23 -102.79 0.83 Allowed Glycine 0 C--N 1.319 -0.397 0 O-C-N 121.535 -0.728 . . . . 0.0 111.454 167.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.14 122.34 5.05 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -172.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.694 ' HG ' ' SD ' ' B' 1207 ' ' MET . 0.2 OUTLIER 67.09 115.76 0.03 OUTLIER Pre-proline 0 N--CA 1.444 -0.734 0 C-N-CA 125.73 1.612 . . . . 0.0 111.598 -177.313 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 76' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' C' ' 75' ' ' LEU . 72.0 Cg_endo -69.09 172.48 11.91 Favored 'Trans proline' 0 C--O 1.26 1.614 0 C-N-CA 123.508 2.805 . . . . 0.0 114.386 169.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.63 -104.69 1.35 Allowed Glycine 0 N--CA 1.441 -0.971 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 -166.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 34.02 -78.07 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 127.256 2.222 . . . . 0.0 116.018 160.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -61.86 -41.44 97.84 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 119.404 1.002 . . . . 0.0 113.078 -175.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -85.82 -23.46 27.15 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 113.944 -1.48 . . . . 0.0 112.249 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 98.7 t -62.37 -51.78 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 171.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 11.1 mt -57.95 -29.78 65.44 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 170.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.568 ' HG ' ' HB ' ' C' ' 88' ' ' VAL . 11.8 tp -62.0 -37.26 84.18 Favored 'General case' 0 C--O 1.239 0.517 0 O-C-N 119.673 -1.892 . . . . 0.0 111.498 167.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.4 -43.16 74.03 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 120.542 -1.349 . . . . 0.0 109.704 173.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -60.05 -31.05 69.62 Favored 'General case' 0 C--N 1.348 0.5 0 O-C-N 120.089 -1.632 . . . . 0.0 113.391 173.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' C' ' 83' ' ' LEU 0.261 . . -73.24 -5.93 42.65 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 120.245 -1.534 . . . . 0.0 112.236 171.752 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 65.49 29.44 11.19 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 118.515 -2.616 . . . . 0.0 116.735 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 88' ' ' VAL . . . . . 0.568 ' HB ' ' HG ' ' C' ' 83' ' ' LEU . 78.0 t -82.83 123.0 78.45 Favored Pre-proline 0 N--CA 1.438 -1.031 0 CA-C-N 112.711 -2.041 . . . . 0.0 106.281 172.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -60.12 103.59 0.21 Allowed 'Trans proline' 0 CA--C 1.545 1.037 1 C-N-CA 125.69 4.26 . . . . 0.0 116.681 -176.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 90' ' ' TYR . . . . . 0.747 ' HA ' ' HB ' ' C' ' 93' ' ' VAL . 1.4 m-30 -50.41 -16.99 0.4 Allowed 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -61.62 -59.82 4.62 Favored 'General case' 0 C--N 1.344 0.349 0 O-C-N 121.383 -0.823 . . . . 0.0 110.554 165.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 5.6 pt -74.94 -18.13 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 118.392 -2.693 . . . . 0.0 111.736 -175.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 93' ' ' VAL . . . . . 0.869 ' HA ' ' HB2' ' C' ' 66' ' ' PHE . 51.7 t -70.05 135.56 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 127.186 2.195 . . . . 0.0 106.574 170.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 94' ' ' LEU . . . . . 0.532 HD22 ' NH2' ' C' ' 65' ' ' ARG . 16.4 tp -138.2 101.72 4.47 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 124.361 2.029 . . . . 0.0 108.353 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 95' ' ' GLU . . . . . 0.618 ' HB3' HD13 ' A' 1157 ' ' ILE . 4.0 mp0 -74.91 84.08 2.21 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 112.004 -2.362 . . . . 0.0 111.06 -177.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.485 ' SD ' ' HD2' ' C' ' 70' ' ' PRO . 24.8 ttp 43.73 60.58 2.61 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 119.548 3.166 . . . . 0.0 119.548 176.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -119.13 -152.02 0.5 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 111.275 -2.693 . . . . 0.0 105.824 -175.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . 0.473 ' HG3' ' NZ ' ' B' 1336 ' ' LYS . 8.6 mt-10 -77.1 54.34 1.05 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 125.098 3.59 . . . . 0.0 113.512 -177.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 9.6 tp -79.11 3.01 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 O-C-N 120.753 -1.217 . . . . 0.0 111.334 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . 0.483 HD22 ' HG3' ' C' ' 137' ' ' GLU . 12.3 t-20 -44.48 -52.49 7.86 Favored 'General case' 0 C--N 1.362 1.121 0 C-N-CA 125.58 1.552 . . . . 0.0 114.144 177.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -57.05 -55.09 39.27 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 124.778 1.299 . . . . 0.0 110.681 -174.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.0 -41.78 77.33 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 113.724 -1.58 . . . . 0.0 107.832 -174.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 103' ' ' PHE . . . . . 0.473 ' HE2' ' HA3' ' C' ' 67' ' ' GLY . 0.2 OUTLIER -59.53 -57.41 13.08 Favored 'General case' 0 C--N 1.358 0.962 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -172.088 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.44 -15.42 63.28 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 118.979 0.809 . . . . 0.0 112.465 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -73.33 -39.2 65.42 Favored 'General case' 0 CA--C 1.568 1.66 0 O-C-N 119.755 -1.84 . . . . 0.0 110.499 174.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 106' ' ' THR . . . . . 0.41 HG21 HG12 ' C' ' 34' ' ' ILE . 19.9 m -52.28 146.16 9.76 Favored 'General case' 0 C--O 1.247 0.948 0 O-C-N 126.984 2.678 . . . . 0.0 116.087 -165.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 107' ' ' ASP . . . . . 0.72 ' HA ' ' HB2' ' C' ' 142' ' ' GLN . 9.5 t70 -81.06 -83.06 0.11 Allowed 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 111.907 -2.406 . . . . 0.0 108.386 165.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' C' ' 143' ' ' ASN . 31.4 m -89.82 118.35 29.35 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 120.565 1.529 . . . . 0.0 112.866 -174.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 109' ' ' VAL . . . . . 0.667 HG21 HG23 ' C' ' 138' ' ' VAL . 84.2 t -101.49 100.05 9.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 C-N-CA 124.266 1.026 . . . . 0.0 109.76 169.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 110' ' ' LEU . . . . . 0.626 HD21 HD21 ' C' ' 27' ' ' LEU . 29.2 mt -72.12 93.29 1.41 Allowed 'General case' 0 C--O 1.236 0.356 0 O-C-N 124.286 0.992 . . . . 0.0 108.776 177.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 111' ' ' VAL . . . . . 0.656 ' HB ' ' HA ' ' C' ' 146' ' ' VAL . 38.3 t -85.51 94.14 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 177.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 8.5 mm -81.13 92.52 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-O 122.697 1.236 . . . . 0.0 111.096 -171.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 113' ' ' GLY . . . . . 0.625 ' HA3' ' HA3' ' C' ' 40' ' ' GLY . . . 75.69 65.81 1.99 Allowed Glycine 0 C--N 1.315 -0.598 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 168.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 114' ' ' ALA . . . . . 0.645 ' HB2' ' HA3' ' C' ' 38' ' ' GLY . . . -170.98 -166.71 0.5 Allowed 'General case' 0 CA--C 1.504 -0.803 0 O-C-N 122.048 -0.677 . . . . 0.0 110.895 -174.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 115' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -174.01 -53.74 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 166.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 116' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -61.26 -25.32 67.01 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 123.58 1.657 . . . . 0.0 112.575 -172.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.6 -43.49 62.52 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 176.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 3.6 m -124.49 13.32 4.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 112.276 -2.238 . . . . 0.0 112.26 -176.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 119' ' ' ASN . . . . . 0.424 ' HA ' ' HD2' ' C' ' 120' ' ' PRO . 25.3 t30 -68.26 112.49 11.07 Favored Pre-proline 0 C--N 1.364 1.201 0 O-C-N 118.372 -2.705 . . . . 0.0 111.814 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 120' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' C' ' 119' ' ' ASN . 10.7 Cg_endo -45.17 -45.38 14.79 Favored 'Trans proline' 0 N--CA 1.444 -1.394 1 C-N-CA 125.353 4.035 . . . . 0.0 115.584 -176.215 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 121' ' ' ALA . . . . . 0.571 ' HA ' ' HB3' ' C' ' 124' ' ' ASP . . . -57.06 -31.72 65.49 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 124.93 1.292 . . . . 0.0 111.864 -177.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 122' ' ' ALA . . . . . 0.773 ' HB1' ' HB3' ' C' ' 133' ' ' MET . . . -67.69 -12.77 61.22 Favored 'General case' 0 N--CA 1.438 -1.035 0 O-C-N 120.325 -1.484 . . . . 0.0 112.883 -174.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -106.97 -35.19 6.97 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 120.662 -1.274 . . . . 0.0 110.341 159.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 124' ' ' ASP . . . . . 0.571 ' HB3' ' HA ' ' C' ' 121' ' ' ALA . 11.3 t70 -65.32 -65.2 0.7 Allowed 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 123.251 1.5 . . . . 0.0 111.253 -172.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 125' ' ' ASP . . . . . 0.489 ' HA ' ' HD3' ' C' ' 126' ' ' PRO . 14.6 t70 -84.07 119.16 72.96 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-N 112.783 -2.008 . . . . 0.0 112.469 -173.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 126' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' C' ' 125' ' ' ASP . 34.6 Cg_exo -70.83 -11.54 29.59 Favored 'Trans proline' 0 N--CA 1.449 -1.145 1 C-N-CA 125.534 4.156 . . . . 0.0 111.984 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 127' ' ' LYS . . . . . 0.603 ' HB3' ' HZ3' ' C' ' 127' ' ' LYS . 6.4 ttpm? -77.09 -0.63 25.46 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 119.337 0.971 . . . . 0.0 112.646 176.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 128' ' ' SER . . . . . 0.438 ' HA ' ' HD2' ' C' ' 129' ' ' PRO . 70.0 m -59.07 121.19 53.52 Favored Pre-proline 0 C--N 1.355 0.824 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 172.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 129' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' C' ' 128' ' ' SER . 42.9 Cg_endo -58.82 -45.36 29.39 Favored 'Trans proline' 0 C--N 1.353 0.774 1 C-N-CA 126.181 4.587 . . . . 0.0 116.816 173.567 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 130' ' ' ILE . . . . . 0.617 HG12 ' HB2' ' C' ' 156' ' ' ALA . 15.0 pt -69.54 92.62 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.716 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 165.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.91 110.2 1.27 Allowed 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 125.801 2.715 . . . . 0.0 112.151 -169.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.89 72.57 0.48 Allowed Glycine 0 N--CA 1.462 0.428 0 CA-C-N 109.11 -3.677 . . . . 0.0 113.411 -176.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 133' ' ' MET . . . . . 0.773 ' HB3' ' HB1' ' C' ' 122' ' ' ALA . 62.0 tpp -82.69 127.6 69.56 Favored Pre-proline 0 C--O 1.249 1.053 0 CA-C-N 118.207 1.004 . . . . 0.0 110.291 -177.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 134' ' ' PRO . . . . . 0.584 ' HD2' ' SD ' ' C' ' 133' ' ' MET . 40.2 Cg_endo -78.95 67.37 8.58 Favored 'Trans proline' 0 C--O 1.243 0.746 0 C-N-CA 124.777 3.651 . . . . 0.0 113.275 -174.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 135' ' ' VAL . . . . . 0.539 HG23 ' HH2' ' C' ' 139' ' ' TRP . 27.7 m -68.96 136.5 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-N 113.414 -1.721 . . . . 0.0 112.464 -177.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 97.4 mt -77.54 153.23 33.57 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.288 -1.778 . . . . 0.0 108.68 -174.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 137' ' ' GLU . . . . . 0.483 ' HG3' HD22 ' C' ' 100' ' ' ASN . 22.8 mm-40 -67.63 59.5 0.06 Allowed 'General case' 0 C--O 1.211 -0.967 0 N-CA-C 118.218 2.673 . . . . 0.0 118.218 -162.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 138' ' ' VAL . . . . . 0.667 HG23 HG21 ' C' ' 109' ' ' VAL . 4.5 p -82.25 20.16 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.254 1.331 0 CA-C-O 123.864 1.792 . . . . 0.0 112.826 -173.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 139' ' ' TRP . . . . . 0.539 ' HH2' HG23 ' C' ' 135' ' ' VAL . 2.2 m95 -70.73 133.12 46.32 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.831 -162.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 140' ' ' LYS . . . . . . . . . . . . . 20.3 pttm 36.62 42.32 0.2 Allowed 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 -169.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 141' ' ' ALA . . . . . 0.469 ' HB3' HG22 ' C' ' 144' ' ' VAL . . . -73.13 152.02 41.34 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 120.574 -1.329 . . . . 0.0 112.154 174.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 142' ' ' GLN . . . . . 0.72 ' HB2' ' HA ' ' C' ' 107' ' ' ASP . 85.7 mm-40 -77.23 -9.21 58.65 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -159.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 143' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' C' ' 108' ' ' THR . 14.4 t30 -164.49 95.29 0.73 Allowed 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.636 1.574 . . . . 0.0 108.672 169.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 144' ' ' VAL . . . . . 0.522 ' HB ' ' HA ' ' C' ' 168' ' ' THR . 21.9 t -89.8 101.0 11.74 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 145' ' ' ILE . . . . . 0.691 HG13 ' HB2' ' C' ' 171' ' ' LEU . 10.1 tp -110.8 102.34 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.352 0 CA-C-O 125.333 2.492 . . . . 0.0 107.359 -166.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 146' ' ' VAL . . . . . 0.921 HG21 ' HB3' ' C' ' 162' ' ' LEU . 28.8 t -95.82 100.67 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 111.728 -2.487 . . . . 0.0 110.998 -168.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 147' ' ' PHE . . . . . 0.554 ' HB2' ' H ' ' C' ' 113' ' ' GLY . 0.7 OUTLIER -60.61 115.07 3.35 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 119.752 -1.842 . . . . 0.0 109.845 178.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 148' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -141.1 138.57 33.62 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 166.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 8.4 tpp85 -59.37 -38.98 81.84 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 117.528 -1.225 . . . . 0.0 111.513 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 20.2 m -148.16 164.49 33.76 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 120.936 1.698 . . . . 0.0 108.816 173.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 8.0 tpt -54.88 108.87 0.44 Allowed 'General case' 0 CA--C 1.502 -0.876 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.239 171.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -155.42 124.18 6.07 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.567 -173.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 153' ' ' THR . . . . . 0.655 HG23 ' HA3' ' C' ' 157' ' ' GLY . 46.2 m -62.16 136.52 57.98 Favored 'General case' 0 N--CA 1.434 -1.232 0 O-C-N 125.767 1.917 . . . . 0.0 107.889 175.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -76.08 -146.3 1.79 Allowed Glycine 0 N--CA 1.443 -0.855 0 O-C-N 119.641 -1.912 . . . . 0.0 110.371 172.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -60.97 -63.25 1.36 Allowed 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 120.955 -1.321 . . . . 0.0 109.438 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 156' ' ' ALA . . . . . 0.617 ' HB2' HG12 ' C' ' 130' ' ' ILE . . . -83.24 -52.36 6.65 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.899 -176.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 157' ' ' GLY . . . . . 0.655 ' HA3' HG23 ' C' ' 153' ' ' THR . . . 65.31 -85.31 0.08 OUTLIER Glycine 0 CA--C 1.531 1.038 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -165.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 158' ' ' VAL . . . . . 0.473 HG22 ' HB1' ' C' ' 156' ' ' ALA 0.293 17.3 m 30.91 104.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 -179.172 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 50.45 12.67 0.1 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -171.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 160' ' ' ASN . . . . . 0.63 ' HB2' ' O ' ' C' ' 157' ' ' GLY . 1.4 t30 -53.05 94.73 0.06 OUTLIER Pre-proline 0 C--N 1.35 0.629 0 N-CA-C 117.338 2.348 . . . . 0.0 117.338 -159.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 161' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' C' ' 160' ' ' ASN . 84.8 Cg_exo -57.81 -34.42 98.23 Favored 'Trans proline' 0 N--CA 1.482 0.795 0 C-N-CA 123.361 2.708 . . . . 0.0 109.974 -169.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 162' ' ' LEU . . . . . 0.921 ' HB3' HG21 ' C' ' 146' ' ' VAL . 13.3 mt -54.29 -17.99 3.52 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 116.966 2.21 . . . . 0.0 116.966 -176.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 163' ' ' PHE . . . . . 0.604 ' HA ' ' HG3' ' C' ' 170' ' ' MET . 20.9 m-30 -91.74 -45.14 8.59 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 123.022 1.392 . . . . 0.0 107.756 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -86.47 -51.8 5.97 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 111.446 -2.615 . . . . 0.0 112.732 -158.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 165' ' ' LYS . . . . . 0.664 ' HB2' ' HB ' ' C' ' 168' ' ' THR . 17.1 mmmt -73.2 -176.16 2.08 Favored 'General case' 0 C--O 1.246 0.871 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -157.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -69.5 -70.0 0.31 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.362 1.065 . . . . 0.0 108.168 -165.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -86.45 -19.04 30.21 Favored 'General case' 0 C--N 1.347 0.478 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 175.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 168' ' ' THR . . . . . 0.697 HG22 ' HA ' ' C' ' 162' ' ' LEU 0.275 37.6 m -93.67 86.33 5.13 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.207 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -150.47 155.74 40.1 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 123.075 1.417 . . . . 0.0 107.877 -164.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 170' ' ' MET . . . . . 0.604 ' HG3' ' HA ' ' C' ' 163' ' ' PHE . 76.7 mtm -73.33 140.38 46.68 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 176.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 171' ' ' LEU . . . . . 0.691 ' HB2' HG13 ' C' ' 145' ' ' ILE . 40.8 tp -92.18 107.51 19.27 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 103.448 -2.797 . . . . 0.0 103.448 167.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -78.4 102.79 7.95 Favored 'General case' 0 C--O 1.253 1.253 0 CA-C-N 111.902 -2.408 . . . . 0.0 111.279 -174.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . 167.97 175.36 37.65 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.203 175.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 174' ' ' ASP . . . . . 0.517 ' HB3' ' HB3' ' C' ' 177' ' ' ALA . 20.6 t70 -62.67 149.13 44.39 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 114.422 -0.889 . . . . 0.0 111.4 173.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 175' ' ' ALA . . . . . 0.411 ' O ' HG23 ' C' ' 179' ' ' VAL . . . -58.57 -59.78 4.84 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 120.088 -1.632 . . . . 0.0 113.651 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 176' ' ' LYS . . . . . 0.592 ' HG3' ' HG3' ' C' ' 45' ' ' GLN . 0.5 OUTLIER -54.59 -66.47 0.39 Allowed 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 124.579 1.175 . . . . 0.0 108.133 176.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 177' ' ' ALA . . . . . 0.517 ' HB3' ' HB3' ' C' ' 174' ' ' ASP . . . -48.16 -39.23 20.1 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 117.781 2.511 . . . . 0.0 117.781 -177.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 56.2 m -67.82 -43.34 79.81 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 120.545 1.52 . . . . 0.0 111.301 173.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 179' ' ' VAL . . . . . 0.411 HG23 ' O ' ' C' ' 175' ' ' ALA . 3.1 t -64.5 -39.68 86.44 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 CA-C-N 121.028 1.74 . . . . 0.0 108.175 175.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -56.78 -45.75 81.94 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 122.786 1.279 . . . . 0.0 112.55 176.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -56.58 -31.22 64.03 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 182' ' ' ILE . . . . . 0.437 HG22 ' HB2' ' C' ' 24' ' ' ALA . 42.9 pt -98.21 -25.81 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -178.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 183' ' ' LEU . . . . . 0.73 ' HA ' HD13 ' C' ' 53' ' ' ILE . 2.9 pp -59.44 -20.16 52.93 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 120.287 3.44 . . . . 0.0 120.287 -164.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -126.65 -34.75 2.4 Favored 'General case' 0 CA--C 1.492 -1.28 0 O-C-N 125.371 1.669 . . . . 0.0 107.118 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -73.06 -14.94 61.5 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 120.299 -1.5 . . . . 0.0 114.151 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 186' ' ' LEU . . . . . 0.84 ' HA ' ' HB1' ' C' ' 24' ' ' ALA . 2.6 pt? . . . . . 0 C--O 1.219 -0.547 0 N-CA-C 119.796 3.258 . . . . 0.0 119.796 -167.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 19.6 t-80 . . . . . 0 C--O 1.236 0.346 0 N-CA-C 102.441 -3.17 . . . . 65.74 102.441 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -67.64 81.47 0.16 Allowed Glycine 0 CA--C 1.544 1.864 0 CA-C-O 123.33 1.516 . . . . 48.66 111.332 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -116.06 122.92 46.6 Favored 'General case' 0 N--CA 1.419 -1.982 1 N-CA-C 100.1 -4.037 . . . . 44.56 100.1 175.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1003 ' ' ILE . . . . . 0.455 HG12 ' HB ' ' A' 1068 ' ' ILE . 30.4 mt -99.13 121.51 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.163 0 N-CA-C 106.024 -1.843 . . . . 34.86 106.024 177.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1004 ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' 1034 ' ' ALA . . . -79.47 135.15 14.76 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 108.35 -1.9 . . . . 30.75 108.35 165.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.637 HG23 ' HB3' ' A' 1017 ' ' ALA . 32.8 mm -110.82 96.25 27.94 Favored Pre-proline 0 C--O 1.242 0.696 0 N-CA-C 101.564 -3.495 . . . . 32.21 101.564 170.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -71.6 171.59 16.03 Favored 'Trans proline' 0 CA--C 1.504 -0.992 0 C-N-CA 122.529 2.153 . . . . 32.98 111.312 170.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1007 ' ' ARG . . . . . 0.433 ' HA ' HG22 ' A' 1016 ' ' VAL . 19.0 ttp85 -104.32 141.36 36.44 Favored 'General case' 0 C--O 1.258 1.549 0 CA-C-N 110.976 -2.829 . . . . 47.98 106.726 169.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1008 ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -65.25 143.32 57.88 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 123.456 1.598 . . . . 34.7 112.699 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1009 ' ' ARG . . . . . 0.479 HH11 ' HD3' ' A' 1009 ' ' ARG . 37.7 mtp180 -108.74 22.29 16.12 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-O 123.473 1.606 . . . . 53.37 113.553 176.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 30.0 tp -77.96 149.65 34.11 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.588 -1.264 . . . . 45.07 107.588 170.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1011 ' ' THR . . . . . . . . . . . . . 23.5 m -74.77 143.99 43.78 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 122.378 2.354 . . . . 40.36 110.023 -174.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 32.4 t30 41.64 64.4 1.06 Allowed 'General case' 0 N--CA 1.439 -0.997 0 CA-C-O 125.178 2.418 . . . . 40.61 113.283 -176.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1013 ' ' GLU . . . . . 0.435 ' O ' HD13 ' A' 1042 ' ' LEU . 8.3 tp10 -134.04 147.61 50.96 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 109.932 -3.304 . . . . 33.76 104.424 -169.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1014 ' ' THR . . . . . 0.823 ' HB ' ' HB3' ' A' 1320 ' ' PRO . 0.0 OUTLIER -124.15 1.1 8.51 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 112.935 0.717 . . . . 27.89 112.935 177.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 1015 ' ' ARG . . . . . 0.932 ' HD2' HG11 ' A' 1072 ' ' VAL . 21.0 mtm180 -68.13 130.57 43.34 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 119.884 -1.76 . . . . 29.02 112.161 -176.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1016 ' ' VAL . . . . . 0.554 ' HB ' ' HB2' ' A' 1043 ' ' ALA . 83.9 t -132.17 141.73 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 110.644 -2.98 . . . . 28.13 103.862 168.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1017 ' ' ALA . . . . . 0.637 ' HB3' HG23 ' A' 1005 ' ' ILE . . . -56.54 -37.23 70.22 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 118.024 2.601 . . . . 26.87 118.024 -171.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -136.08 143.01 44.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 120.077 1.308 . . . . 26.77 110.64 -165.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1019 ' ' THR . . . . . . . . . . . . . 75.5 p -77.67 173.4 7.64 Favored Pre-proline 0 C--N 1.346 0.444 0 O-C-N 120.104 -1.622 . . . . 27.02 108.25 163.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1020 ' ' PRO . . . . . 0.478 ' HB3' ' HB2' ' A' 1053 ' ' ALA . 2.5 Cg_exo -55.39 -35.3 91.53 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 123.837 3.025 . . . . 30.57 111.741 164.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -62.49 -49.55 74.94 Favored 'General case' 0 C--N 1.358 0.957 0 CA-C-N 118.98 0.809 . . . . 47.81 110.826 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1022 ' ' THR . . . . . . . . . . . . . 6.7 p -65.74 -29.16 69.63 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.573 0.953 . . . . 30.77 113.573 176.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1023 ' ' VAL . . . . . 0.892 HG22 HG11 ' A' 1033 ' ' VAL . 3.4 t -62.74 -44.83 99.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 107.65 -1.241 . . . . 33.59 107.65 175.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1024 ' ' GLU . . . . . 0.625 ' O ' ' HG2' ' A' 1028 ' ' LYS . 48.6 mt-10 -59.75 -44.22 93.91 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 117.609 -1.186 . . . . 53.29 111.847 173.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -54.71 -38.69 67.36 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-N 119.998 1.272 . . . . 46.92 114.333 170.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1026 ' ' LEU . . . . . . . . . . . . . 91.2 mt -68.75 -38.63 80.27 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 119.141 0.882 . . . . 37.17 109.278 177.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 12.7 tp -63.83 -43.29 96.62 Favored 'General case' 0 CA--C 1.556 1.183 0 O-C-N 124.074 0.859 . . . . 44.44 109.064 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1028 ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' 1024 ' ' GLU . 28.0 mmmt -59.67 -41.21 90.13 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 123.292 0.637 . . . . 52.58 109.698 175.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1029 ' ' LEU . . . . . 0.478 ' HA ' ' HE3' ' A' 1342 ' ' LYS . 61.9 mt -72.44 7.23 1.9 Allowed 'General case' 0 C--O 1.253 1.247 0 N-CA-C 116.654 2.094 . . . . 45.69 116.654 174.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 94.74 -5.19 69.45 Favored Glycine 0 CA--C 1.494 -1.272 0 O-C-N 121.004 -1.06 . . . . 42.09 112.303 171.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -86.66 137.07 32.76 Favored 'General case' 0 N--CA 1.443 -0.803 0 O-C-N 119.352 -2.264 . . . . 40.72 106.86 -171.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1032 ' ' THR . . . . . . . . . . . . . 37.8 m -76.69 127.38 32.67 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 104.915 -2.254 . . . . 37.77 104.915 162.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1033 ' ' VAL . . . . . 0.892 HG11 HG22 ' A' 1023 ' ' VAL . 4.1 t -94.06 133.71 34.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 103.225 -2.88 . . . . 33.54 103.225 177.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1034 ' ' ALA . . . . . 0.414 ' O ' ' HA2' ' A' 1004 ' ' GLY . . . -126.84 116.61 21.12 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 104.803 -2.295 . . . . 31.68 104.803 172.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1035 ' ' VAL . . . . . . . . . . . . . 21.2 t -109.29 142.34 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 O-C-N 120.91 -1.119 . . . . 31.52 109.765 -174.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1036 ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -65.17 139.14 58.64 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.32 -1.363 . . . . 41.04 107.32 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1037 ' ' SER . . . . . . . . . . . . . 8.6 t -73.56 132.7 43.12 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 106.176 -1.787 . . . . 31.83 106.176 176.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1038 ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' 1041 ' ' GLN . . . 100.04 -20.91 47.01 Favored Glycine 0 C--O 1.22 -0.773 0 N-CA-C 109.278 -1.529 . . . . 29.36 109.278 -175.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -67.73 -34.91 77.79 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 121.484 -1.009 . . . . 27.78 110.649 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1040 ' ' GLY . . . . . 0.583 ' HA2' ' HE2' ' A' 1050 ' ' PHE . . . -59.98 -43.18 98.4 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-O 123.429 1.571 . . . . 28.91 110.622 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1041 ' ' GLN . . . . . 0.418 ' HB3' ' O ' ' A' 1038 ' ' GLY . 8.5 tp60 -52.15 -49.12 64.36 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 112.218 -1.991 . . . . 51.18 113.652 172.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1042 ' ' LEU . . . . . 0.435 HD13 ' O ' ' A' 1013 ' ' GLU . 10.7 mt -78.54 -38.47 40.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.541 -1.974 . . . . 29.91 114.119 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1043 ' ' ALA . . . . . 0.554 ' HB2' ' HB ' ' A' 1016 ' ' VAL . . . -61.26 -14.95 30.06 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 113.719 1.007 . . . . 28.54 113.719 169.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1044 ' ' SER . . . . . . . . . . . . . 51.1 m 68.27 34.56 3.81 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 120.246 -1.534 . . . . 33.06 108.596 173.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1045 ' ' PHE . . . . . 0.439 ' HD2' ' HD2' ' A' 1020 ' ' PRO . 0.0 OUTLIER -161.58 97.74 1.09 Allowed 'General case' 0 C--O 1.247 0.96 0 N-CA-C 101.092 -3.669 . . . . 30.29 101.092 -178.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -71.92 165.77 23.49 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 120.854 3.65 . . . . 48.62 120.854 -149.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.42 -53.97 12.58 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 112.35 -2.205 . . . . 36.74 111.438 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 3.4 pttm -65.02 -39.02 92.79 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-N 121.76 2.073 . . . . 43.73 111.132 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -62.25 -29.86 70.7 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.398 -1.439 . . . . 32.81 112.198 175.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1050 ' ' PHE . . . . . 0.583 ' HE2' ' HA2' ' A' 1040 ' ' GLY . 21.9 m-85 -62.52 -50.01 73.08 Favored 'General case' 0 C--O 1.255 1.352 0 C-N-CA 120.246 -0.581 . . . . 31.86 112.494 169.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1051 ' ' VAL . . . . . 0.517 HG22 HG12 ' A' 1057 ' ' ILE . 11.0 t -62.95 -42.45 96.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 O-C-N 121.101 -0.999 . . . . 33.22 109.289 -176.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -51.01 -44.87 61.04 Favored 'General case' 0 C--O 1.256 1.434 0 C-N-CA 125.212 1.405 . . . . 50.83 110.599 172.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1053 ' ' ALA . . . . . 0.478 ' HB2' ' HB3' ' A' 1020 ' ' PRO . . . -65.87 -44.82 84.27 Favored 'General case' 0 C--O 1.246 0.91 0 CA-C-O 124.819 2.247 . . . . 33.12 113.016 -176.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 147.56 33.88 0.06 OUTLIER Glycine 0 N--CA 1.464 0.511 0 CA-C-N 113.141 -1.845 . . . . 35.83 114.553 -177.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -111.04 139.37 46.46 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-N 118.66 1.23 . . . . 34.82 110.138 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -84.09 121.56 27.59 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 103.297 -2.853 . . . . 49.05 103.297 167.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1057 ' ' ILE . . . . . 0.517 HG12 HG22 ' A' 1051 ' ' VAL . 26.2 mm -85.32 122.49 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 O-C-N 118.105 -2.872 . . . . 38.53 108.807 177.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1058 ' ' VAL . . . . . . . . . . . . . 12.0 m -122.31 147.05 26.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 105.4 -2.074 . . . . 42.11 105.4 -173.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -121.4 135.01 55.11 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 126.026 2.822 . . . . 58.0 111.632 -171.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 57.3 -141.9 43.32 Favored Glycine 0 N--CA 1.465 0.616 0 CA-C-N 110.451 -3.068 . . . . 52.12 113.444 -176.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1061 ' ' ASN . . . . . 0.878 ' HA ' ' HD1' ' A' 1064 ' ' TRP . 1.4 t30 -48.12 -25.34 1.42 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 116.527 2.047 . . . . 54.75 116.527 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1062 ' ' SER . . . . . . . . . . . . . 15.2 m -60.22 -20.73 60.09 Favored 'General case' 0 CA--C 1.552 1.048 0 N-CA-C 114.028 1.122 . . . . 50.34 114.028 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1063 ' ' VAL . . . . . 0.493 ' O ' HD11 ' A' 1069 ' ' ILE . 14.9 p -70.03 -48.36 63.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 107.309 -1.367 . . . . 41.46 107.309 169.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1064 ' ' TRP . . . . . 0.878 ' HD1' ' HA ' ' A' 1061 ' ' ASN . 75.4 m95 -65.34 -30.73 71.6 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 124.397 1.079 . . . . 39.32 110.907 -172.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.43 81.05 4.79 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 113.489 -1.687 . . . . 55.38 109.427 172.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1066 ' ' SER . . . . . . . . . . . . . 68.5 m -145.72 -178.91 6.34 Favored 'General case' 0 C--O 1.242 0.67 0 O-C-N 120.431 -1.418 . . . . 41.87 111.128 172.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1067 ' ' GLU . . . . . 0.447 ' HB3' HD12 ' A' 1068 ' ' ILE . 22.0 tp10 -69.77 -62.81 1.23 Allowed 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.183 -1.414 . . . . 53.2 107.183 174.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1068 ' ' ILE . . . . . 0.455 ' HB ' HG12 ' A' 1003 ' ' ILE . 5.3 mp -107.56 142.17 20.94 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 N-CA-C 105.482 -2.044 . . . . 41.9 105.482 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1069 ' ' ILE . . . . . 0.493 HD11 ' O ' ' A' 1063 ' ' VAL . 5.4 mm -124.38 121.28 61.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 104.177 -2.527 . . . . 38.73 104.177 168.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1070 ' ' LEU . . . . . 0.674 HD22 HD22 ' A' 1331 ' ' LEU . 77.2 mt -98.74 87.05 3.67 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 104.302 -2.481 . . . . 32.44 104.302 172.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1071 ' ' LYS . . . . . 0.407 ' HB3' ' HE3' ' A' 1071 ' ' LYS . 1.1 mmmt -83.59 162.09 20.94 Favored 'General case' 0 C--O 1.257 1.48 0 N-CA-C 105.403 -2.073 . . . . 34.65 105.403 167.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1072 ' ' VAL . . . . . 0.932 HG11 ' HD2' ' A' 1015 ' ' ARG . 18.8 t -88.18 -86.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.705 0 C-N-CA 119.588 -0.845 . . . . 31.32 110.844 175.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -84.4 151.89 24.39 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.133 -1.432 . . . . 33.94 107.133 -170.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1074 ' ' ALA . . . . . 0.448 ' HA ' ' HD2' ' A' 1075 ' ' PRO . . . -33.92 120.29 0.5 Allowed Pre-proline 0 C--O 1.253 1.271 0 C-N-CA 125.084 1.353 . . . . 38.04 114.646 170.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1075 ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' 1074 ' ' ALA . 72.6 Cg_endo -56.81 128.2 28.97 Favored 'Trans proline' 0 N--CA 1.441 -1.579 0 C-N-CA 125.074 3.85 . . . . 42.68 114.887 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 33.0 mt -72.88 158.25 35.87 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 120.712 -1.242 . . . . 46.74 108.295 170.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1077 ' ' ASP . . . . . 0.497 ' HA ' HD12 ' A' 1080 ' ' ILE . 7.4 m-20 -45.98 -39.63 9.25 Favored 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 118.515 2.783 . . . . 58.61 118.515 -176.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 15.7 t70 -61.98 -48.71 79.12 Favored 'General case' 0 C--N 1.352 0.686 0 CA-C-N 119.144 0.884 . . . . 59.2 109.706 173.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1079 ' ' GLU . . . . . 0.427 ' HG2' HH11 ' A' 1009 ' ' ARG . 35.5 mt-10 -62.88 -32.42 73.66 Favored 'General case' 0 C--O 1.259 1.559 0 CA-C-N 114.024 -1.444 . . . . 50.63 109.109 -178.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1080 ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' 1077 ' ' ASP . 73.7 mt -62.88 -44.51 99.64 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-N 118.899 0.772 . . . . 51.48 109.59 173.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -62.53 -26.22 68.44 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 119.789 -1.82 . . . . 50.28 112.321 175.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 15.7 mt -80.96 -24.33 38.16 Favored 'General case' 0 C--O 1.25 1.102 0 O-C-N 119.339 -2.1 . . . . 50.21 112.206 174.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1083 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.22 120.26 10.01 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 124.477 2.084 . . . . 49.06 111.501 176.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -82.99 134.81 45.82 Favored Pre-proline 0 CA--C 1.515 -0.385 0 CA-C-N 112.483 -2.144 . . . . 51.08 111.756 -167.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -48.96 113.18 0.81 Allowed 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 125.106 3.871 . . . . 49.73 119.159 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 104.31 -27.16 20.41 Favored Glycine 0 N--CA 1.436 -1.309 0 O-C-N 124.9 1.375 . . . . 47.71 114.021 177.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1087 ' ' THR . . . . . . . . . . . . . 39.4 m -49.92 128.87 19.45 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 118.316 2.71 . . . . 45.47 118.316 -174.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1088 ' ' THR . . . . . . . . . . . . . 41.2 m -68.77 88.86 0.38 Allowed 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 123.354 1.549 . . . . 42.04 113.047 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1089 ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' 1112 ' ' VAL . 57.2 tp -83.43 98.32 9.44 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 104.291 -2.485 . . . . 38.06 104.291 -176.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1090 ' ' VAL . . . . . 0.625 ' HB ' HD23 ' A' 1070 ' ' LEU . 45.5 t -96.49 109.37 22.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 104.719 -2.326 . . . . 37.4 104.719 175.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1091 ' ' SER . . . . . 0.46 ' HA ' ' OH ' ' A' 1327 ' ' TYR . 13.4 m -152.26 162.91 40.45 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 116.537 2.051 . . . . 36.16 116.537 -175.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1092 ' ' PHE . . . . . 0.438 ' CD1' ' HB3' ' A' 1116 ' ' ASP . 51.4 t80 -74.33 79.42 1.85 Allowed 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 123.133 1.444 . . . . 38.94 107.652 170.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 21.8 mm -82.27 -42.72 18.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 126.571 1.948 . . . . 42.17 114.966 -168.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 2.9 m95 66.67 60.57 0.94 Allowed Pre-proline 0 N--CA 1.436 -1.175 0 C-N-CA 125.113 1.365 . . . . 46.51 114.625 -174.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1095 ' ' PRO . . . . . 0.404 ' HG2' HG11 ' A' 1360 ' ' VAL . 52.4 Cg_exo -56.43 -33.44 92.1 Favored 'Trans proline' 0 C--O 1.253 1.269 0 C-N-CA 124.87 3.713 . . . . 49.76 114.319 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -60.65 -51.8 67.86 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.118 -1.401 . . . . 52.62 111.61 174.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -78.96 -14.4 59.23 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 115.32 1.6 . . . . 60.74 115.32 177.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1098 ' ' ASN . . . . . 0.463 ' HB3' ' HB3' ' A' 1101 ' ' LEU . 43.6 m-20 -125.36 65.91 51.85 Favored Pre-proline 0 N--CA 1.441 -0.901 0 N-CA-C 115.765 1.765 . . . . 58.19 115.765 -173.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -66.24 -41.6 12.28 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.715 2.944 . . . . 54.59 113.308 -175.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.23 -42.09 85.54 Favored 'General case' 0 C--O 1.253 1.237 0 CA-C-O 123.335 1.54 . . . . 63.28 112.696 176.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1101 ' ' LEU . . . . . 0.463 ' HB3' ' HB3' ' A' 1098 ' ' ASN . 21.3 tp -55.78 -37.03 68.03 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 113.162 -1.835 . . . . 54.75 109.928 -178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1102 ' ' MET . . . . . . . . . . . . . 82.3 mmm -61.06 -45.3 95.34 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 108.667 -0.864 . . . . 52.65 108.667 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -64.8 -45.0 88.11 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-N 114.642 -1.163 . . . . 66.26 112.197 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 95.0 mttt -61.62 -41.84 98.04 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 123.132 1.444 . . . . 63.73 110.352 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1105 ' ' LEU . . . . . 0.424 HD13 HG21 ' A' 1112 ' ' VAL . 95.8 mt -74.83 -35.5 62.41 Favored 'General case' 0 C--O 1.246 0.884 0 O-C-N 118.485 -2.635 . . . . 54.68 109.227 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -62.84 -38.87 92.51 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 117.427 -1.273 . . . . 53.64 109.953 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -60.67 -41.19 94.57 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 124.277 0.985 . . . . 67.24 110.671 169.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1108 ' ' ARG . . . . . 0.482 ' HA ' ' HD3' ' A' 1108 ' ' ARG . 12.0 mmt85 -76.28 -0.05 21.02 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 114.281 1.215 . . . . 65.76 114.281 173.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1109 ' ' ASN . . . . . 0.588 ' HA ' ' HA2' ' A' 1364 ' ' GLY . 35.7 t30 61.22 15.22 6.2 Favored 'General case' 0 C--N 1.346 0.422 0 N-CA-C 114.431 1.271 . . . . 58.71 114.431 175.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1110 ' ' VAL . . . . . . . . . . . . . 29.8 m -79.39 132.97 30.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 O-C-N 120.111 -1.618 . . . . 46.63 108.623 -169.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1111 ' ' THR . . . . . 0.652 HG21 HG21 ' A' 1348 ' ' VAL . 56.5 m -74.72 93.91 2.64 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.509 0.671 . . . . 44.13 110.02 -176.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1112 ' ' VAL . . . . . 0.424 HG21 HD13 ' A' 1105 ' ' LEU . 38.9 t -92.84 115.97 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 123.874 1.797 . . . . 40.44 111.376 -170.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1113 ' ' MET . . . . . 0.565 ' SD ' HG13 ' A' 1348 ' ' VAL . 73.9 mtp -107.86 105.93 15.97 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 104.525 -2.398 . . . . 50.76 104.525 173.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1114 ' ' ALA . . . . . . . . . . . . . . . -86.63 109.07 18.91 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.399 -0.819 . . . . 35.64 111.608 -177.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1115 ' ' MET . . . . . 0.639 ' SD ' HD22 ' A' 1334 ' ' LEU . 90.9 mmm -66.19 -21.59 66.32 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 115.929 1.826 . . . . 38.74 115.929 -175.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1116 ' ' ASP . . . . . 0.438 ' HB3' ' CD1' ' A' 1092 ' ' PHE . 6.5 p-10 -73.09 -32.84 65.23 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 114.234 -1.348 . . . . 40.14 109.948 169.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1117 ' ' SER . . . . . . . . . . . . . 29.5 m -82.97 13.19 4.13 Favored 'General case' 0 C--O 1.244 0.772 0 O-C-N 119.777 -1.827 . . . . 44.79 114.937 -175.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1118 ' ' VAL . . . . . 0.676 HG22 HG22 ' A' 1358 ' ' VAL . 12.0 t -64.14 124.3 85.0 Favored Pre-proline 0 N--CA 1.484 1.26 0 CA-C-O 117.246 -1.359 . . . . 43.75 107.426 169.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1119 ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' 1354 ' ' VAL . 47.8 Cg_exo -55.88 134.64 65.31 Favored 'Trans proline' 0 C--O 1.242 0.698 0 C-N-CA 124.93 3.753 . . . . 48.93 110.745 173.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1120 ' ' ARG . . . . . 0.649 ' HD3' HD13 ' A' 1130 ' ' LEU . 41.8 mmm-85 -69.12 17.56 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 120.018 3.34 . . . . 62.9 120.018 -163.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 26.9 pt -85.67 171.46 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 C-N-CA 123.344 0.658 . . . . 57.72 112.562 -165.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1122 ' ' SER . . . . . . . . . . . . . 1.1 p -51.48 -53.79 33.68 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 118.822 -2.424 . . . . 57.26 114.743 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -64.58 -2.19 2.24 Favored 'General case' 0 C--O 1.248 0.997 0 CA-C-N 121.359 1.89 . . . . 62.9 115.875 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1124 ' ' ALA . . . . . 0.454 ' HB2' HG11 ' A' 1354 ' ' VAL . . . -106.41 -11.68 15.88 Favored 'General case' 0 C--O 1.2 -1.521 0 CA-C-O 116.381 -1.771 . . . . 49.83 114.198 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -57.99 -29.36 65.19 Favored 'General case' 0 CA--C 1.488 -1.415 0 N-CA-C 115.628 1.714 . . . . 52.37 115.628 -170.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1126 ' ' SER . . . . . . . . . . . . . 64.0 p -65.16 -41.14 94.98 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 115.102 1.519 . . . . 42.43 115.102 169.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1127 ' ' LEU . . . . . . . . . . . . . 1.6 mp -81.43 -28.44 34.24 Favored 'General case' 0 C--O 1.208 -1.096 0 CA-C-N 115.492 -0.777 . . . . 43.74 111.013 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 61.3 t0 -67.88 101.11 1.03 Allowed 'General case' 0 N--CA 1.439 -0.985 0 O-C-N 119.699 -1.876 . . . . 43.21 110.063 -164.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -74.2 -34.23 63.66 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.963 -0.562 . . . . 35.74 109.977 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1130 ' ' LEU . . . . . 0.649 HD13 ' HD3' ' A' 1120 ' ' ARG . 0.7 OUTLIER -60.16 -26.81 66.6 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 119.029 -2.294 . . . . 38.09 108.627 177.282 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 1131 ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' 1134 ' ' ALA . 61.9 m -84.92 -56.34 3.62 Favored 'General case' 0 C--O 1.216 -0.677 0 O-C-N 120.928 -1.107 . . . . 36.91 110.441 168.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1132 ' ' SER . . . . . 0.489 ' O ' ' HB3' ' A' 1135 ' ' ASN . 13.8 m -73.17 -43.72 61.04 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 116.854 2.168 . . . . 35.79 116.854 -168.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1133 ' ' MET . . . . . 0.891 ' HA ' HD12 ' A' 1136 ' ' ILE . 53.1 mtp -57.55 -45.45 85.08 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 122.463 1.125 . . . . 30.81 113.103 169.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1134 ' ' ALA . . . . . 0.978 ' HB1' ' HB2' ' A' 1176 ' ' ALA . . . -57.03 -39.17 74.27 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 112.91 -1.95 . . . . 28.88 111.144 170.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1135 ' ' ASN . . . . . 0.518 ' ND2' ' HB2' ' A' 1179 ' ' ALA . 22.1 t-20 -58.54 -51.59 69.25 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 120.389 -1.444 . . . . 40.76 113.743 175.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1136 ' ' ILE . . . . . 0.891 HD12 ' HA ' ' A' 1133 ' ' MET . 14.6 mt -52.34 -46.68 46.35 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 CA-C-O 118.163 -0.923 . . . . 31.54 108.977 172.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1137 ' ' ALA . . . . . 0.731 ' HB2' ' HG3' ' A' 1316 ' ' PRO . . . -67.02 -27.11 67.14 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 124.925 1.29 . . . . 29.87 113.6 176.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -74.61 -44.2 27.11 Favored Glycine 0 C--N 1.313 -0.713 0 O-C-N 120.865 -1.147 . . . . 28.73 110.812 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 16.1 t80 -61.85 -46.34 89.88 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.206 -1.173 . . . . 30.39 108.506 171.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1140 ' ' ARG . . . . . 0.679 ' HD3' ' HB2' ' A' 1319 ' ' LEU . 5.6 tpt180 -63.33 -29.75 71.0 Favored 'General case' 0 CA--C 1.493 -1.229 0 O-C-N 121.339 -0.851 . . . . 26.09 112.427 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1141 ' ' ALA . . . . . . . . . . . . . . . -63.29 -43.68 97.19 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 119.905 -1.747 . . . . 27.1 110.674 173.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 47.1 mm -54.3 -45.64 68.3 Favored 'Isoleucine or valine' 0 C--N 1.347 0.488 0 O-C-N 120.693 -1.255 . . . . 28.48 111.77 168.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 25.1 t -62.38 -55.26 25.1 Favored 'Isoleucine or valine' 0 C--O 1.252 1.223 0 CA-C-O 115.88 -2.01 . . . . 23.07 114.243 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1144 ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -70.19 -22.36 62.95 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 123.563 2.892 . . . . 33.4 110.159 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1145 ' ' ALA . . . . . 0.737 ' HA ' HG11 ' A' 1280 ' ' VAL . . . -63.61 -56.33 16.71 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 119.458 -0.897 . . . . 24.22 109.708 167.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -59.28 -21.33 59.49 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-O 117.871 -1.061 . . . . 24.89 112.496 174.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1147 ' ' HIS . . . . . 0.419 ' HA ' ' CG1' ' B' 1143 ' ' VAL . 49.2 t-80 -66.35 -41.51 89.44 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 120.59 1.541 . . . . 26.73 111.691 169.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1148 ' ' GLU . . . . . 0.799 ' HB3' ' HD2' ' A' 1308 ' ' LYS . 77.6 mm-40 -105.98 -2.62 22.63 Favored 'General case' 0 C--O 1.252 1.207 0 N-CA-C 114.991 1.478 . . . . 39.96 114.991 -176.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1149 ' ' PHE . . . . . . . . . . . . . 1.3 t80 -70.18 149.03 47.95 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 116.167 -0.469 . . . . 25.87 111.546 -178.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1150 ' ' GLY . . . . . 0.614 ' HA2' ' HG2' ' B' 1320 ' ' PRO . . . -75.71 -49.9 8.51 Favored Glycine 0 N--CA 1.43 -1.702 0 CA-C-N 114.479 -1.237 . . . . 19.28 113.616 172.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1151 ' ' ARG . . . . . 0.489 ' HG3' ' HB ' ' B' 1321 ' ' THR . 29.1 mtm-85 -97.94 170.68 8.78 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-O 123.308 1.527 . . . . 39.9 113.865 -168.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1152 ' ' PHE . . . . . 0.491 ' HA ' ' CZ ' ' B' 1139 ' ' TYR . 0.3 OUTLIER -72.97 142.63 47.79 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.46 -0.941 . . . . 29.44 108.46 166.011 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 1153 ' ' PHE . . . . . 0.428 ' HD1' ' OH ' ' B' 1139 ' ' TYR . 25.0 m-85 -58.03 -46.87 84.63 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 114.528 1.307 . . . . 32.6 114.528 168.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1154 ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -72.29 145.92 47.53 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 125.068 1.347 . . . . 34.64 109.215 -178.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -77.88 65.99 3.15 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 119.214 -2.179 . . . . 37.14 108.272 169.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -92.1 136.38 33.22 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 107.772 -1.196 . . . . 40.57 107.772 -167.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1157 ' ' ILE . . . . . 0.462 HG12 ' HB3' ' C' ' 95' ' ' GLU . 3.8 tp -96.16 135.58 29.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 105.075 -2.194 . . . . 44.61 105.075 163.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1158 ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.65 -123.72 0.1 Allowed 'General case' 0 C--O 1.242 0.696 0 CA-C-O 117.171 -1.395 . . . . 40.7 112.435 173.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -84.18 -45.71 12.65 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 122.034 2.197 . . . . 40.25 106.94 160.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -126.13 153.53 44.42 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 113.261 -1.791 . . . . 38.47 107.704 170.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1161 ' ' GLY . . . . . 0.683 ' HA3' ' HA ' ' B' 1326 ' ' LEU . . . 87.26 103.95 0.85 Allowed Glycine 0 CA--C 1.496 -1.099 0 C-N-CA 119.632 -1.27 . . . . 37.61 113.559 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1162 ' ' LYS . . . . . 0.428 ' HG3' ' CD ' ' C' ' 95' ' ' GLU . 1.5 tmtp? -102.53 122.05 43.58 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 126.642 2.025 . . . . 48.9 106.026 171.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1163 ' ' VAL . . . . . . . . . . . . . 45.8 t -82.0 133.67 51.0 Favored Pre-proline 0 C--O 1.247 0.943 0 CA-C-O 117.451 -1.262 . . . . 36.52 109.438 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1164 ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -73.3 109.49 2.85 Favored 'Trans proline' 0 N--CA 1.43 -2.248 0 CA-C-N 124.326 2.581 . . . . 35.08 109.739 160.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1165 ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -50.96 161.74 1.34 Allowed 'Trans proline' 0 N--CA 1.483 0.865 1 C-N-CA 125.957 4.438 . . . . 35.33 118.696 -169.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -74.54 122.04 22.48 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.863 -1.162 . . . . 34.69 107.863 -176.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1167 ' ' LYS . . . . . 0.426 ' HB2' ' HA ' ' A' 1249 ' ' VAL . 76.6 mttt -88.2 104.99 17.23 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-O 124.007 1.86 . . . . 45.36 106.628 166.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 58.7 t -94.58 89.99 2.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 113.681 -1.6 . . . . 31.71 108.259 -175.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1169 ' ' MET . . . . . 0.482 ' SD ' ' HB3' ' A' 1245 ' ' GLN . 5.6 ttp -77.9 92.1 4.24 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 113.407 -1.724 . . . . 42.28 111.828 177.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 81.0 t -88.79 112.5 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 106.146 -1.798 . . . . 30.51 106.146 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 57.7 mt -98.24 123.1 50.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 109.631 -0.507 . . . . 31.87 109.631 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1172 ' ' GLY . . . . . 0.444 ' HA3' ' HB2' ' A' 1256 ' ' ALA . . . 77.13 81.58 0.6 Allowed Glycine 0 N--CA 1.436 -1.346 0 CA-C-O 122.77 1.206 . . . . 34.54 113.716 -178.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1173 ' ' ALA . . . . . 0.446 ' HA ' ' HA3' ' A' 1177 ' ' GLY . . . -82.07 80.05 8.42 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 111.773 -2.214 . . . . 32.51 109.212 -172.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -85.09 -157.0 27.14 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 108.056 -2.018 . . . . 29.9 108.056 163.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1175 ' ' VAL . . . . . . . . . . . . . 67.2 t -74.02 -26.9 21.54 Favored 'Isoleucine or valine' 0 C--O 1.259 1.598 0 CA-C-N 120.378 2.089 . . . . 33.11 108.765 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1176 ' ' ALA . . . . . 0.978 ' HB2' ' HB1' ' A' 1134 ' ' ALA . . . -50.22 -47.27 54.95 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.596 0.712 . . . . 28.1 112.623 162.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1177 ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' A' 1173 ' ' ALA . . . -61.25 -52.21 53.18 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 113.475 -1.693 . . . . 28.54 110.115 176.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1178 ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' 1181 ' ' ILE . 94.3 mt -53.14 -43.89 67.33 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 118.923 1.361 . . . . 31.22 113.177 178.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1179 ' ' ALA . . . . . 0.518 ' HB2' ' ND2' ' A' 1135 ' ' ASN . . . -66.47 -34.75 78.62 Favored 'General case' 0 C--O 1.245 0.822 0 O-C-N 118.088 -2.883 . . . . 28.98 114.115 174.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -65.62 -45.74 81.96 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.069 0.85 . . . . 27.83 109.498 176.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1181 ' ' ILE . . . . . 0.562 ' HA ' HG11 ' A' 1191 ' ' VAL . 55.6 mt -59.33 -52.68 58.04 Favored 'Isoleucine or valine' 0 C--N 1.349 0.561 0 C-N-CA 124.571 1.148 . . . . 30.25 109.89 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -51.67 -54.88 22.85 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 125.735 1.636 . . . . 29.59 110.53 176.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -65.26 -43.23 91.94 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 114.176 1.176 . . . . 30.29 114.176 -175.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -68.96 -43.56 74.76 Favored 'General case' 0 N--CA 1.425 -1.699 0 C-N-CA 123.771 0.828 . . . . 30.47 109.404 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -64.76 -35.61 81.63 Favored 'General case' 0 C--O 1.243 0.755 0 O-C-N 120.693 -1.254 . . . . 42.41 109.376 173.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1186 ' ' SER . . . . . 1.075 ' HB3' ' HA ' ' B' 1187 ' ' LEU . 72.9 m -60.25 -36.95 78.95 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 121.509 1.959 . . . . 39.38 112.354 169.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 89.4 mt -82.18 18.68 1.33 Allowed 'General case' 0 C--O 1.244 0.791 0 CA-C-N 120.361 1.437 . . . . 36.18 114.001 169.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 78.93 2.35 86.46 Favored Glycine 0 N--CA 1.47 0.952 0 CA-C-N 119.876 1.217 . . . . 33.78 115.003 170.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -73.34 151.14 41.38 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 124.106 0.962 . . . . 33.93 113.009 -175.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 18.5 mt -86.36 101.67 10.89 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 N-CA-C 103.153 -2.906 . . . . 38.74 103.153 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1191 ' ' VAL . . . . . 0.562 HG11 ' HA ' ' A' 1181 ' ' ILE . 3.0 t -86.99 127.78 40.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 112.921 -1.945 . . . . 33.09 107.231 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1192 ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -119.85 107.33 13.02 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 106.761 -1.57 . . . . 38.92 106.761 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -108.39 121.75 45.57 Favored 'General case' 0 C--O 1.248 0.982 0 O-C-N 120.626 -1.297 . . . . 35.32 109.571 -174.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 75.5 t80 -93.85 147.73 22.8 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 105.517 -2.031 . . . . 39.35 105.517 169.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 7.2 t70 -149.29 157.41 43.32 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 105.874 -1.899 . . . . 40.46 105.874 154.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1196 ' ' THR . . . . . . . . . . . . . 2.7 m -67.08 -43.39 82.71 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 104.962 -2.236 . . . . 45.94 104.962 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1197 ' ' ARG . . . . . . . . . . . . . 72.4 mtm180 -72.48 116.69 52.06 Favored Pre-proline 0 N--CA 1.453 -0.322 0 O-C-N 120.966 -1.084 . . . . 56.02 111.721 -175.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1198 ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -62.05 -26.94 78.78 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 125.244 3.963 . . . . 51.27 116.826 175.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -54.23 -34.65 61.18 Favored 'General case' 0 C--O 1.248 1.023 0 CA-C-N 114.557 -1.201 . . . . 59.1 112.598 -176.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 34.6 m -75.35 -10.7 13.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 117.23 2.307 . . . . 51.06 117.23 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 83.3 tttt -51.2 -46.21 62.1 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 124.709 1.204 . . . . 57.38 111.852 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -72.99 -29.79 63.31 Favored 'General case' 0 CA--C 1.512 -0.482 0 O-C-N 120.472 -1.393 . . . . 62.41 109.845 -173.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -66.3 -42.46 88.27 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.294 -1.373 . . . . 57.78 107.294 173.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1204 ' ' VAL . . . . . 0.61 HG13 ' HB3' ' A' 1209 ' ' ALA . 5.3 t -60.93 -50.23 81.41 Favored 'Isoleucine or valine' 0 C--N 1.344 0.357 0 C-N-CA 124.928 1.291 . . . . 46.38 109.141 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -56.54 -44.59 81.02 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 114.421 1.267 . . . . 50.7 114.421 173.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1206 ' ' SER . . . . . . . . . . . . . 48.7 m -58.44 -34.91 71.34 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.028 1.492 . . . . 49.98 115.028 174.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1207 ' ' MET . . . . . . . . . . . . . 61.4 mtp -92.54 11.02 27.83 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 119.759 -1.838 . . . . 52.99 111.08 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 78.28 51.19 5.81 Favored Glycine 0 CA--C 1.549 2.218 0 CA-C-O 124.39 2.106 . . . . 47.66 111.481 168.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1209 ' ' ALA . . . . . 0.61 ' HB3' HG13 ' A' 1204 ' ' VAL . . . -129.67 143.3 50.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 113.059 -1.57 . . . . 44.77 114.19 171.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -69.84 132.5 46.12 Favored 'General case' 0 C--N 1.347 0.468 0 N-CA-C 105.957 -1.868 . . . . 47.64 105.957 167.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1211 ' ' PHE . . . . . 0.526 ' HD1' HG11 ' A' 1204 ' ' VAL . 26.5 t80 -86.76 134.32 33.58 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 104.739 -2.319 . . . . 45.66 104.739 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 51.7 mt -84.93 109.09 17.9 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 123.719 1.724 . . . . 46.06 108.41 165.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -79.32 145.23 33.57 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 113.703 -1.589 . . . . 60.22 109.414 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 9.2 tp -79.94 85.36 5.57 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 124.369 2.033 . . . . 57.25 108.953 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1215 ' ' ASP . . . . . 0.644 ' H ' HD21 ' A' 1241 ' ' LEU . 12.3 t70 -76.71 111.89 12.71 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 110.978 -2.828 . . . . 64.43 104.696 -176.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1216 ' ' PHE . . . . . 0.642 ' HE1' ' HB1' ' A' 1233 ' ' ALA . 33.4 t80 . . . . . 0 CA--C 1.516 -0.362 0 N-CA-C 107.765 -1.198 . . . . 66.9 107.765 -175.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 2.2 p-10 . . . . . 0 N--CA 1.446 -0.663 0 CA-C-O 120.954 0.407 . . . . 39.09 110.978 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -42.26 -57.07 3.81 Favored Glycine 0 C--O 1.208 -1.492 0 O-C-N 126.427 2.329 . . . . 39.32 113.912 175.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 79.0 t80 -60.9 -47.89 84.34 Favored 'General case' 0 N--CA 1.44 -0.955 0 O-C-N 120.98 -1.306 . . . . 39.3 110.739 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -63.07 -35.98 82.05 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 120.645 -1.284 . . . . 36.3 114.42 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -65.4 -59.83 3.61 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 117.695 -1.145 . . . . 37.38 110.476 176.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -54.23 -47.78 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 121.065 1.757 . . . . 39.11 114.047 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1230 ' ' MET . . . . . . . . . . . . . 20.3 mmt -90.21 68.61 7.06 Favored 'General case' 0 C--O 1.247 0.933 0 CA-C-O 123.094 1.426 . . . . 49.59 112.708 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1231 ' ' SER . . . . . . . . . . . . . 1.9 p -142.43 132.69 24.79 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.222 -1.399 . . . . 43.68 107.222 165.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -49.08 -42.37 38.6 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 116.426 2.01 . . . . 55.57 116.426 -172.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1233 ' ' ALA . . . . . 0.642 ' HB1' ' HE1' ' A' 1216 ' ' PHE . . . -59.57 -39.02 82.72 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 119.109 0.868 . . . . 44.94 113.158 174.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -55.0 -60.59 3.16 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 114.435 1.272 . . . . 42.04 114.435 170.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 59.3 mt -57.89 -42.41 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 124.425 2.059 . . . . 46.28 109.854 -176.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 45.2 tttm -50.86 -53.12 35.07 Favored 'General case' 0 C--O 1.25 1.095 0 CA-C-N 113.289 -1.778 . . . . 47.87 114.15 166.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -63.47 -33.41 75.51 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 120.419 1.463 . . . . 41.61 110.703 -176.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -55.13 -59.66 4.46 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 124.883 1.273 . . . . 50.65 107.708 169.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1239 ' ' MET . . . . . . . . . . . . . 32.7 mtm -56.31 -31.69 63.93 Favored 'General case' 0 C--O 1.238 0.498 0 O-C-N 120.135 -1.603 . . . . 48.87 113.368 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -64.54 -39.72 94.28 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 112.166 0.432 . . . . 54.8 112.166 175.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1241 ' ' LEU . . . . . 0.644 HD21 ' H ' ' A' 1215 ' ' ASP . 1.6 mm? -65.6 -46.24 80.12 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 120.598 -1.314 . . . . 43.21 108.738 177.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -64.0 -34.38 77.86 Favored 'General case' 0 CA--C 1.508 -0.666 0 O-C-N 126.922 2.639 . . . . 38.66 112.635 -168.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -59.19 -54.12 50.54 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 120.403 1.456 . . . . 37.92 113.394 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -67.23 -42.94 83.18 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 119.803 1.183 . . . . 37.28 110.242 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1245 ' ' GLN . . . . . 0.482 ' HB3' ' SD ' ' A' 1169 ' ' MET . 96.7 mm-40 -54.19 -40.97 68.07 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 121.383 -0.823 . . . . 43.07 112.297 177.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -55.49 -37.08 67.37 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.076 0.95 . . . . 38.3 112.172 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1247 ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' A' 1276 ' ' LYS . 12.8 ttmm -54.9 -35.93 64.64 Favored 'General case' 0 C--O 1.258 1.517 0 C-N-CA 125.115 1.366 . . . . 47.6 110.905 177.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -111.24 -20.29 12.37 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.477 1.288 . . . . 45.42 114.477 -175.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1249 ' ' VAL . . . . . 0.437 HG11 ' HB2' ' A' 1169 ' ' MET . 31.2 m -78.27 162.63 4.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 115.303 1.594 . . . . 36.26 115.303 -173.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1250 ' ' ASP . . . . . 0.581 ' O ' ' HB3' ' A' 1279 ' ' SER . 3.6 m-20 -109.42 -60.47 1.77 Allowed 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 115.076 -0.965 . . . . 33.04 111.381 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1251 ' ' ILE . . . . . 0.449 HD12 ' HB1' ' A' 1145 ' ' ALA . 36.1 mm -112.76 102.08 13.43 Favored 'Isoleucine or valine' 0 C--O 1.247 0.934 0 N-CA-C 105.709 -1.96 . . . . 31.4 105.709 -170.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1252 ' ' ILE . . . . . 0.436 ' HB ' HG12 ' A' 1281 ' ' ILE . 64.9 mt -80.63 117.15 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 104.354 -2.462 . . . . 29.42 104.354 167.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1253 ' ' VAL . . . . . 0.598 HG12 HG23 ' A' 1255 ' ' THR . 18.2 t -103.92 109.75 28.14 Favored 'Isoleucine or valine' 0 C--O 1.248 0.985 0 N-CA-C 100.694 -3.817 . . . . 30.37 100.694 175.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1254 ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.53 82.4 5.34 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 124.904 2.287 . . . . 35.72 110.65 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1255 ' ' THR . . . . . 0.742 HG22 HD13 ' A' 1284 ' ' LEU . 1.1 p -86.29 -16.95 35.93 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 112.09 -2.323 . . . . 36.0 115.112 -174.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1256 ' ' ALA . . . . . 0.444 ' HB2' ' HA3' ' A' 1172 ' ' GLY . . . -57.81 64.45 0.0 OUTLIER 'General case' 0 C--O 1.261 1.675 0 N-CA-C 116.927 2.195 . . . . 40.93 116.927 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 44.4 tp -83.67 101.14 11.32 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 124.356 2.027 . . . . 47.82 110.369 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 32.8 mm -82.51 120.99 77.87 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-N 111.883 -2.417 . . . . 52.7 108.24 173.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -72.79 148.7 46.81 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 124.887 3.724 . . . . 54.13 111.366 175.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 74.69 -88.8 0.74 Allowed Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.699 -0.96 . . . . 54.62 110.699 176.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 41.1 mttt -56.78 124.93 66.63 Favored Pre-proline 0 CA--C 1.55 0.946 0 O-C-N 121.288 -1.125 . . . . 55.74 108.194 173.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -57.76 135.31 68.4 Favored 'Trans proline' 0 CA--C 1.521 -0.142 0 C-N-CA 123.306 2.671 . . . . 51.15 109.483 177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1263 ' ' ALA . . . . . 0.557 ' HB1' ' ND2' ' A' 1291 ' ' ASN . . . -57.53 130.59 81.44 Favored Pre-proline 0 N--CA 1.482 1.14 0 O-C-N 124.049 0.843 . . . . 46.06 110.042 -178.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -60.01 143.74 99.54 Favored 'Trans proline' 0 C--O 1.242 0.679 0 C-N-CA 124.187 3.258 . . . . 41.08 117.17 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1265 ' ' LYS . . . . . 0.589 ' HD2' ' HA ' ' A' 1293 ' ' GLU . 69.7 mmtt -79.65 85.54 5.36 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-O 124.423 2.058 . . . . 47.42 106.684 177.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 74.0 mt -84.43 -42.17 15.9 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 109.378 -3.555 . . . . 39.22 108.848 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 4.0 mp -99.07 108.76 22.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.842 0 N-CA-C 102.242 -3.244 . . . . 42.5 102.242 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1268 ' ' THR . . . . . 0.531 ' O ' HG23 ' A' 1272 ' ' VAL . 27.1 p -80.2 163.23 24.2 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 113.931 -1.486 . . . . 37.84 114.31 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 59.2 mtt-85 -58.27 -39.72 79.98 Favored 'General case' 0 C--O 1.212 -0.921 0 CA-C-N 115.883 -0.599 . . . . 54.8 110.487 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -60.15 -53.72 54.33 Favored 'General case' 0 N--CA 1.426 -1.654 0 O-C-N 124.851 1.344 . . . . 54.36 109.443 174.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1271 ' ' MET . . . . . . . . . . . . . 42.1 ttm -58.04 -37.46 74.4 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.087 0.955 . . . . 39.52 113.423 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1272 ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' 1268 ' ' THR . 13.5 t -67.45 -48.48 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 108.72 -0.844 . . . . 38.25 108.72 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.89 -29.18 70.03 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.491 0.922 . . . . 40.77 113.491 175.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1274 ' ' SER . . . . . . . . . . . . . 28.6 m -73.94 -12.43 60.65 Favored 'General case' 0 C--O 1.256 1.395 0 O-C-N 120.863 -1.148 . . . . 36.58 113.81 173.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1275 ' ' MET . . . . . 0.475 ' SD ' HD11 ' A' 1281 ' ' ILE . 70.3 mtp -63.16 155.77 27.11 Favored 'General case' 0 C--O 1.245 0.854 0 O-C-N 119.084 -2.26 . . . . 36.75 113.601 -177.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1276 ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' 1247 ' ' LYS . 36.1 ttpt -61.21 133.52 56.03 Favored 'General case' 0 C--N 1.347 0.471 0 N-CA-C 106.596 -1.631 . . . . 46.11 106.596 171.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1277 ' ' ALA . . . . . . . . . . . . . . . -71.29 175.15 5.6 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 122.441 1.115 . . . . 33.52 112.978 -172.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 67.34 28.16 73.62 Favored Glycine 0 C--O 1.22 -0.76 0 O-C-N 120.907 -1.12 . . . . 31.27 111.932 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1279 ' ' SER . . . . . 0.581 ' HB3' ' O ' ' A' 1250 ' ' ASP . 50.4 m -125.75 170.2 11.81 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.389 -1.065 . . . . 32.95 112.097 -165.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1280 ' ' VAL . . . . . 0.737 HG11 ' HA ' ' A' 1145 ' ' ALA . 65.2 t -130.82 133.45 63.16 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 O-C-N 119.472 -2.017 . . . . 27.43 108.66 -167.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1281 ' ' ILE . . . . . 0.475 HD11 ' SD ' ' A' 1275 ' ' MET . 48.4 mt -110.98 100.75 11.41 Favored 'Isoleucine or valine' 0 C--O 1.251 1.179 0 N-CA-C 103.624 -2.732 . . . . 30.3 103.624 166.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1282 ' ' VAL . . . . . 0.483 HG23 ' HA ' ' A' 1253 ' ' VAL . 0.0 OUTLIER -91.64 97.82 7.67 Favored 'Isoleucine or valine' 0 C--O 1.249 1.065 0 N-CA-C 107.108 -1.441 . . . . 28.63 107.108 176.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 4.4 t70 -86.95 108.72 18.94 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 106.819 -1.549 . . . . 36.27 106.819 -173.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1284 ' ' LEU . . . . . 0.742 HD13 HG22 ' A' 1255 ' ' THR . 9.6 tt -80.14 -35.62 36.4 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.88 0.847 . . . . 38.57 109.207 171.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -63.57 -12.71 35.02 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.497 -0.774 . . . . 37.56 112.765 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . -41.04 -29.51 0.11 Allowed 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 117.011 2.226 . . . . 40.33 117.011 162.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -51.19 -40.55 58.91 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-O 117.978 -1.01 . . . . 56.85 110.8 171.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 48.4 t30 -141.45 96.25 2.95 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 118.976 0.807 . . . . 45.86 110.1 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 92.28 -59.8 2.64 Favored Glycine 0 C--N 1.348 1.196 0 O-C-N 120.305 -1.497 . . . . 40.31 112.607 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 81.63 128.93 1.03 Allowed Glycine 0 N--CA 1.471 0.975 0 CA-C-N 120.485 2.143 . . . . 38.89 114.053 -171.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1291 ' ' ASN . . . . . 0.557 ' ND2' ' HB1' ' A' 1263 ' ' ALA . 20.3 m120 -82.02 -22.51 36.43 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 116.311 1.967 . . . . 37.23 116.311 -170.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1292 ' ' CYS . . . . . 0.565 ' HB3' ' OG1' ' A' 1295 ' ' THR . 29.6 t -94.29 144.36 25.59 Favored 'General case' 0 C--O 1.252 1.228 0 N-CA-C 102.461 -3.163 . . . . 36.5 102.461 174.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1293 ' ' GLU . . . . . 0.589 ' HA ' ' HD2' ' A' 1265 ' ' LYS . 30.5 mt-10 -64.96 -51.46 61.69 Favored 'General case' 0 CA--C 1.56 1.336 0 CA-C-O 122.811 1.291 . . . . 43.32 107.868 172.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -54.78 -18.68 5.06 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 119.916 3.302 . . . . 41.32 119.916 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1295 ' ' THR . . . . . 0.565 ' OG1' ' HB3' ' A' 1292 ' ' CYS . 58.4 m -49.75 103.97 0.06 Allowed 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 122.423 1.106 . . . . 35.3 112.77 167.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 94.6 t -86.1 121.29 72.8 Favored Pre-proline 0 C--O 1.246 0.887 0 N-CA-C 100.913 -3.736 . . . . 34.84 100.913 164.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -65.49 125.09 13.82 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.855 2.37 . . . . 33.51 107.597 -176.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 93.42 -3.23 71.84 Favored Glycine 0 N--CA 1.433 -1.556 0 CA-C-O 117.777 -1.568 . . . . 32.19 113.699 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -130.46 172.28 12.06 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 123.656 3.728 . . . . 34.88 117.206 -177.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1300 ' ' ILE . . . . . 0.576 HG23 HG12 ' A' 1310 ' ' ILE . 59.3 mt -98.72 98.17 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 101.744 -3.428 . . . . 32.29 101.744 170.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1301 ' ' PHE . . . . . 0.533 ' HB3' ' HB ' ' A' 1309 ' ' VAL . 61.9 t80 -71.99 148.56 45.82 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 103.905 -2.628 . . . . 37.25 103.905 161.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1302 ' ' THR . . . . . 0.486 HG22 ' O ' ' A' 1303 ' ' THR . 86.4 m -132.46 141.67 48.92 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 105.644 -1.984 . . . . 35.56 105.644 169.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1303 ' ' THR . . . . . 0.486 ' O ' HG22 ' A' 1302 ' ' THR . 16.8 p -81.23 163.71 22.81 Favored 'General case' 0 N--CA 1.425 -1.693 0 C-N-CA 125.333 1.453 . . . . 36.4 109.795 168.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -55.84 -49.66 72.7 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 124.924 1.29 . . . . 52.32 109.568 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 39.4 p-10 -66.44 -19.56 65.83 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.854 1.057 . . . . 40.04 113.854 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 97.94 63.12 0.88 Allowed Glycine 0 N--CA 1.426 -2.025 0 CA-C-N 113.865 -1.516 . . . . 36.96 112.036 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1307 ' ' VAL . . . . . 0.462 HG11 ' SD ' ' A' 1275 ' ' MET . 45.6 t -118.18 114.5 45.38 Favored 'Isoleucine or valine' 0 C--O 1.251 1.158 0 N-CA-C 108.221 -1.029 . . . . 33.4 108.221 163.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1308 ' ' LYS . . . . . 0.799 ' HD2' ' HB3' ' A' 1148 ' ' GLU . 78.2 mttt -92.75 108.19 19.8 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.943 0.878 . . . . 42.91 112.686 -171.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1309 ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' 1301 ' ' PHE . 14.0 t -94.62 83.43 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 106.025 -1.842 . . . . 32.29 106.025 -174.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1310 ' ' ILE . . . . . 0.576 HG12 HG23 ' A' 1300 ' ' ILE . 47.8 mt -80.83 91.33 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.35 0 CA-C-N 110.737 -2.938 . . . . 30.99 108.648 -173.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1311 ' ' GLY . . . . . 0.408 ' HA3' HG23 ' A' 1295 ' ' THR . . . -87.47 71.17 2.7 Favored Glycine 0 CA--C 1.537 1.442 0 O-C-N 118.284 -2.76 . . . . 28.95 112.318 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1312 ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -90.63 93.9 9.46 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 118.815 -1.154 . . . . 31.69 112.529 -172.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1313 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.53 -36.81 62.18 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 112.985 -1.916 . . . . 34.17 109.756 172.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 29.1 p-10 -84.74 3.87 35.41 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 118.192 2.664 . . . . 36.86 118.192 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1315 ' ' LEU . . . . . . . . . . . . . 28.7 mt -37.11 -50.85 2.26 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 118.322 2.712 . . . . 34.85 118.322 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1316 ' ' PRO . . . . . 0.731 ' HG3' ' HB2' ' A' 1137 ' ' ALA . 82.5 Cg_exo -53.35 -46.82 31.1 Favored 'Trans proline' 0 C--N 1.355 0.9 0 CA-C-N 125.655 3.056 . . . . 29.15 112.791 171.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1317 ' ' GLY . . . . . 0.615 ' HA2' ' HG3' ' A' 1015 ' ' ARG . . . -63.41 -29.89 75.93 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 115.097 0.799 . . . . 27.29 115.097 -175.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1318 ' ' ARG . . . . . 0.479 ' HB3' ' NH2' ' A' 1140 ' ' ARG . 52.3 mtt-85 -65.88 -19.94 66.05 Favored 'General case' 0 C--O 1.255 1.376 0 O-C-N 126.348 1.852 . . . . 41.49 115.345 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1319 ' ' LEU . . . . . 0.679 ' HB2' ' HD3' ' A' 1140 ' ' ARG . 13.3 tp -118.2 72.09 9.23 Favored Pre-proline 0 N--CA 1.438 -1.031 0 N-CA-C 105.232 -2.136 . . . . 27.61 105.232 178.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1320 ' ' PRO . . . . . 0.823 ' HB3' ' HB ' ' A' 1014 ' ' THR . 38.3 Cg_endo -56.04 -53.82 4.91 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.571 2.847 . . . . 25.94 114.698 -164.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1321 ' ' THR . . . . . . . . . . . . . 1.8 m -67.64 -39.52 84.63 Favored 'General case' 0 CA--C 1.499 -0.995 0 O-C-N 119.485 -2.009 . . . . 25.01 110.41 -168.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1322 ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -68.77 -26.57 65.29 Favored 'General case' 0 CA--C 1.511 -0.519 0 O-C-N 118.19 -2.819 . . . . 29.39 110.838 176.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1323 ' ' SER . . . . . 0.767 ' HA ' HD13 ' A' 1136 ' ' ILE . 70.6 m -64.59 -53.11 52.9 Favored 'General case' 0 CA--C 1.501 -0.913 0 O-C-N 119.569 -1.957 . . . . 26.47 109.91 167.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1324 ' ' SER . . . . . . . . . . . . . 4.6 m -55.66 -27.5 50.28 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.96 0.886 . . . . 27.78 113.001 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -86.54 -51.68 6.03 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 118.319 -1.352 . . . . 37.53 110.81 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1326 ' ' LEU . . . . . 0.407 ' HB2' HD11 ' A' 1136 ' ' ILE . 92.9 mt -79.94 -52.2 8.15 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 118.182 -0.913 . . . . 35.71 111.261 -172.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1327 ' ' TYR . . . . . 0.46 ' OH ' ' HA ' ' A' 1091 ' ' SER . 66.8 t80 -57.47 -43.39 84.02 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.799 0.809 . . . . 31.59 110.99 170.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1328 ' ' GLY . . . . . 0.564 ' HA2' HD12 ' A' 1331 ' ' LEU . . . -49.72 -50.11 32.4 Favored Glycine 0 N--CA 1.468 0.798 0 CA-C-O 118.149 -1.362 . . . . 28.0 110.816 171.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1329 ' ' THR . . . . . . . . . . . . . 52.4 m -72.5 -27.7 62.43 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 118.76 -1.176 . . . . 32.15 112.484 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1330 ' ' ASN . . . . . . . . . . . . . 28.5 m120 -60.1 -43.73 95.34 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 118.007 -2.933 . . . . 34.36 108.957 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1331 ' ' LEU . . . . . 0.674 HD22 HD22 ' A' 1070 ' ' LEU . 27.7 mt -59.79 -48.8 80.21 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 112.774 -2.012 . . . . 33.37 108.027 177.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1332 ' ' VAL . . . . . 0.497 HG12 ' HE3' ' A' 1336 ' ' LYS . 77.5 t -54.0 -47.75 64.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 C-N-CA 124.712 1.205 . . . . 35.27 111.682 175.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1333 ' ' ASN . . . . . 0.424 ' HA ' ' HD2' ' A' 1336 ' ' LYS . 82.9 m-20 -61.3 -34.09 74.65 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 115.343 1.608 . . . . 37.66 115.343 -177.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1334 ' ' LEU . . . . . 0.639 HD22 ' SD ' ' A' 1115 ' ' MET . 44.2 tp -72.09 -47.3 52.39 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 106.35 -1.722 . . . . 40.27 106.35 173.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1335 ' ' LEU . . . . . 0.615 ' HA ' ' HB2' ' A' 1338 ' ' LEU . 20.2 mt -64.94 -21.05 66.76 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 115.512 1.671 . . . . 42.5 115.512 -176.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1336 ' ' LYS . . . . . 0.497 ' HE3' HG12 ' A' 1332 ' ' VAL . 94.4 mttt -56.33 -42.93 78.46 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 119.617 -1.927 . . . . 47.81 112.145 164.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1337 ' ' LEU . . . . . 0.636 HD13 HD11 ' A' 1355 ' ' ILE . 96.0 mt -79.01 -33.69 44.68 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.044 -0.98 . . . . 49.27 111.318 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1338 ' ' LEU . . . . . 0.615 ' HB2' ' HA ' ' A' 1335 ' ' LEU . 8.3 mp -65.86 -37.52 86.39 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 114.075 1.139 . . . . 50.54 114.075 174.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1339 ' ' CYS . . . . . . . . . . . . . 27.0 m -116.73 87.19 2.64 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 124.301 2.001 . . . . 53.67 112.538 169.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1340 ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' 1337 ' ' LEU . 96.7 mttt -76.46 -52.8 9.13 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 112.2 -2.273 . . . . 63.38 108.954 -176.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -74.61 -44.87 48.56 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-O 122.707 1.241 . . . . 70.95 110.837 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1342 ' ' LYS . . . . . 0.478 ' HE3' ' HA ' ' A' 1029 ' ' LEU . 2.8 mtpt 61.41 90.44 0.07 Allowed 'General case' 0 C--O 1.214 -0.766 0 C-N-CA 126.122 1.769 . . . . 65.25 113.336 -173.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1343 ' ' ASP . . . . . 0.4 ' HB3' ' N ' ' A' 1342 ' ' LYS . 24.8 t70 70.27 160.75 0.21 Allowed 'General case' 0 C--O 1.247 0.928 2 O-C-N 111.146 -7.221 . . . . 64.53 115.526 -6.082 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 1344 ' ' GLY . . . . . . . . . . . . . . . -140.61 2.18 2.18 Favored Glycine 0 N--CA 1.433 -1.501 0 CA-C-O 122.267 0.926 . . . . 59.72 112.013 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 10.2 t30 -80.03 85.59 5.61 Favored 'General case' 0 C--O 1.247 0.933 0 O-C-N 119.218 -2.342 . . . . 64.09 106.88 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1346 ' ' ILE . . . . . 0.441 ' H ' HG13 ' A' 1346 ' ' ILE . 1.2 pp -54.26 117.18 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 109.877 -3.329 . . . . 58.82 111.176 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1347 ' ' THR . . . . . . . . . . . . . 4.0 m -78.47 96.04 5.29 Favored 'General case' 0 C--N 1.348 0.52 0 N-CA-C 103.779 -2.674 . . . . 54.96 103.779 -177.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1348 ' ' VAL . . . . . 0.652 HG21 HG21 ' A' 1111 ' ' THR . 3.5 t -75.96 85.27 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 N-CA-C 104.511 -2.403 . . . . 55.64 104.511 170.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 33.4 t70 -73.39 150.6 41.63 Favored 'General case' 0 C--O 1.254 1.296 0 CA-C-N 112.065 -2.334 . . . . 61.45 112.805 -169.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1350 ' ' PHE . . . . . 0.434 ' O ' ' HB2' ' A' 1356 ' ' ARG . 49.8 m-85 -111.79 -30.16 7.41 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 113.12 -1.855 . . . . 58.63 108.527 171.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -69.58 -23.47 63.55 Favored 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 120.381 -1.449 . . . . 62.06 114.21 -159.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 10.1 t70 -91.53 136.66 32.96 Favored 'General case' 0 C--O 1.253 1.254 0 N-CA-C 106.429 -1.693 . . . . 54.07 106.429 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 4.6 m -50.42 -41.47 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 123.671 0.788 . . . . 50.68 112.151 177.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1354 ' ' VAL . . . . . 0.525 ' O ' HG23 ' A' 1358 ' ' VAL . 15.2 m -71.83 -41.74 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 C-N-CA 117.137 -1.825 . . . . 47.68 109.143 -175.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1355 ' ' ILE . . . . . 0.636 HD11 HD13 ' A' 1337 ' ' LEU . 26.6 mt -74.13 -29.05 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 120.167 -0.613 . . . . 48.49 111.697 -176.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1356 ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' 1356 ' ' ARG . 32.6 tpt85 -60.96 -24.75 66.32 Favored 'General case' 0 C--O 1.248 0.983 0 O-C-N 120.047 -1.658 . . . . 48.27 112.352 170.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1357 ' ' GLY . . . . . 0.409 ' HA3' ' HD3' ' A' 1119 ' ' PRO . . . -82.97 -32.58 26.05 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-O 123.839 1.8 . . . . 43.53 110.945 175.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1358 ' ' VAL . . . . . 0.676 HG22 HG22 ' A' 1118 ' ' VAL . 21.7 t -76.1 -46.04 34.87 Favored 'Isoleucine or valine' 0 C--O 1.256 1.433 0 O-C-N 121.636 -0.92 . . . . 45.12 108.701 -176.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1359 ' ' THR . . . . . . . . . . . . . 22.1 m -64.82 84.83 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 123.788 1.756 . . . . 42.94 110.474 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1360 ' ' VAL . . . . . 0.404 HG11 ' HG2' ' A' 1095 ' ' PRO . 27.2 m -92.22 -34.95 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 114.828 -1.078 . . . . 43.26 111.883 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1361 ' ' ILE . . . . . 0.417 ' HB ' ' HB ' ' A' 1112 ' ' VAL . 79.6 mt -130.86 109.54 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 106.308 -1.738 . . . . 45.66 106.308 171.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1362 ' ' ARG . . . . . 0.549 ' HA ' HG23 ' A' 1111 ' ' THR . 61.0 ttt180 -94.82 121.58 36.57 Favored 'General case' 0 C--O 1.207 -1.134 0 O-C-N 118.258 -2.776 . . . . 61.34 107.826 169.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 45.25 61.15 2.68 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.184 1.179 . . . . 49.76 114.184 166.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1364 ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' 1109 ' ' ASN . . . 88.3 -47.52 3.5 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 114.016 -1.447 . . . . 50.0 112.042 -178.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -77.83 130.8 37.12 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 118.12 0.96 . . . . 56.92 109.293 -173.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1366 ' ' ILE . . . . . . . . . . . . . 31.2 mt -81.34 93.88 2.4 Favored 'Isoleucine or valine' 0 C--O 1.249 1.053 0 N-CA-C 105.02 -2.215 . . . . 52.78 105.02 177.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1367 ' ' THR . . . . . . . . . . . . . 26.0 p -72.12 -9.91 59.07 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 112.832 -1.985 . . . . 49.44 113.836 176.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 1.4 t90 -65.28 143.96 98.89 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 106.615 -1.624 . . . . 52.38 106.615 164.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -67.93 167.7 61.82 Favored 'Cis proline' 0 C--O 1.244 0.82 0 CA-C-N 124.811 2.754 . . . . 46.94 118.616 2.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -111.3 121.71 39.63 Favored Pre-proline 0 N--CA 1.437 -1.086 0 N-CA-C 106.076 -1.824 . . . . 45.91 106.076 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1371 ' ' PRO . . . . . 0.441 ' HD2' ' HG3' ' A' 1356 ' ' ARG . 17.5 Cg_exo -51.05 139.52 42.02 Favored 'Trans proline' 0 C--O 1.247 0.959 0 C-N-CA 123.67 2.913 . . . . 46.39 110.379 174.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -57.44 -31.09 90.33 Favored 'Trans proline' 0 N--CA 1.44 -1.621 0 C-N-CA 124.761 3.641 . . . . 46.72 112.719 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.231 -4.556 0 O-C-N 119.731 -1.856 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.441 -0.893 0 CA-C-O 117.6 -1.191 . . . . 63.44 110.644 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -79.68 55.6 2.05 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 123.652 2.933 . . . . 51.74 111.034 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1000 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.84 125.34 28.61 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 124.488 1.115 . . . . 54.07 111.407 -172.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 65.76 17.77 65.37 Favored Glycine 0 CA--C 1.531 1.079 0 O-C-N 121.688 -0.633 . . . . 39.22 112.7 -169.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1002 ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' B' 1066 ' ' SER . 13.7 ttp180 -90.19 118.66 29.88 Favored 'General case' 0 C--O 1.211 -0.939 0 CA-C-N 120.327 2.063 . . . . 38.12 111.381 177.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1003 ' ' ILE . . . . . 0.52 HD13 HD11 ' B' 1070 ' ' LEU . 21.8 mt -75.63 150.04 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 112.25 -2.25 . . . . 29.7 110.36 169.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -123.36 118.39 3.51 Favored Glycine 0 C--O 1.241 0.582 0 N-CA-C 110.472 -1.051 . . . . 27.5 110.472 165.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1005 ' ' ILE . . . . . 0.525 HG23 ' HB3' ' B' 1017 ' ' ALA . 23.3 mm -97.55 116.81 65.86 Favored Pre-proline 0 CA--C 1.558 1.278 0 N-CA-C 105.915 -1.883 . . . . 24.83 105.915 173.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -86.81 162.7 9.1 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.709 2.94 . . . . 27.19 112.446 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1007 ' ' ARG . . . . . 0.53 ' HG3' ' HB3' ' B' 1036 ' ' GLU . 19.7 mtp180 -77.59 101.3 6.48 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 102.028 -3.323 . . . . 41.46 102.028 163.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1008 ' ' GLU . . . . . 0.611 ' HG3' ' HB ' ' B' 1072 ' ' VAL . 3.2 mm-40 -58.71 140.62 54.5 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-O 122.369 1.081 . . . . 26.93 113.663 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 43.0 mmm-85 -86.89 -25.46 24.43 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.226 -1.352 . . . . 34.48 109.787 -162.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1010 ' ' LEU . . . . . 0.446 ' HB3' ' HB2' ' B' 1013 ' ' GLU . 4.8 tp -59.42 155.64 14.52 Favored 'General case' 0 C--O 1.25 1.093 0 N-CA-C 115.175 1.546 . . . . 44.22 115.175 -157.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1011 ' ' THR . . . . . . . . . . . . . 28.7 m -61.17 120.06 9.6 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.885 -0.598 . . . . 40.74 111.155 174.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 67.37 41.53 2.42 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 123.523 1.63 . . . . 44.44 112.151 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1013 ' ' GLU . . . . . 0.446 ' HG2' ' HB3' ' B' 1008 ' ' GLU . 8.5 tp10 -102.16 128.4 48.68 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.596 -1.184 . . . . 29.87 111.687 -175.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1014 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.01 -11.35 7.09 Favored 'General case' 0 C--O 1.247 0.934 0 O-C-N 125.456 1.723 . . . . 25.26 110.286 176.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -76.97 98.32 4.9 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 120.174 -1.579 . . . . 29.54 112.633 -175.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1016 ' ' VAL . . . . . 0.989 ' HB ' ' HB2' ' B' 1043 ' ' ALA . 44.0 t -96.56 141.95 14.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 105.02 -2.215 . . . . 23.55 105.02 168.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1017 ' ' ALA . . . . . 0.525 ' HB3' HG23 ' B' 1005 ' ' ILE . . . -62.42 -39.32 92.93 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 118.307 2.706 . . . . 23.59 118.307 -155.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1018 ' ' ALA . . . . . . . . . . . . . . . -128.12 149.95 50.19 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 119.255 -2.153 . . . . 24.93 111.76 -168.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1019 ' ' THR . . . . . 0.409 ' O ' HG23 ' B' 1023 ' ' VAL . 13.2 p -84.9 166.16 33.33 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-O 117.361 -1.304 . . . . 28.09 111.101 165.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1020 ' ' PRO . . . . . 0.471 ' HB3' ' HB2' ' B' 1053 ' ' ALA . 41.0 Cg_exo -55.02 -39.75 89.35 Favored 'Trans proline' 0 CA--C 1.549 1.241 0 C-N-CA 123.163 2.576 . . . . 28.79 112.838 165.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 70.7 tttt -57.49 -49.1 77.38 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 120.17 -1.581 . . . . 47.28 111.144 175.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1022 ' ' THR . . . . . . . . . . . . . 11.8 p -73.64 -27.33 61.2 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 117.068 -1.444 . . . . 30.12 110.275 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1023 ' ' VAL . . . . . 0.438 HG11 ' HB2' ' B' 1055 ' ' ALA . 46.0 t -53.2 -50.32 47.1 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 CA-C-N 120.624 1.556 . . . . 32.24 108.638 165.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1024 ' ' GLU . . . . . 0.462 ' HA ' HD12 ' B' 1027 ' ' LEU . 48.6 mt-10 -63.4 -35.61 80.99 Favored 'General case' 0 CA--C 1.511 -0.553 0 O-C-N 120.42 -1.425 . . . . 49.62 113.038 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -63.74 -43.23 97.08 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.438 -0.789 . . . . 44.68 109.849 172.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1026 ' ' LEU . . . . . 0.584 ' HG ' HG22 ' B' 1332 ' ' VAL . 19.2 mt -63.79 -35.41 80.49 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 115.651 1.722 . . . . 35.71 115.651 176.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1027 ' ' LEU . . . . . 0.462 HD12 ' HA ' ' B' 1024 ' ' GLU . 68.1 mt -62.4 -45.2 94.19 Favored 'General case' 0 C--O 1.237 0.445 0 O-C-N 124.254 0.971 . . . . 42.18 109.937 170.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 62.9 mttm -61.12 -30.06 70.15 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.205 1.187 . . . . 48.34 114.205 172.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1029 ' ' LEU . . . . . 0.446 HD12 HD23 ' B' 1026 ' ' LEU . 85.6 mt -69.27 -30.98 69.21 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-O 122.978 1.37 . . . . 38.69 112.832 165.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 113.34 31.6 2.36 Favored Glycine 0 N--CA 1.465 0.576 0 O-C-N 118.518 -2.614 . . . . 32.28 108.749 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -126.64 112.7 15.78 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 120.551 -1.558 . . . . 35.94 109.158 -177.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1032 ' ' THR . . . . . . . . . . . . . 15.0 m -71.5 137.55 48.25 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 106.942 -1.503 . . . . 33.37 106.942 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1033 ' ' VAL . . . . . 0.428 ' HB ' HG13 ' B' 1023 ' ' VAL . 61.0 t -106.17 119.47 55.6 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 CA-C-N 120.272 1.396 . . . . 29.98 112.774 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -96.07 140.31 30.98 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 106.802 -1.555 . . . . 28.18 106.802 169.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1035 ' ' VAL . . . . . 0.59 ' HB ' HD13 ' B' 1057 ' ' ILE . 39.8 t -133.36 140.56 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 119.02 -2.3 . . . . 25.82 105.923 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1036 ' ' GLU . . . . . 0.53 ' HB3' ' HG3' ' B' 1007 ' ' ARG . 10.5 mt-10 -65.63 142.51 58.03 Favored 'General case' 0 C--O 1.247 0.971 0 O-C-N 121.004 -1.06 . . . . 32.44 112.956 175.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1037 ' ' SER . . . . . 0.411 ' O ' ' HD2' ' B' 1007 ' ' ARG . 24.0 m -59.15 124.35 19.68 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 121.587 -0.695 . . . . 29.54 111.268 170.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 93.65 -18.08 57.24 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.04 -0.824 . . . . 27.76 111.04 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1039 ' ' ALA . . . . . . . . . . . . . . . -66.48 -40.4 89.3 Favored 'General case' 0 C--O 1.243 0.759 0 O-C-N 120.778 -1.425 . . . . 26.02 111.495 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -56.09 -51.36 56.22 Favored Glycine 0 CA--C 1.5 -0.891 0 N-CA-C 110.077 -1.209 . . . . 26.47 110.077 171.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -58.42 -29.49 66.15 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 120.661 -1.494 . . . . 50.98 113.033 173.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 65.0 mt -70.55 -48.27 56.26 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 123.045 2.657 . . . . 29.3 110.631 176.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1043 ' ' ALA . . . . . 0.989 ' HB2' ' HB ' ' B' 1016 ' ' VAL . . . -63.68 -17.96 63.49 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 114.928 -1.033 . . . . 26.74 111.834 174.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1044 ' ' SER . . . . . . . . . . . . . 29.0 m 69.11 47.47 0.74 Allowed 'General case' 0 C--N 1.352 0.694 0 CA-C-O 127.408 3.48 . . . . 31.26 109.813 175.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1045 ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -146.9 105.25 3.78 Favored 'General case' 0 N--CA 1.442 -0.866 1 N-CA-C 97.413 -5.032 . . . . 33.26 97.413 171.464 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 26.7 t0 -57.46 146.86 28.19 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 123.614 1.673 . . . . 46.74 115.465 -164.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -49.4 -43.17 44.12 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 110.803 -2.908 . . . . 34.44 110.091 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1048 ' ' LYS . . . . . 0.405 ' O ' ' HB ' ' B' 1051 ' ' VAL . 1.1 mptm? -66.14 -28.52 68.86 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.228 -0.92 . . . . 48.67 113.218 177.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -66.4 -32.29 73.58 Favored 'General case' 0 C--O 1.246 0.889 0 O-C-N 120.618 -1.301 . . . . 35.26 111.272 167.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1050 ' ' PHE . . . . . 0.631 ' HB2' HD11 ' B' 1057 ' ' ILE . 77.6 m-85 -70.98 -33.46 70.45 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 119.334 0.97 . . . . 32.17 109.005 170.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1051 ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' B' 1048 ' ' LYS . 76.7 t -58.98 -40.19 79.98 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 O-C-N 119.706 -1.871 . . . . 38.37 112.726 170.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -61.16 -38.94 88.26 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-O 118.427 -0.797 . . . . 45.77 112.19 171.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1053 ' ' ALA . . . . . 0.471 ' HB2' ' HB3' ' B' 1020 ' ' PRO . . . -68.15 -22.92 64.83 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 124.281 0.988 . . . . 37.83 113.064 172.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 76.34 59.04 3.44 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 109.782 -1.327 . . . . 35.82 109.782 -175.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1055 ' ' ALA . . . . . 0.438 ' HB2' HG11 ' B' 1023 ' ' VAL . . . -109.99 140.63 43.78 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 122.186 0.993 . . . . 33.77 108.49 166.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -78.34 96.51 5.33 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 118.207 -2.808 . . . . 51.02 108.887 -175.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1057 ' ' ILE . . . . . 0.631 HD11 ' HB2' ' B' 1050 ' ' PHE . 34.4 mm -72.97 110.13 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 106.712 -1.588 . . . . 38.47 106.712 176.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1058 ' ' VAL . . . . . 0.677 ' HB ' ' HB2' ' B' 1062 ' ' SER . 2.9 m -127.1 143.78 39.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 112.195 -2.275 . . . . 39.4 110.988 -174.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -77.44 124.16 27.52 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 122.181 0.991 . . . . 57.07 110.454 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . 50.3 -107.78 0.4 Allowed Glycine 0 CA--C 1.497 -1.074 0 N-CA-C 117.423 1.729 . . . . 44.83 117.423 164.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 25.9 m120 -63.73 -27.85 69.48 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.911 0.862 . . . . 46.27 111.934 -164.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1062 ' ' SER . . . . . 0.677 ' HB2' ' HB ' ' B' 1058 ' ' VAL . 3.1 m -55.48 -39.96 71.07 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 113.848 -1.524 . . . . 43.47 111.822 175.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.71 -27.13 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 O-C-N 119.992 -1.692 . . . . 36.98 113.645 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 96.5 m95 -71.42 -27.49 63.33 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 124.042 1.877 . . . . 37.9 111.993 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -79.12 80.24 5.48 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 118.744 -2.473 . . . . 46.19 108.869 176.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1066 ' ' SER . . . . . 0.45 ' HB3' ' O ' ' B' 1002 ' ' ARG . 72.9 m -156.39 165.05 37.46 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.093 -0.958 . . . . 37.06 109.786 -172.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1067 ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' 1068 ' ' ILE . 0.5 OUTLIER -81.31 -39.15 25.62 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 114.504 -1.225 . . . . 43.95 109.236 -178.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B 1068 ' ' ILE . . . . . 0.409 HD12 ' HB3' ' B' 1067 ' ' GLU . 4.1 mp -123.93 140.45 47.34 Favored 'Isoleucine or valine' 0 C--O 1.251 1.142 0 N-CA-C 104.034 -2.58 . . . . 33.5 104.034 -179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 43.8 mm -112.31 135.65 51.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 N-CA-C 103.599 -2.741 . . . . 30.57 103.599 165.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1070 ' ' LEU . . . . . 0.552 HD13 HD13 ' B' 1331 ' ' LEU . 84.9 mt -114.27 75.67 0.94 Allowed 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 121.391 1.905 . . . . 27.66 105.913 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1071 ' ' LYS . . . . . . . . . . . . . 4.6 mttm -73.34 152.93 40.72 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 124.371 1.068 . . . . 28.4 111.656 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1072 ' ' VAL . . . . . 0.611 ' HB ' ' HG3' ' B' 1008 ' ' GLU . 15.6 t -94.01 -31.93 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-O 118.967 -0.539 . . . . 23.18 110.729 176.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -111.85 -167.84 1.23 Allowed 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 124.242 1.017 . . . . 25.47 111.303 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -71.38 162.36 73.21 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 119.166 0.894 . . . . 27.9 111.902 165.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1075 ' ' PRO . . . . . 0.412 ' O ' HD11 ' B' 1101 ' ' LEU . 38.2 Cg_endo -76.8 143.77 23.89 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.605 2.203 . . . . 31.62 113.727 164.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 31.9 mt -88.86 178.14 6.51 Favored 'General case' 0 CA--C 1.555 1.166 0 O-C-N 120.916 -1.115 . . . . 40.49 109.305 170.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 28.3 t70 -62.16 -31.68 72.2 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 122.418 2.372 . . . . 51.59 114.691 -172.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -68.7 -39.58 80.43 Favored 'General case' 0 N--CA 1.439 -0.991 0 O-C-N 120.844 -1.16 . . . . 42.36 112.112 175.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1079 ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -69.58 -35.95 75.83 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.985 -1.007 . . . . 34.53 109.049 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1080 ' ' ILE . . . . . 0.538 ' HA ' HD12 ' B' 1083 ' ' LEU . 86.5 mt -59.49 -45.28 93.92 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 C-N-CA 124.447 1.099 . . . . 33.25 110.78 171.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -61.23 -39.6 90.9 Favored 'General case' 0 C--O 1.251 1.166 0 N-CA-C 113.095 0.776 . . . . 36.47 113.095 173.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1082 ' ' LEU . . . . . . . . . . . . . 51.7 mt -67.25 -34.04 76.6 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 115.365 1.616 . . . . 37.76 115.365 173.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1083 ' ' LEU . . . . . 0.85 HD21 HD13 ' B' 1089 ' ' LEU . 16.6 mt -56.74 112.01 1.18 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 123.467 1.603 . . . . 37.43 111.045 175.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -69.67 136.07 88.07 Favored Pre-proline 0 C--O 1.219 -0.509 0 CA-C-N 111.754 -2.476 . . . . 37.7 113.267 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -51.69 109.92 0.37 Allowed 'Trans proline' 0 C--O 1.246 0.896 0 C-N-CA 124.383 3.389 . . . . 35.51 116.982 171.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 101.72 3.83 52.36 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 113.726 -1.579 . . . . 33.87 115.253 -172.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1087 ' ' THR . . . . . . . . . . . . . 52.0 m -74.23 127.72 33.69 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-N 119.523 1.661 . . . . 32.5 109.266 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1088 ' ' THR . . . . . 0.549 ' HA ' ' HB ' ' B' 1111 ' ' THR . 1.2 m -62.87 101.23 0.25 Allowed 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 105.312 -2.107 . . . . 30.22 105.312 170.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1089 ' ' LEU . . . . . 0.85 HD13 HD21 ' B' 1083 ' ' LEU . 43.3 tp -96.85 109.69 22.34 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 104.719 -2.326 . . . . 27.24 104.719 -176.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1090 ' ' VAL . . . . . 0.533 HG22 ' HB2' ' B' 1113 ' ' MET . 70.3 t -94.05 123.51 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 105.835 -1.913 . . . . 25.39 105.835 169.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1091 ' ' SER . . . . . . . . . . . . . 58.0 m -156.15 164.62 38.16 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 123.613 1.673 . . . . 28.81 110.544 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1092 ' ' PHE . . . . . . . . . . . . . 10.8 t80 -93.12 95.85 9.68 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 101.557 -3.498 . . . . 30.78 101.557 174.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 37.3 mm -83.43 -52.77 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-O 117.349 -1.31 . . . . 30.28 113.036 -172.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1094 ' ' TRP . . . . . 0.508 ' HB3' ' HB2' ' B' 1097 ' ' GLN . 20.9 m95 52.96 75.9 0.59 Allowed Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 118.631 0.65 . . . . 34.07 109.657 -154.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -57.15 -49.51 13.92 Favored 'Trans proline' 0 CA--C 1.511 -0.638 1 C-N-CA 125.707 4.271 . . . . 38.66 113.502 -171.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -71.52 -14.38 62.09 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 118.643 0.656 . . . . 41.32 111.302 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1097 ' ' GLN . . . . . 0.508 ' HB2' ' HB3' ' B' 1094 ' ' TRP . 15.3 mp0 -103.86 -4.89 22.92 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.794 1.238 . . . . 51.66 109.59 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1098 ' ' ASN . . . . . 0.445 ' N ' ' HD3' ' B' 1099 ' ' PRO . 57.8 m-80 -137.53 62.65 37.34 Favored Pre-proline 0 C--O 1.24 0.573 0 O-C-N 120.456 -1.402 . . . . 40.32 109.087 167.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1099 ' ' PRO . . . . . 0.445 ' HD3' ' N ' ' B' 1098 ' ' ASN . 52.2 Cg_exo -63.07 -45.94 11.46 Favored 'Trans proline' 0 CA--C 1.536 0.604 1 C-N-CA 128.191 5.927 . . . . 41.56 113.92 -171.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B 1100 ' ' GLU . . . . . 0.495 ' CD ' ' H ' ' B' 1100 ' ' GLU . 0.6 OUTLIER -66.14 -38.86 89.17 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 123.945 0.898 . . . . 54.11 108.84 176.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B 1101 ' ' LEU . . . . . 0.44 ' O ' ' HG ' ' B' 1105 ' ' LEU . 6.3 tt -60.31 -48.76 80.35 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.727 0.775 . . . . 37.88 109.006 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1102 ' ' MET . . . . . . . . . . . . . 62.1 mmm -53.44 -45.14 69.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.086 -0.961 . . . . 37.54 112.994 171.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -62.6 -33.1 74.31 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.92 1.082 . . . . 47.01 113.92 175.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1104 ' ' LYS . . . . . 0.403 ' HB3' HG21 ' B' 1080 ' ' ILE . 82.0 mttt -73.02 -32.07 64.88 Favored 'General case' 0 C--O 1.213 -0.827 0 O-C-N 119.994 -1.691 . . . . 48.68 111.539 173.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1105 ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' B' 1101 ' ' LEU . 66.6 mt -66.11 -34.51 78.23 Favored 'General case' 0 C--O 1.256 1.447 0 O-C-N 121.609 -0.682 . . . . 32.21 110.244 174.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -61.18 -46.89 88.64 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 123.209 0.604 . . . . 33.73 111.541 168.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -58.22 -47.75 82.53 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 125.783 2.706 . . . . 51.47 117.016 174.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1108 ' ' ARG . . . . . . . . . . . . . 31.6 mmm180 -69.17 -10.54 58.2 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 112.728 -2.033 . . . . 43.9 111.218 171.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1109 ' ' ASN . . . . . 0.409 ' HA ' ' CA ' ' B' 1364 ' ' GLY . 0.6 OUTLIER 59.19 42.82 18.02 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 123.504 1.621 . . . . 44.82 111.586 170.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B 1110 ' ' VAL . . . . . 0.432 HG11 ' HB3' ' B' 1083 ' ' LEU . 12.4 m -93.32 149.89 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 115.032 -0.986 . . . . 30.52 109.124 -177.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1111 ' ' THR . . . . . 0.549 ' HB ' ' HA ' ' B' 1088 ' ' THR . 88.5 m -86.33 92.39 8.79 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.963 -0.754 . . . . 27.12 108.963 177.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1112 ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' B' 1089 ' ' LEU . 4.1 t -94.99 124.88 47.68 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 120.297 1.408 . . . . 26.4 110.781 -168.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1113 ' ' MET . . . . . 0.533 ' HB2' HG22 ' B' 1090 ' ' VAL . 1.3 mpt? -102.33 115.7 31.11 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 124.388 2.042 . . . . 42.92 107.932 163.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -93.75 106.93 18.87 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 120.55 -1.344 . . . . 24.15 110.216 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1115 ' ' MET . . . . . 0.517 ' HB3' ' HB2' ' B' 1129 ' ' ALA . 14.2 mmm -63.94 -11.14 25.64 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 117.303 2.334 . . . . 29.95 117.303 -176.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1116 ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -84.81 -41.86 15.69 Favored 'General case' 0 C--O 1.218 -0.58 0 C-N-CA 123.721 0.809 . . . . 34.53 109.323 169.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1117 ' ' SER . . . . . . . . . . . . . 25.0 m -91.45 37.49 0.95 Allowed 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 120.066 -1.646 . . . . 33.49 109.666 -173.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1118 ' ' VAL . . . . . 0.749 HG12 ' HB1' ' B' 1124 ' ' ALA . 1.8 t -78.38 147.67 72.59 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 103.988 -2.597 . . . . 34.02 103.988 166.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 1.6 Cg_exo -58.13 165.56 6.87 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.971 2.447 . . . . 38.28 114.192 169.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1120 ' ' ARG . . . . . 0.718 ' HB2' HG21 ' B' 1375 ' ' VAL . 5.0 mmp_? -92.27 -0.07 57.42 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 120.924 -1.11 . . . . 55.05 112.186 -178.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1121 ' ' ILE . . . . . 0.722 HG22 ' HB1' ' C' ' 131' ' ' ALA . 30.3 pt -68.76 141.82 16.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 119.964 1.256 . . . . 42.09 108.65 175.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1122 ' ' SER . . . . . 0.68 ' HB2' ' HA ' ' C' ' 133' ' ' MET . 5.0 m -58.73 -28.45 65.86 Favored 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 116.982 2.216 . . . . 38.02 116.982 -158.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1123 ' ' ARG . . . . . 0.621 ' HG3' HG21 ' B' 1354 ' ' VAL . 19.4 ptt-85 -66.45 -39.59 88.94 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 121.359 1.891 . . . . 34.29 107.849 174.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1124 ' ' ALA . . . . . 0.749 ' HB1' HG12 ' B' 1118 ' ' VAL . . . -68.03 -38.44 82.53 Favored 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 106.764 -1.569 . . . . 32.35 106.764 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1125 ' ' GLN . . . . . 0.622 ' NE2' ' HB3' ' B' 1131 ' ' SER . 17.9 mm100 -51.15 -38.97 55.15 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 118.197 2.666 . . . . 47.17 118.197 170.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1126 ' ' SER . . . . . . . . . . . . . 3.9 p -69.18 -19.68 63.99 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 122.107 0.956 . . . . 31.71 113.549 175.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1127 ' ' LEU . . . . . 0.739 ' HG ' ' HA ' ' B' 1334 ' ' LEU . 5.2 mp -90.26 -36.06 14.94 Favored 'General case' 0 C--N 1.347 0.48 0 N-CA-C 107.911 -1.144 . . . . 37.0 107.911 173.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1128 ' ' ASP . . . . . 0.506 ' HB3' ' HA ' ' B' 1125 ' ' GLN . 4.6 t70 -62.88 130.08 43.27 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 125.958 1.703 . . . . 40.4 115.107 -164.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1129 ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' B' 1115 ' ' MET . . . -72.14 -36.93 69.49 Favored 'General case' 0 C--O 1.255 1.393 0 N-CA-C 106.713 -1.588 . . . . 26.56 106.713 -176.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 56.9 mt -59.83 -24.63 64.35 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 121.191 1.814 . . . . 30.89 112.494 -172.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1131 ' ' SER . . . . . 0.622 ' HB3' ' NE2' ' B' 1125 ' ' GLN . 93.9 p -69.23 -60.48 2.32 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 106.035 -1.839 . . . . 29.84 106.035 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1132 ' ' SER . . . . . 0.557 ' O ' HG12 ' B' 1136 ' ' ILE . 16.0 m -62.64 -34.86 77.91 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 115.438 1.644 . . . . 31.91 115.438 -178.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1133 ' ' MET . . . . . . . . . . . . . 35.3 mmt -72.68 -36.53 67.91 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.872 0.844 . . . . 25.9 111.596 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1134 ' ' ALA . . . . . 0.851 ' HB1' ' HB2' ' B' 1176 ' ' ALA . . . -60.84 -39.44 89.08 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 115.259 -0.882 . . . . 26.62 109.959 167.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -60.37 -50.09 74.98 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 117.782 -1.104 . . . . 36.97 113.738 173.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1136 ' ' ILE . . . . . 0.557 HG12 ' O ' ' B' 1132 ' ' SER . 16.4 mm -53.48 -52.02 36.49 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 O-C-N 124.686 1.241 . . . . 32.11 108.416 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1137 ' ' ALA . . . . . 0.45 ' HB2' ' HG3' ' B' 1316 ' ' PRO . . . -61.87 -35.88 79.6 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 114.132 1.16 . . . . 24.14 114.132 176.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -71.53 -41.55 57.47 Favored Glycine 0 CA--C 1.503 -0.713 0 N-CA-C 109.262 -1.535 . . . . 25.13 109.262 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1139 ' ' TYR . . . . . 0.698 ' HD2' HD21 ' B' 1319 ' ' LEU . 17.8 t80 -61.74 -55.6 28.54 Favored 'General case' 0 C--O 1.211 -0.958 0 O-C-N 120.928 -1.337 . . . . 32.73 109.689 169.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1140 ' ' ARG . . . . . 0.464 ' HA ' ' HB ' ' B' 1143 ' ' VAL . 18.3 tpt180 -59.36 -25.18 64.01 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 119.15 0.886 . . . . 26.36 111.75 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1141 ' ' ALA . . . . . 0.663 ' HA ' HG11 ' B' 1282 ' ' VAL . . . -62.91 -55.65 24.2 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.466 1.106 . . . . 24.12 109.971 170.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 21.4 mm -57.94 -40.7 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 107.839 -1.171 . . . . 23.37 107.839 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1143 ' ' VAL . . . . . 0.464 ' HB ' ' HA ' ' B' 1140 ' ' ARG . 19.4 t -59.29 -66.49 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.662 0 CA-C-O 117.8 -1.095 . . . . 24.96 112.356 177.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -61.1 -33.2 72.97 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.518 1.127 . . . . 32.07 112.09 -175.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1145 ' ' ALA . . . . . 0.659 ' HA ' HG11 ' B' 1280 ' ' VAL . . . -60.54 -59.37 5.5 Favored 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 106.386 -1.709 . . . . 24.87 106.386 174.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1146 ' ' ALA . . . . . 0.463 ' HB2' ' HE1' ' B' 1153 ' ' PHE . . . -58.27 -33.64 69.62 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 120.577 1.535 . . . . 24.67 111.727 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1147 ' ' HIS . . . . . 0.413 ' O ' ' NH2' ' A' 1140 ' ' ARG . 73.8 t60 -59.72 -44.63 93.65 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.052 1.341 . . . . 28.58 111.282 174.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1148 ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -96.8 -6.81 35.22 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 122.614 1.197 . . . . 36.82 113.933 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1149 ' ' PHE . . . . . 0.525 ' CZ ' ' HB3' ' B' 1250 ' ' ASP . 1.0 OUTLIER -76.26 148.84 37.32 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 113.235 -1.802 . . . . 31.97 110.263 -176.65 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B 1150 ' ' GLY . . . . . 0.408 ' HA2' ' HD2' ' A' 1320 ' ' PRO . . . -92.73 -19.34 37.72 Favored Glycine 0 N--CA 1.427 -1.964 0 CA-C-N 113.474 -1.694 . . . . 25.49 115.42 173.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1151 ' ' ARG . . . . . . . . . . . . . 86.5 mtm-85 -121.17 177.22 5.23 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 119.738 1.769 . . . . 59.84 110.97 -169.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1152 ' ' PHE . . . . . 0.574 ' HB2' HG11 ' B' 1163 ' ' VAL . 15.7 m-30 -84.99 155.04 21.75 Favored 'General case' 0 C--N 1.352 0.691 0 CA-C-N 121.544 1.975 . . . . 34.45 108.857 175.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1153 ' ' PHE . . . . . 0.463 ' HE1' ' HB2' ' B' 1146 ' ' ALA . 33.0 m-85 -74.93 -46.82 33.22 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.529 -1.214 . . . . 31.17 109.794 164.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1154 ' ' THR . . . . . . . . . . . . . 22.4 m -71.58 122.64 20.87 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 113.379 -1.737 . . . . 33.89 109.362 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1155 ' ' GLY . . . . . 0.681 ' HA3' ' HG3' ' B' 1165 ' ' PRO . . . -75.18 103.47 1.59 Allowed Glycine 0 C--O 1.269 2.287 0 N-CA-C 106.837 -2.505 . . . . 38.95 106.837 172.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1156 ' ' GLN . . . . . 0.685 ' H ' ' HB ' ' B' 1163 ' ' VAL . 20.1 tt0 -112.09 112.39 23.97 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 105.638 -1.986 . . . . 54.23 105.638 -169.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1157 ' ' ILE . . . . . 0.854 HG23 ' HG2' ' B' 1162 ' ' LYS . 29.6 mm -81.53 96.88 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 102.954 -2.98 . . . . 51.16 102.954 172.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1158 ' ' THR . . . . . . . . . . . . . 34.9 m -95.13 153.93 17.42 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 112.841 -1.981 . . . . 49.61 107.382 -163.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -36.95 -51.35 0.91 Allowed 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 116.64 2.089 . . . . 49.05 116.64 175.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -55.74 -56.15 23.83 Favored 'General case' 0 C--N 1.349 0.577 0 N-CA-C 114.833 1.42 . . . . 47.65 114.833 169.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . 177.53 -165.79 35.77 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 108.773 -1.731 . . . . 45.61 108.773 -175.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1162 ' ' LYS . . . . . 0.854 ' HG2' HG23 ' B' 1157 ' ' ILE . 89.3 mttt -95.49 149.46 21.38 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 122.38 1.086 . . . . 57.46 112.968 -166.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1163 ' ' VAL . . . . . 0.685 ' HB ' ' H ' ' B' 1156 ' ' GLN . 99.1 t -116.69 121.59 32.79 Favored Pre-proline 0 CA--C 1.499 -0.994 0 CA-C-N 113.067 -1.878 . . . . 42.93 106.279 166.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1164 ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' B' 1163 ' ' VAL . 36.5 Cg_endo -68.82 137.55 38.61 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.478 2.118 . . . . 39.29 109.66 168.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1165 ' ' PRO . . . . . 0.681 ' HG3' ' HA3' ' B' 1155 ' ' GLY . 64.2 Cg_exo -62.93 149.08 92.59 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.548 2.832 . . . . 34.17 113.193 -177.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -73.47 122.1 21.6 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 124.837 1.336 . . . . 31.69 109.11 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1167 ' ' LYS . . . . . 0.437 ' HD3' ' HB3' ' B' 1248 ' ' GLU . 80.4 mttt -79.59 104.05 9.92 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 105.63 -1.989 . . . . 44.78 105.63 171.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 62.0 t -102.02 99.59 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 N-CA-C 106.69 -1.596 . . . . 31.23 106.69 -170.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1169 ' ' MET . . . . . 0.499 ' HA ' ' O ' ' B' 1192 ' ' ARG . 30.2 ttp -82.29 112.2 19.06 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 119.419 -0.913 . . . . 37.09 109.132 178.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 60.0 t -104.03 107.21 21.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 N-CA-C 105.511 -2.033 . . . . 30.17 105.511 -177.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1171 ' ' ILE . . . . . . . . . . . . . 70.4 mt -97.49 127.17 50.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 108.222 -1.029 . . . . 33.74 108.222 -177.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 88.72 67.21 1.27 Allowed Glycine 0 C--N 1.318 -0.44 0 CA-C-O 124.502 2.168 . . . . 32.59 108.458 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1173 ' ' ALA . . . . . 0.681 ' HA ' ' HA3' ' B' 1177 ' ' GLY . . . -74.42 42.25 0.16 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 117.975 2.583 . . . . 32.42 117.975 178.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -79.78 -155.26 10.03 Favored Glycine 0 CA--C 1.524 0.601 0 O-C-N 117.573 -3.204 . . . . 31.74 110.397 164.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 86.7 t -48.58 -50.8 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-N 120.762 2.281 . . . . 31.48 115.289 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1176 ' ' ALA . . . . . 0.851 ' HB2' ' HB1' ' B' 1134 ' ' ALA . . . -49.46 -50.83 39.42 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 123.591 1.663 . . . . 26.12 113.324 172.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1177 ' ' GLY . . . . . 0.681 ' HA3' ' HA ' ' B' 1173 ' ' ALA . . . -63.73 -49.79 66.16 Favored Glycine 0 C--O 1.211 -1.3 0 CA-C-N 112.748 -2.024 . . . . 25.73 110.765 -178.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1178 ' ' LEU . . . . . 0.421 HD23 HD12 ' B' 1181 ' ' ILE . 46.3 mt -56.59 -33.38 66.14 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 123.94 0.896 . . . . 32.59 112.718 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -62.34 -57.96 9.42 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.893 -1.049 . . . . 27.72 110.602 172.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -57.78 -39.78 78.29 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 114.137 1.162 . . . . 26.03 114.137 177.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1181 ' ' ILE . . . . . 0.72 HG22 ' SD ' ' B' 1207 ' ' MET . 96.4 mt -57.06 -45.84 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 108.413 -0.958 . . . . 28.61 108.413 172.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -55.25 -54.39 34.46 Favored Glycine 0 N--CA 1.465 0.583 0 N-CA-C 110.4 -1.08 . . . . 25.23 110.4 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -56.93 -61.42 2.45 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.276 1.213 . . . . 24.09 114.276 174.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -67.3 -35.73 80.06 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-O 119.178 -0.439 . . . . 26.68 111.504 -169.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -66.91 -45.32 78.28 Favored 'General case' 0 CA--C 1.502 -0.873 0 O-C-N 120.554 -1.341 . . . . 36.57 110.071 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1186 ' ' SER . . . . . . . . . . . . . 61.3 m -66.04 -32.31 73.71 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 119.923 -0.711 . . . . 28.92 112.823 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1187 ' ' LEU . . . . . 1.075 ' HA ' ' HB3' ' A' 1186 ' ' SER . 25.8 mt -57.87 -23.68 54.13 Favored 'General case' 0 C--O 1.247 0.941 0 N-CA-C 113.4 0.889 . . . . 29.09 113.4 165.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 89.68 20.91 42.04 Favored Glycine 0 CA--C 1.534 1.247 0 N-CA-C 108.593 -1.803 . . . . 29.26 108.593 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1189 ' ' ALA . . . . . . . . . . . . . . . -82.29 149.64 27.69 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 118.385 -0.817 . . . . 30.16 109.461 174.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 74.8 mt -80.51 90.93 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 120.094 1.315 . . . . 35.81 108.32 -176.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1191 ' ' VAL . . . . . 0.43 HG11 HG23 ' B' 1181 ' ' ILE . 67.1 t -77.3 109.24 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 105.421 -2.066 . . . . 31.97 105.421 -172.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1192 ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' B' 1169 ' ' MET . 47.5 mtt180 -101.21 85.58 2.84 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-O 123.776 1.75 . . . . 48.16 106.911 172.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1193 ' ' ALA . . . . . 0.787 ' HB3' HG11 ' B' 1204 ' ' VAL . . . -93.62 152.91 18.69 Favored 'General case' 0 C--O 1.259 1.598 0 CA-C-N 112.223 -2.262 . . . . 35.89 112.227 -171.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 87.7 t80 -144.75 148.72 34.45 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 124.567 2.127 . . . . 41.88 105.592 -176.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1195 ' ' ASP . . . . . 0.479 ' HB2' ' H ' ' B' 1173 ' ' ALA . 22.4 t0 -159.77 154.04 23.65 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 101.513 -3.514 . . . . 38.28 101.513 163.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1196 ' ' THR . . . . . . . . . . . . . 1.1 m -73.53 -27.16 61.2 Favored 'General case' 0 C--O 1.247 0.942 0 C-N-CA 119.654 -0.818 . . . . 40.62 111.469 -176.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1197 ' ' ARG . . . . . . . . . . . . . 22.9 mtm105 -73.41 103.37 0.79 Allowed Pre-proline 0 CA--C 1.565 1.542 0 O-C-N 121.079 -1.013 . . . . 53.09 108.832 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -56.34 -26.2 60.93 Favored 'Trans proline' 0 C--N 1.347 0.481 1 C-N-CA 125.775 4.316 . . . . 42.56 119.25 -162.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.91 -12.74 19.53 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 119.726 -1.859 . . . . 56.31 113.828 -177.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1200 ' ' VAL . . . . . 0.537 ' HA ' ' HG3' ' B' 1203 ' ' GLN . 23.3 m -57.98 -20.88 15.79 Favored 'Isoleucine or valine' 0 C--O 1.25 1.106 0 O-C-N 119.873 -1.767 . . . . 42.91 112.298 172.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1201 ' ' LYS . . . . . 0.467 ' HA ' ' HB2' ' B' 1211 ' ' PHE . 46.2 tttm -50.55 -55.9 14.1 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 122.901 0.48 . . . . 48.89 111.712 166.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1202 ' ' GLU . . . . . 0.572 ' HA ' ' HB2' ' B' 1205 ' ' GLN . 18.2 mp0 -70.07 -34.0 72.62 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 120.727 -1.233 . . . . 51.7 110.488 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1203 ' ' GLN . . . . . 0.589 ' OE1' ' HA ' ' C' ' 74' ' ' ARG . 13.6 mm100 -50.47 -52.09 41.24 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 120.999 -1.063 . . . . 52.57 111.815 176.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1204 ' ' VAL . . . . . 0.787 HG11 ' HB3' ' B' 1193 ' ' ALA . 18.6 m -73.42 -36.95 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 O-C-N 121.247 -0.908 . . . . 33.79 112.16 175.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1205 ' ' GLN . . . . . 0.572 ' HB2' ' HA ' ' B' 1202 ' ' GLU . 39.3 mt-30 -53.6 -39.63 65.03 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 114.957 1.465 . . . . 36.58 114.957 174.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1206 ' ' SER . . . . . . . . . . . . . 84.4 p -60.62 -45.84 92.51 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.45 -1.406 . . . . 39.61 109.096 175.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1207 ' ' MET . . . . . 0.72 ' SD ' HG22 ' B' 1181 ' ' ILE . 5.0 mtp -68.6 -18.14 64.26 Favored 'General case' 0 N--CA 1.44 -0.959 0 O-C-N 119.519 -1.988 . . . . 37.45 113.632 177.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 77.62 56.6 3.82 Favored Glycine 0 N--CA 1.475 1.238 0 N-CA-C 108.686 -1.766 . . . . 31.87 108.686 -172.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1209 ' ' ALA . . . . . 0.595 ' HB3' ' HB ' ' B' 1204 ' ' VAL . . . -139.87 159.52 41.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.886 1.274 . . . . 35.4 111.131 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -90.46 136.21 33.2 Favored 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 120.559 -1.338 . . . . 47.89 110.038 -165.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1211 ' ' PHE . . . . . 0.467 ' HB2' ' HA ' ' B' 1201 ' ' LYS . 29.1 t80 -86.94 141.7 28.53 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.743 -1.206 . . . . 45.53 107.743 167.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1212 ' ' LEU . . . . . 0.873 ' HB3' HD21 ' B' 1241 ' ' LEU . 32.2 mt -81.85 102.92 11.15 Favored 'General case' 0 N--CA 1.433 -1.32 0 O-C-N 121.396 -0.815 . . . . 46.33 111.02 167.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -83.51 124.48 30.78 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 103.864 -2.643 . . . . 60.41 103.864 -176.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1214 ' ' LEU . . . . . 0.459 HD12 ' H ' ' B' 1214 ' ' LEU . 4.6 mp -68.32 164.52 20.59 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 114.075 -1.42 . . . . 57.38 110.108 -177.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 28.0 t70 . . . . . 0 N--CA 1.444 -0.752 0 CA-C-O 116.326 -1.797 . . . . 65.07 107.083 168.932 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B 1230 ' ' MET . . . . . 0.677 ' N ' ' HG ' ' B' 1231 ' ' SER . 3.7 mmt . . . . . 0 N--CA 1.435 -1.217 0 N-CA-C 101.725 -3.435 . . . . 80.32 101.725 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1231 ' ' SER . . . . . 0.677 ' HG ' ' N ' ' B' 1230 ' ' MET 0.275 19.4 m 112.66 155.47 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 3 CA-C-N 130.408 6.003 . . . . 79.92 115.221 -9.924 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 28.6 t70 -43.12 140.24 1.55 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 116.203 1.927 . . . . 77.91 116.203 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 67.46 -54.38 0.48 Allowed 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 115.846 1.795 . . . . 73.88 115.846 -166.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1234 ' ' PHE . . . . . 0.435 ' HE2' HD22 ' B' 1214 ' ' LEU . 1.5 t80 -61.23 -21.68 64.09 Favored 'General case' 0 C--O 1.254 1.293 0 CA-C-N 120.096 1.316 . . . . 68.98 112.92 176.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 1.9 pp -42.05 -38.71 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 O-C-N 120.795 -1.191 . . . . 64.53 113.361 159.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -69.29 -29.26 67.09 Favored 'General case' 0 CA--C 1.501 -0.919 0 O-C-N 120.124 -1.61 . . . . 66.36 112.89 174.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -62.4 -31.11 71.74 Favored 'General case' 0 N--CA 1.438 -1.061 0 O-C-N 117.575 -3.203 . . . . 56.6 111.333 171.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1238 ' ' GLU . . . . . 0.475 ' O ' ' HB3' ' B' 1241 ' ' LEU . 39.0 mt-10 -68.97 -61.41 1.81 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.86 0.864 . . . . 56.79 111.289 170.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1239 ' ' MET . . . . . . . . . . . . . 14.4 mtt -59.01 -44.79 91.75 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 114.842 1.423 . . . . 53.63 114.842 -177.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -68.53 -35.38 77.37 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 120.497 1.499 . . . . 51.74 112.828 -176.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1241 ' ' LEU . . . . . 0.873 HD21 ' HB3' ' B' 1212 ' ' LEU . 46.3 tp -54.27 -49.18 70.14 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.983 -1.008 . . . . 44.86 110.856 166.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 13.0 m-30 -62.68 -38.59 90.99 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 114.096 1.147 . . . . 42.78 114.096 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -59.3 -41.47 89.08 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 114.685 -1.143 . . . . 40.96 110.935 170.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -77.55 -8.66 58.15 Favored 'General case' 0 C--O 1.249 1.049 0 O-C-N 120.385 -1.447 . . . . 43.06 112.361 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1245 ' ' GLN . . . . . 0.433 ' OE1' ' HD3' ' B' 1192 ' ' ARG . 92.6 mm-40 -82.23 -26.4 33.28 Favored 'General case' 0 C--O 1.207 -1.14 0 N-CA-C 114.407 1.262 . . . . 46.45 114.407 164.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -54.69 -38.18 66.7 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 118.941 2.941 . . . . 41.78 118.941 -167.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 11.9 mptt -68.97 -30.22 68.61 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 115.011 1.485 . . . . 52.2 115.011 174.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1248 ' ' GLU . . . . . 0.474 ' CD ' HH12 ' B' 1192 ' ' ARG . 33.5 mt-10 -85.09 -39.91 17.4 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 115.055 1.502 . . . . 53.55 115.055 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1249 ' ' VAL . . . . . . . . . . . . 0.266 18.4 m -68.94 135.4 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 124.165 1.936 . . . . 34.41 115.575 -163.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1250 ' ' ASP . . . . . 0.525 ' HB3' ' CZ ' ' B' 1149 ' ' PHE . 2.7 m-20 -97.57 -48.91 5.07 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 111.969 -2.378 . . . . 33.38 110.387 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1251 ' ' ILE . . . . . 0.631 HD12 ' HB1' ' B' 1145 ' ' ALA . 30.1 mm -128.23 126.3 65.77 Favored 'Isoleucine or valine' 0 C--O 1.248 0.988 0 N-CA-C 103.434 -2.802 . . . . 29.54 103.434 177.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1252 ' ' ILE . . . . . . . . . . . . . 53.6 mt -90.49 97.91 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 107.013 -1.477 . . . . 32.44 107.013 159.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1253 ' ' VAL . . . . . 0.676 HG12 HG23 ' B' 1255 ' ' THR . 4.0 t -83.99 93.05 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 103.181 -2.896 . . . . 30.57 103.181 175.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1254 ' ' THR . . . . . 0.698 HG23 ' HA ' ' B' 1283 ' ' ASP 0.353 8.8 t -90.42 84.63 6.01 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 124.207 1.956 . . . . 35.04 107.158 -178.027 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B 1255 ' ' THR . . . . . 0.676 HG23 HG12 ' B' 1253 ' ' VAL . 2.7 p -69.73 -16.5 63.33 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 110.927 -2.851 . . . . 34.62 114.305 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1256 ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' B' 1285 ' ' ALA . . . -57.46 82.84 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 124.172 0.989 . . . . 42.72 112.773 176.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 3.4 tt -90.82 85.5 6.04 Favored 'General case' 0 CA--C 1.54 0.562 1 N-CA-C 99.175 -4.379 . . . . 52.43 99.175 173.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 2.6 mp -55.5 125.54 60.26 Favored Pre-proline 0 C--N 1.353 0.759 0 O-C-N 120.996 -1.065 . . . . 59.41 111.144 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -57.31 110.45 0.61 Allowed 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 125.119 3.879 . . . . 62.68 111.928 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 77.73 -79.01 1.45 Allowed Glycine 0 CA--C 1.55 2.238 0 O-C-N 119.846 -1.784 . . . . 64.16 113.229 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 37.2 mttm -46.44 125.79 7.68 Favored Pre-proline 0 C--O 1.239 0.549 0 CA-C-O 116.535 -1.698 . . . . 68.53 113.667 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -55.16 120.93 9.0 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 124.027 3.151 . . . . 61.99 111.068 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1263 ' ' ALA . . . . . . . . . . . . . . . -48.73 122.78 11.19 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 117.402 2.371 . . . . 57.15 117.402 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -58.26 141.67 96.91 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 124.477 3.451 . . . . 51.57 111.903 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1265 ' ' LYS . . . . . 0.459 ' HA ' ' HD3' ' B' 1265 ' ' LYS . 35.2 mmtm -75.89 82.37 2.8 Favored 'General case' 0 C--O 1.21 -1.026 0 O-C-N 121.13 -0.981 . . . . 54.55 110.977 -178.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 49.7 mt -74.96 -56.34 4.84 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.352 -1.295 . . . . 46.86 109.567 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1267 ' ' ILE . . . . . 0.581 HG22 HG22 ' B' 1272 ' ' VAL . 32.1 mm -84.43 89.35 2.56 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 N-CA-C 103.655 -2.72 . . . . 41.04 103.655 -175.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1268 ' ' THR . . . . . 0.497 ' HA ' ' HG3' ' B' 1293 ' ' GLU . 1.1 p -80.63 160.09 25.17 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 113.001 -1.909 . . . . 39.58 112.286 -176.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1269 ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -53.31 -54.87 30.11 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 117.467 2.395 . . . . 53.15 117.467 -168.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -55.46 -40.35 71.51 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 125.1 1.5 . . . . 42.96 113.892 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1271 ' ' MET . . . . . 0.406 ' HB3' ' O ' ' B' 1268 ' ' THR . 41.6 ttm -56.89 -58.27 8.87 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 117.673 -1.156 . . . . 43.89 108.394 168.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1272 ' ' VAL . . . . . 0.581 HG22 HG22 ' B' 1267 ' ' ILE . 24.6 t -52.7 -59.83 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.808 0 CA-C-N 120.001 1.273 . . . . 38.37 111.877 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1273 ' ' ASP . . . . . . . . . . . . 0.265 1.2 m-20 -68.28 14.31 0.07 Allowed 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 120.358 3.466 . . . . 47.46 120.358 176.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1274 ' ' SER . . . . . . . . . . . . . 54.7 p -124.36 -2.28 8.04 Favored 'General case' 0 C--O 1.247 0.93 0 O-C-N 119.956 -1.715 . . . . 38.38 110.432 170.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1275 ' ' MET . . . . . 0.653 ' HB2' HG21 ' B' 1307 ' ' VAL . 40.6 mtp -63.88 162.99 12.69 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 114.093 1.145 . . . . 37.81 114.093 177.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.06 134.67 52.76 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.182 -0.949 . . . . 49.26 112.721 175.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -64.84 141.43 58.78 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 123.311 1.529 . . . . 34.46 113.332 -173.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 70.38 24.23 76.88 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 114.922 -1.035 . . . . 33.53 112.165 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1279 ' ' SER . . . . . . . . . . . . . 59.0 m -95.7 153.72 17.59 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 122.91 0.484 . . . . 31.31 109.736 176.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1280 ' ' VAL . . . . . 0.659 HG11 ' HA ' ' B' 1145 ' ' ALA . 84.4 t -118.01 144.29 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 O-C-N 119.307 -2.12 . . . . 29.32 106.815 -170.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1281 ' ' ILE . . . . . 0.452 HD13 HG21 ' B' 1267 ' ' ILE . 75.8 mt -121.5 120.22 61.21 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 N-CA-C 101.054 -3.684 . . . . 31.93 101.054 170.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1282 ' ' VAL . . . . . 0.663 HG11 ' HA ' ' B' 1141 ' ' ALA . 12.3 t -108.22 113.58 44.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 105.983 -1.858 . . . . 29.48 105.983 175.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1283 ' ' ASP . . . . . 0.698 ' HA ' HG23 ' B' 1254 ' ' THR . 5.6 t0 -87.33 102.73 14.79 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-N 113.826 -1.534 . . . . 34.5 110.885 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1284 ' ' LEU . . . . . 0.62 HD22 ' HA ' ' B' 1255 ' ' THR . 8.5 mp -69.46 -23.72 63.7 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 113.977 1.103 . . . . 37.94 113.977 172.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1285 ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' B' 1256 ' ' ALA . . . -88.38 16.09 6.89 Favored 'General case' 0 C--N 1.364 1.216 0 O-C-N 121.548 -0.72 . . . . 40.92 111.454 176.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1286 ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' B' 1297 ' ' PRO . . . -45.42 -37.5 5.16 Favored 'General case' 0 C--O 1.214 -0.786 0 N-CA-C 115.986 1.847 . . . . 44.39 115.986 174.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1287 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.43 -24.54 39.53 Favored 'General case' 0 C--N 1.313 -1.014 0 O-C-N 119.527 -1.983 . . . . 51.46 112.047 176.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 1.5 t30 -114.06 64.7 0.66 Allowed 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 125.101 1.361 . . . . 57.75 109.13 -170.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1289 ' ' GLY . . . . . . . . . . . . . . . 92.34 -39.62 2.98 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-O 117.056 -1.969 . . . . 49.85 114.663 170.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 87.02 117.2 1.1 Allowed Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 120.531 2.166 . . . . 45.93 112.292 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1291 ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -77.25 -29.63 54.08 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 119.761 1.78 . . . . 42.67 111.03 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1292 ' ' CYS . . . . . 0.612 ' HB3' ' OG1' ' B' 1295 ' ' THR . 40.9 t -95.84 146.03 24.88 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 118.704 -2.497 . . . . 38.82 108.442 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1293 ' ' GLU . . . . . 0.497 ' HG3' ' HA ' ' B' 1268 ' ' THR . 25.0 mt-10 -69.74 -38.64 76.9 Favored 'General case' 0 CA--C 1.502 -0.882 0 O-C-N 119.927 -1.733 . . . . 46.71 114.564 172.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -74.33 -3.84 32.68 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.273 0.842 . . . . 47.23 113.273 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1295 ' ' THR . . . . . 0.62 HG23 ' HA3' ' B' 1311 ' ' GLY . 88.2 m -59.6 110.77 1.2 Allowed 'General case' 0 C--O 1.243 0.759 0 CA-C-N 120.077 1.308 . . . . 36.02 111.238 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 51.2 t -78.34 100.25 0.5 Allowed Pre-proline 0 N--CA 1.44 -0.933 0 CA-C-N 112.604 -2.089 . . . . 37.26 105.437 163.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1297 ' ' PRO . . . . . 0.412 ' HB3' ' O ' ' B' 1286 ' ' ALA . 37.2 Cg_exo -65.46 78.22 0.25 Allowed 'Trans proline' 0 N--CA 1.44 -1.672 0 C-N-CA 125.024 3.816 . . . . 35.09 112.464 -177.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 169.09 -43.52 0.22 Allowed Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 109.045 -1.622 . . . . 35.97 109.045 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -134.35 -179.27 5.47 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 115.406 1.632 . . . . 40.39 115.406 -165.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1300 ' ' ILE . . . . . 0.547 HG12 HG12 ' B' 1310 ' ' ILE . 21.2 mt -82.63 140.6 16.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 107.563 -1.273 . . . . 37.43 107.563 172.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 58.6 t80 -119.96 112.66 19.45 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 104.706 -2.331 . . . . 44.13 104.706 163.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1302 ' ' THR . . . . . . . . . . . . . 29.4 m -79.72 137.03 36.92 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 119.92 -1.737 . . . . 39.78 109.623 167.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1303 ' ' THR . . . . . . . . . . . . . 35.7 p -93.32 -179.72 5.15 Favored 'General case' 0 C--O 1.251 1.184 0 N-CA-C 114.54 1.311 . . . . 43.29 114.54 177.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -75.97 -27.34 57.45 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 120.323 -1.486 . . . . 53.07 109.692 -169.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -84.55 2.55 40.7 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 124.519 2.104 . . . . 43.97 110.008 173.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 78.63 38.99 22.83 Favored Glycine 0 CA--C 1.539 1.533 0 O-C-N 118.217 -2.802 . . . . 41.12 113.495 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1307 ' ' VAL . . . . . 0.653 HG21 ' HB2' ' B' 1275 ' ' MET . 18.0 t -100.72 127.4 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-O 122.252 1.025 . . . . 38.12 109.705 172.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1308 ' ' LYS . . . . . . . . . . . . . 98.1 mttt -97.59 99.86 11.26 Favored 'General case' 0 N--CA 1.437 -1.093 0 O-C-N 119.01 -2.306 . . . . 36.34 109.782 -171.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1309 ' ' VAL . . . . . 0.419 HG22 HD12 ' B' 1281 ' ' ILE . 23.9 t -82.53 99.67 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 106.941 -1.503 . . . . 30.4 106.941 175.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1310 ' ' ILE . . . . . 0.547 HG12 HG12 ' B' 1300 ' ' ILE . 72.4 mt -82.82 107.64 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 N-CA-C 106.425 -1.695 . . . . 30.82 106.425 175.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1311 ' ' GLY . . . . . 0.62 ' HA3' HG23 ' B' 1295 ' ' THR . . . -116.0 61.52 0.39 Allowed Glycine 0 C--N 1.354 1.535 0 C-N-CA 118.567 -1.778 . . . . 26.53 111.6 176.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1312 ' ' TYR . . . . . 0.586 ' HB2' ' HG ' ' B' 1315 ' ' LEU . 14.9 m-85 -81.52 123.3 28.52 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 118.526 1.163 . . . . 38.0 108.984 -176.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1313 ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.1 -48.87 70.25 Favored 'General case' 0 C--O 1.256 1.428 0 CA-C-O 123.839 1.78 . . . . 29.8 108.56 167.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -72.41 16.66 0.13 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 116.453 2.02 . . . . 39.04 116.453 -176.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1315 ' ' LEU . . . . . 0.586 ' HG ' ' HB2' ' B' 1312 ' ' TYR . 25.4 mt -53.72 -43.63 96.48 Favored Pre-proline 0 C--O 1.224 -0.272 0 O-C-N 119.549 -1.969 . . . . 31.08 113.995 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1316 ' ' PRO . . . . . 0.45 ' HG3' ' HB2' ' B' 1137 ' ' ALA . 66.8 Cg_exo -63.97 -50.97 2.53 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.909 3.073 . . . . 26.1 112.475 168.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -50.76 -35.39 30.85 Favored Glycine 0 C--N 1.343 0.962 0 C-N-CA 125.867 1.698 . . . . 23.17 115.015 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 53.3 mtt180 -66.52 -7.22 18.39 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 117.492 2.404 . . . . 40.4 117.492 177.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1319 ' ' LEU . . . . . 0.698 HD21 ' HD2' ' B' 1139 ' ' TYR . 38.4 tp -127.48 117.64 21.39 Favored Pre-proline 0 C--N 1.347 0.488 0 O-C-N 119.395 -2.065 . . . . 23.6 110.24 -173.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1320 ' ' PRO . . . . . 0.614 ' HG2' ' HA2' ' A' 1150 ' ' GLY . 87.3 Cg_endo -73.62 -95.48 0.01 OUTLIER 'Trans proline' 0 N--CA 1.481 0.774 0 N-CA-C 121.428 3.588 . . . . 22.35 121.428 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1321 ' ' THR . . . . . 0.489 ' HB ' ' HG3' ' A' 1151 ' ' ARG . 0.2 OUTLIER -55.49 -31.25 61.86 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 116.125 1.898 . . . . 26.52 116.125 -162.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B 1322 ' ' GLN . . . . . . . . . . . . . 35.8 tp60 -52.86 -51.3 61.54 Favored 'General case' 0 C--O 1.248 1.018 0 CA-C-N 113.13 -1.85 . . . . 24.38 109.67 173.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1323 ' ' SER . . . . . . . . . . . . . 8.1 m -62.77 -48.35 79.56 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 118.121 -0.942 . . . . 22.8 112.578 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1324 ' ' SER . . . . . . . . . . . . . 3.0 m -49.49 -35.7 20.67 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 123.797 1.761 . . . . 21.25 115.263 174.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 45.8 tp60 -78.15 -60.82 2.21 Favored 'General case' 0 CA--C 1.505 -0.788 0 O-C-N 119.587 -1.946 . . . . 31.34 110.571 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1326 ' ' LEU . . . . . 0.683 ' HA ' ' HA3' ' A' 1161 ' ' GLY . 12.5 mt -62.7 -59.07 5.41 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 117.182 -1.39 . . . . 31.56 110.372 -174.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1327 ' ' TYR . . . . . . . . . . . . . 57.9 t80 -63.06 -40.32 97.35 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 119.033 0.833 . . . . 22.73 109.798 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1328 ' ' GLY . . . . . 0.463 ' HA2' HD12 ' B' 1331 ' ' LEU . . . -42.8 -49.01 6.14 Favored Glycine 0 C--N 1.308 -1.006 0 O-C-N 124.716 1.26 . . . . 21.91 115.122 165.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1329 ' ' THR . . . . . . . . . . . . . 8.7 m -72.56 -35.28 67.95 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 117.669 0.734 . . . . 22.15 109.631 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1330 ' ' ASN . . . . . . . . . . . . . 9.5 m120 -55.1 -46.07 75.5 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 123.765 0.666 . . . . 26.18 110.362 172.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1331 ' ' LEU . . . . . 0.552 HD13 HD13 ' B' 1070 ' ' LEU . 14.6 mt -66.54 -41.22 89.04 Favored 'General case' 0 C--O 1.253 1.246 0 O-C-N 119.729 -1.857 . . . . 23.68 110.339 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1332 ' ' VAL . . . . . 0.584 HG22 ' HG ' ' B' 1026 ' ' LEU . 69.7 t -55.09 -48.77 75.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 O-C-N 123.493 0.495 . . . . 26.57 109.807 174.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -62.09 -35.18 77.91 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 124.327 1.051 . . . . 28.08 112.13 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1334 ' ' LEU . . . . . 0.739 ' HA ' ' HG ' ' B' 1127 ' ' LEU . 32.3 tp -64.85 -58.9 4.96 Favored 'General case' 0 CA--C 1.492 -1.256 0 C-N-CA 124.446 1.099 . . . . 27.43 109.818 178.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1335 ' ' LEU . . . . . 0.469 HD21 HD21 ' B' 1070 ' ' LEU . 3.8 mm? -60.11 -39.46 86.26 Favored 'General case' 0 C--O 1.242 0.694 0 O-C-N 124.708 1.255 . . . . 30.5 112.977 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1336 ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' B' 1332 ' ' VAL . 31.9 ttmt -54.64 -44.98 73.68 Favored 'General case' 0 CA--C 1.495 -1.17 0 C-N-CA 124.483 1.113 . . . . 41.65 113.16 171.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 13.5 tp -85.75 -25.39 26.45 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.26 -0.9 . . . . 42.08 113.267 -174.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1338 ' ' LEU . . . . . 0.555 ' O ' ' HB ' ' B' 1347 ' ' THR . 7.3 mt -73.08 -67.97 0.53 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.45 -1.315 . . . . 35.03 107.45 170.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 43.8 t -85.43 73.23 10.55 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 107.187 -1.412 . . . . 37.33 107.187 -174.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 61.7 mttp -68.18 -22.28 64.83 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 119.471 -2.018 . . . . 50.51 111.743 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -78.11 -10.51 59.66 Favored 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 120.271 -1.518 . . . . 54.21 113.021 174.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 91.3 mttt 52.31 41.99 30.74 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-O 125.793 2.711 . . . . 50.99 111.787 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -105.73 -43.98 4.77 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 126.196 1.798 . . . . 48.82 109.548 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 132.69 -9.29 5.24 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 109.069 -1.612 . . . . 40.43 109.069 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -82.49 120.8 25.95 Favored 'General case' 0 C--O 1.242 0.665 0 O-C-N 119.256 -2.32 . . . . 47.56 109.453 175.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1346 ' ' ILE . . . . . . . . . . . . . 31.4 mm -68.11 90.5 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-N 114.171 -1.377 . . . . 42.49 110.413 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1347 ' ' THR . . . . . 0.555 ' HB ' ' O ' ' B' 1338 ' ' LEU . 92.5 m -74.47 90.88 2.22 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 123.869 1.795 . . . . 38.12 109.555 -177.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 39.4 t -84.17 90.53 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 106.697 -1.594 . . . . 37.5 106.697 171.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 10.5 t70 -77.7 147.21 35.56 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 109.067 -3.697 . . . . 43.85 108.409 175.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1350 ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -109.5 -16.83 13.9 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 118.599 -1.24 . . . . 39.81 113.689 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -91.35 -16.23 27.77 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 114.094 1.146 . . . . 51.29 114.094 -175.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 54.6 t0 -83.92 116.32 22.73 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 105.027 -2.212 . . . . 39.78 105.027 158.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 11.1 m -55.5 -25.33 17.51 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 C-N-CA 125.186 1.394 . . . . 39.28 109.822 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1354 ' ' VAL . . . . . 0.621 HG21 ' HG3' ' B' 1123 ' ' ARG . 73.9 t -64.48 -50.75 74.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 117.68 -1.152 . . . . 35.7 110.907 175.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1355 ' ' ILE . . . . . 0.52 HD12 HD23 ' B' 1338 ' ' LEU . 23.1 mm -70.95 -42.39 77.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 119.634 -0.826 . . . . 35.77 110.563 -177.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 48.5 tpt85 -52.37 -36.91 54.99 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 112.849 -1.978 . . . . 38.55 113.059 169.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -80.8 -51.05 4.97 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 121.88 2.127 . . . . 29.58 112.525 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1358 ' ' VAL . . . . . 0.521 HG23 HG22 ' B' 1118 ' ' VAL . 10.6 p -63.27 -35.68 73.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 118.917 1.358 . . . . 32.06 112.132 -171.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1359 ' ' THR . . . . . . . . . . . . . 14.0 m -84.21 88.22 7.21 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 103.268 -2.864 . . . . 29.0 103.268 -178.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1360 ' ' VAL . . . . . 0.455 HG12 ' HD1' ' B' 1368 ' ' TRP . 35.7 m -70.83 -25.42 26.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 114.816 -1.083 . . . . 29.68 112.428 -176.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 75.7 mt -139.79 136.92 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 103.121 -2.918 . . . . 32.05 103.121 175.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1362 ' ' ARG . . . . . 0.485 ' HA ' HG23 ' B' 1111 ' ' THR . 64.5 ttt180 -120.66 108.82 14.47 Favored 'General case' 0 C--O 1.254 1.318 0 N-CA-C 105.392 -2.077 . . . . 32.52 105.392 171.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 35.87 77.36 0.04 OUTLIER 'General case' 0 C--O 1.241 0.617 0 N-CA-C 116.335 1.976 . . . . 35.68 116.335 -170.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1364 ' ' GLY . . . . . 0.409 ' CA ' ' HA ' ' B' 1109 ' ' ASN . . . 80.65 -43.74 2.83 Favored Glycine 0 C--N 1.308 -1.013 0 CA-C-N 114.005 -1.452 . . . . 34.26 115.005 176.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -68.01 116.05 8.21 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 119.609 1.704 . . . . 51.07 112.04 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 83.5 mt -68.91 110.55 2.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 121.166 -0.959 . . . . 39.87 109.299 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1367 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.55 -20.14 25.44 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 115.474 1.657 . . . . 38.01 115.474 168.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1368 ' ' TRP . . . . . 0.455 ' HD1' HG12 ' B' 1360 ' ' VAL . 15.2 t90 -57.71 146.07 67.65 Favored Pre-proline 0 C--O 1.244 0.774 0 C-N-CA 123.281 0.632 . . . . 42.14 110.767 176.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1369 ' ' PRO . . . . . 0.417 ' HA ' ' CD1' ' B' 1368 ' ' TRP . 25.1 Cg_endo -78.1 -172.21 10.94 Favored 'Cis proline' 0 C--N 1.369 1.644 0 CA-C-N 121.362 1.522 . . . . 43.26 115.046 -5.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1370 ' ' ALA . . . . . . . . . . . . . . . -78.8 162.01 66.77 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 114.624 -1.171 . . . . 46.52 108.72 166.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -59.59 153.01 58.15 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 123.918 3.078 . . . . 51.95 108.995 162.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -57.53 113.61 1.58 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 1 C-N-CA 126.662 4.908 . . . . 56.27 115.056 -177.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1373 ' ' ILE . . . . . . . . . . . . . 50.7 mm -92.49 120.28 41.5 Favored 'Isoleucine or valine' 0 C--O 1.255 1.377 0 O-C-N 120.715 -1.24 . . . . 60.83 110.927 -174.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -92.46 127.88 38.11 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.961 -1.126 . . . . 66.1 107.961 174.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1375 ' ' VAL . . . . . 0.718 HG21 ' HB2' ' B' 1120 ' ' ARG . 19.9 t -124.72 118.57 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 113.401 -1.727 . . . . 63.47 107.693 -170.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.223 -4.906 0 O-C-N 117.774 -3.079 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.582 0 CA-C-O 118.926 -0.559 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -23.76 67.37 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 121.18 1.809 . . . . 0.0 113.323 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 32.7 mp0 -53.91 -50.68 65.84 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 123.107 1.432 . . . . 0.0 110.734 165.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 3.3 m -65.0 -38.21 90.19 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 113.579 -1.646 . . . . 0.0 109.362 -171.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.95 76.13 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-O 124.193 1.949 . . . . 0.0 114.682 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -70.25 -52.22 24.71 Favored 'General case' 0 C--O 1.249 1.076 0 CA-C-N 114.044 -1.434 . . . . 0.0 112.343 172.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.511 ' HB3' ' OG1' ' C' ' 108' ' ' THR . 74.8 mt -62.58 -43.08 99.7 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-O 116.965 -1.493 . . . . 0.0 113.368 -175.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.521 HD11 HD12 ' C' ' 182' ' ' ILE . 43.7 mt -52.39 -51.32 59.61 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -177.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 28' ' ' LYS . . . . . . . . . . . . . 13.3 pttm -65.93 -26.49 67.62 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -72.32 -35.67 68.68 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.304 1.041 . . . . 0.0 110.178 170.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 58.2 m -54.28 -43.99 71.5 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 120.941 3.682 . . . . 0.0 120.941 -167.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 31' ' ' HIS . . . . . . . . . . . . 0.27 56.3 p-80 43.58 -18.22 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 123.418 2.827 . . . . 0.0 117.288 -160.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 32' ' ' SER . . . . . 0.535 ' HB2' ' HA ' ' C' ' 106' ' ' THR . 19.3 m -136.17 127.32 28.04 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.652 -3.78 . . . . 0.0 104.936 169.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' C' ' 64' ' ' VAL . 77.3 t -137.03 126.88 38.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 104.104 -2.554 . . . . 0.0 104.104 -174.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.489 HD12 HD11 ' C' ' 99' ' ' ILE . 21.8 mm -109.26 132.91 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 172.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . 0.699 HG12 ' HB2' ' C' ' 110' ' ' LEU . 55.5 mt -98.64 117.06 43.06 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 170.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 89.8 m -113.47 99.78 50.29 Favored Pre-proline 0 N--CA 1.44 -0.971 0 CA-C-O 122.597 1.189 . . . . 0.0 110.779 175.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -81.84 147.26 15.12 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 124.573 3.516 . . . . 0.0 114.973 178.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -159.95 120.29 0.95 Allowed Glycine 0 N--CA 1.415 -2.718 0 N-CA-C 108.014 -2.035 . . . . 0.0 108.014 166.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 39' ' ' TYR . . . . . 0.542 ' HB2' ' HA3' ' C' ' 73' ' ' GLY . 4.3 t80 61.45 -67.35 0.06 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.212 1.405 . . . . 0.0 113.839 -175.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -47.85 -43.3 23.12 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-N 121.394 1.906 . . . . 0.0 116.117 -170.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 41' ' ' MET . . . . . 0.822 ' HA ' ' HB3' ' C' ' 46' ' ' ALA . 5.6 ttm -47.24 -46.98 24.79 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 123.097 1.427 . . . . 0.0 113.49 178.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.16 -56.27 4.34 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.68 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 p -62.81 -30.46 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 N-CA-C 117.392 2.367 . . . . 0.0 117.392 -168.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.18 18.75 17.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.366 -0.833 . . . . 0.0 108.857 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 45' ' ' GLN . . . . . . . . . . . . 0.255 0.1 OUTLIER 35.31 46.73 0.27 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 124.95 2.31 . . . . 0.0 112.899 -158.347 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.822 ' HB3' ' HA ' ' C' ' 41' ' ' MET . . . -69.81 -20.16 63.46 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 114.203 -1.362 . . . . 0.0 113.523 -175.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 47' ' ' GLN . . . . . 0.526 ' HB2' ' HB2' ' C' ' 86' ' ' ALA . 0.0 OUTLIER -57.95 -39.13 77.34 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 176.577 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 48' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -59.2 -41.2 86.45 Favored Pre-proline 0 CA--C 1.553 1.07 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 49' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -67.32 -39.76 12.3 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 123.267 2.645 . . . . 0.0 111.671 164.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . 0.452 ' HA ' HG22 ' C' ' 53' ' ' ILE . 64.2 t -58.93 -33.67 50.48 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 O-C-N 121.57 -0.706 . . . . 0.0 110.304 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.35 -54.07 50.97 Favored 'General case' 0 C--O 1.243 0.739 0 O-C-N 120.308 -1.495 . . . . 0.0 107.386 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 52' ' ' GLU . . . . . 0.728 ' HB3' ' HB2' ' C' ' 183' ' ' LEU . 2.5 mm-40 -54.94 -37.64 66.7 Favored 'General case' 0 C--O 1.249 1.037 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -178.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 53' ' ' ILE . . . . . 0.452 HG22 ' HA ' ' C' ' 50' ' ' VAL . 9.0 tp -78.05 -44.47 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 O-C-N 121.466 -0.771 . . . . 0.0 111.493 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 88.3 m -59.87 -34.67 73.45 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -58.98 -52.95 63.57 Favored 'General case' 0 C--O 1.266 1.944 0 C-N-CA 124.658 1.183 . . . . 0.0 107.936 -175.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -74.85 -32.96 62.05 Favored 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 120.753 -1.217 . . . . 0.0 112.597 -177.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 93.6 mt -60.87 -42.08 97.21 Favored 'General case' 0 C--O 1.211 -0.93 0 O-C-N 120.659 -1.275 . . . . 0.0 110.566 174.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . 0.485 ' HD3' HG12 ' C' ' 64' ' ' VAL . 12.9 tpt180 -78.01 -27.78 49.01 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 119.743 -1.848 . . . . 0.0 110.934 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.05 -34.27 77.69 Favored 'General case' 0 C--N 1.349 0.548 0 O-C-N 121.587 -0.696 . . . . 0.0 109.89 173.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 9.2 ttm-85 -79.61 3.34 19.27 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 118.877 0.762 . . . . 0.0 111.182 174.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.44 36.92 78.46 Favored Glycine 0 C--O 1.251 1.185 0 O-C-N 120.395 -1.441 . . . . 0.0 111.067 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 7.0 mt -85.31 140.15 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -68.3 75.87 0.25 Allowed 'General case' 0 C--O 1.239 0.53 0 O-C-N 121.149 -0.969 . . . . 0.0 109.069 166.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 8.1 p -97.06 118.72 44.03 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 175.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 31.7 mmm-85 -126.2 144.35 50.8 Favored 'General case' 0 C--N 1.312 -1.036 0 O-C-N 124.842 1.339 . . . . 0.0 109.004 -173.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . 0.533 ' HB3' HD13 ' C' ' 68' ' ' ILE . 5.5 m-85 -100.08 98.11 8.87 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 123.666 1.698 . . . . 0.0 112.618 -176.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.88 83.11 1.63 Allowed Glycine 0 C--N 1.34 0.786 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 68' ' ' ILE . . . . . 0.533 HD13 ' HB3' ' C' ' 66' ' ' PHE 0.273 1.7 mp -77.89 112.89 16.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 122.006 0.908 . . . . 0.0 110.989 178.742 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -86.13 86.54 0.09 OUTLIER Pre-proline 0 N--CA 1.449 -0.477 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 165.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 70' ' ' PRO . . . . . 0.413 ' HG2' ' H ' ' C' ' 71' ' ' VAL . 94.6 Cg_endo -48.25 -52.87 7.61 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 125.211 3.94 . . . . 0.0 118.055 -165.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 71' ' ' VAL . . . . . 0.688 HG22 ' HB3' ' C' ' 76' ' ' PRO . 21.8 t -80.6 92.07 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 N-CA-C 102.13 -3.285 . . . . 0.0 102.13 178.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -153.68 104.84 2.74 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 123.224 1.487 . . . . 0.0 113.387 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 73' ' ' GLY . . . . . 0.542 ' HA3' ' HB2' ' C' ' 39' ' ' TYR . . . 86.94 -98.32 2.35 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 111.723 -2.489 . . . . 0.0 108.149 177.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 74' ' ' ARG . . . . . 0.589 ' HA ' ' OE1' ' B' 1203 ' ' GLN . 0.8 OUTLIER -128.15 111.89 13.96 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 125.184 1.167 . . . . 0.0 112.549 -170.47 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.634 ' HB2' ' HB2' ' C' ' 78' ' ' HIS . 6.7 mp 71.62 134.04 0.04 OUTLIER Pre-proline 0 C--O 1.254 1.322 0 O-C-N 125.766 1.916 . . . . 0.0 112.481 -170.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 76' ' ' PRO . . . . . 0.688 ' HB3' HG22 ' C' ' 71' ' ' VAL . 56.6 Cg_endo -66.35 124.64 12.78 Favored 'Trans proline' 0 N--CA 1.432 -2.091 0 C-N-CA 121.951 1.767 . . . . 0.0 107.708 167.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 78.26 3.94 86.12 Favored Glycine 0 CA--C 1.54 1.626 0 CA-C-N 114.053 -1.431 . . . . 0.0 114.051 169.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 78' ' ' HIS . . . . . 0.634 ' HB2' ' HB2' ' C' ' 75' ' ' LEU . 21.3 t-160 -54.49 -31.46 55.93 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 79' ' ' MET . . . . . 0.619 ' HB2' ' SD ' ' C' ' 41' ' ' MET . 0.0 OUTLIER -62.18 -44.15 97.24 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 172.384 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -65.81 -36.49 83.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 122.413 1.102 . . . . 0.0 109.638 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 51.1 t -61.08 -43.65 96.67 Favored 'Isoleucine or valine' 0 C--N 1.357 0.903 0 CA-C-O 116.815 -1.564 . . . . 0.0 108.594 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 10.9 mp -82.61 -16.97 46.39 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 120.658 1.572 . . . . 0.0 112.104 174.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 15.0 tp -63.42 -32.15 73.51 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 117.492 -3.255 . . . . 0.0 110.576 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.75 -33.73 64.57 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 169.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -67.27 -45.21 77.31 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 120.274 -1.516 . . . . 0.0 113.598 166.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . 0.526 ' HB2' ' HB2' ' C' ' 47' ' ' GLN . . . -65.52 -11.22 41.66 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 176.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt 64.78 22.8 12.61 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 169.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 88' ' ' VAL . . . . . 0.435 ' HA ' ' HD2' ' C' ' 89' ' ' PRO . 74.9 t -84.55 121.75 74.93 Favored Pre-proline 0 C--O 1.249 1.034 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 173.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 89' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' C' ' 88' ' ' VAL . 37.1 Cg_endo -50.39 124.81 13.84 Favored 'Trans proline' 0 N--CA 1.442 -1.541 1 C-N-CA 126.392 4.728 . . . . 0.0 114.339 177.28 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -63.18 -16.34 59.82 Favored 'General case' 0 C--N 1.363 1.168 0 O-C-N 120.144 -1.598 . . . . 0.0 115.052 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -61.75 -40.04 93.74 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 123.345 0.658 . . . . 0.0 111.485 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 22.5 pt -75.44 -8.29 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 O-C-N 118.023 -2.923 . . . . 0.0 117.387 173.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 93' ' ' VAL . . . . . 0.519 HG13 HD13 ' C' ' 68' ' ' ILE . 16.8 t -88.06 121.47 38.5 Favored 'Isoleucine or valine' 0 C--O 1.248 1.02 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 -177.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 94' ' ' LEU . . . . . 0.553 ' HB3' ' HB3' ' C' ' 97' ' ' ASP . 6.2 mp -104.27 97.26 7.23 Favored 'General case' 0 C--O 1.25 1.107 0 CA-C-N 113.335 -1.757 . . . . 0.0 108.564 168.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 95' ' ' GLU . . . . . 0.462 ' HB3' HG12 ' A' 1157 ' ' ILE . 53.7 mp0 -81.84 93.45 6.87 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 4.0 tpp 56.55 29.57 15.74 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.451 1.9 . . . . 0.0 112.271 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 97' ' ' ASP . . . . . 0.553 ' HB3' ' HB3' ' C' ' 94' ' ' LEU . 18.7 t70 -92.11 172.7 8.25 Favored 'General case' 0 C--O 1.251 1.163 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 173.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -67.7 87.67 0.23 Allowed 'General case' 0 C--N 1.347 0.491 0 CA-C-O 123.724 1.726 . . . . 0.0 113.464 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 99' ' ' ILE . . . . . 0.489 HD11 HD12 ' C' ' 34' ' ' ILE . 6.5 tp -101.29 7.31 9.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-N 110.712 -2.949 . . . . 0.0 110.543 174.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -58.94 -49.11 79.08 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 119.765 -1.834 . . . . 0.0 112.168 -171.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -79.42 -29.54 41.95 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.839 0.828 . . . . 0.0 110.833 -174.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 102' ' ' ASP . . . . . 0.414 ' HB3' HD11 ' C' ' 34' ' ' ILE . 0.8 OUTLIER -63.73 -32.12 73.51 Favored 'General case' 0 N--CA 1.433 -1.319 0 O-C-N 121.051 -1.031 . . . . 0.0 112.826 169.213 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 103' ' ' PHE . . . . . 0.468 ' CE2' HG23 ' C' ' 99' ' ' ILE . 35.1 m-85 -63.22 -48.54 77.86 Favored 'General case' 0 N--CA 1.426 -1.657 0 O-C-N 119.606 -1.934 . . . . 0.0 111.617 169.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.15 -27.67 69.11 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 124.319 1.012 . . . . 0.0 112.959 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -72.16 -40.57 67.89 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.799 1.285 . . . . 0.0 112.179 174.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 106' ' ' THR . . . . . 0.535 ' HA ' ' HB2' ' C' ' 32' ' ' SER . 3.1 m -60.6 143.58 53.6 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 112.901 -1.954 . . . . 0.0 114.856 -174.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 107' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -92.56 -62.87 1.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 112.337 -2.21 . . . . 0.0 107.948 175.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . 0.511 ' OG1' ' HB3' ' C' ' 26' ' ' LEU . 97.0 m -108.44 126.19 52.61 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-O 123.789 1.757 . . . . 0.0 111.134 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 109' ' ' VAL . . . . . 0.594 HG11 HG21 ' C' ' 138' ' ' VAL . 3.2 t -108.96 119.93 59.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.985 0 CA-C-N 113.191 -1.822 . . . . 0.0 106.73 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 110' ' ' LEU . . . . . 0.699 ' HB2' HG12 ' C' ' 35' ' ' ILE . 34.7 mt -91.14 91.54 8.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 123.745 1.736 . . . . 0.0 110.019 177.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 111' ' ' VAL . . . . . 0.806 ' HB ' ' HA ' ' C' ' 146' ' ' VAL . 12.0 t -90.87 99.87 10.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 -175.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 26.4 mm -78.86 97.9 2.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 CA-C-N 112.314 -2.221 . . . . 0.0 110.394 -171.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.04 -100.76 1.16 Allowed Glycine 0 C--N 1.334 0.467 0 N-CA-C 107.233 -2.347 . . . . 0.0 107.233 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 114' ' ' ALA . . . . . 0.544 ' HB3' HG12 ' C' ' 111' ' ' VAL . . . 57.41 -56.55 0.03 OUTLIER 'General case' 0 C--O 1.25 1.113 1 N-CA-C 126.336 5.68 . . . . 0.0 126.336 162.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 115' ' ' ASN . . . . . 0.406 ' HB2' ' CE1' ' C' ' 163' ' ' PHE 0.344 2.7 p-10 24.48 -80.44 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 120.391 3.478 . . . . 0.0 120.391 -169.392 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 116' ' ' ASP . . . . . 0.514 ' HA ' ' HB2' ' C' ' 119' ' ' ASN . 69.7 m-20 -64.35 -18.38 64.6 Favored 'General case' 0 C--O 1.241 0.648 0 O-C-N 118.067 -2.896 . . . . 0.0 114.36 -177.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 117' ' ' THR . . . . . 0.509 ' HB ' ' HB1' ' C' ' 114' ' ' ALA . 30.8 m -45.66 -35.96 4.52 Favored 'General case' 0 C--O 1.248 0.993 0 C-N-CA 125.627 1.571 . . . . 0.0 111.792 169.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.481 ' HA ' ' HB ' ' C' ' 135' ' ' VAL . 4.3 m -127.44 20.45 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 O-C-N 120.28 -1.512 . . . . 0.0 113.184 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 119' ' ' ASN . . . . . 0.514 ' HB2' ' HA ' ' C' ' 116' ' ' ASP . 61.0 t-20 -73.12 108.36 4.47 Favored Pre-proline 0 C--N 1.32 -0.688 0 O-C-N 119.656 -1.902 . . . . 0.0 111.025 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 120' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -56.3 -27.19 65.65 Favored 'Trans proline' 0 N--CA 1.441 -1.601 0 C-N-CA 125.041 3.827 . . . . 0.0 115.868 -172.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -55.88 -39.16 71.15 Favored 'General case' 0 C--O 1.204 -1.324 0 O-C-N 125.719 1.887 . . . . 0.0 111.874 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 122' ' ' ALA . . . . . 0.51 ' HB1' ' HB3' ' C' ' 133' ' ' MET . . . -57.35 -21.86 38.5 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 117.998 2.592 . . . . 0.0 117.998 177.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -102.45 -43.92 5.51 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 117.859 -1.536 . . . . 0.0 112.591 169.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 124' ' ' ASP . . . . . 0.405 ' O ' ' HD3' ' C' ' 126' ' ' PRO . 38.7 t70 -78.37 -30.13 47.78 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 122.98 1.372 . . . . 0.0 111.66 -171.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -107.94 101.7 42.18 Favored Pre-proline 0 N--CA 1.429 -1.477 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 -169.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 126' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' C' ' 124' ' ' ASP . 27.5 Cg_exo -55.13 -39.06 92.92 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 124.009 3.139 . . . . 0.0 114.26 171.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -53.4 -21.09 5.35 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 128' ' ' SER . . . . . 0.509 ' HA ' ' HD2' ' C' ' 129' ' ' PRO . 22.3 m -48.1 134.49 11.95 Favored Pre-proline 0 N--CA 1.434 -1.227 0 O-C-N 120.685 -1.26 . . . . 0.0 113.822 172.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 129' ' ' PRO . . . . . 0.565 ' HG2' ' HA ' ' C' ' 156' ' ' ALA . 36.5 Cg_endo -55.39 -38.0 94.26 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 124.912 3.742 . . . . 0.0 117.777 172.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 130' ' ' ILE . . . . . 0.954 HG12 ' HB2' ' C' ' 156' ' ' ALA 0.291 39.3 pt -77.19 104.64 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.367 168.198 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 131' ' ' ALA . . . . . 0.722 ' HB1' HG22 ' B' 1121 ' ' ILE . . . -63.7 115.02 4.37 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 113.125 -1.852 . . . . 0.0 111.363 -168.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 29.56 69.18 0.08 OUTLIER Glycine 0 N--CA 1.473 1.108 0 CA-C-O 116.525 -2.264 . . . . 0.0 114.192 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 133' ' ' MET . . . . . 0.68 ' HA ' ' HB2' ' B' 1122 ' ' SER . 5.9 tpp -96.2 126.22 45.0 Favored Pre-proline 0 N--CA 1.434 -1.247 0 CA-C-N 119.638 1.719 . . . . 0.0 113.344 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 134' ' ' PRO . . . . . 0.516 ' HD2' ' SD ' ' C' ' 133' ' ' MET . 72.8 Cg_endo -66.54 81.05 0.32 Allowed 'Trans proline' 0 C--O 1.262 1.707 1 C-N-CA 125.696 4.264 . . . . 0.0 107.247 168.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 135' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' C' ' 118' ' ' VAL . 6.3 m -69.38 137.0 25.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.363 171.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 7.8 tp -78.53 83.42 4.73 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.301 -1.318 . . . . 0.0 113.564 -166.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . 0.28 34.2 mm-40 42.04 -26.44 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.329 1 N-CA-C 128.213 6.375 . . . . 0.0 128.213 160.092 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' C' C ' 138' ' ' VAL . . . . . 0.594 HG21 HG11 ' C' ' 109' ' ' VAL . 4.4 p -73.96 14.78 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.491 0 O-C-N 117.144 -3.472 . . . . 0.0 117.152 -160.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 5.3 p90 -69.19 142.67 54.22 Favored 'General case' 0 C--O 1.244 0.772 0 O-C-N 119.45 -2.031 . . . . 0.0 109.006 176.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.77 24.46 0.34 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 127.055 2.142 . . . . 0.0 116.588 -166.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -101.12 70.47 1.34 Allowed 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 123.154 1.454 . . . . 0.0 110.112 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 142' ' ' GLN . . . . . 0.43 ' HB3' ' H ' ' C' ' 143' ' ' ASN . 0.2 OUTLIER 64.75 -135.66 0.26 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 112.271 -2.241 . . . . 0.0 114.487 171.771 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 143' ' ' ASN . . . . . 0.439 ' HB2' ' HA ' ' C' ' 108' ' ' THR . 53.8 m-20 -85.57 84.87 7.48 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 118.986 -1.086 . . . . 0.0 109.102 -168.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 144' ' ' VAL . . . . . 0.481 ' HA ' ' HB ' ' C' ' 109' ' ' VAL . 58.2 t -88.51 88.25 2.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 102.617 -3.105 . . . . 0.0 102.617 -173.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 145' ' ' ILE . . . . . 0.46 HD12 HG23 ' C' ' 108' ' ' THR . 97.4 mt -88.92 97.79 7.31 Favored 'Isoleucine or valine' 0 C--O 1.251 1.171 0 CA-C-O 123.308 1.528 . . . . 0.0 107.802 -173.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 146' ' ' VAL . . . . . 0.806 ' HA ' ' HB ' ' C' ' 111' ' ' VAL . 48.7 t -85.44 104.22 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 113.298 -1.774 . . . . 0.0 106.967 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 147' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -67.55 91.64 0.29 Allowed 'General case' 0 C--O 1.242 0.661 0 O-C-N 120.625 -1.297 . . . . 0.0 109.646 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 148' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' C' ' 172' ' ' PHE . 15.7 mmmt -118.62 110.45 17.34 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.171 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -64.35 -36.0 82.7 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.046 1.338 . . . . 0.0 109.683 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 150' ' ' SER . . . . . 0.424 ' O ' ' HE3' ' C' ' 148' ' ' LYS . 10.7 m -139.5 137.41 35.48 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 151' ' ' MET . . . . . 0.466 ' SD ' ' HE1' ' C' ' 170' ' ' MET . 5.2 tpt -77.35 98.31 5.19 Favored 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 118.791 -2.443 . . . . 0.0 109.007 170.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 152' ' ' ASN . . . . . 0.416 ' OD1' ' NZ ' ' C' ' 148' ' ' LYS . 38.5 p30 -140.68 152.17 45.15 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 110.837 -2.892 . . . . 0.0 108.952 177.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 153' ' ' THR . . . . . 0.646 HG23 ' HA3' ' C' ' 157' ' ' GLY . 98.6 m -65.17 120.39 12.62 Favored 'General case' 0 C--N 1.358 0.977 0 O-C-N 125.073 1.483 . . . . 0.0 107.797 176.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -78.58 -115.76 0.21 Allowed Glycine 0 N--CA 1.424 -2.118 0 CA-C-N 112.358 -2.201 . . . . 0.0 108.272 167.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 155' ' ' TYR . . . . . 0.57 ' HB3' HG21 ' C' ' 130' ' ' ILE . 0.6 OUTLIER -79.7 -53.65 6.61 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 179.157 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 156' ' ' ALA . . . . . 0.954 ' HB2' HG12 ' C' ' 130' ' ' ILE . . . -92.57 -60.32 1.86 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.362 0.983 . . . . 0.0 108.37 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 157' ' ' GLY . . . . . 0.646 ' HA3' HG23 ' C' ' 153' ' ' THR . . . 57.46 44.5 93.66 Favored Glycine 0 CA--C 1.492 -1.368 0 CA-C-N 113.544 -1.662 . . . . 0.0 112.257 -176.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 158' ' ' VAL . . . . . 0.472 HG22 ' HB1' ' C' ' 156' ' ' ALA . 28.4 m -123.37 157.56 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-O 122.309 1.052 . . . . 0.0 112.503 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -30.59 123.67 0.19 Allowed 'General case' 0 C--O 1.242 0.679 1 N-CA-C 122.008 4.077 . . . . 0.0 122.008 178.491 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 160' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -168.22 163.59 8.66 Favored Pre-proline 0 C--O 1.268 2.052 0 C-N-CA 126.088 1.755 . . . . 0.0 109.99 -176.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.74 -36.23 1.66 Allowed 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 124.106 3.204 . . . . 0.0 115.212 169.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 162' ' ' LEU . . . . . . . . . . . . . 8.1 tt -58.07 -35.66 71.7 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -166.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 163' ' ' PHE . . . . . 0.406 ' CE1' ' HB2' ' C' ' 115' ' ' ASN . 12.9 m-30 -70.39 -29.0 65.52 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 118.298 -2.751 . . . . 0.0 113.361 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -102.94 -17.9 15.27 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.169 -1.378 . . . . 0.0 114.206 -162.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 165' ' ' LYS . . . . . 0.448 ' HB2' ' HB ' ' C' ' 168' ' ' THR . 20.5 mmmt -73.64 -177.26 2.65 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.698 1.237 . . . . 0.0 111.986 -170.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -88.63 -63.17 1.34 Allowed 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 120.361 -1.462 . . . . 0.0 109.616 -164.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -86.94 -26.15 24.01 Favored 'General case' 0 C--O 1.243 0.753 0 O-C-N 120.329 -1.482 . . . . 0.0 112.442 170.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 168' ' ' THR . . . . . 0.448 ' HB ' ' HB2' ' C' ' 165' ' ' LYS . 96.3 m -88.81 91.11 8.69 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 124.45 2.072 . . . . 0.0 105.467 165.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -146.89 137.79 23.91 Favored 'General case' 0 N--CA 1.432 -1.34 0 O-C-N 118.682 -2.511 . . . . 0.0 111.585 -160.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 170' ' ' MET . . . . . 0.649 ' HA ' ' HB ' ' C' ' 146' ' ' VAL . 54.3 mtm -69.97 107.58 3.66 Favored 'General case' 0 N--CA 1.418 -2.044 0 O-C-N 121.507 -0.746 . . . . 0.0 110.077 162.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 171' ' ' LEU . . . . . 0.401 ' HB2' HG23 ' C' ' 145' ' ' ILE . 7.5 mp -79.22 130.56 35.6 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 172.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 172' ' ' PHE . . . . . 0.543 ' HA ' ' O ' ' C' ' 148' ' ' LYS . 68.9 m-85 -82.5 85.73 6.89 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 125.675 1.86 . . . . 0.0 110.853 -167.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -162.68 150.14 18.86 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 124.561 1.077 . . . . 0.0 111.388 -173.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 174' ' ' ASP . . . . . 0.638 ' HB3' ' HB3' ' C' ' 177' ' ' ALA . 9.7 t70 -68.07 149.42 49.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.607 -0.796 . . . . 0.0 112.01 176.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.82 -51.67 45.96 Favored 'General case' 0 C--O 1.241 0.653 0 O-C-N 121.329 -0.857 . . . . 0.0 108.879 -175.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.66 -54.5 19.08 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 116.39 -1.767 . . . . 0.0 106.277 178.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 177' ' ' ALA . . . . . 0.638 ' HB3' ' HB3' ' C' ' 174' ' ' ASP . . . -53.47 -55.99 20.69 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 -174.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 6.4 m -60.71 -37.52 81.98 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 121.622 -0.674 . . . . 0.0 110.869 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 179' ' ' VAL . . . . . 0.522 ' HA ' HG12 ' C' ' 182' ' ' ILE . 50.9 t -67.56 -36.99 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 120.617 -1.302 . . . . 0.0 110.366 175.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -59.39 -39.17 82.5 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 125.934 1.694 . . . . 0.0 109.661 174.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.34 -52.98 62.41 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 120.926 0.393 . . . . 0.0 110.075 173.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 182' ' ' ILE . . . . . 0.522 HG12 ' HA ' ' C' ' 179' ' ' VAL . 20.8 pt -75.53 -19.77 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 O-C-N 119.592 -1.943 . . . . 0.0 114.106 -175.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 183' ' ' LEU . . . . . 0.728 ' HB2' ' HB3' ' C' ' 52' ' ' GLU . 4.2 pp -58.57 -44.85 89.87 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 122.106 2.23 . . . . 0.0 115.271 -167.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 184' ' ' LYS . . . . . 0.483 ' N ' HD12 ' C' ' 183' ' ' LEU . 13.5 tttp -96.12 -14.4 22.87 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.575 168.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 185' ' ' ALA . . . . . 0.447 ' HB3' ' HA ' ' C' ' 182' ' ' ILE . . . -80.19 -74.47 0.31 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 119.251 -0.98 . . . . 0.0 111.607 -176.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 186' ' ' LEU . . . . . . . . . . . . 0.301 1.9 pt? . . . . . 0 C--N 1.363 1.158 0 N-CA-C 117.582 2.438 . . . . 0.0 117.582 -171.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1000 ' ' HIS . . . . . 0.426 ' O ' ' HB2' ' A' 1067 ' ' GLU . 26.4 t-80 . . . . . 0 CA--C 1.512 -0.505 0 N-CA-C 102.757 -3.053 . . . . 65.74 102.757 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1001 ' ' GLY . . . . . 0.41 ' HA2' ' HB2' ' A' 1067 ' ' GLU . . . -69.17 78.13 0.3 Allowed Glycine 0 CA--C 1.533 1.176 0 CA-C-O 122.337 0.965 . . . . 48.66 112.565 -167.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1002 ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' 1032 ' ' THR . 21.1 ttp180 -125.55 141.06 52.24 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 103.323 -2.843 . . . . 44.56 103.323 177.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1003 ' ' ILE . . . . . 0.496 HG12 ' HB ' ' A' 1068 ' ' ILE . 96.0 mt -105.88 127.07 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 O-C-N 117.995 -2.941 . . . . 34.86 104.787 169.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -92.89 136.71 13.3 Favored Glycine 0 N--CA 1.434 -1.487 0 CA-C-N 115.463 -0.79 . . . . 30.75 111.419 170.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.729 HG23 ' HB3' ' A' 1017 ' ' ALA . 37.5 mm -109.87 99.31 38.05 Favored Pre-proline 0 C--O 1.248 0.99 0 N-CA-C 103.75 -2.685 . . . . 32.21 103.75 173.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -80.57 144.68 15.95 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 124.536 3.491 . . . . 32.98 112.636 174.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1007 ' ' ARG . . . . . . . . . . . . . 10.0 ttp85 -75.42 155.11 36.68 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 113.25 -1.795 . . . . 47.98 107.878 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1008 ' ' GLU . . . . . 0.486 ' CD ' ' HZ3' ' A' 1071 ' ' LYS . 4.7 mm-40 -83.9 146.23 28.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 118.409 2.744 . . . . 34.7 118.409 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -83.45 -30.28 27.37 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 111.704 -2.498 . . . . 53.37 110.792 166.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1010 ' ' LEU . . . . . 0.441 HD22 ' ND2' ' A' 1073 ' ' ASN . 2.5 mp -49.32 135.64 16.96 Favored 'General case' 0 C--O 1.251 1.175 0 C-N-CA 125.024 1.33 . . . . 45.07 113.389 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1011 ' ' THR . . . . . . . . . . . . . 2.3 m -68.95 147.17 52.03 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 123.289 1.518 . . . . 40.36 107.205 -177.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 10.7 t30 65.06 -17.01 0.09 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 112.795 -2.002 . . . . 40.61 114.354 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -69.53 112.92 6.37 Favored 'General case' 0 C--O 1.243 0.713 0 O-C-N 119.398 -2.064 . . . . 33.76 111.049 -165.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1014 ' ' THR . . . . . 0.57 ' HB ' ' HB3' ' A' 1320 ' ' PRO . 0.0 OUTLIER -96.36 -13.19 23.43 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 112.727 0.64 . . . . 27.89 112.727 173.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1015 ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.02 136.88 39.96 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 118.988 -2.32 . . . . 29.02 106.555 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1016 ' ' VAL . . . . . 0.568 HG12 ' HB2' ' A' 1043 ' ' ALA . 4.2 p -109.72 -178.51 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.101 0 N-CA-C 106.42 -1.696 . . . . 28.13 106.42 168.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1017 ' ' ALA . . . . . 0.729 ' HB3' HG23 ' A' 1005 ' ' ILE . . . -68.99 -53.65 19.45 Favored 'General case' 0 C--N 1.309 -1.18 0 O-C-N 120.538 -1.351 . . . . 26.87 111.817 -176.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -136.03 140.76 44.1 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.675 0.75 . . . . 26.77 112.404 -173.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1019 ' ' THR . . . . . 0.477 HG23 ' HB2' ' A' 1324 ' ' SER . 3.4 p -79.6 166.66 39.69 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 124.311 1.044 . . . . 27.02 111.494 172.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1020 ' ' PRO . . . . . 0.472 ' O ' ' HB2' ' A' 1024 ' ' GLU . 0.2 OUTLIER -51.07 -38.94 60.81 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.614 2.876 . . . . 30.57 114.585 171.262 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 52.2 mttp -56.1 -48.89 75.29 Favored 'General case' 0 C--O 1.219 -0.541 0 O-C-N 123.965 0.791 . . . . 47.81 111.802 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1022 ' ' THR . . . . . . . . . . . . . 1.9 p -74.44 -40.08 62.16 Favored 'General case' 0 C--N 1.348 0.505 0 C-N-CA 119.354 -0.938 . . . . 30.77 111.11 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1023 ' ' VAL . . . . . 0.567 ' HA ' HD12 ' A' 1026 ' ' LEU . 3.3 t -51.65 -42.46 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 113.091 0.775 . . . . 33.59 113.091 170.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1024 ' ' GLU . . . . . 0.583 ' HA ' HD12 ' A' 1027 ' ' LEU . 23.2 tt0 -59.4 -43.77 92.94 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 124.278 1.031 . . . . 53.29 109.545 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -69.06 -40.38 78.56 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 125.294 1.438 . . . . 46.92 110.014 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1026 ' ' LEU . . . . . 0.567 HD12 ' HA ' ' A' 1023 ' ' VAL . 91.0 mt -54.51 -46.49 73.51 Favored 'General case' 0 C--O 1.248 0.974 0 C-N-CA 124.036 0.934 . . . . 37.17 112.364 171.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1027 ' ' LEU . . . . . 0.583 HD12 ' HA ' ' A' 1024 ' ' GLU . 14.3 mt -57.85 -43.0 85.6 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-O 118.177 -0.916 . . . . 44.44 111.922 170.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 55.7 mmtt -60.38 -20.29 58.98 Favored 'General case' 0 C--O 1.257 1.493 0 C-N-CA 124.296 1.039 . . . . 52.58 113.714 174.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1029 ' ' LEU . . . . . 0.502 HD23 ' HE3' ' A' 1342 ' ' LYS . 32.3 mt -78.35 24.31 0.27 Allowed 'General case' 0 N--CA 1.472 0.67 0 O-C-N 119.617 -1.927 . . . . 45.69 114.791 164.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 68.94 13.75 66.99 Favored Glycine 0 C--N 1.343 0.933 0 O-C-N 119.899 -1.75 . . . . 42.09 113.546 -176.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -93.29 159.44 15.27 Favored 'General case' 0 C--O 1.251 1.176 0 CA-C-N 121.91 2.855 . . . . 40.72 110.928 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1032 ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' 1002 ' ' ARG . 0.6 OUTLIER -87.95 155.2 19.96 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 103.707 -2.701 . . . . 37.77 103.707 158.562 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1033 ' ' VAL . . . . . . . . . . . . . 87.2 t -135.51 131.3 51.11 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 O-C-N 120.037 -1.665 . . . . 33.54 108.511 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -116.07 143.59 45.26 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 119.217 0.917 . . . . 31.68 109.46 171.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1035 ' ' VAL . . . . . 0.503 HG21 ' CD1' ' A' 1050 ' ' PHE . 80.0 t -128.77 137.0 58.46 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.52 0 O-C-N 119.452 -2.03 . . . . 31.52 108.273 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1036 ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -73.3 119.43 17.52 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 119.542 -1.974 . . . . 41.04 108.419 174.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1037 ' ' SER . . . . . 0.538 ' HB2' HG23 ' A' 1057 ' ' ILE . 19.7 t -63.49 144.18 57.2 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.853 0.835 . . . . 31.83 110.072 -171.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 110.27 -31.61 7.29 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 107.378 -2.289 . . . . 29.36 107.378 -169.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -52.44 -34.03 46.77 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.456 1.28 . . . . 27.78 114.456 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -60.6 -48.85 84.14 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 120.306 1.412 . . . . 28.91 112.25 172.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1041 ' ' GLN . . . . . 0.649 HE22 ' HB2' ' A' 1047 ' ' ASP . 1.7 mp0 -65.05 -31.72 73.09 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 114.507 -0.847 . . . . 51.18 112.518 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1042 ' ' LEU . . . . . . . . . . . . . 8.9 mp -67.91 -66.9 0.51 Allowed 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.587 0.708 . . . . 29.91 109.407 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1043 ' ' ALA . . . . . 0.568 ' HB2' HG12 ' A' 1016 ' ' VAL . . . -66.36 -5.54 11.11 Favored 'General case' 0 N--CA 1.439 -1.0 0 O-C-N 121.239 -0.913 . . . . 28.54 111.496 -171.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1044 ' ' SER . . . . . 0.446 ' HB3' ' HA2' ' B' 1278 ' ' GLY . 16.6 m 62.45 72.59 0.49 Allowed 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 126.967 3.27 . . . . 33.06 110.077 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1045 ' ' PHE . . . . . . . . . . . . . 1.9 t80 -157.57 155.03 29.49 Favored 'General case' 0 N--CA 1.423 -1.784 1 CA-C-N 108.063 -4.153 . . . . 30.29 101.896 -172.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 10.7 t0 -68.18 123.83 21.77 Favored 'General case' 0 N--CA 1.439 -0.999 0 O-C-N 120.394 -1.441 . . . . 48.62 109.688 171.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1047 ' ' ASP . . . . . 0.649 ' HB2' HE22 ' A' 1041 ' ' GLN . 0.4 OUTLIER -60.65 -49.34 77.93 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 122.811 1.291 . . . . 36.74 111.69 176.306 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.01 -13.71 62.35 Favored 'General case' 0 N--CA 1.434 -1.273 0 O-C-N 119.031 -2.293 . . . . 43.73 112.081 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -65.19 -15.63 62.65 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 116.957 -1.497 . . . . 32.81 113.904 168.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1050 ' ' PHE . . . . . 0.503 ' CD1' HG21 ' A' 1035 ' ' VAL . 62.9 m-85 -65.82 -47.0 76.51 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 106.464 -1.68 . . . . 31.86 106.464 167.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 76.6 t -60.71 -38.55 78.99 Favored 'Isoleucine or valine' 0 C--O 1.254 1.318 0 CA-C-O 118.266 -0.873 . . . . 33.22 111.242 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -52.91 -50.58 63.66 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 119.398 0.999 . . . . 50.83 113.009 171.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -61.37 -33.89 74.39 Favored 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 124.339 1.056 . . . . 33.12 112.213 173.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 114.24 15.96 8.05 Favored Glycine 0 C--O 1.257 1.552 0 O-C-N 120.436 -1.415 . . . . 35.83 111.326 175.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1055 ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' A' 1050 ' ' PHE . . . -84.42 140.15 31.73 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 107.374 -1.343 . . . . 34.82 107.374 177.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -70.09 121.3 17.21 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 117.534 -1.222 . . . . 49.05 111.101 172.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1057 ' ' ILE . . . . . 0.538 HG23 ' HB2' ' A' 1037 ' ' SER . 3.6 mm -90.11 103.16 13.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 104.9 -2.259 . . . . 38.53 104.9 177.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1058 ' ' VAL . . . . . 0.474 ' HB ' ' HB2' ' A' 1062 ' ' SER . 34.6 m -110.98 172.15 2.78 Favored 'Isoleucine or valine' 0 C--O 1.252 1.236 0 CA-C-N 113.309 -1.769 . . . . 42.11 108.432 -170.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -119.35 131.99 55.79 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 106.666 -1.605 . . . . 58.0 106.666 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1060 ' ' GLY . . . . . 0.542 ' O ' HG12 ' A' 1063 ' ' VAL . . . 54.86 -129.14 44.7 Favored Glycine 0 CA--C 1.526 0.736 0 O-C-N 125.375 1.672 . . . . 52.12 112.918 169.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 1.4 t30 -57.0 -26.43 60.22 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 112.807 -1.697 . . . . 54.75 112.643 -168.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1062 ' ' SER . . . . . 0.474 ' HB2' ' HB ' ' A' 1058 ' ' VAL . 3.0 m -55.83 -37.31 68.53 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-O 122.56 1.172 . . . . 50.34 111.863 -179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1063 ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' 1060 ' ' GLY . 9.3 p -62.26 -33.43 58.83 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.186 0 O-C-N 119.19 -2.194 . . . . 41.46 116.183 176.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1064 ' ' TRP . . . . . 0.435 ' HA ' HD11 ' A' 1069 ' ' ILE . 93.2 m95 -74.0 -15.86 61.08 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 113.551 0.945 . . . . 39.32 113.551 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -82.63 83.02 7.77 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.408 1.099 . . . . 55.38 108.427 170.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1066 ' ' SER . . . . . . . . . . . . . 66.1 m -153.65 173.9 15.19 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 113.769 -1.56 . . . . 41.87 110.549 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1067 ' ' GLU . . . . . 0.731 ' HB3' HD12 ' A' 1068 ' ' ILE . 0.3 OUTLIER -77.74 -57.16 3.96 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 106.976 -1.49 . . . . 53.2 106.976 173.341 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1068 ' ' ILE . . . . . 0.731 HD12 ' HB3' ' A' 1067 ' ' GLU . 5.4 mp -109.68 149.22 12.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 105.45 -2.056 . . . . 41.9 105.45 -176.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1069 ' ' ILE . . . . . 0.435 HD11 ' HA ' ' A' 1064 ' ' TRP . 20.6 mm -128.78 120.16 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 N-CA-C 104.39 -2.448 . . . . 38.73 104.39 172.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1070 ' ' LEU . . . . . 0.591 HD22 HD22 ' A' 1331 ' ' LEU . 33.9 mt -97.69 97.93 9.44 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 104.908 -2.256 . . . . 32.44 104.908 175.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1071 ' ' LYS . . . . . 0.486 ' HZ3' ' CD ' ' A' 1008 ' ' GLU . 7.5 tmtt? -90.36 141.51 28.66 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 125.608 2.623 . . . . 34.65 109.074 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1072 ' ' VAL . . . . . 0.434 ' HA ' ' HE2' ' A' 1327 ' ' TYR . 15.1 t -62.86 -46.34 96.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 111.531 -2.577 . . . . 31.32 109.888 -168.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1073 ' ' ASN . . . . . 0.489 ' HA ' ' HB2' ' A' 1092 ' ' PHE . 63.3 m-80 -127.42 -160.11 0.98 Allowed 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.082 -1.081 . . . . 33.94 108.082 172.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -67.96 147.56 98.46 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 121.869 2.122 . . . . 38.04 111.481 173.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1075 ' ' PRO . . . . . 0.605 ' HG2' HD21 ' A' 1089 ' ' LEU . 22.9 Cg_exo -63.38 132.46 36.02 Favored 'Trans proline' 0 C--O 1.266 1.89 0 C-N-CA 123.332 2.688 . . . . 42.68 111.065 163.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 11.8 mt -90.81 175.98 6.8 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 105.51 -2.033 . . . . 46.74 105.51 170.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.71 -31.82 49.56 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.655 1.724 . . . . 58.61 115.655 -171.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 13.1 t70 -65.9 -52.06 53.35 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.037 -0.727 . . . . 59.2 109.037 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1079 ' ' GLU . . . . . 0.578 ' HA ' HD12 ' A' 1082 ' ' LEU . 1.9 mp0 -62.92 -31.03 72.02 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 114.294 1.22 . . . . 50.63 114.294 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1080 ' ' ILE . . . . . 0.447 HD13 ' HB2' ' A' 1104 ' ' LYS . 57.5 mt -61.97 -44.88 99.52 Favored 'Isoleucine or valine' 0 C--N 1.346 0.418 0 CA-C-N 115.948 -0.569 . . . . 51.48 111.109 170.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -59.49 -33.23 71.07 Favored 'General case' 0 C--O 1.25 1.112 0 CA-C-O 122.755 1.264 . . . . 50.28 113.646 170.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1082 ' ' LEU . . . . . 0.578 HD12 ' HA ' ' A' 1079 ' ' GLU . 66.2 mt -72.33 -26.77 62.06 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.228 -1.351 . . . . 50.21 112.49 173.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1083 ' ' LEU . . . . . 0.627 HD12 HG11 ' A' 1110 ' ' VAL . 3.6 mm? -60.81 149.73 34.97 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 125.73 2.681 . . . . 49.06 113.574 172.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -113.3 136.84 21.86 Favored Pre-proline 0 N--CA 1.437 -1.106 0 CA-C-N 111.361 -2.654 . . . . 51.08 107.097 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -60.2 124.59 15.53 Favored 'Trans proline' 0 N--CA 1.435 -1.914 0 C-N-CA 121.4 1.4 . . . . 49.73 115.014 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 91.7 8.43 63.77 Favored Glycine 0 C--O 1.259 1.709 0 N-CA-C 111.158 -0.777 . . . . 47.71 111.158 -177.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1087 ' ' THR . . . . . 0.406 HG21 HG12 ' A' 1069 ' ' ILE . 72.7 m -84.66 145.64 27.87 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 123.208 1.48 . . . . 45.47 110.652 167.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1088 ' ' THR . . . . . . . . . . . . . 52.3 m -91.98 121.53 33.65 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 118.19 -2.819 . . . . 42.04 104.295 173.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1089 ' ' LEU . . . . . 0.605 HD21 ' HG2' ' A' 1075 ' ' PRO . 55.6 tp -106.84 116.66 32.3 Favored 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 123.961 0.904 . . . . 38.06 109.029 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 38.5 t -114.62 124.49 71.32 Favored 'Isoleucine or valine' 0 C--O 1.25 1.081 0 N-CA-C 105.184 -2.154 . . . . 37.4 105.184 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1091 ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' 1073 ' ' ASN . 3.5 m -158.46 168.56 26.62 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 122.424 1.107 . . . . 36.16 113.049 -174.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1092 ' ' PHE . . . . . 0.489 ' HB2' ' HA ' ' A' 1073 ' ' ASN . 14.9 m-85 -82.23 94.85 7.38 Favored 'General case' 0 C--O 1.25 1.087 0 O-C-N 119.579 -1.951 . . . . 38.94 108.486 165.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 26.6 mm -84.76 -34.63 9.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 113.864 1.061 . . . . 42.17 113.864 -172.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 84.0 m95 57.99 60.06 6.29 Favored Pre-proline 0 C--N 1.357 0.921 0 C-N-CA 123.086 0.554 . . . . 46.51 111.56 -169.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -62.78 -34.22 73.59 Favored 'Trans proline' 0 C--O 1.241 0.646 0 C-N-CA 124.185 3.257 . . . . 49.76 117.013 -165.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -69.2 -35.99 76.82 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 124.643 1.215 . . . . 52.62 108.784 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -76.78 -30.28 56.42 Favored 'General case' 0 C--O 1.216 -0.669 0 CA-C-N 115.151 -0.931 . . . . 60.74 109.34 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1098 ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -109.84 36.03 0.11 Allowed Pre-proline 0 CA--C 1.557 1.215 1 N-CA-C 124.96 5.17 . . . . 58.19 124.96 -169.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -52.09 -24.08 18.96 Favored 'Trans proline' 0 C--N 1.366 1.493 0 C-N-CA 124.655 3.57 . . . . 54.59 113.961 175.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -57.84 -59.53 5.09 Favored 'General case' 0 C--O 1.253 1.287 0 CA-C-O 124.396 2.046 . . . . 63.28 110.019 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1101 ' ' LEU . . . . . . . . . . . . . 5.4 mp -70.55 -42.07 71.66 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 111.526 -2.579 . . . . 54.75 107.587 -175.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1102 ' ' MET . . . . . . . . . . . . . 72.0 mtm -56.74 -39.22 73.56 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 114.757 1.391 . . . . 52.65 114.757 174.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -62.78 -38.33 90.2 Favored 'General case' 0 C--N 1.35 0.608 0 O-C-N 119.968 -1.707 . . . . 66.26 110.329 -178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1104 ' ' LYS . . . . . 0.447 ' HB2' HD13 ' A' 1080 ' ' ILE . 87.7 mttt -74.18 -36.76 64.07 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 114.262 -1.335 . . . . 63.73 110.49 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 22.6 mt -63.64 -35.1 79.41 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 120.652 -1.28 . . . . 54.68 112.699 169.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -65.97 -41.45 91.17 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 106.907 -1.516 . . . . 53.64 106.907 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -51.46 -46.01 62.91 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 113.94 1.089 . . . . 67.24 113.94 168.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -67.18 1.12 2.24 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 115.848 1.796 . . . . 65.76 115.848 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 10.0 t30 49.81 44.55 25.03 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 125.088 2.375 . . . . 58.71 113.925 177.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1110 ' ' VAL . . . . . 0.627 HG11 HD12 ' A' 1083 ' ' LEU . 3.7 m -110.75 152.6 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 113.944 -1.48 . . . . 46.63 109.421 -178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1111 ' ' THR . . . . . . . . . . . . . 89.4 m -89.14 99.85 12.75 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 106.881 -1.526 . . . . 44.13 106.881 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1112 ' ' VAL . . . . . 0.57 ' HB ' ' HB ' ' A' 1361 ' ' ILE . 91.6 t -91.56 128.01 43.55 Favored 'Isoleucine or valine' 0 C--O 1.253 1.25 0 CA-C-O 123.829 1.776 . . . . 40.44 110.366 -176.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1113 ' ' MET . . . . . 0.648 ' SD ' HD21 ' A' 1334 ' ' LEU . 35.2 mtp -119.27 123.18 43.63 Favored 'General case' 0 C--O 1.255 1.367 0 N-CA-C 105.79 -1.93 . . . . 50.76 105.79 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1114 ' ' ALA . . . . . . . . . . . . . . . -99.42 96.62 7.82 Favored 'General case' 0 N--CA 1.428 -1.575 0 O-C-N 124.106 0.879 . . . . 35.64 111.896 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1115 ' ' MET . . . . . 0.563 ' HB3' ' HB3' ' A' 1129 ' ' ALA . 36.0 mmm -65.33 -17.77 64.78 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 116.765 2.135 . . . . 38.74 116.765 -173.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1116 ' ' ASP . . . . . 0.462 ' HA ' ' HB2' ' A' 1130 ' ' LEU . 7.5 p-10 -73.67 -36.52 65.35 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 118.179 -0.915 . . . . 40.14 108.561 168.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1117 ' ' SER . . . . . . . . . . . . . 63.6 m -102.37 62.3 0.86 Allowed 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 125.05 2.357 . . . . 44.79 109.801 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1118 ' ' VAL . . . . . . . . . . . . . 87.4 t -90.94 134.31 30.5 Favored Pre-proline 0 C--O 1.243 0.739 0 N-CA-C 106.55 -1.648 . . . . 43.75 106.55 174.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -46.13 120.9 3.96 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.732 3.622 . . . . 48.93 111.299 171.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -63.3 -4.56 2.66 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 117.502 2.408 . . . . 62.9 117.502 -169.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 45.1 pt -66.77 158.14 5.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 115.172 1.545 . . . . 57.72 115.172 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1122 ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.66 -49.19 68.48 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 125.499 1.75 . . . . 57.26 114.242 -173.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 21.4 ptt85 -63.21 -13.34 36.43 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 118.36 -2.712 . . . . 62.9 115.286 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -89.65 -21.37 22.81 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 120.394 -1.441 . . . . 49.83 108.573 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -61.27 -20.51 62.96 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 115.532 1.679 . . . . 52.37 115.532 -163.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1126 ' ' SER . . . . . . . . . . . . . 6.0 p -68.52 -39.0 81.36 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.184 0.902 . . . . 42.43 112.341 168.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1127 ' ' LEU . . . . . 0.438 ' O ' ' HB3' ' A' 1330 ' ' ASN . 5.1 mp -82.56 -23.68 34.36 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.277 -0.874 . . . . 43.74 110.977 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 10.1 t0 -68.04 105.03 1.91 Allowed 'General case' 0 C--O 1.246 0.908 0 CA-C-O 124.658 2.17 . . . . 43.21 112.361 -167.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1129 ' ' ALA . . . . . 0.563 ' HB3' ' HB3' ' A' 1115 ' ' MET . . . -72.37 -41.22 66.63 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 111.159 -2.746 . . . . 35.74 111.502 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1130 ' ' LEU . . . . . 0.462 ' HB2' ' HA ' ' A' 1116 ' ' ASP . 9.0 tp -54.94 -40.94 70.47 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 118.889 0.768 . . . . 38.09 112.009 175.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1131 ' ' SER . . . . . 0.651 ' HA ' HG21 ' A' 1175 ' ' VAL . 68.1 m -54.8 -53.01 60.82 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-N 119.979 1.263 . . . . 36.91 112.732 176.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1132 ' ' SER . . . . . . . . . . . . . 4.6 m -65.2 -37.49 87.48 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 119.312 0.96 . . . . 35.79 113.303 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1133 ' ' MET . . . . . 0.478 ' HE2' HD12 ' A' 1136 ' ' ILE . 24.8 mmt -59.46 -45.46 91.56 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 121.893 2.133 . . . . 30.81 115.69 171.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1134 ' ' ALA . . . . . 0.439 ' HB1' ' HB2' ' A' 1176 ' ' ALA . . . -69.29 -39.75 78.13 Favored 'General case' 0 CA--C 1.504 -0.803 0 O-C-N 124.275 0.984 . . . . 28.88 109.936 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1135 ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -53.27 -47.76 68.86 Favored 'General case' 0 C--O 1.245 0.86 0 O-C-N 123.972 0.795 . . . . 40.76 112.518 169.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1136 ' ' ILE . . . . . 0.744 HG23 HD23 ' A' 1319 ' ' LEU . 71.4 mt -59.95 -44.71 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 107.951 -1.129 . . . . 31.54 107.951 177.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -60.06 -44.01 95.02 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-O 117.251 -1.357 . . . . 29.87 111.109 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -62.3 -46.79 93.17 Favored Glycine 0 N--CA 1.439 -1.155 0 CA-C-N 123.074 2.67 . . . . 28.73 112.478 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 36.5 t80 -59.87 -48.97 79.52 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 122.353 1.073 . . . . 30.39 109.226 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1140 ' ' ARG . . . . . 0.66 HH11 HD13 ' A' 1319 ' ' LEU . 3.7 tpt180 -65.58 -24.46 67.08 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 112.895 0.702 . . . . 26.09 112.895 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1141 ' ' ALA . . . . . 0.839 ' HB2' HD21 ' A' 1284 ' ' LEU . . . -65.73 -44.83 84.82 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 109.655 -0.498 . . . . 27.1 109.655 173.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1142 ' ' ILE . . . . . 0.461 HG13 ' HB3' ' A' 1183 ' ' ALA . 42.2 mm -57.36 -38.67 63.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 123.984 0.914 . . . . 28.48 109.664 175.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 97.7 t -68.05 -59.89 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-O 121.242 0.544 . . . . 23.07 111.804 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1144 ' ' GLU . . . . . 0.421 ' CD ' HH21 ' A' 1140 ' ' ARG . 4.4 mm-40 -61.05 -28.56 69.16 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 120.637 -1.289 . . . . 33.4 111.642 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1145 ' ' ALA . . . . . 0.525 ' HB1' HD12 ' A' 1251 ' ' ILE . . . -65.73 -60.71 2.62 Favored 'General case' 0 C--O 1.206 -1.209 0 CA-C-O 115.256 -2.307 . . . . 24.22 107.227 171.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -55.17 -18.62 6.11 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 121.922 2.146 . . . . 24.89 115.881 176.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -68.21 -56.36 8.97 Favored 'General case' 0 N--CA 1.439 -1.011 0 O-C-N 120.438 -1.413 . . . . 26.73 111.267 169.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1148 ' ' GLU . . . . . 0.666 ' HB2' HD11 ' A' 1310 ' ' ILE . 54.3 mm-40 -90.35 -12.67 36.96 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 118.025 2.602 . . . . 39.96 118.025 -174.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1149 ' ' PHE . . . . . . . . . . . . . 2.9 t80 -67.92 152.24 45.86 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 124.086 1.898 . . . . 25.87 108.186 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1150 ' ' GLY . . . . . . . . . . . . . . . -74.01 -48.62 15.31 Favored Glycine 0 N--CA 1.41 -3.058 0 CA-C-N 111.554 -2.566 . . . . 19.28 113.075 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1151 ' ' ARG . . . . . 0.765 ' HA ' ' HB2' ' B' 1322 ' ' GLN . 61.8 mtm-85 -103.56 176.25 5.21 Favored 'General case' 0 C--O 1.25 1.1 0 N-CA-C 109.241 -0.652 . . . . 39.9 109.241 -164.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1152 ' ' PHE . . . . . 0.7 ' HB2' HG11 ' A' 1163 ' ' VAL . 12.0 m-30 -76.24 161.11 29.04 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 120.87 -1.144 . . . . 29.44 108.122 169.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1153 ' ' PHE . . . . . 0.606 ' HB3' ' HB2' ' A' 1189 ' ' ALA . 7.8 m-85 -78.78 -48.61 14.51 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 122.891 1.329 . . . . 32.6 108.662 168.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1154 ' ' THR . . . . . . . . . . . . . 9.7 m -64.45 116.62 6.3 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 115.252 1.575 . . . . 34.64 115.252 -170.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -66.49 88.67 0.13 Allowed Glycine 0 C--O 1.24 0.486 0 N-CA-C 110.666 -0.973 . . . . 37.14 110.666 173.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -139.45 178.89 6.88 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 124.883 2.278 . . . . 40.57 111.137 -173.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1157 ' ' ILE . . . . . 0.693 ' HB ' ' HG2' ' C' ' 95' ' ' GLU . 3.1 tp -107.53 153.44 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 112.928 -1.942 . . . . 44.61 107.548 167.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1158 ' ' THR . . . . . 0.501 ' O ' HG13 ' A' 1157 ' ' ILE . 24.5 p -103.76 -143.63 0.36 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.539 -1.282 . . . . 40.7 107.539 169.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -94.45 -25.15 17.02 Favored 'General case' 0 C--O 1.246 0.869 0 O-C-N 119.301 -2.124 . . . . 40.25 110.233 167.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -82.78 -56.53 3.78 Favored 'General case' 0 C--O 1.249 1.059 0 O-C-N 121.914 -0.491 . . . . 38.47 111.952 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1161 ' ' GLY . . . . . 0.623 ' HA3' HG21 ' B' 1329 ' ' THR . . . -169.02 -173.42 36.71 Favored Glycine 0 N--CA 1.476 1.333 0 N-CA-C 111.894 -0.483 . . . . 37.61 111.894 -164.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 15.6 tttp -78.35 151.8 32.68 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 126.057 1.743 . . . . 48.9 111.772 -170.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1163 ' ' VAL . . . . . 0.7 HG11 ' HB2' ' A' 1152 ' ' PHE . 92.5 t -102.07 123.86 42.04 Favored Pre-proline 0 N--CA 1.44 -0.942 0 CA-C-N 113.197 -1.82 . . . . 36.52 108.019 161.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1164 ' ' PRO . . . . . 0.502 ' HD2' ' HA ' ' A' 1163 ' ' VAL . 47.2 Cg_endo -62.82 114.47 2.43 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 123.897 3.064 . . . . 35.08 115.046 162.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1165 ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' 1164 ' ' PRO . 61.8 Cg_exo -61.91 130.8 32.34 Favored 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 124.142 3.228 . . . . 35.33 113.42 -171.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1166 ' ' ALA . . . . . 0.427 ' HB2' ' HA ' ' A' 1153 ' ' PHE . . . -66.8 123.39 20.01 Favored 'General case' 0 CA--C 1.501 -0.925 0 O-C-N 125.043 1.464 . . . . 34.69 112.055 172.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1167 ' ' LYS . . . . . 0.522 ' HA ' ' HB ' ' A' 1190 ' ' ILE . 7.1 mttp -96.89 94.32 7.16 Favored 'General case' 0 CA--C 1.486 -1.494 0 N-CA-C 105.227 -2.138 . . . . 45.36 105.227 176.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 20.2 t -82.19 97.83 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 C-N-CA 124.479 1.111 . . . . 31.71 108.215 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1169 ' ' MET . . . . . 0.483 ' O ' ' HA ' ' A' 1252 ' ' ILE . 59.2 ttp -77.96 125.78 29.85 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.037 -1.468 . . . . 42.28 107.037 166.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 94.6 t -111.86 112.04 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 106.828 -1.545 . . . . 30.51 106.828 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1171 ' ' ILE . . . . . 0.535 HD12 HG23 ' A' 1254 ' ' THR . 75.8 mt -88.69 116.29 30.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 119.979 -1.701 . . . . 31.87 109.412 173.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 93.61 89.51 1.61 Allowed Glycine 0 C--O 1.215 -1.043 0 N-CA-C 109.215 -1.554 . . . . 34.54 109.215 171.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1173 ' ' ALA . . . . . 0.489 ' HA ' ' HA3' ' A' 1177 ' ' GLY . . . -80.95 67.73 6.96 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 123.05 1.405 . . . . 32.51 110.19 176.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -100.98 -153.73 26.5 Favored Glycine 0 C--O 1.217 -0.95 0 CA-C-O 117.101 -1.944 . . . . 29.9 108.369 167.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1175 ' ' VAL . . . . . 0.651 HG21 ' HA ' ' A' 1131 ' ' SER . 0.0 OUTLIER -58.45 -49.03 83.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 CA-C-N 121.438 2.619 . . . . 33.11 111.931 -178.542 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1176 ' ' ALA . . . . . 0.439 ' HB2' ' HB1' ' A' 1134 ' ' ALA 0.26 . . -59.89 -36.98 78.11 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 121.984 0.897 . . . . 28.1 110.538 174.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1177 ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' 1173 ' ' ALA . . . -63.96 -55.05 26.57 Favored Glycine 0 C--O 1.215 -1.057 0 N-CA-C 109.63 -1.388 . . . . 28.54 109.63 -175.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1178 ' ' LEU . . . . . 0.673 HD23 HD12 ' A' 1181 ' ' ILE . 29.5 mt -65.7 -30.76 71.49 Favored 'General case' 0 C--O 1.254 1.303 0 CA-C-N 114.231 -0.984 . . . . 31.22 110.869 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -66.28 -40.34 90.03 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.022 -1.674 . . . . 28.98 112.391 173.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -65.03 -42.18 94.59 Favored 'General case' 0 C--O 1.221 -0.433 0 O-C-N 119.23 -2.169 . . . . 27.83 112.261 173.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1181 ' ' ILE . . . . . 0.673 HD12 HD23 ' A' 1178 ' ' LEU . 71.1 mt -54.07 -55.09 15.94 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 CA-C-O 118.46 -0.781 . . . . 30.25 110.055 172.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -59.3 -53.27 47.64 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-O 122.957 1.309 . . . . 29.59 111.633 -175.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1183 ' ' ALA . . . . . 0.461 ' HB3' HG13 ' A' 1142 ' ' ILE . . . -50.39 -64.22 0.88 Allowed 'General case' 0 C--N 1.348 0.535 0 O-C-N 120.022 -1.869 . . . . 30.29 113.535 173.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -60.8 -37.86 83.4 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 115.86 1.8 . . . . 30.47 115.86 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -60.11 -45.91 91.4 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 107.923 -1.14 . . . . 42.41 107.923 174.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1186 ' ' SER . . . . . . . . . . . . . 67.4 m -62.77 -44.33 96.47 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 123.458 1.599 . . . . 39.38 113.026 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 25.2 tp -63.87 -30.94 71.98 Favored 'General case' 0 C--O 1.244 0.796 0 O-C-N 119.765 -1.834 . . . . 36.18 110.36 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 108.89 40.14 1.61 Allowed Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 125.722 1.629 . . . . 33.78 114.114 170.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1189 ' ' ALA . . . . . 0.606 ' HB2' ' HB3' ' A' 1153 ' ' PHE . . . -108.75 161.18 15.34 Favored 'General case' 0 CA--C 1.49 -1.332 0 O-C-N 121.164 -1.198 . . . . 33.93 110.745 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1190 ' ' ILE . . . . . 0.522 ' HB ' ' HA ' ' A' 1167 ' ' LYS . 67.8 mt -72.56 120.29 20.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 104.996 -2.224 . . . . 38.74 104.996 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1191 ' ' VAL . . . . . 0.507 HG11 ' HA ' ' A' 1181 ' ' ILE . 10.1 t -110.65 129.2 66.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.15 -1.426 . . . . 33.09 107.15 175.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1192 ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' 1210 ' ' GLU . 71.9 mtt180 -127.59 101.89 6.6 Favored 'General case' 0 N--CA 1.438 -1.027 0 O-C-N 125.399 1.687 . . . . 38.92 108.022 173.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -100.47 152.3 20.54 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.619 0.723 . . . . 35.32 112.536 -175.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1194 ' ' PHE . . . . . 0.455 ' HZ ' ' HG2' ' A' 1238 ' ' GLU . 79.1 t80 -128.67 148.35 50.81 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 127.751 2.42 . . . . 39.35 105.231 -172.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 7.9 t70 -166.59 161.89 16.22 Favored 'General case' 0 C--O 1.243 0.714 0 O-C-N 124.483 1.114 . . . . 40.46 109.966 170.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1196 ' ' THR . . . . . 0.441 HG23 ' CE2' ' A' 1234 ' ' PHE . 0.8 OUTLIER -67.86 -42.41 81.36 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 113.625 -1.625 . . . . 45.94 107.734 179.684 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1197 ' ' ARG . . . . . . . . . . . . . 47.7 mtm180 -94.26 117.67 67.08 Favored Pre-proline 0 C--O 1.212 -0.892 0 C-N-CA 123.97 0.908 . . . . 56.02 109.65 -162.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1198 ' ' PRO . . . . . 0.47 ' O ' ' HB3' ' A' 1201 ' ' LYS . 74.5 Cg_endo -68.12 -8.82 23.89 Favored 'Trans proline' 0 C--N 1.36 1.142 0 C-N-CA 124.125 3.217 . . . . 51.27 114.555 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.44 -35.63 34.73 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 120.299 -1.501 . . . . 59.1 108.485 -177.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 15.0 m -71.36 -26.39 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 113.662 0.986 . . . . 51.06 113.662 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1201 ' ' LYS . . . . . 0.47 ' HB3' ' O ' ' A' 1198 ' ' PRO . 74.9 tttt -39.39 -42.41 1.07 Allowed 'General case' 0 C--O 1.239 0.512 0 N-CA-C 115.878 1.807 . . . . 57.38 115.878 166.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -57.37 -47.85 80.59 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 114.814 -1.085 . . . . 62.41 111.114 177.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -69.46 -41.61 75.97 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 118.752 -0.642 . . . . 57.78 109.634 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1204 ' ' VAL . . . . . 0.404 HG11 ' HD1' ' A' 1211 ' ' PHE . 99.9 t -51.95 -54.65 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 120.276 1.398 . . . . 46.38 114.529 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -53.42 -51.22 63.29 Favored 'General case' 0 N--CA 1.427 -1.585 0 C-N-CA 125.208 1.403 . . . . 50.7 112.452 169.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1206 ' ' SER . . . . . . . . . . . . . 7.1 m -78.41 4.15 13.86 Favored 'General case' 0 C--O 1.261 1.663 0 O-C-N 119.429 -2.044 . . . . 49.98 115.531 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1207 ' ' MET . . . . . . . . . . . . . 75.6 mtp -99.69 -1.86 36.83 Favored 'General case' 0 C--O 1.244 0.784 0 O-C-N 119.87 -1.769 . . . . 52.99 111.828 169.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 86.79 48.93 4.26 Favored Glycine 0 C--N 1.346 1.13 0 C-N-CA 120.304 -0.95 . . . . 47.66 111.112 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -137.62 153.67 49.86 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 124.532 2.11 . . . . 44.77 108.353 170.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1210 ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' 1192 ' ' ARG . 20.9 tt0 -85.44 134.17 34.07 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 113.094 -1.866 . . . . 47.64 106.351 172.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1211 ' ' PHE . . . . . 0.404 ' HD1' HG11 ' A' 1204 ' ' VAL . 39.2 t80 -86.09 128.06 34.8 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 120.42 -1.425 . . . . 45.66 109.174 175.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 32.5 mt -99.44 115.02 28.32 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 106.072 -1.825 . . . . 46.06 106.072 171.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -88.02 167.88 13.31 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-O 122.708 1.242 . . . . 60.22 109.876 167.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1214 ' ' LEU . . . . . 0.464 HD23 ' HB3' ' A' 1237 ' ' ALA . 4.9 mp -74.22 136.41 42.76 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 106.471 -1.677 . . . . 57.25 106.471 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.75 92.46 1.57 Allowed 'General case' 0 C--O 1.243 0.734 0 N-CA-C 107.411 -1.329 . . . . 64.43 107.411 166.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 5.1 t80 . . . . . 0 CA--C 1.506 -0.734 0 CA-C-N 114.326 -1.306 . . . . 66.9 111.277 -167.368 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 6.1 p-10 . . . . . 0 N--CA 1.443 -0.816 0 N-CA-C 103.313 -2.847 . . . . 39.09 103.313 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -55.09 -37.36 63.28 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.61 -0.723 . . . . 39.32 113.089 -175.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 84.2 t80 -69.3 -54.26 15.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 117.759 0.78 . . . . 39.3 111.11 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -67.05 -34.01 76.75 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 119.277 0.944 . . . . 36.3 112.917 -177.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -62.01 -37.41 84.75 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 113.122 0.786 . . . . 37.38 113.122 168.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -70.87 -36.1 62.8 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 CA-C-N 121.429 1.922 . . . . 39.11 110.579 169.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1230 ' ' MET . . . . . . . . . . . . . 33.2 mmt -90.22 63.5 5.78 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 124.101 1.905 . . . . 49.59 110.97 -177.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1231 ' ' SER . . . . . . . . . . . . . 67.0 m -151.68 126.64 9.73 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 110.847 -2.888 . . . . 43.68 107.141 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -56.78 -18.27 12.1 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 114.136 1.162 . . . . 55.57 114.136 -176.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -56.75 -49.02 76.49 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 114.238 1.199 . . . . 44.94 114.238 167.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1234 ' ' PHE . . . . . 0.441 ' CE2' HG23 ' A' 1196 ' ' THR . 19.5 t80 -63.07 -56.6 15.49 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 124.835 1.254 . . . . 42.04 108.151 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1235 ' ' ILE . . . . . 0.415 ' O ' ' HG2' ' A' 1239 ' ' MET . 93.0 mt -51.72 -45.32 37.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 114.532 -1.213 . . . . 46.28 110.173 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1236 ' ' LYS . . . . . 0.624 ' O ' ' HG3' ' A' 1240 ' ' GLU . 26.7 tttm -66.16 -39.9 90.12 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 115.69 -2.1 . . . . 47.87 111.791 175.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1237 ' ' ALA . . . . . 0.464 ' HB3' HD23 ' A' 1214 ' ' LEU . . . -64.08 -37.5 87.68 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-N 121.98 2.173 . . . . 41.61 112.629 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1238 ' ' GLU . . . . . 0.455 ' HG2' ' HZ ' ' A' 1194 ' ' PHE . 48.5 mt-10 -55.59 -56.87 15.24 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 106.524 -1.658 . . . . 50.65 106.524 170.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1239 ' ' MET . . . . . 0.415 ' HG2' ' O ' ' A' 1235 ' ' ILE . 97.7 mmm -50.0 -48.91 52.17 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.713 1.005 . . . . 48.87 113.713 178.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1240 ' ' GLU . . . . . 0.624 ' HG3' ' O ' ' A' 1236 ' ' LYS . 29.5 mt-10 -62.72 -40.17 96.36 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 119.462 -2.024 . . . . 54.8 110.749 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.32 -46.56 79.81 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.455 0.702 . . . . 43.21 111.855 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -64.33 -47.34 79.77 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 106.659 -1.608 . . . . 38.66 106.659 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -62.63 -32.9 74.02 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 122.761 1.267 . . . . 37.92 114.14 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1244 ' ' ALA . . . . . 0.45 ' O ' ' HE2' ' A' 1247 ' ' LYS . . . -70.02 -51.94 28.13 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.634 -0.876 . . . . 37.28 108.634 174.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -61.31 -29.05 69.64 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 113.593 0.96 . . . . 43.07 113.593 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -51.1 -34.24 29.64 Favored 'General case' 0 C--O 1.248 1.01 0 C-N-CA 126.249 1.82 . . . . 38.3 112.612 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1247 ' ' LYS . . . . . 0.45 ' HE2' ' O ' ' A' 1244 ' ' ALA . 11.3 mtmm -57.7 -22.3 45.49 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 118.505 2.78 . . . . 47.6 118.505 174.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.78 -30.73 0.81 Allowed 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 117.383 2.364 . . . . 45.42 117.383 -171.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1249 ' ' VAL . . . . . . . . . . . . . 34.6 m -70.06 158.6 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 123.661 1.696 . . . . 36.26 111.386 -173.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1250 ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -103.04 -50.78 3.41 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 113.884 -1.507 . . . . 33.04 111.641 -172.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1251 ' ' ILE . . . . . 0.525 HD12 ' HB1' ' A' 1145 ' ' ALA . 51.7 mm -121.05 138.33 51.82 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 N-CA-C 103.938 -2.616 . . . . 31.4 103.938 -177.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1252 ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' 1169 ' ' MET . 39.5 mt -120.87 113.68 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 105.798 -1.927 . . . . 29.42 105.798 166.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 27.7 t -97.0 111.46 26.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 104.504 -2.406 . . . . 30.37 104.504 176.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1254 ' ' THR . . . . . 0.535 HG23 HD12 ' A' 1171 ' ' ILE . 0.2 OUTLIER -108.58 112.01 24.13 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 102.468 -3.16 . . . . 35.72 102.468 -173.532 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1255 ' ' THR . . . . . 0.522 HG22 HD12 ' A' 1284 ' ' LEU . 66.1 p -98.89 -27.55 13.85 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 120.004 3.335 . . . . 36.0 120.004 -159.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1256 ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' 1263 ' ' ALA . . . -71.19 82.31 0.72 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 118.579 2.807 . . . . 40.93 118.579 -140.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 52.9 tp -84.39 84.18 7.73 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 104.897 -2.26 . . . . 47.82 104.897 175.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 26.0 mm -70.26 131.14 88.77 Favored Pre-proline 0 N--CA 1.431 -1.417 0 CA-C-N 112.701 -2.045 . . . . 52.7 107.83 172.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -59.78 133.75 52.99 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.3 2.667 . . . . 54.13 111.144 176.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 76.64 -67.44 2.6 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 122.581 1.101 . . . . 54.62 115.418 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1261 ' ' LYS . . . . . 0.422 ' HA ' ' HD2' ' A' 1262 ' ' PRO . 85.3 mttt -80.8 129.05 69.58 Favored Pre-proline 0 C--O 1.24 0.575 0 N-CA-C 114.839 1.422 . . . . 55.74 114.839 -173.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1262 ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' 1261 ' ' LYS . 11.0 Cg_endo -46.0 134.02 14.58 Favored 'Trans proline' 0 N--CA 1.451 -0.976 1 C-N-CA 127.395 5.397 . . . . 51.15 112.14 167.396 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1263 ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' 1256 ' ' ALA . . . -64.94 131.88 95.32 Favored Pre-proline 0 C--O 1.246 0.881 0 CA-C-O 117.194 -1.384 . . . . 46.06 111.95 171.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -66.66 148.56 83.3 Favored 'Trans proline' 0 C--O 1.255 1.352 0 C-N-CA 123.379 2.719 . . . . 41.08 111.581 -177.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1265 ' ' LYS . . . . . 0.512 ' HD3' ' HA ' ' A' 1293 ' ' GLU . 61.8 mttm -85.75 79.09 9.42 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 124.356 2.026 . . . . 47.42 112.347 -175.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1266 ' ' LEU . . . . . 0.415 ' O ' ' SD ' ' A' 1239 ' ' MET . 93.5 mt -74.19 -59.01 2.92 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 110.737 -2.938 . . . . 39.22 113.125 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 63.8 mt -75.29 112.43 12.83 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 CA-C-N 120.884 1.675 . . . . 42.5 107.801 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1268 ' ' THR . . . . . . . . . . . . . 1.1 p -76.92 163.04 27.11 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.005 -1.452 . . . . 37.84 113.202 -176.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1269 ' ' ARG . . . . . 0.476 ' HG3' ' HB2' ' A' 1293 ' ' GLU . 58.7 mtt-85 -62.5 -40.46 96.78 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-O 121.793 0.806 . . . . 54.8 112.836 172.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -50.38 -51.86 42.36 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 124.874 1.27 . . . . 54.36 113.1 167.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1271 ' ' MET . . . . . . . . . . . . . 30.0 ttm -60.43 -48.04 83.47 Favored 'General case' 0 C--O 1.253 1.249 0 C-N-CA 124.831 1.252 . . . . 39.52 112.136 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1272 ' ' VAL . . . . . . . . . . . . . 60.0 t -57.33 -50.02 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 C-N-CA 123.69 0.796 . . . . 38.25 111.895 176.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -54.05 -43.89 70.61 Favored 'General case' 0 C--O 1.262 1.761 0 O-C-N 119.666 -1.896 . . . . 40.77 114.432 171.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1274 ' ' SER . . . . . . . . . . . . . 10.5 p -73.02 3.18 5.69 Favored 'General case' 0 CA--C 1.556 1.203 0 O-C-N 120.219 -1.55 . . . . 36.58 113.646 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1275 ' ' MET . . . . . 0.629 ' HB3' HG21 ' A' 1307 ' ' VAL . 0.3 OUTLIER -78.63 151.65 32.19 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 118.641 -2.537 . . . . 36.75 108.245 -179.071 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1276 ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -66.4 142.0 57.75 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.056 1.742 . . . . 46.11 113.007 177.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1277 ' ' ALA . . . . . . . . . . . . . . . -72.69 153.06 41.37 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 115.327 1.603 . . . . 33.52 115.327 -169.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 80.02 37.66 21.41 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 108.694 -1.762 . . . . 31.27 108.694 174.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1279 ' ' SER . . . . . . . . . . . . . 19.7 m -139.56 163.27 32.99 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 119.27 1.535 . . . . 32.95 111.065 -160.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1280 ' ' VAL . . . . . 0.629 HG22 ' HB2' ' A' 1308 ' ' LYS . 92.7 t -123.78 148.78 27.76 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 O-C-N 118.496 -2.628 . . . . 27.43 111.175 -173.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1281 ' ' ILE . . . . . 0.406 HG12 ' HB ' ' A' 1252 ' ' ILE . 60.9 mt -121.83 112.18 33.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 103.872 -2.64 . . . . 30.3 103.872 164.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 4.1 t -98.5 134.59 36.55 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 104.984 -2.228 . . . . 28.63 104.984 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 6.1 t0 -111.55 121.32 44.86 Favored 'General case' 0 C--O 1.254 1.32 0 CA-C-N 114.692 -1.14 . . . . 36.27 108.956 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1284 ' ' LEU . . . . . 0.839 HD21 ' HB2' ' A' 1141 ' ' ALA . 72.4 mt -105.96 14.5 27.86 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.678 -0.692 . . . . 38.57 109.814 -175.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1285 ' ' ALA . . . . . 0.459 ' HB3' ' HA2' ' A' 1290 ' ' GLY . . . -104.95 -40.3 5.97 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 122.862 1.315 . . . . 37.56 109.015 169.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1286 ' ' ALA . . . . . 0.471 ' HA ' HG21 ' A' 1295 ' ' THR . . . 49.32 -81.0 0.01 OUTLIER 'General case' 0 C--O 1.263 1.809 0 N-CA-C 117.992 2.59 . . . . 40.33 117.992 173.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -76.61 -36.13 57.66 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 123.938 0.895 . . . . 56.85 111.865 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 52.4 t30 -80.13 77.98 6.81 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 104.802 -2.296 . . . . 45.86 104.802 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 72.16 -72.51 0.93 Allowed Glycine 0 CA--C 1.5 -0.854 0 N-CA-C 109.444 -1.462 . . . . 40.31 109.444 -176.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1290 ' ' GLY . . . . . 0.459 ' HA2' ' HB3' ' A' 1285 ' ' ALA . . . 87.16 117.32 1.13 Allowed Glycine 0 C--O 1.22 -0.722 0 N-CA-C 106.755 -2.538 . . . . 38.89 106.755 -175.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1291 ' ' ASN . . . . . 0.457 ' ND2' ' HB1' ' A' 1263 ' ' ALA . 12.4 m120 -65.46 -16.78 63.99 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 115.633 1.716 . . . . 37.23 115.633 -172.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1292 ' ' CYS . . . . . . . . . . . . . 36.0 t -103.34 157.08 17.27 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 119.45 1.023 . . . . 36.5 109.497 173.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1293 ' ' GLU . . . . . 0.512 ' HA ' ' HD3' ' A' 1265 ' ' LYS . 57.0 mt-10 -82.53 -9.17 59.52 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 115.331 1.604 . . . . 43.32 115.331 173.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -96.38 9.02 42.54 Favored 'General case' 0 C--O 1.244 0.778 0 O-C-N 117.55 -3.219 . . . . 41.32 111.699 172.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1295 ' ' THR . . . . . 0.483 HG23 ' HA3' ' A' 1311 ' ' GLY . 85.3 m -75.61 98.8 4.12 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.871 0.843 . . . . 35.3 111.072 -173.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1296 ' ' VAL . . . . . 0.819 ' HB ' ' HB2' ' A' 1299 ' ' GLU . 2.3 t -81.94 128.25 69.12 Favored Pre-proline 0 C--O 1.251 1.166 0 N-CA-C 102.622 -3.103 . . . . 34.84 102.622 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -51.42 105.34 0.11 Allowed 'Trans proline' 0 C--O 1.251 1.137 0 C-N-CA 124.773 3.649 . . . . 33.51 113.04 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1298 ' ' GLY . . . . . 0.482 ' HA2' ' H ' ' A' 1313 ' ' THR . . . 76.98 23.43 69.12 Favored Glycine 0 CA--C 1.504 -0.635 0 CA-C-N 113.328 -1.76 . . . . 32.19 113.937 175.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1299 ' ' GLU . . . . . 0.819 ' HB2' ' HB ' ' A' 1296 ' ' VAL . 45.5 mt-10 -131.6 170.58 14.56 Favored 'General case' 0 C--O 1.246 0.916 0 CA-C-N 118.86 1.33 . . . . 34.88 112.905 -175.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1300 ' ' ILE . . . . . 0.586 HG12 HG12 ' A' 1310 ' ' ILE . 43.3 mt -108.58 121.84 62.23 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.198 0 N-CA-C 106.044 -1.835 . . . . 32.29 106.044 169.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 16.0 t80 -97.96 126.5 43.4 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 103.624 -2.732 . . . . 37.25 103.624 169.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1302 ' ' THR . . . . . . . . . . . . . 8.2 m -106.41 123.91 48.8 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 119.735 1.152 . . . . 35.56 108.628 174.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1303 ' ' THR . . . . . . . . . . . . . 2.6 p -86.7 165.17 16.3 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 118.37 -0.824 . . . . 36.4 113.191 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -53.96 -41.1 67.44 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 121.254 1.843 . . . . 52.32 115.704 -176.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1305 ' ' ASN . . . . . 0.532 ' HA ' ' HB2' ' B' 1046 ' ' ASP . 53.2 p-10 -62.18 -24.05 66.97 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.369 -1.287 . . . . 40.04 111.741 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 98.23 44.51 2.56 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.294 -1.122 . . . . 36.96 110.294 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1307 ' ' VAL . . . . . 0.629 HG21 ' HB3' ' A' 1275 ' ' MET . 59.7 t -107.08 120.11 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 123.617 1.675 . . . . 33.4 108.584 168.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1308 ' ' LYS . . . . . 0.629 ' HB2' HG22 ' A' 1280 ' ' VAL . 61.2 mmtt -87.3 102.78 14.83 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 110.541 -3.027 . . . . 42.91 106.986 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 39.3 t -88.98 95.22 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.676 0 O-C-N 119.469 -2.019 . . . . 32.29 108.212 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1310 ' ' ILE . . . . . 0.666 HD11 ' HB2' ' A' 1148 ' ' GLU . 91.1 mt -89.54 95.17 5.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 O-C-N 120.76 -1.212 . . . . 30.99 110.093 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1311 ' ' GLY . . . . . 0.483 ' HA3' HG23 ' A' 1295 ' ' THR . . . -97.33 57.9 1.17 Allowed Glycine 0 N--CA 1.441 -1.012 0 O-C-N 120.483 -1.386 . . . . 28.95 113.798 178.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1312 ' ' TYR . . . . . . . . . . . . . 7.0 m-30 -77.36 131.82 38.26 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 122.914 1.34 . . . . 31.69 113.374 -169.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1313 ' ' THR . . . . . 0.482 ' H ' ' HA2' ' A' 1298 ' ' GLY . 8.8 p -86.6 -49.79 7.28 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 120.965 -1.084 . . . . 34.17 110.596 174.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -72.29 14.27 0.25 Allowed 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 117.367 2.358 . . . . 36.86 117.367 -167.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1315 ' ' LEU . . . . . . . . . . . . . 28.5 mt -51.04 -39.45 56.12 Favored Pre-proline 0 C--N 1.347 0.495 0 O-C-N 119.827 -1.796 . . . . 34.85 114.256 -173.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.74 -43.98 40.02 Favored 'Trans proline' 0 C--O 1.257 1.431 0 CA-C-N 124.408 2.61 . . . . 29.15 113.207 170.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -58.25 -45.12 94.55 Favored Glycine 0 CA--C 1.543 1.807 0 N-CA-C 109.124 -1.59 . . . . 27.29 109.124 174.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1318 ' ' ARG . . . . . 0.435 ' HB3' ' NH2' ' A' 1140 ' ' ARG . 90.2 mtt-85 -58.35 -23.38 56.6 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 116.47 2.026 . . . . 41.49 116.47 177.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1319 ' ' LEU . . . . . 0.744 HD23 HG23 ' A' 1136 ' ' ILE . 12.3 tp -123.07 67.27 32.9 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 104.018 -2.586 . . . . 27.61 104.018 175.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1320 ' ' PRO . . . . . 0.57 ' HB3' ' HB ' ' A' 1014 ' ' THR . 64.9 Cg_endo -58.14 -53.05 4.67 Favored 'Trans proline' 0 C--O 1.257 1.456 1 C-N-CA 125.396 4.064 . . . . 25.94 114.67 -163.243 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1321 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.86 -39.79 91.05 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 109.868 -0.419 . . . . 25.01 109.868 -173.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1322 ' ' GLN . . . . . 0.699 ' HB2' ' HA ' ' B' 1151 ' ' ARG . 24.1 tp60 -64.83 -43.82 91.84 Favored 'General case' 0 CA--C 1.51 -0.563 0 O-C-N 123.968 0.792 . . . . 29.39 109.78 -175.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1323 ' ' SER . . . . . . . . . . . . . 49.6 m -58.47 -53.52 57.41 Favored 'General case' 0 CA--C 1.486 -1.514 0 CA-C-N 114.16 -1.382 . . . . 26.47 113.166 173.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1324 ' ' SER . . . . . 0.477 ' HB2' HG23 ' A' 1019 ' ' THR . 5.0 m -65.01 -29.37 70.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.324 -0.86 . . . . 27.78 110.002 -178.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -68.81 -59.66 2.93 Favored 'General case' 0 C--N 1.348 0.519 0 O-C-N 121.653 -0.654 . . . . 37.53 110.783 172.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1326 ' ' LEU . . . . . 0.506 HD12 HD11 ' A' 1136 ' ' ILE . 59.5 mt -72.29 -51.79 19.23 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 115.838 -2.03 . . . . 35.71 111.102 -170.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1327 ' ' TYR . . . . . 0.434 ' HE2' ' HA ' ' A' 1072 ' ' VAL . 7.3 t80 -48.83 -48.26 41.84 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 121.364 1.893 . . . . 31.59 110.96 170.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1328 ' ' GLY . . . . . 0.509 ' O ' HG23 ' A' 1332 ' ' VAL . . . -47.46 -52.52 14.06 Favored Glycine 0 N--CA 1.465 0.61 0 C-N-CA 124.229 0.918 . . . . 28.0 112.49 170.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1329 ' ' THR . . . . . 0.654 ' HB ' ' HB1' ' B' 1160 ' ' ALA . 77.2 m -70.4 -34.81 72.97 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 120.344 -1.68 . . . . 32.15 110.188 -173.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1330 ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' 1127 ' ' LEU . 29.4 m120 -64.65 -43.6 93.13 Favored 'General case' 0 C--O 1.21 -0.997 0 C-N-CA 119.521 -0.871 . . . . 34.36 111.28 173.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1331 ' ' LEU . . . . . 0.591 HD22 HD22 ' A' 1070 ' ' LEU . 80.6 mt -53.09 -44.83 67.88 Favored 'General case' 0 C--O 1.219 -0.534 0 O-C-N 124.71 1.256 . . . . 33.37 111.527 173.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1332 ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' 1328 ' ' GLY . 6.8 t -70.62 -37.12 68.37 Favored 'Isoleucine or valine' 0 C--O 1.245 0.842 0 CA-C-N 114.849 -1.069 . . . . 35.27 110.125 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1333 ' ' ASN . . . . . 0.629 ' HA ' ' HD2' ' A' 1336 ' ' LYS . 76.9 m-20 -69.89 -28.69 65.84 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 121.414 0.626 . . . . 37.66 111.227 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1334 ' ' LEU . . . . . 0.648 HD21 ' SD ' ' A' 1113 ' ' MET . 0.4 OUTLIER -71.52 -51.99 20.62 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 108.805 -0.813 . . . . 40.27 108.805 171.331 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1335 ' ' LEU . . . . . 0.484 HD11 HD21 ' A' 1070 ' ' LEU . 37.1 mt -68.41 -5.91 21.7 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 115.564 1.69 . . . . 42.5 115.564 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1336 ' ' LYS . . . . . 0.629 ' HD2' ' HA ' ' A' 1333 ' ' ASN . 74.8 mttt -66.96 -35.75 80.68 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 119.85 -1.781 . . . . 47.81 111.823 162.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1337 ' ' LEU . . . . . 0.472 ' O ' ' HG3' ' A' 1340 ' ' LYS . 4.8 mp -78.08 -46.74 19.99 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 120.9 -1.125 . . . . 49.27 109.995 169.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1338 ' ' LEU . . . . . 0.466 ' HB2' ' HA ' ' A' 1335 ' ' LEU . 6.0 mp -76.81 16.96 0.46 Allowed 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 115.786 1.773 . . . . 50.54 115.786 176.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1339 ' ' CYS . . . . . . . . . . . . . 36.5 t -156.98 80.34 0.92 Allowed 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 126.042 2.829 . . . . 53.67 104.768 164.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1340 ' ' LYS . . . . . 0.604 ' HD2' HG21 ' A' 1347 ' ' THR . 82.6 mttt -79.08 -40.66 30.61 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 113.431 -1.713 . . . . 63.38 111.139 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -69.69 -51.26 36.1 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 113.706 1.002 . . . . 70.95 113.706 -166.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1342 ' ' LYS . . . . . 0.502 ' HE3' HD23 ' A' 1029 ' ' LEU . 36.3 mtpt 52.77 67.08 1.05 Allowed 'General case' 0 C--O 1.239 0.535 0 N-CA-C 117.499 2.407 . . . . 65.25 117.499 171.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1343 ' ' ASP . . . . . . . . . . . . 0.262 7.8 t70 59.82 -94.19 0.05 OUTLIER 'General case' 0 CA--C 1.502 -0.869 2 O-C-N 110.915 -7.365 . . . . 64.53 117.847 4.486 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A 1344 ' ' GLY . . . . . . . . . . . . . . . 117.86 70.15 0.38 Allowed Glycine 0 C--N 1.348 1.212 0 N-CA-C 107.764 -2.134 . . . . 59.72 107.764 172.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -167.78 149.56 5.52 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 113.683 -1.259 . . . . 64.09 108.12 -177.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1346 ' ' ILE . . . . . 0.442 HG23 HD11 ' A' 1068 ' ' ILE . 8.4 pt -55.38 125.22 10.03 Favored 'Isoleucine or valine' 0 C--O 1.247 0.95 0 N-CA-C 115.211 1.56 . . . . 58.82 115.211 178.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1347 ' ' THR . . . . . 0.604 HG21 ' HD2' ' A' 1340 ' ' LYS . 7.8 m -97.91 100.12 11.45 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 103.309 -2.848 . . . . 54.96 103.309 163.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1348 ' ' VAL . . . . . . . . . . . . . 15.1 t -90.87 113.08 26.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 106.663 -1.606 . . . . 55.64 106.663 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 27.9 t70 -112.55 145.22 40.69 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 122.194 0.997 . . . . 61.45 110.094 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 60.2 t80 -116.23 4.19 13.51 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.509 1.124 . . . . 58.63 109.238 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.77 -62.71 1.25 Allowed 'General case' 0 N--CA 1.477 0.893 0 O-C-N 119.723 -1.861 . . . . 62.06 110.469 -169.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 7.3 t70 -69.83 143.95 52.73 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 114.571 1.322 . . . . 54.07 114.571 -170.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 20.3 m -65.49 -29.73 48.01 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 CA-C-N 119.541 1.064 . . . . 50.68 111.114 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1354 ' ' VAL . . . . . . . . . . . . . 4.3 m -76.53 -17.26 14.97 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 O-C-N 120.284 -1.51 . . . . 47.68 110.404 -176.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1355 ' ' ILE . . . . . 0.406 HG23 HD11 ' A' 1338 ' ' LEU . 74.8 mt -100.34 -69.79 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.867 0 N-CA-C 106.636 -1.616 . . . . 48.49 106.636 171.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 40.4 tpt85 -55.73 -31.99 62.98 Favored 'General case' 0 C--N 1.349 0.548 0 O-C-N 120.653 -1.28 . . . . 48.27 114.286 -175.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -62.27 -46.18 94.45 Favored Glycine 0 CA--C 1.525 0.662 0 O-C-N 120.025 -1.672 . . . . 43.53 111.749 171.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1358 ' ' VAL . . . . . . . . . . . . . 42.4 t -72.18 -35.27 52.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 122.042 0.925 . . . . 45.12 111.025 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1359 ' ' THR . . . . . . . . . . . . . 25.6 m -69.07 88.43 0.41 Allowed 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 122.817 1.294 . . . . 42.94 109.162 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 16.1 m -76.83 -22.82 14.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-O 122.317 1.056 . . . . 43.26 113.122 176.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1361 ' ' ILE . . . . . 0.57 ' HB ' ' HB ' ' A' 1112 ' ' VAL . 30.5 mt -133.29 135.52 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 103.563 -2.754 . . . . 45.66 103.563 169.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1362 ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -117.68 113.11 21.4 Favored 'General case' 0 C--O 1.252 1.228 0 N-CA-C 104.879 -2.267 . . . . 61.34 104.879 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 26.53 73.6 0.03 OUTLIER 'General case' 0 C--O 1.231 0.115 0 C-N-CA 127.047 2.139 . . . . 49.76 113.186 -166.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 88.9 -38.1 3.24 Favored Glycine 0 CA--C 1.529 0.911 0 O-C-N 119.902 -1.749 . . . . 50.0 112.443 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -74.46 124.0 25.75 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 119.416 1.608 . . . . 56.92 109.168 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1366 ' ' ILE . . . . . 0.463 HG22 ' HB3' ' A' 1368 ' ' TRP . 10.2 mt -77.13 86.3 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.256 1.401 0 CA-C-O 123.07 1.414 . . . . 52.78 111.748 -178.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1367 ' ' THR . . . . . . . . . . . . . 16.6 p -70.95 -11.88 61.22 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 111.728 -2.487 . . . . 49.44 114.624 -174.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1368 ' ' TRP . . . . . 0.463 ' HB3' HG22 ' A' 1366 ' ' ILE . 26.3 t90 -47.44 133.81 10.05 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 127.362 2.265 . . . . 52.38 110.157 170.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -81.79 -166.61 5.19 Favored 'Cis proline' 0 C--O 1.238 0.497 0 N-CA-C 117.443 2.055 . . . . 46.94 117.443 4.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -73.63 140.69 78.65 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 117.113 -1.422 . . . . 45.91 110.925 164.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1371 ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -70.43 139.74 38.58 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.691 2.927 . . . . 46.39 107.052 164.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -65.64 -35.86 35.69 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.778 2.319 . . . . 46.72 117.073 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.235 -4.412 0 CA-C-N 120.726 1.603 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 7.1 m80 . . . . . 0 N--CA 1.438 -1.043 0 N-CA-C 104.143 -2.54 . . . . 63.44 104.143 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -106.14 65.49 0.69 Allowed 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 102.939 -2.985 . . . . 51.74 102.939 159.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1000 ' ' HIS . . . . . 0.478 ' HA ' ' CG ' ' B' 1067 ' ' GLU . 5.3 t-80 -76.1 128.03 34.16 Favored 'General case' 0 C--N 1.36 1.054 0 O-C-N 120.584 -1.322 . . . . 54.07 109.986 -173.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1001 ' ' GLY . . . . . 0.486 ' H ' ' HG3' ' B' 1067 ' ' GLU . . . 86.23 -6.47 81.6 Favored Glycine 0 C--O 1.218 -0.885 0 CA-C-O 121.656 0.587 . . . . 39.22 113.696 -169.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1002 ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -93.12 138.85 31.18 Favored 'General case' 0 C--O 1.252 1.185 0 CA-C-O 124.854 2.264 . . . . 38.12 109.482 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1003 ' ' ILE . . . . . 0.415 HG12 ' HB ' ' B' 1068 ' ' ILE . 49.0 mt -98.25 141.63 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 110.835 -2.893 . . . . 29.7 105.201 169.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1004 ' ' GLY . . . . . 0.421 ' CA ' HG22 ' B' 1063 ' ' VAL . . . -111.0 123.79 6.67 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 108.659 -1.776 . . . . 27.5 108.659 172.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1005 ' ' ILE . . . . . . . . . . . . . 41.1 mm -109.8 111.77 58.64 Favored Pre-proline 0 N--CA 1.447 -0.582 0 N-CA-C 106.515 -1.661 . . . . 24.83 106.515 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -74.7 156.36 44.36 Favored 'Trans proline' 0 N--CA 1.44 -1.626 0 C-N-CA 123.473 2.782 . . . . 27.19 115.944 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1007 ' ' ARG . . . . . 0.553 ' NH1' ' HA3' ' B' 1038 ' ' GLY . 37.3 ttt180 -79.0 96.65 5.82 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 118.782 -2.449 . . . . 41.46 106.468 162.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1008 ' ' GLU . . . . . 0.57 ' HG3' ' HB ' ' B' 1072 ' ' VAL . 2.8 mm-40 -51.94 151.5 3.55 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 118.734 2.864 . . . . 26.93 118.734 -170.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 45.1 mmm-85 -92.97 -20.72 20.32 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 112.528 -2.124 . . . . 34.48 115.535 -164.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1010 ' ' LEU . . . . . 0.545 ' HB3' ' HB2' ' B' 1013 ' ' GLU . 4.7 tp -67.74 160.21 28.59 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 119.386 0.994 . . . . 44.22 113.678 -173.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1011 ' ' THR . . . . . 0.49 HG22 HD22 ' B' 1012 ' ' ASN . 63.3 m -68.25 132.61 47.44 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 106.018 -1.845 . . . . 40.74 106.018 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1012 ' ' ASN . . . . . 0.49 HD22 HG22 ' B' 1011 ' ' THR . 27.0 m-80 62.22 22.22 13.01 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 113.984 -1.462 . . . . 44.44 112.119 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1013 ' ' GLU . . . . . 0.545 ' HB2' ' HB3' ' B' 1010 ' ' LEU . 4.7 tp10 -78.1 118.7 20.6 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 117.748 -1.581 . . . . 29.87 111.85 -173.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1014 ' ' THR . . . . . . . . . . . . . 1.6 p -105.17 -9.62 17.63 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 111.514 -2.585 . . . . 25.26 112.413 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1015 ' ' ARG . . . . . 0.501 ' HD3' ' SD ' ' B' 1133 ' ' MET . 77.4 mtm180 -77.01 110.3 11.53 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 123.546 1.641 . . . . 29.54 113.188 -176.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1016 ' ' VAL . . . . . 0.431 HG12 ' HB2' ' B' 1043 ' ' ALA . 7.2 p -87.69 120.54 36.98 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 N-CA-C 104.153 -2.536 . . . . 23.55 104.153 164.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1017 ' ' ALA . . . . . . . . . . . . . . . -62.71 -5.96 3.18 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 116.29 1.959 . . . . 23.59 116.29 -177.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1018 ' ' ALA . . . . . . . . . . . . . . . -150.34 111.95 4.48 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 123.996 1.855 . . . . 24.93 107.059 170.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1019 ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.43 164.38 40.81 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 115.14 -2.362 . . . . 28.09 111.696 172.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 0.7 OUTLIER -38.93 -46.35 2.74 Favored 'Trans proline' 0 C--N 1.362 1.245 1 C-N-CA 125.669 4.246 . . . . 28.79 117.717 -176.528 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 77.3 tttt -63.67 -49.21 74.09 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 120.086 1.312 . . . . 47.28 107.743 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1022 ' ' THR . . . . . . . . . . . . . 39.0 m -61.39 -34.98 76.26 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 114.001 1.111 . . . . 30.12 114.001 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1023 ' ' VAL . . . . . . . . . . . . . 75.4 t -51.11 -52.96 16.44 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 CA-C-N 121.239 1.836 . . . . 32.24 110.381 167.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1024 ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' B' 1028 ' ' LYS . 45.6 mt-10 -64.04 -37.1 86.2 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 113.973 1.101 . . . . 49.62 113.973 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1025 ' ' GLN . . . . . 0.473 ' O ' ' HG ' ' B' 1029 ' ' LEU . 39.2 mt-30 -56.5 -46.4 80.55 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 114.373 -1.285 . . . . 44.68 109.871 177.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 14.4 mt -72.49 -35.86 68.26 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 114.341 1.238 . . . . 35.71 114.341 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1027 ' ' LEU . . . . . . . . . . . . . 75.8 mt -63.51 -41.51 98.51 Favored 'General case' 0 C--N 1.346 0.436 0 N-CA-C 109.896 -0.409 . . . . 42.18 109.896 176.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1028 ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' B' 1024 ' ' GLU . 55.1 mttm -57.96 -40.87 81.66 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 115.897 1.814 . . . . 48.34 115.897 169.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1029 ' ' LEU . . . . . 0.518 HD11 HG13 ' B' 1332 ' ' VAL . 65.4 mt -69.67 -10.51 58.57 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 121.442 -0.787 . . . . 38.69 110.719 173.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 106.12 3.51 38.81 Favored Glycine 0 C--N 1.321 -0.294 0 O-C-N 119.861 -1.774 . . . . 32.28 112.407 166.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -90.77 158.61 16.76 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 119.957 -1.908 . . . . 35.94 108.879 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1032 ' ' THR . . . . . . . . . . . . . 5.9 m -101.06 137.33 39.56 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 103.834 -2.654 . . . . 33.37 103.834 172.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1033 ' ' VAL . . . . . . . . . . . . . 5.1 t -107.88 137.65 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 0 O-C-N 118.222 -2.799 . . . . 29.98 106.701 -172.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -128.21 131.62 48.84 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.243 -1.391 . . . . 28.18 107.243 168.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1035 ' ' VAL . . . . . 0.423 ' HB ' HD13 ' B' 1057 ' ' ILE . 87.5 t -115.79 137.34 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.286 0 CA-C-N 113.225 -1.807 . . . . 25.82 110.216 177.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1036 ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -74.13 125.98 29.55 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 107.425 -1.324 . . . . 32.44 107.425 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1037 ' ' SER . . . . . . . . . . . . . 2.8 t -58.08 121.89 11.73 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 124.313 2.006 . . . . 29.54 113.309 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1038 ' ' GLY . . . . . 0.553 ' HA3' ' NH1' ' B' 1007 ' ' ARG . . . 119.45 -26.72 7.22 Favored Glycine 0 C--O 1.259 1.678 0 CA-C-N 113.187 -1.824 . . . . 27.76 109.413 -175.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1039 ' ' ALA . . . . . . . . . . . . . . . -59.43 -32.21 69.99 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.243 1.02 . . . . 26.02 113.057 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -57.99 -51.63 57.15 Favored Glycine 0 N--CA 1.466 0.686 0 CA-C-N 113.148 -1.842 . . . . 26.47 111.918 165.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -59.46 -30.19 68.34 Favored 'General case' 0 C--O 1.251 1.149 0 CA-C-N 118.254 1.027 . . . . 50.98 112.272 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 75.2 mt -64.65 -58.01 7.47 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-N 115.784 -0.644 . . . . 29.3 110.598 167.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1043 ' ' ALA . . . . . 0.431 ' HB2' HG12 ' B' 1016 ' ' VAL . . . -74.66 14.73 0.44 Allowed 'General case' 0 C--O 1.215 -0.737 0 O-C-N 119.776 -1.828 . . . . 26.74 112.611 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1044 ' ' SER . . . . . . . . . . . . . 72.7 m 63.61 49.3 3.08 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 127.321 3.439 . . . . 31.26 112.646 174.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1045 ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.59 155.25 44.22 Favored 'General case' 0 N--CA 1.432 -1.352 0 O-C-N 119.314 -2.116 . . . . 33.26 107.056 -168.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1046 ' ' ASP . . . . . 0.532 ' HB2' ' HA ' ' A' 1305 ' ' ASN . 14.2 t70 -82.88 127.32 33.39 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 107.385 -1.339 . . . . 46.74 107.385 168.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -57.45 -32.32 66.81 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 124.439 1.096 . . . . 34.44 112.47 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1048 ' ' LYS . . . . . 0.572 ' H ' ' HD3' ' B' 1048 ' ' LYS . 0.0 OUTLIER -68.67 -14.28 62.92 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 121.024 -1.048 . . . . 48.67 111.316 178.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -68.32 -28.9 67.56 Favored 'General case' 0 C--O 1.216 -0.662 0 O-C-N 120.241 -1.537 . . . . 35.26 110.851 169.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1050 ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -69.47 -31.14 69.25 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 108.142 -1.059 . . . . 32.17 108.142 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 83.9 t -70.16 -41.55 78.95 Favored 'Isoleucine or valine' 0 C--O 1.25 1.123 0 N-CA-C 106.305 -1.739 . . . . 38.37 106.305 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -60.49 -29.59 69.17 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 123.133 1.444 . . . . 45.77 110.118 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1053 ' ' ALA . . . . . 0.405 ' HB1' ' HG3' ' B' 1024 ' ' GLU . . . -77.48 -40.17 43.92 Favored 'General case' 0 CA--C 1.5 -0.957 0 O-C-N 120.421 -1.425 . . . . 37.83 112.905 168.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 137.03 18.89 0.64 Allowed Glycine 0 C--N 1.334 0.468 0 O-C-N 120.178 -1.576 . . . . 35.82 113.834 172.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -88.93 144.32 26.26 Favored 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 120.512 2.156 . . . . 33.77 112.724 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -73.83 124.6 26.4 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 103.844 -2.65 . . . . 51.02 103.844 168.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1057 ' ' ILE . . . . . 0.423 HD13 ' HB ' ' B' 1035 ' ' VAL . 39.0 mm -89.42 116.75 31.45 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 O-C-N 120.155 -1.591 . . . . 38.47 107.752 168.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 2.8 m -112.56 139.37 37.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 O-C-N 125.785 1.928 . . . . 39.4 106.345 174.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -100.65 100.54 11.26 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 123.729 0.812 . . . . 57.07 110.012 -172.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . 102.78 -178.95 26.27 Favored Glycine 0 C--O 1.248 0.983 0 CA-C-O 123.005 1.336 . . . . 44.83 112.353 -175.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 30.2 m120 -64.47 2.59 0.6 Allowed 'General case' 0 C--O 1.239 0.523 0 N-CA-C 118.229 2.677 . . . . 46.27 118.229 -168.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1062 ' ' SER . . . . . . . . . . . . . 13.3 m -41.07 -40.77 1.55 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 127.75 2.42 . . . . 43.47 107.325 156.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1063 ' ' VAL . . . . . 0.421 HG22 ' CA ' ' B' 1004 ' ' GLY . 0.3 OUTLIER -52.62 -30.34 14.77 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 O-C-N 119.125 -2.235 . . . . 36.98 114.566 176.051 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 52.1 m95 -76.41 -22.08 55.19 Favored 'General case' 0 N--CA 1.439 -0.99 0 O-C-N 120.867 -1.145 . . . . 37.9 110.68 -174.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -85.65 84.46 7.58 Favored 'General case' 0 C--O 1.205 -1.283 0 N-CA-C 103.482 -2.785 . . . . 46.19 103.482 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1066 ' ' SER . . . . . . . . . . . . . 56.6 m -151.08 173.41 14.39 Favored 'General case' 0 C--O 1.261 1.685 0 C-N-CA 126.117 1.767 . . . . 37.06 107.523 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1067 ' ' GLU . . . . . 0.676 ' HB2' HD12 ' B' 1068 ' ' ILE . 70.9 mm-40 -82.61 -40.55 20.65 Favored 'General case' 0 N--CA 1.433 -1.298 0 O-C-N 120.428 -1.42 . . . . 43.95 111.512 174.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1068 ' ' ILE . . . . . 0.676 HD12 ' HB2' ' B' 1067 ' ' GLU . 1.2 mp -120.8 135.09 62.13 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 N-CA-C 103.777 -2.675 . . . . 33.5 103.777 -175.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1069 ' ' ILE . . . . . 0.483 HG22 ' HB2' ' B' 1071 ' ' LYS . 37.1 mm -120.21 116.06 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 101.208 -3.627 . . . . 30.57 101.208 172.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1070 ' ' LEU . . . . . 0.624 ' HB3' HD13 ' B' 1331 ' ' LEU . 30.1 mt -102.8 105.62 16.06 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 102.845 -3.02 . . . . 27.66 102.845 172.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1071 ' ' LYS . . . . . 0.483 ' HB2' HG22 ' B' 1069 ' ' ILE . 3.2 tmtm? -127.77 147.17 50.41 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 103.873 -2.64 . . . . 28.4 103.873 -168.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1072 ' ' VAL . . . . . 0.57 ' HB ' ' HG3' ' B' 1008 ' ' GLU . 25.5 t -81.4 -65.07 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.85 0 CA-C-O 117.723 -1.132 . . . . 23.18 112.201 -171.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -106.45 -159.42 0.7 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 120.843 1.656 . . . . 25.47 111.817 -161.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -64.28 142.28 98.29 Favored Pre-proline 0 CA--C 1.517 -0.317 0 CA-C-N 120.691 1.587 . . . . 27.9 111.222 -177.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -70.94 118.71 5.84 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.024 3.149 . . . . 31.62 117.116 164.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 5.3 mp -74.48 170.75 15.07 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 124.652 2.168 . . . . 40.49 107.47 166.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 36.6 t70 -56.22 -39.26 72.22 Favored 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 125.222 1.409 . . . . 51.59 113.707 -175.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -67.89 -39.12 83.69 Favored 'General case' 0 C--N 1.348 0.5 0 O-C-N 120.626 -1.296 . . . . 42.36 108.19 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1079 ' ' GLU . . . . . 0.661 ' HA ' HD12 ' B' 1082 ' ' LEU . 32.8 mt-10 -63.5 -45.54 90.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 123.501 1.619 . . . . 34.53 108.94 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1080 ' ' ILE . . . . . 0.646 HG22 ' HG3' ' B' 1108 ' ' ARG . 61.3 mt -60.67 -37.07 74.67 Favored 'Isoleucine or valine' 0 C--O 1.261 1.694 0 CA-C-N 113.354 -1.748 . . . . 33.25 110.959 176.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -74.13 -28.92 61.56 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 115.614 1.709 . . . . 36.47 115.614 172.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1082 ' ' LEU . . . . . 0.661 HD12 ' HA ' ' B' 1079 ' ' GLU . 23.3 mt -71.36 -28.26 63.93 Favored 'General case' 0 C--N 1.317 -0.821 0 O-C-N 119.933 -1.729 . . . . 37.76 110.644 173.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1083 ' ' LEU . . . . . 0.767 HD11 HD22 ' B' 1089 ' ' LEU . 28.7 mt -58.77 127.79 33.96 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 123.037 1.398 . . . . 37.43 111.997 171.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.38 133.55 42.17 Favored Pre-proline 0 C--O 1.243 0.759 0 CA-C-N 112.892 -1.958 . . . . 37.7 107.572 177.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -44.42 111.42 0.27 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 123.996 3.131 . . . . 35.51 113.68 169.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 130.2 -48.96 0.94 Allowed Glycine 0 C--N 1.31 -0.911 0 CA-C-N 110.954 -2.839 . . . . 33.87 109.645 175.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1087 ' ' THR . . . . . . . . . . . . . 72.5 m -43.74 126.84 4.82 Favored 'General case' 0 C--O 1.252 1.21 0 C-N-CA 126.051 1.74 . . . . 32.5 114.504 -165.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1088 ' ' THR . . . . . 0.432 ' HA ' ' O ' ' B' 1111 ' ' THR . 50.1 m -78.97 91.71 4.86 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-O 124.037 1.875 . . . . 30.22 109.843 -176.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1089 ' ' LEU . . . . . 0.767 HD22 HD11 ' B' 1083 ' ' LEU . 36.0 tp -76.15 137.39 40.04 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 113.112 -1.858 . . . . 27.24 111.084 170.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 56.7 t -133.95 112.12 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 103.589 -2.745 . . . . 25.39 103.589 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1091 ' ' SER . . . . . 0.405 ' OG ' ' HB3' ' B' 1071 ' ' LYS . 48.7 m -160.45 163.84 32.71 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 120.43 -1.419 . . . . 28.81 111.201 -171.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1092 ' ' PHE . . . . . 0.56 ' HD1' ' HB3' ' B' 1116 ' ' ASP . 84.5 m-85 -71.18 102.88 2.62 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.005 -1.059 . . . . 30.78 110.606 165.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 29.7 mm -85.29 -45.21 17.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 120.261 1.391 . . . . 30.28 111.807 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1094 ' ' TRP . . . . . . . . . . . . . 93.1 m95 56.21 73.52 0.82 Allowed Pre-proline 0 C--O 1.244 0.809 0 O-C-N 125.091 1.495 . . . . 34.07 110.403 -157.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -55.28 -50.16 13.88 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 123.819 3.013 . . . . 38.66 115.951 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -64.67 -33.05 75.03 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-O 123.057 1.408 . . . . 41.32 110.096 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 8.4 mp0 -80.25 -17.58 51.8 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 116.711 -1.614 . . . . 51.66 110.378 175.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -142.46 59.89 9.33 Favored Pre-proline 0 N--CA 1.481 1.092 0 CA-C-N 122.588 2.449 . . . . 40.32 111.591 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -59.55 -32.72 96.59 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 123.621 2.881 . . . . 41.56 112.955 177.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -63.46 -47.71 80.72 Favored 'General case' 0 C--O 1.206 -1.196 0 CA-C-O 123.001 1.381 . . . . 54.11 109.217 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1101 ' ' LEU . . . . . . . . . . . . . 5.1 tp -62.95 -45.71 91.18 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 113.313 -1.767 . . . . 37.88 108.547 -176.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1102 ' ' MET . . . . . . . . . . . . . 67.9 mmm -49.77 -51.31 40.2 Favored 'General case' 0 CA--C 1.498 -1.03 0 C-N-CA 124.122 0.969 . . . . 37.54 109.994 169.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1103 ' ' GLN . . . . . 0.468 HE21 ' HG3' ' B' 1107 ' ' GLU . 42.3 tp60 -62.83 -36.13 82.22 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 118.772 -1.171 . . . . 47.01 113.922 -177.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1104 ' ' LYS . . . . . . . . . . . . . 93.2 mttt -60.95 -45.8 93.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 120.139 -0.624 . . . . 48.68 112.352 173.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1105 ' ' LEU . . . . . 0.64 HD13 HG21 ' B' 1112 ' ' VAL . 73.9 mt -57.89 -43.35 86.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 124.839 2.257 . . . . 32.21 114.95 175.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -56.24 -55.59 31.45 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 112.089 -2.323 . . . . 33.73 111.717 172.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1107 ' ' GLU . . . . . 0.468 ' HG3' HE21 ' B' 1103 ' ' GLN . 45.9 mt-10 -65.51 -20.69 66.45 Favored 'General case' 0 C--N 1.359 1.01 0 O-C-N 118.811 -2.431 . . . . 51.47 114.159 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1108 ' ' ARG . . . . . 0.646 ' HG3' HG22 ' B' 1080 ' ' ILE . 26.4 mmm180 -82.96 -1.51 52.65 Favored 'General case' 0 C--N 1.348 0.543 0 N-CA-C 114.249 1.204 . . . . 43.9 114.249 170.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1109 ' ' ASN . . . . . . . . . . . . . 12.1 m-80 61.93 28.87 17.6 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 118.813 2.894 . . . . 44.82 118.813 171.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1110 ' ' VAL . . . . . 0.664 HG11 ' HB3' ' B' 1083 ' ' LEU . 30.0 m -89.77 170.04 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.28 0 CA-C-N 113.486 -1.688 . . . . 30.52 111.921 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1111 ' ' THR . . . . . 0.432 ' O ' ' HA ' ' B' 1088 ' ' THR . 59.1 m -111.21 119.02 37.55 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 104.417 -2.438 . . . . 27.12 104.417 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1112 ' ' VAL . . . . . 0.64 HG21 HD13 ' B' 1105 ' ' LEU . 34.3 t -119.15 126.5 75.41 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 CA-C-O 118.726 -0.654 . . . . 26.4 110.129 -171.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1113 ' ' MET . . . . . 0.53 ' HA ' ' O ' ' B' 1358 ' ' VAL . 0.9 OUTLIER -101.01 115.41 30.43 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 106.011 -1.848 . . . . 42.92 106.011 168.048 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B 1114 ' ' ALA . . . . . 0.452 ' HB3' ' HB2' ' B' 1117 ' ' SER . . . -85.91 104.11 15.26 Favored 'General case' 0 N--CA 1.426 -1.631 0 C-N-CA 119.118 -1.033 . . . . 24.15 109.909 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1115 ' ' MET . . . . . . . . . . . . . 44.2 mmm -59.35 -14.86 13.24 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 116.326 1.972 . . . . 29.95 116.326 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1116 ' ' ASP . . . . . 0.56 ' HB3' ' HD1' ' B' 1092 ' ' PHE . 7.5 p-10 -86.42 -37.95 17.85 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 108.246 -1.02 . . . . 34.53 108.246 172.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1117 ' ' SER . . . . . 0.452 ' HB2' ' HB3' ' B' 1114 ' ' ALA . 68.4 m -95.05 38.51 1.13 Allowed 'General case' 0 C--N 1.316 -0.863 0 O-C-N 118.605 -2.56 . . . . 33.49 110.066 -173.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1118 ' ' VAL . . . . . 0.648 HG12 ' HB1' ' B' 1124 ' ' ALA . 2.2 t -78.47 133.22 63.78 Favored Pre-proline 0 N--CA 1.468 0.453 0 N-CA-C 105.8 -1.926 . . . . 34.02 105.8 169.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -47.21 142.16 12.34 Favored 'Trans proline' 0 C--N 1.328 -0.507 1 C-N-CA 126.321 4.681 . . . . 38.28 115.224 -176.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1120 ' ' ARG . . . . . 0.477 HH12 ' CG ' ' B' 1128 ' ' ASP . 0.4 OUTLIER -81.58 56.62 3.04 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 114.226 1.195 . . . . 55.05 114.226 -175.528 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B 1121 ' ' ILE . . . . . 0.609 HD12 ' HB3' ' B' 1123 ' ' ARG . 13.1 pt -129.4 149.22 33.45 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 107.969 -1.123 . . . . 42.09 107.969 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1122 ' ' SER . . . . . . . . . . . . . 48.6 m -51.14 -32.48 23.16 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 116.894 2.183 . . . . 38.02 116.894 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1123 ' ' ARG . . . . . 0.609 ' HB3' HD12 ' B' 1121 ' ' ILE . 6.9 tpt180 -58.02 -39.05 77.37 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.642 1.577 . . . . 34.29 109.219 174.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1124 ' ' ALA . . . . . 0.648 ' HB1' HG12 ' B' 1118 ' ' VAL . . . -84.19 -30.82 25.48 Favored 'General case' 0 C--O 1.206 -1.191 0 O-C-N 121.241 -0.912 . . . . 32.35 111.419 175.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1125 ' ' GLN . . . . . 0.466 ' HA ' ' HB3' ' B' 1128 ' ' ASP . 13.9 mm100 -58.85 -26.84 64.57 Favored 'General case' 0 C--N 1.348 0.534 0 N-CA-C 118.304 2.705 . . . . 47.17 118.304 -165.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1126 ' ' SER . . . . . . . . . . . . . 1.4 p -72.04 -34.49 68.81 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 124.183 1.944 . . . . 31.71 110.805 173.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1127 ' ' LEU . . . . . 0.656 HD23 HD12 ' B' 1334 ' ' LEU . 2.5 mp -80.64 -30.84 36.6 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 113.304 -1.771 . . . . 37.0 110.363 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1128 ' ' ASP . . . . . 0.579 ' HA ' HG21 ' B' 1118 ' ' VAL . 10.1 t70 -62.74 123.43 18.42 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 114.554 1.316 . . . . 40.4 114.554 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1129 ' ' ALA . . . . . . . . . . . . . . . -70.12 -35.17 73.91 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 115.671 -0.695 . . . . 26.56 112.359 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 46.7 mt -57.48 -33.53 68.09 Favored 'General case' 0 CA--C 1.557 1.248 0 CA-C-O 115.635 -2.126 . . . . 30.89 111.751 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1131 ' ' SER . . . . . . . . . . . . . 59.7 p -57.15 -56.99 14.58 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 119.825 1.193 . . . . 29.84 113.047 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1132 ' ' SER . . . . . 0.414 ' HB3' ' HB3' ' B' 1326 ' ' LEU . 24.9 m -64.93 -39.29 93.28 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 126.121 2.138 . . . . 31.91 111.862 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1133 ' ' MET . . . . . 0.614 ' HB3' ' HB3' ' B' 1316 ' ' PRO . 36.4 mmt -69.73 -30.61 68.26 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 113.102 0.779 . . . . 25.9 113.102 178.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1134 ' ' ALA . . . . . . . . . . . . . . . -72.52 -39.04 67.89 Favored 'General case' 0 N--CA 1.415 -2.222 0 CA-C-N 114.447 -1.251 . . . . 26.62 107.95 174.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.85 -35.22 79.54 Favored 'General case' 0 C--O 1.215 -0.763 0 CA-C-N 119.506 1.048 . . . . 36.97 110.902 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1136 ' ' ILE . . . . . 0.428 HG21 ' O ' ' B' 1316 ' ' PRO . 39.5 mm -64.09 -53.67 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 102.457 -3.164 . . . . 32.11 102.457 174.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -55.25 -37.16 66.86 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 114.23 1.196 . . . . 24.14 114.23 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -71.64 -43.28 52.53 Favored Glycine 0 C--N 1.308 -1.018 0 CA-C-N 118.273 0.488 . . . . 25.13 114.291 178.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 34.6 t80 -71.01 -41.59 70.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 123.316 1.531 . . . . 32.73 112.535 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1140 ' ' ARG . . . . . 0.61 HH11 HD13 ' B' 1319 ' ' LEU . 13.2 tpt180 -67.98 -28.59 67.58 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 113.463 -1.699 . . . . 26.36 110.552 175.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1141 ' ' ALA . . . . . . . . . . . . . . . -58.95 -51.46 69.96 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 105.931 -1.877 . . . . 24.12 105.931 174.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 20.6 mm -59.03 -42.29 85.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-O 117.84 -1.076 . . . . 23.37 109.686 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 76.4 t -58.97 -62.41 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 119.528 1.058 . . . . 24.96 113.454 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -62.85 -35.58 80.43 Favored 'General case' 0 C--O 1.267 1.983 0 O-C-N 124.384 1.053 . . . . 32.07 110.258 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1145 ' ' ALA . . . . . 0.655 ' HB1' HD12 ' B' 1251 ' ' ILE . . . -54.65 -61.58 2.22 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.124 0.57 . . . . 24.87 112.085 167.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1146 ' ' ALA . . . . . 0.402 ' HB2' ' CE1' ' B' 1153 ' ' PHE . . . -58.85 -27.5 65.2 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 118.965 -2.334 . . . . 24.67 114.893 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 62.1 t60 -63.57 -45.87 88.51 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 114.374 -1.285 . . . . 28.58 109.973 170.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1148 ' ' GLU . . . . . 0.689 ' HB3' ' HD2' ' B' 1308 ' ' LYS . 71.5 mm-40 -100.59 4.89 43.76 Favored 'General case' 0 C--O 1.255 1.343 0 N-CA-C 114.628 1.344 . . . . 36.82 114.628 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1149 ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' B' 1145 ' ' ALA . 1.4 t80 -76.45 146.09 38.83 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 123.719 1.723 . . . . 31.97 108.099 -174.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1150 ' ' GLY . . . . . . . . . . . . . . . -66.29 -43.82 92.05 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 113.355 -1.748 . . . . 25.49 109.682 170.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1151 ' ' ARG . . . . . 0.699 ' HA ' ' HB2' ' A' 1322 ' ' GLN . 75.2 mtm-85 -119.89 -171.58 2.17 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 117.983 0.892 . . . . 59.84 113.374 -163.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1152 ' ' PHE . . . . . 0.574 ' HB2' HG11 ' B' 1163 ' ' VAL . 17.4 m-30 -88.65 159.11 18.0 Favored 'General case' 0 C--O 1.238 0.486 0 O-C-N 120.264 -1.522 . . . . 34.45 111.759 169.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1153 ' ' PHE . . . . . 0.431 ' CZ ' HG13 ' B' 1251 ' ' ILE . 14.5 m-85 -77.02 -56.59 4.45 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 114.205 -1.361 . . . . 31.17 112.809 171.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1154 ' ' THR . . . . . . . . . . . . . 12.1 m -65.05 142.07 58.53 Favored 'General case' 0 C--O 1.25 1.131 0 CA-C-O 121.899 0.857 . . . . 33.89 109.956 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1155 ' ' GLY . . . . . 0.496 ' HA3' ' HG3' ' B' 1165 ' ' PRO . . . -73.06 59.0 1.83 Allowed Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 110.515 -1.034 . . . . 38.95 110.515 170.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -77.24 134.6 38.54 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 124.938 1.295 . . . . 54.23 110.646 -160.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 15.0 mm -80.68 116.58 25.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 101.454 -3.535 . . . . 51.16 101.454 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1158 ' ' THR . . . . . . . . . . . . . 31.5 m -122.22 155.07 36.6 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.305 1.05 . . . . 49.61 108.396 -175.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -26.36 -61.2 0.08 Allowed 'General case' 0 C--O 1.212 -0.907 0 N-CA-C 119.422 3.119 . . . . 49.05 119.422 172.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1160 ' ' ALA . . . . . 0.654 ' HB1' ' HB ' ' A' 1329 ' ' THR . . . -57.94 -51.03 71.32 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 114.299 1.222 . . . . 47.65 114.299 170.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . 179.6 178.59 48.5 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-O 122.225 0.903 . . . . 45.61 113.717 -165.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 84.4 mttt -79.3 140.61 37.52 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 123.083 1.42 . . . . 57.46 109.764 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1163 ' ' VAL . . . . . 0.574 HG11 ' HB2' ' B' 1152 ' ' PHE . 48.6 t -90.99 130.11 41.62 Favored Pre-proline 0 C--N 1.299 -1.624 0 CA-C-O 116.5 -1.714 . . . . 42.93 107.603 173.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1164 ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' B' 1165 ' ' PRO . 37.9 Cg_endo -59.33 135.83 68.0 Favored 'Trans proline' 0 N--CA 1.479 0.667 0 C-N-CA 123.906 3.071 . . . . 39.29 111.865 167.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1165 ' ' PRO . . . . . 0.496 ' HG3' ' HA3' ' B' 1155 ' ' GLY . 27.9 Cg_exo -67.31 141.46 56.68 Favored 'Trans proline' 0 C--O 1.255 1.327 0 C-N-CA 123.287 2.658 . . . . 34.17 114.254 177.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -73.09 127.68 33.29 Favored 'General case' 0 C--O 1.253 1.266 0 N-CA-C 105.826 -1.916 . . . . 31.69 105.826 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1167 ' ' LYS . . . . . 0.658 ' HB2' ' HA ' ' B' 1249 ' ' VAL . 93.6 mttt -93.81 108.27 20.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 123.201 1.477 . . . . 44.78 107.949 168.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 87.7 t -94.24 95.44 5.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 113.766 -1.561 . . . . 31.23 108.153 -172.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1169 ' ' MET . . . . . 0.563 ' HB2' HG11 ' B' 1249 ' ' VAL . 54.8 ttp -79.83 95.69 6.11 Favored 'General case' 0 C--O 1.245 0.831 0 O-C-N 120.534 -1.354 . . . . 37.09 108.759 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 24.3 t -93.22 99.2 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 N-CA-C 106.435 -1.691 . . . . 30.17 106.435 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1171 ' ' ILE . . . . . 0.401 HG23 ' HD2' ' B' 1194 ' ' PHE . 35.4 mt -93.38 119.75 41.66 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 N-CA-C 105.677 -1.972 . . . . 33.74 105.677 -175.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 98.68 62.52 0.86 Allowed Glycine 0 C--N 1.346 1.131 0 N-CA-C 108.44 -1.864 . . . . 32.59 108.44 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1173 ' ' ALA . . . . . 0.809 ' HA ' ' HA3' ' B' 1177 ' ' GLY . . . -74.44 60.34 0.86 Allowed 'General case' 0 C--O 1.247 0.944 0 N-CA-C 114.89 1.441 . . . . 32.42 114.89 176.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -87.95 -158.76 33.64 Favored Glycine 0 C--O 1.213 -1.203 0 N-CA-C 105.642 -2.983 . . . . 31.74 105.642 160.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 3.7 t -54.42 -39.1 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-N 120.432 2.116 . . . . 31.48 112.439 -172.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1176 ' ' ALA . . . . . 0.614 ' HB3' HG21 ' B' 1255 ' ' THR . . . -67.14 -38.24 85.17 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 120.689 -1.257 . . . . 26.12 110.977 178.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1177 ' ' GLY . . . . . 0.809 ' HA3' ' HA ' ' B' 1173 ' ' ALA . . . -55.29 -54.12 36.34 Favored Glycine 0 C--O 1.208 -1.519 0 C-N-CA 124.534 1.064 . . . . 25.73 110.759 174.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1178 ' ' LEU . . . . . 0.447 ' HA ' HD12 ' B' 1181 ' ' ILE . 15.6 mt -65.39 -30.03 70.8 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 113.285 -1.457 . . . . 32.59 110.846 -177.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -68.82 -42.19 77.58 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.765 -0.584 . . . . 27.72 109.782 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -70.25 -37.57 74.96 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 107.498 -1.297 . . . . 26.03 107.498 -174.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1181 ' ' ILE . . . . . 0.748 HG12 HG11 ' B' 1191 ' ' VAL . 13.3 mt -63.06 -48.8 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 107.342 -1.355 . . . . 28.61 107.342 171.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -58.38 -26.7 59.66 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-O 118.724 -1.042 . . . . 25.23 115.203 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -90.11 -60.78 1.84 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 118.683 1.241 . . . . 24.09 111.308 174.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -61.05 -44.92 96.67 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 116.097 1.888 . . . . 26.68 116.097 -175.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 5.0 t30 -66.14 -45.91 79.37 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 118.099 -0.953 . . . . 36.57 109.344 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1186 ' ' SER . . . . . . . . . . . . . 16.1 m -56.21 -45.61 79.8 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 120.577 1.535 . . . . 28.92 112.876 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1187 ' ' LEU . . . . . . . . . . . . . 58.6 mt -45.1 -52.35 9.23 Favored 'General case' 0 C--O 1.246 0.879 0 O-C-N 123.934 0.771 . . . . 29.09 112.788 165.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 128.41 27.24 0.91 Allowed Glycine 0 N--CA 1.438 -1.175 0 O-C-N 121.26 -0.9 . . . . 29.26 112.969 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1189 ' ' ALA . . . . . 0.428 ' HB2' ' HB3' ' B' 1153 ' ' PHE 0.259 . . -102.48 146.11 28.59 Favored 'General case' 0 C--O 1.251 1.176 0 N-CA-C 107.747 -1.205 . . . . 30.16 107.747 -179.115 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B 1190 ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' B' 1167 ' ' LYS . 74.0 mt -83.82 103.94 11.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 103.178 -2.897 . . . . 35.81 103.178 -171.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1191 ' ' VAL . . . . . 0.748 HG11 HG12 ' B' 1181 ' ' ILE . 53.0 t -81.26 131.85 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.646 0 N-CA-C 104.903 -2.258 . . . . 31.97 104.903 176.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1192 ' ' ARG . . . . . 0.454 ' HG2' ' HB3' ' B' 1210 ' ' GLU . 33.2 mtt180 -120.57 89.85 3.21 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 109.827 -3.351 . . . . 48.16 104.946 171.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -90.31 130.29 36.43 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.401 -1.272 . . . . 35.89 113.151 -176.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1194 ' ' PHE . . . . . 0.401 ' HD2' HG23 ' B' 1171 ' ' ILE . 35.2 t80 -106.31 144.12 33.45 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.72 -1.215 . . . . 41.88 107.72 175.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1195 ' ' ASP . . . . . . . . . . . . . 8.9 t70 -157.98 153.26 25.82 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 104.417 -2.438 . . . . 38.28 104.417 160.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1196 ' ' THR . . . . . . . . . . . . . 13.4 p -84.25 -10.04 58.0 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.114 0.783 . . . . 40.62 113.114 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1197 ' ' ARG . . . . . 0.403 ' HA ' ' HD2' ' B' 1198 ' ' PRO . 39.9 mtm180 -91.43 126.6 53.93 Favored Pre-proline 0 C--O 1.247 0.969 0 C-N-CA 124.294 1.038 . . . . 53.09 108.353 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1198 ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' B' 1197 ' ' ARG . 13.9 Cg_endo -52.6 -45.7 38.37 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 N-CA-C 121.264 3.525 . . . . 42.56 121.264 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1199 ' ' GLU . . . . . 0.862 ' HB2' ' HE1' ' C' ' 155' ' ' TYR . 0.0 OUTLIER -72.66 -8.42 55.21 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 118.351 -2.718 . . . . 56.31 114.094 -157.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B 1200 ' ' VAL . . . . . 0.541 ' HA ' ' HG2' ' B' 1203 ' ' GLN . 34.5 m -85.06 -17.46 9.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 120.799 -1.188 . . . . 42.91 111.257 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1201 ' ' LYS . . . . . 0.494 ' HG3' ' CD2' ' B' 1211 ' ' PHE . 49.1 tttm -50.39 -54.26 23.12 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 121.428 1.922 . . . . 48.89 112.252 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 20.6 mp0 -64.64 -21.96 66.85 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 116.715 2.117 . . . . 51.7 116.715 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1203 ' ' GLN . . . . . 0.581 ' OE1' ' HA ' ' C' ' 74' ' ' ARG . 29.9 mm-40 -64.98 -48.16 74.98 Favored 'General case' 0 C--O 1.248 1.0 0 O-C-N 118.647 -2.533 . . . . 52.57 110.197 172.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1204 ' ' VAL . . . . . 0.444 HG22 HD13 ' B' 1181 ' ' ILE . 12.1 t -59.97 -54.2 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 112.144 -2.298 . . . . 33.79 108.504 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -51.08 -51.73 50.4 Favored 'General case' 0 C--O 1.203 -1.362 0 C-N-CA 124.579 1.152 . . . . 36.58 112.88 177.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1206 ' ' SER . . . . . . . . . . . . . 16.5 m -71.41 -7.58 48.23 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 115.634 1.716 . . . . 39.61 115.634 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1207 ' ' MET . . . . . 0.495 ' SD ' HG22 ' B' 1181 ' ' ILE . 27.5 mtp -80.21 -38.71 30.58 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 123.118 1.437 . . . . 37.45 112.012 167.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 121.58 46.87 0.31 Allowed Glycine 0 CA--C 1.519 0.297 0 CA-C-N 112.035 -2.348 . . . . 31.87 108.031 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -142.36 150.28 40.51 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 114.033 -1.083 . . . . 35.4 110.233 -168.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1210 ' ' GLU . . . . . 0.454 ' HB3' ' HG2' ' B' 1192 ' ' ARG . 10.4 tt0 -81.58 139.51 35.02 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 125.677 1.861 . . . . 47.89 107.421 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1211 ' ' PHE . . . . . 0.494 ' CD2' ' HG3' ' B' 1201 ' ' LYS . 87.7 t80 -107.21 114.24 28.16 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 106.244 -1.761 . . . . 45.53 106.244 170.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1212 ' ' LEU . . . . . . . . . . . . . 62.7 mt -65.94 116.65 7.31 Favored 'General case' 0 N--CA 1.441 -0.913 0 O-C-N 120.616 -1.303 . . . . 46.33 108.075 170.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -80.99 175.81 10.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 122.964 1.364 . . . . 60.41 111.932 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 25.4 mt -56.92 132.0 51.33 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 112.705 -2.043 . . . . 57.38 108.998 168.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 15.1 t70 . . . . . 0 N--CA 1.443 -0.777 0 C-N-CA 124.354 1.062 . . . . 65.07 108.848 -177.102 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B 1230 ' ' MET . . . . . 0.62 ' N ' ' HG ' ' B' 1231 ' ' SER . 3.0 mmt . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 105.121 -2.178 . . . . 80.32 105.121 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1231 ' ' SER . . . . . 0.62 ' HG ' ' N ' ' B' 1230 ' ' MET . 4.8 m 103.83 159.49 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.085 2 O-C-N 114.398 -5.189 . . . . 79.92 114.175 -18.343 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -56.06 154.0 8.22 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 116.579 2.066 . . . . 77.91 116.579 -172.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 66.39 -53.79 0.41 Allowed 'General case' 0 C--N 1.356 0.873 0 C-N-CA 126.273 1.829 . . . . 73.88 112.688 -172.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 32.2 t80 -60.5 -35.7 76.59 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-N 121.025 1.739 . . . . 68.98 109.227 171.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1235 ' ' ILE . . . . . 0.472 ' O ' ' HG2' ' B' 1239 ' ' MET . 15.4 pt -47.46 -32.69 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 120.22 1.373 . . . . 64.53 114.175 169.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -60.17 -46.02 91.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 117.994 -2.941 . . . . 66.36 111.75 169.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -69.5 -29.94 67.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 123.229 1.49 . . . . 56.6 111.527 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -63.79 -48.38 77.13 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 114.16 -1.382 . . . . 56.79 109.196 175.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1239 ' ' MET . . . . . 0.472 ' HG2' ' O ' ' B' 1235 ' ' ILE . 29.6 mmt -57.47 -55.98 27.73 Favored 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 125.359 1.464 . . . . 53.63 107.343 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -53.9 -29.44 41.91 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 114.643 1.349 . . . . 51.74 114.643 176.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 58.3 tp -70.02 -43.46 71.29 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 108.978 -0.749 . . . . 44.86 108.978 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1242 ' ' PHE . . . . . 0.408 ' HB3' ' HE3' ' B' 1169 ' ' MET . 8.9 m-30 -74.08 -39.94 63.1 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 124.722 1.264 . . . . 42.78 111.408 -178.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.97 93.77 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.373 -0.831 . . . . 40.96 109.86 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -60.25 -49.13 78.81 Favored 'General case' 0 C--N 1.316 -0.879 0 O-C-N 121.195 -0.941 . . . . 43.06 110.368 172.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -65.38 -24.19 67.16 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 113.052 -1.885 . . . . 46.45 110.842 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1246 ' ' ALA . . . . . 0.547 ' HB1' ' HA ' ' B' 1275 ' ' MET . . . -48.84 -39.75 26.8 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 119.589 3.181 . . . . 41.78 119.589 -174.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 12.3 mptt -67.91 -31.7 71.65 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.224 -1.548 . . . . 52.2 112.324 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1248 ' ' GLU . . . . . 0.498 ' HB3' ' HD2' ' B' 1167 ' ' LYS . 33.5 mt-10 -80.97 -44.17 18.57 Favored 'General case' 0 C--O 1.251 1.158 0 CA-C-N 114.168 -1.378 . . . . 53.55 111.885 -177.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1249 ' ' VAL . . . . . 0.658 ' HA ' ' HB2' ' B' 1167 ' ' LYS . 35.2 m -85.72 150.36 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 124.454 2.073 . . . . 34.41 111.135 -165.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1250 ' ' ASP . . . . . 0.578 ' O ' ' HB3' ' B' 1279 ' ' SER . 1.5 m-20 -108.08 -47.59 3.53 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 110.749 -2.932 . . . . 33.38 111.328 -176.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1251 ' ' ILE . . . . . 0.655 HD12 ' HB1' ' B' 1145 ' ' ALA . 33.0 mm -119.21 125.15 74.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 105.978 -1.86 . . . . 29.54 105.978 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1252 ' ' ILE . . . . . 0.517 HD12 HG12 ' B' 1281 ' ' ILE . 79.8 mt -103.68 118.56 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 104.583 -2.377 . . . . 32.44 104.583 172.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1253 ' ' VAL . . . . . 0.426 HG23 HG22 ' B' 1251 ' ' ILE . 52.9 t -111.39 89.99 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.072 0 N-CA-C 104.433 -2.432 . . . . 30.57 104.433 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1254 ' ' THR . . . . . . . . . . . . . 14.1 t -101.44 131.94 47.3 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 113.736 -1.575 . . . . 35.04 109.027 -169.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1255 ' ' THR . . . . . 0.614 HG21 ' HB3' ' B' 1176 ' ' ALA . 2.6 m -146.93 31.43 0.94 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.875 -1.057 . . . . 34.62 113.14 -157.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . -73.7 75.62 1.55 Allowed 'General case' 0 C--O 1.244 0.804 0 O-C-N 117.842 -3.036 . . . . 42.72 111.483 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 32.7 mt -83.83 79.18 9.56 Favored 'General case' 0 C--O 1.248 0.976 0 CA-C-O 123.677 1.703 . . . . 52.43 108.084 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1258 ' ' ILE . . . . . 0.461 HG13 ' HB2' ' B' 1261 ' ' LYS . 27.2 pt -81.86 132.91 52.88 Favored Pre-proline 0 N--CA 1.448 -0.568 0 CA-C-N 113.357 -1.747 . . . . 59.41 109.985 -173.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -49.59 99.33 0.04 OUTLIER 'Trans proline' 0 CA--C 1.495 -1.451 0 N-CA-C 120.113 3.082 . . . . 62.68 120.113 -166.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 74.09 3.81 65.93 Favored Glycine 0 N--CA 1.432 -1.574 0 CA-C-N 112.604 -2.089 . . . . 64.16 112.698 173.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1261 ' ' LYS . . . . . 0.461 ' HB2' HG13 ' B' 1258 ' ' ILE . 95.0 mttt -105.53 164.7 14.51 Favored Pre-proline 0 C--O 1.211 -0.946 0 CA-C-O 115.919 -1.991 . . . . 68.53 110.991 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -70.92 142.24 42.36 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 CA-C-N 126.654 3.412 . . . . 61.99 111.957 167.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1263 ' ' ALA . . . . . 0.545 ' H ' ' HA3' ' B' 1289 ' ' GLY . . . -62.68 135.91 95.96 Favored Pre-proline 0 C--O 1.249 1.073 0 N-CA-C 113.851 1.056 . . . . 57.15 113.851 173.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -64.91 154.26 73.98 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 121.991 1.794 . . . . 51.57 114.647 173.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -81.96 82.69 7.49 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 118.649 -1.221 . . . . 54.55 109.019 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 62.5 mt -64.98 -48.19 74.87 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-O 123.125 1.441 . . . . 46.86 113.399 175.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1267 ' ' ILE . . . . . 0.827 HG21 HD13 ' B' 1281 ' ' ILE . 22.9 mm -96.0 97.56 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 122.088 0.947 . . . . 41.04 108.896 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1268 ' ' THR . . . . . 0.424 ' O ' HG23 ' B' 1272 ' ' VAL . 18.1 p -76.5 162.04 28.14 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 113.732 -1.576 . . . . 39.58 113.197 177.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1269 ' ' ARG . . . . . 0.547 ' HG3' ' HB2' ' B' 1293 ' ' GLU . 82.4 mtt85 -59.24 -36.05 74.78 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 124.376 1.07 . . . . 53.15 111.296 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -50.65 -58.65 5.34 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 114.57 -1.196 . . . . 42.96 111.638 167.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1271 ' ' MET . . . . . . . . . . . . . 28.6 ttm -60.08 -33.55 72.22 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.637 1.347 . . . . 43.89 114.637 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1272 ' ' VAL . . . . . 0.424 HG23 ' O ' ' B' 1268 ' ' THR . 58.1 t -66.27 -48.05 82.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 109.048 -0.723 . . . . 38.37 109.048 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 4.7 t70 -77.25 -27.43 53.28 Favored 'General case' 0 C--O 1.244 0.776 0 O-C-N 121.617 -0.677 . . . . 47.46 110.059 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1274 ' ' SER . . . . . . . . . . . . . 67.3 m -74.13 -24.27 59.4 Favored 'General case' 0 C--O 1.246 0.878 0 CA-C-N 115.962 -0.563 . . . . 38.38 111.814 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1275 ' ' MET . . . . . 0.547 ' HA ' ' HB1' ' B' 1246 ' ' ALA . 1.0 OUTLIER -60.51 163.19 5.53 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 115.553 1.686 . . . . 37.81 115.553 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -56.12 130.04 42.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 113.742 -1.572 . . . . 49.26 110.219 169.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -60.59 159.63 10.34 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.732 -1.576 . . . . 34.46 111.141 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1278 ' ' GLY . . . . . 0.446 ' HA2' ' HB3' ' A' 1044 ' ' SER . . . 64.78 33.54 87.51 Favored Glycine 0 CA--C 1.521 0.421 0 O-C-N 121.427 -0.795 . . . . 33.53 113.526 172.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1279 ' ' SER . . . . . 0.578 ' HB3' ' O ' ' B' 1250 ' ' ASP . 15.2 m -133.94 167.28 20.89 Favored 'General case' 0 C--O 1.262 1.763 0 C-N-CA 123.481 0.712 . . . . 31.31 111.598 -164.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1280 ' ' VAL . . . . . 0.466 HG11 ' HA ' ' B' 1145 ' ' ALA . 66.9 t -127.01 131.06 71.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 O-C-N 119.868 -1.77 . . . . 29.32 111.118 -173.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1281 ' ' ILE . . . . . 0.827 HD13 HG21 ' B' 1267 ' ' ILE . 91.3 mt -103.25 99.37 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 102.505 -3.146 . . . . 31.93 102.505 169.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1282 ' ' VAL . . . . . . . . . . . . . 17.4 t -82.52 115.04 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 105.121 -2.177 . . . . 29.48 105.121 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1283 ' ' ASP . . . . . 0.453 ' HB3' ' HA2' ' B' 1311 ' ' GLY . 42.8 t0 -97.99 112.64 24.5 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 123.819 1.771 . . . . 34.5 106.76 174.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1284 ' ' LEU . . . . . 0.58 ' HG ' HD13 ' B' 1315 ' ' LEU . 7.3 mp -90.6 -21.28 21.8 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 113.64 -1.618 . . . . 37.94 110.215 -176.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -96.87 16.68 18.64 Favored 'General case' 0 C--O 1.25 1.115 0 CA-C-O 121.503 0.668 . . . . 40.92 111.784 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1286 ' ' ALA . . . . . 0.707 ' HA ' ' HA2' ' B' 1290 ' ' GLY . . . -63.5 -34.89 78.76 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 122.756 1.265 . . . . 44.39 112.399 -167.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1287 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -45.99 74.36 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 115.237 -0.892 . . . . 51.46 109.656 174.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.4 37.75 1.62 Allowed 'General case' 0 C--O 1.245 0.843 0 CA-C-O 125.214 2.435 . . . . 57.75 108.856 -167.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1289 ' ' GLY . . . . . 0.545 ' HA3' ' H ' ' B' 1263 ' ' ALA . . . 139.57 -61.75 0.56 Allowed Glycine 0 N--CA 1.433 -1.532 0 O-C-N 119.147 -2.221 . . . . 49.85 111.869 175.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1290 ' ' GLY . . . . . 0.707 ' HA2' ' HA ' ' B' 1286 ' ' ALA . . . 96.19 114.39 2.98 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 107.519 -2.232 . . . . 45.93 107.519 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1291 ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -72.86 -16.26 61.59 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.314 -0.995 . . . . 42.67 108.314 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1292 ' ' CYS . . . . . 0.52 ' HB3' ' OG1' ' B' 1295 ' ' THR . 25.3 t -118.93 139.09 52.24 Favored 'General case' 0 N--CA 1.432 -1.33 0 O-C-N 118.748 -2.47 . . . . 38.82 113.265 -175.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1293 ' ' GLU . . . . . 0.547 ' HB2' ' HG3' ' B' 1269 ' ' ARG . 51.2 mt-10 -66.81 -40.84 88.21 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 118.745 -0.645 . . . . 46.71 112.441 177.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.08 -6.41 50.99 Favored 'General case' 0 C--O 1.239 0.531 0 O-C-N 125.866 1.979 . . . . 47.23 113.124 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1295 ' ' THR . . . . . 0.713 HG23 ' HA3' ' B' 1311 ' ' GLY . 74.1 m -52.67 137.76 30.24 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 124.955 2.312 . . . . 36.02 112.025 172.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1296 ' ' VAL . . . . . 0.476 ' HB ' ' HB2' ' B' 1299 ' ' GLU . 3.7 t -117.42 105.14 48.94 Favored Pre-proline 0 C--N 1.321 -0.643 1 N-CA-C 96.65 -5.315 . . . . 37.26 96.65 168.382 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -56.7 128.42 29.93 Favored 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 124.968 3.779 . . . . 35.09 111.311 177.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 96.12 -17.46 59.24 Favored Glycine 0 C--N 1.315 -0.615 0 CA-C-O 122.288 0.938 . . . . 35.97 112.296 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1299 ' ' GLU . . . . . 0.476 ' HB2' ' HB ' ' B' 1296 ' ' VAL . 28.6 mt-10 -123.44 173.64 7.88 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 123.822 1.772 . . . . 40.39 110.751 -171.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1300 ' ' ILE . . . . . 0.6 HD13 ' HG3' ' B' 1148 ' ' GLU . 96.4 mt -113.55 105.96 19.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 110.744 -2.935 . . . . 37.43 103.088 177.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1301 ' ' PHE . . . . . 0.507 ' HB3' ' HB ' ' B' 1309 ' ' VAL . 76.6 t80 -73.1 148.5 43.92 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.347 -1.353 . . . . 44.13 107.347 171.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1302 ' ' THR . . . . . . . . . . . . . 40.7 m -140.46 119.41 12.65 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 122.773 2.533 . . . . 39.78 106.538 175.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1303 ' ' THR . . . . . 0.454 HG23 ' HE2' ' B' 1301 ' ' PHE . 2.7 p -74.21 175.15 7.82 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.854 0.835 . . . . 43.29 109.801 171.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -74.66 -25.39 59.15 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-O 121.849 0.833 . . . . 53.07 109.801 -174.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -80.47 -7.99 59.38 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.342 -0.984 . . . . 43.97 108.342 173.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 90.3 37.46 6.64 Favored Glycine 0 N--CA 1.462 0.382 0 O-C-N 119.752 -1.842 . . . . 41.12 111.382 174.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1307 ' ' VAL . . . . . . . . . . . . . 43.2 t -97.69 108.79 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-O 125.837 2.732 . . . . 38.12 104.019 170.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1308 ' ' LYS . . . . . 0.689 ' HD2' ' HB3' ' B' 1148 ' ' GLU . 83.9 mttt -84.67 102.56 13.05 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 108.783 -3.826 . . . . 36.34 109.498 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1309 ' ' VAL . . . . . 0.507 ' HB ' ' HB3' ' B' 1301 ' ' PHE . 22.0 t -85.02 100.17 7.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 105.483 -2.043 . . . . 30.4 105.483 177.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1310 ' ' ILE . . . . . 0.647 HD11 ' HB2' ' B' 1148 ' ' GLU . 27.1 mt -81.8 90.53 2.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 107.032 -1.47 . . . . 30.82 107.032 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1311 ' ' GLY . . . . . 0.713 ' HA3' HG23 ' B' 1295 ' ' THR . . . -89.57 83.02 1.41 Allowed Glycine 0 C--N 1.301 -1.411 0 N-CA-C 108.751 -1.739 . . . . 26.53 108.751 -172.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1312 ' ' TYR . . . . . 0.504 ' CB ' ' HG ' ' B' 1315 ' ' LEU . 6.6 m-30 -98.57 133.05 43.47 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 119.306 3.076 . . . . 38.0 119.306 -170.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1313 ' ' THR . . . . . . . . . . . . . 2.6 p -76.87 -63.86 1.26 Allowed 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 109.222 -3.626 . . . . 29.8 108.509 166.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 4.3 p30 -69.62 6.85 0.98 Allowed 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 120.405 3.483 . . . . 39.04 120.405 -171.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1315 ' ' LEU . . . . . 0.58 HD13 ' HG ' ' B' 1284 ' ' LEU . 28.4 mt -46.6 -50.42 41.87 Favored Pre-proline 0 C--N 1.352 0.703 0 N-CA-C 118.952 2.945 . . . . 31.08 118.952 175.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1316 ' ' PRO . . . . . 0.614 ' HB3' ' HB3' ' B' 1133 ' ' MET . 92.6 Cg_exo -55.45 -33.39 85.81 Favored 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 123.956 3.104 . . . . 26.1 112.072 174.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -82.56 -53.73 3.5 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 120.424 -1.423 . . . . 23.17 111.247 -175.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1318 ' ' ARG . . . . . 0.4 HH11 ' HD3' ' B' 1318 ' ' ARG . 71.3 mtt-85 -36.95 -16.5 0.0 OUTLIER 'General case' 0 C--O 1.235 0.318 1 N-CA-C 124.077 4.843 . . . . 40.4 124.077 -170.256 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B 1319 ' ' LEU . . . . . 0.61 HD13 HH11 ' B' 1140 ' ' ARG . 1.3 tp -105.52 77.35 0.38 Allowed Pre-proline 0 C--O 1.252 1.232 0 CA-C-N 124.031 3.105 . . . . 23.6 106.684 -176.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1320 ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -39.79 -72.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 124.79 3.66 . . . . 22.35 117.926 -151.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1321 ' ' THR . . . . . . . . . . . . . 2.0 m -66.64 -31.83 72.77 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 112.904 0.705 . . . . 26.52 112.904 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1322 ' ' GLN . . . . . 0.765 ' HB2' ' HA ' ' A' 1151 ' ' ARG . 45.8 tp60 -75.81 -44.66 40.07 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 119.097 -2.252 . . . . 24.38 110.267 -178.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1323 ' ' SER . . . . . . . . . . . . . 50.6 m -46.97 -52.1 15.47 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 120.272 -1.517 . . . . 22.8 110.394 169.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1324 ' ' SER . . . . . . . . . . . . . 29.0 m -57.1 -59.58 4.88 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 113.495 -1.684 . . . . 21.25 113.457 173.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 66.3 tp60 -52.84 -40.58 63.46 Favored 'General case' 0 C--N 1.344 0.346 0 O-C-N 120.303 -1.498 . . . . 31.34 113.957 -177.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1326 ' ' LEU . . . . . 0.428 ' CD1' HG21 ' A' 1158 ' ' THR . 63.4 mt -73.54 -46.94 44.55 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 113.665 0.987 . . . . 31.56 113.665 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1327 ' ' TYR . . . . . 0.428 ' O ' ' HG ' ' B' 1331 ' ' LEU . 47.2 t80 -54.22 -51.68 63.66 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-O 122.947 1.356 . . . . 22.73 108.6 173.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1328 ' ' GLY . . . . . 0.535 ' HA2' HD12 ' B' 1331 ' ' LEU . . . -41.06 -57.22 3.04 Favored Glycine 0 CA--C 1.496 -1.151 0 CA-C-N 112.614 -2.085 . . . . 21.91 115.793 168.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1329 ' ' THR . . . . . 0.623 HG21 ' HA3' ' A' 1161 ' ' GLY . 62.4 m -66.92 -28.96 68.73 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 114.605 1.335 . . . . 22.15 114.605 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1330 ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' B' 1127 ' ' LEU . 30.5 m120 -53.45 -51.42 62.72 Favored 'General case' 0 C--O 1.24 0.573 0 O-C-N 121.365 -0.834 . . . . 26.18 109.952 167.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1331 ' ' LEU . . . . . 0.624 HD13 ' HB3' ' B' 1070 ' ' LEU . 20.2 mt -65.95 -39.0 90.07 Favored 'General case' 0 CA--C 1.508 -0.653 0 O-C-N 125.413 1.696 . . . . 23.68 110.404 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1332 ' ' VAL . . . . . 0.671 HG12 ' HE3' ' B' 1336 ' ' LYS . 59.6 t -55.49 -51.31 58.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 120.073 1.306 . . . . 26.57 109.545 171.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -61.33 -39.86 92.1 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 114.371 -1.286 . . . . 28.08 109.771 -173.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1334 ' ' LEU . . . . . 0.656 HD12 HD23 ' B' 1127 ' ' LEU . 15.2 tp -70.95 -42.78 69.33 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 126.315 1.846 . . . . 27.43 107.482 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1335 ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' B' 1331 ' ' LEU . 79.7 mt -69.6 -24.19 63.63 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 121.195 1.816 . . . . 30.5 111.495 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1336 ' ' LYS . . . . . 0.671 ' HE3' HG12 ' B' 1332 ' ' VAL . 76.1 mttt -67.94 -40.57 83.25 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 120.166 1.348 . . . . 41.65 109.649 169.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 11.5 tp -81.31 -25.88 36.1 Favored 'General case' 0 C--O 1.244 0.802 0 O-C-N 119.266 -2.146 . . . . 42.08 110.985 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1338 ' ' LEU . . . . . 0.477 HD22 HG23 ' B' 1346 ' ' ILE . 12.8 mt -68.81 -78.94 0.06 Allowed 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 122.753 1.263 . . . . 35.03 109.946 164.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 18.0 t -78.75 76.5 5.24 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.278 -1.379 . . . . 37.33 107.278 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 58.2 mttp -65.47 -24.76 67.24 Favored 'General case' 0 C--N 1.35 0.595 0 N-CA-C 113.901 1.074 . . . . 50.51 113.901 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -73.83 -3.3 27.86 Favored 'General case' 0 C--O 1.25 1.097 0 N-CA-C 115.41 1.633 . . . . 54.21 115.41 169.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1342 ' ' LYS . . . . . 0.404 ' HD2' HD22 ' B' 1029 ' ' LEU . 9.3 mtmp? 33.43 66.58 0.22 Allowed 'General case' 0 C--N 1.357 0.923 0 CA-C-O 125.141 2.4 . . . . 50.99 116.891 -173.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -134.76 -37.01 0.83 Allowed 'General case' 0 C--O 1.248 0.981 0 CA-C-N 112.975 -1.92 . . . . 48.82 111.315 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 148.23 -31.37 1.3 Allowed Glycine 0 N--CA 1.434 -1.483 0 CA-C-N 122.64 2.473 . . . . 40.43 109.583 -178.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -75.82 113.96 13.88 Favored 'General case' 0 C--N 1.361 1.087 0 CA-C-N 119.442 1.621 . . . . 47.56 109.758 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1346 ' ' ILE . . . . . 0.477 HG23 HD22 ' B' 1338 ' ' LEU . 46.1 mm -69.4 107.05 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 CA-C-O 125.715 2.674 . . . . 42.49 107.589 177.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1347 ' ' THR . . . . . . . . . . . . . 9.2 m -83.11 108.24 16.24 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 103.154 -2.906 . . . . 38.12 103.154 176.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 11.7 t -84.16 84.78 2.01 Favored 'Isoleucine or valine' 0 C--O 1.257 1.478 0 N-CA-C 108.049 -1.093 . . . . 37.5 108.049 -175.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 50.5 t0 -80.86 129.78 34.71 Favored 'General case' 0 CA--C 1.5 -0.951 0 O-C-N 124.053 0.846 . . . . 43.85 111.244 -169.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1350 ' ' PHE . . . . . 0.478 ' HD1' ' HD2' ' B' 1356 ' ' ARG . 46.2 m-85 -114.67 -8.89 12.65 Favored 'General case' 0 C--O 1.251 1.147 0 O-C-N 118.668 -2.52 . . . . 39.81 110.3 175.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 34.3 t70 -72.78 -49.07 32.98 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 120.306 -1.496 . . . . 51.29 110.075 177.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 2.6 t70 -64.1 135.63 56.54 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 122.098 2.226 . . . . 39.78 109.787 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 7.4 m -57.48 -34.32 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 114.507 -1.224 . . . . 39.28 113.266 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1354 ' ' VAL . . . . . 0.562 HG21 ' HG3' ' B' 1123 ' ' ARG . 35.8 t -76.02 -48.37 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.408 0 CA-C-N 120.124 1.329 . . . . 35.7 109.353 -174.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1355 ' ' ILE . . . . . 0.736 ' HA ' HG12 ' B' 1358 ' ' VAL 0.257 24.1 mm -69.58 -32.86 54.26 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 CA-C-O 116.825 -1.56 . . . . 35.77 112.917 176.516 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B 1356 ' ' ARG . . . . . 0.478 ' HD2' ' HD1' ' B' 1350 ' ' PHE . 39.5 tpt85 -54.79 -49.16 71.63 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 120.488 1.495 . . . . 38.55 109.287 166.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -64.39 -55.96 20.3 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 119.62 1.1 . . . . 29.58 112.91 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1358 ' ' VAL . . . . . 0.736 HG12 ' HA ' ' B' 1355 ' ' ILE . 5.0 p -67.85 -34.19 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 124.334 1.054 . . . . 32.06 112.704 -174.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1359 ' ' THR . . . . . . . . . . . . . 6.2 m -78.34 92.16 4.52 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-O 125.264 2.459 . . . . 29.0 108.733 177.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1360 ' ' VAL . . . . . . . . . . . . . 18.9 m -78.51 -31.68 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.978 0 CA-C-N 108.898 -3.774 . . . . 29.68 108.257 -175.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 70.0 mt -128.97 119.95 50.7 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 N-CA-C 107.027 -1.471 . . . . 32.05 107.027 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1362 ' ' ARG . . . . . 0.454 ' HB2' ' CZ ' ' B' 1350 ' ' PHE . 19.8 ttt180 -97.67 113.13 24.82 Favored 'General case' 0 C--O 1.249 1.035 0 O-C-N 119.171 -2.205 . . . . 32.52 105.187 171.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 26.04 70.75 0.04 OUTLIER 'General case' 0 C--O 1.256 1.432 0 N-CA-C 118.028 2.603 . . . . 35.68 118.028 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 95.06 -50.1 1.94 Allowed Glycine 0 N--CA 1.428 -1.886 0 O-C-N 120.437 -1.414 . . . . 34.26 114.126 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -66.18 126.41 28.58 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.231 -0.655 . . . . 51.07 109.231 -175.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 49.7 mt -76.44 103.38 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.819 0 O-C-N 119.046 -2.284 . . . . 39.87 107.885 169.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1367 ' ' THR . . . . . . . . . . . . . 7.3 p -90.79 1.0 57.28 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 116.167 1.914 . . . . 38.01 116.167 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1368 ' ' TRP . . . . . . . . . . . . . 62.2 t90 -65.26 140.92 98.01 Favored Pre-proline 0 N--CA 1.432 -1.359 0 N-CA-C 105.017 -2.216 . . . . 42.14 105.017 160.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -70.22 157.69 93.1 Favored 'Cis proline' 0 C--O 1.252 1.184 0 N-CA-C 119.223 2.74 . . . . 43.26 119.223 10.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1370 ' ' ALA . . . . . . . . . . . . . . . -82.86 113.0 42.35 Favored Pre-proline 0 C--O 1.247 0.95 0 N-CA-C 104.427 -2.435 . . . . 46.52 104.427 168.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1371 ' ' PRO . . . . . 0.425 ' HA ' ' HD3' ' B' 1372 ' ' PRO . 83.8 Cg_endo -49.46 132.91 30.67 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.796 2.997 . . . . 51.95 116.411 -173.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1372 ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' B' 1371 ' ' PRO . 8.1 Cg_exo -55.83 83.48 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.838 1 C-N-CA 126.144 4.563 . . . . 56.27 113.604 176.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B 1373 ' ' ILE . . . . . . . . . . . . . 12.8 tt -75.46 140.78 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-N 114.335 -1.302 . . . . 60.83 110.552 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -67.4 108.47 2.8 Favored 'General case' 0 C--O 1.249 1.064 0 N-CA-C 107.27 -1.381 . . . . 66.1 107.27 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 60.8 t -102.97 113.64 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 106.437 -1.69 . . . . 63.47 106.437 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.206 -5.637 0 O-C-N 120.889 -1.132 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 20' ' ' ALA . . . . . 0.468 ' HA ' HD11 ' C' ' 171' ' ' LEU . . . . . . . . 0 N--CA 1.431 -1.422 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -52.96 -36.65 60.27 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 116.739 2.126 . . . . 0.0 116.739 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 22' ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' C' ' 22' ' ' GLU . 1.9 mp0 -37.96 -43.68 0.73 Allowed 'General case' 0 C--O 1.242 0.676 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 174.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 22.0 m -42.47 -30.04 0.32 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.678 1.591 . . . . 0.0 114.056 176.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.1 -46.93 86.88 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 123.919 1.819 . . . . 0.0 114.508 171.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 25' ' ' GLU . . . . . 0.822 ' HA ' ' HE2' ' C' ' 28' ' ' LYS . 2.5 mp0 -67.23 -46.11 74.79 Favored 'General case' 0 C--O 1.252 1.202 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.105 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 10.9 mp -52.68 -48.66 66.37 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.638 173.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.579 HD21 HD11 ' C' ' 110' ' ' LEU . 1.3 mm? -60.85 -40.36 92.57 Favored 'General case' 0 C--O 1.223 -0.297 0 O-C-N 119.654 -1.904 . . . . 0.0 115.187 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 28' ' ' LYS . . . . . 0.822 ' HE2' ' HA ' ' C' ' 25' ' ' GLU . 3.0 pttm -67.09 -29.29 69.01 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 118.496 -1.282 . . . . 0.0 113.729 168.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -79.28 -20.12 48.85 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -53.38 -21.34 5.71 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 118.467 2.766 . . . . 0.0 118.467 -160.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 31' ' ' HIS . . . . . 0.413 ' O ' HG23 ' C' ' 62' ' ' ILE . 48.4 m-70 71.63 -69.3 0.19 Allowed 'General case' 0 C--N 1.352 0.682 0 CA-C-N 122.925 2.602 . . . . 0.0 109.137 -176.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 32' ' ' SER . . . . . 0.503 ' HB2' ' OG1' ' C' ' 106' ' ' THR . 48.7 m -120.12 158.62 26.51 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 159.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . 0.442 ' HB ' HG23 ' C' ' 64' ' ' VAL . 32.7 t -123.06 114.56 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.155 0 N-CA-C 101.946 -3.353 . . . . 0.0 101.946 -178.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.494 HD12 HD11 ' C' ' 99' ' ' ILE . 18.5 mm -99.32 113.69 35.12 Favored 'Isoleucine or valine' 0 C--O 1.249 1.055 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 175.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . 0.52 HG12 HD12 ' C' ' 110' ' ' LEU . 75.9 mt -97.03 116.34 39.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 174.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 36' ' ' THR . . . . . 0.429 ' HB ' ' HA ' ' C' ' 111' ' ' VAL . 93.2 m -99.68 100.74 11.59 Favored Pre-proline 0 C--O 1.239 0.552 0 CA-C-N 114.867 -1.06 . . . . 0.0 113.22 174.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' C' ' 35' ' ' ILE . 15.4 Cg_exo -62.48 149.1 92.11 Favored 'Trans proline' 0 C--O 1.238 0.519 1 C-N-CA 125.879 4.386 . . . . 0.0 109.615 176.154 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.18 -153.8 7.92 Favored Glycine 0 C--O 1.217 -0.959 0 CA-C-N 109.694 -3.412 . . . . 0.0 108.62 174.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 39' ' ' TYR . . . . . 0.517 ' CD1' ' HD3' ' C' ' 74' ' ' ARG . 6.8 t80 -65.59 -41.35 92.92 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 110.127 -3.037 . . . . 0.0 108.165 -170.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 40' ' ' GLY . . . . . 0.478 ' H ' ' HA3' ' C' ' 113' ' ' GLY . . . -51.74 -54.76 23.6 Favored Glycine 0 C--N 1.347 1.19 0 O-C-N 120.543 -1.348 . . . . 0.0 113.972 174.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 30.4 ttm -58.97 -35.47 73.24 Favored 'General case' 0 C--O 1.215 -0.722 0 C-N-CA 124.484 1.114 . . . . 0.0 110.307 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.94 -60.59 2.15 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 2.9 p -75.03 -35.49 35.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 CA-C-N 118.422 0.555 . . . . 0.0 111.1 -168.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . 0.419 ' HB3' ' HB3' ' C' ' 175' ' ' ALA . . . -112.5 100.16 8.53 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 103.933 -2.617 . . . . 0.0 103.933 166.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 45' ' ' GLN . . . . . . . . . . . . . 16.3 pm0 -46.97 72.64 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 117.955 2.576 . . . . 0.0 117.955 -175.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.21 -22.69 54.97 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.914 -1.741 . . . . 0.0 111.507 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 47' ' ' GLN . . . . . 0.434 ' HA ' ' HB ' ' C' ' 50' ' ' VAL . 0.0 OUTLIER -56.24 -33.38 65.35 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 -176.185 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 48' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -65.3 -57.78 14.11 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 120.803 1.638 . . . . 0.0 110.59 172.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 49' ' ' PRO . . . . . 0.513 ' HB3' HD13 ' C' ' 183' ' ' LEU . 12.1 Cg_endo -58.47 -29.09 87.55 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 CA-C-N 125.526 3.009 . . . . 0.0 116.619 171.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . 0.503 HG23 HG11 ' C' ' 179' ' ' VAL . 20.3 t -58.16 -51.44 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 120.478 -1.389 . . . . 0.0 108.016 168.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.18 -36.39 79.72 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.324 0.965 . . . . 0.0 112.656 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 52' ' ' GLU . . . . . 0.52 ' O ' ' HE2' ' C' ' 56' ' ' LYS . 0.6 OUTLIER -64.28 -53.98 40.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 117.424 -1.274 . . . . 0.0 112.758 173.407 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 9.6 tp -62.83 -36.48 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 121.991 2.178 . . . . 0.0 110.398 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 74.2 m -47.89 -39.29 18.4 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 176.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -59.9 -42.54 94.08 Favored 'General case' 0 N--CA 1.437 -1.12 0 O-C-N 121.874 -0.517 . . . . 0.0 111.7 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . 0.52 ' HE2' ' O ' ' C' ' 52' ' ' GLU . 0.0 OUTLIER -75.41 -39.27 59.21 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -176.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 57' ' ' LEU . . . . . 0.558 HD21 HD12 ' C' ' 27' ' ' LEU . 72.9 mt -65.59 -33.23 75.42 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.658 1.183 . . . . 0.0 108.72 -176.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . 0.412 ' HD2' ' HA ' ' C' ' 58' ' ' ARG . 0.2 OUTLIER -77.58 -32.49 53.76 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 120.231 -1.543 . . . . 0.0 108.882 177.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.89 -46.93 61.71 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-N 121.005 1.73 . . . . 0.0 109.388 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -42.93 -42.42 3.72 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.329 1.452 . . . . 0.0 112.844 162.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.44 54.72 2.61 Favored Glycine 0 N--CA 1.437 -1.271 0 O-C-N 126.016 2.072 . . . . 0.0 112.154 176.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . 0.413 HG23 ' O ' ' C' ' 31' ' ' HIS . 93.8 mt -103.35 142.7 16.67 Favored 'Isoleucine or valine' 0 C--O 1.248 1.006 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 63' ' ' ASN . . . . . 0.403 ' OD1' ' HD3' ' C' ' 65' ' ' ARG . 31.0 t30 -71.41 74.52 0.75 Allowed 'General case' 0 C--O 1.257 1.466 0 CA-C-O 123.418 1.58 . . . . 0.0 109.418 174.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.442 HG23 ' HB ' ' C' ' 33' ' ' VAL . 3.5 p -88.14 115.34 28.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 117.551 -1.659 . . . . 0.0 108.211 -176.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 65' ' ' ARG . . . . . 0.483 HH21 HD11 ' C' ' 94' ' ' LEU . 14.3 mmm-85 -114.84 134.25 55.29 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.273 -177.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . 0.713 ' HB2' ' HA ' ' C' ' 93' ' ' VAL . 36.9 m-85 -93.5 79.48 4.35 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 123.01 1.386 . . . . 0.0 109.857 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.95 78.04 0.4 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-N 110.316 -3.129 . . . . 0.0 111.809 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 68' ' ' ILE . . . . . 0.512 HD11 HD22 ' C' ' 83' ' ' LEU . 12.9 mt -77.72 148.62 6.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 69' ' ' HIS . . . . . 0.478 ' HB3' ' HB2' ' C' ' 72' ' ' ALA . 32.0 t-80 -103.15 134.39 19.81 Favored Pre-proline 0 C--O 1.242 0.699 0 N-CA-C 104.152 -2.536 . . . . 0.0 104.152 168.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 70' ' ' PRO . . . . . 0.537 ' HB3' HD11 ' A' 1157 ' ' ILE . 27.6 Cg_endo -59.6 -72.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.123 0 C-N-CA 123.862 3.041 . . . . 0.0 114.887 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 23.0 t -70.87 95.53 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 170.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 72' ' ' ALA . . . . . 0.478 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . . . -165.26 161.34 19.16 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 123.252 1.501 . . . . 0.0 108.608 175.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 73' ' ' GLY . . . . . 0.47 ' O ' ' HD2' ' C' ' 74' ' ' ARG . . . 54.15 -110.55 1.58 Allowed Glycine 0 CA--C 1.535 1.296 0 CA-C-N 112.934 -1.939 . . . . 0.0 109.824 171.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 74' ' ' ARG . . . . . 0.581 ' HA ' ' OE1' ' B' 1203 ' ' GLN . 1.5 mpt_? -130.85 108.28 9.73 Favored 'General case' 0 C--O 1.259 1.605 0 O-C-N 121.959 -0.73 . . . . 0.0 111.234 -177.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.455 ' HA ' ' HD2' ' C' ' 76' ' ' PRO . 4.5 tt 63.83 114.67 0.02 OUTLIER Pre-proline 0 N--CA 1.445 -0.682 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 174.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 76' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' C' ' 75' ' ' LEU . 71.8 Cg_endo -56.89 104.28 0.14 Allowed 'Trans proline' 0 C--N 1.32 -0.925 1 C-N-CA 126.037 4.491 . . . . 0.0 107.805 175.469 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 132.01 -68.34 0.55 Allowed Glycine 0 N--CA 1.435 -1.395 0 N-CA-C 106.818 -2.513 . . . . 0.0 106.818 -171.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 78' ' ' HIS . . . . . 0.4 ' HB2' HD22 ' C' ' 75' ' ' LEU . 19.2 t-80 -63.37 -29.19 70.53 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -159.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -42.43 94.67 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 119.406 1.003 . . . . 0.0 110.493 175.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -72.83 -32.16 65.3 Favored 'General case' 0 C--N 1.368 1.377 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.562 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 48.7 t -73.01 -26.22 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 123.893 1.806 . . . . 0.0 110.303 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.9 tp -75.11 -31.92 61.26 Favored 'General case' 0 C--N 1.312 -1.03 0 O-C-N 120.55 -1.343 . . . . 0.0 108.397 166.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.512 HD22 HD11 ' C' ' 68' ' ' ILE . 9.0 mp -63.86 -30.52 71.6 Favored 'General case' 0 C--O 1.241 0.653 0 O-C-N 116.976 -3.577 . . . . 0.0 112.872 166.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 84' ' ' ALA . . . . . 0.479 ' HB2' ' OH ' ' C' ' 90' ' ' TYR . . . -62.21 -49.24 76.54 Favored 'General case' 0 N--CA 1.442 -0.849 0 O-C-N 124.57 1.169 . . . . 0.0 111.877 168.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -55.55 -40.02 71.36 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.225 1.01 . . . . 0.0 111.845 171.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.43 -21.27 53.27 Favored 'General case' 0 C--O 1.254 1.324 0 O-C-N 121.069 -1.019 . . . . 0.0 112.274 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp 77.36 50.82 0.04 OUTLIER 'General case' 0 C--O 1.242 0.682 0 CA-C-O 125.627 2.632 . . . . 0.0 112.95 -177.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 66.5 t -91.56 131.58 35.69 Favored Pre-proline 0 C--N 1.319 -0.751 0 O-C-N 118.885 -2.385 . . . . 0.0 112.146 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -61.28 99.57 0.16 Allowed 'Trans proline' 0 C--O 1.242 0.703 0 C-N-CA 124.471 3.447 . . . . 0.0 116.264 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 90' ' ' TYR . . . . . 0.479 ' OH ' ' HB2' ' C' ' 84' ' ' ALA . 82.2 m-85 -54.49 -26.07 29.15 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -174.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.97 -47.78 77.04 Favored 'General case' 0 C--O 1.248 1.004 0 O-C-N 120.116 -1.615 . . . . 0.0 112.024 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 5.0 pt -88.47 -8.54 10.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 93' ' ' VAL . . . . . 0.713 ' HA ' ' HB2' ' C' ' 66' ' ' PHE . 84.8 t -71.19 119.77 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 165.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 94' ' ' LEU . . . . . 0.523 HD12 HD13 ' C' ' 99' ' ' ILE . 65.0 mt -123.77 99.72 6.42 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.711 -1.132 . . . . 0.0 109.129 -175.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 95' ' ' GLU . . . . . 0.693 ' HG2' ' HB ' ' A' 1157 ' ' ILE . 12.9 mp0 -91.79 74.47 5.74 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 -171.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 6.2 ttp 62.83 124.5 0.01 OUTLIER 'General case' 0 CA--C 1.497 -1.089 0 CA-C-N 111.322 -2.672 . . . . 0.0 111.602 -167.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -159.34 -172.35 3.7 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-N 112.657 -2.065 . . . . 0.0 106.973 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -76.49 61.19 1.71 Allowed 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 121.082 -1.012 . . . . 0.0 111.223 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 99' ' ' ILE . . . . . 0.523 HD13 HD12 ' C' ' 94' ' ' LEU . 6.2 tp -92.64 27.66 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.778 0 CA-C-O 124.851 2.262 . . . . 0.0 109.92 -168.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . 0.447 ' O ' ' HB2' ' C' ' 103' ' ' PHE . 2.2 t-20 -71.64 -60.82 2.03 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.602 -1.311 . . . . 0.0 114.115 -166.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -70.3 -32.49 70.28 Favored 'General case' 0 C--O 1.215 -0.753 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -56.97 -41.44 78.36 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 117.11 -1.424 . . . . 0.0 110.697 173.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 103' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' C' ' 100' ' ' ASN . 3.4 m-85 -54.98 -45.08 74.98 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 120.185 1.357 . . . . 0.0 113.153 169.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.21 -33.19 73.96 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 122.411 1.101 . . . . 0.0 108.722 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -68.03 -33.13 74.01 Favored 'General case' 0 C--O 1.243 0.711 0 O-C-N 118.87 -2.394 . . . . 0.0 111.367 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 106' ' ' THR . . . . . 0.503 ' OG1' ' HB2' ' C' ' 32' ' ' SER . 51.7 m -76.11 122.42 24.26 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.745 1.26 . . . . 0.0 109.183 -175.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.26 -57.97 3.98 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.594 169.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 4.3 m -104.05 104.99 15.02 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -169.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 109' ' ' VAL . . . . . 0.559 ' HB ' ' HA ' ' C' ' 144' ' ' VAL . 24.4 t -94.95 107.95 20.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 172.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 110' ' ' LEU . . . . . 0.579 HD11 HD21 ' C' ' 27' ' ' LEU . 80.2 mt -78.23 86.37 4.35 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.901 -0.499 . . . . 0.0 111.827 178.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 111' ' ' VAL . . . . . 0.543 HG13 ' HB3' ' C' ' 114' ' ' ALA . 98.8 t -79.93 83.1 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-O 124.315 2.007 . . . . 0.0 108.237 177.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 7.4 mt -78.05 77.22 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.747 0 CA-C-O 123.321 1.534 . . . . 0.0 113.03 -172.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 113' ' ' GLY . . . . . 0.478 ' HA3' ' H ' ' C' ' 40' ' ' GLY . . . 71.19 42.07 58.71 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.054 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 114' ' ' ALA . . . . . 0.543 ' HB3' HG13 ' C' ' 111' ' ' VAL . . . -107.83 -24.8 11.52 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 120.84 -1.388 . . . . 0.0 110.321 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 115' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.94 -85.79 0.02 OUTLIER 'General case' 0 C--N 1.352 0.709 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 162.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 116' ' ' ASP . . . . . 0.615 ' HB3' HD13 ' C' ' 130' ' ' ILE . 45.9 m-20 -83.61 -22.74 32.16 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -174.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 2.7 p -80.01 9.99 4.82 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 117.303 2.335 . . . . 0.0 117.303 -175.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.569 HG12 ' HB2' ' C' ' 136' ' ' LEU . 3.0 m -124.66 13.06 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 112.947 -1.933 . . . . 0.0 109.645 169.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 119' ' ' ASN . . . . . 0.481 ' HA ' ' HD2' ' C' ' 120' ' ' PRO . 37.4 t30 -90.08 121.02 69.19 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-O 118.475 -0.774 . . . . 0.0 111.17 -169.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 120' ' ' PRO . . . . . 0.481 ' HD2' ' HA ' ' C' ' 119' ' ' ASN . 36.9 Cg_endo -52.75 -28.33 37.66 Favored 'Trans proline' 0 C--O 1.251 1.153 0 C-N-CA 123.401 2.734 . . . . 0.0 113.701 175.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 121' ' ' ALA . . . . . 0.871 ' HA ' ' HB3' ' C' ' 125' ' ' ASP . . . -64.97 12.48 0.04 OUTLIER 'General case' 0 C--N 1.354 0.784 0 N-CA-C 116.644 2.091 . . . . 0.0 116.644 174.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 122' ' ' ALA . . . . . 0.659 ' HB1' ' HB3' ' C' ' 133' ' ' MET . . . -109.61 -2.34 17.58 Favored 'General case' 0 N--CA 1.426 -1.653 0 O-C-N 120.628 -1.295 . . . . 0.0 113.993 171.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.9 -39.85 0.09 Allowed 'General case' 0 C--N 1.351 0.671 0 CA-C-O 125.021 2.344 . . . . 0.0 115.969 169.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -66.12 -38.6 88.6 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 119.351 -2.093 . . . . 0.0 111.818 173.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 125' ' ' ASP . . . . . 0.871 ' HB3' ' HA ' ' C' ' 121' ' ' ALA . 22.7 t70 -102.63 121.08 50.91 Favored Pre-proline 0 C--N 1.347 0.457 0 O-C-N 124.19 0.931 . . . . 0.0 110.707 171.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 126' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' C' ' 125' ' ' ASP . 9.4 Cg_exo -77.6 -18.28 13.73 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 124.461 3.441 . . . . 0.0 115.677 174.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -62.95 -58.93 5.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 122.061 0.934 . . . . 0.0 112.47 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 128' ' ' SER . . . . . 0.571 ' HB3' HG21 ' C' ' 158' ' ' VAL . 66.6 m -57.36 149.52 48.3 Favored Pre-proline 0 C--O 1.24 0.595 0 N-CA-C 116.496 2.036 . . . . 0.0 116.496 -163.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 129' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -55.18 -17.73 15.98 Favored 'Trans proline' 0 CA--C 1.564 2.012 1 C-N-CA 126.003 4.469 . . . . 0.0 115.296 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 130' ' ' ILE . . . . . 0.615 HD13 ' HB3' ' C' ' 116' ' ' ASP . 8.8 pt -101.67 12.8 6.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 120.004 1.275 . . . . 0.0 114.283 173.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 131' ' ' ALA . . . . . 0.571 ' HA ' ' HA ' ' C' ' 122' ' ' ALA . . . -71.77 86.04 0.94 Allowed 'General case' 0 C--O 1.239 0.549 0 CA-C-O 124.353 2.025 . . . . 0.0 109.147 -172.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 149.5 53.83 0.02 OUTLIER Glycine 0 N--CA 1.423 -2.17 0 CA-C-N 111.963 -2.381 . . . . 0.0 108.777 -175.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 133' ' ' MET . . . . . 0.705 ' SD ' ' HD2' ' C' ' 134' ' ' PRO . 6.6 tpp -147.54 125.3 5.88 Favored Pre-proline 0 CA--C 1.548 0.865 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 134' ' ' PRO . . . . . 0.705 ' HD2' ' SD ' ' C' ' 133' ' ' MET . 22.4 Cg_endo -78.1 83.6 2.17 Favored 'Trans proline' 0 C--O 1.238 0.492 1 C-N-CA 125.612 4.208 . . . . 0.0 107.479 -175.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 135' ' ' VAL . . . . . 0.427 HG23 ' CZ3' ' C' ' 139' ' ' TRP . 8.3 m -64.7 154.02 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 CA-C-N 113.681 -1.6 . . . . 0.0 113.288 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . 0.569 ' HB2' HG12 ' C' ' 118' ' ' VAL . 88.3 mt -74.87 120.51 20.52 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -177.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 137' ' ' GLU . . . . . 0.428 ' HA ' ' CZ3' ' C' ' 139' ' ' TRP . 42.9 mm-40 -21.29 -28.02 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.159 1 N-CA-C 123.738 4.718 . . . . 0.0 123.738 179.162 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 138' ' ' VAL . . . . . 0.521 HG21 HG21 ' C' ' 109' ' ' VAL . 8.3 p -79.6 83.35 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -175.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 139' ' ' TRP . . . . . 0.428 ' CZ3' ' HA ' ' C' ' 137' ' ' GLU . 34.7 p90 -125.91 171.01 11.09 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-N 112.206 -2.27 . . . . 0.0 109.008 165.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 140' ' ' LYS . . . . . . . . . . . . . 21.0 pttm 56.55 -0.55 0.06 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 117.598 2.444 . . . . 0.0 117.598 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -141.76 165.62 26.97 Favored 'General case' 0 C--O 1.256 1.423 0 CA-C-O 116.015 -1.945 . . . . 0.0 109.731 -175.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 64.35 168.1 0.17 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 161.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 143' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -84.24 73.49 10.43 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 124.52 2.105 . . . . 0.0 109.667 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 144' ' ' VAL . . . . . 0.559 ' HA ' ' HB ' ' C' ' 109' ' ' VAL . 3.2 t -81.34 100.58 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 103.393 -2.818 . . . . 0.0 103.393 175.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 145' ' ' ILE . . . . . 0.804 HG12 ' HB2' ' C' ' 171' ' ' LEU 0.287 13.0 tt -98.87 99.27 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 112.31 -2.223 . . . . 0.0 112.062 -173.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 146' ' ' VAL . . . . . 0.608 HG21 ' HB3' ' C' ' 162' ' ' LEU . 39.5 t -84.11 113.38 22.85 Favored 'Isoleucine or valine' 0 C--N 1.343 0.298 0 CA-C-N 112.702 -2.044 . . . . 0.0 107.013 -171.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 147' ' ' PHE . . . . . 0.449 ' HD2' ' HA ' ' C' ' 175' ' ' ALA . 1.3 m-85 -66.41 112.73 4.2 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 122.647 1.213 . . . . 0.0 110.427 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 148' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -146.26 108.76 4.48 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 105.909 -1.885 . . . . 0.0 105.909 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -64.97 -40.7 95.38 Favored 'General case' 0 C--N 1.344 0.333 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.78 145.13 51.88 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 103.988 -2.597 . . . . 0.0 103.988 -174.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 151' ' ' MET . . . . . 0.526 ' HG2' ' SD ' ' C' ' 170' ' ' MET . 0.3 OUTLIER -84.02 68.94 10.24 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 170.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -87.16 168.06 13.59 Favored 'General case' 0 C--O 1.258 1.536 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.294 173.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 13.3 m -71.43 119.52 15.7 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -72.94 -133.16 0.18 Allowed Glycine 0 N--CA 1.478 1.441 0 O-C-N 118.797 -2.439 . . . . 0.0 108.75 172.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 155' ' ' TYR . . . . . 0.862 ' HE1' ' HB2' ' B' 1199 ' ' GLU . 2.8 m-85 -77.03 -50.86 12.15 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 117.135 -1.826 . . . . 0.0 109.881 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 156' ' ' ALA . . . . . 0.631 ' HB1' HG22 ' C' ' 158' ' ' VAL . . . -94.83 -53.32 3.89 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 161.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 65.96 14.68 61.48 Favored Glycine 0 C--O 1.254 1.349 0 CA-C-O 122.504 1.058 . . . . 0.0 114.253 -173.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 158' ' ' VAL . . . . . 0.631 HG22 ' HB1' ' C' ' 156' ' ' ALA . 13.5 m -89.6 124.84 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -162.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . 0.301 0.0 OUTLIER 37.0 24.61 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 118.266 2.691 . . . . 0.0 118.266 172.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 160' ' ' ASN . . . . . 0.71 ' HB3' HD12 ' C' ' 162' ' ' LEU . 3.7 m120 -62.57 111.63 5.1 Favored Pre-proline 0 C--O 1.239 0.535 0 O-C-N 120.461 -1.399 . . . . 0.0 110.22 -171.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -56.18 -41.94 71.46 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.885 2.39 . . . . 0.0 112.48 -177.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 162' ' ' LEU . . . . . 1.003 ' HA ' HG22 ' C' ' 168' ' ' THR . 16.0 mt -17.48 -40.91 0.0 OUTLIER 'General case' 0 C--O 1.244 0.794 0 N-CA-C 120.62 3.563 . . . . 0.0 120.62 155.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 163' ' ' PHE . . . . . 0.409 ' HA ' ' HG3' ' C' ' 170' ' ' MET . 12.9 m-30 -82.02 -48.33 11.55 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-O 124.385 2.041 . . . . 0.0 111.777 176.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -91.06 -17.04 26.88 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 111.963 -2.38 . . . . 0.0 113.611 -158.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -87.88 172.43 9.62 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 121.818 2.099 . . . . 0.0 110.863 -168.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -55.75 10.62 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 120.406 -1.434 . . . . 0.0 114.479 177.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -82.53 -49.97 9.31 Favored 'General case' 0 C--O 1.239 0.538 0 O-C-N 124.848 1.342 . . . . 0.0 108.115 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 168' ' ' THR . . . . . 1.003 HG22 ' HA ' ' C' ' 162' ' ' LEU . 4.8 m -82.84 91.9 7.17 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 123.328 1.537 . . . . 0.0 107.443 177.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -142.41 142.82 32.44 Favored 'General case' 0 N--CA 1.439 -1.013 0 O-C-N 120.88 -1.137 . . . . 0.0 111.686 -154.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 170' ' ' MET . . . . . 0.526 ' SD ' ' HG2' ' C' ' 151' ' ' MET . 54.1 mtm -58.41 126.83 29.21 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 121.169 -0.957 . . . . 0.0 108.878 166.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 171' ' ' LEU . . . . . 0.804 ' HB2' HG12 ' C' ' 145' ' ' ILE . 39.4 tp -89.06 108.78 19.78 Favored 'General case' 0 C--O 1.254 1.329 0 N-CA-C 104.103 -2.554 . . . . 0.0 104.103 166.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -82.22 91.51 6.74 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -174.69 168.19 40.74 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 106.139 -2.784 . . . . 0.0 106.139 175.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 174' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -72.57 151.7 42.23 Favored 'General case' 0 C--O 1.252 1.225 0 O-C-N 119.026 -2.455 . . . . 0.0 111.528 170.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 175' ' ' ALA . . . . . 0.449 ' HA ' ' HD2' ' C' ' 147' ' ' PHE . . . -59.85 -50.79 72.42 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 126.251 1.82 . . . . 0.0 111.676 -170.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.67 -55.9 6.84 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 177' ' ' ALA . . . . . . . . . . . . . . . -41.35 -44.83 2.88 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 117.851 2.537 . . . . 0.0 117.851 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 9.3 m -64.48 -41.34 96.53 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 175.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 179' ' ' VAL . . . . . 0.503 HG11 HG23 ' C' ' 50' ' ' VAL . 5.2 t -72.45 -32.05 40.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 119.278 -2.138 . . . . 0.0 107.615 177.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -67.67 -33.17 74.39 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 117.912 -2.992 . . . . 0.0 111.321 176.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.69 -30.61 70.86 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.202 173.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 182' ' ' ILE . . . . . 0.459 HD12 ' HG ' ' C' ' 27' ' ' LEU . 31.0 pt -87.22 -39.14 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 CA-C-O 122.668 1.223 . . . . 0.0 113.672 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 183' ' ' LEU . . . . . 0.513 HD13 ' HB3' ' C' ' 49' ' ' PRO . 12.9 tp -11.42 -66.9 0.01 OUTLIER 'General case' 0 C--N 1.355 0.838 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -107.7 -19.76 13.44 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 118.365 -1.334 . . . . 0.0 114.486 176.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -70.07 -65.28 0.74 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.941 -1.027 . . . . 0.0 113.743 -172.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 186' ' ' LEU . . . . . . . . . . . . 0.345 2.2 pt? . . . . . 0 N--CA 1.43 -1.433 0 N-CA-C 118.969 2.951 . . . . 0.0 118.969 -165.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 11.9 t-80 . . . . . 0 N--CA 1.418 -2.064 0 N-CA-C 106.906 -1.516 . . . . 65.74 106.906 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -54.63 77.17 0.01 OUTLIER Glycine 0 C--O 1.223 -0.574 0 C-N-CA 125.581 1.562 . . . . 48.66 114.438 164.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 26.1 ttp180 -110.0 134.79 51.75 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.128 -1.536 . . . . 44.56 107.299 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1003 ' ' ILE . . . . . 0.597 HG12 ' HB ' ' A' 1068 ' ' ILE . 30.2 mt -99.75 139.22 21.86 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.757 0 O-C-N 124.482 1.114 . . . . 34.86 110.0 176.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -109.7 135.17 12.68 Favored Glycine 0 C--O 1.25 1.146 0 N-CA-C 107.376 -2.29 . . . . 30.75 107.376 172.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.441 HG21 ' HB2' ' A' 1018 ' ' ALA . 43.6 mm -106.76 112.05 63.63 Favored Pre-proline 0 N--CA 1.427 -1.578 0 N-CA-C 102.008 -3.33 . . . . 32.21 102.008 175.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -71.45 143.86 43.96 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 123.137 2.558 . . . . 32.98 111.438 168.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1007 ' ' ARG . . . . . 0.493 ' HG3' HD11 ' A' 1042 ' ' LEU . 25.3 ttp85 -67.8 126.61 29.95 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 104.248 -2.501 . . . . 47.98 104.248 162.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1008 ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -62.81 130.96 47.18 Favored 'General case' 0 CA--C 1.513 -0.478 0 O-C-N 120.247 -1.533 . . . . 34.7 113.219 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -86.68 -11.48 51.13 Favored 'General case' 0 C--O 1.252 1.191 0 O-C-N 121.125 -0.984 . . . . 53.37 113.579 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 5.9 mp -63.17 148.45 47.99 Favored 'General case' 0 C--O 1.214 -0.786 0 CA-C-O 123.034 1.397 . . . . 45.07 112.529 -176.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1011 ' ' THR . . . . . . . . . . . . . 7.3 m -64.23 107.59 1.35 Allowed 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 114.048 -1.433 . . . . 40.36 111.89 -167.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 33.8 t30 68.31 69.07 0.32 Allowed 'General case' 0 C--O 1.215 -0.73 0 CA-C-N 113.173 -1.831 . . . . 40.61 110.264 176.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1013 ' ' GLU . . . . . 0.616 ' HG3' ' H ' ' A' 1015 ' ' ARG . 8.3 tp10 -104.08 146.1 29.21 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 120.034 -0.666 . . . . 33.76 112.207 -168.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1014 ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' 1043 ' ' ALA . 0.6 OUTLIER -103.93 -6.23 21.5 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 122.758 1.266 . . . . 27.89 112.664 178.517 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 1015 ' ' ARG . . . . . 0.802 ' HD2' HG11 ' A' 1072 ' ' VAL . 69.5 mtm180 -106.19 147.3 29.21 Favored 'General case' 0 N--CA 1.44 -0.932 0 O-C-N 120.691 -1.255 . . . . 29.02 113.413 -172.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1016 ' ' VAL . . . . . 0.699 HG21 ' HB1' ' A' 1039 ' ' ALA . 8.6 p -148.48 138.93 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 N-CA-C 104.033 -2.58 . . . . 28.13 104.033 159.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1017 ' ' ALA . . . . . . . . . . . . . . . -63.44 -12.94 35.24 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 117.742 -3.098 . . . . 26.87 116.749 -176.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1018 ' ' ALA . . . . . 0.441 ' HB2' HG21 ' A' 1005 ' ' ILE . . . -84.11 112.1 19.93 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 123.734 1.73 . . . . 26.77 111.204 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1019 ' ' THR . . . . . 0.672 HG21 ' HA ' ' A' 1325 ' ' GLN . 67.8 p -118.26 167.74 10.85 Favored Pre-proline 0 N--CA 1.416 -2.138 0 N-CA-C 106.297 -1.742 . . . . 27.02 106.297 158.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1020 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -48.0 -57.48 2.31 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 124.767 3.645 . . . . 30.57 109.782 163.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1021 ' ' LYS . . . . . 0.558 ' HB2' ' NE2' ' A' 1325 ' ' GLN . 21.0 mttp -53.7 -31.12 46.73 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.856 1.662 . . . . 47.81 113.966 178.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1022 ' ' THR . . . . . . . . . . . . . 5.0 m -62.67 -65.57 0.67 Allowed 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 120.435 1.47 . . . . 30.77 108.758 169.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1023 ' ' VAL . . . . . 0.513 HG13 ' HB ' ' A' 1033 ' ' VAL . 59.0 t -56.75 -55.91 17.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 O-C-N 126.611 2.444 . . . . 33.59 113.11 -171.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -49.66 -52.24 32.3 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.036 1.334 . . . . 53.29 114.568 -176.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1025 ' ' GLN . . . . . 0.582 ' OE1' ' HE2' ' A' 1336 ' ' LYS . 8.2 tt0 -75.44 -34.46 60.98 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 114.389 -1.278 . . . . 46.92 113.122 -173.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1026 ' ' LEU . . . . . 0.571 HD21 ' HA ' ' A' 1332 ' ' VAL . 95.9 mt -66.87 -39.38 87.51 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.219 -0.901 . . . . 37.17 110.025 177.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1027 ' ' LEU . . . . . 0.501 HD23 ' HA ' ' A' 1032 ' ' THR . 96.5 mt -54.53 -50.03 68.84 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 118.241 -0.885 . . . . 44.44 110.673 172.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 42.5 mttm -57.61 -37.86 73.97 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.94 1.296 . . . . 52.58 112.051 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1029 ' ' LEU . . . . . 0.643 ' HA ' ' HE3' ' A' 1342 ' ' LYS . 98.6 mt -66.97 -40.23 87.4 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 119.015 0.825 . . . . 45.69 110.625 173.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 148.88 -30.31 1.24 Allowed Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.832 -0.699 . . . . 42.09 111.46 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -74.85 109.36 8.25 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 124.72 2.2 . . . . 40.72 108.884 -172.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1032 ' ' THR . . . . . 0.501 ' HA ' HD23 ' A' 1027 ' ' LEU . 18.6 m -74.51 131.14 40.76 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 105.611 -1.996 . . . . 37.77 105.611 176.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1033 ' ' VAL . . . . . 0.513 ' HB ' HG13 ' A' 1023 ' ' VAL . 61.1 t -109.83 136.78 44.73 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.784 0 CA-C-O 121.536 0.684 . . . . 33.54 109.66 -171.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -119.37 130.94 55.58 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 126.789 2.556 . . . . 31.68 109.456 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1035 ' ' VAL . . . . . 0.402 HG11 ' CD2' ' A' 1050 ' ' PHE . 77.6 t -115.34 135.87 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 105.765 -1.939 . . . . 31.52 105.765 -175.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1036 ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -62.31 141.67 58.15 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 123.703 1.716 . . . . 41.04 110.626 169.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1037 ' ' SER . . . . . . . . . . . . . 19.5 m -70.05 151.16 45.83 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.46 -1.245 . . . . 31.83 108.736 174.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 91.71 -29.27 7.49 Favored Glycine 0 C--O 1.213 -1.192 0 C-N-CA 120.057 -1.068 . . . . 29.36 110.561 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1039 ' ' ALA . . . . . 0.699 ' HB1' HG21 ' A' 1016 ' ' VAL . . . -62.37 -21.11 65.07 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 116.825 2.158 . . . . 27.78 116.825 -169.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -61.78 -43.2 99.55 Favored Glycine 0 CA--C 1.538 1.492 0 O-C-N 119.795 -1.816 . . . . 28.91 114.342 -175.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.79 -28.31 68.91 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 116.35 1.982 . . . . 51.18 116.35 -174.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1042 ' ' LEU . . . . . 0.493 HD11 ' HG3' ' A' 1007 ' ' ARG . 19.5 mt -52.82 -60.79 2.83 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 123.615 1.674 . . . . 29.91 107.898 171.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1043 ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' 1014 ' ' THR . . . -84.88 17.8 2.7 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.854 -1.066 . . . . 28.54 112.792 -173.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1044 ' ' SER . . . . . 0.619 ' HB3' ' HA2' ' B' 1278 ' ' GLY . 60.8 m 52.56 63.79 2.1 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-O 124.13 1.919 . . . . 33.06 112.959 -174.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1045 ' ' PHE . . . . . 0.62 ' HA ' ' HB1' ' B' 1277 ' ' ALA . 22.4 m-85 -128.66 157.08 42.34 Favored 'General case' 0 C--O 1.245 0.842 0 O-C-N 120.849 -1.157 . . . . 30.29 110.675 176.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 2.4 t70 -85.26 127.65 34.39 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 111.125 -2.762 . . . . 48.62 104.506 164.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -65.17 -39.34 92.8 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 123.068 1.413 . . . . 36.74 112.342 -174.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 25.5 pttm -66.84 -12.53 59.45 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 120.059 -1.651 . . . . 43.73 113.918 173.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -71.64 -21.65 61.8 Favored 'General case' 0 C--O 1.247 0.964 0 CA-C-O 122.776 1.274 . . . . 32.81 110.819 168.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1050 ' ' PHE . . . . . 0.402 ' CD2' HG11 ' A' 1035 ' ' VAL . 22.3 m-30 -78.84 -32.21 46.05 Favored 'General case' 0 CA--C 1.505 -0.773 0 O-C-N 119.492 -2.005 . . . . 31.86 110.056 169.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1051 ' ' VAL . . . . . 0.485 HG22 HG13 ' A' 1057 ' ' ILE . 62.2 t -62.87 -50.66 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-O 122.452 1.12 . . . . 33.22 109.095 173.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -43.65 -53.38 5.78 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.038 1.735 . . . . 50.83 112.676 165.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -56.75 -29.99 63.13 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-O 118.298 -0.858 . . . . 33.12 111.389 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 104.32 31.28 4.7 Favored Glycine 0 C--N 1.343 0.96 0 N-CA-C 111.896 -0.482 . . . . 35.83 111.896 176.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -90.59 149.51 22.1 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 121.783 -0.834 . . . . 34.82 109.92 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -83.04 122.21 28.02 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 106.295 -1.743 . . . . 49.05 106.295 167.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1057 ' ' ILE . . . . . 0.485 HG13 HG22 ' A' 1051 ' ' VAL . 27.3 mm -98.41 83.71 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.879 0 N-CA-C 106.389 -1.708 . . . . 38.53 106.389 -165.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1058 ' ' VAL . . . . . . . . . . . . . 48.7 t -80.11 130.11 36.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 O-C-N 124.312 1.008 . . . . 42.11 111.976 -173.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -79.62 78.55 6.17 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 123.994 1.854 . . . . 58.0 111.537 177.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 101.84 -142.49 15.68 Favored Glycine 0 CA--C 1.49 -1.531 0 CA-C-N 113.599 -1.637 . . . . 52.12 110.631 167.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1061 ' ' ASN . . . . . 0.547 HD21 HD22 ' A' 1082 ' ' LEU . 2.1 t30 -58.19 -26.4 62.74 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 111.33 -2.435 . . . . 54.75 114.12 -156.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1062 ' ' SER . . . . . . . . . . . . . 49.0 m -63.18 -14.3 47.36 Favored 'General case' 0 N--CA 1.427 -1.617 0 O-C-N 119.4 -2.062 . . . . 50.34 111.194 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -61.47 -29.29 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 O-C-N 119.839 -1.788 . . . . 41.46 109.634 172.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1064 ' ' TRP . . . . . 0.479 ' CH2' ' HB3' ' A' 1079 ' ' GLU . 87.7 m95 -65.28 -26.31 68.03 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 114.791 1.404 . . . . 39.32 114.791 171.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -79.49 75.34 6.11 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 122.508 1.147 . . . . 55.38 109.125 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1066 ' ' SER . . . . . . . . . . . . . 69.6 m -152.32 151.4 30.84 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 107.118 -1.438 . . . . 41.87 107.118 -172.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -66.74 -29.55 69.55 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-O 123.519 1.628 . . . . 53.2 112.324 -174.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1068 ' ' ILE . . . . . 0.597 ' HB ' HG12 ' A' 1003 ' ' ILE . 60.4 mt -131.04 143.21 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 102.868 -3.012 . . . . 41.9 102.868 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1069 ' ' ILE . . . . . 0.439 HG12 HG21 ' A' 1087 ' ' THR . 23.2 mm -123.97 114.29 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 N-CA-C 103.221 -2.881 . . . . 38.73 103.221 175.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1070 ' ' LEU . . . . . 0.599 HD22 HD22 ' A' 1331 ' ' LEU . 95.9 mt -90.05 94.27 9.72 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-N 116.144 -0.48 . . . . 32.44 112.07 172.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1071 ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -91.81 154.3 19.0 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 106.675 -1.602 . . . . 34.65 106.675 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1072 ' ' VAL . . . . . 0.802 HG11 ' HD2' ' A' 1015 ' ' ARG . 12.2 t -90.73 -67.32 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.964 0 N-CA-C 105.038 -2.208 . . . . 31.32 105.038 172.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -88.04 179.24 6.45 Favored 'General case' 0 CA--C 1.508 -0.658 0 O-C-N 120.39 -1.444 . . . . 33.94 110.571 -170.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -52.61 128.89 44.36 Favored Pre-proline 0 N--CA 1.441 -0.894 0 N-CA-C 114.079 1.141 . . . . 38.04 114.079 165.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1075 ' ' PRO . . . . . 0.491 ' HG2' HD21 ' A' 1089 ' ' LEU . 77.9 Cg_exo -67.13 128.39 18.48 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.089 2.526 . . . . 42.68 109.048 174.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 53.4 mt -78.16 158.06 29.19 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 112.557 -2.111 . . . . 46.74 106.068 175.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1077 ' ' ASP . . . . . 0.587 ' HA ' HD12 ' A' 1080 ' ' ILE . 4.1 m-20 -45.39 -35.82 3.88 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 118.054 2.613 . . . . 58.61 118.054 -169.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -68.6 -47.47 66.63 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 125.027 1.454 . . . . 59.2 110.729 173.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1079 ' ' GLU . . . . . 0.479 ' HB3' ' CH2' ' A' 1064 ' ' TRP . 33.0 mt-10 -60.44 -37.77 82.0 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 109.361 -0.607 . . . . 50.63 109.361 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1080 ' ' ILE . . . . . 0.587 HD12 ' HA ' ' A' 1077 ' ' ASP . 96.6 mt -56.5 -56.79 11.86 Favored 'Isoleucine or valine' 0 C--N 1.355 0.836 0 O-C-N 120.942 -1.099 . . . . 51.48 108.077 176.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -62.59 -20.91 65.2 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.712 -1.243 . . . . 50.28 113.028 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1082 ' ' LEU . . . . . 0.547 HD22 HD21 ' A' 1061 ' ' ASN . 75.2 mt -79.17 -16.22 56.92 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 114.954 1.465 . . . . 50.21 114.954 175.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1083 ' ' LEU . . . . . 0.62 HD11 HD13 ' A' 1089 ' ' LEU . 2.3 mm? -59.68 141.04 55.91 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.02 1.282 . . . . 49.06 109.549 172.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -86.61 142.61 35.0 Favored Pre-proline 0 C--O 1.217 -0.626 0 N-CA-C 103.413 -2.81 . . . . 51.08 103.413 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -54.39 120.96 8.88 Favored 'Trans proline' 0 N--CA 1.42 -2.829 0 C-N-CA 124.306 3.337 . . . . 49.73 109.83 168.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 98.67 -3.68 59.27 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-O 117.925 -1.486 . . . . 47.71 112.757 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1087 ' ' THR . . . . . 0.439 HG21 HG12 ' A' 1069 ' ' ILE . 87.1 m -68.09 129.43 39.89 Favored 'General case' 0 C--O 1.251 1.134 0 CA-C-N 119.139 1.47 . . . . 45.47 111.819 173.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1088 ' ' THR . . . . . 0.434 ' HA ' ' HB ' ' A' 1111 ' ' THR . 2.8 m -68.75 110.51 4.35 Favored 'General case' 0 C--O 1.244 0.803 0 O-C-N 119.324 -2.11 . . . . 42.04 108.739 165.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1089 ' ' LEU . . . . . 0.62 HD13 HD11 ' A' 1083 ' ' LEU . 33.1 tp -98.89 118.88 36.66 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 105.741 -1.948 . . . . 38.06 105.741 173.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 24.4 t -113.26 126.43 70.68 Favored 'Isoleucine or valine' 0 C--O 1.256 1.433 0 N-CA-C 104.642 -2.355 . . . . 37.4 104.642 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1091 ' ' SER . . . . . . . . . . . . . 5.1 m -162.17 168.98 21.61 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 121.172 1.805 . . . . 36.16 111.05 -176.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1092 ' ' PHE . . . . . 0.4 ' CE2' ' HG3' ' A' 1133 ' ' MET . 6.5 m-85 -69.46 99.82 1.3 Allowed 'General case' 0 C--N 1.349 0.562 0 O-C-N 120.962 -1.086 . . . . 38.94 109.672 159.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 40.7 mm -90.21 -46.93 14.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 113.316 0.858 . . . . 42.17 113.316 175.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1094 ' ' TRP . . . . . 0.446 ' HB3' ' NE2' ' A' 1097 ' ' GLN . 23.8 m95 61.52 63.35 2.32 Favored Pre-proline 0 N--CA 1.469 0.499 0 C-N-CA 124.02 0.928 . . . . 46.51 112.037 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -55.96 -27.85 65.81 Favored 'Trans proline' 0 C--N 1.346 0.423 0 N-CA-C 120.494 3.229 . . . . 49.76 120.494 -166.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -77.2 -29.57 54.35 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 121.546 1.975 . . . . 52.62 112.538 175.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1097 ' ' GLN . . . . . 0.446 ' NE2' ' HB3' ' A' 1094 ' ' TRP . 1.5 mp0 -86.75 -24.16 25.22 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 124.456 2.074 . . . . 60.74 111.233 173.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1098 ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -127.33 74.24 77.48 Favored Pre-proline 0 N--CA 1.431 -1.422 0 O-C-N 120.024 -1.672 . . . . 58.19 112.81 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1099 ' ' PRO . . . . . 0.546 ' HG2' ' HG3' ' A' 1100 ' ' GLU . 94.5 Cg_endo -70.96 -29.42 18.17 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.947 2.431 . . . . 54.59 113.508 177.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1100 ' ' GLU . . . . . 0.546 ' HG3' ' HG2' ' A' 1099 ' ' PRO . 27.2 mt-10 -80.89 -28.02 36.09 Favored 'General case' 0 N--CA 1.434 -1.225 0 O-C-N 119.424 -2.047 . . . . 63.28 106.067 -163.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1101 ' ' LEU . . . . . 0.406 HD23 HD11 ' A' 1080 ' ' ILE . 15.1 mt -50.72 -41.97 56.73 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 124.917 1.287 . . . . 54.75 110.31 171.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1102 ' ' MET . . . . . 0.423 ' SD ' HD11 ' A' 1361 ' ' ILE . 18.6 mmm -66.77 -47.44 72.17 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 118.676 0.671 . . . . 52.65 111.533 -168.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -64.16 -38.02 89.57 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 120.735 -1.228 . . . . 66.26 112.673 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 86.1 mttt -67.42 -42.33 83.41 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 123.037 1.399 . . . . 63.73 112.926 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 47.8 mt -71.83 -28.41 63.56 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.834 -1.075 . . . . 54.68 112.63 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -65.12 -41.95 94.39 Favored 'General case' 0 C--O 1.243 0.751 0 O-C-N 120.694 -1.254 . . . . 53.64 110.473 170.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -56.28 -39.25 72.36 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.074 0.95 . . . . 67.24 109.696 169.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -69.82 -20.93 63.43 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 115.446 1.647 . . . . 65.76 115.446 173.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 53.7 t30 68.83 38.69 2.06 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 124.594 2.14 . . . . 58.71 109.106 177.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1110 ' ' VAL . . . . . 0.552 HG11 ' HB3' ' A' 1083 ' ' LEU . 27.1 m -97.92 161.05 2.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 N-CA-C 115.41 1.633 . . . . 46.63 115.41 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1111 ' ' THR . . . . . 0.628 HG23 ' HG3' ' A' 1362 ' ' ARG . 95.0 m -97.68 95.22 7.43 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 106.446 -1.687 . . . . 44.13 106.446 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1112 ' ' VAL . . . . . 0.605 ' HB ' ' HB ' ' A' 1361 ' ' ILE . 49.1 t -86.57 110.7 20.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 O-C-N 121.147 -0.971 . . . . 40.44 112.306 -176.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1113 ' ' MET . . . . . 0.685 ' HB3' HG12 ' A' 1358 ' ' VAL . 46.8 mtp -101.74 110.65 22.68 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 106.344 -1.724 . . . . 50.76 106.344 174.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1114 ' ' ALA . . . . . 0.478 ' HB3' ' HB2' ' A' 1117 ' ' SER . . . -83.99 116.52 22.86 Favored 'General case' 0 C--O 1.253 1.244 0 O-C-N 121.369 -0.832 . . . . 35.64 108.989 -176.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1115 ' ' MET . . . . . 0.441 ' O ' HG23 ' A' 1118 ' ' VAL . 32.7 mmm -70.62 -30.65 67.36 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 113.369 0.877 . . . . 38.74 113.369 -176.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -60.33 -35.19 75.07 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 124.486 1.114 . . . . 40.14 112.141 164.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1117 ' ' SER . . . . . 0.478 ' HB2' ' HB3' ' A' 1114 ' ' ALA . 48.5 m -87.58 11.88 13.88 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 118.466 2.765 . . . . 44.79 118.466 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1118 ' ' VAL . . . . . 0.509 ' HA ' HG22 ' A' 1358 ' ' VAL . 40.8 t -60.96 128.39 89.06 Favored Pre-proline 0 N--CA 1.473 0.685 0 N-CA-C 103.755 -2.683 . . . . 43.75 103.755 168.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -46.6 140.78 11.8 Favored 'Trans proline' 0 CA--C 1.543 0.928 1 C-N-CA 127.7 5.6 . . . . 48.93 117.762 179.279 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -64.32 -0.3 1.23 Allowed 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 116.798 2.147 . . . . 62.9 116.798 -174.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 14.5 pt -83.26 148.98 4.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 114.281 1.215 . . . . 57.72 114.281 -170.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1122 ' ' SER . . . . . . . . . . . . . 8.5 m -45.54 -51.56 11.67 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 126.512 1.925 . . . . 57.26 114.432 -176.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.62 -24.19 66.53 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 120.676 -1.265 . . . . 62.9 112.258 -178.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -87.41 -19.0 28.69 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-O 116.642 -1.647 . . . . 49.83 111.097 -176.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1125 ' ' GLN . . . . . 0.607 ' HA ' ' HB3' ' A' 1128 ' ' ASP . 5.4 mm-40 -61.31 -21.34 63.88 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 115.941 1.83 . . . . 52.37 115.941 -167.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1126 ' ' SER . . . . . . . . . . . . . 31.9 m -68.47 -38.77 81.35 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 122.587 1.184 . . . . 42.43 111.117 172.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1127 ' ' LEU . . . . . 0.606 HD21 HD22 ' A' 1337 ' ' LEU . 4.6 mp -77.64 -35.81 52.18 Favored 'General case' 0 C--N 1.35 0.609 0 CA-C-N 115.009 -0.996 . . . . 43.74 110.986 172.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1128 ' ' ASP . . . . . 0.607 ' HB3' ' HA ' ' A' 1125 ' ' GLN . 37.0 t70 -59.71 108.15 0.7 Allowed 'General case' 0 C--N 1.352 0.709 0 CA-C-O 125.892 2.758 . . . . 43.21 115.953 -177.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1129 ' ' ALA . . . . . 0.409 ' CB ' ' HB3' ' A' 1115 ' ' MET . . . -68.09 -29.06 67.9 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 110.459 -3.064 . . . . 35.74 112.293 -176.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 43.3 mt -60.36 -37.09 79.62 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 114.934 -1.03 . . . . 38.09 112.854 172.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1131 ' ' SER . . . . . 0.45 ' HA ' HG11 ' A' 1175 ' ' VAL . 16.5 m -58.95 -48.32 81.92 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 119.255 0.934 . . . . 36.91 111.367 173.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1132 ' ' SER . . . . . . . . . . . . . 73.9 m -59.82 -58.3 9.18 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 119.098 0.863 . . . . 35.79 111.757 175.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1133 ' ' MET . . . . . 0.4 ' HG3' ' CE2' ' A' 1092 ' ' PHE . 27.1 mmt -61.24 -31.17 70.97 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 117.635 2.457 . . . . 30.81 117.635 -176.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1134 ' ' ALA . . . . . . . . . . . . . . . -68.81 -57.06 6.12 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.029 -0.987 . . . . 28.88 112.467 169.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1135 ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -54.8 -48.87 72.22 Favored 'General case' 0 C--O 1.245 0.864 0 C-N-CA 124.379 1.071 . . . . 40.76 110.604 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1136 ' ' ILE . . . . . 0.719 HD13 ' HA ' ' A' 1323 ' ' SER . 42.4 mt -56.31 -50.63 70.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 113.02 0.748 . . . . 31.54 113.02 174.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1137 ' ' ALA . . . . . 0.699 ' HB2' ' HG3' ' A' 1316 ' ' PRO . . . -57.83 -31.55 66.74 Favored 'General case' 0 C--O 1.213 -0.867 0 N-CA-C 114.208 1.188 . . . . 29.87 114.208 174.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -68.07 -51.09 35.74 Favored Glycine 0 N--CA 1.443 -0.863 0 O-C-N 120.54 -1.35 . . . . 28.73 111.287 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 15.7 t80 -62.21 -38.76 90.4 Favored 'General case' 0 C--O 1.217 -0.607 0 O-C-N 122.208 -0.583 . . . . 30.39 110.634 175.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1140 ' ' ARG . . . . . 0.638 ' HG3' HD22 ' A' 1315 ' ' LEU . 7.6 tpt180 -74.54 -24.43 58.95 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.864 1.266 . . . . 26.09 112.521 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1141 ' ' ALA . . . . . 0.551 ' HB2' HD21 ' A' 1284 ' ' LEU . . . -68.15 -40.14 82.44 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.16 -1.422 . . . . 27.1 107.16 170.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1142 ' ' ILE . . . . . 0.443 HG13 ' HB3' ' A' 1183 ' ' ALA . 35.3 mm -64.03 -39.74 86.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 108.259 -1.015 . . . . 28.48 108.259 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 54.4 t -59.97 -64.54 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-O 118.694 -0.67 . . . . 23.07 110.792 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1144 ' ' GLU . . . . . 0.453 ' HG3' HD21 ' A' 1315 ' ' LEU . 6.0 mm-40 -71.88 -23.72 61.55 Favored 'General case' 0 C--O 1.247 0.959 0 CA-C-N 121.257 1.844 . . . . 33.4 114.015 -168.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1145 ' ' ALA . . . . . 0.857 ' HB1' HD12 ' A' 1251 ' ' ILE . . . -58.36 -59.06 5.93 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 115.951 -1.976 . . . . 24.22 108.657 164.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -60.87 -28.21 68.7 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.285 0.991 . . . . 24.89 110.528 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -64.5 -37.23 86.82 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 112.865 0.691 . . . . 26.73 112.865 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1148 ' ' GLU . . . . . 0.461 ' HB2' HD11 ' A' 1310 ' ' ILE . 29.0 mm-40 -107.74 -3.63 18.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 117.981 -1.488 . . . . 39.96 112.41 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1149 ' ' PHE . . . . . 0.611 ' CZ ' ' HB3' ' A' 1250 ' ' ASP . 0.8 OUTLIER -64.67 134.72 54.85 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 107.976 -1.12 . . . . 25.87 107.976 178.045 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 1150 ' ' GLY . . . . . 0.507 ' HA2' ' HD2' ' B' 1320 ' ' PRO . . . -74.12 -38.74 46.76 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 110.638 -0.985 . . . . 19.28 110.638 173.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1151 ' ' ARG . . . . . 0.962 ' HA ' ' HB2' ' B' 1322 ' ' GLN . 46.1 mtm-85 -94.97 177.09 6.0 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 120.67 -1.488 . . . . 39.9 111.48 -178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1152 ' ' PHE . . . . . 0.945 ' HB2' HG11 ' A' 1163 ' ' VAL . 2.6 m-30 -79.48 157.46 27.47 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 120.021 1.282 . . . . 29.44 109.288 169.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1153 ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -66.46 -56.05 12.77 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 105.819 -1.919 . . . . 32.6 105.819 155.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1154 ' ' THR . . . . . . . . . . . . . 25.9 m -51.57 89.24 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 128.352 2.661 . . . . 34.64 116.433 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1155 ' ' GLY . . . . . 0.497 ' HA3' ' HG3' ' A' 1165 ' ' PRO . . . -69.05 83.95 0.23 Allowed Glycine 0 C--O 1.215 -1.05 0 CA-C-O 122.291 0.939 . . . . 37.14 111.328 174.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -117.23 -170.68 1.89 Allowed 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 112.365 -1.917 . . . . 40.57 108.931 168.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1157 ' ' ILE . . . . . 0.718 HG12 ' HG2' ' C' ' 70' ' ' PRO . 1.1 tp -141.83 148.7 20.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 103.404 -2.813 . . . . 44.61 103.404 -175.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1158 ' ' THR . . . . . . . . . . . . . 16.7 p -98.8 -144.23 0.32 Allowed 'General case' 0 C--O 1.249 1.075 0 CA-C-O 116.628 -1.653 . . . . 40.7 110.349 175.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1159 ' ' ALA . . . . . 0.417 ' HB2' HG21 ' C' ' 71' ' ' VAL . . . -95.39 -29.47 14.42 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 121.866 2.121 . . . . 40.25 106.932 163.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1160 ' ' ALA . . . . . 0.439 ' HB2' ' ND2' ' B' 1330 ' ' ASN . . . -76.27 -83.5 0.07 Allowed 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 109.713 -0.477 . . . . 38.47 109.713 173.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . -122.3 169.43 14.93 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-O 123.85 1.806 . . . . 37.61 113.574 -160.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 23.2 tttp -102.01 140.98 35.56 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-N 109.908 -3.146 . . . . 48.9 108.667 -172.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1163 ' ' VAL . . . . . 0.945 HG11 ' HB2' ' A' 1152 ' ' PHE . 47.0 t -98.27 114.98 65.84 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-N 113.658 -1.61 . . . . 36.52 106.8 167.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1164 ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -54.92 123.53 14.0 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.97 2.447 . . . . 35.08 112.103 165.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1165 ' ' PRO . . . . . 0.497 ' HG3' ' HA3' ' A' 1155 ' ' GLY . 91.8 Cg_exo -60.39 119.9 7.35 Favored 'Trans proline' 0 N--CA 1.432 -2.138 0 C-N-CA 125.091 3.86 . . . . 35.33 109.532 176.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1166 ' ' ALA . . . . . 0.435 ' O ' ' HB1' ' A' 1189 ' ' ALA . . . -67.87 126.11 28.4 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 113.838 -1.528 . . . . 34.69 114.615 -167.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1167 ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' A' 1190 ' ' ILE . 9.4 mptt -73.53 90.67 1.76 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 124.662 1.226 . . . . 45.36 109.535 172.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 34.3 t -83.7 89.85 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-O 124.439 2.066 . . . . 31.71 105.823 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1169 ' ' MET . . . . . 0.602 ' HG3' HD11 ' A' 1212 ' ' LEU . 25.7 ttp -74.98 134.09 41.56 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 113.917 -1.492 . . . . 42.28 108.888 174.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 99.1 t -125.26 136.99 59.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 104.442 -2.429 . . . . 30.51 104.442 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1171 ' ' ILE . . . . . 0.46 HG22 ' HB2' ' A' 1256 ' ' ALA . 61.3 mt -121.69 127.57 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 103.979 -2.6 . . . . 31.87 103.979 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 73.82 70.51 1.23 Allowed Glycine 0 CA--C 1.535 1.304 0 N-CA-C 107.557 -2.217 . . . . 34.54 107.557 -170.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1173 ' ' ALA . . . . . 0.669 ' HA ' ' HA3' ' A' 1177 ' ' GLY . . . -72.95 59.96 0.52 Allowed 'General case' 0 N--CA 1.445 -0.725 0 O-C-N 120.311 -1.699 . . . . 32.51 109.577 173.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1174 ' ' GLY . . . . . 0.605 ' HA2' ' NH2' ' A' 1197 ' ' ARG . . . -86.95 -148.98 13.78 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 107.987 -2.045 . . . . 29.9 107.987 -177.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1175 ' ' VAL . . . . . 0.45 HG11 ' HA ' ' A' 1131 ' ' SER . 57.7 t -60.03 -40.43 83.15 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 O-C-N 119.329 -2.277 . . . . 33.11 108.832 176.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1176 ' ' ALA . . . . . 0.641 ' HB3' HG21 ' A' 1255 ' ' THR . . . -69.62 -52.75 23.13 Favored 'General case' 0 C--O 1.224 -0.277 0 O-C-N 121.858 -0.526 . . . . 28.1 110.712 177.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1177 ' ' GLY . . . . . 0.669 ' HA3' ' HA ' ' A' 1173 ' ' ALA . . . -56.27 -48.02 77.94 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 110.892 -0.883 . . . . 28.54 110.892 -176.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1178 ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' 1181 ' ' ILE . 51.4 mt -58.57 -39.4 80.17 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.939 1.459 . . . . 31.22 114.939 177.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -68.84 -36.49 78.23 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.708 -0.62 . . . . 28.98 112.355 173.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -63.92 -37.31 86.93 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.399 0.518 . . . . 27.83 112.399 171.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1181 ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' 1178 ' ' LEU . 90.0 mt -62.46 -53.28 49.33 Favored 'Isoleucine or valine' 0 C--O 1.246 0.904 0 C-N-CA 125.622 1.569 . . . . 30.25 108.775 175.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -50.25 -52.3 28.02 Favored Glycine 0 N--CA 1.435 -1.399 0 O-C-N 125.481 1.738 . . . . 29.59 114.134 175.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1183 ' ' ALA . . . . . 0.443 ' HB3' HG13 ' A' 1142 ' ' ILE . . . -61.42 -45.24 95.13 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.982 0.734 . . . . 30.29 112.982 178.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -74.15 -36.82 64.14 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 113.457 0.91 . . . . 30.47 113.457 -173.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -57.73 -48.77 78.67 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 108.369 -0.974 . . . . 42.41 108.369 167.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1186 ' ' SER . . . . . 0.632 ' HB3' ' HA ' ' B' 1187 ' ' LEU . 74.1 m -56.68 -37.23 70.56 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 123.153 1.454 . . . . 39.38 112.546 176.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1187 ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' 1187 ' ' LEU . 13.5 mt -69.39 -34.84 75.12 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 118.141 -2.849 . . . . 36.18 114.548 173.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 105.11 76.08 1.05 Allowed Glycine 0 C--N 1.308 -0.995 0 O-C-N 119.929 -1.732 . . . . 33.78 112.057 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1189 ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' A' 1166 ' ' ALA . . . -151.64 168.41 25.06 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 113.635 -1.282 . . . . 33.93 109.362 -168.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1190 ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' 1167 ' ' LYS . 86.3 mt -90.67 95.38 5.48 Favored 'Isoleucine or valine' 0 C--O 1.253 1.288 0 N-CA-C 107.122 -1.436 . . . . 38.74 107.122 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 10.8 t -86.93 133.47 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 106.806 -1.553 . . . . 33.09 106.806 -178.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1192 ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' 1169 ' ' MET . 99.0 mtt180 -133.02 121.52 22.85 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 105.295 -2.113 . . . . 38.92 105.295 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -127.39 149.41 50.09 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 115.089 1.514 . . . . 35.32 115.089 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1194 ' ' PHE . . . . . 0.515 ' HB2' HD12 ' A' 1212 ' ' LEU . 47.5 t80 -137.39 154.0 50.08 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.425 -2.065 . . . . 39.35 105.425 176.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 13.4 t0 -146.91 159.16 43.88 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 103.352 -2.833 . . . . 40.46 103.352 173.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1196 ' ' THR . . . . . . . . . . . . . 53.5 m -63.7 -30.7 71.77 Favored 'General case' 0 C--O 1.254 1.32 0 CA-C-N 111.574 -2.557 . . . . 45.94 108.692 171.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1197 ' ' ARG . . . . . 0.605 ' NH2' ' HA2' ' A' 1174 ' ' GLY . 58.2 mtm180 -101.47 100.69 14.56 Favored Pre-proline 0 CA--C 1.509 -0.629 0 N-CA-C 105.391 -2.078 . . . . 56.02 105.391 176.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1198 ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -59.59 -12.57 17.99 Favored 'Trans proline' 0 C--O 1.257 1.44 0 C-N-CA 122.621 2.214 . . . . 51.27 114.914 175.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -48.37 -16.61 0.11 Allowed 'General case' 0 C--O 1.234 0.257 0 N-CA-C 121.219 3.785 . . . . 59.1 121.219 167.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1200 ' ' VAL . . . . . 0.637 HG21 ' HB3' ' A' 1173 ' ' ALA . 33.8 m -80.65 -10.26 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 116.273 1.953 . . . . 51.06 116.273 169.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 75.0 tttt -50.59 -54.4 22.97 Favored 'General case' 0 C--N 1.348 0.516 0 N-CA-C 117.431 2.382 . . . . 57.38 117.431 -167.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.65 -30.78 63.14 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 115.368 -0.833 . . . . 62.41 108.776 -176.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -66.82 -33.2 75.09 Favored 'General case' 0 CA--C 1.501 -0.914 0 O-C-N 119.795 -1.815 . . . . 57.78 111.976 173.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 25.1 t -64.41 -47.9 87.5 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 C-N-CA 124.571 1.148 . . . . 46.38 109.3 172.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1205 ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' 1209 ' ' ALA . 21.6 mm100 -60.3 -45.62 92.74 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 122.006 -0.434 . . . . 50.7 111.403 177.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1206 ' ' SER . . . . . . . . . . . . . 47.5 m -69.54 -24.38 63.71 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 113.098 0.777 . . . . 49.98 113.098 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1207 ' ' MET . . . . . . . . . . . . . 36.6 mtp -86.67 9.77 17.73 Favored 'General case' 0 N--CA 1.443 -0.824 0 O-C-N 120.9 -1.125 . . . . 52.99 113.834 173.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 89.18 49.31 3.54 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 118.565 0.621 . . . . 47.66 112.648 170.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1209 ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' 1205 ' ' GLN . . . -158.28 160.88 37.55 Favored 'General case' 0 C--O 1.246 0.91 0 C-N-CA 124.116 0.966 . . . . 44.77 112.814 -174.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -96.4 147.52 23.73 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 105.476 -2.046 . . . . 47.64 105.476 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1211 ' ' PHE . . . . . . . . . . . . . 44.8 t80 -95.48 130.78 42.19 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.792 -1.188 . . . . 45.66 107.792 166.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1212 ' ' LEU . . . . . 0.602 HD11 ' HG3' ' A' 1169 ' ' MET . 84.6 mt -65.43 105.6 1.2 Allowed 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 113.508 0.929 . . . . 46.06 113.508 -177.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -79.11 124.33 28.21 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 122.58 1.181 . . . . 60.22 110.024 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1214 ' ' LEU . . . . . 0.548 ' HA ' ' HG ' ' A' 1241 ' ' LEU . 9.6 mp -76.5 133.8 39.67 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 112.736 -2.029 . . . . 57.25 108.321 174.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 28.6 t70 -85.56 81.01 8.85 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 104.801 -2.296 . . . . 64.43 104.801 177.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 14.8 t80 . . . . . 0 CA--C 1.503 -0.836 0 CA-C-N 113.483 -1.69 . . . . 66.9 112.66 -167.278 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 CA--C 1.561 1.394 0 CA-C-O 116.809 -1.567 . . . . 39.09 108.576 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -52.12 -49.67 48.79 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 120.689 1.586 . . . . 39.32 114.242 173.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 74.3 t80 -64.25 -41.47 96.94 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.878 0.847 . . . . 39.3 109.738 -175.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -62.05 -41.89 98.61 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 114.479 -1.237 . . . . 36.3 111.466 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -58.14 -49.8 75.72 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 124.078 0.861 . . . . 37.38 109.364 170.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -65.99 -11.17 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 114.77 1.396 . . . . 39.11 114.77 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1230 ' ' MET . . . . . . . . . . . . . 26.4 mmt -107.93 -7.39 16.23 Favored 'General case' 0 C--O 1.244 0.789 0 O-C-N 121.103 -0.998 . . . . 49.59 110.235 175.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1231 ' ' SER . . . . . 0.495 ' O ' HG13 ' A' 1235 ' ' ILE . 69.4 m -87.12 132.74 33.75 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 118.919 0.781 . . . . 43.68 109.06 176.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -49.46 -58.34 5.34 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 114.462 1.282 . . . . 55.57 114.462 -167.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -64.94 -30.13 71.1 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 113.86 1.059 . . . . 44.94 113.86 -173.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 32.5 t80 -66.29 -48.74 69.43 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 115.483 -2.199 . . . . 42.04 107.994 172.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1235 ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' 1231 ' ' SER . 2.9 mt -59.2 -30.92 44.94 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 CA-C-O 123.627 1.679 . . . . 46.28 112.8 177.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 33.3 tttm -74.49 -42.15 59.49 Favored 'General case' 0 C--O 1.215 -0.761 0 O-C-N 119.156 -2.215 . . . . 47.87 105.585 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -61.18 -31.03 70.78 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 119.551 1.069 . . . . 41.61 112.012 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -62.14 -59.1 5.54 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.741 -1.207 . . . . 50.65 107.741 168.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1239 ' ' MET . . . . . . . . . . . . . 38.6 mtt -55.33 -40.15 70.84 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 121.688 0.756 . . . . 48.87 112.667 -178.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -61.43 -51.46 68.65 Favored 'General case' 0 C--O 1.254 1.291 0 O-C-N 120.267 -1.521 . . . . 54.8 108.984 176.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1241 ' ' LEU . . . . . 0.548 ' HG ' ' HA ' ' A' 1214 ' ' LEU . 1.5 tm? -65.43 -37.39 86.77 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.703 -0.851 . . . . 43.21 108.703 -172.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -66.94 -43.06 84.2 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.685 -1.143 . . . . 38.66 112.256 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1243 ' ' ALA . . . . . 0.504 ' HA ' ' HG3' ' A' 1271 ' ' MET . . . -58.41 -45.09 89.08 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 120.799 1.636 . . . . 37.92 111.288 175.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -60.8 -48.57 81.18 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 114.337 -1.301 . . . . 37.28 110.28 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -63.93 -43.45 95.82 Favored 'General case' 0 C--O 1.214 -0.783 0 CA-C-O 115.413 -2.232 . . . . 43.07 112.496 170.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1246 ' ' ALA . . . . . 0.626 ' HB1' ' HG2' ' A' 1275 ' ' MET . . . -57.59 -38.75 75.4 Favored 'General case' 0 C--O 1.212 -0.892 0 CA-C-N 122.471 2.396 . . . . 38.3 110.186 -170.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1247 ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' 1274 ' ' SER . 38.2 mtmt -62.71 -22.1 66.26 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 115.658 1.725 . . . . 47.6 115.658 176.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -118.56 -14.36 9.65 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-O 117.914 -1.041 . . . . 45.42 112.444 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1249 ' ' VAL . . . . . 0.544 HG22 ' HA ' ' A' 1246 ' ' ALA 0.277 34.7 m -78.79 175.66 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 120.801 1.637 . . . . 36.26 113.304 -178.48 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 1250 ' ' ASP . . . . . 0.611 ' HB3' ' CZ ' ' A' 1149 ' ' PHE . 13.1 m-20 -124.28 -47.4 1.88 Allowed 'General case' 0 N--CA 1.432 -1.339 0 O-C-N 124.586 1.179 . . . . 33.04 112.823 -171.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1251 ' ' ILE . . . . . 0.857 HD12 ' HB1' ' A' 1145 ' ' ALA . 38.0 mm -127.04 137.61 57.34 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 N-CA-C 105.147 -2.168 . . . . 31.4 105.147 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1252 ' ' ILE . . . . . 0.685 HD12 HG12 ' A' 1281 ' ' ILE . 33.0 mt -125.14 113.14 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 C-N-CA 119.282 -0.967 . . . . 29.42 108.526 167.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 48.5 t -90.65 102.93 13.87 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 CA-C-O 124.394 2.045 . . . . 30.37 106.728 176.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1254 ' ' THR . . . . . 0.86 ' HB ' ' HA ' ' A' 1283 ' ' ASP . 21.8 m -100.36 99.17 9.77 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 110.473 -3.058 . . . . 35.72 104.04 -158.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1255 ' ' THR . . . . . 0.641 HG21 ' HB3' ' A' 1176 ' ' ALA . 0.2 OUTLIER -137.4 22.75 2.96 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.758 -1.565 . . . . 36.0 113.845 -168.216 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 1256 ' ' ALA . . . . . 0.46 ' HB2' HG22 ' A' 1171 ' ' ILE . . . -78.48 85.84 4.54 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 118.166 -2.834 . . . . 40.93 110.223 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 10.2 tp -142.55 124.2 14.99 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 111.514 -2.585 . . . . 47.82 109.311 -168.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 8.4 mm -78.13 120.71 82.24 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 100.916 -3.735 . . . . 52.7 100.916 160.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 1.3 Cg_exo -44.18 113.33 0.42 Allowed 'Trans proline' 0 C--N 1.319 -0.982 1 C-N-CA 125.551 4.167 . . . . 54.13 116.373 -167.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 78.71 3.96 87.55 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 112.243 -2.253 . . . . 54.62 115.727 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -111.22 145.16 31.92 Favored Pre-proline 0 C--O 1.219 -0.539 0 CA-C-N 121.561 2.68 . . . . 55.74 105.581 -174.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -48.16 108.27 0.17 Allowed 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 125.08 3.853 . . . . 51.15 116.055 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1263 ' ' ALA . . . . . 0.46 ' HB1' ' ND2' ' A' 1291 ' ' ASN . . . -65.12 154.85 85.99 Favored Pre-proline 0 C--O 1.222 -0.358 0 CA-C-N 112.579 -2.1 . . . . 46.06 112.725 -176.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.44 126.26 15.27 Favored 'Trans proline' 0 C--O 1.248 0.983 0 C-N-CA 123.737 2.958 . . . . 41.08 109.826 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 50.1 mmtt -77.56 105.63 8.83 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 106.385 -1.709 . . . . 47.42 106.385 176.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 52.4 mt -107.59 -52.35 2.78 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 113.112 -1.858 . . . . 39.22 110.246 -174.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1267 ' ' ILE . . . . . 0.623 ' HA ' ' SD ' ' A' 1271 ' ' MET . 61.1 mt -88.03 100.46 10.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 104.882 -2.266 . . . . 42.5 104.882 -169.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1268 ' ' THR . . . . . 0.545 ' O ' HG23 ' A' 1272 ' ' VAL . 12.3 p -68.05 157.6 34.81 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 126.146 1.778 . . . . 37.84 113.934 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -57.49 -34.15 68.76 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 115.223 1.564 . . . . 54.8 115.223 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -67.37 -47.24 70.97 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 114.355 -1.293 . . . . 54.36 110.889 172.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1271 ' ' MET . . . . . 0.623 ' SD ' ' HA ' ' A' 1267 ' ' ILE . 54.6 ttm -58.33 -45.41 88.15 Favored 'General case' 0 C--O 1.251 1.18 0 C-N-CA 124.297 1.039 . . . . 39.52 109.862 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1272 ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' 1268 ' ' THR . 21.2 t -57.4 -54.44 30.88 Favored 'Isoleucine or valine' 0 C--O 1.249 1.069 0 CA-C-N 115.843 -0.617 . . . . 38.25 110.379 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.41 -11.91 60.14 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 114.096 1.147 . . . . 40.77 114.096 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1274 ' ' SER . . . . . 0.474 ' O ' ' HG2' ' A' 1247 ' ' LYS . 70.7 m -78.28 -18.96 54.58 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 116.631 -1.652 . . . . 36.58 112.875 172.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1275 ' ' MET . . . . . 0.626 ' HG2' ' HB1' ' A' 1246 ' ' ALA . 85.0 mtp -53.4 155.03 3.05 Favored 'General case' 0 CA--C 1.51 -0.571 0 O-C-N 125.222 1.576 . . . . 36.75 115.156 -176.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1276 ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' 1247 ' ' LYS . 39.8 ttpt -60.93 139.99 57.87 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 105.532 -2.025 . . . . 46.11 105.532 166.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1277 ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' B' 1044 ' ' SER . . . -85.57 165.37 17.12 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 123.182 1.468 . . . . 33.52 110.304 -171.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 74.02 36.5 51.64 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.697 1.141 . . . . 31.27 111.977 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1279 ' ' SER . . . . . 0.48 ' HB2' HG22 ' A' 1307 ' ' VAL . 37.3 m -134.42 166.27 23.24 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 114.2 -1.0 . . . . 32.95 108.539 -165.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1280 ' ' VAL . . . . . 0.782 HG22 ' HB2' ' A' 1308 ' ' LYS . 48.4 t -133.65 142.94 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 O-C-N 118.939 -2.35 . . . . 27.43 111.474 -176.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1281 ' ' ILE . . . . . 0.685 HG12 HD12 ' A' 1252 ' ' ILE . 74.7 mt -110.49 103.23 15.15 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 N-CA-C 102.167 -3.272 . . . . 30.3 102.167 164.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -86.85 95.86 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 N-CA-C 107.291 -1.374 . . . . 28.63 107.291 174.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1283 ' ' ASP . . . . . 0.86 ' HA ' ' HB ' ' A' 1254 ' ' THR . 19.7 t0 -85.96 106.92 17.48 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 105.547 -2.019 . . . . 36.27 105.547 -173.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1284 ' ' LEU . . . . . 0.551 HD21 ' HB2' ' A' 1141 ' ' ALA . 91.0 mt -89.59 -31.9 17.36 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 114.924 -1.035 . . . . 38.57 108.584 175.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -66.43 -11.25 50.86 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 122.449 1.119 . . . . 37.56 110.861 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . -42.48 -20.36 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 126.509 1.924 . . . . 40.33 115.304 163.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -47.92 -41.25 24.22 Favored 'General case' 0 CA--C 1.553 1.071 0 O-C-N 121.378 -0.826 . . . . 56.85 110.675 173.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 1.4 t30 -137.07 99.26 3.95 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 119.787 -0.765 . . . . 45.86 109.509 170.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 82.18 -50.34 4.29 Favored Glycine 0 N--CA 1.476 1.317 0 O-C-N 119.693 -1.879 . . . . 40.31 113.863 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 101.39 164.47 27.41 Favored Glycine 0 N--CA 1.477 1.373 0 CA-C-N 119.749 1.775 . . . . 38.89 113.241 -176.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1291 ' ' ASN . . . . . 0.565 ' HB2' HG22 ' A' 1254 ' ' THR . 33.5 m120 -93.14 -35.84 12.96 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 117.954 0.877 . . . . 37.23 109.1 171.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1292 ' ' CYS . . . . . 0.598 ' HB3' ' OG1' ' A' 1295 ' ' THR . 20.5 t -78.49 153.67 31.16 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 122.885 1.326 . . . . 36.5 109.265 173.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1293 ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -82.89 -50.5 8.55 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 113.104 -1.862 . . . . 43.32 109.666 174.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.64 -24.94 59.19 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 117.454 2.39 . . . . 41.32 117.454 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1295 ' ' THR . . . . . 0.598 ' OG1' ' HB3' ' A' 1292 ' ' CYS . 98.0 m -38.48 112.52 0.23 Allowed 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 124.915 1.286 . . . . 35.3 113.585 167.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 29.6 t -87.65 111.65 43.34 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 102.921 -2.992 . . . . 34.84 102.921 163.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -64.92 86.44 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.697 1 C-N-CA 125.327 4.018 . . . . 33.51 107.056 174.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 154.77 -27.94 0.66 Allowed Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 107.722 -2.151 . . . . 32.19 107.722 178.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -130.94 164.63 24.9 Favored 'General case' 0 C--O 1.251 1.135 0 CA-C-N 122.067 2.934 . . . . 34.88 113.975 -168.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1300 ' ' ILE . . . . . 0.681 HG12 HG12 ' A' 1310 ' ' ILE . 84.1 mt -77.13 124.45 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 104.563 -2.384 . . . . 32.29 104.563 156.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 50.9 t80 -108.0 113.14 26.11 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 102.387 -3.19 . . . . 37.25 102.387 170.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1302 ' ' THR . . . . . . . . . . . . . 5.5 m -94.08 108.42 20.25 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 120.067 -1.646 . . . . 35.56 107.066 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1303 ' ' THR . . . . . . . . . . . . . 8.8 p -74.96 166.32 23.85 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 115.517 1.673 . . . . 36.4 115.517 -174.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.41 -26.53 65.58 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 120.561 -1.337 . . . . 52.32 112.039 -164.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1305 ' ' ASN . . . . . 0.455 HD21 ' HB2' ' A' 1275 ' ' MET . 49.1 p-10 -66.75 -42.99 85.29 Favored 'General case' 0 C--O 1.239 0.552 0 O-C-N 121.116 -0.99 . . . . 40.04 112.116 171.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 123.61 43.15 0.35 Allowed Glycine 0 N--CA 1.414 -2.785 0 CA-C-O 123.244 1.469 . . . . 36.96 111.663 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1307 ' ' VAL . . . . . 0.48 HG22 ' HB2' ' A' 1279 ' ' SER . 41.5 t -113.52 140.89 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-N 113.728 -1.236 . . . . 33.4 109.253 176.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1308 ' ' LYS . . . . . 0.782 ' HB2' HG22 ' A' 1280 ' ' VAL . 34.6 mmtt -97.81 110.73 23.24 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 112.658 -2.064 . . . . 42.91 107.902 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 5.3 t -99.62 87.42 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.817 0 N-CA-C 104.73 -2.322 . . . . 32.29 104.73 -176.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1310 ' ' ILE . . . . . 0.681 HG12 HG12 ' A' 1300 ' ' ILE . 75.2 mt -88.57 83.09 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 113.979 -1.464 . . . . 30.99 109.232 -171.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -82.11 54.83 4.9 Favored Glycine 0 N--CA 1.437 -1.282 0 CA-C-O 123.415 1.564 . . . . 28.95 112.249 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1312 ' ' TYR . . . . . 0.545 ' CB ' ' HG ' ' A' 1315 ' ' LEU . 11.1 m-30 -82.58 98.73 9.13 Favored 'General case' 0 CA--C 1.502 -0.881 0 O-C-N 118.242 -2.916 . . . . 31.69 114.314 -173.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1313 ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -52.05 -44.26 64.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 112.041 -2.345 . . . . 34.17 111.806 170.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -64.9 -10.12 26.3 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 117.827 2.529 . . . . 36.86 117.827 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1315 ' ' LEU . . . . . 0.638 HD22 ' HG3' ' A' 1140 ' ' ARG . 45.9 mt -62.55 -29.24 4.45 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 118.713 2.857 . . . . 34.85 118.713 -175.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1316 ' ' PRO . . . . . 0.699 ' HG3' ' HB2' ' A' 1137 ' ' ALA . 0.7 OUTLIER -59.92 -27.61 85.3 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.446 2.764 . . . . 29.15 114.267 165.223 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -79.98 -48.97 6.23 Favored Glycine 0 CA--C 1.502 -0.764 0 N-CA-C 107.55 -2.22 . . . . 27.29 107.55 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1318 ' ' ARG . . . . . . . . . . . . . 4.7 ttm180 -87.05 57.1 4.31 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 113.627 0.973 . . . . 41.49 113.627 -159.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1319 ' ' LEU . . . . . . . . . . . . . 15.1 tp -135.89 73.31 60.11 Favored Pre-proline 0 C--N 1.32 -0.715 1 N-CA-C 99.327 -4.323 . . . . 27.61 99.327 156.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1320 ' ' PRO . . . . . 0.613 ' HG2' ' HA2' ' B' 1150 ' ' GLY . 60.7 Cg_endo -42.25 -64.18 0.27 Allowed 'Trans proline' 0 N--CA 1.442 -1.531 1 C-N-CA 126.171 4.581 . . . . 25.94 117.999 -158.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 1321 ' ' THR . . . . . 0.528 HG23 ' CZ ' ' A' 1045 ' ' PHE . 6.7 m -58.07 -45.58 86.89 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 119.803 -0.759 . . . . 25.01 111.016 176.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1322 ' ' GLN . . . . . 0.652 ' HB2' ' HA ' ' B' 1151 ' ' ARG . 33.8 tp60 -67.38 -48.07 68.48 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 123.767 0.667 . . . . 29.39 109.76 -169.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1323 ' ' SER . . . . . 0.719 ' HA ' HD13 ' A' 1136 ' ' ILE . 20.4 m -56.08 -48.67 75.66 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 118.391 -0.814 . . . . 26.47 112.946 174.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1324 ' ' SER . . . . . . . . . . . . . 36.0 m -65.03 -29.76 70.69 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 123.069 1.414 . . . . 27.78 112.581 175.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1325 ' ' GLN . . . . . 0.672 ' HA ' HG21 ' A' 1019 ' ' THR . 26.7 tp60 -72.6 -58.84 3.06 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 106.641 -1.614 . . . . 37.53 106.641 -174.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1326 ' ' LEU . . . . . 0.458 ' HG ' HE21 ' A' 1322 ' ' GLN . 37.9 mt -71.21 -42.01 69.51 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 118.385 -0.817 . . . . 35.71 109.151 -172.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1327 ' ' TYR . . . . . 0.496 ' O ' ' HB2' ' A' 1330 ' ' ASN . 53.0 t80 -60.55 -41.32 94.29 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 119.636 1.107 . . . . 31.59 110.857 173.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1328 ' ' GLY . . . . . 0.511 ' HA2' HD12 ' A' 1331 ' ' LEU . . . -61.71 -47.01 93.0 Favored Glycine 0 C--O 1.256 1.487 0 O-C-N 121.336 -0.852 . . . . 28.0 111.653 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1329 ' ' THR . . . . . . . . . . . . . 6.5 m -71.99 -24.05 61.52 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 113.964 -1.118 . . . . 32.15 109.251 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1330 ' ' ASN . . . . . 0.496 ' HB2' ' O ' ' A' 1327 ' ' TYR . 17.6 m120 -60.74 -49.28 78.15 Favored 'General case' 0 C--O 1.24 0.595 0 O-C-N 119.067 -2.27 . . . . 34.36 111.851 168.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1331 ' ' LEU . . . . . 0.599 HD22 HD22 ' A' 1070 ' ' LEU . 16.4 mt -62.41 -37.81 87.22 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 114.758 -1.11 . . . . 33.37 111.136 178.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1332 ' ' VAL . . . . . 0.571 ' HA ' HD21 ' A' 1026 ' ' LEU . 64.1 t -63.76 -45.64 96.69 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 N-CA-C 108.634 -0.876 . . . . 35.27 108.634 173.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1333 ' ' ASN . . . . . 0.402 ' HA ' ' HD2' ' A' 1336 ' ' LYS . 37.0 m-80 -57.8 -44.82 86.58 Favored 'General case' 0 C--O 1.241 0.613 0 O-C-N 118.979 -2.325 . . . . 37.66 112.679 -178.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1334 ' ' LEU . . . . . . . . . . . . . 41.3 tp -53.64 -59.22 4.88 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.886 -1.052 . . . . 40.27 110.443 169.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1335 ' ' LEU . . . . . 0.528 ' HA ' ' HB2' ' A' 1338 ' ' LEU . 32.0 mt -62.9 -14.23 44.05 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 117.472 2.397 . . . . 42.5 117.472 174.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1336 ' ' LYS . . . . . 0.582 ' HE2' ' OE1' ' A' 1025 ' ' GLN . 94.5 mttt -66.52 -46.21 76.93 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 121.749 2.068 . . . . 47.81 107.123 169.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1337 ' ' LEU . . . . . 0.606 HD22 HD21 ' A' 1127 ' ' LEU . 10.9 mp -72.51 -39.68 67.41 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 114.657 -1.156 . . . . 49.27 112.792 177.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1338 ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' 1347 ' ' THR . 9.4 mp -66.85 -32.73 74.19 Favored 'General case' 0 C--O 1.246 0.877 0 O-C-N 120.457 -1.402 . . . . 50.54 112.821 175.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1339 ' ' CYS . . . . . 0.575 ' SG ' ' HA2' ' A' 1344 ' ' GLY . 50.2 t -116.38 68.47 0.73 Allowed 'General case' 0 C--O 1.25 1.079 0 O-C-N 118.711 -2.493 . . . . 53.67 105.532 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1340 ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' 1337 ' ' LEU . 40.2 mtmt -75.02 -42.71 56.74 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.354 1.073 . . . . 63.38 111.132 174.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -68.44 -44.94 73.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 123.63 1.681 . . . . 70.95 114.069 -177.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1342 ' ' LYS . . . . . 0.643 ' HE3' ' HA ' ' A' 1029 ' ' LEU . 18.3 mtpt 59.77 67.61 0.86 Allowed 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 128.072 2.549 . . . . 65.25 112.859 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1343 ' ' ASP . . . . . 0.489 ' HB3' ' N ' ' A' 1342 ' ' LYS 0.269 37.5 t70 60.42 -122.11 0.96 Allowed 'General case' 0 N--CA 1.426 -1.66 2 O-C-N 111.602 -6.936 . . . . 64.53 111.795 9.594 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild core ' A' A 1344 ' ' GLY . . . . . 0.575 ' HA2' ' SG ' ' A' 1339 ' ' CYS . . . 109.97 31.25 3.18 Favored Glycine 0 C--O 1.252 1.225 0 O-C-N 117.289 -3.382 . . . . 59.72 111.461 -174.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 28.5 t30 -84.21 149.0 26.42 Favored 'General case' 0 N--CA 1.436 -1.156 0 O-C-N 120.492 -1.593 . . . . 64.09 107.105 164.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1346 ' ' ILE . . . . . 0.435 HD12 ' H ' ' A' 1346 ' ' ILE . 2.6 mp -81.36 83.56 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 103.198 -2.89 . . . . 58.82 103.198 176.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1347 ' ' THR . . . . . 0.533 ' O ' ' HG ' ' A' 1338 ' ' LEU . 3.3 m -76.91 83.43 3.46 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 105.798 -1.926 . . . . 54.96 105.798 -177.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1348 ' ' VAL . . . . . 0.456 HG21 HG21 ' A' 1111 ' ' THR . 21.8 t -78.33 76.13 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 124.406 2.051 . . . . 55.64 106.508 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 27.0 t70 -75.13 138.38 42.0 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 112.113 -2.312 . . . . 61.45 112.518 -165.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1350 ' ' PHE . . . . . 0.451 ' CZ ' ' HD3' ' A' 1362 ' ' ARG . 11.4 m-30 -103.49 -6.35 21.89 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 112.082 -2.326 . . . . 58.63 112.898 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 15.1 t70 -71.71 -48.24 48.49 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 118.797 0.726 . . . . 62.06 110.072 177.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 18.2 t0 -66.25 130.57 43.67 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.538 -0.756 . . . . 54.07 109.397 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 31.8 m -67.95 -28.31 40.81 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 N-CA-C 113.077 0.769 . . . . 50.68 113.077 -176.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1354 ' ' VAL . . . . . 0.66 ' O ' HG23 ' A' 1358 ' ' VAL . 3.1 m -80.23 -43.65 22.14 Favored 'Isoleucine or valine' 0 C--O 1.246 0.876 0 N-CA-C 105.471 -2.048 . . . . 47.68 105.471 -174.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1355 ' ' ILE . . . . . 0.543 HD11 ' HB3' ' A' 1337 ' ' LEU . 62.2 mt -65.77 -44.08 93.2 Favored 'Isoleucine or valine' 0 C--O 1.25 1.115 0 C-N-CA 119.423 -0.911 . . . . 48.49 109.731 -177.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 35.2 tpt85 -53.61 -48.04 69.67 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 115.269 -2.3 . . . . 48.27 113.329 168.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -57.9 -45.58 93.47 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 122.124 2.238 . . . . 43.53 114.995 174.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1358 ' ' VAL . . . . . 0.685 HG12 ' HB3' ' A' 1113 ' ' MET . 11.6 t -59.44 -49.82 82.18 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 C-N-CA 125.041 1.337 . . . . 45.12 110.913 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1359 ' ' THR . . . . . . . . . . . . . 18.5 m -70.74 87.73 0.7 Allowed 'General case' 0 C--O 1.244 0.774 0 CA-C-O 125.011 2.338 . . . . 42.94 112.479 -177.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 16.5 m -78.13 -28.83 15.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 112.642 -2.072 . . . . 43.26 111.461 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1361 ' ' ILE . . . . . 0.605 ' HB ' ' HB ' ' A' 1112 ' ' VAL . 96.5 mt -131.98 119.83 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 102.972 -2.973 . . . . 45.66 102.972 175.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1362 ' ' ARG . . . . . 0.628 ' HG3' HG23 ' A' 1111 ' ' THR . 2.0 ttp180 -106.41 124.42 49.57 Favored 'General case' 0 C--O 1.253 1.241 1 CA-C-N 126.254 4.116 . . . . 61.34 106.762 168.489 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 43.81 54.6 5.58 Favored 'General case' 0 C--O 1.241 0.627 0 O-C-N 126.447 2.342 . . . . 49.76 115.192 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 86.04 -24.08 8.49 Favored Glycine 0 CA--C 1.526 0.74 0 O-C-N 120.014 -1.678 . . . . 50.0 114.301 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -88.78 124.93 34.62 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 103.692 -2.707 . . . . 56.92 103.692 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1366 ' ' ILE . . . . . 0.518 HG22 ' HB3' ' A' 1368 ' ' TRP . 92.4 mt -75.18 89.32 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.753 0 CA-C-O 123.073 1.416 . . . . 52.78 108.065 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1367 ' ' THR . . . . . . . . . . . . . 17.1 p -75.76 53.05 0.71 Allowed 'General case' 0 C--O 1.252 1.211 0 CA-C-O 125.951 2.786 . . . . 49.44 113.767 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1368 ' ' TRP . . . . . 0.518 ' HB3' HG22 ' A' 1366 ' ' ILE . 57.1 t90 -132.37 144.07 51.49 Favored Pre-proline 0 CA--C 1.545 0.787 0 O-C-N 119.525 -1.984 . . . . 52.38 108.491 -170.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1369 ' ' PRO . . . . . 0.435 ' HA ' ' CD1' ' A' 1368 ' ' TRP . 60.9 Cg_endo -75.39 170.81 70.84 Favored 'Cis proline' 0 C--O 1.25 1.11 0 CA-C-N 123.101 2.143 . . . . 46.94 114.164 -4.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -128.75 117.98 19.7 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 108.5 -0.926 . . . . 45.91 108.5 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1371 ' ' PRO . . . . . 0.469 ' HA ' ' HD2' ' A' 1372 ' ' PRO . 51.6 Cg_exo -61.22 137.62 72.12 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 125.198 3.932 . . . . 46.39 112.823 -174.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1372 ' ' PRO . . . . . 0.469 ' HD2' ' HA ' ' A' 1371 ' ' PRO . 86.9 Cg_endo -78.35 8.61 3.51 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 121.105 1.204 . . . . 46.72 113.797 160.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.214 -5.31 0 O-C-N 119.541 -1.974 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 998' ' ' HIS . . . . . 0.729 ' HB2' ' HB2' ' B' 1000 ' ' HIS . 60.3 m80 . . . . . 0 N--CA 1.436 -1.16 0 N-CA-C 102.989 -2.967 . . . . 63.44 102.989 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -111.05 43.53 1.44 Allowed 'General case' 0 C--O 1.243 0.739 0 CA-C-O 123.21 1.481 . . . . 51.74 109.045 148.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1000 ' ' HIS . . . . . 0.729 ' HB2' ' HB2' ' B' ' 998' ' ' HIS . 18.7 t60 -84.61 135.61 34.11 Favored 'General case' 0 C--O 1.247 0.96 0 N-CA-C 104.924 -2.25 . . . . 54.07 104.924 -166.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 67.01 13.22 61.49 Favored Glycine 0 N--CA 1.451 -0.341 0 O-C-N 119.304 -2.122 . . . . 39.22 111.806 -172.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1002 ' ' ARG . . . . . 0.434 ' NH2' ' O ' ' B' 1065 ' ' GLN . 16.6 ttp180 -97.74 121.93 40.24 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.049 -1.463 . . . . 38.12 107.049 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1003 ' ' ILE . . . . . 0.463 HD13 HD13 ' B' 1026 ' ' LEU 0.279 46.6 mt -78.79 149.94 5.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 106.378 -1.712 . . . . 29.7 106.378 172.054 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -121.18 130.09 8.05 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 108.568 -1.813 . . . . 27.5 108.568 162.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1005 ' ' ILE . . . . . 0.483 ' HB ' ' HA ' ' B' 1035 ' ' VAL . 38.4 mm -104.91 103.14 39.63 Favored Pre-proline 0 C--O 1.243 0.748 0 N-CA-C 105.371 -2.085 . . . . 24.83 105.371 170.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -74.15 162.47 38.71 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 124.399 3.399 . . . . 27.19 108.993 171.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1007 ' ' ARG . . . . . 0.693 ' HB2' ' HA ' ' B' 1039 ' ' ALA . 29.2 ttp180 -80.52 137.33 36.42 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 104.449 -2.426 . . . . 41.46 104.449 157.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1008 ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -68.82 158.84 33.6 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-N 115.076 -0.965 . . . . 26.93 110.779 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1009 ' ' ARG . . . . . 0.416 HH22 ' CG ' ' B' 1078 ' ' ASP . 35.0 mmm-85 -113.91 -35.16 5.2 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 111.975 -2.375 . . . . 34.48 112.848 -171.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1010 ' ' LEU . . . . . 0.476 HD13 ' HB2' ' B' 1073 ' ' ASN . 7.3 mp -61.04 153.31 25.72 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 115.713 1.746 . . . . 44.22 115.713 -169.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1011 ' ' THR . . . . . . . . . . . . . 20.1 m -62.82 131.82 50.09 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 113.74 -1.573 . . . . 40.74 110.781 -173.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 5.2 t30 38.64 47.65 1.17 Allowed 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 129.492 3.117 . . . . 44.44 116.042 -166.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1013 ' ' GLU . . . . . 0.413 ' HG2' ' ND2' ' B' 1073 ' ' ASN . 9.7 tp10 -105.19 118.58 36.9 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 112.217 -2.265 . . . . 29.87 106.809 175.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1014 ' ' THR . . . . . 0.407 ' HA ' ' HB3' ' B' 1042 ' ' LEU . 1.0 OUTLIER -106.0 0.51 25.73 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 115.14 1.533 . . . . 25.26 115.14 176.577 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -80.6 144.42 32.4 Favored 'General case' 0 C--O 1.241 0.62 0 O-C-N 119.53 -1.981 . . . . 29.54 112.957 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1016 ' ' VAL . . . . . . . . . . . . . 4.7 p -111.42 175.63 1.8 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 103.992 -2.596 . . . . 23.55 103.992 165.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1017 ' ' ALA . . . . . 0.42 ' HB3' HD12 ' B' 1005 ' ' ILE . . . -75.91 -40.33 54.49 Favored 'General case' 0 C--N 1.344 0.356 0 O-C-N 117.939 -2.976 . . . . 23.59 115.042 -176.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1018 ' ' ALA . . . . . 0.65 ' HB1' ' HB ' ' B' 1022 ' ' THR . . . -152.19 145.47 24.71 Favored 'General case' 0 C--O 1.247 0.935 0 N-CA-C 105.28 -2.118 . . . . 24.93 105.28 -176.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1019 ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.14 172.6 5.02 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 115.725 -2.083 . . . . 28.09 111.521 -178.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1020 ' ' PRO . . . . . 0.462 ' HB3' ' HB2' ' B' 1053 ' ' ALA . 82.8 Cg_exo -51.61 -42.65 55.14 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 CA-C-N 127.155 3.591 . . . . 28.79 118.161 -172.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 83.6 tttt -54.96 -48.76 72.79 Favored 'General case' 0 CA--C 1.502 -0.89 0 O-C-N 121.236 -0.915 . . . . 47.28 112.617 169.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1022 ' ' THR . . . . . 0.65 ' HB ' ' HB1' ' B' 1018 ' ' ALA . 0.0 OUTLIER -67.77 -24.22 65.3 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 120.755 -1.215 . . . . 30.12 113.253 177.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B 1023 ' ' VAL . . . . . 0.487 HG21 ' HD2' ' B' 1050 ' ' PHE . 43.0 t -67.41 -47.57 80.42 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.711 0 O-C-N 120.244 -1.535 . . . . 32.24 107.713 171.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1024 ' ' GLU . . . . . 0.631 ' HA ' HD12 ' B' 1027 ' ' LEU . 27.6 mt-10 -62.73 -36.09 81.87 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 118.776 -0.63 . . . . 49.62 112.684 176.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -58.68 -43.78 90.06 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 124.305 1.003 . . . . 44.68 113.271 169.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1026 ' ' LEU . . . . . 0.478 HD12 ' HA ' ' B' 1023 ' ' VAL . 35.1 mt -62.14 -43.45 98.8 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 119.895 -1.753 . . . . 35.71 113.217 171.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1027 ' ' LEU . . . . . 0.631 HD12 ' HA ' ' B' 1024 ' ' GLU . 24.7 mt -58.24 -27.16 63.71 Favored 'General case' 0 C--N 1.348 0.542 0 O-C-N 119.808 -1.807 . . . . 42.18 112.332 174.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 62.7 mttm -61.75 -21.48 64.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 121.097 1.772 . . . . 48.34 112.38 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1029 ' ' LEU . . . . . 0.489 HD23 ' HG2' ' B' 1342 ' ' LYS . 49.6 mt -86.45 -4.16 59.13 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 114.233 1.197 . . . . 38.69 114.233 175.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 78.58 21.98 68.08 Favored Glycine 0 N--CA 1.446 -0.693 0 O-C-N 120.314 -1.491 . . . . 32.28 113.301 -174.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1031 ' ' PHE . . . . . 0.433 ' HE2' ' HB3' ' B' 1335 ' ' LEU . 22.5 m-85 -99.35 132.44 44.67 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 105.419 -2.067 . . . . 35.94 105.419 176.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1032 ' ' THR . . . . . . . . . . . . . 3.6 m -89.35 123.97 34.01 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 107.971 -1.122 . . . . 33.37 107.971 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1033 ' ' VAL . . . . . . . . . . . . . 22.8 t -95.34 134.12 33.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.637 -1.616 . . . . 29.98 106.637 -171.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -111.77 145.83 38.68 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.911 -1.144 . . . . 28.18 107.911 159.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1035 ' ' VAL . . . . . 0.526 ' HB ' HD13 ' B' 1057 ' ' ILE . 97.1 t -122.5 149.73 26.06 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 N-CA-C 103.713 -2.699 . . . . 25.82 103.713 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1036 ' ' GLU . . . . . 0.625 ' HB3' ' HB2' ' B' 1039 ' ' ALA . 19.1 tt0 -73.3 147.27 44.65 Favored 'General case' 0 C--O 1.213 -0.835 0 C-N-CA 123.252 0.621 . . . . 32.44 111.293 176.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1037 ' ' SER . . . . . . . . . . . . . 44.0 m -60.25 112.72 2.03 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.347 -1.297 . . . . 29.54 111.015 172.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 77.92 20.4 73.39 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 111.695 -2.502 . . . . 27.76 113.941 -175.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1039 ' ' ALA . . . . . 0.693 ' HA ' ' HB2' ' B' 1007 ' ' ARG . . . -64.81 -57.8 7.93 Favored 'General case' 0 C--O 1.25 1.12 0 N-CA-C 115.69 1.737 . . . . 26.02 115.69 -176.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -67.58 -15.1 65.83 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 114.201 -1.363 . . . . 26.47 113.543 -173.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -53.36 -35.72 60.59 Favored 'General case' 0 C--O 1.255 1.347 0 O-C-N 119.615 -2.109 . . . . 50.98 113.133 172.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1042 ' ' LEU . . . . . 0.407 ' HB3' ' HA ' ' B' 1014 ' ' THR . 60.8 mt -53.03 -54.47 34.79 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 123.028 2.649 . . . . 29.3 110.03 167.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1043 ' ' ALA . . . . . 0.775 ' HA ' ' HB2' ' B' 1320 ' ' PRO . . . -66.67 2.81 1.19 Allowed 'General case' 0 C--O 1.241 0.641 0 N-CA-C 115.706 1.743 . . . . 26.74 115.706 174.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1044 ' ' SER . . . . . 0.47 ' O ' ' HB1' ' A' 1277 ' ' ALA . 24.3 m 62.28 35.67 15.12 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 123.702 1.715 . . . . 31.26 114.668 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1045 ' ' PHE . . . . . 0.405 ' HA ' ' CB ' ' A' 1277 ' ' ALA . 0.3 OUTLIER -132.5 108.81 9.36 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 105.005 -2.221 . . . . 33.26 105.005 177.066 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 8.5 t70 -61.52 144.31 54.5 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 114.975 1.472 . . . . 46.74 114.975 -177.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1047 ' ' ASP . . . . . 0.515 ' HA ' ' HD1' ' B' 1050 ' ' PHE . 43.0 p-10 -65.13 -20.4 66.44 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 114.146 1.165 . . . . 34.44 114.146 -175.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -56.72 -23.47 42.62 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 117.371 2.36 . . . . 48.67 117.371 165.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -83.81 -24.21 31.08 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 123.672 0.789 . . . . 35.26 110.371 172.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1050 ' ' PHE . . . . . 0.515 ' HD1' ' HA ' ' B' 1047 ' ' ASP . 75.3 m-85 -74.22 -28.33 61.2 Favored 'General case' 0 C--O 1.251 1.184 0 O-C-N 119.156 -2.215 . . . . 32.17 110.262 171.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 91.6 t -62.43 -50.29 80.46 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 N-CA-C 105.918 -1.882 . . . . 38.37 105.918 167.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -51.6 -41.52 61.29 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.135 1.531 . . . . 45.77 115.135 172.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1053 ' ' ALA . . . . . 0.462 ' HB2' ' HB3' ' B' 1020 ' ' PRO . . . -65.42 -41.69 93.3 Favored 'General case' 0 C--O 1.218 -0.558 0 O-C-N 123.618 0.574 . . . . 37.83 111.78 173.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 111.61 53.21 0.53 Allowed Glycine 0 C--N 1.35 1.317 0 N-CA-C 110.704 -0.959 . . . . 35.82 110.704 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -120.69 150.26 41.22 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-O 123.854 1.788 . . . . 33.77 109.365 171.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -63.76 142.83 58.26 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 112.227 -2.261 . . . . 51.02 108.493 167.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1057 ' ' ILE . . . . . 0.526 HD13 ' HB ' ' B' 1035 ' ' VAL . 46.2 mm -120.17 112.74 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 N-CA-C 106.17 -1.789 . . . . 38.47 106.17 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 1.8 m -133.74 142.23 42.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 115.445 1.646 . . . . 39.4 115.445 -171.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -72.82 105.01 4.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 113.479 -1.691 . . . . 57.07 114.762 -169.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1060 ' ' GLY . . . . . 0.422 ' O ' HG12 ' B' 1063 ' ' VAL . . . 59.96 -113.7 5.61 Favored Glycine 0 N--CA 1.433 -1.558 0 CA-C-N 114.425 -1.261 . . . . 44.83 112.554 165.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1061 ' ' ASN . . . . . 0.416 ' O ' ' HG2' ' B' 1065 ' ' GLN . 13.8 m-20 -61.96 -25.1 67.41 Favored 'General case' 0 C--O 1.241 0.632 0 O-C-N 120.459 -1.613 . . . . 46.27 111.922 -171.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1062 ' ' SER . . . . . . . . . . . . . 66.5 m -59.08 -41.89 89.1 Favored 'General case' 0 N--CA 1.426 -1.642 0 C-N-CA 124.349 1.06 . . . . 43.47 111.21 173.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1063 ' ' VAL . . . . . 0.422 HG12 ' O ' ' B' 1060 ' ' GLY . 2.0 p -66.91 -31.53 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 O-C-N 118.593 -2.567 . . . . 36.98 109.347 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 38.8 m95 -68.87 -30.55 69.09 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 113.994 1.109 . . . . 37.9 113.994 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1065 ' ' GLN . . . . . 0.434 ' O ' ' NH2' ' B' 1002 ' ' ARG . 47.1 mm-40 -77.47 92.88 4.04 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.03 -1.1 . . . . 46.19 108.03 175.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1066 ' ' SER . . . . . . . . . . . . . 53.5 m -159.94 165.79 31.39 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 119.929 -1.732 . . . . 37.06 110.906 -169.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1067 ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -65.47 -52.52 52.35 Favored 'General case' 0 C--O 1.22 -0.468 0 O-C-N 124.643 1.214 . . . . 43.95 111.277 170.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1068 ' ' ILE . . . . . 0.6 HD11 HD11 ' B' 1346 ' ' ILE . 23.9 mt -123.74 131.81 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 104.888 -2.264 . . . . 33.5 104.888 -173.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1069 ' ' ILE . . . . . 0.433 HD13 ' HA ' ' B' 1069 ' ' ILE . 26.4 mm -111.4 116.92 53.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 104.779 -2.304 . . . . 30.57 104.779 171.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1070 ' ' LEU . . . . . 0.706 HD22 HD22 ' B' 1331 ' ' LEU . 73.7 mt -102.27 114.96 29.57 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 101.72 -3.437 . . . . 27.66 101.72 178.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1071 ' ' LYS . . . . . . . . . . . . . 18.9 tttm -140.14 157.73 45.16 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 106.182 -1.784 . . . . 28.4 106.182 -169.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1072 ' ' VAL . . . . . . . . . . . . . 67.6 t -83.27 -81.14 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.828 0 C-N-CA 117.547 -1.661 . . . . 23.18 110.188 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1073 ' ' ASN . . . . . 0.476 ' HB2' HD13 ' B' 1010 ' ' LEU . 47.6 m-80 -87.04 156.89 19.56 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 114.174 1.176 . . . . 25.47 114.174 -167.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -46.65 117.14 4.21 Favored Pre-proline 0 C--O 1.249 1.075 0 C-N-CA 124.129 0.972 . . . . 27.9 113.049 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -54.48 136.14 68.69 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.903 2.402 . . . . 31.62 114.074 -173.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 38.3 mt -71.33 160.28 33.07 Favored 'General case' 0 CA--C 1.506 -0.74 0 O-C-N 126.51 2.381 . . . . 40.49 106.776 173.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.49 -38.68 63.91 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 115.923 1.823 . . . . 51.59 115.923 -168.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1078 ' ' ASP . . . . . 0.416 ' CG ' HH22 ' B' 1009 ' ' ARG . 9.8 p-10 -68.69 -36.13 78.1 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-O 120.84 0.352 . . . . 42.36 111.751 175.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1079 ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -64.07 -36.02 82.64 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-O 123.551 1.643 . . . . 34.53 111.37 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1080 ' ' ILE . . . . . 0.442 ' O ' ' HG3' ' B' 1108 ' ' ARG . 57.6 mt -60.45 -50.78 78.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 113.119 -1.855 . . . . 33.25 109.64 174.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -57.15 -34.01 67.99 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 115.486 1.661 . . . . 36.47 115.486 173.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1082 ' ' LEU . . . . . . . . . . . . . 86.0 mt -62.94 -26.88 69.03 Favored 'General case' 0 CA--C 1.491 -1.31 0 O-C-N 125.391 1.682 . . . . 37.76 114.303 173.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1083 ' ' LEU . . . . . 0.755 HD11 HD22 ' B' 1089 ' ' LEU . 68.8 mt -55.28 156.63 4.11 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 113.865 1.061 . . . . 37.43 113.865 167.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1084 ' ' ASN . . . . . . . . . . . . 0.252 1.5 m-80 -130.56 148.53 70.36 Favored Pre-proline 0 C--N 1.319 -0.753 0 N-CA-C 103.673 -2.714 . . . . 37.7 103.673 -167.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -55.82 114.0 1.69 Allowed 'Trans proline' 0 C--O 1.25 1.11 0 C-N-CA 125.004 3.803 . . . . 35.51 109.673 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 120.71 -37.65 2.96 Favored Glycine 0 N--CA 1.437 -1.246 0 CA-C-N 111.624 -2.535 . . . . 33.87 114.332 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1087 ' ' THR . . . . . . . . . . . . . 26.4 m -56.2 122.24 11.3 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 114.513 1.301 . . . . 32.5 114.513 -164.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1088 ' ' THR . . . . . 0.408 ' HA ' ' HB ' ' B' 1111 ' ' THR . 13.5 m -70.49 94.72 0.99 Allowed 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 113.633 -1.621 . . . . 30.22 107.268 174.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1089 ' ' LEU . . . . . 0.755 HD22 HD11 ' B' 1083 ' ' LEU . 42.4 tp -85.77 111.36 20.08 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 118.951 0.796 . . . . 27.24 110.05 174.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 6.0 t -112.76 104.53 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 104.037 -2.579 . . . . 25.39 104.037 -175.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1091 ' ' SER . . . . . . . . . . . . . 45.5 m -154.86 163.4 40.34 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.043 -1.435 . . . . 28.81 113.282 -171.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1092 ' ' PHE . . . . . 0.483 ' HZ ' ' HG3' ' B' 1133 ' ' MET . 53.2 m-85 -73.64 99.77 3.18 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 104.233 -2.506 . . . . 30.78 104.233 171.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1093 ' ' ILE . . . . . 0.467 HG13 ' CG1' ' B' 1112 ' ' VAL . 37.6 mm -85.38 -33.71 8.04 Favored 'Isoleucine or valine' 0 C--N 1.355 0.843 0 CA-C-O 118.254 -0.879 . . . . 30.28 111.909 -175.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1094 ' ' TRP . . . . . . . . . . . . . 70.6 m95 53.59 62.23 9.57 Favored Pre-proline 0 C--O 1.248 0.994 0 C-N-CA 124.811 1.245 . . . . 34.07 113.274 -167.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -50.1 -49.2 16.89 Favored 'Trans proline' 0 C--O 1.248 0.992 0 C-N-CA 125.104 3.87 . . . . 38.66 114.089 -170.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -75.18 -19.7 59.7 Favored 'General case' 0 C--O 1.241 0.621 0 O-C-N 120.617 -1.302 . . . . 41.32 110.142 -175.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -85.43 -22.9 28.11 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 122.272 1.034 . . . . 51.66 111.279 173.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1098 ' ' ASN . . . . . 0.405 ' N ' ' HD3' ' B' 1099 ' ' PRO . 27.7 m-20 -127.84 48.87 3.74 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 113.869 1.063 . . . . 40.32 113.869 -170.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1099 ' ' PRO . . . . . 0.405 ' HD3' ' N ' ' B' 1098 ' ' ASN . 77.5 Cg_exo -60.98 -40.26 53.79 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 124.044 3.163 . . . . 41.56 118.051 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -64.11 -39.13 93.37 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 109.206 -0.664 . . . . 54.11 109.206 175.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1101 ' ' LEU . . . . . 0.461 ' O ' ' HG ' ' B' 1105 ' ' LEU . 9.9 mp -61.89 -45.21 94.75 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 118.17 0.441 . . . . 37.88 111.873 172.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1102 ' ' MET . . . . . 0.642 ' HA ' HD12 ' B' 1105 ' ' LEU . 75.1 mmm -55.42 -42.63 74.42 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 123.214 0.605 . . . . 37.54 112.432 173.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -66.55 -40.77 89.23 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-O 122.407 1.098 . . . . 47.01 108.434 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1104 ' ' LYS . . . . . . . . . . . . . 37.8 mtmt -65.65 -27.72 68.57 Favored 'General case' 0 CA--C 1.481 -1.681 0 O-C-N 118.101 -2.875 . . . . 48.68 116.043 170.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1105 ' ' LEU . . . . . 0.642 HD12 ' HA ' ' B' 1102 ' ' MET . 31.3 mt -70.82 -38.81 73.29 Favored 'General case' 0 C--O 1.265 1.869 0 O-C-N 120.385 -1.447 . . . . 32.21 110.374 173.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -61.77 -42.21 98.7 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 109.019 -0.734 . . . . 33.73 109.019 175.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -60.14 -44.92 94.58 Favored 'General case' 0 CA--C 1.497 -1.075 0 O-C-N 121.039 -1.038 . . . . 51.47 113.773 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1108 ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' B' 1080 ' ' ILE . 16.4 mmm180 -62.2 -24.5 67.25 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.649 -1.282 . . . . 43.9 114.332 173.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1109 ' ' ASN . . . . . . . . . . . . . 14.9 m-80 72.01 47.12 0.32 Allowed 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 125.12 2.391 . . . . 44.82 110.94 173.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1110 ' ' VAL . . . . . 0.579 HG11 ' HB3' ' B' 1083 ' ' LEU . 16.5 m -96.46 169.38 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-N 110.081 -3.236 . . . . 30.52 113.826 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1111 ' ' THR . . . . . 0.408 ' HB ' ' HA ' ' B' 1088 ' ' THR . 8.1 m -104.65 97.87 7.7 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 107.548 -1.278 . . . . 27.12 107.548 171.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1112 ' ' VAL . . . . . 0.467 ' CG1' HG13 ' B' 1093 ' ' ILE . 93.4 t -92.8 123.85 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 O-C-N 119.556 -1.965 . . . . 26.4 108.736 -173.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1113 ' ' MET . . . . . 0.691 ' SD ' HD21 ' B' 1334 ' ' LEU . 21.0 mtp -116.87 103.12 9.98 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.986 -1.487 . . . . 42.92 106.986 174.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -79.75 88.04 5.23 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 113.457 -1.701 . . . . 24.15 113.782 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1115 ' ' MET . . . . . 0.48 ' SD ' HD13 ' B' 1334 ' ' LEU . 95.0 mmm -54.71 -19.23 5.79 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 117.073 2.249 . . . . 29.95 117.073 -173.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1116 ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -72.7 -46.23 54.79 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.115 -1.402 . . . . 34.53 114.503 168.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1117 ' ' SER . . . . . . . . . . . . . 66.1 m -93.8 52.87 1.73 Allowed 'General case' 0 C--O 1.255 1.347 0 O-C-N 119.181 -2.199 . . . . 33.49 112.028 -167.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1118 ' ' VAL . . . . . . . . . . . . . 40.5 t -89.53 137.38 28.86 Favored Pre-proline 0 N--CA 1.445 -0.718 0 N-CA-C 106.565 -1.643 . . . . 34.02 106.565 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -63.63 131.07 30.04 Favored 'Trans proline' 0 CA--C 1.512 -0.602 0 C-N-CA 123.765 2.976 . . . . 38.28 108.336 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1120 ' ' ARG . . . . . 0.752 ' HB2' HG11 ' B' 1375 ' ' VAL . 1.8 mmt180 -74.77 50.2 0.44 Allowed 'General case' 0 C--O 1.247 0.97 0 N-CA-C 115.09 1.515 . . . . 55.05 115.09 -163.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1121 ' ' ILE . . . . . 0.526 ' HB ' ' O ' ' C' ' 131' ' ' ALA . 36.1 pt -102.08 172.51 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.912 0 O-C-N 117.082 -3.511 . . . . 42.09 115.969 -177.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1122 ' ' SER . . . . . . . . . . . . . 2.9 m -62.29 -32.73 73.5 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 117.718 2.488 . . . . 38.02 117.718 -172.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1123 ' ' ARG . . . . . 0.416 ' HA ' ' HD3' ' C' ' 134' ' ' PRO . 11.3 ptt-85 -67.25 -35.76 80.21 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 119.378 -0.929 . . . . 34.29 113.407 162.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1124 ' ' ALA . . . . . . . . . . . . . . . -62.22 -36.08 80.88 Favored 'General case' 0 C--N 1.359 0.98 0 N-CA-C 116.877 2.177 . . . . 32.35 116.877 -158.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1125 ' ' GLN . . . . . 0.803 ' HA ' ' HB3' ' B' 1128 ' ' ASP . 2.3 mp0 -64.94 -8.73 16.88 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 115.415 1.635 . . . . 47.17 115.415 -172.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1126 ' ' SER . . . . . . . . . . . . . 21.1 p -75.05 -41.82 58.29 Favored 'General case' 0 C--O 1.24 0.585 0 O-C-N 120.414 -1.429 . . . . 31.71 109.074 173.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1127 ' ' LEU . . . . . . . . . . . . . 3.5 mp -80.13 -40.85 26.58 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-N 113.248 -1.796 . . . . 37.0 111.159 174.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1128 ' ' ASP . . . . . 0.803 ' HB3' ' HA ' ' B' 1125 ' ' GLN . 9.3 t70 -61.6 119.89 9.52 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 123.743 1.735 . . . . 40.4 115.001 -173.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1129 ' ' ALA . . . . . . . . . . . . . . . -68.63 -34.98 76.68 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 111.629 -2.532 . . . . 26.56 109.277 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 58.8 mt -67.8 -28.93 68.01 Favored 'General case' 0 C--N 1.31 -1.111 0 O-C-N 118.957 -2.339 . . . . 30.89 112.451 -169.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1131 ' ' SER . . . . . 0.632 ' HB3' ' HG3' ' B' 1125 ' ' GLN . 57.9 p -65.5 -56.11 14.15 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 107.685 -1.228 . . . . 29.84 107.685 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1132 ' ' SER . . . . . 0.66 ' HB3' ' HB3' ' B' 1326 ' ' LEU . 5.8 m -55.54 -47.69 75.92 Favored 'General case' 0 CA--C 1.507 -0.675 0 O-C-N 125.727 1.892 . . . . 31.91 110.174 178.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1133 ' ' MET . . . . . 0.483 ' HG3' ' HZ ' ' B' 1092 ' ' PHE . 33.2 mmt -65.87 -31.35 72.24 Favored 'General case' 0 C--N 1.361 1.073 0 N-CA-C 115.72 1.748 . . . . 25.9 115.72 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1134 ' ' ALA . . . . . . . . . . . . . . . -67.06 -43.62 82.18 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 107.602 -1.258 . . . . 26.62 107.602 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.97 -35.59 78.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 121.501 1.955 . . . . 36.97 110.466 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1136 ' ' ILE . . . . . 0.691 HD13 ' HE1' ' A' 1152 ' ' PHE . 23.5 mm -52.02 -56.81 4.97 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 O-C-N 121.393 -0.817 . . . . 32.11 110.313 167.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -69.75 -20.32 63.51 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 116.968 -1.491 . . . . 24.14 110.551 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -69.15 -48.16 48.46 Favored Glycine 0 N--CA 1.471 1.002 0 CA-C-N 120.909 1.686 . . . . 25.13 110.545 173.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 81.9 t80 -66.33 -51.85 53.03 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 105.595 -2.002 . . . . 32.73 105.595 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1140 ' ' ARG . . . . . 0.43 ' HA ' ' HB ' ' B' 1143 ' ' VAL . 7.1 tpt180 -54.63 -25.78 28.81 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-O 115.538 -2.172 . . . . 26.36 113.4 173.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1141 ' ' ALA . . . . . 0.557 ' HA ' HG11 ' B' 1282 ' ' VAL . . . -62.17 -54.28 43.26 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 121.381 1.901 . . . . 24.12 109.055 173.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 45.7 mm -57.69 -43.37 83.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 CA-C-O 122.734 1.254 . . . . 23.37 110.96 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1143 ' ' VAL . . . . . 0.43 ' HB ' ' HA ' ' B' 1140 ' ' ARG . 75.3 t -63.46 -56.76 15.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 114.523 1.305 . . . . 24.96 114.523 177.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1144 ' ' GLU . . . . . 0.415 ' OE2' ' HD3' ' B' 1318 ' ' ARG . 20.3 mm-40 -70.16 -29.74 66.72 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 120.47 -1.394 . . . . 32.07 111.639 -178.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1145 ' ' ALA . . . . . 0.825 ' HB1' HD12 ' B' 1251 ' ' ILE . . . -55.99 -60.3 3.67 Favored 'General case' 0 C--N 1.346 0.418 0 N-CA-C 107.68 -1.23 . . . . 24.87 107.68 168.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1146 ' ' ALA . . . . . 0.648 ' HB2' ' HE1' ' B' 1153 ' ' PHE . . . -48.4 -32.48 7.68 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.248 1.573 . . . . 24.67 115.248 175.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 80.7 t60 -53.59 -50.53 65.41 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 119.76 1.164 . . . . 28.58 111.988 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1148 ' ' GLU . . . . . 0.733 ' HB2' HD11 ' B' 1310 ' ' ILE . 28.7 mm-40 -108.14 -5.38 16.97 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 119.561 -1.962 . . . . 36.82 114.377 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1149 ' ' PHE . . . . . . . . . . . . . 2.8 t80 -54.09 138.94 36.55 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 126.029 2.823 . . . . 31.97 109.141 177.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1150 ' ' GLY . . . . . 0.613 ' HA2' ' HG2' ' A' 1320 ' ' PRO . . . -68.6 -35.35 80.71 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 109.784 -3.371 . . . . 25.49 113.816 175.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1151 ' ' ARG . . . . . 0.652 ' HA ' ' HB2' ' A' 1322 ' ' GLN . 55.3 mtm-85 -128.37 -170.56 2.27 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 123.048 3.424 . . . . 59.84 110.022 -162.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1152 ' ' PHE . . . . . 0.804 ' HB2' HG11 ' B' 1163 ' ' VAL . 19.0 m-30 -81.7 161.29 23.43 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 107.734 -1.21 . . . . 34.45 107.734 168.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1153 ' ' PHE . . . . . 0.648 ' HE1' ' HB2' ' B' 1146 ' ' ALA . 53.2 m-85 -79.91 -47.91 14.3 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.102 -1.814 . . . . 31.17 106.102 166.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1154 ' ' THR . . . . . . . . . . . . . 57.5 m -54.77 134.82 47.82 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 112.28 -2.237 . . . . 33.89 112.411 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -78.02 62.64 3.63 Favored Glycine 0 N--CA 1.44 -1.094 0 O-C-N 123.881 0.738 . . . . 38.95 112.86 169.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -83.79 125.04 31.53 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 122.984 1.373 . . . . 54.23 111.767 -166.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1157 ' ' ILE . . . . . 0.545 HG23 ' HE2' ' B' 1162 ' ' LYS . 18.8 mm -78.09 89.39 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 105.375 -2.083 . . . . 51.16 105.375 172.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1158 ' ' THR . . . . . . . . . . . . . 6.2 m -97.79 146.46 25.37 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 107.157 -1.423 . . . . 49.61 107.157 -177.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -44.15 -57.3 3.49 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 115.09 1.515 . . . . 49.05 115.09 -171.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -60.43 -37.27 80.38 Favored 'General case' 0 C--O 1.207 -1.144 0 C-N-CA 125.175 1.39 . . . . 47.65 112.011 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . 179.87 157.52 20.23 Favored Glycine 0 CA--C 1.498 -1.026 0 N-CA-C 109.421 -1.472 . . . . 45.61 109.421 -177.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1162 ' ' LYS . . . . . 0.545 ' HE2' HG23 ' B' 1157 ' ' ILE . 85.6 mttt -75.1 125.63 29.34 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.044 -1.078 . . . . 57.46 110.605 -177.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1163 ' ' VAL . . . . . 0.804 HG11 ' HB2' ' B' 1152 ' ' PHE . 57.1 t -75.81 128.0 84.41 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-O 118.332 -0.842 . . . . 42.93 108.864 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1164 ' ' PRO . . . . . 0.526 ' HA ' ' HD3' ' B' 1165 ' ' PRO . 74.0 Cg_endo -66.92 122.46 9.81 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 124.826 3.684 . . . . 39.29 108.442 172.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1165 ' ' PRO . . . . . 0.526 ' HD3' ' HA ' ' B' 1164 ' ' PRO . 81.1 Cg_exo -64.88 142.48 75.8 Favored 'Trans proline' 0 C--O 1.248 1.013 0 O-C-N 124.289 1.678 . . . . 34.17 109.452 -171.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1166 ' ' ALA . . . . . 0.442 ' HB2' ' HA ' ' B' 1153 ' ' PHE . . . -76.89 120.77 22.49 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 123.833 1.778 . . . . 31.69 108.898 -173.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1167 ' ' LYS . . . . . 0.629 ' HB2' ' HA ' ' B' 1249 ' ' VAL . 87.4 mttt -86.54 101.86 13.59 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 103.085 -2.931 . . . . 44.78 103.085 174.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 35.7 t -97.31 91.59 2.65 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 CA-C-N 112.805 -1.998 . . . . 31.23 109.46 -175.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1169 ' ' MET . . . . . 0.811 ' HB2' HG11 ' B' 1249 ' ' VAL . 48.3 ttp -77.48 99.68 5.75 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 105.442 -2.058 . . . . 37.09 105.442 -177.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 93.3 t -87.6 96.42 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 106.668 -1.605 . . . . 30.17 106.668 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1171 ' ' ILE . . . . . . . . . . . . . 61.3 mt -90.03 113.08 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 N-CA-C 107.132 -1.433 . . . . 33.74 107.132 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 94.91 73.85 1.21 Allowed Glycine 0 CA--C 1.5 -0.895 0 C-N-CA 119.561 -1.304 . . . . 32.59 110.455 170.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1173 ' ' ALA . . . . . 0.677 ' HA ' ' HA3' ' B' 1177 ' ' GLY . . . -78.47 57.16 1.9 Allowed 'General case' 0 C--N 1.329 -0.295 0 O-C-N 126.465 1.921 . . . . 32.42 113.79 -175.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -86.83 -162.52 37.54 Favored Glycine 0 C--O 1.211 -1.3 0 N-CA-C 108.185 -1.966 . . . . 31.74 108.185 164.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 41.4 t -47.37 -46.9 10.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 CA-C-N 121.538 2.669 . . . . 31.48 116.521 -171.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1176 ' ' ALA . . . . . . . . . . . . . . . -53.97 -56.15 20.5 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 115.665 1.728 . . . . 26.12 115.665 169.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1177 ' ' GLY . . . . . 0.677 ' HA3' ' HA ' ' B' 1173 ' ' ALA . . . -51.3 -52.19 33.31 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-N 113.474 -1.694 . . . . 25.73 111.185 176.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1178 ' ' LEU . . . . . 0.494 HD21 HG12 ' B' 1200 ' ' VAL . 37.8 mt -62.13 -44.34 96.84 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 126.02 1.728 . . . . 32.59 113.158 -174.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -59.9 -39.36 85.13 Favored 'General case' 0 C--N 1.348 0.517 0 N-CA-C 113.762 1.023 . . . . 27.72 113.762 171.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -66.53 -39.53 88.66 Favored 'General case' 0 C--O 1.244 0.767 0 O-C-N 124.0 0.813 . . . . 26.03 111.784 178.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1181 ' ' ILE . . . . . 0.672 HG23 HG11 ' B' 1191 ' ' VAL . 62.9 mt -57.03 -52.85 50.74 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 118.375 -0.821 . . . . 28.61 111.3 171.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -46.8 -61.85 4.07 Favored Glycine 0 C--N 1.346 1.106 0 O-C-N 126.148 2.155 . . . . 25.23 109.495 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -64.45 -47.27 79.67 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 121.799 0.809 . . . . 24.09 112.921 -171.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -64.67 -37.78 88.77 Favored 'General case' 0 CA--C 1.509 -0.632 0 O-C-N 121.04 -1.038 . . . . 26.68 112.483 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -66.38 -45.52 79.8 Favored 'General case' 0 C--O 1.252 1.208 0 C-N-CA 124.155 0.982 . . . . 36.57 110.009 176.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1186 ' ' SER . . . . . . . . . . . . . 69.1 m -58.29 -37.3 74.76 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 113.138 0.792 . . . . 28.92 113.138 173.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1187 ' ' LEU . . . . . 0.632 ' HA ' ' HB3' ' A' 1186 ' ' SER . 19.1 mt -69.49 -16.54 63.48 Favored 'General case' 0 C--O 1.249 1.03 0 N-CA-C 114.853 1.427 . . . . 29.09 114.853 173.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 80.42 52.38 4.52 Favored Glycine 0 C--O 1.251 1.187 0 O-C-N 119.151 -2.218 . . . . 29.26 109.168 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1189 ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' B' 1153 ' ' PHE . . . -115.52 155.34 27.72 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 113.325 -1.438 . . . . 30.16 108.597 170.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 80.2 mt -81.48 94.89 2.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 103.413 -2.81 . . . . 35.81 103.413 -175.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1191 ' ' VAL . . . . . 0.672 HG11 HG23 ' B' 1181 ' ' ILE . 23.8 t -71.0 121.8 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 C-N-CA 118.228 -1.389 . . . . 31.97 108.223 170.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1192 ' ' ARG . . . . . 0.516 ' HD2' HD21 ' B' 1212 ' ' LEU . 26.6 mmt85 -104.85 85.12 2.24 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 113.279 -1.782 . . . . 48.16 106.197 173.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -96.3 149.94 21.12 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 118.368 -2.708 . . . . 35.89 114.257 -165.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 20.2 t80 -147.54 153.4 39.43 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 120.397 -1.439 . . . . 41.88 108.615 -177.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1195 ' ' ASP . . . . . . . . . . . . . 8.9 t0 -162.97 159.9 24.06 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 103.409 -2.812 . . . . 38.28 103.409 167.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1196 ' ' THR . . . . . . . . . . . . . 4.7 m -65.48 -47.17 76.97 Favored 'General case' 0 N--CA 1.427 -1.611 0 C-N-CA 125.38 1.472 . . . . 40.62 108.203 171.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1197 ' ' ARG . . . . . 0.421 HH11 ' HD2' ' B' 1197 ' ' ARG . 12.2 mtm180 -75.43 130.56 79.45 Favored Pre-proline 0 C--N 1.345 0.387 0 C-N-CA 124.14 0.976 . . . . 53.09 109.929 -171.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -58.01 -34.58 98.57 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.892 2.395 . . . . 42.56 117.522 -172.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1199 ' ' GLU . . . . . 0.706 ' HB2' ' NH2' ' C' ' 74' ' ' ARG . 0.0 OUTLIER -66.19 -35.83 81.48 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.539 -1.351 . . . . 56.31 113.252 -150.331 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B 1200 ' ' VAL . . . . . 0.494 HG12 HD21 ' B' 1178 ' ' LEU . 17.0 m -59.48 -22.36 22.81 Favored 'Isoleucine or valine' 0 C--O 1.249 1.076 0 CA-C-N 112.699 -2.046 . . . . 42.91 113.44 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 51.8 tttm -52.66 -45.94 66.95 Favored 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 124.665 1.186 . . . . 48.89 113.744 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -65.94 -31.17 71.93 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.823 0.82 . . . . 51.7 112.815 -176.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1203 ' ' GLN . . . . . 0.431 ' OE1' HD22 ' B' 1178 ' ' LEU . 23.8 tt0 -61.37 -48.76 79.8 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.945 -1.131 . . . . 52.57 107.945 172.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1204 ' ' VAL . . . . . 0.453 HG23 ' O ' ' B' 1200 ' ' VAL . 18.9 t -72.87 -33.91 44.96 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.222 0 CA-C-O 125.358 2.504 . . . . 33.79 110.606 -167.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -57.38 -52.25 66.11 Favored 'General case' 0 C--O 1.256 1.435 0 CA-C-N 112.997 -1.911 . . . . 36.58 110.47 168.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1206 ' ' SER . . . . . . . . . . . . . 17.7 m -62.62 -25.39 68.08 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 121.864 2.12 . . . . 39.61 112.135 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1207 ' ' MET . . . . . . . . . . . . . 20.4 mtp -75.04 -21.21 59.2 Favored 'General case' 0 C--N 1.359 0.988 0 N-CA-C 116.348 1.981 . . . . 37.45 116.348 172.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 74.7 52.76 6.94 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-O 125.354 2.641 . . . . 31.87 110.54 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -148.22 151.74 36.01 Favored 'General case' 0 C--O 1.25 1.118 0 N-CA-C 103.382 -2.821 . . . . 35.4 103.382 -173.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -89.61 126.71 35.72 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 119.602 1.092 . . . . 47.89 113.548 -169.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 59.4 t80 -85.52 115.96 23.54 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 103.501 -2.777 . . . . 45.53 103.501 169.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1212 ' ' LEU . . . . . 0.516 HD21 ' HD2' ' B' 1192 ' ' ARG . 97.3 mt -70.27 93.31 0.83 Allowed 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 114.57 -1.196 . . . . 46.33 108.163 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -76.31 150.85 36.87 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 122.61 1.195 . . . . 60.41 111.23 172.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1214 ' ' LEU . . . . . 0.409 HD11 ' HE1' ' B' 1234 ' ' PHE . 97.2 mt -70.7 144.64 50.94 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 110.53 -3.032 . . . . 57.38 112.548 174.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 36.3 t0 . . . . . 0 N--CA 1.425 -1.68 0 O-C-N 125.445 1.716 . . . . 65.07 107.678 173.934 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B 1230 ' ' MET . . . . . . . . . . . . . 15.2 mmt . . . . . 0 N--CA 1.442 -0.836 0 N-CA-C 103.197 -2.89 . . . . 80.32 103.197 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B 1231 ' ' SER . . . . . . . . . . . . 0.324 66.8 m 75.53 132.8 0.05 OUTLIER 'General case' 0 C--O 1.212 -0.912 2 CA-C-N 129.98 5.809 . . . . 79.92 121.428 -0.032 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -70.29 -158.81 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.188 0 O-C-N 125.307 1.63 . . . . 77.91 111.096 -176.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 68.71 -52.9 0.56 Allowed 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 126.043 1.737 . . . . 73.88 110.969 -160.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1234 ' ' PHE . . . . . 0.409 ' HE1' HD11 ' B' 1214 ' ' LEU . 10.9 t80 -39.77 -51.57 2.36 Favored 'General case' 0 CA--C 1.5 -0.965 0 C-N-CA 127.96 2.504 . . . . 68.98 110.937 162.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 46.9 pt -52.4 -25.8 8.16 Favored 'Isoleucine or valine' 0 C--O 1.248 1.01 0 N-CA-C 115.84 1.793 . . . . 64.53 115.84 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -77.97 -48.31 16.54 Favored 'General case' 0 CA--C 1.511 -0.529 0 O-C-N 119.883 -1.761 . . . . 66.36 110.064 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -60.09 -36.15 76.76 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 123.978 0.911 . . . . 56.6 109.832 177.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -59.08 -62.11 2.13 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.259 -1.015 . . . . 56.79 108.259 171.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1239 ' ' MET . . . . . . . . . . . . . 20.3 mmt -59.26 -34.3 72.07 Favored 'General case' 0 C--O 1.222 -0.392 0 O-C-N 119.41 -2.056 . . . . 53.63 114.356 -173.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -46.33 -54.34 9.16 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 113.871 1.063 . . . . 51.74 113.871 168.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 48.8 tp -68.24 -49.16 62.56 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 112.488 -2.142 . . . . 44.86 106.38 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -64.95 -44.22 90.12 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 119.494 -2.004 . . . . 42.78 111.644 -172.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -65.73 -24.05 66.88 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 114.688 1.366 . . . . 40.96 114.688 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -76.63 -58.04 3.51 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 104.834 -2.284 . . . . 43.06 104.834 171.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 75.7 mm-40 -53.45 -30.32 40.05 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.901 1.281 . . . . 46.45 112.195 -173.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -57.67 -35.98 71.29 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.946 1.248 . . . . 41.78 113.003 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 31.4 tptt -67.04 -23.76 65.92 Favored 'General case' 0 C--O 1.241 0.637 0 O-C-N 119.369 -2.082 . . . . 52.2 113.6 176.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1248 ' ' GLU . . . . . 0.422 ' CD ' HH12 ' B' 1192 ' ' ARG . 20.8 mt-10 -95.12 -44.84 7.47 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 114.179 -1.373 . . . . 53.55 113.76 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1249 ' ' VAL . . . . . 0.811 HG11 ' HB2' ' B' 1169 ' ' MET . 29.0 m -77.99 143.13 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-O 126.352 2.977 . . . . 34.41 114.21 -162.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1250 ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -100.05 -37.35 9.02 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 109.066 -3.697 . . . . 33.38 107.247 -177.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1251 ' ' ILE . . . . . 0.825 HD12 ' HB1' ' B' 1145 ' ' ALA . 37.0 mm -128.98 125.64 63.2 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.755 0 O-C-N 119.789 -1.82 . . . . 29.54 107.083 176.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1252 ' ' ILE . . . . . 0.484 HG22 ' HB ' ' B' 1254 ' ' THR . 64.8 mt -103.34 109.2 26.27 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.734 0 N-CA-C 103.927 -2.62 . . . . 32.44 103.927 166.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1253 ' ' VAL . . . . . . . . . . . . . 95.4 t -84.76 82.31 1.86 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.976 0 N-CA-C 103.924 -2.621 . . . . 30.57 103.924 169.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1254 ' ' THR . . . . . 0.484 ' HB ' HG22 ' B' 1252 ' ' ILE 0.283 2.8 t -84.13 91.16 7.62 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-O 127.243 3.402 . . . . 35.04 110.037 -179.618 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B 1255 ' ' THR . . . . . 0.596 ' HA ' ' HB2' ' B' 1284 ' ' LEU . 27.1 m -85.45 -71.24 0.54 Allowed 'General case' 0 C--O 1.242 0.703 0 CA-C-N 110.001 -3.272 . . . . 34.62 108.136 -175.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . 44.1 24.74 0.09 Allowed 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 120.973 3.694 . . . . 42.72 120.973 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 39.3 mt -66.2 112.25 3.85 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-O 123.255 1.502 . . . . 52.43 110.576 -172.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 55.6 mt -91.92 109.01 34.28 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 105.066 -2.198 . . . . 59.41 105.066 175.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -56.3 97.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 123.441 2.761 . . . . 62.68 114.864 -175.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 68.61 47.92 53.46 Favored Glycine 0 N--CA 1.466 0.652 0 N-CA-C 109.353 -1.499 . . . . 64.16 109.353 174.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 55.5 tttt -155.76 149.1 18.56 Favored Pre-proline 0 C--O 1.248 1.019 0 N-CA-C 102.258 -3.238 . . . . 68.53 102.258 168.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.53 132.22 37.09 Favored 'Trans proline' 0 C--N 1.364 1.376 0 C-N-CA 124.746 3.631 . . . . 61.99 112.765 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1263 ' ' ALA . . . . . . . . . . . . . . . -71.69 143.08 86.72 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-N 112.933 -1.94 . . . . 57.15 112.201 175.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -73.08 147.87 43.71 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 124.156 3.237 . . . . 51.57 116.003 -176.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -71.46 82.63 0.8 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 118.567 -2.583 . . . . 54.55 109.58 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 84.9 mt -71.3 -64.4 0.92 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.103 -1.408 . . . . 46.86 113.946 178.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1267 ' ' ILE . . . . . 0.704 HG21 HD13 ' B' 1281 ' ' ILE . 26.5 mm -87.66 89.66 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 107.389 -1.337 . . . . 41.04 107.389 -170.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1268 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.86 150.64 47.56 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 111.504 -2.589 . . . . 39.58 116.51 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1269 ' ' ARG . . . . . 0.513 ' HG3' ' HB2' ' B' 1293 ' ' GLU . 44.3 mtt85 -54.28 -44.27 71.76 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 114.516 1.302 . . . . 53.15 114.516 -169.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -57.53 -44.6 85.23 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.261 0.624 . . . . 42.96 112.551 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1271 ' ' MET . . . . . . . . . . . . . 30.1 ttm -58.91 -52.2 66.78 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 125.687 1.867 . . . . 43.89 109.966 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1272 ' ' VAL . . . . . 0.416 HG22 HG22 ' B' 1267 ' ' ILE . 40.2 t -54.95 -47.09 76.67 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 C-N-CA 124.176 0.99 . . . . 38.37 108.618 -177.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.99 -26.7 67.78 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 115.634 1.716 . . . . 47.46 115.634 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1274 ' ' SER . . . . . . . . . . . . . 3.2 p -92.42 -6.39 50.08 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 114.53 1.307 . . . . 38.38 114.53 174.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1275 ' ' MET . . . . . . . . . . . . . 11.2 ttt -67.02 159.72 28.06 Favored 'General case' 0 C--O 1.24 0.586 0 O-C-N 121.22 -0.925 . . . . 37.81 112.56 -176.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 83.1 tttt -55.62 147.98 17.01 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 124.627 1.171 . . . . 49.26 113.059 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1277 ' ' ALA . . . . . 0.62 ' HB1' ' HA ' ' A' 1045 ' ' PHE . . . -76.35 150.15 36.89 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 108.195 -1.039 . . . . 34.46 108.195 -176.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1278 ' ' GLY . . . . . 0.619 ' HA2' ' HB3' ' A' 1044 ' ' SER . . . 68.28 26.59 74.12 Favored Glycine 0 N--CA 1.466 0.657 0 C-N-CA 125.006 1.289 . . . . 33.53 112.118 173.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1279 ' ' SER . . . . . . . . . . . . . 36.6 m -113.17 156.49 23.14 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 106.198 -1.779 . . . . 31.31 106.198 -171.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1280 ' ' VAL . . . . . 0.771 HG11 ' HA ' ' B' 1145 ' ' ALA . 52.9 t -115.62 140.04 39.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 O-C-N 119.535 -1.978 . . . . 29.32 109.314 -171.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1281 ' ' ILE . . . . . 0.704 HD13 HG21 ' B' 1267 ' ' ILE . 19.5 mt -109.27 105.18 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 104.953 -2.24 . . . . 31.93 104.953 165.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1282 ' ' VAL . . . . . 0.557 HG11 ' HA ' ' B' 1141 ' ' ALA . 15.8 t -84.35 114.92 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 N-CA-C 101.078 -3.675 . . . . 29.48 101.078 176.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 45.7 t0 -97.98 96.62 8.29 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.208 -1.405 . . . . 34.5 107.208 175.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1284 ' ' LEU . . . . . 0.596 ' HB2' ' HA ' ' B' 1255 ' ' THR . 6.6 mp -68.48 -32.84 73.12 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 113.548 -1.66 . . . . 37.94 110.727 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -89.03 20.23 3.74 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 125.54 1.775 . . . . 40.92 112.35 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -48.48 -34.23 10.8 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 120.917 1.69 . . . . 44.39 115.062 177.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1287 ' ' GLN . . . . . 0.895 ' HB3' HG23 ' B' 1313 ' ' THR . 0.0 OUTLIER -90.56 -20.51 22.54 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 113.165 0.802 . . . . 51.46 113.165 175.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -91.21 -17.16 26.49 Favored 'General case' 0 C--O 1.215 -0.727 0 O-C-N 120.515 -1.366 . . . . 57.75 113.575 -177.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1289 ' ' GLY . . . . . . . . . . . . . . . 173.17 -19.55 0.06 OUTLIER Glycine 0 C--O 1.243 0.699 0 CA-C-O 116.82 -2.1 . . . . 49.85 112.97 177.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 74.89 88.3 0.23 Allowed Glycine 0 CA--C 1.524 0.65 0 CA-C-N 122.12 2.96 . . . . 45.93 108.806 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1291 ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -71.41 -30.58 66.27 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 123.015 1.388 . . . . 42.67 113.616 -173.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1292 ' ' CYS . . . . . 0.503 ' HB3' ' OG1' ' B' 1295 ' ' THR . 33.2 t -98.57 145.83 26.43 Favored 'General case' 0 C--O 1.241 0.619 0 O-C-N 121.445 -0.785 . . . . 38.82 109.134 175.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1293 ' ' GLU . . . . . 0.513 ' HB2' ' HG3' ' B' 1269 ' ' ARG . 37.2 mt-10 -73.57 -35.85 65.52 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.463 -0.495 . . . . 46.71 111.07 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -72.94 -13.64 61.29 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.188 0.81 . . . . 47.23 113.188 -178.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1295 ' ' THR . . . . . 0.808 HG23 ' HA3' ' B' 1311 ' ' GLY . 98.1 m -53.39 102.39 0.06 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.992 0.738 . . . . 36.02 112.992 173.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 82.8 t -73.24 113.97 26.99 Favored Pre-proline 0 N--CA 1.429 -1.503 0 N-CA-C 104.298 -2.482 . . . . 37.26 104.298 158.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -62.01 131.06 33.13 Favored 'Trans proline' 0 CA--C 1.507 -0.868 0 C-N-CA 122.773 2.315 . . . . 35.09 114.125 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 81.07 8.78 86.99 Favored Glycine 0 CA--C 1.543 1.826 0 CA-C-O 118.174 -1.348 . . . . 35.97 110.692 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -143.61 172.5 12.72 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 120.82 2.31 . . . . 40.39 112.075 -173.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1300 ' ' ILE . . . . . 0.493 HG12 HG12 ' B' 1310 ' ' ILE . 67.4 mt -101.11 148.1 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 103.848 -2.649 . . . . 37.43 103.848 170.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 65.3 t80 -123.7 125.21 44.36 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 101.561 -3.496 . . . . 44.13 101.561 164.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1302 ' ' THR . . . . . . . . . . . . . 90.8 m -98.03 110.72 23.24 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.476 -1.305 . . . . 39.78 107.476 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1303 ' ' THR . . . . . . . . . . . . . 40.5 p -72.62 162.48 29.43 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 113.515 0.932 . . . . 43.29 113.515 -174.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -53.7 -37.1 62.91 Favored 'General case' 0 C--N 1.354 0.789 0 O-C-N 120.338 -1.476 . . . . 53.07 112.085 173.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -77.81 12.71 1.6 Allowed 'General case' 0 C--N 1.349 0.555 0 O-C-N 120.192 -1.567 . . . . 43.97 114.437 174.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 72.13 34.89 61.14 Favored Glycine 0 CA--C 1.546 1.997 0 C-N-CA 119.078 -1.534 . . . . 41.12 111.879 173.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1307 ' ' VAL . . . . . . . . . . . . . 68.0 t -104.87 133.68 48.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 116.723 -3.81 . . . . 38.12 102.381 175.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1308 ' ' LYS . . . . . 0.651 ' HB2' HG22 ' B' 1280 ' ' VAL . 41.7 mmtt -97.68 97.71 9.25 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 105.938 -1.875 . . . . 36.34 105.938 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1309 ' ' VAL . . . . . 0.414 HG22 HD12 ' B' 1281 ' ' ILE . 21.8 t -85.62 92.22 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 N-CA-C 106.68 -1.6 . . . . 30.4 106.68 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1310 ' ' ILE . . . . . 0.733 HD11 ' HB2' ' B' 1148 ' ' GLU . 56.8 mt -89.45 87.51 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 C-N-CA 124.615 1.166 . . . . 30.82 111.378 -177.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1311 ' ' GLY . . . . . 0.808 ' HA3' HG23 ' B' 1295 ' ' THR . . . -94.48 62.44 1.71 Allowed Glycine 0 C--O 1.245 0.839 0 N-CA-C 110.825 -0.91 . . . . 26.53 110.825 -178.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1312 ' ' TYR . . . . . 0.497 ' O ' ' HG ' ' B' 1315 ' ' LEU . 5.5 m-85 -83.0 99.27 9.73 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 124.02 1.866 . . . . 38.0 111.732 -176.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1313 ' ' THR . . . . . 0.895 HG23 ' HB3' ' B' 1287 ' ' GLN . 26.9 m -51.76 -37.87 53.1 Favored 'General case' 0 C--O 1.255 1.365 0 C-N-CA 126.006 1.722 . . . . 29.8 113.226 170.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -81.09 17.57 1.22 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 116.292 1.96 . . . . 39.04 116.292 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1315 ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' B' 1312 ' ' TYR . 42.9 mt -45.51 -46.76 36.27 Favored Pre-proline 0 C--O 1.254 1.323 0 N-CA-C 117.214 2.301 . . . . 31.08 117.214 174.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1316 ' ' PRO . . . . . 0.417 ' HA ' ' CG2' ' B' 1136 ' ' ILE . 52.5 Cg_exo -61.5 -33.03 88.55 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.244 2.629 . . . . 26.1 115.19 167.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -70.51 -40.69 67.49 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 118.447 -1.835 . . . . 23.17 112.608 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1318 ' ' ARG . . . . . 0.415 ' HD3' ' OE2' ' B' 1144 ' ' GLU . 94.0 mtt-85 -60.84 -2.74 0.6 Allowed 'General case' 0 C--O 1.246 0.894 0 N-CA-C 118.384 2.735 . . . . 40.4 118.384 -174.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1319 ' ' LEU . . . . . 0.468 HD23 HG23 ' B' 1136 ' ' ILE . 3.3 tp -120.52 58.41 6.26 Favored Pre-proline 0 C--N 1.327 -0.38 0 O-C-N 118.843 -2.411 . . . . 23.6 107.003 -176.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1320 ' ' PRO . . . . . 0.775 ' HB2' ' HA ' ' B' 1043 ' ' ALA . 84.9 Cg_endo -54.19 -60.93 0.49 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 124.429 3.419 . . . . 22.35 117.588 -152.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1321 ' ' THR . . . . . 0.479 ' OG1' ' HA3' ' A' 1150 ' ' GLY . 1.3 m -57.03 -49.81 74.67 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.504 1.502 . . . . 26.52 111.375 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1322 ' ' GLN . . . . . 0.962 ' HB2' ' HA ' ' A' 1151 ' ' ARG . 39.1 tp60 -73.26 -33.81 65.47 Favored 'General case' 0 N--CA 1.435 -1.223 0 O-C-N 122.15 -0.344 . . . . 24.38 110.903 -172.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1323 ' ' SER . . . . . . . . . . . . . 68.3 m -57.84 -46.57 84.56 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 123.702 0.801 . . . . 22.8 112.488 165.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1324 ' ' SER . . . . . . . . . . . . . 15.7 m -69.48 -30.74 68.69 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 120.24 -1.538 . . . . 21.25 110.416 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -73.64 -36.54 65.43 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 121.093 1.77 . . . . 31.34 108.692 176.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1326 ' ' LEU . . . . . 0.66 ' HB3' ' HB3' ' B' 1132 ' ' SER . 11.3 mt -70.92 -58.21 3.81 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.871 1.669 . . . . 31.56 108.346 -175.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1327 ' ' TYR . . . . . 0.493 ' O ' ' HB2' ' B' 1330 ' ' ASN . 12.4 t80 -52.63 -45.25 66.55 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 125.44 1.496 . . . . 22.73 110.747 173.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1328 ' ' GLY . . . . . 0.563 ' O ' HG23 ' B' 1332 ' ' VAL . . . -51.87 -50.98 41.97 Favored Glycine 0 C--O 1.249 1.08 0 CA-C-O 118.951 -0.916 . . . . 21.91 111.552 170.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1329 ' ' THR . . . . . . . . . . . . . 8.5 m -66.87 -28.62 68.48 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 121.4 2.6 . . . . 22.15 109.377 -177.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1330 ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' B' 1327 ' ' TYR . 10.1 m120 -60.86 -50.17 74.5 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.312 -0.868 . . . . 26.18 110.649 174.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1331 ' ' LEU . . . . . 0.706 HD22 HD22 ' B' 1070 ' ' LEU . 18.7 mt -60.22 -36.76 78.42 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 126.904 2.081 . . . . 23.68 112.123 174.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1332 ' ' VAL . . . . . 0.563 HG23 ' O ' ' B' 1328 ' ' GLY . 20.9 t -65.15 -48.7 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 N-CA-C 107.301 -1.37 . . . . 26.57 107.301 175.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1333 ' ' ASN . . . . . 0.676 ' HA ' ' HD2' ' B' 1336 ' ' LYS . 62.8 m-20 -59.63 -47.75 84.38 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 109.641 -0.503 . . . . 28.08 109.641 -174.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1334 ' ' LEU . . . . . 0.691 HD21 ' SD ' ' B' 1113 ' ' MET . 6.1 tt -56.25 -50.82 70.24 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 113.486 0.921 . . . . 27.43 113.486 170.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1335 ' ' LEU . . . . . 0.443 HD11 HD21 ' B' 1070 ' ' LEU . 93.0 mt -64.88 -16.89 63.78 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 114.96 1.466 . . . . 30.5 114.96 177.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1336 ' ' LYS . . . . . 0.676 ' HD2' ' HA ' ' B' 1333 ' ' ASN . 86.8 mttt -72.6 -46.28 55.01 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 120.256 1.389 . . . . 41.65 107.292 170.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 11.6 tp -64.63 -32.88 74.74 Favored 'General case' 0 N--CA 1.441 -0.91 0 O-C-N 120.329 -1.482 . . . . 42.08 110.731 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1338 ' ' LEU . . . . . 0.683 HD13 HG23 ' B' 1346 ' ' ILE . 24.2 mt -73.2 -47.01 47.07 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 118.896 -0.573 . . . . 35.03 110.289 168.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1339 ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' B' 1344 ' ' GLY . 0.5 OUTLIER -88.3 81.95 7.17 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 121.522 1.964 . . . . 37.33 109.328 -175.171 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -27.56 66.85 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.7 -1.136 . . . . 50.51 112.207 -160.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -117.14 18.18 14.62 Favored 'General case' 0 C--O 1.242 0.703 0 O-C-N 123.949 0.781 . . . . 54.21 110.831 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1342 ' ' LYS . . . . . 0.489 ' HG2' HD23 ' B' 1029 ' ' LEU . 49.0 mttp 49.09 59.42 4.47 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 124.572 2.129 . . . . 50.99 109.303 -166.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -127.67 31.58 5.13 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 111.683 -2.508 . . . . 48.82 111.083 -165.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1344 ' ' GLY . . . . . 0.528 ' N ' ' SG ' ' B' 1339 ' ' CYS . . . 47.3 24.07 2.19 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 116.912 1.525 . . . . 40.43 116.912 175.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 40.0 t30 -127.28 151.12 49.15 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.775 -1.194 . . . . 47.56 107.775 -169.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1346 ' ' ILE . . . . . 0.683 HG23 HD13 ' B' 1338 ' ' LEU . 32.9 mm -100.24 86.65 1.26 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 105.012 -2.218 . . . . 42.49 105.012 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1347 ' ' THR . . . . . . . . . . . . . 33.2 p -87.34 102.48 14.56 Favored 'General case' 0 C--O 1.241 0.632 0 O-C-N 118.157 -2.839 . . . . 38.12 109.839 164.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1348 ' ' VAL . . . . . 0.595 HG23 HG22 ' B' 1346 ' ' ILE . 61.0 t -90.84 111.89 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 107.094 -1.447 . . . . 37.5 107.094 -177.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 23.6 t70 -97.69 127.92 44.0 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 106.051 -1.833 . . . . 43.85 106.051 172.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1350 ' ' PHE . . . . . 0.434 ' CE1' ' HB ' ' B' 1359 ' ' THR . 0.3 OUTLIER -97.62 -0.12 46.27 Favored 'General case' 0 C--O 1.257 1.476 0 O-C-N 119.92 -1.737 . . . . 39.81 114.016 175.356 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -73.17 -37.21 66.63 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 121.441 1.928 . . . . 51.29 109.122 176.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 22.1 t0 -54.66 118.3 4.09 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 119.754 -0.779 . . . . 39.78 110.754 167.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1353 ' ' VAL . . . . . 0.41 ' HA ' ' HB3' ' B' 1356 ' ' ARG . 33.9 m -55.93 -31.18 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 O-C-N 123.868 0.73 . . . . 39.28 112.843 176.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1354 ' ' VAL . . . . . 0.462 ' O ' HG12 ' B' 1358 ' ' VAL . 83.7 t -70.37 -51.73 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 N-CA-C 106.637 -1.616 . . . . 35.7 106.637 -177.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1355 ' ' ILE . . . . . 0.6 ' HA ' HG12 ' B' 1358 ' ' VAL . 50.4 mm -62.27 -46.02 97.4 Favored 'Isoleucine or valine' 0 C--N 1.359 0.99 0 CA-C-N 121.82 2.1 . . . . 35.77 113.464 173.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1356 ' ' ARG . . . . . 0.41 ' HB3' ' HA ' ' B' 1353 ' ' VAL . 49.5 tpt85 -49.73 -33.63 16.7 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 114.505 1.298 . . . . 38.55 114.505 171.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -83.71 -54.16 3.17 Favored Glycine 0 C--N 1.343 0.963 0 N-CA-C 109.454 -1.458 . . . . 29.58 109.454 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1358 ' ' VAL . . . . . 0.6 HG12 ' HA ' ' B' 1355 ' ' ILE . 14.8 p -62.95 -42.54 96.98 Favored 'Isoleucine or valine' 0 C--O 1.256 1.413 0 CA-C-O 121.916 0.865 . . . . 32.06 112.531 -173.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1359 ' ' THR . . . . . 0.434 ' HB ' ' CE1' ' B' 1350 ' ' PHE . 3.6 m -83.83 81.96 8.54 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 124.13 1.919 . . . . 29.0 109.42 -174.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1360 ' ' VAL . . . . . . . . . . . . . 10.0 m -71.23 -16.98 19.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 113.022 -1.899 . . . . 29.68 113.907 -173.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 57.7 mt -134.98 110.22 12.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 N-CA-C 107.041 -1.466 . . . . 32.05 107.041 170.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1362 ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -98.74 110.43 23.03 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 104.99 -2.226 . . . . 32.52 104.99 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 48.26 60.77 3.39 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 112.922 -1.944 . . . . 35.68 113.528 172.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 83.58 -46.24 3.61 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 115.495 0.958 . . . . 34.26 115.495 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -64.62 124.56 22.21 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 119.277 -0.969 . . . . 51.07 111.802 172.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 69.7 mt -78.47 118.08 25.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 N-CA-C 103.265 -2.865 . . . . 39.87 103.265 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1367 ' ' THR . . . . . . . . . . . . . 1.4 p -107.03 11.57 29.56 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 113.883 -1.508 . . . . 38.01 112.039 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1368 ' ' TRP . . . . . . . . . . . . . 20.7 t90 -82.74 131.96 53.08 Favored Pre-proline 0 C--O 1.241 0.657 0 N-CA-C 103.531 -2.766 . . . . 42.14 103.531 164.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -82.23 171.89 53.15 Favored 'Cis proline' 0 C--N 1.353 0.812 0 N-CA-C 116.805 1.81 . . . . 43.26 116.805 -2.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1370 ' ' ALA . . . . . 0.408 ' HA ' ' HD2' ' B' 1371 ' ' PRO . . . -113.74 130.14 24.07 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 105.712 -1.958 . . . . 46.52 105.712 173.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1371 ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' B' 1370 ' ' ALA . 37.8 Cg_endo -62.73 106.36 0.51 Allowed 'Trans proline' 0 CA--C 1.552 1.419 0 C-N-CA 123.384 2.723 . . . . 51.95 108.671 173.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -65.66 140.56 62.68 Favored 'Trans proline' 0 N--CA 1.441 -1.579 0 C-N-CA 123.584 2.856 . . . . 56.27 119.118 -170.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1373 ' ' ILE . . . . . 0.466 HD13 HD13 ' B' 1121 ' ' ILE . 14.9 tt -74.61 145.67 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 113.902 -1.499 . . . . 60.83 108.02 170.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -65.83 108.9 2.29 Favored 'General case' 0 C--N 1.317 -0.845 0 O-C-N 120.91 -1.119 . . . . 66.1 110.054 176.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1375 ' ' VAL . . . . . 0.752 HG11 ' HB2' ' B' 1120 ' ' ARG . 76.9 t -102.01 108.86 24.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 106.082 -1.822 . . . . 63.47 106.082 -169.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.23 -4.619 0 O-C-N 120.601 -1.312 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 20' ' ' ALA . . . . . 0.585 ' HA ' HD21 ' C' ' 171' ' ' LEU . . . . . . . . 0 C--O 1.253 1.274 0 CA-C-O 121.637 0.732 . . . . 0.0 112.4 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -58.09 -28.01 64.21 Favored 'General case' 0 C--O 1.251 1.162 0 O-C-N 119.141 -2.225 . . . . 0.0 114.1 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -66.08 -53.25 40.47 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 176.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 23' ' ' THR . . . . . 0.464 ' HA ' ' HB2' ' C' ' 26' ' ' LEU . 29.2 m -56.33 -34.11 66.27 Favored 'General case' 0 C--O 1.209 -1.064 0 C-N-CA 126.043 1.737 . . . . 0.0 112.516 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 24' ' ' ALA . . . . . 0.624 ' HB2' HG22 ' C' ' 182' ' ' ILE . . . -62.32 -36.82 83.35 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.59 0.756 . . . . 0.0 112.089 174.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.78 -50.12 16.15 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.917 171.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.464 ' HB2' ' HA ' ' C' ' 23' ' ' THR . 0.2 OUTLIER -52.3 -43.62 64.58 Favored 'General case' 0 C--O 1.213 -0.867 0 C-N-CA 126.239 1.816 . . . . 0.0 113.175 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.558 HD21 HD21 ' C' ' 110' ' ' LEU . 81.1 mt -60.16 -51.23 70.49 Favored 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 118.63 -2.544 . . . . 0.0 115.315 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 28' ' ' LYS . . . . . 0.435 ' HZ2' ' C ' ' C' ' 186' ' ' LEU . 18.5 pttm -67.66 -17.41 64.58 Favored 'General case' 0 CA--C 1.555 1.169 0 O-C-N 121.113 -0.992 . . . . 0.0 110.022 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -75.21 -46.85 31.31 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 119.746 1.157 . . . . 0.0 111.048 164.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 38.9 m -50.28 -35.52 27.53 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 121.229 3.788 . . . . 0.0 121.229 -163.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 31' ' ' HIS . . . . . 0.488 ' HA ' HG12 ' C' ' 62' ' ' ILE 0.4 3.7 p-80 54.32 -38.86 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 119.121 3.008 . . . . 0.0 119.121 -170.477 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 32' ' ' SER . . . . . 0.69 ' HB2' ' HA ' ' C' ' 106' ' ' THR . 17.7 m -123.99 133.61 53.65 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 103.019 -2.956 . . . . 0.0 103.019 169.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 64.3 t -131.7 125.17 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 -174.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.629 HG21 ' HE1' ' C' ' 103' ' ' PHE . 34.4 mm -102.97 128.94 55.43 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 N-CA-C 103.467 -2.79 . . . . 0.0 103.467 172.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 31.8 mt -103.59 117.5 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 172.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 36' ' ' THR . . . . . 0.423 HG21 HG11 ' C' ' 118' ' ' VAL . 93.2 m -111.24 92.42 15.71 Favored Pre-proline 0 C--N 1.347 0.485 0 C-N-CA 124.255 1.022 . . . . 0.0 109.294 176.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . 0.853 ' HD2' HG12 ' C' ' 68' ' ' ILE . 90.2 Cg_exo -78.7 154.88 27.09 Favored 'Trans proline' 0 C--O 1.246 0.911 0 C-N-CA 123.614 2.876 . . . . 0.0 112.856 169.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 38' ' ' GLY . . . . . 0.557 ' HA3' ' HA ' ' C' ' 114' ' ' ALA . . . -150.77 -143.78 3.79 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 109.766 -3.379 . . . . 0.0 105.096 174.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -61.34 -34.49 75.36 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 117.393 -1.289 . . . . 0.0 113.449 -168.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 40' ' ' GLY . . . . . 0.474 ' HA3' ' HA3' ' C' ' 113' ' ' GLY . . . -57.08 -32.55 63.01 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-O 116.528 -2.262 . . . . 0.0 112.474 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 32.8 ttm -75.82 -26.13 56.94 Favored 'General case' 0 C--O 1.253 1.266 0 CA-C-N 119.556 1.678 . . . . 0.0 111.294 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.68 -38.82 58.39 Favored 'General case' 0 C--O 1.221 -0.443 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.274 175.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 59.9 t -74.95 -66.08 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 O-C-N 121.215 -0.928 . . . . 0.0 110.495 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . 0.485 ' HB3' ' HB3' ' C' ' 175' ' ' ALA . . . -91.04 113.51 25.79 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 174.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 45' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -72.0 79.5 0.92 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 124.514 2.102 . . . . 0.0 110.265 -169.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.41 -6.13 22.92 Favored 'General case' 0 C--O 1.239 0.534 0 O-C-N 120.332 -1.48 . . . . 0.0 112.974 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 47' ' ' GLN . . . . . 0.656 ' HG2' ' HB3' ' C' ' 82' ' ' LEU . 0.0 OUTLIER -76.21 -41.81 48.19 Favored 'General case' 0 C--O 1.249 1.05 0 O-C-N 120.155 -1.591 . . . . 0.0 114.235 -159.766 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 48' ' ' TYR . . . . . 0.524 ' CZ ' ' HA ' ' C' ' 86' ' ' ALA . 61.6 m-85 -61.34 -43.74 90.63 Favored Pre-proline 0 CA--C 1.55 0.971 0 O-C-N 119.964 -1.71 . . . . 0.0 113.352 168.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 49' ' ' PRO . . . . . 0.42 ' HA ' ' HB2' ' C' ' 52' ' ' GLU . 11.6 Cg_exo -54.34 -41.44 76.44 Favored 'Trans proline' 0 C--N 1.351 0.696 0 CA-C-N 124.069 2.489 . . . . 0.0 116.536 165.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 48.6 t -60.87 -41.58 89.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 O-C-N 119.971 -1.706 . . . . 0.0 112.509 175.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . 0.449 ' HB2' HG22 ' C' ' 88' ' ' VAL . . . -63.08 -33.72 76.05 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 171.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 52' ' ' GLU . . . . . 0.636 ' HB3' ' HB2' ' C' ' 183' ' ' LEU . 1.5 mm-40 -67.09 -39.41 86.76 Favored 'General case' 0 C--N 1.351 0.638 0 CA-C-O 118.284 -0.865 . . . . 0.0 113.277 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 10.2 tp -76.04 -37.27 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.718 0 CA-C-N 119.775 1.171 . . . . 0.0 110.429 175.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 26.1 m -64.78 -37.53 87.91 Favored 'General case' 0 C--O 1.244 0.814 0 O-C-N 120.219 -1.55 . . . . 0.0 112.889 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . 0.447 ' HB3' ' O ' ' C' ' 52' ' ' GLU . 8.1 tp10 -34.12 -43.36 0.15 Allowed 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 126.808 2.043 . . . . 0.0 112.858 159.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -87.95 -44.57 10.93 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 120.254 1.388 . . . . 0.0 109.92 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 74.8 mt -62.91 -48.74 77.65 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 121.017 -1.052 . . . . 0.0 111.309 -167.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -72.38 -34.51 68.0 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 121.334 1.879 . . . . 0.0 108.901 -171.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.28 -19.42 54.87 Favored 'General case' 0 C--N 1.345 0.384 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 166.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' C' ' 60' ' ' ARG . 28.8 ttm-85 -94.35 14.14 21.4 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-O 120.96 0.409 . . . . 0.0 110.557 173.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.48 22.89 66.2 Favored Glycine 0 C--O 1.24 0.52 0 O-C-N 120.647 -1.283 . . . . 0.0 114.425 -177.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . 0.488 HG12 ' HA ' ' C' ' 31' ' ' HIS . 15.0 mt -76.66 119.93 25.9 Favored 'Isoleucine or valine' 0 C--O 1.254 1.298 0 CA-C-O 122.062 0.934 . . . . 0.0 113.191 177.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 63' ' ' ASN . . . . . 0.433 ' O ' ' HA ' ' C' ' 32' ' ' SER . 12.0 t30 -63.23 84.66 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.561 0 CA-C-O 123.935 1.826 . . . . 0.0 106.285 171.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.478 ' O ' HD12 ' C' ' 92' ' ' ILE . 9.2 p -100.51 135.08 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 5.1 mmm-85 -137.84 140.06 40.26 Favored 'General case' 0 C--O 1.253 1.281 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . 0.601 ' HB2' HG22 ' C' ' 93' ' ' VAL . 33.4 m-85 -101.44 84.05 2.54 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -176.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.95 69.42 2.68 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.399 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 68' ' ' ILE . . . . . 0.853 HG12 ' HD2' ' C' ' 37' ' ' PRO . 10.1 mt -70.07 142.3 16.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 120.763 -1.433 . . . . 0.0 112.772 -174.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 69' ' ' HIS . . . . . 0.426 ' HA ' ' HD3' ' C' ' 70' ' ' PRO . 20.5 t-80 -114.66 89.59 19.17 Favored Pre-proline 0 N--CA 1.475 0.794 0 O-C-N 120.277 -1.514 . . . . 0.0 107.054 176.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 70' ' ' PRO . . . . . 0.718 ' HG2' HG12 ' A' 1157 ' ' ILE . 51.2 Cg_exo -61.84 -53.09 2.36 Favored 'Trans proline' 0 CA--C 1.513 -0.575 1 C-N-CA 125.504 4.136 . . . . 0.0 117.919 -163.126 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 71' ' ' VAL . . . . . 0.417 HG21 ' HB2' ' A' 1159 ' ' ALA . 51.8 t -67.26 104.79 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 168.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -171.89 119.26 0.43 Allowed 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 113.121 -1.854 . . . . 0.0 106.374 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.87 -97.82 2.08 Favored Glycine 0 C--O 1.213 -1.161 0 O-C-N 120.209 -1.557 . . . . 0.0 112.115 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 74' ' ' ARG . . . . . 0.706 ' NH2' ' HB2' ' B' 1199 ' ' GLU . 1.9 mpt_? -149.17 171.22 16.8 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 103.384 -2.821 . . . . 0.0 103.384 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.513 ' HA ' ' HD2' ' C' ' 76' ' ' PRO 0.268 33.0 mt 60.43 103.59 0.03 OUTLIER Pre-proline 0 C--O 1.236 0.385 0 N-CA-C 117.21 2.3 . . . . 0.0 117.21 -175.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 76' ' ' PRO . . . . . 0.513 ' HD2' ' HA ' ' C' ' 75' ' ' LEU . 72.9 Cg_endo -63.53 90.16 0.15 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.891 2.394 . . . . 0.0 112.137 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.08 -7.64 62.87 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-O 116.125 -2.486 . . . . 0.0 115.507 175.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -51.29 -28.01 10.88 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 123.733 3.766 . . . . 0.0 119.592 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 79' ' ' MET . . . . . 0.716 ' HA ' HD12 ' C' ' 82' ' ' LEU . 0.7 OUTLIER -58.52 -32.27 68.69 Favored 'General case' 0 C--O 1.243 0.757 0 O-C-N 118.925 -2.359 . . . . 0.0 113.748 169.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -66.88 -37.79 85.07 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 122.586 0.354 . . . . 0.0 111.054 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' 1155 ' ' GLY . 92.9 t -68.74 -42.76 83.12 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.718 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.383 -175.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.716 HD12 ' HA ' ' C' ' 79' ' ' MET . 34.9 mt -53.56 -41.55 66.59 Favored 'General case' 0 C--N 1.35 0.619 0 C-N-CA 125.319 1.448 . . . . 0.0 113.144 170.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 21.4 tp -65.24 -46.4 80.74 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.181 0.991 . . . . 0.0 110.379 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.44 -35.26 77.08 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-O 118.107 -0.949 . . . . 0.0 112.38 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -64.51 -43.88 92.67 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.597 0.561 . . . . 0.0 112.283 173.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . 0.524 ' HA ' ' CZ ' ' C' ' 48' ' ' TYR . . . -54.35 -3.31 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 119.131 3.011 . . . . 0.0 119.131 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 87' ' ' LYS . . . . . 0.429 ' HA ' ' HD3' ' C' ' 87' ' ' LYS . 31.7 mmtp 60.3 65.9 1.02 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 125.278 2.466 . . . . 0.0 112.184 -175.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 88' ' ' VAL . . . . . 0.449 HG22 ' HB2' ' C' ' 51' ' ' ALA . 87.0 t -115.29 149.96 43.65 Favored Pre-proline 0 N--CA 1.481 1.1 0 CA-C-N 108.748 -3.842 . . . . 0.0 104.208 -178.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -55.94 76.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.476 0.47 1 C-N-CA 127.178 5.252 . . . . 0.0 113.823 164.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -60.4 -30.24 69.47 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 113.062 -1.881 . . . . 0.0 107.004 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -39.02 -39.76 0.59 Allowed 'General case' 0 C--N 1.354 0.763 0 CA-C-O 116.359 -1.781 . . . . 0.0 115.436 168.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 92' ' ' ILE . . . . . 0.478 HD12 ' O ' ' C' ' 64' ' ' VAL . 2.3 pt -107.52 24.92 2.59 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 CA-C-O 124.034 1.873 . . . . 0.0 111.881 -176.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 93' ' ' VAL . . . . . 0.601 HG22 ' HB2' ' C' ' 66' ' ' PHE . 53.4 t -87.52 128.68 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 O-C-N 120.623 -1.298 . . . . 0.0 109.304 174.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 94' ' ' LEU . . . . . 0.59 HD23 ' HB3' ' C' ' 97' ' ' ASP . 4.7 mp -117.36 83.45 1.99 Allowed 'General case' 0 C--O 1.259 1.58 0 CA-C-O 123.644 1.688 . . . . 0.0 110.495 172.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -75.94 111.8 11.7 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 119.876 -1.765 . . . . 0.0 106.729 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.51 ' HA ' HD11 ' C' ' 136' ' ' LEU . 0.9 OUTLIER 68.35 -9.08 0.54 Allowed 'General case' 0 C--O 1.251 1.182 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 173.038 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 97' ' ' ASP . . . . . 0.59 ' HB3' HD23 ' C' ' 94' ' ' LEU . 3.3 t70 -68.09 -177.01 0.78 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 118.109 -0.948 . . . . 0.0 113.089 175.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -77.22 57.84 1.51 Allowed 'General case' 0 C--O 1.24 0.603 0 CA-C-O 125.627 2.632 . . . . 0.0 117.168 -171.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 8.6 tp -77.75 -2.52 4.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 O-C-N 119.174 -2.204 . . . . 0.0 111.334 173.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . 0.423 ' HA ' ' CD2' ' C' ' 103' ' ' PHE . 23.1 t-20 -57.79 -45.33 86.18 Favored 'General case' 0 C--N 1.354 0.768 0 O-C-N 121.292 -0.88 . . . . 0.0 113.226 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -57.05 -43.19 81.74 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 122.936 1.35 . . . . 0.0 113.87 174.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -68.42 -24.32 64.73 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.853 -175.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 103' ' ' PHE . . . . . 0.629 ' HE1' HG21 ' C' ' 34' ' ' ILE . 22.0 m-30 -53.67 -43.48 68.89 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 116.078 -1.915 . . . . 0.0 111.23 167.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.7 -45.73 88.69 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 121.128 1.785 . . . . 0.0 111.066 173.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -57.26 -31.41 65.55 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 106' ' ' THR . . . . . 0.69 ' HA ' ' HB2' ' C' ' 32' ' ' SER . 10.2 m -79.11 159.34 27.52 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-N 113.414 -1.721 . . . . 0.0 113.143 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 107' ' ' ASP . . . . . 0.531 ' HA ' ' HB2' ' C' ' 142' ' ' GLN . 1.8 t70 -99.98 -84.76 0.41 Allowed 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 165.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' C' ' 143' ' ' ASN . 57.2 m -79.01 111.44 15.21 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 125.307 2.48 . . . . 0.0 116.535 178.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 109' ' ' VAL . . . . . 0.774 HG11 HG21 ' C' ' 138' ' ' VAL . 21.0 t -90.3 105.61 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 112.208 -2.269 . . . . 0.0 107.857 174.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 110' ' ' LEU . . . . . 0.558 HD21 HD21 ' C' ' 27' ' ' LEU . 15.4 mt -71.55 87.79 0.91 Allowed 'General case' 0 C--O 1.25 1.125 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 173.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 111' ' ' VAL . . . . . 0.647 ' HB ' ' HA ' ' C' ' 146' ' ' VAL . 89.9 t -82.29 83.07 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 O-C-N 120.277 -1.514 . . . . 0.0 109.862 178.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 112' ' ' ILE . . . . . 0.534 ' HA ' ' HB2' ' C' ' 147' ' ' PHE . 56.0 mt -82.53 92.54 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 123.31 1.528 . . . . 0.0 110.185 -175.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 113' ' ' GLY . . . . . 0.474 ' HA3' ' HA3' ' C' ' 40' ' ' GLY . . . 57.95 29.61 62.32 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 110.513 -3.04 . . . . 0.0 113.681 175.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 114' ' ' ALA . . . . . 0.597 ' HB3' HG13 ' C' ' 111' ' ' VAL . . . -82.66 -28.84 30.41 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 118.485 -1.286 . . . . 0.0 112.322 173.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 115' ' ' ASN . . . . . 0.597 ' ND2' ' H ' ' C' ' 116' ' ' ASP . 6.2 t30 64.93 -163.26 0.26 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 116.377 -1.773 . . . . 0.0 112.564 161.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 116' ' ' ASP . . . . . 0.597 ' H ' ' ND2' ' C' ' 115' ' ' ASN . 1.9 p30 -51.99 -14.48 0.4 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 125.31 3.687 . . . . 0.0 116.881 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 117' ' ' THR . . . . . 0.414 HG22 ' CE1' ' C' ' 69' ' ' HIS . 1.3 m -63.64 -14.07 48.37 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 169.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.564 ' HB ' HG12 ' C' ' 138' ' ' VAL . 21.3 m -106.55 12.96 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 117.242 -3.411 . . . . 0.0 112.871 167.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 119' ' ' ASN . . . . . 0.519 ' HB3' ' HA ' ' C' ' 116' ' ' ASP . 0.1 OUTLIER -102.15 131.81 22.22 Favored Pre-proline 0 N--CA 1.478 0.961 0 O-C-N 118.904 -2.372 . . . . 0.0 114.392 -166.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 120' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -50.89 -40.01 58.22 Favored 'Trans proline' 0 C--O 1.242 0.707 0 C-N-CA 123.939 3.093 . . . . 0.0 113.869 -178.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 121' ' ' ALA . . . . . 0.758 ' HA ' ' HB3' ' C' ' 124' ' ' ASP . . . -58.87 -14.28 8.58 Favored 'General case' 0 C--O 1.208 -1.092 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 -167.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 122' ' ' ALA . . . . . 0.614 ' HB3' ' HB2' ' C' ' 133' ' ' MET . . . -58.98 -37.97 78.04 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 119.241 -2.162 . . . . 0.0 112.365 170.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -95.02 -41.38 9.17 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.369 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 124' ' ' ASP . . . . . 0.758 ' HB3' ' HA ' ' C' ' 121' ' ' ALA . 26.4 t70 -67.77 -46.88 70.77 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 124.305 1.042 . . . . 0.0 111.129 -170.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -108.55 94.85 14.74 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 120.272 1.396 . . . . 0.0 109.264 172.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -49.58 -15.43 0.96 Allowed 'Trans proline' 0 C--O 1.257 1.451 1 C-N-CA 125.677 4.251 . . . . 0.0 112.362 172.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -68.06 -32.62 73.09 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 118.654 -2.528 . . . . 0.0 109.177 176.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 128' ' ' SER . . . . . 0.426 ' HA ' ' HD2' ' C' ' 129' ' ' PRO . 44.6 m -53.44 123.01 34.59 Favored Pre-proline 0 N--CA 1.449 -0.501 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 129' ' ' PRO . . . . . 0.558 ' HG2' ' HA ' ' C' ' 156' ' ' ALA . 34.8 Cg_endo -52.18 -39.72 70.78 Favored 'Trans proline' 0 N--CA 1.435 -1.93 1 C-N-CA 125.701 4.267 . . . . 0.0 115.076 -178.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 130' ' ' ILE . . . . . 0.722 HG12 ' HB2' ' C' ' 156' ' ' ALA . 28.4 pt -78.11 130.6 36.0 Favored 'Isoleucine or valine' 0 C--O 1.252 1.205 0 CA-C-N 120.615 1.552 . . . . 0.0 110.931 170.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 131' ' ' ALA . . . . . 0.526 ' O ' ' HB ' ' B' 1121 ' ' ILE . . . -108.8 124.95 51.41 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-O 122.698 1.237 . . . . 0.0 113.396 -174.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.03 134.14 2.59 Favored Glycine 0 N--CA 1.474 1.225 0 CA-C-N 113.482 -1.69 . . . . 0.0 112.353 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 133' ' ' MET . . . . . 0.614 ' HB2' ' HB3' ' C' ' 122' ' ' ALA . 34.0 tpp -129.25 131.73 23.85 Favored Pre-proline 0 CA--C 1.506 -0.717 0 N-CA-C 104.932 -2.247 . . . . 0.0 104.932 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 134' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' C' ' 133' ' ' MET . 56.7 Cg_endo -57.54 149.93 63.7 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.748 2.299 . . . . 0.0 113.178 165.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 3.2 m -64.08 5.96 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.052 0 N-CA-C 119.054 2.983 . . . . 0.0 119.054 -168.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . 0.51 HD11 ' HA ' ' C' ' 96' ' ' MET . 27.6 mt -80.77 52.49 1.72 Allowed 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 120.193 -1.567 . . . . 0.0 110.199 171.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -82.22 96.37 7.84 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 -177.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 138' ' ' VAL . . . . . 0.774 HG21 HG11 ' C' ' 109' ' ' VAL . 13.4 p -94.12 77.89 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 113.475 -1.693 . . . . 0.0 109.294 -171.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -131.79 165.76 23.07 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 173.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 140' ' ' LYS . . . . . . . . . . . . 0.29 0.8 OUTLIER 61.9 -24.01 0.05 OUTLIER 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 126.708 2.003 . . . . 0.0 113.777 173.79 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -52.51 153.91 2.83 Favored 'General case' 0 C--O 1.252 1.234 0 CA-C-N 123.017 2.644 . . . . 0.0 116.409 163.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 142' ' ' GLN . . . . . 0.531 ' HB2' ' HA ' ' C' ' 107' ' ' ASP . 8.8 mm100 -35.67 -44.69 0.33 Allowed 'General case' 0 C--N 1.354 0.8 0 N-CA-C 120.147 3.388 . . . . 0.0 120.147 -160.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 143' ' ' ASN . . . . . 0.52 ' O ' ' HA ' ' C' ' 108' ' ' THR . 19.2 t-20 -157.56 93.79 1.32 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 122.643 1.211 . . . . 0.0 112.967 162.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 144' ' ' VAL . . . . . 0.572 ' HB ' HG23 ' C' ' 168' ' ' THR . 90.2 t -87.67 104.27 14.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 103.923 -2.621 . . . . 0.0 103.923 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 145' ' ' ILE . . . . . 0.696 HG13 ' HB2' ' C' ' 171' ' ' LEU . 3.7 tp -101.73 104.81 16.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 123.696 1.712 . . . . 0.0 111.748 -177.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 146' ' ' VAL . . . . . 0.647 ' HA ' ' HB ' ' C' ' 111' ' ' VAL . 27.2 t -91.51 98.83 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 O-C-N 119.658 -1.901 . . . . 0.0 109.453 -169.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 147' ' ' PHE . . . . . 0.534 ' HB2' ' HA ' ' C' ' 112' ' ' ILE . 9.3 m-85 -67.95 115.3 7.31 Favored 'General case' 0 C--O 1.249 1.079 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 148' ' ' LYS . . . . . 0.458 ' HB3' ' SD ' ' C' ' 170' ' ' MET . 77.1 tttt -155.5 137.09 14.2 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 149' ' ' ARG . . . . . 0.498 HH11 ' HG2' ' C' ' 149' ' ' ARG . 7.3 tpp85 -48.41 -60.65 2.51 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 110.633 -2.985 . . . . 0.0 113.924 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 8.0 m -133.7 159.75 39.6 Favored 'General case' 0 CA--C 1.552 1.022 0 O-C-N 119.977 -1.702 . . . . 0.0 112.865 -171.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 10.7 tpt -67.51 93.81 0.37 Allowed 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 168.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -155.99 160.38 40.01 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.178 0.991 . . . . 0.0 109.259 -176.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 153' ' ' THR . . . . . 0.593 HG23 ' HA3' ' C' ' 157' ' ' GLY . 8.9 m -62.86 161.33 12.93 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.94 0.896 . . . . 0.0 112.997 175.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 154' ' ' GLY . . . . . 0.574 ' HA3' ' ND2' ' C' ' 115' ' ' ASN . . . -106.8 -92.35 2.26 Favored Glycine 0 CA--C 1.508 -0.382 0 N-CA-C 105.49 -3.044 . . . . 0.0 105.49 153.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -114.92 -20.11 10.68 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 172.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 156' ' ' ALA . . . . . 0.722 ' HB2' HG12 ' C' ' 130' ' ' ILE . . . -103.32 -81.05 0.51 Allowed 'General case' 0 C--N 1.322 -0.614 0 O-C-N 119.121 -2.237 . . . . 0.0 110.703 168.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 157' ' ' GLY . . . . . 0.593 ' HA3' HG23 ' C' ' 153' ' ' THR . . . 88.71 -61.25 3.83 Favored Glycine 0 C--N 1.347 1.139 0 CA-C-N 121.594 1.997 . . . . 0.0 112.064 168.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 34.0 m -37.34 98.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-O 123.951 1.834 . . . . 0.0 115.465 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 35.72 34.62 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 120.515 3.524 . . . . 0.0 120.515 -174.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 160' ' ' ASN . . . . . 0.424 ' HA ' ' HD2' ' C' ' 161' ' ' PRO . 7.5 m120 -70.75 118.65 67.03 Favored Pre-proline 0 C--N 1.347 0.491 0 CA-C-N 113.193 -1.822 . . . . 0.0 111.075 -170.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 161' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' C' ' 160' ' ' ASN . 34.7 Cg_endo -46.64 -25.95 3.99 Favored 'Trans proline' 0 CA--C 1.509 -0.725 1 C-N-CA 126.007 4.471 . . . . 0.0 117.102 -172.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 162' ' ' LEU . . . . . 0.464 ' HG ' HG21 ' C' ' 146' ' ' VAL . 13.6 tp -50.71 -39.64 52.16 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 125.338 1.455 . . . . 0.0 113.529 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 163' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -84.6 -23.1 29.75 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 118.887 -1.125 . . . . 0.0 108.688 -172.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -102.67 -34.21 9.14 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 118.246 2.684 . . . . 0.0 118.246 -160.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 165' ' ' LYS . . . . . 0.718 ' HB2' ' HB ' ' C' ' 168' ' ' THR . 63.7 mmtt -57.16 157.57 5.99 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 -175.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.5 -40.14 96.29 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -99.21 -22.98 15.38 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 119.292 0.951 . . . . 0.0 111.894 173.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 168' ' ' THR . . . . . 0.718 ' HB ' ' HB2' ' C' ' 165' ' ' LYS . 89.5 m -101.24 93.91 5.68 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 175.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.91 146.87 36.21 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.07 -1.052 . . . . 0.0 108.73 -171.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 170' ' ' MET . . . . . 0.458 ' SD ' ' HB3' ' C' ' 148' ' ' LYS . 30.8 mtm -62.16 130.49 45.69 Favored 'General case' 0 C--N 1.36 1.056 0 CA-C-O 123.94 1.829 . . . . 0.0 115.123 167.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 171' ' ' LEU . . . . . 0.696 ' HB2' HG13 ' C' ' 145' ' ' ILE . 20.8 tp -92.96 104.25 16.49 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 101.338 -3.578 . . . . 0.0 101.338 167.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 172' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' C' ' 148' ' ' LYS . 97.0 m-85 -72.44 136.32 45.98 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 113.059 -1.882 . . . . 0.0 110.04 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . 128.66 166.64 12.02 Favored Glycine 0 N--CA 1.432 -1.589 0 CA-C-O 124.525 2.18 . . . . 0.0 110.113 -177.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 174' ' ' ASP . . . . . 0.603 ' HB3' ' HB3' ' C' ' 177' ' ' ALA . 16.5 t70 -62.75 149.2 44.54 Favored 'General case' 0 C--O 1.252 1.198 0 CA-C-N 112.197 -2.001 . . . . 0.0 112.902 -177.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 175' ' ' ALA . . . . . 0.493 ' O ' HG23 ' C' ' 179' ' ' VAL . . . -60.93 -53.44 57.27 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 121.421 -0.799 . . . . 0.0 113.02 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -62.49 -62.94 1.4 Allowed 'General case' 0 C--O 1.217 -0.623 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 177' ' ' ALA . . . . . 0.603 ' HB3' ' HB3' ' C' ' 174' ' ' ASP . . . -51.42 -36.38 43.53 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -176.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 14.7 m -68.6 -39.16 81.0 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 173.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 179' ' ' VAL . . . . . 0.493 HG23 ' O ' ' C' ' 175' ' ' ALA . 5.7 t -74.47 -37.23 43.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 124.041 1.877 . . . . 0.0 109.239 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 180' ' ' ASP . . . . . 0.513 ' O ' ' HG ' ' C' ' 183' ' ' LEU . 16.1 t70 -58.89 -40.77 85.46 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-N 114.299 -1.318 . . . . 0.0 110.67 176.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.04 -29.34 69.67 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.611 175.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 182' ' ' ILE . . . . . 0.624 HG22 ' HB2' ' C' ' 24' ' ' ALA . 19.9 pt -101.07 -16.2 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 -178.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 183' ' ' LEU . . . . . 0.636 ' HB2' ' HB3' ' C' ' 52' ' ' GLU 0.265 2.0 pp -48.29 -35.22 11.8 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 118.981 2.956 . . . . 0.0 118.981 -170.522 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -131.85 -21.21 2.46 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.909 171.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -88.23 60.24 5.65 Favored 'General case' 0 C--O 1.243 0.747 0 O-C-N 119.869 -1.77 . . . . 0.0 109.546 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 186' ' ' LEU . . . . . 0.467 HD23 ' H ' ' C' ' 186' ' ' LEU . 1.7 pt? . . . . . 0 N--CA 1.436 -1.16 0 CA-C-O 114.698 -2.573 . . . . 0.0 113.962 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 20.5 t-80 . . . . . 0 CA--C 1.488 -1.441 0 N-CA-C 108.418 -0.956 . . . . 65.74 108.418 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -72.05 86.71 0.48 Allowed Glycine 0 C--O 1.246 0.866 0 N-CA-C 108.839 -1.704 . . . . 48.66 108.839 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1002 ' ' ARG . . . . . 0.583 ' HD2' ' HB2' ' A' 1034 ' ' ALA . 50.4 ttp180 -118.85 131.38 56.07 Favored 'General case' 0 C--O 1.255 1.382 0 N-CA-C 105.49 -2.041 . . . . 44.56 105.49 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1003 ' ' ILE . . . . . 0.591 HD13 HD22 ' A' 1026 ' ' LEU . 96.9 mt -88.74 130.32 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 103.356 -2.831 . . . . 34.86 103.356 173.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -107.22 123.26 7.2 Favored Glycine 0 C--N 1.316 -0.579 0 N-CA-C 106.398 -2.681 . . . . 30.75 106.398 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.876 HG23 ' HB3' ' A' 1017 ' ' ALA . 39.5 mm -107.56 104.04 51.28 Favored Pre-proline 0 C--O 1.249 1.055 0 N-CA-C 102.832 -3.025 . . . . 32.21 102.832 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -83.01 161.31 15.74 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.973 2.449 . . . . 32.98 113.718 171.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1007 ' ' ARG . . . . . 0.426 ' NH2' ' HG2' ' A' 1009 ' ' ARG . 54.0 ttp85 -69.51 149.57 48.1 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 111.094 -2.776 . . . . 47.98 106.808 161.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1008 ' ' GLU . . . . . 0.477 ' HG2' ' HG2' ' A' 1013 ' ' GLU 0.297 13.9 tp10 -83.17 118.65 23.74 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 116.057 -2.257 . . . . 34.7 109.392 170.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 1009 ' ' ARG . . . . . 0.763 ' NH1' ' HG2' ' A' 1079 ' ' GLU . 14.5 mtp-105 -95.19 -3.91 46.89 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 109.635 -3.439 . . . . 53.37 112.371 -173.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 65.1 tp -65.24 132.61 49.53 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 105.53 -2.026 . . . . 45.07 105.53 167.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1011 ' ' THR . . . . . . . . . . . . . 5.2 m -55.41 123.01 12.5 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 125.525 1.53 . . . . 40.36 112.179 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 66.9 m-80 58.41 28.92 17.5 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 118.259 2.689 . . . . 40.61 118.259 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1013 ' ' GLU . . . . . 0.477 ' HG2' ' HG2' ' A' 1008 ' ' GLU . 8.7 tp10 -89.7 147.08 24.07 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.441 -1.688 . . . . 33.76 106.441 167.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1014 ' ' THR . . . . . 0.512 HG22 ' HB3' ' A' 1320 ' ' PRO . 1.9 m -110.19 -4.54 15.7 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 113.574 0.954 . . . . 27.89 113.574 -170.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1015 ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -83.18 163.37 20.84 Favored 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 120.251 -1.53 . . . . 29.02 114.746 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1016 ' ' VAL . . . . . . . . . . . . . 12.5 p -121.49 162.06 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 103.782 -2.673 . . . . 28.13 103.782 159.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1017 ' ' ALA . . . . . 0.876 ' HB3' HG23 ' A' 1005 ' ' ILE . . . -61.09 -42.45 98.54 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 115.962 1.838 . . . . 26.87 115.962 -178.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -145.45 142.48 29.31 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 122.832 1.301 . . . . 26.77 110.255 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1019 ' ' THR . . . . . . . . . . . . . 8.2 p -84.77 161.19 54.09 Favored Pre-proline 0 N--CA 1.438 -1.071 0 O-C-N 118.877 -2.39 . . . . 27.02 108.468 171.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1020 ' ' PRO . . . . . 0.451 ' HB3' ' HB2' ' A' 1053 ' ' ALA . 0.0 OUTLIER -40.9 -45.31 4.97 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 123.706 2.937 . . . . 30.57 117.009 175.03 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -57.54 -41.05 80.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 123.753 1.739 . . . . 47.81 113.213 177.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1022 ' ' THR . . . . . 0.444 HG21 ' O ' ' A' 1325 ' ' GLN . 1.1 p -77.73 -32.5 52.85 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 114.191 1.182 . . . . 30.77 114.191 175.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1023 ' ' VAL . . . . . 0.584 ' HA ' HD12 ' A' 1026 ' ' LEU . 80.1 t -54.68 -44.96 72.44 Favored 'Isoleucine or valine' 0 C--N 1.345 0.385 0 O-C-N 121.257 -0.902 . . . . 33.59 110.815 170.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -48.62 -46.81 40.14 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.268 1.027 . . . . 53.29 111.184 172.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1025 ' ' GLN . . . . . 0.401 ' HB3' HG11 ' A' 1332 ' ' VAL . 40.6 mt-30 -64.66 -36.4 84.14 Favored 'General case' 0 N--CA 1.436 -1.144 0 O-C-N 123.563 0.54 . . . . 46.92 110.936 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1026 ' ' LEU . . . . . 0.591 HD22 HD13 ' A' 1003 ' ' ILE . 17.4 mt -66.15 -35.38 80.32 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 117.942 -1.027 . . . . 37.17 112.591 171.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.81 -43.55 98.03 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.75 1.159 . . . . 44.44 111.575 173.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 22.9 mmmt -57.7 -36.7 72.34 Favored 'General case' 0 C--O 1.217 -0.648 0 C-N-CA 123.671 0.788 . . . . 52.58 111.674 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1029 ' ' LEU . . . . . 0.547 HD12 ' HA ' ' A' 1026 ' ' LEU . 90.4 mt -58.48 -11.29 2.77 Favored 'General case' 0 C--O 1.249 1.03 0 N-CA-C 115.721 1.749 . . . . 45.69 115.721 173.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 88.21 22.91 39.41 Favored Glycine 0 CA--C 1.506 -0.516 0 O-C-N 118.115 -2.866 . . . . 42.09 112.345 170.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -113.76 162.47 16.26 Favored 'General case' 0 C--O 1.254 1.326 0 N-CA-C 105.905 -1.887 . . . . 40.72 105.905 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1032 ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -80.2 139.59 36.68 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 119.933 -1.73 . . . . 37.77 106.704 173.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1033 ' ' VAL . . . . . . . . . . . . . 11.0 t -121.54 127.18 75.57 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 O-C-N 117.803 -3.061 . . . . 33.54 108.187 -176.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1034 ' ' ALA . . . . . 0.583 ' HB2' ' HD2' ' A' 1002 ' ' ARG . . . -125.75 135.99 52.66 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 106.285 -1.746 . . . . 31.68 106.285 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1035 ' ' VAL . . . . . 0.489 HG22 ' HB ' ' A' 1005 ' ' ILE . 47.1 t -121.21 145.91 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 104.636 -2.357 . . . . 31.52 104.636 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1036 ' ' GLU . . . . . 0.696 ' HB3' ' HB2' ' A' 1039 ' ' ALA . 41.4 tt0 -58.89 154.36 15.32 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 119.52 -0.276 . . . . 41.04 111.584 173.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1037 ' ' SER . . . . . 0.465 ' OG ' ' HA ' ' A' 1059 ' ' GLU . 4.7 m -47.27 96.09 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 113.619 0.97 . . . . 31.83 113.619 173.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 61.25 38.87 96.37 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 114.674 -1.148 . . . . 29.36 112.669 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1039 ' ' ALA . . . . . 0.696 ' HB2' ' HB3' ' A' 1036 ' ' GLU . . . -52.43 -26.35 12.46 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 118.023 2.601 . . . . 27.78 118.023 -174.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1040 ' ' GLY . . . . . 0.461 ' H ' ' HE2' ' A' 1050 ' ' PHE . . . -91.69 13.0 67.85 Favored Glycine 0 N--CA 1.43 -1.731 0 CA-C-O 116.237 -2.424 . . . . 28.91 113.02 -175.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -62.67 -26.95 68.91 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 123.319 3.56 . . . . 51.18 113.482 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1042 ' ' LEU . . . . . . . . . . . . . 96.0 mt -54.94 -44.22 74.12 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 122.003 0.906 . . . . 29.91 110.915 167.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1043 ' ' ALA . . . . . 0.585 ' HA ' ' HB2' ' A' 1320 ' ' PRO . . . -104.1 35.84 2.55 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 114.303 -1.317 . . . . 28.54 109.491 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1044 ' ' SER . . . . . . . . . . . . . 3.0 m 65.8 0.36 1.5 Allowed 'General case' 0 C--O 1.239 0.548 0 N-CA-C 121.51 3.893 . . . . 33.06 121.51 172.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1045 ' ' PHE . . . . . 0.565 ' HD2' ' HB1' ' A' 1049 ' ' ALA . 86.3 m-85 -106.51 118.72 37.38 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 120.952 1.706 . . . . 30.29 114.15 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.9 -176.43 6.31 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 115.399 1.629 . . . . 48.62 115.399 178.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -43.55 -67.39 0.28 Allowed 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 125.642 1.838 . . . . 36.74 111.829 170.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 13.3 pttm -64.7 -24.15 67.48 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.347 0.976 . . . . 43.73 111.786 -172.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1049 ' ' ALA . . . . . 0.565 ' HB1' ' HD2' ' A' 1045 ' ' PHE . . . -63.48 -45.74 89.4 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.831 -1.174 . . . . 32.81 107.831 170.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1050 ' ' PHE . . . . . 0.461 ' HE2' ' H ' ' A' 1040 ' ' GLY . 87.3 m-85 -70.95 -23.03 62.15 Favored 'General case' 0 C--O 1.211 -0.931 0 O-C-N 120.275 -1.516 . . . . 31.86 110.847 173.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 78.5 t -69.39 -27.95 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 O-C-N 118.495 -2.628 . . . . 33.22 109.543 170.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -62.16 -45.63 92.55 Favored 'General case' 0 CA--C 1.509 -0.622 0 O-C-N 119.461 -2.024 . . . . 50.83 110.401 174.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1053 ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' 1020 ' ' PRO . . . -65.38 -38.07 88.9 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 115.86 -0.609 . . . . 33.12 111.705 172.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 99.16 69.21 0.91 Allowed Glycine 0 C--O 1.245 0.832 0 N-CA-C 105.485 -3.046 . . . . 35.83 105.485 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1055 ' ' ALA . . . . . 0.539 ' HB2' HG11 ' A' 1023 ' ' VAL . . . -119.7 138.03 53.55 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 113.662 -1.269 . . . . 34.82 108.059 176.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -66.13 124.63 23.14 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.474 -1.676 . . . . 49.05 106.474 171.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1057 ' ' ILE . . . . . 0.446 HG23 ' HA ' ' A' 1037 ' ' SER . 30.4 mm -90.23 98.77 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.25 0 O-C-N 117.699 -3.126 . . . . 38.53 107.792 177.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1058 ' ' VAL . . . . . 0.401 HG21 ' HA ' ' A' 1063 ' ' VAL . 2.5 m -79.81 123.23 36.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 125.44 2.543 . . . . 42.11 106.155 176.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1059 ' ' GLU . . . . . 0.465 ' HA ' ' OG ' ' A' 1037 ' ' SER . 6.4 mm-40 -76.7 82.91 3.33 Favored 'General case' 0 C--N 1.31 -1.126 1 CA-C-N 107.367 -4.469 . . . . 58.0 110.01 -174.41 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 75.51 -133.0 13.88 Favored Glycine 0 C--O 1.223 -0.589 0 N-CA-C 109.784 -1.326 . . . . 52.12 109.784 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 3.3 t30 -56.49 -25.66 51.95 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 117.427 2.38 . . . . 54.75 117.427 -161.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1062 ' ' SER . . . . . . . . . . . . . 70.5 m -55.66 -15.66 3.28 Favored 'General case' 0 C--O 1.25 1.113 0 O-C-N 120.012 -1.68 . . . . 50.34 113.125 174.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1063 ' ' VAL . . . . . 0.401 ' HA ' HG21 ' A' 1058 ' ' VAL . 14.8 p -57.17 -37.22 54.71 Favored 'Isoleucine or valine' 0 C--N 1.37 1.496 0 O-C-N 120.609 -1.307 . . . . 41.46 113.536 170.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1064 ' ' TRP . . . . . . . . . . . . . 97.9 m95 -70.2 -24.38 63.11 Favored 'General case' 0 N--CA 1.435 -1.216 0 O-C-N 125.525 1.766 . . . . 39.32 114.222 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -87.95 72.04 9.34 Favored 'General case' 0 C--O 1.246 0.883 0 N-CA-C 107.83 -1.174 . . . . 55.38 107.83 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1066 ' ' SER . . . . . . . . . . . . . 11.1 m -151.74 144.61 24.42 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-O 118.552 -0.737 . . . . 41.87 109.376 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.4 -12.28 60.22 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 119.03 2.974 . . . . 53.2 119.03 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1068 ' ' ILE . . . . . 0.43 ' HB ' ' HA ' ' A' 1003 ' ' ILE . 2.4 mp -127.06 124.66 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 104.241 -2.503 . . . . 41.9 104.241 167.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1069 ' ' ILE . . . . . 0.596 HG12 HG21 ' A' 1087 ' ' THR . 46.6 mm -119.08 111.14 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.069 0 N-CA-C 104.337 -2.468 . . . . 38.73 104.337 173.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1070 ' ' LEU . . . . . 0.668 HD13 HD13 ' A' 1331 ' ' LEU . 94.5 mt -90.22 85.17 6.17 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 105.665 -1.976 . . . . 32.44 105.665 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1071 ' ' LYS . . . . . 0.562 ' HE3' ' O ' ' A' 1073 ' ' ASN . 3.8 mmmt -81.79 145.83 30.24 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 107.049 -1.463 . . . . 34.65 107.049 -177.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1072 ' ' VAL . . . . . . . . . . . . . 2.6 t -86.89 -25.9 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-O 124.107 1.908 . . . . 31.32 111.871 -165.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1073 ' ' ASN . . . . . 0.562 ' O ' ' HE3' ' A' 1071 ' ' LYS . 61.9 m-20 -140.86 -173.82 3.82 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 105.694 -1.965 . . . . 33.94 105.694 168.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -52.0 142.7 25.72 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 116.734 2.124 . . . . 38.04 116.734 172.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1075 ' ' PRO . . . . . 0.539 ' HG2' HD21 ' A' 1089 ' ' LEU . 46.4 Cg_exo -63.77 119.21 6.18 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.652 2.902 . . . . 42.68 112.454 162.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 50.8 mt -71.31 158.45 36.32 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 113.036 -1.893 . . . . 46.74 107.098 161.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -57.88 -32.11 67.38 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 119.953 -1.717 . . . . 58.61 114.934 -172.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 14.2 t70 -44.85 -53.38 7.57 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 123.067 1.413 . . . . 59.2 111.858 164.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1079 ' ' GLU . . . . . 0.763 ' HG2' ' NH1' ' A' 1009 ' ' ARG . 18.2 mt-10 -78.2 -34.81 49.21 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.96 -1.018 . . . . 50.63 109.859 -174.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1080 ' ' ILE . . . . . . . . . . . . . 66.3 mt -49.13 -48.05 17.5 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 CA-C-O 123.169 1.461 . . . . 51.48 111.175 170.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -63.47 -38.65 91.94 Favored 'General case' 0 C--O 1.25 1.106 0 CA-C-N 113.73 -1.577 . . . . 50.28 110.332 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 87.2 mt -71.52 -24.64 61.99 Favored 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 120.922 -1.112 . . . . 50.21 113.765 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1083 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.27 161.36 29.41 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 120.211 1.369 . . . . 49.06 109.467 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -123.88 140.28 34.21 Favored Pre-proline 0 C--O 1.248 0.991 0 N-CA-C 105.399 -2.074 . . . . 51.08 105.399 -176.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1085 ' ' PRO . . . . . 0.447 ' HB3' ' HB3' ' A' 1109 ' ' ASN . 64.5 Cg_exo -56.08 155.16 24.83 Favored 'Trans proline' 0 N--CA 1.446 -1.277 1 C-N-CA 125.382 4.055 . . . . 49.73 113.64 175.437 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 81.58 -10.46 50.64 Favored Glycine 0 C--N 1.314 -0.65 0 O-C-N 121.158 -0.964 . . . . 47.71 112.296 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1087 ' ' THR . . . . . 0.596 HG21 HG12 ' A' 1069 ' ' ILE . 92.9 m -82.52 137.91 34.46 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 119.411 1.605 . . . . 45.47 110.187 -171.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1088 ' ' THR . . . . . 0.451 ' HA ' ' HB ' ' A' 1111 ' ' THR . 2.7 m -75.94 87.53 2.9 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 107.311 -1.366 . . . . 42.04 107.311 174.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1089 ' ' LEU . . . . . 0.539 HD21 ' HG2' ' A' 1075 ' ' PRO . 56.4 tp -82.62 97.08 8.32 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 122.733 1.254 . . . . 38.06 108.663 177.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1090 ' ' VAL . . . . . 0.564 HG22 ' HB2' ' A' 1113 ' ' MET . 96.7 t -97.52 116.3 39.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 102.679 -3.082 . . . . 37.4 102.679 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1091 ' ' SER . . . . . . . . . . . . . 1.9 m -153.94 160.98 42.32 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 120.325 1.42 . . . . 36.16 113.179 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1092 ' ' PHE . . . . . 0.434 ' HB2' ' HA ' ' A' 1073 ' ' ASN . 0.8 OUTLIER -58.79 97.51 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.757 0 O-C-N 119.434 -2.041 . . . . 38.94 111.305 154.281 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 1093 ' ' ILE . . . . . 0.42 HG13 ' CG1' ' A' 1112 ' ' VAL . 25.2 mm -96.47 -36.93 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 C-N-CA 123.115 0.566 . . . . 42.17 109.98 -175.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1094 ' ' TRP . . . . . 0.601 ' HB2' HD22 ' A' 1098 ' ' ASN . 45.8 m95 58.16 56.6 6.63 Favored Pre-proline 0 C--O 1.256 1.418 0 O-C-N 124.867 1.354 . . . . 46.51 110.98 -172.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -50.15 -39.41 51.58 Favored 'Trans proline' 0 CA--C 1.504 -1.001 0 C-N-CA 124.414 3.409 . . . . 49.76 116.364 -173.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -72.84 -24.59 60.91 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 120.004 1.275 . . . . 52.62 113.247 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -90.32 -11.76 39.76 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 122.279 1.037 . . . . 60.74 110.032 172.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1098 ' ' ASN . . . . . 0.601 HD22 ' HB2' ' A' 1094 ' ' TRP . 36.4 m-80 -133.05 47.85 3.02 Favored Pre-proline 0 N--CA 1.451 -0.398 0 O-C-N 118.211 -2.806 . . . . 58.19 115.456 -174.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -55.31 -31.21 75.89 Favored 'Trans proline' 0 C--O 1.244 0.78 0 C-N-CA 124.664 3.576 . . . . 54.59 112.84 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1100 ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' 1104 ' ' LYS . 29.4 mp0 -61.46 -53.65 53.71 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.692 1.197 . . . . 63.28 109.971 175.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1101 ' ' LEU . . . . . 0.409 ' HB3' ' HB3' ' A' 1098 ' ' ASN . 24.2 tp -56.54 -40.64 75.43 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 124.027 0.931 . . . . 54.75 109.831 174.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1102 ' ' MET . . . . . . . . . . . . . 81.4 mmm -55.16 -50.72 68.58 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.929 1.24 . . . . 52.65 110.087 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -57.87 -39.95 79.02 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 124.96 1.304 . . . . 66.26 109.16 176.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1104 ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' 1100 ' ' GLU . 51.1 mtmt -71.72 -42.62 67.12 Favored 'General case' 0 C--N 1.313 -0.988 0 O-C-N 120.999 -1.063 . . . . 63.73 111.884 -176.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 68.3 mt -76.35 -21.28 56.32 Favored 'General case' 0 C--O 1.268 2.054 0 O-C-N 119.936 -1.728 . . . . 54.68 111.136 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -62.85 -42.54 99.79 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 120.646 -1.284 . . . . 53.64 111.759 167.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -62.47 -44.98 95.08 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 109.878 -0.415 . . . . 67.24 109.878 172.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.45 -2.79 12.07 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 117.055 -3.528 . . . . 65.76 114.347 174.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1109 ' ' ASN . . . . . 0.731 ' HA ' ' HA2' ' A' 1364 ' ' GLY . 2.1 t30 61.1 35.43 18.68 Favored 'General case' 0 C--O 1.247 0.942 0 O-C-N 118.984 -2.323 . . . . 58.71 113.717 169.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1110 ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.95 156.6 3.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 106.78 -1.563 . . . . 46.63 106.78 -171.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1111 ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' 1362 ' ' ARG . 53.9 m -81.62 97.32 7.81 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 105.878 -1.897 . . . . 44.13 105.878 165.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1112 ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' 1361 ' ' ILE . 42.7 t -95.55 111.69 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-O 123.584 1.659 . . . . 40.44 109.11 -177.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1113 ' ' MET . . . . . 0.564 ' HB2' HG22 ' A' 1090 ' ' VAL . 47.7 mtp -106.21 107.33 18.28 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 112.913 -1.948 . . . . 50.76 109.487 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1114 ' ' ALA . . . . . 0.46 ' HB3' ' HB2' ' A' 1117 ' ' SER . . . -87.64 105.44 17.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 126.338 2.97 . . . . 35.64 111.901 -177.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1115 ' ' MET . . . . . . . . . . . . . 74.2 mmm -60.19 -28.89 68.32 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 110.741 -2.936 . . . . 38.74 117.988 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -66.21 -44.17 84.65 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 113.293 -1.776 . . . . 40.14 109.737 167.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1117 ' ' SER . . . . . 0.46 ' HB2' ' HB3' ' A' 1114 ' ' ALA . 74.5 m -80.38 48.4 1.02 Allowed 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 118.509 2.781 . . . . 44.79 118.509 -175.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1118 ' ' VAL . . . . . . . . . . . . . 37.4 t -89.8 134.9 31.2 Favored Pre-proline 0 C--O 1.25 1.124 0 N-CA-C 107.112 -1.44 . . . . 43.75 107.112 173.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1119 ' ' PRO . . . . . 0.551 ' HG2' ' HA ' ' A' 1354 ' ' VAL . 0.5 OUTLIER -50.22 122.96 10.18 Favored 'Trans proline' 0 N--CA 1.459 -0.546 1 C-N-CA 125.688 4.259 . . . . 48.93 112.119 170.376 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 42.3 mmm-85 -75.31 61.1 1.17 Allowed 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 123.812 0.845 . . . . 62.9 111.905 -169.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 15.6 pt -116.78 167.65 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 O-C-N 118.042 -2.911 . . . . 57.72 110.733 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1122 ' ' SER . . . . . . . . . . . . . 4.2 p -39.0 -65.86 0.33 Allowed 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 117.592 2.442 . . . . 57.26 117.592 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -57.28 -33.29 67.48 Favored 'General case' 0 C--N 1.36 1.06 0 O-C-N 121.012 -1.055 . . . . 62.9 113.381 -176.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -82.17 -15.81 51.98 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-N 113.366 -1.743 . . . . 49.83 109.682 -169.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -56.02 -30.49 61.94 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 122.826 2.557 . . . . 52.37 114.159 -172.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1126 ' ' SER . . . . . . . . . . . . . 16.9 p -66.85 -31.73 72.54 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 122.715 1.245 . . . . 42.43 113.169 172.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1127 ' ' LEU . . . . . 0.411 HD21 HD12 ' A' 1337 ' ' LEU . 3.6 mp -83.65 -25.67 30.55 Favored 'General case' 0 C--N 1.346 0.436 0 O-C-N 121.197 -0.939 . . . . 43.74 111.971 172.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 62.0 t0 -69.84 89.32 0.57 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 123.736 1.731 . . . . 43.21 113.209 -172.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -67.92 -31.73 71.69 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 112.588 -2.096 . . . . 35.74 112.94 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 44.5 tp -54.18 -58.19 8.29 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 124.854 1.346 . . . . 38.09 108.702 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1131 ' ' SER . . . . . . . . . . . . . 7.0 m -69.77 -37.17 76.29 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 113.63 -1.623 . . . . 36.91 111.632 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1132 ' ' SER . . . . . . . . . . . . . 61.0 m -65.16 -38.27 90.04 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 123.048 2.658 . . . . 35.79 110.528 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1133 ' ' MET . . . . . . . . . . . . . 34.3 mmt -77.46 -40.16 44.11 Favored 'General case' 0 CA--C 1.489 -1.384 0 O-C-N 119.586 -1.946 . . . . 30.81 109.748 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1134 ' ' ALA . . . . . 0.604 ' HB1' ' HB2' ' A' 1176 ' ' ALA . . . -52.33 -43.16 64.41 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.094 0.557 . . . . 28.88 111.734 168.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1135 ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -63.93 -51.43 64.46 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.232 1.015 . . . . 40.76 109.796 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1136 ' ' ILE . . . . . 0.508 HD11 HD12 ' A' 1326 ' ' LEU . 94.0 mt -55.07 -42.62 65.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 114.838 -1.074 . . . . 31.54 113.343 171.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -66.54 -31.7 72.58 Favored 'General case' 0 C--O 1.219 -0.544 0 C-N-CA 124.709 1.203 . . . . 29.87 112.645 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -66.08 -50.5 51.41 Favored Glycine 0 C--O 1.216 -1.019 0 O-C-N 120.048 -1.657 . . . . 28.73 110.408 176.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 19.6 t80 -55.58 -47.11 76.97 Favored 'General case' 0 C--O 1.248 0.98 0 C-N-CA 124.187 0.995 . . . . 30.39 109.377 172.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1140 ' ' ARG . . . . . 0.476 ' HE ' ' HG2' ' A' 1144 ' ' GLU . 5.4 tpt180 -68.66 -24.45 64.53 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 114.171 1.174 . . . . 26.09 114.171 177.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1141 ' ' ALA . . . . . 0.466 ' HB2' HD21 ' A' 1284 ' ' LEU . . . -71.32 -40.35 70.84 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 121.572 1.987 . . . . 27.1 106.817 176.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 19.7 mm -63.1 -41.03 91.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.399 -0.593 . . . . 28.48 109.399 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 54.9 t -54.97 -64.85 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.607 0 C-N-CA 123.24 0.616 . . . . 23.07 111.534 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1144 ' ' GLU . . . . . 0.476 ' HG2' ' HE ' ' A' 1140 ' ' ARG . 6.1 mm-40 -68.36 -19.64 64.65 Favored 'General case' 0 C--O 1.244 0.785 0 O-C-N 120.336 -1.477 . . . . 33.4 113.253 -175.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1145 ' ' ALA . . . . . 0.735 ' HA ' HG11 ' A' 1280 ' ' VAL . . . -62.65 -56.96 12.98 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 107.154 -1.425 . . . . 24.22 107.154 164.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -59.75 -20.48 56.88 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 117.477 -3.265 . . . . 24.89 112.655 175.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 29.1 t-80 -66.73 -38.43 86.65 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 117.901 -3.0 . . . . 26.73 111.06 174.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1148 ' ' GLU . . . . . 0.753 ' HB3' ' HD2' ' A' 1308 ' ' LYS . 59.2 mm-40 -109.21 0.07 19.5 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 115.533 1.679 . . . . 39.96 115.533 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1149 ' ' PHE . . . . . 0.476 ' CZ ' ' HB3' ' A' 1250 ' ' ASP . 1.3 t80 -68.19 148.29 51.07 Favored 'General case' 0 C--O 1.246 0.888 0 O-C-N 120.988 -1.07 . . . . 25.87 108.709 -174.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1150 ' ' GLY . . . . . 0.635 ' HA2' ' HG2' ' B' 1320 ' ' PRO . . . -72.81 -40.37 52.72 Favored Glycine 0 N--CA 1.438 -1.197 0 C-N-CA 118.633 -1.746 . . . . 19.28 112.044 173.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1151 ' ' ARG . . . . . 0.803 ' HA ' ' HB2' ' B' 1322 ' ' GLN . 23.9 mtm-85 -108.21 -177.91 3.46 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.236 -1.155 . . . . 39.9 113.845 -166.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1152 ' ' PHE . . . . . 0.609 ' HB2' HG11 ' A' 1163 ' ' VAL . 2.1 m-30 -81.96 154.25 25.84 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 116.562 -2.055 . . . . 29.44 109.887 168.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1153 ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -70.47 -57.43 4.79 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 124.244 1.973 . . . . 32.6 107.177 156.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1154 ' ' THR . . . . . . . . . . . . . 3.5 m -60.16 92.24 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 110.562 -3.017 . . . . 34.64 111.425 -175.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -60.35 128.47 45.79 Favored Glycine 0 C--N 1.344 1.01 0 O-C-N 120.3 -1.5 . . . . 37.14 112.611 175.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1156 ' ' GLN . . . . . 0.449 ' H ' ' HB ' ' A' 1163 ' ' VAL . 3.7 pt20 -159.49 137.57 10.32 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 113.896 1.072 . . . . 40.57 113.896 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1157 ' ' ILE . . . . . 0.533 ' HB ' ' HB3' ' C' ' 95' ' ' GLU . 5.2 tp -80.36 125.15 39.02 Favored 'Isoleucine or valine' 0 C--O 1.257 1.491 0 N-CA-C 102.891 -3.003 . . . . 44.61 102.891 169.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1158 ' ' THR . . . . . 0.433 ' O ' ' HG3' ' C' ' 70' ' ' PRO . 56.0 p -98.44 -173.3 2.52 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 113.394 -1.73 . . . . 40.7 106.607 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -72.02 -19.0 61.92 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 121.48 1.945 . . . . 40.25 109.562 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1160 ' ' ALA . . . . . 0.448 ' HB2' ' ND2' ' B' 1330 ' ' ASN . . . -103.91 -47.81 4.09 Favored 'General case' 0 C--O 1.249 1.038 0 CA-C-N 119.972 1.26 . . . . 38.47 113.888 172.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . -148.54 162.01 28.76 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 117.723 -2.179 . . . . 37.61 114.693 -159.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 26.9 tttt -79.95 124.01 28.31 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 123.188 1.47 . . . . 48.9 113.318 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1163 ' ' VAL . . . . . 0.609 HG11 ' HB2' ' A' 1152 ' ' PHE . 79.4 t -95.29 117.0 66.81 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 105.962 -1.866 . . . . 36.52 105.962 165.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1164 ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -71.27 140.62 37.51 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.636 2.224 . . . . 35.08 112.753 172.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1165 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -59.0 125.63 18.72 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 CA-C-N 122.258 1.842 . . . . 35.33 112.861 169.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -63.85 140.57 58.88 Favored 'General case' 0 C--O 1.244 0.814 0 N-CA-C 114.773 1.398 . . . . 34.69 114.773 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1167 ' ' LYS . . . . . . . . . . . . . 79.4 mttt -88.21 113.13 23.52 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 119.845 1.202 . . . . 45.36 113.061 170.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 64.9 t -101.99 115.5 43.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.063 -1.088 . . . . 31.71 108.063 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1169 ' ' MET . . . . . 0.449 ' O ' ' HA ' ' A' 1252 ' ' ILE . 12.4 ttt -100.03 113.75 26.57 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 121.75 2.068 . . . . 42.28 109.24 170.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1170 ' ' VAL . . . . . 0.409 HG21 HG13 ' A' 1181 ' ' ILE . 68.9 t -82.92 128.69 38.48 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 N-CA-C 105.919 -1.882 . . . . 30.51 105.919 169.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 42.3 mt -119.55 136.46 56.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 O-C-N 119.63 -1.919 . . . . 31.87 106.068 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1172 ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' 1256 ' ' ALA . . . 74.91 58.26 4.12 Favored Glycine 0 CA--C 1.539 1.587 0 N-CA-C 110.043 -1.223 . . . . 34.54 110.043 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1173 ' ' ALA . . . . . . . . . . . . . . . -72.28 85.1 1.07 Allowed 'General case' 0 C--O 1.259 1.555 0 CA-C-O 122.487 1.137 . . . . 32.51 113.867 -166.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -76.16 -175.11 38.87 Favored Glycine 0 CA--C 1.554 2.498 0 N-CA-C 108.325 -1.91 . . . . 29.9 108.325 163.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1175 ' ' VAL . . . . . . . . . . . . . 79.2 t -59.42 -37.12 68.04 Favored 'Isoleucine or valine' 0 C--O 1.25 1.125 0 CA-C-N 118.49 1.145 . . . . 33.11 110.621 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1176 ' ' ALA . . . . . 0.604 ' HB2' ' HB1' ' A' 1134 ' ' ALA . . . -52.52 -42.42 64.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.322 -1.308 . . . . 28.1 114.333 169.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -64.94 -40.13 96.98 Favored Glycine 0 CA--C 1.545 1.91 0 N-CA-C 110.014 -1.234 . . . . 28.54 110.014 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1178 ' ' LEU . . . . . 0.711 HD13 ' HG2' ' A' 1203 ' ' GLN . 69.6 mt -63.31 -48.38 78.3 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.704 -0.85 . . . . 31.22 108.704 178.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -64.44 -34.18 77.59 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 120.259 -1.526 . . . . 28.98 114.937 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -57.95 -40.78 81.36 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 115.82 1.785 . . . . 27.83 115.82 171.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1181 ' ' ILE . . . . . 0.722 ' HA ' HG11 ' A' 1191 ' ' VAL . 96.7 mt -56.96 -49.15 80.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.507 -0.77 . . . . 30.25 111.672 169.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -58.08 -40.63 93.8 Favored Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 111.313 -0.715 . . . . 29.59 111.313 175.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -67.43 -52.43 39.81 Favored 'General case' 0 C--O 1.243 0.728 0 O-C-N 119.51 -2.17 . . . . 30.29 112.906 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -58.6 -40.44 83.25 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-O 122.962 1.363 . . . . 30.47 111.64 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1185 ' ' ASN . . . . . 0.473 ' ND2' ' HA3' ' A' 1208 ' ' GLY . 23.3 t-20 -62.48 -43.51 98.64 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 114.932 -1.031 . . . . 42.41 112.592 177.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1186 ' ' SER . . . . . 0.817 ' HB3' ' HA ' ' B' 1187 ' ' LEU . 43.9 m -58.16 -50.8 72.26 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 123.985 0.914 . . . . 39.38 109.566 172.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 29.5 mt -60.48 -18.76 53.72 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 116.975 2.213 . . . . 36.18 116.975 171.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 97.34 33.33 5.99 Favored Glycine 0 C--N 1.356 1.664 0 CA-C-N 121.876 2.125 . . . . 33.78 112.418 174.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -99.92 155.82 17.47 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 123.249 0.62 . . . . 33.93 112.478 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 34.2 mt -79.26 103.29 6.05 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.462 0 N-CA-C 104.31 -2.478 . . . . 38.74 104.31 175.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1191 ' ' VAL . . . . . 0.722 HG11 ' HA ' ' A' 1181 ' ' ILE . 1.4 t -93.92 148.74 4.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 N-CA-C 106.556 -1.646 . . . . 33.09 106.556 -172.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1192 ' ' ARG . . . . . 0.59 ' HG2' ' HB2' ' A' 1210 ' ' GLU . 90.2 mtt180 -141.76 158.76 43.41 Favored 'General case' 0 C--O 1.252 1.2 0 C-N-CA 124.647 1.179 . . . . 38.92 108.39 176.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1193 ' ' ALA . . . . . 0.562 ' HB2' HD11 ' A' 1181 ' ' ILE . . . -152.24 148.3 27.41 Favored 'General case' 0 C--O 1.25 1.106 0 N-CA-C 114.405 1.261 . . . . 35.32 114.405 176.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 42.3 t80 -138.23 147.64 43.94 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 113.705 -1.589 . . . . 39.35 107.648 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 10.5 t70 -170.78 167.51 7.61 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 103.109 -2.923 . . . . 40.46 103.109 170.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1196 ' ' THR . . . . . . . . . . . . . 4.0 m -69.92 -43.16 72.25 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 125.015 1.326 . . . . 45.94 110.068 175.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1197 ' ' ARG . . . . . 0.441 ' HA ' ' HD2' ' A' 1198 ' ' PRO . 39.6 mtm180 -79.49 112.74 31.21 Favored Pre-proline 0 C--O 1.222 -0.357 0 N-CA-C 114.951 1.463 . . . . 56.02 114.951 -165.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1198 ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' 1197 ' ' ARG . 57.4 Cg_endo -58.39 -20.88 50.58 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.722 2.281 . . . . 51.27 117.666 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -55.68 -25.53 40.21 Favored 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 117.01 2.226 . . . . 59.1 117.01 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 27.7 m -87.55 -14.14 10.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 114.729 1.381 . . . . 51.06 114.729 -175.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 90.8 mttt -62.98 -38.79 92.56 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.123 -0.944 . . . . 57.38 113.443 -169.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -56.38 -48.68 76.36 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 124.638 1.211 . . . . 62.41 110.707 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1203 ' ' GLN . . . . . 0.711 ' HG2' HD13 ' A' 1178 ' ' LEU . 0.0 OUTLIER -65.35 -44.34 87.99 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 124.918 1.386 . . . . 57.78 110.579 175.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 1204 ' ' VAL . . . . . 0.457 HG11 ' HD2' ' A' 1211 ' ' PHE . 54.1 t -55.49 -47.02 78.99 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 CA-C-N 121.083 1.765 . . . . 46.38 111.323 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -66.11 -36.09 82.25 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-N 115.008 -0.997 . . . . 50.7 110.037 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1206 ' ' SER . . . . . . . . . . . . . 59.8 m -71.2 -51.04 26.96 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 112.724 0.639 . . . . 49.98 112.724 -176.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1207 ' ' MET . . . . . . . . . . . . . 45.7 mtp -68.35 -25.78 65.26 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 123.499 0.499 . . . . 52.99 111.008 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1208 ' ' GLY . . . . . 0.473 ' HA3' ' ND2' ' A' 1185 ' ' ASN . . . 131.3 68.14 0.1 OUTLIER Glycine 0 N--CA 1.475 1.289 0 O-C-N 120.018 -1.677 . . . . 47.66 113.27 156.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1209 ' ' ALA . . . . . 0.474 ' HB2' HG23 ' A' 1181 ' ' ILE . . . -155.46 161.88 40.86 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 122.683 1.23 . . . . 44.77 113.173 -174.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1210 ' ' GLU . . . . . 0.59 ' HB2' ' HG2' ' A' 1192 ' ' ARG . 42.0 mt-10 -89.97 113.86 25.6 Favored 'General case' 0 C--N 1.318 -0.787 0 O-C-N 118.961 -2.337 . . . . 47.64 108.313 173.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1211 ' ' PHE . . . . . 0.457 ' HD2' HG11 ' A' 1204 ' ' VAL . 21.7 t80 -84.3 115.32 22.42 Favored 'General case' 0 N--CA 1.432 -1.375 0 C-N-CA 117.885 -1.526 . . . . 45.66 107.229 173.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 37.1 mt -71.01 116.42 11.28 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 125.955 1.702 . . . . 46.06 108.682 -176.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -69.44 144.72 53.22 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 118.444 -1.302 . . . . 60.22 112.84 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1214 ' ' LEU . . . . . 0.704 ' HG ' ' HB2' ' A' 1216 ' ' PHE . 66.6 tp -62.55 95.39 0.07 Allowed 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 113.589 -1.641 . . . . 57.25 109.72 167.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 16.3 t70 -69.45 90.67 0.54 Allowed 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 105.403 -2.073 . . . . 64.43 105.403 172.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1216 ' ' PHE . . . . . 0.704 ' HB2' ' HG ' ' A' 1214 ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.303 -1.428 0 O-C-N 126.325 2.265 . . . . 66.9 106.898 -172.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.429 -1.482 0 CA-C-O 122.174 0.988 . . . . 39.09 108.962 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -59.81 -38.66 94.31 Favored Glycine 0 CA--C 1.543 1.796 0 O-C-N 120.529 -1.357 . . . . 39.32 114.227 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 68.0 t80 -65.88 -46.35 78.72 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 117.336 0.568 . . . . 39.3 111.973 170.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -59.53 -49.46 77.68 Favored 'General case' 0 C--N 1.349 0.556 0 O-C-N 121.96 -0.463 . . . . 36.3 109.995 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -50.99 -56.98 9.81 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-O 117.432 -1.271 . . . . 37.38 111.973 168.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -51.91 -30.42 12.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 118.261 2.689 . . . . 39.11 118.261 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1230 ' ' MET . . . . . . . . . . . . . 38.7 mmt -79.21 -28.86 42.59 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 113.079 0.77 . . . . 49.59 113.079 174.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1231 ' ' SER . . . . . 0.509 ' O ' ' HB3' ' A' 1234 ' ' PHE . 23.1 m -58.21 140.43 53.09 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 117.142 2.275 . . . . 43.68 117.142 -169.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -58.96 -49.79 76.51 Favored 'General case' 0 C--O 1.214 -0.78 0 N-CA-C 116.251 1.945 . . . . 55.57 116.251 175.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -61.44 -25.44 67.22 Favored 'General case' 0 C--O 1.206 -1.19 0 N-CA-C 112.487 0.551 . . . . 44.94 112.487 174.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1234 ' ' PHE . . . . . 0.509 ' HB3' ' O ' ' A' 1231 ' ' SER . 70.7 t80 -69.22 -49.59 55.03 Favored 'General case' 0 N--CA 1.428 -1.569 0 O-C-N 124.299 0.999 . . . . 42.04 110.031 175.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 63.1 mt -62.05 -33.86 60.47 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 O-C-N 123.437 0.46 . . . . 46.28 111.982 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1236 ' ' LYS . . . . . 0.565 ' O ' ' HG3' ' A' 1240 ' ' GLU . 48.3 tttm -57.5 -53.12 61.72 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 118.085 -0.96 . . . . 47.87 111.049 164.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -60.43 -40.4 90.91 Favored 'General case' 0 C--O 1.259 1.558 0 N-CA-C 113.729 1.011 . . . . 41.61 113.729 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -57.13 -52.39 65.5 Favored 'General case' 0 C--O 1.254 1.321 0 O-C-N 121.557 -0.714 . . . . 50.65 109.567 173.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1239 ' ' MET . . . . . 0.541 ' SD ' ' HD2' ' A' 1242 ' ' PHE . 92.9 mmm -62.43 -25.14 67.81 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 113.586 0.958 . . . . 48.87 113.586 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1240 ' ' GLU . . . . . 0.565 ' HG3' ' O ' ' A' 1236 ' ' LYS . 34.7 mt-10 -71.45 -42.73 67.82 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 119.952 1.251 . . . . 54.8 111.596 168.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 2.3 mm? -59.0 -45.18 91.3 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 119.495 -2.003 . . . . 43.21 108.098 172.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1242 ' ' PHE . . . . . 0.541 ' HD2' ' SD ' ' A' 1239 ' ' MET . 12.3 m-30 -62.49 -46.17 89.7 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 125.478 1.511 . . . . 38.66 111.486 178.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -61.49 -39.83 92.39 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 123.589 1.662 . . . . 37.92 111.588 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1244 ' ' ALA . . . . . 0.442 ' HA ' ' NZ ' ' A' 1247 ' ' LYS . . . -65.11 -53.31 47.28 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 120.353 -1.467 . . . . 37.28 111.464 177.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -66.46 -31.16 71.73 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 120.825 -1.172 . . . . 43.07 112.662 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -53.37 -34.36 57.3 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 123.288 0.635 . . . . 38.3 112.099 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1247 ' ' LYS . . . . . 0.442 ' NZ ' ' HA ' ' A' 1244 ' ' ALA . 30.3 mtmm -67.42 -29.0 68.37 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.139 -0.937 . . . . 47.6 113.054 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -114.9 -37.1 4.26 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 114.195 1.183 . . . . 45.42 114.195 -168.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1249 ' ' VAL . . . . . . . . . . . . . 20.7 m -68.94 166.9 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.863 0 CA-C-O 123.624 1.678 . . . . 36.26 114.967 -166.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1250 ' ' ASP . . . . . 0.476 ' HB3' ' CZ ' ' A' 1149 ' ' PHE . 9.7 m-20 -123.68 -43.24 2.15 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 110.935 -2.848 . . . . 33.04 109.439 -172.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1251 ' ' ILE . . . . . 0.592 HD12 ' HB1' ' A' 1145 ' ' ALA . 48.4 mm -123.84 138.28 54.09 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.878 0 O-C-N 118.811 -2.43 . . . . 31.4 105.445 174.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1252 ' ' ILE . . . . . 0.737 ' HB ' HG12 ' A' 1281 ' ' ILE . 19.8 mt -114.44 130.95 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 106.351 -1.722 . . . . 29.42 106.351 162.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 13.4 t -110.22 106.49 20.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 O-C-N 121.14 -0.975 . . . . 30.37 109.222 172.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1254 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.06 108.88 20.0 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 125.022 2.344 . . . . 35.72 110.802 -178.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1255 ' ' THR . . . . . . . . . . . . . 8.5 m -109.5 -27.25 9.54 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 111.441 -2.618 . . . . 36.0 117.437 -158.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1256 ' ' ALA . . . . . 0.434 ' HB2' ' HA3' ' A' 1172 ' ' GLY . . . -70.09 77.78 0.5 Allowed 'General case' 0 C--O 1.246 0.889 0 N-CA-C 115.211 1.56 . . . . 40.93 115.211 -168.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 29.8 tp -90.8 130.27 36.79 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 124.588 1.155 . . . . 47.82 107.944 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 16.7 mm -109.57 138.61 20.64 Favored Pre-proline 0 C--O 1.246 0.91 0 N-CA-C 101.523 -3.51 . . . . 52.7 101.523 176.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -64.9 132.64 33.05 Favored 'Trans proline' 0 N--CA 1.43 -2.222 0 C-N-CA 121.589 1.526 . . . . 54.13 110.539 161.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 90.74 -69.56 2.2 Favored Glycine 0 CA--C 1.507 -0.423 0 N-CA-C 109.419 -1.472 . . . . 54.62 109.419 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 69.3 mttt -71.71 140.22 83.89 Favored Pre-proline 0 C--O 1.251 1.132 0 O-C-N 121.578 -0.954 . . . . 55.74 108.965 -176.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.36 143.95 94.39 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 123.916 3.077 . . . . 51.15 108.96 163.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -59.07 132.44 87.29 Favored Pre-proline 0 N--CA 1.446 -0.67 0 C-N-CA 126.524 1.93 . . . . 46.06 109.784 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -56.82 122.29 11.56 Favored 'Trans proline' 0 N--CA 1.445 -1.328 1 C-N-CA 125.961 4.441 . . . . 41.08 110.275 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1265 ' ' LYS . . . . . 0.596 ' HD3' ' HA ' ' A' 1293 ' ' GLU . 44.3 mttm -79.35 97.78 6.46 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 125.016 2.341 . . . . 47.42 107.721 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 48.9 mt -77.17 -63.9 1.26 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 110.931 -2.849 . . . . 39.22 109.319 -174.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 3.0 mt -87.22 111.71 22.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 CA-C-N 115.284 -0.871 . . . . 42.5 110.551 -166.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1268 ' ' THR . . . . . . . . . . . . . 63.7 m -64.39 141.95 58.59 Favored 'General case' 0 C--N 1.316 -0.85 0 O-C-N 124.728 1.267 . . . . 37.84 111.132 176.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1269 ' ' ARG . . . . . 0.424 ' HG3' ' HB2' ' A' 1293 ' ' GLU . 86.2 mtt180 -49.98 -47.77 52.67 Favored 'General case' 0 C--O 1.214 -0.812 0 N-CA-C 115.655 1.724 . . . . 54.8 115.655 -170.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -41.4 -50.46 3.83 Favored 'General case' 0 C--N 1.345 0.407 0 C-N-CA 126.392 1.877 . . . . 54.36 112.26 172.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1271 ' ' MET . . . . . . . . . . . . . 21.2 ttm -71.15 -25.0 62.37 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 122.661 1.219 . . . . 39.52 114.01 -173.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1272 ' ' VAL . . . . . 0.42 HG12 HG21 ' A' 1303 ' ' THR . 57.2 t -67.89 -41.9 85.27 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 O-C-N 121.003 -1.061 . . . . 38.25 111.273 174.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -59.1 -38.29 79.19 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 122.902 1.335 . . . . 40.77 111.95 172.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1274 ' ' SER . . . . . . . . . . . . . 11.8 m -67.64 -7.43 26.57 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 115.925 1.824 . . . . 36.58 115.925 174.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1275 ' ' MET . . . . . 0.49 ' HB3' HG21 ' A' 1307 ' ' VAL . 8.7 ttt -77.34 151.38 34.95 Favored 'General case' 0 C--O 1.247 0.969 0 O-C-N 120.664 -1.273 . . . . 36.75 108.128 -174.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1276 ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -55.22 126.67 25.86 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 114.007 -1.451 . . . . 46.11 110.698 175.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1277 ' ' ALA . . . . . 0.485 ' HB1' ' HA ' ' B' 1045 ' ' PHE . . . -72.1 170.76 13.26 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 117.012 2.227 . . . . 33.52 117.012 -175.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 68.44 30.28 73.22 Favored Glycine 0 C--O 1.25 1.102 0 C-N-CA 127.267 2.365 . . . . 31.27 111.748 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1279 ' ' SER . . . . . 0.458 ' HB2' HG22 ' A' 1307 ' ' VAL . 64.8 m -125.79 169.17 12.87 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 125.703 1.601 . . . . 32.95 111.216 -167.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1280 ' ' VAL . . . . . 0.735 HG11 ' HA ' ' A' 1145 ' ' ALA . 50.5 t -128.59 149.28 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 O-C-N 119.935 -1.728 . . . . 27.43 108.204 -176.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1281 ' ' ILE . . . . . 0.737 HG12 ' HB ' ' A' 1252 ' ' ILE . 16.4 mt -120.33 103.46 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 104.686 -2.339 . . . . 30.3 104.686 161.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.34 113.64 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 118.782 -1.167 . . . . 28.63 110.681 173.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 5.6 t0 -97.79 104.93 17.0 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 122.176 0.988 . . . . 36.27 109.094 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1284 ' ' LEU . . . . . 0.466 HD21 ' HB2' ' A' 1141 ' ' ALA . 49.1 mt -72.2 -36.31 69.16 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 112.033 -2.349 . . . . 38.57 107.602 176.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -73.38 -6.22 44.83 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 113.841 1.052 . . . . 37.56 113.841 -172.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . -43.41 -30.31 0.53 Allowed 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 127.173 2.189 . . . . 40.33 115.706 176.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1287 ' ' GLN . . . . . 0.604 ' HA ' HG23 ' A' 1313 ' ' THR . 7.8 pt20 -67.86 -2.31 7.09 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 116.017 1.858 . . . . 56.85 116.017 174.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -157.77 97.34 1.56 Allowed 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 102.983 -2.969 . . . . 45.86 102.983 159.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 90.93 -59.9 3.16 Favored Glycine 0 C--O 1.213 -1.168 0 O-C-N 119.222 -2.174 . . . . 40.31 111.931 169.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 80.1 134.97 1.33 Allowed Glycine 0 C--N 1.344 1.005 0 CA-C-N 120.14 1.97 . . . . 38.89 112.423 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1291 ' ' ASN . . . . . . . . . . . . . 33.1 m120 -84.53 -16.5 42.08 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.921 1.452 . . . . 37.23 114.921 -166.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1292 ' ' CYS . . . . . . . . . . . . . 37.2 t -88.75 150.27 23.04 Favored 'General case' 0 C--O 1.259 1.571 0 N-CA-C 105.595 -2.002 . . . . 36.5 105.595 171.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1293 ' ' GLU . . . . . 0.596 ' HA ' ' HD3' ' A' 1265 ' ' LYS . 24.7 mt-10 -78.61 -14.15 59.47 Favored 'General case' 0 C--O 1.216 -0.697 0 N-CA-C 116.877 2.177 . . . . 43.32 116.877 170.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1294 ' ' TYR . . . . . 0.447 ' CZ ' HG23 ' A' 1303 ' ' THR . 1.5 m-85 -75.34 -24.41 57.34 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 113.486 0.921 . . . . 41.32 113.486 178.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1295 ' ' THR . . . . . . . . . . . . . 24.0 m -60.96 105.35 0.46 Allowed 'General case' 0 C--O 1.249 1.036 0 C-N-CA 124.662 1.185 . . . . 35.3 113.894 -165.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 93.5 t -89.47 114.61 61.11 Favored Pre-proline 0 C--O 1.245 0.827 1 N-CA-C 99.662 -4.199 . . . . 34.84 99.662 166.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -56.85 148.89 63.98 Favored 'Trans proline' 0 CA--C 1.513 -0.546 0 C-N-CA 121.546 1.497 . . . . 33.51 111.97 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 90.35 -43.35 2.92 Favored Glycine 0 C--N 1.302 -1.343 0 CA-C-O 115.581 -2.788 . . . . 32.19 113.248 -174.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -104.91 171.39 7.34 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 121.482 2.641 . . . . 34.88 117.964 -168.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1300 ' ' ILE . . . . . 0.526 HD13 ' HG3' ' A' 1148 ' ' GLU . 50.1 mt -96.42 112.2 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 101.157 -3.645 . . . . 32.29 101.157 167.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.8 113.73 25.59 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 101.484 -3.524 . . . . 37.25 101.484 173.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1302 ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' 1308 ' ' LYS . 60.4 m -83.18 111.59 19.06 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.528 -1.656 . . . . 35.56 106.528 174.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1303 ' ' THR . . . . . 0.447 HG23 ' CZ ' ' A' 1294 ' ' TYR . 18.0 m -61.19 137.91 58.23 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 116.656 -1.64 . . . . 36.4 106.78 172.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -57.26 -10.89 1.44 Allowed 'General case' 0 C--N 1.353 0.719 0 N-CA-C 118.047 2.61 . . . . 52.32 118.047 -172.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -79.74 -37.17 36.12 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 125.056 1.473 . . . . 40.04 108.435 172.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1306 ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' B' 1044 ' ' SER . . . 123.44 31.97 0.93 Allowed Glycine 0 N--CA 1.419 -2.441 0 N-CA-C 111.161 -0.776 . . . . 36.96 111.161 -178.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1307 ' ' VAL . . . . . 0.49 HG21 ' HB3' ' A' 1275 ' ' MET . 42.1 t -102.75 109.8 27.65 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 N-CA-C 103.719 -2.697 . . . . 33.4 103.719 171.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1308 ' ' LYS . . . . . 0.753 ' HD2' ' HB3' ' A' 1148 ' ' GLU . 52.2 mttt -85.34 105.4 15.97 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 106.759 -1.571 . . . . 42.91 106.759 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 54.9 t -84.61 101.78 9.62 Favored 'Isoleucine or valine' 0 C--O 1.249 1.071 0 N-CA-C 106.043 -1.836 . . . . 32.29 106.043 176.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1310 ' ' ILE . . . . . 0.648 HD11 ' HB2' ' A' 1148 ' ' GLU . 48.5 mt -96.91 96.39 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 CA-C-N 113.058 -1.883 . . . . 30.99 108.033 -173.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -89.39 61.06 3.62 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 116.423 -0.353 . . . . 28.95 112.403 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1312 ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -80.47 98.52 7.59 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 117.564 -1.654 . . . . 31.69 110.276 -171.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1313 ' ' THR . . . . . 0.604 HG23 ' HA ' ' A' 1287 ' ' GLN . 2.8 m -59.81 -36.29 76.47 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 126.463 1.905 . . . . 34.17 108.46 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -79.54 3.9 17.42 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 114.106 1.15 . . . . 36.86 114.106 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1315 ' ' LEU . . . . . . . . . . . . . 16.6 mt -44.67 -43.83 18.87 Favored Pre-proline 0 C--O 1.22 -0.454 0 N-CA-C 119.028 2.973 . . . . 34.85 119.028 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -65.37 -21.6 60.84 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 123.653 2.902 . . . . 29.15 112.7 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -81.49 -40.29 11.27 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 110.611 -0.996 . . . . 27.29 110.611 173.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1318 ' ' ARG . . . . . . . . . . . . . 44.7 mtt-85 -50.64 -21.06 1.4 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 120.634 3.568 . . . . 41.49 120.634 -167.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1319 ' ' LEU . . . . . . . . . . . . . 14.4 tp -110.47 78.56 1.49 Allowed Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 104.557 -2.386 . . . . 27.61 104.557 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1320 ' ' PRO . . . . . 0.585 ' HB2' ' HA ' ' A' 1043 ' ' ALA . 98.8 Cg_endo -55.53 -61.45 0.36 Allowed 'Trans proline' 0 CA--C 1.514 -0.516 0 C-N-CA 123.793 2.995 . . . . 25.94 114.082 -157.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1321 ' ' THR . . . . . 0.441 HG23 ' HE1' ' A' 1045 ' ' PHE . 15.8 m -64.14 -31.86 73.21 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 120.157 1.344 . . . . 25.01 112.254 -177.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1322 ' ' GLN . . . . . 0.622 ' HB2' ' HA ' ' B' 1151 ' ' ARG . 21.6 tp60 -68.76 -52.72 27.42 Favored 'General case' 0 CA--C 1.506 -0.714 0 O-C-N 119.472 -2.017 . . . . 29.39 109.386 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1323 ' ' SER . . . . . . . . . . . . . 13.7 m -59.18 -41.14 87.76 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 125.143 1.527 . . . . 26.47 109.884 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1324 ' ' SER . . . . . . . . . . . . . 39.5 m -64.55 -42.99 95.34 Favored 'General case' 0 C--O 1.223 -0.337 0 O-C-N 123.948 0.78 . . . . 27.78 110.667 176.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1325 ' ' GLN . . . . . 0.444 ' O ' HG21 ' A' 1022 ' ' THR . 53.7 tp60 -63.57 -51.31 65.91 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.047 -1.033 . . . . 37.53 108.276 -175.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1326 ' ' LEU . . . . . 0.531 HD22 ' HB3' ' B' 1160 ' ' ALA . 96.2 mt -77.23 -35.27 55.61 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-O 116.803 -1.57 . . . . 35.71 113.309 -174.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1327 ' ' TYR . . . . . . . . . . . . . 37.1 t80 -55.94 -52.85 62.68 Favored 'General case' 0 C--N 1.362 1.139 0 CA-C-N 122.028 2.195 . . . . 31.59 108.595 168.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1328 ' ' GLY . . . . . 0.544 ' O ' HG23 ' A' 1332 ' ' VAL . . . -45.15 -46.37 10.29 Favored Glycine 0 N--CA 1.443 -0.838 0 O-C-N 126.037 2.086 . . . . 28.0 111.758 168.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1329 ' ' THR . . . . . 0.599 HG21 ' HA3' ' B' 1161 ' ' GLY . 11.9 m -69.79 -36.41 75.67 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 118.775 -2.603 . . . . 32.15 110.783 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1330 ' ' ASN . . . . . . . . . . . . . 33.7 m120 -61.73 -42.73 99.34 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 120.039 1.29 . . . . 34.36 108.918 171.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1331 ' ' LEU . . . . . 0.668 HD13 HD13 ' A' 1070 ' ' LEU . 22.4 mt -68.49 -39.14 81.43 Favored 'General case' 0 C--O 1.216 -0.663 0 O-C-N 121.439 -0.788 . . . . 33.37 112.515 -177.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1332 ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' 1328 ' ' GLY . 73.1 t -61.76 -46.38 96.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 105.403 -2.073 . . . . 35.27 105.403 175.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -55.51 -43.26 75.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 115.409 1.633 . . . . 37.66 115.409 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1334 ' ' LEU . . . . . . . . . . . . . 14.9 tp -62.92 -54.19 42.4 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 125.157 1.536 . . . . 40.27 109.831 174.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1335 ' ' LEU . . . . . 0.686 ' HA ' ' HB2' ' A' 1338 ' ' LEU . 39.6 mt -65.73 -17.31 64.52 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 118.16 -0.924 . . . . 42.5 113.391 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1336 ' ' LYS . . . . . . . . . . . . . 79.0 mttt -63.07 -49.09 75.9 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.033 -1.099 . . . . 47.81 108.033 169.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1337 ' ' LEU . . . . . 0.411 HD12 HD21 ' A' 1127 ' ' LEU . 77.4 mt -81.99 -20.28 38.81 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-O 124.212 1.958 . . . . 49.27 112.06 -176.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1338 ' ' LEU . . . . . 0.686 ' HB2' ' HA ' ' A' 1335 ' ' LEU . 9.2 mp -75.99 -24.96 55.37 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 113.546 -1.661 . . . . 50.54 112.503 169.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1339 ' ' CYS . . . . . . . . . . . . . 47.3 t -131.5 71.66 1.48 Allowed 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 102.57 -3.122 . . . . 53.67 102.57 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -67.77 -40.6 84.01 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 115.69 -0.686 . . . . 63.38 112.302 -177.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -72.06 -43.45 64.88 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 118.169 2.655 . . . . 70.95 118.169 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1342 ' ' LYS . . . . . 0.54 ' N ' ' HB3' ' A' 1343 ' ' ASP . 7.3 mtpm? 55.1 77.42 0.22 Allowed 'General case' 0 C--O 1.241 0.631 0 C-N-CA 125.505 1.522 . . . . 65.25 114.771 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1343 ' ' ASP . . . . . 0.54 ' HB3' ' N ' ' A' 1342 ' ' LYS 0.34 1.9 t70 78.3 -80.88 0.03 OUTLIER 'General case' 0 C--O 1.251 1.159 2 O-C-N 113.511 -5.743 . . . . 64.53 116.93 -6.638 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A 1344 ' ' GLY . . . . . 0.503 ' H ' ' HA ' ' A' 1342 ' ' LYS . . . 76.16 65.09 2.08 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 119.005 0.82 . . . . 59.72 112.855 -170.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 11.0 t30 -144.14 140.61 29.49 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.764 -0.458 . . . . 64.09 109.764 171.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1346 ' ' ILE . . . . . 0.504 HD12 ' H ' ' A' 1346 ' ' ILE . 3.4 mp -79.51 90.29 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 122.961 1.363 . . . . 58.82 107.628 -171.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1347 ' ' THR . . . . . . . . . . . . . 28.6 m -89.62 89.96 8.04 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-O 124.916 2.293 . . . . 54.96 109.147 175.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1348 ' ' VAL . . . . . . . . . . . . . 92.8 t -74.2 120.34 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 112.678 -2.055 . . . . 55.64 106.524 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1349 ' ' ASP . . . . . 0.441 ' H ' HG21 ' A' 1355 ' ' ILE . 1.5 t70 -94.44 148.64 22.03 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 119.544 1.065 . . . . 61.45 109.856 -176.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -109.28 -38.33 5.53 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.131 -0.941 . . . . 58.63 113.011 170.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 46.2 t0 -68.97 -29.8 68.1 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 123.463 1.601 . . . . 62.06 109.16 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 10.8 t70 -76.34 96.99 4.11 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 105.576 -2.009 . . . . 54.07 105.576 169.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1353 ' ' VAL . . . . . 0.577 ' HA ' ' HB3' ' A' 1356 ' ' ARG . 33.8 m -57.66 -29.7 35.25 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.669 0 CA-C-O 116.099 -1.905 . . . . 50.68 113.138 -174.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1354 ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' 1358 ' ' VAL . 1.5 m -69.05 -35.56 69.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 123.218 2.735 . . . . 47.68 112.633 176.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1355 ' ' ILE . . . . . 0.441 HG21 ' H ' ' A' 1349 ' ' ASP . 75.1 mt -68.93 -45.13 80.92 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 N-CA-C 107.066 -1.457 . . . . 48.49 107.066 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1356 ' ' ARG . . . . . 0.577 ' HB3' ' HA ' ' A' 1353 ' ' VAL . 46.3 tpt85 -52.1 -34.99 46.52 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 119.868 -1.77 . . . . 48.27 112.997 172.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -59.69 -62.91 5.59 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 114.685 0.634 . . . . 43.53 114.685 168.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1358 ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' 1354 ' ' VAL . 14.9 t -58.46 -37.08 62.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 O-C-N 124.848 0.97 . . . . 45.12 111.699 -177.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1359 ' ' THR . . . . . . . . . . . . . 12.7 m -72.16 78.05 0.96 Allowed 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 124.609 2.147 . . . . 42.94 109.803 175.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 29.6 m -74.56 -35.77 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 CA-C-N 113.249 -1.796 . . . . 43.26 109.719 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1361 ' ' ILE . . . . . 0.531 ' HB ' ' HB ' ' A' 1112 ' ' VAL . 60.9 mt -133.08 134.19 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 103.301 -2.852 . . . . 45.66 103.301 176.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1362 ' ' ARG . . . . . 0.494 ' HA ' ' HA ' ' A' 1111 ' ' THR . 30.2 ttt180 -123.02 121.18 35.44 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 122.689 2.495 . . . . 61.34 111.328 169.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 46.69 44.21 13.58 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 127.354 2.909 . . . . 49.76 110.322 173.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1364 ' ' GLY . . . . . 0.731 ' HA2' ' HA ' ' A' 1109 ' ' ASN . . . 115.94 -60.99 0.4 Allowed Glycine 0 C--N 1.347 1.154 0 N-CA-C 117.444 1.738 . . . . 50.0 117.444 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -82.88 130.92 35.2 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 119.619 -0.832 . . . . 56.92 110.321 -175.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1366 ' ' ILE . . . . . 0.491 HG12 HG12 ' A' 1361 ' ' ILE . 71.9 mt -64.64 118.74 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 N-CA-C 108.388 -0.967 . . . . 52.78 108.388 174.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1367 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.79 -0.13 43.22 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 112.613 -2.085 . . . . 49.44 115.975 173.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 7.2 t90 -63.45 150.08 90.6 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-O 115.312 -2.28 . . . . 52.38 112.412 173.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -78.21 -150.69 0.62 Allowed 'Cis proline' 0 CA--C 1.544 1.021 1 CA-C-N 129.259 4.342 . . . . 46.94 111.722 -8.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1370 ' ' ALA . . . . . . . . . . . . 0.264 . . -150.38 156.15 36.9 Favored Pre-proline 0 C--N 1.352 0.708 0 N-CA-C 108.328 -0.99 . . . . 45.91 108.328 -175.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1371 ' ' PRO . . . . . 0.451 ' HA ' ' HD2' ' A' 1372 ' ' PRO . 7.1 Cg_exo -43.16 117.98 1.16 Allowed 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 125.105 3.87 . . . . 46.39 114.782 169.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1372 ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' 1371 ' ' PRO . 72.1 Cg_endo -74.39 4.35 4.5 Favored 'Trans proline' 0 N--CA 1.485 0.994 0 C-N-CA 123.973 3.115 . . . . 46.72 116.93 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.217 -5.184 0 O-C-N 120.477 -1.389 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 73.9 m80 . . . . . 0 N--CA 1.427 -1.586 0 N-CA-C 105.691 -1.966 . . . . 63.44 105.691 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -123.62 43.56 2.93 Favored 'General case' 0 C--O 1.256 1.419 0 O-C-N 117.999 -2.938 . . . . 51.74 114.885 -173.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1000 ' ' HIS . . . . . 0.625 ' HA ' ' HB2' ' B' 1067 ' ' GLU . 17.1 m-70 -69.97 144.11 52.43 Favored 'General case' 0 C--O 1.258 1.533 0 CA-C-O 123.742 1.734 . . . . 54.07 108.096 167.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1001 ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' B' 1344 ' ' GLY . . . 76.98 -12.18 12.49 Favored Glycine 0 CA--C 1.534 1.259 0 O-C-N 120.967 -1.083 . . . . 39.22 112.169 -168.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1002 ' ' ARG . . . . . 0.438 ' O ' ' HB3' ' B' 1066 ' ' SER . 35.7 ttp180 -97.96 142.02 30.2 Favored 'General case' 0 CA--C 1.491 -1.299 0 CA-C-N 120.105 1.953 . . . . 38.12 109.37 174.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1003 ' ' ILE . . . . . . . . . . . . . 21.1 mt -98.74 154.77 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 N-CA-C 106.03 -1.841 . . . . 29.7 106.03 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -123.59 128.08 6.81 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 108.604 -1.799 . . . . 27.5 108.604 164.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1005 ' ' ILE . . . . . 0.783 HG23 ' HB3' ' B' 1017 ' ' ALA . 40.8 mm -116.33 112.11 41.81 Favored Pre-proline 0 C--O 1.243 0.729 0 N-CA-C 104.161 -2.533 . . . . 24.83 104.161 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1006 ' ' PRO . . . . . 0.519 ' HG2' ' HG2' ' B' 1071 ' ' LYS . 85.4 Cg_exo -74.88 154.2 42.94 Favored 'Trans proline' 0 N--CA 1.446 -1.314 1 C-N-CA 125.814 4.343 . . . . 27.19 111.189 176.37 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 63.6 ttt-85 -78.08 125.0 28.71 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 101.877 -3.379 . . . . 41.46 101.877 164.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1008 ' ' GLU . . . . . 0.607 ' HG3' ' HB ' ' B' 1072 ' ' VAL 0.411 0.3 OUTLIER -78.43 126.68 31.11 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 118.899 2.925 . . . . 26.93 118.899 -175.436 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 37.2 mtm180 -98.1 11.46 37.59 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 113.466 -1.697 . . . . 34.48 113.374 -170.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1010 ' ' LEU . . . . . . . . . . . . . 31.9 tp -66.95 143.41 56.82 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 119.803 -1.81 . . . . 44.22 109.051 175.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1011 ' ' THR . . . . . . . . . . . . . 57.9 m -67.57 147.69 52.42 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 122.304 2.32 . . . . 40.74 110.097 165.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 60.8 m-80 58.36 58.06 3.6 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-O 124.231 1.967 . . . . 44.44 110.836 -175.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1013 ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -137.75 143.89 41.38 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.87 -1.514 . . . . 29.87 109.269 -174.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1014 ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' B' 1320 ' ' PRO . 0.2 OUTLIER -137.65 3.37 2.51 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-O 124.088 1.899 . . . . 25.26 110.284 174.54 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 50.5 mtm180 -82.8 142.68 31.37 Favored 'General case' 0 C--O 1.24 0.586 0 O-C-N 119.66 -1.9 . . . . 29.54 112.559 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1016 ' ' VAL . . . . . 0.505 HG21 ' HB1' ' B' 1039 ' ' ALA . 11.1 p -106.43 162.86 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 103.137 -2.912 . . . . 23.55 103.137 154.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1017 ' ' ALA . . . . . 0.783 ' HB3' HG23 ' B' 1005 ' ' ILE . . . -68.2 -21.01 64.89 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 115.557 1.688 . . . . 23.59 115.557 177.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1018 ' ' ALA . . . . . 0.645 ' HB1' ' HB ' ' B' 1022 ' ' THR . . . -158.33 128.15 5.91 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 119.192 0.905 . . . . 24.93 109.254 175.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1019 ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.29 169.96 17.03 Favored Pre-proline 0 N--CA 1.477 0.895 0 CA-C-O 115.34 -2.267 . . . . 28.09 113.397 172.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -45.22 -50.93 8.38 Favored 'Trans proline' 0 CA--C 1.537 0.631 1 C-N-CA 125.371 4.047 . . . . 28.79 116.657 175.39 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 56.2 tttt -55.96 -39.45 71.77 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 113.486 0.921 . . . . 47.28 113.486 173.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1022 ' ' THR . . . . . 0.717 HG21 ' HA3' ' B' 1328 ' ' GLY . 0.3 OUTLIER -70.81 -34.02 71.32 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.401 -0.592 . . . . 30.12 109.401 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B 1023 ' ' VAL . . . . . 0.522 HG11 ' HB2' ' B' 1055 ' ' ALA . 39.7 t -61.93 -43.12 97.05 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 N-CA-C 108.921 -0.77 . . . . 32.24 108.921 176.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1024 ' ' GLU . . . . . 0.403 ' HG3' ' HB1' ' B' 1053 ' ' ALA . 40.9 mt-10 -61.5 -39.54 91.33 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 123.446 0.698 . . . . 49.62 112.35 174.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -55.87 -47.86 76.6 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 122.35 1.072 . . . . 44.68 111.45 174.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 86.1 mt -64.56 -32.48 74.14 Favored 'General case' 0 C--N 1.366 1.294 0 CA-C-N 113.013 -1.903 . . . . 35.71 110.694 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1027 ' ' LEU . . . . . 0.581 HD11 ' HA3' ' B' 1054 ' ' GLY . 86.5 mt -67.81 -41.22 83.42 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 122.314 1.055 . . . . 42.18 112.739 175.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 61.8 mttm -61.21 -32.8 72.57 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-N 112.918 -1.946 . . . . 48.34 111.645 176.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1029 ' ' LEU . . . . . 0.548 HD11 HG13 ' B' 1332 ' ' VAL . 93.9 mt -70.13 -3.61 17.51 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 115.637 1.718 . . . . 38.69 115.637 174.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 96.17 6.72 58.8 Favored Glycine 0 N--CA 1.471 1.007 0 N-CA-C 110.417 -1.073 . . . . 32.28 110.417 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -97.93 170.81 8.69 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.655 -1.239 . . . . 35.94 107.655 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1032 ' ' THR . . . . . . . . . . . . . 1.4 p -113.14 148.89 34.44 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 105.906 -1.887 . . . . 33.37 105.906 170.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1033 ' ' VAL . . . . . 0.444 HG11 HG22 ' B' 1023 ' ' VAL . 15.5 t -114.16 146.81 18.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 O-C-N 117.786 -3.071 . . . . 29.98 108.534 -176.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -125.1 140.84 52.52 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 107.109 -1.441 . . . . 28.18 107.109 163.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1035 ' ' VAL . . . . . 0.453 ' HB ' HD13 ' B' 1057 ' ' ILE . 21.8 t -129.31 146.61 33.96 Favored 'Isoleucine or valine' 0 C--N 1.348 0.528 0 N-CA-C 108.234 -1.024 . . . . 25.82 108.234 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1036 ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -66.11 139.91 58.19 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 121.442 0.639 . . . . 32.44 112.545 167.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1037 ' ' SER . . . . . . . . . . . . . 48.7 m -52.81 139.52 26.61 Favored 'General case' 0 C--O 1.257 1.478 0 CA-C-N 114.207 -1.36 . . . . 29.54 114.489 165.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 89.63 0.2 79.28 Favored Glycine 0 C--O 1.252 1.274 0 C-N-CA 121.322 -0.466 . . . . 27.76 113.271 176.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1039 ' ' ALA . . . . . 0.505 ' HB1' HG21 ' B' 1016 ' ' VAL . . . -64.83 -43.4 93.19 Favored 'General case' 0 CA--C 1.504 -0.796 0 O-C-N 124.502 0.766 . . . . 26.02 110.832 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -49.55 -47.85 36.12 Favored Glycine 0 N--CA 1.419 -2.458 0 C-N-CA 125.663 1.601 . . . . 26.47 111.118 173.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -53.21 -46.28 68.99 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-N 119.525 1.663 . . . . 50.98 112.514 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 94.7 mt -61.24 -57.62 11.64 Favored 'General case' 0 C--O 1.211 -0.964 0 N-CA-C 108.074 -1.084 . . . . 29.3 108.074 174.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1043 ' ' ALA . . . . . . . . . . . . . . . -72.62 11.85 0.57 Allowed 'General case' 0 C--O 1.248 0.982 0 N-CA-C 116.587 2.069 . . . . 26.74 116.587 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1044 ' ' SER . . . . . 0.435 ' O ' ' HA3' ' A' 1306 ' ' GLY . 17.3 m 46.89 25.24 0.44 Allowed 'General case' 0 C--O 1.248 0.987 0 C-N-CA 126.361 1.864 . . . . 31.26 113.717 -176.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1045 ' ' PHE . . . . . 0.485 ' HA ' ' HB1' ' A' 1277 ' ' ALA . 0.9 OUTLIER -112.86 155.93 23.82 Favored 'General case' 0 C--O 1.244 0.797 0 O-C-N 119.885 -1.76 . . . . 33.26 106.962 -177.174 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 11.3 t70 -67.96 126.04 28.22 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.869 -0.789 . . . . 46.74 108.869 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.8 -42.43 90.68 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 107.621 -1.251 . . . . 34.44 107.621 -173.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -53.03 -34.84 58.24 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 113.306 0.854 . . . . 48.67 113.306 172.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1049 ' ' ALA . . . . . 0.521 ' HA ' ' HB2' ' B' 1052 ' ' GLN . . . -62.94 -19.79 64.59 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 116.06 1.874 . . . . 35.26 116.06 176.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1050 ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -62.77 -42.72 99.82 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 123.396 1.57 . . . . 32.17 109.996 168.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 18.0 t -67.4 -50.74 59.37 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 O-C-N 119.546 -1.971 . . . . 38.37 107.061 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1052 ' ' GLN . . . . . 0.521 ' HB2' ' HA ' ' B' 1049 ' ' ALA . 52.9 mt-30 -52.17 -29.72 23.61 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.74 1.216 . . . . 45.77 114.174 175.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1053 ' ' ALA . . . . . 0.403 ' HB1' ' HG3' ' B' 1024 ' ' GLU . . . -80.55 -40.66 25.51 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 123.936 0.773 . . . . 37.83 110.584 176.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1054 ' ' GLY . . . . . 0.581 ' HA3' HD11 ' B' 1027 ' ' LEU . . . 134.81 48.73 0.08 OUTLIER Glycine 0 CA--C 1.532 1.141 0 CA-C-O 123.028 1.349 . . . . 35.82 111.657 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1055 ' ' ALA . . . . . 0.522 ' HB2' HG11 ' B' 1023 ' ' VAL . . . -128.74 140.9 51.51 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 108.206 -1.035 . . . . 33.77 108.206 177.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -76.38 106.79 8.21 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 104.513 -2.403 . . . . 51.02 104.513 166.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1057 ' ' ILE . . . . . 0.453 HD13 ' HB ' ' B' 1035 ' ' VAL . 13.6 mm -82.5 102.82 8.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 N-CA-C 102.079 -3.304 . . . . 38.47 102.079 173.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 30.1 m -86.71 159.34 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-N 109.143 -3.662 . . . . 39.4 108.29 175.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -71.48 -29.24 64.6 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.258 -1.337 . . . . 57.07 114.438 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . 172.79 -97.25 0.12 Allowed Glycine 0 CA--C 1.53 0.976 0 O-C-N 120.359 -1.463 . . . . 44.83 111.541 176.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -58.6 -32.0 68.58 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 125.632 1.573 . . . . 46.27 114.057 -170.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1062 ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -44.32 -33.87 1.76 Allowed 'General case' 0 C--O 1.24 0.578 0 N-CA-C 115.215 1.561 . . . . 43.47 115.215 171.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -54.05 -38.77 38.89 Favored 'Isoleucine or valine' 0 C--N 1.355 0.828 0 C-N-CA 124.385 1.074 . . . . 36.98 111.491 176.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 96.9 m95 -67.72 -14.38 62.9 Favored 'General case' 0 C--O 1.211 -0.949 0 N-CA-C 116.877 2.177 . . . . 37.9 116.877 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -99.83 81.58 2.47 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 104.338 -2.467 . . . . 46.19 104.338 -176.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1066 ' ' SER . . . . . 0.438 ' HB3' ' O ' ' B' 1002 ' ' ARG . 68.5 m -150.65 -178.53 6.61 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 119.006 -2.309 . . . . 37.06 108.244 -174.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1067 ' ' GLU . . . . . 0.625 ' HB2' ' HA ' ' B' 1000 ' ' HIS . 8.8 tp10 -69.8 -56.12 7.98 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 120.457 -1.402 . . . . 43.95 109.473 173.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1068 ' ' ILE . . . . . 0.562 HG23 HG13 ' B' 1346 ' ' ILE . 0.8 OUTLIER -123.07 137.88 54.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 107.411 -1.329 . . . . 33.5 107.411 -178.012 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 24.1 mm -111.28 106.81 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 N-CA-C 103.561 -2.755 . . . . 30.57 103.561 170.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1070 ' ' LEU . . . . . 0.715 HD22 HD22 ' B' 1331 ' ' LEU . 86.7 mt -97.23 118.46 33.73 Favored 'General case' 0 CA--C 1.505 -0.781 1 N-CA-C 98.117 -4.771 . . . . 27.66 98.117 -175.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B 1071 ' ' LYS . . . . . 0.519 ' HG2' ' HG2' ' B' 1006 ' ' PRO . 10.8 tmtt? -141.33 146.77 37.13 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 104.818 -2.29 . . . . 28.4 104.818 -164.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1072 ' ' VAL . . . . . 0.607 ' HB ' ' HG3' ' B' 1008 ' ' GLU . 61.8 t -79.93 -61.68 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-N 120.278 1.399 . . . . 23.18 112.462 -170.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1073 ' ' ASN . . . . . 0.468 ' HA ' ' HB2' ' B' 1092 ' ' PHE . 52.9 m-80 -105.95 -161.76 0.82 Allowed 'General case' 0 C--O 1.237 0.443 0 N-CA-C 106.269 -1.752 . . . . 25.47 106.269 -173.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -61.65 148.68 86.4 Favored Pre-proline 0 C--O 1.259 1.564 0 N-CA-C 112.999 0.74 . . . . 27.9 112.999 177.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -66.56 125.49 13.95 Favored 'Trans proline' 0 CA--C 1.556 1.608 0 N-CA-C 107.939 -1.6 . . . . 31.62 107.939 162.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 57.1 mt -69.14 162.18 27.55 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 107.696 -1.224 . . . . 40.49 107.696 169.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1077 ' ' ASP . . . . . 0.541 ' HA ' HD12 ' B' 1080 ' ' ILE . 1.3 m-20 -69.16 -23.63 63.97 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 118.711 2.856 . . . . 51.59 118.711 -160.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -66.27 -51.36 58.28 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 112.835 -1.984 . . . . 42.36 110.553 166.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1079 ' ' GLU . . . . . 0.419 ' HA ' HD12 ' B' 1082 ' ' LEU . 58.6 mt-10 -55.62 -37.35 68.04 Favored 'General case' 0 C--O 1.249 1.042 0 O-C-N 120.667 -1.271 . . . . 34.53 109.116 173.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1080 ' ' ILE . . . . . 0.612 HD11 HD12 ' B' 1101 ' ' LEU . 73.1 mt -59.28 -50.43 79.86 Favored 'Isoleucine or valine' 0 C--N 1.356 0.891 0 C-N-CA 123.666 0.786 . . . . 33.25 110.355 173.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -63.45 -15.14 56.82 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 118.544 -0.741 . . . . 36.47 112.837 174.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1082 ' ' LEU . . . . . 0.419 HD12 ' HA ' ' B' 1079 ' ' GLU . 41.3 mt -86.45 -24.31 25.68 Favored 'General case' 0 C--N 1.353 0.728 0 CA-C-N 120.466 1.485 . . . . 37.76 113.553 171.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1083 ' ' LEU . . . . . 0.674 ' HB3' HG11 ' B' 1110 ' ' VAL . 12.7 mt -55.2 123.99 15.51 Favored 'General case' 0 C--O 1.25 1.125 0 N-CA-C 115.629 1.714 . . . . 37.43 115.629 -178.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.09 129.35 56.37 Favored Pre-proline 0 N--CA 1.439 -0.991 0 CA-C-N 114.797 -1.092 . . . . 37.7 110.891 -172.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -58.63 123.07 12.75 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 124.55 3.5 . . . . 35.51 109.11 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 115.36 -60.49 0.4 Allowed Glycine 0 C--O 1.244 0.771 0 O-C-N 126.955 2.659 . . . . 33.87 108.097 -172.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1087 ' ' THR . . . . . . . . . . . . . 97.9 m -41.57 130.97 3.09 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 126.757 2.023 . . . . 32.5 116.059 -165.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1088 ' ' THR . . . . . 0.682 ' HA ' ' HB ' ' B' 1111 ' ' THR . 10.0 m -73.68 106.75 5.57 Favored 'General case' 0 C--O 1.216 -0.7 0 N-CA-C 107.306 -1.368 . . . . 30.22 107.306 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1089 ' ' LEU . . . . . 0.476 HD13 HD21 ' B' 1083 ' ' LEU . 20.7 tp -96.91 133.05 42.05 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 103.38 -2.822 . . . . 27.24 103.38 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1090 ' ' VAL . . . . . 0.6 HG13 ' HB2' ' B' 1113 ' ' MET . 15.1 t -134.48 109.93 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 106.889 -1.523 . . . . 25.39 106.889 -174.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1091 ' ' SER . . . . . . . . . . . . . 2.6 m -159.23 168.92 25.28 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.84 0.829 . . . . 28.81 112.127 -166.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1092 ' ' PHE . . . . . 0.536 ' CD1' ' HB3' ' B' 1116 ' ' ASP . 19.9 m-85 -66.1 107.41 1.91 Allowed 'General case' 0 C--O 1.247 0.973 0 CA-C-O 124.42 2.057 . . . . 30.78 110.933 161.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 45.3 mm -103.53 -37.84 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 O-C-N 120.172 -1.58 . . . . 30.28 110.552 -176.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1094 ' ' TRP . . . . . 0.589 ' HB2' ' ND2' ' B' 1098 ' ' ASN . 58.8 m95 53.57 54.79 12.61 Favored Pre-proline 0 C--O 1.249 1.078 0 O-C-N 124.456 1.098 . . . . 34.07 110.342 -174.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1095 ' ' PRO . . . . . 0.458 ' HG2' HG11 ' B' 1360 ' ' VAL . 71.1 Cg_exo -39.6 -60.65 0.51 Allowed 'Trans proline' 0 C--N 1.355 0.872 1 C-N-CA 126.5 4.8 . . . . 38.66 118.433 -167.046 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -62.94 -28.27 69.95 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 119.287 -2.133 . . . . 41.32 112.838 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -82.65 -22.11 34.77 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 122.543 1.163 . . . . 51.66 112.578 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1098 ' ' ASN . . . . . 0.589 ' ND2' ' HB2' ' B' 1094 ' ' TRP . 48.4 m-80 -119.09 58.41 4.01 Favored Pre-proline 0 N--CA 1.447 -0.62 0 N-CA-C 115.511 1.671 . . . . 40.32 115.511 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -57.16 -43.15 55.78 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.561 3.507 . . . . 41.56 111.593 -173.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -76.51 -32.74 58.47 Favored 'General case' 0 C--O 1.208 -1.091 0 N-CA-C 113.139 0.792 . . . . 54.11 113.139 -174.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1101 ' ' LEU . . . . . 0.612 HD12 HD11 ' B' 1080 ' ' ILE . 26.6 tp -61.59 -47.99 82.98 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 107.693 -1.225 . . . . 37.88 107.693 174.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1102 ' ' MET . . . . . . . . . . . . . 69.2 mmm -47.61 -55.15 9.93 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 125.601 1.813 . . . . 37.54 111.154 173.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -55.98 -45.46 78.95 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-O 118.487 -0.768 . . . . 47.01 111.527 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1104 ' ' LYS . . . . . . . . . . . . . 88.9 mttt -61.82 -36.99 82.77 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 124.544 2.116 . . . . 48.68 114.146 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1105 ' ' LEU . . . . . . . . . . . . . 43.6 mt -74.63 -32.82 62.41 Favored 'General case' 0 C--O 1.247 0.931 0 O-C-N 119.614 -1.929 . . . . 32.21 110.03 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -67.69 -43.6 79.74 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.392 0.677 . . . . 33.73 111.177 175.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -59.45 -41.28 89.3 Favored 'General case' 0 C--O 1.25 1.101 0 N-CA-C 115.128 1.529 . . . . 51.47 115.128 169.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1108 ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -71.38 -3.83 22.93 Favored 'General case' 0 C--N 1.345 0.407 0 N-CA-C 113.693 0.997 . . . . 43.9 113.693 170.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1109 ' ' ASN . . . . . . . . . . . . . 8.1 m-80 59.03 32.57 22.35 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.835 1.791 . . . . 44.82 115.835 167.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1110 ' ' VAL . . . . . 0.674 HG11 ' HB3' ' B' 1083 ' ' LEU . 5.8 m -94.92 150.82 3.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-N 114.516 -1.22 . . . . 30.52 109.794 -174.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1111 ' ' THR . . . . . 0.682 ' HB ' ' HA ' ' B' 1088 ' ' THR . 29.9 m -83.16 86.06 7.09 Favored 'General case' 0 C--O 1.247 0.958 0 CA-C-O 122.126 0.965 . . . . 27.12 110.517 178.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1112 ' ' VAL . . . . . 0.405 ' CG2' HG23 ' B' 1110 ' ' VAL . 6.7 t -86.21 130.72 36.12 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 CA-C-O 121.986 0.898 . . . . 26.4 109.192 -169.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1113 ' ' MET . . . . . 0.6 ' HB2' HG13 ' B' 1090 ' ' VAL . 10.8 mtt -120.19 124.71 46.39 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 102.651 -3.092 . . . . 42.92 102.651 175.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -90.65 96.61 10.73 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 113.703 -1.59 . . . . 24.15 113.888 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1115 ' ' MET . . . . . 0.454 ' CG ' HG12 ' B' 1090 ' ' VAL . 78.9 mmm -56.03 -25.54 45.09 Favored 'General case' 0 C--O 1.22 -0.451 0 N-CA-C 115.479 1.659 . . . . 29.95 115.479 -178.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1116 ' ' ASP . . . . . 0.536 ' HB3' ' CD1' ' B' 1092 ' ' PHE . 10.6 p-10 -80.14 -37.14 34.12 Favored 'General case' 0 N--CA 1.439 -0.984 0 O-C-N 121.521 -0.737 . . . . 34.53 109.647 174.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1117 ' ' SER . . . . . . . . . . . . . 57.0 m -102.52 48.16 0.87 Allowed 'General case' 0 C--N 1.355 0.823 0 O-C-N 120.167 -1.583 . . . . 33.49 108.824 -168.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1118 ' ' VAL . . . . . 0.572 HG21 ' HA ' ' B' 1128 ' ' ASP . 54.5 t -81.63 124.08 80.15 Favored Pre-proline 0 N--CA 1.48 1.048 0 N-CA-C 102.357 -3.201 . . . . 34.02 102.357 176.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1119 ' ' PRO . . . . . 0.432 ' HG2' ' HA3' ' B' 1357 ' ' GLY . 90.7 Cg_exo -58.06 103.14 0.14 Allowed 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 124.904 3.736 . . . . 38.28 110.842 -173.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1120 ' ' ARG . . . . . 0.427 ' HB3' ' H4D' ' B' ' 1' ' ' NAD . 13.6 mtm-85 -72.55 71.84 0.98 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 120.338 3.459 . . . . 55.05 120.338 -159.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1121 ' ' ILE . . . . . . . . . . . . . 44.5 pt -104.48 -161.11 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.815 0 N-CA-C 104.641 -2.355 . . . . 42.09 104.641 171.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1122 ' ' SER . . . . . . . . . . . . . 31.4 m -74.56 -48.27 27.81 Favored 'General case' 0 N--CA 1.434 -1.259 0 O-C-N 118.12 -2.862 . . . . 38.02 118.226 -173.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1123 ' ' ARG . . . . . 0.732 ' HD2' HD21 ' B' 1337 ' ' LEU . 10.2 ptt180 -74.71 -21.38 59.41 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 124.305 3.23 . . . . 34.29 114.125 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1124 ' ' ALA . . . . . . . . . . . . . . . -54.46 -48.92 71.21 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 109.182 -3.644 . . . . 32.35 109.759 170.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1125 ' ' GLN . . . . . 0.418 ' HA ' ' HB3' ' B' 1128 ' ' ASP . 16.2 mm-40 -54.75 -38.12 66.78 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 114.42 1.267 . . . . 47.17 114.42 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1126 ' ' SER . . . . . . . . . . . . . 73.9 m -57.03 -36.03 69.98 Favored 'General case' 0 C--O 1.248 1.0 0 CA-C-N 121.088 1.767 . . . . 31.71 114.093 170.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1127 ' ' LEU . . . . . 0.655 HD11 HD13 ' B' 1337 ' ' LEU . 8.4 mp -87.82 -23.77 23.92 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 114.946 -1.025 . . . . 37.0 112.982 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1128 ' ' ASP . . . . . 0.572 ' HA ' HG21 ' B' 1118 ' ' VAL . 12.5 t70 -78.93 118.77 21.26 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-O 123.434 1.587 . . . . 40.4 112.549 -170.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1129 ' ' ALA . . . . . 0.435 ' HB2' ' HB3' ' B' 1115 ' ' MET . . . -62.32 -36.55 82.53 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 110.44 -3.073 . . . . 26.56 111.793 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 39.6 mt -63.09 -23.73 67.58 Favored 'General case' 0 C--O 1.248 0.976 0 CA-C-O 116.512 -1.708 . . . . 30.89 112.251 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1131 ' ' SER . . . . . . . . . . . . . 86.0 p -65.84 -57.5 7.79 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 122.611 2.46 . . . . 29.84 107.932 177.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1132 ' ' SER . . . . . . . . . . . . . 73.4 m -60.74 -43.24 98.19 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.259 -1.337 . . . . 31.91 111.223 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1133 ' ' MET . . . . . 0.509 ' HB3' ' HB3' ' B' 1316 ' ' PRO . 31.2 mmt -60.56 -37.98 83.04 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 115.504 1.668 . . . . 25.9 115.504 174.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1134 ' ' ALA . . . . . 0.76 ' HB1' ' HB2' ' B' 1176 ' ' ALA . . . -68.77 -41.75 78.39 Favored 'General case' 0 C--N 1.352 0.679 0 C-N-CA 119.929 -0.708 . . . . 26.62 109.182 174.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.27 -38.82 90.8 Favored 'General case' 0 C--O 1.206 -1.195 0 C-N-CA 125.076 1.35 . . . . 36.97 109.997 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1136 ' ' ILE . . . . . 0.602 HD13 ' HE1' ' A' 1152 ' ' PHE . 15.0 mm -58.7 -55.4 23.21 Favored 'Isoleucine or valine' 0 C--N 1.352 0.695 0 N-CA-C 106.337 -1.727 . . . . 32.11 106.337 172.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1137 ' ' ALA . . . . . 0.463 ' HA ' ' HB3' ' B' 1140 ' ' ARG . . . -61.95 -25.79 67.81 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 116.019 1.859 . . . . 24.14 116.019 178.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -65.5 -57.83 10.58 Favored Glycine 0 N--CA 1.466 0.699 0 CA-C-N 120.982 1.719 . . . . 25.13 110.28 174.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 77.9 t80 -53.55 -43.8 68.74 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 123.663 1.697 . . . . 32.73 110.534 172.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1140 ' ' ARG . . . . . 0.463 ' HB3' ' HA ' ' B' 1137 ' ' ALA . 9.1 tpt180 -70.61 -25.95 63.28 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 113.78 -1.555 . . . . 26.36 110.492 -174.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1141 ' ' ALA . . . . . 0.405 ' HA ' HG11 ' B' 1282 ' ' VAL . . . -62.89 -49.63 74.05 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 120.661 1.573 . . . . 24.12 107.978 172.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 32.5 mm -56.94 -43.89 81.46 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 CA-C-O 118.697 -0.668 . . . . 23.37 110.801 175.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 70.4 t -68.1 -59.26 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 N-CA-C 112.573 0.582 . . . . 24.96 112.573 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1144 ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' B' 1147 ' ' HIS . 67.4 mm-40 -60.1 -35.83 76.08 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 119.145 -0.455 . . . . 32.07 110.306 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1145 ' ' ALA . . . . . 0.558 ' HB1' HD12 ' B' 1251 ' ' ILE . . . -51.74 -60.32 3.3 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 119.145 0.884 . . . . 24.87 111.365 167.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1146 ' ' ALA . . . . . 0.559 ' HB2' ' HE1' ' B' 1153 ' ' PHE . . . -58.53 -22.94 57.01 Favored 'General case' 0 C--N 1.348 0.506 0 N-CA-C 114.663 1.357 . . . . 24.67 114.663 177.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1147 ' ' HIS . . . . . 0.465 ' HB3' ' O ' ' B' 1144 ' ' GLU . 26.8 t60 -63.15 -43.94 96.92 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 120.84 -1.163 . . . . 28.58 108.97 171.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1148 ' ' GLU . . . . . 0.588 ' HG3' HD13 ' B' 1300 ' ' ILE . 69.7 mm-40 -107.07 3.92 26.39 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 116.996 2.221 . . . . 36.82 116.996 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1149 ' ' PHE . . . . . 0.404 ' HE2' ' HB2' ' B' 1166 ' ' ALA . 1.1 t80 -71.53 140.69 49.99 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-O 124.733 2.206 . . . . 31.97 107.015 -178.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1150 ' ' GLY . . . . . . . . . . . . . . . -71.29 -42.17 57.84 Favored Glycine 0 N--CA 1.42 -2.423 0 CA-C-N 111.079 -2.782 . . . . 25.49 110.858 170.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1151 ' ' ARG . . . . . 0.622 ' HA ' ' HB2' ' A' 1322 ' ' GLN . 58.7 mtm-85 -110.58 179.36 4.09 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 123.961 3.881 . . . . 59.84 113.46 -168.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1152 ' ' PHE . . . . . 0.516 ' HB2' HG11 ' B' 1163 ' ' VAL . 12.1 m-30 -72.9 163.52 28.03 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 120.147 -1.596 . . . . 34.45 109.383 167.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1153 ' ' PHE . . . . . 0.559 ' HE1' ' HB2' ' B' 1146 ' ' ALA . 17.2 m-85 -82.24 -51.7 7.67 Favored 'General case' 0 C--O 1.257 1.484 0 N-CA-C 107.586 -1.265 . . . . 31.17 107.586 166.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1154 ' ' THR . . . . . . . . . . . . . 45.5 m -65.55 127.98 34.06 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 113.02 -1.9 . . . . 33.89 109.724 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -78.86 72.22 2.47 Favored Glycine 0 C--O 1.251 1.217 0 N-CA-C 109.247 -1.541 . . . . 38.95 109.247 172.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -85.03 131.75 34.42 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 103.983 -2.599 . . . . 54.23 103.983 -176.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 24.7 mm -84.16 93.54 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 N-CA-C 100.719 -3.808 . . . . 51.16 100.719 173.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1158 ' ' THR . . . . . . . . . . . . . 26.0 m -81.33 166.52 20.4 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.083 -1.08 . . . . 49.61 108.083 -170.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -51.09 -58.32 6.4 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 117.403 -1.285 . . . . 49.05 112.769 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1160 ' ' ALA . . . . . 0.531 ' HB3' HD22 ' A' 1326 ' ' LEU . . . -44.3 -53.12 7.0 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 116.984 2.216 . . . . 47.65 116.984 170.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1161 ' ' GLY . . . . . 0.599 ' HA3' HG21 ' A' 1329 ' ' THR . . . -177.96 -177.05 46.44 Favored Glycine 0 N--CA 1.426 -1.974 0 N-CA-C 109.103 -1.599 . . . . 45.61 109.103 -174.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 87.8 mttt -75.24 138.21 41.75 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.181 -1.009 . . . . 57.46 108.538 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1163 ' ' VAL . . . . . 0.516 HG11 ' HB2' ' B' 1152 ' ' PHE . 45.7 t -91.34 125.85 56.72 Favored Pre-proline 0 CA--C 1.511 -0.529 0 O-C-N 121.395 -0.816 . . . . 42.93 109.322 170.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1164 ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' B' 1165 ' ' PRO . 49.7 Cg_exo -66.22 122.06 9.49 Favored 'Trans proline' 0 C--O 1.26 1.587 0 C-N-CA 123.917 3.078 . . . . 39.29 106.029 158.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1165 ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' B' 1164 ' ' PRO . 31.3 Cg_exo -76.61 168.24 24.03 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.876 3.717 . . . . 34.17 114.091 -174.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1166 ' ' ALA . . . . . 0.426 ' HB2' ' HA ' ' B' 1153 ' ' PHE . . . -76.5 123.49 26.12 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 114.309 -1.314 . . . . 31.69 112.633 170.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1167 ' ' LYS . . . . . 0.718 ' HB2' ' HA ' ' B' 1249 ' ' VAL . 70.7 mttt -92.4 107.56 19.31 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 125.228 2.442 . . . . 44.78 110.495 165.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 40.2 t -91.76 94.68 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 113.902 -1.499 . . . . 31.23 109.314 -171.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1169 ' ' MET . . . . . 0.644 ' HB2' HG11 ' B' 1249 ' ' VAL . 40.6 ttp -88.99 96.36 10.7 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 123.415 1.579 . . . . 37.09 107.167 -177.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1170 ' ' VAL . . . . . 0.46 ' HA ' ' HB ' ' B' 1253 ' ' VAL . 38.8 t -83.75 114.78 24.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 113.242 -1.799 . . . . 30.17 107.974 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1171 ' ' ILE . . . . . 0.464 ' CD1' HD11 ' B' 1267 ' ' ILE . 78.9 mt -104.23 114.65 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 106.943 -1.502 . . . . 33.74 106.943 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 94.74 66.09 1.0 Allowed Glycine 0 N--CA 1.421 -2.313 0 N-CA-C 108.504 -1.839 . . . . 32.59 108.504 -177.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1173 ' ' ALA . . . . . 0.583 ' H ' ' HB2' ' B' 1195 ' ' ASP . . . -59.05 -9.03 1.68 Allowed 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 116.638 2.088 . . . . 32.42 116.638 -177.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -61.53 128.68 43.9 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 115.122 0.809 . . . . 31.74 115.122 173.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 22.4 t 56.19 -82.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 127.453 2.301 . . . . 31.48 111.407 170.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1176 ' ' ALA . . . . . 0.76 ' HB2' ' HB1' ' B' 1134 ' ' ALA . . . -65.53 -42.93 91.44 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.7 -1.222 . . . . 26.12 107.7 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1177 ' ' GLY . . . . . 0.502 ' O ' HG13 ' B' 1181 ' ' ILE . . . -52.71 -52.79 36.24 Favored Glycine 0 N--CA 1.43 -1.763 0 CA-C-N 118.665 0.666 . . . . 25.73 113.2 172.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1178 ' ' LEU . . . . . 0.524 ' HB3' ' HD2' ' C' ' 76' ' ' PRO . 96.6 mt -53.3 -46.67 69.44 Favored 'General case' 0 C--O 1.241 0.65 0 O-C-N 120.79 -1.418 . . . . 32.59 113.858 173.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -61.82 -40.17 94.34 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 120.23 -0.588 . . . . 27.72 111.365 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -66.34 -38.32 87.38 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 120.686 1.585 . . . . 26.03 108.907 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1181 ' ' ILE . . . . . 0.735 HG23 HG11 ' B' 1191 ' ' VAL . 70.9 mt -65.27 -47.16 88.36 Favored 'Isoleucine or valine' 0 C--N 1.36 1.033 0 O-C-N 125.347 1.654 . . . . 28.61 110.229 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -52.5 -55.24 23.47 Favored Glycine 0 N--CA 1.435 -1.374 0 C-N-CA 125.792 1.663 . . . . 25.23 111.376 174.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -61.96 -51.8 66.62 Favored 'General case' 0 C--O 1.251 1.166 0 C-N-CA 123.346 0.659 . . . . 24.09 111.425 -174.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -62.52 -41.09 98.63 Favored 'General case' 0 C--O 1.247 0.948 0 O-C-N 123.75 0.657 . . . . 26.68 111.123 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -63.31 -37.93 89.18 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 120.13 -1.606 . . . . 36.57 113.009 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1186 ' ' SER . . . . . . . . . . . . . 73.2 m -57.85 -49.83 75.37 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-O 122.804 1.287 . . . . 28.92 110.15 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1187 ' ' LEU . . . . . 0.817 ' HA ' ' HB3' ' A' 1186 ' ' SER . 12.6 mt -62.11 -21.89 65.36 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 118.192 2.664 . . . . 29.09 118.192 169.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 75.02 35.38 49.95 Favored Glycine 0 N--CA 1.433 -1.53 0 N-CA-C 109.053 -1.619 . . . . 29.26 109.053 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1189 ' ' ALA . . . . . . . . . . . . . . . -81.46 151.02 28.05 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.098 -1.816 . . . . 30.16 106.098 167.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1190 ' ' ILE . . . . . 0.458 ' HB ' ' HG2' ' B' 1167 ' ' LYS . 73.8 mt -78.74 97.49 2.35 Favored 'Isoleucine or valine' 0 C--O 1.246 0.914 0 N-CA-C 106.603 -1.629 . . . . 35.81 106.603 -174.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1191 ' ' VAL . . . . . 0.735 HG11 HG23 ' B' 1181 ' ' ILE . 57.7 t -79.94 136.75 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-N 115.408 -0.815 . . . . 31.97 109.102 -178.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1192 ' ' ARG . . . . . 0.69 ' HG2' ' HB2' ' B' 1210 ' ' GLU . 89.7 mtt180 -131.9 127.27 36.1 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 104.426 -2.435 . . . . 48.16 104.426 167.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -134.64 158.21 44.63 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 124.084 1.897 . . . . 35.89 115.618 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1194 ' ' PHE . . . . . 0.446 ' HB2' HD12 ' B' 1212 ' ' LEU . 35.5 t80 -139.28 132.98 30.63 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 114.029 -1.441 . . . . 41.88 107.167 -171.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1195 ' ' ASP . . . . . 0.829 ' HB3' HG21 ' B' 1200 ' ' VAL . 10.0 t70 -159.08 152.44 22.6 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 106.448 -1.686 . . . . 38.28 106.448 167.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1196 ' ' THR . . . . . . . . . . . . . 2.2 p -63.01 -44.3 96.37 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 113.997 1.11 . . . . 40.62 113.997 -177.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1197 ' ' ARG . . . . . 0.418 ' O ' HG22 ' B' 1200 ' ' VAL . 28.4 mtm180 -74.09 125.99 89.62 Favored Pre-proline 0 C--O 1.252 1.195 0 C-N-CA 119.67 -0.812 . . . . 53.09 111.711 -168.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -44.23 -33.79 6.32 Favored 'Trans proline' 0 C--O 1.248 0.984 1 C-N-CA 125.724 4.283 . . . . 42.56 118.219 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -54.05 -30.07 46.45 Favored 'General case' 0 C--N 1.347 0.479 0 N-CA-C 116.929 2.196 . . . . 56.31 116.929 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1200 ' ' VAL . . . . . 0.829 HG21 ' HB3' ' B' 1195 ' ' ASP . 6.4 m -71.82 -29.47 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 O-C-N 124.554 1.159 . . . . 42.91 110.196 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 34.9 tttm -54.58 -48.14 72.47 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 125.714 1.884 . . . . 48.89 113.6 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.93 -48.87 77.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 117.658 -1.163 . . . . 51.7 108.869 175.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1203 ' ' GLN . . . . . 0.846 ' HG2' ' HG3' ' C' ' 74' ' ' ARG . 54.5 mt-30 -58.89 -46.37 88.02 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 125.225 1.578 . . . . 52.57 113.978 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1204 ' ' VAL . . . . . 0.445 ' O ' ' HB3' ' B' 1209 ' ' ALA . 48.5 t -62.52 -46.48 96.29 Favored 'Isoleucine or valine' 0 C--O 1.257 1.498 0 CA-C-N 120.429 1.468 . . . . 33.79 107.744 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -54.85 -38.77 67.86 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.563 1.145 . . . . 36.58 114.025 173.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1206 ' ' SER . . . . . . . . . . . . . 12.0 m -63.38 -37.03 85.68 Favored 'General case' 0 C--N 1.347 0.482 0 O-C-N 121.171 -0.955 . . . . 39.61 110.215 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1207 ' ' MET . . . . . 0.534 ' SD ' HD22 ' C' ' 75' ' ' LEU . 4.9 mtt -87.63 28.34 1.01 Allowed 'General case' 0 C--O 1.248 1.013 0 O-C-N 117.659 -3.151 . . . . 37.45 113.906 -175.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 55.45 30.57 55.85 Favored Glycine 0 CA--C 1.538 1.516 0 O-C-N 120.589 -1.319 . . . . 31.87 113.737 -176.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1209 ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' B' 1204 ' ' VAL . . . -119.04 142.01 48.22 Favored 'General case' 0 N--CA 1.428 -1.541 0 O-C-N 119.582 -2.128 . . . . 35.4 108.87 -164.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1210 ' ' GLU . . . . . 0.69 ' HB2' ' HG2' ' B' 1192 ' ' ARG . 34.5 mt-10 -80.61 129.08 34.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 118.694 -1.202 . . . . 47.89 108.846 -176.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 45.5 t80 -90.09 132.7 35.28 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 101.473 -3.529 . . . . 45.53 101.473 178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1212 ' ' LEU . . . . . 0.446 HD12 ' HB2' ' B' 1194 ' ' PHE . 63.4 mt -84.73 121.58 27.89 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 103.689 -2.708 . . . . 46.33 103.689 173.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -68.81 147.94 51.02 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 115.496 1.665 . . . . 60.41 115.496 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 21.5 mt -66.6 140.64 57.96 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 112.588 -2.096 . . . . 57.38 107.002 167.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1215 ' ' ASP . . . . . 0.43 ' H ' ' HE1' ' B' 1234 ' ' PHE . 23.4 t70 . . . . . 0 N--CA 1.433 -1.325 0 N-CA-C 107.472 -1.307 . . . . 65.07 107.472 177.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1230 ' ' MET . . . . . 0.417 ' HB3' ' CB ' ' B' 1234 ' ' PHE . 5.4 mmm . . . . . 0 N--CA 1.433 -1.319 0 N-CA-C 104.705 -2.331 . . . . 80.32 104.705 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1231 ' ' SER . . . . . . . . . . . . . 2.6 m 78.84 -173.11 0.06 Allowed 'General case' 0 CA--C 1.539 0.542 2 O-C-N 111.99 -6.694 . . . . 79.92 118.805 -17.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1232 ' ' ASP . . . . . 0.544 ' HA ' HG12 ' B' 1235 ' ' ILE . 23.8 p-10 -43.25 154.99 0.07 Allowed 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 119.203 3.038 . . . . 77.91 119.203 -177.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 62.97 -59.19 0.15 Allowed 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 112.253 -2.248 . . . . 73.88 109.439 -159.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1234 ' ' PHE . . . . . 0.43 ' HE1' ' H ' ' B' 1215 ' ' ASP . 8.3 t80 -55.76 -44.78 77.99 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 120.044 -1.66 . . . . 68.98 113.765 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1235 ' ' ILE . . . . . 0.544 HG12 ' HA ' ' B' 1232 ' ' ASP . 8.0 pt -44.6 -38.88 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 121.772 2.078 . . . . 64.53 112.754 175.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1236 ' ' LYS . . . . . 0.489 ' HG2' HG13 ' B' 1235 ' ' ILE . 23.7 mmmt -75.83 -38.03 58.48 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 118.055 -0.974 . . . . 66.36 109.627 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -65.22 -26.22 68.03 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 120.91 1.687 . . . . 56.6 113.243 175.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -66.45 -47.99 71.4 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 106.786 -1.561 . . . . 56.79 106.786 175.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1239 ' ' MET . . . . . 0.474 ' HB2' ' O ' ' B' 1236 ' ' LYS . 19.6 mmm -49.84 -49.18 50.06 Favored 'General case' 0 C--O 1.25 1.087 0 O-C-N 124.528 1.143 . . . . 53.63 111.666 171.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.76 -37.06 85.3 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 121.243 0.544 . . . . 51.74 110.817 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1241 ' ' LEU . . . . . 0.437 HD21 ' HB3' ' B' 1212 ' ' LEU . 60.3 tp -64.78 -47.94 76.31 Favored 'General case' 0 C--N 1.342 0.25 0 O-C-N 120.555 -1.34 . . . . 44.86 107.57 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1242 ' ' PHE . . . . . 0.604 ' HE2' HD13 ' B' 1266 ' ' LEU . 14.8 m-30 -65.88 -34.06 77.26 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 124.546 1.138 . . . . 42.78 111.26 -174.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1243 ' ' ALA . . . . . 0.441 ' HA ' ' HG3' ' B' 1271 ' ' MET . . . -67.14 -51.3 55.61 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 113.929 1.085 . . . . 40.96 113.929 172.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -69.59 -28.92 66.36 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 122.492 1.139 . . . . 43.06 108.763 -173.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1245 ' ' GLN . . . . . 0.4 ' O ' HG22 ' B' 1249 ' ' VAL . 43.3 mm-40 -75.53 -37.27 60.18 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.369 -1.457 . . . . 46.45 112.608 171.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1246 ' ' ALA . . . . . 0.485 ' HA ' HG22 ' B' 1249 ' ' VAL . . . -60.67 -23.42 64.81 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 115.284 1.587 . . . . 41.78 115.284 177.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1247 ' ' LYS . . . . . 0.404 ' HD2' ' HA ' ' B' 1247 ' ' LYS . 26.0 tptt -62.44 -41.85 99.04 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.196 -0.911 . . . . 52.2 109.42 171.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1248 ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -91.26 -30.8 16.41 Favored 'General case' 0 C--O 1.244 0.808 0 O-C-N 121.586 -0.696 . . . . 53.55 112.705 -172.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1249 ' ' VAL . . . . . 0.718 ' HA ' ' HB2' ' B' 1167 ' ' LYS . 19.1 m -84.2 169.43 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 124.684 2.183 . . . . 34.41 114.808 -173.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1250 ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -111.99 -61.89 1.65 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 111.635 -2.53 . . . . 33.38 111.573 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1251 ' ' ILE . . . . . 0.582 ' HA ' ' O ' ' B' 1280 ' ' VAL . 48.5 mm -107.24 106.69 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 123.839 0.712 . . . . 29.54 109.097 -173.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1252 ' ' ILE . . . . . 0.634 ' HB ' HG12 ' B' 1281 ' ' ILE . 51.1 mt -92.41 118.5 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 N-CA-C 105.086 -2.19 . . . . 32.44 105.086 176.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1253 ' ' VAL . . . . . 0.46 ' HB ' ' HA ' ' B' 1170 ' ' VAL . 72.2 t -102.32 87.29 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.254 1.339 0 N-CA-C 104.634 -2.358 . . . . 30.57 104.634 -178.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1254 ' ' THR . . . . . . . . . . . . 0.331 1.4 t -91.3 103.53 16.18 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 127.096 3.331 . . . . 35.04 112.739 -175.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1255 ' ' THR . . . . . . . . . . . . . 17.1 m -99.7 -26.89 13.91 Favored 'General case' 0 C--N 1.318 -0.797 1 CA-C-N 106.0 -5.091 . . . . 34.62 109.451 -177.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1256 ' ' ALA . . . . . 0.495 ' HB3' ' ND2' ' B' 1291 ' ' ASN . . . -47.79 96.65 0.01 OUTLIER 'General case' 0 C--O 1.257 1.475 0 CA-C-N 123.499 2.863 . . . . 42.72 117.74 -169.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1257 ' ' LEU . . . . . 0.431 HD11 ' HB3' ' B' 1288 ' ' ASN . 3.7 tt -133.9 146.0 50.14 Favored 'General case' 0 C--O 1.251 1.156 0 N-CA-C 101.845 -3.391 . . . . 52.43 101.845 -173.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 64.4 mt -119.08 122.14 29.82 Favored Pre-proline 0 C--N 1.313 -1.002 1 N-CA-C 100.102 -4.036 . . . . 59.41 100.102 177.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -56.0 126.73 23.35 Favored 'Trans proline' 0 C--O 1.247 0.955 0 C-N-CA 123.441 2.76 . . . . 62.68 115.659 -173.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 82.26 2.0 90.5 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 112.955 -1.929 . . . . 64.16 111.366 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 85.3 mttt -120.39 145.79 41.36 Favored Pre-proline 0 N--CA 1.475 0.801 0 O-C-N 118.474 -2.78 . . . . 68.53 105.181 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -56.19 136.56 75.85 Favored 'Trans proline' 0 C--N 1.362 1.273 0 C-N-CA 123.899 3.066 . . . . 61.99 112.077 164.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1263 ' ' ALA . . . . . 0.549 ' H ' ' HA3' ' B' 1289 ' ' GLY . . . -61.3 119.83 49.66 Favored Pre-proline 0 C--O 1.242 0.671 0 CA-C-N 113.024 -1.898 . . . . 57.15 112.28 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1264 ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' B' 1263 ' ' ALA . 94.6 Cg_endo -55.08 146.49 58.53 Favored 'Trans proline' 0 CA--C 1.501 -1.157 0 C-N-CA 124.718 3.612 . . . . 51.57 112.339 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -87.91 68.31 9.25 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 122.916 1.341 . . . . 54.55 109.342 -171.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1266 ' ' LEU . . . . . 0.604 HD13 ' HE2' ' B' 1242 ' ' PHE . 91.0 mt -81.03 -30.15 34.92 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 111.51 -2.586 . . . . 46.86 111.798 -172.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1267 ' ' ILE . . . . . 0.588 ' HB ' ' HA ' ' B' 1292 ' ' CYS . 28.3 mm -96.82 100.35 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 N-CA-C 104.665 -2.346 . . . . 41.04 104.665 177.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1268 ' ' THR . . . . . . . . . . . . . 1.1 p -75.03 151.42 38.73 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 125.486 1.741 . . . . 39.58 113.222 175.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1269 ' ' ARG . . . . . . . . . . . . . 78.1 mtt85 -57.65 -40.85 80.23 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-N 119.805 1.184 . . . . 53.15 111.5 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -54.61 -43.6 72.37 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 114.759 1.392 . . . . 42.96 114.759 169.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1271 ' ' MET . . . . . 0.441 ' HG3' ' HA ' ' B' 1243 ' ' ALA . 39.4 ttm -60.8 -47.95 84.0 Favored 'General case' 0 C--O 1.241 0.613 0 O-C-N 120.945 -1.097 . . . . 43.89 111.846 176.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1272 ' ' VAL . . . . . 0.474 HG13 HD12 ' B' 1281 ' ' ILE . 15.3 t -55.26 -52.4 45.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-N 115.091 -0.959 . . . . 38.37 110.113 175.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.94 2.24 7.25 Favored 'General case' 0 C--N 1.362 1.129 0 N-CA-C 115.039 1.496 . . . . 47.46 115.039 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1274 ' ' SER . . . . . . . . . . . . . 50.3 m -97.26 -14.58 21.29 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 114.79 1.404 . . . . 38.38 114.79 172.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1275 ' ' MET . . . . . 0.487 ' SD ' HD11 ' B' 1281 ' ' ILE . 94.1 mtp -64.14 171.27 3.08 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 116.484 2.031 . . . . 37.81 116.484 -177.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -66.63 147.21 53.58 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 114.28 -1.327 . . . . 49.26 109.723 165.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -79.1 161.47 26.49 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.859 0.837 . . . . 34.46 112.931 174.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 81.3 25.22 55.32 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 112.712 -2.04 . . . . 33.53 112.926 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1279 ' ' SER . . . . . . . . . . . . . 13.0 m -126.64 165.35 19.38 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 116.439 -1.743 . . . . 31.31 111.363 -163.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1280 ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' B' 1251 ' ' ILE . 73.8 t -136.7 136.89 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 124.165 3.166 . . . . 29.32 109.856 -171.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1281 ' ' ILE . . . . . 0.634 HG12 ' HB ' ' B' 1252 ' ' ILE . 76.0 mt -113.26 113.36 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 103.735 -2.691 . . . . 31.93 103.735 171.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1282 ' ' VAL . . . . . 0.405 HG11 ' HA ' ' B' 1141 ' ' ALA . 4.0 t -99.33 123.27 51.92 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 N-CA-C 106.408 -1.701 . . . . 29.48 106.408 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 18.2 t0 -93.69 108.76 20.46 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 114.797 -1.092 . . . . 34.5 109.013 174.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1284 ' ' LEU . . . . . 0.495 ' HA ' HD12 ' B' 1315 ' ' LEU . 7.9 mp -84.27 -37.28 21.92 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 104.621 -2.363 . . . . 37.94 104.621 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -80.57 8.23 8.3 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 122.497 1.141 . . . . 40.92 113.277 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1286 ' ' ALA . . . . . 0.551 ' HA ' ' HA2' ' B' 1290 ' ' GLY . . . -43.46 -47.0 7.03 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 117.839 2.533 . . . . 44.39 117.839 175.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1287 ' ' GLN . . . . . 0.443 ' HA ' HG22 ' B' 1313 ' ' THR . 0.6 OUTLIER -75.17 -30.09 60.61 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 112.931 0.715 . . . . 51.46 112.931 -175.332 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B 1288 ' ' ASN . . . . . 0.431 ' HB3' HD11 ' B' 1257 ' ' LEU . 0.5 OUTLIER -107.52 48.1 0.86 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 122.931 1.348 . . . . 57.75 108.559 178.748 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B 1289 ' ' GLY . . . . . 0.549 ' HA3' ' H ' ' B' 1263 ' ' ALA . . . 129.21 -29.43 3.88 Favored Glycine 0 N--CA 1.428 -1.883 0 O-C-N 119.46 -2.025 . . . . 49.85 116.381 169.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1290 ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' B' 1286 ' ' ALA . . . 76.88 100.79 0.16 Allowed Glycine 0 C--O 1.245 0.804 0 CA-C-N 119.111 1.456 . . . . 45.93 109.775 -176.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1291 ' ' ASN . . . . . 0.495 ' ND2' ' HB3' ' B' 1256 ' ' ALA . 22.8 t-20 -71.48 -39.99 70.53 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 119.406 -2.232 . . . . 42.67 113.647 175.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1292 ' ' CYS . . . . . 0.588 ' HA ' ' HB ' ' B' 1267 ' ' ILE . 36.1 t -83.4 150.69 25.9 Favored 'General case' 0 C--O 1.24 0.593 0 O-C-N 119.911 -1.743 . . . . 38.82 106.821 171.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1293 ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -75.39 -49.86 17.68 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 122.58 1.181 . . . . 46.71 109.251 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1294 ' ' TYR . . . . . 0.444 ' HB3' HG11 ' B' 1309 ' ' VAL . 0.1 OUTLIER -59.13 -18.29 34.44 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 115.655 1.724 . . . . 47.23 115.655 -174.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B 1295 ' ' THR . . . . . 0.515 ' O ' ' HD3' ' B' 1297 ' ' PRO . 97.0 m -37.69 105.17 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 115.64 1.719 . . . . 36.02 115.64 168.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 71.4 t -88.34 106.18 11.69 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 105.785 -1.931 . . . . 37.26 105.785 170.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1297 ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' B' 1295 ' ' THR . 60.5 Cg_exo -58.89 111.42 0.89 Allowed 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 123.241 2.627 . . . . 35.09 115.811 -177.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 95.55 10.69 56.58 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 113.307 -1.77 . . . . 35.97 111.059 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -148.01 -178.03 6.06 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 124.9 2.286 . . . . 40.39 110.046 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1300 ' ' ILE . . . . . 0.588 HD13 ' HG3' ' B' 1148 ' ' GLU . 30.3 mt -110.71 162.79 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 111.006 -2.815 . . . . 37.43 105.367 172.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 61.0 t80 -150.77 130.38 13.08 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 104.052 -2.573 . . . . 44.13 104.052 170.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1302 ' ' THR . . . . . . . . . . . . . 25.7 m -95.62 136.16 36.37 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.447 -0.945 . . . . 39.78 108.447 173.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1303 ' ' THR . . . . . . . . . . . . . 46.6 p -77.25 177.22 8.07 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.287 -1.324 . . . . 43.29 113.015 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -57.63 -59.02 5.82 Favored 'General case' 0 N--CA 1.435 -1.214 0 O-C-N 121.091 -1.006 . . . . 53.07 110.805 162.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -60.5 -22.75 63.89 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 113.759 1.022 . . . . 43.97 113.759 -174.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 108.62 47.42 0.91 Allowed Glycine 0 N--CA 1.432 -1.583 0 CA-C-O 122.57 1.094 . . . . 41.12 112.713 166.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1307 ' ' VAL . . . . . 0.435 HG21 ' HB2' ' B' 1275 ' ' MET . 95.1 t -122.95 128.16 75.06 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 N-CA-C 102.226 -3.25 . . . . 38.12 102.226 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1308 ' ' LYS . . . . . 0.477 ' HB2' HG22 ' B' 1280 ' ' VAL . 43.7 mmtt -83.53 109.02 17.04 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 103.013 -2.958 . . . . 36.34 103.013 176.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1309 ' ' VAL . . . . . 0.444 HG11 ' HB3' ' B' 1294 ' ' TYR . 44.9 t -88.1 113.44 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 O-C-N 117.288 -3.382 . . . . 30.4 103.284 168.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1310 ' ' ILE . . . . . 0.49 HG12 HG23 ' B' 1300 ' ' ILE . 19.2 mt -102.41 100.16 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-N 113.617 -1.629 . . . . 30.82 107.626 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1311 ' ' GLY . . . . . 0.494 ' HA3' HG23 ' B' 1295 ' ' THR . . . -97.57 53.59 1.29 Allowed Glycine 0 C--N 1.352 1.426 0 C-N-CA 119.084 -1.531 . . . . 26.53 110.704 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1312 ' ' TYR . . . . . 0.438 ' O ' ' HG ' ' B' 1315 ' ' LEU . 0.6 OUTLIER -74.88 94.37 2.79 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 120.759 -1.436 . . . . 38.0 108.745 -171.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B 1313 ' ' THR . . . . . 0.443 HG22 ' HA ' ' B' 1287 ' ' GLN . 0.7 OUTLIER -54.76 -35.33 63.65 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 121.077 -1.014 . . . . 29.8 112.24 174.551 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -75.1 4.28 7.08 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 126.758 2.023 . . . . 39.04 115.376 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1315 ' ' LEU . . . . . 0.495 HD12 ' HA ' ' B' 1284 ' ' LEU . 34.6 mt -43.9 -50.99 18.52 Favored Pre-proline 0 N--CA 1.465 0.301 0 N-CA-C 118.231 2.678 . . . . 31.08 118.231 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1316 ' ' PRO . . . . . 0.509 ' HB3' ' HB3' ' B' 1133 ' ' MET . 34.3 Cg_exo -56.84 -27.5 72.31 Favored 'Trans proline' 0 CA--C 1.546 1.094 0 C-N-CA 123.628 2.886 . . . . 26.1 115.315 174.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -82.06 -35.01 22.5 Favored Glycine 0 N--CA 1.435 -1.407 0 O-C-N 120.715 -1.24 . . . . 23.17 110.139 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -52.52 3.43 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.588 1 N-CA-C 123.437 4.606 . . . . 40.4 123.437 -171.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 21.3 tp -132.75 66.54 76.71 Favored Pre-proline 0 C--O 1.243 0.741 0 O-C-N 118.746 -2.471 . . . . 23.6 108.269 -175.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1320 ' ' PRO . . . . . 0.635 ' HG2' ' HA2' ' A' 1150 ' ' GLY . 19.1 Cg_endo -26.57 -71.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.053 1 C-N-CA 126.196 4.597 . . . . 22.35 118.72 -166.323 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B 1321 ' ' THR . . . . . 0.483 HG23 ' HD2' ' B' 1045 ' ' PHE . 3.3 m -67.48 -40.62 85.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 119.952 1.251 . . . . 26.52 108.995 -169.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1322 ' ' GLN . . . . . 0.803 ' HB2' ' HA ' ' A' 1151 ' ' ARG . 32.4 tp60 -79.11 -33.14 44.6 Favored 'General case' 0 CA--C 1.488 -1.41 0 O-C-N 120.66 -1.275 . . . . 24.38 110.882 -173.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1323 ' ' SER . . . . . . . . . . . . . 71.3 m -63.07 -47.5 82.66 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 109.184 -0.673 . . . . 22.8 109.184 176.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1324 ' ' SER . . . . . . . . . . . . . 22.0 m -58.32 -37.0 74.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 122.881 1.324 . . . . 21.25 114.248 175.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1325 ' ' GLN . . . . . 0.489 ' NE2' HG23 ' B' 1022 ' ' THR . 51.6 tp60 -65.03 -54.36 31.43 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.468 -1.242 . . . . 31.34 111.804 176.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1326 ' ' LEU . . . . . . . . . . . . . 23.8 mt -73.09 -40.4 65.03 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 117.688 -1.149 . . . . 31.56 110.944 -172.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1327 ' ' TYR . . . . . . . . . . . . . 42.5 t80 -57.94 -50.95 71.62 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 106.118 -1.808 . . . . 22.73 106.118 173.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1328 ' ' GLY . . . . . 0.717 ' HA3' HG21 ' B' 1022 ' ' THR . . . -52.36 -42.63 56.91 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 114.582 0.593 . . . . 21.91 114.582 174.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1329 ' ' THR . . . . . . . . . . . . . 5.5 m -71.94 -25.45 61.89 Favored 'General case' 0 C--O 1.249 1.057 0 O-C-N 120.52 -1.577 . . . . 22.15 111.936 176.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1330 ' ' ASN . . . . . 0.448 ' ND2' ' HB2' ' A' 1160 ' ' ALA . 24.7 m120 -62.56 -37.45 86.21 Favored 'General case' 0 C--O 1.249 1.04 0 CA-C-N 120.893 1.679 . . . . 26.18 110.58 170.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1331 ' ' LEU . . . . . 0.715 HD22 HD22 ' B' 1070 ' ' LEU . 59.1 mt -68.65 -44.0 75.07 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 113.859 -1.519 . . . . 23.68 109.977 176.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1332 ' ' VAL . . . . . 0.548 HG13 HD11 ' B' 1029 ' ' LEU . 69.9 t -53.4 -55.36 13.32 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 CA-C-O 116.846 -1.55 . . . . 26.57 108.139 174.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1333 ' ' ASN . . . . . 0.693 ' HA ' ' HD2' ' B' 1336 ' ' LYS . 84.4 m-20 -55.8 -40.29 72.52 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 115.459 1.652 . . . . 28.08 115.459 175.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1334 ' ' LEU . . . . . 0.457 ' CD2' HG11 ' B' 1090 ' ' VAL . 12.9 tp -56.54 -48.24 77.7 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 124.722 1.209 . . . . 27.43 111.357 169.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1335 ' ' LEU . . . . . 0.458 ' HA ' ' HB2' ' B' 1338 ' ' LEU . 7.2 mt -71.62 -22.32 61.72 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 119.92 -0.712 . . . . 30.5 111.648 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1336 ' ' LYS . . . . . 0.693 ' HD2' ' HA ' ' B' 1333 ' ' ASN . 97.0 mttt -67.01 -47.98 69.79 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.297 -1.001 . . . . 41.65 108.297 171.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1337 ' ' LEU . . . . . 0.732 HD21 ' HD2' ' B' 1123 ' ' ARG . 6.6 mp -71.21 -35.08 71.39 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 119.591 -1.943 . . . . 42.08 112.053 176.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1338 ' ' LEU . . . . . 0.458 ' HB2' ' HA ' ' B' 1335 ' ' LEU . 35.9 mt -69.78 -68.27 0.43 Allowed 'General case' 0 N--CA 1.438 -1.048 0 O-C-N 119.638 -1.914 . . . . 35.03 110.446 176.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1339 ' ' CYS . . . . . 0.515 ' SG ' ' HA ' ' B' 1342 ' ' LYS . 52.6 t -93.32 69.86 4.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.929 1.347 . . . . 37.33 108.595 -174.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 57.3 mttp -65.88 -27.81 68.49 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 114.193 1.183 . . . . 50.51 114.193 -175.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -71.44 -21.32 61.99 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 120.998 -1.064 . . . . 54.21 112.646 168.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1342 ' ' LYS . . . . . 0.515 ' HA ' ' SG ' ' B' 1339 ' ' CYS . 7.3 mptt 52.07 50.48 18.42 Favored 'General case' 0 C--O 1.252 1.199 0 CA-C-O 124.969 2.319 . . . . 50.99 111.575 -163.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -76.55 -33.24 58.54 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 111.264 -2.698 . . . . 48.82 111.274 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1344 ' ' GLY . . . . . 0.424 ' O ' ' HA2' ' B' 1001 ' ' GLY . . . 108.34 14.45 16.35 Favored Glycine 0 C--O 1.244 0.77 0 CA-C-O 117.748 -1.585 . . . . 40.43 112.194 174.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -131.09 156.47 45.16 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 104.835 -2.283 . . . . 47.56 104.835 166.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1346 ' ' ILE . . . . . 0.562 HG13 HG23 ' B' 1068 ' ' ILE . 26.2 mm -81.95 94.23 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 O-C-N 118.955 -2.34 . . . . 42.49 112.195 -172.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1347 ' ' THR . . . . . . . . . . . . . 88.1 m -59.21 105.31 0.32 Allowed 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 106.919 -1.511 . . . . 38.12 106.919 159.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 21.7 t -90.46 96.43 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 104.761 -2.311 . . . . 37.5 104.761 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 6.6 t70 -75.39 129.03 36.67 Favored 'General case' 0 C--O 1.265 1.891 0 CA-C-N 110.995 -2.821 . . . . 43.85 110.301 -175.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1350 ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -117.24 0.82 12.37 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.934 -1.104 . . . . 39.81 111.508 175.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 7.9 t70 -81.13 -43.86 18.77 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 119.236 0.926 . . . . 51.29 109.857 -175.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.2 145.13 51.64 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-O 122.105 0.955 . . . . 39.78 110.936 174.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1353 ' ' VAL . . . . . 0.467 ' HB ' HG13 ' B' 1373 ' ' ILE . 28.7 m -68.47 -36.67 75.75 Favored 'Isoleucine or valine' 0 C--O 1.25 1.131 0 CA-C-N 114.952 -1.022 . . . . 39.28 110.726 -173.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1354 ' ' VAL . . . . . 0.629 HG21 ' HG3' ' B' 1123 ' ' ARG . 49.7 t -70.41 -47.71 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 O-C-N 121.799 -0.563 . . . . 35.7 111.19 -172.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1355 ' ' ILE . . . . . 0.717 ' HA ' HG12 ' B' 1358 ' ' VAL . 38.7 mm -70.11 -41.52 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 O-C-N 121.398 -0.813 . . . . 35.77 109.797 176.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 47.3 tpt85 -47.63 -32.54 5.67 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 115.375 1.62 . . . . 38.55 115.375 169.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1357 ' ' GLY . . . . . 0.585 ' CA ' ' HB2' ' B' 1370 ' ' ALA . . . -91.94 -40.87 5.12 Favored Glycine 0 N--CA 1.442 -0.901 0 O-C-N 121.627 -0.67 . . . . 29.58 114.011 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1358 ' ' VAL . . . . . 0.717 HG12 ' HA ' ' B' 1355 ' ' ILE . 4.0 p -66.76 -36.42 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 114.454 1.279 . . . . 32.06 114.454 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1359 ' ' THR . . . . . . . . . . . . . 4.1 m -72.35 81.16 1.03 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 123.3 1.524 . . . . 29.0 107.205 175.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1360 ' ' VAL . . . . . 0.458 HG11 ' HG2' ' B' 1095 ' ' PRO . 14.6 m -63.24 -29.23 46.73 Favored 'Isoleucine or valine' 0 C--O 1.248 1.001 0 O-C-N 121.129 -0.982 . . . . 29.68 113.392 177.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 49.1 mt -138.3 108.6 4.83 Favored 'Isoleucine or valine' 0 C--O 1.249 1.058 0 N-CA-C 104.173 -2.529 . . . . 32.05 104.173 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1362 ' ' ARG . . . . . 0.664 ' HA ' HG23 ' B' 1111 ' ' THR . 57.1 ttt180 -91.5 105.08 17.5 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 117.99 -2.944 . . . . 32.52 107.396 169.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1363 ' ' ALA . . . . . 0.654 ' H ' ' HA ' ' B' 1111 ' ' THR . . . 45.45 58.82 3.94 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 116.91 2.189 . . . . 35.68 116.91 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 91.96 -47.27 2.7 Favored Glycine 0 CA--C 1.538 1.53 0 CA-C-O 118.017 -1.435 . . . . 34.26 112.646 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -68.32 115.31 7.62 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 123.265 1.507 . . . . 51.07 109.58 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 24.4 mt -74.76 95.8 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.981 0 CA-C-O 123.427 1.584 . . . . 39.87 112.54 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1367 ' ' THR . . . . . . . . . . . . . 11.8 p -90.43 13.63 15.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 110.445 -3.071 . . . . 38.01 113.039 -174.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1368 ' ' TRP . . . . . . . . . . . . . 32.2 t90 -77.96 135.8 62.78 Favored Pre-proline 0 C--O 1.233 0.197 0 C-N-CA 125.582 1.553 . . . . 42.14 111.024 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -91.19 -167.83 3.03 Favored 'Cis proline' 0 CA--C 1.542 0.877 0 CA-C-N 123.616 2.327 . . . . 43.26 110.21 -9.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1370 ' ' ALA . . . . . 0.585 ' HB2' ' CA ' ' B' 1357 ' ' GLY . . . -72.34 167.86 28.64 Favored Pre-proline 0 C--O 1.244 0.8 0 CA-C-O 117.142 -1.408 . . . . 46.52 110.136 163.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1371 ' ' PRO . . . . . 0.514 ' O ' HG12 ' B' 1373 ' ' ILE . 29.6 Cg_endo -56.55 151.48 46.02 Favored 'Trans proline' 0 CA--C 1.548 1.191 0 CA-C-N 125.864 3.13 . . . . 51.95 109.07 164.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1372 ' ' PRO . . . . . 0.473 ' HB2' ' NE2' ' B' 1374 ' ' GLN . 64.7 Cg_endo -64.65 100.44 0.34 Allowed 'Trans proline' 0 C--O 1.24 0.589 0 C-N-CA 122.477 2.118 . . . . 56.27 113.779 -168.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1373 ' ' ILE . . . . . 0.514 HG12 ' O ' ' B' 1371 ' ' PRO . 17.0 mm -100.63 101.33 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 102.22 -3.252 . . . . 60.83 102.22 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1374 ' ' GLN . . . . . 0.473 ' NE2' ' HB2' ' B' 1372 ' ' PRO . 17.3 mp0 -62.55 120.23 10.74 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 122.78 1.276 . . . . 66.1 109.764 -177.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 16.4 t -81.76 121.89 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 104.213 -2.514 . . . . 63.47 104.213 176.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.227 -4.724 0 O-C-N 121.92 -0.488 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.291 0 CA-C-O 120.375 0.131 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.35 -32.81 40.12 Favored 'General case' 0 C--O 1.214 -0.789 0 C-N-CA 124.74 1.216 . . . . 0.0 113.983 176.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -70.14 -63.33 1.1 Allowed 'General case' 0 C--O 1.245 0.865 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 170.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' THR . . . . . 0.564 ' HA ' HD22 ' C' ' 26' ' ' LEU . 0.2 OUTLIER -45.36 -34.84 3.22 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 125.748 1.619 . . . . 0.0 115.061 -174.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.45 -67.0 0.29 Allowed 'General case' 0 C--O 1.256 1.419 0 N-CA-C 115.238 1.569 . . . . 0.0 115.238 166.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -55.43 -38.09 68.54 Favored 'General case' 0 C--N 1.356 0.88 0 O-C-N 119.942 -1.724 . . . . 0.0 113.457 173.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.564 HD22 ' HA ' ' C' ' 23' ' ' THR . 4.8 mp -59.25 -43.4 92.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.438 176.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.555 HD11 HD12 ' C' ' 182' ' ' ILE . 13.6 mt -58.2 -53.46 58.01 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 125.139 1.375 . . . . 0.0 114.268 177.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' LYS . . . . . . . . . . . . . 11.9 pttm -58.58 -31.86 68.41 Favored 'General case' 0 C--O 1.242 0.708 0 O-C-N 120.004 -1.685 . . . . 0.0 113.726 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -65.62 -32.31 73.81 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 174.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.536 ' HA ' ' HB3' ' C' ' 107' ' ' ASP . 67.1 m -58.45 -34.55 70.96 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 119.609 3.188 . . . . 0.0 119.609 -158.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 59.98 -76.93 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 122.509 2.413 . . . . 0.0 107.396 -165.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' SER . . . . . 0.746 ' HB2' ' HA ' ' C' ' 106' ' ' THR . 15.4 m -96.32 136.2 37.12 Favored 'General case' 0 C--O 1.243 0.724 0 O-C-N 118.087 -2.883 . . . . 0.0 110.089 175.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 91.3 t -129.89 122.96 55.68 Favored 'Isoleucine or valine' 0 C--O 1.247 0.962 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.777 ' HB ' HG13 ' C' ' 109' ' ' VAL . 26.9 mm -100.12 117.99 46.13 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 168.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 27.7 mt -94.36 118.04 39.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 119.481 1.037 . . . . 0.0 109.663 170.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' THR . . . . . 0.501 ' HA ' ' HD3' ' C' ' 37' ' ' PRO . 3.6 m -102.96 108.28 57.98 Favored Pre-proline 0 CA--C 1.55 0.95 0 O-C-N 120.172 -1.58 . . . . 0.0 112.424 -176.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . 0.707 ' HG2' HG13 ' C' ' 68' ' ' ILE . 32.5 Cg_exo -74.17 37.74 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 1 C-N-CA 125.657 4.238 . . . . 0.0 118.772 -175.067 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' GLY . . . . . 0.499 ' HA3' ' HB2' ' C' ' 114' ' ' ALA . . . -88.24 94.35 1.98 Allowed Glycine 0 C--N 1.335 0.489 0 O-C-N 119.555 -1.966 . . . . 0.0 111.987 -166.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' TYR . . . . . 0.59 ' HB2' ' HA3' ' C' ' 73' ' ' GLY . 23.4 t80 68.66 -57.07 0.51 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 116.922 -1.513 . . . . 0.0 114.648 175.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -49.07 -46.87 33.29 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-N 120.39 1.45 . . . . 0.0 113.301 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' MET . . . . . 0.575 ' HA ' ' HB3' ' C' ' 46' ' ' ALA . 49.1 ttm -44.67 -52.07 8.58 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 173.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.86 -59.15 2.85 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.812 -175.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 8.2 p -57.84 -43.81 85.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 122.881 1.325 . . . . 0.0 109.179 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' C' ' 176' ' ' LYS . . . -85.44 6.66 25.79 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 119.801 -1.812 . . . . 0.0 113.496 -176.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' GLN . . . . . . . . . . . . 0.348 0.0 OUTLIER 49.52 25.87 1.53 Allowed 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 118.175 2.657 . . . . 0.0 118.175 -169.17 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.575 ' HB3' ' HA ' ' C' ' 41' ' ' MET . . . -70.2 -8.33 49.08 Favored 'General case' 0 C--O 1.255 1.359 0 O-C-N 120.352 -1.467 . . . . 0.0 111.266 -177.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . 0.451 ' O ' HG12 ' C' ' 50' ' ' VAL 0.365 0.0 OUTLIER -69.54 -38.22 77.41 Favored 'General case' 0 CA--C 1.51 -0.568 0 O-C-N 118.677 -2.514 . . . . 0.0 115.532 174.836 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -58.98 -58.45 19.43 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-O 115.292 -2.29 . . . . 0.0 111.313 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -61.71 -36.57 73.89 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 124.324 3.349 . . . . 0.0 111.711 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . 0.506 ' HA ' HG22 ' C' ' 53' ' ' ILE . 0.8 OUTLIER -53.16 -39.09 32.44 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-N 122.047 2.203 . . . . 0.0 112.839 177.254 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.34 -38.98 69.45 Favored 'General case' 0 C--O 1.247 0.927 0 O-C-N 121.66 -0.65 . . . . 0.0 112.007 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -75.65 -48.77 20.67 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 120.746 -1.221 . . . . 0.0 108.277 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' ILE . . . . . 0.556 ' HB ' HD12 ' C' ' 183' ' ' LEU . 8.1 tp -63.38 -37.4 79.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 C-N-CA 119.416 -0.914 . . . . 0.0 113.084 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . 0.541 HG21 ' HE1' ' C' ' 66' ' ' PHE . 90.0 m -68.56 -41.99 78.96 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 119.961 -1.712 . . . . 0.0 109.49 -178.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -53.67 -42.39 67.86 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 124.626 1.17 . . . . 0.0 112.066 168.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -66.44 -39.44 88.89 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 120.927 -1.108 . . . . 0.0 111.378 173.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' C' ' 53' ' ' ILE . 97.9 mt -67.63 -33.52 75.14 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 119.862 1.21 . . . . 0.0 107.896 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . 0.458 ' HD2' ' HA ' ' C' ' 58' ' ' ARG . 0.8 OUTLIER -63.9 -46.51 84.49 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 121.897 0.856 . . . . 0.0 111.473 178.559 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.67 -35.97 71.28 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 124.068 1.89 . . . . 0.0 114.029 173.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -68.06 -24.07 65.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.495 -1.23 . . . . 0.0 113.53 173.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.91 79.75 1.11 Allowed Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 mt -141.94 125.97 16.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 112.89 -1.655 . . . . 0.0 107.913 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 63' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' C' ' 32' ' ' SER . 17.3 t30 -72.41 87.91 1.18 Allowed 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 125.214 1.406 . . . . 0.0 109.601 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.473 HG21 HG23 ' C' ' 54' ' ' THR . 9.2 p -93.17 139.98 17.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 CA-C-O 122.11 0.957 . . . . 0.0 111.591 -177.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 65' ' ' ARG . . . . . 0.416 ' HB2' HD13 ' C' ' 34' ' ' ILE . 84.1 mmt-85 -138.38 120.6 15.79 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 103.19 -2.892 . . . . 0.0 103.19 177.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . 0.541 ' HE1' HG21 ' C' ' 54' ' ' THR . 8.2 m-85 -79.87 126.13 30.6 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 165.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -100.53 86.37 0.64 Allowed Glycine 0 N--CA 1.478 1.45 0 O-C-N 119.002 -2.312 . . . . 0.0 109.509 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 68' ' ' ILE . . . . . 0.707 HG13 ' HG2' ' C' ' 37' ' ' PRO . 3.2 mp -87.09 84.93 2.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 O-C-N 118.982 -2.481 . . . . 0.0 107.857 -172.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -74.24 116.91 57.32 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-O 116.569 -1.681 . . . . 0.0 108.527 170.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 70' ' ' PRO . . . . . 0.479 ' HD3' HG12 ' A' 1157 ' ' ILE . 58.4 Cg_endo -54.62 -59.29 0.89 Allowed 'Trans proline' 0 C--N 1.333 -0.247 0 C-N-CA 124.383 3.389 . . . . 0.0 117.255 -170.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 71' ' ' VAL . . . . . 0.407 ' HA ' ' C7N' ' C' 1001 ' ' NAP . 4.4 m -68.23 95.56 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 113.303 -1.771 . . . . 0.0 108.506 169.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 72' ' ' ALA . . . . . 0.438 ' HA ' ' H3D' ' C' 1001 ' ' NAP . . . -161.17 109.91 1.58 Allowed 'General case' 0 C--O 1.242 0.66 0 CA-C-N 109.031 -3.713 . . . . 0.0 107.16 176.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 73' ' ' GLY . . . . . 0.613 ' C ' ' HD2' ' C' ' 74' ' ' ARG . . . 69.48 -90.96 0.3 Allowed Glycine 0 CA--C 1.506 -0.498 0 CA-C-O 118.285 -1.286 . . . . 0.0 112.975 172.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . 0.846 ' HG3' ' HG2' ' B' 1203 ' ' GLN . 1.7 mpt_? -133.17 114.06 13.41 Favored 'General case' 0 C--O 1.256 1.419 0 CA-C-N 118.196 0.998 . . . . 0.0 111.935 -167.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.534 HD22 ' SD ' ' B' 1207 ' ' MET . 1.7 mp 63.13 142.84 0.06 OUTLIER Pre-proline 0 C--O 1.236 0.344 0 C-N-CA 128.173 2.589 . . . . 0.0 117.069 169.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 76' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' B' 1178 ' ' LEU . 83.1 Cg_endo -71.47 149.9 56.91 Favored 'Trans proline' 0 C--N 1.364 1.365 0 C-N-CA 123.289 2.659 . . . . 0.0 111.093 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 70.81 -96.53 0.59 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -171.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 48.55 -84.32 0.01 OUTLIER 'General case' 0 C--O 1.24 0.602 0 C-N-CA 126.089 1.756 . . . . 0.0 111.677 173.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 79' ' ' MET . . . . . 0.548 ' HA ' ' HB2' ' C' ' 82' ' ' LEU . 0.0 OUTLIER -60.05 -25.81 65.64 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.226 1.01 . . . . 0.0 113.1 177.229 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -58.02 -55.02 40.35 Favored 'General case' 0 C--O 1.24 0.576 0 O-C-N 121.659 -0.651 . . . . 0.0 111.497 170.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 69.8 t -73.3 -38.06 53.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 O-C-N 119.664 -1.898 . . . . 0.0 108.896 177.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.548 ' HB2' ' HA ' ' C' ' 79' ' ' MET . 96.0 mt -48.73 -31.77 7.44 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 122.595 2.452 . . . . 0.0 114.234 169.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.444 HD13 ' O ' ' C' ' 79' ' ' MET . 0.7 OUTLIER -74.82 -32.06 61.86 Favored 'General case' 0 C--O 1.221 -0.399 0 O-C-N 121.429 -0.794 . . . . 0.0 111.2 173.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.08 -32.67 74.5 Favored 'General case' 0 CA--C 1.497 -1.078 0 O-C-N 120.007 -1.683 . . . . 0.0 113.709 170.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -64.3 -50.05 69.36 Favored 'General case' 0 C--O 1.251 1.182 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 172.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.15 -18.18 60.15 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 172.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp 63.1 62.13 1.03 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-O 124.888 2.28 . . . . 0.0 109.558 -173.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 98.2 t -103.84 127.6 29.05 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 111.337 -2.665 . . . . 0.0 105.619 168.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -56.39 126.89 23.8 Favored 'Trans proline' 0 C--O 1.219 -0.469 0 C-N-CA 122.935 2.424 . . . . 0.0 117.965 175.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 90' ' ' TYR . . . . . 0.568 ' HA ' ' HB ' ' C' ' 93' ' ' VAL . 4.2 m-85 -59.3 -12.41 5.59 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 173.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -62.45 -47.48 83.86 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 119.96 1.254 . . . . 0.0 111.555 171.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 39.5 pt -84.09 -14.42 11.46 Favored 'Isoleucine or valine' 0 C--O 1.255 1.351 0 CA-C-O 121.984 0.897 . . . . 0.0 111.521 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . 0.568 ' HB ' ' HA ' ' C' ' 90' ' ' TYR . 50.5 t -76.84 104.56 4.92 Favored 'Isoleucine or valine' 0 C--O 1.247 0.951 0 O-C-N 119.69 -1.881 . . . . 0.0 106.882 175.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 10.8 mp -104.29 103.44 13.19 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 124.831 2.253 . . . . 0.0 109.559 174.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 95' ' ' GLU . . . . . 0.533 ' HB3' ' HB ' ' A' 1157 ' ' ILE . 11.0 mp0 -85.36 117.16 24.12 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 119.675 -1.891 . . . . 0.0 108.28 -176.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.402 ' HB2' ' HD3' ' C' ' 70' ' ' PRO . 12.2 ttp 42.81 29.59 0.19 Allowed 'General case' 0 C--N 1.345 0.385 0 C-N-CA 127.801 2.441 . . . . 0.0 115.162 -178.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -79.92 128.63 33.68 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 103.387 -2.819 . . . . 0.0 103.387 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -87.13 79.56 8.6 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 99' ' ' ILE . . . . . 0.821 HG13 ' HB2' ' C' ' 102' ' ' ASP . 9.5 tp -85.21 58.97 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 112.482 -2.145 . . . . 0.0 108.265 -173.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . 0.467 ' HA ' ' CD2' ' C' ' 103' ' ' PHE . 14.3 t-20 -73.31 -38.58 65.79 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 112.837 -1.983 . . . . 0.0 111.801 -166.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.96 -39.38 79.54 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.079 -1.419 . . . . 0.0 112.437 177.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 102' ' ' ASP . . . . . 0.821 ' HB2' HG13 ' C' ' 99' ' ' ILE . 1.8 m-20 -67.74 -28.43 67.63 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 120.172 -1.58 . . . . 0.0 113.25 167.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 103' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' C' ' 100' ' ' ASN . 6.8 m-30 -56.54 -51.19 69.49 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-O 121.575 0.703 . . . . 0.0 111.95 175.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.99 -45.51 82.91 Favored 'General case' 0 C--O 1.208 -1.117 0 CA-C-N 114.524 -1.217 . . . . 0.0 112.594 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -66.31 -29.18 69.33 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 106' ' ' THR . . . . . 0.746 ' HA ' ' HB2' ' C' ' 32' ' ' SER . 69.6 m -64.92 135.52 55.79 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 177.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 107' ' ' ASP . . . . . 0.665 ' HA ' ' HB3' ' C' ' 142' ' ' GLN . 23.2 t70 -86.94 -102.68 0.07 Allowed 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 112.373 -2.194 . . . . 0.0 109.027 166.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 53.8 m -69.83 91.77 0.66 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 124.398 3.272 . . . . 0.0 113.356 -171.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 109' ' ' VAL . . . . . 0.777 HG13 ' HB ' ' C' ' 34' ' ' ILE . 21.3 t -74.27 110.6 8.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 167.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 110' ' ' LEU . . . . . 0.465 HD11 HD21 ' C' ' 27' ' ' LEU . 96.0 mt -85.6 95.44 9.34 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 111' ' ' VAL . . . . . 0.649 ' HB ' ' HA ' ' C' ' 146' ' ' VAL . 50.3 t -87.1 87.68 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 -176.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 25.3 mm -72.05 79.32 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -171.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 113' ' ' GLY . . . . . 0.429 ' H ' ' HB2' ' C' ' 147' ' ' PHE . . . 88.69 -110.26 3.64 Favored Glycine 0 C--O 1.239 0.409 0 N-CA-C 107.25 -2.34 . . . . 0.0 107.25 -171.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 114' ' ' ALA . . . . . 0.499 ' HB2' ' HA3' ' C' ' 38' ' ' GLY . . . 47.73 9.13 0.01 OUTLIER 'General case' 0 C--N 1.352 0.686 1 N-CA-C 121.817 4.006 . . . . 0.0 121.817 163.093 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.29 -41.94 51.61 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 117.258 2.318 . . . . 0.0 117.258 -175.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 116' ' ' ASP . . . . . 0.553 ' HA ' ' HB2' ' C' ' 119' ' ' ASN . 9.1 m-20 -76.51 -28.01 56.23 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 19.4 m -72.83 -13.3 61.26 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.9 -1.125 . . . . 0.0 108.642 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.701 HG12 ' HB2' ' C' ' 136' ' ' LEU . 18.3 m -120.03 16.86 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 CA-C-N 119.762 1.165 . . . . 0.0 109.873 174.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 119' ' ' ASN . . . . . 0.553 ' HB2' ' HA ' ' C' ' 116' ' ' ASP . 18.4 t30 -79.64 112.28 27.93 Favored Pre-proline 0 N--CA 1.451 -0.391 0 O-C-N 120.118 -1.614 . . . . 0.0 115.188 -171.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 120' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -58.91 -36.47 96.84 Favored 'Trans proline' 0 C--N 1.368 1.602 0 C-N-CA 123.557 2.838 . . . . 0.0 113.288 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.58 4.98 1.55 Allowed 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 122' ' ' ALA . . . . . 0.482 ' HB1' ' HB3' ' C' ' 133' ' ' MET . . . -94.2 -31.7 14.01 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 120.344 -1.472 . . . . 0.0 113.124 173.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -116.03 -52.37 2.61 Favored 'General case' 0 C--O 1.22 -0.49 0 C-N-CA 118.839 -1.144 . . . . 0.0 109.68 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -62.17 -51.01 69.53 Favored 'General case' 0 C--N 1.363 1.188 0 CA-C-O 122.735 1.255 . . . . 0.0 108.905 -173.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -95.54 132.07 28.27 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 102.869 -3.011 . . . . 0.0 102.869 164.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -78.05 46.58 2.11 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 122.223 1.949 . . . . 0.0 110.829 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -107.06 -33.2 7.54 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -152.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 128' ' ' SER . . . . . . . . . . . . . 36.3 m -79.57 144.36 60.94 Favored Pre-proline 0 C--O 1.24 0.559 0 O-C-N 124.735 1.272 . . . . 0.0 111.647 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 129' ' ' PRO . . . . . 0.638 ' HD2' ' HB2' ' C' ' 156' ' ' ALA . 4.6 Cg_exo -44.38 -40.0 12.85 Favored 'Trans proline' 0 CA--C 1.51 -0.677 0 C-N-CA 123.785 2.99 . . . . 0.0 114.69 176.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 35.4 pt -65.61 72.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.88 0 CA-C-O 124.4 2.048 . . . . 0.0 110.413 164.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.71 119.52 10.71 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.511 -1.222 . . . . 0.0 112.987 -172.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 61.71 50.38 66.75 Favored Glycine 0 N--CA 1.431 -1.648 0 CA-C-N 113.083 -1.871 . . . . 0.0 112.149 -175.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 133' ' ' MET . . . . . 0.668 ' SD ' ' HD2' ' C' ' 134' ' ' PRO . 26.5 tpp -75.98 123.79 88.27 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 119.481 1.641 . . . . 0.0 112.099 171.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 134' ' ' PRO . . . . . 0.668 ' HD2' ' SD ' ' C' ' 133' ' ' MET . 61.1 Cg_endo -71.68 82.71 1.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.969 1 C-N-CA 125.833 4.355 . . . . 0.0 107.498 177.216 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 21.7 m -80.99 151.83 4.39 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.183 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.25 -176.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.701 ' HB2' HG12 ' C' ' 118' ' ' VAL . 87.5 mt -74.59 109.27 7.93 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.696 0.76 . . . . 0.0 110.214 -178.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -72.81 80.02 1.14 Allowed 'General case' 0 N--CA 1.423 -1.789 0 CA-C-O 122.964 1.364 . . . . 0.0 112.134 -169.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 3.9 p -113.63 -1.79 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -176.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 13.1 p90 -56.56 148.71 19.0 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.131 -1.606 . . . . 0.0 111.118 174.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 140' ' ' LYS . . . . . . . . . . . . 0.378 0.0 OUTLIER 37.19 46.37 0.57 Allowed 'General case' 0 C--O 1.244 0.765 0 N-CA-C 116.55 2.056 . . . . 0.0 116.55 -160.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.5 -156.36 0.04 OUTLIER 'General case' 0 C--O 1.24 0.596 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 159.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.665 ' HB3' ' HA ' ' C' ' 107' ' ' ASP . 0.0 OUTLIER -84.08 -32.81 24.59 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 119.754 -1.841 . . . . 0.0 113.787 170.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 143' ' ' ASN . . . . . 0.833 ' HA ' ' HB2' ' C' ' 167' ' ' ASN . 16.6 t30 -158.55 138.2 11.9 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 121.837 2.108 . . . . 0.0 110.239 170.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 144' ' ' VAL . . . . . 0.62 ' HB ' HG22 ' C' ' 168' ' ' THR . 21.8 t -136.46 90.43 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.598 0 O-C-N 119.051 -2.28 . . . . 0.0 105.104 -176.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 145' ' ' ILE . . . . . 0.541 HG13 ' HB2' ' C' ' 171' ' ' LEU . 10.5 tp -93.13 102.02 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 -170.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 146' ' ' VAL . . . . . 0.649 ' HA ' ' HB ' ' C' ' 111' ' ' VAL . 26.0 t -90.99 107.41 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 -170.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 147' ' ' PHE . . . . . 0.448 ' CE2' ' HB2' ' C' ' 178' ' ' SER . 2.1 m-85 -70.3 94.09 0.9 Allowed 'General case' 0 C--N 1.35 0.618 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 -177.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 148' ' ' LYS . . . . . 0.491 ' NZ ' ' OD1' ' C' ' 152' ' ' ASN . 26.1 mtpp -140.93 117.67 11.0 Favored 'General case' 0 C--O 1.253 1.254 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 173.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -70.03 -4.47 21.12 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 1.3 m -157.72 159.87 37.33 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 124.256 1.979 . . . . 0.0 108.704 175.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.44 77.72 5.99 Favored 'General case' 0 C--O 1.252 1.194 0 O-C-N 118.901 -2.374 . . . . 0.0 105.992 169.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 152' ' ' ASN . . . . . 0.491 ' OD1' ' NZ ' ' C' ' 148' ' ' LYS . 2.1 p-10 -113.85 157.95 21.67 Favored 'General case' 0 N--CA 1.438 -1.027 0 O-C-N 125.775 1.922 . . . . 0.0 108.826 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 45.7 m -67.55 125.82 27.37 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 123.848 0.717 . . . . 0.0 111.895 174.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -84.74 -108.85 0.63 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 104.7 -3.36 . . . . 0.0 104.7 173.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -91.53 -15.34 28.86 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 164.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 156' ' ' ALA . . . . . 0.638 ' HB2' ' HD2' ' C' ' 129' ' ' PRO . . . -165.54 -93.55 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 159.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 74.93 41.8 32.03 Favored Glycine 0 N--CA 1.437 -1.286 0 CA-C-N 120.876 1.671 . . . . 0.0 110.372 -165.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 15.5 m -80.81 127.94 39.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 O-C-N 120.085 -1.832 . . . . 0.0 108.941 171.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . 0.3 0.0 OUTLIER 43.2 16.31 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 120.613 3.56 . . . . 0.0 120.613 173.5 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 160' ' ' ASN . . . . . 0.734 HD22 HD12 ' C' ' 162' ' ' LEU . 16.9 p-10 -73.9 125.98 89.83 Favored Pre-proline 0 CA--C 1.532 0.269 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -178.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -49.86 -25.63 12.33 Favored 'Trans proline' 0 C--N 1.367 1.548 1 C-N-CA 126.725 4.95 . . . . 0.0 113.367 -176.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 162' ' ' LEU . . . . . 0.88 ' HA ' ' HB ' ' C' ' 168' ' ' THR . 13.2 mt -53.61 -20.14 4.8 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 173.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 163' ' ' PHE . . . . . 0.591 ' HA ' ' HG3' ' C' ' 170' ' ' MET . 9.2 m-30 -82.09 -42.16 19.56 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 123.092 1.425 . . . . 0.0 112.285 175.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -103.11 -41.23 6.16 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 113.18 -1.827 . . . . 0.0 110.099 -153.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 16.0 mttm -74.34 178.92 4.86 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 -164.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -77.43 -56.81 4.22 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-N 113.965 -1.471 . . . . 0.0 108.792 -165.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 167' ' ' ASN . . . . . 0.833 ' HB2' ' HA ' ' C' ' 143' ' ' ASN . 45.9 p30 -75.25 -45.84 37.53 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-O 117.383 -1.294 . . . . 0.0 110.591 168.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 168' ' ' THR . . . . . 0.88 ' HB ' ' HA ' ' C' ' 162' ' ' LEU . 13.6 p -87.54 94.89 9.85 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-N 121.932 2.151 . . . . 0.0 107.829 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -140.18 142.7 35.9 Favored 'General case' 0 C--N 1.353 0.743 0 O-C-N 120.419 -1.426 . . . . 0.0 110.757 -163.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 170' ' ' MET . . . . . 0.591 ' HG3' ' HA ' ' C' ' 163' ' ' PHE . 78.1 mtm -75.66 112.15 11.72 Favored 'General case' 0 CA--C 1.48 -1.72 0 CA-C-O 123.451 1.596 . . . . 0.0 115.232 174.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 171' ' ' LEU . . . . . 0.541 ' HB2' HG13 ' C' ' 145' ' ' ILE . 22.6 tp -71.95 109.81 6.03 Favored 'General case' 0 C--O 1.254 1.31 0 CA-C-N 114.146 -1.388 . . . . 0.0 107.847 169.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -83.26 68.24 9.56 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 126.194 2.902 . . . . 0.0 112.537 -173.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -153.03 163.42 30.51 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 110.161 -3.2 . . . . 0.0 109.735 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 174' ' ' ASP . . . . . 0.549 ' HA ' ' N1A' ' C' 1001 ' ' NAP . 16.7 t70 -74.41 155.32 38.21 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 111.868 -2.166 . . . . 0.0 109.146 173.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.47 -55.74 30.81 Favored 'General case' 0 CA--C 1.496 -1.121 0 CA-C-N 110.292 -3.14 . . . . 0.0 111.91 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 176' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' C' ' 44' ' ' ALA . 0.4 OUTLIER -66.3 -54.44 24.77 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 116.845 -1.55 . . . . 0.0 107.541 176.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 177' ' ' ALA . . . . . . . . . . . . . . . -51.21 -48.98 61.88 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.192 0.997 . . . . 0.0 112.619 -170.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 178' ' ' SER . . . . . 0.448 ' HB2' ' CE2' ' C' ' 147' ' ' PHE . 38.5 m -62.61 -46.46 88.18 Favored 'General case' 0 C--O 1.246 0.877 0 O-C-N 121.004 -1.06 . . . . 0.0 110.746 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 179' ' ' VAL . . . . . 0.433 ' HA ' HG12 ' C' ' 182' ' ' ILE . 22.1 t -61.09 -41.81 90.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 O-C-N 119.789 -1.819 . . . . 0.0 108.14 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 180' ' ' ASP . . . . . 0.417 ' HB2' ' HD2' ' C' ' 176' ' ' LYS . 12.2 t70 -63.97 -37.78 88.67 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.559 -174.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -70.9 -49.72 42.7 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.56 1.073 . . . . 0.0 109.769 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 182' ' ' ILE . . . . . 0.555 HD12 HD11 ' C' ' 27' ' ' LEU . 16.8 pt -63.06 -25.35 38.34 Favored 'Isoleucine or valine' 0 C--N 1.363 1.178 0 O-C-N 119.415 -2.053 . . . . 0.0 112.943 -174.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 183' ' ' LEU . . . . . 0.556 HD12 ' HB ' ' C' ' 53' ' ' ILE . 12.8 tp -49.9 -36.6 28.04 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 126.743 2.017 . . . . 0.0 112.97 170.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 18.7 tptt -112.95 -34.75 5.65 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -57.43 -63.99 1.04 Allowed 'General case' 0 C--O 1.257 1.478 0 N-CA-C 118.823 2.897 . . . . 0.0 118.823 172.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 186' ' ' LEU . . . . . . . . . . . . 0.327 1.3 pt? . . . . . 0 C--O 1.218 -0.586 0 C-N-CA 127.753 2.421 . . . . 0.0 117.349 -167.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' NAD . . . . . 0.427 ' H4D' ' HB3' ' B' 1120 ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C 1001 ' ' NAP . . . . . 0.549 ' N1A' ' HA ' ' C' ' 174' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 22.3 t-80 . . . . . 0 N--CA 1.436 -1.134 0 N-CA-C 104.856 -2.275 . . . . 65.74 104.856 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -69.94 82.09 0.33 Allowed Glycine 0 C--O 1.222 -0.638 0 O-C-N 117.868 -3.02 . . . . 48.66 112.313 169.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -113.44 109.47 18.72 Favored 'General case' 0 CA--C 1.478 -1.81 0 N-CA-C 103.633 -2.728 . . . . 44.56 103.633 170.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1003 ' ' ILE . . . . . . . . . . . . . 61.8 mt -80.18 110.51 15.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 112.179 -2.282 . . . . 34.86 109.187 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1004 ' ' GLY . . . . . 0.551 ' O ' ' HD3' ' A' 1006 ' ' PRO . . . -75.83 122.11 6.53 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.122 -1.191 . . . . 30.75 110.122 163.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.774 HG23 ' HB3' ' A' 1017 ' ' ALA . 16.8 mm -99.58 105.48 34.04 Favored Pre-proline 0 C--O 1.242 0.688 0 N-CA-C 102.567 -3.123 . . . . 32.21 102.567 176.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1006 ' ' PRO . . . . . 0.551 ' HD3' ' O ' ' A' 1004 ' ' GLY . 67.8 Cg_exo -85.8 158.35 10.38 Favored 'Trans proline' 0 N--CA 1.451 -1.007 1 C-N-CA 126.222 4.615 . . . . 32.98 110.468 175.46 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1007 ' ' ARG . . . . . 0.558 ' HG3' HD12 ' A' 1042 ' ' LEU . 1.8 ttp85 -84.98 138.42 32.48 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 103.181 -2.896 . . . . 47.98 103.181 153.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1008 ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -63.44 137.85 58.3 Favored 'General case' 0 N--CA 1.441 -0.89 0 O-C-N 124.41 1.068 . . . . 34.7 109.398 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1009 ' ' ARG . . . . . 0.632 HH11 ' HG2' ' A' 1079 ' ' GLU . 80.9 mtp180 -93.82 -27.53 16.4 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 114.725 -1.125 . . . . 53.37 113.558 -175.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 3.9 mp -52.81 129.2 29.25 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-O 123.018 1.39 . . . . 45.07 111.52 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1011 ' ' THR . . . . . . . . . . . . . 20.7 m -48.19 119.79 3.16 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 113.076 -1.874 . . . . 40.36 112.137 -171.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 12.5 m120 63.28 -4.67 0.28 Allowed 'General case' 0 C--O 1.243 0.753 0 N-CA-C 117.419 2.377 . . . . 40.61 117.419 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -88.1 71.97 9.22 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 104.424 -2.436 . . . . 33.76 104.424 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1014 ' ' THR . . . . . 0.627 HG23 HD13 ' A' 1042 ' ' LEU . 47.1 m -73.29 66.7 0.93 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 125.72 2.676 . . . . 27.89 111.914 -172.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1015 ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -108.51 163.29 13.36 Favored 'General case' 0 C--O 1.224 -0.262 0 O-C-N 120.002 -1.686 . . . . 29.02 108.942 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1016 ' ' VAL . . . . . 0.472 HG22 ' HA ' ' A' 1007 ' ' ARG . 39.4 t -137.05 151.59 27.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 101.505 -3.517 . . . . 28.13 101.505 171.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1017 ' ' ALA . . . . . 0.774 ' HB3' HG23 ' A' 1005 ' ' ILE . . . -55.18 -54.57 41.63 Favored 'General case' 0 C--O 1.256 1.426 0 N-CA-C 119.067 2.988 . . . . 26.87 119.067 -176.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -144.25 159.36 42.81 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 120.478 1.49 . . . . 26.77 112.566 -170.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1019 ' ' THR . . . . . . . . . . . . . 19.2 p -84.25 155.86 63.25 Favored Pre-proline 0 C--O 1.245 0.833 0 CA-C-O 117.762 -1.113 . . . . 27.02 111.423 176.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1020 ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -48.5 -40.16 36.92 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 124.059 3.172 . . . . 30.57 114.41 169.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1021 ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' 1024 ' ' GLU . 2.2 ttmp? -52.33 -48.98 65.15 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.284 1.216 . . . . 47.81 114.284 168.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1022 ' ' THR . . . . . 0.676 ' HB ' HG21 ' A' 1332 ' ' VAL . 2.6 p -75.15 -30.87 60.88 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 124.057 1.885 . . . . 30.77 109.426 -172.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1023 ' ' VAL . . . . . 0.496 HG11 ' HB2' ' A' 1055 ' ' ALA . 55.5 t -56.98 -52.23 58.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 C-N-CA 125.141 1.376 . . . . 33.59 108.691 168.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1024 ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' 1021 ' ' LYS . 26.3 mt-10 -46.2 -51.62 13.89 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 120.694 1.588 . . . . 53.29 110.755 172.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -54.38 -52.4 61.79 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.673 1.36 . . . . 46.92 114.673 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1026 ' ' LEU . . . . . 0.415 HD23 HD12 ' A' 1029 ' ' LEU . 91.7 mt -53.94 -42.79 69.23 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 115.019 1.488 . . . . 37.17 115.019 177.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 7.1 mp -54.32 -49.9 68.62 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.711 -1.131 . . . . 44.44 113.442 168.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1028 ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' 1024 ' ' GLU . 27.4 mmmt -62.08 -29.27 70.19 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 120.367 0.127 . . . . 52.58 111.094 175.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1029 ' ' LEU . . . . . 0.415 HD12 HD23 ' A' 1026 ' ' LEU . 95.3 mt -72.26 -42.33 65.73 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 119.749 -1.844 . . . . 45.69 109.784 175.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 138.06 -8.04 3.52 Favored Glycine 0 CA--C 1.507 -0.411 0 C-N-CA 120.877 -0.678 . . . . 42.09 111.949 173.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -80.15 130.68 35.41 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 118.917 -0.563 . . . . 40.72 112.301 -173.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1032 ' ' THR . . . . . . . . . . . . . 55.8 m -74.11 127.71 33.62 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.707 -1.22 . . . . 37.77 107.707 176.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1033 ' ' VAL . . . . . 0.49 HG11 HG22 ' A' 1023 ' ' VAL . 94.8 t -109.7 123.58 65.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 104.639 -2.356 . . . . 33.54 104.639 -177.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -120.1 113.12 20.01 Favored 'General case' 0 C--O 1.249 1.032 0 N-CA-C 105.966 -1.864 . . . . 31.68 105.966 175.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1035 ' ' VAL . . . . . 0.448 ' HA ' ' HB ' ' A' 1005 ' ' ILE . 17.3 t -94.34 144.3 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 O-C-N 121.553 -0.717 . . . . 31.52 109.282 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1036 ' ' GLU . . . . . 0.445 ' HB2' HG21 ' A' 1063 ' ' VAL . 50.3 tt0 -61.44 140.63 58.02 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 123.392 1.568 . . . . 41.04 111.329 170.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1037 ' ' SER . . . . . . . . . . . . . 1.4 t -61.49 126.75 28.48 Favored 'General case' 0 N--CA 1.44 -0.951 0 O-C-N 120.187 -1.571 . . . . 31.83 114.201 171.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 83.95 9.96 81.68 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 113.976 -1.465 . . . . 29.36 112.032 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -79.04 -41.05 29.76 Favored 'General case' 0 C--N 1.347 0.462 0 O-C-N 121.058 -1.26 . . . . 27.78 110.049 -176.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -52.48 -39.21 52.48 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 122.82 1.233 . . . . 28.91 113.73 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 73.1 tp60 -46.44 -55.63 7.15 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.055 -1.072 . . . . 51.18 113.318 170.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1042 ' ' LEU . . . . . 0.627 HD13 HG23 ' A' 1014 ' ' THR . 27.0 mt -72.35 -42.28 65.49 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 120.727 -1.233 . . . . 29.91 111.213 175.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1043 ' ' ALA . . . . . . . . . . . . . . . -54.9 -22.5 15.02 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.567 0.699 . . . . 28.54 112.35 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1044 ' ' SER . . . . . 0.426 ' HB3' ' CA ' ' B' 1278 ' ' GLY . 67.4 m 63.53 42.28 6.69 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 124.746 2.212 . . . . 33.06 108.628 174.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1045 ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -172.31 92.15 0.12 Allowed 'General case' 0 N--CA 1.441 -0.914 1 N-CA-C 97.761 -4.903 . . . . 30.29 97.761 178.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.67 171.27 15.19 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-N 111.402 -2.635 . . . . 48.62 116.585 -147.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1047 ' ' ASP . . . . . 0.474 ' O ' HG23 ' A' 1051 ' ' VAL . 6.9 m-20 -56.77 -42.07 78.74 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 113.776 -1.556 . . . . 36.74 113.085 -176.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 21.7 pttm -69.9 -25.73 63.83 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.543 1.519 . . . . 43.73 113.661 176.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -71.07 -37.35 72.48 Favored 'General case' 0 CA--C 1.498 -1.04 0 O-C-N 119.862 -1.774 . . . . 32.81 109.801 170.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1050 ' ' PHE . . . . . 0.402 ' CD1' HG21 ' A' 1035 ' ' VAL . 26.4 m-85 -57.82 -42.22 83.86 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 120.429 1.468 . . . . 31.86 112.735 167.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1051 ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' 1047 ' ' ASP . 21.8 t -61.28 -44.9 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 114.578 -1.192 . . . . 33.22 113.081 174.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -58.17 -37.56 74.95 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.568 0.699 . . . . 50.83 112.718 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -59.46 -46.35 89.02 Favored 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 121.62 -0.675 . . . . 33.12 110.062 173.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 128.14 9.48 3.75 Favored Glycine 0 C--N 1.349 1.26 0 C-N-CA 118.905 -1.616 . . . . 35.83 112.188 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1055 ' ' ALA . . . . . 0.496 ' HB2' HG11 ' A' 1023 ' ' VAL . . . -73.49 146.72 44.69 Favored 'General case' 0 N--CA 1.436 -1.169 0 O-C-N 121.975 -0.72 . . . . 34.82 111.151 -177.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -77.52 136.79 38.35 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 101.932 -3.359 . . . . 49.05 101.932 171.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1057 ' ' ILE . . . . . . . . . . . . . 25.7 mm -102.46 134.68 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 N-CA-C 107.063 -1.458 . . . . 38.53 107.063 172.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1058 ' ' VAL . . . . . . . . . . . . . 3.1 m -129.41 143.25 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-O 123.354 1.549 . . . . 42.11 109.444 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -106.21 128.53 54.01 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 113.452 -1.704 . . . . 58.0 108.379 -165.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 66.49 -138.93 36.56 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-O 123.379 1.544 . . . . 52.12 114.019 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1061 ' ' ASN . . . . . 0.541 ' HA ' ' HD1' ' A' 1064 ' ' TRP . 8.2 t30 -64.21 -18.94 64.99 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 113.359 -1.42 . . . . 54.75 111.976 -170.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1062 ' ' SER . . . . . . . . . . . . . 49.9 m -63.05 -8.63 7.85 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 116.743 2.127 . . . . 50.34 116.743 176.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1063 ' ' VAL . . . . . 0.445 HG21 ' HB2' ' A' 1036 ' ' GLU . 9.7 p -72.52 -38.13 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-O 121.921 0.867 . . . . 41.46 110.347 167.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1064 ' ' TRP . . . . . 0.541 ' HD1' ' HA ' ' A' 1061 ' ' ASN . 86.1 m95 -73.07 -20.21 61.01 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.013 0.925 . . . . 39.32 110.389 174.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1065 ' ' GLN . . . . . 0.537 ' NE2' HD21 ' A' 1084 ' ' ASN . 92.3 mm-40 -77.21 64.57 2.65 Favored 'General case' 0 C--O 1.224 -0.272 0 O-C-N 120.31 -1.494 . . . . 55.38 111.36 171.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1066 ' ' SER . . . . . . . . . . . . . 47.8 m -152.17 129.06 10.95 Favored 'General case' 0 N--CA 1.444 -0.734 0 O-C-N 120.69 -1.256 . . . . 41.87 108.054 -174.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -74.54 4.49 6.01 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 120.093 3.368 . . . . 53.2 120.093 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1068 ' ' ILE . . . . . 0.644 HG12 ' HB ' ' A' 1088 ' ' THR . 96.9 mt -128.41 134.76 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 104.135 -2.543 . . . . 41.9 104.135 158.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1069 ' ' ILE . . . . . . . . . . . . . 34.9 mm -128.08 132.95 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 104.677 -2.342 . . . . 38.73 104.677 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1070 ' ' LEU . . . . . 0.803 HD13 HD13 ' A' 1331 ' ' LEU . 19.8 mt -108.13 79.15 1.23 Allowed 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 125.385 2.517 . . . . 32.44 112.164 172.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1071 ' ' LYS . . . . . 0.451 ' HE3' ' O ' ' A' 1073 ' ' ASN . 8.7 mmmt -65.67 127.55 32.38 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 113.302 -1.772 . . . . 34.65 111.005 169.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1072 ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -92.23 -14.32 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 CA-C-N 114.131 -1.395 . . . . 31.32 110.623 -160.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1073 ' ' ASN . . . . . 0.451 ' O ' ' HE3' ' A' 1071 ' ' LYS . 46.9 t30 -149.42 178.23 8.99 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 107.842 -1.17 . . . . 33.94 107.842 173.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1074 ' ' ALA . . . . . 0.468 ' HA ' ' HD3' ' A' 1075 ' ' PRO . . . -38.8 146.57 0.31 Allowed Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 127.547 2.339 . . . . 38.04 116.026 172.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1075 ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' 1074 ' ' ALA . 21.9 Cg_exo -80.8 157.6 21.19 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.932 3.088 . . . . 42.68 119.122 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 42.5 mt -107.77 161.27 15.04 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 105.133 -2.173 . . . . 46.74 105.133 162.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 25.5 t0 -70.27 -21.9 62.92 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.539 -0.726 . . . . 58.61 110.758 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 21.8 t0 -54.12 -56.39 18.52 Favored 'General case' 0 C--N 1.344 0.359 0 N-CA-C 108.134 -1.061 . . . . 59.2 108.134 162.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1079 ' ' GLU . . . . . 0.632 ' HG2' HH11 ' A' 1009 ' ' ARG . 33.0 mt-10 -66.67 -31.22 71.75 Favored 'General case' 0 CA--C 1.501 -0.927 0 O-C-N 121.616 -0.677 . . . . 50.63 110.543 -174.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1080 ' ' ILE . . . . . . . . . . . . . 82.8 mt -68.25 -31.56 52.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 O-C-N 120.996 -1.065 . . . . 51.48 111.704 176.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -70.61 -43.24 69.74 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 118.689 -2.507 . . . . 50.28 110.707 171.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 8.0 mp -69.07 -23.94 64.1 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 114.101 1.148 . . . . 50.21 114.101 177.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1083 ' ' LEU . . . . . 0.571 HD11 HD13 ' A' 1089 ' ' LEU . 0.1 OUTLIER -67.49 116.37 8.15 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 105.41 -2.07 . . . . 49.06 105.41 175.579 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1084 ' ' ASN . . . . . 0.537 HD21 ' NE2' ' A' 1065 ' ' GLN . 13.1 m-80 -75.09 150.64 85.74 Favored Pre-proline 0 N--CA 1.432 -1.325 0 CA-C-O 118.561 -0.733 . . . . 51.08 110.908 171.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -55.91 165.9 3.43 Favored 'Trans proline' 0 C--O 1.249 1.053 0 C-N-CA 123.99 3.127 . . . . 49.73 113.853 167.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 81.78 -28.38 3.2 Favored Glycine 0 C--N 1.338 0.671 0 O-C-N 120.489 -1.382 . . . . 47.71 114.052 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1087 ' ' THR . . . . . . . . . . . . . 13.9 m -51.09 129.74 24.64 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 117.654 2.464 . . . . 45.47 117.654 -174.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1088 ' ' THR . . . . . 0.644 ' HB ' HG12 ' A' 1068 ' ' ILE . 30.0 m -79.6 90.39 5.14 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 106.713 -1.588 . . . . 42.04 106.713 161.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1089 ' ' LEU . . . . . 0.571 HD13 HD11 ' A' 1083 ' ' LEU . 63.5 tp -79.85 80.74 6.21 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 105.451 -2.055 . . . . 38.06 105.451 -174.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1090 ' ' VAL . . . . . 0.584 ' HA ' ' HB2' ' A' 1113 ' ' MET . 36.2 t -81.44 104.67 10.33 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 N-CA-C 101.964 -3.347 . . . . 37.4 101.964 177.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1091 ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' 1114 ' ' ALA . 60.5 m -155.05 164.76 38.42 Favored 'General case' 0 C--O 1.251 1.145 0 O-C-N 119.816 -1.803 . . . . 36.16 113.769 -167.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 17.0 t80 -92.11 90.75 7.48 Favored 'General case' 0 C--O 1.246 0.915 0 O-C-N 120.111 -1.618 . . . . 38.94 107.432 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 30.9 mm -95.15 -30.37 4.1 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 N-CA-C 113.006 0.743 . . . . 42.17 113.006 -160.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 90.7 m95 56.93 74.09 0.72 Allowed Pre-proline 0 C--O 1.236 0.346 0 C-N-CA 125.635 1.574 . . . . 46.51 111.89 -171.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -62.51 -56.24 0.71 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 123.536 2.824 . . . . 49.76 115.815 -167.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -70.34 -11.79 61.14 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 118.138 -2.851 . . . . 52.62 113.514 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -86.53 -32.11 20.9 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 105.938 -1.875 . . . . 60.74 105.938 176.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1098 ' ' ASN . . . . . 0.425 ' HB3' ' HB2' ' A' 1101 ' ' LEU . 76.7 m-20 -119.83 55.96 3.77 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 117.178 2.288 . . . . 58.19 117.178 -177.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.41 -42.77 31.89 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.767 2.978 . . . . 54.59 114.647 -174.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -60.77 -46.47 90.36 Favored 'General case' 0 C--O 1.251 1.171 0 O-C-N 119.943 -1.723 . . . . 63.28 111.918 174.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1101 ' ' LEU . . . . . 0.425 ' HB2' ' HB3' ' A' 1098 ' ' ASN . 20.6 mt -61.7 -33.37 73.9 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.602 -1.181 . . . . 54.75 111.24 176.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1102 ' ' MET . . . . . . . . . . . . . 46.4 mmm -61.58 -48.39 81.17 Favored 'General case' 0 C--O 1.245 0.861 0 O-C-N 121.662 -0.649 . . . . 52.65 111.657 175.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -60.3 -39.61 87.58 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.318 -0.856 . . . . 66.26 108.917 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 88.4 mttt -64.61 -32.51 74.2 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 118.865 0.757 . . . . 63.73 112.006 174.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 34.2 mt -76.15 -26.85 56.7 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 120.308 -1.495 . . . . 54.68 111.877 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -64.48 -47.65 78.16 Favored 'General case' 0 C--O 1.245 0.858 0 O-C-N 120.713 -1.242 . . . . 53.64 111.705 168.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -56.05 -33.69 65.21 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.397 -1.729 . . . . 67.24 114.163 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -60.5 -24.79 65.58 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 117.276 2.324 . . . . 65.76 117.276 170.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1109 ' ' ASN . . . . . 0.499 ' HA ' ' HA3' ' A' 1364 ' ' GLY . 3.7 t30 56.91 67.83 0.94 Allowed 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 123.445 1.593 . . . . 58.71 111.972 -165.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1110 ' ' VAL . . . . . 0.455 HG23 HG23 ' A' 1112 ' ' VAL . 17.0 m -133.28 151.69 34.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 113.89 -1.505 . . . . 46.63 108.299 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1111 ' ' THR . . . . . 0.55 HG21 HG21 ' A' 1348 ' ' VAL . 94.8 m -91.55 93.38 8.93 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 123.027 1.394 . . . . 44.13 110.61 171.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1112 ' ' VAL . . . . . 0.496 HG22 HD23 ' A' 1089 ' ' LEU . 41.3 t -83.55 108.44 16.08 Favored 'Isoleucine or valine' 0 C--O 1.252 1.21 0 O-C-N 119.774 -1.829 . . . . 40.44 109.806 -178.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1113 ' ' MET . . . . . 0.584 ' HB2' ' HA ' ' A' 1090 ' ' VAL . 22.8 mtp -100.97 93.07 5.32 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 111.59 -2.55 . . . . 50.76 109.122 173.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1114 ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' 1091 ' ' SER . . . -85.51 118.39 25.01 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 119.185 -1.006 . . . . 35.64 109.324 -173.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1115 ' ' MET . . . . . 0.436 ' O ' HG23 ' A' 1118 ' ' VAL . 79.5 mmm -66.04 -29.39 69.74 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 115.611 1.708 . . . . 38.74 115.611 -175.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.62 -44.48 69.53 Favored 'General case' 0 C--O 1.25 1.093 0 CA-C-O 121.682 0.753 . . . . 40.14 111.475 165.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1117 ' ' SER . . . . . . . . . . . . . 74.0 m -75.11 14.08 0.6 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 119.487 3.143 . . . . 44.79 119.487 -176.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1118 ' ' VAL . . . . . 0.785 HG22 HG22 ' A' 1358 ' ' VAL . 13.6 t -72.77 133.67 82.12 Favored Pre-proline 0 C--O 1.215 -0.751 0 O-C-N 118.432 -2.668 . . . . 43.75 107.057 177.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -60.65 152.24 70.37 Favored 'Trans proline' 0 N--CA 1.443 -1.455 1 C-N-CA 125.785 4.323 . . . . 48.93 115.451 173.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -70.1 12.88 0.19 Allowed 'General case' 0 C--O 1.255 1.39 0 N-CA-C 121.027 3.714 . . . . 62.9 121.027 -173.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1121 ' ' ILE . . . . . 0.406 HG12 ' H ' ' A' 1121 ' ' ILE . 10.5 pt -86.2 169.35 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 O-C-N 119.088 -2.257 . . . . 57.72 112.951 -170.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1122 ' ' SER . . . . . 0.422 ' HA ' ' HG2' ' A' 1125 ' ' GLN . 69.7 m -63.37 -46.19 87.66 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 124.398 1.079 . . . . 57.26 113.721 -173.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -59.24 -36.11 74.88 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 122.922 2.601 . . . . 62.9 112.128 175.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1124 ' ' ALA . . . . . 0.511 ' HB1' HG12 ' A' 1118 ' ' VAL . . . -71.16 -23.63 62.09 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 125.012 1.445 . . . . 49.83 111.904 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1125 ' ' GLN . . . . . 0.422 ' HG2' ' HA ' ' A' 1122 ' ' SER . 54.1 mm-40 -56.28 -23.69 38.16 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 118.241 2.682 . . . . 52.37 118.241 -171.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1126 ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.83 -35.12 57.77 Favored 'General case' 0 C--O 1.252 1.198 0 N-CA-C 116.463 2.023 . . . . 42.43 116.463 169.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1127 ' ' LEU . . . . . 0.473 ' O ' ' HB3' ' A' 1330 ' ' ASN . 4.5 mp -78.63 -35.82 44.93 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 113.3 -1.773 . . . . 43.74 111.504 177.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 13.3 t70 -73.64 123.04 23.27 Favored 'General case' 0 C--O 1.246 0.892 0 O-C-N 120.244 -1.535 . . . . 43.21 114.764 -165.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -75.39 -27.59 59.15 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 114.231 1.197 . . . . 35.74 114.231 175.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 69.1 mt -67.19 -11.86 58.49 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 118.679 0.672 . . . . 38.09 112.524 170.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1131 ' ' SER . . . . . 0.563 ' HA ' HG11 ' A' 1175 ' ' VAL . 6.4 m -73.86 -77.13 0.11 Allowed 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.274 -0.639 . . . . 36.91 109.274 153.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1132 ' ' SER . . . . . 0.731 ' HB3' ' HB3' ' A' 1326 ' ' LEU . 8.3 m -58.24 -55.71 31.52 Favored 'General case' 0 C--N 1.347 0.491 0 O-C-N 120.899 -1.125 . . . . 35.79 113.278 -162.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1133 ' ' MET . . . . . 0.552 ' HA ' HD12 ' A' 1136 ' ' ILE . 18.3 mtp -62.97 -34.75 78.19 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 113.067 0.766 . . . . 30.81 113.067 -177.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1134 ' ' ALA . . . . . . . . . . . . . . . -66.75 -40.79 88.41 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.536 0.607 . . . . 28.88 109.506 174.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1135 ' ' ASN . . . . . 0.404 ' HB3' ' O ' ' A' 1132 ' ' SER . 10.6 t-20 -57.32 -45.04 84.64 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 117.882 -1.056 . . . . 40.76 111.204 171.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1136 ' ' ILE . . . . . 0.552 HD12 ' HA ' ' A' 1133 ' ' MET . 83.7 mt -56.46 -44.63 80.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-O 122.51 1.147 . . . . 31.54 110.767 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -60.62 -49.2 78.49 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 112.669 -2.06 . . . . 29.87 112.15 175.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1138 ' ' GLY . . . . . 0.447 ' HA2' HD11 ' A' 1284 ' ' LEU . . . -57.44 -46.78 91.54 Favored Glycine 0 N--CA 1.468 0.819 0 O-C-N 120.806 -1.184 . . . . 28.73 111.393 -177.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 18.4 t80 -65.01 -49.29 70.78 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 118.821 -0.609 . . . . 30.39 110.391 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1140 ' ' ARG . . . . . 0.546 ' HG3' HD22 ' A' 1315 ' ' LEU . 5.7 tpt180 -70.69 -19.26 62.79 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 117.155 -1.818 . . . . 26.09 111.951 -175.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1141 ' ' ALA . . . . . 0.721 ' HB2' HD21 ' A' 1284 ' ' LEU . . . -69.76 -45.55 67.83 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 106.957 -1.497 . . . . 27.1 106.957 176.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1142 ' ' ILE . . . . . 0.419 HD13 ' HA ' ' A' 1142 ' ' ILE . 28.5 mm -50.45 -44.82 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 C-N-CA 123.588 0.755 . . . . 28.48 111.929 169.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 58.6 t -62.31 -58.94 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 112.797 0.665 . . . . 23.07 112.797 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1144 ' ' GLU . . . . . 0.468 ' CD ' HH21 ' A' 1140 ' ' ARG . 6.0 mm-40 -63.85 -31.51 72.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.839 0.828 . . . . 33.4 112.562 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1145 ' ' ALA . . . . . 0.7 ' HB1' HD12 ' A' 1251 ' ' ILE . . . -56.88 -54.5 45.85 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 115.859 -2.019 . . . . 24.22 111.554 164.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1146 ' ' ALA . . . . . 0.576 ' HA ' ' HB2' ' A' 1149 ' ' PHE . . . -58.4 -22.91 55.69 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 116.019 1.859 . . . . 24.89 116.019 174.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -70.0 -54.23 14.13 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 105.827 -1.916 . . . . 26.73 105.827 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1148 ' ' GLU . . . . . 0.828 ' HB2' HD11 ' A' 1310 ' ' ILE . 25.3 mm-40 -97.49 21.6 10.0 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 116.955 2.205 . . . . 39.96 116.955 176.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1149 ' ' PHE . . . . . 0.576 ' HB2' ' HA ' ' A' 1146 ' ' ALA . 1.0 OUTLIER -71.92 136.49 46.89 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 106.938 -1.504 . . . . 25.87 106.938 177.488 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1150 ' ' GLY . . . . . 0.452 ' HA2' ' HG2' ' B' 1320 ' ' PRO . . . -74.66 -52.75 6.99 Favored Glycine 0 CA--C 1.502 -0.73 0 O-C-N 127.262 2.851 . . . . 19.28 109.916 170.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1151 ' ' ARG . . . . . 0.72 ' NH2' ' HB2' ' A' 1164 ' ' PRO . 0.4 OUTLIER -101.17 -164.93 1.15 Allowed 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 120.8 -1.412 . . . . 39.9 113.768 -170.536 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1152 ' ' PHE . . . . . 0.521 ' HD2' ' HG2' ' B' 1322 ' ' GLN . 0.7 OUTLIER -107.23 141.21 38.9 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 120.466 -1.396 . . . . 29.44 109.129 -170.223 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1153 ' ' PHE . . . . . 0.536 ' HE2' ' HB2' ' A' 1146 ' ' ALA . 16.9 m-85 -65.22 -58.67 5.39 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 117.804 -3.06 . . . . 32.6 110.181 169.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1154 ' ' THR . . . . . . . . . . . . . 3.0 m -71.75 116.54 12.24 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 124.412 1.07 . . . . 34.64 111.234 -172.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -64.39 96.03 0.19 Allowed Glycine 0 CA--C 1.547 2.04 0 N-CA-C 106.253 -2.739 . . . . 37.14 106.253 165.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -136.1 -158.28 0.86 Allowed 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 118.935 -0.555 . . . . 40.57 112.191 -175.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1157 ' ' ILE . . . . . 0.861 HG21 ' HB2' ' C' ' 70' ' ' PRO . 3.3 tp -155.41 125.68 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 O-C-N 119.615 -1.928 . . . . 44.61 110.22 -159.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1158 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.74 -160.76 1.18 Allowed 'General case' 0 C--O 1.253 1.245 0 N-CA-C 105.436 -2.061 . . . . 40.7 105.436 176.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -48.29 -31.97 6.71 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 119.138 -2.226 . . . . 40.25 116.774 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1160 ' ' ALA . . . . . 0.51 ' HA ' ' HB ' ' B' 1329 ' ' THR . . . -64.58 -11.65 36.94 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-O 117.929 -1.034 . . . . 38.47 113.335 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . 76.8 -117.48 4.91 Favored Glycine 0 N--CA 1.432 -1.617 0 N-CA-C 107.771 -2.132 . . . . 37.61 107.771 -171.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 7.1 tttp -67.89 108.2 2.93 Favored 'General case' 0 CA--C 1.482 -1.672 0 N-CA-C 107.306 -1.368 . . . . 48.9 107.306 171.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1163 ' ' VAL . . . . . . . . . . . . . 38.8 t -82.13 106.17 5.9 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 102.843 -3.021 . . . . 36.52 102.843 163.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1164 ' ' PRO . . . . . 0.72 ' HB2' ' NH2' ' A' 1151 ' ' ARG . 10.2 Cg_endo -65.38 122.21 9.85 Favored 'Trans proline' 0 N--CA 1.443 -1.443 0 C-N-CA 124.504 3.47 . . . . 35.08 116.688 -171.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1165 ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' 1164 ' ' PRO . 95.3 Cg_endo -68.14 156.17 66.78 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 N-CA-C 118.454 2.444 . . . . 35.33 118.454 -177.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -62.92 122.68 16.59 Favored 'General case' 0 N--CA 1.417 -2.098 0 CA-C-N 113.448 -1.705 . . . . 34.69 112.779 169.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1167 ' ' LYS . . . . . 0.674 ' HB2' ' HA ' ' A' 1249 ' ' VAL . 99.0 mttt -93.84 114.35 26.58 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 104.974 -2.232 . . . . 45.36 104.974 164.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1168 ' ' VAL . . . . . 0.415 HG22 ' HB ' ' A' 1251 ' ' ILE . 59.8 t -99.89 134.53 39.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 103.967 -2.605 . . . . 31.71 103.967 -173.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1169 ' ' MET . . . . . . . . . . . . . 46.2 ttp -118.64 105.95 12.11 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 106.416 -1.698 . . . . 42.28 106.416 168.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 38.2 t -78.29 126.4 38.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 107.788 -1.19 . . . . 30.51 107.788 168.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 61.8 mt -112.41 126.16 69.77 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 108.787 -0.82 . . . . 31.87 108.787 171.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 79.6 79.65 0.82 Allowed Glycine 0 CA--C 1.536 1.346 0 N-CA-C 108.65 -1.78 . . . . 34.54 108.65 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1173 ' ' ALA . . . . . . . . . . . . . . . -85.87 89.43 7.77 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 125.568 2.604 . . . . 32.51 110.109 -172.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -113.35 -147.82 9.98 Favored Glycine 0 C--O 1.246 0.906 0 CA-C-N 110.788 -2.915 . . . . 29.9 108.882 174.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1175 ' ' VAL . . . . . 0.563 HG11 ' HA ' ' A' 1131 ' ' SER . 2.7 t -75.57 -37.35 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 119.261 1.531 . . . . 33.11 109.706 -175.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -55.77 -39.87 71.81 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 120.917 -1.115 . . . . 28.1 112.139 165.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -57.35 -49.4 73.06 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-O 118.738 -1.035 . . . . 28.54 110.572 174.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1178 ' ' LEU . . . . . . . . . . . . . 53.3 mt -56.37 -47.1 79.58 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 117.987 0.894 . . . . 31.22 110.588 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -57.28 -46.75 82.81 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 114.085 1.142 . . . . 28.98 114.085 177.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -64.02 -41.65 97.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.284 -0.871 . . . . 27.83 111.026 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1181 ' ' ILE . . . . . . . . . . . . . 92.2 mt -63.86 -46.23 94.84 Favored 'Isoleucine or valine' 0 C--N 1.361 1.085 0 CA-C-O 119.75 -0.167 . . . . 30.25 110.717 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -58.8 -54.54 37.1 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 108.64 -1.784 . . . . 29.59 108.64 -177.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -51.94 -56.1 16.25 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 118.115 0.958 . . . . 30.29 113.309 176.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -63.51 -44.49 94.15 Favored 'General case' 0 C--O 1.254 1.3 0 N-CA-C 115.274 1.583 . . . . 30.47 115.274 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -60.21 -53.25 59.93 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 124.624 1.17 . . . . 42.41 109.284 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1186 ' ' SER . . . . . 0.485 ' HB2' ' HA ' ' B' 1187 ' ' LEU . 85.2 p -57.5 -40.67 79.17 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 120.557 1.526 . . . . 39.38 115.032 175.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 5.6 mt -60.6 -21.57 62.8 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 114.71 1.374 . . . . 36.18 114.71 169.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 93.96 32.75 7.35 Favored Glycine 0 C--O 1.24 0.477 0 CA-C-O 123.085 1.38 . . . . 33.78 110.905 170.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -96.35 168.94 10.26 Favored 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 121.78 -0.836 . . . . 33.93 109.393 176.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 8.4 mt -93.9 109.11 21.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 102.511 -3.144 . . . . 38.74 102.511 -176.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 5.8 t -97.74 131.81 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 118.831 -1.148 . . . . 33.09 109.769 -170.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1192 ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -123.76 151.21 43.51 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 104.054 -2.573 . . . . 38.92 104.054 175.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -143.59 147.91 35.1 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 108.382 -0.97 . . . . 35.32 108.382 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 5.9 t80 -133.18 132.63 41.8 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.006 -1.85 . . . . 39.35 106.006 -178.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 9.0 t0 -156.74 154.5 30.09 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 105.526 -2.027 . . . . 40.46 105.526 170.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1196 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.28 -40.78 81.72 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 120.138 -0.625 . . . . 45.94 109.88 175.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1197 ' ' ARG . . . . . 0.447 ' HA ' ' HD2' ' A' 1198 ' ' PRO . 71.4 mtm180 -71.61 112.15 12.97 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 124.235 1.014 . . . . 56.02 113.516 -168.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1198 ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' 1197 ' ' ARG . 72.6 Cg_endo -60.87 -14.78 34.32 Favored 'Trans proline' 0 C--N 1.325 -0.69 0 C-N-CA 124.775 3.65 . . . . 51.27 116.411 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -69.97 -58.96 3.23 Favored 'General case' 0 C--N 1.356 0.859 0 O-C-N 120.231 -1.543 . . . . 59.1 111.561 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 17.5 m -53.29 -25.02 9.38 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.897 0 N-CA-C 113.262 0.838 . . . . 51.06 113.262 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 86.4 tttt -41.14 -38.3 1.05 Allowed 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 126.593 1.957 . . . . 57.38 114.863 169.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -66.45 -57.93 6.33 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 115.792 -2.051 . . . . 62.41 111.915 172.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -57.18 -28.62 62.98 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 123.924 3.056 . . . . 57.78 116.309 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1204 ' ' VAL . . . . . 0.597 HG11 ' HD1' ' A' 1211 ' ' PHE . 49.8 t -58.5 -60.51 2.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 O-C-N 121.555 -0.716 . . . . 46.38 109.924 168.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -69.92 -49.18 54.53 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 105.958 -1.867 . . . . 50.7 105.958 -170.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1206 ' ' SER . . . . . . . . . . . . . 45.8 m -45.75 -46.83 15.36 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.689 1.737 . . . . 49.98 115.689 169.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1207 ' ' MET . . . . . . . . . . . . . 18.2 mtp -73.21 -11.22 60.44 Favored 'General case' 0 CA--C 1.504 -0.79 0 O-C-N 119.024 -2.298 . . . . 52.99 113.06 175.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 105.27 64.95 0.66 Allowed Glycine 0 N--CA 1.439 -1.136 0 N-CA-C 109.931 -1.268 . . . . 47.66 109.931 166.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -152.81 144.52 23.53 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.099 -1.05 . . . . 44.77 110.147 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -75.49 133.19 41.11 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 105.738 -1.949 . . . . 47.64 105.738 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1211 ' ' PHE . . . . . 0.597 ' HD1' HG11 ' A' 1204 ' ' VAL . 35.1 t80 -99.22 105.93 18.02 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 117.075 -1.85 . . . . 45.66 108.974 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 55.6 mt -67.13 111.31 3.84 Favored 'General case' 0 C--O 1.252 1.229 0 CA-C-O 123.405 1.574 . . . . 46.06 109.9 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -79.18 165.37 23.37 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 113.379 -1.737 . . . . 60.22 115.318 174.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 8.4 mp -72.25 104.99 3.85 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-N 112.827 -1.988 . . . . 57.25 107.241 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1215 ' ' ASP . . . . . 0.45 ' HB3' HD21 ' A' 1241 ' ' LEU . 23.4 t70 -74.13 99.02 3.26 Favored 'General case' 0 CA--C 1.497 -1.071 0 O-C-N 118.416 -2.678 . . . . 64.43 106.617 166.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 14.5 t80 . . . . . 0 CA--C 1.54 0.558 0 CA-C-N 111.055 -2.793 . . . . 66.9 108.203 175.518 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 N--CA 1.425 -1.678 0 CA-C-O 121.843 0.83 . . . . 39.09 109.865 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -65.57 -29.38 75.03 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 126.927 2.203 . . . . 39.32 111.123 -169.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.7 -53.25 9.62 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 118.995 1.398 . . . . 39.3 107.546 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -55.6 -41.63 73.69 Favored 'General case' 0 C--O 1.211 -0.936 0 N-CA-C 113.358 0.873 . . . . 36.3 113.358 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -51.21 -64.77 0.7 Allowed 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 114.093 1.145 . . . . 37.38 114.093 162.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -63.62 -24.03 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 116.731 2.123 . . . . 39.11 116.731 -171.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1230 ' ' MET . . . . . . . . . . . . . 33.7 mmt -79.91 -23.57 41.7 Favored 'General case' 0 C--O 1.241 0.644 0 O-C-N 120.964 -1.085 . . . . 49.59 112.522 178.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1231 ' ' SER . . . . . . . . . . . . . 12.6 p -89.47 137.88 31.94 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 120.484 3.512 . . . . 43.68 120.484 -163.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -41.4 -45.58 3.14 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 117.457 2.392 . . . . 55.57 117.457 -174.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -73.01 -32.98 65.48 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 120.317 -1.489 . . . . 44.94 114.432 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -64.44 -53.9 41.03 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 106.804 -1.554 . . . . 42.04 106.804 172.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 35.9 mt -56.47 -27.5 24.93 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 N-CA-C 114.905 1.446 . . . . 46.28 114.905 173.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -59.08 -56.11 26.46 Favored 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 121.221 -0.924 . . . . 47.87 111.585 170.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -59.91 -52.92 63.35 Favored 'General case' 0 CA--C 1.496 -1.096 0 O-C-N 127.028 2.705 . . . . 41.61 111.339 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -48.68 -48.21 40.19 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 123.851 0.861 . . . . 50.65 112.316 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1239 ' ' MET . . . . . . . . . . . . . 28.4 ttm -55.02 -44.04 74.24 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 124.583 1.177 . . . . 48.87 109.149 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -72.07 -30.33 65.02 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.337 -0.945 . . . . 54.8 113.493 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1241 ' ' LEU . . . . . 0.45 HD21 ' HB3' ' A' 1215 ' ' ASP . 4.1 mm? -60.9 -43.54 98.36 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 118.833 -1.147 . . . . 43.21 113.824 169.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -62.15 -43.61 98.45 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.552 1.158 . . . . 38.66 109.37 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -57.15 -52.95 63.24 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.605 0.595 . . . . 37.92 112.605 171.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -54.35 -29.54 48.6 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 114.046 1.128 . . . . 37.28 114.046 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -85.31 -40.02 17.02 Favored 'General case' 0 C--N 1.315 -0.902 0 O-C-N 123.736 0.647 . . . . 43.07 110.588 174.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1246 ' ' ALA . . . . . 0.803 ' HB1' ' HG2' ' A' 1275 ' ' MET . . . -66.49 -15.5 63.42 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 116.742 2.127 . . . . 38.3 116.742 -158.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1247 ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -87.05 -18.46 30.52 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 113.391 -1.731 . . . . 47.6 113.792 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -105.33 -45.53 4.45 Favored 'General case' 0 C--N 1.358 0.968 0 O-C-N 120.435 -1.415 . . . . 45.42 112.839 165.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1249 ' ' VAL . . . . . 0.674 ' HA ' ' HB2' ' A' 1167 ' ' LYS . 31.4 m -64.67 148.14 12.07 Favored 'Isoleucine or valine' 0 C--N 1.345 0.382 0 CA-C-O 123.221 1.486 . . . . 36.26 114.256 -175.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1250 ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -91.37 -71.97 0.61 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.718 1.247 . . . . 33.04 111.036 -176.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1251 ' ' ILE . . . . . 0.7 HD12 ' HB1' ' A' 1145 ' ' ALA . 37.4 mm -97.68 101.29 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.946 0 C-N-CA 117.462 -1.695 . . . . 31.4 107.776 -171.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1252 ' ' ILE . . . . . . . . . . . . . 68.0 mt -77.09 94.15 1.25 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 106.563 -1.643 . . . . 29.42 106.563 166.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1253 ' ' VAL . . . . . 0.652 ' HA ' HG23 ' A' 1282 ' ' VAL . 2.0 t -81.3 98.61 4.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 104.5 -2.408 . . . . 30.37 104.5 175.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1254 ' ' THR . . . . . 0.767 HG21 ' HB2' ' A' 1291 ' ' ASN . 22.3 m -86.76 82.16 7.94 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 124.587 2.137 . . . . 35.72 105.914 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1255 ' ' THR . . . . . 0.476 HG22 HD12 ' A' 1284 ' ' LEU . 1.9 p -73.8 5.11 4.34 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 120.067 3.358 . . . . 36.0 120.067 -176.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1256 ' ' ALA . . . . . . . . . . . . . . . -85.64 63.03 7.83 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 124.105 1.907 . . . . 40.93 112.76 -170.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 57.1 tp -70.6 91.72 0.81 Allowed 'General case' 0 C--N 1.353 0.733 0 N-CA-C 103.546 -2.761 . . . . 47.82 103.546 172.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 39.5 mm -87.08 108.15 17.63 Favored Pre-proline 0 C--O 1.22 -0.489 0 N-CA-C 104.14 -2.541 . . . . 52.7 104.14 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -56.63 109.52 0.46 Allowed 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 124.398 3.399 . . . . 54.13 116.34 -170.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 78.34 16.32 79.69 Favored Glycine 0 N--CA 1.461 0.343 0 CA-C-N 112.025 -2.352 . . . . 54.62 111.945 174.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 92.1 mttt -125.78 141.72 40.11 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 119.628 1.714 . . . . 55.74 109.022 -176.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -66.46 97.85 0.38 Allowed 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 123.299 2.666 . . . . 51.15 107.031 172.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -56.58 125.02 65.8 Favored Pre-proline 0 N--CA 1.433 -1.294 0 CA-C-O 117.375 -1.298 . . . . 46.06 112.519 176.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -50.15 128.39 22.35 Favored 'Trans proline' 0 C--O 1.25 1.09 1 C-N-CA 126.622 4.881 . . . . 41.08 112.645 -166.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -61.7 97.06 0.07 Allowed 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.933 -1.03 . . . . 47.42 110.408 172.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 83.4 mt -94.77 -54.54 3.44 Favored 'General case' 0 N--CA 1.434 -1.23 0 O-C-N 120.693 -1.254 . . . . 39.22 109.68 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1267 ' ' ILE . . . . . 0.484 ' HB ' ' HA ' ' A' 1292 ' ' CYS . 12.3 mt -78.46 104.36 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 107.937 -1.135 . . . . 42.5 107.937 -172.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1268 ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.54 148.56 48.44 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 119.078 2.992 . . . . 37.84 119.078 175.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 40.6 mtt180 -52.28 -59.45 4.38 Favored 'General case' 0 C--O 1.248 0.996 0 N-CA-C 117.159 2.281 . . . . 54.8 117.159 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.55 -27.01 68.96 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 118.819 0.736 . . . . 54.36 111.919 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1271 ' ' MET . . . . . . . . . . . . . 59.5 ttm -68.45 -36.76 79.47 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.986 1.314 . . . . 39.52 111.704 175.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1272 ' ' VAL . . . . . . . . . . . . . 92.3 t -63.25 -47.94 89.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 N-CA-C 107.503 -1.295 . . . . 38.25 107.503 171.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -57.6 -26.16 61.13 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 113.731 1.012 . . . . 40.77 113.731 175.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1274 ' ' SER . . . . . . . . . . . . . 5.1 m -85.67 -8.24 58.33 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 121.261 1.846 . . . . 36.58 114.945 173.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1275 ' ' MET . . . . . 0.803 ' HG2' ' HB1' ' A' 1246 ' ' ALA . 87.1 mtp -60.76 165.19 4.11 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 116.521 2.045 . . . . 36.75 116.521 176.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1276 ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -67.47 144.47 55.69 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 122.514 1.149 . . . . 46.11 111.585 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1277 ' ' ALA . . . . . 0.494 ' HB1' ' HA ' ' B' 1045 ' ' PHE . . . -60.25 139.89 57.34 Favored 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 124.423 1.089 . . . . 33.52 109.008 176.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 76.43 -0.79 63.14 Favored Glycine 0 CA--C 1.538 1.479 0 O-C-N 119.943 -1.723 . . . . 31.27 113.267 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1279 ' ' SER . . . . . . . . . . . . . 47.0 m -74.56 160.53 30.76 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 118.771 -2.605 . . . . 32.95 109.37 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1280 ' ' VAL . . . . . 0.554 HG11 ' HA ' ' A' 1145 ' ' ALA . 82.9 t -127.49 135.88 62.05 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 O-C-N 119.776 -1.828 . . . . 27.43 108.38 -178.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1281 ' ' ILE . . . . . 0.449 HD12 HG22 ' A' 1309 ' ' VAL . 83.7 mt -108.62 98.62 7.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 103.193 -2.891 . . . . 30.3 103.193 169.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1282 ' ' VAL . . . . . 0.652 HG23 ' HA ' ' A' 1253 ' ' VAL . 0.0 OUTLIER -85.42 97.28 5.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.577 -1.268 . . . . 28.63 107.577 171.216 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1283 ' ' ASP . . . . . 0.646 ' HA ' ' HB ' ' A' 1254 ' ' THR . 19.6 t0 -87.83 109.39 19.72 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.019 -1.474 . . . . 36.27 107.019 178.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1284 ' ' LEU . . . . . 0.721 HD21 ' HB2' ' A' 1141 ' ' ALA . 25.4 mt -74.98 -28.96 60.76 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 112.909 -1.95 . . . . 38.57 115.214 173.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -65.99 -53.18 42.16 Favored 'General case' 0 C--O 1.218 -0.569 0 O-C-N 120.304 -1.497 . . . . 37.56 110.098 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1286 ' ' ALA . . . . . 0.503 ' HA ' HG21 ' A' 1295 ' ' THR . . . 38.02 -74.81 0.0 OUTLIER 'General case' 0 N--CA 1.413 -2.291 0 C-N-CA 128.511 2.724 . . . . 40.33 116.172 176.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -63.07 -47.32 83.46 Favored 'General case' 0 N--CA 1.482 1.175 0 O-C-N 120.365 -1.46 . . . . 56.85 109.634 173.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 5.5 m120 -72.83 70.1 0.97 Allowed 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 124.718 1.261 . . . . 45.86 109.43 175.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 74.26 -58.91 2.36 Favored Glycine 0 CA--C 1.538 1.524 0 N-CA-C 117.657 1.823 . . . . 40.31 117.657 -176.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 84.35 121.79 0.95 Allowed Glycine 0 C--O 1.22 -0.728 0 N-CA-C 108.835 -1.706 . . . . 38.89 108.835 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1291 ' ' ASN . . . . . 0.767 ' HB2' HG21 ' A' 1254 ' ' THR . 24.4 m120 -76.45 -20.6 56.87 Favored 'General case' 0 CA--C 1.492 -1.281 0 CA-C-N 121.26 2.53 . . . . 37.23 112.324 -176.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1292 ' ' CYS . . . . . 0.484 ' HA ' ' HB ' ' A' 1267 ' ' ILE . 36.9 t -85.44 142.99 28.84 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 120.249 -1.532 . . . . 36.5 109.638 170.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1293 ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -74.36 -13.96 60.81 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 116.218 1.932 . . . . 43.32 116.218 169.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -90.03 -4.25 57.5 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 116.018 1.858 . . . . 41.32 116.018 169.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1295 ' ' THR . . . . . 0.503 HG21 ' HA ' ' A' 1286 ' ' ALA . 52.5 m -65.96 119.22 10.96 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 119.375 -2.078 . . . . 35.3 110.971 -175.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1296 ' ' VAL . . . . . 0.577 ' HB ' ' HB2' ' A' 1299 ' ' GLU . 48.4 t -95.53 112.26 58.32 Favored Pre-proline 0 C--O 1.248 1.015 0 N-CA-C 101.575 -3.491 . . . . 34.84 101.575 171.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -55.86 104.54 0.13 Allowed 'Trans proline' 0 C--O 1.22 -0.408 0 C-N-CA 124.114 3.21 . . . . 33.51 111.902 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 112.23 9.77 19.22 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 113.561 -1.654 . . . . 32.19 111.048 172.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1299 ' ' GLU . . . . . 0.577 ' HB2' ' HB ' ' A' 1296 ' ' VAL . 8.7 mm-40 -132.89 162.34 31.85 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 121.248 2.524 . . . . 34.88 116.451 -163.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1300 ' ' ILE . . . . . 0.438 HG23 HG12 ' A' 1310 ' ' ILE . 80.2 mt -90.76 105.82 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 N-CA-C 101.671 -3.455 . . . . 32.29 101.671 163.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1301 ' ' PHE . . . . . 0.68 ' HB3' ' HB ' ' A' 1309 ' ' VAL . 35.5 t80 -81.9 110.67 17.4 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 104.73 -2.322 . . . . 37.25 104.73 166.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1302 ' ' THR . . . . . . . . . . . . . 54.0 m -93.44 119.07 32.1 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.136 -1.802 . . . . 35.56 106.136 175.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1303 ' ' THR . . . . . . . . . . . . . 2.1 m -103.18 142.6 33.88 Favored 'General case' 0 C--O 1.247 0.946 0 N-CA-C 107.643 -1.243 . . . . 36.4 107.643 -173.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -52.4 -42.6 64.17 Favored 'General case' 0 C--O 1.247 0.921 0 C-N-CA 126.285 1.834 . . . . 52.32 113.445 -168.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1305 ' ' ASN . . . . . 0.691 ' HA ' ' HB2' ' B' 1046 ' ' ASP . 38.3 p-10 -61.07 -22.0 64.19 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 115.628 1.714 . . . . 40.04 115.628 175.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 120.56 0.11 12.37 Favored Glycine 0 N--CA 1.413 -2.891 0 C-N-CA 120.333 -0.937 . . . . 36.96 111.223 177.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1307 ' ' VAL . . . . . 0.613 HG21 ' HB2' ' A' 1275 ' ' MET . 71.0 t -82.53 131.51 33.6 Favored 'Isoleucine or valine' 0 C--N 1.347 0.493 0 O-C-N 118.452 -2.793 . . . . 33.4 110.147 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1308 ' ' LYS . . . . . 0.686 ' HG3' ' HB3' ' A' 1148 ' ' GLU . 26.2 mmtp -99.15 94.91 6.76 Favored 'General case' 0 C--O 1.248 1.0 0 N-CA-C 106.226 -1.768 . . . . 42.91 106.226 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1309 ' ' VAL . . . . . 0.68 ' HB ' ' HB3' ' A' 1301 ' ' PHE . 24.0 t -76.08 85.88 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.608 0 CA-C-O 122.296 1.046 . . . . 32.29 109.803 174.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1310 ' ' ILE . . . . . 0.828 HD11 ' HB2' ' A' 1148 ' ' GLU . 55.0 mt -89.95 95.83 5.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 124.566 2.127 . . . . 30.99 106.263 -174.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -90.55 71.26 2.06 Favored Glycine 0 N--CA 1.436 -1.364 0 O-C-N 119.515 -1.991 . . . . 28.95 110.778 171.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1312 ' ' TYR . . . . . 0.482 ' HD1' ' HA ' ' A' 1312 ' ' TYR . 0.0 OUTLIER -91.65 124.52 35.86 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 119.167 1.483 . . . . 31.69 111.187 -171.105 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1313 ' ' THR . . . . . . . . . . . . . 4.5 p -103.71 -21.65 13.67 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 118.862 -1.135 . . . . 34.17 113.827 -175.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -81.85 24.53 0.61 Allowed 'General case' 0 C--O 1.256 1.432 0 CA-C-O 122.06 0.933 . . . . 36.86 112.752 -173.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1315 ' ' LEU . . . . . 0.546 HD22 ' HG3' ' A' 1140 ' ' ARG . 88.3 mt -69.84 -42.52 18.45 Favored Pre-proline 0 N--CA 1.439 -1.012 0 N-CA-C 118.075 2.62 . . . . 34.85 118.075 -168.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -59.54 -35.58 95.24 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 CA-C-N 123.672 2.347 . . . . 29.15 113.8 171.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -65.2 -35.72 91.99 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-O 122.165 0.87 . . . . 27.29 111.413 172.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1318 ' ' ARG . . . . . 0.49 ' HD2' HD23 ' A' 1315 ' ' LEU . 79.7 mtt-85 -64.38 -3.16 2.68 Favored 'General case' 0 C--O 1.24 0.563 0 O-C-N 120.438 -1.625 . . . . 41.49 114.697 168.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1319 ' ' LEU . . . . . 0.471 HD23 HG23 ' A' 1136 ' ' ILE . 8.0 tp -143.51 69.53 17.38 Favored Pre-proline 0 N--CA 1.437 -1.114 0 O-C-N 118.487 -2.633 . . . . 27.61 111.018 178.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1320 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -53.88 -62.72 0.28 Allowed 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 124.948 3.765 . . . . 25.94 116.451 -169.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1321 ' ' THR . . . . . 0.415 HG21 HH11 ' B' 1151 ' ' ARG . 0.2 OUTLIER -59.4 -22.95 62.17 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 121.361 1.891 . . . . 25.01 111.407 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1322 ' ' GLN . . . . . 0.502 HE22 HG21 ' B' 1163 ' ' VAL . 29.7 tp60 -75.18 -37.57 61.17 Favored 'General case' 0 C--O 1.217 -0.617 0 O-C-N 120.192 -1.568 . . . . 29.39 109.088 176.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1323 ' ' SER . . . . . . . . . . . . . 73.6 m -60.4 -66.54 0.51 Allowed 'General case' 0 C--O 1.251 1.149 0 CA-C-O 118.185 -0.912 . . . . 26.47 109.897 166.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1324 ' ' SER . . . . . . . . . . . . . 14.5 m -45.29 -36.36 4.01 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 116.883 2.179 . . . . 27.78 116.883 177.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -77.88 -64.96 1.03 Allowed 'General case' 0 C--O 1.216 -0.701 0 O-C-N 119.805 -1.809 . . . . 37.53 114.723 170.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1326 ' ' LEU . . . . . 0.731 ' HB3' ' HB3' ' A' 1132 ' ' SER . 22.1 mt -70.39 -51.39 29.98 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 120.961 1.71 . . . . 35.71 113.544 -169.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1327 ' ' TYR . . . . . 0.468 ' HA ' ' OD1' ' A' 1330 ' ' ASN . 64.4 t80 -66.14 -46.05 78.86 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 106.779 -1.563 . . . . 31.59 106.779 174.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1328 ' ' GLY . . . . . 0.564 ' HA2' HD12 ' A' 1331 ' ' LEU . . . -40.42 -52.82 3.58 Favored Glycine 0 CA--C 1.541 1.664 0 CA-C-N 119.994 1.27 . . . . 28.0 113.829 166.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1329 ' ' THR . . . . . 0.402 ' HA ' ' HB ' ' A' 1332 ' ' VAL . 1.1 m -79.44 -18.28 52.51 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 117.328 -3.454 . . . . 32.15 108.353 -173.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1330 ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' 1127 ' ' LEU . 29.4 m120 -57.91 -53.96 52.26 Favored 'General case' 0 C--O 1.246 0.893 0 O-C-N 118.344 -2.722 . . . . 34.36 110.487 167.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1331 ' ' LEU . . . . . 0.803 HD13 HD13 ' A' 1070 ' ' LEU . 11.7 mt -57.0 -47.5 80.69 Favored 'General case' 0 C--N 1.353 0.726 0 CA-C-N 113.63 -1.623 . . . . 33.37 110.388 175.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1332 ' ' VAL . . . . . 0.676 HG21 ' HB ' ' A' 1022 ' ' THR . 59.9 t -58.86 -37.53 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 124.884 1.274 . . . . 35.27 109.98 176.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -70.59 -41.75 71.94 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-N 121.801 2.091 . . . . 37.66 112.475 -176.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1334 ' ' LEU . . . . . 0.536 HD23 HG13 ' A' 1090 ' ' VAL . 60.2 tp -58.74 -53.31 59.85 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 121.51 0.671 . . . . 40.27 109.669 170.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1335 ' ' LEU . . . . . 0.484 ' HA ' ' HB2' ' A' 1338 ' ' LEU . 13.5 mt -60.92 -21.11 63.06 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 115.511 1.671 . . . . 42.5 115.511 176.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1336 ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' 1332 ' ' VAL . 96.1 mttt -65.23 -46.83 79.01 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 118.626 0.648 . . . . 47.81 109.589 168.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1337 ' ' LEU . . . . . . . . . . . . . 36.7 mt -63.67 -41.22 98.21 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 124.03 1.871 . . . . 49.27 111.569 178.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1338 ' ' LEU . . . . . 0.484 ' HB2' ' HA ' ' A' 1335 ' ' LEU . 10.3 mp -59.74 -41.49 91.05 Favored 'General case' 0 C--N 1.355 0.823 0 CA-C-O 122.923 1.344 . . . . 50.54 112.624 175.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1339 ' ' CYS . . . . . 0.724 ' SG ' ' HA ' ' A' 1342 ' ' LYS . 18.1 t -74.93 82.01 2.18 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 123.734 1.731 . . . . 53.67 111.905 173.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -58.9 -55.23 37.76 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 112.543 -2.117 . . . . 63.38 113.229 -175.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -115.57 -0.47 13.03 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 115.351 1.611 . . . . 70.95 115.351 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1342 ' ' LYS . . . . . 0.724 ' HA ' ' SG ' ' A' 1339 ' ' CYS . 31.3 mtmm 56.3 66.41 1.2 Allowed 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 118.716 2.858 . . . . 65.25 118.716 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1343 ' ' ASP . . . . . 0.464 ' HB3' ' N ' ' A' 1342 ' ' LYS 0.462 0.0 OUTLIER 87.79 -73.96 0.01 OUTLIER 'General case' 0 C--N 1.359 0.987 3 O-C-N 113.169 -5.957 . . . . 64.53 120.278 -10.645 . . . . . . . . 5 4 . 1 . 002 nuclear nobuild full ' A' A 1344 ' ' GLY . . . . . . . . . . . . . . . 68.55 46.6 61.53 Favored Glycine 0 C--O 1.257 1.553 0 O-C-N 120.764 -1.21 . . . . 59.72 115.562 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1345 ' ' ASN . . . . . 0.444 ' HB2' ' OD2' ' A' 1343 ' ' ASP . 9.1 t-20 -78.81 149.33 32.61 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 115.729 1.751 . . . . 64.09 115.729 176.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1346 ' ' ILE . . . . . . . . . . . . . 2.8 mp -85.04 86.69 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 N-CA-C 100.847 -3.76 . . . . 58.82 100.847 170.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1347 ' ' THR . . . . . . . . . . . . . 9.7 m -93.2 91.94 7.51 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 123.57 1.652 . . . . 54.96 113.859 172.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1348 ' ' VAL . . . . . 0.55 HG21 HG21 ' A' 1111 ' ' THR . 10.4 t -88.01 93.15 4.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 101.294 -3.595 . . . . 55.64 101.294 174.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 21.5 t70 -86.36 133.17 33.81 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-O 123.476 1.608 . . . . 61.45 107.806 169.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -99.88 -8.95 23.42 Favored 'General case' 0 N--CA 1.442 -0.838 0 O-C-N 119.991 -1.693 . . . . 58.63 113.127 176.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -73.36 -35.08 65.92 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-N 115.551 -0.75 . . . . 62.06 112.767 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 7.3 t70 -82.75 125.53 31.37 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.537 -1.283 . . . . 54.07 107.537 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 27.2 m -55.61 -30.79 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 113.53 -1.668 . . . . 50.68 114.088 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1354 ' ' VAL . . . . . 0.474 ' O ' HG23 ' A' 1358 ' ' VAL 0.251 6.0 m -71.03 -49.66 47.8 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 C-N-CA 118.955 -1.098 . . . . 47.68 112.374 178.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1355 ' ' ILE . . . . . . . . . . . . . 72.0 mt -71.36 -37.7 66.25 Favored 'Isoleucine or valine' 0 C--O 1.253 1.241 0 N-CA-C 108.623 -0.881 . . . . 48.49 108.623 -173.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 46.5 tpt85 -57.36 -33.38 67.73 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 113.56 0.948 . . . . 48.27 113.56 167.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -65.72 -52.54 37.7 Favored Glycine 0 N--CA 1.436 -1.357 0 C-N-CA 123.52 0.581 . . . . 43.53 112.486 172.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1358 ' ' VAL . . . . . 0.785 HG22 HG22 ' A' 1118 ' ' VAL . 3.5 t -66.18 -37.93 80.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 107.401 -1.333 . . . . 45.12 107.401 -175.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1359 ' ' THR . . . . . . . . . . . . . 30.3 m -76.43 87.74 3.19 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 119.869 -1.77 . . . . 42.94 111.228 -174.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 33.4 m -77.93 -31.43 16.89 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 O-C-N 121.025 -1.047 . . . . 43.26 110.647 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1361 ' ' ILE . . . . . 0.475 HG12 HG12 ' A' 1366 ' ' ILE . 94.8 mt -128.56 119.62 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 N-CA-C 105.844 -1.91 . . . . 45.66 105.844 176.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1362 ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -103.45 120.29 40.53 Favored 'General case' 0 C--N 1.364 1.209 0 CA-C-N 123.445 2.838 . . . . 61.34 106.365 174.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 36.01 48.5 0.52 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 112.14 -2.3 . . . . 49.76 115.999 -177.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1364 ' ' GLY . . . . . 0.499 ' HA3' ' HA ' ' A' 1109 ' ' ASN . . . 89.23 12.73 62.89 Favored Glycine 0 C--O 1.222 -0.603 0 CA-C-O 116.944 -2.031 . . . . 50.0 113.062 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -122.83 127.07 48.56 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 102.322 -3.214 . . . . 56.92 102.322 172.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1366 ' ' ILE . . . . . 0.475 HG12 HG12 ' A' 1361 ' ' ILE . 43.5 mt -73.75 92.89 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 CA-C-O 123.01 1.386 . . . . 52.78 109.184 -176.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1367 ' ' THR . . . . . . . . . . . . . 6.9 p -76.55 -5.69 48.74 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 123.55 1.643 . . . . 49.44 114.609 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 20.1 t90 -60.42 143.56 89.48 Favored Pre-proline 0 N--CA 1.44 -0.931 0 CA-C-O 116.227 -1.844 . . . . 52.38 110.365 171.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -81.37 -163.88 3.55 Favored 'Cis proline' 0 C--O 1.248 1.005 0 CA-C-N 123.417 2.256 . . . . 46.94 112.571 -6.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -129.14 158.3 73.32 Favored Pre-proline 0 N--CA 1.428 -1.561 0 CA-C-O 117.188 -1.387 . . . . 45.91 108.742 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1371 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -47.28 120.83 4.69 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 124.901 3.734 . . . . 46.39 111.216 170.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -65.66 -41.26 15.17 Favored 'Trans proline' 0 CA--C 1.557 1.64 0 C-N-CA 125.076 3.851 . . . . 46.72 112.077 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.228 -4.699 0 CA-C-N 121.508 1.958 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 20.2 m80 . . . . . 0 N--CA 1.425 -1.697 0 N-CA-C 105.958 -1.867 . . . . 63.44 105.958 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 999' ' ' HIS . . . . . 0.512 ' HB3' ' HB3' ' B' 1002 ' ' ARG . 89.7 m-70 -93.94 57.36 2.43 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 119.485 -2.009 . . . . 51.74 107.449 173.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1000 ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -81.46 118.45 22.72 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 106.792 -1.559 . . . . 54.07 106.792 -167.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 72.78 18.97 79.13 Favored Glycine 0 C--O 1.224 -0.529 0 CA-C-N 114.716 -1.129 . . . . 39.22 111.927 -168.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1002 ' ' ARG . . . . . 0.544 ' HD2' ' HB2' ' B' 1034 ' ' ALA . 33.9 ttp180 -100.6 124.93 46.85 Favored 'General case' 0 C--O 1.256 1.419 0 CA-C-N 121.387 2.594 . . . . 38.12 109.994 169.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1003 ' ' ILE . . . . . . . . . . . . . 51.6 mt -81.41 142.61 13.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 108.942 -3.753 . . . . 29.7 105.029 171.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -112.44 128.56 8.55 Favored Glycine 0 N--CA 1.436 -1.332 0 N-CA-C 106.217 -2.753 . . . . 27.5 106.217 166.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1005 ' ' ILE . . . . . 0.567 ' HB ' ' HA ' ' B' 1035 ' ' VAL . 47.6 mm -105.62 99.71 22.92 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 101.166 -3.642 . . . . 24.83 101.166 173.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -83.88 166.62 13.14 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.672 2.248 . . . . 27.19 112.148 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 30.2 ttm105 -77.17 143.61 38.95 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 103.039 -2.949 . . . . 41.46 103.039 167.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1008 ' ' GLU . . . . . 0.485 ' OE2' ' HG2' ' B' 1071 ' ' LYS . 8.6 mm-40 -63.9 129.8 41.52 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 116.83 2.159 . . . . 26.93 116.83 169.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 48.5 mmm-85 -83.73 -5.7 59.26 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 110.704 -2.953 . . . . 34.48 111.339 171.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1010 ' ' LEU . . . . . 0.401 HD23 ' HB2' ' B' 1013 ' ' GLU . 4.1 tp -60.93 126.16 26.37 Favored 'General case' 0 C--O 1.244 0.792 0 O-C-N 120.805 -1.184 . . . . 44.22 108.919 168.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1011 ' ' THR . . . . . . . . . . . . . 86.9 m -64.93 116.47 6.41 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-O 122.452 1.12 . . . . 40.74 108.95 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 21.7 t30 63.15 92.16 0.06 Allowed 'General case' 0 C--N 1.339 0.15 0 CA-C-N 112.308 -2.224 . . . . 44.44 112.546 -174.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1013 ' ' GLU . . . . . 0.401 ' HB2' HD23 ' B' 1010 ' ' LEU . 10.3 tp10 -137.88 138.72 39.36 Favored 'General case' 0 N--CA 1.415 -2.217 0 CA-C-N 111.147 -2.752 . . . . 29.87 104.385 176.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1014 ' ' THR . . . . . 0.454 HG22 ' HB3' ' B' 1320 ' ' PRO . 0.2 OUTLIER -104.38 -5.07 22.07 Favored 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 120.247 -1.533 . . . . 25.26 111.331 177.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B 1015 ' ' ARG . . . . . 0.701 ' HG3' ' HA2' ' B' 1317 ' ' GLY . 23.6 mtm180 -88.37 148.05 24.44 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 119.904 1.229 . . . . 29.54 113.517 177.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1016 ' ' VAL . . . . . 0.535 HG13 ' H ' ' B' 1018 ' ' ALA . 4.4 p -113.94 -173.19 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 105.643 -1.984 . . . . 23.55 105.643 151.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1017 ' ' ALA . . . . . . . . . . . . . . . -106.37 11.75 30.57 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 121.485 1.948 . . . . 23.59 115.686 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1018 ' ' ALA . . . . . 0.535 ' H ' HG13 ' B' 1016 ' ' VAL . . . -149.98 156.16 41.22 Favored 'General case' 0 C--O 1.211 -0.939 0 CA-C-O 123.018 1.389 . . . . 24.93 113.677 -176.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1019 ' ' THR . . . . . 0.524 HG22 ' HZ ' ' B' 1045 ' ' PHE . 26.1 p -135.12 163.48 50.81 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 110.812 -2.904 . . . . 28.09 103.308 176.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -49.97 -39.25 49.91 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.86 2.374 . . . . 28.79 113.541 168.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1021 ' ' LYS . . . . . 0.4 ' O ' ' HG3' ' B' 1025 ' ' GLN . 76.4 tttt -67.9 -44.7 76.38 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 112.535 0.568 . . . . 47.28 112.535 177.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1022 ' ' THR . . . . . . . . . . . . . 13.7 p -67.99 -29.61 68.66 Favored 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 120.223 -1.548 . . . . 30.12 111.956 178.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1023 ' ' VAL . . . . . . . . . . . . . 69.1 t -56.55 -53.84 35.97 Favored 'Isoleucine or valine' 0 C--N 1.351 0.637 0 N-CA-C 107.107 -1.442 . . . . 32.24 107.107 170.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1024 ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -55.96 -39.36 71.66 Favored 'General case' 0 C--O 1.215 -0.732 0 N-CA-C 114.324 1.231 . . . . 49.62 114.324 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1025 ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' B' 1021 ' ' LYS . 43.9 mt-30 -65.97 -43.26 88.4 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 122.496 1.141 . . . . 44.68 109.869 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1026 ' ' LEU . . . . . 0.404 ' CD2' HG22 ' B' 1332 ' ' VAL . 42.6 mt -67.82 -32.17 72.52 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 119.103 -2.248 . . . . 35.71 114.641 173.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1027 ' ' LEU . . . . . . . . . . . . . 98.1 mt -62.9 -39.91 95.96 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.072 -1.017 . . . . 42.18 110.493 172.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 24.8 mttm -62.17 -47.65 83.56 Favored 'General case' 0 C--O 1.251 1.154 0 N-CA-C 109.21 -0.663 . . . . 48.34 109.21 172.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1029 ' ' LEU . . . . . 0.627 HD21 ' HG2' ' B' 1336 ' ' LYS . 79.8 mt -64.84 -4.27 4.24 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 116.972 2.212 . . . . 38.69 116.972 172.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 88.95 20.95 44.37 Favored Glycine 0 N--CA 1.433 -1.551 0 CA-C-O 122.934 1.296 . . . . 32.28 114.355 166.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -99.05 143.95 28.75 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 123.163 1.459 . . . . 35.94 108.212 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1032 ' ' THR . . . . . . . . . . . . . 31.9 m -79.04 117.14 19.81 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 106.532 -1.655 . . . . 33.37 106.532 164.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1033 ' ' VAL . . . . . . . . . . . . . 2.9 t -91.89 108.62 20.27 Favored 'Isoleucine or valine' 0 C--O 1.262 1.741 0 O-C-N 120.599 -1.313 . . . . 29.98 107.708 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1034 ' ' ALA . . . . . 0.544 ' HB2' ' HD2' ' B' 1002 ' ' ARG . . . -99.84 140.17 34.44 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 107.376 -1.342 . . . . 28.18 107.376 172.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1035 ' ' VAL . . . . . 0.567 ' HA ' ' HB ' ' B' 1005 ' ' ILE . 88.3 t -124.26 145.53 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 103.652 -2.721 . . . . 25.82 103.652 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1036 ' ' GLU . . . . . 0.603 ' HB3' ' HB2' ' B' 1039 ' ' ALA . 26.9 tt0 -65.89 129.75 40.88 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.472 -1.24 . . . . 32.44 112.585 173.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1037 ' ' SER . . . . . . . . . . . . . 12.7 m -57.16 133.9 55.43 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.239 -1.346 . . . . 29.54 108.884 172.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 88.88 -43.59 3.09 Favored Glycine 0 CA--C 1.498 -0.98 0 O-C-N 117.424 -3.297 . . . . 27.76 110.886 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1039 ' ' ALA . . . . . 0.603 ' HB2' ' HB3' ' B' 1036 ' ' GLU . . . -37.52 -37.37 0.2 Allowed 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 118.304 2.705 . . . . 26.02 118.304 -175.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -62.99 -31.13 79.62 Favored Glycine 0 N--CA 1.42 -2.411 0 C-N-CA 126.029 1.776 . . . . 26.47 113.62 -175.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1041 ' ' GLN . . . . . 0.426 ' NE2' ' HA ' ' B' 1046 ' ' ASP . 3.1 mp0 -56.9 -40.62 76.6 Favored 'General case' 0 CA--C 1.518 -0.26 0 O-C-N 120.137 -1.802 . . . . 50.98 114.101 -175.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 29.9 mt -63.5 -44.19 95.04 Favored 'General case' 0 C--O 1.247 0.923 0 O-C-N 121.594 -0.691 . . . . 29.3 109.502 175.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1043 ' ' ALA . . . . . . . . . . . . . . . -87.3 17.41 4.41 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 120.732 -1.23 . . . . 26.74 113.491 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1044 ' ' SER . . . . . . . . . . . . . 10.5 m 67.83 46.24 1.29 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 123.909 1.814 . . . . 31.26 112.191 170.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1045 ' ' PHE . . . . . 0.524 ' HZ ' HG22 ' B' 1019 ' ' THR . 85.3 m-85 -130.86 162.86 28.68 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 104.79 -2.3 . . . . 33.26 104.79 175.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1046 ' ' ASP . . . . . 0.691 ' HB2' ' HA ' ' A' 1305 ' ' ASN . 22.9 t70 -104.19 161.3 14.15 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.011 -1.477 . . . . 46.74 107.011 158.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.55 -39.23 92.94 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 122.399 1.095 . . . . 34.44 111.094 -175.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.6 -22.01 63.29 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 115.443 1.646 . . . . 48.67 115.443 -176.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -62.73 -42.94 99.91 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 118.93 -2.356 . . . . 35.26 110.48 166.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1050 ' ' PHE . . . . . 0.446 ' HB2' HD11 ' B' 1057 ' ' ILE . 91.4 m-85 -69.82 -36.35 75.55 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 119.622 -1.924 . . . . 32.17 110.446 176.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 42.5 t -57.3 -43.34 81.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 116.08 -0.509 . . . . 38.37 110.585 171.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -71.26 -27.26 63.32 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 118.527 0.603 . . . . 45.77 111.504 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -73.02 -23.98 60.68 Favored 'General case' 0 N--CA 1.443 -0.775 0 O-C-N 120.723 -1.236 . . . . 37.83 112.407 174.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 95.15 39.33 4.57 Favored Glycine 0 C--O 1.221 -0.703 0 O-C-N 124.556 1.16 . . . . 35.82 112.85 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -102.21 139.13 38.23 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 124.082 0.953 . . . . 33.77 110.251 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -73.96 101.02 3.7 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.635 1.174 . . . . 51.02 107.955 -177.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1057 ' ' ILE . . . . . 0.446 HD11 ' HB2' ' B' 1050 ' ' PHE . 50.2 mm -88.86 100.4 10.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 119.442 -2.036 . . . . 38.47 106.08 -172.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1058 ' ' VAL . . . . . 0.42 HG23 ' HB ' ' B' 1063 ' ' VAL . 3.2 m -123.87 158.89 29.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 107.267 -1.383 . . . . 39.4 107.267 -173.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -72.33 167.19 20.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 118.421 -0.799 . . . . 57.07 112.732 -175.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1060 ' ' GLY . . . . . 0.411 ' O ' HG12 ' B' 1063 ' ' VAL . . . -52.5 -61.37 6.77 Favored Glycine 0 C--N 1.344 1.021 0 O-C-N 124.695 1.247 . . . . 44.83 114.129 -164.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 2.3 t30 -70.82 -32.55 69.65 Favored 'General case' 0 C--O 1.223 -0.303 0 O-C-N 119.546 -2.149 . . . . 46.27 110.486 -173.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1062 ' ' SER . . . . . . . . . . . . . 5.8 m -61.4 -41.2 96.74 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 113.125 -1.852 . . . . 43.47 113.336 171.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1063 ' ' VAL . . . . . 0.42 ' HB ' HG23 ' B' 1058 ' ' VAL . 6.4 p -72.83 -31.11 35.03 Favored 'Isoleucine or valine' 0 C--O 1.26 1.616 0 CA-C-N 121.069 1.759 . . . . 36.98 109.788 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1064 ' ' TRP . . . . . 0.591 ' HZ3' ' HG ' ' B' 1083 ' ' LEU . 0.1 OUTLIER -63.53 -31.26 72.37 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-O 122.347 1.07 . . . . 37.9 112.662 174.034 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -79.54 80.79 5.88 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 119.594 -1.941 . . . . 46.19 111.172 174.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1066 ' ' SER . . . . . 0.505 ' HB3' ' O ' ' B' 1002 ' ' ARG . 49.3 m -138.23 168.41 19.8 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 121.645 -0.659 . . . . 37.06 110.118 176.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1067 ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -79.42 -25.86 41.97 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 124.217 1.007 . . . . 43.95 109.914 176.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1068 ' ' ILE . . . . . 0.492 HG12 HD11 ' B' 1346 ' ' ILE . 3.5 mp -130.78 138.86 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 O-C-N 119.254 -2.154 . . . . 33.5 108.186 171.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1069 ' ' ILE . . . . . 0.632 HG22 ' HB2' ' B' 1071 ' ' LYS . 35.8 mm -124.31 120.72 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 104.036 -2.579 . . . . 30.57 104.036 176.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1070 ' ' LEU . . . . . 0.819 ' HB3' HD13 ' B' 1331 ' ' LEU . 56.9 mt -103.77 109.48 21.22 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 101.347 -3.575 . . . . 27.66 101.347 175.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1071 ' ' LYS . . . . . 0.632 ' HB2' HG22 ' B' 1069 ' ' ILE . 28.1 tttm -135.93 152.01 50.55 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 103.196 -2.89 . . . . 28.4 103.196 -167.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1072 ' ' VAL . . . . . 0.457 ' HA ' ' CE2' ' B' 1327 ' ' TYR . 45.4 t -80.43 -60.92 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.566 0 N-CA-C 107.717 -1.216 . . . . 23.18 107.717 -171.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -114.86 -173.97 2.4 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 120.265 -1.522 . . . . 25.47 110.803 -166.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1074 ' ' ALA . . . . . 0.407 ' HA ' ' HD2' ' B' 1075 ' ' PRO . . . -46.93 133.74 8.58 Favored Pre-proline 0 C--N 1.367 1.333 0 C-N-CA 124.602 1.161 . . . . 27.9 113.62 175.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1075 ' ' PRO . . . . . 0.544 ' HG2' HD11 ' B' 1101 ' ' LEU . 20.0 Cg_endo -65.62 139.34 57.85 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.892 2.395 . . . . 31.62 109.526 166.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 9.1 mt -80.65 164.1 23.11 Favored 'General case' 0 C--O 1.246 0.908 0 CA-C-N 113.89 -1.504 . . . . 40.49 109.672 166.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1077 ' ' ASP . . . . . 0.542 ' HA ' HD12 ' B' 1080 ' ' ILE . 0.7 OUTLIER -50.81 -34.32 27.17 Favored 'General case' 0 C--O 1.257 1.487 0 CA-C-N 119.821 1.192 . . . . 51.59 114.144 -175.254 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -73.18 -42.84 62.28 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 121.254 -0.904 . . . . 42.36 109.934 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1079 ' ' GLU . . . . . 0.429 ' HA ' HD12 ' B' 1082 ' ' LEU . 23.2 mt-10 -59.88 -35.23 74.4 Favored 'General case' 0 C--O 1.267 1.986 0 C-N-CA 123.805 0.842 . . . . 34.53 109.834 176.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1080 ' ' ILE . . . . . 0.706 ' HA ' HD12 ' B' 1083 ' ' LEU . 97.7 mt -63.33 -43.78 98.76 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 CA-C-O 123.965 1.84 . . . . 33.25 110.268 173.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -65.38 -29.77 70.52 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 118.039 -2.913 . . . . 36.47 114.852 176.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1082 ' ' LEU . . . . . 0.429 HD12 ' HA ' ' B' 1079 ' ' GLU . 41.8 mt -64.6 -40.88 96.31 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 112.836 -1.984 . . . . 37.76 113.663 168.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1083 ' ' LEU . . . . . 0.706 HD12 ' HA ' ' B' 1080 ' ' ILE . 5.6 mt -59.68 107.34 0.58 Allowed 'General case' 0 CA--C 1.495 -1.169 0 CA-C-O 123.322 1.534 . . . . 37.43 110.209 174.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -95.47 143.06 25.47 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 111.347 -2.66 . . . . 37.7 108.58 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1085 ' ' PRO . . . . . 0.633 ' HB3' ' HB2' ' B' 1109 ' ' ASN . 18.2 Cg_endo -52.62 113.86 1.43 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.937 3.092 . . . . 35.51 109.671 177.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 128.74 -32.81 3.24 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 112.357 -2.201 . . . . 33.87 112.433 -173.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1087 ' ' THR . . . . . . . . . . . . . 61.4 m -67.16 139.21 57.45 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-O 123.875 1.798 . . . . 32.5 108.682 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1088 ' ' THR . . . . . . . . . . . . . 7.8 m -98.71 110.61 23.19 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 103.498 -2.778 . . . . 30.22 103.498 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1089 ' ' LEU . . . . . 0.582 HD13 HD21 ' B' 1083 ' ' LEU . 40.1 tp -95.78 118.67 32.87 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 106.715 -1.587 . . . . 27.24 106.715 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1090 ' ' VAL . . . . . 0.459 HG13 ' HB2' ' B' 1113 ' ' MET . 4.2 t -118.22 107.1 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 107.44 -1.318 . . . . 25.39 107.44 176.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1091 ' ' SER . . . . . 0.497 ' OG ' ' HB3' ' B' 1071 ' ' LYS . 19.7 m -161.02 163.8 31.37 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.723 -0.672 . . . . 28.81 112.712 -167.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1092 ' ' PHE . . . . . 0.616 ' HZ ' ' HG3' ' B' 1133 ' ' MET . 40.8 m-85 -69.22 105.09 2.38 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-O 123.586 1.66 . . . . 30.78 106.534 166.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1093 ' ' ILE . . . . . 0.402 HG13 ' CG1' ' B' 1112 ' ' VAL . 32.9 mm -95.54 -37.56 7.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 O-C-N 119.883 -1.761 . . . . 30.28 110.968 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1094 ' ' TRP . . . . . 0.524 ' HB3' ' HB2' ' B' 1097 ' ' GLN . 96.4 m95 55.34 60.62 9.22 Favored Pre-proline 0 CA--C 1.55 0.955 0 O-C-N 124.868 1.355 . . . . 34.07 112.496 -173.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -51.68 -51.47 11.11 Favored 'Trans proline' 0 C--O 1.253 1.273 0 C-N-CA 125.207 3.938 . . . . 38.66 115.466 -171.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -62.98 -28.93 70.43 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-N 120.301 1.41 . . . . 41.32 112.147 176.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1097 ' ' GLN . . . . . 0.524 ' HB2' ' HB3' ' B' 1094 ' ' TRP . 18.6 mp0 -82.75 -22.74 34.25 Favored 'General case' 0 C--O 1.26 1.648 0 N-CA-C 108.066 -1.087 . . . . 51.66 108.066 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -127.82 57.71 27.66 Favored Pre-proline 0 C--O 1.223 -0.341 0 CA-C-N 120.754 1.615 . . . . 40.32 115.207 -175.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 0.7 OUTLIER -52.46 -37.02 72.16 Favored 'Trans proline' 0 C--O 1.248 0.993 0 C-N-CA 124.871 3.714 . . . . 41.56 115.116 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -59.66 -57.85 11.16 Favored 'General case' 0 C--O 1.217 -0.624 0 O-C-N 124.744 1.278 . . . . 54.11 107.69 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1101 ' ' LEU . . . . . 0.544 HD11 ' HG2' ' B' 1075 ' ' PRO . 9.6 tp -51.27 -44.78 61.88 Favored 'General case' 0 C--O 1.211 -0.964 0 CA-C-O 116.656 -1.64 . . . . 37.88 109.452 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1102 ' ' MET . . . . . . . . . . . . . 61.1 mmm -55.75 -49.64 72.54 Favored 'General case' 0 C--O 1.252 1.209 0 CA-C-O 123.26 1.505 . . . . 37.54 113.601 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1103 ' ' GLN . . . . . 0.406 ' O ' ' HB3' ' B' 1106 ' ' ALA . 0.0 OUTLIER -67.12 -39.97 86.73 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 114.211 -1.359 . . . . 47.01 110.73 -175.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B 1104 ' ' LYS . . . . . 0.444 ' HD3' HD13 ' B' 1080 ' ' ILE . 43.3 mttm -55.69 -54.42 44.44 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.395 1.078 . . . . 48.68 110.453 174.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1105 ' ' LEU . . . . . 0.625 HD13 HG21 ' B' 1112 ' ' VAL . 41.4 mt -61.57 -29.42 70.01 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 120.35 -1.469 . . . . 32.21 111.916 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1106 ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' B' 1103 ' ' GLN . . . -66.76 -39.54 87.93 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 117.278 -1.344 . . . . 33.73 111.399 173.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -64.25 -43.26 95.43 Favored 'General case' 0 C--O 1.249 1.04 0 O-C-N 124.36 1.038 . . . . 51.47 110.394 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1108 ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -67.27 -16.63 64.39 Favored 'General case' 0 C--N 1.309 -1.152 0 O-C-N 125.831 1.957 . . . . 43.9 114.031 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1109 ' ' ASN . . . . . 0.633 ' HB2' ' HB3' ' B' 1085 ' ' PRO . 13.9 m120 59.07 49.76 9.01 Favored 'General case' 0 C--N 1.348 0.533 0 CA-C-O 126.397 2.999 . . . . 44.82 115.957 178.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1110 ' ' VAL . . . . . 0.639 HG11 ' HB3' ' B' 1083 ' ' LEU . 12.8 m -107.7 163.77 5.34 Favored 'Isoleucine or valine' 0 C--O 1.248 0.992 0 O-C-N 119.517 -1.989 . . . . 30.52 111.528 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1111 ' ' THR . . . . . . . . . . . . . 18.1 m -107.04 97.5 7.27 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 123.61 1.672 . . . . 27.12 107.547 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1112 ' ' VAL . . . . . 0.67 ' HB ' ' HB ' ' B' 1361 ' ' ILE . 70.6 t -97.31 115.46 37.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 112.563 -2.108 . . . . 26.4 113.457 -170.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1113 ' ' MET . . . . . 0.463 ' HG2' HD21 ' B' 1334 ' ' LEU . 1.8 mpt? -100.13 118.45 36.5 Favored 'General case' 0 CA--C 1.504 -0.821 0 O-C-N 121.37 -0.831 . . . . 42.92 108.901 170.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -88.48 104.74 17.09 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 120.013 -0.675 . . . . 24.15 110.007 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1115 ' ' MET . . . . . 0.536 ' SD ' HD13 ' B' 1334 ' ' LEU . 72.4 mmm -65.61 -17.84 64.88 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 116.583 2.068 . . . . 29.95 116.583 -177.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1116 ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -84.73 -38.37 19.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 113.624 -1.625 . . . . 34.53 109.54 171.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1117 ' ' SER . . . . . . . . . . . . . 70.1 m -97.64 38.45 1.28 Allowed 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 123.44 1.59 . . . . 33.49 111.819 -176.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1118 ' ' VAL . . . . . 0.681 HG21 ' HA ' ' B' 1128 ' ' ASP . 12.3 t -77.59 124.52 86.62 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 102.278 -3.23 . . . . 34.02 102.278 172.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1119 ' ' PRO . . . . . 0.615 ' HB2' HG12 ' B' 1121 ' ' ILE . 75.3 Cg_exo -52.75 153.84 13.81 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.518 2.812 . . . . 38.28 115.964 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1120 ' ' ARG . . . . . 0.533 HH21 HD12 ' B' 1130 ' ' LEU . 0.0 OUTLIER -77.68 47.06 0.58 Allowed 'General case' 0 C--O 1.216 -0.679 0 O-C-N 121.757 -0.589 . . . . 55.05 110.008 178.113 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B 1121 ' ' ILE . . . . . 0.615 HG12 ' HB2' ' B' 1119 ' ' PRO . 37.3 pt -119.94 168.86 11.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 O-C-N 119.182 -2.199 . . . . 42.09 110.146 -172.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1122 ' ' SER . . . . . 0.52 ' HB3' ' HA ' ' C' ' 133' ' ' MET . 62.2 m -49.92 -80.23 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 117.618 2.451 . . . . 38.02 117.618 -161.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1123 ' ' ARG . . . . . 0.808 ' HG3' HG21 ' B' 1354 ' ' VAL . 11.2 ptt180 -66.62 -12.77 59.58 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 124.169 3.168 . . . . 34.29 114.329 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1124 ' ' ALA . . . . . 0.607 ' HB1' HG12 ' B' 1118 ' ' VAL . . . -67.16 -32.04 72.87 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 117.974 -1.012 . . . . 32.35 110.005 175.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1125 ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -58.32 -21.9 51.05 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 121.111 1.778 . . . . 47.17 114.678 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1126 ' ' SER . . . . . . . . . . . . . 10.2 m -71.6 -34.61 70.03 Favored 'General case' 0 C--O 1.246 0.885 0 O-C-N 121.119 -0.988 . . . . 31.71 111.351 173.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1127 ' ' LEU . . . . . . . . . . . . . 5.6 mp -83.9 -33.37 24.76 Favored 'General case' 0 CA--C 1.487 -1.463 0 N-CA-C 106.878 -1.527 . . . . 37.0 106.878 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1128 ' ' ASP . . . . . 0.681 ' HA ' HG21 ' B' 1118 ' ' VAL . 25.8 t70 -61.85 111.32 1.84 Allowed 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 124.303 2.001 . . . . 40.4 114.524 -168.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1129 ' ' ALA . . . . . . . . . . . . . . . -75.53 -20.62 58.59 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 113.22 -1.809 . . . . 26.56 109.52 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1130 ' ' LEU . . . . . 0.533 HD12 HH21 ' B' 1120 ' ' ARG . 17.1 mt -62.81 -40.34 97.07 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 122.294 2.315 . . . . 30.89 111.336 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1131 ' ' SER . . . . . . . . . . . . . 52.7 p -64.33 -53.78 43.47 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 118.051 -0.976 . . . . 29.84 110.782 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1132 ' ' SER . . . . . 0.451 ' HB3' ' HB3' ' B' 1326 ' ' LEU . 40.2 m -50.42 -47.23 56.66 Favored 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 124.967 1.307 . . . . 31.91 114.082 172.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1133 ' ' MET . . . . . 0.637 ' HB3' ' HB3' ' B' 1316 ' ' PRO . 37.3 mmt -70.43 -33.52 71.42 Favored 'General case' 0 CA--C 1.493 -1.221 0 O-C-N 124.37 1.044 . . . . 25.9 112.468 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1134 ' ' ALA . . . . . 0.55 ' HB1' ' HB2' ' B' 1176 ' ' ALA . . . -67.33 -41.56 85.05 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 121.17 -0.956 . . . . 26.62 111.92 171.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -56.32 -53.45 57.14 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 108.292 -1.003 . . . . 36.97 108.292 174.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1136 ' ' ILE . . . . . 0.441 HD13 ' HE2' ' A' 1152 ' ' PHE . 34.9 mm -52.37 -51.73 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 124.285 1.034 . . . . 32.11 109.95 174.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1137 ' ' ALA . . . . . 0.524 ' HB1' HD22 ' B' 1284 ' ' LEU . . . -57.13 -42.49 81.01 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 117.078 -1.439 . . . . 24.14 112.638 177.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -65.28 -45.22 91.89 Favored Glycine 0 C--O 1.253 1.328 0 CA-C-N 122.405 2.366 . . . . 25.13 111.33 -174.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1139 ' ' TYR . . . . . 0.446 ' O ' ' HB ' ' B' 1142 ' ' ILE . 16.0 t80 -63.32 -43.27 98.28 Favored 'General case' 0 C--O 1.21 -1.011 0 CA-C-N 113.241 -1.48 . . . . 32.73 112.22 171.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1140 ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -70.89 -22.4 62.27 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 119.101 -0.476 . . . . 26.36 110.0 -176.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1141 ' ' ALA . . . . . 0.774 ' HA ' HG11 ' B' 1282 ' ' VAL . . . -63.77 -43.98 94.75 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.242 -1.021 . . . . 24.12 108.242 167.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1142 ' ' ILE . . . . . 0.507 HG23 ' CE2' ' B' 1153 ' ' PHE . 16.2 mm -59.31 -47.31 90.92 Favored 'Isoleucine or valine' 0 C--N 1.359 1.004 0 CA-C-O 121.835 0.826 . . . . 23.37 111.765 177.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 71.1 t -53.51 -68.33 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.848 0 N-CA-C 113.477 0.917 . . . . 24.96 113.477 171.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -61.75 -31.14 71.3 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 113.72 1.008 . . . . 32.07 113.72 -172.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1145 ' ' ALA . . . . . 0.777 ' HB1' HD12 ' B' 1251 ' ' ILE . . . -55.11 -57.42 11.81 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.687 -0.688 . . . . 24.87 110.36 168.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1146 ' ' ALA . . . . . 0.56 ' HA ' ' HB2' ' B' 1149 ' ' PHE . . . -64.49 -19.33 65.51 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 115.895 1.813 . . . . 24.67 115.895 176.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 86.0 t60 -65.52 -26.66 68.0 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 116.986 -1.483 . . . . 28.58 112.278 169.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1148 ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -123.89 8.74 8.74 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 123.117 2.69 . . . . 36.82 115.955 170.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1149 ' ' PHE . . . . . 0.56 ' HB2' ' HA ' ' B' 1146 ' ' ALA . 0.8 OUTLIER -65.46 154.07 39.56 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-O 124.255 1.978 . . . . 31.97 111.877 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B 1150 ' ' GLY . . . . . . . . . . . . . . . -86.39 -32.09 17.39 Favored Glycine 0 N--CA 1.432 -1.613 0 CA-C-N 114.05 -1.432 . . . . 25.49 112.313 174.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1151 ' ' ARG . . . . . 0.415 HH11 HG21 ' A' 1321 ' ' THR . 64.4 mtm-85 -119.59 -174.23 2.7 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 115.981 1.845 . . . . 59.84 115.981 -166.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1152 ' ' PHE . . . . . 0.421 ' HD1' ' H ' ' B' 1154 ' ' THR . 0.8 OUTLIER -88.14 145.81 25.74 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-O 118.499 -0.762 . . . . 34.45 111.873 172.372 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B 1153 ' ' PHE . . . . . 0.507 ' CE2' HG23 ' B' 1142 ' ' ILE . 8.8 m-85 -63.16 -52.08 63.85 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 119.17 0.895 . . . . 31.17 112.294 169.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1154 ' ' THR . . . . . 0.421 ' H ' ' HD1' ' B' 1152 ' ' PHE . 7.6 m -73.88 131.08 41.12 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.896 -1.047 . . . . 33.89 110.434 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -72.34 81.84 0.58 Allowed Glycine 0 C--N 1.343 0.93 0 O-C-N 119.689 -1.882 . . . . 38.95 111.029 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -75.27 114.85 14.27 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.556 0.693 . . . . 54.23 111.794 -173.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1157 ' ' ILE . . . . . 0.416 HG23 ' HG2' ' B' 1162 ' ' LYS . 45.1 mm -92.53 104.78 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 1 N-CA-C 99.316 -4.327 . . . . 51.16 99.316 177.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B 1158 ' ' THR . . . . . . . . . . . . . 1.5 m -115.11 138.88 50.4 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 103.002 -2.962 . . . . 49.61 103.002 -172.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -52.61 -32.69 42.85 Favored 'General case' 0 C--O 1.248 1.016 0 CA-C-O 123.777 1.751 . . . . 49.05 115.009 175.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -59.16 -81.04 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 113.303 -1.771 . . . . 47.65 110.088 162.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . -146.68 155.2 26.42 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 121.366 1.894 . . . . 45.61 110.035 -174.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1162 ' ' LYS . . . . . 0.416 ' HG2' HG23 ' B' 1157 ' ' ILE . 89.0 mttt -89.39 132.12 35.13 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.648 1.213 . . . . 57.46 108.352 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1163 ' ' VAL . . . . . 0.502 HG21 HE22 ' A' 1322 ' ' GLN . 90.6 t -100.3 128.56 30.16 Favored Pre-proline 0 C--O 1.247 0.925 0 CA-C-N 113.771 -1.559 . . . . 42.93 108.484 176.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1164 ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' B' 1163 ' ' VAL . 45.9 Cg_endo -67.22 133.2 29.87 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.568 3.512 . . . . 39.29 110.689 166.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1165 ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' B' 1164 ' ' PRO . 16.9 Cg_exo -69.0 161.64 44.99 Favored 'Trans proline' 0 N--CA 1.479 0.629 0 C-N-CA 121.255 1.303 . . . . 34.17 110.04 -172.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -70.56 111.78 6.33 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 118.04 -1.464 . . . . 31.69 108.816 172.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1167 ' ' LYS . . . . . 0.644 ' HB2' ' HA ' ' B' 1249 ' ' VAL . 86.4 mttt -77.65 87.48 3.94 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.144 -1.428 . . . . 44.78 107.144 174.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1168 ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' B' 1191 ' ' VAL . 48.4 t -77.05 94.92 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 114.168 -1.378 . . . . 31.23 108.556 -174.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1169 ' ' MET . . . . . 0.575 ' HA ' ' O ' ' B' 1192 ' ' ARG . 55.5 ttp -86.19 110.37 19.54 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 122.459 1.123 . . . . 37.09 108.433 177.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 50.7 t -97.59 118.76 44.64 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 N-CA-C 107.611 -1.255 . . . . 30.17 107.611 -177.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1171 ' ' ILE . . . . . 0.487 HD13 HG23 ' B' 1252 ' ' ILE . 1.7 mp -91.94 95.97 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 103.848 -2.649 . . . . 33.74 103.848 171.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 115.4 85.18 1.23 Allowed Glycine 0 C--N 1.339 0.707 0 N-CA-C 108.657 -1.777 . . . . 32.59 108.657 170.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1173 ' ' ALA . . . . . 0.455 ' HA ' ' HA3' ' B' 1177 ' ' GLY . . . -84.16 50.33 1.83 Allowed 'General case' 0 C--O 1.255 1.346 0 CA-C-O 124.302 2.001 . . . . 32.42 110.849 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -81.15 -165.56 34.44 Favored Glycine 0 C--N 1.342 0.884 0 O-C-N 118.59 -2.569 . . . . 31.74 107.754 163.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 19.1 t -51.36 -39.96 22.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 O-C-N 119.304 -2.292 . . . . 31.48 114.352 -176.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1176 ' ' ALA . . . . . 0.55 ' HB2' ' HB1' ' B' 1134 ' ' ALA . . . -55.86 -46.82 78.15 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.934 1.087 . . . . 26.12 113.934 171.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1177 ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' B' 1173 ' ' ALA . . . -68.85 -45.8 62.8 Favored Glycine 0 C--N 1.345 1.046 0 N-CA-C 109.106 -1.598 . . . . 25.73 109.106 -176.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1178 ' ' LEU . . . . . 0.544 ' HA ' HD12 ' B' 1181 ' ' ILE . 51.4 mt -60.46 -36.36 78.07 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 118.244 -0.884 . . . . 32.59 108.9 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -68.24 -44.09 76.43 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 119.342 0.973 . . . . 27.72 110.456 176.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -58.63 -36.64 74.4 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 118.192 -0.908 . . . . 26.03 108.773 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1181 ' ' ILE . . . . . 0.544 HD12 ' HA ' ' B' 1178 ' ' LEU . 38.2 mt -61.27 -50.0 82.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 CA-C-N 120.628 1.558 . . . . 28.61 107.783 171.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -62.67 -19.95 61.14 Favored Glycine 0 CA--C 1.543 1.808 0 CA-C-O 118.363 -1.243 . . . . 25.23 114.108 -173.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -97.96 -56.64 2.43 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 117.993 0.896 . . . . 24.09 109.895 171.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -72.01 -38.5 69.6 Favored 'General case' 0 CA--C 1.509 -0.619 0 O-C-N 119.027 -2.296 . . . . 26.68 115.861 -171.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1185 ' ' ASN . . . . . 0.418 ' HB3' ' HE1' ' B' 1207 ' ' MET . 22.1 t30 -61.61 -39.02 89.75 Favored 'General case' 0 C--O 1.247 0.966 0 O-C-N 120.589 -1.319 . . . . 36.57 111.429 174.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1186 ' ' SER . . . . . . . . . . . . . 2.0 m -62.33 -38.73 90.62 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 112.952 -1.931 . . . . 28.92 111.559 174.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1187 ' ' LEU . . . . . 0.485 ' HA ' ' HB2' ' A' 1186 ' ' SER . 4.2 mt -61.02 -31.18 70.81 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 116.038 -0.528 . . . . 29.09 110.914 172.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 111.05 -7.55 29.15 Favored Glycine 0 CA--C 1.525 0.717 0 O-C-N 121.426 -0.796 . . . . 29.26 111.25 -176.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1189 ' ' ALA . . . . . . . . . . . . . . . -62.05 134.72 56.98 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 122.234 1.016 . . . . 30.16 109.559 175.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 18.3 mt -77.19 94.97 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 104.684 -2.339 . . . . 35.81 104.684 -174.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1191 ' ' VAL . . . . . 0.488 HG11 HG12 ' B' 1181 ' ' ILE . 40.6 t -78.24 100.23 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 O-C-N 120.242 -1.536 . . . . 31.97 109.66 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1192 ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' B' 1169 ' ' MET . 98.8 mtt180 -87.07 80.84 8.24 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 124.146 1.927 . . . . 48.16 108.637 174.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -84.93 144.82 28.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 111.438 -2.619 . . . . 35.89 111.335 -172.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 82.1 t80 -134.57 145.39 48.65 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.018 -1.475 . . . . 41.88 107.018 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1195 ' ' ASP . . . . . . . . . . . . . 5.5 t70 -153.03 154.59 35.22 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 103.992 -2.596 . . . . 38.28 103.992 161.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1196 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.42 -21.19 56.28 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 114.468 -1.242 . . . . 40.62 110.59 174.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1197 ' ' ARG . . . . . 0.45 ' O ' HG22 ' B' 1200 ' ' VAL . 40.2 mtm180 -78.06 126.15 84.15 Favored Pre-proline 0 N--CA 1.435 -1.183 0 C-N-CA 120.164 -0.614 . . . . 53.09 110.978 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1198 ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' B' 1197 ' ' ARG . 37.3 Cg_endo -53.04 -46.39 34.29 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 125.273 3.982 . . . . 42.56 116.611 -176.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 10.6 pm0 -70.24 -13.98 62.41 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 115.787 1.773 . . . . 56.31 115.787 -161.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1200 ' ' VAL . . . . . 0.45 HG22 ' O ' ' B' 1197 ' ' ARG . 26.7 m -74.09 -22.17 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 116.145 -0.48 . . . . 42.91 111.24 175.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 26.0 tttm -47.83 -56.45 7.45 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 114.549 1.315 . . . . 48.89 114.549 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -55.7 -42.55 75.4 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 112.716 -2.038 . . . . 51.7 112.565 174.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1203 ' ' GLN . . . . . 0.649 ' HG2' ' HG3' ' C' ' 74' ' ' ARG . 52.1 mt-30 -64.11 -47.84 78.45 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.308 -0.86 . . . . 52.57 109.4 -174.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1204 ' ' VAL . . . . . . . . . . . . . 55.9 t -64.02 -49.84 79.8 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-O 122.677 1.227 . . . . 33.79 108.486 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -57.39 -29.78 64.36 Favored 'General case' 0 C--N 1.359 1.007 0 N-CA-C 115.812 1.782 . . . . 36.58 115.812 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1206 ' ' SER . . . . . . . . . . . . . 43.3 p -71.86 -18.26 62.07 Favored 'General case' 0 C--O 1.248 0.978 0 CA-C-N 119.423 1.011 . . . . 39.61 110.89 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1207 ' ' MET . . . . . 0.531 ' SD ' HG22 ' B' 1181 ' ' ILE . 26.1 mtp -87.39 -9.28 55.19 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 120.954 -1.091 . . . . 37.45 112.469 172.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 68.5 46.74 61.18 Favored Glycine 0 C--O 1.224 -0.484 0 O-C-N 119.319 -2.113 . . . . 31.87 109.548 -168.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -122.71 146.56 47.38 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 103.623 -2.732 . . . . 35.4 103.623 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1210 ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' B' 1192 ' ' ARG . 8.7 tt0 -85.09 116.55 23.53 Favored 'General case' 0 N--CA 1.435 -1.225 0 O-C-N 120.418 -1.426 . . . . 47.89 109.355 -164.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 70.0 t80 -89.5 120.95 31.26 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 107.982 -1.118 . . . . 45.53 107.982 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1212 ' ' LEU . . . . . 0.544 ' HB3' HD21 ' B' 1241 ' ' LEU . 57.8 mt -71.25 115.17 10.09 Favored 'General case' 0 N--CA 1.44 -0.964 0 O-C-N 121.323 -0.861 . . . . 46.33 109.271 174.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -98.38 141.4 31.3 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 124.7 2.19 . . . . 60.41 108.904 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 43.7 mt -66.32 161.33 22.64 Favored 'General case' 0 C--O 1.251 1.148 0 CA-C-N 112.2 -2.273 . . . . 57.38 114.597 168.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 27.0 t70 . . . . . 0 CA--C 1.518 -0.288 0 CA-C-N 114.264 -1.334 . . . . 65.07 110.19 -178.447 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B 1230 ' ' MET . . . . . 0.486 ' SD ' ' HB2' ' B' 1234 ' ' PHE . 13.8 mmt . . . . . 0 N--CA 1.448 -0.557 1 N-CA-C 98.674 -4.565 . . . . 80.32 98.674 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1231 ' ' SER . . . . . 0.4 ' O ' HG23 ' B' 1235 ' ' ILE 0.3 0.1 OUTLIER 63.05 173.77 0.15 Allowed 'General case' 0 C--N 1.356 0.879 2 CA-C-N 127.1 4.5 . . . . 79.92 119.458 0.628 . . . . . . . . 5 4 . 1 . 002 nuclear nobuild full ' B' B 1232 ' ' ASP . . . . . 0.565 ' HA ' HG12 ' B' 1235 ' ' ILE . 5.6 p-10 -67.01 -166.92 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 115.719 1.748 . . . . 77.91 115.719 -172.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 71.0 -80.03 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 107.447 -1.316 . . . . 73.88 107.447 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1234 ' ' PHE . . . . . 0.486 ' HB2' ' SD ' ' B' 1230 ' ' MET . 2.2 m-85 -51.51 -33.45 31.76 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 115.651 1.723 . . . . 68.98 115.651 171.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1235 ' ' ILE . . . . . 0.565 HG12 ' HA ' ' B' 1232 ' ' ASP . 36.1 pt -47.72 -36.5 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 120.271 1.396 . . . . 64.53 113.12 169.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1236 ' ' LYS . . . . . 0.46 ' HD3' ' HA ' ' B' 1236 ' ' LYS . 69.6 mmtt -62.24 -41.62 98.58 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 120.049 -1.657 . . . . 66.36 111.011 172.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -67.34 -42.63 83.24 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 119.418 -0.913 . . . . 56.6 111.533 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -56.18 -51.74 66.94 Favored 'General case' 0 C--O 1.241 0.65 0 O-C-N 124.306 1.003 . . . . 56.79 111.966 171.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1239 ' ' MET . . . . . . . . . . . . . 10.4 tmm? -56.27 -56.74 17.27 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 118.168 -0.92 . . . . 53.63 112.976 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -55.56 -36.32 66.69 Favored 'General case' 0 C--N 1.36 1.028 0 CA-C-N 119.428 1.013 . . . . 51.74 111.111 -177.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1241 ' ' LEU . . . . . 0.544 HD21 ' HB3' ' B' 1212 ' ' LEU . 16.2 tp -57.44 -50.77 71.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 121.067 -1.021 . . . . 44.86 111.475 178.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -64.81 -39.61 93.87 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 125.99 2.056 . . . . 42.78 113.03 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1243 ' ' ALA . . . . . 0.517 ' HA ' ' HG3' ' B' 1271 ' ' MET . . . -64.94 -23.72 67.31 Favored 'General case' 0 C--N 1.36 1.048 0 N-CA-C 113.574 0.953 . . . . 40.96 113.574 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -82.01 -53.99 5.67 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 118.72 -2.488 . . . . 43.06 108.898 172.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 61.0 mm-40 -56.32 -31.99 64.23 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 124.748 1.219 . . . . 46.45 112.861 -176.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1246 ' ' ALA . . . . . 0.412 ' HA ' HG22 ' B' 1249 ' ' VAL . . . -44.46 -34.54 2.1 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 125.435 1.494 . . . . 41.78 114.885 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1247 ' ' LYS . . . . . 0.472 ' HD2' ' HA ' ' B' 1247 ' ' LYS . 34.3 tptt -63.55 -43.78 96.06 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 124.206 1.955 . . . . 52.2 111.863 -176.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1248 ' ' GLU . . . . . 0.465 ' CD ' HH12 ' B' 1192 ' ' ARG . 39.1 mt-10 -84.5 -39.91 18.29 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 113.14 -1.846 . . . . 53.55 114.283 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1249 ' ' VAL . . . . . 0.644 ' HA ' ' HB2' ' B' 1167 ' ' LYS 0.301 10.6 m -76.94 160.91 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 118.907 2.929 . . . . 34.41 118.907 -167.255 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B 1250 ' ' ASP . . . . . 0.456 ' HA ' ' HB3' ' B' 1279 ' ' SER . 16.9 m-20 -117.9 -73.09 0.66 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 124.389 2.042 . . . . 33.38 110.454 -169.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1251 ' ' ILE . . . . . 0.777 HD12 ' HB1' ' B' 1145 ' ' ALA . 23.5 mm -98.11 99.69 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 114.0 -1.455 . . . . 29.54 108.484 -169.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1252 ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' B' 1169 ' ' MET . 17.5 mt -89.54 96.13 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 105.607 -1.998 . . . . 32.44 105.607 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1253 ' ' VAL . . . . . . . . . . . . . 96.7 t -83.16 96.51 4.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 102.369 -3.197 . . . . 30.57 102.369 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1254 ' ' THR . . . . . 0.489 ' HB ' HG22 ' B' 1252 ' ' ILE . 2.4 t -104.99 138.93 40.44 Favored 'General case' 0 N--CA 1.432 -1.339 0 O-C-N 119.877 -1.764 . . . . 35.04 111.89 -175.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1255 ' ' THR . . . . . 0.403 HG22 ' HB2' ' B' 1284 ' ' LEU . 40.1 p -134.09 -83.25 0.44 Allowed 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 114.377 -1.283 . . . . 34.62 108.772 -177.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . 56.72 41.9 27.59 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.254 1.822 . . . . 42.72 114.777 -170.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 45.8 mt -89.85 93.78 9.56 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-O 123.797 1.761 . . . . 52.43 107.309 -174.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1258 ' ' ILE . . . . . 0.414 ' HB ' ' HD2' ' B' 1261 ' ' LYS . 24.7 mt -90.08 129.1 47.19 Favored Pre-proline 0 N--CA 1.438 -1.063 0 N-CA-C 107.043 -1.466 . . . . 59.41 107.043 171.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -57.03 133.31 57.08 Favored 'Trans proline' 0 N--CA 1.441 -1.577 0 C-N-CA 124.707 3.605 . . . . 62.68 114.466 -177.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 66.59 29.49 74.85 Favored Glycine 0 C--O 1.218 -0.856 0 CA-C-O 117.149 -1.917 . . . . 64.16 114.088 -174.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1261 ' ' LYS . . . . . 0.414 ' HD2' ' HB ' ' B' 1258 ' ' ILE . 59.6 mttm -138.32 148.16 58.41 Favored Pre-proline 0 CA--C 1.503 -0.827 0 CA-C-N 121.009 2.404 . . . . 68.53 111.822 172.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.63 136.96 29.27 Favored 'Trans proline' 0 C--O 1.245 0.844 0 CA-C-N 122.856 2.056 . . . . 61.99 107.486 164.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1263 ' ' ALA . . . . . 0.462 ' HA ' ' HD3' ' B' 1264 ' ' PRO . . . -51.63 116.07 7.35 Favored Pre-proline 0 C--O 1.248 1.021 0 N-CA-C 113.24 0.83 . . . . 57.15 113.24 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1264 ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' B' 1263 ' ' ALA . 87.6 Cg_exo -53.61 135.67 62.4 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 124.779 3.653 . . . . 51.57 110.5 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -78.25 84.37 4.46 Favored 'General case' 0 C--O 1.248 0.994 0 C-N-CA 123.785 0.834 . . . . 54.55 109.161 -173.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1266 ' ' LEU . . . . . 0.464 ' HB2' HD21 ' B' 1291 ' ' ASN . 94.9 mt -91.4 -41.31 10.95 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 113.185 0.809 . . . . 46.86 113.185 177.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1267 ' ' ILE . . . . . . . . . . . . . 32.1 mm -78.53 86.96 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 124.432 2.063 . . . . 41.04 111.467 171.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1268 ' ' THR . . . . . 0.597 ' HA ' ' HG3' ' B' 1293 ' ' GLU . 36.2 p -84.54 151.98 24.2 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 112.316 -2.22 . . . . 39.58 112.892 -170.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1269 ' ' ARG . . . . . 0.502 ' HG3' ' HB2' ' B' 1293 ' ' GLU . 84.2 mtt85 -52.22 -39.6 60.45 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 118.256 -2.778 . . . . 53.15 117.194 -176.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -58.27 -40.78 82.78 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-O 123.517 1.627 . . . . 42.96 112.392 173.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1271 ' ' MET . . . . . 0.517 ' HG3' ' HA ' ' B' 1243 ' ' ALA . 54.2 ttm -65.71 -42.61 90.93 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 113.048 -1.887 . . . . 43.89 110.669 -178.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1272 ' ' VAL . . . . . . . . . . . . . 10.4 t -54.78 -48.52 73.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 113.816 -1.538 . . . . 38.37 110.977 170.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 25.9 t70 -58.39 -40.71 83.08 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 114.251 1.204 . . . . 47.46 114.251 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1274 ' ' SER . . . . . . . . . . . . . 49.5 m -68.86 -22.99 64.17 Favored 'General case' 0 C--O 1.238 0.494 0 O-C-N 121.698 -0.626 . . . . 38.38 112.687 174.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1275 ' ' MET . . . . . . . . . . . . . 71.7 mtp -62.12 162.16 9.89 Favored 'General case' 0 C--O 1.252 1.197 0 CA-C-O 124.548 2.118 . . . . 37.81 114.014 -173.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 66.6 tttt -68.07 137.46 55.01 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 111.868 -2.423 . . . . 49.26 109.562 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -75.62 151.06 37.87 Favored 'General case' 0 C--O 1.246 0.874 0 O-C-N 124.121 0.888 . . . . 34.46 110.267 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1278 ' ' GLY . . . . . 0.438 ' O ' ' HD1' ' B' 1149 ' ' PHE . . . 74.55 14.51 81.06 Favored Glycine 0 N--CA 1.47 0.922 0 C-N-CA 120.514 -0.85 . . . . 33.53 112.645 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1279 ' ' SER . . . . . 0.456 ' HB3' ' HA ' ' B' 1250 ' ' ASP . 61.0 m -106.16 148.45 27.85 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 125.322 1.449 . . . . 31.31 109.67 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1280 ' ' VAL . . . . . 0.607 HG22 ' HB2' ' B' 1308 ' ' LYS . 25.9 t -127.07 119.94 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 O-C-N 120.634 -1.291 . . . . 29.32 109.886 -163.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1281 ' ' ILE . . . . . 0.44 HD12 HG22 ' B' 1309 ' ' VAL . 19.5 mt -86.8 112.26 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 102.655 -3.091 . . . . 31.93 102.655 175.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1282 ' ' VAL . . . . . 0.774 HG11 ' HA ' ' B' 1141 ' ' ALA . 21.2 t -106.5 107.71 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 N-CA-C 101.857 -3.386 . . . . 29.48 101.857 175.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 24.3 t0 -87.93 109.08 19.52 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 110.475 -3.057 . . . . 34.5 107.653 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1284 ' ' LEU . . . . . 0.703 HD21 ' HB2' ' B' 1141 ' ' ALA . 71.4 mt -79.58 -23.05 43.0 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-O 121.138 0.494 . . . . 37.94 110.467 177.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -87.52 -5.62 58.71 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 115.371 -0.831 . . . . 40.92 111.525 -175.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -18.72 -54.32 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.736 1 N-CA-C 122.173 4.138 . . . . 44.39 122.173 174.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1287 ' ' GLN . . . . . 0.578 ' HB3' HG23 ' B' 1313 ' ' THR . 0.1 OUTLIER -70.27 -43.89 69.56 Favored 'General case' 0 CA--C 1.501 -0.935 0 C-N-CA 123.431 0.692 . . . . 51.46 111.483 178.773 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 4.9 t30 -97.21 75.68 2.59 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-O 123.915 1.817 . . . . 57.75 109.378 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1289 ' ' GLY . . . . . . . . . . . . . . . 87.88 -76.72 1.95 Allowed Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 107.209 -2.356 . . . . 49.85 107.209 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 99.45 136.74 9.48 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 109.371 -1.492 . . . . 45.93 109.371 -167.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1291 ' ' ASN . . . . . 0.464 HD21 ' HB2' ' B' 1266 ' ' LEU . 24.5 t-20 -88.88 -35.17 16.68 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 120.15 1.975 . . . . 42.67 112.927 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1292 ' ' CYS . . . . . 0.515 ' HB3' ' OG1' ' B' 1295 ' ' THR . 40.4 t -77.87 143.91 37.39 Favored 'General case' 0 N--CA 1.441 -0.923 0 O-C-N 118.944 -2.348 . . . . 38.82 110.829 171.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1293 ' ' GLU . . . . . 0.597 ' HG3' ' HA ' ' B' 1268 ' ' THR . 24.2 mt-10 -69.08 -37.43 78.45 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.702 -1.135 . . . . 46.71 112.049 174.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -82.9 -8.13 59.6 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 115.564 1.691 . . . . 47.23 115.564 -173.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1295 ' ' THR . . . . . 0.67 HG23 ' HA3' ' B' 1311 ' ' GLY . 49.1 m -52.35 120.4 5.49 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 116.135 1.902 . . . . 36.02 116.135 177.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 2.9 t -88.79 108.11 21.37 Favored Pre-proline 0 N--CA 1.448 -0.559 0 CA-C-O 116.007 -1.949 . . . . 37.26 106.396 172.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -64.28 88.39 0.16 Allowed 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 124.29 3.327 . . . . 35.09 113.479 -176.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 139.46 -17.46 3.09 Favored Glycine 0 C--O 1.251 1.18 0 CA-C-N 113.243 -1.798 . . . . 35.97 110.013 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -133.71 -176.69 4.25 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 121.458 2.629 . . . . 40.39 114.554 -161.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1300 ' ' ILE . . . . . 0.491 HG23 HG12 ' B' 1310 ' ' ILE . 9.6 mt -99.8 155.58 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.045 0 N-CA-C 105.759 -1.941 . . . . 37.43 105.759 170.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 65.9 t80 -142.85 105.89 4.55 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 123.008 1.385 . . . . 44.13 107.63 167.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1302 ' ' THR . . . . . . . . . . . . . 96.5 m -75.46 118.58 18.49 Favored 'General case' 0 N--CA 1.438 -1.029 0 O-C-N 119.434 -2.041 . . . . 39.78 106.291 168.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1303 ' ' THR . . . . . . . . . . . . . 76.0 p -69.7 169.42 12.88 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 115.903 1.816 . . . . 43.29 115.903 172.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -48.37 -48.02 36.93 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 124.343 1.057 . . . . 53.07 113.02 167.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -85.8 23.52 1.42 Allowed 'General case' 0 C--O 1.244 0.81 0 N-CA-C 114.68 1.363 . . . . 43.97 114.68 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 69.38 23.5 76.4 Favored Glycine 0 C--N 1.358 1.761 0 O-C-N 119.332 -2.105 . . . . 41.12 114.961 170.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1307 ' ' VAL . . . . . . . . . . . . . 94.7 t -93.46 136.13 26.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 105.767 -1.938 . . . . 38.12 105.767 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1308 ' ' LYS . . . . . 0.607 ' HB2' HG22 ' B' 1280 ' ' VAL . 65.1 mmtt -92.77 99.54 12.19 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.757 -1.201 . . . . 36.34 107.757 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1309 ' ' VAL . . . . . 0.44 HG22 HD12 ' B' 1281 ' ' ILE . 18.0 t -90.02 92.97 4.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 105.602 -1.999 . . . . 30.4 105.602 177.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1310 ' ' ILE . . . . . 0.491 HG12 HG23 ' B' 1300 ' ' ILE . 12.1 mt -87.4 134.2 28.32 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.002 0 C-N-CA 126.02 1.728 . . . . 30.82 107.85 173.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1311 ' ' GLY . . . . . 0.67 ' HA3' HG23 ' B' 1295 ' ' THR . . . -149.09 86.95 0.15 Allowed Glycine 0 CA--C 1.493 -1.34 0 N-CA-C 108.396 -1.882 . . . . 26.53 108.396 171.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1312 ' ' TYR . . . . . 0.794 ' HB2' ' HG ' ' B' 1315 ' ' LEU . 43.6 m-85 -97.8 119.66 36.79 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 118.055 0.927 . . . . 38.0 108.848 -172.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1313 ' ' THR . . . . . 0.578 HG23 ' HB3' ' B' 1287 ' ' GLN . 39.3 m -49.83 -40.37 41.83 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 124.079 1.895 . . . . 29.8 114.355 172.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1314 ' ' ASP . . . . . 0.474 ' OD1' ' HB3' ' B' 1312 ' ' TYR . 22.8 p-10 -78.56 -2.96 41.35 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 112.834 -1.985 . . . . 39.04 116.201 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1315 ' ' LEU . . . . . 0.794 ' HG ' ' HB2' ' B' 1312 ' ' TYR . 13.4 mt -43.29 -51.35 14.45 Favored Pre-proline 0 N--CA 1.47 0.527 0 N-CA-C 119.062 2.986 . . . . 31.08 119.062 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1316 ' ' PRO . . . . . 0.637 ' HB3' ' HB3' ' B' 1133 ' ' MET . 87.7 Cg_exo -65.62 -25.06 54.86 Favored 'Trans proline' 0 C--O 1.218 -0.5 0 CA-C-N 124.606 2.681 . . . . 26.1 112.866 176.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1317 ' ' GLY . . . . . 0.701 ' HA2' ' HG3' ' B' 1015 ' ' ARG . . . -67.53 -49.23 52.17 Favored Glycine 0 N--CA 1.431 -1.688 0 O-C-N 120.496 -1.378 . . . . 23.17 109.964 169.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -39.69 -16.71 0.01 OUTLIER 'General case' 0 C--O 1.246 0.878 1 N-CA-C 125.201 5.26 . . . . 40.4 125.201 -161.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 15.9 tp -102.12 78.58 0.24 Allowed Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 121.301 1.864 . . . . 23.6 108.158 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1320 ' ' PRO . . . . . 0.454 ' HB3' HG22 ' B' 1014 ' ' THR . 48.3 Cg_endo -43.53 -64.28 0.26 Allowed 'Trans proline' 0 CA--C 1.51 -0.719 1 C-N-CA 125.416 4.077 . . . . 22.35 119.138 -156.628 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B 1321 ' ' THR . . . . . 0.417 HG23 ' CE1' ' B' 1045 ' ' PHE . 4.2 m -61.97 -44.79 96.01 Favored 'General case' 0 C--O 1.218 -0.578 0 O-C-N 121.17 -0.957 . . . . 26.52 112.293 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1322 ' ' GLN . . . . . 0.609 ' HB2' ' HA ' ' A' 1151 ' ' ARG . 11.5 tp60 -72.48 -43.44 63.67 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 118.657 -0.687 . . . . 24.38 112.471 -173.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1323 ' ' SER . . . . . 0.533 ' HB3' ' HG2' ' B' 1015 ' ' ARG . 66.6 m -48.78 -49.32 39.21 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 124.176 0.99 . . . . 22.8 110.837 164.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1324 ' ' SER . . . . . . . . . . . . . 11.4 m -61.69 -33.2 73.58 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 122.567 1.175 . . . . 21.25 113.436 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -69.43 -40.38 77.27 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 118.404 -2.685 . . . . 31.34 114.18 170.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1326 ' ' LEU . . . . . 0.451 ' HB3' ' HB3' ' B' 1132 ' ' SER . 3.6 mm? -68.89 -55.8 9.91 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.951 0.881 . . . . 31.56 112.241 -177.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1327 ' ' TYR . . . . . 0.494 ' O ' ' HB2' ' B' 1330 ' ' ASN . 31.3 t80 -56.2 -44.57 79.61 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-N 113.992 -1.458 . . . . 22.73 110.179 175.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1328 ' ' GLY . . . . . 0.672 ' HA2' HD12 ' B' 1331 ' ' LEU . . . -56.7 -60.45 8.98 Favored Glycine 0 C--N 1.343 0.929 0 O-C-N 124.153 0.908 . . . . 21.91 112.794 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1329 ' ' THR . . . . . 0.51 ' HB ' ' HA ' ' A' 1160 ' ' ALA . 9.2 m -58.44 -23.51 57.72 Favored 'General case' 0 C--O 1.252 1.185 0 CA-C-O 116.365 -1.778 . . . . 22.15 111.893 174.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1330 ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' B' 1327 ' ' TYR . 12.1 m120 -63.79 -46.72 83.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 125.4 3.727 . . . . 26.18 110.549 170.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1331 ' ' LEU . . . . . 0.819 HD13 ' HB3' ' B' 1070 ' ' LEU . 13.9 mt -61.14 -37.28 82.27 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.079 -0.964 . . . . 23.68 109.254 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1332 ' ' VAL . . . . . 0.752 HG12 ' HE3' ' B' 1336 ' ' LYS . 96.6 t -69.22 -45.21 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 106.847 -1.538 . . . . 26.57 106.847 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -58.69 -43.73 90.06 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 113.353 0.871 . . . . 28.08 113.353 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1334 ' ' LEU . . . . . 0.536 HD13 ' SD ' ' B' 1115 ' ' MET . 3.9 tt -56.95 -47.31 80.99 Favored 'General case' 0 C--O 1.247 0.929 0 C-N-CA 123.933 0.893 . . . . 27.43 109.337 170.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1335 ' ' LEU . . . . . 0.755 HD23 HD12 ' B' 1338 ' ' LEU . 68.2 mt -74.42 -12.25 60.46 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 120.924 -1.11 . . . . 30.5 113.601 -177.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1336 ' ' LYS . . . . . 0.752 ' HE3' HG12 ' B' 1332 ' ' VAL . 85.5 mttt -72.89 -49.5 29.41 Favored 'General case' 0 CA--C 1.504 -0.793 0 O-C-N 120.828 -1.17 . . . . 41.65 109.225 166.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 7.7 mp -67.51 -26.84 66.54 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 113.258 0.836 . . . . 42.08 113.258 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1338 ' ' LEU . . . . . 0.755 HD12 HD23 ' B' 1335 ' ' LEU . 95.3 mt -72.34 -67.11 0.57 Allowed 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 108.373 -0.973 . . . . 35.03 108.373 168.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 43.6 t -85.34 73.69 10.51 Favored 'General case' 0 N--CA 1.436 -1.161 0 O-C-N 118.699 -2.501 . . . . 37.33 108.185 -170.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 58.0 mttp -57.44 -33.4 67.88 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 125.323 1.449 . . . . 50.51 114.353 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -80.55 -11.61 59.64 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 114.372 1.249 . . . . 54.21 114.372 178.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 60.0 mttp 60.32 34.81 20.75 Favored 'General case' 0 C--N 1.347 0.488 0 CA-C-O 122.884 1.326 . . . . 50.99 111.608 -172.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -99.6 -34.22 10.31 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 114.959 -1.018 . . . . 48.82 111.273 -176.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 125.31 9.52 5.0 Favored Glycine 0 N--CA 1.433 -1.551 0 O-C-N 124.543 1.152 . . . . 40.43 113.407 175.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -98.67 141.17 31.84 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 125.503 1.521 . . . . 47.56 113.639 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1346 ' ' ILE . . . . . 0.492 HD11 HG12 ' B' 1068 ' ' ILE . 43.1 mm -82.79 76.18 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.63 0 CA-C-O 123.136 1.446 . . . . 42.49 108.728 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1347 ' ' THR . . . . . 0.433 ' HB ' ' O ' ' B' 1338 ' ' LEU . 2.4 m -73.82 78.92 1.59 Allowed 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.598 -1.183 . . . . 38.12 109.326 172.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 10.9 t -62.29 121.66 11.35 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 O-C-N 119.598 -1.939 . . . . 37.5 109.379 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 23.1 t0 -96.96 111.08 23.46 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 122.505 1.145 . . . . 43.85 108.565 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1350 ' ' PHE . . . . . 0.569 ' HE2' HG21 ' B' 1367 ' ' THR . 1.4 m-30 -100.52 -0.59 37.55 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 116.385 1.994 . . . . 39.81 116.385 175.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -81.41 -43.55 18.8 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 121.728 0.775 . . . . 51.29 110.776 167.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 14.4 t0 -66.75 121.8 16.23 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 124.373 2.035 . . . . 39.78 111.995 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 3.7 m -52.25 -37.21 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 CA-C-N 110.752 -2.931 . . . . 39.28 112.686 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1354 ' ' VAL . . . . . 0.808 HG21 ' HG3' ' B' 1123 ' ' ARG . 23.1 t -70.6 -54.01 19.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-N 114.894 -1.048 . . . . 35.7 112.355 -177.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1355 ' ' ILE . . . . . 0.42 ' HA ' HG12 ' B' 1358 ' ' VAL . 27.1 mm -64.68 -47.59 88.19 Favored 'Isoleucine or valine' 0 C--N 1.359 1.007 0 CA-C-O 116.95 -1.5 . . . . 35.77 112.073 176.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 42.3 tpt85 -54.1 -37.09 63.89 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 114.168 1.173 . . . . 38.55 114.168 173.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1357 ' ' GLY . . . . . 0.476 ' HA2' ' HB2' ' B' 1370 ' ' ALA . . . -62.63 -54.6 32.67 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 124.621 1.105 . . . . 29.58 115.437 171.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1358 ' ' VAL . . . . . 0.42 HG12 ' HA ' ' B' 1355 ' ' ILE . 9.1 p -69.08 -38.82 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 108.668 -0.864 . . . . 32.06 108.668 -174.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1359 ' ' THR . . . . . 0.44 ' HB ' ' HE1' ' B' 1350 ' ' PHE . 14.8 m -76.46 84.83 3.18 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-O 123.892 1.806 . . . . 29.0 107.944 -177.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1360 ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' B' 1368 ' ' TRP . 22.1 m -73.27 -19.55 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 111.692 -2.504 . . . . 29.68 111.252 -174.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1361 ' ' ILE . . . . . 0.67 ' HB ' ' HB ' ' B' 1112 ' ' VAL . 85.1 mt -139.16 116.28 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 105.76 -1.941 . . . . 32.05 105.76 177.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1362 ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -108.66 119.38 39.37 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 119.205 -2.184 . . . . 32.52 108.885 175.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 36.86 44.08 0.33 Allowed 'General case' 0 C--O 1.246 0.92 0 CA-C-O 124.454 2.073 . . . . 35.68 116.113 -172.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1364 ' ' GLY . . . . . 0.6 ' HA3' ' HA ' ' B' 1109 ' ' ASN . . . 93.36 -7.28 75.38 Favored Glycine 0 CA--C 1.54 1.647 0 CA-C-O 117.225 -1.875 . . . . 34.26 114.356 174.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1365 ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' B' 1361 ' ' ILE . 0.2 OUTLIER -88.6 132.52 34.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 104.653 -2.351 . . . . 51.07 104.653 170.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 59.5 mt -88.75 94.05 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 N-CA-C 107.402 -1.333 . . . . 39.87 107.402 -176.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1367 ' ' THR . . . . . 0.569 HG21 ' HE2' ' B' 1350 ' ' PHE . 3.3 p -84.77 -1.39 56.26 Favored 'General case' 0 N--CA 1.424 -1.735 0 O-C-N 126.528 2.393 . . . . 38.01 114.858 -175.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1368 ' ' TRP . . . . . 0.419 ' HB2' ' HB ' ' B' 1360 ' ' VAL . 35.0 t90 -52.05 142.26 27.29 Favored Pre-proline 0 C--O 1.241 0.635 0 C-N-CA 124.255 1.022 . . . . 42.14 111.674 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -87.91 -114.77 0.0 OUTLIER 'Cis proline' 0 N--CA 1.451 -0.996 0 CA-C-N 122.575 1.955 . . . . 43.26 113.21 -7.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1370 ' ' ALA . . . . . 0.476 ' HB2' ' HA2' ' B' 1357 ' ' GLY . . . -117.97 153.67 51.18 Favored Pre-proline 0 C--N 1.32 -0.696 0 O-C-N 120.104 -1.623 . . . . 46.52 107.297 166.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1371 ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' B' 1372 ' ' PRO . 93.1 Cg_endo -59.52 133.62 53.01 Favored 'Trans proline' 0 C--N 1.33 -0.438 0 CA-C-N 122.589 1.96 . . . . 51.95 110.954 172.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1372 ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' B' 1371 ' ' PRO . 0.1 OUTLIER -36.91 87.7 0.01 OUTLIER 'Trans proline' 0 C--O 1.25 1.091 0 C-N-CA 125.133 3.889 . . . . 56.27 118.108 -174.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B 1373 ' ' ILE . . . . . 0.473 HG21 HD13 ' B' 1121 ' ' ILE . 0.0 OUTLIER -104.13 140.78 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 103.099 -2.926 . . . . 60.83 103.099 177.04 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -107.48 146.64 31.52 Favored 'General case' 0 C--O 1.256 1.423 0 O-C-N 120.203 -1.561 . . . . 66.1 108.184 -174.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 96.2 t -78.95 135.86 24.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 O-C-N 125.454 1.721 . . . . 63.47 111.49 -171.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.23 -4.627 0 O-C-N 120.891 -1.13 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.274 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.6 -16.23 24.29 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.071 1.348 . . . . 0.0 114.464 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 28.7 mp0 -49.54 -42.22 43.37 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.068 -1.02 . . . . 0.0 110.531 172.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 6.6 m -56.67 -46.96 80.81 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 123.593 0.757 . . . . 0.0 111.696 173.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 24' ' ' ALA . . . . . 0.476 ' HB2' HG22 ' C' ' 182' ' ' ILE . . . -62.24 -49.81 74.23 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 123.714 0.805 . . . . 0.0 109.674 -173.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -48.82 -51.07 31.45 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 127.849 3.218 . . . . 0.0 111.409 173.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 13.5 tp -65.28 -39.41 92.53 Favored 'General case' 0 N--CA 1.44 -0.938 0 O-C-N 120.764 -1.21 . . . . 0.0 113.59 -177.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 74.1 mt -53.68 -39.62 65.26 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 118.58 2.808 . . . . 0.0 118.58 -174.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 28' ' ' LYS . . . . . . . . . . . . . 34.5 pttt -63.93 -28.65 69.97 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.082 -0.963 . . . . 0.0 113.015 175.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -82.87 -33.01 27.13 Favored 'General case' 0 C--O 1.246 0.88 0 O-C-N 125.349 1.656 . . . . 0.0 109.823 174.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.437 ' HA ' ' OD2' ' C' ' 107' ' ' ASP . 58.0 m -54.87 127.27 27.85 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -170.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -82.55 -58.37 2.94 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 113.956 -1.475 . . . . 0.0 109.041 -174.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 32' ' ' SER . . . . . 0.432 ' HB2' ' HA ' ' C' ' 106' ' ' THR . 55.5 m -116.15 143.39 45.56 Favored 'General case' 0 C--O 1.251 1.135 0 O-C-N 120.801 -1.187 . . . . 0.0 110.55 166.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 96.6 t -128.44 120.2 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.52 HD13 ' HB2' ' C' ' 65' ' ' ARG . 38.7 mm -101.69 111.41 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 101.598 -3.482 . . . . 0.0 101.598 177.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . 0.705 HG22 ' HD3' ' C' ' 37' ' ' PRO . 42.9 mt -83.7 122.73 38.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 169.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 13.7 m -115.97 92.94 36.65 Favored Pre-proline 0 C--O 1.246 0.919 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.129 173.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . 0.77 ' HD2' HG12 ' C' ' 68' ' ' ILE . 0.5 OUTLIER -56.3 116.66 3.34 Favored 'Trans proline' 0 N--CA 1.449 -1.107 1 C-N-CA 125.47 4.113 . . . . 0.0 112.347 168.926 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' C' C ' 38' ' ' GLY . . . . . 0.418 ' HA3' ' HB3' ' C' ' 114' ' ' ALA . . . -102.29 -175.23 27.52 Favored Glycine 0 N--CA 1.433 -1.558 0 O-C-N 120.869 -1.145 . . . . 0.0 110.441 167.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -38.18 -41.59 0.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.187 1.395 . . . . 0.0 114.605 168.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 40' ' ' GLY . . . . . 0.936 ' HA3' ' HA3' ' C' ' 113' ' ' GLY . . . -52.78 -47.96 57.73 Favored Glycine 0 C--O 1.249 1.08 0 CA-C-O 118.789 -1.006 . . . . 0.0 112.371 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 41' ' ' MET . . . . . 0.456 ' HG3' ' HB3' ' C' ' 46' ' ' ALA . 24.2 ttm -61.27 -31.48 71.3 Favored 'General case' 0 C--N 1.356 0.889 0 CA-C-N 119.801 1.801 . . . . 0.0 113.529 172.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . 0.65 ' HB2' ' HB3' ' C' ' 79' ' ' MET . . . -70.04 -33.33 71.82 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.548 -0.739 . . . . 0.0 110.816 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . 0.431 HG13 ' H ' ' C' ' 44' ' ' ALA . 7.4 p -90.31 -70.95 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 118.448 -0.787 . . . . 0.0 110.6 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' C' ' 175' ' ' ALA . . . -79.27 100.2 7.42 Favored 'General case' 0 C--O 1.252 1.206 0 CA-C-N 120.432 1.469 . . . . 0.0 107.658 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 45' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -69.49 82.73 0.4 Allowed 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -161.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.456 ' HB3' ' HG3' ' C' ' 41' ' ' MET . . . -81.11 -4.42 55.24 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 111.164 -2.744 . . . . 0.0 114.363 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . 0.447 ' HG2' ' HB3' ' C' ' 82' ' ' LEU . 0.0 OUTLIER -71.24 -46.94 59.95 Favored 'General case' 0 C--O 1.25 1.086 0 O-C-N 119.66 -1.9 . . . . 0.0 113.659 -173.481 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 48' ' ' TYR . . . . . 0.422 ' CE1' ' HA ' ' C' ' 86' ' ' ALA . 95.0 m-85 -57.8 -44.38 99.38 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 120.333 1.424 . . . . 0.0 113.401 173.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 49' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -49.92 -49.78 15.11 Favored 'Trans proline' 0 C--O 1.255 1.352 0 C-N-CA 122.391 2.061 . . . . 0.0 115.574 163.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . 0.439 ' HA ' HG22 ' C' ' 53' ' ' ILE . 0.8 OUTLIER -68.86 -21.47 25.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 O-C-N 120.168 -1.582 . . . . 0.0 110.356 -171.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.68 -49.61 74.57 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 122.031 0.919 . . . . 0.0 111.403 172.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.12 -54.92 32.91 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.937 1.295 . . . . 0.0 112.633 176.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 53' ' ' ILE . . . . . 0.439 HG22 ' HA ' ' C' ' 50' ' ' VAL . 6.7 tp -71.57 -33.5 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-N 119.171 0.896 . . . . 0.0 111.054 -176.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 89.2 m -67.01 -32.97 74.54 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 118.997 0.817 . . . . 0.0 109.659 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -56.14 -51.88 66.37 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 4.6 mppt? -65.11 -46.3 81.59 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 57' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' C' ' 53' ' ' ILE . 55.2 mt -58.8 -45.73 89.22 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 120.509 1.504 . . . . 0.0 111.899 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -70.04 -40.86 74.89 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.613 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.59 -45.26 73.55 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 121.478 1.945 . . . . 0.0 113.91 171.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 29.1 ttm-85 -65.38 -23.36 66.95 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.101 1.36 . . . . 0.0 112.346 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.07 21.25 9.66 Favored Glycine 0 CA--C 1.505 -0.545 0 CA-C-O 122.12 0.845 . . . . 0.0 114.053 174.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 59.0 mt -85.16 135.14 25.49 Favored 'Isoleucine or valine' 0 C--O 1.249 1.055 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -79.61 86.73 5.21 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 7.7 p -95.7 122.68 47.41 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 CA-C-O 122.456 1.122 . . . . 0.0 108.894 178.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 65' ' ' ARG . . . . . 0.52 ' HB2' HD13 ' C' ' 34' ' ' ILE . 9.6 mmm-85 -126.27 136.71 53.11 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 122.227 1.013 . . . . 0.0 110.102 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . 0.472 ' O ' HG13 ' C' ' 68' ' ' ILE . 29.8 m-85 -87.92 74.28 9.01 Favored 'General case' 0 C--O 1.243 0.715 0 O-C-N 120.082 -1.636 . . . . 0.0 109.203 177.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.65 83.14 0.91 Allowed Glycine 0 CA--C 1.529 0.965 0 N-CA-C 109.084 -1.607 . . . . 0.0 109.084 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 68' ' ' ILE . . . . . 0.77 HG12 ' HD2' ' C' ' 37' ' ' PRO . 16.5 mt -98.08 144.67 10.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 O-C-N 124.61 0.83 . . . . 0.0 111.066 -167.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -109.84 72.37 0.61 Allowed Pre-proline 0 C--O 1.242 0.69 0 N-CA-C 103.018 -2.956 . . . . 0.0 103.018 169.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 70' ' ' PRO . . . . . 0.861 ' HB2' HG21 ' A' 1157 ' ' ILE . 43.0 Cg_exo -61.47 -20.23 67.65 Favored 'Trans proline' 0 C--N 1.341 0.148 1 C-N-CA 125.335 4.024 . . . . 0.0 113.96 -167.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.84 81.32 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 122.949 1.357 . . . . 0.0 107.555 161.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 72' ' ' ALA . . . . . 0.759 ' HB3' ' SD ' ' C' ' 79' ' ' MET . . . -142.85 97.09 3.04 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 119.38 -2.075 . . . . 0.0 112.834 -172.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 73' ' ' GLY . . . . . 0.51 ' C ' ' HD2' ' C' ' 74' ' ' ARG . . . 74.92 -75.53 1.28 Allowed Glycine 0 N--CA 1.44 -1.08 0 O-C-N 120.388 -1.445 . . . . 0.0 114.632 170.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . 0.649 ' HG3' ' HG2' ' B' 1203 ' ' GLN . 1.5 mpt_? -121.63 98.9 6.17 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -174.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.469 ' HG ' HD22 ' B' 1178 ' ' LEU . 0.3 OUTLIER 75.33 132.29 0.04 OUTLIER Pre-proline 0 C--N 1.35 0.625 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 168.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.32 150.07 84.75 Favored 'Trans proline' 0 C--O 1.239 0.57 0 C-N-CA 123.287 2.658 . . . . 0.0 114.487 174.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.18 -94.16 1.46 Allowed Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 106.964 -2.454 . . . . 0.0 106.964 -169.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 2.1 t60 26.33 -80.7 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 127.83 2.452 . . . . 0.0 116.048 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 79' ' ' MET . . . . . 0.759 ' SD ' ' HB3' ' C' ' 72' ' ' ALA . 0.8 OUTLIER -59.5 -43.62 93.3 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.698 -1.251 . . . . 0.0 111.587 179.545 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -67.98 -44.95 75.46 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 121.652 -0.655 . . . . 0.0 109.643 -176.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.425 ' O ' ' HB3' ' C' ' 84' ' ' ALA . 90.1 t -52.1 -50.88 33.77 Favored 'Isoleucine or valine' 0 C--O 1.249 1.074 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 168.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.447 ' HB3' ' HG2' ' C' ' 47' ' ' GLN . 3.5 mp -53.55 -39.75 65.01 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 174.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 11.7 tp -59.99 -46.41 89.55 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 124.385 1.053 . . . . 0.0 112.667 170.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 84' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' C' ' 81' ' ' VAL . . . -57.37 -39.95 77.09 Favored 'General case' 0 C--O 1.246 0.911 0 C-N-CA 124.253 1.021 . . . . 0.0 111.25 173.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -60.87 -40.1 91.71 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.015 0.526 . . . . 0.0 111.01 172.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . 0.422 ' HA ' ' CE1' ' C' ' 48' ' ' TYR . . . -67.22 0.1 3.02 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 120.645 -1.285 . . . . 0.0 113.315 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp 61.8 51.77 3.72 Favored 'General case' 0 C--O 1.266 1.921 0 C-N-CA 127.873 2.469 . . . . 0.0 111.403 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 88' ' ' VAL . . . . . 0.482 ' HA ' ' HD2' ' C' ' 89' ' ' PRO . 57.8 t -100.93 130.67 24.65 Favored Pre-proline 0 N--CA 1.444 -0.739 0 CA-C-N 112.855 -1.975 . . . . 0.0 106.164 172.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 89' ' ' PRO . . . . . 0.482 ' HD2' ' HA ' ' C' ' 88' ' ' VAL . 27.7 Cg_endo -55.4 111.19 0.68 Allowed 'Trans proline' 0 CA--C 1.509 -0.744 0 C-N-CA 124.889 3.726 . . . . 0.0 116.772 177.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.16 -16.49 20.42 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 108.992 -3.731 . . . . 0.0 118.289 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -69.58 -48.76 59.1 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-O 118.081 -0.962 . . . . 0.0 111.939 174.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 22.9 pt -70.86 -15.24 18.7 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-N 120.563 1.529 . . . . 0.0 114.738 174.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . 0.456 ' HA ' ' HB2' ' C' ' 66' ' ' PHE . 86.4 t -69.36 98.51 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-O 124.111 1.91 . . . . 0.0 106.721 167.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 19.2 mt -105.02 87.76 2.72 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 110.258 -3.155 . . . . 0.0 108.155 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 95' ' ' GLU . . . . . 0.765 ' HB3' HD13 ' A' 1157 ' ' ILE . 34.8 mp0 -69.1 103.91 2.01 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 111.349 -2.66 . . . . 0.0 109.865 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 92.9 mtp 56.96 25.93 11.21 Favored 'General case' 0 C--O 1.25 1.106 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 171.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -81.88 155.46 25.31 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 113.64 -1.618 . . . . 0.0 109.751 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -82.97 56.27 3.4 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 120.095 1.316 . . . . 0.0 109.353 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 99' ' ' ILE . . . . . 0.606 HG13 ' HB2' ' C' ' 102' ' ' ASP . 11.1 tp -74.46 41.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 O-C-N 117.28 -3.387 . . . . 0.0 111.902 173.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -76.85 -27.19 55.0 Favored 'General case' 0 C--O 1.217 -0.607 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -162.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.12 -44.82 87.46 Favored 'General case' 0 C--O 1.24 0.599 0 O-C-N 124.519 1.137 . . . . 0.0 110.274 174.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 102' ' ' ASP . . . . . 0.606 ' HB2' HG13 ' C' ' 99' ' ' ILE . 0.9 OUTLIER -65.42 -39.5 92.21 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 117.131 -1.414 . . . . 0.0 110.729 173.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 103' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -47.84 -56.5 7.33 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-N 123.042 2.655 . . . . 0.0 114.021 169.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.51 -35.89 77.04 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 123.674 0.79 . . . . 0.0 113.128 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -67.52 -39.35 85.07 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 121.221 -0.925 . . . . 0.0 111.568 175.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 106' ' ' THR . . . . . 0.432 ' HA ' ' HB2' ' C' ' 32' ' ' SER . 3.8 m -52.3 133.57 34.34 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-O 126.812 3.196 . . . . 0.0 113.577 -169.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 107' ' ' ASP . . . . . 0.437 ' OD2' ' HA ' ' C' ' 30' ' ' SER . 5.0 t0 -69.26 -70.41 0.28 Allowed 'General case' 0 C--N 1.3 -1.553 1 CA-C-N 107.035 -4.62 . . . . 0.0 108.635 171.656 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 8.4 m -121.19 124.99 46.05 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 120.949 1.704 . . . . 0.0 110.662 -174.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 109' ' ' VAL . . . . . . . . . . . . . 32.5 t -99.33 119.26 47.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 174.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 16.2 mt -95.89 85.35 4.06 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 122.765 1.269 . . . . 0.0 109.854 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 111' ' ' VAL . . . . . 0.42 ' HB ' ' HA ' ' C' ' 146' ' ' VAL . 11.8 t -81.52 103.8 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 177.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 112' ' ' ILE . . . . . 0.571 ' HA ' ' HD2' ' C' ' 147' ' ' PHE . 1.8 mm -81.34 106.45 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 O-C-N 118.164 -2.835 . . . . 0.0 109.142 -171.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 113' ' ' GLY . . . . . 0.936 ' HA3' ' HA3' ' C' ' 40' ' ' GLY . . . 89.22 -78.78 1.63 Allowed Glycine 0 CA--C 1.487 -1.669 0 CA-C-O 125.422 2.679 . . . . 0.0 111.863 170.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 114' ' ' ALA . . . . . 0.418 ' HB3' ' HA3' ' C' ' 38' ' ' GLY . . . -94.43 127.23 40.2 Favored 'General case' 0 C--O 1.21 -0.983 0 O-C-N 120.077 -1.837 . . . . 0.0 111.613 -162.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 115' ' ' ASN . . . . . 0.471 ' HB2' HD23 ' C' ' 162' ' ' LEU . 5.7 p-10 -66.42 -53.79 31.67 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 113.611 -1.631 . . . . 0.0 114.803 -178.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 116' ' ' ASP . . . . . 0.646 ' HA ' ' HB2' ' C' ' 119' ' ' ASN . 61.8 m-20 -65.75 -16.03 63.4 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 117.736 2.495 . . . . 0.0 117.736 -167.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 4.7 m -41.28 -44.85 2.79 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 127.175 2.797 . . . . 0.0 110.067 168.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.468 ' HA ' ' HB ' ' C' ' 135' ' ' VAL . 3.2 m -137.55 67.64 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.507 0 O-C-N 124.339 1.024 . . . . 0.0 108.679 169.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 119' ' ' ASN . . . . . 0.646 ' HB2' ' HA ' ' C' ' 116' ' ' ASP . 28.7 t-20 -87.6 119.56 70.72 Favored Pre-proline 0 C--O 1.26 1.658 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 120' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -60.88 -45.42 20.36 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.851 3.034 . . . . 0.0 110.995 -177.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.64 -14.41 62.05 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.32 -38.1 86.91 Favored 'General case' 0 CA--C 1.552 1.049 0 O-C-N 120.663 -1.273 . . . . 0.0 110.796 170.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 123' ' ' GLN . . . . . 0.718 ' HB2' HG22 ' C' ' 135' ' ' VAL . 3.4 tp-100 -75.95 -50.24 15.5 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-O 122.263 1.03 . . . . 0.0 108.739 177.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -80.76 -45.08 17.6 Favored 'General case' 0 C--O 1.247 0.947 0 N-CA-C 120.196 3.406 . . . . 0.0 120.196 -173.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 125' ' ' ASP . . . . . 0.405 ' HA ' ' HD3' ' C' ' 126' ' ' PRO . 32.3 t70 -103.1 123.44 41.92 Favored Pre-proline 0 CA--C 1.55 0.958 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -162.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 126' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' C' ' 125' ' ' ASP . 1.5 Cg_exo -46.26 -31.99 9.94 Favored 'Trans proline' 0 CA--C 1.503 -1.061 0 C-N-CA 124.534 3.49 . . . . 0.0 118.347 175.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . 0.462 ' HE2' ' HB3' ' C' ' 127' ' ' LYS . 25.2 ttpt -69.51 -32.8 71.88 Favored 'General case' 0 C--N 1.317 -0.829 0 O-C-N 120.904 -1.123 . . . . 0.0 110.648 -174.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 128' ' ' SER . . . . . . . . . . . . . 13.4 m -56.66 133.4 78.1 Favored Pre-proline 0 N--CA 1.467 0.42 0 C-N-CA 125.254 1.422 . . . . 0.0 107.874 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 129' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -55.14 -46.03 36.1 Favored 'Trans proline' 0 C--O 1.221 -0.368 1 C-N-CA 125.464 4.11 . . . . 0.0 114.282 175.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 130' ' ' ILE . . . . . 0.657 ' HB ' ' HB2' ' C' ' 133' ' ' MET . 4.3 pt -86.9 66.54 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.405 0 O-C-N 119.507 -1.996 . . . . 0.0 107.385 170.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -74.3 111.87 9.9 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.429 -1.26 . . . . 0.0 109.048 -174.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.73 34.87 17.82 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 122.821 1.234 . . . . 0.0 111.863 -175.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 133' ' ' MET . . . . . 0.657 ' HB2' ' HB ' ' C' ' 130' ' ' ILE . 39.0 tpp -70.09 123.03 88.0 Favored Pre-proline 0 C--O 1.243 0.722 0 CA-C-N 113.476 -1.362 . . . . 0.0 109.915 173.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 134' ' ' PRO . . . . . 0.56 ' HD2' ' SD ' ' C' ' 133' ' ' MET . 89.0 Cg_endo -68.66 88.15 0.43 Allowed 'Trans proline' 0 N--CA 1.442 -1.536 0 C-N-CA 122.625 2.217 . . . . 0.0 112.198 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 135' ' ' VAL . . . . . 0.718 HG22 ' HB2' ' C' ' 123' ' ' GLN . 28.6 m -88.31 150.09 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-N 113.424 -1.716 . . . . 0.0 106.973 168.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 27.4 mt -77.71 111.57 13.64 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 102.318 -3.215 . . . . 0.0 102.318 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 137' ' ' GLU . . . . . 0.55 ' HB3' ' NE1' ' C' ' 139' ' ' TRP . 48.5 mt-10 -70.24 96.61 1.12 Allowed 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 123.39 1.567 . . . . 0.0 113.047 -155.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 14.8 p -85.28 110.35 19.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 125.177 2.418 . . . . 0.0 109.074 169.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 139' ' ' TRP . . . . . 0.55 ' NE1' ' HB3' ' C' ' 137' ' ' GLU . 76.3 m95 -129.97 138.49 50.88 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 118.945 -2.347 . . . . 0.0 105.308 174.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 140' ' ' LYS . . . . . . . . . . . . . 24.5 pttm 38.15 20.69 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.823 1 N-CA-C 123.057 4.466 . . . . 0.0 123.057 175.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.84 150.82 36.17 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 120.369 -1.457 . . . . 0.0 107.754 163.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' C' ' 167' ' ' ASN . 16.7 mt-30 -62.89 -42.88 99.93 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 117.12 2.267 . . . . 0.0 117.12 -160.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 143' ' ' ASN . . . . . 0.402 ' HB3' HG13 ' C' ' 145' ' ' ILE . 3.8 m-80 -140.33 120.83 14.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 121.339 1.881 . . . . 0.0 108.443 167.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 144' ' ' VAL . . . . . 0.686 ' HB ' ' HA ' ' C' ' 168' ' ' THR . 44.1 t -102.02 85.39 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 101.882 -3.377 . . . . 0.0 101.882 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 145' ' ' ILE . . . . . 0.402 HG13 ' HB3' ' C' ' 143' ' ' ASN . 26.3 mt -82.57 104.37 11.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 125.84 2.733 . . . . 0.0 110.507 -178.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 146' ' ' VAL . . . . . 0.639 HG21 ' HG ' ' C' ' 162' ' ' LEU . 47.8 t -97.77 109.07 22.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 110.711 -2.949 . . . . 0.0 105.083 178.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 147' ' ' PHE . . . . . 0.571 ' HD2' ' HA ' ' C' ' 112' ' ' ILE . 82.9 m-85 -71.59 82.01 0.83 Allowed 'General case' 0 C--O 1.258 1.528 0 O-C-N 120.472 -1.393 . . . . 0.0 111.293 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 148' ' ' LYS . . . . . 0.826 ' HD3' ' SD ' ' C' ' 170' ' ' MET . 28.5 mtpt -103.05 133.09 48.75 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 120.297 -1.502 . . . . 0.0 107.764 177.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 -72.2 -29.3 63.84 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 123.056 1.408 . . . . 0.0 111.793 -175.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 16.0 m -142.04 151.32 42.31 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.337 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -73.23 102.87 3.76 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 103.077 -2.934 . . . . 0.0 103.077 167.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 152' ' ' ASN . . . . . 0.409 ' OD1' ' NZ ' ' C' ' 148' ' ' LYS . 13.0 p-10 -152.72 164.06 38.49 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 23.8 m -53.38 159.0 1.51 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 130.044 3.337 . . . . 0.0 113.741 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -136.21 -137.34 3.66 Favored Glycine 0 C--O 1.249 1.034 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -87.66 -63.75 1.25 Allowed 'General case' 0 C--O 1.238 0.468 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 171.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 156' ' ' ALA . . . . . . . . . . . . . . . -76.0 -53.63 8.08 Favored 'General case' 0 C--N 1.364 1.229 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 166.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 67.33 -89.16 0.17 Allowed Glycine 0 N--CA 1.461 0.327 0 N-CA-C 106.822 -2.511 . . . . 0.0 106.822 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 158' ' ' VAL . . . . . 0.575 HG23 ' HB3' ' C' ' 160' ' ' ASN 0.385 35.1 m 46.3 148.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 120.84 3.644 . . . . 0.0 120.84 -176.002 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.9 83.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 O-C-N 121.159 -0.963 . . . . 0.0 109.477 173.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 160' ' ' ASN . . . . . 0.575 ' HB3' HG23 ' C' ' 158' ' ' VAL . 5.5 p30 -130.77 164.27 42.93 Favored Pre-proline 0 C--O 1.242 0.673 0 CA-C-O 117.472 -1.252 . . . . 0.0 110.616 -164.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -38.33 -51.08 2.17 Favored 'Trans proline' 0 N--CA 1.445 -1.375 0 C-N-CA 124.383 3.388 . . . . 0.0 117.893 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 162' ' ' LEU . . . . . 0.639 ' HG ' HG21 ' C' ' 146' ' ' VAL . 1.4 mp -50.46 -35.41 28.76 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 176.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 163' ' ' PHE . . . . . 0.41 ' HA ' ' HE2' ' C' ' 170' ' ' MET . 12.1 m-85 -73.63 -30.79 63.17 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -107.59 -51.42 2.91 Favored 'General case' 0 C--O 1.257 1.462 0 CA-C-O 123.142 1.448 . . . . 0.0 114.494 -169.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 4.9 mmtm -61.81 153.32 29.06 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 115.983 1.845 . . . . 0.0 115.983 -171.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -85.41 -45.29 12.01 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -164.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 167' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' C' ' 142' ' ' GLN . 27.4 p-10 -89.12 -42.44 11.69 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.186 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 168' ' ' THR . . . . . 0.686 ' HA ' ' HB ' ' C' ' 144' ' ' VAL . 56.2 m -89.44 77.47 7.31 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 106.789 -1.559 . . . . 0.0 106.789 177.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -136.09 135.07 39.03 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.71 -158.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 170' ' ' MET . . . . . 0.826 ' SD ' ' HD3' ' C' ' 148' ' ' LYS . 67.6 mtm -63.99 94.57 0.1 Allowed 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.227 -1.806 . . . . 0.0 107.173 163.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 171' ' ' LEU . . . . . . . . . . . . . 10.4 tp -79.38 117.45 20.37 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 172' ' ' PHE . . . . . 0.564 ' HA ' ' O ' ' C' ' 148' ' ' LYS . 57.7 m-85 -70.65 93.21 0.91 Allowed 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 110.716 -2.947 . . . . 0.0 114.386 -168.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -166.32 159.74 33.1 Favored Glycine 0 C--O 1.248 1.029 0 O-C-N 125.222 1.576 . . . . 0.0 109.664 176.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 174' ' ' ASP . . . . . 0.615 ' HB3' ' HB3' ' C' ' 177' ' ' ALA . 31.6 t70 -69.93 151.74 45.28 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 113.582 -1.309 . . . . 0.0 108.911 177.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 175' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' C' ' 44' ' ' ALA . . . -64.52 -49.04 72.84 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.164 -175.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.53 -47.81 37.99 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -176.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 177' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' C' ' 174' ' ' ASP . . . -56.3 -47.41 78.74 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 122.113 0.959 . . . . 0.0 113.204 -175.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 49.6 m -63.62 -36.23 83.12 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 176.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 179' ' ' VAL . . . . . 0.655 ' HA ' HG12 ' C' ' 182' ' ' ILE . 44.3 t -75.04 -39.56 44.22 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -52.71 -44.5 66.36 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.845 172.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -64.79 -52.09 58.72 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 119.131 -0.461 . . . . 0.0 111.914 174.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 182' ' ' ILE . . . . . 0.655 HG12 ' HA ' ' C' ' 179' ' ' VAL . 20.4 pt -64.79 -33.15 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 O-C-N 123.796 0.685 . . . . 0.0 111.45 -169.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 183' ' ' LEU . . . . . . . . . . . . . 4.0 pp -67.64 -36.29 80.49 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 124.138 0.975 . . . . 0.0 111.66 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -77.23 -48.04 18.6 Favored 'General case' 0 C--O 1.206 -1.215 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -69.79 -71.24 0.24 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 -171.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 186' ' ' LEU . . . . . 0.421 ' HA ' ' HB1' ' C' ' 24' ' ' ALA 0.313 0.9 OUTLIER . . . . . 0 N--CA 1.476 0.873 0 N-CA-C 116.555 2.057 . . . . 0.0 116.555 -155.791 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' NAD . . . . . 0.415 ' H1D' ' HB3' ' B' 1120 ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C 1001 ' ' NAP . . . . . 0.628 H52N ' HA ' ' C' ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 36.6 t-80 . . . . . 0 CA--C 1.508 -0.662 0 N-CA-C 105.874 -1.898 . . . . 65.74 105.874 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -61.83 76.86 0.02 OUTLIER Glycine 0 CA--C 1.538 1.497 0 N-CA-C 116.432 1.333 . . . . 48.66 116.432 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 26.5 ttp180 -118.71 138.03 52.92 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 123.394 1.568 . . . . 44.56 108.532 175.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1003 ' ' ILE . . . . . 0.472 HG12 HD13 ' A' 1068 ' ' ILE . 36.8 mt -106.65 129.75 59.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 102.253 -3.24 . . . . 34.86 102.253 -176.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -91.88 135.76 12.92 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 106.793 -2.523 . . . . 30.75 106.793 170.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.888 HG23 ' HB3' ' A' 1017 ' ' ALA . 19.5 mm -113.5 97.69 44.42 Favored Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 105.954 -1.869 . . . . 32.21 105.954 172.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -81.05 166.28 18.85 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 123.171 2.581 . . . . 32.98 114.275 170.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1007 ' ' ARG . . . . . 0.454 ' HB2' ' HA ' ' A' 1039 ' ' ALA . 6.5 tmm_? -85.31 140.05 31.12 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 113.066 -1.879 . . . . 47.98 106.071 167.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1008 ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -68.94 157.55 36.45 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 123.76 1.743 . . . . 34.7 113.774 -175.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -138.08 132.75 32.57 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 112.324 -2.216 . . . . 53.37 108.352 -171.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 10.8 tp 170.02 -177.24 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 102.96 -2.978 . . . . 45.07 102.96 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1011 ' ' THR . . . . . . . . . . . . . 11.0 m -72.01 114.5 10.18 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 122.745 2.521 . . . . 40.36 107.718 -174.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 4.3 m-20 64.53 43.58 4.38 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 113.712 1.004 . . . . 40.61 113.712 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -87.81 137.42 32.35 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 119.42 -0.912 . . . . 33.76 110.99 -171.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1014 ' ' THR . . . . . . . . . . . . . 19.9 p -103.24 -41.7 5.97 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 122.352 1.072 . . . . 27.89 113.038 -173.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1015 ' ' ARG . . . . . 0.565 ' HG3' ' HA2' ' A' 1317 ' ' GLY . 61.9 mtm180 -48.28 167.74 0.03 OUTLIER 'General case' 0 C--N 1.356 0.88 0 N-CA-C 120.083 3.364 . . . . 29.02 120.083 -173.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1016 ' ' VAL . . . . . 0.595 HG23 ' HB1' ' A' 1039 ' ' ALA . 7.7 p -132.12 162.52 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 113.454 -1.703 . . . . 28.13 106.712 171.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1017 ' ' ALA . . . . . 0.888 ' HB3' HG23 ' A' 1005 ' ' ILE . . . -66.47 -36.5 82.92 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 119.087 -2.258 . . . . 26.87 115.2 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -154.47 144.76 22.05 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 106.277 -1.749 . . . . 26.77 106.277 -174.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1019 ' ' THR . . . . . 0.405 HG21 HG23 ' A' 1321 ' ' THR . 1.7 p -98.5 170.74 6.6 Favored Pre-proline 0 N--CA 1.447 -0.583 0 CA-C-O 116.797 -1.573 . . . . 27.02 113.422 169.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1020 ' ' PRO . . . . . 0.401 ' HD3' ' CE1' ' A' 1050 ' ' PHE . 0.0 OUTLIER -29.45 -61.66 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 125.29 3.993 . . . . 30.57 120.024 173.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -66.85 -28.48 68.37 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 123.216 2.734 . . . . 47.81 110.842 -175.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1022 ' ' THR . . . . . . . . . . . . . 22.4 m -64.38 -47.98 77.19 Favored 'General case' 0 CA--C 1.554 1.118 0 O-C-N 121.621 -0.674 . . . . 30.77 110.178 169.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1023 ' ' VAL . . . . . . . . . . . . . 24.8 t -61.89 -38.6 80.99 Favored 'Isoleucine or valine' 0 C--O 1.254 1.33 0 O-C-N 120.996 -1.065 . . . . 33.59 109.043 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -64.56 -45.12 88.43 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 118.801 -1.16 . . . . 53.29 110.797 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1025 ' ' GLN . . . . . 0.619 ' HB3' HG11 ' A' 1332 ' ' VAL . 78.1 mt-30 -57.37 -40.15 77.54 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 118.762 0.71 . . . . 46.92 112.262 174.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1026 ' ' LEU . . . . . . . . . . . . . 74.7 mt -65.34 -34.67 78.86 Favored 'General case' 0 C--O 1.249 1.043 0 O-C-N 120.189 -1.57 . . . . 37.17 112.322 176.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 81.0 mt -70.87 -38.63 73.11 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.605 -0.887 . . . . 44.44 108.605 174.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -57.85 -36.74 72.75 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.972 0.805 . . . . 52.58 111.989 175.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1029 ' ' LEU . . . . . 0.54 ' HA ' ' HE2' ' A' 1342 ' ' LYS . 90.3 mt -60.97 -27.51 68.32 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 114.435 1.272 . . . . 45.69 114.435 170.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 93.2 32.27 7.94 Favored Glycine 0 C--O 1.242 0.614 0 O-C-N 121.23 -0.919 . . . . 42.09 113.111 -174.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -106.14 154.62 20.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 105.756 -1.942 . . . . 40.72 105.756 165.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1032 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.38 145.85 25.27 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 123.066 1.413 . . . . 37.77 109.42 172.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1033 ' ' VAL . . . . . . . . . . . . . 20.8 t -117.01 136.07 55.34 Favored 'Isoleucine or valine' 0 C--O 1.25 1.092 0 O-C-N 119.927 -1.733 . . . . 33.54 111.756 -172.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -119.79 140.52 50.63 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 108.156 -1.053 . . . . 31.68 108.156 170.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1035 ' ' VAL . . . . . . . . . . . . . 74.0 t -121.67 146.62 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 122.654 1.216 . . . . 31.52 109.387 178.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1036 ' ' GLU . . . . . 0.529 ' HB3' ' HB2' ' A' 1039 ' ' ALA . 34.3 tt0 -71.76 136.54 47.17 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 113.552 -1.658 . . . . 41.04 111.124 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1037 ' ' SER . . . . . . . . . . . . . 49.2 m -70.56 117.8 12.55 Favored 'General case' 0 C--O 1.246 0.883 0 N-CA-C 107.4 -1.333 . . . . 31.83 107.4 175.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 103.96 -7.24 48.48 Favored Glycine 0 C--O 1.219 -0.796 0 O-C-N 120.411 -1.431 . . . . 29.36 110.42 -174.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1039 ' ' ALA . . . . . 0.595 ' HB1' HG23 ' A' 1016 ' ' VAL . . . -68.69 -27.18 65.74 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 118.961 1.381 . . . . 27.78 112.089 -177.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -79.59 -32.57 37.2 Favored Glycine 0 N--CA 1.437 -1.27 0 CA-C-O 122.189 0.883 . . . . 28.91 112.604 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -47.59 -69.17 0.13 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.002 -1.599 . . . . 51.18 114.565 -171.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1042 ' ' LEU . . . . . . . . . . . . . 13.8 mt -77.22 -20.26 55.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.913 1.339 . . . . 29.91 111.869 -174.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1043 ' ' ALA . . . . . . . . . . . . . . . -82.22 -9.62 59.43 Favored 'General case' 0 C--O 1.243 0.759 0 O-C-N 120.419 -1.426 . . . . 28.54 113.153 171.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1044 ' ' SER . . . . . . . . . . . . . 7.9 m 56.33 63.92 1.85 Allowed 'General case' 0 C--N 1.361 1.1 0 O-C-N 126.715 2.509 . . . . 33.06 112.476 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1045 ' ' PHE . . . . . 0.556 ' HD1' ' HB3' ' B' 1277 ' ' ALA . 0.0 OUTLIER -159.78 75.15 0.62 Allowed 'General case' 0 C--N 1.315 -0.931 1 N-CA-C 98.682 -4.562 . . . . 30.29 98.682 162.332 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -62.46 150.63 39.52 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.762 -1.108 . . . . 48.62 113.621 -160.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1047 ' ' ASP . . . . . 0.534 ' HA ' ' HD2' ' A' 1050 ' ' PHE . 1.3 m-20 -46.09 -29.47 1.52 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 117.612 2.449 . . . . 36.74 117.612 -156.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 21.6 pttm -53.35 -33.91 55.44 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 112.956 0.724 . . . . 43.73 112.956 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -60.49 -35.94 77.13 Favored 'General case' 0 CA--C 1.522 -0.133 0 O-C-N 120.366 -1.459 . . . . 32.81 112.917 171.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1050 ' ' PHE . . . . . 0.534 ' HD2' ' HA ' ' A' 1047 ' ' ASP . 95.1 m-85 -72.1 -24.85 61.56 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 120.187 -1.571 . . . . 31.86 111.412 175.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 61.8 t -65.41 -47.32 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 118.236 -0.888 . . . . 33.22 109.435 170.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -56.35 -34.48 66.65 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.565 1.691 . . . . 50.83 115.565 171.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -74.41 -21.78 59.46 Favored 'General case' 0 C--O 1.25 1.117 0 N-CA-C 115.093 1.516 . . . . 33.12 115.093 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 101.34 83.22 1.72 Allowed Glycine 0 CA--C 1.526 0.752 0 C-N-CA 119.453 -1.356 . . . . 35.83 110.219 -177.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -150.58 138.65 20.14 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 119.44 -2.212 . . . . 34.82 115.159 176.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -66.4 121.17 14.68 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 105.511 -2.033 . . . . 49.05 105.511 165.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1057 ' ' ILE . . . . . . . . . . . . . 43.3 mm -100.03 118.2 46.33 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 O-C-N 119.649 -1.907 . . . . 38.53 107.732 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1058 ' ' VAL . . . . . . . . . . . . . 3.2 m -133.93 172.87 15.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 125.602 1.561 . . . . 42.11 111.119 -176.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -87.84 165.36 15.35 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 122.878 2.581 . . . . 58.0 108.202 173.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1060 ' ' GLY . . . . . 0.456 ' HA2' HG12 ' A' 1063 ' ' VAL . . . -49.53 -51.42 27.55 Favored Glycine 0 C--O 1.238 0.368 0 O-C-N 120.718 -1.239 . . . . 52.12 116.044 -172.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1061 ' ' ASN . . . . . 0.443 ' O ' ' HG2' ' A' 1065 ' ' GLN . 7.8 t30 -49.5 -40.27 36.97 Favored 'General case' 0 C--O 1.251 1.159 0 CA-C-O 122.092 0.948 . . . . 54.75 112.817 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1062 ' ' SER . . . . . . . . . . . . . 16.5 m -78.08 -35.82 48.92 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 119.984 -1.697 . . . . 50.34 114.608 173.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1063 ' ' VAL . . . . . 0.456 HG12 ' HA2' ' A' 1060 ' ' GLY . 1.1 p -64.62 -28.98 46.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 119.588 -1.945 . . . . 41.46 111.027 -178.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1064 ' ' TRP . . . . . 0.415 ' HB2' HD22 ' A' 1082 ' ' LEU . 59.6 m95 -80.67 -13.87 58.64 Favored 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 121.064 -1.022 . . . . 39.32 112.736 175.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1065 ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' 1061 ' ' ASN . 92.2 mm-40 -77.34 67.4 3.28 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 119.302 -2.124 . . . . 55.38 105.979 173.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1066 ' ' SER . . . . . . . . . . . . . 60.1 m -148.69 142.87 26.04 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 119.709 -1.87 . . . . 41.87 111.227 -170.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.78 -36.55 79.26 Favored 'General case' 0 N--CA 1.437 -1.104 0 O-C-N 125.671 1.857 . . . . 53.2 112.438 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1068 ' ' ILE . . . . . 0.472 HD13 HG12 ' A' 1003 ' ' ILE . 3.7 mp -121.9 144.47 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 106.515 -1.661 . . . . 41.9 106.515 176.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1069 ' ' ILE . . . . . 0.458 HG12 HG21 ' A' 1087 ' ' THR . 49.0 mm -130.63 129.24 64.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 N-CA-C 107.416 -1.328 . . . . 38.73 107.416 169.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1070 ' ' LEU . . . . . 0.411 ' HB2' ' HB1' ' A' 1017 ' ' ALA . 44.9 mt -97.17 143.81 27.62 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.256 -2.498 . . . . 32.44 104.256 175.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1071 ' ' LYS . . . . . 0.556 ' HB2' ' OG ' ' A' 1091 ' ' SER . 16.0 mmmt -148.12 130.51 15.7 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.647 0.779 . . . . 34.65 111.534 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1072 ' ' VAL . . . . . 0.516 HG13 ' CD2' ' A' 1327 ' ' TYR . 2.1 t -89.32 -13.96 9.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-N 114.86 -1.063 . . . . 31.32 113.747 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -112.89 -176.65 2.95 Favored 'General case' 0 C--O 1.248 1.018 0 N-CA-C 106.583 -1.636 . . . . 33.94 106.583 163.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -73.2 155.12 90.25 Favored Pre-proline 0 C--O 1.259 1.567 0 N-CA-C 109.043 -0.725 . . . . 38.04 109.043 161.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1075 ' ' PRO . . . . . 0.743 ' HG2' HD21 ' A' 1089 ' ' LEU . 3.9 Cg_exo -70.83 117.31 5.08 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 123.599 2.866 . . . . 42.68 114.621 168.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 86.8 mt -71.21 162.64 29.09 Favored 'General case' 0 N--CA 1.434 -1.251 0 O-C-N 125.838 1.961 . . . . 46.74 107.868 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1077 ' ' ASP . . . . . 0.468 ' HA ' HD12 ' A' 1080 ' ' ILE . 0.5 OUTLIER -42.73 -46.3 5.06 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 117.743 2.498 . . . . 58.61 117.743 -177.233 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 38.8 t70 -64.73 -41.33 96.04 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 113.567 0.951 . . . . 59.2 113.567 174.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1079 ' ' GLU . . . . . 0.596 ' HA ' HD12 ' A' 1082 ' ' LEU . 38.2 mt-10 -66.69 -32.96 74.61 Favored 'General case' 0 C--O 1.211 -0.956 0 N-CA-C 108.347 -0.983 . . . . 50.63 108.347 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1080 ' ' ILE . . . . . 0.636 ' HA ' HD23 ' A' 1083 ' ' LEU . 95.7 mt -59.6 -41.53 85.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 123.648 1.69 . . . . 51.48 110.728 175.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -62.62 -29.35 70.55 Favored 'General case' 0 C--O 1.211 -0.969 0 O-C-N 120.876 -1.14 . . . . 50.28 111.958 175.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1082 ' ' LEU . . . . . 0.596 HD12 ' HA ' ' A' 1079 ' ' GLU . 8.0 mt -70.47 -27.26 64.09 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 114.815 1.413 . . . . 50.21 114.815 173.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1083 ' ' LEU . . . . . 0.636 HD23 ' HA ' ' A' 1080 ' ' ILE . 1.3 mm? -64.16 123.95 20.41 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 122.817 1.294 . . . . 49.06 112.099 -176.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -89.81 141.24 28.15 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 104.807 -2.294 . . . . 51.08 104.807 175.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -56.81 148.26 67.51 Favored 'Trans proline' 0 CA--C 1.503 -1.031 0 C-N-CA 122.745 2.297 . . . . 49.73 116.035 -177.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 84.05 -14.11 45.76 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 113.887 -1.506 . . . . 47.71 113.658 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1087 ' ' THR . . . . . 0.458 HG21 HG12 ' A' 1069 ' ' ILE . 38.6 m -59.2 127.04 30.15 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 119.868 1.834 . . . . 45.47 113.293 -175.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1088 ' ' THR . . . . . . . . . . . . . 31.0 m -75.31 96.46 3.38 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 105.66 -1.978 . . . . 42.04 105.66 173.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1089 ' ' LEU . . . . . 0.743 HD21 ' HG2' ' A' 1075 ' ' PRO . 42.7 tp -89.09 113.36 24.5 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 113.301 -1.772 . . . . 38.06 108.028 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 3.3 t -108.37 109.06 26.89 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 N-CA-C 102.265 -3.235 . . . . 37.4 102.265 -173.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1091 ' ' SER . . . . . 0.556 ' OG ' ' HB2' ' A' 1071 ' ' LYS . 19.7 m -145.67 153.87 41.49 Favored 'General case' 0 C--O 1.224 -0.285 0 O-C-N 120.686 -1.259 . . . . 36.16 112.888 -166.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 2.8 t80 -84.67 91.03 7.83 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 105.727 -1.953 . . . . 38.94 105.727 172.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 26.5 mm -83.86 -49.57 16.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 115.37 1.619 . . . . 42.17 115.37 -172.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 96.4 m95 60.42 73.0 0.67 Allowed Pre-proline 0 C--O 1.255 1.366 0 C-N-CA 125.243 1.417 . . . . 46.51 111.021 -159.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -59.76 -38.39 80.9 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 124.754 3.636 . . . . 49.76 116.566 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -55.69 -47.44 76.78 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.618 -1.628 . . . . 52.62 110.824 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -64.77 -27.49 68.93 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 113.361 -1.745 . . . . 60.74 113.577 174.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1098 ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -123.32 56.96 10.34 Favored Pre-proline 0 N--CA 1.449 -0.478 0 N-CA-C 119.363 3.097 . . . . 58.19 119.363 -164.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -59.19 -47.67 16.6 Favored 'Trans proline' 0 N--CA 1.479 0.633 0 C-N-CA 123.399 2.732 . . . . 54.59 115.257 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1100 ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' 1104 ' ' LYS . 0.0 OUTLIER -61.38 -44.52 97.02 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 113.18 0.807 . . . . 63.28 113.18 177.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 1101 ' ' LEU . . . . . . . . . . . . . 8.2 tp -62.5 -46.26 89.26 Favored 'General case' 0 N--CA 1.441 -0.898 0 O-C-N 124.608 1.192 . . . . 54.75 107.853 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1102 ' ' MET . . . . . . . . . . . . . 49.8 mmm -53.98 -45.56 71.42 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 123.366 0.667 . . . . 52.65 112.054 175.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -62.11 -34.41 76.28 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 118.017 -0.992 . . . . 66.26 112.364 175.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1104 ' ' LYS . . . . . 0.453 ' HB3' HG21 ' A' 1080 ' ' ILE . 86.2 mttt -66.58 -46.62 75.38 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.891 -0.781 . . . . 63.73 108.891 175.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.01 -39.08 84.59 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 121.191 -0.943 . . . . 54.68 110.513 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -69.56 -38.8 77.59 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.397 -0.814 . . . . 53.64 111.308 176.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -71.85 -18.87 62.04 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 120.292 1.405 . . . . 67.24 112.186 177.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -77.55 -4.78 47.44 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 116.124 1.898 . . . . 65.76 116.124 163.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 5.2 t30 55.17 40.8 31.85 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 126.166 1.786 . . . . 58.71 111.532 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1110 ' ' VAL . . . . . 0.419 HG23 HG23 ' A' 1112 ' ' VAL . 30.8 m -98.27 153.67 4.01 Favored 'Isoleucine or valine' 0 C--N 1.344 0.357 0 O-C-N 121.24 -0.913 . . . . 46.63 113.007 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1111 ' ' THR . . . . . 0.415 HG23 ' HA ' ' A' 1362 ' ' ARG . 53.6 m -88.89 100.22 13.01 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 104.704 -2.332 . . . . 44.13 104.704 176.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1112 ' ' VAL . . . . . 0.483 HG22 HD23 ' A' 1089 ' ' LEU . 62.2 t -93.82 115.16 31.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 O-C-N 121.111 -0.993 . . . . 40.44 109.743 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1113 ' ' MET . . . . . 0.484 ' HB3' HG12 ' A' 1358 ' ' VAL . 19.3 mtp -101.24 102.42 13.3 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.033 -1.894 . . . . 50.76 108.564 173.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1114 ' ' ALA . . . . . 0.486 ' HB3' ' HB2' ' A' 1117 ' ' SER . . . -80.08 108.07 13.37 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 122.936 1.351 . . . . 35.64 108.88 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1115 ' ' MET . . . . . 0.558 ' SD ' HD22 ' A' 1334 ' ' LEU . 69.9 mmm -71.83 -20.71 61.79 Favored 'General case' 0 C--O 1.243 0.759 0 O-C-N 119.437 -2.04 . . . . 38.74 115.308 -174.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1116 ' ' ASP . . . . . 0.464 ' O ' HD12 ' A' 1130 ' ' LEU . 8.4 p-10 -66.08 -32.63 74.2 Favored 'General case' 0 C--O 1.246 0.915 0 CA-C-O 122.238 1.018 . . . . 40.14 109.289 164.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1117 ' ' SER . . . . . 0.486 ' HB2' ' HB3' ' A' 1114 ' ' ALA . 68.9 m -91.09 34.47 0.93 Allowed 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 117.14 2.274 . . . . 44.79 117.14 -176.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1118 ' ' VAL . . . . . . . . . . . . . 3.5 t -75.56 129.03 82.81 Favored Pre-proline 0 N--CA 1.439 -1.011 0 O-C-N 121.718 -0.614 . . . . 43.75 109.547 165.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -61.19 137.97 74.55 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.714 2.276 . . . . 48.93 111.795 172.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 25.1 mmm-85 -90.16 32.86 0.9 Allowed 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.204 -1.56 . . . . 62.9 111.546 -152.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 30.8 pt -79.89 155.63 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 O-C-N 118.492 -2.63 . . . . 57.72 112.198 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1122 ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -43.27 -58.99 2.27 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 120.653 3.575 . . . . 57.26 120.653 -177.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1123 ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' 1123 ' ' ARG 0.269 0.0 OUTLIER -60.09 -16.55 32.72 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 116.565 2.061 . . . . 62.9 116.565 175.027 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A 1124 ' ' ALA . . . . . 0.806 ' HB2' HG11 ' A' 1354 ' ' VAL . . . -80.41 -15.05 57.74 Favored 'General case' 0 N--CA 1.424 -1.755 0 O-C-N 118.67 -2.519 . . . . 49.83 113.472 177.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 69.6 mm-40 -66.99 -22.04 65.93 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 116.996 2.221 . . . . 52.37 116.996 -163.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1126 ' ' SER . . . . . . . . . . . . . 13.7 m -73.31 -19.18 61.09 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 115.174 1.546 . . . . 42.43 115.174 169.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1127 ' ' LEU . . . . . . . . . . . . . 2.7 mp -95.84 -30.64 13.56 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.591 -0.892 . . . . 43.74 108.591 173.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 65.6 t0 -65.06 106.91 1.37 Allowed 'General case' 0 C--O 1.247 0.954 0 CA-C-O 125.833 2.73 . . . . 43.21 112.045 -173.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1129 ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' 1115 ' ' MET . . . -85.08 -28.72 25.43 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 109.576 -3.465 . . . . 35.74 110.12 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1130 ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' 1116 ' ' ASP . 0.5 OUTLIER -66.82 -20.26 65.9 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-N 120.866 1.666 . . . . 38.09 109.107 177.133 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 1131 ' ' SER . . . . . 0.447 ' HB3' HG21 ' A' 1175 ' ' VAL . 65.4 m -82.5 -64.37 1.19 Allowed 'General case' 0 CA--C 1.545 0.766 0 O-C-N 119.413 -2.054 . . . . 36.91 110.327 161.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1132 ' ' SER . . . . . 0.538 ' O ' ' HB3' ' A' 1135 ' ' ASN . 19.4 m -66.92 -44.51 80.51 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 117.678 2.473 . . . . 35.79 117.678 -168.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1133 ' ' MET . . . . . 0.564 ' HA ' HD12 ' A' 1136 ' ' ILE . 5.2 ttt -68.37 -35.18 77.34 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 121.784 2.084 . . . . 30.81 110.624 176.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1134 ' ' ALA . . . . . . . . . . . . . . . -60.51 -40.82 92.79 Favored 'General case' 0 C--O 1.251 1.18 0 N-CA-C 109.143 -0.688 . . . . 28.88 109.143 173.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1135 ' ' ASN . . . . . 0.882 ' HB2' HG12 ' A' 1175 ' ' VAL . 10.4 t-20 -53.8 -48.06 70.22 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.235 1.414 . . . . 40.76 112.285 175.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1136 ' ' ILE . . . . . 0.631 HD13 ' HA ' ' A' 1323 ' ' SER . 69.0 mt -57.87 -47.48 86.16 Favored 'Isoleucine or valine' 0 C--O 1.247 0.934 0 CA-C-N 114.388 -1.278 . . . . 31.54 110.985 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -60.83 -34.24 74.26 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.068 -1.423 . . . . 29.87 110.495 174.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -62.59 -48.5 81.17 Favored Glycine 0 C--O 1.211 -1.327 0 CA-C-N 119.296 0.953 . . . . 28.73 112.177 176.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 28.3 t80 -59.93 -42.06 93.15 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.596 -0.802 . . . . 30.39 110.317 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1140 ' ' ARG . . . . . 0.708 ' HD3' HD13 ' A' 1319 ' ' LEU . 1.1 tpt180 -73.34 -22.6 60.27 Favored 'General case' 0 CA--C 1.497 -1.066 0 O-C-N 124.445 1.091 . . . . 26.09 113.178 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1141 ' ' ALA . . . . . . . . . . . . . . . -66.62 -48.02 70.78 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 105.545 -2.02 . . . . 27.1 105.545 171.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 25.8 mm -53.66 -43.43 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 C-N-CA 125.442 1.497 . . . . 28.48 111.541 175.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 75.4 t -58.55 -61.68 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 O-C-N 120.653 -1.279 . . . . 23.07 110.113 173.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1144 ' ' GLU . . . . . 0.428 ' CD ' HH21 ' A' 1140 ' ' ARG . 5.7 mm-40 -62.42 -28.28 69.68 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 122.126 2.239 . . . . 33.4 114.137 -177.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1145 ' ' ALA . . . . . 0.78 ' HB1' HD12 ' A' 1251 ' ' ILE . . . -57.38 -60.47 3.59 Favored 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 124.668 1.187 . . . . 24.22 109.721 169.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -65.39 -20.49 66.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.554 0.692 . . . . 24.89 111.038 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -76.61 -33.53 58.39 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-O 115.511 -2.185 . . . . 26.73 110.725 177.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1148 ' ' GLU . . . . . 0.657 ' HB2' HD11 ' A' 1310 ' ' ILE . 40.0 mm-40 -110.16 3.38 20.09 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 122.221 2.282 . . . . 39.96 115.785 175.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1149 ' ' PHE . . . . . 0.613 ' CZ ' ' HB3' ' A' 1250 ' ' ASP . 0.9 OUTLIER -67.08 145.94 54.82 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 126.063 1.745 . . . . 25.87 110.448 -178.359 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 1150 ' ' GLY . . . . . . . . . . . . . . . -69.75 -45.18 59.59 Favored Glycine 0 N--CA 1.43 -1.732 0 O-C-N 121.308 -0.87 . . . . 19.28 113.504 171.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1151 ' ' ARG . . . . . 0.703 ' HA ' ' HB2' ' B' 1322 ' ' GLN . 69.7 mtm-85 -107.42 -173.79 2.37 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 124.362 1.065 . . . . 39.9 113.347 -166.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1152 ' ' PHE . . . . . 0.539 ' CD1' ' HG2' ' B' 1322 ' ' GLN . 5.3 m-30 -84.07 149.68 26.08 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 106.218 -1.771 . . . . 29.44 106.218 172.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1153 ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -64.95 -53.31 48.39 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 124.177 1.942 . . . . 32.6 110.18 152.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1154 ' ' THR . . . . . . . . . . . . 0.255 56.3 m -65.03 110.77 2.6 Favored 'General case' 0 C--O 1.249 1.068 0 CA-C-N 111.908 -2.406 . . . . 34.64 116.427 -174.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -64.07 138.85 41.89 Favored Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 109.579 -1.409 . . . . 37.14 109.579 163.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -173.63 158.84 3.45 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 122.53 1.157 . . . . 40.57 111.507 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1157 ' ' ILE . . . . . 0.52 HD13 ' HB2' ' C' ' 95' ' ' GLU . 6.5 tp -79.03 136.81 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 O-C-N 119.995 -1.691 . . . . 44.61 109.41 163.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1158 ' ' THR . . . . . 0.565 ' O ' ' HB3' ' C' ' 70' ' ' PRO . 68.7 p -111.28 -160.12 0.7 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 105.469 -2.049 . . . . 40.7 105.469 169.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1159 ' ' ALA . . . . . 0.54 ' HB1' ' HA ' ' B' 1126 ' ' SER . . . -83.28 -20.29 34.72 Favored 'General case' 0 CA--C 1.541 0.634 1 O-C-N 116.284 -4.01 . . . . 40.25 108.92 165.526 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -96.46 43.98 1.07 Allowed 'General case' 0 C--O 1.246 0.897 0 CA-C-O 123.32 1.533 . . . . 38.47 110.238 175.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . 74.97 -171.99 53.52 Favored Glycine 0 C--O 1.244 0.762 0 O-C-N 119.943 -1.723 . . . . 37.61 116.074 170.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -72.82 135.1 45.16 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 122.812 1.292 . . . . 48.9 112.186 -174.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1163 ' ' VAL . . . . . 0.527 HG11 ' HB2' ' A' 1152 ' ' PHE . 84.0 t -93.86 127.08 46.87 Favored Pre-proline 0 C--O 1.25 1.089 0 N-CA-C 104.398 -2.445 . . . . 36.52 104.398 162.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1164 ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.09 145.86 40.22 Favored 'Trans proline' 0 N--CA 1.444 -1.403 0 C-N-CA 124.615 3.544 . . . . 35.08 109.838 173.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1165 ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -62.01 147.13 95.75 Favored 'Trans proline' 0 C--O 1.245 0.833 0 C-N-CA 123.889 3.059 . . . . 35.33 109.713 172.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -78.64 135.41 37.21 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.736 1.014 . . . . 34.69 113.736 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1167 ' ' LYS . . . . . . . . . . . . . 44.3 mttp -84.24 100.02 10.93 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 102.263 -3.236 . . . . 45.36 102.263 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 59.9 t -91.38 88.27 2.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 114.793 -1.094 . . . . 31.71 110.241 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1169 ' ' MET . . . . . 0.498 ' HA ' ' O ' ' A' 1192 ' ' ARG . 37.2 ttp -77.2 107.04 9.3 Favored 'General case' 0 CA--C 1.498 -1.037 0 O-C-N 119.49 -2.006 . . . . 42.28 107.884 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 59.4 t -92.29 121.81 43.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 117.27 -1.348 . . . . 30.51 109.612 176.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 20.8 mt -107.36 131.37 57.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 104.609 -2.367 . . . . 31.87 104.609 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 82.22 61.77 1.97 Allowed Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 108.584 -1.807 . . . . 34.54 108.584 174.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1173 ' ' ALA . . . . . 0.557 ' HA ' ' HA3' ' A' 1177 ' ' GLY . . . -77.37 76.98 3.9 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 120.373 -1.663 . . . . 32.51 115.108 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -84.81 -160.77 32.72 Favored Glycine 0 C--O 1.219 -0.796 0 CA-C-O 116.774 -2.126 . . . . 29.9 110.25 156.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1175 ' ' VAL . . . . . 0.882 HG12 ' HB2' ' A' 1135 ' ' ASN . 48.3 t -64.63 -31.09 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 1 CA-C-N 124.977 4.389 . . . . 33.11 114.32 -176.655 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 1176 ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' 1135 ' ' ASN . . . -53.58 -47.58 69.98 Favored 'General case' 0 C--O 1.218 -0.559 0 O-C-N 121.885 -0.509 . . . . 28.1 111.602 165.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1177 ' ' GLY . . . . . 0.557 ' HA3' ' HA ' ' A' 1173 ' ' ALA . . . -63.71 -42.88 98.51 Favored Glycine 0 CA--C 1.507 -0.419 0 CA-C-O 118.846 -0.974 . . . . 28.54 111.759 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1178 ' ' LEU . . . . . 0.408 HD12 HG22 ' A' 1175 ' ' VAL . 52.4 mt -62.9 -35.19 79.25 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 117.462 -1.256 . . . . 31.22 110.698 177.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1179 ' ' ALA . . . . . 0.457 ' HB2' ' ND2' ' A' 1135 ' ' ASN . . . -64.61 -34.88 79.3 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 121.769 2.077 . . . . 28.98 112.374 172.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -67.81 -45.78 73.79 Favored 'General case' 0 C--O 1.253 1.25 0 CA-C-N 115.249 -0.887 . . . . 27.83 112.079 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1181 ' ' ILE . . . . . 0.573 HG12 HG11 ' A' 1191 ' ' VAL . 54.7 mt -57.32 -53.9 37.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.496 0 CA-C-N 114.93 -1.032 . . . . 30.25 109.07 175.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -52.72 -58.0 12.6 Favored Glycine 0 N--CA 1.471 1.005 0 O-C-N 125.161 1.538 . . . . 29.59 109.71 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -60.37 -48.78 80.29 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 115.338 1.607 . . . . 30.29 115.338 -175.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -69.75 -33.22 72.14 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 120.116 1.325 . . . . 30.47 114.394 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -65.99 -43.78 86.76 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.689 -0.856 . . . . 42.41 108.689 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1186 ' ' SER . . . . . . . . . . . . . 68.1 m -59.38 -48.18 82.61 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 121.073 -1.017 . . . . 39.38 112.586 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1187 ' ' LEU . . . . . 0.454 ' HA ' ' HB3' ' B' 1186 ' ' SER . 10.6 mt -53.43 -34.47 57.94 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 117.207 2.299 . . . . 36.18 117.207 170.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 105.36 52.38 0.82 Allowed Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 109.124 -1.591 . . . . 33.78 109.124 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -135.54 143.93 45.99 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 107.488 -1.301 . . . . 33.93 107.488 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 7.5 mt -79.57 106.85 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 103.111 -2.922 . . . . 38.74 103.111 -170.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1191 ' ' VAL . . . . . 0.573 HG11 HG12 ' A' 1181 ' ' ILE . 44.0 t -76.21 135.26 27.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 105.974 -1.861 . . . . 33.09 105.974 173.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1192 ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' 1169 ' ' MET . 95.0 mtt180 -126.4 87.01 2.6 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 102.741 -3.059 . . . . 38.92 102.741 176.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -95.59 154.56 17.15 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 120.33 -1.481 . . . . 35.32 111.794 -170.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 35.6 t80 -155.91 164.31 38.66 Favored 'General case' 0 C--O 1.25 1.115 0 O-C-N 124.557 1.161 . . . . 39.35 108.064 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1195 ' ' ASP . . . . . 0.44 ' HB2' ' H ' ' A' 1173 ' ' ALA . 10.6 t70 -164.77 162.63 21.22 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 104.492 -2.41 . . . . 40.46 104.492 174.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1196 ' ' THR . . . . . . . . . . . . . 5.6 m -58.36 -38.63 77.62 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.836 -1.075 . . . . 45.94 111.877 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1197 ' ' ARG . . . . . 0.45 ' HA ' ' HD2' ' A' 1198 ' ' PRO . 40.5 mtm180 -90.06 113.86 58.76 Favored Pre-proline 0 N--CA 1.449 -0.498 0 C-N-CA 126.191 1.796 . . . . 56.02 108.214 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1198 ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' 1197 ' ' ARG . 39.9 Cg_endo -55.1 -22.27 30.89 Favored 'Trans proline' 0 N--CA 1.435 -1.955 0 C-N-CA 125.202 3.935 . . . . 51.27 116.361 173.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -47.86 -41.0 23.03 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 116.539 2.051 . . . . 59.1 116.539 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 32.8 m -64.16 -9.29 5.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 116.095 1.887 . . . . 51.06 116.095 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 80.6 tttt -53.74 -40.81 66.45 Favored 'General case' 0 N--CA 1.436 -1.126 0 O-C-N 123.769 0.668 . . . . 57.38 111.908 -178.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.91 -47.51 71.11 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 115.444 1.646 . . . . 62.41 115.444 174.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -61.89 -43.41 98.91 Favored 'General case' 0 C--O 1.256 1.44 0 CA-C-O 123.37 1.557 . . . . 57.78 112.538 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 42.2 t -53.68 -57.24 5.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 112.571 -2.104 . . . . 46.38 109.0 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -70.53 -31.57 68.7 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 113.106 -1.861 . . . . 50.7 112.313 -177.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1206 ' ' SER . . . . . . . . . . . . . 66.8 m -70.7 -45.02 65.74 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 119.797 1.18 . . . . 49.98 111.328 -177.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1207 ' ' MET . . . . . . . . . . . . . 59.3 mtm -68.19 -34.18 75.8 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 122.723 1.249 . . . . 52.99 112.988 175.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 123.42 96.25 1.23 Allowed Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 107.56 -2.216 . . . . 47.66 107.56 171.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -168.12 160.19 11.62 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 120.788 -0.365 . . . . 44.77 110.188 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -85.62 145.91 27.11 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 102.894 -3.002 . . . . 47.64 102.894 170.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1211 ' ' PHE . . . . . . . . . . . . . 71.6 t80 -112.93 145.28 41.04 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 103.341 -2.837 . . . . 45.66 103.341 173.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 80.0 mt -71.14 108.54 4.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 123.369 1.557 . . . . 46.06 112.233 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -87.22 123.98 32.82 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 106.238 -1.764 . . . . 60.22 106.238 174.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 8.9 mp -90.34 144.81 25.48 Favored 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 115.259 1.577 . . . . 57.25 115.259 -176.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 35.6 t70 -71.59 83.56 0.85 Allowed 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 112.976 -1.92 . . . . 64.43 109.922 165.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 83.4 t80 . . . . . 0 C--O 1.216 -0.678 0 N-CA-C 102.38 -3.193 . . . . 66.9 102.38 -177.011 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 9.2 p-10 . . . . . 0 N--CA 1.437 -1.114 0 N-CA-C 106.779 -1.563 . . . . 39.09 106.779 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -49.33 -51.11 27.51 Favored Glycine 0 N--CA 1.474 1.185 0 C-N-CA 126.956 2.217 . . . . 39.32 112.943 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 60.3 t80 -64.86 -47.56 77.46 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 119.292 1.546 . . . . 39.3 111.739 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -63.91 -43.33 96.26 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 119.625 1.102 . . . . 36.3 113.105 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -57.07 -34.52 68.35 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 124.263 0.977 . . . . 37.38 112.144 174.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -63.43 -53.99 38.36 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 CA-C-N 121.106 1.775 . . . . 39.11 111.449 166.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1230 ' ' MET . . . . . . . . . . . . . 28.9 mmt -71.13 40.57 0.06 Allowed 'General case' 0 C--O 1.242 0.709 0 N-CA-C 113.706 1.002 . . . . 49.59 113.706 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1231 ' ' SER . . . . . . . . . . . . . 61.8 p -114.12 157.02 23.15 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 118.681 -2.512 . . . . 43.68 108.131 -174.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -55.11 -46.6 75.56 Favored 'General case' 0 C--N 1.356 0.865 0 CA-C-O 123.399 1.571 . . . . 55.57 110.289 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -70.76 -35.6 72.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 117.851 -1.071 . . . . 44.94 113.579 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 31.9 t80 -72.26 -48.44 42.61 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 122.535 2.425 . . . . 42.04 109.403 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 58.9 mt -64.3 -32.17 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 CA-C-N 118.645 0.657 . . . . 46.28 111.893 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 41.1 tttm -52.88 -53.72 44.91 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.783 -1.192 . . . . 47.87 107.783 167.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -62.85 -32.2 73.38 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 114.433 1.272 . . . . 41.61 114.433 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -54.43 -50.24 68.08 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 119.054 0.843 . . . . 50.65 112.614 165.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1239 ' ' MET . . . . . . . . . . . . . 34.3 mmt -61.15 -47.52 85.84 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 123.152 1.453 . . . . 48.87 110.075 -178.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -58.83 -40.08 83.15 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 112.949 -1.932 . . . . 54.8 109.613 175.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 3.5 mm? -75.19 -33.83 61.47 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 122.376 2.353 . . . . 43.21 112.453 176.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -69.81 -40.56 75.87 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 121.788 2.086 . . . . 38.66 109.681 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -64.73 -38.65 91.7 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 125.231 1.412 . . . . 37.92 111.464 171.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -63.69 -25.15 68.08 Favored 'General case' 0 C--O 1.246 0.882 0 O-C-N 120.026 -1.671 . . . . 37.28 112.567 171.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1245 ' ' GLN . . . . . 0.438 ' HG3' ' SD ' ' A' 1169 ' ' MET . 96.5 mm-40 -84.09 -32.15 24.93 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-O 118.548 -0.739 . . . . 43.07 111.83 176.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -49.92 -45.19 50.76 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 113.443 0.905 . . . . 38.3 113.443 -158.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1247 ' ' LYS . . . . . 0.49 ' H ' ' HD2' ' A' 1247 ' ' LYS . 0.4 OUTLIER -80.38 -11.53 59.69 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 119.423 -2.048 . . . . 47.6 111.757 -172.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -106.88 -31.65 8.26 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 118.548 -0.739 . . . . 45.42 110.672 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1249 ' ' VAL . . . . . . . . . . . . 0.307 12.2 m -68.45 152.86 9.26 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 N-CA-C 117.658 2.466 . . . . 36.26 117.658 -172.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1250 ' ' ASP . . . . . 0.613 ' HB3' ' CZ ' ' A' 1149 ' ' PHE . 12.2 m-20 -113.74 -54.77 2.58 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 112.636 -2.074 . . . . 33.04 109.274 -171.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1251 ' ' ILE . . . . . 0.78 HD12 ' HB1' ' A' 1145 ' ' ALA . 25.8 mm -124.13 122.8 65.2 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.692 0 N-CA-C 101.644 -3.465 . . . . 31.4 101.644 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1252 ' ' ILE . . . . . 0.508 HG21 HD11 ' A' 1267 ' ' ILE . 55.5 mt -99.72 127.47 52.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 103.579 -2.749 . . . . 29.42 103.579 161.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1253 ' ' VAL . . . . . 0.567 HG12 HG23 ' A' 1255 ' ' THR . 11.2 t -110.87 104.73 17.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 1 N-CA-C 100.141 -4.022 . . . . 30.37 100.141 176.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 1254 ' ' THR . . . . . 0.41 HG23 HG22 ' A' 1252 ' ' ILE . 0.6 OUTLIER -88.91 84.77 6.64 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-O 125.619 2.628 . . . . 35.72 111.971 -179.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 1255 ' ' THR . . . . . 0.601 HG22 HD13 ' A' 1284 ' ' LEU . 14.6 p -95.09 12.68 27.76 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 110.765 -2.925 . . . . 36.0 116.748 -176.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1256 ' ' ALA . . . . . 0.418 ' HB3' HD21 ' A' 1291 ' ' ASN . . . -83.97 67.4 9.62 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 120.909 1.686 . . . . 40.93 112.011 -176.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 37.3 tp -82.24 99.27 9.2 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 106.561 -1.644 . . . . 47.82 106.561 176.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1258 ' ' ILE . . . . . 0.474 ' HA ' ' HD2' ' A' 1259 ' ' PRO . 30.8 mm -75.87 139.65 70.02 Favored Pre-proline 0 N--CA 1.433 -1.32 0 N-CA-C 108.071 -1.085 . . . . 52.7 108.071 -175.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1259 ' ' PRO . . . . . 0.474 ' HD2' ' HA ' ' A' 1258 ' ' ILE . 29.0 Cg_endo -59.78 114.04 1.9 Allowed 'Trans proline' 0 CA--C 1.512 -0.597 0 C-N-CA 122.573 2.182 . . . . 54.13 112.719 169.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 80.91 -75.47 2.27 Favored Glycine 0 C--O 1.255 1.44 0 N-CA-C 107.047 -2.421 . . . . 54.62 107.047 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 89.9 mttt -51.03 140.38 21.25 Favored Pre-proline 0 C--O 1.252 1.225 0 C-N-CA 126.064 1.746 . . . . 55.74 112.072 -177.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -56.64 136.29 75.21 Favored 'Trans proline' 0 N--CA 1.44 -1.634 1 C-N-CA 125.311 4.008 . . . . 51.15 111.043 176.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1263 ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' 1264 ' ' PRO . . . -54.98 130.81 67.49 Favored Pre-proline 0 N--CA 1.47 0.538 0 CA-C-O 121.791 0.805 . . . . 46.06 110.718 170.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1264 ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' 1263 ' ' ALA . 76.1 Cg_exo -56.5 129.2 33.46 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 124.565 3.51 . . . . 41.08 110.68 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -77.6 70.15 3.94 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 124.923 2.297 . . . . 47.42 111.874 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 61.0 mt -69.91 -58.53 3.75 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 109.572 -3.467 . . . . 39.22 110.75 -164.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1267 ' ' ILE . . . . . 0.508 HD11 HG21 ' A' 1252 ' ' ILE . 31.9 mt -83.78 106.26 14.07 Favored 'Isoleucine or valine' 0 C--O 1.246 0.918 0 N-CA-C 106.987 -1.486 . . . . 42.5 106.987 -174.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1268 ' ' THR . . . . . . . . . . . . . 38.5 p -67.55 156.15 37.43 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 115.83 -0.623 . . . . 37.84 111.562 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -55.32 -34.73 64.43 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.513 -0.551 . . . . 54.8 109.513 171.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -48.73 -54.65 14.09 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 113.403 0.89 . . . . 54.36 113.403 166.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1271 ' ' MET . . . . . . . . . . . . . 26.5 mtm -68.23 -35.52 78.08 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.833 0.679 . . . . 39.52 112.833 -177.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1272 ' ' VAL . . . . . 0.422 HG12 HG21 ' A' 1303 ' ' THR . 79.2 t -62.82 -51.89 66.33 Favored 'Isoleucine or valine' 0 C--O 1.25 1.13 0 N-CA-C 106.611 -1.626 . . . . 38.25 106.611 178.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.05 -33.48 67.28 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 117.776 2.51 . . . . 40.77 117.776 170.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1274 ' ' SER . . . . . . . . . . . . . 41.0 m -80.39 -3.06 48.23 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 113.273 0.842 . . . . 36.58 113.273 174.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1275 ' ' MET . . . . . . . . . . . . . 16.2 mtp -69.31 158.63 34.67 Favored 'General case' 0 CA--C 1.51 -0.583 0 O-C-N 118.705 -2.497 . . . . 36.75 116.706 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1276 ' ' LYS . . . . . 0.446 ' HE3' ' NH2' ' A' 1151 ' ' ARG . 39.5 ttpt -65.21 139.65 58.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 124.343 2.021 . . . . 46.11 108.006 168.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1277 ' ' ALA . . . . . 0.628 ' HB1' ' HA ' ' B' 1045 ' ' PHE 0.253 . . -75.64 157.85 33.18 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 108.588 -3.915 . . . . 33.52 109.889 -179.37 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 73.21 24.1 76.2 Favored Glycine 0 C--N 1.347 1.167 0 N-CA-C 110.917 -0.873 . . . . 31.27 110.917 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1279 ' ' SER . . . . . 0.43 ' HB3' ' O ' ' A' 1250 ' ' ASP . 22.7 m -122.22 169.65 10.69 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.734 -0.733 . . . . 32.95 110.971 -171.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1280 ' ' VAL . . . . . 0.72 HG11 ' HA ' ' A' 1145 ' ' ALA . 42.5 t -132.11 141.92 44.16 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 N-CA-C 108.347 -0.983 . . . . 27.43 108.347 -171.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1281 ' ' ILE . . . . . 0.466 HG12 HD12 ' A' 1252 ' ' ILE . 84.9 mt -114.44 102.32 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 1 N-CA-C 99.335 -4.32 . . . . 30.3 99.335 164.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -87.91 96.44 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 CA-C-O 123.21 1.481 . . . . 28.63 107.343 172.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 4.9 t70 -87.76 100.01 12.52 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 113.989 -1.459 . . . . 36.27 110.941 -175.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1284 ' ' LEU . . . . . 0.601 HD13 HG22 ' A' 1255 ' ' THR . 5.5 tt -74.27 -34.57 63.62 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 123.664 1.697 . . . . 38.57 108.42 177.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -63.42 -13.45 40.18 Favored 'General case' 0 CA--C 1.508 -0.665 0 O-C-N 120.478 -1.389 . . . . 37.56 113.84 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . -34.19 -38.39 0.06 Allowed 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 121.674 3.953 . . . . 40.33 121.674 175.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -66.63 -22.74 66.11 Favored 'General case' 0 C--N 1.345 0.4 0 C-N-CA 118.662 -1.215 . . . . 56.85 113.88 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 30.2 t30 -142.06 86.99 2.01 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.145 -1.428 . . . . 45.86 107.145 177.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 106.16 -67.84 0.24 Allowed Glycine 0 CA--C 1.492 -1.361 0 C-N-CA 120.054 -1.07 . . . . 40.31 111.494 175.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 86.08 111.27 0.8 Allowed Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 105.769 -2.933 . . . . 38.89 105.769 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1291 ' ' ASN . . . . . 0.418 HD21 ' HB3' ' A' 1256 ' ' ALA . 27.1 m120 -70.68 -22.93 62.42 Favored 'General case' 0 C--O 1.223 -0.309 0 O-C-N 120.183 -1.775 . . . . 37.23 113.393 -171.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1292 ' ' CYS . . . . . 0.54 ' HB3' ' OG1' ' A' 1295 ' ' THR . 35.6 t -89.46 143.81 26.53 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 104.335 -2.468 . . . . 36.5 104.335 171.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1293 ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -77.14 -21.21 54.49 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 123.402 1.572 . . . . 43.32 112.425 174.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.92 10.98 12.41 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 116.958 2.207 . . . . 41.32 116.958 170.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1295 ' ' THR . . . . . 0.54 ' OG1' ' HB3' ' A' 1292 ' ' CYS . 89.9 m -68.82 113.97 6.74 Favored 'General case' 0 C--O 1.25 1.092 0 O-C-N 118.282 -2.761 . . . . 35.3 110.579 -175.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 10.4 t -84.19 116.06 63.12 Favored Pre-proline 0 N--CA 1.449 -0.505 0 N-CA-C 107.28 -1.378 . . . . 34.84 107.28 169.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.87 98.66 0.71 Allowed 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 122.866 2.377 . . . . 33.51 111.944 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 115.06 13.32 9.25 Favored Glycine 0 N--CA 1.432 -1.618 0 CA-C-N 114.316 -1.311 . . . . 32.19 112.874 170.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -159.21 168.69 25.88 Favored 'General case' 0 N--CA 1.435 -1.213 0 O-C-N 120.289 -1.712 . . . . 34.88 108.958 -174.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1300 ' ' ILE . . . . . 0.578 HD13 ' HG3' ' A' 1148 ' ' GLU . 48.4 mt -89.32 115.36 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 104.284 -2.487 . . . . 32.29 104.284 175.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 52.9 t80 -85.83 150.15 24.75 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 105.777 -1.934 . . . . 37.25 105.777 162.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1302 ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' 1307 ' ' VAL . 88.5 m -135.16 122.15 21.26 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 119.294 0.952 . . . . 35.56 109.16 174.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1303 ' ' THR . . . . . 0.422 HG21 HG12 ' A' 1272 ' ' VAL . 1.2 p -74.67 160.77 30.38 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 122.289 1.043 . . . . 36.4 111.575 173.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -68.23 -22.73 64.77 Favored 'General case' 0 C--O 1.249 1.069 0 O-C-N 120.376 -1.453 . . . . 52.32 111.747 -174.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1305 ' ' ASN . . . . . 0.875 ' HA ' ' HB2' ' B' 1046 ' ' ASP . 52.8 p-10 -75.41 -10.64 59.63 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 118.402 -0.809 . . . . 40.04 110.82 175.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 94.15 43.74 3.71 Favored Glycine 0 N--CA 1.432 -1.625 0 O-C-N 124.085 0.865 . . . . 36.96 111.5 175.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1307 ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' 1302 ' ' THR . 76.8 t -108.55 123.71 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 117.746 -1.582 . . . . 33.4 107.567 168.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1308 ' ' LYS . . . . . 0.573 ' HB2' HG22 ' A' 1280 ' ' VAL . 32.1 mmtt -86.29 98.4 10.94 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 121.878 0.847 . . . . 42.91 109.144 176.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 7.7 t -84.44 86.53 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 104.73 -2.322 . . . . 32.29 104.73 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1310 ' ' ILE . . . . . 0.657 HD11 ' HB2' ' A' 1148 ' ' GLU . 33.9 mt -81.98 92.26 2.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 113.691 -1.595 . . . . 30.99 109.582 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -85.96 53.86 4.7 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 113.452 -1.704 . . . . 28.95 113.153 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1312 ' ' TYR . . . . . 0.535 ' O ' ' HG ' ' A' 1315 ' ' LEU . 1.4 m-30 -87.67 104.61 16.69 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 125.355 2.503 . . . . 31.69 107.233 -171.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1313 ' ' THR . . . . . . . . . . . . . 33.9 p -66.26 -42.56 88.35 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 110.815 -2.902 . . . . 34.17 111.113 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -68.34 8.27 0.48 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 111.79 -2.459 . . . . 36.86 116.981 -177.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1315 ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' 1312 ' ' TYR . 96.2 mt -45.4 -39.18 9.19 Favored Pre-proline 0 N--CA 1.478 0.945 0 O-C-N 118.345 -2.722 . . . . 34.85 116.498 177.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -56.14 -46.18 32.78 Favored 'Trans proline' 0 C--O 1.247 0.95 0 C-N-CA 123.064 2.509 . . . . 29.15 113.842 168.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1317 ' ' GLY . . . . . 0.565 ' HA2' ' HG3' ' A' 1015 ' ' ARG . . . -60.35 -43.74 98.31 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-N 114.058 -1.428 . . . . 27.29 110.951 178.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1318 ' ' ARG . . . . . 0.508 ' HB3' ' CZ ' ' A' 1140 ' ' ARG . 85.3 mtt-85 -62.37 -29.17 70.28 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 122.027 0.918 . . . . 41.49 113.233 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1319 ' ' LEU . . . . . 0.708 HD13 ' HD3' ' A' 1140 ' ' ARG . 3.9 tp -108.05 68.61 0.3 Allowed Pre-proline 0 N--CA 1.439 -0.982 0 O-C-N 120.002 -1.686 . . . . 27.61 111.074 168.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1320 ' ' PRO . . . . . 0.612 ' HD2' ' HA2' ' B' 1150 ' ' GLY . 95.8 Cg_endo -62.6 -58.25 0.36 Allowed 'Trans proline' 0 CA--C 1.499 -1.233 0 C-N-CA 124.553 3.502 . . . . 25.94 111.963 -163.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1321 ' ' THR . . . . . 0.405 HG23 HG21 ' A' 1019 ' ' THR . 1.8 m -60.55 -28.88 68.78 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 120.512 1.505 . . . . 25.01 110.178 -174.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1322 ' ' GLN . . . . . 0.679 ' HB2' ' HA ' ' B' 1151 ' ' ARG . 9.4 tp60 -79.79 -33.87 40.12 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 117.618 -1.182 . . . . 29.39 110.002 -176.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1323 ' ' SER . . . . . 0.631 ' HA ' HD13 ' A' 1136 ' ' ILE . 31.6 m -57.17 -56.18 25.09 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 119.902 1.228 . . . . 26.47 108.536 165.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1324 ' ' SER . . . . . . . . . . . . . 14.9 m -65.31 -21.67 66.74 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 122.136 0.969 . . . . 27.78 113.501 -172.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -93.12 -55.41 3.34 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 115.939 -1.981 . . . . 37.53 111.138 173.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1326 ' ' LEU . . . . . 0.55 ' HB2' HD11 ' A' 1136 ' ' ILE . 93.0 mt -71.6 -56.44 5.86 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 122.193 2.27 . . . . 35.71 112.552 -178.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1327 ' ' TYR . . . . . 0.516 ' CD2' HG13 ' A' 1072 ' ' VAL . 86.0 t80 -58.71 -42.45 88.68 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 119.37 0.986 . . . . 31.59 108.933 172.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1328 ' ' GLY . . . . . 0.806 ' HA2' HD12 ' A' 1331 ' ' LEU . . . -46.21 -50.51 12.82 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-N 118.44 0.564 . . . . 28.0 112.197 169.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1329 ' ' THR . . . . . . . . . . . . . 34.6 m -71.25 -20.95 62.17 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-O 117.771 -1.109 . . . . 32.15 112.258 174.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1330 ' ' ASN . . . . . 0.417 ' OD1' ' HB2' ' A' 1132 ' ' SER . 13.7 m120 -62.18 -46.17 90.13 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 124.755 3.434 . . . . 34.36 109.73 170.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1331 ' ' LEU . . . . . 0.806 HD12 ' HA2' ' A' 1328 ' ' GLY . 15.7 mt -57.01 -52.18 66.31 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-N 113.159 -1.837 . . . . 33.37 112.689 176.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1332 ' ' VAL . . . . . 0.619 HG11 ' HB3' ' A' 1025 ' ' GLN . 45.6 t -63.5 -42.25 95.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 105.388 -2.078 . . . . 35.27 105.388 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1333 ' ' ASN . . . . . 0.499 ' HA ' ' HD2' ' A' 1336 ' ' LYS . 92.1 m-20 -59.81 -37.08 78.14 Favored 'General case' 0 CA--C 1.504 -0.794 0 O-C-N 119.534 -1.979 . . . . 37.66 113.562 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1334 ' ' LEU . . . . . 0.558 HD22 ' SD ' ' A' 1115 ' ' MET . 43.1 tp -60.03 -52.96 63.14 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.289 -0.634 . . . . 40.27 109.289 165.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1335 ' ' LEU . . . . . 0.511 HD23 HD22 ' A' 1338 ' ' LEU . 19.0 mt -63.8 -18.15 63.81 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 115.308 1.596 . . . . 42.5 115.308 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1336 ' ' LYS . . . . . 0.499 ' HD2' ' HA ' ' A' 1333 ' ' ASN . 78.8 mttt -69.36 -36.38 76.79 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 120.341 -1.474 . . . . 47.81 109.198 172.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1337 ' ' LEU . . . . . . . . . . . . . 10.2 mp -70.33 -40.33 74.2 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 122.864 1.316 . . . . 49.27 111.831 170.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1338 ' ' LEU . . . . . 0.511 HD22 HD23 ' A' 1335 ' ' LEU . 3.1 mp -67.83 -47.6 68.54 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 116.793 2.146 . . . . 50.54 116.793 -177.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1339 ' ' CYS . . . . . 0.493 ' SG ' ' HA2' ' A' 1344 ' ' GLY . 41.1 t -83.21 100.31 10.5 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 102.639 -3.097 . . . . 53.67 102.639 175.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 28.5 mtpt -84.04 -70.37 0.57 Allowed 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 118.878 -2.389 . . . . 63.38 111.883 -177.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1341 ' ' GLU . . . . . 0.542 ' HB2' ' HB3' ' A' 1343 ' ' ASP . 4.3 mp0 -72.7 -15.35 61.69 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.25 0.833 . . . . 70.95 113.25 -171.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1342 ' ' LYS . . . . . 0.57 ' HA ' ' H ' ' A' 1344 ' ' GLY . 9.3 mtpm? 49.11 58.11 5.73 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 116.892 -1.528 . . . . 65.25 111.77 -173.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1343 ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' A' 1341 ' ' GLU 0.404 0.0 OUTLIER 63.72 -78.04 0.03 OUTLIER 'General case' 0 C--N 1.356 0.874 2 O-C-N 113.242 -5.911 . . . . 64.53 114.817 21.309 . . . . . . . . 5 4 . 1 . 003 nuclear nobuild full ' A' A 1344 ' ' GLY . . . . . 0.57 ' H ' ' HA ' ' A' 1342 ' ' LYS . . . 71.58 52.04 14.05 Favored Glycine 0 C--O 1.217 -0.952 0 CA-C-N 120.908 1.685 . . . . 59.72 111.607 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 44.3 t30 -146.73 155.08 42.13 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 119.799 1.799 . . . . 64.09 106.663 172.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1346 ' ' ILE . . . . . . . . . . . . . 34.4 mt -88.94 124.05 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 CA-C-O 124.48 2.086 . . . . 58.82 112.121 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1347 ' ' THR . . . . . . . . . . . . . 33.7 m -100.63 109.54 21.61 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 110.392 -3.095 . . . . 54.96 107.683 167.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1348 ' ' VAL . . . . . . . . . . . . . 34.4 t -85.19 82.39 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 N-CA-C 106.173 -1.788 . . . . 55.64 106.173 176.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 24.2 t0 -78.36 106.25 10.16 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 112.766 -2.015 . . . . 61.45 115.449 -175.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -82.66 -13.07 57.09 Favored 'General case' 0 C--O 1.246 0.921 0 CA-C-N 112.472 -2.149 . . . . 58.63 112.751 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -65.12 -47.14 78.21 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 120.904 -1.122 . . . . 62.06 109.73 172.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 10.3 t70 -65.44 108.71 2.06 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 123.271 1.51 . . . . 54.07 108.994 174.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 22.1 m -43.82 -37.24 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.765 0 N-CA-C 117.614 2.449 . . . . 50.68 117.614 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1354 ' ' VAL . . . . . 0.806 HG11 ' HB2' ' A' 1124 ' ' ALA 0.261 5.4 m -79.72 -43.75 23.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-O 118.099 -0.953 . . . . 47.68 110.374 179.61 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 1355 ' ' ILE . . . . . . . . . . . . . 80.4 mt -60.76 -45.1 98.39 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 121.58 1.991 . . . . 48.49 109.612 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 40.7 tpt85 -43.23 -50.52 6.43 Favored 'General case' 0 C--O 1.249 1.069 0 N-CA-C 115.986 1.847 . . . . 48.27 115.986 163.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -61.15 -50.71 64.29 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.86 -0.967 . . . . 43.53 112.834 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1358 ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' 1354 ' ' VAL . 21.2 t -60.58 -49.38 84.66 Favored 'Isoleucine or valine' 0 C--O 1.249 1.059 0 N-CA-C 106.202 -1.777 . . . . 45.12 106.202 -173.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1359 ' ' THR . . . . . . . . . . . . . 6.0 m -69.01 87.84 0.38 Allowed 'General case' 0 C--N 1.313 -0.98 0 O-C-N 120.581 -1.325 . . . . 42.94 108.626 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 30.9 m -77.68 -23.74 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 CA-C-N 114.865 -1.061 . . . . 43.26 110.971 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1361 ' ' ILE . . . . . 0.494 HG12 HG12 ' A' 1366 ' ' ILE . 73.4 mt -135.58 119.02 23.91 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 N-CA-C 105.567 -2.012 . . . . 45.66 105.567 172.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1362 ' ' ARG . . . . . 0.415 ' HA ' HG23 ' A' 1111 ' ' THR . 33.3 ttt180 -100.65 110.3 22.42 Favored 'General case' 0 C--O 1.219 -0.525 0 O-C-N 119.172 -2.205 . . . . 61.34 106.584 167.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 31.87 79.0 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 O-C-N 126.388 2.305 . . . . 49.76 112.135 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 83.25 -40.54 2.84 Favored Glycine 0 CA--C 1.521 0.457 0 CA-C-O 118.59 -1.116 . . . . 50.0 112.645 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -77.05 111.0 12.16 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 105.87 -1.9 . . . . 56.92 105.87 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1366 ' ' ILE . . . . . 0.494 HG12 HG12 ' A' 1361 ' ' ILE . 66.0 mt -70.11 106.53 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 104.406 -2.442 . . . . 52.78 104.406 173.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1367 ' ' THR . . . . . . . . . . . . . 2.0 p -88.41 -4.9 58.56 Favored 'General case' 0 CA--C 1.496 -1.124 0 N-CA-C 114.901 1.445 . . . . 49.44 114.901 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 1.7 t90 -70.73 148.62 95.0 Favored Pre-proline 0 C--O 1.248 1.016 0 N-CA-C 106.701 -1.592 . . . . 52.38 106.701 166.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -65.43 156.07 77.89 Favored 'Cis proline' 0 CA--C 1.498 -1.321 0 CA-C-N 124.96 2.807 . . . . 46.94 116.32 -7.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -112.04 151.84 43.88 Favored Pre-proline 0 N--CA 1.442 -0.858 0 CA-C-N 113.342 -1.754 . . . . 45.91 110.195 -175.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1371 ' ' PRO . . . . . 0.463 ' HA ' ' HD3' ' A' 1372 ' ' PRO . 18.5 Cg_exo -57.25 145.02 89.21 Favored 'Trans proline' 0 C--O 1.248 1.007 0 C-N-CA 122.789 2.326 . . . . 46.39 117.643 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1372 ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' 1371 ' ' PRO . 51.5 Cg_exo -67.48 -20.45 47.78 Favored 'Trans proline' 0 CA--C 1.539 0.742 1 C-N-CA 125.345 4.03 . . . . 46.72 112.435 171.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.22 -5.055 0 CA-C-N 122.539 2.427 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 35.8 m80 . . . . . 0 N--CA 1.467 0.382 0 N-CA-C 107.738 -1.208 . . . . 63.44 107.738 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 999' ' ' HIS . . . . . 0.498 ' HB3' ' HB2' ' B' 1002 ' ' ARG . 98.8 m-70 -73.54 74.53 1.46 Allowed 'General case' 0 C--O 1.242 0.673 0 CA-C-O 124.37 2.033 . . . . 51.74 115.041 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1000 ' ' HIS . . . . . . . . . . . . . 63.9 t60 -72.62 128.45 35.6 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 114.499 -1.228 . . . . 54.07 108.573 -174.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 68.34 15.76 68.36 Favored Glycine 0 CA--C 1.506 -0.498 0 O-C-N 120.076 -1.64 . . . . 39.22 115.328 -172.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1002 ' ' ARG . . . . . 0.498 ' HB2' ' HB3' ' B' ' 999' ' ' HIS . 30.5 ttp180 -89.06 129.37 35.7 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 119.833 1.816 . . . . 38.12 108.557 176.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1003 ' ' ILE . . . . . 0.643 HG12 ' HB ' ' B' 1068 ' ' ILE . 19.6 mt -84.48 134.78 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-N 111.28 -2.691 . . . . 29.7 105.611 166.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1004 ' ' GLY . . . . . 0.417 ' O ' ' HD3' ' B' 1006 ' ' PRO . . . -114.84 125.65 6.87 Favored Glycine 0 CA--C 1.503 -0.701 0 N-CA-C 106.556 -2.617 . . . . 27.5 106.556 166.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1005 ' ' ILE . . . . . 0.476 HD12 ' HB3' ' B' 1017 ' ' ALA . 27.5 mm -99.4 105.42 33.06 Favored Pre-proline 0 N--CA 1.426 -1.646 0 N-CA-C 104.94 -2.244 . . . . 24.83 104.94 173.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1006 ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' B' 1004 ' ' GLY . 52.9 Cg_exo -74.76 145.69 32.75 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 C-N-CA 123.905 3.07 . . . . 27.19 108.977 173.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1007 ' ' ARG . . . . . 0.404 ' HD2' ' O ' ' B' 1037 ' ' SER . 73.1 ttt180 -74.47 113.16 11.39 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 109.198 -3.637 . . . . 41.46 104.127 171.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1008 ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -40.9 145.36 0.21 Allowed 'General case' 0 C--O 1.247 0.934 0 N-CA-C 120.015 3.339 . . . . 26.93 120.015 175.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1009 ' ' ARG . . . . . 0.446 ' HG3' HH11 ' B' 1009 ' ' ARG . 14.3 mmm-85 -120.27 -10.13 9.4 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-N 112.636 -2.075 . . . . 34.48 111.522 -175.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1010 ' ' LEU . . . . . . . . . . . . . 4.5 tp -64.7 143.52 57.87 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 122.098 0.951 . . . . 44.22 113.002 174.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1011 ' ' THR . . . . . . . . . . . . . 3.6 m -66.7 134.33 52.01 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 108.187 -1.042 . . . . 40.74 108.187 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 49.8 t30 51.21 53.42 12.97 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 115.948 1.832 . . . . 44.44 115.948 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1013 ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -136.67 116.48 13.11 Favored 'General case' 0 C--O 1.252 1.207 0 CA-C-N 114.245 -1.343 . . . . 29.87 108.965 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1014 ' ' THR . . . . . 0.589 ' HA ' HD22 ' B' 1042 ' ' LEU . 0.9 OUTLIER -111.99 -0.65 15.66 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.281 -0.872 . . . . 25.26 112.186 174.522 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B 1015 ' ' ARG . . . . . 0.695 ' HG3' ' HA2' ' B' 1317 ' ' GLY . 65.2 mtm180 -69.07 141.32 54.79 Favored 'General case' 0 C--O 1.248 0.995 0 N-CA-C 105.857 -1.905 . . . . 29.54 105.857 173.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1016 ' ' VAL . . . . . 0.782 HG21 ' HB1' ' B' 1039 ' ' ALA . 11.6 p -139.36 -173.62 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 104.7 -2.333 . . . . 23.55 104.7 171.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1017 ' ' ALA . . . . . 0.476 ' HB3' HD12 ' B' 1005 ' ' ILE . . . -110.0 0.67 18.6 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 118.992 -2.318 . . . . 23.59 113.636 175.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1018 ' ' ALA . . . . . . . . . . . . . . . -88.4 128.71 35.52 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 118.671 -0.681 . . . . 24.93 111.481 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1019 ' ' THR . . . . . 0.403 ' O ' ' HB ' ' B' 1022 ' ' THR . 0.0 OUTLIER -156.34 148.05 17.12 Favored Pre-proline 0 N--CA 1.442 -0.835 0 N-CA-C 105.682 -1.97 . . . . 28.09 105.682 171.055 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -61.96 -54.04 1.75 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 124.549 3.499 . . . . 28.79 112.981 -174.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1021 ' ' LYS . . . . . 0.548 ' O ' ' HG3' ' B' 1025 ' ' GLN . 77.9 tttt -49.49 -48.95 47.54 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 121.289 1.859 . . . . 47.28 108.874 176.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1022 ' ' THR . . . . . 0.403 ' HB ' ' O ' ' B' 1019 ' ' THR . 39.5 m -49.86 -54.27 20.49 Favored 'General case' 0 C--O 1.203 -1.373 0 C-N-CA 125.63 1.572 . . . . 30.12 111.842 174.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1023 ' ' VAL . . . . . 0.653 HG22 HG11 ' B' 1033 ' ' VAL . 54.0 t -60.63 -37.97 77.07 Favored 'Isoleucine or valine' 0 C--N 1.352 0.691 0 CA-C-N 120.702 1.592 . . . . 32.24 108.078 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1024 ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -67.9 -44.86 75.97 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 121.205 1.821 . . . . 49.62 111.401 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1025 ' ' GLN . . . . . 0.737 HE22 HG23 ' B' 1329 ' ' THR . 46.2 mt-30 -58.43 -45.99 87.41 Favored 'General case' 0 N--CA 1.44 -0.959 0 O-C-N 125.457 1.723 . . . . 44.68 108.203 176.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 95.4 mt -63.39 -45.38 91.35 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 118.867 -0.587 . . . . 35.71 109.727 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1027 ' ' LEU . . . . . . . . . . . . . 27.2 mt -60.71 -35.19 75.69 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 118.894 0.77 . . . . 42.18 111.302 173.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 19.3 mttm -72.46 -30.11 64.28 Favored 'General case' 0 C--O 1.239 0.526 0 O-C-N 120.219 -1.551 . . . . 48.34 109.38 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1029 ' ' LEU . . . . . . . . . . . . . 87.3 mt -74.79 -21.03 59.54 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 118.249 -2.782 . . . . 38.69 109.604 169.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 101.22 18.47 19.35 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 117.935 -2.978 . . . . 32.28 110.327 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -98.08 118.48 34.79 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 106.432 -1.692 . . . . 35.94 106.432 170.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1032 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.12 139.94 57.53 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 111.598 -2.546 . . . . 33.37 111.156 171.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1033 ' ' VAL . . . . . 0.653 HG11 HG22 ' B' 1023 ' ' VAL . 6.7 t -114.0 130.92 67.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.704 0 CA-C-N 121.162 1.801 . . . . 29.98 106.931 -174.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1034 ' ' ALA . . . . . 0.493 ' HB2' ' HD2' ' B' 1002 ' ' ARG . . . -123.59 135.98 54.27 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 104.901 -2.259 . . . . 28.18 104.901 166.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1035 ' ' VAL . . . . . . . . . . . . . 46.7 t -121.72 143.43 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 103.678 -2.712 . . . . 25.82 103.678 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1036 ' ' GLU . . . . . 0.518 ' HG3' ' HA2' ' B' 1060 ' ' GLY . 78.4 tt0 -79.68 137.85 37.19 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 120.038 -1.664 . . . . 32.44 110.978 173.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1037 ' ' SER . . . . . 0.404 ' O ' ' HD2' ' B' 1007 ' ' ARG . 16.5 m -52.68 115.72 1.94 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 127.081 2.152 . . . . 29.54 109.958 177.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 115.12 -19.17 15.44 Favored Glycine 0 N--CA 1.423 -2.221 0 CA-C-O 119.382 -0.677 . . . . 27.76 113.381 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1039 ' ' ALA . . . . . 0.782 ' HB1' HG21 ' B' 1016 ' ' VAL . . . -67.0 -28.87 68.6 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 120.511 -0.475 . . . . 26.02 110.266 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -56.81 -55.18 31.43 Favored Glycine 0 C--O 1.246 0.886 0 N-CA-C 110.612 -0.995 . . . . 26.47 110.612 164.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1041 ' ' GLN . . . . . 0.511 ' NE2' ' HA ' ' B' 1046 ' ' ASP . 3.4 mp0 -53.24 -39.81 64.1 Favored 'General case' 0 C--O 1.25 1.095 0 O-C-N 120.463 -1.61 . . . . 50.98 114.32 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1042 ' ' LEU . . . . . 0.589 HD22 ' HA ' ' B' 1014 ' ' THR . 31.3 mt -52.84 -54.62 31.69 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 116.86 2.17 . . . . 29.3 116.86 163.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1043 ' ' ALA . . . . . . . . . . . . . . . -71.41 17.8 0.08 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 117.856 2.539 . . . . 26.74 117.856 172.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1044 ' ' SER . . . . . . . . . . . . . 6.7 m 52.57 41.91 31.26 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 125.187 2.422 . . . . 31.26 111.396 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1045 ' ' PHE . . . . . 0.628 ' HA ' ' HB1' ' A' 1277 ' ' ALA . 1.1 m-85 -127.96 167.3 16.85 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 111.62 -2.536 . . . . 33.26 107.124 -175.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1046 ' ' ASP . . . . . 0.875 ' HB2' ' HA ' ' A' 1305 ' ' ASN . 40.6 t0 -97.15 138.53 34.52 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 117.524 -1.671 . . . . 46.74 107.359 150.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -50.07 -36.3 28.73 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 126.887 2.617 . . . . 34.44 111.892 171.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -35.38 -44.05 0.27 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 116.323 1.972 . . . . 48.67 116.323 165.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -64.24 -27.91 69.37 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 120.205 -1.56 . . . . 35.26 112.988 177.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1050 ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -75.39 -38.75 59.77 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 117.276 -1.345 . . . . 32.17 109.196 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1051 ' ' VAL . . . . . 0.415 HG22 HG12 ' B' 1057 ' ' ILE . 8.3 t -53.44 -50.77 46.91 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 N-CA-C 107.884 -1.154 . . . . 38.37 107.884 171.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -53.53 -34.9 59.88 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 124.069 0.948 . . . . 45.77 112.736 175.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -80.31 -21.7 42.31 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.17 0.895 . . . . 37.83 111.858 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 128.26 20.78 1.56 Allowed Glycine 0 CA--C 1.519 0.304 0 O-C-N 119.658 -1.901 . . . . 35.82 109.571 170.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -100.41 140.71 34.27 Favored 'General case' 0 N--CA 1.435 -1.177 0 O-C-N 119.159 -2.377 . . . . 33.77 112.026 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -76.56 130.03 37.31 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.647 1.579 . . . . 51.02 108.545 171.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1057 ' ' ILE . . . . . 0.415 HG12 HG22 ' B' 1051 ' ' VAL . 35.7 mm -97.92 129.84 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 106.188 -1.782 . . . . 38.47 106.188 168.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 6.6 m -111.21 153.72 12.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 125.337 1.455 . . . . 39.4 108.048 169.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.13 -48.97 71.7 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 120.491 -1.381 . . . . 57.07 114.57 -175.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1060 ' ' GLY . . . . . 0.518 ' HA2' ' HG3' ' B' 1036 ' ' GLU . . . -155.83 -110.79 0.35 Allowed Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.076 -1.059 . . . . 44.83 111.018 -176.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1061 ' ' ASN . . . . . 0.573 ' HA ' ' HD1' ' B' 1064 ' ' TRP . 2.5 m120 -58.27 -25.53 61.89 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 126.385 1.874 . . . . 46.27 115.685 -170.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1062 ' ' SER . . . . . . . . . . . . . 16.4 m -48.4 -28.19 3.08 Favored 'General case' 0 C--N 1.317 -0.81 0 O-C-N 120.731 -1.231 . . . . 43.47 112.999 165.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 1.3 p -59.04 -28.32 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 O-C-N 120.108 -1.62 . . . . 36.98 115.233 171.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1064 ' ' TRP . . . . . 0.573 ' HD1' ' HA ' ' B' 1061 ' ' ASN . 92.4 m95 -74.53 -18.65 60.57 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 122.921 0.488 . . . . 37.9 111.933 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -83.15 66.83 8.91 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 107.966 -1.124 . . . . 46.19 107.966 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1066 ' ' SER . . . . . 0.406 ' HB3' ' O ' ' B' 1002 ' ' ARG . 28.2 m -155.29 148.15 24.42 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 103.923 -2.621 . . . . 37.06 103.923 -172.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1067 ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -82.51 -15.33 52.81 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 115.844 1.794 . . . . 43.95 115.844 -172.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1068 ' ' ILE . . . . . 0.643 ' HB ' HG12 ' B' 1003 ' ' ILE . 1.4 mp -124.54 116.28 47.04 Favored 'Isoleucine or valine' 0 C--O 1.253 1.238 0 N-CA-C 103.129 -2.915 . . . . 33.5 103.129 177.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 26.0 mm -106.42 115.14 47.4 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 N-CA-C 106.733 -1.58 . . . . 30.57 106.733 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1070 ' ' LEU . . . . . 0.945 HD13 HD13 ' B' 1331 ' ' LEU . 85.3 mt -106.85 78.69 1.26 Allowed 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 115.224 -0.898 . . . . 27.66 111.229 -175.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1071 ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -80.75 166.64 20.81 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.836 -0.62 . . . . 28.4 110.749 171.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1072 ' ' VAL . . . . . 0.471 HG11 ' HB2' ' B' 1015 ' ' ARG . 8.9 t -91.51 -84.92 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 104.231 -2.507 . . . . 23.18 104.231 169.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -101.78 -170.49 1.83 Allowed 'General case' 0 C--N 1.312 -1.034 0 O-C-N 118.434 -2.666 . . . . 25.47 111.913 -170.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1074 ' ' ALA . . . . . 0.5 ' HA ' ' HD2' ' B' 1075 ' ' PRO . . . -33.93 125.51 0.47 Allowed Pre-proline 0 CA--C 1.554 1.109 0 N-CA-C 118.157 2.651 . . . . 27.9 118.157 -172.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1075 ' ' PRO . . . . . 0.5 ' HD2' ' HA ' ' B' 1074 ' ' ALA . 40.3 Cg_endo -68.48 126.89 14.79 Favored 'Trans proline' 0 N--CA 1.434 -2.009 0 C-N-CA 123.319 2.679 . . . . 31.62 111.474 166.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 45.2 mt -76.15 160.56 29.62 Favored 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 120.437 -1.414 . . . . 40.49 107.582 168.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.76 -35.5 43.88 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 117.358 2.355 . . . . 51.59 117.358 -174.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -63.97 -42.37 97.27 Favored 'General case' 0 C--O 1.208 -1.091 0 CA-C-O 118.972 -0.537 . . . . 42.36 111.004 172.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1079 ' ' GLU . . . . . 0.631 ' HA ' HD12 ' B' 1082 ' ' LEU . 20.2 mt-10 -66.57 -35.74 80.96 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 125.586 1.804 . . . . 34.53 108.917 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1080 ' ' ILE . . . . . 0.458 HG13 ' HB2' ' B' 1075 ' ' PRO . 63.3 mt -61.79 -51.8 68.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 125.983 2.052 . . . . 33.25 105.766 173.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -59.03 -29.4 67.25 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 120.969 1.713 . . . . 36.47 112.005 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1082 ' ' LEU . . . . . 0.631 HD12 ' HA ' ' B' 1079 ' ' GLU . 10.2 mt -71.74 -28.06 63.41 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.353 1.242 . . . . 37.76 114.353 177.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1083 ' ' LEU . . . . . . . . . . . . . 33.9 mt -64.45 112.97 3.36 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 118.594 -1.242 . . . . 37.43 109.204 -175.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -71.12 139.42 84.98 Favored Pre-proline 0 C--O 1.254 1.306 0 CA-C-N 115.149 -0.932 . . . . 37.7 109.435 167.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1085 ' ' PRO . . . . . 0.729 ' HB3' ' HB2' ' B' 1109 ' ' ASN . 35.1 Cg_exo -55.47 151.92 35.42 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.878 2.385 . . . . 35.51 116.379 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 74.79 -8.72 13.62 Favored Glycine 0 N--CA 1.445 -0.754 0 O-C-N 120.16 -1.587 . . . . 33.87 115.981 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1087 ' ' THR . . . . . . . . . . . . . 89.2 m -71.89 139.55 48.85 Favored 'General case' 0 C--O 1.261 1.688 0 O-C-N 119.608 -2.113 . . . . 32.5 108.062 178.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1088 ' ' THR . . . . . 0.545 ' HA ' ' HB ' ' B' 1111 ' ' THR . 0.2 OUTLIER -81.53 97.09 7.66 Favored 'General case' 0 C--O 1.255 1.387 0 N-CA-C 106.591 -1.633 . . . . 30.22 106.591 -173.613 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B 1089 ' ' LEU . . . . . . . . . . . . . 31.3 tp -91.77 101.21 13.81 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 122.167 0.984 . . . . 27.24 111.214 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1090 ' ' VAL . . . . . 0.644 HG13 ' HB2' ' B' 1113 ' ' MET . 11.7 t -104.11 107.35 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 111.089 -2.778 . . . . 25.39 109.795 -175.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1091 ' ' SER . . . . . . . . . . . . . 13.1 m -163.48 168.14 20.58 Favored 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 117.087 -3.508 . . . . 28.81 113.308 -170.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1092 ' ' PHE . . . . . 0.662 ' HD1' ' HB3' ' B' 1116 ' ' ASP . 68.6 m-85 -65.22 91.71 0.11 Allowed 'General case' 0 C--O 1.278 2.602 0 CA-C-O 124.212 1.958 . . . . 30.78 110.183 168.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 36.8 mm -89.9 -32.25 5.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 O-C-N 120.631 -1.293 . . . . 30.28 111.178 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1094 ' ' TRP . . . . . 0.555 ' HB2' ' ND2' ' B' 1098 ' ' ASN . 67.6 m95 57.92 55.83 6.77 Favored Pre-proline 0 C--O 1.247 0.965 0 CA-C-N 114.823 -1.08 . . . . 34.07 112.021 -175.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -49.97 -34.89 39.18 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 124.952 3.768 . . . . 38.66 113.409 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -56.37 -56.15 24.73 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 120.841 -1.162 . . . . 41.32 110.776 169.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -78.94 -22.68 45.39 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 113.951 1.093 . . . . 51.66 113.951 -174.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1098 ' ' ASN . . . . . 0.555 ' ND2' ' HB2' ' B' 1094 ' ' TRP . 75.9 m-20 -130.22 81.1 69.34 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 119.934 1.243 . . . . 40.32 111.02 -164.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -64.17 -48.93 4.19 Favored 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 120.987 1.124 . . . . 41.56 114.561 176.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -61.93 -35.87 79.7 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.399 -0.964 . . . . 54.11 108.399 -175.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1101 ' ' LEU . . . . . . . . . . . . . 17.0 tp -60.43 -47.17 87.27 Favored 'General case' 0 CA--C 1.515 -0.386 0 O-C-N 120.703 -1.248 . . . . 37.88 110.116 175.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1102 ' ' MET . . . . . . . . . . . . . 73.2 mmm -57.82 -38.62 75.91 Favored 'General case' 0 C--O 1.238 0.45 0 O-C-N 121.116 -0.99 . . . . 37.54 113.196 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -64.21 -45.77 86.82 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.869 -1.06 . . . . 47.01 113.398 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1104 ' ' LYS . . . . . 0.478 ' O ' ' HG2' ' B' 1108 ' ' ARG . 54.1 mttm -65.98 -35.26 80.1 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.506 -0.77 . . . . 48.68 110.264 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1105 ' ' LEU . . . . . . . . . . . . . 50.2 mt -72.86 -29.5 63.25 Favored 'General case' 0 C--O 1.269 2.127 0 O-C-N 120.546 -1.346 . . . . 32.21 112.583 177.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -61.63 -49.55 76.1 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 124.648 1.179 . . . . 33.73 108.098 172.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -54.1 -40.56 67.41 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 122.753 0.421 . . . . 51.47 111.702 172.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1108 ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' B' 1104 ' ' LYS . 20.6 mmm180 -72.97 -9.92 59.25 Favored 'General case' 0 C--O 1.213 -0.847 0 O-C-N 120.241 -1.537 . . . . 43.9 113.617 177.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1109 ' ' ASN . . . . . 0.729 ' HB2' ' HB3' ' B' 1085 ' ' PRO . 8.9 m120 62.93 30.83 16.46 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.556 1.142 . . . . 44.82 110.637 172.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1110 ' ' VAL . . . . . . . . . . . . . 2.7 m -92.76 155.0 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 O-C-N 120.557 -1.34 . . . . 30.52 112.404 -172.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1111 ' ' THR . . . . . 0.545 ' HB ' ' HA ' ' B' 1088 ' ' THR . 1.2 m -82.75 92.26 7.18 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 105.883 -1.895 . . . . 27.12 105.883 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1112 ' ' VAL . . . . . 0.441 ' HB ' ' HB ' ' B' 1361 ' ' ILE . 39.9 t -88.27 121.72 38.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 O-C-N 120.322 -1.486 . . . . 26.4 110.58 -173.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1113 ' ' MET . . . . . 0.644 ' HB2' HG13 ' B' 1090 ' ' VAL . 21.0 mtp -115.95 116.72 28.44 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 104.904 -2.258 . . . . 42.92 104.904 177.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -96.19 107.83 20.22 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 117.34 -1.744 . . . . 24.15 110.893 -172.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1115 ' ' MET . . . . . 0.476 ' HB3' ' HB2' ' B' 1129 ' ' ALA . 83.5 mmm -55.16 -26.88 41.64 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 116.543 2.053 . . . . 29.95 116.543 -176.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1116 ' ' ASP . . . . . 0.662 ' HB3' ' HD1' ' B' 1092 ' ' PHE . 6.9 p-10 -86.54 -39.84 15.82 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.117 -1.856 . . . . 34.53 110.946 177.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1117 ' ' SER . . . . . . . . . . . . . 49.9 m -99.16 31.8 2.93 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-O 123.966 1.841 . . . . 33.49 111.409 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1118 ' ' VAL . . . . . 0.766 HG22 HG23 ' B' 1358 ' ' VAL . 22.0 t -64.16 119.33 54.79 Favored Pre-proline 0 C--O 1.243 0.727 0 N-CA-C 102.402 -3.185 . . . . 34.02 102.402 151.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1119 ' ' PRO . . . . . 0.574 ' HB2' HG12 ' B' 1121 ' ' ILE . 73.1 Cg_exo -62.67 159.64 36.11 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 123.0 2.467 . . . . 38.28 113.047 -176.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1120 ' ' ARG . . . . . 0.787 ' HB2' HG13 ' B' 1375 ' ' VAL . 1.9 mmp_? -77.37 50.53 0.79 Allowed 'General case' 0 C--N 1.354 0.776 0 CA-C-O 122.099 0.952 . . . . 55.05 109.826 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1121 ' ' ILE . . . . . 0.574 HG12 ' HB2' ' B' 1119 ' ' PRO . 39.0 pt -119.21 143.96 28.98 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.844 0 O-C-N 121.232 -0.918 . . . . 42.09 110.042 -169.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1122 ' ' SER . . . . . . . . . . . . . 53.6 p -9.08 -88.82 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 120.479 3.511 . . . . 38.02 120.479 -176.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1123 ' ' ARG . . . . . 0.643 ' HA ' ' HD3' ' C' ' 134' ' ' PRO 0.254 18.7 ptt180 -71.5 -30.12 65.58 Favored 'General case' 0 C--N 1.357 0.892 0 CA-C-N 121.194 1.815 . . . . 34.29 114.502 178.669 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B 1124 ' ' ALA . . . . . 0.562 ' HB2' HG13 ' B' 1354 ' ' VAL . . . -58.83 -34.4 71.51 Favored 'General case' 0 C--O 1.219 -0.525 0 O-C-N 124.056 0.847 . . . . 32.35 109.851 -177.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1125 ' ' GLN . . . . . 0.401 ' NE2' ' HB3' ' B' 1131 ' ' SER . 0.0 OUTLIER -59.2 -9.06 1.86 Allowed 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 117.473 2.397 . . . . 47.17 117.473 176.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B 1126 ' ' SER . . . . . 0.54 ' HA ' ' HB1' ' A' 1159 ' ' ALA . 22.9 p -90.9 -32.95 15.81 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.863 1.211 . . . . 31.71 112.687 169.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1127 ' ' LEU . . . . . 0.601 ' HG ' ' HA ' ' B' 1334 ' ' LEU . 4.1 mp -71.36 -30.06 65.71 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 111.726 -2.488 . . . . 37.0 110.71 175.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1128 ' ' ASP . . . . . 0.402 ' CG ' HH12 ' B' 1120 ' ' ARG . 9.9 t70 -62.56 127.36 30.92 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 115.694 1.738 . . . . 40.4 115.694 -176.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1129 ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' B' 1115 ' ' MET . . . -70.06 -38.02 75.65 Favored 'General case' 0 C--O 1.212 -0.869 0 CA-C-N 113.746 -1.57 . . . . 26.56 108.1 177.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 36.2 mt -66.79 -13.85 61.96 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 115.039 1.496 . . . . 30.89 115.039 -174.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1131 ' ' SER . . . . . 0.401 ' HB3' ' NE2' ' B' 1125 ' ' GLN . 66.5 p -69.24 -56.17 8.37 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 105.507 -2.035 . . . . 29.84 105.507 167.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1132 ' ' SER . . . . . . . . . . . . . 67.5 m -55.05 -55.64 28.74 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 124.332 1.053 . . . . 31.91 113.616 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1133 ' ' MET . . . . . . . . . . . . . 32.2 mmt -54.32 -45.1 72.54 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.463 0.705 . . . . 25.9 111.757 176.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1134 ' ' ALA . . . . . 0.436 ' HB1' ' N ' ' B' 1176 ' ' ALA . . . -56.64 -52.57 64.38 Favored 'General case' 0 C--O 1.209 -1.049 0 C-N-CA 119.477 -0.889 . . . . 26.62 112.898 170.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1135 ' ' ASN . . . . . 0.484 ' HA ' ' HB2' ' B' 1179 ' ' ALA . 0.1 OUTLIER -53.66 -33.41 55.18 Favored 'General case' 0 C--O 1.22 -0.491 0 O-C-N 120.807 -1.183 . . . . 36.97 113.809 174.162 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B 1136 ' ' ILE . . . . . 0.464 HG21 ' HA ' ' B' 1316 ' ' PRO . 37.2 mm -68.96 -54.66 19.07 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 N-CA-C 107.255 -1.387 . . . . 32.11 107.255 175.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -59.53 -30.09 68.35 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 117.087 -1.435 . . . . 24.14 111.95 -171.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -66.49 -58.05 9.21 Favored Glycine 0 N--CA 1.47 0.912 0 CA-C-N 119.27 0.941 . . . . 25.13 111.562 174.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 21.0 t80 -58.88 -49.32 78.2 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.232 -1.025 . . . . 32.73 108.232 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1140 ' ' ARG . . . . . 0.4 ' HA ' ' HB ' ' B' 1143 ' ' VAL . 12.6 tpt180 -63.49 -28.95 70.31 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-O 117.806 -1.092 . . . . 26.36 108.94 -178.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1141 ' ' ALA . . . . . 0.462 ' HA ' HG11 ' B' 1282 ' ' VAL . . . -62.2 -47.92 82.32 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 122.412 2.369 . . . . 24.12 108.809 173.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 45.7 mm -60.92 -39.36 81.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.281 1.432 . . . . 23.37 109.298 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1143 ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' B' 1140 ' ' ARG . 40.6 t -63.84 -57.72 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 124.728 1.211 . . . . 24.96 111.931 176.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -63.6 -37.94 89.25 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 119.819 -1.801 . . . . 32.07 110.991 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1145 ' ' ALA . . . . . 0.772 ' HB1' HD12 ' B' 1251 ' ' ILE . . . -53.35 -51.63 61.84 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 122.432 1.111 . . . . 24.87 113.743 170.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1146 ' ' ALA . . . . . 0.685 ' HB2' ' HE1' ' B' 1153 ' ' PHE . . . -59.15 -37.14 76.6 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 113.835 -1.53 . . . . 24.67 114.677 177.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 42.5 t60 -60.79 -22.9 64.58 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.867 1.267 . . . . 28.58 111.692 177.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1148 ' ' GLU . . . . . 0.784 ' HB3' ' HD2' ' B' 1308 ' ' LYS . 60.9 mm-40 -127.81 16.24 6.89 Favored 'General case' 0 N--CA 1.442 -0.867 0 O-C-N 119.666 -1.896 . . . . 36.82 113.625 173.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1149 ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -77.65 155.93 31.08 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 122.563 1.173 . . . . 31.97 108.621 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1150 ' ' GLY . . . . . 0.612 ' HA2' ' HD2' ' A' 1320 ' ' PRO . . . -88.72 -23.72 35.16 Favored Glycine 0 C--O 1.208 -1.507 0 O-C-N 120.146 -1.596 . . . . 25.49 111.668 176.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1151 ' ' ARG . . . . . 0.679 ' HA ' ' HB2' ' A' 1322 ' ' GLN . 71.3 mtm-85 -131.62 179.98 5.73 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.614 1.166 . . . . 59.84 112.644 -162.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1152 ' ' PHE . . . . . 0.713 ' HB2' HG11 ' B' 1163 ' ' VAL . 5.9 m-30 -83.14 163.16 21.02 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 120.941 1.7 . . . . 34.45 111.177 171.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1153 ' ' PHE . . . . . 0.685 ' HE1' ' HB2' ' B' 1146 ' ' ALA . 46.1 m-85 -85.6 -48.68 8.67 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 112.46 -2.154 . . . . 31.17 109.271 166.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1154 ' ' THR . . . . . . . . . . . . . 6.3 m -72.1 135.57 46.29 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 114.636 -1.166 . . . . 33.89 108.162 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -80.6 73.67 2.49 Favored Glycine 0 CA--C 1.543 1.843 0 N-CA-C 106.47 -2.652 . . . . 38.95 106.47 171.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1156 ' ' GLN . . . . . 0.545 ' NE2' ' HE2' ' B' 1152 ' ' PHE . 6.7 tt0 -75.17 124.17 26.57 Favored 'General case' 0 C--O 1.242 0.668 0 O-C-N 120.796 -1.414 . . . . 54.23 108.065 -174.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1157 ' ' ILE . . . . . 0.411 HD12 ' HG2' ' B' 1162 ' ' LYS . 26.8 mm -73.5 100.54 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 105.07 -2.196 . . . . 51.16 105.07 169.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1158 ' ' THR . . . . . . . . . . . . . 5.6 m -99.72 151.43 21.24 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 103.591 -2.744 . . . . 49.61 103.591 -172.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -57.92 -37.44 74.07 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 121.398 1.908 . . . . 49.05 113.707 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -53.52 -35.21 60.42 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 115.854 1.798 . . . . 47.65 115.854 169.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . 157.88 175.45 28.82 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 108.813 -1.715 . . . . 45.61 108.813 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1162 ' ' LYS . . . . . 0.411 ' HG2' HD12 ' B' 1157 ' ' ILE . 82.7 mttt -83.35 145.27 29.13 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 112.932 0.715 . . . . 57.46 112.932 -177.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1163 ' ' VAL . . . . . 0.713 HG11 ' HB2' ' B' 1152 ' ' PHE . 94.5 t -94.25 142.84 25.44 Favored Pre-proline 0 N--CA 1.433 -1.296 0 N-CA-C 106.385 -1.709 . . . . 42.93 106.385 170.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1164 ' ' PRO . . . . . 0.425 ' HA ' ' HD2' ' B' 1165 ' ' PRO . 98.6 Cg_endo -81.23 133.95 8.92 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 124.989 3.793 . . . . 39.29 104.74 168.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1165 ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' B' 1164 ' ' PRO . 50.3 Cg_endo -62.55 148.46 93.3 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 125.293 3.995 . . . . 34.17 108.199 176.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -75.17 134.7 41.17 Favored 'General case' 0 C--O 1.208 -1.124 0 CA-C-N 115.213 -0.903 . . . . 31.69 111.014 172.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1167 ' ' LYS . . . . . 0.59 ' HB2' ' HA ' ' B' 1249 ' ' VAL . 98.4 mttt -91.6 113.59 25.9 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 124.05 1.881 . . . . 44.78 107.189 167.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 87.6 t -98.25 99.43 8.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 113.099 -1.864 . . . . 31.23 107.212 -174.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1169 ' ' MET . . . . . 0.781 ' HB2' HG11 ' B' 1249 ' ' VAL . 36.5 ttp -83.42 100.85 10.97 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 119.14 -1.024 . . . . 37.09 108.313 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1170 ' ' VAL . . . . . 0.519 HG22 ' HB ' ' B' 1253 ' ' VAL . 45.2 t -91.07 111.76 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 106.948 -1.501 . . . . 30.17 106.948 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1171 ' ' ILE . . . . . . . . . . . . . 2.7 mt -97.84 135.43 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 107.303 -1.369 . . . . 33.74 107.303 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 71.76 71.94 0.99 Allowed Glycine 0 C--O 1.247 0.911 0 N-CA-C 108.564 -1.815 . . . . 32.59 108.564 -177.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1173 ' ' ALA . . . . . 0.483 ' H ' ' HB2' ' B' 1195 ' ' ASP . . . -76.25 74.31 3.06 Favored 'General case' 0 N--CA 1.44 -0.956 0 O-C-N 121.176 -1.191 . . . . 32.42 112.693 -174.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -81.0 -155.68 12.87 Favored Glycine 0 N--CA 1.44 -1.073 0 N-CA-C 109.652 -1.379 . . . . 31.74 109.652 169.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 47.9 t -65.11 -38.94 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.416 0 O-C-N 122.016 -0.696 . . . . 31.48 109.146 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1176 ' ' ALA . . . . . 0.436 ' N ' ' HB1' ' B' 1134 ' ' ALA . . . -65.65 -39.81 91.79 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 122.66 1.219 . . . . 26.12 110.186 174.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1177 ' ' GLY . . . . . 0.415 ' HA2' HG11 ' B' 1170 ' ' VAL . . . -52.29 -54.68 25.54 Favored Glycine 0 CA--C 1.527 0.82 0 O-C-N 120.499 -1.376 . . . . 25.73 111.05 171.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1178 ' ' LEU . . . . . 0.676 ' HA ' HD12 ' B' 1181 ' ' ILE . 65.5 mt -57.78 -39.21 76.93 Favored 'General case' 0 C--N 1.351 0.65 0 N-CA-C 112.863 0.69 . . . . 32.59 112.863 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1179 ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' B' 1135 ' ' ASN . . . -60.67 -46.15 91.42 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 124.664 1.227 . . . . 27.72 111.777 170.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -64.71 -39.35 93.51 Favored 'General case' 0 C--O 1.249 1.075 0 O-C-N 119.884 -1.76 . . . . 26.03 111.764 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1181 ' ' ILE . . . . . 0.676 HD12 ' HA ' ' B' 1178 ' ' LEU . 37.7 mt -56.61 -60.7 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 N-CA-C 104.137 -2.542 . . . . 28.61 104.137 171.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -43.32 -49.7 6.72 Favored Glycine 0 C--O 1.214 -1.099 0 N-CA-C 116.05 1.18 . . . . 25.23 116.05 177.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1183 ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' B' 1186 ' ' SER . . . -72.59 -57.02 4.46 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 112.115 0.413 . . . . 24.09 112.115 -174.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -60.59 -41.42 94.7 Favored 'General case' 0 C--O 1.246 0.892 0 O-C-N 121.518 -0.739 . . . . 26.68 112.689 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -65.7 -32.81 74.57 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-O 118.255 -0.878 . . . . 36.57 109.946 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1186 ' ' SER . . . . . 0.471 ' HB2' ' O ' ' B' 1183 ' ' ALA . 64.8 m -57.33 -49.27 76.67 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 122.48 2.4 . . . . 28.92 108.486 167.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1187 ' ' LEU . . . . . . . . . . . . . 19.6 mt -67.88 -6.51 22.13 Favored 'General case' 0 C--N 1.365 1.267 0 N-CA-C 115.511 1.671 . . . . 29.09 115.511 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 82.39 16.11 72.22 Favored Glycine 0 N--CA 1.447 -0.584 0 O-C-N 120.285 -1.509 . . . . 29.26 113.819 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1189 ' ' ALA . . . . . . . . . . . . . . . -86.81 139.74 30.39 Favored 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 120.514 -1.58 . . . . 30.16 108.407 175.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 8.3 mt -87.08 110.33 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 105.916 -1.883 . . . . 35.81 105.916 -164.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1191 ' ' VAL . . . . . 0.491 HG21 ' HA ' ' B' 1181 ' ' ILE . 43.8 t -81.02 123.5 37.7 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 O-C-N 121.093 -1.004 . . . . 31.97 111.351 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1192 ' ' ARG . . . . . 0.737 ' HG2' ' HB2' ' B' 1210 ' ' GLU . 91.2 mtt180 -105.91 105.13 15.02 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 108.202 -1.036 . . . . 48.16 108.202 170.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -103.04 155.01 18.68 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 115.823 -2.351 . . . . 35.89 110.339 -176.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1194 ' ' PHE . . . . . 0.534 ' HB2' ' HB2' ' B' 1212 ' ' LEU . 39.5 t80 -141.42 136.84 31.75 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 106.318 -1.734 . . . . 41.88 106.318 170.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1195 ' ' ASP . . . . . 0.483 ' HB2' ' H ' ' B' 1173 ' ' ALA . 9.9 t0 -149.84 159.78 44.09 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 100.948 -3.723 . . . . 38.28 100.948 165.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1196 ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.75 -9.85 59.77 Favored 'General case' 0 N--CA 1.435 -1.206 0 O-C-N 120.892 -1.13 . . . . 40.62 112.593 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1197 ' ' ARG . . . . . 0.402 HH11 ' HD2' ' B' 1197 ' ' ARG . 31.9 mtm105 -90.53 134.3 31.18 Favored Pre-proline 0 C--O 1.25 1.115 0 O-C-N 119.992 -1.692 . . . . 53.09 107.815 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -61.81 -34.39 82.66 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 123.417 2.745 . . . . 42.56 116.378 -165.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1199 ' ' GLU . . . . . 0.574 ' O ' ' HG2' ' B' 1203 ' ' GLN . 2.8 pm0 -68.57 -17.9 64.23 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 115.018 1.488 . . . . 56.31 115.018 -165.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1200 ' ' VAL . . . . . . . . . . . . . 14.1 m -58.72 -29.05 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-N 115.137 -0.938 . . . . 42.91 113.335 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 37.9 tttm -60.3 -62.31 1.96 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.685 -1.228 . . . . 48.89 107.685 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -60.16 -26.77 66.56 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 114.909 1.448 . . . . 51.7 114.909 176.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1203 ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' B' 1199 ' ' GLU . 67.6 mm-40 -62.04 -47.82 83.0 Favored 'General case' 0 C--O 1.253 1.283 0 CA-C-N 121.104 1.775 . . . . 52.57 111.449 171.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1204 ' ' VAL . . . . . 0.56 ' HB ' ' HB3' ' B' 1209 ' ' ALA 0.257 34.5 m -67.23 -43.97 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 O-C-N 120.619 -1.3 . . . . 33.79 113.736 175.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -56.61 -52.08 66.23 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 117.068 -1.444 . . . . 36.58 110.876 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1206 ' ' SER . . . . . . . . . . . . . 90.3 p -61.46 -40.88 96.12 Favored 'General case' 0 C--O 1.253 1.288 0 CA-C-N 120.125 1.33 . . . . 39.61 112.196 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1207 ' ' MET . . . . . . . . . . . . . 11.7 ttm -72.78 -18.78 61.45 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 119.738 -1.851 . . . . 37.45 112.808 174.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 84.83 73.36 1.27 Allowed Glycine 0 C--O 1.248 0.995 0 O-C-N 119.368 -2.083 . . . . 31.87 109.933 -176.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1209 ' ' ALA . . . . . 0.56 ' HB3' ' HB ' ' B' 1204 ' ' VAL . . . -163.17 155.51 18.29 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 106.742 -1.577 . . . . 35.4 106.742 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1210 ' ' GLU . . . . . 0.737 ' HB2' ' HG2' ' B' 1192 ' ' ARG . 50.1 mt-10 -86.56 148.48 25.48 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 112.088 -2.324 . . . . 47.89 111.59 -171.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 30.7 t80 -113.92 125.3 53.88 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 120.198 -1.564 . . . . 45.53 108.14 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1212 ' ' LEU . . . . . 0.534 ' HB2' ' HB2' ' B' 1194 ' ' PHE . 44.6 mt -74.36 108.49 7.17 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 103.832 -2.655 . . . . 46.33 103.832 170.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.41 159.64 21.75 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 113.357 -1.747 . . . . 60.41 112.313 -172.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.56 145.38 54.96 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 115.19 1.552 . . . . 57.38 115.19 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 34.4 t70 . . . . . 0 C--O 1.222 -0.349 0 CA-C-N 112.911 -1.95 . . . . 65.07 107.512 173.044 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B 1230 ' ' MET . . . . . . . . . . . . . 28.2 mmt . . . . . 0 N--CA 1.445 -0.696 0 N-CA-C 107.556 -1.275 . . . . 80.32 107.556 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B 1231 ' ' SER . . . . . . . . . . . . . 18.6 m -160.25 157.63 28.49 Favored 'General case' 0 C--O 1.224 -0.286 1 O-C-N 114.94 -4.85 . . . . 79.92 104.658 -10.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.93 -175.06 3.78 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-N 121.968 2.167 . . . . 77.91 105.685 155.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 60.9 -56.48 0.09 Allowed 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 117.032 2.234 . . . . 73.88 117.032 -170.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 4.9 t80 -38.87 -33.1 0.1 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.313 1.445 . . . . 68.98 113.703 169.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1235 ' ' ILE . . . . . 0.514 ' O ' ' HG2' ' B' 1239 ' ' MET . 35.9 pt -36.48 -39.63 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.384 0 N-CA-C 116.967 2.21 . . . . 64.53 116.967 167.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1236 ' ' LYS . . . . . 0.487 ' HA ' ' HD3' ' B' 1236 ' ' LYS . 71.2 mmtt -62.52 -51.03 69.04 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 122.903 0.481 . . . . 66.36 110.986 175.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -67.26 -33.72 75.91 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 125.29 1.619 . . . . 56.6 109.15 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -56.71 -52.77 63.68 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 120.637 1.562 . . . . 56.79 109.805 171.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1239 ' ' MET . . . . . 0.514 ' HG2' ' O ' ' B' 1235 ' ' ILE . 31.1 mmt -56.44 -47.2 79.6 Favored 'General case' 0 C--O 1.238 0.471 0 O-C-N 124.558 1.161 . . . . 53.63 113.38 176.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -63.63 -25.63 68.31 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 115.211 1.56 . . . . 51.74 115.211 175.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 13.1 tp -67.06 -46.25 74.91 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 105.483 -2.043 . . . . 44.86 105.483 174.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 8.4 m-30 -70.48 -45.13 66.3 Favored 'General case' 0 C--O 1.216 -0.701 0 O-C-N 120.268 -1.52 . . . . 42.78 106.999 -173.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -52.82 -43.08 65.71 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.343 1.238 . . . . 40.96 114.343 171.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -62.78 -29.74 70.94 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 115.813 1.782 . . . . 43.06 115.813 170.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -79.72 -24.76 41.42 Favored 'General case' 0 C--O 1.202 -1.445 0 CA-C-O 117.013 -1.47 . . . . 46.45 113.03 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -35.2 -40.45 0.13 Allowed 'General case' 0 C--O 1.241 0.636 1 N-CA-C 121.959 4.059 . . . . 41.78 121.959 -174.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1247 ' ' LYS . . . . . 0.491 ' HA ' ' HB2' ' B' 1276 ' ' LYS . 7.9 mptt -101.74 -4.9 25.65 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-N 120.379 1.445 . . . . 52.2 113.866 175.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1248 ' ' GLU . . . . . 0.483 ' HB3' ' HD2' ' B' 1167 ' ' LYS . 36.2 mt-10 -81.74 -63.23 1.43 Allowed 'General case' 0 C--O 1.25 1.125 0 N-CA-C 108.006 -1.109 . . . . 53.55 108.006 167.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1249 ' ' VAL . . . . . 0.781 HG11 ' HB2' ' B' 1169 ' ' MET . 21.7 m -65.69 154.41 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 123.963 1.84 . . . . 34.41 115.146 -168.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1250 ' ' ASP . . . . . 0.441 ' O ' ' HB3' ' B' 1279 ' ' SER . 2.8 m-20 -118.1 -56.56 2.16 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 105.271 -2.122 . . . . 33.38 105.271 -177.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1251 ' ' ILE . . . . . 0.772 HD12 ' HB1' ' B' 1145 ' ' ALA . 32.5 mm -110.73 109.02 26.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 O-C-N 119.782 -1.824 . . . . 29.54 106.881 -169.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1252 ' ' ILE . . . . . 0.435 HD11 ' SD ' ' B' 1275 ' ' MET . 47.1 mt -88.59 117.86 32.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 119.833 -1.792 . . . . 32.44 108.545 171.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1253 ' ' VAL . . . . . 0.519 ' HB ' HG22 ' B' 1170 ' ' VAL . 74.0 t -104.28 94.34 3.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 100.286 -3.968 . . . . 30.57 100.286 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1254 ' ' THR . . . . . . . . . . . . 0.294 6.5 t -94.78 101.56 13.39 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 125.681 2.658 . . . . 35.04 109.257 -176.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1255 ' ' THR . . . . . 0.446 HG23 HD22 ' B' 1284 ' ' LEU . 33.3 m -100.72 -21.11 15.31 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 109.192 -3.64 . . . . 34.62 113.933 -163.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . -62.17 139.25 58.48 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-O 122.877 1.323 . . . . 42.72 113.051 -162.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 5.6 tt -153.61 126.8 8.47 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 111.165 -2.743 . . . . 52.43 104.945 175.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1258 ' ' ILE . . . . . 0.692 ' HB ' ' HB2' ' B' 1261 ' ' LYS . 58.3 mt -85.69 118.21 70.19 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 101.34 -3.578 . . . . 59.41 101.34 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -51.37 92.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 124.877 3.718 . . . . 62.68 114.974 -175.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 130.46 -64.27 0.61 Allowed Glycine 0 N--CA 1.425 -2.061 0 N-CA-C 107.008 -2.437 . . . . 64.16 107.008 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1261 ' ' LYS . . . . . 0.692 ' HB2' ' HB ' ' B' 1258 ' ' ILE . 79.7 mttt -59.1 166.52 2.66 Favored Pre-proline 0 CA--C 1.51 -0.58 0 C-N-CA 125.992 1.717 . . . . 68.53 115.582 171.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -67.67 166.45 24.09 Favored 'Trans proline' 0 C--O 1.249 1.034 0 C-N-CA 122.659 2.239 . . . . 61.99 114.459 169.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1263 ' ' ALA . . . . . 0.427 ' HB1' ' ND2' ' B' 1291 ' ' ASN . . . -54.71 126.92 59.02 Favored Pre-proline 0 C--O 1.25 1.091 0 CA-C-N 111.819 -2.446 . . . . 57.15 111.52 166.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -60.95 141.49 94.68 Favored 'Trans proline' 0 C--N 1.324 -0.745 0 C-N-CA 123.998 3.132 . . . . 51.57 109.57 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -77.22 73.34 3.8 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-N 114.998 -1.001 . . . . 54.55 112.724 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 43.1 mt -76.02 -40.18 54.1 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 115.217 1.562 . . . . 46.86 115.217 -170.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1267 ' ' ILE . . . . . 0.48 HG21 HD13 ' B' 1281 ' ' ILE . 40.1 mm -110.72 119.75 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 106.432 -1.692 . . . . 41.04 106.432 -173.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1268 ' ' THR . . . . . 0.437 ' O ' HG23 ' B' 1272 ' ' VAL . 19.0 p -84.13 159.0 21.18 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 113.03 -1.895 . . . . 39.58 110.108 177.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1269 ' ' ARG . . . . . 0.494 ' HG3' ' HB2' ' B' 1293 ' ' GLU . 64.8 mtt85 -63.62 -33.6 75.98 Favored 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 120.689 -1.257 . . . . 53.15 111.03 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -64.4 -43.91 92.93 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 109.046 -0.724 . . . . 42.96 109.046 176.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1271 ' ' MET . . . . . . . . . . . . . 5.8 ttm -62.18 -40.45 96.06 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 114.516 1.302 . . . . 43.89 114.516 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1272 ' ' VAL . . . . . 0.545 HG21 ' HD2' ' B' 1294 ' ' TYR . 53.7 t -56.62 -59.12 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 120.339 -0.544 . . . . 38.37 111.53 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -66.84 -25.15 66.29 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 122.779 1.275 . . . . 47.46 114.02 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1274 ' ' SER . . . . . . . . . . . . . 33.2 m -74.71 -17.13 60.71 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 118.262 -2.774 . . . . 38.38 114.131 170.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1275 ' ' MET . . . . . 0.435 ' SD ' HD11 ' B' 1252 ' ' ILE . 34.0 mtp -69.12 163.64 24.35 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 121.388 1.904 . . . . 37.81 112.808 -174.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1276 ' ' LYS . . . . . 0.491 ' HB2' ' HA ' ' B' 1247 ' ' LYS . 87.8 tttt -56.04 126.32 25.41 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 113.131 -1.85 . . . . 49.26 108.778 167.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1277 ' ' ALA . . . . . 0.556 ' HB3' ' HD1' ' A' 1045 ' ' PHE . . . -83.47 169.85 15.07 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 120.559 1.527 . . . . 34.46 114.003 -167.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 62.32 41.64 99.74 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-O 122.995 1.331 . . . . 33.53 110.639 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1279 ' ' SER . . . . . 0.441 ' HB3' ' O ' ' B' 1250 ' ' ASP . 70.4 m -134.59 158.98 42.62 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 110.204 -2.998 . . . . 31.31 104.224 -172.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1280 ' ' VAL . . . . . 0.662 HG11 ' HA ' ' B' 1145 ' ' ALA . 41.4 t -128.66 142.1 44.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 106.708 -1.59 . . . . 29.32 106.708 -169.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1281 ' ' ILE . . . . . 0.48 HD13 HG21 ' B' 1267 ' ' ILE . 43.4 mt -113.31 113.22 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 103.002 -2.962 . . . . 31.93 103.002 167.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1282 ' ' VAL . . . . . 0.462 HG11 ' HA ' ' B' 1141 ' ' ALA . 5.1 t -97.09 127.57 49.17 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 N-CA-C 105.873 -1.899 . . . . 29.48 105.873 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1283 ' ' ASP . . . . . 0.566 ' HB3' ' HA2' ' B' 1311 ' ' GLY . 12.8 t0 -100.12 115.37 29.65 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 104.387 -2.449 . . . . 34.5 104.387 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1284 ' ' LEU . . . . . 0.542 ' HA ' HD12 ' B' 1315 ' ' LEU . 6.9 mp -82.01 -22.74 36.35 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.727 1.01 . . . . 37.94 113.727 -178.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -118.45 30.72 7.05 Favored 'General case' 0 N--CA 1.428 -1.551 0 O-C-N 119.374 -2.079 . . . . 40.92 111.115 -165.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -51.72 -38.2 54.24 Favored 'General case' 0 C--O 1.248 0.987 0 N-CA-C 117.647 2.462 . . . . 44.39 117.647 -169.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1287 ' ' GLN . . . . . 0.78 ' HB3' HG23 ' B' 1313 ' ' THR . 3.7 pm0 -65.31 -22.98 66.9 Favored 'General case' 0 C--O 1.268 2.049 0 N-CA-C 117.226 2.306 . . . . 51.46 117.226 176.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 20.7 m120 -110.31 73.31 0.83 Allowed 'General case' 0 C--N 1.35 0.604 0 N-CA-C 105.65 -1.981 . . . . 57.75 105.65 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1289 ' ' GLY . . . . . . . . . . . . . . . 87.08 -64.05 3.93 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-O 116.443 -2.31 . . . . 49.85 112.484 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 106.26 120.61 4.68 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 118.903 1.352 . . . . 45.93 112.03 -167.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1291 ' ' ASN . . . . . 0.427 ' ND2' ' HB1' ' B' 1263 ' ' ALA . 2.1 m-80 -69.6 -36.95 76.66 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.37 1.468 . . . . 42.67 112.368 176.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1292 ' ' CYS . . . . . . . . . . . . . 31.5 t -99.16 145.37 27.27 Favored 'General case' 0 C--O 1.253 1.257 0 CA-C-N 123.216 2.735 . . . . 38.82 108.401 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1293 ' ' GLU . . . . . 0.494 ' HB2' ' HG3' ' B' 1269 ' ' ARG . 67.6 mt-10 -60.47 -29.94 69.36 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 114.93 1.456 . . . . 46.71 114.93 175.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1294 ' ' TYR . . . . . 0.545 ' HD2' HG21 ' B' 1272 ' ' VAL . 21.3 m-85 -72.09 -16.7 62.02 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 116.396 1.998 . . . . 47.23 116.396 176.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1295 ' ' THR . . . . . 0.579 HG23 ' HA3' ' B' 1311 ' ' GLY . 85.9 m -56.19 122.35 11.55 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 123.854 1.788 . . . . 36.02 115.756 -165.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 7.2 t -107.03 124.18 36.11 Favored Pre-proline 0 N--CA 1.438 -1.054 1 N-CA-C 100.147 -4.02 . . . . 37.26 100.147 175.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -62.67 107.74 0.64 Allowed 'Trans proline' 0 C--O 1.243 0.752 0 C-N-CA 123.906 3.07 . . . . 35.09 112.459 -172.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 83.01 50.93 4.39 Favored Glycine 0 C--O 1.252 1.265 0 N-CA-C 108.035 -2.026 . . . . 35.97 108.035 173.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -151.74 145.25 24.87 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-O 122.181 0.991 . . . . 40.39 109.706 175.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1300 ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' B' 1310 ' ' ILE . 77.1 mt -80.49 130.07 36.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 103.877 -2.638 . . . . 37.43 103.877 156.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 4.5 t80 -121.94 120.79 35.47 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 104.758 -2.312 . . . . 44.13 104.758 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1302 ' ' THR . . . . . . . . . . . . . 59.6 m -83.51 133.97 34.86 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.325 -1.307 . . . . 39.78 108.264 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1303 ' ' THR . . . . . 0.519 HG21 HG11 ' B' 1272 ' ' VAL . 14.0 p -97.75 179.74 4.72 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 121.105 -0.997 . . . . 43.29 112.155 175.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -60.19 -51.69 68.51 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.64 0.733 . . . . 53.07 111.457 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 43.9 p-10 -74.57 -17.18 60.77 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 116.351 1.982 . . . . 43.97 116.351 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 85.25 33.69 16.6 Favored Glycine 0 N--CA 1.468 0.799 0 CA-C-N 114.626 -1.17 . . . . 41.12 113.994 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1307 ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' B' 1279 ' ' SER . 99.8 t -92.08 94.1 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 N-CA-C 105.374 -2.084 . . . . 38.12 105.374 163.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1308 ' ' LYS . . . . . 0.784 ' HD2' ' HB3' ' B' 1148 ' ' GLU . 80.7 mttt -78.59 119.72 22.27 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.649 -1.614 . . . . 36.34 109.662 -165.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1309 ' ' VAL . . . . . 0.412 HG22 HD12 ' B' 1281 ' ' ILE . 59.4 t -90.01 97.18 6.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 125.084 2.373 . . . . 30.4 109.195 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1310 ' ' ILE . . . . . 0.502 HD11 ' HB2' ' B' 1148 ' ' GLU . 14.1 mt -87.39 80.21 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.891 0 CA-C-N 112.239 -2.255 . . . . 30.82 105.314 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1311 ' ' GLY . . . . . 0.579 ' HA3' HG23 ' B' 1295 ' ' THR . . . -81.41 109.42 3.0 Favored Glycine 0 CA--C 1.503 -0.71 0 O-C-N 119.897 -1.752 . . . . 26.53 109.847 -179.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1312 ' ' TYR . . . . . 0.426 ' HB2' ' HG ' ' B' 1315 ' ' LEU . 9.8 m-30 -120.23 124.99 47.03 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 119.741 3.237 . . . . 38.0 119.741 -176.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1313 ' ' THR . . . . . 0.78 HG23 ' HB3' ' B' 1287 ' ' GLN . 4.0 m -69.65 -33.02 72.02 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.3 -1.773 . . . . 29.8 110.419 164.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -118.74 24.14 11.05 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 114.145 -1.389 . . . . 39.04 114.001 -157.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1315 ' ' LEU . . . . . 0.542 HD12 ' HA ' ' B' 1284 ' ' LEU . 18.7 mt -52.1 -41.93 83.08 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 114.728 1.381 . . . . 31.08 114.728 176.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1316 ' ' PRO . . . . . 0.464 ' HA ' HG21 ' B' 1136 ' ' ILE . 96.2 Cg_exo -67.17 -36.84 20.19 Favored 'Trans proline' 0 CA--C 1.499 -1.252 0 CA-C-N 123.831 2.404 . . . . 26.1 113.094 168.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1317 ' ' GLY . . . . . 0.695 ' HA2' ' HG3' ' B' 1015 ' ' ARG . . . -60.29 -44.96 96.96 Favored Glycine 0 CA--C 1.503 -0.685 0 CA-C-N 120.512 1.506 . . . . 23.17 110.606 -177.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 56.1 mtt-85 -66.95 -0.21 2.96 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 116.149 1.907 . . . . 40.4 116.149 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 22.6 tp -120.37 78.79 27.73 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 105.325 -2.102 . . . . 23.6 105.325 172.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1320 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -58.41 -64.78 0.1 Allowed 'Trans proline' 0 CA--C 1.552 1.397 0 C-N-CA 125.158 3.905 . . . . 22.35 113.956 -161.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1321 ' ' THR . . . . . . . . . . . . . 6.3 m -66.16 -40.96 90.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 121.149 1.795 . . . . 26.52 112.874 -175.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1322 ' ' GLN . . . . . 0.703 ' HB2' ' HA ' ' A' 1151 ' ' ARG . 60.0 tp60 -69.67 -43.57 72.27 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 120.262 1.392 . . . . 24.38 110.83 -174.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1323 ' ' SER . . . . . . . . . . . . . 21.0 m -56.13 -50.22 71.72 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 119.217 -0.993 . . . . 22.8 111.091 170.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1324 ' ' SER . . . . . . . . . . . . . 15.1 m -57.57 -34.56 69.34 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 123.242 1.496 . . . . 21.25 112.731 176.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1325 ' ' GLN . . . . . 0.446 ' OE1' ' HB3' ' B' 1021 ' ' LYS . 37.6 tp60 -67.23 -55.73 12.8 Favored 'General case' 0 N--CA 1.438 -1.036 0 O-C-N 119.594 -1.941 . . . . 31.34 111.387 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1326 ' ' LEU . . . . . 0.448 ' HG ' HE21 ' B' 1322 ' ' GLN . 45.0 mt -69.32 -40.41 77.63 Favored 'General case' 0 N--CA 1.435 -1.19 0 O-C-N 120.886 -1.134 . . . . 31.56 111.764 -173.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1327 ' ' TYR . . . . . 0.406 ' O ' ' HG ' ' B' 1331 ' ' LEU . 27.4 t80 -53.42 -53.31 53.15 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.428 -1.323 . . . . 22.73 107.428 171.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1328 ' ' GLY . . . . . . . . . . . . . . . -44.84 -56.89 5.6 Favored Glycine 0 C--O 1.254 1.381 0 C-N-CA 124.539 1.066 . . . . 21.91 114.335 172.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1329 ' ' THR . . . . . 0.737 HG23 HE22 ' B' 1025 ' ' GLN . 19.3 m -69.84 -23.64 63.32 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 121.428 -1.042 . . . . 22.15 110.421 -178.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1330 ' ' ASN . . . . . . . . . . . . . 31.6 m120 -66.3 -42.66 87.99 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.076 -1.64 . . . . 26.18 107.004 172.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1331 ' ' LEU . . . . . 0.945 HD13 HD13 ' B' 1070 ' ' LEU . 41.5 mt -66.6 -39.13 88.23 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.569 -0.9 . . . . 23.68 108.569 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1332 ' ' VAL . . . . . 0.531 HG12 ' HE3' ' B' 1336 ' ' LYS . 70.3 t -58.69 -46.73 90.35 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-O 116.958 -1.496 . . . . 26.57 108.622 171.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -56.53 -43.11 79.53 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 121.018 1.736 . . . . 28.08 113.592 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1334 ' ' LEU . . . . . 0.601 ' HA ' ' HG ' ' B' 1127 ' ' LEU . 46.9 tp -59.6 -50.76 72.64 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 113.82 -1.536 . . . . 27.43 107.855 175.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1335 ' ' LEU . . . . . 0.507 HD23 HD12 ' B' 1338 ' ' LEU . 65.1 mt -69.77 -23.99 63.44 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 119.011 -2.306 . . . . 30.5 111.841 -177.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1336 ' ' LYS . . . . . 0.531 ' HE3' HG12 ' B' 1332 ' ' VAL . 90.9 mttt -64.42 -40.28 95.46 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 122.81 2.55 . . . . 41.65 109.891 169.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 12.4 tp -77.75 -31.09 51.91 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 113.472 0.916 . . . . 42.08 113.472 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1338 ' ' LEU . . . . . 0.507 HD12 HD23 ' B' 1335 ' ' LEU . 95.1 mt -78.64 -69.77 0.54 Allowed 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 122.281 1.039 . . . . 35.03 109.61 173.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 42.4 t -81.1 72.35 8.12 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 124.397 2.046 . . . . 37.33 107.584 -174.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 58.9 mttp -70.18 -19.25 63.2 Favored 'General case' 0 CA--C 1.5 -0.952 0 O-C-N 118.376 -2.703 . . . . 50.51 114.929 -178.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -78.14 -9.18 59.06 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 113.169 0.803 . . . . 54.21 113.169 168.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 44.9 mttt 48.11 56.23 7.61 Favored 'General case' 0 C--N 1.364 1.224 0 C-N-CA 124.96 1.304 . . . . 50.99 113.359 -173.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 26.6 p-10 -122.38 -47.87 2.1 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.857 -0.737 . . . . 48.82 111.17 -172.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 150.37 -3.71 0.56 Allowed Glycine 0 CA--C 1.54 1.623 0 CA-C-O 123.369 1.538 . . . . 40.43 111.195 172.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 22.9 t30 -79.64 116.4 19.81 Favored 'General case' 0 N--CA 1.428 -1.53 0 O-C-N 119.463 -2.198 . . . . 47.56 114.292 175.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1346 ' ' ILE . . . . . . . . . . . . . 40.4 mm -59.74 97.62 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.246 0.902 0 CA-C-O 123.204 1.478 . . . . 42.49 112.234 169.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1347 ' ' THR . . . . . . . . . . . . . 48.2 m -101.38 93.99 5.69 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 113.394 -1.73 . . . . 38.12 107.504 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 85.5 t -87.0 94.84 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 O-C-N 119.309 -2.119 . . . . 37.5 107.802 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 16.2 t70 -75.12 101.97 4.75 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 107.228 -1.397 . . . . 43.85 107.228 170.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1350 ' ' PHE . . . . . 0.715 ' HE1' ' HB ' ' B' 1359 ' ' THR . 0.1 OUTLIER -75.98 -5.24 45.39 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 113.244 -1.798 . . . . 39.81 113.168 -179.284 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 24.2 t70 -79.81 -42.65 23.95 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 120.341 -1.474 . . . . 51.29 107.706 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 20.1 t0 -57.11 113.54 1.76 Allowed 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 122.756 1.265 . . . . 39.78 109.865 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 15.1 m -46.27 -35.24 2.31 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 CA-C-N 113.502 -1.681 . . . . 39.28 114.443 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1354 ' ' VAL . . . . . 0.562 HG13 ' HB2' ' B' 1124 ' ' ALA . 47.4 t -67.72 -50.53 59.69 Favored 'Isoleucine or valine' 0 C--O 1.263 1.794 0 O-C-N 124.72 1.262 . . . . 35.7 110.751 177.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1355 ' ' ILE . . . . . 0.575 ' HA ' HG12 ' B' 1358 ' ' VAL . 34.7 mm -69.0 -40.2 80.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 CA-C-N 120.046 1.294 . . . . 35.77 108.902 178.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 43.8 tpt85 -52.52 -32.18 39.16 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 125.44 1.496 . . . . 38.55 111.662 168.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -74.14 -59.64 3.86 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 110.229 -1.149 . . . . 29.58 110.229 176.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1358 ' ' VAL . . . . . 0.766 HG23 HG22 ' B' 1118 ' ' VAL . 11.6 p -60.32 -38.55 77.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-N 118.393 1.096 . . . . 32.06 111.634 -172.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1359 ' ' THR . . . . . 0.715 ' HB ' ' HE1' ' B' 1350 ' ' PHE . 5.6 m -81.78 92.17 6.61 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 123.049 1.404 . . . . 29.0 107.695 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1360 ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' B' 1368 ' ' TRP . 31.2 m -82.27 -17.88 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 110.771 -2.922 . . . . 29.68 113.903 -176.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1361 ' ' ILE . . . . . 0.461 HG12 ' HA ' ' B' 1366 ' ' ILE . 48.6 mt -133.7 106.88 9.68 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 N-CA-C 101.274 -3.602 . . . . 32.05 101.274 168.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1362 ' ' ARG . . . . . 0.53 HH11 ' HB2' ' B' 1350 ' ' PHE . 46.8 ttt180 -87.62 78.04 8.59 Favored 'General case' 0 C--O 1.243 0.727 0 O-C-N 118.341 -2.725 . . . . 32.52 109.182 174.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 58.62 89.1 0.06 Allowed 'General case' 0 C--O 1.246 0.912 0 CA-C-N 112.488 -2.142 . . . . 35.68 114.161 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 88.56 -72.68 2.3 Favored Glycine 0 N--CA 1.477 1.43 0 CA-C-N 114.733 -1.122 . . . . 34.26 111.253 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.03 117.64 6.73 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.182 0.993 . . . . 51.07 110.46 176.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1366 ' ' ILE . . . . . 0.461 ' HA ' HG12 ' B' 1361 ' ' ILE . 95.9 mt -74.24 104.13 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 104.93 -2.248 . . . . 39.87 104.93 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1367 ' ' THR . . . . . . . . . . . . . 7.2 p -94.2 -1.08 54.68 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.1 -1.409 . . . . 38.01 111.985 -174.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1368 ' ' TRP . . . . . 0.467 ' HB2' ' HB ' ' B' 1360 ' ' VAL . 24.5 t90 -74.23 137.67 75.34 Favored Pre-proline 0 CA--C 1.548 0.876 0 O-C-N 120.236 -1.54 . . . . 42.14 108.009 162.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -72.94 161.22 94.17 Favored 'Cis proline' 0 CA--C 1.512 -0.624 0 CA-C-N 123.171 2.168 . . . . 43.26 116.785 -11.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1370 ' ' ALA . . . . . . . . . . . . . . . -87.38 170.42 11.99 Favored Pre-proline 0 N--CA 1.469 0.505 0 CA-C-O 117.12 -1.419 . . . . 46.52 111.072 176.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -47.93 144.26 12.1 Favored 'Trans proline' 0 CA--C 1.555 1.557 0 C-N-CA 123.43 2.753 . . . . 51.95 112.671 165.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.96 75.76 2.17 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.568 2.845 . . . . 56.27 114.85 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1373 ' ' ILE . . . . . 0.523 HG23 HG21 ' B' 1121 ' ' ILE . 0.0 OUTLIER -82.92 128.76 38.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 104.895 -2.261 . . . . 60.83 104.895 173.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -68.25 123.23 20.15 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 115.707 1.743 . . . . 66.1 115.707 -173.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1375 ' ' VAL . . . . . 0.787 HG13 ' HB2' ' B' 1120 ' ' ARG . 14.4 t -60.88 123.23 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 1 O-C-N 129.208 4.068 . . . . 63.47 110.922 175.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.23 -4.627 0 O-C-N 119.795 -1.816 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 20' ' ' ALA . . . . . 0.814 ' HA ' HD21 ' C' ' 171' ' ' LEU . . . . . . . . 0 C--O 1.242 0.702 0 CA-C-O 118.828 -0.606 . . . . 0.0 111.508 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -45.33 -30.25 1.25 Allowed 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 117.454 2.39 . . . . 0.0 117.454 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -46.57 -40.19 12.34 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.991 1.716 . . . . 0.0 109.436 177.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 23' ' ' THR . . . . . 0.501 ' HA ' HD22 ' C' ' 26' ' ' LEU . 22.4 m -55.97 -29.23 59.9 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -178.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.55 -47.28 86.25 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.276 -1.515 . . . . 0.0 111.104 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -66.56 -34.36 77.73 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.327 1.051 . . . . 0.0 108.284 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.501 HD22 ' HA ' ' C' ' 23' ' ' THR . 2.2 mp -70.06 -31.31 68.86 Favored 'General case' 0 N--CA 1.426 -1.663 0 C-N-CA 123.825 0.85 . . . . 0.0 110.827 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 63.0 mt -61.14 -48.08 83.24 Favored 'General case' 0 CA--C 1.518 -0.282 0 O-C-N 119.431 -2.043 . . . . 0.0 115.334 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 28' ' ' LYS . . . . . . . . . . . . . 10.2 pttm -63.98 -28.2 69.65 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 119.063 -1.055 . . . . 0.0 113.213 172.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -73.87 -35.3 64.72 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 118.632 -0.699 . . . . 0.0 112.053 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.77 ' HA ' ' HB3' ' C' ' 107' ' ' ASP . 39.6 m -56.42 -17.79 9.15 Favored 'General case' 0 C--O 1.239 0.531 1 N-CA-C 124.137 4.865 . . . . 0.0 124.137 -163.677 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 44.2 m-70 66.67 -77.31 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 125.336 1.455 . . . . 0.0 109.726 -174.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 74.2 m -97.5 160.01 14.58 Favored 'General case' 0 C--O 1.242 0.661 0 O-C-N 120.158 -1.589 . . . . 0.0 108.318 168.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 12.8 t -132.23 118.01 34.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 O-C-N 119.01 -2.306 . . . . 0.0 105.658 174.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.629 HD11 ' HB3' ' C' ' 102' ' ' ASP . 27.3 mm -104.29 124.12 58.56 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 N-CA-C 105.882 -1.895 . . . . 0.0 105.882 175.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . 0.583 HG12 HD12 ' C' ' 110' ' ' LEU . 92.3 mt -107.03 125.61 63.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 176.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 82.8 m -106.86 98.79 22.51 Favored Pre-proline 0 N--CA 1.44 -0.962 0 O-C-N 119.316 -2.115 . . . . 0.0 112.249 171.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . 0.804 ' HD2' HG12 ' C' ' 68' ' ' ILE . 84.2 Cg_exo -75.95 56.32 4.75 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.421 2.747 . . . . 0.0 114.526 175.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.92 89.03 1.42 Allowed Glycine 0 N--CA 1.443 -0.894 0 O-C-N 119.78 -1.825 . . . . 0.0 111.137 -170.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 40.1 t80 65.76 -72.71 0.07 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.895 1.278 . . . . 0.0 108.916 -177.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -28.46 -64.09 0.11 Allowed Glycine 0 C--N 1.349 1.285 0 N-CA-C 117.985 1.954 . . . . 0.0 117.985 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 9.2 ttm -49.83 -39.84 40.15 Favored 'General case' 0 C--O 1.25 1.126 0 N-CA-C 118.265 2.691 . . . . 0.0 118.265 173.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -85.35 -22.92 28.25 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 9.0 p -84.13 -38.09 13.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 O-C-N 119.078 -2.264 . . . . 0.0 110.945 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.67 9.57 2.71 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 117.4 2.37 . . . . 0.0 117.4 175.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 45' ' ' GLN . . . . . . . . . . . . 0.388 1.0 OUTLIER 41.75 48.1 3.64 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 119.124 3.009 . . . . 0.0 119.124 -159.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.51 -1.31 57.05 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.887 169.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . 0.526 ' O ' HG12 ' C' ' 50' ' ' VAL . 0.0 OUTLIER -50.56 -48.84 57.3 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 118.335 -0.841 . . . . 0.0 111.455 177.424 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 48' ' ' TYR . . . . . 0.645 ' HB2' ' HD3' ' C' ' 49' ' ' PRO . 18.7 m-85 -71.42 -58.01 4.09 Favored Pre-proline 0 C--O 1.247 0.964 0 CA-C-O 116.87 -1.538 . . . . 0.0 113.922 177.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 49' ' ' PRO . . . . . 0.645 ' HD3' ' HB2' ' C' ' 48' ' ' TYR . 88.5 Cg_exo -50.9 -15.05 1.55 Allowed 'Trans proline' 0 C--N 1.367 1.53 0 N-CA-C 120.412 3.197 . . . . 0.0 120.412 172.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . 0.526 HG12 ' O ' ' C' ' 47' ' ' GLN . 5.5 p -63.6 -29.82 48.25 Favored 'Isoleucine or valine' 0 C--O 1.246 0.87 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.294 172.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.23 93.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 117.951 -2.968 . . . . 0.0 111.148 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 52' ' ' GLU . . . . . 0.519 ' HB3' ' HB2' ' C' ' 183' ' ' LEU . 3.1 mm-40 -47.42 -48.87 26.12 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 171.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 53' ' ' ILE . . . . . . . . . . . . 0.253 8.4 tp -72.99 -46.26 52.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.902 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 60.5 m -53.13 -36.77 61.15 Favored 'General case' 0 C--O 1.256 1.419 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -52.67 -64.22 0.89 Allowed 'General case' 0 C--O 1.238 0.485 0 C-N-CA 127.045 2.138 . . . . 0.0 111.311 173.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . 0.411 ' HE2' ' HB2' ' C' ' 56' ' ' LYS . 3.1 mppt? -66.12 -33.09 74.99 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 117.373 -1.298 . . . . 0.0 109.732 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 50.4 mt -60.54 -45.89 92.2 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 122.372 2.351 . . . . 0.0 108.845 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . 0.487 ' HD2' ' HA ' ' C' ' 58' ' ' ARG . 2.3 tpt180 -66.36 -43.99 84.45 Favored 'General case' 0 C--O 1.255 1.369 0 O-C-N 121.3 -0.875 . . . . 0.0 111.747 -178.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.63 -12.56 61.09 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 121.872 0.844 . . . . 0.0 112.67 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' C' ' 60' ' ' ARG . 1.8 tpm_? -76.87 -31.82 57.06 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-O 123.822 1.772 . . . . 0.0 110.045 171.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.47 42.01 2.62 Favored Glycine 0 N--CA 1.431 -1.638 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.654 -173.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 95.3 mt -109.11 132.1 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 121.568 0.699 . . . . 0.0 109.68 -177.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -68.94 91.74 0.48 Allowed 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 122.684 1.23 . . . . 0.0 108.255 169.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 8.9 p -96.98 122.43 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-O 122.525 1.155 . . . . 0.0 109.687 176.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 65' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' C' ' 34' ' ' ILE . 17.8 mmt-85 -129.27 153.43 47.8 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 175.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . 0.757 ' HB2' ' HA ' ' C' ' 93' ' ' VAL . 6.1 m-85 -112.93 141.67 46.49 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -126.74 99.54 0.54 Allowed Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 107.596 -2.202 . . . . 0.0 107.596 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 68' ' ' ILE . . . . . 0.804 HG12 ' HD2' ' C' ' 37' ' ' PRO . 1.1 mt -102.92 -154.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 O-C-N 124.411 0.712 . . . . 0.0 111.384 174.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -165.2 135.2 2.9 Favored Pre-proline 0 N--CA 1.473 0.68 0 O-C-N 119.243 -2.161 . . . . 0.0 105.61 -169.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 70' ' ' PRO . . . . . 0.565 ' HB3' ' O ' ' A' 1158 ' ' THR . 14.0 Cg_endo -45.4 -61.51 0.58 Allowed 'Trans proline' 0 C--N 1.352 0.716 1 C-N-CA 126.428 4.752 . . . . 0.0 117.526 -179.351 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 71' ' ' VAL . . . . . 0.422 ' HB ' ' H2N' ' C' 1001 ' ' NAP . 14.5 m -94.42 133.41 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.93 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 174.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.57 9.34 8.99 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 117.786 2.513 . . . . 0.0 117.786 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.88 -52.28 0.65 Allowed Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 -169.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . 0.453 ' HA ' ' OE1' ' B' 1203 ' ' GLN . 3.3 mpt_? -147.94 177.64 9.18 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 175.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 7.0 mt 53.71 44.39 1.87 Allowed Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 119.557 3.169 . . . . 0.0 119.557 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -63.31 133.74 41.89 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.691 2.927 . . . . 0.0 113.195 -174.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.22 -70.6 1.84 Allowed Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.385 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 78' ' ' HIS . . . . . . . . . . . . 0.258 0.2 OUTLIER -36.91 -34.2 0.07 Allowed 'General case' 0 C--O 1.25 1.124 0 N-CA-C 121.648 3.944 . . . . 0.0 121.648 177.115 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -54.36 -34.13 60.54 Favored 'General case' 0 C--N 1.347 0.46 0 O-C-N 118.942 -2.348 . . . . 0.0 113.926 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -77.0 -30.38 55.89 Favored 'General case' 0 CA--C 1.501 -0.912 0 O-C-N 120.822 -1.174 . . . . 0.0 112.107 175.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 6.5 t -67.06 -39.77 84.02 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 O-C-N 120.678 -1.264 . . . . 0.0 110.689 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 95.3 mt -54.97 -36.24 65.16 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.111 0.964 . . . . 0.0 112.381 171.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.514 HD21 ' HG2' ' C' ' 37' ' ' PRO . 8.1 mp -71.72 -31.23 66.49 Favored 'General case' 0 C--O 1.249 1.04 0 CA-C-N 119.997 1.272 . . . . 0.0 112.077 176.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.13 -30.15 64.76 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.681 173.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.25 -48.37 78.52 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-O 122.024 0.916 . . . . 0.0 109.146 166.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.03 -1.38 2.05 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 119.171 -2.205 . . . . 0.0 115.827 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp 55.29 53.11 10.42 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -171.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 88' ' ' VAL . . . . . 0.501 HG21 HG13 ' C' ' 50' ' ' VAL . 14.5 t -111.27 125.55 30.33 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 101.483 -3.525 . . . . 0.0 101.483 169.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 89' ' ' PRO . . . . . 0.568 ' HG2' HG12 ' C' ' 92' ' ' ILE . 92.8 Cg_endo -61.66 120.97 8.86 Favored 'Trans proline' 0 C--O 1.241 0.653 1 C-N-CA 126.49 4.793 . . . . 0.0 115.949 -171.005 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.58 -26.73 45.32 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 126.66 1.984 . . . . 0.0 113.008 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -58.46 -51.3 70.43 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 119.965 1.257 . . . . 0.0 112.148 174.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 92' ' ' ILE . . . . . 0.568 HG12 ' HG2' ' C' ' 89' ' ' PRO . 45.2 pt -77.73 -23.11 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 119.655 -1.903 . . . . 0.0 110.575 -175.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . 0.757 ' HA ' ' HB2' ' C' ' 66' ' ' PHE . 67.9 t -68.35 83.55 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 174.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 20.7 mt -89.84 151.85 21.56 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 173.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 95' ' ' GLU . . . . . 0.52 ' HB2' HD13 ' A' 1157 ' ' ILE . 9.6 mp0 -138.53 127.96 24.59 Favored 'General case' 0 C--O 1.249 1.066 0 O-C-N 118.597 -2.565 . . . . 0.0 108.44 176.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 50.3 ttp 45.11 75.17 0.11 Allowed 'General case' 0 C--N 1.354 0.8 0 CA-C-O 124.872 2.272 . . . . 0.0 113.732 -177.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -145.5 164.01 32.93 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 109.994 -3.275 . . . . 0.0 106.809 -162.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -79.97 13.41 2.24 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 112.934 -1.939 . . . . 0.0 111.66 -178.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 4.2 tt -45.42 -16.35 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 124.614 1.166 . . . . 0.0 111.652 153.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . 0.457 ' ND2' ' HB2' ' C' ' 137' ' ' GLU . 1.7 t-20 -33.91 -35.85 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 117.108 2.262 . . . . 0.0 117.108 162.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -65.45 -62.1 1.72 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 119.336 -0.945 . . . . 0.0 111.232 172.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 102' ' ' ASP . . . . . 0.629 ' HB3' HD11 ' C' ' 34' ' ' ILE . 5.1 m-20 -51.0 -32.79 22.3 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 175.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 103' ' ' PHE . . . . . 0.448 ' HB3' ' HB ' ' C' ' 138' ' ' VAL . 3.6 m-85 -55.71 -47.97 75.95 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 125.705 1.602 . . . . 0.0 109.958 170.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -79.97 -18.33 50.62 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 119.01 0.823 . . . . 0.0 111.774 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -73.08 -47.13 47.11 Favored 'General case' 0 C--O 1.239 0.501 0 O-C-N 120.459 -1.401 . . . . 0.0 111.548 171.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 106' ' ' THR . . . . . 0.53 HG21 ' H ' ' C' ' 34' ' ' ILE . 77.0 m -54.14 133.8 44.19 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 122.342 0.257 . . . . 0.0 111.599 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 107' ' ' ASP . . . . . 0.77 ' HB3' ' HA ' ' C' ' 30' ' ' SER . 11.0 t70 -67.07 -65.59 0.66 Allowed 'General case' 0 C--O 1.234 0.252 0 O-C-N 124.076 0.86 . . . . 0.0 112.292 169.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' C' ' 143' ' ' ASN . 68.0 m -103.42 105.91 16.29 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 123.978 0.911 . . . . 0.0 109.64 -178.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 109' ' ' VAL . . . . . 0.612 HG13 ' HB ' ' C' ' 34' ' ' ILE . 16.4 t -89.54 110.97 22.35 Favored 'Isoleucine or valine' 0 C--N 1.349 0.578 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -176.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 110' ' ' LEU . . . . . 0.583 HD12 HG12 ' C' ' 35' ' ' ILE . 28.5 mt -77.96 84.26 4.25 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 123.219 1.485 . . . . 0.0 110.791 -175.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 111' ' ' VAL . . . . . 0.568 HG11 HG21 ' C' ' 118' ' ' VAL . 93.1 t -90.65 96.3 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 CA-C-O 123.154 1.454 . . . . 0.0 108.622 -177.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 112' ' ' ILE . . . . . 0.427 HD11 HG23 ' C' ' 35' ' ' ILE . 1.3 mm -83.67 89.52 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-O 124.001 1.858 . . . . 0.0 108.586 -171.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.55 -103.91 2.47 Favored Glycine 0 CA--C 1.496 -1.116 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.669 -172.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . 56.47 -57.11 0.02 OUTLIER 'General case' 0 C--O 1.249 1.063 0 N-CA-C 120.463 3.505 . . . . 0.0 120.463 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 115' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 59.67 -93.03 0.04 OUTLIER 'General case' 0 C--O 1.241 0.644 0 CA-C-N 122.553 2.433 . . . . 0.0 112.438 173.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 116' ' ' ASP . . . . . 0.765 ' HA ' ' HB2' ' C' ' 119' ' ' ASN . 34.4 m-20 -82.72 -19.38 38.11 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.123 -0.986 . . . . 0.0 111.977 -176.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 117' ' ' THR . . . . . . . . . . . . 0.254 1.0 OUTLIER -67.22 -15.28 63.61 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 176.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.568 HG21 HG11 ' C' ' 111' ' ' VAL . 16.5 m -122.81 30.66 2.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 124.612 1.165 . . . . 0.0 108.327 171.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 119' ' ' ASN . . . . . 0.765 ' HB2' ' HA ' ' C' ' 116' ' ' ASP . 46.7 t-20 -86.78 119.62 71.31 Favored Pre-proline 0 CA--C 1.506 -0.714 0 O-C-N 119.212 -2.18 . . . . 0.0 114.146 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 120' ' ' PRO . . . . . 0.425 ' HG3' ' CE3' ' C' ' 139' ' ' TRP . 40.7 Cg_exo -53.24 -53.22 7.05 Favored 'Trans proline' 0 C--O 1.243 0.733 0 C-N-CA 124.878 3.718 . . . . 0.0 113.127 175.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 121' ' ' ALA . . . . . 0.457 ' HA ' ' HB3' ' C' ' 124' ' ' ASP . . . -61.9 -28.09 69.27 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -174.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 122' ' ' ALA . . . . . 0.42 ' HB1' ' HB3' ' C' ' 133' ' ' MET . . . -54.51 -41.05 69.19 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-O 121.609 0.719 . . . . 0.0 111.622 172.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -92.57 -16.62 25.45 Favored 'General case' 0 C--O 1.245 0.846 0 O-C-N 118.499 -2.625 . . . . 0.0 114.074 173.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 124' ' ' ASP . . . . . 0.457 ' HB3' ' HA ' ' C' ' 121' ' ' ALA . 12.4 t70 -98.77 -35.52 10.12 Favored 'General case' 0 C--O 1.241 0.647 0 O-C-N 121.242 -0.911 . . . . 0.0 112.846 -165.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 125' ' ' ASP . . . . . 0.422 ' OD2' ' HB3' ' C' ' 127' ' ' LYS . 25.4 t70 -117.54 126.94 26.99 Favored Pre-proline 0 C--N 1.321 -0.639 0 C-N-CA 124.516 1.126 . . . . 0.0 113.112 -157.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -62.36 -38.03 56.53 Favored 'Trans proline' 0 CA--C 1.548 1.196 0 C-N-CA 124.971 3.781 . . . . 0.0 114.57 176.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . 0.422 ' HB3' ' OD2' ' C' ' 125' ' ' ASP . 4.2 ttpm? -63.75 -29.57 70.77 Favored 'General case' 0 C--N 1.314 -0.941 0 O-C-N 119.291 -2.131 . . . . 0.0 111.267 -178.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 128' ' ' SER . . . . . 0.471 ' HA ' HG11 ' C' ' 158' ' ' VAL . 18.4 m -58.6 127.94 82.74 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 118.074 -0.965 . . . . 0.0 111.044 172.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 129' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -56.23 -31.36 83.74 Favored 'Trans proline' 0 C--O 1.257 1.428 0 CA-C-N 122.506 1.931 . . . . 0.0 116.17 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 10.5 pt -105.78 53.53 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-O 123.246 1.498 . . . . 0.0 109.278 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.85 120.8 14.17 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 123.3 1.524 . . . . 0.0 111.811 -171.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.61 38.97 10.02 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 133' ' ' MET . . . . . 0.682 ' SD ' ' HD2' ' C' ' 134' ' ' PRO . 42.8 tpp -73.72 134.98 78.23 Favored Pre-proline 0 N--CA 1.45 -0.444 0 O-C-N 119.819 -1.989 . . . . 0.0 110.535 172.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 134' ' ' PRO . . . . . 0.682 ' HD2' ' SD ' ' C' ' 133' ' ' MET . 92.8 Cg_endo -68.25 90.24 0.39 Allowed 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 124.011 3.141 . . . . 0.0 110.418 173.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 135' ' ' VAL . . . . . 0.402 HG22 ' O ' ' C' ' 133' ' ' MET . 1.5 m -110.95 150.8 13.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -175.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.456 ' HB2' HG12 ' C' ' 118' ' ' VAL . 28.7 mt -73.9 104.51 4.79 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.934 0.873 . . . . 0.0 112.589 -165.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 137' ' ' GLU . . . . . 0.457 ' HB2' ' ND2' ' C' ' 100' ' ' ASN . 20.4 mt-10 -64.63 110.97 2.53 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -172.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 138' ' ' VAL . . . . . 0.448 ' HB ' ' HB3' ' C' ' 103' ' ' PHE . 4.9 p -151.71 61.4 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 164.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 139' ' ' TRP . . . . . 0.425 ' CE3' ' HG3' ' C' ' 120' ' ' PRO . 4.5 m95 -81.63 136.67 35.53 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.909 -1.496 . . . . 0.0 112.837 -166.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 41.65 45.54 2.97 Favored 'General case' 0 C--O 1.243 0.755 0 O-C-N 126.886 2.616 . . . . 0.0 116.603 175.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -166.3 162.48 17.29 Favored 'General case' 0 C--N 1.345 0.402 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -170.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 59.91 163.29 0.05 Allowed 'General case' 0 C--O 1.242 0.681 0 N-CA-C 117.77 2.507 . . . . 0.0 117.77 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 143' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' C' ' 108' ' ' THR . 35.9 t30 -82.3 68.91 8.91 Favored 'General case' 0 C--O 1.248 1.01 0 O-C-N 120.979 -1.076 . . . . 0.0 109.269 176.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 144' ' ' VAL . . . . . . . . . . . . . 26.0 t -74.88 96.56 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 113.598 -1.637 . . . . 0.0 108.627 -177.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 145' ' ' ILE . . . . . 0.461 HD11 HD13 ' C' ' 171' ' ' LEU 0.266 7.9 tp -92.1 87.31 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-O 126.416 3.008 . . . . 0.0 113.3 -170.018 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 146' ' ' VAL . . . . . 0.506 ' HA ' ' HB ' ' C' ' 111' ' ' VAL . 26.7 t -77.73 97.42 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 CA-C-N 108.761 -3.836 . . . . 0.0 111.087 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 147' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -67.1 96.24 0.44 Allowed 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 148' ' ' LYS . . . . . 0.599 ' O ' ' HA ' ' C' ' 172' ' ' PHE . 48.2 tptt -123.38 131.01 53.52 Favored 'General case' 0 C--O 1.211 -0.938 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -174.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 9.8 tpp85 -63.65 -49.26 73.92 Favored 'General case' 0 C--O 1.256 1.437 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -171.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 150' ' ' SER . . . . . 0.508 ' O ' ' HE3' ' C' ' 148' ' ' LYS . 1.5 m -143.45 170.47 15.73 Favored 'General case' 0 C--O 1.249 1.073 0 O-C-N 120.86 -1.15 . . . . 0.0 108.966 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 10.5 tpt -79.17 99.11 6.84 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 176.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -155.29 157.51 37.33 Favored 'General case' 0 N--CA 1.426 -1.671 0 C-N-CA 118.131 -1.428 . . . . 0.0 109.973 -176.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 4.8 m -62.75 130.29 44.26 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 125.548 1.78 . . . . 0.0 106.639 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 154' ' ' GLY . . . . . 0.433 ' HA2' ' O3B' ' C' 1001 ' ' NAP . . . -72.32 -120.83 0.06 OUTLIER Glycine 0 N--CA 1.415 -2.732 0 O-C-N 120.745 -1.222 . . . . 0.0 113.387 171.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -86.41 -66.83 0.86 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 170.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 156' ' ' ALA . . . . . . . . . . . . . . . -85.18 -39.65 17.6 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 170.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 54.89 33.41 56.52 Favored Glycine 0 C--N 1.352 1.423 0 C-N-CA 124.692 1.139 . . . . 0.0 114.335 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 158' ' ' VAL . . . . . 0.471 HG11 ' HA ' ' C' ' 128' ' ' SER . 3.3 m -76.42 144.52 11.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 O-C-N 121.441 -1.035 . . . . 0.0 111.265 -173.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.58 136.43 57.98 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 -174.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 160' ' ' ASN . . . . . 0.405 ' OD1' ' HB3' ' C' ' 162' ' ' LEU . 13.8 p30 -169.72 156.54 6.19 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -171.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -54.31 -31.42 67.08 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 124.642 3.561 . . . . 0.0 115.223 177.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 162' ' ' LEU . . . . . 0.405 ' HB3' ' OD1' ' C' ' 160' ' ' ASN . 4.1 tt -68.04 -24.12 65.05 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 118.665 -2.522 . . . . 0.0 111.516 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 163' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -79.16 -10.78 59.91 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 172.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -127.57 -30.93 2.52 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 -169.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 35.8 mmtt -74.83 161.78 29.26 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.25 -170.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -89.84 -38.26 13.88 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.843 -173.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -74.25 -57.27 4.06 Favored 'General case' 0 C--O 1.243 0.716 0 O-C-N 117.329 -3.357 . . . . 0.0 106.93 172.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 168' ' ' THR . . . . . . . . . . . . 0.258 4.2 m -82.53 85.0 7.04 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 103.183 -2.895 . . . . 0.0 103.183 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -129.75 132.03 46.45 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-O 122.953 1.358 . . . . 0.0 113.607 -162.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 170' ' ' MET . . . . . 0.47 ' HA ' ' HB ' ' C' ' 146' ' ' VAL . 51.4 mtm -73.18 99.65 2.89 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 110.337 -3.119 . . . . 0.0 110.069 165.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 171' ' ' LEU . . . . . 0.814 HD21 ' HA ' ' C' ' 20' ' ' ALA . 17.4 tp -76.71 122.49 24.78 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 104.247 -2.501 . . . . 0.0 104.247 177.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 172' ' ' PHE . . . . . 0.599 ' HA ' ' O ' ' C' ' 148' ' ' LYS . 46.3 m-85 -89.26 77.93 7.37 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 120.24 -1.537 . . . . 0.0 111.792 -166.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -149.99 162.78 29.27 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-N 113.46 -1.7 . . . . 0.0 112.295 -172.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 174' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -75.0 144.91 42.88 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 -177.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.06 -39.73 93.37 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 125.367 1.667 . . . . 0.0 112.795 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.92 -51.45 18.49 Favored 'General case' 0 C--N 1.359 1.005 0 C-N-CA 117.759 -1.576 . . . . 0.0 108.511 174.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 177' ' ' ALA . . . . . . . . . . . . . . . -53.7 -55.94 21.73 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 125.939 1.696 . . . . 0.0 114.379 -168.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 4.5 m -57.99 -38.3 75.85 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-N 114.678 -1.146 . . . . 0.0 113.83 175.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 179' ' ' VAL . . . . . 0.458 ' HA ' HG12 ' C' ' 182' ' ' ILE . 40.0 t -72.24 -38.38 61.83 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -57.6 -40.71 79.68 Favored 'General case' 0 C--N 1.351 0.66 0 O-C-N 118.45 -2.656 . . . . 0.0 112.461 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -58.97 -53.37 59.15 Favored 'General case' 0 CA--C 1.552 1.022 0 O-C-N 121.506 -0.746 . . . . 0.0 111.812 170.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 182' ' ' ILE . . . . . 0.458 HG12 ' HA ' ' C' ' 179' ' ' VAL . 30.9 pt -78.15 -24.41 13.87 Favored 'Isoleucine or valine' 0 C--O 1.249 1.077 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -168.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 183' ' ' LEU . . . . . 0.519 ' HB2' ' HB3' ' C' ' 52' ' ' GLU . 4.7 pp -59.0 -24.78 63.08 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 118.831 -2.418 . . . . 0.0 114.815 171.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 28.6 tptt -96.71 -60.18 1.65 Allowed 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 175.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -88.88 107.25 18.89 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 123.172 1.463 . . . . 0.0 108.265 -171.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 186' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--O 1.218 -0.567 0 CA-C-N 114.519 -1.219 . . . . 0.0 112.352 160.851 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' NAD . . . . . 0.604 ' O1N' ' H3D' ' B' ' 1' ' ' NAD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C 1001 ' ' NAP . . . . . 0.433 ' O3B' ' HA2' ' C' ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 48.6 t-80 . . . . . 0 CA--C 1.506 -0.723 0 N-CA-C 108.811 -0.811 . . . . 65.74 108.811 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -67.47 81.28 0.15 Allowed Glycine 0 N--CA 1.424 -2.122 0 CA-C-O 125.576 2.764 . . . . 48.66 114.539 176.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1002 ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' 1032 ' ' THR . 30.6 ttp180 -100.85 118.7 37.43 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 111.07 -2.565 . . . . 44.56 104.154 172.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1003 ' ' ILE . . . . . 0.594 HD13 HD13 ' A' 1335 ' ' LEU . 54.9 mt -101.46 101.91 12.76 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 103.332 -2.84 . . . . 34.86 103.332 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -76.41 122.25 6.37 Favored Glycine 0 C--O 1.256 1.477 0 CA-C-N 109.644 -3.434 . . . . 30.75 110.41 174.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.587 HG23 ' HB3' ' A' 1017 ' ' ALA . 49.0 mm -105.01 98.02 14.55 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 105.912 -1.884 . . . . 32.21 105.912 177.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1006 ' ' PRO . . . . . 0.444 ' HA ' ' HB2' ' A' 1036 ' ' GLU . 80.0 Cg_exo -73.81 155.16 48.92 Favored 'Trans proline' 0 CA--C 1.508 -0.8 0 C-N-CA 123.305 2.67 . . . . 32.98 112.133 167.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1007 ' ' ARG . . . . . 0.448 ' O ' ' HG3' ' A' 1009 ' ' ARG . 33.9 ttp85 -71.85 146.14 48.14 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 110.564 -3.016 . . . . 47.98 105.316 162.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1008 ' ' GLU . . . . . 0.42 ' CD ' ' HZ2' ' A' 1071 ' ' LYS . 4.2 tp10 -75.31 119.49 19.49 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 123.603 1.668 . . . . 34.7 108.254 172.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1009 ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' 1007 ' ' ARG . 25.7 mtp-105 -104.43 7.65 35.54 Favored 'General case' 0 N--CA 1.423 -1.778 0 CA-C-N 109.734 -3.394 . . . . 53.37 108.052 -172.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 19.9 tp -62.88 127.11 29.7 Favored 'General case' 0 CA--C 1.505 -0.774 0 O-C-N 118.376 -2.702 . . . . 45.07 108.171 152.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1011 ' ' THR . . . . . . . . . . . . . 7.9 m -52.95 144.42 14.89 Favored 'General case' 0 C--O 1.255 1.365 0 C-N-CA 125.06 1.344 . . . . 40.36 112.067 -173.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 57.8 t30 70.19 -35.37 0.32 Allowed 'General case' 0 C--O 1.269 2.1 0 N-CA-C 114.728 1.381 . . . . 40.61 114.728 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -74.25 99.59 3.48 Favored 'General case' 0 C--O 1.254 1.331 0 CA-C-N 120.95 1.705 . . . . 33.76 110.647 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1014 ' ' THR . . . . . 0.453 HG22 ' HB3' ' A' 1042 ' ' LEU . 5.3 p -75.81 94.83 3.37 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 112.186 -2.279 . . . . 27.89 106.314 174.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1015 ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -145.63 147.19 31.75 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 104.472 -2.418 . . . . 29.02 104.472 173.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1016 ' ' VAL . . . . . 0.539 HG11 ' HZ ' ' A' 1050 ' ' PHE . 11.7 p -110.85 160.83 9.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 O-C-N 118.791 -2.443 . . . . 28.13 106.245 168.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1017 ' ' ALA . . . . . 0.587 ' HB3' HG23 ' A' 1005 ' ' ILE . . . -69.77 -23.34 63.34 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 118.583 -2.573 . . . . 26.87 114.673 -176.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1018 ' ' ALA . . . . . 0.85 ' HB1' ' HB ' ' A' 1022 ' ' THR . . . -156.72 136.29 12.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.454 -0.943 . . . . 26.77 108.454 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1019 ' ' THR . . . . . 0.422 HG23 ' HB2' ' A' 1324 ' ' SER . 41.6 p -72.58 172.7 7.03 Favored Pre-proline 0 C--O 1.249 1.045 0 CA-C-N 119.822 1.192 . . . . 27.02 114.207 174.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1020 ' ' PRO . . . . . 0.524 ' HD2' ' CD2' ' A' 1045 ' ' PHE . 0.1 OUTLIER -49.96 -38.98 49.9 Favored 'Trans proline' 0 C--O 1.245 0.832 0 C-N-CA 123.216 2.611 . . . . 30.57 113.813 166.262 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -63.78 -39.41 94.2 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 113.029 0.752 . . . . 47.81 113.029 173.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1022 ' ' THR . . . . . 0.85 ' HB ' ' HB1' ' A' 1018 ' ' ALA . 0.2 OUTLIER -71.66 -29.48 64.67 Favored 'General case' 0 C--N 1.312 -1.039 0 O-C-N 121.124 -0.985 . . . . 30.77 113.245 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1023 ' ' VAL . . . . . 0.689 HG22 HG11 ' A' 1033 ' ' VAL . 48.7 t -61.52 -48.49 88.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.862 0 C-N-CA 125.909 1.684 . . . . 33.59 107.416 171.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -55.94 -34.37 65.6 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 120.327 -1.483 . . . . 53.29 112.616 175.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -64.7 -47.76 77.15 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 119.792 1.178 . . . . 46.92 110.596 174.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1026 ' ' LEU . . . . . 0.711 HD21 HG22 ' A' 1332 ' ' VAL . 60.3 mt -59.14 -32.57 69.98 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.574 1.324 . . . . 37.17 114.574 177.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 1.9 tp -65.19 -34.86 79.39 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.874 -1.057 . . . . 44.44 111.689 168.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -67.49 -32.78 73.83 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 122.402 1.096 . . . . 52.58 112.22 175.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1029 ' ' LEU . . . . . 0.605 ' HA ' ' HE2' ' A' 1342 ' ' LYS . 45.2 mt -76.23 -26.11 55.72 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.446 -1.252 . . . . 45.69 110.269 171.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 84.62 43.51 6.84 Favored Glycine 0 N--CA 1.431 -1.698 0 CA-C-O 124.117 1.954 . . . . 42.09 112.679 175.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -118.53 137.71 53.03 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 104.688 -2.338 . . . . 40.72 104.688 -176.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1032 ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' 1002 ' ' ARG . 0.1 OUTLIER -78.5 113.06 16.18 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.187 -1.412 . . . . 37.77 107.187 -172.577 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1033 ' ' VAL . . . . . 0.689 HG11 HG22 ' A' 1023 ' ' VAL . 3.1 t -85.15 134.37 27.23 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 N-CA-C 107.318 -1.364 . . . . 33.54 107.318 -174.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1034 ' ' ALA . . . . . 0.637 ' HA ' ' HB3' ' A' 1056 ' ' GLU . . . -124.86 129.57 50.67 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 116.753 -1.594 . . . . 31.68 106.742 174.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1035 ' ' VAL . . . . . 0.491 HG22 ' HB ' ' A' 1005 ' ' ILE . 90.5 t -122.16 145.84 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 123.589 2.904 . . . . 31.52 108.331 -178.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1036 ' ' GLU . . . . . 0.6 ' HG2' HG11 ' A' 1063 ' ' VAL . 0.1 OUTLIER -64.66 134.66 54.72 Favored 'General case' 0 N--CA 1.436 -1.158 0 O-C-N 125.249 1.593 . . . . 41.04 108.373 178.509 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1037 ' ' SER . . . . . . . . . . . . . 25.5 m -75.22 122.51 23.78 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-N 115.093 -0.958 . . . . 31.83 110.422 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 91.36 21.76 33.99 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 114.764 -1.107 . . . . 29.36 112.236 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1039 ' ' ALA . . . . . 0.438 ' HA ' ' HD3' ' A' 1007 ' ' ARG . . . -87.06 -46.01 10.19 Favored 'General case' 0 CA--C 1.495 -1.172 0 O-C-N 119.952 -1.911 . . . . 27.78 109.847 -178.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -70.44 -24.73 76.55 Favored Glycine 0 C--O 1.242 0.596 0 C-N-CA 120.182 -1.008 . . . . 28.91 113.047 -170.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -61.59 -38.11 86.35 Favored 'General case' 0 CA--C 1.505 -0.756 0 O-C-N 124.314 0.655 . . . . 51.18 111.401 175.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1042 ' ' LEU . . . . . 0.453 ' HB3' HG22 ' A' 1014 ' ' THR . 16.8 mt -70.59 -58.2 3.93 Favored 'General case' 0 CA--C 1.513 -0.459 0 O-C-N 121.468 -0.77 . . . . 29.91 110.118 169.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1043 ' ' ALA . . . . . . . . . . . . . . . -65.5 3.8 0.65 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.375 1.62 . . . . 28.54 115.375 -173.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1044 ' ' SER . . . . . . . . . . . . . 49.5 m 65.73 28.77 10.96 Favored 'General case' 0 C--O 1.244 0.791 0 O-C-N 120.259 -1.526 . . . . 33.06 114.95 172.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1045 ' ' PHE . . . . . 0.524 ' CD2' ' HD2' ' A' 1020 ' ' PRO . 0.8 OUTLIER -155.81 101.33 2.12 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 101.86 -3.385 . . . . 30.29 101.86 174.069 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 4.2 p30 -73.36 161.31 30.61 Favored 'General case' 0 C--O 1.248 0.984 0 N-CA-C 117.676 2.472 . . . . 48.62 117.676 -153.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1047 ' ' ASP . . . . . 0.677 ' HA ' ' HD2' ' A' 1050 ' ' PHE . 5.5 m-20 -57.54 -23.4 50.19 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-N 112.493 -2.139 . . . . 36.74 114.993 177.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.9 -32.12 40.25 Favored 'General case' 0 C--O 1.24 0.605 0 O-C-N 121.156 -0.965 . . . . 43.73 111.298 174.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -72.09 -29.79 64.45 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.967 -0.753 . . . . 32.81 108.967 172.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1050 ' ' PHE . . . . . 0.677 ' HD2' ' HA ' ' A' 1047 ' ' ASP . 48.3 m-85 -58.42 -49.07 78.59 Favored 'General case' 0 C--N 1.346 0.442 0 N-CA-C 114.45 1.278 . . . . 31.86 114.45 165.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 6.9 t -59.16 -39.55 78.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 O-C-N 119.881 -1.762 . . . . 33.22 111.891 174.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -61.15 -40.65 94.64 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 123.244 0.617 . . . . 50.83 111.99 172.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -72.06 -23.8 61.42 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 118.98 -2.325 . . . . 33.12 110.822 173.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 101.8 49.31 1.28 Allowed Glycine 0 N--CA 1.439 -1.118 0 C-N-CA 118.247 -1.93 . . . . 35.83 112.443 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1055 ' ' ALA . . . . . 0.436 ' HB1' HG23 ' A' 1035 ' ' VAL . . . -101.98 135.89 42.76 Favored 'General case' 0 N--CA 1.423 -1.775 0 O-C-N 125.0 1.059 . . . . 34.82 111.369 175.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1056 ' ' GLU . . . . . 0.637 ' HB3' ' HA ' ' A' 1034 ' ' ALA . 46.9 tt0 -77.65 99.04 5.65 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 104.968 -2.234 . . . . 49.05 104.968 -177.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1057 ' ' ILE . . . . . 0.427 HD13 ' HB ' ' A' 1035 ' ' VAL . 32.0 mm -75.18 102.96 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 N-CA-C 108.535 -0.913 . . . . 38.53 108.535 -177.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1058 ' ' VAL . . . . . 0.403 HG23 ' HB ' ' A' 1063 ' ' VAL . 2.8 m -127.08 166.5 23.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 122.512 1.149 . . . . 42.11 108.287 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -114.47 141.34 47.81 Favored 'General case' 0 C--O 1.258 1.513 0 O-C-N 120.602 -1.311 . . . . 58.0 109.832 -161.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 44.25 -116.49 1.62 Allowed Glycine 0 N--CA 1.477 1.411 0 N-CA-C 115.736 1.055 . . . . 52.12 115.736 163.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 6.8 m120 -60.28 -38.44 83.59 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 120.153 -0.619 . . . . 54.75 110.046 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1062 ' ' SER . . . . . . . . . . . . . 14.6 m -74.66 -11.67 60.24 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 120.037 -1.664 . . . . 50.34 110.267 -173.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1063 ' ' VAL . . . . . 0.6 HG11 ' HG2' ' A' 1036 ' ' GLU . 11.6 p -88.79 -41.14 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 O-C-N 119.107 -2.246 . . . . 41.46 106.291 166.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1064 ' ' TRP . . . . . 0.513 ' CH2' ' HB3' ' A' 1079 ' ' GLU . 24.9 m95 -64.44 -24.61 67.69 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 115.283 1.586 . . . . 39.32 115.283 -174.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -87.04 79.58 8.65 Favored 'General case' 0 C--O 1.247 0.94 0 O-C-N 120.943 -1.098 . . . . 55.38 109.729 174.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1066 ' ' SER . . . . . 0.43 ' HB3' ' O ' ' A' 1002 ' ' ARG . 69.2 m -135.41 166.06 24.03 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 120.264 -0.575 . . . . 41.87 111.032 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -68.24 -35.67 78.28 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-O 121.593 0.711 . . . . 53.2 110.241 -177.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1068 ' ' ILE . . . . . 0.447 ' HB ' HG12 ' A' 1003 ' ' ILE . 4.9 mp -124.55 141.24 45.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 O-C-N 119.193 -2.192 . . . . 41.9 107.825 173.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1069 ' ' ILE . . . . . . . . . . . . . 19.5 mm -126.34 118.76 52.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 104.139 -2.541 . . . . 38.73 104.139 171.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1070 ' ' LEU . . . . . 0.756 HD21 HD11 ' A' 1335 ' ' LEU . 64.3 mt -93.02 135.74 33.92 Favored 'General case' 0 C--N 1.316 -0.859 0 O-C-N 124.419 1.075 . . . . 32.44 108.553 172.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1071 ' ' LYS . . . . . 0.42 ' HZ2' ' CD ' ' A' 1008 ' ' GLU . 14.1 mmmt -137.21 147.16 45.65 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-O 123.528 1.632 . . . . 34.65 112.714 -175.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1072 ' ' VAL . . . . . 0.581 ' HA ' ' HE2' ' A' 1327 ' ' TYR . 0.0 OUTLIER -86.75 -35.43 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 CA-C-N 110.088 -3.233 . . . . 31.32 111.094 -163.199 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -127.32 -175.96 3.59 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 106.83 -1.545 . . . . 33.94 106.83 165.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1074 ' ' ALA . . . . . 0.558 ' HB1' HD21 ' A' 1101 ' ' LEU . . . -53.97 132.68 58.46 Favored Pre-proline 0 N--CA 1.465 0.31 0 CA-C-N 113.984 -1.462 . . . . 38.04 108.247 166.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1075 ' ' PRO . . . . . 0.497 ' HG2' HD21 ' A' 1089 ' ' LEU . 92.6 Cg_exo -65.88 145.88 81.49 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 123.677 2.918 . . . . 42.68 111.551 175.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 15.3 mt -71.65 159.63 34.06 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 106.49 -1.67 . . . . 46.74 106.49 173.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -50.45 -32.45 17.95 Favored 'General case' 0 C--O 1.242 0.687 0 O-C-N 119.744 -1.848 . . . . 58.61 113.683 171.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 12.4 t0 -51.98 -60.89 2.67 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 124.294 1.038 . . . . 59.2 109.887 167.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1079 ' ' GLU . . . . . 0.513 ' HB3' ' CH2' ' A' 1064 ' ' TRP . 55.6 mt-10 -65.04 -36.83 85.62 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.047 -1.433 . . . . 50.63 114.016 -173.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1080 ' ' ILE . . . . . 0.661 ' HA ' HD23 ' A' 1083 ' ' LEU . 66.3 mt -48.0 -52.46 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.125 1.77 . . . . 51.48 109.275 171.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -66.44 -25.85 66.94 Favored 'General case' 0 CA--C 1.512 -0.518 0 O-C-N 119.323 -2.111 . . . . 50.28 113.743 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 25.8 mt -77.81 -17.76 57.1 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 115.649 -0.705 . . . . 50.21 112.207 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1083 ' ' LEU . . . . . 0.661 HD23 ' HA ' ' A' 1080 ' ' ILE . 1.2 mm? -58.84 134.1 56.59 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 119.305 -2.122 . . . . 49.06 111.329 168.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.72 152.02 42.03 Favored Pre-proline 0 N--CA 1.473 0.705 0 CA-C-O 117.832 -1.08 . . . . 51.08 109.874 -175.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -54.34 116.39 3.03 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 124.707 3.605 . . . . 49.73 110.052 172.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 110.45 -5.8 29.92 Favored Glycine 0 CA--C 1.489 -1.587 0 N-CA-C 112.3 -0.32 . . . . 47.71 112.3 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1087 ' ' THR . . . . . . . . . . . . . 84.0 m -83.54 132.84 34.9 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 118.097 -3.002 . . . . 45.47 109.905 -174.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1088 ' ' THR . . . . . . . . . . . . . 1.6 m -89.09 94.65 10.01 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.333 -1.729 . . . . 42.04 106.333 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1089 ' ' LEU . . . . . 0.56 HD13 HD11 ' A' 1083 ' ' LEU . 54.2 tp -81.36 102.35 10.4 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.182 -0.949 . . . . 38.06 109.376 176.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1090 ' ' VAL . . . . . 0.752 HG13 ' HB2' ' A' 1113 ' ' MET . 3.2 t -99.75 123.05 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 104.822 -2.288 . . . . 37.4 104.822 174.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1091 ' ' SER . . . . . 0.415 ' OG ' ' HB2' ' A' 1071 ' ' LYS . 4.9 m -153.8 165.48 35.91 Favored 'General case' 0 CA--C 1.549 0.915 0 O-C-N 120.103 -1.623 . . . . 36.16 111.319 -175.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 15.2 t80 -86.66 101.97 13.76 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 106.048 -1.834 . . . . 38.94 106.048 166.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 40.3 mm -91.56 -65.34 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 123.046 1.403 . . . . 42.17 113.256 -170.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1094 ' ' TRP . . . . . 0.454 ' CZ2' HD21 ' A' 1130 ' ' LEU . 29.7 m95 69.69 74.63 0.27 Allowed Pre-proline 0 C--N 1.354 0.773 0 CA-C-N 112.185 -2.28 . . . . 46.51 113.947 -159.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -59.03 -32.6 97.8 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 122.803 2.336 . . . . 49.76 115.301 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -63.23 -43.63 97.53 Favored 'General case' 0 C--N 1.356 0.889 0 CA-C-N 120.846 1.657 . . . . 52.62 110.834 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -66.33 -52.72 44.27 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-N 114.257 -1.338 . . . . 60.74 112.621 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1098 ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -120.48 80.43 30.2 Favored Pre-proline 0 C--O 1.239 0.528 0 O-C-N 118.111 -2.868 . . . . 58.19 115.525 -174.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.95 -28.37 58.12 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 124.667 3.578 . . . . 54.59 111.404 175.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -54.97 -48.39 73.3 Favored 'General case' 0 CA--C 1.504 -0.813 0 O-C-N 120.171 -1.58 . . . . 63.28 109.321 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1101 ' ' LEU . . . . . 0.558 HD21 ' HB1' ' A' 1074 ' ' ALA . 1.3 mp -46.98 -52.62 14.24 Favored 'General case' 0 CA--C 1.513 -0.463 0 O-C-N 125.62 1.825 . . . . 54.75 113.685 172.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1102 ' ' MET . . . . . . . . . . . . . 72.8 mmm -57.8 -49.24 77.3 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 113.497 -1.683 . . . . 52.65 109.864 -176.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1103 ' ' GLN . . . . . 0.481 ' O ' ' HG2' ' A' 1107 ' ' GLU . 33.6 mt-30 -58.66 -51.62 69.15 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 123.192 1.472 . . . . 66.26 109.025 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1104 ' ' LYS . . . . . 0.492 ' HB3' HG21 ' A' 1080 ' ' ILE . 98.7 mttt -64.47 -40.75 96.29 Favored 'General case' 0 C--O 1.239 0.539 0 O-C-N 118.599 -2.563 . . . . 63.73 110.884 -176.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 63.3 mt -69.16 -34.46 75.01 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.095 0.558 . . . . 54.68 111.117 176.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -65.3 -42.65 92.86 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 106.766 -1.568 . . . . 53.64 106.766 177.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1107 ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' 1103 ' ' GLN . 47.4 mm-40 -55.85 -40.84 73.45 Favored 'General case' 0 CA--C 1.501 -0.919 0 O-C-N 125.296 1.623 . . . . 67.24 112.826 170.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1108 ' ' ARG . . . . . 0.405 ' HA ' ' NE ' ' A' 1108 ' ' ARG . 3.4 mmp_? -65.86 -23.02 66.58 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 116.945 -1.503 . . . . 65.76 112.685 175.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 30.8 t30 61.43 60.81 1.62 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 126.895 3.236 . . . . 58.71 113.446 -175.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1110 ' ' VAL . . . . . 0.508 HG11 ' HB3' ' A' 1083 ' ' LEU . 19.3 m -122.1 157.9 26.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 111.543 -2.572 . . . . 46.63 108.558 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1111 ' ' THR . . . . . . . . . . . . . 51.6 m -94.81 109.32 21.3 Favored 'General case' 0 N--CA 1.44 -0.961 0 O-C-N 120.999 -1.063 . . . . 44.13 111.426 171.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1112 ' ' VAL . . . . . . . . . . . . . 49.8 t -99.83 119.52 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-O 122.902 1.334 . . . . 40.44 109.366 -175.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1113 ' ' MET . . . . . 0.752 ' HB2' HG13 ' A' 1090 ' ' VAL . 10.7 mtp -108.17 120.52 42.57 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 104.793 -2.299 . . . . 50.76 104.793 177.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1114 ' ' ALA . . . . . 0.497 ' HB3' ' HB2' ' A' 1117 ' ' SER . . . -107.89 108.84 20.18 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 118.204 -2.81 . . . . 35.64 108.363 -175.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1115 ' ' MET . . . . . . . . . . . . . 62.1 mmm -65.92 -19.12 65.76 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 117.947 2.573 . . . . 38.74 117.947 -173.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -71.88 -36.73 70.15 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 122.553 1.168 . . . . 40.14 108.582 166.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1117 ' ' SER . . . . . 0.497 ' HB2' ' HB3' ' A' 1114 ' ' ALA . 58.3 m -86.35 28.63 0.82 Allowed 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 115.085 1.513 . . . . 44.79 115.085 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1118 ' ' VAL . . . . . 0.533 ' HA ' HG22 ' A' 1358 ' ' VAL . 88.0 t -74.05 132.95 79.09 Favored Pre-proline 0 N--CA 1.471 0.611 0 N-CA-C 106.296 -1.742 . . . . 43.75 106.296 171.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -65.95 132.22 29.58 Favored 'Trans proline' 0 C--N 1.323 -0.777 0 C-N-CA 123.752 2.968 . . . . 48.93 108.211 175.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 30.9 mmm-85 -77.26 32.11 0.15 Allowed 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 116.667 2.099 . . . . 62.9 116.667 -164.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 31.8 pt -89.2 170.78 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 120.599 -1.313 . . . . 57.72 111.754 -169.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1122 ' ' SER . . . . . . . . . . . . . 11.4 p -57.2 -58.65 7.28 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 120.04 1.291 . . . . 57.26 114.286 -172.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 31.5 ptt85 -62.03 -19.1 62.52 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 116.576 2.065 . . . . 62.9 116.576 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -77.92 -15.99 58.56 Favored 'General case' 0 C--O 1.214 -0.77 0 O-C-N 120.254 -1.529 . . . . 49.83 113.965 172.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -56.78 -35.9 69.22 Favored 'General case' 0 C--O 1.258 1.521 0 CA-C-N 121.068 1.758 . . . . 52.37 115.019 -171.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1126 ' ' SER . . . . . . . . . . . . . 38.3 m -67.38 -23.55 65.6 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 119.51 -1.994 . . . . 42.43 111.226 176.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1127 ' ' LEU . . . . . . . . . . . . . 6.8 mp -89.79 -29.3 18.75 Favored 'General case' 0 C--O 1.221 -0.423 0 O-C-N 119.297 -2.127 . . . . 43.74 111.645 172.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 51.2 t0 -61.57 107.78 0.86 Allowed 'General case' 0 C--O 1.247 0.942 0 C-N-CA 125.358 1.463 . . . . 43.21 111.994 -170.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -71.62 -37.49 70.9 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 115.277 -0.874 . . . . 35.74 111.336 174.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1130 ' ' LEU . . . . . 0.454 HD21 ' CZ2' ' A' 1094 ' ' TRP . 45.7 mt -66.47 -16.19 63.93 Favored 'General case' 0 C--O 1.244 0.799 0 O-C-N 119.97 -1.706 . . . . 38.09 112.047 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1131 ' ' SER . . . . . 0.417 ' HA ' ' HB ' ' A' 1175 ' ' VAL . 70.6 m -86.63 -64.25 1.18 Allowed 'General case' 0 CA--C 1.55 0.959 0 O-C-N 120.656 -1.278 . . . . 36.91 109.194 163.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1132 ' ' SER . . . . . 0.566 ' HB2' ' OD1' ' A' 1330 ' ' ASN . 1.6 m -76.6 -45.27 30.92 Favored 'General case' 0 C--O 1.244 0.802 0 O-C-N 117.789 -3.069 . . . . 35.79 114.594 -166.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1133 ' ' MET . . . . . 0.833 ' HA ' HD12 ' A' 1136 ' ' ILE . 5.0 ttp -66.38 -42.81 87.39 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 122.08 2.218 . . . . 30.81 108.996 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1134 ' ' ALA . . . . . 0.635 ' HB1' ' HB2' ' A' 1176 ' ' ALA . . . -50.71 -46.57 59.02 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.627 0.973 . . . . 28.88 113.627 166.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1135 ' ' ASN . . . . . 0.553 ' ND2' ' HB2' ' A' 1179 ' ' ALA . 11.3 t-20 -62.47 -36.62 83.04 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 119.762 1.164 . . . . 40.76 111.354 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1136 ' ' ILE . . . . . 0.833 HD12 ' HA ' ' A' 1133 ' ' MET . 57.3 mt -53.02 -57.1 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 O-C-N 121.597 -0.689 . . . . 31.54 110.274 170.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -60.07 -29.71 68.74 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.57 -0.741 . . . . 29.87 112.486 175.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -64.52 -44.53 95.03 Favored Glycine 0 CA--C 1.533 1.174 0 O-C-N 120.649 -1.282 . . . . 28.73 113.757 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 43.2 t80 -60.64 -50.53 73.14 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 123.587 1.66 . . . . 30.39 107.677 173.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1140 ' ' ARG . . . . . 0.704 ' HG3' HD22 ' A' 1315 ' ' LEU . 4.0 tpt180 -61.68 -24.61 66.87 Favored 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 111.81 -2.45 . . . . 26.09 113.107 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1141 ' ' ALA . . . . . 0.627 ' HB2' HD21 ' A' 1284 ' ' LEU . . . -60.1 -38.83 84.13 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 122.136 0.97 . . . . 27.1 113.584 171.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 40.9 mm -66.43 -46.15 87.4 Favored 'Isoleucine or valine' 0 C--O 1.246 0.894 0 O-C-N 121.222 -0.924 . . . . 28.48 109.777 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 94.4 t -57.38 -60.12 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 114.394 -1.275 . . . . 23.07 110.207 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1144 ' ' GLU . . . . . 0.451 ' HG2' ' HE ' ' A' 1140 ' ' ARG . 5.4 mm-40 -72.93 -21.28 60.91 Favored 'General case' 0 CA--C 1.502 -0.879 0 O-C-N 124.262 0.976 . . . . 33.4 113.322 -175.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1145 ' ' ALA . . . . . 0.842 ' HB1' HD12 ' A' 1251 ' ' ILE . . . -55.48 -57.65 11.03 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 124.013 0.821 . . . . 24.22 108.96 163.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1146 ' ' ALA . . . . . 0.565 ' HB2' ' HE2' ' A' 1153 ' ' PHE . . . -67.43 -16.18 64.08 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 124.522 1.139 . . . . 24.89 111.96 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 66.2 t-80 -72.34 -49.3 35.32 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 117.911 -1.042 . . . . 26.73 108.397 175.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1148 ' ' GLU . . . . . 0.825 ' HB3' ' HD2' ' A' 1308 ' ' LYS . 13.1 mm-40 -81.63 -15.05 55.84 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 121.493 1.951 . . . . 39.96 115.139 175.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1149 ' ' PHE . . . . . 0.557 ' HB2' ' HA ' ' A' 1146 ' ' ALA . 0.6 OUTLIER -59.18 140.03 56.32 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 125.226 2.441 . . . . 25.87 109.767 -170.499 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1150 ' ' GLY . . . . . . . . . . . . . . . -79.99 -35.51 27.41 Favored Glycine 0 N--CA 1.426 -2.019 0 CA-C-N 109.823 -3.353 . . . . 19.28 109.248 170.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1151 ' ' ARG . . . . . 0.568 ' HA ' ' HB2' ' B' 1322 ' ' GLN . 10.9 mtt-85 -108.48 -169.94 1.59 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.789 0.804 . . . . 39.9 112.756 -159.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1152 ' ' PHE . . . . . 0.551 ' HB2' ' HG2' ' B' 1322 ' ' GLN . 1.7 t80 -110.98 145.92 37.57 Favored 'General case' 0 C--O 1.248 0.978 0 CA-C-O 118.178 -0.915 . . . . 29.44 109.078 178.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1153 ' ' PHE . . . . . 0.565 ' HE2' ' HB2' ' A' 1146 ' ' ALA . 25.5 m-85 -66.94 -50.74 61.41 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 120.924 1.693 . . . . 32.6 114.269 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1154 ' ' THR . . . . . 0.438 HG21 HG22 ' C' ' 81' ' ' VAL . 51.6 m -93.59 134.84 35.47 Favored 'General case' 0 CA--C 1.549 0.923 0 O-C-N 120.665 -1.272 . . . . 34.64 110.653 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -76.67 69.77 2.32 Favored Glycine 0 C--N 1.338 0.651 0 O-C-N 121.53 -0.731 . . . . 37.14 112.023 176.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -81.28 151.73 27.94 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 116.107 1.891 . . . . 40.57 116.107 -175.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1157 ' ' ILE . . . . . 0.443 HG23 ' H ' ' C' ' 77' ' ' GLY . 6.9 tp -79.25 119.21 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 123.068 1.413 . . . . 44.61 110.58 165.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1158 ' ' THR . . . . . . . . . . . . . 37.7 p -92.15 -168.27 1.96 Allowed 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.489 -1.232 . . . . 40.7 109.59 174.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -76.13 -23.18 54.84 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 124.091 3.132 . . . . 40.25 108.596 173.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -85.37 -60.8 1.92 Allowed 'General case' 0 C--O 1.251 1.175 0 CA-C-N 115.804 -0.635 . . . . 38.47 110.012 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1161 ' ' GLY . . . . . 0.628 ' HA3' HG21 ' B' 1329 ' ' THR . . . 175.66 -157.55 23.98 Favored Glycine 0 CA--C 1.505 -0.575 0 O-C-N 118.625 -2.547 . . . . 37.61 110.471 -174.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1162 ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' 1163 ' ' VAL . 32.3 tttt -92.84 138.99 31.0 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 125.332 2.491 . . . . 48.9 113.335 -163.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1163 ' ' VAL . . . . . 0.527 HG11 ' HB3' ' A' 1152 ' ' PHE . 24.9 t -83.9 147.11 50.61 Favored Pre-proline 0 C--N 1.305 -1.338 0 CA-C-N 109.202 -3.636 . . . . 36.52 109.241 167.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1164 ' ' PRO . . . . . 0.435 ' HA ' ' HD2' ' A' 1165 ' ' PRO . 45.5 Cg_endo -69.58 119.75 6.66 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 124.756 3.637 . . . . 35.08 116.106 162.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1165 ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' 1164 ' ' PRO . 97.5 Cg_endo -66.16 142.96 69.5 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.612 2.208 . . . . 35.33 115.17 176.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -82.36 126.63 32.39 Favored 'General case' 0 C--N 1.343 0.295 0 O-C-N 120.389 -1.444 . . . . 34.69 112.955 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1167 ' ' LYS . . . . . 0.583 ' HB2' ' HA ' ' A' 1249 ' ' VAL . 61.7 mttp -86.52 102.07 13.77 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 106.293 -1.743 . . . . 45.36 106.293 168.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 16.2 t -88.58 86.36 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 112.567 -2.106 . . . . 31.71 110.006 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1169 ' ' MET . . . . . 0.65 ' HA ' ' O ' ' A' 1192 ' ' ARG . 62.4 ttp -79.34 103.53 9.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 123.933 1.825 . . . . 42.28 110.73 176.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 21.6 t -92.26 119.27 39.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 106.699 -1.593 . . . . 30.51 106.699 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 63.9 mt -108.92 126.84 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 104.898 -2.26 . . . . 31.87 104.898 -173.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1172 ' ' GLY . . . . . 0.584 ' O ' ' HB ' ' A' 1255 ' ' THR . . . 70.83 71.64 1.0 Allowed Glycine 0 C--N 1.352 1.449 0 C-N-CA 119.719 -1.229 . . . . 34.54 110.3 -175.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1173 ' ' ALA . . . . . . . . . . . . . . . -76.97 68.66 3.16 Favored 'General case' 0 C--O 1.243 0.752 0 O-C-N 121.188 -1.183 . . . . 32.51 111.854 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -78.7 -173.03 42.35 Favored Glycine 0 C--N 1.342 0.871 0 N-CA-C 107.667 -2.173 . . . . 29.9 107.667 164.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1175 ' ' VAL . . . . . 0.488 HG12 ' HB2' ' A' 1135 ' ' ASN . 48.8 t -62.83 -31.22 51.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 121.58 2.69 . . . . 33.11 113.995 -172.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1176 ' ' ALA . . . . . 0.635 ' HB2' ' HB1' ' A' 1134 ' ' ALA . . . -58.7 -52.44 65.67 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 118.102 0.41 . . . . 28.1 110.621 168.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -56.72 -36.13 70.64 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.27 0.938 . . . . 28.54 112.653 173.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1178 ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' 1175 ' ' VAL . 56.6 mt -65.64 -37.85 87.73 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 118.244 1.022 . . . . 31.22 110.702 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1179 ' ' ALA . . . . . 0.553 ' HB2' ' ND2' ' A' 1135 ' ' ASN . . . -64.11 -42.7 96.79 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 112.406 0.521 . . . . 28.98 112.406 173.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -58.98 -44.91 91.66 Favored 'General case' 0 C--N 1.352 0.683 0 O-C-N 125.012 1.445 . . . . 27.83 113.995 173.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1181 ' ' ILE . . . . . 0.571 HD13 HG22 ' A' 1204 ' ' VAL . 47.1 mt -60.61 -51.08 77.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 O-C-N 122.045 -0.409 . . . . 30.25 111.232 178.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -60.67 -57.42 19.02 Favored Glycine 0 CA--C 1.525 0.665 0 O-C-N 126.523 2.389 . . . . 29.59 111.56 -174.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -55.09 -50.1 70.03 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 119.057 1.428 . . . . 30.29 111.534 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1184 ' ' ALA . . . . . 0.579 ' HA ' HD12 ' A' 1187 ' ' LEU . . . -70.31 -27.14 64.15 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 114.988 1.477 . . . . 30.47 114.988 -175.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -71.86 -40.31 69.06 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-O 116.144 -1.884 . . . . 42.41 110.181 172.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1186 ' ' SER . . . . . . . . . . . . . 1.5 m -64.52 -31.05 72.1 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-N 119.752 1.16 . . . . 39.38 110.617 172.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1187 ' ' LEU . . . . . 0.846 ' HA ' ' HB3' ' B' 1186 ' ' SER . 58.9 mt -65.75 -33.36 75.7 Favored 'General case' 0 C--N 1.345 0.393 0 O-C-N 119.187 -2.196 . . . . 36.18 111.404 168.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 84.8 60.35 1.88 Allowed Glycine 0 N--CA 1.433 -1.542 0 CA-C-O 123.366 1.537 . . . . 33.78 110.076 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -119.11 160.22 22.48 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 113.751 -1.224 . . . . 33.93 108.722 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 79.0 mt -79.33 81.57 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.825 0 C-N-CA 118.841 -1.144 . . . . 38.74 108.915 -173.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 12.1 t -81.56 131.86 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.792 -1.188 . . . . 33.09 107.792 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1192 ' ' ARG . . . . . 0.65 ' O ' ' HA ' ' A' 1169 ' ' MET . 1.2 ptp180 -139.58 103.29 4.66 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 104.926 -2.25 . . . . 38.92 104.926 177.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -95.46 131.96 41.05 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 110.883 -2.871 . . . . 35.32 110.983 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1194 ' ' PHE . . . . . 0.47 ' HD1' ' O ' ' A' 1212 ' ' LEU . 71.5 t80 -111.93 140.12 46.86 Favored 'General case' 0 C--O 1.248 1.002 0 O-C-N 119.236 -2.165 . . . . 39.35 106.537 168.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 8.9 t0 -141.51 150.12 41.76 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 105.197 -2.149 . . . . 40.46 105.197 163.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1196 ' ' THR . . . . . . . . . . . . . 1.3 m -60.19 -32.33 70.97 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 111.816 -2.447 . . . . 45.94 110.064 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1197 ' ' ARG . . . . . 0.432 ' HA ' ' HD2' ' A' 1198 ' ' PRO . 59.9 mtm180 -83.13 117.81 69.74 Favored Pre-proline 0 N--CA 1.447 -0.624 0 C-N-CA 124.99 1.316 . . . . 56.02 108.739 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1198 ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' 1197 ' ' ARG . 74.5 Cg_endo -67.45 -19.06 49.53 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.891 2.394 . . . . 51.27 110.058 176.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -58.17 -37.97 75.74 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 124.248 1.019 . . . . 59.1 113.146 -174.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 16.1 m -83.96 5.2 2.36 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.583 0 N-CA-C 116.949 2.204 . . . . 51.06 116.949 -172.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1201 ' ' LYS . . . . . 0.403 ' HA ' ' CD1' ' A' 1211 ' ' PHE . 81.2 tttt -62.61 -55.47 26.83 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 126.194 1.798 . . . . 57.38 111.736 -172.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -54.9 -44.36 74.08 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 113.034 -1.894 . . . . 62.41 112.698 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -61.83 -47.87 83.12 Favored 'General case' 0 C--N 1.344 0.349 0 O-C-N 124.166 0.916 . . . . 57.78 112.794 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1204 ' ' VAL . . . . . 0.571 HG22 HD13 ' A' 1181 ' ' ILE . 82.6 t -49.39 -46.76 19.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 122.29 1.043 . . . . 46.38 113.428 176.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -69.61 -30.21 67.91 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 113.432 -1.713 . . . . 50.7 111.592 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1206 ' ' SER . . . . . . . . . . . . . 24.6 m -70.93 -22.1 62.27 Favored 'General case' 0 N--CA 1.435 -1.225 0 O-C-N 120.345 -1.472 . . . . 49.98 113.375 172.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1207 ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -76.58 -49.91 15.18 Favored 'General case' 0 C--N 1.362 1.131 0 O-C-N 118.974 -2.329 . . . . 52.99 108.341 164.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 126.67 58.1 0.14 Allowed Glycine 0 C--N 1.304 -1.233 0 N-CA-C 109.292 -1.523 . . . . 47.66 109.292 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -144.73 150.84 37.95 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 106.407 -1.701 . . . . 44.77 106.407 -177.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -65.98 137.99 57.51 Favored 'General case' 0 C--O 1.252 1.232 0 O-C-N 125.936 2.023 . . . . 47.64 106.587 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1211 ' ' PHE . . . . . 0.403 ' CD1' ' HA ' ' A' 1201 ' ' LYS . 44.6 t80 -104.13 116.92 33.08 Favored 'General case' 0 C--N 1.31 -1.109 1 N-CA-C 99.786 -4.153 . . . . 45.66 99.786 166.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1212 ' ' LEU . . . . . 0.47 ' O ' ' HD1' ' A' 1194 ' ' PHE . 97.1 mt -71.2 119.63 15.62 Favored 'General case' 0 C--O 1.201 -1.486 0 N-CA-C 106.627 -1.62 . . . . 46.06 106.627 -177.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -82.62 140.47 33.17 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 127.45 2.969 . . . . 60.22 110.107 171.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 29.4 tp -81.21 125.81 30.75 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 127.328 3.442 . . . . 57.25 107.886 -166.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 24.6 t70 -74.59 87.66 2.14 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 111.729 -2.487 . . . . 64.43 109.613 165.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 47.8 t80 . . . . . 0 N--CA 1.432 -1.366 0 CA-C-N 113.178 -1.828 . . . . 66.9 107.394 -178.475 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 3.6 p-10 . . . . . 0 N--CA 1.442 -0.867 0 N-CA-C 107.655 -1.239 . . . . 39.09 107.655 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -54.33 -57.14 18.31 Favored Glycine 0 C--O 1.224 -0.474 0 O-C-N 127.301 2.876 . . . . 39.32 115.346 -174.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 24.7 t80 -72.76 -39.82 66.51 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-N 118.294 1.047 . . . . 39.3 111.277 -169.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -68.35 -42.38 79.31 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.675 -1.602 . . . . 36.3 106.675 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -58.9 -44.43 91.21 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 116.211 -1.852 . . . . 37.38 111.293 175.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -59.3 -51.79 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 125.036 1.46 . . . . 39.11 112.665 174.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1230 ' ' MET . . . . . . . . . . . . . 26.8 mmt -84.27 70.46 10.6 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 123.135 1.445 . . . . 49.59 110.211 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1231 ' ' SER . . . . . . . . . . . . . 61.5 m -138.93 154.62 48.36 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.556 -1.202 . . . . 43.68 109.152 176.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -58.63 -66.8 0.44 Allowed 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.311 1.045 . . . . 55.57 111.672 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1233 ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' 1236 ' ' LYS . . . -62.41 -23.83 67.06 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.092 -0.958 . . . . 44.94 113.006 -174.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 15.1 t80 -66.75 -51.89 50.59 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-O 117.522 -1.227 . . . . 42.04 109.383 171.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 13.3 mt -68.57 -26.0 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 123.554 2.888 . . . . 46.28 109.054 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1236 ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' 1233 ' ' ALA . 33.3 tttm -61.75 -46.14 90.9 Favored 'General case' 0 C--O 1.237 0.43 0 O-C-N 119.705 -1.872 . . . . 47.87 109.308 169.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -67.52 -36.52 81.18 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-N 115.816 -0.629 . . . . 41.61 111.81 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -58.5 -56.36 23.11 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.076 0.55 . . . . 50.65 110.142 173.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1239 ' ' MET . . . . . . . . . . . . . 3.2 mtm -52.66 -45.71 66.85 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 114.044 1.127 . . . . 48.87 114.044 173.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -68.91 -33.43 73.74 Favored 'General case' 0 C--N 1.315 -0.907 0 O-C-N 121.618 -0.676 . . . . 54.8 110.998 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.42 -45.12 85.14 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 105.334 -2.099 . . . . 43.21 105.334 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -67.17 -36.92 82.81 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.08 1.352 . . . . 38.66 113.202 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1243 ' ' ALA . . . . . 0.568 ' HA ' ' HG3' ' A' 1271 ' ' MET . . . -62.26 -45.76 91.88 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 123.015 0.526 . . . . 37.92 112.289 175.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -67.16 -36.93 82.87 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 121.445 -0.784 . . . . 37.28 110.99 176.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -65.75 -30.38 71.03 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 112.971 0.73 . . . . 43.07 112.971 172.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -59.09 -34.18 71.69 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 112.565 0.58 . . . . 38.3 112.565 -175.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1247 ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.1 -15.55 63.46 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 119.521 -0.872 . . . . 47.6 112.869 178.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -114.2 -25.39 8.5 Favored 'General case' 0 N--CA 1.441 -0.924 0 O-C-N 119.077 -2.264 . . . . 45.42 115.988 176.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1249 ' ' VAL . . . . . 0.583 ' HA ' ' HB2' ' A' 1167 ' ' LYS . 34.7 m -74.93 163.68 3.92 Favored 'Isoleucine or valine' 0 C--O 1.247 0.944 0 CA-C-N 121.74 2.064 . . . . 36.26 116.541 -173.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1250 ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' 1279 ' ' SER . 2.4 m-20 -124.81 -57.45 1.53 Allowed 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 113.448 -1.705 . . . . 33.04 108.432 -170.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1251 ' ' ILE . . . . . 0.842 HD12 ' HB1' ' A' 1145 ' ' ALA . 34.6 mm -110.91 131.67 61.49 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.977 0 N-CA-C 106.613 -1.625 . . . . 31.4 106.613 175.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1252 ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' 1169 ' ' MET . 52.3 mt -122.43 134.97 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 N-CA-C 103.912 -2.625 . . . . 29.42 103.912 170.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 9.2 t -117.45 92.31 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 103.102 -2.925 . . . . 30.37 103.102 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1254 ' ' THR . . . . . 0.514 ' HB ' ' HB2' ' A' 1291 ' ' ASN . 0.7 OUTLIER -79.35 98.02 6.55 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 123.189 1.471 . . . . 35.72 113.213 179.421 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1255 ' ' THR . . . . . 0.584 ' HB ' ' O ' ' A' 1172 ' ' GLY . 4.0 m -111.5 0.16 16.4 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.09 -1.414 . . . . 36.0 114.466 -168.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1256 ' ' ALA . . . . . . . . . . . . . . . -84.3 79.32 9.58 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 125.607 2.622 . . . . 40.93 113.553 -170.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 41.7 tp -94.36 109.53 21.37 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 112.024 -2.353 . . . . 47.82 106.777 172.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 28.1 mm -66.37 119.05 59.37 Favored Pre-proline 0 CA--C 1.554 1.116 0 N-CA-C 103.651 -2.722 . . . . 52.7 103.651 168.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -53.25 125.32 18.02 Favored 'Trans proline' 0 C--N 1.35 0.637 1 C-N-CA 126.002 4.468 . . . . 54.13 112.313 -173.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 76.2 6.12 82.55 Favored Glycine 0 CA--C 1.489 -1.576 0 CA-C-O 119.907 -0.385 . . . . 54.62 112.947 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 89.2 mttt -128.78 155.84 78.64 Favored Pre-proline 0 C--O 1.252 1.198 0 O-C-N 119.492 -2.181 . . . . 55.74 109.337 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -61.36 117.8 4.63 Favored 'Trans proline' 0 N--CA 1.44 -1.63 0 C-N-CA 121.905 1.737 . . . . 51.15 113.083 168.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -51.26 132.47 32.61 Favored Pre-proline 0 N--CA 1.473 0.695 0 CA-C-N 113.094 -1.866 . . . . 46.06 111.953 176.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1264 ' ' PRO . . . . . 0.46 ' O ' ' HA ' ' A' 1291 ' ' ASN . 57.4 Cg_endo -55.62 138.86 82.09 Favored 'Trans proline' 0 C--O 1.249 1.051 0 C-N-CA 124.974 3.782 . . . . 41.08 112.283 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -78.13 99.59 6.23 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 104.22 -2.511 . . . . 47.42 104.22 171.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 94.6 mt -98.89 -21.09 16.47 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 113.189 -1.823 . . . . 39.22 111.299 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1267 ' ' ILE . . . . . 0.664 HG23 ' SD ' ' A' 1271 ' ' MET . 86.4 mt -117.55 114.23 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 O-C-N 118.298 -2.751 . . . . 42.5 106.718 172.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1268 ' ' THR . . . . . 0.401 ' H ' ' HE3' ' A' 1271 ' ' MET . 5.0 p -80.31 162.49 24.54 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 115.665 1.728 . . . . 37.84 115.665 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -60.6 -41.87 95.61 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-O 116.381 -1.771 . . . . 54.8 112.764 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -53.06 -51.07 62.97 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 125.243 1.417 . . . . 54.36 110.825 171.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1271 ' ' MET . . . . . 0.664 ' SD ' HG23 ' A' 1267 ' ' ILE . 43.0 ttm -55.49 -44.11 76.21 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 125.483 1.739 . . . . 39.52 112.485 -178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1272 ' ' VAL . . . . . 0.408 ' CG1' HG21 ' A' 1303 ' ' THR . 2.4 t -68.05 -45.57 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 120.781 1.628 . . . . 38.25 110.588 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -59.77 -28.27 67.25 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 114.64 1.348 . . . . 40.77 114.64 173.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1274 ' ' SER . . . . . . . . . . . . . 20.4 m -89.02 13.37 13.08 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 113.591 0.96 . . . . 36.58 113.591 172.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1275 ' ' MET . . . . . 0.583 ' HB3' HG21 ' A' 1307 ' ' VAL . 36.0 ttm -85.69 164.53 17.6 Favored 'General case' 0 C--O 1.246 0.87 0 O-C-N 120.899 -1.125 . . . . 36.75 109.573 -175.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1276 ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -76.8 130.62 37.92 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 105.527 -2.027 . . . . 46.11 105.527 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1277 ' ' ALA . . . . . 0.451 ' HB3' ' CD1' ' B' 1045 ' ' PHE . . . -86.01 172.17 10.85 Favored 'General case' 0 CA--C 1.504 -0.796 0 O-C-N 120.181 -1.574 . . . . 33.52 115.14 -168.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 86.26 14.99 65.32 Favored Glycine 0 C--O 1.217 -0.939 0 O-C-N 120.648 -1.283 . . . . 31.27 111.799 -171.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1279 ' ' SER . . . . . 0.468 ' HB3' ' O ' ' A' 1250 ' ' ASP . 36.9 m -130.45 163.88 26.01 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 124.108 0.963 . . . . 32.95 111.006 -156.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1280 ' ' VAL . . . . . . . . . . . . . 65.4 t -134.93 131.65 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 O-C-N 119.959 -1.713 . . . . 27.43 111.466 -170.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1281 ' ' ILE . . . . . 0.553 HD11 ' SD ' ' A' 1275 ' ' MET . 46.3 mt -106.36 104.35 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 106.213 -1.773 . . . . 30.3 106.213 171.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 43.9 t -88.9 109.74 20.52 Favored 'Isoleucine or valine' 0 C--O 1.252 1.215 0 O-C-N 119.189 -2.195 . . . . 28.63 106.773 175.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 5.0 t70 -86.15 96.64 9.97 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 123.277 1.513 . . . . 36.27 108.14 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1284 ' ' LEU . . . . . 0.627 HD21 ' HB2' ' A' 1141 ' ' ALA . 21.1 mt -73.69 -12.73 60.82 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 112.604 -2.089 . . . . 38.57 112.889 172.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -77.24 -34.58 55.84 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 120.922 1.692 . . . . 37.56 110.179 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1286 ' ' ALA . . . . . 0.572 ' HB1' HG23 ' A' 1313 ' ' THR . . . 33.54 -74.33 0.0 OUTLIER 'General case' 0 C--O 1.246 0.883 1 N-CA-C 123.423 4.601 . . . . 40.33 123.423 171.191 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -55.15 -40.54 70.73 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 116.966 2.21 . . . . 56.85 116.966 -166.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 18.0 m120 -125.59 116.89 22.44 Favored 'General case' 0 CA--C 1.491 -1.317 0 O-C-N 119.688 -1.883 . . . . 45.86 107.211 177.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 73.82 -74.6 1.14 Allowed Glycine 0 C--N 1.345 1.033 0 N-CA-C 110.859 -0.896 . . . . 40.31 110.859 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 86.03 134.26 3.52 Favored Glycine 0 C--O 1.237 0.335 0 N-CA-C 109.493 -1.443 . . . . 38.89 109.493 -173.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1291 ' ' ASN . . . . . 0.514 ' HB2' ' HB ' ' A' 1254 ' ' THR . 25.6 m120 -70.93 -24.91 62.54 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-N 118.009 0.905 . . . . 37.23 112.391 -167.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1292 ' ' CYS . . . . . 0.426 ' HB3' ' OG1' ' A' 1295 ' ' THR . 53.7 t -91.58 155.65 18.21 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 120.835 -1.166 . . . . 36.5 111.853 177.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1293 ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -83.46 6.51 19.98 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 119.729 -1.857 . . . . 43.32 115.343 173.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -113.47 8.5 17.84 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-O 123.053 1.406 . . . . 41.32 111.99 171.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1295 ' ' THR . . . . . 0.426 ' OG1' ' HB3' ' A' 1292 ' ' CYS . 33.5 m -75.84 95.14 3.43 Favored 'General case' 0 CA--C 1.501 -0.938 0 O-C-N 118.744 -2.472 . . . . 35.3 112.098 -176.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 60.1 t -92.07 115.94 65.57 Favored Pre-proline 0 N--CA 1.437 -1.124 0 CA-C-N 109.583 -3.462 . . . . 34.84 105.562 169.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -54.51 107.78 0.25 Allowed 'Trans proline' 0 C--O 1.247 0.975 0 C-N-CA 124.969 3.779 . . . . 33.51 115.202 174.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 85.65 28.12 30.39 Favored Glycine 0 N--CA 1.442 -0.9 0 CA-C-N 111.761 -2.472 . . . . 32.19 113.793 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -140.36 158.0 44.68 Favored 'General case' 0 C--O 1.242 0.685 0 O-C-N 118.935 -2.509 . . . . 34.88 111.475 177.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1300 ' ' ILE . . . . . . . . . . . . . 31.4 mt -94.88 124.46 47.39 Favored 'Isoleucine or valine' 0 C--O 1.254 1.315 0 N-CA-C 105.152 -2.166 . . . . 32.29 105.152 169.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -128.4 108.03 10.23 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 105.385 -2.08 . . . . 37.25 105.385 175.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1302 ' ' THR . . . . . . . . . . . . . 55.9 m -75.53 135.26 40.62 Favored 'General case' 0 C--O 1.243 0.736 0 O-C-N 120.847 -1.158 . . . . 35.56 108.529 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1303 ' ' THR . . . . . 0.408 HG21 ' CG1' ' A' 1272 ' ' VAL . 35.8 p -85.07 172.36 11.32 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 119.581 -1.95 . . . . 36.4 109.981 176.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -61.97 -42.67 99.38 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 118.647 0.658 . . . . 52.32 111.914 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -64.56 -35.77 82.06 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.628 0.728 . . . . 40.04 112.644 176.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 117.17 44.79 0.55 Allowed Glycine 0 C--O 1.217 -0.912 0 O-C-N 120.063 -1.648 . . . . 36.96 110.157 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1307 ' ' VAL . . . . . 0.583 HG21 ' HB3' ' A' 1275 ' ' MET . 74.3 t -113.51 124.5 70.21 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.233 0 N-CA-C 104.273 -2.491 . . . . 33.4 104.273 171.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1308 ' ' LYS . . . . . 0.825 ' HD2' ' HB3' ' A' 1148 ' ' GLU . 88.3 mttt -84.6 119.26 25.01 Favored 'General case' 0 CA--C 1.496 -1.127 0 C-N-CA 119.411 -0.916 . . . . 42.91 109.465 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 57.3 t -96.52 130.73 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.082 0 N-CA-C 106.919 -1.511 . . . . 32.29 106.919 172.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1310 ' ' ILE . . . . . . . . . . . . . 1.5 mt -125.06 111.27 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.369 0 O-C-N 120.512 -1.367 . . . . 30.99 108.125 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -83.31 59.3 4.99 Favored Glycine 0 N--CA 1.466 0.686 0 O-C-N 120.448 -1.408 . . . . 28.95 109.885 174.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1312 ' ' TYR . . . . . 0.437 ' HD1' ' HA ' ' A' 1312 ' ' TYR 0.252 0.5 OUTLIER -73.98 85.77 1.79 Allowed 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 121.189 2.495 . . . . 31.69 116.952 -172.301 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A 1313 ' ' THR . . . . . 0.572 HG23 ' HB1' ' A' 1286 ' ' ALA . 0.8 OUTLIER -54.57 -53.44 54.58 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 113.906 -1.497 . . . . 34.17 112.823 168.414 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -65.42 5.9 0.36 Allowed 'General case' 0 C--O 1.248 1.021 0 N-CA-C 116.849 2.166 . . . . 36.86 116.849 -172.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1315 ' ' LEU . . . . . 0.704 HD22 ' HG3' ' A' 1140 ' ' ARG . 58.5 mt -47.09 -39.92 20.48 Favored Pre-proline 0 CA--C 1.547 0.86 0 CA-C-N 121.544 1.975 . . . . 34.85 116.123 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -57.19 -43.12 55.94 Favored 'Trans proline' 0 CA--C 1.505 -0.953 0 CA-C-N 123.311 2.218 . . . . 29.15 116.542 168.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -66.04 -39.19 94.66 Favored Glycine 0 C--N 1.313 -0.709 0 O-C-N 119.918 -1.738 . . . . 27.29 111.859 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1318 ' ' ARG . . . . . 0.488 ' HB3' ' NH2' ' A' 1140 ' ' ARG . 92.7 mtt-85 -62.97 -25.03 68.18 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 124.747 1.219 . . . . 41.49 113.796 174.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1319 ' ' LEU . . . . . 0.482 HD23 HG23 ' A' 1136 ' ' ILE . 12.7 tp -115.91 70.26 3.68 Favored Pre-proline 0 C--O 1.251 1.132 0 N-CA-C 107.748 -1.205 . . . . 27.61 107.748 172.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1320 ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -59.5 -59.68 0.4 Allowed 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 122.722 2.281 . . . . 25.94 115.057 -163.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1321 ' ' THR . . . . . . . . . . . . . 7.6 m -65.0 -36.45 84.45 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 108.735 -0.839 . . . . 25.01 108.735 -171.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1322 ' ' GLN . . . . . 0.461 ' HB2' ' HA ' ' B' 1151 ' ' ARG . 31.6 tp60 -72.97 -32.31 65.13 Favored 'General case' 0 CA--C 1.502 -0.866 0 O-C-N 120.988 -1.07 . . . . 29.39 112.18 -172.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1323 ' ' SER . . . . . 0.586 ' HA ' HD13 ' A' 1136 ' ' ILE . 40.2 m -65.68 -50.66 64.12 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 107.098 -1.445 . . . . 26.47 107.098 172.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1324 ' ' SER . . . . . 0.422 ' HB2' HG23 ' A' 1019 ' ' THR . 3.4 m -60.8 -23.62 65.18 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.962 0.905 . . . . 27.78 112.22 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 19.4 tm0? -86.43 -76.29 0.35 Allowed 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.782 -1.562 . . . . 37.53 106.782 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1326 ' ' LEU . . . . . 0.55 ' HB2' HD11 ' A' 1136 ' ' ILE . 92.8 mt -54.76 -62.27 1.77 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 115.446 1.647 . . . . 35.71 115.446 -175.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1327 ' ' TYR . . . . . 0.581 ' HE2' ' HA ' ' A' 1072 ' ' VAL . 30.3 t80 -63.85 -35.49 80.81 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 107.613 -1.254 . . . . 31.59 107.613 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1328 ' ' GLY . . . . . 0.547 ' HA2' HD12 ' A' 1331 ' ' LEU . . . -54.06 -46.18 70.5 Favored Glycine 0 C--N 1.359 1.818 0 O-C-N 124.156 0.91 . . . . 28.0 111.699 171.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1329 ' ' THR . . . . . 0.507 ' HA ' ' HB ' ' A' 1332 ' ' VAL . 28.5 m -71.29 -24.46 62.15 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 123.241 0.616 . . . . 32.15 110.922 175.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1330 ' ' ASN . . . . . 0.566 ' OD1' ' HB2' ' A' 1132 ' ' SER . 3.1 m120 -61.78 -54.07 47.41 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 116.911 -3.618 . . . . 34.36 107.246 174.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1331 ' ' LEU . . . . . 0.657 HD13 ' HB3' ' A' 1070 ' ' LEU . 12.9 mt -47.01 -54.51 10.04 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 126.548 1.939 . . . . 33.37 111.155 170.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1332 ' ' VAL . . . . . 0.711 HG22 HD21 ' A' 1026 ' ' LEU . 70.0 t -63.98 -32.71 58.27 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.729 0 CA-C-O 117.179 -1.391 . . . . 35.27 114.073 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -73.67 -31.19 63.34 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 124.191 3.178 . . . . 37.66 110.737 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1334 ' ' LEU . . . . . . . . . . . . . 43.3 tp -60.71 -51.11 70.74 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-N 118.687 0.676 . . . . 40.27 110.592 164.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1335 ' ' LEU . . . . . 0.756 HD11 HD21 ' A' 1070 ' ' LEU . 55.2 mt -54.5 -34.96 62.58 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 114.793 1.405 . . . . 42.5 114.793 168.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1336 ' ' LYS . . . . . 0.597 ' HG2' HD21 ' A' 1029 ' ' LEU . 90.0 mttt -60.69 -46.17 91.38 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 123.18 2.718 . . . . 47.81 112.977 174.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1337 ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.85 -36.99 78.0 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 124.365 1.041 . . . . 49.27 113.251 173.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1338 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.8 -32.51 70.99 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 124.628 1.171 . . . . 50.54 111.16 172.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1339 ' ' CYS . . . . . 0.591 ' HB3' ' HG2' ' A' 1342 ' ' LYS . 64.8 m -79.48 88.78 5.04 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 124.052 1.882 . . . . 53.67 107.958 172.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -76.01 -66.26 0.81 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 113.67 -1.605 . . . . 63.38 106.734 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -85.69 -18.88 31.87 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.384 -0.826 . . . . 70.95 110.626 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1342 ' ' LYS . . . . . 0.605 ' HE2' ' HA ' ' A' 1029 ' ' LEU . 5.8 mtpm? 68.41 56.91 0.47 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.129 -1.396 . . . . 65.25 114.437 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1343 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 172.84 -38.49 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.389 2 O-C-N 112.345 -6.472 . . . . 64.53 107.714 -17.335 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1344 ' ' GLY . . . . . . . . . . . . . . . 84.34 -62.45 4.57 Favored Glycine 0 C--N 1.346 1.118 0 O-C-N 117.491 -3.255 . . . . 59.72 111.129 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 4.6 t30 -116.62 132.23 56.74 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 103.666 -2.716 . . . . 64.09 103.666 169.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1346 ' ' ILE . . . . . . . . . . . . . 20.8 pt -62.92 164.47 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.256 1.409 0 O-C-N 123.891 0.744 . . . . 58.82 112.785 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1347 ' ' THR . . . . . . . . . . . . . 1.8 m -124.97 92.98 3.76 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 104.834 -2.284 . . . . 54.96 104.834 -176.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1348 ' ' VAL . . . . . . . . . . . . . 60.2 t -77.29 84.78 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 N-CA-C 105.201 -2.148 . . . . 55.64 105.201 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.67 126.63 30.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 124.113 1.911 . . . . 61.45 112.752 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -96.32 -5.48 39.95 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 118.182 2.66 . . . . 58.63 118.182 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -73.72 -39.89 63.98 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 118.351 -1.34 . . . . 62.06 110.095 172.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 17.3 t70 -70.57 112.5 6.87 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.038 -0.983 . . . . 54.07 112.144 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 15.8 m -59.51 -20.43 18.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 N-CA-C 116.33 1.974 . . . . 50.68 116.33 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1354 ' ' VAL . . . . . 0.576 ' O ' HG23 ' A' 1358 ' ' VAL . 0.9 OUTLIER -79.77 -47.39 21.83 Favored 'Isoleucine or valine' 0 C--N 1.343 0.317 0 CA-C-N 121.485 1.948 . . . . 47.68 105.778 177.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1355 ' ' ILE . . . . . . . . . . . . . 89.9 mt -64.65 -55.14 22.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 108.476 -0.935 . . . . 48.49 108.476 -177.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 34.0 tpt85 -45.36 -46.77 13.28 Favored 'General case' 0 C--O 1.255 1.379 0 O-C-N 124.123 0.889 . . . . 48.27 113.362 167.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -59.39 -51.03 61.57 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-O 117.563 -1.687 . . . . 43.53 111.882 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1358 ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' 1354 ' ' VAL . 17.5 t -63.37 -35.08 70.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 CA-C-N 118.808 1.304 . . . . 45.12 108.544 -175.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1359 ' ' THR . . . . . . . . . . . . . 18.1 m -75.84 93.84 3.24 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 123.959 1.838 . . . . 42.94 109.889 -176.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 16.6 m -80.02 -22.84 11.75 Favored 'Isoleucine or valine' 0 C--O 1.248 1.011 0 CA-C-N 110.998 -2.819 . . . . 43.26 113.858 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1361 ' ' ILE . . . . . . . . . . . . . 43.7 mt -137.11 119.39 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 N-CA-C 104.055 -2.572 . . . . 45.66 104.055 175.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1362 ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -106.92 113.28 26.67 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 104.311 -2.477 . . . . 61.34 104.311 170.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 32.95 77.38 0.03 OUTLIER 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 117.204 2.298 . . . . 49.76 117.204 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 86.52 -50.26 4.19 Favored Glycine 0 N--CA 1.481 1.685 0 CA-C-N 113.645 -1.616 . . . . 50.0 111.628 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -70.37 116.43 10.7 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 106.953 -1.499 . . . . 56.92 106.953 -176.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1366 ' ' ILE . . . . . . . . . . . . . 67.5 mt -72.83 101.57 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.066 0 CA-C-O 123.408 1.575 . . . . 52.78 109.006 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1367 ' ' THR . . . . . . . . . . . . . 10.9 p -92.94 10.49 31.02 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 112.857 -1.974 . . . . 49.44 116.16 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1368 ' ' TRP . . . . . 0.518 ' CD1' ' HA ' ' A' 1369 ' ' PRO . 1.9 t90 -58.82 145.77 77.66 Favored Pre-proline 0 C--O 1.254 1.333 0 O-C-N 117.972 -2.955 . . . . 52.38 105.683 163.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1369 ' ' PRO . . . . . 0.518 ' HA ' ' CD1' ' A' 1368 ' ' TRP . 42.0 Cg_endo -85.76 -175.0 11.55 Favored 'Cis proline' 0 C--O 1.211 -0.829 0 CA-C-N 123.983 2.458 . . . . 46.94 113.553 4.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -83.19 138.66 42.21 Favored Pre-proline 0 CA--C 1.545 0.756 0 O-C-N 124.065 0.853 . . . . 45.91 108.84 164.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1371 ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -58.3 135.29 67.1 Favored 'Trans proline' 0 C--N 1.351 0.678 1 C-N-CA 125.777 4.318 . . . . 46.39 111.509 177.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -59.03 -35.35 98.57 Favored 'Trans proline' 0 CA--C 1.549 1.241 1 C-N-CA 125.36 4.04 . . . . 46.72 116.653 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.233 -4.489 0 O-C-N 118.331 -2.731 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 15.9 m80 . . . . . 0 N--CA 1.432 -1.347 0 N-CA-C 108.174 -1.047 . . . . 63.44 108.174 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -77.44 76.65 3.98 Favored 'General case' 0 C--O 1.254 1.304 0 O-C-N 121.093 -1.005 . . . . 51.74 112.402 -177.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1000 ' ' HIS . . . . . 0.456 ' HA ' ' OE2' ' B' 1067 ' ' GLU . 12.0 t60 -72.55 118.38 15.38 Favored 'General case' 0 C--O 1.247 0.964 0 CA-C-O 122.694 1.235 . . . . 54.07 111.618 -166.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 64.27 27.11 71.11 Favored Glycine 0 C--O 1.209 -1.434 0 CA-C-O 123.46 1.589 . . . . 39.22 111.889 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1002 ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -97.21 134.52 40.42 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 105.515 -2.031 . . . . 38.12 105.515 173.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1003 ' ' ILE . . . . . 0.536 HD12 HG22 ' B' 1033 ' ' VAL . 57.1 mt -84.92 149.97 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 CA-C-N 112.023 -2.353 . . . . 29.7 105.89 170.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -118.71 131.39 9.12 Favored Glycine 0 CA--C 1.492 -1.404 0 N-CA-C 108.351 -1.9 . . . . 27.5 108.351 164.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1005 ' ' ILE . . . . . 0.683 HG23 ' HB3' ' B' 1017 ' ' ALA . 45.4 mm -102.69 110.08 62.4 Favored Pre-proline 0 C--N 1.313 -1.002 0 N-CA-C 104.852 -2.277 . . . . 24.83 104.852 172.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -83.83 155.0 13.4 Favored 'Trans proline' 0 C--O 1.238 0.514 0 C-N-CA 121.743 1.629 . . . . 27.19 111.966 173.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -77.39 114.97 16.77 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 112.031 -2.349 . . . . 41.46 106.013 169.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1008 ' ' GLU . . . . . 0.503 ' OE2' ' HG2' ' B' 1071 ' ' LYS . 25.4 mm-40 -51.43 164.77 0.18 Allowed 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 116.463 2.023 . . . . 26.93 116.463 -178.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1009 ' ' ARG . . . . . 0.428 ' NH2' ' HG2' ' B' 1079 ' ' GLU . 14.4 mtm180 -146.15 59.06 1.23 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 123.314 1.531 . . . . 34.48 108.566 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1010 ' ' LEU . . . . . 0.564 ' HB3' ' HB2' ' B' 1013 ' ' GLU . 17.9 tp -104.37 152.94 21.67 Favored 'General case' 0 N--CA 1.469 0.511 1 O-C-N 116.287 -4.008 . . . . 44.22 107.743 174.246 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B 1011 ' ' THR . . . . . . . . . . . . . 24.3 m -58.99 114.42 2.57 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 123.779 0.832 . . . . 40.74 109.107 167.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 47.6 t30 54.62 80.08 0.13 Allowed 'General case' 0 C--N 1.35 0.624 0 C-N-CA 125.271 1.428 . . . . 44.44 111.861 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1013 ' ' GLU . . . . . 0.564 ' HB2' ' HB3' ' B' 1010 ' ' LEU . 9.5 tp10 -147.29 141.54 26.21 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 123.817 1.77 . . . . 29.87 109.857 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1014 ' ' THR . . . . . 0.617 ' HB ' ' HB3' ' B' 1320 ' ' PRO . 0.2 OUTLIER -128.43 2.96 5.64 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 113.173 -1.83 . . . . 25.26 111.535 -178.756 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 65.4 mtm180 -76.95 145.29 38.23 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 123.925 1.821 . . . . 29.54 110.631 174.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1016 ' ' VAL . . . . . 0.633 HG21 ' HB1' ' B' 1039 ' ' ALA . 2.2 p -126.64 -175.96 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-N 114.45 -1.25 . . . . 23.55 109.161 161.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1017 ' ' ALA . . . . . 0.683 ' HB3' HG23 ' B' 1005 ' ' ILE . . . -93.64 7.95 42.76 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 115.339 1.607 . . . . 23.59 115.339 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1018 ' ' ALA . . . . . 0.487 ' H ' HG13 ' B' 1016 ' ' VAL . . . -164.75 147.55 8.58 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 114.608 1.336 . . . . 24.93 114.608 -177.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1019 ' ' THR . . . . . . . . . . . . . 68.7 p -98.91 172.77 4.4 Favored Pre-proline 0 C--O 1.242 0.688 0 N-CA-C 106.839 -1.541 . . . . 28.09 106.839 159.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -49.56 -51.28 11.05 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.404 3.402 . . . . 28.79 110.959 166.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 37.9 tttp -46.88 -48.29 21.19 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 123.533 2.879 . . . . 47.28 112.728 170.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1022 ' ' THR . . . . . 0.41 HG21 ' HA3' ' B' 1328 ' ' GLY . 3.4 m -62.45 -32.39 73.26 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 117.715 0.234 . . . . 30.12 111.071 -177.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1023 ' ' VAL . . . . . 0.5 HG13 ' HB ' ' B' 1033 ' ' VAL . 91.6 t -64.21 -48.82 83.96 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 O-C-N 120.514 -1.367 . . . . 32.24 108.109 176.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1024 ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' B' 1028 ' ' LYS . 31.3 mt-10 -60.36 -29.15 68.73 Favored 'General case' 0 C--O 1.246 0.921 0 O-C-N 121.937 -0.477 . . . . 49.62 111.305 176.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -66.44 -42.06 88.24 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-O 123.805 1.764 . . . . 44.68 113.034 176.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 34.2 mt -70.38 -37.8 74.62 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 113.71 -1.586 . . . . 35.71 109.392 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1027 ' ' LEU . . . . . 0.461 HD12 ' HA ' ' B' 1024 ' ' GLU . 63.4 mt -67.47 -26.8 66.55 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 115.599 -0.728 . . . . 42.18 111.179 174.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1028 ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' B' 1024 ' ' GLU . 65.1 mttm -61.01 -33.82 73.86 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.273 0.942 . . . . 48.34 111.99 169.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1029 ' ' LEU . . . . . 0.503 ' HB2' ' HD2' ' B' 1031 ' ' PHE . 7.8 mt -88.61 10.39 20.69 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 120.984 -1.072 . . . . 38.69 111.326 176.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 85.09 -10.45 63.24 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 116.169 1.228 . . . . 32.28 116.169 -175.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1031 ' ' PHE . . . . . 0.503 ' HD2' ' HB2' ' B' 1029 ' ' LEU . 66.4 m-85 -78.19 120.21 22.67 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 119.447 1.624 . . . . 35.94 112.659 -170.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1032 ' ' THR . . . . . . . . . . . . . 34.8 m -73.74 132.51 42.72 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 106.596 -1.631 . . . . 33.37 106.596 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1033 ' ' VAL . . . . . 0.536 HG22 HD12 ' B' 1003 ' ' ILE . 16.9 t -117.63 128.93 74.76 Favored 'Isoleucine or valine' 0 C--O 1.249 1.028 0 O-C-N 119.489 -2.007 . . . . 29.98 108.662 -171.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -108.56 143.61 37.36 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.31 -0.859 . . . . 28.18 110.228 166.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1035 ' ' VAL . . . . . 0.432 HG23 ' HB1' ' B' 1055 ' ' ALA . 57.6 t -125.57 131.35 72.2 Favored 'Isoleucine or valine' 0 C--N 1.372 1.552 0 N-CA-C 108.107 -1.071 . . . . 25.82 108.107 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1036 ' ' GLU . . . . . 0.449 ' HB2' HG11 ' B' 1063 ' ' VAL . 30.5 tt0 -73.3 143.16 47.08 Favored 'General case' 0 C--O 1.252 1.223 0 O-C-N 120.455 -1.403 . . . . 32.44 108.996 177.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1037 ' ' SER . . . . . 0.586 ' H ' ' HG3' ' B' 1059 ' ' GLU . 1.2 m -65.95 137.98 57.51 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 119.612 -1.93 . . . . 29.54 111.64 174.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 103.09 -22.08 37.85 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 124.844 1.34 . . . . 27.76 111.165 -175.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1039 ' ' ALA . . . . . 0.633 ' HB1' HG21 ' B' 1016 ' ' VAL . . . -65.46 -40.14 92.84 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 123.089 0.555 . . . . 26.02 110.428 174.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -55.05 -51.71 51.96 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 124.445 1.091 . . . . 26.47 112.093 169.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.19 -28.71 68.18 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 113.745 1.017 . . . . 50.98 113.745 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1042 ' ' LEU . . . . . 0.584 HD22 ' HA ' ' B' 1014 ' ' THR . 76.9 mt -67.63 -52.68 35.38 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 119.951 1.251 . . . . 29.3 109.092 168.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1043 ' ' ALA . . . . . 0.51 ' HB2' HG12 ' B' 1016 ' ' VAL . . . -72.26 29.81 0.05 Allowed 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 118.014 2.598 . . . . 26.74 118.014 174.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1044 ' ' SER . . . . . . . . . . . . . 28.4 m 47.66 36.51 5.6 Favored 'General case' 0 C--N 1.358 0.951 0 N-CA-C 117.713 2.486 . . . . 31.26 117.713 -173.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1045 ' ' PHE . . . . . 0.451 ' CD1' ' HB3' ' A' 1277 ' ' ALA . 0.8 OUTLIER -130.06 163.5 26.39 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 124.112 1.91 . . . . 33.26 112.626 -173.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 3.3 t70 -67.84 139.84 56.56 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 114.548 -1.205 . . . . 46.74 109.525 158.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -68.42 -36.59 79.3 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 121.057 1.753 . . . . 34.44 111.259 174.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1048 ' ' LYS . . . . . 0.427 ' O ' HG12 ' B' 1051 ' ' VAL . 0.1 OUTLIER -70.97 -15.08 62.56 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.463 0.649 . . . . 48.67 112.652 -175.011 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -58.56 -37.04 74.9 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 119.234 -2.166 . . . . 35.26 111.122 165.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1050 ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -65.29 -33.57 76.28 Favored 'General case' 0 CA--C 1.563 1.451 0 CA-C-O 117.843 -1.075 . . . . 32.17 111.725 170.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1051 ' ' VAL . . . . . 0.427 HG12 ' O ' ' B' 1048 ' ' LYS . 0.3 OUTLIER -68.1 -30.28 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 121.404 1.911 . . . . 38.37 108.702 176.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -63.59 -38.46 91.22 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.222 0.919 . . . . 45.77 109.883 173.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -76.97 -21.66 54.39 Favored 'General case' 0 C--N 1.36 1.065 0 CA-C-O 121.557 0.694 . . . . 37.83 112.685 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 118.73 31.12 1.52 Allowed Glycine 0 C--O 1.215 -1.07 0 O-C-N 120.515 -1.366 . . . . 35.82 113.346 176.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1055 ' ' ALA . . . . . 0.432 ' HB1' HG23 ' B' 1035 ' ' VAL . . . -102.05 135.73 43.12 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 123.175 1.464 . . . . 33.77 109.558 178.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -75.4 105.5 6.46 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 106.374 -1.713 . . . . 51.02 106.374 174.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1057 ' ' ILE . . . . . . . . . . . . . 37.5 mm -77.64 85.62 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 O-C-N 120.476 -1.39 . . . . 38.47 107.597 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1058 ' ' VAL . . . . . 0.469 ' O ' ' HB ' ' B' 1063 ' ' VAL . 3.5 m -117.98 123.7 72.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 125.038 1.461 . . . . 39.4 110.712 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1059 ' ' GLU . . . . . 0.586 ' HG3' ' H ' ' B' 1037 ' ' SER . 5.4 mp0 -90.58 155.77 18.63 Favored 'General case' 0 C--O 1.248 1.01 0 O-C-N 120.758 -1.214 . . . . 57.07 110.274 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1060 ' ' GLY . . . . . 0.408 ' O ' HG12 ' B' 1063 ' ' VAL . . . 65.23 -145.61 49.2 Favored Glycine 0 C--O 1.21 -1.375 0 CA-C-N 113.405 -1.725 . . . . 44.83 114.23 169.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 5.4 m120 -55.31 -20.26 10.93 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 115.586 1.699 . . . . 46.27 115.586 -177.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1062 ' ' SER . . . . . . . . . . . . . 28.9 m -59.54 -50.73 72.78 Favored 'General case' 0 CA--C 1.489 -1.395 0 O-C-N 120.166 -1.584 . . . . 43.47 111.9 164.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1063 ' ' VAL . . . . . 0.469 ' HB ' ' O ' ' B' 1058 ' ' VAL . 0.8 OUTLIER -65.41 -38.42 82.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 120.61 1.55 . . . . 36.98 109.91 177.55 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 98.9 m95 -66.48 -21.47 66.19 Favored 'General case' 0 C--O 1.269 2.108 0 N-CA-C 114.936 1.458 . . . . 37.9 114.936 178.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -83.74 90.25 7.29 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 104.687 -2.338 . . . . 46.19 104.687 169.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1066 ' ' SER . . . . . . . . . . . . . 73.4 m -154.36 150.88 28.41 Favored 'General case' 0 CA--C 1.49 -1.335 0 CA-C-N 113.213 -1.812 . . . . 37.06 108.512 176.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1067 ' ' GLU . . . . . 0.456 ' OE2' ' HA ' ' B' 1000 ' ' HIS . 78.4 mt-10 -79.3 -17.87 53.78 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 120.799 -1.188 . . . . 43.95 113.783 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1068 ' ' ILE . . . . . . . . . . . . . 3.1 mp -126.67 143.99 38.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 103.233 -2.877 . . . . 33.5 103.233 173.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 16.5 mm -122.9 105.59 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 102.245 -3.243 . . . . 30.57 102.245 165.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1070 ' ' LEU . . . . . 0.805 ' HB3' HD13 ' B' 1331 ' ' LEU . 81.5 mt -86.7 122.27 30.37 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 101.975 -3.343 . . . . 27.66 101.975 176.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1071 ' ' LYS . . . . . 0.503 ' HG2' ' OE2' ' B' 1008 ' ' GLU . 34.0 tttm -146.58 158.21 43.86 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 108.255 -1.017 . . . . 28.4 108.255 -169.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1072 ' ' VAL . . . . . 0.471 ' HA ' ' CZ ' ' B' 1327 ' ' TYR . 58.7 t -90.82 -77.0 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 108.481 -0.933 . . . . 23.18 108.481 -176.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1073 ' ' ASN . . . . . 0.441 HD21 ' HG2' ' B' 1013 ' ' GLU . 62.8 m-80 -93.89 146.07 24.17 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 108.178 -1.045 . . . . 25.47 108.178 -165.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1074 ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' B' 1092 ' ' PHE . . . -50.11 115.38 5.28 Favored Pre-proline 0 C--O 1.249 1.028 0 N-CA-C 114.386 1.254 . . . . 27.9 114.386 -174.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1075 ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' B' 1074 ' ' ALA . 35.8 Cg_endo -43.57 136.67 6.32 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.26 3.307 . . . . 31.62 115.587 -173.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1076 ' ' LEU . . . . . 0.41 ' O ' HG13 ' B' 1080 ' ' ILE . 13.3 mt -69.75 166.79 18.51 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 112.047 -2.342 . . . . 40.49 107.905 173.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1077 ' ' ASP . . . . . 0.598 ' HA ' HD12 ' B' 1080 ' ' ILE . 27.7 t70 -58.76 -35.83 73.4 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 119.315 -0.954 . . . . 51.59 110.065 -174.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.39 -39.47 81.69 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 122.307 1.051 . . . . 42.36 109.549 -178.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1079 ' ' GLU . . . . . 0.468 ' HA ' HD12 ' B' 1082 ' ' LEU . 27.9 mt-10 -68.11 -27.25 66.3 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 113.678 -1.601 . . . . 34.53 109.636 175.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1080 ' ' ILE . . . . . 0.598 HD12 ' HA ' ' B' 1077 ' ' ASP . 88.3 mt -70.84 -37.75 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 120.461 1.482 . . . . 33.25 108.071 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -64.84 -46.99 79.58 Favored 'General case' 0 C--O 1.247 0.959 0 N-CA-C 109.822 -0.436 . . . . 36.47 109.822 174.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1082 ' ' LEU . . . . . 0.468 HD12 ' HA ' ' B' 1079 ' ' GLU . 33.0 mt -53.96 -44.96 71.18 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 125.119 1.368 . . . . 37.76 113.314 177.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1083 ' ' LEU . . . . . 0.583 ' HB3' HG11 ' B' 1110 ' ' VAL . 9.6 mt -57.89 125.09 21.55 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 122.396 1.093 . . . . 37.43 109.9 175.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -96.17 147.09 32.43 Favored Pre-proline 0 N--CA 1.438 -1.073 0 CA-C-N 114.279 -1.328 . . . . 37.7 108.522 -172.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -51.93 122.6 10.77 Favored 'Trans proline' 0 N--CA 1.451 -0.996 1 C-N-CA 126.114 4.543 . . . . 35.51 114.319 -178.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 98.22 -15.16 61.74 Favored Glycine 0 N--CA 1.466 0.678 0 CA-C-N 113.123 -1.853 . . . . 33.87 113.003 176.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1087 ' ' THR . . . . . . . . . . . . . 29.3 m -63.02 133.14 54.1 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 124.515 2.103 . . . . 32.5 111.299 174.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1088 ' ' THR . . . . . 0.677 ' HA ' ' HB ' ' B' 1111 ' ' THR . 4.8 m -74.42 92.53 2.33 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 113.233 -1.803 . . . . 30.22 111.059 176.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1089 ' ' LEU . . . . . 0.475 HD13 HD11 ' B' 1083 ' ' LEU . 14.2 tp -76.89 119.69 20.99 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 122.374 1.083 . . . . 27.24 108.721 171.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 24.8 t -112.95 122.61 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 107.304 -1.369 . . . . 25.39 107.304 171.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1091 ' ' SER . . . . . 0.42 ' OG ' ' HB3' ' B' 1071 ' ' LYS . 69.0 m -157.58 165.38 35.69 Favored 'General case' 0 CA--C 1.504 -0.799 0 O-C-N 120.122 -1.611 . . . . 28.81 109.995 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1092 ' ' PHE . . . . . 0.449 ' O ' ' HB2' ' B' 1074 ' ' ALA . 2.2 m-85 -62.53 96.35 0.08 Allowed 'General case' 0 N--CA 1.466 0.351 0 O-C-N 119.374 -2.078 . . . . 30.78 107.978 159.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1093 ' ' ILE . . . . . 0.407 ' CD1' ' HB2' ' B' 1091 ' ' SER . 44.0 mm -88.63 -27.7 5.4 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.184 0 O-C-N 121.087 -1.008 . . . . 30.28 112.683 -174.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1094 ' ' TRP . . . . . . . . . . . . . 76.1 m95 50.37 54.7 15.98 Favored Pre-proline 0 C--N 1.321 -0.654 0 O-C-N 124.486 1.116 . . . . 34.07 113.957 -177.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -41.5 -56.26 1.9 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 1 C-N-CA 125.776 4.317 . . . . 38.66 117.607 -164.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -66.99 -38.56 86.26 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 121.015 1.734 . . . . 41.32 111.826 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -68.61 -22.46 64.43 Favored 'General case' 0 C--O 1.209 -1.051 0 CA-C-N 113.644 -1.616 . . . . 51.66 111.199 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1098 ' ' ASN . . . . . 0.567 ' HB3' ' HB2' ' B' 1101 ' ' LEU . 96.0 m-20 -126.25 68.84 66.69 Favored Pre-proline 0 N--CA 1.439 -0.987 0 O-C-N 120.364 -1.46 . . . . 40.32 109.94 -174.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -64.94 -62.18 0.09 OUTLIER 'Trans proline' 0 CA--C 1.559 1.756 0 C-N-CA 124.112 3.208 . . . . 41.56 109.85 -174.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -51.87 -44.0 63.5 Favored 'General case' 0 C--N 1.374 1.664 0 N-CA-C 114.101 1.149 . . . . 54.11 114.101 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1101 ' ' LEU . . . . . 0.567 ' HB2' ' HB3' ' B' 1098 ' ' ASN . 9.1 mp -58.36 -48.16 81.46 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.472 -0.767 . . . . 37.88 110.034 175.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1102 ' ' MET . . . . . . . . . . . . . 39.6 mmm -57.19 -43.1 82.39 Favored 'General case' 0 C--O 1.241 0.607 0 O-C-N 121.459 -0.775 . . . . 37.54 112.446 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -71.62 -41.8 68.45 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 107.798 -1.186 . . . . 47.01 107.798 -171.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1104 ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -61.94 -40.73 96.51 Favored 'General case' 0 C--O 1.262 1.759 0 N-CA-C 114.849 1.425 . . . . 48.68 114.849 175.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1105 ' ' LEU . . . . . 0.479 ' HB3' HG21 ' B' 1112 ' ' VAL . 61.6 mt -64.98 -37.79 88.83 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.779 1.231 . . . . 32.21 111.16 173.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -60.72 -45.78 92.91 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 117.524 -1.226 . . . . 33.73 113.138 172.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -55.98 -44.6 78.71 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 122.379 1.085 . . . . 51.47 112.296 171.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1108 ' ' ARG . . . . . 0.426 ' HG3' HG22 ' B' 1080 ' ' ILE . 24.1 mmm180 -69.51 -6.49 30.99 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 120.747 -1.221 . . . . 43.9 113.205 178.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1109 ' ' ASN . . . . . 0.463 ' HA ' ' HA2' ' B' 1364 ' ' GLY . 13.7 m-80 62.15 27.6 16.61 Favored 'General case' 0 CA--C 1.486 -1.493 0 N-CA-C 114.084 1.142 . . . . 44.82 114.084 170.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1110 ' ' VAL . . . . . 0.583 HG11 ' HB3' ' B' 1083 ' ' LEU . 11.1 m -84.06 154.18 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 113.516 0.932 . . . . 30.52 113.516 174.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1111 ' ' THR . . . . . 0.677 ' HB ' ' HA ' ' B' 1088 ' ' THR . 4.1 m -86.59 90.85 8.38 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 120.749 -1.219 . . . . 27.12 109.22 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1112 ' ' VAL . . . . . 0.479 HG21 ' HB3' ' B' 1105 ' ' LEU . 41.0 t -91.51 125.02 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 124.738 1.274 . . . . 26.4 112.644 -168.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1113 ' ' MET . . . . . 0.679 ' SD ' HD21 ' B' 1334 ' ' LEU . 59.2 mtp -123.18 127.62 48.91 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 104.301 -2.481 . . . . 42.92 104.301 -176.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -101.56 113.1 25.93 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 122.918 1.342 . . . . 24.15 112.2 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1115 ' ' MET . . . . . 0.479 ' HB3' ' HB2' ' B' 1129 ' ' ALA . 24.0 mmm -66.81 -21.16 66.05 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 113.395 -1.729 . . . . 29.95 115.318 -173.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1116 ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -81.02 -52.65 7.19 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 111.253 -2.703 . . . . 34.53 112.793 172.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1117 ' ' SER . . . . . . . . . . . . . 57.8 m -90.11 68.22 7.09 Favored 'General case' 0 C--O 1.242 0.684 0 O-C-N 118.826 -2.421 . . . . 33.49 112.021 -171.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1118 ' ' VAL . . . . . . . . . . . . . 1.8 t -94.87 131.18 30.94 Favored Pre-proline 0 N--CA 1.467 0.376 0 CA-C-N 112.967 -1.924 . . . . 34.02 106.3 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1119 ' ' PRO . . . . . 0.552 ' HG2' ' HA3' ' B' 1357 ' ' GLY . 86.8 Cg_exo -62.34 115.41 2.85 Favored 'Trans proline' 0 C--O 1.249 1.038 1 C-N-CA 125.711 4.274 . . . . 38.28 112.321 175.204 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B 1120 ' ' ARG . . . . . 0.42 HH12 ' CG ' ' B' 1128 ' ' ASP . 7.8 mmt180 -82.19 86.81 6.58 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 122.367 1.079 . . . . 55.05 112.74 -166.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1121 ' ' ILE . . . . . 0.519 HG12 HD11 ' B' 1373 ' ' ILE . 11.1 pt -123.16 142.73 38.71 Favored 'Isoleucine or valine' 0 C--O 1.256 1.41 0 N-CA-C 101.351 -3.574 . . . . 42.09 101.351 151.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1122 ' ' SER . . . . . 0.679 ' HB2' ' HA ' ' C' ' 133' ' ' MET . 2.5 m -37.05 -43.55 0.48 Allowed 'General case' 0 C--O 1.243 0.761 0 N-CA-C 121.466 3.876 . . . . 38.02 121.466 -161.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1123 ' ' ARG . . . . . 0.515 ' HG3' HG21 ' B' 1354 ' ' VAL . 20.8 ptt-85 -47.9 -31.26 4.93 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 121.364 1.893 . . . . 34.29 115.549 175.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1124 ' ' ALA . . . . . . . . . . . . . . . -43.13 -47.53 6.15 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 114.623 1.342 . . . . 32.35 114.623 169.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1125 ' ' GLN . . . . . 0.454 ' HA ' ' HB3' ' B' 1128 ' ' ASP . 30.1 mm100 -52.5 -26.56 13.35 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 116.511 2.041 . . . . 47.17 116.511 -178.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1126 ' ' SER . . . . . . . . . . . . . 47.3 p -71.27 -32.25 68.48 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 124.135 1.922 . . . . 31.71 110.968 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1127 ' ' LEU . . . . . . . . . . . . . 4.3 mp -88.12 -32.02 18.89 Favored 'General case' 0 C--N 1.356 0.888 0 CA-C-N 113.949 -1.478 . . . . 37.0 110.268 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1128 ' ' ASP . . . . . 0.454 ' HB3' ' HA ' ' B' 1125 ' ' GLN . 14.7 t0 -58.73 103.87 0.19 Allowed 'General case' 0 CA--C 1.505 -0.773 0 O-C-N 120.291 -1.506 . . . . 40.4 113.114 -173.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1129 ' ' ALA . . . . . 0.479 ' HB2' ' HB3' ' B' 1115 ' ' MET . . . -63.86 -29.13 70.35 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 111.911 -2.404 . . . . 26.56 113.862 175.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 53.8 mt -67.95 -31.47 71.24 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-O 117.295 -1.336 . . . . 30.89 110.66 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1131 ' ' SER . . . . . 0.42 ' HB3' ' NE2' ' B' 1125 ' ' GLN . 84.0 p -60.16 -53.14 61.21 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 122.301 2.319 . . . . 29.84 110.608 175.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1132 ' ' SER . . . . . 0.454 ' HB3' ' HB3' ' B' 1326 ' ' LEU . 51.7 m -57.93 -49.46 76.68 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 113.451 0.908 . . . . 31.91 113.451 176.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1133 ' ' MET . . . . . . . . . . . . . 32.7 mmt -63.84 -37.63 88.09 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 122.678 1.227 . . . . 25.9 110.667 -175.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1134 ' ' ALA . . . . . 0.864 ' HB1' ' HB2' ' B' 1176 ' ' ALA . . . -62.98 -48.12 80.24 Favored 'General case' 0 N--CA 1.426 -1.64 0 O-C-N 121.139 -0.976 . . . . 26.62 110.097 171.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -51.23 -51.28 55.46 Favored 'General case' 0 C--N 1.35 0.607 0 C-N-CA 125.287 1.435 . . . . 36.97 112.247 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1136 ' ' ILE . . . . . 0.536 HG21 ' HA ' ' B' 1316 ' ' PRO . 29.7 mm -50.25 -58.62 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 C-N-CA 124.938 1.295 . . . . 32.11 108.893 169.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -58.92 -30.14 67.61 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 119.077 -0.487 . . . . 24.14 110.053 -175.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1138 ' ' GLY . . . . . 0.423 ' HA2' HD21 ' B' 1284 ' ' LEU . . . -66.3 -57.38 10.51 Favored Glycine 0 N--CA 1.479 1.555 0 N-CA-C 109.777 -1.329 . . . . 25.13 109.777 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 53.4 t80 -55.65 -47.21 77.06 Favored 'General case' 0 C--O 1.204 -1.32 0 CA-C-N 117.9 0.85 . . . . 32.73 111.706 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1140 ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -67.65 -23.43 65.34 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 116.975 -1.488 . . . . 26.36 110.848 -178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1141 ' ' ALA . . . . . 0.43 ' HB1' HG21 ' B' 1282 ' ' VAL . . . -64.22 -45.33 88.74 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 122.126 2.239 . . . . 24.12 111.152 171.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1142 ' ' ILE . . . . . 0.584 HG13 ' HB3' ' B' 1183 ' ' ALA . 49.4 mm -60.49 -44.76 97.1 Favored 'Isoleucine or valine' 0 C--O 1.247 0.937 0 CA-C-N 115.718 -0.674 . . . . 23.37 110.323 176.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 98.0 t -53.83 -69.99 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 114.607 1.336 . . . . 24.96 114.607 171.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1144 ' ' GLU . . . . . 0.48 ' HG3' ' HE2' ' B' 1312 ' ' TYR . 43.9 mm-40 -59.12 -27.78 65.92 Favored 'General case' 0 C--O 1.243 0.736 0 O-C-N 121.724 -0.61 . . . . 32.07 111.922 -176.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1145 ' ' ALA . . . . . 0.881 ' HB1' HD12 ' B' 1251 ' ' ILE . . . -58.95 -63.89 1.14 Allowed 'General case' 0 C--O 1.246 0.883 0 CA-C-O 117.459 -1.258 . . . . 24.87 108.202 169.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1146 ' ' ALA . . . . . . . . . . . . . . . -58.68 -20.33 47.53 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 121.474 1.943 . . . . 24.67 115.326 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1147 ' ' HIS . . . . . 0.471 ' HB3' ' O ' ' B' 1144 ' ' GLU . 74.9 t60 -62.39 -63.72 1.15 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.254 1.421 . . . . 28.58 107.674 170.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1148 ' ' GLU . . . . . 0.565 ' HB2' HD11 ' B' 1310 ' ' ILE . 59.2 mm-40 -87.83 -1.65 58.11 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 118.663 2.838 . . . . 36.82 118.663 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1149 ' ' PHE . . . . . 0.441 ' HE1' ' NH2' ' B' 1151 ' ' ARG . 2.7 t80 -69.22 141.65 54.43 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 122.801 1.286 . . . . 31.97 110.77 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1150 ' ' GLY . . . . . . . . . . . . . . . -66.79 -34.72 88.15 Favored Glycine 0 CA--C 1.536 1.36 0 CA-C-O 118.599 -1.111 . . . . 25.49 112.461 175.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1151 ' ' ARG . . . . . 0.461 ' HA ' ' HB2' ' A' 1322 ' ' GLN . 71.6 mtm-85 -122.77 177.46 5.46 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 120.773 2.287 . . . . 59.84 109.6 -157.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1152 ' ' PHE . . . . . 0.968 ' HB2' HG11 ' B' 1163 ' ' VAL . 7.7 m-30 -78.67 156.8 28.82 Favored 'General case' 0 C--O 1.25 1.111 0 CA-C-N 119.79 1.177 . . . . 34.45 108.69 167.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1153 ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -68.03 -50.8 53.16 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.441 1.591 . . . . 31.17 108.865 163.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1154 ' ' THR . . . . . . . . . . . . . 2.8 m -61.74 124.32 20.41 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 113.264 -1.789 . . . . 33.89 115.618 -175.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -74.08 69.78 1.58 Allowed Glycine 0 N--CA 1.442 -0.948 0 O-C-N 120.942 -1.098 . . . . 38.95 110.738 175.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1156 ' ' GLN . . . . . 0.483 ' H ' ' HB ' ' B' 1163 ' ' VAL . 18.1 tt0 -99.57 133.02 44.5 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-O 123.436 1.589 . . . . 54.23 112.291 -168.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 20.6 mm -85.77 99.92 8.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 101.191 -3.633 . . . . 51.16 101.191 173.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1158 ' ' THR . . . . . . . . . . . . . 6.4 m -110.63 101.58 10.22 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.592 -1.186 . . . . 49.61 108.809 -171.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . 27.31 -71.41 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 120.28 3.437 . . . . 49.05 120.28 -175.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1160 ' ' ALA . . . . . 0.539 ' HB2' ' ND2' ' A' 1330 ' ' ASN . . . -69.13 -48.87 61.26 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 125.272 1.429 . . . . 47.65 112.926 175.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . -137.05 -171.56 12.23 Favored Glycine 0 C--O 1.243 0.663 0 CA-C-N 121.856 2.116 . . . . 45.61 111.283 -170.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 92.0 mttt -111.58 139.22 47.2 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 111.595 -2.303 . . . . 57.46 109.052 175.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1163 ' ' VAL . . . . . 0.968 HG11 ' HB2' ' B' 1152 ' ' PHE . 74.4 t -98.96 130.91 26.48 Favored Pre-proline 0 N--CA 1.426 -1.662 0 CA-C-O 116.691 -1.623 . . . . 42.93 108.05 170.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1164 ' ' PRO . . . . . 0.506 ' HA ' ' HD3' ' B' 1165 ' ' PRO . 73.0 Cg_endo -69.78 140.2 42.02 Favored 'Trans proline' 0 N--CA 1.441 -1.609 0 C-N-CA 123.715 2.943 . . . . 39.29 110.432 171.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1165 ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' B' 1164 ' ' PRO . 70.4 Cg_exo -66.78 115.51 3.62 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 123.185 2.59 . . . . 34.17 111.72 178.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -64.49 125.59 25.16 Favored 'General case' 0 C--N 1.355 0.837 0 CA-C-N 119.496 1.044 . . . . 31.69 112.875 -177.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1167 ' ' LYS . . . . . 0.625 ' HB2' ' HA ' ' B' 1249 ' ' VAL . 77.4 mttt -90.94 115.12 27.72 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 104.205 -2.517 . . . . 44.78 104.205 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 85.4 t -104.41 96.25 4.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 O-C-N 120.507 -1.371 . . . . 31.23 108.627 -174.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1169 ' ' MET . . . . . 0.833 ' HB2' HG11 ' B' 1249 ' ' VAL . 57.1 ttp -77.36 94.85 4.28 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 122.63 1.205 . . . . 37.09 110.697 177.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1170 ' ' VAL . . . . . 0.471 HG22 ' HB ' ' B' 1253 ' ' VAL . 92.8 t -81.26 115.88 24.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 N-CA-C 107.075 -1.454 . . . . 30.17 107.075 175.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1171 ' ' ILE . . . . . 0.519 HG22 ' HB2' ' B' 1256 ' ' ALA . 84.0 mt -98.85 112.76 31.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 104.456 -2.424 . . . . 33.74 104.456 174.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 98.19 91.39 1.95 Allowed Glycine 0 CA--C 1.486 -1.78 0 CA-C-N 113.547 -1.66 . . . . 32.59 109.166 175.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1173 ' ' ALA . . . . . 0.474 ' H ' ' HB2' ' B' 1195 ' ' ASP . . . -75.68 61.28 1.35 Allowed 'General case' 0 C--O 1.253 1.251 0 CA-C-O 123.46 1.6 . . . . 32.42 112.095 174.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -78.48 -170.06 36.54 Favored Glycine 0 C--O 1.224 -0.502 0 O-C-N 120.745 -1.222 . . . . 31.74 110.063 170.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 36.5 t -56.44 -44.98 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-N 119.224 1.512 . . . . 31.48 111.031 174.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1176 ' ' ALA . . . . . 0.864 ' HB2' ' HB1' ' B' 1134 ' ' ALA . . . -55.19 -50.25 69.85 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 123.856 0.862 . . . . 26.12 112.136 172.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1177 ' ' GLY . . . . . . . . . . . . . . . -54.56 -47.39 70.3 Favored Glycine 0 C--N 1.344 1.01 0 O-C-N 125.008 1.442 . . . . 25.73 109.574 178.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1178 ' ' LEU . . . . . 0.478 ' HA ' HD12 ' B' 1181 ' ' ILE . 81.3 mt -66.57 -34.94 79.01 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.778 -1.424 . . . . 32.59 112.684 -173.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -71.73 -33.93 69.13 Favored 'General case' 0 C--N 1.351 0.674 0 O-C-N 120.452 -1.405 . . . . 27.72 112.26 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -67.16 -42.58 84.08 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 123.044 1.402 . . . . 26.03 110.348 172.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1181 ' ' ILE . . . . . 0.752 HG22 ' HG2' ' B' 1207 ' ' MET . 60.0 mt -58.71 -45.82 90.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 O-C-N 119.6 -1.937 . . . . 28.61 112.314 174.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -53.94 -55.08 27.62 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-N 115.105 -0.952 . . . . 25.23 111.942 172.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1183 ' ' ALA . . . . . 0.584 ' HB3' HG13 ' B' 1142 ' ' ILE . . . -60.31 -50.05 75.18 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.985 1.393 . . . . 24.09 113.265 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -69.58 -33.78 73.2 Favored 'General case' 0 C--O 1.241 0.636 0 O-C-N 121.401 -0.812 . . . . 26.68 110.404 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -68.71 -41.11 79.55 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 120.379 -1.45 . . . . 36.57 111.027 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1186 ' ' SER . . . . . 0.846 ' HB3' ' HA ' ' A' 1187 ' ' LEU . 70.7 m -51.62 -44.36 62.87 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 122.211 1.005 . . . . 28.92 113.497 163.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1187 ' ' LEU . . . . . . . . . . . . . 74.7 mt -78.92 -1.76 36.71 Favored 'General case' 0 N--CA 1.433 -1.298 0 O-C-N 119.893 -1.754 . . . . 29.09 113.92 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 71.17 42.19 58.63 Favored Glycine 0 C--O 1.219 -0.817 0 O-C-N 120.746 -1.221 . . . . 29.26 111.961 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1189 ' ' ALA . . . . . . . . . . . . 0.251 . . -104.59 154.06 20.41 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.491 -0.559 . . . . 30.16 109.491 172.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1190 ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' B' 1167 ' ' LYS . 65.1 mt -81.11 93.37 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 O-C-N 119.726 -1.859 . . . . 35.81 108.389 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1191 ' ' VAL . . . . . 0.437 HG11 HG12 ' B' 1181 ' ' ILE . 4.4 t -78.4 125.57 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.289 -1.004 . . . . 31.97 108.289 -178.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1192 ' ' ARG . . . . . 0.512 HH12 ' CD ' ' B' 1248 ' ' GLU . 27.0 mmt85 -112.33 94.44 4.93 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 106.081 -1.822 . . . . 48.16 106.081 177.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -103.78 133.34 48.93 Favored 'General case' 0 C--N 1.355 0.845 0 O-C-N 119.223 -2.173 . . . . 35.89 115.044 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 38.4 t80 -108.16 156.46 19.29 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 105.02 -2.215 . . . . 41.88 105.02 176.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1195 ' ' ASP . . . . . 0.474 ' HB2' ' H ' ' B' 1173 ' ' ALA . 7.5 t70 -167.23 146.69 5.22 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 113.371 -1.741 . . . . 38.28 107.949 163.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1196 ' ' THR . . . . . . . . . . . . . 2.7 p -68.27 -31.49 70.98 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 115.474 1.657 . . . . 40.62 115.474 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1197 ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -79.02 139.85 57.29 Favored Pre-proline 0 C--N 1.304 -1.391 0 CA-C-O 122.341 1.067 . . . . 53.09 110.928 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -69.09 -37.33 10.94 Favored 'Trans proline' 0 C--O 1.236 0.414 0 N-CA-C 117.991 2.266 . . . . 42.56 117.991 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -30.28 71.47 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 122.286 2.312 . . . . 56.31 116.514 -170.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1200 ' ' VAL . . . . . 0.537 ' HA ' ' HG2' ' B' 1203 ' ' GLN . 2.1 m -63.99 -29.07 46.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 114.654 -1.157 . . . . 42.91 113.201 174.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 41.6 tttm -43.03 -56.57 3.27 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 115.711 1.745 . . . . 48.89 115.711 175.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -56.75 -37.99 71.8 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.604 -1.18 . . . . 51.7 112.824 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1203 ' ' GLN . . . . . 0.604 ' OE1' ' HA ' ' C' ' 74' ' ' ARG . 47.3 mm-40 -60.19 -52.07 66.88 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 109.187 -0.671 . . . . 52.57 109.187 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1204 ' ' VAL . . . . . 0.488 HG22 HD13 ' B' 1181 ' ' ILE . 99.7 t -61.79 -47.57 92.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 O-C-N 125.561 1.788 . . . . 33.79 110.671 -174.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -53.41 -49.34 67.5 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 125.366 1.466 . . . . 36.58 111.025 175.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1206 ' ' SER . . . . . . . . . . . . . 18.8 m -80.01 -3.38 48.2 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 114.149 1.166 . . . . 39.61 114.149 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1207 ' ' MET . . . . . 0.752 ' HG2' HG22 ' B' 1181 ' ' ILE . 9.1 tpt -79.21 -22.38 44.95 Favored 'General case' 0 CA--C 1.511 -0.523 0 O-C-N 120.911 -1.118 . . . . 37.45 111.019 163.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 96.23 41.59 3.69 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 119.777 -1.827 . . . . 31.87 109.522 -173.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -144.95 142.79 30.13 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 123.759 0.824 . . . . 35.4 111.831 -171.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -80.74 130.69 35.22 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.981 -0.748 . . . . 47.89 108.981 -173.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 53.2 t80 -96.77 110.84 23.23 Favored 'General case' 0 C--O 1.247 0.925 0 N-CA-C 105.967 -1.864 . . . . 45.53 105.967 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1212 ' ' LEU . . . . . . . . . . . . . 78.6 mt -70.66 129.68 39.8 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 105.107 -2.182 . . . . 46.33 105.107 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -115.28 164.55 14.07 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 114.603 -1.18 . . . . 60.41 111.246 -170.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 4.9 mp -70.57 137.69 50.29 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-O 121.228 0.537 . . . . 57.38 109.875 -167.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1215 ' ' ASP . . . . . 0.885 ' HB3' ' HB1' ' B' 1237 ' ' ALA . 19.5 t70 . . . . . 0 N--CA 1.476 0.84 0 O-C-N 120.697 -1.252 . . . . 65.07 111.066 -169.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1230 ' ' MET . . . . . 0.493 ' HA ' ' HB2' ' B' 1231 ' ' SER . 28.5 mmt . . . . . 0 N--CA 1.422 -1.865 0 N-CA-C 109.654 -0.499 . . . . 80.32 109.654 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1231 ' ' SER . . . . . 0.493 ' HB2' ' HA ' ' B' 1230 ' ' MET . 40.0 m 70.05 174.51 0.29 Allowed 'General case' 0 N--CA 1.476 0.853 2 O-C-N 112.163 -6.586 . . . . 79.92 117.433 -1.584 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -114.3 -117.37 0.32 Allowed 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 105.254 -2.128 . . . . 77.91 105.254 175.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 57.99 -60.51 0.03 OUTLIER 'General case' 0 C--O 1.241 0.649 0 CA-C-N 123.073 2.669 . . . . 73.88 116.132 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.41 -26.3 66.59 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 120.218 1.372 . . . . 68.98 112.0 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 37.3 pt -31.27 -44.91 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.247 0.931 0 N-CA-C 116.056 1.873 . . . . 64.53 116.056 164.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -63.69 -39.17 93.65 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-O 121.336 0.589 . . . . 66.36 109.656 -177.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1237 ' ' ALA . . . . . 0.885 ' HB1' ' HB3' ' B' 1215 ' ' ASP . . . -68.02 -52.3 37.21 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.507 -0.77 . . . . 56.6 111.888 176.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1238 ' ' GLU . . . . . 0.414 ' HB3' ' CE2' ' B' 1242 ' ' PHE . 75.1 mt-10 -50.39 -66.2 0.43 Allowed 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 125.06 1.344 . . . . 56.79 110.405 176.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1239 ' ' MET . . . . . . . . . . . . . 82.7 mtp -50.49 -40.57 51.54 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 115.929 1.826 . . . . 53.63 115.929 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -57.27 -49.78 75.0 Favored 'General case' 0 C--O 1.259 1.601 0 O-C-N 124.511 1.132 . . . . 51.74 110.742 173.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 4.2 tt -66.34 -37.36 85.16 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 116.214 -0.448 . . . . 44.86 110.525 -174.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1242 ' ' PHE . . . . . 0.414 ' CE2' ' HB3' ' B' 1238 ' ' GLU . 23.1 m-30 -67.17 -42.49 84.21 Favored 'General case' 0 N--CA 1.438 -1.041 0 O-C-N 126.257 2.223 . . . . 42.78 109.597 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1243 ' ' ALA . . . . . 0.509 ' HA ' ' HG3' ' B' 1271 ' ' MET . . . -63.65 -40.84 97.86 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 120.294 -1.504 . . . . 40.96 108.607 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -67.41 -34.43 77.23 Favored 'General case' 0 C--O 1.246 0.907 0 O-C-N 120.58 -1.325 . . . . 43.06 110.798 175.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1245 ' ' GLN . . . . . 0.432 ' O ' HG22 ' B' 1249 ' ' VAL . 25.5 mm-40 -70.03 -27.58 64.78 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.378 0.881 . . . . 46.45 113.378 168.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -57.43 -45.38 84.72 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 119.953 -1.717 . . . . 41.78 111.598 -176.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 21.1 tptt -62.26 -31.69 72.3 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.33 0.863 . . . . 52.2 113.33 173.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1248 ' ' GLU . . . . . 0.512 ' CD ' HH12 ' B' 1192 ' ' ARG . 0.5 OUTLIER -77.35 -43.64 32.23 Favored 'General case' 0 C--O 1.248 0.986 0 O-C-N 121.394 -0.816 . . . . 53.55 113.019 177.646 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B 1249 ' ' VAL . . . . . 0.833 HG11 ' HB2' ' B' 1169 ' ' MET . 30.0 m -81.49 -179.26 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.031 0 O-C-N 120.575 -1.328 . . . . 34.41 114.457 -160.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1250 ' ' ASP . . . . . 0.42 ' O ' ' HB3' ' B' 1279 ' ' SER . 6.2 m-20 -132.94 -37.94 0.99 Allowed 'General case' 0 C--O 1.247 0.948 0 CA-C-N 113.087 -1.869 . . . . 33.38 109.616 -172.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1251 ' ' ILE . . . . . 0.881 HD12 ' HB1' ' B' 1145 ' ' ALA . 41.1 mm -129.8 138.11 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 N-CA-C 104.469 -2.419 . . . . 29.54 104.469 175.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1252 ' ' ILE . . . . . 0.489 HG22 ' HB ' ' B' 1254 ' ' THR . 78.7 mt -112.84 116.36 52.4 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 N-CA-C 103.641 -2.726 . . . . 32.44 103.641 166.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1253 ' ' VAL . . . . . 0.484 HG13 HD11 ' B' 1284 ' ' LEU . 42.8 t -97.57 87.56 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.258 1.52 0 N-CA-C 102.139 -3.282 . . . . 30.57 102.139 176.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1254 ' ' THR . . . . . 0.489 ' HB ' HG22 ' B' 1252 ' ' ILE 0.286 1.3 t -89.7 104.63 17.17 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 126.245 2.926 . . . . 35.04 109.141 -174.274 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B 1255 ' ' THR . . . . . 0.433 ' CG2' ' HB3' ' B' 1176 ' ' ALA . 21.9 m -110.99 -5.26 14.86 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 109.021 -3.718 . . . . 34.62 113.099 -169.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1256 ' ' ALA . . . . . 0.519 ' HB2' HG22 ' B' 1171 ' ' ILE . . . -71.08 79.7 0.68 Allowed 'General case' 0 C--O 1.247 0.921 0 CA-C-O 124.026 1.869 . . . . 42.72 112.45 -162.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1257 ' ' LEU . . . . . 0.583 HD23 ' HB2' ' B' 1263 ' ' ALA . 29.2 mt -92.56 120.9 33.47 Favored 'General case' 0 C--O 1.249 1.077 0 N-CA-C 106.912 -1.514 . . . . 52.43 106.912 169.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 70.1 mt -81.68 113.6 43.65 Favored Pre-proline 0 N--CA 1.449 -0.486 0 N-CA-C 102.055 -3.313 . . . . 59.41 102.055 176.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -57.02 94.44 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 124.077 3.185 . . . . 62.68 115.746 -171.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 135.56 -44.91 1.13 Allowed Glycine 0 CA--C 1.493 -1.285 0 CA-C-N 112.065 -2.334 . . . . 64.16 108.479 174.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 82.5 mttt -68.98 161.78 69.85 Favored Pre-proline 0 N--CA 1.446 -0.626 0 O-C-N 120.215 -1.756 . . . . 68.53 114.335 172.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -61.07 157.48 39.07 Favored 'Trans proline' 0 N--CA 1.44 -1.64 0 C-N-CA 122.235 1.957 . . . . 61.99 111.504 157.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1263 ' ' ALA . . . . . 0.583 ' HB2' HD23 ' B' 1257 ' ' LEU . . . -66.14 128.23 93.7 Favored Pre-proline 0 N--CA 1.416 -2.142 0 O-C-N 120.761 -1.212 . . . . 57.15 112.811 174.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1264 ' ' PRO . . . . . 0.462 ' HD2' ' O ' ' B' 1256 ' ' ALA . 73.1 Cg_endo -68.15 137.94 42.04 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 123.787 2.991 . . . . 51.57 110.24 -176.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -76.9 71.15 3.4 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 123.358 1.552 . . . . 54.55 111.248 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 63.4 mt -70.1 -42.58 72.51 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 124.086 1.898 . . . . 46.86 110.7 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1267 ' ' ILE . . . . . 0.742 ' HB ' ' HA ' ' B' 1292 ' ' CYS . 44.4 mm -80.07 93.44 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 O-C-N 119.207 -2.183 . . . . 41.04 107.129 -177.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1268 ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.81 152.63 31.0 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 113.429 -1.714 . . . . 39.58 112.8 170.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1269 ' ' ARG . . . . . . . . . . . . . 73.1 mtt85 -56.4 -37.97 70.86 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 120.782 -1.199 . . . . 53.15 111.675 172.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -43.85 -54.54 5.17 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 125.888 1.675 . . . . 42.96 114.376 168.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1271 ' ' MET . . . . . 0.509 ' HG3' ' HA ' ' B' 1243 ' ' ALA . 48.7 ttm -64.37 -33.91 76.95 Favored 'General case' 0 C--N 1.353 0.758 0 CA-C-N 114.648 -1.16 . . . . 43.89 109.551 -174.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1272 ' ' VAL . . . . . 0.656 HG11 HG21 ' B' 1303 ' ' THR . 21.5 t -65.89 -48.58 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 123.315 1.531 . . . . 38.37 108.087 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -67.47 -14.63 63.1 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 120.802 -1.187 . . . . 47.46 114.155 173.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1274 ' ' SER . . . . . . . . . . . . . 48.6 m -86.73 0.2 55.14 Favored 'General case' 0 N--CA 1.44 -0.926 0 O-C-N 119.2 -2.187 . . . . 38.38 114.367 168.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1275 ' ' MET . . . . . 0.653 ' HB2' HG21 ' B' 1307 ' ' VAL . 55.6 mtp -82.24 156.98 24.08 Favored 'General case' 0 CA--C 1.486 -1.499 0 O-C-N 118.502 -2.624 . . . . 37.81 112.946 173.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -62.39 146.59 50.9 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 112.743 -2.026 . . . . 49.26 107.25 167.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -73.62 150.43 41.37 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 114.319 1.229 . . . . 34.46 114.319 -176.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 62.18 51.6 55.57 Favored Glycine 0 N--CA 1.479 1.521 0 CA-C-O 124.859 2.366 . . . . 33.53 111.698 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1279 ' ' SER . . . . . 0.42 ' HB3' ' O ' ' B' 1250 ' ' ASP . 45.4 m -134.49 154.27 51.51 Favored 'General case' 0 C--O 1.26 1.607 0 CA-C-N 111.543 -2.328 . . . . 31.31 105.348 -173.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1280 ' ' VAL . . . . . . . . . . . . . 63.3 t -120.65 138.99 49.33 Favored 'Isoleucine or valine' 0 C--O 1.247 0.961 0 O-C-N 119.459 -2.026 . . . . 29.32 109.108 -170.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1281 ' ' ILE . . . . . . . . . . . . . 40.7 mt -106.81 101.48 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 105.874 -1.899 . . . . 31.93 105.874 168.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1282 ' ' VAL . . . . . 0.472 HG23 ' HA ' ' B' 1253 ' ' VAL . 0.0 OUTLIER -89.81 114.65 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.179 0 CA-C-O 124.414 2.054 . . . . 29.48 107.498 176.719 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B 1283 ' ' ASP . . . . . 0.408 ' HA ' HG22 ' B' 1254 ' ' THR . 22.5 t0 -94.51 108.48 20.42 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 113.192 -1.822 . . . . 34.5 106.439 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1284 ' ' LEU . . . . . 0.484 HD11 HG13 ' B' 1253 ' ' VAL . 5.9 mp -84.78 -33.43 22.99 Favored 'General case' 0 C--O 1.255 1.354 0 CA-C-N 112.448 -2.16 . . . . 37.94 108.779 174.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1285 ' ' ALA . . . . . 0.519 ' HB1' ' CB ' ' B' 1263 ' ' ALA . . . -75.23 -9.67 58.76 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 113.298 -1.774 . . . . 40.92 110.881 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -42.65 -30.02 0.34 Allowed 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 118.709 2.855 . . . . 44.39 118.709 169.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1287 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.96 -36.56 83.68 Favored 'General case' 0 C--N 1.363 1.157 0 CA-C-N 121.385 1.902 . . . . 51.46 110.566 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 20.9 t30 -122.92 100.09 6.71 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 122.996 1.379 . . . . 57.75 109.328 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1289 ' ' GLY . . . . . . . . . . . . . . . 82.9 -60.85 4.85 Favored Glycine 0 C--O 1.259 1.693 0 O-C-N 119.858 -1.776 . . . . 49.85 114.274 177.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 90.61 128.35 3.84 Favored Glycine 0 C--O 1.252 1.234 0 O-C-N 120.674 -1.486 . . . . 45.93 111.535 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1291 ' ' ASN . . . . . . . . . . . . . 7.7 m120 -80.83 -31.57 35.46 Favored 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 124.298 0.646 . . . . 42.67 110.667 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1292 ' ' CYS . . . . . 0.742 ' HA ' ' HB ' ' B' 1267 ' ' ILE . 52.5 t -92.1 140.49 29.59 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.285 -1.005 . . . . 38.82 108.285 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1293 ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -65.57 -45.28 83.89 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 113.376 0.88 . . . . 46.71 113.376 171.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1294 ' ' TYR . . . . . 0.513 ' HD2' HG21 ' B' 1272 ' ' VAL . 26.2 m-85 -63.78 -15.57 59.03 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 117.458 2.392 . . . . 47.23 117.458 -178.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1295 ' ' THR . . . . . 0.589 ' OG1' ' HB3' ' B' 1292 ' ' CYS . 33.2 m -59.98 119.02 6.98 Favored 'General case' 0 C--O 1.262 1.755 0 O-C-N 120.986 -1.071 . . . . 36.02 111.41 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 60.8 t -79.49 121.42 82.69 Favored Pre-proline 0 N--CA 1.473 0.694 0 N-CA-C 102.767 -3.049 . . . . 37.26 102.767 163.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -62.45 92.63 0.13 Allowed 'Trans proline' 0 C--O 1.249 1.036 0 C-N-CA 124.592 3.528 . . . . 35.09 110.542 -177.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1298 ' ' GLY . . . . . 0.656 ' HA2' ' HA ' ' B' 1312 ' ' TYR . . . 114.66 27.02 3.43 Favored Glycine 0 N--CA 1.443 -0.886 0 O-C-N 120.861 -1.15 . . . . 35.97 112.237 175.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -153.04 171.4 18.44 Favored 'General case' 0 C--N 1.356 0.861 0 CA-C-N 121.001 2.401 . . . . 40.39 116.079 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1300 ' ' ILE . . . . . 0.681 HG23 HG12 ' B' 1310 ' ' ILE . 18.9 mt -87.82 160.08 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 O-C-N 122.103 -0.373 . . . . 37.43 110.086 165.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 51.6 t80 -150.44 161.71 41.98 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 106.116 -1.809 . . . . 44.13 106.116 169.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1302 ' ' THR . . . . . . . . . . . . . 9.2 m -136.16 138.39 41.9 Favored 'General case' 0 C--O 1.253 1.249 0 O-C-N 120.519 -1.363 . . . . 39.78 109.483 173.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1303 ' ' THR . . . . . 0.656 HG21 HG11 ' B' 1272 ' ' VAL . 41.4 p -98.37 168.49 10.18 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 126.004 2.065 . . . . 43.29 114.095 -167.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -47.74 -49.4 28.38 Favored 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 124.721 1.208 . . . . 53.07 113.161 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 32.9 p-10 -67.69 -39.95 84.39 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 115.226 1.565 . . . . 43.97 115.226 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 127.62 29.03 0.85 Allowed Glycine 0 CA--C 1.527 0.783 0 N-CA-C 109.547 -1.421 . . . . 41.12 109.547 177.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1307 ' ' VAL . . . . . 0.653 HG21 ' HB2' ' B' 1275 ' ' MET . 47.3 t -98.61 148.25 6.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 107.409 -1.33 . . . . 38.12 107.409 173.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1308 ' ' LYS . . . . . 0.454 ' CD ' ' HB3' ' B' 1148 ' ' GLU . 90.6 mttt -113.27 128.51 56.49 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 118.718 -2.489 . . . . 36.34 105.482 -175.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1309 ' ' VAL . . . . . . . . . . . . . 42.7 t -110.06 130.41 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 103.294 -2.854 . . . . 30.4 103.294 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1310 ' ' ILE . . . . . 0.681 HG12 HG23 ' B' 1300 ' ' ILE . 52.9 mt -127.14 113.01 30.48 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.411 0 N-CA-C 105.108 -2.182 . . . . 30.82 105.108 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1311 ' ' GLY . . . . . 0.585 ' HA3' HG23 ' B' 1295 ' ' THR . . . -132.98 117.54 1.97 Allowed Glycine 0 C--O 1.214 -1.134 0 N-CA-C 104.789 -3.324 . . . . 26.53 104.789 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1312 ' ' TYR . . . . . 0.666 ' HB2' ' HG ' ' B' 1315 ' ' LEU . 36.0 m-85 -117.59 128.03 54.55 Favored 'General case' 0 CA--C 1.493 -1.235 0 CA-C-N 118.345 1.073 . . . . 38.0 110.667 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1313 ' ' THR . . . . . . . . . . . . . 26.3 m -68.11 -28.42 67.31 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.511 -1.677 . . . . 29.8 107.601 167.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -89.4 18.61 5.09 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 124.835 1.254 . . . . 39.04 113.592 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1315 ' ' LEU . . . . . 0.666 ' HG ' ' HB2' ' B' 1312 ' ' TYR . 6.9 mt -48.24 -40.21 34.34 Favored Pre-proline 0 CA--C 1.509 -0.633 0 N-CA-C 117.25 2.315 . . . . 31.08 117.25 177.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1316 ' ' PRO . . . . . 0.536 ' HA ' HG21 ' B' 1136 ' ' ILE . 17.9 Cg_exo -64.19 -44.56 11.92 Favored 'Trans proline' 0 CA--C 1.513 -0.548 0 C-N-CA 123.911 3.074 . . . . 26.1 111.968 169.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -56.02 -33.05 60.15 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 115.524 0.969 . . . . 23.17 115.524 172.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -54.9 -23.92 21.03 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 113.623 0.971 . . . . 40.4 113.623 171.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 12.6 tp -126.76 79.73 71.59 Favored Pre-proline 0 N--CA 1.442 -0.874 0 O-C-N 119.08 -2.263 . . . . 23.6 107.194 176.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1320 ' ' PRO . . . . . 0.617 ' HB3' ' HB ' ' B' 1014 ' ' THR . 51.6 Cg_endo -58.65 -63.04 0.15 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.801 3.001 . . . . 22.35 119.246 -171.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1321 ' ' THR . . . . . . . . . . . . . 2.3 m -57.02 -43.82 82.23 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 119.666 1.121 . . . . 26.52 109.779 -175.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1322 ' ' GLN . . . . . 0.568 ' HB2' ' HA ' ' A' 1151 ' ' ARG . 34.4 tp60 -74.13 -35.79 64.14 Favored 'General case' 0 CA--C 1.493 -1.218 0 O-C-N 121.626 -0.671 . . . . 24.38 112.442 -172.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1323 ' ' SER . . . . . . . . . . . . . 68.6 m -61.01 -45.28 95.46 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 113.905 1.076 . . . . 22.8 113.905 168.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1324 ' ' SER . . . . . . . . . . . . . 14.5 m -59.01 -37.94 78.07 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.89 0.476 . . . . 21.25 111.015 175.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1325 ' ' GLN . . . . . 0.435 ' HG2' ' HD2' ' A' 1164 ' ' PRO . 43.6 tp60 -63.05 -49.18 75.59 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 113.12 0.785 . . . . 31.34 113.12 171.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1326 ' ' LEU . . . . . 0.471 ' HA ' HD23 ' B' 1326 ' ' LEU . 35.7 mt -78.57 -48.1 15.87 Favored 'General case' 0 CA--C 1.488 -1.439 0 O-C-N 120.092 -1.63 . . . . 31.56 113.02 -170.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1327 ' ' TYR . . . . . 0.471 ' CZ ' ' HA ' ' B' 1072 ' ' VAL . 38.7 t80 -57.26 -42.81 82.27 Favored 'General case' 0 C--N 1.359 1.003 0 N-CA-C 107.536 -1.283 . . . . 22.73 107.536 170.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1328 ' ' GLY . . . . . 0.803 ' HA2' HD12 ' B' 1331 ' ' LEU . . . -52.37 -50.87 45.52 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 123.472 0.558 . . . . 21.91 112.438 171.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1329 ' ' THR . . . . . 0.628 HG21 ' HA3' ' A' 1161 ' ' GLY . 34.6 m -65.39 -29.46 70.16 Favored 'General case' 0 C--O 1.245 0.84 0 O-C-N 119.004 -2.468 . . . . 22.15 111.265 177.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1330 ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' B' 1327 ' ' TYR . 20.3 m120 -60.59 -49.19 78.53 Favored 'General case' 0 C--O 1.25 1.12 0 CA-C-O 122.446 1.117 . . . . 26.18 110.889 173.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1331 ' ' LEU . . . . . 0.805 HD13 ' HB3' ' B' 1070 ' ' LEU . 36.4 mt -53.21 -46.16 68.95 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 113.278 -1.783 . . . . 23.68 113.16 171.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1332 ' ' VAL . . . . . 0.574 HG12 ' HE3' ' B' 1336 ' ' LYS . 39.0 t -53.79 -50.0 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 115.754 -0.657 . . . . 26.57 110.643 171.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1333 ' ' ASN . . . . . 0.59 ' HA ' ' HD2' ' B' 1336 ' ' LYS . 76.3 m-20 -69.55 -27.37 65.09 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 119.875 -1.766 . . . . 28.08 113.303 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1334 ' ' LEU . . . . . 0.679 HD21 ' SD ' ' B' 1113 ' ' MET . 1.2 tt -66.96 -51.62 52.88 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 106.206 -1.775 . . . . 27.43 106.206 175.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1335 ' ' LEU . . . . . . . . . . . . . 86.3 mt -62.4 -29.75 70.71 Favored 'General case' 0 C--N 1.355 0.844 0 CA-C-N 115.162 -0.926 . . . . 30.5 111.255 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1336 ' ' LYS . . . . . 0.59 ' HD2' ' HA ' ' B' 1333 ' ' ASN . 95.0 mttt -64.8 -45.73 85.05 Favored 'General case' 0 C--O 1.245 0.843 0 O-C-N 120.418 -1.426 . . . . 41.65 110.052 169.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 29.5 tp -76.04 -18.27 59.3 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 119.454 1.024 . . . . 42.08 112.227 -174.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1338 ' ' LEU . . . . . 0.539 HD13 HD12 ' B' 1346 ' ' ILE . 26.8 mt -79.09 -67.92 0.71 Allowed 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 119.637 -1.914 . . . . 35.03 108.194 167.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1339 ' ' CYS . . . . . 0.506 ' SG ' ' HA ' ' B' 1342 ' ' LYS . 43.0 t -76.45 80.46 3.16 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 124.283 1.992 . . . . 37.33 108.282 -173.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1340 ' ' LYS . . . . . 0.422 ' HD2' ' O ' ' B' 1338 ' ' LEU . 2.6 mptp? -62.22 -27.64 69.13 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.531 -1.356 . . . . 50.51 111.984 174.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -84.63 -6.24 59.35 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 114.245 1.202 . . . . 54.21 114.245 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1342 ' ' LYS . . . . . 0.506 ' HA ' ' SG ' ' B' 1339 ' ' CYS . 90.7 mttt 39.07 39.8 0.42 Allowed 'General case' 0 C--O 1.257 1.477 0 N-CA-C 116.717 2.117 . . . . 50.99 116.717 -172.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -89.69 -14.52 34.6 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 113.885 -1.507 . . . . 48.82 107.542 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 89.98 27.99 19.58 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.052 -1.071 . . . . 40.43 112.351 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -136.68 160.84 37.62 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 120.289 2.044 . . . . 47.56 109.012 164.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1346 ' ' ILE . . . . . 0.539 HD12 HD13 ' B' 1338 ' ' LEU . 45.0 mm -68.1 101.13 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 C-N-CA 119.612 -0.835 . . . . 42.49 108.898 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1347 ' ' THR . . . . . . . . . . . . . 17.6 m -71.91 105.56 3.88 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 103.412 -2.81 . . . . 38.12 103.412 163.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 47.3 t -69.03 84.97 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.144 -1.389 . . . . 37.5 109.292 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1349 ' ' ASP . . . . . 0.442 ' HB3' HG21 ' B' 1355 ' ' ILE . 24.5 t70 -81.29 164.13 22.44 Favored 'General case' 0 C--O 1.243 0.761 0 O-C-N 121.298 -0.876 . . . . 43.85 110.701 171.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1350 ' ' PHE . . . . . 0.521 ' HE1' ' HB ' ' B' 1359 ' ' THR . 0.0 OUTLIER -155.0 3.09 0.2 Allowed 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 126.925 2.09 . . . . 39.81 111.17 158.302 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 10.6 t70 -72.94 -32.68 65.43 Favored 'General case' 0 C--O 1.247 0.939 0 CA-C-O 121.761 0.791 . . . . 51.29 112.234 -163.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.39 142.34 31.07 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.31 -0.859 . . . . 39.78 111.904 170.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1353 ' ' VAL . . . . . 0.436 ' HA ' ' HB3' ' B' 1356 ' ' ARG . 22.5 m -62.84 -26.47 40.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 114.956 1.465 . . . . 39.28 114.956 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1354 ' ' VAL . . . . . 0.515 HG21 ' HG3' ' B' 1123 ' ' ARG . 81.1 t -71.06 -49.94 45.73 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.195 0 N-CA-C 106.389 -1.708 . . . . 35.7 106.389 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1355 ' ' ILE . . . . . 0.442 HG21 ' HB3' ' B' 1349 ' ' ASP . 25.6 mm -62.49 -46.63 95.95 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 119.458 1.026 . . . . 35.77 111.766 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1356 ' ' ARG . . . . . 0.436 ' HB3' ' HA ' ' B' 1353 ' ' VAL . 45.1 tpt85 -46.15 -32.2 2.82 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 124.331 1.019 . . . . 38.55 113.091 172.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1357 ' ' GLY . . . . . 0.552 ' HA3' ' HG2' ' B' 1119 ' ' PRO . . . -97.28 -46.37 2.39 Favored Glycine 0 CA--C 1.497 -1.061 0 O-C-N 120.682 -1.261 . . . . 29.58 114.125 -176.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1358 ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' B' 1113 ' ' MET . 10.9 p -65.52 -35.73 75.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 117.035 0.417 . . . . 32.06 111.848 -176.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1359 ' ' THR . . . . . 0.521 ' HB ' ' HE1' ' B' 1350 ' ' PHE . 2.8 m -75.6 80.93 2.59 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.519 -1.66 . . . . 29.0 106.519 172.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1360 ' ' VAL . . . . . . . . . . . . . 15.6 m -68.39 -24.35 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 O-C-N 121.123 -0.986 . . . . 29.68 113.161 -172.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1361 ' ' ILE . . . . . 0.612 HG12 HG12 ' B' 1366 ' ' ILE . 74.7 mt -132.88 97.39 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 103.842 -2.651 . . . . 32.05 103.842 176.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1362 ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -79.71 92.63 5.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 124.442 3.292 . . . . 32.52 109.81 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1363 ' ' ALA . . . . . 0.48 ' H ' ' HA ' ' B' 1111 ' ' THR . . . 57.09 30.68 18.67 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 115.922 1.823 . . . . 35.68 115.922 168.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1364 ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' B' 1109 ' ' ASN . . . 147.97 -73.39 0.29 Allowed Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.26 -0.972 . . . . 34.26 110.887 177.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -69.28 141.45 54.34 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 113.565 0.95 . . . . 51.07 113.565 173.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1366 ' ' ILE . . . . . 0.612 HG12 HG12 ' B' 1361 ' ' ILE . 88.8 mt -86.66 113.33 24.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 125.198 2.428 . . . . 39.87 111.436 -175.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1367 ' ' THR . . . . . . . . . . . . . 1.1 p -98.45 3.14 48.31 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 111.344 -2.662 . . . . 38.01 112.698 -172.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1368 ' ' TRP . . . . . 0.411 ' HA ' ' HA ' ' B' 1369 ' ' PRO . 57.7 t90 -73.07 137.45 79.13 Favored Pre-proline 0 N--CA 1.447 -0.599 0 N-CA-C 107.757 -1.201 . . . . 42.14 107.757 167.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1369 ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' B' 1368 ' ' TRP . 31.5 Cg_exo -94.49 -178.84 8.06 Favored 'Cis proline' 0 N--CA 1.452 -0.939 0 C-N-CA 124.695 -0.96 . . . . 43.26 111.464 -5.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1370 ' ' ALA . . . . . 0.51 ' HB2' ' HA3' ' B' 1357 ' ' GLY . . . -76.08 163.54 65.95 Favored Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 124.718 1.207 . . . . 46.52 108.19 169.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -54.04 126.89 23.55 Favored 'Trans proline' 0 CA--C 1.553 1.46 0 C-N-CA 125.149 3.899 . . . . 51.95 111.003 166.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -37.88 109.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.365 1.442 1 C-N-CA 126.99 5.127 . . . . 56.27 113.375 -173.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1373 ' ' ILE . . . . . 0.519 HD11 HG12 ' B' 1121 ' ' ILE . 8.3 tp -82.44 137.33 21.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 C-N-CA 126.655 1.982 . . . . 60.83 113.094 -174.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 16.1 mp0 -87.49 101.09 13.26 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-O 122.979 1.371 . . . . 66.1 110.188 175.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 43.1 t -73.97 118.34 19.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 112.396 -2.184 . . . . 63.47 108.12 176.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.217 -5.174 0 O-C-N 118.206 -2.809 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.541 0 CA-C-O 116.792 -1.575 . . . . 0.0 111.416 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -58.11 -23.24 54.17 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 122.655 2.479 . . . . 0.0 115.676 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 52.9 mp0 -52.49 -53.07 50.71 Favored 'General case' 0 C--O 1.215 -0.715 0 CA-C-O 122.027 0.918 . . . . 0.0 109.25 171.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 23' ' ' THR . . . . . 0.551 HG21 ' HZ ' ' C' ' 147' ' ' PHE . 16.8 m -67.3 -43.53 81.48 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 114.561 -1.199 . . . . 0.0 109.791 -176.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 24' ' ' ALA . . . . . 0.521 ' HB2' HG22 ' C' ' 182' ' ' ILE . . . -55.87 -36.38 67.52 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 123.993 0.917 . . . . 0.0 111.26 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.12 -57.87 3.62 Favored 'General case' 0 C--O 1.24 0.605 0 O-C-N 120.082 -1.636 . . . . 0.0 112.706 171.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 mp -46.82 -44.94 19.76 Favored 'General case' 0 C--O 1.21 -1.025 0 C-N-CA 125.664 1.585 . . . . 0.0 114.284 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.426 HD11 HD11 ' C' ' 110' ' ' LEU . 27.6 mt -62.77 -49.52 74.68 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 28' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -67.6 -30.33 69.89 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 119.241 -0.983 . . . . 0.0 111.795 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -62.52 -43.2 99.4 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 124.06 0.944 . . . . 0.0 111.937 168.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.778 ' HA ' ' HB3' ' C' ' 107' ' ' ASP . 51.7 m -44.87 -31.7 1.34 Allowed 'General case' 0 CA--C 1.498 -1.028 1 N-CA-C 122.175 4.139 . . . . 0.0 122.175 -164.22 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 31' ' ' HIS . . . . . 0.538 ' O ' HG23 ' C' ' 62' ' ' ILE . 5.6 m-70 70.85 -62.67 0.44 Allowed 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.499 1.12 . . . . 0.0 111.607 -175.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 32' ' ' SER . . . . . 0.454 ' HB2' ' HA ' ' C' ' 106' ' ' THR . 71.7 m -108.52 139.67 42.95 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 162.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 92.2 t -124.05 134.98 65.08 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 103.738 -2.69 . . . . 0.0 103.738 174.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 42.5 mm -109.95 123.73 66.09 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.305 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 165.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . 0.417 ' O ' ' HD3' ' C' ' 37' ' ' PRO . 66.9 mt -108.51 124.8 65.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 172.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 89.2 m -108.1 100.22 35.39 Favored Pre-proline 0 C--O 1.245 0.825 0 CA-C-N 113.359 -1.746 . . . . 0.0 109.147 173.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . 0.687 ' HD2' HG12 ' C' ' 68' ' ' ILE . 66.4 Cg_exo -61.76 82.47 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.482 3.455 . . . . 0.0 110.391 174.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.18 -132.91 3.65 Favored Glycine 0 N--CA 1.432 -1.61 0 CA-C-O 123.3 1.5 . . . . 0.0 110.503 169.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 39' ' ' TYR . . . . . 0.78 ' HB2' ' HB2' ' C' ' 114' ' ' ALA . 4.2 t80 -59.28 -57.4 13.19 Favored 'General case' 0 CA--C 1.5 -0.966 0 O-C-N 121.306 -1.114 . . . . 0.0 110.834 -157.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -55.24 -34.92 59.41 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-O 118.392 -1.227 . . . . 0.0 112.328 -173.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 41' ' ' MET . . . . . 0.44 ' SD ' ' HB3' ' C' ' 37' ' ' PRO . 31.3 ttm -88.15 -37.55 16.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 118.539 1.169 . . . . 0.0 110.421 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.36 -2.37 37.86 Favored 'General case' 0 C--O 1.246 0.887 0 C-N-CA 122.416 0.287 . . . . 0.0 111.525 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 p -111.39 -43.53 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 166.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -135.9 179.03 6.59 Favored 'General case' 0 CA--C 1.507 -0.709 0 O-C-N 119.412 -2.055 . . . . 0.0 110.255 -167.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 45' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -63.64 16.02 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 120.583 3.549 . . . . 0.0 120.583 -169.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.417 ' HA ' ' HG2' ' C' ' 176' ' ' LYS . . . -59.9 -17.01 33.98 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 123.68 2.945 . . . . 0.0 115.048 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . 0.834 ' HG2' ' HB3' ' C' ' 82' ' ' LEU . 0.0 OUTLIER -62.46 -44.22 96.92 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.157 0.983 . . . . 0.0 111.106 174.516 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 48' ' ' TYR . . . . . 0.568 ' HB2' ' HD3' ' C' ' 49' ' ' PRO . 28.1 m-85 -62.74 -47.26 88.01 Favored Pre-proline 0 C--O 1.253 1.265 0 CA-C-N 121.99 2.177 . . . . 0.0 110.011 177.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 49' ' ' PRO . . . . . 0.568 ' HD3' ' HB2' ' C' ' 48' ' ' TYR . 0.1 OUTLIER -53.95 -42.64 65.04 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 124.642 3.561 . . . . 0.0 114.884 169.714 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . 0.415 ' HA ' HG22 ' C' ' 53' ' ' ILE . 1.4 p -65.95 -34.98 73.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 119.203 0.91 . . . . 0.0 111.09 -174.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.3 -50.07 70.53 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.175 0.99 . . . . 0.0 112.419 169.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 52' ' ' GLU . . . . . 0.417 ' HB3' ' HB2' ' C' ' 183' ' ' LEU . 1.5 tm-20 -68.82 -29.41 67.74 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -178.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 53' ' ' ILE . . . . . 0.415 HG22 ' HA ' ' C' ' 50' ' ' VAL . 9.4 tp -76.53 -46.05 32.35 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 N-CA-C 115.597 1.702 . . . . 0.0 115.597 166.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 96.9 m -57.63 -27.93 63.23 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 113.421 0.896 . . . . 0.0 113.421 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -47.43 -57.45 5.32 Favored 'General case' 0 N--CA 1.427 -1.618 0 C-N-CA 125.608 1.563 . . . . 0.0 114.017 167.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -81.17 -25.31 36.92 Favored 'General case' 0 N--CA 1.434 -1.244 0 O-C-N 120.76 -1.213 . . . . 0.0 112.271 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.77 -38.35 90.26 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 123.083 1.421 . . . . 0.0 111.488 171.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . 0.425 ' HA ' ' HD2' ' C' ' 58' ' ' ARG . 8.6 tpt180 -73.42 -32.9 64.66 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.536 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.18 -23.08 66.39 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 167.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -81.71 -6.29 58.89 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 119.157 0.89 . . . . 0.0 110.97 168.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.01 41.74 80.43 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 120.52 -1.363 . . . . 0.0 114.465 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . 0.538 HG23 ' O ' ' C' ' 31' ' ' HIS . 25.2 mt -96.04 134.54 33.22 Favored 'Isoleucine or valine' 0 C--O 1.253 1.253 0 CA-C-O 123.756 1.741 . . . . 0.0 111.081 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -68.99 83.07 0.32 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 124.629 2.156 . . . . 0.0 110.182 168.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.642 HG13 HD12 ' C' ' 92' ' ' ILE . 1.9 p -100.39 92.0 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 113.748 -1.569 . . . . 0.0 107.749 -176.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -91.62 128.08 37.32 Favored 'General case' 0 N--CA 1.442 -0.836 0 O-C-N 120.117 -1.614 . . . . 0.0 111.929 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . 0.517 ' HB2' ' HA ' ' C' ' 93' ' ' VAL . 25.6 m-85 -83.1 78.69 9.56 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 122.639 1.209 . . . . 0.0 109.047 176.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.48 89.06 0.35 Allowed Glycine 0 C--O 1.219 -0.804 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 68' ' ' ILE . . . . . 0.687 HG12 ' HD2' ' C' ' 37' ' ' PRO . 20.6 mt -88.72 132.62 33.13 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.902 0 CA-C-O 120.953 0.406 . . . . 0.0 111.845 -176.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -83.39 128.99 62.15 Favored Pre-proline 0 N--CA 1.472 0.654 0 CA-C-O 117.583 -1.199 . . . . 0.0 109.45 169.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 70' ' ' PRO . . . . . 0.792 ' HD3' ' HB2' ' C' ' 96' ' ' MET . 57.8 Cg_endo -61.11 -66.36 0.06 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.526 0 C-N-CA 124.582 3.521 . . . . 0.0 117.934 -175.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 45.8 t -76.16 107.54 7.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 170.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -168.15 142.71 3.48 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-N 121.315 1.871 . . . . 0.0 111.901 -171.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 61.77 -113.75 6.05 Favored Glycine 0 C--N 1.346 1.103 0 O-C-N 121.208 -0.932 . . . . 0.0 111.493 171.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . 0.604 ' HA ' ' OE1' ' B' 1203 ' ' GLN . 1.0 OUTLIER -128.72 105.88 8.56 Favored 'General case' 0 C--O 1.242 0.681 0 O-C-N 121.163 -1.199 . . . . 0.0 109.914 177.326 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.512 ' HB2' ' HB2' ' C' ' 78' ' ' HIS 0.25 2.0 mp 68.63 132.35 0.04 OUTLIER Pre-proline 0 CA--C 1.553 1.058 0 O-C-N 127.605 3.065 . . . . 0.0 116.269 -177.071 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.42 158.29 57.77 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 124.346 3.364 . . . . 0.0 107.784 167.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 77' ' ' GLY . . . . . 0.443 ' H ' HG23 ' A' 1157 ' ' ILE . . . 73.04 -63.92 1.62 Allowed Glycine 0 C--O 1.212 -1.244 0 CA-C-O 116.802 -2.11 . . . . 0.0 111.856 -168.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 78' ' ' HIS . . . . . 0.512 ' HB2' ' HB2' ' C' ' 75' ' ' LEU . 10.2 t-80 -33.23 -50.25 0.29 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -172.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.37 -45.03 85.7 Favored 'General case' 0 C--O 1.245 0.819 0 O-C-N 124.294 0.996 . . . . 0.0 113.207 -178.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.16 -26.07 42.77 Favored 'General case' 0 C--O 1.246 0.908 0 O-C-N 120.266 -1.521 . . . . 0.0 109.409 -175.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.438 HG22 HG21 ' A' 1154 ' ' THR . 46.5 t -58.48 -52.87 54.24 Favored 'Isoleucine or valine' 0 C--N 1.347 0.477 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 166.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.834 ' HB3' ' HG2' ' C' ' 47' ' ' GLN . 63.0 mt -56.95 -29.5 63.21 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 11.1 mp -63.96 -44.98 91.14 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 121.756 -0.59 . . . . 0.0 111.12 167.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.53 -38.08 86.39 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 120.223 -1.548 . . . . 0.0 112.334 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -50.39 -53.79 26.59 Favored 'General case' 0 C--N 1.349 0.572 0 O-C-N 124.654 1.221 . . . . 0.0 113.167 163.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.51 10.31 3.27 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp 58.68 30.29 19.73 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.867 2.067 . . . . 0.0 112.243 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 65.9 t -70.16 127.36 92.33 Favored Pre-proline 0 C--O 1.242 0.697 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 -174.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -50.56 107.41 0.16 Allowed 'Trans proline' 0 C--O 1.243 0.758 1 C-N-CA 125.313 4.009 . . . . 0.0 112.513 -176.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.75 -26.67 64.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.107 -1.406 . . . . 0.0 112.462 -165.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -40.15 -44.11 1.76 Allowed 'General case' 0 C--O 1.245 0.844 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 174.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 92' ' ' ILE . . . . . 0.642 HD12 HG13 ' C' ' 64' ' ' VAL . 0.5 OUTLIER -90.87 -1.42 9.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 -173.437 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . 0.517 ' HA ' ' HB2' ' C' ' 66' ' ' PHE . 10.6 t -83.36 121.73 36.59 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 O-C-N 120.686 -1.258 . . . . 0.0 114.38 -174.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 45.0 mt -125.59 81.78 2.01 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -170.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 95' ' ' GLU . . . . . 0.446 ' HA ' ' HB ' ' C' ' 68' ' ' ILE . 27.7 mp0 -75.76 104.38 6.28 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 121.677 -0.64 . . . . 0.0 110.433 -174.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.792 ' HB2' ' HD3' ' C' ' 70' ' ' PRO . 41.5 ttp 49.31 59.65 4.33 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.35 -171.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -103.84 135.74 44.82 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 167.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -85.73 75.64 10.05 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 -172.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 8.3 tp -92.97 62.27 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-O 124.777 2.227 . . . . 0.0 110.585 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -60.04 -32.97 71.42 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 112.397 -2.183 . . . . 0.0 109.354 -170.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.83 -59.65 4.57 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 118.155 -0.926 . . . . 0.0 112.23 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.01 -28.66 69.73 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 128.266 3.479 . . . . 0.0 113.239 176.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 103' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -64.52 -39.92 94.67 Favored 'General case' 0 C--O 1.224 -0.269 0 O-C-N 120.415 -1.428 . . . . 0.0 111.231 174.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -103.32 60.76 0.77 Allowed 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 123.263 1.506 . . . . 0.0 109.453 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -168.79 -37.02 0.02 OUTLIER 'General case' 0 C--O 1.241 0.655 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 106' ' ' THR . . . . . 0.454 ' HA ' ' HB2' ' C' ' 32' ' ' SER . 2.7 m -51.12 132.46 28.0 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 121.256 -0.902 . . . . 0.0 113.282 170.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 107' ' ' ASP . . . . . 0.778 ' HB3' ' HA ' ' C' ' 30' ' ' SER . 1.7 t70 -85.84 -60.49 2.0 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 34.6 m -109.22 130.67 55.49 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 118.572 -1.251 . . . . 0.0 112.563 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 109' ' ' VAL . . . . . 0.668 ' HB ' ' HA ' ' C' ' 144' ' ' VAL . 47.9 t -102.17 132.73 47.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 O-C-N 124.647 1.217 . . . . 0.0 108.225 173.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 110' ' ' LEU . . . . . 0.426 HD11 HD11 ' C' ' 27' ' ' LEU . 15.3 mt -98.58 84.24 3.13 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 124.57 1.169 . . . . 0.0 109.679 176.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 61.8 t -78.55 104.74 6.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 124.461 2.077 . . . . 0.0 107.494 170.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 36.3 mm -72.62 76.47 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.185 0 CA-C-O 124.424 2.059 . . . . 0.0 113.779 -175.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.11 -58.21 3.57 Favored Glycine 0 C--N 1.346 1.128 0 O-C-N 118.18 -2.825 . . . . 0.0 114.568 171.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 114' ' ' ALA . . . . . 0.78 ' HB2' ' HB2' ' C' ' 39' ' ' TYR . . . -82.75 95.05 7.75 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 123.153 1.454 . . . . 0.0 111.557 -171.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 115' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -52.25 -57.56 9.33 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 111.098 -2.774 . . . . 0.0 112.127 165.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 116' ' ' ASP . . . . . 0.589 ' HA ' ' HB2' ' C' ' 119' ' ' ASN . 15.1 m-20 -56.95 -34.03 67.63 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -169.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 20.7 m -43.46 -38.36 2.8 Favored 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 169.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 16.8 m -127.22 26.15 2.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 125.22 1.408 . . . . 0.0 110.826 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 119' ' ' ASN . . . . . 0.589 ' HB2' ' HA ' ' C' ' 116' ' ' ASP . 33.6 t-20 -75.54 120.71 82.93 Favored Pre-proline 0 CA--C 1.505 -0.775 0 CA-C-O 117.524 -1.227 . . . . 0.0 109.513 -177.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 120' ' ' PRO . . . . . 1.039 ' HG2' ' HB2' ' C' ' 160' ' ' ASN . 10.1 Cg_endo -53.25 -45.25 42.44 Favored 'Trans proline' 0 CA--C 1.51 -0.696 0 C-N-CA 124.639 3.559 . . . . 0.0 115.419 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 121' ' ' ALA . . . . . 0.47 ' HB2' ' HB3' ' C' ' 160' ' ' ASN . . . -55.4 -32.88 63.02 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 120.675 1.579 . . . . 0.0 112.897 -176.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 122' ' ' ALA . . . . . 0.535 ' HB1' ' HB3' ' C' ' 133' ' ' MET . . . -56.06 -20.15 15.81 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 120.774 -1.203 . . . . 0.0 113.121 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -119.11 -27.42 5.7 Favored 'General case' 0 C--O 1.221 -0.432 0 O-C-N 119.982 -1.699 . . . . 0.0 111.612 166.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -84.07 -11.08 57.26 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.26 -169.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -128.49 99.42 23.77 Favored Pre-proline 0 C--O 1.247 0.967 0 C-N-CA 119.314 -0.954 . . . . 0.0 111.096 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -64.19 69.25 0.21 Allowed 'Trans proline' 0 N--CA 1.441 -1.582 1 C-N-CA 125.62 4.213 . . . . 0.0 114.642 170.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . 0.499 ' HB3' ' HZ3' ' C' ' 127' ' ' LYS . 5.6 ttpm? -177.66 -28.11 0.01 OUTLIER 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 -174.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 128' ' ' SER . . . . . . . . . . . . . 66.2 m -59.46 129.39 86.94 Favored Pre-proline 0 C--O 1.222 -0.355 0 O-C-N 117.532 -3.23 . . . . 0.0 110.6 168.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 129' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -57.29 -46.82 25.54 Favored 'Trans proline' 0 N--CA 1.459 -0.522 1 C-N-CA 126.189 4.592 . . . . 0.0 115.738 -173.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 9.1 pt -84.11 63.7 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.842 0 CA-C-N 121.721 2.055 . . . . 0.0 111.038 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.75 153.44 43.36 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 118.111 2.634 . . . . 0.0 118.111 -168.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.15 22.83 77.46 Favored Glycine 0 C--O 1.213 -1.193 0 CA-C-N 110.232 -3.167 . . . . 0.0 111.553 177.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 133' ' ' MET . . . . . 0.755 ' SD ' ' HD2' ' C' ' 134' ' ' PRO . 34.0 tpp -74.15 119.32 75.76 Favored Pre-proline 0 C--O 1.238 0.481 0 CA-C-N 120.444 2.122 . . . . 0.0 107.956 -175.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 134' ' ' PRO . . . . . 0.755 ' HD2' ' SD ' ' C' ' 133' ' ' MET . 71.6 Cg_endo -67.89 105.17 1.1 Allowed 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 121.112 1.208 . . . . 0.0 108.99 -175.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 4.5 m -117.93 103.71 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 103.503 -2.777 . . . . 0.0 103.503 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 42.2 mt -73.81 90.73 1.9 Allowed 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 110.777 -2.92 . . . . 0.0 113.123 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 51.68 -12.48 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 120.96 3.689 . . . . 0.0 120.96 163.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 8.4 p -80.8 82.88 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-N 125.177 3.626 . . . . 0.0 113.182 -171.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 139' ' ' TRP . . . . . 0.517 ' HA ' HG21 ' C' ' 144' ' ' VAL . 44.6 p90 -163.71 173.12 13.27 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 111.799 -2.455 . . . . 0.0 106.754 173.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 140' ' ' LYS . . . . . . . . . . . . 0.398 25.2 pttm 68.31 -62.81 0.36 Allowed 'General case' 0 C--O 1.242 0.667 0 C-N-CA 128.233 2.613 . . . . 0.0 116.078 171.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.25 110.45 4.05 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-O 121.661 0.743 . . . . 0.0 111.961 169.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.427 ' HB3' ' H ' ' C' ' 143' ' ' ASN 0.261 18.3 mm100 74.75 -163.27 0.08 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 172.189 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 143' ' ' ASN . . . . . 0.427 ' H ' ' HB3' ' C' ' 142' ' ' GLN . 2.1 m-20 -91.03 69.37 6.26 Favored 'General case' 0 C--O 1.248 1.018 0 CA-C-O 124.605 2.145 . . . . 0.0 107.288 -159.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 144' ' ' VAL . . . . . 0.668 ' HA ' ' HB ' ' C' ' 109' ' ' VAL . 20.5 t -75.24 82.69 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 114.145 -1.389 . . . . 0.0 107.384 178.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 145' ' ' ILE . . . . . . . . . . . . . 1.3 mp -80.17 120.71 32.16 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -176.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 146' ' ' VAL . . . . . . . . . . . . . 92.9 t -98.6 115.53 39.19 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 N-CA-C 102.919 -2.993 . . . . 0.0 102.919 172.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 147' ' ' PHE . . . . . 0.551 ' HZ ' HG21 ' C' ' 23' ' ' THR . 37.9 m-85 -64.82 123.96 20.73 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.611 0.719 . . . . 0.0 111.739 173.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 148' ' ' LYS . . . . . 0.61 ' HE3' ' SD ' ' C' ' 151' ' ' MET . 62.6 mmtt -126.54 146.41 50.14 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 2.1 tpp85 -89.02 -55.21 3.78 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 100.513 -3.884 . . . . 0.0 100.513 162.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 150' ' ' SER . . . . . 0.514 ' O ' ' HD2' ' C' ' 148' ' ' LYS . 3.4 m -152.82 -179.82 7.98 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 167.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 151' ' ' MET . . . . . 0.61 ' SD ' ' HE3' ' C' ' 148' ' ' LYS . 10.6 tpt -115.61 111.83 21.23 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 171.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -84.13 -144.1 0.08 Allowed 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 111.802 -2.453 . . . . 0.0 107.371 167.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 91.8 m -97.01 133.9 41.08 Favored 'General case' 0 C--O 1.24 0.577 0 O-C-N 117.243 -3.411 . . . . 0.0 107.43 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -84.57 151.91 27.07 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 113.256 -1.793 . . . . 0.0 110.292 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 16.1 m-30 -59.93 -39.03 84.11 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 117.917 -3.107 . . . . 0.0 114.523 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 156' ' ' ALA . . . . . . . . . . . . . . . -85.17 -54.6 4.51 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 119.199 -2.188 . . . . 0.0 107.548 166.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 80.84 -77.25 2.03 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.302 -0.863 . . . . 0.0 114.56 171.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 20.2 m -63.57 159.93 3.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 117.73 2.493 . . . . 0.0 117.73 -162.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . 0.258 0.0 OUTLIER -2.48 104.56 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.527 1 N-CA-C 122.043 4.09 . . . . 0.0 122.043 -176.071 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' C' C ' 160' ' ' ASN . . . . . 1.039 ' HB2' ' HG2' ' C' ' 120' ' ' PRO . 12.3 p30 -165.89 140.25 3.77 Favored Pre-proline 0 N--CA 1.434 -1.257 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.598 -173.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 161' ' ' PRO . . . . . 0.566 ' HG2' ' HG3' ' C' ' 120' ' ' PRO . 3.4 Cg_endo -45.56 -33.78 10.13 Favored 'Trans proline' 0 CA--C 1.512 -0.599 0 C-N-CA 123.521 2.814 . . . . 0.0 118.638 170.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 162' ' ' LEU . . . . . 0.588 ' HA ' HG22 ' C' ' 168' ' ' THR . 6.6 tp -68.28 -25.75 65.31 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 121.575 -0.703 . . . . 0.0 111.608 -173.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 163' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -87.66 -39.15 15.26 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 120.483 -1.385 . . . . 0.0 113.553 165.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -74.78 -53.26 9.5 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 115.802 1.778 . . . . 0.0 115.802 -169.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 165' ' ' LYS . . . . . 0.449 ' HB2' ' HB ' ' C' ' 168' ' ' THR . 5.4 mtpt -69.8 165.49 21.35 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 117.876 2.547 . . . . 0.0 117.876 -160.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 166' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' C' ' 169' ' ' HIS . 0.0 OUTLIER -73.09 -39.84 65.49 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 127.106 2.162 . . . . 0.0 113.109 174.179 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 167' ' ' ASN . . . . . 0.408 ' O ' ' HA ' ' C' ' 143' ' ' ASN . 42.1 p-10 -102.86 -46.19 4.76 Favored 'General case' 0 CA--C 1.498 -1.047 0 O-C-N 120.25 -1.531 . . . . 0.0 109.887 -174.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 168' ' ' THR . . . . . 0.599 HG23 ' HB ' ' C' ' 144' ' ' VAL . 54.4 m -74.27 91.84 2.2 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 102.92 -2.993 . . . . 0.0 102.92 161.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 169' ' ' HIS . . . . . 0.438 ' HB2' ' O ' ' C' ' 166' ' ' GLU . 16.6 t-80 -132.08 135.38 46.41 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 -164.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 170' ' ' MET . . . . . . . . . . . . . 75.7 mtm -74.1 102.28 4.18 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 113.397 -1.729 . . . . 0.0 108.399 169.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 171' ' ' LEU . . . . . . . . . . . . . 54.6 tp -100.01 129.29 46.05 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 -173.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -76.4 96.29 3.99 Favored 'General case' 0 C--O 1.248 0.976 0 CA-C-O 123.969 1.842 . . . . 0.0 112.839 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -156.88 134.65 4.1 Favored Glycine 0 CA--C 1.503 -0.671 0 N-CA-C 106.323 -2.711 . . . . 0.0 106.323 168.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 174' ' ' ASP . . . . . 0.803 ' HB3' ' HB3' ' C' ' 177' ' ' ALA . 22.5 t70 -60.17 143.12 53.17 Favored 'General case' 0 C--O 1.217 -0.631 0 O-C-N 121.734 -0.863 . . . . 0.0 111.296 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.48 -31.16 72.09 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -173.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 176' ' ' LYS . . . . . 0.516 ' HD3' ' HG2' ' C' ' 49' ' ' PRO . 0.1 OUTLIER -87.42 -61.53 1.7 Allowed 'General case' 0 C--O 1.236 0.357 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 168.507 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 177' ' ' ALA . . . . . 0.803 ' HB3' ' HB3' ' C' ' 174' ' ' ASP . . . -49.35 -44.76 44.88 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 -164.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 3.3 m -65.2 -42.59 93.38 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.58 177.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 179' ' ' VAL . . . . . 0.606 ' HA ' HG12 ' C' ' 182' ' ' ILE . 45.8 t -68.19 -40.95 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 119.451 1.023 . . . . 0.0 108.705 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -61.04 -28.98 69.45 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 114.996 -1.002 . . . . 0.0 113.184 174.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -77.69 -51.55 10.41 Favored 'General case' 0 N--CA 1.445 -0.688 0 O-C-N 117.366 -3.334 . . . . 0.0 112.323 171.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 182' ' ' ILE . . . . . 0.606 HG12 ' HA ' ' C' ' 179' ' ' VAL . 29.1 pt -62.68 -27.01 42.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 117.791 -1.1 . . . . 0.0 110.748 -174.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 183' ' ' LEU . . . . . 0.417 ' HB2' ' HB3' ' C' ' 52' ' ' GLU . 3.5 pp -58.42 -27.8 64.66 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 120.555 1.525 . . . . 0.0 114.315 174.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -94.38 -51.05 4.96 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -68.13 -72.57 0.17 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -175.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 186' ' ' LEU . . . . . . . . . . . . 0.293 0.5 OUTLIER . . . . . 0 CA--C 1.538 0.517 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -158.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' NAD . . . . . 0.443 ' O4B' ' HA ' ' B' 1256 ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C 1001 ' ' NAP . . . . . 0.414 ' O2N' ' HD2' ' C' ' 39' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 57.9 t-80 . . . . . 0 N--CA 1.44 -0.946 0 N-CA-C 106.322 -1.733 . . . . 65.74 106.322 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -52.48 88.01 0.01 OUTLIER Glycine 0 CA--C 1.526 0.753 0 O-C-N 119.562 -1.961 . . . . 48.66 110.462 160.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -130.1 131.39 45.71 Favored 'General case' 0 N--CA 1.431 -1.403 1 N-CA-C 97.445 -5.02 . . . . 44.56 97.445 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1003 ' ' ILE . . . . . 0.487 HD12 ' HB3' ' A' 1026 ' ' LEU . 42.2 mt -100.46 112.18 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 N-CA-C 105.266 -2.124 . . . . 34.86 105.266 176.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -77.73 132.06 11.6 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 112.646 -2.07 . . . . 30.75 110.259 169.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.623 HG23 ' HB3' ' A' 1017 ' ' ALA . 28.0 mm -119.18 91.05 43.07 Favored Pre-proline 0 CA--C 1.508 -0.642 0 N-CA-C 103.857 -2.645 . . . . 32.21 103.857 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -71.82 164.21 36.4 Favored 'Trans proline' 0 C--O 1.245 0.862 0 C-N-CA 123.421 2.747 . . . . 32.98 111.856 172.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1007 ' ' ARG . . . . . 0.56 ' HD2' HD12 ' A' 1042 ' ' LEU . 40.0 ttp85 -87.22 141.83 28.36 Favored 'General case' 0 C--O 1.267 1.998 0 N-CA-C 103.401 -2.814 . . . . 47.98 103.401 161.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1008 ' ' GLU . . . . . . . . . . . . 0.267 22.3 mm-40 -63.95 150.26 45.49 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 114.298 1.222 . . . . 34.7 114.298 177.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 24.4 mtp-105 -121.01 37.81 4.23 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 115.356 1.613 . . . . 53.37 115.356 -175.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1010 ' ' LEU . . . . . 0.639 HD12 HD11 ' A' 1076 ' ' LEU . 11.1 tp -96.63 179.18 5.08 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.144 -1.058 . . . . 45.07 108.144 -176.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1011 ' ' THR . . . . . 0.419 HG22 ' ND2' ' A' 1012 ' ' ASN . 10.3 m -63.2 140.1 58.84 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 107.419 -1.326 . . . . 40.36 107.419 171.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1012 ' ' ASN . . . . . 0.419 ' ND2' HG22 ' A' 1011 ' ' THR . 60.4 m-80 63.17 33.89 13.98 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 122.924 1.345 . . . . 40.61 114.501 169.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -98.4 151.02 21.01 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 116.898 2.185 . . . . 33.76 116.898 -158.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1014 ' ' THR . . . . . 0.451 ' HB ' ' O ' ' A' 1317 ' ' GLY . 5.0 m -136.13 -16.2 1.67 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 118.301 -0.857 . . . . 27.89 112.541 -177.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1015 ' ' ARG . . . . . 0.495 HH11 HG12 ' A' 1072 ' ' VAL . 69.7 mtm180 -70.01 150.68 46.39 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 117.081 2.252 . . . . 29.02 117.081 -173.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1016 ' ' VAL . . . . . 0.473 ' HB ' ' HB2' ' A' 1043 ' ' ALA . 4.3 p -113.96 166.76 7.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 103.976 -2.602 . . . . 28.13 103.976 159.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1017 ' ' ALA . . . . . 0.623 ' HB3' HG23 ' A' 1005 ' ' ILE . . . -67.51 -47.88 68.67 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.099 -1.041 . . . . 26.87 113.205 177.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -146.68 133.44 20.03 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 118.635 -2.54 . . . . 26.77 109.071 -176.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1019 ' ' THR . . . . . 0.685 HG21 HG23 ' A' 1321 ' ' THR . 0.7 OUTLIER -90.51 172.87 6.29 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-O 117.3 -1.333 . . . . 27.02 110.652 -177.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 1020 ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -25.45 -71.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.006 1 C-N-CA 127.496 5.464 . . . . 30.57 119.573 178.41 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 14.3 mptt -54.58 -44.0 72.62 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 120.371 1.441 . . . . 47.81 114.082 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1022 ' ' THR . . . . . 0.536 ' O ' ' HG ' ' A' 1026 ' ' LEU . 0.5 OUTLIER -65.8 -37.33 85.97 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 120.017 1.281 . . . . 30.77 112.217 175.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 1023 ' ' VAL . . . . . . . . . . . . . 25.5 t -59.52 -46.5 92.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 119.015 0.825 . . . . 33.59 110.3 170.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -59.95 -34.22 72.96 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 113.562 0.949 . . . . 53.29 113.562 172.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1025 ' ' GLN . . . . . 0.518 ' HB3' HG11 ' A' 1332 ' ' VAL . 39.2 mt-30 -64.36 -38.47 91.16 Favored 'General case' 0 N--CA 1.441 -0.883 0 O-C-N 120.73 -1.231 . . . . 46.92 112.122 171.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1026 ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' 1022 ' ' THR . 14.5 mt -68.37 -34.84 76.79 Favored 'General case' 0 C--O 1.249 1.078 0 O-C-N 121.082 -1.011 . . . . 37.17 110.195 175.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1027 ' ' LEU . . . . . 0.467 HD21 ' HA3' ' A' 1054 ' ' GLY . 10.8 mp -59.29 -42.58 91.61 Favored 'General case' 0 C--O 1.246 0.876 0 O-C-N 121.062 -1.024 . . . . 44.44 111.349 169.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -49.61 -51.21 39.03 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 124.361 1.038 . . . . 52.58 111.811 169.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1029 ' ' LEU . . . . . 0.664 ' HA ' ' HE2' ' A' 1342 ' ' LYS . 59.7 mt -65.9 -11.64 48.55 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 114.279 1.214 . . . . 45.69 114.279 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 90.12 28.24 18.41 Favored Glycine 0 C--O 1.25 1.148 0 O-C-N 121.223 -0.923 . . . . 42.09 112.646 174.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -119.34 127.63 53.35 Favored 'General case' 0 CA--C 1.488 -1.413 0 CA-C-O 117.854 -1.069 . . . . 40.72 108.255 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1032 ' ' THR . . . . . . . . . . . . . 97.4 m -67.27 135.53 53.51 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 108.683 -0.858 . . . . 37.77 108.683 176.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1033 ' ' VAL . . . . . . . . . . . . . 57.9 t -103.53 134.41 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 O-C-N 119.365 -2.084 . . . . 33.54 108.353 -172.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -121.68 105.26 10.25 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 105.907 -1.886 . . . . 31.68 105.907 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1035 ' ' VAL . . . . . . . . . . . . . 21.9 t -99.16 138.69 22.84 Favored 'Isoleucine or valine' 0 C--O 1.246 0.917 0 CA-C-N 114.944 -1.026 . . . . 31.52 108.737 -173.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1036 ' ' GLU . . . . . 0.443 ' HB3' ' HB2' ' A' 1039 ' ' ALA . 25.4 tt0 -57.76 130.88 48.43 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 123.867 1.794 . . . . 41.04 113.277 173.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1037 ' ' SER . . . . . . . . . . . . . 7.1 t -60.89 132.67 54.59 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 113.176 -1.829 . . . . 31.83 112.746 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 77.02 -4.92 52.43 Favored Glycine 0 CA--C 1.525 0.696 0 O-C-N 119.876 -1.765 . . . . 29.36 111.54 173.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1039 ' ' ALA . . . . . 0.443 ' HB2' ' HB3' ' A' 1036 ' ' GLU . . . -62.61 -40.14 96.03 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 119.04 -2.447 . . . . 27.78 113.667 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1040 ' ' GLY . . . . . 0.643 ' HA2' ' HB3' ' A' 1043 ' ' ALA . . . -62.52 -18.73 59.21 Favored Glycine 0 C--O 1.25 1.121 0 N-CA-C 114.652 0.621 . . . . 28.91 114.652 -177.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -62.38 -47.53 83.74 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.099 -1.236 . . . . 51.18 110.957 173.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1042 ' ' LEU . . . . . 0.56 HD12 ' HD2' ' A' 1007 ' ' ARG . 36.2 mt -64.39 -57.59 8.89 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.969 0.89 . . . . 29.91 112.528 167.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1043 ' ' ALA . . . . . 0.643 ' HB3' ' HA2' ' A' 1040 ' ' GLY . . . -60.38 -7.57 2.12 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 115.241 1.571 . . . . 28.54 115.241 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1044 ' ' SER . . . . . . . . . . . . . 62.9 m 69.81 31.47 3.48 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 125.393 1.477 . . . . 33.06 111.2 169.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1045 ' ' PHE . . . . . 0.695 ' HD1' ' HB3' ' B' 1277 ' ' ALA . 0.1 OUTLIER -157.95 107.06 2.06 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 102.44 -3.17 . . . . 30.29 102.44 169.671 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 1046 ' ' ASP . . . . . 0.471 ' OD2' ' HG2' ' A' 1048 ' ' LYS . 0.3 OUTLIER -79.74 174.22 11.81 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 117.372 2.36 . . . . 48.62 117.372 -148.094 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 28.9 t70 -47.7 -49.64 27.26 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 112.659 -2.064 . . . . 36.74 113.355 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1048 ' ' LYS . . . . . 0.471 ' HG2' ' OD2' ' A' 1046 ' ' ASP . 24.8 pttm -75.27 -26.72 59.01 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 120.947 -1.096 . . . . 43.73 110.206 176.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -62.35 -29.98 70.84 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 118.162 -2.837 . . . . 32.81 110.874 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1050 ' ' PHE . . . . . 0.481 ' HB2' HD11 ' A' 1057 ' ' ILE . 64.4 m-85 -62.46 -41.13 98.54 Favored 'General case' 0 C--O 1.219 -0.536 0 O-C-N 121.72 -0.613 . . . . 31.86 111.345 171.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 25.6 t -66.26 -40.81 87.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 119.889 -0.724 . . . . 33.22 111.771 172.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -56.68 -40.85 76.27 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 122.243 1.021 . . . . 50.83 111.163 176.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -61.98 -50.38 72.33 Favored 'General case' 0 C--O 1.263 1.815 0 N-CA-C 113.596 0.961 . . . . 33.12 113.596 168.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1054 ' ' GLY . . . . . 0.467 ' HA3' HD21 ' A' 1027 ' ' LEU . . . 131.65 47.63 0.12 Allowed Glycine 0 N--CA 1.443 -0.886 0 CA-C-O 119.337 -0.702 . . . . 35.83 113.617 175.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -126.82 150.53 49.14 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 114.698 1.37 . . . . 34.82 114.698 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -73.51 125.64 28.4 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 105.732 -1.951 . . . . 49.05 105.732 174.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1057 ' ' ILE . . . . . 0.481 HD11 ' HB2' ' A' 1050 ' ' PHE . 6.9 mm -89.52 125.46 42.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 106.203 -1.777 . . . . 38.53 106.203 173.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1058 ' ' VAL . . . . . 0.686 ' HB ' ' HB2' ' A' 1062 ' ' SER . 29.8 m -115.99 135.15 57.06 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 107.609 -1.256 . . . . 42.11 107.609 -177.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -75.74 79.13 2.69 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-O 122.696 1.236 . . . . 58.0 114.169 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 76.2 -123.77 7.01 Favored Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 107.739 -2.145 . . . . 52.12 107.739 171.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 39.7 t30 -47.92 -23.65 0.83 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 118.476 2.769 . . . . 54.75 118.476 -172.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1062 ' ' SER . . . . . 0.686 ' HB2' ' HB ' ' A' 1058 ' ' VAL . 1.3 m -53.26 -24.38 11.29 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 116.212 1.93 . . . . 50.34 116.212 171.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 6.1 p -44.71 -35.24 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 116.423 2.008 . . . . 41.46 116.423 172.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1064 ' ' TRP . . . . . . . . . . . . . 46.0 m95 -73.25 -22.41 60.41 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-N 119.64 1.109 . . . . 39.32 111.941 -169.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -69.22 70.39 0.24 Allowed 'General case' 0 CA--C 1.547 0.859 0 O-C-N 119.414 -2.054 . . . . 55.38 110.676 172.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1066 ' ' SER . . . . . . . . . . . . . 72.3 m -160.17 123.17 3.44 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 101.457 -3.535 . . . . 41.87 101.457 -171.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -74.56 2.08 10.54 Favored 'General case' 0 CA--C 1.508 -0.646 0 O-C-N 120.924 -1.11 . . . . 53.2 112.285 -178.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1068 ' ' ILE . . . . . 0.43 ' HB ' HG12 ' A' 1003 ' ' ILE . 4.9 mp -130.19 129.11 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 104.05 -2.574 . . . . 41.9 104.05 167.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1069 ' ' ILE . . . . . . . . . . . . . 25.7 mm -125.58 120.57 58.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 104.972 -2.233 . . . . 38.73 104.972 171.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1070 ' ' LEU . . . . . 0.851 HD13 HD13 ' A' 1331 ' ' LEU . 80.1 mt -101.75 133.95 45.68 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.061 -2.2 . . . . 32.44 105.061 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1071 ' ' LYS . . . . . 0.508 ' HB2' ' OG ' ' A' 1091 ' ' SER . 2.5 mmmp? -133.68 141.78 47.73 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.134 -1.432 . . . . 34.65 107.134 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1072 ' ' VAL . . . . . 0.495 HG12 HH11 ' A' 1015 ' ' ARG . 2.4 t -92.16 -4.1 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.016 0 O-C-N 119.87 -1.769 . . . . 31.32 111.031 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -142.09 159.41 42.28 Favored 'General case' 0 C--O 1.256 1.396 0 N-CA-C 102.393 -3.188 . . . . 33.94 102.393 173.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -42.1 140.89 1.47 Allowed Pre-proline 0 C--O 1.239 0.515 0 C-N-CA 124.872 1.269 . . . . 38.04 113.25 171.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1075 ' ' PRO . . . . . 0.741 ' HG2' HD21 ' A' 1089 ' ' LEU . 44.9 Cg_exo -67.36 99.67 0.52 Allowed 'Trans proline' 0 CA--C 1.492 -1.589 0 C-N-CA 122.18 1.92 . . . . 42.68 107.595 165.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1076 ' ' LEU . . . . . 0.639 HD11 HD12 ' A' 1010 ' ' LEU . 38.9 mt -73.02 167.35 21.28 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 112.219 -2.264 . . . . 46.74 108.61 -173.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1077 ' ' ASP . . . . . 0.449 ' HA ' HD12 ' A' 1080 ' ' ILE . 10.8 m-20 -43.15 -32.94 0.8 Allowed 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 120.46 3.504 . . . . 58.61 120.46 -175.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 16.0 t70 -75.09 -44.08 49.44 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 118.412 -0.804 . . . . 59.2 109.772 176.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1079 ' ' GLU . . . . . 0.434 ' HG2' ' HE2' ' A' 1071 ' ' LYS . 1.8 mp0 -59.73 -40.63 88.65 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 119.525 -0.87 . . . . 50.63 112.378 173.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1080 ' ' ILE . . . . . 0.716 HD11 ' HG ' ' A' 1101 ' ' LEU . 74.5 mt -54.15 -49.56 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 O-C-N 124.443 1.09 . . . . 51.48 108.36 176.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -57.15 -33.82 67.79 Favored 'General case' 0 C--O 1.249 1.075 0 N-CA-C 112.864 0.69 . . . . 50.28 112.864 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 42.0 mt -87.4 -16.75 34.03 Favored 'General case' 0 C--N 1.334 -0.078 0 O-C-N 120.29 -1.506 . . . . 50.21 114.239 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1083 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.81 132.88 48.23 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 118.841 -2.412 . . . . 49.06 116.476 -162.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 31.7 t30 -76.86 123.77 87.48 Favored Pre-proline 0 N--CA 1.452 -0.339 0 CA-C-N 114.293 -1.321 . . . . 51.08 113.651 174.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -61.27 155.59 50.74 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 124.249 3.3 . . . . 49.73 115.939 173.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 68.45 66.16 2.4 Favored Glycine 0 C--O 1.215 -1.058 0 CA-C-O 124.63 2.239 . . . . 47.71 109.539 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1087 ' ' THR . . . . . . . . . . . . . 33.0 m -146.22 137.75 24.74 Favored 'General case' 0 C--O 1.252 1.23 0 O-C-N 119.631 -2.1 . . . . 45.47 107.519 -171.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1088 ' ' THR . . . . . . . . . . . . . 3.0 m -80.21 94.98 6.15 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 104.169 -2.53 . . . . 42.04 104.169 165.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1089 ' ' LEU . . . . . 0.741 HD21 ' HG2' ' A' 1075 ' ' PRO . 27.7 tp -94.35 87.71 5.29 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 106.469 -1.678 . . . . 38.06 106.469 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1090 ' ' VAL . . . . . 0.408 ' HB ' HD23 ' A' 1070 ' ' LEU . 33.8 t -92.95 121.1 43.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 104.544 -2.391 . . . . 37.4 104.544 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1091 ' ' SER . . . . . 0.508 ' OG ' ' HB2' ' A' 1071 ' ' LYS . 26.7 m -153.37 151.83 30.38 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.857 -1.152 . . . . 36.16 112.673 -169.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 5.2 t80 -77.92 109.73 12.21 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 118.748 -2.47 . . . . 38.94 105.561 169.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 29.9 mm -90.56 -45.46 14.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 113.295 0.85 . . . . 42.17 113.295 -168.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 86.3 m95 54.61 66.36 4.21 Favored Pre-proline 0 C--O 1.245 0.827 0 O-C-N 124.485 1.115 . . . . 46.51 111.423 -157.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -52.0 -36.08 63.51 Favored 'Trans proline' 0 N--CA 1.449 -1.124 1 C-N-CA 125.801 4.334 . . . . 49.76 116.268 -175.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -72.35 -31.88 66.0 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-N 119.334 0.97 . . . . 52.62 108.84 -177.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 10.2 mp0 -77.95 -20.65 52.33 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 118.858 0.754 . . . . 60.74 112.243 172.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1098 ' ' ASN . . . . . 0.619 ' HB3' ' HB3' ' A' 1101 ' ' LEU . 69.4 m-80 -118.99 38.85 0.29 Allowed Pre-proline 0 N--CA 1.44 -0.958 0 N-CA-C 117.945 2.572 . . . . 58.19 117.945 -172.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -66.87 -24.59 46.24 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 124.569 3.513 . . . . 54.59 113.04 -168.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.99 -39.0 18.58 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 113.05 0.759 . . . . 63.28 113.05 175.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1101 ' ' LEU . . . . . 0.716 ' HG ' HD11 ' A' 1080 ' ' ILE . 10.2 tt -54.97 -39.78 69.32 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 109.765 -0.458 . . . . 54.75 109.765 166.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1102 ' ' MET . . . . . 0.417 ' HG2' ' O ' ' A' 1098 ' ' ASN . 49.2 mmm -57.74 -45.05 86.36 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.677 -1.264 . . . . 52.65 114.156 175.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -54.78 -43.35 72.75 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 112.536 0.569 . . . . 66.26 112.536 174.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1104 ' ' LYS . . . . . 0.632 ' HB3' HG21 ' A' 1080 ' ' ILE . 82.5 mttt -71.09 -41.67 70.32 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.435 0.636 . . . . 63.73 112.102 -175.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 71.8 mt -68.53 -32.38 72.29 Favored 'General case' 0 C--O 1.241 0.618 0 O-C-N 120.572 -1.33 . . . . 54.68 112.874 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -57.72 -51.52 69.2 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 120.455 1.479 . . . . 53.64 108.203 167.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -57.08 -25.68 59.14 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 122.14 2.246 . . . . 67.24 115.001 169.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -80.01 -3.85 50.15 Favored 'General case' 0 C--N 1.361 1.085 0 CA-C-N 121.177 1.808 . . . . 65.76 111.191 171.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 24.9 t-20 62.7 47.67 4.62 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 122.744 1.259 . . . . 58.71 109.578 168.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1110 ' ' VAL . . . . . . . . . . . . . 17.3 m -118.06 145.71 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 O-C-N 121.558 -0.714 . . . . 46.63 111.607 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1111 ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' 1361 ' ' ILE . 49.2 m -83.62 94.63 8.14 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-O 123.156 1.455 . . . . 44.13 107.681 174.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1112 ' ' VAL . . . . . 0.556 HG22 HD23 ' A' 1089 ' ' LEU . 82.8 t -89.94 118.93 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.008 0 CA-C-N 113.624 -1.625 . . . . 40.44 109.414 -174.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1113 ' ' MET . . . . . 0.696 ' HB3' HG12 ' A' 1358 ' ' VAL . 63.6 mtp -109.75 108.59 19.0 Favored 'General case' 0 C--O 1.252 1.229 0 N-CA-C 107.547 -1.279 . . . . 50.76 107.547 -177.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1114 ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' 1091 ' ' SER . . . -85.12 108.42 17.67 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-O 123.736 1.731 . . . . 35.64 110.653 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1115 ' ' MET . . . . . 0.489 ' HB3' ' CB ' ' A' 1129 ' ' ALA . 61.8 mmm -69.39 -14.35 62.86 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 112.049 -2.342 . . . . 38.74 115.467 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1116 ' ' ASP . . . . . 0.595 ' HA ' ' HB2' ' A' 1130 ' ' LEU . 3.6 p30 -71.14 -36.25 72.01 Favored 'General case' 0 C--N 1.352 0.674 0 CA-C-N 120.189 1.359 . . . . 40.14 111.122 162.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1117 ' ' SER . . . . . . . . . . . . . 49.2 m -80.97 23.33 0.56 Allowed 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 125.121 1.513 . . . . 44.79 114.551 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1118 ' ' VAL . . . . . 0.583 HG12 ' HB1' ' A' 1124 ' ' ALA . 16.5 t -70.3 131.41 88.55 Favored Pre-proline 0 N--CA 1.445 -0.681 0 N-CA-C 104.576 -2.379 . . . . 43.75 104.576 166.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1119 ' ' PRO . . . . . 0.487 ' HB2' HG12 ' A' 1121 ' ' ILE . 91.6 Cg_exo -58.36 146.25 90.48 Favored 'Trans proline' 0 C--O 1.252 1.216 0 C-N-CA 122.63 2.22 . . . . 48.93 113.556 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -66.6 -10.31 44.41 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 120.691 -1.255 . . . . 62.9 113.0 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1121 ' ' ILE . . . . . 0.487 HG12 ' HB2' ' A' 1119 ' ' PRO . 50.0 pt -62.19 152.19 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 N-CA-C 114.003 1.112 . . . . 57.72 114.003 -177.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1122 ' ' SER . . . . . . . . . . . . . 6.5 m -48.52 -52.63 21.61 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 118.304 2.705 . . . . 57.26 118.304 -177.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -56.64 -22.62 35.69 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 118.386 -2.696 . . . . 62.9 113.423 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1124 ' ' ALA . . . . . 0.583 ' HB1' HG12 ' A' 1118 ' ' VAL . . . -90.04 -21.52 22.31 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 117.025 -1.464 . . . . 49.83 111.773 -172.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -61.67 -26.73 68.2 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 116.444 2.016 . . . . 52.37 116.444 -163.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1126 ' ' SER . . . . . . . . . . . . . 5.8 p -66.83 -37.77 85.13 Favored 'General case' 0 C--O 1.245 0.821 0 O-C-N 119.058 -2.276 . . . . 42.43 111.999 170.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1127 ' ' LEU . . . . . . . . . . . . . 3.5 mp -77.23 -31.16 54.94 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 122.95 1.357 . . . . 43.74 110.739 176.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1128 ' ' ASP . . . . . 0.406 ' HA ' HG21 ' A' 1118 ' ' VAL . 6.1 t70 -53.82 109.78 0.5 Allowed 'General case' 0 C--O 1.252 1.227 0 CA-C-O 123.965 1.84 . . . . 43.21 113.649 -176.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1129 ' ' ALA . . . . . 0.489 ' CB ' ' HB3' ' A' 1115 ' ' MET . . . -80.06 -31.65 39.39 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 111.62 -2.536 . . . . 35.74 112.687 177.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1130 ' ' LEU . . . . . 0.595 ' HB2' ' HA ' ' A' 1116 ' ' ASP . 36.0 tp -54.45 -51.64 64.35 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.775 0.716 . . . . 38.09 110.538 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1131 ' ' SER . . . . . 0.464 ' HB3' HG21 ' A' 1175 ' ' VAL . 7.3 m -50.47 -49.26 55.69 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.715 1.206 . . . . 36.91 111.347 174.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1132 ' ' SER . . . . . . . . . . . . . 1.4 m -73.28 -42.29 62.61 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 115.676 -0.693 . . . . 35.79 111.123 -171.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1133 ' ' MET . . . . . 0.517 ' HA ' HD12 ' A' 1136 ' ' ILE . 28.6 mtp -63.2 -43.09 99.15 Favored 'General case' 0 N--CA 1.433 -1.308 0 O-C-N 120.479 -1.388 . . . . 30.81 110.564 177.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1134 ' ' ALA . . . . . 0.651 ' HB1' ' HB2' ' A' 1176 ' ' ALA . . . -52.09 -47.17 65.38 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 122.99 1.376 . . . . 28.88 112.903 168.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1135 ' ' ASN . . . . . 0.774 ' HB2' HG12 ' A' 1175 ' ' VAL . 25.0 t-20 -59.01 -48.21 82.4 Favored 'General case' 0 C--N 1.347 0.463 0 O-C-N 120.832 -1.168 . . . . 40.76 112.18 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1136 ' ' ILE . . . . . 0.575 HD13 ' HA ' ' A' 1323 ' ' SER . 61.3 mt -59.18 -46.48 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 108.782 -0.821 . . . . 31.54 108.782 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -61.39 -30.46 70.56 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 115.905 -1.998 . . . . 29.87 112.771 175.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -75.14 -39.8 36.18 Favored Glycine 0 CA--C 1.499 -0.932 0 CA-C-N 121.472 1.942 . . . . 28.73 109.814 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 25.5 t80 -65.62 -45.68 82.18 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.21 -1.033 . . . . 30.39 108.21 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1140 ' ' ARG . . . . . 0.459 ' HG3' HD22 ' A' 1315 ' ' LEU . 8.7 tpt180 -69.19 -24.82 64.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.906 0.86 . . . . 26.09 112.536 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1141 ' ' ALA . . . . . 0.604 ' HB2' HD21 ' A' 1284 ' ' LEU . . . -62.13 -45.14 94.77 Favored 'General case' 0 C--O 1.245 0.858 0 O-C-N 120.353 -1.467 . . . . 27.1 109.409 168.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 46.7 mm -58.52 -44.48 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 120.444 1.475 . . . . 28.48 114.538 172.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 28.8 t -53.1 -59.62 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 114.72 -1.127 . . . . 23.07 111.266 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1144 ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -75.27 -23.9 57.51 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.982 -0.377 . . . . 33.4 109.982 -171.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1145 ' ' ALA . . . . . 0.531 ' HA ' HG11 ' A' 1280 ' ' VAL . . . -62.12 -51.55 67.44 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.334 -0.987 . . . . 24.22 108.334 171.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -64.07 -28.06 69.53 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 123.8 0.84 . . . . 24.89 112.348 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -65.51 -40.28 92.82 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 118.763 -0.637 . . . . 26.73 110.832 171.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1148 ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -101.68 5.78 41.6 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 119.009 -2.307 . . . . 39.96 113.043 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1149 ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -76.15 144.9 40.29 Favored 'General case' 0 CA--C 1.514 -0.427 0 O-C-N 120.067 -1.645 . . . . 25.87 112.816 -169.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1150 ' ' GLY . . . . . 0.653 ' HA2' ' HG2' ' B' 1320 ' ' PRO . . . -71.21 -48.97 28.8 Favored Glycine 0 C--O 1.218 -0.9 0 N-CA-C 109.799 -1.32 . . . . 19.28 109.799 172.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1151 ' ' ARG . . . . . 0.866 ' HA ' ' HB2' ' B' 1322 ' ' GLN . 74.2 mtm-85 -99.57 -172.17 2.2 Favored 'General case' 0 C--N 1.318 -0.795 0 O-C-N 120.906 -1.35 . . . . 39.9 114.071 -172.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1152 ' ' PHE . . . . . 0.44 ' HD2' ' HG2' ' B' 1322 ' ' GLN . 0.4 OUTLIER -96.51 144.69 26.36 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 103.856 -2.646 . . . . 29.44 103.856 177.282 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 1153 ' ' PHE . . . . . 0.421 ' CZ ' HG13 ' A' 1251 ' ' ILE . 8.7 m-85 -64.21 -57.19 10.2 Favored 'General case' 0 C--N 1.341 0.224 0 O-C-N 121.211 -0.931 . . . . 32.6 110.039 168.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1154 ' ' THR . . . . . 0.519 HG22 ' HB3' ' A' 1156 ' ' GLN . 90.8 m -61.8 123.95 19.41 Favored 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 126.431 1.893 . . . . 34.64 116.015 -177.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -71.78 73.43 0.81 Allowed Glycine 0 N--CA 1.439 -1.158 0 CA-C-O 126.052 3.029 . . . . 37.14 111.259 175.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1156 ' ' GLN . . . . . 0.519 ' HB3' HG22 ' A' 1154 ' ' THR . 4.2 pp0? -108.93 136.2 48.86 Favored 'General case' 0 N--CA 1.434 -1.232 0 O-C-N 118.588 -2.713 . . . . 40.57 115.876 -177.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1157 ' ' ILE . . . . . 0.773 HG13 ' HB3' ' C' ' 70' ' ' PRO . 4.5 tp -90.87 110.2 21.97 Favored 'Isoleucine or valine' 0 C--O 1.256 1.431 0 CA-C-N 113.361 -1.745 . . . . 44.61 106.673 171.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1158 ' ' THR . . . . . . . . . . . . . 17.5 m -78.15 177.11 8.62 Favored 'General case' 0 C--O 1.252 1.202 0 O-C-N 120.87 -1.144 . . . . 40.7 110.563 169.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -65.09 -23.24 67.1 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 116.97 -3.581 . . . . 40.25 111.171 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1160 ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' B' 1126 ' ' SER . . . -134.35 131.01 37.8 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 104.828 -2.286 . . . . 38.47 104.828 159.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . 111.93 115.05 3.42 Favored Glycine 0 C--O 1.247 0.93 0 C-N-CA 119.572 -1.299 . . . . 37.61 112.095 170.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 15.8 tttp -85.7 130.87 34.45 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 104.456 -2.424 . . . . 48.9 104.456 169.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1163 ' ' VAL . . . . . 0.496 HG22 ' NE2' ' B' 1322 ' ' GLN . 69.7 t -85.98 128.19 59.09 Favored Pre-proline 0 N--CA 1.42 -1.933 0 O-C-N 120.01 -1.681 . . . . 36.52 107.896 164.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1164 ' ' PRO . . . . . 0.508 ' HA ' ' HD2' ' A' 1165 ' ' PRO . 28.6 Cg_endo -72.26 108.23 2.44 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.516 2.144 . . . . 35.08 108.904 155.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1165 ' ' PRO . . . . . 0.508 ' HD2' ' HA ' ' A' 1164 ' ' PRO . 30.4 Cg_endo -56.34 148.25 62.67 Favored 'Trans proline' 0 N--CA 1.444 -1.394 1 C-N-CA 126.314 4.676 . . . . 35.33 115.289 -176.524 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 1166 ' ' ALA . . . . . 0.443 ' O ' ' HB1' ' A' 1189 ' ' ALA . . . -66.12 129.02 38.39 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 125.159 1.537 . . . . 34.69 110.962 177.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1167 ' ' LYS . . . . . 0.611 ' HB2' ' HA ' ' A' 1249 ' ' VAL . 64.4 mttp -92.41 106.99 18.88 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 105.17 -2.159 . . . . 45.36 105.17 172.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 60.6 t -91.58 91.57 3.57 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 106.967 -1.494 . . . . 31.71 106.967 -175.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1169 ' ' MET . . . . . 0.465 ' HA ' ' O ' ' A' 1192 ' ' ARG . 25.1 ttp -79.29 92.11 5.1 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 124.593 2.14 . . . . 42.28 108.717 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1170 ' ' VAL . . . . . 0.438 HG13 ' OG1' ' A' 1255 ' ' THR . 13.8 t -75.29 115.14 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 112.128 -2.305 . . . . 30.51 106.629 176.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 64.5 mt -104.07 123.59 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 104.528 -2.397 . . . . 31.87 104.528 176.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 79.32 79.25 0.83 Allowed Glycine 0 CA--C 1.493 -1.332 0 CA-C-O 123.796 1.776 . . . . 34.54 109.81 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1173 ' ' ALA . . . . . 0.613 ' HB3' HG21 ' A' 1200 ' ' VAL . . . -75.7 179.86 5.15 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 123.417 1.58 . . . . 32.51 109.669 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . 138.92 -157.69 24.89 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 106.182 -2.767 . . . . 29.9 106.182 -175.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1175 ' ' VAL . . . . . 0.774 HG12 ' HB2' ' A' 1135 ' ' ASN . 34.3 t -70.49 -30.06 41.19 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 CA-C-N 122.188 2.994 . . . . 33.11 110.66 -170.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1176 ' ' ALA . . . . . 0.651 ' HB2' ' HB1' ' A' 1134 ' ' ALA . . . -65.35 -41.73 93.57 Favored 'General case' 0 C--N 1.348 0.517 0 CA-C-O 122.343 1.068 . . . . 28.1 108.832 171.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -60.67 -42.45 99.32 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 124.478 2.154 . . . . 28.54 109.997 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1178 ' ' LEU . . . . . 0.534 ' HA ' HD12 ' A' 1181 ' ' ILE . 72.8 mt -67.83 -35.69 79.05 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 113.403 -1.399 . . . . 31.22 111.052 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1179 ' ' ALA . . . . . 0.485 ' HB2' ' ND2' ' A' 1135 ' ' ASN . . . -64.99 -44.59 88.79 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-N 122.832 2.56 . . . . 28.98 108.822 175.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -55.25 -45.46 76.08 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 126.317 2.26 . . . . 27.83 113.085 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1181 ' ' ILE . . . . . 0.534 HD12 ' HA ' ' A' 1178 ' ' LEU . 33.5 mt -63.62 -54.28 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 O-C-N 120.237 -1.54 . . . . 30.25 108.819 175.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -52.29 -26.02 20.52 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 112.668 -2.06 . . . . 29.59 112.761 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -85.24 -60.25 2.09 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 115.323 1.601 . . . . 30.29 115.323 165.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -74.8 -39.73 61.52 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 115.386 1.624 . . . . 30.47 115.386 -167.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -60.22 -43.49 95.96 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 119.759 -1.838 . . . . 42.41 109.685 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1186 ' ' SER . . . . . 0.492 ' O ' ' HB3' ' B' 1186 ' ' SER . 21.4 m -58.39 -46.11 87.03 Favored 'General case' 0 C--O 1.213 -0.827 0 CA-C-O 121.957 0.885 . . . . 39.38 111.078 175.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 44.0 mt -62.47 -30.44 71.26 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 114.909 1.448 . . . . 36.18 114.909 174.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 103.36 42.38 2.04 Favored Glycine 0 N--CA 1.428 -1.879 0 CA-C-N 114.839 -1.073 . . . . 33.78 111.015 176.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1189 ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' 1166 ' ' ALA . . . -115.9 144.2 44.38 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 106.915 -1.513 . . . . 33.93 106.915 174.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 45.7 mt -72.07 102.63 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 O-C-N 120.226 -1.546 . . . . 38.74 110.375 -174.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1191 ' ' VAL . . . . . 0.451 HG21 ' HA ' ' A' 1181 ' ' ILE . 17.0 t -86.84 121.27 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 O-C-N 119.817 -1.802 . . . . 33.09 106.854 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1192 ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' 1169 ' ' MET . 73.8 mtt180 -115.68 105.33 12.63 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 105.321 -2.103 . . . . 38.92 105.321 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1193 ' ' ALA . . . . . 0.463 ' HB3' HG11 ' A' 1204 ' ' VAL . . . -102.73 124.67 48.69 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 118.928 -1.109 . . . . 35.32 110.482 -176.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1194 ' ' PHE . . . . . 0.54 ' HB2' HD12 ' A' 1212 ' ' LEU . 69.7 t80 -110.59 140.74 44.63 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 122.133 0.968 . . . . 39.35 109.419 175.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 7.1 t0 -157.52 150.12 22.95 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.182 -1.044 . . . . 40.46 108.182 174.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1196 ' ' THR . . . . . 0.541 HG23 ' CE2' ' A' 1234 ' ' PHE . 8.7 m -58.31 -38.98 78.16 Favored 'General case' 0 N--CA 1.445 -0.698 0 O-C-N 128.391 3.557 . . . . 45.94 109.493 171.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1197 ' ' ARG . . . . . 0.417 ' HA ' ' HD2' ' A' 1198 ' ' PRO . 86.5 mtm180 -87.73 110.92 38.6 Favored Pre-proline 0 C--N 1.318 -0.776 0 C-N-CA 126.67 1.988 . . . . 56.02 109.777 -172.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1198 ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' 1197 ' ' ARG . 72.6 Cg_endo -66.32 -13.32 39.38 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 121.457 1.438 . . . . 51.27 112.072 166.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -52.8 -30.49 33.54 Favored 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 118.66 -2.525 . . . . 59.1 115.1 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1200 ' ' VAL . . . . . 0.613 HG21 ' HB3' ' A' 1173 ' ' ALA . 35.6 m -93.92 -9.84 9.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 114.235 1.198 . . . . 51.06 114.235 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 86.4 tttt -52.17 -61.52 2.21 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 114.991 1.478 . . . . 57.38 114.991 -174.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1202 ' ' GLU . . . . . 0.4 ' HA ' ' HB2' ' A' 1205 ' ' GLN . 23.7 mp0 -69.37 -22.27 63.74 Favored 'General case' 0 C--O 1.211 -0.955 0 CA-C-N 119.934 1.243 . . . . 62.41 112.567 -177.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -63.84 -50.79 67.51 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 113.174 0.805 . . . . 57.78 113.174 170.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1204 ' ' VAL . . . . . 0.463 HG11 ' HB3' ' A' 1193 ' ' ALA . 47.4 t -58.98 -41.01 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 113.751 -1.568 . . . . 46.38 110.634 173.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1205 ' ' GLN . . . . . 0.4 ' HB2' ' HA ' ' A' 1202 ' ' GLU . 97.7 mt-30 -68.19 -29.37 68.21 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 115.401 1.63 . . . . 50.7 115.401 173.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1206 ' ' SER . . . . . . . . . . . . . 64.0 m -74.59 -31.37 62.01 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 121.062 -1.024 . . . . 49.98 110.872 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1207 ' ' MET . . . . . 0.413 ' SD ' ' HB3' ' A' 1178 ' ' LEU . 36.8 mtp -79.68 -15.2 58.0 Favored 'General case' 0 C--O 1.249 1.045 0 O-C-N 120.745 -1.222 . . . . 52.99 113.469 170.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 97.53 83.83 1.72 Allowed Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 109.009 -1.636 . . . . 47.66 109.009 173.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1209 ' ' ALA . . . . . 0.448 ' HB3' ' CG1' ' A' 1204 ' ' VAL . . . -161.27 145.82 13.49 Favored 'General case' 0 C--N 1.289 -2.03 0 O-C-N 119.093 -2.416 . . . . 44.77 107.311 176.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -76.76 123.04 25.59 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 103.74 -2.689 . . . . 47.64 103.74 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1211 ' ' PHE . . . . . . . . . . . . . 11.9 t80 -89.01 136.52 32.97 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 106.606 -1.627 . . . . 45.66 106.606 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1212 ' ' LEU . . . . . 0.54 HD12 ' HB2' ' A' 1194 ' ' PHE . 68.4 mt -94.51 119.22 32.87 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 107.521 -1.288 . . . . 46.06 107.521 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -71.76 144.25 49.28 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 112.79 -2.004 . . . . 60.22 111.875 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1214 ' ' LEU . . . . . 0.537 HD21 ' HZ ' ' A' 1234 ' ' PHE . 17.2 tp -73.66 89.13 1.74 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 109.504 -3.498 . . . . 57.25 112.421 -171.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1215 ' ' ASP . . . . . 0.481 ' O ' ' HB1' ' A' 1237 ' ' ALA . 23.6 t0 -71.53 87.09 0.89 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 114.086 1.143 . . . . 64.43 114.086 -174.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 85.4 t80 . . . . . 0 C--O 1.202 -1.413 0 O-C-N 124.794 1.309 . . . . 66.9 107.814 -170.507 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 30.9 t70 . . . . . 0 N--CA 1.447 -0.578 0 N-CA-C 107.071 -1.455 . . . . 39.09 107.071 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -67.34 -41.87 90.75 Favored Glycine 0 C--N 1.347 1.17 0 CA-C-N 114.484 -1.235 . . . . 39.32 111.598 -173.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 51.0 t80 -73.4 -42.09 62.53 Favored 'General case' 0 CA--C 1.504 -0.788 0 CA-C-O 118.151 -0.928 . . . . 39.3 108.696 -177.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -62.04 -38.51 89.01 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-N 119.539 1.063 . . . . 36.3 109.226 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -57.11 -45.94 83.02 Favored 'General case' 0 C--O 1.207 -1.159 0 CA-C-O 117.903 -1.046 . . . . 37.38 111.241 172.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -53.79 -31.12 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 113.15 0.796 . . . . 39.11 113.15 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1230 ' ' MET . . . . . . . . . . . . . 38.1 mmt -81.36 -23.97 37.37 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 116.394 1.998 . . . . 49.59 116.394 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1231 ' ' SER . . . . . . . . . . . . . 54.0 p -67.77 133.69 49.68 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.194 0.812 . . . . 43.68 113.194 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -50.23 -40.52 47.82 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 116.282 1.956 . . . . 55.57 116.282 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -64.72 -33.12 75.21 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 122.16 0.981 . . . . 44.94 110.271 178.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1234 ' ' PHE . . . . . 0.541 ' CE2' HG23 ' A' 1196 ' ' THR . 26.0 t80 -76.16 -46.48 28.37 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.365 -0.834 . . . . 42.04 109.041 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 12.2 mt -59.26 -31.43 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 122.344 -0.222 . . . . 46.28 111.377 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 53.3 tttm -62.48 -48.46 79.51 Favored 'General case' 0 C--O 1.245 0.867 0 O-C-N 119.531 -1.981 . . . . 47.87 109.0 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1237 ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' A' 1215 ' ' ASP . . . -58.83 -51.68 68.98 Favored 'General case' 0 C--O 1.247 0.931 0 N-CA-C 113.859 1.059 . . . . 41.61 113.859 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -54.79 -53.67 52.16 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 114.615 -1.175 . . . . 50.65 109.629 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1239 ' ' MET . . . . . . . . . . . . . 43.1 ttm -57.95 -41.36 82.66 Favored 'General case' 0 C--O 1.22 -0.484 0 O-C-N 123.694 0.621 . . . . 48.87 110.582 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -76.48 -22.5 54.44 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 120.119 -1.613 . . . . 54.8 111.725 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 1.3 tm? -66.9 -47.35 72.08 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.512 -1.662 . . . . 43.21 106.512 169.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -60.05 -36.51 77.47 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-O 118.701 -0.666 . . . . 38.66 110.283 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -67.19 -47.96 69.37 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 121.003 1.729 . . . . 37.92 111.353 -177.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -56.97 -55.19 37.88 Favored 'General case' 0 C--O 1.249 1.047 0 O-C-N 121.357 -0.839 . . . . 37.28 110.769 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -55.95 -36.33 67.66 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.743 1.217 . . . . 43.07 113.943 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1246 ' ' ALA . . . . . 0.458 ' HA ' HG22 ' A' 1249 ' ' VAL . . . -56.46 -30.4 62.85 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.996 1.11 . . . . 38.3 113.996 -176.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1247 ' ' LYS . . . . . . . . . . . . . 16.4 mtmt -78.89 -10.63 59.87 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 114.94 1.459 . . . . 47.6 114.94 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -121.18 -16.53 7.95 Favored 'General case' 0 C--O 1.246 0.899 0 O-C-N 119.0 -2.313 . . . . 45.42 114.858 173.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1249 ' ' VAL . . . . . 0.611 ' HA ' ' HB2' ' A' 1167 ' ' LYS . 27.7 m -85.33 175.21 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 O-C-N 119.199 -2.188 . . . . 36.26 111.193 -175.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1250 ' ' ASP . . . . . 0.427 ' O ' ' HB3' ' A' 1279 ' ' SER . 10.4 m-20 -134.27 -61.83 0.77 Allowed 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 112.818 -1.992 . . . . 33.04 109.371 -169.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1251 ' ' ILE . . . . . 0.523 HD12 ' HB1' ' A' 1145 ' ' ALA . 39.3 mm -108.61 94.99 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 107.002 -1.481 . . . . 31.4 107.002 -173.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1252 ' ' ILE . . . . . 0.436 ' HB ' HG23 ' A' 1281 ' ' ILE . 44.2 mt -77.7 107.65 9.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 106.13 -1.804 . . . . 29.42 106.13 171.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 5.5 t -99.28 105.19 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 104.635 -2.357 . . . . 30.37 104.635 173.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1254 ' ' THR . . . . . 0.667 HG21 ' HB2' ' A' 1291 ' ' ASN . 29.1 m -74.37 84.58 1.95 Allowed 'General case' 0 C--O 1.248 1.004 0 CA-C-O 122.732 1.253 . . . . 35.72 109.561 171.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1255 ' ' THR . . . . . 0.438 ' OG1' HG13 ' A' 1170 ' ' VAL . 1.1 p -75.89 -4.28 39.98 Favored 'General case' 0 C--O 1.25 1.093 0 N-CA-C 115.067 1.506 . . . . 36.0 115.067 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1256 ' ' ALA . . . . . . . . . . . . . . . -69.34 86.94 0.43 Allowed 'General case' 0 C--O 1.246 0.878 0 CA-C-O 121.65 0.738 . . . . 40.93 109.41 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1257 ' ' LEU . . . . . 0.553 HD22 ' HB2' ' A' 1134 ' ' ALA . 8.8 tp -73.13 91.96 1.67 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 105.653 -1.98 . . . . 47.82 105.653 178.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1258 ' ' ILE . . . . . 0.41 ' HA ' ' HD3' ' A' 1259 ' ' PRO . 41.8 mm -69.49 131.46 89.96 Favored Pre-proline 0 C--O 1.213 -0.865 0 CA-C-N 112.838 -1.983 . . . . 52.7 109.048 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1259 ' ' PRO . . . . . 0.433 ' O ' ' HG2' ' A' 1261 ' ' LYS . 6.8 Cg_exo -99.41 124.74 0.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.816 2.344 . . . . 54.13 114.387 177.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 78.2 -83.63 1.19 Allowed Glycine 0 C--N 1.343 0.962 0 CA-C-O 124.698 2.277 . . . . 54.62 114.786 173.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1261 ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' 1259 ' ' PRO . 55.2 pttt -42.84 146.91 0.7 Allowed Pre-proline 0 C--O 1.257 1.474 0 N-CA-C 117.711 2.486 . . . . 55.74 117.711 171.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -57.22 142.65 94.63 Favored 'Trans proline' 0 N--CA 1.451 -0.999 1 C-N-CA 125.336 4.024 . . . . 51.15 112.579 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1263 ' ' ALA . . . . . 0.414 ' HA ' ' HD2' ' A' 1264 ' ' PRO . . . -66.93 123.51 86.32 Favored Pre-proline 0 C--N 1.343 0.307 0 CA-C-N 113.446 -1.706 . . . . 46.06 111.169 174.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1264 ' ' PRO . . . . . 0.59 ' HG2' HD21 ' A' 1291 ' ' ASN . 43.7 Cg_endo -58.43 115.58 2.64 Favored 'Trans proline' 0 CA--C 1.509 -0.743 0 C-N-CA 123.792 2.995 . . . . 41.08 115.769 175.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1265 ' ' LYS . . . . . 0.435 ' HB3' ' HG2' ' A' 1293 ' ' GLU . 72.7 mmtt -75.6 89.58 2.76 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 122.495 1.141 . . . . 47.42 108.83 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 37.7 mt -97.67 -45.87 6.21 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.243 -1.391 . . . . 39.22 107.243 -177.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 7.9 mt -87.37 93.99 4.35 Favored 'Isoleucine or valine' 0 C--O 1.252 1.224 0 CA-C-O 126.19 2.9 . . . . 42.5 107.739 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1268 ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.75 143.68 30.01 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 111.97 -2.377 . . . . 37.84 112.383 175.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1269 ' ' ARG . . . . . 0.569 ' HG3' ' HB2' ' A' 1293 ' ' GLU . 56.3 mtt-85 -47.51 -39.18 15.54 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.072 0.949 . . . . 54.8 112.199 175.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -56.72 -50.09 73.24 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.388 -1.445 . . . . 54.36 109.154 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1271 ' ' MET . . . . . . . . . . . . . 10.0 mtt -68.78 -25.36 64.67 Favored 'General case' 0 CA--C 1.497 -1.09 0 O-C-N 123.789 0.68 . . . . 39.52 111.189 -170.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1272 ' ' VAL . . . . . 0.476 HG12 HG21 ' A' 1303 ' ' THR . 59.1 t -66.56 -49.62 73.5 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 O-C-N 126.179 2.174 . . . . 38.25 110.473 175.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -68.58 -26.43 65.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 119.985 -1.697 . . . . 40.77 112.445 174.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1274 ' ' SER . . . . . . . . . . . . . 7.2 m -68.76 -11.84 60.79 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 120.527 1.512 . . . . 36.58 114.442 169.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1275 ' ' MET . . . . . . . . . . . . . 62.7 mtp -62.52 145.69 53.63 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-O 124.478 2.085 . . . . 36.75 111.005 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1276 ' ' LYS . . . . . . . . . . . . . 74.1 tttt -50.64 137.38 19.88 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 110.967 -2.833 . . . . 46.11 106.468 165.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1277 ' ' ALA . . . . . 0.418 ' HB3' ' CD1' ' B' 1045 ' ' PHE . . . -90.94 176.85 6.46 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 117.9 -1.52 . . . . 33.52 110.472 -169.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 63.42 31.01 79.31 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 111.404 -0.679 . . . . 31.27 111.404 -170.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1279 ' ' SER . . . . . 0.427 ' HB3' ' O ' ' A' 1250 ' ' ASP . 15.2 m -122.32 171.93 8.68 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 120.587 -1.537 . . . . 32.95 110.528 -171.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1280 ' ' VAL . . . . . 0.531 HG11 ' HA ' ' A' 1145 ' ' ALA . 41.7 t -134.45 136.27 53.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 O-C-N 120.822 -1.174 . . . . 27.43 110.425 -173.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1281 ' ' ILE . . . . . 0.436 HG23 ' HB ' ' A' 1252 ' ' ILE . 66.0 mt -113.37 109.02 27.01 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 N-CA-C 103.122 -2.918 . . . . 30.3 103.122 170.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1282 ' ' VAL . . . . . 0.448 HG21 ' HB2' ' A' 1145 ' ' ALA . 2.4 t -101.15 97.86 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 105.104 -2.184 . . . . 28.63 105.104 176.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1283 ' ' ASP . . . . . 0.621 ' HA ' ' HB ' ' A' 1254 ' ' THR . 9.4 t70 -95.63 101.18 12.86 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 113.568 -1.651 . . . . 36.27 107.155 -171.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1284 ' ' LEU . . . . . 0.604 HD21 ' HB2' ' A' 1141 ' ' ALA . 31.2 mt -64.38 -37.69 88.41 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 119.608 -0.837 . . . . 38.57 110.688 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -59.23 -1.86 0.23 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 116.523 2.046 . . . . 37.56 116.523 173.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . -36.7 -42.52 0.37 Allowed 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 116.687 2.106 . . . . 40.33 116.687 161.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -51.33 -28.19 11.61 Favored 'General case' 0 C--N 1.348 0.534 0 N-CA-C 115.714 1.746 . . . . 56.85 115.714 174.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 11.4 m120 -113.97 22.88 13.49 Favored 'General case' 0 N--CA 1.433 -1.281 0 O-C-N 121.4 -0.813 . . . . 45.86 108.866 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 109.68 -23.11 22.75 Favored Glycine 0 N--CA 1.43 -1.731 0 O-C-N 118.196 -2.815 . . . . 40.31 114.338 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1290 ' ' GLY . . . . . 0.491 ' HA3' ' HB ' ' A' 1295 ' ' THR . . . 87.62 127.92 2.63 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 120.853 2.327 . . . . 38.89 112.2 -177.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1291 ' ' ASN . . . . . 0.667 ' HB2' HG21 ' A' 1254 ' ' THR . 2.8 m120 -71.27 -26.22 62.79 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 113.345 -1.427 . . . . 37.23 113.804 175.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1292 ' ' CYS . . . . . 0.425 ' SG ' HG21 ' A' 1272 ' ' VAL . 1.6 t -82.51 138.86 34.19 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.757 -1.11 . . . . 36.5 108.951 165.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1293 ' ' GLU . . . . . 0.569 ' HB2' ' HG3' ' A' 1269 ' ' ARG . 78.5 mt-10 -68.8 -6.56 27.52 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 115.371 1.619 . . . . 43.32 115.371 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -102.81 -2.09 28.59 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 119.688 -1.883 . . . . 41.32 112.706 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1295 ' ' THR . . . . . 0.491 ' HB ' ' HA3' ' A' 1290 ' ' GLY . 31.5 m -78.04 103.13 7.79 Favored 'General case' 0 C--N 1.355 0.832 0 O-C-N 120.845 -1.16 . . . . 35.3 112.827 -168.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 47.8 t -82.6 121.59 78.1 Favored Pre-proline 0 C--N 1.31 -1.131 0 O-C-N 125.292 1.62 . . . . 34.84 107.4 174.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -63.51 143.46 88.0 Favored 'Trans proline' 0 C--O 1.25 1.118 0 C-N-CA 122.984 2.456 . . . . 33.51 108.884 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 69.69 13.56 68.87 Favored Glycine 0 CA--C 1.544 1.9 0 CA-C-O 116.682 -2.177 . . . . 32.19 115.425 -175.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -147.37 169.98 18.32 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-N 123.988 3.894 . . . . 34.88 112.823 -172.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1300 ' ' ILE . . . . . 0.452 HG12 HG12 ' A' 1310 ' ' ILE . 74.3 mt -107.92 141.44 23.16 Favored 'Isoleucine or valine' 0 C--O 1.248 0.992 0 N-CA-C 106.555 -1.646 . . . . 32.29 106.555 166.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 78.8 t80 -119.74 114.28 21.92 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 104.194 -2.521 . . . . 37.25 104.194 164.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1302 ' ' THR . . . . . . . . . . . . . 46.0 m -93.66 118.9 31.99 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 103.614 -2.735 . . . . 35.56 103.614 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1303 ' ' THR . . . . . 0.476 HG21 HG12 ' A' 1272 ' ' VAL . 8.5 p -70.74 170.92 11.41 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 113.525 -1.671 . . . . 36.4 114.284 -171.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -75.23 -9.65 58.75 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 113.963 1.097 . . . . 52.32 113.963 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 37.3 p-10 -83.84 -46.14 12.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.363 0.601 . . . . 40.04 111.356 166.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 127.45 52.0 0.14 Allowed Glycine 0 N--CA 1.427 -1.903 0 CA-C-N 114.466 -1.243 . . . . 36.96 112.808 -177.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1307 ' ' VAL . . . . . . . . . . . . . 82.0 t -118.77 124.02 72.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 N-CA-C 104.943 -2.243 . . . . 33.4 104.943 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1308 ' ' LYS . . . . . 0.44 ' HB2' HG22 ' A' 1280 ' ' VAL . 53.7 mmtt -80.21 95.11 6.18 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 106.116 -1.809 . . . . 42.91 106.116 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 38.4 t -84.22 92.68 3.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 106.357 -1.72 . . . . 32.29 106.357 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1310 ' ' ILE . . . . . 0.452 HG12 HG12 ' A' 1300 ' ' ILE . 82.6 mt -82.44 103.41 9.62 Favored 'Isoleucine or valine' 0 C--N 1.351 0.642 0 CA-C-N 112.782 -2.008 . . . . 30.99 109.166 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -103.21 60.69 0.48 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 108.936 -1.666 . . . . 28.95 108.936 168.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1312 ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -83.25 95.73 8.24 Favored 'General case' 0 C--O 1.252 1.189 0 CA-C-O 125.278 2.466 . . . . 31.69 111.483 177.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1313 ' ' THR . . . . . . . . . . . . . 2.8 m -51.91 -37.92 54.35 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 112.46 -2.155 . . . . 34.17 111.567 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -84.77 10.38 11.58 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 113.381 -1.736 . . . . 36.86 111.679 -169.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1315 ' ' LEU . . . . . 0.459 HD22 ' HG3' ' A' 1140 ' ' ARG . 96.9 mt -44.05 -44.36 17.0 Favored Pre-proline 0 N--CA 1.474 0.743 0 N-CA-C 119.356 3.095 . . . . 34.85 119.356 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -53.6 -33.46 68.88 Favored 'Trans proline' 0 C--O 1.258 1.518 0 C-N-CA 124.53 3.486 . . . . 29.15 115.025 170.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1317 ' ' GLY . . . . . 0.451 ' O ' ' HB ' ' A' 1014 ' ' THR . . . -76.32 -40.66 28.02 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 109.496 -1.442 . . . . 27.29 109.496 177.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1318 ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' 1318 ' ' ARG . 58.1 mtt-85 -58.05 -26.62 62.73 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 115.641 1.719 . . . . 41.49 115.641 177.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1319 ' ' LEU . . . . . 0.459 HD23 HG23 ' A' 1136 ' ' ILE . 13.1 tp -103.97 71.88 0.17 Allowed Pre-proline 0 C--O 1.238 0.486 0 O-C-N 119.587 -1.946 . . . . 27.61 109.141 168.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1320 ' ' PRO . . . . . 0.706 ' HD2' ' HA2' ' B' 1150 ' ' GLY . 86.1 Cg_endo -58.12 -54.87 2.67 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.854 3.036 . . . . 25.94 113.985 -166.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1321 ' ' THR . . . . . 0.685 HG23 HG21 ' A' 1019 ' ' THR . 4.3 m -63.7 -43.53 96.35 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.937 0.895 . . . . 25.01 109.621 -171.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1322 ' ' GLN . . . . . 0.504 HE21 ' HG ' ' A' 1326 ' ' LEU . 9.3 tp60 -67.56 -26.76 66.46 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 117.451 -1.261 . . . . 29.39 112.803 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1323 ' ' SER . . . . . 0.575 ' HA ' HD13 ' A' 1136 ' ' ILE . 36.9 m -66.81 -51.29 57.34 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 120.346 1.43 . . . . 26.47 111.131 162.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1324 ' ' SER . . . . . . . . . . . . . 4.3 m -63.39 -17.83 63.04 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 116.296 1.962 . . . . 27.78 116.296 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -104.44 -54.87 2.45 Favored 'General case' 0 C--O 1.247 0.937 0 CA-C-N 114.787 -1.097 . . . . 37.53 110.811 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1326 ' ' LEU . . . . . 0.504 ' HG ' HE21 ' A' 1322 ' ' GLN . 33.6 mt -69.3 -59.5 2.96 Favored 'General case' 0 CA--C 1.505 -0.761 0 O-C-N 118.015 -2.928 . . . . 35.71 112.274 175.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1327 ' ' TYR . . . . . 0.531 ' HB3' ' O ' ' A' 1323 ' ' SER . 31.3 t80 -57.16 -37.5 72.18 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-O 122.31 1.052 . . . . 31.59 108.218 177.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1328 ' ' GLY . . . . . 0.463 ' HA2' HD12 ' A' 1331 ' ' LEU . . . -46.77 -58.4 6.13 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.95 1.262 . . . . 28.0 113.226 168.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1329 ' ' THR . . . . . 0.476 HG23 HE22 ' A' 1025 ' ' GLN . 17.3 m -70.14 -25.45 63.47 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.371 1.586 . . . . 32.15 110.619 -177.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1330 ' ' ASN . . . . . . . . . . . . . 26.4 m120 -59.3 -49.97 75.79 Favored 'General case' 0 C--O 1.244 0.792 0 O-C-N 119.807 -1.808 . . . . 34.36 111.361 168.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1331 ' ' LEU . . . . . 0.851 HD13 HD13 ' A' 1070 ' ' LEU . 13.2 mt -55.55 -48.96 73.91 Favored 'General case' 0 C--N 1.357 0.907 0 O-C-N 127.226 2.829 . . . . 33.37 108.747 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1332 ' ' VAL . . . . . 0.518 HG11 ' HB3' ' A' 1025 ' ' GLN . 44.1 t -56.9 -42.66 78.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 O-C-N 124.782 1.301 . . . . 35.27 110.783 175.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -57.55 -49.33 76.71 Favored 'General case' 0 C--O 1.242 0.706 0 O-C-N 119.844 -1.785 . . . . 37.66 112.677 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1334 ' ' LEU . . . . . 0.405 HD22 ' SD ' ' A' 1115 ' ' MET . 53.6 tp -57.06 -54.02 51.52 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 124.736 1.273 . . . . 40.27 108.43 176.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1335 ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' 1331 ' ' LEU . 46.6 mt -62.98 -23.81 67.61 Favored 'General case' 0 N--CA 1.436 -1.154 0 O-C-N 126.369 2.293 . . . . 42.5 111.146 -176.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1336 ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -69.02 -35.19 76.37 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 123.284 2.766 . . . . 47.81 111.944 173.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1337 ' ' LEU . . . . . 0.443 ' O ' ' HG2' ' A' 1340 ' ' LYS . 58.5 mt -67.84 -43.94 78.32 Favored 'General case' 0 CA--C 1.507 -0.709 0 O-C-N 120.84 -1.163 . . . . 49.27 108.297 172.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1338 ' ' LEU . . . . . 0.642 HD23 HG23 ' A' 1346 ' ' ILE . 6.9 mp -66.91 -38.93 87.15 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 116.724 2.12 . . . . 50.54 116.724 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1339 ' ' CYS . . . . . . . . . . . . . 49.1 t -104.82 81.32 1.74 Allowed 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 104.761 -2.311 . . . . 53.67 104.761 -175.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1340 ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' 1337 ' ' LEU . 75.3 mttt -74.31 -52.13 13.16 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 124.312 2.006 . . . . 63.38 113.096 -165.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1341 ' ' GLU . . . . . 0.412 ' HB2' ' HB3' ' A' 1343 ' ' ASP . 15.8 mt-10 -76.48 -44.16 36.61 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 110.077 -3.238 . . . . 70.95 111.85 -166.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1342 ' ' LYS . . . . . 0.664 ' HE2' ' HA ' ' A' 1029 ' ' LEU . 7.6 mtpm? 59.84 67.5 0.87 Allowed 'General case' 0 C--N 1.356 0.881 0 C-N-CA 127.043 2.137 . . . . 65.25 113.216 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1343 ' ' ASP . . . . . 0.412 ' HB3' ' HB2' ' A' 1341 ' ' GLU 0.468 0.0 OUTLIER 68.38 -72.14 0.1 Allowed 'General case' 0 C--N 1.375 1.712 1 O-C-N 115.001 -4.812 . . . . 64.53 118.904 8.507 . . . . . . . . 5 4 . 1 . 005 nuclear nobuild full ' A' A 1344 ' ' GLY . . . . . 0.658 ' H ' ' HA ' ' A' 1342 ' ' LYS . . . 79.71 46.69 7.71 Favored Glycine 0 C--O 1.244 0.755 0 CA-C-N 121.238 1.835 . . . . 59.72 110.462 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 28.8 t30 -130.03 122.8 29.1 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 121.792 0.806 . . . . 64.09 111.081 166.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1346 ' ' ILE . . . . . 0.642 HG23 HD23 ' A' 1338 ' ' LEU . 13.4 mt -79.99 109.9 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 CA-C-O 123.513 1.625 . . . . 58.82 109.382 170.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1347 ' ' THR . . . . . . . . . . . . . 28.6 m -96.84 107.2 19.65 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 110.275 -3.148 . . . . 54.96 104.533 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1348 ' ' VAL . . . . . 0.417 ' HB ' ' NH2' ' A' 1362 ' ' ARG . 42.2 t -84.16 87.78 2.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 103.608 -2.738 . . . . 55.64 103.608 -178.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 29.8 t70 -73.16 111.54 8.37 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.539 -1.21 . . . . 61.45 112.605 178.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1350 ' ' PHE . . . . . 0.454 ' HE2' HG21 ' A' 1367 ' ' THR . 3.1 m-85 -79.79 4.51 16.21 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 114.946 1.461 . . . . 58.63 114.946 171.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -78.45 -33.04 48.71 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 117.12 -1.832 . . . . 62.06 112.377 173.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 5.1 t70 -84.31 123.96 30.73 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 124.703 2.192 . . . . 54.07 108.8 171.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 32.2 m -61.46 -29.83 46.83 Favored 'Isoleucine or valine' 0 C--O 1.247 0.973 0 CA-C-N 109.902 -3.317 . . . . 50.68 113.089 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1354 ' ' VAL . . . . . 0.638 ' O ' HG23 ' A' 1358 ' ' VAL . 5.8 m -69.45 -40.92 80.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 119.908 1.231 . . . . 47.68 109.7 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1355 ' ' ILE . . . . . 0.501 HG23 HD11 ' A' 1338 ' ' LEU . 54.7 mt -68.11 -48.4 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.872 -1.159 . . . . 48.49 107.872 -176.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1356 ' ' ARG . . . . . 0.465 ' HG3' ' HG2' ' A' 1371 ' ' PRO . 22.5 tpt85 -52.08 -40.52 61.34 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.687 1.195 . . . . 48.27 113.145 168.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -58.65 -53.43 46.17 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 125.67 1.605 . . . . 43.53 112.623 174.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1358 ' ' VAL . . . . . 0.696 HG12 ' HB3' ' A' 1113 ' ' MET . 10.9 t -62.92 -39.9 86.86 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.5 0 O-C-N 124.982 1.048 . . . . 45.12 109.079 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1359 ' ' THR . . . . . . . . . . . . . 21.4 m -74.16 88.68 1.97 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 123.278 1.513 . . . . 42.94 109.835 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1360 ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' 1368 ' ' TRP . 29.7 m -78.62 -23.0 13.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 113.874 1.065 . . . . 43.26 113.874 178.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1361 ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' 1111 ' ' THR . 57.7 mt -133.36 120.5 39.11 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.003 0 O-C-N 118.119 -2.863 . . . . 45.66 106.604 170.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1362 ' ' ARG . . . . . 0.417 ' NH2' ' HB ' ' A' 1348 ' ' VAL . 12.9 ttt180 -102.09 109.78 21.57 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 118.474 -2.641 . . . . 61.34 106.358 170.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 43.16 39.92 2.16 Favored 'General case' 0 C--O 1.249 1.044 0 N-CA-C 117.278 2.325 . . . . 49.76 117.278 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1364 ' ' GLY . . . . . 0.44 ' H ' HG22 ' A' 1361 ' ' ILE . . . 119.6 -34.75 4.12 Favored Glycine 0 C--N 1.349 1.283 0 C-N-CA 119.392 -1.385 . . . . 50.0 111.758 177.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -82.4 123.12 28.83 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.002 -1.481 . . . . 56.92 107.002 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1366 ' ' ILE . . . . . 0.42 HG12 HG12 ' A' 1361 ' ' ILE . 93.4 mt -84.85 87.31 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 107.851 -1.166 . . . . 52.78 107.851 -177.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1367 ' ' THR . . . . . 0.454 HG21 ' HE2' ' A' 1350 ' ' PHE . 1.3 p -66.25 -6.76 14.92 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 116.031 1.863 . . . . 49.44 116.031 175.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1368 ' ' TRP . . . . . 0.571 ' CD1' ' HA ' ' A' 1369 ' ' PRO . 20.7 t90 -59.45 141.14 88.16 Favored Pre-proline 0 N--CA 1.442 -0.872 0 CA-C-O 116.13 -1.89 . . . . 52.38 108.128 164.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1369 ' ' PRO . . . . . 0.571 ' HA ' ' CD1' ' A' 1368 ' ' TRP . 72.6 Cg_exo -67.06 160.32 78.85 Favored 'Cis proline' 0 C--N 1.362 1.258 0 N-CA-C 119.733 2.936 . . . . 46.94 119.733 -0.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -89.68 142.53 29.35 Favored Pre-proline 0 C--O 1.24 0.6 0 CA-C-N 114.862 -1.063 . . . . 45.91 113.208 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1371 ' ' PRO . . . . . 0.465 ' HG2' ' HG3' ' A' 1356 ' ' ARG . 0.4 OUTLIER -51.59 124.1 13.63 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 124.366 3.377 . . . . 46.39 114.77 169.295 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 1372 ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' 1371 ' ' PRO . 56.0 Cg_exo -72.29 -59.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.357 1.005 1 C-N-CA 126.839 5.026 . . . . 46.72 109.225 173.381 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.223 -4.904 0 CA-C-N 119.741 1.155 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 79.4 m80 . . . . . 0 CA--C 1.548 0.884 0 N-CA-C 102.436 -3.172 . . . . 63.44 102.436 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 999' ' ' HIS . . . . . 0.552 ' HB3' ' HB3' ' B' 1002 ' ' ARG . 66.3 m-70 -124.02 50.72 1.62 Allowed 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 121.875 2.125 . . . . 51.74 111.849 170.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1000 ' ' HIS . . . . . . . . . . . . . 33.2 t60 -71.53 119.45 15.7 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 111.868 -2.424 . . . . 54.07 107.552 174.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 82.13 15.19 75.22 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 123.773 0.701 . . . . 39.22 111.442 -174.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1002 ' ' ARG . . . . . 0.552 ' HB3' ' HB3' ' B' ' 999' ' ' HIS . 30.6 ttp180 -107.59 128.05 54.19 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 124.534 2.112 . . . . 38.12 108.765 167.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1003 ' ' ILE . . . . . 0.678 HG12 ' HB ' ' B' 1068 ' ' ILE . 14.9 mt -81.79 150.52 4.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 110.191 -3.186 . . . . 29.7 107.229 174.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -129.34 120.42 3.2 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 105.167 -3.173 . . . . 27.5 105.167 171.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1005 ' ' ILE . . . . . 0.639 HG23 ' HB3' ' B' 1017 ' ' ALA . 45.8 mm -100.06 110.4 59.39 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 116.514 -1.708 . . . . 24.83 107.505 173.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -78.77 152.44 25.41 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 124.117 3.211 . . . . 27.19 110.757 175.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1007 ' ' ARG . . . . . 0.449 ' HB3' ' OE1' ' B' 1036 ' ' GLU . 18.2 ttt180 -79.97 110.27 15.19 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 102.938 -2.986 . . . . 41.46 102.938 160.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1008 ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -55.36 131.26 45.29 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 124.176 1.941 . . . . 26.93 115.757 -165.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 36.7 mmm-85 -84.95 -12.28 53.67 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 111.71 -2.496 . . . . 34.48 111.033 -169.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1010 ' ' LEU . . . . . 0.429 ' HB3' ' HB2' ' B' 1013 ' ' GLU . 13.1 tp -55.74 133.67 51.02 Favored 'General case' 0 C--O 1.243 0.728 0 O-C-N 120.776 -1.203 . . . . 44.22 109.609 172.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1011 ' ' THR . . . . . . . . . . . . . 28.7 m -60.46 111.65 1.66 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 114.365 1.246 . . . . 40.74 114.365 -168.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 42.3 t30 54.69 55.73 7.56 Favored 'General case' 0 C--O 1.222 -0.368 0 O-C-N 124.51 1.131 . . . . 44.44 114.047 -170.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1013 ' ' GLU . . . . . 0.429 ' HB2' ' HB3' ' B' 1010 ' ' LEU . 10.7 tp10 -88.49 136.75 32.84 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 115.054 -0.976 . . . . 29.87 108.988 166.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1014 ' ' THR . . . . . 0.523 HG22 ' HB3' ' B' 1320 ' ' PRO . 96.2 m -96.97 -26.18 15.13 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 111.422 -2.626 . . . . 25.26 109.906 -173.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1015 ' ' ARG . . . . . 0.676 ' HG3' ' HA2' ' B' 1317 ' ' GLY . 85.0 mtm180 -70.96 141.81 51.05 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 123.985 1.85 . . . . 29.54 112.218 175.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1016 ' ' VAL . . . . . 0.648 HG12 ' HB2' ' B' 1043 ' ' ALA . 9.9 p -102.47 169.5 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 N-CA-C 105.586 -2.005 . . . . 23.55 105.586 151.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1017 ' ' ALA . . . . . 0.639 ' HB3' HG23 ' B' 1005 ' ' ILE . . . -72.24 -35.93 68.97 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.294 1.22 . . . . 23.59 114.294 -174.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1018 ' ' ALA . . . . . . . . . . . . . . . -147.16 153.08 39.45 Favored 'General case' 0 CA--C 1.509 -0.612 0 O-C-N 124.001 0.813 . . . . 24.93 111.71 -172.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1019 ' ' THR . . . . . . . . . . . . . 12.7 p -91.57 163.75 27.09 Favored Pre-proline 0 C--O 1.25 1.11 0 CA-C-O 117.742 -1.123 . . . . 28.09 110.343 171.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -48.27 -41.76 34.54 Favored 'Trans proline' 0 CA--C 1.501 -1.166 1 C-N-CA 125.664 4.242 . . . . 28.79 111.966 173.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B 1021 ' ' LYS . . . . . 0.567 ' HD2' HE22 ' B' 1325 ' ' GLN . 0.5 OUTLIER -51.4 -47.57 62.9 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 122.638 1.209 . . . . 47.28 112.182 174.502 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B 1022 ' ' THR . . . . . 0.513 ' O ' ' HG ' ' B' 1026 ' ' LEU . 9.6 p -78.41 -22.34 47.93 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 118.835 -1.146 . . . . 30.12 112.038 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1023 ' ' VAL . . . . . . . . . . . . . 51.6 t -66.24 -42.3 90.72 Favored 'Isoleucine or valine' 0 C--N 1.349 0.548 0 O-C-N 120.84 -1.162 . . . . 32.24 110.421 169.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1024 ' ' GLU . . . . . 0.513 ' HA ' HD12 ' B' 1027 ' ' LEU . 43.6 mt-10 -54.57 -48.59 71.88 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 120.451 -1.405 . . . . 49.62 112.42 171.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -49.49 -48.36 47.93 Favored 'General case' 0 C--O 1.21 -0.975 0 N-CA-C 114.31 1.226 . . . . 44.68 114.31 169.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1026 ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' B' 1022 ' ' THR . 70.8 mt -58.07 -41.09 82.63 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 120.063 -1.648 . . . . 35.71 111.432 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1027 ' ' LEU . . . . . 0.513 HD12 ' HA ' ' B' 1024 ' ' GLU . 12.3 mt -70.05 -27.64 64.81 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.894 1.278 . . . . 42.18 114.247 177.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 51.5 mttm -66.11 -47.21 74.91 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 105.877 -1.898 . . . . 48.34 105.877 169.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1029 ' ' LEU . . . . . . . . . . . . . 74.1 mt -69.42 -10.99 60.4 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 120.426 -1.421 . . . . 38.69 113.714 175.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 97.05 10.52 54.79 Favored Glycine 0 C--N 1.353 1.522 0 C-N-CA 125.722 1.63 . . . . 32.28 113.015 166.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -77.12 140.59 40.28 Favored 'General case' 0 N--CA 1.44 -0.974 0 O-C-N 120.735 -1.45 . . . . 35.94 110.913 173.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1032 ' ' THR . . . . . . . . . . . . . 5.9 m -83.95 138.95 32.88 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 104.788 -2.301 . . . . 33.37 104.788 174.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1033 ' ' VAL . . . . . . . . . . . . . 10.0 t -122.34 144.39 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 124.045 3.111 . . . . 29.98 111.769 -172.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -129.57 144.93 51.49 Favored 'General case' 0 C--O 1.249 1.036 0 C-N-CA 125.791 1.636 . . . . 28.18 108.537 169.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1035 ' ' VAL . . . . . . . . . . . . . 47.0 t -136.84 142.47 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 105.831 -1.914 . . . . 25.82 105.831 -174.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1036 ' ' GLU . . . . . 0.595 ' HB2' HG11 ' B' 1063 ' ' VAL . 27.7 tt0 -76.95 141.33 40.5 Favored 'General case' 0 C--O 1.258 1.535 0 C-N-CA 118.886 -1.126 . . . . 32.44 113.968 -174.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1037 ' ' SER . . . . . . . . . . . . . 49.6 m -52.24 128.06 23.92 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.117 0.961 . . . . 29.54 113.178 171.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 92.34 -13.2 67.81 Favored Glycine 0 CA--C 1.542 1.779 0 CA-C-N 115.292 -0.867 . . . . 27.76 113.475 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1039 ' ' ALA . . . . . 0.624 ' HB1' HG21 ' B' 1016 ' ' VAL . . . -62.71 -39.37 93.81 Favored 'General case' 0 N--CA 1.438 -1.062 0 O-C-N 120.553 -1.557 . . . . 26.02 112.062 178.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -61.08 -45.81 95.83 Favored Glycine 0 C--N 1.304 -1.232 0 C-N-CA 119.315 -1.422 . . . . 26.47 110.962 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -68.17 -28.18 67.06 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 118.421 -2.811 . . . . 50.98 111.972 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 15.3 mt -58.91 -51.23 70.95 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 117.955 -2.965 . . . . 29.3 109.97 166.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1043 ' ' ALA . . . . . 0.648 ' HB2' HG12 ' B' 1016 ' ' VAL . . . -68.2 17.13 0.04 OUTLIER 'General case' 0 C--O 1.213 -0.823 0 O-C-N 119.0 -2.313 . . . . 26.74 116.564 167.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1044 ' ' SER . . . . . . . . . . . . . 15.1 m 54.12 34.47 20.13 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 123.707 1.717 . . . . 31.26 114.792 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1045 ' ' PHE . . . . . 0.418 ' CD1' ' HB3' ' A' 1277 ' ' ALA . 0.1 OUTLIER -127.94 158.59 37.41 Favored 'General case' 0 C--O 1.241 0.65 0 O-C-N 121.172 -0.955 . . . . 33.26 108.712 -177.528 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 29.1 t0 -72.71 139.05 46.97 Favored 'General case' 0 C--O 1.245 0.835 0 O-C-N 120.755 -1.215 . . . . 46.74 108.824 170.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.54 -40.57 72.03 Favored 'General case' 0 C--O 1.214 -0.816 0 CA-C-O 122.572 1.177 . . . . 34.44 110.858 175.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.65 -2.41 17.14 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 120.635 -1.291 . . . . 48.67 113.134 -174.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -72.08 -35.68 69.3 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 118.302 -2.749 . . . . 35.26 108.365 167.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1050 ' ' PHE . . . . . 0.661 ' HB2' HD11 ' B' 1057 ' ' ILE . 64.2 m-85 -65.32 -41.63 93.81 Favored 'General case' 0 C--O 1.219 -0.524 0 O-C-N 120.335 -1.478 . . . . 32.17 108.438 176.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1051 ' ' VAL . . . . . 0.629 HG23 HG12 ' B' 1057 ' ' ILE . 17.5 t -50.8 -57.98 2.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 123.757 0.66 . . . . 38.37 111.98 168.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -42.77 -54.28 4.17 Favored 'General case' 0 C--O 1.213 -0.845 0 N-CA-C 113.511 0.93 . . . . 45.77 113.511 172.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -54.25 -38.4 65.75 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.376 1.251 . . . . 37.83 114.376 173.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 126.89 34.53 0.59 Allowed Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.845 -0.902 . . . . 35.82 110.845 174.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -112.23 147.21 36.71 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 107.985 -1.117 . . . . 33.77 107.985 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -76.85 132.82 39.37 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 107.19 -1.411 . . . . 51.02 107.19 168.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1057 ' ' ILE . . . . . 0.661 HD11 ' HB2' ' B' 1050 ' ' PHE . 27.8 mm -100.96 124.68 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-O 122.92 1.343 . . . . 38.47 108.06 169.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1058 ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' B' 1036 ' ' GLU . 0.0 OUTLIER -143.52 142.34 25.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 C-N-CA 124.942 1.297 . . . . 39.4 113.235 -171.553 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -82.17 123.13 28.72 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.998 -1.112 . . . . 57.07 107.998 -171.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1060 ' ' GLY . . . . . 0.495 ' O ' HG12 ' B' 1063 ' ' VAL . . . 57.0 -133.82 52.53 Favored Glycine 0 N--CA 1.432 -1.596 0 CA-C-O 122.605 1.114 . . . . 44.83 114.404 165.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -38.92 -40.52 0.65 Allowed 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 111.084 -2.558 . . . . 46.27 115.403 -172.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1062 ' ' SER . . . . . . . . . . . . . 5.5 m -45.71 -51.31 12.67 Favored 'General case' 0 C--N 1.349 0.586 0 N-CA-C 113.98 1.104 . . . . 43.47 113.98 173.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1063 ' ' VAL . . . . . 0.595 HG11 ' HB2' ' B' 1036 ' ' GLU . 3.6 p -69.3 -35.32 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 C-N-CA 123.371 0.668 . . . . 36.98 110.15 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -64.22 -28.57 69.83 Favored 'General case' 0 N--CA 1.422 -1.844 0 O-C-N 123.813 0.696 . . . . 37.9 111.908 175.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -82.29 82.91 7.61 Favored 'General case' 0 C--O 1.243 0.748 0 O-C-N 118.798 -2.439 . . . . 46.19 110.802 171.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1066 ' ' SER . . . . . . . . . . . . . 44.7 m -150.35 162.36 40.69 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.412 -1.267 . . . . 37.06 108.299 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1067 ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -72.02 -58.3 3.55 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 117.821 -1.551 . . . . 43.95 111.951 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1068 ' ' ILE . . . . . 0.678 ' HB ' HG12 ' B' 1003 ' ' ILE . 4.4 mp -96.22 107.15 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 103.165 -2.902 . . . . 33.5 103.165 -169.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 48.9 mm -97.54 109.22 23.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 107.208 -1.404 . . . . 30.57 107.208 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1070 ' ' LEU . . . . . 0.681 HD22 HD22 ' B' 1331 ' ' LEU . 83.6 mt -95.74 91.86 6.29 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 124.377 2.037 . . . . 27.66 107.174 177.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1071 ' ' LYS . . . . . . . . . . . . . 10.9 mtpt -90.69 161.27 15.44 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-N 112.59 -2.095 . . . . 28.4 109.491 176.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1072 ' ' VAL . . . . . . . . . . . . . 2.7 t -83.91 -56.91 4.97 Favored 'Isoleucine or valine' 0 C--N 1.351 0.637 0 N-CA-C 104.733 -2.321 . . . . 23.18 104.733 -177.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -113.46 173.88 6.19 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 113.808 -1.542 . . . . 25.47 107.448 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -49.41 146.93 6.08 Favored Pre-proline 0 C--O 1.264 1.832 0 C-N-CA 124.899 1.28 . . . . 27.9 113.66 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1075 ' ' PRO . . . . . 0.525 ' HG3' HD21 ' B' 1105 ' ' LEU . 59.7 Cg_endo -60.52 151.89 72.06 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.455 2.77 . . . . 31.62 110.574 166.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 7.4 mp -89.7 165.74 14.01 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 113.828 -1.533 . . . . 40.49 107.171 166.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1077 ' ' ASP . . . . . 0.582 ' HA ' HD12 ' B' 1080 ' ' ILE . 10.1 t70 -58.71 -40.63 84.24 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 116.448 2.018 . . . . 51.59 116.448 -173.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -57.3 -43.43 83.22 Favored 'General case' 0 C--O 1.244 0.773 0 O-C-N 121.489 -0.757 . . . . 42.36 111.202 169.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1079 ' ' GLU . . . . . 0.438 ' OE1' ' HA ' ' B' 1075 ' ' PRO . 43.2 mt-10 -64.8 -28.65 69.71 Favored 'General case' 0 C--O 1.221 -0.426 0 O-C-N 121.404 -0.81 . . . . 34.53 109.868 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1080 ' ' ILE . . . . . 0.843 ' HA ' HD12 ' B' 1083 ' ' LEU . 69.5 mt -64.13 -41.21 91.73 Favored 'Isoleucine or valine' 0 C--N 1.36 1.053 0 O-C-N 119.926 -1.734 . . . . 33.25 110.231 171.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -62.73 -30.01 71.1 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.442 -1.411 . . . . 36.47 114.365 172.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1082 ' ' LEU . . . . . 0.42 HD12 ' HA ' ' B' 1079 ' ' GLU . 65.4 mt -75.16 -28.34 60.05 Favored 'General case' 0 C--N 1.348 0.532 0 O-C-N 121.584 -0.698 . . . . 37.76 110.852 175.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1083 ' ' LEU . . . . . 0.843 HD12 ' HA ' ' B' 1080 ' ' ILE . 34.1 mt -52.78 114.8 1.53 Allowed 'General case' 0 C--O 1.247 0.953 0 N-CA-C 114.928 1.455 . . . . 37.43 114.928 174.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.34 143.83 52.65 Favored Pre-proline 0 N--CA 1.453 -0.314 0 CA-C-N 111.289 -2.687 . . . . 37.7 107.587 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -54.67 123.69 14.33 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.176 3.251 . . . . 35.51 109.434 175.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 83.61 17.16 66.66 Favored Glycine 0 C--N 1.316 -0.565 0 CA-C-O 119.608 -0.551 . . . . 33.87 112.076 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1087 ' ' THR . . . . . . . . . . . . . 52.5 m -69.76 134.44 48.58 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 121.707 2.753 . . . . 32.5 108.72 163.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1088 ' ' THR . . . . . . . . . . . . . 38.9 m -92.93 97.94 11.05 Favored 'General case' 0 C--O 1.254 1.321 0 N-CA-C 105.528 -2.027 . . . . 30.22 105.528 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1089 ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' B' 1112 ' ' VAL . 22.1 tp -96.17 130.19 43.29 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 120.829 -1.169 . . . . 27.24 108.639 -176.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 95.8 t -125.6 128.01 72.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 102.247 -3.242 . . . . 25.39 102.247 -175.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1091 ' ' SER . . . . . . . . . . . . . 3.9 m -160.23 168.38 25.51 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 121.893 2.133 . . . . 28.81 111.925 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1092 ' ' PHE . . . . . 0.421 ' CD2' ' HB3' ' B' 1116 ' ' ASP . 25.2 m-85 -66.71 108.25 2.42 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.549 -1.278 . . . . 30.78 107.549 155.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 26.2 mm -104.31 -36.67 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 O-C-N 118.837 -2.414 . . . . 30.28 114.267 -176.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1094 ' ' TRP . . . . . 0.504 ' HB2' ' ND2' ' B' 1098 ' ' ASN . 61.9 m95 54.53 65.49 5.06 Favored Pre-proline 0 CA--C 1.548 0.886 0 O-C-N 124.319 1.012 . . . . 34.07 110.582 -175.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -47.99 -58.39 1.78 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 1 C-N-CA 127.375 5.383 . . . . 38.66 118.91 -166.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1096 ' ' ALA . . . . . 0.512 ' HB2' ' HZ3' ' B' 1368 ' ' TRP . . . -82.29 -14.89 54.7 Favored 'General case' 0 N--CA 1.436 -1.163 0 O-C-N 119.734 -1.854 . . . . 41.32 110.437 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -76.58 -21.96 54.91 Favored 'General case' 0 C--O 1.246 0.895 0 N-CA-C 108.579 -0.897 . . . . 51.66 108.579 166.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1098 ' ' ASN . . . . . 0.504 ' ND2' ' HB2' ' B' 1094 ' ' TRP . 14.1 m-80 -121.36 42.39 0.56 Allowed Pre-proline 0 C--N 1.309 -1.168 0 N-CA-C 117.391 2.367 . . . . 40.32 117.391 -172.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -56.49 -42.54 64.47 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 123.633 2.889 . . . . 41.56 117.188 -167.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -61.25 -39.84 91.83 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.714 1.143 . . . . 54.11 113.316 175.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1101 ' ' LEU . . . . . 0.403 ' O ' ' HG ' ' B' 1105 ' ' LEU . 6.2 tp -62.78 -49.44 74.97 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 108.521 -0.918 . . . . 37.88 108.521 176.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1102 ' ' MET . . . . . . . . . . . . . 91.6 mmm -51.25 -55.73 16.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.712 -0.676 . . . . 37.54 110.381 177.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -49.34 -49.74 42.86 Favored 'General case' 0 C--O 1.244 0.775 0 O-C-N 121.694 -0.629 . . . . 47.01 112.483 176.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1104 ' ' LYS . . . . . 0.405 ' HB3' HG21 ' B' 1080 ' ' ILE . 83.4 mttt -60.46 -38.25 83.6 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 114.991 1.478 . . . . 48.68 114.991 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1105 ' ' LEU . . . . . 0.622 HD13 HG21 ' B' 1112 ' ' VAL . 31.3 mt -66.96 -36.82 83.07 Favored 'General case' 0 C--O 1.245 0.837 0 O-C-N 121.009 -1.057 . . . . 32.21 109.198 177.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1106 ' ' ALA . . . . . 0.501 ' HA ' ' HA2' ' B' 1364 ' ' GLY . . . -67.87 -28.24 67.36 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 108.871 -0.788 . . . . 33.73 108.871 177.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -68.44 -39.62 81.45 Favored 'General case' 0 CA--C 1.494 -1.197 0 O-C-N 119.412 -2.055 . . . . 51.47 110.207 175.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1108 ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -72.85 -4.05 29.38 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 115.026 1.491 . . . . 43.9 115.026 -178.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1109 ' ' ASN . . . . . 0.584 ' HA ' ' HA3' ' B' 1364 ' ' GLY . 9.9 m120 58.6 32.81 22.55 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 124.027 1.87 . . . . 44.82 113.436 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1110 ' ' VAL . . . . . 0.754 HG11 HD22 ' B' 1083 ' ' LEU . 33.6 m -93.14 166.27 1.8 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.662 0 CA-C-N 114.351 -1.295 . . . . 30.52 111.454 177.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1111 ' ' THR . . . . . 0.597 HG23 ' HA ' ' B' 1362 ' ' ARG . 87.2 m -109.65 103.26 12.09 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 105.532 -2.025 . . . . 27.12 105.532 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1112 ' ' VAL . . . . . 0.622 HG21 HD13 ' B' 1105 ' ' LEU . 40.7 t -99.36 129.11 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-O 122.418 1.104 . . . . 26.4 109.496 -174.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1113 ' ' MET . . . . . 0.572 ' SD ' HD11 ' B' 1338 ' ' LEU . 31.2 mtp -109.65 124.33 50.99 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.921 0.889 . . . . 42.92 110.128 171.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -102.51 106.18 16.85 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 119.716 1.144 . . . . 24.15 109.17 -174.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1115 ' ' MET . . . . . . . . . . . . . 80.2 mmm -71.29 -2.33 15.83 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 113.072 -1.876 . . . . 29.95 112.168 -169.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1116 ' ' ASP . . . . . 0.509 ' HA ' ' HB2' ' B' 1130 ' ' LEU . 7.5 p-10 -93.44 -52.07 4.68 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.745 1.218 . . . . 34.53 112.428 169.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1117 ' ' SER . . . . . . . . . . . . . 51.1 m -86.71 60.94 6.52 Favored 'General case' 0 C--N 1.343 0.298 0 O-C-N 120.401 -1.437 . . . . 33.49 111.118 -175.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1118 ' ' VAL . . . . . . . . . . . . . 17.9 t -95.62 146.56 31.54 Favored Pre-proline 0 C--O 1.245 0.868 0 N-CA-C 105.171 -2.159 . . . . 34.02 105.171 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -60.97 146.02 98.3 Favored 'Trans proline' 0 C--N 1.354 0.82 0 CA-C-N 124.661 2.7 . . . . 38.28 113.308 174.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1120 ' ' ARG . . . . . 0.518 HH12 ' CG ' ' B' 1128 ' ' ASP . 5.3 mmt180 -85.82 56.82 4.14 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 120.685 -1.259 . . . . 55.05 111.481 -167.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1121 ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' C' ' 131' ' ' ALA . 6.7 pt -132.26 164.28 35.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 CA-C-N 114.53 -1.213 . . . . 42.09 112.585 -176.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1122 ' ' SER . . . . . . . . . . . . . 8.9 m -48.75 -63.94 0.95 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 119.12 3.008 . . . . 38.02 119.12 -162.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1123 ' ' ARG . . . . . 0.465 ' HD2' HD21 ' B' 1337 ' ' LEU . 21.4 ptt-85 -70.53 -29.06 65.44 Favored 'General case' 0 C--N 1.354 0.804 1 O-C-N 116.114 -4.116 . . . . 34.29 110.924 -179.288 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B 1124 ' ' ALA . . . . . 0.72 ' HB2' HG22 ' B' 1354 ' ' VAL . . . -60.51 -40.62 92.08 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 113.282 -1.781 . . . . 32.35 108.151 176.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1125 ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -60.75 -24.67 65.91 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 115.744 1.757 . . . . 47.17 115.744 173.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1126 ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' 1160 ' ' ALA . 57.1 m -68.59 -36.66 79.01 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 119.05 -2.281 . . . . 31.71 114.667 165.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1127 ' ' LEU . . . . . 0.717 HD23 HD12 ' B' 1334 ' ' LEU . 6.9 mp -72.84 -30.15 63.79 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.181 -0.949 . . . . 37.0 111.472 172.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1128 ' ' ASP . . . . . 0.518 ' CG ' HH12 ' B' 1120 ' ' ARG . 37.9 t70 -64.54 101.02 0.41 Allowed 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 115.59 -0.732 . . . . 40.4 110.977 -169.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1129 ' ' ALA . . . . . . . . . . . . . . . -72.52 -21.42 61.18 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 118.411 -1.316 . . . . 26.56 110.506 174.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1130 ' ' LEU . . . . . 0.509 ' HB2' ' HA ' ' B' 1116 ' ' ASP . 7.8 tt -55.13 -26.37 37.98 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.378 1.251 . . . . 30.89 114.378 168.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1131 ' ' SER . . . . . . . . . . . . . 13.6 p -77.59 -51.91 9.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 122.68 1.228 . . . . 29.84 113.118 172.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1132 ' ' SER . . . . . 0.423 ' HB3' ' HB3' ' B' 1326 ' ' LEU . 16.6 m -58.23 -49.51 76.83 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.279 -1.513 . . . . 31.91 114.663 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1133 ' ' MET . . . . . 0.645 ' HB3' ' HB3' ' B' 1316 ' ' PRO . 38.1 mmt -68.74 -36.58 78.56 Favored 'General case' 0 CA--C 1.509 -0.598 0 O-C-N 120.776 -1.202 . . . . 25.9 110.765 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1134 ' ' ALA . . . . . 0.809 ' HB1' ' HB2' ' B' 1176 ' ' ALA . . . -55.62 -44.55 77.18 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 119.137 0.881 . . . . 26.62 113.289 164.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -58.03 -48.08 81.15 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 122.272 1.034 . . . . 36.97 112.096 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1136 ' ' ILE . . . . . . . . . . . . . 42.9 mm -52.3 -58.07 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-N 113.294 -1.775 . . . . 32.11 111.48 173.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -57.27 -30.36 64.62 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.888 1.069 . . . . 24.14 113.888 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -68.58 -49.28 44.96 Favored Glycine 0 N--CA 1.484 1.9 0 N-CA-C 110.202 -1.159 . . . . 25.13 110.202 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 55.3 t80 -63.72 -44.47 93.46 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 123.417 1.579 . . . . 32.73 112.748 173.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1140 ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -62.57 -33.94 75.96 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 114.041 -1.436 . . . . 26.36 110.914 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1141 ' ' ALA . . . . . . . . . . . . . . . -55.71 -49.38 73.16 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 123.232 0.613 . . . . 24.12 112.42 168.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 50.1 mm -58.78 -35.97 58.54 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 O-C-N 120.873 -1.142 . . . . 23.37 109.927 174.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 14.3 t -71.24 -46.19 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 O-C-N 119.555 -1.966 . . . . 24.96 111.837 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -72.0 -41.82 67.15 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 106.661 -1.607 . . . . 32.07 106.661 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1145 ' ' ALA . . . . . 0.693 ' HA ' HG11 ' B' 1280 ' ' VAL . . . -53.38 -45.86 69.42 Favored 'General case' 0 C--O 1.206 -1.209 0 O-C-N 121.318 -0.864 . . . . 24.87 111.655 170.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1146 ' ' ALA . . . . . . . . . . . . . . . -63.99 -39.08 93.32 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 123.016 0.527 . . . . 24.67 109.658 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 16.5 t60 -59.06 -34.33 71.82 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 119.746 -1.846 . . . . 28.58 109.177 172.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1148 ' ' GLU . . . . . 0.418 ' HB3' ' CD ' ' B' 1308 ' ' LYS . 44.0 mm-40 -93.93 -10.38 33.96 Favored 'General case' 0 C--O 1.25 1.088 0 O-C-N 120.118 -1.614 . . . . 36.82 113.8 178.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1149 ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -78.9 144.09 35.24 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-O 123.488 1.613 . . . . 31.97 109.257 -171.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1150 ' ' GLY . . . . . 0.706 ' HA2' ' HD2' ' A' 1320 ' ' PRO . . . -93.93 -19.64 33.38 Favored Glycine 0 C--O 1.242 0.644 0 CA-C-N 114.313 -1.312 . . . . 25.49 113.239 174.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1151 ' ' ARG . . . . . . . . . . . . . 81.1 mtm-85 -112.65 166.75 11.06 Favored 'General case' 0 C--O 1.242 0.709 0 O-C-N 121.537 -0.978 . . . . 59.84 111.067 -169.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1152 ' ' PHE . . . . . 0.717 ' HB2' HG11 ' B' 1163 ' ' VAL . 3.3 m-30 -78.85 156.81 28.52 Favored 'General case' 0 C--O 1.239 0.543 0 O-C-N 119.803 -1.811 . . . . 34.45 108.647 174.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1153 ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -84.59 -43.74 14.17 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 123.837 1.78 . . . . 31.17 108.655 166.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1154 ' ' THR . . . . . . . . . . . . . 48.2 m -68.01 128.17 35.56 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 112.934 -1.939 . . . . 33.89 111.367 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -75.94 65.47 2.58 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 109.161 -1.576 . . . . 38.95 109.161 174.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1156 ' ' GLN . . . . . 0.463 ' H ' ' HB ' ' B' 1163 ' ' VAL . 15.4 tt0 -85.17 121.37 27.83 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 119.461 1.631 . . . . 54.23 109.476 -160.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 29.8 mm -70.82 95.09 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.883 0 O-C-N 119.906 -1.746 . . . . 51.16 106.406 173.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1158 ' ' THR . . . . . . . . . . . . . 1.7 m -109.22 138.8 45.02 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 107.783 -1.191 . . . . 49.61 107.783 -175.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -56.62 -30.57 63.42 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 121.034 1.743 . . . . 49.05 115.51 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -52.34 -53.09 48.94 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.245 0.545 . . . . 47.65 111.127 167.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . -179.02 156.14 17.86 Favored Glycine 0 C--O 1.215 -1.062 0 N-CA-C 108.071 -2.012 . . . . 45.61 108.071 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 79.9 mttt -76.91 128.15 34.03 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 120.197 1.998 . . . . 57.46 111.966 177.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1163 ' ' VAL . . . . . 0.717 HG11 ' HB2' ' B' 1152 ' ' PHE . 23.3 t -80.18 129.6 69.18 Favored Pre-proline 0 CA--C 1.514 -0.425 0 CA-C-N 118.923 0.783 . . . . 42.93 110.08 177.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1164 ' ' PRO . . . . . 0.435 ' O ' HG12 ' B' 1163 ' ' VAL . 58.4 Cg_endo -66.74 142.67 64.51 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.618 2.212 . . . . 39.29 110.667 164.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1165 ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -59.85 153.77 54.56 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 C-N-CA 122.898 2.399 . . . . 34.17 114.943 170.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -83.25 159.85 21.87 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 113.088 -1.869 . . . . 31.69 108.383 168.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1167 ' ' LYS . . . . . 0.8 ' HB2' ' HA ' ' B' 1249 ' ' VAL . 67.2 mttt -123.56 118.04 26.45 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 105.466 -2.05 . . . . 44.78 105.466 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1168 ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' B' 1251 ' ' ILE . 60.3 t -104.31 104.83 17.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 O-C-N 121.827 -0.546 . . . . 31.23 111.122 -174.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1169 ' ' MET . . . . . 0.676 ' HB2' HG11 ' B' 1249 ' ' VAL . 42.7 ttp -82.82 98.11 8.97 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.088 -0.708 . . . . 37.09 109.088 -178.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 53.1 t -89.74 119.35 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 N-CA-C 109.029 -0.73 . . . . 30.17 109.029 -177.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1171 ' ' ILE . . . . . . . . . . . . . 9.7 mt -113.52 132.76 61.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 CA-C-N 120.307 1.412 . . . . 33.74 107.578 -175.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 69.56 63.86 3.2 Favored Glycine 0 CA--C 1.502 -0.72 0 N-CA-C 110.046 -1.221 . . . . 32.59 110.046 -176.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1173 ' ' ALA . . . . . 0.539 ' HA ' ' HA3' ' B' 1177 ' ' GLY . . . -79.89 75.6 6.6 Favored 'General case' 0 C--O 1.252 1.233 0 CA-C-O 124.17 1.938 . . . . 32.42 114.018 -174.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -86.52 -165.3 40.86 Favored Glycine 0 C--O 1.216 -0.982 0 N-CA-C 107.367 -2.293 . . . . 31.74 107.367 166.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 46.1 t -48.54 -38.14 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 122.11 2.955 . . . . 31.48 114.279 -176.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1176 ' ' ALA . . . . . 0.809 ' HB2' ' HB1' ' B' 1134 ' ' ALA . . . -58.06 -51.67 68.73 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 113.462 -1.699 . . . . 26.12 114.063 171.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1177 ' ' GLY . . . . . 0.539 ' HA3' ' HA ' ' B' 1173 ' ' ALA . . . -60.46 -48.61 85.35 Favored Glycine 0 CA--C 1.49 -1.473 0 N-CA-C 111.321 -0.712 . . . . 25.73 111.321 176.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1178 ' ' LEU . . . . . 0.669 HD22 ' HG ' ' C' ' 75' ' ' LEU . 91.5 mt -53.75 -38.26 64.2 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 114.899 1.444 . . . . 32.59 114.899 174.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -70.67 -38.68 73.8 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 119.298 0.953 . . . . 27.72 111.734 175.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -60.9 -46.7 89.59 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 114.602 1.334 . . . . 26.03 114.602 175.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1181 ' ' ILE . . . . . 0.779 HG12 HG11 ' B' 1191 ' ' VAL . 79.0 mt -58.32 -48.04 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 123.707 0.803 . . . . 28.61 109.095 173.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1182 ' ' GLY . . . . . 0.413 ' HA2' ' HE1' ' B' 1207 ' ' MET . . . -51.09 -53.11 28.61 Favored Glycine 0 C--N 1.373 2.611 0 CA-C-N 114.827 -1.079 . . . . 25.23 110.721 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -63.26 -50.78 68.83 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 114.419 1.266 . . . . 24.09 114.419 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -69.42 -42.81 74.52 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 121.195 -0.94 . . . . 26.68 112.579 -172.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -57.49 -47.11 82.78 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 115.713 -0.676 . . . . 36.57 111.271 174.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1186 ' ' SER . . . . . 0.492 ' HB3' ' O ' ' A' 1186 ' ' SER . 75.4 m -58.81 -39.87 82.44 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-O 121.81 0.814 . . . . 28.92 112.338 177.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1187 ' ' LEU . . . . . . . . . . . . . 66.1 mt -61.78 -35.13 77.26 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 121.041 -1.037 . . . . 29.09 112.997 172.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 120.3 -7.07 11.65 Favored Glycine 0 CA--C 1.539 1.591 0 N-CA-C 111.113 -0.795 . . . . 29.26 111.113 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1189 ' ' ALA . . . . . . . . . . . . . . . -68.46 121.7 16.89 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 121.666 0.746 . . . . 30.16 112.272 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 37.2 mt -67.31 112.07 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-O 123.594 1.664 . . . . 35.81 109.718 -172.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1191 ' ' VAL . . . . . 0.779 HG11 HG12 ' B' 1181 ' ' ILE . 93.2 t -82.46 128.75 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 107.706 -1.22 . . . . 31.97 107.706 -177.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1192 ' ' ARG . . . . . 0.492 ' O ' ' HA ' ' B' 1169 ' ' MET . 22.9 mmt85 -118.89 90.39 3.32 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 102.903 -2.999 . . . . 48.16 102.903 174.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1193 ' ' ALA . . . . . 0.65 ' HB3' HG21 ' B' 1204 ' ' VAL . . . -103.07 159.69 15.3 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 120.712 -1.242 . . . . 35.89 114.281 -172.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 35.2 t80 -150.13 152.41 34.68 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 123.041 1.4 . . . . 41.88 107.224 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1195 ' ' ASP . . . . . 0.445 ' HB3' HG11 ' B' 1200 ' ' VAL . 10.0 t0 -158.55 155.61 28.68 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 103.666 -2.716 . . . . 38.28 103.666 168.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1196 ' ' THR . . . . . 0.433 HG23 ' HB2' ' B' 1230 ' ' MET . 43.0 m -59.23 -24.15 62.92 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 124.956 1.302 . . . . 40.62 110.53 172.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1197 ' ' ARG . . . . . 0.429 HH11 ' HD2' ' B' 1197 ' ' ARG . 33.1 mtm105 -91.97 144.33 29.06 Favored Pre-proline 0 C--O 1.249 1.066 0 O-C-N 119.925 -1.735 . . . . 53.09 111.026 -174.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -71.95 -42.58 1.53 Allowed 'Trans proline' 0 CA--C 1.548 1.188 1 C-N-CA 125.637 4.225 . . . . 42.56 117.418 -174.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -29.4 70.55 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 121.269 1.85 . . . . 56.31 114.462 -168.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1200 ' ' VAL . . . . . 0.504 ' O ' HG23 ' B' 1204 ' ' VAL . 10.8 p -58.56 -28.65 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 115.133 -0.94 . . . . 42.91 112.596 177.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 35.1 tttm -45.05 -58.66 3.04 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 124.581 1.153 . . . . 48.89 113.535 168.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 16.0 mp0 -63.39 -28.37 69.94 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 114.265 1.209 . . . . 51.7 114.265 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1203 ' ' GLN . . . . . 0.816 ' HG2' ' HG3' ' C' ' 74' ' ' ARG . 51.4 mt-30 -66.13 -46.63 76.83 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.586 -0.734 . . . . 52.57 109.442 176.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1204 ' ' VAL . . . . . 0.65 HG21 ' HB3' ' B' 1193 ' ' ALA . 40.0 t -72.69 -40.67 62.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.255 -1.017 . . . . 33.79 108.255 -173.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -60.98 -29.36 69.62 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 113.57 0.952 . . . . 36.58 113.57 176.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1206 ' ' SER . . . . . . . . . . . . . 44.7 m -68.67 -10.85 58.71 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 120.254 -1.529 . . . . 39.61 114.246 174.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1207 ' ' MET . . . . . 0.413 ' HE1' ' HA2' ' B' 1182 ' ' GLY . 46.1 mmm -97.22 5.21 50.47 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.587 0.708 . . . . 37.45 109.579 174.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 60.5 32.28 77.34 Favored Glycine 0 N--CA 1.471 0.984 0 O-C-N 120.133 -1.604 . . . . 31.87 111.829 -165.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1209 ' ' ALA . . . . . 0.502 ' HB1' ' HB ' ' B' 1191 ' ' VAL . . . -119.6 163.23 17.66 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 105.328 -2.101 . . . . 35.4 105.328 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1210 ' ' GLU . . . . . 0.478 ' HB3' ' HD3' ' B' 1192 ' ' ARG . 36.0 tt0 -108.62 137.23 46.9 Favored 'General case' 0 C--N 1.313 -1.014 0 O-C-N 119.859 -1.776 . . . . 47.89 111.999 -166.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 75.7 t80 -84.97 141.39 30.38 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 106.416 -1.698 . . . . 45.53 106.416 172.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1212 ' ' LEU . . . . . 0.549 ' HB3' HD21 ' B' 1241 ' ' LEU . 73.8 mt -73.74 99.64 3.2 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 125.11 2.386 . . . . 46.33 116.641 -176.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -77.08 122.75 25.4 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 112.101 -2.318 . . . . 60.41 108.147 172.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1214 ' ' LEU . . . . . 0.798 ' HG ' HD22 ' B' 1241 ' ' LEU . 1.0 OUTLIER -99.03 176.38 5.59 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 104.5 -2.407 . . . . 57.38 104.5 -178.173 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 14.0 t70 . . . . . 0 CA--C 1.499 -0.994 0 CA-C-O 117.665 -1.159 . . . . 65.07 108.613 177.149 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B 1230 ' ' MET . . . . . 0.433 ' HB2' HG23 ' B' 1196 ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.429 -1.48 0 N-CA-C 104.147 -2.538 . . . . 80.32 104.147 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1231 ' ' SER . . . . . 0.414 ' HB2' ' HA ' ' B' 1230 ' ' MET . 1.6 m 78.26 156.71 0.17 Allowed 'General case' 0 C--O 1.251 1.174 2 CA-C-N 127.914 4.87 . . . . 79.92 119.591 -8.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -88.7 -157.62 0.44 Allowed 'General case' 0 C--O 1.248 0.991 0 CA-C-N 112.584 -2.098 . . . . 77.91 111.872 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 66.38 -68.2 0.14 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 121.383 1.902 . . . . 73.88 111.036 -170.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 11.4 t80 -55.81 -33.18 64.2 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.75 1.22 . . . . 68.98 110.802 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1235 ' ' ILE . . . . . 0.595 ' O ' ' HG2' ' B' 1239 ' ' MET . 32.6 pt -42.94 -39.24 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 114.858 1.429 . . . . 64.53 114.858 170.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1236 ' ' LYS . . . . . 0.45 ' HD2' ' HA ' ' B' 1236 ' ' LYS . 28.6 mmmt -58.95 -45.81 89.54 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 121.306 1.866 . . . . 66.36 111.306 176.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -67.01 -30.54 70.67 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 114.609 1.337 . . . . 56.6 114.609 170.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.9 -46.4 85.02 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 120.302 1.41 . . . . 56.79 108.643 171.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1239 ' ' MET . . . . . 0.595 ' HG2' ' O ' ' B' 1235 ' ' ILE . 31.0 mmt -67.79 -36.53 80.6 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 120.848 -1.157 . . . . 53.63 108.711 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -70.11 -39.63 75.37 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 119.52 -0.872 . . . . 51.74 109.347 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1241 ' ' LEU . . . . . 0.798 HD22 ' HG ' ' B' 1214 ' ' LEU . 17.4 tp -53.14 -53.59 48.25 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-O 118.17 -0.919 . . . . 44.86 110.116 170.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -64.27 -40.57 96.24 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 112.509 0.559 . . . . 42.78 112.509 -177.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -61.02 -49.41 77.54 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 124.522 1.129 . . . . 40.96 108.138 -178.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -59.35 -43.84 92.76 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.608 1.549 . . . . 43.06 112.215 175.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1245 ' ' GLN . . . . . 0.472 ' O ' HG22 ' B' 1249 ' ' VAL . 46.5 mm-40 -62.01 -28.39 69.54 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.127 -1.397 . . . . 46.45 114.392 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -57.27 -27.44 62.11 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 123.263 1.506 . . . . 41.78 112.171 -174.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 10.5 tptt -77.98 -41.93 34.4 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 114.094 -1.412 . . . . 52.2 110.901 175.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1248 ' ' GLU . . . . . 0.436 ' CD ' HH12 ' B' 1192 ' ' ARG . 26.0 mt-10 -70.26 -41.45 73.46 Favored 'General case' 0 C--O 1.244 0.813 0 O-C-N 120.604 -1.31 . . . . 53.55 111.952 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1249 ' ' VAL . . . . . 0.8 ' HA ' ' HB2' ' B' 1167 ' ' LYS 0.259 32.8 m -84.88 164.3 2.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 124.336 2.017 . . . . 34.41 113.504 -166.203 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B 1250 ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' B' 1279 ' ' SER . 2.6 m-20 -122.63 -50.07 1.98 Allowed 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 113.663 -1.608 . . . . 33.38 107.602 -176.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1251 ' ' ILE . . . . . 0.514 HD12 ' HB1' ' B' 1145 ' ' ALA . 24.5 mm -119.94 114.98 45.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 108.035 -1.098 . . . . 29.54 108.035 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1252 ' ' ILE . . . . . . . . . . . . . 82.3 mt -91.62 119.79 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 N-CA-C 104.477 -2.416 . . . . 32.44 104.477 169.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1253 ' ' VAL . . . . . 0.617 HG12 HG23 ' B' 1255 ' ' THR . 55.9 t -112.81 100.91 11.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 104.665 -2.346 . . . . 30.57 104.665 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1254 ' ' THR . . . . . . . . . . . . . 7.4 t -103.08 98.6 8.51 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 125.982 2.801 . . . . 35.04 108.894 -175.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1255 ' ' THR . . . . . 0.617 HG23 HG12 ' B' 1253 ' ' VAL . 3.2 p -84.74 8.7 16.2 Favored 'General case' 0 N--CA 1.421 -1.888 1 CA-C-N 107.26 -4.518 . . . . 34.62 117.662 -176.618 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B 1256 ' ' ALA . . . . . 0.465 ' HB3' HD21 ' B' 1291 ' ' ASN . . . -72.98 92.06 1.61 Allowed 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 114.115 1.154 . . . . 42.72 114.115 -174.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 13.7 mt -109.0 101.34 10.43 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 102.936 -2.987 . . . . 52.43 102.936 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 2.3 mp -93.99 128.87 39.58 Favored Pre-proline 0 N--CA 1.481 1.123 0 C-N-CA 118.962 -1.095 . . . . 59.41 110.014 -177.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -58.68 126.43 21.23 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.779 2.32 . . . . 62.68 107.831 170.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 81.8 -75.24 2.35 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 117.033 -1.982 . . . . 64.16 108.46 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 91.5 mttt -58.13 149.73 55.44 Favored Pre-proline 0 C--O 1.242 0.676 0 CA-C-N 121.838 2.819 . . . . 68.53 115.715 -174.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.76 118.49 3.47 Favored 'Trans proline' 0 C--O 1.246 0.9 0 C-N-CA 123.544 2.829 . . . . 61.99 113.178 167.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1263 ' ' ALA . . . . . 0.412 ' HB1' ' CG ' ' B' 1291 ' ' ASN . . . -35.78 122.95 0.68 Allowed Pre-proline 0 C--O 1.245 0.831 0 C-N-CA 124.858 1.263 . . . . 57.15 111.052 164.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1264 ' ' PRO . . . . . 0.574 ' O ' ' HA ' ' B' 1291 ' ' ASN . 97.1 Cg_endo -77.13 158.6 33.85 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.292 1.995 . . . . 51.57 111.633 -172.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1265 ' ' LYS . . . . . 0.438 ' NZ ' ' O ' ' B' 1289 ' ' GLY . 46.6 mmtm -78.76 76.09 5.26 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 125.566 2.603 . . . . 54.55 110.751 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 40.3 mt -67.27 -52.99 34.03 Favored 'General case' 0 N--CA 1.438 -1.069 0 O-C-N 118.317 -2.739 . . . . 46.86 111.615 -177.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1267 ' ' ILE . . . . . 0.537 HG21 HD13 ' B' 1281 ' ' ILE . 38.0 mm -89.15 99.19 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 107.13 -1.433 . . . . 41.04 107.13 -176.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1268 ' ' THR . . . . . 0.691 ' HA ' ' HG3' ' B' 1293 ' ' GLU . 7.8 p -73.64 156.82 37.61 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 111.057 -2.792 . . . . 39.58 113.301 -175.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1269 ' ' ARG . . . . . 0.416 ' HG3' ' HB3' ' B' 1293 ' ' GLU . 78.3 mtt85 -55.81 -41.08 73.65 Favored 'General case' 0 C--O 1.206 -1.21 0 N-CA-C 113.371 0.878 . . . . 53.15 113.371 -175.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -59.38 -46.52 88.46 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 124.64 1.212 . . . . 42.96 110.481 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1271 ' ' MET . . . . . . . . . . . . . 48.6 ttm -58.48 -48.08 81.96 Favored 'General case' 0 C--O 1.242 0.66 0 O-C-N 124.096 0.873 . . . . 43.89 110.252 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1272 ' ' VAL . . . . . 0.413 HG23 ' O ' ' B' 1268 ' ' THR . 33.2 t -57.2 -50.26 77.16 Favored 'Isoleucine or valine' 0 C--O 1.257 1.45 0 O-C-N 125.637 1.836 . . . . 38.37 111.521 176.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.83 -29.59 67.03 Favored 'General case' 0 C--N 1.357 0.919 0 N-CA-C 115.364 1.616 . . . . 47.46 115.364 176.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1274 ' ' SER . . . . . . . . . . . . . 50.4 m -84.49 -7.35 59.3 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 126.022 1.729 . . . . 38.38 114.5 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1275 ' ' MET . . . . . 0.563 ' HB2' HG21 ' B' 1307 ' ' VAL . 49.5 mtp -66.5 164.77 15.79 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 113.576 0.954 . . . . 37.81 113.576 -175.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -55.85 137.1 50.87 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 124.645 1.178 . . . . 49.26 108.506 169.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1277 ' ' ALA . . . . . 0.695 ' HB3' ' HD1' ' A' 1045 ' ' PHE . . . -67.96 140.99 56.43 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 121.55 -0.719 . . . . 34.46 111.136 -177.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 72.93 55.15 6.58 Favored Glycine 0 N--CA 1.434 -1.495 0 CA-C-O 122.669 1.149 . . . . 33.53 113.824 175.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1279 ' ' SER . . . . . 0.555 ' O ' ' HA ' ' B' 1307 ' ' VAL . 70.9 m -141.37 160.87 39.23 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 107.7 -1.222 . . . . 31.31 107.7 -167.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1280 ' ' VAL . . . . . 0.693 HG11 ' HA ' ' B' 1145 ' ' ALA . 69.0 t -123.53 141.57 43.32 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 CA-C-N 120.039 1.29 . . . . 29.32 109.547 -169.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1281 ' ' ILE . . . . . 0.537 HD13 HG21 ' B' 1267 ' ' ILE . 74.8 mt -118.2 98.95 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 105.367 -2.086 . . . . 31.93 105.367 170.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1282 ' ' VAL . . . . . . . . . . . . . 5.3 t -86.85 109.84 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 106.77 -1.567 . . . . 29.48 106.77 174.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 58.4 t0 -93.64 111.76 23.5 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 103.236 -2.876 . . . . 34.5 103.236 171.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1284 ' ' LEU . . . . . 0.438 HD22 ' HA ' ' B' 1255 ' ' THR . 7.2 mp -74.15 -40.44 62.59 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 113.686 -1.597 . . . . 37.94 106.718 172.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -76.03 11.52 1.43 Allowed 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 120.285 -1.509 . . . . 40.92 114.898 -160.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -47.73 -45.05 28.42 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 118.486 2.773 . . . . 44.39 118.486 176.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1287 ' ' GLN . . . . . 0.838 ' HB3' HG23 ' B' 1313 ' ' THR . 0.0 OUTLIER -66.87 -28.94 68.74 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 122.588 1.185 . . . . 51.46 112.196 172.623 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -82.57 -33.9 27.91 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 114.671 1.36 . . . . 57.75 114.671 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1289 ' ' GLY . . . . . 0.438 ' O ' ' NZ ' ' B' 1265 ' ' LYS . . . 164.65 -21.95 0.14 Allowed Glycine 0 CA--C 1.536 1.4 0 C-N-CA 120.138 -1.029 . . . . 49.85 113.258 -172.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 80.48 112.01 0.29 Allowed Glycine 0 N--CA 1.464 0.535 0 CA-C-O 118.25 -1.305 . . . . 45.93 112.844 175.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1291 ' ' ASN . . . . . 0.574 ' HA ' ' O ' ' B' 1264 ' ' PRO . 69.2 m-80 -89.93 -15.28 32.37 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 119.152 1.476 . . . . 42.67 114.711 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1292 ' ' CYS . . . . . . . . . . . . . 48.5 t -105.88 144.06 33.13 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.287 0.847 . . . . 38.82 113.287 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1293 ' ' GLU . . . . . 0.691 ' HG3' ' HA ' ' B' 1268 ' ' THR . 6.8 mt-10 -69.5 -16.38 63.44 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 119.189 3.033 . . . . 46.71 119.189 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1294 ' ' TYR . . . . . 0.43 ' HB2' HG21 ' B' 1309 ' ' VAL . 58.5 m-85 -107.39 0.36 22.91 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 120.211 -1.555 . . . . 47.23 113.023 -178.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1295 ' ' THR . . . . . 0.712 HG23 ' HA3' ' B' 1311 ' ' GLY . 91.2 m -53.79 115.58 2.07 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 116.148 1.907 . . . . 36.02 116.148 -178.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1296 ' ' VAL . . . . . 0.466 ' HB ' ' HB3' ' B' 1299 ' ' GLU . 46.5 t -97.13 121.03 60.08 Favored Pre-proline 0 N--CA 1.435 -1.199 0 N-CA-C 102.551 -3.129 . . . . 37.26 102.551 169.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -51.59 114.29 1.51 Allowed 'Trans proline' 0 C--O 1.238 0.475 0 C-N-CA 124.827 3.684 . . . . 35.09 116.612 -177.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1298 ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' B' 1312 ' ' TYR . . . 66.18 42.56 94.25 Favored Glycine 0 C--O 1.245 0.793 0 CA-C-O 116.342 -2.365 . . . . 35.97 114.016 -173.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1299 ' ' GLU . . . . . 0.466 ' HB3' ' HB ' ' B' 1296 ' ' VAL . 18.2 tt0 -151.87 175.48 12.43 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 118.484 1.142 . . . . 40.39 111.17 175.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1300 ' ' ILE . . . . . 0.485 HG12 HG12 ' B' 1310 ' ' ILE . 58.6 mt -110.19 133.49 55.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 107.536 -1.283 . . . . 37.43 107.536 170.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 69.3 t80 -107.8 124.78 50.57 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.509 -0.876 . . . . 44.13 110.347 163.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1302 ' ' THR . . . . . . . . . . . . . 96.0 m -92.84 126.79 38.09 Favored 'General case' 0 C--O 1.248 0.985 0 O-C-N 120.238 -1.539 . . . . 39.78 107.95 176.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1303 ' ' THR . . . . . . . . . . . . . 67.5 p -82.56 175.08 10.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 120.851 1.66 . . . . 43.29 113.249 166.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -69.81 -30.6 68.16 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 122.222 1.01 . . . . 53.07 109.882 -174.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -82.98 14.45 3.31 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 114.5 1.296 . . . . 43.97 114.5 173.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 70.31 32.23 68.59 Favored Glycine 0 C--O 1.211 -1.339 0 O-C-N 120.569 -1.332 . . . . 41.12 110.909 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1307 ' ' VAL . . . . . 0.563 HG21 ' HB2' ' B' 1275 ' ' MET . 73.6 t -98.67 109.45 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 105.075 -2.194 . . . . 38.12 105.075 173.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1308 ' ' LYS . . . . . 0.418 ' CD ' ' HB3' ' B' 1148 ' ' GLU . 78.5 mttt -86.44 98.04 10.8 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 113.321 -1.763 . . . . 36.34 107.562 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1309 ' ' VAL . . . . . 0.43 HG21 ' HB2' ' B' 1294 ' ' TYR . 44.4 t -71.34 90.96 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 CA-C-N 114.608 -1.178 . . . . 30.4 108.93 172.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1310 ' ' ILE . . . . . 0.485 HG12 HG12 ' B' 1300 ' ' ILE . 37.0 mt -83.46 101.96 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 O-C-N 120.564 -1.335 . . . . 30.82 110.225 176.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1311 ' ' GLY . . . . . 0.712 ' HA3' HG23 ' B' 1295 ' ' THR . . . -99.5 63.38 0.7 Allowed Glycine 0 CA--C 1.499 -0.936 0 CA-C-N 114.137 -1.392 . . . . 26.53 111.317 178.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1312 ' ' TYR . . . . . 0.519 ' HB2' ' HG ' ' B' 1315 ' ' LEU . 8.4 m-30 -82.08 100.44 9.77 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 119.635 -2.097 . . . . 38.0 113.995 -175.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1313 ' ' THR . . . . . 0.838 HG23 ' HB3' ' B' 1287 ' ' GLN . 98.3 m -51.42 -38.0 51.39 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 114.082 -1.417 . . . . 29.8 109.733 168.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -95.59 14.86 21.52 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.965 2.106 . . . . 39.04 112.576 -166.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1315 ' ' LEU . . . . . 0.519 ' HG ' ' HB2' ' B' 1312 ' ' TYR . 41.9 mt -50.58 -50.36 72.84 Favored Pre-proline 0 C--O 1.21 -1.019 0 CA-C-O 113.274 -3.25 . . . . 31.08 116.425 176.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1316 ' ' PRO . . . . . 0.645 ' HB3' ' HB3' ' B' 1133 ' ' MET . 68.2 Cg_exo -51.73 -34.69 55.14 Favored 'Trans proline' 0 CA--C 1.536 0.581 1 C-N-CA 125.955 4.437 . . . . 26.1 113.646 174.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B 1317 ' ' GLY . . . . . 0.676 ' HA2' ' HG3' ' B' 1015 ' ' ARG . . . -66.16 -48.47 64.57 Favored Glycine 0 C--N 1.344 0.98 0 O-C-N 120.378 -1.451 . . . . 23.17 113.228 176.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1318 ' ' ARG . . . . . 0.424 ' HD2' HD23 ' B' 1315 ' ' LEU . 75.6 mtt-85 -50.34 -0.55 0.01 OUTLIER 'General case' 0 C--O 1.237 0.405 1 N-CA-C 124.683 5.068 . . . . 40.4 124.683 -169.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 13.5 tp -126.92 72.67 75.95 Favored Pre-proline 0 C--O 1.245 0.843 0 N-CA-C 104.872 -2.27 . . . . 23.6 104.872 176.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1320 ' ' PRO . . . . . 0.653 ' HG2' ' HA2' ' A' 1150 ' ' GLY . 95.7 Cg_endo -43.49 -72.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 124.882 3.721 . . . . 22.35 119.847 -160.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1321 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.9 -37.66 66.61 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 113.349 0.87 . . . . 26.52 113.349 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1322 ' ' GLN . . . . . 0.866 ' HB2' ' HA ' ' A' 1151 ' ' ARG . 55.5 tp60 -74.23 -41.96 60.5 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 118.653 -1.219 . . . . 24.38 110.066 -173.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1323 ' ' SER . . . . . 0.445 ' HB2' ' HG2' ' B' 1015 ' ' ARG . 14.8 m -59.43 -40.81 87.93 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.601 -0.84 . . . . 22.8 112.284 170.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1324 ' ' SER . . . . . . . . . . . . . 13.7 m -64.22 -25.04 67.89 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 115.481 1.66 . . . . 21.25 115.481 170.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1325 ' ' GLN . . . . . 0.567 HE22 ' HD2' ' B' 1021 ' ' LYS . 67.5 tp60 -74.05 -50.17 20.88 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.767 -0.583 . . . . 31.34 109.551 175.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1326 ' ' LEU . . . . . 0.423 ' HB3' ' HB3' ' B' 1132 ' ' SER . 13.7 mt -72.33 -51.84 18.85 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 108.125 -1.065 . . . . 31.56 108.125 -174.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1327 ' ' TYR . . . . . 0.439 ' O ' ' HG ' ' B' 1331 ' ' LEU . 18.7 t80 -51.19 -46.63 62.22 Favored 'General case' 0 C--N 1.377 1.774 0 O-C-N 118.984 -2.322 . . . . 22.73 111.613 172.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1328 ' ' GLY . . . . . 0.461 ' O ' HG23 ' B' 1332 ' ' VAL . . . -51.16 -52.91 29.69 Favored Glycine 0 C--O 1.244 0.763 0 CA-C-O 123.654 1.697 . . . . 21.91 112.115 175.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1329 ' ' THR . . . . . . . . . . . . . 20.1 m -65.69 -36.41 83.56 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.099 -1.074 . . . . 22.15 108.099 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1330 ' ' ASN . . . . . . . . . . . . . 23.7 m120 -60.56 -47.72 84.92 Favored 'General case' 0 N--CA 1.437 -1.082 0 O-C-N 118.673 -2.517 . . . . 26.18 110.275 178.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1331 ' ' LEU . . . . . 0.681 HD22 HD22 ' B' 1070 ' ' LEU . 20.1 mt -57.61 -42.57 83.52 Favored 'General case' 0 N--CA 1.435 -1.179 0 O-C-N 125.853 1.97 . . . . 23.68 111.842 172.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1332 ' ' VAL . . . . . 0.598 HG12 ' HE3' ' B' 1336 ' ' LYS . 97.9 t -59.56 -44.91 94.2 Favored 'Isoleucine or valine' 0 C--N 1.349 0.552 0 CA-C-O 121.436 0.636 . . . . 26.57 110.581 178.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1333 ' ' ASN . . . . . 0.622 ' HA ' ' HD2' ' B' 1336 ' ' LYS . 82.4 m-20 -62.67 -45.72 91.5 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.953 0.901 . . . . 28.08 110.109 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1334 ' ' LEU . . . . . 0.717 HD12 HD23 ' B' 1127 ' ' LEU . 4.3 tp -52.0 -52.17 52.43 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 124.733 1.27 . . . . 27.43 109.616 174.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1335 ' ' LEU . . . . . 0.749 HD23 HD12 ' B' 1338 ' ' LEU . 75.3 mt -72.7 -19.29 61.43 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 114.234 -1.348 . . . . 30.5 113.356 -178.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1336 ' ' LYS . . . . . 0.622 ' HD2' ' HA ' ' B' 1333 ' ' ASN . 88.5 mttt -65.63 -48.17 73.11 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-N 122.9 2.591 . . . . 41.65 107.526 169.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1337 ' ' LEU . . . . . 0.465 HD21 ' HD2' ' B' 1123 ' ' ARG . 10.6 mp -75.1 -30.55 60.93 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.362 0.665 . . . . 42.08 110.663 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1338 ' ' LEU . . . . . 0.749 HD12 HD23 ' B' 1335 ' ' LEU . 79.0 mt -71.11 -51.53 24.55 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 119.697 -1.877 . . . . 35.03 111.052 172.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 49.8 t -96.5 71.67 2.7 Favored 'General case' 0 C--O 1.254 1.298 0 CA-C-O 124.849 2.261 . . . . 37.33 107.462 -173.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 12.8 mttp -54.35 -39.08 66.78 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 111.827 -2.442 . . . . 50.51 112.472 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -98.93 20.06 13.9 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 112.998 0.74 . . . . 54.21 112.998 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 97.1 mttt 42.6 38.35 1.26 Allowed 'General case' 0 C--O 1.248 0.974 0 C-N-CA 127.758 2.423 . . . . 50.99 117.081 159.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -111.76 -2.95 15.12 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 112.456 -2.156 . . . . 48.82 109.808 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 89.08 26.1 27.19 Favored Glycine 0 C--O 1.214 -1.1 0 CA-C-O 116.849 -2.084 . . . . 40.43 111.711 -171.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -116.78 122.76 45.37 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-N 122.277 3.038 . . . . 47.56 113.013 174.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1346 ' ' ILE . . . . . . . . . . . . . 37.6 mm -68.28 113.18 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 124.265 1.026 . . . . 42.49 111.343 -174.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1347 ' ' THR . . . . . . . . . . . . . 11.2 m -106.13 106.28 16.72 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 104.84 -2.281 . . . . 38.12 104.84 170.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 98.9 t -81.04 100.97 5.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 106.573 -1.64 . . . . 37.5 106.573 -174.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 61.0 t0 -72.91 113.2 9.67 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.712 -1.131 . . . . 43.85 111.544 -174.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1350 ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.32 -6.54 25.7 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.567 -1.333 . . . . 39.81 110.909 176.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -76.51 -29.31 56.75 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.809 -0.632 . . . . 51.29 110.827 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 42.6 t0 -88.04 127.47 35.4 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 104.147 -2.538 . . . . 39.78 104.147 -176.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 15.5 m -63.44 -27.26 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 123.766 0.826 . . . . 39.28 111.519 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1354 ' ' VAL . . . . . 0.72 HG22 ' HB2' ' B' 1124 ' ' ALA . 50.6 t -65.16 -56.01 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.796 0.838 . . . . 35.7 112.931 175.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1355 ' ' ILE . . . . . 0.406 ' HA ' HG12 ' B' 1358 ' ' VAL . 27.5 mm -68.86 -45.62 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-O 117.284 -1.341 . . . . 35.77 109.263 178.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 52.3 tpt85 -49.1 -32.1 9.23 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 120.158 1.344 . . . . 38.55 114.577 172.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1357 ' ' GLY . . . . . 0.538 ' HA2' ' HB2' ' B' 1370 ' ' ALA . . . -76.14 -61.33 2.86 Favored Glycine 0 CA--C 1.492 -1.402 0 CA-C-N 116.027 -0.533 . . . . 29.58 113.101 175.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1358 ' ' VAL . . . . . 0.462 HG13 ' HE2' ' B' 1113 ' ' MET . 13.1 p -64.97 -32.65 59.19 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 O-C-N 122.079 -0.659 . . . . 32.06 111.053 -172.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1359 ' ' THR . . . . . . . . . . . . . 4.2 m -71.92 81.78 0.92 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 122.85 1.309 . . . . 29.0 108.274 175.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1360 ' ' VAL . . . . . 0.442 HG12 ' CD1' ' B' 1368 ' ' TRP . 34.8 m -71.13 -26.03 26.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 113.004 -1.907 . . . . 29.68 111.34 -175.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1361 ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' B' 1365 ' ' GLU . 83.9 mt -132.25 119.22 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 107.118 -1.438 . . . . 32.05 107.118 170.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1362 ' ' ARG . . . . . 0.597 ' HA ' HG23 ' B' 1111 ' ' THR . 27.1 ttt180 -106.8 125.34 50.87 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 105.571 -2.011 . . . . 32.52 105.571 172.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 45.62 37.3 3.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 117.542 2.423 . . . . 35.68 117.542 176.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1364 ' ' GLY . . . . . 0.584 ' HA3' ' HA ' ' B' 1109 ' ' ASN . . . 85.84 14.88 66.51 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 113.926 -1.488 . . . . 34.26 116.057 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1365 ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' B' 1361 ' ' ILE . 20.8 mm-40 -108.41 135.48 49.64 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.465 -0.939 . . . . 51.07 108.465 164.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1366 ' ' ILE . . . . . 0.439 ' HA ' HG12 ' B' 1361 ' ' ILE . 61.4 mt -69.6 90.71 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 106.57 -1.641 . . . . 39.87 106.57 173.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1367 ' ' THR . . . . . . . . . . . . 0.252 23.8 p -85.7 10.88 12.21 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 116.698 2.11 . . . . 38.01 116.698 176.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1368 ' ' TRP . . . . . 0.512 ' HZ3' ' HB2' ' B' 1096 ' ' ALA . 1.7 t90 -78.07 138.8 60.78 Favored Pre-proline 0 C--O 1.252 1.232 0 N-CA-C 107.586 -1.264 . . . . 42.14 107.586 166.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1369 ' ' PRO . . . . . 0.403 ' HA ' ' CD1' ' B' 1368 ' ' TRP . 7.9 Cg_exo -94.3 179.77 9.28 Favored 'Cis proline' 0 C--N 1.35 0.627 0 N-CA-C 115.958 1.484 . . . . 43.26 115.958 -3.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1370 ' ' ALA . . . . . 0.538 ' HB2' ' HA2' ' B' 1357 ' ' GLY . . . -81.97 149.99 64.28 Favored Pre-proline 0 C--O 1.242 0.686 0 CA-C-O 116.77 -1.586 . . . . 46.52 108.486 163.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -49.01 120.24 5.26 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 124.44 3.427 . . . . 51.95 110.734 175.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -48.83 100.95 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 125.121 3.88 . . . . 56.27 117.503 -172.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1373 ' ' ILE . . . . . . . . . . . . . 19.1 tt -76.37 126.16 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 106.34 -1.726 . . . . 60.83 106.34 172.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -72.02 106.57 4.34 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-O 125.566 2.603 . . . . 66.1 109.634 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 71.2 t -98.24 121.56 48.92 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 CA-C-N 111.45 -2.614 . . . . 63.47 106.279 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.218 -5.11 0 O-C-N 120.004 -1.685 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.414 -2.236 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.26 -31.82 71.63 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 124.789 1.235 . . . . 0.0 110.026 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -36.15 83.42 Favored 'General case' 0 C--O 1.252 1.19 0 CA-C-N 119.398 0.999 . . . . 0.0 109.787 175.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 84.8 m -67.04 -33.03 74.65 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 118.622 0.646 . . . . 0.0 109.91 171.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 24' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' C' ' 27' ' ' LEU . . . -68.65 -50.35 51.91 Favored 'General case' 0 C--O 1.246 0.87 0 O-C-N 119.41 -2.056 . . . . 0.0 110.973 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 25' ' ' GLU . . . . . 0.587 ' HA ' ' HE2' ' C' ' 28' ' ' LYS . 0.7 OUTLIER -41.72 -57.28 2.37 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.728 -1.233 . . . . 0.0 113.557 162.281 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.618 ' HA ' ' HB3' ' C' ' 29' ' ' ASN . 84.7 mt -60.96 -25.42 66.81 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 175.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.608 HD21 HD21 ' C' ' 110' ' ' LEU . 44.4 mt -58.37 -56.46 21.81 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 116.613 -1.66 . . . . 0.0 110.868 172.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 28' ' ' LYS . . . . . 0.587 ' HE2' ' HA ' ' C' ' 25' ' ' GLU . 12.3 pttt -67.9 -31.33 71.04 Favored 'General case' 0 C--O 1.257 1.459 0 CA-C-O 123.556 1.646 . . . . 0.0 110.272 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 29' ' ' ASN . . . . . 0.618 ' HB3' ' HA ' ' C' ' 26' ' ' LEU . 6.0 t30 -64.46 -27.33 68.91 Favored 'General case' 0 C--O 1.212 -0.886 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 169.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.647 ' HA ' ' HB3' ' C' ' 107' ' ' ASP . 35.4 m -65.69 -31.85 73.08 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 116.582 2.068 . . . . 0.0 116.582 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 31' ' ' HIS . . . . . 0.482 ' O ' HG23 ' C' ' 62' ' ' ILE . 19.7 m-70 61.08 -60.79 0.08 Allowed 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.289 -178.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 32' ' ' SER . . . . . 0.544 ' O ' ' HB3' ' C' ' 30' ' ' SER . 42.0 m -85.74 137.04 33.09 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 117.072 -3.518 . . . . 0.0 106.948 156.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . 0.413 ' HA ' HG23 ' C' ' 106' ' ' THR . 60.7 t -127.99 94.33 2.48 Favored 'Isoleucine or valine' 0 C--O 1.246 0.892 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 174.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.646 HG13 ' HA ' ' C' ' 103' ' ' PHE . 23.6 mm -74.11 110.25 7.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 O-C-N 118.607 -2.558 . . . . 0.0 107.666 168.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . 0.521 HG12 HD12 ' C' ' 110' ' ' LEU . 33.6 mt -85.88 114.59 25.85 Favored 'Isoleucine or valine' 0 C--O 1.254 1.303 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 169.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 36.2 m -93.67 107.88 30.3 Favored Pre-proline 0 C--O 1.246 0.914 0 O-C-N 121.08 -1.013 . . . . 0.0 110.382 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' C' ' 35' ' ' ILE . 80.2 Cg_exo -61.18 91.35 0.1 OUTLIER 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 123.294 2.663 . . . . 0.0 113.382 177.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.56 168.92 40.5 Favored Glycine 0 N--CA 1.432 -1.569 0 CA-C-N 113.086 -1.87 . . . . 0.0 108.624 169.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 39' ' ' TYR . . . . . 0.436 ' HB3' ' HB2' ' C' ' 114' ' ' ALA . 46.9 t80 -57.43 -28.04 62.96 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -177.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 40' ' ' GLY . . . . . 0.465 ' HA2' HG12 ' C' ' 43' ' ' VAL . . . -58.45 -32.71 69.06 Favored Glycine 0 C--O 1.244 0.758 0 O-C-N 120.83 -1.169 . . . . 0.0 112.536 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 41' ' ' MET . . . . . 0.833 ' HA ' ' HB3' ' C' ' 46' ' ' ALA . 16.1 ttm -55.64 -44.54 77.26 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.557 -0.822 . . . . 0.0 111.454 177.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.89 -51.97 10.29 Favored 'General case' 0 C--O 1.214 -0.777 0 O-C-N 124.967 1.417 . . . . 0.0 111.627 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . 0.465 HG12 ' HA2' ' C' ' 40' ' ' GLY . 11.3 p -67.43 -41.47 86.17 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 C-N-CA 119.333 -0.947 . . . . 0.0 113.358 -168.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . 0.43 ' HB1' ' HB2' ' C' ' 176' ' ' LYS . . . -92.47 19.71 6.97 Favored 'General case' 0 N--CA 1.424 -1.731 0 O-C-N 120.899 -1.125 . . . . 0.0 110.597 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 45' ' ' GLN . . . . . . . . . . . . 0.353 0.0 OUTLIER 30.31 56.65 0.19 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 117.819 2.525 . . . . 0.0 117.819 -167.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.833 ' HB3' ' HA ' ' C' ' 41' ' ' MET . . . -78.26 -14.19 59.54 Favored 'General case' 0 C--O 1.202 -1.44 0 CA-C-N 111.891 -2.413 . . . . 0.0 114.094 -178.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . 0.486 ' HA ' ' HB ' ' C' ' 50' ' ' VAL . 0.0 OUTLIER -66.89 -26.38 66.85 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 179.386 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 48' ' ' TYR . . . . . 0.592 ' HB2' ' HD3' ' C' ' 49' ' ' PRO . 47.0 m-85 -62.58 -52.2 66.95 Favored Pre-proline 0 N--CA 1.443 -0.787 0 CA-C-O 117.636 -1.174 . . . . 0.0 111.767 170.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 49' ' ' PRO . . . . . 0.592 ' HD3' ' HB2' ' C' ' 48' ' ' TYR . 8.2 Cg_exo -63.58 -39.34 36.12 Favored 'Trans proline' 0 CA--C 1.551 1.359 0 C-N-CA 122.846 2.364 . . . . 0.0 114.231 170.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . 0.577 ' HA ' HG22 ' C' ' 53' ' ' ILE . 54.2 t -59.81 -37.4 71.39 Favored 'Isoleucine or valine' 0 C--N 1.346 0.442 0 CA-C-O 116.126 -1.892 . . . . 0.0 111.191 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.02 -46.8 89.26 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 122.971 2.623 . . . . 0.0 108.993 -176.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 52' ' ' GLU . . . . . 0.54 ' HB3' HD11 ' C' ' 183' ' ' LEU . 3.6 tm-20 -69.57 -41.18 76.19 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.332 -1.304 . . . . 0.0 113.721 -178.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 53' ' ' ILE . . . . . 0.643 HD13 ' HA ' ' C' ' 183' ' ' LEU . 10.2 tp -60.45 -39.72 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 120.309 1.413 . . . . 0.0 113.002 172.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 95.0 m -60.68 -46.82 88.91 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.166 173.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -55.15 -50.82 68.33 Favored 'General case' 0 C--O 1.252 1.184 0 C-N-CA 127.178 2.191 . . . . 0.0 110.231 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . 0.431 ' HG2' HD12 ' C' ' 186' ' ' LEU . 4.3 ttpt -57.57 -50.73 72.14 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 116.59 2.071 . . . . 0.0 116.59 175.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 57' ' ' LEU . . . . . 0.479 ' O ' ' HB3' ' C' ' 60' ' ' ARG . 29.6 mt -63.06 -40.33 97.38 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.803 -0.561 . . . . 0.0 111.787 175.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . 0.516 ' NH1' ' HA ' ' C' ' 63' ' ' ASN . 2.5 tpt180 -67.7 -46.04 73.41 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 118.787 -0.625 . . . . 0.0 109.882 -175.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.74 -31.72 72.98 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 120.231 1.378 . . . . 0.0 112.502 175.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . 0.479 ' HB3' ' O ' ' C' ' 57' ' ' LEU . 1.7 tpm_? -61.36 -28.52 69.29 Favored 'General case' 0 C--N 1.346 0.45 0 O-C-N 119.913 -1.742 . . . . 0.0 110.89 171.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.4 1.84 40.91 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -177.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . 0.482 HG23 ' O ' ' C' ' 31' ' ' HIS . 64.5 mt -73.28 137.18 23.88 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 CA-C-O 126.096 2.855 . . . . 0.0 107.131 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 63' ' ' ASN . . . . . 0.516 ' HA ' ' NH1' ' C' ' 58' ' ' ARG . 59.3 t30 -81.52 67.01 7.31 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 112.275 -2.239 . . . . 0.0 111.754 -177.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 2.8 p -78.51 128.64 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 173.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 30.2 mmm-85 -137.42 148.78 46.42 Favored 'General case' 0 C--N 1.349 0.546 0 N-CA-C 103.468 -2.79 . . . . 0.0 103.468 -174.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . 0.73 ' HB2' ' HA ' ' C' ' 93' ' ' VAL . 22.4 m-85 -106.09 118.89 37.8 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 122.798 1.285 . . . . 0.0 111.048 -176.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -97.29 83.05 0.72 Allowed Glycine 0 C--O 1.25 1.107 0 N-CA-C 107.919 -2.072 . . . . 0.0 107.919 -177.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 68' ' ' ILE . . . . . 0.76 ' HB ' ' HA ' ' C' ' 95' ' ' GLU . 1.7 mp -73.03 126.38 33.59 Favored 'Isoleucine or valine' 0 C--N 1.348 0.518 0 CA-C-N 119.918 1.859 . . . . 0.0 110.191 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 69' ' ' HIS . . . . . 0.503 ' NE2' ' HG2' ' C' ' 134' ' ' PRO . 18.1 t-80 -118.16 91.98 41.59 Favored Pre-proline 0 CA--C 1.5 -0.945 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.911 -178.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 70' ' ' PRO . . . . . 0.773 ' HB3' HG13 ' A' 1157 ' ' ILE . 98.3 Cg_endo -54.39 -39.29 88.07 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 124.733 3.622 . . . . 0.0 118.307 -168.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 42.2 t -71.03 95.57 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 171.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -161.49 106.58 1.31 Allowed 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.445 1.117 . . . . 0.0 110.762 -172.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 73' ' ' GLY . . . . . 0.466 ' C ' ' HD2' ' C' ' 74' ' ' ARG . . . 72.31 -90.95 0.53 Allowed Glycine 0 N--CA 1.467 0.719 0 O-C-N 118.34 -2.725 . . . . 0.0 113.984 156.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . 0.816 ' HG3' ' HG2' ' B' 1203 ' ' GLN . 2.4 mpt_? -145.91 114.09 6.61 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -169.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.669 ' HG ' HD22 ' B' 1178 ' ' LEU . 4.0 mp 60.36 119.89 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.416 0 O-C-N 127.079 2.737 . . . . 0.0 116.808 175.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 76' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' C' ' 75' ' ' LEU . 73.0 Cg_endo -66.69 165.14 26.54 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 124.244 3.296 . . . . 0.0 109.423 167.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.39 -115.94 5.01 Favored Glycine 0 CA--C 1.505 -0.535 0 O-C-N 120.21 -1.556 . . . . 0.0 110.338 -169.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 49.56 -79.95 0.01 OUTLIER 'General case' 0 C--O 1.248 0.979 0 C-N-CA 124.819 1.248 . . . . 0.0 114.166 155.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -67.65 -35.43 78.87 Favored 'General case' 0 C--O 1.241 0.652 0 O-C-N 118.962 -2.336 . . . . 0.0 110.209 -177.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -64.13 -34.1 77.29 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 74.8 t -65.71 -41.03 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 122.139 -0.351 . . . . 0.0 111.351 176.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 45.9 mt -66.63 -30.27 70.5 Favored 'General case' 0 C--O 1.252 1.194 0 CA-C-O 123.361 1.553 . . . . 0.0 109.904 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.793 HD11 ' SD ' ' C' ' 41' ' ' MET . 6.0 mp -66.89 -48.34 69.05 Favored 'General case' 0 C--O 1.24 0.568 0 O-C-N 120.869 -1.144 . . . . 0.0 110.162 172.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.18 -49.42 77.1 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 177.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -58.59 -55.04 40.18 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-O 117.873 -1.061 . . . . 0.0 109.075 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.77 9.08 0.3 Allowed 'General case' 0 C--O 1.246 0.874 0 CA-C-N 121.158 1.799 . . . . 0.0 114.05 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp 64.14 30.87 13.64 Favored 'General case' 0 C--O 1.257 1.5 0 CA-C-N 122.017 2.19 . . . . 0.0 115.012 172.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 60.7 t -72.34 120.24 79.33 Favored Pre-proline 0 C--O 1.262 1.722 0 N-CA-C 104.462 -2.421 . . . . 0.0 104.462 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -56.71 115.94 2.84 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.854 3.036 . . . . 0.0 116.37 -171.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 90' ' ' TYR . . . . . 0.753 ' HA ' ' HB ' ' C' ' 93' ' ' VAL . 16.4 m-85 -60.69 -22.37 63.85 Favored 'General case' 0 C--O 1.246 0.885 0 CA-C-O 123.381 1.562 . . . . 0.0 114.125 173.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -43.19 -56.75 3.28 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 124.87 1.268 . . . . 0.0 112.758 164.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 1.9 pt -96.43 -10.38 8.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.577 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . 0.753 ' HB ' ' HA ' ' C' ' 90' ' ' TYR . 41.5 t -74.13 108.43 5.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-O 123.749 1.738 . . . . 0.0 110.656 175.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 6.0 mt -106.25 95.61 5.89 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 120.624 -1.297 . . . . 0.0 110.975 176.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 95' ' ' GLU . . . . . 0.76 ' HA ' ' HB ' ' C' ' 68' ' ' ILE . 3.1 mp0 -71.19 91.53 0.95 Allowed 'General case' 0 C--O 1.255 1.352 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.056 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 39.3 ttp 50.52 97.8 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 124.503 2.097 . . . . 0.0 116.445 -175.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -157.94 163.51 37.77 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 113.396 -1.729 . . . . 0.0 107.53 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -84.8 94.92 8.82 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 124.975 2.322 . . . . 0.0 111.471 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 10.3 tp -100.03 41.02 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 CA-C-N 109.079 -3.691 . . . . 0.0 107.386 164.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -76.91 -31.12 56.47 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 119.984 -1.698 . . . . 0.0 108.153 -161.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -63.45 -61.22 2.48 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 124.576 1.15 . . . . 0.0 113.93 170.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 102' ' ' ASP . . . . . 0.438 ' HA ' ' HB3' ' C' ' 105' ' ' ASP . 1.4 m-20 -65.83 -21.08 66.45 Favored 'General case' 0 C--N 1.355 0.818 0 O-C-N 123.852 0.72 . . . . 0.0 111.626 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 103' ' ' PHE . . . . . 0.646 ' HA ' HG13 ' C' ' 34' ' ' ILE . 0.1 OUTLIER -56.62 -60.17 3.94 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 123.304 0.642 . . . . 0.0 110.768 170.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.25 -31.35 72.48 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 173.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . 0.438 ' HB3' ' HA ' ' C' ' 102' ' ' ASP . 8.6 t70 -66.24 -26.45 67.37 Favored 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 120.509 -1.369 . . . . 0.0 111.837 175.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 106' ' ' THR . . . . . 0.557 ' OG1' HG12 ' C' ' 34' ' ' ILE . 53.6 m -73.02 125.75 28.35 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 121.842 2.11 . . . . 0.0 108.946 177.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 107' ' ' ASP . . . . . 0.647 ' HB3' ' HA ' ' C' ' 30' ' ' SER . 11.7 t70 -72.36 -43.37 64.13 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 113.006 -1.906 . . . . 0.0 110.621 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' C' ' 143' ' ' ASN . 80.0 m -125.62 104.53 8.44 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 119.015 0.825 . . . . 0.0 111.622 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 109' ' ' VAL . . . . . 0.445 HG11 HG21 ' C' ' 138' ' ' VAL . 8.1 t -87.0 120.95 37.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -171.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 110' ' ' LEU . . . . . 0.608 HD21 HD21 ' C' ' 27' ' ' LEU . 20.8 mt -90.32 93.77 9.47 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -171.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 19.1 t -84.81 109.31 17.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.037 170.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 112' ' ' ILE . . . . . 0.52 HD11 HG23 ' C' ' 35' ' ' ILE . 6.5 mm -78.06 90.02 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.919 0 CA-C-O 121.888 0.851 . . . . 0.0 110.652 -174.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 113' ' ' GLY . . . . . 0.558 ' HA2' ' O ' ' C' ' 147' ' ' PHE . . . 86.79 -72.95 2.54 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-O 124.106 1.948 . . . . 0.0 113.969 168.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 114' ' ' ALA . . . . . 0.436 ' HB2' ' HB3' ' C' ' 39' ' ' TYR . . . -75.77 108.29 8.52 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 120.773 -1.428 . . . . 0.0 112.819 -168.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 115' ' ' ASN . . . . . 0.511 ' OD1' ' H4B' ' C' 1001 ' ' NAP . 4.6 p-10 -65.75 -58.46 5.62 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 113.106 -1.861 . . . . 0.0 115.213 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 116' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' C' ' 119' ' ' ASN . 81.8 m-20 -57.62 -19.38 25.77 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 116.713 2.116 . . . . 0.0 116.713 -168.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 3.1 m -44.54 -43.47 8.03 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.658 1.983 . . . . 0.0 110.624 173.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.523 HG23 HD21 ' C' ' 162' ' ' LEU . 13.7 m -125.07 37.75 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.624 0 CA-C-O 122.952 1.358 . . . . 0.0 110.83 -177.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 119' ' ' ASN . . . . . 0.506 ' HB2' ' HA ' ' C' ' 116' ' ' ASP . 40.7 t-20 -77.82 114.22 39.55 Favored Pre-proline 0 C--O 1.243 0.73 0 O-C-N 120.463 -1.398 . . . . 0.0 110.832 -176.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 120' ' ' PRO . . . . . 0.416 ' HG2' ' HB2' ' C' ' 160' ' ' ASN . 71.7 Cg_endo -64.6 -34.0 53.69 Favored 'Trans proline' 0 CA--C 1.495 -1.471 0 C-N-CA 125.045 3.83 . . . . 0.0 114.183 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 121' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' C' ' 125' ' ' ASP . . . -64.23 -30.27 71.33 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 118.614 -1.235 . . . . 0.0 110.429 174.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 122' ' ' ALA . . . . . 0.555 ' HA ' ' CB ' ' C' ' 128' ' ' SER . . . -68.72 -19.83 64.37 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 174.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 123' ' ' GLN . . . . . 0.48 ' HB3' ' O ' ' C' ' 133' ' ' MET . 3.9 pt20 -86.7 -59.78 2.17 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 118.039 -2.913 . . . . 0.0 114.621 161.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -65.44 -45.05 85.33 Favored 'General case' 0 N--CA 1.438 -1.067 0 O-C-N 127.431 2.957 . . . . 0.0 115.042 -168.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 125' ' ' ASP . . . . . 0.459 ' HA ' ' HD3' ' C' ' 126' ' ' PRO . 0.9 OUTLIER -80.59 119.98 77.84 Favored Pre-proline 0 C--O 1.243 0.735 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -170.639 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 126' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' C' ' 125' ' ' ASP . 33.1 Cg_exo -75.49 76.01 3.73 Favored 'Trans proline' 0 N--CA 1.436 -1.878 1 C-N-CA 125.843 4.362 . . . . 0.0 109.413 175.114 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . 0.41 ' HB3' ' OD2' ' C' ' 125' ' ' ASP . 6.0 ttpm? 174.98 -25.5 0.0 OUTLIER 'General case' 0 C--O 1.248 0.981 0 C-N-CA 125.98 1.712 . . . . 0.0 108.378 -173.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 128' ' ' SER . . . . . 0.558 ' OG ' HG21 ' C' ' 158' ' ' VAL . 73.8 m -68.17 126.62 92.87 Favored Pre-proline 0 N--CA 1.446 -0.658 0 CA-C-N 120.961 1.709 . . . . 0.0 112.024 175.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 129' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' C' ' 128' ' ' SER . 17.0 Cg_endo -56.72 -58.39 0.98 Allowed 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 123.836 3.024 . . . . 0.0 114.091 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 13.3 pt -73.21 66.32 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 C-N-CA 123.977 0.911 . . . . 0.0 112.308 171.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 131' ' ' ALA . . . . . 0.474 ' O ' ' HB ' ' B' 1121 ' ' ILE . . . -72.93 150.9 42.15 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 122.695 1.236 . . . . 0.0 113.409 -170.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.03 53.36 27.0 Favored Glycine 0 CA--C 1.497 -1.045 0 CA-C-N 111.846 -2.434 . . . . 0.0 107.679 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 133' ' ' MET . . . . . 0.48 ' O ' ' HB3' ' C' ' 123' ' ' GLN . 24.5 tpp -76.62 129.45 79.4 Favored Pre-proline 0 C--O 1.252 1.185 0 CA-C-N 118.69 1.245 . . . . 0.0 110.715 175.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 134' ' ' PRO . . . . . 0.503 ' HG2' ' NE2' ' C' ' 69' ' ' HIS . 40.7 Cg_endo -62.78 101.93 0.28 Allowed 'Trans proline' 0 CA--C 1.517 -0.341 0 C-N-CA 125.22 3.947 . . . . 0.0 110.981 171.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 15.7 t -120.45 93.88 2.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 1 N-CA-C 99.743 -4.169 . . . . 0.0 99.743 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 5.1 mt -73.5 78.84 1.43 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.451 0.643 . . . . 0.0 112.196 -170.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 48.68 5.05 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 120.243 3.423 . . . . 0.0 120.243 -167.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 138' ' ' VAL . . . . . 0.445 HG21 HG11 ' C' ' 109' ' ' VAL 0.291 13.0 p -76.22 61.9 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 117.457 2.391 . . . . 0.0 117.457 -173.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 17.7 p90 -158.2 178.18 10.47 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 123.302 0.641 . . . . 0.0 109.618 171.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 140' ' ' LYS . . . . . . . . . . . . . 15.4 pttm 63.58 -58.16 0.19 Allowed 'General case' 0 C--O 1.247 0.933 0 C-N-CA 126.998 2.119 . . . . 0.0 115.681 174.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -90.76 174.28 7.56 Favored 'General case' 0 C--N 1.319 -0.746 0 O-C-N 120.122 -1.611 . . . . 0.0 107.346 170.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 63.97 157.51 0.08 Allowed 'General case' 0 C--N 1.345 0.383 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 172.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 143' ' ' ASN . . . . . 0.46 ' O ' ' HA ' ' C' ' 108' ' ' THR . 52.9 m-80 -80.14 79.26 6.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 125.167 2.413 . . . . 0.0 107.075 177.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 144' ' ' VAL . . . . . 0.647 ' HB ' HG23 ' C' ' 168' ' ' THR . 58.0 t -85.94 83.97 2.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 O-C-N 118.598 -2.564 . . . . 0.0 106.001 -178.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 145' ' ' ILE . . . . . 0.721 HG23 ' HB2' ' C' ' 171' ' ' LEU . 35.7 mt -88.91 109.18 19.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 125.501 2.572 . . . . 0.0 114.823 -170.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 146' ' ' VAL . . . . . . . . . . . . . 27.1 t -96.05 108.58 21.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 109.444 -3.525 . . . . 0.0 107.142 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 147' ' ' PHE . . . . . 0.558 ' O ' ' HA2' ' C' ' 113' ' ' GLY . 13.8 m-85 -70.75 102.58 2.35 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 148' ' ' LYS . . . . . 0.771 ' HE3' ' HA ' ' C' ' 151' ' ' MET . 60.2 tttp -131.28 133.77 45.73 Favored 'General case' 0 C--O 1.244 0.797 0 O-C-N 118.973 -2.329 . . . . 0.0 109.512 -175.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 149' ' ' ARG . . . . . 0.564 ' HE ' ' HB2' ' C' ' 174' ' ' ASP . 19.6 ttm105 -83.37 -92.27 0.07 Allowed 'General case' 0 C--O 1.24 0.565 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 176.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 1.1 m -70.52 131.46 44.05 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 121.475 1.943 . . . . 0.0 111.056 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 151' ' ' MET . . . . . 0.771 ' HA ' ' HE3' ' C' ' 148' ' ' LYS . 5.7 tpt -75.58 92.86 2.96 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-O 125.823 2.725 . . . . 0.0 107.713 163.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -133.85 152.02 51.73 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-N 110.698 -2.956 . . . . 0.0 109.523 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 153' ' ' THR . . . . . 0.436 ' HA ' ' HA3' ' C' ' 157' ' ' GLY . 73.2 m -63.46 150.63 43.27 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.396 172.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -111.2 -81.32 1.17 Allowed Glycine 0 C--N 1.353 1.527 0 N-CA-C 107.27 -2.332 . . . . 0.0 107.27 165.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -112.0 -46.94 3.17 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 117.51 -1.233 . . . . 0.0 110.876 174.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 156' ' ' ALA . . . . . 0.408 ' HB1' HG22 ' C' ' 158' ' ' VAL . . . -87.4 -69.18 0.7 Allowed 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 119.614 1.097 . . . . 0.0 110.403 166.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 157' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' C' ' 153' ' ' THR . . . 50.15 32.08 20.17 Favored Glycine 0 C--N 1.34 0.802 0 N-CA-C 115.218 0.847 . . . . 0.0 115.218 -170.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 158' ' ' VAL . . . . . 0.558 HG21 ' OG ' ' C' ' 128' ' ' SER . 14.6 m -92.26 153.69 3.26 Favored 'Isoleucine or valine' 0 C--O 1.253 1.27 0 C-N-CA 123.41 0.684 . . . . 0.0 110.007 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -41.76 112.05 0.29 Allowed 'General case' 0 C--N 1.345 0.394 0 N-CA-C 119.75 3.241 . . . . 0.0 119.75 176.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 160' ' ' ASN . . . . . 0.416 ' HB2' ' HG2' ' C' ' 120' ' ' PRO . 3.4 p30 -157.54 159.09 30.9 Favored Pre-proline 0 N--CA 1.436 -1.147 0 O-C-N 120.486 -1.384 . . . . 0.0 110.511 -173.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -38.38 -57.7 0.82 Allowed 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 124.43 3.42 . . . . 0.0 112.313 176.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 162' ' ' LEU . . . . . 0.523 HD21 HG23 ' C' ' 118' ' ' VAL . 9.6 mp -43.21 -31.34 0.59 Allowed 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 163' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -88.11 -59.57 2.2 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.729 -1.578 . . . . 0.0 107.382 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -91.44 -10.16 42.0 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 116.579 2.066 . . . . 0.0 116.579 -161.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -84.58 152.62 23.74 Favored 'General case' 0 C--O 1.243 0.713 0 O-C-N 120.614 -1.304 . . . . 0.0 110.639 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -78.87 -34.08 45.25 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-N 112.936 -1.938 . . . . 0.0 110.546 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 40.3 p-10 -91.78 -63.16 1.28 Allowed 'General case' 0 C--O 1.245 0.848 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 168' ' ' THR . . . . . 0.647 HG23 ' HB ' ' C' ' 144' ' ' VAL . 25.1 m -72.02 102.71 3.03 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 117.091 -3.505 . . . . 0.0 103.328 172.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -143.72 136.57 27.42 Favored 'General case' 0 CA--C 1.5 -0.962 0 O-C-N 119.254 -2.154 . . . . 0.0 112.692 -153.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 170' ' ' MET . . . . . 0.52 ' SD ' ' HD3' ' C' ' 148' ' ' LYS . 76.9 mtm -67.12 119.97 12.93 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 120.526 -1.359 . . . . 0.0 109.057 163.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 171' ' ' LEU . . . . . 0.721 ' HB2' HG23 ' C' ' 145' ' ' ILE . 13.1 tp -83.92 144.65 29.06 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 168.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -89.22 99.27 12.3 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 -167.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . 154.79 166.4 15.18 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-O 124.466 2.148 . . . . 0.0 109.992 167.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 174' ' ' ASP . . . . . 0.564 ' HB2' ' HE ' ' C' ' 149' ' ' ARG . 21.2 t70 -50.68 153.13 1.78 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.339 1.856 . . . . 0.0 112.648 169.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.9 -56.0 27.16 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.886 1.274 . . . . 0.0 110.842 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 176' ' ' LYS . . . . . 0.448 ' HD3' ' HG2' ' C' ' 49' ' ' PRO . 0.1 OUTLIER -69.81 -39.88 76.25 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 121.272 -0.892 . . . . 0.0 112.61 -177.131 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 177' ' ' ALA . . . . . . . . . . . . . . . -53.73 -44.1 69.62 Favored 'General case' 0 C--O 1.256 1.395 0 C-N-CA 125.249 1.42 . . . . 0.0 110.642 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 20.0 m -74.81 -42.5 57.93 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.0 -1.454 . . . . 0.0 111.456 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 179' ' ' VAL . . . . . 0.449 ' HA ' HG12 ' C' ' 182' ' ' ILE . 58.1 t -62.17 -55.01 26.82 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-N 120.223 1.374 . . . . 0.0 112.335 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -55.87 -39.12 71.05 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 119.001 -2.312 . . . . 0.0 112.672 178.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -54.46 -56.59 17.23 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 117.479 -1.248 . . . . 0.0 111.172 169.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 182' ' ' ILE . . . . . 0.449 HG12 ' HA ' ' C' ' 179' ' ' VAL . 19.0 pt -66.59 -32.32 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 121.058 1.754 . . . . 0.0 114.583 -175.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 183' ' ' LEU . . . . . 0.643 ' HA ' HD13 ' C' ' 53' ' ' ILE . 59.3 tp -48.27 -57.14 6.38 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 127.002 2.121 . . . . 0.0 112.581 170.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 184' ' ' LYS . . . . . 0.459 ' HD2' ' HA ' ' C' ' 184' ' ' LYS . 24.6 tptt -75.15 -33.48 61.52 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 124.83 1.332 . . . . 0.0 112.648 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -67.78 -91.61 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.17 0 O-C-N 126.502 2.376 . . . . 0.0 110.972 177.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 186' ' ' LEU . . . . . 0.431 HD12 ' HG2' ' C' ' 56' ' ' LYS 0.25 8.8 mt . . . . . 0 C--O 1.205 -1.255 0 O-C-N 120.237 -1.54 . . . . 0.0 112.505 -152.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' NAD . . . . . 0.497 H51N ' HD2' ' B' 1120 ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C 1001 ' ' NAP . . . . . 0.511 ' H4B' ' OD1' ' C' ' 115' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 42.2 t-80 . . . . . 0 N--CA 1.419 -1.999 0 N-CA-C 105.757 -1.942 . . . . 65.74 105.757 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -69.1 66.88 0.5 Allowed Glycine 0 C--N 1.348 1.236 0 C-N-CA 123.937 0.779 . . . . 48.66 111.622 172.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -80.18 124.86 29.16 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 120.002 -0.679 . . . . 44.56 109.388 173.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1003 ' ' ILE . . . . . 0.84 HG12 ' HB ' ' A' 1068 ' ' ILE . 34.8 mt -95.65 132.71 39.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 120.554 -1.341 . . . . 34.86 107.668 171.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -105.11 127.76 9.17 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 108.438 -1.865 . . . . 30.75 108.438 172.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.496 HG23 ' HB3' ' A' 1017 ' ' ALA . 23.0 mm -103.01 108.63 59.29 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 102.903 -2.999 . . . . 32.21 102.903 172.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -74.09 167.09 28.03 Favored 'Trans proline' 0 N--CA 1.439 -1.68 0 C-N-CA 122.474 2.116 . . . . 32.98 111.104 171.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1007 ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -84.77 131.78 34.51 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 102.438 -3.171 . . . . 47.98 102.438 157.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1008 ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -55.81 134.19 51.58 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 117.157 2.28 . . . . 34.7 117.157 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 21.7 mtp-105 -101.18 0.44 37.61 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 113.658 -1.61 . . . . 53.37 110.796 -171.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 52.7 tp -70.57 136.78 49.53 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 106.314 -1.735 . . . . 45.07 106.314 169.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1011 ' ' THR . . . . . . . . . . . . . 45.8 m -57.27 135.39 56.46 Favored 'General case' 0 C--O 1.243 0.76 0 O-C-N 120.461 -1.4 . . . . 40.36 109.81 -174.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 84.3 m-20 60.34 27.92 17.51 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 116.412 2.004 . . . . 40.61 116.412 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -87.74 147.93 24.97 Favored 'General case' 0 CA--C 1.504 -0.811 0 C-N-CA 118.616 -1.234 . . . . 33.76 109.797 -174.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1014 ' ' THR . . . . . 0.488 HG22 ' HB3' ' A' 1320 ' ' PRO . 1.9 m -117.06 -14.41 10.58 Favored 'General case' 0 C--O 1.257 1.483 0 CA-C-O 124.199 1.952 . . . . 27.89 110.81 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1015 ' ' ARG . . . . . 0.612 ' HG3' ' HA2' ' A' 1317 ' ' GLY . 12.9 mtm180 -66.12 125.76 26.52 Favored 'General case' 0 C--O 1.214 -0.775 0 O-C-N 119.468 -2.02 . . . . 29.02 114.054 173.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1016 ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' 1043 ' ' ALA . 3.4 t -120.52 150.81 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 106.721 -1.585 . . . . 28.13 106.721 165.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1017 ' ' ALA . . . . . 0.496 ' HB3' HG23 ' A' 1005 ' ' ILE . . . -59.19 -53.24 60.6 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 117.311 2.337 . . . . 26.87 117.311 -177.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -129.52 143.05 50.67 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 112.22 0.452 . . . . 26.77 112.22 -167.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1019 ' ' THR . . . . . 0.577 HG23 ' HB2' ' A' 1324 ' ' SER . 1.0 OUTLIER -80.5 174.06 6.74 Favored Pre-proline 0 C--N 1.347 0.475 0 C-N-CA 124.176 0.99 . . . . 27.02 110.887 168.178 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1020 ' ' PRO . . . . . 0.482 ' HB3' ' HB2' ' A' 1053 ' ' ALA . 0.1 OUTLIER -54.18 -34.96 81.03 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.33 2.687 . . . . 30.57 111.455 168.457 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -55.24 -58.02 9.4 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 114.055 -1.43 . . . . 47.81 112.461 173.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1022 ' ' THR . . . . . . . . . . . . 0.281 3.2 p -77.13 -21.75 53.67 Favored 'General case' 0 C--N 1.309 -1.17 0 O-C-N 120.312 -1.492 . . . . 30.77 112.892 -174.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1023 ' ' VAL . . . . . 0.569 HG22 HG11 ' A' 1033 ' ' VAL . 8.9 t -56.89 -51.29 69.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 N-CA-C 108.594 -0.891 . . . . 33.59 108.594 164.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -65.8 -32.73 74.42 Favored 'General case' 0 C--N 1.35 0.617 0 N-CA-C 114.284 1.216 . . . . 53.29 114.284 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1025 ' ' GLN . . . . . 0.662 ' HB3' HG11 ' A' 1332 ' ' VAL . 68.2 mt-30 -58.2 -49.71 76.09 Favored 'General case' 0 C--O 1.254 1.336 0 CA-C-N 119.286 0.948 . . . . 46.92 112.125 170.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1026 ' ' LEU . . . . . 0.583 ' HA ' HD12 ' A' 1029 ' ' LEU . 14.9 mt -59.75 -38.56 82.1 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 118.527 -2.608 . . . . 37.17 114.006 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 29.3 tp -59.11 -40.59 85.83 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 113.848 -1.523 . . . . 44.44 112.404 171.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1028 ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' 1028 ' ' LYS . 12.3 mmmm -70.06 -26.29 63.94 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 119.526 -1.983 . . . . 52.58 113.71 173.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1029 ' ' LEU . . . . . 0.583 HD12 ' HA ' ' A' 1026 ' ' LEU . 25.5 mt -65.51 -39.88 92.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.609 0.719 . . . . 45.69 111.019 162.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 115.55 15.57 7.47 Favored Glycine 0 CA--C 1.503 -0.715 0 O-C-N 118.708 -2.495 . . . . 42.09 110.97 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -92.82 147.54 22.77 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 107.299 -1.371 . . . . 40.72 107.299 168.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1032 ' ' THR . . . . . . . . . . . . . 10.7 m -99.17 118.68 36.44 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.056 -1.091 . . . . 37.77 108.056 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1033 ' ' VAL . . . . . 0.569 HG11 HG22 ' A' 1023 ' ' VAL . 3.5 t -89.49 141.96 13.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.134 -0.939 . . . . 33.54 111.761 -171.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -128.58 135.01 48.77 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 104.445 -2.428 . . . . 31.68 104.445 176.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1035 ' ' VAL . . . . . . . . . . . . . 69.2 t -119.71 144.5 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 O-C-N 120.697 -1.252 . . . . 31.52 110.718 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1036 ' ' GLU . . . . . 0.462 ' HB2' HG11 ' A' 1063 ' ' VAL . 35.5 tt0 -72.7 130.2 39.99 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 124.155 0.91 . . . . 41.04 110.778 176.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1037 ' ' SER . . . . . . . . . . . . . 65.9 m -60.1 111.2 1.42 Allowed 'General case' 0 C--O 1.262 1.714 0 N-CA-C 107.293 -1.373 . . . . 31.83 107.293 165.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 130.01 -32.41 3.14 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.573 -0.822 . . . . 29.36 111.127 -172.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -64.08 -39.89 95.06 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 117.594 -1.193 . . . . 27.78 108.842 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -52.08 -47.32 55.03 Favored Glycine 0 C--N 1.359 1.809 0 CA-C-O 121.817 0.676 . . . . 28.91 112.325 169.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -66.24 -32.37 73.75 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.771 -0.841 . . . . 51.18 110.894 -175.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1042 ' ' LEU . . . . . . . . . . . . . 14.0 mt -69.93 -56.3 7.39 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 121.16 1.8 . . . . 29.91 111.528 165.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1043 ' ' ALA . . . . . 0.497 ' HA ' ' HB2' ' A' 1320 ' ' PRO . . . -69.9 12.31 0.22 Allowed 'General case' 0 CA--C 1.556 1.2 0 O-C-N 119.334 -2.104 . . . . 28.54 112.636 -174.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1044 ' ' SER . . . . . . . . . . . . . 13.8 m 63.27 59.54 1.26 Allowed 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 124.454 2.073 . . . . 33.06 113.863 174.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1045 ' ' PHE . . . . . 0.406 ' HA ' ' HB1' ' B' 1277 ' ' ALA . 97.0 m-85 -150.58 167.15 28.1 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 111.088 -2.778 . . . . 30.29 106.52 177.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -97.25 151.34 19.95 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 106.624 -1.621 . . . . 48.62 106.624 151.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -59.84 -16.99 32.97 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 114.199 1.185 . . . . 36.74 114.199 -166.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 20.5 pttm -55.05 -26.36 36.99 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 121.987 2.176 . . . . 43.73 110.91 174.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -52.73 -53.63 45.17 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 120.661 -1.274 . . . . 32.81 112.576 171.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1050 ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -63.09 -33.38 75.32 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.909 -1.041 . . . . 31.86 113.657 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 25.5 t -63.98 -41.27 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 O-C-N 121.157 -0.964 . . . . 33.22 109.313 173.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -64.41 -41.99 96.31 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 122.468 1.128 . . . . 50.83 111.586 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1053 ' ' ALA . . . . . 0.482 ' HB2' ' HB3' ' A' 1020 ' ' PRO . . . -60.48 -52.76 63.82 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 114.333 -1.303 . . . . 33.12 110.64 170.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 122.34 75.03 0.33 Allowed Glycine 0 CA--C 1.489 -1.555 0 CA-C-O 123.523 1.624 . . . . 35.83 110.057 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -143.26 127.22 17.34 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 105.809 -1.923 . . . . 34.82 105.809 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -62.28 118.57 7.61 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.283 -0.871 . . . . 49.05 111.718 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1057 ' ' ILE . . . . . . . . . . . . . 17.3 mm -89.04 124.62 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 124.538 2.113 . . . . 38.53 110.953 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1058 ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' 1036 ' ' GLU . 0.0 OUTLIER -144.11 158.55 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 110.877 -2.874 . . . . 42.11 107.133 -175.612 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -88.22 167.8 13.28 Favored 'General case' 0 C--O 1.259 1.592 0 N-CA-C 113.925 1.083 . . . . 58.0 113.925 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . -31.05 -69.66 0.09 OUTLIER Glycine 0 C--N 1.348 1.235 0 N-CA-C 117.881 1.912 . . . . 52.12 117.881 -172.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 5.4 m120 -64.37 -33.59 76.2 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 119.912 1.856 . . . . 54.75 112.215 -169.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1062 ' ' SER . . . . . . . . . . . . . 16.8 m -73.91 -40.33 63.22 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 125.972 2.045 . . . . 50.34 108.009 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1063 ' ' VAL . . . . . 0.462 HG11 ' HB2' ' A' 1036 ' ' GLU . 4.1 p -68.88 -25.95 31.46 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 CA-C-N 122.473 2.397 . . . . 41.46 111.415 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1064 ' ' TRP . . . . . 0.402 ' HA ' HD11 ' A' 1069 ' ' ILE . 11.4 m95 -66.21 -29.56 69.84 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-N 115.303 -0.862 . . . . 39.32 112.837 173.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -81.31 79.44 7.94 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 123.423 1.582 . . . . 55.38 107.847 -174.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1066 ' ' SER . . . . . . . . . . . . . 58.7 m -147.63 161.4 41.23 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 120.553 -1.342 . . . . 41.87 108.771 -171.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1067 ' ' GLU . . . . . 0.591 ' HB3' HD12 ' A' 1068 ' ' ILE . 1.5 tp10 -69.62 -44.78 69.98 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 107.009 -1.478 . . . . 53.2 107.009 -176.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1068 ' ' ILE . . . . . 0.84 ' HB ' HG12 ' A' 1003 ' ' ILE . 5.2 mp -120.12 139.44 47.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 103.605 -2.739 . . . . 41.9 103.605 -178.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1069 ' ' ILE . . . . . 0.437 HD13 ' HA ' ' A' 1069 ' ' ILE . 9.7 mm -119.23 126.9 75.76 Favored 'Isoleucine or valine' 0 C--O 1.248 0.989 0 N-CA-C 105.292 -2.114 . . . . 38.73 105.292 170.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1070 ' ' LEU . . . . . 0.629 HD22 HD22 ' A' 1331 ' ' LEU . 71.4 mt -107.47 87.6 2.54 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-O 122.618 1.199 . . . . 32.44 108.233 173.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1071 ' ' LYS . . . . . . . . . . . . . 3.5 mmmt -87.32 171.67 10.43 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 107.429 -1.322 . . . . 34.65 107.429 166.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1072 ' ' VAL . . . . . 0.579 HG21 ' HB3' ' A' 1015 ' ' ARG . 8.0 t -100.37 -78.05 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 107.043 -1.465 . . . . 31.32 107.043 171.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -101.26 140.25 35.82 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 108.038 -1.097 . . . . 33.94 108.038 -161.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . 27.58 103.03 0.01 OUTLIER Pre-proline 0 C--O 1.247 0.933 0 N-CA-C 119.642 3.201 . . . . 38.04 119.642 171.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1075 ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' 1093 ' ' ILE . 34.8 Cg_exo -76.39 91.04 1.15 Allowed 'Trans proline' 0 CA--C 1.509 -0.77 0 C-N-CA 123.678 2.918 . . . . 42.68 109.541 177.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 65.3 mt -71.36 -179.75 2.59 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 114.425 -1.262 . . . . 46.74 114.043 -171.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.38 -35.6 67.9 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 116.907 2.188 . . . . 58.61 116.907 -173.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 16.4 t70 -67.2 -47.86 69.63 Favored 'General case' 0 C--O 1.26 1.641 0 C-N-CA 124.094 0.957 . . . . 59.2 110.388 173.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1079 ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -53.78 -37.35 63.36 Favored 'General case' 0 C--N 1.363 1.173 0 CA-C-O 117.108 -1.425 . . . . 50.63 110.753 174.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1080 ' ' ILE . . . . . 0.531 ' HA ' HD23 ' A' 1083 ' ' LEU . 55.6 mt -54.4 -47.3 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-N 119.433 1.015 . . . . 51.48 111.05 175.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -64.19 -33.77 76.56 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.54 1.518 . . . . 50.28 109.843 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 34.6 mt -71.82 -27.04 62.64 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 114.044 1.127 . . . . 50.21 114.044 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1083 ' ' LEU . . . . . 0.531 HD23 ' HA ' ' A' 1080 ' ' ILE . 0.4 OUTLIER -55.44 133.15 49.79 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-O 122.656 1.217 . . . . 49.06 112.205 174.428 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.02 125.96 62.65 Favored Pre-proline 0 N--CA 1.472 0.627 0 N-CA-C 101.431 -3.544 . . . . 51.08 101.431 177.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.87 63.92 0.03 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 124.165 3.243 . . . . 49.73 119.729 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1086 ' ' GLY . . . . . 0.537 ' H ' HG12 ' A' 1110 ' ' VAL . . . 173.44 -33.68 0.11 Allowed Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.111 -1.195 . . . . 47.71 110.111 -168.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1087 ' ' THR . . . . . . . . . . . . . 98.0 m -44.78 130.13 7.12 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 117.42 2.378 . . . . 45.47 117.42 -175.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1088 ' ' THR . . . . . . . . . . . . . 1.4 m -75.53 93.82 3.06 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 113.427 -1.715 . . . . 42.04 108.956 170.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1089 ' ' LEU . . . . . 0.483 HD22 HD21 ' A' 1083 ' ' LEU . 54.8 tp -90.67 92.83 9.0 Favored 'General case' 0 C--N 1.348 0.535 0 O-C-N 121.074 -1.016 . . . . 38.06 108.398 -178.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 89.1 t -99.65 99.03 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 102.559 -3.126 . . . . 37.4 102.559 -172.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1091 ' ' SER . . . . . . . . . . . . . 49.5 m -152.55 166.31 32.44 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 115.51 1.67 . . . . 36.16 115.51 -174.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1092 ' ' PHE . . . . . 0.417 ' HE1' ' HB1' ' A' 1129 ' ' ALA . 2.6 m-85 -66.42 88.28 0.13 Allowed 'General case' 0 C--O 1.253 1.274 0 O-C-N 118.118 -2.864 . . . . 38.94 109.822 161.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1093 ' ' ILE . . . . . 0.478 HG12 ' HA ' ' A' 1114 ' ' ALA . 26.2 mm -81.22 -32.43 12.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 122.935 1.35 . . . . 42.17 110.981 -173.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1094 ' ' TRP . . . . . 0.431 ' HH2' HD21 ' A' 1257 ' ' LEU . 77.8 m95 60.5 48.53 1.71 Allowed Pre-proline 0 C--O 1.243 0.717 0 C-N-CA 125.306 1.442 . . . . 46.51 111.108 -170.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1095 ' ' PRO . . . . . 0.441 ' HD3' ' HB ' ' A' 1093 ' ' ILE . 92.2 Cg_endo -54.68 -44.62 47.91 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 124.691 3.594 . . . . 49.76 116.468 -169.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1096 ' ' ALA . . . . . 0.589 ' HB3' ' NE2' ' A' 1097 ' ' GLN . . . -67.41 -33.98 76.29 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 122.529 1.157 . . . . 52.62 110.724 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1097 ' ' GLN . . . . . 0.589 ' NE2' ' HB3' ' A' 1096 ' ' ALA . 7.8 mp0 -85.2 -5.39 59.33 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 114.67 -1.15 . . . . 60.74 110.657 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1098 ' ' ASN . . . . . 0.515 ' HB3' ' HB3' ' A' 1101 ' ' LEU . 71.7 m-20 -130.94 64.17 72.83 Favored Pre-proline 0 N--CA 1.439 -0.975 0 N-CA-C 114.082 1.141 . . . . 58.19 114.082 -178.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -61.11 -42.97 32.28 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.759 2.973 . . . . 54.59 114.8 -174.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 52.2 mp0 -70.5 -42.73 70.96 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.541 -0.911 . . . . 63.28 108.541 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1101 ' ' LEU . . . . . 0.515 ' HB3' ' HB3' ' A' 1098 ' ' ASN . 5.7 tp -57.39 -41.14 79.67 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.859 0.864 . . . . 54.75 109.309 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1102 ' ' MET . . . . . . . . . . . . . 43.1 mmm -54.93 -48.37 73.22 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 120.599 -1.313 . . . . 52.65 112.46 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -61.25 -41.11 96.35 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 124.305 1.042 . . . . 66.26 110.479 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -74.23 -34.1 63.57 Favored 'General case' 0 C--O 1.247 0.946 0 O-C-N 121.373 -0.829 . . . . 63.73 110.947 -177.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 79.3 mt -68.51 -35.13 77.06 Favored 'General case' 0 C--O 1.253 1.281 0 CA-C-O 121.218 0.532 . . . . 54.68 109.826 174.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -66.83 -40.37 87.97 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.59 0.709 . . . . 53.64 112.089 172.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -54.91 -33.13 61.76 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.607 2.363 . . . . 67.24 113.981 168.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1108 ' ' ARG . . . . . 0.4 ' O ' HG13 ' A' 1110 ' ' VAL . 0.1 OUTLIER -78.43 10.49 3.08 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 116.121 -1.895 . . . . 65.76 115.343 172.141 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 20.1 t30 53.65 21.17 2.47 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 123.136 2.698 . . . . 58.71 114.602 173.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1110 ' ' VAL . . . . . 0.688 HG23 HG23 ' A' 1112 ' ' VAL . 17.9 m -90.67 175.08 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 O-C-N 118.412 -2.68 . . . . 46.63 114.422 -173.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1111 ' ' THR . . . . . . . . . . . . . 22.0 m -112.91 90.84 3.45 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 106.788 -1.56 . . . . 44.13 106.788 174.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1112 ' ' VAL . . . . . 0.688 HG23 HG23 ' A' 1110 ' ' VAL . 53.0 t -92.14 109.98 22.15 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 CA-C-N 114.653 -1.158 . . . . 40.44 110.446 -173.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1113 ' ' MET . . . . . 0.507 ' HB3' HG12 ' A' 1358 ' ' VAL . 64.6 mtp -102.93 115.52 30.76 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 112.326 -2.216 . . . . 50.76 110.489 178.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1114 ' ' ALA . . . . . 0.478 ' HA ' HG12 ' A' 1093 ' ' ILE . . . -94.44 94.08 8.03 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-N 114.435 -1.257 . . . . 35.64 109.511 -169.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1115 ' ' MET . . . . . 0.541 ' SD ' HD22 ' A' 1334 ' ' LEU . 83.8 mmm -57.7 -34.49 69.5 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 114.951 1.463 . . . . 38.74 114.951 -178.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1116 ' ' ASP . . . . . 0.424 ' OD2' ' HD2' ' A' 1095 ' ' PRO . 9.4 p-10 -61.04 -38.69 87.04 Favored 'General case' 0 C--O 1.219 -0.525 0 O-C-N 121.694 -0.629 . . . . 40.14 110.533 174.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1117 ' ' SER . . . . . . . . . . . . . 47.9 m -94.68 27.88 2.87 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 115.058 1.503 . . . . 44.79 115.058 -176.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1118 ' ' VAL . . . . . . . . . . . . . 10.3 m -53.96 140.93 50.25 Favored Pre-proline 0 N--CA 1.436 -1.166 0 CA-C-O 117.49 -1.243 . . . . 43.75 112.072 168.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -66.2 125.71 14.51 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.373 2.716 . . . . 48.93 109.684 168.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 34.1 mmm-85 -78.81 20.31 0.47 Allowed 'General case' 0 C--O 1.249 1.041 0 N-CA-C 117.082 2.253 . . . . 62.9 117.082 -160.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 38.9 pt -72.86 167.99 2.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 114.538 1.31 . . . . 57.72 114.538 -167.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1122 ' ' SER . . . . . . . . . . . . . 6.7 m -59.73 -40.35 87.76 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-O 118.066 -0.968 . . . . 57.26 111.435 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -56.45 -36.23 68.79 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 121.443 1.929 . . . . 62.9 108.762 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -73.75 -24.34 59.86 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-O 116.114 -1.898 . . . . 49.83 115.68 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1125 ' ' GLN . . . . . . . . . . . . 0.28 73.4 mm-40 -46.8 -21.96 0.26 Allowed 'General case' 0 N--CA 1.474 0.754 1 N-CA-C 122.352 4.205 . . . . 52.37 122.352 -169.238 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A 1126 ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' B' 1160 ' ' ALA . 11.9 p -85.07 -35.66 21.7 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 119.199 -2.188 . . . . 42.43 109.971 172.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1127 ' ' LEU . . . . . 0.663 HD21 HD22 ' A' 1337 ' ' LEU . 4.6 mp -84.78 -18.79 33.92 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.354 1.862 . . . . 43.74 112.394 176.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 53.8 t0 -70.97 92.92 0.95 Allowed 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 125.423 2.535 . . . . 43.21 110.645 -173.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1129 ' ' ALA . . . . . 0.417 ' HB1' ' HE1' ' A' 1092 ' ' PHE . . . -61.02 -40.98 95.67 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 110.024 -3.262 . . . . 35.74 111.273 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.95 -28.63 68.44 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 119.043 -2.286 . . . . 38.09 108.737 -176.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1131 ' ' SER . . . . . . . . . . . . . 75.0 m -67.71 -55.47 13.05 Favored 'General case' 0 CA--C 1.501 -0.935 0 O-C-N 119.487 -2.008 . . . . 36.91 113.634 172.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1132 ' ' SER . . . . . 0.477 ' HB3' ' HB3' ' A' 1326 ' ' LEU . 4.1 m -61.99 -43.85 97.97 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 119.159 0.89 . . . . 35.79 113.203 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1133 ' ' MET . . . . . 0.422 ' HA ' HD12 ' A' 1136 ' ' ILE . 13.9 mmm -59.58 -41.56 90.5 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 121.005 1.73 . . . . 30.81 109.897 176.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1134 ' ' ALA . . . . . 0.652 ' HB1' ' HB2' ' A' 1176 ' ' ALA . . . -63.45 -45.03 92.74 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 123.636 0.775 . . . . 28.88 109.157 175.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1135 ' ' ASN . . . . . 0.646 ' HB2' HG12 ' A' 1175 ' ' VAL . 16.3 t-20 -59.5 -46.25 89.37 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.532 0.682 . . . . 40.76 112.237 -177.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1136 ' ' ILE . . . . . 0.682 HD13 ' HA ' ' A' 1323 ' ' SER . 68.6 mt -55.9 -50.3 69.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 125.038 1.335 . . . . 31.54 109.4 173.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1137 ' ' ALA . . . . . 0.423 ' HB2' ' HG3' ' A' 1316 ' ' PRO . . . -62.55 -32.1 73.01 Favored 'General case' 0 C--N 1.344 0.352 0 N-CA-C 114.193 1.183 . . . . 29.87 114.193 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -70.53 -44.02 59.33 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 118.914 0.779 . . . . 28.73 112.412 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 20.1 t80 -66.76 -48.5 68.89 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 107.321 -1.363 . . . . 30.39 107.321 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1140 ' ' ARG . . . . . 0.548 ' HE ' ' HG2' ' A' 1144 ' ' GLU . 6.0 tpt180 -65.19 -26.22 68.05 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 113.577 0.954 . . . . 26.09 113.577 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1141 ' ' ALA . . . . . 0.69 ' HB2' HD21 ' A' 1284 ' ' LEU . . . -58.84 -53.5 57.68 Favored 'General case' 0 C--N 1.359 1.0 0 CA-C-O 118.521 -0.752 . . . . 27.1 109.914 167.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 32.8 mm -51.8 -43.58 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 O-C-N 124.238 0.961 . . . . 28.48 112.219 172.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 76.2 t -58.98 -62.02 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-N 119.655 1.116 . . . . 23.07 112.687 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1144 ' ' GLU . . . . . 0.548 ' HG2' ' HE ' ' A' 1140 ' ' ARG . 5.6 mm-40 -64.73 -29.1 70.07 Favored 'General case' 0 C--N 1.343 0.296 0 O-C-N 120.703 -1.248 . . . . 33.4 111.551 -177.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1145 ' ' ALA . . . . . 0.591 ' HA ' HG11 ' A' 1280 ' ' VAL . . . -54.61 -63.95 0.99 Allowed 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 117.784 -1.103 . . . . 24.22 112.601 165.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -54.35 -23.17 14.35 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 122.881 1.324 . . . . 24.89 113.908 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -66.63 -69.03 0.33 Allowed 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 120.272 -1.518 . . . . 26.73 110.13 169.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1148 ' ' GLU . . . . . 0.721 ' HB2' HD11 ' A' 1310 ' ' ILE . 68.5 mm-40 -73.72 -9.46 58.68 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 116.684 2.105 . . . . 39.96 116.684 -176.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1149 ' ' PHE . . . . . 0.471 ' HB2' ' O ' ' A' 1145 ' ' ALA . 1.2 t80 -59.99 146.18 43.53 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 123.272 1.511 . . . . 25.87 111.678 176.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1150 ' ' GLY . . . . . . . . . . . . . . . -80.63 -38.92 15.42 Favored Glycine 0 N--CA 1.429 -1.816 0 CA-C-N 113.374 -1.739 . . . . 19.28 109.617 173.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1151 ' ' ARG . . . . . 0.92 ' HA ' ' HB2' ' B' 1322 ' ' GLN . 66.6 mtm-85 -113.84 -170.83 1.78 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 121.157 2.479 . . . . 39.9 114.774 -163.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1152 ' ' PHE . . . . . 0.575 ' CD1' ' HG2' ' B' 1322 ' ' GLN . 2.8 m-85 -83.49 152.97 24.67 Favored 'General case' 0 C--O 1.218 -0.557 0 O-C-N 119.369 -2.082 . . . . 29.44 113.637 165.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1153 ' ' PHE . . . . . 0.419 ' CZ ' HG13 ' A' 1251 ' ' ILE . 10.0 m-85 -70.64 -49.75 44.2 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 113.232 -1.804 . . . . 32.6 107.509 157.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1154 ' ' THR . . . . . 0.507 ' HB ' HE21 ' A' 1156 ' ' GLN . 1.8 m -76.47 115.57 16.34 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 125.236 1.414 . . . . 34.64 113.955 -165.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -69.47 109.06 2.71 Favored Glycine 0 C--O 1.251 1.176 0 N-CA-C 105.838 -2.905 . . . . 37.14 105.838 170.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1156 ' ' GLN . . . . . 0.507 HE21 ' HB ' ' A' 1154 ' ' THR . 11.3 pt20 -158.9 -169.3 2.64 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-N 117.918 0.859 . . . . 40.57 111.99 -174.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1157 ' ' ILE . . . . . 0.708 HD13 ' HB3' ' C' ' 95' ' ' GLU . 1.5 tp -137.02 142.51 37.43 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.201 0 C-N-CA 125.426 1.49 . . . . 44.61 111.298 -171.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1158 ' ' THR . . . . . 0.404 ' HB ' ' H ' ' A' 1159 ' ' ALA . 1.1 p -93.33 -143.07 0.22 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.592 -1.64 . . . . 40.7 109.03 177.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1159 ' ' ALA . . . . . 0.404 ' H ' ' HB ' ' A' 1158 ' ' THR . . . -103.09 -14.3 16.47 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.423 -1.695 . . . . 40.25 106.423 157.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1160 ' ' ALA . . . . . 0.433 ' HB2' ' ND2' ' B' 1330 ' ' ASN . . . -76.09 -58.19 3.43 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 117.198 2.296 . . . . 38.47 117.198 173.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . 175.92 -165.27 35.81 Favored Glycine 0 CA--C 1.505 -0.556 0 CA-C-O 124.58 2.211 . . . . 37.61 111.128 -170.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 8.8 tttp -64.29 130.55 44.29 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 111.823 -2.188 . . . . 48.9 111.327 -171.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1163 ' ' VAL . . . . . 0.608 HG22 HD21 ' B' 1326 ' ' LEU . 10.1 t -100.93 114.69 65.82 Favored Pre-proline 0 N--CA 1.426 -1.661 0 CA-C-N 110.589 -3.005 . . . . 36.52 104.401 165.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1164 ' ' PRO . . . . . 0.46 ' HD2' HE22 ' B' 1322 ' ' GLN . 74.9 Cg_endo -73.05 137.05 25.81 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 124.938 3.759 . . . . 35.08 116.827 -176.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1165 ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.01 138.69 28.71 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 124.003 3.135 . . . . 35.33 116.312 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -79.63 141.96 36.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.212 -1.358 . . . . 34.69 112.415 174.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1167 ' ' LYS . . . . . 0.552 ' HB2' ' HA ' ' A' 1249 ' ' VAL . 44.1 mttp -100.69 115.14 29.55 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 113.099 -1.864 . . . . 45.36 107.298 172.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 49.9 t -100.38 91.38 2.15 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 CA-C-N 113.745 -1.571 . . . . 31.71 108.825 -174.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1169 ' ' MET . . . . . 0.426 ' HA ' ' O ' ' A' 1192 ' ' ARG . 35.3 ttp -76.85 92.67 3.64 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 123.749 1.737 . . . . 42.28 111.981 175.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 42.9 t -81.0 110.58 16.64 Favored 'Isoleucine or valine' 0 C--O 1.246 0.919 0 O-C-N 121.104 -0.997 . . . . 30.51 110.067 174.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 66.7 mt -88.84 119.63 36.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.194 -1.039 . . . . 31.87 108.194 176.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 87.13 87.23 1.09 Allowed Glycine 0 CA--C 1.537 1.428 0 N-CA-C 106.74 -2.544 . . . . 34.54 106.74 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1173 ' ' ALA . . . . . 0.531 ' HA ' ' HA3' ' A' 1177 ' ' GLY . . . -85.05 57.3 4.37 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 120.45 2.125 . . . . 32.51 111.612 176.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1174 ' ' GLY . . . . . 0.458 ' HA2' HH22 ' A' 1197 ' ' ARG . . . -73.85 -163.73 9.27 Favored Glycine 0 N--CA 1.448 -0.566 0 O-C-N 120.224 -1.548 . . . . 29.9 109.439 160.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1175 ' ' VAL . . . . . 0.646 HG12 ' HB2' ' A' 1135 ' ' ASN . 3.5 t -62.25 -36.6 75.34 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 O-C-N 121.342 -1.093 . . . . 33.11 111.651 -174.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1176 ' ' ALA . . . . . 0.652 ' HB2' ' HB1' ' A' 1134 ' ' ALA . . . -61.48 -43.12 99.42 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 113.626 -1.625 . . . . 28.1 114.363 170.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1177 ' ' GLY . . . . . 0.531 ' HA3' ' HA ' ' A' 1173 ' ' ALA . . . -63.32 -49.94 66.59 Favored Glycine 0 C--N 1.312 -0.752 0 N-CA-C 110.322 -1.111 . . . . 28.54 110.322 176.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1178 ' ' LEU . . . . . 0.58 ' HB3' ' SD ' ' A' 1207 ' ' MET . 70.3 mt -53.56 -51.6 62.4 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 117.693 0.747 . . . . 31.22 112.387 177.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -51.21 -46.34 62.19 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.624 0.972 . . . . 28.98 113.624 175.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -60.13 -41.1 91.96 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 116.664 2.098 . . . . 27.83 116.664 174.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1181 ' ' ILE . . . . . 0.471 HD12 ' HA ' ' A' 1178 ' ' LEU . 55.8 mt -64.8 -50.47 75.19 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 O-C-N 121.252 -0.905 . . . . 30.25 109.678 174.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -50.36 -54.77 18.79 Favored Glycine 0 C--O 1.241 0.579 0 O-C-N 120.54 -1.35 . . . . 29.59 110.289 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -59.88 -48.0 83.46 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 116.243 1.942 . . . . 30.29 116.243 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1184 ' ' ALA . . . . . 0.485 ' HB1' ' HB3' ' A' 1189 ' ' ALA . . . -68.77 -43.94 74.73 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.478 -1.389 . . . . 30.47 112.537 178.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -60.18 -43.68 95.67 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 118.482 0.583 . . . . 42.41 110.906 176.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1186 ' ' SER . . . . . 0.557 ' O ' ' HB3' ' B' 1186 ' ' SER . 72.4 m -48.65 -40.44 27.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.719 1.007 . . . . 39.38 113.719 164.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 27.2 mt -91.02 24.83 2.65 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 115.154 1.538 . . . . 36.18 115.154 173.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 69.38 8.9 60.19 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 115.535 0.974 . . . . 33.78 115.535 171.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1189 ' ' ALA . . . . . 0.485 ' HB3' ' HB1' ' A' 1184 ' ' ALA . . . -79.24 145.14 33.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 118.464 1.132 . . . . 33.93 111.63 -177.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 9.5 mt -77.26 88.48 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 105.459 -2.052 . . . . 38.74 105.459 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 14.0 t -76.21 125.59 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 106.828 -1.545 . . . . 33.09 106.828 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1192 ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' 1169 ' ' MET . 94.0 mtt180 -114.39 99.75 7.81 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 105.045 -2.206 . . . . 38.92 105.045 170.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1193 ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' A' 1211 ' ' PHE . . . -92.91 144.35 25.35 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 119.58 -1.95 . . . . 35.32 111.126 177.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1194 ' ' PHE . . . . . 0.646 ' HB2' HD12 ' A' 1212 ' ' LEU . 37.6 t80 -128.76 157.05 42.5 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 106.904 -1.517 . . . . 39.35 106.904 171.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1195 ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' 1173 ' ' ALA . 8.0 t0 -163.1 148.09 11.49 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 105.983 -1.858 . . . . 40.46 105.983 168.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1196 ' ' THR . . . . . . . . . . . . . 1.1 p -77.38 -12.52 59.96 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 114.837 -1.074 . . . . 45.94 112.359 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1197 ' ' ARG . . . . . 0.458 HH22 ' HA2' ' A' 1174 ' ' GLY . 74.4 mtm180 -94.06 115.74 65.56 Favored Pre-proline 0 N--CA 1.471 0.619 0 N-CA-C 106.146 -1.798 . . . . 56.02 106.146 172.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1198 ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -66.3 -14.71 45.38 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.305 2.003 . . . . 51.27 114.473 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -51.72 -54.41 28.7 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 122.328 1.061 . . . . 59.1 112.342 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 26.8 m -71.95 -2.91 3.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 115.402 1.63 . . . . 51.06 115.402 -169.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 83.5 tttt -55.36 -36.08 65.94 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 119.758 -1.839 . . . . 57.38 113.074 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -71.38 -37.73 71.58 Favored 'General case' 0 C--O 1.247 0.922 0 CA-C-N 118.552 0.614 . . . . 62.41 110.657 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -62.84 -37.79 88.2 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 120.739 -1.226 . . . . 57.78 112.719 171.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1204 ' ' VAL . . . . . 0.675 HG13 ' HB3' ' A' 1209 ' ' ALA . 25.4 t -58.49 -47.48 88.15 Favored 'Isoleucine or valine' 0 C--N 1.343 0.297 0 O-C-N 124.006 0.816 . . . . 46.38 111.432 173.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -54.09 -54.08 44.36 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.261 1.024 . . . . 50.7 113.349 171.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1206 ' ' SER . . . . . . . . . . . . . 6.4 m -62.32 -42.85 99.72 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 113.323 0.86 . . . . 49.98 113.323 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1207 ' ' MET . . . . . 0.58 ' SD ' ' HB3' ' A' 1178 ' ' LEU . 29.0 mtp -77.49 -13.31 59.95 Favored 'General case' 0 C--O 1.242 0.692 0 O-C-N 117.635 -3.166 . . . . 52.99 114.107 176.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 97.7 59.64 0.96 Allowed Glycine 0 N--CA 1.429 -1.802 0 O-C-N 121.427 -0.795 . . . . 47.66 111.151 166.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1209 ' ' ALA . . . . . 0.675 ' HB3' HG13 ' A' 1204 ' ' VAL . . . -134.26 151.22 51.17 Favored 'General case' 0 N--CA 1.457 -0.087 0 O-C-N 120.126 -1.808 . . . . 44.77 110.709 167.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1210 ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' 1192 ' ' ARG . 56.3 tt0 -76.15 145.73 39.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.805 -1.089 . . . . 47.64 108.763 165.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1211 ' ' PHE . . . . . 0.582 ' HD1' HG11 ' A' 1204 ' ' VAL . 9.9 t80 -93.97 160.06 14.89 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 106.947 -1.501 . . . . 45.66 106.947 -178.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1212 ' ' LEU . . . . . 0.646 HD12 ' HB2' ' A' 1194 ' ' PHE . 77.7 mt -85.39 106.4 16.73 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 104.613 -2.366 . . . . 46.06 104.613 171.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -73.86 97.59 2.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.314 -0.857 . . . . 60.22 108.793 168.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1214 ' ' LEU . . . . . 0.663 HD11 ' HA ' ' A' 1238 ' ' GLU . 5.8 tp -65.68 101.54 0.64 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.472 -0.785 . . . . 57.25 109.653 -174.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 19.7 t0 -61.08 100.27 0.11 Allowed 'General case' 0 C--O 1.247 0.925 0 O-C-N 124.73 1.268 . . . . 64.43 108.483 175.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 3.8 t80 . . . . . 0 C--O 1.212 -0.91 0 N-CA-C 102.556 -3.127 . . . . 66.9 102.556 179.27 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 2.8 p30 . . . . . 0 N--CA 1.426 -1.659 0 CA-C-O 118.765 -0.636 . . . . 39.09 109.569 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -57.35 -36.88 78.5 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 118.66 0.663 . . . . 39.32 113.565 -170.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 76.8 t80 -74.96 -43.67 52.74 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-O 116.901 -1.523 . . . . 39.3 110.287 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -58.14 -46.35 85.79 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.617 1.099 . . . . 36.3 111.057 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -62.54 -72.09 0.14 Allowed 'General case' 0 C--N 1.346 0.415 0 CA-C-O 117.332 -1.318 . . . . 37.38 110.326 173.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1229 ' ' VAL . . . . . 0.425 ' HA ' ' CD2' ' A' 1234 ' ' PHE . . . -50.18 -42.04 19.47 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 N-CA-C 117.468 2.396 . . . . 39.11 117.468 -172.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1230 ' ' MET . . . . . . . . . . . . . 21.0 mmt -86.23 1.67 49.94 Favored 'General case' 0 C--O 1.25 1.13 0 O-C-N 119.532 -1.98 . . . . 49.59 113.576 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1231 ' ' SER . . . . . . . . . . . . . 22.1 p -76.89 143.38 39.66 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 122.304 2.32 . . . . 43.68 110.52 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -49.08 -47.57 44.92 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.727 1.211 . . . . 55.57 112.961 -174.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -60.18 -34.04 73.05 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 113.333 0.864 . . . . 44.94 113.333 172.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1234 ' ' PHE . . . . . 0.425 ' CD2' ' HA ' ' A' 1229 ' ' VAL . 13.3 t80 -69.27 -49.82 52.57 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 120.46 1.482 . . . . 42.04 108.363 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1235 ' ' ILE . . . . . 0.522 ' O ' ' HG2' ' A' 1239 ' ' MET . 63.4 mt -58.53 -34.6 51.52 Favored 'Isoleucine or valine' 0 C--O 1.249 1.048 0 CA-C-O 118.325 -0.845 . . . . 46.28 110.026 175.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 25.8 tttm -62.43 -44.75 95.69 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 119.743 1.156 . . . . 47.87 108.844 171.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -60.71 -33.77 73.38 Favored 'General case' 0 C--O 1.25 1.104 0 O-C-N 119.406 -2.059 . . . . 41.61 112.755 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1238 ' ' GLU . . . . . 0.663 ' HA ' HD11 ' A' 1214 ' ' LEU . 38.3 mt-10 -56.22 -51.65 67.29 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 113.723 1.008 . . . . 50.65 113.723 168.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1239 ' ' MET . . . . . 0.522 ' HG2' ' O ' ' A' 1235 ' ' ILE . 8.3 mmm -57.55 -47.94 80.66 Favored 'General case' 0 C--O 1.247 0.972 0 C-N-CA 124.745 1.218 . . . . 48.87 112.018 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -58.65 -45.31 89.6 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 118.864 -0.588 . . . . 54.8 112.239 177.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 1.8 mm? -63.07 -39.09 93.68 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 123.672 0.608 . . . . 43.21 112.453 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -70.64 -39.34 73.73 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 125.492 1.745 . . . . 38.66 111.214 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -63.68 -29.49 70.71 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.131 1.772 . . . . 37.92 114.743 174.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -74.22 -66.23 0.75 Allowed 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 113.593 -1.64 . . . . 37.28 110.236 173.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -52.79 -31.48 38.82 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 124.699 1.2 . . . . 43.07 113.619 -177.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1246 ' ' ALA . . . . . 0.424 ' HB1' ' HG2' ' A' 1275 ' ' MET . . . -45.17 -46.2 11.97 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.814 1.246 . . . . 38.3 111.857 175.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1247 ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' 1276 ' ' LYS . 22.4 mtmm -68.77 -18.21 64.16 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 116.682 -1.628 . . . . 47.6 113.736 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -113.29 -30.45 6.92 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 121.322 1.874 . . . . 45.42 114.896 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1249 ' ' VAL . . . . . 0.552 ' HA ' ' HB2' ' A' 1167 ' ' LYS . 29.6 m -78.41 172.35 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 O-C-N 119.954 -1.716 . . . . 36.26 113.607 -171.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1250 ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' 1279 ' ' SER . 4.5 m-20 -121.71 -64.48 1.21 Allowed 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 124.018 0.824 . . . . 33.04 111.245 -173.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1251 ' ' ILE . . . . . 0.484 HD12 ' HB1' ' A' 1145 ' ' ALA . 32.3 mm -102.73 123.21 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 N-CA-C 105.629 -1.989 . . . . 31.4 105.629 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1252 ' ' ILE . . . . . . . . . . . . . 68.3 mt -105.85 136.41 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 O-C-N 124.764 1.29 . . . . 29.42 107.83 165.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 65.3 t -119.23 108.69 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.008 0 N-CA-C 104.265 -2.495 . . . . 30.37 104.265 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1254 ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.53 95.82 7.56 Favored 'General case' 0 C--O 1.246 0.89 0 CA-C-N 121.828 2.103 . . . . 35.72 113.188 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1255 ' ' THR . . . . . 0.535 HG22 HD12 ' A' 1284 ' ' LEU . 36.6 p -72.23 -24.99 61.47 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 119.068 2.988 . . . . 36.0 119.068 -166.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1256 ' ' ALA . . . . . . . . . . . . . . . -70.89 74.81 0.62 Allowed 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 117.571 2.434 . . . . 40.93 117.571 -151.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1257 ' ' LEU . . . . . 0.431 HD21 ' HH2' ' A' 1094 ' ' TRP . 14.0 tp -71.0 81.34 0.66 Allowed 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.174 -1.417 . . . . 47.82 107.174 167.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 42.6 mm -75.44 134.95 72.71 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 104.503 -2.406 . . . . 52.7 104.503 173.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -64.86 92.93 0.21 Allowed 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 122.131 1.887 . . . . 54.13 114.545 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1260 ' ' GLY . . . . . 0.437 ' HA2' ' HG3' ' A' 1097 ' ' GLN . . . 93.99 -57.51 2.14 Favored Glycine 0 CA--C 1.489 -1.57 0 O-C-N 121.019 -1.051 . . . . 54.62 112.754 166.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1261 ' ' LYS . . . . . 0.431 ' HE3' ' HB2' ' A' 1261 ' ' LYS . 25.1 mtmt -63.86 119.93 59.1 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-O 116.567 -1.682 . . . . 55.74 107.652 174.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -56.98 134.44 64.53 Favored 'Trans proline' 0 CA--C 1.5 -1.201 0 C-N-CA 124.131 3.221 . . . . 51.15 114.808 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -62.15 122.96 76.04 Favored Pre-proline 0 C--O 1.247 0.943 0 O-C-N 124.089 0.868 . . . . 46.06 110.114 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -49.59 133.26 31.87 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 125.282 3.988 . . . . 41.08 117.494 -175.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -68.07 83.36 0.22 Allowed 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.528 -0.916 . . . . 47.42 108.528 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1266 ' ' LEU . . . . . 0.456 ' HA ' ' SD ' ' A' 1239 ' ' MET . 98.0 mt -79.42 -41.55 27.4 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 122.476 1.131 . . . . 39.22 108.473 -177.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 21.7 mt -97.65 91.41 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 N-CA-C 105.013 -2.217 . . . . 42.5 105.013 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1268 ' ' THR . . . . . 0.601 ' HA ' ' HG3' ' A' 1293 ' ' GLU . 39.6 p -71.16 153.84 42.18 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.589 -1.187 . . . . 37.84 111.233 176.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1269 ' ' ARG . . . . . 0.549 ' HG3' ' HB2' ' A' 1293 ' ' GLU . 95.5 mtt180 -47.0 -50.67 18.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.354 1.462 . . . . 54.8 111.136 -177.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -42.89 -46.6 5.39 Favored 'General case' 0 C--O 1.249 1.072 0 C-N-CA 124.123 0.969 . . . . 54.36 113.426 172.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1271 ' ' MET . . . . . . . . . . . . . 26.6 mtt -68.83 -41.57 78.38 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 118.522 -0.752 . . . . 39.52 112.213 177.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1272 ' ' VAL . . . . . 0.489 HG21 ' SG ' ' A' 1292 ' ' CYS . 14.0 t -65.95 -44.53 92.37 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 CA-C-O 121.811 0.815 . . . . 38.25 109.648 -177.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -54.66 -44.02 72.91 Favored 'General case' 0 C--O 1.249 1.048 0 C-N-CA 124.466 1.107 . . . . 40.77 111.793 171.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1274 ' ' SER . . . . . . . . . . . . . 76.5 p -86.05 12.3 9.83 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 119.579 -1.951 . . . . 36.58 115.072 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1275 ' ' MET . . . . . 0.442 ' HG3' ' HA ' ' A' 1272 ' ' VAL . 52.5 mtp -70.89 160.92 31.93 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 123.521 1.629 . . . . 36.75 110.751 173.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1276 ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' 1247 ' ' LYS . 36.4 ttpt -68.61 134.84 50.53 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 112.999 -1.909 . . . . 46.11 106.007 166.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1277 ' ' ALA . . . . . . . . . . . . . . . -85.69 -179.73 6.92 Favored 'General case' 0 C--O 1.261 1.677 0 N-CA-C 115.365 1.617 . . . . 33.52 115.365 -176.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 67.99 29.05 73.3 Favored Glycine 0 CA--C 1.538 1.515 0 O-C-N 120.315 -1.491 . . . . 31.27 109.697 -171.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1279 ' ' SER . . . . . 0.525 ' HB3' ' O ' ' A' 1250 ' ' ASP . 16.7 m -131.33 173.21 11.29 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.692 1.746 . . . . 32.95 110.833 -165.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1280 ' ' VAL . . . . . 0.591 HG11 ' HA ' ' A' 1145 ' ' ALA . 98.5 t -140.77 144.63 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 O-C-N 118.623 -2.548 . . . . 27.43 104.783 -169.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1281 ' ' ILE . . . . . . . . . . . . . 59.9 mt -119.08 107.18 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.646 0 N-CA-C 101.813 -3.402 . . . . 30.3 101.813 164.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -92.36 104.2 15.39 Favored 'Isoleucine or valine' 0 C--O 1.25 1.102 0 N-CA-C 107.019 -1.474 . . . . 28.63 107.019 171.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 7.1 t70 -96.03 115.38 27.34 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 111.472 -2.604 . . . . 36.27 109.396 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1284 ' ' LEU . . . . . 0.69 HD21 ' HB2' ' A' 1141 ' ' ALA . 90.9 mt -87.2 -29.19 21.91 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 112.237 -2.256 . . . . 38.57 111.194 -173.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -62.51 -41.67 98.99 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 114.711 -1.132 . . . . 37.56 111.293 176.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . 22.84 -75.97 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 120.158 3.392 . . . . 40.33 120.158 174.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -59.92 -42.73 94.57 Favored 'General case' 0 C--O 1.212 -0.875 0 CA-C-O 121.538 0.685 . . . . 56.85 111.44 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 29.9 t30 -85.34 65.29 9.12 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.094 -1.412 . . . . 45.86 108.633 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 84.34 -57.61 5.02 Favored Glycine 0 C--O 1.246 0.858 0 O-C-N 120.63 -1.294 . . . . 40.31 113.682 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 84.51 128.62 1.75 Allowed Glycine 0 CA--C 1.538 1.515 0 N-CA-C 108.531 -1.828 . . . . 38.89 108.531 -171.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1291 ' ' ASN . . . . . . . . . . . . . 33.8 m120 -74.9 -21.6 59.12 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.743 1.771 . . . . 37.23 111.545 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1292 ' ' CYS . . . . . 0.489 ' SG ' HG21 ' A' 1272 ' ' VAL . 18.0 t -96.79 148.24 23.11 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.417 -1.427 . . . . 36.5 107.851 175.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1293 ' ' GLU . . . . . 0.601 ' HG3' ' HA ' ' A' 1268 ' ' THR . 27.7 mt-10 -75.13 -39.98 60.12 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 120.556 -1.34 . . . . 43.32 111.94 177.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -65.11 -5.88 7.69 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 115.291 1.589 . . . . 41.32 115.291 174.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1295 ' ' THR . . . . . 0.417 ' OG1' ' HB3' ' A' 1292 ' ' CYS . 86.5 m -58.48 115.18 2.84 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 119.262 0.937 . . . . 35.3 110.514 174.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 35.4 t -96.77 114.28 64.27 Favored Pre-proline 0 C--N 1.313 -1.004 0 N-CA-C 102.126 -3.287 . . . . 34.84 102.126 169.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -54.34 118.01 4.56 Favored 'Trans proline' 0 CA--C 1.537 0.669 1 C-N-CA 125.787 4.324 . . . . 33.51 111.757 176.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 99.19 -16.06 59.65 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 113.144 -1.844 . . . . 32.19 113.063 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -135.61 162.91 31.38 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 125.009 2.338 . . . . 34.88 115.541 -167.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1300 ' ' ILE . . . . . 0.799 HG12 HG12 ' A' 1310 ' ' ILE . 50.1 mt -75.58 140.59 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 CA-C-N 112.635 -2.075 . . . . 32.29 110.539 167.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 54.5 t80 -129.38 120.02 24.86 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 120.113 1.324 . . . . 37.25 108.194 159.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1302 ' ' THR . . . . . . . . . . . . . 34.8 m -79.14 125.05 28.92 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 104.198 -2.519 . . . . 35.56 104.198 172.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1303 ' ' THR . . . . . . . . . . . . . 76.3 p -85.45 -179.63 6.97 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 113.991 1.108 . . . . 36.4 113.991 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -67.84 -34.36 76.56 Favored 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 120.131 -1.606 . . . . 52.32 112.33 -170.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -74.99 -41.85 58.69 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.09 -1.414 . . . . 40.04 111.001 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 118.38 57.72 0.28 Allowed Glycine 0 N--CA 1.448 -0.512 0 O-C-N 119.901 -1.749 . . . . 36.96 109.207 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1307 ' ' VAL . . . . . . . . . . . . . 73.5 t -124.32 121.12 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.898 0 N-CA-C 101.336 -3.579 . . . . 33.4 101.336 174.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1308 ' ' LYS . . . . . 0.431 ' HB2' HG22 ' A' 1280 ' ' VAL . 20.8 mmtp -81.81 95.68 7.37 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 113.4 -1.727 . . . . 42.91 108.507 -178.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 44.0 t -85.83 93.44 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 O-C-N 121.125 -0.984 . . . . 32.29 108.618 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1310 ' ' ILE . . . . . 0.799 HG12 HG12 ' A' 1300 ' ' ILE . 61.0 mt -89.52 95.33 5.36 Favored 'Isoleucine or valine' 0 C--O 1.256 1.419 0 N-CA-C 105.378 -2.082 . . . . 30.99 105.378 -174.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1311 ' ' GLY . . . . . 0.417 ' HA3' HG23 ' A' 1295 ' ' THR . . . -91.37 56.75 3.15 Favored Glycine 0 N--CA 1.431 -1.641 0 N-CA-C 110.877 -0.889 . . . . 28.95 110.877 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1312 ' ' TYR . . . . . 0.613 ' HB2' ' HG ' ' A' 1315 ' ' LEU . 9.1 m-30 -78.66 113.54 16.81 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 120.602 2.201 . . . . 31.69 116.808 -170.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1313 ' ' THR . . . . . . . . . . . . . 4.6 p -71.8 -40.38 69.23 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 125.889 2.757 . . . . 34.17 109.841 -177.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -69.81 -0.88 7.91 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 110.072 -3.24 . . . . 36.86 115.802 176.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1315 ' ' LEU . . . . . 0.613 ' HG ' ' HB2' ' A' 1312 ' ' TYR 0.342 42.0 mt -40.65 -45.9 5.9 Favored Pre-proline 0 N--CA 1.487 1.404 0 N-CA-C 121.241 3.793 . . . . 34.85 121.241 178.512 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1316 ' ' PRO . . . . . 0.509 ' HB2' ' HD3' ' A' 1015 ' ' ARG . 46.1 Cg_exo -56.55 -47.26 24.71 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.916 2.411 . . . . 29.15 110.529 168.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1317 ' ' GLY . . . . . 0.612 ' HA2' ' HG3' ' A' 1015 ' ' ARG . . . -61.18 -44.81 97.65 Favored Glycine 0 CA--C 1.483 -1.936 0 CA-C-O 118.545 -1.142 . . . . 27.29 111.578 -177.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1318 ' ' ARG . . . . . 0.447 ' HB3' ' NH2' ' A' 1140 ' ' ARG . 59.2 mtt-85 -60.21 -15.72 26.96 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 114.204 1.187 . . . . 41.49 114.204 174.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1319 ' ' LEU . . . . . 0.525 HD22 ' HB2' ' A' 1140 ' ' ARG . 14.0 tp -110.95 73.2 0.86 Allowed Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-N 123.258 2.754 . . . . 27.61 103.779 166.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1320 ' ' PRO . . . . . 0.615 ' HD2' ' HA2' ' B' 1150 ' ' GLY . 57.4 Cg_endo -59.06 -58.93 0.53 Allowed 'Trans proline' 0 C--O 1.213 -0.769 0 C-N-CA 122.85 2.367 . . . . 25.94 112.567 -159.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1321 ' ' THR . . . . . 0.414 ' H ' ' HG2' ' A' 1320 ' ' PRO . 3.1 m -58.37 -30.37 66.73 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 112.797 -2.001 . . . . 25.01 113.704 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1322 ' ' GLN . . . . . 0.409 HE22 HG13 ' B' 1163 ' ' VAL . 55.0 tp60 -74.23 -39.87 62.79 Favored 'General case' 0 N--CA 1.436 -1.166 0 O-C-N 120.589 -1.32 . . . . 29.39 110.852 176.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1323 ' ' SER . . . . . 0.682 ' HA ' HD13 ' A' 1136 ' ' ILE . 75.0 m -52.7 -53.18 51.1 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 118.912 0.778 . . . . 26.47 109.449 168.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1324 ' ' SER . . . . . 0.577 ' HB2' HG23 ' A' 1019 ' ' THR . 2.3 m -61.0 -26.12 67.37 Favored 'General case' 0 C--O 1.25 1.121 0 N-CA-C 114.335 1.235 . . . . 27.78 114.335 175.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -75.37 -63.15 1.34 Allowed 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 117.739 -3.1 . . . . 37.53 110.228 172.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1326 ' ' LEU . . . . . 0.562 ' HB2' HD11 ' A' 1136 ' ' ILE . 18.2 mt -77.98 -47.86 17.56 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 116.973 -1.489 . . . . 35.71 114.357 -170.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1327 ' ' TYR . . . . . . . . . . . . . 32.1 t80 -59.29 -47.29 85.92 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 105.877 -1.897 . . . . 31.59 105.877 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1328 ' ' GLY . . . . . 0.698 ' HA2' HD12 ' A' 1331 ' ' LEU . . . -40.78 -54.47 3.51 Favored Glycine 0 CA--C 1.544 1.847 0 C-N-CA 124.668 1.127 . . . . 28.0 114.778 167.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1329 ' ' THR . . . . . . . . . . . . . 28.7 m -67.57 -35.09 78.36 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-O 118.106 -0.95 . . . . 32.15 109.449 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1330 ' ' ASN . . . . . . . . . . . . . 29.2 m120 -62.47 -43.86 97.79 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.579 -0.897 . . . . 34.36 108.579 174.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1331 ' ' LEU . . . . . 0.698 HD12 ' HA2' ' A' 1328 ' ' GLY . 13.9 mt -59.96 -50.16 74.84 Favored 'General case' 0 C--O 1.213 -0.85 0 N-CA-C 109.367 -0.605 . . . . 33.37 109.367 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1332 ' ' VAL . . . . . 0.662 HG11 ' HB3' ' A' 1025 ' ' GLN . 44.2 t -57.04 -40.17 71.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 118.787 -0.625 . . . . 35.27 111.181 174.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -68.02 -38.45 82.6 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 114.602 1.334 . . . . 37.66 114.602 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1334 ' ' LEU . . . . . 0.541 HD22 ' SD ' ' A' 1115 ' ' MET . 28.9 tp -60.97 -48.61 81.03 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 106.916 -1.513 . . . . 40.27 106.916 172.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1335 ' ' LEU . . . . . 0.552 ' HA ' ' HB2' ' A' 1338 ' ' LEU . 20.5 mt -71.66 -4.4 27.11 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 114.625 1.343 . . . . 42.5 114.625 175.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1336 ' ' LYS . . . . . 0.515 ' HE3' HG12 ' A' 1332 ' ' VAL . 82.6 mttt -74.76 -44.91 47.22 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 121.81 2.095 . . . . 47.81 111.774 161.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1337 ' ' LEU . . . . . 0.663 HD22 HD21 ' A' 1127 ' ' LEU . 10.4 mp -62.34 -41.02 98.24 Favored 'General case' 0 C--O 1.216 -0.672 0 C-N-CA 118.555 -1.258 . . . . 49.27 113.8 172.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1338 ' ' LEU . . . . . 0.552 ' HB2' ' HA ' ' A' 1335 ' ' LEU . 10.2 mp -70.8 -69.38 0.37 Allowed 'General case' 0 CA--C 1.51 -0.577 0 O-C-N 124.695 1.247 . . . . 50.54 113.054 172.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1339 ' ' CYS . . . . . 0.603 ' SG ' ' HA2' ' A' 1344 ' ' GLY . 51.5 t -69.71 91.95 0.64 Allowed 'General case' 0 CA--C 1.503 -0.835 0 O-C-N 118.396 -2.69 . . . . 53.67 107.571 172.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 72.3 tttt -83.73 -62.56 1.54 Allowed 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.121 -1.4 . . . . 63.38 108.052 -165.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -74.88 -35.89 62.3 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 124.82 1.248 . . . . 70.95 114.057 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1342 ' ' LYS . . . . . 0.428 ' HE2' ' HA ' ' A' 1029 ' ' LEU . 3.2 mtpm? 62.22 83.88 0.15 Allowed 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 125.537 1.535 . . . . 65.25 113.484 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1343 ' ' ASP . . . . . . . . . . . . 0.38 0.0 OUTLIER 79.21 -78.81 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.775 2 O-C-N 112.593 -6.317 . . . . 64.53 120.076 -19.347 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A 1344 ' ' GLY . . . . . 0.603 ' HA2' ' SG ' ' A' 1339 ' ' CYS . . . 104.39 10.73 33.02 Favored Glycine 0 CA--C 1.545 1.94 0 O-C-N 117.536 -3.227 . . . . 59.72 111.379 178.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1345 ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' 1339 ' ' CYS . 19.0 t30 -72.05 131.24 42.61 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 121.932 2.866 . . . . 64.09 112.929 174.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1346 ' ' ILE . . . . . . . . . . . . . 24.7 mt -80.31 79.37 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.83 0 O-C-N 120.018 -1.676 . . . . 58.82 109.063 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1347 ' ' THR . . . . . . . . . . . . . 5.3 m -66.43 85.14 0.1 Allowed 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 119.867 -1.771 . . . . 54.96 112.711 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1348 ' ' VAL . . . . . 0.518 ' HB ' ' NH2' ' A' 1362 ' ' ARG . 40.0 t -76.46 98.45 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.803 0 N-CA-C 102.915 -2.994 . . . . 55.64 102.915 178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 8.8 t70 -87.79 138.14 31.72 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 111.735 -2.484 . . . . 61.45 110.906 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1350 ' ' PHE . . . . . 0.401 ' CE1' ' HD2' ' A' 1362 ' ' ARG . 1.0 OUTLIER -107.22 -12.39 15.38 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 117.443 2.386 . . . . 58.63 117.443 176.692 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -76.69 -48.47 18.83 Favored 'General case' 0 C--O 1.246 0.904 0 O-C-N 124.028 0.83 . . . . 62.06 109.073 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 28.0 t70 -65.76 118.82 10.17 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.651 0.738 . . . . 54.07 112.621 -177.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 13.7 m -40.23 -46.87 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 116.545 2.054 . . . . 50.68 116.545 173.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1354 ' ' VAL . . . . . 0.547 ' O ' HG23 ' A' 1358 ' ' VAL . 3.2 m -77.52 -41.85 29.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 122.426 2.375 . . . . 47.68 109.466 -174.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1355 ' ' ILE . . . . . 0.47 HD11 HD23 ' A' 1337 ' ' LEU . 53.6 mt -64.88 -49.26 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.718 1.207 . . . . 48.49 107.791 -177.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1356 ' ' ARG . . . . . 0.41 ' NH1' ' O ' ' A' 1367 ' ' THR . 31.4 tpt85 -57.17 -40.71 77.86 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.592 0.96 . . . . 48.27 113.592 172.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -67.21 -39.9 92.37 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-O 119.018 -0.879 . . . . 43.53 111.911 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1358 ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' 1354 ' ' VAL . 5.7 t -72.06 -36.35 56.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 CA-C-O 118.554 -0.736 . . . . 45.12 112.045 176.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1359 ' ' THR . . . . . . . . . . . . . 10.6 m -72.21 88.11 1.13 Allowed 'General case' 0 C--O 1.239 0.517 0 CA-C-N 119.346 0.975 . . . . 42.94 110.492 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 27.6 m -85.77 -25.51 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 CA-C-O 121.794 0.807 . . . . 43.26 110.805 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1361 ' ' ILE . . . . . 0.618 ' HB ' ' HB ' ' A' 1112 ' ' VAL . 23.6 mm -126.55 114.71 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 117.705 -3.122 . . . . 45.66 102.994 171.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1362 ' ' ARG . . . . . 0.518 ' NH2' ' HB ' ' A' 1348 ' ' VAL . 32.4 ttt180 -100.93 104.13 15.31 Favored 'General case' 0 CA--C 1.511 -0.548 0 O-C-N 119.128 -2.232 . . . . 61.34 109.687 172.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 54.54 51.34 14.21 Favored 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 114.367 1.247 . . . . 49.76 114.367 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 86.68 -27.38 5.89 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 117.997 1.959 . . . . 50.0 117.997 -175.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -81.71 138.19 35.28 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 120.476 2.138 . . . . 56.92 106.951 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1366 ' ' ILE . . . . . . . . . . . . . 70.1 mt -83.18 100.56 6.89 Favored 'Isoleucine or valine' 0 C--O 1.263 1.811 0 N-CA-C 105.629 -1.989 . . . . 52.78 105.629 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1367 ' ' THR . . . . . 0.41 ' O ' ' NH1' ' A' 1356 ' ' ARG . 10.8 p -94.22 10.92 32.05 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 112.916 -1.947 . . . . 49.44 110.199 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 6.7 t90 -73.32 150.39 89.5 Favored Pre-proline 0 C--O 1.251 1.141 0 N-CA-C 106.479 -1.674 . . . . 52.38 106.479 162.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -68.48 169.58 56.62 Favored 'Cis proline' 0 C--O 1.249 1.057 0 N-CA-C 121.017 3.43 . . . . 46.94 121.017 -0.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1370 ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' 1371 ' ' PRO . . . -86.99 124.89 68.08 Favored Pre-proline 0 CA--C 1.506 -0.728 0 CA-C-O 122.366 1.079 . . . . 45.91 109.404 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1371 ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' 1370 ' ' ALA . 85.3 Cg_exo -70.81 126.84 13.03 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 122.849 2.366 . . . . 46.39 111.974 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -77.31 -57.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 123.538 2.825 . . . . 46.72 108.332 169.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.221 -5.008 0 O-C-N 119.552 -1.968 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 15.4 m80 . . . . . 0 N--CA 1.432 -1.353 0 N-CA-C 104.361 -2.459 . . . . 63.44 104.361 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 999' ' ' HIS . . . . . 0.568 ' HB2' ' HA ' ' B' 1066 ' ' SER . 96.8 m-70 -126.03 56.03 1.44 Allowed 'General case' 0 C--N 1.352 0.698 0 CA-C-N 121.292 1.86 . . . . 51.74 109.792 175.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1000 ' ' HIS . . . . . 0.454 ' HA ' ' HB2' ' B' 1067 ' ' GLU . 20.0 m-70 -71.87 145.71 48.38 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 114.162 -1.381 . . . . 54.07 110.936 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 64.56 5.87 19.58 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 122.435 1.02 . . . . 39.22 112.675 -173.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1002 ' ' ARG . . . . . 0.658 ' HG3' ' HB ' ' B' 1032 ' ' THR . 28.0 ttp180 -104.62 141.41 36.48 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 119.523 -2.163 . . . . 38.12 106.8 -173.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1003 ' ' ILE . . . . . 0.489 HG12 ' HB ' ' B' 1068 ' ' ILE . 87.4 mt -100.79 134.47 40.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 105.827 -1.916 . . . . 29.7 105.827 174.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -94.56 135.13 12.31 Favored Glycine 0 N--CA 1.419 -2.448 0 C-N-CA 119.914 -1.136 . . . . 27.5 111.136 156.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1005 ' ' ILE . . . . . . . . . . . . . 40.6 mm -104.61 104.86 47.76 Favored Pre-proline 0 CA--C 1.553 1.064 0 N-CA-C 102.244 -3.243 . . . . 24.83 102.244 171.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -66.25 157.47 59.84 Favored 'Trans proline' 0 C--N 1.361 1.214 1 C-N-CA 125.818 4.345 . . . . 27.19 114.811 172.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 44.1 ttt180 -86.26 101.78 13.36 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 113.765 -1.561 . . . . 41.46 107.874 173.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1008 ' ' GLU . . . . . 0.423 ' HG3' ' HB ' ' B' 1072 ' ' VAL . 5.4 mm-40 -49.35 134.23 18.89 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 117.342 2.349 . . . . 26.93 117.342 -175.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 32.3 mmm-85 -107.52 -11.32 15.51 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 111.935 -2.393 . . . . 34.48 114.129 -163.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1010 ' ' LEU . . . . . 0.675 ' HB3' ' HB2' ' B' 1013 ' ' GLU . 13.0 tp -63.31 145.5 55.43 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-N 119.796 1.18 . . . . 44.22 112.514 -174.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1011 ' ' THR . . . . . . . . . . . . . 33.1 m -32.95 106.65 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 115.75 1.759 . . . . 40.74 115.75 172.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 53.9 t30 46.25 49.69 12.6 Favored 'General case' 0 C--O 1.254 1.302 0 C-N-CA 125.552 1.541 . . . . 44.44 112.737 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1013 ' ' GLU . . . . . 0.675 ' HB2' ' HB3' ' B' 1010 ' ' LEU . 7.9 tp10 -79.97 133.57 36.19 Favored 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 118.292 -1.363 . . . . 29.87 108.102 177.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1014 ' ' THR . . . . . 0.479 ' HB ' ' O ' ' B' 1317 ' ' GLY . 3.4 m -112.76 -9.01 13.73 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 107.353 -1.351 . . . . 25.26 107.353 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1015 ' ' ARG . . . . . 0.626 ' HG3' ' HA2' ' B' 1317 ' ' GLY . 67.9 mtm180 -77.92 129.42 35.33 Favored 'General case' 0 CA--C 1.503 -0.854 0 O-C-N 120.359 -1.463 . . . . 29.54 110.694 174.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1016 ' ' VAL . . . . . 0.678 HG21 ' HB1' ' B' 1039 ' ' ALA . 5.0 p -97.65 177.64 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 120.388 -1.445 . . . . 23.55 107.452 155.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1017 ' ' ALA . . . . . 0.591 ' H ' HG22 ' B' 1016 ' ' VAL . . . -79.89 -19.37 48.35 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.154 -1.591 . . . . 23.59 113.604 -177.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1018 ' ' ALA . . . . . 0.532 ' HB1' ' HB ' ' B' 1022 ' ' THR . . . -153.43 146.87 24.9 Favored 'General case' 0 N--CA 1.442 -0.825 0 O-C-N 119.908 -1.745 . . . . 24.93 114.143 -167.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1019 ' ' THR . . . . . . . . . . . . . 76.7 p -88.75 172.29 7.79 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 118.594 0.634 . . . . 28.09 112.509 169.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1020 ' ' PRO . . . . . 0.475 ' O ' ' HB ' ' B' 1023 ' ' VAL . 42.7 Cg_exo -55.25 -36.1 92.67 Favored 'Trans proline' 0 C--O 1.249 1.046 0 C-N-CA 122.448 2.098 . . . . 28.79 116.631 165.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 51.4 tttt -54.13 -51.12 65.25 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 119.013 -2.304 . . . . 47.28 113.325 161.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1022 ' ' THR . . . . . 0.532 ' HB ' ' HB1' ' B' 1018 ' ' ALA . 22.8 m -52.77 -38.68 61.38 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 118.471 0.578 . . . . 30.12 109.873 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1023 ' ' VAL . . . . . 0.521 ' HA ' HG21 ' B' 1033 ' ' VAL . 73.5 t -53.41 -53.37 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 O-C-N 121.254 -0.904 . . . . 32.24 109.156 174.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1024 ' ' GLU . . . . . 0.545 ' O ' ' HG3' ' B' 1028 ' ' LYS . 15.1 mt-10 -57.42 -41.94 81.38 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.906 0.86 . . . . 49.62 113.193 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -58.39 -47.77 82.79 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 123.044 1.402 . . . . 44.68 111.735 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 41.5 mt -72.13 -34.37 68.52 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.528 -1.215 . . . . 35.71 110.487 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1027 ' ' LEU . . . . . 0.51 HD23 ' O ' ' B' 1031 ' ' PHE . 50.5 mt -57.64 -40.52 79.41 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 122.927 1.346 . . . . 42.18 110.636 175.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1028 ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' B' 1024 ' ' GLU . 58.2 mttm -58.34 -36.45 73.43 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 115.211 -0.904 . . . . 48.34 111.425 173.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1029 ' ' LEU . . . . . 0.724 HD21 ' HG2' ' B' 1336 ' ' LYS . 20.7 mt -77.33 -1.87 32.07 Favored 'General case' 0 C--O 1.259 1.56 0 N-CA-C 116.414 2.005 . . . . 38.69 116.414 175.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 90.03 25.0 28.04 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 125.877 1.703 . . . . 32.28 111.189 176.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1031 ' ' PHE . . . . . 0.51 ' O ' HD23 ' B' 1027 ' ' LEU . 55.0 m-85 -103.89 127.96 51.39 Favored 'General case' 0 C--O 1.252 1.236 0 N-CA-C 107.78 -1.193 . . . . 35.94 107.78 -177.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1032 ' ' THR . . . . . 0.658 ' HB ' ' HG3' ' B' 1002 ' ' ARG . 11.9 m -72.22 122.2 20.65 Favored 'General case' 0 C--O 1.251 1.166 0 N-CA-C 103.165 -2.902 . . . . 33.37 103.165 167.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1033 ' ' VAL . . . . . 0.521 HG21 ' HA ' ' B' 1023 ' ' VAL . 48.8 t -93.32 134.92 29.48 Favored 'Isoleucine or valine' 0 C--O 1.258 1.508 0 N-CA-C 104.681 -2.34 . . . . 29.98 104.681 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -123.0 140.11 53.38 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 104.063 -2.569 . . . . 28.18 104.063 172.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1035 ' ' VAL . . . . . 0.442 HG21 ' CD2' ' B' 1050 ' ' PHE . 89.3 t -131.5 135.14 59.79 Favored 'Isoleucine or valine' 0 C--O 1.255 1.373 0 N-CA-C 104.29 -2.485 . . . . 25.82 104.29 -170.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1036 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.91 151.23 43.49 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-O 123.123 1.44 . . . . 32.44 109.755 177.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1037 ' ' SER . . . . . . . . . . . . . 47.1 p -65.99 130.09 42.06 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 111.839 -2.437 . . . . 29.54 112.413 177.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 92.96 -15.57 62.5 Favored Glycine 0 CA--C 1.504 -0.645 0 O-C-N 118.366 -2.709 . . . . 27.76 111.62 -177.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1039 ' ' ALA . . . . . 0.678 ' HB1' HG21 ' B' 1016 ' ' VAL . . . -73.52 -33.93 64.99 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-O 122.29 1.043 . . . . 26.02 112.874 -171.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -59.86 -53.78 43.06 Favored Glycine 0 C--O 1.249 1.076 0 N-CA-C 110.477 -1.049 . . . . 26.47 110.477 167.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.07 -26.79 64.93 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 117.154 -1.403 . . . . 50.98 112.154 -177.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 58.3 mt -54.47 -48.84 71.31 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 120.944 1.702 . . . . 29.3 112.091 167.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1043 ' ' ALA . . . . . 0.507 ' HA ' ' HB2' ' B' 1320 ' ' PRO . . . -88.27 36.37 0.78 Allowed 'General case' 0 C--O 1.238 0.486 0 CA-C-O 116.166 -1.873 . . . . 26.74 111.341 -177.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1044 ' ' SER . . . . . . . . . . . . . 18.9 m 47.72 31.3 2.12 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 116.038 1.866 . . . . 31.26 116.038 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1045 ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.77 147.93 48.4 Favored 'General case' 0 C--N 1.36 1.051 0 CA-C-O 122.585 1.183 . . . . 33.26 109.366 177.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 11.3 t0 -71.2 123.75 22.92 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.153 -1.054 . . . . 46.74 108.153 173.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.75 -29.3 64.68 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 124.993 1.317 . . . . 34.44 112.1 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1048 ' ' LYS . . . . . 0.506 ' HA ' HG22 ' B' 1051 ' ' VAL . 0.8 OUTLIER -64.32 -22.45 66.95 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 119.624 -1.923 . . . . 48.67 113.12 172.327 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -64.69 -26.5 68.4 Favored 'General case' 0 C--N 1.365 1.262 0 O-C-N 119.311 -2.118 . . . . 35.26 112.692 169.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1050 ' ' PHE . . . . . 0.442 ' CD2' HG21 ' B' 1035 ' ' VAL . 64.4 m-85 -69.1 -40.38 78.42 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 118.474 -0.774 . . . . 32.17 111.952 168.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1051 ' ' VAL . . . . . 0.506 HG22 ' HA ' ' B' 1048 ' ' LYS . 20.6 m -70.93 -29.25 36.47 Favored 'Isoleucine or valine' 0 C--N 1.347 0.477 0 CA-C-N 120.668 1.576 . . . . 38.37 111.155 175.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -60.18 -48.05 83.36 Favored 'General case' 0 C--O 1.205 -1.257 0 O-C-N 119.013 -2.304 . . . . 45.77 111.405 167.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1053 ' ' ALA . . . . . . . . . . . . . . . -64.62 -16.56 62.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 115.29 1.589 . . . . 37.83 115.29 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 99.39 31.53 6.1 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.632 -0.987 . . . . 35.82 110.632 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -110.77 143.45 41.29 Favored 'General case' 0 C--N 1.356 0.858 0 O-C-N 120.859 -1.377 . . . . 33.77 108.448 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -90.81 115.88 28.22 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 120.113 -1.617 . . . . 51.02 109.46 -172.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1057 ' ' ILE . . . . . . . . . . . . . 11.8 mm -76.15 109.59 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 106.494 -1.669 . . . . 38.47 106.494 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 6.5 m -126.03 126.26 69.39 Favored 'Isoleucine or valine' 0 C--O 1.247 0.969 0 CA-C-O 123.613 1.673 . . . . 39.4 111.576 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -86.52 125.49 33.8 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.977 -1.011 . . . . 57.07 111.195 -162.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . 71.31 -124.66 11.24 Favored Glycine 0 CA--C 1.517 0.206 0 O-C-N 125.785 1.928 . . . . 44.83 112.795 167.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 5.8 m120 -57.84 -31.36 66.58 Favored 'General case' 0 CA--C 1.481 -1.709 0 CA-C-N 118.566 1.183 . . . . 46.27 113.946 -175.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1062 ' ' SER . . . . . . . . . . . . . 4.8 m -52.47 -51.17 60.68 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 116.727 -1.606 . . . . 43.47 107.407 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.21 -39.81 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 121.313 1.87 . . . . 36.98 110.59 -177.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 93.2 m95 -60.41 -38.46 84.11 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 117.072 2.249 . . . . 37.9 117.072 174.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1065 ' ' GLN . . . . . 0.417 ' O ' ' NH2' ' B' 1002 ' ' ARG . 6.0 mm-40 -74.0 106.92 5.91 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 122.875 2.58 . . . . 46.19 104.952 172.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1066 ' ' SER . . . . . 0.568 ' HA ' ' HB2' ' B' ' 999' ' ' HIS . 51.1 m -164.76 166.49 19.81 Favored 'General case' 0 C--O 1.25 1.121 0 N-CA-C 109.304 -0.628 . . . . 37.06 109.304 -178.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1067 ' ' GLU . . . . . 0.454 ' HB2' ' HA ' ' B' 1000 ' ' HIS . 1.0 OUTLIER -65.55 -53.36 43.08 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 125.662 1.851 . . . . 43.95 111.993 169.586 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B 1068 ' ' ILE . . . . . 0.489 ' HB ' HG12 ' B' 1003 ' ' ILE . 4.5 mp -120.33 145.47 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 102.907 -2.997 . . . . 33.5 102.907 -173.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 16.8 mm -127.52 117.77 47.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 103.452 -2.796 . . . . 30.57 103.452 170.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1070 ' ' LEU . . . . . 0.741 HD22 HD22 ' B' 1331 ' ' LEU . 96.8 mt -106.42 114.46 28.59 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 103.934 -2.617 . . . . 27.66 103.934 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1071 ' ' LYS . . . . . 0.503 ' HB3' ' OG ' ' B' 1091 ' ' SER . 43.6 tttm -133.99 153.71 51.6 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 106.848 -1.538 . . . . 28.4 106.848 -168.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1072 ' ' VAL . . . . . 0.423 ' HB ' ' HG3' ' B' 1008 ' ' GLU . 61.5 t -85.03 -65.62 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 CA-C-N 119.517 1.053 . . . . 23.18 108.507 -174.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -107.02 165.34 11.42 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 105.865 -1.902 . . . . 25.47 105.865 -168.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -51.58 135.91 33.87 Favored Pre-proline 0 C--O 1.206 -1.22 0 CA-C-N 111.841 -2.436 . . . . 27.9 113.468 -171.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -60.22 123.49 13.26 Favored 'Trans proline' 0 N--CA 1.429 -2.279 0 C-N-CA 123.491 2.794 . . . . 31.62 113.425 171.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 91.6 mt -70.78 161.96 29.98 Favored 'General case' 0 C--O 1.244 0.802 0 O-C-N 125.61 1.818 . . . . 40.49 107.453 174.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1077 ' ' ASP . . . . . 0.471 ' HA ' HD12 ' B' 1080 ' ' ILE . 33.6 t70 -44.79 -42.28 7.68 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 120.072 3.36 . . . . 51.59 120.072 -173.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -68.09 -44.38 76.38 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 113.535 -1.666 . . . . 42.36 112.059 173.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1079 ' ' GLU . . . . . 0.431 ' HA ' HD12 ' B' 1082 ' ' LEU . 36.3 mt-10 -61.63 -35.7 78.66 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.109 -1.071 . . . . 34.53 108.109 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1080 ' ' ILE . . . . . 0.601 HG21 ' HB3' ' B' 1104 ' ' LYS . 76.5 mt -56.42 -50.91 70.15 Favored 'Isoleucine or valine' 0 C--O 1.25 1.082 0 O-C-N 119.936 -1.728 . . . . 33.25 108.524 172.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -63.59 -33.85 76.51 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 119.579 -1.95 . . . . 36.47 112.74 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1082 ' ' LEU . . . . . 0.431 HD12 ' HA ' ' B' 1079 ' ' GLU . 67.5 mt -61.05 -38.43 86.13 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.873 -0.603 . . . . 37.76 112.119 174.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1083 ' ' LEU . . . . . 0.448 ' HB3' HG11 ' B' 1110 ' ' VAL . 14.2 mt -58.66 154.31 14.74 Favored 'General case' 0 C--O 1.261 1.667 0 CA-C-O 123.594 1.664 . . . . 37.43 110.851 172.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1084 ' ' ASN . . . . . 0.407 ' HB2' ' OG1' ' B' 1087 ' ' THR . 3.0 m-80 -124.1 154.73 68.31 Favored Pre-proline 0 C--O 1.237 0.429 0 N-CA-C 106.747 -1.575 . . . . 37.7 106.747 -158.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -50.42 129.87 27.52 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 124.515 3.477 . . . . 35.51 110.667 171.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 93.58 -46.37 2.34 Favored Glycine 0 CA--C 1.542 1.738 0 CA-C-O 117.041 -1.977 . . . . 33.87 113.306 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1087 ' ' THR . . . . . 0.407 ' OG1' ' HB2' ' B' 1084 ' ' ASN . 59.1 m -46.28 118.13 1.82 Allowed 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 114.906 1.446 . . . . 32.5 114.906 -164.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1088 ' ' THR . . . . . . . . . . . . . 54.6 m -69.17 101.27 1.42 Allowed 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 106.782 -1.562 . . . . 30.22 106.782 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1089 ' ' LEU . . . . . 0.443 HD13 HD21 ' B' 1083 ' ' LEU . 13.2 tp -95.6 128.74 42.72 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-O 123.691 1.71 . . . . 27.24 110.245 174.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1090 ' ' VAL . . . . . 0.465 HG13 ' HB2' ' B' 1113 ' ' MET . 19.2 t -123.53 115.59 45.8 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 N-CA-C 105.677 -1.972 . . . . 25.39 105.677 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1091 ' ' SER . . . . . 0.503 ' OG ' ' HB3' ' B' 1071 ' ' LYS . 14.8 m -155.76 165.39 36.65 Favored 'General case' 0 C--N 1.352 0.685 0 O-C-N 120.654 -1.278 . . . . 28.81 110.123 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1092 ' ' PHE . . . . . 0.651 ' HZ ' ' HG3' ' B' 1133 ' ' MET . 88.4 m-85 -64.53 103.86 0.72 Allowed 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 107.119 -1.437 . . . . 30.78 107.119 158.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 26.9 mm -94.79 -37.92 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.221 0 CA-C-N 114.561 -1.2 . . . . 30.28 111.632 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1094 ' ' TRP . . . . . 0.469 ' HB3' ' HB2' ' B' 1097 ' ' GLN . 82.6 m95 60.25 71.83 0.82 Allowed Pre-proline 0 C--O 1.242 0.659 0 N-CA-C 107.057 -1.461 . . . . 34.07 107.057 -178.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -55.95 -58.06 1.24 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 125.24 3.96 . . . . 38.66 115.416 -170.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -66.22 -21.34 66.3 Favored 'General case' 0 CA--C 1.505 -0.762 0 O-C-N 120.627 -1.296 . . . . 41.32 112.321 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1097 ' ' GLN . . . . . 0.469 ' HB2' ' HB3' ' B' 1094 ' ' TRP . 12.6 mp0 -89.07 -20.89 23.77 Favored 'General case' 0 C--O 1.25 1.118 0 N-CA-C 107.23 -1.396 . . . . 51.66 107.23 -176.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1098 ' ' ASN . . . . . 0.416 ' HB3' ' HB3' ' B' 1101 ' ' LEU . 73.6 m-20 -135.57 54.92 11.36 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-N 120.7 1.591 . . . . 40.32 110.387 -176.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1099 ' ' PRO . . . . . 0.452 ' O ' ' HB2' ' B' 1102 ' ' MET . 58.8 Cg_endo -55.51 -49.01 17.45 Favored 'Trans proline' 0 CA--C 1.54 0.819 1 C-N-CA 125.314 4.009 . . . . 41.56 119.478 -175.343 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.85 -40.38 88.4 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.538 0.94 . . . . 54.11 113.538 173.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1101 ' ' LEU . . . . . 0.416 ' HB3' ' HB3' ' B' 1098 ' ' ASN . 9.3 tt -58.51 -49.51 77.13 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 125.194 1.398 . . . . 37.88 107.374 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1102 ' ' MET . . . . . 0.452 ' HB2' ' O ' ' B' 1099 ' ' PRO . 69.7 mmm -49.74 -45.64 49.59 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 113.934 1.087 . . . . 37.54 113.934 165.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -65.26 -44.14 89.08 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 121.288 1.858 . . . . 47.01 110.367 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1104 ' ' LYS . . . . . 0.601 ' HB3' HG21 ' B' 1080 ' ' ILE . 74.1 mttt -60.36 -38.49 84.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 119.423 -2.048 . . . . 48.68 110.652 -178.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1105 ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.04 -41.44 99.5 Favored 'General case' 0 C--O 1.25 1.081 0 CA-C-O 122.888 1.327 . . . . 32.21 113.977 171.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -63.91 -44.59 92.48 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.26 1.824 . . . . 33.73 108.93 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -54.11 -49.33 69.4 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 121.406 -0.809 . . . . 51.47 110.056 170.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1108 ' ' ARG . . . . . 0.589 ' HG2' ' O ' ' B' 1104 ' ' LYS . 13.9 mmm180 -67.86 -16.46 64.1 Favored 'General case' 0 C--O 1.207 -1.179 0 CA-C-N 120.221 1.373 . . . . 43.9 110.92 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1109 ' ' ASN . . . . . . . . . . . . . 4.6 m-80 69.41 28.84 4.62 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 123.73 1.728 . . . . 44.82 113.158 174.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1110 ' ' VAL . . . . . 0.448 HG11 ' HB3' ' B' 1083 ' ' LEU . 17.4 m -72.87 151.19 7.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 CA-C-N 114.179 -1.373 . . . . 30.52 109.45 174.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1111 ' ' THR . . . . . 0.431 ' HA ' ' H ' ' B' 1363 ' ' ALA . 6.4 m -94.77 107.3 19.31 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 106.524 -1.658 . . . . 27.12 106.524 176.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1112 ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' B' 1089 ' ' LEU . 4.0 t -101.29 126.14 55.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 115.237 1.569 . . . . 26.4 115.237 -169.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1113 ' ' MET . . . . . 0.465 ' HB2' HG13 ' B' 1090 ' ' VAL . 0.0 OUTLIER -107.43 127.57 53.71 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 106.08 -1.822 . . . . 42.92 106.08 165.209 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -100.74 105.74 17.09 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 113.362 -1.745 . . . . 24.15 108.044 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1115 ' ' MET . . . . . 0.491 ' HB3' ' HB2' ' B' 1129 ' ' ALA . 56.8 mmm -60.51 -23.33 64.45 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 112.896 -1.956 . . . . 29.95 116.24 -173.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1116 ' ' ASP . . . . . 0.603 ' HB3' ' HD1' ' B' 1092 ' ' PHE . 9.2 p-10 -78.46 -33.3 48.45 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 113.249 -1.796 . . . . 34.53 112.076 176.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1117 ' ' SER . . . . . . . . . . . . . 51.2 m -111.36 48.77 0.92 Allowed 'General case' 0 N--CA 1.435 -1.207 0 O-C-N 120.483 -1.386 . . . . 33.49 109.691 -178.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1118 ' ' VAL . . . . . 0.503 HG21 ' HA ' ' B' 1128 ' ' ASP . 55.3 t -76.73 139.91 67.08 Favored Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 104.81 -2.293 . . . . 34.02 104.81 167.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -50.35 141.06 33.22 Favored 'Trans proline' 0 C--O 1.245 0.871 0 C-N-CA 123.021 2.481 . . . . 38.28 117.395 175.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1120 ' ' ARG . . . . . 0.431 ' NH2' HD12 ' B' 1130 ' ' LEU . 9.7 mmt-85 -74.69 36.35 0.11 Allowed 'General case' 0 C--O 1.242 0.694 0 N-CA-C 116.714 2.116 . . . . 55.05 116.714 177.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1121 ' ' ILE . . . . . 0.411 ' HB ' ' O ' ' C' ' 131' ' ' ALA . 17.3 pt -118.8 142.75 32.29 Favored 'Isoleucine or valine' 0 C--N 1.347 0.466 0 O-C-N 117.702 -3.124 . . . . 42.09 106.695 -176.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1122 ' ' SER . . . . . . . . . . . . . 62.0 m -35.88 -47.96 0.54 Allowed 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 117.91 2.559 . . . . 38.02 117.91 -175.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1123 ' ' ARG . . . . . 0.462 ' HG3' HG21 ' B' 1354 ' ' VAL . 37.9 ptt85 -74.86 -35.92 62.34 Favored 'General case' 0 C--O 1.208 -1.122 0 CA-C-N 123.581 2.9 . . . . 34.29 113.416 177.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1124 ' ' ALA . . . . . 0.598 ' HA ' HD13 ' B' 1127 ' ' LEU . . . -68.51 -26.54 65.5 Favored 'General case' 0 C--O 1.218 -0.57 0 O-C-N 120.314 -1.491 . . . . 32.35 109.823 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1125 ' ' GLN . . . . . 0.406 ' HA ' ' HB3' ' B' 1128 ' ' ASP . 13.1 mm100 -60.01 -15.07 19.52 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 115.42 1.637 . . . . 47.17 115.42 171.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1126 ' ' SER . . . . . . . . . . . . . 97.1 p -77.47 -30.54 53.2 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 114.568 1.321 . . . . 31.71 114.568 170.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1127 ' ' LEU . . . . . 0.598 HD13 ' HA ' ' B' 1124 ' ' ALA . 3.4 mp -83.58 -25.22 31.11 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 112.395 -2.184 . . . . 37.0 109.212 175.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1128 ' ' ASP . . . . . 0.503 ' HA ' HG21 ' B' 1118 ' ' VAL . 33.9 t70 -69.76 118.86 13.14 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 115.421 1.637 . . . . 40.4 115.421 -174.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1129 ' ' ALA . . . . . 0.491 ' HB2' ' HB3' ' B' 1115 ' ' MET . . . -62.93 -46.09 89.43 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 109.851 -3.34 . . . . 26.56 111.095 177.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1130 ' ' LEU . . . . . 0.431 HD12 ' NH2' ' B' 1120 ' ' ARG . 35.2 mt -53.95 -41.83 68.2 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 117.071 -1.442 . . . . 30.89 114.452 -173.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1131 ' ' SER . . . . . . . . . . . . . 16.3 p -62.09 -46.97 86.73 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 124.473 1.108 . . . . 29.84 113.271 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1132 ' ' SER . . . . . 0.654 ' HB3' ' HB3' ' B' 1326 ' ' LEU . 14.6 m -65.13 -46.64 80.11 Favored 'General case' 0 N--CA 1.421 -1.881 0 O-C-N 119.421 -2.049 . . . . 31.91 111.17 174.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1133 ' ' MET . . . . . 0.651 ' HG3' ' HZ ' ' B' 1092 ' ' PHE . 38.8 mmt -59.32 -32.17 69.83 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 120.555 -1.341 . . . . 25.9 114.182 175.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1134 ' ' ALA . . . . . 0.611 ' HB1' ' HB2' ' B' 1176 ' ' ALA . . . -75.07 -35.66 61.82 Favored 'General case' 0 C--O 1.203 -1.369 0 O-C-N 120.393 -1.442 . . . . 26.62 108.542 173.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -61.23 -41.71 97.34 Favored 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 119.092 -2.255 . . . . 36.97 110.527 176.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1136 ' ' ILE . . . . . 0.62 HG21 ' HA ' ' B' 1316 ' ' PRO . 48.5 mm -59.33 -56.7 15.38 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 O-C-N 125.406 1.691 . . . . 32.11 108.47 171.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -55.69 -42.25 74.91 Favored 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 126.128 1.771 . . . . 24.14 114.682 -174.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -64.75 -45.47 92.64 Favored Glycine 0 C--N 1.316 -0.549 0 CA-C-N 122.031 2.196 . . . . 25.13 111.577 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 16.1 t80 -67.14 -43.21 82.94 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 122.683 1.23 . . . . 32.73 108.917 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1140 ' ' ARG . . . . . 0.584 HH11 HD13 ' B' 1319 ' ' LEU . 8.6 tpt180 -68.0 -32.54 73.01 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.709 -0.849 . . . . 26.36 108.709 -175.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1141 ' ' ALA . . . . . . . . . . . . . . . -55.98 -53.9 51.34 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 113.015 0.746 . . . . 24.12 113.015 170.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 36.5 mm -52.38 -45.51 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 124.052 0.941 . . . . 23.37 110.163 174.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 75.5 t -60.05 -62.8 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 117.537 -1.22 . . . . 24.96 114.274 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1144 ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' B' 1147 ' ' HIS . 59.5 mm-40 -61.87 -36.13 80.35 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-N 120.764 1.62 . . . . 32.07 111.138 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1145 ' ' ALA . . . . . 0.741 ' HA ' HG11 ' B' 1280 ' ' VAL . . . -54.28 -49.66 69.07 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 117.476 -1.25 . . . . 24.87 109.987 169.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1146 ' ' ALA . . . . . . . . . . . . . . . -67.26 -27.13 66.95 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 119.105 0.866 . . . . 24.67 110.792 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1147 ' ' HIS . . . . . 0.416 ' CD2' ' HG2' ' B' 1148 ' ' GLU . 51.9 t60 -57.85 -47.04 83.85 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 119.056 -0.497 . . . . 28.58 111.053 169.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1148 ' ' GLU . . . . . 0.416 ' HG2' ' CD2' ' B' 1147 ' ' HIS . 68.3 mm-40 -94.53 -5.09 46.78 Favored 'General case' 0 CA--C 1.501 -0.912 0 O-C-N 120.102 -1.624 . . . . 36.82 113.462 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1149 ' ' PHE . . . . . . . . . . . . . 3.3 t80 -67.73 137.52 55.54 Favored 'General case' 0 C--O 1.254 1.313 0 C-N-CA 124.827 1.251 . . . . 31.97 108.945 -177.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1150 ' ' GLY . . . . . 0.615 ' HA2' ' HD2' ' A' 1320 ' ' PRO . . . -75.31 -19.07 79.81 Favored Glycine 0 N--CA 1.44 -1.081 0 CA-C-O 118.135 -1.37 . . . . 25.49 114.083 174.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1151 ' ' ARG . . . . . . . . . . . . . 71.1 mtm-85 -130.34 177.59 7.22 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 122.811 3.305 . . . . 59.84 114.306 -158.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1152 ' ' PHE . . . . . 0.59 ' HB2' HG11 ' B' 1163 ' ' VAL . 7.1 m-30 -81.36 162.21 23.49 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 123.111 1.434 . . . . 34.45 109.238 170.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1153 ' ' PHE . . . . . 0.484 ' HB3' ' HB2' ' B' 1189 ' ' ALA . 77.4 m-85 -82.14 -50.15 9.36 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 112.949 -1.932 . . . . 31.17 108.834 165.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1154 ' ' THR . . . . . . . . . . . . . 3.5 m -77.19 126.68 31.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 112.273 -2.239 . . . . 33.89 108.666 -168.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -81.37 65.91 3.91 Favored Glycine 0 N--CA 1.433 -1.535 0 N-CA-C 110.132 -1.187 . . . . 38.95 110.132 -176.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -67.05 146.99 53.74 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.587 1.955 . . . . 54.23 115.786 -170.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 12.7 mm -90.87 125.89 43.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 102.012 -3.329 . . . . 51.16 102.012 173.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1158 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.75 138.08 51.91 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 102.327 -3.212 . . . . 49.61 102.327 172.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -58.65 -29.2 66.38 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.744 1.156 . . . . 49.05 110.817 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1160 ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' 1126 ' ' SER . . . -55.0 -58.92 5.67 Favored 'General case' 0 C--N 1.363 1.171 0 N-CA-C 112.993 0.738 . . . . 47.65 112.993 165.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . -171.52 143.27 7.47 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 107.766 -2.133 . . . . 45.61 107.766 -165.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 92.7 mttt -78.25 138.56 38.69 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 118.584 1.192 . . . . 57.46 109.55 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1163 ' ' VAL . . . . . 0.59 HG11 ' HB2' ' B' 1152 ' ' PHE . 48.0 t -88.01 133.34 37.49 Favored Pre-proline 0 C--O 1.251 1.144 0 N-CA-C 105.533 -2.025 . . . . 42.93 105.533 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1164 ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' B' 1165 ' ' PRO . 48.2 Cg_endo -67.48 145.06 69.56 Favored 'Trans proline' 0 C--N 1.323 -0.815 0 C-N-CA 123.265 2.643 . . . . 39.29 113.655 170.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1165 ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' B' 1164 ' ' PRO . 75.7 Cg_exo -65.54 152.77 80.84 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 CA-C-N 124.016 2.47 . . . . 34.17 113.836 176.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -88.42 143.65 26.86 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.57 -1.27 . . . . 31.69 107.57 167.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1167 ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -107.7 117.35 33.89 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 106.945 -1.502 . . . . 44.78 106.945 173.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1168 ' ' VAL . . . . . 0.529 HG22 ' HB ' ' B' 1251 ' ' ILE . 61.8 t -102.59 113.83 40.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 106.418 -1.697 . . . . 31.23 106.418 -174.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1169 ' ' MET . . . . . 0.628 ' HB2' HG11 ' B' 1249 ' ' VAL . 43.0 ttp -95.94 97.52 9.68 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 120.892 0.377 . . . . 37.09 110.967 178.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1170 ' ' VAL . . . . . 0.448 HG22 ' HB ' ' B' 1253 ' ' VAL . 61.4 t -88.78 122.0 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.851 -1.166 . . . . 30.17 107.851 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1171 ' ' ILE . . . . . 0.409 HG22 ' HB2' ' B' 1256 ' ' ALA . 44.4 mt -112.07 131.94 62.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 104.097 -2.557 . . . . 33.74 104.097 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 81.29 64.6 1.76 Allowed Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 108.11 -1.996 . . . . 32.59 108.11 -174.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1173 ' ' ALA . . . . . 0.469 ' H ' ' HB2' ' B' 1195 ' ' ASP . . . -62.93 -7.01 4.37 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 120.842 -1.387 . . . . 32.42 114.683 -177.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -58.11 129.19 49.2 Favored Glycine 0 C--O 1.245 0.799 0 CA-C-O 122.8 1.222 . . . . 31.74 112.23 175.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 1.5 t 48.81 -82.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 112.612 -1.794 . . . . 31.48 114.441 173.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1176 ' ' ALA . . . . . 0.611 ' HB2' ' HB1' ' B' 1134 ' ' ALA . . . -65.34 -42.38 92.95 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.548 0.69 . . . . 26.12 112.609 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1177 ' ' GLY . . . . . . . . . . . . . . . -56.72 -45.22 91.11 Favored Glycine 0 N--CA 1.464 0.563 0 CA-C-N 113.123 -1.853 . . . . 25.73 108.781 174.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1178 ' ' LEU . . . . . 0.592 ' HA ' HD12 ' B' 1181 ' ' ILE . 5.5 tp -58.62 -48.89 79.48 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 126.288 1.835 . . . . 32.59 108.336 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -58.74 -38.81 79.22 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 114.347 1.24 . . . . 27.72 114.347 175.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -65.82 -43.21 89.28 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.884 0.874 . . . . 26.03 112.034 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1181 ' ' ILE . . . . . 0.599 HD13 HG22 ' B' 1204 ' ' VAL . 9.5 mt -56.12 -48.29 79.33 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 O-C-N 120.299 -1.5 . . . . 28.61 108.633 170.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -57.68 -49.88 70.17 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 117.749 -1.584 . . . . 25.23 112.986 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -63.48 -49.57 73.1 Favored 'General case' 0 C--O 1.249 1.063 0 CA-C-N 120.78 2.29 . . . . 24.09 113.253 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -68.02 -38.44 82.58 Favored 'General case' 0 C--O 1.24 0.605 0 O-C-N 121.497 -0.752 . . . . 26.68 109.323 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 45.5 t30 -62.32 -33.65 75.09 Favored 'General case' 0 C--O 1.249 1.042 0 O-C-N 118.075 -2.891 . . . . 36.57 111.004 174.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1186 ' ' SER . . . . . 0.557 ' HB3' ' O ' ' A' 1186 ' ' SER . 61.4 m -67.42 -45.85 74.9 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 111.941 0.348 . . . . 28.92 111.941 174.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1187 ' ' LEU . . . . . 0.513 ' HA ' ' HB3' ' A' 1186 ' ' SER . 5.6 mt -60.49 -24.64 65.45 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.093 0.957 . . . . 29.09 111.477 169.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 93.75 34.74 6.42 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 121.559 1.981 . . . . 29.26 112.224 175.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1189 ' ' ALA . . . . . 0.484 ' HB2' ' HB3' ' B' 1153 ' ' PHE . . . -104.3 146.02 29.4 Favored 'General case' 0 C--O 1.252 1.192 0 N-CA-C 107.772 -1.196 . . . . 30.16 107.772 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 69.9 mt -77.18 110.76 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 102.776 -3.046 . . . . 35.81 102.776 -173.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1191 ' ' VAL . . . . . . . . . . . . . 17.4 t -91.93 128.28 43.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 C-N-CA 118.485 -1.286 . . . . 31.97 108.024 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1192 ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' B' 1169 ' ' MET . 87.6 mtt180 -113.83 107.76 16.16 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 106.868 -1.53 . . . . 48.16 106.868 168.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -114.92 147.39 40.03 Favored 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 120.381 -1.449 . . . . 35.89 110.74 -173.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1194 ' ' PHE . . . . . 0.537 ' HB2' ' HB2' ' B' 1212 ' ' LEU . 42.0 t80 -135.9 146.96 47.92 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.304 -1.369 . . . . 41.88 107.304 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1195 ' ' ASP . . . . . 0.871 ' HB3' HG21 ' B' 1200 ' ' VAL . 23.7 t0 -154.46 154.06 32.57 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 102.051 -3.314 . . . . 38.28 102.051 172.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1196 ' ' THR . . . . . 0.459 ' HB ' ' HG2' ' B' 1230 ' ' MET . 1.8 p -85.76 37.92 0.72 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 117.695 -1.145 . . . . 40.62 110.811 -170.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1197 ' ' ARG . . . . . . . . . . . . . 75.4 mtm180 -140.24 166.2 25.13 Favored Pre-proline 0 C--O 1.246 0.878 0 CA-C-N 121.955 2.161 . . . . 53.09 112.386 -166.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -72.35 -64.33 0.03 OUTLIER 'Trans proline' 0 C--O 1.254 1.299 0 N-CA-C 119.149 2.711 . . . . 42.56 119.149 168.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.02 -34.26 63.33 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 115.574 1.694 . . . . 56.31 115.574 -167.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1200 ' ' VAL . . . . . 0.871 HG21 ' HB3' ' B' 1195 ' ' ASP . 0.3 OUTLIER -43.96 -42.18 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 N-CA-C 116.102 1.89 . . . . 42.91 116.102 172.417 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 43.5 tttm -58.2 -51.79 68.27 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 120.038 -1.664 . . . . 48.89 110.216 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -61.34 -28.05 68.94 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 122.36 1.076 . . . . 51.7 112.847 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1203 ' ' GLN . . . . . 0.551 ' HG2' ' HA ' ' B' 1200 ' ' VAL . 34.7 mm-40 -68.16 -46.55 70.45 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 107.641 -1.244 . . . . 52.57 107.641 173.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1204 ' ' VAL . . . . . 0.599 HG22 HD13 ' B' 1181 ' ' ILE . 25.5 t -63.99 -34.34 67.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 120.383 1.447 . . . . 33.79 111.292 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -61.97 -34.92 77.03 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.806 0.843 . . . . 36.58 109.972 171.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1206 ' ' SER . . . . . . . . . . . . . 14.9 m -72.78 -1.64 17.35 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 115.359 1.615 . . . . 39.61 115.359 173.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1207 ' ' MET . . . . . 0.469 ' SD ' HD11 ' C' ' 75' ' ' LEU . 2.8 mpp? -98.42 -18.68 18.13 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 113.258 0.836 . . . . 37.45 113.258 165.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 72.04 43.97 46.98 Favored Glycine 0 N--CA 1.484 1.843 0 O-C-N 119.624 -1.923 . . . . 31.87 110.868 -167.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -126.38 166.96 16.21 Favored 'General case' 0 CA--C 1.505 -0.772 0 O-C-N 120.471 -1.605 . . . . 35.4 111.899 -176.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -81.0 125.56 30.32 Favored 'General case' 0 C--O 1.216 -0.663 0 O-C-N 120.529 -1.357 . . . . 47.89 108.989 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 70.9 t80 -92.1 130.7 37.77 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 104.33 -2.47 . . . . 45.53 104.33 165.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1212 ' ' LEU . . . . . 0.537 ' HB2' ' HB2' ' B' 1194 ' ' PHE . 53.0 mt -76.25 106.89 8.12 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 105.2 -2.148 . . . . 46.33 105.2 167.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.17 150.79 37.09 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 124.07 1.89 . . . . 60.41 111.577 -173.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1214 ' ' LEU . . . . . 0.566 ' HB3' ' HE2' ' B' 1234 ' ' PHE . 8.0 mp -60.97 127.41 31.45 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 111.847 -2.433 . . . . 57.38 112.895 176.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 30.9 t0 . . . . . 0 N--CA 1.45 -0.465 0 C-N-CA 127.154 2.182 . . . . 65.07 110.46 -169.088 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B 1230 ' ' MET . . . . . 0.459 ' HG2' ' HB ' ' B' 1196 ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.417 -2.123 0 N-CA-C 102.489 -3.152 . . . . 80.32 102.489 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1231 ' ' SER . . . . . . . . . . . . 0.298 2.6 p 58.75 169.15 0.06 Allowed 'General case' 0 N--CA 1.444 -0.762 2 CA-C-N 130.094 5.861 . . . . 79.92 116.365 2.152 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -61.04 -49.76 76.06 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.274 -1.517 . . . . 77.91 108.304 175.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 34.22 -77.56 0.0 OUTLIER 'General case' 0 C--O 1.248 1.012 0 N-CA-C 119.657 3.206 . . . . 73.88 119.657 175.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1234 ' ' PHE . . . . . 0.566 ' HE2' ' HB3' ' B' 1214 ' ' LEU . 8.3 m-30 -93.59 -0.25 56.29 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 120.98 1.718 . . . . 68.98 110.365 -168.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 13.5 pt -33.16 -33.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 119.213 3.042 . . . . 64.53 119.213 -174.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -80.27 -38.57 30.63 Favored 'General case' 0 C--O 1.245 0.859 0 O-C-N 120.74 -1.225 . . . . 66.36 113.79 173.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -63.89 -47.65 79.78 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-O 117.45 -1.262 . . . . 56.6 109.154 170.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1238 ' ' GLU . . . . . 0.48 ' HG2' ' HE2' ' B' 1194 ' ' PHE . 47.7 mt-10 -47.96 -61.14 2.11 Favored 'General case' 0 C--N 1.36 1.06 0 O-C-N 124.347 1.029 . . . . 56.79 112.284 174.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1239 ' ' MET . . . . . . . . . . . . . 14.1 ttm -54.28 -50.15 67.92 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 124.853 1.261 . . . . 53.63 111.029 -175.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -72.41 -27.9 62.64 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 117.432 2.382 . . . . 51.74 117.432 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 28.2 tp -63.48 -50.46 69.6 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 106.498 -1.667 . . . . 44.86 106.498 169.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1242 ' ' PHE . . . . . 0.453 ' HE2' HD13 ' B' 1266 ' ' LEU . 18.3 m-30 -58.62 -41.91 86.99 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.998 1.436 . . . . 42.78 111.375 176.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -59.46 -44.77 92.91 Favored 'General case' 0 C--O 1.25 1.088 0 CA-C-N 120.577 1.535 . . . . 40.96 114.876 173.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -61.43 -51.84 67.07 Favored 'General case' 0 C--O 1.25 1.085 0 C-N-CA 120.169 -0.612 . . . . 43.06 110.063 174.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 -58.84 -28.64 66.26 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 116.203 1.927 . . . . 46.45 116.203 173.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -52.34 -33.09 41.21 Favored 'General case' 0 C--O 1.254 1.323 0 CA-C-N 119.291 0.95 . . . . 41.78 113.143 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1247 ' ' LYS . . . . . 0.438 ' HD2' ' HA ' ' B' 1247 ' ' LYS . 22.0 tptt -76.61 -31.56 57.52 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 120.932 -1.105 . . . . 52.2 112.322 177.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1248 ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -84.49 -42.12 15.87 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 120.818 -1.176 . . . . 53.55 112.697 178.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1249 ' ' VAL . . . . . 0.628 HG11 ' HB2' ' B' 1169 ' ' MET . 36.0 m -82.03 160.11 3.82 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.788 0 CA-C-O 123.154 1.454 . . . . 34.41 113.713 -162.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1250 ' ' ASP . . . . . 0.603 ' O ' ' HB3' ' B' 1279 ' ' SER . 3.7 m-20 -107.48 -69.72 0.83 Allowed 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 111.832 -2.44 . . . . 33.38 113.748 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1251 ' ' ILE . . . . . 0.714 HD12 ' HB1' ' B' 1145 ' ' ALA . 44.2 mm -101.6 102.5 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 N-CA-C 108.04 -1.096 . . . . 29.54 108.04 -175.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1252 ' ' ILE . . . . . 0.56 HD12 HG12 ' B' 1281 ' ' ILE . 75.0 mt -83.29 116.41 27.34 Favored 'Isoleucine or valine' 0 C--O 1.25 1.127 0 N-CA-C 107.082 -1.451 . . . . 32.44 107.082 168.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1253 ' ' VAL . . . . . 0.545 HG13 HD11 ' B' 1284 ' ' LEU . 39.0 t -101.16 87.9 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 105.644 -1.984 . . . . 30.57 105.644 174.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1254 ' ' THR . . . . . . . . . . . . . 1.2 t -92.85 115.02 27.73 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-O 125.462 2.553 . . . . 35.04 111.331 -174.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1255 ' ' THR . . . . . . . . . . . . . 7.1 m -135.83 10.16 3.35 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 110.606 -2.997 . . . . 34.62 108.987 -161.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1256 ' ' ALA . . . . . 0.409 ' HB2' HG22 ' B' 1171 ' ' ILE . . . -70.37 84.86 0.58 Allowed 'General case' 0 C--N 1.35 0.628 0 O-C-N 121.086 -1.009 . . . . 42.72 113.552 -172.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 41.1 mt -105.89 126.63 52.41 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 125.387 1.475 . . . . 52.43 110.103 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1258 ' ' ILE . . . . . 0.407 ' HA ' ' HD2' ' B' 1259 ' ' PRO . 2.6 mp -77.14 132.1 71.2 Favored Pre-proline 0 N--CA 1.438 -1.057 0 N-CA-C 103.151 -2.907 . . . . 59.41 103.151 168.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1259 ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' B' 1258 ' ' ILE . 67.7 Cg_endo -65.22 69.87 0.29 Allowed 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 124.217 3.278 . . . . 62.68 111.967 169.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 153.19 -81.12 0.18 Allowed Glycine 0 CA--C 1.534 1.266 0 O-C-N 118.653 -2.53 . . . . 64.16 108.43 -171.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 38.3 tttt -64.69 138.45 97.46 Favored Pre-proline 0 N--CA 1.44 -0.968 0 N-CA-C 114.755 1.391 . . . . 68.53 114.755 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -55.31 132.08 50.07 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 124.703 3.602 . . . . 61.99 111.392 166.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1263 ' ' ALA . . . . . . . . . . . . . . . -59.53 128.18 85.73 Favored Pre-proline 0 C--O 1.239 0.544 0 CA-C-N 111.675 -2.511 . . . . 57.15 111.407 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1264 ' ' PRO . . . . . 0.475 ' O ' ' HA ' ' B' 1291 ' ' ASN . 97.1 Cg_endo -64.19 146.08 89.95 Favored 'Trans proline' 0 C--O 1.25 1.077 0 C-N-CA 124.69 3.594 . . . . 51.57 113.815 177.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1265 ' ' LYS . . . . . 0.463 ' NZ ' ' O ' ' B' 1289 ' ' GLY . 38.5 mmtm -71.7 97.44 1.75 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 123.56 1.647 . . . . 54.55 108.309 167.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1266 ' ' LEU . . . . . 0.453 HD13 ' HE2' ' B' 1242 ' ' PHE . 91.3 mt -94.14 -47.85 6.47 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 123.223 1.487 . . . . 46.86 112.134 172.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1267 ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' B' 1292 ' ' CYS . 20.7 mm -84.06 82.36 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 104.651 -2.351 . . . . 41.04 104.651 -175.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1268 ' ' THR . . . . . 0.643 ' HA ' ' HG3' ' B' 1293 ' ' GLU . 23.2 p -82.36 175.45 10.24 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 111.068 -2.787 . . . . 39.58 108.729 -175.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1269 ' ' ARG . . . . . 0.457 ' HG2' ' CE2' ' B' 1294 ' ' TYR . 64.8 mtt85 -52.56 -41.28 63.42 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.019 0.927 . . . . 53.15 111.765 175.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -60.57 -21.06 62.18 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 115.727 1.751 . . . . 42.96 115.727 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1271 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.42 -51.51 6.89 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 120.338 1.426 . . . . 43.89 110.725 162.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1272 ' ' VAL . . . . . 0.41 HG23 ' O ' ' B' 1268 ' ' THR . 96.4 t -57.72 -60.68 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 CA-C-N 115.187 -0.915 . . . . 38.37 112.203 -168.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.26 -34.93 77.49 Favored 'General case' 0 C--O 1.247 0.97 0 O-C-N 119.541 -1.974 . . . . 47.46 112.708 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1274 ' ' SER . . . . . . . . . . . . . 5.2 m -74.32 -17.03 60.9 Favored 'General case' 0 C--O 1.244 0.786 0 O-C-N 120.044 -1.66 . . . . 38.38 111.16 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1275 ' ' MET . . . . . 0.581 ' SD ' HD11 ' B' 1281 ' ' ILE . 38.3 mtp -53.75 145.07 16.53 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 118.747 2.869 . . . . 37.81 118.747 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -61.39 130.76 47.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.547 -1.206 . . . . 49.26 109.101 171.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1277 ' ' ALA . . . . . 0.406 ' HB1' ' HA ' ' A' 1045 ' ' PHE . . . -64.03 165.35 9.12 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 118.5 2.778 . . . . 34.46 118.5 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 67.34 26.47 73.52 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-O 124.711 2.284 . . . . 33.53 115.363 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1279 ' ' SER . . . . . 0.603 ' HB3' ' O ' ' B' 1250 ' ' ASP . 36.6 m -127.89 159.75 33.95 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 111.243 -2.478 . . . . 31.31 106.139 -168.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1280 ' ' VAL . . . . . 0.741 HG11 ' HA ' ' B' 1145 ' ' ALA . 94.8 t -128.28 129.31 69.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.537 -0.912 . . . . 29.32 108.537 -165.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1281 ' ' ILE . . . . . 0.581 HD11 ' SD ' ' B' 1275 ' ' MET . 58.5 mt -99.49 96.28 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 N-CA-C 107.304 -1.369 . . . . 31.93 107.304 170.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1282 ' ' VAL . . . . . . . . . . . . . 14.2 t -80.63 110.99 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 O-C-N 120.383 -1.448 . . . . 29.48 110.793 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 33.6 t0 -90.57 95.81 10.34 Favored 'General case' 0 N--CA 1.417 -2.115 0 O-C-N 120.289 -1.507 . . . . 34.5 107.189 173.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1284 ' ' LEU . . . . . 0.545 HD11 HG13 ' B' 1253 ' ' VAL . 5.0 mp -76.65 -21.97 54.72 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-N 113.18 -1.827 . . . . 37.94 111.207 173.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -87.0 8.01 25.2 Favored 'General case' 0 C--N 1.35 0.589 0 N-CA-C 115.656 1.724 . . . . 40.92 115.656 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -50.29 -42.66 52.79 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 119.524 3.157 . . . . 44.39 119.524 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1287 ' ' GLN . . . . . 0.452 ' HB3' HG22 ' B' 1313 ' ' THR . 0.1 OUTLIER -64.03 -28.86 70.09 Favored 'General case' 0 C--O 1.257 1.495 0 O-C-N 119.322 -2.111 . . . . 51.46 114.137 178.497 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 38.9 t30 -121.91 76.78 1.31 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.243 -1.021 . . . . 57.75 108.243 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1289 ' ' GLY . . . . . 0.463 ' O ' ' NZ ' ' B' 1265 ' ' LYS . . . 98.45 -60.68 0.9 Allowed Glycine 0 C--N 1.336 0.531 0 O-C-N 120.102 -1.624 . . . . 49.85 114.902 176.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 80.99 119.48 0.44 Allowed Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 121.247 2.523 . . . . 45.93 112.128 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1291 ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' B' 1264 ' ' PRO . 27.0 m120 -81.5 -25.84 35.66 Favored 'General case' 0 C--N 1.346 0.429 0 N-CA-C 114.457 1.28 . . . . 42.67 114.457 -175.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1292 ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' B' 1267 ' ' ILE . 48.2 t -95.14 144.44 25.77 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 120.399 -1.438 . . . . 38.82 111.754 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1293 ' ' GLU . . . . . 0.643 ' HG3' ' HA ' ' B' 1268 ' ' THR . 22.7 mt-10 -68.82 -34.25 75.2 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 113.784 1.031 . . . . 46.71 113.784 178.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1294 ' ' TYR . . . . . 0.457 ' CE2' ' HG2' ' B' 1269 ' ' ARG . 52.7 m-85 -80.91 7.76 9.86 Favored 'General case' 0 C--O 1.248 0.982 0 N-CA-C 116.766 2.135 . . . . 47.23 116.766 -176.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1295 ' ' THR . . . . . 0.455 ' OG1' ' HB3' ' B' 1292 ' ' CYS . 26.4 m -71.79 107.73 4.74 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 114.007 1.114 . . . . 36.02 114.007 -173.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 36.7 t -93.57 123.42 60.14 Favored Pre-proline 0 C--N 1.304 -1.394 0 N-CA-C 103.448 -2.797 . . . . 37.26 103.448 155.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -61.16 136.8 67.14 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.649 2.233 . . . . 35.09 114.268 177.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 71.69 40.73 58.16 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 113.699 -1.591 . . . . 35.97 112.691 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -148.91 152.75 36.94 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-O 124.882 2.277 . . . . 40.39 114.671 -172.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1300 ' ' ILE . . . . . . . . . . . . . 55.3 mt -99.84 107.61 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 101.422 -3.547 . . . . 37.43 101.422 166.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 15.2 t80 -104.78 103.12 12.68 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.07 -1.085 . . . . 44.13 108.07 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1302 ' ' THR . . . . . . . . . . . . . 17.7 m -82.98 120.42 25.69 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-O 123.337 1.541 . . . . 39.78 111.012 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1303 ' ' THR . . . . . . . . . . . . . 3.2 p -79.84 139.35 37.22 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 112.929 -1.941 . . . . 43.29 109.398 175.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -48.25 -31.22 5.59 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 117.352 2.352 . . . . 53.07 117.352 -175.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -59.88 -21.93 61.68 Favored 'General case' 0 C--O 1.262 1.713 0 C-N-CA 126.496 1.918 . . . . 43.97 116.062 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 113.35 1.09 24.94 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 110.987 -0.845 . . . . 41.12 110.987 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1307 ' ' VAL . . . . . . . . . . . . . 45.6 t -88.95 148.28 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-N 118.653 1.227 . . . . 38.12 109.437 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1308 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.09 114.87 27.97 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 107.726 -1.212 . . . . 36.34 107.726 177.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1309 ' ' VAL . . . . . 0.405 HG21 ' HB2' ' B' 1294 ' ' TYR . 85.2 t -84.05 97.04 4.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 107.108 -1.441 . . . . 30.4 107.108 172.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1310 ' ' ILE . . . . . . . . . . . . . 19.0 mt -88.32 91.58 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 CA-C-O 122.912 1.339 . . . . 30.82 108.228 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1311 ' ' GLY . . . . . 0.415 ' HA3' HG23 ' B' 1295 ' ' THR . . . -88.97 93.32 1.88 Allowed Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 109.65 -1.38 . . . . 26.53 109.65 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1312 ' ' TYR . . . . . . . . . . . . . 13.9 m-30 -116.56 128.18 55.19 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 117.755 2.502 . . . . 38.0 117.755 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1313 ' ' THR . . . . . 0.452 HG22 ' HB3' ' B' 1287 ' ' GLN . 24.0 p -81.83 -56.25 4.1 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 112.668 -2.06 . . . . 29.8 108.64 173.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -70.05 21.26 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 117.991 2.589 . . . . 39.04 117.991 -173.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1315 ' ' LEU . . . . . . . . . . . . . 63.8 mt -50.78 -34.29 11.57 Favored Pre-proline 0 CA--C 1.545 0.777 0 O-C-N 118.013 -2.93 . . . . 31.08 117.128 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1316 ' ' PRO . . . . . 0.62 ' HA ' HG21 ' B' 1136 ' ' ILE . 51.3 Cg_exo -61.87 -54.23 1.67 Allowed 'Trans proline' 0 C--O 1.24 0.589 0 C-N-CA 123.213 2.608 . . . . 26.1 112.173 166.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1317 ' ' GLY . . . . . 0.626 ' HA2' ' HG3' ' B' 1015 ' ' ARG . . . -58.1 -32.99 68.07 Favored Glycine 0 C--O 1.213 -1.168 0 O-C-N 121.548 -0.72 . . . . 23.17 113.004 -177.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 74.7 mtt-85 -60.24 -27.44 67.21 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 113.584 0.957 . . . . 40.4 113.584 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1319 ' ' LEU . . . . . 0.584 HD13 HH11 ' B' 1140 ' ' ARG . 14.1 tp -111.86 77.98 2.1 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 105.397 -2.075 . . . . 23.6 105.397 171.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1320 ' ' PRO . . . . . 0.507 ' HB2' ' HA ' ' B' 1043 ' ' ALA . 81.2 Cg_endo -59.71 -64.66 0.1 OUTLIER 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.309 2.673 . . . . 22.35 115.414 -163.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1321 ' ' THR . . . . . . . . . . . . . 1.5 m -60.6 -38.07 83.48 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 120.552 -1.342 . . . . 26.52 111.404 -172.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1322 ' ' GLN . . . . . 0.92 ' HB2' ' HA ' ' A' 1151 ' ' ARG . 43.1 tp60 -72.34 -35.37 68.54 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 120.288 -1.508 . . . . 24.38 109.342 -175.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1323 ' ' SER . . . . . . . . . . . . . 68.8 m -61.56 -47.6 84.77 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 124.633 1.208 . . . . 22.8 111.433 171.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1324 ' ' SER . . . . . . . . . . . . . 7.6 m -60.71 -28.86 68.97 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 119.612 -1.93 . . . . 21.25 112.915 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -74.61 -47.27 33.25 Favored 'General case' 0 C--O 1.252 1.211 0 O-C-N 119.82 -1.8 . . . . 31.34 109.973 176.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1326 ' ' LEU . . . . . 0.654 ' HB3' ' HB3' ' B' 1132 ' ' SER . 86.1 mt -74.85 -47.35 30.76 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 120.343 1.429 . . . . 31.56 109.527 -173.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1327 ' ' TYR . . . . . 0.409 ' O ' ' HG ' ' B' 1331 ' ' LEU . 55.9 t80 -58.35 -45.1 88.81 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 109.547 -0.538 . . . . 22.73 109.547 174.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1328 ' ' GLY . . . . . 0.632 ' HA2' HD12 ' B' 1331 ' ' LEU . . . -55.4 -46.49 80.15 Favored Glycine 0 C--N 1.357 1.719 0 N-CA-C 111.253 -0.739 . . . . 21.91 111.253 173.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1329 ' ' THR . . . . . . . . . . . . . 48.2 m -67.98 -25.24 65.32 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 120.323 -1.692 . . . . 22.15 111.217 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1330 ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' B' 1127 ' ' LEU . 31.7 m120 -69.25 -48.47 61.75 Favored 'General case' 0 C--N 1.314 -0.941 0 O-C-N 119.637 -1.914 . . . . 26.18 107.252 173.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1331 ' ' LEU . . . . . 0.741 HD22 HD22 ' B' 1070 ' ' LEU . 33.8 mt -56.7 -38.9 72.93 Favored 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 123.003 0.521 . . . . 23.68 110.663 176.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1332 ' ' VAL . . . . . 0.489 HG23 ' O ' ' B' 1328 ' ' GLY . 71.0 t -54.3 -53.76 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 CA-C-N 120.157 1.344 . . . . 26.57 111.897 171.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -61.9 -44.24 97.2 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 122.37 1.081 . . . . 28.08 111.387 -177.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1334 ' ' LEU . . . . . . . . . . . . . 5.0 tt -53.92 -47.84 70.78 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 123.745 1.735 . . . . 27.43 113.016 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1335 ' ' LEU . . . . . 0.526 HD11 HD21 ' B' 1070 ' ' LEU . 39.1 mt -78.9 -15.29 58.52 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 119.844 -1.785 . . . . 30.5 109.606 -177.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1336 ' ' LYS . . . . . 0.724 ' HG2' HD21 ' B' 1029 ' ' LEU . 89.7 mttt -72.08 -36.68 69.6 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-N 119.583 1.083 . . . . 41.65 109.771 167.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1337 ' ' LEU . . . . . 0.592 HD22 HD21 ' B' 1127 ' ' LEU . 10.4 mp -67.33 -34.12 76.68 Favored 'General case' 0 N--CA 1.434 -1.251 0 O-C-N 120.086 -1.634 . . . . 42.08 113.749 169.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1338 ' ' LEU . . . . . 0.605 ' HB3' HG23 ' B' 1346 ' ' ILE . 85.6 mt -81.78 -43.71 17.98 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 118.878 -2.389 . . . . 35.03 113.774 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 41.5 t -105.23 60.3 0.68 Allowed 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 105.462 -2.051 . . . . 37.33 105.462 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 56.7 mttp -57.83 -21.15 40.88 Favored 'General case' 0 N--CA 1.432 -1.339 0 O-C-N 118.964 -2.335 . . . . 50.51 115.906 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -85.52 -5.42 59.29 Favored 'General case' 0 C--O 1.249 1.053 0 N-CA-C 114.856 1.428 . . . . 54.21 114.856 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1342 ' ' LYS . . . . . 0.534 ' HG2' HD23 ' B' 1029 ' ' LEU . 45.7 mttp 56.85 56.57 5.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 123.826 1.774 . . . . 50.99 111.16 -176.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -133.04 -1.97 3.25 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 113.344 -1.753 . . . . 48.82 113.809 -168.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 88.95 -30.72 5.32 Favored Glycine 0 CA--C 1.541 1.657 0 N-CA-C 117.509 1.764 . . . . 40.43 117.509 -170.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -86.4 124.22 32.5 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 117.839 -1.545 . . . . 47.56 110.369 -171.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1346 ' ' ILE . . . . . 0.605 HG23 ' HB3' ' B' 1338 ' ' LEU . 39.4 mm -80.51 117.11 25.86 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.416 0 N-CA-C 107.12 -1.437 . . . . 42.49 107.12 -177.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1347 ' ' THR . . . . . . . . . . . . . 35.6 m -82.73 106.44 14.58 Favored 'General case' 0 C--N 1.352 0.708 0 CA-C-O 123.748 1.737 . . . . 38.12 108.935 164.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 18.8 t -84.0 93.14 3.14 Favored 'Isoleucine or valine' 0 C--O 1.257 1.457 0 N-CA-C 107.259 -1.386 . . . . 37.5 107.259 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 4.4 t70 -68.86 167.09 16.33 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.179 -1.373 . . . . 43.85 109.296 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1350 ' ' PHE . . . . . . . . . . . . . 13.5 t80 -131.61 -42.32 1.04 Allowed 'General case' 0 C--N 1.314 -0.945 0 O-C-N 121.023 -1.048 . . . . 39.81 110.391 169.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -64.51 -39.86 94.57 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 114.607 1.336 . . . . 51.29 114.607 -174.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 34.4 t70 -62.42 112.95 2.66 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 121.523 -0.736 . . . . 39.78 111.991 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 27.0 m -47.99 -37.88 6.97 Favored 'Isoleucine or valine' 0 C--N 1.35 0.628 0 N-CA-C 114.101 1.149 . . . . 39.28 114.101 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1354 ' ' VAL . . . . . 0.499 HG13 ' HB2' ' B' 1124 ' ' ALA . 99.5 t -67.79 -53.96 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 O-C-N 120.311 -1.493 . . . . 35.7 111.392 -178.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1355 ' ' ILE . . . . . . . . . . . . . 25.0 mm -56.11 -51.79 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 114.153 1.168 . . . . 35.77 114.153 174.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 43.0 tpt85 -55.43 -31.47 61.92 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 115.725 1.75 . . . . 38.55 115.725 176.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1357 ' ' GLY . . . . . 0.451 ' HA2' ' HB1' ' B' 1370 ' ' ALA . . . -68.96 -58.84 6.39 Favored Glycine 0 C--N 1.341 0.857 0 C-N-CA 125.855 1.693 . . . . 29.58 109.934 172.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1358 ' ' VAL . . . . . 0.426 HG22 ' HB3' ' B' 1113 ' ' MET . 13.0 p -71.65 -36.67 60.32 Favored 'Isoleucine or valine' 0 C--O 1.249 1.072 0 O-C-N 120.763 -1.433 . . . . 32.06 112.152 -171.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1359 ' ' THR . . . . . 0.42 HG23 ' HE3' ' B' 1113 ' ' MET . 54.1 m -78.29 93.22 4.61 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 103.575 -2.75 . . . . 29.0 103.575 -176.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1360 ' ' VAL . . . . . . . . . . . . . 18.6 m -80.17 -27.88 12.08 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 CA-C-N 111.467 -2.606 . . . . 29.68 110.394 -175.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 97.7 mt -128.31 106.64 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.644 -1.243 . . . . 32.05 107.644 172.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1362 ' ' ARG . . . . . . . . . . . . . 46.1 ttt85 -83.08 90.45 7.05 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 105.643 -1.984 . . . . 32.52 105.643 172.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1363 ' ' ALA . . . . . 0.431 ' H ' ' HA ' ' B' 1111 ' ' THR . . . 47.35 71.66 0.31 Allowed 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 123.809 1.766 . . . . 35.68 112.786 170.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 85.85 -41.41 3.07 Favored Glycine 0 C--N 1.344 1.026 0 N-CA-C 116.311 1.284 . . . . 34.26 116.311 -173.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -78.87 112.24 15.84 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 106.508 -1.664 . . . . 51.07 106.508 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 65.5 mt -67.98 93.71 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 O-C-N 120.152 -1.593 . . . . 39.87 108.167 176.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1367 ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.02 -4.13 54.12 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 126.063 1.745 . . . . 38.01 113.247 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1368 ' ' TRP . . . . . . . . . . . . . 49.3 t90 -86.52 134.3 38.24 Favored Pre-proline 0 C--O 1.242 0.671 0 N-CA-C 103.248 -2.871 . . . . 42.14 103.248 168.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -64.6 140.89 43.49 Favored 'Cis proline' 0 N--CA 1.489 1.243 0 N-CA-C 121.457 3.599 . . . . 43.26 121.457 9.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1370 ' ' ALA . . . . . 0.451 ' HB1' ' HA2' ' B' 1357 ' ' GLY . . . -87.57 160.97 46.57 Favored Pre-proline 0 C--N 1.307 -1.261 0 CA-C-N 113.527 -1.67 . . . . 46.52 107.243 -174.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -56.25 153.28 34.26 Favored 'Trans proline' 0 C--O 1.245 0.866 0 C-N-CA 125.212 3.941 . . . . 51.95 111.838 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -63.9 114.13 2.47 Favored 'Trans proline' 0 C--O 1.251 1.146 0 C-N-CA 122.804 2.336 . . . . 56.27 114.544 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1373 ' ' ILE . . . . . 0.414 HG21 ' H ' ' B' 1120 ' ' ARG . 37.2 mm -93.81 129.85 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 114.588 -1.187 . . . . 60.83 108.558 -171.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -70.03 121.57 17.69 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-O 123.642 1.687 . . . . 66.1 109.035 166.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 59.7 t -109.96 127.25 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 113.827 -1.533 . . . . 63.47 108.545 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.226 -4.764 0 CA-C-N 120.254 1.388 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.209 -1.044 0 CA-C-O 118.445 -0.788 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -47.53 -36.86 11.05 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 123.769 1.747 . . . . 0.0 113.915 168.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 35.4 mp0 -56.14 -42.0 76.27 Favored 'General case' 0 C--O 1.249 1.075 0 C-N-CA 126.308 1.843 . . . . 0.0 108.904 176.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 14.6 m -66.05 -32.62 74.2 Favored 'General case' 0 C--O 1.24 0.583 0 O-C-N 120.026 -1.671 . . . . 0.0 111.122 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 24' ' ' ALA . . . . . 0.498 ' HB1' ' HA ' ' C' ' 186' ' ' LEU . . . -64.31 -46.81 81.92 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 121.438 1.926 . . . . 0.0 111.249 175.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 25' ' ' GLU . . . . . 0.442 ' HA ' ' HE2' ' C' ' 28' ' ' LYS . 24.2 mm-40 -57.38 -35.17 69.65 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 126.356 2.285 . . . . 0.0 113.62 174.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 14.6 tp -68.12 -60.81 2.2 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.31 -1.314 . . . . 0.0 111.219 177.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 7.9 mt -48.4 -43.46 33.98 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 115.931 -1.985 . . . . 0.0 113.746 -169.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 28' ' ' LYS . . . . . 0.442 ' HE2' ' HA ' ' C' ' 25' ' ' GLU . 34.4 pttt -58.05 -30.48 66.21 Favored 'General case' 0 C--O 1.244 0.783 0 O-C-N 125.076 1.485 . . . . 0.0 114.813 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -93.12 -23.76 18.5 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 174.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 53.2 m -57.85 -16.91 13.26 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 120.201 3.408 . . . . 0.0 120.201 -168.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . 0.45 1.3 p-80 53.9 -55.4 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 117.373 2.36 . . . . 0.0 117.373 -174.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 32' ' ' SER . . . . . 0.564 ' HB2' ' HA ' ' C' ' 106' ' ' THR . 68.0 m -108.53 133.88 52.06 Favored 'General case' 0 CA--C 1.476 -1.902 0 O-C-N 118.419 -2.676 . . . . 0.0 110.426 167.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' C' ' 64' ' ' VAL . 42.6 t -134.38 115.01 19.46 Favored 'Isoleucine or valine' 0 C--N 1.355 0.833 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 174.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 42.5 mt -106.22 100.76 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . 0.643 ' O ' ' HD3' ' C' ' 37' ' ' PRO . 84.4 mt -81.59 108.36 14.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 103.719 -2.697 . . . . 0.0 103.719 -177.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 89.2 m -103.56 95.31 7.1 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -171.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . 0.643 ' HD3' ' O ' ' C' ' 35' ' ' ILE . 37.6 Cg_exo -63.29 114.1 2.35 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.091 2.528 . . . . 0.0 113.21 176.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.85 -166.44 33.16 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 158.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 39' ' ' TYR . . . . . 0.61 ' HB3' ' HB2' ' C' ' 114' ' ' ALA . 41.0 t80 -50.08 -21.18 1.17 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 175.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 40' ' ' GLY . . . . . 0.569 ' HA3' ' HA3' ' C' ' 113' ' ' GLY . . . -60.24 -38.46 94.57 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-N 121.154 1.797 . . . . 0.0 111.365 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 41' ' ' MET . . . . . 0.614 ' SD ' HD11 ' C' ' 83' ' ' LEU . 26.4 ttm -74.98 -6.73 50.89 Favored 'General case' 0 C--O 1.248 1.018 0 O-C-N 121.271 -1.135 . . . . 0.0 113.887 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.78 -52.26 3.5 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 121.147 1.794 . . . . 0.0 109.16 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.09 -45.57 90.14 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.557 0 O-C-N 123.734 0.646 . . . . 0.0 110.691 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . 0.491 ' HB1' ' HB2' ' C' ' 176' ' ' LYS . . . -95.23 144.62 25.67 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 174.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.7 55.58 0.52 Allowed 'General case' 0 CA--C 1.552 1.022 0 CA-C-O 123.118 1.437 . . . . 0.0 112.475 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' C' ' 41' ' ' MET . . . -75.26 -16.13 60.47 Favored 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 120.617 -1.302 . . . . 0.0 111.047 -171.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . 0.549 ' HB2' ' HB2' ' C' ' 86' ' ' ALA . 0.0 OUTLIER -69.97 -38.04 75.95 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 117.68 2.474 . . . . 0.0 117.68 177.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 48' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -62.22 -36.66 30.33 Favored Pre-proline 0 CA--C 1.517 -0.308 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -175.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 49' ' ' PRO . . . . . 0.586 ' O ' HD11 ' C' ' 183' ' ' LEU . 98.0 Cg_endo -75.19 -28.98 8.4 Favored 'Trans proline' 0 C--N 1.318 -1.026 0 C-N-CA 122.34 2.026 . . . . 0.0 115.223 164.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.93 -35.54 61.4 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 O-C-N 118.38 -2.7 . . . . 0.0 115.318 -170.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.17 -27.12 67.76 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.45 -30.49 66.09 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.2 176.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 53' ' ' ILE . . . . . 0.607 ' HB ' HD12 ' C' ' 183' ' ' LEU . 10.9 tp -76.76 -41.5 33.19 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 O-C-N 120.056 -1.653 . . . . 0.0 107.664 170.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 27.5 m -53.77 -27.26 27.79 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 121.256 1.844 . . . . 0.0 113.662 172.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -57.32 -57.18 13.74 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 121.014 -1.053 . . . . 0.0 108.963 172.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -74.89 -27.87 60.41 Favored 'General case' 0 C--O 1.253 1.266 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 57' ' ' LEU . . . . . 0.422 ' HA ' HD12 ' C' ' 62' ' ' ILE . 95.9 mt -66.16 -47.68 73.23 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . 0.462 ' HD2' ' HA ' ' C' ' 58' ' ' ARG . 1.8 tpt180 -66.5 -44.22 83.16 Favored 'General case' 0 C--N 1.359 0.988 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.583 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.72 -30.18 55.39 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 171.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . 0.409 ' HD3' HH11 ' C' ' 60' ' ' ARG . 3.9 ttm180 -89.83 8.14 33.51 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 175.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.97 36.75 91.46 Favored Glycine 0 N--CA 1.432 -1.589 0 O-C-N 119.896 -1.753 . . . . 0.0 110.418 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' C' ' 57' ' ' LEU . 64.1 mt -94.66 126.61 47.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -62.99 91.5 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.326 171.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 7.1 p -107.71 129.68 61.32 Favored 'Isoleucine or valine' 0 C--O 1.258 1.522 0 C-N-CA 119.629 -0.828 . . . . 0.0 108.811 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 23.1 mmm-85 -127.01 156.35 41.77 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 175.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . 0.559 ' HB2' ' HA ' ' C' ' 93' ' ' VAL . 33.5 m-85 -117.71 105.4 11.97 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-O 122.65 1.215 . . . . 0.0 108.434 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.92 80.14 1.85 Allowed Glycine 0 C--O 1.24 0.477 0 CA-C-O 117.347 -1.807 . . . . 0.0 109.593 -174.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 68' ' ' ILE . . . . . 0.577 HD13 HG13 ' C' ' 93' ' ' VAL . 1.8 mp -72.06 126.25 32.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 121.447 2.624 . . . . 0.0 109.639 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -94.67 126.43 47.54 Favored Pre-proline 0 N--CA 1.437 -1.082 0 C-N-CA 117.626 -1.63 . . . . 0.0 108.728 -177.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 70' ' ' PRO . . . . . 0.439 ' O ' ' HA ' ' C' ' 76' ' ' PRO . 28.3 Cg_endo -57.92 -62.74 0.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.967 2.444 . . . . 0.0 112.806 175.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 71' ' ' VAL . . . . . 0.408 ' O ' HG23 ' C' ' 117' ' ' THR . 42.4 t -64.01 92.33 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.211 -0.927 0 CA-C-O 123.252 1.501 . . . . 0.0 107.096 166.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 72' ' ' ALA . . . . . 0.406 ' HB2' ' HA2' ' C' ' 77' ' ' GLY . . . -84.19 -32.79 24.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 113.451 -1.704 . . . . 0.0 114.134 -174.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 129.97 -51.23 0.86 Allowed Glycine 0 CA--C 1.504 -0.63 0 CA-C-N 113.302 -1.772 . . . . 0.0 109.26 -171.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . 0.506 ' HD3' ' CZ ' ' C' ' 39' ' ' TYR . 2.4 mpt_? -130.86 129.2 42.0 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 101.625 -3.472 . . . . 0.0 101.625 163.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.469 HD11 ' SD ' ' B' 1207 ' ' MET . 1.9 mp 68.59 153.38 0.14 Allowed Pre-proline 0 N--CA 1.441 -0.892 0 C-N-CA 127.034 2.133 . . . . 0.0 115.8 177.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 76' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' C' ' 70' ' ' PRO . 14.9 Cg_endo -57.46 88.31 0.05 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 123.689 2.926 . . . . 0.0 110.659 158.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 77' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' C' ' 72' ' ' ALA . . . 46.17 48.47 15.11 Favored Glycine 0 C--O 1.216 -1.001 0 N-CA-C 118.139 2.016 . . . . 0.0 118.139 175.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -49.91 -24.19 2.37 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 122.032 2.916 . . . . 0.0 116.346 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -63.81 -25.89 68.38 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -69.14 -22.52 63.94 Favored 'General case' 0 CA--C 1.561 1.369 0 O-C-N 124.102 0.876 . . . . 0.0 111.751 -176.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 40.7 t -66.13 -52.97 42.09 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 169.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.462 ' HB3' ' HG2' ' C' ' 47' ' ' GLN . 6.9 mp -57.64 -30.32 65.29 Favored 'General case' 0 CA--C 1.512 -0.499 0 O-C-N 119.944 -1.723 . . . . 0.0 114.319 178.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.614 HD11 ' SD ' ' C' ' 41' ' ' MET . 5.3 mp -64.46 -22.22 66.9 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 117.836 -1.078 . . . . 0.0 113.063 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.99 -34.89 76.02 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 120.338 1.426 . . . . 0.0 113.178 173.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -69.07 -42.3 76.4 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 172.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . 0.549 ' HB2' ' HB2' ' C' ' 47' ' ' GLN . . . -66.37 -21.69 66.24 Favored 'General case' 0 C--O 1.213 -0.833 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 177.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp 70.73 45.49 0.57 Allowed 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 128.165 2.586 . . . . 0.0 108.436 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 45.6 t -81.58 130.8 60.1 Favored Pre-proline 0 C--N 1.351 0.672 0 CA-C-O 117.664 -1.16 . . . . 0.0 108.259 174.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -61.81 115.4 2.78 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 124.025 3.15 . . . . 0.0 114.143 176.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 90' ' ' TYR . . . . . 0.582 ' HA ' ' HB ' ' C' ' 93' ' ' VAL . 35.4 m-85 -60.76 -13.09 12.92 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-N 114.765 -1.107 . . . . 0.0 113.481 -177.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -59.16 -51.73 68.76 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 166.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 26.3 pt -82.64 -15.71 11.77 Favored 'Isoleucine or valine' 0 C--O 1.249 1.047 0 CA-C-N 119.169 0.895 . . . . 0.0 110.447 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . 0.582 ' HB ' ' HA ' ' C' ' 90' ' ' TYR . 73.5 t -75.59 99.99 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 123.026 1.394 . . . . 0.0 109.453 175.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' C' ' 97' ' ' ASP . 53.0 mt -103.7 100.44 10.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 113.707 -1.588 . . . . 0.0 112.621 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 95' ' ' GLU . . . . . 0.708 ' HB3' HD13 ' A' 1157 ' ' ILE . 40.9 mp0 -81.06 91.8 6.15 Favored 'General case' 0 C--O 1.267 1.989 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 -178.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.643 ' SD ' ' HB2' ' C' ' 134' ' ' PRO . 31.8 ttp 47.94 73.47 0.21 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 123.892 1.806 . . . . 0.0 115.606 -171.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 97' ' ' ASP . . . . . 0.496 ' HB2' ' HB3' ' C' ' 94' ' ' LEU . 4.2 t70 -91.74 144.42 25.52 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 168.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -92.82 51.9 1.77 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 123.844 1.783 . . . . 0.0 112.247 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 99' ' ' ILE . . . . . 0.557 HG12 ' HB2' ' C' ' 102' ' ' ASP 0.286 10.2 tt -87.22 70.0 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-O 126.978 3.275 . . . . 0.0 108.852 -166.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -54.73 -52.49 62.33 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 108.834 -3.803 . . . . 0.0 114.935 -174.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -62.49 -42.98 99.86 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 118.368 -0.825 . . . . 0.0 112.861 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 102' ' ' ASP . . . . . 0.557 ' HB2' HG12 ' C' ' 99' ' ' ILE . 0.5 OUTLIER -68.54 -39.32 81.18 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-N 119.974 1.261 . . . . 0.0 108.785 -174.257 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 103' ' ' PHE . . . . . 0.458 ' HB3' ' HB2' ' C' ' 137' ' ' GLU . 4.6 m-85 -55.34 -52.5 63.29 Favored 'General case' 0 C--O 1.251 1.173 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 168.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.85 -26.02 67.06 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -75.62 -39.53 57.73 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 106' ' ' THR . . . . . 0.564 ' HA ' ' HB2' ' C' ' 32' ' ' SER . 96.0 m -61.34 141.52 57.53 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 -162.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 107' ' ' ASP . . . . . 0.87 ' HA ' ' HB2' ' C' ' 142' ' ' GLN . 9.9 t0 -71.53 -87.8 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 124.019 0.928 . . . . 0.0 108.714 161.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' C' ' 143' ' ' ASN . 0.3 OUTLIER -89.09 112.35 23.31 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 122.448 1.118 . . . . 0.0 112.395 -165.362 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 109' ' ' VAL . . . . . 0.682 HG11 HG23 ' C' ' 138' ' ' VAL . 4.4 t -102.92 104.2 16.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 174.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 110' ' ' LEU . . . . . 0.589 HD12 HG12 ' C' ' 35' ' ' ILE . 95.9 mt -88.3 90.6 8.46 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.521 -172.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 28.2 t -81.19 104.84 10.33 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 CA-C-O 124.338 2.018 . . . . 0.0 107.771 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 112' ' ' ILE . . . . . 0.421 ' HB ' ' HA ' ' C' ' 37' ' ' PRO . 45.1 mm -78.24 97.79 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 CA-C-O 122.635 1.207 . . . . 0.0 108.45 -171.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 113' ' ' GLY . . . . . 0.569 ' HA3' ' HA3' ' C' ' 40' ' ' GLY . . . 85.21 -70.45 3.1 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-N 111.275 -2.693 . . . . 0.0 113.738 165.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 114' ' ' ALA . . . . . 0.61 ' HB2' ' HB3' ' C' ' 39' ' ' TYR . . . -87.57 121.84 30.51 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 120.775 -1.427 . . . . 0.0 112.441 -163.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 115' ' ' ASN . . . . . 0.481 ' HB2' ' HE1' ' C' ' 163' ' ' PHE . 10.2 p-10 -85.09 -55.1 4.22 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 118.156 -0.926 . . . . 0.0 113.192 -173.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 116' ' ' ASP . . . . . 0.64 ' HB2' H51N ' C' 1001 ' ' NAP . 0.9 OUTLIER -54.19 -38.89 66.12 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 121.298 1.863 . . . . 0.0 109.915 -175.084 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 117' ' ' THR . . . . . 0.408 HG23 ' O ' ' C' ' 71' ' ' VAL . 67.6 m -33.61 -36.31 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 118.751 2.871 . . . . 0.0 118.751 166.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.46 ' HB ' HG11 ' C' ' 138' ' ' VAL . 26.7 m -119.58 2.53 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-O 117.646 -1.168 . . . . 0.0 110.459 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 119' ' ' ASN . . . . . 0.551 HD21 ' HB3' ' C' ' 121' ' ' ALA . 23.1 t30 -52.09 117.77 10.81 Favored Pre-proline 0 C--O 1.257 1.454 0 CA-C-N 122.472 2.396 . . . . 0.0 115.708 -164.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 120' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' C' ' 119' ' ' ASN . 0.8 OUTLIER -45.1 -59.92 1.0 Allowed 'Trans proline' 0 C--N 1.363 1.339 1 C-N-CA 127.954 5.77 . . . . 0.0 110.706 174.293 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' C' C ' 121' ' ' ALA . . . . . 0.551 ' HB3' HD21 ' C' ' 119' ' ' ASN . . . -48.28 -38.75 19.56 Favored 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 176.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.92 -16.54 63.42 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 118.618 -1.233 . . . . 0.0 114.256 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 123' ' ' GLN . . . . . 0.602 ' HG2' HG23 ' C' ' 135' ' ' VAL . 0.0 OUTLIER -101.25 -41.68 6.61 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 117.359 -1.736 . . . . 0.0 110.892 165.692 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.68 -60.95 2.98 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 126.297 1.839 . . . . 0.0 114.27 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -82.09 117.04 66.92 Favored Pre-proline 0 C--O 1.246 0.918 0 O-C-N 124.851 1.345 . . . . 0.0 111.222 173.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -67.52 -26.53 40.19 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.732 3.621 . . . . 0.0 112.157 176.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . 0.49 ' HB3' ' HZ3' ' C' ' 127' ' ' LYS . 6.0 ttpm? -64.96 -28.34 69.45 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 122.445 1.117 . . . . 0.0 113.934 -175.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 128' ' ' SER . . . . . 0.423 ' HA ' ' HD2' ' C' ' 129' ' ' PRO . 70.3 m -32.9 116.66 0.42 Allowed Pre-proline 0 C--N 1.357 0.92 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 166.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 129' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' C' ' 128' ' ' SER . 16.1 Cg_endo -50.03 -48.84 18.03 Favored 'Trans proline' 0 C--O 1.241 0.67 0 C-N-CA 124.042 3.162 . . . . 0.0 111.58 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 130' ' ' ILE . . . . . 0.474 HG21 ' O3D' ' C' 1001 ' ' NAP . 13.1 pt -73.97 84.07 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 O-C-N 119.732 -1.855 . . . . 0.0 108.669 168.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 131' ' ' ALA . . . . . 0.411 ' O ' ' HB ' ' B' 1121 ' ' ILE . . . -75.93 119.17 19.54 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -172.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 73.76 78.36 0.57 Allowed Glycine 0 N--CA 1.48 1.57 0 CA-C-N 114.715 -1.13 . . . . 0.0 113.113 177.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 133' ' ' MET . . . . . 0.417 ' SD ' ' HD2' ' C' ' 134' ' ' PRO . 41.6 tpp -76.01 124.06 88.32 Favored Pre-proline 0 C--N 1.313 -0.999 0 O-C-N 118.965 -2.491 . . . . 0.0 109.638 171.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 134' ' ' PRO . . . . . 0.643 ' HB2' ' SD ' ' C' ' 96' ' ' MET . 49.2 Cg_endo -70.62 85.52 0.74 Allowed 'Trans proline' 0 CA--C 1.5 -1.188 0 C-N-CA 123.562 2.841 . . . . 0.0 113.734 176.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 135' ' ' VAL . . . . . 0.602 HG23 ' HG2' ' C' ' 123' ' ' GLN . 0.5 OUTLIER -134.93 137.54 50.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 124.889 2.28 . . . . 0.0 111.233 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -105.17 137.59 42.7 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 111.839 -2.437 . . . . 0.0 107.134 167.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 137' ' ' GLU . . . . . 0.458 ' HB2' ' HB3' ' C' ' 103' ' ' PHE 0.258 6.3 mm-40 23.23 40.68 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.964 1 N-CA-C 122.531 4.271 . . . . 0.0 122.531 166.429 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' C' C ' 138' ' ' VAL . . . . . 0.682 HG23 HG11 ' C' ' 109' ' ' VAL . 13.7 p -88.01 48.35 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 126.228 2.918 . . . . 0.0 109.386 174.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -159.0 148.54 18.92 Favored 'General case' 0 C--O 1.256 1.434 0 CA-C-N 111.185 -2.734 . . . . 0.0 104.597 -172.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 140' ' ' LYS . . . . . . . . . . . . 0.356 23.6 pttm 65.63 -26.57 0.1 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 118.017 2.599 . . . . 0.0 118.017 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -45.4 146.71 0.93 Allowed 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 125.665 1.586 . . . . 0.0 113.614 161.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.87 ' HB2' ' HA ' ' C' ' 107' ' ' ASP . 21.0 mt-30 -58.62 -28.88 66.05 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 120.136 3.384 . . . . 0.0 120.136 -151.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 143' ' ' ASN . . . . . 0.511 ' O ' ' HA ' ' C' ' 108' ' ' THR . 2.5 t-20 -153.57 87.51 1.24 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 172.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 144' ' ' VAL . . . . . 0.684 ' HB ' ' HA ' ' C' ' 168' ' ' THR . 37.4 t -81.24 89.76 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.146 0 O-C-N 119.803 -1.811 . . . . 0.0 107.358 177.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 145' ' ' ILE . . . . . . . . . . . . . 21.7 mt -92.28 104.63 15.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 125.545 2.593 . . . . 0.0 107.977 -173.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 146' ' ' VAL . . . . . 0.652 ' HB ' ' HA ' ' C' ' 170' ' ' MET . 10.0 t -86.25 102.7 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 CA-C-N 111.38 -2.645 . . . . 0.0 107.552 176.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 147' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -64.34 94.48 0.11 Allowed 'General case' 0 C--O 1.242 0.7 0 CA-C-O 122.372 1.082 . . . . 0.0 112.105 177.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 148' ' ' LYS . . . . . 0.642 ' O ' ' HA ' ' C' ' 172' ' ' PHE . 20.9 mmmt -128.22 111.59 13.59 Favored 'General case' 0 CA--C 1.485 -1.541 0 C-N-CA 123.98 0.912 . . . . 0.0 109.352 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 10.7 ptp85 -54.0 -31.96 52.59 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 174.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 19.4 m -153.0 155.47 36.98 Favored 'General case' 0 C--O 1.249 1.067 0 O-C-N 118.682 -2.511 . . . . 0.0 106.185 -170.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 151' ' ' MET . . . . . 0.608 ' SD ' ' SD ' ' C' ' 170' ' ' MET . 6.8 tpt -88.03 67.17 8.87 Favored 'General case' 0 C--O 1.254 1.329 0 CA-C-O 125.865 2.745 . . . . 0.0 108.074 177.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -94.93 117.32 29.93 Favored 'General case' 0 N--CA 1.44 -0.958 0 O-C-N 119.636 -1.915 . . . . 0.0 106.109 170.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 7.4 m -64.18 138.99 58.72 Favored 'General case' 0 C--O 1.249 1.074 0 CA-C-N 113.286 -1.779 . . . . 0.0 107.696 171.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 154' ' ' GLY . . . . . 0.416 ' HA3' H52A ' C' 1001 ' ' NAP . . . -86.85 -53.42 2.87 Favored Glycine 0 C--O 1.214 -1.105 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -132.17 -78.3 0.5 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 118.002 0.901 . . . . 0.0 108.901 164.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 156' ' ' ALA . . . . . . . . . . . . . . . -86.71 -61.44 1.73 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -170.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.81 28.85 5.69 Favored Glycine 0 C--N 1.353 1.475 0 C-N-CA 127.387 2.422 . . . . 0.0 114.654 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 6.1 m -54.76 138.97 14.26 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 N-CA-C 119.414 3.116 . . . . 0.0 119.414 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . 0.263 0.0 OUTLIER 6.76 92.53 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.974 1 N-CA-C 122.811 4.375 . . . . 0.0 122.811 173.663 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' C' C ' 160' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -150.1 152.16 33.25 Favored Pre-proline 0 N--CA 1.469 0.493 0 CA-C-O 117.602 -1.19 . . . . 0.0 112.952 -174.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.76 -27.85 37.41 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 124.551 3.501 . . . . 0.0 114.025 167.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 162' ' ' LEU . . . . . 0.583 ' HA ' HG22 ' C' ' 168' ' ' THR . 16.3 tp -43.8 -31.5 0.84 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 119.415 3.117 . . . . 0.0 119.415 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 163' ' ' PHE . . . . . 0.532 ' HA ' ' HG3' ' C' ' 170' ' ' MET . 14.0 m-30 -85.7 -60.62 1.97 Allowed 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 124.611 2.148 . . . . 0.0 109.749 171.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -82.8 -7.43 59.66 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-N 111.752 -2.476 . . . . 0.0 113.97 -158.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -91.71 177.16 6.28 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 122.0 0.905 . . . . 0.0 110.611 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.77 -51.98 4.66 Favored 'General case' 0 C--O 1.254 1.316 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -174.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 167' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' C' ' 142' ' ' GLN . 20.7 p-10 -78.88 -45.55 20.44 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 120.552 -1.342 . . . . 0.0 111.344 177.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 168' ' ' THR . . . . . 0.684 ' HA ' ' HB ' ' C' ' 144' ' ' VAL . 3.0 m -89.75 95.15 10.12 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 101.495 -3.52 . . . . 0.0 101.495 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -150.26 132.3 15.27 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 123.662 1.696 . . . . 0.0 112.302 -162.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 170' ' ' MET . . . . . 0.652 ' HA ' ' HB ' ' C' ' 146' ' ' VAL . 33.7 mtm -64.88 110.78 2.55 Favored 'General case' 0 C--O 1.253 1.288 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 165.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 171' ' ' LEU . . . . . . . . . . . . . 15.2 tp -91.16 124.01 35.05 Favored 'General case' 0 C--O 1.256 1.401 0 N-CA-C 103.545 -2.761 . . . . 0.0 103.545 172.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 172' ' ' PHE . . . . . 0.642 ' HA ' ' O ' ' C' ' 148' ' ' LYS . 3.6 m-85 -70.76 82.74 0.63 Allowed 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 111.774 -2.466 . . . . 0.0 115.317 -175.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -157.97 147.5 15.52 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 106.611 -2.595 . . . . 0.0 106.611 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 174' ' ' ASP . . . . . 0.641 ' HB3' ' HB3' ' C' ' 177' ' ' ALA . 14.1 t70 -63.69 147.69 50.99 Favored 'General case' 0 N--CA 1.431 -1.378 0 O-C-N 121.706 -0.879 . . . . 0.0 112.609 172.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -52.24 -60.22 3.47 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 176' ' ' LYS . . . . . 0.491 ' HB2' ' HB1' ' C' ' 44' ' ' ALA . 0.0 OUTLIER -69.01 -48.8 62.14 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 -171.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 177' ' ' ALA . . . . . 0.641 ' HB3' ' HB3' ' C' ' 174' ' ' ASP . . . -55.25 -50.55 69.18 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 127.03 2.706 . . . . 0.0 109.978 -176.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 44.2 m -68.26 -32.87 73.35 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.941 -1.1 . . . . 0.0 110.697 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 179' ' ' VAL . . . . . . . . . . . . . 86.9 t -62.87 -45.51 98.68 Favored 'Isoleucine or valine' 0 C--N 1.343 0.287 0 CA-C-N 119.642 1.11 . . . . 0.0 108.421 176.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -68.06 -28.9 67.77 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 119.966 -1.709 . . . . 0.0 111.471 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -64.99 -56.27 14.12 Favored 'General case' 0 C--N 1.348 0.536 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 182' ' ' ILE . . . . . 0.432 ' HA ' ' HB2' ' C' ' 24' ' ' ALA . 23.8 pt -64.29 -33.47 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 183' ' ' LEU . . . . . 0.607 HD12 ' HB ' ' C' ' 53' ' ' ILE . 5.9 tp -32.02 -50.62 0.22 Allowed 'General case' 0 C--O 1.248 1.012 0 C-N-CA 128.934 2.894 . . . . 0.0 118.565 -171.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -123.79 -7.11 7.92 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.633 169.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -62.39 -44.12 97.2 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -170.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 186' ' ' LEU . . . . . 0.498 ' HA ' ' HB1' ' C' ' 24' ' ' ALA 0.331 88.1 mt . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 121.588 3.922 . . . . 0.0 121.588 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' NAD . . . . . 0.423 ' H3B' ' O3 ' ' B' ' 1' ' ' NAD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C 1001 ' ' NAP . . . . . 0.64 H51N ' HB2' ' C' ' 116' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 9.8 t-80 . . . . . 0 N--CA 1.444 -0.738 0 N-CA-C 103.958 -2.608 . . . . 65.74 103.958 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -75.04 78.28 1.09 Allowed Glycine 0 C--O 1.256 1.487 0 CA-C-O 119.067 -0.852 . . . . 48.66 112.326 -174.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 24.2 ttp180 -86.81 131.98 33.97 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 120.045 1.922 . . . . 44.56 106.289 153.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1003 ' ' ILE . . . . . 0.522 ' HA ' ' O ' ' A' 1068 ' ' ILE . 39.9 mt -101.4 124.74 55.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 102.471 -3.159 . . . . 34.86 102.471 177.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1004 ' ' GLY . . . . . 0.663 ' O ' ' HD3' ' A' 1006 ' ' PRO . . . -88.1 129.25 9.47 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 107.486 -2.245 . . . . 30.75 107.486 165.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.746 HG23 ' HB3' ' A' 1017 ' ' ALA . 48.2 mm -98.63 99.55 7.77 Favored Pre-proline 0 C--O 1.249 1.027 0 N-CA-C 105.647 -1.982 . . . . 32.21 105.647 174.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1006 ' ' PRO . . . . . 0.663 ' HD3' ' O ' ' A' 1004 ' ' GLY . 99.5 Cg_exo -71.51 131.03 18.1 Favored 'Trans proline' 0 CA--C 1.499 -1.24 0 C-N-CA 123.779 2.986 . . . . 32.98 109.317 174.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1007 ' ' ARG . . . . . 0.481 ' HG2' HD12 ' A' 1042 ' ' LEU . 7.1 ttp85 -73.86 121.34 20.75 Favored 'General case' 0 C--O 1.255 1.347 0 CA-C-N 110.284 -3.144 . . . . 47.98 106.734 155.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1008 ' ' GLU . . . . . 0.428 ' CD ' ' HZ2' ' A' 1071 ' ' LYS . 6.4 tp10 -73.33 133.33 43.81 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 123.306 1.527 . . . . 34.7 112.956 -165.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -97.86 9.43 42.7 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 112.805 -1.998 . . . . 53.37 111.456 -174.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 17.7 tp -70.28 146.54 50.53 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 117.211 -1.796 . . . . 45.07 106.396 168.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1011 ' ' THR . . . . . . . . . . . . . 5.7 m -54.58 146.42 16.51 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-O 117.7 -1.143 . . . . 40.36 110.698 174.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 76.8 m-20 61.81 -10.67 0.07 Allowed 'General case' 0 C--O 1.258 1.508 0 N-CA-C 119.089 2.996 . . . . 40.61 119.089 -175.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1013 ' ' GLU . . . . . 0.544 ' HG3' ' H ' ' A' 1015 ' ' ARG . 8.6 tp10 -68.99 114.93 7.73 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 124.35 2.024 . . . . 33.76 113.838 -160.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1014 ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.56 -26.95 68.93 Favored 'General case' 0 N--CA 1.427 -1.597 1 CA-C-N 108.27 -4.059 . . . . 27.89 114.86 174.518 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 1015 ' ' ARG . . . . . 0.676 ' HB3' HG11 ' A' 1072 ' ' VAL . 57.8 mtm180 -79.81 151.32 30.35 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 126.65 3.119 . . . . 29.02 116.621 -171.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1016 ' ' VAL . . . . . . . . . . . . . 2.6 p -115.8 169.02 6.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 1 CA-C-N 107.745 -4.298 . . . . 28.13 106.655 160.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1017 ' ' ALA . . . . . 0.746 ' HB3' HG23 ' A' 1005 ' ' ILE . . . -60.98 -46.92 88.81 Favored 'General case' 0 C--O 1.217 -0.617 0 O-C-N 119.296 -2.128 . . . . 26.87 113.45 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -155.82 133.55 11.15 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 120.838 -1.164 . . . . 26.77 108.516 -175.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1019 ' ' THR . . . . . 0.471 HG21 HG23 ' A' 1321 ' ' THR . 0.6 OUTLIER -85.41 167.39 25.6 Favored Pre-proline 0 C--O 1.239 0.517 0 O-C-N 120.36 -1.462 . . . . 27.02 114.539 177.173 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 1020 ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -42.87 -53.57 3.87 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 124.667 3.578 . . . . 30.57 119.546 -174.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 9.5 tttp -58.28 -39.26 78.81 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 124.111 1.91 . . . . 47.81 112.853 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1022 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.57 -40.38 92.71 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 113.188 -1.824 . . . . 30.77 109.833 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1023 ' ' VAL . . . . . 0.518 HG13 HG11 ' A' 1033 ' ' VAL . 8.9 t -59.75 -42.61 89.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 118.953 -0.546 . . . . 33.59 110.475 176.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -49.32 -46.44 46.68 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 124.165 0.915 . . . . 53.29 112.05 172.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -68.04 -32.74 73.32 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.97 0.89 . . . . 46.92 111.383 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1026 ' ' LEU . . . . . 0.419 ' CD2' HG22 ' A' 1332 ' ' VAL . 99.0 mt -68.61 -41.53 79.41 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.166 -1.584 . . . . 37.17 112.434 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1027 ' ' LEU . . . . . 0.44 HD22 ' HA3' ' A' 1054 ' ' GLY . 36.0 tp -61.67 -50.69 71.47 Favored 'General case' 0 C--O 1.254 1.294 0 CA-C-N 111.928 -2.396 . . . . 44.44 107.039 173.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -48.79 -41.62 33.15 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 116.762 2.134 . . . . 52.58 116.762 171.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1029 ' ' LEU . . . . . . . . . . . . . 77.0 mt -71.78 -11.32 60.76 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 121.467 1.939 . . . . 45.69 110.21 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 110.84 33.28 2.45 Favored Glycine 0 C--O 1.244 0.756 0 CA-C-O 122.971 1.317 . . . . 42.09 111.641 166.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1031 ' ' PHE . . . . . 0.646 ' HZ ' ' SG ' ' A' 1339 ' ' CYS . 50.1 m-85 -117.19 155.14 29.9 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 118.584 -2.715 . . . . 40.72 109.785 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1032 ' ' THR . . . . . . . . . . . . . 40.1 m -86.62 114.93 23.74 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 104.225 -2.509 . . . . 37.77 104.225 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1033 ' ' VAL . . . . . 0.518 HG11 HG13 ' A' 1023 ' ' VAL . 19.3 t -88.77 125.78 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 105.837 -1.912 . . . . 33.54 105.837 -177.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -117.26 126.37 52.63 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 104.446 -2.428 . . . . 31.68 104.446 173.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1035 ' ' VAL . . . . . 0.541 ' HA ' ' HB ' ' A' 1005 ' ' ILE . 59.4 t -116.01 145.69 21.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 105.1 -2.185 . . . . 31.52 105.1 -177.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1036 ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -69.38 133.47 47.84 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 122.971 0.509 . . . . 41.04 111.915 174.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1037 ' ' SER . . . . . . . . . . . . . 54.4 m -54.89 123.33 13.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 123.926 1.822 . . . . 31.83 114.414 168.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 99.83 -8.14 59.5 Favored Glycine 0 N--CA 1.444 -0.806 0 O-C-N 119.035 -2.29 . . . . 29.36 112.159 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -64.53 -34.19 77.67 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 113.898 1.073 . . . . 27.78 113.898 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1040 ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' 1046 ' ' ASP . . . -59.76 -19.48 49.49 Favored Glycine 0 N--CA 1.427 -1.963 0 CA-C-N 112.14 -2.3 . . . . 28.91 114.648 175.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -76.24 -44.94 35.26 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 120.076 1.938 . . . . 51.18 110.646 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1042 ' ' LEU . . . . . 0.481 HD12 ' HG2' ' A' 1007 ' ' ARG . 20.6 mt -64.32 -50.01 69.5 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.949 0.881 . . . . 29.91 111.39 173.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1043 ' ' ALA . . . . . 0.411 ' HB3' ' HA2' ' A' 1040 ' ' GLY 0.267 . . -53.5 -22.65 8.46 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 112.807 -1.997 . . . . 28.54 114.477 172.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 1044 ' ' SER . . . . . . . . . . . . . 15.5 m 53.98 44.93 28.65 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 124.688 2.185 . . . . 33.06 110.281 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1045 ' ' PHE . . . . . 0.437 ' HA ' ' HB3' ' B' 1277 ' ' ALA . 0.1 OUTLIER -167.59 102.82 0.5 Allowed 'General case' 0 C--O 1.249 1.066 0 N-CA-C 100.292 -3.966 . . . . 30.29 100.292 178.105 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 1046 ' ' ASP . . . . . 0.5 ' HA ' ' HA3' ' A' 1040 ' ' GLY . 2.9 p-10 -84.51 168.85 15.05 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 123.479 1.609 . . . . 48.62 114.464 -151.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1047 ' ' ASP . . . . . 0.479 ' HA ' ' HD2' ' A' 1050 ' ' PHE . 2.8 m-20 -46.01 -45.85 16.16 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 112.499 -2.137 . . . . 36.74 115.609 -172.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 22.5 pttm -54.21 -40.71 67.88 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 115.191 1.552 . . . . 43.73 115.191 169.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -65.02 -31.52 72.8 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 119.752 1.16 . . . . 32.81 112.275 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1050 ' ' PHE . . . . . 0.479 ' HD2' ' HA ' ' A' 1047 ' ' ASP . 58.4 m-85 -64.01 -42.37 97.16 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 111.612 0.227 . . . . 31.86 111.612 169.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 41.3 t -61.68 -46.61 96.18 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 N-CA-C 106.774 -1.565 . . . . 33.22 106.774 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -55.15 -37.06 66.47 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 123.914 0.885 . . . . 50.83 112.521 174.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -62.56 -41.45 98.93 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 120.065 1.302 . . . . 33.12 112.578 172.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1054 ' ' GLY . . . . . 0.44 ' HA3' HD22 ' A' 1027 ' ' LEU . . . 120.31 81.36 0.67 Allowed Glycine 0 C--O 1.21 -1.399 0 N-CA-C 106.039 -2.824 . . . . 35.83 106.039 -177.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -161.06 132.22 5.45 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 125.162 1.154 . . . . 34.82 109.204 -173.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -71.19 135.3 47.48 Favored 'General case' 0 N--CA 1.44 -0.945 0 O-C-N 126.727 2.517 . . . . 49.05 107.201 166.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1057 ' ' ILE . . . . . . . . . . . . . 36.1 mm -104.43 125.95 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 101.951 -3.351 . . . . 38.53 101.951 169.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1058 ' ' VAL . . . . . 0.556 ' HB ' ' HB ' ' A' 1063 ' ' VAL . 44.1 t -102.29 135.72 37.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 103.566 -2.753 . . . . 42.11 103.566 174.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -69.38 76.08 0.38 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 114.13 1.159 . . . . 58.0 114.13 178.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1060 ' ' GLY . . . . . 0.466 ' O ' HG12 ' A' 1063 ' ' VAL . . . 80.08 -129.83 9.38 Favored Glycine 0 N--CA 1.422 -2.253 0 C-N-CA 121.092 -0.575 . . . . 52.12 113.187 177.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 29.4 t30 -46.79 -40.14 13.13 Favored 'General case' 0 C--O 1.217 -0.612 0 N-CA-C 117.963 2.579 . . . . 54.75 117.963 -156.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1062 ' ' SER . . . . . . . . . . . . . 15.3 m -67.79 -9.36 43.58 Favored 'General case' 0 C--O 1.247 0.932 0 O-C-N 118.23 -2.794 . . . . 50.34 116.468 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1063 ' ' VAL . . . . . 0.556 ' HB ' ' HB ' ' A' 1058 ' ' VAL . 8.3 p -64.08 -26.57 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 O-C-N 120.763 -1.211 . . . . 41.46 111.444 169.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1064 ' ' TRP . . . . . . . . . . . . . 76.8 m95 -72.42 -23.01 61.02 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.941 1.296 . . . . 39.32 112.312 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -83.49 73.58 10.18 Favored 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 120.743 -1.223 . . . . 55.38 109.058 175.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1066 ' ' SER . . . . . . . . . . . . . 70.5 m -146.34 164.7 31.56 Favored 'General case' 0 C--O 1.257 1.468 0 CA-C-O 121.661 0.743 . . . . 41.87 109.983 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.11 -66.84 0.63 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.04 -0.982 . . . . 53.2 109.571 -176.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1068 ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' 1003 ' ' ILE . 31.4 mt -88.63 110.48 21.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 O-C-N 118.236 -2.79 . . . . 41.9 104.97 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1069 ' ' ILE . . . . . . . . . . . . . 28.1 mm -102.12 119.42 50.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 107.046 -1.465 . . . . 38.73 107.046 168.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1070 ' ' LEU . . . . . 0.681 ' HB3' HD13 ' A' 1331 ' ' LEU . 81.6 mt -88.02 74.83 8.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.736 -1.12 . . . . 32.44 110.126 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1071 ' ' LYS . . . . . 0.576 ' HE2' ' HA ' ' A' 1075 ' ' PRO . 5.1 mmmt -71.54 128.65 36.53 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 121.98 0.895 . . . . 34.65 111.111 -176.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1072 ' ' VAL . . . . . 0.676 HG11 ' HB3' ' A' 1015 ' ' ARG . 0.8 OUTLIER -82.04 -30.7 10.08 Favored 'Isoleucine or valine' 0 C--O 1.251 1.17 0 N-CA-C 109.167 -0.679 . . . . 31.32 109.167 -163.083 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 1073 ' ' ASN . . . . . 0.448 ' O ' ' HE3' ' A' 1071 ' ' LYS . 73.1 m-20 -128.61 -171.1 2.38 Favored 'General case' 0 C--O 1.246 0.902 0 N-CA-C 108.305 -0.998 . . . . 33.94 108.305 171.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -54.5 141.89 52.85 Favored Pre-proline 0 N--CA 1.47 0.556 0 CA-C-N 119.783 1.174 . . . . 38.04 112.069 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1075 ' ' PRO . . . . . 0.69 ' HG2' HD21 ' A' 1089 ' ' LEU . 82.2 Cg_exo -72.76 130.56 15.93 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.37 2.047 . . . . 42.68 112.892 173.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 17.8 mt -105.98 165.13 11.43 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 103.969 -2.604 . . . . 46.74 103.969 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1077 ' ' ASP . . . . . 0.422 ' O ' ' HB ' ' A' 1080 ' ' ILE . 75.3 m-20 -31.01 -58.7 0.22 Allowed 'General case' 0 C--N 1.357 0.909 0 N-CA-C 117.057 2.243 . . . . 58.61 117.057 -173.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 13.8 t70 -62.79 -43.63 98.28 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 113.496 0.924 . . . . 59.2 113.496 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1079 ' ' GLU . . . . . 0.433 ' CD ' ' HZ3' ' A' 1071 ' ' LYS . 33.4 mt-10 -64.93 -37.88 89.1 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 113.581 0.956 . . . . 50.63 113.581 176.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1080 ' ' ILE . . . . . 0.522 HG12 HD21 ' A' 1105 ' ' LEU . 25.0 mt -54.01 -54.03 23.48 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.88 0 CA-C-N 112.906 -1.952 . . . . 51.48 108.882 175.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -59.34 -25.69 64.41 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 123.812 1.768 . . . . 50.28 114.315 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 61.5 mt -77.92 -41.88 34.98 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 120.48 -1.387 . . . . 50.21 111.424 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1083 ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' 1080 ' ' ILE . 0.0 OUTLIER -55.27 139.92 40.88 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 123.93 1.824 . . . . 49.06 112.936 -178.119 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -101.8 152.69 38.17 Favored Pre-proline 0 N--CA 1.435 -1.185 0 CA-C-N 112.197 -2.274 . . . . 51.08 108.543 -156.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -64.07 109.67 1.18 Allowed 'Trans proline' 0 C--N 1.322 -0.824 0 CA-C-N 121.446 1.552 . . . . 49.73 114.006 170.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 110.94 -7.04 29.3 Favored Glycine 0 C--N 1.316 -0.539 0 C-N-CA 119.103 -1.522 . . . . 47.71 113.424 -171.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1087 ' ' THR . . . . . 0.6 ' HB ' HG12 ' A' 1110 ' ' VAL . 2.8 m -64.18 118.35 8.46 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 117.487 0.643 . . . . 45.47 110.921 176.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1088 ' ' THR . . . . . . . . . . . . . 99.2 m -83.86 93.51 8.02 Favored 'General case' 0 N--CA 1.411 -2.4 0 N-CA-C 104.491 -2.411 . . . . 42.04 104.491 172.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1089 ' ' LEU . . . . . 0.69 HD21 ' HG2' ' A' 1075 ' ' PRO . 55.0 tp -84.88 87.31 7.33 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 110.321 -3.127 . . . . 38.06 108.796 -174.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 15.8 t -83.11 120.16 33.91 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.813 0 N-CA-C 105.2 -2.148 . . . . 37.4 105.2 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1091 ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' 1071 ' ' LYS . 13.7 p -154.46 143.38 20.99 Favored 'General case' 0 C--O 1.247 0.974 0 O-C-N 119.454 -2.029 . . . . 36.16 114.897 -168.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1092 ' ' PHE . . . . . . . . . . . . . 45.5 t80 -84.26 82.48 8.36 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-O 124.138 1.923 . . . . 38.94 109.694 168.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.28 -31.39 3.7 Favored 'Isoleucine or valine' 0 C--O 1.254 1.294 0 N-CA-C 116.865 2.172 . . . . 42.17 116.865 -169.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 99.0 m95 58.5 75.08 0.55 Allowed Pre-proline 0 C--O 1.247 0.932 0 CA-C-O 122.782 1.277 . . . . 46.51 113.039 -168.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1095 ' ' PRO . . . . . 0.563 ' HG3' HG11 ' A' 1360 ' ' VAL . 46.7 Cg_endo -60.04 -40.81 58.05 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 124.613 3.542 . . . . 49.76 115.687 -172.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1096 ' ' ALA . . . . . 0.457 ' HA ' ' HZ2' ' A' 1368 ' ' TRP . . . -61.15 -29.31 69.71 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.633 1.206 . . . . 52.62 113.84 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1097 ' ' GLN . . . . . 0.537 ' NE2' ' HA2' ' A' 1260 ' ' GLY . 28.0 mp0 -83.84 -24.27 30.99 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 106.276 -1.75 . . . . 60.74 106.276 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1098 ' ' ASN . . . . . 0.487 ' HB3' ' HB3' ' A' 1101 ' ' LEU . 61.1 m-80 -122.15 55.05 5.9 Favored Pre-proline 0 C--O 1.239 0.514 0 O-C-N 119.817 -1.802 . . . . 58.19 115.426 -168.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.01 -41.57 73.64 Favored 'Trans proline' 0 N--CA 1.476 0.478 1 C-N-CA 125.891 4.394 . . . . 54.59 114.218 -176.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -47.69 77.2 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.027 -0.988 . . . . 63.28 111.845 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1101 ' ' LEU . . . . . 0.487 ' HB3' ' HB3' ' A' 1098 ' ' ASN . 7.6 tp -56.89 -41.43 78.07 Favored 'General case' 0 C--O 1.254 1.307 0 CA-C-N 113.304 -1.771 . . . . 54.75 112.288 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1102 ' ' MET . . . . . 0.46 ' HE1' ' HB ' ' A' 1360 ' ' VAL . 75.0 mmm -57.09 -49.0 77.22 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 126.204 2.19 . . . . 52.65 109.598 174.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -65.01 -35.34 80.89 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.41 1.005 . . . . 66.26 111.116 -175.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -64.87 -43.88 91.53 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 109.136 -0.69 . . . . 63.73 109.136 177.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1105 ' ' LEU . . . . . 0.522 HD21 HG12 ' A' 1080 ' ' ILE . 49.0 mt -69.51 -30.57 68.45 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.926 0.869 . . . . 54.68 112.593 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -55.63 -48.92 74.13 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.482 0.919 . . . . 53.64 113.482 165.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -52.57 -46.58 66.92 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 114.479 1.289 . . . . 67.24 114.479 173.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -58.39 -22.16 52.87 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.702 -0.681 . . . . 65.76 111.95 174.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 45.2 t30 68.58 44.33 1.23 Allowed 'General case' 0 C--O 1.239 0.552 0 CA-C-O 124.322 2.011 . . . . 58.71 112.075 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1110 ' ' VAL . . . . . 0.6 HG12 ' HB ' ' A' 1087 ' ' THR . 28.3 m -93.11 165.7 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 O-C-N 119.288 -2.132 . . . . 46.63 112.109 175.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1111 ' ' THR . . . . . 0.485 HG21 HG21 ' A' 1348 ' ' VAL . 58.7 m -102.32 101.4 11.65 Favored 'General case' 0 C--O 1.214 -0.794 0 O-C-N 119.281 -2.137 . . . . 44.13 110.078 165.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1112 ' ' VAL . . . . . 0.679 HG22 HD23 ' A' 1089 ' ' LEU . 48.6 t -90.96 117.58 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 109.513 -0.551 . . . . 40.44 109.513 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1113 ' ' MET . . . . . 0.744 ' SD ' HD21 ' A' 1338 ' ' LEU . 58.3 mtp -112.61 108.16 17.13 Favored 'General case' 0 N--CA 1.422 -1.842 0 C-N-CA 124.105 0.962 . . . . 50.76 108.788 178.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1114 ' ' ALA . . . . . 0.603 ' HB3' ' HB2' ' A' 1117 ' ' SER . . . -81.37 115.42 20.71 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 116.065 -0.516 . . . . 35.64 111.575 -172.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1115 ' ' MET . . . . . 0.502 ' SD ' HD22 ' A' 1334 ' ' LEU . 93.5 mmm -76.0 -21.0 57.37 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 123.616 1.674 . . . . 38.74 114.877 -176.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -62.73 -50.38 71.33 Favored 'General case' 0 CA--C 1.482 -1.643 0 CA-C-N 112.767 -2.015 . . . . 40.14 111.692 163.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1117 ' ' SER . . . . . 0.603 ' HB2' ' HB3' ' A' 1114 ' ' ALA . 75.8 m -76.12 22.22 0.16 Allowed 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 118.866 2.913 . . . . 44.79 118.866 -175.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1118 ' ' VAL . . . . . 0.499 ' HA ' HG22 ' A' 1358 ' ' VAL . 59.9 t -66.12 130.75 94.36 Favored Pre-proline 0 C--O 1.249 1.063 0 N-CA-C 107.322 -1.362 . . . . 43.75 107.322 175.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -61.63 133.64 46.53 Favored 'Trans proline' 0 N--CA 1.428 -2.33 0 N-CA-C 107.903 -1.614 . . . . 48.93 107.903 175.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1120 ' ' ARG . . . . . 0.456 ' HD2' ' O ' ' A' 1118 ' ' VAL . 23.4 mmm-85 -79.5 41.02 0.46 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 113.861 -1.518 . . . . 62.9 114.665 -161.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 18.1 pt -116.56 155.15 18.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 O-C-N 119.978 -1.701 . . . . 57.72 113.132 -167.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1122 ' ' SER . . . . . . . . . . . . . 2.8 m -27.23 -64.73 0.08 Allowed 'General case' 0 C--N 1.312 -1.024 0 O-C-N 127.07 2.731 . . . . 57.26 116.637 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 39.9 ptt85 -68.53 -22.36 64.52 Favored 'General case' 0 C--N 1.353 0.726 0 O-C-N 119.655 -1.903 . . . . 62.9 112.428 -172.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1124 ' ' ALA . . . . . 0.409 ' HA ' HD13 ' A' 1127 ' ' LEU . . . -77.68 -13.66 59.84 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 115.108 1.521 . . . . 49.83 115.108 174.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 42.0 mm-40 -59.85 -29.22 68.14 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 119.04 2.978 . . . . 52.37 119.04 -165.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1126 ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' B' 1160 ' ' ALA . 15.8 m -69.96 -22.28 63.17 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 115.43 1.641 . . . . 42.43 115.43 168.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1127 ' ' LEU . . . . . 0.566 HD23 HD12 ' A' 1334 ' ' LEU . 3.3 mp -88.22 -45.48 10.05 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.179 -2.156 . . . . 43.74 105.179 177.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 30.3 t0 -50.45 109.23 0.29 Allowed 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 116.238 1.94 . . . . 43.21 116.238 -176.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -79.04 -30.06 43.9 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.68 -1.6 . . . . 35.74 113.134 176.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 80.8 mt -72.7 -6.52 45.01 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 119.545 -1.972 . . . . 38.09 111.945 175.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1131 ' ' SER . . . . . 0.556 ' HB3' HG11 ' A' 1175 ' ' VAL . 32.9 m -94.73 -57.66 2.4 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 107.801 -1.185 . . . . 36.91 107.801 161.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1132 ' ' SER . . . . . . . . . . . . . 22.2 m -77.28 -51.9 10.1 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 117.094 -1.431 . . . . 35.79 113.848 -169.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1133 ' ' MET . . . . . 0.582 ' HA ' HD12 ' A' 1136 ' ' ILE . 81.6 mtp -58.25 -37.81 75.67 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 124.274 3.215 . . . . 30.81 110.045 173.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1134 ' ' ALA . . . . . 0.514 ' HB1' ' HB2' ' A' 1176 ' ' ALA . . . -65.98 -34.19 77.53 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 120.538 -0.465 . . . . 28.88 110.333 177.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1135 ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -60.79 -46.21 91.4 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 120.704 -1.248 . . . . 40.76 108.938 173.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1136 ' ' ILE . . . . . 0.893 HD13 ' HA ' ' A' 1323 ' ' SER . 16.8 mt -56.78 -50.65 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 117.631 -1.176 . . . . 31.54 111.745 172.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1137 ' ' ALA . . . . . 0.526 ' HB2' ' HG3' ' A' 1316 ' ' PRO . . . -53.56 -38.41 63.85 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 114.672 1.36 . . . . 29.87 114.672 169.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -63.9 -41.41 98.73 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-O 123.41 1.561 . . . . 28.73 111.652 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 17.0 t80 -71.68 -46.37 59.03 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-N 114.16 -1.02 . . . . 30.39 110.428 176.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1140 ' ' ARG . . . . . 0.513 HH11 HD13 ' A' 1319 ' ' LEU . 14.9 tpt180 -67.94 -19.97 65.03 Favored 'General case' 0 C--N 1.356 0.884 0 N-CA-C 107.949 -1.13 . . . . 26.09 107.949 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1141 ' ' ALA . . . . . 0.445 ' HB1' HG21 ' A' 1282 ' ' VAL . . . -62.89 -48.66 78.04 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 106.833 -1.543 . . . . 27.1 106.833 172.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 36.3 mm -64.53 -42.68 95.9 Favored 'Isoleucine or valine' 0 C--N 1.346 0.44 0 CA-C-N 119.343 0.974 . . . . 28.48 109.792 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1143 ' ' VAL . . . . . 0.408 ' HB ' ' HA ' ' A' 1140 ' ' ARG . 21.8 t -54.86 -60.04 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 113.533 0.938 . . . . 23.07 113.533 175.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1144 ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -71.7 -27.98 63.4 Favored 'General case' 0 C--O 1.248 0.989 0 O-C-N 119.561 -1.962 . . . . 33.4 112.456 -174.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1145 ' ' ALA . . . . . 0.701 ' HB1' HD12 ' A' 1251 ' ' ILE . . . -62.18 -49.04 77.38 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 106.54 -1.652 . . . . 24.22 106.54 175.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1146 ' ' ALA . . . . . 0.557 ' HA ' ' HB2' ' A' 1149 ' ' PHE . . . -58.76 -33.74 70.62 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 115.375 1.62 . . . . 24.89 115.375 171.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -61.96 -31.62 71.98 Favored 'General case' 0 C--N 1.372 1.569 0 CA-C-O 117.925 -1.036 . . . . 26.73 111.628 175.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1148 ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -109.77 1.63 19.5 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 115.706 1.743 . . . . 39.96 115.706 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1149 ' ' PHE . . . . . 0.557 ' HB2' ' HA ' ' A' 1146 ' ' ALA . 0.6 OUTLIER -64.47 138.38 58.38 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 126.06 1.744 . . . . 25.87 110.516 -170.125 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 1150 ' ' GLY . . . . . 0.566 ' HA2' ' HG2' ' B' 1320 ' ' PRO . . . -73.01 -55.46 6.34 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 110.259 -1.136 . . . . 19.28 110.259 171.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1151 ' ' ARG . . . . . 0.759 ' HA ' ' HB2' ' B' 1322 ' ' GLN . 33.4 mtm-85 -94.37 -178.8 4.7 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 113.025 0.75 . . . . 39.9 113.025 -174.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1152 ' ' PHE . . . . . 0.821 ' HB2' HG11 ' A' 1163 ' ' VAL . 19.3 m-30 -85.68 160.6 19.52 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 116.578 -2.049 . . . . 29.44 111.716 171.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1153 ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -73.27 -58.45 3.31 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 122.45 1.119 . . . . 32.6 108.523 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1154 ' ' THR . . . . . . . . . . . . . 20.9 m -62.86 123.93 19.74 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 125.536 1.534 . . . . 34.64 110.379 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -80.48 71.26 2.85 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 109.957 -1.257 . . . . 37.14 109.957 174.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -90.75 139.36 30.8 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 120.848 -0.341 . . . . 40.57 111.113 -166.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1157 ' ' ILE . . . . . 0.659 HG13 ' HB3' ' C' ' 70' ' ' PRO . 2.6 tp -73.77 112.28 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 107.86 -1.163 . . . . 44.61 107.86 168.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1158 ' ' THR . . . . . . . . . . . . . 42.6 p -91.21 174.53 7.35 Favored 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 109.013 -0.736 . . . . 40.7 109.013 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -49.06 -39.97 29.64 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 115.469 1.655 . . . . 40.25 115.469 167.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -86.55 -46.69 9.91 Favored 'General case' 0 C--O 1.253 1.255 0 N-CA-C 116.194 1.924 . . . . 38.47 116.194 178.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1161 ' ' GLY . . . . . 0.533 ' HA3' HG21 ' B' 1329 ' ' THR . . . -172.24 179.07 44.08 Favored Glycine 0 N--CA 1.475 1.259 0 CA-C-O 124.456 2.142 . . . . 37.61 116.493 -170.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1162 ' ' LYS . . . . . 0.486 ' HB2' ' HB2' ' C' ' 95' ' ' GLU . 17.1 tttt -76.27 115.06 15.65 Favored 'General case' 0 C--O 1.251 1.168 0 CA-C-N 111.995 -2.103 . . . . 48.9 108.788 -178.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1163 ' ' VAL . . . . . 0.821 HG11 ' HB2' ' A' 1152 ' ' PHE . 38.8 t -69.36 128.97 92.11 Favored Pre-proline 0 C--O 1.243 0.747 0 CA-C-O 116.662 -1.637 . . . . 36.52 108.977 171.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1164 ' ' PRO . . . . . 0.502 ' HA ' ' HD2' ' A' 1165 ' ' PRO . 42.6 Cg_exo -77.29 103.79 1.79 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 124.047 3.165 . . . . 35.08 112.151 177.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1165 ' ' PRO . . . . . 0.502 ' HD2' ' HA ' ' A' 1164 ' ' PRO . 55.5 Cg_endo -46.86 151.37 2.18 Favored 'Trans proline' 0 N--CA 1.455 -0.762 1 C-N-CA 125.46 4.107 . . . . 35.33 117.67 -173.072 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -79.27 137.47 37.39 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.948 1.356 . . . . 34.69 109.284 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1167 ' ' LYS . . . . . 0.606 ' HB2' ' HA ' ' A' 1249 ' ' VAL . 6.7 mptt -99.91 105.86 17.62 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 103.972 -2.603 . . . . 45.36 103.972 171.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 58.8 t -90.57 90.2 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 N-CA-C 105.039 -2.208 . . . . 31.71 105.039 -176.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1169 ' ' MET . . . . . 0.456 ' O ' ' HA ' ' A' 1252 ' ' ILE . 6.2 ttp -80.5 116.81 20.74 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.449 -1.315 . . . . 42.28 107.449 172.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 86.0 t -91.08 136.06 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 105.574 -2.01 . . . . 30.51 105.574 176.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 15.8 mt -109.92 120.5 61.12 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 N-CA-C 104.46 -2.422 . . . . 31.87 104.46 170.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1172 ' ' GLY . . . . . 0.457 ' HA3' ' HB2' ' A' 1256 ' ' ALA . . . 87.3 80.73 1.22 Allowed Glycine 0 C--O 1.256 1.489 0 N-CA-C 109.63 -1.388 . . . . 34.54 109.63 175.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1173 ' ' ALA . . . . . . . . . . . . . . . -87.34 118.83 27.04 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 122.726 1.25 . . . . 32.51 109.819 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1174 ' ' GLY . . . . . 0.587 ' HA2' HG11 ' A' 1200 ' ' VAL . . . -148.34 -149.8 5.06 Favored Glycine 0 N--CA 1.437 -1.249 0 N-CA-C 106.513 -2.635 . . . . 29.9 106.513 164.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1175 ' ' VAL . . . . . 0.556 HG11 ' HB3' ' A' 1131 ' ' SER . 54.1 t -57.21 -41.67 78.45 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 CA-C-N 121.101 2.45 . . . . 33.11 111.382 -175.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1176 ' ' ALA . . . . . 0.514 ' HB2' ' HB1' ' A' 1134 ' ' ALA . . . -60.02 -49.5 77.42 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-N 114.301 -1.318 . . . . 28.1 111.659 176.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1177 ' ' GLY . . . . . . . . . . . . . . . -59.52 -46.96 93.1 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 108.458 -1.857 . . . . 28.54 108.458 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1178 ' ' LEU . . . . . . . . . . . . . 47.9 mt -58.77 -29.72 67.0 Favored 'General case' 0 C--O 1.241 0.62 0 O-C-N 119.129 -2.395 . . . . 31.22 113.447 175.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -58.68 -55.74 31.24 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-O 122.356 1.074 . . . . 28.98 110.88 168.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -55.85 -43.43 77.06 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 113.886 -1.507 . . . . 27.83 114.446 177.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1181 ' ' ILE . . . . . . . . . . . . . 74.8 mt -62.05 -49.52 83.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 107.89 -1.152 . . . . 30.25 107.89 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -54.47 -34.54 55.08 Favored Glycine 0 C--N 1.343 0.928 0 O-C-N 126.744 2.527 . . . . 29.59 113.512 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -74.92 -61.77 1.77 Allowed 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 117.503 0.652 . . . . 30.29 112.52 170.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1184 ' ' ALA . . . . . 0.427 ' HA ' HD12 ' A' 1187 ' ' LEU . . . -59.69 -32.21 70.29 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-O 121.752 0.787 . . . . 30.47 113.088 -166.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1185 ' ' ASN . . . . . 0.589 ' ND2' ' HA3' ' A' 1208 ' ' GLY . 14.5 t-20 -56.49 -53.3 59.04 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.622 1.169 . . . . 42.41 112.206 173.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1186 ' ' SER . . . . . . . . . . . . . 3.6 m -64.41 -39.66 94.28 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.765 -1.107 . . . . 39.38 109.295 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1187 ' ' LEU . . . . . 0.942 ' HA ' ' HB3' ' B' 1186 ' ' SER . 25.8 mt -55.87 -34.71 65.73 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 115.826 1.787 . . . . 36.18 115.826 173.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 93.27 48.37 2.84 Favored Glycine 0 CA--C 1.534 1.259 0 O-C-N 124.108 0.88 . . . . 33.78 112.317 -177.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -113.98 162.02 16.94 Favored 'General case' 0 C--O 1.247 0.958 0 O-C-N 126.114 1.714 . . . . 33.93 108.756 172.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 66.1 mt -84.8 103.02 11.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 104.55 -2.389 . . . . 38.74 104.55 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 3.5 t -94.48 142.5 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 O-C-N 120.958 -1.089 . . . . 33.09 108.847 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1192 ' ' ARG . . . . . 0.498 ' HB3' ' HG ' ' A' 1212 ' ' LEU . 98.6 mtt180 -143.76 108.78 4.97 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.06 -1.089 . . . . 38.92 108.06 177.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -96.42 120.16 36.22 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 120.335 -1.478 . . . . 35.32 113.988 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 87.4 t80 -80.34 131.13 35.59 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 114.984 -1.007 . . . . 39.35 109.501 166.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 8.0 t70 -150.74 178.56 9.0 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 105.397 -2.075 . . . . 40.46 105.397 153.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1196 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.08 -31.98 9.91 Favored 'General case' 0 N--CA 1.428 -1.556 0 O-C-N 119.569 -1.957 . . . . 45.94 108.875 175.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1197 ' ' ARG . . . . . . . . . . . . . 53.0 mtm180 -69.63 133.44 88.73 Favored Pre-proline 0 N--CA 1.445 -0.684 0 O-C-N 120.832 -1.167 . . . . 56.02 109.916 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1198 ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -67.08 -28.29 41.31 Favored 'Trans proline' 0 C--O 1.242 0.719 0 C-N-CA 124.537 3.491 . . . . 51.27 118.276 173.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -55.71 -55.14 35.8 Favored 'General case' 0 C--O 1.254 1.334 0 O-C-N 119.925 -1.734 . . . . 59.1 114.037 -168.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1200 ' ' VAL . . . . . 0.587 HG11 ' HA2' ' A' 1174 ' ' GLY . 18.5 m -53.8 -25.35 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 116.749 2.129 . . . . 51.06 116.749 176.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 98.9 mttt -47.36 -43.45 23.13 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 115.774 1.768 . . . . 57.38 115.774 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -54.17 -51.29 64.8 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 122.942 1.353 . . . . 62.41 113.542 -175.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -70.87 -41.72 71.02 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 111.31 -2.677 . . . . 57.78 112.97 177.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1204 ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' 1209 ' ' ALA . 4.8 t -45.29 -49.88 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.448 1.499 . . . . 46.38 112.429 174.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -68.22 -52.82 29.85 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 113.639 -1.618 . . . . 50.7 112.435 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1206 ' ' SER . . . . . . . . . . . . . 41.0 p -66.87 -28.39 68.3 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.65 -0.705 . . . . 49.98 112.37 -172.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1207 ' ' MET . . . . . . . . . . . . . 12.3 mtt -66.55 -67.79 0.42 Allowed 'General case' 0 C--O 1.249 1.055 0 N-CA-C 106.562 -1.644 . . . . 52.99 106.562 166.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1208 ' ' GLY . . . . . 0.589 ' HA3' ' ND2' ' A' 1185 ' ' ASN . . . 154.9 60.25 0.01 OUTLIER Glycine 0 CA--C 1.522 0.522 0 CA-C-O 123.217 1.454 . . . . 47.66 112.955 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1209 ' ' ALA . . . . . 0.421 ' HB3' HG13 ' A' 1204 ' ' VAL . . . -141.44 145.5 35.36 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 112.347 -1.926 . . . . 44.77 111.32 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1210 ' ' GLU . . . . . 0.407 ' HB2' ' HG2' ' A' 1192 ' ' ARG . 37.3 mt-10 -74.01 155.51 38.51 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 104.068 -2.568 . . . . 47.64 104.068 163.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1211 ' ' PHE . . . . . . . . . . . . . 44.0 t80 -94.61 131.58 40.24 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 105.772 -1.936 . . . . 45.66 105.772 163.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1212 ' ' LEU . . . . . 0.498 ' HG ' ' HB3' ' A' 1192 ' ' ARG . 72.7 mt -88.33 108.42 19.33 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 106.993 -1.484 . . . . 46.06 106.993 174.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -82.19 133.26 35.25 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 111.801 -2.454 . . . . 60.22 109.012 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 4.9 tp -41.72 133.51 2.72 Favored 'General case' 0 C--O 1.241 0.609 0 O-C-N 127.858 3.224 . . . . 57.25 110.69 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 27.8 t0 -76.58 75.16 3.29 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 123.509 1.623 . . . . 64.43 114.013 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 3.2 t80 . . . . . 0 C--O 1.213 -0.853 0 N-CA-C 102.801 -3.037 . . . . 66.9 102.801 -171.806 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 N--CA 1.421 -1.886 0 N-CA-C 107.917 -1.142 . . . . 39.09 107.917 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -61.62 -45.26 96.68 Favored Glycine 0 CA--C 1.535 1.285 0 N-CA-C 115.988 1.155 . . . . 39.32 115.988 -174.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 91.5 t80 -72.98 -43.53 62.11 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 120.455 2.128 . . . . 39.3 112.639 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -69.31 -27.17 65.15 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 118.311 -2.743 . . . . 36.3 112.4 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -61.89 -60.44 3.64 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 120.089 -1.632 . . . . 37.38 106.988 163.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -52.42 -61.13 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.581 0 N-CA-C 116.769 2.137 . . . . 39.11 116.769 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1230 ' ' MET . . . . . 0.507 ' SD ' HD11 ' A' 1235 ' ' ILE . 34.7 mmt -89.94 49.38 1.71 Allowed 'General case' 0 C--O 1.251 1.166 0 O-C-N 118.197 -2.814 . . . . 49.59 116.202 -174.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1231 ' ' SER . . . . . . . . . . . . . 67.7 p -98.57 163.85 12.5 Favored 'General case' 0 C--O 1.253 1.286 0 CA-C-N 113.972 -1.467 . . . . 43.68 108.999 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.43 -36.85 83.84 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 116.172 -0.467 . . . . 55.57 110.928 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1233 ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' A' 1236 ' ' LYS . . . -60.31 -54.79 41.53 Favored 'General case' 0 C--O 1.215 -0.748 0 C-N-CA 125.403 1.481 . . . . 44.94 112.157 173.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -60.63 -52.49 64.91 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 115.23 1.566 . . . . 42.04 115.23 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1235 ' ' ILE . . . . . 0.507 HD11 ' SD ' ' A' 1230 ' ' MET . 94.8 mt -57.28 -32.26 40.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-O 123.491 1.615 . . . . 46.28 113.65 173.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1236 ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' 1233 ' ' ALA . 47.9 tttm -58.12 -57.67 11.81 Favored 'General case' 0 C--O 1.252 1.21 0 CA-C-O 124.525 2.107 . . . . 47.87 111.323 170.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1237 ' ' ALA . . . . . 0.422 ' HA ' ' HB2' ' A' 1240 ' ' GLU . . . -70.92 -11.89 61.23 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 115.731 1.752 . . . . 41.61 115.731 -175.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -67.73 -62.94 1.17 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.714 -1.587 . . . . 50.65 106.714 170.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1239 ' ' MET . . . . . . . . . . . . . 2.4 mtm -58.44 -35.42 72.1 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 121.158 -0.964 . . . . 48.87 113.249 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1240 ' ' GLU . . . . . 0.422 ' HB2' ' HA ' ' A' 1237 ' ' ALA . 91.0 mt-10 -68.73 -26.64 65.36 Favored 'General case' 0 C--O 1.25 1.11 0 C-N-CA 120.79 -0.364 . . . . 54.8 111.379 176.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 2.3 tm? -69.83 -56.99 5.64 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.962 -0.755 . . . . 43.21 108.962 166.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1242 ' ' PHE . . . . . 0.573 ' HE2' HD13 ' A' 1266 ' ' LEU . 22.9 m-30 -57.95 -41.79 83.58 Favored 'General case' 0 C--O 1.221 -0.409 0 O-C-N 124.76 1.287 . . . . 38.66 111.749 -166.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -68.84 -38.07 79.55 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.402 1.001 . . . . 37.92 111.764 -175.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -63.38 -51.0 67.69 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 120.266 -1.521 . . . . 37.28 109.994 174.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 -59.2 -34.36 72.06 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.232 1.413 . . . . 43.07 109.897 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1246 ' ' ALA . . . . . 0.438 ' HB1' ' HG3' ' A' 1275 ' ' MET . . . -62.77 -17.95 61.86 Favored 'General case' 0 N--CA 1.439 -1.021 0 O-C-N 119.314 -2.116 . . . . 38.3 116.272 176.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1247 ' ' LYS . . . . . . . . . . . . . 16.5 mtmm -81.83 -1.93 49.18 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 122.532 1.158 . . . . 47.6 112.929 174.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1248 ' ' GLU . . . . . 0.448 ' CD ' HH12 ' A' 1192 ' ' ARG . 14.6 pt-20 -129.35 -35.69 1.75 Allowed 'General case' 0 C--O 1.239 0.537 0 CA-C-O 116.117 -1.897 . . . . 45.42 113.6 177.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1249 ' ' VAL . . . . . 0.606 ' HA ' ' HB2' ' A' 1167 ' ' LYS . 33.0 m -75.71 161.77 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 121.635 2.016 . . . . 36.26 114.614 -168.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1250 ' ' ASP . . . . . 0.506 ' O ' ' HB3' ' A' 1279 ' ' SER . 4.7 m-20 -108.84 -60.32 1.76 Allowed 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.129 -1.396 . . . . 33.04 109.647 -175.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1251 ' ' ILE . . . . . 0.701 HD12 ' HB1' ' A' 1145 ' ' ALA . 51.5 mm -110.91 112.89 42.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 107.436 -1.32 . . . . 31.4 107.436 -168.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1252 ' ' ILE . . . . . 0.652 HD12 HG12 ' A' 1281 ' ' ILE . 64.2 mt -100.6 102.8 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 104.249 -2.5 . . . . 29.42 104.249 176.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1253 ' ' VAL . . . . . 0.586 ' HA ' HG23 ' A' 1282 ' ' VAL . 89.9 t -84.78 97.74 5.56 Favored 'Isoleucine or valine' 0 C--O 1.251 1.173 0 N-CA-C 104.296 -2.483 . . . . 30.37 104.296 175.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1254 ' ' THR . . . . . 0.479 ' CG2' ' HB2' ' A' 1291 ' ' ASN . 3.8 m -93.58 70.48 4.22 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 104.449 -2.426 . . . . 35.72 104.449 -167.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1255 ' ' THR . . . . . 0.663 ' HA ' ' HB2' ' A' 1284 ' ' LEU . 0.8 OUTLIER -78.48 0.88 24.23 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 119.443 -2.036 . . . . 36.0 115.844 -175.235 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 1256 ' ' ALA . . . . . 0.457 ' HB2' ' HA3' ' A' 1172 ' ' GLY . . . -64.77 68.83 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 118.297 2.702 . . . . 40.93 118.297 176.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 60.4 tp -77.8 91.81 4.15 Favored 'General case' 0 C--O 1.246 0.909 0 N-CA-C 106.456 -1.683 . . . . 47.82 106.456 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1258 ' ' ILE . . . . . 0.527 ' HA ' ' HD3' ' A' 1259 ' ' PRO . 39.3 mm -64.53 128.85 93.86 Favored Pre-proline 0 C--O 1.241 0.608 0 N-CA-C 108.275 -1.009 . . . . 52.7 108.275 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1259 ' ' PRO . . . . . 0.527 ' HD3' ' HA ' ' A' 1258 ' ' ILE . 51.0 Cg_exo -62.05 108.49 0.67 Allowed 'Trans proline' 0 N--CA 1.439 -1.701 0 C-N-CA 123.933 3.089 . . . . 54.13 109.786 -175.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1260 ' ' GLY . . . . . 0.537 ' HA2' ' NE2' ' A' 1097 ' ' GLN . . . 82.44 -64.95 4.19 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-O 118.186 -1.341 . . . . 54.62 113.589 168.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 13.5 mttp -65.9 137.03 95.87 Favored Pre-proline 0 C--O 1.216 -0.677 0 C-N-CA 125.468 1.507 . . . . 55.74 110.728 173.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -52.81 144.79 42.56 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.636 2.891 . . . . 51.15 116.371 176.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1263 ' ' ALA . . . . . . . . . . . . . . . -67.28 133.72 93.31 Favored Pre-proline 0 CA--C 1.529 0.157 0 O-C-N 121.996 -0.44 . . . . 46.06 110.933 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -63.51 145.38 91.95 Favored 'Trans proline' 0 C--N 1.344 0.308 1 C-N-CA 125.914 4.409 . . . . 41.08 111.596 -178.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1265 ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' 1265 ' ' LYS . 67.8 mmtt -78.14 78.92 4.61 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 122.147 0.975 . . . . 47.42 109.785 -178.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1266 ' ' LEU . . . . . 0.573 HD13 ' HE2' ' A' 1242 ' ' PHE . 62.4 mt -83.82 -37.08 22.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.034 -1.439 . . . . 39.22 110.109 -171.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 15.4 mt -94.5 97.41 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 103.783 -2.673 . . . . 42.5 103.783 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1268 ' ' THR . . . . . 0.571 ' O ' HG23 ' A' 1272 ' ' VAL . 16.5 p -70.51 157.01 38.63 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 114.631 -1.168 . . . . 37.84 111.309 -176.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1269 ' ' ARG . . . . . 0.585 ' HG3' ' HB3' ' A' 1293 ' ' GLU . 97.5 mtt180 -52.09 -41.4 62.38 Favored 'General case' 0 CA--C 1.512 -0.499 0 O-C-N 120.994 -1.066 . . . . 54.8 111.833 168.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -44.37 -62.57 1.12 Allowed 'General case' 0 N--CA 1.476 0.836 0 O-C-N 125.362 1.664 . . . . 54.36 111.547 164.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1271 ' ' MET . . . . . . . . . . . . . 34.0 ttm -58.52 -44.36 89.48 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 120.726 1.603 . . . . 39.52 111.36 -173.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1272 ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' 1268 ' ' THR . 20.0 t -66.77 -46.58 85.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 115.793 -0.64 . . . . 38.25 111.553 -175.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.44 -3.84 26.65 Favored 'General case' 0 CA--C 1.506 -0.713 0 O-C-N 119.943 -1.723 . . . . 40.77 115.583 172.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1274 ' ' SER . . . . . . . . . . . . . 8.6 m -113.03 14.75 19.67 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 116.085 1.883 . . . . 36.58 116.085 164.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1275 ' ' MET . . . . . 0.633 ' HB3' HG21 ' A' 1307 ' ' VAL . 4.8 ttt -85.35 162.44 19.06 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.362 -0.977 . . . . 36.75 108.362 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1276 ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -63.07 132.48 52.05 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 124.198 1.951 . . . . 46.11 109.536 174.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1277 ' ' ALA . . . . . 0.68 ' HB1' ' HA ' ' B' 1045 ' ' PHE . . . -70.56 162.22 29.26 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 111.736 -2.484 . . . . 33.52 113.713 -172.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 67.28 27.54 73.52 Favored Glycine 0 N--CA 1.479 1.535 0 O-C-N 119.485 -2.01 . . . . 31.27 113.449 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1279 ' ' SER . . . . . 0.506 ' HB3' ' O ' ' A' 1250 ' ' ASP . 14.0 m -132.0 154.21 49.57 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 113.671 -1.265 . . . . 32.95 107.912 -168.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1280 ' ' VAL . . . . . 0.432 HG11 ' HA ' ' A' 1145 ' ' ALA . 18.5 t -126.52 123.88 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 122.082 0.944 . . . . 27.43 112.988 -171.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1281 ' ' ILE . . . . . 0.652 HG12 HD12 ' A' 1252 ' ' ILE . 52.1 mt -91.66 108.37 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 105.973 -1.862 . . . . 30.3 105.973 166.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1282 ' ' VAL . . . . . 0.586 HG23 ' HA ' ' A' 1253 ' ' VAL . 0.1 OUTLIER -89.13 124.0 41.66 Favored 'Isoleucine or valine' 0 C--O 1.25 1.108 0 O-C-N 120.813 -1.179 . . . . 28.63 108.729 170.575 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 1283 ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' 1286 ' ' ALA . 14.5 t0 -96.42 121.72 38.54 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 120.595 1.543 . . . . 36.27 110.482 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1284 ' ' LEU . . . . . 0.663 ' HB2' ' HA ' ' A' 1255 ' ' THR . 2.1 mm? -107.01 -9.08 16.33 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-O 122.968 1.366 . . . . 38.57 112.149 -176.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1285 ' ' ALA . . . . . 0.56 ' HB3' ' HA2' ' A' 1290 ' ' GLY . . . -76.99 -29.85 55.68 Favored 'General case' 0 C--O 1.243 0.736 0 O-C-N 120.691 -1.256 . . . . 37.56 108.092 164.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1286 ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' 1283 ' ' ASP . . . 28.06 -82.79 0.0 OUTLIER 'General case' 0 C--N 1.361 1.094 0 N-CA-C 118.545 2.795 . . . . 40.33 118.545 173.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -66.33 -41.93 88.92 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 113.905 1.076 . . . . 56.85 113.905 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 46.9 t30 -85.7 82.32 8.26 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 122.65 1.214 . . . . 45.86 111.824 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 73.52 -67.14 1.59 Allowed Glycine 0 CA--C 1.538 1.524 0 O-C-N 119.498 -2.001 . . . . 40.31 111.724 -175.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1290 ' ' GLY . . . . . 0.56 ' HA2' ' HB3' ' A' 1285 ' ' ALA . . . 89.26 129.49 3.62 Favored Glycine 0 CA--C 1.536 1.356 0 N-CA-C 110.357 -1.097 . . . . 38.89 110.357 -177.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1291 ' ' ASN . . . . . 0.479 ' HB2' ' CG2' ' A' 1254 ' ' THR . 32.2 m120 -73.47 -17.06 61.28 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.469 1.634 . . . . 37.23 115.3 -172.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1292 ' ' CYS . . . . . 0.476 ' SG ' HG11 ' A' 1309 ' ' VAL . 49.1 t -91.75 146.33 23.85 Favored 'General case' 0 C--O 1.248 1.016 0 CA-C-O 125.36 2.505 . . . . 36.5 110.359 173.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1293 ' ' GLU . . . . . 0.585 ' HB3' ' HG3' ' A' 1269 ' ' ARG . 6.5 mt-10 -75.67 -7.99 55.7 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 119.259 -2.151 . . . . 43.32 115.782 172.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -109.05 26.56 10.48 Favored 'General case' 0 C--O 1.215 -0.735 0 O-C-N 120.124 -1.61 . . . . 41.32 113.629 175.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1295 ' ' THR . . . . . . . . . . . . . 54.6 m -81.3 81.15 7.55 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 125.868 2.747 . . . . 35.3 108.925 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1296 ' ' VAL . . . . . 0.467 ' HA ' ' HD3' ' A' 1297 ' ' PRO . 72.5 t -76.58 124.11 87.79 Favored Pre-proline 0 N--CA 1.424 -1.733 0 O-C-N 119.794 -1.817 . . . . 34.84 108.389 -176.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1297 ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' 1296 ' ' VAL . 50.4 Cg_exo -56.47 99.21 0.08 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.684 0 C-N-CA 124.362 3.375 . . . . 33.51 115.291 -167.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 81.83 37.8 15.43 Favored Glycine 0 N--CA 1.437 -1.266 0 CA-C-N 112.565 -2.107 . . . . 32.19 111.575 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -145.3 153.6 41.45 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 124.234 1.969 . . . . 34.88 110.151 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1300 ' ' ILE . . . . . 0.54 HG12 HG12 ' A' 1310 ' ' ILE . 77.2 mt -83.75 157.6 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 CA-C-N 111.203 -2.726 . . . . 32.29 105.328 161.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 58.3 t80 -137.47 147.31 45.21 Favored 'General case' 0 C--O 1.253 1.262 0 N-CA-C 104.948 -2.241 . . . . 37.25 104.948 176.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1302 ' ' THR . . . . . . . . . . . . . 8.3 m -126.65 134.68 50.69 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 106.098 -1.816 . . . . 35.56 106.098 170.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1303 ' ' THR . . . . . 0.424 HG21 HG12 ' A' 1272 ' ' VAL . 24.9 p -79.78 174.71 11.31 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 112.705 0.631 . . . . 36.4 112.705 176.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -53.32 -56.34 17.46 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 121.335 -0.853 . . . . 52.32 111.218 171.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -68.46 10.01 0.29 Allowed 'General case' 0 C--N 1.352 0.684 0 N-CA-C 117.189 2.292 . . . . 40.04 117.189 176.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 70.67 38.12 67.4 Favored Glycine 0 C--O 1.244 0.753 0 O-C-N 121.909 -0.494 . . . . 36.96 112.9 169.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1307 ' ' VAL . . . . . 0.633 HG21 ' HB3' ' A' 1275 ' ' MET . 87.5 t -99.83 133.9 41.13 Favored 'Isoleucine or valine' 0 C--O 1.262 1.715 0 N-CA-C 101.412 -3.551 . . . . 33.4 101.412 170.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1308 ' ' LYS . . . . . 0.426 ' HB2' HG22 ' A' 1280 ' ' VAL . 67.2 mmtt -94.93 136.41 35.27 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 111.659 -2.519 . . . . 42.91 108.809 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1309 ' ' VAL . . . . . 0.476 HG11 ' SG ' ' A' 1292 ' ' CYS . 21.8 t -118.13 116.75 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 N-CA-C 106.581 -1.637 . . . . 32.29 106.581 171.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1310 ' ' ILE . . . . . 0.54 HG12 HG12 ' A' 1300 ' ' ILE . 27.3 mt -102.61 98.09 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 105.423 -2.066 . . . . 30.99 105.423 -178.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -103.68 51.29 0.83 Allowed Glycine 0 CA--C 1.529 0.962 0 N-CA-C 106.353 -2.699 . . . . 28.95 106.353 175.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1312 ' ' TYR . . . . . 0.594 ' HB2' ' HG ' ' A' 1315 ' ' LEU . 5.0 m-85 -72.64 101.82 3.14 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 105.037 -2.209 . . . . 31.69 105.037 171.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1313 ' ' THR . . . . . 0.409 ' HA ' ' HB1' ' A' 1286 ' ' ALA . 1.6 p -53.3 -31.79 45.67 Favored 'General case' 0 C--O 1.243 0.719 0 O-C-N 121.022 -1.049 . . . . 34.17 111.426 177.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -81.46 7.74 11.12 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 118.695 2.85 . . . . 36.86 118.695 174.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1315 ' ' LEU . . . . . 0.594 ' HG ' ' HB2' ' A' 1312 ' ' TYR . 26.7 mt -47.69 -39.35 22.47 Favored Pre-proline 0 C--O 1.252 1.223 0 CA-C-N 123.798 2.999 . . . . 34.85 118.511 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1316 ' ' PRO . . . . . 0.526 ' HG3' ' HB2' ' A' 1137 ' ' ALA . 73.0 Cg_exo -59.15 -35.83 96.98 Favored 'Trans proline' 0 C--O 1.205 -1.17 0 C-N-CA 123.143 2.562 . . . . 29.15 112.961 173.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1317 ' ' GLY . . . . . 0.42 ' HA3' ' HE ' ' A' 1015 ' ' ARG . . . -94.74 -12.87 55.09 Favored Glycine 0 CA--C 1.495 -1.209 0 O-C-N 120.5 -1.375 . . . . 27.29 116.173 -177.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1318 ' ' ARG . . . . . . . . . . . . . 8.2 ttt-85 -64.76 6.1 0.25 Allowed 'General case' 0 C--O 1.244 0.777 0 N-CA-C 117.057 2.243 . . . . 41.49 117.057 -175.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1319 ' ' LEU . . . . . 0.513 HD13 HH11 ' A' 1140 ' ' ARG . 15.4 tp -116.6 78.96 9.11 Favored Pre-proline 0 N--CA 1.439 -1.008 0 CA-C-N 123.23 2.741 . . . . 27.61 107.011 173.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1320 ' ' PRO . . . . . 0.561 ' HG2' ' HA2' ' B' 1150 ' ' GLY . 20.4 Cg_endo -40.89 -57.87 1.19 Allowed 'Trans proline' 0 CA--C 1.504 -0.988 0 C-N-CA 124.476 3.45 . . . . 25.94 118.126 -155.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1321 ' ' THR . . . . . 0.471 HG23 HG21 ' A' 1019 ' ' THR . 3.0 m -72.04 -33.65 68.16 Favored 'General case' 0 N--CA 1.437 -1.125 0 O-C-N 118.597 -2.564 . . . . 25.01 109.678 -174.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1322 ' ' GLN . . . . . 0.843 ' HB2' ' HA ' ' B' 1151 ' ' ARG . 61.3 tp60 -84.88 -39.08 18.66 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 120.26 1.391 . . . . 29.39 110.575 -171.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1323 ' ' SER . . . . . 0.893 ' HA ' HD13 ' A' 1136 ' ' ILE . 17.6 m -47.5 -56.69 6.54 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.963 1.098 . . . . 26.47 113.963 158.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1324 ' ' SER . . . . . . . . . . . . . 14.4 m -68.93 -17.28 63.93 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.274 0.842 . . . . 27.78 113.274 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -75.62 -67.91 0.62 Allowed 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 103.856 -2.646 . . . . 37.53 103.856 174.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1326 ' ' LEU . . . . . 0.758 ' HB2' HD11 ' A' 1136 ' ' ILE . 89.8 mt -72.42 -43.83 63.3 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 115.042 -2.409 . . . . 35.71 112.921 -168.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1327 ' ' TYR . . . . . 0.415 ' HE2' ' HA ' ' A' 1072 ' ' VAL . 73.8 t80 -58.02 -43.63 86.84 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-N 122.501 2.41 . . . . 31.59 107.703 169.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1328 ' ' GLY . . . . . 0.656 ' HA2' HD12 ' A' 1331 ' ' LEU . . . -58.17 -37.28 85.92 Favored Glycine 0 C--N 1.345 1.058 0 N-CA-C 110.884 -0.886 . . . . 28.0 110.884 176.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1329 ' ' THR . . . . . 0.418 HG21 ' HA3' ' B' 1161 ' ' GLY . 36.5 m -77.8 -28.7 50.49 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 118.938 1.369 . . . . 32.15 111.415 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1330 ' ' ASN . . . . . 0.4 ' HA ' ' O ' ' A' 1126 ' ' SER . 16.2 m120 -55.31 -48.31 74.31 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 120.693 1.588 . . . . 34.36 111.611 164.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1331 ' ' LEU . . . . . 0.681 HD13 ' HB3' ' A' 1070 ' ' LEU . 19.6 mt -56.1 -53.35 58.08 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 124.507 1.123 . . . . 33.37 111.241 175.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1332 ' ' VAL . . . . . 0.58 HG12 ' HE3' ' A' 1336 ' ' LYS . 59.8 t -49.13 -47.45 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 C-N-CA 125.898 1.679 . . . . 35.27 111.125 175.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1333 ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -70.19 -30.35 67.45 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-O 117.243 -1.361 . . . . 37.66 113.85 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1334 ' ' LEU . . . . . 0.566 HD12 HD23 ' A' 1127 ' ' LEU . 18.3 tp -62.76 -48.67 78.15 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 122.887 1.327 . . . . 40.27 108.451 169.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1335 ' ' LEU . . . . . . . . . . . . . 82.0 mt -66.12 -23.65 66.53 Favored 'General case' 0 C--O 1.246 0.899 0 O-C-N 120.252 -1.53 . . . . 42.5 110.096 -175.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1336 ' ' LYS . . . . . 0.58 ' HE3' HG12 ' A' 1332 ' ' VAL . 96.9 mttt -60.24 -45.31 93.67 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.445 -1.41 . . . . 47.81 112.836 168.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1337 ' ' LEU . . . . . 0.486 HD22 HD21 ' A' 1127 ' ' LEU . 8.1 mp -75.03 -38.97 61.33 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 113.218 -1.81 . . . . 49.27 113.049 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1338 ' ' LEU . . . . . 0.744 HD21 ' SD ' ' A' 1113 ' ' MET . 6.3 mp -72.56 -58.37 3.43 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 125.818 1.647 . . . . 50.54 111.204 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1339 ' ' CYS . . . . . 0.675 ' HB3' ' HA2' ' A' 1344 ' ' GLY . 58.7 m -92.38 68.45 4.95 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-O 124.408 2.051 . . . . 53.67 106.35 -177.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1340 ' ' LYS . . . . . . . . . . . . . 75.3 tttt -76.02 -47.93 22.95 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 111.526 -2.579 . . . . 63.38 109.016 -158.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -70.08 -25.64 63.62 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 113.425 0.898 . . . . 70.95 113.425 -175.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1342 ' ' LYS . . . . . 0.487 ' N ' ' HB3' ' A' 1343 ' ' ASP . 46.5 mtpt 52.12 68.27 0.84 Allowed 'General case' 0 C--O 1.253 1.26 0 N-CA-C 118.106 2.632 . . . . 65.25 118.106 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1343 ' ' ASP . . . . . 0.487 ' HB3' ' N ' ' A' 1342 ' ' LYS 0.278 10.9 t70 67.04 -88.14 0.03 OUTLIER 'General case' 0 C--O 1.236 0.387 2 O-C-N 110.921 -7.362 . . . . 64.53 119.784 -0.177 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A 1344 ' ' GLY . . . . . 0.675 ' HA2' ' HB3' ' A' 1339 ' ' CYS . . . 86.29 17.85 60.02 Favored Glycine 0 N--CA 1.425 -2.036 0 O-C-N 119.98 -1.7 . . . . 59.72 115.963 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 19.5 t30 -80.4 143.24 33.63 Favored 'General case' 0 N--CA 1.434 -1.226 0 O-C-N 120.469 -1.607 . . . . 64.09 108.767 160.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1346 ' ' ILE . . . . . 0.414 ' HA ' ' SG ' ' A' 1339 ' ' CYS . 14.7 mt -91.6 100.18 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 104.49 -2.411 . . . . 58.82 104.49 -167.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1347 ' ' THR . . . . . . . . . . . . . 6.9 m -84.08 98.8 10.07 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 104.339 -2.467 . . . . 54.96 104.339 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1348 ' ' VAL . . . . . 0.485 HG21 HG21 ' A' 1111 ' ' THR . 19.5 t -93.4 80.02 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.257 1.475 0 N-CA-C 105.448 -2.056 . . . . 55.64 105.448 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 12.9 t70 -76.68 135.17 39.09 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 115.238 1.57 . . . . 61.45 115.238 -167.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -80.89 -28.28 35.99 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-N 114.864 -1.062 . . . . 58.63 111.882 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -85.82 -31.82 22.08 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 119.977 -1.702 . . . . 62.06 114.747 -170.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 9.9 t70 -64.07 123.08 18.11 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 125.046 1.466 . . . . 54.07 109.238 169.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 18.6 m -57.44 -45.66 85.66 Favored 'Isoleucine or valine' 0 C--O 1.253 1.268 0 N-CA-C 113.508 0.929 . . . . 50.68 113.508 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1354 ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' 1358 ' ' VAL . 12.9 m -77.45 -38.53 26.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 119.971 -0.692 . . . . 47.68 110.188 -172.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1355 ' ' ILE . . . . . . . . . . . . . 90.3 mt -62.39 -54.05 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-N 121.141 1.791 . . . . 48.49 108.589 174.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1356 ' ' ARG . . . . . 0.451 ' HG3' ' HD2' ' A' 1371 ' ' PRO . 45.3 tpt85 -55.92 -37.92 69.58 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 112.107 0.41 . . . . 48.27 112.107 178.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -59.72 -46.92 93.22 Favored Glycine 0 N--CA 1.469 0.846 0 O-C-N 125.41 1.694 . . . . 43.53 112.466 174.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1358 ' ' VAL . . . . . 0.499 HG22 ' HA ' ' A' 1118 ' ' VAL . 30.2 t -75.08 -28.69 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 O-C-N 118.428 -2.807 . . . . 45.12 109.726 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1359 ' ' THR . . . . . 0.466 ' CG2' ' HB2' ' A' 1362 ' ' ARG . 26.2 m -64.71 96.16 0.17 Allowed 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 118.082 -2.886 . . . . 42.94 114.706 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1360 ' ' VAL . . . . . 0.563 HG11 ' HG3' ' A' 1095 ' ' PRO . 17.5 m -96.55 -30.62 3.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 112.214 0.449 . . . . 43.26 112.214 -177.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1361 ' ' ILE . . . . . . . . . . . . . 95.7 mt -131.49 136.22 57.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 101.919 -3.363 . . . . 45.66 101.919 163.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1362 ' ' ARG . . . . . 0.466 ' HB2' ' CG2' ' A' 1359 ' ' THR . 50.4 ttt180 -124.62 125.77 44.67 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 104.428 -2.434 . . . . 61.34 104.428 165.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 48.89 55.7 8.83 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 125.507 1.754 . . . . 49.76 113.996 172.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 82.08 -42.33 2.85 Favored Glycine 0 C--O 1.218 -0.871 0 CA-C-N 113.021 -1.899 . . . . 50.0 112.569 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -69.9 126.47 29.81 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 119.953 1.876 . . . . 56.92 107.071 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1366 ' ' ILE . . . . . . . . . . . . . 96.5 mt -74.59 96.18 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.391 0 N-CA-C 107.19 -1.411 . . . . 52.78 107.19 178.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1367 ' ' THR . . . . . . . . . . . . . 17.6 p -82.75 1.52 38.39 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 115.932 1.827 . . . . 49.44 115.932 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1368 ' ' TRP . . . . . 0.457 ' HZ2' ' HA ' ' A' 1096 ' ' ALA . 29.6 t90 -78.66 133.71 62.35 Favored Pre-proline 0 N--CA 1.442 -0.872 0 N-CA-C 105.313 -2.106 . . . . 52.38 105.313 161.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -58.28 130.09 4.53 Favored 'Cis proline' 0 C--N 1.329 -0.47 0 N-CA-C 119.687 2.918 . . . . 46.94 119.687 5.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1370 ' ' ALA . . . . . 0.461 ' HA ' ' HD3' ' A' 1371 ' ' PRO . . . -72.84 112.53 15.65 Favored Pre-proline 0 C--O 1.245 0.838 0 C-N-CA 124.567 1.147 . . . . 45.91 110.837 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1371 ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' 1370 ' ' ALA . 32.3 Cg_exo -67.61 120.65 7.68 Favored 'Trans proline' 0 N--CA 1.433 -2.082 0 C-N-CA 124.636 3.558 . . . . 46.39 118.104 -173.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -71.89 -62.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 123.179 2.586 . . . . 46.72 109.968 164.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.239 -4.238 0 CA-C-N 120.642 1.564 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 23.1 m80 . . . . . 0 C--O 1.245 0.826 0 N-CA-C 107.24 -1.393 . . . . 63.44 107.24 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 999' ' ' HIS . . . . . 0.475 ' HB3' ' HB3' ' B' 1002 ' ' ARG . 23.2 m-70 -120.75 59.74 0.91 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.857 -0.794 . . . . 51.74 108.857 164.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1000 ' ' HIS . . . . . 0.599 ' HA ' ' HB2' ' B' 1067 ' ' GLU . 1.8 t-80 -77.18 139.53 39.93 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 102.795 -3.039 . . . . 54.07 102.795 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 81.88 -0.46 88.37 Favored Glycine 0 C--O 1.26 1.721 0 CA-C-N 113.728 -1.578 . . . . 39.22 111.814 -171.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1002 ' ' ARG . . . . . 0.475 ' HB3' ' HB3' ' B' ' 999' ' ' HIS . 34.1 ttp180 -108.52 148.36 30.38 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 119.59 1.695 . . . . 38.12 106.677 177.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1003 ' ' ILE . . . . . 0.714 HG12 HD12 ' B' 1068 ' ' ILE . 24.3 mt -102.61 147.27 9.38 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 N-CA-C 105.724 -1.954 . . . . 29.7 105.724 172.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -107.38 121.72 6.58 Favored Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 108.492 -1.843 . . . . 27.5 108.492 167.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1005 ' ' ILE . . . . . 0.515 HG23 ' HB3' ' B' 1017 ' ' ALA . 40.7 mm -105.77 106.51 56.8 Favored Pre-proline 0 N--CA 1.439 -1.006 0 N-CA-C 106.689 -1.597 . . . . 24.83 106.689 171.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1006 ' ' PRO . . . . . 0.58 ' HA ' ' HG3' ' B' 1036 ' ' GLU . 26.4 Cg_exo -80.12 176.82 8.93 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 124.687 3.591 . . . . 27.19 108.35 -175.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1007 ' ' ARG . . . . . . . . . . . . . 22.9 ttm105 -84.82 131.51 34.52 Favored 'General case' 0 C--N 1.318 -0.773 0 O-C-N 120.128 -1.608 . . . . 41.46 108.124 165.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1008 ' ' GLU . . . . . 0.649 ' HG3' ' HB ' ' B' 1072 ' ' VAL 0.311 25.2 mm-40 -68.93 136.18 52.16 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 119.612 3.19 . . . . 26.93 119.612 173.71 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 47.6 mmm-85 -99.08 -3.76 33.95 Favored 'General case' 0 C--O 1.253 1.285 0 CA-C-N 111.512 -2.585 . . . . 34.48 116.068 -165.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1010 ' ' LEU . . . . . . . . . . . . . 65.6 tp -58.21 138.6 56.14 Favored 'General case' 0 N--CA 1.441 -0.875 0 O-C-N 121.177 -0.952 . . . . 44.22 112.108 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1011 ' ' THR . . . . . . . . . . . . . 1.3 m -59.72 111.93 1.63 Allowed 'General case' 0 C--N 1.319 -0.759 0 O-C-N 124.573 1.171 . . . . 40.74 108.187 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 38.8 t30 60.63 92.75 0.05 OUTLIER 'General case' 0 C--O 1.252 1.199 0 O-C-N 126.657 2.473 . . . . 44.44 107.894 -171.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1013 ' ' GLU . . . . . 0.539 ' HG2' ' HB3' ' B' 1008 ' ' GLU . 9.3 tp10 -130.99 132.72 45.2 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 124.88 2.276 . . . . 29.87 109.609 -177.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1014 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.16 -32.49 50.27 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-N 108.816 -3.811 . . . . 25.26 117.642 176.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 43.5 mtm180 -95.64 159.86 14.78 Favored 'General case' 0 C--O 1.252 1.201 0 CA-C-O 124.021 1.867 . . . . 29.54 115.179 -161.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1016 ' ' VAL . . . . . 0.553 HG13 ' H ' ' B' 1018 ' ' ALA . 4.7 p -128.86 -176.5 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 102.936 -2.987 . . . . 23.55 102.936 159.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1017 ' ' ALA . . . . . 0.515 ' HB3' HG23 ' B' 1005 ' ' ILE . . . -90.34 -8.81 49.84 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 116.854 2.168 . . . . 23.59 116.854 -178.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1018 ' ' ALA . . . . . 0.553 ' H ' HG13 ' B' 1016 ' ' VAL . . . -159.75 145.72 15.86 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-O 121.528 0.68 . . . . 24.93 110.313 -177.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1019 ' ' THR . . . . . 0.516 HG21 HG23 ' B' 1321 ' ' THR . 0.7 OUTLIER -108.8 165.45 12.64 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-O 116.682 -1.628 . . . . 28.09 111.924 172.297 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B 1020 ' ' PRO . . . . . 0.482 ' HB3' ' HB2' ' B' 1053 ' ' ALA . 0.2 OUTLIER -47.88 -43.2 30.15 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 124.331 3.354 . . . . 28.79 116.652 175.251 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 47.7 tptt -50.71 -41.53 56.16 Favored 'General case' 0 C--O 1.256 1.446 0 N-CA-C 113.358 0.873 . . . . 47.28 113.358 168.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1022 ' ' THR . . . . . 0.539 HG21 ' HA3' ' B' 1328 ' ' GLY . 0.2 OUTLIER -72.63 -38.49 67.73 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 118.83 -0.605 . . . . 30.12 111.63 177.679 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B 1023 ' ' VAL . . . . . 0.427 HG22 HG11 ' B' 1033 ' ' VAL . 79.8 t -49.23 -48.63 17.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-O 122.61 1.195 . . . . 32.24 113.156 -178.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1024 ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -53.25 -48.16 68.45 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 112.684 -2.053 . . . . 49.62 110.492 174.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -61.71 -43.24 99.24 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 120.831 -1.168 . . . . 44.68 110.316 -174.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 51.1 mt -64.93 -39.03 92.89 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 115.069 1.507 . . . . 35.71 115.069 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1027 ' ' LEU . . . . . . . . . . . . . 58.1 mt -64.78 -41.58 95.74 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 125.581 1.552 . . . . 42.18 109.006 174.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 31.4 mttm -63.5 -35.9 81.97 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 123.731 0.644 . . . . 48.34 110.652 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1029 ' ' LEU . . . . . . . . . . . . . 82.0 mt -59.47 -62.36 1.93 Allowed 'General case' 0 CA--C 1.504 -0.808 0 C-N-CA 123.618 0.767 . . . . 38.69 109.212 170.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 143.35 45.02 0.05 OUTLIER Glycine 0 C--N 1.312 -0.758 0 N-CA-C 110.309 -1.116 . . . . 32.28 110.309 168.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -133.17 122.7 24.39 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 123.038 1.399 . . . . 35.94 108.733 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1032 ' ' THR . . . . . . . . . . . . . 28.0 m -66.3 133.2 50.06 Favored 'General case' 0 C--O 1.25 1.098 0 CA-C-N 114.121 -1.399 . . . . 33.37 108.414 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1033 ' ' VAL . . . . . 0.427 HG11 HG22 ' B' 1023 ' ' VAL . 22.2 t -107.38 126.88 63.57 Favored 'Isoleucine or valine' 0 C--O 1.251 1.169 0 O-C-N 120.068 -1.645 . . . . 29.98 107.271 -169.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -122.45 139.15 54.2 Favored 'General case' 0 C--O 1.243 0.714 0 O-C-N 124.134 0.896 . . . . 28.18 111.553 168.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1035 ' ' VAL . . . . . 0.605 ' HB ' HD13 ' B' 1057 ' ' ILE . 21.2 t -127.35 149.33 32.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 105.866 -1.901 . . . . 25.82 105.866 -175.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1036 ' ' GLU . . . . . 0.58 ' HG3' ' HA ' ' B' 1006 ' ' PRO . 13.3 mt-10 -62.67 145.61 54.22 Favored 'General case' 0 C--O 1.257 1.473 0 N-CA-C 113.7 1.0 . . . . 32.44 113.7 171.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1037 ' ' SER . . . . . . . . . . . . . 13.0 m -70.54 148.13 48.54 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 106.038 -1.838 . . . . 29.54 106.038 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 82.11 -53.2 4.73 Favored Glycine 0 CA--C 1.534 1.27 0 O-C-N 119.205 -2.184 . . . . 27.76 110.401 -172.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1039 ' ' ALA . . . . . . . . . . . . . . . -51.61 -40.99 60.91 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-N 119.434 1.617 . . . . 26.02 112.547 172.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -57.59 -49.08 76.68 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 120.465 -0.874 . . . . 26.47 112.288 171.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1041 ' ' GLN . . . . . 0.667 ' NE2' ' HA ' ' B' 1046 ' ' ASP . 2.6 tp60 -59.12 -40.62 85.98 Favored 'General case' 0 C--O 1.246 0.877 0 C-N-CA 123.233 0.613 . . . . 50.98 110.429 178.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 46.2 mt -66.5 -26.51 67.2 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.771 1.026 . . . . 29.3 113.771 -171.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1043 ' ' ALA . . . . . . . . . . . . . . . -83.88 40.48 0.75 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 119.521 1.055 . . . . 26.74 111.926 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1044 ' ' SER . . . . . . . . . . . . . 38.6 m 44.3 54.62 6.07 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 126.284 1.833 . . . . 31.26 110.899 -166.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1045 ' ' PHE . . . . . 0.68 ' HA ' ' HB1' ' A' 1277 ' ' ALA . 0.2 OUTLIER -144.68 -167.39 2.64 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.439 -1.255 . . . . 33.26 109.775 -174.526 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B 1046 ' ' ASP . . . . . 0.667 ' HA ' ' NE2' ' B' 1041 ' ' GLN . 22.3 t70 -131.06 140.22 50.02 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 105.805 -1.924 . . . . 46.74 105.805 174.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -68.06 -37.47 81.31 Favored 'General case' 0 CA--C 1.502 -0.866 0 O-C-N 125.954 2.034 . . . . 34.44 111.407 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -77.85 -23.95 48.75 Favored 'General case' 0 N--CA 1.435 -1.2 0 O-C-N 119.279 -2.138 . . . . 48.67 109.955 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1049 ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' B' 1046 ' ' ASP . . . -58.45 -43.42 88.8 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 118.762 -0.637 . . . . 35.26 111.896 163.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1050 ' ' PHE . . . . . 0.461 ' HD1' ' O ' ' B' 1046 ' ' ASP . 31.1 m-85 -60.87 -37.85 83.57 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 120.889 1.677 . . . . 32.17 112.167 170.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 98.0 t -59.67 -45.74 94.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 O-C-N 119.585 -1.947 . . . . 38.37 108.503 174.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -63.76 -23.36 67.33 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 116.261 1.949 . . . . 45.77 116.261 174.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1053 ' ' ALA . . . . . 0.482 ' HB2' ' HB3' ' B' 1020 ' ' PRO . . . -78.35 -4.67 49.26 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 124.91 1.284 . . . . 37.83 112.269 170.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 87.75 34.57 9.99 Favored Glycine 0 CA--C 1.5 -0.866 0 CA-C-N 120.29 1.404 . . . . 35.82 110.681 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -114.62 138.1 51.09 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-O 124.151 1.929 . . . . 33.77 107.401 174.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -77.45 134.77 38.29 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 104.487 -2.412 . . . . 51.02 104.487 173.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1057 ' ' ILE . . . . . 0.605 HD13 ' HB ' ' B' 1035 ' ' VAL . 19.5 mm -108.46 107.16 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 106.259 -1.756 . . . . 38.47 106.259 175.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 88.1 t -86.29 132.77 31.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 CA-C-N 113.163 -1.835 . . . . 39.4 108.045 -173.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -72.5 95.82 1.85 Allowed 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 123.291 1.519 . . . . 57.07 110.576 168.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . 82.27 -151.16 29.54 Favored Glycine 0 C--O 1.248 1.026 0 CA-C-O 125.093 2.496 . . . . 44.83 116.191 166.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 5.0 m120 -58.64 -21.28 53.44 Favored 'General case' 0 C--O 1.212 -0.869 0 N-CA-C 118.91 2.93 . . . . 46.27 118.91 -167.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1062 ' ' SER . . . . . . . . . . . . . 4.2 m -53.65 -22.12 8.2 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.188 -1.57 . . . . 43.47 112.677 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 1.5 p -53.28 -35.31 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 O-C-N 120.983 -1.073 . . . . 36.98 111.181 176.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1064 ' ' TRP . . . . . 0.549 ' HA ' HD11 ' B' 1069 ' ' ILE . 55.2 m95 -63.16 -23.35 67.39 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 116.155 1.909 . . . . 37.9 116.155 177.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -83.44 93.58 7.82 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 124.475 2.083 . . . . 46.19 108.923 173.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1066 ' ' SER . . . . . 0.427 ' HB3' ' O ' ' B' 1002 ' ' ARG . 71.4 m -149.77 179.7 7.81 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 111.206 -2.725 . . . . 37.06 107.211 -174.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1067 ' ' GLU . . . . . 0.599 ' HB2' ' HA ' ' B' 1000 ' ' HIS . 35.2 tt0 -83.37 -51.3 7.52 Favored 'General case' 0 N--CA 1.437 -1.103 0 O-C-N 123.792 0.683 . . . . 43.95 109.952 166.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1068 ' ' ILE . . . . . 0.714 HD12 HG12 ' B' 1003 ' ' ILE . 1.3 mt -108.99 145.15 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 N-CA-C 107.061 -1.459 . . . . 33.5 107.061 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1069 ' ' ILE . . . . . 0.549 HD11 ' HA ' ' B' 1064 ' ' TRP . 46.0 mm -109.0 118.26 56.15 Favored 'Isoleucine or valine' 0 C--O 1.254 1.299 0 N-CA-C 104.33 -2.47 . . . . 30.57 104.33 158.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1070 ' ' LEU . . . . . 0.83 HD22 HD22 ' B' 1331 ' ' LEU . 94.5 mt -101.8 117.75 35.51 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 106.674 -1.602 . . . . 27.66 106.674 170.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1071 ' ' LYS . . . . . 0.54 ' HG2' ' OE2' ' B' 1008 ' ' GLU 0.279 13.6 tttm -140.83 160.16 40.64 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 125.994 2.059 . . . . 28.4 111.042 -170.025 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B 1072 ' ' VAL . . . . . 0.649 ' HB ' ' HG3' ' B' 1008 ' ' GLU . 99.7 t -94.63 -70.76 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.429 0 O-C-N 120.629 -1.294 . . . . 23.18 108.155 -173.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -97.4 152.68 18.69 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.893 -1.129 . . . . 25.47 108.011 -170.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -53.3 133.05 52.35 Favored Pre-proline 0 C--O 1.243 0.725 0 C-N-CA 126.29 1.836 . . . . 27.9 111.907 -173.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -60.32 129.75 31.13 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 122.752 2.301 . . . . 31.62 114.949 -173.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 49.2 mt -72.65 158.56 35.41 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.202 -1.036 . . . . 40.49 108.202 173.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.23 -29.7 10.04 Favored 'General case' 0 C--O 1.214 -0.768 0 O-C-N 118.937 -2.352 . . . . 51.59 117.014 -171.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -67.28 -46.21 74.3 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-N 114.986 -1.006 . . . . 42.36 110.017 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1079 ' ' GLU . . . . . 0.472 ' HA ' HD12 ' B' 1082 ' ' LEU . 31.8 mt-10 -63.07 -40.49 97.83 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 123.162 1.458 . . . . 34.53 109.029 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1080 ' ' ILE . . . . . 0.487 HG21 ' HB3' ' B' 1104 ' ' LYS . 84.3 mt -59.1 -48.81 85.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 108.333 -0.988 . . . . 33.25 108.333 175.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -56.84 -39.7 74.73 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 119.143 0.883 . . . . 36.47 112.874 175.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1082 ' ' LEU . . . . . 0.472 HD12 ' HA ' ' B' 1079 ' ' GLU . 28.6 mt -61.12 -38.51 86.61 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 125.762 1.625 . . . . 37.76 111.08 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1083 ' ' LEU . . . . . 0.447 HD11 HD22 ' B' 1089 ' ' LEU . 21.8 mt -56.73 121.11 9.02 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 123.17 0.588 . . . . 37.43 110.679 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -78.07 148.7 75.45 Favored Pre-proline 0 CA--C 1.558 1.271 0 N-CA-C 106.953 -1.499 . . . . 37.7 106.953 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1085 ' ' PRO . . . . . 0.647 ' HA ' ' O ' ' B' 1108 ' ' ARG . 0.1 OUTLIER -40.3 102.37 0.04 OUTLIER 'Trans proline' 0 C--O 1.239 0.562 0 C-N-CA 122.826 2.35 . . . . 35.51 115.564 169.674 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B 1086 ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' B' 1110 ' ' VAL . . . 84.49 26.38 39.46 Favored Glycine 0 C--N 1.345 1.04 0 CA-C-N 112.652 -2.067 . . . . 33.87 114.532 177.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1087 ' ' THR . . . . . . . . . . . . . 16.8 m -66.67 155.79 37.03 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 120.956 2.378 . . . . 32.5 108.491 166.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1088 ' ' THR . . . . . 0.655 ' HB ' ' HA ' ' B' 1068 ' ' ILE . 4.1 m -87.49 131.37 34.38 Favored 'General case' 0 C--O 1.205 -1.245 0 N-CA-C 105.088 -2.189 . . . . 30.22 105.088 174.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1089 ' ' LEU . . . . . 0.447 HD22 HD11 ' B' 1083 ' ' LEU . 39.3 tp -122.87 127.65 49.28 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 107.926 -1.139 . . . . 27.24 107.926 173.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 44.2 t -120.2 120.1 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 N-CA-C 103.326 -2.842 . . . . 25.39 103.326 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1091 ' ' SER . . . . . 0.549 ' O ' ' HA ' ' B' 1114 ' ' ALA . 2.6 m -164.53 160.31 20.2 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.528 1.513 . . . . 28.81 108.857 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1092 ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -59.48 99.43 0.06 Allowed 'General case' 0 C--O 1.247 0.971 0 O-C-N 121.088 -1.008 . . . . 30.78 111.204 158.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 32.2 mm -95.73 -28.53 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 109.199 -0.667 . . . . 30.28 109.199 -171.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1094 ' ' TRP . . . . . 0.441 ' HB2' HD22 ' B' 1098 ' ' ASN . 68.5 m95 52.06 56.08 15.48 Favored Pre-proline 0 N--CA 1.472 0.659 0 O-C-N 121.129 -0.982 . . . . 34.07 112.551 -175.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -53.43 -51.05 11.82 Favored 'Trans proline' 0 CA--C 1.505 -0.952 1 C-N-CA 126.541 4.828 . . . . 38.66 115.999 -162.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -69.17 -28.77 66.71 Favored 'General case' 0 C--O 1.247 0.929 0 O-C-N 120.714 -1.241 . . . . 41.32 110.684 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.04 -17.82 48.87 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 120.71 -1.244 . . . . 51.66 111.197 172.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1098 ' ' ASN . . . . . 0.534 ' HB3' ' HB3' ' B' 1101 ' ' LEU . 70.7 m-20 -125.73 61.19 36.82 Favored Pre-proline 0 C--O 1.243 0.728 0 N-CA-C 114.719 1.377 . . . . 40.32 114.719 176.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -60.45 -38.68 72.18 Favored 'Trans proline' 0 CA--C 1.506 -0.887 0 C-N-CA 123.743 2.962 . . . . 41.56 113.13 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -69.52 -45.24 69.32 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 106.863 -1.532 . . . . 54.11 106.863 -174.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1101 ' ' LEU . . . . . 0.534 ' HB3' ' HB3' ' B' 1098 ' ' ASN . 7.0 tt -60.64 -48.77 80.29 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.645 -1.243 . . . . 37.88 107.645 177.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1102 ' ' MET . . . . . . . . . . . . . 43.2 mmm -50.86 -46.76 60.37 Favored 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 120.616 -1.302 . . . . 37.54 114.341 173.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -64.55 -39.0 92.96 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 123.173 1.463 . . . . 47.01 112.794 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1104 ' ' LYS . . . . . 0.487 ' HB3' HG21 ' B' 1080 ' ' ILE . 52.5 mttm -60.98 -45.47 94.68 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 118.928 -2.358 . . . . 48.68 111.77 175.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1105 ' ' LEU . . . . . 0.673 HD13 HG21 ' B' 1112 ' ' VAL . 52.2 mt -62.05 -39.25 91.74 Favored 'General case' 0 C--O 1.252 1.235 0 O-C-N 120.668 -1.27 . . . . 32.21 109.604 177.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -57.36 -37.05 71.99 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 112.968 0.729 . . . . 33.73 112.968 171.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -67.63 -45.92 73.97 Favored 'General case' 0 CA--C 1.504 -0.824 0 O-C-N 118.888 -2.383 . . . . 51.47 112.105 172.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1108 ' ' ARG . . . . . 0.647 ' O ' ' HA ' ' B' 1085 ' ' PRO . 21.9 mmm180 -61.42 -11.64 11.24 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 120.577 -1.327 . . . . 43.9 112.013 169.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1109 ' ' ASN . . . . . 0.407 ' HA ' ' HA2' ' B' 1364 ' ' GLY . 27.0 m-80 63.04 24.86 14.73 Favored 'General case' 0 C--N 1.358 0.96 0 O-C-N 120.024 -1.673 . . . . 44.82 114.253 172.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1110 ' ' VAL . . . . . 0.478 ' HA ' ' HA2' ' B' 1086 ' ' GLY . 18.4 m -83.59 167.87 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 N-CA-C 112.563 0.579 . . . . 30.52 112.563 -171.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1111 ' ' THR . . . . . 0.702 HG23 ' HA ' ' B' 1362 ' ' ARG . 95.9 m -109.74 111.14 22.41 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.439 -1.689 . . . . 27.12 106.439 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1112 ' ' VAL . . . . . 0.673 HG21 HD13 ' B' 1105 ' ' LEU . 63.6 t -113.27 120.3 62.86 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.621 0 N-CA-C 108.178 -1.045 . . . . 26.4 108.178 -165.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1113 ' ' MET . . . . . 0.453 ' SD ' HD11 ' B' 1338 ' ' LEU . 0.8 OUTLIER -94.79 105.92 17.88 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-O 123.596 1.665 . . . . 42.92 109.376 164.274 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B 1114 ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' B' 1091 ' ' SER . . . -86.4 108.55 18.52 Favored 'General case' 0 CA--C 1.5 -0.958 0 O-C-N 119.302 -2.124 . . . . 24.15 108.444 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1115 ' ' MET . . . . . 0.565 ' HB3' ' CB ' ' B' 1129 ' ' ALA . 82.1 mmm -67.98 -16.93 64.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 111.971 -2.377 . . . . 29.95 113.32 -173.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1116 ' ' ASP . . . . . 0.573 ' HA ' ' HG ' ' B' 1130 ' ' LEU . 9.8 p-10 -79.6 -35.01 40.25 Favored 'General case' 0 C--O 1.253 1.244 0 O-C-N 120.018 -1.676 . . . . 34.53 109.481 171.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1117 ' ' SER . . . . . . . . . . . . . 69.1 m -87.62 31.13 0.77 Allowed 'General case' 0 C--O 1.247 0.97 0 C-N-CA 126.293 1.837 . . . . 33.49 114.451 -166.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1118 ' ' VAL . . . . . 0.624 HG12 ' HB1' ' B' 1124 ' ' ALA . 15.1 t -77.98 136.96 61.7 Favored Pre-proline 0 C--O 1.259 1.555 0 N-CA-C 107.887 -1.153 . . . . 34.02 107.887 -177.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1119 ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' B' 1118 ' ' VAL . 55.4 Cg_exo -62.06 132.31 38.7 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 124.226 3.284 . . . . 38.28 108.232 174.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1120 ' ' ARG . . . . . 0.552 ' HB2' HG11 ' B' 1375 ' ' VAL . 2.0 mmt180 -73.27 29.36 0.07 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 119.158 3.022 . . . . 55.05 119.158 -160.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1121 ' ' ILE . . . . . 0.54 HG21 HD12 ' B' 1373 ' ' ILE . 23.8 pt -90.51 162.74 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 CA-C-N 119.176 0.898 . . . . 42.09 110.582 -169.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1122 ' ' SER . . . . . 0.648 ' HB2' ' HA ' ' C' ' 133' ' ' MET . 1.1 m -51.29 -40.91 59.98 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 112.954 -1.93 . . . . 38.02 115.576 -175.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1123 ' ' ARG . . . . . . . . . . . . . 24.1 ptt-85 -72.37 -41.48 66.32 Favored 'General case' 0 C--N 1.361 1.084 0 O-C-N 119.921 -1.737 . . . . 34.29 112.632 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1124 ' ' ALA . . . . . 0.624 ' HB1' HG12 ' B' 1118 ' ' VAL . . . -53.49 -35.3 60.46 Favored 'General case' 0 N--CA 1.434 -1.232 0 O-C-N 124.957 1.411 . . . . 32.35 114.766 175.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1125 ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -58.71 -20.77 51.77 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 117.964 2.579 . . . . 47.17 117.964 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1126 ' ' SER . . . . . 0.525 ' OG ' HD12 ' B' 1127 ' ' LEU . 73.3 p -70.72 -35.89 72.93 Favored 'General case' 0 C--O 1.251 1.178 0 O-C-N 120.05 -1.656 . . . . 31.71 112.099 170.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1127 ' ' LEU . . . . . 0.604 HD22 HG11 ' B' 1354 ' ' VAL . 4.5 mp -86.56 -16.85 35.57 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.884 -1.053 . . . . 37.0 112.35 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1128 ' ' ASP . . . . . . . . . . . . . 24.3 t70 -75.09 117.38 16.87 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 126.49 3.043 . . . . 40.4 117.06 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1129 ' ' ALA . . . . . 0.565 ' CB ' ' HB3' ' B' 1115 ' ' MET . . . -70.13 -33.83 72.31 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-N 109.924 -3.307 . . . . 26.56 107.419 -176.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1130 ' ' LEU . . . . . 0.573 ' HG ' ' HA ' ' B' 1116 ' ' ASP . 32.0 mt -61.98 -35.34 78.19 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 124.045 0.938 . . . . 30.89 110.664 177.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1131 ' ' SER . . . . . . . . . . . . . 61.4 m -71.39 -51.43 24.06 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 120.937 1.699 . . . . 29.84 109.164 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1132 ' ' SER . . . . . . . . . . . . . 55.5 m -55.85 -44.45 78.02 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.51 1.505 . . . . 31.91 112.47 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1133 ' ' MET . . . . . 0.607 ' HB3' ' HB3' ' B' 1316 ' ' PRO . 36.7 mmt -71.56 -33.66 69.3 Favored 'General case' 0 CA--C 1.51 -0.57 0 O-C-N 121.175 -0.953 . . . . 25.9 111.101 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1134 ' ' ALA . . . . . 0.609 ' HB1' ' HB2' ' B' 1176 ' ' ALA . . . -66.72 -38.15 86.12 Favored 'General case' 0 C--O 1.201 -1.483 0 O-C-N 119.767 -1.833 . . . . 26.62 110.558 170.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.45 -30.75 71.17 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 120.126 1.33 . . . . 36.97 113.064 176.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1136 ' ' ILE . . . . . . . . . . . . . 39.3 mm -58.37 -56.96 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 CA-C-O 117.492 -1.242 . . . . 32.11 110.231 164.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1137 ' ' ALA . . . . . 0.427 ' HB2' ' HG3' ' B' 1316 ' ' PRO . . . -53.76 -37.96 63.92 Favored 'General case' 0 CA--C 1.508 -0.64 0 O-C-N 124.901 1.376 . . . . 24.14 112.985 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -71.74 -40.71 57.91 Favored Glycine 0 N--CA 1.441 -1.033 0 CA-C-O 122.22 0.9 . . . . 25.13 111.492 -176.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 4.5 t80 -68.25 -41.86 80.52 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 120.847 -1.384 . . . . 32.73 108.405 174.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1140 ' ' ARG . . . . . 0.495 ' HA ' ' HB ' ' B' 1143 ' ' VAL . 11.5 tpt180 -71.2 -19.68 62.36 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 118.51 -0.757 . . . . 26.36 110.901 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1141 ' ' ALA . . . . . 0.74 ' HB2' HD21 ' B' 1284 ' ' LEU . . . -60.34 -52.72 64.07 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 119.721 1.146 . . . . 24.12 108.682 171.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 42.6 mm -64.98 -36.08 76.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 O-C-N 124.219 0.949 . . . . 23.37 111.623 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1143 ' ' VAL . . . . . 0.495 ' HB ' ' HA ' ' B' 1140 ' ' ARG . 57.2 t -65.58 -67.39 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 C-N-CA 124.018 0.927 . . . . 24.96 112.112 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -55.56 -31.95 62.59 Favored 'General case' 0 C--N 1.354 0.783 0 O-C-N 120.103 -1.623 . . . . 32.07 114.116 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1145 ' ' ALA . . . . . 0.634 ' HB1' HD12 ' B' 1251 ' ' ILE . . . -58.21 -57.2 13.92 Favored 'General case' 0 C--O 1.203 -1.388 0 CA-C-N 115.817 -0.629 . . . . 24.87 109.589 170.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1146 ' ' ALA . . . . . . . . . . . . . . . -58.04 -38.95 77.21 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.831 0.824 . . . . 24.67 113.051 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 83.4 t60 -51.7 -56.96 10.68 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.699 -1.137 . . . . 28.58 111.152 170.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1148 ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -90.13 1.76 56.04 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 115.557 1.688 . . . . 36.82 115.557 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1149 ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' B' 1145 ' ' ALA . 0.7 OUTLIER -72.23 153.06 41.79 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.886 1.674 . . . . 31.97 109.277 -174.386 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B 1150 ' ' GLY . . . . . 0.561 ' HA2' ' HG2' ' A' 1320 ' ' PRO . . . -86.24 -36.06 10.25 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 117.211 -1.883 . . . . 25.49 112.685 169.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1151 ' ' ARG . . . . . 0.843 ' HA ' ' HB2' ' A' 1322 ' ' GLN . 25.8 mtm-85 -119.05 -177.95 3.45 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 122.717 3.258 . . . . 59.84 115.893 -168.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1152 ' ' PHE . . . . . 0.723 ' HB2' HG11 ' B' 1163 ' ' VAL . 18.2 m-30 -81.75 165.66 20.74 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 124.124 1.916 . . . . 34.45 110.092 175.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1153 ' ' PHE . . . . . 0.523 ' HB3' ' HB2' ' B' 1189 ' ' ALA . 56.7 m-85 -82.31 -49.89 9.55 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.415 -1.266 . . . . 31.17 111.605 166.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1154 ' ' THR . . . . . . . . . . . . . 3.1 m -65.31 142.42 58.26 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.684 1.193 . . . . 33.89 111.31 -176.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -80.52 72.35 2.68 Favored Glycine 0 C--N 1.34 0.786 0 O-C-N 117.871 -3.018 . . . . 38.95 108.754 169.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1156 ' ' GLN . . . . . 0.439 ' H ' ' HB ' ' B' 1163 ' ' VAL . 12.7 tt0 -89.82 114.53 26.27 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 123.169 1.461 . . . . 54.23 110.77 -163.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 6.9 mm -67.87 95.07 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 113.441 -1.709 . . . . 51.16 106.426 166.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1158 ' ' THR . . . . . 0.561 HG21 HD13 ' A' 1326 ' ' LEU . 10.3 m -95.9 157.24 15.99 Favored 'General case' 0 C--O 1.249 1.069 0 N-CA-C 108.03 -1.1 . . . . 49.61 108.03 -172.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -46.92 -51.56 16.56 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.024 0.75 . . . . 49.05 113.024 174.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1160 ' ' ALA . . . . . 0.535 ' HA ' ' HA ' ' A' 1126 ' ' SER . . . -63.65 -58.27 7.44 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 114.659 1.355 . . . . 47.65 114.659 173.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1161 ' ' GLY . . . . . 0.418 ' HA3' HG21 ' A' 1329 ' ' THR . . . -159.87 179.18 35.6 Favored Glycine 0 C--O 1.25 1.119 0 CA-C-O 118.079 -1.401 . . . . 45.61 110.864 -168.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 95.6 mttt -94.46 140.14 30.21 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.169 -1.048 . . . . 57.46 108.169 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1163 ' ' VAL . . . . . 0.723 HG11 ' HB2' ' B' 1152 ' ' PHE . 59.2 t -97.41 128.57 34.32 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-N 114.59 -1.186 . . . . 42.93 112.573 176.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1164 ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' B' 1165 ' ' PRO . 92.7 Cg_endo -71.21 130.42 17.54 Favored 'Trans proline' 0 N--CA 1.483 0.911 0 C-N-CA 122.84 2.36 . . . . 39.29 108.322 174.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1165 ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' B' 1164 ' ' PRO . 39.4 Cg_exo -68.27 146.1 68.25 Favored 'Trans proline' 0 C--O 1.245 0.829 0 C-N-CA 123.251 2.634 . . . . 34.17 111.02 -172.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1166 ' ' ALA . . . . . 0.417 ' CB ' ' HA ' ' B' 1153 ' ' PHE . . . -68.98 119.41 13.23 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-O 123.731 1.729 . . . . 31.69 111.438 170.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1167 ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' B' 1190 ' ' ILE . 87.9 mttt -89.41 98.04 11.54 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 125.42 2.533 . . . . 44.78 107.566 171.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1168 ' ' VAL . . . . . 0.446 HG12 HG23 ' B' 1170 ' ' VAL . 60.5 t -89.03 100.48 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 109.739 -3.391 . . . . 31.23 108.867 -178.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1169 ' ' MET . . . . . 0.468 ' HA ' ' O ' ' B' 1192 ' ' ARG . 42.6 ttp -85.02 89.93 7.72 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.29 -0.868 . . . . 37.09 108.908 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1170 ' ' VAL . . . . . 0.446 HG23 HG12 ' B' 1168 ' ' VAL . 62.8 t -83.22 105.45 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-O 122.728 1.252 . . . . 30.17 108.415 177.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1171 ' ' ILE . . . . . 0.566 ' HB ' ' HA ' ' B' 1254 ' ' THR . 97.3 mt -88.93 87.86 2.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 105.285 -2.117 . . . . 33.74 105.285 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1172 ' ' GLY . . . . . 0.477 ' O ' ' HA3' ' B' 1177 ' ' GLY . . . 134.37 95.85 0.54 Allowed Glycine 0 N--CA 1.437 -1.298 0 CA-C-N 113.499 -1.682 . . . . 32.59 109.962 178.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1173 ' ' ALA . . . . . . . . . . . . . . . -92.99 46.09 1.21 Allowed 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 119.911 1.856 . . . . 32.42 112.978 -175.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -134.22 151.94 20.44 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 108.241 -1.944 . . . . 31.74 108.241 -174.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 23.4 t 24.97 -84.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 127.324 2.249 . . . . 31.48 115.242 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1176 ' ' ALA . . . . . 0.609 ' HB2' ' HB1' ' B' 1134 ' ' ALA . . . -62.61 -41.36 98.95 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 123.418 1.58 . . . . 26.12 111.137 -175.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1177 ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' B' 1172 ' ' GLY . . . -68.95 -31.37 72.52 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 113.093 -1.867 . . . . 25.73 111.284 177.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1178 ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.0 -48.41 81.67 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 121.445 2.622 . . . . 32.59 108.126 175.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -61.43 -46.78 88.69 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 112.764 0.653 . . . . 27.72 112.764 176.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -56.86 -46.52 81.72 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 121.993 0.902 . . . . 26.03 112.875 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1181 ' ' ILE . . . . . 0.605 HG22 ' SD ' ' B' 1207 ' ' MET . 72.5 mt -60.11 -50.55 79.74 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.435 0 C-N-CA 126.559 1.944 . . . . 28.61 107.784 174.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -48.07 -55.78 9.78 Favored Glycine 0 N--CA 1.44 -1.042 0 O-C-N 124.228 0.955 . . . . 25.23 113.151 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -63.9 -51.09 66.12 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 117.754 -1.117 . . . . 24.09 110.882 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -62.23 -43.77 98.08 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-O 123.549 1.642 . . . . 26.68 113.963 -175.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -67.24 -40.35 86.29 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 119.346 -2.096 . . . . 36.57 109.02 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1186 ' ' SER . . . . . 0.942 ' HB3' ' HA ' ' A' 1187 ' ' LEU . 61.0 m -66.44 -23.63 66.32 Favored 'General case' 0 C--O 1.25 1.088 0 CA-C-N 119.914 1.234 . . . . 28.92 113.226 173.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1187 ' ' LEU . . . . . 0.405 ' HG ' HD21 ' A' 1187 ' ' LEU . 19.5 mt -84.32 6.8 21.61 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 119.871 -1.768 . . . . 29.09 112.997 165.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 83.62 14.05 74.27 Favored Glycine 0 CA--C 1.538 1.524 0 O-C-N 118.546 -2.596 . . . . 29.26 114.33 172.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1189 ' ' ALA . . . . . 0.523 ' HB2' ' HB3' ' B' 1153 ' ' PHE . . . -88.98 143.76 26.63 Favored 'General case' 0 N--CA 1.433 -1.276 0 O-C-N 120.843 -1.386 . . . . 30.16 112.396 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1190 ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' B' 1167 ' ' LYS . 97.0 mt -76.77 97.43 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 105.13 -2.174 . . . . 35.81 105.13 174.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1191 ' ' VAL . . . . . 0.441 HG11 HG12 ' B' 1181 ' ' ILE . 47.7 t -74.35 115.95 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 104.955 -2.239 . . . . 31.97 104.955 176.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1192 ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' B' 1169 ' ' MET . 83.3 mtt180 -103.3 77.91 1.57 Allowed 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 106.438 -1.69 . . . . 48.16 106.438 174.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1193 ' ' ALA . . . . . 0.625 ' HB3' HG21 ' B' 1204 ' ' VAL . . . -87.07 155.64 20.06 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 114.719 1.377 . . . . 35.89 114.719 -172.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 44.7 t80 -138.87 139.25 38.05 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 104.872 -2.27 . . . . 41.88 104.872 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1195 ' ' ASP . . . . . . . . . . . . . 8.8 t0 -146.1 150.07 35.23 Favored 'General case' 0 C--O 1.245 0.857 0 N-CA-C 102.289 -3.226 . . . . 38.28 102.289 165.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1196 ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -72.15 -27.47 62.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 120.383 -1.448 . . . . 40.62 111.605 176.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1197 ' ' ARG . . . . . . . . . . . . . 36.5 mtm180 -84.4 132.09 48.34 Favored Pre-proline 0 N--CA 1.444 -0.759 0 N-CA-C 115.876 1.806 . . . . 53.09 115.876 -171.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -69.31 -30.32 24.58 Favored 'Trans proline' 0 CA--C 1.498 -1.291 0 C-N-CA 122.906 2.404 . . . . 42.56 117.35 -176.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -54.89 -26.74 37.83 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 113.199 0.814 . . . . 56.31 113.199 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1200 ' ' VAL . . . . . 0.56 ' HB ' ' NE2' ' B' 1203 ' ' GLN . 3.5 m -114.5 20.34 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 CA-C-O 123.59 1.662 . . . . 42.91 114.717 -173.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 58.0 tttm -69.94 -56.12 7.86 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 122.53 1.157 . . . . 48.89 110.931 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -55.66 -43.51 76.36 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 115.957 1.836 . . . . 51.7 115.957 -165.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1203 ' ' GLN . . . . . 0.56 ' NE2' ' HB ' ' B' 1200 ' ' VAL . 9.6 pt20 -43.37 -38.51 2.76 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 119.307 3.077 . . . . 52.57 119.307 -175.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1204 ' ' VAL . . . . . 0.625 HG21 ' HB3' ' B' 1193 ' ' ALA . 43.7 t -71.91 -47.05 57.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 106.058 -1.83 . . . . 33.79 106.058 -177.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -62.65 -44.58 95.9 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.773 -0.455 . . . . 36.58 109.773 175.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1206 ' ' SER . . . . . . . . . . . . . 16.8 m -60.87 -22.24 64.06 Favored 'General case' 0 CA--C 1.504 -0.808 0 C-N-CA 127.186 2.194 . . . . 39.61 115.333 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1207 ' ' MET . . . . . 0.694 ' SD ' ' HG ' ' C' ' 75' ' ' LEU . 27.0 mtp -87.59 -23.59 24.25 Favored 'General case' 0 C--O 1.253 1.249 0 CA-C-O 123.98 1.848 . . . . 37.45 111.523 175.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 95.32 73.58 1.19 Allowed Glycine 0 CA--C 1.5 -0.858 0 O-C-N 118.274 -2.766 . . . . 31.87 107.158 -175.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1209 ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' B' 1191 ' ' VAL . . . -169.67 -170.96 1.12 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 109.842 -3.179 . . . . 35.4 106.448 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -125.45 147.55 49.16 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 121.581 1.992 . . . . 47.89 111.885 -172.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 14.9 t80 -105.92 138.95 41.22 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 105.673 -1.973 . . . . 45.53 105.673 173.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1212 ' ' LEU . . . . . . . . . . . . . 78.9 mt -86.86 128.06 35.04 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 122.449 1.119 . . . . 46.33 111.344 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -94.44 145.2 24.94 Favored 'General case' 0 C--O 1.254 1.317 0 CA-C-N 112.299 -2.228 . . . . 60.41 111.72 177.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.62 153.51 17.68 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 114.184 -1.371 . . . . 57.38 108.775 -175.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 18.2 t70 . . . . . 0 CA--C 1.506 -0.738 0 N-CA-C 112.72 0.637 . . . . 65.07 112.72 -178.329 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B 1230 ' ' MET . . . . . 0.645 ' N ' ' HG ' ' B' 1231 ' ' SER . 16.3 mmt . . . . . 0 N--CA 1.432 -1.372 1 N-CA-C 99.374 -4.306 . . . . 80.32 99.374 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1231 ' ' SER . . . . . 0.645 ' HG ' ' N ' ' B' 1230 ' ' MET . 67.1 m 127.5 147.28 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.348 3 O-C-N 110.924 -7.36 . . . . 79.92 107.109 -10.319 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -63.79 150.54 44.43 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 120.618 1.554 . . . . 77.91 110.338 -172.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 65.92 -43.11 0.38 Allowed 'General case' 0 C--N 1.356 0.888 0 C-N-CA 125.065 1.346 . . . . 73.88 114.08 -170.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 12.0 t80 -56.35 -50.91 70.14 Favored 'General case' 0 CA--C 1.507 -0.707 0 O-C-N 118.935 -2.353 . . . . 68.98 109.996 172.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 30.3 pt -54.77 -31.87 24.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 112.57 -2.104 . . . . 64.53 113.048 172.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -74.43 -30.45 61.91 Favored 'General case' 0 C--O 1.218 -0.598 0 O-C-N 117.947 -2.971 . . . . 66.36 111.632 172.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -64.61 -41.75 96.01 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-N 119.629 1.104 . . . . 56.6 110.645 170.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -55.85 -52.66 63.27 Favored 'General case' 0 C--O 1.249 1.065 0 O-C-N 121.606 -0.684 . . . . 56.79 111.368 169.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1239 ' ' MET . . . . . 0.403 ' HG2' ' O ' ' B' 1266 ' ' LEU . 14.2 mtm -49.05 -45.05 42.34 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 114.589 1.329 . . . . 53.63 114.589 174.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -65.59 -37.1 85.67 Favored 'General case' 0 C--O 1.247 0.971 0 CA-C-O 123.042 1.401 . . . . 51.74 109.995 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 31.4 tp -63.17 -44.75 94.55 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 118.319 -2.738 . . . . 44.86 107.474 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 11.4 m-30 -68.85 -37.57 79.22 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.362 -1.29 . . . . 42.78 109.772 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -62.48 -33.73 75.45 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 121.123 1.783 . . . . 40.96 109.58 175.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -66.23 -47.52 73.53 Favored 'General case' 0 C--N 1.345 0.413 0 CA-C-O 122.253 1.025 . . . . 43.06 110.278 173.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -63.97 -25.54 68.18 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.588 -1.642 . . . . 46.45 113.241 176.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -31.85 -51.16 0.22 Allowed 'General case' 0 N--CA 1.472 0.671 1 N-CA-C 122.109 4.114 . . . . 41.78 122.109 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 6.2 tptt -86.08 -18.28 32.84 Favored 'General case' 0 C--N 1.347 0.49 0 O-C-N 120.438 -1.414 . . . . 52.2 111.874 176.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1248 ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -80.96 -48.15 12.68 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 118.745 -2.472 . . . . 53.55 112.618 172.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1249 ' ' VAL . . . . . . . . . . . . 0.255 26.8 m -71.02 137.38 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 CA-C-O 126.54 3.067 . . . . 34.41 114.933 -168.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1250 ' ' ASP . . . . . 0.435 ' HB3' ' CZ ' ' B' 1149 ' ' PHE . 3.8 m-20 -98.29 -51.43 3.99 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 108.62 -3.9 . . . . 33.38 111.225 -176.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1251 ' ' ILE . . . . . 0.634 HD12 ' HB1' ' B' 1145 ' ' ALA . 40.4 mm -126.39 111.7 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 O-C-N 118.439 -2.663 . . . . 29.54 106.543 -174.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1252 ' ' ILE . . . . . 0.468 HG22 ' HB ' ' B' 1254 ' ' THR . 61.8 mt -98.28 108.62 22.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 105.947 -1.871 . . . . 32.44 105.947 176.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1253 ' ' VAL . . . . . 0.441 ' HB ' ' HA ' ' B' 1170 ' ' VAL . 39.9 t -90.71 87.13 2.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 N-CA-C 102.342 -3.207 . . . . 30.57 102.342 176.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1254 ' ' THR . . . . . 0.568 HG23 ' HB2' ' B' 1291 ' ' ASN 0.275 2.0 t -88.33 96.17 10.47 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 103.452 -2.795 . . . . 35.04 103.452 -176.361 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B 1255 ' ' THR . . . . . 0.582 ' HA ' ' HB2' ' B' 1284 ' ' LEU . 21.6 m -90.11 -73.56 0.52 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 109.795 -3.366 . . . . 34.62 108.515 -175.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1256 ' ' ALA . . . . . 0.539 ' HB3' ' OD1' ' B' 1291 ' ' ASN . . . 45.3 1.51 0.0 OUTLIER 'General case' 0 C--O 1.242 0.671 1 N-CA-C 123.175 4.509 . . . . 42.72 123.175 -178.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B 1257 ' ' LEU . . . . . 0.467 ' HB2' ' O2A' ' B' ' 1' ' ' NAD . 2.6 mp -65.64 92.79 0.15 Allowed 'General case' 0 C--O 1.242 0.68 0 CA-C-N 123.173 2.715 . . . . 52.43 113.863 -177.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1258 ' ' ILE . . . . . 0.6 HG23 ' H8A' ' B' ' 1' ' ' NAD . 0.3 OUTLIER -76.0 137.59 69.21 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 112.319 -2.218 . . . . 59.41 108.7 171.612 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -55.22 113.3 1.35 Allowed 'Trans proline' 0 N--CA 1.444 -1.411 0 C-N-CA 124.499 3.466 . . . . 62.68 116.391 -165.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 89.77 -36.4 3.54 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 109.772 -1.331 . . . . 64.16 109.772 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1261 ' ' LYS . . . . . 0.499 ' HB2' HG13 ' B' 1258 ' ' ILE . 70.6 mttt -75.16 135.69 73.12 Favored Pre-proline 0 C--O 1.247 0.95 0 CA-C-N 120.886 2.343 . . . . 68.53 107.63 -175.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.58 145.49 98.72 Favored 'Trans proline' 0 CA--C 1.5 -1.205 0 C-N-CA 123.895 3.064 . . . . 61.99 113.097 161.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1263 ' ' ALA . . . . . . . . . . . . . . . -81.92 128.81 67.14 Favored Pre-proline 0 C--O 1.24 0.561 0 O-C-N 120.618 -1.301 . . . . 57.15 112.833 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -64.32 153.03 78.93 Favored 'Trans proline' 0 C--O 1.247 0.969 0 C-N-CA 122.416 2.077 . . . . 51.57 116.101 169.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1265 ' ' LYS . . . . . 0.416 ' NZ ' ' O ' ' B' 1289 ' ' GLY . 41.9 mmtm -77.22 88.59 3.67 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 122.603 1.192 . . . . 54.55 110.065 -174.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1266 ' ' LEU . . . . . 0.403 ' O ' ' HG2' ' B' 1239 ' ' MET . 68.6 mt -80.35 -43.49 21.06 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 115.102 1.519 . . . . 46.86 115.102 178.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1267 ' ' ILE . . . . . 0.591 HG21 HD13 ' B' 1281 ' ' ILE . 35.1 mm -87.7 101.94 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 105.809 -1.923 . . . . 41.04 105.809 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1268 ' ' THR . . . . . 0.482 ' O ' HG23 ' B' 1272 ' ' VAL . 24.4 p -73.96 159.16 33.15 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-N 113.858 -1.519 . . . . 39.58 112.484 -178.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1269 ' ' ARG . . . . . . . . . . . . . 79.1 mtt85 -55.45 -43.42 75.42 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 115.997 -0.547 . . . . 53.15 110.471 172.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -56.37 -41.33 76.01 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 113.816 1.043 . . . . 42.96 113.816 175.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1271 ' ' MET . . . . . 0.44 ' SD ' HG23 ' B' 1267 ' ' ILE . 43.4 ttm -65.94 -47.79 73.48 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.704 -0.68 . . . . 43.89 110.189 -177.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1272 ' ' VAL . . . . . 0.482 HG23 ' O ' ' B' 1268 ' ' THR . 38.5 t -65.68 -41.97 91.67 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.671 0 CA-C-O 121.467 0.651 . . . . 38.37 110.922 -177.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -63.13 -35.78 81.43 Favored 'General case' 0 C--O 1.239 0.541 0 O-C-N 118.53 -2.606 . . . . 47.46 112.664 173.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1274 ' ' SER . . . . . . . . . . . . . 72.8 m -70.14 -25.34 63.43 Favored 'General case' 0 N--CA 1.441 -0.917 0 O-C-N 120.845 -1.16 . . . . 38.38 113.868 173.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1275 ' ' MET . . . . . 0.491 ' SD ' HD11 ' B' 1281 ' ' ILE . 40.2 mtp -60.79 163.53 5.57 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 117.95 2.574 . . . . 37.81 117.95 -174.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 81.8 tttt -62.95 131.79 49.88 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 110.242 -3.163 . . . . 49.26 108.97 166.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1277 ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' 1045 ' ' PHE . . . -84.24 166.37 17.58 Favored 'General case' 0 CA--C 1.51 -0.594 0 O-C-N 124.83 1.331 . . . . 34.46 110.023 -177.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 63.2 30.53 77.81 Favored Glycine 0 C--N 1.334 0.467 0 O-C-N 120.886 -1.134 . . . . 33.53 111.861 -172.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1279 ' ' SER . . . . . . . . . . . . . 42.3 m -126.5 146.81 49.97 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 106.062 -1.829 . . . . 31.31 106.062 -176.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1280 ' ' VAL . . . . . 0.412 HG11 ' HA ' ' B' 1145 ' ' ALA . 58.1 t -117.66 135.36 58.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 122.592 1.187 . . . . 29.32 109.278 -171.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1281 ' ' ILE . . . . . 0.591 HD13 HG21 ' B' 1267 ' ' ILE . 67.4 mt -110.62 104.09 16.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 103.601 -2.74 . . . . 31.93 103.601 178.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1282 ' ' VAL . . . . . 0.698 HG11 ' HA ' ' B' 1141 ' ' ALA . 31.7 t -95.78 111.72 26.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 N-CA-C 101.681 -3.451 . . . . 29.48 101.681 -175.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 36.8 t0 -87.67 107.01 18.42 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.231 -1.349 . . . . 34.5 108.544 175.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1284 ' ' LEU . . . . . 0.74 HD21 ' HB2' ' B' 1141 ' ' ALA . 19.6 mt -79.02 -17.21 55.72 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 118.609 -1.236 . . . . 37.94 111.045 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -102.12 29.23 5.22 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.664 0.745 . . . . 40.92 111.868 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -51.83 -36.59 48.63 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.64 1.976 . . . . 44.39 115.797 177.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1287 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.19 -38.86 21.74 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.497 1.119 . . . . 51.46 110.347 171.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 11.3 t30 -98.37 71.95 2.07 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-O 121.482 0.658 . . . . 57.75 111.574 -171.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1289 ' ' GLY . . . . . 0.416 ' O ' ' NZ ' ' B' 1265 ' ' LYS . . . 86.61 -40.74 3.07 Favored Glycine 0 N--CA 1.47 0.948 0 CA-C-O 117.949 -1.473 . . . . 49.85 113.614 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 72.57 119.73 0.06 OUTLIER Glycine 0 CA--C 1.541 1.672 0 CA-C-N 121.42 2.61 . . . . 45.93 112.195 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1291 ' ' ASN . . . . . 0.568 ' HB2' HG23 ' B' 1254 ' ' THR . 54.8 m-80 -85.52 -21.75 28.46 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.625 1.17 . . . . 42.67 110.034 -175.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1292 ' ' CYS . . . . . 0.486 ' HB3' ' OG1' ' B' 1295 ' ' THR . 27.1 t -110.83 132.19 54.41 Favored 'General case' 0 CA--C 1.51 -0.582 0 O-C-N 118.503 -2.623 . . . . 38.82 111.608 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1293 ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -58.17 -41.79 84.62 Favored 'General case' 0 C--O 1.245 0.856 0 CA-C-O 121.399 0.619 . . . . 46.71 111.928 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -75.56 -7.71 54.91 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 115.37 1.618 . . . . 47.23 115.37 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1295 ' ' THR . . . . . 0.563 HG23 ' HA3' ' B' 1311 ' ' GLY . 38.6 m -53.89 122.3 9.75 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.239 0.616 . . . . 36.02 112.551 172.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1296 ' ' VAL . . . . . 0.558 HG23 ' HB2' ' B' 1301 ' ' PHE . 26.3 t -89.0 106.31 12.84 Favored Pre-proline 0 N--CA 1.488 1.452 0 N-CA-C 101.993 -3.336 . . . . 37.26 101.993 161.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -59.97 76.15 0.06 OUTLIER 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 125.227 3.951 . . . . 35.09 115.536 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1298 ' ' GLY . . . . . 0.567 ' HA2' ' H ' ' B' 1313 ' ' THR . . . 149.24 -14.92 1.12 Allowed Glycine 0 CA--C 1.528 0.887 0 CA-C-N 113.218 -1.81 . . . . 35.97 111.679 -178.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -139.48 -174.31 3.85 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 123.487 3.643 . . . . 40.39 112.262 -174.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1300 ' ' ILE . . . . . 0.756 HG12 HG12 ' B' 1310 ' ' ILE . 30.7 mt -88.44 133.91 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-N 113.917 -1.492 . . . . 37.43 109.374 166.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1301 ' ' PHE . . . . . 0.558 ' HB2' HG23 ' B' 1296 ' ' VAL . 61.8 t80 -108.66 116.84 32.74 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 107.223 -1.399 . . . . 44.13 107.223 159.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1302 ' ' THR . . . . . 0.659 HG23 ' HG2' ' B' 1308 ' ' LYS . 13.9 m -84.82 112.38 20.48 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.632 -1.618 . . . . 39.78 106.632 172.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1303 ' ' THR . . . . . . . . . . . . . 34.5 p -74.36 162.32 28.99 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 120.879 -1.138 . . . . 43.29 111.628 175.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -49.96 -47.72 52.49 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 125.192 1.397 . . . . 53.07 114.313 -168.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1305 ' ' ASN . . . . . 0.537 ' OD1' HG23 ' B' 1307 ' ' VAL . 47.7 p30 -70.51 -23.96 62.74 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 115.531 1.678 . . . . 43.97 115.531 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 114.38 21.13 5.62 Favored Glycine 0 CA--C 1.529 0.932 0 O-C-N 121.177 -0.952 . . . . 41.12 111.885 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1307 ' ' VAL . . . . . 0.537 HG23 ' OD1' ' B' 1305 ' ' ASN . 47.6 t -80.08 128.56 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 O-C-N 119.6 -2.118 . . . . 38.12 106.439 163.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1308 ' ' LYS . . . . . 0.659 ' HG2' HG23 ' B' 1302 ' ' THR . 92.6 mttt -109.76 114.67 28.43 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-N 120.58 1.536 . . . . 36.34 109.285 -176.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1309 ' ' VAL . . . . . . . . . . . . . 44.0 t -89.88 103.26 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 O-C-N 120.589 -1.32 . . . . 30.4 110.059 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1310 ' ' ILE . . . . . 0.756 HG12 HG12 ' B' 1300 ' ' ILE . 40.4 mt -92.93 104.4 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.98 0 N-CA-C 104.921 -2.252 . . . . 30.82 104.921 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1311 ' ' GLY . . . . . 0.563 ' HA3' HG23 ' B' 1295 ' ' THR . . . -124.09 81.59 0.35 Allowed Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 104.246 -3.542 . . . . 26.53 104.246 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1312 ' ' TYR . . . . . 0.692 ' HB2' ' HG ' ' B' 1315 ' ' LEU . 16.9 m-85 -92.4 137.82 32.04 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 120.452 -1.617 . . . . 38.0 111.849 176.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1313 ' ' THR . . . . . 0.567 ' H ' ' HA2' ' B' 1298 ' ' GLY . 3.4 p -61.72 -36.37 80.76 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.79 -1.189 . . . . 29.8 107.79 168.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -83.49 12.13 6.04 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 118.143 2.645 . . . . 39.04 118.143 -175.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1315 ' ' LEU . . . . . 0.692 ' HG ' ' HB2' ' B' 1312 ' ' TYR . 12.2 mt -58.37 -42.76 96.45 Favored Pre-proline 0 C--O 1.245 0.831 0 O-C-N 118.671 -2.518 . . . . 31.08 114.992 170.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1316 ' ' PRO . . . . . 0.607 ' HB3' ' HB3' ' B' 1133 ' ' MET . 83.4 Cg_exo -67.22 -3.45 9.9 Favored 'Trans proline' 0 C--O 1.24 0.602 0 C-N-CA 122.509 2.139 . . . . 26.1 113.361 169.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -89.12 -57.26 1.81 Allowed Glycine 0 CA--C 1.536 1.373 0 O-C-N 119.243 -2.16 . . . . 23.17 110.409 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1318 ' ' ARG . . . . . 0.431 ' HB2' ' HG2' ' B' 1140 ' ' ARG . 79.0 mtt180 -68.89 52.65 0.09 Allowed 'General case' 0 CA--C 1.529 0.139 1 N-CA-C 122.582 4.29 . . . . 40.4 122.582 -158.088 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B 1319 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -133.66 76.47 66.33 Favored Pre-proline 0 C--O 1.236 0.394 0 O-C-N 118.579 -2.576 . . . . 23.6 104.94 151.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1320 ' ' PRO . . . . . 0.566 ' HG2' ' HA2' ' A' 1150 ' ' GLY . 18.1 Cg_endo -35.32 -70.78 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.199 3.266 . . . . 22.35 120.553 -166.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1321 ' ' THR . . . . . 0.516 HG23 HG21 ' B' 1019 ' ' THR . 2.8 m -55.69 -43.45 76.43 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 114.858 1.429 . . . . 26.52 114.858 173.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1322 ' ' GLN . . . . . 0.759 ' HB2' ' HA ' ' A' 1151 ' ' ARG . 42.3 tp60 -72.94 -37.59 67.1 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 118.144 -2.847 . . . . 24.38 109.296 -173.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1323 ' ' SER . . . . . . . . . . . . . 49.7 m -61.13 -54.37 45.4 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 116.925 -1.512 . . . . 22.8 107.653 174.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1324 ' ' SER . . . . . . . . . . . . . 15.2 m -54.16 -35.88 62.75 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 114.417 1.266 . . . . 21.25 114.417 173.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -67.44 -57.41 6.61 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 120.921 -1.112 . . . . 31.34 110.783 173.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1326 ' ' LEU . . . . . 0.539 ' HG ' HE21 ' B' 1322 ' ' GLN . 97.3 mt -73.3 -32.6 64.71 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-N 121.765 2.075 . . . . 31.56 108.349 -166.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1327 ' ' TYR . . . . . 0.403 ' CZ ' ' HA ' ' B' 1072 ' ' VAL . 24.7 t80 -60.94 -56.97 14.83 Favored 'General case' 0 C--O 1.257 1.471 0 N-CA-C 105.421 -2.066 . . . . 22.73 105.421 169.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1328 ' ' GLY . . . . . 0.694 ' HA2' HD12 ' B' 1331 ' ' LEU . . . -48.24 -41.55 23.58 Favored Glycine 0 N--CA 1.467 0.725 0 CA-C-O 119.786 -0.452 . . . . 21.91 114.162 173.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1329 ' ' THR . . . . . 0.533 HG21 ' HA3' ' A' 1161 ' ' GLY . 16.5 m -72.0 -31.17 65.97 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 118.709 1.255 . . . . 22.15 110.598 -175.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1330 ' ' ASN . . . . . . . . . . . . . 33.0 m120 -63.6 -46.46 85.69 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.291 -0.881 . . . . 26.18 109.885 170.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1331 ' ' LEU . . . . . 0.83 HD22 HD22 ' B' 1070 ' ' LEU . 73.1 mt -53.72 -48.13 69.9 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.77 0.828 . . . . 23.68 112.224 176.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1332 ' ' VAL . . . . . 0.432 HG12 ' HE3' ' B' 1336 ' ' LYS . 90.8 t -51.92 -57.49 3.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 O-C-N 124.638 1.212 . . . . 26.57 110.804 169.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -55.06 -37.49 66.81 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.79 1.177 . . . . 28.08 112.165 -177.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1334 ' ' LEU . . . . . . . . . . . . . 32.4 tp -64.78 -49.29 71.28 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 124.779 1.3 . . . . 27.43 111.39 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1335 ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' B' 1331 ' ' LEU . 64.4 mt -62.13 -35.43 78.72 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 114.68 -1.146 . . . . 30.5 109.616 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1336 ' ' LYS . . . . . 0.473 ' NZ ' ' HG3' ' C' ' 98' ' ' GLU . 83.2 mttt -57.87 -42.04 83.71 Favored 'General case' 0 CA--C 1.512 -0.498 0 O-C-N 121.486 -0.758 . . . . 41.65 112.555 171.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 8.2 mp -72.74 -34.85 67.31 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 113.164 0.801 . . . . 42.08 113.164 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1338 ' ' LEU . . . . . 0.453 HD11 ' SD ' ' B' 1113 ' ' MET . 47.0 mt -74.59 -72.81 0.27 Allowed 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 122.804 1.288 . . . . 35.03 107.967 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1339 ' ' CYS . . . . . 0.509 ' SG ' HD13 ' B' 1346 ' ' ILE . 50.0 m -81.02 69.93 7.73 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-O 123.442 1.591 . . . . 37.33 113.982 -175.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 55.4 mttp -67.69 -6.28 19.91 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 113.65 -1.613 . . . . 50.51 115.262 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -95.07 -24.62 16.8 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.508 0.723 . . . . 54.21 110.753 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.23 34.85 21.25 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.957 1.703 . . . . 50.99 111.501 -174.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -82.7 -30.11 29.4 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 114.177 -1.374 . . . . 48.82 111.658 -172.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 116.16 22.61 4.47 Favored Glycine 0 N--CA 1.473 1.141 0 CA-C-O 118.335 -1.258 . . . . 40.43 110.319 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -134.32 140.14 46.17 Favored 'General case' 0 C--O 1.25 1.102 0 CA-C-N 120.955 2.378 . . . . 47.56 108.149 173.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1346 ' ' ILE . . . . . 0.509 HD13 ' SG ' ' B' 1339 ' ' CYS . 22.6 mm -63.9 92.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 CA-C-O 126.284 2.945 . . . . 42.49 108.807 171.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1347 ' ' THR . . . . . . . . . . . . . 61.1 m -80.19 99.36 7.75 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 100.778 -3.786 . . . . 38.12 100.778 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1348 ' ' VAL . . . . . 0.466 HG22 HG22 ' B' 1346 ' ' ILE . 6.7 t -82.32 102.42 8.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 106.515 -1.661 . . . . 37.5 106.515 -176.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1349 ' ' ASP . . . . . 0.765 ' HB3' HG21 ' B' 1355 ' ' ILE . 29.0 t70 -67.14 164.61 17.68 Favored 'General case' 0 C--O 1.214 -0.767 0 O-C-N 125.645 1.841 . . . . 43.85 110.264 178.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1350 ' ' PHE . . . . . 0.401 ' HD1' ' HA ' ' B' 1350 ' ' PHE . 0.1 OUTLIER -148.7 5.42 0.69 Allowed 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.769 -0.826 . . . . 39.81 108.769 177.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 32.4 t70 -92.18 -56.59 3.0 Favored 'General case' 0 C--O 1.247 0.946 0 N-CA-C 114.26 1.207 . . . . 51.29 114.26 -174.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 7.7 t0 -65.06 134.68 54.35 Favored 'General case' 0 C--O 1.258 1.513 0 CA-C-O 121.703 0.764 . . . . 39.78 110.381 -174.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1353 ' ' VAL . . . . . 0.487 HG21 HG13 ' B' 1373 ' ' ILE . 30.6 m -48.71 -38.52 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 116.813 2.153 . . . . 39.28 116.813 175.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1354 ' ' VAL . . . . . 0.604 HG11 HD22 ' B' 1127 ' ' LEU . 95.0 t -58.84 -59.34 3.87 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 CA-C-N 114.805 -1.089 . . . . 35.7 109.306 173.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1355 ' ' ILE . . . . . 0.765 HG21 ' HB3' ' B' 1349 ' ' ASP . 43.6 mm -61.06 -42.95 95.11 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.93 0 O-C-N 124.319 1.012 . . . . 35.77 109.557 -173.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1356 ' ' ARG . . . . . 0.636 ' HG3' ' HD3' ' B' 1371 ' ' PRO . 39.9 tpt85 -58.98 -25.01 63.22 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 120.002 -1.686 . . . . 38.55 113.865 175.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -82.33 -67.03 1.52 Allowed Glycine 0 CA--C 1.535 1.316 0 N-CA-C 110.1 -1.2 . . . . 29.58 110.1 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1358 ' ' VAL . . . . . 0.44 HG12 ' HA ' ' B' 1355 ' ' ILE . 10.0 p -54.42 -35.34 30.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 116.025 1.861 . . . . 32.06 116.025 -177.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1359 ' ' THR . . . . . . . . . . . . . 8.0 m -85.09 83.21 8.11 Favored 'General case' 0 CA--C 1.513 -0.464 0 O-C-N 118.413 -2.679 . . . . 29.0 108.173 178.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1360 ' ' VAL . . . . . 0.499 ' HB ' ' HB2' ' B' 1368 ' ' TRP . 36.0 m -76.06 -21.99 15.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 109.905 -3.316 . . . . 29.68 112.478 -168.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 60.6 mt -133.17 129.45 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 101.832 -3.396 . . . . 32.05 101.832 172.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1362 ' ' ARG . . . . . 0.702 ' HA ' HG23 ' B' 1111 ' ' THR . 11.7 mtp180 -112.45 104.83 12.97 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 123.484 1.611 . . . . 32.52 108.327 168.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 50.9 60.03 4.18 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 122.711 1.243 . . . . 35.68 111.706 171.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1364 ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' B' 1109 ' ' ASN . . . 94.46 -43.69 2.33 Favored Glycine 0 CA--C 1.529 0.911 0 O-C-N 119.019 -2.301 . . . . 34.26 110.743 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -72.45 117.59 14.3 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-O 117.711 -1.138 . . . . 51.07 109.769 -174.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 54.1 mt -73.92 94.87 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.34 0 CA-C-O 123.39 1.567 . . . . 39.87 108.368 174.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1367 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.14 -14.08 59.33 Favored 'General case' 0 C--O 1.25 1.092 0 CA-C-N 111.903 -2.408 . . . . 38.01 114.701 -173.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1368 ' ' TRP . . . . . 0.499 ' HB2' ' HB ' ' B' 1360 ' ' VAL . 73.8 t90 -59.81 140.05 89.93 Favored Pre-proline 0 N--CA 1.47 0.529 0 CA-C-N 110.941 -2.845 . . . . 42.14 106.362 170.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -78.77 178.07 35.85 Favored 'Cis proline' 0 N--CA 1.446 -1.31 0 CA-C-N 124.811 2.754 . . . . 43.26 118.12 4.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1370 ' ' ALA . . . . . . . . . . . . . . . -76.84 149.03 80.0 Favored Pre-proline 0 C--O 1.248 1.021 0 CA-C-N 110.897 -2.865 . . . . 46.52 110.718 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1371 ' ' PRO . . . . . 0.636 ' HD3' ' HG3' ' B' 1356 ' ' ARG . 92.6 Cg_endo -62.71 142.63 90.03 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.573 2.182 . . . . 51.95 113.702 170.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.0 72.57 1.55 Allowed 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 124.853 3.702 . . . . 56.27 113.648 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1373 ' ' ILE . . . . . 0.54 HD12 HG21 ' B' 1121 ' ' ILE 0.26 0.1 OUTLIER -79.71 135.12 26.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 O-C-N 119.627 -1.921 . . . . 60.83 106.929 173.957 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -75.31 116.62 16.23 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.032 -1.47 . . . . 66.1 107.032 -176.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1375 ' ' VAL . . . . . 0.552 HG11 ' HB2' ' B' 1120 ' ' ARG . 49.1 t -104.06 109.1 26.25 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 CA-C-N 113.061 -1.882 . . . . 63.47 106.712 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.223 -4.929 0 O-C-N 118.967 -2.333 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.818 0 CA-C-O 121.723 0.773 . . . . 0.0 111.997 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.66 -42.86 65.08 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 175.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.93 -43.73 77.67 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 122.572 2.442 . . . . 0.0 108.456 177.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 85.6 m -64.11 -37.91 89.15 Favored 'General case' 0 C--O 1.249 1.077 0 CA-C-O 117.924 -1.036 . . . . 0.0 111.846 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 24' ' ' ALA . . . . . 0.84 ' HB1' ' HA ' ' C' ' 186' ' ' LEU . . . -59.2 -51.58 69.37 Favored 'General case' 0 CA--C 1.559 1.326 0 CA-C-N 120.016 1.28 . . . . 0.0 110.625 173.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 25' ' ' GLU . . . . . 0.763 ' HA ' ' HE2' ' C' ' 28' ' ' LYS . 0.8 OUTLIER -54.99 -33.09 62.22 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.515 1.126 . . . . 0.0 110.897 174.637 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.7 -54.33 33.31 Favored 'General case' 0 C--O 1.214 -0.78 0 O-C-N 119.608 -1.933 . . . . 0.0 111.556 171.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.626 HD21 HD21 ' C' ' 110' ' ' LEU . 2.3 mm? -47.81 -59.02 3.62 Favored 'General case' 0 C--O 1.247 0.949 0 C-N-CA 127.187 2.195 . . . . 0.0 113.382 -175.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 28' ' ' LYS . . . . . 0.763 ' HE2' ' HA ' ' C' ' 25' ' ' GLU . 27.2 pttt -59.32 -35.91 74.68 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.328 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -79.05 -30.37 44.01 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.434 ' HB3' ' HB3' ' C' ' 107' ' ' ASP . 69.7 m -43.25 -35.99 1.64 Allowed 'General case' 0 CA--C 1.508 -0.659 1 N-CA-C 122.869 4.396 . . . . 0.0 122.869 -167.385 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 67.73 -41.62 0.43 Allowed 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.887 1.675 . . . . 0.0 112.309 -171.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 12.0 m -121.15 139.42 53.37 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 120.028 1.285 . . . . 0.0 109.533 162.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' C' ' 64' ' ' VAL . 89.0 t -130.08 125.88 60.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 175.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.597 ' HB ' HG22 ' C' ' 109' ' ' VAL . 41.5 mm -104.74 123.56 58.82 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 O-C-N 118.93 -2.356 . . . . 0.0 106.071 169.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . 0.417 HD12 ' CZ ' ' C' ' 66' ' ' PHE . 29.7 mt -100.97 128.22 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 172.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 52.7 m -113.91 107.85 51.83 Favored Pre-proline 0 N--CA 1.426 -1.643 0 C-N-CA 125.565 1.546 . . . . 0.0 108.721 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . 0.481 ' HG3' ' SD ' ' C' ' 41' ' ' MET . 32.5 Cg_exo -64.69 117.59 4.65 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.311 3.341 . . . . 0.0 110.16 170.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 38' ' ' GLY . . . . . 0.645 ' HA3' ' HB2' ' C' ' 114' ' ' ALA . . . -115.39 -155.63 10.87 Favored Glycine 0 N--CA 1.416 -2.634 0 CA-C-N 111.906 -2.406 . . . . 0.0 110.465 164.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -66.82 -42.57 85.62 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.512 -0.993 . . . . 0.0 111.202 -173.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 40' ' ' GLY . . . . . 0.625 ' HA3' ' HA3' ' C' ' 113' ' ' GLY . . . -60.52 -39.84 96.95 Favored Glycine 0 N--CA 1.437 -1.247 0 CA-C-O 117.483 -1.732 . . . . 0.0 110.781 -178.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 41' ' ' MET . . . . . 0.587 ' HA ' ' HB3' ' C' ' 46' ' ' ALA . 9.1 ttm -56.66 -43.47 80.41 Favored 'General case' 0 C--N 1.36 1.036 0 CA-C-N 122.221 3.01 . . . . 0.0 111.284 177.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.36 -36.72 26.55 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 121.617 -0.677 . . . . 0.0 112.47 -171.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 85.6 t -77.79 -64.09 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.965 1.306 . . . . 0.0 110.533 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.95 65.81 2.97 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.535 1.159 . . . . 0.0 109.626 -172.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 45' ' ' GLN . . . . . 0.592 ' HG3' ' HG3' ' C' ' 176' ' ' LYS . 8.9 pt20 17.71 36.18 0.0 OUTLIER 'General case' 0 C--O 1.245 0.863 1 N-CA-C 123.805 4.743 . . . . 0.0 123.805 175.006 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.587 ' HB3' ' HA ' ' C' ' 41' ' ' MET . . . -73.81 -14.94 61.18 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 119.033 2.975 . . . . 0.0 119.033 -176.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . 0.251 0.0 OUTLIER -65.83 -46.85 77.03 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 114.721 -2.561 . . . . 0.0 114.762 -178.358 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 48' ' ' TYR . . . . . 0.525 ' CD1' ' HD3' ' C' ' 49' ' ' PRO 0.37 2.8 p90 -65.88 -32.59 6.0 Favored Pre-proline 0 N--CA 1.474 0.771 0 CA-C-N 125.389 3.722 . . . . 0.0 115.294 174.124 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 49' ' ' PRO . . . . . 0.525 ' HD3' ' CD1' ' C' ' 48' ' ' TYR . 8.8 Cg_exo -58.96 -44.85 32.04 Favored 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 123.042 2.494 . . . . 0.0 111.293 164.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . 0.447 ' HA ' HG22 ' C' ' 53' ' ' ILE . 23.2 t -55.55 -40.64 60.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 119.59 1.086 . . . . 0.0 109.655 173.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.33 -42.04 77.03 Favored 'General case' 0 C--N 1.367 1.334 0 CA-C-N 121.004 1.729 . . . . 0.0 112.763 175.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -60.81 -40.03 91.18 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 173.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 53' ' ' ILE . . . . . 0.73 HD13 ' HA ' ' C' ' 183' ' ' LEU . 8.2 tp -75.93 -31.53 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 120.368 1.44 . . . . 0.0 109.659 177.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 89.6 m -68.89 -29.34 67.6 Favored 'General case' 0 CA--C 1.498 -1.028 0 O-C-N 119.833 -1.792 . . . . 0.0 112.458 -174.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -48.93 -67.82 0.23 Allowed 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 163.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -57.59 -41.4 81.08 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -172.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 57' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' C' ' 53' ' ' ILE . 58.0 mt -61.91 -52.25 64.84 Favored 'General case' 0 N--CA 1.434 -1.249 0 O-C-N 124.779 1.3 . . . . 0.0 109.443 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . 0.446 ' HD2' ' HA ' ' C' ' 58' ' ' ARG . 10.1 tpt180 -70.07 -36.1 74.71 Favored 'General case' 0 C--O 1.245 0.865 0 O-C-N 120.27 -1.519 . . . . 0.0 108.74 -174.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.54 -27.55 64.65 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 173.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 30.3 ttm-85 -87.8 2.34 51.58 Favored 'General case' 0 CA--C 1.543 0.712 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 175.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.22 3.36 84.89 Favored Glycine 0 C--N 1.343 0.962 0 O-C-N 118.557 -2.589 . . . . 0.0 111.782 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 88.2 mt -66.87 130.05 31.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 CA-C-N 118.732 1.266 . . . . 0.0 109.676 -177.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -70.11 75.67 0.5 Allowed 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 122.844 1.307 . . . . 0.0 109.111 169.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 2.9 p -86.64 103.28 12.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-O 123.096 1.427 . . . . 0.0 107.76 173.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 65' ' ' ARG . . . . . 0.532 ' NH2' HD22 ' C' ' 94' ' ' LEU . 50.0 mmm-85 -108.74 151.4 26.25 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 124.833 2.254 . . . . 0.0 109.573 173.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . 0.869 ' HB2' ' HA ' ' C' ' 93' ' ' VAL . 19.8 m-85 -106.94 114.5 28.62 Favored 'General case' 0 C--O 1.251 1.142 0 C-N-CA 117.664 -1.614 . . . . 0.0 108.049 -176.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . 0.473 ' HA3' ' HE2' ' C' ' 103' ' ' PHE . . . -98.99 98.57 2.01 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 106.79 -2.524 . . . . 0.0 106.79 176.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 68' ' ' ILE . . . . . 0.636 HD11 HG13 ' C' ' 93' ' ' VAL . 3.2 mp -89.93 140.25 16.2 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -114.21 121.74 35.84 Favored Pre-proline 0 CA--C 1.506 -0.747 0 CA-C-O 116.034 -1.936 . . . . 0.0 106.029 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 70' ' ' PRO . . . . . 0.659 ' HB3' HG13 ' A' 1157 ' ' ILE . 32.1 Cg_endo -61.56 -50.52 5.42 Favored 'Trans proline' 0 N--CA 1.482 0.823 0 C-N-CA 124.237 3.291 . . . . 0.0 112.214 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 73.0 t -72.86 96.71 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.256 1.397 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 168.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -158.54 128.58 5.92 Favored 'General case' 0 C--O 1.259 1.585 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 176.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.23 -102.79 0.83 Allowed Glycine 0 C--N 1.319 -0.397 0 O-C-N 121.535 -0.728 . . . . 0.0 111.454 167.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.14 122.34 5.05 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -172.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.694 ' HG ' ' SD ' ' B' 1207 ' ' MET . 0.2 OUTLIER 67.09 115.76 0.03 OUTLIER Pre-proline 0 N--CA 1.444 -0.734 0 C-N-CA 125.73 1.612 . . . . 0.0 111.598 -177.313 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 76' ' ' PRO . . . . . 0.47 ' HD3' ' O7N' ' C' 1001 ' ' NAP . 72.0 Cg_endo -69.09 172.48 11.91 Favored 'Trans proline' 0 C--O 1.26 1.614 0 C-N-CA 123.508 2.805 . . . . 0.0 114.386 169.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.63 -104.69 1.35 Allowed Glycine 0 N--CA 1.441 -0.971 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 -166.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 34.02 -78.07 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 127.256 2.222 . . . . 0.0 116.018 160.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -61.86 -41.44 97.84 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 119.404 1.002 . . . . 0.0 113.078 -175.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -85.82 -23.46 27.15 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 113.944 -1.48 . . . . 0.0 112.249 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 98.7 t -62.37 -51.78 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 171.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 11.1 mt -57.95 -29.78 65.44 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 170.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.568 ' HG ' ' HB ' ' C' ' 88' ' ' VAL . 11.8 tp -62.0 -37.26 84.18 Favored 'General case' 0 C--O 1.239 0.517 0 O-C-N 119.673 -1.892 . . . . 0.0 111.498 167.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.4 -43.16 74.03 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 120.542 -1.349 . . . . 0.0 109.704 173.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -60.05 -31.05 69.62 Favored 'General case' 0 C--N 1.348 0.5 0 O-C-N 120.089 -1.632 . . . . 0.0 113.391 173.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' C' ' 83' ' ' LEU 0.261 . . -73.24 -5.93 42.65 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 120.245 -1.534 . . . . 0.0 112.236 171.752 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 65.49 29.44 11.19 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 118.515 -2.616 . . . . 0.0 116.735 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 88' ' ' VAL . . . . . 0.568 ' HB ' ' HG ' ' C' ' 83' ' ' LEU . 78.0 t -82.83 123.0 78.45 Favored Pre-proline 0 N--CA 1.438 -1.031 0 CA-C-N 112.711 -2.041 . . . . 0.0 106.281 172.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -60.12 103.59 0.21 Allowed 'Trans proline' 0 CA--C 1.545 1.037 1 C-N-CA 125.69 4.26 . . . . 0.0 116.681 -176.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 90' ' ' TYR . . . . . 0.747 ' HA ' ' HB ' ' C' ' 93' ' ' VAL . 1.4 m-30 -50.41 -16.99 0.4 Allowed 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -61.62 -59.82 4.62 Favored 'General case' 0 C--N 1.344 0.349 0 O-C-N 121.383 -0.823 . . . . 0.0 110.554 165.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 5.6 pt -74.94 -18.13 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 118.392 -2.693 . . . . 0.0 111.736 -175.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . 0.869 ' HA ' ' HB2' ' C' ' 66' ' ' PHE . 51.7 t -70.05 135.56 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 127.186 2.195 . . . . 0.0 106.574 170.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . 0.532 HD22 ' NH2' ' C' ' 65' ' ' ARG . 16.4 tp -138.2 101.72 4.47 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 124.361 2.029 . . . . 0.0 108.353 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 95' ' ' GLU . . . . . 0.618 ' HB3' HD13 ' A' 1157 ' ' ILE . 4.0 mp0 -74.91 84.08 2.21 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 112.004 -2.362 . . . . 0.0 111.06 -177.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.485 ' SD ' ' HD2' ' C' ' 70' ' ' PRO . 24.8 ttp 43.73 60.58 2.61 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 119.548 3.166 . . . . 0.0 119.548 176.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -119.13 -152.02 0.5 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 111.275 -2.693 . . . . 0.0 105.824 -175.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . 0.473 ' HG3' ' NZ ' ' B' 1336 ' ' LYS . 8.6 mt-10 -77.1 54.34 1.05 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 125.098 3.59 . . . . 0.0 113.512 -177.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 9.6 tp -79.11 3.01 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 O-C-N 120.753 -1.217 . . . . 0.0 111.334 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . 0.483 HD22 ' HG3' ' C' ' 137' ' ' GLU . 12.3 t-20 -44.48 -52.49 7.86 Favored 'General case' 0 C--N 1.362 1.121 0 C-N-CA 125.58 1.552 . . . . 0.0 114.144 177.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -57.05 -55.09 39.27 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 124.778 1.299 . . . . 0.0 110.681 -174.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.0 -41.78 77.33 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 113.724 -1.58 . . . . 0.0 107.832 -174.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 103' ' ' PHE . . . . . 0.473 ' HE2' ' HA3' ' C' ' 67' ' ' GLY . 0.2 OUTLIER -59.53 -57.41 13.08 Favored 'General case' 0 C--N 1.358 0.962 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -172.088 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.44 -15.42 63.28 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 118.979 0.809 . . . . 0.0 112.465 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -73.33 -39.2 65.42 Favored 'General case' 0 CA--C 1.568 1.66 0 O-C-N 119.755 -1.84 . . . . 0.0 110.499 174.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 106' ' ' THR . . . . . 0.41 HG21 HG12 ' C' ' 34' ' ' ILE . 19.9 m -52.28 146.16 9.76 Favored 'General case' 0 C--O 1.247 0.948 0 O-C-N 126.984 2.678 . . . . 0.0 116.087 -165.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 107' ' ' ASP . . . . . 0.72 ' HA ' ' HB2' ' C' ' 142' ' ' GLN . 9.5 t70 -81.06 -83.06 0.11 Allowed 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 111.907 -2.406 . . . . 0.0 108.386 165.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' C' ' 143' ' ' ASN . 31.4 m -89.82 118.35 29.35 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 120.565 1.529 . . . . 0.0 112.866 -174.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 109' ' ' VAL . . . . . 0.667 HG21 HG23 ' C' ' 138' ' ' VAL . 84.2 t -101.49 100.05 9.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 C-N-CA 124.266 1.026 . . . . 0.0 109.76 169.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 110' ' ' LEU . . . . . 0.626 HD21 HD21 ' C' ' 27' ' ' LEU . 29.2 mt -72.12 93.29 1.41 Allowed 'General case' 0 C--O 1.236 0.356 0 O-C-N 124.286 0.992 . . . . 0.0 108.776 177.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 111' ' ' VAL . . . . . 0.656 ' HB ' ' HA ' ' C' ' 146' ' ' VAL . 38.3 t -85.51 94.14 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 177.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 8.5 mm -81.13 92.52 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-O 122.697 1.236 . . . . 0.0 111.096 -171.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 113' ' ' GLY . . . . . 0.625 ' HA3' ' HA3' ' C' ' 40' ' ' GLY . . . 75.69 65.81 1.99 Allowed Glycine 0 C--N 1.315 -0.598 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 168.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 114' ' ' ALA . . . . . 0.645 ' HB2' ' HA3' ' C' ' 38' ' ' GLY . . . -170.98 -166.71 0.5 Allowed 'General case' 0 CA--C 1.504 -0.803 0 O-C-N 122.048 -0.677 . . . . 0.0 110.895 -174.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 115' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -174.01 -53.74 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 166.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 116' ' ' ASP . . . . . 0.577 ' HB2' H51N ' C' 1001 ' ' NAP . 4.0 m-20 -61.26 -25.32 67.01 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 123.58 1.657 . . . . 0.0 112.575 -172.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.6 -43.49 62.52 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 176.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 3.6 m -124.49 13.32 4.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 112.276 -2.238 . . . . 0.0 112.26 -176.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 119' ' ' ASN . . . . . 0.424 ' HA ' ' HD2' ' C' ' 120' ' ' PRO . 25.3 t30 -68.26 112.49 11.07 Favored Pre-proline 0 C--N 1.364 1.201 0 O-C-N 118.372 -2.705 . . . . 0.0 111.814 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 120' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' C' ' 119' ' ' ASN . 10.7 Cg_endo -45.17 -45.38 14.79 Favored 'Trans proline' 0 N--CA 1.444 -1.394 1 C-N-CA 125.353 4.035 . . . . 0.0 115.584 -176.215 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 121' ' ' ALA . . . . . 0.571 ' HA ' ' HB3' ' C' ' 124' ' ' ASP . . . -57.06 -31.72 65.49 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 124.93 1.292 . . . . 0.0 111.864 -177.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 122' ' ' ALA . . . . . 0.773 ' HB1' ' HB3' ' C' ' 133' ' ' MET . . . -67.69 -12.77 61.22 Favored 'General case' 0 N--CA 1.438 -1.035 0 O-C-N 120.325 -1.484 . . . . 0.0 112.883 -174.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -106.97 -35.19 6.97 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 120.662 -1.274 . . . . 0.0 110.341 159.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 124' ' ' ASP . . . . . 0.571 ' HB3' ' HA ' ' C' ' 121' ' ' ALA . 11.3 t70 -65.32 -65.2 0.7 Allowed 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 123.251 1.5 . . . . 0.0 111.253 -172.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 125' ' ' ASP . . . . . 0.489 ' HA ' ' HD3' ' C' ' 126' ' ' PRO . 14.6 t70 -84.07 119.16 72.96 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-N 112.783 -2.008 . . . . 0.0 112.469 -173.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 126' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' C' ' 125' ' ' ASP . 34.6 Cg_exo -70.83 -11.54 29.59 Favored 'Trans proline' 0 N--CA 1.449 -1.145 1 C-N-CA 125.534 4.156 . . . . 0.0 111.984 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . 0.603 ' HB3' ' HZ3' ' C' ' 127' ' ' LYS . 6.4 ttpm? -77.09 -0.63 25.46 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 119.337 0.971 . . . . 0.0 112.646 176.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 128' ' ' SER . . . . . 0.438 ' HA ' ' HD2' ' C' ' 129' ' ' PRO . 70.0 m -59.07 121.19 53.52 Favored Pre-proline 0 C--N 1.355 0.824 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 172.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 129' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' C' ' 128' ' ' SER . 42.9 Cg_endo -58.82 -45.36 29.39 Favored 'Trans proline' 0 C--N 1.353 0.774 1 C-N-CA 126.181 4.587 . . . . 0.0 116.816 173.567 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 130' ' ' ILE . . . . . 0.617 HG12 ' HB2' ' C' ' 156' ' ' ALA . 15.0 pt -69.54 92.62 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.716 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 165.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.91 110.2 1.27 Allowed 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 125.801 2.715 . . . . 0.0 112.151 -169.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.89 72.57 0.48 Allowed Glycine 0 N--CA 1.462 0.428 0 CA-C-N 109.11 -3.677 . . . . 0.0 113.411 -176.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 133' ' ' MET . . . . . 0.773 ' HB3' ' HB1' ' C' ' 122' ' ' ALA . 62.0 tpp -82.69 127.6 69.56 Favored Pre-proline 0 C--O 1.249 1.053 0 CA-C-N 118.207 1.004 . . . . 0.0 110.291 -177.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 134' ' ' PRO . . . . . 0.584 ' HD2' ' SD ' ' C' ' 133' ' ' MET . 40.2 Cg_endo -78.95 67.37 8.58 Favored 'Trans proline' 0 C--O 1.243 0.746 0 C-N-CA 124.777 3.651 . . . . 0.0 113.275 -174.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 135' ' ' VAL . . . . . 0.539 HG23 ' HH2' ' C' ' 139' ' ' TRP . 27.7 m -68.96 136.5 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-N 113.414 -1.721 . . . . 0.0 112.464 -177.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 97.4 mt -77.54 153.23 33.57 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.288 -1.778 . . . . 0.0 108.68 -174.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 137' ' ' GLU . . . . . 0.483 ' HG3' HD22 ' C' ' 100' ' ' ASN . 22.8 mm-40 -67.63 59.5 0.06 Allowed 'General case' 0 C--O 1.211 -0.967 0 N-CA-C 118.218 2.673 . . . . 0.0 118.218 -162.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 138' ' ' VAL . . . . . 0.667 HG23 HG21 ' C' ' 109' ' ' VAL . 4.5 p -82.25 20.16 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.254 1.331 0 CA-C-O 123.864 1.792 . . . . 0.0 112.826 -173.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 139' ' ' TRP . . . . . 0.539 ' HH2' HG23 ' C' ' 135' ' ' VAL . 2.2 m95 -70.73 133.12 46.32 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.831 -162.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 140' ' ' LYS . . . . . . . . . . . . . 20.3 pttm 36.62 42.32 0.2 Allowed 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 -169.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 141' ' ' ALA . . . . . 0.469 ' HB3' HG22 ' C' ' 144' ' ' VAL . . . -73.13 152.02 41.34 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 120.574 -1.329 . . . . 0.0 112.154 174.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.72 ' HB2' ' HA ' ' C' ' 107' ' ' ASP . 85.7 mm-40 -77.23 -9.21 58.65 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -159.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 143' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' C' ' 108' ' ' THR . 14.4 t30 -164.49 95.29 0.73 Allowed 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.636 1.574 . . . . 0.0 108.672 169.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 144' ' ' VAL . . . . . 0.522 ' HB ' ' HA ' ' C' ' 168' ' ' THR . 21.9 t -89.8 101.0 11.74 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 145' ' ' ILE . . . . . 0.691 HG13 ' HB2' ' C' ' 171' ' ' LEU . 10.1 tp -110.8 102.34 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.352 0 CA-C-O 125.333 2.492 . . . . 0.0 107.359 -166.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 146' ' ' VAL . . . . . 0.921 HG21 ' HB3' ' C' ' 162' ' ' LEU . 28.8 t -95.82 100.67 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 111.728 -2.487 . . . . 0.0 110.998 -168.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 147' ' ' PHE . . . . . 0.554 ' HB2' ' H ' ' C' ' 113' ' ' GLY . 0.7 OUTLIER -60.61 115.07 3.35 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 119.752 -1.842 . . . . 0.0 109.845 178.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 148' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -141.1 138.57 33.62 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 166.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 8.4 tpp85 -59.37 -38.98 81.84 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 117.528 -1.225 . . . . 0.0 111.513 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 20.2 m -148.16 164.49 33.76 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 120.936 1.698 . . . . 0.0 108.816 173.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 8.0 tpt -54.88 108.87 0.44 Allowed 'General case' 0 CA--C 1.502 -0.876 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.239 171.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -155.42 124.18 6.07 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.567 -173.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 153' ' ' THR . . . . . 0.655 HG23 ' HA3' ' C' ' 157' ' ' GLY . 46.2 m -62.16 136.52 57.98 Favored 'General case' 0 N--CA 1.434 -1.232 0 O-C-N 125.767 1.917 . . . . 0.0 107.889 175.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -76.08 -146.3 1.79 Allowed Glycine 0 N--CA 1.443 -0.855 0 O-C-N 119.641 -1.912 . . . . 0.0 110.371 172.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -60.97 -63.25 1.36 Allowed 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 120.955 -1.321 . . . . 0.0 109.438 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 156' ' ' ALA . . . . . 0.617 ' HB2' HG12 ' C' ' 130' ' ' ILE . . . -83.24 -52.36 6.65 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.899 -176.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 157' ' ' GLY . . . . . 0.655 ' HA3' HG23 ' C' ' 153' ' ' THR . . . 65.31 -85.31 0.08 OUTLIER Glycine 0 CA--C 1.531 1.038 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -165.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 158' ' ' VAL . . . . . 0.473 HG22 ' HB1' ' C' ' 156' ' ' ALA 0.293 17.3 m 30.91 104.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 -179.172 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 50.45 12.67 0.1 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -171.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 160' ' ' ASN . . . . . 0.63 ' HB2' ' O ' ' C' ' 157' ' ' GLY . 1.4 t30 -53.05 94.73 0.06 OUTLIER Pre-proline 0 C--N 1.35 0.629 0 N-CA-C 117.338 2.348 . . . . 0.0 117.338 -159.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 161' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' C' ' 160' ' ' ASN . 84.8 Cg_exo -57.81 -34.42 98.23 Favored 'Trans proline' 0 N--CA 1.482 0.795 0 C-N-CA 123.361 2.708 . . . . 0.0 109.974 -169.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 162' ' ' LEU . . . . . 0.921 ' HB3' HG21 ' C' ' 146' ' ' VAL . 13.3 mt -54.29 -17.99 3.52 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 116.966 2.21 . . . . 0.0 116.966 -176.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 163' ' ' PHE . . . . . 0.604 ' HA ' ' HG3' ' C' ' 170' ' ' MET . 20.9 m-30 -91.74 -45.14 8.59 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 123.022 1.392 . . . . 0.0 107.756 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -86.47 -51.8 5.97 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 111.446 -2.615 . . . . 0.0 112.732 -158.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 165' ' ' LYS . . . . . 0.664 ' HB2' ' HB ' ' C' ' 168' ' ' THR . 17.1 mmmt -73.2 -176.16 2.08 Favored 'General case' 0 C--O 1.246 0.871 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -157.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -69.5 -70.0 0.31 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.362 1.065 . . . . 0.0 108.168 -165.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -86.45 -19.04 30.21 Favored 'General case' 0 C--N 1.347 0.478 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 175.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 168' ' ' THR . . . . . 0.697 HG22 ' HA ' ' C' ' 162' ' ' LEU 0.275 37.6 m -93.67 86.33 5.13 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.207 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -150.47 155.74 40.1 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 123.075 1.417 . . . . 0.0 107.877 -164.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 170' ' ' MET . . . . . 0.604 ' HG3' ' HA ' ' C' ' 163' ' ' PHE . 76.7 mtm -73.33 140.38 46.68 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 176.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 171' ' ' LEU . . . . . 0.691 ' HB2' HG13 ' C' ' 145' ' ' ILE . 40.8 tp -92.18 107.51 19.27 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 103.448 -2.797 . . . . 0.0 103.448 167.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -78.4 102.79 7.95 Favored 'General case' 0 C--O 1.253 1.253 0 CA-C-N 111.902 -2.408 . . . . 0.0 111.279 -174.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . 167.97 175.36 37.65 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.203 175.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 174' ' ' ASP . . . . . 0.517 ' HB3' ' HB3' ' C' ' 177' ' ' ALA . 20.6 t70 -62.67 149.13 44.39 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 114.422 -0.889 . . . . 0.0 111.4 173.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 175' ' ' ALA . . . . . 0.411 ' O ' HG23 ' C' ' 179' ' ' VAL . . . -58.57 -59.78 4.84 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 120.088 -1.632 . . . . 0.0 113.651 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 176' ' ' LYS . . . . . 0.592 ' HG3' ' HG3' ' C' ' 45' ' ' GLN . 0.5 OUTLIER -54.59 -66.47 0.39 Allowed 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 124.579 1.175 . . . . 0.0 108.133 176.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 177' ' ' ALA . . . . . 0.517 ' HB3' ' HB3' ' C' ' 174' ' ' ASP . . . -48.16 -39.23 20.1 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 117.781 2.511 . . . . 0.0 117.781 -177.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 56.2 m -67.82 -43.34 79.81 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 120.545 1.52 . . . . 0.0 111.301 173.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 179' ' ' VAL . . . . . 0.411 HG23 ' O ' ' C' ' 175' ' ' ALA . 3.1 t -64.5 -39.68 86.44 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 CA-C-N 121.028 1.74 . . . . 0.0 108.175 175.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -56.78 -45.75 81.94 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 122.786 1.279 . . . . 0.0 112.55 176.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -56.58 -31.22 64.03 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 182' ' ' ILE . . . . . 0.437 HG22 ' HB2' ' C' ' 24' ' ' ALA . 42.9 pt -98.21 -25.81 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -178.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 183' ' ' LEU . . . . . 0.73 ' HA ' HD13 ' C' ' 53' ' ' ILE . 2.9 pp -59.44 -20.16 52.93 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 120.287 3.44 . . . . 0.0 120.287 -164.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -126.65 -34.75 2.4 Favored 'General case' 0 CA--C 1.492 -1.28 0 O-C-N 125.371 1.669 . . . . 0.0 107.118 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -73.06 -14.94 61.5 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 120.299 -1.5 . . . . 0.0 114.151 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 186' ' ' LEU . . . . . 0.84 ' HA ' ' HB1' ' C' ' 24' ' ' ALA . 2.6 pt? . . . . . 0 C--O 1.219 -0.547 0 N-CA-C 119.796 3.258 . . . . 0.0 119.796 -167.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' NAD . . . . . 0.6 ' H8A' HG23 ' B' 1258 ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C 1001 ' ' NAP . . . . . 0.577 H51N ' HB2' ' C' ' 116' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 19.6 t-80 . . . . . 0 C--O 1.236 0.346 0 N-CA-C 102.441 -3.17 . . . . 65.74 102.441 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -67.64 81.47 0.16 Allowed Glycine 0 CA--C 1.544 1.864 0 CA-C-O 123.33 1.516 . . . . 48.66 111.332 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -116.06 122.92 46.6 Favored 'General case' 0 N--CA 1.419 -1.982 1 N-CA-C 100.1 -4.037 . . . . 44.56 100.1 175.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1003 ' ' ILE . . . . . 0.455 HG12 ' HB ' ' A' 1068 ' ' ILE . 30.4 mt -99.13 121.51 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.163 0 N-CA-C 106.024 -1.843 . . . . 34.86 106.024 177.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1004 ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' 1034 ' ' ALA . . . -79.47 135.15 14.76 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 108.35 -1.9 . . . . 30.75 108.35 165.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.637 HG23 ' HB3' ' A' 1017 ' ' ALA . 32.8 mm -110.82 96.25 27.94 Favored Pre-proline 0 C--O 1.242 0.696 0 N-CA-C 101.564 -3.495 . . . . 32.21 101.564 170.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -71.6 171.59 16.03 Favored 'Trans proline' 0 CA--C 1.504 -0.992 0 C-N-CA 122.529 2.153 . . . . 32.98 111.312 170.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1007 ' ' ARG . . . . . 0.433 ' HA ' HG22 ' A' 1016 ' ' VAL . 19.0 ttp85 -104.32 141.36 36.44 Favored 'General case' 0 C--O 1.258 1.549 0 CA-C-N 110.976 -2.829 . . . . 47.98 106.726 169.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1008 ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -65.25 143.32 57.88 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 123.456 1.598 . . . . 34.7 112.699 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1009 ' ' ARG . . . . . 0.479 HH11 ' HD3' ' A' 1009 ' ' ARG . 37.7 mtp180 -108.74 22.29 16.12 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-O 123.473 1.606 . . . . 53.37 113.553 176.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 30.0 tp -77.96 149.65 34.11 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.588 -1.264 . . . . 45.07 107.588 170.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1011 ' ' THR . . . . . . . . . . . . . 23.5 m -74.77 143.99 43.78 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 122.378 2.354 . . . . 40.36 110.023 -174.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 32.4 t30 41.64 64.4 1.06 Allowed 'General case' 0 N--CA 1.439 -0.997 0 CA-C-O 125.178 2.418 . . . . 40.61 113.283 -176.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1013 ' ' GLU . . . . . 0.435 ' O ' HD13 ' A' 1042 ' ' LEU . 8.3 tp10 -134.04 147.61 50.96 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 109.932 -3.304 . . . . 33.76 104.424 -169.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1014 ' ' THR . . . . . 0.823 ' HB ' ' HB3' ' A' 1320 ' ' PRO . 0.0 OUTLIER -124.15 1.1 8.51 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 112.935 0.717 . . . . 27.89 112.935 177.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 1015 ' ' ARG . . . . . 0.932 ' HD2' HG11 ' A' 1072 ' ' VAL . 21.0 mtm180 -68.13 130.57 43.34 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 119.884 -1.76 . . . . 29.02 112.161 -176.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1016 ' ' VAL . . . . . 0.554 ' HB ' ' HB2' ' A' 1043 ' ' ALA . 83.9 t -132.17 141.73 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 110.644 -2.98 . . . . 28.13 103.862 168.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1017 ' ' ALA . . . . . 0.637 ' HB3' HG23 ' A' 1005 ' ' ILE . . . -56.54 -37.23 70.22 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 118.024 2.601 . . . . 26.87 118.024 -171.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -136.08 143.01 44.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 120.077 1.308 . . . . 26.77 110.64 -165.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1019 ' ' THR . . . . . . . . . . . . . 75.5 p -77.67 173.4 7.64 Favored Pre-proline 0 C--N 1.346 0.444 0 O-C-N 120.104 -1.622 . . . . 27.02 108.25 163.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1020 ' ' PRO . . . . . 0.478 ' HB3' ' HB2' ' A' 1053 ' ' ALA . 2.5 Cg_exo -55.39 -35.3 91.53 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 123.837 3.025 . . . . 30.57 111.741 164.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -62.49 -49.55 74.94 Favored 'General case' 0 C--N 1.358 0.957 0 CA-C-N 118.98 0.809 . . . . 47.81 110.826 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1022 ' ' THR . . . . . . . . . . . . . 6.7 p -65.74 -29.16 69.63 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.573 0.953 . . . . 30.77 113.573 176.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1023 ' ' VAL . . . . . 0.892 HG22 HG11 ' A' 1033 ' ' VAL . 3.4 t -62.74 -44.83 99.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 107.65 -1.241 . . . . 33.59 107.65 175.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1024 ' ' GLU . . . . . 0.625 ' O ' ' HG2' ' A' 1028 ' ' LYS . 48.6 mt-10 -59.75 -44.22 93.91 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 117.609 -1.186 . . . . 53.29 111.847 173.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -54.71 -38.69 67.36 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-N 119.998 1.272 . . . . 46.92 114.333 170.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1026 ' ' LEU . . . . . . . . . . . . . 91.2 mt -68.75 -38.63 80.27 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 119.141 0.882 . . . . 37.17 109.278 177.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 12.7 tp -63.83 -43.29 96.62 Favored 'General case' 0 CA--C 1.556 1.183 0 O-C-N 124.074 0.859 . . . . 44.44 109.064 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1028 ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' 1024 ' ' GLU . 28.0 mmmt -59.67 -41.21 90.13 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 123.292 0.637 . . . . 52.58 109.698 175.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1029 ' ' LEU . . . . . 0.478 ' HA ' ' HE3' ' A' 1342 ' ' LYS . 61.9 mt -72.44 7.23 1.9 Allowed 'General case' 0 C--O 1.253 1.247 0 N-CA-C 116.654 2.094 . . . . 45.69 116.654 174.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 94.74 -5.19 69.45 Favored Glycine 0 CA--C 1.494 -1.272 0 O-C-N 121.004 -1.06 . . . . 42.09 112.303 171.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -86.66 137.07 32.76 Favored 'General case' 0 N--CA 1.443 -0.803 0 O-C-N 119.352 -2.264 . . . . 40.72 106.86 -171.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1032 ' ' THR . . . . . . . . . . . . . 37.8 m -76.69 127.38 32.67 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 104.915 -2.254 . . . . 37.77 104.915 162.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1033 ' ' VAL . . . . . 0.892 HG11 HG22 ' A' 1023 ' ' VAL . 4.1 t -94.06 133.71 34.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 103.225 -2.88 . . . . 33.54 103.225 177.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1034 ' ' ALA . . . . . 0.414 ' O ' ' HA2' ' A' 1004 ' ' GLY . . . -126.84 116.61 21.12 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 104.803 -2.295 . . . . 31.68 104.803 172.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1035 ' ' VAL . . . . . . . . . . . . . 21.2 t -109.29 142.34 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 O-C-N 120.91 -1.119 . . . . 31.52 109.765 -174.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1036 ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -65.17 139.14 58.64 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.32 -1.363 . . . . 41.04 107.32 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1037 ' ' SER . . . . . . . . . . . . . 8.6 t -73.56 132.7 43.12 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 106.176 -1.787 . . . . 31.83 106.176 176.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1038 ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' 1041 ' ' GLN . . . 100.04 -20.91 47.01 Favored Glycine 0 C--O 1.22 -0.773 0 N-CA-C 109.278 -1.529 . . . . 29.36 109.278 -175.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -67.73 -34.91 77.79 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 121.484 -1.009 . . . . 27.78 110.649 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1040 ' ' GLY . . . . . 0.583 ' HA2' ' HE2' ' A' 1050 ' ' PHE . . . -59.98 -43.18 98.4 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-O 123.429 1.571 . . . . 28.91 110.622 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1041 ' ' GLN . . . . . 0.418 ' HB3' ' O ' ' A' 1038 ' ' GLY . 8.5 tp60 -52.15 -49.12 64.36 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 112.218 -1.991 . . . . 51.18 113.652 172.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1042 ' ' LEU . . . . . 0.435 HD13 ' O ' ' A' 1013 ' ' GLU . 10.7 mt -78.54 -38.47 40.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.541 -1.974 . . . . 29.91 114.119 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1043 ' ' ALA . . . . . 0.554 ' HB2' ' HB ' ' A' 1016 ' ' VAL . . . -61.26 -14.95 30.06 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 113.719 1.007 . . . . 28.54 113.719 169.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1044 ' ' SER . . . . . . . . . . . . . 51.1 m 68.27 34.56 3.81 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 120.246 -1.534 . . . . 33.06 108.596 173.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1045 ' ' PHE . . . . . 0.439 ' HD2' ' HD2' ' A' 1020 ' ' PRO . 0.0 OUTLIER -161.58 97.74 1.09 Allowed 'General case' 0 C--O 1.247 0.96 0 N-CA-C 101.092 -3.669 . . . . 30.29 101.092 -178.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -71.92 165.77 23.49 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 120.854 3.65 . . . . 48.62 120.854 -149.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.42 -53.97 12.58 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 112.35 -2.205 . . . . 36.74 111.438 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 3.4 pttm -65.02 -39.02 92.79 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-N 121.76 2.073 . . . . 43.73 111.132 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -62.25 -29.86 70.7 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.398 -1.439 . . . . 32.81 112.198 175.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1050 ' ' PHE . . . . . 0.583 ' HE2' ' HA2' ' A' 1040 ' ' GLY . 21.9 m-85 -62.52 -50.01 73.08 Favored 'General case' 0 C--O 1.255 1.352 0 C-N-CA 120.246 -0.581 . . . . 31.86 112.494 169.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1051 ' ' VAL . . . . . 0.517 HG22 HG12 ' A' 1057 ' ' ILE . 11.0 t -62.95 -42.45 96.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 O-C-N 121.101 -0.999 . . . . 33.22 109.289 -176.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -51.01 -44.87 61.04 Favored 'General case' 0 C--O 1.256 1.434 0 C-N-CA 125.212 1.405 . . . . 50.83 110.599 172.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1053 ' ' ALA . . . . . 0.478 ' HB2' ' HB3' ' A' 1020 ' ' PRO . . . -65.87 -44.82 84.27 Favored 'General case' 0 C--O 1.246 0.91 0 CA-C-O 124.819 2.247 . . . . 33.12 113.016 -176.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 147.56 33.88 0.06 OUTLIER Glycine 0 N--CA 1.464 0.511 0 CA-C-N 113.141 -1.845 . . . . 35.83 114.553 -177.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -111.04 139.37 46.46 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-N 118.66 1.23 . . . . 34.82 110.138 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -84.09 121.56 27.59 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 103.297 -2.853 . . . . 49.05 103.297 167.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1057 ' ' ILE . . . . . 0.517 HG12 HG22 ' A' 1051 ' ' VAL . 26.2 mm -85.32 122.49 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 O-C-N 118.105 -2.872 . . . . 38.53 108.807 177.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1058 ' ' VAL . . . . . . . . . . . . . 12.0 m -122.31 147.05 26.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 105.4 -2.074 . . . . 42.11 105.4 -173.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -121.4 135.01 55.11 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 126.026 2.822 . . . . 58.0 111.632 -171.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 57.3 -141.9 43.32 Favored Glycine 0 N--CA 1.465 0.616 0 CA-C-N 110.451 -3.068 . . . . 52.12 113.444 -176.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1061 ' ' ASN . . . . . 0.878 ' HA ' ' HD1' ' A' 1064 ' ' TRP . 1.4 t30 -48.12 -25.34 1.42 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 116.527 2.047 . . . . 54.75 116.527 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1062 ' ' SER . . . . . . . . . . . . . 15.2 m -60.22 -20.73 60.09 Favored 'General case' 0 CA--C 1.552 1.048 0 N-CA-C 114.028 1.122 . . . . 50.34 114.028 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1063 ' ' VAL . . . . . 0.493 ' O ' HD11 ' A' 1069 ' ' ILE . 14.9 p -70.03 -48.36 63.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 107.309 -1.367 . . . . 41.46 107.309 169.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1064 ' ' TRP . . . . . 0.878 ' HD1' ' HA ' ' A' 1061 ' ' ASN . 75.4 m95 -65.34 -30.73 71.6 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 124.397 1.079 . . . . 39.32 110.907 -172.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.43 81.05 4.79 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 113.489 -1.687 . . . . 55.38 109.427 172.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1066 ' ' SER . . . . . . . . . . . . . 68.5 m -145.72 -178.91 6.34 Favored 'General case' 0 C--O 1.242 0.67 0 O-C-N 120.431 -1.418 . . . . 41.87 111.128 172.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1067 ' ' GLU . . . . . 0.447 ' HB3' HD12 ' A' 1068 ' ' ILE . 22.0 tp10 -69.77 -62.81 1.23 Allowed 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.183 -1.414 . . . . 53.2 107.183 174.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1068 ' ' ILE . . . . . 0.455 ' HB ' HG12 ' A' 1003 ' ' ILE . 5.3 mp -107.56 142.17 20.94 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 N-CA-C 105.482 -2.044 . . . . 41.9 105.482 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1069 ' ' ILE . . . . . 0.493 HD11 ' O ' ' A' 1063 ' ' VAL . 5.4 mm -124.38 121.28 61.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 104.177 -2.527 . . . . 38.73 104.177 168.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1070 ' ' LEU . . . . . 0.674 HD22 HD22 ' A' 1331 ' ' LEU . 77.2 mt -98.74 87.05 3.67 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 104.302 -2.481 . . . . 32.44 104.302 172.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1071 ' ' LYS . . . . . 0.407 ' HB3' ' HE3' ' A' 1071 ' ' LYS . 1.1 mmmt -83.59 162.09 20.94 Favored 'General case' 0 C--O 1.257 1.48 0 N-CA-C 105.403 -2.073 . . . . 34.65 105.403 167.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1072 ' ' VAL . . . . . 0.932 HG11 ' HD2' ' A' 1015 ' ' ARG . 18.8 t -88.18 -86.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.705 0 C-N-CA 119.588 -0.845 . . . . 31.32 110.844 175.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -84.4 151.89 24.39 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.133 -1.432 . . . . 33.94 107.133 -170.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1074 ' ' ALA . . . . . 0.448 ' HA ' ' HD2' ' A' 1075 ' ' PRO . . . -33.92 120.29 0.5 Allowed Pre-proline 0 C--O 1.253 1.271 0 C-N-CA 125.084 1.353 . . . . 38.04 114.646 170.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1075 ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' 1074 ' ' ALA . 72.6 Cg_endo -56.81 128.2 28.97 Favored 'Trans proline' 0 N--CA 1.441 -1.579 0 C-N-CA 125.074 3.85 . . . . 42.68 114.887 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 33.0 mt -72.88 158.25 35.87 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 120.712 -1.242 . . . . 46.74 108.295 170.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1077 ' ' ASP . . . . . 0.497 ' HA ' HD12 ' A' 1080 ' ' ILE . 7.4 m-20 -45.98 -39.63 9.25 Favored 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 118.515 2.783 . . . . 58.61 118.515 -176.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 15.7 t70 -61.98 -48.71 79.12 Favored 'General case' 0 C--N 1.352 0.686 0 CA-C-N 119.144 0.884 . . . . 59.2 109.706 173.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1079 ' ' GLU . . . . . 0.427 ' HG2' HH11 ' A' 1009 ' ' ARG . 35.5 mt-10 -62.88 -32.42 73.66 Favored 'General case' 0 C--O 1.259 1.559 0 CA-C-N 114.024 -1.444 . . . . 50.63 109.109 -178.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1080 ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' 1077 ' ' ASP . 73.7 mt -62.88 -44.51 99.64 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-N 118.899 0.772 . . . . 51.48 109.59 173.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -62.53 -26.22 68.44 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 119.789 -1.82 . . . . 50.28 112.321 175.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1082 ' ' LEU . . . . . . . . . . . . . 15.7 mt -80.96 -24.33 38.16 Favored 'General case' 0 C--O 1.25 1.102 0 O-C-N 119.339 -2.1 . . . . 50.21 112.206 174.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1083 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.22 120.26 10.01 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 124.477 2.084 . . . . 49.06 111.501 176.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -82.99 134.81 45.82 Favored Pre-proline 0 CA--C 1.515 -0.385 0 CA-C-N 112.483 -2.144 . . . . 51.08 111.756 -167.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -48.96 113.18 0.81 Allowed 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 125.106 3.871 . . . . 49.73 119.159 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 104.31 -27.16 20.41 Favored Glycine 0 N--CA 1.436 -1.309 0 O-C-N 124.9 1.375 . . . . 47.71 114.021 177.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1087 ' ' THR . . . . . . . . . . . . . 39.4 m -49.92 128.87 19.45 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 118.316 2.71 . . . . 45.47 118.316 -174.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1088 ' ' THR . . . . . . . . . . . . . 41.2 m -68.77 88.86 0.38 Allowed 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 123.354 1.549 . . . . 42.04 113.047 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1089 ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' 1112 ' ' VAL . 57.2 tp -83.43 98.32 9.44 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 104.291 -2.485 . . . . 38.06 104.291 -176.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1090 ' ' VAL . . . . . 0.625 ' HB ' HD23 ' A' 1070 ' ' LEU . 45.5 t -96.49 109.37 22.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 104.719 -2.326 . . . . 37.4 104.719 175.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1091 ' ' SER . . . . . 0.46 ' HA ' ' OH ' ' A' 1327 ' ' TYR . 13.4 m -152.26 162.91 40.45 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 116.537 2.051 . . . . 36.16 116.537 -175.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1092 ' ' PHE . . . . . 0.438 ' CD1' ' HB3' ' A' 1116 ' ' ASP . 51.4 t80 -74.33 79.42 1.85 Allowed 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 123.133 1.444 . . . . 38.94 107.652 170.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 21.8 mm -82.27 -42.72 18.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 126.571 1.948 . . . . 42.17 114.966 -168.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 2.9 m95 66.67 60.57 0.94 Allowed Pre-proline 0 N--CA 1.436 -1.175 0 C-N-CA 125.113 1.365 . . . . 46.51 114.625 -174.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1095 ' ' PRO . . . . . 0.404 ' HG2' HG11 ' A' 1360 ' ' VAL . 52.4 Cg_exo -56.43 -33.44 92.1 Favored 'Trans proline' 0 C--O 1.253 1.269 0 C-N-CA 124.87 3.713 . . . . 49.76 114.319 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -60.65 -51.8 67.86 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.118 -1.401 . . . . 52.62 111.61 174.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -78.96 -14.4 59.23 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 115.32 1.6 . . . . 60.74 115.32 177.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1098 ' ' ASN . . . . . 0.463 ' HB3' ' HB3' ' A' 1101 ' ' LEU . 43.6 m-20 -125.36 65.91 51.85 Favored Pre-proline 0 N--CA 1.441 -0.901 0 N-CA-C 115.765 1.765 . . . . 58.19 115.765 -173.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -66.24 -41.6 12.28 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.715 2.944 . . . . 54.59 113.308 -175.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.23 -42.09 85.54 Favored 'General case' 0 C--O 1.253 1.237 0 CA-C-O 123.335 1.54 . . . . 63.28 112.696 176.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1101 ' ' LEU . . . . . 0.463 ' HB3' ' HB3' ' A' 1098 ' ' ASN . 21.3 tp -55.78 -37.03 68.03 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 113.162 -1.835 . . . . 54.75 109.928 -178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1102 ' ' MET . . . . . . . . . . . . . 82.3 mmm -61.06 -45.3 95.34 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 108.667 -0.864 . . . . 52.65 108.667 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -64.8 -45.0 88.11 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-N 114.642 -1.163 . . . . 66.26 112.197 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 95.0 mttt -61.62 -41.84 98.04 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 123.132 1.444 . . . . 63.73 110.352 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1105 ' ' LEU . . . . . 0.424 HD13 HG21 ' A' 1112 ' ' VAL . 95.8 mt -74.83 -35.5 62.41 Favored 'General case' 0 C--O 1.246 0.884 0 O-C-N 118.485 -2.635 . . . . 54.68 109.227 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -62.84 -38.87 92.51 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 117.427 -1.273 . . . . 53.64 109.953 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -60.67 -41.19 94.57 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 124.277 0.985 . . . . 67.24 110.671 169.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1108 ' ' ARG . . . . . 0.482 ' HA ' ' HD3' ' A' 1108 ' ' ARG . 12.0 mmt85 -76.28 -0.05 21.02 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 114.281 1.215 . . . . 65.76 114.281 173.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1109 ' ' ASN . . . . . 0.588 ' HA ' ' HA2' ' A' 1364 ' ' GLY . 35.7 t30 61.22 15.22 6.2 Favored 'General case' 0 C--N 1.346 0.422 0 N-CA-C 114.431 1.271 . . . . 58.71 114.431 175.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1110 ' ' VAL . . . . . . . . . . . . . 29.8 m -79.39 132.97 30.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 O-C-N 120.111 -1.618 . . . . 46.63 108.623 -169.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1111 ' ' THR . . . . . 0.652 HG21 HG21 ' A' 1348 ' ' VAL . 56.5 m -74.72 93.91 2.64 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.509 0.671 . . . . 44.13 110.02 -176.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1112 ' ' VAL . . . . . 0.424 HG21 HD13 ' A' 1105 ' ' LEU . 38.9 t -92.84 115.97 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 123.874 1.797 . . . . 40.44 111.376 -170.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1113 ' ' MET . . . . . 0.565 ' SD ' HG13 ' A' 1348 ' ' VAL . 73.9 mtp -107.86 105.93 15.97 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 104.525 -2.398 . . . . 50.76 104.525 173.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1114 ' ' ALA . . . . . . . . . . . . . . . -86.63 109.07 18.91 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.399 -0.819 . . . . 35.64 111.608 -177.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1115 ' ' MET . . . . . 0.639 ' SD ' HD22 ' A' 1334 ' ' LEU . 90.9 mmm -66.19 -21.59 66.32 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 115.929 1.826 . . . . 38.74 115.929 -175.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1116 ' ' ASP . . . . . 0.438 ' HB3' ' CD1' ' A' 1092 ' ' PHE . 6.5 p-10 -73.09 -32.84 65.23 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 114.234 -1.348 . . . . 40.14 109.948 169.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1117 ' ' SER . . . . . . . . . . . . . 29.5 m -82.97 13.19 4.13 Favored 'General case' 0 C--O 1.244 0.772 0 O-C-N 119.777 -1.827 . . . . 44.79 114.937 -175.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1118 ' ' VAL . . . . . 0.676 HG22 HG22 ' A' 1358 ' ' VAL . 12.0 t -64.14 124.3 85.0 Favored Pre-proline 0 N--CA 1.484 1.26 0 CA-C-O 117.246 -1.359 . . . . 43.75 107.426 169.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1119 ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' 1354 ' ' VAL . 47.8 Cg_exo -55.88 134.64 65.31 Favored 'Trans proline' 0 C--O 1.242 0.698 0 C-N-CA 124.93 3.753 . . . . 48.93 110.745 173.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1120 ' ' ARG . . . . . 0.649 ' HD3' HD13 ' A' 1130 ' ' LEU . 41.8 mmm-85 -69.12 17.56 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 120.018 3.34 . . . . 62.9 120.018 -163.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 26.9 pt -85.67 171.46 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 C-N-CA 123.344 0.658 . . . . 57.72 112.562 -165.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1122 ' ' SER . . . . . . . . . . . . . 1.1 p -51.48 -53.79 33.68 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 118.822 -2.424 . . . . 57.26 114.743 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -64.58 -2.19 2.24 Favored 'General case' 0 C--O 1.248 0.997 0 CA-C-N 121.359 1.89 . . . . 62.9 115.875 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1124 ' ' ALA . . . . . 0.454 ' HB2' HG11 ' A' 1354 ' ' VAL . . . -106.41 -11.68 15.88 Favored 'General case' 0 C--O 1.2 -1.521 0 CA-C-O 116.381 -1.771 . . . . 49.83 114.198 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -57.99 -29.36 65.19 Favored 'General case' 0 CA--C 1.488 -1.415 0 N-CA-C 115.628 1.714 . . . . 52.37 115.628 -170.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1126 ' ' SER . . . . . . . . . . . . . 64.0 p -65.16 -41.14 94.98 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 115.102 1.519 . . . . 42.43 115.102 169.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1127 ' ' LEU . . . . . . . . . . . . . 1.6 mp -81.43 -28.44 34.24 Favored 'General case' 0 C--O 1.208 -1.096 0 CA-C-N 115.492 -0.777 . . . . 43.74 111.013 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 61.3 t0 -67.88 101.11 1.03 Allowed 'General case' 0 N--CA 1.439 -0.985 0 O-C-N 119.699 -1.876 . . . . 43.21 110.063 -164.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1129 ' ' ALA . . . . . . . . . . . . . . . -74.2 -34.23 63.66 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.963 -0.562 . . . . 35.74 109.977 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1130 ' ' LEU . . . . . 0.649 HD13 ' HD3' ' A' 1120 ' ' ARG . 0.7 OUTLIER -60.16 -26.81 66.6 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 119.029 -2.294 . . . . 38.09 108.627 177.282 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 1131 ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' 1134 ' ' ALA . 61.9 m -84.92 -56.34 3.62 Favored 'General case' 0 C--O 1.216 -0.677 0 O-C-N 120.928 -1.107 . . . . 36.91 110.441 168.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1132 ' ' SER . . . . . 0.489 ' O ' ' HB3' ' A' 1135 ' ' ASN . 13.8 m -73.17 -43.72 61.04 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 116.854 2.168 . . . . 35.79 116.854 -168.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1133 ' ' MET . . . . . 0.891 ' HA ' HD12 ' A' 1136 ' ' ILE . 53.1 mtp -57.55 -45.45 85.08 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 122.463 1.125 . . . . 30.81 113.103 169.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1134 ' ' ALA . . . . . 0.978 ' HB1' ' HB2' ' A' 1176 ' ' ALA . . . -57.03 -39.17 74.27 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 112.91 -1.95 . . . . 28.88 111.144 170.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1135 ' ' ASN . . . . . 0.518 ' ND2' ' HB2' ' A' 1179 ' ' ALA . 22.1 t-20 -58.54 -51.59 69.25 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 120.389 -1.444 . . . . 40.76 113.743 175.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1136 ' ' ILE . . . . . 0.891 HD12 ' HA ' ' A' 1133 ' ' MET . 14.6 mt -52.34 -46.68 46.35 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 CA-C-O 118.163 -0.923 . . . . 31.54 108.977 172.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1137 ' ' ALA . . . . . 0.731 ' HB2' ' HG3' ' A' 1316 ' ' PRO . . . -67.02 -27.11 67.14 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 124.925 1.29 . . . . 29.87 113.6 176.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -74.61 -44.2 27.11 Favored Glycine 0 C--N 1.313 -0.713 0 O-C-N 120.865 -1.147 . . . . 28.73 110.812 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 16.1 t80 -61.85 -46.34 89.88 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.206 -1.173 . . . . 30.39 108.506 171.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1140 ' ' ARG . . . . . 0.679 ' HD3' ' HB2' ' A' 1319 ' ' LEU . 5.6 tpt180 -63.33 -29.75 71.0 Favored 'General case' 0 CA--C 1.493 -1.229 0 O-C-N 121.339 -0.851 . . . . 26.09 112.427 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1141 ' ' ALA . . . . . . . . . . . . . . . -63.29 -43.68 97.19 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 119.905 -1.747 . . . . 27.1 110.674 173.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 47.1 mm -54.3 -45.64 68.3 Favored 'Isoleucine or valine' 0 C--N 1.347 0.488 0 O-C-N 120.693 -1.255 . . . . 28.48 111.77 168.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 25.1 t -62.38 -55.26 25.1 Favored 'Isoleucine or valine' 0 C--O 1.252 1.223 0 CA-C-O 115.88 -2.01 . . . . 23.07 114.243 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1144 ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -70.19 -22.36 62.95 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 123.563 2.892 . . . . 33.4 110.159 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1145 ' ' ALA . . . . . 0.737 ' HA ' HG11 ' A' 1280 ' ' VAL . . . -63.61 -56.33 16.71 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 119.458 -0.897 . . . . 24.22 109.708 167.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -59.28 -21.33 59.49 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-O 117.871 -1.061 . . . . 24.89 112.496 174.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1147 ' ' HIS . . . . . 0.419 ' HA ' ' CG1' ' B' 1143 ' ' VAL . 49.2 t-80 -66.35 -41.51 89.44 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 120.59 1.541 . . . . 26.73 111.691 169.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1148 ' ' GLU . . . . . 0.799 ' HB3' ' HD2' ' A' 1308 ' ' LYS . 77.6 mm-40 -105.98 -2.62 22.63 Favored 'General case' 0 C--O 1.252 1.207 0 N-CA-C 114.991 1.478 . . . . 39.96 114.991 -176.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1149 ' ' PHE . . . . . . . . . . . . . 1.3 t80 -70.18 149.03 47.95 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 116.167 -0.469 . . . . 25.87 111.546 -178.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1150 ' ' GLY . . . . . 0.614 ' HA2' ' HG2' ' B' 1320 ' ' PRO . . . -75.71 -49.9 8.51 Favored Glycine 0 N--CA 1.43 -1.702 0 CA-C-N 114.479 -1.237 . . . . 19.28 113.616 172.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1151 ' ' ARG . . . . . 0.489 ' HG3' ' HB ' ' B' 1321 ' ' THR . 29.1 mtm-85 -97.94 170.68 8.78 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-O 123.308 1.527 . . . . 39.9 113.865 -168.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1152 ' ' PHE . . . . . 0.491 ' HA ' ' CZ ' ' B' 1139 ' ' TYR . 0.3 OUTLIER -72.97 142.63 47.79 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.46 -0.941 . . . . 29.44 108.46 166.011 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 1153 ' ' PHE . . . . . 0.428 ' HD1' ' OH ' ' B' 1139 ' ' TYR . 25.0 m-85 -58.03 -46.87 84.63 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 114.528 1.307 . . . . 32.6 114.528 168.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1154 ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -72.29 145.92 47.53 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 125.068 1.347 . . . . 34.64 109.215 -178.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -77.88 65.99 3.15 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 119.214 -2.179 . . . . 37.14 108.272 169.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -92.1 136.38 33.22 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 107.772 -1.196 . . . . 40.57 107.772 -167.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1157 ' ' ILE . . . . . 0.462 HG12 ' HB3' ' C' ' 95' ' ' GLU . 3.8 tp -96.16 135.58 29.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 105.075 -2.194 . . . . 44.61 105.075 163.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1158 ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.65 -123.72 0.1 Allowed 'General case' 0 C--O 1.242 0.696 0 CA-C-O 117.171 -1.395 . . . . 40.7 112.435 173.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -84.18 -45.71 12.65 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 122.034 2.197 . . . . 40.25 106.94 160.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -126.13 153.53 44.42 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 113.261 -1.791 . . . . 38.47 107.704 170.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1161 ' ' GLY . . . . . 0.683 ' HA3' ' HA ' ' B' 1326 ' ' LEU . . . 87.26 103.95 0.85 Allowed Glycine 0 CA--C 1.496 -1.099 0 C-N-CA 119.632 -1.27 . . . . 37.61 113.559 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1162 ' ' LYS . . . . . 0.428 ' HG3' ' CD ' ' C' ' 95' ' ' GLU . 1.5 tmtp? -102.53 122.05 43.58 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 126.642 2.025 . . . . 48.9 106.026 171.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1163 ' ' VAL . . . . . . . . . . . . . 45.8 t -82.0 133.67 51.0 Favored Pre-proline 0 C--O 1.247 0.943 0 CA-C-O 117.451 -1.262 . . . . 36.52 109.438 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1164 ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -73.3 109.49 2.85 Favored 'Trans proline' 0 N--CA 1.43 -2.248 0 CA-C-N 124.326 2.581 . . . . 35.08 109.739 160.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1165 ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -50.96 161.74 1.34 Allowed 'Trans proline' 0 N--CA 1.483 0.865 1 C-N-CA 125.957 4.438 . . . . 35.33 118.696 -169.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1166 ' ' ALA . . . . . . . . . . . . . . . -74.54 122.04 22.48 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.863 -1.162 . . . . 34.69 107.863 -176.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1167 ' ' LYS . . . . . 0.426 ' HB2' ' HA ' ' A' 1249 ' ' VAL . 76.6 mttt -88.2 104.99 17.23 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-O 124.007 1.86 . . . . 45.36 106.628 166.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 58.7 t -94.58 89.99 2.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 113.681 -1.6 . . . . 31.71 108.259 -175.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1169 ' ' MET . . . . . 0.482 ' SD ' ' HB3' ' A' 1245 ' ' GLN . 5.6 ttp -77.9 92.1 4.24 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 113.407 -1.724 . . . . 42.28 111.828 177.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 81.0 t -88.79 112.5 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 106.146 -1.798 . . . . 30.51 106.146 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1171 ' ' ILE . . . . . . . . . . . . . 57.7 mt -98.24 123.1 50.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 109.631 -0.507 . . . . 31.87 109.631 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1172 ' ' GLY . . . . . 0.444 ' HA3' ' HB2' ' A' 1256 ' ' ALA . . . 77.13 81.58 0.6 Allowed Glycine 0 N--CA 1.436 -1.346 0 CA-C-O 122.77 1.206 . . . . 34.54 113.716 -178.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1173 ' ' ALA . . . . . 0.446 ' HA ' ' HA3' ' A' 1177 ' ' GLY . . . -82.07 80.05 8.42 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 111.773 -2.214 . . . . 32.51 109.212 -172.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -85.09 -157.0 27.14 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 108.056 -2.018 . . . . 29.9 108.056 163.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1175 ' ' VAL . . . . . . . . . . . . . 67.2 t -74.02 -26.9 21.54 Favored 'Isoleucine or valine' 0 C--O 1.259 1.598 0 CA-C-N 120.378 2.089 . . . . 33.11 108.765 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1176 ' ' ALA . . . . . 0.978 ' HB2' ' HB1' ' A' 1134 ' ' ALA . . . -50.22 -47.27 54.95 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.596 0.712 . . . . 28.1 112.623 162.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1177 ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' A' 1173 ' ' ALA . . . -61.25 -52.21 53.18 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 113.475 -1.693 . . . . 28.54 110.115 176.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1178 ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' 1181 ' ' ILE . 94.3 mt -53.14 -43.89 67.33 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 118.923 1.361 . . . . 31.22 113.177 178.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1179 ' ' ALA . . . . . 0.518 ' HB2' ' ND2' ' A' 1135 ' ' ASN . . . -66.47 -34.75 78.62 Favored 'General case' 0 C--O 1.245 0.822 0 O-C-N 118.088 -2.883 . . . . 28.98 114.115 174.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -65.62 -45.74 81.96 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.069 0.85 . . . . 27.83 109.498 176.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1181 ' ' ILE . . . . . 0.562 ' HA ' HG11 ' A' 1191 ' ' VAL . 55.6 mt -59.33 -52.68 58.04 Favored 'Isoleucine or valine' 0 C--N 1.349 0.561 0 C-N-CA 124.571 1.148 . . . . 30.25 109.89 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -51.67 -54.88 22.85 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 125.735 1.636 . . . . 29.59 110.53 176.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1183 ' ' ALA . . . . . . . . . . . . . . . -65.26 -43.23 91.94 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 114.176 1.176 . . . . 30.29 114.176 -175.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -68.96 -43.56 74.76 Favored 'General case' 0 N--CA 1.425 -1.699 0 C-N-CA 123.771 0.828 . . . . 30.47 109.404 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -64.76 -35.61 81.63 Favored 'General case' 0 C--O 1.243 0.755 0 O-C-N 120.693 -1.254 . . . . 42.41 109.376 173.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1186 ' ' SER . . . . . 1.075 ' HB3' ' HA ' ' B' 1187 ' ' LEU . 72.9 m -60.25 -36.95 78.95 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 121.509 1.959 . . . . 39.38 112.354 169.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 89.4 mt -82.18 18.68 1.33 Allowed 'General case' 0 C--O 1.244 0.791 0 CA-C-N 120.361 1.437 . . . . 36.18 114.001 169.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 78.93 2.35 86.46 Favored Glycine 0 N--CA 1.47 0.952 0 CA-C-N 119.876 1.217 . . . . 33.78 115.003 170.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1189 ' ' ALA . . . . . . . . . . . . . . . -73.34 151.14 41.38 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 124.106 0.962 . . . . 33.93 113.009 -175.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1190 ' ' ILE . . . . . . . . . . . . . 18.5 mt -86.36 101.67 10.89 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 N-CA-C 103.153 -2.906 . . . . 38.74 103.153 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1191 ' ' VAL . . . . . 0.562 HG11 ' HA ' ' A' 1181 ' ' ILE . 3.0 t -86.99 127.78 40.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 112.921 -1.945 . . . . 33.09 107.231 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1192 ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -119.85 107.33 13.02 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 106.761 -1.57 . . . . 38.92 106.761 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -108.39 121.75 45.57 Favored 'General case' 0 C--O 1.248 0.982 0 O-C-N 120.626 -1.297 . . . . 35.32 109.571 -174.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1194 ' ' PHE . . . . . . . . . . . . . 75.5 t80 -93.85 147.73 22.8 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 105.517 -2.031 . . . . 39.35 105.517 169.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 7.2 t70 -149.29 157.41 43.32 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 105.874 -1.899 . . . . 40.46 105.874 154.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1196 ' ' THR . . . . . . . . . . . . . 2.7 m -67.08 -43.39 82.71 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 104.962 -2.236 . . . . 45.94 104.962 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1197 ' ' ARG . . . . . . . . . . . . . 72.4 mtm180 -72.48 116.69 52.06 Favored Pre-proline 0 N--CA 1.453 -0.322 0 O-C-N 120.966 -1.084 . . . . 56.02 111.721 -175.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1198 ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -62.05 -26.94 78.78 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 125.244 3.963 . . . . 51.27 116.826 175.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -54.23 -34.65 61.18 Favored 'General case' 0 C--O 1.248 1.023 0 CA-C-N 114.557 -1.201 . . . . 59.1 112.598 -176.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 34.6 m -75.35 -10.7 13.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 117.23 2.307 . . . . 51.06 117.23 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 83.3 tttt -51.2 -46.21 62.1 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 124.709 1.204 . . . . 57.38 111.852 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -72.99 -29.79 63.31 Favored 'General case' 0 CA--C 1.512 -0.482 0 O-C-N 120.472 -1.393 . . . . 62.41 109.845 -173.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -66.3 -42.46 88.27 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.294 -1.373 . . . . 57.78 107.294 173.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1204 ' ' VAL . . . . . 0.61 HG13 ' HB3' ' A' 1209 ' ' ALA . 5.3 t -60.93 -50.23 81.41 Favored 'Isoleucine or valine' 0 C--N 1.344 0.357 0 C-N-CA 124.928 1.291 . . . . 46.38 109.141 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -56.54 -44.59 81.02 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 114.421 1.267 . . . . 50.7 114.421 173.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1206 ' ' SER . . . . . . . . . . . . . 48.7 m -58.44 -34.91 71.34 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.028 1.492 . . . . 49.98 115.028 174.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1207 ' ' MET . . . . . . . . . . . . . 61.4 mtp -92.54 11.02 27.83 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 119.759 -1.838 . . . . 52.99 111.08 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 78.28 51.19 5.81 Favored Glycine 0 CA--C 1.549 2.218 0 CA-C-O 124.39 2.106 . . . . 47.66 111.481 168.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1209 ' ' ALA . . . . . 0.61 ' HB3' HG13 ' A' 1204 ' ' VAL . . . -129.67 143.3 50.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 113.059 -1.57 . . . . 44.77 114.19 171.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -69.84 132.5 46.12 Favored 'General case' 0 C--N 1.347 0.468 0 N-CA-C 105.957 -1.868 . . . . 47.64 105.957 167.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1211 ' ' PHE . . . . . 0.526 ' HD1' HG11 ' A' 1204 ' ' VAL . 26.5 t80 -86.76 134.32 33.58 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 104.739 -2.319 . . . . 45.66 104.739 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 51.7 mt -84.93 109.09 17.9 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 123.719 1.724 . . . . 46.06 108.41 165.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -79.32 145.23 33.57 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 113.703 -1.589 . . . . 60.22 109.414 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1214 ' ' LEU . . . . . . . . . . . . . 9.2 tp -79.94 85.36 5.57 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 124.369 2.033 . . . . 57.25 108.953 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1215 ' ' ASP . . . . . 0.644 ' H ' HD21 ' A' 1241 ' ' LEU . 12.3 t70 -76.71 111.89 12.71 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 110.978 -2.828 . . . . 64.43 104.696 -176.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1216 ' ' PHE . . . . . 0.642 ' HE1' ' HB1' ' A' 1233 ' ' ALA . 33.4 t80 . . . . . 0 CA--C 1.516 -0.362 0 N-CA-C 107.765 -1.198 . . . . 66.9 107.765 -175.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 2.2 p-10 . . . . . 0 N--CA 1.446 -0.663 0 CA-C-O 120.954 0.407 . . . . 39.09 110.978 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -42.26 -57.07 3.81 Favored Glycine 0 C--O 1.208 -1.492 0 O-C-N 126.427 2.329 . . . . 39.32 113.912 175.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 79.0 t80 -60.9 -47.89 84.34 Favored 'General case' 0 N--CA 1.44 -0.955 0 O-C-N 120.98 -1.306 . . . . 39.3 110.739 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -63.07 -35.98 82.05 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 120.645 -1.284 . . . . 36.3 114.42 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -65.4 -59.83 3.61 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 117.695 -1.145 . . . . 37.38 110.476 176.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -54.23 -47.78 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 121.065 1.757 . . . . 39.11 114.047 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1230 ' ' MET . . . . . . . . . . . . . 20.3 mmt -90.21 68.61 7.06 Favored 'General case' 0 C--O 1.247 0.933 0 CA-C-O 123.094 1.426 . . . . 49.59 112.708 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1231 ' ' SER . . . . . . . . . . . . . 1.9 p -142.43 132.69 24.79 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.222 -1.399 . . . . 43.68 107.222 165.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -49.08 -42.37 38.6 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 116.426 2.01 . . . . 55.57 116.426 -172.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1233 ' ' ALA . . . . . 0.642 ' HB1' ' HE1' ' A' 1216 ' ' PHE . . . -59.57 -39.02 82.72 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 119.109 0.868 . . . . 44.94 113.158 174.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -55.0 -60.59 3.16 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 114.435 1.272 . . . . 42.04 114.435 170.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1235 ' ' ILE . . . . . . . . . . . . . 59.3 mt -57.89 -42.41 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 124.425 2.059 . . . . 46.28 109.854 -176.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 45.2 tttm -50.86 -53.12 35.07 Favored 'General case' 0 C--O 1.25 1.095 0 CA-C-N 113.289 -1.778 . . . . 47.87 114.15 166.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -63.47 -33.41 75.51 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 120.419 1.463 . . . . 41.61 110.703 -176.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -55.13 -59.66 4.46 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 124.883 1.273 . . . . 50.65 107.708 169.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1239 ' ' MET . . . . . . . . . . . . . 32.7 mtm -56.31 -31.69 63.93 Favored 'General case' 0 C--O 1.238 0.498 0 O-C-N 120.135 -1.603 . . . . 48.87 113.368 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -64.54 -39.72 94.28 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 112.166 0.432 . . . . 54.8 112.166 175.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1241 ' ' LEU . . . . . 0.644 HD21 ' H ' ' A' 1215 ' ' ASP . 1.6 mm? -65.6 -46.24 80.12 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 120.598 -1.314 . . . . 43.21 108.738 177.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -64.0 -34.38 77.86 Favored 'General case' 0 CA--C 1.508 -0.666 0 O-C-N 126.922 2.639 . . . . 38.66 112.635 -168.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -59.19 -54.12 50.54 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 120.403 1.456 . . . . 37.92 113.394 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -67.23 -42.94 83.18 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 119.803 1.183 . . . . 37.28 110.242 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1245 ' ' GLN . . . . . 0.482 ' HB3' ' SD ' ' A' 1169 ' ' MET . 96.7 mm-40 -54.19 -40.97 68.07 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 121.383 -0.823 . . . . 43.07 112.297 177.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -55.49 -37.08 67.37 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.076 0.95 . . . . 38.3 112.172 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1247 ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' A' 1276 ' ' LYS . 12.8 ttmm -54.9 -35.93 64.64 Favored 'General case' 0 C--O 1.258 1.517 0 C-N-CA 125.115 1.366 . . . . 47.6 110.905 177.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -111.24 -20.29 12.37 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.477 1.288 . . . . 45.42 114.477 -175.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1249 ' ' VAL . . . . . 0.437 HG11 ' HB2' ' A' 1169 ' ' MET . 31.2 m -78.27 162.63 4.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 115.303 1.594 . . . . 36.26 115.303 -173.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1250 ' ' ASP . . . . . 0.581 ' O ' ' HB3' ' A' 1279 ' ' SER . 3.6 m-20 -109.42 -60.47 1.77 Allowed 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 115.076 -0.965 . . . . 33.04 111.381 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1251 ' ' ILE . . . . . 0.449 HD12 ' HB1' ' A' 1145 ' ' ALA . 36.1 mm -112.76 102.08 13.43 Favored 'Isoleucine or valine' 0 C--O 1.247 0.934 0 N-CA-C 105.709 -1.96 . . . . 31.4 105.709 -170.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1252 ' ' ILE . . . . . 0.436 ' HB ' HG12 ' A' 1281 ' ' ILE . 64.9 mt -80.63 117.15 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 104.354 -2.462 . . . . 29.42 104.354 167.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1253 ' ' VAL . . . . . 0.598 HG12 HG23 ' A' 1255 ' ' THR . 18.2 t -103.92 109.75 28.14 Favored 'Isoleucine or valine' 0 C--O 1.248 0.985 0 N-CA-C 100.694 -3.817 . . . . 30.37 100.694 175.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1254 ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.53 82.4 5.34 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 124.904 2.287 . . . . 35.72 110.65 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1255 ' ' THR . . . . . 0.742 HG22 HD13 ' A' 1284 ' ' LEU . 1.1 p -86.29 -16.95 35.93 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 112.09 -2.323 . . . . 36.0 115.112 -174.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1256 ' ' ALA . . . . . 0.444 ' HB2' ' HA3' ' A' 1172 ' ' GLY . . . -57.81 64.45 0.0 OUTLIER 'General case' 0 C--O 1.261 1.675 0 N-CA-C 116.927 2.195 . . . . 40.93 116.927 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 44.4 tp -83.67 101.14 11.32 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 124.356 2.027 . . . . 47.82 110.369 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 32.8 mm -82.51 120.99 77.87 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-N 111.883 -2.417 . . . . 52.7 108.24 173.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -72.79 148.7 46.81 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 124.887 3.724 . . . . 54.13 111.366 175.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 74.69 -88.8 0.74 Allowed Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.699 -0.96 . . . . 54.62 110.699 176.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 41.1 mttt -56.78 124.93 66.63 Favored Pre-proline 0 CA--C 1.55 0.946 0 O-C-N 121.288 -1.125 . . . . 55.74 108.194 173.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -57.76 135.31 68.4 Favored 'Trans proline' 0 CA--C 1.521 -0.142 0 C-N-CA 123.306 2.671 . . . . 51.15 109.483 177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1263 ' ' ALA . . . . . 0.557 ' HB1' ' ND2' ' A' 1291 ' ' ASN . . . -57.53 130.59 81.44 Favored Pre-proline 0 N--CA 1.482 1.14 0 O-C-N 124.049 0.843 . . . . 46.06 110.042 -178.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -60.01 143.74 99.54 Favored 'Trans proline' 0 C--O 1.242 0.679 0 C-N-CA 124.187 3.258 . . . . 41.08 117.17 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1265 ' ' LYS . . . . . 0.589 ' HD2' ' HA ' ' A' 1293 ' ' GLU . 69.7 mmtt -79.65 85.54 5.36 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-O 124.423 2.058 . . . . 47.42 106.684 177.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 74.0 mt -84.43 -42.17 15.9 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 109.378 -3.555 . . . . 39.22 108.848 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 4.0 mp -99.07 108.76 22.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.842 0 N-CA-C 102.242 -3.244 . . . . 42.5 102.242 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1268 ' ' THR . . . . . 0.531 ' O ' HG23 ' A' 1272 ' ' VAL . 27.1 p -80.2 163.23 24.2 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 113.931 -1.486 . . . . 37.84 114.31 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 59.2 mtt-85 -58.27 -39.72 79.98 Favored 'General case' 0 C--O 1.212 -0.921 0 CA-C-N 115.883 -0.599 . . . . 54.8 110.487 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -60.15 -53.72 54.33 Favored 'General case' 0 N--CA 1.426 -1.654 0 O-C-N 124.851 1.344 . . . . 54.36 109.443 174.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1271 ' ' MET . . . . . . . . . . . . . 42.1 ttm -58.04 -37.46 74.4 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.087 0.955 . . . . 39.52 113.423 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1272 ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' 1268 ' ' THR . 13.5 t -67.45 -48.48 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 108.72 -0.844 . . . . 38.25 108.72 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.89 -29.18 70.03 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.491 0.922 . . . . 40.77 113.491 175.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1274 ' ' SER . . . . . . . . . . . . . 28.6 m -73.94 -12.43 60.65 Favored 'General case' 0 C--O 1.256 1.395 0 O-C-N 120.863 -1.148 . . . . 36.58 113.81 173.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1275 ' ' MET . . . . . 0.475 ' SD ' HD11 ' A' 1281 ' ' ILE . 70.3 mtp -63.16 155.77 27.11 Favored 'General case' 0 C--O 1.245 0.854 0 O-C-N 119.084 -2.26 . . . . 36.75 113.601 -177.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1276 ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' 1247 ' ' LYS . 36.1 ttpt -61.21 133.52 56.03 Favored 'General case' 0 C--N 1.347 0.471 0 N-CA-C 106.596 -1.631 . . . . 46.11 106.596 171.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1277 ' ' ALA . . . . . . . . . . . . . . . -71.29 175.15 5.6 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 122.441 1.115 . . . . 33.52 112.978 -172.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 67.34 28.16 73.62 Favored Glycine 0 C--O 1.22 -0.76 0 O-C-N 120.907 -1.12 . . . . 31.27 111.932 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1279 ' ' SER . . . . . 0.581 ' HB3' ' O ' ' A' 1250 ' ' ASP . 50.4 m -125.75 170.2 11.81 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.389 -1.065 . . . . 32.95 112.097 -165.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1280 ' ' VAL . . . . . 0.737 HG11 ' HA ' ' A' 1145 ' ' ALA . 65.2 t -130.82 133.45 63.16 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 O-C-N 119.472 -2.017 . . . . 27.43 108.66 -167.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1281 ' ' ILE . . . . . 0.475 HD11 ' SD ' ' A' 1275 ' ' MET . 48.4 mt -110.98 100.75 11.41 Favored 'Isoleucine or valine' 0 C--O 1.251 1.179 0 N-CA-C 103.624 -2.732 . . . . 30.3 103.624 166.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1282 ' ' VAL . . . . . 0.483 HG23 ' HA ' ' A' 1253 ' ' VAL . 0.0 OUTLIER -91.64 97.82 7.67 Favored 'Isoleucine or valine' 0 C--O 1.249 1.065 0 N-CA-C 107.108 -1.441 . . . . 28.63 107.108 176.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 4.4 t70 -86.95 108.72 18.94 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 106.819 -1.549 . . . . 36.27 106.819 -173.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1284 ' ' LEU . . . . . 0.742 HD13 HG22 ' A' 1255 ' ' THR . 9.6 tt -80.14 -35.62 36.4 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.88 0.847 . . . . 38.57 109.207 171.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -63.57 -12.71 35.02 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.497 -0.774 . . . . 37.56 112.765 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . -41.04 -29.51 0.11 Allowed 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 117.011 2.226 . . . . 40.33 117.011 162.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -51.19 -40.55 58.91 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-O 117.978 -1.01 . . . . 56.85 110.8 171.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 48.4 t30 -141.45 96.25 2.95 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 118.976 0.807 . . . . 45.86 110.1 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 92.28 -59.8 2.64 Favored Glycine 0 C--N 1.348 1.196 0 O-C-N 120.305 -1.497 . . . . 40.31 112.607 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 81.63 128.93 1.03 Allowed Glycine 0 N--CA 1.471 0.975 0 CA-C-N 120.485 2.143 . . . . 38.89 114.053 -171.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1291 ' ' ASN . . . . . 0.557 ' ND2' ' HB1' ' A' 1263 ' ' ALA . 20.3 m120 -82.02 -22.51 36.43 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 116.311 1.967 . . . . 37.23 116.311 -170.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1292 ' ' CYS . . . . . 0.565 ' HB3' ' OG1' ' A' 1295 ' ' THR . 29.6 t -94.29 144.36 25.59 Favored 'General case' 0 C--O 1.252 1.228 0 N-CA-C 102.461 -3.163 . . . . 36.5 102.461 174.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1293 ' ' GLU . . . . . 0.589 ' HA ' ' HD2' ' A' 1265 ' ' LYS . 30.5 mt-10 -64.96 -51.46 61.69 Favored 'General case' 0 CA--C 1.56 1.336 0 CA-C-O 122.811 1.291 . . . . 43.32 107.868 172.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -54.78 -18.68 5.06 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 119.916 3.302 . . . . 41.32 119.916 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1295 ' ' THR . . . . . 0.565 ' OG1' ' HB3' ' A' 1292 ' ' CYS . 58.4 m -49.75 103.97 0.06 Allowed 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 122.423 1.106 . . . . 35.3 112.77 167.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 94.6 t -86.1 121.29 72.8 Favored Pre-proline 0 C--O 1.246 0.887 0 N-CA-C 100.913 -3.736 . . . . 34.84 100.913 164.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -65.49 125.09 13.82 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.855 2.37 . . . . 33.51 107.597 -176.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 93.42 -3.23 71.84 Favored Glycine 0 N--CA 1.433 -1.556 0 CA-C-O 117.777 -1.568 . . . . 32.19 113.699 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -130.46 172.28 12.06 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 123.656 3.728 . . . . 34.88 117.206 -177.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1300 ' ' ILE . . . . . 0.576 HG23 HG12 ' A' 1310 ' ' ILE . 59.3 mt -98.72 98.17 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 101.744 -3.428 . . . . 32.29 101.744 170.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1301 ' ' PHE . . . . . 0.533 ' HB3' ' HB ' ' A' 1309 ' ' VAL . 61.9 t80 -71.99 148.56 45.82 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 103.905 -2.628 . . . . 37.25 103.905 161.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1302 ' ' THR . . . . . 0.486 HG22 ' O ' ' A' 1303 ' ' THR . 86.4 m -132.46 141.67 48.92 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 105.644 -1.984 . . . . 35.56 105.644 169.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1303 ' ' THR . . . . . 0.486 ' O ' HG22 ' A' 1302 ' ' THR . 16.8 p -81.23 163.71 22.81 Favored 'General case' 0 N--CA 1.425 -1.693 0 C-N-CA 125.333 1.453 . . . . 36.4 109.795 168.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -55.84 -49.66 72.7 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 124.924 1.29 . . . . 52.32 109.568 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1305 ' ' ASN . . . . . . . . . . . . . 39.4 p-10 -66.44 -19.56 65.83 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.854 1.057 . . . . 40.04 113.854 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 97.94 63.12 0.88 Allowed Glycine 0 N--CA 1.426 -2.025 0 CA-C-N 113.865 -1.516 . . . . 36.96 112.036 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1307 ' ' VAL . . . . . 0.462 HG11 ' SD ' ' A' 1275 ' ' MET . 45.6 t -118.18 114.5 45.38 Favored 'Isoleucine or valine' 0 C--O 1.251 1.158 0 N-CA-C 108.221 -1.029 . . . . 33.4 108.221 163.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1308 ' ' LYS . . . . . 0.799 ' HD2' ' HB3' ' A' 1148 ' ' GLU . 78.2 mttt -92.75 108.19 19.8 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.943 0.878 . . . . 42.91 112.686 -171.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1309 ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' 1301 ' ' PHE . 14.0 t -94.62 83.43 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 106.025 -1.842 . . . . 32.29 106.025 -174.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1310 ' ' ILE . . . . . 0.576 HG12 HG23 ' A' 1300 ' ' ILE . 47.8 mt -80.83 91.33 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.35 0 CA-C-N 110.737 -2.938 . . . . 30.99 108.648 -173.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1311 ' ' GLY . . . . . 0.408 ' HA3' HG23 ' A' 1295 ' ' THR . . . -87.47 71.17 2.7 Favored Glycine 0 CA--C 1.537 1.442 0 O-C-N 118.284 -2.76 . . . . 28.95 112.318 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1312 ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -90.63 93.9 9.46 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 118.815 -1.154 . . . . 31.69 112.529 -172.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1313 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.53 -36.81 62.18 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 112.985 -1.916 . . . . 34.17 109.756 172.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 29.1 p-10 -84.74 3.87 35.41 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 118.192 2.664 . . . . 36.86 118.192 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1315 ' ' LEU . . . . . . . . . . . . . 28.7 mt -37.11 -50.85 2.26 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 118.322 2.712 . . . . 34.85 118.322 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1316 ' ' PRO . . . . . 0.731 ' HG3' ' HB2' ' A' 1137 ' ' ALA . 82.5 Cg_exo -53.35 -46.82 31.1 Favored 'Trans proline' 0 C--N 1.355 0.9 0 CA-C-N 125.655 3.056 . . . . 29.15 112.791 171.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1317 ' ' GLY . . . . . 0.615 ' HA2' ' HG3' ' A' 1015 ' ' ARG . . . -63.41 -29.89 75.93 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 115.097 0.799 . . . . 27.29 115.097 -175.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1318 ' ' ARG . . . . . 0.479 ' HB3' ' NH2' ' A' 1140 ' ' ARG . 52.3 mtt-85 -65.88 -19.94 66.05 Favored 'General case' 0 C--O 1.255 1.376 0 O-C-N 126.348 1.852 . . . . 41.49 115.345 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1319 ' ' LEU . . . . . 0.679 ' HB2' ' HD3' ' A' 1140 ' ' ARG . 13.3 tp -118.2 72.09 9.23 Favored Pre-proline 0 N--CA 1.438 -1.031 0 N-CA-C 105.232 -2.136 . . . . 27.61 105.232 178.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1320 ' ' PRO . . . . . 0.823 ' HB3' ' HB ' ' A' 1014 ' ' THR . 38.3 Cg_endo -56.04 -53.82 4.91 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.571 2.847 . . . . 25.94 114.698 -164.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1321 ' ' THR . . . . . . . . . . . . . 1.8 m -67.64 -39.52 84.63 Favored 'General case' 0 CA--C 1.499 -0.995 0 O-C-N 119.485 -2.009 . . . . 25.01 110.41 -168.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1322 ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -68.77 -26.57 65.29 Favored 'General case' 0 CA--C 1.511 -0.519 0 O-C-N 118.19 -2.819 . . . . 29.39 110.838 176.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1323 ' ' SER . . . . . 0.767 ' HA ' HD13 ' A' 1136 ' ' ILE . 70.6 m -64.59 -53.11 52.9 Favored 'General case' 0 CA--C 1.501 -0.913 0 O-C-N 119.569 -1.957 . . . . 26.47 109.91 167.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1324 ' ' SER . . . . . . . . . . . . . 4.6 m -55.66 -27.5 50.28 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.96 0.886 . . . . 27.78 113.001 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -86.54 -51.68 6.03 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 118.319 -1.352 . . . . 37.53 110.81 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1326 ' ' LEU . . . . . 0.407 ' HB2' HD11 ' A' 1136 ' ' ILE . 92.9 mt -79.94 -52.2 8.15 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 118.182 -0.913 . . . . 35.71 111.261 -172.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1327 ' ' TYR . . . . . 0.46 ' OH ' ' HA ' ' A' 1091 ' ' SER . 66.8 t80 -57.47 -43.39 84.02 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.799 0.809 . . . . 31.59 110.99 170.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1328 ' ' GLY . . . . . 0.564 ' HA2' HD12 ' A' 1331 ' ' LEU . . . -49.72 -50.11 32.4 Favored Glycine 0 N--CA 1.468 0.798 0 CA-C-O 118.149 -1.362 . . . . 28.0 110.816 171.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1329 ' ' THR . . . . . . . . . . . . . 52.4 m -72.5 -27.7 62.43 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 118.76 -1.176 . . . . 32.15 112.484 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1330 ' ' ASN . . . . . . . . . . . . . 28.5 m120 -60.1 -43.73 95.34 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 118.007 -2.933 . . . . 34.36 108.957 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1331 ' ' LEU . . . . . 0.674 HD22 HD22 ' A' 1070 ' ' LEU . 27.7 mt -59.79 -48.8 80.21 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 112.774 -2.012 . . . . 33.37 108.027 177.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1332 ' ' VAL . . . . . 0.497 HG12 ' HE3' ' A' 1336 ' ' LYS . 77.5 t -54.0 -47.75 64.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 C-N-CA 124.712 1.205 . . . . 35.27 111.682 175.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1333 ' ' ASN . . . . . 0.424 ' HA ' ' HD2' ' A' 1336 ' ' LYS . 82.9 m-20 -61.3 -34.09 74.65 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 115.343 1.608 . . . . 37.66 115.343 -177.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1334 ' ' LEU . . . . . 0.639 HD22 ' SD ' ' A' 1115 ' ' MET . 44.2 tp -72.09 -47.3 52.39 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 106.35 -1.722 . . . . 40.27 106.35 173.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1335 ' ' LEU . . . . . 0.615 ' HA ' ' HB2' ' A' 1338 ' ' LEU . 20.2 mt -64.94 -21.05 66.76 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 115.512 1.671 . . . . 42.5 115.512 -176.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1336 ' ' LYS . . . . . 0.497 ' HE3' HG12 ' A' 1332 ' ' VAL . 94.4 mttt -56.33 -42.93 78.46 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 119.617 -1.927 . . . . 47.81 112.145 164.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1337 ' ' LEU . . . . . 0.636 HD13 HD11 ' A' 1355 ' ' ILE . 96.0 mt -79.01 -33.69 44.68 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.044 -0.98 . . . . 49.27 111.318 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1338 ' ' LEU . . . . . 0.615 ' HB2' ' HA ' ' A' 1335 ' ' LEU . 8.3 mp -65.86 -37.52 86.39 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 114.075 1.139 . . . . 50.54 114.075 174.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1339 ' ' CYS . . . . . . . . . . . . . 27.0 m -116.73 87.19 2.64 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 124.301 2.001 . . . . 53.67 112.538 169.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1340 ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' 1337 ' ' LEU . 96.7 mttt -76.46 -52.8 9.13 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 112.2 -2.273 . . . . 63.38 108.954 -176.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -74.61 -44.87 48.56 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-O 122.707 1.241 . . . . 70.95 110.837 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1342 ' ' LYS . . . . . 0.478 ' HE3' ' HA ' ' A' 1029 ' ' LEU . 2.8 mtpt 61.41 90.44 0.07 Allowed 'General case' 0 C--O 1.214 -0.766 0 C-N-CA 126.122 1.769 . . . . 65.25 113.336 -173.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1343 ' ' ASP . . . . . 0.4 ' HB3' ' N ' ' A' 1342 ' ' LYS . 24.8 t70 70.27 160.75 0.21 Allowed 'General case' 0 C--O 1.247 0.928 2 O-C-N 111.146 -7.221 . . . . 64.53 115.526 -6.082 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 1344 ' ' GLY . . . . . . . . . . . . . . . -140.61 2.18 2.18 Favored Glycine 0 N--CA 1.433 -1.501 0 CA-C-O 122.267 0.926 . . . . 59.72 112.013 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 10.2 t30 -80.03 85.59 5.61 Favored 'General case' 0 C--O 1.247 0.933 0 O-C-N 119.218 -2.342 . . . . 64.09 106.88 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1346 ' ' ILE . . . . . 0.441 ' H ' HG13 ' A' 1346 ' ' ILE . 1.2 pp -54.26 117.18 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 109.877 -3.329 . . . . 58.82 111.176 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1347 ' ' THR . . . . . . . . . . . . . 4.0 m -78.47 96.04 5.29 Favored 'General case' 0 C--N 1.348 0.52 0 N-CA-C 103.779 -2.674 . . . . 54.96 103.779 -177.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1348 ' ' VAL . . . . . 0.652 HG21 HG21 ' A' 1111 ' ' THR . 3.5 t -75.96 85.27 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 N-CA-C 104.511 -2.403 . . . . 55.64 104.511 170.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 33.4 t70 -73.39 150.6 41.63 Favored 'General case' 0 C--O 1.254 1.296 0 CA-C-N 112.065 -2.334 . . . . 61.45 112.805 -169.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1350 ' ' PHE . . . . . 0.434 ' O ' ' HB2' ' A' 1356 ' ' ARG . 49.8 m-85 -111.79 -30.16 7.41 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 113.12 -1.855 . . . . 58.63 108.527 171.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -69.58 -23.47 63.55 Favored 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 120.381 -1.449 . . . . 62.06 114.21 -159.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 10.1 t70 -91.53 136.66 32.96 Favored 'General case' 0 C--O 1.253 1.254 0 N-CA-C 106.429 -1.693 . . . . 54.07 106.429 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 4.6 m -50.42 -41.47 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 123.671 0.788 . . . . 50.68 112.151 177.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1354 ' ' VAL . . . . . 0.525 ' O ' HG23 ' A' 1358 ' ' VAL . 15.2 m -71.83 -41.74 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 C-N-CA 117.137 -1.825 . . . . 47.68 109.143 -175.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1355 ' ' ILE . . . . . 0.636 HD11 HD13 ' A' 1337 ' ' LEU . 26.6 mt -74.13 -29.05 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 120.167 -0.613 . . . . 48.49 111.697 -176.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1356 ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' 1356 ' ' ARG . 32.6 tpt85 -60.96 -24.75 66.32 Favored 'General case' 0 C--O 1.248 0.983 0 O-C-N 120.047 -1.658 . . . . 48.27 112.352 170.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1357 ' ' GLY . . . . . 0.409 ' HA3' ' HD3' ' A' 1119 ' ' PRO . . . -82.97 -32.58 26.05 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-O 123.839 1.8 . . . . 43.53 110.945 175.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1358 ' ' VAL . . . . . 0.676 HG22 HG22 ' A' 1118 ' ' VAL . 21.7 t -76.1 -46.04 34.87 Favored 'Isoleucine or valine' 0 C--O 1.256 1.433 0 O-C-N 121.636 -0.92 . . . . 45.12 108.701 -176.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1359 ' ' THR . . . . . . . . . . . . . 22.1 m -64.82 84.83 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 123.788 1.756 . . . . 42.94 110.474 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1360 ' ' VAL . . . . . 0.404 HG11 ' HG2' ' A' 1095 ' ' PRO . 27.2 m -92.22 -34.95 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 114.828 -1.078 . . . . 43.26 111.883 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1361 ' ' ILE . . . . . 0.417 ' HB ' ' HB ' ' A' 1112 ' ' VAL . 79.6 mt -130.86 109.54 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 106.308 -1.738 . . . . 45.66 106.308 171.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1362 ' ' ARG . . . . . 0.549 ' HA ' HG23 ' A' 1111 ' ' THR . 61.0 ttt180 -94.82 121.58 36.57 Favored 'General case' 0 C--O 1.207 -1.134 0 O-C-N 118.258 -2.776 . . . . 61.34 107.826 169.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 45.25 61.15 2.68 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.184 1.179 . . . . 49.76 114.184 166.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1364 ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' 1109 ' ' ASN . . . 88.3 -47.52 3.5 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 114.016 -1.447 . . . . 50.0 112.042 -178.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -77.83 130.8 37.12 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 118.12 0.96 . . . . 56.92 109.293 -173.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1366 ' ' ILE . . . . . . . . . . . . . 31.2 mt -81.34 93.88 2.4 Favored 'Isoleucine or valine' 0 C--O 1.249 1.053 0 N-CA-C 105.02 -2.215 . . . . 52.78 105.02 177.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1367 ' ' THR . . . . . . . . . . . . . 26.0 p -72.12 -9.91 59.07 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 112.832 -1.985 . . . . 49.44 113.836 176.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1368 ' ' TRP . . . . . . . . . . . . . 1.4 t90 -65.28 143.96 98.89 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 106.615 -1.624 . . . . 52.38 106.615 164.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -67.93 167.7 61.82 Favored 'Cis proline' 0 C--O 1.244 0.82 0 CA-C-N 124.811 2.754 . . . . 46.94 118.616 2.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -111.3 121.71 39.63 Favored Pre-proline 0 N--CA 1.437 -1.086 0 N-CA-C 106.076 -1.824 . . . . 45.91 106.076 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1371 ' ' PRO . . . . . 0.441 ' HD2' ' HG3' ' A' 1356 ' ' ARG . 17.5 Cg_exo -51.05 139.52 42.02 Favored 'Trans proline' 0 C--O 1.247 0.959 0 C-N-CA 123.67 2.913 . . . . 46.39 110.379 174.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -57.44 -31.09 90.33 Favored 'Trans proline' 0 N--CA 1.44 -1.621 0 C-N-CA 124.761 3.641 . . . . 46.72 112.719 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.231 -4.556 0 O-C-N 119.731 -1.856 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.441 -0.893 0 CA-C-O 117.6 -1.191 . . . . 63.44 110.644 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -79.68 55.6 2.05 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 123.652 2.933 . . . . 51.74 111.034 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1000 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.84 125.34 28.61 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 124.488 1.115 . . . . 54.07 111.407 -172.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 65.76 17.77 65.37 Favored Glycine 0 CA--C 1.531 1.079 0 O-C-N 121.688 -0.633 . . . . 39.22 112.7 -169.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1002 ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' B' 1066 ' ' SER . 13.7 ttp180 -90.19 118.66 29.88 Favored 'General case' 0 C--O 1.211 -0.939 0 CA-C-N 120.327 2.063 . . . . 38.12 111.381 177.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1003 ' ' ILE . . . . . 0.52 HD13 HD11 ' B' 1070 ' ' LEU . 21.8 mt -75.63 150.04 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 112.25 -2.25 . . . . 29.7 110.36 169.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -123.36 118.39 3.51 Favored Glycine 0 C--O 1.241 0.582 0 N-CA-C 110.472 -1.051 . . . . 27.5 110.472 165.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1005 ' ' ILE . . . . . 0.525 HG23 ' HB3' ' B' 1017 ' ' ALA . 23.3 mm -97.55 116.81 65.86 Favored Pre-proline 0 CA--C 1.558 1.278 0 N-CA-C 105.915 -1.883 . . . . 24.83 105.915 173.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -86.81 162.7 9.1 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.709 2.94 . . . . 27.19 112.446 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1007 ' ' ARG . . . . . 0.53 ' HG3' ' HB3' ' B' 1036 ' ' GLU . 19.7 mtp180 -77.59 101.3 6.48 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 102.028 -3.323 . . . . 41.46 102.028 163.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1008 ' ' GLU . . . . . 0.611 ' HG3' ' HB ' ' B' 1072 ' ' VAL . 3.2 mm-40 -58.71 140.62 54.5 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-O 122.369 1.081 . . . . 26.93 113.663 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 43.0 mmm-85 -86.89 -25.46 24.43 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.226 -1.352 . . . . 34.48 109.787 -162.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1010 ' ' LEU . . . . . 0.446 ' HB3' ' HB2' ' B' 1013 ' ' GLU . 4.8 tp -59.42 155.64 14.52 Favored 'General case' 0 C--O 1.25 1.093 0 N-CA-C 115.175 1.546 . . . . 44.22 115.175 -157.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1011 ' ' THR . . . . . . . . . . . . . 28.7 m -61.17 120.06 9.6 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.885 -0.598 . . . . 40.74 111.155 174.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 67.37 41.53 2.42 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 123.523 1.63 . . . . 44.44 112.151 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1013 ' ' GLU . . . . . 0.446 ' HG2' ' HB3' ' B' 1008 ' ' GLU . 8.5 tp10 -102.16 128.4 48.68 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.596 -1.184 . . . . 29.87 111.687 -175.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1014 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.01 -11.35 7.09 Favored 'General case' 0 C--O 1.247 0.934 0 O-C-N 125.456 1.723 . . . . 25.26 110.286 176.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -76.97 98.32 4.9 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 120.174 -1.579 . . . . 29.54 112.633 -175.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1016 ' ' VAL . . . . . 0.989 ' HB ' ' HB2' ' B' 1043 ' ' ALA . 44.0 t -96.56 141.95 14.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 105.02 -2.215 . . . . 23.55 105.02 168.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1017 ' ' ALA . . . . . 0.525 ' HB3' HG23 ' B' 1005 ' ' ILE . . . -62.42 -39.32 92.93 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 118.307 2.706 . . . . 23.59 118.307 -155.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1018 ' ' ALA . . . . . . . . . . . . . . . -128.12 149.95 50.19 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 119.255 -2.153 . . . . 24.93 111.76 -168.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1019 ' ' THR . . . . . 0.409 ' O ' HG23 ' B' 1023 ' ' VAL . 13.2 p -84.9 166.16 33.33 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-O 117.361 -1.304 . . . . 28.09 111.101 165.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1020 ' ' PRO . . . . . 0.471 ' HB3' ' HB2' ' B' 1053 ' ' ALA . 41.0 Cg_exo -55.02 -39.75 89.35 Favored 'Trans proline' 0 CA--C 1.549 1.241 0 C-N-CA 123.163 2.576 . . . . 28.79 112.838 165.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 70.7 tttt -57.49 -49.1 77.38 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 120.17 -1.581 . . . . 47.28 111.144 175.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1022 ' ' THR . . . . . . . . . . . . . 11.8 p -73.64 -27.33 61.2 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 117.068 -1.444 . . . . 30.12 110.275 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1023 ' ' VAL . . . . . 0.438 HG11 ' HB2' ' B' 1055 ' ' ALA . 46.0 t -53.2 -50.32 47.1 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 CA-C-N 120.624 1.556 . . . . 32.24 108.638 165.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1024 ' ' GLU . . . . . 0.462 ' HA ' HD12 ' B' 1027 ' ' LEU . 48.6 mt-10 -63.4 -35.61 80.99 Favored 'General case' 0 CA--C 1.511 -0.553 0 O-C-N 120.42 -1.425 . . . . 49.62 113.038 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -63.74 -43.23 97.08 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.438 -0.789 . . . . 44.68 109.849 172.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1026 ' ' LEU . . . . . 0.584 ' HG ' HG22 ' B' 1332 ' ' VAL . 19.2 mt -63.79 -35.41 80.49 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 115.651 1.722 . . . . 35.71 115.651 176.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1027 ' ' LEU . . . . . 0.462 HD12 ' HA ' ' B' 1024 ' ' GLU . 68.1 mt -62.4 -45.2 94.19 Favored 'General case' 0 C--O 1.237 0.445 0 O-C-N 124.254 0.971 . . . . 42.18 109.937 170.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 62.9 mttm -61.12 -30.06 70.15 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.205 1.187 . . . . 48.34 114.205 172.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1029 ' ' LEU . . . . . 0.446 HD12 HD23 ' B' 1026 ' ' LEU . 85.6 mt -69.27 -30.98 69.21 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-O 122.978 1.37 . . . . 38.69 112.832 165.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 113.34 31.6 2.36 Favored Glycine 0 N--CA 1.465 0.576 0 O-C-N 118.518 -2.614 . . . . 32.28 108.749 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -126.64 112.7 15.78 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 120.551 -1.558 . . . . 35.94 109.158 -177.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1032 ' ' THR . . . . . . . . . . . . . 15.0 m -71.5 137.55 48.25 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 106.942 -1.503 . . . . 33.37 106.942 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1033 ' ' VAL . . . . . 0.428 ' HB ' HG13 ' B' 1023 ' ' VAL . 61.0 t -106.17 119.47 55.6 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 CA-C-N 120.272 1.396 . . . . 29.98 112.774 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -96.07 140.31 30.98 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 106.802 -1.555 . . . . 28.18 106.802 169.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1035 ' ' VAL . . . . . 0.59 ' HB ' HD13 ' B' 1057 ' ' ILE . 39.8 t -133.36 140.56 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 119.02 -2.3 . . . . 25.82 105.923 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1036 ' ' GLU . . . . . 0.53 ' HB3' ' HG3' ' B' 1007 ' ' ARG . 10.5 mt-10 -65.63 142.51 58.03 Favored 'General case' 0 C--O 1.247 0.971 0 O-C-N 121.004 -1.06 . . . . 32.44 112.956 175.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1037 ' ' SER . . . . . 0.411 ' O ' ' HD2' ' B' 1007 ' ' ARG . 24.0 m -59.15 124.35 19.68 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 121.587 -0.695 . . . . 29.54 111.268 170.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 93.65 -18.08 57.24 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.04 -0.824 . . . . 27.76 111.04 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1039 ' ' ALA . . . . . . . . . . . . . . . -66.48 -40.4 89.3 Favored 'General case' 0 C--O 1.243 0.759 0 O-C-N 120.778 -1.425 . . . . 26.02 111.495 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -56.09 -51.36 56.22 Favored Glycine 0 CA--C 1.5 -0.891 0 N-CA-C 110.077 -1.209 . . . . 26.47 110.077 171.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -58.42 -29.49 66.15 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 120.661 -1.494 . . . . 50.98 113.033 173.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 65.0 mt -70.55 -48.27 56.26 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 123.045 2.657 . . . . 29.3 110.631 176.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1043 ' ' ALA . . . . . 0.989 ' HB2' ' HB ' ' B' 1016 ' ' VAL . . . -63.68 -17.96 63.49 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 114.928 -1.033 . . . . 26.74 111.834 174.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1044 ' ' SER . . . . . . . . . . . . . 29.0 m 69.11 47.47 0.74 Allowed 'General case' 0 C--N 1.352 0.694 0 CA-C-O 127.408 3.48 . . . . 31.26 109.813 175.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1045 ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -146.9 105.25 3.78 Favored 'General case' 0 N--CA 1.442 -0.866 1 N-CA-C 97.413 -5.032 . . . . 33.26 97.413 171.464 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 26.7 t0 -57.46 146.86 28.19 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 123.614 1.673 . . . . 46.74 115.465 -164.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -49.4 -43.17 44.12 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 110.803 -2.908 . . . . 34.44 110.091 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1048 ' ' LYS . . . . . 0.405 ' O ' ' HB ' ' B' 1051 ' ' VAL . 1.1 mptm? -66.14 -28.52 68.86 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.228 -0.92 . . . . 48.67 113.218 177.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -66.4 -32.29 73.58 Favored 'General case' 0 C--O 1.246 0.889 0 O-C-N 120.618 -1.301 . . . . 35.26 111.272 167.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1050 ' ' PHE . . . . . 0.631 ' HB2' HD11 ' B' 1057 ' ' ILE . 77.6 m-85 -70.98 -33.46 70.45 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 119.334 0.97 . . . . 32.17 109.005 170.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1051 ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' B' 1048 ' ' LYS . 76.7 t -58.98 -40.19 79.98 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 O-C-N 119.706 -1.871 . . . . 38.37 112.726 170.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -61.16 -38.94 88.26 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-O 118.427 -0.797 . . . . 45.77 112.19 171.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1053 ' ' ALA . . . . . 0.471 ' HB2' ' HB3' ' B' 1020 ' ' PRO . . . -68.15 -22.92 64.83 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 124.281 0.988 . . . . 37.83 113.064 172.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 76.34 59.04 3.44 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 109.782 -1.327 . . . . 35.82 109.782 -175.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1055 ' ' ALA . . . . . 0.438 ' HB2' HG11 ' B' 1023 ' ' VAL . . . -109.99 140.63 43.78 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 122.186 0.993 . . . . 33.77 108.49 166.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -78.34 96.51 5.33 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 118.207 -2.808 . . . . 51.02 108.887 -175.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1057 ' ' ILE . . . . . 0.631 HD11 ' HB2' ' B' 1050 ' ' PHE . 34.4 mm -72.97 110.13 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 106.712 -1.588 . . . . 38.47 106.712 176.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1058 ' ' VAL . . . . . 0.677 ' HB ' ' HB2' ' B' 1062 ' ' SER . 2.9 m -127.1 143.78 39.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 112.195 -2.275 . . . . 39.4 110.988 -174.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -77.44 124.16 27.52 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 122.181 0.991 . . . . 57.07 110.454 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . 50.3 -107.78 0.4 Allowed Glycine 0 CA--C 1.497 -1.074 0 N-CA-C 117.423 1.729 . . . . 44.83 117.423 164.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 25.9 m120 -63.73 -27.85 69.48 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.911 0.862 . . . . 46.27 111.934 -164.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1062 ' ' SER . . . . . 0.677 ' HB2' ' HB ' ' B' 1058 ' ' VAL . 3.1 m -55.48 -39.96 71.07 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 113.848 -1.524 . . . . 43.47 111.822 175.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1063 ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.71 -27.13 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 O-C-N 119.992 -1.692 . . . . 36.98 113.645 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 96.5 m95 -71.42 -27.49 63.33 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 124.042 1.877 . . . . 37.9 111.993 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -79.12 80.24 5.48 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 118.744 -2.473 . . . . 46.19 108.869 176.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1066 ' ' SER . . . . . 0.45 ' HB3' ' O ' ' B' 1002 ' ' ARG . 72.9 m -156.39 165.05 37.46 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.093 -0.958 . . . . 37.06 109.786 -172.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1067 ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' 1068 ' ' ILE . 0.5 OUTLIER -81.31 -39.15 25.62 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 114.504 -1.225 . . . . 43.95 109.236 -178.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B 1068 ' ' ILE . . . . . 0.409 HD12 ' HB3' ' B' 1067 ' ' GLU . 4.1 mp -123.93 140.45 47.34 Favored 'Isoleucine or valine' 0 C--O 1.251 1.142 0 N-CA-C 104.034 -2.58 . . . . 33.5 104.034 -179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1069 ' ' ILE . . . . . . . . . . . . . 43.8 mm -112.31 135.65 51.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 N-CA-C 103.599 -2.741 . . . . 30.57 103.599 165.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1070 ' ' LEU . . . . . 0.552 HD13 HD13 ' B' 1331 ' ' LEU . 84.9 mt -114.27 75.67 0.94 Allowed 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 121.391 1.905 . . . . 27.66 105.913 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1071 ' ' LYS . . . . . . . . . . . . . 4.6 mttm -73.34 152.93 40.72 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 124.371 1.068 . . . . 28.4 111.656 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1072 ' ' VAL . . . . . 0.611 ' HB ' ' HG3' ' B' 1008 ' ' GLU . 15.6 t -94.01 -31.93 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-O 118.967 -0.539 . . . . 23.18 110.729 176.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -111.85 -167.84 1.23 Allowed 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 124.242 1.017 . . . . 25.47 111.303 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -71.38 162.36 73.21 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 119.166 0.894 . . . . 27.9 111.902 165.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1075 ' ' PRO . . . . . 0.412 ' O ' HD11 ' B' 1101 ' ' LEU . 38.2 Cg_endo -76.8 143.77 23.89 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.605 2.203 . . . . 31.62 113.727 164.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 31.9 mt -88.86 178.14 6.51 Favored 'General case' 0 CA--C 1.555 1.166 0 O-C-N 120.916 -1.115 . . . . 40.49 109.305 170.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 28.3 t70 -62.16 -31.68 72.2 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 122.418 2.372 . . . . 51.59 114.691 -172.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -68.7 -39.58 80.43 Favored 'General case' 0 N--CA 1.439 -0.991 0 O-C-N 120.844 -1.16 . . . . 42.36 112.112 175.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1079 ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -69.58 -35.95 75.83 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.985 -1.007 . . . . 34.53 109.049 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1080 ' ' ILE . . . . . 0.538 ' HA ' HD12 ' B' 1083 ' ' LEU . 86.5 mt -59.49 -45.28 93.92 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 C-N-CA 124.447 1.099 . . . . 33.25 110.78 171.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -61.23 -39.6 90.9 Favored 'General case' 0 C--O 1.251 1.166 0 N-CA-C 113.095 0.776 . . . . 36.47 113.095 173.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1082 ' ' LEU . . . . . . . . . . . . . 51.7 mt -67.25 -34.04 76.6 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 115.365 1.616 . . . . 37.76 115.365 173.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1083 ' ' LEU . . . . . 0.85 HD21 HD13 ' B' 1089 ' ' LEU . 16.6 mt -56.74 112.01 1.18 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 123.467 1.603 . . . . 37.43 111.045 175.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -69.67 136.07 88.07 Favored Pre-proline 0 C--O 1.219 -0.509 0 CA-C-N 111.754 -2.476 . . . . 37.7 113.267 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -51.69 109.92 0.37 Allowed 'Trans proline' 0 C--O 1.246 0.896 0 C-N-CA 124.383 3.389 . . . . 35.51 116.982 171.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 101.72 3.83 52.36 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 113.726 -1.579 . . . . 33.87 115.253 -172.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1087 ' ' THR . . . . . . . . . . . . . 52.0 m -74.23 127.72 33.69 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-N 119.523 1.661 . . . . 32.5 109.266 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1088 ' ' THR . . . . . 0.549 ' HA ' ' HB ' ' B' 1111 ' ' THR . 1.2 m -62.87 101.23 0.25 Allowed 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 105.312 -2.107 . . . . 30.22 105.312 170.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1089 ' ' LEU . . . . . 0.85 HD13 HD21 ' B' 1083 ' ' LEU . 43.3 tp -96.85 109.69 22.34 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 104.719 -2.326 . . . . 27.24 104.719 -176.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1090 ' ' VAL . . . . . 0.533 HG22 ' HB2' ' B' 1113 ' ' MET . 70.3 t -94.05 123.51 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 105.835 -1.913 . . . . 25.39 105.835 169.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1091 ' ' SER . . . . . . . . . . . . . 58.0 m -156.15 164.62 38.16 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 123.613 1.673 . . . . 28.81 110.544 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1092 ' ' PHE . . . . . . . . . . . . . 10.8 t80 -93.12 95.85 9.68 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 101.557 -3.498 . . . . 30.78 101.557 174.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 37.3 mm -83.43 -52.77 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-O 117.349 -1.31 . . . . 30.28 113.036 -172.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1094 ' ' TRP . . . . . 0.508 ' HB3' ' HB2' ' B' 1097 ' ' GLN . 20.9 m95 52.96 75.9 0.59 Allowed Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 118.631 0.65 . . . . 34.07 109.657 -154.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -57.15 -49.51 13.92 Favored 'Trans proline' 0 CA--C 1.511 -0.638 1 C-N-CA 125.707 4.271 . . . . 38.66 113.502 -171.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -71.52 -14.38 62.09 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 118.643 0.656 . . . . 41.32 111.302 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1097 ' ' GLN . . . . . 0.508 ' HB2' ' HB3' ' B' 1094 ' ' TRP . 15.3 mp0 -103.86 -4.89 22.92 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.794 1.238 . . . . 51.66 109.59 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1098 ' ' ASN . . . . . 0.445 ' N ' ' HD3' ' B' 1099 ' ' PRO . 57.8 m-80 -137.53 62.65 37.34 Favored Pre-proline 0 C--O 1.24 0.573 0 O-C-N 120.456 -1.402 . . . . 40.32 109.087 167.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1099 ' ' PRO . . . . . 0.445 ' HD3' ' N ' ' B' 1098 ' ' ASN . 52.2 Cg_exo -63.07 -45.94 11.46 Favored 'Trans proline' 0 CA--C 1.536 0.604 1 C-N-CA 128.191 5.927 . . . . 41.56 113.92 -171.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B 1100 ' ' GLU . . . . . 0.495 ' CD ' ' H ' ' B' 1100 ' ' GLU . 0.6 OUTLIER -66.14 -38.86 89.17 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 123.945 0.898 . . . . 54.11 108.84 176.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B 1101 ' ' LEU . . . . . 0.44 ' O ' ' HG ' ' B' 1105 ' ' LEU . 6.3 tt -60.31 -48.76 80.35 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.727 0.775 . . . . 37.88 109.006 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1102 ' ' MET . . . . . . . . . . . . . 62.1 mmm -53.44 -45.14 69.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.086 -0.961 . . . . 37.54 112.994 171.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -62.6 -33.1 74.31 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.92 1.082 . . . . 47.01 113.92 175.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1104 ' ' LYS . . . . . 0.403 ' HB3' HG21 ' B' 1080 ' ' ILE . 82.0 mttt -73.02 -32.07 64.88 Favored 'General case' 0 C--O 1.213 -0.827 0 O-C-N 119.994 -1.691 . . . . 48.68 111.539 173.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1105 ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' B' 1101 ' ' LEU . 66.6 mt -66.11 -34.51 78.23 Favored 'General case' 0 C--O 1.256 1.447 0 O-C-N 121.609 -0.682 . . . . 32.21 110.244 174.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -61.18 -46.89 88.64 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 123.209 0.604 . . . . 33.73 111.541 168.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -58.22 -47.75 82.53 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 125.783 2.706 . . . . 51.47 117.016 174.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1108 ' ' ARG . . . . . . . . . . . . . 31.6 mmm180 -69.17 -10.54 58.2 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 112.728 -2.033 . . . . 43.9 111.218 171.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1109 ' ' ASN . . . . . 0.409 ' HA ' ' CA ' ' B' 1364 ' ' GLY . 0.6 OUTLIER 59.19 42.82 18.02 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 123.504 1.621 . . . . 44.82 111.586 170.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B 1110 ' ' VAL . . . . . 0.432 HG11 ' HB3' ' B' 1083 ' ' LEU . 12.4 m -93.32 149.89 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 115.032 -0.986 . . . . 30.52 109.124 -177.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1111 ' ' THR . . . . . 0.549 ' HB ' ' HA ' ' B' 1088 ' ' THR . 88.5 m -86.33 92.39 8.79 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.963 -0.754 . . . . 27.12 108.963 177.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1112 ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' B' 1089 ' ' LEU . 4.1 t -94.99 124.88 47.68 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 120.297 1.408 . . . . 26.4 110.781 -168.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1113 ' ' MET . . . . . 0.533 ' HB2' HG22 ' B' 1090 ' ' VAL . 1.3 mpt? -102.33 115.7 31.11 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 124.388 2.042 . . . . 42.92 107.932 163.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -93.75 106.93 18.87 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 120.55 -1.344 . . . . 24.15 110.216 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1115 ' ' MET . . . . . 0.517 ' HB3' ' HB2' ' B' 1129 ' ' ALA . 14.2 mmm -63.94 -11.14 25.64 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 117.303 2.334 . . . . 29.95 117.303 -176.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1116 ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -84.81 -41.86 15.69 Favored 'General case' 0 C--O 1.218 -0.58 0 C-N-CA 123.721 0.809 . . . . 34.53 109.323 169.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1117 ' ' SER . . . . . . . . . . . . . 25.0 m -91.45 37.49 0.95 Allowed 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 120.066 -1.646 . . . . 33.49 109.666 -173.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1118 ' ' VAL . . . . . 0.749 HG12 ' HB1' ' B' 1124 ' ' ALA . 1.8 t -78.38 147.67 72.59 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 103.988 -2.597 . . . . 34.02 103.988 166.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 1.6 Cg_exo -58.13 165.56 6.87 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.971 2.447 . . . . 38.28 114.192 169.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1120 ' ' ARG . . . . . 0.718 ' HB2' HG21 ' B' 1375 ' ' VAL . 5.0 mmp_? -92.27 -0.07 57.42 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 120.924 -1.11 . . . . 55.05 112.186 -178.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1121 ' ' ILE . . . . . 0.722 HG22 ' HB1' ' C' ' 131' ' ' ALA . 30.3 pt -68.76 141.82 16.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 119.964 1.256 . . . . 42.09 108.65 175.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1122 ' ' SER . . . . . 0.68 ' HB2' ' HA ' ' C' ' 133' ' ' MET . 5.0 m -58.73 -28.45 65.86 Favored 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 116.982 2.216 . . . . 38.02 116.982 -158.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1123 ' ' ARG . . . . . 0.621 ' HG3' HG21 ' B' 1354 ' ' VAL . 19.4 ptt-85 -66.45 -39.59 88.94 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 121.359 1.891 . . . . 34.29 107.849 174.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1124 ' ' ALA . . . . . 0.749 ' HB1' HG12 ' B' 1118 ' ' VAL . . . -68.03 -38.44 82.53 Favored 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 106.764 -1.569 . . . . 32.35 106.764 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1125 ' ' GLN . . . . . 0.622 ' NE2' ' HB3' ' B' 1131 ' ' SER . 17.9 mm100 -51.15 -38.97 55.15 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 118.197 2.666 . . . . 47.17 118.197 170.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1126 ' ' SER . . . . . . . . . . . . . 3.9 p -69.18 -19.68 63.99 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 122.107 0.956 . . . . 31.71 113.549 175.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1127 ' ' LEU . . . . . 0.739 ' HG ' ' HA ' ' B' 1334 ' ' LEU . 5.2 mp -90.26 -36.06 14.94 Favored 'General case' 0 C--N 1.347 0.48 0 N-CA-C 107.911 -1.144 . . . . 37.0 107.911 173.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1128 ' ' ASP . . . . . 0.506 ' HB3' ' HA ' ' B' 1125 ' ' GLN . 4.6 t70 -62.88 130.08 43.27 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 125.958 1.703 . . . . 40.4 115.107 -164.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1129 ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' B' 1115 ' ' MET . . . -72.14 -36.93 69.49 Favored 'General case' 0 C--O 1.255 1.393 0 N-CA-C 106.713 -1.588 . . . . 26.56 106.713 -176.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 56.9 mt -59.83 -24.63 64.35 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 121.191 1.814 . . . . 30.89 112.494 -172.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1131 ' ' SER . . . . . 0.622 ' HB3' ' NE2' ' B' 1125 ' ' GLN . 93.9 p -69.23 -60.48 2.32 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 106.035 -1.839 . . . . 29.84 106.035 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1132 ' ' SER . . . . . 0.557 ' O ' HG12 ' B' 1136 ' ' ILE . 16.0 m -62.64 -34.86 77.91 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 115.438 1.644 . . . . 31.91 115.438 -178.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1133 ' ' MET . . . . . . . . . . . . . 35.3 mmt -72.68 -36.53 67.91 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.872 0.844 . . . . 25.9 111.596 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1134 ' ' ALA . . . . . 0.851 ' HB1' ' HB2' ' B' 1176 ' ' ALA . . . -60.84 -39.44 89.08 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 115.259 -0.882 . . . . 26.62 109.959 167.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -60.37 -50.09 74.98 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 117.782 -1.104 . . . . 36.97 113.738 173.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1136 ' ' ILE . . . . . 0.557 HG12 ' O ' ' B' 1132 ' ' SER . 16.4 mm -53.48 -52.02 36.49 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 O-C-N 124.686 1.241 . . . . 32.11 108.416 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1137 ' ' ALA . . . . . 0.45 ' HB2' ' HG3' ' B' 1316 ' ' PRO . . . -61.87 -35.88 79.6 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 114.132 1.16 . . . . 24.14 114.132 176.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -71.53 -41.55 57.47 Favored Glycine 0 CA--C 1.503 -0.713 0 N-CA-C 109.262 -1.535 . . . . 25.13 109.262 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1139 ' ' TYR . . . . . 0.698 ' HD2' HD21 ' B' 1319 ' ' LEU . 17.8 t80 -61.74 -55.6 28.54 Favored 'General case' 0 C--O 1.211 -0.958 0 O-C-N 120.928 -1.337 . . . . 32.73 109.689 169.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1140 ' ' ARG . . . . . 0.464 ' HA ' ' HB ' ' B' 1143 ' ' VAL . 18.3 tpt180 -59.36 -25.18 64.01 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 119.15 0.886 . . . . 26.36 111.75 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1141 ' ' ALA . . . . . 0.663 ' HA ' HG11 ' B' 1282 ' ' VAL . . . -62.91 -55.65 24.2 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.466 1.106 . . . . 24.12 109.971 170.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 21.4 mm -57.94 -40.7 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 107.839 -1.171 . . . . 23.37 107.839 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1143 ' ' VAL . . . . . 0.464 ' HB ' ' HA ' ' B' 1140 ' ' ARG . 19.4 t -59.29 -66.49 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.662 0 CA-C-O 117.8 -1.095 . . . . 24.96 112.356 177.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -61.1 -33.2 72.97 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.518 1.127 . . . . 32.07 112.09 -175.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1145 ' ' ALA . . . . . 0.659 ' HA ' HG11 ' B' 1280 ' ' VAL . . . -60.54 -59.37 5.5 Favored 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 106.386 -1.709 . . . . 24.87 106.386 174.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1146 ' ' ALA . . . . . 0.463 ' HB2' ' HE1' ' B' 1153 ' ' PHE . . . -58.27 -33.64 69.62 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 120.577 1.535 . . . . 24.67 111.727 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1147 ' ' HIS . . . . . 0.413 ' O ' ' NH2' ' A' 1140 ' ' ARG . 73.8 t60 -59.72 -44.63 93.65 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.052 1.341 . . . . 28.58 111.282 174.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1148 ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -96.8 -6.81 35.22 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 122.614 1.197 . . . . 36.82 113.933 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1149 ' ' PHE . . . . . 0.525 ' CZ ' ' HB3' ' B' 1250 ' ' ASP . 1.0 OUTLIER -76.26 148.84 37.32 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 113.235 -1.802 . . . . 31.97 110.263 -176.65 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B 1150 ' ' GLY . . . . . 0.408 ' HA2' ' HD2' ' A' 1320 ' ' PRO . . . -92.73 -19.34 37.72 Favored Glycine 0 N--CA 1.427 -1.964 0 CA-C-N 113.474 -1.694 . . . . 25.49 115.42 173.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1151 ' ' ARG . . . . . . . . . . . . . 86.5 mtm-85 -121.17 177.22 5.23 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 119.738 1.769 . . . . 59.84 110.97 -169.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1152 ' ' PHE . . . . . 0.574 ' HB2' HG11 ' B' 1163 ' ' VAL . 15.7 m-30 -84.99 155.04 21.75 Favored 'General case' 0 C--N 1.352 0.691 0 CA-C-N 121.544 1.975 . . . . 34.45 108.857 175.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1153 ' ' PHE . . . . . 0.463 ' HE1' ' HB2' ' B' 1146 ' ' ALA . 33.0 m-85 -74.93 -46.82 33.22 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.529 -1.214 . . . . 31.17 109.794 164.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1154 ' ' THR . . . . . . . . . . . . . 22.4 m -71.58 122.64 20.87 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 113.379 -1.737 . . . . 33.89 109.362 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1155 ' ' GLY . . . . . 0.681 ' HA3' ' HG3' ' B' 1165 ' ' PRO . . . -75.18 103.47 1.59 Allowed Glycine 0 C--O 1.269 2.287 0 N-CA-C 106.837 -2.505 . . . . 38.95 106.837 172.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1156 ' ' GLN . . . . . 0.685 ' H ' ' HB ' ' B' 1163 ' ' VAL . 20.1 tt0 -112.09 112.39 23.97 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 105.638 -1.986 . . . . 54.23 105.638 -169.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1157 ' ' ILE . . . . . 0.854 HG23 ' HG2' ' B' 1162 ' ' LYS . 29.6 mm -81.53 96.88 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 102.954 -2.98 . . . . 51.16 102.954 172.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1158 ' ' THR . . . . . . . . . . . . . 34.9 m -95.13 153.93 17.42 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 112.841 -1.981 . . . . 49.61 107.382 -163.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -36.95 -51.35 0.91 Allowed 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 116.64 2.089 . . . . 49.05 116.64 175.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -55.74 -56.15 23.83 Favored 'General case' 0 C--N 1.349 0.577 0 N-CA-C 114.833 1.42 . . . . 47.65 114.833 169.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . 177.53 -165.79 35.77 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 108.773 -1.731 . . . . 45.61 108.773 -175.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1162 ' ' LYS . . . . . 0.854 ' HG2' HG23 ' B' 1157 ' ' ILE . 89.3 mttt -95.49 149.46 21.38 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 122.38 1.086 . . . . 57.46 112.968 -166.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1163 ' ' VAL . . . . . 0.685 ' HB ' ' H ' ' B' 1156 ' ' GLN . 99.1 t -116.69 121.59 32.79 Favored Pre-proline 0 CA--C 1.499 -0.994 0 CA-C-N 113.067 -1.878 . . . . 42.93 106.279 166.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1164 ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' B' 1163 ' ' VAL . 36.5 Cg_endo -68.82 137.55 38.61 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.478 2.118 . . . . 39.29 109.66 168.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1165 ' ' PRO . . . . . 0.681 ' HG3' ' HA3' ' B' 1155 ' ' GLY . 64.2 Cg_exo -62.93 149.08 92.59 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.548 2.832 . . . . 34.17 113.193 -177.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -73.47 122.1 21.6 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 124.837 1.336 . . . . 31.69 109.11 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1167 ' ' LYS . . . . . 0.437 ' HD3' ' HB3' ' B' 1248 ' ' GLU . 80.4 mttt -79.59 104.05 9.92 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 105.63 -1.989 . . . . 44.78 105.63 171.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 62.0 t -102.02 99.59 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 N-CA-C 106.69 -1.596 . . . . 31.23 106.69 -170.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1169 ' ' MET . . . . . 0.499 ' HA ' ' O ' ' B' 1192 ' ' ARG . 30.2 ttp -82.29 112.2 19.06 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 119.419 -0.913 . . . . 37.09 109.132 178.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 60.0 t -104.03 107.21 21.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 N-CA-C 105.511 -2.033 . . . . 30.17 105.511 -177.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1171 ' ' ILE . . . . . . . . . . . . . 70.4 mt -97.49 127.17 50.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 108.222 -1.029 . . . . 33.74 108.222 -177.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 88.72 67.21 1.27 Allowed Glycine 0 C--N 1.318 -0.44 0 CA-C-O 124.502 2.168 . . . . 32.59 108.458 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1173 ' ' ALA . . . . . 0.681 ' HA ' ' HA3' ' B' 1177 ' ' GLY . . . -74.42 42.25 0.16 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 117.975 2.583 . . . . 32.42 117.975 178.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1174 ' ' GLY . . . . . 0.438 ' HA3' ' O3B' ' B' ' 1' ' ' NAD . . . -79.78 -155.26 10.03 Favored Glycine 0 CA--C 1.524 0.601 0 O-C-N 117.573 -3.204 . . . . 31.74 110.397 164.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 86.7 t -48.58 -50.8 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-N 120.762 2.281 . . . . 31.48 115.289 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1176 ' ' ALA . . . . . 0.851 ' HB2' ' HB1' ' B' 1134 ' ' ALA . . . -49.46 -50.83 39.42 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 123.591 1.663 . . . . 26.12 113.324 172.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1177 ' ' GLY . . . . . 0.681 ' HA3' ' HA ' ' B' 1173 ' ' ALA . . . -63.73 -49.79 66.16 Favored Glycine 0 C--O 1.211 -1.3 0 CA-C-N 112.748 -2.024 . . . . 25.73 110.765 -178.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1178 ' ' LEU . . . . . 0.421 HD23 HD12 ' B' 1181 ' ' ILE . 46.3 mt -56.59 -33.38 66.14 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 123.94 0.896 . . . . 32.59 112.718 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -62.34 -57.96 9.42 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.893 -1.049 . . . . 27.72 110.602 172.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -57.78 -39.78 78.29 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 114.137 1.162 . . . . 26.03 114.137 177.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1181 ' ' ILE . . . . . 0.72 HG22 ' SD ' ' B' 1207 ' ' MET . 96.4 mt -57.06 -45.84 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 108.413 -0.958 . . . . 28.61 108.413 172.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -55.25 -54.39 34.46 Favored Glycine 0 N--CA 1.465 0.583 0 N-CA-C 110.4 -1.08 . . . . 25.23 110.4 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -56.93 -61.42 2.45 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.276 1.213 . . . . 24.09 114.276 174.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -67.3 -35.73 80.06 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-O 119.178 -0.439 . . . . 26.68 111.504 -169.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -66.91 -45.32 78.28 Favored 'General case' 0 CA--C 1.502 -0.873 0 O-C-N 120.554 -1.341 . . . . 36.57 110.071 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1186 ' ' SER . . . . . . . . . . . . . 61.3 m -66.04 -32.31 73.71 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 119.923 -0.711 . . . . 28.92 112.823 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1187 ' ' LEU . . . . . 1.075 ' HA ' ' HB3' ' A' 1186 ' ' SER . 25.8 mt -57.87 -23.68 54.13 Favored 'General case' 0 C--O 1.247 0.941 0 N-CA-C 113.4 0.889 . . . . 29.09 113.4 165.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 89.68 20.91 42.04 Favored Glycine 0 CA--C 1.534 1.247 0 N-CA-C 108.593 -1.803 . . . . 29.26 108.593 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1189 ' ' ALA . . . . . . . . . . . . . . . -82.29 149.64 27.69 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 118.385 -0.817 . . . . 30.16 109.461 174.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 74.8 mt -80.51 90.93 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 120.094 1.315 . . . . 35.81 108.32 -176.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1191 ' ' VAL . . . . . 0.43 HG11 HG23 ' B' 1181 ' ' ILE . 67.1 t -77.3 109.24 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 105.421 -2.066 . . . . 31.97 105.421 -172.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1192 ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' B' 1169 ' ' MET . 47.5 mtt180 -101.21 85.58 2.84 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-O 123.776 1.75 . . . . 48.16 106.911 172.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1193 ' ' ALA . . . . . 0.787 ' HB3' HG11 ' B' 1204 ' ' VAL . . . -93.62 152.91 18.69 Favored 'General case' 0 C--O 1.259 1.598 0 CA-C-N 112.223 -2.262 . . . . 35.89 112.227 -171.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 87.7 t80 -144.75 148.72 34.45 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 124.567 2.127 . . . . 41.88 105.592 -176.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1195 ' ' ASP . . . . . 0.479 ' HB2' ' H ' ' B' 1173 ' ' ALA . 22.4 t0 -159.77 154.04 23.65 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 101.513 -3.514 . . . . 38.28 101.513 163.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1196 ' ' THR . . . . . . . . . . . . . 1.1 m -73.53 -27.16 61.2 Favored 'General case' 0 C--O 1.247 0.942 0 C-N-CA 119.654 -0.818 . . . . 40.62 111.469 -176.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1197 ' ' ARG . . . . . . . . . . . . . 22.9 mtm105 -73.41 103.37 0.79 Allowed Pre-proline 0 CA--C 1.565 1.542 0 O-C-N 121.079 -1.013 . . . . 53.09 108.832 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -56.34 -26.2 60.93 Favored 'Trans proline' 0 C--N 1.347 0.481 1 C-N-CA 125.775 4.316 . . . . 42.56 119.25 -162.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1199 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.91 -12.74 19.53 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 119.726 -1.859 . . . . 56.31 113.828 -177.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1200 ' ' VAL . . . . . 0.537 ' HA ' ' HG3' ' B' 1203 ' ' GLN . 23.3 m -57.98 -20.88 15.79 Favored 'Isoleucine or valine' 0 C--O 1.25 1.106 0 O-C-N 119.873 -1.767 . . . . 42.91 112.298 172.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1201 ' ' LYS . . . . . 0.467 ' HA ' ' HB2' ' B' 1211 ' ' PHE . 46.2 tttm -50.55 -55.9 14.1 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 122.901 0.48 . . . . 48.89 111.712 166.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1202 ' ' GLU . . . . . 0.572 ' HA ' ' HB2' ' B' 1205 ' ' GLN . 18.2 mp0 -70.07 -34.0 72.62 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 120.727 -1.233 . . . . 51.7 110.488 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1203 ' ' GLN . . . . . 0.589 ' OE1' ' HA ' ' C' ' 74' ' ' ARG . 13.6 mm100 -50.47 -52.09 41.24 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 120.999 -1.063 . . . . 52.57 111.815 176.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1204 ' ' VAL . . . . . 0.787 HG11 ' HB3' ' B' 1193 ' ' ALA . 18.6 m -73.42 -36.95 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 O-C-N 121.247 -0.908 . . . . 33.79 112.16 175.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1205 ' ' GLN . . . . . 0.572 ' HB2' ' HA ' ' B' 1202 ' ' GLU . 39.3 mt-30 -53.6 -39.63 65.03 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 114.957 1.465 . . . . 36.58 114.957 174.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1206 ' ' SER . . . . . . . . . . . . . 84.4 p -60.62 -45.84 92.51 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.45 -1.406 . . . . 39.61 109.096 175.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1207 ' ' MET . . . . . 0.72 ' SD ' HG22 ' B' 1181 ' ' ILE . 5.0 mtp -68.6 -18.14 64.26 Favored 'General case' 0 N--CA 1.44 -0.959 0 O-C-N 119.519 -1.988 . . . . 37.45 113.632 177.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 77.62 56.6 3.82 Favored Glycine 0 N--CA 1.475 1.238 0 N-CA-C 108.686 -1.766 . . . . 31.87 108.686 -172.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1209 ' ' ALA . . . . . 0.595 ' HB3' ' HB ' ' B' 1204 ' ' VAL . . . -139.87 159.52 41.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.886 1.274 . . . . 35.4 111.131 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -90.46 136.21 33.2 Favored 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 120.559 -1.338 . . . . 47.89 110.038 -165.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1211 ' ' PHE . . . . . 0.467 ' HB2' ' HA ' ' B' 1201 ' ' LYS . 29.1 t80 -86.94 141.7 28.53 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.743 -1.206 . . . . 45.53 107.743 167.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1212 ' ' LEU . . . . . 0.873 ' HB3' HD21 ' B' 1241 ' ' LEU . 32.2 mt -81.85 102.92 11.15 Favored 'General case' 0 N--CA 1.433 -1.32 0 O-C-N 121.396 -0.815 . . . . 46.33 111.02 167.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -83.51 124.48 30.78 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 103.864 -2.643 . . . . 60.41 103.864 -176.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1214 ' ' LEU . . . . . 0.459 HD12 ' H ' ' B' 1214 ' ' LEU . 4.6 mp -68.32 164.52 20.59 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 114.075 -1.42 . . . . 57.38 110.108 -177.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 28.0 t70 . . . . . 0 N--CA 1.444 -0.752 0 CA-C-O 116.326 -1.797 . . . . 65.07 107.083 168.932 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B 1230 ' ' MET . . . . . 0.677 ' N ' ' HG ' ' B' 1231 ' ' SER . 3.7 mmt . . . . . 0 N--CA 1.435 -1.217 0 N-CA-C 101.725 -3.435 . . . . 80.32 101.725 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1231 ' ' SER . . . . . 0.677 ' HG ' ' N ' ' B' 1230 ' ' MET 0.275 19.4 m 112.66 155.47 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 3 CA-C-N 130.408 6.003 . . . . 79.92 115.221 -9.924 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 28.6 t70 -43.12 140.24 1.55 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 116.203 1.927 . . . . 77.91 116.203 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 67.46 -54.38 0.48 Allowed 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 115.846 1.795 . . . . 73.88 115.846 -166.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1234 ' ' PHE . . . . . 0.435 ' HE2' HD22 ' B' 1214 ' ' LEU . 1.5 t80 -61.23 -21.68 64.09 Favored 'General case' 0 C--O 1.254 1.293 0 CA-C-N 120.096 1.316 . . . . 68.98 112.92 176.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 1.9 pp -42.05 -38.71 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 O-C-N 120.795 -1.191 . . . . 64.53 113.361 159.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -69.29 -29.26 67.09 Favored 'General case' 0 CA--C 1.501 -0.919 0 O-C-N 120.124 -1.61 . . . . 66.36 112.89 174.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -62.4 -31.11 71.74 Favored 'General case' 0 N--CA 1.438 -1.061 0 O-C-N 117.575 -3.203 . . . . 56.6 111.333 171.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1238 ' ' GLU . . . . . 0.475 ' O ' ' HB3' ' B' 1241 ' ' LEU . 39.0 mt-10 -68.97 -61.41 1.81 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.86 0.864 . . . . 56.79 111.289 170.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1239 ' ' MET . . . . . . . . . . . . . 14.4 mtt -59.01 -44.79 91.75 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 114.842 1.423 . . . . 53.63 114.842 -177.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -68.53 -35.38 77.37 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 120.497 1.499 . . . . 51.74 112.828 -176.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1241 ' ' LEU . . . . . 0.873 HD21 ' HB3' ' B' 1212 ' ' LEU . 46.3 tp -54.27 -49.18 70.14 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.983 -1.008 . . . . 44.86 110.856 166.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 13.0 m-30 -62.68 -38.59 90.99 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 114.096 1.147 . . . . 42.78 114.096 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -59.3 -41.47 89.08 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 114.685 -1.143 . . . . 40.96 110.935 170.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -77.55 -8.66 58.15 Favored 'General case' 0 C--O 1.249 1.049 0 O-C-N 120.385 -1.447 . . . . 43.06 112.361 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1245 ' ' GLN . . . . . 0.433 ' OE1' ' HD3' ' B' 1192 ' ' ARG . 92.6 mm-40 -82.23 -26.4 33.28 Favored 'General case' 0 C--O 1.207 -1.14 0 N-CA-C 114.407 1.262 . . . . 46.45 114.407 164.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -54.69 -38.18 66.7 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 118.941 2.941 . . . . 41.78 118.941 -167.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 11.9 mptt -68.97 -30.22 68.61 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 115.011 1.485 . . . . 52.2 115.011 174.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1248 ' ' GLU . . . . . 0.474 ' CD ' HH12 ' B' 1192 ' ' ARG . 33.5 mt-10 -85.09 -39.91 17.4 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 115.055 1.502 . . . . 53.55 115.055 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1249 ' ' VAL . . . . . . . . . . . . 0.266 18.4 m -68.94 135.4 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 124.165 1.936 . . . . 34.41 115.575 -163.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1250 ' ' ASP . . . . . 0.525 ' HB3' ' CZ ' ' B' 1149 ' ' PHE . 2.7 m-20 -97.57 -48.91 5.07 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 111.969 -2.378 . . . . 33.38 110.387 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1251 ' ' ILE . . . . . 0.631 HD12 ' HB1' ' B' 1145 ' ' ALA . 30.1 mm -128.23 126.3 65.77 Favored 'Isoleucine or valine' 0 C--O 1.248 0.988 0 N-CA-C 103.434 -2.802 . . . . 29.54 103.434 177.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1252 ' ' ILE . . . . . . . . . . . . . 53.6 mt -90.49 97.91 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 107.013 -1.477 . . . . 32.44 107.013 159.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1253 ' ' VAL . . . . . 0.676 HG12 HG23 ' B' 1255 ' ' THR . 4.0 t -83.99 93.05 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 103.181 -2.896 . . . . 30.57 103.181 175.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1254 ' ' THR . . . . . 0.698 HG23 ' HA ' ' B' 1283 ' ' ASP 0.353 8.8 t -90.42 84.63 6.01 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 124.207 1.956 . . . . 35.04 107.158 -178.027 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B 1255 ' ' THR . . . . . 0.676 HG23 HG12 ' B' 1253 ' ' VAL . 2.7 p -69.73 -16.5 63.33 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 110.927 -2.851 . . . . 34.62 114.305 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1256 ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' B' 1285 ' ' ALA . . . -57.46 82.84 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 124.172 0.989 . . . . 42.72 112.773 176.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 3.4 tt -90.82 85.5 6.04 Favored 'General case' 0 CA--C 1.54 0.562 1 N-CA-C 99.175 -4.379 . . . . 52.43 99.175 173.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 2.6 mp -55.5 125.54 60.26 Favored Pre-proline 0 C--N 1.353 0.759 0 O-C-N 120.996 -1.065 . . . . 59.41 111.144 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -57.31 110.45 0.61 Allowed 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 125.119 3.879 . . . . 62.68 111.928 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 77.73 -79.01 1.45 Allowed Glycine 0 CA--C 1.55 2.238 0 O-C-N 119.846 -1.784 . . . . 64.16 113.229 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 37.2 mttm -46.44 125.79 7.68 Favored Pre-proline 0 C--O 1.239 0.549 0 CA-C-O 116.535 -1.698 . . . . 68.53 113.667 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -55.16 120.93 9.0 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 124.027 3.151 . . . . 61.99 111.068 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1263 ' ' ALA . . . . . . . . . . . . . . . -48.73 122.78 11.19 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 117.402 2.371 . . . . 57.15 117.402 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -58.26 141.67 96.91 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 124.477 3.451 . . . . 51.57 111.903 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1265 ' ' LYS . . . . . 0.459 ' HA ' ' HD3' ' B' 1265 ' ' LYS . 35.2 mmtm -75.89 82.37 2.8 Favored 'General case' 0 C--O 1.21 -1.026 0 O-C-N 121.13 -0.981 . . . . 54.55 110.977 -178.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 49.7 mt -74.96 -56.34 4.84 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.352 -1.295 . . . . 46.86 109.567 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1267 ' ' ILE . . . . . 0.581 HG22 HG22 ' B' 1272 ' ' VAL . 32.1 mm -84.43 89.35 2.56 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 N-CA-C 103.655 -2.72 . . . . 41.04 103.655 -175.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1268 ' ' THR . . . . . 0.497 ' HA ' ' HG3' ' B' 1293 ' ' GLU . 1.1 p -80.63 160.09 25.17 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 113.001 -1.909 . . . . 39.58 112.286 -176.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1269 ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -53.31 -54.87 30.11 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 117.467 2.395 . . . . 53.15 117.467 -168.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -55.46 -40.35 71.51 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 125.1 1.5 . . . . 42.96 113.892 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1271 ' ' MET . . . . . 0.406 ' HB3' ' O ' ' B' 1268 ' ' THR . 41.6 ttm -56.89 -58.27 8.87 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 117.673 -1.156 . . . . 43.89 108.394 168.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1272 ' ' VAL . . . . . 0.581 HG22 HG22 ' B' 1267 ' ' ILE . 24.6 t -52.7 -59.83 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.808 0 CA-C-N 120.001 1.273 . . . . 38.37 111.877 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1273 ' ' ASP . . . . . . . . . . . . 0.265 1.2 m-20 -68.28 14.31 0.07 Allowed 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 120.358 3.466 . . . . 47.46 120.358 176.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1274 ' ' SER . . . . . . . . . . . . . 54.7 p -124.36 -2.28 8.04 Favored 'General case' 0 C--O 1.247 0.93 0 O-C-N 119.956 -1.715 . . . . 38.38 110.432 170.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1275 ' ' MET . . . . . 0.653 ' HB2' HG21 ' B' 1307 ' ' VAL . 40.6 mtp -63.88 162.99 12.69 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 114.093 1.145 . . . . 37.81 114.093 177.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.06 134.67 52.76 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.182 -0.949 . . . . 49.26 112.721 175.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -64.84 141.43 58.78 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 123.311 1.529 . . . . 34.46 113.332 -173.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1278 ' ' GLY . . . . . . . . . . . . . . . 70.38 24.23 76.88 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 114.922 -1.035 . . . . 33.53 112.165 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1279 ' ' SER . . . . . . . . . . . . . 59.0 m -95.7 153.72 17.59 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 122.91 0.484 . . . . 31.31 109.736 176.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1280 ' ' VAL . . . . . 0.659 HG11 ' HA ' ' B' 1145 ' ' ALA . 84.4 t -118.01 144.29 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 O-C-N 119.307 -2.12 . . . . 29.32 106.815 -170.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1281 ' ' ILE . . . . . 0.452 HD13 HG21 ' B' 1267 ' ' ILE . 75.8 mt -121.5 120.22 61.21 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 N-CA-C 101.054 -3.684 . . . . 31.93 101.054 170.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1282 ' ' VAL . . . . . 0.663 HG11 ' HA ' ' B' 1141 ' ' ALA . 12.3 t -108.22 113.58 44.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 105.983 -1.858 . . . . 29.48 105.983 175.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1283 ' ' ASP . . . . . 0.698 ' HA ' HG23 ' B' 1254 ' ' THR . 5.6 t0 -87.33 102.73 14.79 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-N 113.826 -1.534 . . . . 34.5 110.885 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1284 ' ' LEU . . . . . 0.62 HD22 ' HA ' ' B' 1255 ' ' THR . 8.5 mp -69.46 -23.72 63.7 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 113.977 1.103 . . . . 37.94 113.977 172.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1285 ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' B' 1256 ' ' ALA . . . -88.38 16.09 6.89 Favored 'General case' 0 C--N 1.364 1.216 0 O-C-N 121.548 -0.72 . . . . 40.92 111.454 176.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1286 ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' B' 1297 ' ' PRO . . . -45.42 -37.5 5.16 Favored 'General case' 0 C--O 1.214 -0.786 0 N-CA-C 115.986 1.847 . . . . 44.39 115.986 174.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1287 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.43 -24.54 39.53 Favored 'General case' 0 C--N 1.313 -1.014 0 O-C-N 119.527 -1.983 . . . . 51.46 112.047 176.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 1.5 t30 -114.06 64.7 0.66 Allowed 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 125.101 1.361 . . . . 57.75 109.13 -170.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1289 ' ' GLY . . . . . . . . . . . . . . . 92.34 -39.62 2.98 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-O 117.056 -1.969 . . . . 49.85 114.663 170.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 87.02 117.2 1.1 Allowed Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 120.531 2.166 . . . . 45.93 112.292 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1291 ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -77.25 -29.63 54.08 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 119.761 1.78 . . . . 42.67 111.03 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1292 ' ' CYS . . . . . 0.612 ' HB3' ' OG1' ' B' 1295 ' ' THR . 40.9 t -95.84 146.03 24.88 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 118.704 -2.497 . . . . 38.82 108.442 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1293 ' ' GLU . . . . . 0.497 ' HG3' ' HA ' ' B' 1268 ' ' THR . 25.0 mt-10 -69.74 -38.64 76.9 Favored 'General case' 0 CA--C 1.502 -0.882 0 O-C-N 119.927 -1.733 . . . . 46.71 114.564 172.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -74.33 -3.84 32.68 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.273 0.842 . . . . 47.23 113.273 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1295 ' ' THR . . . . . 0.62 HG23 ' HA3' ' B' 1311 ' ' GLY . 88.2 m -59.6 110.77 1.2 Allowed 'General case' 0 C--O 1.243 0.759 0 CA-C-N 120.077 1.308 . . . . 36.02 111.238 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 51.2 t -78.34 100.25 0.5 Allowed Pre-proline 0 N--CA 1.44 -0.933 0 CA-C-N 112.604 -2.089 . . . . 37.26 105.437 163.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1297 ' ' PRO . . . . . 0.412 ' HB3' ' O ' ' B' 1286 ' ' ALA . 37.2 Cg_exo -65.46 78.22 0.25 Allowed 'Trans proline' 0 N--CA 1.44 -1.672 0 C-N-CA 125.024 3.816 . . . . 35.09 112.464 -177.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 169.09 -43.52 0.22 Allowed Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 109.045 -1.622 . . . . 35.97 109.045 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -134.35 -179.27 5.47 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 115.406 1.632 . . . . 40.39 115.406 -165.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1300 ' ' ILE . . . . . 0.547 HG12 HG12 ' B' 1310 ' ' ILE . 21.2 mt -82.63 140.6 16.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 107.563 -1.273 . . . . 37.43 107.563 172.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 58.6 t80 -119.96 112.66 19.45 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 104.706 -2.331 . . . . 44.13 104.706 163.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1302 ' ' THR . . . . . . . . . . . . . 29.4 m -79.72 137.03 36.92 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 119.92 -1.737 . . . . 39.78 109.623 167.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1303 ' ' THR . . . . . . . . . . . . . 35.7 p -93.32 -179.72 5.15 Favored 'General case' 0 C--O 1.251 1.184 0 N-CA-C 114.54 1.311 . . . . 43.29 114.54 177.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -75.97 -27.34 57.45 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 120.323 -1.486 . . . . 53.07 109.692 -169.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -84.55 2.55 40.7 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 124.519 2.104 . . . . 43.97 110.008 173.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 78.63 38.99 22.83 Favored Glycine 0 CA--C 1.539 1.533 0 O-C-N 118.217 -2.802 . . . . 41.12 113.495 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1307 ' ' VAL . . . . . 0.653 HG21 ' HB2' ' B' 1275 ' ' MET . 18.0 t -100.72 127.4 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-O 122.252 1.025 . . . . 38.12 109.705 172.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1308 ' ' LYS . . . . . . . . . . . . . 98.1 mttt -97.59 99.86 11.26 Favored 'General case' 0 N--CA 1.437 -1.093 0 O-C-N 119.01 -2.306 . . . . 36.34 109.782 -171.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1309 ' ' VAL . . . . . 0.419 HG22 HD12 ' B' 1281 ' ' ILE . 23.9 t -82.53 99.67 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 106.941 -1.503 . . . . 30.4 106.941 175.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1310 ' ' ILE . . . . . 0.547 HG12 HG12 ' B' 1300 ' ' ILE . 72.4 mt -82.82 107.64 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 N-CA-C 106.425 -1.695 . . . . 30.82 106.425 175.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1311 ' ' GLY . . . . . 0.62 ' HA3' HG23 ' B' 1295 ' ' THR . . . -116.0 61.52 0.39 Allowed Glycine 0 C--N 1.354 1.535 0 C-N-CA 118.567 -1.778 . . . . 26.53 111.6 176.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1312 ' ' TYR . . . . . 0.586 ' HB2' ' HG ' ' B' 1315 ' ' LEU . 14.9 m-85 -81.52 123.3 28.52 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 118.526 1.163 . . . . 38.0 108.984 -176.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1313 ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.1 -48.87 70.25 Favored 'General case' 0 C--O 1.256 1.428 0 CA-C-O 123.839 1.78 . . . . 29.8 108.56 167.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -72.41 16.66 0.13 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 116.453 2.02 . . . . 39.04 116.453 -176.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1315 ' ' LEU . . . . . 0.586 ' HG ' ' HB2' ' B' 1312 ' ' TYR . 25.4 mt -53.72 -43.63 96.48 Favored Pre-proline 0 C--O 1.224 -0.272 0 O-C-N 119.549 -1.969 . . . . 31.08 113.995 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1316 ' ' PRO . . . . . 0.45 ' HG3' ' HB2' ' B' 1137 ' ' ALA . 66.8 Cg_exo -63.97 -50.97 2.53 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.909 3.073 . . . . 26.1 112.475 168.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -50.76 -35.39 30.85 Favored Glycine 0 C--N 1.343 0.962 0 C-N-CA 125.867 1.698 . . . . 23.17 115.015 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1318 ' ' ARG . . . . . . . . . . . . . 53.3 mtt180 -66.52 -7.22 18.39 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 117.492 2.404 . . . . 40.4 117.492 177.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1319 ' ' LEU . . . . . 0.698 HD21 ' HD2' ' B' 1139 ' ' TYR . 38.4 tp -127.48 117.64 21.39 Favored Pre-proline 0 C--N 1.347 0.488 0 O-C-N 119.395 -2.065 . . . . 23.6 110.24 -173.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1320 ' ' PRO . . . . . 0.614 ' HG2' ' HA2' ' A' 1150 ' ' GLY . 87.3 Cg_endo -73.62 -95.48 0.01 OUTLIER 'Trans proline' 0 N--CA 1.481 0.774 0 N-CA-C 121.428 3.588 . . . . 22.35 121.428 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1321 ' ' THR . . . . . 0.489 ' HB ' ' HG3' ' A' 1151 ' ' ARG . 0.2 OUTLIER -55.49 -31.25 61.86 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 116.125 1.898 . . . . 26.52 116.125 -162.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B 1322 ' ' GLN . . . . . . . . . . . . . 35.8 tp60 -52.86 -51.3 61.54 Favored 'General case' 0 C--O 1.248 1.018 0 CA-C-N 113.13 -1.85 . . . . 24.38 109.67 173.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1323 ' ' SER . . . . . . . . . . . . . 8.1 m -62.77 -48.35 79.56 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 118.121 -0.942 . . . . 22.8 112.578 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1324 ' ' SER . . . . . . . . . . . . . 3.0 m -49.49 -35.7 20.67 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 123.797 1.761 . . . . 21.25 115.263 174.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 45.8 tp60 -78.15 -60.82 2.21 Favored 'General case' 0 CA--C 1.505 -0.788 0 O-C-N 119.587 -1.946 . . . . 31.34 110.571 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1326 ' ' LEU . . . . . 0.683 ' HA ' ' HA3' ' A' 1161 ' ' GLY . 12.5 mt -62.7 -59.07 5.41 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 117.182 -1.39 . . . . 31.56 110.372 -174.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1327 ' ' TYR . . . . . . . . . . . . . 57.9 t80 -63.06 -40.32 97.35 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 119.033 0.833 . . . . 22.73 109.798 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1328 ' ' GLY . . . . . 0.463 ' HA2' HD12 ' B' 1331 ' ' LEU . . . -42.8 -49.01 6.14 Favored Glycine 0 C--N 1.308 -1.006 0 O-C-N 124.716 1.26 . . . . 21.91 115.122 165.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1329 ' ' THR . . . . . . . . . . . . . 8.7 m -72.56 -35.28 67.95 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 117.669 0.734 . . . . 22.15 109.631 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1330 ' ' ASN . . . . . . . . . . . . . 9.5 m120 -55.1 -46.07 75.5 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 123.765 0.666 . . . . 26.18 110.362 172.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1331 ' ' LEU . . . . . 0.552 HD13 HD13 ' B' 1070 ' ' LEU . 14.6 mt -66.54 -41.22 89.04 Favored 'General case' 0 C--O 1.253 1.246 0 O-C-N 119.729 -1.857 . . . . 23.68 110.339 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1332 ' ' VAL . . . . . 0.584 HG22 ' HG ' ' B' 1026 ' ' LEU . 69.7 t -55.09 -48.77 75.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 O-C-N 123.493 0.495 . . . . 26.57 109.807 174.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -62.09 -35.18 77.91 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 124.327 1.051 . . . . 28.08 112.13 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1334 ' ' LEU . . . . . 0.739 ' HA ' ' HG ' ' B' 1127 ' ' LEU . 32.3 tp -64.85 -58.9 4.96 Favored 'General case' 0 CA--C 1.492 -1.256 0 C-N-CA 124.446 1.099 . . . . 27.43 109.818 178.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1335 ' ' LEU . . . . . 0.469 HD21 HD21 ' B' 1070 ' ' LEU . 3.8 mm? -60.11 -39.46 86.26 Favored 'General case' 0 C--O 1.242 0.694 0 O-C-N 124.708 1.255 . . . . 30.5 112.977 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1336 ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' B' 1332 ' ' VAL . 31.9 ttmt -54.64 -44.98 73.68 Favored 'General case' 0 CA--C 1.495 -1.17 0 C-N-CA 124.483 1.113 . . . . 41.65 113.16 171.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 13.5 tp -85.75 -25.39 26.45 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.26 -0.9 . . . . 42.08 113.267 -174.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1338 ' ' LEU . . . . . 0.555 ' O ' ' HB ' ' B' 1347 ' ' THR . 7.3 mt -73.08 -67.97 0.53 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.45 -1.315 . . . . 35.03 107.45 170.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 43.8 t -85.43 73.23 10.55 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 107.187 -1.412 . . . . 37.33 107.187 -174.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 61.7 mttp -68.18 -22.28 64.83 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 119.471 -2.018 . . . . 50.51 111.743 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -78.11 -10.51 59.66 Favored 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 120.271 -1.518 . . . . 54.21 113.021 174.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1342 ' ' LYS . . . . . . . . . . . . . 91.3 mttt 52.31 41.99 30.74 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-O 125.793 2.711 . . . . 50.99 111.787 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -105.73 -43.98 4.77 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 126.196 1.798 . . . . 48.82 109.548 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 132.69 -9.29 5.24 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 109.069 -1.612 . . . . 40.43 109.069 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -82.49 120.8 25.95 Favored 'General case' 0 C--O 1.242 0.665 0 O-C-N 119.256 -2.32 . . . . 47.56 109.453 175.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1346 ' ' ILE . . . . . . . . . . . . . 31.4 mm -68.11 90.5 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-N 114.171 -1.377 . . . . 42.49 110.413 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1347 ' ' THR . . . . . 0.555 ' HB ' ' O ' ' B' 1338 ' ' LEU . 92.5 m -74.47 90.88 2.22 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 123.869 1.795 . . . . 38.12 109.555 -177.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 39.4 t -84.17 90.53 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 106.697 -1.594 . . . . 37.5 106.697 171.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 10.5 t70 -77.7 147.21 35.56 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 109.067 -3.697 . . . . 43.85 108.409 175.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1350 ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -109.5 -16.83 13.9 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 118.599 -1.24 . . . . 39.81 113.689 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -91.35 -16.23 27.77 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 114.094 1.146 . . . . 51.29 114.094 -175.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 54.6 t0 -83.92 116.32 22.73 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 105.027 -2.212 . . . . 39.78 105.027 158.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 11.1 m -55.5 -25.33 17.51 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 C-N-CA 125.186 1.394 . . . . 39.28 109.822 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1354 ' ' VAL . . . . . 0.621 HG21 ' HG3' ' B' 1123 ' ' ARG . 73.9 t -64.48 -50.75 74.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 117.68 -1.152 . . . . 35.7 110.907 175.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1355 ' ' ILE . . . . . 0.52 HD12 HD23 ' B' 1338 ' ' LEU . 23.1 mm -70.95 -42.39 77.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 119.634 -0.826 . . . . 35.77 110.563 -177.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1356 ' ' ARG . . . . . . . . . . . . . 48.5 tpt85 -52.37 -36.91 54.99 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 112.849 -1.978 . . . . 38.55 113.059 169.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -80.8 -51.05 4.97 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 121.88 2.127 . . . . 29.58 112.525 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1358 ' ' VAL . . . . . 0.521 HG23 HG22 ' B' 1118 ' ' VAL . 10.6 p -63.27 -35.68 73.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 118.917 1.358 . . . . 32.06 112.132 -171.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1359 ' ' THR . . . . . . . . . . . . . 14.0 m -84.21 88.22 7.21 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 103.268 -2.864 . . . . 29.0 103.268 -178.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1360 ' ' VAL . . . . . 0.455 HG12 ' HD1' ' B' 1368 ' ' TRP . 35.7 m -70.83 -25.42 26.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 114.816 -1.083 . . . . 29.68 112.428 -176.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 75.7 mt -139.79 136.92 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 103.121 -2.918 . . . . 32.05 103.121 175.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1362 ' ' ARG . . . . . 0.485 ' HA ' HG23 ' B' 1111 ' ' THR . 64.5 ttt180 -120.66 108.82 14.47 Favored 'General case' 0 C--O 1.254 1.318 0 N-CA-C 105.392 -2.077 . . . . 32.52 105.392 171.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 35.87 77.36 0.04 OUTLIER 'General case' 0 C--O 1.241 0.617 0 N-CA-C 116.335 1.976 . . . . 35.68 116.335 -170.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1364 ' ' GLY . . . . . 0.409 ' CA ' ' HA ' ' B' 1109 ' ' ASN . . . 80.65 -43.74 2.83 Favored Glycine 0 C--N 1.308 -1.013 0 CA-C-N 114.005 -1.452 . . . . 34.26 115.005 176.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -68.01 116.05 8.21 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 119.609 1.704 . . . . 51.07 112.04 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 83.5 mt -68.91 110.55 2.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 121.166 -0.959 . . . . 39.87 109.299 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1367 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.55 -20.14 25.44 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 115.474 1.657 . . . . 38.01 115.474 168.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1368 ' ' TRP . . . . . 0.455 ' HD1' HG12 ' B' 1360 ' ' VAL . 15.2 t90 -57.71 146.07 67.65 Favored Pre-proline 0 C--O 1.244 0.774 0 C-N-CA 123.281 0.632 . . . . 42.14 110.767 176.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1369 ' ' PRO . . . . . 0.417 ' HA ' ' CD1' ' B' 1368 ' ' TRP . 25.1 Cg_endo -78.1 -172.21 10.94 Favored 'Cis proline' 0 C--N 1.369 1.644 0 CA-C-N 121.362 1.522 . . . . 43.26 115.046 -5.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1370 ' ' ALA . . . . . . . . . . . . . . . -78.8 162.01 66.77 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 114.624 -1.171 . . . . 46.52 108.72 166.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1371 ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -59.59 153.01 58.15 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 123.918 3.078 . . . . 51.95 108.995 162.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -57.53 113.61 1.58 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 1 C-N-CA 126.662 4.908 . . . . 56.27 115.056 -177.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1373 ' ' ILE . . . . . . . . . . . . . 50.7 mm -92.49 120.28 41.5 Favored 'Isoleucine or valine' 0 C--O 1.255 1.377 0 O-C-N 120.715 -1.24 . . . . 60.83 110.927 -174.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -92.46 127.88 38.11 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.961 -1.126 . . . . 66.1 107.961 174.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1375 ' ' VAL . . . . . 0.718 HG21 ' HB2' ' B' 1120 ' ' ARG . 19.9 t -124.72 118.57 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 113.401 -1.727 . . . . 63.47 107.693 -170.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.223 -4.906 0 O-C-N 117.774 -3.079 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.582 0 CA-C-O 118.926 -0.559 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -23.76 67.37 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 121.18 1.809 . . . . 0.0 113.323 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 32.7 mp0 -53.91 -50.68 65.84 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 123.107 1.432 . . . . 0.0 110.734 165.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 3.3 m -65.0 -38.21 90.19 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 113.579 -1.646 . . . . 0.0 109.362 -171.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.95 76.13 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-O 124.193 1.949 . . . . 0.0 114.682 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -70.25 -52.22 24.71 Favored 'General case' 0 C--O 1.249 1.076 0 CA-C-N 114.044 -1.434 . . . . 0.0 112.343 172.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.511 ' HB3' ' OG1' ' C' ' 108' ' ' THR . 74.8 mt -62.58 -43.08 99.7 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-O 116.965 -1.493 . . . . 0.0 113.368 -175.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.521 HD11 HD12 ' C' ' 182' ' ' ILE . 43.7 mt -52.39 -51.32 59.61 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -177.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 28' ' ' LYS . . . . . . . . . . . . . 13.3 pttm -65.93 -26.49 67.62 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -72.32 -35.67 68.68 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.304 1.041 . . . . 0.0 110.178 170.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 58.2 m -54.28 -43.99 71.5 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 120.941 3.682 . . . . 0.0 120.941 -167.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . 0.27 56.3 p-80 43.58 -18.22 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 123.418 2.827 . . . . 0.0 117.288 -160.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 32' ' ' SER . . . . . 0.535 ' HB2' ' HA ' ' C' ' 106' ' ' THR . 19.3 m -136.17 127.32 28.04 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.652 -3.78 . . . . 0.0 104.936 169.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' C' ' 64' ' ' VAL . 77.3 t -137.03 126.88 38.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 104.104 -2.554 . . . . 0.0 104.104 -174.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.489 HD12 HD11 ' C' ' 99' ' ' ILE . 21.8 mm -109.26 132.91 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 172.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . 0.699 HG12 ' HB2' ' C' ' 110' ' ' LEU . 55.5 mt -98.64 117.06 43.06 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 170.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 36' ' ' THR . . . . . . . . . . . . . 89.8 m -113.47 99.78 50.29 Favored Pre-proline 0 N--CA 1.44 -0.971 0 CA-C-O 122.597 1.189 . . . . 0.0 110.779 175.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -81.84 147.26 15.12 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 124.573 3.516 . . . . 0.0 114.973 178.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -159.95 120.29 0.95 Allowed Glycine 0 N--CA 1.415 -2.718 0 N-CA-C 108.014 -2.035 . . . . 0.0 108.014 166.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 39' ' ' TYR . . . . . 0.542 ' HB2' ' HA3' ' C' ' 73' ' ' GLY . 4.3 t80 61.45 -67.35 0.06 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.212 1.405 . . . . 0.0 113.839 -175.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -47.85 -43.3 23.12 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-N 121.394 1.906 . . . . 0.0 116.117 -170.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 41' ' ' MET . . . . . 0.822 ' HA ' ' HB3' ' C' ' 46' ' ' ALA . 5.6 ttm -47.24 -46.98 24.79 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 123.097 1.427 . . . . 0.0 113.49 178.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.16 -56.27 4.34 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.68 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 p -62.81 -30.46 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 N-CA-C 117.392 2.367 . . . . 0.0 117.392 -168.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.18 18.75 17.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.366 -0.833 . . . . 0.0 108.857 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 45' ' ' GLN . . . . . . . . . . . . 0.255 0.1 OUTLIER 35.31 46.73 0.27 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 124.95 2.31 . . . . 0.0 112.899 -158.347 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.822 ' HB3' ' HA ' ' C' ' 41' ' ' MET . . . -69.81 -20.16 63.46 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 114.203 -1.362 . . . . 0.0 113.523 -175.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . 0.526 ' HB2' ' HB2' ' C' ' 86' ' ' ALA . 0.0 OUTLIER -57.95 -39.13 77.34 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 176.577 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 48' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -59.2 -41.2 86.45 Favored Pre-proline 0 CA--C 1.553 1.07 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 49' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -67.32 -39.76 12.3 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 123.267 2.645 . . . . 0.0 111.671 164.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . 0.452 ' HA ' HG22 ' C' ' 53' ' ' ILE . 64.2 t -58.93 -33.67 50.48 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 O-C-N 121.57 -0.706 . . . . 0.0 110.304 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.35 -54.07 50.97 Favored 'General case' 0 C--O 1.243 0.739 0 O-C-N 120.308 -1.495 . . . . 0.0 107.386 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 52' ' ' GLU . . . . . 0.728 ' HB3' ' HB2' ' C' ' 183' ' ' LEU . 2.5 mm-40 -54.94 -37.64 66.7 Favored 'General case' 0 C--O 1.249 1.037 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -178.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 53' ' ' ILE . . . . . 0.452 HG22 ' HA ' ' C' ' 50' ' ' VAL . 9.0 tp -78.05 -44.47 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 O-C-N 121.466 -0.771 . . . . 0.0 111.493 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 88.3 m -59.87 -34.67 73.45 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -58.98 -52.95 63.57 Favored 'General case' 0 C--O 1.266 1.944 0 C-N-CA 124.658 1.183 . . . . 0.0 107.936 -175.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -74.85 -32.96 62.05 Favored 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 120.753 -1.217 . . . . 0.0 112.597 -177.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 93.6 mt -60.87 -42.08 97.21 Favored 'General case' 0 C--O 1.211 -0.93 0 O-C-N 120.659 -1.275 . . . . 0.0 110.566 174.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . 0.485 ' HD3' HG12 ' C' ' 64' ' ' VAL . 12.9 tpt180 -78.01 -27.78 49.01 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 119.743 -1.848 . . . . 0.0 110.934 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.05 -34.27 77.69 Favored 'General case' 0 C--N 1.349 0.548 0 O-C-N 121.587 -0.696 . . . . 0.0 109.89 173.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 9.2 ttm-85 -79.61 3.34 19.27 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 118.877 0.762 . . . . 0.0 111.182 174.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.44 36.92 78.46 Favored Glycine 0 C--O 1.251 1.185 0 O-C-N 120.395 -1.441 . . . . 0.0 111.067 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 7.0 mt -85.31 140.15 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 63' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -68.3 75.87 0.25 Allowed 'General case' 0 C--O 1.239 0.53 0 O-C-N 121.149 -0.969 . . . . 0.0 109.069 166.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 8.1 p -97.06 118.72 44.03 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 175.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 31.7 mmm-85 -126.2 144.35 50.8 Favored 'General case' 0 C--N 1.312 -1.036 0 O-C-N 124.842 1.339 . . . . 0.0 109.004 -173.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . 0.533 ' HB3' HD13 ' C' ' 68' ' ' ILE . 5.5 m-85 -100.08 98.11 8.87 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 123.666 1.698 . . . . 0.0 112.618 -176.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.88 83.11 1.63 Allowed Glycine 0 C--N 1.34 0.786 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 68' ' ' ILE . . . . . 0.533 HD13 ' HB3' ' C' ' 66' ' ' PHE 0.273 1.7 mp -77.89 112.89 16.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 122.006 0.908 . . . . 0.0 110.989 178.742 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -86.13 86.54 0.09 OUTLIER Pre-proline 0 N--CA 1.449 -0.477 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 165.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 70' ' ' PRO . . . . . 0.413 ' HG2' ' H ' ' C' ' 71' ' ' VAL . 94.6 Cg_endo -48.25 -52.87 7.61 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 125.211 3.94 . . . . 0.0 118.055 -165.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 71' ' ' VAL . . . . . 0.688 HG22 ' HB3' ' C' ' 76' ' ' PRO . 21.8 t -80.6 92.07 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 N-CA-C 102.13 -3.285 . . . . 0.0 102.13 178.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 72' ' ' ALA . . . . . 0.505 ' HA ' H52N ' C' 1001 ' ' NAP . . . -153.68 104.84 2.74 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 123.224 1.487 . . . . 0.0 113.387 178.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 73' ' ' GLY . . . . . 0.542 ' HA3' ' HB2' ' C' ' 39' ' ' TYR . . . 86.94 -98.32 2.35 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 111.723 -2.489 . . . . 0.0 108.149 177.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . 0.589 ' HA ' ' OE1' ' B' 1203 ' ' GLN . 0.8 OUTLIER -128.15 111.89 13.96 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 125.184 1.167 . . . . 0.0 112.549 -170.47 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.634 ' HB2' ' HB2' ' C' ' 78' ' ' HIS . 6.7 mp 71.62 134.04 0.04 OUTLIER Pre-proline 0 C--O 1.254 1.322 0 O-C-N 125.766 1.916 . . . . 0.0 112.481 -170.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 76' ' ' PRO . . . . . 0.688 ' HB3' HG22 ' C' ' 71' ' ' VAL . 56.6 Cg_endo -66.35 124.64 12.78 Favored 'Trans proline' 0 N--CA 1.432 -2.091 0 C-N-CA 121.951 1.767 . . . . 0.0 107.708 167.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 78.26 3.94 86.12 Favored Glycine 0 CA--C 1.54 1.626 0 CA-C-N 114.053 -1.431 . . . . 0.0 114.051 169.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 78' ' ' HIS . . . . . 0.634 ' HB2' ' HB2' ' C' ' 75' ' ' LEU . 21.3 t-160 -54.49 -31.46 55.93 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 79' ' ' MET . . . . . 0.619 ' HB2' ' SD ' ' C' ' 41' ' ' MET . 0.0 OUTLIER -62.18 -44.15 97.24 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 172.384 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -65.81 -36.49 83.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 122.413 1.102 . . . . 0.0 109.638 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 51.1 t -61.08 -43.65 96.67 Favored 'Isoleucine or valine' 0 C--N 1.357 0.903 0 CA-C-O 116.815 -1.564 . . . . 0.0 108.594 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 10.9 mp -82.61 -16.97 46.39 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 120.658 1.572 . . . . 0.0 112.104 174.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 15.0 tp -63.42 -32.15 73.51 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 117.492 -3.255 . . . . 0.0 110.576 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.75 -33.73 64.57 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 169.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -67.27 -45.21 77.31 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 120.274 -1.516 . . . . 0.0 113.598 166.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . 0.526 ' HB2' ' HB2' ' C' ' 47' ' ' GLN . . . -65.52 -11.22 41.66 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 176.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt 64.78 22.8 12.61 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 169.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 88' ' ' VAL . . . . . 0.435 ' HA ' ' HD2' ' C' ' 89' ' ' PRO . 74.9 t -84.55 121.75 74.93 Favored Pre-proline 0 C--O 1.249 1.034 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 173.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 89' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' C' ' 88' ' ' VAL . 37.1 Cg_endo -50.39 124.81 13.84 Favored 'Trans proline' 0 N--CA 1.442 -1.541 1 C-N-CA 126.392 4.728 . . . . 0.0 114.339 177.28 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -63.18 -16.34 59.82 Favored 'General case' 0 C--N 1.363 1.168 0 O-C-N 120.144 -1.598 . . . . 0.0 115.052 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -61.75 -40.04 93.74 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 123.345 0.658 . . . . 0.0 111.485 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 22.5 pt -75.44 -8.29 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 O-C-N 118.023 -2.923 . . . . 0.0 117.387 173.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . 0.519 HG13 HD13 ' C' ' 68' ' ' ILE . 16.8 t -88.06 121.47 38.5 Favored 'Isoleucine or valine' 0 C--O 1.248 1.02 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 -177.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . 0.553 ' HB3' ' HB3' ' C' ' 97' ' ' ASP . 6.2 mp -104.27 97.26 7.23 Favored 'General case' 0 C--O 1.25 1.107 0 CA-C-N 113.335 -1.757 . . . . 0.0 108.564 168.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 95' ' ' GLU . . . . . 0.462 ' HB3' HG12 ' A' 1157 ' ' ILE . 53.7 mp0 -81.84 93.45 6.87 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 4.0 tpp 56.55 29.57 15.74 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.451 1.9 . . . . 0.0 112.271 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 97' ' ' ASP . . . . . 0.553 ' HB3' ' HB3' ' C' ' 94' ' ' LEU . 18.7 t70 -92.11 172.7 8.25 Favored 'General case' 0 C--O 1.251 1.163 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 173.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -67.7 87.67 0.23 Allowed 'General case' 0 C--N 1.347 0.491 0 CA-C-O 123.724 1.726 . . . . 0.0 113.464 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 99' ' ' ILE . . . . . 0.489 HD11 HD12 ' C' ' 34' ' ' ILE . 6.5 tp -101.29 7.31 9.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-N 110.712 -2.949 . . . . 0.0 110.543 174.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -58.94 -49.11 79.08 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 119.765 -1.834 . . . . 0.0 112.168 -171.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -79.42 -29.54 41.95 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.839 0.828 . . . . 0.0 110.833 -174.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 102' ' ' ASP . . . . . 0.414 ' HB3' HD11 ' C' ' 34' ' ' ILE . 0.8 OUTLIER -63.73 -32.12 73.51 Favored 'General case' 0 N--CA 1.433 -1.319 0 O-C-N 121.051 -1.031 . . . . 0.0 112.826 169.213 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 103' ' ' PHE . . . . . 0.468 ' CE2' HG23 ' C' ' 99' ' ' ILE . 35.1 m-85 -63.22 -48.54 77.86 Favored 'General case' 0 N--CA 1.426 -1.657 0 O-C-N 119.606 -1.934 . . . . 0.0 111.617 169.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.15 -27.67 69.11 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 124.319 1.012 . . . . 0.0 112.959 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -72.16 -40.57 67.89 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.799 1.285 . . . . 0.0 112.179 174.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 106' ' ' THR . . . . . 0.535 ' HA ' ' HB2' ' C' ' 32' ' ' SER . 3.1 m -60.6 143.58 53.6 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 112.901 -1.954 . . . . 0.0 114.856 -174.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 107' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -92.56 -62.87 1.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 112.337 -2.21 . . . . 0.0 107.948 175.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . 0.511 ' OG1' ' HB3' ' C' ' 26' ' ' LEU . 97.0 m -108.44 126.19 52.61 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-O 123.789 1.757 . . . . 0.0 111.134 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 109' ' ' VAL . . . . . 0.594 HG11 HG21 ' C' ' 138' ' ' VAL . 3.2 t -108.96 119.93 59.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.985 0 CA-C-N 113.191 -1.822 . . . . 0.0 106.73 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 110' ' ' LEU . . . . . 0.699 ' HB2' HG12 ' C' ' 35' ' ' ILE . 34.7 mt -91.14 91.54 8.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 123.745 1.736 . . . . 0.0 110.019 177.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 111' ' ' VAL . . . . . 0.806 ' HB ' ' HA ' ' C' ' 146' ' ' VAL . 12.0 t -90.87 99.87 10.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 -175.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 26.4 mm -78.86 97.9 2.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 CA-C-N 112.314 -2.221 . . . . 0.0 110.394 -171.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.04 -100.76 1.16 Allowed Glycine 0 C--N 1.334 0.467 0 N-CA-C 107.233 -2.347 . . . . 0.0 107.233 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 114' ' ' ALA . . . . . 0.544 ' HB3' HG12 ' C' ' 111' ' ' VAL . . . 57.41 -56.55 0.03 OUTLIER 'General case' 0 C--O 1.25 1.113 1 N-CA-C 126.336 5.68 . . . . 0.0 126.336 162.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 115' ' ' ASN . . . . . 0.406 ' HB2' ' CE1' ' C' ' 163' ' ' PHE 0.344 2.7 p-10 24.48 -80.44 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 120.391 3.478 . . . . 0.0 120.391 -169.392 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 116' ' ' ASP . . . . . 0.514 ' HA ' ' HB2' ' C' ' 119' ' ' ASN . 69.7 m-20 -64.35 -18.38 64.6 Favored 'General case' 0 C--O 1.241 0.648 0 O-C-N 118.067 -2.896 . . . . 0.0 114.36 -177.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 117' ' ' THR . . . . . 0.509 ' HB ' ' HB1' ' C' ' 114' ' ' ALA . 30.8 m -45.66 -35.96 4.52 Favored 'General case' 0 C--O 1.248 0.993 0 C-N-CA 125.627 1.571 . . . . 0.0 111.792 169.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.481 ' HA ' ' HB ' ' C' ' 135' ' ' VAL . 4.3 m -127.44 20.45 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 O-C-N 120.28 -1.512 . . . . 0.0 113.184 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 119' ' ' ASN . . . . . 0.514 ' HB2' ' HA ' ' C' ' 116' ' ' ASP . 61.0 t-20 -73.12 108.36 4.47 Favored Pre-proline 0 C--N 1.32 -0.688 0 O-C-N 119.656 -1.902 . . . . 0.0 111.025 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 120' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -56.3 -27.19 65.65 Favored 'Trans proline' 0 N--CA 1.441 -1.601 0 C-N-CA 125.041 3.827 . . . . 0.0 115.868 -172.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -55.88 -39.16 71.15 Favored 'General case' 0 C--O 1.204 -1.324 0 O-C-N 125.719 1.887 . . . . 0.0 111.874 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 122' ' ' ALA . . . . . 0.51 ' HB1' ' HB3' ' C' ' 133' ' ' MET . . . -57.35 -21.86 38.5 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 117.998 2.592 . . . . 0.0 117.998 177.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -102.45 -43.92 5.51 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 117.859 -1.536 . . . . 0.0 112.591 169.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 124' ' ' ASP . . . . . 0.405 ' O ' ' HD3' ' C' ' 126' ' ' PRO . 38.7 t70 -78.37 -30.13 47.78 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 122.98 1.372 . . . . 0.0 111.66 -171.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -107.94 101.7 42.18 Favored Pre-proline 0 N--CA 1.429 -1.477 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 -169.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 126' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' C' ' 124' ' ' ASP . 27.5 Cg_exo -55.13 -39.06 92.92 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 124.009 3.139 . . . . 0.0 114.26 171.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -53.4 -21.09 5.35 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 128' ' ' SER . . . . . 0.509 ' HA ' ' HD2' ' C' ' 129' ' ' PRO . 22.3 m -48.1 134.49 11.95 Favored Pre-proline 0 N--CA 1.434 -1.227 0 O-C-N 120.685 -1.26 . . . . 0.0 113.822 172.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 129' ' ' PRO . . . . . 0.565 ' HG2' ' HA ' ' C' ' 156' ' ' ALA . 36.5 Cg_endo -55.39 -38.0 94.26 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 124.912 3.742 . . . . 0.0 117.777 172.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 130' ' ' ILE . . . . . 0.954 HG12 ' HB2' ' C' ' 156' ' ' ALA 0.291 39.3 pt -77.19 104.64 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.367 168.198 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 131' ' ' ALA . . . . . 0.722 ' HB1' HG22 ' B' 1121 ' ' ILE . . . -63.7 115.02 4.37 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 113.125 -1.852 . . . . 0.0 111.363 -168.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 29.56 69.18 0.08 OUTLIER Glycine 0 N--CA 1.473 1.108 0 CA-C-O 116.525 -2.264 . . . . 0.0 114.192 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 133' ' ' MET . . . . . 0.68 ' HA ' ' HB2' ' B' 1122 ' ' SER . 5.9 tpp -96.2 126.22 45.0 Favored Pre-proline 0 N--CA 1.434 -1.247 0 CA-C-N 119.638 1.719 . . . . 0.0 113.344 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 134' ' ' PRO . . . . . 0.516 ' HD2' ' SD ' ' C' ' 133' ' ' MET . 72.8 Cg_endo -66.54 81.05 0.32 Allowed 'Trans proline' 0 C--O 1.262 1.707 1 C-N-CA 125.696 4.264 . . . . 0.0 107.247 168.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 135' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' C' ' 118' ' ' VAL . 6.3 m -69.38 137.0 25.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.363 171.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 7.8 tp -78.53 83.42 4.73 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.301 -1.318 . . . . 0.0 113.564 -166.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . 0.28 34.2 mm-40 42.04 -26.44 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.329 1 N-CA-C 128.213 6.375 . . . . 0.0 128.213 160.092 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' C' C ' 138' ' ' VAL . . . . . 0.594 HG21 HG11 ' C' ' 109' ' ' VAL . 4.4 p -73.96 14.78 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.491 0 O-C-N 117.144 -3.472 . . . . 0.0 117.152 -160.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 5.3 p90 -69.19 142.67 54.22 Favored 'General case' 0 C--O 1.244 0.772 0 O-C-N 119.45 -2.031 . . . . 0.0 109.006 176.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.77 24.46 0.34 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 127.055 2.142 . . . . 0.0 116.588 -166.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -101.12 70.47 1.34 Allowed 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 123.154 1.454 . . . . 0.0 110.112 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.43 ' HB3' ' H ' ' C' ' 143' ' ' ASN . 0.2 OUTLIER 64.75 -135.66 0.26 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 112.271 -2.241 . . . . 0.0 114.487 171.771 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 143' ' ' ASN . . . . . 0.439 ' HB2' ' HA ' ' C' ' 108' ' ' THR . 53.8 m-20 -85.57 84.87 7.48 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 118.986 -1.086 . . . . 0.0 109.102 -168.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 144' ' ' VAL . . . . . 0.481 ' HA ' ' HB ' ' C' ' 109' ' ' VAL . 58.2 t -88.51 88.25 2.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 102.617 -3.105 . . . . 0.0 102.617 -173.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 145' ' ' ILE . . . . . 0.46 HD12 HG23 ' C' ' 108' ' ' THR . 97.4 mt -88.92 97.79 7.31 Favored 'Isoleucine or valine' 0 C--O 1.251 1.171 0 CA-C-O 123.308 1.528 . . . . 0.0 107.802 -173.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 146' ' ' VAL . . . . . 0.806 ' HA ' ' HB ' ' C' ' 111' ' ' VAL . 48.7 t -85.44 104.22 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 113.298 -1.774 . . . . 0.0 106.967 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 147' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -67.55 91.64 0.29 Allowed 'General case' 0 C--O 1.242 0.661 0 O-C-N 120.625 -1.297 . . . . 0.0 109.646 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 148' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' C' ' 172' ' ' PHE . 15.7 mmmt -118.62 110.45 17.34 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.171 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -64.35 -36.0 82.7 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.046 1.338 . . . . 0.0 109.683 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 150' ' ' SER . . . . . 0.424 ' O ' ' HE3' ' C' ' 148' ' ' LYS . 10.7 m -139.5 137.41 35.48 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 151' ' ' MET . . . . . 0.466 ' SD ' ' HE1' ' C' ' 170' ' ' MET . 5.2 tpt -77.35 98.31 5.19 Favored 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 118.791 -2.443 . . . . 0.0 109.007 170.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 152' ' ' ASN . . . . . 0.416 ' OD1' ' NZ ' ' C' ' 148' ' ' LYS . 38.5 p30 -140.68 152.17 45.15 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 110.837 -2.892 . . . . 0.0 108.952 177.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 153' ' ' THR . . . . . 0.646 HG23 ' HA3' ' C' ' 157' ' ' GLY . 98.6 m -65.17 120.39 12.62 Favored 'General case' 0 C--N 1.358 0.977 0 O-C-N 125.073 1.483 . . . . 0.0 107.797 176.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -78.58 -115.76 0.21 Allowed Glycine 0 N--CA 1.424 -2.118 0 CA-C-N 112.358 -2.201 . . . . 0.0 108.272 167.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 155' ' ' TYR . . . . . 0.57 ' HB3' HG21 ' C' ' 130' ' ' ILE . 0.6 OUTLIER -79.7 -53.65 6.61 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 179.157 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 156' ' ' ALA . . . . . 0.954 ' HB2' HG12 ' C' ' 130' ' ' ILE . . . -92.57 -60.32 1.86 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.362 0.983 . . . . 0.0 108.37 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 157' ' ' GLY . . . . . 0.646 ' HA3' HG23 ' C' ' 153' ' ' THR . . . 57.46 44.5 93.66 Favored Glycine 0 CA--C 1.492 -1.368 0 CA-C-N 113.544 -1.662 . . . . 0.0 112.257 -176.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 158' ' ' VAL . . . . . 0.472 HG22 ' HB1' ' C' ' 156' ' ' ALA . 28.4 m -123.37 157.56 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-O 122.309 1.052 . . . . 0.0 112.503 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -30.59 123.67 0.19 Allowed 'General case' 0 C--O 1.242 0.679 1 N-CA-C 122.008 4.077 . . . . 0.0 122.008 178.491 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 160' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -168.22 163.59 8.66 Favored Pre-proline 0 C--O 1.268 2.052 0 C-N-CA 126.088 1.755 . . . . 0.0 109.99 -176.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.74 -36.23 1.66 Allowed 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 124.106 3.204 . . . . 0.0 115.212 169.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 162' ' ' LEU . . . . . . . . . . . . . 8.1 tt -58.07 -35.66 71.7 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -166.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 163' ' ' PHE . . . . . 0.406 ' CE1' ' HB2' ' C' ' 115' ' ' ASN . 12.9 m-30 -70.39 -29.0 65.52 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 118.298 -2.751 . . . . 0.0 113.361 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -102.94 -17.9 15.27 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.169 -1.378 . . . . 0.0 114.206 -162.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 165' ' ' LYS . . . . . 0.448 ' HB2' ' HB ' ' C' ' 168' ' ' THR . 20.5 mmmt -73.64 -177.26 2.65 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.698 1.237 . . . . 0.0 111.986 -170.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -88.63 -63.17 1.34 Allowed 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 120.361 -1.462 . . . . 0.0 109.616 -164.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -86.94 -26.15 24.01 Favored 'General case' 0 C--O 1.243 0.753 0 O-C-N 120.329 -1.482 . . . . 0.0 112.442 170.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 168' ' ' THR . . . . . 0.448 ' HB ' ' HB2' ' C' ' 165' ' ' LYS . 96.3 m -88.81 91.11 8.69 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 124.45 2.072 . . . . 0.0 105.467 165.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -146.89 137.79 23.91 Favored 'General case' 0 N--CA 1.432 -1.34 0 O-C-N 118.682 -2.511 . . . . 0.0 111.585 -160.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 170' ' ' MET . . . . . 0.649 ' HA ' ' HB ' ' C' ' 146' ' ' VAL . 54.3 mtm -69.97 107.58 3.66 Favored 'General case' 0 N--CA 1.418 -2.044 0 O-C-N 121.507 -0.746 . . . . 0.0 110.077 162.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 171' ' ' LEU . . . . . 0.401 ' HB2' HG23 ' C' ' 145' ' ' ILE . 7.5 mp -79.22 130.56 35.6 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 172.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 172' ' ' PHE . . . . . 0.543 ' HA ' ' O ' ' C' ' 148' ' ' LYS . 68.9 m-85 -82.5 85.73 6.89 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 125.675 1.86 . . . . 0.0 110.853 -167.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -162.68 150.14 18.86 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 124.561 1.077 . . . . 0.0 111.388 -173.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 174' ' ' ASP . . . . . 0.638 ' HB3' ' HB3' ' C' ' 177' ' ' ALA . 9.7 t70 -68.07 149.42 49.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.607 -0.796 . . . . 0.0 112.01 176.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.82 -51.67 45.96 Favored 'General case' 0 C--O 1.241 0.653 0 O-C-N 121.329 -0.857 . . . . 0.0 108.879 -175.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.66 -54.5 19.08 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 116.39 -1.767 . . . . 0.0 106.277 178.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 177' ' ' ALA . . . . . 0.638 ' HB3' ' HB3' ' C' ' 174' ' ' ASP . . . -53.47 -55.99 20.69 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 -174.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 6.4 m -60.71 -37.52 81.98 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 121.622 -0.674 . . . . 0.0 110.869 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 179' ' ' VAL . . . . . 0.522 ' HA ' HG12 ' C' ' 182' ' ' ILE . 50.9 t -67.56 -36.99 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 120.617 -1.302 . . . . 0.0 110.366 175.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -59.39 -39.17 82.5 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 125.934 1.694 . . . . 0.0 109.661 174.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.34 -52.98 62.41 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 120.926 0.393 . . . . 0.0 110.075 173.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 182' ' ' ILE . . . . . 0.522 HG12 ' HA ' ' C' ' 179' ' ' VAL . 20.8 pt -75.53 -19.77 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 O-C-N 119.592 -1.943 . . . . 0.0 114.106 -175.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 183' ' ' LEU . . . . . 0.728 ' HB2' ' HB3' ' C' ' 52' ' ' GLU . 4.2 pp -58.57 -44.85 89.87 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 122.106 2.23 . . . . 0.0 115.271 -167.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 184' ' ' LYS . . . . . 0.483 ' N ' HD12 ' C' ' 183' ' ' LEU . 13.5 tttp -96.12 -14.4 22.87 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.575 168.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 185' ' ' ALA . . . . . 0.447 ' HB3' ' HA ' ' C' ' 182' ' ' ILE . . . -80.19 -74.47 0.31 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 119.251 -0.98 . . . . 0.0 111.607 -176.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 186' ' ' LEU . . . . . . . . . . . . 0.301 1.9 pt? . . . . . 0 C--N 1.363 1.158 0 N-CA-C 117.582 2.438 . . . . 0.0 117.582 -171.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' NAD . . . . . 0.471 ' O3 ' ' H3D' ' B' ' 1' ' ' NAD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C 1001 ' ' NAP . . . . . 0.54 ' O3D' ' HG2' ' C' ' 133' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1000 ' ' HIS . . . . . 0.426 ' O ' ' HB2' ' A' 1067 ' ' GLU . 26.4 t-80 . . . . . 0 CA--C 1.512 -0.505 0 N-CA-C 102.757 -3.053 . . . . 65.74 102.757 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1001 ' ' GLY . . . . . 0.41 ' HA2' ' HB2' ' A' 1067 ' ' GLU . . . -69.17 78.13 0.3 Allowed Glycine 0 CA--C 1.533 1.176 0 CA-C-O 122.337 0.965 . . . . 48.66 112.565 -167.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1002 ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' 1032 ' ' THR . 21.1 ttp180 -125.55 141.06 52.24 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 103.323 -2.843 . . . . 44.56 103.323 177.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1003 ' ' ILE . . . . . 0.496 HG12 ' HB ' ' A' 1068 ' ' ILE . 96.0 mt -105.88 127.07 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 O-C-N 117.995 -2.941 . . . . 34.86 104.787 169.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -92.89 136.71 13.3 Favored Glycine 0 N--CA 1.434 -1.487 0 CA-C-N 115.463 -0.79 . . . . 30.75 111.419 170.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.729 HG23 ' HB3' ' A' 1017 ' ' ALA . 37.5 mm -109.87 99.31 38.05 Favored Pre-proline 0 C--O 1.248 0.99 0 N-CA-C 103.75 -2.685 . . . . 32.21 103.75 173.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -80.57 144.68 15.95 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 124.536 3.491 . . . . 32.98 112.636 174.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1007 ' ' ARG . . . . . . . . . . . . . 10.0 ttp85 -75.42 155.11 36.68 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 113.25 -1.795 . . . . 47.98 107.878 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1008 ' ' GLU . . . . . 0.486 ' CD ' ' HZ3' ' A' 1071 ' ' LYS . 4.7 mm-40 -83.9 146.23 28.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 118.409 2.744 . . . . 34.7 118.409 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -83.45 -30.28 27.37 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 111.704 -2.498 . . . . 53.37 110.792 166.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1010 ' ' LEU . . . . . 0.441 HD22 ' ND2' ' A' 1073 ' ' ASN . 2.5 mp -49.32 135.64 16.96 Favored 'General case' 0 C--O 1.251 1.175 0 C-N-CA 125.024 1.33 . . . . 45.07 113.389 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1011 ' ' THR . . . . . . . . . . . . . 2.3 m -68.95 147.17 52.03 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 123.289 1.518 . . . . 40.36 107.205 -177.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 10.7 t30 65.06 -17.01 0.09 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 112.795 -2.002 . . . . 40.61 114.354 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1013 ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -69.53 112.92 6.37 Favored 'General case' 0 C--O 1.243 0.713 0 O-C-N 119.398 -2.064 . . . . 33.76 111.049 -165.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1014 ' ' THR . . . . . 0.57 ' HB ' ' HB3' ' A' 1320 ' ' PRO . 0.0 OUTLIER -96.36 -13.19 23.43 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 112.727 0.64 . . . . 27.89 112.727 173.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1015 ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.02 136.88 39.96 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 118.988 -2.32 . . . . 29.02 106.555 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1016 ' ' VAL . . . . . 0.568 HG12 ' HB2' ' A' 1043 ' ' ALA . 4.2 p -109.72 -178.51 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.101 0 N-CA-C 106.42 -1.696 . . . . 28.13 106.42 168.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1017 ' ' ALA . . . . . 0.729 ' HB3' HG23 ' A' 1005 ' ' ILE . . . -68.99 -53.65 19.45 Favored 'General case' 0 C--N 1.309 -1.18 0 O-C-N 120.538 -1.351 . . . . 26.87 111.817 -176.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1018 ' ' ALA . . . . . . . . . . . . . . . -136.03 140.76 44.1 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.675 0.75 . . . . 26.77 112.404 -173.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1019 ' ' THR . . . . . 0.477 HG23 ' HB2' ' A' 1324 ' ' SER . 3.4 p -79.6 166.66 39.69 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 124.311 1.044 . . . . 27.02 111.494 172.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1020 ' ' PRO . . . . . 0.472 ' O ' ' HB2' ' A' 1024 ' ' GLU . 0.2 OUTLIER -51.07 -38.94 60.81 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.614 2.876 . . . . 30.57 114.585 171.262 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1021 ' ' LYS . . . . . . . . . . . . . 52.2 mttp -56.1 -48.89 75.29 Favored 'General case' 0 C--O 1.219 -0.541 0 O-C-N 123.965 0.791 . . . . 47.81 111.802 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1022 ' ' THR . . . . . . . . . . . . . 1.9 p -74.44 -40.08 62.16 Favored 'General case' 0 C--N 1.348 0.505 0 C-N-CA 119.354 -0.938 . . . . 30.77 111.11 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1023 ' ' VAL . . . . . 0.567 ' HA ' HD12 ' A' 1026 ' ' LEU . 3.3 t -51.65 -42.46 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 113.091 0.775 . . . . 33.59 113.091 170.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1024 ' ' GLU . . . . . 0.583 ' HA ' HD12 ' A' 1027 ' ' LEU . 23.2 tt0 -59.4 -43.77 92.94 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 124.278 1.031 . . . . 53.29 109.545 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1025 ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -69.06 -40.38 78.56 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 125.294 1.438 . . . . 46.92 110.014 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1026 ' ' LEU . . . . . 0.567 HD12 ' HA ' ' A' 1023 ' ' VAL . 91.0 mt -54.51 -46.49 73.51 Favored 'General case' 0 C--O 1.248 0.974 0 C-N-CA 124.036 0.934 . . . . 37.17 112.364 171.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1027 ' ' LEU . . . . . 0.583 HD12 ' HA ' ' A' 1024 ' ' GLU . 14.3 mt -57.85 -43.0 85.6 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-O 118.177 -0.916 . . . . 44.44 111.922 170.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 55.7 mmtt -60.38 -20.29 58.98 Favored 'General case' 0 C--O 1.257 1.493 0 C-N-CA 124.296 1.039 . . . . 52.58 113.714 174.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1029 ' ' LEU . . . . . 0.502 HD23 ' HE3' ' A' 1342 ' ' LYS . 32.3 mt -78.35 24.31 0.27 Allowed 'General case' 0 N--CA 1.472 0.67 0 O-C-N 119.617 -1.927 . . . . 45.69 114.791 164.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 68.94 13.75 66.99 Favored Glycine 0 C--N 1.343 0.933 0 O-C-N 119.899 -1.75 . . . . 42.09 113.546 -176.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -93.29 159.44 15.27 Favored 'General case' 0 C--O 1.251 1.176 0 CA-C-N 121.91 2.855 . . . . 40.72 110.928 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1032 ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' 1002 ' ' ARG . 0.6 OUTLIER -87.95 155.2 19.96 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 103.707 -2.701 . . . . 37.77 103.707 158.562 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1033 ' ' VAL . . . . . . . . . . . . . 87.2 t -135.51 131.3 51.11 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 O-C-N 120.037 -1.665 . . . . 33.54 108.511 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -116.07 143.59 45.26 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 119.217 0.917 . . . . 31.68 109.46 171.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1035 ' ' VAL . . . . . 0.503 HG21 ' CD1' ' A' 1050 ' ' PHE . 80.0 t -128.77 137.0 58.46 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.52 0 O-C-N 119.452 -2.03 . . . . 31.52 108.273 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1036 ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -73.3 119.43 17.52 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 119.542 -1.974 . . . . 41.04 108.419 174.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1037 ' ' SER . . . . . 0.538 ' HB2' HG23 ' A' 1057 ' ' ILE . 19.7 t -63.49 144.18 57.2 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.853 0.835 . . . . 31.83 110.072 -171.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 110.27 -31.61 7.29 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 107.378 -2.289 . . . . 29.36 107.378 -169.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1039 ' ' ALA . . . . . . . . . . . . . . . -52.44 -34.03 46.77 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.456 1.28 . . . . 27.78 114.456 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -60.6 -48.85 84.14 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 120.306 1.412 . . . . 28.91 112.25 172.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1041 ' ' GLN . . . . . 0.649 HE22 ' HB2' ' A' 1047 ' ' ASP . 1.7 mp0 -65.05 -31.72 73.09 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 114.507 -0.847 . . . . 51.18 112.518 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1042 ' ' LEU . . . . . . . . . . . . . 8.9 mp -67.91 -66.9 0.51 Allowed 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.587 0.708 . . . . 29.91 109.407 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1043 ' ' ALA . . . . . 0.568 ' HB2' HG12 ' A' 1016 ' ' VAL . . . -66.36 -5.54 11.11 Favored 'General case' 0 N--CA 1.439 -1.0 0 O-C-N 121.239 -0.913 . . . . 28.54 111.496 -171.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1044 ' ' SER . . . . . 0.446 ' HB3' ' HA2' ' B' 1278 ' ' GLY . 16.6 m 62.45 72.59 0.49 Allowed 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 126.967 3.27 . . . . 33.06 110.077 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1045 ' ' PHE . . . . . . . . . . . . . 1.9 t80 -157.57 155.03 29.49 Favored 'General case' 0 N--CA 1.423 -1.784 1 CA-C-N 108.063 -4.153 . . . . 30.29 101.896 -172.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 10.7 t0 -68.18 123.83 21.77 Favored 'General case' 0 N--CA 1.439 -0.999 0 O-C-N 120.394 -1.441 . . . . 48.62 109.688 171.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1047 ' ' ASP . . . . . 0.649 ' HB2' HE22 ' A' 1041 ' ' GLN . 0.4 OUTLIER -60.65 -49.34 77.93 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 122.811 1.291 . . . . 36.74 111.69 176.306 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.01 -13.71 62.35 Favored 'General case' 0 N--CA 1.434 -1.273 0 O-C-N 119.031 -2.293 . . . . 43.73 112.081 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -65.19 -15.63 62.65 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 116.957 -1.497 . . . . 32.81 113.904 168.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1050 ' ' PHE . . . . . 0.503 ' CD1' HG21 ' A' 1035 ' ' VAL . 62.9 m-85 -65.82 -47.0 76.51 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 106.464 -1.68 . . . . 31.86 106.464 167.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1051 ' ' VAL . . . . . . . . . . . . . 76.6 t -60.71 -38.55 78.99 Favored 'Isoleucine or valine' 0 C--O 1.254 1.318 0 CA-C-O 118.266 -0.873 . . . . 33.22 111.242 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -52.91 -50.58 63.66 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 119.398 0.999 . . . . 50.83 113.009 171.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -61.37 -33.89 74.39 Favored 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 124.339 1.056 . . . . 33.12 112.213 173.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 114.24 15.96 8.05 Favored Glycine 0 C--O 1.257 1.552 0 O-C-N 120.436 -1.415 . . . . 35.83 111.326 175.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1055 ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' A' 1050 ' ' PHE . . . -84.42 140.15 31.73 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 107.374 -1.343 . . . . 34.82 107.374 177.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -70.09 121.3 17.21 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 117.534 -1.222 . . . . 49.05 111.101 172.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1057 ' ' ILE . . . . . 0.538 HG23 ' HB2' ' A' 1037 ' ' SER . 3.6 mm -90.11 103.16 13.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 104.9 -2.259 . . . . 38.53 104.9 177.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1058 ' ' VAL . . . . . 0.474 ' HB ' ' HB2' ' A' 1062 ' ' SER . 34.6 m -110.98 172.15 2.78 Favored 'Isoleucine or valine' 0 C--O 1.252 1.236 0 CA-C-N 113.309 -1.769 . . . . 42.11 108.432 -170.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -119.35 131.99 55.79 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 106.666 -1.605 . . . . 58.0 106.666 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1060 ' ' GLY . . . . . 0.542 ' O ' HG12 ' A' 1063 ' ' VAL . . . 54.86 -129.14 44.7 Favored Glycine 0 CA--C 1.526 0.736 0 O-C-N 125.375 1.672 . . . . 52.12 112.918 169.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1061 ' ' ASN . . . . . . . . . . . . . 1.4 t30 -57.0 -26.43 60.22 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 112.807 -1.697 . . . . 54.75 112.643 -168.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1062 ' ' SER . . . . . 0.474 ' HB2' ' HB ' ' A' 1058 ' ' VAL . 3.0 m -55.83 -37.31 68.53 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-O 122.56 1.172 . . . . 50.34 111.863 -179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1063 ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' 1060 ' ' GLY . 9.3 p -62.26 -33.43 58.83 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.186 0 O-C-N 119.19 -2.194 . . . . 41.46 116.183 176.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1064 ' ' TRP . . . . . 0.435 ' HA ' HD11 ' A' 1069 ' ' ILE . 93.2 m95 -74.0 -15.86 61.08 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 113.551 0.945 . . . . 39.32 113.551 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -82.63 83.02 7.77 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.408 1.099 . . . . 55.38 108.427 170.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1066 ' ' SER . . . . . . . . . . . . . 66.1 m -153.65 173.9 15.19 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 113.769 -1.56 . . . . 41.87 110.549 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1067 ' ' GLU . . . . . 0.731 ' HB3' HD12 ' A' 1068 ' ' ILE . 0.3 OUTLIER -77.74 -57.16 3.96 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 106.976 -1.49 . . . . 53.2 106.976 173.341 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1068 ' ' ILE . . . . . 0.731 HD12 ' HB3' ' A' 1067 ' ' GLU . 5.4 mp -109.68 149.22 12.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 105.45 -2.056 . . . . 41.9 105.45 -176.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1069 ' ' ILE . . . . . 0.435 HD11 ' HA ' ' A' 1064 ' ' TRP . 20.6 mm -128.78 120.16 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 N-CA-C 104.39 -2.448 . . . . 38.73 104.39 172.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1070 ' ' LEU . . . . . 0.591 HD22 HD22 ' A' 1331 ' ' LEU . 33.9 mt -97.69 97.93 9.44 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 104.908 -2.256 . . . . 32.44 104.908 175.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1071 ' ' LYS . . . . . 0.486 ' HZ3' ' CD ' ' A' 1008 ' ' GLU . 7.5 tmtt? -90.36 141.51 28.66 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 125.608 2.623 . . . . 34.65 109.074 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1072 ' ' VAL . . . . . 0.434 ' HA ' ' HE2' ' A' 1327 ' ' TYR . 15.1 t -62.86 -46.34 96.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 111.531 -2.577 . . . . 31.32 109.888 -168.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1073 ' ' ASN . . . . . 0.489 ' HA ' ' HB2' ' A' 1092 ' ' PHE . 63.3 m-80 -127.42 -160.11 0.98 Allowed 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.082 -1.081 . . . . 33.94 108.082 172.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -67.96 147.56 98.46 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 121.869 2.122 . . . . 38.04 111.481 173.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1075 ' ' PRO . . . . . 0.605 ' HG2' HD21 ' A' 1089 ' ' LEU . 22.9 Cg_exo -63.38 132.46 36.02 Favored 'Trans proline' 0 C--O 1.266 1.89 0 C-N-CA 123.332 2.688 . . . . 42.68 111.065 163.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 11.8 mt -90.81 175.98 6.8 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 105.51 -2.033 . . . . 46.74 105.51 170.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1077 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.71 -31.82 49.56 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.655 1.724 . . . . 58.61 115.655 -171.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 13.1 t70 -65.9 -52.06 53.35 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.037 -0.727 . . . . 59.2 109.037 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1079 ' ' GLU . . . . . 0.578 ' HA ' HD12 ' A' 1082 ' ' LEU . 1.9 mp0 -62.92 -31.03 72.02 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 114.294 1.22 . . . . 50.63 114.294 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1080 ' ' ILE . . . . . 0.447 HD13 ' HB2' ' A' 1104 ' ' LYS . 57.5 mt -61.97 -44.88 99.52 Favored 'Isoleucine or valine' 0 C--N 1.346 0.418 0 CA-C-N 115.948 -0.569 . . . . 51.48 111.109 170.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -59.49 -33.23 71.07 Favored 'General case' 0 C--O 1.25 1.112 0 CA-C-O 122.755 1.264 . . . . 50.28 113.646 170.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1082 ' ' LEU . . . . . 0.578 HD12 ' HA ' ' A' 1079 ' ' GLU . 66.2 mt -72.33 -26.77 62.06 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.228 -1.351 . . . . 50.21 112.49 173.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1083 ' ' LEU . . . . . 0.627 HD12 HG11 ' A' 1110 ' ' VAL . 3.6 mm? -60.81 149.73 34.97 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 125.73 2.681 . . . . 49.06 113.574 172.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -113.3 136.84 21.86 Favored Pre-proline 0 N--CA 1.437 -1.106 0 CA-C-N 111.361 -2.654 . . . . 51.08 107.097 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -60.2 124.59 15.53 Favored 'Trans proline' 0 N--CA 1.435 -1.914 0 C-N-CA 121.4 1.4 . . . . 49.73 115.014 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 91.7 8.43 63.77 Favored Glycine 0 C--O 1.259 1.709 0 N-CA-C 111.158 -0.777 . . . . 47.71 111.158 -177.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1087 ' ' THR . . . . . 0.406 HG21 HG12 ' A' 1069 ' ' ILE . 72.7 m -84.66 145.64 27.87 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 123.208 1.48 . . . . 45.47 110.652 167.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1088 ' ' THR . . . . . . . . . . . . . 52.3 m -91.98 121.53 33.65 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 118.19 -2.819 . . . . 42.04 104.295 173.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1089 ' ' LEU . . . . . 0.605 HD21 ' HG2' ' A' 1075 ' ' PRO . 55.6 tp -106.84 116.66 32.3 Favored 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 123.961 0.904 . . . . 38.06 109.029 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 38.5 t -114.62 124.49 71.32 Favored 'Isoleucine or valine' 0 C--O 1.25 1.081 0 N-CA-C 105.184 -2.154 . . . . 37.4 105.184 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1091 ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' 1073 ' ' ASN . 3.5 m -158.46 168.56 26.62 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 122.424 1.107 . . . . 36.16 113.049 -174.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1092 ' ' PHE . . . . . 0.489 ' HB2' ' HA ' ' A' 1073 ' ' ASN . 14.9 m-85 -82.23 94.85 7.38 Favored 'General case' 0 C--O 1.25 1.087 0 O-C-N 119.579 -1.951 . . . . 38.94 108.486 165.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 26.6 mm -84.76 -34.63 9.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 113.864 1.061 . . . . 42.17 113.864 -172.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1094 ' ' TRP . . . . . . . . . . . . . 84.0 m95 57.99 60.06 6.29 Favored Pre-proline 0 C--N 1.357 0.921 0 C-N-CA 123.086 0.554 . . . . 46.51 111.56 -169.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -62.78 -34.22 73.59 Favored 'Trans proline' 0 C--O 1.241 0.646 0 C-N-CA 124.185 3.257 . . . . 49.76 117.013 -165.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -69.2 -35.99 76.82 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 124.643 1.215 . . . . 52.62 108.784 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1097 ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -76.78 -30.28 56.42 Favored 'General case' 0 C--O 1.216 -0.669 0 CA-C-N 115.151 -0.931 . . . . 60.74 109.34 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1098 ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -109.84 36.03 0.11 Allowed Pre-proline 0 CA--C 1.557 1.215 1 N-CA-C 124.96 5.17 . . . . 58.19 124.96 -169.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1099 ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -52.09 -24.08 18.96 Favored 'Trans proline' 0 C--N 1.366 1.493 0 C-N-CA 124.655 3.57 . . . . 54.59 113.961 175.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1100 ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -57.84 -59.53 5.09 Favored 'General case' 0 C--O 1.253 1.287 0 CA-C-O 124.396 2.046 . . . . 63.28 110.019 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1101 ' ' LEU . . . . . . . . . . . . . 5.4 mp -70.55 -42.07 71.66 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 111.526 -2.579 . . . . 54.75 107.587 -175.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1102 ' ' MET . . . . . . . . . . . . . 72.0 mtm -56.74 -39.22 73.56 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 114.757 1.391 . . . . 52.65 114.757 174.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -62.78 -38.33 90.2 Favored 'General case' 0 C--N 1.35 0.608 0 O-C-N 119.968 -1.707 . . . . 66.26 110.329 -178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1104 ' ' LYS . . . . . 0.447 ' HB2' HD13 ' A' 1080 ' ' ILE . 87.7 mttt -74.18 -36.76 64.07 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 114.262 -1.335 . . . . 63.73 110.49 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 22.6 mt -63.64 -35.1 79.41 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 120.652 -1.28 . . . . 54.68 112.699 169.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -65.97 -41.45 91.17 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 106.907 -1.516 . . . . 53.64 106.907 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -51.46 -46.01 62.91 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 113.94 1.089 . . . . 67.24 113.94 168.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -67.18 1.12 2.24 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 115.848 1.796 . . . . 65.76 115.848 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 10.0 t30 49.81 44.55 25.03 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 125.088 2.375 . . . . 58.71 113.925 177.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1110 ' ' VAL . . . . . 0.627 HG11 HD12 ' A' 1083 ' ' LEU . 3.7 m -110.75 152.6 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 113.944 -1.48 . . . . 46.63 109.421 -178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1111 ' ' THR . . . . . . . . . . . . . 89.4 m -89.14 99.85 12.75 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 106.881 -1.526 . . . . 44.13 106.881 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1112 ' ' VAL . . . . . 0.57 ' HB ' ' HB ' ' A' 1361 ' ' ILE . 91.6 t -91.56 128.01 43.55 Favored 'Isoleucine or valine' 0 C--O 1.253 1.25 0 CA-C-O 123.829 1.776 . . . . 40.44 110.366 -176.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1113 ' ' MET . . . . . 0.648 ' SD ' HD21 ' A' 1334 ' ' LEU . 35.2 mtp -119.27 123.18 43.63 Favored 'General case' 0 C--O 1.255 1.367 0 N-CA-C 105.79 -1.93 . . . . 50.76 105.79 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1114 ' ' ALA . . . . . . . . . . . . . . . -99.42 96.62 7.82 Favored 'General case' 0 N--CA 1.428 -1.575 0 O-C-N 124.106 0.879 . . . . 35.64 111.896 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1115 ' ' MET . . . . . 0.563 ' HB3' ' HB3' ' A' 1129 ' ' ALA . 36.0 mmm -65.33 -17.77 64.78 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 116.765 2.135 . . . . 38.74 116.765 -173.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1116 ' ' ASP . . . . . 0.462 ' HA ' ' HB2' ' A' 1130 ' ' LEU . 7.5 p-10 -73.67 -36.52 65.35 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 118.179 -0.915 . . . . 40.14 108.561 168.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1117 ' ' SER . . . . . . . . . . . . . 63.6 m -102.37 62.3 0.86 Allowed 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 125.05 2.357 . . . . 44.79 109.801 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1118 ' ' VAL . . . . . . . . . . . . . 87.4 t -90.94 134.31 30.5 Favored Pre-proline 0 C--O 1.243 0.739 0 N-CA-C 106.55 -1.648 . . . . 43.75 106.55 174.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -46.13 120.9 3.96 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.732 3.622 . . . . 48.93 111.299 171.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -63.3 -4.56 2.66 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 117.502 2.408 . . . . 62.9 117.502 -169.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 45.1 pt -66.77 158.14 5.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 115.172 1.545 . . . . 57.72 115.172 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1122 ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.66 -49.19 68.48 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 125.499 1.75 . . . . 57.26 114.242 -173.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 21.4 ptt85 -63.21 -13.34 36.43 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 118.36 -2.712 . . . . 62.9 115.286 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -89.65 -21.37 22.81 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 120.394 -1.441 . . . . 49.83 108.573 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1125 ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -61.27 -20.51 62.96 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 115.532 1.679 . . . . 52.37 115.532 -163.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1126 ' ' SER . . . . . . . . . . . . . 6.0 p -68.52 -39.0 81.36 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.184 0.902 . . . . 42.43 112.341 168.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1127 ' ' LEU . . . . . 0.438 ' O ' ' HB3' ' A' 1330 ' ' ASN . 5.1 mp -82.56 -23.68 34.36 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.277 -0.874 . . . . 43.74 110.977 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1128 ' ' ASP . . . . . . . . . . . . . 10.1 t0 -68.04 105.03 1.91 Allowed 'General case' 0 C--O 1.246 0.908 0 CA-C-O 124.658 2.17 . . . . 43.21 112.361 -167.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1129 ' ' ALA . . . . . 0.563 ' HB3' ' HB3' ' A' 1115 ' ' MET . . . -72.37 -41.22 66.63 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 111.159 -2.746 . . . . 35.74 111.502 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1130 ' ' LEU . . . . . 0.462 ' HB2' ' HA ' ' A' 1116 ' ' ASP . 9.0 tp -54.94 -40.94 70.47 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 118.889 0.768 . . . . 38.09 112.009 175.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1131 ' ' SER . . . . . 0.651 ' HA ' HG21 ' A' 1175 ' ' VAL . 68.1 m -54.8 -53.01 60.82 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-N 119.979 1.263 . . . . 36.91 112.732 176.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1132 ' ' SER . . . . . . . . . . . . . 4.6 m -65.2 -37.49 87.48 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 119.312 0.96 . . . . 35.79 113.303 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1133 ' ' MET . . . . . 0.478 ' HE2' HD12 ' A' 1136 ' ' ILE . 24.8 mmt -59.46 -45.46 91.56 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 121.893 2.133 . . . . 30.81 115.69 171.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1134 ' ' ALA . . . . . 0.439 ' HB1' ' HB2' ' A' 1176 ' ' ALA . . . -69.29 -39.75 78.13 Favored 'General case' 0 CA--C 1.504 -0.803 0 O-C-N 124.275 0.984 . . . . 28.88 109.936 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1135 ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -53.27 -47.76 68.86 Favored 'General case' 0 C--O 1.245 0.86 0 O-C-N 123.972 0.795 . . . . 40.76 112.518 169.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1136 ' ' ILE . . . . . 0.744 HG23 HD23 ' A' 1319 ' ' LEU . 71.4 mt -59.95 -44.71 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 107.951 -1.129 . . . . 31.54 107.951 177.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1137 ' ' ALA . . . . . . . . . . . . . . . -60.06 -44.01 95.02 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-O 117.251 -1.357 . . . . 29.87 111.109 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -62.3 -46.79 93.17 Favored Glycine 0 N--CA 1.439 -1.155 0 CA-C-N 123.074 2.67 . . . . 28.73 112.478 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 36.5 t80 -59.87 -48.97 79.52 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 122.353 1.073 . . . . 30.39 109.226 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1140 ' ' ARG . . . . . 0.66 HH11 HD13 ' A' 1319 ' ' LEU . 3.7 tpt180 -65.58 -24.46 67.08 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 112.895 0.702 . . . . 26.09 112.895 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1141 ' ' ALA . . . . . 0.839 ' HB2' HD21 ' A' 1284 ' ' LEU . . . -65.73 -44.83 84.82 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 109.655 -0.498 . . . . 27.1 109.655 173.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1142 ' ' ILE . . . . . 0.461 HG13 ' HB3' ' A' 1183 ' ' ALA . 42.2 mm -57.36 -38.67 63.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 123.984 0.914 . . . . 28.48 109.664 175.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 97.7 t -68.05 -59.89 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-O 121.242 0.544 . . . . 23.07 111.804 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1144 ' ' GLU . . . . . 0.421 ' CD ' HH21 ' A' 1140 ' ' ARG . 4.4 mm-40 -61.05 -28.56 69.16 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 120.637 -1.289 . . . . 33.4 111.642 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1145 ' ' ALA . . . . . 0.525 ' HB1' HD12 ' A' 1251 ' ' ILE . . . -65.73 -60.71 2.62 Favored 'General case' 0 C--O 1.206 -1.209 0 CA-C-O 115.256 -2.307 . . . . 24.22 107.227 171.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -55.17 -18.62 6.11 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 121.922 2.146 . . . . 24.89 115.881 176.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -68.21 -56.36 8.97 Favored 'General case' 0 N--CA 1.439 -1.011 0 O-C-N 120.438 -1.413 . . . . 26.73 111.267 169.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1148 ' ' GLU . . . . . 0.666 ' HB2' HD11 ' A' 1310 ' ' ILE . 54.3 mm-40 -90.35 -12.67 36.96 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 118.025 2.602 . . . . 39.96 118.025 -174.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1149 ' ' PHE . . . . . . . . . . . . . 2.9 t80 -67.92 152.24 45.86 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 124.086 1.898 . . . . 25.87 108.186 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1150 ' ' GLY . . . . . . . . . . . . . . . -74.01 -48.62 15.31 Favored Glycine 0 N--CA 1.41 -3.058 0 CA-C-N 111.554 -2.566 . . . . 19.28 113.075 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1151 ' ' ARG . . . . . 0.765 ' HA ' ' HB2' ' B' 1322 ' ' GLN . 61.8 mtm-85 -103.56 176.25 5.21 Favored 'General case' 0 C--O 1.25 1.1 0 N-CA-C 109.241 -0.652 . . . . 39.9 109.241 -164.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1152 ' ' PHE . . . . . 0.7 ' HB2' HG11 ' A' 1163 ' ' VAL . 12.0 m-30 -76.24 161.11 29.04 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 120.87 -1.144 . . . . 29.44 108.122 169.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1153 ' ' PHE . . . . . 0.606 ' HB3' ' HB2' ' A' 1189 ' ' ALA . 7.8 m-85 -78.78 -48.61 14.51 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 122.891 1.329 . . . . 32.6 108.662 168.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1154 ' ' THR . . . . . . . . . . . . . 9.7 m -64.45 116.62 6.3 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 115.252 1.575 . . . . 34.64 115.252 -170.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1155 ' ' GLY . . . . . . . . . . . . . . . -66.49 88.67 0.13 Allowed Glycine 0 C--O 1.24 0.486 0 N-CA-C 110.666 -0.973 . . . . 37.14 110.666 173.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -139.45 178.89 6.88 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 124.883 2.278 . . . . 40.57 111.137 -173.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1157 ' ' ILE . . . . . 0.693 ' HB ' ' HG2' ' C' ' 95' ' ' GLU . 3.1 tp -107.53 153.44 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 112.928 -1.942 . . . . 44.61 107.548 167.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1158 ' ' THR . . . . . 0.501 ' O ' HG13 ' A' 1157 ' ' ILE . 24.5 p -103.76 -143.63 0.36 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.539 -1.282 . . . . 40.7 107.539 169.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1159 ' ' ALA . . . . . . . . . . . . . . . -94.45 -25.15 17.02 Favored 'General case' 0 C--O 1.246 0.869 0 O-C-N 119.301 -2.124 . . . . 40.25 110.233 167.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1160 ' ' ALA . . . . . . . . . . . . . . . -82.78 -56.53 3.78 Favored 'General case' 0 C--O 1.249 1.059 0 O-C-N 121.914 -0.491 . . . . 38.47 111.952 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1161 ' ' GLY . . . . . 0.623 ' HA3' HG21 ' B' 1329 ' ' THR . . . -169.02 -173.42 36.71 Favored Glycine 0 N--CA 1.476 1.333 0 N-CA-C 111.894 -0.483 . . . . 37.61 111.894 -164.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 15.6 tttp -78.35 151.8 32.68 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 126.057 1.743 . . . . 48.9 111.772 -170.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1163 ' ' VAL . . . . . 0.7 HG11 ' HB2' ' A' 1152 ' ' PHE . 92.5 t -102.07 123.86 42.04 Favored Pre-proline 0 N--CA 1.44 -0.942 0 CA-C-N 113.197 -1.82 . . . . 36.52 108.019 161.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1164 ' ' PRO . . . . . 0.502 ' HD2' ' HA ' ' A' 1163 ' ' VAL . 47.2 Cg_endo -62.82 114.47 2.43 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 123.897 3.064 . . . . 35.08 115.046 162.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1165 ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' 1164 ' ' PRO . 61.8 Cg_exo -61.91 130.8 32.34 Favored 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 124.142 3.228 . . . . 35.33 113.42 -171.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1166 ' ' ALA . . . . . 0.427 ' HB2' ' HA ' ' A' 1153 ' ' PHE . . . -66.8 123.39 20.01 Favored 'General case' 0 CA--C 1.501 -0.925 0 O-C-N 125.043 1.464 . . . . 34.69 112.055 172.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1167 ' ' LYS . . . . . 0.522 ' HA ' ' HB ' ' A' 1190 ' ' ILE . 7.1 mttp -96.89 94.32 7.16 Favored 'General case' 0 CA--C 1.486 -1.494 0 N-CA-C 105.227 -2.138 . . . . 45.36 105.227 176.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 20.2 t -82.19 97.83 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 C-N-CA 124.479 1.111 . . . . 31.71 108.215 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1169 ' ' MET . . . . . 0.483 ' O ' ' HA ' ' A' 1252 ' ' ILE . 59.2 ttp -77.96 125.78 29.85 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.037 -1.468 . . . . 42.28 107.037 166.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 94.6 t -111.86 112.04 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 106.828 -1.545 . . . . 30.51 106.828 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1171 ' ' ILE . . . . . 0.535 HD12 HG23 ' A' 1254 ' ' THR . 75.8 mt -88.69 116.29 30.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 119.979 -1.701 . . . . 31.87 109.412 173.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 93.61 89.51 1.61 Allowed Glycine 0 C--O 1.215 -1.043 0 N-CA-C 109.215 -1.554 . . . . 34.54 109.215 171.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1173 ' ' ALA . . . . . 0.489 ' HA ' ' HA3' ' A' 1177 ' ' GLY . . . -80.95 67.73 6.96 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 123.05 1.405 . . . . 32.51 110.19 176.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1174 ' ' GLY . . . . . . . . . . . . . . . -100.98 -153.73 26.5 Favored Glycine 0 C--O 1.217 -0.95 0 CA-C-O 117.101 -1.944 . . . . 29.9 108.369 167.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1175 ' ' VAL . . . . . 0.651 HG21 ' HA ' ' A' 1131 ' ' SER . 0.0 OUTLIER -58.45 -49.03 83.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 CA-C-N 121.438 2.619 . . . . 33.11 111.931 -178.542 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1176 ' ' ALA . . . . . 0.439 ' HB2' ' HB1' ' A' 1134 ' ' ALA 0.26 . . -59.89 -36.98 78.11 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 121.984 0.897 . . . . 28.1 110.538 174.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1177 ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' 1173 ' ' ALA . . . -63.96 -55.05 26.57 Favored Glycine 0 C--O 1.215 -1.057 0 N-CA-C 109.63 -1.388 . . . . 28.54 109.63 -175.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1178 ' ' LEU . . . . . 0.673 HD23 HD12 ' A' 1181 ' ' ILE . 29.5 mt -65.7 -30.76 71.49 Favored 'General case' 0 C--O 1.254 1.303 0 CA-C-N 114.231 -0.984 . . . . 31.22 110.869 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -66.28 -40.34 90.03 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.022 -1.674 . . . . 28.98 112.391 173.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -65.03 -42.18 94.59 Favored 'General case' 0 C--O 1.221 -0.433 0 O-C-N 119.23 -2.169 . . . . 27.83 112.261 173.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1181 ' ' ILE . . . . . 0.673 HD12 HD23 ' A' 1178 ' ' LEU . 71.1 mt -54.07 -55.09 15.94 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 CA-C-O 118.46 -0.781 . . . . 30.25 110.055 172.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -59.3 -53.27 47.64 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-O 122.957 1.309 . . . . 29.59 111.633 -175.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1183 ' ' ALA . . . . . 0.461 ' HB3' HG13 ' A' 1142 ' ' ILE . . . -50.39 -64.22 0.88 Allowed 'General case' 0 C--N 1.348 0.535 0 O-C-N 120.022 -1.869 . . . . 30.29 113.535 173.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -60.8 -37.86 83.4 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 115.86 1.8 . . . . 30.47 115.86 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -60.11 -45.91 91.4 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 107.923 -1.14 . . . . 42.41 107.923 174.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1186 ' ' SER . . . . . . . . . . . . . 67.4 m -62.77 -44.33 96.47 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 123.458 1.599 . . . . 39.38 113.026 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1187 ' ' LEU . . . . . . . . . . . . . 25.2 tp -63.87 -30.94 71.98 Favored 'General case' 0 C--O 1.244 0.796 0 O-C-N 119.765 -1.834 . . . . 36.18 110.36 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 108.89 40.14 1.61 Allowed Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 125.722 1.629 . . . . 33.78 114.114 170.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1189 ' ' ALA . . . . . 0.606 ' HB2' ' HB3' ' A' 1153 ' ' PHE . . . -108.75 161.18 15.34 Favored 'General case' 0 CA--C 1.49 -1.332 0 O-C-N 121.164 -1.198 . . . . 33.93 110.745 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1190 ' ' ILE . . . . . 0.522 ' HB ' ' HA ' ' A' 1167 ' ' LYS . 67.8 mt -72.56 120.29 20.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 104.996 -2.224 . . . . 38.74 104.996 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1191 ' ' VAL . . . . . 0.507 HG11 ' HA ' ' A' 1181 ' ' ILE . 10.1 t -110.65 129.2 66.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.15 -1.426 . . . . 33.09 107.15 175.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1192 ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' 1210 ' ' GLU . 71.9 mtt180 -127.59 101.89 6.6 Favored 'General case' 0 N--CA 1.438 -1.027 0 O-C-N 125.399 1.687 . . . . 38.92 108.022 173.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -100.47 152.3 20.54 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.619 0.723 . . . . 35.32 112.536 -175.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1194 ' ' PHE . . . . . 0.455 ' HZ ' ' HG2' ' A' 1238 ' ' GLU . 79.1 t80 -128.67 148.35 50.81 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 127.751 2.42 . . . . 39.35 105.231 -172.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 7.9 t70 -166.59 161.89 16.22 Favored 'General case' 0 C--O 1.243 0.714 0 O-C-N 124.483 1.114 . . . . 40.46 109.966 170.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1196 ' ' THR . . . . . 0.441 HG23 ' CE2' ' A' 1234 ' ' PHE . 0.8 OUTLIER -67.86 -42.41 81.36 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 113.625 -1.625 . . . . 45.94 107.734 179.684 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1197 ' ' ARG . . . . . . . . . . . . . 47.7 mtm180 -94.26 117.67 67.08 Favored Pre-proline 0 C--O 1.212 -0.892 0 C-N-CA 123.97 0.908 . . . . 56.02 109.65 -162.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1198 ' ' PRO . . . . . 0.47 ' O ' ' HB3' ' A' 1201 ' ' LYS . 74.5 Cg_endo -68.12 -8.82 23.89 Favored 'Trans proline' 0 C--N 1.36 1.142 0 C-N-CA 124.125 3.217 . . . . 51.27 114.555 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.44 -35.63 34.73 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 120.299 -1.501 . . . . 59.1 108.485 -177.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1200 ' ' VAL . . . . . . . . . . . . . 15.0 m -71.36 -26.39 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 113.662 0.986 . . . . 51.06 113.662 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1201 ' ' LYS . . . . . 0.47 ' HB3' ' O ' ' A' 1198 ' ' PRO . 74.9 tttt -39.39 -42.41 1.07 Allowed 'General case' 0 C--O 1.239 0.512 0 N-CA-C 115.878 1.807 . . . . 57.38 115.878 166.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -57.37 -47.85 80.59 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 114.814 -1.085 . . . . 62.41 111.114 177.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -69.46 -41.61 75.97 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 118.752 -0.642 . . . . 57.78 109.634 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1204 ' ' VAL . . . . . 0.404 HG11 ' HD1' ' A' 1211 ' ' PHE . 99.9 t -51.95 -54.65 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 120.276 1.398 . . . . 46.38 114.529 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1205 ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -53.42 -51.22 63.29 Favored 'General case' 0 N--CA 1.427 -1.585 0 C-N-CA 125.208 1.403 . . . . 50.7 112.452 169.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1206 ' ' SER . . . . . . . . . . . . . 7.1 m -78.41 4.15 13.86 Favored 'General case' 0 C--O 1.261 1.663 0 O-C-N 119.429 -2.044 . . . . 49.98 115.531 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1207 ' ' MET . . . . . . . . . . . . . 75.6 mtp -99.69 -1.86 36.83 Favored 'General case' 0 C--O 1.244 0.784 0 O-C-N 119.87 -1.769 . . . . 52.99 111.828 169.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 86.79 48.93 4.26 Favored Glycine 0 C--N 1.346 1.13 0 C-N-CA 120.304 -0.95 . . . . 47.66 111.112 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -137.62 153.67 49.86 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 124.532 2.11 . . . . 44.77 108.353 170.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1210 ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' 1192 ' ' ARG . 20.9 tt0 -85.44 134.17 34.07 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 113.094 -1.866 . . . . 47.64 106.351 172.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1211 ' ' PHE . . . . . 0.404 ' HD1' HG11 ' A' 1204 ' ' VAL . 39.2 t80 -86.09 128.06 34.8 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 120.42 -1.425 . . . . 45.66 109.174 175.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 32.5 mt -99.44 115.02 28.32 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 106.072 -1.825 . . . . 46.06 106.072 171.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -88.02 167.88 13.31 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-O 122.708 1.242 . . . . 60.22 109.876 167.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1214 ' ' LEU . . . . . 0.464 HD23 ' HB3' ' A' 1237 ' ' ALA . 4.9 mp -74.22 136.41 42.76 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 106.471 -1.677 . . . . 57.25 106.471 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.75 92.46 1.57 Allowed 'General case' 0 C--O 1.243 0.734 0 N-CA-C 107.411 -1.329 . . . . 64.43 107.411 166.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 5.1 t80 . . . . . 0 CA--C 1.506 -0.734 0 CA-C-N 114.326 -1.306 . . . . 66.9 111.277 -167.368 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 6.1 p-10 . . . . . 0 N--CA 1.443 -0.816 0 N-CA-C 103.313 -2.847 . . . . 39.09 103.313 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -55.09 -37.36 63.28 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.61 -0.723 . . . . 39.32 113.089 -175.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 84.2 t80 -69.3 -54.26 15.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 117.759 0.78 . . . . 39.3 111.11 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -67.05 -34.01 76.75 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 119.277 0.944 . . . . 36.3 112.917 -177.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -62.01 -37.41 84.75 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 113.122 0.786 . . . . 37.38 113.122 168.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -70.87 -36.1 62.8 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 CA-C-N 121.429 1.922 . . . . 39.11 110.579 169.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1230 ' ' MET . . . . . . . . . . . . . 33.2 mmt -90.22 63.5 5.78 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 124.101 1.905 . . . . 49.59 110.97 -177.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1231 ' ' SER . . . . . . . . . . . . . 67.0 m -151.68 126.64 9.73 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 110.847 -2.888 . . . . 43.68 107.141 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -56.78 -18.27 12.1 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 114.136 1.162 . . . . 55.57 114.136 -176.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -56.75 -49.02 76.49 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 114.238 1.199 . . . . 44.94 114.238 167.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1234 ' ' PHE . . . . . 0.441 ' CE2' HG23 ' A' 1196 ' ' THR . 19.5 t80 -63.07 -56.6 15.49 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 124.835 1.254 . . . . 42.04 108.151 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1235 ' ' ILE . . . . . 0.415 ' O ' ' HG2' ' A' 1239 ' ' MET . 93.0 mt -51.72 -45.32 37.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 114.532 -1.213 . . . . 46.28 110.173 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1236 ' ' LYS . . . . . 0.624 ' O ' ' HG3' ' A' 1240 ' ' GLU . 26.7 tttm -66.16 -39.9 90.12 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 115.69 -2.1 . . . . 47.87 111.791 175.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1237 ' ' ALA . . . . . 0.464 ' HB3' HD23 ' A' 1214 ' ' LEU . . . -64.08 -37.5 87.68 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-N 121.98 2.173 . . . . 41.61 112.629 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1238 ' ' GLU . . . . . 0.455 ' HG2' ' HZ ' ' A' 1194 ' ' PHE . 48.5 mt-10 -55.59 -56.87 15.24 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 106.524 -1.658 . . . . 50.65 106.524 170.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1239 ' ' MET . . . . . 0.415 ' HG2' ' O ' ' A' 1235 ' ' ILE . 97.7 mmm -50.0 -48.91 52.17 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.713 1.005 . . . . 48.87 113.713 178.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1240 ' ' GLU . . . . . 0.624 ' HG3' ' O ' ' A' 1236 ' ' LYS . 29.5 mt-10 -62.72 -40.17 96.36 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 119.462 -2.024 . . . . 54.8 110.749 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1241 ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.32 -46.56 79.81 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.455 0.702 . . . . 43.21 111.855 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -64.33 -47.34 79.77 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 106.659 -1.608 . . . . 38.66 106.659 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1243 ' ' ALA . . . . . . . . . . . . . . . -62.63 -32.9 74.02 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 122.761 1.267 . . . . 37.92 114.14 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1244 ' ' ALA . . . . . 0.45 ' O ' ' HE2' ' A' 1247 ' ' LYS . . . -70.02 -51.94 28.13 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.634 -0.876 . . . . 37.28 108.634 174.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -61.31 -29.05 69.64 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 113.593 0.96 . . . . 43.07 113.593 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1246 ' ' ALA . . . . . . . . . . . . . . . -51.1 -34.24 29.64 Favored 'General case' 0 C--O 1.248 1.01 0 C-N-CA 126.249 1.82 . . . . 38.3 112.612 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1247 ' ' LYS . . . . . 0.45 ' HE2' ' O ' ' A' 1244 ' ' ALA . 11.3 mtmm -57.7 -22.3 45.49 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 118.505 2.78 . . . . 47.6 118.505 174.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.78 -30.73 0.81 Allowed 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 117.383 2.364 . . . . 45.42 117.383 -171.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1249 ' ' VAL . . . . . . . . . . . . . 34.6 m -70.06 158.6 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 123.661 1.696 . . . . 36.26 111.386 -173.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1250 ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -103.04 -50.78 3.41 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 113.884 -1.507 . . . . 33.04 111.641 -172.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1251 ' ' ILE . . . . . 0.525 HD12 ' HB1' ' A' 1145 ' ' ALA . 51.7 mm -121.05 138.33 51.82 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 N-CA-C 103.938 -2.616 . . . . 31.4 103.938 -177.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1252 ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' 1169 ' ' MET . 39.5 mt -120.87 113.68 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 105.798 -1.927 . . . . 29.42 105.798 166.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 27.7 t -97.0 111.46 26.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 104.504 -2.406 . . . . 30.37 104.504 176.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1254 ' ' THR . . . . . 0.535 HG23 HD12 ' A' 1171 ' ' ILE . 0.2 OUTLIER -108.58 112.01 24.13 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 102.468 -3.16 . . . . 35.72 102.468 -173.532 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1255 ' ' THR . . . . . 0.522 HG22 HD12 ' A' 1284 ' ' LEU . 66.1 p -98.89 -27.55 13.85 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 120.004 3.335 . . . . 36.0 120.004 -159.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1256 ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' 1263 ' ' ALA . . . -71.19 82.31 0.72 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 118.579 2.807 . . . . 40.93 118.579 -140.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 52.9 tp -84.39 84.18 7.73 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 104.897 -2.26 . . . . 47.82 104.897 175.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 26.0 mm -70.26 131.14 88.77 Favored Pre-proline 0 N--CA 1.431 -1.417 0 CA-C-N 112.701 -2.045 . . . . 52.7 107.83 172.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -59.78 133.75 52.99 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.3 2.667 . . . . 54.13 111.144 176.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 76.64 -67.44 2.6 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 122.581 1.101 . . . . 54.62 115.418 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1261 ' ' LYS . . . . . 0.422 ' HA ' ' HD2' ' A' 1262 ' ' PRO . 85.3 mttt -80.8 129.05 69.58 Favored Pre-proline 0 C--O 1.24 0.575 0 N-CA-C 114.839 1.422 . . . . 55.74 114.839 -173.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1262 ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' 1261 ' ' LYS . 11.0 Cg_endo -46.0 134.02 14.58 Favored 'Trans proline' 0 N--CA 1.451 -0.976 1 C-N-CA 127.395 5.397 . . . . 51.15 112.14 167.396 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1263 ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' 1256 ' ' ALA . . . -64.94 131.88 95.32 Favored Pre-proline 0 C--O 1.246 0.881 0 CA-C-O 117.194 -1.384 . . . . 46.06 111.95 171.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -66.66 148.56 83.3 Favored 'Trans proline' 0 C--O 1.255 1.352 0 C-N-CA 123.379 2.719 . . . . 41.08 111.581 -177.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1265 ' ' LYS . . . . . 0.512 ' HD3' ' HA ' ' A' 1293 ' ' GLU . 61.8 mttm -85.75 79.09 9.42 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 124.356 2.026 . . . . 47.42 112.347 -175.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1266 ' ' LEU . . . . . 0.415 ' O ' ' SD ' ' A' 1239 ' ' MET . 93.5 mt -74.19 -59.01 2.92 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 110.737 -2.938 . . . . 39.22 113.125 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1267 ' ' ILE . . . . . . . . . . . . . 63.8 mt -75.29 112.43 12.83 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 CA-C-N 120.884 1.675 . . . . 42.5 107.801 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1268 ' ' THR . . . . . . . . . . . . . 1.1 p -76.92 163.04 27.11 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.005 -1.452 . . . . 37.84 113.202 -176.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1269 ' ' ARG . . . . . 0.476 ' HG3' ' HB2' ' A' 1293 ' ' GLU . 58.7 mtt-85 -62.5 -40.46 96.78 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-O 121.793 0.806 . . . . 54.8 112.836 172.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -50.38 -51.86 42.36 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 124.874 1.27 . . . . 54.36 113.1 167.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1271 ' ' MET . . . . . . . . . . . . . 30.0 ttm -60.43 -48.04 83.47 Favored 'General case' 0 C--O 1.253 1.249 0 C-N-CA 124.831 1.252 . . . . 39.52 112.136 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1272 ' ' VAL . . . . . . . . . . . . . 60.0 t -57.33 -50.02 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 C-N-CA 123.69 0.796 . . . . 38.25 111.895 176.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -54.05 -43.89 70.61 Favored 'General case' 0 C--O 1.262 1.761 0 O-C-N 119.666 -1.896 . . . . 40.77 114.432 171.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1274 ' ' SER . . . . . . . . . . . . . 10.5 p -73.02 3.18 5.69 Favored 'General case' 0 CA--C 1.556 1.203 0 O-C-N 120.219 -1.55 . . . . 36.58 113.646 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1275 ' ' MET . . . . . 0.629 ' HB3' HG21 ' A' 1307 ' ' VAL . 0.3 OUTLIER -78.63 151.65 32.19 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 118.641 -2.537 . . . . 36.75 108.245 -179.071 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1276 ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -66.4 142.0 57.75 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.056 1.742 . . . . 46.11 113.007 177.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1277 ' ' ALA . . . . . . . . . . . . . . . -72.69 153.06 41.37 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 115.327 1.603 . . . . 33.52 115.327 -169.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 80.02 37.66 21.41 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 108.694 -1.762 . . . . 31.27 108.694 174.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1279 ' ' SER . . . . . . . . . . . . . 19.7 m -139.56 163.27 32.99 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 119.27 1.535 . . . . 32.95 111.065 -160.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1280 ' ' VAL . . . . . 0.629 HG22 ' HB2' ' A' 1308 ' ' LYS . 92.7 t -123.78 148.78 27.76 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 O-C-N 118.496 -2.628 . . . . 27.43 111.175 -173.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1281 ' ' ILE . . . . . 0.406 HG12 ' HB ' ' A' 1252 ' ' ILE . 60.9 mt -121.83 112.18 33.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 103.872 -2.64 . . . . 30.3 103.872 164.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 4.1 t -98.5 134.59 36.55 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 104.984 -2.228 . . . . 28.63 104.984 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1283 ' ' ASP . . . . . . . . . . . . . 6.1 t0 -111.55 121.32 44.86 Favored 'General case' 0 C--O 1.254 1.32 0 CA-C-N 114.692 -1.14 . . . . 36.27 108.956 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1284 ' ' LEU . . . . . 0.839 HD21 ' HB2' ' A' 1141 ' ' ALA . 72.4 mt -105.96 14.5 27.86 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.678 -0.692 . . . . 38.57 109.814 -175.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1285 ' ' ALA . . . . . 0.459 ' HB3' ' HA2' ' A' 1290 ' ' GLY . . . -104.95 -40.3 5.97 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 122.862 1.315 . . . . 37.56 109.015 169.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1286 ' ' ALA . . . . . 0.471 ' HA ' HG21 ' A' 1295 ' ' THR . . . 49.32 -81.0 0.01 OUTLIER 'General case' 0 C--O 1.263 1.809 0 N-CA-C 117.992 2.59 . . . . 40.33 117.992 173.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -76.61 -36.13 57.66 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 123.938 0.895 . . . . 56.85 111.865 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 52.4 t30 -80.13 77.98 6.81 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 104.802 -2.296 . . . . 45.86 104.802 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 72.16 -72.51 0.93 Allowed Glycine 0 CA--C 1.5 -0.854 0 N-CA-C 109.444 -1.462 . . . . 40.31 109.444 -176.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1290 ' ' GLY . . . . . 0.459 ' HA2' ' HB3' ' A' 1285 ' ' ALA . . . 87.16 117.32 1.13 Allowed Glycine 0 C--O 1.22 -0.722 0 N-CA-C 106.755 -2.538 . . . . 38.89 106.755 -175.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1291 ' ' ASN . . . . . 0.457 ' ND2' ' HB1' ' A' 1263 ' ' ALA . 12.4 m120 -65.46 -16.78 63.99 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 115.633 1.716 . . . . 37.23 115.633 -172.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1292 ' ' CYS . . . . . . . . . . . . . 36.0 t -103.34 157.08 17.27 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 119.45 1.023 . . . . 36.5 109.497 173.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1293 ' ' GLU . . . . . 0.512 ' HA ' ' HD3' ' A' 1265 ' ' LYS . 57.0 mt-10 -82.53 -9.17 59.52 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 115.331 1.604 . . . . 43.32 115.331 173.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -96.38 9.02 42.54 Favored 'General case' 0 C--O 1.244 0.778 0 O-C-N 117.55 -3.219 . . . . 41.32 111.699 172.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1295 ' ' THR . . . . . 0.483 HG23 ' HA3' ' A' 1311 ' ' GLY . 85.3 m -75.61 98.8 4.12 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.871 0.843 . . . . 35.3 111.072 -173.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1296 ' ' VAL . . . . . 0.819 ' HB ' ' HB2' ' A' 1299 ' ' GLU . 2.3 t -81.94 128.25 69.12 Favored Pre-proline 0 C--O 1.251 1.166 0 N-CA-C 102.622 -3.103 . . . . 34.84 102.622 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -51.42 105.34 0.11 Allowed 'Trans proline' 0 C--O 1.251 1.137 0 C-N-CA 124.773 3.649 . . . . 33.51 113.04 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1298 ' ' GLY . . . . . 0.482 ' HA2' ' H ' ' A' 1313 ' ' THR . . . 76.98 23.43 69.12 Favored Glycine 0 CA--C 1.504 -0.635 0 CA-C-N 113.328 -1.76 . . . . 32.19 113.937 175.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1299 ' ' GLU . . . . . 0.819 ' HB2' ' HB ' ' A' 1296 ' ' VAL . 45.5 mt-10 -131.6 170.58 14.56 Favored 'General case' 0 C--O 1.246 0.916 0 CA-C-N 118.86 1.33 . . . . 34.88 112.905 -175.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1300 ' ' ILE . . . . . 0.586 HG12 HG12 ' A' 1310 ' ' ILE . 43.3 mt -108.58 121.84 62.23 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.198 0 N-CA-C 106.044 -1.835 . . . . 32.29 106.044 169.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 16.0 t80 -97.96 126.5 43.4 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 103.624 -2.732 . . . . 37.25 103.624 169.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1302 ' ' THR . . . . . . . . . . . . . 8.2 m -106.41 123.91 48.8 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 119.735 1.152 . . . . 35.56 108.628 174.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1303 ' ' THR . . . . . . . . . . . . . 2.6 p -86.7 165.17 16.3 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 118.37 -0.824 . . . . 36.4 113.191 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -53.96 -41.1 67.44 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 121.254 1.843 . . . . 52.32 115.704 -176.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1305 ' ' ASN . . . . . 0.532 ' HA ' ' HB2' ' B' 1046 ' ' ASP . 53.2 p-10 -62.18 -24.05 66.97 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.369 -1.287 . . . . 40.04 111.741 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 98.23 44.51 2.56 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.294 -1.122 . . . . 36.96 110.294 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1307 ' ' VAL . . . . . 0.629 HG21 ' HB3' ' A' 1275 ' ' MET . 59.7 t -107.08 120.11 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 123.617 1.675 . . . . 33.4 108.584 168.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1308 ' ' LYS . . . . . 0.629 ' HB2' HG22 ' A' 1280 ' ' VAL . 61.2 mmtt -87.3 102.78 14.83 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 110.541 -3.027 . . . . 42.91 106.986 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 39.3 t -88.98 95.22 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.676 0 O-C-N 119.469 -2.019 . . . . 32.29 108.212 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1310 ' ' ILE . . . . . 0.666 HD11 ' HB2' ' A' 1148 ' ' GLU . 91.1 mt -89.54 95.17 5.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 O-C-N 120.76 -1.212 . . . . 30.99 110.093 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1311 ' ' GLY . . . . . 0.483 ' HA3' HG23 ' A' 1295 ' ' THR . . . -97.33 57.9 1.17 Allowed Glycine 0 N--CA 1.441 -1.012 0 O-C-N 120.483 -1.386 . . . . 28.95 113.798 178.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1312 ' ' TYR . . . . . . . . . . . . . 7.0 m-30 -77.36 131.82 38.26 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 122.914 1.34 . . . . 31.69 113.374 -169.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1313 ' ' THR . . . . . 0.482 ' H ' ' HA2' ' A' 1298 ' ' GLY . 8.8 p -86.6 -49.79 7.28 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 120.965 -1.084 . . . . 34.17 110.596 174.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -72.29 14.27 0.25 Allowed 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 117.367 2.358 . . . . 36.86 117.367 -167.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1315 ' ' LEU . . . . . . . . . . . . . 28.5 mt -51.04 -39.45 56.12 Favored Pre-proline 0 C--N 1.347 0.495 0 O-C-N 119.827 -1.796 . . . . 34.85 114.256 -173.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1316 ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.74 -43.98 40.02 Favored 'Trans proline' 0 C--O 1.257 1.431 0 CA-C-N 124.408 2.61 . . . . 29.15 113.207 170.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -58.25 -45.12 94.55 Favored Glycine 0 CA--C 1.543 1.807 0 N-CA-C 109.124 -1.59 . . . . 27.29 109.124 174.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1318 ' ' ARG . . . . . 0.435 ' HB3' ' NH2' ' A' 1140 ' ' ARG . 90.2 mtt-85 -58.35 -23.38 56.6 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 116.47 2.026 . . . . 41.49 116.47 177.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1319 ' ' LEU . . . . . 0.744 HD23 HG23 ' A' 1136 ' ' ILE . 12.3 tp -123.07 67.27 32.9 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 104.018 -2.586 . . . . 27.61 104.018 175.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1320 ' ' PRO . . . . . 0.57 ' HB3' ' HB ' ' A' 1014 ' ' THR . 64.9 Cg_endo -58.14 -53.05 4.67 Favored 'Trans proline' 0 C--O 1.257 1.456 1 C-N-CA 125.396 4.064 . . . . 25.94 114.67 -163.243 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1321 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.86 -39.79 91.05 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 109.868 -0.419 . . . . 25.01 109.868 -173.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1322 ' ' GLN . . . . . 0.699 ' HB2' ' HA ' ' B' 1151 ' ' ARG . 24.1 tp60 -64.83 -43.82 91.84 Favored 'General case' 0 CA--C 1.51 -0.563 0 O-C-N 123.968 0.792 . . . . 29.39 109.78 -175.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1323 ' ' SER . . . . . . . . . . . . . 49.6 m -58.47 -53.52 57.41 Favored 'General case' 0 CA--C 1.486 -1.514 0 CA-C-N 114.16 -1.382 . . . . 26.47 113.166 173.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1324 ' ' SER . . . . . 0.477 ' HB2' HG23 ' A' 1019 ' ' THR . 5.0 m -65.01 -29.37 70.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.324 -0.86 . . . . 27.78 110.002 -178.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1325 ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -68.81 -59.66 2.93 Favored 'General case' 0 C--N 1.348 0.519 0 O-C-N 121.653 -0.654 . . . . 37.53 110.783 172.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1326 ' ' LEU . . . . . 0.506 HD12 HD11 ' A' 1136 ' ' ILE . 59.5 mt -72.29 -51.79 19.23 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 115.838 -2.03 . . . . 35.71 111.102 -170.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1327 ' ' TYR . . . . . 0.434 ' HE2' ' HA ' ' A' 1072 ' ' VAL . 7.3 t80 -48.83 -48.26 41.84 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 121.364 1.893 . . . . 31.59 110.96 170.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1328 ' ' GLY . . . . . 0.509 ' O ' HG23 ' A' 1332 ' ' VAL . . . -47.46 -52.52 14.06 Favored Glycine 0 N--CA 1.465 0.61 0 C-N-CA 124.229 0.918 . . . . 28.0 112.49 170.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1329 ' ' THR . . . . . 0.654 ' HB ' ' HB1' ' B' 1160 ' ' ALA . 77.2 m -70.4 -34.81 72.97 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 120.344 -1.68 . . . . 32.15 110.188 -173.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1330 ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' 1127 ' ' LEU . 29.4 m120 -64.65 -43.6 93.13 Favored 'General case' 0 C--O 1.21 -0.997 0 C-N-CA 119.521 -0.871 . . . . 34.36 111.28 173.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1331 ' ' LEU . . . . . 0.591 HD22 HD22 ' A' 1070 ' ' LEU . 80.6 mt -53.09 -44.83 67.88 Favored 'General case' 0 C--O 1.219 -0.534 0 O-C-N 124.71 1.256 . . . . 33.37 111.527 173.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1332 ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' 1328 ' ' GLY . 6.8 t -70.62 -37.12 68.37 Favored 'Isoleucine or valine' 0 C--O 1.245 0.842 0 CA-C-N 114.849 -1.069 . . . . 35.27 110.125 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1333 ' ' ASN . . . . . 0.629 ' HA ' ' HD2' ' A' 1336 ' ' LYS . 76.9 m-20 -69.89 -28.69 65.84 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 121.414 0.626 . . . . 37.66 111.227 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1334 ' ' LEU . . . . . 0.648 HD21 ' SD ' ' A' 1113 ' ' MET . 0.4 OUTLIER -71.52 -51.99 20.62 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 108.805 -0.813 . . . . 40.27 108.805 171.331 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1335 ' ' LEU . . . . . 0.484 HD11 HD21 ' A' 1070 ' ' LEU . 37.1 mt -68.41 -5.91 21.7 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 115.564 1.69 . . . . 42.5 115.564 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1336 ' ' LYS . . . . . 0.629 ' HD2' ' HA ' ' A' 1333 ' ' ASN . 74.8 mttt -66.96 -35.75 80.68 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 119.85 -1.781 . . . . 47.81 111.823 162.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1337 ' ' LEU . . . . . 0.472 ' O ' ' HG3' ' A' 1340 ' ' LYS . 4.8 mp -78.08 -46.74 19.99 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 120.9 -1.125 . . . . 49.27 109.995 169.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1338 ' ' LEU . . . . . 0.466 ' HB2' ' HA ' ' A' 1335 ' ' LEU . 6.0 mp -76.81 16.96 0.46 Allowed 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 115.786 1.773 . . . . 50.54 115.786 176.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1339 ' ' CYS . . . . . . . . . . . . . 36.5 t -156.98 80.34 0.92 Allowed 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 126.042 2.829 . . . . 53.67 104.768 164.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1340 ' ' LYS . . . . . 0.604 ' HD2' HG21 ' A' 1347 ' ' THR . 82.6 mttt -79.08 -40.66 30.61 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 113.431 -1.713 . . . . 63.38 111.139 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -69.69 -51.26 36.1 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 113.706 1.002 . . . . 70.95 113.706 -166.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1342 ' ' LYS . . . . . 0.502 ' HE3' HD23 ' A' 1029 ' ' LEU . 36.3 mtpt 52.77 67.08 1.05 Allowed 'General case' 0 C--O 1.239 0.535 0 N-CA-C 117.499 2.407 . . . . 65.25 117.499 171.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1343 ' ' ASP . . . . . . . . . . . . 0.262 7.8 t70 59.82 -94.19 0.05 OUTLIER 'General case' 0 CA--C 1.502 -0.869 2 O-C-N 110.915 -7.365 . . . . 64.53 117.847 4.486 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A 1344 ' ' GLY . . . . . . . . . . . . . . . 117.86 70.15 0.38 Allowed Glycine 0 C--N 1.348 1.212 0 N-CA-C 107.764 -2.134 . . . . 59.72 107.764 172.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -167.78 149.56 5.52 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 113.683 -1.259 . . . . 64.09 108.12 -177.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1346 ' ' ILE . . . . . 0.442 HG23 HD11 ' A' 1068 ' ' ILE . 8.4 pt -55.38 125.22 10.03 Favored 'Isoleucine or valine' 0 C--O 1.247 0.95 0 N-CA-C 115.211 1.56 . . . . 58.82 115.211 178.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1347 ' ' THR . . . . . 0.604 HG21 ' HD2' ' A' 1340 ' ' LYS . 7.8 m -97.91 100.12 11.45 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 103.309 -2.848 . . . . 54.96 103.309 163.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1348 ' ' VAL . . . . . . . . . . . . . 15.1 t -90.87 113.08 26.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 106.663 -1.606 . . . . 55.64 106.663 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 27.9 t70 -112.55 145.22 40.69 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 122.194 0.997 . . . . 61.45 110.094 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1350 ' ' PHE . . . . . . . . . . . . . 60.2 t80 -116.23 4.19 13.51 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.509 1.124 . . . . 58.63 109.238 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.77 -62.71 1.25 Allowed 'General case' 0 N--CA 1.477 0.893 0 O-C-N 119.723 -1.861 . . . . 62.06 110.469 -169.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 7.3 t70 -69.83 143.95 52.73 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 114.571 1.322 . . . . 54.07 114.571 -170.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 20.3 m -65.49 -29.73 48.01 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 CA-C-N 119.541 1.064 . . . . 50.68 111.114 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1354 ' ' VAL . . . . . . . . . . . . . 4.3 m -76.53 -17.26 14.97 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 O-C-N 120.284 -1.51 . . . . 47.68 110.404 -176.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1355 ' ' ILE . . . . . 0.406 HG23 HD11 ' A' 1338 ' ' LEU . 74.8 mt -100.34 -69.79 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.867 0 N-CA-C 106.636 -1.616 . . . . 48.49 106.636 171.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 40.4 tpt85 -55.73 -31.99 62.98 Favored 'General case' 0 C--N 1.349 0.548 0 O-C-N 120.653 -1.28 . . . . 48.27 114.286 -175.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -62.27 -46.18 94.45 Favored Glycine 0 CA--C 1.525 0.662 0 O-C-N 120.025 -1.672 . . . . 43.53 111.749 171.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1358 ' ' VAL . . . . . . . . . . . . . 42.4 t -72.18 -35.27 52.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 122.042 0.925 . . . . 45.12 111.025 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1359 ' ' THR . . . . . . . . . . . . . 25.6 m -69.07 88.43 0.41 Allowed 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 122.817 1.294 . . . . 42.94 109.162 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 16.1 m -76.83 -22.82 14.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-O 122.317 1.056 . . . . 43.26 113.122 176.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1361 ' ' ILE . . . . . 0.57 ' HB ' ' HB ' ' A' 1112 ' ' VAL . 30.5 mt -133.29 135.52 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 103.563 -2.754 . . . . 45.66 103.563 169.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1362 ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -117.68 113.11 21.4 Favored 'General case' 0 C--O 1.252 1.228 0 N-CA-C 104.879 -2.267 . . . . 61.34 104.879 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 26.53 73.6 0.03 OUTLIER 'General case' 0 C--O 1.231 0.115 0 C-N-CA 127.047 2.139 . . . . 49.76 113.186 -166.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 88.9 -38.1 3.24 Favored Glycine 0 CA--C 1.529 0.911 0 O-C-N 119.902 -1.749 . . . . 50.0 112.443 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -74.46 124.0 25.75 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 119.416 1.608 . . . . 56.92 109.168 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1366 ' ' ILE . . . . . 0.463 HG22 ' HB3' ' A' 1368 ' ' TRP . 10.2 mt -77.13 86.3 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.256 1.401 0 CA-C-O 123.07 1.414 . . . . 52.78 111.748 -178.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1367 ' ' THR . . . . . . . . . . . . . 16.6 p -70.95 -11.88 61.22 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 111.728 -2.487 . . . . 49.44 114.624 -174.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1368 ' ' TRP . . . . . 0.463 ' HB3' HG22 ' A' 1366 ' ' ILE . 26.3 t90 -47.44 133.81 10.05 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 127.362 2.265 . . . . 52.38 110.157 170.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1369 ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -81.79 -166.61 5.19 Favored 'Cis proline' 0 C--O 1.238 0.497 0 N-CA-C 117.443 2.055 . . . . 46.94 117.443 4.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -73.63 140.69 78.65 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 117.113 -1.422 . . . . 45.91 110.925 164.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1371 ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -70.43 139.74 38.58 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.691 2.927 . . . . 46.39 107.052 164.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1372 ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -65.64 -35.86 35.69 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.778 2.319 . . . . 46.72 117.073 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.235 -4.412 0 CA-C-N 120.726 1.603 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 998' ' ' HIS . . . . . . . . . . . . . 7.1 m80 . . . . . 0 N--CA 1.438 -1.043 0 N-CA-C 104.143 -2.54 . . . . 63.44 104.143 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -106.14 65.49 0.69 Allowed 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 102.939 -2.985 . . . . 51.74 102.939 159.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1000 ' ' HIS . . . . . 0.478 ' HA ' ' CG ' ' B' 1067 ' ' GLU . 5.3 t-80 -76.1 128.03 34.16 Favored 'General case' 0 C--N 1.36 1.054 0 O-C-N 120.584 -1.322 . . . . 54.07 109.986 -173.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1001 ' ' GLY . . . . . 0.486 ' H ' ' HG3' ' B' 1067 ' ' GLU . . . 86.23 -6.47 81.6 Favored Glycine 0 C--O 1.218 -0.885 0 CA-C-O 121.656 0.587 . . . . 39.22 113.696 -169.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1002 ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -93.12 138.85 31.18 Favored 'General case' 0 C--O 1.252 1.185 0 CA-C-O 124.854 2.264 . . . . 38.12 109.482 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1003 ' ' ILE . . . . . 0.415 HG12 ' HB ' ' B' 1068 ' ' ILE . 49.0 mt -98.25 141.63 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 110.835 -2.893 . . . . 29.7 105.201 169.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1004 ' ' GLY . . . . . 0.421 ' CA ' HG22 ' B' 1063 ' ' VAL . . . -111.0 123.79 6.67 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 108.659 -1.776 . . . . 27.5 108.659 172.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1005 ' ' ILE . . . . . . . . . . . . . 41.1 mm -109.8 111.77 58.64 Favored Pre-proline 0 N--CA 1.447 -0.582 0 N-CA-C 106.515 -1.661 . . . . 24.83 106.515 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -74.7 156.36 44.36 Favored 'Trans proline' 0 N--CA 1.44 -1.626 0 C-N-CA 123.473 2.782 . . . . 27.19 115.944 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1007 ' ' ARG . . . . . 0.553 ' NH1' ' HA3' ' B' 1038 ' ' GLY . 37.3 ttt180 -79.0 96.65 5.82 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 118.782 -2.449 . . . . 41.46 106.468 162.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1008 ' ' GLU . . . . . 0.57 ' HG3' ' HB ' ' B' 1072 ' ' VAL . 2.8 mm-40 -51.94 151.5 3.55 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 118.734 2.864 . . . . 26.93 118.734 -170.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1009 ' ' ARG . . . . . . . . . . . . . 45.1 mmm-85 -92.97 -20.72 20.32 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 112.528 -2.124 . . . . 34.48 115.535 -164.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1010 ' ' LEU . . . . . 0.545 ' HB3' ' HB2' ' B' 1013 ' ' GLU . 4.7 tp -67.74 160.21 28.59 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 119.386 0.994 . . . . 44.22 113.678 -173.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1011 ' ' THR . . . . . 0.49 HG22 HD22 ' B' 1012 ' ' ASN . 63.3 m -68.25 132.61 47.44 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 106.018 -1.845 . . . . 40.74 106.018 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1012 ' ' ASN . . . . . 0.49 HD22 HG22 ' B' 1011 ' ' THR . 27.0 m-80 62.22 22.22 13.01 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 113.984 -1.462 . . . . 44.44 112.119 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1013 ' ' GLU . . . . . 0.545 ' HB2' ' HB3' ' B' 1010 ' ' LEU . 4.7 tp10 -78.1 118.7 20.6 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 117.748 -1.581 . . . . 29.87 111.85 -173.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1014 ' ' THR . . . . . . . . . . . . . 1.6 p -105.17 -9.62 17.63 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 111.514 -2.585 . . . . 25.26 112.413 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1015 ' ' ARG . . . . . 0.501 ' HD3' ' SD ' ' B' 1133 ' ' MET . 77.4 mtm180 -77.01 110.3 11.53 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 123.546 1.641 . . . . 29.54 113.188 -176.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1016 ' ' VAL . . . . . 0.431 HG12 ' HB2' ' B' 1043 ' ' ALA . 7.2 p -87.69 120.54 36.98 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 N-CA-C 104.153 -2.536 . . . . 23.55 104.153 164.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1017 ' ' ALA . . . . . . . . . . . . . . . -62.71 -5.96 3.18 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 116.29 1.959 . . . . 23.59 116.29 -177.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1018 ' ' ALA . . . . . . . . . . . . . . . -150.34 111.95 4.48 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 123.996 1.855 . . . . 24.93 107.059 170.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1019 ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.43 164.38 40.81 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 115.14 -2.362 . . . . 28.09 111.696 172.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1020 ' ' PRO . . . . . . . . . . . . . 0.7 OUTLIER -38.93 -46.35 2.74 Favored 'Trans proline' 0 C--N 1.362 1.245 1 C-N-CA 125.669 4.246 . . . . 28.79 117.717 -176.528 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 77.3 tttt -63.67 -49.21 74.09 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 120.086 1.312 . . . . 47.28 107.743 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1022 ' ' THR . . . . . . . . . . . . . 39.0 m -61.39 -34.98 76.26 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 114.001 1.111 . . . . 30.12 114.001 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1023 ' ' VAL . . . . . . . . . . . . . 75.4 t -51.11 -52.96 16.44 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 CA-C-N 121.239 1.836 . . . . 32.24 110.381 167.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1024 ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' B' 1028 ' ' LYS . 45.6 mt-10 -64.04 -37.1 86.2 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 113.973 1.101 . . . . 49.62 113.973 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1025 ' ' GLN . . . . . 0.473 ' O ' ' HG ' ' B' 1029 ' ' LEU . 39.2 mt-30 -56.5 -46.4 80.55 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 114.373 -1.285 . . . . 44.68 109.871 177.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1026 ' ' LEU . . . . . . . . . . . . . 14.4 mt -72.49 -35.86 68.26 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 114.341 1.238 . . . . 35.71 114.341 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1027 ' ' LEU . . . . . . . . . . . . . 75.8 mt -63.51 -41.51 98.51 Favored 'General case' 0 C--N 1.346 0.436 0 N-CA-C 109.896 -0.409 . . . . 42.18 109.896 176.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1028 ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' B' 1024 ' ' GLU . 55.1 mttm -57.96 -40.87 81.66 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 115.897 1.814 . . . . 48.34 115.897 169.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1029 ' ' LEU . . . . . 0.518 HD11 HG13 ' B' 1332 ' ' VAL . 65.4 mt -69.67 -10.51 58.57 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 121.442 -0.787 . . . . 38.69 110.719 173.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 106.12 3.51 38.81 Favored Glycine 0 C--N 1.321 -0.294 0 O-C-N 119.861 -1.774 . . . . 32.28 112.407 166.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1031 ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -90.77 158.61 16.76 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 119.957 -1.908 . . . . 35.94 108.879 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1032 ' ' THR . . . . . . . . . . . . . 5.9 m -101.06 137.33 39.56 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 103.834 -2.654 . . . . 33.37 103.834 172.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1033 ' ' VAL . . . . . . . . . . . . . 5.1 t -107.88 137.65 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 0 O-C-N 118.222 -2.799 . . . . 29.98 106.701 -172.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -128.21 131.62 48.84 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.243 -1.391 . . . . 28.18 107.243 168.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1035 ' ' VAL . . . . . 0.423 ' HB ' HD13 ' B' 1057 ' ' ILE . 87.5 t -115.79 137.34 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.286 0 CA-C-N 113.225 -1.807 . . . . 25.82 110.216 177.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1036 ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -74.13 125.98 29.55 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 107.425 -1.324 . . . . 32.44 107.425 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1037 ' ' SER . . . . . . . . . . . . . 2.8 t -58.08 121.89 11.73 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 124.313 2.006 . . . . 29.54 113.309 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1038 ' ' GLY . . . . . 0.553 ' HA3' ' NH1' ' B' 1007 ' ' ARG . . . 119.45 -26.72 7.22 Favored Glycine 0 C--O 1.259 1.678 0 CA-C-N 113.187 -1.824 . . . . 27.76 109.413 -175.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1039 ' ' ALA . . . . . . . . . . . . . . . -59.43 -32.21 69.99 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.243 1.02 . . . . 26.02 113.057 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -57.99 -51.63 57.15 Favored Glycine 0 N--CA 1.466 0.686 0 CA-C-N 113.148 -1.842 . . . . 26.47 111.918 165.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -59.46 -30.19 68.34 Favored 'General case' 0 C--O 1.251 1.149 0 CA-C-N 118.254 1.027 . . . . 50.98 112.272 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1042 ' ' LEU . . . . . . . . . . . . . 75.2 mt -64.65 -58.01 7.47 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-N 115.784 -0.644 . . . . 29.3 110.598 167.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1043 ' ' ALA . . . . . 0.431 ' HB2' HG12 ' B' 1016 ' ' VAL . . . -74.66 14.73 0.44 Allowed 'General case' 0 C--O 1.215 -0.737 0 O-C-N 119.776 -1.828 . . . . 26.74 112.611 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1044 ' ' SER . . . . . . . . . . . . . 72.7 m 63.61 49.3 3.08 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 127.321 3.439 . . . . 31.26 112.646 174.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1045 ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.59 155.25 44.22 Favored 'General case' 0 N--CA 1.432 -1.352 0 O-C-N 119.314 -2.116 . . . . 33.26 107.056 -168.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1046 ' ' ASP . . . . . 0.532 ' HB2' ' HA ' ' A' 1305 ' ' ASN . 14.2 t70 -82.88 127.32 33.39 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 107.385 -1.339 . . . . 46.74 107.385 168.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1047 ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -57.45 -32.32 66.81 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 124.439 1.096 . . . . 34.44 112.47 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1048 ' ' LYS . . . . . 0.572 ' H ' ' HD3' ' B' 1048 ' ' LYS . 0.0 OUTLIER -68.67 -14.28 62.92 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 121.024 -1.048 . . . . 48.67 111.316 178.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -68.32 -28.9 67.56 Favored 'General case' 0 C--O 1.216 -0.662 0 O-C-N 120.241 -1.537 . . . . 35.26 110.851 169.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1050 ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -69.47 -31.14 69.25 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 108.142 -1.059 . . . . 32.17 108.142 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 83.9 t -70.16 -41.55 78.95 Favored 'Isoleucine or valine' 0 C--O 1.25 1.123 0 N-CA-C 106.305 -1.739 . . . . 38.37 106.305 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -60.49 -29.59 69.17 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 123.133 1.444 . . . . 45.77 110.118 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1053 ' ' ALA . . . . . 0.405 ' HB1' ' HG3' ' B' 1024 ' ' GLU . . . -77.48 -40.17 43.92 Favored 'General case' 0 CA--C 1.5 -0.957 0 O-C-N 120.421 -1.425 . . . . 37.83 112.905 168.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 137.03 18.89 0.64 Allowed Glycine 0 C--N 1.334 0.468 0 O-C-N 120.178 -1.576 . . . . 35.82 113.834 172.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -88.93 144.32 26.26 Favored 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 120.512 2.156 . . . . 33.77 112.724 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -73.83 124.6 26.4 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 103.844 -2.65 . . . . 51.02 103.844 168.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1057 ' ' ILE . . . . . 0.423 HD13 ' HB ' ' B' 1035 ' ' VAL . 39.0 mm -89.42 116.75 31.45 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 O-C-N 120.155 -1.591 . . . . 38.47 107.752 168.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 2.8 m -112.56 139.37 37.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 O-C-N 125.785 1.928 . . . . 39.4 106.345 174.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -100.65 100.54 11.26 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 123.729 0.812 . . . . 57.07 110.012 -172.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1060 ' ' GLY . . . . . . . . . . . . . . . 102.78 -178.95 26.27 Favored Glycine 0 C--O 1.248 0.983 0 CA-C-O 123.005 1.336 . . . . 44.83 112.353 -175.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1061 ' ' ASN . . . . . . . . . . . . . 30.2 m120 -64.47 2.59 0.6 Allowed 'General case' 0 C--O 1.239 0.523 0 N-CA-C 118.229 2.677 . . . . 46.27 118.229 -168.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1062 ' ' SER . . . . . . . . . . . . . 13.3 m -41.07 -40.77 1.55 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 127.75 2.42 . . . . 43.47 107.325 156.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1063 ' ' VAL . . . . . 0.421 HG22 ' CA ' ' B' 1004 ' ' GLY . 0.3 OUTLIER -52.62 -30.34 14.77 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 O-C-N 119.125 -2.235 . . . . 36.98 114.566 176.051 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 52.1 m95 -76.41 -22.08 55.19 Favored 'General case' 0 N--CA 1.439 -0.99 0 O-C-N 120.867 -1.145 . . . . 37.9 110.68 -174.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1065 ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -85.65 84.46 7.58 Favored 'General case' 0 C--O 1.205 -1.283 0 N-CA-C 103.482 -2.785 . . . . 46.19 103.482 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1066 ' ' SER . . . . . . . . . . . . . 56.6 m -151.08 173.41 14.39 Favored 'General case' 0 C--O 1.261 1.685 0 C-N-CA 126.117 1.767 . . . . 37.06 107.523 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1067 ' ' GLU . . . . . 0.676 ' HB2' HD12 ' B' 1068 ' ' ILE . 70.9 mm-40 -82.61 -40.55 20.65 Favored 'General case' 0 N--CA 1.433 -1.298 0 O-C-N 120.428 -1.42 . . . . 43.95 111.512 174.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1068 ' ' ILE . . . . . 0.676 HD12 ' HB2' ' B' 1067 ' ' GLU . 1.2 mp -120.8 135.09 62.13 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 N-CA-C 103.777 -2.675 . . . . 33.5 103.777 -175.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1069 ' ' ILE . . . . . 0.483 HG22 ' HB2' ' B' 1071 ' ' LYS . 37.1 mm -120.21 116.06 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 101.208 -3.627 . . . . 30.57 101.208 172.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1070 ' ' LEU . . . . . 0.624 ' HB3' HD13 ' B' 1331 ' ' LEU . 30.1 mt -102.8 105.62 16.06 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 102.845 -3.02 . . . . 27.66 102.845 172.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1071 ' ' LYS . . . . . 0.483 ' HB2' HG22 ' B' 1069 ' ' ILE . 3.2 tmtm? -127.77 147.17 50.41 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 103.873 -2.64 . . . . 28.4 103.873 -168.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1072 ' ' VAL . . . . . 0.57 ' HB ' ' HG3' ' B' 1008 ' ' GLU . 25.5 t -81.4 -65.07 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.85 0 CA-C-O 117.723 -1.132 . . . . 23.18 112.201 -171.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1073 ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -106.45 -159.42 0.7 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 120.843 1.656 . . . . 25.47 111.817 -161.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -64.28 142.28 98.29 Favored Pre-proline 0 CA--C 1.517 -0.317 0 CA-C-N 120.691 1.587 . . . . 27.9 111.222 -177.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -70.94 118.71 5.84 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.024 3.149 . . . . 31.62 117.116 164.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 5.3 mp -74.48 170.75 15.07 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 124.652 2.168 . . . . 40.49 107.47 166.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 36.6 t70 -56.22 -39.26 72.22 Favored 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 125.222 1.409 . . . . 51.59 113.707 -175.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1078 ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -67.89 -39.12 83.69 Favored 'General case' 0 C--N 1.348 0.5 0 O-C-N 120.626 -1.296 . . . . 42.36 108.19 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1079 ' ' GLU . . . . . 0.661 ' HA ' HD12 ' B' 1082 ' ' LEU . 32.8 mt-10 -63.5 -45.54 90.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 123.501 1.619 . . . . 34.53 108.94 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1080 ' ' ILE . . . . . 0.646 HG22 ' HG3' ' B' 1108 ' ' ARG . 61.3 mt -60.67 -37.07 74.67 Favored 'Isoleucine or valine' 0 C--O 1.261 1.694 0 CA-C-N 113.354 -1.748 . . . . 33.25 110.959 176.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -74.13 -28.92 61.56 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 115.614 1.709 . . . . 36.47 115.614 172.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1082 ' ' LEU . . . . . 0.661 HD12 ' HA ' ' B' 1079 ' ' GLU . 23.3 mt -71.36 -28.26 63.93 Favored 'General case' 0 C--N 1.317 -0.821 0 O-C-N 119.933 -1.729 . . . . 37.76 110.644 173.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1083 ' ' LEU . . . . . 0.767 HD11 HD22 ' B' 1089 ' ' LEU . 28.7 mt -58.77 127.79 33.96 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 123.037 1.398 . . . . 37.43 111.997 171.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1084 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.38 133.55 42.17 Favored Pre-proline 0 C--O 1.243 0.759 0 CA-C-N 112.892 -1.958 . . . . 37.7 107.572 177.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -44.42 111.42 0.27 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 123.996 3.131 . . . . 35.51 113.68 169.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 130.2 -48.96 0.94 Allowed Glycine 0 C--N 1.31 -0.911 0 CA-C-N 110.954 -2.839 . . . . 33.87 109.645 175.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1087 ' ' THR . . . . . . . . . . . . . 72.5 m -43.74 126.84 4.82 Favored 'General case' 0 C--O 1.252 1.21 0 C-N-CA 126.051 1.74 . . . . 32.5 114.504 -165.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1088 ' ' THR . . . . . 0.432 ' HA ' ' O ' ' B' 1111 ' ' THR . 50.1 m -78.97 91.71 4.86 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-O 124.037 1.875 . . . . 30.22 109.843 -176.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1089 ' ' LEU . . . . . 0.767 HD22 HD11 ' B' 1083 ' ' LEU . 36.0 tp -76.15 137.39 40.04 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 113.112 -1.858 . . . . 27.24 111.084 170.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 56.7 t -133.95 112.12 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 103.589 -2.745 . . . . 25.39 103.589 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1091 ' ' SER . . . . . 0.405 ' OG ' ' HB3' ' B' 1071 ' ' LYS . 48.7 m -160.45 163.84 32.71 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 120.43 -1.419 . . . . 28.81 111.201 -171.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1092 ' ' PHE . . . . . 0.56 ' HD1' ' HB3' ' B' 1116 ' ' ASP . 84.5 m-85 -71.18 102.88 2.62 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.005 -1.059 . . . . 30.78 110.606 165.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1093 ' ' ILE . . . . . . . . . . . . . 29.7 mm -85.29 -45.21 17.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 120.261 1.391 . . . . 30.28 111.807 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1094 ' ' TRP . . . . . . . . . . . . . 93.1 m95 56.21 73.52 0.82 Allowed Pre-proline 0 C--O 1.244 0.809 0 O-C-N 125.091 1.495 . . . . 34.07 110.403 -157.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -55.28 -50.16 13.88 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 123.819 3.013 . . . . 38.66 115.951 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -64.67 -33.05 75.03 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-O 123.057 1.408 . . . . 41.32 110.096 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 8.4 mp0 -80.25 -17.58 51.8 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 116.711 -1.614 . . . . 51.66 110.378 175.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -142.46 59.89 9.33 Favored Pre-proline 0 N--CA 1.481 1.092 0 CA-C-N 122.588 2.449 . . . . 40.32 111.591 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1099 ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -59.55 -32.72 96.59 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 123.621 2.881 . . . . 41.56 112.955 177.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -63.46 -47.71 80.72 Favored 'General case' 0 C--O 1.206 -1.196 0 CA-C-O 123.001 1.381 . . . . 54.11 109.217 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1101 ' ' LEU . . . . . . . . . . . . . 5.1 tp -62.95 -45.71 91.18 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 113.313 -1.767 . . . . 37.88 108.547 -176.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1102 ' ' MET . . . . . . . . . . . . . 67.9 mmm -49.77 -51.31 40.2 Favored 'General case' 0 CA--C 1.498 -1.03 0 C-N-CA 124.122 0.969 . . . . 37.54 109.994 169.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1103 ' ' GLN . . . . . 0.468 HE21 ' HG3' ' B' 1107 ' ' GLU . 42.3 tp60 -62.83 -36.13 82.22 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 118.772 -1.171 . . . . 47.01 113.922 -177.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1104 ' ' LYS . . . . . . . . . . . . . 93.2 mttt -60.95 -45.8 93.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 120.139 -0.624 . . . . 48.68 112.352 173.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1105 ' ' LEU . . . . . 0.64 HD13 HG21 ' B' 1112 ' ' VAL . 73.9 mt -57.89 -43.35 86.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 124.839 2.257 . . . . 32.21 114.95 175.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -56.24 -55.59 31.45 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 112.089 -2.323 . . . . 33.73 111.717 172.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1107 ' ' GLU . . . . . 0.468 ' HG3' HE21 ' B' 1103 ' ' GLN . 45.9 mt-10 -65.51 -20.69 66.45 Favored 'General case' 0 C--N 1.359 1.01 0 O-C-N 118.811 -2.431 . . . . 51.47 114.159 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1108 ' ' ARG . . . . . 0.646 ' HG3' HG22 ' B' 1080 ' ' ILE . 26.4 mmm180 -82.96 -1.51 52.65 Favored 'General case' 0 C--N 1.348 0.543 0 N-CA-C 114.249 1.204 . . . . 43.9 114.249 170.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1109 ' ' ASN . . . . . . . . . . . . . 12.1 m-80 61.93 28.87 17.6 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 118.813 2.894 . . . . 44.82 118.813 171.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1110 ' ' VAL . . . . . 0.664 HG11 ' HB3' ' B' 1083 ' ' LEU . 30.0 m -89.77 170.04 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.28 0 CA-C-N 113.486 -1.688 . . . . 30.52 111.921 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1111 ' ' THR . . . . . 0.432 ' O ' ' HA ' ' B' 1088 ' ' THR . 59.1 m -111.21 119.02 37.55 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 104.417 -2.438 . . . . 27.12 104.417 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1112 ' ' VAL . . . . . 0.64 HG21 HD13 ' B' 1105 ' ' LEU . 34.3 t -119.15 126.5 75.41 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 CA-C-O 118.726 -0.654 . . . . 26.4 110.129 -171.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1113 ' ' MET . . . . . 0.53 ' HA ' ' O ' ' B' 1358 ' ' VAL . 0.9 OUTLIER -101.01 115.41 30.43 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 106.011 -1.848 . . . . 42.92 106.011 168.048 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B 1114 ' ' ALA . . . . . 0.452 ' HB3' ' HB2' ' B' 1117 ' ' SER . . . -85.91 104.11 15.26 Favored 'General case' 0 N--CA 1.426 -1.631 0 C-N-CA 119.118 -1.033 . . . . 24.15 109.909 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1115 ' ' MET . . . . . . . . . . . . . 44.2 mmm -59.35 -14.86 13.24 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 116.326 1.972 . . . . 29.95 116.326 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1116 ' ' ASP . . . . . 0.56 ' HB3' ' HD1' ' B' 1092 ' ' PHE . 7.5 p-10 -86.42 -37.95 17.85 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 108.246 -1.02 . . . . 34.53 108.246 172.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1117 ' ' SER . . . . . 0.452 ' HB2' ' HB3' ' B' 1114 ' ' ALA . 68.4 m -95.05 38.51 1.13 Allowed 'General case' 0 C--N 1.316 -0.863 0 O-C-N 118.605 -2.56 . . . . 33.49 110.066 -173.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1118 ' ' VAL . . . . . 0.648 HG12 ' HB1' ' B' 1124 ' ' ALA . 2.2 t -78.47 133.22 63.78 Favored Pre-proline 0 N--CA 1.468 0.453 0 N-CA-C 105.8 -1.926 . . . . 34.02 105.8 169.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -47.21 142.16 12.34 Favored 'Trans proline' 0 C--N 1.328 -0.507 1 C-N-CA 126.321 4.681 . . . . 38.28 115.224 -176.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1120 ' ' ARG . . . . . 0.477 HH12 ' CG ' ' B' 1128 ' ' ASP . 0.4 OUTLIER -81.58 56.62 3.04 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 114.226 1.195 . . . . 55.05 114.226 -175.528 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B 1121 ' ' ILE . . . . . 0.609 HD12 ' HB3' ' B' 1123 ' ' ARG . 13.1 pt -129.4 149.22 33.45 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 107.969 -1.123 . . . . 42.09 107.969 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1122 ' ' SER . . . . . . . . . . . . . 48.6 m -51.14 -32.48 23.16 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 116.894 2.183 . . . . 38.02 116.894 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1123 ' ' ARG . . . . . 0.609 ' HB3' HD12 ' B' 1121 ' ' ILE . 6.9 tpt180 -58.02 -39.05 77.37 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.642 1.577 . . . . 34.29 109.219 174.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1124 ' ' ALA . . . . . 0.648 ' HB1' HG12 ' B' 1118 ' ' VAL . . . -84.19 -30.82 25.48 Favored 'General case' 0 C--O 1.206 -1.191 0 O-C-N 121.241 -0.912 . . . . 32.35 111.419 175.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1125 ' ' GLN . . . . . 0.466 ' HA ' ' HB3' ' B' 1128 ' ' ASP . 13.9 mm100 -58.85 -26.84 64.57 Favored 'General case' 0 C--N 1.348 0.534 0 N-CA-C 118.304 2.705 . . . . 47.17 118.304 -165.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1126 ' ' SER . . . . . . . . . . . . . 1.4 p -72.04 -34.49 68.81 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 124.183 1.944 . . . . 31.71 110.805 173.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1127 ' ' LEU . . . . . 0.656 HD23 HD12 ' B' 1334 ' ' LEU . 2.5 mp -80.64 -30.84 36.6 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 113.304 -1.771 . . . . 37.0 110.363 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1128 ' ' ASP . . . . . 0.579 ' HA ' HG21 ' B' 1118 ' ' VAL . 10.1 t70 -62.74 123.43 18.42 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 114.554 1.316 . . . . 40.4 114.554 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1129 ' ' ALA . . . . . . . . . . . . . . . -70.12 -35.17 73.91 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 115.671 -0.695 . . . . 26.56 112.359 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 46.7 mt -57.48 -33.53 68.09 Favored 'General case' 0 CA--C 1.557 1.248 0 CA-C-O 115.635 -2.126 . . . . 30.89 111.751 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1131 ' ' SER . . . . . . . . . . . . . 59.7 p -57.15 -56.99 14.58 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 119.825 1.193 . . . . 29.84 113.047 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1132 ' ' SER . . . . . 0.414 ' HB3' ' HB3' ' B' 1326 ' ' LEU . 24.9 m -64.93 -39.29 93.28 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 126.121 2.138 . . . . 31.91 111.862 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1133 ' ' MET . . . . . 0.614 ' HB3' ' HB3' ' B' 1316 ' ' PRO . 36.4 mmt -69.73 -30.61 68.26 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 113.102 0.779 . . . . 25.9 113.102 178.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1134 ' ' ALA . . . . . . . . . . . . . . . -72.52 -39.04 67.89 Favored 'General case' 0 N--CA 1.415 -2.222 0 CA-C-N 114.447 -1.251 . . . . 26.62 107.95 174.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.85 -35.22 79.54 Favored 'General case' 0 C--O 1.215 -0.763 0 CA-C-N 119.506 1.048 . . . . 36.97 110.902 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1136 ' ' ILE . . . . . 0.428 HG21 ' O ' ' B' 1316 ' ' PRO . 39.5 mm -64.09 -53.67 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 102.457 -3.164 . . . . 32.11 102.457 174.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -55.25 -37.16 66.86 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 114.23 1.196 . . . . 24.14 114.23 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -71.64 -43.28 52.53 Favored Glycine 0 C--N 1.308 -1.018 0 CA-C-N 118.273 0.488 . . . . 25.13 114.291 178.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 34.6 t80 -71.01 -41.59 70.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 123.316 1.531 . . . . 32.73 112.535 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1140 ' ' ARG . . . . . 0.61 HH11 HD13 ' B' 1319 ' ' LEU . 13.2 tpt180 -67.98 -28.59 67.58 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 113.463 -1.699 . . . . 26.36 110.552 175.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1141 ' ' ALA . . . . . . . . . . . . . . . -58.95 -51.46 69.96 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 105.931 -1.877 . . . . 24.12 105.931 174.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 20.6 mm -59.03 -42.29 85.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-O 117.84 -1.076 . . . . 23.37 109.686 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1143 ' ' VAL . . . . . . . . . . . . . 76.4 t -58.97 -62.41 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 119.528 1.058 . . . . 24.96 113.454 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1144 ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -62.85 -35.58 80.43 Favored 'General case' 0 C--O 1.267 1.983 0 O-C-N 124.384 1.053 . . . . 32.07 110.258 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1145 ' ' ALA . . . . . 0.655 ' HB1' HD12 ' B' 1251 ' ' ILE . . . -54.65 -61.58 2.22 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.124 0.57 . . . . 24.87 112.085 167.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1146 ' ' ALA . . . . . 0.402 ' HB2' ' CE1' ' B' 1153 ' ' PHE . . . -58.85 -27.5 65.2 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 118.965 -2.334 . . . . 24.67 114.893 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 62.1 t60 -63.57 -45.87 88.51 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 114.374 -1.285 . . . . 28.58 109.973 170.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1148 ' ' GLU . . . . . 0.689 ' HB3' ' HD2' ' B' 1308 ' ' LYS . 71.5 mm-40 -100.59 4.89 43.76 Favored 'General case' 0 C--O 1.255 1.343 0 N-CA-C 114.628 1.344 . . . . 36.82 114.628 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1149 ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' B' 1145 ' ' ALA . 1.4 t80 -76.45 146.09 38.83 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 123.719 1.723 . . . . 31.97 108.099 -174.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1150 ' ' GLY . . . . . . . . . . . . . . . -66.29 -43.82 92.05 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 113.355 -1.748 . . . . 25.49 109.682 170.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1151 ' ' ARG . . . . . 0.699 ' HA ' ' HB2' ' A' 1322 ' ' GLN . 75.2 mtm-85 -119.89 -171.58 2.17 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 117.983 0.892 . . . . 59.84 113.374 -163.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1152 ' ' PHE . . . . . 0.574 ' HB2' HG11 ' B' 1163 ' ' VAL . 17.4 m-30 -88.65 159.11 18.0 Favored 'General case' 0 C--O 1.238 0.486 0 O-C-N 120.264 -1.522 . . . . 34.45 111.759 169.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1153 ' ' PHE . . . . . 0.431 ' CZ ' HG13 ' B' 1251 ' ' ILE . 14.5 m-85 -77.02 -56.59 4.45 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 114.205 -1.361 . . . . 31.17 112.809 171.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1154 ' ' THR . . . . . . . . . . . . . 12.1 m -65.05 142.07 58.53 Favored 'General case' 0 C--O 1.25 1.131 0 CA-C-O 121.899 0.857 . . . . 33.89 109.956 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1155 ' ' GLY . . . . . 0.496 ' HA3' ' HG3' ' B' 1165 ' ' PRO . . . -73.06 59.0 1.83 Allowed Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 110.515 -1.034 . . . . 38.95 110.515 170.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -77.24 134.6 38.54 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 124.938 1.295 . . . . 54.23 110.646 -160.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1157 ' ' ILE . . . . . . . . . . . . . 15.0 mm -80.68 116.58 25.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 101.454 -3.535 . . . . 51.16 101.454 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1158 ' ' THR . . . . . . . . . . . . . 31.5 m -122.22 155.07 36.6 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.305 1.05 . . . . 49.61 108.396 -175.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -26.36 -61.2 0.08 Allowed 'General case' 0 C--O 1.212 -0.907 0 N-CA-C 119.422 3.119 . . . . 49.05 119.422 172.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1160 ' ' ALA . . . . . 0.654 ' HB1' ' HB ' ' A' 1329 ' ' THR . . . -57.94 -51.03 71.32 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 114.299 1.222 . . . . 47.65 114.299 170.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . 179.6 178.59 48.5 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-O 122.225 0.903 . . . . 45.61 113.717 -165.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1162 ' ' LYS . . . . . . . . . . . . . 84.4 mttt -79.3 140.61 37.52 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 123.083 1.42 . . . . 57.46 109.764 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1163 ' ' VAL . . . . . 0.574 HG11 ' HB2' ' B' 1152 ' ' PHE . 48.6 t -90.99 130.11 41.62 Favored Pre-proline 0 C--N 1.299 -1.624 0 CA-C-O 116.5 -1.714 . . . . 42.93 107.603 173.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1164 ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' B' 1165 ' ' PRO . 37.9 Cg_endo -59.33 135.83 68.0 Favored 'Trans proline' 0 N--CA 1.479 0.667 0 C-N-CA 123.906 3.071 . . . . 39.29 111.865 167.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1165 ' ' PRO . . . . . 0.496 ' HG3' ' HA3' ' B' 1155 ' ' GLY . 27.9 Cg_exo -67.31 141.46 56.68 Favored 'Trans proline' 0 C--O 1.255 1.327 0 C-N-CA 123.287 2.658 . . . . 34.17 114.254 177.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1166 ' ' ALA . . . . . . . . . . . . . . . -73.09 127.68 33.29 Favored 'General case' 0 C--O 1.253 1.266 0 N-CA-C 105.826 -1.916 . . . . 31.69 105.826 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1167 ' ' LYS . . . . . 0.658 ' HB2' ' HA ' ' B' 1249 ' ' VAL . 93.6 mttt -93.81 108.27 20.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 123.201 1.477 . . . . 44.78 107.949 168.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 87.7 t -94.24 95.44 5.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 113.766 -1.561 . . . . 31.23 108.153 -172.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1169 ' ' MET . . . . . 0.563 ' HB2' HG11 ' B' 1249 ' ' VAL . 54.8 ttp -79.83 95.69 6.11 Favored 'General case' 0 C--O 1.245 0.831 0 O-C-N 120.534 -1.354 . . . . 37.09 108.759 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 24.3 t -93.22 99.2 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 N-CA-C 106.435 -1.691 . . . . 30.17 106.435 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1171 ' ' ILE . . . . . 0.401 HG23 ' HD2' ' B' 1194 ' ' PHE . 35.4 mt -93.38 119.75 41.66 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 N-CA-C 105.677 -1.972 . . . . 33.74 105.677 -175.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 98.68 62.52 0.86 Allowed Glycine 0 C--N 1.346 1.131 0 N-CA-C 108.44 -1.864 . . . . 32.59 108.44 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1173 ' ' ALA . . . . . 0.809 ' HA ' ' HA3' ' B' 1177 ' ' GLY . . . -74.44 60.34 0.86 Allowed 'General case' 0 C--O 1.247 0.944 0 N-CA-C 114.89 1.441 . . . . 32.42 114.89 176.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -87.95 -158.76 33.64 Favored Glycine 0 C--O 1.213 -1.203 0 N-CA-C 105.642 -2.983 . . . . 31.74 105.642 160.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 3.7 t -54.42 -39.1 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-N 120.432 2.116 . . . . 31.48 112.439 -172.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1176 ' ' ALA . . . . . 0.614 ' HB3' HG21 ' B' 1255 ' ' THR . . . -67.14 -38.24 85.17 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 120.689 -1.257 . . . . 26.12 110.977 178.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1177 ' ' GLY . . . . . 0.809 ' HA3' ' HA ' ' B' 1173 ' ' ALA . . . -55.29 -54.12 36.34 Favored Glycine 0 C--O 1.208 -1.519 0 C-N-CA 124.534 1.064 . . . . 25.73 110.759 174.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1178 ' ' LEU . . . . . 0.447 ' HA ' HD12 ' B' 1181 ' ' ILE . 15.6 mt -65.39 -30.03 70.8 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 113.285 -1.457 . . . . 32.59 110.846 -177.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -68.82 -42.19 77.58 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.765 -0.584 . . . . 27.72 109.782 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -70.25 -37.57 74.96 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 107.498 -1.297 . . . . 26.03 107.498 -174.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1181 ' ' ILE . . . . . 0.748 HG12 HG11 ' B' 1191 ' ' VAL . 13.3 mt -63.06 -48.8 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 107.342 -1.355 . . . . 28.61 107.342 171.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -58.38 -26.7 59.66 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-O 118.724 -1.042 . . . . 25.23 115.203 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -90.11 -60.78 1.84 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 118.683 1.241 . . . . 24.09 111.308 174.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -61.05 -44.92 96.67 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 116.097 1.888 . . . . 26.68 116.097 -175.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 5.0 t30 -66.14 -45.91 79.37 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 118.099 -0.953 . . . . 36.57 109.344 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1186 ' ' SER . . . . . . . . . . . . . 16.1 m -56.21 -45.61 79.8 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 120.577 1.535 . . . . 28.92 112.876 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1187 ' ' LEU . . . . . . . . . . . . . 58.6 mt -45.1 -52.35 9.23 Favored 'General case' 0 C--O 1.246 0.879 0 O-C-N 123.934 0.771 . . . . 29.09 112.788 165.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 128.41 27.24 0.91 Allowed Glycine 0 N--CA 1.438 -1.175 0 O-C-N 121.26 -0.9 . . . . 29.26 112.969 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1189 ' ' ALA . . . . . 0.428 ' HB2' ' HB3' ' B' 1153 ' ' PHE 0.259 . . -102.48 146.11 28.59 Favored 'General case' 0 C--O 1.251 1.176 0 N-CA-C 107.747 -1.205 . . . . 30.16 107.747 -179.115 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B 1190 ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' B' 1167 ' ' LYS . 74.0 mt -83.82 103.94 11.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 103.178 -2.897 . . . . 35.81 103.178 -171.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1191 ' ' VAL . . . . . 0.748 HG11 HG12 ' B' 1181 ' ' ILE . 53.0 t -81.26 131.85 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.646 0 N-CA-C 104.903 -2.258 . . . . 31.97 104.903 176.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1192 ' ' ARG . . . . . 0.454 ' HG2' ' HB3' ' B' 1210 ' ' GLU . 33.2 mtt180 -120.57 89.85 3.21 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 109.827 -3.351 . . . . 48.16 104.946 171.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -90.31 130.29 36.43 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.401 -1.272 . . . . 35.89 113.151 -176.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1194 ' ' PHE . . . . . 0.401 ' HD2' HG23 ' B' 1171 ' ' ILE . 35.2 t80 -106.31 144.12 33.45 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.72 -1.215 . . . . 41.88 107.72 175.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1195 ' ' ASP . . . . . . . . . . . . . 8.9 t70 -157.98 153.26 25.82 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 104.417 -2.438 . . . . 38.28 104.417 160.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1196 ' ' THR . . . . . . . . . . . . . 13.4 p -84.25 -10.04 58.0 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.114 0.783 . . . . 40.62 113.114 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1197 ' ' ARG . . . . . 0.403 ' HA ' ' HD2' ' B' 1198 ' ' PRO . 39.9 mtm180 -91.43 126.6 53.93 Favored Pre-proline 0 C--O 1.247 0.969 0 C-N-CA 124.294 1.038 . . . . 53.09 108.353 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1198 ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' B' 1197 ' ' ARG . 13.9 Cg_endo -52.6 -45.7 38.37 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 N-CA-C 121.264 3.525 . . . . 42.56 121.264 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1199 ' ' GLU . . . . . 0.862 ' HB2' ' HE1' ' C' ' 155' ' ' TYR . 0.0 OUTLIER -72.66 -8.42 55.21 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 118.351 -2.718 . . . . 56.31 114.094 -157.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B 1200 ' ' VAL . . . . . 0.541 ' HA ' ' HG2' ' B' 1203 ' ' GLN . 34.5 m -85.06 -17.46 9.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 120.799 -1.188 . . . . 42.91 111.257 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1201 ' ' LYS . . . . . 0.494 ' HG3' ' CD2' ' B' 1211 ' ' PHE . 49.1 tttm -50.39 -54.26 23.12 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 121.428 1.922 . . . . 48.89 112.252 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 20.6 mp0 -64.64 -21.96 66.85 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 116.715 2.117 . . . . 51.7 116.715 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1203 ' ' GLN . . . . . 0.581 ' OE1' ' HA ' ' C' ' 74' ' ' ARG . 29.9 mm-40 -64.98 -48.16 74.98 Favored 'General case' 0 C--O 1.248 1.0 0 O-C-N 118.647 -2.533 . . . . 52.57 110.197 172.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1204 ' ' VAL . . . . . 0.444 HG22 HD13 ' B' 1181 ' ' ILE . 12.1 t -59.97 -54.2 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 112.144 -2.298 . . . . 33.79 108.504 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -51.08 -51.73 50.4 Favored 'General case' 0 C--O 1.203 -1.362 0 C-N-CA 124.579 1.152 . . . . 36.58 112.88 177.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1206 ' ' SER . . . . . . . . . . . . . 16.5 m -71.41 -7.58 48.23 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 115.634 1.716 . . . . 39.61 115.634 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1207 ' ' MET . . . . . 0.495 ' SD ' HG22 ' B' 1181 ' ' ILE . 27.5 mtp -80.21 -38.71 30.58 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 123.118 1.437 . . . . 37.45 112.012 167.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 121.58 46.87 0.31 Allowed Glycine 0 CA--C 1.519 0.297 0 CA-C-N 112.035 -2.348 . . . . 31.87 108.031 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -142.36 150.28 40.51 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 114.033 -1.083 . . . . 35.4 110.233 -168.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1210 ' ' GLU . . . . . 0.454 ' HB3' ' HG2' ' B' 1192 ' ' ARG . 10.4 tt0 -81.58 139.51 35.02 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 125.677 1.861 . . . . 47.89 107.421 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1211 ' ' PHE . . . . . 0.494 ' CD2' ' HG3' ' B' 1201 ' ' LYS . 87.7 t80 -107.21 114.24 28.16 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 106.244 -1.761 . . . . 45.53 106.244 170.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1212 ' ' LEU . . . . . . . . . . . . . 62.7 mt -65.94 116.65 7.31 Favored 'General case' 0 N--CA 1.441 -0.913 0 O-C-N 120.616 -1.303 . . . . 46.33 108.075 170.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -80.99 175.81 10.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 122.964 1.364 . . . . 60.41 111.932 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1214 ' ' LEU . . . . . . . . . . . . . 25.4 mt -56.92 132.0 51.33 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 112.705 -2.043 . . . . 57.38 108.998 168.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 15.1 t70 . . . . . 0 N--CA 1.443 -0.777 0 C-N-CA 124.354 1.062 . . . . 65.07 108.848 -177.102 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B 1230 ' ' MET . . . . . 0.62 ' N ' ' HG ' ' B' 1231 ' ' SER . 3.0 mmt . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 105.121 -2.178 . . . . 80.32 105.121 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1231 ' ' SER . . . . . 0.62 ' HG ' ' N ' ' B' 1230 ' ' MET . 4.8 m 103.83 159.49 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.085 2 O-C-N 114.398 -5.189 . . . . 79.92 114.175 -18.343 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -56.06 154.0 8.22 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 116.579 2.066 . . . . 77.91 116.579 -172.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 66.39 -53.79 0.41 Allowed 'General case' 0 C--N 1.356 0.873 0 C-N-CA 126.273 1.829 . . . . 73.88 112.688 -172.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1234 ' ' PHE . . . . . . . . . . . . . 32.2 t80 -60.5 -35.7 76.59 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-N 121.025 1.739 . . . . 68.98 109.227 171.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1235 ' ' ILE . . . . . 0.472 ' O ' ' HG2' ' B' 1239 ' ' MET . 15.4 pt -47.46 -32.69 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 120.22 1.373 . . . . 64.53 114.175 169.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -60.17 -46.02 91.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 117.994 -2.941 . . . . 66.36 111.75 169.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -69.5 -29.94 67.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 123.229 1.49 . . . . 56.6 111.527 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -63.79 -48.38 77.13 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 114.16 -1.382 . . . . 56.79 109.196 175.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1239 ' ' MET . . . . . 0.472 ' HG2' ' O ' ' B' 1235 ' ' ILE . 29.6 mmt -57.47 -55.98 27.73 Favored 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 125.359 1.464 . . . . 53.63 107.343 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -53.9 -29.44 41.91 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 114.643 1.349 . . . . 51.74 114.643 176.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 58.3 tp -70.02 -43.46 71.29 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 108.978 -0.749 . . . . 44.86 108.978 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1242 ' ' PHE . . . . . 0.408 ' HB3' ' HE3' ' B' 1169 ' ' MET . 8.9 m-30 -74.08 -39.94 63.1 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 124.722 1.264 . . . . 42.78 111.408 -178.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.97 93.77 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.373 -0.831 . . . . 40.96 109.86 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -60.25 -49.13 78.81 Favored 'General case' 0 C--N 1.316 -0.879 0 O-C-N 121.195 -0.941 . . . . 43.06 110.368 172.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -65.38 -24.19 67.16 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 113.052 -1.885 . . . . 46.45 110.842 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1246 ' ' ALA . . . . . 0.547 ' HB1' ' HA ' ' B' 1275 ' ' MET . . . -48.84 -39.75 26.8 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 119.589 3.181 . . . . 41.78 119.589 -174.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 12.3 mptt -67.91 -31.7 71.65 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.224 -1.548 . . . . 52.2 112.324 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1248 ' ' GLU . . . . . 0.498 ' HB3' ' HD2' ' B' 1167 ' ' LYS . 33.5 mt-10 -80.97 -44.17 18.57 Favored 'General case' 0 C--O 1.251 1.158 0 CA-C-N 114.168 -1.378 . . . . 53.55 111.885 -177.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1249 ' ' VAL . . . . . 0.658 ' HA ' ' HB2' ' B' 1167 ' ' LYS . 35.2 m -85.72 150.36 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 124.454 2.073 . . . . 34.41 111.135 -165.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1250 ' ' ASP . . . . . 0.578 ' O ' ' HB3' ' B' 1279 ' ' SER . 1.5 m-20 -108.08 -47.59 3.53 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 110.749 -2.932 . . . . 33.38 111.328 -176.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1251 ' ' ILE . . . . . 0.655 HD12 ' HB1' ' B' 1145 ' ' ALA . 33.0 mm -119.21 125.15 74.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 105.978 -1.86 . . . . 29.54 105.978 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1252 ' ' ILE . . . . . 0.517 HD12 HG12 ' B' 1281 ' ' ILE . 79.8 mt -103.68 118.56 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 104.583 -2.377 . . . . 32.44 104.583 172.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1253 ' ' VAL . . . . . 0.426 HG23 HG22 ' B' 1251 ' ' ILE . 52.9 t -111.39 89.99 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.072 0 N-CA-C 104.433 -2.432 . . . . 30.57 104.433 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1254 ' ' THR . . . . . . . . . . . . . 14.1 t -101.44 131.94 47.3 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 113.736 -1.575 . . . . 35.04 109.027 -169.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1255 ' ' THR . . . . . 0.614 HG21 ' HB3' ' B' 1176 ' ' ALA . 2.6 m -146.93 31.43 0.94 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.875 -1.057 . . . . 34.62 113.14 -157.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . -73.7 75.62 1.55 Allowed 'General case' 0 C--O 1.244 0.804 0 O-C-N 117.842 -3.036 . . . . 42.72 111.483 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 32.7 mt -83.83 79.18 9.56 Favored 'General case' 0 C--O 1.248 0.976 0 CA-C-O 123.677 1.703 . . . . 52.43 108.084 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1258 ' ' ILE . . . . . 0.461 HG13 ' HB2' ' B' 1261 ' ' LYS . 27.2 pt -81.86 132.91 52.88 Favored Pre-proline 0 N--CA 1.448 -0.568 0 CA-C-N 113.357 -1.747 . . . . 59.41 109.985 -173.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -49.59 99.33 0.04 OUTLIER 'Trans proline' 0 CA--C 1.495 -1.451 0 N-CA-C 120.113 3.082 . . . . 62.68 120.113 -166.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 74.09 3.81 65.93 Favored Glycine 0 N--CA 1.432 -1.574 0 CA-C-N 112.604 -2.089 . . . . 64.16 112.698 173.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1261 ' ' LYS . . . . . 0.461 ' HB2' HG13 ' B' 1258 ' ' ILE . 95.0 mttt -105.53 164.7 14.51 Favored Pre-proline 0 C--O 1.211 -0.946 0 CA-C-O 115.919 -1.991 . . . . 68.53 110.991 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -70.92 142.24 42.36 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 CA-C-N 126.654 3.412 . . . . 61.99 111.957 167.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1263 ' ' ALA . . . . . 0.545 ' H ' ' HA3' ' B' 1289 ' ' GLY . . . -62.68 135.91 95.96 Favored Pre-proline 0 C--O 1.249 1.073 0 N-CA-C 113.851 1.056 . . . . 57.15 113.851 173.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -64.91 154.26 73.98 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 121.991 1.794 . . . . 51.57 114.647 173.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -81.96 82.69 7.49 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 118.649 -1.221 . . . . 54.55 109.019 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 62.5 mt -64.98 -48.19 74.87 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-O 123.125 1.441 . . . . 46.86 113.399 175.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1267 ' ' ILE . . . . . 0.827 HG21 HD13 ' B' 1281 ' ' ILE . 22.9 mm -96.0 97.56 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 122.088 0.947 . . . . 41.04 108.896 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1268 ' ' THR . . . . . 0.424 ' O ' HG23 ' B' 1272 ' ' VAL . 18.1 p -76.5 162.04 28.14 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 113.732 -1.576 . . . . 39.58 113.197 177.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1269 ' ' ARG . . . . . 0.547 ' HG3' ' HB2' ' B' 1293 ' ' GLU . 82.4 mtt85 -59.24 -36.05 74.78 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 124.376 1.07 . . . . 53.15 111.296 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -50.65 -58.65 5.34 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 114.57 -1.196 . . . . 42.96 111.638 167.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1271 ' ' MET . . . . . . . . . . . . . 28.6 ttm -60.08 -33.55 72.22 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.637 1.347 . . . . 43.89 114.637 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1272 ' ' VAL . . . . . 0.424 HG23 ' O ' ' B' 1268 ' ' THR . 58.1 t -66.27 -48.05 82.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 109.048 -0.723 . . . . 38.37 109.048 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 4.7 t70 -77.25 -27.43 53.28 Favored 'General case' 0 C--O 1.244 0.776 0 O-C-N 121.617 -0.677 . . . . 47.46 110.059 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1274 ' ' SER . . . . . . . . . . . . . 67.3 m -74.13 -24.27 59.4 Favored 'General case' 0 C--O 1.246 0.878 0 CA-C-N 115.962 -0.563 . . . . 38.38 111.814 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1275 ' ' MET . . . . . 0.547 ' HA ' ' HB1' ' B' 1246 ' ' ALA . 1.0 OUTLIER -60.51 163.19 5.53 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 115.553 1.686 . . . . 37.81 115.553 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -56.12 130.04 42.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 113.742 -1.572 . . . . 49.26 110.219 169.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1277 ' ' ALA . . . . . . . . . . . . . . . -60.59 159.63 10.34 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.732 -1.576 . . . . 34.46 111.141 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1278 ' ' GLY . . . . . 0.446 ' HA2' ' HB3' ' A' 1044 ' ' SER . . . 64.78 33.54 87.51 Favored Glycine 0 CA--C 1.521 0.421 0 O-C-N 121.427 -0.795 . . . . 33.53 113.526 172.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1279 ' ' SER . . . . . 0.578 ' HB3' ' O ' ' B' 1250 ' ' ASP . 15.2 m -133.94 167.28 20.89 Favored 'General case' 0 C--O 1.262 1.763 0 C-N-CA 123.481 0.712 . . . . 31.31 111.598 -164.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1280 ' ' VAL . . . . . 0.466 HG11 ' HA ' ' B' 1145 ' ' ALA . 66.9 t -127.01 131.06 71.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 O-C-N 119.868 -1.77 . . . . 29.32 111.118 -173.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1281 ' ' ILE . . . . . 0.827 HD13 HG21 ' B' 1267 ' ' ILE . 91.3 mt -103.25 99.37 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 102.505 -3.146 . . . . 31.93 102.505 169.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1282 ' ' VAL . . . . . . . . . . . . . 17.4 t -82.52 115.04 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 105.121 -2.177 . . . . 29.48 105.121 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1283 ' ' ASP . . . . . 0.453 ' HB3' ' HA2' ' B' 1311 ' ' GLY . 42.8 t0 -97.99 112.64 24.5 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 123.819 1.771 . . . . 34.5 106.76 174.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1284 ' ' LEU . . . . . 0.58 ' HG ' HD13 ' B' 1315 ' ' LEU . 7.3 mp -90.6 -21.28 21.8 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 113.64 -1.618 . . . . 37.94 110.215 -176.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -96.87 16.68 18.64 Favored 'General case' 0 C--O 1.25 1.115 0 CA-C-O 121.503 0.668 . . . . 40.92 111.784 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1286 ' ' ALA . . . . . 0.707 ' HA ' ' HA2' ' B' 1290 ' ' GLY . . . -63.5 -34.89 78.76 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 122.756 1.265 . . . . 44.39 112.399 -167.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1287 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -45.99 74.36 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 115.237 -0.892 . . . . 51.46 109.656 174.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.4 37.75 1.62 Allowed 'General case' 0 C--O 1.245 0.843 0 CA-C-O 125.214 2.435 . . . . 57.75 108.856 -167.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1289 ' ' GLY . . . . . 0.545 ' HA3' ' H ' ' B' 1263 ' ' ALA . . . 139.57 -61.75 0.56 Allowed Glycine 0 N--CA 1.433 -1.532 0 O-C-N 119.147 -2.221 . . . . 49.85 111.869 175.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1290 ' ' GLY . . . . . 0.707 ' HA2' ' HA ' ' B' 1286 ' ' ALA . . . 96.19 114.39 2.98 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 107.519 -2.232 . . . . 45.93 107.519 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1291 ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -72.86 -16.26 61.59 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.314 -0.995 . . . . 42.67 108.314 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1292 ' ' CYS . . . . . 0.52 ' HB3' ' OG1' ' B' 1295 ' ' THR . 25.3 t -118.93 139.09 52.24 Favored 'General case' 0 N--CA 1.432 -1.33 0 O-C-N 118.748 -2.47 . . . . 38.82 113.265 -175.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1293 ' ' GLU . . . . . 0.547 ' HB2' ' HG3' ' B' 1269 ' ' ARG . 51.2 mt-10 -66.81 -40.84 88.21 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 118.745 -0.645 . . . . 46.71 112.441 177.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.08 -6.41 50.99 Favored 'General case' 0 C--O 1.239 0.531 0 O-C-N 125.866 1.979 . . . . 47.23 113.124 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1295 ' ' THR . . . . . 0.713 HG23 ' HA3' ' B' 1311 ' ' GLY . 74.1 m -52.67 137.76 30.24 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 124.955 2.312 . . . . 36.02 112.025 172.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1296 ' ' VAL . . . . . 0.476 ' HB ' ' HB2' ' B' 1299 ' ' GLU . 3.7 t -117.42 105.14 48.94 Favored Pre-proline 0 C--N 1.321 -0.643 1 N-CA-C 96.65 -5.315 . . . . 37.26 96.65 168.382 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -56.7 128.42 29.93 Favored 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 124.968 3.779 . . . . 35.09 111.311 177.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 96.12 -17.46 59.24 Favored Glycine 0 C--N 1.315 -0.615 0 CA-C-O 122.288 0.938 . . . . 35.97 112.296 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1299 ' ' GLU . . . . . 0.476 ' HB2' ' HB ' ' B' 1296 ' ' VAL . 28.6 mt-10 -123.44 173.64 7.88 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 123.822 1.772 . . . . 40.39 110.751 -171.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1300 ' ' ILE . . . . . 0.6 HD13 ' HG3' ' B' 1148 ' ' GLU . 96.4 mt -113.55 105.96 19.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 110.744 -2.935 . . . . 37.43 103.088 177.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1301 ' ' PHE . . . . . 0.507 ' HB3' ' HB ' ' B' 1309 ' ' VAL . 76.6 t80 -73.1 148.5 43.92 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.347 -1.353 . . . . 44.13 107.347 171.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1302 ' ' THR . . . . . . . . . . . . . 40.7 m -140.46 119.41 12.65 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 122.773 2.533 . . . . 39.78 106.538 175.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1303 ' ' THR . . . . . 0.454 HG23 ' HE2' ' B' 1301 ' ' PHE . 2.7 p -74.21 175.15 7.82 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.854 0.835 . . . . 43.29 109.801 171.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -74.66 -25.39 59.15 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-O 121.849 0.833 . . . . 53.07 109.801 -174.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -80.47 -7.99 59.38 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.342 -0.984 . . . . 43.97 108.342 173.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 90.3 37.46 6.64 Favored Glycine 0 N--CA 1.462 0.382 0 O-C-N 119.752 -1.842 . . . . 41.12 111.382 174.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1307 ' ' VAL . . . . . . . . . . . . . 43.2 t -97.69 108.79 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-O 125.837 2.732 . . . . 38.12 104.019 170.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1308 ' ' LYS . . . . . 0.689 ' HD2' ' HB3' ' B' 1148 ' ' GLU . 83.9 mttt -84.67 102.56 13.05 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 108.783 -3.826 . . . . 36.34 109.498 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1309 ' ' VAL . . . . . 0.507 ' HB ' ' HB3' ' B' 1301 ' ' PHE . 22.0 t -85.02 100.17 7.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 105.483 -2.043 . . . . 30.4 105.483 177.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1310 ' ' ILE . . . . . 0.647 HD11 ' HB2' ' B' 1148 ' ' GLU . 27.1 mt -81.8 90.53 2.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 107.032 -1.47 . . . . 30.82 107.032 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1311 ' ' GLY . . . . . 0.713 ' HA3' HG23 ' B' 1295 ' ' THR . . . -89.57 83.02 1.41 Allowed Glycine 0 C--N 1.301 -1.411 0 N-CA-C 108.751 -1.739 . . . . 26.53 108.751 -172.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1312 ' ' TYR . . . . . 0.504 ' CB ' ' HG ' ' B' 1315 ' ' LEU . 6.6 m-30 -98.57 133.05 43.47 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 119.306 3.076 . . . . 38.0 119.306 -170.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1313 ' ' THR . . . . . . . . . . . . . 2.6 p -76.87 -63.86 1.26 Allowed 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 109.222 -3.626 . . . . 29.8 108.509 166.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 4.3 p30 -69.62 6.85 0.98 Allowed 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 120.405 3.483 . . . . 39.04 120.405 -171.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1315 ' ' LEU . . . . . 0.58 HD13 ' HG ' ' B' 1284 ' ' LEU . 28.4 mt -46.6 -50.42 41.87 Favored Pre-proline 0 C--N 1.352 0.703 0 N-CA-C 118.952 2.945 . . . . 31.08 118.952 175.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1316 ' ' PRO . . . . . 0.614 ' HB3' ' HB3' ' B' 1133 ' ' MET . 92.6 Cg_exo -55.45 -33.39 85.81 Favored 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 123.956 3.104 . . . . 26.1 112.072 174.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -82.56 -53.73 3.5 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 120.424 -1.423 . . . . 23.17 111.247 -175.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1318 ' ' ARG . . . . . 0.4 HH11 ' HD3' ' B' 1318 ' ' ARG . 71.3 mtt-85 -36.95 -16.5 0.0 OUTLIER 'General case' 0 C--O 1.235 0.318 1 N-CA-C 124.077 4.843 . . . . 40.4 124.077 -170.256 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B 1319 ' ' LEU . . . . . 0.61 HD13 HH11 ' B' 1140 ' ' ARG . 1.3 tp -105.52 77.35 0.38 Allowed Pre-proline 0 C--O 1.252 1.232 0 CA-C-N 124.031 3.105 . . . . 23.6 106.684 -176.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1320 ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -39.79 -72.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 124.79 3.66 . . . . 22.35 117.926 -151.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1321 ' ' THR . . . . . . . . . . . . . 2.0 m -66.64 -31.83 72.77 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 112.904 0.705 . . . . 26.52 112.904 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1322 ' ' GLN . . . . . 0.765 ' HB2' ' HA ' ' A' 1151 ' ' ARG . 45.8 tp60 -75.81 -44.66 40.07 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 119.097 -2.252 . . . . 24.38 110.267 -178.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1323 ' ' SER . . . . . . . . . . . . . 50.6 m -46.97 -52.1 15.47 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 120.272 -1.517 . . . . 22.8 110.394 169.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1324 ' ' SER . . . . . . . . . . . . . 29.0 m -57.1 -59.58 4.88 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 113.495 -1.684 . . . . 21.25 113.457 173.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 66.3 tp60 -52.84 -40.58 63.46 Favored 'General case' 0 C--N 1.344 0.346 0 O-C-N 120.303 -1.498 . . . . 31.34 113.957 -177.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1326 ' ' LEU . . . . . 0.428 ' CD1' HG21 ' A' 1158 ' ' THR . 63.4 mt -73.54 -46.94 44.55 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 113.665 0.987 . . . . 31.56 113.665 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1327 ' ' TYR . . . . . 0.428 ' O ' ' HG ' ' B' 1331 ' ' LEU . 47.2 t80 -54.22 -51.68 63.66 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-O 122.947 1.356 . . . . 22.73 108.6 173.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1328 ' ' GLY . . . . . 0.535 ' HA2' HD12 ' B' 1331 ' ' LEU . . . -41.06 -57.22 3.04 Favored Glycine 0 CA--C 1.496 -1.151 0 CA-C-N 112.614 -2.085 . . . . 21.91 115.793 168.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1329 ' ' THR . . . . . 0.623 HG21 ' HA3' ' A' 1161 ' ' GLY . 62.4 m -66.92 -28.96 68.73 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 114.605 1.335 . . . . 22.15 114.605 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1330 ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' B' 1127 ' ' LEU . 30.5 m120 -53.45 -51.42 62.72 Favored 'General case' 0 C--O 1.24 0.573 0 O-C-N 121.365 -0.834 . . . . 26.18 109.952 167.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1331 ' ' LEU . . . . . 0.624 HD13 ' HB3' ' B' 1070 ' ' LEU . 20.2 mt -65.95 -39.0 90.07 Favored 'General case' 0 CA--C 1.508 -0.653 0 O-C-N 125.413 1.696 . . . . 23.68 110.404 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1332 ' ' VAL . . . . . 0.671 HG12 ' HE3' ' B' 1336 ' ' LYS . 59.6 t -55.49 -51.31 58.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 120.073 1.306 . . . . 26.57 109.545 171.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1333 ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -61.33 -39.86 92.1 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 114.371 -1.286 . . . . 28.08 109.771 -173.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1334 ' ' LEU . . . . . 0.656 HD12 HD23 ' B' 1127 ' ' LEU . 15.2 tp -70.95 -42.78 69.33 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 126.315 1.846 . . . . 27.43 107.482 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1335 ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' B' 1331 ' ' LEU . 79.7 mt -69.6 -24.19 63.63 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 121.195 1.816 . . . . 30.5 111.495 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1336 ' ' LYS . . . . . 0.671 ' HE3' HG12 ' B' 1332 ' ' VAL . 76.1 mttt -67.94 -40.57 83.25 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 120.166 1.348 . . . . 41.65 109.649 169.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 11.5 tp -81.31 -25.88 36.1 Favored 'General case' 0 C--O 1.244 0.802 0 O-C-N 119.266 -2.146 . . . . 42.08 110.985 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1338 ' ' LEU . . . . . 0.477 HD22 HG23 ' B' 1346 ' ' ILE . 12.8 mt -68.81 -78.94 0.06 Allowed 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 122.753 1.263 . . . . 35.03 109.946 164.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1339 ' ' CYS . . . . . . . . . . . . . 18.0 t -78.75 76.5 5.24 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.278 -1.379 . . . . 37.33 107.278 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 58.2 mttp -65.47 -24.76 67.24 Favored 'General case' 0 C--N 1.35 0.595 0 N-CA-C 113.901 1.074 . . . . 50.51 113.901 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -73.83 -3.3 27.86 Favored 'General case' 0 C--O 1.25 1.097 0 N-CA-C 115.41 1.633 . . . . 54.21 115.41 169.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1342 ' ' LYS . . . . . 0.404 ' HD2' HD22 ' B' 1029 ' ' LEU . 9.3 mtmp? 33.43 66.58 0.22 Allowed 'General case' 0 C--N 1.357 0.923 0 CA-C-O 125.141 2.4 . . . . 50.99 116.891 -173.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -134.76 -37.01 0.83 Allowed 'General case' 0 C--O 1.248 0.981 0 CA-C-N 112.975 -1.92 . . . . 48.82 111.315 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1344 ' ' GLY . . . . . . . . . . . . . . . 148.23 -31.37 1.3 Allowed Glycine 0 N--CA 1.434 -1.483 0 CA-C-N 122.64 2.473 . . . . 40.43 109.583 -178.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -75.82 113.96 13.88 Favored 'General case' 0 C--N 1.361 1.087 0 CA-C-N 119.442 1.621 . . . . 47.56 109.758 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1346 ' ' ILE . . . . . 0.477 HG23 HD22 ' B' 1338 ' ' LEU . 46.1 mm -69.4 107.05 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 CA-C-O 125.715 2.674 . . . . 42.49 107.589 177.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1347 ' ' THR . . . . . . . . . . . . . 9.2 m -83.11 108.24 16.24 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 103.154 -2.906 . . . . 38.12 103.154 176.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1348 ' ' VAL . . . . . . . . . . . . . 11.7 t -84.16 84.78 2.01 Favored 'Isoleucine or valine' 0 C--O 1.257 1.478 0 N-CA-C 108.049 -1.093 . . . . 37.5 108.049 -175.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 50.5 t0 -80.86 129.78 34.71 Favored 'General case' 0 CA--C 1.5 -0.951 0 O-C-N 124.053 0.846 . . . . 43.85 111.244 -169.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1350 ' ' PHE . . . . . 0.478 ' HD1' ' HD2' ' B' 1356 ' ' ARG . 46.2 m-85 -114.67 -8.89 12.65 Favored 'General case' 0 C--O 1.251 1.147 0 O-C-N 118.668 -2.52 . . . . 39.81 110.3 175.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 34.3 t70 -72.78 -49.07 32.98 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 120.306 -1.496 . . . . 51.29 110.075 177.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 2.6 t70 -64.1 135.63 56.54 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 122.098 2.226 . . . . 39.78 109.787 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1353 ' ' VAL . . . . . . . . . . . . . 7.4 m -57.48 -34.32 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 114.507 -1.224 . . . . 39.28 113.266 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1354 ' ' VAL . . . . . 0.562 HG21 ' HG3' ' B' 1123 ' ' ARG . 35.8 t -76.02 -48.37 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.408 0 CA-C-N 120.124 1.329 . . . . 35.7 109.353 -174.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1355 ' ' ILE . . . . . 0.736 ' HA ' HG12 ' B' 1358 ' ' VAL 0.257 24.1 mm -69.58 -32.86 54.26 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 CA-C-O 116.825 -1.56 . . . . 35.77 112.917 176.516 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B 1356 ' ' ARG . . . . . 0.478 ' HD2' ' HD1' ' B' 1350 ' ' PHE . 39.5 tpt85 -54.79 -49.16 71.63 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 120.488 1.495 . . . . 38.55 109.287 166.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -64.39 -55.96 20.3 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 119.62 1.1 . . . . 29.58 112.91 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1358 ' ' VAL . . . . . 0.736 HG12 ' HA ' ' B' 1355 ' ' ILE . 5.0 p -67.85 -34.19 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 124.334 1.054 . . . . 32.06 112.704 -174.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1359 ' ' THR . . . . . . . . . . . . . 6.2 m -78.34 92.16 4.52 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-O 125.264 2.459 . . . . 29.0 108.733 177.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1360 ' ' VAL . . . . . . . . . . . . . 18.9 m -78.51 -31.68 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.978 0 CA-C-N 108.898 -3.774 . . . . 29.68 108.257 -175.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 70.0 mt -128.97 119.95 50.7 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 N-CA-C 107.027 -1.471 . . . . 32.05 107.027 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1362 ' ' ARG . . . . . 0.454 ' HB2' ' CZ ' ' B' 1350 ' ' PHE . 19.8 ttt180 -97.67 113.13 24.82 Favored 'General case' 0 C--O 1.249 1.035 0 O-C-N 119.171 -2.205 . . . . 32.52 105.187 171.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 26.04 70.75 0.04 OUTLIER 'General case' 0 C--O 1.256 1.432 0 N-CA-C 118.028 2.603 . . . . 35.68 118.028 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 95.06 -50.1 1.94 Allowed Glycine 0 N--CA 1.428 -1.886 0 O-C-N 120.437 -1.414 . . . . 34.26 114.126 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -66.18 126.41 28.58 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.231 -0.655 . . . . 51.07 109.231 -175.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 49.7 mt -76.44 103.38 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.819 0 O-C-N 119.046 -2.284 . . . . 39.87 107.885 169.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1367 ' ' THR . . . . . . . . . . . . . 7.3 p -90.79 1.0 57.28 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 116.167 1.914 . . . . 38.01 116.167 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1368 ' ' TRP . . . . . . . . . . . . . 62.2 t90 -65.26 140.92 98.01 Favored Pre-proline 0 N--CA 1.432 -1.359 0 N-CA-C 105.017 -2.216 . . . . 42.14 105.017 160.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -70.22 157.69 93.1 Favored 'Cis proline' 0 C--O 1.252 1.184 0 N-CA-C 119.223 2.74 . . . . 43.26 119.223 10.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1370 ' ' ALA . . . . . . . . . . . . . . . -82.86 113.0 42.35 Favored Pre-proline 0 C--O 1.247 0.95 0 N-CA-C 104.427 -2.435 . . . . 46.52 104.427 168.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1371 ' ' PRO . . . . . 0.425 ' HA ' ' HD3' ' B' 1372 ' ' PRO . 83.8 Cg_endo -49.46 132.91 30.67 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.796 2.997 . . . . 51.95 116.411 -173.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1372 ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' B' 1371 ' ' PRO . 8.1 Cg_exo -55.83 83.48 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.838 1 C-N-CA 126.144 4.563 . . . . 56.27 113.604 176.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B 1373 ' ' ILE . . . . . . . . . . . . . 12.8 tt -75.46 140.78 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-N 114.335 -1.302 . . . . 60.83 110.552 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -67.4 108.47 2.8 Favored 'General case' 0 C--O 1.249 1.064 0 N-CA-C 107.27 -1.381 . . . . 66.1 107.27 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1375 ' ' VAL . . . . . . . . . . . . . 60.8 t -102.97 113.64 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 106.437 -1.69 . . . . 63.47 106.437 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.206 -5.637 0 O-C-N 120.889 -1.132 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 20' ' ' ALA . . . . . 0.468 ' HA ' HD11 ' C' ' 171' ' ' LEU . . . . . . . . 0 N--CA 1.431 -1.422 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -52.96 -36.65 60.27 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 116.739 2.126 . . . . 0.0 116.739 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 22' ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' C' ' 22' ' ' GLU . 1.9 mp0 -37.96 -43.68 0.73 Allowed 'General case' 0 C--O 1.242 0.676 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 174.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 22.0 m -42.47 -30.04 0.32 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.678 1.591 . . . . 0.0 114.056 176.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.1 -46.93 86.88 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 123.919 1.819 . . . . 0.0 114.508 171.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 25' ' ' GLU . . . . . 0.822 ' HA ' ' HE2' ' C' ' 28' ' ' LYS . 2.5 mp0 -67.23 -46.11 74.79 Favored 'General case' 0 C--O 1.252 1.202 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.105 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 10.9 mp -52.68 -48.66 66.37 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.638 173.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.579 HD21 HD11 ' C' ' 110' ' ' LEU . 1.3 mm? -60.85 -40.36 92.57 Favored 'General case' 0 C--O 1.223 -0.297 0 O-C-N 119.654 -1.904 . . . . 0.0 115.187 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 28' ' ' LYS . . . . . 0.822 ' HE2' ' HA ' ' C' ' 25' ' ' GLU . 3.0 pttm -67.09 -29.29 69.01 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 118.496 -1.282 . . . . 0.0 113.729 168.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -79.28 -20.12 48.85 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -53.38 -21.34 5.71 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 118.467 2.766 . . . . 0.0 118.467 -160.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 31' ' ' HIS . . . . . 0.413 ' O ' HG23 ' C' ' 62' ' ' ILE . 48.4 m-70 71.63 -69.3 0.19 Allowed 'General case' 0 C--N 1.352 0.682 0 CA-C-N 122.925 2.602 . . . . 0.0 109.137 -176.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 32' ' ' SER . . . . . 0.503 ' HB2' ' OG1' ' C' ' 106' ' ' THR . 48.7 m -120.12 158.62 26.51 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 159.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . 0.442 ' HB ' HG23 ' C' ' 64' ' ' VAL . 32.7 t -123.06 114.56 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.155 0 N-CA-C 101.946 -3.353 . . . . 0.0 101.946 -178.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.494 HD12 HD11 ' C' ' 99' ' ' ILE . 18.5 mm -99.32 113.69 35.12 Favored 'Isoleucine or valine' 0 C--O 1.249 1.055 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 175.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . 0.52 HG12 HD12 ' C' ' 110' ' ' LEU . 75.9 mt -97.03 116.34 39.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 174.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 36' ' ' THR . . . . . 0.429 ' HB ' ' HA ' ' C' ' 111' ' ' VAL . 93.2 m -99.68 100.74 11.59 Favored Pre-proline 0 C--O 1.239 0.552 0 CA-C-N 114.867 -1.06 . . . . 0.0 113.22 174.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' C' ' 35' ' ' ILE . 15.4 Cg_exo -62.48 149.1 92.11 Favored 'Trans proline' 0 C--O 1.238 0.519 1 C-N-CA 125.879 4.386 . . . . 0.0 109.615 176.154 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.18 -153.8 7.92 Favored Glycine 0 C--O 1.217 -0.959 0 CA-C-N 109.694 -3.412 . . . . 0.0 108.62 174.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 39' ' ' TYR . . . . . 0.517 ' CD1' ' HD3' ' C' ' 74' ' ' ARG . 6.8 t80 -65.59 -41.35 92.92 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 110.127 -3.037 . . . . 0.0 108.165 -170.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 40' ' ' GLY . . . . . 0.478 ' H ' ' HA3' ' C' ' 113' ' ' GLY . . . -51.74 -54.76 23.6 Favored Glycine 0 C--N 1.347 1.19 0 O-C-N 120.543 -1.348 . . . . 0.0 113.972 174.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 30.4 ttm -58.97 -35.47 73.24 Favored 'General case' 0 C--O 1.215 -0.722 0 C-N-CA 124.484 1.114 . . . . 0.0 110.307 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.94 -60.59 2.15 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 2.9 p -75.03 -35.49 35.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 CA-C-N 118.422 0.555 . . . . 0.0 111.1 -168.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . 0.419 ' HB3' ' HB3' ' C' ' 175' ' ' ALA . . . -112.5 100.16 8.53 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 103.933 -2.617 . . . . 0.0 103.933 166.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 45' ' ' GLN . . . . . . . . . . . . . 16.3 pm0 -46.97 72.64 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 117.955 2.576 . . . . 0.0 117.955 -175.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.21 -22.69 54.97 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.914 -1.741 . . . . 0.0 111.507 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . 0.434 ' HA ' ' HB ' ' C' ' 50' ' ' VAL . 0.0 OUTLIER -56.24 -33.38 65.35 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 -176.185 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 48' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -65.3 -57.78 14.11 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 120.803 1.638 . . . . 0.0 110.59 172.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 49' ' ' PRO . . . . . 0.513 ' HB3' HD13 ' C' ' 183' ' ' LEU . 12.1 Cg_endo -58.47 -29.09 87.55 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 CA-C-N 125.526 3.009 . . . . 0.0 116.619 171.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . 0.503 HG23 HG11 ' C' ' 179' ' ' VAL . 20.3 t -58.16 -51.44 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 120.478 -1.389 . . . . 0.0 108.016 168.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.18 -36.39 79.72 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.324 0.965 . . . . 0.0 112.656 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 52' ' ' GLU . . . . . 0.52 ' O ' ' HE2' ' C' ' 56' ' ' LYS . 0.6 OUTLIER -64.28 -53.98 40.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 117.424 -1.274 . . . . 0.0 112.758 173.407 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 9.6 tp -62.83 -36.48 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 121.991 2.178 . . . . 0.0 110.398 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 74.2 m -47.89 -39.29 18.4 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 176.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -59.9 -42.54 94.08 Favored 'General case' 0 N--CA 1.437 -1.12 0 O-C-N 121.874 -0.517 . . . . 0.0 111.7 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . 0.52 ' HE2' ' O ' ' C' ' 52' ' ' GLU . 0.0 OUTLIER -75.41 -39.27 59.21 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -176.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 57' ' ' LEU . . . . . 0.558 HD21 HD12 ' C' ' 27' ' ' LEU . 72.9 mt -65.59 -33.23 75.42 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.658 1.183 . . . . 0.0 108.72 -176.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . 0.412 ' HD2' ' HA ' ' C' ' 58' ' ' ARG . 0.2 OUTLIER -77.58 -32.49 53.76 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 120.231 -1.543 . . . . 0.0 108.882 177.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.89 -46.93 61.71 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-N 121.005 1.73 . . . . 0.0 109.388 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -42.93 -42.42 3.72 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.329 1.452 . . . . 0.0 112.844 162.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.44 54.72 2.61 Favored Glycine 0 N--CA 1.437 -1.271 0 O-C-N 126.016 2.072 . . . . 0.0 112.154 176.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . 0.413 HG23 ' O ' ' C' ' 31' ' ' HIS . 93.8 mt -103.35 142.7 16.67 Favored 'Isoleucine or valine' 0 C--O 1.248 1.006 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 63' ' ' ASN . . . . . 0.403 ' OD1' ' HD3' ' C' ' 65' ' ' ARG . 31.0 t30 -71.41 74.52 0.75 Allowed 'General case' 0 C--O 1.257 1.466 0 CA-C-O 123.418 1.58 . . . . 0.0 109.418 174.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.442 HG23 ' HB ' ' C' ' 33' ' ' VAL . 3.5 p -88.14 115.34 28.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 117.551 -1.659 . . . . 0.0 108.211 -176.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 65' ' ' ARG . . . . . 0.483 HH21 HD11 ' C' ' 94' ' ' LEU . 14.3 mmm-85 -114.84 134.25 55.29 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.273 -177.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . 0.713 ' HB2' ' HA ' ' C' ' 93' ' ' VAL . 36.9 m-85 -93.5 79.48 4.35 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 123.01 1.386 . . . . 0.0 109.857 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.95 78.04 0.4 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-N 110.316 -3.129 . . . . 0.0 111.809 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 68' ' ' ILE . . . . . 0.512 HD11 HD22 ' C' ' 83' ' ' LEU . 12.9 mt -77.72 148.62 6.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 69' ' ' HIS . . . . . 0.478 ' HB3' ' HB2' ' C' ' 72' ' ' ALA . 32.0 t-80 -103.15 134.39 19.81 Favored Pre-proline 0 C--O 1.242 0.699 0 N-CA-C 104.152 -2.536 . . . . 0.0 104.152 168.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 70' ' ' PRO . . . . . 0.537 ' HB3' HD11 ' A' 1157 ' ' ILE . 27.6 Cg_endo -59.6 -72.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.123 0 C-N-CA 123.862 3.041 . . . . 0.0 114.887 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 23.0 t -70.87 95.53 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 170.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 72' ' ' ALA . . . . . 0.478 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . . . -165.26 161.34 19.16 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 123.252 1.501 . . . . 0.0 108.608 175.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 73' ' ' GLY . . . . . 0.47 ' O ' ' HD2' ' C' ' 74' ' ' ARG . . . 54.15 -110.55 1.58 Allowed Glycine 0 CA--C 1.535 1.296 0 CA-C-N 112.934 -1.939 . . . . 0.0 109.824 171.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . 0.581 ' HA ' ' OE1' ' B' 1203 ' ' GLN . 1.5 mpt_? -130.85 108.28 9.73 Favored 'General case' 0 C--O 1.259 1.605 0 O-C-N 121.959 -0.73 . . . . 0.0 111.234 -177.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.455 ' HA ' ' HD2' ' C' ' 76' ' ' PRO . 4.5 tt 63.83 114.67 0.02 OUTLIER Pre-proline 0 N--CA 1.445 -0.682 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 174.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 76' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' C' ' 75' ' ' LEU . 71.8 Cg_endo -56.89 104.28 0.14 Allowed 'Trans proline' 0 C--N 1.32 -0.925 1 C-N-CA 126.037 4.491 . . . . 0.0 107.805 175.469 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 132.01 -68.34 0.55 Allowed Glycine 0 N--CA 1.435 -1.395 0 N-CA-C 106.818 -2.513 . . . . 0.0 106.818 -171.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 78' ' ' HIS . . . . . 0.4 ' HB2' HD22 ' C' ' 75' ' ' LEU . 19.2 t-80 -63.37 -29.19 70.53 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -159.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -42.43 94.67 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 119.406 1.003 . . . . 0.0 110.493 175.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -72.83 -32.16 65.3 Favored 'General case' 0 C--N 1.368 1.377 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.562 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 48.7 t -73.01 -26.22 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 123.893 1.806 . . . . 0.0 110.303 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.9 tp -75.11 -31.92 61.26 Favored 'General case' 0 C--N 1.312 -1.03 0 O-C-N 120.55 -1.343 . . . . 0.0 108.397 166.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.512 HD22 HD11 ' C' ' 68' ' ' ILE . 9.0 mp -63.86 -30.52 71.6 Favored 'General case' 0 C--O 1.241 0.653 0 O-C-N 116.976 -3.577 . . . . 0.0 112.872 166.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 84' ' ' ALA . . . . . 0.479 ' HB2' ' OH ' ' C' ' 90' ' ' TYR . . . -62.21 -49.24 76.54 Favored 'General case' 0 N--CA 1.442 -0.849 0 O-C-N 124.57 1.169 . . . . 0.0 111.877 168.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -55.55 -40.02 71.36 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.225 1.01 . . . . 0.0 111.845 171.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.43 -21.27 53.27 Favored 'General case' 0 C--O 1.254 1.324 0 O-C-N 121.069 -1.019 . . . . 0.0 112.274 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp 77.36 50.82 0.04 OUTLIER 'General case' 0 C--O 1.242 0.682 0 CA-C-O 125.627 2.632 . . . . 0.0 112.95 -177.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 66.5 t -91.56 131.58 35.69 Favored Pre-proline 0 C--N 1.319 -0.751 0 O-C-N 118.885 -2.385 . . . . 0.0 112.146 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -61.28 99.57 0.16 Allowed 'Trans proline' 0 C--O 1.242 0.703 0 C-N-CA 124.471 3.447 . . . . 0.0 116.264 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 90' ' ' TYR . . . . . 0.479 ' OH ' ' HB2' ' C' ' 84' ' ' ALA . 82.2 m-85 -54.49 -26.07 29.15 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -174.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.97 -47.78 77.04 Favored 'General case' 0 C--O 1.248 1.004 0 O-C-N 120.116 -1.615 . . . . 0.0 112.024 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 92' ' ' ILE . . . . . . . . . . . . . 5.0 pt -88.47 -8.54 10.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . 0.713 ' HA ' ' HB2' ' C' ' 66' ' ' PHE . 84.8 t -71.19 119.77 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 165.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . 0.523 HD12 HD13 ' C' ' 99' ' ' ILE . 65.0 mt -123.77 99.72 6.42 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.711 -1.132 . . . . 0.0 109.129 -175.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 95' ' ' GLU . . . . . 0.693 ' HG2' ' HB ' ' A' 1157 ' ' ILE . 12.9 mp0 -91.79 74.47 5.74 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 -171.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 6.2 ttp 62.83 124.5 0.01 OUTLIER 'General case' 0 CA--C 1.497 -1.089 0 CA-C-N 111.322 -2.672 . . . . 0.0 111.602 -167.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 97' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -159.34 -172.35 3.7 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-N 112.657 -2.065 . . . . 0.0 106.973 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -76.49 61.19 1.71 Allowed 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 121.082 -1.012 . . . . 0.0 111.223 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 99' ' ' ILE . . . . . 0.523 HD13 HD12 ' C' ' 94' ' ' LEU . 6.2 tp -92.64 27.66 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.778 0 CA-C-O 124.851 2.262 . . . . 0.0 109.92 -168.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . 0.447 ' O ' ' HB2' ' C' ' 103' ' ' PHE . 2.2 t-20 -71.64 -60.82 2.03 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.602 -1.311 . . . . 0.0 114.115 -166.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -70.3 -32.49 70.28 Favored 'General case' 0 C--O 1.215 -0.753 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -56.97 -41.44 78.36 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 117.11 -1.424 . . . . 0.0 110.697 173.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 103' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' C' ' 100' ' ' ASN . 3.4 m-85 -54.98 -45.08 74.98 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 120.185 1.357 . . . . 0.0 113.153 169.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.21 -33.19 73.96 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 122.411 1.101 . . . . 0.0 108.722 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -68.03 -33.13 74.01 Favored 'General case' 0 C--O 1.243 0.711 0 O-C-N 118.87 -2.394 . . . . 0.0 111.367 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 106' ' ' THR . . . . . 0.503 ' OG1' ' HB2' ' C' ' 32' ' ' SER . 51.7 m -76.11 122.42 24.26 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.745 1.26 . . . . 0.0 109.183 -175.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.26 -57.97 3.98 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.594 169.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 4.3 m -104.05 104.99 15.02 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -169.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 109' ' ' VAL . . . . . 0.559 ' HB ' ' HA ' ' C' ' 144' ' ' VAL . 24.4 t -94.95 107.95 20.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 172.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 110' ' ' LEU . . . . . 0.579 HD11 HD21 ' C' ' 27' ' ' LEU . 80.2 mt -78.23 86.37 4.35 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.901 -0.499 . . . . 0.0 111.827 178.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 111' ' ' VAL . . . . . 0.543 HG13 ' HB3' ' C' ' 114' ' ' ALA . 98.8 t -79.93 83.1 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-O 124.315 2.007 . . . . 0.0 108.237 177.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 112' ' ' ILE . . . . . . . . . . . . . 7.4 mt -78.05 77.22 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.747 0 CA-C-O 123.321 1.534 . . . . 0.0 113.03 -172.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 113' ' ' GLY . . . . . 0.478 ' HA3' ' H ' ' C' ' 40' ' ' GLY . . . 71.19 42.07 58.71 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.054 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 114' ' ' ALA . . . . . 0.543 ' HB3' HG13 ' C' ' 111' ' ' VAL . . . -107.83 -24.8 11.52 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 120.84 -1.388 . . . . 0.0 110.321 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 115' ' ' ASN . . . . . 0.541 ' HB3' ' O1N' ' C' 1001 ' ' NAP . 0.2 OUTLIER 56.94 -85.79 0.02 OUTLIER 'General case' 0 C--N 1.352 0.709 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 162.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 116' ' ' ASP . . . . . 0.615 ' HB3' HD13 ' C' ' 130' ' ' ILE . 45.9 m-20 -83.61 -22.74 32.16 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -174.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 117' ' ' THR . . . . . 0.497 HG23 H51N ' C' 1001 ' ' NAP . 2.7 p -80.01 9.99 4.82 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 117.303 2.335 . . . . 0.0 117.303 -175.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.569 HG12 ' HB2' ' C' ' 136' ' ' LEU . 3.0 m -124.66 13.06 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 112.947 -1.933 . . . . 0.0 109.645 169.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 119' ' ' ASN . . . . . 0.481 ' HA ' ' HD2' ' C' ' 120' ' ' PRO . 37.4 t30 -90.08 121.02 69.19 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-O 118.475 -0.774 . . . . 0.0 111.17 -169.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 120' ' ' PRO . . . . . 0.481 ' HD2' ' HA ' ' C' ' 119' ' ' ASN . 36.9 Cg_endo -52.75 -28.33 37.66 Favored 'Trans proline' 0 C--O 1.251 1.153 0 C-N-CA 123.401 2.734 . . . . 0.0 113.701 175.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 121' ' ' ALA . . . . . 0.871 ' HA ' ' HB3' ' C' ' 125' ' ' ASP . . . -64.97 12.48 0.04 OUTLIER 'General case' 0 C--N 1.354 0.784 0 N-CA-C 116.644 2.091 . . . . 0.0 116.644 174.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 122' ' ' ALA . . . . . 0.659 ' HB1' ' HB3' ' C' ' 133' ' ' MET . . . -109.61 -2.34 17.58 Favored 'General case' 0 N--CA 1.426 -1.653 0 O-C-N 120.628 -1.295 . . . . 0.0 113.993 171.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.9 -39.85 0.09 Allowed 'General case' 0 C--N 1.351 0.671 0 CA-C-O 125.021 2.344 . . . . 0.0 115.969 169.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 124' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -66.12 -38.6 88.6 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 119.351 -2.093 . . . . 0.0 111.818 173.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 125' ' ' ASP . . . . . 0.871 ' HB3' ' HA ' ' C' ' 121' ' ' ALA . 22.7 t70 -102.63 121.08 50.91 Favored Pre-proline 0 C--N 1.347 0.457 0 O-C-N 124.19 0.931 . . . . 0.0 110.707 171.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 126' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' C' ' 125' ' ' ASP . 9.4 Cg_exo -77.6 -18.28 13.73 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 124.461 3.441 . . . . 0.0 115.677 174.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -62.95 -58.93 5.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 122.061 0.934 . . . . 0.0 112.47 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 128' ' ' SER . . . . . 0.571 ' HB3' HG21 ' C' ' 158' ' ' VAL . 66.6 m -57.36 149.52 48.3 Favored Pre-proline 0 C--O 1.24 0.595 0 N-CA-C 116.496 2.036 . . . . 0.0 116.496 -163.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 129' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -55.18 -17.73 15.98 Favored 'Trans proline' 0 CA--C 1.564 2.012 1 C-N-CA 126.003 4.469 . . . . 0.0 115.296 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 130' ' ' ILE . . . . . 0.615 HD13 ' HB3' ' C' ' 116' ' ' ASP . 8.8 pt -101.67 12.8 6.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 120.004 1.275 . . . . 0.0 114.283 173.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 131' ' ' ALA . . . . . 0.571 ' HA ' ' HA ' ' C' ' 122' ' ' ALA . . . -71.77 86.04 0.94 Allowed 'General case' 0 C--O 1.239 0.549 0 CA-C-O 124.353 2.025 . . . . 0.0 109.147 -172.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 149.5 53.83 0.02 OUTLIER Glycine 0 N--CA 1.423 -2.17 0 CA-C-N 111.963 -2.381 . . . . 0.0 108.777 -175.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 133' ' ' MET . . . . . 0.705 ' SD ' ' HD2' ' C' ' 134' ' ' PRO . 6.6 tpp -147.54 125.3 5.88 Favored Pre-proline 0 CA--C 1.548 0.865 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 134' ' ' PRO . . . . . 0.705 ' HD2' ' SD ' ' C' ' 133' ' ' MET . 22.4 Cg_endo -78.1 83.6 2.17 Favored 'Trans proline' 0 C--O 1.238 0.492 1 C-N-CA 125.612 4.208 . . . . 0.0 107.479 -175.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 135' ' ' VAL . . . . . 0.427 HG23 ' CZ3' ' C' ' 139' ' ' TRP . 8.3 m -64.7 154.02 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 CA-C-N 113.681 -1.6 . . . . 0.0 113.288 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.569 ' HB2' HG12 ' C' ' 118' ' ' VAL . 88.3 mt -74.87 120.51 20.52 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -177.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 137' ' ' GLU . . . . . 0.428 ' HA ' ' CZ3' ' C' ' 139' ' ' TRP . 42.9 mm-40 -21.29 -28.02 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.159 1 N-CA-C 123.738 4.718 . . . . 0.0 123.738 179.162 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 138' ' ' VAL . . . . . 0.521 HG21 HG21 ' C' ' 109' ' ' VAL . 8.3 p -79.6 83.35 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -175.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 139' ' ' TRP . . . . . 0.428 ' CZ3' ' HA ' ' C' ' 137' ' ' GLU . 34.7 p90 -125.91 171.01 11.09 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-N 112.206 -2.27 . . . . 0.0 109.008 165.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 140' ' ' LYS . . . . . . . . . . . . . 21.0 pttm 56.55 -0.55 0.06 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 117.598 2.444 . . . . 0.0 117.598 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -141.76 165.62 26.97 Favored 'General case' 0 C--O 1.256 1.423 0 CA-C-O 116.015 -1.945 . . . . 0.0 109.731 -175.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 64.35 168.1 0.17 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 161.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 143' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -84.24 73.49 10.43 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 124.52 2.105 . . . . 0.0 109.667 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 144' ' ' VAL . . . . . 0.559 ' HA ' ' HB ' ' C' ' 109' ' ' VAL . 3.2 t -81.34 100.58 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 103.393 -2.818 . . . . 0.0 103.393 175.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 145' ' ' ILE . . . . . 0.804 HG12 ' HB2' ' C' ' 171' ' ' LEU 0.287 13.0 tt -98.87 99.27 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 112.31 -2.223 . . . . 0.0 112.062 -173.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 146' ' ' VAL . . . . . 0.608 HG21 ' HB3' ' C' ' 162' ' ' LEU . 39.5 t -84.11 113.38 22.85 Favored 'Isoleucine or valine' 0 C--N 1.343 0.298 0 CA-C-N 112.702 -2.044 . . . . 0.0 107.013 -171.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 147' ' ' PHE . . . . . 0.449 ' HD2' ' HA ' ' C' ' 175' ' ' ALA . 1.3 m-85 -66.41 112.73 4.2 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 122.647 1.213 . . . . 0.0 110.427 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 148' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -146.26 108.76 4.48 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 105.909 -1.885 . . . . 0.0 105.909 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 149' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -64.97 -40.7 95.38 Favored 'General case' 0 C--N 1.344 0.333 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.78 145.13 51.88 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 103.988 -2.597 . . . . 0.0 103.988 -174.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 151' ' ' MET . . . . . 0.526 ' HG2' ' SD ' ' C' ' 170' ' ' MET . 0.3 OUTLIER -84.02 68.94 10.24 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 170.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -87.16 168.06 13.59 Favored 'General case' 0 C--O 1.258 1.536 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.294 173.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 13.3 m -71.43 119.52 15.7 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 154' ' ' GLY . . . . . . . . . . . . . . . -72.94 -133.16 0.18 Allowed Glycine 0 N--CA 1.478 1.441 0 O-C-N 118.797 -2.439 . . . . 0.0 108.75 172.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 155' ' ' TYR . . . . . 0.862 ' HE1' ' HB2' ' B' 1199 ' ' GLU . 2.8 m-85 -77.03 -50.86 12.15 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 117.135 -1.826 . . . . 0.0 109.881 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 156' ' ' ALA . . . . . 0.631 ' HB1' HG22 ' C' ' 158' ' ' VAL . . . -94.83 -53.32 3.89 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 161.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . 65.96 14.68 61.48 Favored Glycine 0 C--O 1.254 1.349 0 CA-C-O 122.504 1.058 . . . . 0.0 114.253 -173.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 158' ' ' VAL . . . . . 0.631 HG22 ' HB1' ' C' ' 156' ' ' ALA . 13.5 m -89.6 124.84 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -162.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . 0.301 0.0 OUTLIER 37.0 24.61 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 118.266 2.691 . . . . 0.0 118.266 172.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 160' ' ' ASN . . . . . 0.71 ' HB3' HD12 ' C' ' 162' ' ' LEU . 3.7 m120 -62.57 111.63 5.1 Favored Pre-proline 0 C--O 1.239 0.535 0 O-C-N 120.461 -1.399 . . . . 0.0 110.22 -171.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 161' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -56.18 -41.94 71.46 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.885 2.39 . . . . 0.0 112.48 -177.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 162' ' ' LEU . . . . . 1.003 ' HA ' HG22 ' C' ' 168' ' ' THR . 16.0 mt -17.48 -40.91 0.0 OUTLIER 'General case' 0 C--O 1.244 0.794 0 N-CA-C 120.62 3.563 . . . . 0.0 120.62 155.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 163' ' ' PHE . . . . . 0.409 ' HA ' ' HG3' ' C' ' 170' ' ' MET . 12.9 m-30 -82.02 -48.33 11.55 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-O 124.385 2.041 . . . . 0.0 111.777 176.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -91.06 -17.04 26.88 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 111.963 -2.38 . . . . 0.0 113.611 -158.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 165' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -87.88 172.43 9.62 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 121.818 2.099 . . . . 0.0 110.863 -168.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -55.75 10.62 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 120.406 -1.434 . . . . 0.0 114.479 177.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -82.53 -49.97 9.31 Favored 'General case' 0 C--O 1.239 0.538 0 O-C-N 124.848 1.342 . . . . 0.0 108.115 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 168' ' ' THR . . . . . 1.003 HG22 ' HA ' ' C' ' 162' ' ' LEU . 4.8 m -82.84 91.9 7.17 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 123.328 1.537 . . . . 0.0 107.443 177.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -142.41 142.82 32.44 Favored 'General case' 0 N--CA 1.439 -1.013 0 O-C-N 120.88 -1.137 . . . . 0.0 111.686 -154.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 170' ' ' MET . . . . . 0.526 ' SD ' ' HG2' ' C' ' 151' ' ' MET . 54.1 mtm -58.41 126.83 29.21 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 121.169 -0.957 . . . . 0.0 108.878 166.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 171' ' ' LEU . . . . . 0.804 ' HB2' HG12 ' C' ' 145' ' ' ILE . 39.4 tp -89.06 108.78 19.78 Favored 'General case' 0 C--O 1.254 1.329 0 N-CA-C 104.103 -2.554 . . . . 0.0 104.103 166.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -82.22 91.51 6.74 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . -174.69 168.19 40.74 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 106.139 -2.784 . . . . 0.0 106.139 175.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 174' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -72.57 151.7 42.23 Favored 'General case' 0 C--O 1.252 1.225 0 O-C-N 119.026 -2.455 . . . . 0.0 111.528 170.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 175' ' ' ALA . . . . . 0.449 ' HA ' ' HD2' ' C' ' 147' ' ' PHE . . . -59.85 -50.79 72.42 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 126.251 1.82 . . . . 0.0 111.676 -170.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.67 -55.9 6.84 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 177' ' ' ALA . . . . . . . . . . . . . . . -41.35 -44.83 2.88 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 117.851 2.537 . . . . 0.0 117.851 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 9.3 m -64.48 -41.34 96.53 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 175.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 179' ' ' VAL . . . . . 0.503 HG11 HG23 ' C' ' 50' ' ' VAL . 5.2 t -72.45 -32.05 40.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 119.278 -2.138 . . . . 0.0 107.615 177.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 180' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -67.67 -33.17 74.39 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 117.912 -2.992 . . . . 0.0 111.321 176.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.69 -30.61 70.86 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.202 173.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 182' ' ' ILE . . . . . 0.459 HD12 ' HG ' ' C' ' 27' ' ' LEU . 31.0 pt -87.22 -39.14 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 CA-C-O 122.668 1.223 . . . . 0.0 113.672 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 183' ' ' LEU . . . . . 0.513 HD13 ' HB3' ' C' ' 49' ' ' PRO . 12.9 tp -11.42 -66.9 0.01 OUTLIER 'General case' 0 C--N 1.355 0.838 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -107.7 -19.76 13.44 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 118.365 -1.334 . . . . 0.0 114.486 176.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -70.07 -65.28 0.74 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.941 -1.027 . . . . 0.0 113.743 -172.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 186' ' ' LEU . . . . . . . . . . . . 0.345 2.2 pt? . . . . . 0 N--CA 1.43 -1.433 0 N-CA-C 118.969 2.951 . . . . 0.0 118.969 -165.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' NAD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C 1001 ' ' NAP . . . . . 0.541 ' O1N' ' HB3' ' C' ' 115' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1000 ' ' HIS . . . . . . . . . . . . . 11.9 t-80 . . . . . 0 N--CA 1.418 -2.064 0 N-CA-C 106.906 -1.516 . . . . 65.74 106.906 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 1001 ' ' GLY . . . . . . . . . . . . . . . -54.63 77.17 0.01 OUTLIER Glycine 0 C--O 1.223 -0.574 0 C-N-CA 125.581 1.562 . . . . 48.66 114.438 164.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1002 ' ' ARG . . . . . . . . . . . . . 26.1 ttp180 -110.0 134.79 51.75 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.128 -1.536 . . . . 44.56 107.299 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1003 ' ' ILE . . . . . 0.597 HG12 ' HB ' ' A' 1068 ' ' ILE . 30.2 mt -99.75 139.22 21.86 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.757 0 O-C-N 124.482 1.114 . . . . 34.86 110.0 176.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -109.7 135.17 12.68 Favored Glycine 0 C--O 1.25 1.146 0 N-CA-C 107.376 -2.29 . . . . 30.75 107.376 172.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.441 HG21 ' HB2' ' A' 1018 ' ' ALA . 43.6 mm -106.76 112.05 63.63 Favored Pre-proline 0 N--CA 1.427 -1.578 0 N-CA-C 102.008 -3.33 . . . . 32.21 102.008 175.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1006 ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -71.45 143.86 43.96 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 123.137 2.558 . . . . 32.98 111.438 168.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1007 ' ' ARG . . . . . 0.493 ' HG3' HD11 ' A' 1042 ' ' LEU . 25.3 ttp85 -67.8 126.61 29.95 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 104.248 -2.501 . . . . 47.98 104.248 162.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1008 ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -62.81 130.96 47.18 Favored 'General case' 0 CA--C 1.513 -0.478 0 O-C-N 120.247 -1.533 . . . . 34.7 113.219 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1009 ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -86.68 -11.48 51.13 Favored 'General case' 0 C--O 1.252 1.191 0 O-C-N 121.125 -0.984 . . . . 53.37 113.579 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1010 ' ' LEU . . . . . . . . . . . . . 5.9 mp -63.17 148.45 47.99 Favored 'General case' 0 C--O 1.214 -0.786 0 CA-C-O 123.034 1.397 . . . . 45.07 112.529 -176.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1011 ' ' THR . . . . . . . . . . . . . 7.3 m -64.23 107.59 1.35 Allowed 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 114.048 -1.433 . . . . 40.36 111.89 -167.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1012 ' ' ASN . . . . . . . . . . . . . 33.8 t30 68.31 69.07 0.32 Allowed 'General case' 0 C--O 1.215 -0.73 0 CA-C-N 113.173 -1.831 . . . . 40.61 110.264 176.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1013 ' ' GLU . . . . . 0.616 ' HG3' ' H ' ' A' 1015 ' ' ARG . 8.3 tp10 -104.08 146.1 29.21 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 120.034 -0.666 . . . . 33.76 112.207 -168.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1014 ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' 1043 ' ' ALA . 0.6 OUTLIER -103.93 -6.23 21.5 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 122.758 1.266 . . . . 27.89 112.664 178.517 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1015 ' ' ARG . . . . . 0.802 ' HD2' HG11 ' A' 1072 ' ' VAL . 69.5 mtm180 -106.19 147.3 29.21 Favored 'General case' 0 N--CA 1.44 -0.932 0 O-C-N 120.691 -1.255 . . . . 29.02 113.413 -172.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1016 ' ' VAL . . . . . 0.699 HG21 ' HB1' ' A' 1039 ' ' ALA . 8.6 p -148.48 138.93 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 N-CA-C 104.033 -2.58 . . . . 28.13 104.033 159.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1017 ' ' ALA . . . . . . . . . . . . . . . -63.44 -12.94 35.24 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 117.742 -3.098 . . . . 26.87 116.749 -176.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1018 ' ' ALA . . . . . 0.441 ' HB2' HG21 ' A' 1005 ' ' ILE . . . -84.11 112.1 19.93 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 123.734 1.73 . . . . 26.77 111.204 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1019 ' ' THR . . . . . 0.672 HG21 ' HA ' ' A' 1325 ' ' GLN . 67.8 p -118.26 167.74 10.85 Favored Pre-proline 0 N--CA 1.416 -2.138 0 N-CA-C 106.297 -1.742 . . . . 27.02 106.297 158.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1020 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -48.0 -57.48 2.31 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 124.767 3.645 . . . . 30.57 109.782 163.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1021 ' ' LYS . . . . . 0.558 ' HB2' ' NE2' ' A' 1325 ' ' GLN . 21.0 mttp -53.7 -31.12 46.73 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.856 1.662 . . . . 47.81 113.966 178.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1022 ' ' THR . . . . . . . . . . . . . 5.0 m -62.67 -65.57 0.67 Allowed 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 120.435 1.47 . . . . 30.77 108.758 169.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1023 ' ' VAL . . . . . 0.513 HG13 ' HB ' ' A' 1033 ' ' VAL . 59.0 t -56.75 -55.91 17.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 O-C-N 126.611 2.444 . . . . 33.59 113.11 -171.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1024 ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -49.66 -52.24 32.3 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.036 1.334 . . . . 53.29 114.568 -176.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1025 ' ' GLN . . . . . 0.582 ' OE1' ' HE2' ' A' 1336 ' ' LYS . 8.2 tt0 -75.44 -34.46 60.98 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 114.389 -1.278 . . . . 46.92 113.122 -173.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1026 ' ' LEU . . . . . 0.571 HD21 ' HA ' ' A' 1332 ' ' VAL . 95.9 mt -66.87 -39.38 87.51 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.219 -0.901 . . . . 37.17 110.025 177.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1027 ' ' LEU . . . . . 0.501 HD23 ' HA ' ' A' 1032 ' ' THR . 96.5 mt -54.53 -50.03 68.84 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 118.241 -0.885 . . . . 44.44 110.673 172.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1028 ' ' LYS . . . . . . . . . . . . . 42.5 mttm -57.61 -37.86 73.97 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.94 1.296 . . . . 52.58 112.051 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1029 ' ' LEU . . . . . 0.643 ' HA ' ' HE3' ' A' 1342 ' ' LYS . 98.6 mt -66.97 -40.23 87.4 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 119.015 0.825 . . . . 45.69 110.625 173.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1030 ' ' GLY . . . . . . . . . . . . . . . 148.88 -30.31 1.24 Allowed Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.832 -0.699 . . . . 42.09 111.46 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1031 ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -74.85 109.36 8.25 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 124.72 2.2 . . . . 40.72 108.884 -172.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1032 ' ' THR . . . . . 0.501 ' HA ' HD23 ' A' 1027 ' ' LEU . 18.6 m -74.51 131.14 40.76 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 105.611 -1.996 . . . . 37.77 105.611 176.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1033 ' ' VAL . . . . . 0.513 ' HB ' HG13 ' A' 1023 ' ' VAL . 61.1 t -109.83 136.78 44.73 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.784 0 CA-C-O 121.536 0.684 . . . . 33.54 109.66 -171.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1034 ' ' ALA . . . . . . . . . . . . . . . -119.37 130.94 55.58 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 126.789 2.556 . . . . 31.68 109.456 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1035 ' ' VAL . . . . . 0.402 HG11 ' CD2' ' A' 1050 ' ' PHE . 77.6 t -115.34 135.87 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 105.765 -1.939 . . . . 31.52 105.765 -175.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1036 ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -62.31 141.67 58.15 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 123.703 1.716 . . . . 41.04 110.626 169.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1037 ' ' SER . . . . . . . . . . . . . 19.5 m -70.05 151.16 45.83 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.46 -1.245 . . . . 31.83 108.736 174.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1038 ' ' GLY . . . . . . . . . . . . . . . 91.71 -29.27 7.49 Favored Glycine 0 C--O 1.213 -1.192 0 C-N-CA 120.057 -1.068 . . . . 29.36 110.561 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1039 ' ' ALA . . . . . 0.699 ' HB1' HG21 ' A' 1016 ' ' VAL . . . -62.37 -21.11 65.07 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 116.825 2.158 . . . . 27.78 116.825 -169.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1040 ' ' GLY . . . . . . . . . . . . . . . -61.78 -43.2 99.55 Favored Glycine 0 CA--C 1.538 1.492 0 O-C-N 119.795 -1.816 . . . . 28.91 114.342 -175.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1041 ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.79 -28.31 68.91 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 116.35 1.982 . . . . 51.18 116.35 -174.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1042 ' ' LEU . . . . . 0.493 HD11 ' HG3' ' A' 1007 ' ' ARG . 19.5 mt -52.82 -60.79 2.83 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 123.615 1.674 . . . . 29.91 107.898 171.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1043 ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' 1014 ' ' THR . . . -84.88 17.8 2.7 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.854 -1.066 . . . . 28.54 112.792 -173.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1044 ' ' SER . . . . . 0.619 ' HB3' ' HA2' ' B' 1278 ' ' GLY . 60.8 m 52.56 63.79 2.1 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-O 124.13 1.919 . . . . 33.06 112.959 -174.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1045 ' ' PHE . . . . . 0.62 ' HA ' ' HB1' ' B' 1277 ' ' ALA . 22.4 m-85 -128.66 157.08 42.34 Favored 'General case' 0 C--O 1.245 0.842 0 O-C-N 120.849 -1.157 . . . . 30.29 110.675 176.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1046 ' ' ASP . . . . . . . . . . . . . 2.4 t70 -85.26 127.65 34.39 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 111.125 -2.762 . . . . 48.62 104.506 164.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1047 ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -65.17 -39.34 92.8 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 123.068 1.413 . . . . 36.74 112.342 -174.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1048 ' ' LYS . . . . . . . . . . . . . 25.5 pttm -66.84 -12.53 59.45 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 120.059 -1.651 . . . . 43.73 113.918 173.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1049 ' ' ALA . . . . . . . . . . . . . . . -71.64 -21.65 61.8 Favored 'General case' 0 C--O 1.247 0.964 0 CA-C-O 122.776 1.274 . . . . 32.81 110.819 168.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1050 ' ' PHE . . . . . 0.402 ' CD2' HG11 ' A' 1035 ' ' VAL . 22.3 m-30 -78.84 -32.21 46.05 Favored 'General case' 0 CA--C 1.505 -0.773 0 O-C-N 119.492 -2.005 . . . . 31.86 110.056 169.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1051 ' ' VAL . . . . . 0.485 HG22 HG13 ' A' 1057 ' ' ILE . 62.2 t -62.87 -50.66 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-O 122.452 1.12 . . . . 33.22 109.095 173.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1052 ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -43.65 -53.38 5.78 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.038 1.735 . . . . 50.83 112.676 165.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1053 ' ' ALA . . . . . . . . . . . . . . . -56.75 -29.99 63.13 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-O 118.298 -0.858 . . . . 33.12 111.389 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1054 ' ' GLY . . . . . . . . . . . . . . . 104.32 31.28 4.7 Favored Glycine 0 C--N 1.343 0.96 0 N-CA-C 111.896 -0.482 . . . . 35.83 111.896 176.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1055 ' ' ALA . . . . . . . . . . . . . . . -90.59 149.51 22.1 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 121.783 -0.834 . . . . 34.82 109.92 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1056 ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -83.04 122.21 28.02 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 106.295 -1.743 . . . . 49.05 106.295 167.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1057 ' ' ILE . . . . . 0.485 HG13 HG22 ' A' 1051 ' ' VAL . 27.3 mm -98.41 83.71 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.879 0 N-CA-C 106.389 -1.708 . . . . 38.53 106.389 -165.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1058 ' ' VAL . . . . . . . . . . . . . 48.7 t -80.11 130.11 36.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 O-C-N 124.312 1.008 . . . . 42.11 111.976 -173.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1059 ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -79.62 78.55 6.17 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 123.994 1.854 . . . . 58.0 111.537 177.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 101.84 -142.49 15.68 Favored Glycine 0 CA--C 1.49 -1.531 0 CA-C-N 113.599 -1.637 . . . . 52.12 110.631 167.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1061 ' ' ASN . . . . . 0.547 HD21 HD22 ' A' 1082 ' ' LEU . 2.1 t30 -58.19 -26.4 62.74 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 111.33 -2.435 . . . . 54.75 114.12 -156.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1062 ' ' SER . . . . . . . . . . . . . 49.0 m -63.18 -14.3 47.36 Favored 'General case' 0 N--CA 1.427 -1.617 0 O-C-N 119.4 -2.062 . . . . 50.34 111.194 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -61.47 -29.29 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 O-C-N 119.839 -1.788 . . . . 41.46 109.634 172.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1064 ' ' TRP . . . . . 0.479 ' CH2' ' HB3' ' A' 1079 ' ' GLU . 87.7 m95 -65.28 -26.31 68.03 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 114.791 1.404 . . . . 39.32 114.791 171.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1065 ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -79.49 75.34 6.11 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 122.508 1.147 . . . . 55.38 109.125 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1066 ' ' SER . . . . . . . . . . . . . 69.6 m -152.32 151.4 30.84 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 107.118 -1.438 . . . . 41.87 107.118 -172.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1067 ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -66.74 -29.55 69.55 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-O 123.519 1.628 . . . . 53.2 112.324 -174.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1068 ' ' ILE . . . . . 0.597 ' HB ' HG12 ' A' 1003 ' ' ILE . 60.4 mt -131.04 143.21 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 102.868 -3.012 . . . . 41.9 102.868 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1069 ' ' ILE . . . . . 0.439 HG12 HG21 ' A' 1087 ' ' THR . 23.2 mm -123.97 114.29 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 N-CA-C 103.221 -2.881 . . . . 38.73 103.221 175.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1070 ' ' LEU . . . . . 0.599 HD22 HD22 ' A' 1331 ' ' LEU . 95.9 mt -90.05 94.27 9.72 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-N 116.144 -0.48 . . . . 32.44 112.07 172.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1071 ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -91.81 154.3 19.0 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 106.675 -1.602 . . . . 34.65 106.675 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1072 ' ' VAL . . . . . 0.802 HG11 ' HD2' ' A' 1015 ' ' ARG . 12.2 t -90.73 -67.32 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.964 0 N-CA-C 105.038 -2.208 . . . . 31.32 105.038 172.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1073 ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -88.04 179.24 6.45 Favored 'General case' 0 CA--C 1.508 -0.658 0 O-C-N 120.39 -1.444 . . . . 33.94 110.571 -170.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1074 ' ' ALA . . . . . . . . . . . . . . . -52.61 128.89 44.36 Favored Pre-proline 0 N--CA 1.441 -0.894 0 N-CA-C 114.079 1.141 . . . . 38.04 114.079 165.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1075 ' ' PRO . . . . . 0.491 ' HG2' HD21 ' A' 1089 ' ' LEU . 77.9 Cg_exo -67.13 128.39 18.48 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.089 2.526 . . . . 42.68 109.048 174.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1076 ' ' LEU . . . . . . . . . . . . . 53.4 mt -78.16 158.06 29.19 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 112.557 -2.111 . . . . 46.74 106.068 175.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1077 ' ' ASP . . . . . 0.587 ' HA ' HD12 ' A' 1080 ' ' ILE . 4.1 m-20 -45.39 -35.82 3.88 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 118.054 2.613 . . . . 58.61 118.054 -169.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -68.6 -47.47 66.63 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 125.027 1.454 . . . . 59.2 110.729 173.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1079 ' ' GLU . . . . . 0.479 ' HB3' ' CH2' ' A' 1064 ' ' TRP . 33.0 mt-10 -60.44 -37.77 82.0 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 109.361 -0.607 . . . . 50.63 109.361 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1080 ' ' ILE . . . . . 0.587 HD12 ' HA ' ' A' 1077 ' ' ASP . 96.6 mt -56.5 -56.79 11.86 Favored 'Isoleucine or valine' 0 C--N 1.355 0.836 0 O-C-N 120.942 -1.099 . . . . 51.48 108.077 176.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1081 ' ' ALA . . . . . . . . . . . . . . . -62.59 -20.91 65.2 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.712 -1.243 . . . . 50.28 113.028 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1082 ' ' LEU . . . . . 0.547 HD22 HD21 ' A' 1061 ' ' ASN . 75.2 mt -79.17 -16.22 56.92 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 114.954 1.465 . . . . 50.21 114.954 175.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1083 ' ' LEU . . . . . 0.62 HD11 HD13 ' A' 1089 ' ' LEU . 2.3 mm? -59.68 141.04 55.91 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.02 1.282 . . . . 49.06 109.549 172.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1084 ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -86.61 142.61 35.0 Favored Pre-proline 0 C--O 1.217 -0.626 0 N-CA-C 103.413 -2.81 . . . . 51.08 103.413 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1085 ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -54.39 120.96 8.88 Favored 'Trans proline' 0 N--CA 1.42 -2.829 0 C-N-CA 124.306 3.337 . . . . 49.73 109.83 168.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 98.67 -3.68 59.27 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-O 117.925 -1.486 . . . . 47.71 112.757 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1087 ' ' THR . . . . . 0.439 HG21 HG12 ' A' 1069 ' ' ILE . 87.1 m -68.09 129.43 39.89 Favored 'General case' 0 C--O 1.251 1.134 0 CA-C-N 119.139 1.47 . . . . 45.47 111.819 173.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1088 ' ' THR . . . . . 0.434 ' HA ' ' HB ' ' A' 1111 ' ' THR . 2.8 m -68.75 110.51 4.35 Favored 'General case' 0 C--O 1.244 0.803 0 O-C-N 119.324 -2.11 . . . . 42.04 108.739 165.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1089 ' ' LEU . . . . . 0.62 HD13 HD11 ' A' 1083 ' ' LEU . 33.1 tp -98.89 118.88 36.66 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 105.741 -1.948 . . . . 38.06 105.741 173.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1090 ' ' VAL . . . . . . . . . . . . . 24.4 t -113.26 126.43 70.68 Favored 'Isoleucine or valine' 0 C--O 1.256 1.433 0 N-CA-C 104.642 -2.355 . . . . 37.4 104.642 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1091 ' ' SER . . . . . . . . . . . . . 5.1 m -162.17 168.98 21.61 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 121.172 1.805 . . . . 36.16 111.05 -176.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1092 ' ' PHE . . . . . 0.4 ' CE2' ' HG3' ' A' 1133 ' ' MET . 6.5 m-85 -69.46 99.82 1.3 Allowed 'General case' 0 C--N 1.349 0.562 0 O-C-N 120.962 -1.086 . . . . 38.94 109.672 159.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1093 ' ' ILE . . . . . . . . . . . . . 40.7 mm -90.21 -46.93 14.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 113.316 0.858 . . . . 42.17 113.316 175.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1094 ' ' TRP . . . . . 0.446 ' HB3' ' NE2' ' A' 1097 ' ' GLN . 23.8 m95 61.52 63.35 2.32 Favored Pre-proline 0 N--CA 1.469 0.499 0 C-N-CA 124.02 0.928 . . . . 46.51 112.037 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1095 ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -55.96 -27.85 65.81 Favored 'Trans proline' 0 C--N 1.346 0.423 0 N-CA-C 120.494 3.229 . . . . 49.76 120.494 -166.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1096 ' ' ALA . . . . . . . . . . . . . . . -77.2 -29.57 54.35 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 121.546 1.975 . . . . 52.62 112.538 175.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1097 ' ' GLN . . . . . 0.446 ' NE2' ' HB3' ' A' 1094 ' ' TRP . 1.5 mp0 -86.75 -24.16 25.22 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 124.456 2.074 . . . . 60.74 111.233 173.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1098 ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -127.33 74.24 77.48 Favored Pre-proline 0 N--CA 1.431 -1.422 0 O-C-N 120.024 -1.672 . . . . 58.19 112.81 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1099 ' ' PRO . . . . . 0.546 ' HG2' ' HG3' ' A' 1100 ' ' GLU . 94.5 Cg_endo -70.96 -29.42 18.17 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.947 2.431 . . . . 54.59 113.508 177.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1100 ' ' GLU . . . . . 0.546 ' HG3' ' HG2' ' A' 1099 ' ' PRO . 27.2 mt-10 -80.89 -28.02 36.09 Favored 'General case' 0 N--CA 1.434 -1.225 0 O-C-N 119.424 -2.047 . . . . 63.28 106.067 -163.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1101 ' ' LEU . . . . . 0.406 HD23 HD11 ' A' 1080 ' ' ILE . 15.1 mt -50.72 -41.97 56.73 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 124.917 1.287 . . . . 54.75 110.31 171.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1102 ' ' MET . . . . . 0.423 ' SD ' HD11 ' A' 1361 ' ' ILE . 18.6 mmm -66.77 -47.44 72.17 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 118.676 0.671 . . . . 52.65 111.533 -168.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1103 ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -64.16 -38.02 89.57 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 120.735 -1.228 . . . . 66.26 112.673 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1104 ' ' LYS . . . . . . . . . . . . . 86.1 mttt -67.42 -42.33 83.41 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 123.037 1.399 . . . . 63.73 112.926 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 47.8 mt -71.83 -28.41 63.56 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.834 -1.075 . . . . 54.68 112.63 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1106 ' ' ALA . . . . . . . . . . . . . . . -65.12 -41.95 94.39 Favored 'General case' 0 C--O 1.243 0.751 0 O-C-N 120.694 -1.254 . . . . 53.64 110.473 170.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1107 ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -56.28 -39.25 72.36 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.074 0.95 . . . . 67.24 109.696 169.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1108 ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -69.82 -20.93 63.43 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 115.446 1.647 . . . . 65.76 115.446 173.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1109 ' ' ASN . . . . . . . . . . . . . 53.7 t30 68.83 38.69 2.06 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 124.594 2.14 . . . . 58.71 109.106 177.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1110 ' ' VAL . . . . . 0.552 HG11 ' HB3' ' A' 1083 ' ' LEU . 27.1 m -97.92 161.05 2.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 N-CA-C 115.41 1.633 . . . . 46.63 115.41 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1111 ' ' THR . . . . . 0.628 HG23 ' HG3' ' A' 1362 ' ' ARG . 95.0 m -97.68 95.22 7.43 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 106.446 -1.687 . . . . 44.13 106.446 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1112 ' ' VAL . . . . . 0.605 ' HB ' ' HB ' ' A' 1361 ' ' ILE . 49.1 t -86.57 110.7 20.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 O-C-N 121.147 -0.971 . . . . 40.44 112.306 -176.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1113 ' ' MET . . . . . 0.685 ' HB3' HG12 ' A' 1358 ' ' VAL . 46.8 mtp -101.74 110.65 22.68 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 106.344 -1.724 . . . . 50.76 106.344 174.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1114 ' ' ALA . . . . . 0.478 ' HB3' ' HB2' ' A' 1117 ' ' SER . . . -83.99 116.52 22.86 Favored 'General case' 0 C--O 1.253 1.244 0 O-C-N 121.369 -0.832 . . . . 35.64 108.989 -176.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1115 ' ' MET . . . . . 0.441 ' O ' HG23 ' A' 1118 ' ' VAL . 32.7 mmm -70.62 -30.65 67.36 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 113.369 0.877 . . . . 38.74 113.369 -176.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1116 ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -60.33 -35.19 75.07 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 124.486 1.114 . . . . 40.14 112.141 164.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1117 ' ' SER . . . . . 0.478 ' HB2' ' HB3' ' A' 1114 ' ' ALA . 48.5 m -87.58 11.88 13.88 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 118.466 2.765 . . . . 44.79 118.466 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1118 ' ' VAL . . . . . 0.509 ' HA ' HG22 ' A' 1358 ' ' VAL . 40.8 t -60.96 128.39 89.06 Favored Pre-proline 0 N--CA 1.473 0.685 0 N-CA-C 103.755 -2.683 . . . . 43.75 103.755 168.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1119 ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -46.6 140.78 11.8 Favored 'Trans proline' 0 CA--C 1.543 0.928 1 C-N-CA 127.7 5.6 . . . . 48.93 117.762 179.279 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1120 ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -64.32 -0.3 1.23 Allowed 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 116.798 2.147 . . . . 62.9 116.798 -174.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1121 ' ' ILE . . . . . . . . . . . . . 14.5 pt -83.26 148.98 4.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 114.281 1.215 . . . . 57.72 114.281 -170.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1122 ' ' SER . . . . . . . . . . . . . 8.5 m -45.54 -51.56 11.67 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 126.512 1.925 . . . . 57.26 114.432 -176.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1123 ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.62 -24.19 66.53 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 120.676 -1.265 . . . . 62.9 112.258 -178.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1124 ' ' ALA . . . . . . . . . . . . . . . -87.41 -19.0 28.69 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-O 116.642 -1.647 . . . . 49.83 111.097 -176.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1125 ' ' GLN . . . . . 0.607 ' HA ' ' HB3' ' A' 1128 ' ' ASP . 5.4 mm-40 -61.31 -21.34 63.88 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 115.941 1.83 . . . . 52.37 115.941 -167.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1126 ' ' SER . . . . . . . . . . . . . 31.9 m -68.47 -38.77 81.35 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 122.587 1.184 . . . . 42.43 111.117 172.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1127 ' ' LEU . . . . . 0.606 HD21 HD22 ' A' 1337 ' ' LEU . 4.6 mp -77.64 -35.81 52.18 Favored 'General case' 0 C--N 1.35 0.609 0 CA-C-N 115.009 -0.996 . . . . 43.74 110.986 172.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1128 ' ' ASP . . . . . 0.607 ' HB3' ' HA ' ' A' 1125 ' ' GLN . 37.0 t70 -59.71 108.15 0.7 Allowed 'General case' 0 C--N 1.352 0.709 0 CA-C-O 125.892 2.758 . . . . 43.21 115.953 -177.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1129 ' ' ALA . . . . . 0.409 ' CB ' ' HB3' ' A' 1115 ' ' MET . . . -68.09 -29.06 67.9 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 110.459 -3.064 . . . . 35.74 112.293 -176.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 43.3 mt -60.36 -37.09 79.62 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 114.934 -1.03 . . . . 38.09 112.854 172.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1131 ' ' SER . . . . . 0.45 ' HA ' HG11 ' A' 1175 ' ' VAL . 16.5 m -58.95 -48.32 81.92 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 119.255 0.934 . . . . 36.91 111.367 173.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1132 ' ' SER . . . . . . . . . . . . . 73.9 m -59.82 -58.3 9.18 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 119.098 0.863 . . . . 35.79 111.757 175.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1133 ' ' MET . . . . . 0.4 ' HG3' ' CE2' ' A' 1092 ' ' PHE . 27.1 mmt -61.24 -31.17 70.97 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 117.635 2.457 . . . . 30.81 117.635 -176.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1134 ' ' ALA . . . . . . . . . . . . . . . -68.81 -57.06 6.12 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.029 -0.987 . . . . 28.88 112.467 169.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1135 ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -54.8 -48.87 72.22 Favored 'General case' 0 C--O 1.245 0.864 0 C-N-CA 124.379 1.071 . . . . 40.76 110.604 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1136 ' ' ILE . . . . . 0.719 HD13 ' HA ' ' A' 1323 ' ' SER . 42.4 mt -56.31 -50.63 70.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 113.02 0.748 . . . . 31.54 113.02 174.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1137 ' ' ALA . . . . . 0.699 ' HB2' ' HG3' ' A' 1316 ' ' PRO . . . -57.83 -31.55 66.74 Favored 'General case' 0 C--O 1.213 -0.867 0 N-CA-C 114.208 1.188 . . . . 29.87 114.208 174.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1138 ' ' GLY . . . . . . . . . . . . . . . -68.07 -51.09 35.74 Favored Glycine 0 N--CA 1.443 -0.863 0 O-C-N 120.54 -1.35 . . . . 28.73 111.287 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1139 ' ' TYR . . . . . . . . . . . . . 15.7 t80 -62.21 -38.76 90.4 Favored 'General case' 0 C--O 1.217 -0.607 0 O-C-N 122.208 -0.583 . . . . 30.39 110.634 175.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1140 ' ' ARG . . . . . 0.638 ' HG3' HD22 ' A' 1315 ' ' LEU . 7.6 tpt180 -74.54 -24.43 58.95 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.864 1.266 . . . . 26.09 112.521 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1141 ' ' ALA . . . . . 0.551 ' HB2' HD21 ' A' 1284 ' ' LEU . . . -68.15 -40.14 82.44 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.16 -1.422 . . . . 27.1 107.16 170.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1142 ' ' ILE . . . . . 0.443 HG13 ' HB3' ' A' 1183 ' ' ALA . 35.3 mm -64.03 -39.74 86.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 108.259 -1.015 . . . . 28.48 108.259 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1143 ' ' VAL . . . . . . . . . . . . . 54.4 t -59.97 -64.54 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-O 118.694 -0.67 . . . . 23.07 110.792 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1144 ' ' GLU . . . . . 0.453 ' HG3' HD21 ' A' 1315 ' ' LEU . 6.0 mm-40 -71.88 -23.72 61.55 Favored 'General case' 0 C--O 1.247 0.959 0 CA-C-N 121.257 1.844 . . . . 33.4 114.015 -168.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1145 ' ' ALA . . . . . 0.857 ' HB1' HD12 ' A' 1251 ' ' ILE . . . -58.36 -59.06 5.93 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 115.951 -1.976 . . . . 24.22 108.657 164.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1146 ' ' ALA . . . . . . . . . . . . . . . -60.87 -28.21 68.7 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.285 0.991 . . . . 24.89 110.528 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1147 ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -64.5 -37.23 86.82 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 112.865 0.691 . . . . 26.73 112.865 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1148 ' ' GLU . . . . . 0.461 ' HB2' HD11 ' A' 1310 ' ' ILE . 29.0 mm-40 -107.74 -3.63 18.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 117.981 -1.488 . . . . 39.96 112.41 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1149 ' ' PHE . . . . . 0.611 ' CZ ' ' HB3' ' A' 1250 ' ' ASP . 0.8 OUTLIER -64.67 134.72 54.85 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 107.976 -1.12 . . . . 25.87 107.976 178.045 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1150 ' ' GLY . . . . . 0.507 ' HA2' ' HD2' ' B' 1320 ' ' PRO . . . -74.12 -38.74 46.76 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 110.638 -0.985 . . . . 19.28 110.638 173.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1151 ' ' ARG . . . . . 0.962 ' HA ' ' HB2' ' B' 1322 ' ' GLN . 46.1 mtm-85 -94.97 177.09 6.0 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 120.67 -1.488 . . . . 39.9 111.48 -178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1152 ' ' PHE . . . . . 0.945 ' HB2' HG11 ' A' 1163 ' ' VAL . 2.6 m-30 -79.48 157.46 27.47 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 120.021 1.282 . . . . 29.44 109.288 169.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1153 ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -66.46 -56.05 12.77 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 105.819 -1.919 . . . . 32.6 105.819 155.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1154 ' ' THR . . . . . . . . . . . . . 25.9 m -51.57 89.24 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 128.352 2.661 . . . . 34.64 116.433 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1155 ' ' GLY . . . . . 0.497 ' HA3' ' HG3' ' A' 1165 ' ' PRO . . . -69.05 83.95 0.23 Allowed Glycine 0 C--O 1.215 -1.05 0 CA-C-O 122.291 0.939 . . . . 37.14 111.328 174.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -117.23 -170.68 1.89 Allowed 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 112.365 -1.917 . . . . 40.57 108.931 168.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1157 ' ' ILE . . . . . 0.718 HG12 ' HG2' ' C' ' 70' ' ' PRO . 1.1 tp -141.83 148.7 20.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 103.404 -2.813 . . . . 44.61 103.404 -175.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1158 ' ' THR . . . . . . . . . . . . . 16.7 p -98.8 -144.23 0.32 Allowed 'General case' 0 C--O 1.249 1.075 0 CA-C-O 116.628 -1.653 . . . . 40.7 110.349 175.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1159 ' ' ALA . . . . . 0.417 ' HB2' HG21 ' C' ' 71' ' ' VAL . . . -95.39 -29.47 14.42 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 121.866 2.121 . . . . 40.25 106.932 163.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1160 ' ' ALA . . . . . 0.439 ' HB2' ' ND2' ' B' 1330 ' ' ASN . . . -76.27 -83.5 0.07 Allowed 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 109.713 -0.477 . . . . 38.47 109.713 173.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1161 ' ' GLY . . . . . . . . . . . . . . . -122.3 169.43 14.93 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-O 123.85 1.806 . . . . 37.61 113.574 -160.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1162 ' ' LYS . . . . . . . . . . . . . 23.2 tttp -102.01 140.98 35.56 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-N 109.908 -3.146 . . . . 48.9 108.667 -172.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1163 ' ' VAL . . . . . 0.945 HG11 ' HB2' ' A' 1152 ' ' PHE . 47.0 t -98.27 114.98 65.84 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-N 113.658 -1.61 . . . . 36.52 106.8 167.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1164 ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -54.92 123.53 14.0 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.97 2.447 . . . . 35.08 112.103 165.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1165 ' ' PRO . . . . . 0.497 ' HG3' ' HA3' ' A' 1155 ' ' GLY . 91.8 Cg_exo -60.39 119.9 7.35 Favored 'Trans proline' 0 N--CA 1.432 -2.138 0 C-N-CA 125.091 3.86 . . . . 35.33 109.532 176.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1166 ' ' ALA . . . . . 0.435 ' O ' ' HB1' ' A' 1189 ' ' ALA . . . -67.87 126.11 28.4 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 113.838 -1.528 . . . . 34.69 114.615 -167.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1167 ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' A' 1190 ' ' ILE . 9.4 mptt -73.53 90.67 1.76 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 124.662 1.226 . . . . 45.36 109.535 172.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1168 ' ' VAL . . . . . . . . . . . . . 34.3 t -83.7 89.85 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-O 124.439 2.066 . . . . 31.71 105.823 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1169 ' ' MET . . . . . 0.602 ' HG3' HD11 ' A' 1212 ' ' LEU . 25.7 ttp -74.98 134.09 41.56 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 113.917 -1.492 . . . . 42.28 108.888 174.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1170 ' ' VAL . . . . . . . . . . . . . 99.1 t -125.26 136.99 59.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 104.442 -2.429 . . . . 30.51 104.442 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1171 ' ' ILE . . . . . 0.46 HG22 ' HB2' ' A' 1256 ' ' ALA . 61.3 mt -121.69 127.57 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 103.979 -2.6 . . . . 31.87 103.979 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1172 ' ' GLY . . . . . . . . . . . . . . . 73.82 70.51 1.23 Allowed Glycine 0 CA--C 1.535 1.304 0 N-CA-C 107.557 -2.217 . . . . 34.54 107.557 -170.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1173 ' ' ALA . . . . . 0.669 ' HA ' ' HA3' ' A' 1177 ' ' GLY . . . -72.95 59.96 0.52 Allowed 'General case' 0 N--CA 1.445 -0.725 0 O-C-N 120.311 -1.699 . . . . 32.51 109.577 173.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1174 ' ' GLY . . . . . 0.605 ' HA2' ' NH2' ' A' 1197 ' ' ARG . . . -86.95 -148.98 13.78 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 107.987 -2.045 . . . . 29.9 107.987 -177.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1175 ' ' VAL . . . . . 0.45 HG11 ' HA ' ' A' 1131 ' ' SER . 57.7 t -60.03 -40.43 83.15 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 O-C-N 119.329 -2.277 . . . . 33.11 108.832 176.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1176 ' ' ALA . . . . . 0.641 ' HB3' HG21 ' A' 1255 ' ' THR . . . -69.62 -52.75 23.13 Favored 'General case' 0 C--O 1.224 -0.277 0 O-C-N 121.858 -0.526 . . . . 28.1 110.712 177.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1177 ' ' GLY . . . . . 0.669 ' HA3' ' HA ' ' A' 1173 ' ' ALA . . . -56.27 -48.02 77.94 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 110.892 -0.883 . . . . 28.54 110.892 -176.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1178 ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' 1181 ' ' ILE . 51.4 mt -58.57 -39.4 80.17 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.939 1.459 . . . . 31.22 114.939 177.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -68.84 -36.49 78.23 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.708 -0.62 . . . . 28.98 112.355 173.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1180 ' ' ALA . . . . . . . . . . . . . . . -63.92 -37.31 86.93 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.399 0.518 . . . . 27.83 112.399 171.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1181 ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' 1178 ' ' LEU . 90.0 mt -62.46 -53.28 49.33 Favored 'Isoleucine or valine' 0 C--O 1.246 0.904 0 C-N-CA 125.622 1.569 . . . . 30.25 108.775 175.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1182 ' ' GLY . . . . . . . . . . . . . . . -50.25 -52.3 28.02 Favored Glycine 0 N--CA 1.435 -1.399 0 O-C-N 125.481 1.738 . . . . 29.59 114.134 175.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1183 ' ' ALA . . . . . 0.443 ' HB3' HG13 ' A' 1142 ' ' ILE . . . -61.42 -45.24 95.13 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.982 0.734 . . . . 30.29 112.982 178.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1184 ' ' ALA . . . . . . . . . . . . . . . -74.15 -36.82 64.14 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 113.457 0.91 . . . . 30.47 113.457 -173.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1185 ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -57.73 -48.77 78.67 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 108.369 -0.974 . . . . 42.41 108.369 167.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1186 ' ' SER . . . . . 0.632 ' HB3' ' HA ' ' B' 1187 ' ' LEU . 74.1 m -56.68 -37.23 70.56 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 123.153 1.454 . . . . 39.38 112.546 176.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1187 ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' 1187 ' ' LEU . 13.5 mt -69.39 -34.84 75.12 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 118.141 -2.849 . . . . 36.18 114.548 173.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1188 ' ' GLY . . . . . . . . . . . . . . . 105.11 76.08 1.05 Allowed Glycine 0 C--N 1.308 -0.995 0 O-C-N 119.929 -1.732 . . . . 33.78 112.057 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1189 ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' A' 1166 ' ' ALA . . . -151.64 168.41 25.06 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 113.635 -1.282 . . . . 33.93 109.362 -168.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1190 ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' 1167 ' ' LYS . 86.3 mt -90.67 95.38 5.48 Favored 'Isoleucine or valine' 0 C--O 1.253 1.288 0 N-CA-C 107.122 -1.436 . . . . 38.74 107.122 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1191 ' ' VAL . . . . . . . . . . . . . 10.8 t -86.93 133.47 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 106.806 -1.553 . . . . 33.09 106.806 -178.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1192 ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' 1169 ' ' MET . 99.0 mtt180 -133.02 121.52 22.85 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 105.295 -2.113 . . . . 38.92 105.295 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1193 ' ' ALA . . . . . . . . . . . . . . . -127.39 149.41 50.09 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 115.089 1.514 . . . . 35.32 115.089 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1194 ' ' PHE . . . . . 0.515 ' HB2' HD12 ' A' 1212 ' ' LEU . 47.5 t80 -137.39 154.0 50.08 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.425 -2.065 . . . . 39.35 105.425 176.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1195 ' ' ASP . . . . . . . . . . . . . 13.4 t0 -146.91 159.16 43.88 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 103.352 -2.833 . . . . 40.46 103.352 173.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1196 ' ' THR . . . . . . . . . . . . . 53.5 m -63.7 -30.7 71.77 Favored 'General case' 0 C--O 1.254 1.32 0 CA-C-N 111.574 -2.557 . . . . 45.94 108.692 171.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1197 ' ' ARG . . . . . 0.605 ' NH2' ' HA2' ' A' 1174 ' ' GLY . 58.2 mtm180 -101.47 100.69 14.56 Favored Pre-proline 0 CA--C 1.509 -0.629 0 N-CA-C 105.391 -2.078 . . . . 56.02 105.391 176.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1198 ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -59.59 -12.57 17.99 Favored 'Trans proline' 0 C--O 1.257 1.44 0 C-N-CA 122.621 2.214 . . . . 51.27 114.914 175.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1199 ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -48.37 -16.61 0.11 Allowed 'General case' 0 C--O 1.234 0.257 0 N-CA-C 121.219 3.785 . . . . 59.1 121.219 167.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1200 ' ' VAL . . . . . 0.637 HG21 ' HB3' ' A' 1173 ' ' ALA . 33.8 m -80.65 -10.26 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 116.273 1.953 . . . . 51.06 116.273 169.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1201 ' ' LYS . . . . . . . . . . . . . 75.0 tttt -50.59 -54.4 22.97 Favored 'General case' 0 C--N 1.348 0.516 0 N-CA-C 117.431 2.382 . . . . 57.38 117.431 -167.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1202 ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.65 -30.78 63.14 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 115.368 -0.833 . . . . 62.41 108.776 -176.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1203 ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -66.82 -33.2 75.09 Favored 'General case' 0 CA--C 1.501 -0.914 0 O-C-N 119.795 -1.815 . . . . 57.78 111.976 173.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 25.1 t -64.41 -47.9 87.5 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 C-N-CA 124.571 1.148 . . . . 46.38 109.3 172.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1205 ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' 1209 ' ' ALA . 21.6 mm100 -60.3 -45.62 92.74 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 122.006 -0.434 . . . . 50.7 111.403 177.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1206 ' ' SER . . . . . . . . . . . . . 47.5 m -69.54 -24.38 63.71 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 113.098 0.777 . . . . 49.98 113.098 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1207 ' ' MET . . . . . . . . . . . . . 36.6 mtp -86.67 9.77 17.73 Favored 'General case' 0 N--CA 1.443 -0.824 0 O-C-N 120.9 -1.125 . . . . 52.99 113.834 173.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1208 ' ' GLY . . . . . . . . . . . . . . . 89.18 49.31 3.54 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 118.565 0.621 . . . . 47.66 112.648 170.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1209 ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' 1205 ' ' GLN . . . -158.28 160.88 37.55 Favored 'General case' 0 C--O 1.246 0.91 0 C-N-CA 124.116 0.966 . . . . 44.77 112.814 -174.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1210 ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -96.4 147.52 23.73 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 105.476 -2.046 . . . . 47.64 105.476 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1211 ' ' PHE . . . . . . . . . . . . . 44.8 t80 -95.48 130.78 42.19 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.792 -1.188 . . . . 45.66 107.792 166.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1212 ' ' LEU . . . . . 0.602 HD11 ' HG3' ' A' 1169 ' ' MET . 84.6 mt -65.43 105.6 1.2 Allowed 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 113.508 0.929 . . . . 46.06 113.508 -177.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1213 ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -79.11 124.33 28.21 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 122.58 1.181 . . . . 60.22 110.024 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1214 ' ' LEU . . . . . 0.548 ' HA ' ' HG ' ' A' 1241 ' ' LEU . 9.6 mp -76.5 133.8 39.67 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 112.736 -2.029 . . . . 57.25 108.321 174.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1215 ' ' ASP . . . . . . . . . . . . . 28.6 t70 -85.56 81.01 8.85 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 104.801 -2.296 . . . . 64.43 104.801 177.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1216 ' ' PHE . . . . . . . . . . . . . 14.8 t80 . . . . . 0 CA--C 1.503 -0.836 0 CA-C-N 113.483 -1.69 . . . . 66.9 112.66 -167.278 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 1224 ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 CA--C 1.561 1.394 0 CA-C-O 116.809 -1.567 . . . . 39.09 108.576 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 1225 ' ' GLY . . . . . . . . . . . . . . . -52.12 -49.67 48.79 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 120.689 1.586 . . . . 39.32 114.242 173.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1226 ' ' TYR . . . . . . . . . . . . . 74.3 t80 -64.25 -41.47 96.94 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.878 0.847 . . . . 39.3 109.738 -175.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -62.05 -41.89 98.61 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 114.479 -1.237 . . . . 36.3 111.466 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1228 ' ' LYS . . . . . . . . . . . . . . . -58.14 -49.8 75.72 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 124.078 0.861 . . . . 37.38 109.364 170.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1229 ' ' VAL . . . . . . . . . . . . . . . -65.99 -11.17 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 114.77 1.396 . . . . 39.11 114.77 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1230 ' ' MET . . . . . . . . . . . . . 26.4 mmt -107.93 -7.39 16.23 Favored 'General case' 0 C--O 1.244 0.789 0 O-C-N 121.103 -0.998 . . . . 49.59 110.235 175.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1231 ' ' SER . . . . . 0.495 ' O ' HG13 ' A' 1235 ' ' ILE . 69.4 m -87.12 132.74 33.75 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 118.919 0.781 . . . . 43.68 109.06 176.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1232 ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -49.46 -58.34 5.34 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 114.462 1.282 . . . . 55.57 114.462 -167.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1233 ' ' ALA . . . . . . . . . . . . . . . -64.94 -30.13 71.1 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 113.86 1.059 . . . . 44.94 113.86 -173.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1234 ' ' PHE . . . . . . . . . . . . . 32.5 t80 -66.29 -48.74 69.43 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 115.483 -2.199 . . . . 42.04 107.994 172.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1235 ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' 1231 ' ' SER . 2.9 mt -59.2 -30.92 44.94 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 CA-C-O 123.627 1.679 . . . . 46.28 112.8 177.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1236 ' ' LYS . . . . . . . . . . . . . 33.3 tttm -74.49 -42.15 59.49 Favored 'General case' 0 C--O 1.215 -0.761 0 O-C-N 119.156 -2.215 . . . . 47.87 105.585 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1237 ' ' ALA . . . . . . . . . . . . . . . -61.18 -31.03 70.78 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 119.551 1.069 . . . . 41.61 112.012 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1238 ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -62.14 -59.1 5.54 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.741 -1.207 . . . . 50.65 107.741 168.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1239 ' ' MET . . . . . . . . . . . . . 38.6 mtt -55.33 -40.15 70.84 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 121.688 0.756 . . . . 48.87 112.667 -178.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1240 ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -61.43 -51.46 68.65 Favored 'General case' 0 C--O 1.254 1.291 0 O-C-N 120.267 -1.521 . . . . 54.8 108.984 176.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1241 ' ' LEU . . . . . 0.548 ' HG ' ' HA ' ' A' 1214 ' ' LEU . 1.5 tm? -65.43 -37.39 86.77 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.703 -0.851 . . . . 43.21 108.703 -172.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1242 ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -66.94 -43.06 84.2 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.685 -1.143 . . . . 38.66 112.256 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1243 ' ' ALA . . . . . 0.504 ' HA ' ' HG3' ' A' 1271 ' ' MET . . . -58.41 -45.09 89.08 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 120.799 1.636 . . . . 37.92 111.288 175.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1244 ' ' ALA . . . . . . . . . . . . . . . -60.8 -48.57 81.18 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 114.337 -1.301 . . . . 37.28 110.28 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1245 ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -63.93 -43.45 95.82 Favored 'General case' 0 C--O 1.214 -0.783 0 CA-C-O 115.413 -2.232 . . . . 43.07 112.496 170.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1246 ' ' ALA . . . . . 0.626 ' HB1' ' HG2' ' A' 1275 ' ' MET . . . -57.59 -38.75 75.4 Favored 'General case' 0 C--O 1.212 -0.892 0 CA-C-N 122.471 2.396 . . . . 38.3 110.186 -170.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1247 ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' 1274 ' ' SER . 38.2 mtmt -62.71 -22.1 66.26 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 115.658 1.725 . . . . 47.6 115.658 176.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1248 ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -118.56 -14.36 9.65 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-O 117.914 -1.041 . . . . 45.42 112.444 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1249 ' ' VAL . . . . . 0.544 HG22 ' HA ' ' A' 1246 ' ' ALA 0.277 34.7 m -78.79 175.66 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 120.801 1.637 . . . . 36.26 113.304 -178.48 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1250 ' ' ASP . . . . . 0.611 ' HB3' ' CZ ' ' A' 1149 ' ' PHE . 13.1 m-20 -124.28 -47.4 1.88 Allowed 'General case' 0 N--CA 1.432 -1.339 0 O-C-N 124.586 1.179 . . . . 33.04 112.823 -171.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1251 ' ' ILE . . . . . 0.857 HD12 ' HB1' ' A' 1145 ' ' ALA . 38.0 mm -127.04 137.61 57.34 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 N-CA-C 105.147 -2.168 . . . . 31.4 105.147 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1252 ' ' ILE . . . . . 0.685 HD12 HG12 ' A' 1281 ' ' ILE . 33.0 mt -125.14 113.14 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 C-N-CA 119.282 -0.967 . . . . 29.42 108.526 167.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1253 ' ' VAL . . . . . . . . . . . . . 48.5 t -90.65 102.93 13.87 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 CA-C-O 124.394 2.045 . . . . 30.37 106.728 176.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1254 ' ' THR . . . . . 0.86 ' HB ' ' HA ' ' A' 1283 ' ' ASP . 21.8 m -100.36 99.17 9.77 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 110.473 -3.058 . . . . 35.72 104.04 -158.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1255 ' ' THR . . . . . 0.641 HG21 ' HB3' ' A' 1176 ' ' ALA . 0.2 OUTLIER -137.4 22.75 2.96 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.758 -1.565 . . . . 36.0 113.845 -168.216 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1256 ' ' ALA . . . . . 0.46 ' HB2' HG22 ' A' 1171 ' ' ILE . . . -78.48 85.84 4.54 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 118.166 -2.834 . . . . 40.93 110.223 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1257 ' ' LEU . . . . . . . . . . . . . 10.2 tp -142.55 124.2 14.99 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 111.514 -2.585 . . . . 47.82 109.311 -168.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1258 ' ' ILE . . . . . . . . . . . . . 8.4 mm -78.13 120.71 82.24 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 100.916 -3.735 . . . . 52.7 100.916 160.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1259 ' ' PRO . . . . . . . . . . . . . 1.3 Cg_exo -44.18 113.33 0.42 Allowed 'Trans proline' 0 C--N 1.319 -0.982 1 C-N-CA 125.551 4.167 . . . . 54.13 116.373 -167.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1260 ' ' GLY . . . . . . . . . . . . . . . 78.71 3.96 87.55 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 112.243 -2.253 . . . . 54.62 115.727 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1261 ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -111.22 145.16 31.92 Favored Pre-proline 0 C--O 1.219 -0.539 0 CA-C-N 121.561 2.68 . . . . 55.74 105.581 -174.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1262 ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -48.16 108.27 0.17 Allowed 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 125.08 3.853 . . . . 51.15 116.055 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1263 ' ' ALA . . . . . 0.46 ' HB1' ' ND2' ' A' 1291 ' ' ASN . . . -65.12 154.85 85.99 Favored Pre-proline 0 C--O 1.222 -0.358 0 CA-C-N 112.579 -2.1 . . . . 46.06 112.725 -176.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1264 ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.44 126.26 15.27 Favored 'Trans proline' 0 C--O 1.248 0.983 0 C-N-CA 123.737 2.958 . . . . 41.08 109.826 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1265 ' ' LYS . . . . . . . . . . . . . 50.1 mmtt -77.56 105.63 8.83 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 106.385 -1.709 . . . . 47.42 106.385 176.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1266 ' ' LEU . . . . . . . . . . . . . 52.4 mt -107.59 -52.35 2.78 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 113.112 -1.858 . . . . 39.22 110.246 -174.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1267 ' ' ILE . . . . . 0.623 ' HA ' ' SD ' ' A' 1271 ' ' MET . 61.1 mt -88.03 100.46 10.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 104.882 -2.266 . . . . 42.5 104.882 -169.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1268 ' ' THR . . . . . 0.545 ' O ' HG23 ' A' 1272 ' ' VAL . 12.3 p -68.05 157.6 34.81 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 126.146 1.778 . . . . 37.84 113.934 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1269 ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -57.49 -34.15 68.76 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 115.223 1.564 . . . . 54.8 115.223 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1270 ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -67.37 -47.24 70.97 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 114.355 -1.293 . . . . 54.36 110.889 172.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1271 ' ' MET . . . . . 0.623 ' SD ' ' HA ' ' A' 1267 ' ' ILE . 54.6 ttm -58.33 -45.41 88.15 Favored 'General case' 0 C--O 1.251 1.18 0 C-N-CA 124.297 1.039 . . . . 39.52 109.862 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1272 ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' 1268 ' ' THR . 21.2 t -57.4 -54.44 30.88 Favored 'Isoleucine or valine' 0 C--O 1.249 1.069 0 CA-C-N 115.843 -0.617 . . . . 38.25 110.379 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1273 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.41 -11.91 60.14 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 114.096 1.147 . . . . 40.77 114.096 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1274 ' ' SER . . . . . 0.474 ' O ' ' HG2' ' A' 1247 ' ' LYS . 70.7 m -78.28 -18.96 54.58 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 116.631 -1.652 . . . . 36.58 112.875 172.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1275 ' ' MET . . . . . 0.626 ' HG2' ' HB1' ' A' 1246 ' ' ALA . 85.0 mtp -53.4 155.03 3.05 Favored 'General case' 0 CA--C 1.51 -0.571 0 O-C-N 125.222 1.576 . . . . 36.75 115.156 -176.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1276 ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' 1247 ' ' LYS . 39.8 ttpt -60.93 139.99 57.87 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 105.532 -2.025 . . . . 46.11 105.532 166.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1277 ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' B' 1044 ' ' SER . . . -85.57 165.37 17.12 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 123.182 1.468 . . . . 33.52 110.304 -171.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1278 ' ' GLY . . . . . . . . . . . . . . . 74.02 36.5 51.64 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.697 1.141 . . . . 31.27 111.977 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1279 ' ' SER . . . . . 0.48 ' HB2' HG22 ' A' 1307 ' ' VAL . 37.3 m -134.42 166.27 23.24 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 114.2 -1.0 . . . . 32.95 108.539 -165.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1280 ' ' VAL . . . . . 0.782 HG22 ' HB2' ' A' 1308 ' ' LYS . 48.4 t -133.65 142.94 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 O-C-N 118.939 -2.35 . . . . 27.43 111.474 -176.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1281 ' ' ILE . . . . . 0.685 HG12 HD12 ' A' 1252 ' ' ILE . 74.7 mt -110.49 103.23 15.15 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 N-CA-C 102.167 -3.272 . . . . 30.3 102.167 164.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1282 ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -86.85 95.86 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 N-CA-C 107.291 -1.374 . . . . 28.63 107.291 174.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1283 ' ' ASP . . . . . 0.86 ' HA ' ' HB ' ' A' 1254 ' ' THR . 19.7 t0 -85.96 106.92 17.48 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 105.547 -2.019 . . . . 36.27 105.547 -173.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1284 ' ' LEU . . . . . 0.551 HD21 ' HB2' ' A' 1141 ' ' ALA . 91.0 mt -89.59 -31.9 17.36 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 114.924 -1.035 . . . . 38.57 108.584 175.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1285 ' ' ALA . . . . . . . . . . . . . . . -66.43 -11.25 50.86 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 122.449 1.119 . . . . 37.56 110.861 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1286 ' ' ALA . . . . . . . . . . . . . . . -42.48 -20.36 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 126.509 1.924 . . . . 40.33 115.304 163.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1287 ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -47.92 -41.25 24.22 Favored 'General case' 0 CA--C 1.553 1.071 0 O-C-N 121.378 -0.826 . . . . 56.85 110.675 173.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1288 ' ' ASN . . . . . . . . . . . . . 1.4 t30 -137.07 99.26 3.95 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 119.787 -0.765 . . . . 45.86 109.509 170.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1289 ' ' GLY . . . . . . . . . . . . . . . 82.18 -50.34 4.29 Favored Glycine 0 N--CA 1.476 1.317 0 O-C-N 119.693 -1.879 . . . . 40.31 113.863 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1290 ' ' GLY . . . . . . . . . . . . . . . 101.39 164.47 27.41 Favored Glycine 0 N--CA 1.477 1.373 0 CA-C-N 119.749 1.775 . . . . 38.89 113.241 -176.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1291 ' ' ASN . . . . . 0.565 ' HB2' HG22 ' A' 1254 ' ' THR . 33.5 m120 -93.14 -35.84 12.96 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 117.954 0.877 . . . . 37.23 109.1 171.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1292 ' ' CYS . . . . . 0.598 ' HB3' ' OG1' ' A' 1295 ' ' THR . 20.5 t -78.49 153.67 31.16 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 122.885 1.326 . . . . 36.5 109.265 173.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1293 ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -82.89 -50.5 8.55 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 113.104 -1.862 . . . . 43.32 109.666 174.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1294 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.64 -24.94 59.19 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 117.454 2.39 . . . . 41.32 117.454 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1295 ' ' THR . . . . . 0.598 ' OG1' ' HB3' ' A' 1292 ' ' CYS . 98.0 m -38.48 112.52 0.23 Allowed 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 124.915 1.286 . . . . 35.3 113.585 167.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1296 ' ' VAL . . . . . . . . . . . . . 29.6 t -87.65 111.65 43.34 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 102.921 -2.992 . . . . 34.84 102.921 163.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1297 ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -64.92 86.44 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.697 1 C-N-CA 125.327 4.018 . . . . 33.51 107.056 174.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1298 ' ' GLY . . . . . . . . . . . . . . . 154.77 -27.94 0.66 Allowed Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 107.722 -2.151 . . . . 32.19 107.722 178.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1299 ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -130.94 164.63 24.9 Favored 'General case' 0 C--O 1.251 1.135 0 CA-C-N 122.067 2.934 . . . . 34.88 113.975 -168.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1300 ' ' ILE . . . . . 0.681 HG12 HG12 ' A' 1310 ' ' ILE . 84.1 mt -77.13 124.45 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 104.563 -2.384 . . . . 32.29 104.563 156.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1301 ' ' PHE . . . . . . . . . . . . . 50.9 t80 -108.0 113.14 26.11 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 102.387 -3.19 . . . . 37.25 102.387 170.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1302 ' ' THR . . . . . . . . . . . . . 5.5 m -94.08 108.42 20.25 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 120.067 -1.646 . . . . 35.56 107.066 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1303 ' ' THR . . . . . . . . . . . . . 8.8 p -74.96 166.32 23.85 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 115.517 1.673 . . . . 36.4 115.517 -174.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1304 ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.41 -26.53 65.58 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 120.561 -1.337 . . . . 52.32 112.039 -164.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1305 ' ' ASN . . . . . 0.455 HD21 ' HB2' ' A' 1275 ' ' MET . 49.1 p-10 -66.75 -42.99 85.29 Favored 'General case' 0 C--O 1.239 0.552 0 O-C-N 121.116 -0.99 . . . . 40.04 112.116 171.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1306 ' ' GLY . . . . . . . . . . . . . . . 123.61 43.15 0.35 Allowed Glycine 0 N--CA 1.414 -2.785 0 CA-C-O 123.244 1.469 . . . . 36.96 111.663 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1307 ' ' VAL . . . . . 0.48 HG22 ' HB2' ' A' 1279 ' ' SER . 41.5 t -113.52 140.89 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-N 113.728 -1.236 . . . . 33.4 109.253 176.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1308 ' ' LYS . . . . . 0.782 ' HB2' HG22 ' A' 1280 ' ' VAL . 34.6 mmtt -97.81 110.73 23.24 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 112.658 -2.064 . . . . 42.91 107.902 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1309 ' ' VAL . . . . . . . . . . . . . 5.3 t -99.62 87.42 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.817 0 N-CA-C 104.73 -2.322 . . . . 32.29 104.73 -176.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1310 ' ' ILE . . . . . 0.681 HG12 HG12 ' A' 1300 ' ' ILE . 75.2 mt -88.57 83.09 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 113.979 -1.464 . . . . 30.99 109.232 -171.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1311 ' ' GLY . . . . . . . . . . . . . . . -82.11 54.83 4.9 Favored Glycine 0 N--CA 1.437 -1.282 0 CA-C-O 123.415 1.564 . . . . 28.95 112.249 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1312 ' ' TYR . . . . . 0.545 ' CB ' ' HG ' ' A' 1315 ' ' LEU . 11.1 m-30 -82.58 98.73 9.13 Favored 'General case' 0 CA--C 1.502 -0.881 0 O-C-N 118.242 -2.916 . . . . 31.69 114.314 -173.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1313 ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -52.05 -44.26 64.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 112.041 -2.345 . . . . 34.17 111.806 170.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1314 ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -64.9 -10.12 26.3 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 117.827 2.529 . . . . 36.86 117.827 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1315 ' ' LEU . . . . . 0.638 HD22 ' HG3' ' A' 1140 ' ' ARG . 45.9 mt -62.55 -29.24 4.45 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 118.713 2.857 . . . . 34.85 118.713 -175.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1316 ' ' PRO . . . . . 0.699 ' HG3' ' HB2' ' A' 1137 ' ' ALA . 0.7 OUTLIER -59.92 -27.61 85.3 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.446 2.764 . . . . 29.15 114.267 165.223 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1317 ' ' GLY . . . . . . . . . . . . . . . -79.98 -48.97 6.23 Favored Glycine 0 CA--C 1.502 -0.764 0 N-CA-C 107.55 -2.22 . . . . 27.29 107.55 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1318 ' ' ARG . . . . . . . . . . . . . 4.7 ttm180 -87.05 57.1 4.31 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 113.627 0.973 . . . . 41.49 113.627 -159.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1319 ' ' LEU . . . . . . . . . . . . . 15.1 tp -135.89 73.31 60.11 Favored Pre-proline 0 C--N 1.32 -0.715 1 N-CA-C 99.327 -4.323 . . . . 27.61 99.327 156.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1320 ' ' PRO . . . . . 0.613 ' HG2' ' HA2' ' B' 1150 ' ' GLY . 60.7 Cg_endo -42.25 -64.18 0.27 Allowed 'Trans proline' 0 N--CA 1.442 -1.531 1 C-N-CA 126.171 4.581 . . . . 25.94 117.999 -158.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1321 ' ' THR . . . . . 0.528 HG23 ' CZ ' ' A' 1045 ' ' PHE . 6.7 m -58.07 -45.58 86.89 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 119.803 -0.759 . . . . 25.01 111.016 176.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1322 ' ' GLN . . . . . 0.652 ' HB2' ' HA ' ' B' 1151 ' ' ARG . 33.8 tp60 -67.38 -48.07 68.48 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 123.767 0.667 . . . . 29.39 109.76 -169.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1323 ' ' SER . . . . . 0.719 ' HA ' HD13 ' A' 1136 ' ' ILE . 20.4 m -56.08 -48.67 75.66 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 118.391 -0.814 . . . . 26.47 112.946 174.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1324 ' ' SER . . . . . . . . . . . . . 36.0 m -65.03 -29.76 70.69 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 123.069 1.414 . . . . 27.78 112.581 175.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1325 ' ' GLN . . . . . 0.672 ' HA ' HG21 ' A' 1019 ' ' THR . 26.7 tp60 -72.6 -58.84 3.06 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 106.641 -1.614 . . . . 37.53 106.641 -174.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1326 ' ' LEU . . . . . 0.458 ' HG ' HE21 ' A' 1322 ' ' GLN . 37.9 mt -71.21 -42.01 69.51 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 118.385 -0.817 . . . . 35.71 109.151 -172.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1327 ' ' TYR . . . . . 0.496 ' O ' ' HB2' ' A' 1330 ' ' ASN . 53.0 t80 -60.55 -41.32 94.29 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 119.636 1.107 . . . . 31.59 110.857 173.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1328 ' ' GLY . . . . . 0.511 ' HA2' HD12 ' A' 1331 ' ' LEU . . . -61.71 -47.01 93.0 Favored Glycine 0 C--O 1.256 1.487 0 O-C-N 121.336 -0.852 . . . . 28.0 111.653 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1329 ' ' THR . . . . . . . . . . . . . 6.5 m -71.99 -24.05 61.52 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 113.964 -1.118 . . . . 32.15 109.251 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1330 ' ' ASN . . . . . 0.496 ' HB2' ' O ' ' A' 1327 ' ' TYR . 17.6 m120 -60.74 -49.28 78.15 Favored 'General case' 0 C--O 1.24 0.595 0 O-C-N 119.067 -2.27 . . . . 34.36 111.851 168.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1331 ' ' LEU . . . . . 0.599 HD22 HD22 ' A' 1070 ' ' LEU . 16.4 mt -62.41 -37.81 87.22 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 114.758 -1.11 . . . . 33.37 111.136 178.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1332 ' ' VAL . . . . . 0.571 ' HA ' HD21 ' A' 1026 ' ' LEU . 64.1 t -63.76 -45.64 96.69 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 N-CA-C 108.634 -0.876 . . . . 35.27 108.634 173.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1333 ' ' ASN . . . . . 0.402 ' HA ' ' HD2' ' A' 1336 ' ' LYS . 37.0 m-80 -57.8 -44.82 86.58 Favored 'General case' 0 C--O 1.241 0.613 0 O-C-N 118.979 -2.325 . . . . 37.66 112.679 -178.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1334 ' ' LEU . . . . . . . . . . . . . 41.3 tp -53.64 -59.22 4.88 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.886 -1.052 . . . . 40.27 110.443 169.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1335 ' ' LEU . . . . . 0.528 ' HA ' ' HB2' ' A' 1338 ' ' LEU . 32.0 mt -62.9 -14.23 44.05 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 117.472 2.397 . . . . 42.5 117.472 174.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1336 ' ' LYS . . . . . 0.582 ' HE2' ' OE1' ' A' 1025 ' ' GLN . 94.5 mttt -66.52 -46.21 76.93 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 121.749 2.068 . . . . 47.81 107.123 169.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1337 ' ' LEU . . . . . 0.606 HD22 HD21 ' A' 1127 ' ' LEU . 10.9 mp -72.51 -39.68 67.41 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 114.657 -1.156 . . . . 49.27 112.792 177.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1338 ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' 1347 ' ' THR . 9.4 mp -66.85 -32.73 74.19 Favored 'General case' 0 C--O 1.246 0.877 0 O-C-N 120.457 -1.402 . . . . 50.54 112.821 175.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1339 ' ' CYS . . . . . 0.575 ' SG ' ' HA2' ' A' 1344 ' ' GLY . 50.2 t -116.38 68.47 0.73 Allowed 'General case' 0 C--O 1.25 1.079 0 O-C-N 118.711 -2.493 . . . . 53.67 105.532 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1340 ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' 1337 ' ' LEU . 40.2 mtmt -75.02 -42.71 56.74 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.354 1.073 . . . . 63.38 111.132 174.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1341 ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -68.44 -44.94 73.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 123.63 1.681 . . . . 70.95 114.069 -177.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1342 ' ' LYS . . . . . 0.643 ' HE3' ' HA ' ' A' 1029 ' ' LEU . 18.3 mtpt 59.77 67.61 0.86 Allowed 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 128.072 2.549 . . . . 65.25 112.859 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1343 ' ' ASP . . . . . 0.489 ' HB3' ' N ' ' A' 1342 ' ' LYS 0.269 37.5 t70 60.42 -122.11 0.96 Allowed 'General case' 0 N--CA 1.426 -1.66 2 O-C-N 111.602 -6.936 . . . . 64.53 111.795 9.594 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A 1344 ' ' GLY . . . . . 0.575 ' HA2' ' SG ' ' A' 1339 ' ' CYS . . . 109.97 31.25 3.18 Favored Glycine 0 C--O 1.252 1.225 0 O-C-N 117.289 -3.382 . . . . 59.72 111.461 -174.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1345 ' ' ASN . . . . . . . . . . . . . 28.5 t30 -84.21 149.0 26.42 Favored 'General case' 0 N--CA 1.436 -1.156 0 O-C-N 120.492 -1.593 . . . . 64.09 107.105 164.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1346 ' ' ILE . . . . . 0.435 HD12 ' H ' ' A' 1346 ' ' ILE . 2.6 mp -81.36 83.56 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 103.198 -2.89 . . . . 58.82 103.198 176.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1347 ' ' THR . . . . . 0.533 ' O ' ' HG ' ' A' 1338 ' ' LEU . 3.3 m -76.91 83.43 3.46 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 105.798 -1.926 . . . . 54.96 105.798 -177.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1348 ' ' VAL . . . . . 0.456 HG21 HG21 ' A' 1111 ' ' THR . 21.8 t -78.33 76.13 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 124.406 2.051 . . . . 55.64 106.508 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1349 ' ' ASP . . . . . . . . . . . . . 27.0 t70 -75.13 138.38 42.0 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 112.113 -2.312 . . . . 61.45 112.518 -165.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1350 ' ' PHE . . . . . 0.451 ' CZ ' ' HD3' ' A' 1362 ' ' ARG . 11.4 m-30 -103.49 -6.35 21.89 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 112.082 -2.326 . . . . 58.63 112.898 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1351 ' ' ASP . . . . . . . . . . . . . 15.1 t70 -71.71 -48.24 48.49 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 118.797 0.726 . . . . 62.06 110.072 177.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1352 ' ' ASP . . . . . . . . . . . . . 18.2 t0 -66.25 130.57 43.67 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.538 -0.756 . . . . 54.07 109.397 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1353 ' ' VAL . . . . . . . . . . . . . 31.8 m -67.95 -28.31 40.81 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 N-CA-C 113.077 0.769 . . . . 50.68 113.077 -176.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1354 ' ' VAL . . . . . 0.66 ' O ' HG23 ' A' 1358 ' ' VAL . 3.1 m -80.23 -43.65 22.14 Favored 'Isoleucine or valine' 0 C--O 1.246 0.876 0 N-CA-C 105.471 -2.048 . . . . 47.68 105.471 -174.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1355 ' ' ILE . . . . . 0.543 HD11 ' HB3' ' A' 1337 ' ' LEU . 62.2 mt -65.77 -44.08 93.2 Favored 'Isoleucine or valine' 0 C--O 1.25 1.115 0 C-N-CA 119.423 -0.911 . . . . 48.49 109.731 -177.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1356 ' ' ARG . . . . . . . . . . . . . 35.2 tpt85 -53.61 -48.04 69.67 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 115.269 -2.3 . . . . 48.27 113.329 168.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1357 ' ' GLY . . . . . . . . . . . . . . . -57.9 -45.58 93.47 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 122.124 2.238 . . . . 43.53 114.995 174.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1358 ' ' VAL . . . . . 0.685 HG12 ' HB3' ' A' 1113 ' ' MET . 11.6 t -59.44 -49.82 82.18 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 C-N-CA 125.041 1.337 . . . . 45.12 110.913 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1359 ' ' THR . . . . . . . . . . . . . 18.5 m -70.74 87.73 0.7 Allowed 'General case' 0 C--O 1.244 0.774 0 CA-C-O 125.011 2.338 . . . . 42.94 112.479 -177.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1360 ' ' VAL . . . . . . . . . . . . . 16.5 m -78.13 -28.83 15.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 112.642 -2.072 . . . . 43.26 111.461 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1361 ' ' ILE . . . . . 0.605 ' HB ' ' HB ' ' A' 1112 ' ' VAL . 96.5 mt -131.98 119.83 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 102.972 -2.973 . . . . 45.66 102.972 175.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1362 ' ' ARG . . . . . 0.628 ' HG3' HG23 ' A' 1111 ' ' THR . 2.0 ttp180 -106.41 124.42 49.57 Favored 'General case' 0 C--O 1.253 1.241 1 CA-C-N 126.254 4.116 . . . . 61.34 106.762 168.489 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1363 ' ' ALA . . . . . . . . . . . . . . . 43.81 54.6 5.58 Favored 'General case' 0 C--O 1.241 0.627 0 O-C-N 126.447 2.342 . . . . 49.76 115.192 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1364 ' ' GLY . . . . . . . . . . . . . . . 86.04 -24.08 8.49 Favored Glycine 0 CA--C 1.526 0.74 0 O-C-N 120.014 -1.678 . . . . 50.0 114.301 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1365 ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -88.78 124.93 34.62 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 103.692 -2.707 . . . . 56.92 103.692 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1366 ' ' ILE . . . . . 0.518 HG22 ' HB3' ' A' 1368 ' ' TRP . 92.4 mt -75.18 89.32 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.753 0 CA-C-O 123.073 1.416 . . . . 52.78 108.065 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1367 ' ' THR . . . . . . . . . . . . . 17.1 p -75.76 53.05 0.71 Allowed 'General case' 0 C--O 1.252 1.211 0 CA-C-O 125.951 2.786 . . . . 49.44 113.767 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1368 ' ' TRP . . . . . 0.518 ' HB3' HG22 ' A' 1366 ' ' ILE . 57.1 t90 -132.37 144.07 51.49 Favored Pre-proline 0 CA--C 1.545 0.787 0 O-C-N 119.525 -1.984 . . . . 52.38 108.491 -170.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1369 ' ' PRO . . . . . 0.435 ' HA ' ' CD1' ' A' 1368 ' ' TRP . 60.9 Cg_endo -75.39 170.81 70.84 Favored 'Cis proline' 0 C--O 1.25 1.11 0 CA-C-N 123.101 2.143 . . . . 46.94 114.164 -4.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1370 ' ' ALA . . . . . . . . . . . . . . . -128.75 117.98 19.7 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 108.5 -0.926 . . . . 45.91 108.5 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1371 ' ' PRO . . . . . 0.469 ' HA ' ' HD2' ' A' 1372 ' ' PRO . 51.6 Cg_exo -61.22 137.62 72.12 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 125.198 3.932 . . . . 46.39 112.823 -174.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1372 ' ' PRO . . . . . 0.469 ' HD2' ' HA ' ' A' 1371 ' ' PRO . 86.9 Cg_endo -78.35 8.61 3.51 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 121.105 1.204 . . . . 46.72 113.797 160.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1373 ' ' ILE . . . . . . . . . . . . . . . . . . . . 1 C--N 1.214 -5.31 0 O-C-N 119.541 -1.974 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 998' ' ' HIS . . . . . 0.729 ' HB2' ' HB2' ' B' 1000 ' ' HIS . 60.3 m80 . . . . . 0 N--CA 1.436 -1.16 0 N-CA-C 102.989 -2.967 . . . . 63.44 102.989 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 999' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -111.05 43.53 1.44 Allowed 'General case' 0 C--O 1.243 0.739 0 CA-C-O 123.21 1.481 . . . . 51.74 109.045 148.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1000 ' ' HIS . . . . . 0.729 ' HB2' ' HB2' ' B' ' 998' ' ' HIS . 18.7 t60 -84.61 135.61 34.11 Favored 'General case' 0 C--O 1.247 0.96 0 N-CA-C 104.924 -2.25 . . . . 54.07 104.924 -166.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1001 ' ' GLY . . . . . . . . . . . . . . . 67.01 13.22 61.49 Favored Glycine 0 N--CA 1.451 -0.341 0 O-C-N 119.304 -2.122 . . . . 39.22 111.806 -172.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1002 ' ' ARG . . . . . 0.434 ' NH2' ' O ' ' B' 1065 ' ' GLN . 16.6 ttp180 -97.74 121.93 40.24 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.049 -1.463 . . . . 38.12 107.049 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1003 ' ' ILE . . . . . 0.463 HD13 HD13 ' B' 1026 ' ' LEU 0.279 46.6 mt -78.79 149.94 5.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 106.378 -1.712 . . . . 29.7 106.378 172.054 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B 1004 ' ' GLY . . . . . . . . . . . . . . . -121.18 130.09 8.05 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 108.568 -1.813 . . . . 27.5 108.568 162.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1005 ' ' ILE . . . . . 0.483 ' HB ' ' HA ' ' B' 1035 ' ' VAL . 38.4 mm -104.91 103.14 39.63 Favored Pre-proline 0 C--O 1.243 0.748 0 N-CA-C 105.371 -2.085 . . . . 24.83 105.371 170.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1006 ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -74.15 162.47 38.71 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 124.399 3.399 . . . . 27.19 108.993 171.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1007 ' ' ARG . . . . . 0.693 ' HB2' ' HA ' ' B' 1039 ' ' ALA . 29.2 ttp180 -80.52 137.33 36.42 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 104.449 -2.426 . . . . 41.46 104.449 157.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1008 ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -68.82 158.84 33.6 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-N 115.076 -0.965 . . . . 26.93 110.779 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1009 ' ' ARG . . . . . 0.416 HH22 ' CG ' ' B' 1078 ' ' ASP . 35.0 mmm-85 -113.91 -35.16 5.2 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 111.975 -2.375 . . . . 34.48 112.848 -171.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1010 ' ' LEU . . . . . 0.476 HD13 ' HB2' ' B' 1073 ' ' ASN . 7.3 mp -61.04 153.31 25.72 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 115.713 1.746 . . . . 44.22 115.713 -169.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1011 ' ' THR . . . . . . . . . . . . . 20.1 m -62.82 131.82 50.09 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 113.74 -1.573 . . . . 40.74 110.781 -173.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1012 ' ' ASN . . . . . . . . . . . . . 5.2 t30 38.64 47.65 1.17 Allowed 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 129.492 3.117 . . . . 44.44 116.042 -166.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1013 ' ' GLU . . . . . 0.413 ' HG2' ' ND2' ' B' 1073 ' ' ASN . 9.7 tp10 -105.19 118.58 36.9 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 112.217 -2.265 . . . . 29.87 106.809 175.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1014 ' ' THR . . . . . 0.407 ' HA ' ' HB3' ' B' 1042 ' ' LEU . 1.0 OUTLIER -106.0 0.51 25.73 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 115.14 1.533 . . . . 25.26 115.14 176.577 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B 1015 ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -80.6 144.42 32.4 Favored 'General case' 0 C--O 1.241 0.62 0 O-C-N 119.53 -1.981 . . . . 29.54 112.957 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1016 ' ' VAL . . . . . . . . . . . . . 4.7 p -111.42 175.63 1.8 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 103.992 -2.596 . . . . 23.55 103.992 165.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1017 ' ' ALA . . . . . 0.42 ' HB3' HD12 ' B' 1005 ' ' ILE . . . -75.91 -40.33 54.49 Favored 'General case' 0 C--N 1.344 0.356 0 O-C-N 117.939 -2.976 . . . . 23.59 115.042 -176.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1018 ' ' ALA . . . . . 0.65 ' HB1' ' HB ' ' B' 1022 ' ' THR . . . -152.19 145.47 24.71 Favored 'General case' 0 C--O 1.247 0.935 0 N-CA-C 105.28 -2.118 . . . . 24.93 105.28 -176.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1019 ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.14 172.6 5.02 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 115.725 -2.083 . . . . 28.09 111.521 -178.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1020 ' ' PRO . . . . . 0.462 ' HB3' ' HB2' ' B' 1053 ' ' ALA . 82.8 Cg_exo -51.61 -42.65 55.14 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 CA-C-N 127.155 3.591 . . . . 28.79 118.161 -172.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1021 ' ' LYS . . . . . . . . . . . . . 83.6 tttt -54.96 -48.76 72.79 Favored 'General case' 0 CA--C 1.502 -0.89 0 O-C-N 121.236 -0.915 . . . . 47.28 112.617 169.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1022 ' ' THR . . . . . 0.65 ' HB ' ' HB1' ' B' 1018 ' ' ALA . 0.0 OUTLIER -67.77 -24.22 65.3 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 120.755 -1.215 . . . . 30.12 113.253 177.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B 1023 ' ' VAL . . . . . 0.487 HG21 ' HD2' ' B' 1050 ' ' PHE . 43.0 t -67.41 -47.57 80.42 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.711 0 O-C-N 120.244 -1.535 . . . . 32.24 107.713 171.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1024 ' ' GLU . . . . . 0.631 ' HA ' HD12 ' B' 1027 ' ' LEU . 27.6 mt-10 -62.73 -36.09 81.87 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 118.776 -0.63 . . . . 49.62 112.684 176.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1025 ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -58.68 -43.78 90.06 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 124.305 1.003 . . . . 44.68 113.271 169.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1026 ' ' LEU . . . . . 0.478 HD12 ' HA ' ' B' 1023 ' ' VAL . 35.1 mt -62.14 -43.45 98.8 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 119.895 -1.753 . . . . 35.71 113.217 171.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1027 ' ' LEU . . . . . 0.631 HD12 ' HA ' ' B' 1024 ' ' GLU . 24.7 mt -58.24 -27.16 63.71 Favored 'General case' 0 C--N 1.348 0.542 0 O-C-N 119.808 -1.807 . . . . 42.18 112.332 174.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1028 ' ' LYS . . . . . . . . . . . . . 62.7 mttm -61.75 -21.48 64.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 121.097 1.772 . . . . 48.34 112.38 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1029 ' ' LEU . . . . . 0.489 HD23 ' HG2' ' B' 1342 ' ' LYS . 49.6 mt -86.45 -4.16 59.13 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 114.233 1.197 . . . . 38.69 114.233 175.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1030 ' ' GLY . . . . . . . . . . . . . . . 78.58 21.98 68.08 Favored Glycine 0 N--CA 1.446 -0.693 0 O-C-N 120.314 -1.491 . . . . 32.28 113.301 -174.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1031 ' ' PHE . . . . . 0.433 ' HE2' ' HB3' ' B' 1335 ' ' LEU . 22.5 m-85 -99.35 132.44 44.67 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 105.419 -2.067 . . . . 35.94 105.419 176.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1032 ' ' THR . . . . . . . . . . . . . 3.6 m -89.35 123.97 34.01 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 107.971 -1.122 . . . . 33.37 107.971 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1033 ' ' VAL . . . . . . . . . . . . . 22.8 t -95.34 134.12 33.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.637 -1.616 . . . . 29.98 106.637 -171.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1034 ' ' ALA . . . . . . . . . . . . . . . -111.77 145.83 38.68 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.911 -1.144 . . . . 28.18 107.911 159.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1035 ' ' VAL . . . . . 0.526 ' HB ' HD13 ' B' 1057 ' ' ILE . 97.1 t -122.5 149.73 26.06 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 N-CA-C 103.713 -2.699 . . . . 25.82 103.713 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1036 ' ' GLU . . . . . 0.625 ' HB3' ' HB2' ' B' 1039 ' ' ALA . 19.1 tt0 -73.3 147.27 44.65 Favored 'General case' 0 C--O 1.213 -0.835 0 C-N-CA 123.252 0.621 . . . . 32.44 111.293 176.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1037 ' ' SER . . . . . . . . . . . . . 44.0 m -60.25 112.72 2.03 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.347 -1.297 . . . . 29.54 111.015 172.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1038 ' ' GLY . . . . . . . . . . . . . . . 77.92 20.4 73.39 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 111.695 -2.502 . . . . 27.76 113.941 -175.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1039 ' ' ALA . . . . . 0.693 ' HA ' ' HB2' ' B' 1007 ' ' ARG . . . -64.81 -57.8 7.93 Favored 'General case' 0 C--O 1.25 1.12 0 N-CA-C 115.69 1.737 . . . . 26.02 115.69 -176.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1040 ' ' GLY . . . . . . . . . . . . . . . -67.58 -15.1 65.83 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 114.201 -1.363 . . . . 26.47 113.543 -173.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1041 ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -53.36 -35.72 60.59 Favored 'General case' 0 C--O 1.255 1.347 0 O-C-N 119.615 -2.109 . . . . 50.98 113.133 172.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1042 ' ' LEU . . . . . 0.407 ' HB3' ' HA ' ' B' 1014 ' ' THR . 60.8 mt -53.03 -54.47 34.79 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 123.028 2.649 . . . . 29.3 110.03 167.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1043 ' ' ALA . . . . . 0.775 ' HA ' ' HB2' ' B' 1320 ' ' PRO . . . -66.67 2.81 1.19 Allowed 'General case' 0 C--O 1.241 0.641 0 N-CA-C 115.706 1.743 . . . . 26.74 115.706 174.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1044 ' ' SER . . . . . 0.47 ' O ' ' HB1' ' A' 1277 ' ' ALA . 24.3 m 62.28 35.67 15.12 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 123.702 1.715 . . . . 31.26 114.668 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1045 ' ' PHE . . . . . 0.405 ' HA ' ' CB ' ' A' 1277 ' ' ALA . 0.3 OUTLIER -132.5 108.81 9.36 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 105.005 -2.221 . . . . 33.26 105.005 177.066 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B 1046 ' ' ASP . . . . . . . . . . . . . 8.5 t70 -61.52 144.31 54.5 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 114.975 1.472 . . . . 46.74 114.975 -177.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1047 ' ' ASP . . . . . 0.515 ' HA ' ' HD1' ' B' 1050 ' ' PHE . 43.0 p-10 -65.13 -20.4 66.44 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 114.146 1.165 . . . . 34.44 114.146 -175.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1048 ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -56.72 -23.47 42.62 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 117.371 2.36 . . . . 48.67 117.371 165.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1049 ' ' ALA . . . . . . . . . . . . . . . -83.81 -24.21 31.08 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 123.672 0.789 . . . . 35.26 110.371 172.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1050 ' ' PHE . . . . . 0.515 ' HD1' ' HA ' ' B' 1047 ' ' ASP . 75.3 m-85 -74.22 -28.33 61.2 Favored 'General case' 0 C--O 1.251 1.184 0 O-C-N 119.156 -2.215 . . . . 32.17 110.262 171.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1051 ' ' VAL . . . . . . . . . . . . . 91.6 t -62.43 -50.29 80.46 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 N-CA-C 105.918 -1.882 . . . . 38.37 105.918 167.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1052 ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -51.6 -41.52 61.29 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.135 1.531 . . . . 45.77 115.135 172.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1053 ' ' ALA . . . . . 0.462 ' HB2' ' HB3' ' B' 1020 ' ' PRO . . . -65.42 -41.69 93.3 Favored 'General case' 0 C--O 1.218 -0.558 0 O-C-N 123.618 0.574 . . . . 37.83 111.78 173.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1054 ' ' GLY . . . . . . . . . . . . . . . 111.61 53.21 0.53 Allowed Glycine 0 C--N 1.35 1.317 0 N-CA-C 110.704 -0.959 . . . . 35.82 110.704 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1055 ' ' ALA . . . . . . . . . . . . . . . -120.69 150.26 41.22 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-O 123.854 1.788 . . . . 33.77 109.365 171.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1056 ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -63.76 142.83 58.26 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 112.227 -2.261 . . . . 51.02 108.493 167.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1057 ' ' ILE . . . . . 0.526 HD13 ' HB ' ' B' 1035 ' ' VAL . 46.2 mm -120.17 112.74 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 N-CA-C 106.17 -1.789 . . . . 38.47 106.17 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1058 ' ' VAL . . . . . . . . . . . . . 1.8 m -133.74 142.23 42.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 115.445 1.646 . . . . 39.4 115.445 -171.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1059 ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -72.82 105.01 4.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 113.479 -1.691 . . . . 57.07 114.762 -169.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1060 ' ' GLY . . . . . 0.422 ' O ' HG12 ' B' 1063 ' ' VAL . . . 59.96 -113.7 5.61 Favored Glycine 0 N--CA 1.433 -1.558 0 CA-C-N 114.425 -1.261 . . . . 44.83 112.554 165.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1061 ' ' ASN . . . . . 0.416 ' O ' ' HG2' ' B' 1065 ' ' GLN . 13.8 m-20 -61.96 -25.1 67.41 Favored 'General case' 0 C--O 1.241 0.632 0 O-C-N 120.459 -1.613 . . . . 46.27 111.922 -171.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1062 ' ' SER . . . . . . . . . . . . . 66.5 m -59.08 -41.89 89.1 Favored 'General case' 0 N--CA 1.426 -1.642 0 C-N-CA 124.349 1.06 . . . . 43.47 111.21 173.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1063 ' ' VAL . . . . . 0.422 HG12 ' O ' ' B' 1060 ' ' GLY . 2.0 p -66.91 -31.53 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 O-C-N 118.593 -2.567 . . . . 36.98 109.347 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1064 ' ' TRP . . . . . . . . . . . . . 38.8 m95 -68.87 -30.55 69.09 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 113.994 1.109 . . . . 37.9 113.994 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1065 ' ' GLN . . . . . 0.434 ' O ' ' NH2' ' B' 1002 ' ' ARG . 47.1 mm-40 -77.47 92.88 4.04 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.03 -1.1 . . . . 46.19 108.03 175.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1066 ' ' SER . . . . . . . . . . . . . 53.5 m -159.94 165.79 31.39 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 119.929 -1.732 . . . . 37.06 110.906 -169.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1067 ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -65.47 -52.52 52.35 Favored 'General case' 0 C--O 1.22 -0.468 0 O-C-N 124.643 1.214 . . . . 43.95 111.277 170.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1068 ' ' ILE . . . . . 0.6 HD11 HD11 ' B' 1346 ' ' ILE . 23.9 mt -123.74 131.81 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 104.888 -2.264 . . . . 33.5 104.888 -173.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1069 ' ' ILE . . . . . 0.433 HD13 ' HA ' ' B' 1069 ' ' ILE . 26.4 mm -111.4 116.92 53.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 104.779 -2.304 . . . . 30.57 104.779 171.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1070 ' ' LEU . . . . . 0.706 HD22 HD22 ' B' 1331 ' ' LEU . 73.7 mt -102.27 114.96 29.57 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 101.72 -3.437 . . . . 27.66 101.72 178.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1071 ' ' LYS . . . . . . . . . . . . . 18.9 tttm -140.14 157.73 45.16 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 106.182 -1.784 . . . . 28.4 106.182 -169.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1072 ' ' VAL . . . . . . . . . . . . . 67.6 t -83.27 -81.14 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.828 0 C-N-CA 117.547 -1.661 . . . . 23.18 110.188 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1073 ' ' ASN . . . . . 0.476 ' HB2' HD13 ' B' 1010 ' ' LEU . 47.6 m-80 -87.04 156.89 19.56 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 114.174 1.176 . . . . 25.47 114.174 -167.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1074 ' ' ALA . . . . . . . . . . . . . . . -46.65 117.14 4.21 Favored Pre-proline 0 C--O 1.249 1.075 0 C-N-CA 124.129 0.972 . . . . 27.9 113.049 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1075 ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -54.48 136.14 68.69 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.903 2.402 . . . . 31.62 114.074 -173.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1076 ' ' LEU . . . . . . . . . . . . . 38.3 mt -71.33 160.28 33.07 Favored 'General case' 0 CA--C 1.506 -0.74 0 O-C-N 126.51 2.381 . . . . 40.49 106.776 173.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1077 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.49 -38.68 63.91 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 115.923 1.823 . . . . 51.59 115.923 -168.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1078 ' ' ASP . . . . . 0.416 ' CG ' HH22 ' B' 1009 ' ' ARG . 9.8 p-10 -68.69 -36.13 78.1 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-O 120.84 0.352 . . . . 42.36 111.751 175.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1079 ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -64.07 -36.02 82.64 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-O 123.551 1.643 . . . . 34.53 111.37 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1080 ' ' ILE . . . . . 0.442 ' O ' ' HG3' ' B' 1108 ' ' ARG . 57.6 mt -60.45 -50.78 78.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 113.119 -1.855 . . . . 33.25 109.64 174.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1081 ' ' ALA . . . . . . . . . . . . . . . -57.15 -34.01 67.99 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 115.486 1.661 . . . . 36.47 115.486 173.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1082 ' ' LEU . . . . . . . . . . . . . 86.0 mt -62.94 -26.88 69.03 Favored 'General case' 0 CA--C 1.491 -1.31 0 O-C-N 125.391 1.682 . . . . 37.76 114.303 173.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1083 ' ' LEU . . . . . 0.755 HD11 HD22 ' B' 1089 ' ' LEU . 68.8 mt -55.28 156.63 4.11 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 113.865 1.061 . . . . 37.43 113.865 167.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1084 ' ' ASN . . . . . . . . . . . . 0.252 1.5 m-80 -130.56 148.53 70.36 Favored Pre-proline 0 C--N 1.319 -0.753 0 N-CA-C 103.673 -2.714 . . . . 37.7 103.673 -167.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1085 ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -55.82 114.0 1.69 Allowed 'Trans proline' 0 C--O 1.25 1.11 0 C-N-CA 125.004 3.803 . . . . 35.51 109.673 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1086 ' ' GLY . . . . . . . . . . . . . . . 120.71 -37.65 2.96 Favored Glycine 0 N--CA 1.437 -1.246 0 CA-C-N 111.624 -2.535 . . . . 33.87 114.332 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1087 ' ' THR . . . . . . . . . . . . . 26.4 m -56.2 122.24 11.3 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 114.513 1.301 . . . . 32.5 114.513 -164.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1088 ' ' THR . . . . . 0.408 ' HA ' ' HB ' ' B' 1111 ' ' THR . 13.5 m -70.49 94.72 0.99 Allowed 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 113.633 -1.621 . . . . 30.22 107.268 174.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1089 ' ' LEU . . . . . 0.755 HD22 HD11 ' B' 1083 ' ' LEU . 42.4 tp -85.77 111.36 20.08 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 118.951 0.796 . . . . 27.24 110.05 174.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1090 ' ' VAL . . . . . . . . . . . . . 6.0 t -112.76 104.53 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 104.037 -2.579 . . . . 25.39 104.037 -175.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1091 ' ' SER . . . . . . . . . . . . . 45.5 m -154.86 163.4 40.34 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.043 -1.435 . . . . 28.81 113.282 -171.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1092 ' ' PHE . . . . . 0.483 ' HZ ' ' HG3' ' B' 1133 ' ' MET . 53.2 m-85 -73.64 99.77 3.18 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 104.233 -2.506 . . . . 30.78 104.233 171.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1093 ' ' ILE . . . . . 0.467 HG13 ' CG1' ' B' 1112 ' ' VAL . 37.6 mm -85.38 -33.71 8.04 Favored 'Isoleucine or valine' 0 C--N 1.355 0.843 0 CA-C-O 118.254 -0.879 . . . . 30.28 111.909 -175.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1094 ' ' TRP . . . . . . . . . . . . . 70.6 m95 53.59 62.23 9.57 Favored Pre-proline 0 C--O 1.248 0.994 0 C-N-CA 124.811 1.245 . . . . 34.07 113.274 -167.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1095 ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -50.1 -49.2 16.89 Favored 'Trans proline' 0 C--O 1.248 0.992 0 C-N-CA 125.104 3.87 . . . . 38.66 114.089 -170.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1096 ' ' ALA . . . . . . . . . . . . . . . -75.18 -19.7 59.7 Favored 'General case' 0 C--O 1.241 0.621 0 O-C-N 120.617 -1.302 . . . . 41.32 110.142 -175.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1097 ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -85.43 -22.9 28.11 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 122.272 1.034 . . . . 51.66 111.279 173.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1098 ' ' ASN . . . . . 0.405 ' N ' ' HD3' ' B' 1099 ' ' PRO . 27.7 m-20 -127.84 48.87 3.74 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 113.869 1.063 . . . . 40.32 113.869 -170.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1099 ' ' PRO . . . . . 0.405 ' HD3' ' N ' ' B' 1098 ' ' ASN . 77.5 Cg_exo -60.98 -40.26 53.79 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 124.044 3.163 . . . . 41.56 118.051 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1100 ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -64.11 -39.13 93.37 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 109.206 -0.664 . . . . 54.11 109.206 175.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1101 ' ' LEU . . . . . 0.461 ' O ' ' HG ' ' B' 1105 ' ' LEU . 9.9 mp -61.89 -45.21 94.75 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 118.17 0.441 . . . . 37.88 111.873 172.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1102 ' ' MET . . . . . 0.642 ' HA ' HD12 ' B' 1105 ' ' LEU . 75.1 mmm -55.42 -42.63 74.42 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 123.214 0.605 . . . . 37.54 112.432 173.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1103 ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -66.55 -40.77 89.23 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-O 122.407 1.098 . . . . 47.01 108.434 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1104 ' ' LYS . . . . . . . . . . . . . 37.8 mtmt -65.65 -27.72 68.57 Favored 'General case' 0 CA--C 1.481 -1.681 0 O-C-N 118.101 -2.875 . . . . 48.68 116.043 170.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1105 ' ' LEU . . . . . 0.642 HD12 ' HA ' ' B' 1102 ' ' MET . 31.3 mt -70.82 -38.81 73.29 Favored 'General case' 0 C--O 1.265 1.869 0 O-C-N 120.385 -1.447 . . . . 32.21 110.374 173.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1106 ' ' ALA . . . . . . . . . . . . . . . -61.77 -42.21 98.7 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 109.019 -0.734 . . . . 33.73 109.019 175.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1107 ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -60.14 -44.92 94.58 Favored 'General case' 0 CA--C 1.497 -1.075 0 O-C-N 121.039 -1.038 . . . . 51.47 113.773 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1108 ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' B' 1080 ' ' ILE . 16.4 mmm180 -62.2 -24.5 67.25 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.649 -1.282 . . . . 43.9 114.332 173.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1109 ' ' ASN . . . . . . . . . . . . . 14.9 m-80 72.01 47.12 0.32 Allowed 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 125.12 2.391 . . . . 44.82 110.94 173.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1110 ' ' VAL . . . . . 0.579 HG11 ' HB3' ' B' 1083 ' ' LEU . 16.5 m -96.46 169.38 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-N 110.081 -3.236 . . . . 30.52 113.826 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1111 ' ' THR . . . . . 0.408 ' HB ' ' HA ' ' B' 1088 ' ' THR . 8.1 m -104.65 97.87 7.7 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 107.548 -1.278 . . . . 27.12 107.548 171.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1112 ' ' VAL . . . . . 0.467 ' CG1' HG13 ' B' 1093 ' ' ILE . 93.4 t -92.8 123.85 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 O-C-N 119.556 -1.965 . . . . 26.4 108.736 -173.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1113 ' ' MET . . . . . 0.691 ' SD ' HD21 ' B' 1334 ' ' LEU . 21.0 mtp -116.87 103.12 9.98 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.986 -1.487 . . . . 42.92 106.986 174.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1114 ' ' ALA . . . . . . . . . . . . . . . -79.75 88.04 5.23 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 113.457 -1.701 . . . . 24.15 113.782 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1115 ' ' MET . . . . . 0.48 ' SD ' HD13 ' B' 1334 ' ' LEU . 95.0 mmm -54.71 -19.23 5.79 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 117.073 2.249 . . . . 29.95 117.073 -173.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1116 ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -72.7 -46.23 54.79 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.115 -1.402 . . . . 34.53 114.503 168.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1117 ' ' SER . . . . . . . . . . . . . 66.1 m -93.8 52.87 1.73 Allowed 'General case' 0 C--O 1.255 1.347 0 O-C-N 119.181 -2.199 . . . . 33.49 112.028 -167.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1118 ' ' VAL . . . . . . . . . . . . . 40.5 t -89.53 137.38 28.86 Favored Pre-proline 0 N--CA 1.445 -0.718 0 N-CA-C 106.565 -1.643 . . . . 34.02 106.565 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1119 ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -63.63 131.07 30.04 Favored 'Trans proline' 0 CA--C 1.512 -0.602 0 C-N-CA 123.765 2.976 . . . . 38.28 108.336 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1120 ' ' ARG . . . . . 0.752 ' HB2' HG11 ' B' 1375 ' ' VAL . 1.8 mmt180 -74.77 50.2 0.44 Allowed 'General case' 0 C--O 1.247 0.97 0 N-CA-C 115.09 1.515 . . . . 55.05 115.09 -163.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1121 ' ' ILE . . . . . 0.526 ' HB ' ' O ' ' C' ' 131' ' ' ALA . 36.1 pt -102.08 172.51 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.912 0 O-C-N 117.082 -3.511 . . . . 42.09 115.969 -177.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1122 ' ' SER . . . . . . . . . . . . . 2.9 m -62.29 -32.73 73.5 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 117.718 2.488 . . . . 38.02 117.718 -172.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1123 ' ' ARG . . . . . 0.416 ' HA ' ' HD3' ' C' ' 134' ' ' PRO . 11.3 ptt-85 -67.25 -35.76 80.21 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 119.378 -0.929 . . . . 34.29 113.407 162.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1124 ' ' ALA . . . . . . . . . . . . . . . -62.22 -36.08 80.88 Favored 'General case' 0 C--N 1.359 0.98 0 N-CA-C 116.877 2.177 . . . . 32.35 116.877 -158.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1125 ' ' GLN . . . . . 0.803 ' HA ' ' HB3' ' B' 1128 ' ' ASP . 2.3 mp0 -64.94 -8.73 16.88 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 115.415 1.635 . . . . 47.17 115.415 -172.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1126 ' ' SER . . . . . . . . . . . . . 21.1 p -75.05 -41.82 58.29 Favored 'General case' 0 C--O 1.24 0.585 0 O-C-N 120.414 -1.429 . . . . 31.71 109.074 173.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1127 ' ' LEU . . . . . . . . . . . . . 3.5 mp -80.13 -40.85 26.58 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-N 113.248 -1.796 . . . . 37.0 111.159 174.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1128 ' ' ASP . . . . . 0.803 ' HB3' ' HA ' ' B' 1125 ' ' GLN . 9.3 t70 -61.6 119.89 9.52 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 123.743 1.735 . . . . 40.4 115.001 -173.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1129 ' ' ALA . . . . . . . . . . . . . . . -68.63 -34.98 76.68 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 111.629 -2.532 . . . . 26.56 109.277 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1130 ' ' LEU . . . . . . . . . . . . . 58.8 mt -67.8 -28.93 68.01 Favored 'General case' 0 C--N 1.31 -1.111 0 O-C-N 118.957 -2.339 . . . . 30.89 112.451 -169.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1131 ' ' SER . . . . . 0.632 ' HB3' ' HG3' ' B' 1125 ' ' GLN . 57.9 p -65.5 -56.11 14.15 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 107.685 -1.228 . . . . 29.84 107.685 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1132 ' ' SER . . . . . 0.66 ' HB3' ' HB3' ' B' 1326 ' ' LEU . 5.8 m -55.54 -47.69 75.92 Favored 'General case' 0 CA--C 1.507 -0.675 0 O-C-N 125.727 1.892 . . . . 31.91 110.174 178.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1133 ' ' MET . . . . . 0.483 ' HG3' ' HZ ' ' B' 1092 ' ' PHE . 33.2 mmt -65.87 -31.35 72.24 Favored 'General case' 0 C--N 1.361 1.073 0 N-CA-C 115.72 1.748 . . . . 25.9 115.72 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1134 ' ' ALA . . . . . . . . . . . . . . . -67.06 -43.62 82.18 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 107.602 -1.258 . . . . 26.62 107.602 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1135 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.97 -35.59 78.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 121.501 1.955 . . . . 36.97 110.466 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1136 ' ' ILE . . . . . 0.691 HD13 ' HE1' ' A' 1152 ' ' PHE . 23.5 mm -52.02 -56.81 4.97 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 O-C-N 121.393 -0.817 . . . . 32.11 110.313 167.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1137 ' ' ALA . . . . . . . . . . . . . . . -69.75 -20.32 63.51 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 116.968 -1.491 . . . . 24.14 110.551 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1138 ' ' GLY . . . . . . . . . . . . . . . -69.15 -48.16 48.46 Favored Glycine 0 N--CA 1.471 1.002 0 CA-C-N 120.909 1.686 . . . . 25.13 110.545 173.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1139 ' ' TYR . . . . . . . . . . . . . 81.9 t80 -66.33 -51.85 53.03 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 105.595 -2.002 . . . . 32.73 105.595 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1140 ' ' ARG . . . . . 0.43 ' HA ' ' HB ' ' B' 1143 ' ' VAL . 7.1 tpt180 -54.63 -25.78 28.81 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-O 115.538 -2.172 . . . . 26.36 113.4 173.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1141 ' ' ALA . . . . . 0.557 ' HA ' HG11 ' B' 1282 ' ' VAL . . . -62.17 -54.28 43.26 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 121.381 1.901 . . . . 24.12 109.055 173.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1142 ' ' ILE . . . . . . . . . . . . . 45.7 mm -57.69 -43.37 83.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 CA-C-O 122.734 1.254 . . . . 23.37 110.96 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1143 ' ' VAL . . . . . 0.43 ' HB ' ' HA ' ' B' 1140 ' ' ARG . 75.3 t -63.46 -56.76 15.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 114.523 1.305 . . . . 24.96 114.523 177.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1144 ' ' GLU . . . . . 0.415 ' OE2' ' HD3' ' B' 1318 ' ' ARG . 20.3 mm-40 -70.16 -29.74 66.72 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 120.47 -1.394 . . . . 32.07 111.639 -178.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1145 ' ' ALA . . . . . 0.825 ' HB1' HD12 ' B' 1251 ' ' ILE . . . -55.99 -60.3 3.67 Favored 'General case' 0 C--N 1.346 0.418 0 N-CA-C 107.68 -1.23 . . . . 24.87 107.68 168.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1146 ' ' ALA . . . . . 0.648 ' HB2' ' HE1' ' B' 1153 ' ' PHE . . . -48.4 -32.48 7.68 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.248 1.573 . . . . 24.67 115.248 175.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1147 ' ' HIS . . . . . . . . . . . . . 80.7 t60 -53.59 -50.53 65.41 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 119.76 1.164 . . . . 28.58 111.988 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1148 ' ' GLU . . . . . 0.733 ' HB2' HD11 ' B' 1310 ' ' ILE . 28.7 mm-40 -108.14 -5.38 16.97 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 119.561 -1.962 . . . . 36.82 114.377 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1149 ' ' PHE . . . . . . . . . . . . . 2.8 t80 -54.09 138.94 36.55 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 126.029 2.823 . . . . 31.97 109.141 177.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1150 ' ' GLY . . . . . 0.613 ' HA2' ' HG2' ' A' 1320 ' ' PRO . . . -68.6 -35.35 80.71 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 109.784 -3.371 . . . . 25.49 113.816 175.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1151 ' ' ARG . . . . . 0.652 ' HA ' ' HB2' ' A' 1322 ' ' GLN . 55.3 mtm-85 -128.37 -170.56 2.27 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 123.048 3.424 . . . . 59.84 110.022 -162.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1152 ' ' PHE . . . . . 0.804 ' HB2' HG11 ' B' 1163 ' ' VAL . 19.0 m-30 -81.7 161.29 23.43 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 107.734 -1.21 . . . . 34.45 107.734 168.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1153 ' ' PHE . . . . . 0.648 ' HE1' ' HB2' ' B' 1146 ' ' ALA . 53.2 m-85 -79.91 -47.91 14.3 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.102 -1.814 . . . . 31.17 106.102 166.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1154 ' ' THR . . . . . . . . . . . . . 57.5 m -54.77 134.82 47.82 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 112.28 -2.237 . . . . 33.89 112.411 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1155 ' ' GLY . . . . . . . . . . . . . . . -78.02 62.64 3.63 Favored Glycine 0 N--CA 1.44 -1.094 0 O-C-N 123.881 0.738 . . . . 38.95 112.86 169.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1156 ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -83.79 125.04 31.53 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 122.984 1.373 . . . . 54.23 111.767 -166.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1157 ' ' ILE . . . . . 0.545 HG23 ' HE2' ' B' 1162 ' ' LYS . 18.8 mm -78.09 89.39 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 105.375 -2.083 . . . . 51.16 105.375 172.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1158 ' ' THR . . . . . . . . . . . . . 6.2 m -97.79 146.46 25.37 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 107.157 -1.423 . . . . 49.61 107.157 -177.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1159 ' ' ALA . . . . . . . . . . . . . . . -44.15 -57.3 3.49 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 115.09 1.515 . . . . 49.05 115.09 -171.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1160 ' ' ALA . . . . . . . . . . . . . . . -60.43 -37.27 80.38 Favored 'General case' 0 C--O 1.207 -1.144 0 C-N-CA 125.175 1.39 . . . . 47.65 112.011 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1161 ' ' GLY . . . . . . . . . . . . . . . 179.87 157.52 20.23 Favored Glycine 0 CA--C 1.498 -1.026 0 N-CA-C 109.421 -1.472 . . . . 45.61 109.421 -177.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1162 ' ' LYS . . . . . 0.545 ' HE2' HG23 ' B' 1157 ' ' ILE . 85.6 mttt -75.1 125.63 29.34 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.044 -1.078 . . . . 57.46 110.605 -177.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1163 ' ' VAL . . . . . 0.804 HG11 ' HB2' ' B' 1152 ' ' PHE . 57.1 t -75.81 128.0 84.41 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-O 118.332 -0.842 . . . . 42.93 108.864 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1164 ' ' PRO . . . . . 0.526 ' HA ' ' HD3' ' B' 1165 ' ' PRO . 74.0 Cg_endo -66.92 122.46 9.81 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 124.826 3.684 . . . . 39.29 108.442 172.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1165 ' ' PRO . . . . . 0.526 ' HD3' ' HA ' ' B' 1164 ' ' PRO . 81.1 Cg_exo -64.88 142.48 75.8 Favored 'Trans proline' 0 C--O 1.248 1.013 0 O-C-N 124.289 1.678 . . . . 34.17 109.452 -171.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1166 ' ' ALA . . . . . 0.442 ' HB2' ' HA ' ' B' 1153 ' ' PHE . . . -76.89 120.77 22.49 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 123.833 1.778 . . . . 31.69 108.898 -173.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1167 ' ' LYS . . . . . 0.629 ' HB2' ' HA ' ' B' 1249 ' ' VAL . 87.4 mttt -86.54 101.86 13.59 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 103.085 -2.931 . . . . 44.78 103.085 174.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1168 ' ' VAL . . . . . . . . . . . . . 35.7 t -97.31 91.59 2.65 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 CA-C-N 112.805 -1.998 . . . . 31.23 109.46 -175.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1169 ' ' MET . . . . . 0.811 ' HB2' HG11 ' B' 1249 ' ' VAL . 48.3 ttp -77.48 99.68 5.75 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 105.442 -2.058 . . . . 37.09 105.442 -177.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1170 ' ' VAL . . . . . . . . . . . . . 93.3 t -87.6 96.42 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 106.668 -1.605 . . . . 30.17 106.668 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1171 ' ' ILE . . . . . . . . . . . . . 61.3 mt -90.03 113.08 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 N-CA-C 107.132 -1.433 . . . . 33.74 107.132 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1172 ' ' GLY . . . . . . . . . . . . . . . 94.91 73.85 1.21 Allowed Glycine 0 CA--C 1.5 -0.895 0 C-N-CA 119.561 -1.304 . . . . 32.59 110.455 170.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1173 ' ' ALA . . . . . 0.677 ' HA ' ' HA3' ' B' 1177 ' ' GLY . . . -78.47 57.16 1.9 Allowed 'General case' 0 C--N 1.329 -0.295 0 O-C-N 126.465 1.921 . . . . 32.42 113.79 -175.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1174 ' ' GLY . . . . . . . . . . . . . . . -86.83 -162.52 37.54 Favored Glycine 0 C--O 1.211 -1.3 0 N-CA-C 108.185 -1.966 . . . . 31.74 108.185 164.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1175 ' ' VAL . . . . . . . . . . . . . 41.4 t -47.37 -46.9 10.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 CA-C-N 121.538 2.669 . . . . 31.48 116.521 -171.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1176 ' ' ALA . . . . . . . . . . . . . . . -53.97 -56.15 20.5 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 115.665 1.728 . . . . 26.12 115.665 169.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1177 ' ' GLY . . . . . 0.677 ' HA3' ' HA ' ' B' 1173 ' ' ALA . . . -51.3 -52.19 33.31 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-N 113.474 -1.694 . . . . 25.73 111.185 176.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1178 ' ' LEU . . . . . 0.494 HD21 HG12 ' B' 1200 ' ' VAL . 37.8 mt -62.13 -44.34 96.84 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 126.02 1.728 . . . . 32.59 113.158 -174.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1179 ' ' ALA . . . . . . . . . . . . . . . -59.9 -39.36 85.13 Favored 'General case' 0 C--N 1.348 0.517 0 N-CA-C 113.762 1.023 . . . . 27.72 113.762 171.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1180 ' ' ALA . . . . . . . . . . . . . . . -66.53 -39.53 88.66 Favored 'General case' 0 C--O 1.244 0.767 0 O-C-N 124.0 0.813 . . . . 26.03 111.784 178.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1181 ' ' ILE . . . . . 0.672 HG23 HG11 ' B' 1191 ' ' VAL . 62.9 mt -57.03 -52.85 50.74 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 118.375 -0.821 . . . . 28.61 111.3 171.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1182 ' ' GLY . . . . . . . . . . . . . . . -46.8 -61.85 4.07 Favored Glycine 0 C--N 1.346 1.106 0 O-C-N 126.148 2.155 . . . . 25.23 109.495 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1183 ' ' ALA . . . . . . . . . . . . . . . -64.45 -47.27 79.67 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 121.799 0.809 . . . . 24.09 112.921 -171.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1184 ' ' ALA . . . . . . . . . . . . . . . -64.67 -37.78 88.77 Favored 'General case' 0 CA--C 1.509 -0.632 0 O-C-N 121.04 -1.038 . . . . 26.68 112.483 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1185 ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -66.38 -45.52 79.8 Favored 'General case' 0 C--O 1.252 1.208 0 C-N-CA 124.155 0.982 . . . . 36.57 110.009 176.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1186 ' ' SER . . . . . . . . . . . . . 69.1 m -58.29 -37.3 74.76 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 113.138 0.792 . . . . 28.92 113.138 173.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1187 ' ' LEU . . . . . 0.632 ' HA ' ' HB3' ' A' 1186 ' ' SER . 19.1 mt -69.49 -16.54 63.48 Favored 'General case' 0 C--O 1.249 1.03 0 N-CA-C 114.853 1.427 . . . . 29.09 114.853 173.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1188 ' ' GLY . . . . . . . . . . . . . . . 80.42 52.38 4.52 Favored Glycine 0 C--O 1.251 1.187 0 O-C-N 119.151 -2.218 . . . . 29.26 109.168 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1189 ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' B' 1153 ' ' PHE . . . -115.52 155.34 27.72 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 113.325 -1.438 . . . . 30.16 108.597 170.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1190 ' ' ILE . . . . . . . . . . . . . 80.2 mt -81.48 94.89 2.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 103.413 -2.81 . . . . 35.81 103.413 -175.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1191 ' ' VAL . . . . . 0.672 HG11 HG23 ' B' 1181 ' ' ILE . 23.8 t -71.0 121.8 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 C-N-CA 118.228 -1.389 . . . . 31.97 108.223 170.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1192 ' ' ARG . . . . . 0.516 ' HD2' HD21 ' B' 1212 ' ' LEU . 26.6 mmt85 -104.85 85.12 2.24 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 113.279 -1.782 . . . . 48.16 106.197 173.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1193 ' ' ALA . . . . . . . . . . . . . . . -96.3 149.94 21.12 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 118.368 -2.708 . . . . 35.89 114.257 -165.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1194 ' ' PHE . . . . . . . . . . . . . 20.2 t80 -147.54 153.4 39.43 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 120.397 -1.439 . . . . 41.88 108.615 -177.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1195 ' ' ASP . . . . . . . . . . . . . 8.9 t0 -162.97 159.9 24.06 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 103.409 -2.812 . . . . 38.28 103.409 167.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1196 ' ' THR . . . . . . . . . . . . . 4.7 m -65.48 -47.17 76.97 Favored 'General case' 0 N--CA 1.427 -1.611 0 C-N-CA 125.38 1.472 . . . . 40.62 108.203 171.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1197 ' ' ARG . . . . . 0.421 HH11 ' HD2' ' B' 1197 ' ' ARG . 12.2 mtm180 -75.43 130.56 79.45 Favored Pre-proline 0 C--N 1.345 0.387 0 C-N-CA 124.14 0.976 . . . . 53.09 109.929 -171.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1198 ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -58.01 -34.58 98.57 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.892 2.395 . . . . 42.56 117.522 -172.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1199 ' ' GLU . . . . . 0.706 ' HB2' ' NH2' ' C' ' 74' ' ' ARG . 0.0 OUTLIER -66.19 -35.83 81.48 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.539 -1.351 . . . . 56.31 113.252 -150.331 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B 1200 ' ' VAL . . . . . 0.494 HG12 HD21 ' B' 1178 ' ' LEU . 17.0 m -59.48 -22.36 22.81 Favored 'Isoleucine or valine' 0 C--O 1.249 1.076 0 CA-C-N 112.699 -2.046 . . . . 42.91 113.44 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1201 ' ' LYS . . . . . . . . . . . . . 51.8 tttm -52.66 -45.94 66.95 Favored 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 124.665 1.186 . . . . 48.89 113.744 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1202 ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -65.94 -31.17 71.93 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.823 0.82 . . . . 51.7 112.815 -176.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1203 ' ' GLN . . . . . 0.431 ' OE1' HD22 ' B' 1178 ' ' LEU . 23.8 tt0 -61.37 -48.76 79.8 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.945 -1.131 . . . . 52.57 107.945 172.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1204 ' ' VAL . . . . . 0.453 HG23 ' O ' ' B' 1200 ' ' VAL . 18.9 t -72.87 -33.91 44.96 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.222 0 CA-C-O 125.358 2.504 . . . . 33.79 110.606 -167.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1205 ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -57.38 -52.25 66.11 Favored 'General case' 0 C--O 1.256 1.435 0 CA-C-N 112.997 -1.911 . . . . 36.58 110.47 168.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1206 ' ' SER . . . . . . . . . . . . . 17.7 m -62.62 -25.39 68.08 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 121.864 2.12 . . . . 39.61 112.135 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1207 ' ' MET . . . . . . . . . . . . . 20.4 mtp -75.04 -21.21 59.2 Favored 'General case' 0 C--N 1.359 0.988 0 N-CA-C 116.348 1.981 . . . . 37.45 116.348 172.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1208 ' ' GLY . . . . . . . . . . . . . . . 74.7 52.76 6.94 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-O 125.354 2.641 . . . . 31.87 110.54 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1209 ' ' ALA . . . . . . . . . . . . . . . -148.22 151.74 36.01 Favored 'General case' 0 C--O 1.25 1.118 0 N-CA-C 103.382 -2.821 . . . . 35.4 103.382 -173.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1210 ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -89.61 126.71 35.72 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 119.602 1.092 . . . . 47.89 113.548 -169.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1211 ' ' PHE . . . . . . . . . . . . . 59.4 t80 -85.52 115.96 23.54 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 103.501 -2.777 . . . . 45.53 103.501 169.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1212 ' ' LEU . . . . . 0.516 HD21 ' HD2' ' B' 1192 ' ' ARG . 97.3 mt -70.27 93.31 0.83 Allowed 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 114.57 -1.196 . . . . 46.33 108.163 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1213 ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -76.31 150.85 36.87 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 122.61 1.195 . . . . 60.41 111.23 172.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1214 ' ' LEU . . . . . 0.409 HD11 ' HE1' ' B' 1234 ' ' PHE . 97.2 mt -70.7 144.64 50.94 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 110.53 -3.032 . . . . 57.38 112.548 174.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1215 ' ' ASP . . . . . . . . . . . . . 36.3 t0 . . . . . 0 N--CA 1.425 -1.68 0 O-C-N 125.445 1.716 . . . . 65.07 107.678 173.934 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B 1230 ' ' MET . . . . . . . . . . . . . 15.2 mmt . . . . . 0 N--CA 1.442 -0.836 0 N-CA-C 103.197 -2.89 . . . . 80.32 103.197 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B 1231 ' ' SER . . . . . . . . . . . . 0.324 66.8 m 75.53 132.8 0.05 OUTLIER 'General case' 0 C--O 1.212 -0.912 2 CA-C-N 129.98 5.809 . . . . 79.92 121.428 -0.032 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' B' B 1232 ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -70.29 -158.81 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.188 0 O-C-N 125.307 1.63 . . . . 77.91 111.096 -176.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1233 ' ' ALA . . . . . . . . . . . . . . . 68.71 -52.9 0.56 Allowed 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 126.043 1.737 . . . . 73.88 110.969 -160.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1234 ' ' PHE . . . . . 0.409 ' HE1' HD11 ' B' 1214 ' ' LEU . 10.9 t80 -39.77 -51.57 2.36 Favored 'General case' 0 CA--C 1.5 -0.965 0 C-N-CA 127.96 2.504 . . . . 68.98 110.937 162.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1235 ' ' ILE . . . . . . . . . . . . . 46.9 pt -52.4 -25.8 8.16 Favored 'Isoleucine or valine' 0 C--O 1.248 1.01 0 N-CA-C 115.84 1.793 . . . . 64.53 115.84 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1236 ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -77.97 -48.31 16.54 Favored 'General case' 0 CA--C 1.511 -0.529 0 O-C-N 119.883 -1.761 . . . . 66.36 110.064 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1237 ' ' ALA . . . . . . . . . . . . . . . -60.09 -36.15 76.76 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 123.978 0.911 . . . . 56.6 109.832 177.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1238 ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -59.08 -62.11 2.13 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.259 -1.015 . . . . 56.79 108.259 171.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1239 ' ' MET . . . . . . . . . . . . . 20.3 mmt -59.26 -34.3 72.07 Favored 'General case' 0 C--O 1.222 -0.392 0 O-C-N 119.41 -2.056 . . . . 53.63 114.356 -173.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1240 ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -46.33 -54.34 9.16 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 113.871 1.063 . . . . 51.74 113.871 168.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1241 ' ' LEU . . . . . . . . . . . . . 48.8 tp -68.24 -49.16 62.56 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 112.488 -2.142 . . . . 44.86 106.38 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1242 ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -64.95 -44.22 90.12 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 119.494 -2.004 . . . . 42.78 111.644 -172.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1243 ' ' ALA . . . . . . . . . . . . . . . -65.73 -24.05 66.88 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 114.688 1.366 . . . . 40.96 114.688 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1244 ' ' ALA . . . . . . . . . . . . . . . -76.63 -58.04 3.51 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 104.834 -2.284 . . . . 43.06 104.834 171.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1245 ' ' GLN . . . . . . . . . . . . . 75.7 mm-40 -53.45 -30.32 40.05 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.901 1.281 . . . . 46.45 112.195 -173.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1246 ' ' ALA . . . . . . . . . . . . . . . -57.67 -35.98 71.29 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.946 1.248 . . . . 41.78 113.003 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1247 ' ' LYS . . . . . . . . . . . . . 31.4 tptt -67.04 -23.76 65.92 Favored 'General case' 0 C--O 1.241 0.637 0 O-C-N 119.369 -2.082 . . . . 52.2 113.6 176.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1248 ' ' GLU . . . . . 0.422 ' CD ' HH12 ' B' 1192 ' ' ARG . 20.8 mt-10 -95.12 -44.84 7.47 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 114.179 -1.373 . . . . 53.55 113.76 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1249 ' ' VAL . . . . . 0.811 HG11 ' HB2' ' B' 1169 ' ' MET . 29.0 m -77.99 143.13 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-O 126.352 2.977 . . . . 34.41 114.21 -162.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1250 ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -100.05 -37.35 9.02 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 109.066 -3.697 . . . . 33.38 107.247 -177.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1251 ' ' ILE . . . . . 0.825 HD12 ' HB1' ' B' 1145 ' ' ALA . 37.0 mm -128.98 125.64 63.2 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.755 0 O-C-N 119.789 -1.82 . . . . 29.54 107.083 176.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1252 ' ' ILE . . . . . 0.484 HG22 ' HB ' ' B' 1254 ' ' THR . 64.8 mt -103.34 109.2 26.27 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.734 0 N-CA-C 103.927 -2.62 . . . . 32.44 103.927 166.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1253 ' ' VAL . . . . . . . . . . . . . 95.4 t -84.76 82.31 1.86 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.976 0 N-CA-C 103.924 -2.621 . . . . 30.57 103.924 169.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1254 ' ' THR . . . . . 0.484 ' HB ' HG22 ' B' 1252 ' ' ILE 0.283 2.8 t -84.13 91.16 7.62 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-O 127.243 3.402 . . . . 35.04 110.037 -179.618 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B 1255 ' ' THR . . . . . 0.596 ' HA ' ' HB2' ' B' 1284 ' ' LEU . 27.1 m -85.45 -71.24 0.54 Allowed 'General case' 0 C--O 1.242 0.703 0 CA-C-N 110.001 -3.272 . . . . 34.62 108.136 -175.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1256 ' ' ALA . . . . . . . . . . . . . . . 44.1 24.74 0.09 Allowed 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 120.973 3.694 . . . . 42.72 120.973 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1257 ' ' LEU . . . . . . . . . . . . . 39.3 mt -66.2 112.25 3.85 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-O 123.255 1.502 . . . . 52.43 110.576 -172.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1258 ' ' ILE . . . . . . . . . . . . . 55.6 mt -91.92 109.01 34.28 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 105.066 -2.198 . . . . 59.41 105.066 175.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1259 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -56.3 97.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 123.441 2.761 . . . . 62.68 114.864 -175.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1260 ' ' GLY . . . . . . . . . . . . . . . 68.61 47.92 53.46 Favored Glycine 0 N--CA 1.466 0.652 0 N-CA-C 109.353 -1.499 . . . . 64.16 109.353 174.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1261 ' ' LYS . . . . . . . . . . . . . 55.5 tttt -155.76 149.1 18.56 Favored Pre-proline 0 C--O 1.248 1.019 0 N-CA-C 102.258 -3.238 . . . . 68.53 102.258 168.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1262 ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.53 132.22 37.09 Favored 'Trans proline' 0 C--N 1.364 1.376 0 C-N-CA 124.746 3.631 . . . . 61.99 112.765 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1263 ' ' ALA . . . . . . . . . . . . . . . -71.69 143.08 86.72 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-N 112.933 -1.94 . . . . 57.15 112.201 175.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1264 ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -73.08 147.87 43.71 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 124.156 3.237 . . . . 51.57 116.003 -176.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1265 ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -71.46 82.63 0.8 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 118.567 -2.583 . . . . 54.55 109.58 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1266 ' ' LEU . . . . . . . . . . . . . 84.9 mt -71.3 -64.4 0.92 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.103 -1.408 . . . . 46.86 113.946 178.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1267 ' ' ILE . . . . . 0.704 HG21 HD13 ' B' 1281 ' ' ILE . 26.5 mm -87.66 89.66 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 107.389 -1.337 . . . . 41.04 107.389 -170.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1268 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.86 150.64 47.56 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 111.504 -2.589 . . . . 39.58 116.51 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1269 ' ' ARG . . . . . 0.513 ' HG3' ' HB2' ' B' 1293 ' ' GLU . 44.3 mtt85 -54.28 -44.27 71.76 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 114.516 1.302 . . . . 53.15 114.516 -169.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1270 ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -57.53 -44.6 85.23 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.261 0.624 . . . . 42.96 112.551 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1271 ' ' MET . . . . . . . . . . . . . 30.1 ttm -58.91 -52.2 66.78 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 125.687 1.867 . . . . 43.89 109.966 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1272 ' ' VAL . . . . . 0.416 HG22 HG22 ' B' 1267 ' ' ILE . 40.2 t -54.95 -47.09 76.67 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 C-N-CA 124.176 0.99 . . . . 38.37 108.618 -177.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1273 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.99 -26.7 67.78 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 115.634 1.716 . . . . 47.46 115.634 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1274 ' ' SER . . . . . . . . . . . . . 3.2 p -92.42 -6.39 50.08 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 114.53 1.307 . . . . 38.38 114.53 174.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1275 ' ' MET . . . . . . . . . . . . . 11.2 ttt -67.02 159.72 28.06 Favored 'General case' 0 C--O 1.24 0.586 0 O-C-N 121.22 -0.925 . . . . 37.81 112.56 -176.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1276 ' ' LYS . . . . . . . . . . . . . 83.1 tttt -55.62 147.98 17.01 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 124.627 1.171 . . . . 49.26 113.059 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1277 ' ' ALA . . . . . 0.62 ' HB1' ' HA ' ' A' 1045 ' ' PHE . . . -76.35 150.15 36.89 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 108.195 -1.039 . . . . 34.46 108.195 -176.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1278 ' ' GLY . . . . . 0.619 ' HA2' ' HB3' ' A' 1044 ' ' SER . . . 68.28 26.59 74.12 Favored Glycine 0 N--CA 1.466 0.657 0 C-N-CA 125.006 1.289 . . . . 33.53 112.118 173.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1279 ' ' SER . . . . . . . . . . . . . 36.6 m -113.17 156.49 23.14 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 106.198 -1.779 . . . . 31.31 106.198 -171.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1280 ' ' VAL . . . . . 0.771 HG11 ' HA ' ' B' 1145 ' ' ALA . 52.9 t -115.62 140.04 39.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 O-C-N 119.535 -1.978 . . . . 29.32 109.314 -171.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1281 ' ' ILE . . . . . 0.704 HD13 HG21 ' B' 1267 ' ' ILE . 19.5 mt -109.27 105.18 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 104.953 -2.24 . . . . 31.93 104.953 165.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1282 ' ' VAL . . . . . 0.557 HG11 ' HA ' ' B' 1141 ' ' ALA . 15.8 t -84.35 114.92 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 N-CA-C 101.078 -3.675 . . . . 29.48 101.078 176.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1283 ' ' ASP . . . . . . . . . . . . . 45.7 t0 -97.98 96.62 8.29 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.208 -1.405 . . . . 34.5 107.208 175.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1284 ' ' LEU . . . . . 0.596 ' HB2' ' HA ' ' B' 1255 ' ' THR . 6.6 mp -68.48 -32.84 73.12 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 113.548 -1.66 . . . . 37.94 110.727 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1285 ' ' ALA . . . . . . . . . . . . . . . -89.03 20.23 3.74 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 125.54 1.775 . . . . 40.92 112.35 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1286 ' ' ALA . . . . . . . . . . . . . . . -48.48 -34.23 10.8 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 120.917 1.69 . . . . 44.39 115.062 177.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1287 ' ' GLN . . . . . 0.895 ' HB3' HG23 ' B' 1313 ' ' THR . 0.0 OUTLIER -90.56 -20.51 22.54 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 113.165 0.802 . . . . 51.46 113.165 175.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B 1288 ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -91.21 -17.16 26.49 Favored 'General case' 0 C--O 1.215 -0.727 0 O-C-N 120.515 -1.366 . . . . 57.75 113.575 -177.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1289 ' ' GLY . . . . . . . . . . . . . . . 173.17 -19.55 0.06 OUTLIER Glycine 0 C--O 1.243 0.699 0 CA-C-O 116.82 -2.1 . . . . 49.85 112.97 177.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1290 ' ' GLY . . . . . . . . . . . . . . . 74.89 88.3 0.23 Allowed Glycine 0 CA--C 1.524 0.65 0 CA-C-N 122.12 2.96 . . . . 45.93 108.806 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1291 ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -71.41 -30.58 66.27 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 123.015 1.388 . . . . 42.67 113.616 -173.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1292 ' ' CYS . . . . . 0.503 ' HB3' ' OG1' ' B' 1295 ' ' THR . 33.2 t -98.57 145.83 26.43 Favored 'General case' 0 C--O 1.241 0.619 0 O-C-N 121.445 -0.785 . . . . 38.82 109.134 175.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1293 ' ' GLU . . . . . 0.513 ' HB2' ' HG3' ' B' 1269 ' ' ARG . 37.2 mt-10 -73.57 -35.85 65.52 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.463 -0.495 . . . . 46.71 111.07 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1294 ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -72.94 -13.64 61.29 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.188 0.81 . . . . 47.23 113.188 -178.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1295 ' ' THR . . . . . 0.808 HG23 ' HA3' ' B' 1311 ' ' GLY . 98.1 m -53.39 102.39 0.06 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.992 0.738 . . . . 36.02 112.992 173.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1296 ' ' VAL . . . . . . . . . . . . . 82.8 t -73.24 113.97 26.99 Favored Pre-proline 0 N--CA 1.429 -1.503 0 N-CA-C 104.298 -2.482 . . . . 37.26 104.298 158.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1297 ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -62.01 131.06 33.13 Favored 'Trans proline' 0 CA--C 1.507 -0.868 0 C-N-CA 122.773 2.315 . . . . 35.09 114.125 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1298 ' ' GLY . . . . . . . . . . . . . . . 81.07 8.78 86.99 Favored Glycine 0 CA--C 1.543 1.826 0 CA-C-O 118.174 -1.348 . . . . 35.97 110.692 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1299 ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -143.61 172.5 12.72 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 120.82 2.31 . . . . 40.39 112.075 -173.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1300 ' ' ILE . . . . . 0.493 HG12 HG12 ' B' 1310 ' ' ILE . 67.4 mt -101.11 148.1 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 103.848 -2.649 . . . . 37.43 103.848 170.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1301 ' ' PHE . . . . . . . . . . . . . 65.3 t80 -123.7 125.21 44.36 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 101.561 -3.496 . . . . 44.13 101.561 164.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1302 ' ' THR . . . . . . . . . . . . . 90.8 m -98.03 110.72 23.24 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.476 -1.305 . . . . 39.78 107.476 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1303 ' ' THR . . . . . . . . . . . . . 40.5 p -72.62 162.48 29.43 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 113.515 0.932 . . . . 43.29 113.515 -174.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1304 ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -53.7 -37.1 62.91 Favored 'General case' 0 C--N 1.354 0.789 0 O-C-N 120.338 -1.476 . . . . 53.07 112.085 173.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1305 ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -77.81 12.71 1.6 Allowed 'General case' 0 C--N 1.349 0.555 0 O-C-N 120.192 -1.567 . . . . 43.97 114.437 174.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1306 ' ' GLY . . . . . . . . . . . . . . . 72.13 34.89 61.14 Favored Glycine 0 CA--C 1.546 1.997 0 C-N-CA 119.078 -1.534 . . . . 41.12 111.879 173.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1307 ' ' VAL . . . . . . . . . . . . . 68.0 t -104.87 133.68 48.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 116.723 -3.81 . . . . 38.12 102.381 175.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1308 ' ' LYS . . . . . 0.651 ' HB2' HG22 ' B' 1280 ' ' VAL . 41.7 mmtt -97.68 97.71 9.25 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 105.938 -1.875 . . . . 36.34 105.938 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1309 ' ' VAL . . . . . 0.414 HG22 HD12 ' B' 1281 ' ' ILE . 21.8 t -85.62 92.22 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 N-CA-C 106.68 -1.6 . . . . 30.4 106.68 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1310 ' ' ILE . . . . . 0.733 HD11 ' HB2' ' B' 1148 ' ' GLU . 56.8 mt -89.45 87.51 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 C-N-CA 124.615 1.166 . . . . 30.82 111.378 -177.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1311 ' ' GLY . . . . . 0.808 ' HA3' HG23 ' B' 1295 ' ' THR . . . -94.48 62.44 1.71 Allowed Glycine 0 C--O 1.245 0.839 0 N-CA-C 110.825 -0.91 . . . . 26.53 110.825 -178.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1312 ' ' TYR . . . . . 0.497 ' O ' ' HG ' ' B' 1315 ' ' LEU . 5.5 m-85 -83.0 99.27 9.73 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 124.02 1.866 . . . . 38.0 111.732 -176.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1313 ' ' THR . . . . . 0.895 HG23 ' HB3' ' B' 1287 ' ' GLN . 26.9 m -51.76 -37.87 53.1 Favored 'General case' 0 C--O 1.255 1.365 0 C-N-CA 126.006 1.722 . . . . 29.8 113.226 170.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1314 ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -81.09 17.57 1.22 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 116.292 1.96 . . . . 39.04 116.292 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1315 ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' B' 1312 ' ' TYR . 42.9 mt -45.51 -46.76 36.27 Favored Pre-proline 0 C--O 1.254 1.323 0 N-CA-C 117.214 2.301 . . . . 31.08 117.214 174.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1316 ' ' PRO . . . . . 0.417 ' HA ' ' CG2' ' B' 1136 ' ' ILE . 52.5 Cg_exo -61.5 -33.03 88.55 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.244 2.629 . . . . 26.1 115.19 167.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1317 ' ' GLY . . . . . . . . . . . . . . . -70.51 -40.69 67.49 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 118.447 -1.835 . . . . 23.17 112.608 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1318 ' ' ARG . . . . . 0.415 ' HD3' ' OE2' ' B' 1144 ' ' GLU . 94.0 mtt-85 -60.84 -2.74 0.6 Allowed 'General case' 0 C--O 1.246 0.894 0 N-CA-C 118.384 2.735 . . . . 40.4 118.384 -174.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1319 ' ' LEU . . . . . 0.468 HD23 HG23 ' B' 1136 ' ' ILE . 3.3 tp -120.52 58.41 6.26 Favored Pre-proline 0 C--N 1.327 -0.38 0 O-C-N 118.843 -2.411 . . . . 23.6 107.003 -176.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1320 ' ' PRO . . . . . 0.775 ' HB2' ' HA ' ' B' 1043 ' ' ALA . 84.9 Cg_endo -54.19 -60.93 0.49 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 124.429 3.419 . . . . 22.35 117.588 -152.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1321 ' ' THR . . . . . 0.479 ' OG1' ' HA3' ' A' 1150 ' ' GLY . 1.3 m -57.03 -49.81 74.67 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.504 1.502 . . . . 26.52 111.375 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1322 ' ' GLN . . . . . 0.962 ' HB2' ' HA ' ' A' 1151 ' ' ARG . 39.1 tp60 -73.26 -33.81 65.47 Favored 'General case' 0 N--CA 1.435 -1.223 0 O-C-N 122.15 -0.344 . . . . 24.38 110.903 -172.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1323 ' ' SER . . . . . . . . . . . . . 68.3 m -57.84 -46.57 84.56 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 123.702 0.801 . . . . 22.8 112.488 165.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1324 ' ' SER . . . . . . . . . . . . . 15.7 m -69.48 -30.74 68.69 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 120.24 -1.538 . . . . 21.25 110.416 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1325 ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -73.64 -36.54 65.43 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 121.093 1.77 . . . . 31.34 108.692 176.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1326 ' ' LEU . . . . . 0.66 ' HB3' ' HB3' ' B' 1132 ' ' SER . 11.3 mt -70.92 -58.21 3.81 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.871 1.669 . . . . 31.56 108.346 -175.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1327 ' ' TYR . . . . . 0.493 ' O ' ' HB2' ' B' 1330 ' ' ASN . 12.4 t80 -52.63 -45.25 66.55 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 125.44 1.496 . . . . 22.73 110.747 173.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1328 ' ' GLY . . . . . 0.563 ' O ' HG23 ' B' 1332 ' ' VAL . . . -51.87 -50.98 41.97 Favored Glycine 0 C--O 1.249 1.08 0 CA-C-O 118.951 -0.916 . . . . 21.91 111.552 170.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1329 ' ' THR . . . . . . . . . . . . . 8.5 m -66.87 -28.62 68.48 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 121.4 2.6 . . . . 22.15 109.377 -177.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1330 ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' B' 1327 ' ' TYR . 10.1 m120 -60.86 -50.17 74.5 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.312 -0.868 . . . . 26.18 110.649 174.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1331 ' ' LEU . . . . . 0.706 HD22 HD22 ' B' 1070 ' ' LEU . 18.7 mt -60.22 -36.76 78.42 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 126.904 2.081 . . . . 23.68 112.123 174.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1332 ' ' VAL . . . . . 0.563 HG23 ' O ' ' B' 1328 ' ' GLY . 20.9 t -65.15 -48.7 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 N-CA-C 107.301 -1.37 . . . . 26.57 107.301 175.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1333 ' ' ASN . . . . . 0.676 ' HA ' ' HD2' ' B' 1336 ' ' LYS . 62.8 m-20 -59.63 -47.75 84.38 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 109.641 -0.503 . . . . 28.08 109.641 -174.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1334 ' ' LEU . . . . . 0.691 HD21 ' SD ' ' B' 1113 ' ' MET . 6.1 tt -56.25 -50.82 70.24 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 113.486 0.921 . . . . 27.43 113.486 170.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1335 ' ' LEU . . . . . 0.443 HD11 HD21 ' B' 1070 ' ' LEU . 93.0 mt -64.88 -16.89 63.78 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 114.96 1.466 . . . . 30.5 114.96 177.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1336 ' ' LYS . . . . . 0.676 ' HD2' ' HA ' ' B' 1333 ' ' ASN . 86.8 mttt -72.6 -46.28 55.01 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 120.256 1.389 . . . . 41.65 107.292 170.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1337 ' ' LEU . . . . . . . . . . . . . 11.6 tp -64.63 -32.88 74.74 Favored 'General case' 0 N--CA 1.441 -0.91 0 O-C-N 120.329 -1.482 . . . . 42.08 110.731 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1338 ' ' LEU . . . . . 0.683 HD13 HG23 ' B' 1346 ' ' ILE . 24.2 mt -73.2 -47.01 47.07 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 118.896 -0.573 . . . . 35.03 110.289 168.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1339 ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' B' 1344 ' ' GLY . 0.5 OUTLIER -88.3 81.95 7.17 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 121.522 1.964 . . . . 37.33 109.328 -175.171 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B 1340 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -27.56 66.85 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.7 -1.136 . . . . 50.51 112.207 -160.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1341 ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -117.14 18.18 14.62 Favored 'General case' 0 C--O 1.242 0.703 0 O-C-N 123.949 0.781 . . . . 54.21 110.831 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1342 ' ' LYS . . . . . 0.489 ' HG2' HD23 ' B' 1029 ' ' LEU . 49.0 mttp 49.09 59.42 4.47 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 124.572 2.129 . . . . 50.99 109.303 -166.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1343 ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -127.67 31.58 5.13 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 111.683 -2.508 . . . . 48.82 111.083 -165.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1344 ' ' GLY . . . . . 0.528 ' N ' ' SG ' ' B' 1339 ' ' CYS . . . 47.3 24.07 2.19 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 116.912 1.525 . . . . 40.43 116.912 175.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1345 ' ' ASN . . . . . . . . . . . . . 40.0 t30 -127.28 151.12 49.15 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.775 -1.194 . . . . 47.56 107.775 -169.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1346 ' ' ILE . . . . . 0.683 HG23 HD13 ' B' 1338 ' ' LEU . 32.9 mm -100.24 86.65 1.26 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 105.012 -2.218 . . . . 42.49 105.012 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1347 ' ' THR . . . . . . . . . . . . . 33.2 p -87.34 102.48 14.56 Favored 'General case' 0 C--O 1.241 0.632 0 O-C-N 118.157 -2.839 . . . . 38.12 109.839 164.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1348 ' ' VAL . . . . . 0.595 HG23 HG22 ' B' 1346 ' ' ILE . 61.0 t -90.84 111.89 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 107.094 -1.447 . . . . 37.5 107.094 -177.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1349 ' ' ASP . . . . . . . . . . . . . 23.6 t70 -97.69 127.92 44.0 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 106.051 -1.833 . . . . 43.85 106.051 172.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1350 ' ' PHE . . . . . 0.434 ' CE1' ' HB ' ' B' 1359 ' ' THR . 0.3 OUTLIER -97.62 -0.12 46.27 Favored 'General case' 0 C--O 1.257 1.476 0 O-C-N 119.92 -1.737 . . . . 39.81 114.016 175.356 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B 1351 ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -73.17 -37.21 66.63 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 121.441 1.928 . . . . 51.29 109.122 176.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1352 ' ' ASP . . . . . . . . . . . . . 22.1 t0 -54.66 118.3 4.09 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 119.754 -0.779 . . . . 39.78 110.754 167.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1353 ' ' VAL . . . . . 0.41 ' HA ' ' HB3' ' B' 1356 ' ' ARG . 33.9 m -55.93 -31.18 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 O-C-N 123.868 0.73 . . . . 39.28 112.843 176.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1354 ' ' VAL . . . . . 0.462 ' O ' HG12 ' B' 1358 ' ' VAL . 83.7 t -70.37 -51.73 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 N-CA-C 106.637 -1.616 . . . . 35.7 106.637 -177.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1355 ' ' ILE . . . . . 0.6 ' HA ' HG12 ' B' 1358 ' ' VAL . 50.4 mm -62.27 -46.02 97.4 Favored 'Isoleucine or valine' 0 C--N 1.359 0.99 0 CA-C-N 121.82 2.1 . . . . 35.77 113.464 173.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1356 ' ' ARG . . . . . 0.41 ' HB3' ' HA ' ' B' 1353 ' ' VAL . 49.5 tpt85 -49.73 -33.63 16.7 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 114.505 1.298 . . . . 38.55 114.505 171.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1357 ' ' GLY . . . . . . . . . . . . . . . -83.71 -54.16 3.17 Favored Glycine 0 C--N 1.343 0.963 0 N-CA-C 109.454 -1.458 . . . . 29.58 109.454 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1358 ' ' VAL . . . . . 0.6 HG12 ' HA ' ' B' 1355 ' ' ILE . 14.8 p -62.95 -42.54 96.98 Favored 'Isoleucine or valine' 0 C--O 1.256 1.413 0 CA-C-O 121.916 0.865 . . . . 32.06 112.531 -173.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1359 ' ' THR . . . . . 0.434 ' HB ' ' CE1' ' B' 1350 ' ' PHE . 3.6 m -83.83 81.96 8.54 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 124.13 1.919 . . . . 29.0 109.42 -174.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1360 ' ' VAL . . . . . . . . . . . . . 10.0 m -71.23 -16.98 19.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 113.022 -1.899 . . . . 29.68 113.907 -173.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1361 ' ' ILE . . . . . . . . . . . . . 57.7 mt -134.98 110.22 12.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 N-CA-C 107.041 -1.466 . . . . 32.05 107.041 170.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1362 ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -98.74 110.43 23.03 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 104.99 -2.226 . . . . 32.52 104.99 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1363 ' ' ALA . . . . . . . . . . . . . . . 48.26 60.77 3.39 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 112.922 -1.944 . . . . 35.68 113.528 172.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1364 ' ' GLY . . . . . . . . . . . . . . . 83.58 -46.24 3.61 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 115.495 0.958 . . . . 34.26 115.495 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1365 ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -64.62 124.56 22.21 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 119.277 -0.969 . . . . 51.07 111.802 172.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1366 ' ' ILE . . . . . . . . . . . . . 69.7 mt -78.47 118.08 25.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 N-CA-C 103.265 -2.865 . . . . 39.87 103.265 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1367 ' ' THR . . . . . . . . . . . . . 1.4 p -107.03 11.57 29.56 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 113.883 -1.508 . . . . 38.01 112.039 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1368 ' ' TRP . . . . . . . . . . . . . 20.7 t90 -82.74 131.96 53.08 Favored Pre-proline 0 C--O 1.241 0.657 0 N-CA-C 103.531 -2.766 . . . . 42.14 103.531 164.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1369 ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -82.23 171.89 53.15 Favored 'Cis proline' 0 C--N 1.353 0.812 0 N-CA-C 116.805 1.81 . . . . 43.26 116.805 -2.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1370 ' ' ALA . . . . . 0.408 ' HA ' ' HD2' ' B' 1371 ' ' PRO . . . -113.74 130.14 24.07 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 105.712 -1.958 . . . . 46.52 105.712 173.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1371 ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' B' 1370 ' ' ALA . 37.8 Cg_endo -62.73 106.36 0.51 Allowed 'Trans proline' 0 CA--C 1.552 1.419 0 C-N-CA 123.384 2.723 . . . . 51.95 108.671 173.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1372 ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -65.66 140.56 62.68 Favored 'Trans proline' 0 N--CA 1.441 -1.579 0 C-N-CA 123.584 2.856 . . . . 56.27 119.118 -170.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1373 ' ' ILE . . . . . 0.466 HD13 HD13 ' B' 1121 ' ' ILE . 14.9 tt -74.61 145.67 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 113.902 -1.499 . . . . 60.83 108.02 170.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1374 ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -65.83 108.9 2.29 Favored 'General case' 0 C--N 1.317 -0.845 0 O-C-N 120.91 -1.119 . . . . 66.1 110.054 176.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1375 ' ' VAL . . . . . 0.752 HG11 ' HB2' ' B' 1120 ' ' ARG . 76.9 t -102.01 108.86 24.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 106.082 -1.822 . . . . 63.47 106.082 -169.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1376 ' ' SER . . . . . . . . . . . . . . . . . . . . 1 C--N 1.23 -4.619 0 O-C-N 120.601 -1.312 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 20' ' ' ALA . . . . . 0.585 ' HA ' HD21 ' C' ' 171' ' ' LEU . . . . . . . . 0 C--O 1.253 1.274 0 CA-C-O 121.637 0.732 . . . . 0.0 112.4 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -58.09 -28.01 64.21 Favored 'General case' 0 C--O 1.251 1.162 0 O-C-N 119.141 -2.225 . . . . 0.0 114.1 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 22' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -66.08 -53.25 40.47 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 176.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 23' ' ' THR . . . . . 0.464 ' HA ' ' HB2' ' C' ' 26' ' ' LEU . 29.2 m -56.33 -34.11 66.27 Favored 'General case' 0 C--O 1.209 -1.064 0 C-N-CA 126.043 1.737 . . . . 0.0 112.516 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 24' ' ' ALA . . . . . 0.624 ' HB2' HG22 ' C' ' 182' ' ' ILE . . . -62.32 -36.82 83.35 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.59 0.756 . . . . 0.0 112.089 174.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.78 -50.12 16.15 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.917 171.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.464 ' HB2' ' HA ' ' C' ' 23' ' ' THR . 0.2 OUTLIER -52.3 -43.62 64.58 Favored 'General case' 0 C--O 1.213 -0.867 0 C-N-CA 126.239 1.816 . . . . 0.0 113.175 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.558 HD21 HD21 ' C' ' 110' ' ' LEU . 81.1 mt -60.16 -51.23 70.49 Favored 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 118.63 -2.544 . . . . 0.0 115.315 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 28' ' ' LYS . . . . . 0.435 ' HZ2' ' C ' ' C' ' 186' ' ' LEU . 18.5 pttm -67.66 -17.41 64.58 Favored 'General case' 0 CA--C 1.555 1.169 0 O-C-N 121.113 -0.992 . . . . 0.0 110.022 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 29' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -75.21 -46.85 31.31 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 119.746 1.157 . . . . 0.0 111.048 164.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 38.9 m -50.28 -35.52 27.53 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 121.229 3.788 . . . . 0.0 121.229 -163.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 31' ' ' HIS . . . . . 0.488 ' HA ' HG12 ' C' ' 62' ' ' ILE 0.4 3.7 p-80 54.32 -38.86 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 119.121 3.008 . . . . 0.0 119.121 -170.477 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 32' ' ' SER . . . . . 0.69 ' HB2' ' HA ' ' C' ' 106' ' ' THR . 17.7 m -123.99 133.61 53.65 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 103.019 -2.956 . . . . 0.0 103.019 169.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 64.3 t -131.7 125.17 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 -174.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.629 HG21 ' HE1' ' C' ' 103' ' ' PHE . 34.4 mm -102.97 128.94 55.43 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 N-CA-C 103.467 -2.79 . . . . 0.0 103.467 172.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 31.8 mt -103.59 117.5 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 172.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 36' ' ' THR . . . . . 0.423 HG21 HG11 ' C' ' 118' ' ' VAL . 93.2 m -111.24 92.42 15.71 Favored Pre-proline 0 C--N 1.347 0.485 0 C-N-CA 124.255 1.022 . . . . 0.0 109.294 176.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . 0.853 ' HD2' HG12 ' C' ' 68' ' ' ILE . 90.2 Cg_exo -78.7 154.88 27.09 Favored 'Trans proline' 0 C--O 1.246 0.911 0 C-N-CA 123.614 2.876 . . . . 0.0 112.856 169.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 38' ' ' GLY . . . . . 0.557 ' HA3' ' HA ' ' C' ' 114' ' ' ALA . . . -150.77 -143.78 3.79 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 109.766 -3.379 . . . . 0.0 105.096 174.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -61.34 -34.49 75.36 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 117.393 -1.289 . . . . 0.0 113.449 -168.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 40' ' ' GLY . . . . . 0.474 ' HA3' ' HA3' ' C' ' 113' ' ' GLY . . . -57.08 -32.55 63.01 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-O 116.528 -2.262 . . . . 0.0 112.474 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 32.8 ttm -75.82 -26.13 56.94 Favored 'General case' 0 C--O 1.253 1.266 0 CA-C-N 119.556 1.678 . . . . 0.0 111.294 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.68 -38.82 58.39 Favored 'General case' 0 C--O 1.221 -0.443 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.274 175.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 59.9 t -74.95 -66.08 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 O-C-N 121.215 -0.928 . . . . 0.0 110.495 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . 0.597 ' HB2' H62A ' C' 1001 ' ' NAP . . . -91.04 113.51 25.79 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 174.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 45' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -72.0 79.5 0.92 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 124.514 2.102 . . . . 0.0 110.265 -169.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.41 -6.13 22.92 Favored 'General case' 0 C--O 1.239 0.534 0 O-C-N 120.332 -1.48 . . . . 0.0 112.974 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . 0.656 ' HG2' ' HB3' ' C' ' 82' ' ' LEU . 0.0 OUTLIER -76.21 -41.81 48.19 Favored 'General case' 0 C--O 1.249 1.05 0 O-C-N 120.155 -1.591 . . . . 0.0 114.235 -159.766 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 48' ' ' TYR . . . . . 0.524 ' CZ ' ' HA ' ' C' ' 86' ' ' ALA . 61.6 m-85 -61.34 -43.74 90.63 Favored Pre-proline 0 CA--C 1.55 0.971 0 O-C-N 119.964 -1.71 . . . . 0.0 113.352 168.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 49' ' ' PRO . . . . . 0.42 ' HA ' ' HB2' ' C' ' 52' ' ' GLU . 11.6 Cg_exo -54.34 -41.44 76.44 Favored 'Trans proline' 0 C--N 1.351 0.696 0 CA-C-N 124.069 2.489 . . . . 0.0 116.536 165.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 48.6 t -60.87 -41.58 89.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 O-C-N 119.971 -1.706 . . . . 0.0 112.509 175.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . 0.449 ' HB2' HG22 ' C' ' 88' ' ' VAL . . . -63.08 -33.72 76.05 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 171.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 52' ' ' GLU . . . . . 0.636 ' HB3' ' HB2' ' C' ' 183' ' ' LEU . 1.5 mm-40 -67.09 -39.41 86.76 Favored 'General case' 0 C--N 1.351 0.638 0 CA-C-O 118.284 -0.865 . . . . 0.0 113.277 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 10.2 tp -76.04 -37.27 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.718 0 CA-C-N 119.775 1.171 . . . . 0.0 110.429 175.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 26.1 m -64.78 -37.53 87.91 Favored 'General case' 0 C--O 1.244 0.814 0 O-C-N 120.219 -1.55 . . . . 0.0 112.889 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . 0.447 ' HB3' ' O ' ' C' ' 52' ' ' GLU . 8.1 tp10 -34.12 -43.36 0.15 Allowed 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 126.808 2.043 . . . . 0.0 112.858 159.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -87.95 -44.57 10.93 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 120.254 1.388 . . . . 0.0 109.92 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 74.8 mt -62.91 -48.74 77.65 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 121.017 -1.052 . . . . 0.0 111.309 -167.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -72.38 -34.51 68.0 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 121.334 1.879 . . . . 0.0 108.901 -171.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.28 -19.42 54.87 Favored 'General case' 0 C--N 1.345 0.384 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 166.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' C' ' 60' ' ' ARG . 28.8 ttm-85 -94.35 14.14 21.4 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-O 120.96 0.409 . . . . 0.0 110.557 173.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.48 22.89 66.2 Favored Glycine 0 C--O 1.24 0.52 0 O-C-N 120.647 -1.283 . . . . 0.0 114.425 -177.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . 0.488 HG12 ' HA ' ' C' ' 31' ' ' HIS . 15.0 mt -76.66 119.93 25.9 Favored 'Isoleucine or valine' 0 C--O 1.254 1.298 0 CA-C-O 122.062 0.934 . . . . 0.0 113.191 177.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 63' ' ' ASN . . . . . 0.433 ' O ' ' HA ' ' C' ' 32' ' ' SER . 12.0 t30 -63.23 84.66 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.561 0 CA-C-O 123.935 1.826 . . . . 0.0 106.285 171.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.478 ' O ' HD12 ' C' ' 92' ' ' ILE . 9.2 p -100.51 135.08 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 65' ' ' ARG . . . . . . . . . . . . . 5.1 mmm-85 -137.84 140.06 40.26 Favored 'General case' 0 C--O 1.253 1.281 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . 0.601 ' HB2' HG22 ' C' ' 93' ' ' VAL . 33.4 m-85 -101.44 84.05 2.54 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -176.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.95 69.42 2.68 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.399 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 68' ' ' ILE . . . . . 0.853 HG12 ' HD2' ' C' ' 37' ' ' PRO . 10.1 mt -70.07 142.3 16.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 120.763 -1.433 . . . . 0.0 112.772 -174.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 69' ' ' HIS . . . . . 0.426 ' HA ' ' HD3' ' C' ' 70' ' ' PRO . 20.5 t-80 -114.66 89.59 19.17 Favored Pre-proline 0 N--CA 1.475 0.794 0 O-C-N 120.277 -1.514 . . . . 0.0 107.054 176.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 70' ' ' PRO . . . . . 0.718 ' HG2' HG12 ' A' 1157 ' ' ILE . 51.2 Cg_exo -61.84 -53.09 2.36 Favored 'Trans proline' 0 CA--C 1.513 -0.575 1 C-N-CA 125.504 4.136 . . . . 0.0 117.919 -163.126 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 71' ' ' VAL . . . . . 0.417 HG21 ' HB2' ' A' 1159 ' ' ALA . 51.8 t -67.26 104.79 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 168.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -171.89 119.26 0.43 Allowed 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 113.121 -1.854 . . . . 0.0 106.374 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.87 -97.82 2.08 Favored Glycine 0 C--O 1.213 -1.161 0 O-C-N 120.209 -1.557 . . . . 0.0 112.115 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . 0.706 ' NH2' ' HB2' ' B' 1199 ' ' GLU . 1.9 mpt_? -149.17 171.22 16.8 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 103.384 -2.821 . . . . 0.0 103.384 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.513 ' HA ' ' HD2' ' C' ' 76' ' ' PRO 0.268 33.0 mt 60.43 103.59 0.03 OUTLIER Pre-proline 0 C--O 1.236 0.385 0 N-CA-C 117.21 2.3 . . . . 0.0 117.21 -175.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 76' ' ' PRO . . . . . 0.513 ' HD2' ' HA ' ' C' ' 75' ' ' LEU . 72.9 Cg_endo -63.53 90.16 0.15 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.891 2.394 . . . . 0.0 112.137 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.08 -7.64 62.87 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-O 116.125 -2.486 . . . . 0.0 115.507 175.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -51.29 -28.01 10.88 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 123.733 3.766 . . . . 0.0 119.592 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 79' ' ' MET . . . . . 0.716 ' HA ' HD12 ' C' ' 82' ' ' LEU . 0.7 OUTLIER -58.52 -32.27 68.69 Favored 'General case' 0 C--O 1.243 0.757 0 O-C-N 118.925 -2.359 . . . . 0.0 113.748 169.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -66.88 -37.79 85.07 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 122.586 0.354 . . . . 0.0 111.054 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' 1155 ' ' GLY . 92.9 t -68.74 -42.76 83.12 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.718 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.383 -175.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.716 HD12 ' HA ' ' C' ' 79' ' ' MET . 34.9 mt -53.56 -41.55 66.59 Favored 'General case' 0 C--N 1.35 0.619 0 C-N-CA 125.319 1.448 . . . . 0.0 113.144 170.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 21.4 tp -65.24 -46.4 80.74 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.181 0.991 . . . . 0.0 110.379 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.44 -35.26 77.08 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-O 118.107 -0.949 . . . . 0.0 112.38 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 85' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -64.51 -43.88 92.67 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.597 0.561 . . . . 0.0 112.283 173.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . 0.524 ' HA ' ' CZ ' ' C' ' 48' ' ' TYR . . . -54.35 -3.31 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 119.131 3.011 . . . . 0.0 119.131 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 87' ' ' LYS . . . . . 0.429 ' HA ' ' HD3' ' C' ' 87' ' ' LYS . 31.7 mmtp 60.3 65.9 1.02 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 125.278 2.466 . . . . 0.0 112.184 -175.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 88' ' ' VAL . . . . . 0.449 HG22 ' HB2' ' C' ' 51' ' ' ALA . 87.0 t -115.29 149.96 43.65 Favored Pre-proline 0 N--CA 1.481 1.1 0 CA-C-N 108.748 -3.842 . . . . 0.0 104.208 -178.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -55.94 76.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.476 0.47 1 C-N-CA 127.178 5.252 . . . . 0.0 113.823 164.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -60.4 -30.24 69.47 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 113.062 -1.881 . . . . 0.0 107.004 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 91' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -39.02 -39.76 0.59 Allowed 'General case' 0 C--N 1.354 0.763 0 CA-C-O 116.359 -1.781 . . . . 0.0 115.436 168.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 92' ' ' ILE . . . . . 0.478 HD12 ' O ' ' C' ' 64' ' ' VAL . 2.3 pt -107.52 24.92 2.59 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 CA-C-O 124.034 1.873 . . . . 0.0 111.881 -176.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . 0.601 HG22 ' HB2' ' C' ' 66' ' ' PHE . 53.4 t -87.52 128.68 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 O-C-N 120.623 -1.298 . . . . 0.0 109.304 174.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . 0.59 HD23 ' HB3' ' C' ' 97' ' ' ASP . 4.7 mp -117.36 83.45 1.99 Allowed 'General case' 0 C--O 1.259 1.58 0 CA-C-O 123.644 1.688 . . . . 0.0 110.495 172.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -75.94 111.8 11.7 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 119.876 -1.765 . . . . 0.0 106.729 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.51 ' HA ' HD11 ' C' ' 136' ' ' LEU . 0.9 OUTLIER 68.35 -9.08 0.54 Allowed 'General case' 0 C--O 1.251 1.182 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 173.038 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 97' ' ' ASP . . . . . 0.59 ' HB3' HD23 ' C' ' 94' ' ' LEU . 3.3 t70 -68.09 -177.01 0.78 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 118.109 -0.948 . . . . 0.0 113.089 175.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -77.22 57.84 1.51 Allowed 'General case' 0 C--O 1.24 0.603 0 CA-C-O 125.627 2.632 . . . . 0.0 117.168 -171.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 8.6 tp -77.75 -2.52 4.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 O-C-N 119.174 -2.204 . . . . 0.0 111.334 173.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . 0.423 ' HA ' ' CD2' ' C' ' 103' ' ' PHE . 23.1 t-20 -57.79 -45.33 86.18 Favored 'General case' 0 C--N 1.354 0.768 0 O-C-N 121.292 -0.88 . . . . 0.0 113.226 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 101' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -57.05 -43.19 81.74 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 122.936 1.35 . . . . 0.0 113.87 174.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -68.42 -24.32 64.73 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.853 -175.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 103' ' ' PHE . . . . . 0.629 ' HE1' HG21 ' C' ' 34' ' ' ILE . 22.0 m-30 -53.67 -43.48 68.89 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 116.078 -1.915 . . . . 0.0 111.23 167.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.7 -45.73 88.69 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 121.128 1.785 . . . . 0.0 111.066 173.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -57.26 -31.41 65.55 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 106' ' ' THR . . . . . 0.69 ' HA ' ' HB2' ' C' ' 32' ' ' SER . 10.2 m -79.11 159.34 27.52 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-N 113.414 -1.721 . . . . 0.0 113.143 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 107' ' ' ASP . . . . . 0.531 ' HA ' ' HB2' ' C' ' 142' ' ' GLN . 1.8 t70 -99.98 -84.76 0.41 Allowed 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 165.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' C' ' 143' ' ' ASN . 57.2 m -79.01 111.44 15.21 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 125.307 2.48 . . . . 0.0 116.535 178.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 109' ' ' VAL . . . . . 0.774 HG11 HG21 ' C' ' 138' ' ' VAL . 21.0 t -90.3 105.61 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 112.208 -2.269 . . . . 0.0 107.857 174.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 110' ' ' LEU . . . . . 0.558 HD21 HD21 ' C' ' 27' ' ' LEU . 15.4 mt -71.55 87.79 0.91 Allowed 'General case' 0 C--O 1.25 1.125 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 173.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 111' ' ' VAL . . . . . 0.647 ' HB ' ' HA ' ' C' ' 146' ' ' VAL . 89.9 t -82.29 83.07 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 O-C-N 120.277 -1.514 . . . . 0.0 109.862 178.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 112' ' ' ILE . . . . . 0.534 ' HA ' ' HB2' ' C' ' 147' ' ' PHE . 56.0 mt -82.53 92.54 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 123.31 1.528 . . . . 0.0 110.185 -175.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 113' ' ' GLY . . . . . 0.474 ' HA3' ' HA3' ' C' ' 40' ' ' GLY . . . 57.95 29.61 62.32 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 110.513 -3.04 . . . . 0.0 113.681 175.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 114' ' ' ALA . . . . . 0.597 ' HB3' HG13 ' C' ' 111' ' ' VAL . . . -82.66 -28.84 30.41 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 118.485 -1.286 . . . . 0.0 112.322 173.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 115' ' ' ASN . . . . . 0.597 ' ND2' ' H ' ' C' ' 116' ' ' ASP . 6.2 t30 64.93 -163.26 0.26 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 116.377 -1.773 . . . . 0.0 112.564 161.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 116' ' ' ASP . . . . . 0.597 ' H ' ' ND2' ' C' ' 115' ' ' ASN . 1.9 p30 -51.99 -14.48 0.4 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 125.31 3.687 . . . . 0.0 116.881 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 117' ' ' THR . . . . . 0.414 HG22 ' CE1' ' C' ' 69' ' ' HIS . 1.3 m -63.64 -14.07 48.37 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 169.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.564 ' HB ' HG12 ' C' ' 138' ' ' VAL . 21.3 m -106.55 12.96 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 117.242 -3.411 . . . . 0.0 112.871 167.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 119' ' ' ASN . . . . . 0.519 ' HB3' ' HA ' ' C' ' 116' ' ' ASP . 0.1 OUTLIER -102.15 131.81 22.22 Favored Pre-proline 0 N--CA 1.478 0.961 0 O-C-N 118.904 -2.372 . . . . 0.0 114.392 -166.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 120' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -50.89 -40.01 58.22 Favored 'Trans proline' 0 C--O 1.242 0.707 0 C-N-CA 123.939 3.093 . . . . 0.0 113.869 -178.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 121' ' ' ALA . . . . . 0.758 ' HA ' ' HB3' ' C' ' 124' ' ' ASP . . . -58.87 -14.28 8.58 Favored 'General case' 0 C--O 1.208 -1.092 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 -167.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 122' ' ' ALA . . . . . 0.614 ' HB3' ' HB2' ' C' ' 133' ' ' MET . . . -58.98 -37.97 78.04 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 119.241 -2.162 . . . . 0.0 112.365 170.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 123' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -95.02 -41.38 9.17 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.369 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 124' ' ' ASP . . . . . 0.758 ' HB3' ' HA ' ' C' ' 121' ' ' ALA . 26.4 t70 -67.77 -46.88 70.77 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 124.305 1.042 . . . . 0.0 111.129 -170.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -108.55 94.85 14.74 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 120.272 1.396 . . . . 0.0 109.264 172.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 126' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -49.58 -15.43 0.96 Allowed 'Trans proline' 0 C--O 1.257 1.451 1 C-N-CA 125.677 4.251 . . . . 0.0 112.362 172.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -68.06 -32.62 73.09 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 118.654 -2.528 . . . . 0.0 109.177 176.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 128' ' ' SER . . . . . 0.426 ' HA ' ' HD2' ' C' ' 129' ' ' PRO . 44.6 m -53.44 123.01 34.59 Favored Pre-proline 0 N--CA 1.449 -0.501 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 129' ' ' PRO . . . . . 0.558 ' HG2' ' HA ' ' C' ' 156' ' ' ALA . 34.8 Cg_endo -52.18 -39.72 70.78 Favored 'Trans proline' 0 N--CA 1.435 -1.93 1 C-N-CA 125.701 4.267 . . . . 0.0 115.076 -178.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 130' ' ' ILE . . . . . 0.722 HG12 ' HB2' ' C' ' 156' ' ' ALA . 28.4 pt -78.11 130.6 36.0 Favored 'Isoleucine or valine' 0 C--O 1.252 1.205 0 CA-C-N 120.615 1.552 . . . . 0.0 110.931 170.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 131' ' ' ALA . . . . . 0.526 ' O ' ' HB ' ' B' 1121 ' ' ILE . . . -108.8 124.95 51.41 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-O 122.698 1.237 . . . . 0.0 113.396 -174.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.03 134.14 2.59 Favored Glycine 0 N--CA 1.474 1.225 0 CA-C-N 113.482 -1.69 . . . . 0.0 112.353 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 133' ' ' MET . . . . . 0.614 ' HB2' ' HB3' ' C' ' 122' ' ' ALA . 34.0 tpp -129.25 131.73 23.85 Favored Pre-proline 0 CA--C 1.506 -0.717 0 N-CA-C 104.932 -2.247 . . . . 0.0 104.932 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 134' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' C' ' 133' ' ' MET . 56.7 Cg_endo -57.54 149.93 63.7 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.748 2.299 . . . . 0.0 113.178 165.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 3.2 m -64.08 5.96 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.052 0 N-CA-C 119.054 2.983 . . . . 0.0 119.054 -168.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.51 HD11 ' HA ' ' C' ' 96' ' ' MET . 27.6 mt -80.77 52.49 1.72 Allowed 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 120.193 -1.567 . . . . 0.0 110.199 171.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -82.22 96.37 7.84 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 -177.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 138' ' ' VAL . . . . . 0.774 HG21 HG11 ' C' ' 109' ' ' VAL . 13.4 p -94.12 77.89 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 113.475 -1.693 . . . . 0.0 109.294 -171.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 139' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -131.79 165.76 23.07 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 173.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 140' ' ' LYS . . . . . . . . . . . . 0.29 0.8 OUTLIER 61.9 -24.01 0.05 OUTLIER 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 126.708 2.003 . . . . 0.0 113.777 173.79 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . -52.51 153.91 2.83 Favored 'General case' 0 C--O 1.252 1.234 0 CA-C-N 123.017 2.644 . . . . 0.0 116.409 163.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.531 ' HB2' ' HA ' ' C' ' 107' ' ' ASP . 8.8 mm100 -35.67 -44.69 0.33 Allowed 'General case' 0 C--N 1.354 0.8 0 N-CA-C 120.147 3.388 . . . . 0.0 120.147 -160.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 143' ' ' ASN . . . . . 0.52 ' O ' ' HA ' ' C' ' 108' ' ' THR . 19.2 t-20 -157.56 93.79 1.32 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 122.643 1.211 . . . . 0.0 112.967 162.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 144' ' ' VAL . . . . . 0.572 ' HB ' HG23 ' C' ' 168' ' ' THR . 90.2 t -87.67 104.27 14.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 103.923 -2.621 . . . . 0.0 103.923 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 145' ' ' ILE . . . . . 0.696 HG13 ' HB2' ' C' ' 171' ' ' LEU . 3.7 tp -101.73 104.81 16.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 123.696 1.712 . . . . 0.0 111.748 -177.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 146' ' ' VAL . . . . . 0.647 ' HA ' ' HB ' ' C' ' 111' ' ' VAL . 27.2 t -91.51 98.83 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 O-C-N 119.658 -1.901 . . . . 0.0 109.453 -169.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 147' ' ' PHE . . . . . 0.534 ' HB2' ' HA ' ' C' ' 112' ' ' ILE . 9.3 m-85 -67.95 115.3 7.31 Favored 'General case' 0 C--O 1.249 1.079 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 148' ' ' LYS . . . . . 0.591 ' HE3' ' O2B' ' C' 1001 ' ' NAP . 77.1 tttt -155.5 137.09 14.2 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 149' ' ' ARG . . . . . 0.498 HH11 ' HG2' ' C' ' 149' ' ' ARG . 7.3 tpp85 -48.41 -60.65 2.51 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 110.633 -2.985 . . . . 0.0 113.924 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 150' ' ' SER . . . . . . . . . . . . . 8.0 m -133.7 159.75 39.6 Favored 'General case' 0 CA--C 1.552 1.022 0 O-C-N 119.977 -1.702 . . . . 0.0 112.865 -171.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 151' ' ' MET . . . . . . . . . . . . . 10.7 tpt -67.51 93.81 0.37 Allowed 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 168.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -155.99 160.38 40.01 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.178 0.991 . . . . 0.0 109.259 -176.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 153' ' ' THR . . . . . 0.593 HG23 ' HA3' ' C' ' 157' ' ' GLY . 8.9 m -62.86 161.33 12.93 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.94 0.896 . . . . 0.0 112.997 175.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 154' ' ' GLY . . . . . 0.574 ' HA3' ' ND2' ' C' ' 115' ' ' ASN . . . -106.8 -92.35 2.26 Favored Glycine 0 CA--C 1.508 -0.382 0 N-CA-C 105.49 -3.044 . . . . 0.0 105.49 153.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 155' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -114.92 -20.11 10.68 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 172.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 156' ' ' ALA . . . . . 0.722 ' HB2' HG12 ' C' ' 130' ' ' ILE . . . -103.32 -81.05 0.51 Allowed 'General case' 0 C--N 1.322 -0.614 0 O-C-N 119.121 -2.237 . . . . 0.0 110.703 168.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 157' ' ' GLY . . . . . 0.593 ' HA3' HG23 ' C' ' 153' ' ' THR . . . 88.71 -61.25 3.83 Favored Glycine 0 C--N 1.347 1.139 0 CA-C-N 121.594 1.997 . . . . 0.0 112.064 168.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 34.0 m -37.34 98.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-O 123.951 1.834 . . . . 0.0 115.465 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 35.72 34.62 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 120.515 3.524 . . . . 0.0 120.515 -174.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 160' ' ' ASN . . . . . 0.424 ' HA ' ' HD2' ' C' ' 161' ' ' PRO . 7.5 m120 -70.75 118.65 67.03 Favored Pre-proline 0 C--N 1.347 0.491 0 CA-C-N 113.193 -1.822 . . . . 0.0 111.075 -170.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 161' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' C' ' 160' ' ' ASN . 34.7 Cg_endo -46.64 -25.95 3.99 Favored 'Trans proline' 0 CA--C 1.509 -0.725 1 C-N-CA 126.007 4.471 . . . . 0.0 117.102 -172.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 162' ' ' LEU . . . . . 0.464 ' HG ' HG21 ' C' ' 146' ' ' VAL . 13.6 tp -50.71 -39.64 52.16 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 125.338 1.455 . . . . 0.0 113.529 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 163' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -84.6 -23.1 29.75 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 118.887 -1.125 . . . . 0.0 108.688 -172.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 164' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -102.67 -34.21 9.14 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 118.246 2.684 . . . . 0.0 118.246 -160.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 165' ' ' LYS . . . . . 0.718 ' HB2' ' HB ' ' C' ' 168' ' ' THR . 63.7 mmtt -57.16 157.57 5.99 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 -175.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 166' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.5 -40.14 96.29 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 167' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -99.21 -22.98 15.38 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 119.292 0.951 . . . . 0.0 111.894 173.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 168' ' ' THR . . . . . 0.718 ' HB ' ' HB2' ' C' ' 165' ' ' LYS . 89.5 m -101.24 93.91 5.68 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 175.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 169' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.91 146.87 36.21 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.07 -1.052 . . . . 0.0 108.73 -171.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 170' ' ' MET . . . . . 0.458 ' SD ' ' HB3' ' C' ' 148' ' ' LYS . 30.8 mtm -62.16 130.49 45.69 Favored 'General case' 0 C--N 1.36 1.056 0 CA-C-O 123.94 1.829 . . . . 0.0 115.123 167.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 171' ' ' LEU . . . . . 0.696 ' HB2' HG13 ' C' ' 145' ' ' ILE . 20.8 tp -92.96 104.25 16.49 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 101.338 -3.578 . . . . 0.0 101.338 167.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 172' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' C' ' 148' ' ' LYS . 97.0 m-85 -72.44 136.32 45.98 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 113.059 -1.882 . . . . 0.0 110.04 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 173' ' ' GLY . . . . . . . . . . . . . . . 128.66 166.64 12.02 Favored Glycine 0 N--CA 1.432 -1.589 0 CA-C-O 124.525 2.18 . . . . 0.0 110.113 -177.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 174' ' ' ASP . . . . . 0.603 ' HB3' ' HB3' ' C' ' 177' ' ' ALA . 16.5 t70 -62.75 149.2 44.54 Favored 'General case' 0 C--O 1.252 1.198 0 CA-C-N 112.197 -2.001 . . . . 0.0 112.902 -177.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 175' ' ' ALA . . . . . 0.493 ' O ' HG23 ' C' ' 179' ' ' VAL . . . -60.93 -53.44 57.27 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 121.421 -0.799 . . . . 0.0 113.02 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 176' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -62.49 -62.94 1.4 Allowed 'General case' 0 C--O 1.217 -0.623 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 177' ' ' ALA . . . . . 0.603 ' HB3' ' HB3' ' C' ' 174' ' ' ASP . . . -51.42 -36.38 43.53 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -176.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 14.7 m -68.6 -39.16 81.0 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 173.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 179' ' ' VAL . . . . . 0.493 HG23 ' O ' ' C' ' 175' ' ' ALA . 5.7 t -74.47 -37.23 43.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 124.041 1.877 . . . . 0.0 109.239 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 180' ' ' ASP . . . . . 0.513 ' O ' ' HG ' ' C' ' 183' ' ' LEU . 16.1 t70 -58.89 -40.77 85.46 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-N 114.299 -1.318 . . . . 0.0 110.67 176.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.04 -29.34 69.67 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.611 175.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 182' ' ' ILE . . . . . 0.624 HG22 ' HB2' ' C' ' 24' ' ' ALA . 19.9 pt -101.07 -16.2 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 -178.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 183' ' ' LEU . . . . . 0.636 ' HB2' ' HB3' ' C' ' 52' ' ' GLU 0.265 2.0 pp -48.29 -35.22 11.8 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 118.981 2.956 . . . . 0.0 118.981 -170.522 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -131.85 -21.21 2.46 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.909 171.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 185' ' ' ALA . . . . . . . . . . . . . . . -88.23 60.24 5.65 Favored 'General case' 0 C--O 1.243 0.747 0 O-C-N 119.869 -1.77 . . . . 0.0 109.546 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 186' ' ' LEU . . . . . 0.467 HD23 ' H ' ' C' ' 186' ' ' LEU . 1.7 pt? . . . . . 0 N--CA 1.436 -1.16 0 CA-C-O 114.698 -2.573 . . . . 0.0 113.962 176.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' NAD . . . . . 0.624 ' H1D' ' HB3' ' B' 1120 ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C 1001 ' ' NAP . . . . . 0.597 H62A ' HB2' ' C' ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_